data_5jtn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5jtn _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.8 m . . . . . 0 CA--C 1.534 0.357 0 N-CA-C 106.942 -1.503 . . . . 75.44 106.942 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -137.32 121.11 17.48 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.752 -1.203 . . . . 73.21 107.752 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -143.02 110.82 5.91 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.157 -0.683 . . . . 70.21 109.157 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.432 HG22 ' HG3' ' C' ' 130' ' ' PRO . 23.9 mt -70.39 114.39 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.317 -0.623 . . . . 73.25 109.317 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -82.18 -39.93 22.47 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.653 0.595 . . . . 70.1 110.206 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -175.06 122.42 0.23 Allowed 'General case' 0 N--CA 1.481 1.098 0 O-C-N 123.608 0.568 . . . . 75.13 110.862 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 97.0 mt -106.21 136.0 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.378 -0.971 . . . . 73.15 108.378 171.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.7 p90 -166.78 164.93 16.54 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 123.843 0.714 . . . . 72.05 111.196 -174.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.3 p -88.33 124.0 33.47 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.77 -0.456 . . . . 74.34 109.77 175.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HE3' ' HB1' ' B' ' 28' ' ' ALA . 38.4 mtpt -90.85 -36.94 13.91 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.891 -0.781 . . . . 73.24 108.891 175.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.713 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 24.7 t70 -138.8 136.84 36.09 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.982 -1.008 . . . . 63.4 109.125 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 76.4 mt -130.88 142.62 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.804 1.242 . . . . 71.32 107.818 173.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.2 t -149.44 116.6 6.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.394 0.678 . . . . 74.22 109.983 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.676 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.1 t80 -122.79 136.69 54.95 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.472 -1.307 . . . . 73.43 107.472 168.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -133.47 129.55 37.37 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.196 0.598 . . . . 73.22 110.088 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.47 69.87 12.65 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 105.852 -1.907 . . . . 75.24 105.852 167.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.07 -16.58 17.83 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.325 2.017 . . . . 62.51 111.124 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -94.71 9.43 38.94 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.651 1.18 . . . . 74.5 110.369 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.66 -58.53 7.4 Favored Pre-proline 0 CA--C 1.569 1.698 0 C-N-CA 124.785 1.234 . . . . 73.25 113.853 -165.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.473 ' HB3' HD11 ' B' ' 51' ' ' LEU . 69.4 Cg_exo -51.85 -44.56 44.17 Favored 'Trans proline' 0 C--N 1.398 3.152 0 C-N-CA 122.715 2.277 . . . . 73.21 113.856 -173.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -96.18 -13.03 23.81 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.485 -0.78 . . . . 73.25 112.205 -174.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -77.45 -15.86 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 120.869 0.366 . . . . 74.51 110.708 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -77.41 -22.39 51.63 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.299 0.64 . . . . 74.12 110.904 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -77.62 -23.79 49.73 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.921 0.889 . . . . 75.2 110.283 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HE2' ' HB3' ' A' ' 71' ' ' GLU . 30.3 mmmt -65.64 144.93 56.63 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.22 1.008 . . . . 73.21 111.94 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -60.47 117.72 5.61 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.661 -0.866 . . . . 70.25 108.661 168.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.421 ' CE3' HD21 ' A' ' 68' ' ' LEU . 70.6 t-105 -75.6 84.68 2.65 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.676 0.75 . . . . 74.51 110.022 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.74 78.32 74.0 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 105.882 -1.896 . . . . 63.45 105.882 169.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -81.93 140.67 11.52 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.665 2.243 . . . . 73.44 111.908 -173.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -97.66 83.78 3.27 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.072 -1.455 . . . . 71.32 107.072 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.607 HG22 ' HB1' ' A' ' 66' ' ' ALA . 58.0 t -81.96 119.16 30.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 CA-C-N 114.745 -1.116 . . . . 74.33 109.549 -174.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 74.0 mttt -113.86 113.57 25.06 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.237 1.015 . . . . 74.31 108.467 -170.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -98.43 121.16 40.02 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 108.294 -1.002 . . . . 71.33 108.294 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -130.43 138.57 50.39 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.39 1.076 . . . . 70.22 108.265 -176.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.435 HD22 HD21 ' A' ' 60' ' ' LEU . 88.3 mt -128.89 140.14 51.82 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.939 0.496 . . . . 73.33 110.95 -173.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.52 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 27.7 t70 -142.9 146.19 33.8 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.465 1.106 . . . . 74.02 108.742 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.2 m -131.8 128.85 39.63 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.117 0.567 . . . . 74.45 110.076 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.71 110.04 10.11 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.66 0.784 . . . . 62.13 109.151 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.4 p -90.68 161.23 15.47 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 109.512 -0.551 . . . . 72.42 109.512 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.4 t -152.97 121.17 6.21 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.966 0.906 . . . . 74.43 108.702 -172.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -79.72 104.23 10.17 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.589 -0.893 . . . . 73.43 108.589 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.437 HD12 HG22 ' A' ' 83' ' ' ILE . 97.6 mt -81.83 -35.58 29.25 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.893 0.477 . . . . 72.24 109.96 177.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.45 -176.47 5.08 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.628 0.771 . . . . 65.13 110.391 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.68 113.95 4.1 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.501 0.72 . . . . 74.2 110.181 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 66.27 17.89 10.8 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.629 1.172 . . . . 52.13 111.609 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.5 t -119.69 106.85 19.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 107.73 -1.211 . . . . 73.34 107.73 173.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -123.12 125.49 45.25 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.29 -1.004 . . . . 75.33 108.29 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -86.35 139.48 30.93 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.46 -0.941 . . . . 74.32 108.46 168.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.1 t -120.17 140.93 42.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.02 -1.104 . . . . 71.51 108.02 171.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.8 t -121.07 130.26 74.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.515 -0.92 . . . . 74.31 108.515 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.489 HD23 HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -105.13 107.88 19.1 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.875 -1.528 . . . . 74.12 106.875 177.386 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.52 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 32.1 ttp180 -92.35 99.66 12.38 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.224 -1.399 . . . . 75.25 107.224 174.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.489 HG23 HD23 ' A' ' 60' ' ' LEU . 21.9 t -96.27 127.98 47.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 107.689 -1.226 . . . . 74.11 107.689 174.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.5 m -121.05 125.08 46.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.402 0.62 . . . . 54.01 109.672 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.582 HG12 HD21 ' A' ' 126' ' ' LEU . 58.9 t -116.23 125.12 73.15 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 C-N-CA 124.962 1.305 . . . . 74.2 107.567 177.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.42 ' HB ' ' HD2' ' A' ' 41' ' ' LYS . 13.8 m -127.75 127.07 42.98 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.155 0.889 . . . . 74.04 109.629 172.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.607 ' HB1' HG22 ' A' ' 40' ' ' VAL . . . -118.07 126.46 52.32 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.346 -0.983 . . . . 71.25 108.346 178.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 35.2 m -130.24 132.82 46.13 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.461 0.704 . . . . 63.23 110.352 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.421 HD21 ' CE3' ' A' ' 36' ' ' TRP . 12.6 mt -93.08 70.35 4.52 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 125.26 1.424 . . . . 73.01 109.058 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.8 -107.03 2.36 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-N 115.595 -0.73 . . . . 64.22 111.404 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.1 -26.77 17.31 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.551 0.74 . . . . 70.35 111.216 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.424 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 6.3 tp10 -93.81 123.9 37.46 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.587 0.755 . . . . 74.3 109.001 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 89.8 m -75.82 136.79 40.21 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 117.744 0.247 . . . . 65.43 110.57 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.34 -64.83 0.94 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.763 -0.828 . . . . 63.23 108.763 174.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -158.94 170.31 22.38 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.325 -0.852 . . . . 62.25 112.002 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 64' ' ' VAL . 57.2 tp -125.28 135.83 52.9 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.91 1.284 . . . . 72.32 107.831 167.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.452 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 73.7 m -135.4 97.75 3.78 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.692 0.797 . . . . 64.41 110.249 174.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -117.66 118.26 31.61 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.112 0.965 . . . . 75.41 108.543 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.9 t -127.68 121.82 57.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 109.134 -0.691 . . . . 75.51 109.134 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.713 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.2 mt-30 -92.79 86.37 5.49 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.275 -0.875 . . . . 72.14 108.865 173.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -76.71 99.37 5.06 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 113.786 -1.552 . . . . 75.45 109.469 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.14 159.73 32.85 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 111.419 -0.672 . . . . 73.04 111.419 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.433 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -161.02 122.45 1.12 Allowed Glycine 0 CA--C 1.498 -0.987 0 N-CA-C 110.336 -1.106 . . . . 55.31 110.336 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.437 HG22 HD12 ' A' ' 51' ' ' LEU . 53.6 mt -78.72 124.65 37.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 N-CA-C 107.337 -1.357 . . . . 74.41 107.337 173.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -123.79 160.04 28.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.884 -0.784 . . . . 74.34 108.884 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.6 t -117.75 101.57 8.43 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.349 -1.352 . . . . 74.01 107.349 173.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.631 HG21 ' SG ' ' A' ' 97' ' ' CYS . 9.0 mm -107.72 145.4 15.03 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 O-C-N 123.736 0.647 . . . . 75.44 110.249 -176.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.51 177.25 8.28 Favored 'General case' 0 C--O 1.231 0.116 0 O-C-N 123.761 0.663 . . . . 73.43 110.971 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.93 -27.18 11.61 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-N 116.061 -0.518 . . . . 62.31 113.047 176.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.45 148.19 24.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 C-N-CA 123.772 0.829 . . . . 70.24 110.808 -171.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.614 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 2.3 mp0 -135.9 175.42 9.61 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.915 0.886 . . . . 73.53 109.952 176.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.12 -119.77 9.88 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-N 115.341 -0.845 . . . . 74.52 113.497 174.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.5 p -73.2 -30.21 63.37 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.114 0.966 . . . . 54.12 110.448 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -74.66 -36.52 62.83 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.14 -0.937 . . . . 71.13 109.852 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.614 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 2.6 tpt -61.22 -44.78 96.72 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.295 0.638 . . . . 75.42 109.75 172.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.4 -29.48 69.0 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.269 -0.878 . . . . 62.21 111.271 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.456 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 54.0 t-80 -71.88 -27.66 63.01 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.288 0.635 . . . . 73.12 111.068 176.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.631 ' SG ' HG21 ' A' ' 86' ' ' ILE . 37.1 t -79.55 -60.73 2.24 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.147 -0.686 . . . . 73.15 109.147 175.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 78.5 mt -67.92 -34.15 76.06 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.03 0.932 . . . . 71.51 113.196 -172.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.87 3.46 52.5 Favored Glycine 0 N--CA 1.47 0.963 0 CA-C-O 119.688 -0.506 . . . . 73.4 113.775 -173.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.557 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -140.14 -70.47 0.39 Allowed 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 117.348 0.574 . . . . 71.13 111.332 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -67.69 -39.19 84.46 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 111.879 0.325 . . . . 74.13 111.879 -171.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 63.5 m -66.68 -53.35 28.87 Favored Pre-proline 0 CA--C 1.564 1.492 0 C-N-CA 124.566 1.146 . . . . 65.05 112.164 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.46 ' HA ' HD13 ' A' ' 106' ' ' LEU . 58.2 Cg_endo -68.35 -18.89 44.2 Favored 'Trans proline' 0 C--N 1.399 3.219 0 C-N-CA 121.965 1.777 . . . . 73.23 112.616 175.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.4 -47.24 70.87 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.934 -0.765 . . . . 72.05 108.934 174.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.3 mm -59.56 -33.45 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.758 1.223 . . . . 71.04 111.299 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.46 HD13 ' HA ' ' A' ' 103' ' ' PRO . 49.3 mt -79.86 -18.8 49.85 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.315 0.646 . . . . 71.04 112.153 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -66.51 -40.55 34.14 Favored Pre-proline 0 CA--C 1.558 1.251 0 N-CA-C 114.737 1.384 . . . . 75.03 114.737 -172.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.5 -37.71 94.72 Favored 'Trans proline' 0 C--N 1.389 2.69 0 C-N-CA 121.998 1.798 . . . . 74.43 112.757 173.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.458 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 55.7 m-85 -82.32 -35.2 28.16 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.098 -0.955 . . . . 75.43 111.022 -175.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.73 -49.39 73.24 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.157 -0.683 . . . . 73.31 109.157 174.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.517 ' NH1' HD13 ' C' ' 105' ' ' ILE . 32.3 ttm180 -49.86 -55.14 15.43 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 125.19 1.556 . . . . 73.45 110.511 174.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.85 -42.57 94.79 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.25 0.969 . . . . 72.01 111.686 -173.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 117' ' ' MET . 48.7 t -60.45 -40.79 92.44 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 123.5 0.5 . . . . 71.14 110.795 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.546 HD13 HD12 ' A' ' 128' ' ' LEU . 63.2 mt -64.58 -50.34 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.224 1.01 . . . . 75.4 110.597 174.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 82.9 m -58.03 -44.62 87.44 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.367 1.067 . . . . 74.4 111.245 -174.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 24.0 t -65.69 -40.74 92.64 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.329 -1.305 . . . . 74.22 110.21 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.676 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 38.0 mtm -64.07 -41.28 97.39 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.61 0.364 . . . . 73.13 111.034 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.454 HG21 HD22 ' A' ' 126' ' ' LEU . 79.3 t -61.58 -45.37 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 O-C-N 124.051 0.844 . . . . 65.0 110.587 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.3 p -71.91 -32.76 67.69 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.014 0.525 . . . . 73.21 111.273 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.458 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.5 mtt-85 -69.96 -30.88 68.35 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.271 0.629 . . . . 73.21 109.704 174.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.99 12.72 57.16 Favored Glycine 0 C--N 1.355 1.604 0 O-C-N 123.905 0.753 . . . . 61.1 112.861 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.424 HG23 ' HE ' ' B' ' 15' ' ' ARG . 1.5 t 62.19 14.19 6.46 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.153 2.181 . . . . 74.15 113.615 172.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -80.49 149.35 68.26 Favored Pre-proline 0 C--O 1.244 0.813 0 N-CA-C 107.068 -1.456 . . . . 75.4 107.068 169.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.63 142.88 81.3 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.163 1.909 . . . . 74.51 111.396 176.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -55.53 122.63 11.71 Favored 'General case' 0 C--N 1.352 0.705 0 O-C-N 124.246 0.966 . . . . 74.03 111.481 -169.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.582 HD21 HG12 ' A' ' 64' ' ' VAL . 22.6 tp -106.15 121.15 43.59 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 108.35 -0.982 . . . . 73.31 108.35 -176.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.593 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 88.6 m-20 -117.74 124.28 48.08 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.657 -1.238 . . . . 75.33 107.657 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.546 HD12 HD13 ' A' ' 114' ' ' ILE . 9.6 mt -74.24 140.3 44.92 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.966 -0.753 . . . . 74.3 108.966 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.62 140.16 89.36 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-O 119.251 -0.404 . . . . 72.41 111.025 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -56.09 115.68 2.64 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 123.392 2.728 . . . . 73.51 113.343 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 92.0 t -102.72 123.38 56.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-N 115.421 -0.809 . . . . 73.44 109.517 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -87.24 90.72 8.46 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 107.778 -1.193 . . . . 72.14 107.778 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -63.58 -28.6 70.04 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.396 0.678 . . . . 63.33 111.465 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.557 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 14.8 t70 -61.7 -39.39 91.33 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.486 0.715 . . . . 75.43 110.11 175.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.5 -40.17 89.09 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.728 0.811 . . . . 71.31 110.651 173.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.97 -38.74 89.67 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.259 0.623 . . . . 73.53 111.352 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . 0.411 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 60.1 t80 . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 109.79 -0.448 . . . . 74.33 109.79 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.578 ' HE3' ' SG ' ' B' ' 97' ' ' CYS . 24.6 ttt . . . . . 0 CA--C 1.562 1.413 0 CA-C-O 121.628 0.728 . . . . 73.22 111.564 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.6 t -138.75 126.58 22.26 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.691 1.196 . . . . 61.22 108.46 169.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -127.9 137.41 52.3 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.286 -1.005 . . . . 74.12 108.286 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -151.86 109.71 3.67 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.624 0.369 . . . . 72.24 110.359 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 47.4 mt -60.84 144.65 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 108.853 -0.795 . . . . 73.3 108.853 172.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -110.04 -45.21 3.64 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.684 -0.487 . . . . 75.52 109.684 176.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.424 ' HE ' HG23 ' A' ' 122' ' ' THR . 50.0 ttt180 -167.45 132.66 1.98 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.386 -0.598 . . . . 65.22 109.386 -173.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.4 mt -118.88 147.93 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 107.494 -1.299 . . . . 74.4 107.494 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.479 ' HE2' ' HZ3' ' B' ' 19' ' ' LYS . 33.6 p90 -169.91 163.89 9.6 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.836 0.827 . . . . 73.2 112.139 -174.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 82.7 m -92.49 122.74 35.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.627 -1.624 . . . . 72.45 108.237 171.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.479 ' HZ3' ' HE2' ' B' ' 17' ' ' TYR . 33.1 mttp -80.05 -49.94 11.07 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.571 0.748 . . . . 64.42 110.732 170.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -144.99 139.46 27.5 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 122.113 -0.367 . . . . 73.2 111.185 -168.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.502 HD13 ' SG ' ' B' ' 113' ' ' CYS . 49.5 mm -128.86 141.77 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.247 1.019 . . . . 74.0 109.911 173.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -144.82 133.35 22.02 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.69 1.196 . . . . 71.12 108.002 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -143.6 109.9 5.41 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.016 -1.105 . . . . 74.14 108.016 173.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -117.97 114.86 23.8 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.562 0.745 . . . . 74.21 109.039 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' B' ' 28' ' ' ALA . . . -105.25 88.31 2.47 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 106.431 -1.692 . . . . 75.11 106.431 170.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -72.02 -31.8 11.87 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.092 2.528 . . . . 73.43 113.256 -168.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -109.42 25.72 11.47 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.307 0.643 . . . . 74.53 109.268 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.422 ' HB1' ' HE3' ' A' ' 19' ' ' LYS . . . -44.36 -58.41 5.1 Favored Pre-proline 0 CA--C 1.564 1.487 0 N-CA-C 114.633 1.346 . . . . 74.13 114.633 -163.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.3 -35.94 81.83 Favored 'Trans proline' 0 C--N 1.393 2.889 0 C-N-CA 122.078 1.852 . . . . 75.34 112.962 -174.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -95.08 -25.18 16.56 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.478 -0.783 . . . . 73.4 112.47 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.559 HG21 ' HG3' ' B' ' 71' ' ' GLU . 4.5 p -71.15 -14.25 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-O 121.332 0.587 . . . . 74.54 110.14 -175.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -73.31 -2.66 22.95 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.265 1.026 . . . . 74.34 112.459 174.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -68.63 -19.64 64.43 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.435 0.694 . . . . 73.24 110.116 169.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.542 ' HB2' HD13 ' B' ' 68' ' ' LEU . 29.4 mmtp -98.31 102.62 14.42 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 125.497 1.519 . . . . 74.4 108.884 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -99.8 77.35 2.04 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.807 0.443 . . . . 74.03 110.639 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 43.6 p90 -160.99 167.97 25.45 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.976 0.91 . . . . 74.52 109.581 169.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.46 113.97 22.45 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 107.328 -1.36 . . . . 73.22 107.328 176.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.42 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 19.6 Cg_endo -60.92 163.92 15.22 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.809 2.339 . . . . 64.21 113.709 -173.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -71.21 103.95 2.95 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.388 -0.967 . . . . 54.34 108.388 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 49.0 t -94.33 146.5 6.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 114.996 -1.002 . . . . 64.45 110.253 -176.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -149.14 125.96 11.17 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.24 1.016 . . . . 74.3 108.282 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 16.3 tp -89.65 137.95 31.89 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.061 0.545 . . . . 75.33 109.768 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -139.56 113.29 8.57 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.441 1.096 . . . . 64.31 108.309 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 91.3 mt -99.69 152.46 20.05 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.751 0.82 . . . . 74.21 109.636 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.787 ' HB3' ' HD2' ' B' ' 61' ' ' ARG . 31.7 t70 -156.03 151.59 27.04 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 107.324 -1.362 . . . . 72.02 107.324 173.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' THR . . . . . 0.45 HG23 ' HA ' ' B' ' 60' ' ' LEU . 0.9 OUTLIER -143.83 146.45 33.07 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.664 0.745 . . . . 75.04 112.315 -170.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.11 153.2 41.91 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.931 1.292 . . . . 72.31 108.359 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.479 ' HB2' ' CE2' ' B' ' 56' ' ' TYR . 74.4 p -145.7 176.05 9.93 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.565 0.579 . . . . 73.43 112.565 -174.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 65.5 p -162.01 139.29 8.46 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.688 1.195 . . . . 75.13 109.869 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -90.79 109.93 21.13 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.284 -0.635 . . . . 74.24 109.284 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.473 HD11 ' HB3' ' A' ' 29' ' ' PRO . 39.3 mt -86.56 -23.34 25.85 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.763 0.425 . . . . 73.54 110.531 175.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . 0.558 ' HB1' ' HB ' ' B' ' 55' ' ' VAL . . . -163.1 167.42 22.28 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.452 0.701 . . . . 71.51 111.08 -176.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -82.17 138.49 34.69 Favored 'General case' 0 C--O 1.248 0.99 0 N-CA-C 107.291 -1.374 . . . . 74.42 107.291 161.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 78.17 -5.35 2.09 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 125.758 1.623 . . . . 74.44 112.258 -175.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.558 ' HB ' ' HB1' ' B' ' 52' ' ' ALA . 50.1 t -144.34 117.97 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.539 0.735 . . . . 74.23 109.044 -175.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.479 ' CE2' ' HB2' ' B' ' 48' ' ' SER . 26.9 t80 -126.61 151.58 47.8 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.195 0.598 . . . . 75.41 110.002 -173.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -116.26 121.0 40.73 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 107.755 -1.202 . . . . 74.31 107.755 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 12.9 p -127.48 147.93 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.128 0.571 . . . . 72.43 109.984 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 17.4 t -125.37 116.26 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.73 0.812 . . . . 64.33 109.808 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.45 ' HA ' HG23 ' B' ' 46' ' ' THR . 58.0 tp -94.72 105.27 17.21 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.051 -0.722 . . . . 74.32 109.051 170.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.787 ' HD2' ' HB3' ' B' ' 45' ' ' ASP . 1.7 tmt_? -86.54 120.46 27.89 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.709 -1.219 . . . . 72.43 107.709 172.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 32.3 t -114.81 133.04 62.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.284 -1.006 . . . . 70.42 108.284 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 24.7 m -131.03 131.81 44.54 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.325 0.583 . . . . 75.23 109.628 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.536 HG21 HD21 ' B' ' 128' ' ' LEU . 97.2 t -111.54 118.74 58.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 C-N-CA 124.419 1.087 . . . . 74.03 108.338 176.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 68.5 m -92.51 130.94 38.03 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.114 -1.069 . . . . 70.24 108.114 168.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.39 134.34 27.19 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.863 -0.792 . . . . 72.33 108.863 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.428 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 18.8 p -144.63 133.26 22.2 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 123.736 0.648 . . . . 63.22 110.803 -175.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.542 HD13 ' HB2' ' B' ' 34' ' ' LYS . 78.4 mt -99.45 103.05 14.79 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.47 1.108 . . . . 75.5 110.056 176.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.7 -111.7 3.41 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.797 -0.521 . . . . 63.31 111.797 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -115.19 1.32 13.81 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.256 0.622 . . . . 74.32 110.706 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.559 ' HG3' HG21 ' B' ' 31' ' ' VAL . 18.2 pt-20 -115.47 143.1 45.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.415 0.686 . . . . 75.51 109.396 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 63.4 m -69.11 132.13 46.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 121.235 0.54 . . . . 73.22 110.999 -178.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.54 ' HA ' HG23 ' B' ' 31' ' ' VAL . . . -83.31 -63.03 1.44 Allowed 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.819 -1.178 . . . . 72.22 107.819 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -153.87 152.36 30.55 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.523 -1.217 . . . . 74.54 110.358 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -125.79 111.85 15.36 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.427 -1.694 . . . . 75.15 106.427 170.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.485 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 49.5 t -117.42 134.63 54.62 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.909 -1.145 . . . . 73.34 107.909 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -146.09 126.36 13.92 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.427 -0.953 . . . . 73.24 108.427 -173.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.436 HG22 HG13 ' B' ' 114' ' ' ILE . 66.1 t -123.08 148.02 27.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.259 -1.015 . . . . 72.14 108.259 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -120.46 106.96 12.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.083 -1.451 . . . . 75.21 107.083 168.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -100.82 103.07 14.27 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.609 -0.885 . . . . 75.53 108.609 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.59 158.8 18.59 Favored Glycine 0 C--N 1.342 0.885 0 O-C-N 123.762 0.664 . . . . 74.34 111.548 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.44 142.45 7.86 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 117.314 0.557 . . . . 72.15 113.414 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 3.8 mp -90.34 124.68 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 107.941 -1.133 . . . . 75.42 107.941 170.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -129.59 153.35 48.15 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.315 1.046 . . . . 75.44 109.28 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 30.3 m -107.76 109.1 20.58 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.742 0.817 . . . . 73.12 109.191 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.602 HG21 HD12 ' B' ' 89' ' ' ILE . 4.0 mp -111.74 108.52 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.756 1.223 . . . . 73.32 107.93 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.98 158.43 43.92 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.048 0.539 . . . . 64.44 111.22 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.73 -56.14 0.88 Allowed Glycine 0 C--N 1.349 1.261 0 C-N-CA 123.292 0.472 . . . . 74.32 112.668 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.602 HD12 HG21 ' B' ' 86' ' ' ILE . 0.6 OUTLIER -56.22 166.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 124.528 1.131 . . . . 74.21 113.035 173.238 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -158.42 160.03 36.39 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.078 -0.964 . . . . 74.42 110.057 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.08 -109.92 3.81 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 112.166 -0.373 . . . . 54.11 112.166 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 80.0 m -99.94 -42.42 6.78 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.482 0.713 . . . . 74.05 110.677 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -65.66 -19.14 65.79 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.207 1.003 . . . . 75.23 112.448 -173.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.42 ' HA ' HD13 ' B' ' 89' ' ' ILE . 20.3 ptm -61.69 -66.07 0.59 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.102 0.561 . . . . 72.41 111.613 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . 0.4 ' H ' ' HG3' ' B' ' 94' ' ' MET . . . -79.69 -14.26 58.89 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.801 0.44 . . . . 53.5 111.621 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -63.32 -34.9 78.7 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.278 0.631 . . . . 74.02 110.888 171.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.578 ' SG ' ' HE3' ' B' ' 9' ' ' MET . 48.7 t -66.72 -44.21 82.2 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.819 0.447 . . . . 72.11 111.594 -177.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.561 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 1.5 pp -80.23 -30.18 38.54 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.098 0.559 . . . . 74.13 111.464 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.51 -30.57 44.34 Favored Glycine 0 C--N 1.342 0.866 0 O-C-N 123.601 0.563 . . . . 72.41 113.601 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.41 -53.95 1.47 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.324 0.65 . . . . 62.25 111.967 -169.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -67.79 -37.46 82.08 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.333 0.653 . . . . 72.32 112.197 -174.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.561 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 79.9 m -71.14 -43.56 13.13 Favored Pre-proline 0 CA--C 1.563 1.456 0 CA-C-O 118.383 -0.818 . . . . 64.1 112.367 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -50.89 -36.88 54.38 Favored 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 122.366 2.044 . . . . 74.21 113.402 166.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -67.42 -29.75 69.32 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.2 0.6 . . . . 74.23 111.865 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.407 HG22 ' NH2' ' D' ' 111' ' ' ARG . 74.9 mt -69.49 -41.57 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.314 0.646 . . . . 74.14 109.691 171.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.6 mt -76.85 -21.57 54.82 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.962 -1.017 . . . . 71.31 112.028 -174.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.401 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 69.1 t80 -59.15 -49.76 91.3 Favored Pre-proline 0 N--CA 1.485 1.314 0 CA-C-O 118.165 -0.921 . . . . 72.22 113.021 -176.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' B' ' 105' ' ' ILE . 86.9 Cg_exo -53.17 -43.04 60.48 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 122.715 2.277 . . . . 75.15 114.224 175.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -67.29 -41.27 85.7 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.396 0.678 . . . . 72.33 110.565 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.407 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -64.32 -38.45 91.1 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.601 -0.727 . . . . 75.25 110.689 175.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.0 ttt-85 -64.93 -47.12 78.84 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.529 1.532 . . . . 74.23 110.831 -176.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -70.87 -34.0 71.17 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.988 0.515 . . . . 72.33 109.855 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.52 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.9 t -66.23 -34.66 78.52 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 123.352 0.408 . . . . 75.22 110.741 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.485 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 51.8 mt -65.46 -55.71 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.924 0.889 . . . . 75.12 109.858 173.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 10.2 m -63.35 -24.83 68.02 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.479 0.712 . . . . 74.34 111.496 -175.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.442 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 36.4 t -64.24 -50.15 69.11 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 123.385 0.674 . . . . 72.35 109.251 173.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.52 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.2 mmt -69.5 -34.35 74.18 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.305 0.642 . . . . 74.35 110.826 -176.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 85.5 t -62.26 -43.73 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.88 0.872 . . . . 74.21 110.082 173.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 48.3 t -66.25 -31.89 72.98 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.027 -0.988 . . . . 71.23 111.041 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' B' ' 116' ' ' SER . 86.4 mtt-85 -68.95 -39.77 79.33 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.488 -0.778 . . . . 73.44 110.5 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.08 -14.26 81.98 Favored Glycine 0 C--N 1.354 1.531 0 O-C-N 123.698 0.624 . . . . 62.24 112.222 172.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 7.5 m 65.58 37.15 6.11 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.595 1.558 . . . . 75.14 110.058 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.429 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 57.5 m-85 -85.22 159.54 56.37 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 114.576 -1.193 . . . . 74.53 110.051 173.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -47.89 159.79 0.56 Allowed 'Trans proline' 0 C--N 1.385 2.458 0 C-N-CA 123.851 3.034 . . . . 74.34 115.249 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.456 HE21 ' ND2' ' B' ' 127' ' ' ASN . 60.0 tp60 -61.3 118.19 6.58 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 115.112 -0.949 . . . . 73.42 111.762 -173.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 32.8 tp -110.85 103.33 11.83 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.556 -0.747 . . . . 71.43 110.052 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . 0.456 ' ND2' HE21 ' B' ' 125' ' ' GLN . 34.4 m-80 -108.1 114.9 29.15 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 107.908 -1.145 . . . . 73.23 107.908 169.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.536 HD21 HG21 ' B' ' 64' ' ' VAL . 41.9 mt -70.42 140.94 52.15 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.272 0.358 . . . . 75.23 110.352 176.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.47 145.79 98.99 Favored Pre-proline 0 CA--C 1.551 1.01 0 O-C-N 123.7 0.625 . . . . 73.5 110.529 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -60.88 92.05 0.1 OUTLIER 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.827 2.352 . . . . 75.43 111.74 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 94.7 t -99.23 112.51 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 123.24 0.616 . . . . 73.51 109.778 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 46.6 t30 . . . . . 0 CA--C 1.541 0.618 0 C-N-CA 123.943 0.897 . . . . 71.45 109.141 173.254 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 58.5 t80 . . . . . 0 C--O 1.238 0.497 0 N-CA-C 109.118 -0.697 . . . . 73.25 109.118 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -141.33 118.09 11.05 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.206 0.603 . . . . 74.51 109.698 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 60.4 mt -73.52 134.13 30.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 109.018 -0.734 . . . . 72.42 109.018 173.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.436 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.3 mm-40 -96.79 -49.97 4.86 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 108.998 -0.742 . . . . 71.31 108.998 171.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.593 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -178.2 146.0 0.38 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.32 1.048 . . . . 74.03 110.477 179.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 4.9 mp -109.7 124.84 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 107.549 -1.278 . . . . 72.42 107.549 172.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.47 ' HB3' HG22 ' D' ' 122' ' ' THR . 44.1 p90 -147.74 170.52 17.39 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.584 0.707 . . . . 74.25 111.712 -171.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' THR . . . . . 0.489 HG21 ' HG ' ' C' ' 113' ' ' CYS . 75.5 p -102.7 108.17 19.32 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.493 -0.776 . . . . 74.12 109.936 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.47 ' HE3' ' HB2' ' D' ' 28' ' ' ALA . 26.7 mtpt -78.66 -23.15 45.89 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 109.468 -0.567 . . . . 74.42 109.468 174.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.493 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 10.5 t70 -148.51 138.88 22.59 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.699 0.8 . . . . 55.21 109.774 176.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.474 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 82.7 mt -136.89 140.17 43.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 106.314 -1.736 . . . . 73.23 106.314 169.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.9 t -153.18 143.92 22.75 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.457 0.703 . . . . 75.25 109.949 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -156.22 109.25 2.65 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 107.657 -1.238 . . . . 74.12 107.657 172.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -116.34 111.49 20.17 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.477 -0.564 . . . . 75.21 109.477 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.79 79.64 31.95 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 108.006 -1.109 . . . . 72.21 108.006 170.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.05 -17.04 25.26 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.614 2.209 . . . . 74.12 111.399 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -105.01 11.99 32.78 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.762 1.225 . . . . 74.33 110.274 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.492 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -50.96 -54.05 41.44 Favored Pre-proline 0 C--N 1.371 1.501 0 C-N-CA 124.351 1.06 . . . . 64.02 113.742 -169.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.574 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 12.4 Cg_endo -56.92 -52.7 6.22 Favored 'Trans proline' 0 C--N 1.391 2.789 0 C-N-CA 121.658 1.572 . . . . 74.14 111.67 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.432 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 85.4 t60 -67.77 -28.64 67.78 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.659 0.784 . . . . 65.33 112.654 -172.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.69 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.6 p -77.43 -19.68 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 N-CA-C 112.43 0.53 . . . . 73.52 112.43 -174.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -71.66 -13.52 61.77 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.856 0.687 . . . . 72.03 112.856 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 28.1 pt20 -99.18 6.34 46.43 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.188 0.595 . . . . 61.34 111.68 175.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.798 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -94.48 150.91 19.79 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.778 0.831 . . . . 72.35 110.442 -178.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.16 119.78 11.49 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.343 0.657 . . . . 72.34 109.277 169.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -82.89 92.37 7.28 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.557 0.743 . . . . 73.43 112.053 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -142.9 79.99 14.2 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 124.606 1.162 . . . . 74.3 107.895 169.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -87.29 163.06 8.41 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.732 2.288 . . . . 73.15 111.235 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -85.57 76.06 10.06 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.306 -1.368 . . . . 62.44 107.306 173.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.416 HG23 HD23 ' C' ' 126' ' ' LEU . 2.0 p -62.75 97.34 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 114.603 -1.18 . . . . 62.05 108.735 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -107.56 102.96 12.18 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 113.627 -1.624 . . . . 73.44 107.442 -171.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -88.3 129.36 35.4 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.017 -1.105 . . . . 70.52 108.017 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.435 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 15.4 t70 -124.62 139.04 54.24 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.95 -0.759 . . . . 75.21 108.95 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.48 HD23 HD23 ' C' ' 60' ' ' LEU . 79.0 mt -130.43 110.65 11.63 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.083 0.953 . . . . 75.54 108.568 175.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -124.22 119.77 30.31 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.175 -1.417 . . . . 75.13 107.175 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.1 t -119.91 145.32 46.82 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 109.621 -0.511 . . . . 73.53 109.621 -176.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.54 162.13 36.65 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.912 0.885 . . . . 54.42 108.931 176.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.474 ' HG ' ' HB3' ' C' ' 98' ' ' LEU . 5.4 m -129.12 164.08 24.11 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 109.468 -0.568 . . . . 62.31 109.468 174.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -148.65 125.61 11.3 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.675 -1.231 . . . . 72.31 107.675 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -84.21 114.83 22.09 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.897 -1.149 . . . . 74.33 107.897 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.64 HD12 ' HB2' ' C' ' 57' ' ' GLU . 50.1 mt -88.71 -42.67 11.82 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.4 0.68 . . . . 73.41 109.782 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.04 -171.22 3.85 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 115.081 -0.963 . . . . 63.52 109.967 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.37 113.32 2.85 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 114.92 -1.036 . . . . 74.31 109.307 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 63.86 15.29 8.99 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.037 0.935 . . . . 75.51 112.387 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 85.1 t -111.71 115.88 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.136 -1.061 . . . . 70.23 108.136 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -125.14 124.73 42.44 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.804 0.841 . . . . 74.4 109.185 -177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.64 ' HB2' HD12 ' C' ' 51' ' ' LEU . 38.7 tt0 -83.74 133.63 34.78 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.238 -1.023 . . . . 74.21 108.238 164.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -118.94 135.61 58.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 108.247 -1.02 . . . . 74.43 108.247 168.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 57.3 t -119.75 141.93 37.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 123.644 0.778 . . . . 72.12 109.128 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.48 HD23 HD23 ' C' ' 44' ' ' LEU . 0.0 OUTLIER -123.11 102.01 7.73 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.713 -1.217 . . . . 75.44 107.713 177.586 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -81.87 106.97 14.21 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.687 -0.857 . . . . 73.51 108.687 172.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 11.0 t -109.86 113.91 45.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.24 -1.022 . . . . 74.32 108.24 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 26.8 m -111.98 132.13 54.97 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.197 -0.668 . . . . 73.42 109.197 -177.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.519 HG23 HG21 ' C' ' 114' ' ' ILE . 50.6 t -118.32 114.71 45.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.774 -0.824 . . . . 73.14 108.774 171.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.4 m -99.19 139.17 35.25 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.285 -1.006 . . . . 73.41 108.285 172.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.6 109.82 8.35 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.638 -0.875 . . . . 64.34 108.638 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 36.5 m -136.94 131.75 33.45 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.874 0.47 . . . . 74.0 110.293 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.798 HD11 ' HG2' ' C' ' 34' ' ' LYS . 1.6 mt -93.16 50.34 1.51 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.214 1.006 . . . . 73.2 108.572 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.32 -119.95 6.46 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 110.3 -1.12 . . . . 75.45 110.3 -171.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -90.48 -11.94 38.77 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.239 0.616 . . . . 75.54 109.836 172.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -71.58 119.53 15.87 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.753 0.821 . . . . 75.21 109.239 172.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 30.9 m -79.27 125.1 29.05 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.071 -0.714 . . . . 71.34 109.071 170.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.69 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -82.43 -53.92 5.61 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.39 -1.337 . . . . 75.33 107.39 168.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . 0.428 ' HZ ' HD13 ' C' ' 126' ' ' LEU . 32.7 p90 -169.77 168.56 8.88 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 114.73 -1.123 . . . . 74.23 110.41 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.409 HD12 ' N ' ' C' ' 76' ' ' CYS . 3.1 tm? -130.44 144.93 51.71 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 106.14 -1.8 . . . . 75.54 106.14 169.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.409 ' N ' HD12 ' C' ' 75' ' ' LEU . 49.2 t -150.17 146.21 26.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.739 0.416 . . . . 74.53 109.991 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -157.68 137.47 12.26 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.701 0.8 . . . . 75.21 109.673 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.451 HG21 HG12 ' C' ' 21' ' ' ILE . 24.2 t -134.34 113.51 17.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 124.562 1.145 . . . . 72.21 107.923 174.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.493 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 69.3 mt-30 -91.55 88.42 6.76 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.966 -1.124 . . . . 65.12 107.966 174.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -79.27 96.86 6.06 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.821 -1.081 . . . . 75.2 109.195 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.56 145.79 17.82 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 111.27 -0.732 . . . . 61.43 111.27 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.85 132.75 4.01 Favored Glycine 0 CA--C 1.501 -0.787 0 N-CA-C 110.898 -0.881 . . . . 74.21 110.898 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.462 HD11 ' HB3' ' D' ' 29' ' ' PRO . 26.5 mm -89.48 132.0 35.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 N-CA-C 109.174 -0.676 . . . . 73.14 109.174 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -134.51 119.27 18.27 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.727 0.811 . . . . 74.0 109.376 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 27.8 m -81.8 102.07 10.57 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.202 -1.036 . . . . 73.14 108.202 171.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.518 HG21 ' HE2' ' C' ' 94' ' ' MET . 27.5 mt -116.22 131.6 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.732 0.813 . . . . 65.11 109.481 -176.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.03 169.45 17.57 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.756 0.423 . . . . 74.31 110.956 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.21 -29.48 5.59 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 115.817 -0.629 . . . . 61.43 113.971 171.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 39.5 pt -96.95 171.79 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.338 0.655 . . . . 73.23 110.933 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -166.23 -179.15 4.91 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.198 0.999 . . . . 75.12 109.256 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.29 -119.9 13.71 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 123.925 0.766 . . . . 64.54 114.116 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 26.1 p -73.93 -30.83 62.77 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.696 0.798 . . . . 74.25 112.105 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -63.47 -48.24 78.48 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.944 0.498 . . . . 75.1 109.709 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.518 ' HE2' HG21 ' C' ' 86' ' ' ILE . 5.4 tpt -63.99 -48.08 77.83 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-N 115.547 -0.751 . . . . 75.44 110.501 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.4 -35.23 73.58 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.287 0.635 . . . . 54.13 111.486 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -83.74 -28.84 27.94 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.956 0.502 . . . . 70.24 110.954 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.509 ' SG ' HD13 ' C' ' 86' ' ' ILE . 18.8 t -68.34 -38.58 81.61 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.688 -0.856 . . . . 75.13 108.688 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.474 ' HB3' ' HG ' ' C' ' 48' ' ' SER . 53.9 mt -83.63 -33.34 25.31 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.523 -1.217 . . . . 71.42 110.857 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.27 -24.38 63.67 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.297 -0.865 . . . . 73.44 114.28 -169.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.36 -52.54 0.11 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.802 0.667 . . . . 72.42 112.802 -164.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -57.02 -57.54 12.11 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 123.999 0.812 . . . . 71.23 111.177 -176.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 95.3 m -64.28 -49.11 74.38 Favored Pre-proline 0 CA--C 1.564 1.486 0 C-N-CA 124.151 0.981 . . . . 71.22 112.422 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.43 -32.89 64.6 Favored 'Trans proline' 0 C--N 1.402 3.359 0 C-N-CA 122.701 2.267 . . . . 74.41 113.889 173.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -67.97 -31.47 71.21 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.608 0.763 . . . . 70.43 110.694 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.517 HD13 ' NH1' ' A' ' 111' ' ' ARG . 25.7 mm -74.74 -35.62 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 122.899 0.48 . . . . 71.22 109.85 175.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.95 -27.74 57.66 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.781 0.832 . . . . 75.45 111.443 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -58.77 -50.93 85.37 Favored Pre-proline 0 N--CA 1.483 1.18 0 N-CA-C 114.552 1.316 . . . . 74.34 114.552 -171.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -58.69 -38.05 91.11 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 121.967 1.778 . . . . 72.33 112.873 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -67.25 -45.22 77.34 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.844 0.858 . . . . 74.13 110.3 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.08 86.3 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.162 -0.927 . . . . 72.32 110.907 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 41.8 ttt-85 -67.84 -43.87 78.52 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.883 1.273 . . . . 74.03 110.259 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . 0.404 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.1 tm-20 -66.29 -39.95 89.7 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.293 0.637 . . . . 64.24 109.591 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . 0.489 ' HG ' HG21 ' C' ' 18' ' ' THR . 28.6 m -59.91 -48.93 79.67 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.584 0.753 . . . . 73.3 111.996 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.519 HG21 HG23 ' C' ' 64' ' ' VAL . 71.0 mt -64.09 -52.32 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 123.439 0.462 . . . . 71.51 110.85 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 14.2 m -66.7 -29.07 68.97 Favored 'General case' 0 CA--C 1.556 1.181 0 O-C-N 123.462 0.476 . . . . 73.13 110.746 -175.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 39.2 t -63.91 -46.38 85.07 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.3 -0.63 . . . . 72.22 109.3 170.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.586 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.17 -41.01 96.03 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.469 1.107 . . . . 73.1 112.215 179.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 92.6 t -64.81 -41.23 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.938 0.895 . . . . 71.4 109.572 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 11.6 t -67.12 -29.95 69.83 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.813 1.245 . . . . 75.23 112.129 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.451 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 75.3 mtt-85 -74.16 -41.3 61.71 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.575 0.75 . . . . 72.3 109.668 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.06 -0.42 60.67 Favored Glycine 0 C--N 1.354 1.572 0 O-C-N 123.719 0.637 . . . . 62.22 112.608 169.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 31.0 p 63.84 30.67 14.4 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.989 2.115 . . . . 72.25 113.025 169.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -82.33 156.44 68.82 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 107.916 -1.142 . . . . 64.53 107.916 167.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -57.19 157.05 22.51 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.479 2.119 . . . . 73.43 112.845 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' B' ' 123' ' ' PHE . 53.8 mm-40 -56.02 112.78 1.29 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.21 0.944 . . . . 73.22 111.601 -176.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.428 HD13 ' HZ ' ' C' ' 74' ' ' PHE . 5.2 tt -116.75 85.15 2.26 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.476 -1.305 . . . . 73.44 107.476 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -95.28 122.17 37.7 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.691 -0.855 . . . . 74.13 108.691 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.79 144.38 37.18 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.589 0.556 . . . . 75.43 109.872 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.89 148.42 98.84 Favored Pre-proline 0 CA--C 1.55 0.958 0 O-C-N 124.076 0.86 . . . . 74.13 111.125 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.458 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 17.7 Cg_endo -57.84 108.53 0.39 Allowed 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.798 2.332 . . . . 74.1 112.22 173.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 43.3 t -99.6 112.68 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.46 -0.941 . . . . 73.02 108.46 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -77.74 104.95 8.59 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.141 -0.689 . . . . 70.2 109.141 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -63.39 -35.52 80.68 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.664 0.785 . . . . 74.21 111.575 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.08 -21.51 65.88 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.931 0.892 . . . . 74.35 111.839 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.52 -47.31 33.75 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.96 0.904 . . . . 75.11 109.296 172.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 35.0 mt -65.79 -43.52 88.48 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.824 -0.625 . . . . 72.31 111.087 -176.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 24.5 t80 . . . . . 0 CA--C 1.542 0.664 0 CA-C-N 115.039 -0.982 . . . . 74.21 110.495 -177.139 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 59.2 m . . . . . 0 C--O 1.241 0.645 0 N-CA-C 109.939 -0.393 . . . . 74.41 109.939 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.523 ' HA ' ' O ' ' D' ' 85' ' ' SER . 47.3 t80 -142.94 91.65 2.32 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.023 -1.102 . . . . 75.33 108.023 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -113.24 123.74 50.87 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.517 -0.92 . . . . 72.54 108.517 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 12.4 mt -79.28 128.34 38.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.347 -0.982 . . . . 72.44 108.347 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -85.57 -43.19 13.72 Favored 'General case' 0 C--O 1.239 0.538 0 O-C-N 123.638 0.587 . . . . 75.22 109.817 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -171.09 131.62 0.8 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.799 -0.637 . . . . 74.44 110.575 -171.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 4.0 mp -106.46 141.48 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 107.348 -1.353 . . . . 74.11 107.348 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -167.01 145.51 5.06 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.648 0.592 . . . . 71.31 111.819 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -76.86 116.34 17.44 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.492 -0.776 . . . . 74.55 109.573 175.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.574 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 43.0 mtpt -88.92 -13.02 40.04 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.45 0.7 . . . . 70.22 110.439 178.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.645 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 25.3 t70 -162.55 141.63 9.07 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.099 0.96 . . . . 73.45 109.699 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.586 HG23 ' HE1' ' C' ' 117' ' ' MET . 98.4 mt -141.28 141.35 30.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 125.278 1.431 . . . . 72.35 107.884 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 41.1 t -149.3 141.38 23.91 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.667 1.187 . . . . 62.24 108.109 173.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.474 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 81.2 t80 -152.54 125.72 8.62 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 106.562 -1.644 . . . . 75.3 106.562 171.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -129.42 145.64 51.39 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.286 -0.635 . . . . 74.12 109.286 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.76 80.46 65.85 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 107.263 -1.384 . . . . 71.04 107.263 174.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.61 -38.54 31.64 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 123.513 2.809 . . . . 71.14 113.419 -169.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 42.2 m-20 -106.94 12.38 28.83 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 118.762 -0.637 . . . . 75.41 110.959 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.47 ' HB2' ' HE3' ' C' ' 19' ' ' LYS . . . -27.63 -69.42 0.08 OUTLIER Pre-proline 0 CA--C 1.571 1.772 0 N-CA-C 116.742 2.127 . . . . 73.13 116.742 -164.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.462 ' HB3' HD11 ' C' ' 83' ' ' ILE . 86.9 Cg_endo -77.45 -18.69 13.69 Favored 'Trans proline' 0 C--N 1.385 2.483 0 CA-C-N 123.661 2.343 . . . . 74.44 114.212 -174.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.416 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 6.1 t-160 -74.49 -38.66 62.82 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.295 1.038 . . . . 72.01 109.103 174.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' D' ' 73' ' ' ALA . 4.3 p -84.76 -20.66 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 CA-C-N 115.328 -0.851 . . . . 73.51 111.676 -174.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.51 ' HD2' HH21 ' C' ' 15' ' ' ARG . 20.6 m-85 -67.6 -18.54 65.02 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 122.586 0.354 . . . . 75.34 111.945 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . 0.416 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 60.7 mt-30 -65.29 -16.84 63.99 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.203 1.001 . . . . 64.54 111.06 175.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.76 ' HZ1' ' HG2' ' D' ' 71' ' ' GLU . 96.4 mttt -97.42 90.26 5.0 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 125.086 1.354 . . . . 74.54 110.463 -178.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -90.67 93.22 9.16 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.954 0.502 . . . . 70.44 109.772 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 20.5 p90 -162.47 -170.39 2.42 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.874 0.87 . . . . 70.14 109.466 168.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -67.98 109.78 4.47 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.707 1.203 . . . . 71.54 110.898 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -58.54 122.27 11.38 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.27 1.98 . . . . 74.14 110.565 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 0.2 OUTLIER -66.68 107.21 2.06 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 106.983 -1.488 . . . . 75.31 106.983 175.289 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.534 HG11 HG13 ' D' ' 64' ' ' VAL . 93.8 t -111.67 142.93 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.876 -0.787 . . . . 73.11 108.876 -174.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -129.76 123.87 32.07 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.369 -0.974 . . . . 70.53 108.369 168.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.536 HD12 HG13 ' D' ' 62' ' ' VAL . 51.5 tp -95.73 125.98 40.68 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.001 -0.74 . . . . 75.24 109.001 174.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -124.9 111.11 15.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.787 -1.56 . . . . 72.23 106.787 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.494 HD21 HG21 ' D' ' 62' ' ' VAL . 62.0 mt -97.58 164.53 12.39 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.932 -1.031 . . . . 72.43 108.958 177.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -164.4 144.93 7.98 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.979 -1.119 . . . . 72.51 107.979 167.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 70.4 p -102.62 151.14 22.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.735 0.779 . . . . 74.13 109.769 -176.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.54 161.72 41.1 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 106.686 -1.598 . . . . 44.31 106.686 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 12.8 p . . . . . 0 C--O 1.238 0.464 0 C-N-CA 122.786 0.434 . . . . 53.41 110.255 -176.866 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' D' ' 85' ' ' SER . 6.5 m-20 . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 112.836 0.68 . . . . 71.12 112.836 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.87 117.81 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 108.239 -1.023 . . . . 74.22 108.239 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -135.13 125.55 26.59 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.626 -0.879 . . . . 72.14 108.626 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -90.0 129.97 36.26 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 106.857 -1.534 . . . . 73.34 106.857 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 83.3 t -132.96 131.26 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 124.097 0.959 . . . . 72.03 108.631 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.491 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 32.3 t -119.94 144.51 28.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 C-N-CA 124.642 1.177 . . . . 74.43 108.853 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.6 108.94 12.06 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.389 -1.337 . . . . 74.4 107.389 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 ttt85 -85.41 106.01 16.47 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.144 -0.687 . . . . 72.03 109.144 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.562 HG22 ' HB1' ' D' ' 110' ' ' ALA . 59.7 t -108.1 118.29 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 123.95 0.9 . . . . 71.43 109.07 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 17.0 m -128.71 131.14 47.91 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.613 0.57 . . . . 54.24 109.948 -171.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.534 HG13 HG11 ' D' ' 40' ' ' VAL . 90.9 t -113.78 135.3 53.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 124.536 1.134 . . . . 72.54 109.545 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 7.1 m -121.01 94.72 4.43 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.921 -1.14 . . . . 72.2 107.921 171.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.502 ' HB3' HG22 ' D' ' 40' ' ' VAL . . . -109.42 142.08 40.91 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.614 0.366 . . . . 74.33 110.711 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.47 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 49.6 m -148.61 132.72 17.29 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.069 0.947 . . . . 75.12 110.561 -171.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.2 mt -98.34 105.71 17.9 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.967 -1.123 . . . . 75.3 107.967 173.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.07 -120.39 5.19 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 115.506 -0.77 . . . . 54.4 112.391 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.12 6.7 27.12 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.592 0.757 . . . . 74.15 111.383 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.76 ' HG2' ' HZ1' ' D' ' 34' ' ' LYS . 10.9 pt-20 -127.6 159.59 34.19 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.258 0.623 . . . . 72.43 109.321 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 93.9 m -70.34 136.92 50.16 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.335 0.654 . . . . 65.44 111.961 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.528 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -91.75 -70.52 0.68 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.19 -1.411 . . . . 53.2 107.19 174.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -146.35 148.09 32.0 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.092 -0.958 . . . . 74.13 110.414 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 73.6 mt -116.17 153.52 31.68 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.757 1.223 . . . . 75.52 107.741 171.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.605 ' SG ' HG12 ' D' ' 114' ' ' ILE . 34.6 t -154.35 146.66 23.87 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.584 -0.524 . . . . 75.02 109.584 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -157.4 122.21 4.43 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.728 0.411 . . . . 74.12 110.625 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 94.8 t -132.79 115.46 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.106 0.962 . . . . 75.51 109.277 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.645 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.0 mt-30 -89.3 88.51 7.53 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.693 -0.854 . . . . 74.44 108.693 172.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -83.01 103.59 12.57 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.338 -1.301 . . . . 71.34 109.528 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -102.83 167.84 17.69 Favored Glycine 0 N--CA 1.468 0.825 0 O-C-N 123.219 0.324 . . . . 64.41 113.055 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.16 143.07 6.07 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 112.447 -0.261 . . . . 63.15 112.447 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 2.5 mp -91.29 127.34 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.218 -1.03 . . . . 74.43 108.218 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -122.41 134.86 54.6 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.538 1.135 . . . . 75.42 109.532 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 34.1 t -84.96 103.53 14.09 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 108.287 -1.005 . . . . 74.14 108.287 171.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.547 HG22 HD13 ' D' ' 89' ' ' ILE . 15.1 mt -109.54 131.9 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.569 -0.9 . . . . 75.51 108.569 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.65 164.02 14.49 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.706 0.629 . . . . 75.32 111.281 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.71 21.59 74.27 Favored Glycine 0 C--N 1.353 1.473 0 O-C-N 123.918 0.761 . . . . 73.34 114.619 170.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.547 HD13 HG22 ' D' ' 86' ' ' ILE . 1.0 OUTLIER -133.27 140.91 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.306 1.042 . . . . 63.22 109.457 177.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 32.0 mp0 -129.56 175.79 8.5 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 123.962 0.905 . . . . 75.03 109.601 -175.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.64 -137.8 23.04 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.219 -0.901 . . . . 64.54 112.458 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 45.5 p -66.46 -45.6 79.22 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.692 0.797 . . . . 71.21 111.035 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -58.84 -28.5 66.11 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.009 1.324 . . . . 75.23 112.331 -175.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.465 ' HA ' HD11 ' D' ' 89' ' ' ILE . 26.4 ttt -49.17 -63.54 1.07 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.98 1.312 . . . . 73.43 112.508 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.91 -16.43 35.97 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.333 0.653 . . . . 65.12 111.81 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -72.78 -21.8 60.94 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.715 0.406 . . . . 75.12 111.625 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 75.3 m -56.99 -50.98 71.06 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 123.467 0.479 . . . . 72.21 111.654 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 pp -68.42 -18.23 64.39 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.266 0.627 . . . . 74.54 112.586 -176.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.83 -2.22 42.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 114.775 0.67 . . . . 71.33 114.775 -174.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.42 -54.29 0.29 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 118.011 0.905 . . . . 71.2 111.459 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -73.49 -51.1 18.28 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.039 0.535 . . . . 75.21 111.287 -172.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.421 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 35.1 m -61.18 -44.83 95.0 Favored Pre-proline 0 CA--C 1.566 1.573 0 C-N-CA 123.914 0.886 . . . . 61.25 112.44 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 50.0 Cg_exo -58.35 -36.45 97.6 Favored 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 122.331 2.021 . . . . 75.14 113.468 169.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -64.19 -31.11 72.19 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.279 0.632 . . . . 73.23 110.997 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 33.1 mm -67.54 -38.55 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.046 0.938 . . . . 70.42 110.623 174.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 60.5 mt -73.31 -20.47 60.79 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.261 -0.881 . . . . 75.34 111.895 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -67.44 -41.74 33.74 Favored Pre-proline 0 CA--C 1.556 1.195 0 N-CA-C 114.274 1.212 . . . . 72.32 114.274 -172.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -45.42 -44.97 16.18 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.508 2.139 . . . . 74.3 113.584 169.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -78.18 -35.03 49.24 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.829 0.852 . . . . 73.14 111.496 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . 0.562 ' HB1' HG22 ' D' ' 62' ' ' VAL . . . -62.25 -56.15 21.42 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.652 0.781 . . . . 74.12 110.339 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.421 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 40.3 ttp180 -58.19 -42.88 87.06 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 114.038 -1.437 . . . . 75.43 110.574 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -55.29 -52.64 62.77 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.084 0.865 . . . . 74.52 110.481 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.4 t -56.27 -45.63 80.03 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.306 1.004 . . . . 73.14 111.13 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.605 HG12 ' SG ' ' D' ' 76' ' ' CYS . 42.3 mt -62.02 -57.36 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.379 -0.828 . . . . 75.31 111.1 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 30.2 m -55.35 -38.58 68.97 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.537 1.135 . . . . 72.53 111.124 -174.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 22.6 t -60.4 -50.96 71.52 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.62 -1.173 . . . . 63.24 109.662 176.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.444 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 75.7 mtm -68.72 -32.4 72.15 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.628 0.771 . . . . 63.42 112.178 -176.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 84.0 t -60.44 -46.41 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.746 0.819 . . . . 73.11 109.519 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 32.4 t -72.49 -29.16 63.39 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 115.004 -0.998 . . . . 72.44 110.881 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.459 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 74.9 mtt-85 -71.49 -24.42 61.98 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.441 0.696 . . . . 74.41 110.674 176.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.21 11.71 71.33 Favored Glycine 0 C--N 1.353 1.476 0 CA-C-O 119.448 -0.64 . . . . 75.55 112.791 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.47 HG22 ' HB3' ' C' ' 17' ' ' TYR . 72.2 p 56.71 25.67 10.41 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 125.988 1.715 . . . . 64.34 113.242 -177.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -92.02 150.9 41.33 Favored Pre-proline 0 C--O 1.241 0.635 0 C-N-CA 123.38 0.672 . . . . 73.53 109.893 173.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -46.12 121.33 4.33 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 123.556 2.837 . . . . 72.11 112.883 170.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -45.86 131.08 9.58 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 124.48 1.113 . . . . 61.14 111.655 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.461 HD11 HG13 ' D' ' 40' ' ' VAL . 23.7 tp -117.55 107.17 13.94 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.208 1.003 . . . . 74.23 109.209 -175.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -101.02 96.08 7.01 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 108.041 -1.096 . . . . 74.23 108.041 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.421 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 47.1 mt -61.73 116.72 5.03 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 122.787 0.435 . . . . 71.05 110.134 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . 0.451 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -54.47 130.78 62.84 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 123.352 0.661 . . . . 74.32 112.487 -174.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 6.1 Cg_exo -73.29 109.64 2.88 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 123.286 2.657 . . . . 74.21 110.985 -178.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.07 152.9 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.877 0.871 . . . . 75.34 110.897 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -75.02 108.54 7.81 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.647 0.779 . . . . 73.54 109.021 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 N--CA 1.488 1.437 0 C-N-CA 124.219 1.007 . . . . 74.22 111.803 179.979 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.8 m . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 108.459 -0.941 . . . . 72.33 108.459 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.436 ' CD1' HD13 ' A' ' 86' ' ' ILE . 70.4 t80 -121.13 112.46 18.71 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.228 -1.397 . . . . 74.34 107.228 167.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -135.68 135.64 40.27 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.804 -1.184 . . . . 64.12 107.804 171.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.9 mt -91.57 115.83 31.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.281 -1.007 . . . . 74.13 108.281 176.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -73.88 -40.24 63.35 Favored 'General case' 0 C--O 1.242 0.708 0 O-C-N 123.388 0.43 . . . . 70.32 110.51 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.49 ' HE ' ' HB ' ' B' ' 122' ' ' THR . 26.0 ttt180 -174.86 122.65 0.24 Allowed 'General case' 0 N--CA 1.479 1.0 0 O-C-N 123.227 0.33 . . . . 72.51 110.432 -169.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 73.7 mt -106.47 136.52 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 108.723 -0.843 . . . . 73.23 108.723 172.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.464 ' HB2' ' HA2' ' B' ' 121' ' ' GLY . 26.4 p90 -166.65 177.95 6.27 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 124.206 0.941 . . . . 75.02 111.802 -172.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.6 p -110.35 118.8 37.27 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.064 -0.971 . . . . 75.43 109.386 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 35.8 mtpt -82.97 -29.33 29.12 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.066 0.46 . . . . 73.14 109.79 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.436 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 30.6 t70 -150.52 136.8 18.67 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.765 -1.107 . . . . 71.4 109.28 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.8 mt -135.06 138.78 48.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.904 -1.147 . . . . 75.14 107.904 174.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.4 t -150.02 124.32 9.54 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.641 0.588 . . . . 71.2 110.04 173.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.672 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.6 t80 -120.95 132.97 55.25 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 106.87 -1.529 . . . . 74.21 106.87 168.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -128.5 139.93 52.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.301 -0.629 . . . . 73.32 109.301 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.13 78.07 65.68 Favored Pre-proline 0 C--O 1.24 0.581 0 N-CA-C 106.908 -1.516 . . . . 75.31 106.908 171.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -64.18 -34.51 56.61 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.671 2.247 . . . . 73.2 112.303 -171.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -106.11 22.34 15.85 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 118.146 -0.931 . . . . 73.44 110.488 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.415 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -43.04 -56.08 6.81 Favored Pre-proline 0 N--CA 1.493 1.721 0 CA-C-O 117.923 -1.037 . . . . 54.42 113.752 -171.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 22.8 Cg_exo -65.03 -27.87 57.6 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 121.906 1.738 . . . . 64.4 113.29 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -80.65 -40.43 25.57 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.847 0.859 . . . . 71.13 110.922 -175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.667 HG22 ' HA ' ' A' ' 73' ' ' ALA . 9.3 p -78.1 -21.33 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 CA-C-N 114.935 -1.029 . . . . 72.53 112.837 -158.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -71.05 -12.14 61.35 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.168 0.587 . . . . 74.32 111.438 176.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -90.22 -18.31 25.92 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.537 1.135 . . . . 75.24 111.011 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -81.55 161.01 23.73 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.494 0.717 . . . . 73.12 112.126 -172.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.13 116.14 6.9 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 114.75 -1.113 . . . . 74.33 108.765 173.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.435 ' NE1' ' HG2' ' A' ' 124' ' ' PRO . 63.6 t-105 -80.79 80.18 7.31 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.875 0.845 . . . . 75.45 109.678 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.401 ' H ' HD23 ' A' ' 68' ' ' LEU . 9.2 tt0 -123.97 69.71 48.39 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 124.898 1.279 . . . . 73.32 108.24 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -86.4 118.25 1.59 Allowed 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.602 2.201 . . . . 73.43 112.816 -170.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -94.45 103.46 15.43 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 105.023 -2.214 . . . . 74.45 105.023 168.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.656 HG23 ' HB1' ' A' ' 66' ' ' ALA . 57.5 t -90.74 101.8 12.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 123.39 0.676 . . . . 74.22 110.334 -177.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -79.6 117.97 21.01 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.662 -0.699 . . . . 74.51 109.855 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.3 mt -97.02 107.04 19.49 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.281 -1.007 . . . . 75.22 108.281 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.528 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.7 m-20 -106.85 106.77 17.45 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.174 0.99 . . . . 74.13 108.679 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.433 HD22 HD21 ' A' ' 60' ' ' LEU . 85.3 mt -98.91 149.64 22.74 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.858 0.463 . . . . 74.15 110.631 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -154.92 148.68 25.52 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.856 -1.065 . . . . 75.05 108.696 177.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.3 m -131.51 130.89 42.94 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.583 0.753 . . . . 74.33 109.878 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.87 109.12 9.87 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.806 0.842 . . . . 63.34 109.121 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.2 p -98.7 156.95 16.58 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.214 0.606 . . . . 73.45 110.327 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.2 t -150.2 151.63 33.37 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.629 1.172 . . . . 75.04 108.609 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -100.16 111.56 23.85 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.091 -1.077 . . . . 74.3 108.091 172.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 74.1 mt -79.22 -43.03 24.64 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.136 0.574 . . . . 62.04 110.234 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.98 -177.28 5.65 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.962 -0.563 . . . . 54.24 110.708 -176.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.02 110.76 0.87 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.088 0.955 . . . . 73.03 109.883 174.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 65.1 9.59 5.65 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.529 1.132 . . . . 72.55 112.655 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.2 t -104.27 107.24 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.299 -1.0 . . . . 74.44 108.299 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -114.77 126.55 54.97 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.495 -0.928 . . . . 75.45 108.495 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -90.51 151.63 21.28 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.163 -0.681 . . . . 74.35 109.163 168.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.1 t -132.57 136.34 56.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 124.882 1.273 . . . . 52.25 107.568 170.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 52.5 t -118.01 130.12 73.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.765 -0.828 . . . . 71.03 108.765 175.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.474 HD23 HG23 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -102.32 103.47 13.92 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.643 -1.614 . . . . 73.24 106.643 176.258 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -90.21 98.77 11.97 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.16 -1.422 . . . . 72.42 107.16 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.474 HG23 HD23 ' A' ' 60' ' ' LEU . 21.5 t -100.61 132.24 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 114.757 -1.111 . . . . 71.13 108.177 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.528 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 6.8 m -125.51 146.65 49.56 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.395 -0.965 . . . . 72.51 108.395 175.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.549 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 23.2 t -145.61 117.37 2.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 124.867 1.267 . . . . 74.43 107.933 -168.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.7 m -126.2 120.55 30.36 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.129 0.422 . . . . 74.42 110.004 177.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.656 ' HB1' HG23 ' A' ' 40' ' ' VAL . . . -101.24 105.59 16.72 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.264 -1.384 . . . . 54.21 107.264 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.2 m -109.07 126.13 52.84 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.044 0.537 . . . . 73.2 110.007 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.412 HD21 ' CE3' ' A' ' 36' ' ' TRP . 35.0 mt -89.79 74.76 7.42 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 125.021 1.328 . . . . 74.11 108.671 175.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.99 -84.39 0.92 Allowed Glycine 0 C--N 1.341 0.856 0 CA-C-N 115.713 -0.676 . . . . 73.12 111.921 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -114.28 -29.0 7.06 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.787 0.835 . . . . 75.21 111.007 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -88.89 134.41 33.96 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.837 0.455 . . . . 65.44 110.211 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -80.2 136.45 36.48 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 118.019 0.372 . . . . 65.21 110.126 175.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.667 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -87.12 -58.25 2.66 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.166 0.986 . . . . 63.03 109.264 176.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -154.54 168.28 27.26 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.579 -1.191 . . . . 70.22 110.695 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 67.1 tp -124.56 147.37 48.48 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.213 1.405 . . . . 71.34 108.042 172.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.549 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 79.8 m -142.86 128.1 18.73 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.2 -1.037 . . . . 73.41 108.2 175.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -146.27 118.45 8.33 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.775 -0.454 . . . . 74.3 109.775 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.4 t -127.41 112.81 29.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.49 1.116 . . . . 64.51 108.97 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 51.7 mt-30 -86.28 84.18 7.53 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.652 -0.87 . . . . 74.12 108.652 171.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -76.78 94.92 3.93 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.506 -1.224 . . . . 73.23 109.578 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.82 144.26 18.06 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 111.87 -0.492 . . . . 64.33 111.87 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.403 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -139.03 124.18 2.75 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.265 -1.134 . . . . 73.4 110.265 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.413 HG13 ' HE1' ' A' ' 17' ' ' TYR . 48.9 mt -81.74 129.15 37.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.923 -1.14 . . . . 73.01 107.923 172.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.661 ' HB3' HD11 ' A' ' 86' ' ' ILE . 88.9 m-85 -128.5 122.99 32.43 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.189 0.996 . . . . 74.44 109.298 -174.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.0 t -89.75 93.27 9.39 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.36 1.064 . . . . 73.05 108.841 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.661 HD11 ' HB3' ' A' ' 84' ' ' PHE . 15.9 mm -120.73 132.89 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.895 0.878 . . . . 74.13 111.379 -168.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.75 167.43 28.23 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.617 0.767 . . . . 63.33 110.708 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.86 8.67 72.5 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 119.325 -0.709 . . . . 63.24 114.73 173.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -143.41 164.07 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 124.112 0.965 . . . . 65.54 109.922 174.704 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.476 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 19.8 tt0 -154.94 179.05 9.49 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.501 -0.772 . . . . 74.42 109.089 174.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.476 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 61.99 -130.03 44.44 Favored Glycine 0 C--N 1.347 1.149 0 C-N-CA 123.283 0.468 . . . . 63.51 113.792 175.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.5 p -67.92 -28.58 67.62 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.995 0.918 . . . . 55.04 111.259 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -66.59 -43.22 85.46 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.71 0.804 . . . . 62.1 110.25 177.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.574 ' HE3' HG22 ' A' ' 86' ' ' ILE . 4.3 tpt -70.84 -41.3 71.68 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.571 -0.74 . . . . 75.41 110.594 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.71 84.87 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.359 0.663 . . . . 64.43 111.136 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -71.7 -29.77 64.93 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.324 0.65 . . . . 73.51 110.75 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.8 t -71.41 -48.31 50.52 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.603 -0.517 . . . . 73.34 109.603 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 79.0 mt -80.37 -25.49 39.13 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.141 0.576 . . . . 74.15 112.494 -174.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.79 4.3 32.3 Favored Glycine 0 N--CA 1.474 1.175 0 CA-C-O 119.669 -0.517 . . . . 64.22 113.954 -173.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.2 -65.48 0.36 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 117.469 0.634 . . . . 74.31 111.33 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -67.6 -45.93 74.03 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 116.193 -0.458 . . . . 74.02 112.209 -171.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 68.6 m -66.98 -48.34 50.65 Favored Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 124.073 0.949 . . . . 73.41 112.863 -176.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -66.92 -21.02 50.73 Favored 'Trans proline' 0 C--N 1.393 2.893 0 C-N-CA 121.596 1.531 . . . . 74.4 112.562 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -71.84 -35.23 69.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.122 0.569 . . . . 54.21 110.364 174.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 38.6 mm -64.08 -42.72 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.65 0.78 . . . . 75.15 109.968 171.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.403 HD22 ' HA3' ' A' ' 82' ' ' GLY . 65.3 mt -76.17 -21.15 56.86 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.253 -0.885 . . . . 64.51 111.997 -174.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -64.31 -43.85 74.12 Favored Pre-proline 0 N--CA 1.484 1.261 0 CA-C-O 117.296 -1.335 . . . . 75.34 114.47 -172.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.78 -37.21 75.99 Favored 'Trans proline' 0 C--N 1.384 2.402 0 CA-C-N 122.04 1.764 . . . . 51.11 113.039 171.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.469 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 95.1 m-85 -77.82 -39.39 43.84 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.581 0.753 . . . . 64.55 111.777 -177.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.56 -47.07 77.09 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.592 -0.521 . . . . 75.22 109.592 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.528 ' NH1' HD13 ' C' ' 105' ' ' ILE . 29.5 ttm180 -48.19 -56.06 8.87 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 125.157 1.535 . . . . 74.45 110.32 173.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.07 -44.96 94.32 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 124.432 1.082 . . . . 65.01 112.186 -174.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.494 ' O ' ' HG3' ' A' ' 117' ' ' MET . 42.1 t -59.27 -41.42 88.84 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.893 0.745 . . . . 72.02 110.82 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.586 HD13 HD12 ' A' ' 128' ' ' LEU . 74.4 mt -64.32 -50.77 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.443 1.097 . . . . 75.3 110.561 174.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.0 m -59.56 -36.36 76.05 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.376 1.071 . . . . 75.12 111.386 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -71.38 -41.59 69.5 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 114.712 -1.131 . . . . 73.43 109.859 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.672 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 44.4 mtm -62.1 -38.37 88.62 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.731 0.413 . . . . 74.5 111.101 175.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 65.6 t -63.52 -47.38 91.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 124.325 1.05 . . . . 73.05 111.157 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.8 p -71.79 -35.27 69.95 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.007 0.523 . . . . 72.2 111.327 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.462 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 87.5 mtt-85 -68.18 -30.75 69.93 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.561 0.744 . . . . 75.42 109.886 173.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.412 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.06 14.51 48.93 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-O 118.953 -0.915 . . . . 61.01 113.218 175.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.415 HG23 ' HE ' ' B' ' 15' ' ' ARG . 1.6 t 61.54 10.21 3.13 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 127.233 2.213 . . . . 74.43 114.214 176.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -82.18 145.08 51.75 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-O 119.176 -0.44 . . . . 74.23 109.82 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.435 ' HG2' ' NE1' ' A' ' 36' ' ' TRP . 92.7 Cg_exo -48.55 149.75 6.66 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 124.039 3.16 . . . . 75.43 113.83 174.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -55.68 128.4 34.55 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 124.246 0.966 . . . . 74.42 112.021 -171.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.537 HD13 HG12 ' A' ' 40' ' ' VAL . 41.4 tp -118.99 102.54 8.84 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.432 0.693 . . . . 74.42 110.172 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.477 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 82.2 m-20 -102.77 115.38 30.47 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 107.798 -1.186 . . . . 74.1 107.798 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.586 HD12 HD13 ' A' ' 114' ' ' ILE . 10.3 mt -67.17 134.09 51.06 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.339 -0.615 . . . . 74.21 109.339 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.15 137.8 94.27 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 123.532 0.733 . . . . 63.52 111.379 -175.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.81 107.11 0.36 Allowed 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.337 2.691 . . . . 70.53 113.47 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.3 t -100.95 134.46 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.119 0.568 . . . . 74.23 111.518 -174.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.512 ' ND2' ' HB3' ' A' ' 135' ' ' ALA . 52.7 t30 -96.26 87.54 4.52 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.347 -1.297 . . . . 75.1 109.134 175.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -59.74 -25.07 64.56 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.979 0.911 . . . . 74.41 112.531 175.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.429 ' HB3' ' OD1' ' A' ' 132' ' ' ASN . 19.8 t70 -58.68 -49.94 75.69 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.651 0.78 . . . . 72.51 109.812 172.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.512 ' HB3' ' ND2' ' A' ' 132' ' ' ASN . . . -59.51 -49.6 77.16 Favored 'General case' 0 C--N 1.358 0.956 0 O-C-N 123.731 0.645 . . . . 61.32 110.727 175.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 85.7 mt -53.13 -44.65 67.89 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 124.144 0.903 . . . . 73.35 111.925 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 82.7 t80 . . . . . 0 N--CA 1.47 0.536 0 CA-C-N 115.533 -0.758 . . . . 72.25 110.467 179.643 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.525 ' SD ' HG22 ' B' ' 89' ' ' ILE . 11.8 tpt . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 121.459 0.647 . . . . 71.13 111.425 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 9.4 t -153.92 132.26 11.98 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 107.483 -1.303 . . . . 73.55 107.483 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.425 ' HB2' ' HE2' ' B' ' 9' ' ' MET . 57.2 t80 -137.69 136.97 37.89 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.146 -0.687 . . . . 74.14 109.146 -175.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -155.72 141.5 18.02 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.373 0.669 . . . . 74.42 109.523 173.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 55.6 mt -87.72 125.16 41.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.199 -1.037 . . . . 73.33 108.199 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -89.94 -39.63 12.88 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.672 -0.695 . . . . 74.23 109.802 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.415 ' HE ' HG23 ' A' ' 122' ' ' THR . 38.6 ttt180 -171.49 143.79 1.83 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.687 -0.688 . . . . 72.21 109.725 -174.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 71.4 mt -130.25 138.14 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 107.519 -1.289 . . . . 73.14 107.519 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.433 ' HE1' HG13 ' B' ' 83' ' ' ILE . 26.7 p90 -161.66 143.37 11.42 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.248 0.547 . . . . 75.52 111.479 -172.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.538 HG23 HD11 ' B' ' 21' ' ' ILE . 21.1 m -76.44 123.26 25.73 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.946 -1.025 . . . . 74.54 108.522 171.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.407 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.8 mtpt -93.84 -26.54 16.88 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.265 0.626 . . . . 71.13 110.337 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.504 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 34.0 t70 -152.53 141.75 21.44 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.91 0.484 . . . . 75.11 110.814 -175.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.538 HD11 HG23 ' B' ' 18' ' ' THR . 32.8 mm -129.5 142.47 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.022 1.329 . . . . 74.44 108.449 174.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 46.5 m -147.58 134.27 19.97 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.846 -1.07 . . . . 73.31 109.668 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -147.16 109.05 4.4 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.752 -1.573 . . . . 71.23 106.752 167.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -120.98 114.84 22.1 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.487 -0.931 . . . . 74.34 108.487 -177.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.58 87.02 2.48 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 107.327 -1.36 . . . . 72.14 107.327 175.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.65 -37.28 22.12 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.502 2.134 . . . . 74.23 112.552 -169.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.526 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 82.4 m-20 -102.13 17.46 23.25 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.05 0.94 . . . . 73.33 110.621 -176.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -39.88 -60.74 1.28 Allowed Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 115.465 1.654 . . . . 75.53 115.465 -163.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.57 -28.48 38.02 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 121.844 1.696 . . . . 74.32 112.349 -173.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.459 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 79.1 m80 -92.83 -25.43 18.12 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.137 -0.938 . . . . 74.03 112.145 -173.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.562 HG21 ' HA ' ' B' ' 73' ' ' ALA . 6.0 p -83.02 -7.55 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 121.259 0.552 . . . . 75.43 110.725 -176.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -77.76 -9.23 58.91 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.207 0.603 . . . . 72.54 112.626 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 10.5 pt20 -67.23 -17.25 64.73 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.809 0.444 . . . . 71.11 110.582 170.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.513 ' HB2' HD13 ' B' ' 68' ' ' LEU . 30.5 mmtp -92.92 98.43 11.36 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.841 1.257 . . . . 74.24 109.23 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -100.1 78.25 2.06 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.322 0.649 . . . . 75.14 110.233 -176.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 25.2 p90 -166.06 172.46 11.35 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.575 0.75 . . . . 74.44 110.244 174.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -71.73 117.59 59.02 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 123.201 0.6 . . . . 74.33 110.104 175.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.421 ' HD3' ' HG2' ' B' ' 124' ' ' PRO . 55.8 Cg_endo -70.53 147.35 57.74 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 121.754 1.636 . . . . 72.33 110.474 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -72.47 110.0 6.56 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.22 -1.03 . . . . 73.42 108.22 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.745 HG21 ' HB1' ' B' ' 66' ' ' ALA . 59.9 t -99.32 146.05 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 114.955 -1.02 . . . . 73.24 110.44 -174.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -119.23 117.86 29.77 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.981 1.312 . . . . 73.34 108.578 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.602 HD12 HD21 ' B' ' 128' ' ' LEU . 24.2 tp -89.26 144.77 25.85 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.922 -0.399 . . . . 75.12 109.922 172.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.41 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 12.3 t70 -150.82 119.25 6.42 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.752 -0.832 . . . . 74.04 108.752 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 90.5 mt -99.47 126.24 45.36 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.475 -0.565 . . . . 71.52 109.475 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -124.79 127.45 47.2 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.765 -1.198 . . . . 74.15 107.765 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.8 t -109.46 141.37 41.97 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 122.746 0.418 . . . . 74.2 110.178 -172.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.69 140.73 27.47 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.477 1.111 . . . . 74.35 108.104 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.447 ' HG ' HG23 ' B' ' 58' ' ' VAL . 14.9 m -137.92 163.8 30.57 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.764 0.426 . . . . 72.4 110.021 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 72.1 p -156.41 136.31 12.64 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.246 0.618 . . . . 73.3 109.705 174.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -91.43 134.6 34.49 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.248 -1.019 . . . . 73.04 108.248 170.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 pp -150.67 14.22 0.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.432 -0.804 . . . . 74.34 109.717 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.98 158.82 35.64 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.439 -0.801 . . . . 71.5 110.953 -174.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -83.66 127.03 33.46 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.778 -1.101 . . . . 72.14 108.897 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 64.03 4.0 1.88 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 124.472 1.109 . . . . 71.14 113.065 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 53.6 t -132.32 122.73 48.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.63 -0.878 . . . . 74.31 108.63 -173.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.43 140.62 44.49 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 108.214 -1.032 . . . . 74.13 108.214 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -99.48 101.37 12.59 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 105.442 -2.058 . . . . 74.44 105.442 172.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.447 HG23 ' HG ' ' B' ' 48' ' ' SER . 14.6 p -109.29 140.14 29.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 121.407 0.622 . . . . 72.12 109.329 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 17.0 t -114.2 144.56 21.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 124.614 1.166 . . . . 63.45 108.683 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 48.1 tp -121.12 110.36 16.12 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 107.751 -1.203 . . . . 73.34 107.751 167.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -84.25 118.36 24.12 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.673 -1.232 . . . . 74.42 107.673 171.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.4 121.24 57.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.44 -0.948 . . . . 74.31 108.44 173.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.41 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 17.8 m -108.75 135.29 50.22 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.74 0.816 . . . . 65.42 109.384 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 82.0 t -134.11 119.88 32.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.903 0.881 . . . . 73.12 109.171 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 66.6 m -109.5 138.98 45.06 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 123.659 0.783 . . . . 75.14 109.072 173.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.745 ' HB1' HG21 ' B' ' 40' ' ' VAL . . . -148.73 141.86 24.96 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.728 0.411 . . . . 73.43 109.909 178.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.516 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 35.4 p -141.68 132.68 26.07 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.607 0.763 . . . . 73.14 110.904 -176.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.513 HD13 ' HB2' ' B' ' 34' ' ' LYS . 68.8 mt -102.04 103.41 14.0 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 124.664 1.186 . . . . 71.51 109.196 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.96 -124.59 7.88 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.794 -0.639 . . . . 62.31 111.986 -175.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -96.08 2.24 53.1 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.937 0.895 . . . . 74.12 111.037 -173.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.526 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 19.9 pt-20 -130.16 149.38 51.89 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.988 0.515 . . . . 73.3 110.901 -173.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 85.9 m -73.73 123.68 24.57 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.014 -0.539 . . . . 75.32 110.673 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.562 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -76.35 -60.94 2.12 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.651 -1.159 . . . . 74.51 108.704 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -153.13 152.71 31.58 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.058 -0.974 . . . . 75.11 111.85 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 75.2 mt -121.05 110.62 16.46 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.53 -1.656 . . . . 74.51 106.53 169.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 28.9 t -119.28 121.25 39.21 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.028 -0.73 . . . . 73.14 109.028 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -138.22 128.49 26.0 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.244 0.618 . . . . 74.34 109.409 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.406 HG11 ' HA ' ' B' ' 110' ' ' ALA . 73.3 t -126.44 134.94 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.596 0.758 . . . . 70.0 109.172 175.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.504 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.3 mt-30 -108.67 107.72 18.3 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.305 -0.998 . . . . 75.31 108.305 175.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -100.8 107.81 19.46 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.753 -0.832 . . . . 74.0 108.753 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.407 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -91.73 170.01 33.16 Favored Glycine 0 C--O 1.245 0.784 0 N-CA-C 111.865 -0.494 . . . . 54.22 111.865 175.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.53 139.66 5.78 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 121.727 -0.273 . . . . 71.22 113.069 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.433 HG13 ' HE1' ' B' ' 17' ' ' TYR . 66.5 mt -98.23 110.75 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 125.019 1.327 . . . . 75.04 108.182 176.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -122.79 143.95 49.5 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.713 0.805 . . . . 74.43 110.839 -175.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 37.1 m -102.2 122.94 45.16 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.73 0.812 . . . . 70.3 109.894 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.519 ' HB ' HD13 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -131.89 122.74 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 124.911 1.284 . . . . 75.3 109.302 179.266 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.94 150.51 24.4 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.885 0.474 . . . . 62.51 111.579 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.36 -35.67 4.73 Favored Glycine 0 N--CA 1.479 1.503 0 C-N-CA 123.263 0.458 . . . . 75.22 112.394 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.525 HG22 ' SD ' ' B' ' 9' ' ' MET . 7.1 pt -63.75 160.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 124.891 1.276 . . . . 73.34 112.655 173.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -153.78 176.07 12.57 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.023 0.929 . . . . 75.41 110.317 -173.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.4 -130.86 41.2 Favored Glycine 0 C--N 1.354 1.533 0 O-C-N 123.73 0.643 . . . . 74.42 112.859 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 18.0 m -67.5 -45.29 76.26 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.678 0.791 . . . . 75.34 109.75 172.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -59.12 -23.66 62.31 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 113.556 -1.656 . . . . 74.3 112.238 -167.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 20.6 ttt -58.6 -70.23 0.15 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.014 1.326 . . . . 74.13 111.931 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.39 -12.8 56.08 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.803 0.441 . . . . 70.25 112.137 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -63.24 -41.78 99.11 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.355 0.662 . . . . 72.21 110.267 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -60.69 -43.64 97.5 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.855 -0.611 . . . . 72.31 111.6 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.563 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.2 pp -81.28 -23.83 37.67 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.726 0.41 . . . . 73.15 111.776 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.51 -1.61 60.46 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-O 119.784 -0.453 . . . . 65.43 113.877 -174.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.47 -55.99 0.39 Allowed 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.303 0.551 . . . . 70.42 111.891 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -69.11 -46.23 68.23 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.745 0.418 . . . . 74.25 110.33 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.563 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 79.3 m -66.19 -47.98 59.85 Favored Pre-proline 0 CA--C 1.569 1.687 0 N-CA-C 113.711 1.004 . . . . 73.4 113.711 -177.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.44 ' HG3' HG22 ' B' ' 58' ' ' VAL . 15.2 Cg_exo -65.12 -28.82 56.52 Favored 'Trans proline' 0 C--N 1.402 3.359 0 C-N-CA 122.033 1.822 . . . . 72.24 112.87 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -69.62 -29.03 66.44 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.092 0.557 . . . . 73.05 110.325 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.23 -35.69 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.339 0.656 . . . . 74.41 110.334 170.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 76.5 mt -80.26 -17.98 50.68 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.821 0.848 . . . . 74.12 112.33 -177.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -59.42 -50.71 85.89 Favored Pre-proline 0 CA--C 1.561 1.375 0 CA-C-O 117.515 -1.231 . . . . 73.02 112.898 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -54.73 -37.11 91.84 Favored 'Trans proline' 0 C--N 1.39 2.727 0 C-N-CA 122.429 2.086 . . . . 70.2 114.028 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.414 ' HE2' HG23 ' D' ' 115' ' ' THR . 55.5 m-85 -68.73 -46.69 68.24 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.376 0.671 . . . . 74.1 110.583 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.406 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -64.55 -34.72 78.91 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.592 -0.731 . . . . 63.5 110.924 176.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 31.2 ttt180 -64.99 -50.13 67.54 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.226 1.41 . . . . 73.45 110.813 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.38 -32.52 70.21 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.403 0.681 . . . . 64.51 109.933 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.547 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.9 t -67.31 -41.37 85.46 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 122.923 0.489 . . . . 71.11 110.728 177.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 49.8 mt -59.83 -54.42 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.837 0.855 . . . . 74.34 110.445 172.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 25.1 m -61.79 -29.22 70.0 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 123.757 0.661 . . . . 75.24 111.371 -177.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 44.6 t -64.5 -52.44 57.83 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 123.543 0.737 . . . . 74.5 109.839 173.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.547 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 15.6 mmt -66.02 -33.62 76.22 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.27 0.628 . . . . 72.15 111.612 -175.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.658 HG23 HD21 ' B' ' 126' ' ' LEU . 74.3 t -66.76 -44.48 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.639 1.176 . . . . 75.45 110.602 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.5 t -64.66 -32.83 74.67 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.099 -0.955 . . . . 74.22 110.567 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' B' ' 116' ' ' SER . 78.5 mtt-85 -64.67 -47.78 77.16 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 115.709 -0.678 . . . . 73.44 109.339 175.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -67.95 -5.99 42.71 Favored Glycine 0 C--N 1.358 1.772 0 O-C-N 123.735 0.647 . . . . 31.31 113.615 174.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.49 ' HB ' ' HE ' ' A' ' 15' ' ' ARG . 2.2 m 66.77 27.62 9.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.539 1.536 . . . . 74.51 110.563 175.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -84.87 156.06 61.18 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.214 0.605 . . . . 74.32 110.971 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.421 ' HG2' ' HD3' ' B' ' 38' ' ' PRO . 71.6 Cg_exo -51.89 167.86 0.41 Allowed 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 123.991 3.127 . . . . 71.22 115.219 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -63.52 112.56 2.83 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.832 -1.076 . . . . 74.4 111.605 -167.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.658 HD21 HG23 ' B' ' 118' ' ' VAL . 43.6 tp -116.56 105.82 12.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.282 0.633 . . . . 74.35 109.56 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -121.49 120.96 36.41 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.034 -1.098 . . . . 74.41 108.034 170.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.602 HD21 HD12 ' B' ' 42' ' ' LEU . 59.2 mt -74.21 143.92 44.96 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.58 0.55 . . . . 71.14 110.988 -174.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.91 141.14 63.19 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 122.961 0.504 . . . . 74.11 110.843 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.627 ' HG3' HD11 ' D' ' 16' ' ' ILE . 61.7 Cg_endo -70.14 79.98 1.02 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.334 2.689 . . . . 73.33 111.216 174.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 p -100.01 125.42 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 115.498 -0.774 . . . . 74.44 110.053 -177.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 60.3 t30 . . . . . 0 CA--C 1.539 0.556 0 CA-C-N 115.677 -0.692 . . . . 74.35 110.108 -177.403 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 68.3 t80 . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 109.264 -0.643 . . . . 72.0 109.264 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -161.97 126.54 3.32 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.559 0.744 . . . . 75.32 109.591 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 48.5 mt -78.84 123.59 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 108.438 -0.949 . . . . 74.24 108.438 169.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.447 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 81.6 mm-40 -90.44 -42.12 11.07 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.644 0.777 . . . . 72.43 109.688 176.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.477 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 9.0 ptp85 -173.42 150.9 1.89 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.312 -0.858 . . . . 74.53 110.212 -178.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 74.3 mt -128.17 135.15 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 106.731 -1.581 . . . . 73.53 106.731 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -173.06 158.64 3.77 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.379 0.609 . . . . 72.41 111.724 -170.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 70.2 p -82.46 113.24 20.08 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.341 -0.845 . . . . 74.14 109.123 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.439 ' HE3' ' HB2' ' D' ' 28' ' ' ALA . 10.4 mmmm -68.61 -49.13 61.64 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.046 -1.094 . . . . 73.11 108.046 169.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.697 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 20.8 t70 -136.19 143.68 44.54 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 113.852 -1.522 . . . . 73.44 109.681 -172.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.55 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.5 mt -138.47 145.66 27.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 125.435 1.494 . . . . 75.23 107.25 175.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 41.3 t -153.17 147.75 26.12 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.463 0.649 . . . . 74.1 110.048 175.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -151.83 125.61 9.04 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.04 -1.467 . . . . 74.44 107.04 170.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -129.35 117.81 21.23 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.682 0.793 . . . . 71.05 108.867 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.22 85.62 5.62 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 107.304 -1.369 . . . . 75.41 107.304 167.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.91 -33.61 63.11 Favored 'Trans proline' 0 C--N 1.387 2.605 0 C-N-CA 123.097 2.531 . . . . 72.51 112.209 -172.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -113.6 31.51 6.45 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.861 -1.063 . . . . 73.0 109.605 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.452 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -43.91 -54.68 10.54 Favored Pre-proline 0 C--N 1.377 1.764 0 CA-C-O 117.837 -1.078 . . . . 71.01 113.383 -174.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 50.1 Cg_exo -53.28 -52.16 9.33 Favored 'Trans proline' 0 C--N 1.395 3.003 0 C-N-CA 122.001 1.801 . . . . 74.41 113.128 175.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -69.52 -32.57 71.49 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.608 -1.178 . . . . 74.4 113.2 -171.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.628 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.9 p -79.05 -24.44 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 N-CA-C 112.48 0.548 . . . . 73.51 112.48 -173.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -71.42 -17.86 62.36 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 112.349 0.5 . . . . 71.51 112.349 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -93.75 7.39 45.01 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.918 0.487 . . . . 75.01 111.759 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.687 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -94.62 158.74 15.39 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.232 0.613 . . . . 71.42 110.788 -177.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -68.22 129.65 40.55 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.057 0.943 . . . . 65.43 109.539 164.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . 0.556 ' HZ2' HD21 ' C' ' 126' ' ' LEU . 64.0 t-105 -82.24 90.49 6.62 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.211 0.604 . . . . 74.41 110.5 -178.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -143.14 78.38 15.16 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 107.709 -1.219 . . . . 74.35 107.709 171.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -93.79 169.85 1.99 Allowed 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 122.527 2.151 . . . . 64.35 112.835 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -92.78 89.76 6.76 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 106.181 -1.785 . . . . 71.54 106.181 171.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 61.2 t -68.16 96.97 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 109.037 -0.727 . . . . 74.14 109.037 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -96.75 104.68 16.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.884 -1.053 . . . . 74.42 108.641 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.611 ' H ' HD23 ' C' ' 42' ' ' LEU . 1.8 pt? -97.07 121.14 38.62 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.788 -1.56 . . . . 74.13 106.788 168.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -119.39 141.12 49.36 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.571 -0.9 . . . . 72.1 108.571 -174.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 50.0 mt -130.97 110.74 11.47 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.32 0.648 . . . . 65.54 110.165 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -114.54 122.86 47.85 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.967 1.707 . . . . 73.13 107.469 173.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.1 t -121.8 149.28 43.55 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.029 -0.73 . . . . 73.1 109.029 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.45 153.57 32.74 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.543 0.737 . . . . 75.42 109.281 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.448 ' HG ' ' HB3' ' C' ' 98' ' ' LEU . 12.8 m -131.71 145.36 51.59 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.304 0.642 . . . . 74.13 109.414 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.3 p -144.91 127.37 15.96 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.566 -0.901 . . . . 75.21 108.566 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -80.28 117.91 21.47 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 108.717 -0.846 . . . . 72.13 108.717 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.465 HD11 HD13 ' C' ' 83' ' ' ILE . 25.6 mt -83.82 -47.18 11.39 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.585 0.707 . . . . 71.34 109.656 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.57 -166.96 2.69 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 114.486 -1.233 . . . . 63.51 110.029 -171.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -57.77 105.0 0.22 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.399 1.079 . . . . 71.33 110.535 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 60.1 22.17 11.41 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.329 1.018 . . . . 75.34 112.978 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 85.6 t -104.3 119.64 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.661 0.785 . . . . 74.41 108.989 173.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -121.28 121.31 37.42 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.821 -1.177 . . . . 75.43 107.821 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -89.93 114.43 26.23 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.033 -1.099 . . . . 71.2 108.033 168.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 97.9 t -95.14 134.94 30.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.278 -1.379 . . . . 61.34 107.278 168.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 93.8 t -121.11 138.0 52.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 108.356 -0.979 . . . . 64.45 108.356 174.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.27 101.08 8.84 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.994 -1.113 . . . . 74.33 107.994 175.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 21.0 ttm-85 -81.07 107.13 13.62 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 108.434 -0.95 . . . . 74.44 108.434 170.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.491 ' HB ' HD11 ' C' ' 114' ' ' ILE . 7.8 t -106.58 120.11 57.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 108.09 -1.078 . . . . 70.32 108.09 173.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 17.5 m -119.21 116.16 25.72 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.251 0.621 . . . . 64.02 109.572 -174.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.528 HG21 HG21 ' C' ' 114' ' ' ILE . 63.3 t -104.06 109.04 26.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 123.452 0.701 . . . . 75.55 109.114 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 3.8 m -99.4 140.1 34.08 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.668 -1.234 . . . . 64.23 107.668 170.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.41 119.42 19.62 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 106.661 -1.607 . . . . 74.25 106.661 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 44.9 m -133.29 126.02 30.54 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.579 0.549 . . . . 65.1 110.452 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.687 HD11 ' HG2' ' C' ' 34' ' ' LYS . 11.0 mt -86.78 47.08 1.44 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.766 1.226 . . . . 65.33 109.317 176.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.65 -110.8 3.84 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 111.001 -0.84 . . . . 71.03 111.001 -174.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.16 -28.87 19.73 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.093 -0.706 . . . . 75.34 109.093 173.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -62.86 120.67 11.76 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.584 1.153 . . . . 75.32 109.194 172.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 20.9 m -84.24 125.06 31.87 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 108.443 -0.947 . . . . 75.13 108.443 169.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.628 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -73.45 -62.97 1.29 Allowed 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.328 -0.99 . . . . 64.4 108.328 174.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -157.33 169.89 23.7 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-O 121.917 0.865 . . . . 73.31 110.782 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.431 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.7 tm? -123.43 147.01 47.56 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 106.388 -1.708 . . . . 74.34 106.388 166.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.431 ' N ' HD13 ' C' ' 75' ' ' LEU . 48.4 t -149.22 145.62 27.2 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.846 -1.168 . . . . 71.15 107.846 177.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -157.07 136.56 12.17 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.301 -0.629 . . . . 74.15 109.301 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.476 HG12 ' HA ' ' C' ' 110' ' ' ALA . 54.7 t -134.22 113.52 17.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.136 -1.061 . . . . 63.3 108.136 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.697 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.4 mt-30 -94.44 89.21 5.77 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.828 -0.805 . . . . 74.42 108.828 173.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -79.68 102.4 8.94 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.509 -1.223 . . . . 74.55 110.09 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.58 150.47 26.93 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 112.007 -0.437 . . . . 61.41 112.007 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.22 117.69 0.84 Allowed Glycine 0 CA--C 1.502 -0.771 0 N-CA-C 110.233 -1.147 . . . . 63.3 110.233 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.474 HD11 ' HB3' ' D' ' 29' ' ' PRO . 25.5 mm -85.23 121.15 36.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.53 -0.915 . . . . 73.51 108.53 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -129.9 117.18 19.74 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.16 -1.052 . . . . 72.22 108.16 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 53.9 p -90.45 103.5 16.18 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.954 -0.758 . . . . 63.35 108.954 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.497 HD12 ' SG ' ' C' ' 97' ' ' CYS . 25.4 mt -116.86 138.74 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.146 0.978 . . . . 74.1 110.746 -171.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.06 170.4 19.48 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.657 0.783 . . . . 73.3 110.869 175.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.83 -18.67 38.01 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-N 115.534 -0.757 . . . . 50.22 113.756 172.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.446 HG23 HE21 ' C' ' 93' ' ' GLN . 34.8 pt -106.33 170.59 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.232 0.613 . . . . 72.3 111.261 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -160.81 158.84 29.13 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.645 0.778 . . . . 74.14 109.854 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.55 -114.76 7.1 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 123.615 0.572 . . . . 74.13 113.846 168.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 13.4 t -66.25 -35.5 80.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.635 0.774 . . . . 74.53 111.082 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.446 HE21 HG23 ' C' ' 89' ' ' ILE . 29.5 mt-30 -71.81 -42.66 66.78 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.646 0.778 . . . . 73.44 110.622 -178.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 6.2 tpt -62.5 -52.36 63.78 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 123.923 0.765 . . . . 75.33 110.024 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.87 -31.42 72.59 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.753 -0.658 . . . . 75.23 111.817 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -72.17 -34.18 68.26 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.142 0.577 . . . . 70.1 110.553 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.497 ' SG ' HD12 ' C' ' 86' ' ' ILE . 18.2 t -71.2 -41.37 70.35 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.699 -0.482 . . . . 71.34 109.699 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.448 ' HB3' ' HG ' ' C' ' 48' ' ' SER . 89.9 mt -85.05 -44.51 12.96 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.959 0.904 . . . . 72.21 112.815 -170.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.52 3.17 57.68 Favored Glycine 0 N--CA 1.472 1.072 0 CA-C-N 116.067 -0.515 . . . . 43.31 113.481 -170.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.31 -68.98 0.45 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.999 0.4 . . . . 64.2 111.096 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -60.21 -55.1 37.93 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.765 0.826 . . . . 72.14 112.475 -171.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 98.2 m -59.75 -46.74 98.45 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.794 0.838 . . . . 72.13 112.523 -177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -50.85 -35.21 48.09 Favored 'Trans proline' 0 C--N 1.395 3.018 0 C-N-CA 123.071 2.514 . . . . 75.02 115.119 169.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -66.8 -33.9 76.63 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 118.719 0.69 . . . . 74.32 111.075 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.528 HD13 ' NH1' ' A' ' 111' ' ' ARG . 42.0 mm -72.53 -34.83 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 123.004 0.521 . . . . 75.34 109.907 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 89.4 mt -84.49 -24.56 29.37 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.855 0.862 . . . . 70.5 112.326 -177.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -57.05 -52.11 76.6 Favored Pre-proline 0 N--CA 1.482 1.137 0 CA-C-O 117.334 -1.317 . . . . 71.15 113.867 -172.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.01 -34.41 80.65 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.168 1.912 . . . . 74.54 112.915 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -66.35 -47.62 72.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.483 0.713 . . . . 74.32 110.236 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.476 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -63.39 -36.88 85.2 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.855 -1.066 . . . . 73.15 110.943 177.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.2 ttt-85 -68.99 -46.57 67.71 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.409 1.484 . . . . 75.34 111.176 -175.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -67.97 -34.33 76.36 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.528 0.731 . . . . 71.35 109.486 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 12.8 t -65.86 -35.67 81.32 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.462 0.705 . . . . 74.22 111.249 177.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.528 HG21 HG21 ' C' ' 64' ' ' VAL . 85.7 mt -69.23 -58.04 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.345 0.658 . . . . 72.43 110.485 176.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 4.7 m -64.43 -28.38 69.64 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 122.707 0.403 . . . . 70.03 111.249 -173.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 42.0 t -61.6 -52.78 62.99 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 123.279 0.632 . . . . 72.52 109.37 169.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.571 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.08 -42.59 80.96 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.011 1.324 . . . . 74.43 113.002 -179.568 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 87.3 t -63.62 -45.67 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.381 1.072 . . . . 72.34 110.253 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.4 t -67.52 -29.67 69.13 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.281 -1.327 . . . . 74.13 111.429 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.487 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 87.3 mtt-85 -68.59 -39.53 80.89 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.072 -0.714 . . . . 74.43 109.072 176.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.79 12.03 58.04 Favored Glycine 0 C--N 1.354 1.535 0 CA-C-N 115.698 -0.683 . . . . 71.01 113.0 175.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 69.0 p 53.8 37.53 26.56 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 126.212 1.805 . . . . 75.33 114.146 175.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -93.99 148.03 34.52 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 107.583 -1.266 . . . . 74.14 107.583 165.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.01 169.45 0.64 Allowed 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.224 2.616 . . . . 73.0 114.168 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -59.32 123.3 16.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.159 0.984 . . . . 74.32 111.975 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.556 HD21 ' HZ2' ' C' ' 36' ' ' TRP . 3.5 mm? -116.27 86.14 2.43 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.674 -1.232 . . . . 74.13 107.674 166.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -91.46 95.17 9.82 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.727 -0.842 . . . . 74.41 108.727 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 8.5 mp -55.84 131.01 45.85 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.102 0.961 . . . . 73.23 111.583 -175.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.44 137.08 96.48 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-O 118.694 -0.669 . . . . 75.53 110.453 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.469 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 4.2 Cg_endo -49.52 110.91 0.41 Allowed 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.673 2.915 . . . . 73.4 113.442 178.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.9 t -100.93 114.55 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 123.142 0.577 . . . . 75.41 109.455 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -80.88 105.7 12.32 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.421 0.689 . . . . 73.32 109.418 176.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -68.8 -20.78 64.34 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.372 0.669 . . . . 75.33 112.329 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.55 -29.85 65.22 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.116 0.566 . . . . 65.51 110.554 173.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.01 -35.0 64.36 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.064 0.546 . . . . 73.21 110.004 173.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 83.1 mt -67.68 -40.28 84.42 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.82 -0.627 . . . . 71.3 110.418 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 55.9 t80 . . . . . 0 N--CA 1.473 0.717 0 C-N-CA 123.741 0.816 . . . . 75.32 110.488 179.793 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 C--O 1.242 0.687 0 N-CA-C 109.525 -0.546 . . . . 64.14 109.525 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.489 ' HA ' ' O ' ' D' ' 85' ' ' SER . 58.5 t80 -134.5 105.41 6.53 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.648 -1.242 . . . . 70.32 107.648 175.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -129.83 115.82 17.8 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.724 -0.843 . . . . 64.51 108.724 -174.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.514 HD11 HG21 ' D' ' 105' ' ' ILE . 8.1 mt -76.04 122.53 30.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 108.314 -0.995 . . . . 73.41 108.314 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -89.16 -29.05 19.6 Favored 'General case' 0 C--O 1.242 0.675 0 O-C-N 123.822 0.701 . . . . 72.34 110.982 -176.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -172.77 138.2 0.81 Allowed 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.464 0.477 . . . . 74.51 110.146 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.627 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.5 mp -120.88 135.97 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.681 -1.229 . . . . 73.44 107.681 173.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -162.4 170.14 19.3 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.207 1.003 . . . . 72.23 112.85 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.5 p -105.05 119.24 38.54 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.224 -1.353 . . . . 63.51 108.509 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -88.0 -21.29 24.9 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.035 -0.53 . . . . 75.32 109.925 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 31.8 t70 -159.9 138.61 10.6 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.182 0.993 . . . . 63.14 109.219 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.571 HG23 ' HE1' ' C' ' 117' ' ' MET . 72.5 mt -139.77 138.29 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.971 1.308 . . . . 73.35 107.802 176.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.5 t -139.69 143.35 37.05 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.104 0.962 . . . . 74.21 109.008 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.55 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 91.7 t80 -150.0 122.99 8.78 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 106.612 -1.625 . . . . 73.34 106.612 170.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.63 111.65 11.9 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.715 0.806 . . . . 62.41 109.584 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.93 84.66 4.47 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 107.665 -1.235 . . . . 70.33 107.665 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.16 -43.64 0.53 Allowed 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.415 2.077 . . . . 73.42 112.336 -171.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -93.81 10.52 32.77 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.256 1.022 . . . . 72.21 110.414 -176.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.439 ' HB2' ' HE3' ' C' ' 19' ' ' LYS . . . -31.69 -64.79 0.22 Allowed Pre-proline 0 N--CA 1.488 1.441 0 C-N-CA 127.259 2.224 . . . . 71.31 116.334 -166.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.474 ' HB3' HD11 ' C' ' 83' ' ' ILE . 93.5 Cg_endo -75.84 -21.65 14.13 Favored 'Trans proline' 0 C--N 1.38 2.222 0 CA-C-N 122.735 2.013 . . . . 74.53 114.073 -175.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -77.33 -37.29 52.79 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.377 1.071 . . . . 73.44 109.909 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.418 HG21 ' HB2' ' D' ' 68' ' ' LEU . 7.7 p -82.98 -25.57 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-N 115.452 -0.795 . . . . 72.44 111.308 -172.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -60.65 -25.78 66.58 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 122.883 0.473 . . . . 74.43 112.099 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -64.9 -8.66 16.43 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.776 1.23 . . . . 73.05 112.231 -175.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.55 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 89.6 mttt -96.41 95.01 7.75 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.2 1.4 . . . . 75.44 109.041 175.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -81.91 81.71 7.8 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.356 0.662 . . . . 74.11 111.093 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -160.78 -179.88 7.95 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.18 0.992 . . . . 72.12 109.1 166.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . 0.422 ' NE2' ' HD2' ' D' ' 38' ' ' PRO . 35.3 tp60 -75.78 114.12 33.61 Favored Pre-proline 0 N--CA 1.477 0.9 0 CA-C-O 118.294 -0.86 . . . . 72.31 109.167 178.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.422 ' HD2' ' NE2' ' D' ' 37' ' ' GLN . 51.1 Cg_exo -53.35 134.79 58.54 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.045 2.497 . . . . 75.02 111.856 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -63.81 107.82 1.3 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 107.623 -1.251 . . . . 74.22 107.623 175.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.661 HG11 HG13 ' D' ' 64' ' ' VAL . 86.5 t -104.4 129.55 56.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 109.416 -0.587 . . . . 75.5 109.416 -176.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -105.35 112.28 25.33 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 106.348 -1.723 . . . . 73.55 106.348 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.486 HD21 ' HB2' ' D' ' 128' ' ' LEU . 64.8 tp -94.33 150.02 20.68 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.678 -1.23 . . . . 72.52 107.678 174.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -148.27 140.07 23.83 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.255 -1.017 . . . . 75.23 108.255 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.489 HD21 HG21 ' D' ' 62' ' ' VAL . 91.4 mt -130.7 145.09 51.85 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.584 0.754 . . . . 73.02 109.452 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -155.62 141.35 18.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.766 -1.198 . . . . 73.41 107.766 169.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 25.9 m -102.84 156.18 17.83 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.214 1.005 . . . . 74.22 109.292 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.09 167.13 26.7 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 126.039 1.736 . . . . 74.32 106.8 172.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 13.5 p . . . . . 0 C--O 1.244 0.783 0 N-CA-C 109.306 -0.627 . . . . 70.45 109.306 -179.79 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' D' ' 85' ' ' SER . 1.9 m-20 . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 112.011 0.374 . . . . 73.32 112.011 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.26 94.88 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 109.054 -0.721 . . . . 73.43 109.054 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -122.95 127.99 49.64 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.787 -0.82 . . . . 74.45 108.787 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -94.64 119.42 33.27 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.468 -0.938 . . . . 60.33 108.468 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 73.8 t -101.33 134.45 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.853 0.861 . . . . 71.13 108.851 173.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.499 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 33.4 t -116.02 128.44 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.185 0.994 . . . . 63.44 108.745 173.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.39 111.69 24.14 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.86 -1.163 . . . . 72.44 107.86 175.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 ttt85 -85.82 106.48 17.08 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.233 -0.655 . . . . 73.54 109.233 174.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' D' ' 110' ' ' ALA . 61.1 t -105.75 130.65 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.268 1.027 . . . . 73.22 108.624 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 7.3 m -134.75 144.46 47.72 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.014 0.435 . . . . 73.44 110.964 -173.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.661 HG13 HG11 ' D' ' 40' ' ' VAL . 55.0 t -133.85 114.28 19.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 C-N-CA 125.447 1.499 . . . . 65.43 108.902 -173.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 19.2 m -106.12 93.46 4.63 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.074 -1.084 . . . . 74.43 108.074 169.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.08 144.94 27.04 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.363 0.665 . . . . 72.25 109.937 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.428 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 48.2 m -151.89 127.85 10.35 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 123.424 0.69 . . . . 75.13 110.879 -177.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.418 ' HB2' HG21 ' D' ' 31' ' ' VAL . 16.6 mt -93.45 109.31 20.9 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 107.764 -1.199 . . . . 74.32 107.764 168.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.19 -124.32 8.27 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 116.064 -0.516 . . . . 74.35 112.496 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.15 3.99 28.55 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.329 0.652 . . . . 72.45 111.775 -176.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.55 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 11.8 pt-20 -118.42 158.88 24.46 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 109.574 -0.528 . . . . 73.42 109.574 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 52.0 m -72.43 129.56 38.63 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.615 -0.72 . . . . 74.31 111.685 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.428 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -81.54 -69.19 0.63 Allowed 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.829 -1.174 . . . . 72.31 107.829 173.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -153.54 153.77 33.03 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 115.841 -0.618 . . . . 74.43 111.105 176.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 50.0 mt -119.32 109.93 16.38 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.396 -1.335 . . . . 75.41 107.396 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.537 ' SG ' HG12 ' D' ' 114' ' ' ILE . 42.0 t -120.61 136.98 54.66 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 123.544 0.737 . . . . 74.31 109.586 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -152.06 123.88 7.98 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.9 0.48 . . . . 74.0 109.794 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 88.3 t -127.58 118.52 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.926 0.89 . . . . 73.21 109.836 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.413 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.2 mt-30 -90.72 90.13 7.82 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.517 0.727 . . . . 71.24 109.251 171.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -82.77 98.74 9.26 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.723 -1.126 . . . . 74.23 109.422 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -102.19 156.4 18.55 Favored Glycine 0 N--CA 1.471 1.012 0 N-CA-C 112.077 -0.409 . . . . 60.41 112.077 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.4 150.05 13.78 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 117.2 0.5 . . . . 64.12 112.619 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 57.5 mt -90.0 132.71 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 109.082 -0.71 . . . . 73.34 109.082 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -128.98 140.46 51.64 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.305 1.042 . . . . 73.04 109.575 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 39.8 t -93.59 108.27 20.01 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 107.682 -1.229 . . . . 71.32 107.682 168.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 33.9 pt -109.13 123.9 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 N-CA-C 108.654 -0.869 . . . . 74.04 108.654 172.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.45 168.29 6.52 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.173 0.589 . . . . 62.34 111.458 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.3 19.18 72.44 Favored Glycine 0 C--N 1.347 1.165 0 O-C-N 123.683 0.614 . . . . 61.4 112.941 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.43 164.25 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.266 1.027 . . . . 74.54 109.799 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -146.68 -179.35 6.72 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.749 0.82 . . . . 73.5 110.57 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.82 -140.29 27.64 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 115.984 -0.553 . . . . 71.3 112.472 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 60.8 p -89.62 -29.83 18.57 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.366 0.666 . . . . 74.04 110.752 172.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -53.4 -33.22 53.03 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.578 1.151 . . . . 74.12 112.474 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.492 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 2.9 ppp? -60.71 -50.63 72.72 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.876 0.87 . . . . 72.24 113.197 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . 0.492 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.25 -19.4 31.66 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.061 0.544 . . . . 71.13 110.978 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -67.88 -38.37 82.94 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.674 0.79 . . . . 74.11 110.49 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 86.9 m -61.15 -33.59 73.66 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.585 0.754 . . . . 72.21 111.587 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 27.0 tp -69.54 -37.57 77.13 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.916 0.486 . . . . 75.5 111.119 -176.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.2 0.11 68.47 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-O 119.388 -0.673 . . . . 74.44 113.6 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.75 -58.32 0.77 Allowed 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 117.74 0.77 . . . . 73.42 112.932 -171.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -72.35 -43.84 63.48 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.064 0.545 . . . . 75.2 110.925 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 75.2 m -60.45 -45.48 97.38 Favored Pre-proline 0 CA--C 1.571 1.752 0 C-N-CA 124.132 0.973 . . . . 70.41 112.166 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.28 -42.05 72.33 Favored 'Trans proline' 0 C--N 1.395 3.014 0 C-N-CA 123.188 2.592 . . . . 70.04 113.836 165.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -63.38 -24.88 68.03 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.537 0.735 . . . . 74.44 110.972 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.514 HG21 HD11 ' D' ' 13' ' ' ILE . 44.8 mm -75.84 -45.5 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.798 0.839 . . . . 73.14 110.545 172.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.04 -25.79 65.54 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.477 -0.783 . . . . 75.24 111.672 -176.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -68.57 -40.01 17.26 Favored Pre-proline 0 CA--C 1.563 1.467 0 N-CA-C 114.507 1.299 . . . . 73.24 114.507 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -47.83 -46.64 20.9 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.447 2.098 . . . . 71.31 113.69 167.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . 0.438 ' OH ' ' HB3' ' B' ' 130' ' ' PRO . 99.0 m-85 -72.26 -38.46 68.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.631 0.773 . . . . 74.14 111.096 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . 0.52 ' HB3' HG22 ' D' ' 62' ' ' VAL . . . -65.93 -38.73 89.43 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.842 0.857 . . . . 75.31 110.776 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.486 HH12 ' HB3' ' D' ' 130' ' ' PRO . 24.3 ttp-105 -66.02 -48.93 69.49 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 115.104 -0.953 . . . . 75.13 110.032 175.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -56.16 -47.63 77.85 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.64 1.213 . . . . 72.21 110.977 -175.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.401 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 48.5 t -56.74 -46.26 81.48 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 124.032 0.832 . . . . 74.14 111.331 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.537 HG12 ' SG ' ' D' ' 76' ' ' CYS . 62.6 mt -63.33 -57.08 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.962 0.905 . . . . 72.02 111.096 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.414 HG23 ' HE2' ' B' ' 109' ' ' TYR . 38.8 m -52.89 -43.13 65.94 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.527 1.131 . . . . 74.25 111.273 -175.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 29.7 t -63.49 -43.42 97.31 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 114.251 -1.341 . . . . 75.04 109.925 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.486 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 71.8 mtm -69.87 -30.33 67.77 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.12 0.568 . . . . 74.2 111.763 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.441 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.4 t -64.56 -45.97 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.508 0.723 . . . . 62.34 109.916 175.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.2 p -74.53 -29.72 61.5 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.636 -0.711 . . . . 74.51 110.74 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 66.5 mtt-85 -70.65 -30.2 66.75 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.639 0.775 . . . . 73.21 109.868 173.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.62 8.97 75.59 Favored Glycine 0 C--N 1.354 1.539 0 O-C-N 123.62 0.575 . . . . 71.02 112.898 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 78.0 p 54.95 27.56 9.35 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 126.167 1.787 . . . . 73.04 113.974 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -88.67 151.04 47.29 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 109.211 -0.663 . . . . 72.52 109.211 168.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -48.3 133.85 25.11 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.642 2.895 . . . . 74.12 113.002 171.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -56.5 128.63 37.09 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.754 0.822 . . . . 64.03 112.006 -170.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.542 HD12 HG23 ' D' ' 40' ' ' VAL . 28.9 tp -108.93 98.23 7.74 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.612 1.165 . . . . 74.34 109.419 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -99.58 80.88 2.42 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.884 -1.154 . . . . 75.03 107.884 174.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.591 HD21 ' H ' ' D' ' 128' ' ' LEU . 0.3 OUTLIER -58.44 112.3 1.53 Allowed 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.64 -1.164 . . . . 74.12 109.686 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.6 139.48 75.6 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 125.102 1.361 . . . . 65.33 113.064 -169.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.486 ' HB3' HH12 ' D' ' 111' ' ' ARG . 96.2 Cg_endo -76.75 155.89 35.11 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.95 2.433 . . . . 73.21 112.633 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 9.6 p -148.79 143.47 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.551 -0.75 . . . . 71.33 109.568 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -81.49 105.98 13.09 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.161 -1.052 . . . . 60.31 108.161 172.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 . . . . . 0 N--CA 1.483 1.18 0 C-N-CA 124.154 0.982 . . . . 64.01 110.601 -177.801 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.0 m . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 109.361 -0.607 . . . . 74.32 109.361 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -125.32 114.43 18.89 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.847 -1.168 . . . . 71.34 107.847 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -134.38 133.4 40.55 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.254 -0.647 . . . . 75.44 109.254 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.459 HD12 HG21 ' A' ' 105' ' ' ILE . 4.7 mt -95.32 120.68 45.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 109.26 -0.644 . . . . 72.1 109.26 177.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -83.76 -39.6 19.86 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 123.554 0.534 . . . . 70.41 111.052 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -173.47 120.14 0.32 Allowed 'General case' 0 N--CA 1.472 0.675 0 O-C-N 123.393 0.433 . . . . 75.32 110.0 -170.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.491 HD13 ' HG3' ' C' ' 130' ' ' PRO . 64.7 mt -107.5 137.63 37.71 Favored 'Isoleucine or valine' 0 C--O 1.247 0.921 0 N-CA-C 108.17 -1.048 . . . . 75.12 108.17 171.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.45 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 35.9 p90 -166.4 179.27 5.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 124.304 1.003 . . . . 75.3 110.936 -170.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -111.39 120.21 41.43 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.422 0.689 . . . . 73.3 110.095 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.45 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.1 mtpt -86.08 -28.8 23.85 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.807 -0.442 . . . . 64.15 109.807 177.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.418 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 18.0 t70 -144.54 139.3 28.1 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.511 -0.768 . . . . 73.54 109.408 177.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.4 mt -139.42 140.47 37.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.405 -1.331 . . . . 64.44 107.405 172.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.5 t -153.6 125.29 7.69 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.58 0.752 . . . . 74.42 109.479 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.528 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 70.3 t80 -128.59 130.86 47.94 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 106.594 -1.632 . . . . 71.0 106.594 173.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -130.58 135.43 47.89 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.049 0.386 . . . . 71.32 110.002 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.2 76.29 12.34 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.234 1.014 . . . . 73.33 108.358 172.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.31 -34.87 9.22 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.509 2.139 . . . . 74.31 112.264 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.402 ' ND2' ' HG2' ' A' ' 71' ' ' GLU . 6.7 m-20 -91.34 11.77 22.61 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.537 -0.756 . . . . 63.1 110.74 -176.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.27 -54.12 23.66 Favored Pre-proline 0 CA--C 1.57 1.722 0 CA-C-O 118.03 -0.986 . . . . 74.44 113.035 -171.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.86 -30.41 76.86 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 122.343 2.028 . . . . 75.22 113.451 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -81.05 -43.19 19.9 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.271 0.628 . . . . 73.32 110.165 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 73' ' ' ALA . 2.0 p -77.58 -22.26 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 114.782 -1.099 . . . . 75.01 112.685 -159.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -73.28 -21.7 60.54 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.069 0.548 . . . . 73.1 111.629 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -77.96 -22.98 48.66 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.267 -0.879 . . . . 64.43 110.43 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -82.78 165.95 19.45 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.283 1.033 . . . . 74.3 111.323 -174.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -76.77 123.11 25.71 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.601 -0.727 . . . . 53.33 109.48 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -76.23 87.39 3.06 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.666 0.746 . . . . 74.44 110.329 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.94 75.96 47.21 Favored Pre-proline 0 C--O 1.242 0.663 0 N-CA-C 105.898 -1.89 . . . . 51.21 105.898 170.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.63 149.1 14.36 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.819 2.346 . . . . 53.45 112.923 -173.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -96.0 100.89 12.52 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 106.625 -1.62 . . . . 74.23 106.625 167.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 65' ' ' THR . 39.0 t -91.52 108.2 19.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 109.804 -0.443 . . . . 65.32 109.804 -176.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -102.54 114.09 28.01 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.963 -1.017 . . . . 73.12 109.178 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.598 HD11 HD13 ' A' ' 128' ' ' LEU . 6.7 tt -108.91 138.1 45.77 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.416 -0.957 . . . . 72.14 108.416 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -137.8 141.43 40.85 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.75 0.82 . . . . 63.35 109.396 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.526 HD22 HD21 ' A' ' 60' ' ' LEU . 97.3 mt -120.79 142.23 49.78 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.598 0.759 . . . . 72.32 111.337 -172.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.574 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 7.8 m-20 -134.54 137.72 44.05 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.49 -0.93 . . . . 72.4 108.49 176.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.6 m -123.48 126.81 47.42 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.36 0.664 . . . . 61.21 109.441 175.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.44 153.56 50.73 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 124.393 1.077 . . . . 75.03 108.915 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.451 ' HG ' ' HB3' ' A' ' 98' ' ' LEU . 49.8 m -126.8 159.55 33.49 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 122.962 0.505 . . . . 74.33 110.315 175.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.7 t -148.93 117.97 6.75 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.252 -1.018 . . . . 74.01 108.252 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -77.92 104.01 8.21 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.958 -0.756 . . . . 75.15 108.958 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 71.4 mt -78.63 -27.66 45.43 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.626 -0.716 . . . . 72.43 109.953 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.37 172.75 14.14 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.357 1.063 . . . . 74.31 109.093 175.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -66.44 127.98 34.39 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.582 -0.895 . . . . 53.23 108.582 169.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 69.0 12.83 8.72 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.482 1.113 . . . . 74.31 112.328 -174.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.6 t -127.79 112.02 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.01 0.924 . . . . 73.42 108.651 173.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -128.7 124.38 35.49 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.344 -0.614 . . . . 72.51 109.344 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -91.41 145.32 24.73 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.861 -0.792 . . . . 75.12 108.861 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.9 t -128.7 141.39 46.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.496 -0.928 . . . . 75.12 108.496 172.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 73.5 t -123.32 132.43 71.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 123.634 0.774 . . . . 74.04 109.225 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.526 HD21 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -110.07 110.14 20.94 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.22 -1.4 . . . . 74.14 107.22 175.672 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.574 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 22.0 ttp180 -93.88 100.55 12.7 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.189 -1.411 . . . . 75.03 107.189 175.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.476 HG23 HD23 ' A' ' 60' ' ' LEU . 23.1 t -95.13 124.6 47.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.228 -1.027 . . . . 61.42 108.228 174.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.9 m -121.04 122.0 39.14 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.346 -0.612 . . . . 74.11 109.346 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.526 HG23 HD12 ' A' ' 114' ' ' ILE . 86.9 t -109.58 132.43 57.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 124.49 1.116 . . . . 74.02 108.28 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 10.1 m -123.49 141.04 52.39 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.058 -1.46 . . . . 75.14 107.058 168.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.417 ' HB1' HG23 ' A' ' 40' ' ' VAL . . . -130.5 125.12 33.53 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 106.278 -1.749 . . . . 74.35 106.278 170.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.9 m -134.39 131.6 38.41 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 123.6 0.562 . . . . 75.43 111.205 -176.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.459 HD12 ' CG2' ' A' ' 31' ' ' VAL . 27.0 mt -89.82 84.79 6.27 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 108.134 -1.061 . . . . 74.44 108.134 174.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.65 -117.94 4.73 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 111.256 -0.738 . . . . 72.42 111.256 -173.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -88.18 -30.05 20.05 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 117.403 0.601 . . . . 73.12 109.588 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.402 ' HG2' ' ND2' ' A' ' 27' ' ' ASN . 22.4 tt0 -80.18 125.67 30.13 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.711 -0.477 . . . . 74.44 109.711 -175.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.2 m -80.27 134.75 36.12 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.271 0.558 . . . . 65.51 111.283 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.54 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -77.27 -60.7 2.25 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.148 -0.933 . . . . 72.23 108.96 174.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -152.14 163.61 39.01 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.786 -0.643 . . . . 73.34 111.033 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 32.0 tp -134.86 113.29 11.43 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.435 1.094 . . . . 74.05 108.611 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.479 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 70.5 m -104.88 140.26 38.4 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.92 0.888 . . . . 61.44 109.453 175.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -148.22 124.56 10.91 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.627 0.771 . . . . 55.41 109.466 172.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.0 t -133.75 112.77 17.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 124.274 1.029 . . . . 71.32 109.429 -174.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.418 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 65.4 mt-30 -84.68 89.45 7.49 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.39 -0.967 . . . . 73.04 108.39 167.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -76.4 93.83 3.55 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.896 -0.779 . . . . 71.43 108.896 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.11 148.36 21.43 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 111.551 -0.619 . . . . 65.32 111.551 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.04 122.33 1.45 Allowed Glycine 0 CA--C 1.506 -0.531 0 N-CA-C 110.801 -0.919 . . . . 72.22 110.801 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.8 mt -80.33 125.84 39.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 N-CA-C 108.305 -0.998 . . . . 74.31 108.305 171.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.598 ' HB3' HD11 ' A' ' 86' ' ' ILE . 86.3 m-85 -129.76 124.11 32.63 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.196 0.598 . . . . 65.44 109.687 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.4 m -85.5 93.65 8.82 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.777 -0.823 . . . . 71.53 108.777 172.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.598 HD11 ' HB3' ' A' ' 84' ' ' PHE . 7.9 mm -109.74 148.13 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 116.14 -0.482 . . . . 74.51 109.847 -176.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.79 171.12 19.37 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.057 0.543 . . . . 73.21 110.67 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.49 -34.21 5.61 Favored Glycine 0 C--N 1.344 0.973 0 O-C-N 123.853 0.721 . . . . 65.35 112.915 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.8 153.5 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.968 0.507 . . . . 71.22 111.364 -169.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.446 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 21.5 tt0 -143.89 -179.11 6.27 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.961 -1.018 . . . . 73.03 108.254 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.446 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 61.5 -133.19 47.77 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 113.784 0.274 . . . . 35.53 113.784 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.7 t -72.51 -23.22 60.99 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 122.951 0.5 . . . . 64.1 111.612 -177.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -71.73 -36.83 70.6 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.454 0.701 . . . . 75.11 110.183 177.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.485 ' HA ' ' HE1' ' A' ' 94' ' ' MET . 4.6 tpt -66.07 -49.91 65.96 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.903 -0.59 . . . . 73.23 109.881 174.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.11 -33.27 70.65 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.146 -0.934 . . . . 73.23 111.192 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.409 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 55.1 t-80 -72.26 -41.51 66.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.461 0.704 . . . . 72.13 110.898 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 46.5 t -64.25 -35.79 81.98 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 121.226 0.536 . . . . 72.22 110.189 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.451 ' HB3' ' HG ' ' A' ' 48' ' ' SER . 67.9 mt -89.54 -26.81 20.67 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.146 -0.934 . . . . 75.22 112.214 -177.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.06 4.47 45.24 Favored Glycine 0 N--CA 1.473 1.118 0 O-C-N 123.102 0.251 . . . . 73.31 113.363 -173.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.555 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -141.87 -68.46 0.38 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 122.75 0.42 . . . . 73.04 110.805 -177.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -66.88 -46.63 74.35 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 116.246 -0.434 . . . . 75.11 111.864 -171.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 92.6 m -62.3 -52.91 62.95 Favored Pre-proline 0 CA--C 1.565 1.529 0 CA-C-O 118.489 -0.767 . . . . 75.43 112.672 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -66.97 -20.27 51.18 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 121.647 1.565 . . . . 75.01 113.054 176.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -66.9 -38.87 87.04 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.187 0.595 . . . . 75.52 110.343 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.459 HG21 HD12 ' A' ' 13' ' ' ILE . 43.6 mm -68.18 -42.91 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.634 0.773 . . . . 73.24 109.63 174.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.6 mt -69.95 -28.18 65.35 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.14 -0.936 . . . . 73.03 112.297 -174.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -62.61 -44.85 88.07 Favored Pre-proline 0 N--CA 1.487 1.382 0 N-CA-C 114.033 1.123 . . . . 72.44 114.033 -171.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 85.4 Cg_exo -50.78 -39.27 57.76 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.135 1.89 . . . . 64.31 113.585 171.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -77.68 -38.95 46.4 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.343 0.657 . . . . 75.43 111.706 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.1 -49.77 70.92 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.248 0.619 . . . . 63.22 109.444 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -49.13 -49.91 39.9 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.925 1.29 . . . . 74.03 110.741 173.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.76 -46.8 83.68 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 124.004 0.815 . . . . 73.35 111.558 -176.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 117' ' ' MET . 41.9 t -59.3 -35.56 74.02 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.446 0.698 . . . . 75.02 111.066 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.526 HD12 HG23 ' A' ' 64' ' ' VAL . 83.5 mt -70.51 -57.25 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 115.571 -0.74 . . . . 73.23 110.593 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.7 m -51.98 -39.23 59.03 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 124.586 1.154 . . . . 72.03 111.676 -174.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.3 t -66.37 -44.33 83.44 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.441 -1.254 . . . . 73.44 110.102 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.528 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 40.9 mtm -62.95 -39.76 95.61 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.561 0.344 . . . . 74.5 110.828 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.4 t -57.43 -48.38 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 O-C-N 124.018 0.824 . . . . 73.32 110.183 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 95.3 p -73.79 -33.2 64.13 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.887 -0.597 . . . . 74.41 111.711 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.407 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.2 mtt-85 -68.15 -32.46 72.75 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.293 0.637 . . . . 74.24 109.86 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.422 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.33 15.84 42.84 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 115.498 -0.774 . . . . 72.25 113.216 174.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 121' ' ' GLY . 0.8 OUTLIER 65.14 10.89 6.73 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.388 1.875 . . . . 74.22 113.234 172.578 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -83.42 144.09 45.73 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 109.506 -0.553 . . . . 75.32 109.506 175.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -50.81 137.53 42.68 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.288 2.658 . . . . 63.05 112.955 175.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -55.31 128.39 33.91 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.27 0.981 . . . . 63.21 111.986 -172.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.5 tp -113.43 129.1 56.62 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.568 0.747 . . . . 73.53 109.121 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.573 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 87.1 m-20 -119.77 114.44 22.14 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.188 -1.041 . . . . 75.34 108.188 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.598 HD13 HD11 ' A' ' 42' ' ' LEU . 14.7 mt -72.86 127.41 32.47 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 109.558 -0.534 . . . . 74.44 109.558 -176.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.85 134.49 92.45 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-O 119.157 -0.449 . . . . 65.32 110.415 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.89 124.7 16.61 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.822 2.348 . . . . 71.43 112.689 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 98.8 t -101.1 128.28 53.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-N 115.745 -0.661 . . . . 73.42 109.787 -177.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -86.87 85.88 7.29 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.75 -0.833 . . . . 73.22 108.75 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -61.23 -27.43 68.43 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.425 -0.807 . . . . 75.54 111.947 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.555 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 17.2 t70 -61.71 -51.63 67.59 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.204 0.602 . . . . 74.55 109.72 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.14 86.97 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.237 0.961 . . . . 75.4 110.83 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.8 mt -61.73 -48.3 81.35 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.244 0.618 . . . . 74.45 111.457 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 31.6 t80 . . . . . 0 N--CA 1.473 0.698 0 N-CA-C 109.938 -0.393 . . . . 74.32 109.938 178.601 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.719 ' HB3' HG21 ' B' ' 89' ' ' ILE . 22.0 ptm . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 115.632 1.715 . . . . 74.12 115.632 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.3 p -133.47 104.08 6.24 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 106.949 -1.5 . . . . 75.31 106.949 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.464 ' CD2' ' HG3' ' D' ' 130' ' ' PRO . 24.0 t80 -107.91 137.03 46.62 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.149 -1.056 . . . . 74.23 108.149 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.611 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 0.1 OUTLIER -141.15 118.37 11.34 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.257 -0.646 . . . . 74.44 109.257 -178.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 57.1 mt -77.89 124.35 36.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.738 -1.208 . . . . 73.1 107.738 166.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -100.29 -35.57 9.57 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.527 -0.546 . . . . 75.15 109.527 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -176.89 134.5 0.2 Allowed 'General case' 0 C--N 1.352 0.69 0 O-C-N 123.917 0.761 . . . . 74.32 109.846 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.597 HG21 ' CD1' ' B' ' 109' ' ' TYR . 78.6 mt -119.65 145.05 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.117 -1.068 . . . . 75.42 108.117 175.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -165.11 145.09 7.01 Favored 'General case' 0 C--N 1.346 0.414 0 N-CA-C 112.974 0.731 . . . . 73.43 112.974 -173.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.53 HG23 HD12 ' B' ' 21' ' ' ILE . 38.7 m -76.3 122.79 24.93 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.477 -0.783 . . . . 73.05 108.903 170.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.412 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.4 mtpt -100.12 -14.75 18.44 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.423 0.689 . . . . 75.45 111.392 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.6 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.1 t70 -158.48 141.81 15.01 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.644 0.378 . . . . 74.13 111.433 -174.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.565 HD12 ' SG ' ' B' ' 113' ' ' CYS . 29.0 mm -136.68 143.12 36.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 124.915 1.286 . . . . 74.02 108.408 174.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 68.8 m -148.4 131.84 16.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.544 -1.207 . . . . 45.34 108.484 167.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -143.71 108.79 4.98 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.719 -1.586 . . . . 73.34 106.719 168.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -124.88 112.84 17.11 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.527 -0.916 . . . . 74.41 108.527 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.6 88.29 4.12 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.749 -1.204 . . . . 61.51 107.749 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.04 -40.91 8.23 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.75 2.3 . . . . 72.1 112.772 -168.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -101.02 19.96 16.44 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.777 0.831 . . . . 73.22 110.672 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.471 ' HB1' ' HD3' ' B' ' 29' ' ' PRO . . . -39.38 -62.13 0.87 Allowed Pre-proline 0 CA--C 1.566 1.588 0 N-CA-C 114.737 1.384 . . . . 74.12 114.737 -163.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.471 ' HD3' ' HB1' ' B' ' 28' ' ' ALA . 22.9 Cg_exo -62.95 -29.41 75.86 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 122.21 1.94 . . . . 74.32 112.983 -174.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -87.97 -38.18 15.76 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.228 -0.896 . . . . 73.51 111.659 -174.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.477 HG21 HD11 ' B' ' 68' ' ' LEU . 5.7 p -72.7 -15.78 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.156 0.583 . . . . 74.32 110.927 -173.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -70.58 -10.02 58.26 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 113.693 0.997 . . . . 74.42 113.693 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -72.79 -17.16 61.6 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 120.832 0.348 . . . . 74.44 110.465 174.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -98.68 97.61 8.85 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 124.92 1.288 . . . . 71.13 110.109 -175.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -102.22 85.77 2.71 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.222 -0.659 . . . . 74.24 109.222 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 7.6 p90 -156.83 -176.47 5.99 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.958 0.903 . . . . 75.34 109.797 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -68.63 114.41 22.12 Favored Pre-proline 0 N--CA 1.472 0.658 0 C-N-CA 123.559 0.744 . . . . 74.12 110.542 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.491 ' HA ' HD21 ' B' ' 68' ' ' LEU . 27.9 Cg_endo -68.34 145.15 64.62 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 121.22 1.28 . . . . 65.4 110.693 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 9.7 tp10 -64.62 99.71 0.33 Allowed 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.235 -1.024 . . . . 61.33 108.235 170.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.591 HG12 HD13 ' B' ' 126' ' ' LEU . 53.5 t -106.79 141.71 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 123.778 0.674 . . . . 73.14 110.324 -174.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -142.27 109.37 5.53 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.374 1.069 . . . . 73.41 108.753 -172.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.459 HD12 HG21 ' B' ' 64' ' ' VAL . 38.2 tp -90.55 127.3 36.21 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.389 -0.597 . . . . 74.42 109.389 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.68 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 9.5 m-20 -122.29 116.8 24.71 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.241 1.016 . . . . 73.1 108.678 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.464 HD11 HG11 ' B' ' 131' ' ' VAL . 69.3 mt -99.39 126.74 45.34 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.42 -0.956 . . . . 75.41 108.42 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -140.68 155.52 46.47 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.293 1.037 . . . . 74.41 108.52 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.4 t -148.18 117.83 7.05 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 121.328 0.585 . . . . 65.13 110.336 -177.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.64 125.34 53.64 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 106.726 -1.583 . . . . 73.31 106.726 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.528 ' HB2' ' HE2' ' B' ' 56' ' ' TYR . 62.0 p -139.41 177.15 8.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 119.652 -0.214 . . . . 74.5 110.886 -166.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 36.0 p -170.52 137.94 1.44 Allowed 'General case' 0 C--O 1.245 0.861 0 O-C-N 123.382 0.426 . . . . 75.4 111.16 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -76.0 126.36 30.86 Favored 'General case' 0 C--N 1.348 0.507 0 N-CA-C 108.573 -0.899 . . . . 75.41 108.573 165.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 pp -143.64 23.51 1.76 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.969 0.907 . . . . 65.44 109.092 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' B' ' 55' ' ' VAL . . . -166.25 170.89 12.74 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 123.457 0.703 . . . . 73.32 111.221 -175.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -100.76 118.02 36.02 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.666 0.787 . . . . 75.45 109.564 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 62.13 9.67 3.28 Favored 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 124.799 1.24 . . . . 64.31 112.584 -173.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.461 ' O ' ' HB1' ' B' ' 52' ' ' ALA . 74.8 t -128.75 129.96 68.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 107.631 -1.248 . . . . 74.12 107.631 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.528 ' HE2' ' HB2' ' B' ' 48' ' ' SER . 28.0 t80 -132.01 140.98 49.11 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.633 -0.877 . . . . 72.12 108.633 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -109.69 110.76 21.89 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 107.143 -1.428 . . . . 73.12 107.143 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.79 132.06 61.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 C-N-CA 123.333 0.653 . . . . 74.02 109.25 -177.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 32.7 t -111.53 113.85 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.022 -0.733 . . . . 61.43 109.022 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 60.9 tp -93.49 106.71 18.65 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.606 0.362 . . . . 62.23 110.103 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.447 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 20.9 ttm180 -86.06 108.23 18.17 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.356 0.662 . . . . 74.01 109.784 172.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 59.5 t -103.99 106.23 19.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.223 -1.029 . . . . 71.13 108.223 175.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.68 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 15.8 m -97.18 142.83 28.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.002 -0.999 . . . . 74.13 108.995 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.708 HG12 HD23 ' B' ' 126' ' ' LEU . 73.4 t -134.73 122.58 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.718 -0.845 . . . . 61.33 108.718 173.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 87.6 m -98.97 141.55 31.59 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.757 -1.201 . . . . 71.4 107.757 169.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.18 137.48 23.36 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.76 -0.459 . . . . 53.43 109.76 174.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.4 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 19.1 m -148.25 128.52 13.82 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.542 0.337 . . . . 70.32 111.489 -174.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.491 HD21 ' HA ' ' B' ' 38' ' ' PRO . 85.3 mt -93.95 99.92 12.16 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.174 -0.676 . . . . 75.51 109.174 178.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.69 -130.32 9.62 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 115.219 -0.901 . . . . 64.35 111.01 -171.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -97.18 2.0 50.49 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.087 0.955 . . . . 63.22 111.726 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -115.09 147.11 40.61 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.024 0.53 . . . . 72.15 110.569 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 49.7 m -68.92 133.06 47.7 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 123.5 0.5 . . . . 75.12 111.283 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.457 ' HA ' HG22 ' B' ' 31' ' ' VAL . . . -86.83 -60.74 1.9 Allowed 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.926 -1.138 . . . . 72.32 107.926 175.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -154.14 161.94 41.53 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 114.45 -1.25 . . . . 74.31 110.019 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -129.96 112.67 13.73 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.645 -1.613 . . . . 74.44 106.645 172.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 23.0 t -118.88 114.1 22.07 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.07 -0.715 . . . . 71.03 109.07 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -128.49 122.9 32.26 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.359 -0.978 . . . . 74.34 108.359 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 88.2 t -124.73 150.26 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.512 1.125 . . . . 63.22 108.552 -178.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.6 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 27.1 mt-30 -121.15 115.02 22.27 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.769 -0.826 . . . . 75.5 108.769 167.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -100.82 107.26 18.76 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.632 -0.877 . . . . 73.15 108.632 172.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.412 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -99.89 170.56 22.96 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 111.861 -0.496 . . . . 71.43 111.861 176.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.01 141.34 6.67 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 121.643 -0.313 . . . . 73.23 112.554 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 41.1 mt -97.77 106.61 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 108.517 -0.92 . . . . 70.11 108.517 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -116.08 135.24 54.12 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.103 0.561 . . . . 74.53 110.952 -175.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.611 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 57.7 m -95.24 129.6 42.31 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.889 0.876 . . . . 75.12 110.12 172.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.54 ' HB ' HD13 ' B' ' 89' ' ' ILE . 35.2 pt -138.39 136.61 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 124.048 0.939 . . . . 75.11 110.437 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.64 173.79 16.33 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.032 0.933 . . . . 74.03 109.787 174.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.86 -40.86 3.08 Favored Glycine 0 N--CA 1.479 1.557 0 CA-C-O 121.133 0.296 . . . . 65.41 112.823 177.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.719 HG21 ' HB3' ' B' ' 9' ' ' MET . 3.5 pt -58.8 154.76 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.474 1.11 . . . . 74.43 111.146 165.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -164.72 146.05 7.98 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.956 -1.02 . . . . 64.42 108.697 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.52 -134.8 12.28 Favored Glycine 0 C--N 1.348 1.218 0 O-C-N 123.442 0.464 . . . . 74.41 112.117 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 52.6 m -73.64 -54.22 8.65 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.757 0.823 . . . . 75.31 110.618 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.417 ' HA ' ' HB3' ' B' ' 96' ' ' HIS . 16.0 mm100 -56.52 -19.72 16.97 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.905 1.282 . . . . 74.14 113.197 -176.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.552 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 41.8 ttp -61.04 -70.29 0.19 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.325 1.05 . . . . 74.31 111.597 -177.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.51 -15.11 53.63 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 111.845 0.313 . . . . 74.44 111.845 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . 0.417 ' HB3' ' HA ' ' B' ' 93' ' ' GLN . 1.4 t-80 -58.78 -34.66 71.7 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.433 0.693 . . . . 74.44 110.313 168.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.6 t -58.71 -26.0 63.47 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.554 0.742 . . . . 72.41 111.694 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.401 HD22 ' HB3' ' B' ' 56' ' ' TYR . 52.0 mt -84.41 -29.04 26.49 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.96 0.904 . . . . 75.43 112.129 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.79 -10.53 57.64 Favored Glycine 0 C--N 1.342 0.873 0 O-C-N 123.56 0.538 . . . . 73.12 113.021 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.38 -59.19 1.48 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.088 0.555 . . . . 64.34 112.167 -174.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -78.01 -48.82 15.31 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.112 0.565 . . . . 74.2 110.937 -168.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 73.5 m -61.52 -50.17 83.88 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 123.865 0.866 . . . . 74.31 112.073 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.09 -17.98 35.76 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 121.73 1.62 . . . . 72.02 112.917 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -70.86 -30.47 66.87 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.598 0.359 . . . . 72.35 110.42 173.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.425 HG22 ' NH2' ' D' ' 111' ' ' ARG . 69.5 mt -71.82 -42.42 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.18 0.592 . . . . 73.03 109.831 171.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 77.8 mt -73.89 -28.49 61.58 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.047 -0.979 . . . . 74.24 111.825 -175.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -60.12 -49.41 91.02 Favored Pre-proline 0 N--CA 1.484 1.248 0 CA-C-O 118.024 -0.988 . . . . 74.43 113.28 -172.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -54.83 -33.78 82.72 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.545 2.163 . . . . 74.12 113.598 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.597 ' CD1' HG21 ' B' ' 16' ' ' ILE . 7.7 m-30 -78.82 -40.46 32.83 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.047 0.539 . . . . 72.44 110.504 -176.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.25 -39.9 95.9 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.489 0.716 . . . . 73.14 110.136 172.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.474 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 47.1 ttt-85 -62.6 -53.3 56.64 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.429 1.491 . . . . 74.52 110.724 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -66.49 -30.54 70.9 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.461 0.705 . . . . 75.3 109.848 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.565 ' SG ' HD12 ' B' ' 21' ' ' ILE . 4.1 t -70.16 -42.36 72.59 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 122.946 0.498 . . . . 75.13 110.273 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.582 HD12 HG23 ' B' ' 64' ' ' VAL . 45.4 mt -58.79 -55.79 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.853 0.861 . . . . 73.14 110.408 173.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 9.6 m -63.7 -29.89 71.06 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.632 0.773 . . . . 74.41 111.382 -173.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.3 t -58.31 -54.94 41.28 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 108.831 -0.803 . . . . 74.34 108.831 171.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.525 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.8 mmt -64.98 -37.3 87.21 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.602 0.761 . . . . 75.43 111.4 -175.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 81.4 t -59.89 -48.82 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 124.019 0.928 . . . . 73.53 110.544 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 32.8 t -75.27 -19.85 59.48 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.899 -1.046 . . . . 73.43 111.075 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' B' ' 116' ' ' SER . 90.3 mtt-85 -68.21 -32.47 72.7 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 110.027 -0.36 . . . . 75.52 110.027 170.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . 0.43 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -79.49 -5.58 89.22 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 123.655 0.597 . . . . 64.2 112.397 169.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 6.6 m 66.39 25.57 10.31 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.624 1.57 . . . . 63.23 110.652 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -77.33 163.21 65.8 Favored Pre-proline 0 CA--C 1.555 1.148 0 CA-C-N 114.884 -1.053 . . . . 74.23 110.836 175.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -48.51 144.49 13.8 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 123.312 2.675 . . . . 64.44 114.764 174.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.472 ' HB2' ' HG2' ' C' ' 125' ' ' GLN . 41.0 tp60 -54.59 118.05 3.86 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.055 0.942 . . . . 74.15 110.758 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.708 HD23 HG12 ' B' ' 64' ' ' VAL . 20.5 tp -110.04 99.36 8.47 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.14 -0.936 . . . . 74.23 109.602 -171.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -96.03 110.68 22.88 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.453 -0.573 . . . . 75.14 109.453 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.474 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 55.0 mt -77.21 126.21 30.57 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.871 -0.789 . . . . 75.43 108.871 171.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.58 154.6 83.66 Favored Pre-proline 0 CA--C 1.552 1.051 0 O-C-N 124.268 0.98 . . . . 61.42 111.706 -169.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.466 ' HG3' HD12 ' D' ' 16' ' ' ILE . 3.8 Cg_exo -77.33 87.68 1.48 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.401 2.734 . . . . 72.41 112.686 -167.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.464 HG11 HD11 ' B' ' 44' ' ' LEU . 4.6 p -92.8 122.35 44.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 115.333 -0.849 . . . . 75.0 110.517 177.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 9.0 p30 . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 107.464 -1.31 . . . . 74.41 107.464 169.03 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 59.7 t80 . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 109.353 -0.61 . . . . 73.13 109.353 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -152.96 131.55 12.25 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 109.617 -0.512 . . . . 72.52 109.617 171.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 57.2 mt -69.88 125.96 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 108.65 -0.87 . . . . 74.43 108.65 170.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -89.93 -49.78 6.41 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.961 -0.755 . . . . 74.21 108.961 175.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.573 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -173.53 150.92 1.85 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.111 0.964 . . . . 75.22 109.973 174.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 pp -114.54 152.28 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 107.878 -1.156 . . . . 70.34 107.878 173.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.636 ' HB3' HG22 ' D' ' 122' ' ' THR . 28.2 p90 -179.56 162.46 1.11 Allowed 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.456 0.646 . . . . 73.34 110.882 -174.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.2 p -92.35 115.33 27.99 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 123.43 0.692 . . . . 74.43 109.882 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -64.43 -40.47 95.8 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.233 -1.025 . . . . 75.3 108.233 170.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -150.07 147.87 28.32 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.407 -1.269 . . . . 73.52 110.787 -174.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.536 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.6 mt -138.39 144.51 30.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 C-N-CA 125.896 1.679 . . . . 74.24 106.584 174.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 31.2 t -153.46 150.01 28.34 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 122.568 0.347 . . . . 72.41 110.481 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -155.28 137.08 14.41 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.451 1.1 . . . . 73.32 108.166 175.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -140.23 133.73 30.08 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.281 0.633 . . . . 71.2 109.433 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.79 81.41 22.87 Favored Pre-proline 0 C--O 1.241 0.621 0 N-CA-C 108.001 -1.111 . . . . 64.22 108.001 169.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.2 -30.41 74.48 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 123.017 2.478 . . . . 73.01 112.622 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . 0.47 ' OD1' ' HB ' ' C' ' 31' ' ' VAL . 5.9 p30 -117.07 34.54 5.06 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.222 0.609 . . . . 61.32 109.575 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -40.08 -57.85 2.56 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 114.148 1.166 . . . . 74.22 114.148 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -64.61 -35.39 47.82 Favored 'Trans proline' 0 C--N 1.382 2.292 0 CA-C-N 121.569 1.596 . . . . 75.44 112.64 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.596 ' HA ' HE21 ' C' ' 33' ' ' GLN . 80.5 t60 -68.71 -38.09 79.97 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.813 0.845 . . . . 74.43 112.24 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.601 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.5 p -76.34 -30.27 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 N-CA-C 112.573 0.583 . . . . 74.13 112.573 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -59.79 -34.02 72.48 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 112.447 0.536 . . . . 73.22 112.447 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . 0.596 HE21 ' HA ' ' C' ' 30' ' ' HIS . 24.7 pt20 -86.15 11.89 10.89 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.398 0.679 . . . . 73.14 112.408 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.412 ' HG2' HD11 ' C' ' 68' ' ' LEU . 1.8 ttpm? -113.95 147.85 37.86 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.877 0.871 . . . . 74.53 110.124 177.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.16 125.26 23.11 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 123.381 0.673 . . . . 71.41 110.93 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -81.55 105.81 13.01 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.927 -1.033 . . . . 73.01 110.993 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -162.78 79.44 1.77 Allowed Pre-proline 0 C--O 1.241 0.607 0 N-CA-C 107.469 -1.308 . . . . 75.21 107.469 164.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -87.04 164.52 8.67 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 122.913 2.409 . . . . 65.22 113.02 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -86.75 85.32 7.28 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 106.725 -1.583 . . . . 73.21 106.725 168.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 99.2 t -68.58 109.7 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 115.008 -0.996 . . . . 75.41 109.767 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.59 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 65.7 mttm -92.08 103.96 16.4 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.354 -0.98 . . . . 73.02 108.354 178.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 tt -89.08 123.91 33.81 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 107.057 -1.46 . . . . 65.42 107.057 174.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.604 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 17.0 t70 -128.39 139.53 52.32 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.153 0.981 . . . . 74.54 108.409 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.612 HD21 HD21 ' C' ' 60' ' ' LEU . 24.6 mt -135.3 126.41 27.96 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.438 0.695 . . . . 74.54 110.218 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -130.53 139.29 50.48 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.63 1.172 . . . . 73.3 108.193 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.0 t -144.07 139.47 28.94 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.019 0.438 . . . . 75.33 110.283 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.95 156.05 45.48 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.937 0.895 . . . . 54.13 109.608 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.42 ' HG ' ' HB3' ' C' ' 98' ' ' LEU . 2.3 m -132.43 144.18 50.31 Favored 'General case' 0 C--O 1.24 0.564 0 O-C-N 123.299 0.374 . . . . 63.24 110.034 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 22.4 p -145.12 126.07 14.48 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.916 0.886 . . . . 72.53 109.473 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -78.76 118.67 21.04 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.317 -0.623 . . . . 74.24 109.317 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.624 HD12 ' HB2' ' C' ' 57' ' ' GLU . 34.5 mt -88.45 -41.47 12.76 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.83 0.852 . . . . 73.42 110.638 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.19 -172.66 4.22 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.061 -0.972 . . . . 65.24 110.181 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.42 112.62 1.83 Allowed 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.036 0.835 . . . . 44.45 110.591 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 66.31 9.33 6.31 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.661 1.185 . . . . 62.51 112.425 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 87.0 t -106.81 107.62 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.23 0.612 . . . . 73.43 109.857 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -106.72 124.63 49.89 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.768 0.827 . . . . 74.53 109.073 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.624 ' HB2' HD12 ' C' ' 51' ' ' LEU . 30.2 tt0 -82.72 126.65 32.61 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.296 -1.002 . . . . 75.21 108.296 169.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.8 t -112.4 138.2 42.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.486 -0.931 . . . . 74.3 108.486 167.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 86.6 t -120.9 131.37 73.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 108.529 -0.915 . . . . 75.1 108.529 170.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.612 HD21 HD21 ' C' ' 44' ' ' LEU . 0.9 OUTLIER -114.22 107.23 15.33 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.676 -1.231 . . . . 74.04 107.676 172.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.9 117.74 31.18 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 114.671 -1.149 . . . . 74.53 109.153 178.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.423 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.8 t -102.07 132.37 48.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 107.838 -1.171 . . . . 65.44 107.838 172.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.604 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 29.9 m -123.31 128.02 49.35 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.099 -1.074 . . . . 71.05 108.099 175.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 85.7 t -122.95 128.75 75.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.576 -0.738 . . . . 71.33 109.34 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.59 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 25.4 m -118.32 139.24 51.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.621 -1.251 . . . . 71.44 107.621 176.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.24 113.01 15.76 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.669 -1.604 . . . . 65.45 106.669 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 65.4 m -135.62 126.21 27.05 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.672 0.607 . . . . 75.11 109.9 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.412 HD11 ' HG2' ' C' ' 34' ' ' LYS . 12.0 mt -85.98 56.06 3.81 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.224 1.41 . . . . 72.35 107.908 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.58 -107.73 3.08 Favored Glycine 0 C--N 1.341 0.851 0 N-CA-C 110.026 -1.23 . . . . 70.42 110.026 -169.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -103.59 -17.14 15.29 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.64 0.776 . . . . 73.14 110.044 173.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -68.55 99.89 1.04 Allowed 'General case' 0 C--N 1.348 0.542 0 C-N-CA 123.341 0.656 . . . . 74.5 109.44 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 50.4 m -73.36 114.83 12.01 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.169 -0.678 . . . . 71.31 109.169 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.601 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -67.84 -57.52 6.13 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.248 -1.342 . . . . 71.45 108.613 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -155.13 159.64 40.34 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.745 -1.116 . . . . 71.42 110.732 172.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -118.68 143.06 47.09 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.799 -1.556 . . . . 74.5 106.799 167.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 46.6 t -149.7 141.9 24.08 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.598 -0.89 . . . . 72.33 108.598 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -154.65 134.9 13.21 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.472 -0.566 . . . . 71.4 109.472 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' C' ' 110' ' ' ALA . 40.9 t -133.71 114.65 20.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 124.263 1.025 . . . . 74.31 108.836 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -91.27 87.64 6.57 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.654 -0.869 . . . . 73.13 108.654 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -79.86 99.11 7.38 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.408 0.683 . . . . 75.42 110.121 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.67 149.11 25.43 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 116.329 -0.396 . . . . 73.1 112.36 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.506 ' HA3' HD23 ' C' ' 106' ' ' LEU . . . -150.27 125.73 2.01 Favored Glycine 0 CA--C 1.503 -0.678 0 N-CA-C 110.508 -1.037 . . . . 50.24 110.508 -178.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.542 HD13 HD12 ' C' ' 51' ' ' LEU . 31.8 mm -93.7 125.24 46.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 108.278 -1.008 . . . . 65.21 108.278 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -133.64 121.84 22.6 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.457 0.703 . . . . 74.43 109.721 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 20.6 p -82.28 103.99 12.27 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 108.745 -0.835 . . . . 71.12 108.745 171.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.518 HG21 ' HE2' ' C' ' 94' ' ' MET . 17.8 mt -116.19 137.57 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.585 0.754 . . . . 75.52 109.74 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.28 170.51 19.33 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.199 0.6 . . . . 74.2 110.639 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.34 -49.12 1.51 Allowed Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.98 -0.555 . . . . 73.02 113.371 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.663 HD13 ' HA ' ' C' ' 94' ' ' MET . 42.7 pt -91.06 171.28 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 123.445 0.698 . . . . 74.34 112.635 -167.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -157.97 157.47 33.1 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.751 -1.113 . . . . 64.13 109.508 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.66 -131.16 21.25 Favored Glycine 0 C--N 1.348 1.241 0 O-C-N 123.412 0.445 . . . . 73.32 113.805 172.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.8 p -60.46 -35.21 75.33 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.27 1.028 . . . . 74.2 111.789 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -57.72 -57.47 12.61 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.857 0.863 . . . . 73.42 110.607 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.663 ' HA ' HD13 ' C' ' 89' ' ' ILE . 4.1 tpt -55.23 -50.17 70.13 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.067 0.947 . . . . 75.11 112.505 175.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.68 -33.88 74.76 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.114 0.566 . . . . 75.15 111.253 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -73.99 -36.55 64.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.974 0.51 . . . . 75.44 110.55 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.46 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 33.7 t -69.45 -33.56 73.12 Favored 'General case' 0 C--N 1.35 0.614 0 N-CA-C 109.734 -0.469 . . . . 75.12 109.734 -177.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.42 ' HB3' ' HG ' ' C' ' 48' ' ' SER . 96.9 mt -85.78 -37.48 19.23 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.982 0.913 . . . . 71.03 111.896 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.87 3.92 45.56 Favored Glycine 0 N--CA 1.473 1.15 0 CA-C-O 119.525 -0.597 . . . . 53.2 114.58 -168.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.555 ' HA ' ' HB3' ' C' ' 133' ' ' PHE . . . -149.35 -54.46 0.17 Allowed 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.808 0.804 . . . . 71.45 112.045 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.46 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 51.3 t80 -66.6 -56.68 9.61 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.286 0.634 . . . . 75.53 112.111 -174.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 97.2 m -60.89 -47.26 96.14 Favored Pre-proline 0 CA--C 1.562 1.41 0 CA-C-O 118.787 -0.625 . . . . 74.42 112.42 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -54.54 -30.88 67.07 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 122.409 2.072 . . . . 74.22 114.318 172.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -70.72 -30.9 67.57 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.026 0.53 . . . . 64.24 111.114 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 44.5 mm -73.01 -35.3 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 109.62 -0.511 . . . . 71.53 109.62 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.506 HD23 ' HA3' ' C' ' 82' ' ' GLY . 94.7 mt -81.22 -30.97 34.06 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.971 0.908 . . . . 74.43 112.733 -175.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -55.92 -50.11 89.13 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 113.884 1.068 . . . . 74.41 113.884 -172.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.85 -36.25 95.14 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.251 1.968 . . . . 71.34 113.396 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -70.05 -44.37 69.31 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.05 0.54 . . . . 75.42 111.356 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.51 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -66.7 -33.6 76.0 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.876 -0.602 . . . . 73.24 110.713 175.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -62.63 -51.49 67.09 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.925 1.29 . . . . 75.43 110.446 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -69.37 -29.36 67.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.95 0.5 . . . . 72.31 110.377 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.9 t -69.18 -37.68 78.29 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 122.75 0.42 . . . . 73.32 110.709 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.44 ' O ' HG23 ' C' ' 118' ' ' VAL . 98.6 mt -71.65 -47.39 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 122.931 0.492 . . . . 75.42 110.054 174.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.7 m -53.23 -42.44 66.39 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.532 1.133 . . . . 71.25 111.664 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.44 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.1 t -66.68 -38.94 87.82 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.425 -0.807 . . . . 74.12 109.538 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.591 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -66.2 -39.83 89.93 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.187 0.995 . . . . 73.33 111.778 178.404 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.44 HG23 ' O ' ' C' ' 114' ' ' ILE . 61.8 t -59.04 -42.79 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 109.258 -0.645 . . . . 73.41 109.258 172.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.2 t -66.13 -38.67 88.72 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.816 -1.083 . . . . 74.03 112.248 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' C' ' 116' ' ' SER . 64.7 mtt-85 -69.58 -39.21 77.45 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.264 0.625 . . . . 73.32 110.19 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.45 3.71 84.0 Favored Glycine 0 C--N 1.351 1.361 0 CA-C-N 115.669 -0.696 . . . . 74.33 112.544 173.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.441 HG22 ' O ' ' D' ' 16' ' ' ILE . 33.6 p 58.38 30.74 20.04 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.058 1.743 . . . . 72.43 113.068 171.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -81.94 154.58 70.27 Favored Pre-proline 0 C--O 1.242 0.684 0 CA-C-N 115.703 -0.681 . . . . 73.01 109.57 175.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.48 127.76 27.32 Favored 'Trans proline' 0 C--N 1.363 1.333 0 C-N-CA 122.093 1.862 . . . . 73.12 112.022 168.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.472 ' HG2' ' HB2' ' B' ' 125' ' ' GLN . 23.6 mm-40 -53.72 154.6 3.69 Favored 'General case' 0 C--O 1.248 0.981 0 O-C-N 124.623 1.202 . . . . 74.32 113.604 -170.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 21.1 tp -147.76 86.38 1.59 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-N 113.847 -1.524 . . . . 75.54 108.168 -172.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -91.97 108.63 20.07 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.787 -1.097 . . . . 73.5 108.692 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -67.81 137.99 55.79 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.513 0.725 . . . . 74.43 110.118 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.78 152.53 95.12 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 123.665 0.786 . . . . 54.02 111.106 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.491 ' HG3' HD13 ' A' ' 16' ' ' ILE . 52.1 Cg_exo -54.98 114.93 2.09 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.662 2.241 . . . . 74.54 112.272 172.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . 0.443 HG12 HD13 ' C' ' 44' ' ' LEU . 5.0 p -98.14 125.95 51.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 123.103 0.561 . . . . 72.2 110.19 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -81.53 101.7 10.11 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.653 -0.869 . . . . 75.32 108.653 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . 0.555 ' HB3' ' HA ' ' C' ' 100' ' ' ALA . 82.9 m-85 -67.3 -25.34 65.99 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.356 -0.838 . . . . 74.5 111.31 177.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -63.86 -36.5 84.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.324 0.649 . . . . 64.31 110.323 175.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.64 -42.1 95.69 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.647 0.779 . . . . 75.23 110.414 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 71.0 mt -72.72 -27.09 61.84 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.839 -1.073 . . . . 72.24 110.873 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 70.9 t80 . . . . . 0 C--O 1.213 -0.864 0 C-N-CA 123.029 0.531 . . . . 74.13 110.699 177.853 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 C--O 1.244 0.808 0 N-CA-C 109.03 -0.73 . . . . 74.33 109.03 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -137.4 101.16 4.43 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.371 -1.344 . . . . 71.42 107.371 175.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -125.92 124.47 40.89 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.692 0.797 . . . . 72.21 109.104 -175.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.658 HD11 HG21 ' D' ' 105' ' ' ILE . 5.4 mt -84.18 137.42 20.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.786 -0.82 . . . . 63.21 108.786 177.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -97.02 -42.5 7.87 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 122.975 0.51 . . . . 72.35 110.461 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . 0.426 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 40.8 ttt180 -174.23 142.77 0.83 Allowed 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.313 0.383 . . . . 75.43 111.383 -170.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.471 HD11 HG21 ' D' ' 13' ' ' ILE . 2.1 mp -115.55 137.75 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 105.882 -1.895 . . . . 72.43 105.882 174.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.426 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 19.0 p90 -161.54 137.0 7.64 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 123.609 0.568 . . . . 73.11 110.967 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.4 p -76.65 110.63 11.39 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.321 -0.854 . . . . 64.3 109.487 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -85.53 -9.81 56.86 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.496 -0.775 . . . . 71.32 109.712 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.635 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 17.4 t70 -169.11 143.43 3.01 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 124.896 1.278 . . . . 75.12 109.733 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.591 HG23 ' HE1' ' C' ' 117' ' ' MET . 80.4 mt -147.4 144.71 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 125.266 1.427 . . . . 74.0 107.9 177.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.8 t -147.04 145.92 29.85 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.967 0.907 . . . . 75.22 109.249 170.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.536 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 81.1 t80 -149.87 118.55 6.57 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 106.963 -1.495 . . . . 72.23 106.963 169.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -123.54 140.27 53.17 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.479 -0.563 . . . . 74.23 109.479 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.68 82.39 60.97 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 107.813 -1.18 . . . . 75.54 107.813 174.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.8 -29.24 42.51 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.924 2.416 . . . . 75.14 113.008 -170.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.402 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 38.0 m-80 -108.66 8.86 27.17 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-O 118.479 -0.772 . . . . 70.43 110.852 -177.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.406 ' HB2' ' HD3' ' D' ' 29' ' ' PRO . . . -20.05 -73.17 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 116.63 2.085 . . . . 65.11 116.63 -166.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.424 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 92.2 Cg_endo -75.5 -21.66 14.72 Favored 'Trans proline' 0 C--N 1.386 2.552 0 CA-C-N 124.056 2.484 . . . . 74.2 114.117 -176.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.412 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 5.6 t-160 -74.46 -37.93 63.08 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.257 1.023 . . . . 72.31 110.25 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.58 HG22 HD11 ' D' ' 68' ' ' LEU . 11.0 p -82.04 -20.51 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 115.953 -0.567 . . . . 74.14 111.506 -174.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.424 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 23.0 m-85 -63.75 -28.67 70.04 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 120.801 0.334 . . . . 74.0 111.819 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . 0.412 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 60.8 mt-30 -58.41 -22.27 53.48 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.71 1.204 . . . . 73.5 111.241 177.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.61 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 89.8 mttt -90.22 69.42 7.14 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.994 1.318 . . . . 73.52 110.2 177.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.73 85.45 4.74 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.411 -0.813 . . . . 62.23 110.67 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 10.2 p90 -154.07 -173.21 4.49 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.453 0.701 . . . . 63.41 109.902 172.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -63.27 112.4 6.91 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.377 1.071 . . . . 70.1 110.772 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -60.76 120.25 7.87 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.066 1.844 . . . . 75.1 110.805 172.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -67.63 104.32 1.58 Allowed 'General case' 0 C--N 1.35 0.592 0 N-CA-C 106.417 -1.697 . . . . 74.41 106.417 169.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.477 HG11 HG12 ' D' ' 64' ' ' VAL . 71.3 t -103.05 115.31 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 N-CA-C 108.792 -0.818 . . . . 74.13 108.792 -174.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -96.98 110.25 22.83 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 105.783 -1.932 . . . . 75.52 105.783 176.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.467 HD12 HG13 ' D' ' 62' ' ' VAL . 63.4 tp -94.37 138.5 32.26 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.418 -1.327 . . . . 74.3 107.418 175.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -141.75 147.92 38.15 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.528 -1.286 . . . . 71.44 107.528 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.409 HD13 ' CE2' ' D' ' 133' ' ' PHE . 73.7 mt -131.0 136.06 48.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.548 0.689 . . . . 74.53 110.874 -173.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.454 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 11.6 t70 -133.03 129.17 37.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 113.977 -1.465 . . . . 64.13 107.692 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 2.6 p -106.94 150.78 26.1 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.546 0.689 . . . . 75.24 110.094 174.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.87 166.57 29.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.233 -1.349 . . . . 74.21 107.86 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.8 p . . . . . 0 C--O 1.241 0.614 0 N-CA-C 109.633 -0.506 . . . . 62.41 109.633 -179.962 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 113.811 1.041 . . . . 75.33 113.811 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 45.8 t -128.57 100.94 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 107.484 -1.302 . . . . 71.31 107.484 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -122.18 127.81 50.47 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.946 -0.761 . . . . 73.41 108.946 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -87.91 114.88 24.95 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 108.158 -1.053 . . . . 71.02 108.158 169.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 95.4 t -100.35 134.91 38.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 107.286 -1.376 . . . . 75.15 107.286 171.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 49.1 t -128.9 126.79 65.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.687 -1.227 . . . . 74.41 107.687 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.497 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -114.52 103.93 11.51 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.505 -1.294 . . . . 74.4 107.505 -176.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.454 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 41.1 ttm-85 -83.35 103.14 12.5 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.579 -0.897 . . . . 73.43 108.579 173.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.467 HG13 HD12 ' D' ' 42' ' ' LEU . 66.4 t -97.32 121.83 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.027 -0.731 . . . . 74.23 109.027 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 56.8 m -119.4 133.44 55.71 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.005 0.922 . . . . 74.41 109.106 -172.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.477 HG12 HG11 ' D' ' 40' ' ' VAL . 75.4 t -125.81 132.44 70.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 124.226 1.01 . . . . 74.22 108.788 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 26.7 m -127.93 93.14 3.61 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.676 -1.602 . . . . 72.0 106.676 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.83 147.24 24.62 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.704 -0.85 . . . . 71.0 108.704 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.498 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 32.5 p -149.56 133.94 17.44 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.208 0.528 . . . . 74.24 111.505 -173.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.58 HD11 HG22 ' D' ' 31' ' ' VAL . 79.4 mt -104.17 102.62 12.35 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.923 -1.035 . . . . 72.31 108.283 170.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.03 -128.96 17.49 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 115.764 -0.653 . . . . 70.4 113.154 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -84.56 3.08 38.32 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.931 0.892 . . . . 73.33 113.022 -174.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.61 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 10.5 pt-20 -137.0 154.92 50.28 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-O 121.115 0.483 . . . . 74.23 110.871 -173.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.0 m -69.18 126.56 30.17 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.583 -1.189 . . . . 73.43 111.072 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.565 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -75.65 -64.78 1.0 Allowed 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.624 -1.25 . . . . 71.51 107.624 173.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -153.24 141.84 20.88 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.266 -0.879 . . . . 75.12 111.152 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 65.9 mt -101.11 153.58 19.46 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.284 1.034 . . . . 74.42 108.771 167.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.71 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.8 t -156.82 142.19 17.42 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.123 0.569 . . . . 74.35 109.496 176.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -155.37 122.22 5.39 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.213 -0.292 . . . . 71.5 110.213 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.6 t -126.0 115.11 41.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 124.066 0.947 . . . . 73.12 109.338 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.635 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.6 mt-30 -88.72 87.64 7.32 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.6 -0.889 . . . . 75.33 108.6 171.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -83.39 100.84 10.94 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.483 -1.235 . . . . 74.44 109.083 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.37 149.01 17.74 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 112.327 -0.309 . . . . 70.3 112.327 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.37 142.97 10.49 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.77 -0.532 . . . . 65.21 111.77 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.0 mt -89.29 117.01 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 108.099 -1.074 . . . . 71.3 108.099 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.24 127.78 55.71 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.701 0.8 . . . . 74.24 110.548 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 33.6 t -84.87 122.79 29.67 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.275 -1.009 . . . . 71.42 108.275 166.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.4 HD13 ' HB2' ' D' ' 97' ' ' CYS . 3.0 tt -143.67 125.78 11.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 108.565 -0.902 . . . . 73.2 108.565 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.06 167.99 14.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.784 0.834 . . . . 74.14 110.458 -174.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.56 21.13 52.43 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.447 0.467 . . . . 74.35 114.01 173.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.64 171.54 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.045 0.938 . . . . 75.44 108.975 177.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -147.62 179.92 7.34 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.645 -0.872 . . . . 62.11 108.645 -175.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.85 -136.66 22.11 Favored Glycine 0 C--N 1.347 1.16 0 C-N-CA 122.992 0.329 . . . . 74.03 112.875 172.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.6 m -91.91 -36.76 13.28 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.126 0.571 . . . . 73.22 111.242 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -65.65 -19.63 65.98 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.185 0.594 . . . . 65.15 112.46 -171.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.422 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 0.0 OUTLIER -64.51 -36.99 86.0 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.951 0.5 . . . . 74.11 112.247 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . 0.422 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.11 -14.88 45.74 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.267 0.627 . . . . 71.55 111.851 178.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -63.96 -38.84 92.57 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.52 0.728 . . . . 64.34 112.282 -176.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . 0.4 ' HB2' HD13 ' D' ' 86' ' ' ILE . 69.1 m -65.43 -49.58 68.65 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.476 0.31 . . . . 74.35 111.629 -177.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.685 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 3.6 pp -67.47 -22.16 65.49 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.05 0.389 . . . . 70.22 112.05 -176.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.93 -29.33 11.84 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-O 119.881 -0.399 . . . . 72.43 113.593 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.0 -52.89 2.3 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 117.309 0.555 . . . . 75.04 111.838 -173.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -73.71 -39.57 64.23 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 112.103 0.408 . . . . 74.41 112.103 -173.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.685 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 89.1 m -65.31 -46.76 71.31 Favored Pre-proline 0 CA--C 1.556 1.189 0 CA-C-O 118.728 -0.653 . . . . 75.21 111.692 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.497 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 50.1 Cg_exo -58.71 -35.12 99.1 Favored 'Trans proline' 0 C--N 1.389 2.692 0 C-N-CA 121.653 1.569 . . . . 65.03 112.777 168.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.47 -31.73 73.06 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.346 0.658 . . . . 71.34 111.394 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.658 HG21 HD11 ' D' ' 13' ' ' ILE . 36.5 mm -69.78 -43.67 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.533 0.733 . . . . 74.12 110.223 172.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 74.6 mt -72.81 -19.74 61.28 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.26 -0.882 . . . . 75.42 111.699 -175.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -66.32 -45.42 60.08 Favored Pre-proline 0 CA--C 1.556 1.175 0 N-CA-C 113.498 0.925 . . . . 75.2 113.498 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -49.27 -41.02 43.17 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.443 2.095 . . . . 73.44 113.86 170.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -78.97 -33.23 45.37 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.458 0.703 . . . . 73.54 112.102 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.91 -44.27 73.51 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.523 0.677 . . . . 70.45 109.506 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.425 ' NH2' HG22 ' B' ' 105' ' ' ILE . 46.5 ttp180 -66.42 -37.29 84.87 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 114.005 -1.452 . . . . 74.53 110.172 175.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . 0.444 ' HA ' ' CE2' ' B' ' 109' ' ' TYR . 8.7 tt0 -52.29 -46.86 66.08 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.732 0.813 . . . . 73.41 111.148 176.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.8 t -66.72 -47.77 71.27 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.775 -1.102 . . . . 71.34 110.71 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.71 HG12 ' SG ' ' D' ' 76' ' ' CYS . 42.6 mt -60.29 -62.77 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.978 0.511 . . . . 75.34 110.363 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 98.3 m -41.68 -46.32 3.71 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 125.709 1.603 . . . . 72.04 112.799 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 22.9 t -68.48 -45.17 73.08 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.192 -0.913 . . . . 74.13 110.67 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.1 mtm -67.44 -34.3 76.93 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.802 0.441 . . . . 71.33 111.589 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.421 HG22 ' O ' ' D' ' 114' ' ' ILE . 84.9 t -60.54 -46.81 94.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 123.797 0.839 . . . . 75.44 110.082 176.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.0 p -70.45 -28.5 65.07 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 115.785 -0.643 . . . . 71.13 110.705 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' D' ' 116' ' ' SER . 72.6 mtt-85 -71.89 -22.92 61.43 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.531 0.733 . . . . 75.22 111.251 176.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.52 12.71 68.56 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-O 119.564 -0.576 . . . . 45.23 112.709 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.636 HG22 ' HB3' ' C' ' 17' ' ' TYR . 72.6 p 60.03 11.87 2.89 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 126.735 2.014 . . . . 74.31 113.391 -174.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -81.51 149.38 64.7 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.776 -0.453 . . . . 75.33 109.776 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -48.22 120.06 4.61 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 123.095 2.53 . . . . 75.13 113.03 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -42.23 119.73 1.44 Allowed 'General case' 0 C--N 1.364 1.237 0 O-C-N 124.875 1.359 . . . . 72.13 111.402 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 29.8 tp -106.48 99.61 9.18 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.309 0.644 . . . . 74.13 109.51 -171.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -97.82 97.9 9.37 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 107.449 -1.315 . . . . 70.03 107.449 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.403 HD11 HD13 ' D' ' 114' ' ' ILE . 38.8 mt -59.59 137.14 58.12 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-N 115.133 -0.939 . . . . 74.34 109.995 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.49 148.49 73.66 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 123.541 0.736 . . . . 72.3 111.184 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.464 ' HG3' ' CD2' ' B' ' 11' ' ' PHE . 32.0 Cg_endo -60.47 122.95 12.09 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.647 2.231 . . . . 75.2 111.298 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 99.9 t -108.08 115.26 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.395 -0.366 . . . . 75.32 110.631 -175.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -83.64 96.55 8.71 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 107.745 -1.206 . . . . 73.53 107.745 167.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . 0.409 ' CE2' HD13 ' D' ' 44' ' ' LEU . 28.5 m-85 . . . . . 0 N--CA 1.489 1.501 0 C-N-CA 124.047 0.939 . . . . 72.02 112.109 -174.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 84.6 m . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 120.934 0.397 . . . . 74.14 110.486 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.54 ' HE1' ' SG ' ' A' ' 102' ' ' CYS . 72.6 t80 -120.62 124.87 46.3 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.767 -1.197 . . . . 73.2 107.767 172.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -132.23 132.72 43.36 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.284 -0.635 . . . . 75.2 109.284 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.458 HG23 ' HG2' ' C' ' 130' ' ' PRO . 69.4 mt -89.69 109.63 20.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.158 -1.053 . . . . 64.45 108.158 171.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.63 -40.66 17.19 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 109.048 -0.723 . . . . 72.23 109.048 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 -168.88 122.28 0.82 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.64 0.376 . . . . 74.41 110.283 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 83.7 mt -107.07 136.71 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.776 -0.824 . . . . 74.4 108.776 170.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.443 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 22.1 p90 -164.92 169.51 16.4 Favored 'General case' 0 C--N 1.347 0.47 0 O-C-N 123.822 0.701 . . . . 61.43 111.699 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -94.47 120.6 34.96 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.116 -0.698 . . . . 70.41 109.116 172.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.443 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 34.8 mtpt -78.9 -34.88 44.35 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.164 0.507 . . . . 70.2 109.673 175.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.421 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 17.8 t70 -150.01 140.47 22.41 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.646 -1.161 . . . . 71.03 109.865 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.4 mt -130.92 139.69 50.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 124.873 1.269 . . . . 72.41 107.835 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -145.54 127.97 15.95 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.297 -1.001 . . . . 61.34 108.297 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.459 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 86.9 t80 -135.63 129.49 32.91 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.112 -1.44 . . . . 74.01 107.112 171.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -129.59 135.95 49.2 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.165 -0.679 . . . . 75.13 109.165 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.31 76.93 71.66 Favored Pre-proline 0 C--O 1.24 0.553 0 N-CA-C 105.817 -1.919 . . . . 72.15 105.817 167.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.67 -22.92 36.91 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.591 2.194 . . . . 74.52 112.027 -171.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -110.12 22.3 15.74 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.233 1.013 . . . . 65.51 109.447 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.453 ' HB2' ' HE3' ' B' ' 19' ' ' LYS . . . -46.88 -52.79 30.47 Favored Pre-proline 0 CA--C 1.568 1.654 0 CA-C-O 117.846 -1.073 . . . . 75.02 113.658 -171.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.57 -23.22 64.31 Favored 'Trans proline' 0 C--N 1.391 2.778 0 CA-C-N 121.536 1.584 . . . . 73.24 113.374 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -84.12 -39.69 19.17 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.675 0.79 . . . . 74.51 111.017 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.758 HG22 ' HA ' ' A' ' 73' ' ' ALA . 5.5 p -78.23 -23.56 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 CA-C-N 115.306 -0.861 . . . . 73.21 113.159 -157.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -70.06 -19.35 63.29 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 122.739 0.416 . . . . 74.43 110.874 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -86.81 -16.5 36.03 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.568 1.147 . . . . 74.31 110.772 177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -81.5 158.06 24.63 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.873 0.869 . . . . 74.41 111.884 -174.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.48 118.27 8.53 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 123.992 0.917 . . . . 74.11 109.413 173.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -78.55 84.92 4.65 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.661 0.743 . . . . 75.14 109.91 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -122.85 76.09 48.44 Favored Pre-proline 0 C--O 1.243 0.745 0 N-CA-C 106.799 -1.556 . . . . 74.53 106.799 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.411 ' HB2' HG22 ' A' ' 40' ' ' VAL . 83.7 Cg_endo -78.47 115.1 3.61 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 121.817 1.678 . . . . 72.32 111.363 -171.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -93.31 81.59 4.45 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 105.554 -2.017 . . . . 73.15 105.554 172.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.538 HG23 ' HB1' ' A' ' 66' ' ' ALA . 46.0 t -86.05 93.74 3.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 CA-C-N 114.532 -1.213 . . . . 61.55 109.555 -174.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.72 118.82 21.88 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.953 -1.476 . . . . 63.11 108.384 174.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.7 mt -95.39 108.55 20.75 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.435 -1.32 . . . . 75.45 107.435 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -102.61 141.18 35.85 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.387 -0.968 . . . . 75.32 108.387 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.516 HD12 HG22 ' A' ' 131' ' ' VAL . 75.5 mt -135.39 131.41 36.28 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 109.498 -0.556 . . . . 75.13 109.498 -174.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -134.03 129.56 36.27 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.448 -1.316 . . . . 71.52 107.448 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.3 m -108.54 130.97 55.28 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.876 -0.787 . . . . 53.12 108.876 172.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.72 109.37 9.11 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.819 -0.808 . . . . 73.5 108.819 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.6 p -91.28 163.42 14.24 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.318 0.647 . . . . 74.31 110.098 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.9 t -160.39 154.14 22.6 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.28 1.432 . . . . 75.41 107.328 -166.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -116.29 125.41 52.12 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.681 -0.489 . . . . 74.34 109.681 171.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.7 mt -95.02 -32.99 12.89 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.21 0.604 . . . . 74.43 110.583 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.95 -179.5 7.2 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.192 0.597 . . . . 64.14 111.39 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -63.51 123.7 19.47 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 109.346 -0.613 . . . . 70.14 109.346 174.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 70.2 -8.53 0.84 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 125.835 1.654 . . . . 64.54 112.886 -173.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.7 t -100.64 106.61 19.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 121.496 0.665 . . . . 73.43 109.301 -177.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -114.27 125.61 54.1 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.735 -1.209 . . . . 71.43 107.735 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -94.32 128.77 41.02 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.919 -0.771 . . . . 72.42 108.919 172.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.1 t -113.2 137.71 45.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.369 -0.974 . . . . 71.01 108.369 171.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.7 t -119.32 130.58 73.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.905 -0.776 . . . . 75.44 108.905 173.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.31 97.8 7.56 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 105.675 -1.972 . . . . 73.12 105.675 172.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -84.94 97.58 9.87 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.928 -1.138 . . . . 73.32 107.928 174.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 50.0 t -94.97 131.25 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 107.49 -1.3 . . . . 74.33 107.49 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.8 m -127.12 118.4 24.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.817 0.817 . . . . 74.24 110.203 175.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 91.5 t -104.33 125.49 59.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 124.56 1.144 . . . . 71.43 108.905 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.1 m -122.43 126.49 48.05 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.648 -0.871 . . . . 72.31 108.648 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.538 ' HB1' HG23 ' A' ' 40' ' ' VAL . . . -113.21 108.3 17.08 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 107.847 -1.168 . . . . 73.32 107.847 175.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.0 m -109.03 134.29 51.85 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.179 0.591 . . . . 72.21 110.037 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.459 HD13 ' HB1' ' A' ' 73' ' ' ALA . 14.4 mt -100.7 57.74 0.91 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.247 1.019 . . . . 75.21 108.341 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.46 -103.15 3.0 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 110.82 -0.912 . . . . 63.21 110.82 -169.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -96.59 -28.56 14.31 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.352 0.661 . . . . 73.45 111.428 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -102.74 123.07 45.74 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.471 0.308 . . . . 73.43 110.639 -173.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.6 m -71.5 138.42 48.92 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.514 0.726 . . . . 63.21 110.871 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.758 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -79.78 -60.06 2.49 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.317 1.047 . . . . 74.2 109.817 173.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -151.02 156.64 41.55 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 114.629 -1.169 . . . . 74.42 111.071 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 39.9 tp -126.82 115.05 18.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.633 1.173 . . . . 64.51 108.58 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.595 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 66.3 m -105.9 142.3 35.85 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.044 0.937 . . . . 72.32 109.339 175.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -146.44 121.35 9.98 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.644 -0.873 . . . . 73.22 108.644 166.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.4 t -126.09 109.81 22.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.703 -0.851 . . . . 73.52 108.703 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -85.78 82.01 8.36 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 114.379 -1.282 . . . . 72.33 108.443 174.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -76.23 95.55 3.74 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.828 -1.078 . . . . 61.14 109.164 -177.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.32 154.88 29.15 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 111.361 -0.696 . . . . 73.02 111.361 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.29 121.51 1.23 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.682 -0.967 . . . . 54.34 110.682 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.4 mt -81.68 127.1 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 107.823 -1.177 . . . . 74.12 107.823 171.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.627 ' HB3' HD11 ' A' ' 86' ' ' ILE . 71.0 m-85 -135.71 125.15 24.95 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.095 0.958 . . . . 72.24 109.561 -171.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.1 m -94.65 97.95 10.46 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 109.216 -0.661 . . . . 73.42 109.216 175.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.627 HD11 ' HB3' ' A' ' 84' ' ' PHE . 6.0 mm -108.04 156.69 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.385 0.674 . . . . 72.13 110.679 -172.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.41 162.84 8.47 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.523 1.129 . . . . 75.34 110.909 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.21 -13.94 62.81 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-N 115.951 -0.568 . . . . 73.24 114.422 174.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.46 146.6 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.824 0.85 . . . . 74.03 110.736 -177.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.403 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 50.5 mt-10 -144.16 174.76 10.6 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.296 1.038 . . . . 64.41 109.735 174.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.99 -139.01 26.42 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 116.012 -0.54 . . . . 60.21 112.618 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.7 p -69.79 -16.61 63.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 117.105 0.453 . . . . 73.12 111.501 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.57 -45.71 85.88 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.254 0.621 . . . . 74.12 109.959 170.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.469 ' HE2' HD22 ' A' ' 98' ' ' LEU . 6.1 tpt -66.75 -43.79 83.2 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.103 -0.953 . . . . 63.35 109.662 -178.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.95 -31.16 72.25 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.601 -0.727 . . . . 63.3 111.125 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -74.3 -30.3 62.01 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.667 0.787 . . . . 72.22 110.696 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.4 t -72.8 -44.54 61.38 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 109.115 -0.698 . . . . 61.14 109.115 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.469 HD22 ' HE2' ' A' ' 94' ' ' MET . 35.9 mt -84.99 -24.72 28.14 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.389 -0.823 . . . . 74.33 112.019 -174.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.01 4.45 33.89 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 119.597 -0.557 . . . . 52.03 113.947 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.581 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -147.52 -64.22 0.27 Allowed 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 117.667 0.734 . . . . 64.31 112.372 -177.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -68.16 -47.27 68.48 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 123.352 0.408 . . . . 74.35 111.697 -171.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.54 ' SG ' ' HE1' ' A' ' 11' ' ' PHE . 98.4 m -65.2 -45.83 71.87 Favored Pre-proline 0 CA--C 1.56 1.333 0 CA-C-O 117.987 -1.006 . . . . 73.22 112.316 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -54.26 -35.26 82.78 Favored 'Trans proline' 0 C--N 1.398 3.178 0 C-N-CA 122.188 1.925 . . . . 72.13 112.889 169.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -68.53 -34.25 75.54 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.531 0.732 . . . . 74.15 111.093 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.5 mm -67.88 -43.23 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.49 0.716 . . . . 73.11 110.054 172.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 55.9 mt -75.19 -20.24 59.4 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.053 -0.976 . . . . 62.23 111.877 -174.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -65.63 -45.24 67.1 Favored Pre-proline 0 N--CA 1.478 0.93 0 CA-C-O 117.05 -1.452 . . . . 75.44 113.537 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -50.72 -34.11 42.8 Favored 'Trans proline' 0 C--N 1.39 2.715 0 CA-C-N 122.182 1.815 . . . . 72.33 113.592 171.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -85.69 -36.47 20.22 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.711 0.804 . . . . 72.21 112.054 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.42 -48.25 67.84 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.968 -0.752 . . . . 64.02 108.968 175.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.407 ' NH1' HD13 ' C' ' 105' ' ' ILE . 27.9 ttm180 -47.87 -58.48 4.32 Favored 'General case' 0 C--O 1.213 -0.82 0 O-C-N 125.203 1.565 . . . . 70.43 110.677 171.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -60.79 -45.35 94.74 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 124.321 1.013 . . . . 74.44 111.792 -173.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.412 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 47.4 t -58.74 -45.9 88.62 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.045 0.841 . . . . 74.04 110.498 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.585 HD13 HD12 ' A' ' 128' ' ' LEU . 83.3 mt -61.16 -51.44 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 124.27 0.982 . . . . 64.33 110.603 175.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.2 m -58.75 -37.11 75.5 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.36 1.064 . . . . 73.21 110.687 -173.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.1 t -70.59 -44.56 67.06 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.444 -1.253 . . . . 75.33 109.866 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.439 ' HE2' ' HB2' ' A' ' 23' ' ' PHE . 10.4 mtp -59.39 -38.62 81.0 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.658 0.783 . . . . 71.23 111.774 176.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 114' ' ' ILE . 79.3 t -67.27 -46.08 84.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.211 1.004 . . . . 71.43 110.073 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.9 p -71.88 -30.63 65.61 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.828 -0.624 . . . . 64.12 111.106 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.408 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 81.7 mtt-85 -72.22 -33.69 67.78 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.675 0.79 . . . . 75.31 109.432 172.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.61 -2.17 74.32 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 115.019 -0.991 . . . . 73.21 112.962 175.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.484 HG22 HH21 ' B' ' 15' ' ' ARG . 52.1 m 76.92 19.99 1.34 Allowed 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 122.593 1.187 . . . . 74.33 111.882 168.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -93.31 148.75 36.17 Favored Pre-proline 0 C--O 1.248 1.022 0 N-CA-C 108.296 -1.002 . . . . 73.43 108.296 170.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -54.47 138.96 74.9 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.494 2.129 . . . . 72.04 111.156 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -56.21 127.48 30.96 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.332 1.02 . . . . 75.34 112.274 -167.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.528 HD21 HG12 ' A' ' 64' ' ' VAL . 36.0 tp -113.04 97.14 6.33 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 114.454 -1.248 . . . . 74.44 109.406 -175.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -96.04 103.23 15.11 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.038 -1.467 . . . . 74.34 107.038 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.585 HD12 HD13 ' A' ' 114' ' ' ILE . 17.3 mt -55.24 136.12 49.08 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.778 0.673 . . . . 74.51 111.134 -169.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.84 137.86 97.28 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 122.755 0.422 . . . . 42.03 111.274 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.521 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 53.2 Cg_exo -55.47 114.84 2.07 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.593 2.862 . . . . 70.24 113.689 -178.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.516 HG22 HD12 ' A' ' 44' ' ' LEU . 45.1 t -104.2 133.24 48.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 CA-C-N 115.455 -0.793 . . . . 74.24 109.842 177.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 63.4 t-20 -96.97 87.12 4.16 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.515 -0.921 . . . . 71.01 108.515 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -59.68 -26.6 65.7 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.708 0.803 . . . . 74.04 113.056 175.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.581 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 8.6 t0 -63.67 -43.97 95.15 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.931 -0.766 . . . . 75.42 108.931 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.05 -35.22 80.46 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.893 -1.048 . . . . 72.31 111.476 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 77.9 mt -71.83 -40.66 68.93 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.022 0.826 . . . . 74.45 111.879 -177.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 59.8 t80 . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 108.796 -0.816 . . . . 74.12 108.796 175.688 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.554 ' HG3' HG23 ' B' ' 89' ' ' ILE . 1.2 tmt? . . . . . 0 N--CA 1.486 1.354 0 N-CA-C 111.804 0.298 . . . . 74.12 111.804 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.484 ' N ' ' SD ' ' B' ' 9' ' ' MET . 9.5 t -159.89 133.59 7.16 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.844 0.857 . . . . 72.25 109.405 176.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -117.36 141.85 47.81 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 107.842 -1.17 . . . . 75.4 107.842 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -149.46 137.54 20.54 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 122.76 0.424 . . . . 74.41 110.701 176.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 44.6 mt -96.23 128.16 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.049 -1.093 . . . . 73.43 108.049 173.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -95.35 -42.03 8.72 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.524 0.515 . . . . 73.41 110.525 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.484 HH21 HG22 ' A' ' 122' ' ' THR . 22.8 ttt180 -172.93 138.69 0.8 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.737 -0.665 . . . . 73.33 109.303 -172.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.8 mt -123.31 139.88 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 106.661 -1.607 . . . . 74.2 106.661 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -164.01 145.21 8.7 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.22 0.822 . . . . 73.44 113.22 -174.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 64.0 m -76.28 120.43 21.54 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.737 -1.119 . . . . 74.52 109.094 172.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.613 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 37.0 mtpt -97.82 -22.82 16.17 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.049 0.94 . . . . 75.03 111.006 -178.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.526 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 17.8 t70 -158.53 143.25 16.07 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.185 0.594 . . . . 74.12 110.358 -175.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.595 HD13 ' SG ' ' B' ' 113' ' ' CYS . 38.9 mm -138.9 141.47 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.252 1.421 . . . . 74.1 107.849 174.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 67.8 m -145.83 138.45 25.69 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.529 0.732 . . . . 71.04 109.13 170.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.3 t80 -143.41 116.76 9.05 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.792 -1.929 . . . . 74.1 105.792 169.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -127.89 111.14 13.26 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.323 -0.992 . . . . 62.03 108.323 -176.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.477 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -110.2 87.91 6.6 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 108.211 -1.033 . . . . 73.32 108.211 175.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.07 -34.06 14.28 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.232 1.955 . . . . 74.25 111.547 -175.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -99.97 3.81 44.54 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.325 1.05 . . . . 75.23 110.902 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.524 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -24.89 -64.68 0.1 OUTLIER Pre-proline 0 N--CA 1.504 2.266 0 C-N-CA 126.606 1.962 . . . . 72.44 115.332 -172.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 7.9 Cg_exo -66.57 -42.34 9.66 Favored 'Trans proline' 0 C--N 1.388 2.63 0 C-N-CA 122.154 1.903 . . . . 74.43 112.386 -170.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -86.03 -28.19 24.31 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.651 0.78 . . . . 75.22 111.89 -171.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 p -77.59 -11.66 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 122.889 0.476 . . . . 64.33 110.696 -175.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -65.89 -20.52 66.25 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 113.101 0.778 . . . . 73.23 113.101 173.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -63.21 -25.16 68.21 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.313 0.578 . . . . 75.34 110.111 173.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.555 ' HZ3' ' HG2' ' B' ' 71' ' ' GLU . 88.4 mttt -90.83 66.98 6.12 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.307 1.043 . . . . 73.11 109.713 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -80.6 82.08 6.7 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 122.291 1.043 . . . . 75.15 109.114 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -152.83 -173.3 4.52 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.102 -0.954 . . . . 75.32 109.122 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -72.51 110.35 7.97 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 123.992 0.917 . . . . 75.42 109.631 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.532 ' HA ' HD21 ' B' ' 68' ' ' LEU . 49.2 Cg_endo -70.38 141.1 41.88 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 121.653 1.569 . . . . 74.35 109.747 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -68.12 99.97 0.95 Allowed 'General case' 0 C--O 1.242 0.687 0 N-CA-C 106.906 -1.516 . . . . 70.43 106.906 171.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.509 HG11 HD13 ' B' ' 126' ' ' LEU . 39.1 t -95.72 154.2 3.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 114.593 -1.185 . . . . 73.54 108.734 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.408 ' N ' HG13 ' B' ' 40' ' ' VAL . 53.6 tttm -143.81 117.5 9.25 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.93 -0.766 . . . . 73.33 108.93 175.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.465 HD12 HD21 ' B' ' 128' ' ' LEU . 31.1 tp -93.27 137.31 32.71 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 108.832 -0.803 . . . . 65.01 108.832 172.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -159.55 128.22 5.11 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 107.702 -1.221 . . . . 73.05 107.702 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.415 HD23 HG21 ' B' ' 62' ' ' VAL . 4.0 mp -108.59 151.25 26.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.879 -0.785 . . . . 72.45 108.879 -174.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.545 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.4 t70 -127.54 144.14 51.1 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.027 0.931 . . . . 73.31 109.111 -177.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 26.1 p -113.07 106.51 14.76 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.534 0.734 . . . . 64.44 110.653 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.99 136.25 52.77 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.971 -1.122 . . . . 64.11 107.971 171.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.542 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 58.0 m -142.85 177.55 8.26 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.567 0.347 . . . . 70.42 110.774 -173.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 79.4 p -159.21 139.18 11.89 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.785 0.434 . . . . 74.53 111.136 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -90.24 125.16 35.39 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 108.696 -0.853 . . . . 71.35 108.696 169.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.6 pp -140.32 17.71 2.41 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.978 0.911 . . . . 75.13 109.845 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.77 152.65 17.93 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.454 1.102 . . . . 75.33 109.078 174.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -76.98 135.43 38.7 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.279 -1.008 . . . . 74.22 108.279 164.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 70.59 -4.25 1.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.139 0.976 . . . . 71.11 113.113 172.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.425 HG13 ' HG ' ' B' ' 85' ' ' SER . 63.6 t -136.27 128.46 45.0 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 106.725 -1.583 . . . . 74.1 106.725 -175.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.542 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 4.9 t80 -122.16 169.64 10.67 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.836 0.351 . . . . 74.34 110.564 -172.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -134.72 111.45 9.98 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 107.664 -1.235 . . . . 72.45 107.664 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 61.5 t -106.75 130.67 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.056 0.942 . . . . 75.52 109.198 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.2 t -111.28 113.31 43.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 N-CA-C 109.277 -0.638 . . . . 73.45 109.277 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 63.1 tp -93.79 110.77 22.4 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 109.076 -0.713 . . . . 73.15 109.076 171.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.545 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 14.0 ttm180 -84.66 132.89 34.43 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.855 -1.165 . . . . 75.32 107.855 169.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.415 HG21 HD23 ' B' ' 44' ' ' LEU . 43.8 t -123.49 104.15 13.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.571 -1.27 . . . . 72.3 107.571 174.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 15.2 m -100.63 131.71 46.4 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.068 0.461 . . . . 75.21 110.112 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.568 HG23 HD12 ' B' ' 114' ' ' ILE . 70.3 t -122.92 126.54 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.222 1.009 . . . . 74.41 108.5 175.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.8 m -111.3 138.9 47.18 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 107.54 -1.281 . . . . 71.22 107.54 168.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.12 137.09 28.88 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.034 -0.728 . . . . 74.53 109.034 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.541 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 25.1 p -147.05 128.28 14.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.085 0.469 . . . . 64.41 111.584 -172.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.532 HD21 ' HA ' ' B' ' 38' ' ' PRO . 56.4 mt -99.03 103.79 15.76 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 124.919 1.288 . . . . 72.24 108.507 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.3 -119.04 4.82 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 115.657 -0.701 . . . . 62.54 111.824 -174.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -112.22 3.93 17.47 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.94 0.896 . . . . 73.33 111.368 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.555 ' HG2' ' HZ3' ' B' ' 34' ' ' LYS . 11.8 pt-20 -118.0 148.62 42.05 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.119 0.567 . . . . 75.11 109.672 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 99.2 m -72.63 125.66 28.02 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.8 -0.636 . . . . 62.45 111.232 -177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.541 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -71.66 -62.43 1.42 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.81 -1.181 . . . . 61.42 107.81 173.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -152.89 157.89 41.35 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.586 -1.188 . . . . 73.42 111.186 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 70.8 mt -126.08 108.5 11.42 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 106.255 -1.758 . . . . 74.51 106.255 172.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 39.3 t -119.17 113.76 21.4 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.507 -0.923 . . . . 74.12 108.507 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -128.57 124.62 36.38 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.973 -1.121 . . . . 75.33 107.973 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.491 HG12 HD11 ' B' ' 21' ' ' ILE . 67.3 t -123.63 155.84 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.855 0.862 . . . . 72.3 109.24 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.526 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.7 mt-30 -131.25 108.03 9.4 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.19 -0.67 . . . . 55.13 109.19 171.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.411 ' HB2' ' HB1' ' B' ' 110' ' ' ALA . 8.5 tp-100 -96.89 109.38 22.11 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.568 0.747 . . . . 70.43 109.518 173.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.613 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -99.64 170.61 23.25 Favored Glycine 0 N--CA 1.464 0.535 0 N-CA-C 112.021 -0.432 . . . . 73.42 112.021 174.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.97 138.78 5.12 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 112.573 -0.211 . . . . 62.5 112.573 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 49.5 mt -92.17 122.08 43.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.267 1.027 . . . . 74.12 108.764 174.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -127.45 135.21 50.1 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.002 0.921 . . . . 73.3 109.727 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.425 ' HG ' HG13 ' B' ' 55' ' ' VAL . 24.1 m -106.32 128.65 54.15 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.691 0.796 . . . . 73.11 109.5 174.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.491 ' HB ' HD11 ' B' ' 89' ' ' ILE . 1.9 pp -139.77 147.06 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.374 0.669 . . . . 72.52 111.089 -177.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.68 165.92 35.03 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.4 0.68 . . . . 75.51 111.104 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 90.8 -45.83 2.91 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 116.087 -0.506 . . . . 31.2 112.741 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.564 HD13 ' HA ' ' B' ' 94' ' ' MET . 4.0 pt -56.38 152.33 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.559 1.143 . . . . 72.34 111.426 169.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -157.94 164.09 37.2 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.536 0.734 . . . . 74.22 109.536 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.36 -111.07 3.49 Favored Glycine 0 C--N 1.355 1.631 0 O-C-N 123.197 0.31 . . . . 75.14 112.699 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 25.0 m -84.34 -43.22 14.97 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 123.695 0.798 . . . . 74.44 109.696 175.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -62.53 -24.66 67.62 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 113.758 -1.565 . . . . 75.43 111.694 -168.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.564 ' HA ' HD13 ' B' ' 89' ' ' ILE . 23.9 ptm -66.1 -65.67 0.65 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.084 0.772 . . . . 75.54 113.084 -177.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.19 -14.4 58.48 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.21 0.448 . . . . 71.32 112.21 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -61.33 -37.03 81.82 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.365 0.666 . . . . 74.15 110.554 171.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.459 ' SG ' HG21 ' B' ' 86' ' ' ILE . 43.8 t -60.13 -24.56 64.78 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.114 0.966 . . . . 73.41 112.024 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.504 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 26.7 mt -97.76 -39.13 9.19 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.124 0.969 . . . . 72.42 111.497 -177.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.26 -19.27 69.69 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 116.43 -0.35 . . . . 73.52 113.572 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.87 -48.48 1.89 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.003 0.521 . . . . 73.24 111.767 -172.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -83.05 -41.96 18.03 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 111.877 0.325 . . . . 73.23 111.877 -171.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.504 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 94.8 m -63.05 -43.23 81.15 Favored Pre-proline 0 CA--C 1.57 1.733 0 N-CA-C 113.569 0.952 . . . . 45.23 113.569 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.27 -27.62 81.52 Favored 'Trans proline' 0 C--N 1.399 3.196 0 C-N-CA 122.239 1.96 . . . . 73.24 113.674 173.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -65.01 -33.55 76.31 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.663 0.785 . . . . 74.12 110.591 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 57.4 mt -73.89 -41.7 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.883 0.873 . . . . 75.01 110.088 176.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 92.5 mt -75.94 -30.01 58.53 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.23 -0.896 . . . . 65.32 112.424 -172.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -56.98 -49.7 92.44 Favored Pre-proline 0 N--CA 1.484 1.239 0 CA-C-O 117.342 -1.313 . . . . 72.25 113.477 -172.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -50.31 -39.64 53.01 Favored 'Trans proline' 0 C--N 1.391 2.788 0 C-N-CA 122.512 2.141 . . . . 75.14 114.161 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -70.15 -47.15 62.89 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.334 0.654 . . . . 72.23 110.509 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' B' ' 80' ' ' GLN . . . -62.35 -35.53 79.41 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.37 -0.832 . . . . 65.44 111.337 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.522 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 50.2 ttt-85 -67.53 -49.73 61.97 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.134 1.374 . . . . 72.41 110.349 -177.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.6 -32.34 73.61 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.021 0.826 . . . . 71.51 109.687 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.595 ' SG ' HD13 ' B' ' 21' ' ' ILE . 3.3 t -69.56 -42.84 74.02 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.257 0.623 . . . . 65.24 110.829 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.568 HD12 HG23 ' B' ' 64' ' ' VAL . 74.9 mt -60.23 -54.52 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.392 0.677 . . . . 75.44 110.603 172.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 25.5 m -58.9 -28.69 66.43 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.503 0.721 . . . . 73.23 111.276 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 22.9 t -67.69 -53.2 29.58 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 123.203 0.601 . . . . 75.34 109.59 173.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.2 mmt -64.52 -31.89 73.3 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 122.758 0.423 . . . . 75.15 111.774 -175.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.489 HG22 HD22 ' B' ' 126' ' ' LEU . 79.8 t -69.7 -42.1 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.268 1.027 . . . . 73.04 110.562 176.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 81.5 p -72.43 -28.89 63.24 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.001 0.429 . . . . 71.25 111.087 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' B' ' 116' ' ' SER . 88.5 mtt-85 -67.93 -40.72 83.31 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.12 -0.945 . . . . 71.54 109.505 175.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.45 -6.18 61.43 Favored Glycine 0 C--N 1.352 1.467 0 O-C-N 123.764 0.665 . . . . 72.23 113.071 173.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 9.7 m 64.98 31.45 11.25 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.282 1.433 . . . . 73.12 110.298 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -89.53 164.03 31.08 Favored Pre-proline 0 CA--C 1.556 1.193 0 CA-C-N 114.22 -1.354 . . . . 75.42 111.129 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -39.74 146.55 0.22 Allowed 'Trans proline' 0 C--N 1.393 2.885 0 C-N-CA 124.647 3.565 . . . . 74.11 115.86 174.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -61.05 112.84 2.25 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.301 0.641 . . . . 74.41 109.768 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.509 HD13 HG11 ' B' ' 40' ' ' VAL . 43.4 tp -109.93 110.72 21.76 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.424 0.69 . . . . 72.0 109.463 -174.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -107.29 117.53 34.32 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.201 -1.037 . . . . 73.02 108.201 175.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.522 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 51.4 mt -78.56 147.46 33.74 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 120.535 0.207 . . . . 64.23 110.53 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -73.13 142.11 81.97 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 123.641 0.776 . . . . 71.54 112.375 -170.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 129' ' ' ALA . 11.2 Cg_endo -85.04 104.04 0.86 Allowed 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.312 2.675 . . . . 71.3 111.192 176.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.95 134.93 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 122.83 0.452 . . . . 74.51 110.327 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 41.0 t30 . . . . . 0 N--CA 1.474 0.756 0 C-N-CA 123.259 0.624 . . . . 73.4 109.432 177.926 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.521 ' HD2' ' HG2' ' A' ' 130' ' ' PRO . 35.0 t80 . . . . . 0 C--O 1.239 0.53 0 N-CA-C 108.0 -1.111 . . . . 75.21 108.0 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -142.03 131.25 23.44 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.711 -0.848 . . . . 71.4 108.711 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 19.9 mt -84.22 134.77 26.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.723 -0.843 . . . . 73.14 108.723 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.511 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 20.9 mm-40 -91.35 -45.67 8.45 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.592 -0.892 . . . . 74.22 108.592 175.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -177.58 153.35 0.88 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.048 1.339 . . . . 75.14 109.455 175.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.441 HG21 HD23 ' C' ' 106' ' ' LEU . 75.0 mt -128.75 118.55 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.731 1.212 . . . . 63.34 108.379 177.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.483 ' HB3' HG22 ' D' ' 122' ' ' THR . 6.1 p90 -151.37 154.45 36.7 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.008 0.908 . . . . 74.21 112.249 -164.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.2 p -79.22 108.85 13.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.562 -1.199 . . . . 73.41 109.406 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' D' ' 28' ' ' ALA . 8.9 mmmm -72.83 -45.01 60.69 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 107.557 -1.275 . . . . 75.04 107.557 172.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.705 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 10.4 t70 -134.52 137.54 43.94 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 113.186 -1.825 . . . . 64.11 109.19 -174.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.4 mt -134.78 143.44 37.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 125.455 1.502 . . . . 70.22 106.969 172.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.7 t -150.01 138.0 20.24 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 109.154 -0.684 . . . . 75.31 109.154 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -139.01 128.61 24.57 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.48 -1.304 . . . . 71.33 107.48 171.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -130.18 120.19 24.14 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.534 1.134 . . . . 70.53 108.784 -174.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.14 84.0 58.66 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 106.969 -1.493 . . . . 74.5 106.969 169.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.5 -26.9 28.36 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 122.397 2.064 . . . . 64.13 111.227 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -107.39 21.83 16.89 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.486 1.114 . . . . 65.44 109.836 -176.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.82 -64.94 0.71 Allowed Pre-proline 0 CA--C 1.571 1.777 0 N-CA-C 114.466 1.284 . . . . 54.51 114.466 -165.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -67.54 -27.87 38.83 Favored 'Trans proline' 0 C--N 1.385 2.453 0 CA-C-N 122.326 1.867 . . . . 74.34 112.615 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -68.13 -37.86 81.57 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.893 0.877 . . . . 73.13 111.366 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.633 HG21 ' HA ' ' C' ' 73' ' ' ALA . 14.8 p -82.01 -24.87 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 116.184 -0.462 . . . . 71.15 111.941 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -65.72 -30.66 71.36 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 121.787 -0.57 . . . . 73.43 111.015 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -90.82 29.93 1.27 Allowed 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.109 0.964 . . . . 64.0 111.228 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.729 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 1.3 tppp? -124.74 153.38 42.49 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.457 1.103 . . . . 71.3 109.711 -177.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -67.76 129.76 40.9 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 122.994 0.518 . . . . 75.34 109.89 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 66.5 t-105 -85.0 83.44 8.06 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.8 0.84 . . . . 74.22 111.346 -173.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -131.21 78.87 71.74 Favored Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 123.739 0.816 . . . . 71.41 109.071 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -83.23 155.61 14.6 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.553 2.169 . . . . 71.11 112.428 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -88.52 100.48 13.11 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 106.749 -1.574 . . . . 74.01 106.749 168.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 57.4 t -74.64 99.42 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 109.024 -0.732 . . . . 71.24 109.024 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 32.5 mmtm -131.65 106.79 8.39 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.086 0.954 . . . . 75.44 109.472 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 pp -95.74 165.35 12.35 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.69 0.796 . . . . 73.02 109.933 175.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.583 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 19.9 t70 -139.86 143.98 37.01 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.414 1.086 . . . . 73.21 108.235 175.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 97.4 mt -128.58 112.57 14.43 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.382 0.611 . . . . 73.31 109.613 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -112.87 121.18 43.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.635 -1.617 . . . . 64.4 106.635 172.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.2 t -118.68 142.92 47.2 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.36 0.6 . . . . 75.12 109.382 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.45 151.86 49.62 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.561 1.144 . . . . 74.42 108.274 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 53.1 p -147.32 142.21 26.89 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 109.348 -0.612 . . . . 74.1 109.348 174.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 72.6 p -150.35 151.85 33.5 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.291 1.036 . . . . 64.14 108.585 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -98.87 117.22 32.87 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.925 -0.769 . . . . 73.44 108.925 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.678 HD12 ' HB2' ' C' ' 57' ' ' GLU . 61.4 mt -84.42 -37.01 21.98 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.497 0.719 . . . . 75.43 110.233 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.38 -175.76 5.6 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.169 0.988 . . . . 63.54 109.759 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -59.16 110.23 1.02 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 123.641 0.588 . . . . 72.52 110.363 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 62.85 22.72 13.58 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.287 1.035 . . . . 71.22 112.066 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 95.6 t -117.63 117.49 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.874 1.27 . . . . 62.13 107.58 173.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -127.28 125.36 40.74 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.068 0.947 . . . . 75.13 109.554 -174.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.678 ' HB2' HD12 ' C' ' 51' ' ' LEU . 40.0 tt0 -88.33 122.12 31.48 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.832 -0.803 . . . . 61.51 108.832 169.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 65.8 t -112.49 124.13 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 108.713 -0.847 . . . . 75.44 108.713 172.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.53 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 61.6 t -109.75 134.75 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.019 0.528 . . . . 64.3 109.938 176.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.47 99.56 8.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.848 -1.168 . . . . 75.4 107.848 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -80.31 106.8 12.6 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.121 -1.066 . . . . 75.14 108.121 170.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.442 HG22 ' HB3' ' C' ' 110' ' ' ALA . 22.0 t -105.15 122.5 58.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 107.866 -1.161 . . . . 74.42 107.866 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 25.1 m -113.3 138.61 49.77 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 107.415 -1.328 . . . . 74.32 107.415 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.475 HG22 HG23 ' C' ' 114' ' ' ILE . 69.1 t -134.34 111.64 14.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 108.021 -1.103 . . . . 71.33 108.021 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.401 HG23 HD22 ' C' ' 75' ' ' LEU . 4.3 m -108.22 117.4 34.05 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.707 -0.679 . . . . 74.4 109.17 -177.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.42 104.04 10.71 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.565 -0.902 . . . . 63.11 108.565 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 63.4 m -128.77 132.91 47.94 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.186 -0.672 . . . . 73.23 109.186 176.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 9.6 mt -84.68 42.32 0.9 Allowed 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 125.428 1.491 . . . . 74.35 109.889 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.22 -104.61 2.46 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 110.97 -0.852 . . . . 53.12 110.97 -172.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -89.7 -32.19 17.13 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.514 0.726 . . . . 75.3 109.945 174.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.729 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 10.7 tp10 -75.95 105.84 7.21 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 114.877 -1.056 . . . . 72.43 109.808 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 61.4 m -74.21 124.52 26.55 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 118.479 0.582 . . . . 53.42 109.597 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.633 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -77.79 -53.89 6.98 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.582 -0.736 . . . . 53.54 109.111 176.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -162.03 164.13 28.42 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.827 -1.079 . . . . 75.55 110.729 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.401 HD22 HG23 ' C' ' 65' ' ' THR . 2.7 tm? -128.41 142.17 51.19 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.211 -1.774 . . . . 72.13 106.211 167.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 42.5 t -149.44 129.8 13.8 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.94 -0.763 . . . . 72.15 108.94 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -140.66 128.62 21.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.714 0.406 . . . . 72.31 110.027 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 37.3 t -125.24 115.69 44.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 124.468 1.107 . . . . 75.21 108.891 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.705 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.5 mt-30 -90.41 91.09 8.32 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.57 -0.9 . . . . 72.44 108.57 172.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -83.78 96.07 8.63 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.342 -1.299 . . . . 75.21 109.183 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -93.2 145.73 17.75 Favored Glycine 0 C--O 1.222 -0.638 0 N-CA-C 111.616 -0.594 . . . . 71.34 111.616 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.94 132.13 4.91 Favored Glycine 0 CA--C 1.503 -0.703 0 N-CA-C 110.991 -0.844 . . . . 74.43 110.991 -176.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.511 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 22.8 mm -85.66 124.46 40.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 107.467 -1.308 . . . . 74.02 107.467 174.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -129.94 118.2 21.29 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.638 0.775 . . . . 75.43 109.703 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.6 p -86.92 104.62 16.43 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.035 -0.728 . . . . 64.22 109.035 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.546 HG21 ' HE2' ' C' ' 94' ' ' MET . 19.5 mt -116.73 126.98 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.532 0.733 . . . . 73.53 110.314 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.25 169.01 18.54 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.125 0.97 . . . . 63.23 109.887 177.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.66 -17.65 57.2 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 119.365 -0.686 . . . . 53.11 114.47 174.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.642 HD13 ' HA ' ' C' ' 94' ' ' MET . 38.0 pt -119.01 166.76 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 CA-C-N 118.079 0.94 . . . . 74.12 112.493 -175.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -159.39 156.44 28.47 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.685 1.194 . . . . 75.33 109.078 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.08 -138.14 14.88 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-O 120.073 -0.293 . . . . 74.41 112.926 171.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 47.1 p -65.08 -25.18 67.68 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.796 0.838 . . . . 63.25 111.457 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -61.15 -54.24 46.87 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.166 0.986 . . . . 74.43 110.635 171.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.642 ' HA ' HD13 ' C' ' 89' ' ' ILE . 4.5 tpt -56.67 -48.61 77.23 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 124.058 0.849 . . . . 73.43 111.803 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.17 -40.96 91.76 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 123.59 0.556 . . . . 54.44 111.514 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -69.56 -30.95 68.86 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.055 0.942 . . . . 75.14 111.239 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.406 ' SG ' HD12 ' C' ' 86' ' ' ILE . 12.2 t -75.41 -35.39 61.02 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.652 -0.499 . . . . 73.41 109.652 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 96.2 mt -84.14 -32.82 24.46 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.002 0.921 . . . . 73.34 112.521 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.88 8.77 27.6 Favored Glycine 0 N--CA 1.473 1.166 0 CA-C-O 119.656 -0.525 . . . . 74.32 114.135 -170.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.75 -55.32 0.22 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 117.411 0.606 . . . . 70.23 111.644 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -71.36 -54.34 11.08 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 117.566 0.166 . . . . 75.44 111.264 -174.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.431 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 84.8 m -57.58 -50.48 87.92 Favored Pre-proline 0 CA--C 1.565 1.524 0 CA-C-O 118.182 -0.913 . . . . 55.4 111.974 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.472 ' HA ' HD12 ' C' ' 106' ' ' LEU . 38.9 Cg_exo -60.11 -28.21 86.5 Favored 'Trans proline' 0 C--N 1.4 3.256 0 C-N-CA 122.601 2.201 . . . . 75.11 113.567 174.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -68.09 -35.61 78.45 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.201 0.6 . . . . 73.03 110.778 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.407 HD13 ' NH1' ' A' ' 111' ' ' ARG . 19.9 mm -79.86 -29.62 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 109.972 -0.381 . . . . 73.04 109.972 177.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' C' ' 103' ' ' PRO . 73.9 mt -70.09 -32.08 69.96 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.406 0.683 . . . . 73.21 111.254 176.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -53.29 -53.26 58.08 Favored Pre-proline 0 N--CA 1.485 1.322 0 CA-C-O 117.228 -1.368 . . . . 72.05 114.459 -173.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.82 -36.46 96.98 Favored 'Trans proline' 0 C--N 1.391 2.783 0 C-N-CA 122.074 1.849 . . . . 54.44 113.219 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -70.17 -46.55 64.42 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.706 0.802 . . . . 72.41 110.307 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.442 ' HB3' HG22 ' C' ' 62' ' ' VAL . . . -58.61 -39.94 81.86 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 115.027 -0.988 . . . . 60.25 110.369 175.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.9 ttt-85 -65.74 -47.16 76.2 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.199 1.399 . . . . 73.51 110.757 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -69.63 -33.78 73.13 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.362 0.665 . . . . 74.34 110.055 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 40.2 t -68.68 -39.53 80.53 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.336 0.655 . . . . 64.31 111.258 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.475 HG23 HG22 ' C' ' 64' ' ' VAL . 96.7 mt -69.35 -48.19 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.572 0.749 . . . . 73.15 110.406 174.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 28.5 m -54.52 -40.16 68.35 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.561 1.144 . . . . 65.41 110.876 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.4 t -64.55 -48.05 76.48 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.002 -0.999 . . . . 52.13 109.0 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.565 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.8 -40.24 79.44 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.839 1.256 . . . . 74.24 112.672 178.433 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.424 HG23 ' O ' ' C' ' 114' ' ' ILE . 86.8 t -66.72 -41.0 87.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.531 0.732 . . . . 64.23 110.287 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 46.7 t -71.94 -27.82 63.05 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.782 0.833 . . . . 72.42 111.501 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 82.5 mtt-85 -72.52 -34.17 67.42 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.494 0.718 . . . . 74.55 109.495 175.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.24 10.39 63.81 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.388 -0.823 . . . . 74.42 112.636 173.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 72.5 p 58.7 22.9 10.47 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 126.153 1.781 . . . . 72.13 114.286 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -83.66 149.16 56.59 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 108.689 -0.856 . . . . 74.14 108.689 171.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -55.53 157.67 14.66 Favored 'Trans proline' 0 C--N 1.382 2.322 0 C-N-CA 123.073 2.516 . . . . 63.41 113.702 176.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -58.49 114.16 2.33 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.882 0.873 . . . . 72.14 112.223 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.9 tt -110.56 86.04 2.23 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 106.601 -1.629 . . . . 72.33 106.601 172.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -91.19 105.02 17.5 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.046 -0.724 . . . . 74.24 109.046 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.5 145.59 55.88 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.484 0.714 . . . . 72.51 111.983 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.22 153.15 84.24 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.575 0.75 . . . . 63.4 110.347 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.458 ' HG2' HG23 ' A' ' 13' ' ' ILE . 51.9 Cg_exo -54.71 115.68 2.58 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.892 2.395 . . . . 74.13 112.548 173.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.3 t -98.05 116.91 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.656 -0.868 . . . . 70.51 108.656 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -76.02 103.25 5.98 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.368 0.667 . . . . 75.01 110.531 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -67.18 -22.41 65.74 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.489 0.716 . . . . 75.44 112.065 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -65.46 -42.91 91.81 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.498 0.719 . . . . 72.12 110.476 175.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.08 -46.74 87.78 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 123.675 0.61 . . . . 72.14 110.354 176.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.03 -27.75 67.67 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.267 -0.878 . . . . 74.44 111.435 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 88.2 t80 . . . . . 0 N--CA 1.472 0.647 0 C-N-CA 123.262 0.625 . . . . 74.12 110.494 -179.821 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 8.2 t . . . . . 0 C--O 1.24 0.563 0 N-CA-C 109.149 -0.685 . . . . 54.1 109.149 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.468 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 54.9 t80 -143.41 89.76 2.11 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.183 -1.414 . . . . 71.34 107.183 174.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -116.85 119.85 36.67 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.24 -1.022 . . . . 74.31 108.24 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 5.5 mt -75.79 121.17 27.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.061 -1.088 . . . . 75.11 108.061 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . 0.658 ' HB2' HG23 ' D' ' 83' ' ' ILE . 10.8 mm-40 -84.9 -30.04 24.7 Favored 'General case' 0 C--O 1.242 0.674 0 O-C-N 123.802 0.688 . . . . 71.3 110.462 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -174.63 131.42 0.35 Allowed 'General case' 0 C--N 1.364 1.222 0 O-C-N 123.415 0.447 . . . . 73.12 111.149 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.419 ' N ' HD13 ' D' ' 16' ' ' ILE . 3.5 mp -108.18 135.24 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.423 -1.325 . . . . 74.44 107.423 172.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -165.84 170.57 13.71 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.744 0.783 . . . . 71.04 111.89 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -101.46 124.31 46.93 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.406 -1.27 . . . . 73.33 109.357 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.434 ' HD2' ' HA3' ' D' ' 81' ' ' GLY . 28.3 mtpt -95.28 -28.92 14.76 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.735 -0.839 . . . . 74.32 108.735 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 7.9 t70 -146.1 135.09 22.59 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 113.997 -1.456 . . . . 71.34 108.915 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.565 HG23 ' HE1' ' C' ' 117' ' ' MET . 61.9 mt -136.5 138.99 45.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.937 -1.134 . . . . 75.55 107.937 170.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.9 t -141.44 140.81 33.68 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.233 1.013 . . . . 73.34 108.52 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.49 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.2 t80 -144.71 130.44 19.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 106.059 -1.83 . . . . 74.34 106.059 168.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -134.28 138.03 44.71 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.51 -0.922 . . . . 75.41 108.51 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.14 78.12 13.94 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 107.718 -1.216 . . . . 74.24 107.718 174.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.37 -28.98 9.88 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.803 2.335 . . . . 72.42 112.688 -173.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -101.18 3.64 41.25 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.857 0.863 . . . . 74.51 110.692 -176.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.42 ' HB2' ' HE3' ' C' ' 19' ' ' LYS . . . -33.06 -64.07 0.26 Allowed Pre-proline 0 CA--C 1.566 1.56 0 N-CA-C 116.46 2.022 . . . . 74.32 116.46 -164.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.454 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 73.3 Cg_endo -74.39 -29.12 9.69 Favored 'Trans proline' 0 C--N 1.389 2.68 0 CA-C-N 123.503 2.287 . . . . 71.51 113.311 -178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -65.53 -39.73 92.1 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.649 1.18 . . . . 74.35 109.68 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.467 HG23 ' HA ' ' D' ' 73' ' ' ALA . 9.8 p -85.53 -16.39 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 CA-C-N 115.423 -0.808 . . . . 75.43 111.532 -176.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.454 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 17.7 m-85 -65.66 -20.92 66.48 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 118.05 0.386 . . . . 73.34 111.585 176.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -61.86 -23.22 66.14 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.7 0.8 . . . . 74.24 110.865 174.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.607 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 99.6 mttt -92.77 95.57 9.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.723 1.209 . . . . 72.1 110.219 178.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -94.3 94.86 8.54 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.551 0.74 . . . . 74.34 110.153 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -161.84 179.32 8.16 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.686 0.794 . . . . 73.41 110.164 166.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -58.07 111.48 3.59 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.563 1.145 . . . . 72.4 110.031 173.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.403 ' O ' HG21 ' D' ' 40' ' ' VAL . 51.3 Cg_exo -55.6 125.4 18.99 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.205 1.936 . . . . 72.55 110.288 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -72.29 107.33 4.84 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.32 -1.363 . . . . 74.3 107.32 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.648 HG22 ' HB3' ' D' ' 66' ' ' ALA . 87.5 t -113.1 103.14 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 123.308 0.38 . . . . 75.11 110.08 -168.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -87.16 119.25 27.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.796 -1.187 . . . . 71.23 107.796 172.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.78 HD21 HD13 ' D' ' 128' ' ' LEU . 57.0 tp -92.82 148.01 22.38 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.333 -0.988 . . . . 75.23 108.333 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.492 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 27.6 t70 -144.76 111.96 6.0 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.388 -1.338 . . . . 73.43 107.388 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' D' ' 62' ' ' VAL . 85.2 mt -108.11 131.83 54.21 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.062 0.545 . . . . 74.32 110.073 -173.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -132.15 133.92 44.82 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.89 -1.522 . . . . 75.02 106.89 173.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.8 t -139.24 141.79 37.85 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.833 0.825 . . . . 72.31 110.009 176.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.8 161.82 41.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.391 -1.277 . . . . 64.54 107.738 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 34.0 p . . . . . 0 C--N 1.322 -0.617 0 N-CA-C 109.287 -0.634 . . . . 75.22 109.287 177.755 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.506 2.333 0 N-CA-C 114.232 1.197 . . . . 71.15 114.232 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.495 ' HB ' HD13 ' D' ' 83' ' ' ILE . 23.3 m -130.97 129.09 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 107.262 -1.384 . . . . 73.53 107.262 173.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -141.81 130.09 22.29 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.822 -0.807 . . . . 74.11 108.822 -171.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -87.77 109.98 20.13 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.409 -0.96 . . . . 75.33 108.409 173.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.538 HG12 ' HD3' ' D' ' 103' ' ' PRO . 67.3 t -99.08 120.16 48.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 107.443 -1.317 . . . . 73.15 107.443 175.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.459 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.5 t -107.41 134.76 48.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.606 -0.887 . . . . 75.15 108.606 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.54 116.09 26.98 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.997 -0.742 . . . . 73.41 108.997 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -97.76 96.97 8.6 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.252 1.021 . . . . 74.23 109.051 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.411 HG13 HD12 ' D' ' 42' ' ' LEU . 57.7 t -94.73 109.14 21.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 108.523 -0.918 . . . . 75.43 108.523 175.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.492 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 40.6 m -106.11 132.18 52.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.957 -1.019 . . . . 70.33 109.065 -176.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.545 HG21 HD11 ' D' ' 114' ' ' ILE . 86.6 t -120.39 127.61 75.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.032 -0.729 . . . . 73.0 109.032 177.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 14.7 m -117.61 93.37 4.13 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.306 -1.368 . . . . 73.13 107.306 169.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.648 ' HB3' HG22 ' D' ' 40' ' ' VAL . . . -102.06 134.94 44.48 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.438 -0.579 . . . . 72.2 109.438 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.487 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 50.2 m -144.5 139.28 28.15 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 115.749 -0.66 . . . . 74.12 110.532 -171.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 21.1 mt -109.88 110.51 21.49 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.081 -1.451 . . . . 74.2 107.081 172.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.88 -147.34 38.08 Favored Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.956 -0.458 . . . . 73.34 111.956 -175.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.75 4.22 22.79 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.088 0.555 . . . . 73.15 112.357 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.607 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 12.3 pt-20 -119.63 161.95 19.79 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.399 0.68 . . . . 72.4 109.995 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.8 m -71.97 137.8 47.57 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.245 -0.889 . . . . 72.21 111.106 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.487 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -89.14 -65.8 0.98 Allowed 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.114 -1.439 . . . . 73.41 107.114 170.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -153.8 143.37 21.68 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.646 -1.161 . . . . 71.42 109.967 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 63.2 mt -101.53 149.24 24.3 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.047 -1.094 . . . . 75.43 108.047 167.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.606 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 35.3 t -158.92 118.91 3.14 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 117.724 0.238 . . . . 74.3 110.373 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -140.77 122.03 14.85 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.776 0.43 . . . . 63.14 110.035 -174.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 92.7 t -127.71 117.17 45.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 123.951 0.9 . . . . 74.12 109.488 -175.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.604 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.8 mt-30 -90.09 90.48 8.14 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.133 -0.691 . . . . 75.15 109.133 171.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -80.72 99.53 8.26 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.669 -1.151 . . . . 73.15 108.709 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -92.44 143.3 16.44 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 112.193 -0.363 . . . . 42.31 112.193 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.58 130.83 4.08 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 111.822 -0.511 . . . . 53.12 111.822 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.658 HG23 ' HB2' ' D' ' 14' ' ' GLN . 5.2 tp -91.22 114.43 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.554 -0.906 . . . . 74.43 108.554 174.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -111.0 130.22 55.65 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.143 0.977 . . . . 73.34 110.291 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 10.8 t -94.6 100.79 12.68 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 109.02 -0.733 . . . . 74.32 109.02 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.519 HG22 HD22 ' D' ' 98' ' ' LEU . 3.6 tt -117.73 133.61 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.611 1.165 . . . . 73.33 109.552 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.93 169.6 11.25 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.921 0.888 . . . . 64.32 110.502 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.91 21.54 55.35 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 115.88 -0.6 . . . . 61.3 113.974 174.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' D' ' 94' ' ' MET . 0.9 OUTLIER -142.34 168.51 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.809 0.843 . . . . 73.01 110.978 175.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.21 -168.43 3.1 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.68 1.192 . . . . 75.53 109.744 177.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.7 -139.4 22.89 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-N 116.156 -0.474 . . . . 73.11 112.794 174.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 11.7 m -80.23 -39.35 29.22 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.248 0.619 . . . . 75.41 109.756 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -58.16 -36.28 72.78 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.384 1.074 . . . . 73.43 112.68 -173.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.407 ' HA ' HD13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -60.03 -48.56 81.22 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 112.807 0.669 . . . . 74.23 112.807 -172.243 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . 0.406 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.91 -26.05 25.79 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.833 0.453 . . . . 72.13 111.754 177.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -63.01 -34.25 77.15 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.587 0.755 . . . . 74.12 110.061 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 82.4 m -59.43 -50.41 74.03 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.055 0.542 . . . . 72.01 111.071 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.636 HD23 ' SG ' ' D' ' 102' ' ' CYS . 93.2 mt -69.5 -27.53 65.28 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.961 0.504 . . . . 75.33 111.95 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.82 3.71 71.16 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.488 -0.618 . . . . 70.02 113.829 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.83 -63.36 0.17 Allowed 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 117.695 0.748 . . . . 72.13 112.403 -175.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . 0.427 ' O ' HG12 ' D' ' 105' ' ' ILE . 71.1 t80 -69.01 -39.4 79.31 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.177 0.436 . . . . 75.12 112.177 -172.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.636 ' SG ' HD23 ' D' ' 98' ' ' LEU . 50.5 m -69.61 -47.07 25.85 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 123.712 0.805 . . . . 74.15 111.477 -176.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.538 ' HD3' HG12 ' D' ' 58' ' ' VAL . 28.1 Cg_endo -64.1 -26.78 65.31 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 121.421 1.414 . . . . 74.43 112.638 170.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -66.92 -31.2 71.64 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.741 0.416 . . . . 73.24 110.94 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.427 HG12 ' O ' ' D' ' 101' ' ' TYR . 41.9 mm -68.74 -39.76 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.006 0.923 . . . . 75.55 110.51 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' D' ' 103' ' ' PRO . 42.5 mt -74.31 -22.6 59.18 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.534 -0.757 . . . . 75.23 111.573 -175.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -65.28 -41.45 52.04 Favored Pre-proline 0 CA--C 1.562 1.431 0 N-CA-C 114.095 1.146 . . . . 74.54 114.095 -172.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -47.26 -48.31 15.29 Favored 'Trans proline' 0 C--N 1.389 2.669 0 C-N-CA 122.466 2.111 . . . . 73.3 113.649 169.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -73.53 -38.15 65.37 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.93 0.892 . . . . 73.1 111.26 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.39 -44.04 79.86 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.577 -0.738 . . . . 74.31 110.794 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 28.3 ttp180 -59.91 -49.01 79.39 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.21 0.944 . . . . 74.31 110.33 174.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -59.83 -46.0 90.62 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.142 0.901 . . . . 75.02 110.697 -175.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.449 ' SG ' HD11 ' D' ' 21' ' ' ILE . 42.5 t -55.04 -45.67 75.24 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 124.343 1.027 . . . . 63.15 110.309 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.558 HG22 ' SG ' ' D' ' 76' ' ' CYS . 72.4 mt -61.25 -60.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 124.067 0.854 . . . . 74.35 110.851 175.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 37.7 m -52.5 -42.77 64.57 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.032 1.333 . . . . 73.02 111.786 -172.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 33.1 t -65.72 -43.6 88.61 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.465 -1.243 . . . . 61.22 109.823 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.606 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 72.2 mtm -68.77 -28.07 66.46 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.059 0.544 . . . . 74.33 111.964 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.451 HG22 ' O ' ' D' ' 114' ' ' ILE . 92.6 t -67.23 -46.34 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.597 0.759 . . . . 74.53 109.566 176.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.7 p -73.13 -29.71 63.08 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.618 -0.719 . . . . 74.02 110.448 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 66.7 mtt-85 -69.54 -30.75 68.65 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 123.595 0.758 . . . . 73.13 109.557 172.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.65 7.23 81.75 Favored Glycine 0 C--N 1.357 1.71 0 C-N-CA 123.536 0.588 . . . . 61.11 113.0 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.483 HG22 ' HB3' ' C' ' 17' ' ' TYR . 66.4 p 55.37 38.92 31.01 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 126.402 1.881 . . . . 75.32 114.268 176.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -99.88 158.46 32.03 Favored Pre-proline 0 C--O 1.243 0.747 0 C-N-CA 123.427 0.691 . . . . 73.04 109.249 170.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_exo -48.72 125.19 12.28 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.7 2.267 . . . . 73.25 112.156 168.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -47.28 126.69 9.79 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.826 1.329 . . . . 63.32 112.495 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.557 HD12 HG23 ' D' ' 40' ' ' VAL . 17.5 tp -107.21 97.75 7.48 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.9 0.88 . . . . 74.21 109.058 -176.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -99.35 99.0 9.87 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.608 -1.256 . . . . 75.11 107.608 173.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.78 HD13 HD21 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -68.47 120.24 14.22 Favored 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 108.259 -1.015 . . . . 75.22 108.259 -179.445 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.49 141.7 94.45 Favored Pre-proline 0 CA--C 1.562 1.413 0 C-N-CA 123.535 0.734 . . . . 72.52 110.914 -177.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -57.74 132.61 51.07 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 123.091 2.527 . . . . 74.34 113.388 -174.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 96.1 t -107.44 123.43 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 108.415 -0.957 . . . . 73.24 108.415 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -86.9 91.93 8.84 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.044 -1.095 . . . . 75.1 108.044 173.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 . . . . . 0 N--CA 1.484 1.275 0 C-N-CA 124.397 1.079 . . . . 75.5 111.796 -174.349 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 87' ' ' ALA . 25.8 m . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 108.159 -1.052 . . . . 74.22 108.159 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -137.24 119.04 15.13 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.09 -1.078 . . . . 75.31 108.09 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -134.78 132.21 38.44 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.646 -0.872 . . . . 61.03 108.646 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.528 HD12 HG21 ' A' ' 105' ' ' ILE . 4.9 mt -94.33 113.36 28.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.645 -0.872 . . . . 73.25 108.645 175.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -78.43 -40.26 36.34 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 123.375 0.422 . . . . 75.1 110.006 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -170.68 124.7 0.68 Allowed 'General case' 0 C--N 1.354 0.799 0 CA-C-N 115.946 -0.57 . . . . 74.12 111.042 -173.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 81.2 mt -106.97 140.28 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 107.944 -1.132 . . . . 72.31 107.944 167.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.444 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 31.7 p90 -164.92 166.25 19.66 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.306 0.574 . . . . 74.31 111.366 -174.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -94.27 122.06 36.42 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 109.484 -0.562 . . . . 72.45 109.484 172.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 43.0 mtpt -80.11 -35.08 37.33 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.211 -0.662 . . . . 73.23 109.211 174.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -149.93 137.95 20.3 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.277 -1.329 . . . . 65.13 109.826 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.566 HG21 ' SD ' ' B' ' 117' ' ' MET . 73.1 mt -134.99 143.82 36.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 125.317 1.447 . . . . 74.35 108.008 178.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.9 t -156.71 119.93 4.16 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 123.524 0.515 . . . . 61.33 110.593 170.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.595 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.8 t80 -111.5 143.41 42.38 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.019 -1.475 . . . . 74.32 107.019 165.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -139.66 141.31 37.03 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.703 0.401 . . . . 72.12 110.669 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.19 69.92 13.01 Favored Pre-proline 0 C--O 1.242 0.692 0 N-CA-C 107.181 -1.415 . . . . 71.02 107.181 170.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.35 -8.21 19.48 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.448 2.099 . . . . 61.23 112.303 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -114.72 17.52 17.08 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 124.311 1.044 . . . . 63.01 109.246 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.507 ' HB2' ' HE3' ' B' ' 19' ' ' LYS . . . -46.24 -54.31 18.4 Favored Pre-proline 0 CA--C 1.567 1.607 0 CA-C-O 118.006 -0.997 . . . . 75.2 113.667 -169.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 39.5 Cg_exo -61.81 -24.02 76.8 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 122.016 1.81 . . . . 73.01 113.542 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -84.84 -44.86 12.86 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.757 0.823 . . . . 74.11 111.017 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.477 ' CG2' ' HA ' ' A' ' 73' ' ' ALA . 8.6 p -77.03 -21.71 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 115.346 -0.843 . . . . 74.25 112.815 -161.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -66.96 -17.24 64.82 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 116.151 -0.477 . . . . 73.21 111.471 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -91.87 -14.46 29.65 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.551 1.14 . . . . 71.25 110.87 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.476 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 19.0 mmtp -79.54 160.31 26.53 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.21 0.604 . . . . 70.33 111.549 -176.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -69.59 131.24 44.35 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.896 0.879 . . . . 72.43 109.152 173.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.48 ' CE3' HD21 ' A' ' 68' ' ' LEU . 68.6 t-105 -81.6 81.07 7.8 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.494 0.664 . . . . 73.21 110.042 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -129.08 77.76 77.31 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.552 1.141 . . . . 72.03 108.035 172.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -85.96 145.22 8.71 Favored 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.669 2.246 . . . . 62.15 113.192 -173.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -101.31 84.97 2.71 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.826 -1.176 . . . . 71.41 107.826 164.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.68 HG23 ' HB1' ' A' ' 66' ' ' ALA . 77.7 t -81.65 96.96 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 108.419 -0.956 . . . . 63.24 108.419 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -95.96 123.3 39.5 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.347 -0.612 . . . . 74.43 109.347 177.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mp -97.91 107.05 19.45 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.504 -1.295 . . . . 71.31 107.504 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -111.58 119.16 37.79 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.469 -0.937 . . . . 73.05 108.469 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.445 HD22 HD21 ' A' ' 60' ' ' LEU . 89.0 mt -112.17 139.4 47.74 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.441 0.696 . . . . 73.1 111.805 -169.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 19.4 t70 -132.29 144.09 50.35 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.78 1.232 . . . . 74.22 108.536 176.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.436 HG22 ' HG3' ' A' ' 103' ' ' PRO . 67.4 m -141.35 135.19 30.23 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.495 0.718 . . . . 72.55 109.434 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.6 123.78 10.83 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.633 0.773 . . . . 63.42 109.483 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 98' ' ' LEU . 78.9 p -97.54 162.39 13.33 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.445 0.698 . . . . 74.3 110.27 175.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.0 t -158.56 155.59 28.62 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.299 1.04 . . . . 75.11 108.53 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -102.53 115.96 31.63 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.296 -0.631 . . . . 70.24 109.296 175.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.683 HD12 ' HB2' ' A' ' 57' ' ' GLU . 56.6 mt -82.52 -40.83 20.48 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.494 0.718 . . . . 71.04 110.257 176.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.41 -174.57 5.0 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.251 -0.886 . . . . 74.14 110.713 -176.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -59.65 115.84 3.61 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.796 0.838 . . . . 72.15 110.135 176.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 71.74 -6.16 1.5 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.907 1.283 . . . . 74.44 112.843 -177.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.6 t -98.76 115.65 39.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.718 -0.845 . . . . 73.02 108.718 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -126.01 125.08 42.08 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.161 0.984 . . . . 73.34 109.061 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.683 ' HB2' HD12 ' A' ' 51' ' ' LEU . 33.2 tt0 -92.05 123.33 35.33 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.483 -0.562 . . . . 63.11 109.483 171.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.8 t -107.28 136.03 43.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.405 -0.961 . . . . 74.12 108.405 168.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.7 t -120.18 130.33 74.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.191 -1.04 . . . . 71.42 108.191 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.466 HD23 HG23 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -107.07 105.03 14.85 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.411 -1.7 . . . . 71.44 106.411 175.188 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.486 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 31.6 ttp180 -92.51 100.49 13.03 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.216 -1.402 . . . . 74.4 107.216 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.466 HG23 HD23 ' A' ' 60' ' ' LEU . 20.2 t -96.15 127.05 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 108.182 -1.044 . . . . 74.12 108.182 176.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.1 m -123.86 118.56 27.39 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.598 -0.89 . . . . 74.51 108.598 174.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.416 HG13 HD23 ' A' ' 126' ' ' LEU . 71.9 t -120.52 132.4 70.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 107.914 -1.143 . . . . 64.3 107.914 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 m -137.2 132.43 33.87 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.583 -0.895 . . . . 71.44 108.583 174.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.68 ' HB1' HG23 ' A' ' 40' ' ' VAL . . . -114.31 114.95 26.62 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.541 1.137 . . . . 75.52 108.142 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 71.2 m -120.81 134.98 55.27 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.401 0.619 . . . . 74.42 111.146 178.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.48 HD21 ' CE3' ' A' ' 36' ' ' TRP . 42.0 mt -94.91 42.27 1.09 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.402 1.481 . . . . 74.41 111.111 -176.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.61 -84.87 1.51 Allowed Glycine 0 C--N 1.339 0.698 0 CA-C-O 119.749 -0.473 . . . . 74.52 112.164 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -86.56 -30.66 21.71 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.211 0.529 . . . . 73.11 111.353 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.442 ' HB2' ' NZ ' ' A' ' 34' ' ' LYS . 4.6 tp10 -119.96 133.64 55.49 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.62 -0.881 . . . . 42.52 108.62 -174.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 73.7 m -77.71 134.37 38.13 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.111 -0.7 . . . . 74.34 109.111 170.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.477 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . . . -71.83 -64.59 0.9 Allowed 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.507 0.723 . . . . 74.21 109.45 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -159.57 166.72 30.18 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.253 -0.885 . . . . 75.0 112.039 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.7 tp -117.92 143.11 46.62 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.571 -1.195 . . . . 64.43 108.693 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.446 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 79.1 m -143.07 104.53 4.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.131 0.973 . . . . 75.4 109.622 175.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -123.1 127.69 49.07 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.539 0.736 . . . . 74.21 109.017 177.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.3 t -137.55 112.75 10.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 124.352 1.061 . . . . 74.31 109.094 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -86.21 85.65 7.34 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.781 -0.822 . . . . 72.44 108.781 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -78.37 96.26 5.29 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.948 -1.024 . . . . 71.32 110.31 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.14 155.74 30.23 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 111.724 -0.551 . . . . 73.11 111.724 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.488 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -151.51 122.3 1.33 Allowed Glycine 0 C--N 1.329 0.164 0 N-CA-C 111.703 -0.559 . . . . 62.41 111.703 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.9 mt -81.17 117.63 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.941 0.896 . . . . 74.21 108.665 171.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.546 ' HB3' HD11 ' A' ' 86' ' ' ILE . 90.8 m-85 -124.27 122.26 37.26 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.489 1.116 . . . . 74.01 109.491 -177.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.1 t -91.77 105.39 17.68 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.239 -0.652 . . . . 75.11 109.239 173.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.645 HG22 ' HE3' ' A' ' 94' ' ' MET . 1.9 mm -112.38 153.78 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.489 0.715 . . . . 74.31 109.43 -177.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.427 ' HB2' ' HB ' ' A' ' 10' ' ' THR . . . -158.23 160.61 37.31 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.557 0.743 . . . . 73.24 111.235 177.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.1 -7.62 64.58 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 119.184 -0.787 . . . . 73.44 113.928 174.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.06 153.37 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 124.056 0.942 . . . . 74.41 111.695 -178.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -141.84 178.25 7.63 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.01 1.724 . . . . 72.2 108.625 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.47 -139.78 29.62 Favored Glycine 0 C--N 1.349 1.26 0 N-CA-C 114.063 0.385 . . . . 73.43 114.063 173.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.2 t -72.4 -19.38 61.61 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.258 0.623 . . . . 74.24 111.439 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -70.78 -43.82 67.94 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.992 0.917 . . . . 72.21 109.576 173.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.645 ' HE3' HG22 ' A' ' 86' ' ' ILE . 4.8 tpt -63.82 -42.31 97.69 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.085 -0.961 . . . . 74.4 109.849 174.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.3 -33.75 76.2 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.449 -0.796 . . . . 62.41 111.344 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.431 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 53.0 t-80 -71.1 -27.02 63.3 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.169 0.588 . . . . 70.4 111.193 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -78.6 -52.79 7.95 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.823 -0.436 . . . . 72.3 109.823 175.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.401 ' HB3' ' HB3' ' A' ' 48' ' ' SER . 89.6 mt -72.98 -35.24 66.84 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.789 0.835 . . . . 74.21 112.773 -171.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.08 4.0 60.55 Favored Glycine 0 N--CA 1.469 0.842 0 CA-C-N 115.97 -0.559 . . . . 64.31 113.674 -172.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.575 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -146.51 -58.45 0.29 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 117.31 0.555 . . . . 72.05 112.19 -173.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -71.83 -42.28 67.15 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.046 0.451 . . . . 74.04 110.742 -176.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 63.7 m -67.63 -49.43 40.03 Favored Pre-proline 0 CA--C 1.565 1.552 0 C-N-CA 124.733 1.213 . . . . 74.01 112.852 -175.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.436 ' HG3' HG22 ' A' ' 46' ' ' THR . 47.5 Cg_endo -65.79 -24.85 53.86 Favored 'Trans proline' 0 C--N 1.395 2.982 0 C-N-CA 122.035 1.823 . . . . 75.23 112.437 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -64.91 -37.14 86.64 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.457 0.703 . . . . 74.52 110.476 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.528 HG21 HD12 ' A' ' 13' ' ' ILE . 49.5 mm -69.02 -40.73 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.544 0.737 . . . . 73.24 110.407 174.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.488 HD22 ' HA3' ' A' ' 82' ' ' GLY . 48.3 mt -72.74 -25.18 61.11 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.475 -0.784 . . . . 74.44 112.123 -175.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -61.68 -45.09 93.15 Favored Pre-proline 0 N--CA 1.487 1.394 0 N-CA-C 113.768 1.025 . . . . 73.21 113.768 -172.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -52.05 -37.34 68.16 Favored 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 122.51 2.14 . . . . 75.53 113.876 170.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -84.09 -29.11 27.06 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.51 0.724 . . . . 74.32 112.001 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.76 -45.19 75.61 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.554 -0.906 . . . . 75.4 108.554 172.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.533 ' NH1' HD13 ' C' ' 105' ' ' ILE . 36.5 ttm180 -59.9 -40.81 90.06 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.071 -1.422 . . . . 74.31 110.515 174.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.535 ' HB2' ' HB3' ' C' ' 108' ' ' PRO . 25.7 tt0 -51.21 -54.53 24.77 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.623 1.169 . . . . 74.43 110.813 177.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.451 ' O ' ' HG3' ' A' ' 117' ' ' MET . 48.9 t -66.17 -47.21 74.72 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.435 -1.257 . . . . 64.12 111.437 -176.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.496 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 92.1 mt -58.69 -59.14 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 124.173 0.989 . . . . 73.22 110.953 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.1 m -56.82 -38.55 72.77 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.359 1.064 . . . . 74.1 111.575 -177.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.1 t -63.35 -48.82 76.39 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.892 -1.049 . . . . 61.22 110.817 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.595 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 41.2 mtm -61.46 -40.25 93.83 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.816 0.697 . . . . 74.14 111.253 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.494 HG22 ' HB3' ' A' ' 126' ' ' LEU . 82.5 t -56.77 -49.97 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 O-C-N 124.252 0.97 . . . . 75.12 110.813 175.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.6 t -68.17 -33.51 74.59 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.234 -0.893 . . . . 65.24 111.165 -177.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.536 HH12 ' HG3' ' B' ' 112' ' ' GLU . 81.8 mtt-85 -72.61 -29.43 63.48 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.537 0.735 . . . . 73.34 110.172 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.17 16.41 43.54 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-O 118.812 -0.993 . . . . 73.4 113.375 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.466 HG23 ' HE ' ' B' ' 15' ' ' ARG . 3.0 t 60.47 11.65 3.09 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 126.781 2.033 . . . . 74.41 113.66 176.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -81.88 156.66 69.86 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.708 0.803 . . . . 75.44 109.911 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.21 129.29 29.41 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.503 2.136 . . . . 71.54 111.33 175.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -49.05 121.68 5.06 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 125.116 1.51 . . . . 73.43 112.213 -173.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.541 HD13 HG12 ' A' ' 40' ' ' VAL . 56.5 tp -108.78 102.11 11.18 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.922 -0.581 . . . . 75.53 109.662 -174.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -98.85 121.87 41.35 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.594 -1.262 . . . . 64.03 107.594 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 11.2 mt -72.02 129.88 39.61 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 110.082 -0.34 . . . . 74.35 110.082 -177.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.91 141.36 98.35 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 116.046 -0.524 . . . . 74.22 110.771 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.594 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 49.2 Cg_exo -57.7 128.74 30.37 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.284 2.656 . . . . 75.34 113.558 -176.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 85.8 t -120.58 132.3 70.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 C-N-CA 123.942 0.897 . . . . 74.13 109.824 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -96.43 95.48 8.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.752 0.821 . . . . 71.32 108.871 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -62.57 -21.09 65.33 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.941 0.897 . . . . 65.43 112.576 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.575 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 11.7 t70 -56.96 -51.03 70.81 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.55 0.74 . . . . 65.13 110.045 170.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.7 -40.49 95.22 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 124.106 0.879 . . . . 74.32 111.326 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.92 -32.07 73.47 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.463 -0.79 . . . . 73.24 111.248 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 62.6 t80 . . . . . 0 N--CA 1.469 0.522 0 CA-C-N 115.737 -0.665 . . . . 74.33 110.413 176.409 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.571 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 0.5 OUTLIER . . . . . 0 CA--C 1.563 1.461 0 CA-C-O 121.232 0.539 . . . . 74.22 112.026 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.494 ' N ' ' SD ' ' B' ' 9' ' ' MET . 78.8 m -153.22 105.93 2.93 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.181 0.992 . . . . 74.42 108.746 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -109.72 139.46 44.73 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.413 -0.958 . . . . 73.52 108.413 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -149.89 141.24 23.26 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.699 0.8 . . . . 73.12 109.272 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 19.0 mt -94.6 124.98 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 107.545 -1.28 . . . . 74.43 107.545 171.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -87.53 -48.95 7.52 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.827 -0.434 . . . . 73.03 109.827 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.466 ' HE ' HG23 ' A' ' 122' ' ' THR . 48.2 ttt180 -166.45 136.35 3.2 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.609 0.568 . . . . 71.22 109.991 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 97.7 mt -115.25 135.64 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 107.602 -1.259 . . . . 73.22 107.602 174.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -163.18 143.88 9.31 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 112.767 0.654 . . . . 71.31 112.767 -174.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 56.0 m -73.79 120.8 19.88 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.617 -1.174 . . . . 65.11 108.918 170.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.522 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.2 mtpt -98.53 -18.9 17.93 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.113 0.965 . . . . 74.23 111.897 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -166.02 144.31 5.74 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.608 0.567 . . . . 72.42 110.824 -174.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.502 HD13 ' SG ' ' B' ' 113' ' ' CYS . 45.6 mm -139.19 140.9 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.277 1.431 . . . . 74.12 108.745 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.5 t -142.71 125.8 16.34 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.649 1.18 . . . . 62.34 108.303 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.5 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 78.1 t80 -140.35 121.27 14.54 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.573 -1.269 . . . . 74.32 107.573 169.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -130.25 121.13 25.58 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.522 -0.918 . . . . 54.32 108.522 175.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.46 89.31 3.2 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 106.259 -1.756 . . . . 75.21 106.259 168.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -59.43 -36.72 93.06 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.86 2.374 . . . . 74.14 111.975 -171.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -106.47 16.54 24.54 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 118.06 -0.972 . . . . 74.3 111.611 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -30.73 -62.12 0.24 Allowed Pre-proline 0 N--CA 1.502 2.128 0 N-CA-C 115.117 1.525 . . . . 72.02 115.117 -171.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -59.5 -41.39 57.73 Favored 'Trans proline' 0 C--N 1.399 3.19 0 C-N-CA 121.951 1.767 . . . . 71.44 112.686 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -96.78 -19.35 18.98 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.079 -0.964 . . . . 72.22 113.296 -169.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.569 HG23 ' HA ' ' B' ' 73' ' ' ALA . 9.6 p -74.96 -12.93 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-O 121.155 0.502 . . . . 75.03 110.735 -176.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -77.44 -5.93 51.64 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.296 0.85 . . . . 74.23 113.296 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -68.31 -21.52 64.76 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.867 0.467 . . . . 75.45 110.433 169.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.643 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 93.8 mttt -94.33 87.1 5.09 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.254 1.021 . . . . 74.04 110.533 -175.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -86.54 90.97 8.41 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.522 -0.763 . . . . 75.31 110.346 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 34.8 p90 -173.98 -172.05 0.69 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.474 1.11 . . . . 72.44 109.3 171.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -80.15 117.61 68.38 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.101 0.561 . . . . 75.32 111.099 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.538 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 19.3 Cg_endo -64.73 147.4 89.77 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 121.74 1.627 . . . . 74.11 110.496 173.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.18 102.68 0.86 Allowed 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.728 -0.841 . . . . 73.11 108.728 174.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.79 HG21 ' HB1' ' B' ' 66' ' ' ALA . 41.8 t -99.86 145.86 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.213 -0.903 . . . . 74.52 109.875 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -140.06 127.35 21.23 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.69 1.196 . . . . 73.33 107.853 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.542 HD12 HD21 ' B' ' 128' ' ' LEU . 25.6 tp -86.4 145.29 26.92 Favored 'General case' 0 C--O 1.244 0.811 0 O-C-N 123.81 0.694 . . . . 74.04 109.211 173.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.545 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 11.4 t70 -143.95 150.07 37.76 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.992 -1.114 . . . . 75.41 107.992 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 72.5 mt -126.9 139.89 52.74 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.635 0.774 . . . . 74.01 109.458 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.422 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 29.5 t70 -132.11 151.15 51.93 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.07 0.948 . . . . 60.12 109.072 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.7 m -124.61 111.97 16.26 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.151 0.58 . . . . 71.24 110.574 -166.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.63 117.48 7.66 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 109.379 -0.6 . . . . 72.12 109.379 174.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 48.1 p -143.89 170.87 15.08 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.063 0.545 . . . . 64.21 110.08 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 64.8 p -152.04 142.55 22.66 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.422 0.289 . . . . 71.34 111.62 -173.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -96.86 94.33 7.18 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.984 -0.747 . . . . 74.32 108.984 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 pp -110.13 24.43 13.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.008 0.523 . . . . 71.41 110.611 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . 0.502 ' HB1' ' HB ' ' B' ' 55' ' ' VAL . . . -164.87 172.04 13.38 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 123.717 0.807 . . . . 70.53 111.153 172.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -97.15 124.73 41.28 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 107.922 -1.14 . . . . 53.44 107.922 172.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 66.02 4.72 3.16 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 124.362 1.065 . . . . 75.4 112.917 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.502 ' HB ' ' HB1' ' B' ' 52' ' ' ALA . 44.9 t -133.73 126.47 51.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.447 0 N-CA-C 107.041 -1.466 . . . . 73.43 107.041 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -132.7 141.19 48.46 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.794 -0.447 . . . . 74.31 109.794 -168.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -106.03 105.84 16.07 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.75 -1.204 . . . . 73.02 107.75 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 38.1 t -100.54 129.53 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.431 1.093 . . . . 74.43 109.54 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 t -118.26 114.59 45.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.629 -0.878 . . . . 73.44 108.629 173.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -100.71 108.58 20.48 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.72 -1.215 . . . . 74.34 107.72 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.422 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 31.5 ttm180 -85.98 119.7 26.57 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.288 -1.004 . . . . 74.3 108.288 173.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 31.4 t -105.18 123.94 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.92 -1.141 . . . . 75.32 107.92 175.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 45.2 m -111.02 136.78 49.51 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.89 -0.781 . . . . 73.43 108.89 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.609 HG13 HD23 ' B' ' 126' ' ' LEU . 59.4 t -129.44 114.87 32.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 124.054 0.942 . . . . 75.45 108.58 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 32.7 m -100.89 135.36 42.47 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.521 -0.918 . . . . 75.13 108.521 170.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.79 ' HB1' HG21 ' B' ' 40' ' ' VAL . . . -144.36 141.93 30.04 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.21 -0.663 . . . . 55.13 109.21 176.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.486 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 55.2 p -142.52 127.8 18.75 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 123.921 0.763 . . . . 63.23 111.324 -175.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.538 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 17.5 mt -92.93 111.79 23.52 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.056 0.943 . . . . 74.52 108.61 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.75 -123.51 19.22 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 124.054 0.846 . . . . 72.21 112.214 -175.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -97.41 3.23 51.0 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.311 0.644 . . . . 74.32 112.241 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.643 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 12.0 pt-20 -128.72 158.36 38.82 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.519 0.728 . . . . 72.21 110.063 -177.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 41.8 m -70.02 135.33 49.21 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.03 0.532 . . . . 65.54 111.041 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.569 ' HA ' HG23 ' B' ' 31' ' ' VAL . . . -87.03 -62.26 1.54 Allowed 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.78 -1.192 . . . . 73.41 107.78 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -152.23 157.04 40.88 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.161 -1.382 . . . . 74.3 110.166 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 85.5 mt -127.73 110.48 12.68 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.216 -1.772 . . . . 72.14 106.216 173.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.46 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 36.7 t -119.98 137.41 54.09 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.686 -0.857 . . . . 71.55 108.686 -177.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -153.96 136.58 15.17 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.819 -0.808 . . . . 74.12 108.819 -173.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.485 HG11 ' HA ' ' B' ' 110' ' ' ALA . 91.1 t -133.6 148.31 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.291 -1.003 . . . . 72.51 108.291 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -121.42 100.52 7.07 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 108.186 -1.042 . . . . 73.42 108.186 172.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.4 ' HB2' ' HB1' ' B' ' 110' ' ' ALA . 8.0 tp-100 -93.29 104.18 16.37 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.53 -0.915 . . . . 73.11 108.53 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.522 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -93.43 163.56 26.36 Favored Glycine 0 C--O 1.24 0.49 0 CA-C-N 115.496 -0.775 . . . . 52.32 111.681 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.13 132.67 2.67 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.617 -0.325 . . . . 74.1 112.555 -176.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 45.0 mt -91.82 123.01 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 N-CA-C 107.745 -1.205 . . . . 73.32 107.745 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -129.82 135.56 48.55 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.736 0.814 . . . . 75.34 109.935 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 58.7 m -100.42 128.25 46.53 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.76 0.824 . . . . 42.41 109.71 174.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.412 HG21 ' HE2' ' B' ' 9' ' ' MET . 1.4 pp -140.77 135.31 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 124.582 1.153 . . . . 73.41 111.029 -173.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.13 168.0 26.7 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.203 1.001 . . . . 70.24 109.557 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 91.36 -36.05 3.75 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 116.242 -0.435 . . . . 74.34 112.874 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.627 ' HB ' ' HA ' ' B' ' 94' ' ' MET . 9.0 pt -66.67 149.46 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.275 1.43 . . . . 74.32 111.81 175.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -147.45 162.02 39.88 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 124.351 1.06 . . . . 71.53 110.114 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.49 -136.04 27.66 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-N 114.432 -1.258 . . . . 72.41 113.985 175.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.9 m -66.04 -48.54 70.74 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.78 0.832 . . . . 61.3 109.759 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -60.25 -25.6 65.81 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 113.882 -1.508 . . . . 73.3 112.059 -171.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.627 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 2.0 tmt? -59.78 -69.97 0.19 Allowed 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.349 1.06 . . . . 74.52 112.163 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . 0.47 ' HB2' ' SD ' ' B' ' 94' ' ' MET . . . -80.38 -13.57 59.04 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 122.374 0.27 . . . . 65.33 111.584 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.89 -44.74 78.49 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.21 0.604 . . . . 72.34 109.591 167.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 44.4 t -57.46 -29.09 63.93 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.814 0.845 . . . . 53.55 111.965 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 71.6 mt -72.1 -40.06 68.45 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.991 0.916 . . . . 73.2 111.494 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.39 4.08 54.48 Favored Glycine 0 C--N 1.341 0.812 0 CA-C-N 116.068 -0.515 . . . . 74.33 113.768 -176.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.3 -65.4 0.98 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.385 0.674 . . . . 73.13 111.218 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -74.52 -45.13 47.78 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.955 -0.566 . . . . 74.45 111.354 -172.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.425 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 79.2 m -62.66 -47.46 87.94 Favored Pre-proline 0 CA--C 1.57 1.729 0 CA-C-O 118.519 -0.753 . . . . 74.43 112.228 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.425 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 76.1 Cg_exo -57.21 -33.37 95.84 Favored 'Trans proline' 0 C--N 1.398 3.172 0 C-N-CA 122.935 2.423 . . . . 72.32 113.705 171.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -67.47 -31.01 70.87 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.225 0.61 . . . . 72.13 111.243 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.0 mt -71.62 -40.18 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.596 0.758 . . . . 74.12 110.036 173.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 83.9 mt -77.46 -30.46 53.25 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.318 -0.855 . . . . 74.02 112.023 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -58.11 -44.67 99.48 Favored Pre-proline 0 CA--C 1.561 1.374 0 C-N-CA 124.394 1.078 . . . . 74.35 113.333 -172.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -50.21 -46.73 27.2 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 122.863 2.375 . . . . 62.42 114.491 173.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -65.78 -40.73 92.28 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.202 0.601 . . . . 75.21 110.796 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.485 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -66.07 -40.65 91.06 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.159 -0.928 . . . . 70.12 111.139 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -61.22 -51.54 68.54 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.117 1.367 . . . . 73.34 110.231 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . 0.536 ' HG3' HH12 ' A' ' 120' ' ' ARG . 9.2 tp10 -61.8 -39.0 90.18 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.249 1.02 . . . . 73.03 110.396 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.51 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.1 t -68.72 -32.87 72.97 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.067 0.147 . . . . 71.02 110.764 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.524 HD13 HD13 ' B' ' 128' ' ' LEU . 50.9 mt -66.81 -53.02 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.832 0.853 . . . . 74.44 110.025 173.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.459 HG22 ' OG ' ' C' ' 119' ' ' SER . 15.3 m -59.31 -30.91 68.69 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.794 0.684 . . . . 41.33 111.027 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.497 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.1 t -64.31 -50.19 68.8 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.068 0.947 . . . . 74.2 110.174 175.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.566 ' SD ' HG21 ' A' ' 21' ' ' ILE . 33.5 mmt -62.9 -40.34 97.26 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.933 0.493 . . . . 72.24 110.889 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.482 HG13 ' HB2' ' B' ' 123' ' ' PHE . 88.0 t -65.17 -39.67 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.728 1.211 . . . . 75.04 110.786 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 36.1 t -65.89 -36.19 82.73 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.156 -0.929 . . . . 74.43 111.032 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.497 ' HG3' ' O ' ' B' ' 116' ' ' SER . 71.3 mtt-85 -70.46 -37.86 74.37 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 115.646 -0.706 . . . . 72.51 109.945 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.77 -13.65 69.22 Favored Glycine 0 C--N 1.357 1.737 0 O-C-N 123.651 0.594 . . . . 73.44 112.765 171.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 13.4 m 67.35 32.26 5.98 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.644 1.578 . . . . 74.53 110.218 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.482 ' HB2' HG13 ' B' ' 118' ' ' VAL . 52.1 m-85 -81.06 167.95 28.48 Favored Pre-proline 0 CA--C 1.558 1.252 0 CA-C-N 114.631 -1.168 . . . . 73.42 110.0 173.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -60.18 168.78 5.7 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 122.792 2.328 . . . . 74.4 113.519 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.555 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 59.9 tp60 -64.8 112.63 3.33 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 114.895 -1.048 . . . . 74.24 110.666 -174.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.609 HD23 HG13 ' B' ' 64' ' ' VAL . 23.5 tp -111.23 111.33 22.32 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 123.689 0.618 . . . . 74.42 109.353 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -123.47 134.08 53.96 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 107.895 -1.15 . . . . 72.11 107.895 170.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.542 HD21 HD12 ' B' ' 42' ' ' LEU . 74.7 mt -85.86 149.26 25.36 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 122.656 0.383 . . . . 74.51 111.251 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.02 138.38 94.98 Favored Pre-proline 0 CA--C 1.55 0.954 0 O-C-N 124.447 1.092 . . . . 54.01 110.343 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -68.19 99.37 0.58 Allowed 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.774 2.316 . . . . 72.3 111.122 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 60.8 t -89.2 110.54 21.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.188 -1.042 . . . . 73.1 108.188 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 . . . . . 0 C--O 1.243 0.721 0 N-CA-C 108.389 -0.967 . . . . 75.25 108.389 174.914 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.594 ' HD2' ' HG2' ' A' ' 130' ' ' PRO . 37.1 t80 . . . . . 0 C--O 1.239 0.505 0 N-CA-C 108.212 -1.033 . . . . 73.03 108.212 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -150.73 121.05 7.31 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.431 -0.951 . . . . 75.3 108.431 177.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.49 HD11 HG21 ' C' ' 105' ' ' ILE . 30.2 mt -67.79 127.6 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 123.963 0.789 . . . . 72.13 108.905 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -93.69 -37.75 11.67 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 123.506 0.504 . . . . 74.43 109.902 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 178.45 155.54 0.41 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.038 1.335 . . . . 74.23 109.134 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.445 ' HA ' ' HA2' ' C' ' 82' ' ' GLY . 2.8 pp -127.5 152.97 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 107.656 -1.239 . . . . 75.21 107.656 171.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.535 ' HE1' HG12 ' C' ' 83' ' ' ILE . 31.4 p90 -170.36 144.74 2.56 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 110.135 -0.32 . . . . 74.51 110.135 -174.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 66.2 p -73.08 111.77 8.5 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.976 0.51 . . . . 73.45 109.899 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.634 ' HE3' ' HB2' ' D' ' 28' ' ' ALA . 11.2 mmmm -66.91 -37.06 83.65 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.899 -0.778 . . . . 72.23 108.899 170.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.418 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.6 t70 -148.33 145.42 28.12 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.4 -1.273 . . . . 73.24 110.192 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.53 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.1 mt -136.89 144.15 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.722 1.609 . . . . 75.5 106.785 172.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.4 t -155.6 148.66 24.53 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.994 0.426 . . . . 74.44 110.337 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -151.4 127.72 10.61 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 107.255 -1.387 . . . . 74.01 107.255 173.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -135.49 112.24 10.12 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.065 0.546 . . . . 71.03 110.08 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.61 82.69 20.26 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 106.753 -1.573 . . . . 72.21 106.753 161.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.87 -25.94 32.43 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 122.626 2.217 . . . . 74.1 111.601 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -96.03 23.99 5.97 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.657 1.183 . . . . 72.22 109.618 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.423 ' HA ' HG11 ' C' ' 31' ' ' VAL . . . -44.2 -58.4 4.99 Favored Pre-proline 0 C--N 1.374 1.634 0 C-N-CA 124.999 1.32 . . . . 71.04 114.539 -163.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 19.9 Cg_exo -61.57 -42.64 31.74 Favored 'Trans proline' 0 C--N 1.386 2.532 0 CA-C-N 121.362 1.522 . . . . 71.35 111.856 -176.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -69.92 -34.39 73.41 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 114.89 -1.05 . . . . 75.25 112.541 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.562 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.9 p -79.98 -27.67 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.189 0.441 . . . . 74.15 112.189 -175.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -67.88 -34.06 75.93 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.011 0.434 . . . . 74.42 111.197 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -87.31 6.71 32.12 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.852 0.861 . . . . 74.42 111.743 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.63 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 2.5 tppp? -85.99 154.93 21.1 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.579 0.752 . . . . 74.54 111.199 -175.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -60.8 115.85 3.99 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.286 1.034 . . . . 74.41 109.929 172.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -84.36 82.79 8.23 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.984 0.914 . . . . 73.43 110.787 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -133.82 78.91 59.52 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 107.398 -1.334 . . . . 52.21 107.398 168.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -92.7 135.24 1.3 Allowed 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 123.243 2.629 . . . . 74.11 113.351 -175.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -85.64 96.89 9.82 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.981 -1.489 . . . . 72.32 106.981 169.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' C' ' 65' ' ' THR . 94.3 t -90.48 106.38 17.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 115.71 -0.677 . . . . 75.01 110.316 -175.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.08 105.04 16.93 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.172 -1.047 . . . . 62.43 108.172 173.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.431 ' H ' HD21 ' C' ' 42' ' ' LEU . 2.5 pt? -86.47 124.11 32.43 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 107.344 -1.354 . . . . 73.02 107.344 171.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.425 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 21.5 t70 -118.01 140.84 49.16 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.846 -0.798 . . . . 73.2 108.846 -176.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.557 HD13 HG12 ' C' ' 131' ' ' VAL . 51.2 mt -127.38 113.32 16.08 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.02 0.928 . . . . 75.45 109.489 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -122.48 121.3 36.24 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.266 -1.383 . . . . 64.21 107.266 174.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 6.5 t -117.17 137.03 52.6 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.058 0.456 . . . . 72.2 111.013 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.99 157.87 25.06 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.146 0.978 . . . . 71.22 108.769 175.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 60.2 p -158.58 146.35 18.07 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.14 0.576 . . . . 71.53 109.978 177.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.1 p -156.07 160.29 39.85 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.012 0.925 . . . . 72.44 109.214 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -99.59 120.08 39.1 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.569 -0.901 . . . . 73.4 108.569 172.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.575 HD12 ' HB2' ' C' ' 57' ' ' GLU . 33.6 mt -84.42 -50.8 7.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.645 0.778 . . . . 72.2 109.809 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.58 -168.25 2.86 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.845 -1.071 . . . . 75.35 109.73 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.66 118.56 9.73 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.886 -0.597 . . . . 60.32 109.904 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 68.06 -4.91 0.94 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.995 1.318 . . . . 74.42 112.109 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.0 t -99.58 116.82 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 123.741 0.816 . . . . 75.32 109.199 -174.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -124.36 129.49 50.81 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.836 1.254 . . . . 72.22 108.7 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.575 ' HB2' HD12 ' C' ' 51' ' ' LEU . 42.0 tt0 -89.72 137.1 32.62 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 108.522 -0.918 . . . . 72.44 108.522 167.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 82.2 t -123.85 140.85 46.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 108.08 -1.082 . . . . 72.52 108.08 167.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.444 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 85.3 t -122.03 146.41 27.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 108.759 -0.83 . . . . 75.25 108.759 172.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.565 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -128.76 99.8 5.47 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.91 -1.515 . . . . 74.23 106.91 177.078 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 33.3 ttm-85 -80.85 105.54 12.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.799 -1.091 . . . . 71.43 108.322 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' C' ' 43' ' ' ASP . 26.1 t -106.08 121.16 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 108.432 -0.951 . . . . 71.55 108.432 175.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 14.2 m -120.15 110.46 16.65 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.678 -0.86 . . . . 73.34 108.678 -174.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.545 HG21 HG23 ' C' ' 114' ' ' ILE . 47.6 t -98.16 109.5 23.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.95 -0.759 . . . . 74.41 108.95 177.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' C' ' 40' ' ' VAL . 32.1 m -96.5 131.73 42.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.596 -1.261 . . . . 73.15 107.596 171.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.54 118.23 19.85 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.344 -1.724 . . . . 71.23 106.344 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 29.9 m -133.25 125.74 29.99 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.089 0.243 . . . . 62.02 110.838 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.404 ' HG ' ' HB3' ' C' ' 73' ' ' ALA . 16.5 mt -87.45 49.3 1.79 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.395 1.478 . . . . 74.33 109.723 177.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.82 -115.35 5.16 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 110.533 -1.027 . . . . 65.03 110.533 -170.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -90.22 -28.37 18.9 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.796 0.838 . . . . 71.14 110.124 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.63 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 5.4 tp10 -63.68 122.09 15.52 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.804 1.242 . . . . 73.33 109.491 171.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.2 m -77.78 122.87 25.99 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.726 -0.842 . . . . 74.55 108.726 168.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.562 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -65.72 -59.39 3.96 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.307 -0.997 . . . . 62.33 108.307 171.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -165.39 164.37 19.69 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.908 -1.042 . . . . 73.23 110.658 174.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.402 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.7 tm? -120.51 141.01 50.62 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 106.354 -1.721 . . . . 63.34 106.354 166.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.436 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.6 t -146.95 110.06 4.76 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.79 -0.819 . . . . 74.13 108.79 177.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -117.44 119.74 36.01 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.08 -0.711 . . . . 75.43 109.08 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 55.1 t -117.08 114.17 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.78 -0.822 . . . . 74.15 108.78 173.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.418 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 78.2 mt-30 -90.06 87.22 6.81 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.185 -1.043 . . . . 74.3 108.185 173.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -78.42 104.48 9.05 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 115.693 -0.685 . . . . 74.43 109.325 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -83.48 179.3 52.53 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-N 116.613 -0.267 . . . . 64.25 112.717 172.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' C' ' 16' ' ' ILE . . . -178.73 136.81 3.01 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-O 119.945 -0.364 . . . . 73.33 112.719 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.535 HG12 ' HE1' ' C' ' 17' ' ' TYR . 36.6 mm -96.34 133.46 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 108.829 -0.804 . . . . 75.13 108.829 174.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -135.33 131.99 37.12 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.854 0.861 . . . . 74.43 110.308 -176.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 24.6 p -85.27 99.59 11.22 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.094 -1.076 . . . . 74.53 108.094 166.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 11.7 mt -114.57 140.41 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.138 -1.06 . . . . 74.34 108.138 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.42 162.62 38.99 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 122.415 0.286 . . . . 75.52 111.245 -174.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.26 -35.88 3.5 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 115.917 -0.583 . . . . 52.43 113.279 172.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.621 HD13 ' HA ' ' C' ' 94' ' ' MET . 36.1 pt -88.04 165.23 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.713 0.805 . . . . 73.3 112.059 -175.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -162.24 151.73 15.94 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.941 0.896 . . . . 63.24 109.874 -177.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.98 -119.39 9.64 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 115.344 -0.844 . . . . 61.51 112.794 172.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 68.9 p -62.15 -38.16 87.95 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.004 0.922 . . . . 74.51 111.307 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.543 HE21 HG23 ' C' ' 89' ' ' ILE . 27.0 mt-30 -65.22 -52.75 52.7 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.829 0.852 . . . . 71.13 111.22 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.621 ' HA ' HD13 ' C' ' 89' ' ' ILE . 6.1 tpt -53.03 -52.9 56.95 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 124.074 0.859 . . . . 73.02 111.722 176.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.55 -35.4 80.73 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.186 0.595 . . . . 73.35 112.15 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -68.13 -35.48 78.17 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.437 0.695 . . . . 74.2 110.708 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -71.82 -37.17 70.38 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.495 -0.775 . . . . 72.5 110.433 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.57 ' HG ' ' HE1' ' C' ' 94' ' ' MET . 83.8 mt -83.59 -33.7 25.31 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.999 0.92 . . . . 74.53 112.431 -175.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -113.14 11.09 24.54 Favored Glycine 0 N--CA 1.472 1.082 0 O-C-N 123.333 0.396 . . . . 50.23 113.803 -169.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.65 -54.29 0.19 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.77 0.428 . . . . 70.44 111.257 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.422 ' HH ' ' HB3' ' A' ' 130' ' ' PRO . 64.2 t80 -75.2 -47.73 26.87 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 112.479 0.548 . . . . 75.2 112.479 -172.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.475 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 91.5 m -64.43 -49.32 72.26 Favored Pre-proline 0 CA--C 1.561 1.367 0 C-N-CA 123.499 0.72 . . . . 72.52 110.886 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.565 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 51.2 Cg_exo -57.83 -28.21 81.44 Favored 'Trans proline' 0 C--N 1.396 3.074 0 C-N-CA 122.639 2.226 . . . . 72.11 113.633 174.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -66.06 -34.88 79.08 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.189 0.596 . . . . 71.34 110.916 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.533 HD13 ' NH1' ' A' ' 111' ' ' ARG . 35.7 mm -80.75 -29.98 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 122.556 0.343 . . . . 72.11 110.089 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 mp -75.34 -25.89 58.14 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.715 0.806 . . . . 71.34 111.496 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -58.97 -51.23 83.36 Favored Pre-proline 0 C--O 1.206 -1.225 0 CA-C-O 117.476 -1.25 . . . . 75.32 112.492 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . 0.535 ' HB3' ' HB2' ' A' ' 112' ' ' GLU . 65.3 Cg_exo -47.71 -44.47 26.29 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.774 2.316 . . . . 71.1 114.817 176.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -74.2 -40.49 62.44 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.095 0.558 . . . . 74.11 111.606 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.28 -42.35 93.28 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.268 0.627 . . . . 61.45 110.153 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . 0.608 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 31.6 ttt-85 -59.89 -52.16 66.6 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.029 1.732 . . . . 72.41 110.447 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.06 -37.7 88.4 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.234 0.959 . . . . 72.03 109.967 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 38.4 t -68.78 -35.66 77.33 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.476 0.485 . . . . 61.44 111.444 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.545 HG23 HG21 ' C' ' 64' ' ' VAL . 90.9 mt -68.65 -49.58 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.283 0.633 . . . . 74.24 110.203 174.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.6 m -66.36 -28.14 68.42 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.21 0.604 . . . . 75.33 110.991 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.436 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 46.2 t -66.45 -43.05 86.64 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.071 0.949 . . . . 74.43 109.041 172.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.592 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -67.76 -34.39 76.71 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.134 0.974 . . . . 75.41 112.089 177.527 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.465 HG23 ' O ' ' C' ' 114' ' ' ILE . 88.2 t -62.6 -43.96 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.619 0.767 . . . . 74.41 108.997 172.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.459 ' OG ' HG22 ' B' ' 115' ' ' THR . 29.4 t -63.88 -39.55 94.45 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.606 -1.179 . . . . 63.35 111.786 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.504 HH12 ' HG2' ' D' ' 112' ' ' GLU . 67.0 mtt-85 -69.95 -38.31 76.09 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.578 0.751 . . . . 72.34 109.942 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.6 -1.04 88.69 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 115.426 -0.806 . . . . 70.24 112.788 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 31.5 p 61.72 30.49 18.46 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.43 1.892 . . . . 74.14 113.587 171.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -85.66 151.31 55.35 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 107.871 -1.159 . . . . 74.33 107.871 166.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.555 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 24.5 Cg_endo -63.06 157.94 46.38 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 122.354 2.036 . . . . 64.33 112.721 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 -53.06 112.71 0.91 Allowed 'General case' 0 N--CA 1.477 0.908 0 O-C-N 124.585 1.178 . . . . 75.15 112.891 -172.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 61.0 tp -109.61 87.8 2.59 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 113.924 -1.489 . . . . 75.35 107.512 174.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -92.93 99.91 12.46 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.899 -0.778 . . . . 74.24 108.899 -174.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.608 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 4.0 mm? -56.47 125.05 20.33 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.943 0.897 . . . . 75.33 111.274 -175.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.72 152.4 95.2 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 124.212 1.005 . . . . 74.31 111.4 -175.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.424 ' HG2' HG23 ' A' ' 13' ' ' ILE . 51.2 Cg_exo -54.72 108.26 0.28 Allowed 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.979 2.453 . . . . 74.41 112.926 175.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . 0.557 HG12 HD13 ' C' ' 44' ' ' LEU . 6.8 p -101.0 135.55 36.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.599 0.76 . . . . 75.02 109.446 175.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -97.36 101.25 12.76 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.632 0.773 . . . . 75.35 109.359 -174.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . 0.44 ' CE1' HD11 ' C' ' 44' ' ' LEU . 66.4 m-85 -68.98 -33.79 74.25 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.63 0.772 . . . . 73.51 111.462 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -59.15 -43.41 92.05 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.92 0.888 . . . . 62.21 109.435 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.88 -41.34 95.81 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 114.691 -1.141 . . . . 61.14 111.805 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 76.4 mt -65.91 -36.05 82.32 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.308 0.643 . . . . 75.53 110.831 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 18.0 t80 . . . . . 0 CA--C 1.554 1.108 0 CA-C-N 115.124 -0.944 . . . . 73.5 109.955 177.051 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 4.6 t . . . . . 0 C--O 1.243 0.724 0 N-CA-C 108.721 -0.844 . . . . 64.13 108.721 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.416 ' HD2' HG21 ' D' ' 86' ' ' ILE . 70.8 t80 -133.75 106.06 7.14 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.085 -1.45 . . . . 73.34 107.085 174.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -124.81 127.15 46.74 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.241 -1.022 . . . . 75.53 108.241 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.424 HG22 HD11 ' D' ' 16' ' ' ILE . 26.9 mt -77.09 116.51 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 109.296 -0.631 . . . . 73.41 109.296 178.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . 0.406 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 8.5 mm100 -84.07 -43.92 14.59 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.281 0.632 . . . . 75.0 110.385 -173.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -170.71 142.71 2.03 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.947 0.499 . . . . 72.42 110.362 -176.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.424 HD11 HG22 ' D' ' 13' ' ' ILE . 3.0 mp -115.07 148.48 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 106.872 -1.529 . . . . 73.43 106.872 172.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -169.59 168.33 9.26 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-O 121.54 0.686 . . . . 74.25 111.643 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.6 p -105.09 121.16 43.21 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 114.929 -1.032 . . . . 71.44 109.078 171.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -86.25 -25.28 25.64 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.42 0.688 . . . . 74.23 109.238 176.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.4 t70 -156.74 137.38 13.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.63 -1.168 . . . . 62.42 109.973 -175.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.592 HG23 ' HE1' ' C' ' 117' ' ' MET . 74.1 mt -140.14 141.4 33.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.218 1.407 . . . . 71.15 107.471 173.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.9 t -146.71 143.63 28.86 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.91 0.884 . . . . 72.45 109.116 173.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.53 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 84.5 t80 -146.99 133.64 19.91 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 106.581 -1.637 . . . . 74.14 106.581 172.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 48.0 mt-10 -135.27 141.77 45.79 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.96 0.904 . . . . 65.15 109.382 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.49 77.97 16.77 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 107.796 -1.187 . . . . 74.43 107.796 176.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.69 -19.42 21.31 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.666 2.244 . . . . 71.33 113.195 -173.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -108.45 -0.65 20.4 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.865 0.866 . . . . 74.4 110.707 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.634 ' HB2' ' HE3' ' C' ' 19' ' ' LYS . . . -19.51 -71.7 0.03 OUTLIER Pre-proline 0 CA--C 1.571 1.757 0 N-CA-C 116.908 2.188 . . . . 55.24 116.908 -165.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.437 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 81.4 Cg_endo -74.76 -25.1 12.71 Favored 'Trans proline' 0 C--N 1.385 2.458 0 CA-C-N 124.454 2.626 . . . . 74.44 113.84 -176.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.505 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 4.6 t-160 -69.67 -39.68 76.89 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 124.419 1.087 . . . . 75.55 110.07 178.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.591 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.8 p -82.71 -22.53 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 CA-C-N 115.666 -0.697 . . . . 74.33 111.426 -175.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.437 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 22.1 m-85 -64.25 -26.39 68.48 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 122.265 0.226 . . . . 75.21 111.221 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . 0.505 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 61.7 mt-30 -65.45 -7.08 12.39 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.834 1.253 . . . . 72.43 111.844 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.709 ' HZ1' ' HG2' ' D' ' 71' ' ' GLU . 91.6 mttt -95.71 103.86 15.76 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.152 1.381 . . . . 72.01 110.095 175.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -95.36 76.32 3.38 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.581 0.752 . . . . 73.05 110.312 -175.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 44.2 p90 -156.75 -177.78 6.86 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.8 -0.815 . . . . 75.44 108.8 168.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -65.08 117.65 41.64 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.532 1.133 . . . . 73.32 110.91 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.41 ' O ' HG23 ' D' ' 40' ' ' VAL . 74.9 Cg_exo -55.49 112.88 1.18 Allowed 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 121.807 1.672 . . . . 75.02 109.457 165.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -70.95 107.41 4.05 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.055 -1.091 . . . . 73.3 108.055 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.679 HG21 ' HB2' ' D' ' 66' ' ' ALA . 96.0 t -102.45 131.4 50.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 115.122 -0.945 . . . . 73.11 109.913 -170.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -119.45 125.13 48.18 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.715 -1.217 . . . . 74.51 107.715 170.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.456 HD12 HG13 ' D' ' 62' ' ' VAL . 51.9 tp -96.18 141.48 29.5 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.852 -0.795 . . . . 73.41 108.852 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.571 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 35.1 t70 -134.71 113.28 11.51 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.026 -1.101 . . . . 74.43 108.026 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' D' ' 62' ' ' VAL . 93.7 mt -114.49 151.7 32.85 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.295 0.638 . . . . 64.24 110.696 -177.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.536 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 13.5 t0 -152.07 143.44 23.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.19 -0.914 . . . . 72.51 108.656 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 23.9 m -105.34 141.33 37.04 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.073 -0.714 . . . . 74.21 109.073 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.538 ' HB2' ' HB ' ' D' ' 59' ' ' VAL . . . -152.86 162.5 41.21 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.214 1.006 . . . . 75.13 108.864 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 36.3 p . . . . . 0 C--O 1.243 0.722 0 C-N-CA 123.601 0.76 . . . . 75.32 110.011 175.507 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 112.505 0.557 . . . . 73.23 112.505 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 t -108.82 99.37 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 108.773 -0.825 . . . . 73.4 108.773 -176.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -133.88 129.57 36.6 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.53 -0.915 . . . . 71.12 108.53 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.583 ' HB3' HG13 ' D' ' 83' ' ' ILE . 0.0 OUTLIER -101.66 120.14 39.87 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.835 -1.172 . . . . 71.32 107.835 168.298 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.494 ' O ' ' HA2' ' D' ' 81' ' ' GLY . 79.7 t -101.02 132.9 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-N 114.472 -1.24 . . . . 64.21 109.451 -176.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' D' ' 47' ' ' ALA . 36.6 t -106.63 138.81 30.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 124.383 1.073 . . . . 75.02 108.722 178.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.569 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -120.73 118.31 29.72 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.016 -1.475 . . . . 75.4 107.016 173.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.536 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 55.3 ttm-85 -88.57 109.35 20.01 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.848 -1.168 . . . . 72.11 107.848 175.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.541 HG22 ' HB1' ' D' ' 110' ' ' ALA . 38.5 t -114.69 113.23 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.345 -0.613 . . . . 74.13 109.345 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.571 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 24.4 m -119.75 131.96 55.5 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 123.954 0.902 . . . . 73.44 108.978 -172.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.665 HG13 HG11 ' D' ' 40' ' ' VAL . 85.1 t -118.71 104.69 16.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 C-N-CA 123.294 0.638 . . . . 74.42 109.384 177.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 10.1 m -97.98 94.03 6.64 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.26 -1.385 . . . . 75.24 107.26 170.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.679 ' HB2' HG21 ' D' ' 40' ' ' VAL . . . -112.02 138.71 48.29 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.015 0.926 . . . . 74.23 108.679 -175.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.507 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 61.1 m -144.55 136.03 25.53 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.346 0.658 . . . . 74.31 111.61 -172.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.528 HD11 HG23 ' D' ' 31' ' ' VAL . 32.1 mt -100.5 106.93 18.51 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.473 1.109 . . . . 71.12 109.061 174.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.17 -126.32 8.65 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-O 119.869 -0.406 . . . . 62.11 112.807 175.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.23 5.3 52.19 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.328 0.651 . . . . 65.12 112.081 -177.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.709 ' HG2' ' HZ1' ' D' ' 34' ' ' LYS . 9.3 pt-20 -133.69 164.55 26.97 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.991 0.516 . . . . 74.41 109.965 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 21.4 m -68.02 143.69 55.44 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.994 0.917 . . . . 74.13 111.766 178.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.591 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -91.75 -69.66 0.73 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.616 -1.624 . . . . 74.12 106.616 173.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -149.22 146.89 27.83 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 114.812 -1.086 . . . . 74.33 110.059 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.422 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 82.7 mt -110.36 145.97 36.59 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.015 -1.105 . . . . 75.33 108.015 174.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.446 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 46.6 t -156.49 147.03 21.6 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.469 0.308 . . . . 71.03 110.207 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -156.63 130.52 8.39 Favored 'General case' 0 C--N 1.345 0.373 0 C-N-CA 123.274 0.63 . . . . 74.03 109.724 168.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 92.0 t -129.76 114.45 30.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 C-N-CA 124.512 1.125 . . . . 72.21 108.52 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.488 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.5 mt-30 -90.13 88.24 7.19 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.837 0.827 . . . . 73.45 109.074 173.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.7 107.2 13.31 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 113.688 -1.596 . . . . 74.43 109.912 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' D' ' 58' ' ' VAL . . . -110.85 162.22 12.58 Favored Glycine 0 N--CA 1.465 0.625 0 O-C-N 123.032 0.208 . . . . 63.34 113.397 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.09 148.9 9.15 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-O 119.366 -0.686 . . . . 52.11 112.935 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.583 HG13 ' HB3' ' D' ' 57' ' ' GLU . 3.7 mp -89.1 136.74 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.197 -1.038 . . . . 73.24 108.197 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -132.43 129.42 39.26 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.477 1.111 . . . . 73.13 108.303 176.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 30.2 p -81.53 101.89 10.24 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.043 -0.725 . . . . 75.03 109.043 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.416 HG21 ' HD2' ' D' ' 11' ' ' PHE . 2.3 pp -119.24 121.0 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 120.749 0.309 . . . . 75.31 110.757 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.16 167.93 8.49 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.481 1.112 . . . . 42.45 111.313 174.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.0 19.02 23.0 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 124.046 0.841 . . . . 71.34 112.626 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' D' ' 94' ' ' MET . 0.7 OUTLIER -140.18 162.16 24.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 C-N-CA 125.157 1.383 . . . . 72.43 109.461 177.617 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -147.8 -174.05 4.45 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.404 0.682 . . . . 74.32 111.386 -173.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.7 -146.05 29.47 Favored Glycine 0 C--N 1.349 1.255 0 C-N-CA 124.047 0.832 . . . . 61.13 112.242 -172.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 68.0 p -94.32 -39.62 10.39 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.611 0.706 . . . . 70.53 111.027 174.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -65.61 -17.82 64.87 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.363 1.065 . . . . 75.34 113.591 -171.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.589 ' HB2' HD11 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -57.04 -30.24 64.08 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.047 0.758 . . . . 70.41 113.047 176.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . 0.437 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -80.54 -13.97 58.63 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.486 0.714 . . . . 74.54 112.351 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -63.05 -29.83 71.12 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.072 0.549 . . . . 74.54 111.084 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 55.5 m -62.69 -28.3 69.84 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.387 0.675 . . . . 62.33 111.488 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.1 tt -92.41 -46.93 7.43 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.601 1.16 . . . . 61.12 110.063 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.22 -15.09 65.22 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 116.2 -0.455 . . . . 71.41 114.167 -169.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.91 -52.0 1.22 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.91 0.484 . . . . 73.31 110.685 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -73.74 -39.73 64.04 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 112.272 0.471 . . . . 74.3 112.272 -174.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 92.7 m -65.15 -46.97 73.13 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-O 118.542 -0.742 . . . . 72.41 111.638 177.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.569 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 84.2 Cg_exo -54.61 -33.77 80.42 Favored 'Trans proline' 0 C--N 1.393 2.907 0 C-N-CA 122.763 2.309 . . . . 75.43 113.661 167.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.27 -32.66 74.43 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.439 0.696 . . . . 74.0 110.978 177.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 51.1 mm -74.33 -38.37 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.284 0.633 . . . . 75.42 110.244 173.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 70.6 mt -73.65 -22.9 59.83 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.521 -0.763 . . . . 64.1 111.709 -175.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -67.55 -42.01 34.18 Favored Pre-proline 0 N--CA 1.484 1.268 0 N-CA-C 113.635 0.976 . . . . 75.23 113.635 -172.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -47.15 -44.11 24.29 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.446 2.097 . . . . 73.33 113.855 167.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -79.36 -28.28 41.97 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.921 0.888 . . . . 74.41 112.252 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . 0.541 ' HB1' HG22 ' D' ' 62' ' ' VAL . . . -64.48 -47.4 79.11 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.733 0.777 . . . . 74.24 109.451 173.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -69.04 -34.29 74.96 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 113.723 -1.58 . . . . 75.33 110.385 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . 0.504 ' HG2' HH12 ' C' ' 120' ' ' ARG . 20.5 tt0 -53.42 -49.73 66.71 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.118 0.967 . . . . 74.11 110.452 175.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.426 ' O ' ' HG3' ' D' ' 117' ' ' MET . 46.1 t -67.69 -54.4 19.8 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.701 -1.136 . . . . 73.41 110.794 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.436 HG12 ' SG ' ' D' ' 76' ' ' CYS . 52.9 mt -60.28 -58.07 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.365 0.666 . . . . 74.13 111.855 -174.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 91.5 m -51.3 -41.15 60.3 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.102 0.876 . . . . 75.32 111.769 -175.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.429 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 47.2 t -66.09 -42.12 89.75 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 114.681 -1.145 . . . . 72.14 110.078 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 66.6 mtm -69.03 -30.53 68.91 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.057 0.543 . . . . 73.44 111.981 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 95.7 t -62.97 -47.21 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.682 0.793 . . . . 72.34 109.198 174.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.3 p -74.25 -26.14 60.05 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.405 -0.816 . . . . 73.13 111.206 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' D' ' 116' ' ' SER . 88.6 mtt-85 -69.77 -32.85 71.58 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.464 0.705 . . . . 74.45 109.775 174.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.84 10.95 63.48 Favored Glycine 0 C--N 1.35 1.358 0 O-C-N 123.939 0.774 . . . . 63.02 112.501 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 70.3 p 54.79 27.04 8.32 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 126.095 1.758 . . . . 74.34 113.464 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -88.85 150.93 46.65 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 109.064 -0.717 . . . . 72.41 109.064 170.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -46.99 122.31 6.07 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.081 2.521 . . . . 63.35 113.53 171.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -45.62 123.19 4.1 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.682 1.593 . . . . 75.13 112.174 -175.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.436 HD12 HG22 ' D' ' 40' ' ' VAL . 20.6 tp -103.08 109.79 21.48 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.629 -0.878 . . . . 64.41 108.629 -175.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -98.93 86.54 3.5 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 107.679 -1.23 . . . . 75.24 107.679 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.411 HD11 HD13 ' D' ' 114' ' ' ILE . 96.5 mt -54.38 115.04 1.88 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.026 0.53 . . . . 71.43 110.351 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.8 135.04 95.73 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 123.693 0.62 . . . . 73.5 110.557 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.62 121.81 10.45 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.545 2.163 . . . . 74.14 111.183 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 p -108.04 137.84 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.205 1.002 . . . . 74.12 108.903 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -78.27 98.4 5.89 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.176 -0.675 . . . . 74.14 109.176 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 . . . . . 0 N--CA 1.475 0.804 0 C-N-CA 124.102 0.961 . . . . 75.31 111.05 -178.432 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.2 m . . . . . 0 CA--C 1.536 0.432 0 N-CA-C 108.929 -0.767 . . . . 72.1 108.929 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.408 ' CD1' HD13 ' A' ' 86' ' ' ILE . 89.5 t80 -120.38 120.68 36.68 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.295 1.038 . . . . 73.2 108.761 -177.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -140.45 135.33 31.9 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.993 0.517 . . . . 74.13 109.756 173.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.617 HD12 HG21 ' A' ' 105' ' ' ILE . 3.6 mt -92.77 115.26 31.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 108.349 -0.982 . . . . 74.41 108.349 173.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.67 -40.25 29.52 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.235 -0.654 . . . . 74.12 109.235 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -176.21 122.93 0.17 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 123.146 0.279 . . . . 74.22 110.706 -171.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 79.4 mt -105.61 136.76 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.833 -0.802 . . . . 70.24 108.833 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.457 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 33.2 p90 -169.76 155.43 5.85 Favored 'General case' 0 C--N 1.346 0.42 0 O-C-N 124.197 0.936 . . . . 71.54 110.704 -173.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -83.28 121.94 27.78 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.513 -0.767 . . . . 75.12 109.475 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.457 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.5 mtpt -84.71 -26.7 27.51 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.71 -0.478 . . . . 73.01 109.71 175.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.583 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 11.0 t70 -153.49 143.44 22.07 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 114.63 -1.168 . . . . 43.4 109.837 -178.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.461 HD11 ' SD ' ' B' ' 117' ' ' MET . 91.5 mt -143.63 142.2 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.498 1.519 . . . . 63.41 107.857 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.9 t -149.97 133.22 16.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.289 0.635 . . . . 74.13 109.839 172.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -125.58 140.44 52.74 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 107.014 -1.476 . . . . 73.21 107.014 169.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -142.01 108.5 5.32 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.586 0.755 . . . . 75.34 109.042 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.57 ' HB1' ' HB3' ' A' ' 28' ' ' ALA . . . -106.96 85.65 2.03 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 106.639 -1.615 . . . . 73.15 106.639 165.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.55 -38.79 5.65 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.392 2.061 . . . . 73.42 112.177 -169.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -111.22 31.41 6.1 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.871 0.869 . . . . 64.22 108.867 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.57 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . . . -47.13 -54.72 18.98 Favored Pre-proline 0 N--CA 1.493 1.678 0 CA-C-O 117.693 -1.146 . . . . 64.15 113.72 -173.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -61.25 -28.2 84.5 Favored 'Trans proline' 0 C--N 1.401 3.334 0 C-N-CA 121.888 1.725 . . . . 74.41 112.667 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.503 ' HA ' ' NE2' ' A' ' 33' ' ' GLN . 9.0 t60 -90.64 -31.8 16.49 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.741 1.216 . . . . 54.21 112.055 -173.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.625 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.9 p -79.22 -21.4 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 120.875 0.369 . . . . 74.2 111.142 -171.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -73.58 -6.2 45.12 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 115.991 -0.55 . . . . 73.41 111.025 172.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.503 ' NE2' ' HA ' ' A' ' 30' ' ' HIS . 9.9 mt-30 -88.8 -28.98 20.07 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.925 0.89 . . . . 73.22 110.202 172.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.434 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 14.5 mmmm -77.0 157.58 31.1 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.636 0.774 . . . . 74.25 110.929 -176.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.78 119.37 9.2 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.438 0.695 . . . . 75.11 110.464 174.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.463 ' CE3' HD21 ' A' ' 68' ' ' LEU . 67.2 t-105 -81.6 87.69 6.25 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.49 0.662 . . . . 73.51 111.393 -175.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.429 ' H ' HD23 ' A' ' 68' ' ' LEU . 35.7 tt0 -124.1 82.93 56.25 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 124.652 1.181 . . . . 74.23 107.869 171.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.34 121.17 7.52 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.762 2.308 . . . . 73.2 113.257 -170.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -97.19 89.36 4.75 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.829 -0.804 . . . . 74.21 108.829 172.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.547 HG12 HD13 ' A' ' 126' ' ' LEU . 48.8 t -79.66 111.76 16.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-N 114.846 -1.07 . . . . 73.22 110.109 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -99.03 123.49 43.36 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.076 -0.713 . . . . 74.45 109.076 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 84.6 mt -99.31 108.48 21.02 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.515 0.726 . . . . 73.44 109.665 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.638 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 11.2 m-20 -104.72 106.07 16.41 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.418 -1.327 . . . . 54.33 107.418 170.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.408 HD11 ' CZ ' ' A' ' 133' ' ' PHE . 79.4 mt -106.95 117.31 33.71 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.04 -0.726 . . . . 73.12 109.04 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -122.62 130.77 53.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.882 -1.525 . . . . 60.15 106.882 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.9 m -108.35 136.0 48.73 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.69 -0.485 . . . . 70.45 109.69 177.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.38 109.93 6.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.127 0.971 . . . . 74.31 108.966 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 79.2 p -94.96 158.79 15.32 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.97 0.508 . . . . 74.5 109.955 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.0 t -148.74 119.96 7.8 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.519 -0.919 . . . . 75.12 108.519 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -81.88 115.87 21.27 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.365 -0.606 . . . . 75.1 109.365 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.0 mt -80.56 -42.42 22.39 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.532 0.733 . . . . 75.24 110.516 -176.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.67 -179.61 7.57 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.023 0.929 . . . . 74.34 110.139 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -60.73 121.48 12.37 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.673 0.789 . . . . 73.55 109.903 170.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 65.84 -2.56 0.88 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.381 1.472 . . . . 72.13 112.974 -176.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.0 t -104.68 105.1 17.94 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 N-CA-C 108.158 -1.053 . . . . 74.1 108.158 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -107.64 162.66 13.77 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.562 -0.903 . . . . 71.51 108.562 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -131.77 153.3 50.24 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 107.444 -1.317 . . . . 73.14 107.444 168.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.443 HG11 ' HD3' ' A' ' 103' ' ' PRO . 68.0 t -133.48 136.41 54.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 107.513 -1.291 . . . . 74.32 107.513 173.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.433 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 47.9 t -119.82 133.58 66.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.831 -0.803 . . . . 75.41 108.831 174.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.419 HD22 HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -104.01 100.07 9.84 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 106.564 -1.643 . . . . 74.33 106.564 177.012 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -82.97 99.21 9.66 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.867 -1.16 . . . . 74.02 107.867 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.478 HG21 ' HB1' ' A' ' 110' ' ' ALA . 47.2 t -98.96 130.57 47.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 N-CA-C 108.353 -0.98 . . . . 73.24 108.353 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.638 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 9.3 m -127.36 107.76 10.25 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.731 -0.84 . . . . 75.14 108.731 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.638 HG13 HD21 ' A' ' 126' ' ' LEU . 54.1 t -101.24 128.23 53.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 124.547 1.139 . . . . 74.24 108.275 174.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.8 m -131.44 116.89 18.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.816 -0.809 . . . . 73.52 108.816 172.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.53 119.43 39.15 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.61 -1.256 . . . . 71.14 107.61 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -127.7 142.31 51.36 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.515 0.674 . . . . 74.42 110.597 -177.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.463 HD21 ' CE3' ' A' ' 36' ' ' TRP . 50.4 mt -91.18 61.19 4.45 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.262 1.425 . . . . 72.14 107.927 170.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.2 -98.28 1.47 Allowed Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.198 -0.91 . . . . 61.14 112.684 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -88.35 -29.6 20.18 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.128 0.971 . . . . 73.11 110.287 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.434 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 5.1 tp10 -85.88 101.17 12.62 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.149 -0.932 . . . . 75.05 108.954 -174.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.4 m -68.16 124.27 22.98 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 119.291 0.951 . . . . 75.13 108.559 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.625 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -79.81 -54.52 5.76 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.17 -0.923 . . . . 74.3 108.853 -177.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -155.34 162.23 40.88 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.276 -0.874 . . . . 71.52 111.527 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.0 tp -131.14 118.44 20.49 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 113.765 -1.561 . . . . 72.42 107.498 175.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 85.3 m -115.3 126.89 55.02 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.595 -0.891 . . . . 74.31 108.595 175.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -139.18 115.77 10.65 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.32 -0.622 . . . . 72.4 109.32 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.4 t -125.64 112.35 30.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.42 1.088 . . . . 71.14 109.047 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 4.2 mt-30 -84.62 84.89 7.52 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.505 -0.924 . . . . 74.31 108.505 169.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -76.7 96.85 4.3 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 114.681 -1.145 . . . . 73.21 108.941 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -84.91 160.8 35.69 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.88 -0.488 . . . . 45.04 111.88 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.486 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -156.49 125.05 1.54 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.186 -1.166 . . . . 72.22 110.186 174.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.418 HG13 ' HE1' ' A' ' 17' ' ' TYR . 65.1 mt -79.79 124.66 38.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.893 -1.151 . . . . 73.32 107.893 171.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.604 ' HB3' HD11 ' A' ' 86' ' ' ILE . 96.3 m-85 -125.03 119.42 28.63 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.889 -0.782 . . . . 73.35 108.889 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.7 t -89.14 90.99 8.62 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.249 -1.019 . . . . 63.45 108.249 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 84' ' ' PHE . 13.1 mm -116.87 148.69 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 121.205 0.526 . . . . 74.24 110.816 -169.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.56 171.06 16.34 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.735 -1.12 . . . . 73.51 110.114 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 106.24 -32.89 6.89 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.239 -0.437 . . . . 72.41 112.92 177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.467 HD11 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -121.39 169.0 13.25 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 124.278 1.031 . . . . 74.51 110.1 -175.227 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.433 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 12.6 tt0 -156.85 174.9 14.81 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 124.133 0.895 . . . . 74.54 109.07 176.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.43 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 59.73 -114.03 5.89 Favored Glycine 0 C--N 1.343 0.957 0 CA-C-N 115.69 -0.686 . . . . 70.03 114.293 176.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.4 p -71.36 -41.54 69.59 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.62 1.168 . . . . 75.43 112.217 -174.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -71.2 -34.77 71.18 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.067 0.547 . . . . 61.42 110.279 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.433 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 5.8 tpt -66.67 -42.52 86.43 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 123.469 0.481 . . . . 73.41 110.098 174.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.98 -35.08 79.51 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.373 0.669 . . . . 72.4 111.005 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -71.71 -28.28 63.58 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.663 0.785 . . . . 71.51 110.777 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.7 t -76.19 -50.49 14.38 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.461 -0.57 . . . . 63.25 109.461 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 87.1 mt -75.98 -23.96 55.34 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.532 0.733 . . . . 75.22 112.515 -173.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.09 3.52 22.46 Favored Glycine 0 N--CA 1.473 1.139 0 CA-C-O 119.553 -0.582 . . . . 73.41 113.952 -171.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.41 -63.24 0.4 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 117.541 0.67 . . . . 72.43 111.276 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -68.62 -46.19 69.9 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.175 0.59 . . . . 74.31 111.777 -170.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 80.3 m -70.49 -47.41 18.53 Favored Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 124.235 1.014 . . . . 73.34 112.928 -176.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.443 ' HD3' HG11 ' A' ' 58' ' ' VAL . 51.5 Cg_endo -67.08 -18.66 51.59 Favored 'Trans proline' 0 C--N 1.394 2.967 0 CA-C-N 121.462 1.558 . . . . 75.13 112.461 174.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.77 -35.23 67.39 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.055 0.542 . . . . 73.44 109.74 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.617 HG21 HD12 ' A' ' 13' ' ' ILE . 39.1 mm -65.42 -44.38 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.849 0.859 . . . . 73.12 110.113 170.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.486 HD22 ' HA3' ' A' ' 82' ' ' GLY . 75.7 mt -71.49 -15.8 62.33 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.445 -0.798 . . . . 75.24 111.904 -175.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -70.03 -44.98 22.28 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 114.748 1.388 . . . . 72.31 114.748 -170.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.97 -32.14 84.66 Favored 'Trans proline' 0 C--N 1.384 2.437 0 CA-C-N 122.285 1.852 . . . . 74.43 112.314 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -76.84 -41.28 44.74 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.69 0.796 . . . . 65.13 111.65 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.478 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -66.44 -49.44 66.71 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.033 0.533 . . . . 75.3 109.749 178.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.458 ' NH1' HD13 ' C' ' 105' ' ' ILE . 30.5 ttm180 -46.8 -51.67 15.9 Favored 'General case' 0 C--N 1.353 0.761 0 O-C-N 125.258 1.599 . . . . 73.44 110.716 173.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -67.39 -43.78 80.5 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.316 1.01 . . . . 73.45 111.982 -175.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.547 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.7 t -57.68 -42.6 83.94 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.932 0.77 . . . . 74.03 110.122 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.609 HD13 HD12 ' A' ' 128' ' ' LEU . 96.5 mt -64.33 -54.84 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 114.451 -1.25 . . . . 70.2 110.253 175.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.5 m -56.59 -37.29 70.43 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.258 0.974 . . . . 72.2 111.567 -173.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.0 t -68.81 -47.9 64.92 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.664 -1.153 . . . . 74.34 110.096 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 8.6 mtp -57.12 -37.71 72.38 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.615 0.766 . . . . 75.14 111.664 175.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.3 t -67.48 -49.16 73.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.378 1.071 . . . . 75.22 110.461 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.8 p -70.44 -33.19 71.03 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.018 0.527 . . . . 75.12 111.076 -175.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.532 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.9 mtt-85 -69.48 -31.97 70.57 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.959 0.904 . . . . 75.11 109.67 172.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.84 6.08 49.74 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-O 119.304 -0.72 . . . . 73.31 113.688 174.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.553 HG21 ' HE ' ' B' ' 15' ' ' ARG . 18.1 m 73.15 7.29 5.32 Favored 'General case' 0 C--N 1.367 1.345 0 C-N-CA 125.147 1.379 . . . . 71.03 112.152 176.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -86.51 137.53 34.24 Favored Pre-proline 0 C--O 1.24 0.568 0 N-CA-C 107.197 -1.409 . . . . 71.33 107.197 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -54.67 165.87 2.25 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 123.416 2.744 . . . . 70.11 113.855 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.556 ' HG2' ' HB2' ' C' ' 15' ' ' ARG . 40.6 tp60 -52.88 117.8 3.22 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 114.534 -1.212 . . . . 75.53 111.877 -172.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.638 HD21 HG13 ' A' ' 64' ' ' VAL . 25.5 tp -113.6 114.39 26.39 Favored 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 109.175 -0.676 . . . . 71.31 109.175 173.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.414 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 5.7 m-80 -110.03 125.69 53.18 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 106.152 -1.795 . . . . 65.11 106.152 176.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.609 HD12 HD13 ' A' ' 114' ' ' ILE . 10.9 mt -72.09 144.18 48.78 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 109.173 -0.677 . . . . 65.31 109.173 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.18 138.64 91.51 Favored Pre-proline 0 N--CA 1.48 1.059 0 CA-C-O 118.864 -0.588 . . . . 73.44 111.011 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -55.09 108.17 0.29 Allowed 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.519 2.146 . . . . 75.04 111.849 168.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 75.4 t -104.18 137.17 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.078 0.951 . . . . 71.54 111.634 -173.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -89.53 97.29 11.11 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.791 -1.095 . . . . 70.14 108.656 170.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.408 ' CZ ' HD11 ' A' ' 44' ' ' LEU . 57.2 m-85 -70.49 -18.58 62.96 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 112.827 0.677 . . . . 74.42 112.827 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -69.6 -40.02 76.9 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.45 -0.945 . . . . 63.43 108.45 174.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.07 -46.22 85.28 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.5 0.72 . . . . 72.55 110.942 174.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 56.9 mt -62.87 -33.58 75.58 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 123.748 0.655 . . . . 73.01 111.044 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 74.6 t80 . . . . . 0 C--O 1.218 -0.588 0 CA-C-N 115.507 -0.77 . . . . 74.23 109.808 176.661 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 1.4 tmt? . . . . . 0 CA--C 1.552 1.055 0 CA-C-O 120.801 0.334 . . . . 74.23 110.772 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.1 t -143.38 99.14 3.38 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.135 0.969 . . . . 62.33 109.373 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.452 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 54.1 t80 -112.63 141.0 46.92 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.334 -1.303 . . . . 75.23 107.684 173.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -147.55 134.14 19.85 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.764 -0.458 . . . . 73.2 109.764 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.415 HG13 ' HD3' ' D' ' 130' ' ' PRO . 41.4 mt -80.66 116.47 24.95 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 N-CA-C 107.011 -1.477 . . . . 62.34 107.011 170.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -90.06 -37.55 14.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.973 -0.751 . . . . 73.43 108.973 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.553 ' HE ' HG21 ' A' ' 122' ' ' THR . 11.7 ttt85 -168.92 151.88 5.07 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 123.611 0.569 . . . . 71.4 110.812 -177.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 53.8 mt -135.16 135.87 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 106.668 -1.604 . . . . 71.55 106.668 171.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.483 ' HE1' HG13 ' B' ' 83' ' ' ILE . 10.9 p90 -166.34 143.03 4.98 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.281 0.563 . . . . 73.01 111.79 -173.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 41.2 m -74.24 121.39 21.19 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.81 -1.086 . . . . 74.12 108.971 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.438 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.5 mtpt -98.51 -17.09 18.91 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.363 0.665 . . . . 74.52 110.979 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.416 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 3.2 t70 -163.67 145.36 9.3 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.83 0.852 . . . . 74.03 110.418 -177.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.511 HD11 HG12 ' B' ' 78' ' ' VAL . 39.4 mm -133.13 144.93 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 107.618 -1.253 . . . . 73.51 107.618 170.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 39.2 t -143.94 135.82 26.32 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.792 -0.818 . . . . 74.11 108.792 174.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.459 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.6 t80 -149.53 114.55 5.42 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 107.402 -1.333 . . . . 74.21 107.402 170.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -126.17 114.3 18.17 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.102 -1.073 . . . . 75.24 108.102 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.85 88.82 3.83 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 107.912 -1.144 . . . . 73.31 107.912 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.55 -33.33 46.33 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.723 2.282 . . . . 74.55 112.295 -172.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -106.32 7.96 31.53 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.075 0.95 . . . . 74.24 111.613 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -33.26 -64.03 0.27 Allowed Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 115.662 1.727 . . . . 74.11 115.662 -167.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -60.72 -32.58 93.23 Favored 'Trans proline' 0 C--N 1.4 3.272 0 C-N-CA 122.438 2.092 . . . . 65.34 112.914 -170.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -94.77 -39.58 10.21 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 114.664 -1.153 . . . . 75.32 111.583 -170.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.659 HG23 HD13 ' B' ' 68' ' ' LEU . 7.4 p -66.32 -19.41 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.052 0.541 . . . . 72.34 111.925 -172.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -60.47 -21.63 62.57 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.015 0.926 . . . . 75.23 113.312 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -63.9 -18.27 64.03 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.346 0.658 . . . . 75.52 111.766 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.555 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 95.6 mttt -94.06 105.29 17.29 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.256 1.022 . . . . 75.25 109.142 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -100.52 79.58 2.12 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.477 0.711 . . . . 64.43 110.441 -172.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 46.5 p90 -154.41 167.84 28.67 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.824 -1.176 . . . . 74.14 107.824 165.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 22.9 tm0? -76.51 115.44 47.64 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 107.7 -1.222 . . . . 74.3 107.7 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.27 154.38 52.84 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.982 2.455 . . . . 74.33 114.285 -170.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -66.41 115.94 6.87 Favored 'General case' 0 C--N 1.347 0.486 0 N-CA-C 108.521 -0.918 . . . . 74.21 108.521 172.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.588 HG21 ' HB1' ' B' ' 66' ' ' ALA . 57.6 t -104.27 134.86 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.36 0.6 . . . . 74.52 111.015 -172.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -106.39 103.25 12.67 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.056 -1.461 . . . . 73.24 107.056 169.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.606 HD12 HD21 ' B' ' 128' ' ' LEU . 23.8 tp -85.48 147.05 26.65 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 107.855 -1.165 . . . . 74.25 107.855 171.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.515 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 12.0 t0 -155.27 154.09 31.61 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.337 -0.616 . . . . 70.2 109.337 -176.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.515 HD11 HG13 ' B' ' 131' ' ' VAL . 97.8 mt -124.92 130.54 52.56 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.341 0.657 . . . . 63.1 110.406 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -127.93 146.94 50.48 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.259 1.424 . . . . 72.54 108.048 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 7.8 t -145.32 127.42 15.63 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.004 0.431 . . . . 72.53 110.604 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.72 116.4 10.24 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.992 -1.114 . . . . 70.55 107.992 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.488 ' HB3' ' HA ' ' B' ' 58' ' ' VAL . 56.1 p -144.69 165.07 29.1 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.094 0.405 . . . . 62.23 112.094 -173.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 67.1 p -160.96 153.05 20.01 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.337 -0.847 . . . . 65.34 110.21 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -82.57 115.03 21.36 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.875 -0.787 . . . . 72.53 108.875 166.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 pp -122.26 24.26 9.47 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.283 0.633 . . . . 74.31 110.746 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . 0.619 ' HB2' ' HB ' ' B' ' 55' ' ' VAL . . . -169.17 169.0 9.59 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.585 0.754 . . . . 72.44 111.548 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . 0.416 ' O ' HG23 ' B' ' 55' ' ' VAL . 2.8 m-20 -60.59 95.43 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.392 1.077 . . . . 73.3 112.572 -175.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 56.56 25.24 9.62 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.417 1.087 . . . . 75.54 111.866 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.619 ' HB ' ' HB2' ' B' ' 52' ' ' ALA . 89.0 t -116.93 111.79 36.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-N 114.322 -1.308 . . . . 74.4 108.117 177.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.588 ' HB3' HD11 ' B' ' 86' ' ' ILE . 8.2 t80 -101.41 138.64 38.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.099 1.36 . . . . 74.52 109.275 -174.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -116.41 114.22 23.95 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.467 -1.308 . . . . 74.02 107.467 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.488 ' HA ' ' HB3' ' B' ' 48' ' ' SER . 2.7 p -108.72 129.18 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 122.766 0.427 . . . . 75.34 110.993 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.473 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.3 t -102.33 108.48 24.07 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 N-CA-C 107.777 -1.194 . . . . 73.25 107.777 171.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 56.8 tp -95.11 102.58 14.4 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 108.516 -0.92 . . . . 73.33 108.516 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -94.05 117.88 30.73 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.588 -0.733 . . . . 75.33 109.241 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 54.1 t -105.02 128.3 58.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 108.706 -0.85 . . . . 75.34 108.706 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 14.9 m -104.88 138.4 41.19 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.998 0.519 . . . . 73.23 110.026 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.494 HG23 HD12 ' B' ' 114' ' ' ILE . 58.2 t -133.38 112.31 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.191 -1.04 . . . . 72.45 108.191 173.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.401 HG23 ' CD2' ' B' ' 75' ' ' LEU . 87.0 m -111.48 105.64 14.29 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.25 -1.019 . . . . 74.32 108.25 174.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.588 ' HB1' HG21 ' B' ' 40' ' ' VAL . . . -110.89 150.54 29.05 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.871 0.367 . . . . 74.04 110.145 -178.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.495 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 30.7 p -144.69 130.7 19.36 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.424 -0.807 . . . . 74.42 111.015 -171.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.659 HD13 HG23 ' B' ' 31' ' ' VAL . 85.8 mt -94.35 98.45 10.91 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.053 -1.092 . . . . 73.15 108.053 173.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.1 -122.55 11.48 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 115.2 -0.909 . . . . 74.44 113.992 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -82.1 2.66 30.25 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.523 0.729 . . . . 74.1 112.764 -172.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.555 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 12.4 pt-20 -143.57 159.52 42.29 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.843 0.457 . . . . 73.31 110.89 -171.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 40.0 m -69.62 133.54 47.7 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.256 -0.884 . . . . 71.41 110.325 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.495 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -84.75 -60.94 1.91 Allowed 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.03 -1.47 . . . . 62.21 107.03 172.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -154.06 162.74 40.99 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.749 -1.114 . . . . 73.21 111.541 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.401 ' CD2' HG23 ' B' ' 65' ' ' THR . 35.3 mt -123.47 112.25 17.28 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 106.129 -1.804 . . . . 74.54 106.129 169.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.548 ' SG ' ' HB2' ' B' ' 117' ' ' MET . 40.5 t -124.54 118.34 26.36 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.364 -0.606 . . . . 74.01 109.364 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -140.2 128.66 22.75 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.564 0.745 . . . . 72.51 109.208 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.511 HG12 HD11 ' B' ' 21' ' ' ILE . 42.4 t -125.5 150.7 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.801 0.84 . . . . 73.24 110.125 -175.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.416 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 22.4 mt-30 -114.94 110.48 19.69 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.56 -0.533 . . . . 73.23 109.56 171.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.458 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.1 tp-100 -99.77 102.84 14.4 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.397 -0.594 . . . . 73.53 109.397 170.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.46 160.46 29.19 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 111.011 -0.836 . . . . 60.24 111.011 174.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.66 126.54 1.62 Allowed Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.916 -0.474 . . . . 62.43 111.916 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.483 HG13 ' HE1' ' B' ' 17' ' ' TYR . 57.9 mt -88.05 122.56 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 108.224 -1.028 . . . . 75.31 108.224 175.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -135.63 140.62 44.7 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.554 0.741 . . . . 72.54 110.067 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.431 ' HG ' HG21 ' B' ' 55' ' ' VAL . 21.2 m -88.72 118.69 28.58 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.458 0.703 . . . . 51.12 109.104 170.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.588 HD11 ' HB3' ' B' ' 56' ' ' TYR . 4.0 mp -116.94 110.59 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.048 -1.464 . . . . 75.54 107.048 175.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.88 172.06 19.0 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.959 0.504 . . . . 73.42 111.14 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.02 -60.46 0.82 Allowed Glycine 0 C--N 1.344 1.012 0 N-CA-C 111.072 -0.811 . . . . 63.21 111.072 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -68.53 169.84 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 123.446 0.698 . . . . 71.43 111.876 173.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -154.52 177.9 10.67 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.319 0.648 . . . . 74.11 110.838 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.34 -126.68 8.32 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-N 115.703 -0.68 . . . . 62.13 114.145 172.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.6 m -89.73 -47.59 7.82 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.788 0.835 . . . . 72.1 109.946 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -64.33 -19.02 65.17 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.379 -1.282 . . . . 74.54 112.152 -169.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -62.53 -37.13 84.89 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.735 0.814 . . . . 74.41 112.015 177.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.97 -13.27 59.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.414 0.686 . . . . 74.14 112.466 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -63.72 -32.16 73.57 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.843 0.457 . . . . 71.23 109.929 170.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -64.45 -49.47 71.34 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.51 0.724 . . . . 74.34 111.428 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.478 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.4 pp -76.95 -32.02 57.01 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.066 -0.516 . . . . 74.33 111.827 -174.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.89 -22.08 37.26 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 123.26 0.35 . . . . 64.31 113.859 -173.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.01 -59.35 1.74 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.091 0.556 . . . . 72.53 111.516 -173.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -67.23 -42.77 83.49 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.224 0.61 . . . . 74.13 111.662 -172.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.478 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 63.3 m -68.43 -49.07 32.93 Favored Pre-proline 0 CA--C 1.566 1.575 0 N-CA-C 113.413 0.894 . . . . 70.31 113.413 -175.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 35.6 Cg_exo -64.72 -28.07 60.15 Favored 'Trans proline' 0 C--N 1.39 2.757 0 C-N-CA 121.851 1.701 . . . . 74.41 113.245 177.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -58.36 -34.43 70.66 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 123.216 0.606 . . . . 73.24 111.94 174.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 58.2 mt -68.49 -35.97 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 115.387 -0.824 . . . . 75.02 110.469 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 93.8 mt -88.5 -31.65 18.61 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.312 0.856 . . . . 73.52 113.312 -170.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -53.26 -43.7 95.69 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 113.855 1.057 . . . . 73.33 113.855 -173.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -52.18 -42.41 59.75 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.893 2.395 . . . . 73.14 114.84 174.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.458 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 86.0 m-85 -68.62 -43.59 76.04 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.731 0.412 . . . . 73.11 110.749 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.14 -43.04 99.51 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.407 -0.815 . . . . 75.44 110.661 175.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.447 ' HA ' HD12 ' B' ' 128' ' ' LEU . 28.8 ttt-85 -57.74 -53.9 53.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.14 1.376 . . . . 70.21 110.902 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -66.03 -39.17 89.98 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.247 0.967 . . . . 72.53 110.669 -175.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.532 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 7.4 t -70.25 -34.26 72.62 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.869 -0.605 . . . . 71.53 110.989 -176.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.558 HD13 HD13 ' B' ' 128' ' ' LEU . 67.7 mt -60.47 -53.46 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.626 0.771 . . . . 73.3 109.652 169.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.449 HG22 ' OG ' ' C' ' 119' ' ' SER . 17.0 m -60.14 -28.56 67.99 Favored 'General case' 0 CA--C 1.551 1.011 0 O-C-N 123.807 0.692 . . . . 73.32 111.332 -177.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 29.7 m -64.47 -52.04 59.97 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 123.543 0.737 . . . . 53.53 110.656 171.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.548 ' HB2' ' SG ' ' B' ' 76' ' ' CYS . 25.2 mmt -63.21 -33.13 74.81 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.049 0.54 . . . . 75.54 111.345 -177.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.576 HG22 HD22 ' B' ' 126' ' ' LEU . 92.1 t -72.07 -38.38 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.84 1.256 . . . . 75.51 110.902 176.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 47.2 t -66.54 -34.7 78.5 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.314 -0.857 . . . . 65.13 110.53 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.547 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 74.6 mtt-85 -71.37 -37.52 71.61 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 114.788 -1.097 . . . . 74.44 109.408 177.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.49 -9.73 78.33 Favored Glycine 0 C--N 1.355 1.587 0 O-C-N 123.522 0.514 . . . . 74.5 112.69 172.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 3.2 m 69.93 20.81 6.49 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 125.487 1.515 . . . . 72.23 111.721 171.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -78.24 159.67 74.81 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.524 0.73 . . . . 75.32 111.169 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.91 172.07 0.88 Allowed 'Trans proline' 0 C--N 1.387 2.569 0 C-N-CA 123.271 2.647 . . . . 71.33 114.558 174.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.727 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 56.3 tp60 -62.75 132.51 52.47 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.482 0.919 . . . . 73.43 113.482 -166.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.576 HD22 HG22 ' B' ' 118' ' ' VAL . 59.6 tp -126.71 106.43 9.37 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.681 0.792 . . . . 74.3 109.031 176.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -112.59 119.37 37.9 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 107.639 -1.245 . . . . 64.13 107.639 170.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.606 HD21 HD12 ' B' ' 42' ' ' LEU . 31.0 mt -77.67 145.95 36.34 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 122.99 0.182 . . . . 73.14 111.39 -176.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.96 128.33 91.8 Favored Pre-proline 0 CA--C 1.546 0.812 0 O-C-N 124.366 1.041 . . . . 75.1 111.845 -175.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.495 ' HG3' HD11 ' D' ' 16' ' ' ILE . 51.3 Cg_endo -68.54 87.31 0.42 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.897 2.398 . . . . 72.35 112.033 176.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.515 HG13 HD11 ' B' ' 44' ' ' LEU . 2.5 p -90.49 109.8 21.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 108.291 -1.003 . . . . 75.15 108.291 172.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 37.0 t30 . . . . . 0 CA--C 1.533 0.289 0 CA-C-N 114.726 -1.124 . . . . 74.21 108.216 178.066 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.509 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 64.0 t80 . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 108.539 -0.912 . . . . 73.42 108.539 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -135.79 125.21 24.93 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.275 -0.639 . . . . 73.53 109.275 -177.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 45.4 mt -77.16 128.16 38.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 109.466 -0.568 . . . . 70.32 109.466 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -88.69 -49.74 6.67 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.826 -0.805 . . . . 73.32 108.826 174.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.556 ' HB2' ' HG2' ' A' ' 125' ' ' GLN . 0.0 OUTLIER -174.58 149.48 1.27 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.221 1.008 . . . . 74.53 110.245 176.27 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.461 HG22 HD21 ' C' ' 106' ' ' LEU . 78.0 mt -120.57 131.59 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.503 1.121 . . . . 74.24 108.299 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.569 ' HB3' HG22 ' D' ' 122' ' ' THR . 20.8 p90 -164.44 172.19 13.7 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 121.422 0.63 . . . . 72.32 112.17 -167.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.1 p -100.38 120.3 39.76 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.268 -0.878 . . . . 72.35 109.248 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -69.29 -48.75 60.72 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 106.979 -1.489 . . . . 74.25 106.979 165.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.627 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.3 t70 -134.56 145.59 48.85 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 113.655 -1.611 . . . . 65.15 110.663 -173.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.5 mt -137.64 149.17 25.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 126.717 2.007 . . . . 74.51 105.714 172.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.1 t -156.95 149.58 23.45 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.829 -0.434 . . . . 75.35 109.829 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -155.98 129.59 8.39 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 107.265 -1.383 . . . . 74.31 107.265 174.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -132.15 132.91 43.66 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.681 -0.859 . . . . 75.41 108.681 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.33 80.55 22.6 Favored Pre-proline 0 CA--C 1.549 0.93 0 N-CA-C 106.625 -1.62 . . . . 73.13 106.625 170.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -65.25 -41.19 16.88 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.82 2.347 . . . . 71.42 111.702 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -94.82 18.37 11.92 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 114.398 -1.274 . . . . 74.1 110.779 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.41 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -41.98 -61.02 1.67 Allowed Pre-proline 0 C--N 1.369 1.427 0 C-N-CA 124.974 1.31 . . . . 75.25 114.097 -171.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -61.52 -39.48 54.89 Favored 'Trans proline' 0 C--N 1.39 2.715 0 C-N-CA 121.66 1.573 . . . . 75.31 112.15 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.465 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 85.2 t60 -71.4 -30.63 66.32 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 115.44 -0.8 . . . . 74.41 112.385 -178.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.632 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.0 p -82.96 -15.88 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 O-C-N 121.794 -0.566 . . . . 73.03 111.836 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -75.45 -20.76 58.64 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.112 0.565 . . . . 73.33 112.227 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 20.8 pt20 -94.07 8.69 40.61 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.493 0.717 . . . . 64.43 110.944 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.666 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 1.2 tppp? -99.12 161.76 13.44 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.881 0.872 . . . . 74.41 110.988 -171.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -71.49 121.79 19.29 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.403 0.681 . . . . 75.04 109.638 172.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -83.74 93.39 7.93 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.22 0.608 . . . . 74.45 111.016 -174.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -145.43 78.98 11.77 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.06 0.944 . . . . 71.22 108.494 173.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -82.45 141.33 11.2 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.695 2.263 . . . . 75.23 113.179 -173.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -87.38 88.43 7.68 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.012 -1.477 . . . . 73.44 107.012 163.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 40.3 t -83.87 111.96 20.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-N 115.117 -0.947 . . . . 74.53 110.078 -175.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.512 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 13.7 tmtt? -91.1 101.08 13.83 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 107.85 -1.167 . . . . 73.21 107.85 172.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.9 tt -87.61 121.69 30.36 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.069 -1.826 . . . . 74.44 106.069 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -118.31 138.35 52.45 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.428 -0.953 . . . . 72.3 108.428 -175.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.484 HD21 HD23 ' C' ' 60' ' ' LEU . 25.7 mt -132.02 111.84 11.86 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.852 0.834 . . . . 74.22 110.298 178.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -127.5 122.43 33.34 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.904 1.682 . . . . 72.55 107.268 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -123.16 125.86 45.93 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 120.99 0.424 . . . . 71.3 110.057 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.16 160.51 16.86 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.218 1.007 . . . . 62.45 109.384 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 31.1 p -151.94 146.06 25.33 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.308 0.643 . . . . 60.25 110.27 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 54.1 p -146.99 135.9 22.31 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.694 0.798 . . . . 72.14 109.351 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -78.32 117.08 19.22 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 108.856 -0.794 . . . . 72.24 108.856 175.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.679 HD12 ' HB2' ' C' ' 57' ' ' GLU . 30.8 mt -85.54 -33.28 21.79 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.899 0.88 . . . . 74.25 110.478 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.96 -174.48 3.34 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.408 1.083 . . . . 73.11 109.6 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.23 117.21 6.25 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.464 -0.789 . . . . 73.12 109.288 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 70.35 11.92 7.48 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.884 1.274 . . . . 75.12 112.044 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 30.4 t -118.32 116.27 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.196 -0.668 . . . . 75.01 109.196 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -127.46 125.12 39.95 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.017 0.927 . . . . 72.14 108.672 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.679 ' HB2' HD12 ' C' ' 51' ' ' LEU . 34.8 tt0 -85.8 142.14 29.15 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.964 -0.754 . . . . 71.1 108.964 169.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 60.1 t -128.8 122.84 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 107.817 -1.179 . . . . 64.5 107.817 167.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 68.2 t -109.64 127.56 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 109.283 -0.636 . . . . 74.12 109.283 173.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.484 HD23 HD21 ' C' ' 44' ' ' LEU . 0.1 OUTLIER -107.38 100.99 10.38 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 107.738 -1.208 . . . . 64.23 107.738 -176.544 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -82.22 106.12 13.85 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.455 0.702 . . . . 75.13 109.16 172.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.465 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.6 t -102.88 124.7 57.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.417 -1.327 . . . . 73.11 107.417 169.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 12.5 m -125.34 113.24 17.31 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.526 0.679 . . . . 62.2 109.486 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.479 HG21 HD12 ' C' ' 114' ' ' ILE . 99.5 t -102.49 111.07 30.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 124.482 1.113 . . . . 72.41 109.132 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.515 HG23 HD22 ' C' ' 75' ' ' LEU . 6.8 m -104.35 108.62 20.12 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 109.121 -0.696 . . . . 71.21 109.121 176.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.9 100.63 10.18 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.642 -0.873 . . . . 72.32 108.642 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 40.5 m -129.03 131.76 47.4 Favored 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 109.038 -0.727 . . . . 75.32 109.038 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 12.2 mt -84.91 26.51 0.83 Allowed 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 125.137 1.375 . . . . 73.21 111.3 -175.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.62 -109.49 1.06 Allowed Glycine 0 C--N 1.348 1.229 0 N-CA-C 109.486 -1.446 . . . . 60.31 109.486 -170.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.59 -31.56 16.64 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.215 -0.661 . . . . 74.21 109.215 169.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.666 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 10.0 tp10 -69.37 104.25 2.22 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 124.065 0.946 . . . . 72.11 109.964 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.1 m -78.55 123.95 27.63 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 109.384 -0.598 . . . . 72.43 109.384 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.632 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -77.42 -57.61 3.73 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.091 -1.077 . . . . 72.33 108.091 176.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . 0.438 ' HZ ' HD23 ' C' ' 126' ' ' LEU . 49.5 p90 -156.52 154.97 31.16 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.846 -1.07 . . . . 75.41 111.268 175.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.515 HD22 HG23 ' C' ' 65' ' ' THR . 2.5 tm? -113.09 145.47 40.85 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 106.094 -1.817 . . . . 74.43 106.094 163.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.437 ' SG ' HG21 ' C' ' 114' ' ' ILE . 49.6 t -151.68 125.16 8.88 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.989 -0.745 . . . . 74.31 108.989 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -131.76 136.71 47.79 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.331 -0.618 . . . . 74.15 109.331 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.504 HG12 ' HA ' ' C' ' 110' ' ' ALA . 22.7 t -132.13 113.92 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.658 -0.867 . . . . 74.3 108.658 174.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.627 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.3 mt-30 -91.73 87.96 6.5 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.017 0.927 . . . . 64.14 109.115 172.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -79.45 96.9 6.19 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.402 1.081 . . . . 53.11 110.337 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.77 144.54 22.15 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.396 -0.366 . . . . 75.44 112.694 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.407 ' HA3' HD23 ' C' ' 106' ' ' LEU . . . -147.24 128.11 2.86 Favored Glycine 0 CA--C 1.503 -0.713 0 N-CA-C 111.096 -0.802 . . . . 72.42 111.096 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 27.3 mm -95.09 123.54 47.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.248 -1.019 . . . . 75.14 108.248 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -132.23 118.68 19.83 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.517 0.727 . . . . 71.01 109.986 -173.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 56.9 m -76.41 100.8 5.32 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.464 -0.569 . . . . 71.43 109.464 170.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.517 HG21 ' HE2' ' C' ' 94' ' ' MET . 18.4 mt -114.13 131.6 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.239 0.615 . . . . 70.44 110.042 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.4 169.4 23.23 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.163 0.985 . . . . 65.52 109.956 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.53 -19.2 41.78 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.936 -0.574 . . . . 75.44 113.452 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.408 HD11 ' HE2' ' C' ' 94' ' ' MET . 22.3 pt -111.03 170.5 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.051 0.54 . . . . 74.0 111.135 -175.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -166.21 149.51 7.36 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.905 0.482 . . . . 74.33 110.7 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.81 -113.15 5.06 Favored Glycine 0 C--N 1.354 1.547 0 CA-C-N 115.872 -0.604 . . . . 63.11 113.43 170.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 34.6 p -61.19 -43.43 98.89 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.858 0.863 . . . . 75.32 111.281 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -59.24 -42.7 91.72 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 114.965 -1.016 . . . . 74.54 110.739 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.517 ' HE2' HG21 ' C' ' 86' ' ' ILE . 6.7 tpt -68.48 -43.63 76.52 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.845 -1.07 . . . . 65.23 110.573 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.75 -36.49 79.04 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.472 0.709 . . . . 71.31 111.318 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -77.32 -31.7 54.78 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.102 0.408 . . . . 74.03 112.102 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.42 ' SG ' HD12 ' C' ' 86' ' ' ILE . 24.7 t -66.36 -43.83 84.92 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.688 -0.856 . . . . 73.14 108.688 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 43.3 mt -78.69 -28.3 45.21 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.374 -1.285 . . . . 75.44 111.104 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.61 -27.97 52.92 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 115.701 -0.681 . . . . 65.15 114.14 -172.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.422 ' HA ' ' HB3' ' C' ' 133' ' ' PHE . . . -154.83 -48.75 0.09 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.172 1.175 . . . . 72.44 114.172 -163.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -62.73 -51.86 65.52 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.686 0.616 . . . . 64.41 111.465 -173.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.509 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 57.6 m -66.52 -50.05 48.86 Favored Pre-proline 0 CA--C 1.56 1.351 0 CA-C-O 118.271 -0.871 . . . . 62.22 111.502 177.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 85.4 Cg_exo -51.56 -30.99 38.0 Favored 'Trans proline' 0 C--N 1.399 3.227 0 C-N-CA 123.029 2.486 . . . . 61.41 114.898 172.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -65.35 -43.51 90.63 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.06 0.544 . . . . 75.24 109.717 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.458 HD13 ' NH1' ' A' ' 111' ' ' ARG . 35.1 mm -72.74 -29.12 28.99 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 CA-C-N 115.663 -0.699 . . . . 75.32 110.462 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.461 HD21 HG22 ' C' ' 16' ' ' ILE . 89.0 mt -77.62 -29.68 51.96 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.815 0.846 . . . . 74.45 111.883 178.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -58.78 -50.19 89.37 Favored Pre-proline 0 N--CA 1.482 1.173 0 CA-C-O 117.448 -1.263 . . . . 74.12 114.279 -168.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.93 -32.54 92.63 Favored 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 121.832 1.688 . . . . 62.22 112.75 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -68.42 -48.26 65.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.414 0.685 . . . . 75.41 110.425 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.504 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -62.57 -35.49 79.65 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 115.952 -0.567 . . . . 75.5 111.149 176.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -63.07 -54.85 31.51 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.313 1.445 . . . . 71.31 111.374 -177.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -66.98 -30.13 70.17 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.305 0.642 . . . . 71.1 110.153 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 14.0 t -68.43 -34.5 76.09 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.456 0.702 . . . . 73.21 111.394 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.479 HD12 HG21 ' C' ' 64' ' ' VAL . 96.3 mt -74.46 -50.56 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.478 0.711 . . . . 75.4 110.298 174.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 9.1 m -66.34 -28.39 68.63 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.26 0.624 . . . . 62.44 111.602 -173.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.489 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 79.5 p -66.59 -45.36 79.48 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 109.13 -0.693 . . . . 61.54 109.13 172.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.593 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.42 -40.65 78.79 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.421 1.088 . . . . 73.52 112.478 176.384 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 62.8 t -64.73 -40.83 90.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.29 0.636 . . . . 75.13 110.609 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.449 ' OG ' HG22 ' B' ' 115' ' ' THR . 28.2 t -67.02 -34.63 78.15 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.05 0.94 . . . . 72.01 112.016 175.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' C' ' 116' ' ' SER . 66.0 mtt-85 -65.73 -36.3 83.19 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.237 0.615 . . . . 74.34 109.502 177.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.61 11.21 62.2 Favored Glycine 0 C--N 1.356 1.668 0 CA-C-O 119.284 -0.731 . . . . 65.13 113.322 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.446 HG22 ' HB3' ' D' ' 17' ' ' TYR . 67.6 p 59.09 21.76 9.77 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 126.139 1.776 . . . . 75.23 114.648 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -85.37 157.21 59.11 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 108.385 -0.969 . . . . 73.31 108.385 170.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.727 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 30.1 Cg_endo -61.6 168.46 8.28 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.831 2.354 . . . . 75.42 113.966 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -62.01 110.73 1.66 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.749 -1.114 . . . . 74.14 111.532 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.438 HD23 ' HZ ' ' C' ' 74' ' ' PHE . 9.5 mp -106.3 87.03 2.46 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.343 -1.354 . . . . 75.4 107.343 169.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -90.03 109.17 20.23 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.205 -1.035 . . . . 74.14 108.205 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 64.1 mt -61.04 131.29 50.13 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.529 0.732 . . . . 75.31 110.758 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.1 146.92 98.85 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 118.786 -0.626 . . . . 64.51 110.454 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -48.85 99.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.776 2.317 . . . . 75.32 112.7 172.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 58.0 t -97.4 109.03 22.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 107.494 -1.299 . . . . 74.41 107.494 172.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -86.11 101.3 12.85 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.669 -0.863 . . . . 75.22 108.669 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . 0.422 ' HB3' ' HA ' ' C' ' 100' ' ' ALA . 73.4 m-85 -57.18 -35.62 69.81 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.011 0.925 . . . . 74.21 111.347 176.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -68.46 -25.91 65.23 Favored 'General case' 0 C--O 1.219 -0.533 0 C-N-CA 123.949 0.9 . . . . 65.52 111.942 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.55 -40.54 56.68 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.031 0.532 . . . . 74.35 110.243 171.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 79.0 mt -65.65 -36.0 82.41 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.407 -0.815 . . . . 74.25 111.096 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 2.1 t80 . . . . . 0 C--O 1.211 -0.939 0 CA-C-N 115.878 -0.601 . . . . 74.23 110.265 179.376 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 C--O 1.242 0.666 0 CA-C-O 120.983 0.421 . . . . 73.34 110.133 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.442 ' HD2' HG21 ' D' ' 86' ' ' ILE . 80.3 t80 -132.83 107.91 8.63 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.178 -1.416 . . . . 73.11 107.178 176.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -128.91 116.06 18.81 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.994 0.918 . . . . 74.41 108.658 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.437 HD11 HG22 ' D' ' 105' ' ' ILE . 10.7 mt -82.75 130.45 35.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 108.303 -0.999 . . . . 74.32 108.303 174.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -94.82 -34.65 12.39 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 123.621 0.575 . . . . 72.11 110.429 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -167.76 141.43 3.43 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.323 0.389 . . . . 75.1 111.015 -173.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.495 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.7 mp -122.98 134.92 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 107.292 -1.373 . . . . 75.13 107.292 171.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.446 ' HB3' HG22 ' C' ' 122' ' ' THR . 36.4 p90 -161.54 176.42 11.07 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.535 0.683 . . . . 75.43 112.372 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 53.6 p -103.47 127.22 50.9 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.422 -0.808 . . . . 75.42 109.357 173.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.442 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 32.5 mtpt -97.39 -19.22 18.62 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.027 0.531 . . . . 75.32 109.823 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.6 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 31.7 t70 -158.52 144.29 16.78 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.836 0.855 . . . . 75.33 109.876 177.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.593 HG23 ' HE1' ' C' ' 117' ' ' MET . 81.2 mt -148.59 142.91 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.624 1.569 . . . . 75.04 107.528 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.9 t -154.78 134.43 12.77 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.45 0.7 . . . . 64.53 109.419 164.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 88.8 t80 -119.75 133.92 55.43 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 105.827 -1.916 . . . . 74.55 105.827 166.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -138.69 120.59 15.46 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.349 0.659 . . . . 75.1 109.518 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.561 ' HB2' ' HB1' ' D' ' 28' ' ' ALA . . . -119.03 85.04 28.28 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 107.527 -1.286 . . . . 72.25 107.527 175.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -71.9 -29.55 15.11 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.873 2.382 . . . . 72.32 112.801 -168.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -115.27 16.58 16.83 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.077 0.951 . . . . 75.12 110.74 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.561 ' HB1' ' HB2' ' D' ' 25' ' ' ALA . . . -42.96 -58.03 4.4 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 114.887 1.44 . . . . 74.0 114.887 -161.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.31 -26.18 17.73 Favored 'Trans proline' 0 C--N 1.378 2.124 0 CA-C-N 122.356 1.877 . . . . 74.51 113.992 -175.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -74.95 -36.68 62.08 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.848 0.859 . . . . 73.12 109.887 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.472 HG13 ' HA ' ' D' ' 28' ' ' ALA . 9.8 p -83.91 -16.89 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-N 115.94 -0.573 . . . . 73.11 111.683 -172.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -68.15 -13.06 61.94 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 111.741 0.275 . . . . 74.03 111.741 175.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -69.48 -3.74 15.81 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.293 0.637 . . . . 74.52 111.3 174.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.599 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 96.5 mttt -110.69 102.88 11.4 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.276 1.43 . . . . 75.21 109.505 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -99.98 84.56 2.89 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.387 0.675 . . . . 64.04 111.125 -174.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -156.82 172.81 17.97 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 114.68 -1.145 . . . . 74.4 108.507 166.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -68.15 120.18 72.67 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-O 118.251 -0.88 . . . . 74.41 108.744 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.42 ' O ' HG21 ' D' ' 40' ' ' VAL . 81.5 Cg_exo -51.02 134.76 43.42 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 122.892 2.395 . . . . 64.41 112.124 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -69.34 110.52 4.7 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.879 -1.526 . . . . 73.43 106.879 170.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.528 HG13 HG13 ' D' ' 64' ' ' VAL . 38.4 t -107.05 108.86 26.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.84 0 CA-C-N 115.759 -0.655 . . . . 74.22 109.907 -173.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -87.95 109.27 19.68 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.603 -0.888 . . . . 73.53 108.603 168.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.409 HD11 ' O ' ' D' ' 63' ' ' THR . 58.9 tp -97.18 141.05 30.77 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.273 1.029 . . . . 62.22 109.228 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.606 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 21.5 t70 -123.94 131.9 53.64 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.385 -1.339 . . . . 74.24 107.385 173.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.418 ' CD2' HG21 ' D' ' 62' ' ' VAL . 31.9 mt -119.65 129.9 54.8 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.095 -0.706 . . . . 75.14 109.095 174.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.595 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 30.7 t70 -138.07 140.53 40.06 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 107.7 -1.222 . . . . 72.32 107.7 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 3.8 t -104.2 148.17 26.62 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.242 -0.651 . . . . 64.43 109.242 -176.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.96 151.22 33.0 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.812 0.845 . . . . 70.33 109.423 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 10.1 p . . . . . 0 C--O 1.243 0.759 0 C-N-CA 123.904 0.882 . . . . 75.11 109.235 177.968 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 . . . . . 0 N--CA 1.486 1.353 0 N-CA-C 113.639 0.978 . . . . 72.33 113.639 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 50.9 t -134.39 117.63 24.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 108.767 -0.827 . . . . 74.2 108.767 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -131.98 132.74 43.74 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 107.016 -1.476 . . . . 75.41 107.016 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -85.83 115.35 23.42 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 107.357 -1.349 . . . . 75.14 107.357 171.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 70.3 t -99.97 130.55 48.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.643 -1.162 . . . . 74.33 108.687 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.545 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 16.5 t -111.85 146.78 16.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.879 -0.786 . . . . 74.25 108.879 176.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.41 119.87 37.01 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.581 -1.266 . . . . 74.25 107.581 176.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.595 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 2.9 tmm_? -95.4 96.21 8.96 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 108.042 -1.095 . . . . 74.53 108.042 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.418 HG21 ' CD2' ' D' ' 44' ' ' LEU . 54.0 t -101.67 125.12 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.574 -0.899 . . . . 75.0 108.574 176.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 50.0 m -121.66 131.07 53.9 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 123.285 0.634 . . . . 72.12 109.526 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.528 HG13 HG13 ' D' ' 40' ' ' VAL . 83.7 t -113.86 127.06 71.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.778 -0.823 . . . . 73.43 108.778 172.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 22.4 m -119.61 92.92 3.91 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.336 -1.727 . . . . 73.41 106.336 168.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.54 143.59 30.53 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 109.652 -0.499 . . . . 71.21 109.652 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 77.9 p -147.7 137.3 22.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.238 0.542 . . . . 63.22 111.158 -173.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 26.8 mt -108.73 110.5 21.91 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.404 -1.332 . . . . 74.5 107.404 171.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.98 -134.98 20.85 Favored Glycine 0 C--N 1.342 0.909 0 O-C-N 123.589 0.556 . . . . 72.11 113.302 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.24 6.05 46.71 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.554 0.741 . . . . 73.33 112.179 -176.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.599 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 14.3 pt-20 -130.07 167.86 17.65 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.074 0.55 . . . . 74.31 110.602 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 66.0 m -71.46 138.67 49.2 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.454 -0.794 . . . . 72.33 111.217 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.77 -63.11 1.33 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.239 -1.393 . . . . 65.4 107.239 169.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -158.56 161.08 37.26 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.652 -1.158 . . . . 74.11 110.951 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 68.8 mt -131.8 112.64 12.67 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.458 1.503 . . . . 73.12 107.151 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.718 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 49.2 t -131.94 106.23 7.92 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 122.583 0.353 . . . . 72.25 110.378 -168.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -129.0 125.89 38.35 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.428 0.691 . . . . 72.22 109.657 -173.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 88.2 t -132.6 115.39 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.114 0.965 . . . . 73.24 109.822 -174.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.6 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 2.3 mp0 -90.03 87.31 6.85 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.892 0.877 . . . . 72.0 109.051 175.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -81.81 102.9 11.11 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.691 -1.14 . . . . 75.11 109.346 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -111.64 147.24 17.98 Favored Glycine 0 N--CA 1.475 1.236 0 CA-C-O 120.157 -0.246 . . . . 62.23 112.517 -178.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.91 151.91 23.1 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 117.133 0.467 . . . . 62.12 112.252 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 3.0 mp -89.74 118.22 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 108.707 -0.849 . . . . 71.51 108.707 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -115.29 150.08 36.81 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.943 0.897 . . . . 74.43 110.165 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 33.1 t -115.76 104.73 11.95 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.992 0.917 . . . . 63.11 109.152 175.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.447 HD13 HD23 ' D' ' 98' ' ' LEU . 47.2 pt -115.03 130.28 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.153 0.581 . . . . 73.53 109.838 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.87 165.29 34.98 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.587 0.755 . . . . 64.34 109.767 175.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.69 23.39 75.24 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-O 119.692 -0.504 . . . . 74.43 114.315 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.466 HG23 ' H ' ' D' ' 90' ' ' GLU . 0.1 OUTLIER -103.1 168.81 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 108.733 -0.84 . . . . 73.22 108.733 172.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.466 ' H ' HG23 ' D' ' 89' ' ' ILE . 8.8 pt-20 -135.1 178.17 7.24 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.02 0.928 . . . . 75.23 111.08 -178.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.79 -138.77 42.47 Favored Glycine 0 C--N 1.358 1.797 0 CA-C-N 115.676 -0.693 . . . . 75.11 113.068 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 65.5 p -88.31 -20.37 25.48 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.167 0.587 . . . . 65.34 110.284 170.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.739 ' HA ' ' HB3' ' D' ' 96' ' ' HIS . 25.7 tp60 -59.69 -21.42 60.56 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.186 1.395 . . . . 71.43 112.295 -175.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.463 ' HA ' ' HB ' ' D' ' 89' ' ' ILE . 16.8 ptp -57.51 -51.04 71.07 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.435 0.694 . . . . 71.12 111.856 172.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.23 -22.77 26.72 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.943 0.497 . . . . 72.42 111.771 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . 0.739 ' HB3' ' HA ' ' D' ' 93' ' ' GLN . 19.6 t-80 -75.02 -11.27 60.06 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.184 0.593 . . . . 64.23 110.094 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 43.7 t -72.99 -51.2 19.17 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.966 0.506 . . . . 74.52 110.447 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.516 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 3.2 pp -77.64 -19.03 56.14 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.037 0.384 . . . . 73.11 112.037 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.35 -0.82 64.91 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-O 119.817 -0.435 . . . . 73.35 113.345 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.14 -66.78 0.39 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.903 0.481 . . . . 74.22 111.212 -176.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -66.84 -43.33 83.97 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.436 0.294 . . . . 72.43 111.78 -173.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.516 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 75.6 m -63.74 -47.44 81.71 Favored Pre-proline 0 CA--C 1.567 1.629 0 CA-C-O 118.289 -0.862 . . . . 75.12 112.591 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.518 ' HA ' HD12 ' D' ' 106' ' ' LEU . 27.9 Cg_exo -62.51 -28.53 77.75 Favored 'Trans proline' 0 C--N 1.399 3.233 0 C-N-CA 122.153 1.902 . . . . 75.43 112.964 170.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -67.91 -32.86 73.63 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.616 0.367 . . . . 75.44 111.068 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.437 HG22 HD11 ' D' ' 13' ' ' ILE . 48.0 mm -65.58 -34.38 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.149 0.58 . . . . 74.2 110.241 173.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' D' ' 103' ' ' PRO . 29.5 mt -77.81 -18.27 56.55 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.381 -0.827 . . . . 72.31 111.933 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.04 -41.3 10.74 Favored Pre-proline 0 N--CA 1.486 1.358 0 N-CA-C 113.91 1.078 . . . . 71.2 113.91 -173.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -50.65 -42.91 48.34 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.208 1.939 . . . . 73.43 112.721 169.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . 0.451 ' OH ' ' HB3' ' B' ' 130' ' ' PRO . 93.2 m-85 -79.49 -27.29 41.47 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.634 0.774 . . . . 74.3 111.732 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.06 -49.5 67.41 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.049 -0.722 . . . . 75.24 109.049 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -67.13 -33.37 75.29 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 113.868 -1.515 . . . . 75.34 110.864 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -53.92 -55.79 23.73 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 124.007 0.923 . . . . 70.24 110.268 174.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.406 ' O ' ' HG3' ' D' ' 117' ' ' MET . 47.2 t -62.99 -47.52 82.79 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 114.225 -1.352 . . . . 74.32 111.182 -177.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.608 HG22 ' SG ' ' D' ' 76' ' ' CYS . 68.5 mt -60.95 -61.74 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.324 0.65 . . . . 75.41 111.576 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 22.3 m -51.97 -40.42 60.86 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 124.198 0.937 . . . . 73.42 111.455 -175.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 37.5 t -60.41 -50.77 72.27 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 114.343 -1.299 . . . . 74.42 110.751 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.718 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 72.4 mtm -66.54 -30.85 71.25 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.122 0.569 . . . . 75.41 112.16 -178.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.421 HG22 ' O ' ' D' ' 114' ' ' ILE . 89.8 t -66.56 -44.34 90.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.722 0.809 . . . . 75.31 110.042 176.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 83.7 p -74.83 -28.67 60.79 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.746 -0.661 . . . . 73.3 110.56 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' D' ' 116' ' ' SER . 88.3 mtt-85 -69.84 -29.73 67.05 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.648 0.779 . . . . 70.54 109.809 173.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.46 6.98 80.88 Favored Glycine 0 C--N 1.356 1.672 0 O-C-N 123.656 0.598 . . . . 65.23 113.157 177.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.569 HG22 ' HB3' ' C' ' 17' ' ' TYR . 81.2 p 55.69 28.25 11.84 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 126.277 1.831 . . . . 75.11 113.442 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -90.9 151.34 43.34 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 123.641 0.776 . . . . 75.35 109.289 169.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -51.58 125.15 15.99 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.64 2.227 . . . . 71.34 112.211 172.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -42.89 135.64 2.95 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 126.191 1.796 . . . . 75.22 113.277 -175.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.515 HD12 HG23 ' D' ' 40' ' ' VAL . 28.7 tp -116.55 96.99 5.76 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.774 0.83 . . . . 71.52 109.78 -176.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -97.11 96.48 8.49 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 106.931 -1.507 . . . . 73.1 106.931 175.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.543 HD13 HD13 ' D' ' 114' ' ' ILE . 92.9 mt -54.13 127.25 25.95 Favored 'General case' 0 C--O 1.246 0.884 0 O-C-N 123.649 0.593 . . . . 73.15 110.397 -177.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.18 140.81 82.81 Favored Pre-proline 0 CA--C 1.551 0.982 0 O-C-N 124.185 0.928 . . . . 74.23 110.734 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.415 ' HD3' HG13 ' B' ' 13' ' ' ILE . 98.0 Cg_endo -74.22 108.4 2.66 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.566 2.177 . . . . 75.53 111.739 -170.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 59.1 t -106.48 117.25 51.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 108.186 -1.042 . . . . 74.55 108.186 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -74.28 113.14 11.14 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.698 -0.853 . . . . 70.42 108.698 169.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . 0.434 ' CD2' ' HB2' ' D' ' 103' ' ' PRO . 2.0 m-85 . . . . . 0 N--CA 1.471 0.594 0 CA-C-N 115.239 -0.891 . . . . 72.55 110.826 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 75.9 m . . . . . 0 N--CA 1.457 -0.118 0 N-CA-C 107.672 -1.233 . . . . 74.21 107.672 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -114.91 120.5 40.16 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.725 -1.213 . . . . 73.25 107.725 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -139.11 123.77 18.51 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.55 -0.907 . . . . 71.43 108.55 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.526 HD12 HG21 ' A' ' 105' ' ' ILE . 3.0 mt -88.43 119.59 35.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.624 -0.88 . . . . 73.33 108.624 177.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -91.39 -37.27 13.31 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 123.785 0.678 . . . . 74.1 110.516 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -171.17 121.49 0.54 Allowed 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.353 0.408 . . . . 74.1 109.948 -176.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.547 HD13 ' HG3' ' C' ' 130' ' ' PRO . 76.2 mt -106.72 137.18 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.201 -1.037 . . . . 73.12 108.201 171.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.501 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 37.3 p90 -164.44 175.89 9.53 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-O 122.042 0.925 . . . . 73.11 111.92 -174.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 56.2 p -102.78 111.56 23.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.677 -1.147 . . . . 75.5 108.724 176.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.501 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 34.2 mtpt -72.92 -34.32 66.54 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.283 -0.636 . . . . 75.02 109.283 175.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.475 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.1 t70 -150.35 145.79 26.33 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.965 -1.016 . . . . 73.33 110.142 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.55 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 75.5 mt -142.78 143.3 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.663 1.585 . . . . 74.51 107.43 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.4 t -154.72 131.24 10.56 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.899 0.48 . . . . 63.2 110.165 173.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.497 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 87.6 t80 -126.99 141.9 51.68 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.332 -1.358 . . . . 65.03 107.332 172.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -135.04 142.52 46.39 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.785 -0.45 . . . . 73.31 109.785 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.83 71.08 13.74 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 106.991 -1.485 . . . . 64.42 106.991 166.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -71.78 -17.84 28.93 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 122.434 2.089 . . . . 75.13 112.2 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -104.71 17.38 24.24 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-O 118.007 -0.996 . . . . 72.32 109.698 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.444 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -46.34 -55.72 13.03 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 113.674 0.99 . . . . 63.12 113.674 -169.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.444 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 32.2 Cg_exo -60.83 -26.85 83.83 Favored 'Trans proline' 0 C--N 1.388 2.616 0 C-N-CA 121.73 1.62 . . . . 63.44 113.612 178.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -81.86 -41.23 21.28 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.876 0.871 . . . . 71.24 110.522 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.546 HG22 ' HA ' ' A' ' 73' ' ' ALA . 3.8 p -74.95 -20.66 16.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 124.576 1.15 . . . . 73.43 111.787 -161.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -76.91 -21.27 55.13 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.584 0.754 . . . . 74.24 110.852 176.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -90.51 -11.94 38.71 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.697 1.199 . . . . 71.44 110.879 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -83.07 164.06 20.53 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.165 0.986 . . . . 72.41 111.44 -178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.96 118.86 17.41 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.538 0.735 . . . . 61.31 109.367 173.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.459 ' CE3' HD21 ' A' ' 68' ' ' LEU . 71.2 t-105 -81.06 93.14 6.34 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 121.05 0.453 . . . . 75.24 110.737 -176.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -128.04 84.1 64.22 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 107.342 -1.355 . . . . 72.32 107.342 168.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -76.31 110.48 3.07 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.534 2.156 . . . . 70.33 112.443 -171.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -92.85 84.78 5.01 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 106.68 -1.6 . . . . 70.13 106.68 175.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.722 HG23 ' HB1' ' A' ' 66' ' ' ALA . 48.8 t -86.81 106.51 15.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 114.789 -1.096 . . . . 75.3 110.431 -173.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -79.01 123.47 27.33 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.19 -0.914 . . . . 74.13 109.454 171.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.8 mt -97.57 106.21 18.49 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.203 -1.036 . . . . 74.31 108.203 173.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.455 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 29.3 t70 -108.52 140.69 41.51 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.803 -1.184 . . . . 75.54 107.803 176.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.468 HD22 HD21 ' A' ' 60' ' ' LEU . 85.5 mt -136.56 150.95 48.87 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.173 0.589 . . . . 73.1 110.925 -172.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.422 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 21.8 t0 -154.77 148.98 25.98 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.931 -1.032 . . . . 71.01 109.417 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.501 HG21 ' HA2' ' A' ' 99' ' ' GLY . 89.3 m -130.86 147.44 52.51 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.614 0.766 . . . . 73.22 109.582 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -157.33 109.73 2.44 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.625 0.77 . . . . 73.34 109.661 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.3 p -93.15 154.38 18.1 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.111 0.564 . . . . 62.01 110.229 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.8 t -151.62 121.51 7.07 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.047 0.939 . . . . 73.51 109.023 -176.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -73.03 105.57 4.55 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.034 0.533 . . . . 73.34 109.679 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.494 HD13 HG22 ' A' ' 83' ' ' ILE . 60.6 mt -79.09 -38.65 35.73 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.195 0.598 . . . . 73.52 110.275 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.27 -179.88 7.93 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.925 -1.034 . . . . 71.02 109.485 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -68.46 124.93 24.9 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.012 0.525 . . . . 73.01 109.944 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 63.72 16.6 9.86 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.008 1.323 . . . . 74.42 111.717 -173.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.0 t -124.93 109.22 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.083 0.953 . . . . 65.22 108.526 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -121.9 125.62 46.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.332 -0.988 . . . . 74.43 108.332 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.486 ' HB2' HD11 ' A' ' 51' ' ' LEU . 21.7 tt0 -83.44 150.33 26.11 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.984 -1.117 . . . . 74.13 107.984 166.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.0 t -131.16 136.27 58.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 107.642 -1.244 . . . . 74.13 107.642 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.436 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 48.7 t -109.56 135.97 46.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.367 -0.975 . . . . 74.55 108.367 175.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.478 HD23 HG23 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -112.95 104.09 12.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.643 -1.614 . . . . 74.44 106.643 170.606 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.422 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 16.6 ttp180 -92.79 100.15 12.69 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.363 -1.347 . . . . 73.41 107.363 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.478 HG23 HD23 ' A' ' 60' ' ' LEU . 22.8 t -98.44 128.97 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 N-CA-C 108.235 -1.024 . . . . 74.43 108.235 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.455 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 16.8 m -120.95 112.04 18.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.524 0.678 . . . . 73.53 109.322 175.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.491 HG22 HG21 ' A' ' 114' ' ' ILE . 80.4 t -106.14 125.94 61.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 124.731 1.212 . . . . 74.34 107.883 -178.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.1 m -134.08 115.05 13.83 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 118.379 0.536 . . . . 71.25 109.848 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.722 ' HB1' HG23 ' A' ' 40' ' ' VAL . . . -100.79 121.85 42.4 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.059 -1.46 . . . . 63.41 107.059 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.1 m -121.84 135.71 54.91 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.435 0.694 . . . . 73.12 109.876 176.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.459 HD21 ' CE3' ' A' ' 36' ' ' TRP . 17.6 mt -88.13 72.1 9.18 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 107.65 -1.241 . . . . 72.42 107.65 174.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.77 -90.85 1.07 Allowed Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.218 -0.901 . . . . 64.13 111.515 -171.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -113.27 -27.03 8.12 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.165 0.586 . . . . 74.4 111.933 -174.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -85.65 129.83 34.72 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.504 -0.924 . . . . 72.34 108.504 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.3 m -72.85 125.87 28.57 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.876 -0.416 . . . . 72.34 109.876 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.546 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -71.26 -57.68 4.25 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.844 0.858 . . . . 74.15 110.319 175.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -155.06 164.5 38.8 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.261 -0.881 . . . . 74.31 111.497 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 64' ' ' VAL . 65.6 tp -118.82 140.95 49.11 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.8 -1.091 . . . . 75.33 108.202 170.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.469 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 83.2 m -140.07 96.84 3.12 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.711 0.805 . . . . 65.32 109.66 173.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -111.49 117.44 33.03 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.575 -0.528 . . . . 64.41 109.575 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.1 t -126.58 113.96 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.003 0.921 . . . . 72.4 109.845 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 53.0 mt-30 -86.3 85.58 7.34 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.774 0.83 . . . . 70.31 109.21 171.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.472 ' HG3' HD23 ' A' ' 106' ' ' LEU . 7.9 tp-100 -78.62 96.34 5.47 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.079 -0.964 . . . . 75.13 109.978 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -100.72 145.43 17.11 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.552 -0.619 . . . . 74.11 111.552 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.47 130.42 3.94 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.65 -0.98 . . . . 74.11 110.65 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.494 HG22 HD13 ' A' ' 51' ' ' LEU . 48.8 mt -79.55 126.56 39.22 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 108.501 -0.925 . . . . 74.41 108.501 174.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.555 ' HB3' HD12 ' A' ' 86' ' ' ILE . 74.0 m-85 -131.6 123.29 27.59 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.426 0.69 . . . . 72.54 109.894 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.9 t -83.44 106.23 15.02 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.237 -0.653 . . . . 75.01 109.237 171.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.555 HD12 ' HB3' ' A' ' 84' ' ' PHE . 7.7 mm -117.05 150.52 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.418 0.687 . . . . 72.34 110.157 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.96 163.38 16.04 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.571 0.544 . . . . 64.24 112.079 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.22 -19.41 46.03 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-N 115.543 -0.753 . . . . 72.2 113.124 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.11 148.95 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.741 0.816 . . . . 75.31 111.216 -171.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -138.05 175.24 9.75 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.942 1.297 . . . . 71.3 109.183 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.5 -123.99 33.52 Favored Glycine 0 CA--C 1.533 1.195 0 O-C-N 123.623 0.577 . . . . 34.2 114.185 175.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 38.1 p -73.2 -30.34 63.45 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.037 0.935 . . . . 65.35 110.825 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -67.66 -37.83 82.93 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.306 1.042 . . . . 64.33 110.359 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.408 ' HE3' HG21 ' A' ' 86' ' ' ILE . 5.3 tpt -68.38 -45.55 72.44 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.939 -0.573 . . . . 74.24 109.648 175.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.69 -38.1 77.5 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.187 0.929 . . . . 75.4 111.75 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -67.94 -33.91 75.58 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.31 0.644 . . . . 65.2 111.269 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.4 t -69.99 -45.11 68.0 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.019 0.437 . . . . 75.45 110.065 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.7 mt -80.79 -31.03 35.89 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.103 -0.953 . . . . 74.5 112.677 -170.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.501 ' HA2' HG21 ' A' ' 46' ' ' THR . . . -106.6 4.59 37.12 Favored Glycine 0 N--CA 1.472 1.059 0 CA-C-O 119.953 -0.36 . . . . 65.51 113.783 -173.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.608 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -136.13 -68.43 0.5 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 117.191 0.495 . . . . 61.24 111.186 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -68.22 -43.7 77.39 Favored 'General case' 0 CA--C 1.555 1.135 0 CA-C-N 116.316 -0.402 . . . . 73.45 111.914 -172.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.2 m -63.71 -51.47 65.38 Favored Pre-proline 0 CA--C 1.57 1.73 0 C-N-CA 124.247 1.019 . . . . 73.21 113.084 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.47 -19.97 48.39 Favored 'Trans proline' 0 C--N 1.397 3.084 0 C-N-CA 121.842 1.695 . . . . 74.13 113.008 173.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -67.99 -37.52 81.58 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.187 0.595 . . . . 63.33 110.519 174.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.526 HG21 HD12 ' A' ' 13' ' ' ILE . 48.7 mm -67.29 -41.45 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.529 0.732 . . . . 72.25 110.084 173.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.472 HD23 ' HG3' ' A' ' 80' ' ' GLN . 61.5 mt -73.5 -25.59 60.51 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.018 -0.992 . . . . 74.34 112.422 -174.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -61.12 -45.57 95.97 Favored Pre-proline 0 N--CA 1.486 1.354 0 N-CA-C 114.127 1.158 . . . . 75.55 114.127 -173.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -53.46 -36.46 79.77 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.265 1.977 . . . . 74.52 113.611 171.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.489 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 88.0 m-85 -83.36 -28.96 28.6 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.635 0.774 . . . . 70.43 112.252 -177.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.93 -46.77 70.57 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.414 -0.958 . . . . 73.15 108.414 172.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.506 ' NH1' HD13 ' C' ' 105' ' ' ILE . 32.0 ttm180 -58.25 -43.17 87.71 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 114.04 -1.436 . . . . 75.14 109.739 175.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 109' ' ' TYR . 11.6 tt0 -48.83 -57.94 5.6 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 125.055 1.342 . . . . 73.2 111.462 175.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.463 ' SG ' HD11 ' A' ' 21' ' ' ILE . 53.6 t -64.92 -45.19 86.91 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.428 -1.26 . . . . 65.52 111.693 -174.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.568 HD12 HD12 ' A' ' 128' ' ' LEU . 8.5 mt -58.6 -60.27 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.818 0.847 . . . . 63.53 110.554 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.9 m -50.1 -41.87 49.16 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 125.058 1.343 . . . . 65.51 112.513 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -67.97 -43.03 79.91 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.714 -1.13 . . . . 75.31 110.635 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.532 ' HE1' ' HA ' ' A' ' 114' ' ' ILE . 52.6 mtm -62.28 -39.32 92.55 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 122.807 0.443 . . . . 65.43 110.875 177.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.429 HG21 ' O ' ' A' ' 114' ' ' ILE . 94.9 t -57.58 -49.56 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 124.341 1.056 . . . . 75.13 110.232 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 81.6 p -71.61 -29.36 64.58 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.89 -0.595 . . . . 74.42 111.61 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -72.33 -29.19 63.59 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.673 0.789 . . . . 74.12 110.17 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.76 18.3 31.16 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-O 119.459 -0.634 . . . . 72.54 112.762 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.467 HG23 ' HE ' ' B' ' 15' ' ' ARG . 5.6 t 58.03 13.08 2.04 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 127.445 2.298 . . . . 61.31 114.014 178.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -78.98 150.25 74.72 Favored Pre-proline 0 C--O 1.245 0.85 0 N-CA-C 108.156 -1.053 . . . . 63.23 108.156 171.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -58.61 144.25 97.64 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.278 1.985 . . . . 70.31 110.852 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -55.07 129.34 37.64 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 124.562 1.164 . . . . 72.42 111.698 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.9 tp -107.37 138.1 44.2 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 108.416 -0.957 . . . . 73.14 108.416 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -122.74 125.85 46.35 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.1 -1.074 . . . . 73.35 108.1 175.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.568 HD12 HD12 ' A' ' 114' ' ' ILE . 10.2 mt -73.1 126.54 30.24 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.492 -0.929 . . . . 74.34 108.492 177.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.71 134.99 82.79 Favored Pre-proline 0 CA--C 1.554 1.108 0 CA-C-O 118.974 -0.536 . . . . 72.21 110.883 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.59 116.56 2.8 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.653 2.902 . . . . 73.21 113.843 -175.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.4 t -105.87 131.94 54.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-O 121.058 0.456 . . . . 71.23 110.456 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 134' ' ' ASP . 52.0 t-20 -99.66 91.79 5.04 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.581 -1.191 . . . . 53.25 107.82 175.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -63.16 -25.83 68.53 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.715 0.806 . . . . 72.44 112.637 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.608 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 28.9 t70 -59.37 -49.56 77.34 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.286 -0.635 . . . . 74.25 109.286 171.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.37 96.54 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.326 1.017 . . . . 73.23 111.286 177.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 72.6 mt -60.7 -43.4 97.83 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.084 0.554 . . . . 72.1 111.14 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 39.3 t80 . . . . . 0 CA--C 1.539 0.548 0 CA-C-N 115.863 -0.608 . . . . 75.42 110.153 178.878 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.476 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 1.0 OUTLIER . . . . . 0 CA--C 1.565 1.539 0 CA-C-O 120.905 0.383 . . . . 72.53 110.97 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.467 ' N ' ' SD ' ' B' ' 9' ' ' MET . 79.3 m -149.45 108.48 3.9 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 123.987 0.915 . . . . 72.13 108.71 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.476 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 65.9 t80 -116.55 145.63 43.21 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.433 0.693 . . . . 73.0 109.363 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -158.91 141.7 14.36 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.194 -1.039 . . . . 72.4 108.194 170.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 31.6 mt -76.86 145.67 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 N-CA-C 108.267 -1.012 . . . . 74.34 108.267 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -109.25 -40.51 4.92 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.901 0.481 . . . . 71.02 110.183 174.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.467 ' HE ' HG23 ' A' ' 122' ' ' THR . 48.0 ttt180 -173.68 137.13 0.6 Allowed 'General case' 0 N--CA 1.476 0.871 0 O-C-N 123.73 0.644 . . . . 74.42 109.881 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 93.4 mt -114.92 138.55 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.848 1.259 . . . . 73.01 107.678 176.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -164.43 140.68 6.16 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.919 0.711 . . . . 72.23 112.919 -173.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 69.9 m -73.7 121.48 20.83 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.057 -0.974 . . . . 74.44 109.121 170.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.499 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 46.9 mtpt -98.77 -16.96 18.74 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.636 0.774 . . . . 65.02 111.764 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.571 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 34.5 t70 -169.81 144.66 2.86 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.724 0.64 . . . . 64.53 111.186 -172.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.543 HD12 ' SG ' ' B' ' 113' ' ' CYS . 30.6 mm -143.53 146.36 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.677 1.191 . . . . 75.4 110.173 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.488 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 72.4 m -144.02 139.28 28.92 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.528 1.531 . . . . 73.01 108.558 171.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.55 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 89.4 t80 -148.36 108.73 4.13 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.297 -1.742 . . . . 74.5 106.297 164.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -118.8 114.64 22.96 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.079 -1.082 . . . . 64.21 108.079 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.68 86.9 2.47 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.164 -1.421 . . . . 64.03 107.164 173.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.9 -35.52 20.65 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.883 2.389 . . . . 64.04 112.171 -171.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -103.1 16.38 26.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.977 0.911 . . . . 75.54 110.962 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.77 -58.52 4.49 Favored Pre-proline 0 N--CA 1.491 1.591 0 C-N-CA 124.985 1.314 . . . . 70.1 114.479 -168.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -57.99 -45.42 32.35 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 122.367 2.044 . . . . 74.45 113.328 -171.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -96.55 -17.24 20.6 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.172 -0.922 . . . . 73.43 112.802 -170.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.444 HG22 ' HA ' ' B' ' 73' ' ' ALA . 5.2 p -73.07 -20.32 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 118.169 0.44 . . . . 73.41 110.345 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -72.61 -1.06 14.67 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.493 0.923 . . . . 75.14 113.493 -177.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -71.56 -16.88 62.33 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 120.911 0.386 . . . . 74.42 110.097 167.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.422 ' HZ1' ' HG2' ' B' ' 71' ' ' GLU . 96.7 mttt -105.9 69.38 0.81 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.525 1.53 . . . . 74.41 110.0 -176.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -84.85 76.59 10.22 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.773 0.797 . . . . 72.04 110.492 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.424 ' O ' ' HG2' ' B' ' 124' ' ' PRO . 3.8 p90 -152.92 173.15 15.73 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.037 -1.097 . . . . 73.35 108.037 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -66.52 115.33 23.1 Favored Pre-proline 0 CA--C 1.563 1.445 0 N-CA-C 112.353 0.501 . . . . 72.12 112.353 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.411 ' HD3' ' HG2' ' B' ' 124' ' ' PRO . 60.2 Cg_endo -71.85 157.06 55.86 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.512 2.141 . . . . 64.32 111.593 176.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.68 103.96 5.16 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.252 -1.018 . . . . 75.43 108.252 169.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.538 HG22 ' HB1' ' B' ' 66' ' ' ALA . 21.5 t -96.18 157.08 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.204 1.002 . . . . 74.41 110.031 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -142.97 124.65 14.95 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.625 1.17 . . . . 75.43 107.94 172.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.466 HD11 HD12 ' B' ' 128' ' ' LEU . 21.5 tp -87.56 136.85 32.78 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 108.32 -0.992 . . . . 74.24 108.32 170.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -137.04 149.89 47.73 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.711 -0.848 . . . . 64.11 108.711 -173.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mp -128.6 150.5 50.19 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.92 0.888 . . . . 71.43 109.578 -174.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.426 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 27.2 t70 -154.55 152.15 29.72 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.57 1.148 . . . . 74.11 108.673 173.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' THR . . . . . 0.411 HG23 HD22 ' B' ' 60' ' ' LEU . 75.9 p -126.76 134.5 50.6 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 121.176 0.513 . . . . 73.12 111.474 -177.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.05 116.17 6.06 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.04 -1.467 . . . . 74.33 107.04 169.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.483 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 41.0 m -143.0 161.15 38.9 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.572 0.349 . . . . 61.34 110.741 -171.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.8 p -152.1 139.91 19.93 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.904 0.482 . . . . 71.04 111.288 -172.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -83.47 129.25 34.97 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.465 -0.939 . . . . 74.41 108.465 169.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 pp -141.84 25.05 1.99 Allowed 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.774 0.829 . . . . 74.33 109.823 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' B' ' 55' ' ' VAL . . . -161.43 148.01 14.44 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.154 -0.93 . . . . 74.02 109.789 -173.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.41 121.71 24.18 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.1 -0.704 . . . . 72.23 109.1 171.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 68.53 12.12 8.59 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 124.675 1.235 . . . . 70.34 113.03 174.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.415 ' O ' ' HB1' ' B' ' 52' ' ' ALA . 89.6 t -140.01 129.87 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 N-CA-C 107.068 -1.456 . . . . 74.42 107.068 -175.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.483 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 11.8 t80 -118.0 153.37 33.78 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.902 -0.499 . . . . 64.23 110.104 -175.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -116.3 105.77 12.92 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.63 -1.248 . . . . 75.33 107.63 176.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.43 143.41 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.859 0.864 . . . . 75.23 109.787 -176.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 22.7 t -129.83 127.06 63.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 C-N-CA 123.982 0.913 . . . . 63.53 108.756 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.411 HD22 HG23 ' B' ' 46' ' ' THR . 0.3 OUTLIER -110.53 120.41 42.32 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 107.628 -1.249 . . . . 71.22 107.628 172.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.426 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 16.7 ttm-85 -86.82 113.28 22.5 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.86 -0.793 . . . . 74.13 108.86 174.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.41 HG11 ' CD1' ' B' ' 114' ' ' ILE . 48.9 t -109.17 105.19 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.095 0.958 . . . . 74.31 108.652 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 23.9 m -107.08 148.01 29.29 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.209 1.004 . . . . 72.34 109.991 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.581 HG23 HG23 ' B' ' 114' ' ' ILE . 24.4 t -136.47 117.78 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.107 1.363 . . . . 74.24 108.797 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 85.8 m -104.96 136.53 44.27 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 108.119 -1.067 . . . . 63.14 108.119 169.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.538 ' HB1' HG22 ' B' ' 40' ' ' VAL . . . -140.2 144.65 36.69 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.801 -0.814 . . . . 71.01 108.801 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.465 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 61.2 p -144.54 133.35 22.44 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.745 0.646 . . . . 44.32 112.745 -173.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 53.0 mt -107.61 128.44 54.54 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.672 1.189 . . . . 71.23 110.506 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.76 -110.57 3.41 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 111.751 -0.539 . . . . 63.44 111.751 -173.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -116.9 1.73 12.7 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 123.536 0.734 . . . . 73.25 110.432 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.422 ' HG2' ' HZ1' ' B' ' 34' ' ' LYS . 14.0 pt-20 -115.03 158.37 22.19 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.749 -0.595 . . . . 75.11 110.218 -174.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.8 m -68.77 130.87 44.07 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 110.062 -0.348 . . . . 65.02 110.062 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.465 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -81.0 -64.82 1.11 Allowed 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.634 -1.247 . . . . 73.11 107.634 173.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -151.29 164.77 35.88 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.058 -0.974 . . . . 73.12 111.492 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 74.5 mt -127.01 131.61 50.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 105.992 -1.855 . . . . 74.25 105.992 170.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.469 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 34.2 t -131.51 149.79 52.39 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.036 -1.098 . . . . 71.25 108.036 172.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.488 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 49.7 tt0 -158.41 131.89 7.56 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.072 -0.714 . . . . 72.33 109.072 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.427 HG11 ' HA ' ' B' ' 110' ' ' ALA . 87.4 t -129.44 148.38 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.443 -0.947 . . . . 74.32 108.443 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.571 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 27.2 mt-30 -124.91 93.56 3.93 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.958 -1.127 . . . . 74.52 107.958 171.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -89.76 108.93 19.98 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.229 -0.896 . . . . 73.14 108.878 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.499 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -104.4 171.78 19.77 Favored Glycine 0 C--N 1.337 0.62 0 O-C-N 123.791 0.682 . . . . 63.42 111.867 177.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.46 137.48 4.26 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.468 -0.396 . . . . 74.42 112.47 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 51.4 mt -88.79 121.26 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 107.42 -1.326 . . . . 73.43 107.42 170.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -131.54 145.14 51.59 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.27 1.028 . . . . 63.44 108.974 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 56.4 m -89.53 121.88 32.16 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.548 0.739 . . . . 72.32 110.058 170.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.651 HG23 HD13 ' B' ' 89' ' ' ILE . 5.3 mp -125.29 108.79 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 107.472 -1.307 . . . . 74.02 107.472 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.86 166.12 26.17 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.609 0.763 . . . . 74.24 111.069 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 94.37 -29.81 8.49 Favored Glycine 0 N--CA 1.482 1.739 0 CA-C-O 121.098 0.277 . . . . 54.34 113.419 176.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.651 HD13 HG23 ' B' ' 86' ' ' ILE . 0.7 OUTLIER -90.83 168.26 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 124.598 1.159 . . . . 73.11 110.999 176.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -157.16 163.47 38.85 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.649 0.78 . . . . 74.54 110.299 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.51 -113.4 4.33 Favored Glycine 0 C--N 1.356 1.641 0 C-N-CA 123.473 0.558 . . . . 63.41 112.521 171.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 31.4 m -104.22 -35.42 8.01 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.71 0.804 . . . . 55.5 109.604 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -66.3 -17.31 64.68 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.104 0.962 . . . . 74.23 111.98 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.465 ' HA ' HD11 ' B' ' 89' ' ' ILE . 21.5 ptm -61.21 -56.57 19.16 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 122.865 0.466 . . . . 74.13 111.514 173.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . 0.405 ' HA ' ' HG ' ' B' ' 98' ' ' LEU . . . -81.0 -11.47 59.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.793 0.837 . . . . 64.34 111.939 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -64.75 -36.04 83.03 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.68 0.392 . . . . 75.21 110.778 169.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.1 t -66.76 -41.13 88.27 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.748 0.419 . . . . 74.45 111.516 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.607 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.6 pp -84.19 -29.82 26.29 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.892 0.477 . . . . 74.51 111.402 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.86 -24.65 31.88 Favored Glycine 0 C--N 1.345 1.081 0 O-C-N 123.535 0.522 . . . . 73.53 113.913 -172.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.4 -48.48 2.19 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.291 0.637 . . . . 73.11 111.513 -174.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -75.94 -47.07 26.62 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.689 0.396 . . . . 72.14 111.692 -173.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.607 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 73.6 m -64.03 -42.42 69.26 Favored Pre-proline 0 CA--C 1.566 1.559 0 N-CA-C 113.6 0.963 . . . . 70.51 113.6 -177.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.55 -21.22 53.01 Favored 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 121.878 1.719 . . . . 65.3 113.806 173.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -70.13 -30.55 67.75 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 122.539 0.335 . . . . 71.22 110.772 173.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.404 HG22 ' NH2' ' D' ' 111' ' ' ARG . 84.0 mt -67.34 -40.77 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.789 0.836 . . . . 75.44 109.689 170.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 96.8 mt -76.47 -27.36 56.1 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.831 -1.077 . . . . 73.15 112.51 -174.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -55.23 -47.47 98.47 Favored Pre-proline 0 CA--C 1.567 1.597 0 CA-C-O 118.042 -0.98 . . . . 72.44 113.494 -175.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -52.45 -41.3 68.23 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 122.838 2.359 . . . . 74.54 114.711 174.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -68.83 -36.62 78.41 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.057 0.543 . . . . 75.13 110.656 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.427 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -70.5 -36.08 73.59 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.765 0.826 . . . . 75.35 111.062 174.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.553 ' HA ' HD13 ' B' ' 128' ' ' LEU . 35.4 ttt-85 -63.3 -56.05 19.68 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.167 1.387 . . . . 70.45 110.661 -178.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . 0.466 ' HG3' ' NH2' ' C' ' 120' ' ' ARG . 1.4 tm-20 -69.48 -22.53 63.61 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.762 -0.654 . . . . 75.42 109.832 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.543 ' SG ' HD12 ' B' ' 21' ' ' ILE . 4.3 t -75.97 -28.37 57.85 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 122.64 0.376 . . . . 74.43 111.138 176.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.581 HG23 HG23 ' B' ' 64' ' ' VAL . 52.3 mt -74.97 -56.22 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.515 0.726 . . . . 74.14 109.234 173.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 52.6 m -58.56 -27.95 65.07 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.185 0.994 . . . . 75.1 111.556 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 29.8 t -58.59 -53.76 54.75 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.921 0.888 . . . . 72.2 110.365 173.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.494 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.4 mmt -71.6 -32.8 68.41 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.905 0.882 . . . . 75.41 111.074 -172.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.471 HG23 HD21 ' B' ' 126' ' ' LEU . 98.7 t -64.67 -42.87 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.658 1.183 . . . . 65.13 110.459 173.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.7 t -65.93 -39.09 90.21 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.033 -0.985 . . . . 70.11 110.408 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' B' ' 116' ' ' SER . 66.4 mtt-85 -64.91 -45.44 85.89 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.518 -0.765 . . . . 74.44 109.214 174.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -64.22 -11.16 44.98 Favored Glycine 0 C--N 1.361 1.917 0 O-C-N 124.58 1.175 . . . . 74.45 113.494 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 15.8 m 66.01 29.16 10.25 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.792 1.237 . . . . 73.41 110.329 174.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -83.33 162.63 53.29 Favored Pre-proline 0 CA--C 1.552 1.036 0 CA-C-N 114.841 -1.072 . . . . 74.12 110.652 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.424 ' HG2' ' O ' ' B' ' 36' ' ' TRP . 92.0 Cg_exo -48.36 159.61 0.73 Allowed 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.786 2.991 . . . . 70.02 114.787 173.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.422 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 22.8 tp60 -60.55 113.19 2.3 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.36 -0.837 . . . . 73.11 111.484 -173.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.533 HD13 HG11 ' B' ' 40' ' ' VAL . 15.9 tp -112.23 120.08 40.54 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.843 -0.799 . . . . 75.03 108.843 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -133.0 126.53 32.15 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 107.801 -1.185 . . . . 64.31 107.801 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.553 HD13 ' HA ' ' B' ' 111' ' ' ARG . 76.1 mt -83.27 134.2 34.95 Favored 'General case' 0 C--O 1.242 0.7 0 O-C-N 123.409 0.443 . . . . 73.04 110.96 -176.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.61 143.88 90.55 Favored Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 124.58 1.175 . . . . 73.02 110.144 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -65.79 92.74 0.26 Allowed 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.68 2.253 . . . . 72.24 111.429 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 98.6 t -90.66 109.49 20.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.682 -1.229 . . . . 73.44 107.682 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 . . . . . 0 C--O 1.245 0.821 0 N-CA-C 107.539 -1.282 . . . . 74.53 107.539 177.15 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 65.0 t80 . . . . . 0 C--O 1.237 0.425 0 N-CA-C 108.594 -0.891 . . . . 73.24 108.594 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -159.22 123.9 4.04 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 108.898 -0.779 . . . . 63.52 108.898 175.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 62.2 mt -68.56 127.16 29.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 N-CA-C 108.741 -0.837 . . . . 74.12 108.741 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -89.38 -48.35 7.4 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 109.308 -0.627 . . . . 72.42 109.308 174.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.88 148.98 0.43 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.219 1.408 . . . . 73.24 108.731 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 2.7 pp -116.59 155.2 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 106.978 -1.49 . . . . 74.31 106.978 173.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.445 ' HB3' HG22 ' D' ' 122' ' ' THR . 29.5 p90 -175.28 151.36 1.25 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.68 0.752 . . . . 74.42 111.3 -174.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 64.7 p -78.79 102.62 8.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.818 -1.083 . . . . 73.45 108.84 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 8.8 mtmt -72.8 -30.4 64.04 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.061 -0.718 . . . . 73.41 109.061 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.755 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 20.8 t70 -143.91 138.8 28.81 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.104 -0.953 . . . . 74.01 109.732 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.6 mt -137.43 143.66 33.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 106.818 -1.549 . . . . 71.32 106.818 174.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 26.1 t -155.04 141.04 18.33 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 123.76 0.663 . . . . 71.32 110.084 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -145.32 113.0 6.32 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 106.974 -1.491 . . . . 74.03 106.974 171.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -117.71 122.92 44.77 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.167 0.587 . . . . 72.55 109.99 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.35 75.79 73.56 Favored Pre-proline 0 CA--C 1.552 1.026 0 N-CA-C 107.388 -1.338 . . . . 73.23 107.388 171.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -69.82 -22.75 31.36 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 122.77 2.314 . . . . 71.25 111.511 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -101.36 12.45 37.38 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.541 1.136 . . . . 73.43 110.191 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.1 -58.14 9.55 Favored Pre-proline 0 C--N 1.375 1.715 0 C-N-CA 124.388 1.075 . . . . 72.3 113.554 -169.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -64.29 -35.95 48.45 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 121.704 1.603 . . . . 65.41 112.132 -176.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -69.82 -37.75 76.32 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.293 1.037 . . . . 74.35 112.297 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.592 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.1 p -81.29 -21.71 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 C-N-CA 122.819 0.448 . . . . 72.32 111.889 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -65.48 -26.84 68.11 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 120.681 0.277 . . . . 73.22 111.263 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -100.41 34.58 2.35 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.652 0.781 . . . . 74.23 110.279 174.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.614 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 0.6 OUTLIER -125.05 163.08 23.15 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.523 0.729 . . . . 71.35 110.23 177.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -66.58 112.99 4.42 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.532 0.733 . . . . 70.3 110.656 173.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 69.5 t-105 -76.8 81.97 3.39 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.363 0.665 . . . . 73.31 110.529 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -136.17 73.72 57.31 Favored Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 124.522 1.129 . . . . 73.11 108.465 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.31 155.48 25.25 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.702 2.268 . . . . 63.24 113.837 -171.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -87.4 87.71 7.49 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 105.146 -2.168 . . . . 74.53 105.146 161.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.48 HG13 HD13 ' C' ' 126' ' ' LEU . 68.7 t -76.66 98.34 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.578 0 N-CA-C 107.527 -1.286 . . . . 73.14 107.527 177.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -114.59 103.8 11.37 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.953 -1.021 . . . . 75.31 108.329 -175.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.27 160.63 18.36 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.214 0.531 . . . . 74.02 110.287 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.598 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 18.1 t70 -145.69 121.15 10.34 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.614 1.166 . . . . 73.53 108.287 -177.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 81.8 mt -125.44 111.95 15.7 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.526 0.73 . . . . 74.12 109.99 -177.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -136.52 127.06 26.9 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.439 -0.949 . . . . 70.13 108.439 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 12.4 t -115.05 146.27 41.45 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.272 0.629 . . . . 74.41 109.47 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.36 163.96 27.53 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.067 0.947 . . . . 75.44 109.304 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' C' ' 98' ' ' LEU . 3.2 m -142.89 143.71 32.16 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.805 -0.442 . . . . 73.3 109.805 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.9 t -145.2 127.81 16.12 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.0 0.92 . . . . 55.51 108.548 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -79.55 117.4 20.45 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.077 -0.712 . . . . 73.04 109.077 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.703 HD12 ' HB2' ' C' ' 57' ' ' GLU . 61.0 mt -86.39 -35.08 19.98 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.266 0.626 . . . . 74.31 111.027 -176.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.19 179.64 8.96 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.961 -1.018 . . . . 71.21 109.088 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.5 116.46 7.5 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.148 -0.686 . . . . 75.24 109.148 -178.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 68.33 18.9 9.08 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.447 1.099 . . . . 74.24 112.068 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 90.5 t -123.81 115.23 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 108.639 -0.874 . . . . 73.31 108.639 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -121.71 128.96 52.38 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.337 1.055 . . . . 73.43 109.577 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.703 ' HB2' HD12 ' C' ' 51' ' ' LEU . 44.2 tt0 -93.16 138.62 31.41 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.088 -0.708 . . . . 73.02 109.088 167.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 83.5 t -122.83 139.68 48.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.911 -1.144 . . . . 74.31 107.911 171.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 54.3 t -127.85 130.26 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 109.516 -0.55 . . . . 74.02 109.516 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.79 111.2 23.61 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.702 -1.221 . . . . 72.25 107.702 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -83.1 111.85 19.28 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 108.556 -0.905 . . . . 75.23 108.556 170.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.404 HG13 ' CD1' ' C' ' 114' ' ' ILE . 21.9 t -114.38 115.5 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 108.02 -1.104 . . . . 72.53 108.02 175.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.598 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 10.9 m -125.39 125.54 43.58 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.598 0.759 . . . . 72.4 108.956 -171.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.568 HG23 HG21 ' C' ' 114' ' ' ILE . 84.2 t -112.92 125.16 70.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 123.964 0.906 . . . . 73.02 108.89 177.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 12.5 m -104.12 138.81 40.08 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.77 -0.826 . . . . 74.21 108.77 170.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.97 101.56 5.48 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.636 -1.616 . . . . 74.54 106.636 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 41.1 m -134.02 126.46 30.26 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.537 -0.542 . . . . 74.43 109.537 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 9.7 mt -84.47 52.85 2.47 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.618 1.167 . . . . 64.3 109.213 -178.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.1 -99.83 1.93 Allowed Glycine 0 C--N 1.349 1.259 0 N-CA-C 110.515 -1.034 . . . . 72.23 110.515 -172.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -101.11 -30.44 11.58 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.943 0.897 . . . . 64.44 110.439 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.614 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 10.1 tp10 -70.33 109.98 5.02 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.424 1.089 . . . . 72.32 109.451 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 38.9 m -83.41 124.46 30.7 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.897 0.772 . . . . 73.34 110.025 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.592 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -76.6 -57.93 3.57 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 114.398 -1.274 . . . . 72.54 109.618 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -154.65 166.26 33.96 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.025 -0.989 . . . . 73.33 110.706 174.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.41 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.4 tm? -129.23 142.56 50.82 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 105.894 -1.891 . . . . 73.22 105.894 166.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.41 ' N ' HD13 ' C' ' 75' ' ' LEU . 49.1 t -143.59 143.31 31.44 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.075 -1.083 . . . . 64.32 108.075 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -157.18 132.11 8.85 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 122.796 0.439 . . . . 74.21 109.973 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.411 HG12 ' HA ' ' C' ' 110' ' ' ALA . 55.2 t -133.85 115.41 21.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 124.748 1.219 . . . . 73.23 108.804 -176.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.755 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.2 mt-30 -96.19 90.56 5.54 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.677 0.791 . . . . 74.3 109.116 173.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.459 ' HG3' HD21 ' C' ' 106' ' ' LEU . 7.1 tp-100 -80.67 99.74 8.33 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.698 -1.137 . . . . 73.11 109.515 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.56 153.78 27.74 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.862 -0.495 . . . . 62.13 111.862 174.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.5 126.44 2.08 Favored Glycine 0 CA--C 1.501 -0.785 0 N-CA-C 110.966 -0.854 . . . . 74.24 110.966 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.497 HD13 HD12 ' C' ' 51' ' ' LEU . 13.3 mm -88.96 128.71 40.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 N-CA-C 108.891 -0.781 . . . . 75.11 108.891 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -135.87 118.39 15.88 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.379 0.671 . . . . 73.24 109.369 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.5 p -79.6 101.32 8.24 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.262 -1.014 . . . . 60.54 108.262 172.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.563 HG21 ' HE2' ' C' ' 94' ' ' MET . 21.3 mt -117.53 129.94 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.582 0.753 . . . . 73.1 110.52 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.28 164.62 29.33 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.297 0.639 . . . . 73.55 110.671 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.39 -19.24 44.86 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 114.896 0.718 . . . . 72.32 114.896 170.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.717 HD13 ' HA ' ' C' ' 94' ' ' MET . 47.4 pt -108.53 167.97 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 117.593 0.697 . . . . 74.24 111.457 -176.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -159.35 177.9 10.51 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.364 -1.289 . . . . 74.5 109.263 175.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.63 -120.53 12.07 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 115.815 1.086 . . . . 75.11 115.815 173.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 46.4 p -64.91 -36.87 85.77 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.408 1.083 . . . . 75.01 111.173 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -62.23 -58.31 8.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.496 1.118 . . . . 74.31 110.538 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.717 ' HA ' HD13 ' C' ' 89' ' ' ILE . 4.6 tpt -54.15 -52.51 60.88 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 124.066 0.946 . . . . 73.54 112.243 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.96 -40.9 77.33 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 123.87 0.731 . . . . 74.32 111.235 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -68.7 -37.31 79.42 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.2 0.6 . . . . 73.42 111.222 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 35.4 t -67.6 -34.56 77.25 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.659 -0.497 . . . . 70.23 109.659 -177.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.457 ' HB3' ' OG ' ' C' ' 48' ' ' SER . 79.9 mt -88.16 -33.03 18.33 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.527 1.131 . . . . 75.31 112.173 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.5 10.91 26.02 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 114.63 0.612 . . . . 73.02 114.63 -167.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.11 -48.66 0.07 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 117.401 0.6 . . . . 70.14 111.613 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -72.74 -55.03 7.37 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.302 0.641 . . . . 74.34 111.306 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 94.4 m -63.74 -44.99 81.7 Favored Pre-proline 0 CA--C 1.562 1.419 0 CA-C-O 118.213 -0.898 . . . . 63.33 112.031 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -53.02 -31.55 54.07 Favored 'Trans proline' 0 C--N 1.394 2.962 0 C-N-CA 122.88 2.387 . . . . 74.35 114.204 170.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -67.52 -35.54 79.29 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.537 0.735 . . . . 75.13 110.373 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.506 HD13 ' NH1' ' A' ' 111' ' ' ARG . 46.0 mm -77.06 -33.26 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.375 0.67 . . . . 75.24 110.449 177.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.459 HD21 ' HG3' ' C' ' 80' ' ' GLN . 94.3 mt -82.23 -30.02 31.01 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.865 0.866 . . . . 72.44 112.034 -175.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -57.18 -49.45 93.86 Favored Pre-proline 0 N--CA 1.484 1.23 0 CA-C-O 117.891 -1.052 . . . . 73.34 113.457 -173.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.61 -40.91 81.86 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 122.561 2.174 . . . . 72.11 114.31 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . 0.475 ' OH ' ' HG2' ' A' ' 111' ' ' ARG . 89.6 m-85 -74.98 -37.56 61.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.155 0.582 . . . . 72.35 111.425 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.411 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -68.34 -34.89 76.92 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.353 -0.84 . . . . 54.03 110.498 176.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 24.2 ttt-85 -66.12 -51.24 59.8 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.604 1.561 . . . . 75.12 109.757 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -60.0 -39.53 86.1 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 124.093 0.871 . . . . 74.34 110.154 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 35.1 t -66.41 -39.86 89.23 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.461 -0.79 . . . . 74.32 110.933 -177.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.568 HG21 HG23 ' C' ' 64' ' ' VAL . 84.2 mt -69.19 -56.16 12.84 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 O-C-N 123.376 0.423 . . . . 72.15 110.565 177.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.1 m -63.21 -27.73 69.55 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 122.928 0.491 . . . . 74.1 111.066 -173.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 38.4 t -65.68 -49.34 68.91 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.383 0.673 . . . . 71.42 109.486 169.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.556 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.63 -36.63 79.1 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 124.607 1.163 . . . . 73.04 112.719 179.319 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.409 HG23 ' O ' ' C' ' 114' ' ' ILE . 76.6 t -64.23 -46.41 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.636 0.774 . . . . 74.32 108.962 175.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 39.5 t -67.3 -31.18 71.31 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.004 -0.998 . . . . 64.11 111.47 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.466 ' NH2' ' HG3' ' B' ' 112' ' ' GLU . 72.7 mtt-85 -71.17 -37.24 72.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.891 0.876 . . . . 75.54 109.566 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.46 4.3 84.45 Favored Glycine 0 C--N 1.353 1.474 0 O-C-N 123.848 0.717 . . . . 71.43 112.496 172.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 71.9 p 59.02 29.31 18.83 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.385 1.874 . . . . 75.24 113.696 172.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -85.38 143.2 38.64 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 107.018 -1.475 . . . . 73.2 107.018 166.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -48.69 143.3 16.82 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 123.088 2.525 . . . . 73.12 112.979 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.422 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 20.7 mm-40 -46.9 142.67 3.31 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 124.565 1.165 . . . . 74.42 112.786 -174.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.48 HD13 HG13 ' C' ' 40' ' ' VAL . 23.6 tp -144.88 88.49 1.9 Allowed 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.188 -1.041 . . . . 75.2 108.188 -177.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -91.85 117.2 29.56 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.502 -1.226 . . . . 63.24 109.063 -174.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.91 124.53 24.55 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 123.893 0.745 . . . . 74.05 109.864 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.13 145.17 85.65 Favored Pre-proline 0 CA--C 1.548 0.874 0 O-C-N 124.219 0.949 . . . . 74.43 111.333 -175.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.547 ' HG3' HD13 ' A' ' 16' ' ' ILE . 16.1 Cg_endo -55.86 108.77 0.35 Allowed 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.555 2.837 . . . . 74.22 112.081 173.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 14.0 p -98.67 152.48 4.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 109.203 -0.666 . . . . 70.52 109.203 174.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -82.97 99.17 9.64 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.163 0.985 . . . . 73.2 108.832 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -68.66 -20.44 64.45 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.091 0.556 . . . . 74.23 112.121 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.78 -32.5 67.71 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.295 0.638 . . . . 74.44 110.792 172.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.14 -31.65 64.41 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.329 0.652 . . . . 74.01 110.588 174.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 56.3 mt -78.8 -20.91 48.64 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.423 -0.808 . . . . 72.15 110.438 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 69.0 t80 . . . . . 0 CA--C 1.548 0.88 0 C-N-CA 123.596 0.758 . . . . 75.41 110.582 172.976 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 28.9 p . . . . . 0 CA--C 1.545 0.776 0 N-CA-C 109.301 -0.629 . . . . 70.45 109.301 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -143.04 116.41 9.06 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.444 -1.317 . . . . 75.21 107.444 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -141.0 153.49 45.58 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.635 0.774 . . . . 71.22 109.415 172.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 73.8 mt -102.74 120.48 52.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.087 -1.079 . . . . 74.55 108.087 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -89.05 -42.57 11.66 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.17 0.588 . . . . 74.21 110.66 -175.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -163.37 142.36 8.27 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.285 0.366 . . . . 74.12 110.496 -172.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.7 mp -124.8 135.07 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 105.579 -2.008 . . . . 61.54 105.579 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.432 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 34.8 p90 -162.31 172.72 15.21 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 122.12 0.962 . . . . 72.35 112.079 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.7 p -107.34 120.48 42.26 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.181 -1.372 . . . . 71.34 109.028 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.432 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 29.6 mtpt -92.02 -19.7 22.1 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.742 -0.663 . . . . 74.32 109.493 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 32.6 t70 -162.14 138.77 8.0 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.94 0.896 . . . . 73.33 109.743 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.556 HG23 ' HE1' ' C' ' 117' ' ' MET . 63.9 mt -141.81 139.64 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.809 1.244 . . . . 71.33 107.773 175.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.7 t -141.9 145.44 34.59 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.37 1.068 . . . . 75.12 108.608 170.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.519 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.0 t80 -144.95 117.66 8.67 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.143 -1.799 . . . . 74.32 106.143 167.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -125.55 118.91 26.76 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.159 0.584 . . . . 75.25 109.787 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.89 80.32 5.19 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 107.695 -1.224 . . . . 61.53 107.695 174.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.6 -19.07 16.97 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.681 2.254 . . . . 74.22 113.014 -169.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -113.49 1.42 15.02 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.599 0.76 . . . . 75.34 111.178 -177.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -27.44 -70.01 0.07 OUTLIER Pre-proline 0 CA--C 1.567 1.61 0 N-CA-C 117.481 2.4 . . . . 74.11 117.481 -167.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.464 ' HB3' HD11 ' C' ' 83' ' ' ILE . 89.4 Cg_endo -76.56 -18.01 15.8 Favored 'Trans proline' 0 C--N 1.387 2.564 0 CA-C-N 124.19 2.532 . . . . 65.11 113.971 -172.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.44 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 3.4 t-160 -78.31 -38.8 41.52 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.702 1.201 . . . . 72.11 109.699 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.422 HG22 ' HA ' ' D' ' 73' ' ' ALA . 5.1 p -83.83 -19.31 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-N 115.874 -0.603 . . . . 75.44 111.096 -175.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -64.07 -24.83 67.85 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 122.544 0.338 . . . . 75.23 111.159 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . 0.44 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 62.1 mt-30 -65.97 -9.05 26.47 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.263 1.025 . . . . 74.42 111.711 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.626 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 87.4 mttt -100.52 99.33 9.91 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.225 1.41 . . . . 73.42 109.602 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -97.33 83.2 3.25 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.254 -0.885 . . . . 74.54 110.876 -171.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -158.82 176.97 11.68 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.822 0.849 . . . . 64.23 109.402 169.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -69.94 110.96 7.6 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.353 1.061 . . . . 73.33 109.829 174.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.463 ' HB3' ' HG ' ' D' ' 68' ' ' LEU . 38.9 Cg_endo -68.81 129.63 18.98 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.014 1.809 . . . . 74.33 110.588 175.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -67.4 116.55 8.29 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 107.514 -1.291 . . . . 73.54 107.514 168.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' D' ' 66' ' ' ALA . 16.1 t -98.23 114.41 35.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 108.9 -0.778 . . . . 74.21 108.9 176.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -89.54 116.93 28.06 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.81 -0.811 . . . . 74.55 108.81 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.51 HD21 HD12 ' D' ' 128' ' ' LEU . 49.2 tp -97.27 144.43 27.07 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.065 0.459 . . . . 74.12 110.23 -176.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -135.17 139.5 44.62 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.681 -1.6 . . . . 74.34 106.681 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.417 HD13 HG13 ' D' ' 131' ' ' VAL . 45.4 mt -130.0 132.07 46.12 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.226 0.61 . . . . 64.31 110.666 -174.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -140.35 154.11 46.63 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.598 1.159 . . . . 71.44 108.317 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 2.1 p -128.61 159.69 34.76 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.597 0.713 . . . . 75.55 110.778 176.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.541 ' HB1' ' HB ' ' D' ' 59' ' ' VAL . . . -149.75 177.8 9.46 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.218 -1.356 . . . . 73.52 108.528 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 61.9 p . . . . . 0 N--CA 1.476 0.866 0 C-N-CA 123.883 0.873 . . . . 64.22 108.977 -175.187 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.497 1.899 0 N-CA-C 113.951 1.093 . . . . 74.51 113.951 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.06 106.06 20.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.166 -1.42 . . . . 75.33 107.166 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -129.6 147.81 51.44 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.385 -0.598 . . . . 73.42 109.385 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -111.98 148.85 32.9 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.065 -1.087 . . . . 75.4 108.065 161.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 71.2 t -123.27 140.78 45.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 124.811 1.244 . . . . 75.22 107.692 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.541 ' HB ' ' HB1' ' D' ' 47' ' ' ALA . 30.3 t -125.89 137.31 58.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.727 -1.212 . . . . 72.22 107.727 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.418 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -125.74 105.4 8.95 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.511 -1.292 . . . . 73.12 107.511 -176.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 41.4 ttm-85 -85.14 102.49 13.32 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.748 0.819 . . . . 74.42 109.214 174.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.504 HG13 HD12 ' D' ' 42' ' ' LEU . 57.9 t -100.86 116.4 44.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.603 -0.888 . . . . 74.14 108.603 173.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.8 m -119.0 122.96 43.38 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.944 0.878 . . . . 73.43 110.233 -171.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 51.9 t -108.39 130.64 60.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 125.746 1.618 . . . . 74.33 109.635 -176.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 80.9 m -134.81 92.1 2.85 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.841 -1.17 . . . . 74.51 107.841 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -96.48 154.82 17.05 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.65 0.78 . . . . 44.54 109.123 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.449 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 25.2 p -149.58 135.02 18.37 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 123.648 0.592 . . . . 72.14 112.178 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' D' ' 38' ' ' PRO . 20.9 mt -105.46 102.43 11.9 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 124.81 1.244 . . . . 72.44 108.302 171.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.32 -125.4 10.6 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.572 -0.74 . . . . 72.41 113.438 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -84.97 4.96 31.22 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.554 1.142 . . . . 74.41 112.893 -174.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.626 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 12.8 pt-20 -146.32 165.75 28.35 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 120.9 0.381 . . . . 75.13 111.13 -172.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 55.7 m -64.03 135.26 56.27 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.529 -1.214 . . . . 65.34 111.435 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.449 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.46 -71.33 0.57 Allowed 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.236 -1.394 . . . . 63.32 107.236 170.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -145.11 151.95 39.29 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-O 121.179 0.514 . . . . 74.22 111.002 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 66.3 mt -117.08 152.54 34.47 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.095 1.358 . . . . 72.43 107.872 175.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.539 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 40.6 t -159.29 149.64 19.28 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.692 0.797 . . . . 75.14 108.883 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -154.91 121.71 5.45 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.48 -0.563 . . . . 75.41 109.48 170.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.58 115.82 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.64 0.776 . . . . 75.01 109.543 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.459 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.7 mt-30 -90.68 90.19 7.85 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.47 0.708 . . . . 74.0 109.415 170.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . 0.406 ' O ' HD11 ' D' ' 106' ' ' LEU . 7.8 tp-100 -80.98 101.57 9.6 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.877 -1.056 . . . . 74.04 108.897 178.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.92 143.88 15.9 Favored Glycine 0 C--N 1.338 0.693 0 N-CA-C 111.397 -0.681 . . . . 74.23 111.397 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.8 140.72 7.84 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 111.758 -0.537 . . . . 74.32 111.758 -174.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 50.8 mt -90.48 120.57 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.724 -0.843 . . . . 75.3 108.724 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -121.01 126.48 50.02 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.099 0.96 . . . . 73.12 109.521 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 44.5 p -88.86 96.6 10.76 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.913 -0.773 . . . . 74.14 108.913 173.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.56 HD13 HD23 ' D' ' 98' ' ' LEU . 37.7 pt -119.83 129.16 75.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 115.465 -0.789 . . . . 73.5 109.615 -172.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.75 167.79 7.56 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.357 0.663 . . . . 75.23 110.926 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.25 12.3 61.74 Favored Glycine 0 N--CA 1.476 1.364 0 CA-C-N 116.629 -0.26 . . . . 72.43 112.993 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.516 HG12 ' SG ' ' D' ' 97' ' ' CYS . 1.0 OUTLIER -125.34 159.93 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.892 1.277 . . . . 72.31 109.074 176.171 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -149.4 156.38 41.95 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 122.989 0.516 . . . . 64.15 110.472 -168.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.37 -131.55 10.71 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 116.003 -0.544 . . . . 75.22 114.374 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 40.0 p -84.55 -41.0 16.9 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.183 0.993 . . . . 74.24 111.067 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -66.69 -19.05 65.68 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.279 -0.873 . . . . 73.54 111.408 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.428 ' HA ' HD12 ' D' ' 89' ' ' ILE . 59.4 ttp -54.33 -57.76 10.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.954 1.301 . . . . 70.4 111.392 174.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.21 -15.18 51.46 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.308 -0.86 . . . . 71.02 111.854 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -64.01 -22.93 67.14 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.938 0.495 . . . . 75.21 111.43 172.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . 0.516 ' SG ' HG12 ' D' ' 89' ' ' ILE . 81.8 m -59.89 -46.52 89.07 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.236 0.614 . . . . 74.04 111.187 175.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.56 HD23 HD13 ' D' ' 86' ' ' ILE . 3.1 pp -94.59 -20.71 19.37 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.352 0.501 . . . . 74.23 112.352 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.98 -29.38 23.29 Favored Glycine 0 C--N 1.346 1.134 0 O-C-N 123.353 0.408 . . . . 62.01 113.396 -173.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.36 -49.18 1.08 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.809 0.444 . . . . 75.4 111.289 -174.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -74.91 -41.94 58.74 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 112.697 0.629 . . . . 73.12 112.697 -172.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 71.7 m -66.26 -44.79 59.69 Favored Pre-proline 0 CA--C 1.558 1.262 0 CA-C-O 118.558 -0.734 . . . . 55.42 111.704 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.418 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 68.6 Cg_exo -56.59 -33.73 93.76 Favored 'Trans proline' 0 C--N 1.391 2.814 0 C-N-CA 122.021 1.814 . . . . 73.43 112.909 167.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -68.32 -29.57 68.35 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.523 0.729 . . . . 73.21 111.172 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.2 mm -74.93 -37.28 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.355 0.662 . . . . 61.44 109.945 172.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.406 HD11 ' O ' ' D' ' 80' ' ' GLN . 93.3 mt -79.95 -17.76 52.16 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.472 0.709 . . . . 72.21 112.443 -177.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -68.03 -44.08 38.16 Favored Pre-proline 0 N--CA 1.486 1.348 0 CA-C-O 118.472 -0.775 . . . . 75.04 112.725 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.47 -37.11 72.38 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.368 2.046 . . . . 75.35 113.687 170.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -81.02 -32.9 33.97 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.971 0.909 . . . . 73.22 112.428 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.96 -45.21 71.27 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.177 -0.675 . . . . 74.53 109.177 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.404 ' NH2' HG22 ' B' ' 105' ' ' ILE . 43.2 ttp180 -65.51 -39.13 91.48 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 114.371 -1.286 . . . . 75.31 110.139 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -52.59 -46.32 66.9 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 123.986 0.914 . . . . 75.3 110.523 175.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.476 ' SG ' HD11 ' D' ' 21' ' ' ILE . 49.2 t -67.71 -50.28 58.32 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.903 -1.044 . . . . 74.23 110.86 -178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.534 HG12 ' SG ' ' D' ' 76' ' ' CYS . 79.3 mt -59.58 -62.14 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 123.951 0.782 . . . . 74.21 110.883 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 17.3 m -50.48 -39.65 48.75 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.949 1.299 . . . . 65.53 111.954 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.43 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 24.6 t -64.0 -48.08 77.79 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.046 -0.979 . . . . 62.51 109.977 177.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 68.6 mtm -69.35 -27.21 65.15 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.282 0.633 . . . . 72.24 112.093 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.446 HG21 ' O ' ' D' ' 114' ' ' ILE . 89.6 t -66.33 -46.07 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.407 0.683 . . . . 75.42 109.196 175.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.5 p -73.19 -28.98 62.51 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.576 -0.738 . . . . 73.34 110.698 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' D' ' 116' ' ' SER . 87.9 mtt-85 -70.86 -28.58 64.68 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.816 0.846 . . . . 74.44 110.416 173.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . 0.422 ' HA2' ' HB2' ' C' ' 17' ' ' TYR . . . -89.11 8.08 80.67 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 123.824 0.703 . . . . 70.33 112.763 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.445 HG22 ' HB3' ' C' ' 17' ' ' TYR . 47.7 p 59.09 20.47 8.38 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 126.35 1.86 . . . . 64.13 113.507 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -87.04 154.44 55.01 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 123.614 0.766 . . . . 74.41 110.106 174.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -50.3 127.44 20.1 Favored 'Trans proline' 0 C--N 1.386 2.532 0 C-N-CA 123.576 2.851 . . . . 72.52 113.013 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -52.24 128.93 26.63 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 124.522 1.139 . . . . 74.42 111.596 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.415 HD21 HG12 ' D' ' 40' ' ' VAL . 33.8 tp -107.13 97.23 7.02 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.726 -0.472 . . . . 73.21 109.726 -176.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -98.45 89.87 4.58 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 107.272 -1.381 . . . . 75.4 107.272 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.51 HD12 HD21 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -67.98 122.29 17.9 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 108.872 -0.788 . . . . 72.41 108.872 -175.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.57 142.65 87.24 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 123.798 0.839 . . . . 72.02 111.05 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.07 121.68 10.34 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.889 2.393 . . . . 75.32 112.098 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . 0.417 HG13 HD13 ' D' ' 44' ' ' LEU . 8.3 p -107.39 133.4 52.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 123.623 0.769 . . . . 75.15 109.551 -173.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -87.01 92.4 9.03 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.592 0.757 . . . . 74.13 108.96 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 N--CA 1.486 1.368 0 C-N-CA 124.392 1.077 . . . . 74.45 112.81 -175.683 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.0 m . . . . . 0 N--CA 1.467 0.4 0 N-CA-C 108.774 -0.824 . . . . 75.23 108.774 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -135.33 114.36 12.14 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.529 -1.286 . . . . 72.34 107.529 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -134.05 135.26 43.21 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.826 -1.176 . . . . 74.2 107.826 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.54 HD12 HG21 ' A' ' 105' ' ' ILE . 8.7 mt -93.95 114.44 30.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.381 -0.97 . . . . 75.32 108.381 174.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.473 ' NE2' HG21 ' A' ' 83' ' ' ILE . 29.0 tt0 -81.54 -30.36 33.16 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 123.731 0.644 . . . . 71.53 110.47 -177.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -175.87 134.27 0.28 Allowed 'General case' 0 C--N 1.361 1.089 0 C-N-CA 123.13 0.572 . . . . 73.23 110.372 -175.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.584 HD13 ' HG3' ' C' ' 130' ' ' PRO . 66.2 mt -118.13 133.77 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.998 -1.112 . . . . 74.51 107.998 169.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HE1' HG13 ' A' ' 83' ' ' ILE . 24.9 p90 -164.23 149.39 10.31 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 124.098 0.874 . . . . 74.23 110.838 -174.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.0 p -75.27 130.18 38.67 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.862 -0.792 . . . . 73.23 108.862 172.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.9 mtpt -97.55 -30.05 13.1 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.778 -0.452 . . . . 74.53 109.778 175.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.44 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 7.7 t70 -143.37 141.58 30.97 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.351 -0.611 . . . . 74.24 109.351 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.477 HG22 ' SD ' ' A' ' 117' ' ' MET . 62.6 mt -142.24 146.29 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.164 1.386 . . . . 74.54 107.917 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.8 t -155.8 132.48 10.42 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.482 0.713 . . . . 65.11 109.737 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.605 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 80.5 t80 -139.08 114.65 9.85 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 107.199 -1.408 . . . . 75.24 107.199 172.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -118.24 114.36 22.89 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.996 -0.742 . . . . 74.43 108.996 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.47 79.57 1.75 Allowed Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 107.892 -1.151 . . . . 74.02 107.892 164.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.07 -26.13 21.87 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.547 2.164 . . . . 61.52 112.04 -172.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -104.49 17.9 23.24 Favored 'General case' 0 C--O 1.21 -1.02 0 CA-C-O 117.942 -1.027 . . . . 71.53 110.056 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.0 -51.96 21.19 Favored Pre-proline 0 N--CA 1.503 2.197 0 N-CA-C 114.291 1.219 . . . . 65.12 114.291 -169.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.09 -26.07 43.26 Favored 'Trans proline' 0 C--N 1.386 2.529 0 C-N-CA 121.764 1.643 . . . . 73.14 112.808 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -81.43 -43.22 19.21 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.251 1.02 . . . . 71.13 110.245 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.545 HG22 ' HA ' ' A' ' 73' ' ' ALA . 8.2 p -78.96 -21.87 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 114.762 -1.108 . . . . 71.45 112.142 -163.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -70.79 -18.17 62.76 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.579 0.351 . . . . 73.14 111.785 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -76.02 -21.32 56.99 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.682 0.793 . . . . 72.12 110.581 173.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.407 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 35.1 mmtp -83.11 154.67 24.23 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.792 0.837 . . . . 75.43 111.625 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -68.36 136.61 53.65 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.12 -0.946 . . . . 70.34 109.995 172.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.551 ' CE3' HD21 ' A' ' 68' ' ' LEU . 67.9 t-105 -82.45 86.16 6.8 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.512 0.673 . . . . 75.5 110.634 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.404 ' H ' HD23 ' A' ' 68' ' ' LEU . 29.1 tt0 -124.55 80.47 60.95 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 107.757 -1.201 . . . . 70.5 107.757 167.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.18 122.88 9.43 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.535 2.157 . . . . 64.12 112.647 -174.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -95.81 85.67 4.17 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 105.847 -1.909 . . . . 71.33 105.847 172.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.8 t -90.31 134.91 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 114.972 -1.013 . . . . 73.51 110.085 -171.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -121.5 114.78 21.73 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.168 0.987 . . . . 75.52 108.395 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 128' ' ' LEU . 2.6 tt -101.59 119.03 38.13 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.35 -0.981 . . . . 75.12 108.35 -175.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -121.43 133.49 55.07 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.162 0.985 . . . . 64.04 109.174 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.48 HD22 HD21 ' A' ' 60' ' ' LEU . 72.6 mt -121.65 131.06 53.89 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.745 0.818 . . . . 64.11 110.693 -178.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -135.66 149.21 49.22 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.071 0.948 . . . . 65.22 108.816 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.5 m -135.87 129.13 31.86 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.424 0.69 . . . . 65.41 110.099 -177.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.43 111.15 11.06 Favored 'General case' 0 C--N 1.345 0.385 0 C-N-CA 124.179 0.992 . . . . 71.42 109.512 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.0 m -90.35 159.24 16.72 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.215 -0.661 . . . . 61.22 109.215 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.9 t -158.35 117.37 3.11 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.245 -0.65 . . . . 74.23 109.245 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -76.06 106.96 7.95 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.72 -0.474 . . . . 70.13 109.72 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.4 mt -79.8 -33.55 40.36 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.402 0.681 . . . . 73.44 111.02 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.92 -174.77 4.56 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.084 0.554 . . . . 63.24 111.086 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.46 114.93 4.66 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.761 0.825 . . . . 75.45 109.362 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 64.89 18.63 11.56 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.064 1.346 . . . . 72.24 112.335 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.7 t -118.29 105.37 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.452 -0.944 . . . . 74.11 108.452 174.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -115.96 122.81 46.38 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.809 0.844 . . . . 74.42 108.724 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -86.6 148.58 25.42 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.778 -0.823 . . . . 74.2 108.778 170.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.6 t -130.33 139.37 51.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 N-CA-C 107.821 -1.178 . . . . 74.02 107.821 168.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.4 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 26.4 t -121.13 127.46 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.84 -0.8 . . . . 75.52 108.84 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.529 HD23 HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -102.23 106.75 17.62 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 106.817 -1.549 . . . . 71.33 106.817 176.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -92.76 101.82 14.22 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.865 -1.161 . . . . 71.31 107.865 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.529 HG23 HD23 ' A' ' 60' ' ' LEU . 21.9 t -96.23 126.91 48.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 N-CA-C 108.482 -0.933 . . . . 75.32 108.482 174.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.8 m -116.25 142.7 46.49 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.978 -0.749 . . . . 73.23 108.978 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.569 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 92.6 t -139.3 109.3 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 125.169 1.388 . . . . 75.41 107.749 -176.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.4 m -107.4 123.02 47.77 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.993 -0.743 . . . . 71.32 108.993 169.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.94 120.57 36.77 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.354 -0.98 . . . . 72.23 108.354 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.5 m -124.14 136.07 53.95 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.211 0.604 . . . . 64.03 110.755 -176.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.551 HD21 ' CE3' ' A' ' 36' ' ' TRP . 91.6 mt -87.75 74.99 9.02 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.354 -0.98 . . . . 75.32 108.354 174.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.47 -116.38 4.68 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 114.33 -1.305 . . . . 64.03 110.956 -169.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -91.94 -13.85 30.49 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.875 0.87 . . . . 63.42 110.743 176.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.407 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 5.9 tp10 -77.26 133.28 38.89 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.39 1.076 . . . . 75.43 108.267 173.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.6 m -87.7 127.5 35.3 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.729 0.695 . . . . 74.31 109.521 174.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.545 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -79.83 -58.85 2.98 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.53 -0.915 . . . . 73.43 108.53 173.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -162.39 165.24 26.67 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 115.458 -0.792 . . . . 74.02 111.652 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.3 tp -127.17 118.98 25.38 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.393 -1.276 . . . . 70.12 107.988 166.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.569 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.0 m -105.56 138.11 42.3 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.054 0.942 . . . . 71.24 109.257 171.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -147.92 132.75 18.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.694 -0.854 . . . . 73.32 108.694 168.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.2 t -138.7 110.85 5.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 C-N-CA 124.194 0.998 . . . . 65.22 108.461 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -84.89 85.46 7.47 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.282 -1.007 . . . . 74.02 108.282 169.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -75.92 96.99 3.85 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.096 -0.956 . . . . 74.21 109.011 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.06 160.14 34.78 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 111.513 -0.635 . . . . 75.01 111.513 178.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.9 127.68 2.01 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.773 -0.931 . . . . 62.23 110.773 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.473 HG21 ' NE2' ' A' ' 14' ' ' GLN . 63.6 mt -80.97 124.0 38.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 107.948 -1.13 . . . . 74.33 107.948 171.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.597 ' HB3' HD11 ' A' ' 86' ' ' ILE . 87.7 m-85 -125.65 127.42 46.27 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 109.003 -0.74 . . . . 72.41 109.003 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.3 t -89.3 97.57 11.27 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.955 -0.757 . . . . 64.24 108.955 173.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.597 HD11 ' HB3' ' A' ' 84' ' ' PHE . 4.7 mm -112.76 150.92 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 122.74 0.416 . . . . 75.44 110.502 -175.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.54 170.85 12.36 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.003 0.814 . . . . 73.43 110.869 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.11 -31.39 7.05 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 115.987 -0.551 . . . . 74.54 113.924 172.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.2 161.03 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.812 0.845 . . . . 73.13 108.993 176.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.557 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 17.0 tt0 -153.5 176.65 11.8 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 109.457 -0.572 . . . . 75.21 109.457 -175.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.557 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 57.5 -123.37 32.5 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 124.144 0.902 . . . . 72.23 113.921 177.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.2 t -75.23 -24.72 57.75 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.262 0.625 . . . . 64.01 111.91 -176.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -76.27 -34.79 59.12 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.42 0.688 . . . . 74.3 110.368 176.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.573 ' HE3' HG21 ' A' ' 86' ' ' ILE . 6.4 tpt -62.86 -48.68 78.0 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.383 -0.599 . . . . 75.23 109.383 171.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.71 -36.62 72.24 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.645 0.778 . . . . 53.33 110.751 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -67.96 -38.0 82.24 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.422 0.689 . . . . 74.33 111.182 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.5 t -66.38 -40.43 89.68 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.849 -0.426 . . . . 70.42 109.849 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.532 HD22 ' HE2' ' A' ' 94' ' ' MET . 53.9 mt -83.66 -25.61 30.59 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.741 0.816 . . . . 72.33 112.322 -174.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.53 3.38 34.53 Favored Glycine 0 N--CA 1.475 1.268 0 O-C-N 123.417 0.448 . . . . 73.12 113.726 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.544 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -136.8 -68.69 0.48 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.029 0.532 . . . . 70.14 110.059 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -65.82 -46.97 76.64 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.436 0.694 . . . . 74.02 111.721 -171.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 59.4 m -66.29 -50.75 47.75 Favored Pre-proline 0 CA--C 1.567 1.619 0 C-N-CA 124.464 1.105 . . . . 73.03 112.659 -175.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.96 -20.05 45.28 Favored 'Trans proline' 0 C--N 1.39 2.749 0 C-N-CA 121.841 1.694 . . . . 71.24 112.948 174.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -69.7 -35.71 75.3 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.847 0.459 . . . . 75.3 110.188 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.54 HG21 HD12 ' A' ' 13' ' ' ILE . 46.7 mm -64.25 -47.87 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.27 0.628 . . . . 73.12 109.828 171.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.5 mt -72.22 -21.7 61.36 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.116 -0.947 . . . . 74.21 112.552 -171.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -65.03 -45.46 73.44 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 114.26 1.207 . . . . 73.01 114.26 -172.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.426 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 82.8 Cg_exo -50.54 -40.95 54.29 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.055 1.837 . . . . 73.42 113.626 171.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -76.13 -38.58 56.64 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.371 0.668 . . . . 74.32 111.084 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.21 -48.12 74.46 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.347 0.659 . . . . 64.15 109.915 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.408 HH11 ' HA ' ' A' ' 108' ' ' PRO . 29.3 ttm105 -47.99 -55.91 8.92 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 125.023 1.452 . . . . 74.22 110.079 174.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -61.81 -48.34 81.02 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 124.478 1.111 . . . . 75.54 111.879 -175.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.528 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.0 t -57.05 -42.39 80.44 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 123.786 0.679 . . . . 73.23 110.57 -177.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.573 HD13 HD12 ' A' ' 128' ' ' LEU . 82.9 mt -62.95 -52.15 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 115.097 -0.956 . . . . 74.35 110.319 173.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 61.7 m -55.28 -41.08 71.79 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.047 0.939 . . . . 70.32 111.319 -175.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.8 t -68.99 -42.57 76.32 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 114.626 -1.17 . . . . 72.11 109.706 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.519 ' HE2' ' HB2' ' A' ' 23' ' ' PHE . 7.9 mtp -60.02 -42.49 94.45 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.871 0.868 . . . . 72.41 111.063 175.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.1 t -61.66 -45.84 97.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 124.278 1.031 . . . . 72.12 110.1 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.5 p -73.95 -30.51 62.58 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.271 0.628 . . . . 75.34 111.647 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 78.6 mtt-85 -72.59 -29.21 63.32 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.509 0.724 . . . . 73.33 109.594 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.07 5.42 62.77 Favored Glycine 0 C--N 1.354 1.56 0 CA-C-O 119.213 -0.771 . . . . 65.33 112.962 175.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.501 ' O ' HG23 ' A' ' 122' ' ' THR . 44.6 m 72.61 10.35 5.63 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 122.587 1.184 . . . . 74.44 111.703 173.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -86.35 144.42 38.14 Favored Pre-proline 0 C--O 1.244 0.765 0 O-C-N 121.064 -1.023 . . . . 75.21 109.151 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -51.69 142.52 40.52 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.06 2.507 . . . . 74.35 112.159 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -57.06 136.34 56.33 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 123.999 0.812 . . . . 72.34 112.667 -170.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.477 HD21 HG12 ' A' ' 64' ' ' VAL . 35.8 tp -121.58 123.37 41.8 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.626 1.17 . . . . 74.02 108.486 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.512 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 92.2 m-20 -122.44 109.46 14.41 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.543 0.737 . . . . 71.12 109.124 -176.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.573 HD12 HD13 ' A' ' 114' ' ' ILE . 7.9 mt -70.01 116.46 10.4 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 109.217 -0.66 . . . . 75.44 109.217 -173.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.68 143.4 93.9 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 122.873 0.469 . . . . 55.43 111.57 -172.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -56.24 125.14 18.09 Favored 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.488 2.792 . . . . 72.22 114.141 -172.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 90.3 t -102.46 134.26 43.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 CA-C-N 115.335 -0.848 . . . . 73.11 110.382 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -90.54 86.54 6.44 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.709 -0.848 . . . . 71.34 108.709 176.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -63.11 -27.65 69.53 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.579 0.751 . . . . 75.42 112.029 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.544 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 18.7 t70 -66.91 -43.37 83.51 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 123.45 0.469 . . . . 75.31 109.745 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.65 -40.51 95.58 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 124.228 0.955 . . . . 71.23 111.105 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 89.3 mt -60.01 -51.94 67.5 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.275 0.63 . . . . 74.03 111.033 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 25.1 t80 . . . . . 0 N--CA 1.47 0.538 0 N-CA-C 109.686 -0.487 . . . . 71.04 109.686 -179.823 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.634 ' HB3' HG23 ' B' ' 89' ' ' ILE . 25.5 ptm . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 113.437 0.903 . . . . 70.31 113.437 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.3 t -143.54 127.37 17.24 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 124.437 1.095 . . . . 72.01 108.096 171.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.401 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 75.2 t80 -123.51 146.19 48.27 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.613 0.765 . . . . 74.11 109.521 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.432 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 8.5 tt0 -149.99 131.26 14.57 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.248 0.619 . . . . 72.3 109.739 176.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 54.9 mt -80.3 122.82 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.538 -1.282 . . . . 73.12 107.538 168.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -93.58 -49.77 5.73 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.692 -0.855 . . . . 64.34 108.692 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.41 ' HE ' HG21 ' A' ' 122' ' ' THR . 26.1 ttt180 -164.14 143.57 7.75 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.767 -0.651 . . . . 73.31 110.841 -174.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 94.6 mt -124.02 141.45 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 107.039 -1.467 . . . . 74.33 107.039 173.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -165.43 138.98 4.56 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 112.886 0.699 . . . . 72.44 112.886 -174.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.6 m -73.91 119.38 18.05 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.668 0.787 . . . . 74.34 109.373 172.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.493 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.9 mtpt -96.89 -20.44 18.14 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.707 0.803 . . . . 74.11 111.678 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 34.0 t70 -160.18 149.64 17.72 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.097 0.559 . . . . 74.12 111.022 -177.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.605 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 26.9 mm -145.86 146.16 19.58 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 125.485 1.514 . . . . 75.3 108.374 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 36.3 t -155.6 145.6 21.51 Favored 'General case' 0 C--O 1.242 0.693 0 O-C-N 124.351 1.032 . . . . 73.32 110.087 169.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.44 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 87.1 t80 -151.56 108.54 3.54 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 107.457 -1.312 . . . . 74.24 107.457 169.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.18 113.53 21.69 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.243 -1.021 . . . . 74.2 108.243 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.518 ' HB3' ' HB3' ' B' ' 28' ' ' ALA . . . -107.78 86.42 2.97 Favored Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 107.888 -1.153 . . . . 74.54 107.888 174.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.2 -33.69 7.0 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.734 2.29 . . . . 72.11 112.933 -170.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -100.95 6.15 43.48 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.815 0.846 . . . . 72.11 111.389 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.518 ' HB3' ' HB3' ' B' ' 25' ' ' ALA . . . -41.39 -62.59 1.02 Allowed Pre-proline 0 N--CA 1.491 1.606 0 C-N-CA 125.436 1.494 . . . . 65.33 113.924 -168.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.37 -38.29 73.21 Favored 'Trans proline' 0 C--N 1.391 2.792 0 C-N-CA 122.89 2.393 . . . . 72.02 113.756 -172.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -93.54 -35.03 13.12 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.193 -0.912 . . . . 74.02 111.636 -171.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 4.3 p -73.14 -14.74 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.239 0.616 . . . . 75.22 111.574 -171.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -64.31 -20.46 66.1 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.445 0.698 . . . . 73.03 112.771 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -65.17 -18.18 65.09 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.146 0.578 . . . . 72.11 110.942 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.457 ' HZ3' ' HG2' ' B' ' 71' ' ' GLU . 93.0 mttt -91.2 79.61 5.69 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.787 1.235 . . . . 75.44 110.048 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -85.31 78.01 9.86 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.321 -0.854 . . . . 74.44 110.098 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 14.9 p90 -154.3 -174.68 5.06 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.952 0.901 . . . . 75.44 108.875 172.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.0 120.19 77.95 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 123.157 0.583 . . . . 70.1 111.079 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.536 ' HA ' HD21 ' B' ' 68' ' ' LEU . 58.1 Cg_endo -70.33 139.32 38.0 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 121.244 1.296 . . . . 71.24 109.513 172.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.61 101.02 1.2 Allowed 'General case' 0 C--O 1.242 0.691 0 N-CA-C 107.27 -1.381 . . . . 62.45 107.27 170.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.535 HG21 ' HB1' ' B' ' 66' ' ' ALA . 35.4 t -102.94 145.66 11.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 115.066 -0.97 . . . . 63.53 109.184 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -135.07 130.41 35.52 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.344 -0.844 . . . . 72.1 108.91 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.41 HD11 HG13 ' B' ' 62' ' ' VAL . 21.8 tp -94.09 126.97 39.63 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 124.212 0.945 . . . . 72.22 109.245 170.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -142.87 126.38 16.8 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.289 1.036 . . . . 71.12 108.466 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.498 HD21 HG21 ' B' ' 62' ' ' VAL . 4.0 mp -119.9 148.72 43.16 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.985 0.514 . . . . 72.43 110.537 -172.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.411 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 18.1 t70 -124.4 141.61 51.95 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.172 1.389 . . . . 73.13 108.097 176.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 27.4 m -113.34 104.16 12.04 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.561 -0.533 . . . . 64.01 109.561 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.59 134.43 55.05 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.088 -1.449 . . . . 74.25 107.088 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.426 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 51.9 m -142.99 162.8 34.51 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 122.493 0.317 . . . . 72.11 110.745 -175.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.9 p -152.09 135.6 16.08 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.431 0.692 . . . . 73.03 109.693 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -90.49 122.66 33.52 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 109.013 -0.736 . . . . 75.22 109.013 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 pp -143.96 25.11 1.62 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.286 -0.87 . . . . 73.11 109.589 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.97 156.76 20.19 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 123.632 0.773 . . . . 74.32 110.312 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.7 131.83 36.05 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 108.521 -0.918 . . . . 73.21 108.521 167.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 64.49 7.31 3.59 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.929 1.292 . . . . 72.42 112.215 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.696 HG21 ' HA ' ' B' ' 85' ' ' SER . 54.2 t -138.68 123.33 21.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 107.239 -1.393 . . . . 73.3 107.239 -174.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.426 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 1.5 t80 -117.26 145.45 43.93 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 108.364 -0.976 . . . . 71.32 108.364 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -100.51 103.13 14.45 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 106.547 -1.649 . . . . 71.05 106.547 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 6.8 p -102.52 132.44 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.345 -0.613 . . . . 71.32 109.345 -176.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.414 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 19.0 t -115.12 122.41 69.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 108.688 -0.856 . . . . 73.23 108.688 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 38.9 tp -103.54 105.89 16.25 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.754 -0.832 . . . . 71.22 108.754 173.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.428 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 14.4 ttm180 -84.9 110.09 18.61 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 108.588 -0.893 . . . . 74.3 108.588 174.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.498 HG21 HD21 ' B' ' 44' ' ' LEU . 61.4 t -105.03 104.7 17.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 123.572 0.749 . . . . 73.02 109.011 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 6.7 m -98.83 137.15 37.82 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.134 -0.939 . . . . 73.13 109.684 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.631 HG23 HD12 ' B' ' 114' ' ' ILE . 30.6 t -128.42 116.29 41.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 124.225 1.01 . . . . 75.21 108.524 174.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 97.0 m -101.95 136.56 41.58 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.985 -1.117 . . . . 73.51 107.985 168.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.535 ' HB1' HG21 ' B' ' 40' ' ' VAL . . . -139.87 141.22 36.61 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 109.443 -0.577 . . . . 73.43 109.443 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.489 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 40.9 p -148.15 130.98 16.08 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.542 0.526 . . . . 73.02 111.585 -173.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.536 HD21 ' HA ' ' B' ' 38' ' ' PRO . 75.8 mt -97.04 107.11 19.57 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.181 0.992 . . . . 71.45 108.664 176.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.58 -111.98 3.37 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 111.195 -0.762 . . . . 74.02 111.195 -172.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -117.54 1.65 12.31 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.674 0.79 . . . . 72.13 110.297 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.457 ' HG2' ' HZ3' ' B' ' 34' ' ' LYS . 12.3 pt-20 -114.43 142.15 46.73 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.768 -0.583 . . . . 73.42 110.37 -174.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 25.4 m -66.39 115.25 6.11 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.719 0.808 . . . . 64.51 111.394 -175.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.489 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -70.02 -56.34 7.2 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.992 -1.114 . . . . 74.41 107.992 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -158.37 164.47 36.29 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 114.398 -1.274 . . . . 73.32 111.151 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 67.8 mt -129.9 112.23 13.33 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 106.683 -1.599 . . . . 71.32 106.683 172.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.517 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 34.2 t -119.94 115.12 23.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.772 -0.825 . . . . 73.3 108.772 177.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -128.0 124.81 38.11 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.885 0.874 . . . . 75.32 109.044 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 73.1 t -124.49 153.17 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.227 1.011 . . . . 73.34 109.276 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.58 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.5 mt-30 -122.9 111.78 17.05 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.349 -0.982 . . . . 72.33 108.349 167.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.435 ' HG3' HD23 ' B' ' 106' ' ' LEU . 8.0 tp-100 -101.54 106.83 17.97 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.526 -0.916 . . . . 74.23 108.526 171.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.493 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -100.91 167.28 19.59 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 111.525 -0.63 . . . . 55.44 111.525 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.26 143.82 8.67 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.127 -0.559 . . . . 70.24 112.98 -174.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 79.3 mt -101.76 113.65 38.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 107.651 -1.24 . . . . 72.44 107.651 174.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . 0.406 ' O ' HG12 ' B' ' 55' ' ' VAL . 38.9 m-85 -127.49 147.46 50.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.311 0.644 . . . . 73.22 109.593 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.696 ' HA ' HG21 ' B' ' 55' ' ' VAL . 49.3 m -94.25 115.71 28.01 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.542 1.137 . . . . 62.11 110.456 177.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.628 HG21 HD12 ' B' ' 89' ' ' ILE . 3.8 mp -120.67 104.89 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 106.929 -1.508 . . . . 73.4 106.929 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.34 167.79 21.32 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.107 0.563 . . . . 74.3 110.559 -175.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.46 -45.82 3.29 Favored Glycine 0 N--CA 1.476 1.321 0 O-C-N 123.138 0.274 . . . . 70.13 113.096 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.634 HG23 ' HB3' ' B' ' 9' ' ' MET . 0.8 OUTLIER -58.03 167.74 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 124.839 1.255 . . . . 75.24 113.415 175.326 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -152.55 149.85 28.93 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.467 -1.242 . . . . 75.34 110.696 -174.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.19 -126.67 7.61 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.519 0.512 . . . . 71.42 112.236 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 20.3 m -90.1 -19.58 24.15 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.028 0.531 . . . . 64.12 110.202 175.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -53.44 -33.7 55.08 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.055 0.942 . . . . 75.11 111.368 176.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -62.22 -59.42 5.06 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.259 1.024 . . . . 74.44 111.707 -174.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.85 -14.15 58.29 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.348 0.659 . . . . 70.45 111.428 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -61.87 -38.61 88.91 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.846 0.858 . . . . 64.54 110.688 170.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.7 t -68.89 -55.36 11.29 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.81 0.444 . . . . 74.31 110.615 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.625 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 1.9 pp -74.17 -18.4 60.78 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.717 0.636 . . . . 73.01 112.717 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.41 0.93 55.78 Favored Glycine 0 N--CA 1.472 1.072 0 CA-C-O 119.413 -0.659 . . . . 74.21 114.199 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.04 -50.86 0.15 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 117.888 0.844 . . . . 71.45 112.006 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.401 ' O ' ' HB3' ' B' ' 104' ' ' ASN . 39.7 t80 -73.01 -39.58 65.9 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.333 0.653 . . . . 75.43 111.046 -177.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.625 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 82.0 m -75.13 -43.7 4.56 Favored Pre-proline 0 CA--C 1.563 1.446 0 CA-C-O 118.476 -0.773 . . . . 72.2 113.027 -175.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.7 -22.39 64.27 Favored 'Trans proline' 0 C--N 1.389 2.669 0 CA-C-N 121.185 1.459 . . . . 71.41 112.692 170.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . 0.401 ' HB3' ' O ' ' B' ' 101' ' ' TYR . 22.8 t-20 -64.15 -37.44 87.46 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.886 0.474 . . . . 75.2 110.861 172.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.9 mt -66.37 -40.85 87.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.536 0.735 . . . . 75.31 110.09 173.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.435 HD23 ' HG3' ' B' ' 80' ' ' GLN . 88.1 mt -75.0 -28.17 60.43 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.822 0.849 . . . . 73.12 112.775 -174.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -56.16 -47.35 99.01 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 118.068 -0.968 . . . . 74.33 113.464 -173.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . 0.513 ' HG2' ' HB2' ' D' ' 108' ' ' PRO . 85.0 Cg_exo -53.53 -42.99 61.45 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.813 2.342 . . . . 74.05 114.604 174.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.408 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 40.4 m-85 -67.62 -36.05 80.09 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.187 0.595 . . . . 73.23 110.476 -177.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.21 -39.75 74.95 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.573 0.749 . . . . 74.41 110.778 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.433 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 51.3 ttt-85 -60.79 -55.16 36.37 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.282 1.433 . . . . 74.0 111.175 -177.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -69.15 -26.15 64.73 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.618 0.574 . . . . 74.41 110.427 -177.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.498 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.8 t -70.44 -39.4 74.37 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 110.265 -0.272 . . . . 72.34 110.265 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.631 HD12 HG23 ' B' ' 64' ' ' VAL . 72.3 mt -61.44 -54.81 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 123.987 0.915 . . . . 74.03 109.762 170.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 36.7 m -59.1 -28.3 66.39 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.921 0.888 . . . . 74.14 111.263 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.475 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.8 t -68.28 -50.97 50.06 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 123.475 0.71 . . . . 73.22 109.943 175.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.4 mmt -68.22 -36.34 79.36 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.204 0.601 . . . . 75.11 111.206 -175.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.2 -43.55 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.606 1.162 . . . . 72.41 110.198 173.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 30.9 t -63.65 -34.44 77.84 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.014 -0.994 . . . . 72.45 110.581 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.528 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 81.2 mtt-85 -69.23 -34.76 75.34 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.89 -0.596 . . . . 73.23 110.297 178.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.28 -11.96 83.84 Favored Glycine 0 C--N 1.357 1.705 0 O-C-N 123.736 0.647 . . . . 64.43 112.456 170.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 16.9 m 66.92 33.63 5.79 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.769 1.628 . . . . 75.05 110.186 176.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -79.52 163.54 58.45 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 115.259 -0.882 . . . . 75.41 110.434 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -58.76 165.65 7.8 Favored 'Trans proline' 0 C--N 1.388 2.624 0 C-N-CA 122.655 2.237 . . . . 75.43 112.894 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.424 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 23.9 tp60 -63.88 112.47 2.93 Favored 'General case' 0 C--N 1.345 0.405 0 C-N-CA 123.86 0.864 . . . . 61.21 111.378 -167.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.546 HD23 HG13 ' B' ' 64' ' ' VAL . 23.3 tp -110.52 112.53 24.51 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.168 -0.924 . . . . 65.42 109.018 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.17 124.3 41.5 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 108.288 -1.005 . . . . 74.41 108.288 176.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.449 HD21 HG22 ' B' ' 64' ' ' VAL . 77.3 mt -83.59 136.62 34.17 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.691 0.396 . . . . 62.52 110.514 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.32 140.99 52.87 Favored Pre-proline 0 CA--C 1.55 0.952 0 O-C-N 123.972 0.795 . . . . 73.02 111.284 -174.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -60.02 93.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.541 2.828 . . . . 71.33 111.99 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 4.0 p -90.55 118.34 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 108.496 -0.927 . . . . 74.42 108.496 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 . . . . . 0 C--O 1.242 0.662 0 CA-C-N 115.617 -0.72 . . . . 73.21 109.182 -175.975 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.462 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 59.8 t80 . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 108.428 -0.953 . . . . 74.34 108.428 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -138.45 132.32 31.14 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 109.556 -0.535 . . . . 74.33 109.556 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 21.6 mt -77.71 128.89 38.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 O-C-N 123.957 0.786 . . . . 74.14 109.395 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.434 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.8 mm-40 -89.05 -46.57 8.75 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.471 0.709 . . . . 64.5 109.153 174.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.512 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 13.6 ptp180 -176.26 150.17 0.91 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.61 1.164 . . . . 73.14 109.63 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 76.9 mt -128.22 129.9 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.409 1.083 . . . . 74.02 108.3 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.503 ' HB3' HG22 ' D' ' 122' ' ' THR . 35.7 p90 -158.07 175.1 14.23 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.804 0.841 . . . . 73.31 110.421 -166.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.6 p -98.07 114.23 26.34 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 122.932 0.493 . . . . 73.32 109.982 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.534 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 27.9 mmtp -65.39 -30.37 71.18 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.449 -0.574 . . . . 75.3 109.449 165.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.61 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.1 t70 -162.35 146.65 12.1 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.142 -0.935 . . . . 72.15 110.651 -172.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.7 mt -138.32 147.11 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.785 1.634 . . . . 74.43 107.25 173.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 43.8 t -152.45 148.04 26.96 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 122.935 0.494 . . . . 74.44 110.535 175.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . 0.433 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 79.8 t80 -155.82 119.4 4.4 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 114.652 -1.158 . . . . 73.13 108.119 172.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -126.87 118.0 23.71 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.15 -0.685 . . . . 72.3 109.15 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.4 81.53 46.18 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 107.574 -1.269 . . . . 75.14 107.574 167.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.73 -36.05 43.01 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 122.739 2.292 . . . . 74.23 111.408 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -101.4 30.48 4.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.56 1.144 . . . . 74.32 109.535 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.24 -54.04 28.72 Favored Pre-proline 0 N--CA 1.495 1.789 0 C-N-CA 124.259 1.024 . . . . 73.51 113.297 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.46 -42.02 29.67 Favored 'Trans proline' 0 C--N 1.381 2.24 0 CA-C-N 121.17 1.454 . . . . 75.43 111.421 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -71.0 -27.75 63.92 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 114.277 -1.329 . . . . 71.41 113.042 -174.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.668 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.8 p -80.8 -28.93 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 O-C-N 122.059 -0.401 . . . . 72.33 111.664 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -65.15 -15.6 62.6 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 112.762 0.653 . . . . 75.01 112.762 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -105.32 22.46 15.37 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.947 0.899 . . . . 75.04 111.113 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.717 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -110.23 160.63 16.34 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.591 0.756 . . . . 65.52 110.562 -178.019 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -66.34 126.85 30.07 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.335 -0.617 . . . . 75.14 109.335 166.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -80.21 77.78 6.92 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.611 0.719 . . . . 65.2 109.683 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -129.02 66.44 76.31 Favored Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 123.963 0.905 . . . . 75.11 109.43 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -90.8 153.01 4.09 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.421 2.08 . . . . 52.44 112.578 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . 0.611 ' HB2' ' HE3' ' C' ' 41' ' ' LYS . 8.7 pt-20 -88.33 104.04 16.38 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.55 -1.278 . . . . 72.11 107.55 165.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.421 HG13 HD21 ' C' ' 126' ' ' LEU . 59.4 t -77.17 100.03 2.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.361 -0.977 . . . . 72.51 108.361 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.611 ' HE3' ' HB2' ' C' ' 39' ' ' GLU . 34.1 mmtp -103.59 105.57 15.84 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.421 -0.809 . . . . 75.23 109.96 -177.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mp -87.31 122.36 30.97 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 107.106 -1.442 . . . . 75.33 107.106 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.436 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 28.4 t70 -124.54 105.2 9.19 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.131 -0.692 . . . . 73.14 109.131 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.507 HD21 HG11 ' C' ' 62' ' ' VAL . 98.7 mt -94.2 141.96 27.95 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.871 0.868 . . . . 72.22 110.526 -177.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -148.46 143.64 26.87 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.255 -1.387 . . . . 73.51 107.255 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -133.93 149.55 51.29 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.883 -0.784 . . . . 74.11 108.883 175.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.77 143.55 27.6 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.443 -0.947 . . . . 72.13 108.443 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.424 ' HG ' ' HB3' ' C' ' 98' ' ' LEU . 7.0 m -132.3 150.71 52.1 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 109.908 -0.405 . . . . 74.42 109.908 -175.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.3 t -145.71 125.46 13.42 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.574 -0.898 . . . . 63.02 108.574 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -79.86 116.67 20.15 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.977 -0.749 . . . . 73.52 108.977 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.527 HD12 ' HB2' ' C' ' 57' ' ' GLU . 48.3 mt -86.04 -36.4 19.74 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.852 0.861 . . . . 74.03 110.614 -175.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.55 -172.04 3.81 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.015 0.926 . . . . 74.55 109.851 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -63.89 112.95 3.14 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.744 0.818 . . . . 64.43 109.958 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 63.99 20.8 12.36 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.641 1.176 . . . . 74.22 112.27 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 66.2 t -114.9 113.58 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.066 -1.087 . . . . 74.23 108.066 173.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -122.79 124.6 43.69 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.121 0.968 . . . . 74.0 109.673 -176.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.527 ' HB2' HD12 ' C' ' 51' ' ' LEU . 29.3 tt0 -84.46 137.74 33.19 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.501 -0.925 . . . . 65.31 108.501 168.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 92.4 t -127.21 136.37 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.544 -0.91 . . . . 75.41 108.544 172.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.433 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 58.4 t -130.08 126.06 61.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 108.931 -0.766 . . . . 74.31 108.931 177.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.503 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -102.61 98.16 8.25 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 107.162 -1.421 . . . . 75.33 107.162 -178.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -82.72 105.72 13.98 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.551 -0.907 . . . . 73.31 108.551 174.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.507 HG11 HD21 ' C' ' 44' ' ' LEU . 20.2 t -107.14 135.37 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.352 -0.981 . . . . 75.44 108.352 176.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 62.3 m -125.7 139.83 53.21 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.619 -0.882 . . . . 74.24 108.619 177.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.564 HG21 HG23 ' C' ' 114' ' ' ILE . 98.1 t -127.37 117.69 47.7 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 N-CA-C 108.744 -0.836 . . . . 74.11 108.744 173.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 19.3 m -103.81 140.16 38.03 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.114 -0.699 . . . . 73.12 109.114 171.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.39 112.35 17.45 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.61 -1.256 . . . . 74.33 107.61 174.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 30.4 m -126.67 127.67 45.52 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.008 0.432 . . . . 72.42 110.074 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.717 HD11 ' HG2' ' C' ' 34' ' ' LYS . 12.7 mt -96.96 23.37 7.27 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.96 1.304 . . . . 74.44 110.618 -174.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.74 -77.73 0.3 Allowed Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.196 -0.762 . . . . 50.33 111.196 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -117.48 -30.6 5.48 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.037 0.935 . . . . 74.1 109.418 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -79.68 122.54 26.68 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.551 1.14 . . . . 75.11 110.225 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 27.4 m -76.73 119.53 20.65 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 107.937 -1.134 . . . . 74.51 107.937 164.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.668 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -73.08 -48.51 35.27 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.385 0.612 . . . . 61.4 109.601 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -166.59 166.84 15.89 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 113.878 -1.51 . . . . 64.55 110.42 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -128.98 141.45 51.25 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.646 -1.612 . . . . 74.32 106.646 167.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 41.9 t -144.52 146.24 32.28 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.185 -1.043 . . . . 74.43 108.185 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -157.61 138.47 13.22 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.66 -0.496 . . . . 72.32 109.66 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.464 HG12 ' HA ' ' C' ' 110' ' ' ALA . 43.9 t -136.44 115.37 15.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 124.62 1.168 . . . . 64.33 108.375 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.61 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 50.9 mt-30 -90.59 86.85 6.51 Favored 'General case' 0 CA--C 1.523 -0.067 0 N-CA-C 107.922 -1.14 . . . . 62.32 107.922 168.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -80.11 99.38 7.71 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 108.573 -0.899 . . . . 75.55 108.573 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -102.34 146.09 16.75 Favored Glycine 0 C--O 1.217 -0.931 0 O-C-N 123.179 0.299 . . . . 63.33 113.193 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.13 146.18 14.37 Favored Glycine 0 C--N 1.331 0.264 0 N-CA-C 111.54 -0.624 . . . . 74.45 111.54 -176.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.515 HD13 HD12 ' C' ' 51' ' ' LEU . 30.7 mm -96.04 138.49 21.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.84 0 N-CA-C 109.389 -0.597 . . . . 74.25 109.389 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.527 ' CZ ' HD12 ' C' ' 106' ' ' LEU . 85.4 m-85 -136.36 123.08 21.11 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 123.36 0.664 . . . . 73.1 110.363 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 28.2 p -79.36 102.78 8.86 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 107.971 -1.122 . . . . 71.11 107.971 167.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 19.2 mt -117.21 114.94 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.949 0.899 . . . . 63.11 110.412 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -122.01 170.88 9.39 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.885 0.874 . . . . 74.11 109.131 172.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.73 -22.72 39.54 Favored Glycine 0 C--N 1.341 0.809 0 N-CA-C 114.308 0.483 . . . . 63.43 114.308 170.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.697 HD13 ' HA ' ' C' ' 94' ' ' MET . 44.8 pt -122.66 162.35 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 112.613 0.597 . . . . 74.14 112.613 -172.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -159.09 156.64 29.53 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 115.011 -0.995 . . . . 72.3 109.909 175.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.13 -122.36 6.15 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 123.802 0.689 . . . . 63.13 113.008 171.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 42.3 p -67.56 -29.89 69.37 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.504 0.722 . . . . 75.44 110.958 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -64.69 -59.94 3.68 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.753 0.821 . . . . 75.25 110.489 175.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.697 ' HA ' HD13 ' C' ' 89' ' ' ILE . 5.2 tpt -46.64 -53.93 10.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.951 1.3 . . . . 73.42 112.2 173.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.09 -44.61 91.92 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.447 0.699 . . . . 73.33 111.41 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -64.12 -33.44 75.77 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.027 0.931 . . . . 75.43 111.73 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.463 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 19.4 t -68.85 -55.85 9.81 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.551 -0.907 . . . . 75.44 108.551 177.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.424 ' HB3' ' HG ' ' C' ' 48' ' ' SER . 72.7 mt -65.43 -25.61 67.6 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.611 1.164 . . . . 74.35 112.964 -175.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.16 -8.77 26.92 Favored Glycine 0 C--N 1.347 1.174 0 N-CA-C 115.035 0.774 . . . . 71.13 115.035 -171.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.09 -52.88 0.38 Allowed 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 118.213 1.007 . . . . 74.11 111.766 -175.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.463 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 73.7 t80 -70.75 -58.49 3.58 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.272 0.629 . . . . 74.11 111.498 -173.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.561 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 83.0 m -53.52 -59.07 10.35 Favored Pre-proline 0 CA--C 1.559 1.321 0 CA-C-O 117.663 -1.161 . . . . 75.31 110.968 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.561 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 82.4 Cg_exo -50.51 -34.22 41.43 Favored 'Trans proline' 0 C--N 1.395 3.012 0 C-N-CA 122.822 2.348 . . . . 65.01 114.85 -177.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -65.03 -32.32 73.99 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.442 0.697 . . . . 72.23 111.24 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 35.3 mm -72.63 -31.77 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 123.922 0.889 . . . . 72.14 110.414 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.527 HD12 ' CZ ' ' C' ' 84' ' ' PHE . 5.5 mp -90.03 -17.12 28.4 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.474 0.71 . . . . 73.31 111.734 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -55.93 -49.6 92.05 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-O 117.829 -1.081 . . . . 75.42 113.778 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -61.16 -34.68 88.67 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 121.935 1.757 . . . . 74.31 113.07 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -64.24 -46.8 82.18 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.555 0.742 . . . . 75.43 110.217 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.464 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -65.07 -36.29 83.87 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.122 -0.945 . . . . 62.55 110.723 177.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -64.96 -49.45 70.28 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.058 1.343 . . . . 74.44 110.238 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.89 -32.52 73.06 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.484 0.714 . . . . 63.44 109.625 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 9.0 t -70.24 -39.7 74.9 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 122.985 0.514 . . . . 71.31 110.964 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.564 HG23 HG21 ' C' ' 64' ' ' VAL . 96.6 mt -67.68 -48.79 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.346 0.658 . . . . 73.1 109.828 177.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 15.7 m -66.03 -29.34 69.68 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.915 -0.584 . . . . 55.33 110.755 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 30.2 t -64.77 -50.29 67.38 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.363 -0.606 . . . . 73.03 109.363 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.591 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -55.8 -46.9 77.91 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.432 1.093 . . . . 74.34 111.59 177.536 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 69.2 t -65.69 -40.48 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.874 0.87 . . . . 73.42 110.87 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 33.8 t -72.18 -29.52 64.08 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.607 0.763 . . . . 73.55 111.481 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.551 HH22 ' HG2' ' D' ' 112' ' ' GLU . 64.6 mtt-85 -74.1 -29.62 61.94 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.447 -0.797 . . . . 74.43 109.782 176.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.23 12.43 58.35 Favored Glycine 0 C--N 1.353 1.479 0 O-C-N 124.015 0.822 . . . . 44.12 112.886 172.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 69.4 p 54.16 28.34 8.9 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 126.519 1.928 . . . . 70.33 114.214 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -84.24 151.93 60.58 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 109.365 -0.605 . . . . 74.44 109.365 172.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -47.39 136.23 19.93 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.35 2.7 . . . . 73.31 113.11 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.424 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 41.9 mm-40 -53.69 110.98 0.64 Allowed 'General case' 0 N--CA 1.478 0.965 0 O-C-N 124.317 1.01 . . . . 74.04 111.839 -175.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.421 HD21 HG13 ' C' ' 40' ' ' VAL . 3.9 tt -113.95 90.46 3.35 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.983 -1.117 . . . . 74.34 107.983 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -94.41 122.31 36.84 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.463 -0.94 . . . . 73.41 108.463 173.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 6.4 mp -66.73 145.18 55.81 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.174 0.921 . . . . 75.04 111.288 -171.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.8 151.9 77.06 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-N 115.602 -0.726 . . . . 64.32 110.791 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.584 ' HG3' HD13 ' A' ' 16' ' ' ILE . 21.6 Cg_exo -63.82 107.32 0.74 Allowed 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 123.062 2.508 . . . . 75.21 112.385 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . 0.439 HG13 HD13 ' C' ' 44' ' ' LEU . 7.4 p -103.84 139.84 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 123.926 0.89 . . . . 73.33 109.096 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -94.43 104.35 16.32 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.709 0.804 . . . . 63.24 110.325 -171.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -63.4 -34.58 78.03 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.909 0.884 . . . . 74.23 112.425 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -64.99 -40.15 94.53 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.218 0.607 . . . . 61.21 110.414 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.43 -30.42 67.26 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.573 0.749 . . . . 73.0 111.177 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 91.6 mt -72.39 -40.23 67.4 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.011 0.524 . . . . 75.42 110.139 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 25.8 t80 . . . . . 0 CA--C 1.546 0.825 0 CA-C-N 115.198 -0.91 . . . . 73.4 110.226 178.615 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 C--O 1.242 0.67 0 CA-C-O 120.98 0.419 . . . . 74.05 109.899 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -133.23 92.4 3.0 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 106.875 -1.528 . . . . 75.33 106.875 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -114.19 117.35 30.92 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.629 0.772 . . . . 75.22 109.163 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 9.0 mt -82.25 132.59 31.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.009 -1.108 . . . . 73.12 108.009 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -101.35 -28.59 12.52 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.624 0.77 . . . . 74.22 110.556 -174.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -173.44 133.12 0.48 Allowed 'General case' 0 C--N 1.361 1.09 0 O-C-N 123.618 0.574 . . . . 75.03 110.41 -176.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.402 ' N ' HD13 ' D' ' 16' ' ' ILE . 3.3 mp -114.04 130.47 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 107.212 -1.403 . . . . 73.2 107.212 173.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.452 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 37.4 p90 -163.65 175.79 10.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.987 0.899 . . . . 72.12 112.45 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.8 p -108.18 118.76 37.61 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 114.218 -1.356 . . . . 74.1 108.871 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.452 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 29.9 mtpt -90.52 -11.27 40.68 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.991 -0.744 . . . . 61.43 108.991 177.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.749 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 18.7 t70 -166.23 135.67 3.18 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 124.766 1.226 . . . . 75.24 109.376 -175.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.591 HG23 ' HE1' ' C' ' 117' ' ' MET . 52.8 mt -144.36 138.22 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.185 1.394 . . . . 71.33 107.937 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -145.45 138.64 26.32 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.838 0.855 . . . . 74.22 109.21 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.591 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.4 t80 -142.07 135.69 29.41 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.113 -1.44 . . . . 75.32 107.113 170.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -135.74 148.45 48.82 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 108.837 -0.801 . . . . 74.41 108.837 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' D' ' 28' ' ' ALA . . . -142.87 75.72 17.63 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 107.104 -1.443 . . . . 65.15 107.104 175.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.92 -27.81 30.17 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.777 2.318 . . . . 72.13 112.938 -169.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -108.2 1.01 21.82 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 115.415 -0.811 . . . . 75.4 110.696 -175.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' D' ' 25' ' ' ALA . . . -20.87 -73.09 0.03 OUTLIER Pre-proline 0 CA--C 1.567 1.61 0 N-CA-C 116.612 2.078 . . . . 73.54 116.612 -166.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.534 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 93.1 Cg_endo -75.15 -20.55 16.47 Favored 'Trans proline' 0 C--N 1.379 2.182 0 CA-C-N 123.962 2.451 . . . . 73.53 114.135 -173.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.466 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 5.1 t-160 -72.7 -40.63 66.06 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.877 0.871 . . . . 75.2 109.495 174.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.494 HG21 ' HA ' ' D' ' 73' ' ' ALA . 5.5 p -83.52 -20.66 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 CA-C-N 115.612 -0.722 . . . . 72.45 111.566 -173.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.415 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 22.5 m-85 -66.99 -20.65 65.92 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 111.982 0.364 . . . . 74.13 111.982 178.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . 0.466 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 62.0 mt-30 -64.03 -15.05 58.58 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.374 1.069 . . . . 73.34 110.926 176.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.642 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 93.2 mttt -92.7 96.62 10.28 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.117 1.367 . . . . 75.32 109.718 175.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -92.07 79.67 5.16 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.808 -1.087 . . . . 73.21 110.808 -172.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -158.89 171.33 20.26 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.447 -0.797 . . . . 73.54 109.727 168.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . 0.427 HE21 ' HD2' ' D' ' 38' ' ' PRO . 31.1 tp60 -67.65 115.3 25.9 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 123.836 0.855 . . . . 75.23 109.274 177.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.427 ' HD2' HE21 ' D' ' 37' ' ' GLN . 81.3 Cg_exo -49.05 131.12 25.3 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 123.079 2.519 . . . . 73.3 112.475 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -65.04 110.37 2.46 Favored 'General case' 0 C--N 1.346 0.428 0 N-CA-C 107.008 -1.478 . . . . 73.21 107.008 171.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.653 HG11 HG13 ' D' ' 64' ' ' VAL . 96.9 t -113.05 127.19 70.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 108.517 -0.92 . . . . 73.14 108.517 -175.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.453 ' HE3' ' HB3' ' D' ' 41' ' ' LYS . 0.5 OUTLIER -120.76 129.42 53.6 Favored 'General case' 0 C--O 1.248 0.991 0 N-CA-C 106.493 -1.669 . . . . 74.32 106.493 172.414 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.549 HD12 HG13 ' D' ' 62' ' ' VAL . 33.1 tp -97.1 129.29 44.53 Favored 'General case' 0 C--O 1.238 0.477 0 O-C-N 123.931 0.77 . . . . 73.45 110.111 -172.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.578 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.2 m-20 -108.98 112.38 24.55 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.535 -1.654 . . . . 75.24 106.535 177.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.403 ' CD2' HG21 ' D' ' 62' ' ' VAL . 25.8 mt -107.23 131.95 53.62 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.374 0.606 . . . . 65.4 109.903 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.512 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.3 t70 -133.85 153.65 51.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.21 -1.359 . . . . 55.31 108.063 176.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 5.1 t -126.61 149.85 49.23 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.006 0.922 . . . . 64.13 109.047 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.478 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -148.78 141.11 24.14 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.216 -1.031 . . . . 72.4 108.216 178.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 91.3 p . . . . . 0 C--O 1.243 0.723 0 N-CA-C 108.438 -0.949 . . . . 72.31 108.438 178.775 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 121.213 0.53 . . . . 75.02 111.024 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 p -133.57 101.06 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.398 1.079 . . . . 73.33 108.217 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -118.24 144.27 45.9 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 114.634 -1.166 . . . . 75.24 108.84 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -105.43 136.26 45.31 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.428 0.632 . . . . 64.3 110.81 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 90.3 t -114.54 144.8 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-N 114.098 -1.41 . . . . 73.23 108.03 174.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 52.2 t -135.99 127.76 44.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.668 -1.234 . . . . 73.14 107.668 176.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.552 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -109.67 102.14 10.99 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 106.844 -1.539 . . . . 63.25 106.844 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.512 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.6 ttt180 -83.8 95.2 8.37 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.46 -0.941 . . . . 75.24 108.46 176.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.549 HG13 HD12 ' D' ' 42' ' ' LEU . 66.5 t -96.33 117.18 40.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.661 -1.154 . . . . 73.42 108.97 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.578 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 23.8 m -123.06 130.25 52.54 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 114.9 -1.045 . . . . 75.11 108.725 -174.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.653 HG13 HG11 ' D' ' 40' ' ' VAL . 47.2 t -111.25 121.37 63.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 C-N-CA 124.821 1.248 . . . . 73.4 108.967 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 18.4 m -100.26 110.92 23.18 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.463 -1.31 . . . . 54.4 107.463 164.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.07 138.62 54.1 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.986 -0.746 . . . . 75.13 108.986 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.449 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 80.9 p -142.07 140.67 32.62 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.347 0.594 . . . . 73.53 111.241 -175.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 35.3 mt -112.92 114.5 27.02 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 106.889 -1.522 . . . . 71.22 106.889 169.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.19 -129.2 9.23 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 123.166 0.291 . . . . 73.43 112.423 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.76 5.34 36.03 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.492 0.717 . . . . 75.52 110.901 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.642 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 12.6 pt-20 -121.97 165.15 16.43 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.469 0.708 . . . . 74.1 109.586 -177.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 72' ' ' THR . . . . . 0.412 HG22 HD22 ' D' ' 75' ' ' LEU . 94.1 m -69.26 135.26 50.26 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.803 -0.635 . . . . 75.1 111.484 177.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.494 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -82.32 -68.69 0.68 Allowed 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.595 -1.261 . . . . 75.04 107.595 170.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -149.3 161.88 41.17 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 114.974 -1.012 . . . . 71.41 110.363 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.412 HD22 HG22 ' D' ' 72' ' ' THR . 78.7 mt -120.9 120.35 35.26 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.482 1.113 . . . . 73.53 108.22 176.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.625 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 1.7 m -116.78 139.15 50.91 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.214 -1.032 . . . . 70.13 108.214 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -157.12 121.85 4.46 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.931 0.493 . . . . 70.11 109.676 173.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -136.13 119.12 22.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 123.705 0.802 . . . . 71.43 109.041 -175.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.749 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.2 mt-30 -89.04 88.59 7.63 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 108.647 -0.871 . . . . 73.43 108.647 170.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -80.27 99.19 7.73 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.371 -1.286 . . . . 74.3 108.739 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.35 142.33 15.56 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 116.316 -0.402 . . . . 71.42 112.141 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.68 140.88 11.64 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 111.117 -0.793 . . . . 64.44 111.117 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 61.3 mt -90.78 119.14 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.933 -1.136 . . . . 73.32 107.933 175.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -119.85 131.31 55.24 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.692 0.797 . . . . 72.23 110.192 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 35.4 t -107.9 100.47 9.83 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.363 -0.977 . . . . 62.23 108.363 172.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 39.9 pt -110.54 147.67 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.674 1.19 . . . . 73.41 108.807 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.7 168.56 12.45 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.792 0.682 . . . . 65.0 111.033 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.6 21.92 49.09 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.596 0.56 . . . . 65.14 114.166 174.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -138.84 161.14 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.8 0.84 . . . . 74.32 111.475 -177.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -149.22 -171.89 3.99 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.215 -1.357 . . . . 74.33 109.192 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.31 -140.19 24.22 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-O 119.709 -0.495 . . . . 54.12 111.934 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 81.1 p -91.87 -35.82 13.84 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 117.529 0.664 . . . . 73.21 111.268 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.544 ' HA ' ' HB3' ' D' ' 96' ' ' HIS . 27.8 tp60 -65.63 -22.03 66.62 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.203 1.001 . . . . 73.51 112.023 -172.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.475 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 0.0 OUTLIER -60.85 -43.59 98.12 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.802 0.441 . . . . 73.01 111.433 177.257 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . 0.475 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -79.59 -31.01 41.72 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.775 0.83 . . . . 62.4 110.543 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . 0.544 ' HB3' ' HA ' ' D' ' 93' ' ' GLN . 18.8 t-80 -75.06 -25.3 58.53 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 123.935 0.894 . . . . 75.12 112.153 -175.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 85.2 m -65.87 -38.27 88.35 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.56 0.695 . . . . 74.11 109.795 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.611 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 12.9 tp -77.97 -35.96 49.63 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.831 -1.077 . . . . 74.53 110.421 177.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.74 -28.45 42.63 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.434 -0.803 . . . . 62.23 115.03 -171.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.24 -47.2 2.27 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 118.295 1.047 . . . . 74.12 111.396 -175.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -74.7 -34.59 62.65 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 112.031 0.382 . . . . 74.51 112.031 -174.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.611 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 90.3 m -67.01 -47.55 52.35 Favored Pre-proline 0 CA--C 1.565 1.553 0 CA-C-O 118.46 -0.781 . . . . 75.32 112.174 177.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.552 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.5 Cg_exo -55.84 -34.27 90.92 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 122.158 1.905 . . . . 72.24 113.136 169.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -61.96 -37.34 84.38 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.482 0.713 . . . . 65.04 111.123 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 44.9 mm -68.25 -41.53 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.528 0.731 . . . . 74.15 110.601 174.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 96.6 mt -78.17 -15.13 59.11 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.742 -0.663 . . . . 72.22 112.331 -172.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -70.03 -44.09 20.63 Favored Pre-proline 0 N--CA 1.485 1.294 0 N-CA-C 113.858 1.059 . . . . 71.32 113.858 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . 0.513 ' HB2' ' HG2' ' B' ' 108' ' ' PRO . 18.8 Cg_endo -58.03 -29.24 86.2 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 121.624 1.55 . . . . 71.34 112.771 172.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -81.18 -31.23 34.1 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.782 0.833 . . . . 71.54 111.493 175.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.91 -50.28 71.48 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.792 0.837 . . . . 63.14 109.934 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -73.51 -29.47 62.5 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.198 -0.91 . . . . 74.22 110.593 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . 0.551 ' HG2' HH22 ' C' ' 120' ' ' ARG . 23.5 tt0 -53.19 -46.18 68.88 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.458 0.703 . . . . 71.34 110.479 173.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.1 t -70.38 -47.37 61.23 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.426 -0.806 . . . . 75.34 111.226 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.501 HD12 HG21 ' D' ' 64' ' ' VAL . 76.8 mt -60.12 -61.27 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.887 0.875 . . . . 74.2 111.643 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 10.3 m -50.94 -38.94 53.54 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.448 1.099 . . . . 75.24 111.638 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 23.2 t -64.27 -48.29 76.32 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.347 -0.842 . . . . 73.01 110.012 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.447 ' HE2' ' HG ' ' D' ' 76' ' ' CYS . 73.7 mtm -67.24 -29.85 69.6 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.148 0.579 . . . . 74.45 111.767 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.443 HG23 ' O ' ' D' ' 114' ' ' ILE . 76.0 t -64.84 -46.69 91.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.62 0.768 . . . . 73.44 109.39 176.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.5 p -72.87 -31.42 64.72 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.875 -0.602 . . . . 62.21 110.588 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' D' ' 116' ' ' SER . 77.6 mtt-85 -69.46 -28.87 66.47 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.775 0.83 . . . . 74.12 110.405 174.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.8 10.01 74.1 Favored Glycine 0 C--N 1.351 1.378 0 CA-C-O 119.317 -0.713 . . . . 73.45 112.647 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.503 HG22 ' HB3' ' C' ' 17' ' ' TYR . 74.5 p 52.68 37.45 23.6 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 126.12 1.768 . . . . 65.32 113.499 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -99.81 151.86 37.62 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 115.01 -0.995 . . . . 75.3 109.645 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -51.84 145.38 32.05 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.478 2.786 . . . . 73.11 113.194 171.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -61.16 136.86 58.2 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.836 0.854 . . . . 73.54 112.631 -169.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.419 HD11 HG13 ' D' ' 40' ' ' VAL . 16.4 tp -124.81 99.42 6.14 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.434 1.094 . . . . 73.42 109.267 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -100.11 108.28 20.38 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 107.702 -1.222 . . . . 64.4 107.702 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 6.7 mp -70.81 116.28 10.94 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.333 -0.618 . . . . 73.44 109.333 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.11 141.38 93.84 Favored Pre-proline 0 CA--C 1.55 0.972 0 O-C-N 124.078 0.861 . . . . 63.13 111.772 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.67 116.05 3.03 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.537 2.158 . . . . 71.43 110.868 175.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 13.1 p -108.62 146.53 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.811 0.845 . . . . 75.33 109.315 -172.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -73.6 104.45 4.55 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.834 -0.802 . . . . 72.41 108.834 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 . . . . . 0 N--CA 1.471 0.601 0 C-N-CA 123.571 0.748 . . . . 74.12 111.516 -178.543 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.2 m . . . . . 0 CA--C 1.535 0.379 0 N-CA-C 109.177 -0.675 . . . . 62.33 109.177 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.464 ' CD1' HD13 ' A' ' 86' ' ' ILE . 65.6 t80 -131.42 112.48 12.73 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.823 -1.547 . . . . 70.43 106.823 167.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -137.72 114.15 10.27 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 107.809 -1.182 . . . . 72.14 107.809 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.565 HG23 ' HG2' ' C' ' 130' ' ' PRO . 51.0 mt -69.41 114.42 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 109.034 -0.728 . . . . 75.44 109.034 177.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -78.79 -34.74 45.21 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.285 -0.635 . . . . 73.45 109.285 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.419 ' HE ' ' HB ' ' B' ' 122' ' ' THR . 14.0 ttt85 -172.63 132.52 0.58 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.973 0.509 . . . . 75.35 110.227 -174.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.513 HD11 HD13 ' A' ' 13' ' ' ILE . 80.6 mt -117.44 127.35 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.021 -1.103 . . . . 75.14 108.021 166.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.44 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 25.0 p90 -163.78 154.02 15.28 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.787 0.679 . . . . 72.52 110.827 -171.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.7 p -80.03 116.78 20.35 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 109.712 -0.477 . . . . 73.41 109.712 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.44 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 42.9 mtpt -79.11 -25.52 43.0 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.601 -0.518 . . . . 72.1 109.601 172.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.495 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.1 t70 -155.06 146.8 23.31 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 114.882 -1.054 . . . . 73.34 110.526 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 81.2 mt -141.28 141.7 30.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 C-N-CA 126.114 1.766 . . . . 73.21 107.012 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.4 t -143.72 132.76 22.88 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.218 -1.03 . . . . 64.15 108.218 170.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.592 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 85.2 t80 -139.87 141.8 36.59 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.539 -1.282 . . . . 73.12 107.539 172.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -144.37 149.41 36.09 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.773 0.829 . . . . 72.25 108.889 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.28 74.83 11.67 Favored Pre-proline 0 C--O 1.241 0.639 0 N-CA-C 106.173 -1.788 . . . . 71.21 106.173 170.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.72 -29.93 28.53 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.233 1.955 . . . . 74.14 111.88 -171.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -96.82 9.43 41.81 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.798 0.839 . . . . 75.45 111.899 -175.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.36 -58.56 7.11 Favored Pre-proline 0 CA--C 1.563 1.471 0 N-CA-C 114.4 1.259 . . . . 73.23 114.4 -166.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.84 -40.3 48.41 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.884 2.389 . . . . 72.44 114.455 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -100.16 -13.97 18.73 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.214 0.82 . . . . 74.21 113.214 -175.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 73' ' ' ALA . 3.7 p -77.27 -18.75 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-O 120.892 0.377 . . . . 74.34 110.912 -175.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -74.11 -19.96 60.41 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.393 0.677 . . . . 75.3 111.127 175.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -73.87 -28.92 61.82 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.631 0.773 . . . . 74.13 109.779 174.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -69.8 159.5 33.48 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.956 0.902 . . . . 72.01 112.119 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -68.94 123.35 20.76 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.538 -0.756 . . . . 63.34 109.234 171.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.488 ' CE3' HD21 ' A' ' 68' ' ' LEU . 71.9 t-105 -75.04 84.88 2.29 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.894 0.854 . . . . 74.43 109.841 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.426 ' H ' HD23 ' A' ' 68' ' ' LEU . 23.7 tt0 -120.48 79.63 29.44 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 125.48 1.512 . . . . 74.43 107.53 173.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.31 112.66 3.52 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.04 1.826 . . . . 64.04 112.446 -174.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.56 97.32 9.67 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 105.38 -2.082 . . . . 75.33 105.38 168.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.517 HG12 HD23 ' A' ' 126' ' ' LEU . 17.6 t -95.45 100.87 11.73 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-N 115.406 -0.815 . . . . 74.35 110.826 -170.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -77.84 114.03 16.31 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.774 -1.103 . . . . 73.32 110.027 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.3 mt -103.36 111.16 23.45 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.591 0.756 . . . . 73.52 109.671 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.611 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.8 m-20 -102.23 147.28 26.84 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.592 -0.892 . . . . 74.53 108.592 172.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.595 HD13 HG22 ' A' ' 131' ' ' VAL . 77.0 mt -131.23 141.34 50.0 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.413 0.685 . . . . 75.13 110.293 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.487 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 25.6 t70 -144.51 122.11 11.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.412 -1.267 . . . . 74.13 108.056 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.4 m -113.37 129.09 56.62 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.926 -0.768 . . . . 73.24 108.926 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.74 117.46 15.03 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.583 0.753 . . . . 63.34 109.567 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 98' ' ' LEU . 19.4 p -88.86 173.32 8.59 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 122.968 0.507 . . . . 75.12 110.552 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.6 t -163.82 145.57 9.17 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.377 1.071 . . . . 74.55 108.771 -170.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -114.9 122.7 47.12 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.272 0.629 . . . . 72.21 109.31 170.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.421 HD12 HG23 ' A' ' 83' ' ' ILE . 51.6 mt -97.65 -37.61 9.84 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.387 0.675 . . . . 75.45 109.824 178.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.1 177.45 10.79 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.874 0.87 . . . . 72.05 109.481 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -64.59 125.36 24.45 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.853 0.461 . . . . 64.11 109.986 170.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 68.22 8.75 6.77 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.139 1.376 . . . . 74.34 112.163 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 51.5 t -115.62 92.74 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 108.31 -0.996 . . . . 65.44 108.31 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -110.59 122.3 47.42 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.077 0.465 . . . . 75.12 109.751 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -93.86 147.49 23.03 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.818 0.847 . . . . 73.42 109.101 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.8 t -131.79 143.32 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 107.986 -1.116 . . . . 75.12 107.986 173.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.503 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 60.6 t -121.42 137.96 53.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 108.487 -0.931 . . . . 71.22 108.487 176.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.89 98.76 6.51 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.243 -1.392 . . . . 72.24 107.243 175.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.487 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 43.3 ttp180 -84.98 101.23 12.21 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.48 -0.933 . . . . 74.44 108.48 173.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.6 t -95.69 132.71 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 108.003 -1.11 . . . . 70.33 108.003 175.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.611 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 12.0 m -112.93 142.15 45.93 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.927 -0.768 . . . . 64.22 108.927 171.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.586 HG22 HG21 ' A' ' 114' ' ' ILE . 77.1 t -135.84 114.85 16.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 107.502 -1.296 . . . . 71.4 107.502 -176.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.4 m -121.92 107.63 12.49 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.928 -0.767 . . . . 72.01 108.928 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.421 ' HB1' HG23 ' A' ' 40' ' ' VAL . . . -102.74 111.59 23.98 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 106.703 -1.592 . . . . 72.41 106.703 -176.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 54.7 m -120.73 135.91 55.01 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.716 0.77 . . . . 73.5 111.289 -173.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.488 HD21 ' CE3' ' A' ' 36' ' ' TRP . 35.1 mt -88.86 81.66 6.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.482 1.513 . . . . 62.31 107.779 175.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.12 -99.06 1.03 Allowed Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.471 -0.786 . . . . 54.42 111.894 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -94.84 -29.58 14.65 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.274 0.63 . . . . 74.42 111.175 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -98.18 127.82 44.33 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.269 0.628 . . . . 65.14 109.892 -170.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.3 m -69.25 132.81 47.07 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 120.993 0.425 . . . . 71.43 110.406 173.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.447 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -76.93 -52.21 9.82 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.188 -0.914 . . . . 75.01 108.728 174.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -160.26 164.17 32.88 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.814 -1.085 . . . . 75.31 110.916 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.9 tp -124.31 132.07 53.55 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.414 1.086 . . . . 73.24 108.438 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.461 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 37.0 m -130.48 116.63 18.47 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.78 0.832 . . . . 73.43 109.147 175.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -131.04 116.25 17.54 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.494 -0.558 . . . . 74.02 109.494 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.0 t -124.25 114.3 40.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 124.14 0.976 . . . . 75.1 109.374 -173.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.495 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 35.4 mt-30 -85.36 83.59 7.91 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.5 -0.926 . . . . 73.32 108.5 172.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -75.77 94.55 3.3 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 114.773 -1.103 . . . . 75.14 108.564 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.24 169.49 47.88 Favored Glycine 0 C--O 1.241 0.557 0 N-CA-C 111.013 -0.835 . . . . 73.41 111.013 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.23 120.74 0.91 Allowed Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 110.87 -0.892 . . . . 74.44 110.87 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.427 HG13 ' HE1' ' A' ' 17' ' ' TYR . 51.6 mt -82.61 127.07 40.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 107.805 -1.183 . . . . 74.24 107.805 174.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.634 ' HB3' HD11 ' A' ' 86' ' ' ILE . 66.7 m-85 -128.06 123.51 34.77 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.528 -0.916 . . . . 74.55 108.528 -174.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.7 t -87.32 93.55 9.43 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.361 -0.977 . . . . 73.42 108.361 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.634 HD11 ' HB3' ' A' ' 84' ' ' PHE . 18.9 mm -117.23 147.95 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.451 0.7 . . . . 71.23 111.146 -169.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.61 173.73 11.62 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.666 0.786 . . . . 75.11 110.307 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.22 -33.2 5.77 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.973 -0.558 . . . . 71.21 113.022 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.42 140.12 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.602 0.761 . . . . 71.53 110.515 -173.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.463 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 11.6 mp0 -131.52 174.78 9.74 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.709 0.804 . . . . 72.33 110.02 178.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.88 -123.21 27.98 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 124.0 0.813 . . . . 71.31 114.205 173.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.9 t -71.93 -25.25 61.82 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.289 0.635 . . . . 70.02 111.354 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -75.37 -38.0 60.28 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.599 0.76 . . . . 74.53 109.527 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.584 ' HE2' HD22 ' A' ' 98' ' ' LEU . 6.1 tpt -66.5 -45.55 79.17 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.511 -0.768 . . . . 62.44 109.367 174.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.8 -37.01 77.93 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.358 -0.837 . . . . 54.54 110.883 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -68.54 -34.62 76.17 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.738 -0.664 . . . . 75.55 111.001 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.2 t -69.3 -45.61 69.16 Favored 'General case' 0 C--N 1.348 0.5 0 N-CA-C 109.445 -0.576 . . . . 72.43 109.445 178.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.584 HD22 ' HE2' ' A' ' 94' ' ' MET . 49.2 mt -80.85 -22.3 40.01 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.47 -0.787 . . . . 71.54 112.273 -172.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.13 4.14 30.08 Favored Glycine 0 N--CA 1.475 1.239 0 CA-C-O 119.677 -0.513 . . . . 72.32 114.055 -174.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.498 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -142.71 -65.91 0.39 Allowed 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 117.406 0.603 . . . . 74.54 111.192 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -69.94 -43.34 71.81 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 111.988 0.366 . . . . 74.45 111.988 -173.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 65.6 m -66.65 -47.22 56.9 Favored Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 124.044 0.937 . . . . 71.0 112.806 -176.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.412 ' HA ' ' HB2' ' A' ' 106' ' ' LEU . 52.2 Cg_endo -67.41 -23.61 43.88 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 121.77 1.646 . . . . 71.42 113.168 170.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -66.39 -38.21 87.0 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 122.604 0.362 . . . . 74.41 110.033 173.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.9 mm -65.12 -45.71 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.742 0.817 . . . . 73.53 110.276 171.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 103' ' ' PRO . 61.4 mt -72.02 -21.77 61.5 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.763 0.825 . . . . 74.01 113.074 -172.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -66.85 -44.28 51.67 Favored Pre-proline 0 N--CA 1.484 1.264 0 N-CA-C 114.057 1.132 . . . . 73.45 114.057 -169.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -54.89 -31.54 73.78 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.812 1.675 . . . . 65.44 113.714 172.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.433 ' OH ' ' HB3' ' C' ' 130' ' ' PRO . 67.8 m-85 -84.49 -37.13 21.69 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.497 0.719 . . . . 72.43 111.305 -175.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.5 -46.87 78.03 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.286 -0.635 . . . . 64.23 109.286 172.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.526 ' NH1' HD13 ' C' ' 105' ' ' ILE . 32.9 ttm180 -49.57 -52.66 28.52 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 124.884 1.365 . . . . 74.4 110.463 174.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -63.27 -45.89 89.37 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.223 0.952 . . . . 73.24 112.05 -175.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.424 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 45.1 t -58.14 -46.25 85.98 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 124.045 0.84 . . . . 74.01 110.364 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.586 HG21 HG22 ' A' ' 64' ' ' VAL . 32.5 mt -60.93 -52.5 60.93 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 115.2 -0.909 . . . . 74.22 110.632 175.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.4 m -56.21 -40.16 73.6 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.127 0.892 . . . . 71.22 111.28 -174.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 41.9 t -67.62 -42.97 81.5 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 114.772 -1.104 . . . . 74.02 110.356 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.592 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 12.9 mtp -62.5 -37.38 85.79 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.552 0.741 . . . . 73.1 111.661 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 114' ' ' ILE . 86.1 t -62.2 -53.7 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.254 1.022 . . . . 61.1 109.917 177.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.5 p -69.92 -26.71 64.28 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.95 -1.023 . . . . 61.11 111.587 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.532 ' HG2' ' HG1' ' B' ' 18' ' ' THR . 18.0 ttm-85 -75.49 -31.61 60.27 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.182 0.993 . . . . 75.43 109.083 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.88 19.82 18.96 Favored Glycine 0 C--N 1.354 1.576 0 CA-C-N 114.948 -1.024 . . . . 55.14 112.916 171.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.5 t 61.44 9.12 2.48 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 127.497 2.319 . . . . 75.11 114.03 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -78.93 140.05 57.8 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 108.409 -0.96 . . . . 74.34 108.409 175.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.08 136.06 44.94 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.857 2.372 . . . . 63.21 111.854 175.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -52.07 133.54 33.09 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.308 1.005 . . . . 73.42 113.269 -170.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.517 HD23 HG12 ' A' ' 40' ' ' VAL . 58.7 tp -112.42 137.3 50.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.406 -1.27 . . . . 70.23 108.986 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.515 HD22 ' HA ' ' C' ' 15' ' ' ARG . 83.7 m-20 -122.93 123.75 41.64 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 107.806 -1.183 . . . . 74.43 107.806 178.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.5 mt -74.78 125.6 29.13 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.122 -0.696 . . . . 74.42 109.122 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.31 135.99 96.49 Favored Pre-proline 0 CA--C 1.555 1.17 0 CA-C-O 119.186 -0.435 . . . . 75.02 111.028 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.85 131.59 46.96 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 123.284 2.656 . . . . 75.21 113.705 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.595 HG22 HD13 ' A' ' 44' ' ' LEU . 67.2 t -115.07 133.56 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.87 0.868 . . . . 74.32 110.513 -177.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -88.49 87.87 7.42 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 108.663 -0.866 . . . . 73.02 108.663 173.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -60.87 -26.9 67.74 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.001 0.92 . . . . 73.34 111.965 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.498 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 4.1 t70 -71.02 -40.77 71.59 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 123.592 0.557 . . . . 64.03 109.648 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.52 94.17 Favored 'General case' 0 C--N 1.351 0.635 0 O-C-N 123.897 0.748 . . . . 72.55 110.772 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.7 mt -58.71 -50.95 71.99 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.694 0.621 . . . . 63.54 110.59 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 53.9 t80 . . . . . 0 N--CA 1.474 0.74 0 CA-C-N 115.855 -0.611 . . . . 64.45 110.363 178.979 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 14.6 ptm . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 114.053 1.131 . . . . 73.14 114.053 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 91.5 m -151.72 111.04 3.93 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.513 1.125 . . . . 71.43 108.424 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -109.56 144.48 37.81 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.853 0.461 . . . . 75.41 109.918 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -156.69 139.97 15.63 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.888 0.875 . . . . 64.03 109.505 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.8 mt -94.08 131.47 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.258 -1.386 . . . . 74.33 107.258 169.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -93.73 -46.69 7.12 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 120.968 0.414 . . . . 73.11 109.986 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -176.74 130.9 0.19 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.22 -0.9 . . . . 70.52 109.067 -172.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.555 HG21 ' CD1' ' B' ' 109' ' ' TYR . 81.6 mt -116.2 148.37 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 108.45 -0.945 . . . . 73.02 108.45 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -165.17 147.01 7.74 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 113.059 0.763 . . . . 74.42 113.059 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.532 ' HG1' ' HG2' ' A' ' 120' ' ' ARG . 54.2 m -73.53 121.42 20.57 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.457 -1.247 . . . . 74.43 108.991 168.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -99.4 -20.79 16.3 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.499 0.719 . . . . 75.45 111.929 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -164.67 135.54 4.14 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.326 0.25 . . . . 74.03 110.742 -171.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.527 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 48.4 mm -132.57 139.11 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.871 1.268 . . . . 72.14 109.601 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.527 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 37.2 t -136.28 126.73 26.78 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.38 -1.341 . . . . 70.54 107.38 174.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.463 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.8 t80 -145.01 111.6 5.75 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 107.589 -1.263 . . . . 73.53 107.589 170.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -128.32 112.73 14.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.311 -0.996 . . . . 61.51 108.311 -173.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.62 85.06 8.73 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 107.792 -1.188 . . . . 74.41 107.792 174.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.5 -30.07 12.73 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.579 2.186 . . . . 75.33 112.256 -175.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.447 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 2.1 m-20 -98.46 10.06 41.72 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.193 0.997 . . . . 74.2 110.571 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.92 -61.89 1.35 Allowed Pre-proline 0 CA--C 1.56 1.357 0 N-CA-C 115.293 1.59 . . . . 70.04 115.293 -164.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -62.76 -27.65 75.69 Favored 'Trans proline' 0 C--N 1.391 2.765 0 C-N-CA 122.347 2.031 . . . . 71.51 112.721 -169.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -94.24 -37.89 11.31 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.704 -1.134 . . . . 74.31 111.804 -172.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.542 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.1 p -69.6 -12.22 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 122.753 0.421 . . . . 74.32 112.109 -173.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -70.38 -9.72 57.07 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 112.868 0.692 . . . . 73.24 112.868 177.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -61.92 -26.2 68.03 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.623 0.769 . . . . 72.44 110.915 171.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.551 ' HB2' HD13 ' B' ' 68' ' ' LEU . 30.4 mmtp -89.24 84.73 6.51 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.482 1.113 . . . . 74.44 110.171 -174.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -88.3 82.53 7.04 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.125 0.488 . . . . 70.22 110.834 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 26.8 p90 -160.92 -172.05 3.32 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.513 1.125 . . . . 73.52 108.966 169.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -79.59 119.29 76.4 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.152 0.581 . . . . 74.54 110.722 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.506 ' HA ' HD21 ' B' ' 68' ' ' LEU . 20.6 Cg_endo -68.59 152.02 74.89 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 121.843 1.695 . . . . 74.02 111.343 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -71.35 102.68 2.67 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.596 -0.89 . . . . 72.35 108.596 173.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.667 HG21 ' HB1' ' B' ' 66' ' ' ALA . 50.6 t -94.84 142.77 13.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 114.667 -1.151 . . . . 74.31 110.24 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -140.0 109.74 6.35 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 106.933 -1.506 . . . . 75.35 106.933 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.463 HD12 HG21 ' B' ' 64' ' ' VAL . 35.6 tp -92.61 146.08 23.94 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.949 0.9 . . . . 74.54 109.845 -173.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.581 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 16.2 m-20 -131.34 143.16 50.29 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.758 1.223 . . . . 73.43 108.62 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 98.0 mt -129.99 128.63 42.44 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.922 -1.14 . . . . 73.34 107.922 174.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -140.84 143.96 35.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.091 0.956 . . . . 74.53 108.595 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 25.8 m -118.91 102.35 8.72 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.644 -0.502 . . . . 74.04 109.644 -175.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.46 ' O ' ' HB ' ' B' ' 59' ' ' VAL . . . -125.3 115.62 20.64 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 106.672 -1.603 . . . . 42.53 106.672 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 24.2 m -142.42 -178.27 5.67 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.75 0.42 . . . . 75.4 111.401 -164.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 69.4 p -150.67 137.01 18.65 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 123.396 0.678 . . . . 72.15 109.91 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -95.17 128.47 42.03 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.7 0.4 . . . . 74.04 110.097 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 19.0 mt -92.6 -30.99 15.34 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.491 0.494 . . . . 71.44 110.234 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . 0.478 ' HB1' ' HB ' ' B' ' 55' ' ' VAL . . . -171.41 175.15 4.23 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.842 0.857 . . . . 72.24 111.418 -176.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.72 137.33 57.74 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 107.019 -1.475 . . . . 74.44 107.019 159.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 70.81 -4.1 1.8 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.421 1.088 . . . . 74.33 113.234 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.478 ' HB ' ' HB1' ' B' ' 52' ' ' ALA . 41.2 t -135.15 96.71 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 108.334 -0.987 . . . . 74.22 108.334 -178.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -115.9 140.71 48.98 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.73 -0.841 . . . . 74.54 108.73 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -110.44 96.84 6.45 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.149 -1.426 . . . . 71.24 107.149 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -99.85 146.77 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 115.893 -0.594 . . . . 75.42 109.999 -174.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.46 ' HB ' ' O ' ' B' ' 47' ' ' ALA . 26.9 t -127.86 143.54 40.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 123.942 0.897 . . . . 74.04 108.802 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 46.4 tp -119.46 114.34 22.15 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.547 -0.909 . . . . 74.44 108.547 170.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -84.39 111.92 19.88 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.377 -0.972 . . . . 75.43 108.377 171.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 20.8 t -105.78 103.37 15.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.458 -1.312 . . . . 75.03 107.458 173.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.581 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 16.8 m -103.29 131.09 50.63 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.699 -0.482 . . . . 74.13 109.699 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.544 HG23 HD12 ' B' ' 114' ' ' ILE . 88.0 t -116.84 128.12 74.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 123.377 0.671 . . . . 61.23 109.903 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 90.0 m -106.67 141.19 38.33 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.637 -1.246 . . . . 74.42 107.637 163.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.667 ' HB1' HG21 ' B' ' 40' ' ' VAL . . . -147.47 140.58 25.12 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.537 -0.912 . . . . 70.34 108.537 174.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.456 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 29.2 p -142.91 128.28 18.87 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.748 -0.66 . . . . 73.42 110.589 -171.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.551 HD13 ' HB2' ' B' ' 34' ' ' LYS . 39.0 mt -99.52 108.81 21.33 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.133 0.973 . . . . 74.32 109.668 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.66 -125.86 9.49 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 116.018 -0.537 . . . . 74.32 111.872 -175.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -96.72 2.95 52.58 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.425 0.69 . . . . 64.41 112.105 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.447 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 17.3 pt-20 -125.01 159.43 31.32 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.901 0.48 . . . . 72.41 111.3 -174.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 85.0 m -67.77 130.58 43.43 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.582 0.753 . . . . 73.33 110.329 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.542 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -84.86 -67.51 0.79 Allowed 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.598 -1.26 . . . . 72.51 107.598 170.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -147.71 156.87 43.21 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.157 -0.929 . . . . 74.44 110.988 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 89.0 mt -124.24 109.89 13.97 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 107.008 -1.479 . . . . 73.24 107.008 172.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.5 t -117.87 156.72 27.93 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.653 -0.499 . . . . 61.24 109.653 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.527 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 38.1 tt0 -165.11 139.32 4.92 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.615 -0.883 . . . . 75.31 108.615 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.437 HG11 ' HA ' ' B' ' 110' ' ' ALA . 84.5 t -133.79 145.5 33.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.879 -1.156 . . . . 75.43 107.879 173.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -125.77 93.63 3.89 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.48 -0.933 . . . . 71.13 108.48 175.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.415 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.2 tp-100 -87.77 104.91 17.01 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.395 -0.821 . . . . 73.44 109.24 -177.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.06 173.37 29.02 Favored Glycine 0 C--N 1.336 0.553 0 O-C-N 123.664 0.603 . . . . 65.04 112.168 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.39 139.65 4.64 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 121.784 -0.246 . . . . 71.21 112.785 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 52.1 mt -85.69 113.45 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 108.37 -0.974 . . . . 71.33 108.37 173.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -117.4 135.45 53.87 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.643 0.777 . . . . 73.31 109.943 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 72.4 m -94.9 105.45 17.37 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.744 0.818 . . . . 65.23 109.633 172.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.535 ' H ' HD12 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -114.3 105.15 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 124.236 1.015 . . . . 74.14 108.685 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.0 163.02 24.64 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.335 0.654 . . . . 71.42 111.523 -174.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.72 -30.76 3.43 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 114.402 0.521 . . . . 53.22 114.402 172.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.584 HD13 ' HA ' ' B' ' 94' ' ' MET . 2.0 pt -67.83 161.29 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 124.495 1.118 . . . . 64.51 111.443 172.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -148.6 171.96 15.3 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 123.863 0.865 . . . . 75.21 111.062 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.52 -130.85 11.5 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 114.557 -1.201 . . . . 62.52 113.875 173.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 24.5 m -86.59 -35.7 19.3 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.853 0.861 . . . . 74.33 109.636 174.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -65.17 -23.33 67.08 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.103 -1.408 . . . . 73.32 111.666 -170.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.584 ' HA ' HD13 ' B' ' 89' ' ' ILE . 19.0 ptt? -66.23 -51.23 59.64 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.526 -0.761 . . . . 74.11 111.761 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.74 -13.46 59.43 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.483 0.713 . . . . 75.22 111.128 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -68.91 -32.57 72.29 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.308 0.643 . . . . 64.24 110.516 169.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -65.32 -52.09 56.27 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 120.899 0.381 . . . . 74.25 110.729 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.439 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.4 pp -71.13 -22.09 62.11 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 116.049 -0.523 . . . . 72.1 111.135 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.15 4.38 44.82 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 118.764 -1.02 . . . . 61.24 115.029 -172.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.27 -45.95 0.11 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 118.557 1.178 . . . . 72.03 111.294 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -74.82 -40.77 60.87 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.093 0.557 . . . . 73.45 110.686 -176.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.439 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 74.3 m -73.46 -46.19 7.55 Favored Pre-proline 0 CA--C 1.561 1.38 0 CA-C-O 118.492 -0.766 . . . . 72.44 112.94 -177.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.64 -16.48 54.95 Favored 'Trans proline' 0 C--N 1.396 3.064 0 C-N-CA 121.9 1.734 . . . . 73.52 113.246 171.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -73.33 -32.19 64.42 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.123 0.569 . . . . 74.04 110.644 172.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 91.3 mt -70.35 -39.73 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.04 0.936 . . . . 73.42 109.758 172.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 76.1 mt -75.57 -32.22 60.29 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.88 -1.054 . . . . 74.55 111.912 -174.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -57.24 -50.11 90.04 Favored Pre-proline 0 N--CA 1.488 1.471 0 CA-C-O 117.78 -1.105 . . . . 75.31 113.451 -173.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.35 -37.44 97.57 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 121.84 1.693 . . . . 70.25 112.593 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.555 ' CD1' HG21 ' B' ' 16' ' ' ILE . 3.6 m-30 -66.37 -39.37 89.08 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.727 0.811 . . . . 73.21 110.078 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.437 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -71.12 -31.56 67.91 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.15 0.98 . . . . 70.14 111.331 175.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -69.12 -52.96 22.93 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.529 1.132 . . . . 73.42 111.068 -173.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.0 -27.33 66.47 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.52 -0.548 . . . . 74.1 109.52 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.51 ' SG ' HD13 ' B' ' 21' ' ' ILE . 31.0 t -65.29 -42.6 92.95 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 122.945 0.498 . . . . 74.25 111.256 178.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.544 HD12 HG23 ' B' ' 64' ' ' VAL . 65.0 mt -62.74 -54.16 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.209 0.604 . . . . 72.51 109.573 173.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 4.3 m -62.32 -23.22 66.64 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 124.053 0.846 . . . . 74.23 111.334 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.447 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.3 t -69.19 -50.93 43.01 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 109.072 -0.714 . . . . 64.12 109.072 174.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.0 mmt -67.86 -34.96 77.7 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.074 0.55 . . . . 72.44 111.241 -176.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.505 HG22 HD22 ' B' ' 126' ' ' LEU . 70.4 t -64.75 -43.93 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.775 1.23 . . . . 74.54 110.216 174.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 31.4 t -64.74 -34.72 78.99 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.007 -0.997 . . . . 62.12 111.291 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' B' ' 116' ' ' SER . 82.1 mtt-85 -67.84 -35.88 79.36 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-N 115.718 -0.674 . . . . 62.25 109.802 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.31 -7.04 81.92 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.595 0.559 . . . . 64.15 113.324 172.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.419 ' HB ' ' HE ' ' A' ' 15' ' ' ARG . 8.5 m 64.94 33.4 9.89 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 125.144 1.377 . . . . 74.52 110.447 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -86.21 162.8 45.06 Favored Pre-proline 0 CA--C 1.555 1.173 0 CA-C-N 114.407 -1.269 . . . . 74.15 110.395 174.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.21 169.97 15.61 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.528 2.152 . . . . 71.01 113.415 -176.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.444 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 62.4 tp60 -64.44 115.93 5.6 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 115.224 -0.898 . . . . 75.31 111.759 -169.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.505 HD22 HG22 ' B' ' 118' ' ' VAL . 55.8 tp -109.82 98.04 7.44 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.334 -0.848 . . . . 74.42 109.357 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -103.5 103.05 12.97 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.611 -1.255 . . . . 73.11 107.611 173.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.541 HD13 HD13 ' B' ' 114' ' ' ILE . 91.0 mt -62.54 141.54 58.39 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.566 0.346 . . . . 74.1 111.14 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.3 140.28 88.07 Favored Pre-proline 0 CA--C 1.55 0.96 0 O-C-N 124.016 0.822 . . . . 53.41 111.128 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -65.92 97.35 0.34 Allowed 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.513 2.142 . . . . 74.33 111.072 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 27.4 m -90.86 112.37 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.728 0.775 . . . . 74.55 110.501 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 55.7 t30 . . . . . 0 C--O 1.24 0.595 0 N-CA-C 107.936 -1.135 . . . . 74.14 107.936 171.44 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 71.0 t80 . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 109.354 -0.61 . . . . 75.5 109.354 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -154.13 141.58 19.72 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.679 0.392 . . . . 75.42 110.11 171.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 17.1 mt -91.31 123.56 43.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 109.452 -0.573 . . . . 74.42 109.452 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -88.22 -42.89 11.99 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.127 0.571 . . . . 64.23 109.542 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.515 ' HA ' HD22 ' A' ' 127' ' ' ASN . 14.2 ptp180 -172.56 147.35 1.83 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.154 0.982 . . . . 75.34 110.307 -178.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 70.6 mt -125.03 130.79 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.104 1.362 . . . . 73.1 107.535 174.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.507 ' HB3' HG22 ' D' ' 122' ' ' THR . 31.1 p90 -162.96 173.26 13.87 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.682 0.753 . . . . 73.52 111.523 -167.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -98.36 117.28 32.42 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.982 -1.008 . . . . 63.1 109.586 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.476 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 21.4 mmtp -67.61 -48.08 67.83 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 107.904 -1.147 . . . . 63.45 107.904 168.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -139.32 144.01 38.08 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 113.85 -1.523 . . . . 73.04 109.921 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.9 mt -133.88 142.99 39.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 125.393 1.477 . . . . 74.24 107.078 173.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.0 t -152.5 146.0 24.91 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.325 0.583 . . . . 74.0 110.342 174.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -150.18 128.26 11.93 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 107.066 -1.457 . . . . 74.23 107.066 172.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -133.92 112.16 11.04 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.195 -0.668 . . . . 75.53 109.195 -177.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.56 80.81 69.32 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 107.695 -1.224 . . . . 72.25 107.695 166.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.29 -21.69 30.66 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.453 2.102 . . . . 70.23 111.609 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -100.49 15.0 29.38 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.985 1.314 . . . . 75.41 110.946 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.44 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -42.21 -56.51 5.32 Favored Pre-proline 0 N--CA 1.487 1.423 0 N-CA-C 114.385 1.254 . . . . 51.2 114.385 -169.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.44 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 36.1 Cg_exo -60.68 -41.6 45.78 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.286 1.991 . . . . 72.42 112.666 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -68.36 -39.09 81.94 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.025 -0.989 . . . . 65.34 112.059 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.711 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.1 p -79.2 -17.13 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.507 0 N-CA-C 112.841 0.682 . . . . 64.45 112.841 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -69.41 -26.85 64.83 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 112.745 0.646 . . . . 74.03 112.745 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -87.14 13.63 9.11 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.174 0.59 . . . . 70.5 111.591 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.44 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 0.7 OUTLIER -105.79 160.34 15.31 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.796 0.838 . . . . 75.51 110.756 -173.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -71.59 129.83 39.7 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.603 0.761 . . . . 71.44 109.877 173.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -82.9 90.19 6.93 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.574 0.75 . . . . 75.42 110.724 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -146.55 79.46 10.4 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 124.095 0.958 . . . . 74.41 108.845 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -86.24 158.36 9.75 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.547 2.165 . . . . 70.42 112.852 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.47 79.3 9.02 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 106.703 -1.592 . . . . 75.23 106.703 167.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 25.7 t -71.73 96.75 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.112 -0.949 . . . . 74.43 108.845 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.93 104.0 12.55 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.767 -1.568 . . . . 73.25 106.767 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 pp -85.48 145.59 27.35 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.967 -0.753 . . . . 75.02 108.967 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.418 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 22.5 t70 -128.12 115.44 18.43 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.746 -0.835 . . . . 72.44 108.746 178.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.509 HD11 HG13 ' C' ' 131' ' ' VAL . 93.0 mt -97.35 110.97 23.42 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.598 -0.519 . . . . 73.35 109.598 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -113.52 145.96 40.39 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.374 -1.343 . . . . 71.41 107.374 169.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.0 t -137.42 146.76 44.78 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.232 -0.655 . . . . 71.11 109.232 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.84 171.82 13.55 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.116 0.967 . . . . 61.05 108.8 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 32.8 p -156.15 156.03 33.53 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.284 0.633 . . . . 71.33 109.621 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -145.41 127.62 15.73 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.49 -0.93 . . . . 74.41 108.49 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -78.9 113.46 17.02 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 107.452 -1.314 . . . . 73.54 107.452 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.528 HD13 HD13 ' C' ' 83' ' ' ILE . 67.0 mt -84.61 -27.35 27.26 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.008 0.523 . . . . 72.14 110.444 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.3 -175.06 2.78 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.737 -1.12 . . . . 72.31 110.182 -176.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -64.37 104.11 0.73 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.101 -0.954 . . . . 71.04 110.343 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 65.56 21.33 11.73 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.453 1.101 . . . . 74.0 112.302 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.5 t -108.55 114.96 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 107.613 -1.254 . . . . 74.34 107.613 166.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . 0.409 ' HB2' HD12 ' C' ' 86' ' ' ILE . 85.2 m-85 -121.63 124.39 44.21 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.343 0.657 . . . . 72.44 109.542 -177.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -82.95 143.22 30.83 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 124.542 1.137 . . . . 74.41 108.563 165.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.448 HG12 ' HD3' ' C' ' 103' ' ' PRO . 96.0 t -132.95 133.55 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.787 -0.82 . . . . 73.44 108.787 171.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.445 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 58.7 t -113.4 139.71 37.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 123.661 0.785 . . . . 74.52 109.112 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.465 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -122.63 100.73 7.07 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.045 -1.465 . . . . 65.2 107.045 173.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -82.48 107.42 15.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.193 -0.912 . . . . 74.05 109.244 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 24.4 t -107.76 114.75 47.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.885 -1.154 . . . . 65.52 107.885 173.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 21.4 m -105.1 145.51 30.43 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.195 0.998 . . . . 74.02 108.783 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.544 HG23 HG21 ' C' ' 114' ' ' ILE . 87.4 t -126.49 119.49 53.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 109.103 -0.703 . . . . 74.44 109.103 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 38.6 m -99.14 134.72 41.59 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.559 -1.274 . . . . 72.53 107.559 166.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.27 103.83 4.5 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.115 -1.068 . . . . 75.12 108.115 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 42.4 m -130.31 132.25 45.79 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 121.156 0.503 . . . . 73.25 109.862 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 12.7 mt -85.54 38.21 0.73 Allowed 'General case' 0 CA--C 1.556 1.212 0 C-N-CA 124.793 1.237 . . . . 71.31 109.87 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.49 -111.8 2.64 Favored Glycine 0 C--N 1.354 1.533 0 N-CA-C 110.217 -1.153 . . . . 64.25 110.217 -168.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -90.47 -31.22 16.88 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.151 0.981 . . . . 72.5 109.879 174.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.44 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 7.0 tp10 -67.16 101.03 0.84 Allowed 'General case' 0 C--N 1.346 0.423 0 C-N-CA 124.032 0.933 . . . . 75.11 109.793 175.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 46.4 m -72.43 116.31 12.73 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.978 -0.749 . . . . 61.0 108.978 173.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.711 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -64.44 -49.17 72.53 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.072 0.858 . . . . 73.5 109.506 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -167.54 164.73 14.79 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.133 -1.394 . . . . 74.23 110.459 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.49 138.2 53.3 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 106.38 -1.711 . . . . 73.33 106.38 164.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 51.3 t -144.89 145.71 31.7 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.777 -0.823 . . . . 73.43 108.777 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -159.94 136.89 9.31 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.796 -0.446 . . . . 64.54 109.796 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 69.1 t -131.24 124.39 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.174 0.99 . . . . 72.35 108.668 175.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -99.85 84.12 2.85 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.789 -1.189 . . . . 73.41 107.789 177.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -78.63 95.74 5.32 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.33 -0.85 . . . . 74.14 109.502 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -94.56 146.52 18.2 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 115.697 -0.683 . . . . 72.41 111.905 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.08 140.74 9.64 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.346 -0.702 . . . . 72.43 111.346 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.574 HD11 ' HB3' ' D' ' 29' ' ' PRO . 15.4 mm -97.12 133.1 40.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 109.52 -0.548 . . . . 72.11 109.52 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.43 ' HZ ' HD11 ' C' ' 106' ' ' LEU . 25.7 m-85 -135.84 147.09 48.12 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.854 0.721 . . . . 74.42 110.029 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 12.9 p -101.2 101.16 11.8 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.806 -1.183 . . . . 73.4 107.806 168.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.606 HD11 ' SG ' ' C' ' 97' ' ' CYS . 22.5 mt -116.25 129.94 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.39 0.676 . . . . 75.33 110.303 -172.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.05 172.82 16.27 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.21 1.004 . . . . 74.23 109.516 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.32 -34.04 5.08 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-N 116.547 -0.297 . . . . 62.32 112.654 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.458 ' HB ' ' HB3' ' C' ' 93' ' ' GLN . 33.8 pt -96.69 162.28 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.54 0.736 . . . . 75.12 111.517 -176.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -158.52 152.47 23.69 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.674 0.79 . . . . 64.14 110.417 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.58 -127.94 8.38 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-O 119.717 -0.491 . . . . 73.55 112.879 174.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -59.46 -32.91 70.67 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 123.258 0.623 . . . . 71.05 110.817 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.458 ' HB3' ' HB ' ' C' ' 89' ' ' ILE . 21.6 mt-30 -62.74 -48.95 76.99 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.357 1.063 . . . . 75.51 111.695 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.551 ' HE3' ' HA ' ' C' ' 94' ' ' MET . 4.2 tpt -55.09 -52.67 62.49 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 123.784 0.677 . . . . 72.54 110.453 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.06 -32.49 73.87 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.146 0.578 . . . . 63.51 111.955 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -70.4 -32.64 70.35 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.87 0.868 . . . . 74.21 111.153 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.606 ' SG ' HD11 ' C' ' 86' ' ' ILE . 18.7 t -72.11 -43.96 63.93 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.295 0.569 . . . . 71.33 109.622 177.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 67.6 mt -81.02 -25.3 37.29 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 114.625 -1.17 . . . . 74.33 112.121 -174.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.4 3.29 20.23 Favored Glycine 0 N--CA 1.476 1.337 0 CA-C-O 119.201 -0.777 . . . . 74.14 114.719 -172.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.99 -53.15 0.15 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 118.151 0.976 . . . . 73.11 112.559 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -70.58 -58.6 3.51 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.884 0.474 . . . . 71.31 110.404 -171.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 58.9 m -64.64 -44.18 72.98 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-O 118.494 -0.765 . . . . 72.44 112.191 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.465 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 82.7 Cg_exo -53.7 -32.87 67.26 Favored 'Trans proline' 0 C--N 1.389 2.692 0 C-N-CA 122.366 2.044 . . . . 71.45 114.021 169.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -67.55 -40.72 84.95 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 122.974 0.51 . . . . 74.43 111.028 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.526 HD13 ' NH1' ' A' ' 111' ' ' ARG . 35.8 mm -70.66 -32.57 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 C-N-CA 122.812 0.445 . . . . 71.51 110.204 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.43 HD11 ' HZ ' ' C' ' 84' ' ' PHE . 2.5 mp -83.89 -20.83 32.38 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.455 1.102 . . . . 74.44 112.105 -176.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -58.44 -47.91 97.92 Favored Pre-proline 0 CA--C 1.554 1.108 0 CA-C-O 117.811 -1.09 . . . . 72.31 113.9 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -60.14 -37.37 84.24 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 121.91 1.74 . . . . 73.21 113.044 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -68.87 -43.74 74.75 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.602 0.761 . . . . 73.44 110.309 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.11 -40.17 94.96 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.035 -0.984 . . . . 75.5 110.35 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -63.98 -48.89 74.66 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.7 1.2 . . . . 73.54 110.496 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.74 -38.91 84.16 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.136 0.575 . . . . 70.4 109.805 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . 0.44 ' O ' ' SD ' ' C' ' 117' ' ' MET . 6.8 t -63.88 -42.78 97.42 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.685 0.394 . . . . 74.12 111.136 -178.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.544 HG21 HG23 ' C' ' 64' ' ' VAL . 75.8 mt -63.27 -52.01 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 122.911 0.484 . . . . 75.21 110.244 175.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 22.0 m -63.32 -27.92 69.65 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.849 -0.614 . . . . 74.4 110.877 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 26.6 t -66.86 -52.18 46.58 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.491 0.717 . . . . 74.3 109.274 173.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.658 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.1 OUTLIER -48.76 -46.56 41.42 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.706 1.202 . . . . 75.54 112.354 175.044 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 93.4 t -67.35 -43.03 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.557 1.143 . . . . 75.1 111.004 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 15.0 t -65.72 -30.99 71.74 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.226 1.011 . . . . 75.14 111.619 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.409 HH12 ' CD ' ' D' ' 112' ' ' GLU . 70.9 mtt-85 -75.0 -39.5 61.19 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.805 0.842 . . . . 72.51 109.676 178.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.68 -2.54 64.64 Favored Glycine 0 C--N 1.356 1.645 0 CA-C-N 115.436 -0.802 . . . . 64.51 112.876 170.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.1 p 65.38 30.01 11.18 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.316 1.846 . . . . 75.15 113.533 169.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -83.81 144.28 44.89 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 108.348 -0.982 . . . . 75.11 108.348 169.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.408 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 77.8 Cg_exo -50.42 143.26 27.74 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 123.318 2.679 . . . . 74.51 113.728 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.444 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 55.5 mm-40 -51.76 119.71 4.5 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.639 1.212 . . . . 70.14 112.337 -174.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 36.6 tp -124.15 84.22 2.25 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 107.587 -1.264 . . . . 75.21 107.587 -177.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -92.68 97.68 10.94 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.377 -0.829 . . . . 73.32 108.864 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -60.36 143.82 52.17 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.47 0.708 . . . . 75.42 112.019 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.2 142.54 97.92 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-N 115.171 -0.922 . . . . 75.33 110.617 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.565 ' HG2' HG23 ' A' ' 13' ' ' ILE . 4.9 Cg_exo -67.13 152.73 79.36 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.027 1.818 . . . . 71.42 112.762 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . 0.509 HG13 HD11 ' C' ' 44' ' ' LEU . 7.2 p -136.5 134.92 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.442 -0.799 . . . . 72.13 108.855 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -87.57 103.4 15.52 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.975 0.51 . . . . 74.42 110.254 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -61.87 -29.53 70.25 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.897 0.879 . . . . 73.23 111.82 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -56.58 -55.19 37.02 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.559 0.744 . . . . 75.23 110.061 173.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.23 -47.95 77.45 Favored 'General case' 0 C--N 1.349 0.55 0 O-C-N 124.227 0.954 . . . . 65.2 111.594 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 73.2 mt -59.02 -38.3 78.96 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.559 0.744 . . . . 73.44 111.559 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 39.8 t80 . . . . . 0 N--CA 1.471 0.624 0 CA-C-N 115.138 -0.937 . . . . 71.53 110.806 -177.271 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 C--O 1.242 0.694 0 N-CA-C 108.938 -0.764 . . . . 73.13 108.938 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.462 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 60.4 t80 -133.62 99.87 4.62 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.565 -1.272 . . . . 75.34 107.565 177.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -124.63 126.72 46.21 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.713 0.805 . . . . 73.53 108.868 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 11.0 mt -89.84 122.56 41.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.339 -0.985 . . . . 73.4 108.339 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -95.34 -18.94 20.36 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.37 0.668 . . . . 75.0 111.639 -171.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 179.05 124.28 0.05 Allowed 'General case' 0 C--N 1.359 0.989 0 C-N-CA 122.958 0.503 . . . . 72.34 109.818 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.54 136.34 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 106.854 -1.536 . . . . 71.42 106.854 167.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -160.6 145.08 14.14 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 123.389 0.43 . . . . 75.11 111.363 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.2 p -84.48 112.3 20.26 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.681 -0.69 . . . . 71.12 109.677 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -79.81 -18.07 51.78 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.664 -0.698 . . . . 74.45 109.377 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 4.3 t70 -157.51 147.5 20.55 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 124.803 1.241 . . . . 73.02 110.005 175.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.658 HG23 ' HE1' ' C' ' 117' ' ' MET . 69.6 mt -141.99 147.28 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.661 1.584 . . . . 74.11 107.423 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 22' ' ' SER . . . . . 0.632 ' HB3' ' HB2' ' D' ' 77' ' ' GLU . 32.8 t -155.35 144.48 20.88 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.327 1.051 . . . . 64.53 109.266 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.417 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 91.6 t80 -151.96 129.43 11.4 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.37 -1.715 . . . . 75.1 106.37 170.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -134.14 126.98 31.14 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.527 0.731 . . . . 71.34 109.248 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.43 86.41 48.38 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 107.621 -1.251 . . . . 74.44 107.621 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.48 -36.24 15.75 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.721 2.281 . . . . 70.34 112.815 -170.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -110.53 12.32 22.86 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.856 0.862 . . . . 74.45 110.359 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.41 ' O ' HG11 ' D' ' 31' ' ' VAL . . . -20.98 -70.23 0.04 OUTLIER Pre-proline 0 CA--C 1.57 1.714 0 N-CA-C 116.776 2.139 . . . . 72.2 116.776 -169.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.574 ' HB3' HD11 ' C' ' 83' ' ' ILE . 83.0 Cg_endo -76.26 -23.11 12.09 Favored 'Trans proline' 0 C--N 1.38 2.187 0 CA-C-N 123.741 2.372 . . . . 73.22 114.309 -174.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -71.24 -39.34 71.71 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.183 0.993 . . . . 74.35 109.3 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.52 HG23 ' HA ' ' D' ' 73' ' ' ALA . 9.8 p -84.0 -20.6 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.232 0 CA-C-N 114.798 -1.092 . . . . 73.03 111.825 -173.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.411 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 22.8 m-85 -67.22 -19.8 65.59 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 112.198 0.444 . . . . 74.22 112.198 177.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -63.09 -13.45 36.37 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.786 0.834 . . . . 73.2 110.958 176.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.684 ' HZ1' ' HG2' ' D' ' 71' ' ' GLU . 95.3 mttt -99.18 91.14 4.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.24 1.416 . . . . 73.12 109.804 176.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -88.25 85.45 6.91 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.271 0.558 . . . . 72.23 110.691 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 38.9 p90 -156.91 172.22 19.04 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.001 -1.111 . . . . 75.44 108.001 165.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -68.13 116.75 42.31 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 109.351 -0.611 . . . . 71.21 109.351 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -57.38 131.14 42.92 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.648 2.232 . . . . 74.54 111.752 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 22.5 tt0 -60.02 109.98 1.09 Allowed 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.837 0.711 . . . . 74.31 109.366 175.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.809 HG13 HG13 ' D' ' 64' ' ' VAL . 45.8 t -105.43 115.25 46.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 114.622 -1.172 . . . . 72.14 109.377 -177.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.31 126.36 52.14 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 106.71 -1.589 . . . . 74.3 106.71 170.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.487 HD12 HG12 ' D' ' 62' ' ' VAL . 50.1 tp -97.57 141.92 30.02 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.605 0.762 . . . . 75.43 110.046 -168.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.708 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.5 m-20 -125.05 123.92 40.83 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 107.244 -1.391 . . . . 74.54 107.244 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 88.7 mt -124.37 138.48 54.37 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.173 0.511 . . . . 73.12 111.078 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.523 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 9.5 t70 -143.18 155.35 44.52 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.434 1.494 . . . . 72.43 107.685 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.7 t -139.71 153.48 47.24 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-O 121.386 0.612 . . . . 74.42 110.074 174.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.9 170.46 18.76 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 114.588 -1.187 . . . . 63.4 109.005 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.3 p . . . . . 0 C--O 1.24 0.597 0 C-N-CA 123.406 0.682 . . . . 74.05 109.574 -177.394 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 112.914 0.709 . . . . 73.52 112.914 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 4.1 p -118.0 95.54 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 122.265 1.031 . . . . 73.1 108.95 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -117.46 146.56 43.41 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.12 -0.945 . . . . 72.41 109.924 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -102.82 145.41 29.8 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.876 -0.602 . . . . 74.43 110.462 173.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 70.3 t -131.45 141.82 44.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 114.06 -1.427 . . . . 70.53 107.523 172.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.43 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 46.3 t -131.23 132.07 63.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 108.294 -1.002 . . . . 75.33 108.294 176.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.469 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -107.96 117.45 34.16 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 106.632 -1.618 . . . . 75.55 106.632 172.308 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.635 ' HG2' ' HG2' ' D' ' 79' ' ' GLN . 0.0 OUTLIER -101.32 97.23 7.75 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.208 -1.405 . . . . 75.44 107.208 178.312 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.487 HG12 HD12 ' D' ' 42' ' ' LEU . 54.2 t -91.08 144.25 9.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.43 -0.952 . . . . 71.22 108.43 172.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.708 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 52.2 m -138.77 135.89 35.14 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.571 -1.27 . . . . 73.33 107.571 174.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.809 HG13 HG13 ' D' ' 40' ' ' VAL . 94.9 t -117.52 127.11 75.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.976 -0.75 . . . . 73.31 108.976 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 6.0 m -111.49 93.95 4.72 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.16 -1.052 . . . . 72.23 108.16 173.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.491 ' HB3' HG21 ' D' ' 40' ' ' VAL . . . -105.29 142.29 35.31 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.002 0.521 . . . . 75.51 111.295 -177.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.437 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 42.0 m -145.52 142.27 29.05 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.153 0.581 . . . . 72.43 110.81 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.412 HD12 HG22 ' D' ' 31' ' ' VAL . 19.4 mt -108.57 109.49 20.73 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.7 -1.222 . . . . 72.21 107.7 170.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.61 -124.39 7.51 Favored Glycine 0 C--N 1.345 1.056 0 O-C-N 123.212 0.32 . . . . 61.32 112.953 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.4 5.61 37.23 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.171 0.588 . . . . 73.52 111.842 -177.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.684 ' HG2' ' HZ1' ' D' ' 34' ' ' LYS . 11.2 pt-20 -124.3 155.39 38.75 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.093 0.557 . . . . 74.41 109.986 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 75.7 m -66.32 136.53 55.94 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 122.767 0.427 . . . . 72.25 110.726 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.52 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -89.51 -64.66 1.11 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.348 -1.352 . . . . 72.42 107.348 174.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -154.96 164.13 39.33 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 114.409 -1.269 . . . . 73.3 110.68 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 62.6 mt -130.12 144.49 51.38 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 105.821 -1.918 . . . . 75.55 105.821 174.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.687 ' SG ' ' HE3' ' D' ' 117' ' ' MET . 9.1 t -152.72 106.81 3.11 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 118.812 0.733 . . . . 63.15 110.777 -173.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . 0.632 ' HB2' ' HB3' ' D' ' 22' ' ' SER . 10.9 mp0 -122.69 127.82 49.78 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.193 0.997 . . . . 71.53 109.793 -169.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 64.3 t -138.53 121.81 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 122.876 0.47 . . . . 65.53 109.741 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.635 ' HG2' ' HG2' ' D' ' 61' ' ' ARG . 43.2 mt-30 -89.99 88.58 7.36 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 108.965 -0.754 . . . . 73.14 108.965 167.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -82.58 94.58 7.54 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.236 -0.893 . . . . 64.13 108.925 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.78 173.06 37.88 Favored Glycine 0 C--O 1.242 0.623 0 CA-C-N 116.141 -0.481 . . . . 63.34 112.432 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.44 148.27 10.95 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.519 -0.34 . . . . 54.43 112.459 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.4 mt -100.44 113.67 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 108.211 -1.033 . . . . 73.22 108.211 175.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -114.24 133.51 55.58 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.969 0.908 . . . . 73.44 109.891 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 35.6 p -96.68 105.44 17.55 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.977 -0.749 . . . . 43.3 108.977 172.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.467 HD11 ' SG ' ' D' ' 102' ' ' CYS . 61.7 mt -117.12 119.23 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.252 1.021 . . . . 75.44 109.25 -173.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.19 125.66 5.1 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.539 0.735 . . . . 53.42 110.569 -176.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.93 19.47 7.27 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-O 119.583 -0.565 . . . . 55.4 114.497 170.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.577 HD12 ' HA ' ' D' ' 94' ' ' MET . 0.8 OUTLIER -118.15 149.25 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 108.86 -0.793 . . . . 73.33 108.86 167.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -129.33 -179.96 5.44 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.183 0.993 . . . . 73.15 108.664 -171.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.07 -140.44 34.22 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 116.152 -0.477 . . . . 73.51 113.685 173.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 61.4 p -82.0 -33.79 29.93 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.313 0.645 . . . . 72.04 111.038 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -64.65 -26.25 68.31 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.516 0.726 . . . . 71.53 111.891 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.577 ' HA ' HD12 ' D' ' 89' ' ' ILE . 48.2 ttp -46.37 -60.46 2.32 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.913 1.285 . . . . 74.34 112.805 -176.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.68 -14.41 48.58 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.38 0.672 . . . . 63.12 112.248 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 45.2 m170 -72.05 -28.79 63.58 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.926 0.49 . . . . 73.45 110.579 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 70.9 m -62.02 -30.15 70.76 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.158 0.583 . . . . 74.45 111.078 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.2 tt -89.49 -44.98 9.75 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.827 0.851 . . . . 75.14 110.197 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.3 -13.3 74.1 Favored Glycine 0 N--CA 1.472 1.095 0 CA-C-N 115.983 -0.553 . . . . 75.45 114.331 -170.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.7 -53.16 0.81 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 117.314 0.557 . . . . 72.54 111.544 -173.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -68.37 -40.95 81.27 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 112.043 0.386 . . . . 75.22 112.043 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.467 ' SG ' HD11 ' D' ' 86' ' ' ILE . 78.2 m -66.33 -46.13 60.37 Favored Pre-proline 0 CA--C 1.562 1.415 0 CA-C-O 118.447 -0.787 . . . . 74.41 112.655 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.469 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 73.4 Cg_exo -55.08 -37.4 94.02 Favored 'Trans proline' 0 C--N 1.396 3.039 0 C-N-CA 122.152 1.901 . . . . 72.41 112.812 168.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -62.47 -36.86 83.82 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.256 0.622 . . . . 74.12 111.018 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 38.2 mm -69.98 -40.6 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.923 0.889 . . . . 73.33 110.865 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 89.4 mt -73.26 -16.89 61.38 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.877 -0.602 . . . . 72.3 111.937 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -68.53 -43.39 30.62 Favored Pre-proline 0 CA--C 1.555 1.168 0 CA-C-O 118.095 -0.955 . . . . 74.33 113.235 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . 0.402 ' HA ' ' NH2' ' D' ' 111' ' ' ARG . 58.9 Cg_exo -46.09 -43.42 20.49 Favored 'Trans proline' 0 C--N 1.382 2.322 0 C-N-CA 122.151 1.901 . . . . 72.33 113.897 167.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -77.78 -36.66 50.26 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.64 0.776 . . . . 73.32 111.769 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.84 -50.68 47.95 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.405 0.682 . . . . 64.32 110.127 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.622 HH12 ' HB3' ' D' ' 130' ' ' PRO . 36.5 ttp180 -54.92 -41.81 71.47 Favored 'General case' 0 C--O 1.211 -0.969 0 O-C-N 124.727 1.267 . . . . 75.04 111.02 172.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . 0.409 ' CD ' HH12 ' C' ' 120' ' ' ARG . 1.6 tm-20 -56.97 -53.84 53.52 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.161 0.913 . . . . 72.43 111.293 -175.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.0 t -55.02 -41.56 71.5 Favored 'General case' 0 C--N 1.348 0.523 0 O-C-N 124.469 1.106 . . . . 75.31 110.955 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.57 HG22 ' SG ' ' D' ' 76' ' ' CYS . 90.5 mt -64.22 -53.56 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.949 0.9 . . . . 74.03 110.834 177.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 93.2 m -55.45 -39.63 70.58 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.202 1.401 . . . . 71.42 110.375 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.0 t -66.97 -47.52 71.32 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.824 -1.535 . . . . 74.34 110.596 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.687 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 78.8 mtm -68.4 -25.56 65.11 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.557 0.577 . . . . 74.34 112.557 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.446 HG22 ' HB3' ' D' ' 126' ' ' LEU . 76.0 t -68.65 -45.8 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.656 0.782 . . . . 74.51 109.294 175.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 72.5 p -73.95 -27.21 60.89 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 115.536 -0.757 . . . . 75.52 110.48 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 78.0 mtt-85 -74.4 -27.3 60.57 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.694 0.798 . . . . 75.21 110.123 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.7 10.22 73.03 Favored Glycine 0 C--N 1.351 1.372 0 O-C-N 123.653 0.595 . . . . 51.12 112.704 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.507 HG22 ' HB3' ' C' ' 17' ' ' TYR . 82.5 p 51.38 37.18 18.38 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.195 1.798 . . . . 71.32 114.203 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -95.99 154.04 39.04 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.148 -0.933 . . . . 73.43 109.345 168.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -49.62 132.53 30.78 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 123.173 2.582 . . . . 74.23 112.517 168.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -50.1 128.45 19.04 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.155 0.982 . . . . 72.02 112.508 -174.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.543 HD11 HG22 ' D' ' 40' ' ' VAL . 21.4 tp -107.68 128.74 54.82 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.938 0.895 . . . . 71.33 109.066 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -129.16 99.78 5.37 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.164 -1.05 . . . . 64.35 108.164 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.48 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 2.8 mm? -64.26 121.18 13.65 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.513 0.725 . . . . 75.51 110.032 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.35 123.0 74.28 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 123.123 0.569 . . . . 73.04 111.179 -176.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.622 ' HB3' HH12 ' D' ' 111' ' ' ARG . 72.2 Cg_endo -76.41 114.77 3.95 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.542 2.161 . . . . 74.21 112.431 -176.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.25 145.22 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.806 0.842 . . . . 75.33 109.355 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -70.38 115.06 9.12 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.341 -0.615 . . . . 73.24 109.341 173.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 . . . . . 0 N--CA 1.482 1.157 0 C-N-CA 123.801 0.84 . . . . 74.43 111.367 -179.69 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.3 m . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 109.261 -0.644 . . . . 74.22 109.261 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -129.01 120.75 26.57 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.006 -1.109 . . . . 74.25 108.006 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -147.65 108.92 4.28 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.472 -0.566 . . . . 74.51 109.472 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.6 mt -72.84 123.55 27.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 109.117 -0.698 . . . . 73.42 109.117 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -88.25 -37.55 15.96 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.167 0.587 . . . . 72.53 110.73 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -167.41 141.46 3.66 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 116.269 -0.423 . . . . 74.41 109.903 -173.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.0 mt -130.16 134.85 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 108.277 -1.008 . . . . 74.32 108.277 173.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -163.09 178.17 8.51 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 124.296 0.998 . . . . 74.34 111.434 -170.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -108.55 122.03 46.22 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.949 -0.76 . . . . 71.23 108.949 175.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.461 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 37.2 mtpt -81.38 -25.93 35.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.176 0.59 . . . . 72.53 110.338 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -160.13 152.63 20.96 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.331 -0.849 . . . . 74.12 109.186 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.467 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 73.9 mt -144.14 150.82 16.49 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 C-N-CA 125.346 1.458 . . . . 72.2 107.725 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.438 ' N ' HG23 ' A' ' 21' ' ' ILE . 47.0 t -155.35 137.5 14.71 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.467 0.707 . . . . 75.33 109.842 173.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.495 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 86.5 t80 -143.67 122.07 12.38 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.402 -1.333 . . . . 74.34 107.402 174.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -124.76 114.72 19.64 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 109.227 -0.657 . . . . 74.2 109.227 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.05 80.75 0.44 Allowed Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 105.919 -1.882 . . . . 64.54 105.919 165.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.461 ' HG2' ' ND2' ' A' ' 27' ' ' ASN . 57.7 Cg_endo -68.99 -29.02 28.28 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.784 2.322 . . . . 53.31 112.59 -162.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.461 ' ND2' ' HG2' ' A' ' 26' ' ' PRO . 1.6 m-80 -115.86 30.13 7.54 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.864 0.865 . . . . 73.0 108.822 -175.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.454 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -44.8 -58.91 4.7 Favored Pre-proline 0 CA--C 1.569 1.673 0 N-CA-C 114.703 1.371 . . . . 73.4 114.703 -165.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.454 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 38.7 Cg_exo -60.34 -31.97 93.46 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 122.06 1.84 . . . . 71.35 113.087 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.5 ' HA ' ' NE2' ' A' ' 33' ' ' GLN . 6.8 t60 -81.74 -35.2 29.97 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.308 1.043 . . . . 74.55 112.385 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.571 HG22 ' HA ' ' A' ' 73' ' ' ALA . 6.0 p -79.87 -15.1 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 121.395 0.617 . . . . 75.22 111.718 -171.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -74.9 -12.19 60.3 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 116.089 -0.505 . . . . 73.22 111.482 168.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.5 ' NE2' ' HA ' ' A' ' 30' ' ' HIS . 9.3 mt-30 -83.37 -18.0 40.36 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 124.009 0.923 . . . . 70.51 110.584 171.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.55 ' HE2' ' HB3' ' A' ' 71' ' ' GLU . 26.3 mmmt -79.33 146.19 33.05 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.361 1.065 . . . . 65.14 111.451 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -61.67 128.14 34.84 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.134 0.974 . . . . 65.33 109.74 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.517 ' CE3' HD21 ' A' ' 68' ' ' LEU . 73.5 t-105 -82.21 88.83 6.48 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 121.121 0.486 . . . . 74.54 110.617 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 17.5 tm0? -129.33 84.96 60.62 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 106.205 -1.776 . . . . 74.24 106.205 167.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.07 125.23 10.72 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.475 2.117 . . . . 74.43 112.694 -173.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -97.0 92.95 6.32 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.757 -1.201 . . . . 62.31 107.757 169.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.73 HG23 ' HB1' ' A' ' 66' ' ' ALA . 88.2 t -94.82 107.63 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.345 0.658 . . . . 73.44 110.98 -175.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -88.13 129.52 35.29 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.361 -0.836 . . . . 73.45 109.415 175.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -95.88 119.33 34.18 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.897 -1.149 . . . . 64.31 107.897 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -130.18 141.6 50.64 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 108.795 -0.817 . . . . 70.11 108.795 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.601 HD13 HG23 ' A' ' 131' ' ' VAL . 56.6 mt -140.36 146.66 38.71 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.663 0.785 . . . . 74.42 110.0 -175.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -154.88 118.32 4.51 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.591 -0.892 . . . . 61.14 108.591 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.0 m -108.59 151.59 25.91 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.696 0.798 . . . . 74.34 110.453 -173.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.673 ' HB1' HH22 ' A' ' 61' ' ' ARG . . . -145.33 154.23 42.1 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.139 0.976 . . . . 73.44 109.886 172.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.408 ' HB3' HD12 ' A' ' 98' ' ' LEU . 4.1 m -112.87 154.68 25.95 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.991 -0.744 . . . . 71.5 108.991 172.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.0 t -149.61 117.57 6.31 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.125 -1.065 . . . . 74.03 108.125 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -79.96 105.14 11.02 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.154 -0.684 . . . . 75.23 109.154 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 57' ' ' GLU . 45.9 mt -78.96 -35.68 42.73 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.094 0.558 . . . . 74.34 109.616 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.57 175.28 14.1 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.104 0.962 . . . . 65.33 109.848 176.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -65.25 124.98 23.62 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.583 -0.895 . . . . 75.23 108.583 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 66.67 11.32 8.1 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.251 1.42 . . . . 74.45 112.728 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.03 107.06 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.401 -0.962 . . . . 75.41 108.401 173.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -119.69 126.11 50.32 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.864 0.866 . . . . 74.1 109.018 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.7 ' HB2' HD12 ' A' ' 51' ' ' LEU . 32.2 tt0 -86.32 146.15 26.61 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.162 -0.681 . . . . 74.4 109.162 167.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.8 t -128.19 133.89 66.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.045 -1.095 . . . . 74.33 108.045 171.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.4 t -115.28 132.53 64.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.256 -0.646 . . . . 74.35 109.256 176.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.04 108.67 18.97 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.639 -0.874 . . . . 75.54 108.639 172.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.673 HH22 ' HB1' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -80.53 99.92 8.31 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 106.489 -1.671 . . . . 74.23 106.489 164.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.441 HG21 ' HB1' ' A' ' 110' ' ' ALA . 43.2 t -96.46 122.01 47.55 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 107.583 -1.266 . . . . 74.22 107.583 172.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.4 m -118.47 137.87 52.88 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 123.91 0.756 . . . . 74.14 109.034 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 77.0 t -140.98 139.05 34.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 125.055 1.342 . . . . 73.32 107.435 -172.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 37.1 m -137.53 130.77 30.77 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 109.411 -0.588 . . . . 75.42 109.411 171.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.73 ' HB1' HG23 ' A' ' 40' ' ' VAL . . . -114.68 120.37 39.88 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.298 -1.371 . . . . 72.31 107.298 174.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -125.93 135.45 51.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.392 0.677 . . . . 74.52 110.607 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.517 HD21 ' CE3' ' A' ' 36' ' ' TRP . 27.4 mt -92.92 84.69 4.96 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.944 1.298 . . . . 64.24 108.8 177.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.41 -100.95 1.45 Allowed Glycine 0 C--N 1.342 0.877 0 CA-C-N 115.267 -0.878 . . . . 64.52 111.782 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.33 -19.62 13.41 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.871 0.868 . . . . 73.45 109.85 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.55 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 10.0 tp10 -94.02 124.69 38.19 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.637 1.175 . . . . 71.15 109.317 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -74.41 134.51 42.4 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.207 0.458 . . . . 75.4 110.963 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.571 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -78.3 -59.31 2.83 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.721 -0.844 . . . . 74.4 108.721 174.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -159.12 161.52 36.35 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.303 -0.862 . . . . 72.23 112.139 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.7 tp -111.71 148.35 33.64 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.992 1.717 . . . . 73.12 107.645 168.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.542 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 94.6 m -140.97 136.8 32.54 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.273 1.029 . . . . 75.24 109.154 177.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 28.1 tt0 -149.29 137.96 21.05 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.076 -0.713 . . . . 73.3 109.076 172.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.6 t -141.73 115.69 4.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 123.967 0.907 . . . . 74.23 108.91 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.517 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 79.1 mt-30 -83.63 84.43 7.54 Favored 'General case' 0 C--N 1.343 0.31 0 N-CA-C 108.705 -0.85 . . . . 72.42 108.705 170.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.418 ' HG3' HD23 ' A' ' 106' ' ' LEU . 8.5 tp-100 -77.88 92.0 4.22 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.514 -0.921 . . . . 75.44 108.514 177.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.03 144.94 17.49 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 110.746 -0.942 . . . . 71.35 110.746 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.17 134.35 5.33 Favored Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 111.081 -0.808 . . . . 75.04 111.081 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.9 mt -82.07 124.77 39.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 108.416 -0.957 . . . . 75.33 108.416 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.572 ' HB3' HD11 ' A' ' 86' ' ' ILE . 92.4 m-85 -129.79 121.57 27.09 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.736 0.814 . . . . 74.34 109.029 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.4 t -86.36 103.44 14.93 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.436 -0.95 . . . . 72.22 108.436 174.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.572 HD11 ' HB3' ' A' ' 84' ' ' PHE . 3.5 mm -118.56 149.67 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 109.689 -0.486 . . . . 63.51 109.689 -177.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.53 168.14 25.67 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.061 0.544 . . . . 74.14 110.735 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.23 -32.35 6.27 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 116.044 -0.526 . . . . 75.21 113.061 178.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.512 ' HB ' ' HB3' ' A' ' 93' ' ' GLN . 0.2 OUTLIER -122.21 141.12 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.622 0.769 . . . . 70.3 111.343 -173.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.629 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 21.7 mt-10 -142.37 173.54 11.44 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.54 1.136 . . . . 74.43 110.135 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.5 -125.33 28.68 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-O 119.771 -0.461 . . . . 64.24 112.614 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 77.3 p -76.83 -27.93 55.33 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.342 0.571 . . . . 70.12 110.616 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.512 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 0.8 OUTLIER -58.98 -41.98 88.86 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.588 0.755 . . . . 74.3 109.25 175.379 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.629 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 3.0 tpt -69.98 -42.27 73.33 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 114.662 -1.153 . . . . 75.33 110.986 175.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.42 -25.21 67.06 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.09 0.956 . . . . 74.52 111.901 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -70.67 -49.36 48.11 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.806 0.442 . . . . 63.41 110.364 172.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.44 -37.46 85.93 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 123.177 0.298 . . . . 70.53 110.755 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.408 HD12 ' HB3' ' A' ' 48' ' ' SER . 52.7 mt -91.26 -30.89 16.36 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.032 0.533 . . . . 73.44 112.438 -175.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.95 4.08 33.91 Favored Glycine 0 N--CA 1.476 1.333 0 CA-C-O 119.94 -0.366 . . . . 73.02 113.752 -172.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -142.85 -61.92 0.43 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 117.006 0.403 . . . . 74.3 111.192 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -73.63 -46.28 47.79 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 112.17 0.433 . . . . 75.42 112.17 -172.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 47.5 m -64.8 -47.91 73.88 Favored Pre-proline 0 N--CA 1.49 1.539 0 CA-C-O 118.303 -0.856 . . . . 75.21 112.465 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.17 -21.11 67.74 Favored 'Trans proline' 0 C--N 1.39 2.72 0 C-N-CA 121.805 1.67 . . . . 62.33 112.786 173.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -75.41 -33.0 60.93 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.866 0.466 . . . . 74.12 109.856 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 48.4 mm -69.93 -41.49 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.381 0.672 . . . . 74.24 109.753 171.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.418 HD23 ' HG3' ' A' ' 80' ' ' GLN . 66.1 mt -72.04 -30.51 65.24 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.654 0.781 . . . . 73.04 111.807 -175.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -61.01 -40.51 74.77 Favored Pre-proline 0 N--CA 1.488 1.431 0 N-CA-C 114.401 1.259 . . . . 74.52 114.401 -171.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -51.57 -42.99 53.26 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.071 1.847 . . . . 75.13 113.462 168.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.472 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 68.4 m-85 -75.83 -35.7 59.89 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.269 0.628 . . . . 65.45 111.045 -177.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.441 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -65.81 -48.38 71.9 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.734 0.813 . . . . 73.33 109.52 176.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.522 ' NH1' HD13 ' C' ' 105' ' ' ILE . 27.8 ttm105 -51.46 -52.15 48.86 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 125.05 1.469 . . . . 75.41 110.289 174.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -62.6 -45.98 90.41 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.61 1.194 . . . . 64.24 111.78 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.53 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.3 t -60.88 -36.98 80.61 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 123.872 0.733 . . . . 74.1 110.759 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.611 HD13 HD12 ' A' ' 128' ' ' LEU . 95.6 mt -67.94 -47.2 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.127 0.971 . . . . 75.52 110.439 174.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.4 HG22 ' HE2' ' C' ' 109' ' ' TYR . 35.7 m -59.37 -39.29 82.81 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.621 1.168 . . . . 75.45 111.27 -177.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -68.68 -44.12 74.7 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.364 -1.289 . . . . 65.23 110.224 -176.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.608 ' HE3' ' HA ' ' A' ' 114' ' ' ILE . 25.6 mtm -60.48 -39.43 87.61 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.987 0.515 . . . . 64.53 110.831 177.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 114' ' ' ILE . 71.6 t -63.19 -47.85 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.296 1.038 . . . . 74.32 111.424 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.8 p -71.52 -33.36 69.13 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 116.147 -0.478 . . . . 74.33 111.178 -176.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.462 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 90.0 mtt-85 -67.96 -33.28 74.35 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.739 0.816 . . . . 74.14 109.742 173.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.411 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.14 15.12 40.67 Favored Glycine 0 C--N 1.352 1.417 0 CA-C-N 115.437 -0.801 . . . . 54.42 113.37 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.6 t 62.0 9.47 3.07 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 127.281 2.232 . . . . 71.15 114.016 173.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -81.33 138.79 48.32 Favored Pre-proline 0 C--O 1.244 0.793 0 N-CA-C 107.672 -1.232 . . . . 75.43 107.672 172.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -53.98 142.53 64.57 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.75 2.3 . . . . 75.31 112.154 176.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -49.41 130.72 20.25 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.539 1.136 . . . . 74.34 113.779 -164.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.609 HD13 HG12 ' A' ' 40' ' ' VAL . 36.6 tp -109.27 108.62 19.28 Favored 'General case' 0 C--N 1.345 0.384 0 C-N-CA 123.169 0.588 . . . . 73.13 110.441 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.59 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 88.8 m-20 -103.26 125.76 50.08 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 107.699 -1.223 . . . . 74.03 107.699 175.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.611 HD12 HD13 ' A' ' 114' ' ' ILE . 17.8 mt -72.85 144.59 47.4 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 117.735 0.243 . . . . 71.33 110.809 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -70.74 133.49 86.48 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.105 0.562 . . . . 64.14 110.089 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.519 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 32.3 Cg_exo -59.97 114.4 2.07 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.576 2.85 . . . . 73.24 113.604 -173.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.601 HG23 HD13 ' A' ' 44' ' ' LEU . 45.6 t -100.23 135.64 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.372 0.669 . . . . 75.05 110.017 -177.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -101.84 89.93 3.83 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.207 -1.034 . . . . 75.44 108.207 175.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.489 ' CE1' HD11 ' A' ' 44' ' ' LEU . 44.5 m-85 -63.82 -30.79 71.84 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.814 0.846 . . . . 72.31 111.568 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.525 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 6.4 m-20 -66.08 -33.35 75.58 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.347 -0.842 . . . . 63.03 110.476 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.76 -42.25 64.23 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.155 0.582 . . . . 70.11 110.491 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.12 -49.07 79.26 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.521 0.677 . . . . 73.05 110.59 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 59.8 t80 . . . . . 0 CA--C 1.536 0.405 0 CA-C-N 114.142 -1.39 . . . . 71.15 110.071 177.919 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.533 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 19.6 ptm . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 111.976 0.361 . . . . 71.34 111.976 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 5.5 t -153.09 138.99 18.06 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 109.147 -0.686 . . . . 73.43 109.147 166.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.451 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 68.9 t80 -134.28 137.74 44.5 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.13 0.972 . . . . 75.32 108.418 176.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -144.51 141.28 29.41 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.991 0.516 . . . . 55.32 109.938 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 66.9 mt -88.86 110.01 20.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 107.699 -1.223 . . . . 74.5 107.699 171.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -81.8 -39.1 24.57 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 123.282 0.364 . . . . 73.14 110.322 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -169.3 134.71 1.55 Allowed 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.304 0.377 . . . . 74.41 110.384 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.0 mt -114.97 142.58 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 107.247 -1.39 . . . . 71.34 107.247 171.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.425 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 40.1 p90 -169.81 162.67 9.59 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-O 122.045 0.926 . . . . 74.24 113.127 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 56.7 m -90.04 121.18 31.88 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 113.414 -1.721 . . . . 74.11 108.585 171.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.425 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 22.7 mtpp -87.29 -32.43 19.69 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.724 0.81 . . . . 74.51 110.52 178.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -158.52 143.49 16.25 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.022 -0.536 . . . . 74.44 110.89 -170.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.495 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 45.9 mm -136.3 142.88 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.466 1.506 . . . . 75.11 109.093 176.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 24.1 t -145.56 134.66 22.73 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.521 -1.218 . . . . 74.31 107.907 168.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.467 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 91.2 t80 -138.71 128.08 24.41 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.421 -1.696 . . . . 74.31 106.421 169.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -135.47 112.02 9.96 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.913 -1.143 . . . . 74.13 107.913 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.83 87.34 4.42 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 107.144 -1.428 . . . . 73.44 107.144 171.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.86 -42.01 21.48 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.654 2.236 . . . . 70.33 111.298 -174.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -97.39 5.77 49.28 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.726 -1.125 . . . . 74.43 111.65 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -29.81 -67.78 0.13 Allowed Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 115.428 1.64 . . . . 73.32 115.428 -166.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.461 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 21.3 Cg_endo -60.43 -28.49 86.84 Favored 'Trans proline' 0 C--N 1.397 3.106 0 C-N-CA 122.605 2.203 . . . . 61.42 113.03 -171.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -95.86 -39.76 9.66 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.981 -1.009 . . . . 70.32 111.996 -171.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.483 HG22 HD11 ' B' ' 68' ' ' LEU . 10.5 p -69.47 -11.76 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.22 0.608 . . . . 73.1 111.419 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -63.39 -13.18 36.95 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.269 0.628 . . . . 75.43 112.65 172.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -68.84 -13.07 62.18 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 123.874 0.87 . . . . 73.42 112.077 175.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.453 ' HB2' HD13 ' B' ' 68' ' ' LEU . 32.8 mmtp -97.41 92.71 6.09 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.494 1.118 . . . . 74.13 109.813 -174.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -92.81 80.44 4.68 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.364 0.665 . . . . 74.53 110.914 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 37.3 p90 -165.07 177.53 7.68 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.056 0.942 . . . . 73.41 110.123 170.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -69.12 116.65 44.17 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 123.677 0.791 . . . . 74.42 109.667 173.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.429 ' HD3' ' HG2' ' B' ' 124' ' ' PRO . 34.2 Cg_endo -68.28 148.77 74.91 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 121.704 1.602 . . . . 72.31 110.727 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -71.19 104.07 2.98 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.776 -1.194 . . . . 74.35 107.776 172.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.722 HG21 ' HB1' ' B' ' 66' ' ' ALA . 32.9 t -98.09 141.51 16.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 114.705 -1.134 . . . . 71.22 109.568 -177.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -118.75 114.53 22.84 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.405 -1.702 . . . . 73.05 106.405 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.529 HD12 HD21 ' B' ' 128' ' ' LEU . 17.8 tp -89.15 132.21 34.93 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.238 -0.652 . . . . 73.32 109.238 174.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -129.41 148.2 51.3 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.871 1.268 . . . . 70.32 108.398 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.77 151.53 41.32 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.643 0.777 . . . . 75.42 110.469 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 19.8 t70 -148.11 139.37 23.45 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.654 1.182 . . . . 64.14 108.252 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.5 m -113.5 115.37 27.89 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.732 -0.84 . . . . 75.24 108.732 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.62 134.31 55.16 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.632 -0.877 . . . . 64.11 108.632 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.651 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 16.4 m -142.76 160.24 40.71 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.849 -0.426 . . . . 65.42 109.849 -175.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 29.5 p -166.63 136.9 3.21 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.678 0.791 . . . . 75.14 110.379 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -85.96 79.64 9.14 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 108.242 -1.021 . . . . 72.33 108.242 172.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.429 HD21 ' HB3' ' B' ' 57' ' ' GLU . 2.7 pp -93.1 6.57 47.49 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.506 -0.77 . . . . 73.31 111.02 -177.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.65 154.61 18.48 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.77 1.228 . . . . 74.3 108.773 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -75.75 129.19 36.68 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.646 0.378 . . . . 74.02 110.726 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 70.62 -3.12 2.01 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.957 1.303 . . . . 73.5 113.55 173.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 30.7 m -134.65 122.9 40.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.013 -1.106 . . . . 73.14 108.013 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.651 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 0.1 OUTLIER -99.34 156.76 16.83 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.654 0.782 . . . . 71.23 109.424 -177.087 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.429 ' HB3' HD21 ' B' ' 51' ' ' LEU . 4.5 tm-20 -121.41 97.43 5.51 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 105.728 -1.953 . . . . 75.24 105.728 166.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.522 HG22 ' HG ' ' B' ' 48' ' ' SER . 12.5 p -100.56 141.76 16.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.768 -0.827 . . . . 75.1 108.768 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.43 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 18.4 t -115.57 148.25 18.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 124.944 1.298 . . . . 73.15 108.645 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 60.1 tp -128.36 107.06 9.44 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.477 -0.935 . . . . 75.53 108.477 171.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.465 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 31.3 ttm180 -86.64 132.72 33.81 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.151 -1.055 . . . . 73.53 108.151 172.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 38.9 t -129.46 124.65 60.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 107.243 -1.391 . . . . 75.43 107.243 175.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 6.3 m -120.78 131.06 54.28 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.378 -0.601 . . . . 74.03 109.378 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.472 HG13 HD23 ' B' ' 126' ' ' LEU . 89.6 t -119.41 108.41 23.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 123.905 0.882 . . . . 65.32 109.335 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 93.9 m -90.21 138.4 31.56 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.346 -0.983 . . . . 71.53 108.346 167.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.722 ' HB1' HG21 ' B' ' 40' ' ' VAL . . . -148.25 142.47 26.13 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.234 -0.654 . . . . 75.54 109.234 175.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 17.0 p -144.28 134.69 24.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.367 -0.833 . . . . 55.33 109.973 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.483 HD11 HG22 ' B' ' 31' ' ' VAL . 62.9 mt -101.19 113.89 27.35 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.577 1.151 . . . . 73.15 110.072 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.18 -112.02 3.62 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-N 115.686 -0.688 . . . . 65.45 111.548 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.58 27.62 6.85 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.396 0.679 . . . . 63.3 109.795 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -141.23 153.27 45.17 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.192 -0.67 . . . . 73.52 109.192 176.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 56.8 m -68.17 135.2 51.71 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.225 0.536 . . . . 74.44 110.855 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.453 ' HA ' HG23 ' B' ' 31' ' ' VAL . . . -88.26 -66.01 0.96 Allowed 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.41 -1.33 . . . . 75.14 107.41 174.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -150.27 159.29 44.55 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 114.881 -1.054 . . . . 75.3 110.267 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 78.4 mt -134.07 108.53 8.39 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.396 -1.705 . . . . 74.01 106.396 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.1 t -119.82 151.53 38.7 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.104 -0.702 . . . . 71.04 109.104 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -159.23 134.39 8.29 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.511 -0.922 . . . . 73.32 108.511 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.433 HG21 HD12 ' B' ' 21' ' ' ILE . 85.4 t -128.99 143.92 39.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.997 -1.112 . . . . 74.13 107.997 175.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -122.94 96.18 4.91 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.382 -0.97 . . . . 64.12 108.382 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -91.12 102.38 15.13 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.284 -0.636 . . . . 75.23 109.284 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -94.9 165.84 25.81 Favored Glycine 0 C--N 1.339 0.749 0 O-C-N 123.58 0.55 . . . . 41.44 112.138 177.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.9 134.6 3.27 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-O 119.772 -0.46 . . . . 71.41 113.314 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.409 HD12 ' HE1' ' B' ' 17' ' ' TYR . 3.9 mp -86.12 117.82 31.47 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 107.226 -1.398 . . . . 74.24 107.226 170.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -121.84 135.94 54.92 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.592 0.757 . . . . 73.53 109.112 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 56.1 m -89.34 126.26 35.46 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.785 0.834 . . . . 72.22 109.254 173.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.557 ' HB ' HD12 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -133.65 130.3 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.079 0.951 . . . . 72.41 108.468 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.67 171.98 19.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.505 0.722 . . . . 63.23 110.645 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 87.18 -50.13 4.07 Favored Glycine 0 C--N 1.352 1.437 0 C-N-CA 123.608 0.623 . . . . 72.22 111.949 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.557 HD12 ' HB ' ' B' ' 86' ' ' ILE . 11.3 pt -59.08 148.08 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.981 1.313 . . . . 70.21 111.81 171.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -153.19 163.31 40.11 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.837 0.855 . . . . 71.33 109.595 -176.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.35 -121.73 6.22 Favored Glycine 0 C--N 1.351 1.371 0 C-N-CA 123.358 0.504 . . . . 53.43 112.847 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 18.8 m -73.58 -39.71 64.44 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.883 0.849 . . . . 74.2 109.909 174.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -66.68 -27.11 67.39 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 113.623 -1.626 . . . . 72.12 111.96 -167.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.406 ' HA ' HD11 ' B' ' 89' ' ' ILE . 9.6 ptm -65.95 -57.71 7.22 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.675 -0.693 . . . . 74.21 111.661 -175.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.23 -14.51 57.42 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.352 0.661 . . . . 64.21 111.89 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -61.12 -40.28 93.18 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.735 0.814 . . . . 71.31 110.906 169.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.1 t -66.36 -54.27 26.47 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.705 0.402 . . . . 75.42 111.29 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.48 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.2 pp -68.34 -25.38 65.07 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.855 0.462 . . . . 72.44 112.167 -176.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.89 2.88 58.5 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-O 119.649 -0.528 . . . . 65.34 114.2 -175.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.73 -55.06 0.19 Allowed 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 117.56 0.68 . . . . 65.45 112.136 -174.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -70.56 -43.34 69.7 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.426 0.69 . . . . 74.34 111.146 -176.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.48 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 56.5 m -72.86 -43.27 8.12 Favored Pre-proline 0 CA--C 1.566 1.586 0 CA-C-O 118.621 -0.704 . . . . 72.21 112.784 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.0 -30.52 93.62 Favored 'Trans proline' 0 C--N 1.396 3.058 0 C-N-CA 122.229 1.953 . . . . 73.4 113.906 170.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.15 -37.66 77.85 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.567 0.747 . . . . 72.23 111.503 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 54.9 mt -65.11 -39.08 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.882 0.873 . . . . 74.4 110.782 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.19 -23.06 54.64 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.152 -0.931 . . . . 74.13 112.215 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -60.66 -47.17 96.73 Favored Pre-proline 0 CA--C 1.567 1.606 0 N-CA-C 114.281 1.215 . . . . 75.54 114.281 -174.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -53.86 -41.74 72.25 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 122.517 2.145 . . . . 72.03 114.106 175.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -68.98 -42.17 76.91 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.4 0.68 . . . . 74.12 110.754 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.413 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -63.3 -41.05 98.92 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.321 -0.854 . . . . 71.52 110.774 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -61.35 -49.69 75.95 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.469 1.108 . . . . 74.23 110.763 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -67.3 -32.67 73.81 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.149 0.58 . . . . 72.12 110.19 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.511 ' O ' ' HG2' ' B' ' 117' ' ' MET . 9.1 t -71.11 -38.49 72.34 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 122.879 0.472 . . . . 75.31 111.082 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.426 HD12 HG23 ' B' ' 64' ' ' VAL . 81.8 mt -62.25 -56.77 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 123.684 0.794 . . . . 75.24 109.712 173.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 19.7 m -63.08 -24.74 68.04 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.763 0.825 . . . . 72.12 111.371 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.9 t -63.62 -52.45 60.79 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 109.265 -0.642 . . . . 74.33 109.265 171.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.511 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.9 mmt -66.67 -32.49 73.84 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.42 0.688 . . . . 75.31 111.357 -176.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.3 t -69.78 -40.28 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.073 0.949 . . . . 71.35 110.672 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 40.4 t -67.26 -32.07 72.84 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.304 -0.862 . . . . 72.41 110.367 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.53 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 77.8 mtt-85 -68.66 -34.6 75.99 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 115.478 -0.783 . . . . 72.52 109.851 176.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.01 -17.95 80.23 Favored Glycine 0 C--N 1.351 1.39 0 O-C-N 123.544 0.528 . . . . 52.23 112.483 170.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 18.0 m 66.93 31.23 7.23 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 123.153 1.454 . . . . 74.11 110.193 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.428 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 41.5 m-85 -78.02 167.26 37.25 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-N 114.099 -1.41 . . . . 75.42 111.168 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.429 ' HG2' ' HD3' ' B' ' 38' ' ' PRO . 50.4 Cg_exo -45.23 145.12 3.74 Favored 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 123.366 2.711 . . . . 72.12 114.566 170.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -60.09 118.38 6.24 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.083 0.953 . . . . 74.3 111.301 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.472 HD23 HG13 ' B' ' 64' ' ' VAL . 12.0 tp -110.03 119.46 39.38 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.358 1.063 . . . . 71.53 108.727 -175.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -125.0 127.85 47.64 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.265 -1.013 . . . . 61.52 108.265 174.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.529 HD21 HD12 ' B' ' 42' ' ' LEU . 43.6 mt -86.55 143.29 27.76 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.022 0.529 . . . . 75.14 110.639 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.67 132.51 94.09 Favored Pre-proline 0 CA--C 1.548 0.889 0 O-C-N 124.085 0.866 . . . . 54.1 111.014 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.26 89.34 0.32 Allowed 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.085 2.524 . . . . 71.24 111.595 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.55 113.55 26.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 CA-C-O 121.535 0.683 . . . . 72.12 109.501 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 58.9 t30 . . . . . 0 C--O 1.237 0.401 0 N-CA-C 107.665 -1.235 . . . . 75.14 107.665 171.562 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.519 ' HD2' ' HG2' ' A' ' 130' ' ' PRO . 28.9 t80 . . . . . 0 C--O 1.24 0.558 0 N-CA-C 107.335 -1.357 . . . . 75.01 107.335 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -137.97 133.35 33.58 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.206 -1.035 . . . . 72.15 108.206 172.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.477 HD12 HG21 ' C' ' 105' ' ' ILE . 17.3 mt -77.82 126.86 38.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 108.739 -0.838 . . . . 75.03 108.739 174.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.416 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 27.5 mm-40 -82.05 -53.36 6.17 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.259 -1.015 . . . . 74.42 108.259 173.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.59 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -172.96 146.84 1.57 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.648 0.779 . . . . 74.12 110.471 178.323 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.5 mt -116.68 132.84 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.202 1.401 . . . . 74.41 107.586 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.459 ' HB3' HG22 ' D' ' 122' ' ' THR . 39.5 p90 -161.62 156.52 23.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.372 0.606 . . . . 73.52 112.105 -164.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 42.4 p -88.18 107.65 18.89 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.511 -0.768 . . . . 71.32 109.572 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.41 ' HG2' ' CE1' ' C' ' 17' ' ' TYR . 20.6 mtmt -74.32 -29.26 61.53 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.495 -0.557 . . . . 74.42 109.495 172.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.601 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 30.7 t70 -150.21 140.91 22.65 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.309 -0.86 . . . . 63.23 110.16 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 93.7 mt -137.37 144.81 30.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 125.562 1.545 . . . . 65.01 106.943 173.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -150.26 145.51 26.24 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 123.595 0.559 . . . . 75.03 109.624 173.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -151.52 116.77 5.3 Favored 'General case' 0 C--O 1.225 -0.21 0 N-CA-C 107.987 -1.116 . . . . 75.54 107.987 171.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -121.64 121.47 37.45 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.077 0.951 . . . . 75.15 108.547 176.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.17 87.6 6.22 Favored Pre-proline 0 C--O 1.239 0.525 0 N-CA-C 106.275 -1.75 . . . . 75.04 106.275 169.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.06 -21.65 36.46 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.631 2.221 . . . . 72.23 111.828 -168.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -125.65 31.18 5.57 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.201 1.0 . . . . 74.2 109.742 -177.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.24 -61.0 2.02 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 114.644 1.35 . . . . 54.12 114.644 -169.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.11 -34.73 45.29 Favored 'Trans proline' 0 C--N 1.382 2.337 0 CA-C-N 121.848 1.696 . . . . 73.41 112.268 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -69.0 -36.7 78.12 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.773 -1.103 . . . . 75.11 111.837 -176.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.44 ' HA ' ' NZ ' ' C' ' 34' ' ' LYS . 14.5 p -80.71 -28.67 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 112.863 0.69 . . . . 75.15 112.863 -176.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -63.71 -31.42 72.59 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.718 0.407 . . . . 74.15 111.984 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -88.12 12.48 13.52 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.419 1.088 . . . . 62.04 111.803 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.768 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 10.2 ttpp -126.73 160.39 30.96 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.046 0.938 . . . . 75.01 111.434 -174.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -51.25 122.66 8.09 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.539 1.536 . . . . 74.2 112.435 178.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -86.13 82.56 8.02 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.622 0.725 . . . . 72.33 109.523 170.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -135.79 76.6 53.15 Favored Pre-proline 0 N--CA 1.472 0.662 0 N-CA-C 107.528 -1.286 . . . . 71.3 107.528 169.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -83.88 152.43 12.92 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.641 2.227 . . . . 64.41 111.703 -175.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -86.41 113.32 22.27 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.419 -1.326 . . . . 75.2 107.419 171.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 39.4 t -74.36 96.69 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.615 -0.883 . . . . 72.41 108.615 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.466 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 14.2 mptt -101.04 101.47 12.24 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 106.33 -1.73 . . . . 74.52 106.33 168.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pp -105.64 162.88 13.13 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.823 0.449 . . . . 75.01 110.065 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.635 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 4.7 t70 -148.08 135.32 20.43 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.103 0.961 . . . . 70.15 108.878 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 45.5 mt -131.86 110.98 11.2 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.123 -1.066 . . . . 63.32 108.123 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -131.77 128.31 38.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.961 -1.125 . . . . 74.21 107.961 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -126.68 140.9 52.06 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 109.444 -0.576 . . . . 74.34 109.444 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.54 142.63 33.53 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.38 0.672 . . . . 70.41 109.81 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.533 ' HG ' HG21 ' C' ' 58' ' ' VAL . 20.4 m -124.34 148.5 47.44 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.331 0.653 . . . . 71.14 110.776 -175.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 21.4 p -147.38 127.11 13.41 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.134 0.974 . . . . 70.23 108.881 176.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -78.84 120.44 23.47 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.108 -0.701 . . . . 74.24 109.108 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.534 HD12 HD13 ' C' ' 83' ' ' ILE . 33.7 mt -84.07 -44.56 13.95 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.766 0.826 . . . . 73.2 109.89 -176.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.93 -174.52 4.82 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.255 -0.884 . . . . 71.3 109.789 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.44 111.52 1.42 Allowed 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.84 0.712 . . . . 71.44 110.417 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 64.91 17.09 10.89 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.763 1.225 . . . . 65.23 112.471 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.77 113.65 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.151 -1.055 . . . . 72.12 108.151 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -122.54 126.36 47.62 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.153 0.981 . . . . 64.0 109.706 -173.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.522 ' HB2' HD12 ' C' ' 51' ' ' LEU . 43.4 tt0 -89.36 132.82 34.78 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.792 -0.818 . . . . 74.02 108.792 167.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.533 HG21 ' HG ' ' C' ' 48' ' ' SER . 90.5 t -122.68 137.28 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.582 -1.266 . . . . 74.24 107.582 168.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.14 133.07 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.17 -0.678 . . . . 72.12 109.17 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.15 98.98 8.12 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.403 -1.332 . . . . 75.24 107.403 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -83.2 106.53 15.07 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.932 -0.766 . . . . 74.03 108.932 171.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 16.4 t -103.32 129.42 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 108.175 -1.046 . . . . 72.44 108.175 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.635 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 22.6 m -119.0 139.97 50.8 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.674 -0.862 . . . . 74.41 108.674 176.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.65 HG23 HG21 ' C' ' 114' ' ' ILE . 91.6 t -129.58 120.44 50.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 124.097 0.959 . . . . 65.52 108.792 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 2.0 m -115.4 109.21 17.54 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.182 -1.044 . . . . 75.23 108.182 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.44 105.52 15.67 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.945 -1.131 . . . . 73.12 107.945 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 43.0 m -131.16 128.82 40.84 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.797 -0.446 . . . . 62.11 109.797 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 16.0 mt -86.96 35.79 0.7 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.617 1.167 . . . . 73.03 110.379 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.27 -112.36 2.79 Favored Glycine 0 C--N 1.346 1.084 0 N-CA-C 110.523 -1.031 . . . . 73.35 110.523 -169.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -90.97 -26.26 19.33 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.44 0.696 . . . . 74.04 110.78 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.768 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 14.4 tp10 -68.87 118.49 11.88 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.334 -0.848 . . . . 74.24 109.095 170.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 94.9 m -87.49 120.5 28.86 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.82 -0.808 . . . . 74.33 108.82 165.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.97 -50.92 44.83 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.823 -1.08 . . . . 71.32 108.545 177.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -165.11 168.35 17.35 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 114.043 -1.435 . . . . 74.31 111.048 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.462 HD22 HG23 ' C' ' 65' ' ' THR . 2.6 tm? -127.46 140.9 51.85 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 106.269 -1.752 . . . . 74.41 106.269 166.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 51.2 t -142.83 148.39 37.0 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.656 -0.868 . . . . 74.32 108.656 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -157.81 140.13 14.45 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.708 -0.478 . . . . 74.02 109.708 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' C' ' 110' ' ' ALA . 68.9 t -136.13 115.04 15.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 124.462 1.105 . . . . 70.54 108.518 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.601 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.7 mt-30 -91.75 88.6 6.74 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.74 -0.837 . . . . 75.23 108.74 169.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -80.12 96.69 6.59 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.031 -0.986 . . . . 71.31 109.083 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.51 153.3 30.04 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 111.185 -0.766 . . . . 73.43 111.185 175.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.83 123.78 1.38 Allowed Glycine 0 CA--C 1.498 -1.011 0 N-CA-C 110.722 -0.951 . . . . 50.43 110.722 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.534 HD13 HD12 ' C' ' 51' ' ' LEU . 32.1 mm -89.96 130.48 39.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 108.758 -0.83 . . . . 75.12 108.758 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -132.03 119.35 20.91 Favored 'General case' 0 C--O 1.241 0.651 0 O-C-N 124.191 0.932 . . . . 75.54 108.49 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 21.1 p -79.36 100.48 7.62 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.656 -1.238 . . . . 71.13 107.656 171.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.442 HG21 ' HE2' ' C' ' 94' ' ' MET . 25.2 mt -115.2 129.58 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.226 0.61 . . . . 73.24 109.612 -175.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.42 168.04 22.14 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.443 0.697 . . . . 72.53 110.315 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.76 -32.15 6.3 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 115.324 -0.853 . . . . 35.01 112.634 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.696 HD13 ' HA ' ' C' ' 94' ' ' MET . 37.9 pt -106.97 164.06 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.16 0.584 . . . . 74.31 111.791 -173.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -154.17 163.5 40.01 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.112 0.965 . . . . 75.25 109.189 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.97 -126.54 9.66 Favored Glycine 0 C--N 1.351 1.374 0 O-C-N 123.364 0.415 . . . . 63.3 113.923 168.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 67.2 p -69.58 -29.74 67.36 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.504 0.721 . . . . 74.04 111.223 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -63.82 -52.21 61.22 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.655 0.782 . . . . 73.4 110.157 175.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.696 ' HA ' HD13 ' C' ' 89' ' ' ILE . 4.6 tpt -53.53 -50.88 64.5 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 124.318 1.011 . . . . 72.42 111.904 173.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.35 -40.02 92.73 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.162 0.585 . . . . 74.24 111.829 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -70.6 -34.09 71.76 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.197 0.999 . . . . 73.33 111.087 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 38.5 t -69.86 -37.12 76.01 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.764 -0.653 . . . . 73.53 109.896 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.427 ' HB3' ' HG ' ' C' ' 48' ' ' SER . 90.8 mt -84.69 -32.32 23.63 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.299 1.04 . . . . 75.24 112.297 -176.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.52 11.38 28.19 Favored Glycine 0 N--CA 1.475 1.234 0 CA-C-O 119.785 -0.453 . . . . 73.04 114.102 -170.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.28 -51.58 0.11 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 117.372 0.586 . . . . 73.11 111.662 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -72.99 -49.88 26.43 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.32 0.248 . . . . 63.02 111.006 -175.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.408 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 86.0 m -64.68 -49.33 70.49 Favored Pre-proline 0 CA--C 1.561 1.39 0 CA-C-O 118.244 -0.884 . . . . 74.21 112.251 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 49.1 Cg_exo -58.75 -27.71 84.45 Favored 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 122.655 2.237 . . . . 74.23 113.547 174.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -64.51 -39.7 94.26 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.462 0.705 . . . . 75.43 110.415 174.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.522 HD13 ' NH1' ' A' ' 111' ' ' ARG . 29.2 mm -75.46 -35.73 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 O-C-N 123.267 0.355 . . . . 73.4 110.177 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 87.8 mt -74.41 -31.67 62.4 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.563 0.745 . . . . 73.14 112.223 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -55.83 -49.96 89.88 Favored Pre-proline 0 N--CA 1.484 1.26 0 CA-C-O 117.465 -1.255 . . . . 73.55 114.346 -173.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.63 -37.79 95.67 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.425 2.083 . . . . 72.1 113.445 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . 0.4 ' HE2' HG22 ' A' ' 115' ' ' THR . 52.4 m-85 -67.6 -44.27 78.49 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.624 0.77 . . . . 74.54 110.247 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.442 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -64.9 -38.69 91.81 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.963 -1.017 . . . . 70.24 110.66 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -65.04 -46.06 82.83 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.385 1.474 . . . . 74.22 110.449 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.94 -38.45 79.47 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.586 -0.734 . . . . 74.52 109.402 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 32.1 t -65.35 -36.2 83.29 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.955 0.502 . . . . 73.34 111.663 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.65 HG21 HG23 ' C' ' 64' ' ' VAL . 96.3 mt -68.85 -57.95 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.218 0.607 . . . . 74.23 110.054 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 10.8 m -65.26 -27.69 68.83 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 122.792 0.437 . . . . 71.11 111.277 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 40.8 t -64.12 -48.87 74.41 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.359 0.664 . . . . 70.45 109.242 170.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.557 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.03 -38.44 76.22 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.428 1.091 . . . . 73.22 112.351 177.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.403 HG22 ' O ' ' C' ' 114' ' ' ILE . 91.8 t -69.75 -38.44 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.019 0.928 . . . . 73.55 110.105 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 28.5 t -71.56 -27.66 63.32 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.37 1.068 . . . . 75.33 111.729 174.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' C' ' 116' ' ' SER . 76.4 mtt-85 -73.63 -40.96 63.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.582 0.753 . . . . 73.52 109.09 178.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.27 1.0 66.27 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.365 -0.834 . . . . 72.14 112.505 170.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.8 p 62.25 29.25 17.36 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.505 1.922 . . . . 64.23 113.588 170.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -80.29 151.18 72.12 Favored Pre-proline 0 C--O 1.246 0.882 0 N-CA-C 107.704 -1.221 . . . . 75.01 107.704 168.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.04 150.76 54.22 Favored 'Trans proline' 0 C--N 1.366 1.457 0 C-N-CA 122.015 1.81 . . . . 71.34 111.393 172.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' B' ' 123' ' ' PHE . 57.6 mm-40 -45.8 129.8 9.29 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.551 1.157 . . . . 75.25 112.274 -175.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 38.3 tp -136.09 86.78 2.25 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.026 -1.472 . . . . 74.42 107.026 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -92.6 122.36 34.95 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.934 -1.03 . . . . 74.11 109.267 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.57 121.88 17.32 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 108.749 -0.834 . . . . 75.23 108.749 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.14 140.66 97.95 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 123.717 0.807 . . . . 73.33 110.917 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.472 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 18.3 Cg_endo -58.8 108.64 0.43 Allowed 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.603 2.202 . . . . 75.32 112.759 177.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 26.3 t -99.9 122.0 51.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.386 -0.968 . . . . 74.12 108.386 173.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . 0.424 ' O ' ' HG ' ' C' ' 136' ' ' LEU . 56.7 t-20 -75.0 104.53 5.62 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.377 1.071 . . . . 74.33 110.297 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -66.65 -27.05 67.37 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.835 0.854 . . . . 72.21 112.687 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -66.87 -39.44 87.54 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.565 0.746 . . . . 74.33 110.201 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.04 92.66 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.7 -0.682 . . . . 73.44 110.708 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' C' ' 132' ' ' ASN . 71.5 mt -68.17 -32.79 73.29 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.368 0.667 . . . . 74.44 111.051 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 25.2 t80 . . . . . 0 CA--C 1.542 0.667 0 CA-C-N 116.03 -0.532 . . . . 73.33 109.917 177.663 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 8.2 t . . . . . 0 C--O 1.243 0.733 0 CA-C-O 121.237 0.541 . . . . 73.2 109.965 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -152.14 103.99 2.93 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.209 -1.404 . . . . 73.21 107.209 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . 0.516 ' HB2' ' HB3' ' D' ' 85' ' ' SER . 38.2 mt-30 -112.77 114.0 26.35 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.345 -0.983 . . . . 74.41 108.345 -175.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.55 HG21 HD11 ' D' ' 16' ' ' ILE . 53.9 mt -77.91 125.13 37.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.489 -0.93 . . . . 74.15 108.489 175.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -88.77 -41.66 12.39 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 123.844 0.715 . . . . 74.35 109.861 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -177.43 136.91 0.2 Allowed 'General case' 0 N--CA 1.481 1.1 0 O-C-N 123.436 0.46 . . . . 74.11 110.864 -169.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.55 HD11 HG21 ' D' ' 13' ' ' ILE . 4.1 mp -110.98 142.72 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 107.193 -1.41 . . . . 74.53 107.193 169.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -166.35 163.42 17.51 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.868 0.842 . . . . 73.24 111.768 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 59.3 p -97.65 116.14 29.29 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.797 -1.092 . . . . 74.34 108.929 176.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.425 ' HD2' ' HA3' ' D' ' 81' ' ' GLY . 41.1 mtpt -85.39 -26.98 26.11 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.822 -0.807 . . . . 72.32 108.822 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.665 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 26.7 t70 -152.75 142.71 22.2 Favored 'General case' 0 C--N 1.35 0.597 0 C-N-CA 124.397 1.079 . . . . 72.13 109.749 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.557 HG23 ' HE1' ' C' ' 117' ' ' MET . 55.9 mt -141.96 145.65 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.865 1.266 . . . . 75.25 108.45 175.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -148.15 141.0 24.71 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.765 1.226 . . . . 74.22 109.384 174.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -144.81 129.45 18.1 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.319 -1.363 . . . . 70.04 107.319 167.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -137.44 111.56 8.42 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 123.98 0.912 . . . . 73.21 108.895 -171.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.19 86.08 1.91 Allowed Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 108.055 -1.091 . . . . 63.5 108.055 174.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -68.19 -35.67 18.67 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.808 2.338 . . . . 74.22 113.333 -165.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.465 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 50.1 m-20 -107.26 15.62 24.86 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.896 0.878 . . . . 54.2 110.813 -174.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -27.0 -71.19 0.05 OUTLIER Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 116.459 2.022 . . . . 72.32 116.459 -160.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.529 ' HB3' HD11 ' C' ' 83' ' ' ILE . 93.9 Cg_endo -74.12 -24.18 15.08 Favored 'Trans proline' 0 C--N 1.378 2.086 0 CA-C-N 123.491 2.283 . . . . 71.02 113.936 -172.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.464 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 4.8 t-160 -73.1 -40.96 64.56 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.649 0.78 . . . . 75.34 109.776 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.692 HG23 HD11 ' D' ' 68' ' ' LEU . 7.6 p -79.37 -26.58 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.506 -0.77 . . . . 72.12 111.609 -170.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -61.45 -23.69 66.03 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 122.797 0.439 . . . . 70.52 112.16 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 64.6 mt-30 -67.21 -9.07 36.51 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.698 1.199 . . . . 71.03 112.009 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -97.73 98.47 9.89 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.996 1.319 . . . . 73.34 110.182 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -88.78 88.44 7.6 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.792 0.837 . . . . 70.41 110.826 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 22.0 p90 -167.08 -177.99 3.98 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.103 0.961 . . . . 74.52 109.715 170.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . 0.421 HE21 ' HD2' ' D' ' 38' ' ' PRO . 29.6 tp60 -80.58 115.31 54.36 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 123.551 0.74 . . . . 73.33 109.471 177.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.421 ' HD2' HE21 ' D' ' 37' ' ' GLN . 52.6 Cg_exo -58.38 142.68 97.92 Favored 'Trans proline' 0 C--N 1.386 2.501 0 C-N-CA 123.028 2.486 . . . . 73.42 112.379 177.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 14.0 mm-40 -67.18 106.46 2.02 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 107.531 -1.285 . . . . 72.11 107.531 171.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.551 HG12 HD11 ' D' ' 126' ' ' LEU . 62.4 t -106.17 116.09 49.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 O-C-N 123.729 0.643 . . . . 72.34 109.797 -178.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -98.98 152.64 19.58 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.642 -0.708 . . . . 75.25 109.569 169.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 31.9 tp -126.63 134.52 50.74 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.967 -1.015 . . . . 73.52 109.759 -173.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.546 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 13.2 t70 -130.35 113.77 14.77 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.415 -1.328 . . . . 74.34 107.415 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.427 ' CD2' HG21 ' D' ' 62' ' ' VAL . 94.3 mt -118.56 129.14 55.17 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.22 0.608 . . . . 73.45 109.438 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -160.03 155.76 25.86 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.633 -0.877 . . . . 73.32 108.633 172.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 46' ' ' THR . . . . . 0.45 HG23 ' HA ' ' D' ' 60' ' ' LEU . 30.4 p -123.61 168.64 12.37 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 122.167 0.984 . . . . 74.24 113.035 -170.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.13 143.97 26.33 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 113.465 -1.698 . . . . 73.34 107.208 173.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 37.2 p . . . . . 0 C--O 1.242 0.678 0 CA-C-O 120.58 0.229 . . . . 72.33 111.322 -178.675 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' D' ' 85' ' ' SER . 6.0 m-20 . . . . . 0 N--CA 1.485 1.322 0 N-CA-C 112.932 0.715 . . . . 75.03 112.932 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 58.8 t -134.87 102.16 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 107.635 -1.246 . . . . 74.45 107.635 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -135.33 135.06 40.47 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.039 0.535 . . . . 75.31 109.856 -174.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.483 ' HG2' HG12 ' D' ' 83' ' ' ILE . 42.3 mt-10 -87.14 115.02 24.25 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.882 -1.155 . . . . 72.21 107.882 167.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 70.6 t -97.58 136.22 29.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 106.797 -1.557 . . . . 70.12 106.797 171.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.4 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.1 t -128.41 123.76 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 108.239 -1.023 . . . . 73.44 108.239 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -103.31 121.21 42.27 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.824 -1.176 . . . . 73.02 107.824 176.189 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -100.53 105.99 17.47 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.237 -1.394 . . . . 73.44 107.237 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.427 HG21 ' CD2' ' D' ' 44' ' ' LEU . 59.1 t -99.99 120.43 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 N-CA-C 108.234 -1.025 . . . . 73.35 108.234 176.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 28.2 m -120.84 140.13 52.2 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.872 -0.788 . . . . 72.43 108.872 -177.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.477 HG13 HG13 ' D' ' 40' ' ' VAL . 77.3 t -131.37 130.36 62.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 115.398 -0.819 . . . . 74.15 109.914 -173.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 10.2 m -119.84 93.03 3.93 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.409 -0.96 . . . . 74.24 108.409 172.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.505 ' HB3' HG22 ' D' ' 40' ' ' VAL . . . -100.53 146.34 27.21 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.191 0.596 . . . . 71.45 110.037 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.459 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 23.5 p -153.89 127.93 8.97 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 112.815 0.672 . . . . 64.2 112.815 -169.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.692 HD11 HG23 ' D' ' 31' ' ' VAL . 80.0 mt -96.31 102.24 14.0 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.667 0.787 . . . . 73.33 109.121 174.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.84 -132.66 11.74 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 116.286 -0.415 . . . . 72.04 112.389 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.51 2.85 56.45 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.752 0.421 . . . . 71.33 111.038 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -114.94 158.31 22.19 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.362 -0.607 . . . . 71.2 109.362 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 91.6 m -75.33 139.14 42.25 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.083 0.553 . . . . 74.21 110.722 178.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.605 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.04 -62.32 1.51 Allowed 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.548 -1.279 . . . . 74.44 107.548 175.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -158.41 149.53 20.75 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.784 -1.098 . . . . 75.41 110.864 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 74.9 mt -116.75 120.8 39.7 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.689 1.596 . . . . 72.4 107.412 174.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.541 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 38.9 t -131.97 137.34 47.87 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.855 -0.424 . . . . 73.44 109.855 -174.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' D' ' 62' ' ' VAL . 38.5 tt0 -154.24 130.84 10.67 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.702 0.401 . . . . 75.45 110.984 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 96.2 t -134.31 121.59 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.048 0.939 . . . . 71.52 109.487 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.665 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.7 mt-30 -90.2 86.35 6.5 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.677 -0.86 . . . . 74.33 108.677 169.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -80.36 101.29 8.89 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.217 -1.356 . . . . 73.44 109.073 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.425 ' HA3' ' HD2' ' D' ' 19' ' ' LYS . . . -96.85 161.07 21.78 Favored Glycine 0 N--CA 1.464 0.544 0 N-CA-C 112.479 -0.249 . . . . 70.53 112.479 178.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.03 140.72 6.63 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.729 -0.549 . . . . 74.14 111.729 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.483 HG12 ' HG2' ' D' ' 57' ' ' GLU . 50.1 mt -89.2 123.23 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.547 -1.279 . . . . 73.45 107.547 175.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -125.24 151.06 46.41 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.929 0.891 . . . . 71.45 109.768 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.516 ' HB3' ' HB2' ' D' ' 12' ' ' GLN . 33.7 t -113.19 103.76 11.66 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.324 -0.991 . . . . 71.31 108.324 173.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.586 HG23 HD12 ' D' ' 89' ' ' ILE . 3.1 mp -108.4 119.33 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 107.607 -1.257 . . . . 72.23 107.607 -176.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.33 168.69 24.59 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 123.645 0.591 . . . . 72.24 112.276 -172.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.83 22.59 68.82 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 115.307 -0.86 . . . . 53.21 112.957 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.586 HD12 HG23 ' D' ' 86' ' ' ILE . 0.5 OUTLIER -135.62 156.67 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.04 1.336 . . . . 73.24 108.401 176.218 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -152.08 163.85 38.47 Favored 'General case' 0 CA--C 1.561 1.379 0 N-CA-C 107.96 -1.126 . . . . 65.3 107.96 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . 0.47 ' O ' ' HE1' ' D' ' 94' ' ' MET . . . 79.19 -134.31 13.65 Favored Glycine 0 C--N 1.349 1.279 0 C-N-CA 123.545 0.593 . . . . 52.21 111.971 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 13.1 m -81.89 -25.13 35.26 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 117.964 0.882 . . . . 75.32 110.625 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -66.99 -19.04 65.65 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.634 1.174 . . . . 74.44 112.898 -174.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.512 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 0.0 OUTLIER -81.06 -43.41 19.55 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.618 0.599 . . . . 75.12 112.618 -176.348 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -78.73 -15.31 58.61 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.046 0.539 . . . . 74.55 110.614 177.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -58.9 -46.89 86.81 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.63 1.172 . . . . 75.33 110.734 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.3 m -72.23 -31.12 65.55 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.577 0.751 . . . . 73.5 111.538 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -64.51 -52.5 57.49 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.678 1.191 . . . . 74.34 109.457 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.78 -25.43 62.6 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 115.364 -0.835 . . . . 72.32 114.054 -173.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.9 -55.4 2.42 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 117.621 0.71 . . . . 73.24 112.25 -170.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -74.54 -39.76 62.14 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 111.799 0.296 . . . . 74.12 111.799 -171.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.45 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 73.8 m -63.47 -47.4 83.53 Favored Pre-proline 0 CA--C 1.569 1.708 0 CA-C-O 118.762 -0.637 . . . . 73.41 112.273 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.481 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 50.3 Cg_exo -59.72 -31.86 94.8 Favored 'Trans proline' 0 C--N 1.396 3.048 0 C-N-CA 122.656 2.237 . . . . 74.24 113.546 169.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -67.23 -28.84 68.4 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.279 0.631 . . . . 75.35 110.746 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.9 mm -74.12 -40.94 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.482 0.713 . . . . 73.34 110.227 172.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 88.3 mt -73.72 -24.92 59.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.367 0.667 . . . . 75.52 112.548 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -64.56 -44.69 75.33 Favored Pre-proline 0 N--CA 1.485 1.284 0 N-CA-C 113.766 1.024 . . . . 72.3 113.766 -171.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -55.1 -38.85 93.27 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 121.946 1.764 . . . . 74.15 113.17 173.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -73.77 -37.38 65.03 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.528 0.731 . . . . 64.5 111.074 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.62 -46.01 73.76 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.912 0.885 . . . . 73.13 110.759 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -73.8 -30.84 62.97 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-N 115.08 -0.963 . . . . 72.52 110.781 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -64.45 -46.52 82.74 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 124.105 0.878 . . . . 75.13 109.809 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.424 ' SG ' HD11 ' D' ' 21' ' ' ILE . 42.1 t -55.68 -44.84 77.7 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 124.14 0.9 . . . . 65.51 110.405 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.458 HG21 ' SG ' ' D' ' 76' ' ' CYS . 72.1 mt -62.99 -50.22 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.859 0.864 . . . . 74.14 111.064 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 63.0 m -55.27 -47.08 76.0 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.08 0.952 . . . . 65.4 110.781 -175.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.4 t -62.57 -42.18 99.39 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 113.778 -1.555 . . . . 71.15 109.967 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.541 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 74.2 mtm -70.18 -31.89 69.57 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.194 0.597 . . . . 71.43 112.047 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.435 HG22 ' O ' ' D' ' 114' ' ' ILE . 76.4 t -67.74 -42.67 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.659 0.784 . . . . 73.04 110.058 176.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.5 p -73.15 -28.05 62.02 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-N 115.628 -0.715 . . . . 74.53 110.449 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' C' ' 17' ' ' TYR . 68.8 mtt-85 -70.65 -30.41 67.02 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.426 0.69 . . . . 75.14 109.601 172.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.93 11.61 66.41 Favored Glycine 0 C--N 1.353 1.477 0 CA-C-O 119.54 -0.589 . . . . 61.43 113.587 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.459 HG22 ' HB3' ' C' ' 17' ' ' TYR . 74.2 p 58.07 21.77 8.25 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 126.122 1.769 . . . . 74.02 114.365 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -90.55 155.92 45.67 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 109.409 -0.589 . . . . 74.44 109.409 171.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.3 137.86 71.86 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 122.902 2.402 . . . . 74.11 112.076 173.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -49.35 122.17 5.82 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.05 1.34 . . . . 74.15 112.215 -175.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.551 HD11 HG12 ' D' ' 40' ' ' VAL . 37.7 tp -107.64 99.54 9.02 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.423 0.689 . . . . 74.11 110.431 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -99.33 104.59 16.49 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 106.956 -1.498 . . . . 75.11 106.956 172.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -62.9 129.25 39.61 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.038 -0.727 . . . . 73.53 109.038 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.27 134.11 90.78 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 123.854 0.862 . . . . 61.45 111.533 -170.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -68.47 111.11 2.44 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.758 2.306 . . . . 63.14 111.85 -174.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.8 m -107.99 142.25 21.14 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 CA-C-O 121.218 0.532 . . . . 75.14 109.603 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -86.42 111.66 20.73 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 107.916 -1.142 . . . . 54.3 107.916 174.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 . . . . . 0 N--CA 1.483 1.221 0 C-N-CA 123.269 0.628 . . . . 71.34 112.532 -174.518 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 99.4 m . . . . . 0 CA--C 1.544 0.724 0 N-CA-C 109.022 -0.733 . . . . 71.12 109.022 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -125.31 133.44 52.62 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.534 -0.913 . . . . 74.22 108.534 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -147.91 135.51 20.81 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.472 0.709 . . . . 72.22 109.452 171.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.795 HG22 ' HG2' ' C' ' 130' ' ' PRO . 3.9 mt -82.47 115.74 25.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.433 -0.951 . . . . 73.33 108.433 169.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.76 -41.12 19.59 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 109.451 -0.574 . . . . 64.31 109.451 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -169.51 126.74 0.91 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.629 0.372 . . . . 74.25 110.962 -175.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 86.6 mt -111.76 137.21 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.902 -0.777 . . . . 74.11 108.902 170.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.447 ' HB2' ' HA2' ' B' ' 121' ' ' GLY . 31.6 p90 -164.29 176.33 9.24 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 124.136 0.898 . . . . 73.13 111.178 -172.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.6 p -103.57 123.36 46.8 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.36 0.664 . . . . 72.55 109.289 174.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 39.5 mtpt -87.74 -27.23 22.49 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.506 -0.553 . . . . 73.43 109.506 174.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.452 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 22.3 t70 -152.25 142.05 21.98 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 114.931 -1.031 . . . . 71.45 109.418 -177.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 85.3 mt -139.63 142.24 33.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 C-N-CA 125.24 1.416 . . . . 70.05 107.409 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.8 t -149.64 123.22 9.15 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.934 0.494 . . . . 74.03 110.189 175.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.426 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 89.7 t80 -127.88 124.52 37.66 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 106.986 -1.487 . . . . 73.51 106.986 172.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 80.1 mt-10 -126.77 121.18 31.23 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.054 0.388 . . . . 75.13 110.105 -177.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.45 76.38 61.92 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 108.249 -1.019 . . . . 75.44 108.249 169.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -74.48 -23.59 14.84 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.676 2.25 . . . . 65.44 112.357 -177.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -97.43 15.57 22.73 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-O 118.198 -0.906 . . . . 71.31 109.954 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.492 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -39.94 -59.24 1.84 Allowed Pre-proline 0 CA--C 1.572 1.79 0 C-N-CA 124.703 1.201 . . . . 63.44 113.705 -168.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.492 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 32.5 Cg_exo -60.11 -35.11 93.66 Favored 'Trans proline' 0 C--N 1.387 2.601 0 C-N-CA 122.075 1.85 . . . . 75.01 113.199 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -76.38 -35.55 58.58 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.117 -0.947 . . . . 72.4 110.92 -174.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.609 HG22 ' HA ' ' A' ' 73' ' ' ALA . 5.5 p -80.61 -15.51 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.707 -0.679 . . . . 63.24 112.236 -168.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -77.11 -35.49 56.29 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.513 0.325 . . . . 73.42 110.51 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -78.19 -16.19 58.11 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.161 0.584 . . . . 75.5 111.139 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -73.33 154.6 40.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.51 0.724 . . . . 73.32 111.368 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.52 119.25 7.69 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.753 1.221 . . . . 65.24 110.331 177.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -79.67 80.76 6.02 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.709 0.766 . . . . 74.45 109.842 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -123.62 81.15 54.61 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 106.094 -1.817 . . . . 73.5 106.094 169.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -86.91 122.0 1.84 Allowed 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.695 2.264 . . . . 74.34 112.324 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -95.91 115.54 27.58 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 105.917 -1.883 . . . . 73.31 105.917 168.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.0 t -94.55 94.3 4.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 O-C-N 123.783 0.677 . . . . 65.0 109.711 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -80.19 113.55 18.45 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.922 -1.035 . . . . 74.15 109.282 175.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.522 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.6 pt? -109.81 111.64 23.21 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.549 0.69 . . . . 73.33 109.809 -177.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -101.6 137.72 39.54 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.576 1.15 . . . . 75.51 108.295 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.9 mt -126.56 120.45 29.63 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.412 0.625 . . . . 73.21 111.015 -173.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -125.17 122.12 36.16 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 114.028 -1.442 . . . . 74.4 108.047 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.426 HG22 ' HG3' ' A' ' 103' ' ' PRO . 83.8 m -122.9 135.81 54.64 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.312 0.645 . . . . 72.45 109.961 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.94 126.31 11.54 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.494 0.717 . . . . 74.41 109.734 176.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 64.7 p -96.94 172.78 7.64 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.457 0.703 . . . . 64.13 110.743 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.1 t -162.7 163.32 26.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.842 1.257 . . . . 74.02 108.871 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -110.92 116.91 32.04 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.277 0.631 . . . . 75.44 109.446 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.456 HD13 HG22 ' A' ' 83' ' ' ILE . 81.9 mt -85.91 -33.59 21.16 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.092 0.557 . . . . 75.22 110.376 175.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.9 -176.49 4.95 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.767 0.827 . . . . 72.34 110.348 -178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -62.37 118.99 8.23 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.131 0.572 . . . . 72.44 109.61 176.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 65.35 10.43 6.51 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.767 1.227 . . . . 74.33 112.438 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.38 106.65 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.772 -0.825 . . . . 73.32 108.772 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -113.99 126.42 55.11 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.991 0.916 . . . . 75.25 109.876 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -93.62 136.69 33.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.942 -0.762 . . . . 73.53 108.942 171.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.4 t -120.85 138.16 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 108.31 -0.996 . . . . 74.3 108.31 170.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.4 t -120.52 131.25 73.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.015 -0.735 . . . . 72.52 109.015 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.626 HD23 HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -109.18 105.02 14.29 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.18 -1.415 . . . . 75.34 107.18 174.784 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -88.91 100.78 13.45 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.322 -1.362 . . . . 74.4 107.322 172.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.626 HG23 HD23 ' A' ' 60' ' ' LEU . 32.0 t -94.06 126.65 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.5 -1.296 . . . . 73.21 107.5 172.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.3 m -117.61 126.59 52.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.022 -0.733 . . . . 73.12 109.022 177.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 64.0 t -115.31 126.15 72.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.087 -1.079 . . . . 73.43 108.087 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.9 m -120.68 130.5 54.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.54 -0.911 . . . . 73.5 108.54 172.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.7 123.57 29.6 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.947 -1.501 . . . . 71.11 106.947 175.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -137.27 128.92 28.62 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.23 0.538 . . . . 72.02 110.691 -174.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.543 HD12 ' CG2' ' A' ' 31' ' ' VAL . 33.5 mt -92.29 81.36 4.95 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.145 1.378 . . . . 70.35 107.913 175.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.71 -119.51 6.08 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 110.852 -0.899 . . . . 75.41 110.852 -174.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.4 -19.36 25.28 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.926 0.49 . . . . 61.24 110.201 175.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -80.92 106.69 13.13 Favored 'General case' 0 C--N 1.347 0.469 0 C-N-CA 124.035 0.934 . . . . 72.05 109.038 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.8 m -68.76 131.07 44.56 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 118.16 0.436 . . . . 65.03 109.939 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.609 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -77.66 -61.26 2.05 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.286 -1.005 . . . . 74.13 108.286 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 46.6 p90 -158.9 157.78 32.1 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.525 -0.761 . . . . 75.54 111.801 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 64' ' ' VAL . 57.1 tp -123.44 109.29 13.67 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.46 -1.245 . . . . 73.34 107.734 171.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.512 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 86.0 m -108.17 96.27 6.25 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.111 0.565 . . . . 74.52 110.301 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -111.42 115.67 29.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.9 -0.778 . . . . 74.44 108.9 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.65 133.06 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.603 0.761 . . . . 54.32 109.887 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.452 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 61.9 mt-30 -105.12 88.22 2.82 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 107.956 -1.127 . . . . 74.15 107.956 175.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -76.8 96.43 4.27 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.166 -0.924 . . . . 70.14 109.208 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.54 145.09 20.1 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 111.349 -0.701 . . . . 73.33 111.349 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.5 122.95 1.79 Allowed Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.696 -0.962 . . . . 62.23 110.696 -176.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.456 HG22 HD13 ' A' ' 51' ' ' LEU . 53.7 mt -80.77 127.29 39.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 108.151 -1.055 . . . . 63.42 108.151 170.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.448 ' HB3' ' CD1' ' A' ' 86' ' ' ILE . 92.8 m-85 -131.74 123.91 28.65 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.371 0.668 . . . . 74.33 109.4 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 t -86.43 98.0 10.77 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 108.903 -0.777 . . . . 73.42 108.903 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.453 HG21 ' HE3' ' A' ' 94' ' ' MET . 4.1 mm -112.5 149.24 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 122.857 0.463 . . . . 74.45 110.886 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.26 167.28 16.2 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.748 0.819 . . . . 61.45 110.827 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.44 -32.92 6.24 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 114.304 0.482 . . . . 74.21 114.304 172.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.436 HD11 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -113.01 150.33 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.411 0.684 . . . . 75.35 110.639 -174.513 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -138.8 174.58 10.37 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.379 1.072 . . . . 64.44 109.527 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.86 -133.28 40.56 Favored Glycine 0 C--N 1.345 1.07 0 O-C-N 123.792 0.683 . . . . 64.01 113.732 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 47.5 p -67.77 -25.51 65.65 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.876 0.87 . . . . 64.54 111.631 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -69.37 -42.74 74.79 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.387 0.675 . . . . 74.11 110.827 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.453 ' HE3' HG21 ' A' ' 86' ' ' ILE . 5.8 tpt -66.34 -46.72 75.85 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 116.004 -0.544 . . . . 65.44 109.897 177.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.36 -34.77 72.8 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.563 -0.744 . . . . 70.21 110.894 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -68.84 -34.29 75.24 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.651 -0.704 . . . . 75.12 111.431 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.9 t -65.76 -44.27 86.4 Favored 'General case' 0 C--N 1.348 0.516 0 N-CA-C 109.815 -0.439 . . . . 62.02 109.815 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.6 mt -84.22 -35.31 23.56 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.235 -0.893 . . . . 73.42 112.036 -170.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.86 3.93 49.25 Favored Glycine 0 N--CA 1.473 1.11 0 CA-C-O 119.713 -0.493 . . . . 74.41 114.2 -172.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.556 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -141.67 -66.57 0.41 Allowed 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 117.587 0.694 . . . . 73.43 111.537 -177.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -65.48 -44.59 86.61 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 115.968 -0.56 . . . . 71.31 111.581 -173.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.6 m -63.44 -51.08 70.22 Favored Pre-proline 0 CA--C 1.564 1.494 0 C-N-CA 124.03 0.932 . . . . 65.25 112.354 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.426 ' HG3' HG22 ' A' ' 46' ' ' THR . 34.5 Cg_endo -64.45 -27.13 62.48 Favored 'Trans proline' 0 C--N 1.395 2.985 0 C-N-CA 121.717 1.611 . . . . 73.55 113.491 173.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.456 HD22 ' HA ' ' A' ' 132' ' ' ASN . 3.0 m120 -60.88 -38.29 85.1 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 118.09 0.405 . . . . 71.35 110.613 172.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.586 HG21 HD12 ' A' ' 13' ' ' ILE . 47.3 mm -72.12 -44.21 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.467 0.707 . . . . 65.0 110.065 176.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 70.2 mt -71.75 -23.61 61.63 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.551 -0.749 . . . . 75.52 112.29 -173.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -63.98 -47.27 80.53 Favored Pre-proline 0 N--CA 1.483 1.207 0 CA-C-O 117.932 -1.033 . . . . 75.02 113.391 -172.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.414 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 83.0 Cg_exo -51.29 -36.15 56.01 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.138 1.892 . . . . 65.23 113.943 172.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -80.55 -39.37 27.87 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.396 0.678 . . . . 74.05 111.716 -177.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.78 -47.49 74.96 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 109.457 -0.572 . . . . 50.23 109.457 176.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.46 HH12 HD13 ' C' ' 105' ' ' ILE . 27.9 ttm180 -51.6 -47.07 63.72 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.85 1.26 . . . . 72.12 110.568 172.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.43 -49.12 78.14 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.033 0.833 . . . . 74.44 111.433 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.4 t -57.17 -47.19 81.84 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.084 0.865 . . . . 61.44 110.193 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.486 HD12 HD13 ' A' ' 128' ' ' LEU . 23.5 mt -56.75 -51.76 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.743 1.217 . . . . 72.51 111.124 174.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.9 m -56.23 -45.09 80.09 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.535 1.134 . . . . 74.24 111.108 -176.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.2 t -67.66 -41.05 84.4 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.41 -1.268 . . . . 73.45 110.006 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 11.6 mtp -59.66 -44.61 93.5 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.59 0.756 . . . . 75.13 111.054 176.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 82.1 t -59.33 -48.41 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 124.225 1.01 . . . . 64.12 110.543 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.9 p -71.19 -30.6 66.6 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.603 -0.726 . . . . 74.33 111.617 -176.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.451 HH12 ' HG3' ' B' ' 112' ' ' GLU . 80.3 mtt-85 -72.66 -28.31 62.64 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.98 0.512 . . . . 73.24 109.974 176.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.34 17.17 35.16 Favored Glycine 0 C--N 1.354 1.559 0 CA-C-O 119.291 -0.727 . . . . 70.12 113.432 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.411 HG23 ' HE ' ' B' ' 15' ' ' ARG . 1.4 t 59.73 9.96 1.84 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 127.202 2.201 . . . . 75.43 113.404 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -79.26 140.04 56.5 Favored Pre-proline 0 C--O 1.242 0.671 0 N-CA-C 108.311 -0.996 . . . . 73.33 108.311 175.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -46.49 126.7 10.64 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 123.065 2.51 . . . . 72.23 112.268 172.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -50.67 131.6 25.66 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.599 1.187 . . . . 72.33 112.84 -168.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.4 tp -109.24 138.09 46.12 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.642 0.777 . . . . 70.05 109.858 -176.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -132.97 117.67 17.92 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.531 -0.914 . . . . 72.22 108.531 174.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.486 HD13 HD12 ' A' ' 114' ' ' ILE . 16.1 mt -72.72 135.29 45.33 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.152 -0.684 . . . . 71.13 109.152 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.13 142.78 98.69 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 122.651 0.38 . . . . 73.25 111.254 -177.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.447 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 63.3 Cg_exo -54.17 118.39 4.95 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.421 2.748 . . . . 73.24 114.074 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 88.5 t -102.86 129.03 55.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 123.518 0.727 . . . . 74.31 110.272 178.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.471 ' ND2' ' HB3' ' A' ' 135' ' ' ALA . 56.6 t30 -96.37 92.89 6.54 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.678 0.791 . . . . 65.43 109.12 176.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -67.98 -22.84 64.99 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.55 -0.75 . . . . 71.3 111.368 177.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.556 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 13.5 t70 -54.91 -50.96 67.52 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.574 0.75 . . . . 75.13 110.105 172.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' ND2' ' A' ' 132' ' ' ASN . . . -60.91 -55.65 30.47 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 114.78 -1.1 . . . . 71.43 110.086 177.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 91.8 mt -56.82 -36.91 70.5 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 124.217 0.948 . . . . 73.31 112.479 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 81.8 t80 . . . . . 0 C--O 1.219 -0.542 0 O-C-N 123.777 0.673 . . . . 74.5 110.257 178.288 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.621 ' HE3' ' SG ' ' B' ' 97' ' ' CYS . 27.0 ttt . . . . . 0 CA--C 1.566 1.571 0 CA-C-O 121.454 0.645 . . . . 74.01 111.59 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 85.3 m -138.01 123.08 19.12 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.875 1.27 . . . . 64.42 108.13 169.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' B' ' 85' ' ' SER . 62.1 t80 -137.29 133.79 35.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.248 0.619 . . . . 71.34 109.608 177.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -150.57 140.13 21.57 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.568 0.747 . . . . 74.2 109.223 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.539 HD11 HD12 ' B' ' 105' ' ' ILE . 53.4 mt -83.16 130.27 36.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.23 -1.026 . . . . 75.12 108.23 171.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -98.78 -41.57 7.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.975 0.51 . . . . 75.11 110.4 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.411 ' HE ' HG23 ' A' ' 122' ' ' THR . 55.3 ttt180 -173.03 129.29 0.48 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.617 -0.72 . . . . 74.4 109.177 -175.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.592 HG21 ' CD1' ' B' ' 109' ' ' TYR . 75.1 mt -116.32 148.89 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.448 -0.945 . . . . 70.11 108.448 173.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -167.09 161.95 15.06 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-O 121.671 0.748 . . . . 71.24 112.016 -175.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.4 m -88.26 123.03 32.46 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.191 -1.368 . . . . 71.33 108.408 168.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.436 ' HZ2' HG22 ' B' ' 59' ' ' VAL . 43.0 mttp -80.05 -51.76 8.64 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.233 0.613 . . . . 75.11 110.593 170.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -144.85 141.77 29.39 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.283 -0.417 . . . . 64.51 110.725 -164.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.504 HD13 ' SG ' ' B' ' 113' ' ' CYS . 46.3 mm -134.95 138.66 48.73 Favored 'Isoleucine or valine' 0 C--N 1.354 0.791 0 C-N-CA 124.572 1.149 . . . . 71.42 109.726 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 40.2 t -138.32 128.47 25.76 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.923 1.289 . . . . 70.31 107.65 176.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.405 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 77.5 t80 -144.29 114.32 7.36 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 107.974 -1.121 . . . . 65.24 107.974 171.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -122.43 116.98 24.91 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.076 0.95 . . . . 74.33 108.941 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.18 86.57 3.35 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 107.595 -1.261 . . . . 72.12 107.595 169.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.86 -30.64 40.08 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.956 2.437 . . . . 71.21 112.715 -170.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -107.87 12.27 27.35 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 118.407 -0.806 . . . . 74.23 110.899 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -31.24 -73.22 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.918 0 C-N-CA 126.026 1.73 . . . . 74.32 114.604 -164.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.462 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 27.6 Cg_endo -64.06 -26.19 65.88 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 122.084 1.856 . . . . 74.14 112.954 -170.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -87.11 -41.74 13.56 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.14 -0.936 . . . . 65.44 111.383 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.54 HG22 HD11 ' B' ' 68' ' ' LEU . 8.8 p -69.18 -17.75 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.218 0.607 . . . . 71.1 111.175 -175.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -65.54 -11.09 40.6 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.128 0.788 . . . . 74.1 113.128 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.473 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.2 pt20 -63.13 -13.72 40.02 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.455 0.702 . . . . 73.4 111.446 172.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.475 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 97.9 mttt -109.06 110.3 21.53 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.779 1.632 . . . . 75.44 110.629 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -111.27 88.95 2.92 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.641 0.776 . . . . 64.22 109.822 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.435 ' O ' ' HG3' ' B' ' 124' ' ' PRO . 33.7 p90 -167.66 172.49 9.28 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.879 0.872 . . . . 74.12 109.098 170.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -65.18 110.17 3.91 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 123.424 0.69 . . . . 74.2 110.704 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.83 166.3 18.63 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.051 1.834 . . . . 74.35 112.384 -177.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 33.8 tt0 -64.35 100.84 0.38 Allowed 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.509 -1.293 . . . . 62.14 107.509 168.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.474 HG11 HD13 ' B' ' 126' ' ' LEU . 54.6 t -104.32 149.31 8.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.213 -0.903 . . . . 70.01 109.125 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.511 ' HE3' ' HB2' ' B' ' 43' ' ' ASP . 12.6 ttpt -141.3 120.67 13.13 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.393 -1.336 . . . . 71.42 107.393 173.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.462 HD12 HD21 ' B' ' 128' ' ' LEU . 20.4 tp -88.53 134.62 33.81 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.614 -0.884 . . . . 74.44 108.614 174.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.511 ' HB2' ' HE3' ' B' ' 41' ' ' LYS . 2.5 t0 -142.41 146.66 35.11 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.879 -1.156 . . . . 62.42 107.879 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 mp -131.25 146.2 52.21 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.476 -0.565 . . . . 75.24 109.476 -175.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.514 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 35.0 m-20 -130.47 153.86 48.36 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.953 1.301 . . . . 73.52 108.087 170.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 5.9 t -139.11 130.86 27.49 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.344 0.593 . . . . 75.44 110.251 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.05 136.46 18.97 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.918 1.287 . . . . 75.53 107.662 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 19.0 m -140.8 175.22 9.79 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.923 0.489 . . . . 71.41 110.948 -170.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 58.9 p -151.66 136.94 17.55 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.725 0.41 . . . . 75.31 111.146 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -87.79 107.16 18.53 Favored 'General case' 0 C--N 1.349 0.545 0 N-CA-C 108.978 -0.749 . . . . 72.0 108.978 173.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.0 pp -125.34 15.43 8.32 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.273 -0.876 . . . . 72.01 109.717 177.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.76 151.1 14.25 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 124.439 1.096 . . . . 64.3 109.373 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -83.36 134.72 34.89 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.619 -0.882 . . . . 70.54 108.619 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . 0.624 ' HB3' ' HB1' ' B' ' 87' ' ' ALA . 1.7 m-20 64.3 7.88 3.83 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.065 0.946 . . . . 74.52 112.275 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 86.8 t -142.03 112.17 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 107.556 -1.276 . . . . 71.53 107.556 -174.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -115.3 139.68 49.77 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 109.012 -0.736 . . . . 73.2 109.012 -171.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -101.33 104.37 15.36 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.79 -1.189 . . . . 72.52 107.79 -177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.403 HG13 ' HG3' ' B' ' 103' ' ' PRO . 60.1 t -101.58 135.87 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.775 0.83 . . . . 73.24 110.072 -174.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.436 HG22 ' HZ2' ' B' ' 19' ' ' LYS . 15.4 t -122.81 111.28 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.6 0.76 . . . . 72.14 108.956 177.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 56.5 tp -98.27 115.0 27.47 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.261 -0.644 . . . . 72.03 109.261 175.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.514 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 37.9 ttm180 -85.39 130.74 34.52 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.893 -0.78 . . . . 75.45 108.893 170.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 64.6 t -123.45 104.72 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 108.228 -1.027 . . . . 75.3 108.228 173.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 11.9 m -100.66 136.7 40.12 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.737 0.815 . . . . 75.24 109.906 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.604 HG23 HD12 ' B' ' 114' ' ' ILE . 76.8 t -121.1 125.83 74.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 123.957 0.903 . . . . 74.01 109.227 173.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.4 m -100.49 138.67 37.25 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 107.806 -1.183 . . . . 74.43 107.806 169.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.03 144.49 27.96 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.887 0.375 . . . . 72.01 111.08 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.433 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 34.9 p -151.96 128.52 10.74 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.271 -0.877 . . . . 73.24 110.568 -178.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.54 HD11 HG22 ' B' ' 31' ' ' VAL . 66.9 mt -91.76 98.3 11.53 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.654 -1.239 . . . . 65.03 107.654 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.07 -119.49 5.93 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 114.397 -1.274 . . . . 65.13 112.287 -174.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -100.91 1.39 39.82 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.622 0.769 . . . . 62.33 111.552 -174.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.475 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 14.3 pt-20 -122.02 148.55 44.69 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.705 -0.48 . . . . 74.42 109.705 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.5 m -68.46 133.72 49.06 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.119 0.485 . . . . 71.44 111.019 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.433 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -87.95 -64.4 1.15 Allowed 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.914 -1.143 . . . . 73.43 107.914 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -154.06 155.09 34.82 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.262 -1.335 . . . . 75.33 109.364 -177.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 72.4 mt -131.68 111.68 11.89 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.815 -1.55 . . . . 75.13 106.815 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 37.5 t -117.78 151.51 37.17 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.912 -0.773 . . . . 72.41 108.912 -176.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 34.9 tt0 -162.1 129.26 3.84 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.768 -0.826 . . . . 64.32 108.768 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.464 HG22 HG13 ' B' ' 114' ' ' ILE . 85.6 t -124.44 149.68 28.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 124.013 0.925 . . . . 73.22 108.535 178.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -126.51 95.83 4.48 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.181 -1.044 . . . . 74.35 108.181 171.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -90.75 107.39 19.15 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.671 -0.863 . . . . 75.04 108.671 -176.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.94 154.82 20.3 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 112.075 -0.41 . . . . 74.54 112.075 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.5 132.83 3.13 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 117.089 0.444 . . . . 71.24 112.938 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 3.7 mp -86.02 113.66 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 N-CA-C 107.941 -1.133 . . . . 74.14 107.941 170.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -121.48 153.83 37.41 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.786 0.834 . . . . 74.4 109.266 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 49.1 m -100.71 107.41 19.01 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.245 0.618 . . . . 74.25 109.868 176.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.28 102.0 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 106.676 -1.601 . . . . 71.14 106.676 175.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.624 ' HB1' ' HB3' ' B' ' 54' ' ' ASP . . . -147.77 170.84 16.73 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.24 0.616 . . . . 61.12 111.368 -169.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.39 -54.62 4.86 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-O 121.253 0.363 . . . . 63.14 112.414 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.57 HG13 ' HG3' ' B' ' 9' ' ' MET . 1.1 pp -68.4 168.57 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.242 1.017 . . . . 70.53 111.826 171.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.59 -171.3 3.63 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.168 -0.924 . . . . 73.13 110.092 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.64 -132.57 22.53 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 115.081 -0.963 . . . . 64.31 114.166 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 15.8 m -83.55 -40.97 18.44 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.953 0.901 . . . . 63.25 109.86 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -65.49 -25.99 67.72 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 113.609 -1.632 . . . . 74.52 112.131 -165.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.438 ' HB2' HD13 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -65.05 -40.82 95.31 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.054 0.942 . . . . 75.0 112.642 -177.728 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.23 -14.05 59.83 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.048 0.539 . . . . 75.14 112.276 -177.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -64.84 -32.44 74.15 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.833 0.453 . . . . 74.35 110.537 170.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.621 ' SG ' ' HE3' ' B' ' 9' ' ' MET . 41.2 t -66.12 -56.29 12.2 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.592 0.357 . . . . 73.23 110.889 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.431 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.5 pp -67.2 -21.71 65.76 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.711 0.404 . . . . 75.02 111.378 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.84 0.37 57.73 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-O 119.093 -0.837 . . . . 65.04 114.506 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.4 -56.07 0.21 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 118.39 1.095 . . . . 75.14 111.937 -177.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -68.4 -43.79 76.51 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.436 0.695 . . . . 71.13 111.393 -173.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.437 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 58.9 m -70.89 -47.42 15.41 Favored Pre-proline 0 CA--C 1.562 1.441 0 C-N-CA 123.477 0.711 . . . . 74.44 112.21 -176.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.437 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 31.9 Cg_exo -60.85 -28.32 86.22 Favored 'Trans proline' 0 C--N 1.394 2.931 0 C-N-CA 121.953 1.769 . . . . 72.35 113.346 173.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.25 -32.9 72.71 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.577 0.751 . . . . 70.22 111.849 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.539 HD12 HD11 ' B' ' 13' ' ' ILE . 70.0 mt -75.6 -34.94 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.639 0.776 . . . . 65.23 110.155 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 85.4 mt -75.44 -31.8 60.45 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.207 -0.906 . . . . 74.04 111.372 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -57.67 -48.63 96.87 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 113.885 1.068 . . . . 73.45 113.885 -173.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.8 -32.48 91.81 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 122.293 1.996 . . . . 74.54 113.211 177.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.592 ' CD1' HG21 ' B' ' 16' ' ' ILE . 5.0 m-30 -79.53 -37.69 35.96 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.315 0.646 . . . . 75.53 110.514 -176.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.46 -37.95 88.39 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.35 -0.841 . . . . 71.34 110.077 173.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.522 ' HA ' HD12 ' B' ' 128' ' ' LEU . 46.2 ttt-85 -61.02 -55.24 35.11 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.888 1.275 . . . . 74.25 110.181 177.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . 0.451 ' HG3' HH12 ' A' ' 120' ' ' ARG . 13.3 tp10 -61.24 -35.23 76.67 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.903 0.881 . . . . 73.35 110.747 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.58 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.0 t -69.13 -32.59 72.06 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 110.267 -0.271 . . . . 73.22 110.267 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.604 HD12 HG23 ' B' ' 64' ' ' VAL . 69.0 mt -71.19 -56.42 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.443 0.697 . . . . 72.3 110.411 174.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 22.7 m -58.24 -28.56 64.99 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.39 1.076 . . . . 74.4 111.416 -174.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.5 t -63.05 -57.14 11.67 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-N 115.782 -0.645 . . . . 74.12 109.574 171.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.58 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.2 mmt -64.02 -36.75 85.0 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.562 0.745 . . . . 65.42 111.254 -173.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.463 HG23 HD22 ' B' ' 126' ' ' LEU . 82.3 t -57.97 -50.08 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 124.545 1.138 . . . . 73.33 110.075 175.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 47.2 t -73.48 -20.25 60.73 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.785 -1.098 . . . . 74.33 111.496 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 90.9 mtt-85 -68.77 -31.19 70.04 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 110.149 -0.315 . . . . 74.44 110.149 173.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . 0.447 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -78.65 -4.72 87.99 Favored Glycine 0 C--N 1.355 1.607 0 O-C-N 123.62 0.575 . . . . 64.41 112.485 168.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 8.6 m 62.93 33.36 15.04 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 125.684 1.594 . . . . 65.13 110.19 -177.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -76.92 163.75 63.47 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 114.353 -1.294 . . . . 75.21 110.534 176.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.435 ' HG3' ' O ' ' B' ' 36' ' ' TRP . 36.3 Cg_endo -61.34 157.34 41.11 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 122.557 2.171 . . . . 75.34 111.63 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -63.01 130.11 43.29 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.374 0.606 . . . . 65.22 111.924 -171.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.474 HD13 HG11 ' B' ' 40' ' ' VAL . 59.9 tp -120.74 99.86 6.77 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.485 -1.234 . . . . 73.45 109.004 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -95.66 121.99 37.95 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.75 -1.204 . . . . 72.54 107.75 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' B' ' 111' ' ' ARG . 38.6 mt -79.79 132.88 36.25 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 117.831 0.287 . . . . 72.24 110.522 176.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.45 131.82 82.21 Favored Pre-proline 0 C--O 1.243 0.717 0 O-C-N 123.993 0.808 . . . . 75.01 110.91 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.541 ' HG3' HD11 ' D' ' 16' ' ' ILE . 54.0 Cg_endo -67.85 110.04 2.05 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.456 2.104 . . . . 75.33 110.698 172.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 7.7 p -88.18 141.95 13.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 N-CA-C 108.134 -1.062 . . . . 75.2 108.134 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 . . . . . 0 CA--C 1.547 0.83 0 CA-C-O 122.537 1.161 . . . . 74.34 108.645 -179.452 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.48 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 75.6 t80 . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 109.265 -0.643 . . . . 74.4 109.265 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 45.8 tp60 -151.81 142.87 23.16 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.268 0.627 . . . . 73.22 109.383 170.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 23.0 mt -88.18 131.9 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 108.107 -1.071 . . . . 74.43 108.107 173.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -90.26 -47.05 8.02 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.065 -0.717 . . . . 75.01 109.065 172.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -179.25 143.54 0.21 Allowed 'General case' 0 C--O 1.239 0.517 0 CA-C-N 113.914 -1.494 . . . . 75.31 108.424 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 pp -107.72 152.31 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.751 -1.203 . . . . 73.51 107.751 175.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.617 ' HB3' HG22 ' D' ' 122' ' ' THR . 23.6 p90 -173.77 142.41 0.9 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.317 0.58 . . . . 74.43 111.368 -175.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -76.27 127.11 32.23 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.294 1.038 . . . . 63.42 110.669 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -86.31 -22.23 26.87 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.58 -0.896 . . . . 60.44 108.58 168.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.625 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.2 t70 -148.53 133.42 18.05 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.759 -0.655 . . . . 61.22 109.419 -175.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 63.6 mt -136.57 137.33 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 106.035 -1.839 . . . . 71.44 106.035 170.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.3 t -155.16 151.8 28.65 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.516 0.674 . . . . 73.0 112.174 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -153.31 143.73 22.48 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 113.747 -1.57 . . . . 74.15 107.843 174.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -145.57 113.52 6.48 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.174 0.589 . . . . 74.54 110.161 -177.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.23 77.21 48.83 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 108.059 -1.089 . . . . 44.41 108.059 164.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.46 -25.31 63.26 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.708 2.272 . . . . 73.3 111.938 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -94.39 18.65 10.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.111 1.364 . . . . 74.13 111.451 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.59 -57.24 5.9 Favored Pre-proline 0 CA--C 1.559 1.294 0 N-CA-C 113.837 1.051 . . . . 73.3 113.837 -170.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -61.72 -36.74 72.89 Favored 'Trans proline' 0 C--N 1.386 2.507 0 CA-C-N 121.575 1.598 . . . . 72.4 112.468 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -70.06 -40.25 75.18 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.967 0.907 . . . . 75.44 112.39 -178.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.735 HG21 ' HA ' ' C' ' 73' ' ' ALA . 11.3 p -76.78 -26.11 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 N-CA-C 112.649 0.611 . . . . 74.12 112.649 -176.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -61.73 -29.24 69.98 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 112.933 0.716 . . . . 75.32 112.933 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -91.72 13.09 19.16 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.921 0.488 . . . . 72.1 112.073 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.675 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -97.4 163.24 12.96 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.727 0.811 . . . . 74.34 109.662 177.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.62 127.96 34.91 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.425 0.69 . . . . 63.1 109.573 170.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -84.27 83.43 7.98 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.535 0.734 . . . . 74.12 110.808 -176.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -134.9 78.93 53.09 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.77 0.828 . . . . 74.14 108.799 171.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -86.76 154.39 8.77 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.755 2.303 . . . . 73.44 112.405 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -88.68 82.06 6.92 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.126 -1.435 . . . . 64.21 107.126 166.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 44.4 t -68.82 95.97 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.663 0 N-CA-C 107.856 -1.164 . . . . 71.44 107.856 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.75 ' HZ2' ' HB2' ' C' ' 43' ' ' ASP . 0.4 OUTLIER -104.18 104.87 14.86 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.124 -1.435 . . . . 71.12 107.124 -178.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.461 HD21 HD21 ' C' ' 128' ' ' LEU . 2.2 mp -86.74 144.97 26.84 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.689 -1.226 . . . . 73.51 107.689 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.75 ' HB2' ' HZ2' ' C' ' 41' ' ' LYS . 32.6 t70 -138.26 140.97 39.87 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.176 -0.676 . . . . 73.03 109.176 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 92.8 mt -126.59 111.61 14.55 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.718 -0.845 . . . . 75.42 108.718 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -113.94 143.82 44.08 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.018 -1.475 . . . . 72.44 107.018 169.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.3 t -139.05 154.22 48.18 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 120.939 0.399 . . . . 71.23 110.034 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.82 156.26 42.98 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.172 -0.922 . . . . 74.23 108.99 175.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 30.5 p -152.66 150.45 29.48 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.27 0.628 . . . . 74.32 109.976 -175.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 49.9 p -160.56 144.85 14.05 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.201 0.6 . . . . 73.53 110.388 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -77.83 130.52 36.77 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.396 0.678 . . . . 74.24 110.176 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.732 HD12 ' HB2' ' C' ' 57' ' ' GLU . 54.0 mt -95.94 -39.75 9.63 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.521 0.729 . . . . 73.23 109.981 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.24 -171.41 2.6 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.847 0.859 . . . . 50.23 110.363 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -60.26 115.48 3.54 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.182 -0.917 . . . . 74.24 110.403 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 63.16 18.04 10.65 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.051 1.34 . . . . 65.54 111.733 177.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.8 t -121.76 117.56 52.89 Favored 'Isoleucine or valine' 0 C--N 1.354 0.763 0 C-N-CA 124.64 1.176 . . . . 54.24 108.578 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -131.14 130.35 42.96 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.313 1.045 . . . . 72.31 109.114 -176.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.732 ' HB2' HD12 ' C' ' 51' ' ' LEU . 40.0 tt0 -95.85 139.6 31.82 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.186 0.595 . . . . 73.51 109.841 173.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.01 135.01 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 108.648 -0.871 . . . . 75.31 108.648 170.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.509 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 84.3 t -113.75 144.08 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.111 0.964 . . . . 73.13 108.619 171.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.77 107.22 10.32 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.342 -0.984 . . . . 75.15 108.342 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 35.4 ttm-85 -82.08 107.63 14.93 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.517 0.727 . . . . 75.03 109.047 171.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 26.2 t -106.87 112.45 39.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.342 -0.984 . . . . 74.11 108.342 170.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 31.7 m -104.49 144.34 31.8 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.382 -0.827 . . . . 73.11 109.181 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.681 HG23 HG21 ' C' ' 114' ' ' ILE . 88.6 t -132.42 111.53 17.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 N-CA-C 107.301 -1.37 . . . . 74.41 107.301 175.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.0 m -99.11 137.27 37.87 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.908 -1.145 . . . . 71.41 107.908 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.38 104.88 5.29 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.441 -0.948 . . . . 63.34 108.441 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.9 m -129.56 132.2 46.76 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.99 0.424 . . . . 71.31 110.255 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.421 HD11 ' HG2' ' C' ' 34' ' ' LYS . 14.9 mt -85.36 36.94 0.66 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.623 1.169 . . . . 75.11 110.307 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.1 -108.05 2.64 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 110.954 -0.858 . . . . 61.42 110.954 -172.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -90.21 -31.98 16.79 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.113 0.565 . . . . 75.3 110.42 176.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -70.58 119.99 15.54 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.521 -0.918 . . . . 71.11 108.521 171.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 31.3 m -82.72 125.12 30.89 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.333 -0.988 . . . . 72.01 108.333 170.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.735 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.17 -52.6 18.29 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 109.226 -0.657 . . . . 74.4 109.226 176.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . 0.552 ' HZ ' HD23 ' C' ' 126' ' ' LEU . 33.9 p90 -165.7 169.6 14.99 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.653 -1.158 . . . . 73.43 110.913 176.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -128.48 143.25 50.95 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.422 -1.695 . . . . 73.33 106.422 167.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.513 ' SG ' HG22 ' C' ' 114' ' ' ILE . 48.6 t -150.03 122.97 8.75 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.17 -0.678 . . . . 62.12 109.17 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -137.98 134.22 34.61 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.547 -0.538 . . . . 74.24 109.547 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 71.7 t -128.75 136.76 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.093 0.957 . . . . 75.33 108.895 175.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.625 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.1 mt-30 -116.37 87.73 2.75 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.048 -1.093 . . . . 73.53 108.048 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -78.8 102.53 8.2 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.517 -1.22 . . . . 65.32 110.139 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -84.32 -179.64 51.62 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 116.511 -0.313 . . . . 63.24 112.646 173.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.46 134.42 2.27 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-O 119.96 -0.356 . . . . 74.52 112.511 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.522 HG12 ' HE1' ' C' ' 17' ' ' TYR . 33.5 mm -88.66 127.53 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.336 -0.987 . . . . 75.41 108.336 173.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -129.35 140.01 51.52 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.371 0.668 . . . . 73.01 110.595 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 57.8 m -97.42 103.51 15.45 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.551 0.74 . . . . 62.52 109.492 170.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.566 HG21 ' HE2' ' C' ' 94' ' ' MET . 51.0 mt -116.71 135.15 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.639 0.776 . . . . 75.32 109.358 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.92 164.38 30.24 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.157 0.583 . . . . 72.05 110.783 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.46 -18.2 57.9 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.711 -0.677 . . . . 63.54 114.487 172.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.658 HD13 ' HA ' ' C' ' 94' ' ' MET . 40.3 pt -119.91 173.55 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-N 118.019 0.91 . . . . 75.41 112.948 -171.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -161.74 178.99 8.47 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 114.028 -1.442 . . . . 71.32 109.769 174.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.96 -124.27 31.96 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 115.072 0.789 . . . . 74.2 115.072 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 4.6 m -72.28 -27.6 62.58 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.004 0.922 . . . . 73.44 111.21 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -67.15 -47.77 70.04 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.493 0.717 . . . . 73.31 109.558 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.658 ' HA ' HD13 ' C' ' 89' ' ' ILE . 4.6 tpt -55.03 -49.26 72.01 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 114.936 -1.029 . . . . 74.31 111.43 169.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.71 -33.37 68.35 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.785 0.678 . . . . 72.11 111.439 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . 0.4 ' HA ' ' CE1' ' C' ' 137' ' ' PHE . 14.6 t-80 -77.35 -36.16 53.96 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.016 0.526 . . . . 73.13 111.795 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 30.2 t -67.06 -36.58 82.34 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.999 -0.741 . . . . 64.43 108.999 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 55.6 mt -86.96 -22.51 25.54 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.522 1.129 . . . . 73.32 111.439 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.91 -29.19 23.97 Favored Glycine 0 C--N 1.346 1.093 0 O-C-N 123.489 0.493 . . . . 74.01 113.962 -172.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.35 -56.0 0.85 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.854 0.462 . . . . 63.2 111.351 -171.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -63.87 -59.0 5.07 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 123.543 0.527 . . . . 75.41 111.74 -169.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.48 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 72.9 m -58.83 -49.93 90.72 Favored Pre-proline 0 CA--C 1.559 1.309 0 CA-C-O 118.241 -0.885 . . . . 65.41 111.9 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.451 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 52.7 Cg_exo -57.94 -33.56 97.28 Favored 'Trans proline' 0 C--N 1.393 2.903 0 C-N-CA 122.122 1.882 . . . . 72.04 113.54 174.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -70.74 -28.45 64.72 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.832 0.453 . . . . 71.04 110.833 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.46 HD13 HH12 ' A' ' 111' ' ' ARG . 33.0 mm -74.75 -37.39 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.004 0.522 . . . . 74.31 109.833 173.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 82.4 mt -73.01 -25.18 60.88 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.894 0.877 . . . . 75.11 112.038 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . 0.404 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 71.7 t80 -58.23 -52.6 73.38 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 117.717 -1.135 . . . . 74.45 113.813 -174.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . 0.404 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 52.9 Cg_exo -55.3 -34.4 88.39 Favored 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 121.917 1.745 . . . . 74.14 113.258 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -74.82 -45.55 42.56 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.492 0.717 . . . . 64.41 111.264 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.77 -35.05 75.45 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.872 0.869 . . . . 71.13 110.325 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -64.23 -49.72 70.85 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.408 1.483 . . . . 75.45 110.481 178.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -68.48 -34.21 75.53 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.127 0.571 . . . . 75.0 110.571 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . 0.624 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 18.1 m -60.18 -53.61 55.67 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.973 0.509 . . . . 73.42 111.124 174.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.681 HG21 HG23 ' C' ' 64' ' ' VAL . 98.6 mt -58.98 -50.43 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 123.494 0.496 . . . . 74.23 110.02 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.3 m -50.17 -44.91 52.94 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 124.36 1.037 . . . . 75.24 111.415 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.3 t -66.32 -43.15 87.01 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.232 -0.895 . . . . 74.55 109.786 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.845 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.1 OUTLIER -60.28 -46.19 90.71 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.226 1.01 . . . . 64.23 111.664 178.018 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.497 HG23 ' O ' ' C' ' 114' ' ' ILE . 61.4 t -60.88 -43.31 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.723 0.809 . . . . 72.51 109.482 177.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 13.5 t -63.26 -39.12 93.7 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.038 -1.437 . . . . 72.21 111.993 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -71.61 -37.15 70.98 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.342 0.657 . . . . 54.54 109.883 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.2 -4.08 67.25 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.982 0.801 . . . . 61.23 112.608 172.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 24.9 p 65.61 26.19 11.6 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.527 1.931 . . . . 74.1 113.288 170.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -83.04 150.05 60.53 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 108.539 -0.912 . . . . 75.35 108.539 171.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -47.33 138.75 17.42 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 123.342 2.695 . . . . 64.35 113.02 174.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -57.26 145.78 30.73 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.196 0.935 . . . . 75.45 113.514 -171.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.552 HD23 ' HZ ' ' C' ' 74' ' ' PHE . 3.4 pp -147.47 119.12 7.99 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.182 -0.917 . . . . 75.45 109.133 173.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -113.72 115.11 27.31 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.352 -1.351 . . . . 73.24 107.352 176.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.461 HD21 HD21 ' C' ' 42' ' ' LEU . 6.0 mp -61.22 134.15 56.69 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 124.156 0.91 . . . . 73.53 111.321 -170.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.39 146.77 96.05 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 123.513 0.725 . . . . 73.33 110.59 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.795 ' HG2' HG22 ' A' ' 13' ' ' ILE . 46.0 Cg_exo -55.93 104.1 0.13 Allowed 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.584 2.189 . . . . 65.02 112.295 174.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 52.7 t -99.08 113.65 34.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.157 -1.053 . . . . 73.23 108.157 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -75.66 103.32 5.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.954 0.501 . . . . 73.22 110.124 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -62.8 -28.13 69.78 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.441 0.696 . . . . 71.51 111.185 177.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.38 -43.13 86.74 Favored 'General case' 0 C--N 1.349 0.572 0 O-C-N 123.726 0.641 . . . . 75.35 109.769 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.53 -40.31 71.67 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.186 0.994 . . . . 74.4 111.051 175.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 49.8 mt -76.46 -35.0 58.7 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.116 -0.947 . . . . 74.15 111.158 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . 0.4 ' CE1' ' HA ' ' C' ' 96' ' ' HIS . 42.2 t80 . . . . . 0 N--CA 1.478 0.941 0 C-N-CA 122.922 0.489 . . . . 73.54 111.428 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.414 ' HG1' ' HB2' ' D' ' 87' ' ' ALA . 27.2 p . . . . . 0 N--CA 1.464 0.246 0 N-CA-C 109.501 -0.555 . . . . 73.44 109.501 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -142.78 104.44 4.35 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.434 -1.321 . . . . 73.24 107.434 174.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . 0.425 HE22 ' HB3' ' D' ' 85' ' ' SER . 0.4 OUTLIER -142.96 147.23 34.87 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.256 -0.646 . . . . 74.12 109.256 176.137 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mt -93.15 127.79 45.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.628 -1.249 . . . . 71.22 107.628 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . 0.606 ' HB2' HG21 ' D' ' 83' ' ' ILE . 34.5 mt-30 -90.51 -31.02 16.93 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 123.588 0.555 . . . . 73.35 110.041 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -167.57 131.05 1.72 Allowed 'General case' 0 C--N 1.347 0.487 0 CA-C-N 115.984 -0.553 . . . . 73.54 110.259 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.541 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.8 mp -103.57 140.69 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 106.662 -1.607 . . . . 74.21 106.662 171.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -165.01 141.08 5.58 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.46 0.573 . . . . 74.13 111.981 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.7 p -84.08 114.33 21.67 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.651 -0.704 . . . . 73.31 109.772 175.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.0 mtpt -83.81 -10.25 58.19 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.309 -0.859 . . . . 74.13 110.309 175.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.634 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 14.2 t70 -166.01 144.86 5.94 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.609 1.164 . . . . 74.12 108.907 176.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.845 HG21 ' HE1' ' C' ' 117' ' ' MET . 82.6 mt -139.81 145.56 26.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 125.267 1.427 . . . . 72.32 107.428 174.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -153.41 144.36 22.84 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 123.634 0.584 . . . . 74.11 110.522 176.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -153.4 129.43 10.32 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.063 -1.458 . . . . 71.51 107.063 171.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -140.61 119.16 12.3 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.325 0.65 . . . . 71.43 110.407 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.02 90.04 3.37 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 108.132 -1.062 . . . . 63.41 108.132 170.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.97 -42.71 2.96 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 123.582 2.855 . . . . 73.13 113.072 -171.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -96.81 20.9 10.26 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.491 0.716 . . . . 72.44 110.708 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.429 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -40.13 -66.66 0.34 Allowed Pre-proline 0 CA--C 1.576 1.964 0 N-CA-C 116.109 1.892 . . . . 64.25 116.109 -155.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.483 ' HB3' HD11 ' C' ' 83' ' ' ILE . 66.9 Cg_endo -74.35 -22.49 16.3 Favored 'Trans proline' 0 C--N 1.393 2.881 0 CA-C-N 123.686 2.352 . . . . 64.33 113.712 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -70.97 -37.95 72.76 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.836 0.854 . . . . 73.53 110.079 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.52 HG22 ' HG3' ' D' ' 71' ' ' GLU . 5.1 p -83.85 -19.78 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 122.615 0.366 . . . . 63.31 111.392 -173.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.406 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 23.3 m-30 -64.12 -18.58 64.55 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 112.411 0.523 . . . . 73.42 112.411 173.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -57.6 -26.26 61.26 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.713 0.805 . . . . 64.2 110.696 172.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.458 ' CB ' ' HB3' ' D' ' 68' ' ' LEU . 28.8 mmtp -85.74 99.43 11.33 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.728 1.211 . . . . 74.33 109.233 174.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -94.58 85.11 4.42 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 122.726 0.411 . . . . 71.43 110.336 -178.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 39.6 p90 -167.68 179.73 4.69 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.216 1.006 . . . . 73.44 109.824 169.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -68.79 118.34 59.82 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.248 0.619 . . . . 74.32 110.045 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.61 124.94 16.91 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.863 2.375 . . . . 74.43 111.89 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -63.31 108.72 1.37 Allowed 'General case' 0 C--N 1.353 0.759 0 N-CA-C 109.285 -0.635 . . . . 75.03 109.285 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.696 HG22 ' HB3' ' D' ' 66' ' ' ALA . 73.4 t -100.07 131.56 47.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.258 -0.883 . . . . 61.35 108.878 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.404 ' HE2' ' HB ' ' D' ' 65' ' ' THR . 0.0 OUTLIER -111.07 149.13 31.23 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 107.815 -1.18 . . . . 75.14 107.815 169.403 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.423 HD12 HG12 ' D' ' 62' ' ' VAL . 37.1 tp -116.19 136.23 53.2 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 116.037 -0.529 . . . . 74.34 110.212 -177.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.533 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 0.6 OUTLIER -126.92 132.23 50.93 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 107.382 -1.34 . . . . 75.14 107.382 172.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.441 ' CD2' HG21 ' D' ' 62' ' ' VAL . 89.5 mt -125.18 130.81 52.89 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.093 0.473 . . . . 72.42 110.084 178.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -134.53 120.15 19.33 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.209 -1.404 . . . . 74.35 107.209 177.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 46' ' ' THR . . . . . 0.422 HG21 ' HG3' ' D' ' 103' ' ' PRO . 56.7 m -105.56 148.51 27.2 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.365 0.602 . . . . 63.13 110.266 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.27 -179.11 6.93 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.668 1.187 . . . . 73.53 108.721 173.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 25.8 p . . . . . 0 C--N 1.317 -0.824 0 N-CA-C 107.112 -1.44 . . . . 71.14 107.112 174.337 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 114.372 1.249 . . . . 72.34 114.372 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 72.8 t -135.13 98.12 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 108.306 -0.998 . . . . 73.21 108.306 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -138.08 131.2 30.2 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.221 -0.659 . . . . 63.14 109.221 -174.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.48 118.51 36.91 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.026 -1.101 . . . . 65.52 108.026 170.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.417 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 85.7 t -101.9 141.29 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.771 0.828 . . . . 72.43 109.33 -177.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 15.3 t -121.63 131.45 73.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 124.2 1.0 . . . . 73.25 108.747 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.19 122.94 47.22 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 107.244 -1.391 . . . . 75.12 107.244 176.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.484 ' HG2' ' HG2' ' D' ' 79' ' ' GLN . 0.0 OUTLIER -101.69 95.6 6.54 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 106.732 -1.581 . . . . 74.34 106.732 177.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.441 HG21 ' CD2' ' D' ' 44' ' ' LEU . 84.0 t -90.73 134.52 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 108.764 -0.828 . . . . 74.31 108.764 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.533 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 89.9 m -124.19 132.91 53.65 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 124.393 1.058 . . . . 73.42 109.246 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.586 HG13 HG11 ' D' ' 40' ' ' VAL . 73.5 t -127.31 130.3 70.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 124.671 1.188 . . . . 72.44 108.09 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.404 ' HB ' ' HE2' ' D' ' 41' ' ' LYS . 30.7 m -130.0 103.52 6.82 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.099 -1.074 . . . . 70.23 108.099 171.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.696 ' HB3' HG22 ' D' ' 40' ' ' VAL . . . -97.29 141.73 30.03 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.353 -0.84 . . . . 72.43 109.088 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.412 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 40.6 p -145.6 139.84 26.95 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.847 -0.615 . . . . 64.04 110.707 -172.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.462 HD11 HG23 ' D' ' 31' ' ' VAL . 31.7 mt -116.69 106.1 13.14 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.537 1.135 . . . . 71.35 108.832 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.4 -113.89 3.97 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 111.429 -0.668 . . . . 65.14 111.429 -173.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -121.06 23.2 10.73 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.531 0.732 . . . . 73.31 110.169 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.52 ' HG3' HG22 ' D' ' 31' ' ' VAL . 12.9 pt-20 -134.74 158.1 45.01 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 121.698 -0.626 . . . . 61.32 110.416 175.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 40.5 m -75.41 124.29 26.88 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.236 -0.893 . . . . 75.02 111.89 -175.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.504 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -75.32 -69.96 0.45 Allowed 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.117 -1.068 . . . . 63.02 108.117 171.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -148.08 169.22 20.45 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.222 -0.899 . . . . 73.1 110.528 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 58.3 mt -130.38 151.18 51.15 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.103 -1.814 . . . . 72.41 106.103 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.647 ' SG ' HG12 ' D' ' 114' ' ' ILE . 12.0 t -159.17 128.22 5.35 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.561 -0.533 . . . . 71.33 109.561 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -150.7 121.44 7.53 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.611 0.244 . . . . 74.12 110.545 -171.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 93.7 t -131.6 126.87 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.696 0.798 . . . . 74.31 109.918 -171.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.634 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 44.3 mt-30 -91.6 89.02 6.98 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.679 -0.86 . . . . 72.42 108.679 166.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -87.34 98.14 11.19 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.357 -0.838 . . . . 71.21 109.359 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.07 165.0 23.92 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.797 -0.638 . . . . 74.13 112.69 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.67 137.57 4.72 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 111.642 -0.583 . . . . 42.31 111.642 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.606 HG21 ' HB2' ' D' ' 14' ' ' GLN . 8.4 tp -90.66 118.32 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 CA-C-O 121.568 0.699 . . . . 74.33 109.969 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . 0.417 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 64.7 m-85 -112.99 138.91 49.15 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.624 1.17 . . . . 64.31 109.893 -178.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.425 ' HB3' HE22 ' D' ' 12' ' ' GLN . 23.7 t -115.49 104.36 11.67 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.639 -1.245 . . . . 62.25 107.639 169.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 50.2 pt -119.2 138.62 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.406 0.283 . . . . 64.41 110.466 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.414 ' HB2' ' HG1' ' D' ' 10' ' ' THR . . . -150.89 169.01 22.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.432 1.093 . . . . 74.22 110.243 -175.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.63 -13.68 66.76 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 114.519 0.568 . . . . 65.04 114.519 171.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.431 HD11 ' HG2' ' D' ' 94' ' ' MET . 0.8 OUTLIER -107.74 153.79 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.424 0.69 . . . . 73.0 110.781 -179.347 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -134.52 170.34 15.91 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.682 1.193 . . . . 74.02 109.818 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . 0.412 ' O ' ' HE3' ' D' ' 94' ' ' MET . . . 74.34 -141.49 28.93 Favored Glycine 0 N--CA 1.472 1.074 0 O-C-N 123.271 0.357 . . . . 63.52 113.901 174.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 36.4 p -80.77 -43.81 19.57 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.355 0.662 . . . . 74.35 110.779 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -56.93 -26.95 60.44 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.196 0.998 . . . . 74.45 112.3 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.431 ' HG2' HD11 ' D' ' 89' ' ' ILE . 10.6 tmm? -59.15 -60.93 3.08 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 124.79 1.236 . . . . 74.42 112.103 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.91 -15.7 55.57 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.911 0.484 . . . . 64.33 111.345 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -66.35 -41.58 89.33 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.78 0.832 . . . . 74.25 109.851 175.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 73.0 m -60.65 -29.58 69.36 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.165 0.586 . . . . 73.41 111.406 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.594 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 18.5 tp -82.7 -43.26 17.07 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.06 0.544 . . . . 74.12 110.948 178.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.88 -21.83 73.29 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-N 115.682 -0.69 . . . . 74.2 113.661 -174.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -122.44 -56.55 1.79 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.241 0.616 . . . . 74.33 111.531 -174.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . 0.402 ' O ' HG12 ' D' ' 105' ' ' ILE . 31.6 t80 -73.28 -31.9 64.33 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 112.001 0.371 . . . . 74.3 112.001 -172.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.594 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 84.4 m -65.82 -49.89 56.79 Favored Pre-proline 0 CA--C 1.566 1.588 0 CA-C-O 118.309 -0.853 . . . . 74.22 112.334 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.422 ' HG3' HG21 ' D' ' 46' ' ' THR . 33.4 Cg_endo -65.13 -23.83 59.98 Favored 'Trans proline' 0 C--N 1.389 2.683 0 C-N-CA 121.753 1.635 . . . . 71.04 113.259 171.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.34 -36.28 83.62 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.694 -0.484 . . . . 73.33 109.694 174.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.405 ' O ' ' HD2' ' D' ' 108' ' ' PRO . 28.8 mm -70.13 -40.47 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.743 1.217 . . . . 74.34 111.012 175.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 55.4 mt -70.17 -20.36 63.14 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 116.017 -0.538 . . . . 63.33 111.617 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -68.84 -43.95 29.04 Favored Pre-proline 0 CA--C 1.56 1.334 0 N-CA-C 113.997 1.11 . . . . 75.34 113.997 -173.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . 0.405 ' HD2' ' O ' ' D' ' 105' ' ' ILE . 71.4 Cg_exo -45.93 -43.0 20.21 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 122.53 2.153 . . . . 71.13 113.732 168.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -80.53 -29.85 37.17 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.683 0.793 . . . . 74.51 112.206 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.93 -49.87 64.14 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.586 0.708 . . . . 74.45 109.397 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.54 HH12 ' HB3' ' D' ' 130' ' ' PRO . 34.4 ttp180 -63.0 -34.73 78.19 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 113.843 -1.526 . . . . 74.4 110.756 174.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . 0.492 ' HA ' ' CE2' ' B' ' 109' ' ' TYR . 9.5 tt0 -55.14 -54.2 46.25 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.625 0.77 . . . . 64.11 111.351 177.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.0 t -59.28 -46.24 89.06 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.726 -1.125 . . . . 75.03 110.508 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.647 HG12 ' SG ' ' D' ' 76' ' ' CYS . 74.9 mt -60.95 -56.5 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.411 1.084 . . . . 75.54 111.785 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 95.5 m -55.02 -40.95 70.75 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.823 1.249 . . . . 63.12 111.693 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 42.7 t -69.53 -27.95 65.61 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.435 -0.802 . . . . 64.2 111.327 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.55 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 76.8 mtm -84.33 -30.12 25.77 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.174 0.59 . . . . 73.22 111.873 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.4 HG22 ' O ' ' D' ' 114' ' ' ILE . 61.0 t -66.33 -39.38 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.725 0.81 . . . . 72.44 110.656 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.7 p -66.62 -27.29 67.58 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 115.652 -0.704 . . . . 73.5 110.678 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.624 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 64.3 mtt-85 -80.61 -16.25 54.56 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.775 0.83 . . . . 74.54 111.582 177.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.3 4.71 74.15 Favored Glycine 0 C--N 1.352 1.468 0 CA-C-O 119.621 -0.544 . . . . 54.21 113.156 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.617 HG22 ' HB3' ' C' ' 17' ' ' TYR . 81.0 p 56.17 27.67 11.95 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.874 1.669 . . . . 71.14 113.003 -174.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -95.08 149.62 36.5 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 123.121 0.568 . . . . 74.01 109.533 172.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -50.4 146.96 17.69 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 123.174 2.583 . . . . 73.13 113.966 171.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 41.2 tp60 -47.64 124.18 6.8 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.28 1.832 . . . . 73.43 112.911 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.458 HD12 HG23 ' D' ' 40' ' ' VAL . 13.0 tp -107.24 117.72 34.81 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.535 -0.913 . . . . 74.31 108.535 175.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -121.12 100.09 6.86 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.62 -1.252 . . . . 70.21 107.62 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.401 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 90.1 mt -65.21 120.09 12.08 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 109.411 -0.588 . . . . 72.43 109.411 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.87 122.96 69.49 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 122.839 0.455 . . . . 73.54 110.599 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.54 ' HB3' HH12 ' D' ' 111' ' ' ARG . 60.1 Cg_endo -71.42 114.31 3.89 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.395 2.063 . . . . 75.24 111.44 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 12.3 p -108.43 150.08 11.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 123.461 0.704 . . . . 75.04 109.276 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -79.03 109.53 13.43 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.116 -0.698 . . . . 74.21 109.116 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 . . . . . 0 N--CA 1.483 1.208 0 C-N-CA 123.725 0.81 . . . . 75.41 110.904 179.111 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 76.2 m . . . . . 0 C--O 1.239 0.552 0 N-CA-C 107.611 -1.255 . . . . 71.43 107.611 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.417 ' CD1' HD13 ' A' ' 86' ' ' ILE . 90.3 t80 -100.27 116.29 31.91 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.881 -1.155 . . . . 65.32 107.881 174.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.5 tp60 -133.99 132.91 40.68 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.541 -0.911 . . . . 74.22 108.541 174.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.2 mt -91.17 119.84 39.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.233 -1.025 . . . . 75.3 108.233 175.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.54 -41.73 21.2 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.044 -0.725 . . . . 74.22 109.044 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -170.38 131.43 0.95 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.885 0.474 . . . . 73.34 110.049 -169.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.4 mt -117.46 131.22 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 108.492 -0.929 . . . . 71.13 108.492 173.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.448 ' HE1' HG13 ' A' ' 83' ' ' ILE . 27.2 p90 -161.78 177.85 9.51 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 123.952 0.783 . . . . 74.44 111.52 -173.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.6 p -107.09 126.29 52.17 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.438 -0.579 . . . . 73.25 109.438 173.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.437 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 44.4 mtpt -86.14 -33.44 20.87 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.623 -0.51 . . . . 74.03 109.623 175.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -148.15 142.95 26.75 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.632 -1.167 . . . . 75.21 109.874 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.437 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 81.7 mt -142.02 142.3 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.821 1.249 . . . . 75.44 108.23 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -149.42 121.5 8.29 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.03 0.532 . . . . 64.25 109.797 173.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.571 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 86.0 t80 -116.37 141.94 47.5 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.315 -1.365 . . . . 72.43 107.315 168.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 26.9 mt-10 -136.39 143.14 43.84 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.998 0.519 . . . . 74.25 109.834 175.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.17 75.74 10.53 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 107.427 -1.323 . . . . 74.43 107.427 170.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.83 -33.01 44.86 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.767 2.311 . . . . 72.34 112.267 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -100.86 15.5 28.26 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 114.682 -1.145 . . . . 73.31 110.171 -176.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.562 ' HB2' ' HE3' ' B' ' 19' ' ' LYS . . . -41.18 -56.19 4.45 Favored Pre-proline 0 N--CA 1.496 1.859 0 CA-C-O 117.698 -1.144 . . . . 64.42 113.477 -170.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -61.78 -32.43 85.99 Favored 'Trans proline' 0 C--N 1.391 2.783 0 CA-C-N 121.524 1.58 . . . . 74.03 112.788 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -75.96 -46.02 31.88 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.126 -0.943 . . . . 71.15 111.096 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.759 HG22 ' HA ' ' A' ' 73' ' ' ALA . 10.0 p -76.77 -14.8 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 124.111 0.964 . . . . 75.24 112.771 -160.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -69.02 -20.09 64.13 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.842 0.457 . . . . 61.43 111.439 171.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -82.81 -22.43 34.18 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.494 1.117 . . . . 75.52 111.016 174.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.478 ' HE2' ' HB3' ' A' ' 71' ' ' GLU . 24.8 mmmt -67.1 154.61 40.81 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.235 1.014 . . . . 72.22 112.172 -178.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -74.92 125.55 29.1 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.286 -0.87 . . . . 72.04 109.259 173.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -77.71 88.33 3.97 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.605 0.717 . . . . 71.11 110.604 -174.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -117.14 83.51 15.51 Favored Pre-proline 0 N--CA 1.472 0.672 0 N-CA-C 106.313 -1.736 . . . . 71.31 106.313 170.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.8 93.85 0.87 Allowed 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 121.678 1.586 . . . . 72.54 111.151 -175.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -93.68 83.87 4.53 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 105.751 -1.944 . . . . 72.21 105.751 175.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.687 HG23 ' HB1' ' A' ' 66' ' ' ALA . 42.7 t -91.68 117.84 35.82 Favored 'Isoleucine or valine' 0 C--N 1.342 0.279 0 CA-C-N 113.573 -1.649 . . . . 61.33 110.456 -168.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.59 ' HE2' ' HB2' ' A' ' 43' ' ' ASP . 85.6 tttt -79.28 121.59 25.28 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.932 -0.766 . . . . 65.13 108.932 169.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.0 mt -101.38 106.54 17.71 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.267 -1.012 . . . . 74.33 108.267 169.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.59 ' HB2' ' HE2' ' A' ' 41' ' ' LYS . 16.5 t70 -106.1 136.8 45.15 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.167 -1.42 . . . . 74.44 107.167 175.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.701 HD22 HD23 ' A' ' 60' ' ' LEU . 87.1 mt -130.56 134.3 46.91 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.22 0.533 . . . . 64.45 110.784 -174.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.483 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 21.3 t70 -134.48 146.78 50.08 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.63 1.172 . . . . 74.44 108.331 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.8 m -136.47 127.29 27.42 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.991 0.516 . . . . 72.41 109.633 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.62 110.53 9.95 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.555 0.742 . . . . 71.15 109.987 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 61.4 p -102.17 153.98 19.44 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.773 0.429 . . . . 74.43 110.747 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.3 t -150.78 125.13 9.47 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.65 0.78 . . . . 71.44 109.044 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -72.24 105.96 4.24 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.712 -0.477 . . . . 75.32 109.712 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.743 HD12 ' HB2' ' A' ' 57' ' ' GLU . 76.3 mt -78.83 -38.49 37.9 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.051 0.54 . . . . 73.13 109.902 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.65 176.21 11.99 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.455 1.102 . . . . 74.41 109.253 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -68.13 123.19 19.99 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 108.667 -0.864 . . . . 75.14 108.667 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 66.54 20.09 10.84 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.466 1.106 . . . . 74.41 111.793 -174.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.2 t -132.17 105.19 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 107.734 -1.21 . . . . 72.35 107.734 172.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -123.15 126.4 46.94 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.716 -0.846 . . . . 73.13 108.716 -177.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.743 ' HB2' HD12 ' A' ' 51' ' ' LEU . 33.9 tt0 -84.7 149.34 25.86 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.014 -0.736 . . . . 74.34 109.014 171.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.487 HG11 ' HD3' ' A' ' 103' ' ' PRO . 73.8 t -131.48 138.68 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 C-N-CA 124.364 1.066 . . . . 74.44 108.19 169.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.41 135.74 57.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.806 -0.812 . . . . 75.05 108.806 174.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.701 HD23 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -110.19 99.35 8.43 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 106.796 -1.557 . . . . 74.34 106.796 172.037 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.483 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 30.4 ttp180 -87.11 100.56 12.74 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.086 -1.079 . . . . 62.52 108.086 173.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 32.0 t -95.29 134.56 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 108.222 -1.029 . . . . 73.12 108.222 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 9.4 m -121.89 125.14 45.75 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.078 -0.712 . . . . 65.25 109.078 174.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.465 ' O ' HD12 ' A' ' 75' ' ' LEU . 70.4 t -121.81 120.02 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 124.456 1.103 . . . . 65.24 109.156 -174.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.6 m -128.54 116.6 19.91 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.406 0.548 . . . . 73.51 109.867 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.687 ' HB1' HG23 ' A' ' 40' ' ' VAL . . . -102.94 113.07 26.22 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 107.838 -1.171 . . . . 74.42 107.838 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 46.3 m -108.89 128.52 54.99 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.21 0.604 . . . . 72.32 110.012 177.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.527 HD13 ' HB1' ' A' ' 73' ' ' ALA . 19.6 mt -95.84 77.76 3.22 Favored 'General case' 0 C--O 1.247 0.961 0 C-N-CA 124.365 1.066 . . . . 65.45 108.566 -178.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.99 -85.69 0.89 Allowed Glycine 0 C--N 1.344 0.998 0 CA-C-N 115.376 -0.829 . . . . 62.21 111.764 -174.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -112.62 -30.92 6.93 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.844 0.857 . . . . 75.42 110.354 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.478 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 7.6 tp10 -101.98 119.07 38.19 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.858 0.463 . . . . 73.22 110.26 -170.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 88.2 m -70.99 135.59 47.93 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 122.809 0.443 . . . . 62.44 111.176 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.759 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -77.06 -64.42 1.14 Allowed 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.333 1.053 . . . . 63.11 110.135 175.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -151.08 170.39 19.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.751 0.786 . . . . 71.44 112.786 -177.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 64' ' ' VAL . 62.5 tp -123.92 144.94 49.48 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 113.809 -1.541 . . . . 73.32 107.911 169.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.43 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.1 m -146.44 102.5 3.59 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.722 0.809 . . . . 73.34 109.268 176.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 37.4 tt0 -119.5 116.31 25.83 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.311 0.644 . . . . 72.52 109.276 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.463 HG12 ' HB3' ' A' ' 113' ' ' CYS . 39.4 t -127.31 113.68 33.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.221 1.008 . . . . 75.51 109.629 -174.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -85.27 87.24 7.36 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.539 -0.912 . . . . 74.22 108.539 171.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -76.44 92.8 3.43 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.453 -0.794 . . . . 74.35 109.173 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.74 146.13 19.79 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-N 115.703 -0.681 . . . . 74.23 111.467 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.27 122.67 1.68 Allowed Glycine 0 CA--C 1.503 -0.708 0 N-CA-C 110.258 -1.137 . . . . 61.45 110.258 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.47 HG23 HD11 ' A' ' 51' ' ' LEU . 49.0 mt -81.81 129.23 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.578 -1.267 . . . . 70.22 107.578 172.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.634 ' HB3' HD11 ' A' ' 86' ' ' ILE . 92.9 m-85 -130.46 134.5 47.14 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.326 -0.99 . . . . 73.41 108.326 -176.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.3 t -98.31 99.9 11.14 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.928 -1.138 . . . . 70.53 107.928 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.634 HD11 ' HB3' ' A' ' 84' ' ' PHE . 20.0 mm -120.35 129.86 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.235 0.614 . . . . 75.23 110.632 -169.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.41 173.26 12.44 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.964 0.905 . . . . 73.32 110.567 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.56 -32.1 7.12 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 116.309 -0.405 . . . . 63.12 112.925 175.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.39 159.98 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.942 0.897 . . . . 72.11 110.447 -176.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.483 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 19.7 tt0 -150.24 -179.29 7.07 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 108.886 -0.783 . . . . 71.41 108.886 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.483 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 59.3 -125.77 40.47 Favored Glycine 0 C--N 1.348 1.2 0 N-CA-C 114.547 0.579 . . . . 74.32 114.547 176.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.2 t -70.58 -27.14 63.89 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.116 0.566 . . . . 62.43 111.503 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -73.05 -36.14 66.84 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.96 0.904 . . . . 75.35 110.002 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.478 ' HA ' ' HE1' ' A' ' 94' ' ' MET . 4.4 tpt -65.43 -46.42 80.0 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-N 115.381 -0.827 . . . . 73.05 109.628 175.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.4 -34.71 75.81 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.447 -0.797 . . . . 75.34 111.357 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -71.92 -32.97 67.89 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.462 0.705 . . . . 71.41 111.426 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -71.64 -44.8 63.7 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.019 0.438 . . . . 73.41 109.854 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 76.2 mt -80.73 -32.37 35.73 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.496 -0.775 . . . . 73.3 112.193 -173.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.42 3.49 59.65 Favored Glycine 0 N--CA 1.469 0.856 0 CA-C-O 119.591 -0.56 . . . . 71.24 113.736 -174.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.651 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -148.16 -62.61 0.26 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.664 0.616 . . . . 70.42 112.664 -174.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -68.05 -44.59 76.04 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 120.827 0.346 . . . . 72.31 111.572 -172.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 99.3 m -69.13 -47.38 29.15 Favored Pre-proline 0 CA--C 1.563 1.457 0 C-N-CA 124.086 0.954 . . . . 61.12 112.936 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.487 ' HD3' HG11 ' A' ' 58' ' ' VAL . 44.8 Cg_endo -66.89 -19.24 52.66 Favored 'Trans proline' 0 C--N 1.395 3.025 0 CA-C-N 121.694 1.641 . . . . 64.43 112.755 173.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -70.86 -38.18 73.13 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.021 0.528 . . . . 73.41 109.951 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 38.7 mm -64.22 -42.91 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.896 0.879 . . . . 75.2 110.155 171.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.5 mt -73.92 -22.73 59.57 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.325 -0.852 . . . . 74.34 112.289 -174.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -61.57 -46.64 93.97 Favored Pre-proline 0 N--CA 1.486 1.33 0 N-CA-C 114.416 1.265 . . . . 74.13 114.416 -172.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -52.89 -35.84 72.18 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 121.784 1.656 . . . . 74.31 113.045 172.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.416 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 84.4 m-85 -79.88 -36.94 35.84 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.946 0.898 . . . . 62.21 111.877 -177.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.76 -49.6 65.42 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 109.161 -0.681 . . . . 72.34 109.161 176.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 32.5 ttm180 -50.17 -45.92 53.75 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.905 1.378 . . . . 74.43 110.218 173.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -62.94 -52.21 63.91 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.836 0.71 . . . . 61.14 111.504 -177.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.496 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 52.6 t -59.43 -34.78 72.91 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.827 0.704 . . . . 74.14 111.588 -178.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.443 HG21 HG22 ' A' ' 64' ' ' VAL . 24.4 mt -66.7 -59.27 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.691 0.796 . . . . 75.13 109.952 173.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 94.6 m -53.51 -37.65 62.98 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.829 1.252 . . . . 74.23 111.696 -174.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.2 t -69.62 -42.63 74.09 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 114.232 -1.349 . . . . 70.05 109.889 -178.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.571 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 35.3 mtm -65.69 -35.57 81.14 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.492 0.317 . . . . 73.14 110.998 176.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 114' ' ' ILE . 85.5 t -58.82 -49.42 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.892 0.877 . . . . 72.31 109.536 175.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.5 p -76.93 -27.97 55.07 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.644 -0.707 . . . . 71.23 111.725 -175.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -73.77 -28.96 61.93 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.48 0.712 . . . . 71.03 109.46 174.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.448 ' O ' HG22 ' A' ' 122' ' ' THR . . . -86.29 12.25 61.07 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.956 0.785 . . . . 73.41 112.557 171.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.3 t 63.2 11.5 5.37 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 127.127 2.171 . . . . 72.23 114.23 173.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -77.35 148.25 77.14 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 109.492 -0.559 . . . . 64.32 109.492 176.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.9 128.1 27.42 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.788 2.326 . . . . 74.42 111.93 175.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -46.85 125.43 7.36 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.804 1.315 . . . . 75.21 112.404 -171.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 61.0 tp -106.77 137.33 45.0 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.625 -0.88 . . . . 73.25 108.625 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.427 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 90.9 m-20 -129.7 113.95 15.39 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.802 -1.185 . . . . 75.41 107.802 -178.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.443 HD12 HD12 ' A' ' 114' ' ' ILE . 7.4 mt -70.57 133.08 46.41 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.951 -0.759 . . . . 74.35 108.951 -176.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.55 136.66 94.59 Favored Pre-proline 0 CA--C 1.552 1.049 0 CA-C-O 118.997 -0.525 . . . . 74.35 111.047 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -55.72 109.88 0.48 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.272 2.648 . . . . 72.31 113.558 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.441 HG22 HD13 ' A' ' 44' ' ' LEU . 58.9 t -98.43 133.05 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.07 0.462 . . . . 74.55 110.215 -175.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -92.15 80.04 5.09 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.597 -1.183 . . . . 75.34 109.049 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -57.35 -35.52 70.02 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.179 0.992 . . . . 74.25 111.615 175.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.651 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 24.1 t70 -54.29 -47.78 72.01 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 124.373 1.046 . . . . 74.54 111.095 175.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.41 -42.02 83.94 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.953 0.783 . . . . 74.15 111.083 176.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 92.5 mt -54.48 -41.28 69.34 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.067 0.547 . . . . 74.23 111.224 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 33.6 t80 . . . . . 0 CA--C 1.541 0.624 0 CA-C-N 115.591 -0.731 . . . . 74.41 110.253 176.527 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 18.7 ptm . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 114.776 1.398 . . . . 75.13 114.776 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 5.2 t -135.08 130.09 35.01 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 106.627 -1.62 . . . . 72.23 106.627 167.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.475 ' HD1' HG23 ' B' ' 86' ' ' ILE . 87.9 t80 -135.02 145.44 48.05 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.141 0.576 . . . . 71.34 110.016 -171.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -151.13 140.04 20.95 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.021 0.929 . . . . 75.24 109.121 171.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 49.8 mt -87.78 127.21 41.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.077 -1.083 . . . . 75.41 108.077 170.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -84.03 -49.21 9.14 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 109.187 -0.672 . . . . 71.13 109.187 176.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -170.31 134.54 1.19 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.314 -0.857 . . . . 75.51 110.231 -172.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.417 HD13 HD21 ' D' ' 127' ' ' ASN . 91.4 mt -114.82 137.62 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 107.673 -1.232 . . . . 74.12 107.673 175.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -161.96 142.09 10.21 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.097 0.475 . . . . 65.2 111.537 -172.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.422 HG23 HD13 ' B' ' 21' ' ' ILE . 18.9 m -77.65 126.62 31.16 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 108.57 -0.9 . . . . 61.31 108.57 171.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.562 ' HE3' ' HB2' ' A' ' 28' ' ' ALA . 42.3 mtpt -99.57 -18.35 17.41 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.969 0.907 . . . . 73.33 111.798 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -161.31 138.73 8.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.9 0.48 . . . . 73.11 110.82 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.674 HD13 ' SG ' ' B' ' 113' ' ' CYS . 47.0 mm -126.97 143.23 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.399 1.08 . . . . 75.54 108.331 168.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 27.9 t -144.79 119.81 10.03 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.227 -1.027 . . . . 63.24 108.227 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.437 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 82.9 t80 -132.1 116.46 17.06 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.808 -1.182 . . . . 72.23 107.808 173.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -123.01 113.89 19.67 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.87 0.868 . . . . 73.32 109.124 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.55 87.21 3.27 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 106.82 -1.548 . . . . 73.33 106.82 166.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.73 -26.41 45.56 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 122.559 2.173 . . . . 74.5 111.778 -173.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.446 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 72.2 m-20 -110.13 10.57 23.91 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 118.048 -0.977 . . . . 73.1 110.901 -177.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.4 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -33.71 -64.28 0.28 Allowed Pre-proline 0 N--CA 1.502 2.13 0 C-N-CA 124.955 1.302 . . . . 74.3 114.07 -171.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -64.5 -29.75 61.8 Favored 'Trans proline' 0 C--N 1.396 3.041 0 C-N-CA 122.27 1.98 . . . . 74.34 112.889 -171.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -95.14 -26.49 15.99 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.848 0.859 . . . . 73.03 111.993 -171.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.541 HG23 ' HA ' ' B' ' 73' ' ' ALA . 4.8 p -82.43 -14.57 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 C-N-CA 122.678 0.391 . . . . 72.41 110.756 -176.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -68.39 -9.88 51.28 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 113.378 0.881 . . . . 73.13 113.378 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -71.37 -13.0 61.72 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 122.907 0.483 . . . . 75.3 110.8 173.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.565 ' HZ3' ' HG2' ' B' ' 71' ' ' GLU . 89.3 mttt -103.21 81.57 1.97 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.597 1.159 . . . . 74.42 109.582 -175.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -88.48 74.86 8.48 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.453 -0.794 . . . . 62.35 110.077 -176.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -153.17 179.1 9.03 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.819 -0.628 . . . . 74.14 109.66 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.06 110.15 6.69 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.057 0.943 . . . . 74.41 109.283 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -71.54 145.97 48.5 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 121.956 1.771 . . . . 75.32 111.274 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 9.8 tp10 -64.56 102.09 0.52 Allowed 'General case' 0 C--N 1.343 0.321 0 N-CA-C 108.068 -1.086 . . . . 71.55 108.068 173.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.722 HG21 ' HB1' ' B' ' 66' ' ' ALA . 23.4 t -98.6 154.49 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 108.771 -0.826 . . . . 73.15 108.771 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -145.11 130.07 18.33 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.447 -0.946 . . . . 73.21 108.447 170.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.404 HD11 ' CG1' ' B' ' 62' ' ' VAL . 14.8 tp -86.21 138.21 32.05 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.491 -0.929 . . . . 75.24 108.491 170.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -137.0 117.02 13.29 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.933 -1.136 . . . . 64.35 107.933 -177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 4.4 mp -99.91 128.06 46.03 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.464 -0.939 . . . . 75.12 108.464 -171.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -132.17 143.87 50.27 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.325 -0.62 . . . . 73.31 109.325 175.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 18.5 p -128.91 125.86 38.46 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.472 0.709 . . . . 74.42 109.979 -174.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.419 ' O ' ' HB ' ' B' ' 59' ' ' VAL . . . -147.41 125.99 12.5 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 107.72 -1.215 . . . . 73.34 107.72 175.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 35.8 m -130.18 -179.01 4.99 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.085 0.554 . . . . 75.53 110.498 -176.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.8 p -152.17 135.64 16.05 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.916 -0.772 . . . . 72.2 108.916 172.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -91.83 119.14 31.36 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.286 -1.005 . . . . 71.5 108.286 170.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 pp -130.56 16.61 5.37 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.094 0.958 . . . . 75.33 110.077 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.19 157.8 36.51 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 123.583 0.753 . . . . 72.42 110.388 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -89.24 136.35 33.07 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 107.755 -1.202 . . . . 71.53 107.755 163.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 71.97 4.35 4.99 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.793 1.237 . . . . 75.12 111.852 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.628 HG22 ' HA ' ' B' ' 85' ' ' SER . 25.6 t -146.53 129.05 8.24 Favored 'Isoleucine or valine' 0 C--N 1.355 0.838 0 C-N-CA 124.08 0.952 . . . . 74.44 109.691 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.464 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 0.4 OUTLIER -113.53 163.53 14.8 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 108.713 -0.847 . . . . 74.41 108.713 166.38 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -119.92 107.23 12.87 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.287 -1.375 . . . . 65.22 107.287 177.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 65.8 t -100.42 125.21 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.714 0.805 . . . . 74.1 110.145 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.483 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.2 t -107.52 112.16 38.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 108.723 -0.843 . . . . 71.24 108.723 174.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 62.0 tp -93.92 112.58 24.45 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.633 -0.506 . . . . 72.41 109.633 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -95.76 106.06 18.14 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.482 0.713 . . . . 74.24 109.275 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.404 ' CG1' HD11 ' B' ' 42' ' ' LEU . 45.0 t -105.81 111.16 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 108.399 -0.963 . . . . 72.44 108.399 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 21.0 m -108.45 135.68 49.33 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.879 0.871 . . . . 71.51 109.965 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.609 HG23 HG23 ' B' ' 114' ' ' ILE . 44.4 t -129.36 115.69 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.945 1.298 . . . . 75.05 109.592 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 64.2 m -103.3 138.94 39.4 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.805 -0.813 . . . . 72.12 108.805 171.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.722 ' HB1' HG21 ' B' ' 40' ' ' VAL . . . -145.61 143.19 29.72 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.995 0.518 . . . . 74.24 109.776 176.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.508 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 67.4 p -141.5 131.81 25.07 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.546 -0.752 . . . . 71.33 110.913 -175.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.41 ' HG ' ' HB3' ' B' ' 73' ' ' ALA . 61.7 mt -100.49 111.55 23.82 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.556 1.142 . . . . 72.43 108.522 174.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.01 -128.63 11.06 Favored Glycine 0 C--N 1.342 0.887 0 O-C-N 123.436 0.46 . . . . 63.41 112.634 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -90.5 2.51 55.66 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.95 0.9 . . . . 74.33 112.207 -176.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.565 ' HG2' ' HZ3' ' B' ' 34' ' ' LYS . 12.6 pt-20 -137.84 157.25 46.81 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.768 0.427 . . . . 74.2 111.565 -169.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.5 m -69.1 128.43 36.63 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.435 -0.802 . . . . 74.03 110.938 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.541 ' HA ' HG23 ' B' ' 31' ' ' VAL . . . -79.96 -64.02 1.28 Allowed 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.565 -1.272 . . . . 74.41 107.565 174.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -150.52 158.48 44.2 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 114.83 -1.077 . . . . 75.11 111.687 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 95.8 mt -125.27 113.34 17.48 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 106.333 -1.729 . . . . 61.41 106.333 172.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.529 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 27.0 t -118.28 146.35 44.37 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.915 -1.143 . . . . 72.41 107.915 175.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -161.62 126.76 3.53 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.254 -1.017 . . . . 62.45 108.254 -176.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.2 t -124.54 148.29 28.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.007 0.923 . . . . 63.21 108.729 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -121.95 96.82 5.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.226 -1.027 . . . . 74.23 108.226 169.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -89.19 101.34 14.0 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.992 -0.744 . . . . 74.25 108.992 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.29 170.75 37.68 Favored Glycine 0 C--N 1.339 0.698 0 O-C-N 123.523 0.514 . . . . 75.24 112.017 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.99 132.76 2.5 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.512 -0.375 . . . . 74.04 112.659 -176.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 79.4 mt -91.26 111.11 23.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 108.001 -1.111 . . . . 64.21 108.001 173.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -113.34 133.8 54.95 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.104 0.562 . . . . 72.51 109.933 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.628 ' HA ' HG22 ' B' ' 55' ' ' VAL . 66.9 m -95.56 122.06 37.92 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.015 0.926 . . . . 72.32 109.319 175.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.475 HG23 ' HD1' ' B' ' 11' ' ' PHE . 0.2 OUTLIER -138.36 134.32 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.991 0.917 . . . . 74.54 110.599 -173.377 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.93 171.08 20.69 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.534 1.134 . . . . 74.35 108.191 169.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.9 -43.14 3.06 Favored Glycine 0 N--CA 1.469 0.878 0 N-CA-C 111.991 -0.444 . . . . 53.13 111.991 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.645 ' HB ' ' HA ' ' B' ' 94' ' ' MET . 9.4 pt -58.34 143.46 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.42 0.688 . . . . 73.35 110.802 171.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -161.26 152.68 18.97 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 123.858 0.724 . . . . 74.34 110.813 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.65 -133.88 13.3 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.625 -0.716 . . . . 75.5 111.854 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 2.8 m -67.15 -44.03 80.82 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.666 0.787 . . . . 71.11 110.326 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -67.3 -18.93 65.38 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.048 -1.433 . . . . 74.15 111.757 -168.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.645 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 17.7 tmm? -68.14 -66.36 0.58 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.155 0.982 . . . . 73.34 111.56 -174.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . 0.42 ' O ' ' HG ' ' B' ' 98' ' ' LEU . . . -80.76 -9.36 59.81 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 120.857 0.36 . . . . 73.4 111.909 177.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -60.99 -31.74 71.34 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 122.866 0.467 . . . . 73.13 110.807 164.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.6 t -61.39 -40.45 94.39 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.831 0.852 . . . . 75.32 112.411 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' B' ' 95' ' ' ALA . 4.1 pp -69.69 -22.92 63.38 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.895 0.478 . . . . 65.33 112.001 177.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.05 -12.75 51.62 Favored Glycine 0 C--N 1.348 1.209 0 O-C-N 123.309 0.381 . . . . 75.44 113.797 -177.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.86 -57.67 1.04 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 117.364 0.582 . . . . 61.52 112.047 -173.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -75.16 -46.58 33.32 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.144 0.578 . . . . 73.54 111.615 -169.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.464 ' SG ' ' HE1' ' B' ' 56' ' ' TYR . 78.4 m -65.99 -47.18 63.93 Favored Pre-proline 0 CA--C 1.561 1.394 0 CA-C-O 118.459 -0.781 . . . . 61.44 112.595 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.96 -26.87 66.45 Favored 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 121.735 1.623 . . . . 72.41 112.746 172.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.42 -37.11 82.31 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.127 0.571 . . . . 74.23 110.868 175.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 66.7 mt -71.85 -44.49 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.758 0.823 . . . . 74.52 110.322 176.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 86.9 mt -78.47 -17.31 56.48 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.166 -0.924 . . . . 74.31 112.509 -171.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.415 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 55.4 t80 -63.33 -50.82 72.45 Favored Pre-proline 0 CA--C 1.55 0.957 0 CA-C-O 117.953 -1.022 . . . . 75.31 112.728 -176.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . 0.58 ' HG2' ' HB2' ' D' ' 108' ' ' PRO . 93.6 Cg_exo -50.84 -42.58 50.87 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.261 1.974 . . . . 64.23 114.185 174.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -66.74 -44.44 81.5 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.361 0.665 . . . . 74.23 111.364 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.17 -37.2 83.34 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.676 -0.693 . . . . 73.23 110.995 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 60.7 ttt-85 -62.18 -51.54 67.43 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.341 1.456 . . . . 74.15 110.203 177.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -62.41 -36.8 83.48 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.238 0.961 . . . . 73.22 110.448 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.674 ' SG ' HD13 ' B' ' 21' ' ' ILE . 1.9 t -73.84 -30.2 62.55 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.018 0.127 . . . . 71.13 111.085 -177.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.609 HG23 HG23 ' B' ' 64' ' ' VAL . 41.8 mt -66.29 -55.82 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.679 0.791 . . . . 73.24 109.008 172.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.508 HG22 ' OG ' ' C' ' 119' ' ' SER . 31.9 m -62.08 -26.51 68.32 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 114.928 -1.033 . . . . 71.02 111.577 -177.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.482 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.3 t -61.65 -53.75 51.94 Favored 'General case' 0 C--N 1.347 0.458 0 N-CA-C 109.295 -0.631 . . . . 74.24 109.295 174.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.8 mmt -70.22 -30.81 67.98 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.599 0.76 . . . . 74.52 111.331 -174.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.501 HG23 HD21 ' B' ' 126' ' ' LEU . 68.8 t -66.41 -44.34 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.339 1.056 . . . . 75.11 110.271 172.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.1 t -67.28 -31.36 71.63 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.226 -0.897 . . . . 62.14 110.045 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.496 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 75.6 mtt-85 -68.44 -41.06 80.86 Favored 'General case' 0 C--O 1.211 -0.948 0 CA-C-N 115.818 -0.628 . . . . 75.21 109.561 176.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.97 -11.86 70.52 Favored Glycine 0 C--N 1.357 1.729 0 O-C-N 123.647 0.592 . . . . 71.43 112.628 171.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 11.3 m 67.11 30.74 7.2 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 125.51 1.524 . . . . 63.42 110.407 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -77.49 165.69 49.67 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-N 115.189 -0.914 . . . . 73.5 111.085 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -48.23 151.07 4.65 Favored 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 123.257 2.638 . . . . 64.43 113.52 173.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.546 ' HB2' ' H ' ' C' ' 125' ' ' GLN . 29.2 tp60 -61.71 114.89 3.56 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.055 0.542 . . . . 71.41 111.572 -172.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.606 HD23 HG13 ' B' ' 64' ' ' VAL . 34.7 tp -108.79 110.35 21.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.888 -1.051 . . . . 73.14 108.656 -177.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -121.77 116.89 25.31 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.049 -1.093 . . . . 73.34 108.049 176.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.506 HD21 HG22 ' B' ' 64' ' ' VAL . 73.3 mt -75.37 144.75 42.13 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 120.909 0.385 . . . . 74.03 111.541 -175.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.85 151.62 82.31 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 124.481 1.112 . . . . 72.25 110.708 -177.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.502 ' HG3' HD12 ' D' ' 16' ' ' ILE . 3.8 Cg_endo -80.23 84.53 2.0 Allowed 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.843 2.362 . . . . 74.13 110.666 -177.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 p -89.07 111.32 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 N-CA-C 108.714 -0.847 . . . . 74.52 108.714 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 43.5 t30 . . . . . 0 N--CA 1.472 0.628 0 CA-C-N 115.521 -0.763 . . . . 65.3 109.539 -176.951 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 61.7 t80 . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.358 -0.608 . . . . 75.43 109.358 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -150.53 135.24 17.4 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.821 0.848 . . . . 73.14 108.884 169.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 53.4 mt -77.22 119.11 25.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 107.655 -1.239 . . . . 70.23 107.655 166.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -84.56 -43.08 14.84 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.7 -0.852 . . . . 75.33 108.7 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.427 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER 178.97 158.31 0.55 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.195 1.398 . . . . 73.1 109.44 176.761 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 2.0 pp -128.68 141.52 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.382 -1.34 . . . . 74.04 107.382 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -170.52 157.57 5.96 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.284 0.564 . . . . 74.44 111.694 -168.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 66.5 p -80.33 113.31 18.42 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.982 -0.554 . . . . 75.0 109.639 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -34.6 71.58 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 108.04 -1.096 . . . . 75.04 108.04 171.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.467 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.5 t70 -151.24 145.55 25.45 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.372 -1.285 . . . . 63.12 110.385 -175.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.561 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.4 mt -139.82 147.42 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.9 1.68 . . . . 73.24 106.778 175.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -159.42 150.03 19.39 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.046 0.45 . . . . 73.02 110.217 171.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -151.12 135.89 17.24 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 107.454 -1.313 . . . . 73.31 107.454 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -136.0 124.73 23.86 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.888 0.475 . . . . 75.43 109.878 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.16 75.55 77.85 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 107.76 -1.2 . . . . 54.41 107.76 162.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -74.92 -10.01 21.14 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.291 1.994 . . . . 71.35 111.677 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -106.17 13.15 29.35 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.803 1.241 . . . . 72.14 109.798 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.98 -57.0 7.78 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 115.078 1.51 . . . . 73.0 115.078 -165.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -64.34 -41.14 22.01 Favored 'Trans proline' 0 C--N 1.378 2.116 0 CA-C-N 121.813 1.683 . . . . 60.43 112.177 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -68.67 -34.31 75.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.36 1.064 . . . . 73.14 111.702 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.538 HG23 ' HA ' ' C' ' 73' ' ' ALA . 9.1 p -79.67 -27.43 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 CA-C-N 116.147 -0.479 . . . . 75.41 111.877 -178.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -69.79 -31.51 69.47 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 111.598 0.221 . . . . 74.3 111.598 174.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -96.49 30.78 2.45 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.203 0.601 . . . . 74.05 110.552 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.47 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 0.5 OUTLIER -112.75 167.44 10.48 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.315 1.046 . . . . 71.1 109.334 178.306 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -75.99 120.64 21.59 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.538 -0.541 . . . . 70.34 109.538 171.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -85.23 89.28 7.61 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.73 0.812 . . . . 74.35 110.857 -174.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -131.09 80.61 68.59 Favored Pre-proline 0 N--CA 1.481 1.109 0 C-N-CA 123.999 0.92 . . . . 74.21 108.839 167.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -71.8 111.41 3.14 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.292 1.994 . . . . 62.42 110.814 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -83.02 91.72 7.23 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 104.522 -2.399 . . . . 73.24 104.522 170.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.45 HG22 HD11 ' C' ' 126' ' ' LEU . 62.0 t -75.28 140.59 17.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 113.623 -1.626 . . . . 75.22 110.729 -167.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -128.36 103.16 7.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.352 1.061 . . . . 71.3 108.766 171.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 87.0 mt -85.3 150.06 25.03 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.929 0.892 . . . . 74.43 108.74 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.414 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 31.6 t70 -143.64 141.93 30.8 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.296 0.638 . . . . 73.01 109.613 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 47.9 mt -132.42 133.18 43.58 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.192 0.997 . . . . 75.13 109.116 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -143.23 123.44 13.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.801 -1.555 . . . . 74.43 106.801 175.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 46' ' ' THR . . . . . 0.41 ' OG1' ' HG3' ' C' ' 103' ' ' PRO . 15.0 t -118.42 130.47 55.99 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.471 0.653 . . . . 72.13 109.418 176.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.35 153.41 29.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.177 -0.92 . . . . 62.33 109.095 176.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 37.2 p -146.64 143.0 28.48 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.862 -0.792 . . . . 75.51 108.862 175.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 45.9 t -156.89 135.82 11.78 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.163 0.585 . . . . 74.54 109.487 -177.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -79.48 116.82 19.93 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.764 -0.828 . . . . 74.1 108.764 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.676 HD12 ' HB2' ' C' ' 57' ' ' GLU . 63.4 mt -84.75 -34.94 22.75 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.613 0.765 . . . . 73.22 110.616 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.67 -176.02 5.63 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.143 -0.935 . . . . 72.32 109.868 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -58.44 108.61 0.65 Allowed 'General case' 0 C--O 1.242 0.674 0 O-C-N 124.122 0.889 . . . . 73.22 109.695 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . 0.563 ' HB3' ' HB3' ' C' ' 87' ' ' ALA . 16.9 m-20 66.2 24.63 10.74 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 124.311 1.007 . . . . 74.45 111.853 175.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.7 t -122.24 118.97 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 108.835 -0.802 . . . . 72.33 108.835 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -120.6 125.44 47.76 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.082 0.953 . . . . 74.32 109.997 -176.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.676 ' HB2' HD12 ' C' ' 51' ' ' LEU . 36.2 tt0 -84.71 131.99 34.51 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.531 -0.915 . . . . 73.54 108.531 166.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.52 HG12 ' HD3' ' C' ' 103' ' ' PRO . 61.3 t -122.45 123.05 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.08 -1.081 . . . . 73.14 108.08 168.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.562 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 73.5 t -108.84 145.44 15.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.19 -0.67 . . . . 71.2 109.19 174.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.06 101.27 7.44 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.651 -1.241 . . . . 75.13 107.651 174.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 35.9 ttm-85 -79.98 106.29 11.89 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.068 -1.086 . . . . 72.41 108.068 169.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.451 ' HB ' HD11 ' C' ' 114' ' ' ILE . 16.0 t -107.17 123.9 62.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.731 -1.211 . . . . 75.02 107.731 172.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 12.5 m -122.83 116.19 23.27 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.721 -0.844 . . . . 72.52 108.721 -176.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.466 HG22 HG23 ' C' ' 114' ' ' ILE . 73.8 t -111.35 110.69 33.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 124.463 1.105 . . . . 75.12 108.767 -174.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.4 m -99.67 139.28 35.56 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 115.356 -0.838 . . . . 71.21 108.88 175.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.45 105.23 6.81 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.093 -1.447 . . . . 74.42 107.093 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.0 m -123.33 135.28 54.12 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 108.179 -1.045 . . . . 71.41 108.179 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 36.2 mt -84.13 25.98 0.79 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.474 1.11 . . . . 71.01 110.714 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.76 -91.75 0.8 Allowed Glycine 0 C--N 1.357 1.722 0 N-CA-C 111.041 -0.823 . . . . 74.35 111.041 -177.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -89.11 -31.33 18.05 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.587 0.755 . . . . 73.34 110.261 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.47 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 5.6 tp10 -89.34 124.06 34.08 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.819 1.248 . . . . 74.5 109.466 173.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.0 m -80.93 126.45 31.39 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.603 -0.888 . . . . 73.41 108.603 166.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.538 ' HA ' HG23 ' C' ' 31' ' ' VAL . . . -78.47 -55.81 4.93 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.42 -0.585 . . . . 74.23 109.42 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -159.01 166.05 32.64 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.665 0.745 . . . . 74.32 112.16 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -130.05 143.14 50.63 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 106.683 -1.599 . . . . 75.24 106.683 167.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -149.87 112.08 4.65 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.661 -0.496 . . . . 74.1 109.661 179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -116.68 124.61 50.14 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.219 -0.66 . . . . 74.25 109.219 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 49.4 t -122.97 115.07 44.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.77 -0.826 . . . . 72.2 108.77 172.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.467 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.1 mt-30 -93.86 87.69 5.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.046 0.938 . . . . 74.51 109.209 175.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -80.2 101.56 8.91 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.855 -1.066 . . . . 73.43 109.976 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -100.66 150.2 18.73 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-O 121.143 0.302 . . . . 52.51 112.746 177.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.7 132.51 4.78 Favored Glycine 0 CA--C 1.501 -0.798 0 N-CA-C 110.756 -0.937 . . . . 63.32 110.756 -175.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 34.7 mm -90.87 128.14 42.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 108.531 -0.915 . . . . 73.55 108.531 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -136.15 119.39 16.68 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.609 -0.885 . . . . 73.41 108.609 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 33.3 p -78.49 102.26 7.76 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.472 -0.936 . . . . 75.13 108.472 173.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.565 HD11 ' SG ' ' C' ' 97' ' ' CYS . 5.7 mt -116.07 140.32 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 122.832 0.453 . . . . 73.25 110.073 -176.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' C' ' 54' ' ' ASP . . . -160.35 172.07 17.97 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.777 0.831 . . . . 63.31 110.732 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.99 -47.19 3.5 Favored Glycine 0 C--N 1.345 1.062 0 O-C-N 123.896 0.747 . . . . 73.54 111.61 175.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.5 HD13 ' HA ' ' C' ' 94' ' ' MET . 41.7 pt -83.1 146.77 6.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 123.64 0.776 . . . . 63.24 111.154 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -149.38 -179.13 6.83 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.907 0.883 . . . . 75.32 109.595 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.57 -126.94 30.89 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-O 119.603 -0.554 . . . . 63.03 112.107 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.6 -26.0 62.41 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.269 0.627 . . . . 62.33 111.611 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.429 ' HB3' ' HB ' ' C' ' 89' ' ' ILE . 26.5 mt-30 -65.42 -60.77 2.6 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.527 0.331 . . . . 74.21 110.266 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.5 ' HA ' HD13 ' C' ' 89' ' ' ILE . 1.8 tpt -54.93 -48.36 73.24 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 123.796 0.685 . . . . 72.04 112.152 173.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.2 -40.2 76.92 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.728 0.642 . . . . 75.24 111.608 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -83.46 -23.34 32.28 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.403 0.681 . . . . 74.41 111.638 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.565 ' SG ' HD11 ' C' ' 86' ' ' ILE . 34.3 t -69.56 -37.89 77.19 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 108.354 -0.98 . . . . 73.1 108.354 175.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.432 ' HG ' ' HE3' ' C' ' 94' ' ' MET . 76.9 mt -81.1 -31.81 34.13 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.972 -1.013 . . . . 74.13 110.801 174.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . 0.4 ' HA3' ' CE2' ' C' ' 137' ' ' PHE . . . -78.05 -28.88 55.52 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.163 -0.926 . . . . 74.34 114.755 -168.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.99 -47.57 0.09 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.469 0.544 . . . . 73.52 112.469 -167.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.46 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 70.3 t80 -56.05 -59.3 5.11 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.345 0.658 . . . . 75.42 111.772 -176.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 88.6 m -63.66 -46.01 82.7 Favored Pre-proline 0 CA--C 1.566 1.582 0 C-N-CA 124.173 0.989 . . . . 73.32 111.691 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.52 ' HD3' HG12 ' C' ' 58' ' ' VAL . 96.0 Cg_exo -49.67 -36.11 40.24 Favored 'Trans proline' 0 C--N 1.395 2.997 0 C-N-CA 123.088 2.525 . . . . 64.41 114.832 168.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -67.97 -31.98 72.08 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.477 0.711 . . . . 62.5 111.249 177.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 32.2 mm -69.66 -38.78 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 109.185 -0.672 . . . . 71.1 109.185 175.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 53.5 mt -78.82 -34.4 45.27 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.262 1.025 . . . . 71.21 112.516 -174.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -54.46 -47.11 98.64 Favored Pre-proline 0 N--CA 1.484 1.24 0 N-CA-C 114.238 1.199 . . . . 74.32 114.238 -170.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.48 -39.06 58.54 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.167 1.912 . . . . 74.14 113.345 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -68.5 -40.42 80.9 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.278 0.631 . . . . 71.23 110.793 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.28 -41.86 99.04 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.16 -0.927 . . . . 73.33 109.866 174.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -60.71 -49.35 77.86 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.936 1.294 . . . . 73.34 110.61 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.27 -40.88 90.42 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.724 0.64 . . . . 74.22 109.943 -176.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 49.4 t -68.83 -34.88 76.22 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.504 0.503 . . . . 74.44 111.986 -176.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.466 HG23 HG22 ' C' ' 64' ' ' VAL . 97.0 mt -69.43 -52.33 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.443 0.697 . . . . 75.51 110.363 175.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.4 m -67.95 -27.23 66.43 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 122.974 0.509 . . . . 63.31 111.254 -175.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 40.4 t -62.97 -47.06 84.81 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.971 0.908 . . . . 73.52 109.367 170.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.685 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.86 -38.68 91.79 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.433 1.093 . . . . 74.23 112.125 178.227 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 98.9 t -58.39 -45.79 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.462 0.705 . . . . 73.34 109.685 173.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.508 ' OG ' HG22 ' B' ' 115' ' ' THR . 28.9 t -68.76 -31.65 70.84 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.836 -1.074 . . . . 74.53 112.268 -178.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.435 HH12 ' HG2' ' D' ' 112' ' ' GLU . 73.0 mtt-85 -69.47 -40.4 77.11 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.162 -0.681 . . . . 74.2 109.162 177.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.56 -1.07 86.01 Favored Glycine 0 C--N 1.356 1.683 0 O-C-N 123.983 0.802 . . . . 62.42 112.66 172.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.3 p 65.46 25.61 11.89 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 126.819 2.048 . . . . 64.3 114.075 169.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -83.67 143.83 44.53 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 109.313 -0.625 . . . . 75.12 109.313 174.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -45.61 135.9 12.63 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 123.459 2.773 . . . . 75.04 113.055 171.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.546 ' H ' ' HB2' ' B' ' 125' ' ' GLN . 36.8 mm-40 -44.07 112.82 0.44 Allowed 'General case' 0 N--CA 1.483 1.211 0 O-C-N 124.882 1.364 . . . . 72.4 111.934 -174.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.45 HD11 HG22 ' C' ' 40' ' ' VAL . 20.2 tp -108.18 83.94 1.86 Allowed 'General case' 0 C--O 1.239 0.525 0 N-CA-C 106.565 -1.643 . . . . 64.51 106.565 170.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -97.54 94.52 7.05 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 114.357 -1.292 . . . . 73.32 108.378 -170.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.527 ' H ' HD22 ' C' ' 128' ' ' LEU . 1.5 pt? -56.3 139.09 49.41 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.089 0.956 . . . . 73.52 111.967 -175.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.51 150.83 64.19 Favored Pre-proline 0 CA--C 1.548 0.891 0 CA-C-N 114.759 -1.109 . . . . 72.44 110.945 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.416 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 19.2 Cg_endo -60.41 113.7 1.8 Allowed 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.852 2.368 . . . . 75.42 112.674 175.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 49.0 t -99.31 118.39 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 107.676 -1.231 . . . . 64.24 107.676 171.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -71.84 103.44 3.15 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.265 0.626 . . . . 73.32 110.42 -175.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -62.64 -31.46 72.32 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.253 1.021 . . . . 73.31 111.944 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -66.36 -37.66 85.81 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.278 0.631 . . . . 74.53 110.685 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.92 86.56 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.516 0.726 . . . . 75.42 110.373 175.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 98.4 mt -64.94 -35.34 80.83 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.925 -1.034 . . . . 75.2 110.889 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . 0.4 ' CE2' ' HA3' ' C' ' 99' ' ' GLY . 3.4 t80 . . . . . 0 C--O 1.238 0.463 0 CA-C-N 115.95 -0.568 . . . . 74.32 111.307 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 8.2 t . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 120.975 0.417 . . . . 75.35 109.942 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.471 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 49.9 t80 -135.3 91.01 2.68 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 106.781 -1.563 . . . . 72.54 106.781 176.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -121.2 126.8 50.54 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.474 0.71 . . . . 71.0 109.252 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.535 HD11 HG21 ' D' ' 105' ' ' ILE . 1.8 mt -96.21 132.77 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 107.84 -1.17 . . . . 73.22 107.84 178.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -104.09 -19.58 14.12 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 119.116 -0.468 . . . . 70.2 111.417 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . 0.425 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 41.1 ttt180 -172.29 131.92 0.62 Allowed 'General case' 0 C--N 1.36 1.042 0 N-CA-C 112.065 0.395 . . . . 73.33 112.065 -176.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.502 HD12 ' HG3' ' B' ' 130' ' ' PRO . 2.6 mp -110.41 134.95 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 106.842 -1.54 . . . . 64.51 106.842 170.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.425 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 22.2 p90 -158.16 140.28 14.14 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 123.521 0.513 . . . . 73.33 111.685 -177.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -78.6 113.17 16.4 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.498 -0.774 . . . . 75.35 109.668 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -85.76 -11.24 54.06 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.602 -0.726 . . . . 75.11 109.9 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.642 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.4 t70 -165.54 145.25 6.59 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.594 1.158 . . . . 53.54 109.846 177.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.685 HG21 ' HE1' ' C' ' 117' ' ' MET . 66.4 mt -148.41 148.23 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 125.622 1.569 . . . . 74.43 107.695 175.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.1 t -154.98 146.24 22.89 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.356 1.062 . . . . 74.02 109.092 171.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.561 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 92.0 t80 -143.61 126.32 16.07 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 106.669 -1.604 . . . . 71.51 106.669 169.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 47.9 mt-10 -121.16 142.73 49.61 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.549 0.74 . . . . 73.53 109.227 175.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.69 75.51 37.1 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 107.018 -1.475 . . . . 75.14 107.018 169.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -71.99 -19.93 26.09 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.453 2.102 . . . . 73.44 112.772 -171.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -110.7 3.98 19.69 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.655 0.782 . . . . 74.24 111.153 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -27.33 -70.63 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 116.805 2.15 . . . . 73.41 116.805 -167.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.32 -19.46 15.17 Favored 'Trans proline' 0 C--N 1.388 2.618 0 CA-C-N 124.036 2.477 . . . . 52.44 114.011 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -74.5 -39.6 62.32 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.045 0.938 . . . . 70.14 109.816 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.549 HG23 ' HA ' ' D' ' 73' ' ' ALA . 9.3 p -82.98 -16.25 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 CA-C-N 116.065 -0.516 . . . . 75.1 111.101 -171.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -68.42 -13.42 62.28 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.07 0.767 . . . . 75.55 113.07 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -60.34 -27.29 67.24 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.788 0.835 . . . . 73.24 110.713 173.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.555 ' HZ3' ' HG2' ' D' ' 71' ' ' GLU . 97.3 mttt -91.78 88.13 6.55 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.494 1.518 . . . . 74.31 110.179 -177.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -83.11 90.92 7.12 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.221 -0.9 . . . . 72.22 110.682 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 40.7 p90 -165.4 172.01 12.72 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.138 0.975 . . . . 75.43 109.29 166.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -70.58 111.27 9.02 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.644 0.778 . . . . 75.24 109.321 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.44 128.47 30.23 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 122.937 2.424 . . . . 63.51 112.058 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.74 113.1 5.23 Favored 'General case' 0 C--O 1.24 0.566 0 O-C-N 123.773 0.671 . . . . 74.25 109.462 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.635 HG21 ' HB3' ' D' ' 66' ' ' ALA . 78.7 t -98.53 107.13 19.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-N 115.343 -0.844 . . . . 72.54 110.102 -174.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -87.65 111.04 20.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 105.693 -1.965 . . . . 74.02 105.693 165.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 49.7 tp -95.52 143.44 26.84 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.498 -0.927 . . . . 74.32 108.498 -172.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.592 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 15.8 m-20 -120.02 117.01 26.88 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.688 -1.226 . . . . 74.42 107.688 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.4 ' CD2' HG21 ' D' ' 62' ' ' VAL . 23.4 mt -116.31 131.0 57.06 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.048 0.452 . . . . 71.4 110.014 177.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -143.99 145.2 32.06 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.246 -1.02 . . . . 73.33 108.246 171.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 46' ' ' THR . . . . . 0.406 HG21 ' O ' ' D' ' 99' ' ' GLY . 22.8 p -104.6 170.57 7.81 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.105 0.562 . . . . 72.01 110.493 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -166.35 163.08 17.49 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.463 1.105 . . . . 62.55 108.621 172.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 53.7 p . . . . . 0 C--O 1.245 0.861 0 N-CA-C 108.147 -1.057 . . . . 65.55 108.147 169.62 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.498 1.95 0 N-CA-C 113.586 0.958 . . . . 73.34 113.586 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 p -109.24 94.54 3.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 107.305 -1.368 . . . . 73.52 107.305 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.408 ' HD2' HD11 ' D' ' 98' ' ' LEU . 5.7 m-30 -122.18 128.3 51.05 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.676 -0.861 . . . . 73.12 108.676 -171.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -85.89 152.99 22.53 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 107.318 -1.364 . . . . 74.21 107.318 162.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 53.3 t -130.16 138.57 53.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.302 -1.37 . . . . 72.5 107.302 165.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.462 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 32.3 t -126.11 130.12 72.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 108.249 -1.019 . . . . 71.23 108.249 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.558 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -109.02 119.96 41.1 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 106.824 -1.547 . . . . 72.44 106.824 178.722 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -99.36 97.99 8.97 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.384 -0.969 . . . . 72.2 108.384 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.4 HG21 ' CD2' ' D' ' 44' ' ' LEU . 31.9 t -101.82 117.14 46.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.291 -0.868 . . . . 74.14 108.713 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.592 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 22.6 m -126.7 119.14 26.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.382 0.673 . . . . 73.33 109.25 -173.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.573 HG11 HG13 ' D' ' 40' ' ' VAL . 55.1 t -100.89 124.16 54.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 123.715 0.806 . . . . 63.43 110.022 -177.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 28.4 m -114.69 96.19 5.61 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.239 -1.022 . . . . 75.54 108.239 170.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.635 ' HB3' HG21 ' D' ' 40' ' ' VAL . . . -106.69 142.56 36.13 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.482 -0.781 . . . . 71.51 110.076 -175.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.469 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 48.9 m -139.75 141.64 36.83 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.441 0.638 . . . . 73.44 112.258 -173.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 46.7 mt -111.57 114.71 27.96 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.32 -1.309 . . . . 73.41 107.642 170.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.52 -131.73 22.09 Favored Glycine 0 C--N 1.341 0.835 0 O-C-N 123.155 0.284 . . . . 74.13 112.768 -176.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.84 1.61 55.38 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.942 0.497 . . . . 75.41 111.41 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.555 ' HG2' ' HZ3' ' D' ' 34' ' ' LYS . 12.3 pt-20 -119.15 164.66 15.24 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.751 0.42 . . . . 75.31 110.366 -175.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 98.8 m -67.82 131.59 45.82 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.06 -0.973 . . . . 73.13 110.998 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.549 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -84.9 -63.49 1.32 Allowed 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.698 -1.223 . . . . 53.23 107.698 170.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -152.05 148.82 28.14 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 114.587 -1.188 . . . . 73.45 110.607 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.452 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 82.6 mt -109.65 154.12 23.27 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.454 1.102 . . . . 74.31 108.27 170.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.532 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 43.0 t -157.9 148.62 20.86 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.316 -0.624 . . . . 72.33 109.316 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -155.6 131.45 9.91 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.313 0.645 . . . . 75.53 109.796 174.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -135.13 113.82 16.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 108.267 -1.012 . . . . 74.54 108.267 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.642 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.8 mt-30 -89.54 83.88 6.35 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.239 -1.023 . . . . 74.41 108.239 169.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -80.31 96.87 6.77 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 113.734 -1.575 . . . . 64.32 109.377 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.25 168.51 35.23 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.689 -0.687 . . . . 73.14 112.468 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.02 138.09 4.75 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 110.707 -0.957 . . . . 73.42 110.707 173.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.99 123.97 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 N-CA-C 108.549 -0.908 . . . . 71.33 108.549 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -115.13 125.73 53.81 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.681 1.192 . . . . 73.3 110.002 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 35.0 m -87.87 95.08 9.97 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 108.513 -0.921 . . . . 55.24 108.513 168.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 37.0 pt -109.78 142.7 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.415 -0.587 . . . . 75.43 109.415 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.63 166.94 9.82 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.933 0.893 . . . . 74.25 110.378 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.23 22.75 56.46 Favored Glycine 0 C--N 1.352 1.448 0 O-C-N 123.517 0.51 . . . . 54.54 113.796 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.566 ' HB ' ' HB3' ' D' ' 94' ' ' MET . 0.2 OUTLIER -120.33 148.97 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 124.187 0.995 . . . . 75.43 109.668 -179.068 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -129.06 -178.3 4.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.79 0.836 . . . . 64.52 109.904 -175.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.58 -142.58 47.05 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.363 -0.835 . . . . 72.21 112.63 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.2 p -90.81 -14.72 31.38 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.649 0.779 . . . . 74.41 111.267 173.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -56.38 -34.1 66.37 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.356 1.062 . . . . 72.34 112.247 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.566 ' HB3' ' HB ' ' D' ' 89' ' ' ILE . 0.0 OUTLIER -62.57 -43.5 98.65 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.306 0.642 . . . . 70.12 112.049 -179.426 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . 0.453 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.05 -22.92 28.8 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.384 0.674 . . . . 65.24 111.862 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -74.93 -38.4 61.78 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.734 -0.469 . . . . 73.43 109.734 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 73.7 m -73.05 -26.7 61.38 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.493 0.717 . . . . 71.01 110.888 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.408 HD11 ' HD2' ' D' ' 56' ' ' TYR . 53.2 tp -63.89 -43.63 95.44 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.711 0.804 . . . . 75.21 110.319 175.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . 0.406 ' O ' HG21 ' D' ' 46' ' ' THR . . . -94.56 -12.05 56.28 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 119.298 -0.723 . . . . 63.1 114.381 -175.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.04 -58.34 1.88 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 118.439 1.12 . . . . 70.23 112.341 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -74.57 -41.73 60.01 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.224 0.453 . . . . 75.41 112.224 -172.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.482 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 75.5 m -61.46 -47.52 93.17 Favored Pre-proline 0 CA--C 1.568 1.636 0 C-N-CA 123.383 0.673 . . . . 70.22 111.69 178.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.558 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 53.2 Cg_exo -61.63 -31.24 86.63 Favored 'Trans proline' 0 C--N 1.39 2.718 0 C-N-CA 122.344 2.029 . . . . 73.21 113.795 170.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -63.0 -33.33 75.19 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.022 0.529 . . . . 64.2 110.843 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.535 HG21 HD11 ' D' ' 13' ' ' ILE . 47.4 mm -67.22 -42.08 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.776 0.83 . . . . 73.31 110.49 173.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 54.0 mt -76.18 -11.35 59.91 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.357 -0.838 . . . . 74.52 111.638 -175.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -70.63 -44.81 17.42 Favored Pre-proline 0 CA--C 1.558 1.282 0 N-CA-C 114.086 1.143 . . . . 72.43 114.086 -172.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . 0.58 ' HB2' ' HG2' ' B' ' 108' ' ' PRO . 29.1 Cg_endo -61.97 -32.07 84.42 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 121.649 1.566 . . . . 75.35 112.469 172.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . 0.409 ' O ' ' HB3' ' D' ' 112' ' ' GLU . 62.5 m-85 -72.82 -31.69 64.99 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.752 0.821 . . . . 74.45 111.634 175.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.98 -48.08 72.43 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.437 0.637 . . . . 75.4 109.334 175.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 33.2 ttp180 -65.66 -31.92 73.21 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.174 -1.375 . . . . 74.12 110.858 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . 0.435 ' HG2' HH12 ' C' ' 120' ' ' ARG . 16.0 tt0 -53.17 -52.63 58.17 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.343 1.057 . . . . 75.41 110.317 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.9 t -69.51 -47.59 63.31 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.511 -1.222 . . . . 74.31 111.061 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.458 HD12 HG21 ' D' ' 64' ' ' VAL . 63.4 mt -62.37 -58.23 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.346 0.658 . . . . 75.22 111.062 -176.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 86.0 m -52.84 -39.57 62.64 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.107 0.879 . . . . 74.23 111.564 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.447 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 43.4 t -65.19 -45.11 86.14 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.128 -0.942 . . . . 63.2 110.121 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.502 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 79.0 mtm -66.31 -32.87 74.54 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.198 0.599 . . . . 75.43 111.959 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.413 HG23 ' O ' ' D' ' 114' ' ' ILE . 92.5 t -62.79 -48.47 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.616 0.767 . . . . 75.15 109.794 175.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 96.4 p -71.24 -27.67 63.63 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.593 -0.731 . . . . 74.52 110.787 -178.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' D' ' 116' ' ' SER . 90.4 mtt-85 -69.64 -33.76 73.08 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.541 0.736 . . . . 74.34 109.936 174.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.46 9.16 71.71 Favored Glycine 0 C--N 1.355 1.624 0 O-C-N 123.578 0.548 . . . . 62.33 112.933 176.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 82.1 p 56.51 36.56 27.76 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.93 1.692 . . . . 74.41 113.631 177.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -98.62 149.63 35.93 Favored Pre-proline 0 C--O 1.243 0.754 0 N-CA-C 108.557 -0.905 . . . . 73.34 108.557 171.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -45.58 131.1 12.44 Favored 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 123.308 2.672 . . . . 73.24 112.616 172.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -52.95 130.88 34.92 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 124.344 1.027 . . . . 75.5 111.479 -172.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.453 HD12 HG22 ' D' ' 40' ' ' VAL . 10.1 tp -105.71 98.61 8.28 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.182 -0.917 . . . . 72.42 108.603 -173.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . 0.417 HD21 HD13 ' B' ' 16' ' ' ILE . 10.2 m120 -100.51 78.61 2.02 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.94 -1.133 . . . . 63.33 107.94 177.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.06 132.33 48.29 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 109.791 -0.448 . . . . 74.52 109.791 -175.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.77 144.03 97.99 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 123.815 0.846 . . . . 75.41 111.425 -174.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.65 132.63 46.67 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.635 2.223 . . . . 75.12 111.945 176.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 73.6 t -107.48 128.63 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.729 -0.841 . . . . 74.33 108.729 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -85.59 97.84 10.31 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.657 0.783 . . . . 75.21 108.997 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 . . . . . 0 N--CA 1.487 1.424 0 C-N-CA 124.658 1.183 . . . . 64.32 112.229 -173.621 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.7 m . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 107.352 -1.351 . . . . 73.23 107.352 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -129.49 113.91 15.46 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.068 -1.086 . . . . 75.03 108.068 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -134.08 118.44 17.74 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.016 -0.735 . . . . 75.1 109.016 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.4 mt -80.69 119.82 31.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 109.362 -0.607 . . . . 71.23 109.362 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -85.83 -38.78 17.76 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 123.607 0.567 . . . . 71.43 110.163 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -173.52 129.26 0.43 Allowed 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.599 -0.273 . . . . 74.55 110.365 -170.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.467 HD13 ' HG3' ' C' ' 130' ' ' PRO . 87.0 mt -119.79 134.02 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 108.235 -1.024 . . . . 62.51 108.235 173.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.428 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 36.8 p90 -162.27 168.1 22.87 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 124.036 0.835 . . . . 75.22 110.87 -170.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -89.78 119.49 30.21 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.665 -0.865 . . . . 73.11 108.665 172.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.428 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 32.8 mtpt -78.97 -26.33 43.44 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.736 -0.468 . . . . 74.24 109.736 172.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -159.08 146.31 17.31 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.292 1.037 . . . . 72.34 109.614 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.8 mt -135.85 146.36 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.092 1.357 . . . . 73.14 107.836 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.0 t -148.01 131.95 17.15 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 109.059 -0.719 . . . . 70.43 109.059 171.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.594 ' HB2' ' HE1' ' A' ' 117' ' ' MET . 89.3 t80 -137.09 127.75 27.02 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 106.988 -1.486 . . . . 73.55 106.988 171.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -134.5 129.18 34.76 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.009 0.523 . . . . 74.41 109.856 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.93 75.21 79.84 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.479 -1.304 . . . . 73.43 107.479 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.49 -28.0 32.67 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.713 2.275 . . . . 62.21 112.377 -172.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -104.8 15.38 27.96 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.203 -0.908 . . . . 75.41 110.154 -177.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.5 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -43.85 -56.41 7.48 Favored Pre-proline 0 N--CA 1.494 1.763 0 N-CA-C 113.996 1.11 . . . . 71.22 113.996 -169.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 70.8 Cg_exo -54.98 -35.22 89.38 Favored 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 122.515 2.143 . . . . 72.4 113.607 176.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.419 ' HA ' ' NE2' ' A' ' 33' ' ' GLN . 1.9 m-70 -78.36 -42.47 30.36 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.508 0.723 . . . . 73.22 110.042 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.567 HG22 ' HA ' ' A' ' 73' ' ' ALA . 1.1 p -67.05 -27.57 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 114.593 -1.185 . . . . 74.42 111.951 -159.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -72.99 -29.33 62.96 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.952 -0.567 . . . . 74.11 110.767 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.419 ' NE2' ' HA ' ' A' ' 30' ' ' HIS . 38.9 mt-30 -75.1 -24.29 58.08 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.239 1.016 . . . . 73.25 110.888 178.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -77.24 152.28 34.76 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.853 0.861 . . . . 65.33 110.707 -175.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.83 118.29 7.0 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.752 0.657 . . . . 54.33 109.623 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -83.82 85.06 7.35 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.679 0.752 . . . . 74.45 110.991 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -121.01 84.05 38.69 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 107.001 -1.481 . . . . 74.52 107.001 170.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.45 116.89 4.63 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.361 2.041 . . . . 62.45 111.982 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -96.38 101.79 13.48 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.319 -0.993 . . . . 75.31 108.319 174.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 t -97.39 108.1 21.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 114.818 -1.083 . . . . 70.14 110.796 -169.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -83.65 119.94 25.37 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.747 0.819 . . . . 72.5 109.035 170.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.6 tp -97.25 106.53 18.88 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.371 -0.974 . . . . 74.33 108.371 175.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.455 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.4 m-20 -107.92 148.52 29.53 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.373 1.069 . . . . 72.34 108.77 176.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.556 HD12 HG22 ' A' ' 131' ' ' VAL . 92.6 mt -137.68 154.91 49.62 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.306 0.642 . . . . 64.31 111.246 -175.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.6 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 6.8 m-20 -137.72 141.29 41.02 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.166 -1.379 . . . . 64.24 108.113 175.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.3 m -141.0 123.16 15.64 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.249 -0.649 . . . . 64.1 109.249 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.75 138.16 23.06 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.505 0.722 . . . . 64.33 109.511 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.8 m -90.57 165.77 13.57 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.078 0.551 . . . . 75.25 109.56 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.2 t -154.69 119.48 4.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.398 -0.964 . . . . 71.44 108.398 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -85.15 103.33 14.04 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.953 -1.129 . . . . 72.11 107.953 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.437 HD13 ' HB2' ' A' ' 57' ' ' GLU . 83.4 mt -77.9 -40.1 40.97 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.12 0.568 . . . . 74.24 109.474 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.35 -178.41 6.96 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.0 -1.0 . . . . 71.01 109.731 178.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -61.7 115.85 4.31 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.475 -0.784 . . . . 73.12 109.358 172.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 72.05 -4.19 2.04 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 125.178 1.391 . . . . 74.44 113.427 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.1 t -100.94 104.59 16.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.477 -0.935 . . . . 75.33 108.477 175.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -115.18 123.31 48.56 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.622 -0.881 . . . . 72.14 108.622 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.437 ' HB2' HD13 ' A' ' 51' ' ' LEU . 32.4 tt0 -89.58 151.59 21.85 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 123.396 0.679 . . . . 74.43 109.313 166.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.418 HG11 ' HD3' ' A' ' 103' ' ' PRO . 83.2 t -130.03 138.03 55.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.983 -1.117 . . . . 75.33 107.983 168.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.1 t -114.3 132.51 63.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 CA-C-O 121.232 0.539 . . . . 74.25 109.749 174.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.483 HD21 HD23 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -113.68 110.3 19.98 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 106.313 -1.736 . . . . 73.51 106.313 174.326 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.616 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 16.8 ttp180 -101.31 107.07 18.33 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.878 -1.156 . . . . 74.43 107.878 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.422 HG23 HD23 ' A' ' 60' ' ' LEU . 36.1 t -93.67 123.61 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 108.585 -0.894 . . . . 74.23 108.585 176.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 22.1 m -114.7 111.88 21.97 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.212 -0.662 . . . . 74.33 109.212 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.509 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 81.7 t -103.02 120.9 53.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 124.539 1.135 . . . . 73.14 109.004 177.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.421 ' HG1' HD12 ' A' ' 75' ' ' LEU . 18.5 m -115.39 129.48 56.59 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.859 -0.793 . . . . 72.24 108.859 166.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.6 129.2 56.65 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.266 -1.383 . . . . 74.51 107.266 171.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.1 m -125.04 171.14 10.49 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.504 0.668 . . . . 73.13 109.936 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.7 mt -130.09 62.4 1.56 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 105.781 -1.933 . . . . 75.22 105.781 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.96 -103.52 2.01 Favored Glycine 0 C--N 1.338 0.648 0 CA-C-N 115.559 -0.746 . . . . 63.43 111.257 -173.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -91.16 -27.18 18.69 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.846 0.459 . . . . 71.52 111.708 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -97.44 123.84 41.42 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.802 0.441 . . . . 75.24 109.937 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 57.6 m -70.61 134.55 47.7 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.975 0.417 . . . . 71.55 110.391 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.567 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -79.26 -59.12 2.89 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.252 -0.885 . . . . 71.34 109.66 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -156.47 166.11 34.36 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.93 -1.032 . . . . 74.15 110.93 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.421 HD12 ' HG1' ' A' ' 65' ' ' THR . 35.7 tp -135.46 114.11 11.81 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.366 1.066 . . . . 74.43 108.848 176.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.509 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 57.4 m -107.02 139.91 40.67 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.09 0.956 . . . . 70.11 108.917 174.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -149.95 117.81 6.26 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.592 -0.521 . . . . 72.11 109.592 175.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.5 t -127.59 114.5 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.835 0.854 . . . . 73.42 109.859 -175.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.616 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 10.4 mt-30 -86.77 81.18 8.27 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.548 -0.908 . . . . 75.01 108.548 174.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -76.57 95.94 4.02 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.59 -0.732 . . . . 74.12 109.407 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.85 146.48 16.38 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 111.351 -0.7 . . . . 64.1 111.351 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.29 134.05 6.49 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.104 -0.798 . . . . 51.13 111.104 -176.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.9 mt -81.24 125.57 39.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 108.777 -0.823 . . . . 75.54 108.777 173.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.683 ' HB3' HD11 ' A' ' 86' ' ' ILE . 82.0 m-85 -127.68 128.03 44.75 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.981 0.912 . . . . 74.15 109.202 -174.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.1 t -94.89 101.04 12.81 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.194 -1.039 . . . . 74.24 108.194 175.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.683 HD11 ' HB3' ' A' ' 84' ' ' PHE . 5.8 mm -113.5 153.52 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 122.4 0.28 . . . . 74.53 111.11 -171.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.06 167.5 12.51 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.546 1.139 . . . . 61.41 110.248 175.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.87 2.16 64.97 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-O 119.372 -0.682 . . . . 74.21 114.724 169.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.07 161.49 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 123.965 0.906 . . . . 74.01 110.554 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.505 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 18.1 tt0 -153.61 175.56 13.08 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 109.574 -0.528 . . . . 63.45 109.574 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.505 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 53.74 -121.23 17.22 Favored Glycine 0 C--N 1.349 1.299 0 O-C-N 124.099 0.874 . . . . 63.32 114.34 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.9 t -69.25 -30.35 68.45 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.028 0.931 . . . . 71.14 111.941 -176.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -74.42 -36.64 63.44 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.146 0.579 . . . . 75.41 110.459 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.465 ' HE3' HG21 ' A' ' 86' ' ' ILE . 4.9 tpt -65.26 -44.56 87.69 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.442 0.464 . . . . 74.52 110.405 175.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.62 -41.66 86.45 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.318 -0.855 . . . . 60.52 111.208 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.425 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 54.8 t-80 -78.58 -25.55 45.33 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.419 -0.809 . . . . 73.11 111.508 -177.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 44.0 t -69.95 -42.91 72.59 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.265 0.555 . . . . 75.44 109.962 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 88.0 mt -81.85 -40.97 21.68 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.846 -1.07 . . . . 74.51 111.732 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.32 3.16 81.91 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 116.035 -0.529 . . . . 71.11 114.284 -170.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.637 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -146.93 -58.76 0.28 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.54 0.67 . . . . 64.24 112.007 -171.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -67.65 -45.29 75.73 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-N 116.006 -0.543 . . . . 73.44 111.049 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.401 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 88.3 m -63.45 -52.34 60.83 Favored Pre-proline 0 CA--C 1.566 1.573 0 N-CA-C 113.435 0.902 . . . . 74.33 113.435 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.418 ' HD3' HG11 ' A' ' 58' ' ' VAL . 44.3 Cg_endo -65.7 -20.6 59.35 Favored 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 122.051 1.834 . . . . 71.44 113.052 177.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -63.83 -43.69 95.45 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 120.99 0.424 . . . . 72.21 110.043 172.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.401 ' HB ' ' O ' ' A' ' 102' ' ' CYS . 31.2 mm -61.74 -38.15 79.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 124.405 1.082 . . . . 75.41 110.673 174.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 78.0 mt -77.64 -22.46 50.66 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.079 0.952 . . . . 74.32 112.96 -173.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -70.3 -41.94 14.84 Favored Pre-proline 0 CA--C 1.557 1.245 0 N-CA-C 114.434 1.272 . . . . 74.24 114.434 -170.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -54.12 -39.39 86.07 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 121.902 1.734 . . . . 75.12 112.742 173.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -74.55 -40.81 61.45 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.748 0.819 . . . . 72.41 111.484 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.66 -49.01 74.91 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.974 0.509 . . . . 70.35 110.241 177.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.494 HH12 HD13 ' C' ' 105' ' ' ILE . 29.7 ttm180 -52.04 -48.88 64.36 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.719 1.262 . . . . 74.33 110.491 176.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -61.95 -50.51 71.82 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 124.204 0.94 . . . . 75.4 111.63 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.447 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 44.9 t -54.3 -44.75 72.24 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.361 1.038 . . . . 72.45 110.691 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.598 HD13 HD12 ' A' ' 128' ' ' LEU . 96.9 mt -63.05 -55.06 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 114.968 -1.014 . . . . 75.22 111.14 176.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 91.4 m -52.83 -43.44 66.0 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.12 0.968 . . . . 74.32 111.53 -175.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 22.9 t -68.0 -44.21 77.09 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.382 -1.281 . . . . 74.52 109.782 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.594 ' HE1' ' HB2' ' A' ' 23' ' ' PHE . 11.1 mtp -57.45 -42.45 82.51 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.887 0.875 . . . . 73.1 111.596 175.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.3 t -59.72 -49.27 84.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.4 1.08 . . . . 75.45 110.274 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -72.42 -27.66 62.48 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.855 -0.612 . . . . 71.24 111.775 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 116' ' ' SER . 50.3 mtt-85 -70.77 -31.43 68.21 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.363 0.665 . . . . 72.34 109.932 175.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.48 18.2 25.57 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.572 -0.74 . . . . 74.35 113.073 175.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.444 HG23 ' HE ' ' B' ' 15' ' ' ARG . 2.5 t 59.61 11.57 2.44 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 126.952 2.101 . . . . 74.14 113.225 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -79.07 139.31 56.78 Favored Pre-proline 0 C--O 1.245 0.858 0 N-CA-C 108.271 -1.011 . . . . 65.4 108.271 174.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -48.58 135.79 27.0 Favored 'Trans proline' 0 C--N 1.365 1.438 0 C-N-CA 123.249 2.633 . . . . 74.3 112.519 173.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -58.8 127.5 32.5 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 124.292 0.995 . . . . 70.44 111.988 -166.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.0 tp -110.22 134.61 52.06 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 123.974 0.91 . . . . 73.0 108.859 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.493 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 85.6 m-20 -129.02 122.22 29.58 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.823 -0.806 . . . . 64.03 108.823 178.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.598 HD12 HD13 ' A' ' 114' ' ' ILE . 6.2 mt -74.15 148.04 42.1 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.481 -0.562 . . . . 71.31 109.481 -176.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.38 142.73 58.79 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 119.34 -0.362 . . . . 64.54 111.042 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.487 ' HB3' ' OH ' ' C' ' 101' ' ' TYR . 53.3 Cg_exo -56.22 121.66 10.39 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 123.446 2.764 . . . . 73.45 113.774 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.556 HG22 HD12 ' A' ' 44' ' ' LEU . 57.7 t -102.35 121.03 52.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-N 115.485 -0.779 . . . . 75.52 109.265 176.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.415 ' ND2' ' HB2' ' A' ' 135' ' ' ALA . 46.5 t30 -91.15 81.31 5.57 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.618 -0.882 . . . . 74.11 108.618 176.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -59.29 -31.58 69.26 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 114.893 -1.049 . . . . 74.22 111.578 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.637 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 13.9 t70 -55.22 -47.84 74.75 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.966 0.906 . . . . 74.43 109.937 178.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.415 ' HB2' ' ND2' ' A' ' 132' ' ' ASN . . . -72.75 -42.43 64.05 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.384 -0.825 . . . . 73.4 111.694 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 76.1 mt -65.22 -42.15 93.75 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.034 0.534 . . . . 73.11 112.323 -174.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 25.3 t80 . . . . . 0 C--O 1.212 -0.915 0 N-CA-C 109.349 -0.611 . . . . 63.24 109.349 175.919 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.609 ' HB3' HG23 ' B' ' 89' ' ' ILE . 21.4 ptm . . . . . 0 N--CA 1.484 1.226 0 CA-C-O 122.035 0.922 . . . . 74.43 113.225 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 90.7 m -148.29 124.76 10.99 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.536 -1.283 . . . . 74.33 107.536 169.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -113.54 145.03 41.87 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.997 -0.742 . . . . 75.55 108.997 173.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.483 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -155.66 139.76 16.46 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.314 -0.624 . . . . 74.21 109.314 172.513 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.434 HD11 HD12 ' B' ' 105' ' ' ILE . 50.4 mt -82.07 132.25 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 108.022 -1.103 . . . . 72.23 108.022 168.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -100.61 -43.73 6.07 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.528 -0.545 . . . . 73.3 109.528 178.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.444 ' HE ' HG23 ' A' ' 122' ' ' THR . 55.0 ttt180 -173.27 134.22 0.53 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.473 -0.785 . . . . 75.32 108.907 -174.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.582 HG21 ' CD1' ' B' ' 109' ' ' TYR . 88.8 mt -121.1 148.37 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 108.596 -0.89 . . . . 74.33 108.596 177.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -162.39 142.87 9.99 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 112.857 0.688 . . . . 74.41 112.857 -175.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.3 m -73.15 117.14 14.52 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.686 -1.143 . . . . 73.32 108.445 167.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.442 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 42.3 mtpt -91.43 -33.76 15.11 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.076 0.551 . . . . 71.52 110.294 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.595 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 19.3 t70 -149.79 136.21 19.09 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.093 -0.503 . . . . 61.52 110.811 -167.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 43.9 mm -134.92 139.55 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.793 1.237 . . . . 74.31 108.033 174.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 47.0 t -144.21 115.1 7.81 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.256 -1.016 . . . . 74.22 108.256 177.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' B' ' 75' ' ' LEU . 77.9 t80 -126.4 130.47 50.79 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 107.715 -1.217 . . . . 64.12 107.715 171.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -140.24 120.69 14.08 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.863 0.865 . . . . 52.21 108.744 175.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.98 85.58 6.66 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 107.257 -1.386 . . . . 61.35 107.257 170.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.7 -26.57 53.16 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.799 2.333 . . . . 63.34 112.313 -173.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -108.5 5.24 25.02 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.469 -0.787 . . . . 72.41 111.078 -177.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -30.23 -67.18 0.15 Allowed Pre-proline 0 N--CA 1.498 1.959 0 C-N-CA 125.447 1.499 . . . . 54.52 114.868 -167.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -61.95 -28.37 80.76 Favored 'Trans proline' 0 C--N 1.392 2.838 0 C-N-CA 122.043 1.828 . . . . 70.11 113.0 -170.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -94.03 -34.72 12.91 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.092 -0.958 . . . . 72.41 111.871 -172.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.599 HG21 HD11 ' B' ' 68' ' ' LEU . 9.9 p -72.19 -15.23 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 122.659 0.383 . . . . 74.53 111.202 -176.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -68.36 -9.81 50.67 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.557 0.743 . . . . 72.4 112.573 177.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.473 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.2 pt20 -67.0 -20.47 65.88 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.036 0.534 . . . . 74.01 110.808 174.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.473 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 99.5 mttt -103.03 110.78 22.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.991 1.316 . . . . 75.33 110.116 -175.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -112.92 97.31 6.46 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.692 0.397 . . . . 74.15 110.529 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 35.1 p90 -167.49 -171.31 1.64 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.439 1.096 . . . . 65.3 108.943 170.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 13.0 pm0 -71.36 111.39 10.01 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.482 0.713 . . . . 75.31 110.416 176.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.489 ' HA ' HD21 ' B' ' 68' ' ' LEU . 15.2 Cg_endo -65.61 152.14 82.62 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 121.204 1.27 . . . . 75.5 110.452 177.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 32.0 tt0 -69.72 99.85 1.4 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.787 -1.19 . . . . 71.4 107.787 173.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.596 HG21 ' HB1' ' B' ' 66' ' ' ALA . 31.7 t -101.73 142.04 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 O-C-N 123.655 0.597 . . . . 73.34 110.134 -171.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -126.91 107.67 10.3 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.519 1.128 . . . . 63.41 108.51 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 17.9 tp -87.25 125.57 34.28 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.39 -0.966 . . . . 73.42 108.39 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -137.45 111.39 8.3 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.842 -1.17 . . . . 74.41 107.842 -170.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mp -100.99 140.65 34.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.039 0.536 . . . . 73.13 109.737 -175.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -142.96 145.33 32.89 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.107 0.963 . . . . 74.1 109.846 -177.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 4.0 t -126.37 104.62 8.27 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.701 0.8 . . . . 74.11 109.177 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.76 113.91 23.23 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.341 -1.355 . . . . 62.4 107.341 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 30.9 p -146.51 164.7 31.69 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.583 0.353 . . . . 75.52 111.819 -167.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 55.0 p -151.39 142.94 23.59 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.201 0.601 . . . . 60.23 110.83 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -82.6 111.83 18.93 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 109.315 -0.624 . . . . 73.54 109.315 172.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 pp -121.64 21.81 10.75 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.336 -0.847 . . . . 74.01 109.851 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . 0.457 ' HB2' ' HB ' ' B' ' 55' ' ' VAL . . . -168.04 148.37 4.95 Favored 'General case' 0 C--N 1.361 1.079 0 C-N-CA 123.401 0.68 . . . . 64.43 111.743 176.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.62 141.26 46.56 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 107.609 -1.256 . . . . 64.2 107.609 158.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 70.05 -2.49 2.05 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.692 1.197 . . . . 75.4 112.472 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.457 ' HB ' ' HB2' ' B' ' 52' ' ' ALA . 24.8 t -141.08 127.47 20.29 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 CA-C-N 118.755 0.707 . . . . 70.54 109.821 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.461 ' HD2' HG23 ' B' ' 58' ' ' VAL . 14.9 t80 -115.67 138.48 51.05 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 106.976 -1.49 . . . . 73.12 106.976 171.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -100.88 99.89 10.44 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 106.958 -1.497 . . . . 73.31 106.958 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.461 HG23 ' HD2' ' B' ' 56' ' ' TYR . 32.3 t -96.11 127.35 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.152 -0.931 . . . . 74.14 109.589 -173.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 17.5 t -114.9 112.44 40.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 109.149 -0.686 . . . . 74.15 109.149 175.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 63.4 tp -94.2 107.25 19.2 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 116.018 -0.537 . . . . 74.51 109.586 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -85.68 108.58 18.09 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.954 -0.758 . . . . 72.34 108.954 171.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.405 HG11 ' CD1' ' B' ' 114' ' ' ILE . 39.8 t -104.38 103.17 14.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 106.842 -1.54 . . . . 73.01 106.842 175.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 25.6 m -99.46 141.57 32.07 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.176 -0.92 . . . . 74.34 109.506 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.529 HG23 HD12 ' B' ' 114' ' ' ILE . 41.5 t -133.77 118.29 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.128 0.971 . . . . 75.11 109.425 175.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 40.5 m -105.3 139.65 39.62 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.162 -1.421 . . . . 72.41 107.162 172.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.596 ' HB1' HG21 ' B' ' 40' ' ' VAL . . . -146.06 141.02 27.19 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.537 0.608 . . . . 54.23 110.536 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.506 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 19.8 m -143.12 128.37 18.75 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.452 0.47 . . . . 73.24 112.018 -172.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.599 HD11 HG21 ' B' ' 31' ' ' VAL . 90.4 mt -95.1 117.74 30.72 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.673 0.789 . . . . 75.03 109.007 176.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.51 -110.59 3.09 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.948 -0.861 . . . . 70.41 110.948 -172.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.22 6.38 8.47 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.771 0.829 . . . . 74.55 109.698 177.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.45 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 12.6 pt-20 -113.75 148.34 36.66 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.039 0.536 . . . . 75.51 109.627 -175.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 27.7 m -66.1 120.75 13.73 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.787 0.435 . . . . 73.41 110.966 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.506 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -73.53 -63.8 1.12 Allowed 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.612 -1.255 . . . . 72.55 107.612 172.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -152.59 161.82 42.06 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 114.405 -1.271 . . . . 65.44 111.087 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 58.1 mt -123.26 112.34 17.52 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 105.328 -2.101 . . . . 74.43 105.328 171.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.524 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 47.5 t -120.43 139.94 52.11 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.612 -0.884 . . . . 71.43 108.612 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -157.09 135.47 11.31 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.273 -0.64 . . . . 72.22 109.273 -174.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.427 HG11 ' HA ' ' B' ' 110' ' ' ALA . 62.6 t -132.88 147.54 31.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.097 -0.956 . . . . 74.21 108.798 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.595 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 17.9 mt-30 -123.68 106.95 10.95 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.073 -1.084 . . . . 65.33 108.073 168.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.424 ' O ' HD13 ' B' ' 106' ' ' LEU . 8.2 tp-100 -97.03 104.39 16.4 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.356 -0.979 . . . . 73.13 108.356 176.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.442 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -94.77 167.57 27.05 Favored Glycine 0 C--N 1.338 0.649 0 O-C-N 123.543 0.527 . . . . 65.43 111.969 175.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.15 138.52 5.26 Favored Glycine 0 C--N 1.341 0.826 0 C-N-CA 121.156 -0.545 . . . . 70.42 114.053 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.422 HG22 HG13 ' B' ' 55' ' ' VAL . 70.3 mt -86.37 114.36 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 124.862 1.265 . . . . 70.01 108.184 169.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -126.31 133.4 51.4 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.278 0.631 . . . . 75.22 110.514 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 58.3 m -89.39 106.06 18.2 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.573 0.749 . . . . 74.21 110.767 175.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.584 HG21 HD13 ' B' ' 89' ' ' ILE . 54.9 mt -116.95 104.74 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 125.274 1.43 . . . . 72.42 108.395 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.12 166.7 23.47 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.938 0.895 . . . . 54.4 110.648 -174.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.6 -53.17 2.7 Favored Glycine 0 N--CA 1.476 1.36 0 O-C-N 123.111 0.257 . . . . 62.1 112.635 177.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.609 HG23 ' HB3' ' B' ' 9' ' ' MET . 0.5 OUTLIER -62.5 166.38 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 124.283 1.033 . . . . 74.5 112.271 171.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -159.79 151.9 20.68 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.108 -0.951 . . . . 73.15 110.41 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.67 -127.7 9.02 Favored Glycine 0 C--N 1.354 1.562 0 CA-C-N 116.365 -0.379 . . . . 63.15 113.179 174.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.6 m -79.8 -39.31 31.12 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.995 0.903 . . . . 71.14 110.292 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -60.77 -34.38 74.39 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 113.217 -1.81 . . . . 74.53 111.731 -168.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.533 ' SD ' ' N ' ' B' ' 95' ' ' ALA . 2.1 ppp? -65.72 -46.09 80.22 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.091 -0.959 . . . . 72.25 111.822 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . 0.533 ' N ' ' SD ' ' B' ' 94' ' ' MET . . . -79.44 -12.45 59.89 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.472 0.709 . . . . 70.31 112.724 -175.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -62.4 -34.74 77.33 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 110.18 -0.304 . . . . 64.24 110.18 167.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -68.67 -51.18 44.67 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.944 0.498 . . . . 71.45 111.049 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.49 ' HG ' ' HA ' ' B' ' 95' ' ' ALA . 4.2 pp -70.82 -27.81 64.15 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.636 0.375 . . . . 75.44 111.687 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.1 3.82 67.15 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-O 119.142 -0.81 . . . . 72.42 114.185 -174.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.95 -51.88 0.1 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 117.948 0.874 . . . . 74.51 112.257 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -71.52 -40.36 70.18 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.051 0.54 . . . . 74.3 111.263 -175.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.48 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 72.3 m -68.87 -48.51 29.42 Favored Pre-proline 0 CA--C 1.56 1.337 0 CA-C-O 118.544 -0.741 . . . . 75.11 111.493 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.5 -32.72 64.47 Favored 'Trans proline' 0 C--N 1.399 3.189 0 C-N-CA 122.636 2.224 . . . . 74.11 113.627 169.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -61.94 -34.84 76.82 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.366 0.666 . . . . 74.35 111.47 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.434 HD12 HD11 ' B' ' 13' ' ' ILE . 72.4 mt -75.99 -41.45 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.765 0.826 . . . . 73.14 110.195 176.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.424 HD13 ' O ' ' B' ' 80' ' ' GLN . 78.2 mt -71.29 -25.0 62.25 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 114.718 -1.128 . . . . 75.2 111.207 -176.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -62.63 -52.14 67.2 Favored Pre-proline 0 CA--C 1.552 1.024 0 CA-C-O 117.363 -1.304 . . . . 73.2 113.2 -172.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -54.06 -40.26 82.18 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.266 1.977 . . . . 72.33 113.023 177.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.582 ' CD1' HG21 ' B' ' 16' ' ' ILE . 5.2 m-30 -65.92 -44.13 86.05 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.981 -1.009 . . . . 73.02 110.495 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.427 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -70.81 -37.16 73.22 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.889 0.876 . . . . 73.34 111.456 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.648 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 52.4 ttt-85 -65.73 -54.88 21.28 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.243 1.417 . . . . 74.22 110.815 -176.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -73.23 -18.06 61.28 Favored 'General case' 0 CA--C 1.551 0.982 0 O-C-N 123.898 0.749 . . . . 74.14 110.06 -177.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.467 ' O ' ' HG2' ' B' ' 117' ' ' MET . 15.6 t -72.8 -42.1 64.24 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 122.739 0.416 . . . . 73.44 109.93 172.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.529 HD12 HG23 ' B' ' 64' ' ' VAL . 75.3 mt -57.52 -54.32 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 123.637 0.775 . . . . 73.31 109.704 171.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 21.3 m -59.43 -29.91 68.11 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 124.34 1.025 . . . . 72.23 111.517 -177.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.6 t -68.39 -47.83 66.32 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.004 0.522 . . . . 73.2 110.357 174.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.6 mmt -69.66 -30.14 67.76 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.83 0.452 . . . . 71.45 111.115 -176.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.545 HG22 HD22 ' B' ' 126' ' ' LEU . 91.0 t -67.68 -41.87 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.194 0.998 . . . . 75.55 109.861 172.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.8 t -66.86 -29.72 69.7 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.206 -0.906 . . . . 73.42 111.058 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' B' ' 116' ' ' SER . 84.5 mtt-85 -72.11 -35.2 69.11 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 123.116 0.566 . . . . 64.43 109.66 176.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.3 -9.85 81.41 Favored Glycine 0 C--N 1.354 1.562 0 O-C-N 123.531 0.519 . . . . 73.43 112.42 170.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.2 m 69.95 25.52 4.87 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 125.444 1.497 . . . . 72.54 110.643 174.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -78.38 165.26 51.33 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 124.043 0.937 . . . . 75.13 111.764 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.04 163.77 4.04 Favored 'Trans proline' 0 C--N 1.392 2.851 0 C-N-CA 123.313 2.675 . . . . 75.31 113.673 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -64.83 113.59 3.91 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.128 -0.942 . . . . 71.04 112.175 -171.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.545 HD22 HG22 ' B' ' 118' ' ' VAL . 48.6 tp -112.57 88.63 2.87 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 115.829 -0.623 . . . . 74.44 109.774 177.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -93.92 110.13 21.82 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.763 -1.199 . . . . 70.35 107.763 169.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.648 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 74.1 mt -65.46 146.32 55.02 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.331 0.253 . . . . 71.33 111.047 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.74 144.94 98.9 Favored Pre-proline 0 CA--C 1.55 0.964 0 O-C-N 124.406 1.066 . . . . 74.32 112.387 -173.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -68.11 84.47 0.44 Allowed 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.919 2.413 . . . . 62.31 111.61 173.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 19.8 m -101.28 126.92 55.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-O 121.2 0.524 . . . . 74.2 109.976 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 54.4 t30 . . . . . 0 C--O 1.244 0.785 0 N-CA-C 108.04 -1.096 . . . . 73.53 108.04 172.113 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 29.6 t80 . . . . . 0 C--O 1.24 0.561 0 N-CA-C 107.1 -1.444 . . . . 74.33 107.1 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -140.49 114.8 9.26 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.891 -1.151 . . . . 74.03 107.891 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 37.6 mt -72.31 131.75 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.639 -0.875 . . . . 75.15 108.639 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -86.59 -49.47 7.52 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.352 -0.61 . . . . 71.15 109.352 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.573 HH21 ' HD2' ' D' ' 32' ' ' PHE . 0.0 OUTLIER -178.36 151.83 0.64 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.48 1.112 . . . . 75.4 109.104 173.213 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 pp -109.43 151.7 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 107.653 -1.24 . . . . 74.44 107.653 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.565 ' HE1' HG12 ' C' ' 83' ' ' ILE . 49.2 p90 -172.28 153.35 2.98 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.145 0.43 . . . . 64.53 111.245 -176.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.2 p -85.31 111.59 20.02 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.704 -0.68 . . . . 74.3 111.533 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.455 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 31.2 mmtp -65.52 -33.07 75.06 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.382 0.673 . . . . 74.55 110.733 170.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -151.79 146.28 25.6 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.7 -1.136 . . . . 71.21 109.756 -177.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 80.8 mt -142.84 139.81 27.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 106.37 -1.715 . . . . 74.04 106.37 171.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.4 t -154.27 147.53 24.85 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.452 0.644 . . . . 73.14 109.901 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -146.94 136.33 22.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 106.811 -1.551 . . . . 71.12 106.811 172.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -137.94 133.44 33.75 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.502 -0.925 . . . . 62.41 108.502 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.11 77.65 6.11 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 108.197 -1.038 . . . . 71.33 108.197 172.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.34 -27.8 28.05 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.761 2.308 . . . . 70.24 111.144 177.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -99.08 14.33 29.66 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.773 -1.103 . . . . 73.54 111.052 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.59 -55.39 12.41 Favored Pre-proline 0 N--CA 1.49 1.525 0 C-N-CA 124.429 1.092 . . . . 75.35 113.11 -177.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.55 -46.47 20.62 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.062 1.842 . . . . 73.43 112.316 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -69.71 -32.51 71.13 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.567 -1.197 . . . . 73.24 112.534 -174.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.1 p -79.5 -29.27 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 111.991 0.367 . . . . 75.24 111.991 -176.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -63.75 -32.28 73.73 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.704 0.401 . . . . 74.3 111.838 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -88.62 17.3 5.58 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.211 0.604 . . . . 72.44 111.621 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.416 ' HG2' HD11 ' C' ' 68' ' ' LEU . 2.4 ttpm? -120.33 152.06 38.37 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.076 0.951 . . . . 75.12 110.552 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -59.27 129.46 42.16 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.368 1.067 . . . . 75.41 111.361 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -85.49 85.7 7.41 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.973 0.909 . . . . 72.33 110.749 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -131.53 78.36 71.47 Favored Pre-proline 0 N--CA 1.479 1.008 0 N-CA-C 107.118 -1.438 . . . . 70.53 107.118 171.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -93.44 143.4 2.0 Allowed 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.538 2.158 . . . . 75.4 113.312 -175.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -85.5 98.21 10.48 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 106.686 -1.598 . . . . 74.45 106.686 159.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 94.7 t -76.48 99.52 2.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.14 -1.059 . . . . 75.32 108.14 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -90.8 100.72 13.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.148 -1.797 . . . . 75.22 106.148 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.507 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.5 pt? -97.44 162.0 13.52 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 115.626 -0.716 . . . . 74.52 109.587 -174.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.805 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 25.6 m-20 -142.32 146.26 34.83 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.744 0.818 . . . . 74.5 110.055 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.464 HD13 HG13 ' C' ' 131' ' ' VAL . 95.1 mt -134.53 111.12 9.83 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.771 0.828 . . . . 74.04 108.949 174.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -116.43 142.87 46.29 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.27 1.428 . . . . 73.24 107.277 173.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.6 t -152.69 152.67 31.99 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.752 -0.462 . . . . 74.13 109.752 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.82 157.63 38.19 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.466 0.706 . . . . 70.23 109.988 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.415 ' HG ' ' HB3' ' C' ' 98' ' ' LEU . 6.2 m -130.01 144.59 51.41 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.134 0.574 . . . . 70.52 109.629 176.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 37.8 p -145.29 127.48 15.71 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.672 0.789 . . . . 60.03 109.438 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -75.99 120.65 21.61 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.475 0.71 . . . . 74.14 110.51 -177.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.654 HD12 ' HB2' ' C' ' 57' ' ' GLU . 40.6 mt -91.42 -31.06 16.16 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.427 0.691 . . . . 71.4 110.661 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.55 -177.41 5.92 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.778 0.831 . . . . 73.44 110.375 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -65.24 119.71 11.41 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.769 -0.65 . . . . 73.23 110.116 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 65.94 11.56 7.79 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.902 1.281 . . . . 73.13 112.126 -175.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.3 t -116.23 111.59 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.051 -0.722 . . . . 72.31 109.051 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -123.0 124.2 42.6 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.965 -1.124 . . . . 74.42 107.965 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.654 ' HB2' HD12 ' C' ' 51' ' ' LEU . 40.1 tt0 -85.78 137.96 32.42 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.773 -0.825 . . . . 74.31 108.773 170.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.66 138.43 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 108.27 -1.011 . . . . 55.33 108.27 170.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.439 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 44.9 t -127.07 133.74 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 109.283 -0.636 . . . . 74.43 109.283 174.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.485 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -117.56 105.24 11.86 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.669 -1.234 . . . . 72.21 107.669 -177.886 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 16.9 ttm-85 -81.62 108.36 15.12 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.599 0.76 . . . . 75.11 109.505 171.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 44.0 t -104.78 119.06 53.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 108.015 -1.106 . . . . 74.42 108.015 171.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.805 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 79.2 m -114.66 145.41 42.05 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.056 0.942 . . . . 71.41 108.95 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.466 HG22 HG23 ' C' ' 114' ' ' ILE . 35.7 t -135.45 112.43 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.69 1.196 . . . . 73.14 108.314 178.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.7 m -101.77 122.66 44.37 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.309 -0.997 . . . . 74.53 108.309 168.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.6 119.24 38.93 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.148 -1.427 . . . . 74.01 107.148 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 32.2 m -141.25 129.01 21.64 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.109 0.255 . . . . 74.44 110.343 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.416 HD11 ' HG2' ' C' ' 34' ' ' LYS . 23.0 mt -86.56 44.08 1.12 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.506 1.122 . . . . 73.42 109.914 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.95 -104.96 2.54 Favored Glycine 0 C--N 1.344 1.019 0 N-CA-C 110.275 -1.13 . . . . 74.12 110.275 -172.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -90.85 -31.52 16.42 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.57 0.748 . . . . 72.22 109.438 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -65.91 121.56 15.35 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.71 1.204 . . . . 64.55 110.478 174.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 52.2 m -83.87 120.27 25.87 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.973 -0.751 . . . . 74.42 108.973 167.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.603 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.94 -55.07 8.12 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 123.945 0.778 . . . . 54.04 108.944 174.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -162.03 162.5 28.86 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 115.446 -0.797 . . . . 74.13 110.316 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.413 HD11 ' N ' ' C' ' 76' ' ' CYS . 2.9 tm? -114.33 142.65 46.04 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 106.491 -1.67 . . . . 71.31 106.491 163.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.413 ' N ' HD11 ' C' ' 75' ' ' LEU . 46.1 t -145.06 143.49 30.46 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.29 -1.004 . . . . 61.14 108.29 175.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -156.98 130.01 7.8 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.465 -0.569 . . . . 74.13 109.465 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 86.0 t -130.96 122.19 51.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.504 -0.924 . . . . 75.03 108.504 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -99.05 88.46 3.97 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.839 -1.171 . . . . 75.25 107.839 177.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -79.36 100.17 7.48 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.972 -1.013 . . . . 74.15 109.633 -175.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -82.09 174.55 53.7 Favored Glycine 0 C--O 1.237 0.316 0 CA-C-N 115.923 -0.58 . . . . 54.24 112.301 174.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.79 126.67 1.17 Allowed Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 111.786 -0.526 . . . . 72.24 111.786 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.565 HG12 ' HE1' ' C' ' 17' ' ' TYR . 31.7 mm -87.13 126.45 40.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.241 -1.022 . . . . 75.24 108.241 174.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -127.93 118.56 23.83 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.534 0.734 . . . . 72.23 109.431 -177.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 28.5 p -84.67 102.11 12.69 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.588 -0.893 . . . . 74.31 108.588 169.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 29.6 mt -115.43 118.59 59.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.692 1.197 . . . . 62.41 109.702 -175.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -124.96 170.1 11.44 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.712 0.805 . . . . 74.35 109.898 174.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.98 -39.64 2.68 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 116.432 -0.349 . . . . 65.53 113.616 171.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.647 HD13 ' HA ' ' C' ' 94' ' ' MET . 39.8 pt -103.93 165.33 3.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 123.283 0.633 . . . . 71.02 111.574 -171.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -159.92 154.35 23.84 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.254 -0.884 . . . . 74.34 109.195 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.2 -120.41 17.94 Favored Glycine 0 C--N 1.346 1.084 0 O-C-N 123.534 0.521 . . . . 63.25 113.579 174.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 35.1 p -61.6 -40.63 95.49 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.574 0.75 . . . . 75.3 111.831 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -63.49 -49.58 73.04 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.837 0.455 . . . . 75.41 110.908 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.647 ' HA ' HD13 ' C' ' 89' ' ' ILE . 6.2 tpt -52.36 -54.06 36.66 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 124.239 0.962 . . . . 75.32 111.909 174.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.63 -42.33 96.68 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.292 0.567 . . . . 73.13 111.639 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -65.4 -31.77 73.05 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.729 1.211 . . . . 74.41 111.037 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 48.7 t -76.63 -27.67 55.78 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.286 -0.87 . . . . 71.1 110.864 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.441 ' HG ' ' HE1' ' C' ' 94' ' ' MET . 94.3 mt -94.53 -32.14 13.6 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.672 0.789 . . . . 72.13 112.975 -172.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.03 -8.0 37.19 Favored Glycine 0 N--CA 1.473 1.123 0 CA-C-O 119.963 -0.354 . . . . 55.01 113.7 -173.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.23 -54.42 1.11 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.853 0.461 . . . . 73.41 110.874 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.487 ' OH ' ' HB3' ' A' ' 130' ' ' PRO . 52.2 t80 -73.4 -49.84 24.98 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.898 -0.592 . . . . 71.42 112.0 -170.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 68.0 m -63.23 -47.74 84.44 Favored Pre-proline 0 CA--C 1.557 1.228 0 CA-C-O 118.64 -0.695 . . . . 74.43 111.55 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.485 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 78.1 Cg_exo -56.43 -31.8 86.89 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.453 2.102 . . . . 73.24 113.594 170.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -68.02 -32.48 72.89 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.971 0.508 . . . . 74.21 110.726 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.494 HD13 HH12 ' A' ' 111' ' ' ARG . 10.0 mm -72.62 -41.68 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 109.509 -0.552 . . . . 65.44 109.509 174.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 85.0 mt -74.48 -23.62 58.9 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.899 0.88 . . . . 73.23 112.238 -175.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . 0.401 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 53.7 t80 -59.77 -53.43 65.62 Favored Pre-proline 0 N--CA 1.48 1.027 0 CA-C-O 117.431 -1.271 . . . . 65.42 113.445 -174.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . 0.401 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 51.1 Cg_exo -56.29 -36.59 97.13 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 121.84 1.693 . . . . 75.3 113.155 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -67.4 -47.53 70.03 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.27 0.628 . . . . 74.34 111.271 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.2 -38.93 88.33 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.176 0.99 . . . . 74.41 110.601 177.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -64.72 -47.26 78.93 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.165 1.386 . . . . 75.13 110.178 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -67.48 -34.03 76.32 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 123.861 0.726 . . . . 54.51 110.062 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.6 t -72.11 -34.58 68.72 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.933 0.493 . . . . 73.33 111.052 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.466 HG23 HG22 ' C' ' 64' ' ' VAL . 65.2 mt -73.91 -50.36 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 122.856 0.462 . . . . 72.13 110.34 176.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.1 m -65.71 -28.43 69.06 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.101 0.56 . . . . 72.03 110.872 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 29.3 t -62.85 -49.18 75.89 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 108.951 -0.759 . . . . 75.24 108.951 169.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.569 ' HG3' HD12 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.64 -36.47 78.72 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.322 1.049 . . . . 74.44 112.629 179.04 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 92.3 t -62.65 -49.25 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.544 0.737 . . . . 74.53 109.603 175.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.2 t -65.44 -32.91 74.78 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.978 -1.01 . . . . 72.13 111.552 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.502 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 76.5 mtt-85 -67.18 -37.6 83.97 Favored 'General case' 0 C--O 1.214 -0.8 0 C-N-CA 123.448 0.699 . . . . 73.14 109.465 176.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.84 8.15 70.98 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.31 -0.717 . . . . 72.32 113.249 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.404 HG22 ' HB3' ' D' ' 17' ' ' TYR . 81.0 p 55.6 33.66 21.62 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.05 1.74 . . . . 73.51 113.124 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -93.28 145.7 30.52 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 108.431 -0.951 . . . . 74.5 108.431 171.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -51.32 148.58 18.77 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 123.72 2.946 . . . . 73.12 114.249 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -55.43 112.47 1.12 Allowed 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.274 0.984 . . . . 71.14 112.261 -176.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 53.8 tp -110.49 86.87 2.39 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.481 -1.236 . . . . 73.21 107.805 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -91.6 101.62 14.25 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.555 -0.906 . . . . 74.33 108.555 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.9 127.84 33.35 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.898 0.879 . . . . 75.21 110.393 -174.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.72 151.48 94.71 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 123.916 0.886 . . . . 62.34 111.811 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.467 ' HG3' HD13 ' A' ' 16' ' ' ILE . 51.6 Cg_exo -52.95 107.93 0.23 Allowed 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.017 2.478 . . . . 72.31 112.995 175.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . 0.464 HG13 HD13 ' C' ' 44' ' ' LEU . 6.3 p -101.56 124.25 55.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 109.254 -0.647 . . . . 74.21 109.254 175.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -85.54 104.65 15.5 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.176 0.59 . . . . 63.35 109.686 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -66.05 -22.41 66.43 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.948 -0.569 . . . . 72.21 111.493 176.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -71.18 -36.57 72.02 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.566 0.541 . . . . 73.33 109.802 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.71 -43.35 99.02 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.441 -0.8 . . . . 71.45 110.22 172.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 73.5 mt -71.3 -25.74 62.56 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.855 0.862 . . . . 63.32 111.537 178.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 40.2 t80 . . . . . 0 N--CA 1.472 0.667 0 C-N-CA 123.313 0.645 . . . . 73.43 110.01 -179.272 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 5.6 t . . . . . 0 C--O 1.243 0.76 0 N-CA-C 109.5 -0.555 . . . . 71.42 109.5 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -152.88 103.25 2.74 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.734 -1.21 . . . . 73.02 107.734 -175.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -112.68 128.67 56.46 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.252 -1.018 . . . . 75.53 108.252 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.448 HG21 HD13 ' D' ' 16' ' ' ILE . 12.8 mt -94.24 134.97 29.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.173 -1.047 . . . . 65.11 108.173 175.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -106.34 -33.45 7.76 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 122.779 0.431 . . . . 75.31 111.629 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -169.32 127.0 0.95 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 120.592 0.234 . . . . 72.52 111.594 -166.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.448 HD13 HG21 ' D' ' 13' ' ' ILE . 2.5 mp -107.22 134.46 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 107.67 -1.233 . . . . 75.51 107.67 168.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' C' ' 120' ' ' ARG . 39.4 p90 -163.73 150.39 11.88 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-O 121.821 0.82 . . . . 75.41 111.873 175.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.4 p -85.89 126.3 33.96 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.684 -1.144 . . . . 74.22 109.199 176.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -99.37 -14.22 19.27 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.349 -0.611 . . . . 73.5 109.349 175.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.67 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.2 t70 -160.02 136.87 9.2 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.309 1.044 . . . . 72.11 109.032 176.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.569 HD12 ' HG3' ' C' ' 117' ' ' MET . 65.7 mt -137.67 144.66 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.626 1.17 . . . . 74.41 108.121 174.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.1 t -146.62 139.28 25.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.185 0.994 . . . . 73.22 108.955 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.452 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 77.5 t80 -150.31 123.24 8.73 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.753 -1.573 . . . . 75.42 106.753 167.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -127.38 129.67 48.0 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.15 -0.685 . . . . 75.11 109.15 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.1 79.49 14.32 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 107.57 -1.27 . . . . 73.33 107.57 169.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.75 -35.06 13.38 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.375 2.05 . . . . 74.44 112.151 -171.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -104.99 6.51 33.52 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.101 0.96 . . . . 75.03 110.515 -174.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -23.65 -77.75 0.02 OUTLIER Pre-proline 0 CA--C 1.567 1.613 0 N-CA-C 117.428 2.381 . . . . 72.51 117.428 -169.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.455 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 87.1 Cg_endo -75.29 -17.48 18.9 Favored 'Trans proline' 0 C--N 1.388 2.652 0 CA-C-N 124.643 2.694 . . . . 73.41 113.224 -170.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.472 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 6.4 t-160 -70.88 -43.71 67.84 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.949 -0.76 . . . . 72.34 108.949 172.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.459 HG22 ' HA ' ' D' ' 73' ' ' ALA . 4.8 p -83.88 -19.62 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 CA-C-N 115.748 -0.66 . . . . 74.23 111.517 -170.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.573 ' HD2' HH21 ' C' ' 15' ' ' ARG . 22.7 m-85 -67.4 -20.72 65.57 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 120.914 0.388 . . . . 63.34 111.416 177.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . 0.472 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 58.8 mt-30 -64.31 -18.33 64.51 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.103 0.961 . . . . 64.23 111.083 174.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.519 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 92.7 mttt -92.19 81.54 5.01 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.747 1.219 . . . . 75.43 108.784 174.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -83.43 79.7 9.33 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 122.074 0.94 . . . . 75.1 111.062 -174.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -152.93 -174.91 5.1 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.092 -0.958 . . . . 65.14 109.041 169.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -77.21 114.59 41.52 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 123.516 0.726 . . . . 73.44 110.43 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -53.94 119.98 7.17 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 122.53 2.154 . . . . 74.22 110.764 172.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -67.2 108.83 2.84 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.76 -1.2 . . . . 74.0 107.76 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.676 HG11 HG13 ' D' ' 64' ' ' VAL . 93.9 t -100.88 132.51 46.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 CA-C-N 115.419 -0.809 . . . . 73.5 109.823 -171.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -115.24 118.94 34.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.569 -1.271 . . . . 75.54 107.569 173.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.679 HD12 HG13 ' D' ' 62' ' ' VAL . 37.9 tp -97.39 137.58 36.16 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.27 0.557 . . . . 64.34 110.131 -178.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.407 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 6.5 m-20 -133.66 122.19 23.08 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.028 1.331 . . . . 73.24 108.083 -175.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 89.1 mt -119.8 144.58 47.24 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.814 0.445 . . . . 74.42 110.759 -176.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.474 ' HB2' ' HB3' ' D' ' 61' ' ' ARG . 11.7 m-20 -142.13 134.61 28.05 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.218 1.007 . . . . 72.21 109.061 176.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 46' ' ' THR . . . . . 0.428 HG23 ' HA2' ' D' ' 99' ' ' GLY . 59.1 m -104.15 139.05 39.76 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.154 -1.054 . . . . 64.1 108.154 168.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.42 141.05 21.72 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.585 -1.265 . . . . 72.32 107.585 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 30.8 p . . . . . 0 C--O 1.243 0.731 0 N-CA-C 109.806 -0.442 . . . . 75.53 109.806 -175.962 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' D' ' 85' ' ' SER . 80.9 m-20 . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 113.396 0.887 . . . . 73.11 113.396 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 9.0 m -129.64 110.2 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.402 -0.962 . . . . 74.23 108.402 169.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -126.88 132.58 50.89 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 109.31 -0.626 . . . . 73.2 109.31 -175.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -87.28 112.43 22.04 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.594 -0.891 . . . . 71.34 108.594 175.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.584 HG12 ' HD3' ' D' ' 103' ' ' PRO . 84.8 t -101.13 116.9 45.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.322 -0.992 . . . . 70.0 108.322 176.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.471 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 26.3 t -102.71 129.36 54.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 108.777 -0.823 . . . . 71.11 108.777 176.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.31 122.78 48.48 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.41 -0.959 . . . . 74.43 108.41 -178.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.474 ' HB3' ' HB2' ' D' ' 45' ' ' ASP . 49.3 ttp180 -98.53 101.47 12.91 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.996 -0.742 . . . . 75.35 108.996 173.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.679 HG13 HD12 ' D' ' 42' ' ' LEU . 61.9 t -98.24 113.64 33.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 114.898 -1.046 . . . . 73.31 108.678 173.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.407 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 11.0 m -122.44 124.22 43.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.356 -0.838 . . . . 73.21 109.706 -172.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.676 HG13 HG11 ' D' ' 40' ' ' VAL . 39.9 t -109.15 123.24 64.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 C-N-CA 125.409 1.484 . . . . 64.05 108.774 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 20.4 m -113.52 101.27 9.19 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.902 -1.147 . . . . 65.23 107.902 169.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.47 142.95 41.53 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.636 -0.711 . . . . 75.22 109.105 -173.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.451 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 17.1 p -149.72 134.0 17.32 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.746 0.647 . . . . 73.1 112.746 -171.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 34.3 mt -109.06 112.01 23.96 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.797 1.239 . . . . 71.21 107.733 173.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.5 -140.41 22.7 Favored Glycine 0 C--N 1.344 1.004 0 O-C-N 123.286 0.367 . . . . 50.5 112.545 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.29 6.64 42.11 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.348 0.659 . . . . 63.01 111.799 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.519 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 11.1 pt-20 -132.35 173.99 10.71 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.885 0.474 . . . . 72.5 110.611 -178.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 31.2 m -73.6 140.03 45.94 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.452 -0.794 . . . . 71.41 111.775 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.459 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -87.25 -67.19 0.84 Allowed 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.404 -1.332 . . . . 75.51 107.404 169.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -148.41 148.75 30.68 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.52 -1.218 . . . . 72.53 110.26 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 78.6 mt -103.41 150.38 23.89 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.73 1.212 . . . . 74.53 108.197 169.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.539 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.9 t -158.12 140.58 14.45 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.359 -0.608 . . . . 73.33 109.359 176.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -155.54 127.62 7.61 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.106 0.562 . . . . 73.33 109.698 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.93 114.97 34.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 123.126 0.57 . . . . 75.15 109.553 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.67 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.0 mt-30 -90.71 85.67 6.13 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.872 0.844 . . . . 75.34 109.394 171.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -81.18 101.44 9.67 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 113.818 -1.537 . . . . 74.4 109.726 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.42 143.89 17.56 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 112.273 -0.331 . . . . 72.31 112.273 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.65 134.0 6.57 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 111.855 -0.498 . . . . 74.04 111.855 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.411 HG13 ' HE1' ' D' ' 17' ' ' TYR . 61.6 mt -89.23 103.17 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 107.925 -1.139 . . . . 72.24 107.925 175.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -108.78 144.11 37.05 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.807 0.843 . . . . 73.22 110.641 -177.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' D' ' 54' ' ' ASP . 16.4 p -116.46 137.34 52.24 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.679 0.792 . . . . 63.23 110.097 171.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.446 HG12 HD11 ' D' ' 89' ' ' ILE . 6.3 tt -145.24 138.68 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.394 0.678 . . . . 73.4 110.81 -163.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.26 170.76 9.83 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.425 0.69 . . . . 73.41 111.645 175.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.61 7.58 61.56 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 115.748 -0.66 . . . . 53.43 112.793 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.447 HG21 ' NE2' ' D' ' 93' ' ' GLN . 1.4 pp -140.1 149.96 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.542 1.137 . . . . 74.1 110.225 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.9 173.26 17.26 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.746 0.819 . . . . 72.32 110.456 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.86 -118.26 4.68 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 114.781 0.673 . . . . 64.41 114.781 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 54.2 p -90.08 -44.67 9.66 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.384 0.674 . . . . 63.31 111.388 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.447 ' NE2' HG21 ' D' ' 89' ' ' ILE . 12.8 pt20 -66.86 -23.61 66.04 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 113.177 0.806 . . . . 71.44 113.177 -172.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 21.7 ptm -56.72 -51.31 69.33 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 113.851 1.056 . . . . 74.12 113.851 -174.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.9 -12.85 59.71 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.577 0.751 . . . . 65.34 112.411 -168.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -61.8 -37.62 85.05 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.942 0.497 . . . . 74.25 110.53 171.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 61.8 m -66.72 -25.48 66.54 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.876 -0.602 . . . . 72.03 111.943 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.443 HD22 HG23 ' D' ' 86' ' ' ILE . 89.6 mt -92.84 -39.34 11.25 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.815 0.846 . . . . 73.05 111.281 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . 0.428 ' HA2' HG23 ' D' ' 46' ' ' THR . . . -90.53 -1.85 73.9 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.622 -0.717 . . . . 73.45 113.54 -171.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.23 -49.64 0.13 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.157 0.429 . . . . 72.34 112.157 -173.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -73.63 -42.99 60.73 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 118.168 0.44 . . . . 72.55 111.958 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.439 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 89.8 m -60.27 -48.83 93.07 Favored Pre-proline 0 CA--C 1.562 1.425 0 CA-C-O 118.964 -0.541 . . . . 75.44 112.091 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.584 ' HD3' HG12 ' D' ' 58' ' ' VAL . 37.6 Cg_endo -65.54 -24.88 55.7 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 121.924 1.749 . . . . 64.13 112.835 173.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -67.98 -31.13 70.63 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.561 0.344 . . . . 75.2 110.262 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 37.5 mm -73.02 -38.92 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.025 0.93 . . . . 73.32 110.829 173.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' D' ' 103' ' ' PRO . 71.6 mt -69.76 -26.92 64.53 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.333 0.653 . . . . 70.05 111.899 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -62.82 -41.61 72.85 Favored Pre-proline 0 CA--C 1.554 1.132 0 N-CA-C 113.93 1.085 . . . . 74.41 113.93 -170.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -47.12 -45.43 21.54 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.205 1.937 . . . . 75.22 114.087 167.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -79.9 -32.69 40.22 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.678 0.791 . . . . 75.1 111.961 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.39 -36.14 66.0 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.236 0.614 . . . . 75.21 110.153 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.493 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.8 ttp180 -66.18 -45.1 82.02 Favored 'General case' 0 C--O 1.208 -1.116 0 CA-C-N 114.839 -1.073 . . . . 73.25 109.305 171.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -55.05 -48.56 73.29 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.958 0.903 . . . . 75.5 111.302 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.469 ' SG ' HD11 ' D' ' 21' ' ' ILE . 46.0 t -58.35 -45.8 87.49 Favored 'General case' 0 C--N 1.347 0.487 0 O-C-N 124.22 0.95 . . . . 74.23 111.032 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.539 HG12 ' SG ' ' D' ' 76' ' ' CYS . 45.1 mt -64.06 -55.04 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.111 0.565 . . . . 75.15 110.915 177.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.2 m -50.71 -40.66 54.8 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.354 1.462 . . . . 71.5 111.455 -176.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 34.4 t -66.66 -47.85 71.22 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.912 -1.04 . . . . 61.45 110.434 177.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.418 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 64.2 mtm -69.57 -29.5 67.06 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.495 0.554 . . . . 74.34 112.495 -175.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.402 HG22 ' O ' ' D' ' 114' ' ' ILE . 86.4 t -67.82 -44.44 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.503 0.721 . . . . 74.03 109.471 176.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 65.9 p -71.66 -28.44 63.75 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 115.626 -0.716 . . . . 74.42 110.048 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' D' ' 116' ' ' SER . 92.7 mtt-85 -71.79 -30.05 65.12 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.82 0.848 . . . . 74.45 110.191 173.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.85 8.64 77.18 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 123.642 0.588 . . . . 71.32 112.748 176.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 82.0 p 54.91 31.12 15.2 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 126.165 1.786 . . . . 63.45 113.99 178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -95.27 153.19 39.72 Favored Pre-proline 0 C--O 1.245 0.819 0 N-CA-C 107.702 -1.222 . . . . 73.43 107.702 168.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.49 150.33 60.75 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.657 2.238 . . . . 74.25 112.314 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -59.15 122.02 12.76 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.768 0.827 . . . . 73.44 111.829 -169.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 19.8 tp -107.42 100.68 10.09 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.066 0.947 . . . . 75.42 109.087 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -100.04 104.97 16.59 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.214 -1.032 . . . . 74.01 108.214 172.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.493 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 2.9 mm? -66.57 115.73 6.76 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 109.183 -0.673 . . . . 72.02 109.183 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . 0.446 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -57.24 129.48 79.61 Favored Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 123.294 0.638 . . . . 54.43 112.087 -172.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 1.2 Cg_endo -79.05 117.09 3.8 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.068 2.512 . . . . 74.24 111.243 -175.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 14.8 p -127.03 149.21 31.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 123.697 0.799 . . . . 73.11 109.126 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -69.75 113.73 7.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.908 -0.775 . . . . 75.42 108.908 172.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 . . . . . 0 N--CA 1.481 1.121 0 C-N-CA 123.898 0.879 . . . . 74.34 111.213 -178.637 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 58.5 m . . . . . 0 C--O 1.235 0.295 0 N-CA-C 107.08 -1.452 . . . . 74.14 107.08 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -131.66 118.82 20.55 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.047 -0.724 . . . . 74.43 109.047 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.495 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 0.0 OUTLIER -136.98 131.7 33.3 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 106.603 -1.628 . . . . 75.24 106.603 175.171 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.554 HD12 HG21 ' A' ' 105' ' ' ILE . 6.4 mt -94.38 107.54 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.496 -0.928 . . . . 75.41 108.496 173.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.96 -40.31 68.75 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.519 -0.919 . . . . 74.43 108.519 -176.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 -173.89 122.85 0.33 Allowed 'General case' 0 C--N 1.351 0.655 0 CA-C-N 115.949 -0.569 . . . . 75.44 110.527 -169.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.565 HD13 ' HG3' ' C' ' 130' ' ' PRO . 65.0 mt -106.49 134.72 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 107.979 -1.119 . . . . 74.31 107.979 169.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.481 ' HE1' HG13 ' A' ' 83' ' ' ILE . 30.9 p90 -164.5 178.79 7.14 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 124.165 0.916 . . . . 74.24 110.807 -172.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.1 p -109.47 124.15 50.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.624 -0.716 . . . . 60.22 109.316 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.407 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 42.7 mtpt -86.46 -30.73 21.81 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.66 -0.496 . . . . 75.54 109.66 175.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 31.9 t70 -149.6 145.59 26.86 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.065 -0.97 . . . . 53.22 109.739 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.3 mt -141.02 146.02 24.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 C-N-CA 125.086 1.354 . . . . 74.41 107.835 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.2 t -152.15 137.7 17.76 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.55 0.74 . . . . 72.33 109.791 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.487 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 92.2 t80 -144.42 132.49 21.6 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.993 -1.484 . . . . 75.2 106.993 173.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -133.05 111.75 11.23 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.869 -0.789 . . . . 74.24 108.869 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.511 ' HB1' ' HB3' ' A' ' 28' ' ' ALA . . . -104.36 81.92 0.57 Allowed Pre-proline 0 C--O 1.245 0.817 0 N-CA-C 106.415 -1.698 . . . . 72.33 106.415 161.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.56 -29.05 25.46 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.282 1.988 . . . . 73.13 111.281 -172.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -111.45 19.1 18.53 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-N 114.451 -1.25 . . . . 71.44 109.297 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.511 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . . . -44.83 -49.35 28.17 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 113.633 0.975 . . . . 72.04 113.633 -171.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -59.82 -39.62 70.71 Favored 'Trans proline' 0 C--N 1.392 2.858 0 C-N-CA 121.686 1.591 . . . . 75.12 112.744 176.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.417 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 3.7 m-70 -76.72 -38.04 55.0 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.223 -1.353 . . . . 74.14 110.588 -173.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.443 HG11 ' O ' ' A' ' 28' ' ' ALA . 3.6 p -72.6 -25.68 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 124.563 1.145 . . . . 75.03 111.281 -163.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -76.21 -18.82 58.88 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.557 0.743 . . . . 74.41 110.98 176.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -85.11 -28.21 25.74 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.171 0.989 . . . . 74.54 110.258 173.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 1.3 mmmp? -79.35 159.69 27.04 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.291 1.036 . . . . 74.35 111.735 -173.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.85 119.74 9.96 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.853 0.861 . . . . 65.31 110.353 176.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -82.47 85.18 6.98 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.543 0.687 . . . . 72.03 110.16 -178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.483 ' H ' HD23 ' A' ' 68' ' ' LEU . 8.3 tp-100 -121.07 76.05 30.32 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.673 1.189 . . . . 75.34 108.263 172.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.53 113.11 2.81 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.599 2.199 . . . . 72.31 112.622 -171.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -94.69 92.17 6.88 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.585 -1.265 . . . . 73.3 107.585 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.617 HG23 ' HB1' ' A' ' 66' ' ' ALA . 61.5 t -89.44 106.38 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.718 -1.128 . . . . 64.24 111.037 -173.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -86.45 140.43 29.98 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.372 0.669 . . . . 74.13 110.561 171.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.9 mt -106.67 106.21 16.61 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.038 -1.097 . . . . 74.12 108.038 171.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -107.4 108.59 20.02 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.691 1.196 . . . . 71.2 108.157 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.543 HD12 HG22 ' A' ' 131' ' ' VAL . 83.7 mt -104.25 155.07 19.04 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.692 0.758 . . . . 64.23 112.249 -170.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.451 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 17.3 t70 -158.2 139.45 13.36 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 113.705 -1.589 . . . . 64.52 108.357 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.8 m -138.87 122.25 17.16 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.163 -0.681 . . . . 75.53 109.163 175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.86 111.8 11.91 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.56 0.744 . . . . 71.44 109.213 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 p -91.66 153.1 19.91 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.384 0.674 . . . . 71.32 110.342 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.2 t -149.64 121.21 8.0 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.711 0.804 . . . . 63.24 109.454 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -71.35 112.48 7.52 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.56 -0.533 . . . . 75.43 109.56 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.677 HD12 ' HB2' ' A' ' 57' ' ' GLU . 46.8 mt -81.28 -43.76 18.69 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.128 0.571 . . . . 75.44 109.76 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.77 178.76 8.58 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.282 -0.872 . . . . 74.53 110.074 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.32 129.43 39.89 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 109.311 -0.626 . . . . 74.12 109.311 175.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 63.18 18.75 11.21 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.368 1.067 . . . . 72.03 111.262 -175.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.2 t -130.85 102.53 6.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.821 0 C-N-CA 124.374 1.069 . . . . 74.14 108.576 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -113.74 123.19 49.28 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.524 -1.287 . . . . 74.51 107.524 175.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.677 ' HB2' HD12 ' A' ' 51' ' ' LEU . 32.8 tt0 -85.46 151.38 24.02 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.686 -0.857 . . . . 73.12 108.686 173.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.401 HG11 ' HD3' ' A' ' 103' ' ' PRO . 70.2 t -130.3 135.57 60.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.137 -1.06 . . . . 73.11 108.137 169.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.2 t -117.49 128.35 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.748 -0.834 . . . . 75.21 108.748 173.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.95 100.03 9.55 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 106.769 -1.567 . . . . 72.3 106.769 176.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.504 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 21.0 ttp180 -86.83 101.61 13.51 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.617 -0.883 . . . . 73.4 108.617 173.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 37.3 t -97.85 126.95 50.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 107.442 -1.318 . . . . 74.42 107.442 173.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.6 m -124.05 123.48 40.45 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.499 -0.926 . . . . 75.22 108.499 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.644 HG13 HD21 ' A' ' 126' ' ' LEU . 69.3 t -117.09 135.42 57.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 124.843 1.257 . . . . 75.51 108.472 -174.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.6 m -136.47 127.93 28.54 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 109.657 -0.498 . . . . 65.13 109.657 169.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.617 ' HB1' HG23 ' A' ' 40' ' ' VAL . . . -106.05 128.3 53.76 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 107.025 -1.472 . . . . 75.23 107.025 172.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.1 m -132.21 129.82 40.2 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.05 0.54 . . . . 63.21 110.884 -175.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 37' ' ' GLN . 17.2 mt -89.92 51.48 2.08 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.355 1.462 . . . . 73.44 109.917 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.3 -86.37 1.12 Allowed Glycine 0 C--N 1.349 1.271 0 CA-C-N 116.228 -0.442 . . . . 55.15 113.097 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.42 -28.94 20.58 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.504 0.722 . . . . 73.33 111.044 -177.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -111.69 135.79 51.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.067 0.947 . . . . 71.24 109.181 -174.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.6 m -76.64 134.03 39.42 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.392 -0.596 . . . . 74.14 109.392 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.432 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -77.55 -60.2 2.46 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.436 0.694 . . . . 75.33 109.69 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -153.38 163.22 40.3 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.092 -0.958 . . . . 70.44 111.027 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 tp -126.1 142.63 51.44 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.057 1.343 . . . . 74.03 108.277 173.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.572 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.2 m -137.77 139.49 40.1 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.784 1.234 . . . . 73.25 108.318 176.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -148.7 124.34 10.44 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.955 -0.757 . . . . 72.41 108.955 169.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.5 t -128.66 119.87 51.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 109.041 -0.725 . . . . 71.13 109.041 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.504 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 51.9 mt-30 -92.97 85.5 5.15 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.286 -1.005 . . . . 75.3 108.286 172.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -76.2 94.78 3.58 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 114.363 -1.29 . . . . 63.33 109.183 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.0 145.47 19.27 Favored Glycine 0 C--N 1.341 0.828 0 N-CA-C 111.399 -0.681 . . . . 72.4 111.399 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.12 122.93 1.9 Allowed Glycine 0 CA--C 1.507 -0.415 0 N-CA-C 110.455 -1.058 . . . . 61.23 110.455 -176.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.481 HG13 ' HE1' ' A' ' 17' ' ' TYR . 53.0 mt -80.36 115.83 23.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 107.93 -1.137 . . . . 74.13 107.93 173.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.632 ' HB3' HD11 ' A' ' 86' ' ' ILE . 98.3 m-85 -120.3 123.78 43.98 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.92 -0.77 . . . . 74.43 108.92 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.495 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 17.8 m -86.33 94.28 9.31 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.631 -0.878 . . . . 74.01 108.631 176.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.632 HD11 ' HB3' ' A' ' 84' ' ' PHE . 6.3 mm -109.48 147.98 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 122.151 0.181 . . . . 63.42 110.598 -175.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -172.33 177.84 2.98 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.386 1.075 . . . . 71.25 109.566 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.88 -24.09 27.97 Favored Glycine 0 N--CA 1.467 0.75 0 CA-C-O 120.246 -0.197 . . . . 53.22 113.192 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.54 170.16 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.816 0.846 . . . . 75.41 110.87 -176.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 13.1 tt0 -155.55 179.15 9.45 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.337 -0.847 . . . . 75.04 109.478 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.404 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 59.53 -122.0 28.61 Favored Glycine 0 C--N 1.347 1.165 0 C-N-CA 123.531 0.586 . . . . 74.34 114.033 177.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.8 p -73.04 -30.81 64.0 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.032 0.933 . . . . 65.54 111.887 -176.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -71.19 -37.21 72.13 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.136 0.574 . . . . 74.05 110.189 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.424 ' HE1' ' HG ' ' A' ' 98' ' ' LEU . 4.9 tpt -66.47 -46.44 76.37 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.726 -0.67 . . . . 72.34 109.997 175.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.1 -35.6 75.58 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.654 -0.703 . . . . 65.42 110.798 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -71.12 -35.11 71.64 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.232 0.613 . . . . 74.13 111.327 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -65.12 -44.01 90.11 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 109.437 -0.579 . . . . 73.54 109.437 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.424 ' HG ' ' HE1' ' A' ' 94' ' ' MET . 33.0 mt -82.75 -27.53 31.02 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.213 -0.903 . . . . 75.0 112.534 -175.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.07 4.29 38.52 Favored Glycine 0 N--CA 1.473 1.16 0 CA-C-O 119.689 -0.506 . . . . 73.15 114.124 -171.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.419 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -145.93 -67.67 0.29 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 117.388 0.594 . . . . 75.14 111.503 -176.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -66.97 -47.76 70.58 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 112.506 0.558 . . . . 64.3 112.506 -172.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 86.6 m -64.55 -48.44 74.35 Favored Pre-proline 0 CA--C 1.561 1.397 0 CA-C-O 118.364 -0.827 . . . . 72.51 112.635 -177.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.401 ' HD3' HG11 ' A' ' 58' ' ' VAL . 32.5 Cg_endo -64.42 -24.08 64.45 Favored 'Trans proline' 0 C--N 1.395 2.999 0 C-N-CA 121.671 1.58 . . . . 73.14 112.797 172.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -67.7 -36.67 81.07 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.179 0.592 . . . . 72.31 110.38 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.554 HG21 HD12 ' A' ' 13' ' ' ILE . 44.2 mm -69.37 -42.5 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.635 0.774 . . . . 75.01 110.133 173.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.2 mt -72.41 -23.88 61.16 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.153 -0.931 . . . . 75.52 112.068 -174.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -66.41 -41.33 40.64 Favored Pre-proline 0 N--CA 1.484 1.262 0 N-CA-C 114.306 1.225 . . . . 74.41 114.306 -171.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -50.0 -44.39 37.57 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 121.92 1.746 . . . . 72.22 113.214 168.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -74.67 -36.37 62.8 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.627 0.771 . . . . 74.21 111.709 -177.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.19 -46.65 64.17 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.345 0.658 . . . . 52.13 109.846 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.506 ' NH1' HD13 ' C' ' 105' ' ' ILE . 33.2 ttm105 -49.72 -54.8 16.69 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.812 1.32 . . . . 72.54 109.994 173.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -63.06 -44.26 96.31 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.156 0.91 . . . . 73.41 111.798 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.449 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.6 t -61.79 -31.89 72.14 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.919 0.487 . . . . 73.54 111.432 -179.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.556 HD13 HD12 ' A' ' 128' ' ' LEU . 71.1 mt -71.49 -54.95 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.602 0.761 . . . . 75.15 109.657 172.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 46.2 m -56.32 -35.12 67.21 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.039 1.336 . . . . 72.14 111.605 -173.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.5 t -69.81 -44.24 70.41 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 114.956 -1.02 . . . . 74.25 109.734 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.513 ' HE3' ' HA ' ' A' ' 114' ' ' ILE . 51.7 mtm -63.42 -38.83 92.67 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.886 0.474 . . . . 74.14 110.715 177.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.9 t -61.51 -47.85 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 124.399 1.08 . . . . 74.14 110.475 178.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.8 p -74.24 -34.38 63.62 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.124 0.569 . . . . 60.42 111.393 -175.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.521 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.1 mtt-85 -70.7 -27.22 63.83 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.744 0.818 . . . . 75.44 109.696 174.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.52 7.24 62.06 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.361 -0.836 . . . . 75.24 112.714 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 122' ' ' THR . 36.0 m 72.88 9.21 5.49 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 124.625 1.17 . . . . 70.13 112.083 173.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -83.91 139.91 40.21 Favored Pre-proline 0 C--O 1.244 0.794 0 O-C-N 121.225 -0.922 . . . . 71.43 108.785 173.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -56.31 141.5 88.79 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.282 1.988 . . . . 75.13 110.85 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -56.57 140.43 46.57 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 124.324 1.015 . . . . 72.55 113.08 -165.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.644 HD21 HG13 ' A' ' 64' ' ' VAL . 31.6 tp -119.56 105.29 11.08 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 113.665 -1.607 . . . . 74.55 109.424 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -99.28 118.85 36.87 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 107.941 -1.133 . . . . 75.54 107.941 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.556 HD12 HD13 ' A' ' 114' ' ' ILE . 11.9 mt -70.75 147.14 49.31 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.616 0.573 . . . . 74.1 110.012 -174.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.55 132.52 95.42 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 123.043 0.537 . . . . 71.41 110.329 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.87 116.85 3.81 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.794 2.329 . . . . 71.11 112.221 -176.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.543 HG22 HD12 ' A' ' 44' ' ' LEU . 87.3 t -99.04 130.46 47.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 C-N-CA 123.131 0.572 . . . . 74.1 110.549 -172.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -90.76 89.06 7.33 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 108.324 -0.991 . . . . 65.04 108.324 174.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -65.03 -23.17 67.12 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.512 0.725 . . . . 74.33 112.373 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.419 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 4.0 m-20 -68.31 -39.37 82.03 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.484 0.714 . . . . 64.34 110.29 174.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.88 83.94 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.237 0.615 . . . . 63.24 110.309 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 60.3 mt -65.54 -41.32 93.19 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.033 0.533 . . . . 65.34 111.052 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.7 t80 . . . . . 0 N--CA 1.47 0.561 0 CA-C-N 115.432 -0.803 . . . . 71.04 109.808 178.414 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.565 ' HE2' ' HB2' ' B' ' 11' ' ' PHE . 26.3 ttt . . . . . 0 CA--C 1.562 1.435 0 CA-C-O 121.789 0.804 . . . . 73.21 112.109 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 41.7 m -142.39 101.98 4.0 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 107.262 -1.384 . . . . 60.51 107.262 172.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.565 ' HB2' ' HE2' ' B' ' 9' ' ' MET . 43.0 t80 -123.54 132.96 54.04 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.547 -0.909 . . . . 74.54 108.547 175.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -157.8 140.34 14.64 Favored 'General case' 0 C--O 1.244 0.768 0 O-C-N 123.768 0.667 . . . . 73.22 109.621 171.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.556 HD13 HD11 ' B' ' 16' ' ' ILE . 41.2 mt -67.81 131.52 33.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 114.774 -1.103 . . . . 74.44 109.624 177.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -94.9 -45.41 7.3 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.984 -0.747 . . . . 70.45 108.984 173.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.507 ' HE ' HG21 ' A' ' 122' ' ' THR . 16.4 ttt180 -169.96 131.68 1.06 Allowed 'General case' 0 C--N 1.353 0.725 0 CA-C-N 115.494 -0.775 . . . . 74.24 110.301 -174.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.556 HD11 HD13 ' B' ' 13' ' ' ILE . 93.9 mt -115.11 146.0 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 108.057 -1.09 . . . . 72.31 108.057 174.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -168.31 149.65 5.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 112.813 0.672 . . . . 72.12 112.813 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 46.4 m -76.84 123.82 26.8 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 114.834 -1.075 . . . . 74.31 109.61 170.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.566 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.4 mtpt -96.6 -17.65 20.27 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.602 0.761 . . . . 73.41 111.326 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -164.31 141.84 6.78 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 123.649 0.593 . . . . 41.33 110.406 -174.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.617 HD11 ' SG ' ' B' ' 113' ' ' CYS . 30.5 mm -130.9 144.35 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.062 0.945 . . . . 74.21 108.957 170.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 34.7 t -149.59 140.96 23.24 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.961 -1.018 . . . . 75.03 109.032 174.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -148.2 124.83 11.09 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.07 -1.456 . . . . 74.41 107.07 169.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -132.18 112.92 12.7 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.527 0.731 . . . . 75.22 109.233 -177.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.8 87.69 3.84 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.469 -1.308 . . . . 73.21 107.469 171.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.3 -27.28 34.63 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.532 2.155 . . . . 72.22 112.081 -172.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.505 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 78.6 m-20 -110.4 9.71 23.42 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.069 0.948 . . . . 70.2 110.911 -177.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -30.64 -66.35 0.17 Allowed Pre-proline 0 N--CA 1.493 1.68 0 C-N-CA 125.668 1.587 . . . . 75.54 115.23 -167.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -58.51 -36.27 97.61 Favored 'Trans proline' 0 C--N 1.398 3.173 0 C-N-CA 122.13 1.887 . . . . 72.2 113.266 -174.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -86.63 -37.66 17.83 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.168 -0.924 . . . . 74.41 111.79 -171.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.52 HG22 HD11 ' B' ' 68' ' ' LEU . 8.7 p -71.06 -9.21 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.371 0.668 . . . . 75.51 111.64 -174.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -72.87 -9.52 58.78 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.112 0.565 . . . . 74.2 112.301 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -67.97 -28.89 67.84 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.232 0.613 . . . . 61.11 110.221 171.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.423 ' HB3' ' HB3' ' B' ' 68' ' ' LEU . 30.5 mmtp -81.55 102.19 10.45 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.573 1.149 . . . . 75.14 108.941 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -107.38 87.95 2.62 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 120.956 0.408 . . . . 70.21 110.857 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -169.61 172.08 7.13 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.772 1.229 . . . . 71.01 108.64 169.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.7 117.74 53.71 Favored Pre-proline 0 N--CA 1.479 1.0 0 N-CA-C 109.021 -0.733 . . . . 75.54 109.021 175.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.497 ' HA ' HD21 ' B' ' 68' ' ' LEU . 16.8 Cg_endo -60.52 150.21 82.65 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.245 1.963 . . . . 73.53 112.546 -176.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -70.64 112.31 6.78 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.087 -1.079 . . . . 72.23 108.087 172.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.413 HG12 HD13 ' B' ' 126' ' ' LEU . 59.9 t -105.53 146.79 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 115.361 -0.836 . . . . 72.02 110.818 -172.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -129.78 106.44 8.7 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 106.933 -1.506 . . . . 74.44 106.933 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.476 HD12 HG21 ' B' ' 64' ' ' VAL . 23.6 tp -90.38 125.48 35.56 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.621 -0.511 . . . . 73.53 109.621 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -130.92 155.71 46.31 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.521 1.128 . . . . 71.42 108.112 -178.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.2 162.91 34.28 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.439 0.695 . . . . 63.42 111.547 -173.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.656 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 8.7 m-20 -138.5 126.11 22.08 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.753 1.221 . . . . 74.15 109.394 175.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 7.8 t -114.98 111.14 20.68 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.544 0.687 . . . . 75.25 109.902 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.41 141.85 21.64 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.812 0.845 . . . . 75.34 109.013 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.404 ' HB3' ' HA ' ' B' ' 58' ' ' VAL . 79.0 p -142.07 172.22 12.99 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.571 0.348 . . . . 72.03 111.183 -176.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 54.4 p -151.27 141.37 22.17 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.387 0.675 . . . . 75.35 110.407 -174.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . 0.471 ' HB2' ' CE1' ' B' ' 56' ' ' TYR . 43.5 tt0 -85.98 103.71 14.94 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 109.218 -0.66 . . . . 72.53 109.218 173.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 pp -126.07 24.94 6.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.352 -0.84 . . . . 72.34 109.027 174.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.85 157.67 24.36 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.535 -1.211 . . . . 73.44 109.7 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -83.18 104.47 13.39 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.524 0.73 . . . . 75.35 111.575 -167.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 58.16 23.97 10.81 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 124.696 1.198 . . . . 74.51 111.534 -172.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 85.9 t -131.13 115.85 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 113.788 -1.551 . . . . 60.41 107.288 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.471 ' CE1' ' HB2' ' B' ' 50' ' ' GLN . 0.2 OUTLIER -104.78 140.92 37.38 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.107 0.563 . . . . 74.13 109.769 -174.167 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -100.18 97.64 8.42 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.481 -1.303 . . . . 75.01 107.481 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.404 ' HA ' ' HB3' ' B' ' 48' ' ' SER . 55.3 t -93.06 126.97 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 123.642 0.777 . . . . 74.42 110.078 -177.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.415 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 20.3 t -107.22 142.77 19.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 123.453 0.701 . . . . 74.33 109.426 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.459 HD12 ' HB3' ' B' ' 103' ' ' PRO . 52.7 tp -129.73 108.8 10.46 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.253 -1.017 . . . . 74.54 108.253 171.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.656 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 37.9 ttm180 -87.06 115.34 24.38 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.063 -1.088 . . . . 74.12 108.063 171.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 25.1 t -103.89 119.4 52.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.548 -1.279 . . . . 71.11 107.548 173.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 24.4 m -119.83 128.81 54.04 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.207 -0.664 . . . . 73.34 109.207 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.546 HG22 HG23 ' B' ' 114' ' ' ILE . 84.9 t -117.96 109.55 27.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 123.975 0.91 . . . . 73.11 109.102 -175.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 99.5 m -89.13 138.04 31.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.676 -1.231 . . . . 71.45 107.676 168.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.41 141.09 25.61 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.191 -0.67 . . . . 71.05 109.191 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.409 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 31.9 p -145.28 138.07 26.15 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.522 0.514 . . . . 73.13 111.221 -173.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.52 HD11 HG22 ' B' ' 31' ' ' VAL . 77.7 mt -110.97 102.21 10.71 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.487 1.115 . . . . 74.01 109.159 176.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.77 -137.45 19.47 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.129 -0.788 . . . . 64.33 111.129 -172.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -92.54 3.14 56.11 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 117.405 0.602 . . . . 70.4 110.613 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.505 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 16.7 pt-20 -113.68 151.87 31.23 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.013 0.525 . . . . 74.44 109.654 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 60.7 m -72.88 133.23 44.32 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.119 -0.491 . . . . 73.31 110.216 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.515 ' HA ' HG23 ' B' ' 31' ' ' VAL . . . -84.23 -64.57 1.14 Allowed 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.883 -1.155 . . . . 63.31 107.883 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -155.36 158.88 39.4 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.45 -1.25 . . . . 71.52 110.581 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 53.4 mt -132.35 108.89 9.49 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 106.432 -1.692 . . . . 74.14 106.432 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 48.5 t -119.5 116.34 25.89 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.076 -0.713 . . . . 74.34 109.076 -177.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.401 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 43.9 tt0 -124.67 121.76 35.61 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.761 -0.829 . . . . 74.1 108.761 -175.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' B' ' 110' ' ' ALA . 79.4 t -126.41 135.37 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.89 0.876 . . . . 75.33 109.014 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -107.7 119.77 40.36 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.073 -1.084 . . . . 74.31 108.073 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -110.03 106.01 15.35 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.659 -0.867 . . . . 73.32 108.659 174.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.566 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -98.94 160.81 20.13 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.189 -0.764 . . . . 74.24 111.189 174.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.32 126.2 1.7 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 112.18 -0.368 . . . . 72.41 112.18 -174.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -85.39 114.17 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 N-CA-C 107.718 -1.215 . . . . 74.1 107.718 173.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -129.75 143.66 50.92 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.043 0.937 . . . . 73.03 109.774 -175.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.3 m -88.98 123.3 33.18 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.47 -0.567 . . . . 73.33 109.47 172.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.55 HG22 HD13 ' B' ' 89' ' ' ILE . 4.2 mp -122.98 115.64 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 N-CA-C 108.159 -1.052 . . . . 75.11 108.159 177.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.91 172.64 17.71 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.786 0.835 . . . . 73.0 110.389 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.73 -37.93 3.25 Favored Glycine 0 N--CA 1.481 1.669 0 C-N-CA 123.042 0.353 . . . . 64.13 113.942 172.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.55 HD13 HG22 ' B' ' 86' ' ' ILE . 0.8 OUTLIER -81.15 169.14 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 124.433 1.093 . . . . 73.41 111.87 176.304 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -154.06 175.18 13.73 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.282 -0.872 . . . . 65.53 110.349 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.1 -136.87 27.41 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.802 -0.635 . . . . 72.41 113.221 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.4 m -93.82 -29.16 15.48 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.01 0.524 . . . . 73.13 110.907 -177.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -56.19 -29.55 61.05 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.916 0.887 . . . . 72.13 111.224 175.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.413 ' SD ' ' N ' ' B' ' 95' ' ' ALA . 0.7 OUTLIER -66.8 -57.2 7.53 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.612 1.565 . . . . 75.31 112.592 -179.237 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . 0.413 ' N ' ' SD ' ' B' ' 94' ' ' MET . . . -78.41 -15.12 59.01 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 111.958 0.355 . . . . 72.34 111.958 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -59.51 -30.03 68.28 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.834 0.854 . . . . 74.35 110.499 169.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.411 ' SG ' ' HE3' ' B' ' 9' ' ' MET . 41.9 t -63.48 -55.38 24.59 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.072 0.549 . . . . 74.21 111.774 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.487 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.6 pp -69.45 -31.96 70.6 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.631 0.372 . . . . 73.53 111.961 -174.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.02 -23.77 51.0 Favored Glycine 0 C--N 1.348 1.207 0 O-C-N 123.379 0.424 . . . . 62.42 113.567 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.43 -59.28 1.39 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.054 0.542 . . . . 71.1 112.002 -169.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -64.48 -43.74 93.19 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.266 0.626 . . . . 74.15 111.798 -174.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 79.8 m -65.59 -48.13 65.88 Favored Pre-proline 0 CA--C 1.566 1.58 0 CA-C-O 118.309 -0.853 . . . . 64.13 112.201 -176.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.459 ' HB3' HD12 ' B' ' 60' ' ' LEU . 85.8 Cg_exo -53.47 -34.55 72.4 Favored 'Trans proline' 0 C--N 1.397 3.122 0 C-N-CA 122.557 2.171 . . . . 70.23 113.829 170.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -65.4 -29.47 70.18 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.14 0.576 . . . . 75.13 111.941 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.415 HG22 ' NH2' ' D' ' 111' ' ' ARG . 62.6 mt -71.56 -41.54 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.085 0.554 . . . . 73.52 109.858 174.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.4 mt -78.3 -29.87 48.06 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 114.79 -1.096 . . . . 74.43 112.453 -169.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -55.67 -49.6 91.82 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-O 117.739 -1.124 . . . . 74.33 113.304 -174.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -48.12 -47.51 19.23 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 122.907 2.405 . . . . 54.31 114.695 176.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -65.01 -46.27 82.1 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.137 0.575 . . . . 75.43 110.931 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.512 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -62.41 -39.54 93.61 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.204 -0.907 . . . . 63.42 110.698 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.461 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 52.3 ttt-85 -62.92 -47.06 84.9 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.552 1.541 . . . . 74.41 111.213 -176.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.23 -34.95 73.49 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.598 0.561 . . . . 72.53 110.09 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.617 ' SG ' HD11 ' B' ' 21' ' ' ILE . 8.8 t -68.58 -36.61 78.96 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.612 -0.267 . . . . 75.24 111.082 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.546 HG23 HG22 ' B' ' 64' ' ' VAL . 85.0 mt -59.49 -53.65 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.745 0.818 . . . . 73.44 109.897 169.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 54.5 m -57.13 -32.54 66.46 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.654 0.781 . . . . 73.22 111.546 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.477 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 42.8 t -63.79 -49.8 71.5 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.666 0.786 . . . . 72.33 109.891 174.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.554 ' HE2' HG22 ' B' ' 21' ' ' ILE . 12.5 mmt -70.67 -30.76 67.45 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.096 0.558 . . . . 73.24 111.54 -175.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.482 HG23 ' O ' ' B' ' 114' ' ' ILE . 95.3 t -66.35 -41.74 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.667 0.787 . . . . 75.14 109.704 173.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.2 t -65.83 -32.22 73.62 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.879 -1.055 . . . . 64.42 110.804 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.478 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 88.1 mtt-85 -70.02 -34.71 73.64 Favored 'General case' 0 C--O 1.206 -1.23 0 CA-C-N 115.782 -0.644 . . . . 74.2 110.179 176.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.05 -13.89 82.77 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.428 0.455 . . . . 71.52 112.364 170.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.6 m 69.55 24.1 5.73 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 125.125 1.37 . . . . 72.11 110.519 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.483 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 71.5 m-85 -77.57 159.05 77.87 Favored Pre-proline 0 N--CA 1.477 0.91 0 CA-C-N 114.875 -1.057 . . . . 74.14 110.366 175.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.14 158.56 4.99 Favored 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 123.204 2.603 . . . . 62.25 113.794 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.433 HE21 ' ND2' ' B' ' 127' ' ' ASN . 42.6 tp60 -62.14 126.35 27.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.71 0.804 . . . . 74.41 112.459 -170.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.447 HD23 HG12 ' B' ' 64' ' ' VAL . 39.6 tp -109.81 101.13 10.02 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-N 115.225 -0.898 . . . . 63.25 109.131 178.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . 0.433 ' ND2' HE21 ' B' ' 125' ' ' GLN . 21.6 m-80 -99.25 105.69 17.74 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 107.187 -1.412 . . . . 71.24 107.187 167.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.461 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 46.8 mt -63.64 127.88 33.34 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.332 -0.618 . . . . 75.21 109.332 175.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.01 148.47 92.47 Favored Pre-proline 0 CA--C 1.553 1.078 0 O-C-N 123.775 0.672 . . . . 60.52 111.225 -175.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -69.57 90.3 0.5 Allowed 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.872 2.381 . . . . 72.2 111.863 -174.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 81.9 t -95.45 109.75 23.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.611 -0.885 . . . . 73.22 108.611 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 41.7 t30 . . . . . 0 C--O 1.24 0.6 0 N-CA-C 107.549 -1.278 . . . . 71.55 107.549 171.691 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 66.6 t80 . . . . . 0 N--CA 1.471 0.586 0 N-CA-C 107.317 -1.364 . . . . 74.0 107.317 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -141.27 136.03 31.23 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 120.919 0.39 . . . . 74.43 110.177 175.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.444 HG12 ' HE2' ' C' ' 84' ' ' PHE . 16.2 mt -75.92 120.11 25.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 115.083 -0.962 . . . . 73.25 108.407 174.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.525 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.0 mm-40 -87.88 -39.08 15.1 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 123.639 0.587 . . . . 75.44 109.486 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.3 ptt-85 177.96 153.86 0.31 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.513 1.125 . . . . 74.25 110.392 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 70.7 mt -135.05 125.69 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.179 1.391 . . . . 74.3 107.262 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.442 ' HB3' HG22 ' D' ' 122' ' ' THR . 29.8 p90 -164.42 158.68 18.73 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.229 0.538 . . . . 75.42 111.408 -166.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.7 p -87.8 109.63 19.88 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.455 -0.793 . . . . 74.23 110.164 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.463 ' HD2' ' HB2' ' D' ' 28' ' ' ALA . 13.8 mtmt -82.39 -16.68 48.2 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 110.069 -0.345 . . . . 74.42 110.069 172.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.677 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.4 t70 -153.7 139.01 17.53 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.862 -0.608 . . . . 71.44 109.911 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.6 mt -141.57 145.75 24.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 106.57 -1.641 . . . . 74.3 106.57 173.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.4 t -157.23 144.99 18.98 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.262 0.553 . . . . 74.12 110.2 173.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -142.93 129.68 20.4 Favored 'General case' 0 C--O 1.225 -0.208 0 N-CA-C 107.054 -1.462 . . . . 74.11 107.054 170.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -135.73 112.56 10.2 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.24 -0.652 . . . . 73.25 109.24 -175.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.25 85.73 5.77 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 106.981 -1.488 . . . . 42.34 106.981 168.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.26 -19.96 37.81 Favored 'Trans proline' 0 C--N 1.383 2.38 0 C-N-CA 122.69 2.26 . . . . 64.22 111.874 -174.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -120.02 31.01 6.71 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.332 1.053 . . . . 74.43 109.022 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.56 -60.63 2.77 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 114.24 1.2 . . . . 73.25 114.24 -170.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.21 -32.71 41.84 Favored 'Trans proline' 0 C--N 1.379 2.152 0 CA-C-N 121.34 1.514 . . . . 75.15 111.926 -177.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.472 ' HA ' HE21 ' C' ' 33' ' ' GLN . 81.4 t60 -69.32 -38.34 78.18 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.662 -1.153 . . . . 73.13 111.986 -177.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.598 HG21 ' HA ' ' C' ' 73' ' ' ALA . 13.9 p -79.08 -29.55 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 112.075 0.398 . . . . 73.13 112.075 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -62.61 -30.01 71.03 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.013 0.525 . . . . 62.13 112.383 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . 0.472 HE21 ' HA ' ' C' ' 30' ' ' HIS . 29.3 pt20 -88.59 7.13 34.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.201 0.6 . . . . 72.34 111.949 178.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.42 ' HG2' HD11 ' C' ' 68' ' ' LEU . 2.8 ttpm? -114.71 143.2 45.43 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.659 0.783 . . . . 65.42 110.076 175.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.66 131.79 49.06 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.559 1.144 . . . . 72.11 111.985 -175.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . 0.406 ' HZ2' HD22 ' C' ' 126' ' ' LEU . 75.3 t-105 -74.41 87.58 2.05 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.653 1.181 . . . . 73.32 111.683 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -132.91 73.05 76.27 Favored Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 124.253 1.021 . . . . 75.32 108.732 169.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -91.39 148.92 3.57 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.816 2.344 . . . . 73.42 112.598 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -88.25 81.12 7.38 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 107.268 -1.382 . . . . 72.11 107.268 164.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.54 113.3 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 CA-C-N 114.911 -1.041 . . . . 73.34 109.964 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -94.02 101.31 13.35 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.561 -0.903 . . . . 73.42 108.561 175.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 tt -87.81 129.82 35.07 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 106.97 -1.493 . . . . 74.55 106.97 176.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.523 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 14.2 t70 -128.93 140.56 51.61 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.08 0.952 . . . . 64.41 109.477 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.494 HD22 HG21 ' C' ' 62' ' ' VAL . 45.5 mt -125.95 111.12 14.4 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.616 -0.883 . . . . 73.4 108.616 172.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -122.46 121.32 36.33 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 107.74 -1.207 . . . . 73.31 107.74 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.3 t -121.32 144.18 48.78 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.324 -0.621 . . . . 65.23 109.324 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.99 151.56 42.62 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.907 0.883 . . . . 74.45 108.729 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 56.7 p -138.06 143.4 40.47 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 122.863 0.465 . . . . 71.25 110.304 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 78.9 p -145.41 153.52 41.29 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.545 0.738 . . . . 75.4 110.006 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -81.94 118.02 22.63 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 109.035 -0.728 . . . . 75.14 109.035 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.564 HD13 ' HB2' ' C' ' 57' ' ' GLU . 87.5 mt -82.89 -53.14 6.08 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.32 0.648 . . . . 55.42 109.288 174.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.15 -172.59 3.52 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 114.206 -1.361 . . . . 74.14 109.14 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.44 107.73 1.44 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.702 0.801 . . . . 74.03 110.068 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 70.69 12.62 7.27 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.367 1.467 . . . . 63.52 112.683 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 90.4 t -110.55 118.92 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.064 -0.717 . . . . 72.42 109.064 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -121.5 129.98 53.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.621 1.169 . . . . 72.54 109.343 -174.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.564 ' HB2' HD13 ' C' ' 51' ' ' LEU . 44.8 tt0 -96.77 115.09 26.84 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.208 -0.664 . . . . 74.31 109.208 170.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 89.1 t -96.76 116.01 37.76 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 N-CA-C 107.894 -1.151 . . . . 74.14 107.894 169.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.441 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 61.0 t -103.76 131.53 52.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.882 -0.785 . . . . 74.42 108.882 173.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.424 HD23 HD23 ' C' ' 44' ' ' LEU . 0.1 OUTLIER -104.47 98.51 8.27 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 107.709 -1.219 . . . . 74.24 107.709 172.727 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -82.44 106.78 14.59 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.525 -0.917 . . . . 75.41 108.525 172.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.494 HG21 HD22 ' C' ' 44' ' ' LEU . 12.8 t -104.61 125.19 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.906 -0.775 . . . . 64.1 108.906 177.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.523 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 89.9 m -110.23 130.7 55.5 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.94 -0.763 . . . . 54.32 108.94 178.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.66 HG23 HG21 ' C' ' 114' ' ' ILE . 97.4 t -124.37 109.05 21.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.506 -0.924 . . . . 52.34 108.506 174.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.8 m -101.56 141.89 33.75 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.824 -0.806 . . . . 72.41 108.824 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.21 117.96 18.92 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.266 -1.012 . . . . 73.51 108.266 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 37.3 m -140.03 125.99 19.64 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.201 0.313 . . . . 72.31 111.297 -177.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.42 HD11 ' HG2' ' C' ' 34' ' ' LYS . 21.2 mt -87.9 46.63 1.4 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.728 1.211 . . . . 70.34 110.138 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.94 -114.45 4.65 Favored Glycine 0 C--N 1.344 1.011 0 N-CA-C 110.519 -1.033 . . . . 64.55 110.519 -170.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.18 -12.53 37.88 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.25 0.62 . . . . 73.4 110.395 174.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -75.27 121.33 22.02 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 124.359 1.064 . . . . 72.12 109.678 174.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.1 m -82.58 115.9 21.75 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 108.685 -0.858 . . . . 71.01 108.685 165.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.598 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -69.96 -48.57 57.83 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.148 -1.056 . . . . 64.33 108.148 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -168.22 172.11 8.85 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 114.316 -1.311 . . . . 73.14 111.27 175.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.407 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.9 tm? -127.56 144.51 51.06 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 106.667 -1.605 . . . . 72.31 106.667 166.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.407 ' N ' HD13 ' C' ' 75' ' ' LEU . 54.1 t -145.86 145.86 30.9 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.71 -0.848 . . . . 73.05 108.71 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -158.81 140.28 13.31 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.762 -0.459 . . . . 75.45 109.762 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' C' ' 110' ' ' ALA . 27.0 t -135.81 114.39 15.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 124.65 1.18 . . . . 73.32 107.875 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.677 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.4 mt-30 -94.27 89.07 5.79 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.951 -0.759 . . . . 75.55 108.951 171.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -79.96 96.47 6.42 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.576 -1.193 . . . . 74.45 109.108 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -82.78 145.09 23.42 Favored Glycine 0 C--N 1.343 0.945 0 N-CA-C 111.425 -0.67 . . . . 70.53 111.425 177.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.05 117.68 1.09 Allowed Glycine 0 CA--C 1.507 -0.42 0 N-CA-C 111.028 -0.829 . . . . 73.44 111.028 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 15.5 mm -86.01 131.44 34.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.859 -0.793 . . . . 74.35 108.859 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.444 ' HE2' HG12 ' C' ' 13' ' ' ILE . 94.6 m-85 -137.8 120.54 16.31 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.667 0.787 . . . . 75.42 109.913 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 17.1 p -79.9 100.51 8.09 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 108.282 -1.007 . . . . 64.42 108.282 170.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.559 HG23 ' HE1' ' C' ' 94' ' ' MET . 15.6 mt -114.3 140.28 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 123.168 0.587 . . . . 73.3 109.698 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.96 158.27 36.28 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.512 1.125 . . . . 74.32 109.315 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.01 -18.54 57.25 Favored Glycine 0 C--O 1.246 0.903 0 N-CA-C 115.761 1.064 . . . . 62.02 115.761 166.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 13.5 pt -106.98 170.53 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 117.315 0.558 . . . . 74.0 111.225 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -157.68 151.19 23.74 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.328 0.651 . . . . 74.02 110.65 -175.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.73 -121.99 10.02 Favored Glycine 0 C--N 1.348 1.213 0 O-C-N 123.929 0.768 . . . . 73.24 113.647 171.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.1 p -62.16 -30.56 71.14 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.836 0.855 . . . . 73.44 111.617 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -69.98 -49.94 46.65 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.315 1.046 . . . . 72.3 111.137 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.559 ' HE1' HG23 ' C' ' 86' ' ' ILE . 0.4 OUTLIER -60.04 -46.28 90.04 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 124.105 0.878 . . . . 74.22 110.429 176.749 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.39 90.92 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.477 0.711 . . . . 64.34 111.226 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -69.44 -35.88 76.11 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.221 0.609 . . . . 75.02 110.697 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.491 ' SG ' HD12 ' C' ' 86' ' ' ILE . 33.8 t -66.83 -51.28 57.51 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.871 0.732 . . . . 74.04 109.291 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 68.7 mt -74.85 -35.52 62.37 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.354 1.062 . . . . 75.34 113.063 -177.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.37 -14.05 33.97 Favored Glycine 0 N--CA 1.473 1.135 0 N-CA-C 115.032 0.773 . . . . 63.41 115.032 -165.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' C' ' 137' ' ' PHE . . . -138.01 -49.05 0.56 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 117.854 0.827 . . . . 60.41 111.944 -173.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -73.12 -49.95 25.51 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.951 0.901 . . . . 75.41 111.633 -172.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 84.5 m -67.25 -47.49 49.71 Favored Pre-proline 0 CA--C 1.564 1.516 0 C-N-CA 123.478 0.711 . . . . 74.14 112.233 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -58.19 -27.8 81.74 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 122.464 2.109 . . . . 74.4 113.552 175.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -65.68 -38.27 88.79 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.188 0.595 . . . . 61.2 110.543 176.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.506 HD13 ' NH1' ' A' ' 111' ' ' ARG . 30.1 mm -71.01 -36.94 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 116.029 -0.532 . . . . 75.02 109.732 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 6.1 mp -79.19 -25.5 42.75 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.431 1.092 . . . . 75.41 112.768 -176.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . 0.41 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 56.6 t80 -57.23 -50.71 86.62 Favored Pre-proline 0 N--CA 1.479 0.997 0 CA-C-O 117.849 -1.072 . . . . 73.44 113.394 -172.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 38.7 Cg_exo -60.71 -34.21 92.19 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.016 1.81 . . . . 72.52 113.158 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -64.7 -47.87 76.75 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.226 0.61 . . . . 71.12 110.633 177.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.433 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -66.73 -35.51 80.29 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.775 -0.648 . . . . 54.54 110.788 177.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -61.31 -53.13 60.64 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.246 1.418 . . . . 74.42 110.593 -178.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . 0.41 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.7 tm-20 -66.07 -34.31 77.78 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.403 -0.817 . . . . 74.21 110.28 -178.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.0 t -67.06 -39.17 86.82 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.06 0.544 . . . . 74.21 111.099 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.66 HG21 HG23 ' C' ' 64' ' ' VAL . 87.1 mt -69.17 -50.78 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.371 0.669 . . . . 74.15 110.579 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.2 m -64.14 -28.69 69.94 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 123.486 0.491 . . . . 70.44 110.476 -176.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.4 t -64.44 -51.82 61.21 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 123.57 0.748 . . . . 71.52 109.704 171.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.562 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -50.33 -47.92 55.63 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 124.361 1.064 . . . . 73.03 112.013 177.101 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 91.8 t -67.95 -38.83 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 124.228 1.011 . . . . 73.43 111.12 -177.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 77.6 p -72.7 -30.44 64.21 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.188 0.595 . . . . 73.53 111.44 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' C' ' 116' ' ' SER . 86.8 mtt-85 -67.82 -39.83 83.86 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.239 1.016 . . . . 72.12 110.252 175.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.84 7.23 59.66 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-N 115.295 -0.866 . . . . 62.51 112.659 174.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 29.9 p 62.59 26.87 15.93 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.567 1.947 . . . . 75.11 113.46 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -87.3 152.29 52.41 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 107.821 -1.177 . . . . 71.15 107.821 166.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.17 169.11 6.61 Favored 'Trans proline' 0 C--N 1.369 1.653 0 C-N-CA 122.783 2.322 . . . . 72.32 113.383 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' B' ' 123' ' ' PHE . 57.4 mm-40 -59.86 113.46 2.29 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.405 -1.27 . . . . 74.03 112.485 -177.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.406 HD22 ' HZ2' ' C' ' 36' ' ' TRP . 63.6 mt -107.33 87.92 2.61 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.965 -1.124 . . . . 65.25 107.965 168.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -89.94 112.65 24.1 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.925 -1.139 . . . . 75.44 107.925 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.449 HD12 HD13 ' C' ' 114' ' ' ILE . 40.2 mt -64.73 129.64 40.56 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 123.434 0.459 . . . . 72.4 110.686 -175.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.53 150.65 93.75 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.571 0.748 . . . . 64.52 110.468 178.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.565 ' HG3' HD13 ' A' ' 16' ' ' ILE . 26.8 Cg_exo -59.81 105.39 0.27 Allowed 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.34 2.027 . . . . 72.3 112.268 174.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 35.7 t -99.52 117.36 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 108.12 -1.067 . . . . 65.43 108.12 176.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -77.08 103.37 6.97 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.826 0.85 . . . . 74.33 110.515 -172.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -65.78 -24.98 67.05 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.63 -0.714 . . . . 75.34 111.654 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -67.1 -40.07 86.83 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.327 0.651 . . . . 74.43 109.973 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.8 -45.79 91.01 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.362 0.665 . . . . 64.34 110.509 174.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 81.2 mt -69.34 -23.46 63.77 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.043 -0.98 . . . . 74.25 111.388 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . 0.444 ' HB2' ' HB3' ' C' ' 100' ' ' ALA . 79.1 t80 . . . . . 0 C--O 1.217 -0.61 0 CA-C-N 116.313 -0.403 . . . . 74.13 110.104 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 24.3 m . . . . . 0 C--O 1.235 0.3 0 N-CA-C 109.168 -0.679 . . . . 74.22 109.168 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.497 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 50.6 t80 -133.98 98.61 4.2 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.457 -1.312 . . . . 72.4 107.457 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -132.51 127.97 36.33 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.257 -0.646 . . . . 72.14 109.257 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 6.1 mt -83.88 127.22 39.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 108.572 -0.899 . . . . 72.31 108.572 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . 0.516 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 75.1 mm-40 -81.96 -35.21 29.25 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.478 0.711 . . . . 73.32 110.302 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -171.25 133.8 0.87 Allowed 'General case' 0 C--N 1.357 0.914 0 O-C-N 123.737 0.648 . . . . 74.31 110.7 -175.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.459 ' N ' HD13 ' D' ' 16' ' ' ILE . 3.4 mp -105.57 141.85 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 107.144 -1.428 . . . . 72.34 107.144 171.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -166.72 152.92 8.45 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.438 0.637 . . . . 74.11 111.7 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 71.3 p -89.14 117.29 28.03 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 114.882 -1.054 . . . . 73.32 109.702 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -86.56 -29.74 22.42 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.652 -0.704 . . . . 63.54 109.371 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.594 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.6 t70 -150.87 142.15 23.28 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.815 -1.084 . . . . 65.31 109.589 176.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.562 HG23 ' HE1' ' C' ' 117' ' ' MET . 76.7 mt -140.73 141.07 32.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 C-N-CA 125.367 1.467 . . . . 72.02 107.402 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.7 t -147.21 144.29 28.81 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.681 0.793 . . . . 73.24 109.54 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.492 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.6 t80 -147.51 134.42 20.2 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 107.301 -1.37 . . . . 75.43 107.301 168.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.636 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 43.6 mt-10 -133.33 148.69 51.89 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.13 0.972 . . . . 74.1 108.954 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.73 80.07 6.92 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 107.44 -1.319 . . . . 55.23 107.44 171.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -67.46 -52.38 0.59 Allowed 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.545 2.163 . . . . 72.52 112.385 -174.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -87.61 19.63 3.31 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.457 0.703 . . . . 73.11 111.05 -176.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.463 ' HB2' ' HD2' ' C' ' 19' ' ' LYS . . . -48.26 -61.09 3.45 Favored Pre-proline 0 CA--C 1.556 1.201 0 N-CA-C 114.826 1.417 . . . . 73.22 114.826 -164.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.52 ' HB3' HD11 ' C' ' 83' ' ' ILE . 60.2 Cg_endo -68.13 -20.5 43.7 Favored 'Trans proline' 0 C--N 1.388 2.617 0 CA-C-N 121.704 1.644 . . . . 73.42 113.288 -173.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.402 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 6.1 t-160 -81.83 -40.72 22.09 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.987 -1.006 . . . . 75.03 110.795 177.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -83.12 -16.06 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 O-C-N 122.246 -0.284 . . . . 73.43 111.424 -169.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -62.58 -16.85 58.45 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 112.529 0.566 . . . . 75.45 112.529 170.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . 0.402 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 56.8 mt-30 -69.12 -7.68 38.36 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.717 0.807 . . . . 73.14 111.424 174.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.587 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 91.4 mttt -106.27 100.57 10.1 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.797 1.239 . . . . 72.23 109.638 -178.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -97.86 92.77 5.99 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.775 0.83 . . . . 72.03 110.327 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -167.09 -178.34 4.12 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.033 0.933 . . . . 74.31 109.918 171.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -69.64 113.14 14.99 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.132 0.973 . . . . 74.03 109.841 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -58.84 125.89 19.56 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.46 2.106 . . . . 64.12 111.239 176.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -76.75 114.09 15.12 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.085 -1.08 . . . . 72.32 108.085 173.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.569 HG12 HD21 ' D' ' 126' ' ' LEU . 9.0 t -112.69 129.79 67.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.886 -0.597 . . . . 75.31 110.341 -171.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.59 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 72.0 mmtt -88.6 108.51 19.48 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.979 -1.119 . . . . 74.3 107.979 168.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 42.5 tp -98.52 121.08 40.02 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.785 -0.82 . . . . 74.34 108.785 173.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.497 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 8.8 t0 -120.38 143.99 48.14 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.009 -1.478 . . . . 70.21 107.009 177.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 58.1 mt -133.84 129.67 36.8 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.495 0.718 . . . . 74.52 109.577 -175.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.422 ' HB2' ' HB3' ' D' ' 61' ' ' ARG . 54.0 m-20 -134.56 145.67 48.93 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.708 -1.219 . . . . 72.22 107.708 173.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 7.1 t -105.03 161.15 14.46 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.788 -0.819 . . . . 72.21 108.788 169.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.625 ' HB1' ' HB ' ' D' ' 59' ' ' VAL . . . -149.83 152.68 35.53 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.945 0.898 . . . . 74.32 108.649 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.471 0.579 0 C-N-CA 123.35 0.66 . . . . 65.44 110.037 -179.704 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . 0.4 ' HA ' ' HE1' ' D' ' 56' ' ' TYR . 61.8 m-20 . . . . . 0 N--CA 1.487 1.391 0 N-CA-C 113.36 0.874 . . . . 64.25 113.36 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 15.7 t -124.26 98.65 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 107.89 -1.152 . . . . 74.25 107.89 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.4 ' HE1' ' HA ' ' D' ' 54' ' ' ASP . 30.2 m-85 -115.63 135.01 54.48 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.075 0.55 . . . . 74.4 109.742 -174.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.442 ' HG2' HD12 ' D' ' 83' ' ' ILE . 39.4 mt-10 -90.62 114.06 26.24 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.068 -1.086 . . . . 73.24 108.068 162.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 88.7 t -103.19 140.08 22.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.849 -1.167 . . . . 74.32 107.849 168.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.625 ' HB ' ' HB1' ' D' ' 47' ' ' ALA . 41.7 t -133.56 146.97 31.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 107.625 -1.25 . . . . 73.13 107.625 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.63 115.91 20.19 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.63 -1.248 . . . . 64.12 107.63 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.422 ' HB3' ' HB2' ' D' ' 45' ' ' ASP . 24.8 ttm-85 -93.07 98.56 11.41 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.046 -1.094 . . . . 74.22 108.046 175.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.457 HG22 ' HB1' ' D' ' 110' ' ' ALA . 49.4 t -99.12 112.72 32.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.785 -0.82 . . . . 75.51 108.785 176.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 63.9 m -105.72 134.21 49.2 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.75 -1.114 . . . . 74.54 109.206 -175.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.464 HG22 HD12 ' D' ' 114' ' ' ILE . 71.5 t -131.63 119.75 43.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 124.287 1.035 . . . . 74.14 108.556 -177.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.59 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 24.1 m -126.49 90.76 3.23 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.757 -1.201 . . . . 75.0 107.757 177.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -97.37 146.43 25.18 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.831 -0.622 . . . . 73.41 110.136 -174.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.473 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 31.4 p -147.31 139.93 24.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 123.871 0.732 . . . . 75.14 110.97 -173.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 24.0 mt -112.08 112.89 24.84 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 107.755 -1.202 . . . . 75.22 107.755 171.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.73 -114.29 3.8 Favored Glycine 0 C--N 1.347 1.14 0 N-CA-C 113.692 0.237 . . . . 62.43 113.692 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.06 12.53 11.95 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.345 0.658 . . . . 64.53 110.487 -178.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.587 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 10.9 pt-20 -130.52 162.37 29.41 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.024 0.53 . . . . 73.14 109.63 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -71.89 130.41 40.95 Favored 'General case' 0 C--O 1.243 0.721 0 O-C-N 123.809 0.693 . . . . 70.33 110.71 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.473 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -81.68 -65.24 1.04 Allowed 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.648 -1.241 . . . . 65.25 107.648 172.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -151.61 150.22 30.04 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.132 -0.94 . . . . 73.53 111.125 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.636 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 63.4 mt -108.55 153.94 22.65 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.516 1.126 . . . . 75.12 108.765 171.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.491 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.2 t -160.33 142.53 12.94 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.086 0.555 . . . . 63.22 109.796 174.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -154.9 126.15 7.27 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.943 -0.392 . . . . 75.44 109.943 171.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.0 t -125.76 117.03 48.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 123.771 0.828 . . . . 73.35 109.187 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.594 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.6 mt-30 -90.23 86.94 6.65 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.816 -0.809 . . . . 75.52 108.816 172.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.14 110.5 15.61 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.181 -1.372 . . . . 73.05 109.342 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.39 173.03 17.5 Favored Glycine 0 C--N 1.338 0.659 0 O-C-N 123.067 0.23 . . . . 45.24 113.468 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.74 152.83 14.6 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 115.735 -0.233 . . . . 73.44 112.937 177.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 19.3 mm -90.19 115.72 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 107.997 -1.112 . . . . 75.52 107.997 173.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -112.65 135.08 53.8 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.759 0.823 . . . . 74.22 110.326 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 39.3 t -102.11 106.96 17.91 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.817 -0.808 . . . . 74.54 108.817 172.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 42.9 pt -121.34 132.84 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.104 -0.702 . . . . 75.05 109.104 173.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.87 165.61 22.66 Favored 'General case' 0 C--O 1.243 0.744 0 O-C-N 123.448 0.468 . . . . 73.23 111.796 -173.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.27 -4.63 83.19 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.15 -0.932 . . . . 64.02 114.015 177.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -104.57 163.34 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 121.365 0.602 . . . . 74.12 110.665 -177.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.445 ' HG2' ' H ' ' D' ' 91' ' ' GLY . 29.6 tt0 -148.05 174.34 12.02 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 114.453 -1.249 . . . . 74.33 108.639 -173.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . 0.445 ' H ' ' HG2' ' D' ' 90' ' ' GLU . . . 77.6 -140.9 24.91 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 123.218 0.437 . . . . 74.03 112.628 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 60.8 p -90.48 -29.64 17.8 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.212 0.605 . . . . 74.01 110.838 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.486 ' HA ' ' HB3' ' D' ' 96' ' ' HIS . 20.7 pt20 -64.63 -23.66 67.33 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.744 0.818 . . . . 74.24 112.401 -173.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.482 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 0.0 OUTLIER -64.78 -43.37 93.47 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.101 0.56 . . . . 74.2 111.327 178.054 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . 0.482 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.15 -17.33 37.55 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.477 0.711 . . . . 75.13 111.406 177.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . 0.486 ' HB3' ' HA ' ' D' ' 93' ' ' GLN . 78.1 t60 -73.89 -37.58 64.64 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.67 0.788 . . . . 74.53 110.608 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 71.1 m -60.71 -34.91 75.09 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.947 0.499 . . . . 64.3 110.74 174.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.407 HD21 ' HA ' ' D' ' 98' ' ' LEU . 1.1 tm? -75.42 -43.45 49.82 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.264 1.026 . . . . 74.14 110.508 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.4 -26.68 60.93 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 115.565 -0.743 . . . . 74.3 114.06 -173.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -122.37 -59.02 1.67 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.026 0.53 . . . . 71.42 112.028 -169.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -71.04 -37.81 72.55 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 112.13 0.418 . . . . 74.22 112.13 -170.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.497 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 73.9 m -66.58 -47.76 56.28 Favored Pre-proline 0 CA--C 1.568 1.657 0 CA-C-O 118.723 -0.656 . . . . 71.13 111.943 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 51.8 Cg_exo -58.9 -33.3 98.57 Favored 'Trans proline' 0 C--N 1.394 2.948 0 C-N-CA 122.052 1.834 . . . . 75.3 113.372 170.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -64.22 -35.13 79.79 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.802 0.441 . . . . 75.42 110.849 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 24.1 mm -63.91 -39.52 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.08 0.952 . . . . 72.14 110.71 173.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 85.7 mt -78.13 -14.59 59.41 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.474 -0.784 . . . . 74.34 112.222 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -72.16 -40.68 7.76 Favored Pre-proline 0 N--CA 1.486 1.334 0 N-CA-C 113.497 0.925 . . . . 71.55 113.497 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -47.68 -49.06 14.22 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.351 2.034 . . . . 65.45 113.298 166.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -71.6 -35.15 70.41 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.43 0.692 . . . . 74.42 111.535 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . 0.457 ' HB1' HG22 ' D' ' 62' ' ' VAL . . . -64.81 -57.46 8.83 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.713 0.805 . . . . 73.44 110.185 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.415 ' NH2' HG22 ' B' ' 105' ' ' ILE . 39.5 ttp180 -56.72 -42.2 78.77 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 114.332 -1.304 . . . . 71.44 110.761 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -56.78 -54.62 44.26 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.891 0.744 . . . . 74.25 110.727 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.4 t -54.87 -45.32 74.58 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.291 0.995 . . . . 74.5 110.867 -177.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.491 HG12 ' SG ' ' D' ' 76' ' ' CYS . 85.1 mt -61.16 -58.54 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.67 0.788 . . . . 73.05 110.923 176.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.7 m -51.87 -43.87 63.46 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.932 1.293 . . . . 75.03 111.598 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 33.3 t -63.79 -44.72 92.53 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 114.505 -1.225 . . . . 73.35 109.826 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 68.1 mtm -69.82 -30.88 68.5 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.034 0.534 . . . . 71.11 111.613 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 80.3 t -64.4 -45.96 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.582 0.753 . . . . 75.44 109.573 175.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 95.2 p -74.4 -28.32 61.04 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.451 -0.795 . . . . 75.13 110.722 -178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' D' ' 116' ' ' SER . 69.4 mtt-85 -70.26 -27.12 64.19 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.53 0.732 . . . . 73.01 109.932 173.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.75 10.5 67.44 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 123.804 0.69 . . . . 72.33 112.887 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.442 HG22 ' HB3' ' C' ' 17' ' ' TYR . 68.8 p 53.79 29.41 9.63 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 126.113 1.765 . . . . 73.2 113.561 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -92.47 158.49 38.53 Favored Pre-proline 0 C--O 1.242 0.688 0 CA-C-N 115.449 -0.796 . . . . 71.14 109.737 171.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -48.16 119.96 4.48 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.768 2.312 . . . . 74.41 112.113 169.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -46.54 124.51 5.99 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 124.72 1.262 . . . . 74.32 111.757 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.569 HD21 HG12 ' D' ' 40' ' ' VAL . 33.7 tp -107.5 98.69 8.27 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.962 0.41 . . . . 74.12 111.042 -173.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . 0.404 ' ND2' ' H ' ' B' ' 16' ' ' ILE . 83.4 m-20 -97.98 96.85 8.44 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 107.11 -1.441 . . . . 75.43 107.11 173.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.05 132.56 54.33 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.519 -0.764 . . . . 75.13 109.481 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.16 136.72 96.82 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 122.714 0.405 . . . . 71.31 110.45 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.538 ' HD3' HG13 ' B' ' 13' ' ' ILE . 93.8 Cg_endo -79.55 145.79 18.72 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.577 2.184 . . . . 75.14 111.864 -174.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 9.0 p -141.24 141.1 31.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 109.003 -0.74 . . . . 73.43 109.003 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -78.95 108.61 12.55 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.676 -0.861 . . . . 74.34 108.676 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 . . . . . 0 N--CA 1.484 1.232 0 C-N-CA 123.391 0.676 . . . . 72.42 110.346 178.261 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 63.0 m . . . . . 0 CA--C 1.532 0.273 0 N-CA-C 106.496 -1.668 . . . . 75.14 106.496 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -137.45 125.21 22.45 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.845 -0.798 . . . . 75.55 108.845 -173.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -145.73 129.69 17.37 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.259 -0.645 . . . . 71.41 109.259 173.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.0 mt -84.77 126.18 40.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.505 -0.924 . . . . 73.24 108.505 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -93.04 -41.23 10.09 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.172 0.589 . . . . 71.53 110.347 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -172.73 121.49 0.41 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.62 -0.718 . . . . 74.44 109.969 -173.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 80.1 mt -105.4 132.43 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 107.373 -1.343 . . . . 70.22 107.373 172.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.467 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 28.2 p90 -162.98 164.02 25.86 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 123.687 0.617 . . . . 74.25 111.445 -172.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.422 HG23 ' HB3' ' B' ' 120' ' ' ARG . 68.7 p -90.37 122.19 33.02 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.779 -0.452 . . . . 61.03 109.779 174.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.467 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.1 mtpt -83.24 -33.55 26.05 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.055 0.542 . . . . 71.14 109.922 175.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -148.49 142.06 25.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.112 -0.949 . . . . 65.02 109.06 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.7 mt -135.47 145.9 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.778 1.231 . . . . 74.42 107.845 175.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -151.19 131.16 13.35 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.215 0.606 . . . . 71.15 109.999 172.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.445 ' HB2' ' HE2' ' A' ' 117' ' ' MET . 90.6 t80 -131.37 133.1 44.95 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 106.781 -1.563 . . . . 75.22 106.781 171.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -135.67 125.97 26.5 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.627 -0.509 . . . . 74.44 109.627 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.82 79.21 4.41 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 106.16 -1.793 . . . . 75.03 106.16 163.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -65.7 -35.53 36.61 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.455 2.103 . . . . 74.01 112.027 -167.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -107.81 27.07 9.57 Favored 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 124.461 1.104 . . . . 73.52 109.261 -172.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.452 ' HB2' ' HE3' ' B' ' 19' ' ' LYS . . . -46.09 -54.94 14.85 Favored Pre-proline 0 CA--C 1.568 1.652 0 N-CA-C 114.723 1.379 . . . . 63.33 114.723 -165.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.443 ' HG3' ' HG3' ' B' ' 57' ' ' GLU . 28.0 Cg_exo -62.5 -25.85 76.0 Favored 'Trans proline' 0 C--N 1.39 2.736 0 CA-C-N 121.904 1.716 . . . . 74.02 113.26 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.483 ' O ' ' HG2' ' A' ' 33' ' ' GLN . 2.5 m-70 -86.83 -34.32 19.54 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.614 0.765 . . . . 62.3 110.479 -178.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.519 HG22 ' HA ' ' A' ' 73' ' ' ALA . 3.7 p -74.75 -12.04 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 C-N-CA 123.204 0.602 . . . . 75.41 111.894 -164.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -91.78 -18.44 23.87 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.44 0.696 . . . . 73.32 111.291 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 29.9 pt20 -96.98 -11.55 24.43 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.251 0.62 . . . . 74.42 110.251 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 14.3 mmmm -76.93 156.36 32.08 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.407 0.683 . . . . 74.31 111.106 177.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.06 119.3 10.54 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.467 0.707 . . . . 74.44 110.005 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.4 ' CE3' HD21 ' A' ' 68' ' ' LEU . 60.9 t-105 -76.89 84.74 3.45 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-O 121.596 0.713 . . . . 75.41 109.798 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -116.17 79.2 8.41 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 106.246 -1.761 . . . . 72.54 106.246 172.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -81.12 106.62 1.78 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.436 2.091 . . . . 72.24 112.188 -172.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -95.87 88.64 4.99 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 122.6 1.19 . . . . 71.41 107.859 174.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.629 HG23 ' HB1' ' A' ' 66' ' ' ALA . 61.6 t -86.85 101.55 11.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 114.474 -1.239 . . . . 74.22 110.237 -174.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.611 ' HZ2' ' HB2' ' A' ' 43' ' ' ASP . 56.3 tttm -82.32 118.66 23.32 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.994 -1.003 . . . . 72.21 109.121 171.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.3 mp -95.56 108.16 20.39 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.633 -1.247 . . . . 75.04 107.633 173.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.611 ' HB2' ' HZ2' ' A' ' 41' ' ' LYS . 18.5 t70 -105.93 150.67 25.44 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.267 -1.012 . . . . 64.42 108.267 176.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.463 HD22 HD21 ' A' ' 60' ' ' LEU . 67.1 mt -133.29 158.77 42.11 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.406 0.682 . . . . 75.11 110.766 -177.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 25.5 t70 -160.14 121.7 3.17 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.579 -1.191 . . . . 75.2 108.037 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.6 m -112.27 126.51 55.32 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 122.838 0.455 . . . . 75.24 110.196 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.46 112.91 11.32 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.776 0.83 . . . . 74.1 109.493 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.1 p -89.41 177.19 6.64 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.94 0.496 . . . . 55.24 109.867 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.452 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 26.0 t -165.38 153.31 11.21 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.284 1.034 . . . . 73.23 109.112 -168.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -113.73 131.1 56.31 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 109.034 -0.728 . . . . 74.12 109.034 172.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.531 HD12 HG22 ' A' ' 83' ' ' ILE . 80.5 mt -110.48 -34.45 6.31 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.5 0.72 . . . . 74.24 111.4 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.424 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -157.82 -171.23 3.46 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 123.536 0.734 . . . . 74.14 110.537 -177.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -70.59 119.09 14.23 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.533 -0.914 . . . . 75.41 108.533 172.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 65.54 10.72 6.88 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.361 1.065 . . . . 74.34 112.107 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.424 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 57.2 t -116.21 112.6 40.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 107.835 -1.172 . . . . 62.32 107.835 175.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -126.7 126.33 43.32 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.892 0.877 . . . . 73.34 109.036 -176.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 37.8 tt0 -86.65 149.11 25.14 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.512 -0.551 . . . . 75.24 109.512 175.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.1 t -130.77 142.13 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 108.062 -1.088 . . . . 74.14 108.062 173.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.507 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 52.5 t -123.48 133.02 70.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.434 -0.95 . . . . 71.4 108.434 175.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.463 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -113.57 106.81 14.98 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.506 -1.294 . . . . 75.2 107.506 173.129 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.459 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 24.8 ttp180 -93.63 100.59 12.81 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.856 -1.164 . . . . 73.31 107.856 175.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.6 t -94.57 122.92 46.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 107.562 -1.273 . . . . 74.3 107.562 174.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.4 m -116.77 107.61 14.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.567 0.698 . . . . 64.24 109.426 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.616 HG13 HD21 ' A' ' 126' ' ' LEU . 58.0 t -104.38 133.91 47.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 C-N-CA 124.788 1.235 . . . . 73.1 107.871 -178.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.0 m -135.44 136.4 41.32 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.697 -0.853 . . . . 75.03 108.697 170.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.629 ' HB1' HG23 ' A' ' 40' ' ' VAL . . . -116.19 130.89 57.01 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.487 -1.301 . . . . 73.01 107.487 171.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.7 m -124.79 169.76 11.7 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.102 -0.703 . . . . 71.13 109.102 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.4 HD21 ' CE3' ' A' ' 36' ' ' TRP . 62.7 mt -124.09 42.95 3.12 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.754 1.222 . . . . 73.4 108.265 -176.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.22 -89.66 1.58 Allowed Glycine 0 C--N 1.34 0.756 0 CA-C-N 114.725 -1.125 . . . . 72.42 111.34 -172.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.43 -19.53 19.81 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.74 0.816 . . . . 72.3 112.539 -173.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -121.49 132.78 54.91 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 109.693 -0.484 . . . . 75.23 109.693 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.0 m -72.18 137.13 46.7 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 122.449 0.3 . . . . 70.44 110.469 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.519 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -79.17 -62.24 1.76 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.721 -0.672 . . . . 70.12 109.609 176.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -157.07 168.4 27.58 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.164 -0.925 . . . . 73.02 111.614 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 64' ' ' VAL . 61.4 tp -125.41 141.97 51.76 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.939 1.296 . . . . 73.23 108.434 171.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.424 ' HB3' HG22 ' A' ' 114' ' ' ILE . 77.7 m -143.15 99.15 3.39 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.487 1.115 . . . . 72.41 109.289 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -124.25 117.55 24.81 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.711 -0.848 . . . . 74.03 108.711 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.7 t -130.65 128.86 63.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 123.84 0.856 . . . . 74.52 109.613 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.459 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 77.3 mt-30 -96.95 90.9 5.37 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.557 0.743 . . . . 74.41 109.151 169.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -77.59 94.16 4.32 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.79 -0.819 . . . . 72.44 108.79 174.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.507 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.84 172.35 49.86 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.986 -0.846 . . . . 72.45 110.986 175.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.08 126.36 1.2 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.16 -0.776 . . . . 74.0 111.16 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.531 HG22 HD12 ' A' ' 51' ' ' LEU . 50.0 mt -81.59 126.48 39.85 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 108.66 -0.867 . . . . 72.42 108.66 174.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.564 ' HB3' HD11 ' A' ' 86' ' ' ILE . 91.8 m-85 -132.23 121.0 22.96 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.15 0.58 . . . . 73.4 109.961 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.3 m -84.97 97.44 9.8 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.903 -0.777 . . . . 75.3 108.903 174.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.564 HD11 ' HB3' ' A' ' 84' ' ' PHE . 3.5 mm -108.28 153.89 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 122.949 0.5 . . . . 72.11 109.994 -178.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.417 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -165.27 166.03 19.1 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.943 0.497 . . . . 74.23 111.261 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.45 -21.85 42.39 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 116.113 -0.494 . . . . 42.0 114.003 174.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.95 147.61 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.176 0.59 . . . . 72.54 111.535 -172.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -134.28 175.54 9.41 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.91 1.284 . . . . 74.31 109.439 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.62 -124.64 36.28 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.854 0.721 . . . . 64.11 113.828 175.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.0 t -71.19 -29.56 65.33 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.328 0.651 . . . . 62.41 111.741 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -69.33 -43.89 72.77 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.94 0.496 . . . . 70.22 110.324 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.411 ' HE1' ' HG ' ' A' ' 98' ' ' LEU . 2.5 tpt -66.79 -40.3 88.08 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.819 -0.628 . . . . 75.42 110.457 177.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.13 -32.59 74.36 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.236 0.614 . . . . 74.24 110.846 176.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -73.14 -30.94 63.96 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.343 0.657 . . . . 72.24 110.934 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.8 t -73.1 -51.6 17.4 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 109.27 -0.641 . . . . 64.24 109.27 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.411 ' HG ' ' HE1' ' A' ' 94' ' ' MET . 77.2 mt -76.9 -26.9 54.68 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.427 0.691 . . . . 73.11 112.258 -174.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.81 3.56 34.04 Favored Glycine 0 N--CA 1.468 0.815 0 CA-C-O 119.492 -0.616 . . . . 63.55 114.033 -171.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.556 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -148.72 -60.34 0.23 Allowed 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 117.671 0.736 . . . . 64.1 112.323 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.416 ' O ' HG12 ' A' ' 105' ' ' ILE . 73.5 t80 -66.44 -45.54 79.51 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.858 0.463 . . . . 75.54 111.509 -175.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 85.9 m -67.51 -46.79 47.85 Favored Pre-proline 0 CA--C 1.564 1.484 0 C-N-CA 124.381 1.072 . . . . 72.34 111.818 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -55.76 -34.17 90.13 Favored 'Trans proline' 0 C--N 1.397 3.126 0 C-N-CA 122.615 2.21 . . . . 75.13 113.523 168.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -63.42 -39.77 95.39 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.777 0.831 . . . . 74.32 110.499 176.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 101' ' ' TYR . 49.8 mm -66.41 -40.08 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.562 0.745 . . . . 74.44 110.212 174.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 68.9 mt -77.69 -22.38 50.58 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.244 -0.889 . . . . 62.21 112.5 -172.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -65.3 -42.33 58.13 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 114.291 1.219 . . . . 73.22 114.291 -172.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -53.2 -38.05 80.92 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 121.974 1.782 . . . . 72.1 113.12 171.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -82.03 -30.2 31.58 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.514 0.725 . . . . 74.15 111.651 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.85 -48.21 72.38 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.941 -0.763 . . . . 72.12 108.941 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.495 ' HG2' ' OH ' ' C' ' 109' ' ' TYR . 31.5 ttm180 -60.81 -39.86 90.54 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 113.741 -1.572 . . . . 71.52 110.088 176.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -52.46 -56.37 15.54 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.376 1.07 . . . . 74.14 110.727 176.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 45.1 t -60.17 -47.82 84.31 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 113.945 -1.48 . . . . 65.24 111.206 -175.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.594 HD13 HD12 ' A' ' 128' ' ' LEU . 96.1 mt -63.22 -59.85 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.714 0.806 . . . . 74.31 110.926 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 92.4 m -49.1 -42.5 39.23 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 124.338 1.024 . . . . 74.23 112.226 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.3 t -68.9 -46.75 67.54 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.745 -1.116 . . . . 61.32 110.582 -178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.445 ' HE2' ' HB2' ' A' ' 23' ' ' PHE . 9.9 mtp -53.67 -44.34 69.61 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.917 0.887 . . . . 72.44 111.226 175.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 114' ' ' ILE . 97.0 t -59.63 -49.71 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-N 114.726 -1.125 . . . . 60.23 110.772 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.4 p -70.9 -28.55 64.62 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.98 -0.554 . . . . 72.52 111.62 -177.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.483 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.4 mtt-85 -71.03 -29.9 65.94 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.674 0.79 . . . . 75.52 110.123 176.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.07 23.05 10.0 Favored Glycine 0 C--N 1.352 1.46 0 CA-C-O 118.957 -0.913 . . . . 64.3 113.407 176.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.428 HG23 ' HE ' ' B' ' 15' ' ' ARG . 4.1 t 57.36 10.71 0.97 Allowed 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 127.047 2.139 . . . . 54.32 113.853 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -81.17 144.02 53.61 Favored Pre-proline 0 C--O 1.242 0.709 0 N-CA-C 108.392 -0.966 . . . . 73.22 108.392 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -49.15 146.57 12.59 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 123.138 2.559 . . . . 73.14 111.94 173.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -59.74 133.24 55.92 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.105 0.478 . . . . 74.11 111.595 -174.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.616 HD21 HG13 ' A' ' 64' ' ' VAL . 28.1 tp -118.03 110.1 17.26 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.658 1.183 . . . . 75.13 108.753 176.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.453 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 72.3 m-20 -100.44 126.39 46.83 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.525 -1.287 . . . . 75.21 107.525 172.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.594 HD12 HD13 ' A' ' 114' ' ' ILE . 13.5 mt -73.27 141.37 47.22 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 123.125 0.266 . . . . 74.33 110.303 -178.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.59 135.65 95.78 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.299 0.64 . . . . 72.13 110.822 177.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.74 120.69 8.44 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 123.307 2.671 . . . . 75.53 112.833 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 84.4 t -103.4 136.77 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.538 0.735 . . . . 72.05 110.809 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.463 ' ND2' ' HB3' ' A' ' 135' ' ' ALA . 37.2 t30 -94.61 90.38 6.12 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 108.327 -0.99 . . . . 75.13 108.327 172.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -63.44 -28.67 70.13 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.091 0.957 . . . . 74.2 112.561 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.556 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 7.9 m-20 -63.41 -35.79 81.57 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.122 0.569 . . . . 73.11 110.626 176.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.463 ' HB3' ' ND2' ' A' ' 132' ' ' ASN . . . -65.19 -48.93 71.71 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 123.549 0.531 . . . . 74.34 110.053 171.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 62.3 mt -56.67 -39.29 73.49 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.808 0.843 . . . . 71.0 111.329 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 84.8 t80 . . . . . 0 C--N 1.349 0.569 0 CA-C-N 115.301 -0.863 . . . . 73.22 110.252 176.75 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.56 ' HE3' ' SG ' ' B' ' 97' ' ' CYS . 25.6 ttt . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 112.766 0.654 . . . . 75.33 112.766 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 89.5 m -151.05 128.12 11.12 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.965 1.306 . . . . 74.01 107.694 171.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.46 ' CE1' ' HE2' ' B' ' 101' ' ' TYR . 0.1 OUTLIER -146.86 135.54 22.11 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.304 0.573 . . . . 74.44 110.252 179.115 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.484 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -131.09 130.05 42.67 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.819 1.248 . . . . 75.11 109.212 -179.575 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 69.4 mt -73.24 127.49 35.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 108.357 -0.979 . . . . 73.24 108.357 170.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -92.42 -43.67 9.09 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 123.744 0.652 . . . . 75.34 109.595 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.428 ' HE ' HG23 ' A' ' 122' ' ' THR . 45.6 ttt180 -174.27 135.84 0.46 Allowed 'General case' 0 C--N 1.352 0.71 0 CA-C-N 115.703 -0.68 . . . . 70.41 109.932 -173.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.547 HG23 ' CE1' ' B' ' 109' ' ' TYR . 80.7 mt -122.84 138.8 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.065 -1.087 . . . . 73.31 108.065 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -164.15 157.33 17.95 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.127 0.788 . . . . 73.42 113.127 -171.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 53.5 m -83.66 119.48 24.81 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.366 -1.288 . . . . 75.35 108.864 171.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.452 ' HE3' ' HB2' ' A' ' 28' ' ' ALA . 39.6 mtpt -91.81 -24.98 19.21 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.658 0.783 . . . . 71.23 111.522 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -159.57 142.76 14.25 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 123.387 0.429 . . . . 72.11 111.02 -175.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.564 HD13 ' SG ' ' B' ' 113' ' ' CYS . 48.6 mm -134.37 144.19 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.939 1.295 . . . . 75.35 108.321 171.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 29.5 t -147.68 134.45 20.04 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.221 1.009 . . . . 63.44 108.35 171.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -134.87 131.89 37.91 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.979 -1.489 . . . . 74.1 106.979 167.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -132.69 125.39 30.18 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.177 -1.046 . . . . 74.21 108.177 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.505 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -114.75 87.37 14.55 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 106.899 -1.519 . . . . 61.43 106.899 164.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.39 -35.04 74.89 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.554 2.17 . . . . 74.21 111.228 -173.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -110.29 14.93 22.59 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.47 -1.241 . . . . 53.24 110.742 -175.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.505 ' HB1' ' HB2' ' B' ' 25' ' ' ALA . . . -31.63 -66.3 0.19 Allowed Pre-proline 0 N--CA 1.493 1.715 0 C-N-CA 125.951 1.701 . . . . 75.42 115.278 -172.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.496 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 24.8 Cg_exo -60.83 -36.51 83.62 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 122.457 2.105 . . . . 75.11 113.269 -167.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -93.31 -32.22 14.39 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.403 0.52 . . . . 74.11 112.403 -174.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.605 HG21 HD11 ' B' ' 68' ' ' LEU . 7.2 p -67.6 -11.69 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-N 118.209 0.458 . . . . 75.22 111.534 -173.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -74.1 -15.09 61.06 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.868 0.867 . . . . 75.41 112.976 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -61.54 -28.91 69.66 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.476 0.655 . . . . 55.24 109.543 172.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -88.91 105.17 17.58 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.894 1.278 . . . . 75.12 109.451 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -113.43 99.18 7.57 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.625 -0.88 . . . . 65.13 108.625 172.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 11.2 p90 -160.71 -172.78 3.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.368 -0.975 . . . . 75.24 108.368 170.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -73.84 107.3 3.32 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.353 0.661 . . . . 74.34 111.014 175.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.11 143.65 60.36 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 121.533 1.488 . . . . 74.12 110.5 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.23 101.46 1.19 Allowed 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.543 -0.91 . . . . 75.32 108.543 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.703 HG21 ' HB1' ' B' ' 66' ' ' ALA . 33.9 t -91.78 144.71 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 114.245 -1.343 . . . . 74.43 109.695 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.61 ' HZ1' ' HB2' ' B' ' 43' ' ' ASP . 0.5 OUTLIER -144.15 119.65 10.35 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.067 -1.827 . . . . 75.01 106.067 -175.243 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.43 HD12 HD21 ' B' ' 128' ' ' LEU . 20.9 tp -95.06 147.23 23.64 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.625 0.77 . . . . 74.52 109.362 -174.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.61 ' HB2' ' HZ1' ' B' ' 41' ' ' LYS . 13.0 t70 -140.62 134.29 30.25 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.692 -1.225 . . . . 75.12 107.692 -175.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 64.3 mt -128.0 126.27 41.02 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.632 -0.877 . . . . 73.22 108.632 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.579 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 19.5 t70 -126.1 119.79 28.48 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.369 1.067 . . . . 75.0 108.612 -173.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.8 p -110.29 102.95 11.57 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.33 0.652 . . . . 74.23 111.516 -169.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.73 136.83 51.11 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.135 0.974 . . . . 71.25 108.554 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.1 p -139.86 175.86 9.23 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.418 0.687 . . . . 73.02 109.721 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 75.3 p -157.12 140.15 15.34 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.093 0.557 . . . . 75.15 110.337 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -94.87 128.46 41.65 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.617 -0.883 . . . . 74.13 108.617 172.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.91 16.41 2.48 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.72 0.808 . . . . 73.1 110.923 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . 0.737 ' HB2' ' HB ' ' B' ' 55' ' ' VAL . . . -173.67 165.12 4.49 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.819 1.248 . . . . 73.34 109.73 173.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.45 119.24 13.41 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.884 -0.784 . . . . 72.22 108.884 176.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 69.16 -5.63 1.05 Allowed 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 124.687 1.195 . . . . 74.53 113.145 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.737 ' HB ' ' HB2' ' B' ' 52' ' ' ALA . 44.4 t -119.57 97.49 5.26 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.226 -1.028 . . . . 75.13 108.226 -172.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.64 ' HE1' HD12 ' B' ' 86' ' ' ILE . 54.4 p90 -99.23 -176.86 3.43 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 114.556 -1.202 . . . . 73.45 109.207 177.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.443 ' HG3' ' HG3' ' A' ' 29' ' ' PRO . 5.5 tm-20 -138.69 107.2 5.85 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 106.383 -1.71 . . . . 74.3 106.383 173.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 14.8 p -101.0 135.03 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 109.863 -0.421 . . . . 74.24 109.863 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 29.9 t -109.38 115.23 49.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 123.754 0.821 . . . . 61.34 108.955 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 54.5 tp -93.89 101.13 13.2 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.378 -0.971 . . . . 64.21 108.378 170.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.579 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 14.1 ttm-85 -87.33 116.82 25.69 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.681 -0.859 . . . . 74.35 108.681 172.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.37 125.9 66.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.029 -1.1 . . . . 72.23 108.029 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 8.7 m -121.84 131.67 54.17 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.242 -0.651 . . . . 73.13 109.242 178.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.509 HG23 HD12 ' B' ' 114' ' ' ILE . 56.7 t -115.88 125.2 72.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 124.569 1.148 . . . . 75.11 109.131 176.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 88.9 m -105.06 138.72 40.82 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.463 -0.94 . . . . 75.23 108.463 164.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.703 ' HB1' HG21 ' B' ' 40' ' ' VAL . . . -142.19 144.27 33.32 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 107.96 -1.126 . . . . 73.43 107.96 174.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.465 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 49.6 p -144.7 134.26 23.34 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.388 0.43 . . . . 72.23 111.978 -171.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.605 HD11 HG21 ' B' ' 31' ' ' VAL . 70.6 mt -102.61 99.57 9.58 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.487 -0.931 . . . . 73.23 108.487 175.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.05 -134.3 14.18 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.991 -0.549 . . . . 73.22 112.364 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -82.32 3.55 27.29 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.26 0.624 . . . . 75.13 112.515 -177.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -128.76 150.68 50.19 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.789 0.435 . . . . 72.11 111.767 -174.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 68.3 m -68.7 128.43 36.62 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.418 -0.81 . . . . 71.24 110.36 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.502 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . . . -80.14 -59.28 2.77 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.366 -0.976 . . . . 75.21 108.366 176.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -152.51 157.85 41.71 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 114.701 -1.136 . . . . 74.11 111.437 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 98.2 mt -125.15 113.58 17.88 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.682 1.593 . . . . 75.35 107.262 171.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.9 t -118.39 140.14 50.31 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.177 -1.045 . . . . 75.44 108.177 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -151.22 127.64 10.68 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.813 -0.81 . . . . 74.54 108.813 -174.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.438 HG21 HD12 ' B' ' 21' ' ' ILE . 90.4 t -124.44 147.71 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 123.942 0.897 . . . . 73.34 108.83 177.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -120.74 106.38 11.64 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.477 -1.305 . . . . 74.14 107.477 168.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -98.41 101.3 12.7 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.504 -1.295 . . . . 54.13 107.504 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.4 159.57 22.56 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 111.062 -0.815 . . . . 71.25 111.062 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.9 132.61 3.12 Favored Glycine 0 C--O 1.239 0.446 0 C-N-CA 121.718 -0.277 . . . . 72.42 112.411 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 54.6 mt -91.66 108.13 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 108.497 -0.927 . . . . 72.22 108.497 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -119.47 143.89 47.28 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.159 -1.052 . . . . 75.35 108.159 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 15.8 m -115.17 114.23 25.0 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.476 -0.935 . . . . 75.13 108.476 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.64 HD12 ' HE1' ' B' ' 56' ' ' TYR . 0.2 OUTLIER -115.56 142.22 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.359 -0.978 . . . . 73.34 108.359 178.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.38 168.6 26.83 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.981 0.512 . . . . 65.1 110.622 -177.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.86 -44.92 2.69 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.966 -0.561 . . . . 72.03 111.895 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.414 HD12 ' HB2' ' B' ' 94' ' ' MET . 1.0 OUTLIER -81.74 157.25 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.5 1.12 . . . . 75.22 111.261 178.131 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.5 ' HA ' ' SD ' ' B' ' 94' ' ' MET . 9.7 mp0 -145.9 177.95 8.55 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.483 1.113 . . . . 73.01 109.605 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.62 -125.42 23.07 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.127 -0.942 . . . . 73.42 113.81 173.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 27.2 m -79.27 -45.39 19.83 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.703 0.801 . . . . 75.34 110.724 -178.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -67.47 -28.91 68.25 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 113.953 -1.476 . . . . 74.3 111.886 -166.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.5 ' SD ' ' HA ' ' B' ' 90' ' ' GLU . 26.9 ptt? -64.34 -47.49 79.15 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.227 0.611 . . . . 72.53 111.373 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . 0.458 ' HA ' ' HG ' ' B' ' 98' ' ' LEU . . . -81.0 -13.34 58.96 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.996 0.919 . . . . 63.44 112.186 -175.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -64.74 -32.13 73.67 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.655 0.382 . . . . 72.0 110.277 170.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.56 ' SG ' ' HE3' ' B' ' 9' ' ' MET . 48.0 t -67.51 -30.92 70.72 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.584 0.754 . . . . 64.31 111.53 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.458 ' HG ' ' HA ' ' B' ' 95' ' ' ALA . 4.0 pp -101.38 -24.48 14.19 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 112.942 0.719 . . . . 73.5 112.942 -175.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.76 -26.24 61.09 Favored Glycine 0 C--N 1.338 0.671 0 O-C-N 123.584 0.553 . . . . 65.24 112.736 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.08 -49.75 0.33 Allowed 'General case' 0 C--O 1.242 0.671 0 N-CA-C 112.568 0.581 . . . . 74.45 112.568 -165.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.46 ' HE2' ' CE1' ' B' ' 11' ' ' PHE . 16.0 t80 -68.02 -48.75 64.83 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.69 0.796 . . . . 74.34 112.155 -174.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 98.1 m -73.69 -37.94 3.74 Favored Pre-proline 0 CA--C 1.557 1.238 0 N-CA-C 112.627 0.603 . . . . 74.54 112.627 -177.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -51.43 -31.49 38.87 Favored 'Trans proline' 0 C--N 1.387 2.553 0 C-N-CA 122.399 2.066 . . . . 73.52 114.181 162.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -68.89 -25.41 64.59 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 122.767 0.427 . . . . 74.44 111.504 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.497 HG23 ' NH2' ' D' ' 111' ' ' ARG . 71.5 mt -69.05 -39.8 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 121.336 0.589 . . . . 74.21 109.413 170.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.461 ' CD2' HG21 ' B' ' 16' ' ' ILE . 70.3 mt -77.09 -24.6 51.8 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.689 1.196 . . . . 72.43 111.893 -177.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -59.18 -53.71 63.58 Favored Pre-proline 0 N--CA 1.484 1.248 0 N-CA-C 113.822 1.045 . . . . 72.21 113.822 -171.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.16 -30.56 55.26 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 121.62 1.547 . . . . 75.21 111.98 -177.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.547 ' CE1' HG23 ' B' ' 16' ' ' ILE . 2.4 m-30 -64.54 -47.8 77.46 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.02 0.928 . . . . 73.5 110.058 176.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.18 -40.57 97.9 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.026 0.93 . . . . 71.55 110.747 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.4 ttt-85 -64.69 -46.34 82.79 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.225 1.41 . . . . 75.3 110.861 -175.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.38 -35.06 77.15 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 123.776 0.673 . . . . 64.22 109.454 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.564 ' SG ' HD13 ' B' ' 21' ' ' ILE . 4.4 t -68.99 -35.51 76.8 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.891 0.476 . . . . 74.34 111.157 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.509 HD12 HG23 ' B' ' 64' ' ' VAL . 49.2 mt -62.89 -56.88 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.649 0.78 . . . . 72.43 109.339 173.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 18.1 m -59.63 -28.21 67.02 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.941 0.896 . . . . 55.03 111.459 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.461 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.7 t -66.25 -51.45 57.42 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.981 0.912 . . . . 54.41 110.3 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.5 mmt -70.14 -29.98 67.03 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.183 0.593 . . . . 73.12 111.245 -176.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.614 HG23 HD21 ' B' ' 126' ' ' LEU . 77.6 t -67.95 -41.86 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.513 1.125 . . . . 72.43 110.389 172.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.7 t -67.69 -32.03 72.41 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.604 -0.726 . . . . 75.31 110.341 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' B' ' 116' ' ' SER . 70.3 mtt-85 -69.74 -42.59 73.74 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 115.688 -0.687 . . . . 73.41 109.162 175.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.12 -10.82 62.81 Favored Glycine 0 C--N 1.358 1.801 0 O-C-N 123.736 0.648 . . . . 75.53 112.639 172.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 8.9 m 68.75 23.1 7.11 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 125.762 1.625 . . . . 72.11 110.973 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -78.96 164.26 55.96 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 124.019 0.927 . . . . 74.52 111.341 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -45.28 147.56 2.35 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 123.839 3.026 . . . . 73.52 114.85 172.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -59.95 113.29 2.23 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.272 1.029 . . . . 72.01 112.512 -172.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.614 HD21 HG23 ' B' ' 118' ' ' VAL . 28.5 tp -107.71 104.72 14.3 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.151 0.58 . . . . 74.34 109.457 -172.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -111.49 120.9 43.7 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.442 -0.947 . . . . 74.22 108.442 175.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.43 HD21 HD12 ' B' ' 42' ' ' LEU . 57.9 mt -78.14 149.29 33.82 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 110.296 -0.261 . . . . 74.43 110.296 175.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.61 143.39 84.9 Favored Pre-proline 0 CA--C 1.55 0.961 0 O-C-N 123.503 0.502 . . . . 54.03 111.238 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.61 81.76 0.76 Allowed 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 123.345 2.697 . . . . 70.42 112.191 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.17 110.68 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 121.402 0.62 . . . . 73.35 109.423 177.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 107.692 -1.225 . . . . 65.14 107.692 171.279 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 88.2 t80 . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 109.074 -0.713 . . . . 64.24 109.074 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -151.59 124.62 8.66 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.989 -0.745 . . . . 64.35 108.989 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.401 ' HA ' ' HD2' ' C' ' 84' ' ' PHE . 53.0 mt -70.11 135.0 29.1 Favored 'Isoleucine or valine' 0 C--N 1.349 0.586 0 N-CA-C 108.45 -0.945 . . . . 74.11 108.45 174.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -97.5 -47.71 5.56 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.273 -0.64 . . . . 73.31 109.273 176.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.453 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 11.8 ptm180 -179.01 143.02 0.2 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.288 1.035 . . . . 74.34 109.255 -176.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.31 146.8 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 107.363 -1.347 . . . . 75.11 107.363 171.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.419 ' HB3' HG22 ' D' ' 122' ' ' THR . 28.6 p90 -170.78 154.58 4.4 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.201 0.524 . . . . 64.51 111.943 -168.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.0 p -81.01 109.24 15.4 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.216 -0.902 . . . . 71.44 108.848 173.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -77.3 -29.78 53.84 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.186 -0.672 . . . . 74.5 109.186 173.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.664 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 22.5 t70 -146.07 143.77 29.6 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.905 -1.043 . . . . 73.45 109.663 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 99.3 mt -137.92 145.34 29.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 125.237 1.415 . . . . 73.35 107.389 173.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.3 t -152.91 146.05 24.67 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.129 0.571 . . . . 73.55 109.723 175.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -147.48 118.58 7.74 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 107.861 -1.162 . . . . 71.32 107.861 170.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -120.79 113.48 20.23 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.073 0.949 . . . . 75.12 108.981 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.63 87.81 7.02 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 106.446 -1.687 . . . . 73.14 106.446 169.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.89 -42.67 23.35 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.845 2.363 . . . . 72.12 112.042 -170.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -113.06 35.53 3.89 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.759 -1.109 . . . . 72.1 109.239 -177.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.474 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -43.92 -53.27 13.34 Favored Pre-proline 0 C--N 1.373 1.604 0 C-N-CA 124.915 1.286 . . . . 73.32 114.113 -176.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.96 -50.88 7.91 Favored 'Trans proline' 0 C--N 1.39 2.749 0 C-N-CA 121.521 1.481 . . . . 74.32 111.906 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -70.04 -28.07 65.17 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.309 -1.314 . . . . 74.1 113.016 -173.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.654 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.0 p -77.79 -23.88 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 112.235 0.458 . . . . 64.22 112.235 -175.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -71.9 -21.27 61.66 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 112.118 0.414 . . . . 71.32 112.118 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -93.54 16.35 13.89 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.027 0.531 . . . . 75.4 111.016 175.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.757 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -104.17 154.01 20.27 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.748 0.819 . . . . 75.42 109.974 176.111 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -72.4 130.78 41.5 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.31 0.644 . . . . 74.34 109.711 171.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -85.39 90.24 7.89 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.819 0.848 . . . . 74.1 112.2 -171.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -145.7 77.52 12.32 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 124.675 1.19 . . . . 75.34 108.907 170.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -91.53 165.77 3.47 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.758 2.305 . . . . 71.14 113.562 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -87.97 100.56 13.0 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.969 -1.122 . . . . 72.52 107.969 166.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 42.0 t -79.89 98.59 3.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.549 -0.908 . . . . 70.41 108.549 177.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -93.06 102.52 14.85 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.068 -1.456 . . . . 75.52 107.068 175.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 tt -87.78 138.21 31.66 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 106.817 -1.549 . . . . 70.35 106.817 176.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.454 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 36.0 t70 -131.56 134.71 46.36 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.053 0.941 . . . . 65.13 108.85 -175.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 96.2 mt -128.54 114.48 16.79 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.602 0.761 . . . . 72.14 110.018 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -117.12 120.75 39.29 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.671 -1.233 . . . . 71.14 107.671 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 10.1 t -118.24 149.24 41.45 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 109.778 -0.453 . . . . 75.22 109.778 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.17 149.12 26.72 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.572 0.749 . . . . 75.03 109.359 174.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.48 ' HG ' ' HB3' ' C' ' 98' ' ' LEU . 14.3 m -123.77 152.53 42.09 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.122 -0.696 . . . . 64.24 109.122 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 72.9 p -154.61 127.37 8.11 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.506 -0.924 . . . . 75.5 108.506 177.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -79.62 117.7 20.78 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.994 -0.743 . . . . 74.44 108.994 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.731 HD12 ' HB2' ' C' ' 57' ' ' GLU . 41.5 mt -83.55 -44.76 14.3 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.492 0.717 . . . . 75.0 110.273 -176.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.99 -176.55 4.72 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.449 -0.796 . . . . 64.31 109.691 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.08 107.77 0.59 Allowed 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.786 -1.097 . . . . 73.31 110.505 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 64.38 25.31 13.38 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.452 1.101 . . . . 75.21 112.113 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 87.9 t -119.05 114.77 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.328 -0.989 . . . . 75.04 108.328 174.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -117.81 125.55 50.78 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.354 1.062 . . . . 75.11 109.291 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.731 ' HB2' HD12 ' C' ' 51' ' ' LEU . 37.4 tt0 -91.17 117.71 29.84 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.246 -0.65 . . . . 64.22 109.246 168.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.8 t -99.61 142.02 15.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.083 -1.08 . . . . 75.23 108.083 169.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 90.5 t -127.4 144.08 38.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.786 -0.82 . . . . 75.04 108.786 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.401 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -130.37 99.02 4.87 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 107.848 -1.168 . . . . 74.05 107.848 177.61 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -82.52 110.78 17.93 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.369 0.668 . . . . 75.22 109.41 171.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.404 HG13 ' CD1' ' C' ' 114' ' ' ILE . 39.6 t -108.52 122.77 63.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.698 -0.853 . . . . 73.33 108.698 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 16.8 m -126.1 127.48 45.86 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.449 0.7 . . . . 74.42 109.521 -176.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.423 HG22 HG23 ' C' ' 114' ' ' ILE . 60.2 t -114.36 112.11 38.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 124.165 0.986 . . . . 72.54 108.893 178.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 11.2 m -98.12 135.86 39.18 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.457 -1.312 . . . . 75.33 107.457 171.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.71 118.22 17.86 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.225 -1.398 . . . . 62.02 107.225 -175.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.5 m -133.9 130.89 38.43 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.194 0.521 . . . . 73.11 110.545 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.757 HD11 ' HG2' ' C' ' 34' ' ' LYS . 14.2 mt -88.48 39.48 0.91 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.624 1.169 . . . . 74.33 109.626 174.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.91 -106.22 2.66 Favored Glycine 0 C--N 1.353 1.474 0 CA-C-N 115.823 -0.626 . . . . 63.44 111.701 -173.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -90.24 -30.05 17.79 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.792 -0.818 . . . . 71.13 108.792 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -65.76 121.05 14.14 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 114.713 -1.131 . . . . 75.14 109.435 169.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 89.8 m -83.97 120.65 26.36 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.124 -1.065 . . . . 73.32 108.124 164.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.654 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -67.41 -58.57 4.52 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 123.945 0.778 . . . . 51.12 109.139 175.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -165.13 176.57 8.39 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 121.984 0.897 . . . . 72.41 111.078 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.424 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.1 tm? -134.84 145.35 48.23 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 105.766 -1.939 . . . . 74.42 105.766 170.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.469 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.2 t -147.82 141.88 25.99 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.878 -1.156 . . . . 73.15 107.878 174.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -150.88 131.54 13.97 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.473 -0.566 . . . . 75.22 109.473 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 75.8 t -131.76 114.05 24.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.345 -0.983 . . . . 75.24 108.345 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.664 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.7 mt-30 -90.49 86.14 6.34 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.417 -0.957 . . . . 72.32 108.417 173.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -79.01 102.15 8.19 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.225 -1.352 . . . . 75.24 108.88 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.9 159.44 32.9 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 111.475 -0.65 . . . . 62.51 111.475 172.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.69 116.73 0.73 Allowed Glycine 0 CA--C 1.507 -0.428 0 N-CA-C 111.317 -0.713 . . . . 75.21 111.317 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.622 HD11 ' HB3' ' D' ' 29' ' ' PRO . 17.2 mm -84.4 132.42 31.61 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 N-CA-C 108.778 -0.823 . . . . 74.45 108.778 178.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.401 ' HD2' ' HA ' ' C' ' 13' ' ' ILE . 66.0 m-85 -135.66 139.07 43.44 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.483 0.713 . . . . 75.44 109.837 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 21.7 p -99.01 104.0 16.0 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.809 -1.182 . . . . 72.34 107.809 169.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 46.1 mt -115.72 132.62 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.898 0.879 . . . . 74.25 109.128 -176.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.83 164.46 33.58 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 122.902 0.481 . . . . 75.45 111.187 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.83 -41.75 2.71 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 115.353 -0.84 . . . . 75.32 113.392 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.533 HD13 ' HA ' ' C' ' 94' ' ' MET . 39.7 pt -85.98 168.84 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.274 0.629 . . . . 75.44 111.787 -174.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -164.5 168.23 18.58 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.981 1.312 . . . . 71.42 108.339 176.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.22 -119.46 11.7 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.805 -0.441 . . . . 62.51 112.982 171.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 69.9 p -69.0 -41.78 77.36 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.134 0.574 . . . . 73.34 110.644 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -61.93 -46.51 89.01 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.519 0.728 . . . . 72.11 110.9 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.533 ' HA ' HD13 ' C' ' 89' ' ' ILE . 5.4 tpt -59.74 -51.45 69.69 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 123.734 0.646 . . . . 74.32 111.579 177.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.26 -40.88 97.67 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.68 0.612 . . . . 55.53 111.319 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -72.36 -34.54 68.06 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.901 -1.045 . . . . 71.04 111.119 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -65.11 -42.5 93.89 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.317 0.58 . . . . 65.12 109.885 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.48 ' HB3' ' HG ' ' C' ' 48' ' ' SER . 97.3 mt -79.44 -37.24 37.49 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.798 -1.092 . . . . 64.45 112.78 -175.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.78 11.66 45.81 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-O 119.429 -0.65 . . . . 74.52 114.597 -167.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' C' ' 137' ' ' PHE . . . -155.95 -56.67 0.09 Allowed 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 117.827 0.814 . . . . 72.22 111.385 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -63.7 -56.17 17.72 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.617 0.767 . . . . 70.4 111.815 -175.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.426 ' O ' HD13 ' C' ' 106' ' ' LEU . 85.5 m -65.25 -47.3 71.38 Favored Pre-proline 0 CA--C 1.561 1.397 0 C-N-CA 123.925 0.89 . . . . 71.12 112.371 -177.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.401 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 53.7 Cg_exo -55.66 -30.53 75.71 Favored 'Trans proline' 0 C--N 1.397 3.092 0 C-N-CA 122.44 2.093 . . . . 65.51 113.628 173.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -70.18 -28.71 65.54 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.289 0.636 . . . . 74.03 111.116 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.454 HD13 HH12 ' A' ' 111' ' ' ARG . 33.8 mm -77.91 -32.27 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 123.163 0.585 . . . . 73.34 109.971 175.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.426 HD13 ' O ' ' C' ' 102' ' ' CYS . 7.3 mp -78.4 -27.55 46.75 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.05 0.94 . . . . 62.15 111.578 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -56.82 -49.81 91.7 Favored Pre-proline 0 N--CA 1.48 1.069 0 CA-C-O 117.556 -1.212 . . . . 75.44 113.672 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -50.91 -40.68 57.83 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.72 2.28 . . . . 64.44 114.674 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . 0.495 ' OH ' ' HG2' ' A' ' 111' ' ' ARG . 89.2 m-85 -79.15 -37.44 38.47 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.263 0.625 . . . . 73.41 111.455 -175.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.64 96.26 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.436 -0.802 . . . . 75.45 109.956 173.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 34.6 ttt-85 -62.97 -50.9 68.98 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.579 1.551 . . . . 75.41 110.394 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -60.67 -40.8 93.44 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.094 0.871 . . . . 74.33 110.126 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 31.8 t -72.33 -32.18 66.29 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.709 -0.678 . . . . 65.32 111.212 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.469 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 44.2 mt -69.1 -53.35 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.905 -0.406 . . . . 75.14 109.905 174.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 22.5 m -62.62 -28.98 70.27 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.442 0.697 . . . . 74.11 111.196 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 37.6 t -67.51 -49.21 64.48 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.254 0.622 . . . . 72.04 109.348 173.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.554 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.39 -39.79 84.48 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 124.432 1.093 . . . . 72.22 112.402 179.838 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.425 HG21 ' O ' ' C' ' 114' ' ' ILE . 93.7 t -65.23 -43.99 95.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.73 0.812 . . . . 74.12 110.223 176.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 22.0 t -66.07 -29.87 70.28 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.067 -0.97 . . . . 72.33 111.577 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 88.1 mtt-85 -73.02 -39.82 65.68 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.603 0.761 . . . . 72.14 109.506 177.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.61 -0.79 68.99 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 123.895 0.747 . . . . 63.41 112.522 171.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.429 HG21 ' HB3' ' D' ' 17' ' ' TYR . 32.0 p 63.4 32.17 14.66 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.823 2.049 . . . . 75.0 113.384 170.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -83.98 149.83 57.16 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 108.027 -1.101 . . . . 64.31 108.027 166.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.06 161.06 5.37 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 123.3 2.667 . . . . 73.12 113.96 176.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -58.55 113.57 2.06 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.751 0.82 . . . . 74.34 112.222 -172.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 50.8 tp -109.35 87.83 2.59 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.924 -1.034 . . . . 73.34 108.254 173.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -90.2 106.7 18.66 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.175 -1.046 . . . . 73.21 108.175 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 86.5 mt -64.45 129.25 39.16 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.41 0.684 . . . . 71.23 110.618 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.07 151.2 96.11 Favored Pre-proline 0 CA--C 1.553 1.076 0 O-C-N 124.34 1.025 . . . . 73.55 111.089 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.87 116.71 3.4 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.15 2.566 . . . . 55.42 112.853 177.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 28.9 t -99.35 133.22 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.042 -0.725 . . . . 72.24 109.042 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -87.64 96.47 10.44 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.745 0.818 . . . . 71.11 109.169 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -68.92 -24.58 64.31 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.396 0.679 . . . . 75.44 112.085 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -66.13 -41.15 90.88 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 109.076 -0.713 . . . . 75.35 109.076 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.79 -39.98 95.91 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.303 -0.862 . . . . 72.11 110.819 175.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 77.2 mt -67.6 -26.23 66.16 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.551 -0.75 . . . . 74.4 111.012 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . 0.516 ' HB2' ' HB3' ' C' ' 100' ' ' ALA . 34.5 t80 . . . . . 0 CA--C 1.546 0.804 0 CA-C-O 120.613 0.244 . . . . 72.12 110.878 176.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.424 HG21 ' HB2' ' D' ' 87' ' ' ALA . 10.2 t . . . . . 0 N--CA 1.47 0.565 0 CA-C-O 120.941 0.4 . . . . 74.32 110.286 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -133.37 111.2 10.58 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.642 -1.244 . . . . 74.11 107.642 173.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -136.4 139.64 42.61 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.086 0.954 . . . . 64.54 108.655 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.54 HG21 HD11 ' D' ' 16' ' ' ILE . 7.4 mt -100.2 142.02 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 108.717 -0.846 . . . . 75.32 108.717 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -103.45 -34.6 8.65 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.324 0.65 . . . . 75.53 111.483 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -169.42 137.13 1.8 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.015 0.376 . . . . 74.25 112.015 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.54 HD11 HG21 ' D' ' 13' ' ' ILE . 3.5 mp -115.66 140.09 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 107.216 -1.402 . . . . 75.21 107.216 170.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.429 ' HB3' HG21 ' C' ' 122' ' ' THR . 38.3 p90 -168.72 171.08 8.92 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.977 0.911 . . . . 75.23 110.15 176.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -98.41 117.83 33.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.888 -1.051 . . . . 74.11 109.089 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.426 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 22.4 mtpt -85.79 -25.8 26.15 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.721 -0.844 . . . . 65.01 108.721 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.625 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 26.6 t70 -155.68 136.87 13.83 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.648 -1.16 . . . . 75.21 109.576 -178.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.554 HG23 ' HE1' ' C' ' 117' ' ' MET . 67.9 mt -136.59 146.84 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.326 1.05 . . . . 74.54 109.019 174.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -145.5 141.25 28.13 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.608 1.163 . . . . 72.21 109.515 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.491 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.1 t80 -145.67 134.52 22.44 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 106.415 -1.698 . . . . 74.21 106.415 165.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 50.0 mt-10 -135.03 144.99 47.6 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.94 0.896 . . . . 74.34 109.366 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.96 79.77 8.32 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 107.037 -1.468 . . . . 75.54 107.037 170.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.16 -15.49 28.73 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.821 2.347 . . . . 73.43 112.232 -175.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -114.78 16.38 17.38 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 124.383 1.073 . . . . 73.23 110.588 -174.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.55 -65.11 0.98 Allowed Pre-proline 0 CA--C 1.562 1.412 0 N-CA-C 115.067 1.506 . . . . 61.13 115.067 -159.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.622 ' HB3' HD11 ' C' ' 83' ' ' ILE . 57.4 Cg_endo -69.96 -22.98 30.42 Favored 'Trans proline' 0 C--N 1.392 2.833 0 CA-C-N 122.51 1.932 . . . . 73.22 113.484 -177.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -69.47 -44.63 70.79 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.275 1.03 . . . . 74.54 110.498 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' D' ' 73' ' ' ALA . 5.7 p -85.0 -18.52 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 123.192 0.597 . . . . 73.4 111.613 -170.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -60.9 -23.55 65.31 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 112.447 0.536 . . . . 74.02 112.447 172.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -63.8 -22.73 67.05 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.434 0.694 . . . . 63.21 110.919 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.545 ' NZ ' ' HB3' ' D' ' 71' ' ' GLU . 90.9 mttt -85.59 104.78 15.65 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.489 1.115 . . . . 73.42 109.599 176.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -102.09 90.56 3.99 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.379 -0.6 . . . . 64.52 109.379 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 35.4 p90 -165.42 -168.44 1.36 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.882 0.873 . . . . 75.11 109.624 171.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . 0.404 HE21 ' HD2' ' D' ' 38' ' ' PRO . 27.3 tp60 -72.7 117.17 57.05 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.8 0.84 . . . . 74.43 110.497 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.404 ' HD2' HE21 ' D' ' 37' ' ' GLN . 53.0 Cg_exo -56.88 110.63 0.62 Allowed 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 121.788 1.659 . . . . 64.23 109.862 168.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -67.79 109.61 3.44 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.048 -1.093 . . . . 74.22 108.048 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.656 HG11 HG13 ' D' ' 64' ' ' VAL . 92.3 t -106.62 122.68 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.4 -0.364 . . . . 71.44 110.397 -170.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.458 ' HB3' ' HZ1' ' D' ' 41' ' ' LYS . 0.0 OUTLIER -106.95 119.29 38.97 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.726 -1.583 . . . . 71.31 106.726 172.856 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 45.3 tp -95.11 141.91 28.19 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.334 -0.987 . . . . 75.24 108.334 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -136.53 125.3 23.97 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.229 -1.397 . . . . 73.21 107.229 -177.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.411 ' CD2' HG21 ' D' ' 62' ' ' VAL . 83.6 mt -120.08 142.13 49.15 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.143 0.577 . . . . 74.11 110.491 -175.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -146.38 143.22 28.92 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.344 1.458 . . . . 74.02 107.612 174.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 15.2 t -103.95 165.37 11.09 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.983 -0.747 . . . . 72.21 108.983 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.584 ' HB1' ' HB ' ' D' ' 59' ' ' VAL . . . -151.37 147.44 26.92 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.258 -1.386 . . . . 65.51 107.258 175.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 6.4 p . . . . . 0 C--O 1.246 0.899 0 C-N-CA 123.753 0.821 . . . . 70.21 108.879 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' D' ' 85' ' ' SER . 3.5 m-20 . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 114.05 1.13 . . . . 55.52 114.05 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 89.8 t -134.18 100.54 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.001 -1.111 . . . . 70.31 108.001 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -117.84 138.47 52.07 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.034 0.934 . . . . 74.44 109.891 -170.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.667 ' HG2' HG13 ' D' ' 83' ' ' ILE . 33.8 mt-10 -87.95 108.34 19.15 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 108.521 -0.918 . . . . 72.2 108.521 170.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 97.4 t -101.08 123.79 54.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.77 -0.826 . . . . 64.23 108.77 175.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.584 ' HB ' ' HB1' ' D' ' 47' ' ' ALA . 21.3 t -114.24 130.86 67.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.994 -1.113 . . . . 74.34 107.994 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.558 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -105.35 119.81 40.01 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.792 -1.188 . . . . 71.52 107.792 -178.563 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -98.6 99.79 10.96 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.237 -1.024 . . . . 64.53 108.237 177.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.411 HG21 ' CD2' ' D' ' 44' ' ' LEU . 58.3 t -105.86 118.46 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 108.66 -0.867 . . . . 74.35 108.66 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.0 m -125.45 130.59 52.13 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.593 -0.73 . . . . 63.44 109.751 -170.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.656 HG13 HG11 ' D' ' 40' ' ' VAL . 70.3 t -113.22 130.6 66.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 124.845 1.258 . . . . 73.22 109.445 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 37.3 m -119.55 93.49 4.09 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.218 -1.401 . . . . 74.22 107.218 167.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.71 138.13 36.32 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.787 -0.82 . . . . 74.52 108.787 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.507 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 66.9 m -143.43 132.29 22.73 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.193 0.521 . . . . 75.54 111.232 -175.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 35.6 mt -95.55 99.26 11.16 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.482 -1.303 . . . . 64.12 107.482 173.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.57 -137.36 17.37 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.578 -0.737 . . . . 74.12 112.619 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.44 5.26 31.84 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.611 0.764 . . . . 74.14 111.95 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.545 ' HB3' ' NZ ' ' D' ' 34' ' ' LYS . 5.4 tp10 -136.6 145.67 45.17 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.194 0.998 . . . . 72.22 109.599 -169.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 91.8 m -59.83 135.95 57.85 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.741 1.217 . . . . 53.22 112.522 -175.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.507 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.6 -65.62 1.0 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.301 -1.37 . . . . 74.12 107.301 170.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -152.57 158.26 42.23 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 114.542 -1.208 . . . . 75.13 110.045 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.447 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 76.0 mt -116.84 155.02 29.73 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.867 1.267 . . . . 73.52 108.269 171.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.561 ' SG ' HG12 ' D' ' 114' ' ' ILE . 49.1 t -154.42 147.71 24.9 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.059 -0.719 . . . . 70.0 109.059 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -157.43 123.78 4.88 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.818 0.447 . . . . 64.11 110.129 174.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 50.2 t -124.3 116.93 49.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 123.523 0.729 . . . . 72.24 109.118 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.625 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.9 mt-30 -93.25 85.1 4.92 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.938 0.875 . . . . 72.55 109.08 171.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -80.4 102.64 9.74 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 113.713 -1.585 . . . . 71.33 109.465 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.84 150.83 21.31 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 116.742 -0.208 . . . . 73.5 113.219 -178.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.58 137.24 5.58 Favored Glycine 0 C--N 1.34 0.791 0 N-CA-C 112.092 -0.403 . . . . 52.24 112.092 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.667 HG13 ' HG2' ' D' ' 57' ' ' GLU . 2.6 mp -91.15 112.84 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 107.775 -1.194 . . . . 65.13 107.775 174.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -115.33 145.29 42.64 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.69 0.796 . . . . 73.43 109.669 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' D' ' 54' ' ' ASP . 39.8 m -116.29 107.78 15.27 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.836 0.854 . . . . 63.41 109.766 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.452 HD13 HD22 ' D' ' 98' ' ' LEU . 46.9 pt -116.8 129.35 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.387 0.675 . . . . 73.42 109.391 176.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.424 ' HB2' HG21 ' D' ' 10' ' ' THR . . . -143.49 158.18 43.85 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.675 0.79 . . . . 71.44 110.149 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.07 23.64 44.18 Favored Glycine 0 C--N 1.347 1.16 0 O-C-N 123.709 0.631 . . . . 73.4 114.247 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.423 HD11 ' HG3' ' D' ' 94' ' ' MET . 0.7 OUTLIER -134.85 160.94 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.476 0.71 . . . . 70.33 110.726 178.254 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.13 160.2 40.48 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.137 0.898 . . . . 75.14 111.019 -171.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.67 -141.35 36.52 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.194 -0.912 . . . . 71.54 113.945 175.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.5 p -78.41 -32.31 48.62 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.138 0.575 . . . . 74.23 110.739 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -56.46 -33.58 66.06 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.881 0.873 . . . . 74.23 111.266 177.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.423 ' HG3' HD11 ' D' ' 89' ' ' ILE . 40.0 ttp -62.44 -62.19 1.93 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.146 1.378 . . . . 71.22 112.165 177.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.28 -15.09 51.54 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.066 0.546 . . . . 53.32 112.176 -171.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -70.83 -26.59 63.35 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.109 0.564 . . . . 74.22 110.088 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.7 t -66.41 -45.65 79.21 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.273 0.629 . . . . 75.42 110.947 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.604 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 4.3 pp -74.35 -23.08 58.97 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 116.608 -0.269 . . . . 74.42 111.207 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.82 -28.59 34.44 Favored Glycine 0 C--N 1.348 1.23 0 O-C-N 123.458 0.474 . . . . 73.34 112.958 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.24 -57.37 2.01 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 117.332 0.566 . . . . 62.11 112.233 -170.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -72.48 -37.64 68.39 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.524 0.329 . . . . 74.24 111.833 -174.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.604 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 88.6 m -65.35 -46.62 70.81 Favored Pre-proline 0 CA--C 1.566 1.592 0 CA-C-O 118.775 -0.631 . . . . 73.41 112.198 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.558 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 76.2 Cg_exo -57.61 -31.3 91.4 Favored 'Trans proline' 0 C--N 1.394 2.923 0 C-N-CA 122.622 2.215 . . . . 74.34 113.902 168.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -65.57 -28.55 69.23 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.092 0.557 . . . . 61.43 111.186 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.4 mm -73.32 -35.29 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.316 0.646 . . . . 75.05 110.332 174.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 68.3 mt -77.1 -18.24 58.1 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.352 -0.84 . . . . 74.14 111.891 -177.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -70.46 -39.91 10.5 Favored Pre-proline 0 CA--C 1.557 1.218 0 N-CA-C 114.353 1.242 . . . . 74.4 114.353 -171.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.79 -44.9 45.15 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.962 1.775 . . . . 71.33 112.68 169.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -71.83 -32.58 67.69 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.845 0.858 . . . . 71.12 111.554 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.99 -50.52 64.01 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.467 0.707 . . . . 55.34 110.237 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.497 ' NH2' HG23 ' B' ' 105' ' ' ILE . 31.3 ttp180 -60.22 -43.06 96.31 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 124.353 1.033 . . . . 72.22 110.031 176.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -57.0 -52.77 63.94 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.102 0.876 . . . . 63.31 111.455 -176.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.437 ' O ' ' HG3' ' D' ' 117' ' ' MET . 43.2 t -57.06 -44.17 82.76 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 124.177 0.923 . . . . 73.3 110.598 -177.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.561 HG12 ' SG ' ' D' ' 76' ' ' CYS . 83.7 mt -60.62 -54.95 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.743 0.817 . . . . 73.31 110.696 175.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 77.2 m -53.43 -43.74 68.23 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.382 1.473 . . . . 62.2 111.055 -175.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -65.36 -45.9 82.31 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.403 -1.272 . . . . 72.04 109.805 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.448 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 71.2 mtm -70.87 -26.97 63.48 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.0 0.52 . . . . 73.43 112.391 -177.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.432 HG23 ' O ' ' D' ' 114' ' ' ILE . 71.0 t -68.64 -46.16 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.216 0.606 . . . . 70.51 109.419 175.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 81.5 p -70.75 -29.69 66.0 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.588 -0.733 . . . . 72.45 110.463 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -70.83 -34.15 71.41 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.815 0.846 . . . . 72.55 110.0 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.7 6.17 71.06 Favored Glycine 0 C--N 1.355 1.625 0 O-C-N 123.681 0.613 . . . . 53.14 113.203 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.419 HG22 ' HB3' ' C' ' 17' ' ' TYR . 65.3 p 56.18 28.94 13.87 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 126.39 1.876 . . . . 72.53 113.349 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -92.79 148.93 36.94 Favored Pre-proline 0 C--O 1.241 0.655 0 N-CA-C 108.598 -0.89 . . . . 75.54 108.598 167.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.35 125.96 13.04 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 123.318 2.679 . . . . 71.04 112.466 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -47.91 124.9 8.05 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 124.607 1.192 . . . . 74.54 112.149 -173.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.655 HD12 HG23 ' D' ' 40' ' ' VAL . 16.6 tp -106.49 106.1 16.46 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.165 0.986 . . . . 75.03 109.682 -176.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -109.47 83.01 1.68 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.322 1.049 . . . . 73.44 108.532 175.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.442 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.6 pp -62.98 141.91 58.57 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.958 0.503 . . . . 64.34 110.393 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.24 139.86 90.14 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 122.74 0.416 . . . . 75.42 111.609 -173.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.51 144.73 36.54 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.682 2.255 . . . . 75.51 111.365 176.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.99 145.59 23.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.815 0 C-N-CA 122.977 0.511 . . . . 71.22 110.129 -177.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -78.71 112.28 15.67 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.508 0.723 . . . . 71.42 109.24 176.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 . . . . . 0 N--CA 1.48 1.039 0 C-N-CA 123.968 0.907 . . . . 74.23 112.146 -176.489 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.3 m . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 108.218 -1.03 . . . . 75.24 108.218 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -120.96 119.77 33.54 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.978 0.911 . . . . 65.43 109.211 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -135.25 132.47 37.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.006 0.923 . . . . 73.44 108.586 174.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.531 HD12 HG21 ' A' ' 105' ' ' ILE . 4.8 mt -96.17 114.47 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 108.617 -0.883 . . . . 73.3 108.617 173.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -78.32 -32.95 49.52 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.014 0.525 . . . . 75.1 110.249 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -171.85 148.69 2.37 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 123.378 0.424 . . . . 75.14 110.144 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.2 mt -133.12 135.26 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 124.632 1.173 . . . . 73.45 108.502 173.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -163.2 171.74 15.81 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 123.982 0.801 . . . . 75.32 112.104 -171.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -101.78 124.39 47.34 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.366 -0.976 . . . . 72.21 108.366 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -85.91 -35.69 20.36 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.039 0.447 . . . . 74.25 109.889 175.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.518 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 19.7 t70 -146.66 138.96 24.9 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.15 -0.932 . . . . 74.11 109.401 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 81.0 mt -129.11 140.32 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.009 -1.108 . . . . 71.2 108.009 174.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.7 t -138.87 123.67 18.71 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.365 0.666 . . . . 72.11 109.279 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 86.9 t80 -133.59 129.38 36.89 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.265 -1.754 . . . . 74.33 106.265 170.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -139.17 124.45 19.11 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.955 -1.128 . . . . 74.13 107.955 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.7 89.26 7.42 Favored Pre-proline 0 C--O 1.241 0.658 0 N-CA-C 107.886 -1.153 . . . . 71.44 107.886 175.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -52.31 -53.39 7.0 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 123.684 2.923 . . . . 72.24 113.504 -169.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.26 41.27 2.83 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.779 -0.823 . . . . 74.53 108.779 -173.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.433 ' O ' HG11 ' A' ' 31' ' ' VAL . . . -44.66 -59.13 4.34 Favored Pre-proline 0 N--CA 1.495 1.789 0 CA-C-O 117.584 -1.198 . . . . 71.21 113.968 -171.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.431 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 20.9 Cg_exo -62.37 -22.54 74.22 Favored 'Trans proline' 0 C--N 1.389 2.669 0 CA-C-N 121.952 1.733 . . . . 74.5 112.618 -177.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -94.47 -28.36 15.5 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.613 1.165 . . . . 72.21 111.244 -173.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.433 HG11 ' O ' ' A' ' 28' ' ' ALA . 5.9 p -80.05 -17.09 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 122.698 0.399 . . . . 62.13 111.877 -170.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -78.23 -24.12 47.11 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.393 0.677 . . . . 75.24 111.206 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -92.56 -16.08 26.15 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.782 0.833 . . . . 75.35 110.687 176.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -67.57 157.81 33.5 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.29 0.636 . . . . 74.04 111.156 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -67.54 116.63 8.48 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.401 -0.963 . . . . 72.42 108.401 171.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.42 ' CE3' HD21 ' A' ' 68' ' ' LEU . 73.7 t-105 -83.8 82.13 8.46 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.092 0.557 . . . . 72.53 110.372 -175.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -115.16 81.78 8.33 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 107.572 -1.27 . . . . 74.51 107.572 168.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -86.53 121.34 1.88 Allowed 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.424 2.083 . . . . 73.4 112.499 -173.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -94.95 95.45 8.64 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.069 -1.456 . . . . 75.31 107.069 168.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.731 HG23 ' HB1' ' A' ' 66' ' ' ALA . 48.0 t -85.71 104.38 13.41 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-N 115.727 -0.67 . . . . 74.23 109.554 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.543 ' HB2' ' HZ2' ' A' ' 41' ' ' LYS . 7.1 mtmp? -79.18 121.44 25.03 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.025 -1.102 . . . . 73.32 108.025 173.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tt -96.19 105.12 17.13 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 105.841 -1.911 . . . . 75.52 105.841 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -112.39 145.25 40.44 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 107.907 -1.146 . . . . 73.41 107.907 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.492 HD11 HG22 ' A' ' 131' ' ' VAL . 90.1 mt -136.82 146.98 46.3 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.913 0.485 . . . . 74.12 112.094 -171.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -155.09 117.52 4.25 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.906 -1.043 . . . . 73.12 108.765 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.404 HG22 ' HG3' ' A' ' 103' ' ' PRO . 54.3 m -117.5 126.9 53.4 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.068 0.547 . . . . 71.31 109.997 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.52 127.15 23.42 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.179 0.591 . . . . 75.23 109.94 176.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 61.7 p -101.82 170.72 7.97 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.943 0.897 . . . . 64.33 111.391 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 94.5 p -150.17 124.4 9.48 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.94 0.896 . . . . 53.1 109.382 -173.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -78.88 103.7 9.0 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.187 -0.671 . . . . 73.31 109.187 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.42 HD13 ' HB2' ' A' ' 57' ' ' GLU . 69.9 mt -79.39 -26.8 41.87 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.512 0.725 . . . . 75.52 110.848 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.14 -175.08 2.51 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.918 0.887 . . . . 73.4 110.049 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.92 112.33 2.27 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 109.152 -0.684 . . . . 70.22 109.152 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 68.21 6.33 5.21 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.745 1.218 . . . . 75.22 112.884 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.6 t -105.16 116.23 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.014 -1.106 . . . . 62.43 108.014 173.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -132.25 127.33 35.49 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.302 -0.999 . . . . 73.1 108.302 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.42 ' HB2' HD13 ' A' ' 51' ' ' LEU . 23.9 tt0 -88.55 143.37 27.0 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 108.036 -1.098 . . . . 74.22 108.036 167.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.6 t -118.51 134.67 61.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.049 -1.093 . . . . 74.14 108.049 170.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.8 t -117.72 124.46 73.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 108.607 -0.886 . . . . 73.55 108.607 174.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.23 119.68 39.49 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.535 -1.283 . . . . 72.22 107.535 175.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 46.3 ttp85 -109.48 100.98 9.98 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.559 -1.274 . . . . 74.24 107.559 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 43.7 t -96.23 103.0 14.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 114.204 -1.362 . . . . 71.21 107.909 -178.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.8 m -96.27 107.45 19.8 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 122.066 0.936 . . . . 75.52 108.918 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.427 ' O ' HD12 ' A' ' 75' ' ' LEU . 43.4 t -104.72 135.91 40.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 114.599 -1.182 . . . . 74.03 108.592 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 35.7 m -138.1 126.43 23.17 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.497 -0.557 . . . . 75.32 109.497 173.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.731 ' HB1' HG23 ' A' ' 40' ' ' VAL . . . -105.31 130.34 53.45 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.326 -1.361 . . . . 70.34 107.326 173.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 54.9 m -136.52 134.15 37.23 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.7 0.625 . . . . 74.41 110.507 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.42 HD21 ' CE3' ' A' ' 36' ' ' TRP . 23.7 mt -87.25 69.12 10.01 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 107.532 -1.284 . . . . 75.03 107.532 174.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.26 -100.83 1.3 Allowed Glycine 0 C--N 1.346 1.117 0 CA-C-N 114.307 -1.315 . . . . 74.22 111.939 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -91.14 -27.54 18.47 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.931 0.892 . . . . 75.42 111.604 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -91.33 123.02 34.45 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.485 -0.561 . . . . 74.35 109.485 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.9 m -71.49 129.96 40.07 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.029 0.443 . . . . 74.12 110.431 172.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.33 -52.2 8.41 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.389 1.075 . . . . 75.12 109.162 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -160.47 160.49 32.11 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.225 -0.898 . . . . 73.22 111.615 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 64' ' ' VAL . 63.9 tp -112.68 143.53 43.74 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.806 1.242 . . . . 74.31 108.132 166.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 88.5 m -143.75 98.81 3.3 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.86 0.864 . . . . 74.21 109.651 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 35.0 tt0 -122.37 116.12 23.48 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.915 -0.772 . . . . 64.05 108.915 -176.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.6 t -124.38 122.28 63.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 121.441 0.638 . . . . 64.41 109.885 -177.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -99.75 82.07 2.55 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.298 -1.319 . . . . 71.12 108.019 -178.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -76.02 94.47 3.43 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.038 -0.983 . . . . 74.14 109.11 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.05 150.99 21.8 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.664 -0.698 . . . . 75.41 111.383 177.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.76 132.68 3.35 Favored Glycine 0 CA--C 1.507 -0.446 0 N-CA-C 111.017 -0.833 . . . . 61.11 111.017 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.7 mt -81.41 127.07 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.384 -0.969 . . . . 71.1 108.384 175.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.554 ' HB3' HD11 ' A' ' 86' ' ' ILE . 95.8 m-85 -124.81 120.02 30.52 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.311 1.044 . . . . 72.35 108.618 -177.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.9 m -92.67 99.2 11.94 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.346 -1.353 . . . . 64.14 107.346 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.554 HD11 ' HB3' ' A' ' 84' ' ' PHE . 10.9 mm -117.15 145.99 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 122.787 0.435 . . . . 73.31 110.118 -174.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.91 169.95 17.41 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.688 0.617 . . . . 74.43 110.859 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.45 -15.12 63.36 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.702 -0.681 . . . . 63.51 112.824 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.45 164.54 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 124.188 0.995 . . . . 73.31 110.412 -177.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.605 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 13.8 tt0 -154.8 -177.74 6.72 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 109.402 -0.592 . . . . 74.12 109.402 173.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.537 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 67.53 -122.14 16.84 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 123.208 0.433 . . . . 65.44 113.513 176.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.5 t -74.36 -28.94 61.36 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.711 0.804 . . . . 73.22 111.522 -176.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -73.64 -37.29 65.38 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.518 0.727 . . . . 75.0 109.582 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.605 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 3.2 tpt -66.24 -42.79 88.09 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.237 -0.892 . . . . 73.23 110.053 175.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.18 88.82 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.362 -0.835 . . . . 50.41 111.109 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.473 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 55.8 t-80 -74.9 -20.53 59.68 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.014 0.526 . . . . 73.43 111.163 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.5 t -78.21 -49.01 14.57 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.785 -0.572 . . . . 75.15 109.539 174.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 76.1 mt -78.81 -31.44 45.9 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.245 0.618 . . . . 75.22 112.575 -172.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.35 4.41 51.36 Favored Glycine 0 N--CA 1.47 0.953 0 CA-C-O 119.649 -0.528 . . . . 75.15 113.583 -174.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.537 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -144.47 -63.64 0.36 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.448 0.624 . . . . 65.21 112.009 -175.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -69.61 -47.1 64.63 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 112.083 0.401 . . . . 73.14 112.083 -172.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 88.8 m -65.78 -47.13 66.26 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.401 1.08 . . . . 60.33 112.966 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.404 ' HG3' HG22 ' A' ' 46' ' ' THR . 37.8 Cg_endo -65.0 -24.81 59.75 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 122.023 1.815 . . . . 74.24 112.955 173.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -68.83 -33.69 74.25 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.13 0.572 . . . . 73.31 110.505 174.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.531 HG21 HD12 ' A' ' 13' ' ' ILE . 43.8 mm -68.3 -42.44 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.77 0.828 . . . . 73.52 110.4 172.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.8 mt -74.25 -25.01 59.38 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.054 -0.976 . . . . 75.44 112.089 -174.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -64.69 -40.87 52.73 Favored Pre-proline 0 CA--C 1.558 1.282 0 N-CA-C 114.49 1.293 . . . . 75.42 114.49 -171.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -52.55 -42.05 64.33 Favored 'Trans proline' 0 C--N 1.385 2.452 0 CA-C-N 121.966 1.738 . . . . 73.34 113.23 170.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -73.43 -40.28 64.36 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.533 0.733 . . . . 75.2 111.318 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.52 -46.59 82.25 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.483 0.713 . . . . 65.32 110.106 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.541 ' NH1' HD13 ' C' ' 105' ' ' ILE . 29.8 ttm180 -52.06 -50.43 61.51 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.959 1.304 . . . . 74.54 110.869 174.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -62.6 -47.79 82.26 Favored 'General case' 0 C--N 1.346 0.429 0 O-C-N 124.431 1.082 . . . . 70.15 111.436 -175.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.414 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 49.7 t -57.51 -42.76 83.42 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 124.173 0.921 . . . . 74.45 110.455 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.588 HD13 HD12 ' A' ' 128' ' ' LEU . 96.6 mt -60.97 -50.13 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.488 1.115 . . . . 73.14 110.607 175.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.0 m -61.33 -39.31 90.08 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.015 0.926 . . . . 74.13 111.379 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -69.89 -43.11 72.45 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.98 -1.009 . . . . 71.21 109.813 -177.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 6.9 mtp -56.97 -43.95 82.14 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.774 0.83 . . . . 75.01 111.129 174.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.8 t -62.07 -47.11 94.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.556 1.142 . . . . 74.3 111.101 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.7 p -73.95 -29.38 61.98 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 122.906 0.483 . . . . 75.42 111.654 -176.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.444 ' NH1' ' HA ' ' B' ' 113' ' ' CYS . 68.4 mtt-85 -71.62 -30.93 66.33 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.214 0.606 . . . . 70.14 109.627 174.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.92 14.24 44.34 Favored Glycine 0 C--N 1.35 1.33 0 CA-C-N 115.413 -0.812 . . . . 74.32 112.976 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.477 HG23 ' HE ' ' B' ' 15' ' ' ARG . 3.2 t 57.31 13.8 1.88 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 127.156 2.183 . . . . 71.31 113.605 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -77.47 142.14 66.52 Favored Pre-proline 0 C--O 1.244 0.774 0 N-CA-C 108.903 -0.777 . . . . 73.32 108.903 175.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -43.84 128.25 6.88 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 123.612 2.875 . . . . 74.51 112.622 170.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -55.35 131.88 46.76 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.22 0.95 . . . . 65.41 112.375 -167.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.623 HD13 HG12 ' A' ' 40' ' ' VAL . 42.6 tp -112.62 117.16 31.51 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.751 1.22 . . . . 75.24 109.932 -174.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -121.14 104.61 9.9 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.028 -0.73 . . . . 72.23 109.028 -174.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.588 HD12 HD13 ' A' ' 114' ' ' ILE . 79.2 mt -61.81 144.69 54.42 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.367 0.667 . . . . 73.34 112.336 -173.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.98 144.84 90.82 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.299 0.64 . . . . 72.32 110.304 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.432 ' HA ' HH22 ' A' ' 111' ' ' ARG . 24.8 Cg_exo -64.05 117.51 4.52 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.834 2.356 . . . . 71.34 112.599 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.492 HG22 HD11 ' A' ' 44' ' ' LEU . 87.9 t -100.22 132.6 45.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-N 116.126 -0.488 . . . . 73.22 110.299 -179.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.432 ' OD1' ' HB3' ' A' ' 134' ' ' ASP . 63.7 t30 -97.59 92.94 6.15 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.725 -1.213 . . . . 74.12 107.725 172.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -65.3 -25.18 67.52 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.577 0.751 . . . . 64.32 111.355 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.537 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 1.1 t70 -54.74 -48.27 72.79 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.958 0.903 . . . . 72.32 110.291 168.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.81 -45.41 92.77 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.571 0.748 . . . . 44.12 111.711 177.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.74 -35.98 79.66 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.365 0.666 . . . . 74.24 111.396 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 42.4 t80 . . . . . 0 CA--C 1.538 0.517 0 CA-C-N 115.504 -0.771 . . . . 73.43 109.858 177.939 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.579 ' HE3' ' SG ' ' B' ' 97' ' ' CYS . 11.8 ptm . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 115.442 1.645 . . . . 71.03 115.442 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 5.0 t -135.79 126.93 28.04 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.46 -1.245 . . . . 75.52 107.701 168.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.411 ' HB2' ' HE2' ' B' ' 9' ' ' MET . 59.0 t80 -130.82 144.18 51.27 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.909 0.484 . . . . 75.41 110.132 -176.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -150.28 141.92 23.58 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 108.693 -0.855 . . . . 72.31 108.693 169.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.482 HD12 HD11 ' B' ' 16' ' ' ILE . 63.1 mt -81.44 125.2 39.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.527 -1.286 . . . . 73.1 107.527 171.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . 0.543 ' HB2' HG23 ' B' ' 83' ' ' ILE . 9.3 mm100 -90.16 -39.06 13.07 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.785 -0.45 . . . . 65.43 109.785 -176.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.477 ' HE ' HG23 ' A' ' 122' ' ' THR . 43.2 ttt180 -176.97 134.48 0.2 Allowed 'General case' 0 N--CA 1.477 0.917 0 O-C-N 123.919 0.762 . . . . 75.15 109.81 176.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.551 ' HB ' ' ND2' ' D' ' 127' ' ' ASN . 96.7 mt -115.63 141.37 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 107.851 -1.166 . . . . 71.41 107.851 173.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -168.44 151.35 5.41 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-O 121.386 0.613 . . . . 74.44 111.568 -174.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 89.5 m -79.06 126.9 31.3 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.953 -1.021 . . . . 71.4 109.24 172.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -89.61 -42.74 11.22 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.73 0.412 . . . . 70.01 110.071 169.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.478 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.1 t70 -140.65 136.82 33.07 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.573 -0.285 . . . . 75.43 110.541 -169.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.575 HD13 ' SG ' ' B' ' 113' ' ' CYS . 46.6 mm -126.18 137.09 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.015 0.926 . . . . 74.01 108.772 169.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.486 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 47.7 t -140.52 131.62 26.34 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.686 1.194 . . . . 75.23 107.866 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 80.2 t80 -143.68 121.81 12.18 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.319 -1.734 . . . . 73.0 106.319 170.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -126.71 113.59 16.87 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.117 -1.068 . . . . 75.22 108.117 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.464 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -106.7 87.21 2.66 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 106.633 -1.617 . . . . 65.1 106.633 167.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.66 -27.85 52.69 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.327 2.018 . . . . 74.21 110.962 -172.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.415 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 67.5 m-20 -109.82 11.49 24.31 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.507 1.123 . . . . 71.4 110.939 -177.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.464 ' HB1' ' HB2' ' B' ' 25' ' ' ALA . . . -30.48 -64.34 0.21 Allowed Pre-proline 0 N--CA 1.5 2.049 0 C-N-CA 125.517 1.527 . . . . 64.51 114.699 -172.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.422 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 14.3 Cg_exo -60.48 -34.8 92.52 Favored 'Trans proline' 0 C--N 1.395 3.015 0 C-N-CA 122.729 2.286 . . . . 72.42 112.199 -170.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.412 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 80.5 m80 -92.52 -39.76 11.19 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 114.442 -1.253 . . . . 73.44 112.39 -170.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -69.76 -12.66 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.032 0.533 . . . . 74.33 111.808 -171.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -69.76 -6.7 33.82 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.651 0.78 . . . . 74.45 112.92 173.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.42 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 29.4 pt20 -67.9 -22.11 65.1 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.816 0.447 . . . . 74.44 110.168 169.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.508 ' HZ1' ' HG2' ' B' ' 71' ' ' GLU . 92.6 mttt -101.43 92.79 5.08 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.672 1.189 . . . . 74.31 109.869 -176.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -99.17 82.5 2.72 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.623 0.769 . . . . 73.15 110.057 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -157.01 -177.97 7.02 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.733 0.813 . . . . 72.03 109.61 172.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -66.86 114.77 19.41 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.63 0.772 . . . . 64.01 110.588 175.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.528 ' HA ' HD21 ' B' ' 68' ' ' LEU . 41.8 Cg_endo -66.3 144.36 74.02 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 121.597 1.531 . . . . 73.55 110.678 172.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -71.4 113.3 8.29 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.525 -0.917 . . . . 73.24 108.525 172.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.582 HG12 HD13 ' B' ' 126' ' ' LEU . 57.4 t -106.5 150.41 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.063 0.945 . . . . 73.52 111.378 -170.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -138.0 119.29 14.66 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.925 1.29 . . . . 74.04 107.854 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.473 HD12 HG21 ' B' ' 64' ' ' VAL . 23.3 tp -85.43 138.62 32.13 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.359 -0.978 . . . . 74.44 108.359 173.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -140.05 112.38 7.77 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.858 -1.164 . . . . 73.02 107.858 -171.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 88.4 mt -103.1 139.57 38.45 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.275 0.63 . . . . 74.12 110.778 -171.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -148.28 146.02 28.43 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.126 1.37 . . . . 74.22 107.638 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.4 t -151.24 110.91 4.02 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 121.432 0.634 . . . . 74.13 111.737 -177.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.63 148.53 40.88 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.346 1.058 . . . . 74.2 108.367 175.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 20.8 p -142.8 177.18 8.51 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.429 0.691 . . . . 72.14 111.109 -172.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 58.7 p -156.2 134.6 11.52 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.314 1.045 . . . . 72.3 108.675 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -92.17 111.05 22.46 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.158 -1.053 . . . . 73.45 108.158 172.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 pp -120.53 17.31 12.09 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.945 0.898 . . . . 64.24 110.955 -175.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . 0.456 ' HB1' ' HB ' ' B' ' 55' ' ' VAL . . . -162.3 150.86 14.88 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.321 1.048 . . . . 70.13 109.3 175.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -67.15 116.58 8.11 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.578 0.351 . . . . 53.24 110.341 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 72.35 -3.61 2.25 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.422 1.489 . . . . 64.34 112.357 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.456 ' HB ' ' HB1' ' B' ' 52' ' ' ALA . 44.0 t -119.32 102.15 12.48 Favored 'Isoleucine or valine' 0 C--N 1.347 0.483 0 N-CA-C 107.45 -1.315 . . . . 61.44 107.45 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.497 ' CE2' ' HB ' ' B' ' 58' ' ' VAL . 0.1 OUTLIER -94.31 -177.96 4.44 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.736 -0.838 . . . . 75.34 108.736 -178.055 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.512 ' HG2' ' HB ' ' B' ' 83' ' ' ILE . 4.2 tm-20 -142.34 118.54 10.76 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 107.218 -1.401 . . . . 75.13 107.218 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.497 ' HB ' ' CE2' ' B' ' 56' ' ' TYR . 12.0 p -111.09 148.19 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-O 121.094 0.473 . . . . 74.12 110.938 -178.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.459 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 28.7 t -119.02 134.36 62.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.052 -1.092 . . . . 73.14 108.052 171.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 59.1 tp -114.21 103.39 11.06 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 108.291 -1.003 . . . . 73.34 108.291 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -84.81 109.48 18.12 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.593 0.711 . . . . 74.14 109.241 175.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 56.1 t -107.06 103.44 15.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 107.769 -1.197 . . . . 72.42 107.769 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.9 m -102.21 132.69 47.98 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.738 -0.664 . . . . 74.45 109.567 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.584 HG23 HD12 ' B' ' 114' ' ' ILE . 82.6 t -116.76 117.31 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.138 0.975 . . . . 73.13 109.362 174.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 10.6 m -87.23 140.42 29.56 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.126 -1.064 . . . . 73.24 108.126 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.9 140.39 23.38 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 118.045 0.384 . . . . 71.33 110.413 175.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.405 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 52.6 p -146.44 133.13 19.93 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.058 0.456 . . . . 64.3 111.598 -175.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.528 HD21 ' HA ' ' B' ' 38' ' ' PRO . 72.9 mt -100.11 100.96 11.89 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.341 1.056 . . . . 75.35 108.661 176.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.58 -134.73 24.46 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.992 -0.549 . . . . 72.13 112.248 -176.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -83.01 4.28 26.66 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.755 0.822 . . . . 75.51 113.033 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.508 ' HG2' ' HZ1' ' B' ' 34' ' ' LYS . 12.0 pt-20 -127.1 150.91 49.26 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.851 0.296 . . . . 74.01 110.49 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 85.8 m -69.4 135.84 50.85 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 123.533 0.521 . . . . 72.35 110.464 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.405 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -85.88 -63.64 1.29 Allowed 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.414 -1.328 . . . . 72.0 107.414 175.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -151.92 162.87 40.37 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.326 -1.306 . . . . 70.14 110.58 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 52.0 mt -132.32 110.42 10.57 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 105.443 -2.058 . . . . 73.31 105.443 175.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 34.4 t -116.96 145.32 43.71 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.323 -0.991 . . . . 75.34 108.323 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.486 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.9 tt0 -155.1 132.03 10.79 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.306 -0.998 . . . . 73.43 108.306 -177.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.433 HG21 HD12 ' B' ' 21' ' ' ILE . 94.7 t -127.26 143.53 40.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.973 -1.121 . . . . 55.33 107.973 174.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.478 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 26.2 mt-30 -119.6 86.99 2.65 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.092 -1.077 . . . . 74.12 108.092 174.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.46 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.5 tp-100 -82.95 102.84 11.97 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 114.738 -1.119 . . . . 74.42 109.281 -177.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -87.74 162.71 33.1 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-N 115.893 -0.594 . . . . 62.21 111.634 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.9 125.76 1.34 Allowed Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.544 -1.022 . . . . 63.32 110.544 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.543 HG23 ' HB2' ' B' ' 14' ' ' GLN . 18.8 tt -95.68 131.01 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 108.57 -0.9 . . . . 74.22 108.57 175.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -137.0 141.25 42.54 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.604 0.762 . . . . 74.53 109.437 -175.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.2 m -88.77 106.93 18.68 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.658 -0.867 . . . . 72.51 108.658 172.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 23.8 mm -97.37 109.66 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 107.873 -1.158 . . . . 74.02 107.873 -173.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.31 172.14 18.69 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.025 0.441 . . . . 75.43 111.58 -172.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 83.28 -47.11 3.76 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.506 -0.77 . . . . 73.3 112.631 -178.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.54 HG21 ' HB3' ' B' ' 9' ' ' MET . 1.0 OUTLIER -78.52 159.43 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 109.743 -0.465 . . . . 74.21 109.743 168.647 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -165.75 145.16 6.33 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 123.556 0.535 . . . . 74.32 110.86 -171.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.97 -100.54 2.7 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-O 120.174 -0.237 . . . . 74.32 113.347 175.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.1 m -95.96 -54.9 3.16 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 122.08 0.943 . . . . 73.22 110.12 -175.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -67.58 -18.23 64.92 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 113.52 -1.673 . . . . 61.44 111.383 -171.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.42 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 22.6 ptt? -61.42 -44.25 97.45 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.836 0.854 . . . . 74.52 113.057 -176.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.02 -11.72 60.01 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.049 0.54 . . . . 71.21 112.142 -175.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -63.79 -38.56 91.57 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.129 0.572 . . . . 64.32 110.359 168.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.579 ' SG ' ' HE3' ' B' ' 9' ' ' MET . 41.5 t -58.75 -52.67 64.7 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.258 0.551 . . . . 74.02 111.164 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.8 pp -83.44 -27.19 29.7 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.525 -0.761 . . . . 73.4 112.146 -174.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.21 -16.62 62.37 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-O 120.016 -0.324 . . . . 72.22 113.338 -176.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.82 -58.13 0.72 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.784 0.434 . . . . 71.42 112.093 -170.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -66.37 -43.53 85.69 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.125 0.57 . . . . 75.31 112.196 -173.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 59.7 m -71.38 -44.81 13.39 Favored Pre-proline 0 CA--C 1.562 1.437 0 CA-C-O 118.567 -0.73 . . . . 75.23 112.33 -175.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -59.17 -31.83 96.06 Favored 'Trans proline' 0 C--N 1.394 2.934 0 C-N-CA 121.887 1.725 . . . . 71.15 113.247 168.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -62.11 -36.81 82.87 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.192 0.597 . . . . 72.4 110.303 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 59.1 mt -65.39 -40.86 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.489 0.716 . . . . 73.35 110.433 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 94.7 mt -76.26 -24.88 54.51 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.698 -0.683 . . . . 75.12 112.668 -173.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -62.32 -45.04 89.93 Favored Pre-proline 0 CA--C 1.566 1.587 0 CA-C-O 117.78 -1.105 . . . . 72.43 113.691 -173.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -52.3 -43.33 54.55 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.516 2.144 . . . . 73.22 113.371 173.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.46 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 95.3 m-85 -64.17 -45.24 89.29 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.285 0.634 . . . . 74.44 110.149 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.87 82.37 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.457 -0.792 . . . . 62.14 111.049 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.499 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 65.0 ttt-85 -64.56 -61.34 2.27 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.454 1.102 . . . . 72.1 110.989 -175.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -67.44 -25.85 66.11 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 123.505 0.503 . . . . 73.14 111.032 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.575 ' SG ' HD13 ' B' ' 21' ' ' ILE . 3.9 t -66.19 -40.75 90.63 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 109.681 -0.488 . . . . 74.51 109.681 176.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.584 HD12 HG23 ' B' ' 64' ' ' VAL . 70.3 mt -62.9 -54.47 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.784 0.834 . . . . 71.44 110.418 172.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 6.3 m -60.89 -30.68 70.3 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.886 0.875 . . . . 72.21 111.68 -173.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 44.4 t -65.41 -48.63 72.17 Favored 'General case' 0 C--N 1.347 0.5 0 C-N-CA 123.6 0.76 . . . . 73.35 110.191 174.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.54 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.4 mmt -68.35 -29.74 68.54 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.032 0.533 . . . . 74.55 111.194 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.5 t -65.37 -44.36 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.442 1.097 . . . . 74.25 110.02 173.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 40.5 t -68.72 -29.92 68.44 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.241 -0.89 . . . . 64.44 111.174 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' B' ' 116' ' ' SER . 88.7 mtt-85 -65.14 -39.7 93.37 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 108.934 -0.765 . . . . 70.51 108.934 174.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.0 -5.28 75.09 Favored Glycine 0 C--N 1.356 1.675 0 O-C-N 123.651 0.595 . . . . 62.11 113.558 172.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 8.0 m 67.58 31.11 6.31 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.136 1.374 . . . . 74.04 111.006 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -91.68 160.45 36.38 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-N 114.821 -1.081 . . . . 74.2 111.143 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -51.31 157.72 4.33 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.838 3.025 . . . . 75.34 115.598 177.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.507 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 55.1 tp60 -58.26 113.91 2.16 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.257 1.423 . . . . 74.51 111.529 -177.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.582 HD13 HG12 ' B' ' 40' ' ' VAL . 32.5 tp -106.96 102.37 11.73 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.075 0.464 . . . . 74.33 109.771 -172.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . 0.432 HD22 ' HG3' ' B' ' 125' ' ' GLN . 29.2 m-80 -101.07 117.88 35.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.271 0.629 . . . . 71.34 109.431 -177.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.499 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 69.4 mt -85.89 135.9 33.5 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 109.886 -0.413 . . . . 73.21 109.886 172.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.34 138.43 74.94 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 123.494 0.718 . . . . 61.23 110.807 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.432 ' HG3' HD11 ' D' ' 16' ' ' ILE . 21.3 Cg_endo -60.19 101.99 0.17 Allowed 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 123.207 2.605 . . . . 75.31 111.946 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 18.1 m -90.15 109.95 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 122.013 0.911 . . . . 73.35 109.38 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 . . . . . 0 C--O 1.242 0.701 0 CA-C-N 115.068 -0.969 . . . . 75.24 109.402 -178.46 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.619 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 69.1 t80 . . . . . 0 C--O 1.237 0.422 0 N-CA-C 108.094 -1.076 . . . . 75.23 108.094 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -136.81 122.69 20.06 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.641 -0.874 . . . . 70.24 108.641 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.535 HD11 HG21 ' C' ' 105' ' ' ILE . 46.5 mt -83.05 126.78 40.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 109.279 -0.637 . . . . 74.15 109.279 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.406 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 27.7 mm-40 -87.06 -44.27 11.69 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.852 -0.796 . . . . 73.11 108.852 174.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 179.96 151.06 0.4 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.032 1.333 . . . . 75.44 109.462 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 83.7 mt -123.44 128.44 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 107.877 -1.157 . . . . 72.54 107.877 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.588 ' HB3' HG22 ' D' ' 122' ' ' THR . 35.5 p90 -161.27 149.92 16.01 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.318 0.58 . . . . 75.01 111.56 -167.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.7 p -80.61 119.72 23.62 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.35 -0.841 . . . . 74.3 110.575 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp -71.88 -36.62 70.14 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.619 -0.882 . . . . 73.42 108.619 169.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -148.85 148.43 29.89 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-N 115.092 -0.958 . . . . 72.21 110.006 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.1 mt -140.64 140.47 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 106.347 -1.724 . . . . 72.24 106.347 175.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 28.3 t -154.12 146.64 24.07 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.204 0.526 . . . . 74.12 110.526 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -155.17 129.37 8.9 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 107.013 -1.477 . . . . 75.51 107.013 172.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -137.69 123.96 20.55 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.247 0.619 . . . . 73.42 109.544 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -121.38 84.13 41.04 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 107.145 -1.428 . . . . 71.11 107.145 166.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.47 -24.07 43.01 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 122.422 2.081 . . . . 74.1 111.578 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -104.0 17.27 24.45 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.36 1.064 . . . . 74.21 110.516 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.53 -57.1 10.54 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 113.526 0.936 . . . . 75.4 113.526 -171.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -63.04 -39.16 41.51 Favored 'Trans proline' 0 C--N 1.393 2.884 0 C-N-CA 122.112 1.874 . . . . 70.31 111.962 -176.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -69.26 -37.06 77.75 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.367 -1.288 . . . . 73.24 111.996 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.686 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.8 p -82.55 -21.03 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 N-CA-C 112.907 0.706 . . . . 62.41 112.907 -176.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -66.28 -29.22 69.4 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 120.856 0.36 . . . . 73.21 111.652 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -94.96 14.18 22.55 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.848 0.859 . . . . 74.21 111.371 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -104.55 158.26 16.61 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.708 0.803 . . . . 75.45 109.668 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -70.25 115.38 9.37 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.672 0.789 . . . . 75.24 110.158 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -80.6 91.57 5.84 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.243 1.017 . . . . 72.25 111.333 -171.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . 0.432 ' H ' HD23 ' C' ' 68' ' ' LEU . 0.2 OUTLIER -139.58 73.72 34.89 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.368 1.067 . . . . 74.03 109.206 169.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -79.85 149.13 20.3 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.282 1.988 . . . . 72.13 112.192 -174.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -86.91 93.19 9.25 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.637 -1.616 . . . . 74.51 106.637 165.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 56.2 t -68.3 102.84 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 108.429 -0.952 . . . . 75.01 108.429 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -109.81 102.5 11.28 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.149 -1.056 . . . . 70.32 108.149 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 pp -87.96 139.57 30.38 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.011 -1.107 . . . . 71.2 108.011 172.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -139.86 118.64 12.42 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.148 -0.686 . . . . 75.42 109.148 -175.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 92.7 mt -111.95 138.95 47.88 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.77 0.828 . . . . 61.43 111.369 -171.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -147.62 127.08 13.17 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.788 1.235 . . . . 74.04 107.96 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 8.7 t -120.64 145.02 47.84 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 109.447 -0.575 . . . . 61.22 109.447 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.39 150.55 40.81 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.473 0.709 . . . . 75.01 109.781 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.507 ' HG ' HG21 ' C' ' 58' ' ' VAL . 32.8 m -141.64 155.0 45.73 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.053 0.541 . . . . 74.52 110.74 -177.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 61.7 p -151.85 129.86 11.81 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.082 0.953 . . . . 75.44 109.06 178.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -73.71 117.44 15.48 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.04 -0.726 . . . . 74.35 109.04 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.669 HD12 ' HB2' ' C' ' 57' ' ' GLU . 71.1 mt -86.89 -43.56 12.34 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.41 0.684 . . . . 73.32 109.976 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.26 -173.93 4.52 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.341 -0.845 . . . . 64.1 110.249 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.3 107.74 0.81 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.011 0.924 . . . . 72.05 110.217 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 66.37 22.05 10.84 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.221 1.008 . . . . 75.13 111.026 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 96.0 t -119.39 119.31 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.025 0.93 . . . . 71.44 108.732 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -127.15 126.82 43.56 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.289 1.036 . . . . 72.42 108.988 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.669 ' HB2' HD12 ' C' ' 51' ' ' LEU . 35.9 tt0 -83.9 126.19 32.74 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.402 -0.962 . . . . 73.23 108.402 168.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.507 HG21 ' HG ' ' C' ' 48' ' ' SER . 88.6 t -118.05 137.09 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.25 -0.648 . . . . 71.43 109.25 173.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.428 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 44.8 t -128.67 145.26 35.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.096 0.958 . . . . 73.02 108.869 177.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.435 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -126.72 104.35 8.03 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.476 -1.305 . . . . 75.41 107.476 177.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -81.98 106.17 13.68 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.285 -1.006 . . . . 75.44 108.285 171.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 23.2 t -104.65 133.57 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.907 -1.145 . . . . 72.13 107.907 172.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 84.9 m -126.97 136.74 52.68 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.385 -0.969 . . . . 71.41 108.385 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.455 HG22 HD12 ' C' ' 114' ' ' ILE . 85.2 t -122.56 114.12 41.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 109.422 -0.584 . . . . 74.34 109.422 173.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 18.7 m -98.54 137.34 37.34 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.716 -0.846 . . . . 74.1 108.716 172.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.79 113.81 17.12 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.14 -1.43 . . . . 72.35 107.14 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 44.0 m -136.76 128.61 29.15 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.464 0.477 . . . . 75.25 110.17 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.432 HD23 ' H ' ' C' ' 37' ' ' GLN . 49.8 mt -84.41 29.05 0.61 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.151 1.38 . . . . 73.32 111.265 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.64 -91.04 0.75 Allowed Glycine 0 C--N 1.35 1.345 0 N-CA-C 111.169 -0.772 . . . . 72.31 111.169 -175.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -90.67 -33.7 15.71 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.55 0.74 . . . . 71.15 109.27 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -88.87 122.18 31.99 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.597 1.159 . . . . 74.22 110.463 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 89.1 m -81.73 129.09 34.6 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.482 -0.562 . . . . 73.12 109.482 169.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.686 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -80.72 -58.45 3.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.791 0.836 . . . . 74.14 110.059 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -157.12 167.98 28.8 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.85 0.833 . . . . 75.32 111.224 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -131.51 137.35 48.5 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 106.655 -1.609 . . . . 75.52 106.655 166.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 41.8 t -137.07 149.32 47.32 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.582 -0.896 . . . . 54.45 108.582 176.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -157.78 133.65 9.27 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.44 -0.578 . . . . 73.12 109.44 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 73.7 t -132.75 132.46 59.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 124.143 0.977 . . . . 75.04 108.889 174.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -104.39 87.13 2.65 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.295 -1.002 . . . . 74.0 108.295 173.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -79.39 97.92 6.54 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.349 -0.841 . . . . 71.43 109.145 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -83.72 177.86 52.39 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 115.781 -0.645 . . . . 63.1 112.293 175.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 178.18 134.27 2.04 Favored Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 111.356 -0.698 . . . . 74.41 111.356 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.406 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 35.4 mm -88.7 125.81 41.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.361 -0.977 . . . . 75.54 108.361 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -130.3 117.86 20.44 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.47 0.708 . . . . 74.42 109.37 -178.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 11.4 p -85.01 102.19 12.99 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 108.466 -0.939 . . . . 72.23 108.466 172.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.501 HG21 ' HE2' ' C' ' 94' ' ' MET . 24.4 mt -114.29 129.54 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.814 0.845 . . . . 70.53 109.949 -175.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.86 171.15 14.86 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.654 0.782 . . . . 61.13 110.385 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.81 -35.06 4.62 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 116.26 -0.427 . . . . 55.44 113.075 176.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.692 HD13 ' HA ' ' C' ' 94' ' ' MET . 27.7 pt -108.12 171.71 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.251 0.62 . . . . 74.41 111.709 -171.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -167.19 156.93 10.79 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.801 0.84 . . . . 72.24 109.923 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.07 -115.62 6.24 Favored Glycine 0 C--N 1.349 1.304 0 O-C-N 123.324 0.39 . . . . 61.1 113.535 171.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 58.3 p -64.22 -40.07 95.28 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 123.688 0.795 . . . . 72.22 110.953 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -68.37 -47.66 66.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.899 0.88 . . . . 74.32 111.097 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.692 ' HA ' HD13 ' C' ' 89' ' ' ILE . 5.2 tpt -53.86 -49.86 67.55 Favored 'General case' 0 C--N 1.352 0.694 0 O-C-N 123.875 0.734 . . . . 63.02 111.705 173.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.69 -38.76 89.01 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 123.637 0.585 . . . . 73.11 111.032 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . 0.471 ' O ' ' HB2' ' C' ' 100' ' ' ALA . 44.5 t-80 -71.59 -19.68 62.1 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.553 1.141 . . . . 75.13 111.483 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 9.3 t -82.2 -51.96 7.44 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.517 -0.92 . . . . 73.31 108.517 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.11 -30.11 69.19 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.841 -1.072 . . . . 74.13 112.978 -172.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.94 11.28 29.54 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-O 119.45 -0.639 . . . . 63.3 113.64 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.545 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -151.34 -61.14 0.18 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 117.535 0.667 . . . . 64.0 112.222 -176.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -74.04 -53.31 10.28 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.422 0.689 . . . . 74.41 112.14 -169.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.619 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 34.5 m -58.56 -49.18 94.88 Favored Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.15 0.98 . . . . 73.2 111.924 176.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 77.1 Cg_exo -53.83 -35.76 80.44 Favored 'Trans proline' 0 C--N 1.402 3.384 0 C-N-CA 122.686 2.257 . . . . 73.13 113.24 173.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -68.76 -33.15 73.4 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.418 0.687 . . . . 74.45 111.708 -176.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.541 HD13 ' NH1' ' A' ' 111' ' ' ARG . 31.4 mm -70.11 -43.03 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 122.332 0.253 . . . . 71.32 110.691 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 1.7 pp -95.93 -3.56 45.01 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.372 0.878 . . . . 74.43 113.372 -176.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . 0.497 ' HZ ' HD23 ' C' ' 128' ' ' LEU . 56.0 t80 -55.06 -48.15 96.76 Favored Pre-proline 0 N--CA 1.485 1.317 0 CA-C-O 117.742 -1.123 . . . . 74.52 113.578 172.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -60.94 -30.67 90.4 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 121.738 1.626 . . . . 73.25 112.979 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -68.66 -43.05 77.01 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.371 0.669 . . . . 74.32 109.479 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.54 -39.34 94.16 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.041 -0.981 . . . . 75.34 110.625 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -61.87 -52.77 62.75 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.382 1.073 . . . . 74.33 110.191 176.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -67.22 -28.37 68.01 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.596 0.759 . . . . 72.11 110.383 -174.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . 0.49 ' O ' ' SD ' ' C' ' 117' ' ' MET . 8.2 t -71.05 -49.2 47.32 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 122.997 0.519 . . . . 70.12 110.334 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.455 HD12 HG22 ' C' ' 64' ' ' VAL . 86.8 mt -59.77 -47.28 91.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 123.29 0.636 . . . . 75.04 110.167 174.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 99.4 m -63.53 -31.05 72.1 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.812 0.845 . . . . 63.53 111.109 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 25.2 t -65.51 -48.42 72.59 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 108.808 -0.812 . . . . 73.13 108.808 171.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.906 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.2 OUTLIER -56.29 -43.19 78.6 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.953 0.901 . . . . 75.24 112.485 178.441 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.434 HG21 ' O ' ' C' ' 114' ' ' ILE . 87.9 t -69.33 -41.89 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.869 0.868 . . . . 74.05 110.26 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 30.6 t -64.1 -37.8 88.75 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.111 -0.949 . . . . 73.43 111.454 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.535 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 60.3 mtt-85 -69.64 -40.14 76.69 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.149 -0.932 . . . . 73.31 110.222 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.64 2.26 64.03 Favored Glycine 0 C--N 1.355 1.631 0 O-C-N 123.796 0.685 . . . . 74.21 112.847 174.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 44.2 p 60.94 28.19 18.0 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.952 1.701 . . . . 71.02 113.098 168.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -83.23 144.08 46.27 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.12 -1.067 . . . . 75.12 108.12 169.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -44.75 141.93 5.4 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.791 2.994 . . . . 74.44 114.071 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.507 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 13.3 mm-40 -59.22 124.75 21.02 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.908 0.755 . . . . 75.21 112.802 -170.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 40.1 tp -121.38 103.26 8.82 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.268 -1.012 . . . . 72.41 108.268 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -96.19 116.0 28.31 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.387 -0.824 . . . . 74.42 109.658 -176.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.497 HD23 ' HZ ' ' C' ' 107' ' ' PHE . 0.9 OUTLIER -71.59 117.4 13.1 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.588 0.755 . . . . 75.22 109.027 -178.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.74 159.15 70.98 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 123.95 0.9 . . . . 73.11 111.654 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -55.49 100.74 0.08 OUTLIER 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.726 2.284 . . . . 73.14 113.199 174.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.9 t -99.56 111.09 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 108.218 -1.03 . . . . 63.12 108.218 172.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -86.06 104.38 15.61 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.407 0.683 . . . . 73.43 110.722 -175.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -64.51 -23.76 67.38 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.164 0.986 . . . . 72.43 112.041 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.545 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 2.4 t70 -65.25 -36.67 84.84 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.766 0.826 . . . . 62.3 109.753 178.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.4 -19.32 33.73 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.382 -1.281 . . . . 63.51 111.614 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 36.0 mt -82.88 -22.35 34.0 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 120.895 0.378 . . . . 74.31 110.697 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 38.0 t80 . . . . . 0 CA--C 1.554 1.119 0 C-N-CA 123.473 0.709 . . . . 65.13 110.469 177.371 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 C--O 1.244 0.765 0 N-CA-C 109.644 -0.502 . . . . 73.43 109.644 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -138.64 93.88 2.77 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.397 -1.335 . . . . 73.44 107.397 174.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -124.3 126.11 45.49 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.754 -0.832 . . . . 72.04 108.754 -177.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 mt -82.41 121.35 35.44 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 N-CA-C 108.773 -0.825 . . . . 75.04 108.773 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -85.26 -29.66 24.44 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.282 1.033 . . . . 74.31 110.303 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -170.14 142.11 2.22 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 123.625 0.578 . . . . 74.51 110.426 -177.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.432 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.9 mp -118.24 130.4 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 105.503 -2.036 . . . . 74.03 105.503 170.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -159.99 141.92 12.98 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 118.701 0.682 . . . . 74.24 111.359 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 71.3 p -78.36 110.8 13.73 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.882 -1.054 . . . . 64.45 109.176 174.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -78.41 -24.76 46.06 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.562 -0.744 . . . . 75.01 109.253 176.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.703 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 2.8 t70 -149.97 147.96 28.5 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.665 1.186 . . . . 71.34 110.02 174.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.906 HG21 ' HE1' ' C' ' 117' ' ' MET . 83.1 mt -139.51 146.51 25.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 126.07 1.748 . . . . 73.31 107.598 174.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 39.9 t -155.86 145.38 21.0 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.167 0.587 . . . . 75.12 110.428 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.502 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 79.7 t80 -151.98 139.88 20.01 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.703 -1.591 . . . . 75.33 106.703 171.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 40.6 mt-10 -142.99 146.3 33.77 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.404 0.681 . . . . 73.42 109.604 -175.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.75 85.57 6.55 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.039 0.935 . . . . 75.34 108.573 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.87 -36.9 21.72 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.348 2.699 . . . . 63.44 112.935 -177.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.434 ' ND2' ' HB2' ' D' ' 71' ' ' GLU . 67.9 m-20 -103.66 16.17 27.06 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.14 -0.936 . . . . 75.04 110.749 -173.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -34.06 -66.2 0.23 Allowed Pre-proline 0 CA--C 1.571 1.761 0 N-CA-C 116.292 1.96 . . . . 73.54 116.292 -162.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.82 -21.96 13.88 Favored 'Trans proline' 0 C--N 1.386 2.529 0 CA-C-N 123.977 2.456 . . . . 75.43 114.165 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -70.51 -41.81 72.12 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.712 1.205 . . . . 73.31 110.306 178.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.622 HG22 HD11 ' D' ' 68' ' ' LEU . 13.4 p -82.53 -20.53 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-N 115.233 -0.894 . . . . 71.22 111.56 -173.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -62.41 -29.04 70.21 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 112.299 0.481 . . . . 72.3 112.299 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -63.87 -14.66 55.14 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.42 1.088 . . . . 73.32 111.567 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.518 ' HZ3' ' HG2' ' D' ' 71' ' ' GLU . 94.2 mttt -93.6 109.36 20.98 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.829 1.252 . . . . 74.11 110.1 175.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -102.94 92.89 4.76 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.175 0.59 . . . . 74.41 111.059 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 42.4 p90 -168.46 -177.28 3.12 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.838 1.255 . . . . 73.21 108.421 168.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 61.0 tp60 -74.02 118.32 68.54 Favored Pre-proline 0 N--CA 1.479 0.985 0 CA-C-O 119.09 -0.481 . . . . 71.24 109.834 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -58.95 137.39 79.54 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.332 2.021 . . . . 72.41 111.195 174.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 25.5 mt-10 -62.81 106.9 0.87 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.447 -0.946 . . . . 73.12 108.447 174.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.492 HG13 HG13 ' D' ' 64' ' ' VAL . 57.2 t -99.96 108.48 22.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.374 -0.602 . . . . 74.33 109.374 -175.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -86.76 109.69 19.41 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.387 -1.338 . . . . 73.44 107.387 169.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.497 HD12 HG12 ' D' ' 62' ' ' VAL . 40.4 tp -96.08 123.31 39.64 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.5 -0.926 . . . . 74.32 108.5 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -118.86 143.91 46.69 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 106.282 -1.747 . . . . 75.01 106.282 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 94.9 mt -136.73 148.23 47.18 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.419 0.688 . . . . 65.15 109.159 -174.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.746 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.8 t70 -145.38 136.32 24.64 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.426 -0.953 . . . . 72.12 108.426 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.3 t -102.43 158.42 16.22 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.967 -1.123 . . . . 74.41 107.967 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.572 ' HB2' ' HB ' ' D' ' 59' ' ' VAL . . . -161.9 165.92 26.95 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.995 0.518 . . . . 74.33 109.731 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.4 p . . . . . 0 C--O 1.242 0.69 0 C-N-CA 124.681 1.192 . . . . 75.52 108.201 -175.762 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 112.445 0.535 . . . . 75.24 112.445 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 47.6 t -118.05 100.18 9.56 Favored 'Isoleucine or valine' 0 C--N 1.35 0.588 0 N-CA-C 107.452 -1.314 . . . . 65.54 107.452 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -119.82 129.93 54.67 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 107.908 -1.145 . . . . 75.25 107.908 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -111.02 118.33 35.76 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.059 -1.46 . . . . 75.52 107.059 165.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.404 HG12 ' O ' ' D' ' 47' ' ' ALA . 72.1 t -100.29 134.98 38.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.382 -0.97 . . . . 75.14 108.382 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' D' ' 47' ' ' ALA . 24.8 t -114.97 137.97 46.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.341 -0.985 . . . . 72.23 108.341 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.518 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -115.08 118.61 33.86 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.382 -1.34 . . . . 72.43 107.382 174.339 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.746 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 45.3 ttm-85 -95.54 99.31 11.21 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.831 -1.174 . . . . 73.04 107.831 171.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.497 HG12 HD12 ' D' ' 42' ' ' LEU . 94.8 t -89.25 128.98 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 106.746 -1.576 . . . . 64.41 106.746 169.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 5.3 m -129.56 126.07 37.69 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.64 -0.874 . . . . 74.34 108.64 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.492 HG13 HG13 ' D' ' 40' ' ' VAL . 55.6 t -108.41 132.0 57.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 108.049 -1.093 . . . . 73.54 108.049 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 49.5 m -126.69 90.86 3.24 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.322 -1.362 . . . . 72.15 107.322 171.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -104.35 139.07 39.84 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.28 -0.873 . . . . 73.13 109.838 -176.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.483 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 77.4 p -144.17 128.95 18.31 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-O 121.07 0.462 . . . . 75.4 112.233 -172.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.622 HD11 HG22 ' D' ' 31' ' ' VAL . 43.9 mt -92.4 104.08 16.45 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.956 -1.498 . . . . 74.35 106.956 170.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.15 -145.85 38.52 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 123.674 0.608 . . . . 64.22 111.998 -172.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.69 2.93 31.23 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 112.503 0.556 . . . . 75.23 112.503 -177.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.518 ' HG2' ' HZ3' ' D' ' 34' ' ' LYS . 13.1 pt-20 -117.21 146.55 43.17 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 117.924 0.329 . . . . 75.32 110.163 -176.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 98.8 m -63.99 121.07 13.24 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 124.002 0.814 . . . . 74.52 111.108 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.483 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -76.86 -71.89 0.37 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.157 -1.423 . . . . 71.23 107.157 170.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -147.43 141.11 25.6 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.672 -0.695 . . . . 75.51 111.201 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.454 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 56.1 mt -103.96 149.53 25.05 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.218 -1.401 . . . . 74.44 107.218 166.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.68 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 6.3 t -157.94 106.23 2.02 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.081 0.401 . . . . 74.14 110.087 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -120.37 122.22 40.3 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.011 0.524 . . . . 74.41 110.204 -176.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 98.2 t -123.84 117.68 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.607 0.763 . . . . 75.12 109.42 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.703 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.1 mt-30 -88.68 83.37 6.74 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.482 -0.933 . . . . 72.54 108.482 168.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -80.53 96.54 6.83 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.172 -1.376 . . . . 75.44 109.316 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.61 161.87 28.78 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 111.765 -0.534 . . . . 74.43 111.765 177.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.21 134.55 3.36 Favored Glycine 0 C--N 1.332 0.315 0 N-CA-C 111.624 -0.59 . . . . 75.42 111.624 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 48.4 mt -90.03 117.45 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 108.687 -0.857 . . . . 73.42 108.687 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -115.64 125.94 53.53 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.473 1.109 . . . . 73.23 109.804 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 53.6 p -84.2 104.13 13.98 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.736 -0.839 . . . . 72.11 108.736 171.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 45.3 mt -115.61 122.6 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.403 0.681 . . . . 74.21 109.492 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.08 168.43 25.55 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.659 1.183 . . . . 73.12 109.595 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.28 22.66 43.55 Favored Glycine 0 N--CA 1.476 1.325 0 N-CA-C 114.364 0.505 . . . . 71.33 114.364 172.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.579 HD12 ' HA ' ' D' ' 94' ' ' MET . 1.0 OUTLIER -136.63 172.42 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 124.349 1.06 . . . . 73.45 109.569 -179.318 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -153.17 -170.76 3.71 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.854 0.462 . . . . 74.43 110.583 177.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.49 -141.66 30.11 Favored Glycine 0 C--N 1.349 1.281 0 CA-C-N 116.011 -0.54 . . . . 54.13 112.383 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 11.2 t -89.91 -20.91 22.81 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.364 0.666 . . . . 75.04 109.878 170.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -58.63 -30.93 67.66 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.692 1.197 . . . . 75.24 112.03 -176.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.579 ' HA ' HD12 ' D' ' 89' ' ' ILE . 12.5 ptp -53.48 -54.12 41.69 Favored 'General case' 0 CA--C 1.55 0.968 0 O-C-N 123.817 0.698 . . . . 74.32 111.905 177.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . 0.412 ' N ' ' HG3' ' D' ' 94' ' ' MET . . . -87.38 -15.48 37.71 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.051 0.94 . . . . 75.23 112.071 -176.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -66.1 -39.11 89.72 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.628 0.771 . . . . 73.5 110.319 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 75.0 m -63.97 -38.9 92.75 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.423 -0.808 . . . . 73.51 110.987 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.532 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 6.2 tt -71.96 -39.51 69.31 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 115.389 -0.823 . . . . 74.44 110.666 -176.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.21 -27.51 52.19 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-O 119.793 -0.449 . . . . 73.44 114.212 -173.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.7 -51.89 2.25 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 122.985 0.514 . . . . 61.54 112.019 -172.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -73.64 -39.97 64.1 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.057 0.543 . . . . 73.13 111.526 -171.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.532 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 85.7 m -63.04 -47.98 85.2 Favored Pre-proline 0 CA--C 1.563 1.466 0 CA-C-O 118.4 -0.809 . . . . 74.54 112.345 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.518 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 53.1 Cg_exo -58.19 -36.76 97.53 Favored 'Trans proline' 0 C--N 1.396 3.058 0 C-N-CA 122.231 1.954 . . . . 73.03 112.963 168.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -62.33 -33.82 75.44 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.424 0.69 . . . . 72.44 111.535 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.0 mm -69.68 -39.27 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.665 0.786 . . . . 64.33 110.888 175.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 77.3 mt -73.86 -21.48 60.09 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.645 -0.707 . . . . 73.12 112.091 -175.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -66.78 -41.18 36.24 Favored Pre-proline 0 CA--C 1.56 1.364 0 CA-C-O 117.718 -1.134 . . . . 74.1 113.909 -172.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -45.63 -48.19 12.43 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 122.516 2.144 . . . . 74.41 113.75 168.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -72.2 -40.78 67.61 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.864 0.865 . . . . 75.44 111.771 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.01 -44.04 90.5 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.622 0.769 . . . . 71.32 110.933 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -61.99 -46.96 86.94 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.685 -1.143 . . . . 75.41 110.364 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -61.49 -44.9 96.25 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.976 0.91 . . . . 73.3 111.327 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.535 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 51.9 t -56.01 -46.59 78.71 Favored 'General case' 0 C--N 1.349 0.565 0 O-C-N 124.086 0.866 . . . . 75.31 110.472 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.557 HG12 ' SG ' ' D' ' 76' ' ' CYS . 69.8 mt -63.29 -48.84 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 114.956 -1.02 . . . . 71.42 111.472 176.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 86.1 m -56.05 -44.11 78.54 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 124.029 0.932 . . . . 74.41 111.123 -172.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.455 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 40.6 t -65.16 -41.47 94.65 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.386 -1.279 . . . . 73.33 110.467 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.68 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 75.5 mtm -71.29 -29.64 65.3 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.961 0.504 . . . . 73.44 111.754 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.471 HG21 ' HB3' ' D' ' 126' ' ' LEU . 75.1 t -65.47 -43.35 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.008 0.923 . . . . 75.23 109.606 175.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 96.3 p -74.74 -24.45 58.72 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.613 -0.721 . . . . 62.43 110.902 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' D' ' 116' ' ' SER . 92.5 mtt-85 -70.08 -31.37 68.92 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.876 0.47 . . . . 75.31 110.107 172.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.92 10.24 68.96 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 123.581 0.55 . . . . 75.51 112.901 174.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.588 HG22 ' HB3' ' C' ' 17' ' ' TYR . 50.3 p 60.51 12.16 3.4 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 126.844 2.057 . . . . 64.14 114.411 -178.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -79.46 155.31 76.48 Favored Pre-proline 0 N--CA 1.48 1.031 0 CA-C-O 118.966 -0.54 . . . . 74.32 110.629 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -47.53 122.89 7.35 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.307 2.672 . . . . 71.45 111.474 173.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -50.27 132.33 24.22 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 124.759 1.287 . . . . 75.21 111.592 -171.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.471 ' HB3' HG21 ' D' ' 118' ' ' VAL . 48.7 tp -106.39 98.53 8.2 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 121.635 0.731 . . . . 75.23 109.968 -173.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . 0.551 ' ND2' ' HB ' ' B' ' 16' ' ' ILE . 6.9 m120 -99.08 89.32 4.22 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 106.269 -1.752 . . . . 74.11 106.269 174.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 87.7 mt -55.79 113.47 1.49 Allowed 'General case' 0 C--N 1.357 0.903 0 O-C-N 123.739 0.649 . . . . 73.3 109.518 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.91 123.03 82.55 Favored Pre-proline 0 CA--C 1.547 0.862 0 O-C-N 123.829 0.705 . . . . 73.52 109.393 -175.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.21 136.04 33.39 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.641 2.228 . . . . 74.22 112.4 -168.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.43 143.37 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.201 1.0 . . . . 75.31 109.079 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -73.99 115.2 13.18 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.226 0.61 . . . . 74.13 109.395 177.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 . . . . . 0 N--CA 1.483 1.181 0 C-N-CA 124.384 1.074 . . . . 75.41 111.845 -175.969 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.4 m . . . . . 0 CA--C 1.541 0.622 0 N-CA-C 108.19 -1.041 . . . . 75.04 108.19 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -119.99 117.5 28.19 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.95 1.3 . . . . 72.13 108.337 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -133.89 109.8 9.29 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.619 -0.882 . . . . 74.21 108.619 -178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.8 mt -74.17 122.17 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.749 -0.834 . . . . 73.11 108.749 174.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -92.91 -42.17 9.64 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.088 0.555 . . . . 72.42 110.818 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -170.68 121.8 0.59 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 110.05 -0.352 . . . . 74.22 110.05 -175.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 98.1 mt -105.71 126.14 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 107.57 -1.27 . . . . 74.3 107.57 172.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.489 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 28.3 p90 -162.11 157.11 22.85 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 123.736 0.647 . . . . 75.11 110.896 -171.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.1 p -85.01 117.09 23.77 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 109.408 -0.59 . . . . 72.41 109.408 174.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.489 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.0 mtpt -78.19 -31.31 49.47 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.407 -0.59 . . . . 71.33 109.407 174.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 30.4 t70 -150.25 145.82 26.43 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.759 -1.109 . . . . 62.13 110.68 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.401 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 75.0 mt -138.92 145.41 27.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 C-N-CA 125.395 1.478 . . . . 74.5 107.951 176.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.3 t -149.26 133.05 16.95 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.833 0.853 . . . . 73.54 109.538 173.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -130.54 139.39 50.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.087 -1.449 . . . . 74.14 107.087 169.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -135.12 134.11 39.9 Favored 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 123.068 0.547 . . . . 73.24 109.621 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.524 ' HB1' ' HB1' ' A' ' 28' ' ' ALA . . . -147.8 71.57 11.45 Favored Pre-proline 0 C--O 1.243 0.738 0 N-CA-C 105.829 -1.915 . . . . 73.43 105.829 169.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.78 -30.99 10.9 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.142 1.895 . . . . 75.12 111.389 -177.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -94.03 12.97 24.41 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 118.35 -0.833 . . . . 70.52 109.91 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.524 ' HB1' ' HB1' ' A' ' 25' ' ' ALA . . . -42.91 -59.08 3.28 Favored Pre-proline 0 CA--C 1.573 1.844 0 CA-C-O 118.146 -0.931 . . . . 73.13 112.919 -173.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -63.46 -15.02 45.91 Favored 'Trans proline' 0 C--N 1.395 2.995 0 C-N-CA 122.541 2.16 . . . . 71.51 113.956 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -92.29 -42.65 9.71 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.868 0.867 . . . . 73.01 110.154 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.535 HG21 HD12 ' A' ' 68' ' ' LEU . 4.3 p -79.32 -13.48 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-N 114.02 -1.446 . . . . 60.3 112.617 -161.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -72.42 -15.38 61.83 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.186 0.594 . . . . 74.23 110.968 173.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -87.46 -12.56 45.71 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.352 1.061 . . . . 74.25 111.15 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -82.46 155.71 24.47 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.646 0.778 . . . . 63.12 111.394 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.98 128.53 36.31 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.49 0.716 . . . . 72.33 109.457 170.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.469 ' CE3' HD21 ' A' ' 68' ' ' LEU . 49.9 t-105 -81.04 76.34 7.99 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.848 0.832 . . . . 74.42 110.266 -177.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.3 tm0? -126.8 81.88 68.39 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 105.025 -2.213 . . . . 74.44 105.025 168.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -83.68 144.98 11.42 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.347 2.031 . . . . 73.43 112.141 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -96.46 84.11 3.64 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.457 -1.312 . . . . 64.33 107.457 173.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.404 HG22 ' HB1' ' A' ' 66' ' ' ALA . 43.3 t -88.13 94.44 4.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 CA-C-N 115.537 -0.756 . . . . 71.34 109.819 -175.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -92.93 134.12 35.43 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.056 -0.974 . . . . 71.42 109.978 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.1 mt -103.66 108.95 20.46 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.477 -0.935 . . . . 75.35 108.477 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.599 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 10.2 m-20 -101.63 107.92 19.31 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.367 -1.346 . . . . 74.11 107.367 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.471 HD22 HD21 ' A' ' 60' ' ' LEU . 86.8 mt -103.52 135.53 44.94 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.448 0.642 . . . . 73.32 111.279 -174.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 24.8 t70 -132.55 143.45 49.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.334 -1.303 . . . . 74.02 108.254 178.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.6 m -127.25 133.4 50.21 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.663 0.785 . . . . 73.31 108.963 175.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.77 147.71 52.32 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 124.547 1.139 . . . . 71.12 108.502 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.433 ' HG ' ' HB3' ' A' ' 98' ' ' LEU . 68.1 m -131.68 156.51 45.76 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 122.747 0.419 . . . . 73.21 109.883 174.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.9 t -154.31 118.89 4.87 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.257 -1.016 . . . . 73.21 108.257 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -72.87 107.48 5.3 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 108.544 -0.91 . . . . 74.33 108.544 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.5 mt -79.95 -36.62 35.96 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.987 -0.552 . . . . 75.24 110.454 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.55 -174.02 4.81 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.272 0.629 . . . . 62.44 110.869 -177.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -65.29 119.84 11.67 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.203 0.601 . . . . 61.41 109.634 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 65.73 5.61 3.45 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.988 1.315 . . . . 73.52 112.532 -175.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.5 t -107.12 111.12 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 109.108 -0.701 . . . . 73.23 109.108 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -121.23 124.58 45.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.108 -1.071 . . . . 72.05 108.108 176.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -87.78 143.63 27.05 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.677 -0.86 . . . . 72.02 108.677 170.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.419 HG11 ' HD3' ' A' ' 103' ' ' PRO . 96.9 t -126.4 137.58 57.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 107.873 -1.158 . . . . 71.43 107.873 170.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.441 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 44.7 t -119.27 130.75 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.473 -0.936 . . . . 74.25 108.473 174.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.484 HD23 HG23 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -104.74 105.91 16.19 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 105.957 -1.868 . . . . 74.31 105.957 173.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.565 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 28.6 ttp180 -92.88 99.98 12.53 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.345 -1.354 . . . . 72.41 107.345 176.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.484 HG23 HD23 ' A' ' 60' ' ' LEU . 29.5 t -94.93 129.24 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 107.705 -1.22 . . . . 74.54 107.705 176.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.3 m -121.71 114.58 21.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.887 -0.783 . . . . 72.12 108.887 176.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 90.6 t -102.06 106.89 20.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.32 -0.993 . . . . 73.13 108.32 177.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.9 m -103.3 132.68 49.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.43 -0.952 . . . . 70.34 108.43 172.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.404 ' HB1' HG22 ' A' ' 40' ' ' VAL . . . -137.98 118.26 13.65 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.527 -0.545 . . . . 74.31 109.527 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.0 m -123.24 138.2 54.69 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.368 0.667 . . . . 63.35 110.521 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.535 HD12 HG21 ' A' ' 31' ' ' VAL . 22.0 mt -92.32 86.31 5.67 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.973 1.309 . . . . 70.42 108.396 172.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.5 -95.75 0.89 Allowed Glycine 0 C--N 1.339 0.705 0 O-C-N 123.393 0.433 . . . . 74.01 112.34 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.85 -26.17 13.23 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.634 0.773 . . . . 70.15 110.752 -177.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -104.07 126.19 50.99 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.398 0.679 . . . . 74.41 110.4 -174.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.1 m -63.62 125.94 25.92 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 123.561 0.538 . . . . 64.14 110.75 173.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.492 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -72.63 -60.26 2.32 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.818 -0.808 . . . . 72.55 108.818 174.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -160.31 168.17 25.88 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.652 0.739 . . . . 74.53 111.757 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 64' ' ' VAL . 65.1 tp -127.2 143.11 51.32 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.003 1.321 . . . . 71.1 107.739 169.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.555 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 70.9 m -144.76 98.28 3.16 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.386 0.674 . . . . 63.02 109.777 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 33.9 tt0 -118.64 116.93 27.61 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.673 -0.491 . . . . 74.34 109.673 -176.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.0 t -125.33 110.87 25.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 123.836 0.855 . . . . 75.13 109.022 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.434 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 51.9 mt-30 -84.9 82.51 8.41 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.231 -1.026 . . . . 65.43 108.231 172.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -76.07 94.43 3.45 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 114.474 -1.239 . . . . 71.35 108.574 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.46 163.34 40.73 Favored Glycine 0 C--O 1.24 0.474 0 N-CA-C 111.011 -0.836 . . . . 61.44 111.011 177.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.83 121.71 1.05 Allowed Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 110.371 -1.092 . . . . 74.51 110.371 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.8 mt -81.49 122.65 36.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.499 -1.297 . . . . 73.44 107.499 173.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.542 ' HB3' HD11 ' A' ' 86' ' ' ILE . 93.3 m-85 -128.19 121.17 28.8 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.359 0.664 . . . . 74.11 109.513 -178.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.1 t -85.25 98.1 10.31 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.418 -0.956 . . . . 74.35 108.418 173.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.542 HD11 ' HB3' ' A' ' 84' ' ' PHE . 4.2 mm -107.87 147.95 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.418 -0.586 . . . . 75.33 109.418 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.53 170.1 23.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.647 -0.706 . . . . 74.43 110.121 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.15 -34.17 5.73 Favored Glycine 0 C--N 1.341 0.818 0 O-C-N 123.613 0.571 . . . . 73.34 113.574 176.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.5 146.34 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 122.928 0.491 . . . . 71.01 111.739 -169.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.24 175.17 9.49 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.658 1.183 . . . . 65.43 109.335 175.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.26 -131.29 27.32 Favored Glycine 0 C--N 1.352 1.443 0 O-C-N 123.46 0.475 . . . . 75.41 113.611 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.9 t -72.8 -21.53 60.97 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.23 0.612 . . . . 73.42 111.212 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -73.64 -42.39 61.47 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.606 0.762 . . . . 71.41 109.387 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.3 tpt -66.55 -42.52 87.02 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 115.596 -0.729 . . . . 74.31 110.262 173.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.54 -29.2 70.4 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.385 -0.825 . . . . 72.43 111.13 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.461 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 60.4 t-80 -71.53 -35.27 70.61 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.98 -0.555 . . . . 74.44 110.926 176.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.9 t -71.89 -44.16 64.2 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 110.005 -0.368 . . . . 72.23 110.005 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.433 ' HB3' ' HG ' ' A' ' 48' ' ' SER . 55.6 mt -82.38 -32.07 29.38 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.66 0.615 . . . . 74.42 112.66 -173.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.89 4.36 42.07 Favored Glycine 0 N--CA 1.472 1.034 0 CA-C-O 119.89 -0.395 . . . . 71.42 113.639 -172.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.562 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -140.49 -68.6 0.41 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 117.014 0.407 . . . . 62.32 110.759 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -67.97 -45.33 74.46 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 116.01 -0.541 . . . . 74.43 112.266 -168.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 82.4 m -67.19 -48.42 48.16 Favored Pre-proline 0 CA--C 1.559 1.296 0 CA-C-O 118.065 -0.969 . . . . 75.34 112.783 -176.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.419 ' HD3' HG11 ' A' ' 58' ' ' VAL . 41.0 Cg_endo -66.51 -18.72 54.72 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 121.576 1.517 . . . . 74.22 112.682 173.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -76.12 -34.62 59.47 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.923 0.489 . . . . 74.11 110.529 173.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.2 mm -64.35 -43.84 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.448 0.699 . . . . 73.32 109.447 170.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.2 mt -73.36 -23.48 60.21 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.045 -0.98 . . . . 74.2 112.522 -174.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -63.61 -45.64 82.88 Favored Pre-proline 0 N--CA 1.485 1.279 0 N-CA-C 114.331 1.234 . . . . 75.25 114.331 -172.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -52.95 -36.53 75.58 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 121.985 1.79 . . . . 73.14 113.47 172.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -79.08 -39.36 33.98 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.559 0.744 . . . . 74.12 111.352 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.45 -49.53 73.33 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.252 0.621 . . . . 64.03 109.369 175.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.47 ' NH1' HD13 ' C' ' 105' ' ' ILE . 27.4 ttm180 -49.96 -50.5 46.56 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 125.137 1.523 . . . . 72.0 111.084 175.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -65.24 -47.85 75.37 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 124.374 1.046 . . . . 75.24 111.747 -176.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.519 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 53.7 t -56.0 -42.01 75.75 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.135 0.897 . . . . 54.11 110.468 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.534 HD12 HG23 ' A' ' 64' ' ' VAL . 68.8 mt -62.66 -53.69 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 114.736 -1.12 . . . . 75.44 110.616 174.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 33.1 m -55.87 -36.86 68.04 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.679 0.791 . . . . 74.24 111.027 -175.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.7 t -68.68 -46.9 67.86 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.582 -1.19 . . . . 72.21 110.186 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.6 mtp -59.94 -42.29 93.7 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.605 0.762 . . . . 73.34 111.897 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.5 t -63.76 -44.16 98.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 124.254 1.022 . . . . 71.24 110.252 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 99.4 p -73.23 -32.3 64.67 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.803 -0.635 . . . . 71.33 111.108 -176.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -67.78 -33.38 74.72 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.469 0.708 . . . . 71.51 109.738 173.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.54 15.05 37.67 Favored Glycine 0 C--N 1.354 1.562 0 CA-C-N 115.585 -0.734 . . . . 53.11 113.578 175.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.419 HG23 ' HE ' ' B' ' 15' ' ' ARG . 2.4 t 59.9 11.54 2.63 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 127.26 2.224 . . . . 73.51 114.488 174.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -79.76 140.01 54.56 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 107.96 -1.126 . . . . 72.51 107.96 175.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -43.15 133.56 6.21 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 123.529 2.819 . . . . 74.4 112.647 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -52.36 131.0 32.71 Favored 'General case' 0 C--N 1.363 1.164 0 O-C-N 123.93 0.769 . . . . 71.35 112.474 -169.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.489 HD21 HG12 ' A' ' 64' ' ' VAL . 22.3 tp -120.22 115.73 24.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.688 1.195 . . . . 74.24 109.303 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -109.17 128.04 54.7 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 105.715 -1.957 . . . . 63.44 105.715 173.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.494 HD12 HD13 ' A' ' 114' ' ' ILE . 15.4 mt -71.7 147.44 47.41 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 118.29 0.496 . . . . 74.21 110.926 -175.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.33 137.6 86.53 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 122.98 0.512 . . . . 65.14 110.677 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.2 124.21 15.65 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 123.132 2.555 . . . . 63.34 113.329 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 68.6 t -109.43 128.6 65.3 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 C-N-CA 123.78 0.832 . . . . 75.21 110.388 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -92.18 84.3 5.22 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.466 -0.939 . . . . 74.01 108.466 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -60.83 -29.67 69.64 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.884 0.874 . . . . 74.43 111.587 177.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.562 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 5.5 t70 -64.24 -42.24 96.62 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 124.007 0.817 . . . . 70.41 109.559 178.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.92 -40.18 87.56 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.125 0.891 . . . . 75.4 111.275 176.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.64 -42.86 99.48 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 123.779 0.674 . . . . 75.33 111.016 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 69.2 t80 . . . . . 0 C--N 1.346 0.445 0 CA-C-N 116.014 -0.539 . . . . 73.4 109.834 174.742 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.518 ' HB3' HG22 ' B' ' 89' ' ' ILE . 20.7 ptm . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 121.433 0.635 . . . . 70.3 112.71 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -147.68 140.03 24.47 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 108.425 -0.954 . . . . 72.3 108.425 169.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -138.35 140.46 39.47 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.741 -0.837 . . . . 75.51 108.741 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -151.5 140.02 20.59 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 109.087 -0.708 . . . . 72.32 109.087 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.573 HD13 ' HD3' ' D' ' 130' ' ' PRO . 33.8 mt -75.1 133.0 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 107.535 -1.283 . . . . 61.4 107.535 167.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -98.43 -43.76 6.78 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.054 -0.721 . . . . 75.12 109.054 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.419 ' HE ' HG23 ' A' ' 122' ' ' THR . 52.0 ttt180 -172.88 131.72 0.52 Allowed 'General case' 0 C--N 1.348 0.536 0 CA-C-N 115.723 -0.671 . . . . 72.23 109.69 -177.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.561 HG21 ' CD1' ' B' ' 109' ' ' TYR . 58.6 mt -115.63 144.13 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.108 -1.071 . . . . 74.12 108.108 173.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -164.69 145.58 7.82 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.489 0.661 . . . . 75.22 111.931 -175.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.1 m -72.91 118.17 15.53 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.405 -1.27 . . . . 71.33 108.086 169.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -94.59 -23.29 17.7 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.509 0.724 . . . . 74.24 111.02 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -161.48 143.47 11.76 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.986 0.179 . . . . 74.21 110.9 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.517 HD13 ' SG ' ' B' ' 113' ' ' CYS . 47.1 mm -136.1 143.92 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.536 1.135 . . . . 75.25 109.536 176.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 68.9 m -141.27 132.58 26.63 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.962 1.705 . . . . 63.11 107.208 169.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 88.0 t80 -142.87 109.26 5.33 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.483 -1.673 . . . . 72.2 106.483 166.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -119.53 111.54 18.22 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.501 -0.925 . . . . 75.42 108.501 -176.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.56 86.47 1.78 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 106.566 -1.642 . . . . 71.2 106.566 173.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.28 -35.7 8.13 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.464 2.11 . . . . 73.15 112.199 -165.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -106.93 21.02 18.2 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.1 -0.954 . . . . 71.32 109.663 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.417 ' HB1' ' HD3' ' B' ' 29' ' ' PRO . . . -42.66 -62.33 1.31 Allowed Pre-proline 0 N--CA 1.487 1.424 0 C-N-CA 125.221 1.408 . . . . 73.35 114.722 -165.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.417 ' HD3' ' HB1' ' B' ' 28' ' ' ALA . 16.6 Cg_exo -61.81 -30.18 84.05 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 122.08 1.854 . . . . 74.33 112.375 -171.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -96.04 -27.99 14.84 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.564 -1.198 . . . . 74.31 111.983 -169.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.441 HG21 ' HA ' ' B' ' 73' ' ' ALA . 6.4 p -81.81 -10.02 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 120.775 0.322 . . . . 72.12 111.043 -176.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -70.57 -19.96 62.83 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.383 0.673 . . . . 74.23 112.678 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -65.92 -12.78 57.3 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.144 0.497 . . . . 74.51 111.229 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -97.36 92.26 5.89 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.053 1.341 . . . . 73.13 109.744 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -97.38 78.92 2.73 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.755 -0.657 . . . . 73.15 109.622 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 15.1 p90 -153.8 -173.24 4.5 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.092 0.557 . . . . 74.44 110.017 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -73.03 109.47 6.33 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 124.143 0.977 . . . . 74.45 110.088 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.493 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 55.6 Cg_endo -72.91 132.24 18.1 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 121.199 1.266 . . . . 70.02 111.317 175.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -65.6 104.86 1.09 Allowed 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.184 0.594 . . . . 72.22 109.809 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.563 HG21 ' HB1' ' B' ' 66' ' ' ALA . 74.8 t -99.5 143.38 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 114.355 -1.293 . . . . 72.33 111.221 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -124.09 132.05 53.61 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 106.949 -1.5 . . . . 73.43 106.949 173.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.408 HD12 HG21 ' B' ' 64' ' ' VAL . 17.1 tp -102.06 124.98 48.6 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.073 -1.084 . . . . 70.22 108.073 172.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -124.85 139.59 53.7 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.615 -1.254 . . . . 73.44 107.615 -175.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mp -122.3 138.25 54.57 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.837 0.855 . . . . 65.42 109.453 -171.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.552 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 9.8 t70 -135.22 146.85 49.05 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.715 1.206 . . . . 74.4 108.442 173.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.1 m -126.74 103.42 7.53 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.919 -0.771 . . . . 74.14 108.919 -176.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.75 117.89 31.52 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 108.625 -0.879 . . . . 63.41 108.625 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 51.7 p -144.6 161.04 40.14 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 122.429 0.291 . . . . 75.42 110.752 -176.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.7 p -159.45 138.88 11.35 Favored 'General case' 0 C--O 1.244 0.799 0 O-C-N 123.444 0.465 . . . . 74.0 111.211 -174.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -78.37 104.57 9.04 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 108.845 -0.798 . . . . 72.23 108.845 171.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 3.0 pp -122.53 11.31 9.88 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.647 -0.706 . . . . 72.32 109.928 175.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.07 158.49 43.09 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 115.702 -0.681 . . . . 63.41 110.49 -174.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.93 107.74 17.86 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.418 1.087 . . . . 72.23 110.883 -172.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 62.53 18.63 10.6 Favored 'General case' 0 N--CA 1.501 2.122 0 C-N-CA 124.275 1.03 . . . . 71.15 111.589 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 90.3 t -135.6 121.63 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.372 1.469 . . . . 62.32 107.248 -174.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -113.43 139.25 49.07 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.69 -0.856 . . . . 75.32 108.69 -172.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -104.51 101.29 10.96 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 106.578 -1.638 . . . . 62.52 106.578 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -104.04 133.66 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.201 0.601 . . . . 73.43 109.491 -177.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.486 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 25.8 t -118.4 122.11 68.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 C-N-CA 124.183 0.993 . . . . 74.42 108.437 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.45 109.94 21.78 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 107.796 -1.187 . . . . 72.11 107.796 174.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.552 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 39.2 ttm180 -85.85 112.23 20.94 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.889 -0.782 . . . . 71.24 108.889 175.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 61.7 t -105.37 103.59 15.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.42 -0.956 . . . . 73.4 108.42 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 7.5 m -99.44 131.39 45.48 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.427 -0.806 . . . . 74.41 109.648 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.577 HG23 HD12 ' B' ' 114' ' ' ILE . 72.4 t -120.05 133.14 67.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 123.758 0.823 . . . . 65.34 110.042 176.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 72.6 m -110.76 147.35 34.63 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 108.355 -0.98 . . . . 75.34 108.355 167.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.563 ' HB1' HG21 ' B' ' 40' ' ' VAL . . . -144.5 133.19 22.28 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.446 0.698 . . . . 62.23 109.359 173.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.457 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 16.6 m -133.98 126.38 30.15 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 123.418 0.449 . . . . 74.22 110.675 -174.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.493 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 60.4 mt -99.08 101.29 12.61 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.841 -1.17 . . . . 75.23 107.841 174.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.82 -144.82 24.33 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 115.747 -0.661 . . . . 74.43 111.54 -173.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -82.41 2.36 32.91 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.017 0.927 . . . . 72.33 112.652 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -123.34 158.83 30.18 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.638 0.775 . . . . 70.55 110.354 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 92.4 m -81.35 126.16 31.26 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.683 0.793 . . . . 74.14 110.689 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.457 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -77.67 -57.85 3.59 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.321 1.049 . . . . 71.43 108.96 174.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -143.99 162.41 36.26 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 122.249 1.023 . . . . 73.44 111.937 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 84.4 mt -126.76 147.5 49.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 112.886 -1.961 . . . . 75.41 106.554 171.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 32.5 t -149.45 150.85 33.01 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.006 -1.109 . . . . 70.24 108.006 174.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -161.84 125.15 3.1 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.207 -1.034 . . . . 74.41 108.207 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.439 HG11 ' HA ' ' B' ' 110' ' ' ALA . 84.6 t -122.94 146.6 27.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.542 -0.911 . . . . 72.41 108.542 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -117.72 107.53 14.29 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.012 -1.107 . . . . 74.12 108.012 169.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -99.43 100.62 11.69 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.224 -1.028 . . . . 72.12 108.224 175.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -96.22 162.2 22.67 Favored Glycine 0 C--N 1.336 0.55 0 O-C-N 123.785 0.678 . . . . 55.03 111.599 177.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.9 131.98 2.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.695 -0.288 . . . . 70.31 112.642 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 47.0 mt -85.54 115.03 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 N-CA-C 107.612 -1.255 . . . . 73.21 107.612 171.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -127.32 140.95 51.85 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.832 0.853 . . . . 73.42 109.621 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 56.1 m -95.19 123.26 38.59 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.381 0.672 . . . . 75.34 110.191 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.699 HG23 HD13 ' B' ' 89' ' ' ILE . 2.4 mp -127.63 113.07 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 108.018 -1.104 . . . . 71.14 108.018 -178.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.82 155.46 35.84 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.176 0.59 . . . . 71.24 110.812 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 102.02 -34.15 5.93 Favored Glycine 0 N--CA 1.48 1.571 0 C-N-CA 123.786 0.707 . . . . 74.24 112.496 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.699 HD13 HG23 ' B' ' 86' ' ' ILE . 0.9 OUTLIER -80.74 167.63 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 124.509 1.124 . . . . 64.42 112.345 178.804 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -156.59 148.98 23.37 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.819 0.848 . . . . 71.13 110.655 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.15 -134.16 12.34 Favored Glycine 0 C--N 1.356 1.673 0 C-N-CA 123.013 0.34 . . . . 70.5 113.655 172.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.5 m -64.64 -48.47 74.71 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.42 1.088 . . . . 63.44 110.255 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -66.28 -24.7 66.61 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 113.437 -1.711 . . . . 74.21 111.466 -170.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.8 -65.7 0.65 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.637 1.175 . . . . 74.1 112.215 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.52 -13.24 59.93 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.686 0.395 . . . . 72.24 111.983 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -59.82 -36.07 76.03 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.286 0.634 . . . . 75.32 110.402 168.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.4 t -65.16 -55.43 18.68 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.215 0.606 . . . . 74.12 111.524 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.623 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.6 pp -76.49 -18.25 58.86 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 112.646 0.61 . . . . 75.3 112.646 -177.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.93 -19.6 30.8 Favored Glycine 0 C--N 1.348 1.239 0 CA-C-O 119.766 -0.463 . . . . 54.2 113.861 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.72 -51.94 1.06 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 117.324 0.562 . . . . 73.13 111.49 -173.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -70.17 -40.15 74.87 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.414 0.686 . . . . 75.41 111.244 -175.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.623 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 81.8 m -70.99 -48.83 13.64 Favored Pre-proline 0 CA--C 1.56 1.36 0 CA-C-O 118.443 -0.789 . . . . 72.23 112.086 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.431 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 84.2 Cg_exo -54.14 -29.12 54.53 Favored 'Trans proline' 0 C--N 1.393 2.906 0 C-N-CA 122.49 2.127 . . . . 70.21 114.029 169.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -64.75 -33.31 75.68 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.4 0.68 . . . . 71.21 111.488 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 65.0 mt -72.89 -39.12 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.772 0.829 . . . . 75.04 110.122 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 71.2 mt -75.33 -34.18 61.19 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.737 -1.119 . . . . 74.22 111.722 -174.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -57.73 -47.34 99.11 Favored Pre-proline 0 N--CA 1.487 1.377 0 CA-C-O 117.559 -1.21 . . . . 71.32 113.776 -171.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -54.94 -35.93 90.78 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.21 1.94 . . . . 73.33 113.299 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.561 ' CD1' HG21 ' B' ' 16' ' ' ILE . 5.0 m-30 -76.03 -40.43 53.47 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.827 -0.624 . . . . 75.04 110.364 -176.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.439 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -63.04 -42.76 99.83 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.486 -0.779 . . . . 74.05 110.257 174.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 28.4 ttt-85 -60.47 -49.61 76.89 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.075 1.35 . . . . 74.1 110.819 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -69.32 -31.5 70.0 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.885 0.741 . . . . 74.52 109.998 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.531 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.9 t -68.51 -40.54 80.78 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 122.915 0.486 . . . . 54.41 110.316 177.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.577 HD12 HG23 ' B' ' 64' ' ' VAL . 81.8 mt -62.37 -54.82 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.63 0.772 . . . . 74.31 110.128 174.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.9 m -61.18 -27.95 68.78 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 123.916 0.76 . . . . 73.02 111.068 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.461 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.3 t -64.92 -53.27 49.12 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 123.208 0.603 . . . . 73.03 109.555 173.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.531 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.1 mmt -65.92 -33.8 76.66 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.27 0.628 . . . . 74.21 111.573 -175.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.438 HG22 HD22 ' B' ' 126' ' ' LEU . 78.2 t -68.3 -41.72 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.732 1.213 . . . . 62.44 110.604 176.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 39.0 t -67.11 -31.15 71.43 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.227 -0.897 . . . . 74.11 110.785 175.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.519 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 82.0 mtt-85 -69.55 -37.78 77.17 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 123.237 0.615 . . . . 75.41 110.001 176.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.31 -11.42 71.38 Favored Glycine 0 C--N 1.353 1.515 0 O-C-N 123.429 0.456 . . . . 64.13 112.749 170.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 10.1 m 67.93 26.93 7.36 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 125.804 1.641 . . . . 75.23 110.204 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -78.07 164.99 53.76 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-N 114.964 -1.016 . . . . 75.3 111.448 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -47.54 154.48 1.7 Allowed 'Trans proline' 0 C--N 1.393 2.911 0 C-N-CA 123.429 2.753 . . . . 72.5 114.351 171.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.468 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -62.37 115.95 4.64 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.003 0.921 . . . . 62.24 111.595 -175.508 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.451 HD13 HG12 ' B' ' 40' ' ' VAL . 37.8 tp -109.57 108.13 18.46 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.546 -0.752 . . . . 72.14 109.392 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -114.35 120.51 40.63 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 107.73 -1.211 . . . . 73.33 107.73 169.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.472 HD13 HD13 ' B' ' 114' ' ' ILE . 87.9 mt -74.98 130.13 38.83 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 122.873 0.469 . . . . 75.44 110.32 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.11 136.24 90.94 Favored Pre-proline 0 CA--C 1.55 0.971 0 O-C-N 124.393 1.058 . . . . 65.4 110.77 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.03 94.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.711 2.274 . . . . 75.33 111.907 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 19.5 m -90.61 110.44 22.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.847 0.832 . . . . 75.14 109.201 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 108.542 -0.91 . . . . 74.11 108.542 174.501 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 56.1 t80 . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 108.325 -0.991 . . . . 71.22 108.325 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -150.3 126.05 10.37 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 109.045 -0.724 . . . . 75.2 109.045 174.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 59.5 mt -64.79 134.69 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 107.88 -1.156 . . . . 75.23 107.88 168.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.421 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 31.5 mm-40 -102.73 -39.22 7.12 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.847 0.459 . . . . 74.33 109.822 176.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -178.6 142.31 0.23 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.506 1.123 . . . . 74.32 109.448 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 35.1 mm -119.84 117.8 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 108.128 -1.064 . . . . 72.33 108.128 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.554 ' HB3' HG22 ' D' ' 122' ' ' THR . 41.2 p90 -145.4 162.03 38.26 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.489 0.661 . . . . 74.02 112.031 -167.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.4 p -93.72 115.36 27.79 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.112 -0.949 . . . . 73.23 109.086 175.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.406 ' HG2' ' HE2' ' C' ' 17' ' ' TYR . 77.6 mttt -77.59 -45.31 25.62 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.477 -0.935 . . . . 75.25 108.477 170.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.677 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 26.4 t70 -131.08 135.65 47.72 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 113.662 -1.608 . . . . 64.32 109.435 -171.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.411 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 77.5 mt -138.09 142.02 36.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 106.423 -1.695 . . . . 73.14 106.423 174.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.0 t -154.32 145.62 22.96 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.401 0.619 . . . . 71.13 110.326 177.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -149.68 126.03 10.81 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 106.745 -1.576 . . . . 64.4 106.745 170.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -131.63 116.54 17.5 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.478 0.711 . . . . 73.33 109.521 -175.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.54 78.34 62.59 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 124.021 0.928 . . . . 63.13 108.502 172.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.73 -25.99 39.4 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 122.431 2.087 . . . . 75.42 111.037 174.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -97.67 14.04 28.17 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.127 0.971 . . . . 73.55 110.937 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.65 -55.15 24.74 Favored Pre-proline 0 N--CA 1.491 1.602 0 CA-C-O 117.96 -1.019 . . . . 43.43 113.502 -172.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.13 -43.79 39.35 Favored 'Trans proline' 0 C--N 1.391 2.815 0 C-N-CA 121.836 1.691 . . . . 64.04 112.077 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -68.78 -32.94 73.05 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.271 -1.331 . . . . 73.03 112.649 -174.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.59 HG21 ' HA ' ' C' ' 73' ' ' ALA . 12.9 p -80.81 -27.19 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 N-CA-C 112.146 0.425 . . . . 72.22 112.146 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -64.86 -27.73 69.07 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 122.893 0.477 . . . . 74.42 111.834 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -88.86 8.37 29.54 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.619 0.767 . . . . 74.14 111.504 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.498 ' HG2' HD11 ' C' ' 68' ' ' LEU . 1.0 OUTLIER -114.69 152.16 32.44 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.014 0.926 . . . . 75.3 110.258 -179.467 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -62.77 128.65 36.91 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.238 0.615 . . . . 64.53 111.12 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 65.8 t-105 -85.05 95.86 9.23 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.298 -0.865 . . . . 74.35 111.121 -174.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . 0.402 ' H ' HD23 ' C' ' 68' ' ' LEU . 34.5 tt0 -144.43 75.44 15.05 Favored Pre-proline 0 CA--C 1.549 0.918 0 N-CA-C 108.132 -1.062 . . . . 72.3 108.132 172.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -87.52 162.35 8.06 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.602 2.201 . . . . 74.43 112.686 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -90.08 108.1 19.53 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.407 -1.27 . . . . 72.22 107.692 171.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.45 96.99 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 109.078 -0.712 . . . . 73.43 109.078 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.48 101.98 12.66 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.021 -1.103 . . . . 73.14 108.021 176.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.612 HD22 HG12 ' C' ' 62' ' ' VAL . 1.9 tt -103.65 127.44 51.1 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 107.3 -1.37 . . . . 75.3 107.3 177.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -119.56 117.85 29.46 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.575 0.75 . . . . 70.13 109.008 174.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -99.97 109.27 21.62 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.725 -0.843 . . . . 73.31 108.725 173.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -121.65 121.04 36.46 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.869 -1.16 . . . . 75.45 107.869 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.1 t -124.91 148.01 48.54 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.146 0.498 . . . . 73.43 110.309 -176.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.65 151.07 35.56 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.144 0.977 . . . . 72.14 108.733 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.428 ' HG ' ' HB3' ' C' ' 98' ' ' LEU . 14.4 m -123.1 150.41 43.22 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 123.715 0.806 . . . . 64.0 109.386 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 25.8 t -147.64 126.4 12.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.481 0.712 . . . . 70.34 109.319 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -76.86 117.56 18.59 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.206 -0.664 . . . . 74.34 109.206 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.596 HD12 ' HB2' ' C' ' 57' ' ' GLU . 50.3 mt -84.1 -43.64 14.84 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.618 0.767 . . . . 75.0 110.413 -175.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.47 -176.14 4.92 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.985 -1.007 . . . . 74.24 109.815 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.71 109.86 2.17 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.967 0.907 . . . . 71.41 110.4 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 65.27 19.98 11.79 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.923 1.289 . . . . 73.54 112.385 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 57.7 t -113.25 110.01 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 108.362 -0.977 . . . . 71.14 108.362 172.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -112.4 124.89 53.5 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.438 1.095 . . . . 75.31 109.794 -177.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.596 ' HB2' HD12 ' C' ' 51' ' ' LEU . 43.1 tt0 -91.24 142.66 27.48 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.759 -0.83 . . . . 75.24 108.759 170.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 82.8 t -124.81 139.4 51.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.995 -1.113 . . . . 73.23 107.995 167.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.06 130.07 72.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.975 -0.75 . . . . 74.34 108.975 173.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.542 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -110.48 111.73 23.17 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.218 -1.401 . . . . 72.13 107.218 178.545 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -90.67 107.24 19.04 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.303 -0.999 . . . . 74.35 108.303 173.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.612 HG12 HD22 ' C' ' 42' ' ' LEU . 38.9 t -101.32 118.89 48.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.949 -1.13 . . . . 74.34 107.949 173.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 26.0 m -118.7 137.48 53.29 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.984 -0.747 . . . . 73.42 108.984 -175.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.413 HG22 HG22 ' C' ' 114' ' ' ILE . 84.8 t -132.02 120.39 43.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 124.02 0.928 . . . . 75.14 109.046 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 10.0 m -113.17 130.31 56.25 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.349 -0.982 . . . . 74.23 108.349 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.88 115.71 24.36 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.16 -1.052 . . . . 73.21 108.16 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 54.5 m -134.02 130.21 37.22 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.431 0.457 . . . . 64.32 110.342 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.498 HD11 ' HG2' ' C' ' 34' ' ' LYS . 39.2 mt -85.84 39.34 0.8 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.699 1.2 . . . . 75.55 109.687 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.43 -102.48 2.2 Favored Glycine 0 C--N 1.348 1.24 0 N-CA-C 110.19 -1.164 . . . . 64.21 110.19 -170.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -89.79 -30.72 17.78 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.753 0.821 . . . . 72.43 110.397 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.401 ' HG2' HD12 ' C' ' 68' ' ' LEU . 4.3 tp10 -69.7 121.36 17.03 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 123.95 0.9 . . . . 74.35 109.788 176.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -81.19 117.28 21.59 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.262 -1.014 . . . . 71.31 108.262 165.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.59 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.91 -50.8 21.48 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.654 -0.869 . . . . 73.51 108.654 176.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . 0.462 ' HZ ' HD22 ' C' ' 126' ' ' LEU . 31.3 p90 -164.86 164.49 20.91 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.284 -1.326 . . . . 74.15 110.723 177.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -121.62 144.57 48.67 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 105.965 -1.865 . . . . 64.13 105.965 164.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.401 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.9 t -149.13 137.73 21.07 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.085 -1.08 . . . . 64.3 108.085 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -155.69 132.74 10.7 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.892 -0.41 . . . . 75.32 109.892 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 92.8 t -126.02 135.93 62.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.122 0.969 . . . . 64.51 109.037 174.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.677 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.7 mt-30 -109.99 96.2 6.08 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.069 0.948 . . . . 74.13 108.925 171.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -80.66 102.31 9.78 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.501 -1.227 . . . . 61.25 109.189 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.41 148.85 25.51 Favored Glycine 0 C--N 1.342 0.898 0 N-CA-C 111.181 -0.767 . . . . 70.14 111.181 174.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.74 119.23 1.04 Allowed Glycine 0 N--CA 1.465 0.591 0 CA-C-N 117.419 0.609 . . . . 55.42 111.98 -176.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.457 HG12 ' HE1' ' C' ' 17' ' ' TYR . 22.8 mm -86.75 129.12 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.024 -0.732 . . . . 73.14 109.024 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -133.41 126.64 31.69 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.912 0.885 . . . . 74.04 109.227 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 10.2 p -87.49 101.67 13.82 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.881 -1.155 . . . . 53.3 107.881 168.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 7.7 mt -117.27 124.87 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.648 0.779 . . . . 75.5 110.317 -174.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.5 171.31 14.23 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.098 0.959 . . . . 64.53 109.2 177.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.21 -25.36 12.63 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-O 119.701 -0.499 . . . . 62.14 114.091 174.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.639 HD13 ' HA ' ' C' ' 94' ' ' MET . 37.7 pt -106.63 164.09 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 123.366 0.667 . . . . 72.33 111.393 -178.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -156.04 154.84 31.65 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.639 0.776 . . . . 73.24 110.127 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.41 -117.85 8.72 Favored Glycine 0 C--N 1.351 1.383 0 O-C-N 123.724 0.64 . . . . 71.2 113.411 169.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 17.7 m -62.19 -38.36 88.83 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.006 0.922 . . . . 74.32 111.134 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.433 HE21 HG23 ' C' ' 89' ' ' ILE . 28.7 mt-30 -67.43 -51.25 53.95 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.947 0.899 . . . . 74.33 111.239 -177.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.639 ' HA ' HD13 ' C' ' 89' ' ' ILE . 5.3 tpt -55.55 -50.72 69.29 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 124.176 0.923 . . . . 75.4 111.431 174.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.32 -43.36 92.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.377 0.671 . . . . 74.51 111.801 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -70.93 -36.49 72.65 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.684 0.794 . . . . 75.31 111.288 -175.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -64.23 -36.79 85.23 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.601 -0.727 . . . . 62.1 110.394 177.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.495 ' HG ' ' HE1' ' C' ' 94' ' ' MET . 91.7 mt -83.65 -37.56 22.66 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.295 1.038 . . . . 75.22 112.752 -176.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.87 -13.62 36.66 Favored Glycine 0 N--CA 1.475 1.279 0 N-CA-C 113.996 0.359 . . . . 72.41 113.996 -168.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.17 -54.32 1.19 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 117.014 0.407 . . . . 71.32 111.488 -175.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -70.72 -52.05 23.42 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 116.251 -0.431 . . . . 75.42 111.781 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.407 ' O ' HD11 ' C' ' 106' ' ' LEU . 96.9 m -64.18 -48.67 76.33 Favored Pre-proline 0 CA--C 1.559 1.309 0 CA-C-O 118.101 -0.952 . . . . 63.43 112.487 -177.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.542 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 50.4 Cg_exo -57.46 -27.3 75.59 Favored 'Trans proline' 0 C--N 1.393 2.891 0 C-N-CA 122.228 1.952 . . . . 71.13 113.373 175.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.43 -38.02 80.81 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.413 0.685 . . . . 73.12 109.878 177.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.47 HD13 ' NH1' ' A' ' 111' ' ' ARG . 47.3 mm -72.47 -34.28 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.684 0.794 . . . . 74.14 110.338 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.407 HD11 ' O ' ' C' ' 102' ' ' CYS . 7.3 mp -80.52 -24.19 39.53 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.906 0.883 . . . . 72.23 112.259 -177.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -58.86 -50.73 86.4 Favored Pre-proline 0 N--CA 1.481 1.081 0 CA-C-O 117.335 -1.317 . . . . 75.0 113.968 -172.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -59.53 -37.34 89.49 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 121.968 1.779 . . . . 74.11 113.206 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -65.2 -47.27 77.49 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.643 0.777 . . . . 74.1 110.392 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.96 -34.25 77.97 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 114.48 -1.236 . . . . 74.44 111.329 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -67.3 -50.19 61.24 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.205 1.402 . . . . 73.41 110.701 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -65.76 -35.26 80.21 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 123.805 0.69 . . . . 74.31 109.696 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 18.9 t -67.83 -29.49 68.65 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.305 0.642 . . . . 54.2 111.964 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.427 ' CD1' HG13 ' C' ' 62' ' ' VAL . 65.4 mt -79.07 -53.51 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 123.15 0.58 . . . . 74.13 110.678 174.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 17.8 m -61.91 -28.36 69.47 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.283 0.633 . . . . 74.31 111.162 -175.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.6 t -65.52 -50.07 66.59 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.676 0.791 . . . . 74.1 109.568 171.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.614 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.69 -40.35 87.57 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.464 1.105 . . . . 75.12 112.519 -179.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.42 -42.61 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.752 0.821 . . . . 73.1 109.995 175.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 39.7 t -71.45 -27.6 63.38 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.082 -0.963 . . . . 71.13 111.776 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' C' ' 116' ' ' SER . 79.9 mtt-85 -72.88 -41.83 64.26 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.002 -0.74 . . . . 73.21 109.002 176.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.88 -3.33 63.68 Favored Glycine 0 C--N 1.357 1.733 0 CA-C-N 115.419 -0.81 . . . . 73.42 112.901 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 26.1 p 62.32 30.49 17.47 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.632 1.973 . . . . 63.43 112.823 172.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -83.75 145.84 48.19 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 108.504 -0.924 . . . . 73.52 108.504 169.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -46.01 140.51 10.26 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 124.013 3.142 . . . . 71.34 114.898 176.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -60.24 134.6 57.21 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.659 1.184 . . . . 72.0 113.116 -174.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.462 HD22 ' HZ ' ' C' ' 74' ' ' PHE . 0.8 OUTLIER -141.53 98.7 3.4 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 114.791 -1.095 . . . . 74.53 108.567 174.429 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -91.5 102.82 15.48 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.412 -0.959 . . . . 74.25 108.412 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -57.58 129.93 44.08 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.62 1.168 . . . . 75.21 112.498 -167.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.68 144.53 98.92 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.096 0.958 . . . . 74.14 111.6 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.19 123.62 12.85 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.948 2.432 . . . . 75.4 112.918 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 24.2 t -115.5 121.4 67.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 108.49 -0.929 . . . . 75.31 108.49 175.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . 0.455 HD22 ' HB3' ' C' ' 134' ' ' ASP . 57.3 t30 -75.13 107.47 7.24 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.587 0.755 . . . . 74.52 111.276 -175.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -65.37 -18.35 65.25 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.77 0.828 . . . . 74.23 112.994 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.455 ' HB3' HD22 ' C' ' 132' ' ' ASN . 9.9 t70 -65.52 -43.09 91.13 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.143 0.577 . . . . 71.52 109.846 172.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.09 -42.43 96.93 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.52 -0.764 . . . . 65.24 110.656 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 76.3 mt -70.64 -24.54 62.73 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.164 -0.925 . . . . 73.51 111.844 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 83.4 t80 . . . . . 0 N--CA 1.47 0.568 0 C-N-CA 123.26 0.624 . . . . 74.21 110.868 -178.496 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 C--O 1.243 0.748 0 N-CA-C 109.836 -0.431 . . . . 74.41 109.836 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.424 ' HD2' HG22 ' D' ' 86' ' ' ILE . 84.9 t80 -134.84 101.93 5.08 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 107.861 -1.163 . . . . 73.43 107.861 176.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -127.5 120.07 27.46 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.421 -0.955 . . . . 60.34 108.421 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 10.5 mt -80.25 133.01 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 109.341 -0.614 . . . . 64.13 109.341 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -89.82 -40.58 12.36 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.829 0.852 . . . . 65.1 110.805 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -167.69 137.77 2.76 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.351 -0.386 . . . . 73.24 110.385 -175.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.415 ' N ' HD13 ' D' ' 16' ' ' ILE . 3.9 mp -110.17 137.26 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 107.048 -1.464 . . . . 73.42 107.048 169.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -164.31 142.49 7.04 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.372 0.533 . . . . 75.43 111.457 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 67.9 p -77.95 121.0 23.6 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.866 -0.606 . . . . 73.5 109.749 176.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.486 ' HD2' ' HA3' ' D' ' 81' ' ' GLY . 34.9 mtpt -96.08 -13.89 23.31 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.297 0.639 . . . . 74.1 109.909 -178.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.6 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.4 t70 -163.79 139.7 6.51 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.352 1.061 . . . . 71.41 108.915 177.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.614 HG23 ' HE1' ' C' ' 117' ' ' MET . 76.8 mt -141.9 147.41 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.614 1.166 . . . . 74.21 108.488 177.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 74.3 m -148.85 142.01 24.99 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.0 1.72 . . . . 72.41 108.155 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 83.0 t80 -145.86 113.53 6.38 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 105.012 -2.218 . . . . 74.14 105.012 166.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -131.07 110.04 10.92 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.79 0.436 . . . . 63.41 110.254 -168.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.35 82.06 11.5 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 107.92 -1.141 . . . . 74.52 107.92 176.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.74 -17.6 17.85 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.57 2.18 . . . . 73.05 112.361 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 76.8 m-20 -107.48 9.08 29.69 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.84 0.856 . . . . 72.53 110.735 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -33.31 -67.82 0.18 Allowed Pre-proline 0 CA--C 1.572 1.808 0 N-CA-C 115.976 1.843 . . . . 65.13 115.976 -165.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.455 ' HB3' HD11 ' C' ' 83' ' ' ILE . 88.6 Cg_endo -77.79 -15.19 15.26 Favored 'Trans proline' 0 C--N 1.385 2.495 0 CA-C-N 124.077 2.492 . . . . 72.13 114.014 -176.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.41 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 7.2 t-160 -72.99 -40.99 64.79 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.652 1.181 . . . . 75.44 109.399 173.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.562 HG23 ' HA ' ' D' ' 73' ' ' ALA . 8.7 p -86.08 -19.69 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 CA-C-N 115.018 -0.992 . . . . 64.53 111.473 -175.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -67.66 -19.66 65.22 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 117.837 0.29 . . . . 75.21 111.658 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -67.28 -14.14 62.64 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.711 0.804 . . . . 70.3 110.832 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.571 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 93.1 mttt -103.22 69.1 1.0 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.958 1.303 . . . . 73.31 109.255 177.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -84.07 74.6 10.25 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-O 122.314 1.054 . . . . 72.25 110.489 -176.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 4.7 p90 -142.8 -165.05 1.97 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.587 -0.733 . . . . 73.41 109.311 175.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -64.5 108.51 1.99 Allowed Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 124.163 0.985 . . . . 74.54 111.027 177.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -72.24 126.89 12.12 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.168 1.912 . . . . 72.42 110.747 176.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.91 111.83 11.69 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.915 -1.142 . . . . 74.22 107.915 176.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.611 HG11 HG13 ' D' ' 64' ' ' VAL . 65.9 t -108.61 137.01 42.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 C-N-CA 123.846 0.858 . . . . 65.44 108.911 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 29.7 mmtm -126.85 134.47 50.51 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.456 0.702 . . . . 74.4 109.796 170.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 20.7 tp -96.68 147.68 23.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.255 -0.884 . . . . 74.3 109.971 -175.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.537 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 19.9 t70 -139.98 112.48 7.86 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.83 -1.174 . . . . 73.24 107.83 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.0 mt -115.08 132.73 56.51 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.391 0.677 . . . . 74.52 109.817 -172.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.569 ' HB2' ' HB3' ' D' ' 61' ' ' ARG . 3.5 m-20 -132.49 151.28 51.96 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.816 1.246 . . . . 75.43 108.658 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 20.5 p -107.88 146.48 32.26 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.368 0.667 . . . . 74.12 110.47 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.654 ' HB2' ' HB ' ' D' ' 59' ' ' VAL . . . -149.37 163.39 37.88 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.126 0.97 . . . . 61.21 109.217 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 61.6 p . . . . . 0 CA--C 1.542 0.642 0 O-C-N 123.798 0.686 . . . . 73.44 110.917 -173.748 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 . . . . . 0 N--CA 1.499 2.019 0 N-CA-C 112.015 0.376 . . . . 73.25 112.015 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 11.7 t -113.13 99.2 8.17 Favored 'Isoleucine or valine' 0 C--N 1.349 0.571 0 N-CA-C 107.422 -1.325 . . . . 75.34 107.422 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -127.84 131.79 49.46 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 120.596 0.236 . . . . 73.53 110.443 -173.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -87.6 138.49 31.42 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.651 -0.87 . . . . 74.11 108.651 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 78.7 t -136.25 138.33 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 C-N-CA 124.846 1.258 . . . . 73.12 107.909 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.654 ' HB ' ' HB2' ' D' ' 47' ' ' ALA . 21.5 t -132.94 120.24 40.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.424 -0.954 . . . . 75.54 108.424 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.49 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -93.2 124.84 37.46 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.112 -1.07 . . . . 74.13 108.112 174.149 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.569 ' HB3' ' HB2' ' D' ' 45' ' ' ASP . 1.5 tmm_? -100.27 104.65 16.14 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.095 -1.076 . . . . 73.11 108.095 174.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.435 HG11 HD12 ' D' ' 114' ' ' ILE . 82.8 t -103.1 121.5 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 123.923 0.889 . . . . 72.3 108.734 175.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 60.3 m -120.82 133.69 55.31 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.617 0.722 . . . . 74.12 109.47 175.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.611 HG13 HG11 ' D' ' 40' ' ' VAL . 34.5 t -110.26 119.69 59.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 114.457 -1.247 . . . . 74.42 108.662 174.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 15.6 m -109.04 91.86 3.81 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.21 -1.404 . . . . 65.21 107.21 171.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.63 147.19 25.07 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.513 -0.767 . . . . 73.32 109.372 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 53.8 p -156.28 132.86 10.2 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 123.513 0.508 . . . . 63.41 111.092 -173.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 21.5 mt -104.62 112.22 25.22 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.077 -1.083 . . . . 74.42 108.077 170.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.34 -115.94 4.41 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.926 -0.579 . . . . 72.42 111.737 -172.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -115.91 4.53 13.86 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 117.381 0.591 . . . . 72.41 111.388 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.571 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 12.5 pt-20 -114.25 154.86 27.2 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.49 0.316 . . . . 72.55 110.656 -175.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 95.3 m -63.12 120.06 10.74 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 123.975 0.797 . . . . 73.24 111.144 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.562 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -76.18 -67.37 0.69 Allowed 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.02 -1.474 . . . . 64.04 107.02 167.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -154.23 142.95 20.9 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.997 -0.547 . . . . 75.31 110.997 176.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 57.8 mt -106.12 107.95 19.21 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 107.249 -1.389 . . . . 73.14 107.249 170.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.666 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 17.5 t -118.45 107.78 14.22 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.023 -0.732 . . . . 75.4 109.023 -172.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' D' ' 62' ' ' VAL . 34.4 tt0 -128.9 131.37 47.58 Favored 'General case' 0 C--O 1.22 -0.487 0 C-N-CA 123.265 0.626 . . . . 74.52 110.088 -171.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 86.3 t -134.43 116.18 21.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 123.734 0.814 . . . . 74.13 108.928 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.6 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 78.6 mt-30 -88.88 84.43 6.65 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.177 -1.045 . . . . 71.45 108.177 171.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -82.32 108.05 15.46 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 113.998 -1.456 . . . . 73.53 109.52 -176.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.486 ' HA3' ' HD2' ' D' ' 19' ' ' LYS . . . -99.61 172.95 25.45 Favored Glycine 0 C--O 1.241 0.558 0 O-C-N 123.374 0.421 . . . . 34.22 112.893 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.63 144.26 6.53 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.513 -0.344 . . . . 64.24 112.865 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 54.7 mt -90.11 128.08 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.019 -1.104 . . . . 74.42 108.019 172.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -124.57 140.27 53.1 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.914 0.886 . . . . 75.55 110.771 -175.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 7.1 m -98.83 98.73 9.79 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.387 1.075 . . . . 70.15 108.92 172.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.639 HG12 HD21 ' D' ' 98' ' ' LEU . 2.6 pp -115.96 132.87 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 109.26 -0.645 . . . . 75.3 109.26 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.92 168.19 19.71 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.234 1.014 . . . . 71.52 109.404 -177.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.74 -21.55 32.62 Favored Glycine 0 N--CA 1.477 1.381 0 C-N-CA 123.221 0.439 . . . . 42.32 113.91 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -101.03 155.85 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.864 0.865 . . . . 74.43 109.374 172.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -144.4 175.11 10.35 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.286 1.034 . . . . 71.22 110.457 -176.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.26 -140.56 23.05 Favored Glycine 0 C--N 1.357 1.732 0 N-CA-C 114.68 0.632 . . . . 75.24 114.68 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 86.2 m -79.79 -38.35 33.27 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.974 0.91 . . . . 73.33 111.046 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -60.72 -36.37 78.68 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.365 1.066 . . . . 74.12 111.198 -174.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -37.53 81.37 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.973 0.731 . . . . 73.2 112.973 -172.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.58 -25.35 33.36 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.383 0.673 . . . . 75.21 109.927 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -66.89 -27.39 67.47 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.099 0.96 . . . . 73.33 110.302 174.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 94.8 m -62.21 -42.83 99.65 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.383 0.673 . . . . 73.42 111.387 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.639 HD21 HG12 ' D' ' 86' ' ' ILE . 86.9 mt -70.71 -22.24 62.47 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.586 0.355 . . . . 73.0 111.361 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.63 14.02 56.44 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-O 119.499 -0.612 . . . . 64.41 113.28 176.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.98 -66.11 0.11 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 118.277 1.039 . . . . 73.03 112.355 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -65.43 -51.63 58.87 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.12 0.568 . . . . 75.02 111.632 -172.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.412 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 78.8 m -60.89 -47.01 96.87 Favored Pre-proline 0 CA--C 1.565 1.554 0 C-N-CA 123.772 0.829 . . . . 72.31 112.359 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.49 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.7 Cg_exo -54.32 -40.01 84.54 Favored 'Trans proline' 0 C--N 1.394 2.955 0 C-N-CA 122.388 2.059 . . . . 60.12 113.678 168.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . 0.424 ' HB2' ' HB2' ' D' ' 133' ' ' PHE . 2.6 t-20 -61.98 -33.5 74.43 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.458 0.703 . . . . 75.31 111.325 -178.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 43.6 mm -72.85 -36.12 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.361 1.064 . . . . 74.42 110.76 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 91.1 mt -71.93 -19.06 61.97 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.907 -0.588 . . . . 74.42 111.629 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -65.96 -44.42 61.37 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-O 117.782 -1.104 . . . . 74.4 113.335 -173.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.89 -42.12 31.57 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 122.343 2.028 . . . . 75.04 113.964 168.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -79.52 -32.35 42.32 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.687 0.795 . . . . 74.51 111.921 -177.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.94 -44.69 65.58 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.415 0.626 . . . . 73.53 109.996 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.58 HH12 ' HB3' ' D' ' 130' ' ' PRO . 37.4 ttp180 -65.67 -35.65 81.39 Favored 'General case' 0 C--O 1.206 -1.216 0 CA-C-N 114.012 -1.449 . . . . 74.03 110.365 174.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . 0.499 ' HA ' ' CE2' ' B' ' 109' ' ' TYR . 6.1 tt0 -52.86 -51.21 61.91 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.845 0.858 . . . . 73.44 111.151 176.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.453 ' O ' ' HG3' ' D' ' 117' ' ' MET . 43.8 t -63.7 -45.04 91.82 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.527 -1.215 . . . . 75.32 110.717 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.595 HG22 ' SG ' ' D' ' 76' ' ' CYS . 31.5 mt -60.55 -64.42 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.392 0.677 . . . . 72.24 111.269 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.441 HG21 ' OD1' ' D' ' 127' ' ' ASN . 85.4 m -40.54 -46.89 2.59 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.027 1.731 . . . . 75.43 112.63 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -62.95 -48.14 80.19 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 114.867 -1.061 . . . . 74.21 110.657 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.666 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 71.6 mtm -67.24 -31.46 71.83 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.42 0.688 . . . . 64.31 112.296 -178.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.456 HG21 ' HB3' ' D' ' 126' ' ' LEU . 87.2 t -65.53 -45.06 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.765 0.826 . . . . 75.53 109.946 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 56.0 p -70.38 -33.05 70.96 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 115.289 -0.869 . . . . 72.45 110.363 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 51.8 mtt-85 -67.36 -35.07 78.63 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.872 0.869 . . . . 75.14 110.576 175.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.21 11.19 61.31 Favored Glycine 0 C--N 1.355 1.6 0 CA-C-O 119.581 -0.566 . . . . 72.35 114.082 -178.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.554 HG22 ' HB3' ' C' ' 17' ' ' TYR . 66.9 p 57.2 30.25 18.06 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 126.2 1.8 . . . . 65.13 114.073 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -97.87 149.36 35.64 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.147 0.579 . . . . 75.21 109.781 170.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -45.17 120.99 3.36 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 123.75 2.967 . . . . 74.24 112.832 169.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -48.54 122.75 5.81 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 124.539 1.149 . . . . 74.1 111.876 -174.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.456 ' HB3' HG21 ' D' ' 118' ' ' VAL . 22.5 tp -105.44 106.59 17.16 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.45 0.7 . . . . 73.22 109.598 -174.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . 0.441 ' OD1' HG21 ' D' ' 115' ' ' THR . 93.0 m-20 -106.53 89.87 3.16 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.288 1.035 . . . . 73.45 108.936 175.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.409 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 37.6 mt -57.39 117.88 4.57 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.048 0.939 . . . . 75.54 110.498 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.43 123.81 78.07 Favored Pre-proline 0 CA--C 1.56 1.338 0 C-N-CA 122.679 0.391 . . . . 74.41 111.176 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.58 ' HB3' HH12 ' D' ' 111' ' ' ARG . 76.6 Cg_endo -75.54 141.31 24.97 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 122.603 2.202 . . . . 71.1 111.876 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.87 152.22 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.574 0.75 . . . . 74.34 109.748 -175.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -68.58 103.9 1.82 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.382 0.673 . . . . 75.52 110.391 176.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . 0.424 ' HB2' ' HB2' ' D' ' 104' ' ' ASN . 3.7 m-30 . . . . . 0 N--CA 1.486 1.349 0 C-N-CA 124.097 0.959 . . . . 75.22 112.639 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.0 m . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 109.586 -0.524 . . . . 72.44 109.586 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -125.32 113.09 17.13 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.554 -0.906 . . . . 65.23 108.554 170.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -135.72 136.66 41.01 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.508 -0.923 . . . . 74.14 108.508 170.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.501 HD12 HG21 ' A' ' 105' ' ' ILE . 5.2 mt -93.35 117.15 36.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 108.762 -0.829 . . . . 75.13 108.762 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.03 -42.36 32.7 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.948 0.78 . . . . 72.35 109.32 -177.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -173.69 121.41 0.32 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 110.276 -0.268 . . . . 73.25 110.276 -171.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.443 HD13 ' HG3' ' C' ' 130' ' ' PRO . 65.8 mt -106.26 133.92 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.767 -0.827 . . . . 74.13 108.767 173.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.438 ' HE1' HG13 ' A' ' 83' ' ' ILE . 31.4 p90 -164.12 158.09 18.87 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 124.011 0.819 . . . . 74.32 111.33 -174.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.6 p -86.78 117.0 25.24 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.291 -0.633 . . . . 63.22 109.291 172.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.434 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 38.5 mtpt -75.82 -34.13 60.13 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.415 -0.587 . . . . 73.43 109.415 175.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 23.4 t70 -149.59 142.85 25.13 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.607 -1.179 . . . . 72.33 110.064 -178.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 76.1 mt -137.34 144.88 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.762 1.225 . . . . 65.15 108.119 175.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.5 t -148.92 138.3 21.71 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.667 0.787 . . . . 74.32 109.034 171.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.551 ' HB2' ' HE1' ' A' ' 117' ' ' MET . 91.5 t80 -135.22 134.61 40.22 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.572 -1.64 . . . . 75.13 106.572 169.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -133.3 137.54 46.03 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.347 0.659 . . . . 73.45 109.542 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.94 76.64 11.38 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 106.582 -1.636 . . . . 71.31 106.582 171.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.75 -28.59 36.74 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.316 2.011 . . . . 71.15 111.199 -178.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -97.99 11.23 38.19 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.067 -0.969 . . . . 71.21 111.189 -175.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.428 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -44.87 -59.61 3.96 Favored Pre-proline 0 CA--C 1.564 1.51 0 N-CA-C 114.2 1.185 . . . . 71.14 114.2 -165.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HG3' ' HZ1' ' B' ' 19' ' ' LYS . 31.7 Cg_exo -58.78 -36.85 96.41 Favored 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 122.015 1.81 . . . . 72.35 113.675 -171.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -99.39 -12.47 20.24 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.491 0.716 . . . . 75.3 112.863 -175.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.608 HG22 ' HA ' ' A' ' 73' ' ' ALA . 3.6 p -77.07 -23.49 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-N 118.073 0.397 . . . . 74.43 110.396 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -71.46 -18.47 62.31 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.514 0.726 . . . . 74.3 111.328 173.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -80.03 -27.58 39.45 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.496 0.719 . . . . 74.11 110.543 175.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.501 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 12.7 mmmm -72.87 152.64 41.39 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.942 0.897 . . . . 75.15 111.371 -175.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.25 123.45 18.69 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.547 0.739 . . . . 74.33 109.322 174.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -76.97 81.35 3.51 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.75 0.786 . . . . 74.42 110.116 -175.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.461 ' H ' HD22 ' A' ' 68' ' ' LEU . 19.5 tm0? -115.64 78.77 6.99 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 106.478 -1.675 . . . . 61.2 106.478 172.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -84.63 112.5 1.57 Allowed 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.224 1.95 . . . . 63.4 111.62 -172.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -92.88 88.09 6.06 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.445 -1.687 . . . . 74.13 106.445 171.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.51 HG23 ' HB1' ' A' ' 66' ' ' ALA . 48.7 t -88.15 102.92 13.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 114.332 -1.304 . . . . 70.15 110.392 -173.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -78.12 115.66 18.01 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.682 -1.145 . . . . 74.42 109.181 172.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.449 HD11 ' HB3' ' A' ' 128' ' ' LEU . 3.6 tt -96.89 107.49 20.0 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 106.504 -1.665 . . . . 74.44 106.504 176.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -104.94 147.19 28.05 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.407 1.083 . . . . 72.13 108.739 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.554 HD22 HD21 ' A' ' 60' ' ' LEU . 87.5 mt -133.58 138.9 46.25 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.198 0.599 . . . . 62.15 110.891 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.555 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 24.2 t70 -136.62 144.82 44.27 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.105 1.362 . . . . 53.41 107.847 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.9 m -139.11 126.83 21.97 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.808 0.443 . . . . 74.33 110.354 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.2 127.01 32.85 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.867 0.867 . . . . 73.4 109.931 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.451 ' HG ' ' HB3' ' A' ' 98' ' ' LEU . 49.7 m -112.73 161.42 16.89 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.486 0.66 . . . . 62.32 111.185 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 90.0 p -149.12 162.12 40.6 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.344 1.458 . . . . 74.1 107.654 175.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -113.46 107.45 15.85 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.806 -0.812 . . . . 72.04 108.806 169.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.3 mt -79.4 -29.3 41.94 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.7 -0.682 . . . . 65.25 111.523 -175.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.67 -172.47 3.12 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.128 0.571 . . . . 74.42 111.352 -177.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -61.47 112.5 2.22 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.992 0.917 . . . . 55.43 109.751 174.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 69.89 2.0 3.69 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.955 1.702 . . . . 75.31 112.703 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.68 108.11 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.661 -0.65 . . . . 73.53 109.645 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -114.49 126.24 54.72 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.609 1.164 . . . . 75.22 108.31 177.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -91.71 139.9 30.23 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 108.46 -0.941 . . . . 73.13 108.46 171.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.45 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 98.1 t -123.5 139.64 49.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.196 -1.039 . . . . 71.45 108.196 170.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.426 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 50.3 t -120.04 132.64 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.424 -0.954 . . . . 63.32 108.424 174.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.554 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -111.94 104.5 12.78 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.751 -1.574 . . . . 73.21 106.751 170.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.555 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 13.3 ttp180 -94.28 100.49 12.53 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.443 -1.317 . . . . 72.13 107.443 176.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.472 HG23 HD23 ' A' ' 60' ' ' LEU . 36.0 t -93.72 123.99 46.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.663 -1.236 . . . . 73.34 107.663 177.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 m -118.68 115.72 25.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.829 0.823 . . . . 74.12 109.448 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.546 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 91.8 t -104.2 128.92 57.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 C-N-CA 124.866 1.266 . . . . 73.15 108.98 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.1 m -125.4 128.56 48.3 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 108.586 -0.894 . . . . 73.34 108.586 171.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.51 ' HB1' HG23 ' A' ' 40' ' ' VAL . . . -118.12 129.28 55.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.818 -1.178 . . . . 75.22 107.818 175.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.7 m -135.57 139.08 43.61 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.595 0.712 . . . . 74.22 110.655 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.461 HD22 ' H ' ' A' ' 37' ' ' GLN . 59.4 mt -95.86 62.63 2.28 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.373 1.869 . . . . 75.2 108.701 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.11 -84.63 0.92 Allowed Glycine 0 CA--C 1.529 0.955 0 CA-C-N 115.806 -0.634 . . . . 30.15 112.275 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.35 -26.79 11.84 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.542 0.737 . . . . 61.23 111.737 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.501 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 2.9 tp10 -95.66 112.86 24.49 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.702 0.801 . . . . 75.35 109.641 -174.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.9 m -67.96 129.97 41.53 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.933 0.788 . . . . 73.25 110.124 176.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.608 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -76.78 -60.64 2.27 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.34 -0.846 . . . . 72.43 109.173 177.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -159.09 170.45 21.99 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.48 -0.782 . . . . 74.53 111.489 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.4 tp -140.75 113.32 8.1 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.885 1.274 . . . . 74.05 108.457 176.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.546 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 58.9 m -105.63 141.66 36.7 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.181 0.993 . . . . 70.31 108.85 176.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -148.3 116.75 6.56 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.449 -0.575 . . . . 70.33 109.449 173.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.5 t -127.05 112.82 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.713 0.805 . . . . 73.21 109.38 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -84.82 83.36 8.07 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.181 -1.044 . . . . 74.34 108.181 170.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -76.17 92.17 3.22 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.191 -1.04 . . . . 74.44 108.191 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.93 164.91 41.27 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.777 -0.929 . . . . 70.31 110.777 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.25 122.01 1.06 Allowed Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.132 -1.187 . . . . 74.44 110.132 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.438 HG13 ' HE1' ' A' ' 17' ' ' TYR . 57.0 mt -81.13 125.92 39.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 107.654 -1.239 . . . . 71.34 107.654 171.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.599 ' HB3' HD11 ' A' ' 86' ' ' ILE . 87.7 m-85 -127.25 136.92 52.65 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.518 0.727 . . . . 74.21 109.285 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.5 p -100.38 90.98 4.5 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.695 0.798 . . . . 74.5 109.023 174.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 84' ' ' PHE . 14.7 mm -111.12 147.45 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 114.859 -1.064 . . . . 75.31 110.638 -173.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.85 167.38 18.82 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.581 0.352 . . . . 73.13 111.754 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.96 1.67 88.72 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 115.145 0.818 . . . . 75.21 115.145 172.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.2 172.13 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.642 0.777 . . . . 73.54 110.179 177.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.489 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 0.6 OUTLIER -160.64 177.78 10.15 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.25 -0.886 . . . . 74.53 109.607 176.231 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.9 -116.36 8.61 Favored Glycine 0 C--N 1.351 1.391 0 O-C-N 123.793 0.683 . . . . 75.11 113.786 172.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.4 p -64.2 -41.15 97.19 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.762 1.225 . . . . 73.44 111.528 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -74.38 -36.87 63.56 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.045 0.538 . . . . 71.11 111.323 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.494 ' HA ' ' HE1' ' A' ' 94' ' ' MET . 4.8 tpt -68.16 -45.92 72.2 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.55 -0.537 . . . . 71.52 109.55 177.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.88 -32.18 73.38 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.181 -0.918 . . . . 74.34 110.781 176.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -73.69 -38.04 65.02 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.105 0.562 . . . . 75.24 110.342 176.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.8 t -67.92 -39.31 83.56 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.619 -0.511 . . . . 63.34 109.619 -178.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.451 ' HB3' ' HG ' ' A' ' 48' ' ' SER . 78.8 mt -85.68 -28.1 24.92 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.679 0.792 . . . . 73.0 111.975 -177.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -114.7 4.48 22.88 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 114.508 0.563 . . . . 72.31 114.508 -170.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.447 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -143.31 -62.19 0.41 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 117.72 0.76 . . . . 73.02 110.958 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -62.84 -57.78 9.68 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.961 0.904 . . . . 74.33 111.593 -173.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 82.6 m -64.43 -46.78 78.12 Favored Pre-proline 0 CA--C 1.558 1.269 0 CA-C-O 117.895 -1.05 . . . . 73.35 113.102 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.7 -20.25 59.43 Favored 'Trans proline' 0 C--N 1.396 3.059 0 CA-C-N 121.446 1.552 . . . . 65.35 112.896 174.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -76.58 -32.32 58.05 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.952 0.501 . . . . 61.41 109.883 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.501 HG21 HD12 ' A' ' 13' ' ' ILE . 46.2 mm -67.0 -45.19 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.445 0.698 . . . . 74.34 109.7 169.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 59.1 mt -73.14 -22.97 60.41 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.788 -1.096 . . . . 74.22 111.946 -174.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -65.3 -44.49 68.55 Favored Pre-proline 0 N--CA 1.481 1.076 0 CA-C-O 117.296 -1.335 . . . . 75.3 113.78 -172.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 77.8 Cg_exo -54.33 -36.69 87.75 Favored 'Trans proline' 0 C--N 1.387 2.553 0 CA-C-N 121.96 1.736 . . . . 72.41 113.383 171.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.451 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 93.3 m-85 -76.49 -39.2 53.83 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.187 0.595 . . . . 73.41 111.5 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.97 -47.07 75.79 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.519 0.728 . . . . 73.4 109.346 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -51.44 -52.66 44.4 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 125.546 1.538 . . . . 74.55 110.016 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -61.93 -47.74 83.57 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.554 1.159 . . . . 72.42 111.853 -175.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.51 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 49.9 t -55.91 -45.16 78.77 Favored 'General case' 0 C--N 1.351 0.631 0 O-C-N 124.498 1.124 . . . . 61.15 110.242 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.55 HD13 HD12 ' A' ' 128' ' ' LEU . 84.2 mt -62.35 -53.14 51.39 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 CA-C-N 114.844 -1.071 . . . . 74.31 110.804 175.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 38.5 m -57.73 -37.35 73.43 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.263 1.025 . . . . 74.03 110.964 -173.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.6 t -69.26 -46.24 67.76 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.766 -1.106 . . . . 72.31 109.818 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.551 ' HE1' ' HB2' ' A' ' 23' ' ' PHE . 9.0 mtp -58.84 -37.31 76.17 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.796 0.839 . . . . 72.24 111.837 176.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 114' ' ' ILE . 74.2 t -67.27 -45.61 85.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 124.183 0.993 . . . . 70.02 110.284 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 94.2 p -73.63 -28.04 61.58 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 116.248 -0.433 . . . . 74.44 110.772 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -70.38 -33.97 72.03 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.698 0.799 . . . . 74.43 109.376 172.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.439 ' O ' HG22 ' A' ' 122' ' ' THR . . . -81.99 8.13 61.17 Favored Glycine 0 C--N 1.353 1.502 0 CA-C-N 115.095 -0.957 . . . . 73.52 112.767 172.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.4 t 65.14 11.47 7.2 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 127.42 2.288 . . . . 60.31 113.888 171.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -79.38 143.81 60.68 Favored Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 108.962 -0.755 . . . . 74.32 108.962 177.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -48.05 143.54 13.8 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.372 2.715 . . . . 55.24 113.285 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -53.13 116.09 2.21 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.835 1.254 . . . . 73.32 113.283 -165.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.541 HD21 HG12 ' A' ' 64' ' ' VAL . 55.6 tp -110.71 96.06 5.94 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.159 0.584 . . . . 75.02 109.625 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.632 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 1.0 OUTLIER -100.31 113.51 26.28 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 106.287 -1.745 . . . . 75.44 106.287 175.566 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.55 HD12 HD13 ' A' ' 114' ' ' ILE . 16.2 mt -65.65 130.57 43.74 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 123.553 0.533 . . . . 63.44 109.751 -174.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.73 139.11 97.56 Favored Pre-proline 0 CA--C 1.554 1.128 0 CA-C-O 118.767 -0.635 . . . . 72.23 110.755 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.528 ' HD2' HE21 ' C' ' 12' ' ' GLN . 75.6 Cg_exo -50.31 140.51 34.06 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 123.617 2.878 . . . . 72.25 113.686 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.538 HG22 HD12 ' A' ' 44' ' ' LEU . 70.9 t -115.6 132.34 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 122.95 0.5 . . . . 75.11 110.082 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -93.06 79.77 4.56 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.201 -1.037 . . . . 70.22 108.201 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.447 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 84.8 m-85 -58.42 -25.0 61.66 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.977 0.911 . . . . 75.14 111.791 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -67.97 -49.67 60.3 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.223 1.009 . . . . 75.23 110.594 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.57 92.66 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.076 0.86 . . . . 73.23 110.194 177.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.7 mt -62.46 -36.62 83.02 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 114.727 -1.124 . . . . 74.11 111.312 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.1 t80 . . . . . 0 C--O 1.216 -0.67 0 O-C-N 123.789 0.681 . . . . 71.12 110.109 177.042 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.527 ' HG3' HG13 ' B' ' 89' ' ' ILE . 26.9 ttt . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 121.698 0.761 . . . . 71.43 112.148 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.8 m -140.84 125.69 18.14 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.936 -1.135 . . . . 62.14 107.936 167.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.431 ' HB2' ' HE3' ' B' ' 9' ' ' MET . 55.4 t80 -136.18 142.07 44.1 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.705 0.802 . . . . 74.55 108.975 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -156.11 141.44 17.56 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 109.124 -0.695 . . . . 75.22 109.124 170.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.511 HD11 HD12 ' B' ' 105' ' ' ILE . 61.6 mt -80.77 134.23 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.033 -1.099 . . . . 74.1 108.033 175.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -99.98 -50.61 3.94 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.591 0.357 . . . . 75.31 110.224 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -167.47 129.72 1.62 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.255 -0.646 . . . . 72.25 109.255 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.558 HG21 ' CD1' ' B' ' 109' ' ' TYR . 86.8 mt -115.32 149.6 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 108.539 -0.912 . . . . 74.3 108.539 175.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.598 ' HE2' ' HZ3' ' B' ' 19' ' ' LYS . 20.7 p90 -167.41 162.85 14.88 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.63 0.728 . . . . 74.34 111.492 -173.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 55.4 m -90.19 124.29 34.72 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 114.342 -1.299 . . . . 75.35 108.307 170.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.598 ' HZ3' ' HE2' ' B' ' 17' ' ' TYR . 35.3 mttp -85.96 -45.56 11.37 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.944 0.898 . . . . 72.5 110.343 172.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 24.4 t70 -144.64 142.76 30.36 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.519 -0.309 . . . . 61.04 110.91 -167.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.448 HD13 ' SG ' ' B' ' 113' ' ' CYS . 46.4 mm -136.25 142.76 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.628 1.171 . . . . 72.1 109.116 177.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.403 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 29.4 m -138.17 135.37 35.6 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.102 1.361 . . . . 75.22 108.029 168.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 80.9 t80 -142.12 108.42 5.27 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 105.659 -1.978 . . . . 73.45 105.659 164.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -118.95 112.18 19.28 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.315 -0.994 . . . . 74.21 108.315 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.01 87.08 4.34 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 107.029 -1.471 . . . . 72.24 107.029 171.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.91 -26.63 21.93 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 122.24 1.96 . . . . 74.33 111.911 -172.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.55 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 75.2 m-20 -107.99 14.62 25.09 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.537 1.135 . . . . 64.52 110.453 -176.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.98 -55.27 9.58 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 125.339 1.456 . . . . 70.43 114.832 -167.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -55.46 -44.68 46.21 Favored 'Trans proline' 0 C--N 1.4 3.239 0 C-N-CA 122.054 1.836 . . . . 73.12 113.348 -175.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -98.03 -16.79 19.48 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.899 1.074 . . . . 75.12 113.899 -171.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.455 HG23 ' HA ' ' B' ' 73' ' ' ALA . 9.5 p -76.1 -8.72 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-N 118.811 0.732 . . . . 75.4 112.05 -172.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -80.45 -1.62 42.37 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.897 0.479 . . . . 74.13 112.187 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -64.01 -25.19 68.01 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.086 0.554 . . . . 55.32 110.304 166.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.496 ' HB2' HD13 ' B' ' 68' ' ' LEU . 31.1 mmtp -90.96 107.94 19.53 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.988 1.315 . . . . 71.32 108.979 -178.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -115.89 86.09 2.41 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.384 0.611 . . . . 72.23 110.806 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 37.4 p90 -163.97 160.51 21.99 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.325 1.45 . . . . 73.34 107.78 171.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -62.75 116.18 22.1 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 108.376 -0.972 . . . . 73.42 108.376 172.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.01 157.54 58.91 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.042 1.828 . . . . 72.3 111.665 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -69.13 115.32 8.28 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 108.233 -1.025 . . . . 62.32 108.233 172.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.659 HG21 ' HB1' ' B' ' 66' ' ' ALA . 60.8 t -106.21 129.45 59.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 O-C-N 124.146 0.904 . . . . 71.02 110.602 -173.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.483 ' HE3' ' HB2' ' B' ' 43' ' ' ASP . 18.7 ttpt -106.48 120.5 42.08 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.509 -0.923 . . . . 75.54 108.509 168.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 16.1 tp -88.03 134.16 33.8 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.585 -0.894 . . . . 72.41 108.585 173.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.484 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 9.4 t0 -134.66 112.11 10.54 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.094 -1.076 . . . . 72.04 108.094 -172.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.417 HD12 HG11 ' B' ' 131' ' ' VAL . 78.4 mt -107.35 150.88 26.23 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.094 0.558 . . . . 74.24 110.306 -173.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.528 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.2 t70 -151.66 139.27 19.67 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.607 0.763 . . . . 74.3 109.686 -173.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 4.7 t -114.55 103.66 11.24 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-O 121.694 0.759 . . . . 73.13 109.68 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.28 118.67 30.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.555 -0.906 . . . . 73.43 108.555 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 54.0 p -145.77 172.35 13.43 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 122.086 -0.383 . . . . 71.43 111.563 -175.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 24.4 p -159.62 137.39 10.03 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.684 0.793 . . . . 74.23 110.702 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . 0.479 ' HB2' ' CE2' ' B' ' 56' ' ' TYR . 58.8 tt0 -84.98 105.71 15.95 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 108.566 -0.901 . . . . 75.31 108.566 170.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 pp -123.72 14.12 9.35 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.1 -0.954 . . . . 74.04 110.161 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.67 142.98 12.73 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.6 -1.182 . . . . 73.45 108.571 -176.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -75.99 117.25 17.51 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.642 0.777 . . . . 73.44 109.982 -172.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 66.12 5.21 3.45 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 125.566 1.547 . . . . 75.12 112.758 -176.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.423 HG23 ' HG ' ' B' ' 85' ' ' SER . 61.9 t -125.07 96.64 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.422 -1.325 . . . . 74.23 107.422 -175.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.479 ' CE2' ' HB2' ' B' ' 50' ' ' GLN . 1.8 t80 -94.27 140.24 30.03 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.97 -0.752 . . . . 75.54 108.97 -172.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -106.47 105.09 14.96 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.524 -1.287 . . . . 70.41 107.524 -177.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -103.11 129.08 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.331 1.052 . . . . 75.45 109.718 -174.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 16.3 t -115.84 112.44 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.762 -0.829 . . . . 75.33 108.762 176.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -94.18 110.31 22.04 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.751 -1.203 . . . . 74.04 107.751 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.528 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 7.1 tmm_? -91.19 124.67 35.58 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.758 -0.83 . . . . 72.54 108.758 176.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 19.3 t -111.63 135.35 51.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.66 -1.237 . . . . 74.51 107.66 173.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 22.9 m -128.64 128.52 44.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.81 0.814 . . . . 72.13 109.274 171.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.483 HG23 HD12 ' B' ' 114' ' ' ILE . 79.6 t -107.09 114.84 47.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 114.09 -1.414 . . . . 63.04 108.584 172.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 88.6 m -96.03 135.93 37.16 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.017 -1.105 . . . . 73.41 108.017 165.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.659 ' HB1' HG21 ' B' ' 40' ' ' VAL . . . -148.35 141.82 25.35 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.207 -0.664 . . . . 73.04 109.207 177.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.542 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 18.5 p -143.61 134.87 25.85 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.646 -0.707 . . . . 65.04 111.207 -172.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.521 ' HG ' ' HB3' ' B' ' 73' ' ' ALA . 85.2 mt -106.88 104.01 13.59 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.925 1.29 . . . . 74.13 110.733 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.44 -125.08 7.15 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-O 120.118 -0.268 . . . . 73.4 112.781 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -91.01 3.54 54.44 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.456 0.703 . . . . 64.43 111.77 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.55 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 13.1 pt-20 -135.2 146.68 48.92 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.066 0.546 . . . . 74.33 110.945 -170.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 49.1 m -71.91 130.54 41.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.843 -0.617 . . . . 73.33 110.842 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.542 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -79.33 -65.48 0.99 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.881 -1.054 . . . . 70.01 108.306 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -151.18 152.02 32.73 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.221 -0.899 . . . . 75.52 111.459 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 78.4 mt -118.99 109.39 15.89 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 105.928 -1.878 . . . . 74.43 105.928 168.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.6 t -117.29 135.43 53.83 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.877 -1.156 . . . . 64.4 107.877 -178.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.403 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 38.1 tt0 -149.5 135.96 19.23 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.725 -0.843 . . . . 73.22 108.725 -172.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -131.16 143.2 41.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.845 -0.798 . . . . 72.12 108.845 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -116.56 96.69 5.62 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.811 -1.181 . . . . 74.31 107.811 171.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.422 ' HB2' ' HB1' ' B' ' 110' ' ' ALA . 7.6 tp-100 -90.89 100.02 12.95 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.95 -0.759 . . . . 74.3 108.95 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.74 142.26 16.15 Favored Glycine 0 C--N 1.344 1.027 0 O-C-N 123.624 0.578 . . . . 74.23 111.705 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.432 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -142.67 125.93 2.75 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.643 -0.583 . . . . 71.44 111.643 -176.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 40.8 mt -84.93 115.73 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 107.517 -1.29 . . . . 74.33 107.517 171.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -128.93 146.26 51.0 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.583 0.753 . . . . 65.43 109.913 -177.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.423 ' HG ' HG23 ' B' ' 55' ' ' VAL . 44.4 m -94.0 110.09 21.8 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.374 0.67 . . . . 65.3 109.36 172.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 4.7 mp -112.91 111.42 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 108.154 -1.054 . . . . 75.52 108.154 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.51 169.24 24.73 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.11 0.564 . . . . 75.32 111.325 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.12 -67.63 0.85 Allowed Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.525 -0.63 . . . . 65.04 111.525 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.527 HG13 ' HG3' ' B' ' 9' ' ' MET . 0.9 OUTLIER -52.69 159.05 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 124.338 1.055 . . . . 72.24 111.759 168.333 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -151.46 145.77 25.45 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 112.624 0.602 . . . . 75.35 112.624 -171.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . 0.428 ' O ' ' HG2' ' B' ' 94' ' ' MET . . . 70.09 -111.88 4.06 Favored Glycine 0 C--N 1.358 1.781 0 CA-C-N 115.453 -0.794 . . . . 70.31 113.985 173.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 8.9 m -73.44 -38.03 65.64 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 122.081 0.943 . . . . 70.44 109.625 177.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -69.63 -27.73 65.31 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 113.404 -1.725 . . . . 74.23 110.903 -170.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.428 ' HG2' ' O ' ' B' ' 91' ' ' GLY . 25.1 ptt? -81.45 -43.91 18.2 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.345 0.658 . . . . 73.44 112.687 -173.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.3 -11.29 59.94 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.598 0.759 . . . . 72.42 112.19 -173.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -61.25 -35.31 76.91 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.505 0.322 . . . . 74.43 110.259 165.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.3 t -61.34 -61.09 2.79 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.812 0.445 . . . . 62.55 111.282 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.56 -15.82 62.29 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 113.004 0.742 . . . . 74.34 113.004 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.31 -2.45 59.02 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.689 -0.506 . . . . 71.14 113.532 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.83 -59.87 0.18 Allowed 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.405 0.603 . . . . 61.44 111.881 -174.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -67.61 -48.25 67.34 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.077 0.951 . . . . 72.54 111.784 -173.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.5 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 63.6 m -65.0 -48.69 70.78 Favored Pre-proline 0 CA--C 1.563 1.47 0 C-N-CA 123.802 0.841 . . . . 75.1 111.509 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.5 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 74.6 Cg_exo -57.33 -29.49 84.32 Favored 'Trans proline' 0 C--N 1.4 3.26 0 C-N-CA 122.731 2.287 . . . . 75.33 113.991 170.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -67.7 -30.35 69.84 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.032 0.933 . . . . 72.42 110.682 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.511 HD12 HD11 ' B' ' 13' ' ' ILE . 62.2 mt -76.04 -41.29 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.466 0.706 . . . . 75.0 110.135 175.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.432 HD21 ' HA3' ' B' ' 82' ' ' GLY . 80.9 mt -71.86 -34.22 69.04 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.801 -1.091 . . . . 75.14 111.912 -175.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -59.49 -47.62 97.47 Favored Pre-proline 0 CA--C 1.56 1.327 0 CA-C-O 117.513 -1.232 . . . . 74.0 113.167 -170.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -56.2 -36.72 96.99 Favored 'Trans proline' 0 C--N 1.392 2.849 0 C-N-CA 122.363 2.042 . . . . 75.3 113.229 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.558 ' CD1' HG21 ' B' ' 16' ' ' ILE . 4.0 m-30 -70.68 -42.62 70.48 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.526 0.731 . . . . 72.23 109.978 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' B' ' 80' ' ' GLN . . . -66.76 -36.53 82.64 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.009 -0.996 . . . . 71.14 110.91 176.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.474 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 50.4 ttt-85 -64.36 -48.91 73.69 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.231 1.413 . . . . 75.31 110.749 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -70.07 -31.62 69.32 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.549 0.739 . . . . 61.24 109.768 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.508 ' O ' ' HG2' ' B' ' 117' ' ' MET . 11.5 t -67.29 -38.64 85.34 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 123.017 0.527 . . . . 75.02 110.515 177.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.483 HD12 HG23 ' B' ' 64' ' ' VAL . 63.5 mt -63.36 -55.71 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.971 0.908 . . . . 72.2 110.141 174.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.401 HG22 ' OG ' ' C' ' 119' ' ' SER . 24.2 m -60.97 -30.41 70.23 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 124.136 0.898 . . . . 73.14 111.268 -175.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.464 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 29.8 t -60.49 -52.29 65.83 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.469 0.708 . . . . 74.15 109.235 173.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.508 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.6 mmt -65.85 -35.82 81.72 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.28 0.632 . . . . 73.42 111.414 -175.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.6 t -63.75 -44.59 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 124.144 0.978 . . . . 63.42 110.655 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.3 t -67.55 -32.59 73.46 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.713 -1.13 . . . . 75.15 111.294 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.51 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 77.3 mtt-85 -66.55 -43.46 85.01 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.572 -0.74 . . . . 74.1 109.507 175.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.68 -7.79 66.05 Favored Glycine 0 C--N 1.352 1.444 0 O-C-N 123.801 0.688 . . . . 74.44 113.259 175.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.58 HG21 HD21 ' C' ' 127' ' ' ASN . 7.4 m 63.94 29.98 14.33 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.897 1.279 . . . . 71.51 110.662 177.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -83.14 159.47 62.33 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.138 0.975 . . . . 74.15 111.062 176.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -48.76 149.12 7.87 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.489 2.793 . . . . 72.14 114.65 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.407 HE21 ' ND2' ' B' ' 127' ' ' ASN . 65.9 tp60 -59.49 114.34 2.65 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 124.382 1.051 . . . . 73.33 111.613 -171.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 21.2 tp -111.66 102.07 10.41 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.891 0.876 . . . . 75.01 109.88 -178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . 0.407 ' ND2' HE21 ' B' ' 125' ' ' GLN . 58.2 m-80 -107.58 119.01 38.24 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 107.793 -1.188 . . . . 72.41 107.793 167.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.474 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 42.1 mt -69.01 148.54 49.95 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 123.159 0.287 . . . . 75.31 110.711 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.36 147.5 97.08 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.429 0.692 . . . . 64.12 110.589 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.12 92.49 0.1 Allowed 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.505 2.137 . . . . 74.42 112.111 173.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.417 HG11 HD12 ' B' ' 44' ' ' LEU . 69.7 t -90.17 110.83 22.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 109.321 -0.622 . . . . 74.33 109.321 177.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 108.34 -0.985 . . . . 65.01 108.34 176.477 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.416 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 55.7 t80 . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 108.713 -0.847 . . . . 75.14 108.713 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . 0.528 HE21 ' HD2' ' A' ' 130' ' ' PRO . 1.3 tp60 -157.91 144.23 17.55 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.3 0.375 . . . . 75.24 110.54 168.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 57.2 mt -82.65 135.07 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 115.467 -0.788 . . . . 72.34 109.384 175.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -98.92 -46.47 5.61 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.475 0.71 . . . . 65.13 109.706 172.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.632 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -170.69 146.16 2.61 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.603 0.761 . . . . 74.31 110.746 174.037 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 36.3 mm -115.64 139.23 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 106.467 -1.679 . . . . 70.41 106.467 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.46 ' HB3' HG22 ' D' ' 122' ' ' THR . 19.3 p90 -169.45 157.78 7.53 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.896 0.855 . . . . 72.32 111.987 -171.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.6 p -82.9 102.87 11.96 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.222 -1.354 . . . . 74.43 109.422 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.432 ' HE3' ' HB2' ' D' ' 28' ' ' ALA . 11.2 mmmm -65.14 -34.36 78.21 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.381 0.61 . . . . 74.14 109.392 171.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.591 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.5 t70 -153.4 145.7 23.93 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.63 -1.168 . . . . 74.42 109.24 -175.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.5 mt -140.85 145.77 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.615 1.566 . . . . 74.02 107.098 176.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.6 t -156.27 150.57 25.5 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.179 0.514 . . . . 61.13 110.266 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -149.37 131.74 15.62 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.168 -1.419 . . . . 74.1 107.168 174.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -133.92 111.8 10.74 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.108 -0.701 . . . . 72.33 109.108 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.66 82.14 67.45 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 107.657 -1.238 . . . . 70.32 107.657 170.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.84 -44.97 18.37 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.552 2.168 . . . . 71.54 111.276 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -92.89 21.06 5.96 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.472 -1.24 . . . . 75.4 111.082 -176.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.44 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -46.62 -58.3 7.07 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 124.226 1.01 . . . . 75.41 113.471 -172.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -60.94 -38.95 65.11 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 121.679 1.586 . . . . 63.43 112.44 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -69.24 -39.38 78.55 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.348 -0.842 . . . . 73.54 111.419 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.646 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.5 p -78.46 -17.29 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 C-N-CA 123.009 0.524 . . . . 73.31 112.308 -171.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -70.81 -15.54 62.66 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 112.194 0.442 . . . . 74.53 112.194 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -109.17 19.68 19.19 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.13 0.572 . . . . 72.55 111.09 174.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.651 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -92.85 158.7 15.72 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.385 0.674 . . . . 72.15 109.757 173.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.56 125.33 23.91 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.34 0.656 . . . . 52.3 109.377 167.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 62.3 t-105 -85.37 80.25 9.2 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.164 0.586 . . . . 74.23 110.364 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -121.79 76.92 38.56 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 124.368 1.067 . . . . 75.01 108.316 170.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -85.35 119.45 2.03 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 123.553 2.835 . . . . 55.23 112.608 -170.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -87.35 94.62 9.73 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.468 -1.242 . . . . 70.34 108.487 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.02 110.12 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 113.869 -1.514 . . . . 75.22 110.526 -172.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.52 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 18.2 tptm -92.2 105.47 17.68 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.45 -0.945 . . . . 74.31 108.45 169.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 pp -86.9 128.89 35.06 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 106.64 -1.615 . . . . 74.32 106.64 169.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.529 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 16.3 t70 -125.78 105.31 8.87 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 108.897 -0.779 . . . . 75.43 108.897 -172.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.457 HD21 HG11 ' C' ' 62' ' ' VAL . 96.1 mt -96.27 130.85 43.26 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.356 0.662 . . . . 64.11 110.521 -174.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -144.58 125.71 14.6 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.731 1.212 . . . . 73.12 107.938 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.1 t -121.86 151.74 40.34 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 109.621 -0.511 . . . . 73.4 109.621 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.93 148.24 31.58 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 124.355 1.062 . . . . 74.3 108.354 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.408 ' HG ' ' HB3' ' C' ' 98' ' ' LEU . 13.6 m -143.43 143.77 31.75 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.332 -0.618 . . . . 74.52 109.332 -178.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 65.0 p -145.22 136.36 24.88 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.931 0.892 . . . . 73.54 109.34 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -79.07 117.69 20.34 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 109.016 -0.735 . . . . 75.23 109.016 176.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.652 HD12 ' HB2' ' C' ' 57' ' ' GLU . 68.4 mt -84.25 -38.91 19.92 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.483 0.713 . . . . 65.52 110.19 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.22 -169.48 3.06 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.349 -0.841 . . . . 75.44 110.273 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.02 104.27 0.1 Allowed 'General case' 0 N--CA 1.481 1.088 0 O-C-N 124.185 0.928 . . . . 51.5 110.985 176.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 60.25 35.74 20.85 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 124.603 1.19 . . . . 73.15 111.338 174.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.4 t -127.7 119.24 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.867 -1.16 . . . . 72.11 107.867 174.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -123.63 124.13 42.1 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.961 0.905 . . . . 75.52 109.602 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.652 ' HB2' HD12 ' C' ' 51' ' ' LEU . 39.0 tt0 -85.51 132.11 34.25 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.471 -0.937 . . . . 74.35 108.471 167.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 51.5 t -118.82 143.71 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.32 -0.622 . . . . 71.31 109.32 171.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 90.3 t -124.33 140.54 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 C-N-CA 125.226 1.41 . . . . 75.24 108.433 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.4 HD13 ' CZ ' ' C' ' 133' ' ' PHE . 0.0 OUTLIER -121.14 96.96 5.3 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.184 -1.413 . . . . 75.1 107.184 173.833 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -82.2 105.91 13.67 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.465 -0.939 . . . . 74.51 108.465 173.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.457 HG11 HD21 ' C' ' 44' ' ' LEU . 28.6 t -105.38 129.01 58.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.769 -1.197 . . . . 75.42 107.769 173.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.529 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 69.5 m -116.42 125.06 51.49 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.499 -0.926 . . . . 64.54 108.499 175.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.422 HG21 HG23 ' C' ' 114' ' ' ILE . 68.0 t -103.83 110.25 29.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.2 -0.667 . . . . 70.22 109.2 170.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 7.4 m -96.48 131.97 42.52 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.83 -1.544 . . . . 75.21 106.83 170.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.75 113.39 14.66 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 106.682 -1.599 . . . . 72.23 106.682 -176.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 36.8 m -134.04 126.97 31.28 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-O 121.0 0.429 . . . . 75.24 110.144 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 16.2 mt -85.09 36.9 0.64 Allowed 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 125.829 1.652 . . . . 72.41 110.482 177.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.5 -92.62 1.04 Allowed Glycine 0 C--N 1.358 1.8 0 N-CA-C 111.085 -0.806 . . . . 74.2 111.085 176.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -90.33 -19.61 23.84 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.424 1.09 . . . . 73.14 110.697 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -103.54 124.13 48.21 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 125.335 1.454 . . . . 74.24 109.293 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 83.5 m -78.78 123.94 27.7 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.042 0.837 . . . . 72.4 109.222 167.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.646 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -70.55 -59.03 3.08 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.957 0.786 . . . . 74.51 109.335 174.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -162.54 173.77 13.54 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-O 121.468 0.651 . . . . 64.23 110.953 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.43 HD23 HG21 ' C' ' 65' ' ' THR . 2.7 tm? -138.0 104.16 5.17 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 106.435 -1.691 . . . . 64.34 106.435 175.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 49.3 t -108.21 145.42 34.28 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.26 -1.015 . . . . 71.31 108.26 176.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -154.25 128.79 9.23 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.304 -0.628 . . . . 75.25 109.304 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 69.1 t -126.91 136.2 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.011 0.924 . . . . 74.45 109.025 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.591 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.1 mt-30 -105.03 90.2 3.37 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.165 -1.05 . . . . 71.23 108.165 170.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -80.33 98.85 7.62 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.475 -0.784 . . . . 74.01 109.862 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.47 170.28 48.39 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 116.255 -0.429 . . . . 71.32 112.274 176.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.94 119.75 0.78 Allowed Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.82 -0.912 . . . . 64.2 110.82 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.536 HD11 ' HB3' ' D' ' 29' ' ' PRO . 36.0 mm -82.02 124.96 39.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.741 -0.837 . . . . 71.02 108.741 176.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -126.7 119.06 26.03 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 124.059 0.849 . . . . 72.03 108.779 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 12.4 p -80.65 99.21 8.04 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.895 -1.15 . . . . 74.55 107.895 172.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.64 HG21 ' HE2' ' C' ' 94' ' ' MET . 20.9 mt -118.14 123.87 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 109.403 -0.591 . . . . 74.55 109.403 -177.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.59 155.22 44.2 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.903 0.705 . . . . 63.04 112.903 -171.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.88 -28.13 6.79 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.13 -0.941 . . . . 63.3 115.14 168.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.711 HD13 ' HA ' ' C' ' 94' ' ' MET . 37.5 pt -96.16 159.04 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-O 121.726 0.774 . . . . 75.14 112.232 -175.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -149.41 -173.08 4.29 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 113.781 -1.554 . . . . 74.45 108.069 171.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.74 -128.22 46.15 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.494 0.496 . . . . 55.43 113.973 171.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 10.2 t -74.08 -32.13 63.12 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.142 0.977 . . . . 71.33 112.571 -174.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -65.88 -52.72 47.77 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.186 0.595 . . . . 75.44 109.987 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.711 ' HA ' HD13 ' C' ' 89' ' ' ILE . 4.6 tpt -54.72 -48.75 72.13 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 124.149 0.905 . . . . 75.31 111.632 173.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.43 -38.14 76.82 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.988 0.805 . . . . 71.12 111.388 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -80.42 -29.58 37.65 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.31 0.644 . . . . 74.41 111.805 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 35.0 t -70.35 -34.79 73.05 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.999 -0.741 . . . . 74.23 108.999 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.408 ' HB3' ' HG ' ' C' ' 48' ' ' SER . 69.3 mt -87.36 -28.8 21.99 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.035 1.334 . . . . 75.41 111.123 176.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.42 -28.07 41.24 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 115.804 -0.635 . . . . 63.53 114.397 -170.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.487 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -139.21 -52.33 0.55 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 111.934 0.346 . . . . 63.33 111.934 -169.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -64.73 -53.65 43.81 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 123.293 0.371 . . . . 74.23 110.988 -173.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.416 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 94.9 m -59.23 -49.93 90.24 Favored Pre-proline 0 CA--C 1.564 1.5 0 CA-C-O 118.173 -0.918 . . . . 72.55 111.976 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -53.79 -33.25 69.93 Favored 'Trans proline' 0 C--N 1.397 3.125 0 C-N-CA 122.666 2.244 . . . . 72.35 114.628 171.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -67.1 -32.3 73.37 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 122.86 0.464 . . . . 71.34 110.958 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 44.0 mm -72.87 -40.71 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.041 0.536 . . . . 74.42 109.637 176.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 76.0 mt -78.9 -27.01 43.85 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.144 0.978 . . . . 71.11 112.272 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -56.43 -49.41 93.63 Favored Pre-proline 0 CA--C 1.56 1.328 0 N-CA-C 114.547 1.314 . . . . 71.52 114.547 -173.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -60.84 -38.65 68.54 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 122.022 1.815 . . . . 74.21 112.67 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -67.93 -41.06 83.13 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.451 -0.795 . . . . 72.42 110.119 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.9 -42.69 99.87 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.784 0.834 . . . . 75.11 109.929 175.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -57.76 -55.65 32.16 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.329 1.052 . . . . 72.34 110.377 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -66.07 -30.59 71.13 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.16 0.584 . . . . 75.31 110.426 -174.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . 0.415 ' SG ' HG12 ' C' ' 21' ' ' ILE . 21.4 t -72.54 -33.89 67.15 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 122.94 0.496 . . . . 74.01 111.453 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.422 HG23 HG21 ' C' ' 64' ' ' VAL . 96.3 mt -75.15 -49.58 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 123.554 0.742 . . . . 74.34 110.144 175.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 13.5 m -67.14 -28.95 68.56 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.249 1.02 . . . . 71.14 110.819 -175.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.445 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 27.2 t -63.07 -50.07 72.05 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 108.612 -0.884 . . . . 71.53 108.612 170.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.546 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.52 -35.44 77.72 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.585 1.154 . . . . 75.12 112.602 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 93.3 t -63.36 -47.01 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.61 0.764 . . . . 73.53 109.706 173.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.401 ' OG ' HG22 ' B' ' 115' ' ' THR . 46.5 t -68.53 -28.94 67.43 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.813 -1.085 . . . . 73.11 111.506 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' C' ' 116' ' ' SER . 86.5 mtt-85 -72.06 -42.45 66.22 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.031 -0.729 . . . . 74.55 109.031 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.65 -0.82 60.04 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 115.588 -0.733 . . . . 70.03 112.686 170.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.409 HG21 ' HB3' ' D' ' 17' ' ' TYR . 32.8 p 61.59 32.68 18.57 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.493 1.917 . . . . 73.52 113.375 171.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -83.34 155.19 66.53 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 108.638 -0.875 . . . . 73.14 108.638 170.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -50.63 159.42 2.23 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.994 2.462 . . . . 73.33 113.947 171.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -51.01 138.79 18.82 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.815 1.246 . . . . 74.41 112.292 -176.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 50.7 tp -149.1 86.2 1.49 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.123 -0.695 . . . . 71.45 109.123 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . 0.58 HD21 HG21 ' B' ' 122' ' ' THR . 83.6 m-20 -91.64 123.29 34.93 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.219 -0.9 . . . . 74.11 108.707 175.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.08 119.81 15.74 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.403 -0.962 . . . . 75.43 108.403 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.29 143.57 95.45 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 123.768 0.827 . . . . 75.14 110.923 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.451 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 8.5 Cg_endo -51.71 98.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.128 2.552 . . . . 72.13 113.014 174.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 60.2 t -98.29 111.7 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.489 -1.301 . . . . 75.24 107.489 173.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -74.03 102.82 4.3 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.048 0.539 . . . . 71.43 110.566 -174.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . 0.4 ' CZ ' HD13 ' C' ' 60' ' ' LEU . 81.0 m-85 -62.18 -25.26 67.68 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.841 0.856 . . . . 74.43 111.454 176.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.487 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 23.9 t70 -62.17 -49.96 73.71 Favored 'General case' 0 C--N 1.347 0.485 0 O-C-N 123.881 0.738 . . . . 62.15 109.713 177.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.16 -43.05 92.09 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 124.176 0.922 . . . . 43.54 111.654 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 79.7 mt -64.28 -39.89 94.85 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.953 -1.021 . . . . 73.54 111.428 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 27.3 t80 . . . . . 0 CA--C 1.543 0.689 0 CA-C-N 116.256 -0.429 . . . . 74.54 111.468 -177.954 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 109.806 -0.442 . . . . 64.42 109.806 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -142.67 102.34 4.03 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.078 -1.082 . . . . 73.41 108.078 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -119.55 126.29 50.87 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.46 0.704 . . . . 74.14 109.465 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mt -91.79 137.89 21.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 123.657 0.783 . . . . 55.43 109.203 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . 0.424 ' NE2' HG23 ' D' ' 83' ' ' ILE . 51.2 mt-30 -110.92 -44.41 3.62 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.191 0.596 . . . . 55.51 111.678 -176.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -169.03 122.98 0.82 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.822 -0.172 . . . . 72.0 110.566 -168.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.1 mp -103.82 137.17 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 107.287 -1.375 . . . . 73.14 107.287 166.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.409 ' HB3' HG21 ' C' ' 122' ' ' THR . 41.5 p90 -158.33 146.62 18.62 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.228 0.611 . . . . 73.44 110.804 174.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -76.88 114.53 15.75 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.398 -0.819 . . . . 61.02 109.034 173.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -81.12 -21.13 40.09 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.586 -0.733 . . . . 54.5 109.896 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 7.3 t70 -162.12 142.67 10.29 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.941 1.297 . . . . 71.31 109.225 -176.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.546 HG23 ' HE1' ' C' ' 117' ' ' MET . 79.5 mt -142.94 148.73 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 124.889 1.276 . . . . 73.34 108.549 176.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.3 t -150.28 145.3 26.1 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.052 1.341 . . . . 64.51 108.352 172.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.519 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.5 t80 -151.69 136.18 16.92 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.497 -1.668 . . . . 75.33 106.497 171.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.509 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 48.0 mt-10 -138.97 148.55 43.64 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.335 0.654 . . . . 74.33 109.819 -176.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.68 78.43 9.1 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 107.718 -1.216 . . . . 74.41 107.718 175.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.6 -31.31 8.86 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.514 2.142 . . . . 74.52 112.827 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -94.46 -1.48 53.48 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.368 0.667 . . . . 71.31 111.096 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.432 ' HB2' ' HE3' ' C' ' 19' ' ' LYS . . . -24.55 -66.96 0.07 OUTLIER Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 126.841 2.057 . . . . 71.24 116.356 -164.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.536 ' HB3' HD11 ' C' ' 83' ' ' ILE . 86.4 Cg_endo -77.71 -20.7 11.83 Favored 'Trans proline' 0 C--N 1.385 2.472 0 CA-C-N 123.046 2.124 . . . . 75.11 113.92 -176.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.506 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 3.9 t-160 -73.25 -39.24 65.61 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.055 0.942 . . . . 75.43 109.365 174.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.566 HG21 ' HA ' ' D' ' 73' ' ' ALA . 5.6 p -83.57 -24.12 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 CA-C-N 115.627 -0.715 . . . . 73.41 111.14 -172.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -63.83 -29.31 70.52 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.085 0.469 . . . . 75.14 111.207 176.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . 0.506 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 69.5 mt-30 -56.87 -29.3 62.81 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.547 -1.206 . . . . 71.34 110.493 176.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.552 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 98.4 mttt -84.42 71.48 10.7 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.731 1.212 . . . . 75.45 109.498 169.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -76.85 92.92 3.66 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.185 -0.916 . . . . 71.22 109.676 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -164.91 -165.82 0.96 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.128 0.971 . . . . 73.31 109.964 173.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -77.68 115.02 46.43 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.471 1.108 . . . . 74.41 110.965 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' HG2' ' D' ' 124' ' ' PRO . 24.0 Cg_exo -64.73 130.45 26.3 Favored 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 122.649 2.233 . . . . 71.31 111.203 173.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 30.0 mm-40 -67.52 109.6 3.3 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 108.122 -1.066 . . . . 75.14 108.122 171.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.663 HG11 HG13 ' D' ' 64' ' ' VAL . 45.7 t -99.16 128.07 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.774 -0.824 . . . . 75.33 108.774 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.02 127.87 48.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.605 -1.628 . . . . 65.5 106.605 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.549 HD21 HD11 ' D' ' 128' ' ' LEU . 55.4 tp -95.82 145.64 25.19 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.533 0.733 . . . . 73.51 110.522 -173.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.499 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 10.1 t70 -142.47 111.9 6.65 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 106.486 -1.672 . . . . 71.25 106.486 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 79.1 mt -109.71 145.27 36.86 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.256 0.55 . . . . 75.02 110.87 -174.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.69 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.0 t70 -137.33 149.88 47.35 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.71 1.204 . . . . 71.32 108.378 177.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 30.2 m -120.92 144.16 48.59 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.82 -0.807 . . . . 60.43 108.82 173.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.535 ' HB2' ' HB ' ' D' ' 59' ' ' VAL . . . -147.23 170.31 17.51 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.931 1.292 . . . . 73.41 107.653 -177.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.469 0.478 0 C-N-CA 122.692 0.397 . . . . 60.14 110.7 -172.139 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . 0.543 ' O ' ' HA ' ' D' ' 85' ' ' SER . 68.0 m-20 . . . . . 0 N--CA 1.498 1.952 0 N-CA-C 114.74 1.385 . . . . 75.31 114.74 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 40.4 t -135.62 96.04 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 119.316 0.962 . . . . 73.21 108.557 -173.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -152.51 161.27 42.81 Favored 'General case' 0 C--O 1.247 0.921 0 CA-C-N 114.299 -1.319 . . . . 71.2 108.649 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.52 ' HG2' HG12 ' D' ' 83' ' ' ILE . 36.1 mt-10 -89.77 143.74 26.55 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 114.934 -1.03 . . . . 74.2 110.323 177.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 91.6 t -116.75 139.67 42.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 113.251 -1.795 . . . . 74.31 106.902 167.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' D' ' 47' ' ' ALA . 41.5 t -129.22 129.87 67.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.426 -0.953 . . . . 74.15 108.426 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.521 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -110.95 120.64 43.07 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.251 -1.389 . . . . 73.22 107.251 173.849 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.69 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 7.3 ttm180 -102.03 100.88 11.19 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.091 -1.077 . . . . 75.52 108.091 175.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.424 HG12 HD12 ' D' ' 42' ' ' LEU . 49.0 t -92.12 122.84 43.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.299 -1.0 . . . . 72.32 108.299 173.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 17.5 m -122.05 129.13 52.14 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.745 -0.835 . . . . 73.41 108.745 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.663 HG13 HG11 ' D' ' 40' ' ' VAL . 67.5 t -118.8 121.02 65.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 124.281 1.032 . . . . 73.11 109.186 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 49.8 m -106.84 114.61 28.8 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.155 -1.424 . . . . 75.44 107.155 164.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.594 ' HB3' HG22 ' D' ' 40' ' ' VAL . . . -119.86 142.84 48.29 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.553 0.741 . . . . 64.25 109.25 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.508 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 68.6 p -147.32 130.92 16.83 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.141 0.422 . . . . 71.12 112.141 -170.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 18.7 mt -93.84 105.95 17.95 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.15 0.98 . . . . 63.22 108.38 175.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.08 -116.28 4.29 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 110.94 -0.864 . . . . 70.43 110.94 -174.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.51 4.95 16.44 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.312 0.645 . . . . 60.43 111.955 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.552 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 10.3 pt-20 -115.9 155.43 27.97 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.604 0.361 . . . . 72.15 110.842 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 61.7 m -64.91 119.85 11.46 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.924 0.889 . . . . 75.41 112.209 -177.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.566 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -79.24 -69.8 0.55 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.623 -1.251 . . . . 75.43 107.623 171.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -145.6 149.52 34.7 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 114.988 -1.005 . . . . 73.34 110.704 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.509 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 65.6 mt -112.54 152.97 28.21 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.906 1.282 . . . . 74.41 107.957 172.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.731 ' SG ' HG12 ' D' ' 114' ' ' ILE . 53.3 t -158.35 144.91 17.43 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.784 0.434 . . . . 74.11 110.058 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -155.65 125.89 6.68 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.042 0.537 . . . . 73.43 109.757 173.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 87.7 t -131.26 115.42 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.759 0.824 . . . . 74.44 109.231 -177.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.516 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.7 mt-30 -88.63 85.16 6.75 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.636 -0.876 . . . . 70.2 108.636 170.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -81.05 98.86 8.17 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 113.998 -1.456 . . . . 74.33 109.377 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.51 162.16 24.37 Favored Glycine 0 N--CA 1.465 0.596 0 N-CA-C 112.295 -0.322 . . . . 75.04 112.295 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.87 136.94 4.49 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.676 -0.569 . . . . 74.24 111.676 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.52 HG12 ' HG2' ' D' ' 57' ' ' GLU . 44.2 mt -90.76 105.59 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.779 -0.823 . . . . 73.22 108.779 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -107.93 141.75 39.09 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.727 0.811 . . . . 73.13 109.821 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' D' ' 54' ' ' ASP . 3.9 t -115.73 110.36 19.01 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 109.078 -0.712 . . . . 55.14 109.078 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 44.2 pt -126.67 134.33 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 123.531 0.732 . . . . 74.54 110.942 -174.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.95 170.36 17.87 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.888 0.875 . . . . 71.43 110.813 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.3 23.81 53.3 Favored Glycine 0 C--N 1.355 1.602 0 O-C-N 123.424 0.452 . . . . 71.34 113.171 173.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.553 HG22 HE21 ' D' ' 93' ' ' GLN . 0.7 OUTLIER -140.82 144.86 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.449 0.7 . . . . 75.0 110.327 179.016 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -131.65 175.92 8.76 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.406 1.082 . . . . 73.44 110.492 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.82 -128.22 10.94 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 115.628 -0.715 . . . . 73.13 113.518 173.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 9.7 t -87.0 -38.39 16.63 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.233 0.613 . . . . 70.22 110.903 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.553 HE21 HG22 ' D' ' 89' ' ' ILE . 13.8 pt20 -69.05 -22.07 64.05 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.261 0.625 . . . . 75.34 112.666 -171.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -64.49 -49.63 70.6 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.078 0.466 . . . . 74.54 111.081 177.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.09 -13.82 49.13 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.868 0.867 . . . . 73.12 110.965 -177.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -75.49 -22.83 56.85 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.061 0.545 . . . . 74.43 109.677 175.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 75.3 m -71.33 -50.98 26.9 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.077 0.551 . . . . 72.54 110.749 176.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 pp -67.03 -28.1 67.95 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.854 0.461 . . . . 72.33 111.772 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.15 -20.64 48.65 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.609 -0.551 . . . . 65.33 113.584 -178.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.52 -57.31 1.21 Allowed 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 117.794 0.797 . . . . 64.05 112.689 -170.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -68.94 -39.04 79.8 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 122.907 0.483 . . . . 74.51 111.281 -173.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 91.9 m -68.29 -47.09 38.82 Favored Pre-proline 0 CA--C 1.57 1.723 0 CA-C-O 118.401 -0.809 . . . . 73.42 111.767 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.521 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 86.4 Cg_exo -54.98 -33.31 82.46 Favored 'Trans proline' 0 C--N 1.402 3.355 0 C-N-CA 122.605 2.204 . . . . 75.31 113.685 166.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -65.86 -29.06 69.45 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.967 0.507 . . . . 71.24 111.139 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.1 mm -79.33 -33.66 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.901 0.88 . . . . 65.45 110.689 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 89.7 mt -75.1 -24.13 58.05 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.057 0.543 . . . . 72.32 112.147 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -67.37 -39.29 19.45 Favored Pre-proline 0 CA--C 1.562 1.437 0 CA-C-O 117.742 -1.123 . . . . 73.05 113.751 -172.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -50.48 -44.19 40.9 Favored 'Trans proline' 0 C--N 1.389 2.661 0 C-N-CA 122.182 1.921 . . . . 75.13 113.419 168.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -77.37 -35.49 54.47 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.778 0.831 . . . . 75.12 111.566 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.26 -47.51 67.53 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.546 0.738 . . . . 74.33 109.757 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.479 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 34.8 ttp180 -59.27 -43.67 92.49 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-N 114.643 -1.162 . . . . 74.21 110.254 172.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.13 -50.35 69.48 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 124.022 0.826 . . . . 61.21 111.365 -176.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.457 ' O ' ' HG3' ' D' ' 117' ' ' MET . 42.5 t -56.77 -44.58 81.97 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 124.453 1.096 . . . . 74.42 110.549 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.731 HG12 ' SG ' ' D' ' 76' ' ' CYS . 76.7 mt -62.71 -52.6 57.6 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 C-N-CA 124.159 0.984 . . . . 75.1 110.941 176.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 91.9 m -53.39 -45.58 69.33 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.502 1.521 . . . . 74.51 110.337 -175.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -64.94 -45.82 84.16 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.514 -1.676 . . . . 75.12 110.072 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 71.8 mtm -68.99 -30.13 68.48 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.824 0.449 . . . . 73.53 111.964 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.44 HG23 ' O ' ' D' ' 114' ' ' ILE . 78.6 t -67.07 -46.03 85.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.793 0.837 . . . . 74.41 109.218 176.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 83.4 p -72.61 -28.42 62.76 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 115.737 -0.665 . . . . 75.34 110.682 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 55.0 mtt-85 -74.61 -31.04 61.89 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.68 0.792 . . . . 75.3 110.165 175.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.94 4.41 85.37 Favored Glycine 0 C--N 1.354 1.574 0 O-C-N 123.466 0.479 . . . . 62.01 112.629 177.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.46 HG22 ' HB3' ' C' ' 17' ' ' TYR . 43.5 p 58.9 32.1 21.93 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 126.152 1.781 . . . . 64.52 112.67 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -96.83 150.11 36.52 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 115.392 -0.822 . . . . 73.33 109.786 170.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.407 ' HG2' ' HD3' ' D' ' 38' ' ' PRO . 22.5 Cg_exo -43.29 122.82 3.15 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 124.042 3.161 . . . . 73.23 114.121 172.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -52.44 123.18 10.31 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.858 1.263 . . . . 72.54 112.049 -173.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.474 HD11 HG13 ' D' ' 40' ' ' VAL . 28.1 tp -107.63 112.46 25.19 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.299 1.04 . . . . 75.15 109.655 -176.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -116.07 79.63 1.33 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.505 -0.924 . . . . 74.41 108.505 176.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.549 HD11 HD21 ' D' ' 42' ' ' LEU . 0.3 OUTLIER -58.42 119.7 7.44 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 123.153 0.581 . . . . 75.44 109.918 -174.159 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -54.32 130.04 60.93 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 124.233 1.013 . . . . 63.33 112.317 -175.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.464 ' HG3' HH12 ' D' ' 111' ' ' ARG . 1.6 Cg_endo -76.59 118.19 4.79 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.481 2.121 . . . . 74.53 111.134 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 12.8 p -108.47 152.07 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.531 0.733 . . . . 74.05 109.51 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -72.99 102.21 3.42 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.414 -0.587 . . . . 73.3 109.414 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 . . . . . 0 N--CA 1.487 1.39 0 C-N-CA 123.766 0.826 . . . . 74.35 111.205 -179.141 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.2 m . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 109.375 -0.602 . . . . 65.33 109.375 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.454 ' HE1' ' SG ' ' A' ' 102' ' ' CYS . 62.0 t80 -110.24 121.39 45.16 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.737 -1.209 . . . . 74.01 107.737 173.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -133.92 134.62 42.84 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.148 -0.686 . . . . 74.54 109.148 176.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.402 HG21 HD12 ' A' ' 13' ' ' ILE . 47.8 mt -92.55 114.09 28.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 108.252 -1.018 . . . . 72.34 108.252 175.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -83.95 -35.46 23.98 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 123.399 0.437 . . . . 74.22 110.533 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -175.93 121.73 0.18 Allowed 'General case' 0 C--N 1.351 0.652 0 N-CA-C 109.553 -0.536 . . . . 73.5 109.553 -168.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.532 HD13 ' HG3' ' C' ' 130' ' ' PRO . 78.7 mt -109.42 135.75 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 107.832 -1.173 . . . . 74.34 107.832 171.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -161.83 177.1 10.17 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 124.021 0.826 . . . . 74.41 111.66 -174.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.5 p -102.49 118.64 37.29 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.942 -0.762 . . . . 65.52 108.942 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -75.95 -35.87 59.52 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.229 -0.441 . . . . 74.54 110.002 172.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 18.2 t70 -145.51 144.46 30.56 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.654 -0.703 . . . . 72.12 109.787 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.403 HG22 ' SD ' ' A' ' 117' ' ' MET . 57.4 mt -140.5 141.66 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 107.563 -1.273 . . . . 74.33 107.563 175.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.5 t -154.54 139.85 17.64 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.714 -0.476 . . . . 71.35 109.714 170.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.66 ' HB2' ' HE2' ' A' ' 117' ' ' MET . 80.6 t80 -142.33 116.15 9.26 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.221 -1.4 . . . . 71.13 107.221 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -118.32 134.28 55.18 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.809 0.443 . . . . 71.44 109.991 -176.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.8 74.34 58.3 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 107.651 -1.24 . . . . 71.0 107.651 172.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.07 -27.23 20.59 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.528 2.152 . . . . 73.41 111.964 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -99.2 9.82 42.67 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.067 -0.97 . . . . 74.14 110.587 -177.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.483 ' O ' HG11 ' A' ' 31' ' ' VAL . . . -45.82 -60.32 3.59 Favored Pre-proline 0 C--N 1.371 1.529 0 C-N-CA 124.295 1.038 . . . . 73.23 113.724 -166.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -60.07 -31.31 93.21 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 121.755 1.636 . . . . 74.34 113.027 -171.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.52 -15.73 18.55 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.515 -0.766 . . . . 75.2 112.25 -175.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.627 HG22 ' HA ' ' A' ' 73' ' ' ALA . 4.8 p -77.04 -24.71 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-N 117.945 0.339 . . . . 74.34 110.391 -176.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -69.02 -22.34 64.06 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.92 -0.582 . . . . 75.24 110.583 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -74.68 -21.57 59.33 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.042 0.937 . . . . 74.43 111.437 176.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -81.93 161.42 23.09 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.208 0.603 . . . . 73.24 110.521 -177.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -63.11 117.52 6.62 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.244 0.618 . . . . 73.14 109.389 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.447 ' CE3' HD21 ' A' ' 68' ' ' LEU . 71.7 t-105 -81.32 89.05 6.06 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.629 0.728 . . . . 75.45 110.684 -178.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.46 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -145.85 74.54 13.39 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 125.061 1.344 . . . . 75.3 108.569 172.728 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.0 149.79 17.76 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.924 2.416 . . . . 75.11 113.618 -171.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -97.92 97.79 9.24 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 107.108 -1.441 . . . . 75.32 107.108 167.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.725 HG23 ' HB1' ' A' ' 66' ' ' ALA . 59.4 t -83.03 94.71 3.25 Favored 'Isoleucine or valine' 0 C--N 1.345 0.382 0 CA-C-O 121.699 0.762 . . . . 74.11 109.303 176.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -78.02 117.12 19.03 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.299 -1.773 . . . . 73.41 109.456 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.5 tp -97.79 106.68 19.03 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.842 -0.617 . . . . 70.34 109.542 -175.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.649 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 2.0 m-20 -104.86 145.26 30.64 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.498 1.119 . . . . 72.44 108.51 172.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.7 mt -137.84 148.1 45.12 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.677 0.791 . . . . 73.54 109.626 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -148.55 142.22 25.54 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.507 1.123 . . . . 63.52 108.269 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.7 m -140.81 136.42 32.42 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.198 0.599 . . . . 75.42 110.129 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.99 130.22 9.62 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.687 0.795 . . . . 64.22 109.508 174.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 68.4 p -90.45 -179.52 5.61 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.71 0.804 . . . . 75.21 110.6 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.511 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 39.1 t -159.63 141.04 12.84 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.855 0.862 . . . . 54.21 109.149 -177.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -93.44 107.84 19.62 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.434 -0.95 . . . . 72.45 108.434 171.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' A' ' 57' ' ' GLU . 53.6 mt -84.79 -43.57 14.1 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.004 0.522 . . . . 74.51 109.731 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.07 -173.34 4.53 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.26 -0.882 . . . . 52.41 110.041 -177.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -70.05 118.33 12.75 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.641 0.776 . . . . 72.01 109.295 176.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 64.18 14.26 8.48 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.152 1.381 . . . . 72.23 112.237 -174.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.0 t -117.41 110.26 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 108.664 -0.865 . . . . 74.44 108.664 176.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -121.99 124.66 44.52 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.198 0.999 . . . . 73.15 109.066 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.511 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 30.6 tt0 -86.12 152.85 22.52 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.763 -0.828 . . . . 55.15 108.763 169.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 77.2 t -132.03 138.79 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 N-CA-C 108.232 -1.025 . . . . 75.01 108.232 167.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.428 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 51.1 t -113.93 134.81 55.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.262 -0.644 . . . . 74.44 109.262 174.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.62 105.32 12.93 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.408 -1.331 . . . . 73.53 107.408 168.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 42.0 ttp180 -93.67 101.99 14.15 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.95 -1.13 . . . . 71.03 107.95 177.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.5 t -93.72 132.27 38.34 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 108.174 -1.047 . . . . 74.34 108.174 176.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.649 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 24.2 m -120.27 139.39 52.78 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.563 -0.902 . . . . 75.22 108.563 172.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.671 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.2 t -142.51 109.11 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 124.878 1.271 . . . . 74.33 107.692 -169.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.3 m -115.17 124.18 50.8 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 109.351 -0.611 . . . . 74.55 109.351 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.725 ' HB1' HG23 ' A' ' 40' ' ' VAL . . . -103.38 120.65 41.21 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.478 -1.675 . . . . 64.22 106.478 172.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 59.5 m -129.16 134.74 48.16 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.024 0.44 . . . . 72.24 110.496 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.46 HD23 ' H ' ' A' ' 37' ' ' GLN . 32.9 mt -88.46 64.39 7.47 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.338 -1.356 . . . . 75.34 107.338 174.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.26 -109.11 2.72 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 114.74 -1.118 . . . . 62.12 111.954 -174.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -86.93 -21.45 26.25 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.793 0.837 . . . . 73.42 109.133 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 9.5 tp10 -77.9 133.0 38.18 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.001 0.92 . . . . 74.42 108.857 172.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.4 m -89.03 129.07 35.73 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.799 0.727 . . . . 71.31 109.469 167.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.627 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -78.4 -59.58 2.72 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.019 -0.734 . . . . 72.31 109.019 173.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -159.47 169.63 23.48 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.443 -0.799 . . . . 73.54 110.892 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.417 HD11 ' H ' ' A' ' 76' ' ' CYS . 20.0 tp -132.44 142.17 49.14 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.484 -1.234 . . . . 74.23 107.939 174.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.671 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 64.6 m -137.32 132.96 34.38 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.773 1.229 . . . . 71.22 108.155 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -145.94 119.51 9.12 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.258 -0.645 . . . . 74.52 109.258 173.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.3 t -127.91 110.51 22.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.51 1.124 . . . . 74.24 108.7 -176.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 18.3 mt-30 -85.33 82.58 8.28 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.105 -1.072 . . . . 71.35 108.105 172.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -75.23 92.94 2.77 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.308 -0.86 . . . . 74.51 108.924 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -97.47 146.16 18.14 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 115.407 -0.815 . . . . 50.3 111.19 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.88 133.31 5.64 Favored Glycine 0 CA--C 1.505 -0.584 0 N-CA-C 110.64 -0.984 . . . . 65.54 110.64 -176.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.408 HG23 HD12 ' A' ' 51' ' ' LEU . 43.6 mt -81.59 126.41 39.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 108.43 -0.952 . . . . 75.43 108.43 173.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.589 ' HB3' HD11 ' A' ' 86' ' ' ILE . 84.7 m-85 -130.1 120.87 25.31 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.207 1.003 . . . . 63.14 109.036 -176.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.9 t -89.39 101.54 14.22 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.987 -0.746 . . . . 74.33 108.987 176.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.688 HG22 ' HE3' ' A' ' 94' ' ' MET . 2.2 mm -113.45 137.81 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 122.789 0.436 . . . . 74.32 110.068 -175.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.9 167.24 25.32 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.755 0.822 . . . . 72.03 110.243 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.29 -31.8 8.14 Favored Glycine 0 C--N 1.352 1.426 0 N-CA-C 114.176 0.43 . . . . 74.01 114.176 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.51 163.08 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 123.331 0.652 . . . . 73.41 112.486 -166.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.76 175.11 13.67 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 114.454 -1.248 . . . . 75.12 109.105 175.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.02 -132.45 19.29 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 116.168 -0.469 . . . . 65.43 112.781 176.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.0 p -68.59 -30.63 69.42 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.503 0.721 . . . . 51.22 112.526 -177.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -66.38 -42.41 87.99 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 120.861 0.362 . . . . 75.13 110.12 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.688 ' HE3' HG22 ' A' ' 86' ' ' ILE . 6.1 tpt -68.87 -47.8 65.0 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.428 -0.806 . . . . 74.11 110.078 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.47 -41.34 72.82 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.623 0.769 . . . . 71.35 111.048 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -65.93 -37.38 85.89 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.473 -0.785 . . . . 72.42 111.422 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.7 t -66.52 -44.66 81.89 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.744 -0.465 . . . . 64.41 109.744 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.564 HD22 ' HE2' ' A' ' 94' ' ' MET . 70.8 mt -78.04 -29.71 49.51 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.342 -0.844 . . . . 75.53 112.37 -171.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.34 0.22 43.63 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-O 119.592 -0.56 . . . . 62.23 114.488 -172.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.492 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -139.83 -63.41 0.5 Allowed 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 117.726 0.763 . . . . 53.22 111.406 -175.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -68.67 -43.92 75.17 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 116.067 -0.515 . . . . 74.42 111.851 -174.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.454 ' SG ' ' HE1' ' A' ' 11' ' ' PHE . 77.6 m -66.19 -49.6 54.46 Favored Pre-proline 0 CA--C 1.564 1.495 0 C-N-CA 124.218 1.007 . . . . 74.11 112.452 -176.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.39 -22.91 59.16 Favored 'Trans proline' 0 C--N 1.394 2.929 0 C-N-CA 121.751 1.634 . . . . 72.51 112.684 174.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -68.43 -37.17 80.03 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.248 0.619 . . . . 71.12 110.245 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.3 mm -65.46 -40.07 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.649 0.78 . . . . 74.04 110.233 172.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.7 mt -78.3 -19.12 54.25 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.032 0.933 . . . . 72.01 112.526 -174.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -70.63 -41.91 13.31 Favored Pre-proline 0 CA--C 1.559 1.29 0 N-CA-C 114.351 1.241 . . . . 74.24 114.351 -171.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.0 -37.23 78.45 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 121.901 1.734 . . . . 73.04 112.657 172.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -80.44 -36.01 34.18 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.857 0.863 . . . . 70.41 111.611 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.45 -51.2 64.29 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.073 0.549 . . . . 70.13 109.701 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.428 ' NH1' HD13 ' C' ' 105' ' ' ILE . 30.3 ttm180 -47.57 -53.28 14.99 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 124.862 1.351 . . . . 72.2 110.277 173.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -62.01 -45.98 91.23 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 124.433 1.083 . . . . 71.51 111.859 -174.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.609 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.3 t -57.2 -45.91 83.36 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.84 0.713 . . . . 73.12 110.352 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.496 HD12 HG22 ' A' ' 64' ' ' VAL . 56.0 mt -61.8 -52.71 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 115.113 -0.948 . . . . 75.3 110.739 176.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 47.9 m -54.17 -42.33 69.51 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.219 1.008 . . . . 74.35 111.401 -174.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.3 t -69.05 -44.79 71.93 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.736 -1.12 . . . . 74.52 110.355 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.66 ' HE2' ' HB2' ' A' ' 23' ' ' PHE . 8.9 mtp -56.04 -43.58 77.97 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.762 0.825 . . . . 74.31 111.082 176.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.4 t -59.71 -48.96 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.711 1.204 . . . . 74.03 110.465 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.0 p -72.47 -27.41 62.27 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.137 0.575 . . . . 71.33 111.632 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.474 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.3 mtt-85 -72.37 -29.05 63.42 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.46 0.704 . . . . 72.54 109.942 175.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.56 18.05 36.12 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-O 119.165 -0.797 . . . . 74.32 113.32 172.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.423 HG23 ' NE ' ' B' ' 15' ' ' ARG . 1.5 t 60.41 9.82 2.18 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 127.227 2.211 . . . . 73.21 113.76 177.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -80.79 142.66 52.92 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 108.161 -1.051 . . . . 74.35 108.161 172.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.49 147.16 59.54 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.74 2.293 . . . . 72.33 112.768 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -54.28 129.0 33.69 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 124.65 1.219 . . . . 73.25 112.63 -172.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.423 HD23 HG12 ' A' ' 40' ' ' VAL . 31.3 tp -117.42 105.94 12.67 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.032 0.933 . . . . 74.31 109.901 -177.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -99.93 113.02 25.29 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.306 -0.998 . . . . 63.01 108.306 176.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.405 HD12 ' CD1' ' A' ' 114' ' ' ILE . 18.4 mt -67.64 154.48 41.38 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 120.714 0.292 . . . . 74.43 110.984 -175.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.22 136.37 93.77 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 123.535 0.734 . . . . 74.54 111.377 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -62.45 112.1 1.49 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.547 2.165 . . . . 75.14 111.528 173.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 90.7 t -101.88 139.98 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 121.126 0.489 . . . . 74.11 111.17 -173.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.407 ' OD1' ' HB3' ' A' ' 134' ' ' ASP . 46.4 t-20 -90.63 86.68 6.45 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.285 -1.325 . . . . 72.53 109.024 176.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -62.87 -23.99 67.59 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 112.804 0.668 . . . . 75.24 112.804 172.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.492 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 21.8 t70 -65.61 -37.89 87.9 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.028 0.531 . . . . 74.21 109.639 175.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.15 -50.04 51.4 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.822 0.849 . . . . 53.3 110.294 174.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.04 -41.98 75.87 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.416 0.687 . . . . 73.23 111.435 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.5 t80 . . . . . 0 N--CA 1.467 0.399 0 CA-C-N 115.767 -0.651 . . . . 75.32 110.094 179.415 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.467 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 18.2 ptm . . . . . 0 N--CA 1.487 1.383 0 N-CA-C 114.197 1.184 . . . . 70.41 114.197 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 54.9 m -135.41 122.71 21.74 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.71 -1.218 . . . . 72.32 107.71 172.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -111.69 142.27 44.23 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.811 -0.811 . . . . 74.22 108.811 -177.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -150.08 120.52 7.4 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.72 0.408 . . . . 73.41 110.092 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.1 mt -77.96 126.83 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.368 -0.975 . . . . 72.53 108.368 171.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -98.27 -40.07 8.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.066 0.546 . . . . 73.13 109.838 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.423 ' NE ' HG23 ' A' ' 122' ' ' THR . 50.8 ttt180 -173.09 134.96 0.57 Allowed 'General case' 0 C--N 1.353 0.745 0 O-C-N 123.554 0.534 . . . . 72.42 109.686 -173.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.2 mt -122.06 143.79 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 107.119 -1.437 . . . . 75.24 107.119 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -169.25 153.48 5.41 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.599 0.592 . . . . 75.54 112.599 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.584 HG23 HD11 ' B' ' 21' ' ' ILE . 30.6 m -82.05 118.58 23.13 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.03 -0.986 . . . . 74.02 109.778 176.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.407 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 44.4 mtpt -95.81 -18.01 20.72 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.437 0.695 . . . . 75.13 111.521 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.522 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 28.8 t70 -155.09 140.04 17.31 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.47 0.481 . . . . 72.44 110.916 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.584 HD11 HG23 ' B' ' 18' ' ' THR . 32.3 mm -129.25 144.38 38.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 N-CA-C 107.763 -1.199 . . . . 75.4 107.763 172.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 46.6 t -147.82 132.76 18.12 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.381 -1.282 . . . . 74.52 108.296 169.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.3 t80 -145.29 118.02 8.67 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 107.189 -1.411 . . . . 73.54 107.189 168.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -119.84 133.68 55.5 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.664 -0.865 . . . . 63.11 108.664 173.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.485 ' CB ' ' HB1' ' B' ' 28' ' ' ALA . . . -117.32 82.15 14.42 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 106.51 -1.663 . . . . 70.45 106.51 166.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.2 -24.96 27.06 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.885 2.39 . . . . 75.34 111.96 -171.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -114.41 9.67 16.87 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.908 0.883 . . . . 63.43 110.751 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.523 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -30.8 -64.99 0.2 Allowed Pre-proline 0 N--CA 1.494 1.736 0 C-N-CA 125.992 1.717 . . . . 70.24 114.812 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 14.6 Cg_exo -64.09 -36.72 46.46 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 122.398 2.065 . . . . 73.53 112.338 -166.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.45 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 77.5 m80 -95.98 -18.63 20.11 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.006 -0.997 . . . . 74.2 112.321 -173.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 3.6 p -83.17 -10.33 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 117.991 0.36 . . . . 74.54 110.654 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -76.06 -3.49 36.19 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 112.843 0.683 . . . . 75.33 112.843 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.8 pt20 -78.98 -5.01 52.79 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.8 0.44 . . . . 75.32 110.223 169.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.481 ' HZ1' ' HG2' ' B' ' 71' ' ' GLU . 89.8 mttt -107.22 87.57 2.54 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.832 1.253 . . . . 72.43 110.395 -177.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -93.37 87.57 5.66 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.135 -0.939 . . . . 71.23 110.318 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 18.6 p90 -162.97 -171.24 2.6 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.416 0.686 . . . . 72.54 110.04 172.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.466 ' H ' ' NE2' ' B' ' 37' ' ' GLN . 0.0 OUTLIER -79.1 111.82 23.09 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 124.367 1.067 . . . . 71.23 110.295 178.47 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.84 141.03 36.36 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 121.879 1.719 . . . . 75.21 111.522 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.64 108.07 2.76 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 109.626 -0.509 . . . . 64.43 109.626 176.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.724 HG21 ' HB1' ' B' ' 66' ' ' ALA . 88.0 t -99.21 149.29 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 115.045 -0.979 . . . . 72.02 110.554 -175.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -135.46 129.67 33.54 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.354 1.462 . . . . 71.45 107.541 172.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.491 HD12 HD21 ' B' ' 128' ' ' LEU . 20.5 tp -97.04 140.82 30.99 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.449 -0.945 . . . . 74.04 108.449 170.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.624 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 7.2 t70 -137.93 141.0 40.6 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.222 -1.399 . . . . 73.12 107.222 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 49.3 mt -137.61 126.71 24.39 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.42 -0.585 . . . . 75.32 109.42 -170.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -124.57 139.95 53.4 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.023 1.329 . . . . 72.11 108.753 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.12 105.61 11.17 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 109.084 -0.71 . . . . 63.13 109.084 -172.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.76 152.01 50.7 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.034 0.933 . . . . 53.5 109.208 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 29.5 p -149.72 -169.54 3.4 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.932 -0.48 . . . . 73.42 110.94 -175.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 50.9 p -155.23 136.16 13.7 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.884 0.874 . . . . 74.24 109.183 170.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . 0.4 ' HB2' ' HE2' ' B' ' 56' ' ' TYR . 43.4 tt0 -91.26 112.24 24.07 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.566 -1.272 . . . . 74.44 107.566 168.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 pp -131.17 17.23 5.02 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.119 0.567 . . . . 74.11 110.474 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.26 152.15 21.93 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.691 -0.686 . . . . 71.54 110.568 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -72.38 117.35 13.93 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.242 -0.89 . . . . 73.32 109.168 172.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 65.65 13.79 9.13 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.075 0.95 . . . . 72.22 112.979 172.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.5 t -137.3 123.52 27.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.794 -1.558 . . . . 73.43 106.794 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.539 ' HB2' HD13 ' B' ' 86' ' ' ILE . 16.2 t80 -124.4 140.34 53.04 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.473 -0.566 . . . . 75.2 109.473 -167.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -108.96 106.13 15.96 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 107.843 -1.169 . . . . 73.14 107.843 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 94.5 t -100.78 138.28 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.652 0.781 . . . . 75.03 109.703 -176.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 24.1 t -122.79 110.77 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.029 0.932 . . . . 73.32 109.255 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -95.19 112.29 24.02 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.997 -1.112 . . . . 74.13 107.997 174.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -85.18 118.79 24.95 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 108.487 -0.931 . . . . 74.53 108.487 174.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 23.0 t -105.63 131.87 53.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 107.848 -1.167 . . . . 65.51 107.848 171.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.624 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 19.9 m -121.18 139.13 53.78 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.924 -1.139 . . . . 74.21 107.924 173.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.55 HG11 HD23 ' B' ' 126' ' ' LEU . 80.8 t -130.12 130.91 66.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.242 0.544 . . . . 64.45 109.707 175.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.4 m -106.57 144.57 33.05 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.727 -1.124 . . . . 75.42 108.871 168.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.724 ' HB1' HG21 ' B' ' 40' ' ' VAL . . . -148.97 136.47 20.31 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.895 -1.15 . . . . 72.35 107.895 171.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 15.6 m -137.65 128.07 26.46 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.585 0.553 . . . . 71.23 111.436 -173.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.414 ' HG ' ' HB3' ' B' ' 73' ' ' ALA . 44.8 mt -94.56 105.2 17.15 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.569 -0.9 . . . . 73.44 108.569 176.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.62 -120.42 5.13 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.881 -0.599 . . . . 61.32 111.873 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.42 10.75 25.32 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.506 0.722 . . . . 74.0 110.972 -178.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.481 ' HG2' ' HZ1' ' B' ' 34' ' ' LYS . 12.1 pt-20 -129.25 156.01 44.66 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.382 0.673 . . . . 73.44 109.734 -177.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 32.3 m -65.18 136.25 56.44 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 123.544 0.528 . . . . 71.11 110.433 176.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.414 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . . . -89.27 -60.72 1.87 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 107.397 -1.335 . . . . 71.32 107.397 172.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -155.39 163.51 39.98 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 114.169 -1.378 . . . . 74.22 110.891 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 93.1 mt -136.42 113.54 10.57 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.156 1.383 . . . . 73.21 107.696 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.543 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 39.2 t -121.73 117.26 26.18 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.758 -0.46 . . . . 73.31 109.758 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.466 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 37.9 tt0 -124.54 123.21 39.6 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.6 1.16 . . . . 70.04 108.993 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 96.8 t -128.84 130.42 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.583 0.753 . . . . 75.11 110.272 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.522 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 26.3 mt-30 -100.01 119.84 38.89 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.135 -1.061 . . . . 64.11 108.135 171.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.505 ' HB2' ' HB1' ' B' ' 110' ' ' ALA . 7.9 tp-100 -108.9 109.05 20.05 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.224 -1.028 . . . . 73.23 108.224 176.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.407 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -104.84 170.24 17.77 Favored Glycine 0 C--N 1.335 0.5 0 O-C-N 123.883 0.739 . . . . 73.3 112.115 177.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.22 144.63 7.64 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.201 -0.523 . . . . 75.33 113.321 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 3.2 mp -85.64 117.41 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 107.607 -1.257 . . . . 74.24 107.607 172.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -121.93 134.59 54.84 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.836 0.854 . . . . 73.12 109.152 176.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 49.1 m -88.87 113.51 24.49 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.473 -0.936 . . . . 74.23 108.473 174.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.539 HD13 ' HB2' ' B' ' 56' ' ' TYR . 1.0 OUTLIER -121.99 105.1 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.096 0.958 . . . . 75.41 108.536 -174.676 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.22 170.42 19.52 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.041 0.448 . . . . 63.44 110.338 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 97.83 -57.5 1.1 Allowed Glycine 0 C--N 1.339 0.725 0 N-CA-C 110.069 -1.212 . . . . 75.22 110.069 -170.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.498 HD12 ' HB2' ' B' ' 94' ' ' MET . 1.0 OUTLIER -67.18 156.53 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 124.019 0.928 . . . . 73.41 111.845 175.425 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -155.5 147.14 23.05 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.765 0.826 . . . . 74.14 109.368 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.95 -123.91 7.94 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 123.328 0.392 . . . . 72.24 113.323 174.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.0 m -84.08 -44.71 13.79 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.801 0.81 . . . . 73.54 110.217 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -64.96 -19.92 66.21 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 113.877 -1.511 . . . . 74.45 111.8 -169.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.498 ' HB2' HD12 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -74.73 -41.9 59.28 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.557 0.743 . . . . 74.54 111.422 -178.559 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.81 -15.19 59.26 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.448 0.699 . . . . 64.21 111.4 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -66.02 -37.81 86.82 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.725 0.81 . . . . 72.31 110.149 170.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 37.2 t -64.75 -62.87 1.31 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.435 0.636 . . . . 74.24 110.81 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.608 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.4 pp -70.09 -20.74 63.19 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 116.065 -0.516 . . . . 73.23 112.298 -176.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.15 -2.08 64.45 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-O 119.435 -0.647 . . . . 72.25 114.43 -177.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.88 -49.57 0.15 Allowed 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 117.714 0.757 . . . . 75.54 111.611 -175.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.538 ' HH ' ' HB2' ' D' ' 130' ' ' PRO . 46.7 t80 -71.81 -44.97 63.03 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.666 0.786 . . . . 74.22 111.087 -177.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.608 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 80.7 m -66.01 -47.81 62.16 Favored Pre-proline 0 CA--C 1.562 1.404 0 CA-C-O 118.734 -0.65 . . . . 75.21 111.818 178.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -51.01 -37.63 57.32 Favored 'Trans proline' 0 C--N 1.388 2.652 0 C-N-CA 122.796 2.33 . . . . 65.35 113.866 169.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.55 -32.28 73.69 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.58 0.752 . . . . 74.2 111.406 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.0 mt -74.53 -37.69 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.631 0.772 . . . . 72.22 110.403 176.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 80.4 mt -75.45 -29.65 59.73 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.808 0.843 . . . . 73.15 111.961 -176.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -57.64 -47.99 98.0 Favored Pre-proline 0 CA--C 1.561 1.385 0 CA-C-O 117.777 -1.106 . . . . 74.35 113.201 -174.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -47.13 -45.87 20.56 Favored 'Trans proline' 0 C--N 1.387 2.599 0 C-N-CA 122.976 2.451 . . . . 74.21 114.664 174.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -72.36 -41.91 65.88 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.079 0.552 . . . . 73.42 111.032 -175.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.505 ' HB1' ' HB2' ' B' ' 80' ' ' GLN . . . -64.61 -40.68 95.93 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 122.599 0.36 . . . . 73.25 110.503 176.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 53.2 ttt-85 -60.16 -50.54 73.26 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.351 1.461 . . . . 72.33 110.734 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -68.38 -32.53 72.68 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.629 0.772 . . . . 74.15 109.98 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.502 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.6 t -69.96 -41.15 74.89 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.961 0.504 . . . . 63.12 110.577 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.543 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 73.6 mt -57.77 -53.77 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.391 1.077 . . . . 72.5 110.132 172.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.429 HG22 ' OG ' ' C' ' 119' ' ' SER . 17.7 m -60.78 -30.42 70.03 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.166 0.586 . . . . 73.14 111.138 -177.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.0 t -63.37 -50.48 69.74 Favored 'General case' 0 C--N 1.348 0.537 0 C-N-CA 123.041 0.536 . . . . 74.14 109.559 173.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.7 mmt -65.51 -32.66 74.38 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.439 0.696 . . . . 73.41 111.459 -176.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.426 HG23 ' O ' ' B' ' 114' ' ' ILE . 97.5 t -68.8 -42.69 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.733 0.813 . . . . 72.24 110.345 174.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.3 t -62.91 -35.1 78.95 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.326 -0.852 . . . . 52.1 110.838 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.609 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 77.0 mtt-85 -70.18 -38.53 75.4 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 114.679 -1.146 . . . . 74.35 110.096 177.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.39 -7.73 68.98 Favored Glycine 0 C--N 1.352 1.429 0 O-C-N 123.845 0.715 . . . . 71.24 112.839 173.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 16.8 m 66.94 24.92 9.51 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 125.118 1.367 . . . . 70.34 110.329 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -85.07 163.23 46.62 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 123.861 0.864 . . . . 71.42 111.145 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.21 166.76 1.5 Allowed 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 123.339 2.693 . . . . 73.32 114.524 175.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -65.05 114.64 4.74 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.329 1.051 . . . . 75.54 111.353 -172.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.55 HD23 HG11 ' B' ' 64' ' ' VAL . 26.4 tp -112.4 107.1 15.78 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.032 -0.729 . . . . 72.24 109.032 174.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -121.55 127.11 50.62 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.133 -1.062 . . . . 63.53 108.133 171.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.491 HD21 HD12 ' B' ' 42' ' ' LEU . 84.0 mt -77.56 138.58 39.25 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 123.427 0.454 . . . . 72.35 110.267 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.05 147.26 98.91 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.714 0.805 . . . . 63.02 111.066 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.27 81.01 0.29 Allowed 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.261 2.64 . . . . 72.11 111.678 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 4.1 p -96.51 112.24 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 115.259 -0.882 . . . . 74.43 109.545 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 37.6 t30 . . . . . 0 C--O 1.236 0.344 0 N-CA-C 108.302 -0.999 . . . . 73.53 108.302 172.436 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 75.2 t80 . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 108.396 -0.964 . . . . 73.34 108.396 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -141.71 122.51 14.39 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.015 0.526 . . . . 75.45 109.675 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 55.5 mt -71.88 120.49 20.28 Favored 'Isoleucine or valine' 0 C--N 1.35 0.624 0 N-CA-C 108.586 -0.894 . . . . 74.4 108.586 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -84.72 -45.28 12.58 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.545 -0.909 . . . . 73.22 108.545 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 178.15 165.71 0.74 Allowed 'General case' 0 C--N 1.353 0.724 0 CA-C-N 114.34 -1.3 . . . . 75.35 109.848 -176.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.5 ' HA ' ' HA2' ' C' ' 82' ' ' GLY . 2.8 pp -130.53 150.13 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 106.476 -1.676 . . . . 75.23 106.476 168.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.47 ' HB3' HG22 ' D' ' 122' ' ' THR . 19.2 p90 -178.35 141.38 0.23 Allowed 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 118.852 0.751 . . . . 72.24 110.777 -176.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 69.6 p -72.44 119.83 17.2 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.976 0.91 . . . . 72.14 110.116 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -73.16 -44.07 60.56 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.211 -1.033 . . . . 73.44 108.211 169.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 26.9 t70 -134.49 141.89 46.88 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 113.577 -1.647 . . . . 70.41 109.772 -169.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.564 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.6 mt -144.77 143.8 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 106.92 -1.511 . . . . 73.41 106.92 176.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.3 t -156.38 150.92 25.69 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.161 0.505 . . . . 71.01 110.306 176.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -152.83 123.43 7.28 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 107.065 -1.458 . . . . 74.54 107.065 172.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.0 113.46 14.0 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.245 0.618 . . . . 75.23 109.765 -174.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.11 82.7 67.95 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 107.666 -1.235 . . . . 70.43 107.666 167.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.2 -24.82 31.81 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.783 2.322 . . . . 61.34 112.04 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -106.9 26.03 10.58 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.132 1.373 . . . . 62.31 110.315 178.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.66 -52.25 18.71 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 113.915 1.08 . . . . 60.14 113.915 -174.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.97 -42.64 29.25 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 121.75 1.633 . . . . 74.05 112.251 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -68.32 -33.89 75.13 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.611 -1.177 . . . . 75.23 111.897 -175.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.698 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.1 p -80.23 -25.27 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 N-CA-C 112.757 0.651 . . . . 73.11 112.757 177.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -69.48 -28.98 66.54 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.55 -0.719 . . . . 70.22 112.184 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -89.4 35.04 0.81 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.378 0.671 . . . . 65.4 110.346 176.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.414 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.5 OUTLIER -125.69 165.34 18.76 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.77 0.828 . . . . 74.13 110.856 -174.439 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -78.39 124.19 27.84 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 115.459 -0.791 . . . . 74.1 109.709 169.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -85.38 96.06 9.44 Favored 'General case' 0 C--O 1.242 0.674 0 O-C-N 123.514 0.509 . . . . 74.31 110.18 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -150.38 76.77 8.34 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 107.106 -1.442 . . . . 74.35 107.106 169.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -90.95 164.95 3.89 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.733 2.289 . . . . 70.52 113.025 -175.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -88.6 82.51 6.88 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.147 -1.427 . . . . 72.54 107.147 170.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 56.5 t -73.93 114.96 14.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 114.809 -1.087 . . . . 75.23 109.344 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -135.53 125.24 25.37 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.274 -0.875 . . . . 75.43 109.427 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.426 HD23 HD22 ' C' ' 128' ' ' LEU . 3.8 pp -89.3 159.59 17.31 Favored 'General case' 0 C--O 1.246 0.913 0 N-CA-C 108.71 -0.848 . . . . 73.45 108.71 165.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.521 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 17.5 t70 -134.33 134.21 41.55 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.636 -1.246 . . . . 75.22 107.636 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.438 HD13 HG23 ' C' ' 131' ' ' VAL . 78.6 mt -123.54 110.98 15.72 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.602 0.715 . . . . 74.33 110.341 -176.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -120.76 129.73 53.73 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 106.543 -1.651 . . . . 72.42 106.543 173.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.8 t -129.95 150.67 51.13 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.624 -0.509 . . . . 73.43 109.624 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.24 149.78 29.81 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.342 0.657 . . . . 74.12 110.274 -177.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 32.9 p -125.59 150.3 47.63 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.697 0.799 . . . . 73.21 109.744 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 36.1 t -145.44 126.6 14.72 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.84 -1.17 . . . . 72.34 107.84 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -81.89 117.32 22.05 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.94 -0.763 . . . . 74.24 108.94 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.542 HD12 ' HB2' ' C' ' 57' ' ' GLU . 51.0 mt -86.23 -43.15 13.2 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.862 0.865 . . . . 73.01 110.081 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.47 -177.31 5.7 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 114.501 -1.227 . . . . 74.54 108.777 176.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -66.76 116.94 8.2 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.242 -0.651 . . . . 72.02 109.242 -177.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 68.62 21.84 7.8 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.824 1.25 . . . . 74.2 112.887 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.3 t -126.81 110.76 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 108.873 -0.788 . . . . 75.23 108.873 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -117.99 125.37 50.26 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.853 0.861 . . . . 75.13 110.583 -174.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.542 ' HB2' HD12 ' C' ' 51' ' ' LEU . 28.4 tt0 -83.11 109.99 17.63 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.238 1.015 . . . . 74.04 108.543 168.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 77.5 t -99.18 139.04 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.341 -0.985 . . . . 75.12 108.341 169.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.0 t -134.1 132.83 56.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 108.779 -0.822 . . . . 75.34 108.779 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -112.63 105.06 13.15 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.628 -1.249 . . . . 75.44 107.628 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 30.4 ttm-85 -81.13 111.23 17.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.766 0.826 . . . . 71.44 109.216 171.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 24.6 t -111.28 113.54 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 108.12 -1.067 . . . . 72.11 108.12 173.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 22.0 m -116.21 123.25 47.3 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.925 0.89 . . . . 73.53 109.603 -174.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.502 HG21 HG21 ' C' ' 114' ' ' ILE . 71.6 t -100.99 120.12 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 122.965 0.506 . . . . 65.41 109.786 177.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 3.8 m -107.29 110.03 21.95 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.174 -1.047 . . . . 72.41 108.174 172.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.37 115.86 28.76 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.337 -0.986 . . . . 70.12 108.337 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -138.38 127.51 24.22 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.008 0.523 . . . . 72.42 110.097 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.414 HD11 ' HG2' ' C' ' 34' ' ' LYS . 16.9 mt -83.07 32.52 0.44 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.586 1.554 . . . . 73.33 111.276 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.68 -109.22 2.79 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 110.454 -1.058 . . . . 64.22 110.454 -171.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -89.94 -19.74 24.16 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.611 0.764 . . . . 73.2 110.366 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -87.43 121.12 29.45 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.51 1.124 . . . . 72.34 108.765 174.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 88.7 m -75.48 131.3 40.03 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.856 -0.794 . . . . 74.23 108.856 168.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.698 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.43 -61.1 2.02 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.05 -0.722 . . . . 74.41 109.05 171.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -162.57 155.14 19.27 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.365 -0.834 . . . . 74.54 109.918 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -114.38 135.81 53.68 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.979 -1.489 . . . . 74.44 106.979 167.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 49.8 t -142.13 148.03 37.65 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.321 -0.992 . . . . 70.21 108.321 -175.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -154.99 131.11 10.24 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.166 0.586 . . . . 74.2 109.703 177.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 68.8 t -125.23 132.03 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 108.273 -1.01 . . . . 74.11 108.273 167.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -107.83 90.81 3.41 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.96 -1.126 . . . . 72.33 107.96 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -78.4 108.6 11.87 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 114.876 -1.056 . . . . 74.44 109.072 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.71 171.87 54.14 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 111.778 -0.529 . . . . 70.01 111.778 173.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' C' ' 16' ' ' ILE . . . 179.18 116.28 0.5 Allowed Glycine 0 CA--C 1.508 -0.403 0 N-CA-C 110.055 -1.218 . . . . 72.23 110.055 -178.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.428 HG12 ' HA ' ' C' ' 57' ' ' GLU . 66.9 mt -105.93 136.29 40.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 123.607 0.763 . . . . 74.43 109.234 -173.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -137.34 126.58 24.66 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.426 1.09 . . . . 75.55 109.274 -171.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 70.8 m -78.52 101.25 7.27 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.362 -0.977 . . . . 72.21 108.362 168.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.53 HG21 ' HE2' ' C' ' 94' ' ' MET . 21.2 mt -116.21 126.84 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.183 -0.673 . . . . 73.54 109.183 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.92 168.33 19.54 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 122.937 0.495 . . . . 75.01 110.649 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.84 -49.96 3.67 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.868 0.73 . . . . 71.33 112.479 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 26.5 pt -82.19 161.19 3.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 123.296 0.639 . . . . 71.41 111.671 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -156.63 156.13 32.98 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.477 -0.783 . . . . 74.12 110.113 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.5 -113.6 5.99 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 124.069 0.856 . . . . 62.52 113.744 171.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 9.6 t -64.85 -36.18 83.51 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.828 0.851 . . . . 73.43 111.65 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -68.3 -44.06 76.28 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.585 0.754 . . . . 73.21 109.722 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.53 ' HE2' HG21 ' C' ' 86' ' ' ILE . 5.9 tpt -64.42 -47.26 79.82 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.777 -1.101 . . . . 73.05 110.372 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.84 -39.51 81.48 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.029 0.932 . . . . 71.32 111.034 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -65.35 -32.39 74.01 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.244 -0.889 . . . . 71.04 111.602 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.413 ' SG ' HD12 ' C' ' 86' ' ' ILE . 22.1 t -75.49 -45.32 39.08 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 109.644 -0.502 . . . . 53.32 109.644 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 61.4 mt -74.21 -32.7 63.14 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.21 1.004 . . . . 72.14 112.786 -172.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.71 11.77 30.06 Favored Glycine 0 N--CA 1.473 1.104 0 CA-C-O 119.646 -0.53 . . . . 62.54 114.361 -170.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.411 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -153.26 -56.91 0.12 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 117.677 0.739 . . . . 73.41 111.967 -176.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -70.61 -48.33 55.64 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.037 0.535 . . . . 72.32 111.426 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 70.7 m -69.77 -47.4 24.15 Favored Pre-proline 0 CA--C 1.563 1.472 0 C-N-CA 123.958 0.903 . . . . 72.34 111.92 -176.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.481 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 77.8 Cg_exo -56.67 -26.29 64.54 Favored 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.407 2.072 . . . . 74.25 113.924 172.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -66.99 -37.96 85.15 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.981 0.513 . . . . 74.44 110.606 175.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.428 HD13 ' NH1' ' A' ' 111' ' ' ARG . 44.5 mm -73.85 -35.81 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.189 0.596 . . . . 71.15 109.928 177.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.23 -28.6 47.93 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.132 0.973 . . . . 74.45 112.744 -176.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -57.29 -51.39 82.07 Favored Pre-proline 0 N--CA 1.486 1.331 0 N-CA-C 113.951 1.093 . . . . 73.33 113.951 -172.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -58.51 -36.75 97.01 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 121.722 1.614 . . . . 74.33 113.239 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -67.97 -46.58 70.98 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.265 0.626 . . . . 75.43 110.918 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.66 -36.86 79.75 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.233 1.013 . . . . 72.42 110.78 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . 0.5 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 38.9 ttt-85 -62.61 -55.52 26.34 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.294 1.438 . . . . 63.54 110.408 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -64.69 -35.77 82.12 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 123.853 0.72 . . . . 73.35 110.203 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 14.0 t -66.22 -33.79 76.54 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.055 0.542 . . . . 73.5 111.313 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.502 HG21 HG21 ' C' ' 64' ' ' VAL . 96.0 mt -72.07 -52.21 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 122.833 0.453 . . . . 71.52 109.806 172.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -61.65 -28.97 69.76 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.141 0.576 . . . . 72.15 111.634 -173.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 25.9 t -66.13 -47.08 75.28 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.782 0.833 . . . . 75.3 108.967 173.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.598 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.3 -40.99 92.51 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.473 1.109 . . . . 74.43 111.757 176.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.428 HG21 ' O ' ' C' ' 114' ' ' ILE . 64.1 t -61.18 -44.6 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.655 0.782 . . . . 64.33 109.33 176.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.429 ' OG ' HG22 ' B' ' 115' ' ' THR . 30.1 t -66.69 -34.59 78.19 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 114.989 -1.005 . . . . 75.12 112.037 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.441 ' NH1' ' HA ' ' D' ' 113' ' ' CYS . 68.3 mtt-85 -69.81 -39.4 76.54 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.329 0.652 . . . . 74.02 109.585 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.28 6.48 71.89 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 123.853 0.721 . . . . 75.22 112.696 173.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.9 p 58.42 31.79 21.35 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.394 1.878 . . . . 74.33 113.204 171.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -87.2 150.64 49.93 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 108.678 -0.86 . . . . 73.51 108.678 168.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -44.41 147.05 1.73 Allowed 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 124.575 3.517 . . . . 73.24 115.73 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -51.83 117.18 2.54 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.356 1.062 . . . . 74.23 112.008 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 52.6 tp -107.71 90.57 3.34 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.607 0.718 . . . . 75.21 109.401 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -96.91 95.35 7.78 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.403 -0.817 . . . . 72.43 109.254 -175.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.5 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 90.6 mt -62.32 146.91 49.83 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.524 0.73 . . . . 73.23 112.096 -174.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.56 147.93 64.65 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 123.819 0.848 . . . . 71.41 110.791 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.532 ' HG3' HD13 ' A' ' 16' ' ' ILE . 43.9 Cg_exo -57.63 116.1 2.99 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 123.218 2.612 . . . . 72.44 112.279 175.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . 0.438 HG23 HD13 ' C' ' 44' ' ' LEU . 60.5 t -100.02 132.93 44.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 110.243 -0.28 . . . . 73.42 110.243 176.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -94.99 92.32 6.81 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.888 0.875 . . . . 72.52 108.953 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -66.65 -26.99 67.32 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.503 0.721 . . . . 74.01 111.851 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.411 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 15.8 t70 -66.03 -41.21 91.21 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.552 0.741 . . . . 74.34 110.18 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.37 -42.3 96.27 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.774 0.829 . . . . 73.03 110.746 176.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 79.5 mt -66.1 -36.02 82.07 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.443 -0.799 . . . . 64.03 111.08 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 63.2 t80 . . . . . 0 N--CA 1.476 0.851 0 C-N-CA 123.754 0.822 . . . . 73.52 110.135 177.598 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.247 0.951 0 N-CA-C 109.223 -0.658 . . . . 74.52 109.223 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.41 ' HD2' HG22 ' D' ' 86' ' ' ILE . 84.7 t80 -156.35 120.11 4.36 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.097 -1.075 . . . . 62.42 108.097 -175.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -132.81 116.59 16.72 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.486 0.714 . . . . 72.4 109.376 -177.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 63.8 mt -78.92 129.06 38.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 115.288 -0.869 . . . . 74.42 108.932 176.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -99.2 -44.57 6.21 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.716 0.406 . . . . 75.23 110.98 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -167.84 147.41 4.89 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.265 0.226 . . . . 70.34 111.181 -174.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.0 mp -125.56 140.48 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 106.031 -1.84 . . . . 74.12 106.031 172.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -164.28 146.97 9.09 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 124.038 0.836 . . . . 75.42 110.614 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.1 p -85.01 112.87 20.99 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.396 -0.82 . . . . 74.22 109.622 176.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -83.76 -18.92 36.16 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.394 0.678 . . . . 73.33 109.661 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.672 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 30.6 t70 -159.8 131.73 6.27 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.976 0.91 . . . . 73.12 109.694 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.598 HG23 ' HE1' ' C' ' 117' ' ' MET . 77.3 mt -134.94 142.43 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 107.375 -1.342 . . . . 74.24 107.375 171.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 22' ' ' SER . . . . . 0.419 ' HB3' ' HB2' ' D' ' 77' ' ' GLU . 33.8 t -142.67 143.88 32.51 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.794 1.237 . . . . 75.21 107.961 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.564 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.9 t80 -152.69 117.91 5.22 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.279 -1.378 . . . . 75.45 107.279 172.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -130.28 113.1 13.98 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.717 0.807 . . . . 74.31 109.112 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.517 ' HB2' ' HB1' ' D' ' 28' ' ' ALA . . . -105.3 90.55 3.96 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 107.912 -1.144 . . . . 45.51 107.912 172.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.8 -30.47 9.36 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.977 2.452 . . . . 73.33 112.733 -172.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -109.57 7.64 24.7 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.593 0.757 . . . . 61.55 111.439 -171.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.517 ' HB1' ' HB2' ' D' ' 25' ' ' ALA . . . -44.45 -60.58 2.78 Favored Pre-proline 0 CA--C 1.558 1.25 0 N-CA-C 115.298 1.592 . . . . 64.22 115.298 -158.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.82 -34.54 23.88 Favored 'Trans proline' 0 C--N 1.377 2.035 0 CA-C-N 122.474 1.919 . . . . 71.34 113.873 -172.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -86.19 -21.34 27.55 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 116.637 -0.256 . . . . 74.51 110.497 -175.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.473 HG12 ' O ' ' D' ' 28' ' ' ALA . 1.8 p -83.1 -21.1 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.068 0.547 . . . . 74.24 110.307 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -57.88 -23.6 53.85 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.601 0.76 . . . . 72.1 112.864 174.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -59.31 -27.38 65.82 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.839 0.856 . . . . 70.54 111.167 176.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.498 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 96.7 mttt -83.92 90.79 7.45 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.697 1.199 . . . . 74.32 109.749 177.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -83.45 92.7 7.63 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.935 -1.03 . . . . 64.34 111.46 -175.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 44.6 p90 -167.8 172.68 8.93 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.247 1.019 . . . . 75.15 109.234 166.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -64.19 114.83 15.37 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 108.518 -0.919 . . . . 71.12 108.518 173.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.421 ' O ' HG23 ' D' ' 40' ' ' VAL . 53.3 Cg_exo -54.25 119.35 6.2 Favored 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 122.762 2.308 . . . . 74.52 110.457 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.47 111.05 3.38 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.991 -0.744 . . . . 73.44 108.991 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.626 HG11 HG13 ' D' ' 64' ' ' VAL . 88.3 t -99.07 140.86 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 113.983 -1.462 . . . . 73.31 108.6 -175.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -124.6 122.95 38.99 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.012 -1.477 . . . . 73.22 107.012 171.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 64.3 tp -97.17 138.54 34.52 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.757 0.823 . . . . 75.53 109.863 -170.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.732 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 9.0 m-20 -125.64 114.01 18.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.728 -1.124 . . . . 73.32 108.033 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 90.5 mt -109.23 135.27 50.6 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.091 -0.707 . . . . 73.34 109.091 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -146.04 154.03 41.41 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.388 1.075 . . . . 73.02 108.477 -177.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 8.8 t -117.96 150.84 38.57 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.294 0.569 . . . . 74.15 110.274 -177.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.07 170.35 19.61 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.415 1.486 . . . . 74.41 107.777 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 72.1 p . . . . . 0 C--O 1.243 0.724 0 CA-C-O 121.174 0.512 . . . . 65.3 110.925 -177.311 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' D' ' 85' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 N-CA-C 113.112 0.782 . . . . 71.34 113.112 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 16.4 m -122.44 112.22 33.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 107.933 -1.136 . . . . 74.54 107.933 175.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.557 ' HB2' HD11 ' D' ' 98' ' ' LEU . 9.8 m-85 -134.88 133.12 39.33 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 106.746 -1.575 . . . . 72.41 106.746 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.462 ' HB3' HG13 ' D' ' 83' ' ' ILE . 7.4 pt-20 -86.92 122.67 31.1 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.708 -0.849 . . . . 72.12 108.708 173.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 78.3 t -101.06 141.44 17.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.421 -1.263 . . . . 73.31 108.272 177.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.559 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 36.3 t -128.18 123.97 61.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 108.181 -1.044 . . . . 73.12 108.181 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.493 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -95.09 109.11 21.21 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 106.828 -1.545 . . . . 75.34 106.828 177.763 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.49 95.3 10.21 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.388 -1.708 . . . . 73.13 106.388 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.448 HG22 HD22 ' D' ' 60' ' ' LEU . 44.9 t -97.69 145.13 9.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 115.406 -0.816 . . . . 74.01 109.057 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.732 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 52.7 m -141.21 143.12 34.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.939 -1.028 . . . . 74.12 108.683 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.626 HG13 HG11 ' D' ' 40' ' ' VAL . 12.3 t -133.6 115.69 22.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 123.796 0.838 . . . . 71.32 108.784 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 17.2 m -106.68 94.77 5.3 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.796 -0.816 . . . . 73.32 108.796 171.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.603 ' HB3' HG21 ' D' ' 40' ' ' VAL . . . -99.07 145.85 26.69 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 109.595 -0.52 . . . . 61.34 109.595 176.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.403 ' HA ' ' N ' ' D' ' 73' ' ' ALA . 22.7 p -153.4 137.63 16.54 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.737 -0.665 . . . . 63.52 111.257 -171.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 22.1 mt -107.54 116.4 31.87 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.898 1.279 . . . . 74.13 108.225 173.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.26 -133.54 18.33 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-N 116.161 -0.472 . . . . 70.25 112.081 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -94.57 3.57 54.94 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.148 0.579 . . . . 74.42 111.551 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.498 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 15.7 pt-20 -124.39 167.43 14.39 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.729 0.412 . . . . 64.43 110.249 -176.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 12.0 m -68.1 144.91 54.85 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 124.137 0.898 . . . . 75.41 111.731 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.403 ' N ' ' HA ' ' D' ' 67' ' ' SER . . . -99.54 -59.91 1.63 Allowed 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.308 -1.367 . . . . 64.52 107.308 168.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -157.97 158.95 35.91 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.476 -1.238 . . . . 74.23 110.306 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 51.2 mt -124.73 145.39 49.72 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 107.137 -1.431 . . . . 74.53 107.137 176.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.663 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 45.6 t -156.49 109.45 2.61 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 117.884 0.311 . . . . 63.44 110.738 -171.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' D' ' 22' ' ' SER . 12.1 mp0 -124.5 127.69 47.84 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.079 0.952 . . . . 74.35 109.384 -173.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 87.1 t -135.47 115.17 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.125 0.57 . . . . 74.14 109.887 -178.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.672 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.9 mt-30 -88.68 84.75 6.72 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.428 -0.953 . . . . 74.34 108.428 170.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -83.1 96.92 8.53 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 113.736 -1.574 . . . . 75.11 109.604 -176.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -100.02 170.53 22.8 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.538 -0.301 . . . . 74.52 113.678 -175.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.78 148.5 8.36 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-O 119.243 -0.754 . . . . 73.12 112.675 177.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.462 HG13 ' HB3' ' D' ' 57' ' ' GLU . 3.4 mp -89.32 126.3 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.099 -1.075 . . . . 74.34 108.099 176.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -123.37 149.77 44.54 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.97 0.908 . . . . 74.32 110.239 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' D' ' 54' ' ' ASP . 31.2 t -115.44 111.71 21.19 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.884 0.874 . . . . 74.31 109.073 176.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.411 HD12 ' HB2' ' D' ' 98' ' ' LEU . 46.0 pt -114.88 140.07 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.966 0.906 . . . . 72.25 108.985 177.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.16 161.92 28.21 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.062 0.458 . . . . 73.15 111.917 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.93 8.89 81.78 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.065 -0.971 . . . . 73.44 115.099 167.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.542 ' HB ' ' HA ' ' D' ' 94' ' ' MET . 0.5 OUTLIER -98.77 171.69 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 N-CA-C 107.986 -1.116 . . . . 74.21 107.986 174.773 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.454 ' H ' HG22 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -138.96 175.3 9.67 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.87 -0.519 . . . . 71.24 110.85 -177.57 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.8 -133.12 29.41 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 114.876 -1.057 . . . . 65.44 112.805 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -92.08 -29.99 16.25 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.639 0.776 . . . . 63.25 111.057 175.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -68.8 -15.5 63.52 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.234 0.613 . . . . 74.04 112.359 -173.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.542 ' HA ' ' HB ' ' D' ' 89' ' ' ILE . 0.0 OUTLIER -59.21 -37.74 78.2 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.708 0.633 . . . . 70.42 112.708 173.538 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.73 -16.97 42.88 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.399 0.68 . . . . 74.34 111.481 177.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -66.62 -38.2 86.44 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.935 0.894 . . . . 74.33 111.154 -178.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 63.8 m -59.91 -30.47 69.06 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.623 0.769 . . . . 74.12 111.96 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.557 HD11 ' HB2' ' D' ' 56' ' ' TYR . 14.5 tp -79.53 -42.58 24.82 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.047 -0.979 . . . . 72.05 110.45 -177.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.08 -18.52 69.36 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 115.739 -0.664 . . . . 72.52 113.794 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.16 -63.08 1.37 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.06 0.544 . . . . 73.44 112.289 -170.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -70.59 -31.88 69.04 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 112.236 0.458 . . . . 75.33 112.236 -174.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.428 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 87.4 m -68.32 -49.5 32.4 Favored Pre-proline 0 CA--C 1.568 1.669 0 CA-C-O 118.531 -0.747 . . . . 71.41 112.114 177.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.493 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 51.7 Cg_exo -60.46 -27.36 84.71 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 122.273 1.982 . . . . 73.51 113.373 169.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -64.76 -36.07 83.13 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.325 0.65 . . . . 65.04 110.532 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 31.1 mm -66.5 -43.14 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.724 0.81 . . . . 74.44 110.371 172.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 75.0 mt -75.52 -12.37 60.21 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.8 0.84 . . . . 75.34 112.979 -173.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -75.47 -45.9 4.36 Favored Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 113.559 0.948 . . . . 75.44 113.559 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.53 -33.57 78.83 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 121.871 1.714 . . . . 71.34 112.578 169.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -76.65 -32.06 57.74 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.468 0.707 . . . . 75.53 111.793 176.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.96 85.98 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.836 -0.431 . . . . 70.2 109.836 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' D' ' 111' ' ' ARG . 9.6 ptt-85 -76.61 -29.11 56.39 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 123.313 0.383 . . . . 73.32 110.697 178.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -51.13 -43.34 61.16 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.851 0.834 . . . . 74.33 109.878 172.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.441 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 18.8 t -72.8 -60.93 1.99 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.071 -1.422 . . . . 65.04 109.927 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.474 ' O ' HG23 ' D' ' 118' ' ' VAL . 80.4 mt -53.5 -56.7 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 124.77 1.228 . . . . 74.44 112.873 -174.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 28.7 m -48.72 -38.35 21.26 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.873 0.869 . . . . 74.43 111.545 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 12.7 t -69.02 -47.59 65.06 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.741 -1.118 . . . . 74.22 110.25 -178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.663 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 4.0 mpp? -63.14 -32.59 74.01 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 117.973 0.351 . . . . 63.53 111.65 178.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.474 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.2 t -62.24 -49.47 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 123.397 0.679 . . . . 73.45 109.927 176.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.7 p -71.92 -29.07 63.92 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.776 -0.647 . . . . 73.12 110.768 -177.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.4 mtt-85 -71.36 -30.41 66.13 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.746 0.818 . . . . 73.42 110.367 175.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.61 8.41 75.31 Favored Glycine 0 C--N 1.355 1.591 0 CA-C-O 119.367 -0.685 . . . . 52.23 112.82 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.47 HG22 ' HB3' ' C' ' 17' ' ' TYR . 74.7 p 51.75 56.8 7.3 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.497 1.519 . . . . 71.52 112.274 -175.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -120.74 148.28 47.9 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 108.518 -0.919 . . . . 73.15 108.518 169.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -50.28 141.13 32.53 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 123.167 2.578 . . . . 70.4 112.668 174.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -55.4 140.54 39.58 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.383 1.073 . . . . 74.52 113.2 -167.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.502 HD23 HG22 ' D' ' 40' ' ' VAL . 13.4 tp -126.8 98.55 5.41 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.008 0.923 . . . . 73.3 109.328 -178.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -102.1 103.0 13.54 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.163 -1.051 . . . . 63.42 108.163 175.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.403 HD22 HD11 ' D' ' 126' ' ' LEU . 79.4 mt -62.08 121.92 14.25 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 123.59 0.556 . . . . 73.11 110.412 -178.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.89 128.95 91.31 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.811 0.844 . . . . 72.11 110.977 -175.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.538 ' HB2' ' HH ' ' B' ' 101' ' ' TYR . 4.1 Cg_endo -79.99 105.61 1.82 Allowed 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.905 2.403 . . . . 60.11 111.938 -170.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -107.79 124.62 64.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.015 -1.105 . . . . 75.21 108.015 172.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -68.2 117.06 9.53 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.932 -0.766 . . . . 75.54 108.932 175.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 N--CA 1.486 1.354 0 C-N-CA 125.025 1.33 . . . . 62.45 112.048 -171.68 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 79.2 m . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 120.568 0.223 . . . . 74.35 110.845 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.405 ' CD1' HD13 ' A' ' 86' ' ' ILE . 93.9 t80 -99.36 114.58 27.54 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 106.359 -1.719 . . . . 74.22 106.359 161.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -133.32 112.5 11.69 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.189 -0.671 . . . . 73.43 109.189 -177.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.781 HG22 ' HG2' ' C' ' 130' ' ' PRO . 41.3 mt -83.65 113.96 23.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 107.745 -1.206 . . . . 75.43 107.745 169.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -94.77 -28.72 15.13 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 109.705 -0.48 . . . . 65.45 109.705 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -166.37 139.96 4.09 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 122.741 0.416 . . . . 75.34 111.101 -177.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.571 HD12 ' HG3' ' C' ' 130' ' ' PRO . 95.5 mt -128.45 138.45 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.687 1.195 . . . . 73.01 107.828 169.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.46 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 32.5 p90 -163.74 174.88 11.09 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.735 0.647 . . . . 75.23 111.395 -175.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.0 p -101.17 121.89 42.65 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.196 -0.668 . . . . 72.13 109.196 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 35.5 mtpt -81.5 -38.2 26.68 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.129 0.49 . . . . 72.2 109.908 175.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 21.0 t70 -142.59 144.24 32.77 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.825 -1.079 . . . . 74.31 110.17 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.6 HD13 ' SD ' ' B' ' 117' ' ' MET . 97.4 mt -144.03 144.75 22.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 125.581 1.552 . . . . 70.32 107.43 176.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.4 t -159.13 142.85 14.99 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 122.917 0.487 . . . . 64.14 110.22 168.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -136.84 143.74 43.26 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 107.427 -1.323 . . . . 73.42 107.427 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -137.84 127.0 24.42 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.841 0.456 . . . . 74.32 110.387 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.21 66.31 9.28 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 125.382 1.473 . . . . 72.44 108.236 167.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.89 -34.25 30.69 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.25 1.967 . . . . 73.33 110.804 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.417 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 20.0 p-10 -89.96 24.68 2.35 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 114.175 -1.375 . . . . 55.55 111.292 174.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.87 -49.8 71.89 Favored Pre-proline 0 CA--C 1.571 1.773 0 CA-C-O 118.44 -0.79 . . . . 55.32 112.659 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.48 -26.79 70.21 Favored 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 121.718 1.612 . . . . 61.41 113.765 175.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 27' ' ' ASN . 16.9 m-70 -77.33 -49.04 15.83 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.664 0.745 . . . . 74.53 110.564 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.682 HG22 ' HA ' ' A' ' 73' ' ' ALA . 9.9 p -72.4 -25.61 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 CA-C-N 114.302 -1.317 . . . . 75.54 112.741 -167.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -64.72 -19.75 65.95 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 122.875 0.47 . . . . 74.51 111.882 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -86.47 -31.39 21.37 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.426 1.091 . . . . 71.34 110.129 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.509 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 4.0 tmtp? -68.97 142.9 54.54 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.138 0.975 . . . . 71.2 109.642 -174.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.509 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 10.2 m-20 -53.23 124.03 13.45 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.566 1.146 . . . . 73.33 110.922 176.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -85.13 85.07 7.5 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 121.629 0.728 . . . . 74.2 110.722 -175.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -130.96 76.97 76.14 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 107.137 -1.431 . . . . 72.42 107.137 167.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -85.55 133.43 4.49 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.281 1.988 . . . . 75.2 112.432 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -97.06 90.7 5.26 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.061 -1.459 . . . . 72.11 107.061 166.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.766 HG23 ' HB1' ' A' ' 66' ' ' ALA . 62.1 t -77.69 93.12 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 108.581 -0.896 . . . . 74.42 108.581 175.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.458 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -90.35 127.12 36.09 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.903 -1.044 . . . . 74.35 109.168 177.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.517 HD22 HG12 ' A' ' 62' ' ' VAL . 3.7 tt -108.48 123.05 48.29 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.205 -1.035 . . . . 74.34 108.205 -171.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.514 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 10.8 m-20 -113.24 114.69 27.08 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.471 1.108 . . . . 74.22 109.514 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.7 mt -99.38 146.96 25.74 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.068 0.547 . . . . 73.11 112.033 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -148.02 146.9 29.09 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.079 1.351 . . . . 64.43 108.46 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 84.4 m -134.61 140.82 46.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.276 0.63 . . . . 72.33 110.169 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.07 154.04 49.29 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.662 1.185 . . . . 75.32 109.339 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.5 p -130.43 155.46 46.39 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.21 0.604 . . . . 62.43 109.63 173.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.7 t -149.09 120.21 7.75 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.217 1.007 . . . . 74.34 108.371 -176.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -73.27 111.11 8.09 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.382 -0.599 . . . . 64.44 109.382 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.703 HD12 ' HB2' ' A' ' 57' ' ' GLU . 52.6 mt -84.81 -30.45 24.56 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.215 0.606 . . . . 73.33 110.072 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.74 177.02 10.3 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.667 1.187 . . . . 74.2 109.596 177.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -63.67 125.06 23.07 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.581 -0.896 . . . . 72.33 108.581 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 60.0 18.92 8.04 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.129 0.972 . . . . 71.14 112.72 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.5 t -126.05 110.43 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 107.824 -1.176 . . . . 75.21 107.824 173.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -123.52 127.86 48.94 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.849 0.86 . . . . 74.3 109.008 -175.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.703 ' HB2' HD12 ' A' ' 51' ' ' LEU . 31.5 tt0 -84.55 139.32 32.21 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.487 -0.931 . . . . 74.53 108.487 165.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.442 HG11 ' HD3' ' A' ' 103' ' ' PRO . 72.0 t -120.71 136.41 57.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.936 -1.135 . . . . 70.4 107.936 169.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.11 131.97 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.687 -0.857 . . . . 74.5 108.687 174.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.59 107.22 17.95 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.8 -1.556 . . . . 74.2 106.8 173.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -92.97 99.84 12.4 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.192 -1.04 . . . . 62.43 108.192 176.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.517 HG12 HD22 ' A' ' 42' ' ' LEU . 40.4 t -95.91 124.75 48.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 114.256 -1.338 . . . . 72.11 107.648 176.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.514 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 5.0 m -115.61 136.88 52.63 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.91 -1.144 . . . . 74.42 107.91 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.552 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 71.8 t -137.91 126.2 31.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 107.487 -1.301 . . . . 65.25 107.487 -172.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.458 ' HB ' ' HD2' ' A' ' 41' ' ' LYS . 27.5 m -137.72 131.69 31.71 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.984 -0.747 . . . . 73.34 108.984 169.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.766 ' HB1' HG23 ' A' ' 40' ' ' VAL . . . -105.56 120.76 42.45 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 107.618 -1.253 . . . . 72.02 107.618 174.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.3 m -118.02 126.47 52.36 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.744 0.418 . . . . 71.21 110.006 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.2 mt -90.54 66.51 6.3 Favored 'General case' 0 C--O 1.248 1.011 0 C-N-CA 125.046 1.339 . . . . 74.54 108.68 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.05 -86.74 0.78 Allowed Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.796 -0.638 . . . . 70.2 111.842 -176.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -108.95 -29.19 8.72 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.004 0.922 . . . . 73.43 110.902 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -89.3 113.57 24.85 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.663 -0.865 . . . . 72.31 108.663 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.2 m -69.0 130.37 42.58 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.81 0.732 . . . . 72.31 109.203 174.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.682 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -75.99 -58.65 3.16 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.387 -0.824 . . . . 60.34 109.884 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -159.33 163.68 35.44 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.723 -1.126 . . . . 72.2 110.691 177.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.2 tp -124.27 135.57 53.49 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.483 1.113 . . . . 75.41 108.705 172.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.552 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 68.6 m -133.5 133.11 41.81 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.54 1.136 . . . . 72.35 109.133 175.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -145.36 123.05 11.83 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.872 -0.788 . . . . 72.13 108.872 172.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.7 t -131.09 125.12 57.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 123.947 0.899 . . . . 75.14 108.948 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 53.8 mt-30 -99.67 91.63 4.96 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.919 0.887 . . . . 71.53 108.879 173.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -78.66 97.98 6.03 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.969 -1.014 . . . . 73.53 109.625 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.54 150.65 23.57 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 111.54 -0.624 . . . . 74.43 111.54 177.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.48 125.82 2.08 Favored Glycine 0 CA--C 1.508 -0.384 0 N-CA-C 110.665 -0.974 . . . . 74.02 110.665 -177.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.2 mt -84.59 112.87 22.36 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 N-CA-C 109.052 -0.721 . . . . 70.24 109.052 176.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.648 ' HB3' HD11 ' A' ' 86' ' ' ILE . 81.7 m-85 -121.77 118.69 29.65 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.093 0.957 . . . . 75.33 108.752 -177.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.5 t -92.75 95.87 9.82 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.771 -1.196 . . . . 70.3 107.771 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.648 HD11 ' HB3' ' A' ' 84' ' ' PHE . 11.9 mm -112.72 142.73 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.902 -0.59 . . . . 72.5 110.109 -172.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.9 164.87 30.9 Favored 'General case' 0 C--O 1.241 0.615 0 O-C-N 123.584 0.553 . . . . 73.41 112.25 -172.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.77 6.65 85.15 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 114.852 -1.067 . . . . 64.51 114.191 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.423 HD11 ' HE3' ' A' ' 94' ' ' MET . 0.2 OUTLIER -134.11 165.23 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.159 0.984 . . . . 75.15 108.89 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -159.27 175.95 12.77 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 109.451 -0.574 . . . . 73.15 109.451 175.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.01 -117.19 8.42 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.007 0.813 . . . . 62.02 114.323 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 t -70.12 -31.08 68.44 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.279 1.032 . . . . 74.42 111.755 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -74.61 -39.72 61.99 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 123.181 0.592 . . . . 71.3 110.713 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.423 ' HE3' HD11 ' A' ' 89' ' ' ILE . 3.9 tpt -68.13 -40.8 82.4 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.311 0.382 . . . . 74.12 110.111 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.88 98.13 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.329 -0.85 . . . . 75.04 110.745 175.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -68.4 -31.93 71.62 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.076 -0.511 . . . . 73.52 111.632 179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 48.5 t -69.46 -44.97 70.14 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 110.062 -0.347 . . . . 63.12 110.062 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 65.0 mt -83.12 -26.68 30.77 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.38 0.672 . . . . 73.04 111.961 -174.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.23 3.35 37.71 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-O 119.525 -0.597 . . . . 63.1 114.15 -173.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.553 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -142.38 -68.44 0.37 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 117.684 0.742 . . . . 74.03 111.646 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -69.38 -41.93 75.83 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 112.465 0.543 . . . . 63.41 112.465 -170.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 70.1 m -66.46 -50.08 49.29 Favored Pre-proline 0 CA--C 1.568 1.659 0 CA-C-O 118.53 -0.747 . . . . 73.43 111.93 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.442 ' HD3' HG11 ' A' ' 58' ' ' VAL . 37.8 Cg_endo -65.86 -21.02 58.12 Favored 'Trans proline' 0 C--N 1.395 3.019 0 C-N-CA 121.781 1.654 . . . . 73.13 113.288 172.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -66.25 -42.91 87.89 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.161 0.584 . . . . 72.5 109.812 172.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.42 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 39.7 mm -62.01 -43.39 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.899 0.879 . . . . 72.34 110.318 174.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.7 mt -72.04 -24.13 61.49 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.398 -0.819 . . . . 74.24 112.627 -173.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -62.93 -44.89 86.6 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 114.339 1.237 . . . . 73.4 114.339 -172.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 92.5 Cg_exo -50.06 -40.98 50.13 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.203 1.935 . . . . 70.14 114.083 171.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -76.92 -39.56 50.39 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.619 0.768 . . . . 75.5 111.049 -177.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.37 -47.24 82.89 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.648 0.779 . . . . 74.22 110.016 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.477 ' NH1' HD13 ' C' ' 105' ' ' ILE . 29.7 ttm180 -49.4 -55.93 11.36 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 125.023 1.452 . . . . 75.24 110.142 172.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -60.89 -45.48 94.4 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.496 1.122 . . . . 74.14 111.664 -174.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 45.1 t -56.91 -45.32 82.72 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.026 0.829 . . . . 73.14 110.434 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.564 HD13 HD12 ' A' ' 128' ' ' LEU . 66.2 mt -63.27 -51.62 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 115.077 -0.965 . . . . 74.14 110.535 175.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 50.6 m -55.54 -41.48 73.26 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.113 0.965 . . . . 71.22 111.246 -174.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -69.78 -42.85 73.26 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.498 -1.228 . . . . 71.45 109.913 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.515 ' SD ' HG22 ' A' ' 21' ' ' ILE . 10.2 mtp -58.79 -41.73 87.39 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.642 0.777 . . . . 75.54 111.19 175.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 114' ' ' ILE . 83.1 t -65.08 -48.13 85.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.384 1.074 . . . . 75.23 110.329 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.3 p -71.62 -30.94 66.34 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.911 -0.586 . . . . 75.03 111.298 -176.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.464 HH12 ' HG3' ' B' ' 112' ' ' GLU . 64.8 mtt-85 -72.4 -30.25 64.48 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.554 0.742 . . . . 73.15 109.197 173.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.43 -2.6 74.91 Favored Glycine 0 C--N 1.356 1.643 0 O-C-N 123.88 0.737 . . . . 73.15 112.921 174.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 92.2 m 71.68 26.59 3.07 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 122.912 1.339 . . . . 75.11 111.288 174.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -98.26 145.08 29.23 Favored Pre-proline 0 C--O 1.244 0.801 0 N-CA-C 108.51 -0.922 . . . . 72.3 108.51 170.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -43.98 132.68 8.44 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.389 2.726 . . . . 75.21 112.891 174.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -52.93 123.2 10.9 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 124.162 0.914 . . . . 74.35 112.399 -170.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.414 HD23 HG12 ' A' ' 40' ' ' VAL . 45.5 tp -109.24 100.68 9.78 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.908 0.883 . . . . 70.53 110.207 -174.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.463 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 88.9 m-20 -97.78 113.06 24.76 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.63 -1.248 . . . . 74.15 107.63 174.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.564 HD12 HD13 ' A' ' 114' ' ' ILE . 19.1 mt -65.21 147.68 53.02 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 123.58 0.55 . . . . 74.12 110.46 -175.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.76 134.74 88.05 Favored Pre-proline 0 CA--C 1.549 0.933 0 CA-C-O 118.914 -0.565 . . . . 72.54 111.158 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.49 120.93 9.17 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.256 2.637 . . . . 74.21 113.337 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 64.7 t -107.31 130.44 59.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 123.644 0.778 . . . . 74.43 110.37 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -92.51 92.22 7.97 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.051 -1.092 . . . . 75.24 108.051 173.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -62.64 -29.4 70.6 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.88 0.872 . . . . 73.31 112.22 176.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.553 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 6.7 m-20 -70.86 -25.48 62.84 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.291 0.636 . . . . 73.43 111.131 177.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.01 -40.96 37.32 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.239 0.616 . . . . 60.41 110.233 172.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.61 -44.69 96.53 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.207 0.603 . . . . 74.41 110.938 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.3 t80 . . . . . 0 C--O 1.216 -0.708 0 CA-C-N 115.073 -0.967 . . . . 73.12 109.74 179.199 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.638 ' HG2' HG22 ' B' ' 89' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.57 1.713 0 CA-C-O 121.318 0.58 . . . . 74.24 111.701 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.535 ' HB ' ' HB2' ' B' ' 87' ' ' ALA . 85.2 m -154.41 102.26 2.41 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.11 -1.07 . . . . 74.34 108.11 168.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.427 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 50.9 t80 -119.9 134.35 55.27 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.068 -1.086 . . . . 73.21 108.068 173.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.401 ' HG3' ' HB2' ' D' ' 129' ' ' ALA . 12.2 tt0 -164.01 142.12 7.3 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 123.702 0.626 . . . . 71.31 110.791 169.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.473 HD11 HD12 ' B' ' 105' ' ' ILE . 37.8 mt -80.07 132.4 31.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.021 -0.991 . . . . 74.45 109.43 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -99.12 -38.72 8.82 Favored 'General case' 0 C--O 1.242 0.662 0 O-C-N 123.816 0.697 . . . . 74.02 110.299 178.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -173.46 137.18 0.63 Allowed 'General case' 0 C--N 1.349 0.583 0 O-C-N 123.747 0.654 . . . . 72.24 109.8 -175.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.407 HD11 HD12 ' B' ' 13' ' ' ILE . 96.6 mt -120.31 143.43 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 107.577 -1.268 . . . . 72.41 107.577 174.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -162.9 139.48 7.44 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.696 0.628 . . . . 75.43 112.696 -173.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.9 m -73.96 118.01 16.43 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.042 0.937 . . . . 63.12 109.499 172.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.454 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.6 mtpt -98.15 -9.98 24.89 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.932 0.893 . . . . 71.13 112.045 -176.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.449 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 16.1 t70 -174.27 144.6 0.95 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.168 0.587 . . . . 64.5 110.745 -176.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.557 HD13 ' SG ' ' B' ' 113' ' ' CYS . 43.8 mm -138.28 148.67 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 125.047 1.339 . . . . 64.4 108.792 175.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.497 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 38.9 t -148.68 139.99 23.3 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 125.159 1.384 . . . . 63.14 108.214 172.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.48 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 81.2 t80 -152.85 113.7 4.13 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.375 -1.343 . . . . 75.44 107.375 171.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -121.18 119.09 31.32 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.953 0.901 . . . . 72.52 108.712 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.477 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -107.45 87.12 3.11 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 107.194 -1.41 . . . . 72.14 107.194 167.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.68 -34.44 31.97 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.987 2.458 . . . . 73.02 111.662 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -101.84 3.39 39.25 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.44 1.096 . . . . 70.15 110.375 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.516 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -30.0 -65.06 0.19 Allowed Pre-proline 0 N--CA 1.499 1.997 0 C-N-CA 126.331 1.853 . . . . 71.33 114.886 -172.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.516 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 28.8 Cg_exo -57.69 -48.07 18.53 Favored 'Trans proline' 0 C--N 1.391 2.802 0 C-N-CA 122.934 2.423 . . . . 63.53 113.462 -166.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -96.36 -15.37 21.89 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.297 -0.865 . . . . 75.23 112.648 -172.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 3.4 p -73.76 -17.7 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-N 118.657 0.662 . . . . 75.23 110.647 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -68.62 -6.32 25.08 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 113.764 1.024 . . . . 70.12 113.764 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -71.24 -13.53 61.94 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 120.991 0.424 . . . . 74.0 110.747 172.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.699 ' HZ1' ' HG2' ' B' ' 71' ' ' GLU . 91.1 mttt -98.62 88.0 3.96 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.729 1.212 . . . . 75.11 110.049 -177.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.45 77.92 9.92 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.989 -1.005 . . . . 71.34 110.99 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -158.37 164.58 36.18 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.881 0.873 . . . . 75.44 108.721 169.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.54 117.4 60.34 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 108.181 -1.044 . . . . 73.13 108.181 177.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.425 ' O ' HG23 ' B' ' 40' ' ' VAL . 31.8 Cg_endo -65.98 147.56 84.8 Favored 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 122.207 1.938 . . . . 75.31 112.231 -177.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -69.93 114.17 7.86 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 109.004 -0.739 . . . . 75.2 109.004 178.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.522 HG22 HD11 ' B' ' 126' ' ' LEU . 77.7 t -111.04 138.06 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 114.998 -1.001 . . . . 74.22 111.939 -172.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.481 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 44.4 tttp -107.27 126.97 53.12 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 126.017 1.727 . . . . 73.41 107.503 174.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.615 HD12 HD21 ' B' ' 128' ' ' LEU . 15.6 tp -103.01 127.3 50.3 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.729 -0.841 . . . . 74.45 108.729 174.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -143.8 136.13 26.85 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 106.999 -1.482 . . . . 44.11 106.999 -177.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.7 mp -127.05 149.24 50.0 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.952 -0.758 . . . . 74.34 108.952 -171.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.567 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 7.6 t70 -125.77 146.29 49.84 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.772 1.229 . . . . 54.34 109.255 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 26.9 m -124.84 105.64 9.41 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.495 0.718 . . . . 74.22 109.643 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.7 120.45 39.39 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.366 -1.346 . . . . 71.51 107.366 176.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.705 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 25.1 m -135.41 161.57 35.06 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.495 0.318 . . . . 75.53 111.506 -168.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 42.0 p -165.15 139.29 4.88 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.322 0.649 . . . . 74.45 111.06 -177.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -87.57 96.65 10.48 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 108.782 -0.822 . . . . 74.41 108.782 171.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 pp -107.53 14.78 25.46 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.801 0.44 . . . . 74.24 110.688 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.98 143.75 22.83 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.775 0.83 . . . . 74.12 109.56 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -74.06 132.13 42.02 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.646 -0.872 . . . . 74.41 108.646 170.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 67.76 1.9 2.83 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.946 1.298 . . . . 61.45 113.442 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 58.2 t -140.08 128.28 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 107.851 -1.166 . . . . 72.24 107.851 -172.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.705 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 6.7 t80 -115.38 154.26 29.52 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.797 -0.565 . . . . 72.33 109.566 -176.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -124.24 117.67 25.08 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 107.739 -1.208 . . . . 61.0 107.739 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 p -118.71 127.8 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.881 0.873 . . . . 70.42 109.363 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.414 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.9 t -103.77 112.33 36.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 108.072 -1.085 . . . . 75.0 108.072 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -103.18 108.68 19.98 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.473 -0.936 . . . . 71.41 108.473 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.567 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 6.2 ttm180 -85.12 135.4 33.99 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.131 -0.941 . . . . 74.03 109.238 174.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.484 ' HB ' HD11 ' B' ' 114' ' ' ILE . 17.5 t -122.57 117.13 51.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.14 -1.059 . . . . 53.23 108.14 169.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 17.3 m -109.78 133.36 53.23 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.874 0.87 . . . . 74.1 109.786 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.611 HG22 HG21 ' B' ' 114' ' ' ILE . 55.4 t -115.78 114.5 46.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 125.308 1.443 . . . . 73.32 109.139 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 41.4 m -91.79 138.09 31.84 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.698 -1.223 . . . . 73.13 107.698 166.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.515 ' HB1' HG21 ' B' ' 40' ' ' VAL . . . -148.78 143.01 26.08 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 117.943 0.338 . . . . 64.2 110.467 178.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 73.7 p -147.96 133.42 18.64 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 123.768 0.667 . . . . 74.24 111.032 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.561 HD13 ' HB2' ' B' ' 34' ' ' LYS . 54.0 mt -93.89 108.73 20.49 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.171 0.988 . . . . 74.43 108.508 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.87 -116.64 4.39 Favored Glycine 0 C--N 1.342 0.861 0 N-CA-C 111.469 -0.652 . . . . 42.41 111.469 -175.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -111.62 -0.08 16.21 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.054 0.942 . . . . 72.44 110.645 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.699 ' HG2' ' HZ1' ' B' ' 34' ' ' LYS . 9.8 pt-20 -116.77 154.37 30.79 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.328 -0.619 . . . . 72.42 109.328 -178.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 39.4 m -62.81 141.4 58.64 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.972 0.509 . . . . 63.51 111.285 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.443 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . . . -97.78 -64.06 1.07 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.658 -1.238 . . . . 74.32 107.658 172.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -151.88 154.4 36.07 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.639 -1.164 . . . . 73.23 109.949 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 88.5 mt -130.44 112.87 13.64 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 106.916 -1.513 . . . . 73.14 106.916 175.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.1 t -117.63 156.19 28.59 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.134 -0.691 . . . . 62.2 109.134 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.497 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.0 tt0 -161.93 129.63 4.03 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.649 0.78 . . . . 75.23 108.997 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.415 HG22 HG13 ' B' ' 114' ' ' ILE . 94.2 t -126.41 150.13 31.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.125 -1.065 . . . . 75.15 108.125 175.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.6 mt-30 -124.86 97.95 5.49 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.181 -1.044 . . . . 74.24 108.181 170.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -93.26 103.14 15.42 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.676 -0.693 . . . . 73.11 109.255 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.454 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -94.19 172.32 31.91 Favored Glycine 0 C--O 1.243 0.675 0 CA-C-N 115.824 -0.626 . . . . 62.24 111.862 176.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.91 142.71 6.88 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.808 -0.517 . . . . 71.1 111.808 -178.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 16.3 tt -107.54 116.86 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 C-N-CA 123.997 0.919 . . . . 74.21 108.661 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -123.3 134.7 54.04 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.089 0.955 . . . . 75.31 109.578 -172.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.0 m -89.12 130.83 35.49 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.024 0.53 . . . . 65.12 109.592 174.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.496 ' HB ' HD13 ' B' ' 89' ' ' ILE . 0.1 OUTLIER -135.75 139.55 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.14 0.976 . . . . 72.44 109.114 -178.472 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.535 ' HB2' ' HB ' ' B' ' 10' ' ' THR . . . -157.9 169.39 24.69 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.98 0.912 . . . . 73.35 110.426 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.31 -41.47 3.0 Favored Glycine 0 C--N 1.352 1.449 0 C-N-CA 123.718 0.675 . . . . 71.4 113.35 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.638 HG22 ' HG2' ' B' ' 9' ' ' MET . 9.5 pt -65.5 153.29 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.388 1.475 . . . . 72.12 113.052 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -151.36 172.37 16.03 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.515 1.126 . . . . 64.35 110.049 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.73 -133.72 32.28 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-N 116.231 -0.44 . . . . 43.44 114.0 177.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.0 m -80.73 -47.27 14.2 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.972 0.909 . . . . 74.44 110.888 -175.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -65.51 -20.73 66.46 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.818 -1.083 . . . . 74.35 111.259 -172.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.597 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 11.0 ttt -52.47 -70.22 0.09 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.29 1.436 . . . . 71.02 112.428 174.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.9 -12.74 60.04 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.427 -0.351 . . . . 61.21 111.489 -175.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -61.87 -41.58 98.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.215 0.606 . . . . 74.42 110.713 167.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 t -64.06 -28.08 69.55 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.291 0.636 . . . . 72.21 112.346 -176.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.707 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.5 pp -103.23 -17.72 15.21 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.352 0.661 . . . . 73.32 111.501 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.11 -4.09 41.58 Favored Glycine 0 N--CA 1.478 1.48 0 N-CA-C 114.201 0.44 . . . . 51.22 114.201 -173.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.87 -49.71 0.52 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.459 0.704 . . . . 73.1 110.362 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -71.15 -39.02 72.19 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 122.7 0.4 . . . . 74.02 111.648 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.707 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 84.5 m -67.72 -47.45 44.48 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-O 118.493 -0.765 . . . . 73.21 111.717 177.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.44 -34.4 41.49 Favored 'Trans proline' 0 C--N 1.394 2.928 0 C-N-CA 122.66 2.24 . . . . 75.32 114.244 167.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -67.41 -35.6 79.59 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.043 0.937 . . . . 73.43 110.563 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.473 HD12 HD11 ' B' ' 13' ' ' ILE . 79.6 mt -68.58 -40.45 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.759 0.824 . . . . 75.34 110.164 173.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 95.5 mt -75.72 -20.97 57.97 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.971 -1.013 . . . . 73.12 112.191 -174.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -61.68 -50.29 82.7 Favored Pre-proline 0 CA--C 1.561 1.376 0 CA-C-O 118.012 -0.994 . . . . 63.34 112.8 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -50.9 -40.38 57.92 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 122.633 2.222 . . . . 64.34 114.145 173.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -67.97 -44.57 76.39 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.518 0.727 . . . . 74.42 110.879 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.67 -34.86 79.29 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.248 0.619 . . . . 74.14 110.829 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.491 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 31.5 ttt180 -66.35 -52.63 45.04 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.219 1.407 . . . . 74.25 110.094 -175.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . 0.464 ' HG3' HH12 ' A' ' 120' ' ' ARG . 12.3 tp10 -65.0 -33.43 76.03 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.033 0.933 . . . . 74.31 110.647 176.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.557 ' SG ' HD13 ' B' ' 21' ' ' ILE . 1.9 t -70.57 -32.57 70.01 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 122.439 -0.163 . . . . 73.4 110.967 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.611 HG21 HG22 ' B' ' 64' ' ' VAL . 66.3 mt -70.56 -57.9 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.277 0.631 . . . . 63.51 109.445 173.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 13.3 m -61.54 -22.96 65.61 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 124.205 0.94 . . . . 72.31 111.346 -173.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.3 t -62.04 -52.7 62.9 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 123.444 0.698 . . . . 74.24 109.851 170.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.6 ' SD ' HD13 ' A' ' 21' ' ' ILE . 12.7 mmt -68.44 -33.39 74.12 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.862 0.865 . . . . 63.33 111.113 -175.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.554 HG23 HD21 ' B' ' 126' ' ' LEU . 86.4 t -65.45 -43.96 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.806 1.242 . . . . 71.04 110.135 173.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.5 t -63.83 -34.87 78.9 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.73 -1.123 . . . . 73.53 110.564 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' B' ' 116' ' ' SER . 77.4 mtt-85 -69.24 -33.31 73.09 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.05 -0.977 . . . . 73.55 110.373 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.37 -15.75 81.25 Favored Glycine 0 C--N 1.356 1.686 0 O-C-N 123.57 0.544 . . . . 73.43 112.389 170.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 15.7 m 65.33 37.91 6.08 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.715 1.606 . . . . 71.42 110.261 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -81.5 156.92 70.66 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 114.61 -1.177 . . . . 74.53 109.53 172.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -50.91 163.83 0.71 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.38 2.72 . . . . 74.33 114.48 175.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -59.4 118.25 5.78 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 115.481 -0.782 . . . . 70.53 111.342 -171.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.554 HD21 HG23 ' B' ' 118' ' ' VAL . 54.8 tp -107.62 95.21 5.54 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.614 -0.884 . . . . 70.02 108.614 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -96.55 106.4 18.66 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.998 -1.112 . . . . 73.44 107.998 172.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.615 HD21 HD12 ' B' ' 42' ' ' LEU . 30.4 mt -67.05 134.84 52.68 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 110.135 -0.32 . . . . 71.4 110.135 175.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.71 131.46 94.9 Favored Pre-proline 0 CA--C 1.549 0.914 0 O-C-N 124.106 0.879 . . . . 74.32 110.713 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -61.75 90.79 0.11 Allowed 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.087 2.525 . . . . 64.14 111.618 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 p -90.35 111.69 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.591 -0.731 . . . . 74.22 109.493 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 44.5 t30 . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 107.671 -1.233 . . . . 55.24 107.671 171.984 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.476 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 78.8 t80 . . . . . 0 C--O 1.237 0.438 0 N-CA-C 108.959 -0.756 . . . . 74.14 108.959 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -140.42 128.45 22.13 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.136 -0.69 . . . . 72.04 109.136 174.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 50.2 mt -76.77 128.85 37.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 108.809 -0.811 . . . . 75.23 108.809 172.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -90.15 -49.59 6.48 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.934 -0.765 . . . . 73.23 108.934 172.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.463 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -176.46 153.52 1.18 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.431 1.092 . . . . 73.33 110.049 179.213 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 84.3 mt -127.7 134.92 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.087 1.355 . . . . 73.52 107.71 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.513 ' HE2' ' HD3' ' C' ' 19' ' ' LYS . 42.4 p90 -163.72 174.2 11.94 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.439 0.695 . . . . 64.52 110.288 -164.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.7 p -105.92 116.16 31.46 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 122.988 0.515 . . . . 71.15 109.838 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.513 ' HD3' ' HE2' ' C' ' 17' ' ' TYR . 30.8 mmtp -65.78 -37.97 87.74 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.947 -0.76 . . . . 75.53 108.947 167.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.421 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 13.1 t70 -149.56 147.19 27.87 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 114.482 -1.235 . . . . 73.33 110.4 -174.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.504 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 91.5 mt -139.36 146.11 26.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 106.505 -1.665 . . . . 75.23 106.505 173.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 18.2 t -157.35 148.13 21.37 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 121.064 0.459 . . . . 72.0 110.32 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -156.2 108.56 2.58 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.635 -1.246 . . . . 74.45 107.635 174.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -117.29 112.02 20.18 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 122.92 0.488 . . . . 73.41 110.065 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -121.47 83.05 40.33 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.63 1.172 . . . . 75.21 107.951 169.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.66 -17.82 25.87 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.684 2.256 . . . . 64.53 111.385 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -102.8 12.26 36.45 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.543 1.137 . . . . 74.04 110.543 -178.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.99 -57.9 5.47 Favored Pre-proline 0 C--N 1.374 1.646 0 C-N-CA 124.761 1.224 . . . . 61.15 113.687 -169.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -60.25 -46.62 17.61 Favored 'Trans proline' 0 C--N 1.385 2.484 0 CA-C-N 121.427 1.545 . . . . 75.44 113.143 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -69.41 -29.41 67.14 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.155 -0.929 . . . . 72.25 111.899 -174.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.616 HG22 ' HA ' ' C' ' 73' ' ' ALA . 6.7 p -83.14 -21.14 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 N-CA-C 113.286 0.847 . . . . 63.41 113.286 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -67.9 -18.02 64.66 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 112.517 0.562 . . . . 75.04 112.517 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -100.12 16.25 24.72 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.875 0.87 . . . . 75.14 111.253 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.474 ' HZ2' ' HA ' ' C' ' 31' ' ' VAL . 0.1 OUTLIER -100.59 155.54 17.81 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.474 0.71 . . . . 74.23 110.339 -174.428 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.32 125.07 25.56 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.089 0.556 . . . . 75.33 110.303 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.1 t-105 -83.03 87.97 6.88 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.731 0.812 . . . . 74.22 110.627 -173.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -139.54 75.95 31.31 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 123.932 0.893 . . . . 74.52 108.891 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -82.83 145.03 12.54 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.224 1.949 . . . . 73.32 112.056 -175.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -86.15 89.1 7.73 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 104.849 -2.278 . . . . 74.01 104.849 168.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 58.1 t -78.64 98.33 2.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 114.996 -1.002 . . . . 73.45 109.175 -175.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -97.5 102.31 14.05 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.548 -0.908 . . . . 73.4 108.548 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 pp -87.31 123.5 32.36 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.446 -1.316 . . . . 73.43 107.446 171.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -130.46 143.42 50.75 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.393 -0.966 . . . . 74.4 108.393 -172.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.444 HD11 ' CE1' ' C' ' 133' ' ' PHE . 91.9 mt -131.6 112.64 12.78 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.959 0.504 . . . . 72.21 110.959 -171.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -115.03 126.72 55.05 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 107.46 -1.311 . . . . 74.41 107.46 169.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -116.2 153.93 30.97 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 109.091 -0.707 . . . . 65.43 109.091 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.72 133.4 23.7 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.763 -0.828 . . . . 63.33 108.763 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.428 ' HG ' ' HB3' ' C' ' 98' ' ' LEU . 32.9 p -144.87 144.79 31.3 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.834 0.453 . . . . 74.44 110.154 -174.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 62.9 p -149.07 152.65 36.56 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.658 0.783 . . . . 73.24 109.872 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -85.43 117.99 24.68 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.043 -1.095 . . . . 74.14 108.043 173.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.682 HD12 ' HB2' ' C' ' 57' ' ' GLU . 31.9 mt -84.64 -40.2 17.73 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.595 0.758 . . . . 75.1 109.689 -176.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.31 -173.73 4.56 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.707 -1.133 . . . . 73.12 109.119 175.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -62.43 126.65 28.07 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.445 -0.798 . . . . 75.44 109.565 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 66.13 -0.72 1.33 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.847 1.259 . . . . 55.14 112.965 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 45.7 t -118.29 111.39 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 109.367 -0.605 . . . . 74.53 109.367 -176.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -113.32 166.62 11.3 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.973 0.909 . . . . 74.34 109.751 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.682 ' HB2' HD12 ' C' ' 51' ' ' LEU . 41.4 tt0 -127.86 144.55 51.09 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.174 0.99 . . . . 73.33 108.734 171.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 82.6 t -131.23 133.73 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 108.182 -1.044 . . . . 70.33 108.182 167.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.451 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 60.2 t -120.25 130.1 74.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 107.66 -1.237 . . . . 71.45 107.66 176.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.443 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -113.18 97.36 6.45 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.742 -1.207 . . . . 64.45 107.742 -176.678 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 7.9 ttm-85 -81.84 110.45 17.15 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.961 -0.755 . . . . 75.32 108.961 173.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.499 ' HB ' HD11 ' C' ' 114' ' ' ILE . 19.4 t -106.68 123.86 61.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.074 -1.084 . . . . 71.11 108.074 173.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 59.6 m -115.03 132.11 56.71 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.026 -1.102 . . . . 72.4 108.026 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.556 HG21 HG23 ' C' ' 114' ' ' ILE . 89.0 t -121.28 116.95 51.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 109.141 -0.689 . . . . 75.24 109.141 176.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 12.5 m -101.76 139.04 37.95 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.635 -0.876 . . . . 73.11 108.635 173.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.57 105.72 4.58 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.607 -0.886 . . . . 62.12 108.607 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 36.9 m -127.04 133.54 50.47 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.356 0.662 . . . . 72.11 109.705 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 11.3 mt -91.04 15.0 12.43 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.988 1.315 . . . . 74.24 111.474 -176.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 145.25 -110.46 0.55 Allowed Glycine 0 C--N 1.351 1.377 0 N-CA-C 110.026 -1.229 . . . . 70.34 110.026 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -88.74 -27.25 21.3 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.523 0.729 . . . . 72.34 109.088 169.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -74.55 119.47 18.79 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 124.438 1.095 . . . . 74.21 109.492 175.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 53.4 m -84.29 124.41 31.22 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.994 -0.743 . . . . 75.31 108.994 169.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.616 ' HA ' HG22 ' C' ' 31' ' ' VAL . . . -70.07 -54.86 11.24 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.462 0.705 . . . . 74.51 109.457 176.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -163.85 163.24 23.86 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.101 -0.954 . . . . 73.04 110.906 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -126.94 141.25 51.85 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 106.635 -1.617 . . . . 74.54 106.635 167.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.442 ' SG ' HG21 ' C' ' 114' ' ' ILE . 48.9 t -141.17 150.72 43.12 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.976 -0.749 . . . . 72.12 108.976 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -158.18 136.45 10.89 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.321 0.648 . . . . 72.3 109.853 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -135.82 114.21 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 124.496 1.118 . . . . 64.1 108.201 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.419 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 68.7 mt-30 -94.19 88.25 5.54 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.562 -0.903 . . . . 74.5 108.562 173.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -81.01 95.51 6.83 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.243 -0.89 . . . . 75.22 109.743 -176.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -83.58 149.1 25.53 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 116.016 -0.538 . . . . 52.13 112.23 178.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.08 125.49 1.79 Allowed Glycine 0 CA--C 1.505 -0.586 0 N-CA-C 111.143 -0.783 . . . . 71.44 111.143 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.523 HD13 ' HB3' ' D' ' 29' ' ' PRO . 26.4 mm -85.29 130.8 35.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 N-CA-C 108.475 -0.935 . . . . 73.23 108.475 175.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -135.75 118.76 16.38 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.474 0.71 . . . . 74.23 109.977 -178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 64.7 m -76.87 102.44 6.34 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.898 -0.778 . . . . 64.53 108.898 171.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.569 HG21 ' HE2' ' C' ' 94' ' ' MET . 22.3 mt -116.95 137.87 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 108.69 -0.855 . . . . 74.12 108.69 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.44 169.82 17.59 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.355 0.662 . . . . 64.52 109.309 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.62 -15.5 61.37 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 114.881 0.713 . . . . 75.11 114.881 169.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.712 HD13 ' HA ' ' C' ' 94' ' ' MET . 27.6 pt -117.14 169.66 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-N 117.762 0.781 . . . . 74.02 111.561 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -159.97 152.03 20.51 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.289 -0.869 . . . . 73.11 109.995 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.67 -126.86 9.28 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 123.524 0.515 . . . . 70.44 113.345 172.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 35.5 p -67.37 -26.01 66.25 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.129 0.971 . . . . 74.0 111.828 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -65.57 -52.92 48.7 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.692 0.797 . . . . 70.31 109.711 174.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.712 ' HA ' HD13 ' C' ' 89' ' ' ILE . 5.5 tpt -54.14 -48.7 70.55 Favored 'General case' 0 C--N 1.353 0.72 0 CA-C-N 114.916 -1.038 . . . . 73.2 112.096 172.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.84 83.07 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.313 0.645 . . . . 61.22 111.181 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -68.05 -34.23 76.06 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.257 -0.883 . . . . 74.32 111.342 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.404 ' SG ' HD12 ' C' ' 86' ' ' ILE . 33.7 t -72.86 -42.08 64.08 Favored 'General case' 0 C--N 1.347 0.488 0 N-CA-C 109.392 -0.595 . . . . 74.22 109.392 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.428 ' HB3' ' HG ' ' C' ' 48' ' ' SER . 92.3 mt -77.46 -28.79 52.47 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.959 0.904 . . . . 71.31 112.518 -175.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -114.44 11.1 21.73 Favored Glycine 0 N--CA 1.477 1.423 0 CA-C-O 119.597 -0.557 . . . . 55.25 114.27 -170.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.22 -55.05 0.12 Allowed 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 117.52 0.66 . . . . 73.24 111.846 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -70.4 -55.25 9.53 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.061 0.544 . . . . 73.32 111.705 -173.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.476 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 50.3 m -68.31 -43.92 34.63 Favored Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 123.764 0.826 . . . . 73.04 112.454 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.443 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 72.6 Cg_exo -55.62 -27.58 61.15 Favored 'Trans proline' 0 C--N 1.399 3.188 0 C-N-CA 122.402 2.068 . . . . 71.13 114.182 172.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -67.67 -35.42 78.82 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.328 0.651 . . . . 72.1 110.75 176.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.477 HD13 ' NH1' ' A' ' 111' ' ' ARG . 49.7 mm -75.71 -32.42 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.358 0.663 . . . . 74.43 110.212 177.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.75 -28.79 55.86 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.867 0.867 . . . . 73.35 111.79 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -56.78 -48.78 96.69 Favored Pre-proline 0 N--CA 1.482 1.175 0 N-CA-C 114.458 1.281 . . . . 73.53 114.458 -173.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.63 -38.69 92.64 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 121.895 1.73 . . . . 73.0 113.119 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -67.54 -43.56 80.41 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.832 0.853 . . . . 74.14 110.671 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.414 ' O ' HG13 ' C' ' 114' ' ' ILE . . . -65.22 -39.6 92.98 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.548 -0.751 . . . . 75.24 110.338 176.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -59.65 -49.89 75.97 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.205 1.402 . . . . 74.23 110.527 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.74 -37.8 88.83 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 123.944 0.778 . . . . 75.42 109.727 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.7 t -69.54 -33.13 72.35 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.176 0.59 . . . . 72.43 111.593 -176.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.556 HG23 HG21 ' C' ' 64' ' ' VAL . 88.2 mt -71.98 -51.91 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.236 0.614 . . . . 73.3 109.54 176.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.2 m -67.24 -29.23 68.81 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 123.695 0.622 . . . . 75.42 111.193 -175.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 48.3 t -63.47 -46.53 85.8 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.523 0.729 . . . . 74.34 109.077 172.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.576 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.53 -35.46 81.03 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.018 0.927 . . . . 75.54 112.32 178.105 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.447 HG13 ' HB2' ' C' ' 123' ' ' PHE . 95.4 t -68.85 -36.63 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.346 0.658 . . . . 61.21 109.71 174.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.0 t -71.13 -32.31 68.83 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.18 0.992 . . . . 71.03 111.447 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' C' ' 116' ' ' SER . 81.2 mtt-85 -73.3 -39.19 65.52 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.17 -0.678 . . . . 73.05 109.17 177.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.49 -3.72 78.59 Favored Glycine 0 C--N 1.353 1.488 0 O-C-N 123.928 0.767 . . . . 51.33 112.663 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 25.7 p 63.11 28.66 16.11 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 126.797 2.039 . . . . 64.55 113.627 170.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . 0.447 ' HB2' HG13 ' C' ' 118' ' ' VAL . 94.8 m-85 -82.62 161.22 59.58 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.663 0.785 . . . . 74.44 109.077 169.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -51.91 140.94 47.51 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.815 2.343 . . . . 74.51 112.817 172.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -55.35 109.17 0.5 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.312 1.045 . . . . 75.13 112.323 -175.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 56.4 tp -112.02 88.43 2.81 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.318 -0.623 . . . . 74.31 109.318 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -90.54 123.04 33.89 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.783 -0.821 . . . . 73.24 108.783 177.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.67 140.55 51.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.659 0.784 . . . . 73.51 110.781 -176.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.95 155.17 82.91 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 115.33 -0.85 . . . . 71.24 111.058 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.781 ' HG2' HG22 ' A' ' 13' ' ' ILE . 39.6 Cg_exo -55.55 106.99 0.21 Allowed 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.995 2.463 . . . . 70.12 112.132 173.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 18.3 t -99.6 120.59 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 108.361 -0.977 . . . . 74.33 108.361 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -79.53 100.9 7.96 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.82 0.848 . . . . 75.55 109.751 -176.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . 0.444 ' CE1' HD11 ' C' ' 44' ' ' LEU . 93.6 m-85 -66.47 -29.13 69.19 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.826 0.85 . . . . 70.34 112.48 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -64.28 -42.79 96.25 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.341 0.657 . . . . 70.02 109.605 176.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.42 -36.38 81.15 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.229 -0.896 . . . . 75.4 110.858 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 54.0 mt -66.63 -38.9 87.88 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.902 0.481 . . . . 74.52 110.779 177.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 38.1 t80 . . . . . 0 CA--C 1.546 0.817 0 CA-C-N 115.367 -0.833 . . . . 74.15 110.41 179.524 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 C--O 1.244 0.785 0 CA-C-O 121.296 0.57 . . . . 75.03 110.855 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.437 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 69.8 t80 -138.91 106.3 5.54 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 106.418 -1.697 . . . . 74.45 106.418 175.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . 0.48 ' HB2' ' OG ' ' D' ' 85' ' ' SER . 41.9 mt-30 -119.6 116.89 26.94 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.409 -0.589 . . . . 65.33 109.409 -175.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 63.1 mt -78.94 118.77 26.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.29 -1.004 . . . . 73.01 108.29 174.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . 0.506 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 8.5 mm-40 -95.84 -39.71 9.69 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.433 0.293 . . . . 71.23 110.474 -174.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -173.36 137.87 0.68 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.699 0.4 . . . . 74.33 110.166 -176.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.5 mp -115.09 142.4 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 107.195 -1.409 . . . . 65.11 107.195 172.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -163.12 147.27 11.08 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.305 0.642 . . . . 73.44 110.866 175.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.6 p -82.59 114.39 20.95 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.059 -0.973 . . . . 74.33 109.39 175.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -87.24 -15.76 37.23 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.919 0.888 . . . . 72.32 109.634 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.671 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.9 t70 -163.34 130.85 3.54 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.81 1.244 . . . . 75.41 109.081 -177.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.576 HG23 ' HE1' ' C' ' 117' ' ' MET . 76.2 mt -134.56 142.86 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.225 -1.028 . . . . 72.51 108.225 173.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.9 t -143.17 137.25 28.91 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.502 1.121 . . . . 64.31 108.556 172.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.504 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.1 t80 -135.44 121.44 19.96 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.134 -1.802 . . . . 75.23 106.134 166.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 40.5 mt-10 -127.08 110.49 12.98 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.662 0.785 . . . . 73.35 109.054 -177.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.99 89.14 3.45 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 107.761 -1.199 . . . . 51.24 107.761 171.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -71.46 -37.74 5.28 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.596 2.197 . . . . 75.11 112.314 -174.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -99.44 4.55 46.19 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.085 0.954 . . . . 74.42 110.367 -174.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.403 ' HB2' ' HD3' ' D' ' 29' ' ' PRO . . . -25.14 -70.22 0.05 OUTLIER Pre-proline 0 CA--C 1.564 1.514 0 C-N-CA 127.471 2.309 . . . . 74.24 116.62 -166.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.523 ' HB3' HD13 ' C' ' 83' ' ' ILE . 76.7 Cg_endo -76.99 -19.76 13.58 Favored 'Trans proline' 0 C--N 1.382 2.291 0 CA-C-N 123.293 2.212 . . . . 72.43 113.95 -171.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -78.56 -38.55 40.05 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.274 1.03 . . . . 72.24 109.922 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.717 HG22 ' HA ' ' D' ' 73' ' ' ALA . 11.1 p -82.8 -19.53 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 CA-C-N 115.61 -0.723 . . . . 65.24 111.574 -171.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -62.9 -23.39 67.33 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 112.558 0.577 . . . . 74.44 112.558 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -57.1 -31.1 64.92 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.346 1.058 . . . . 74.54 110.668 177.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.549 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 86.3 mttt -84.92 78.93 9.8 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.905 1.282 . . . . 73.5 110.047 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -79.87 83.79 5.75 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 121.684 0.754 . . . . 70.44 110.698 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -157.77 -179.08 7.81 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.508 -0.923 . . . . 73.41 108.508 167.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -64.02 114.48 13.89 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 123.771 0.828 . . . . 74.24 110.693 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.479 ' O ' HG21 ' D' ' 40' ' ' VAL . 60.5 Cg_exo -56.46 122.69 12.24 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 121.897 1.732 . . . . 72.34 110.677 171.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -66.43 110.58 3.17 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 107.391 -1.337 . . . . 74.34 107.391 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.666 HG23 HD12 ' D' ' 126' ' ' LEU . 85.2 t -100.82 136.71 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.987 0.915 . . . . 74.54 110.845 -170.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -111.0 119.34 38.73 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.507 -0.923 . . . . 72.51 108.507 167.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 63.2 tp -96.94 143.23 28.01 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.194 -0.669 . . . . 73.2 109.194 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.494 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 31.5 t70 -142.15 144.14 33.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.041 -0.981 . . . . 63.05 108.575 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 72.8 mt -134.65 133.89 40.58 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.393 -0.965 . . . . 65.43 108.393 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 16.4 t70 -134.04 151.18 51.32 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.847 1.259 . . . . 74.15 107.764 177.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.22 163.58 14.19 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.506 0.67 . . . . 72.43 111.396 -175.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -167.25 147.7 5.48 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 113.84 -1.527 . . . . 75.43 107.382 169.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 29.0 p . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.835 -0.431 . . . . 55.43 109.835 171.877 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' D' ' 85' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 113.419 0.896 . . . . 74.01 113.419 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.96 105.52 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 108.869 -0.789 . . . . 75.22 108.869 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -132.19 131.62 42.37 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.228 0.611 . . . . 74.44 110.478 -174.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.679 ' HG2' HG13 ' D' ' 83' ' ' ILE . 53.4 mt-10 -90.11 111.68 22.89 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.897 -0.779 . . . . 73.34 108.897 168.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 84.1 t -100.85 135.91 34.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 O-C-N 124.112 0.882 . . . . 73.3 109.379 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.524 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 47.2 t -122.78 133.96 67.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.033 1.333 . . . . 71.34 108.199 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.45 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -113.82 117.44 31.45 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.506 -1.294 . . . . 75.23 107.506 174.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.417 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 50.0 ttm-85 -93.87 95.02 8.83 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.419 -1.326 . . . . 74.14 107.419 174.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 49.0 t -91.11 144.13 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.44 -0.948 . . . . 73.23 108.44 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 36.0 m -139.87 141.25 36.61 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.036 -0.727 . . . . 71.32 109.036 -176.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.629 HG13 HG11 ' D' ' 40' ' ' VAL . 50.5 t -132.97 128.66 56.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 124.465 1.106 . . . . 75.14 108.49 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 56.6 m -125.01 93.37 3.87 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.371 -1.344 . . . . 65.4 107.371 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -95.71 154.59 17.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.941 -0.763 . . . . 75.54 108.941 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 28.7 p -153.37 132.56 12.67 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 123.331 0.394 . . . . 75.1 110.878 -173.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.508 HD11 HG21 ' D' ' 31' ' ' VAL . 52.1 mt -105.42 112.42 25.52 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.167 -1.049 . . . . 73.21 108.167 174.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.88 -133.42 15.3 Favored Glycine 0 C--N 1.345 1.057 0 O-C-N 123.38 0.425 . . . . 74.34 112.563 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.77 2.5 56.72 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.969 0.507 . . . . 75.4 111.758 -178.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.549 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 12.3 pt-20 -123.3 160.89 25.73 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.207 0.603 . . . . 74.54 110.528 -176.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 94.6 m -64.59 140.51 58.87 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.108 0.963 . . . . 72.34 110.992 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.717 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -92.33 -62.49 1.39 Allowed 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.855 -1.165 . . . . 74.14 107.855 172.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.84 165.78 35.55 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 114.347 -1.297 . . . . 73.32 109.937 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 87.5 mt -132.32 153.02 51.14 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.616 1.566 . . . . 74.44 107.257 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.637 ' SG ' HG12 ' D' ' 114' ' ' ILE . 53.0 t -158.61 145.1 17.2 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.747 0.419 . . . . 52.13 110.168 -177.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -154.54 126.8 7.84 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 123.103 0.561 . . . . 73.54 110.168 172.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 95.3 t -128.76 116.69 42.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 124.033 0.933 . . . . 75.1 109.059 -178.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.671 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.5 mt-30 -87.98 86.32 7.11 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.899 0.857 . . . . 74.53 108.863 168.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -82.46 97.9 8.63 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 113.831 -1.531 . . . . 73.11 109.394 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -96.2 166.62 24.58 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-N 116.48 -0.327 . . . . 71.11 112.706 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.7 153.26 12.97 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-O 119.837 -0.424 . . . . 74.22 112.783 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.679 HG13 ' HG2' ' D' ' 57' ' ' GLU . 3.0 mp -94.24 128.6 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 108.083 -1.08 . . . . 72.14 108.083 176.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -131.35 124.59 30.7 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.165 -1.05 . . . . 73.42 108.165 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.48 ' OG ' ' HB2' ' D' ' 12' ' ' GLN . 51.4 p -95.92 126.43 41.17 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 109.06 -0.719 . . . . 75.12 109.06 174.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 31.2 pt -133.61 129.39 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.452 -0.944 . . . . 74.43 108.452 -170.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.07 167.93 28.98 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.263 0.225 . . . . 63.1 111.18 -171.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.03 23.43 71.77 Favored Glycine 0 C--N 1.353 1.485 0 O-C-N 124.122 0.888 . . . . 74.02 114.484 171.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.641 HD11 ' HA ' ' D' ' 94' ' ' MET . 0.7 OUTLIER -133.54 155.45 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.158 0.583 . . . . 74.42 110.593 177.637 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.33 177.19 8.1 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.824 -1.08 . . . . 73.22 109.506 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.79 -140.78 25.49 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 123.29 0.368 . . . . 74.15 113.108 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 81.8 p -77.32 -43.09 34.3 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.772 0.829 . . . . 63.03 111.107 -175.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -57.96 -33.36 68.76 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.34 1.056 . . . . 75.32 111.771 -177.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.641 ' HA ' HD11 ' D' ' 89' ' ' ILE . 1.6 tmt? -47.56 -60.66 2.38 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.522 1.529 . . . . 74.44 112.729 -176.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.15 -15.7 46.19 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.204 0.601 . . . . 72.02 112.034 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -76.95 -17.52 58.85 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 122.859 0.464 . . . . 74.11 111.895 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 71.5 m -60.7 -44.26 96.77 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.586 0.354 . . . . 75.44 111.135 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.508 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 4.3 pp -79.27 -30.35 43.0 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.1 0.56 . . . . 75.25 111.816 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.55 -29.09 25.24 Favored Glycine 0 C--N 1.35 1.335 0 O-C-N 123.247 0.342 . . . . 61.24 113.669 -172.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.42 -57.12 2.02 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.447 0.699 . . . . 70.25 111.336 -171.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -72.87 -38.96 66.83 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 112.225 0.454 . . . . 61.45 112.225 -171.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.508 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 72.1 m -66.97 -46.1 53.58 Favored Pre-proline 0 CA--C 1.567 1.609 0 CA-C-O 118.679 -0.677 . . . . 75.13 111.937 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.45 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.4 Cg_exo -59.54 -32.0 95.46 Favored 'Trans proline' 0 C--N 1.393 2.913 0 C-N-CA 122.016 1.81 . . . . 73.51 112.911 169.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -64.63 -29.02 70.02 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.076 0.55 . . . . 71.41 111.125 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.404 ' O ' ' HD2' ' D' ' 108' ' ' PRO . 46.2 mm -78.23 -33.86 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.812 0.845 . . . . 74.22 110.786 174.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 65.3 mt -74.63 -18.79 60.49 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.24 0.616 . . . . 74.13 111.752 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -66.28 -45.81 60.63 Favored Pre-proline 0 CA--C 1.559 1.315 0 CA-C-O 118.195 -0.907 . . . . 75.31 113.306 -176.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' D' ' 105' ' ' ILE . 81.7 Cg_exo -52.37 -42.57 59.95 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.371 2.047 . . . . 74.23 114.323 171.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -71.99 -40.44 68.55 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.554 0.742 . . . . 70.35 111.49 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.03 -44.72 91.71 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.623 -0.717 . . . . 74.41 109.912 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.508 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 27.3 ttp180 -57.72 -49.1 77.66 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.74 1.275 . . . . 73.24 110.311 178.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -58.71 -49.02 79.12 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.373 1.045 . . . . 74.34 110.45 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 43.1 t -57.26 -45.64 83.8 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 124.031 0.832 . . . . 74.11 111.186 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.637 HG12 ' SG ' ' D' ' 76' ' ' CYS . 89.0 mt -61.17 -55.94 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.772 0.829 . . . . 74.32 110.673 175.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 90.7 m -52.86 -42.3 65.1 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 124.764 1.226 . . . . 74.32 111.088 -174.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.419 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 29.9 t -66.69 -43.14 85.18 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.492 -1.231 . . . . 74.12 109.863 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.6 mtm -70.69 -26.93 63.65 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.056 0.543 . . . . 74.14 111.941 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.459 HG22 ' HB3' ' D' ' 126' ' ' LEU . 79.8 t -64.73 -47.75 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.384 0.674 . . . . 71.42 109.38 173.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.9 p -72.82 -28.94 62.86 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.569 -0.741 . . . . 75.01 110.559 -178.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' D' ' 116' ' ' SER . 76.4 mtt-85 -71.16 -27.17 63.34 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.757 0.823 . . . . 73.14 110.097 173.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.46 8.87 79.11 Favored Glycine 0 C--N 1.351 1.398 0 CA-C-O 119.354 -0.692 . . . . 63.11 112.615 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 69.7 p 55.88 40.81 30.54 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.781 1.632 . . . . 64.54 113.761 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -105.93 152.95 40.4 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 109.001 -0.74 . . . . 75.33 109.001 170.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -48.91 133.46 28.08 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.024 2.483 . . . . 73.4 112.141 171.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -55.78 128.6 35.7 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 124.308 1.005 . . . . 75.04 112.389 -170.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.666 HD12 HG23 ' D' ' 40' ' ' VAL . 14.2 tp -111.23 102.57 10.98 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.139 0.976 . . . . 70.41 108.973 -176.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -100.9 104.39 15.59 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.647 -1.242 . . . . 53.1 107.647 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.508 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.2 mm? -64.32 114.75 4.47 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.189 0.595 . . . . 75.4 109.806 -177.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . 0.401 ' HB2' ' HG3' ' B' ' 12' ' ' GLN . . . -62.14 132.76 93.94 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 123.105 0.562 . . . . 75.34 111.023 -174.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -61.43 116.66 3.55 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.06 2.507 . . . . 73.32 112.357 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p -110.54 136.1 47.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 N-CA-C 108.901 -0.777 . . . . 73.41 108.901 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -80.65 113.13 18.63 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.798 -0.816 . . . . 55.21 108.798 176.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 124.027 0.931 . . . . 71.22 110.952 -177.326 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 mmt . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 108.773 -0.825 . . . . 74.34 108.773 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.0 m -143.44 97.4 3.07 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.004 0.521 . . . . 73.14 109.828 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -67.63 118.09 10.45 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.108 0.563 . . . . 75.53 109.587 176.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -108.61 81.6 1.49 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.585 0.754 . . . . 75.32 109.669 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -76.86 142.29 40.27 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.512 -0.767 . . . . 75.12 109.986 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -87.89 116.02 25.76 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.751 0.82 . . . . 74.32 108.907 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.0 p -126.62 161.78 27.25 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.026 0.93 . . . . 74.43 110.797 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 66.2 45.19 2.36 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.073 1.349 . . . . 74.43 112.201 172.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -83.94 167.49 16.91 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.657 0.741 . . . . 73.34 111.542 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.8 m -140.12 126.03 19.55 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 106.942 -1.503 . . . . 75.44 106.942 164.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -137.32 121.11 17.48 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.752 -1.203 . . . . 73.21 107.752 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -143.02 110.82 5.91 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.157 -0.683 . . . . 70.21 109.157 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.432 HG22 ' HG3' ' C' ' 130' ' ' PRO . 23.9 mt -70.39 114.39 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.317 -0.623 . . . . 73.25 109.317 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -82.18 -39.93 22.47 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.653 0.595 . . . . 70.1 110.206 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -175.06 122.42 0.23 Allowed 'General case' 0 N--CA 1.481 1.098 0 O-C-N 123.608 0.568 . . . . 75.13 110.862 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 97.0 mt -106.21 136.0 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.378 -0.971 . . . . 73.15 108.378 171.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.7 p90 -166.78 164.93 16.54 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 123.843 0.714 . . . . 72.05 111.196 -174.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.3 p -88.33 124.0 33.47 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.77 -0.456 . . . . 74.34 109.77 175.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HE3' ' HB1' ' B' ' 28' ' ' ALA . 38.4 mtpt -90.85 -36.94 13.91 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.891 -0.781 . . . . 73.24 108.891 175.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.713 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 24.7 t70 -138.8 136.84 36.09 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.982 -1.008 . . . . 63.4 109.125 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 76.4 mt -130.88 142.62 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.804 1.242 . . . . 71.32 107.818 173.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.2 t -149.44 116.6 6.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.394 0.678 . . . . 74.22 109.983 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.676 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.1 t80 -122.79 136.69 54.95 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.472 -1.307 . . . . 73.43 107.472 168.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -133.47 129.55 37.37 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.196 0.598 . . . . 73.22 110.088 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.47 69.87 12.65 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 105.852 -1.907 . . . . 75.24 105.852 167.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.07 -16.58 17.83 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.325 2.017 . . . . 62.51 111.124 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -94.71 9.43 38.94 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.651 1.18 . . . . 74.5 110.369 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.66 -58.53 7.4 Favored Pre-proline 0 CA--C 1.569 1.698 0 C-N-CA 124.785 1.234 . . . . 73.25 113.853 -165.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.473 ' HB3' HD11 ' B' ' 51' ' ' LEU . 69.4 Cg_exo -51.85 -44.56 44.17 Favored 'Trans proline' 0 C--N 1.398 3.152 0 C-N-CA 122.715 2.277 . . . . 73.21 113.856 -173.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -96.18 -13.03 23.81 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.485 -0.78 . . . . 73.25 112.205 -174.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -77.45 -15.86 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 120.869 0.366 . . . . 74.51 110.708 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -77.41 -22.39 51.63 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.299 0.64 . . . . 74.12 110.904 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -77.62 -23.79 49.73 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.921 0.889 . . . . 75.2 110.283 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HE2' ' HB3' ' A' ' 71' ' ' GLU . 30.3 mmmt -65.64 144.93 56.63 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.22 1.008 . . . . 73.21 111.94 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -60.47 117.72 5.61 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.661 -0.866 . . . . 70.25 108.661 168.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.421 ' CE3' HD21 ' A' ' 68' ' ' LEU . 70.6 t-105 -75.6 84.68 2.65 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.676 0.75 . . . . 74.51 110.022 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.74 78.32 74.0 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 105.882 -1.896 . . . . 63.45 105.882 169.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -81.93 140.67 11.52 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.665 2.243 . . . . 73.44 111.908 -173.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -97.66 83.78 3.27 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.072 -1.455 . . . . 71.32 107.072 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.607 HG22 ' HB1' ' A' ' 66' ' ' ALA . 58.0 t -81.96 119.16 30.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 CA-C-N 114.745 -1.116 . . . . 74.33 109.549 -174.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 74.0 mttt -113.86 113.57 25.06 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.237 1.015 . . . . 74.31 108.467 -170.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -98.43 121.16 40.02 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 108.294 -1.002 . . . . 71.33 108.294 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -130.43 138.57 50.39 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.39 1.076 . . . . 70.22 108.265 -176.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.435 HD22 HD21 ' A' ' 60' ' ' LEU . 88.3 mt -128.89 140.14 51.82 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.939 0.496 . . . . 73.33 110.95 -173.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.52 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 27.7 t70 -142.9 146.19 33.8 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.465 1.106 . . . . 74.02 108.742 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.2 m -131.8 128.85 39.63 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.117 0.567 . . . . 74.45 110.076 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.71 110.04 10.11 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.66 0.784 . . . . 62.13 109.151 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.4 p -90.68 161.23 15.47 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 109.512 -0.551 . . . . 72.42 109.512 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.4 t -152.97 121.17 6.21 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.966 0.906 . . . . 74.43 108.702 -172.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -79.72 104.23 10.17 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.589 -0.893 . . . . 73.43 108.589 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.437 HD12 HG22 ' A' ' 83' ' ' ILE . 97.6 mt -81.83 -35.58 29.25 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.893 0.477 . . . . 72.24 109.96 177.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.45 -176.47 5.08 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.628 0.771 . . . . 65.13 110.391 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.68 113.95 4.1 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.501 0.72 . . . . 74.2 110.181 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 66.27 17.89 10.8 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.629 1.172 . . . . 52.13 111.609 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.5 t -119.69 106.85 19.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 107.73 -1.211 . . . . 73.34 107.73 173.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -123.12 125.49 45.25 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.29 -1.004 . . . . 75.33 108.29 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -86.35 139.48 30.93 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.46 -0.941 . . . . 74.32 108.46 168.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.1 t -120.17 140.93 42.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.02 -1.104 . . . . 71.51 108.02 171.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.8 t -121.07 130.26 74.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.515 -0.92 . . . . 74.31 108.515 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.489 HD23 HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -105.13 107.88 19.1 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.875 -1.528 . . . . 74.12 106.875 177.386 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.52 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 32.1 ttp180 -92.35 99.66 12.38 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.224 -1.399 . . . . 75.25 107.224 174.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.489 HG23 HD23 ' A' ' 60' ' ' LEU . 21.9 t -96.27 127.98 47.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 107.689 -1.226 . . . . 74.11 107.689 174.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.5 m -121.05 125.08 46.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.402 0.62 . . . . 54.01 109.672 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.582 HG12 HD21 ' A' ' 126' ' ' LEU . 58.9 t -116.23 125.12 73.15 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 C-N-CA 124.962 1.305 . . . . 74.2 107.567 177.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.42 ' HB ' ' HD2' ' A' ' 41' ' ' LYS . 13.8 m -127.75 127.07 42.98 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.155 0.889 . . . . 74.04 109.629 172.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.607 ' HB1' HG22 ' A' ' 40' ' ' VAL . . . -118.07 126.46 52.32 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.346 -0.983 . . . . 71.25 108.346 178.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 35.2 m -130.24 132.82 46.13 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.461 0.704 . . . . 63.23 110.352 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.421 HD21 ' CE3' ' A' ' 36' ' ' TRP . 12.6 mt -93.08 70.35 4.52 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 125.26 1.424 . . . . 73.01 109.058 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.8 -107.03 2.36 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-N 115.595 -0.73 . . . . 64.22 111.404 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.1 -26.77 17.31 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.551 0.74 . . . . 70.35 111.216 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.424 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 6.3 tp10 -93.81 123.9 37.46 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.587 0.755 . . . . 74.3 109.001 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 89.8 m -75.82 136.79 40.21 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 117.744 0.247 . . . . 65.43 110.57 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.34 -64.83 0.94 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.763 -0.828 . . . . 63.23 108.763 174.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -158.94 170.31 22.38 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.325 -0.852 . . . . 62.25 112.002 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 64' ' ' VAL . 57.2 tp -125.28 135.83 52.9 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.91 1.284 . . . . 72.32 107.831 167.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.452 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 73.7 m -135.4 97.75 3.78 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.692 0.797 . . . . 64.41 110.249 174.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -117.66 118.26 31.61 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.112 0.965 . . . . 75.41 108.543 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.9 t -127.68 121.82 57.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 109.134 -0.691 . . . . 75.51 109.134 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.713 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.2 mt-30 -92.79 86.37 5.49 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.275 -0.875 . . . . 72.14 108.865 173.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -76.71 99.37 5.06 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 113.786 -1.552 . . . . 75.45 109.469 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.14 159.73 32.85 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 111.419 -0.672 . . . . 73.04 111.419 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.433 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -161.02 122.45 1.12 Allowed Glycine 0 CA--C 1.498 -0.987 0 N-CA-C 110.336 -1.106 . . . . 55.31 110.336 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.437 HG22 HD12 ' A' ' 51' ' ' LEU . 53.6 mt -78.72 124.65 37.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 N-CA-C 107.337 -1.357 . . . . 74.41 107.337 173.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -123.79 160.04 28.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.884 -0.784 . . . . 74.34 108.884 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.6 t -117.75 101.57 8.43 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.349 -1.352 . . . . 74.01 107.349 173.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.631 HG21 ' SG ' ' A' ' 97' ' ' CYS . 9.0 mm -107.72 145.4 15.03 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 O-C-N 123.736 0.647 . . . . 75.44 110.249 -176.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.51 177.25 8.28 Favored 'General case' 0 C--O 1.231 0.116 0 O-C-N 123.761 0.663 . . . . 73.43 110.971 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.93 -27.18 11.61 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-N 116.061 -0.518 . . . . 62.31 113.047 176.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.45 148.19 24.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 C-N-CA 123.772 0.829 . . . . 70.24 110.808 -171.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.614 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 2.3 mp0 -135.9 175.42 9.61 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.915 0.886 . . . . 73.53 109.952 176.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.12 -119.77 9.88 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-N 115.341 -0.845 . . . . 74.52 113.497 174.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.5 p -73.2 -30.21 63.37 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.114 0.966 . . . . 54.12 110.448 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -74.66 -36.52 62.83 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.14 -0.937 . . . . 71.13 109.852 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.614 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 2.6 tpt -61.22 -44.78 96.72 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.295 0.638 . . . . 75.42 109.75 172.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.4 -29.48 69.0 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.269 -0.878 . . . . 62.21 111.271 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.456 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 54.0 t-80 -71.88 -27.66 63.01 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.288 0.635 . . . . 73.12 111.068 176.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.631 ' SG ' HG21 ' A' ' 86' ' ' ILE . 37.1 t -79.55 -60.73 2.24 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.147 -0.686 . . . . 73.15 109.147 175.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 78.5 mt -67.92 -34.15 76.06 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.03 0.932 . . . . 71.51 113.196 -172.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.87 3.46 52.5 Favored Glycine 0 N--CA 1.47 0.963 0 CA-C-O 119.688 -0.506 . . . . 73.4 113.775 -173.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.557 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -140.14 -70.47 0.39 Allowed 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 117.348 0.574 . . . . 71.13 111.332 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -67.69 -39.19 84.46 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 111.879 0.325 . . . . 74.13 111.879 -171.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 63.5 m -66.68 -53.35 28.87 Favored Pre-proline 0 CA--C 1.564 1.492 0 C-N-CA 124.566 1.146 . . . . 65.05 112.164 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.46 ' HA ' HD13 ' A' ' 106' ' ' LEU . 58.2 Cg_endo -68.35 -18.89 44.2 Favored 'Trans proline' 0 C--N 1.399 3.219 0 C-N-CA 121.965 1.777 . . . . 73.23 112.616 175.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.464 ' ND2' ' HA ' ' E' ' 145' ' ' ASP . 0.1 OUTLIER -67.4 -47.24 70.87 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.934 -0.765 . . . . 72.05 108.934 174.74 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.3 mm -59.56 -33.45 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.758 1.223 . . . . 71.04 111.299 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.46 HD13 ' HA ' ' A' ' 103' ' ' PRO . 49.3 mt -79.86 -18.8 49.85 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.315 0.646 . . . . 71.04 112.153 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -66.51 -40.55 34.14 Favored Pre-proline 0 CA--C 1.558 1.251 0 N-CA-C 114.737 1.384 . . . . 75.03 114.737 -172.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.5 -37.71 94.72 Favored 'Trans proline' 0 C--N 1.389 2.69 0 C-N-CA 121.998 1.798 . . . . 74.43 112.757 173.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.458 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 55.7 m-85 -82.32 -35.2 28.16 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.098 -0.955 . . . . 75.43 111.022 -175.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.73 -49.39 73.24 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.157 -0.683 . . . . 73.31 109.157 174.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.517 ' NH1' HD13 ' C' ' 105' ' ' ILE . 32.3 ttm180 -49.86 -55.14 15.43 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 125.19 1.556 . . . . 73.45 110.511 174.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.85 -42.57 94.79 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.25 0.969 . . . . 72.01 111.686 -173.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 117' ' ' MET . 48.7 t -60.45 -40.79 92.44 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 123.5 0.5 . . . . 71.14 110.795 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.546 HD13 HD12 ' A' ' 128' ' ' LEU . 63.2 mt -64.58 -50.34 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.224 1.01 . . . . 75.4 110.597 174.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 82.9 m -58.03 -44.62 87.44 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.367 1.067 . . . . 74.4 111.245 -174.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 24.0 t -65.69 -40.74 92.64 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.329 -1.305 . . . . 74.22 110.21 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.676 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 38.0 mtm -64.07 -41.28 97.39 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.61 0.364 . . . . 73.13 111.034 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.454 HG21 HD22 ' A' ' 126' ' ' LEU . 79.3 t -61.58 -45.37 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 O-C-N 124.051 0.844 . . . . 65.0 110.587 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.3 p -71.91 -32.76 67.69 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.014 0.525 . . . . 73.21 111.273 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.458 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.5 mtt-85 -69.96 -30.88 68.35 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.271 0.629 . . . . 73.21 109.704 174.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.99 12.72 57.16 Favored Glycine 0 C--N 1.355 1.604 0 O-C-N 123.905 0.753 . . . . 61.1 112.861 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.424 HG23 ' HE ' ' B' ' 15' ' ' ARG . 1.5 t 62.19 14.19 6.46 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.153 2.181 . . . . 74.15 113.615 172.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -80.49 149.35 68.26 Favored Pre-proline 0 C--O 1.244 0.813 0 N-CA-C 107.068 -1.456 . . . . 75.4 107.068 169.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.687 ' HB3' ' HA ' ' E' ' 131' ' ' TRP . 12.2 Cg_endo -55.63 142.88 81.3 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.163 1.909 . . . . 74.51 111.396 176.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -55.53 122.63 11.71 Favored 'General case' 0 C--N 1.352 0.705 0 O-C-N 124.246 0.966 . . . . 74.03 111.481 -169.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.582 HD21 HG12 ' A' ' 64' ' ' VAL . 22.6 tp -106.15 121.15 43.59 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 108.35 -0.982 . . . . 73.31 108.35 -176.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.593 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 88.6 m-20 -117.74 124.28 48.08 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.657 -1.238 . . . . 75.33 107.657 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.546 HD12 HD13 ' A' ' 114' ' ' ILE . 9.6 mt -74.24 140.3 44.92 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.966 -0.753 . . . . 74.3 108.966 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.42 ' HB2' ' HD1' ' E' ' 138' ' ' TYR . . . -69.62 140.16 89.36 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-O 119.251 -0.404 . . . . 72.41 111.025 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -56.09 115.68 2.64 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 123.392 2.728 . . . . 73.51 113.343 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 92.0 t -102.72 123.38 56.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-N 115.421 -0.809 . . . . 73.44 109.517 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -87.24 90.72 8.46 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 107.778 -1.193 . . . . 72.14 107.778 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -63.58 -28.6 70.04 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.396 0.678 . . . . 63.33 111.465 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.557 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 14.8 t70 -61.7 -39.39 91.33 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.486 0.715 . . . . 75.43 110.11 175.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.5 -40.17 89.09 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.728 0.811 . . . . 71.31 110.651 173.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.97 -38.74 89.67 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.259 0.623 . . . . 73.53 111.352 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.411 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 60.1 t80 -74.51 -39.73 62.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.79 -0.448 . . . . 74.33 109.79 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.9 tpt -54.46 -35.86 63.48 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.273 1.029 . . . . 74.14 111.027 178.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -56.23 -55.33 34.58 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.915 0.886 . . . . 73.11 110.851 176.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -71.0 -31.5 68.05 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.625 0.77 . . . . 73.51 111.253 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 32.0 tp -68.13 -52.77 31.05 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.09 0.556 . . . . 72.12 111.37 -170.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 179.18 -15.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 113.681 0.993 . . . . 74.24 113.681 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 58.99 56.0 4.21 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.556 0.742 . . . . 72.14 111.348 -173.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -164.18 100.89 0.85 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.381 0.672 . . . . 74.45 110.185 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -167.95 135.6 2.26 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.71 1.204 . . . . 64.44 108.525 175.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -168.14 125.92 1.35 Allowed Glycine 0 C--N 1.348 1.196 0 C-N-CA 121.631 -0.319 . . . . 72.32 113.006 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.611 ' HA ' ' HA3' ' C' ' 148' ' ' GLY . 42.5 mt-10 -132.75 147.81 52.32 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.544 1.137 . . . . 75.1 109.227 173.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 140.26 117.19 1.39 Allowed Glycine 0 C--N 1.341 0.851 0 N-CA-C 111.428 -0.669 . . . . 61.11 111.428 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.421 HG23 ' O ' ' C' ' 147' ' ' GLU . 5.1 t -149.88 65.74 0.98 Allowed 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.408 -0.96 . . . . 72.21 108.408 170.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -66.92 98.67 0.57 Allowed 'General case' 0 C--N 1.35 0.592 0 CA-C-N 114.59 -1.186 . . . . 75.12 110.466 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -104.64 127.91 52.53 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.469 -0.937 . . . . 64.21 108.469 171.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -83.19 100.74 10.76 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.338 -0.616 . . . . 71.24 109.338 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -118.63 102.53 8.94 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.773 0.829 . . . . 75.24 108.808 173.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -163.54 133.06 4.09 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.462 0.705 . . . . 71.31 109.859 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.941 0 C-N-CA 124.158 0.983 . . . . 72.21 108.732 178.867 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 110.06 -0.348 . . . . 75.12 110.06 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 74.9 m -93.32 78.18 4.48 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 123.433 0.693 . . . . 70.41 109.767 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -175.23 32.11 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.225 -0.898 . . . . 70.15 110.795 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -132.98 -179.72 5.66 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.795 0.438 . . . . 74.12 110.761 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -90.95 95.87 10.34 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.679 0.792 . . . . 55.53 109.274 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . 0.583 ' HB3' ' HB2' ' B' ' 154' ' ' ASP . 63.4 t30 -151.61 170.29 20.05 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.718 0.807 . . . . 73.44 109.144 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 45.8 p -56.96 134.99 56.11 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.364 1.066 . . . . 65.24 111.087 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -70.94 127.3 32.13 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.204 1.001 . . . . 71.42 110.536 -171.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.578 ' HE3' ' SG ' ' B' ' 97' ' ' CYS . 24.6 ttt 65.97 166.94 0.2 Allowed 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 124.725 1.21 . . . . 73.22 111.564 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.6 t -138.75 126.58 22.26 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.691 1.196 . . . . 61.22 108.46 169.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -127.9 137.41 52.3 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.286 -1.005 . . . . 74.12 108.286 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.541 HE21 ' HB3' ' E' ' 126' ' ' ALA . 26.2 tp60 -151.86 109.71 3.67 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.624 0.369 . . . . 72.24 110.359 -176.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 47.4 mt -60.84 144.65 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 108.853 -0.795 . . . . 73.3 108.853 172.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -110.04 -45.21 3.64 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.684 -0.487 . . . . 75.52 109.684 176.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.424 ' HE ' HG23 ' A' ' 122' ' ' THR . 50.0 ttt180 -167.45 132.66 1.98 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.386 -0.598 . . . . 65.22 109.386 -173.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.4 mt -118.88 147.93 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 107.494 -1.299 . . . . 74.4 107.494 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.479 ' HE2' ' HZ3' ' B' ' 19' ' ' LYS . 33.6 p90 -169.91 163.89 9.6 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.836 0.827 . . . . 73.2 112.139 -174.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 82.7 m -92.49 122.74 35.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.627 -1.624 . . . . 72.45 108.237 171.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.479 ' HZ3' ' HE2' ' B' ' 17' ' ' TYR . 33.1 mttp -80.05 -49.94 11.07 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.571 0.748 . . . . 64.42 110.732 170.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -144.99 139.46 27.5 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 122.113 -0.367 . . . . 73.2 111.185 -168.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.502 HD13 ' SG ' ' B' ' 113' ' ' CYS . 49.5 mm -128.86 141.77 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.247 1.019 . . . . 74.0 109.911 173.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -144.82 133.35 22.02 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.69 1.196 . . . . 71.12 108.002 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -143.6 109.9 5.41 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.016 -1.105 . . . . 74.14 108.016 173.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -117.97 114.86 23.8 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.562 0.745 . . . . 74.21 109.039 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' B' ' 28' ' ' ALA . . . -105.25 88.31 2.47 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 106.431 -1.692 . . . . 75.11 106.431 170.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -72.02 -31.8 11.87 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.092 2.528 . . . . 73.43 113.256 -168.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -109.42 25.72 11.47 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.307 0.643 . . . . 74.53 109.268 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.422 ' HB1' ' HE3' ' A' ' 19' ' ' LYS . . . -44.36 -58.41 5.1 Favored Pre-proline 0 CA--C 1.564 1.487 0 N-CA-C 114.633 1.346 . . . . 74.13 114.633 -163.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.3 -35.94 81.83 Favored 'Trans proline' 0 C--N 1.393 2.889 0 C-N-CA 122.078 1.852 . . . . 75.34 112.962 -174.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -95.08 -25.18 16.56 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.478 -0.783 . . . . 73.4 112.47 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.559 HG21 ' HG3' ' B' ' 71' ' ' GLU . 4.5 p -71.15 -14.25 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-O 121.332 0.587 . . . . 74.54 110.14 -175.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -73.31 -2.66 22.95 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.265 1.026 . . . . 74.34 112.459 174.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -68.63 -19.64 64.43 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.435 0.694 . . . . 73.24 110.116 169.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.542 ' HB2' HD13 ' B' ' 68' ' ' LEU . 29.4 mmtp -98.31 102.62 14.42 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 125.497 1.519 . . . . 74.4 108.884 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -99.8 77.35 2.04 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.807 0.443 . . . . 74.03 110.639 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 43.6 p90 -160.99 167.97 25.45 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.976 0.91 . . . . 74.52 109.581 169.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.46 113.97 22.45 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 107.328 -1.36 . . . . 73.22 107.328 176.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.42 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 19.6 Cg_endo -60.92 163.92 15.22 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.809 2.339 . . . . 64.21 113.709 -173.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -71.21 103.95 2.95 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.388 -0.967 . . . . 54.34 108.388 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 49.0 t -94.33 146.5 6.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 114.996 -1.002 . . . . 64.45 110.253 -176.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -149.14 125.96 11.17 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.24 1.016 . . . . 74.3 108.282 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 16.3 tp -89.65 137.95 31.89 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.061 0.545 . . . . 75.33 109.768 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -139.56 113.29 8.57 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.441 1.096 . . . . 64.31 108.309 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 91.3 mt -99.69 152.46 20.05 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.751 0.82 . . . . 74.21 109.636 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.787 ' HB3' ' HD2' ' B' ' 61' ' ' ARG . 31.7 t70 -156.03 151.59 27.04 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 107.324 -1.362 . . . . 72.02 107.324 173.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' THR . . . . . 0.488 ' HB ' ' CE2' ' F' ' 106' ' ' TYR . 0.9 OUTLIER -143.83 146.45 33.07 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.664 0.745 . . . . 75.04 112.315 -170.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.11 153.2 41.91 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.931 1.292 . . . . 72.31 108.359 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.479 ' HB2' ' CE2' ' B' ' 56' ' ' TYR . 74.4 p -145.7 176.05 9.93 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.565 0.579 . . . . 73.43 112.565 -174.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 65.5 p -162.01 139.29 8.46 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.688 1.195 . . . . 75.13 109.869 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -90.79 109.93 21.13 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.284 -0.635 . . . . 74.24 109.284 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.473 HD11 ' HB3' ' A' ' 29' ' ' PRO . 39.3 mt -86.56 -23.34 25.85 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.763 0.425 . . . . 73.54 110.531 175.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . 0.558 ' HB1' ' HB ' ' B' ' 55' ' ' VAL . . . -163.1 167.42 22.28 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.452 0.701 . . . . 71.51 111.08 -176.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -82.17 138.49 34.69 Favored 'General case' 0 C--O 1.248 0.99 0 N-CA-C 107.291 -1.374 . . . . 74.42 107.291 161.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 78.17 -5.35 2.09 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 125.758 1.623 . . . . 74.44 112.258 -175.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.558 ' HB ' ' HB1' ' B' ' 52' ' ' ALA . 50.1 t -144.34 117.97 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.539 0.735 . . . . 74.23 109.044 -175.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.479 ' CE2' ' HB2' ' B' ' 48' ' ' SER . 26.9 t80 -126.61 151.58 47.8 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.195 0.598 . . . . 75.41 110.002 -173.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -116.26 121.0 40.73 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 107.755 -1.202 . . . . 74.31 107.755 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 12.9 p -127.48 147.93 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.128 0.571 . . . . 72.43 109.984 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 17.4 t -125.37 116.26 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.73 0.812 . . . . 64.33 109.808 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.45 ' HA ' HG23 ' B' ' 46' ' ' THR . 58.0 tp -94.72 105.27 17.21 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.051 -0.722 . . . . 74.32 109.051 170.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.787 ' HD2' ' HB3' ' B' ' 45' ' ' ASP . 1.7 tmt_? -86.54 120.46 27.89 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.709 -1.219 . . . . 72.43 107.709 172.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 32.3 t -114.81 133.04 62.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.284 -1.006 . . . . 70.42 108.284 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 24.7 m -131.03 131.81 44.54 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.325 0.583 . . . . 75.23 109.628 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.536 HG21 HD21 ' B' ' 128' ' ' LEU . 97.2 t -111.54 118.74 58.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 C-N-CA 124.419 1.087 . . . . 74.03 108.338 176.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 68.5 m -92.51 130.94 38.03 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.114 -1.069 . . . . 70.24 108.114 168.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.39 134.34 27.19 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.863 -0.792 . . . . 72.33 108.863 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.428 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 18.8 p -144.63 133.26 22.2 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 123.736 0.648 . . . . 63.22 110.803 -175.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.542 HD13 ' HB2' ' B' ' 34' ' ' LYS . 78.4 mt -99.45 103.05 14.79 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.47 1.108 . . . . 75.5 110.056 176.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.7 -111.7 3.41 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.797 -0.521 . . . . 63.31 111.797 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -115.19 1.32 13.81 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.256 0.622 . . . . 74.32 110.706 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.559 ' HG3' HG21 ' B' ' 31' ' ' VAL . 18.2 pt-20 -115.47 143.1 45.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.415 0.686 . . . . 75.51 109.396 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 63.4 m -69.11 132.13 46.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 121.235 0.54 . . . . 73.22 110.999 -178.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.54 ' HA ' HG23 ' B' ' 31' ' ' VAL . . . -83.31 -63.03 1.44 Allowed 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.819 -1.178 . . . . 72.22 107.819 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -153.87 152.36 30.55 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.523 -1.217 . . . . 74.54 110.358 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -125.79 111.85 15.36 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.427 -1.694 . . . . 75.15 106.427 170.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.485 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 49.5 t -117.42 134.63 54.62 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.909 -1.145 . . . . 73.34 107.909 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -146.09 126.36 13.92 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.427 -0.953 . . . . 73.24 108.427 -173.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.436 HG22 HG13 ' B' ' 114' ' ' ILE . 66.1 t -123.08 148.02 27.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.259 -1.015 . . . . 72.14 108.259 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -120.46 106.96 12.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.083 -1.451 . . . . 75.21 107.083 168.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -100.82 103.07 14.27 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.609 -0.885 . . . . 75.53 108.609 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.59 158.8 18.59 Favored Glycine 0 C--N 1.342 0.885 0 O-C-N 123.762 0.664 . . . . 74.34 111.548 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.44 142.45 7.86 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 117.314 0.557 . . . . 72.15 113.414 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 3.8 mp -90.34 124.68 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 107.941 -1.133 . . . . 75.42 107.941 170.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -129.59 153.35 48.15 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.315 1.046 . . . . 75.44 109.28 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 30.3 m -107.76 109.1 20.58 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.742 0.817 . . . . 73.12 109.191 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.602 HG21 HD12 ' B' ' 89' ' ' ILE . 4.0 mp -111.74 108.52 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.756 1.223 . . . . 73.32 107.93 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.98 158.43 43.92 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.048 0.539 . . . . 64.44 111.22 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.73 -56.14 0.88 Allowed Glycine 0 C--N 1.349 1.261 0 C-N-CA 123.292 0.472 . . . . 74.32 112.668 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.602 HD12 HG21 ' B' ' 86' ' ' ILE . 0.6 OUTLIER -56.22 166.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 124.528 1.131 . . . . 74.21 113.035 173.238 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -158.42 160.03 36.39 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.078 -0.964 . . . . 74.42 110.057 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.08 -109.92 3.81 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 112.166 -0.373 . . . . 54.11 112.166 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 80.0 m -99.94 -42.42 6.78 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.482 0.713 . . . . 74.05 110.677 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -65.66 -19.14 65.79 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.207 1.003 . . . . 75.23 112.448 -173.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.489 ' HE1' HG12 ' F' ' 97' ' ' ILE . 20.3 ptm -61.69 -66.07 0.59 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.102 0.561 . . . . 72.41 111.613 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . 0.4 ' H ' ' HG3' ' B' ' 94' ' ' MET . . . -79.69 -14.26 58.89 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.801 0.44 . . . . 53.5 111.621 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -63.32 -34.9 78.7 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.278 0.631 . . . . 74.02 110.888 171.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.578 ' SG ' ' HE3' ' B' ' 9' ' ' MET . 48.7 t -66.72 -44.21 82.2 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.819 0.447 . . . . 72.11 111.594 -177.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.561 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 1.5 pp -80.23 -30.18 38.54 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.098 0.559 . . . . 74.13 111.464 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.51 -30.57 44.34 Favored Glycine 0 C--N 1.342 0.866 0 O-C-N 123.601 0.563 . . . . 72.41 113.601 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.41 -53.95 1.47 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.324 0.65 . . . . 62.25 111.967 -169.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -67.79 -37.46 82.08 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.333 0.653 . . . . 72.32 112.197 -174.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.561 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 79.9 m -71.14 -43.56 13.13 Favored Pre-proline 0 CA--C 1.563 1.456 0 CA-C-O 118.383 -0.818 . . . . 64.1 112.367 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -50.89 -36.88 54.38 Favored 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 122.366 2.044 . . . . 74.21 113.402 166.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -67.42 -29.75 69.32 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.2 0.6 . . . . 74.23 111.865 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.407 HG22 ' NH2' ' D' ' 111' ' ' ARG . 74.9 mt -69.49 -41.57 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.314 0.646 . . . . 74.14 109.691 171.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.6 mt -76.85 -21.57 54.82 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.962 -1.017 . . . . 71.31 112.028 -174.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.401 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 69.1 t80 -59.15 -49.76 91.3 Favored Pre-proline 0 N--CA 1.485 1.314 0 CA-C-O 118.165 -0.921 . . . . 72.22 113.021 -176.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' B' ' 105' ' ' ILE . 86.9 Cg_exo -53.17 -43.04 60.48 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 122.715 2.277 . . . . 75.15 114.224 175.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -67.29 -41.27 85.7 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.396 0.678 . . . . 72.33 110.565 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.407 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -64.32 -38.45 91.1 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.601 -0.727 . . . . 75.25 110.689 175.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.0 ttt-85 -64.93 -47.12 78.84 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.529 1.532 . . . . 74.23 110.831 -176.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -70.87 -34.0 71.17 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.988 0.515 . . . . 72.33 109.855 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.52 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.9 t -66.23 -34.66 78.52 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 123.352 0.408 . . . . 75.22 110.741 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.485 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 51.8 mt -65.46 -55.71 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.924 0.889 . . . . 75.12 109.858 173.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 10.2 m -63.35 -24.83 68.02 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.479 0.712 . . . . 74.34 111.496 -175.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.442 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 36.4 t -64.24 -50.15 69.11 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 123.385 0.674 . . . . 72.35 109.251 173.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.52 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.2 mmt -69.5 -34.35 74.18 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.305 0.642 . . . . 74.35 110.826 -176.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 85.5 t -62.26 -43.73 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.88 0.872 . . . . 74.21 110.082 173.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 48.3 t -66.25 -31.89 72.98 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.027 -0.988 . . . . 71.23 111.041 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' B' ' 116' ' ' SER . 86.4 mtt-85 -68.95 -39.77 79.33 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.488 -0.778 . . . . 73.44 110.5 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.08 -14.26 81.98 Favored Glycine 0 C--N 1.354 1.531 0 O-C-N 123.698 0.624 . . . . 62.24 112.222 172.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 7.5 m 65.58 37.15 6.11 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.595 1.558 . . . . 75.14 110.058 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.429 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 57.5 m-85 -85.22 159.54 56.37 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 114.576 -1.193 . . . . 74.53 110.051 173.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.454 ' HG3' ' HB2' ' F' ' 131' ' ' TRP . 86.6 Cg_exo -47.89 159.79 0.56 Allowed 'Trans proline' 0 C--N 1.385 2.458 0 C-N-CA 123.851 3.034 . . . . 74.34 115.249 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.456 HE21 ' ND2' ' B' ' 127' ' ' ASN . 60.0 tp60 -61.3 118.19 6.58 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 115.112 -0.949 . . . . 73.42 111.762 -173.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 32.8 tp -110.85 103.33 11.83 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.556 -0.747 . . . . 71.43 110.052 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . 0.456 ' ND2' HE21 ' B' ' 125' ' ' GLN . 34.4 m-80 -108.1 114.9 29.15 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 107.908 -1.145 . . . . 73.23 107.908 169.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.536 HD21 HG21 ' B' ' 64' ' ' VAL . 41.9 mt -70.42 140.94 52.15 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.272 0.358 . . . . 75.23 110.352 176.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.47 145.79 98.99 Favored Pre-proline 0 CA--C 1.551 1.01 0 O-C-N 123.7 0.625 . . . . 73.5 110.529 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' F' ' 125' ' ' ALA . 39.3 Cg_exo -60.88 92.05 0.1 OUTLIER 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.827 2.352 . . . . 75.43 111.74 174.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 94.7 t -99.23 112.51 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 123.24 0.616 . . . . 73.51 109.778 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -79.2 113.74 17.58 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.943 0.897 . . . . 71.45 109.141 173.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -62.56 -36.01 81.3 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.134 0.974 . . . . 75.45 110.76 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -55.31 -45.6 76.29 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.37 1.044 . . . . 73.33 110.912 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -50.74 -39.74 52.83 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.347 1.03 . . . . 74.3 113.594 -170.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 5.5 mp -72.0 -42.08 66.86 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.617 0.367 . . . . 73.44 111.053 -176.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -74.91 -25.88 59.24 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 116.381 -0.372 . . . . 73.42 111.666 175.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -73.21 -37.92 66.27 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.433 0.693 . . . . 74.03 109.81 -177.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -75.23 -22.83 57.62 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 116.253 -0.43 . . . . 53.02 110.491 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -82.76 -23.54 33.9 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.256 0.622 . . . . 75.11 111.037 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 24.4 tp -117.31 25.08 10.71 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.648 0.779 . . . . 72.12 109.398 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -71.65 -47.07 56.83 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.586 0.754 . . . . 73.13 110.093 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -70.97 90.77 0.84 Allowed 'General case' 0 C--N 1.354 0.769 0 N-CA-C 107.649 -1.241 . . . . 74.51 107.649 177.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -167.7 -51.57 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.243 -0.89 . . . . 74.14 109.375 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . 68.88 168.44 0.28 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.918 1.287 . . . . 72.32 111.551 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 162.31 68.27 0.02 OUTLIER Glycine 0 C--N 1.343 0.949 0 N-CA-C 111.961 -0.456 . . . . 64.45 111.961 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -83.18 97.32 8.77 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.187 -0.671 . . . . 70.24 109.187 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.76 179.05 38.55 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 115.895 -0.593 . . . . 40.11 113.559 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 27.7 m -98.2 144.5 27.59 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 109.078 -0.712 . . . . 71.52 109.078 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -66.35 92.38 0.19 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.709 0.804 . . . . 73.32 110.417 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -158.27 114.71 2.79 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.958 1.303 . . . . 75.14 107.52 176.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -84.75 140.98 30.86 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 122.292 0.237 . . . . 72.02 110.489 -175.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -85.55 -163.84 0.92 Allowed 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 109.296 -0.631 . . . . 75.44 109.296 171.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . 0.583 ' HB2' ' HB3' ' B' ' 6' ' ' ASN . 18.3 p-10 -135.99 179.05 6.58 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.067 0.547 . . . . 74.43 110.712 177.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-N 114.959 -1.019 . . . . 73.41 110.171 -179.95 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.473 0.707 0 CA-C-O 119.538 -0.267 . . . . 70.14 111.434 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 31.9 t -171.53 30.9 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.622 0.369 . . . . 73.1 111.617 -172.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -80.73 80.91 7.11 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.379 0.609 . . . . 73.22 110.066 -177.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -113.67 16.36 18.63 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.803 0.841 . . . . 71.32 110.637 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -81.9 102.44 10.89 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.94 0.896 . . . . 73.11 109.45 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -113.27 99.43 7.8 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.631 0.773 . . . . 74.13 110.062 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 31.4 p -127.65 -175.52 3.49 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.242 1.017 . . . . 74.35 109.854 174.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -69.35 137.26 52.75 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.86 -1.163 . . . . 71.41 107.86 165.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.516 ' HE1' HD12 ' C' ' 89' ' ' ILE . 55.6 ttm 61.5 111.58 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.046 1.338 . . . . 75.2 111.284 -172.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' C' ' 87' ' ' ALA . 58.0 m -103.15 80.37 1.84 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 106.942 -1.503 . . . . 73.01 106.942 172.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -92.26 126.86 37.52 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 114.96 -1.018 . . . . 73.25 109.118 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -141.33 118.09 11.05 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.206 0.603 . . . . 74.51 109.698 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 60.4 mt -73.52 134.13 30.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 109.018 -0.734 . . . . 72.42 109.018 173.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.436 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.3 mm-40 -96.79 -49.97 4.86 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 108.998 -0.742 . . . . 71.31 108.998 171.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.593 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -178.2 146.0 0.38 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.32 1.048 . . . . 74.03 110.477 179.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 4.9 mp -109.7 124.84 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 107.549 -1.278 . . . . 72.42 107.549 172.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.47 ' HB3' HG22 ' D' ' 122' ' ' THR . 44.1 p90 -147.74 170.52 17.39 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.584 0.707 . . . . 74.25 111.712 -171.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' THR . . . . . 0.489 HG21 ' HG ' ' C' ' 113' ' ' CYS . 75.5 p -102.7 108.17 19.32 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.493 -0.776 . . . . 74.12 109.936 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.47 ' HE3' ' HB2' ' D' ' 28' ' ' ALA . 26.7 mtpt -78.66 -23.15 45.89 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 109.468 -0.567 . . . . 74.42 109.468 174.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.493 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 10.5 t70 -148.51 138.88 22.59 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.699 0.8 . . . . 55.21 109.774 176.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.474 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 82.7 mt -136.89 140.17 43.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 106.314 -1.736 . . . . 73.23 106.314 169.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.9 t -153.18 143.92 22.75 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.457 0.703 . . . . 75.25 109.949 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -156.22 109.25 2.65 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 107.657 -1.238 . . . . 74.12 107.657 172.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -116.34 111.49 20.17 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.477 -0.564 . . . . 75.21 109.477 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.79 79.64 31.95 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 108.006 -1.109 . . . . 72.21 108.006 170.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.05 -17.04 25.26 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.614 2.209 . . . . 74.12 111.399 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -105.01 11.99 32.78 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.762 1.225 . . . . 74.33 110.274 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.492 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -50.96 -54.05 41.44 Favored Pre-proline 0 C--N 1.371 1.501 0 C-N-CA 124.351 1.06 . . . . 64.02 113.742 -169.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.574 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 12.4 Cg_endo -56.92 -52.7 6.22 Favored 'Trans proline' 0 C--N 1.391 2.789 0 C-N-CA 121.658 1.572 . . . . 74.14 111.67 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.432 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 85.4 t60 -67.77 -28.64 67.78 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.659 0.784 . . . . 65.33 112.654 -172.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.69 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.6 p -77.43 -19.68 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 N-CA-C 112.43 0.53 . . . . 73.52 112.43 -174.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -71.66 -13.52 61.77 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.856 0.687 . . . . 72.03 112.856 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 28.1 pt20 -99.18 6.34 46.43 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.188 0.595 . . . . 61.34 111.68 175.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.798 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -94.48 150.91 19.79 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.778 0.831 . . . . 72.35 110.442 -178.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.16 119.78 11.49 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.343 0.657 . . . . 72.34 109.277 169.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -82.89 92.37 7.28 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.557 0.743 . . . . 73.43 112.053 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -142.9 79.99 14.2 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 124.606 1.162 . . . . 74.3 107.895 169.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -87.29 163.06 8.41 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.732 2.288 . . . . 73.15 111.235 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -85.57 76.06 10.06 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.306 -1.368 . . . . 62.44 107.306 173.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.416 HG23 HD23 ' C' ' 126' ' ' LEU . 2.0 p -62.75 97.34 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 114.603 -1.18 . . . . 62.05 108.735 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -107.56 102.96 12.18 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 113.627 -1.624 . . . . 73.44 107.442 -171.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -88.3 129.36 35.4 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.017 -1.105 . . . . 70.52 108.017 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.435 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 15.4 t70 -124.62 139.04 54.24 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.95 -0.759 . . . . 75.21 108.95 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.48 HD23 HD23 ' C' ' 60' ' ' LEU . 79.0 mt -130.43 110.65 11.63 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.083 0.953 . . . . 75.54 108.568 175.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -124.22 119.77 30.31 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.175 -1.417 . . . . 75.13 107.175 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.1 t -119.91 145.32 46.82 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 109.621 -0.511 . . . . 73.53 109.621 -176.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.54 162.13 36.65 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.912 0.885 . . . . 54.42 108.931 176.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.474 ' HG ' ' HB3' ' C' ' 98' ' ' LEU . 5.4 m -129.12 164.08 24.11 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 109.468 -0.568 . . . . 62.31 109.468 174.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -148.65 125.61 11.3 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.675 -1.231 . . . . 72.31 107.675 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -84.21 114.83 22.09 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.897 -1.149 . . . . 74.33 107.897 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.64 HD12 ' HB2' ' C' ' 57' ' ' GLU . 50.1 mt -88.71 -42.67 11.82 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.4 0.68 . . . . 73.41 109.782 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.04 -171.22 3.85 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 115.081 -0.963 . . . . 63.52 109.967 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.37 113.32 2.85 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 114.92 -1.036 . . . . 74.31 109.307 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 63.86 15.29 8.99 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.037 0.935 . . . . 75.51 112.387 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 85.1 t -111.71 115.88 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.136 -1.061 . . . . 70.23 108.136 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -125.14 124.73 42.44 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.804 0.841 . . . . 74.4 109.185 -177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.64 ' HB2' HD12 ' C' ' 51' ' ' LEU . 38.7 tt0 -83.74 133.63 34.78 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.238 -1.023 . . . . 74.21 108.238 164.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -118.94 135.61 58.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 108.247 -1.02 . . . . 74.43 108.247 168.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 57.3 t -119.75 141.93 37.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 123.644 0.778 . . . . 72.12 109.128 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.48 HD23 HD23 ' C' ' 44' ' ' LEU . 0.0 OUTLIER -123.11 102.01 7.73 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.713 -1.217 . . . . 75.44 107.713 177.586 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -81.87 106.97 14.21 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.687 -0.857 . . . . 73.51 108.687 172.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 11.0 t -109.86 113.91 45.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.24 -1.022 . . . . 74.32 108.24 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 26.8 m -111.98 132.13 54.97 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.197 -0.668 . . . . 73.42 109.197 -177.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.519 HG23 HG21 ' C' ' 114' ' ' ILE . 50.6 t -118.32 114.71 45.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.774 -0.824 . . . . 73.14 108.774 171.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.4 m -99.19 139.17 35.25 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.285 -1.006 . . . . 73.41 108.285 172.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.6 109.82 8.35 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.638 -0.875 . . . . 64.34 108.638 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 36.5 m -136.94 131.75 33.45 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.874 0.47 . . . . 74.0 110.293 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.798 HD11 ' HG2' ' C' ' 34' ' ' LYS . 1.6 mt -93.16 50.34 1.51 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.214 1.006 . . . . 73.2 108.572 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.32 -119.95 6.46 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 110.3 -1.12 . . . . 75.45 110.3 -171.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -90.48 -11.94 38.77 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.239 0.616 . . . . 75.54 109.836 172.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -71.58 119.53 15.87 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.753 0.821 . . . . 75.21 109.239 172.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 30.9 m -79.27 125.1 29.05 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.071 -0.714 . . . . 71.34 109.071 170.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.69 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -82.43 -53.92 5.61 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.39 -1.337 . . . . 75.33 107.39 168.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . 0.428 ' HZ ' HD13 ' C' ' 126' ' ' LEU . 32.7 p90 -169.77 168.56 8.88 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 114.73 -1.123 . . . . 74.23 110.41 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.409 HD12 ' N ' ' C' ' 76' ' ' CYS . 3.1 tm? -130.44 144.93 51.71 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 106.14 -1.8 . . . . 75.54 106.14 169.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.409 ' N ' HD12 ' C' ' 75' ' ' LEU . 49.2 t -150.17 146.21 26.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.739 0.416 . . . . 74.53 109.991 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -157.68 137.47 12.26 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.701 0.8 . . . . 75.21 109.673 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.451 HG21 HG12 ' C' ' 21' ' ' ILE . 24.2 t -134.34 113.51 17.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 124.562 1.145 . . . . 72.21 107.923 174.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.493 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 69.3 mt-30 -91.55 88.42 6.76 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.966 -1.124 . . . . 65.12 107.966 174.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -79.27 96.86 6.06 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.821 -1.081 . . . . 75.2 109.195 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.56 145.79 17.82 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 111.27 -0.732 . . . . 61.43 111.27 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.85 132.75 4.01 Favored Glycine 0 CA--C 1.501 -0.787 0 N-CA-C 110.898 -0.881 . . . . 74.21 110.898 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.462 HD11 ' HB3' ' D' ' 29' ' ' PRO . 26.5 mm -89.48 132.0 35.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 N-CA-C 109.174 -0.676 . . . . 73.14 109.174 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -134.51 119.27 18.27 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.727 0.811 . . . . 74.0 109.376 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 27.8 m -81.8 102.07 10.57 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.202 -1.036 . . . . 73.14 108.202 171.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.518 HG21 ' HE2' ' C' ' 94' ' ' MET . 27.5 mt -116.22 131.6 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.732 0.813 . . . . 65.11 109.481 -176.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.456 ' HB2' ' HB ' ' C' ' 10' ' ' THR . . . -142.03 169.45 17.57 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.756 0.423 . . . . 74.31 110.956 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.21 -29.48 5.59 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 115.817 -0.629 . . . . 61.43 113.971 171.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.516 HD12 ' HE1' ' C' ' 9' ' ' MET . 39.5 pt -96.95 171.79 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.338 0.655 . . . . 73.23 110.933 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -166.23 -179.15 4.91 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.198 0.999 . . . . 75.12 109.256 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.29 -119.9 13.71 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 123.925 0.766 . . . . 64.54 114.116 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 92' ' ' THR . . . . . 0.681 ' HB ' HD12 ' C' ' 141' ' ' LEU . 26.1 p -73.93 -30.83 62.77 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.696 0.798 . . . . 74.25 112.105 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -63.47 -48.24 78.48 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.944 0.498 . . . . 75.1 109.709 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.518 ' HE2' HG21 ' C' ' 86' ' ' ILE . 5.4 tpt -63.99 -48.08 77.83 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-N 115.547 -0.751 . . . . 75.44 110.501 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.4 -35.23 73.58 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.287 0.635 . . . . 54.13 111.486 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -83.74 -28.84 27.94 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.956 0.502 . . . . 70.24 110.954 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.509 ' SG ' HD13 ' C' ' 86' ' ' ILE . 18.8 t -68.34 -38.58 81.61 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.688 -0.856 . . . . 75.13 108.688 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.474 ' HB3' ' HG ' ' C' ' 48' ' ' SER . 53.9 mt -83.63 -33.34 25.31 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.523 -1.217 . . . . 71.42 110.857 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.27 -24.38 63.67 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.297 -0.865 . . . . 73.44 114.28 -169.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.36 -52.54 0.11 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.802 0.667 . . . . 72.42 112.802 -164.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -57.02 -57.54 12.11 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 123.999 0.812 . . . . 71.23 111.177 -176.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 95.3 m -64.28 -49.11 74.38 Favored Pre-proline 0 CA--C 1.564 1.486 0 C-N-CA 124.151 0.981 . . . . 71.22 112.422 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.43 -32.89 64.6 Favored 'Trans proline' 0 C--N 1.402 3.359 0 C-N-CA 122.701 2.267 . . . . 74.41 113.889 173.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -67.97 -31.47 71.21 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.608 0.763 . . . . 70.43 110.694 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.517 HD13 ' NH1' ' A' ' 111' ' ' ARG . 25.7 mm -74.74 -35.62 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 122.899 0.48 . . . . 71.22 109.85 175.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.95 -27.74 57.66 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.781 0.832 . . . . 75.45 111.443 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -58.77 -50.93 85.37 Favored Pre-proline 0 N--CA 1.483 1.18 0 N-CA-C 114.552 1.316 . . . . 74.34 114.552 -171.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -58.69 -38.05 91.11 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 121.967 1.778 . . . . 72.33 112.873 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -67.25 -45.22 77.34 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.844 0.858 . . . . 74.13 110.3 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.08 86.3 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.162 -0.927 . . . . 72.32 110.907 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 41.8 ttt-85 -67.84 -43.87 78.52 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.883 1.273 . . . . 74.03 110.259 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . 0.404 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.1 tm-20 -66.29 -39.95 89.7 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.293 0.637 . . . . 64.24 109.591 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . 0.489 ' HG ' HG21 ' C' ' 18' ' ' THR . 28.6 m -59.91 -48.93 79.67 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.584 0.753 . . . . 73.3 111.996 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.519 HG21 HG23 ' C' ' 64' ' ' VAL . 71.0 mt -64.09 -52.32 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 123.439 0.462 . . . . 71.51 110.85 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 14.2 m -66.7 -29.07 68.97 Favored 'General case' 0 CA--C 1.556 1.181 0 O-C-N 123.462 0.476 . . . . 73.13 110.746 -175.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 39.2 t -63.91 -46.38 85.07 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.3 -0.63 . . . . 72.22 109.3 170.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.586 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.17 -41.01 96.03 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.469 1.107 . . . . 73.1 112.215 179.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 92.6 t -64.81 -41.23 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.938 0.895 . . . . 71.4 109.572 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 11.6 t -67.12 -29.95 69.83 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.813 1.245 . . . . 75.23 112.129 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.451 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 75.3 mtt-85 -74.16 -41.3 61.71 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.575 0.75 . . . . 72.3 109.668 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.06 -0.42 60.67 Favored Glycine 0 C--N 1.354 1.572 0 O-C-N 123.719 0.637 . . . . 62.22 112.608 169.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.402 ' O ' HG22 ' F' ' 129' ' ' THR . 31.0 p 63.84 30.67 14.4 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.989 2.115 . . . . 72.25 113.025 169.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -82.33 156.44 68.82 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 107.916 -1.142 . . . . 64.53 107.916 167.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -57.19 157.05 22.51 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.479 2.119 . . . . 73.43 112.845 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.429 ' HG3' ' O ' ' B' ' 123' ' ' PHE . 53.8 mm-40 -56.02 112.78 1.29 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.21 0.944 . . . . 73.22 111.601 -176.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.466 ' HA ' HG22 ' F' ' 133' ' ' THR . 5.2 tt -116.75 85.15 2.26 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.476 -1.305 . . . . 73.44 107.476 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -95.28 122.17 37.7 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.691 -0.855 . . . . 74.13 108.691 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.79 144.38 37.18 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.589 0.556 . . . . 75.43 109.872 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.89 148.42 98.84 Favored Pre-proline 0 CA--C 1.55 0.958 0 O-C-N 124.076 0.86 . . . . 74.13 111.125 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.458 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 17.7 Cg_endo -57.84 108.53 0.39 Allowed 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.798 2.332 . . . . 74.1 112.22 173.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 43.3 t -99.6 112.68 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.46 -0.941 . . . . 73.02 108.46 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -77.74 104.95 8.59 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.141 -0.689 . . . . 70.2 109.141 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -63.39 -35.52 80.68 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.664 0.785 . . . . 74.21 111.575 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.08 -21.51 65.88 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.931 0.892 . . . . 74.35 111.839 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.52 -47.31 33.75 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.96 0.904 . . . . 75.11 109.296 172.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 35.0 mt -65.79 -43.52 88.48 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.824 -0.625 . . . . 72.31 111.087 -176.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -77.67 -16.33 58.58 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.039 -0.982 . . . . 74.21 110.495 -177.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 50.4 ttm -59.75 -30.62 68.98 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.731 0.813 . . . . 73.13 110.967 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -68.65 -42.83 77.43 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.8 -1.091 . . . . 73.01 110.353 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -72.71 -87.03 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 123.856 0.862 . . . . 73.24 111.805 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.681 HD12 ' HB ' ' C' ' 92' ' ' THR . 4.2 mm? 52.15 -99.79 0.09 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.443 1.097 . . . . 75.22 111.174 -168.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 176.9 -67.06 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.72 1.208 . . . . 74.42 108.233 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -91.28 131.57 36.71 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.135 -0.691 . . . . 72.34 109.135 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -88.27 85.9 6.98 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 107.383 -1.34 . . . . 74.3 107.383 174.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -171.68 114.46 0.36 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.284 1.034 . . . . 54.2 108.834 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -165.96 13.98 0.08 OUTLIER Glycine 0 C--N 1.344 1.007 0 O-C-N 123.316 0.385 . . . . 72.44 113.197 -176.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . 0.421 ' O ' HG23 ' A' ' 149' ' ' THR . 1.0 OUTLIER -73.58 161.06 30.75 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.713 0.805 . . . . 75.14 110.667 176.109 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' A' ' 147' ' ' GLU . . . -160.4 -108.04 0.23 Allowed Glycine 0 C--N 1.339 0.7 0 N-CA-C 110.945 -0.862 . . . . 61.34 110.945 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 56.3 p 48.89 80.78 0.06 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.621 1.168 . . . . 73.13 112.192 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -146.31 141.66 27.51 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.303 -1.369 . . . . 73.34 107.303 177.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.05 120.26 9.35 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.989 -0.745 . . . . 74.41 108.989 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -153.41 119.68 5.49 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.317 -0.623 . . . . 75.24 109.317 -172.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.19 73.89 5.77 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 109.183 -0.673 . . . . 63.01 109.183 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -176.22 169.16 2.8 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.688 1.195 . . . . 71.01 109.293 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.366 0 N-CA-C 107.997 -1.112 . . . . 73.32 107.997 176.613 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 56.0 ttm . . . . . 0 N--CA 1.484 1.263 0 N-CA-C 109.437 -0.579 . . . . 74.21 109.437 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 16.1 m 64.03 20.67 12.3 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.868 1.267 . . . . 63.14 110.722 -171.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -177.07 165.98 2.38 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 125.47 1.508 . . . . 75.14 108.545 -173.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -81.19 -13.33 58.71 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.74 0.416 . . . . 73.51 111.155 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -68.77 103.12 1.68 Allowed 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.999 -0.741 . . . . 72.25 108.999 175.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . 0.485 ' HB3' ' HB2' ' D' ' 9' ' ' MET . 57.7 m-20 -67.29 -46.93 72.13 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.962 0.905 . . . . 74.1 110.033 -176.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 21.3 m 64.89 -73.61 0.06 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.612 1.565 . . . . 61.25 113.207 169.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -93.57 0.69 56.71 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.64 0.776 . . . . 65.23 112.308 -174.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.495 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 0.0 OUTLIER -32.14 126.51 0.26 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 125.193 1.397 . . . . 73.05 113.253 174.565 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 59.2 m -127.68 132.84 49.62 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.308 0.643 . . . . 74.41 109.939 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.523 ' HA ' ' O ' ' D' ' 85' ' ' SER . 47.3 t80 -142.94 91.65 2.32 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.023 -1.102 . . . . 75.33 108.023 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -113.24 123.74 50.87 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.517 -0.92 . . . . 72.54 108.517 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 12.4 mt -79.28 128.34 38.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.347 -0.982 . . . . 72.44 108.347 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -85.57 -43.19 13.72 Favored 'General case' 0 C--O 1.239 0.538 0 O-C-N 123.638 0.587 . . . . 75.22 109.817 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -171.09 131.62 0.8 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.799 -0.637 . . . . 74.44 110.575 -171.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 4.0 mp -106.46 141.48 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 107.348 -1.353 . . . . 74.11 107.348 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -167.01 145.51 5.06 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.648 0.592 . . . . 71.31 111.819 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -76.86 116.34 17.44 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.492 -0.776 . . . . 74.55 109.573 175.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.574 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 43.0 mtpt -88.92 -13.02 40.04 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.45 0.7 . . . . 70.22 110.439 178.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.645 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 25.3 t70 -162.55 141.63 9.07 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.099 0.96 . . . . 73.45 109.699 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.586 HG23 ' HE1' ' C' ' 117' ' ' MET . 98.4 mt -141.28 141.35 30.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 125.278 1.431 . . . . 72.35 107.884 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 41.1 t -149.3 141.38 23.91 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.667 1.187 . . . . 62.24 108.109 173.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.474 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 81.2 t80 -152.54 125.72 8.62 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 106.562 -1.644 . . . . 75.3 106.562 171.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -129.42 145.64 51.39 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.286 -0.635 . . . . 74.12 109.286 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.76 80.46 65.85 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 107.263 -1.384 . . . . 71.04 107.263 174.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.61 -38.54 31.64 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 123.513 2.809 . . . . 71.14 113.419 -169.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 42.2 m-20 -106.94 12.38 28.83 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 118.762 -0.637 . . . . 75.41 110.959 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.47 ' HB2' ' HE3' ' C' ' 19' ' ' LYS . . . -27.63 -69.42 0.08 OUTLIER Pre-proline 0 CA--C 1.571 1.772 0 N-CA-C 116.742 2.127 . . . . 73.13 116.742 -164.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.462 ' HB3' HD11 ' C' ' 83' ' ' ILE . 86.9 Cg_endo -77.45 -18.69 13.69 Favored 'Trans proline' 0 C--N 1.385 2.483 0 CA-C-N 123.661 2.343 . . . . 74.44 114.212 -174.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.416 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 6.1 t-160 -74.49 -38.66 62.82 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.295 1.038 . . . . 72.01 109.103 174.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' D' ' 73' ' ' ALA . 4.3 p -84.76 -20.66 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 CA-C-N 115.328 -0.851 . . . . 73.51 111.676 -174.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.51 ' HD2' HH21 ' C' ' 15' ' ' ARG . 20.6 m-85 -67.6 -18.54 65.02 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 122.586 0.354 . . . . 75.34 111.945 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . 0.416 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 60.7 mt-30 -65.29 -16.84 63.99 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.203 1.001 . . . . 64.54 111.06 175.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.76 ' HZ1' ' HG2' ' D' ' 71' ' ' GLU . 96.4 mttt -97.42 90.26 5.0 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 125.086 1.354 . . . . 74.54 110.463 -178.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -90.67 93.22 9.16 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.954 0.502 . . . . 70.44 109.772 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 20.5 p90 -162.47 -170.39 2.42 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.874 0.87 . . . . 70.14 109.466 168.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -67.98 109.78 4.47 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.707 1.203 . . . . 71.54 110.898 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -58.54 122.27 11.38 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.27 1.98 . . . . 74.14 110.565 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 0.2 OUTLIER -66.68 107.21 2.06 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 106.983 -1.488 . . . . 75.31 106.983 175.289 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.534 HG11 HG13 ' D' ' 64' ' ' VAL . 93.8 t -111.67 142.93 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.876 -0.787 . . . . 73.11 108.876 -174.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -129.76 123.87 32.07 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.369 -0.974 . . . . 70.53 108.369 168.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.536 HD12 HG13 ' D' ' 62' ' ' VAL . 51.5 tp -95.73 125.98 40.68 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.001 -0.74 . . . . 75.24 109.001 174.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -124.9 111.11 15.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.787 -1.56 . . . . 72.23 106.787 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.494 HD21 HG21 ' D' ' 62' ' ' VAL . 62.0 mt -97.58 164.53 12.39 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.932 -1.031 . . . . 72.43 108.958 177.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -164.4 144.93 7.98 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.979 -1.119 . . . . 72.51 107.979 167.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' THR . . . . . 0.431 ' OG1' HG21 ' E' ' 107' ' ' THR . 70.4 p -102.62 151.14 22.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.735 0.779 . . . . 74.13 109.769 -176.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.54 161.72 41.1 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 106.686 -1.598 . . . . 44.31 106.686 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 12.8 p -175.32 -176.95 0.97 Allowed 'General case' 0 C--O 1.238 0.464 0 C-N-CA 122.786 0.434 . . . . 53.41 110.255 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 57.9 p -148.47 119.01 7.41 Favored 'General case' 0 C--O 1.247 0.95 0 N-CA-C 107.667 -1.234 . . . . 74.22 107.667 174.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . 0.531 ' HB2' HD13 ' E' ' 102' ' ' LEU . 51.2 tt0 -72.11 86.02 1.04 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.323 -1.308 . . . . 73.0 108.896 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -80.85 -37.13 30.46 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.762 -1.199 . . . . 75.33 107.762 177.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . 68.38 -175.48 0.2 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.949 1.3 . . . . 62.14 112.175 175.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 25.0 t70 52.21 55.1 9.68 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.36 1.064 . . . . 71.42 109.677 -168.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.572 ' HB2' ' HB3' ' E' ' 93' ' ' PHE . 6.5 m-20 67.03 3.98 3.38 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 114.007 -1.451 . . . . 71.12 112.836 175.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.87 117.81 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 108.239 -1.023 . . . . 74.22 108.239 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.414 ' HH ' HG13 ' E' ' 97' ' ' ILE . 89.4 m-85 -135.13 125.55 26.59 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.626 -0.879 . . . . 72.14 108.626 172.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -90.0 129.97 36.26 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 106.857 -1.534 . . . . 73.34 106.857 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 83.3 t -132.96 131.26 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 124.097 0.959 . . . . 72.03 108.631 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.491 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 32.3 t -119.94 144.51 28.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 C-N-CA 124.642 1.177 . . . . 74.43 108.853 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.6 108.94 12.06 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.389 -1.337 . . . . 74.4 107.389 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 ttt85 -85.41 106.01 16.47 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.144 -0.687 . . . . 72.03 109.144 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.562 HG22 ' HB1' ' D' ' 110' ' ' ALA . 59.7 t -108.1 118.29 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 123.95 0.9 . . . . 71.43 109.07 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 17.0 m -128.71 131.14 47.91 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.613 0.57 . . . . 54.24 109.948 -171.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.534 HG13 HG11 ' D' ' 40' ' ' VAL . 90.9 t -113.78 135.3 53.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 124.536 1.134 . . . . 72.54 109.545 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 7.1 m -121.01 94.72 4.43 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.921 -1.14 . . . . 72.2 107.921 171.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.502 ' HB3' HG22 ' D' ' 40' ' ' VAL . . . -109.42 142.08 40.91 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.614 0.366 . . . . 74.33 110.711 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.47 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 49.6 m -148.61 132.72 17.29 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.069 0.947 . . . . 75.12 110.561 -171.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.2 mt -98.34 105.71 17.9 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.967 -1.123 . . . . 75.3 107.967 173.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.07 -120.39 5.19 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 115.506 -0.77 . . . . 54.4 112.391 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.12 6.7 27.12 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.592 0.757 . . . . 74.15 111.383 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.76 ' HG2' ' HZ1' ' D' ' 34' ' ' LYS . 10.9 pt-20 -127.6 159.59 34.19 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.258 0.623 . . . . 72.43 109.321 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 93.9 m -70.34 136.92 50.16 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.335 0.654 . . . . 65.44 111.961 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.528 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -91.75 -70.52 0.68 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.19 -1.411 . . . . 53.2 107.19 174.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -146.35 148.09 32.0 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.092 -0.958 . . . . 74.13 110.414 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 73.6 mt -116.17 153.52 31.68 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.757 1.223 . . . . 75.52 107.741 171.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.605 ' SG ' HG12 ' D' ' 114' ' ' ILE . 34.6 t -154.35 146.66 23.87 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.584 -0.524 . . . . 75.02 109.584 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -157.4 122.21 4.43 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.728 0.411 . . . . 74.12 110.625 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 94.8 t -132.79 115.46 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.106 0.962 . . . . 75.51 109.277 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.645 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.0 mt-30 -89.3 88.51 7.53 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.693 -0.854 . . . . 74.44 108.693 172.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -83.01 103.59 12.57 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.338 -1.301 . . . . 71.34 109.528 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -102.83 167.84 17.69 Favored Glycine 0 N--CA 1.468 0.825 0 O-C-N 123.219 0.324 . . . . 64.41 113.055 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.16 143.07 6.07 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 112.447 -0.261 . . . . 63.15 112.447 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 2.5 mp -91.29 127.34 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.218 -1.03 . . . . 74.43 108.218 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -122.41 134.86 54.6 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.538 1.135 . . . . 75.42 109.532 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 34.1 t -84.96 103.53 14.09 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 108.287 -1.005 . . . . 74.14 108.287 171.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.547 HG22 HD13 ' D' ' 89' ' ' ILE . 15.1 mt -109.54 131.9 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.569 -0.9 . . . . 75.51 108.569 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.65 164.02 14.49 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.706 0.629 . . . . 75.32 111.281 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 76.71 21.59 74.27 Favored Glycine 0 C--N 1.353 1.473 0 O-C-N 123.918 0.761 . . . . 73.34 114.619 170.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.547 HD13 HG22 ' D' ' 86' ' ' ILE . 1.0 OUTLIER -133.27 140.91 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.306 1.042 . . . . 63.22 109.457 177.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 32.0 mp0 -129.56 175.79 8.5 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 123.962 0.905 . . . . 75.03 109.601 -175.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.64 -137.8 23.04 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.219 -0.901 . . . . 64.54 112.458 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 45.5 p -66.46 -45.6 79.22 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.692 0.797 . . . . 71.21 111.035 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -58.84 -28.5 66.11 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.009 1.324 . . . . 75.23 112.331 -175.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.465 ' HA ' HD11 ' D' ' 89' ' ' ILE . 26.4 ttt -49.17 -63.54 1.07 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.98 1.312 . . . . 73.43 112.508 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.91 -16.43 35.97 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.333 0.653 . . . . 65.12 111.81 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -72.78 -21.8 60.94 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.715 0.406 . . . . 75.12 111.625 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 75.3 m -56.99 -50.98 71.06 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 123.467 0.479 . . . . 72.21 111.654 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 pp -68.42 -18.23 64.39 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.266 0.627 . . . . 74.54 112.586 -176.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . 0.461 ' HA3' HG23 ' E' ' 103' ' ' THR . . . -104.83 -2.22 42.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 114.775 0.67 . . . . 71.33 114.775 -174.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.42 -54.29 0.29 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 118.011 0.905 . . . . 71.2 111.459 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -73.49 -51.1 18.28 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.039 0.535 . . . . 75.21 111.287 -172.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.421 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 35.1 m -61.18 -44.83 95.0 Favored Pre-proline 0 CA--C 1.566 1.573 0 C-N-CA 123.914 0.886 . . . . 61.25 112.44 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 50.0 Cg_exo -58.35 -36.45 97.6 Favored 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 122.331 2.021 . . . . 75.14 113.468 169.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -64.19 -31.11 72.19 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.279 0.632 . . . . 73.23 110.997 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 33.1 mm -67.54 -38.55 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.046 0.938 . . . . 70.42 110.623 174.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 60.5 mt -73.31 -20.47 60.79 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.261 -0.881 . . . . 75.34 111.895 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -67.44 -41.74 33.74 Favored Pre-proline 0 CA--C 1.556 1.195 0 N-CA-C 114.274 1.212 . . . . 72.32 114.274 -172.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -45.42 -44.97 16.18 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.508 2.139 . . . . 74.3 113.584 169.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -78.18 -35.03 49.24 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.829 0.852 . . . . 73.14 111.496 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . 0.562 ' HB1' HG22 ' D' ' 62' ' ' VAL . . . -62.25 -56.15 21.42 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.652 0.781 . . . . 74.12 110.339 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.421 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 40.3 ttp180 -58.19 -42.88 87.06 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 114.038 -1.437 . . . . 75.43 110.574 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -55.29 -52.64 62.77 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.084 0.865 . . . . 74.52 110.481 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.4 t -56.27 -45.63 80.03 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.306 1.004 . . . . 73.14 111.13 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.605 HG12 ' SG ' ' D' ' 76' ' ' CYS . 42.3 mt -62.02 -57.36 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.379 -0.828 . . . . 75.31 111.1 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 30.2 m -55.35 -38.58 68.97 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.537 1.135 . . . . 72.53 111.124 -174.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 22.6 t -60.4 -50.96 71.52 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.62 -1.173 . . . . 63.24 109.662 176.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.444 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 75.7 mtm -68.72 -32.4 72.15 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.628 0.771 . . . . 63.42 112.178 -176.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 84.0 t -60.44 -46.41 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.746 0.819 . . . . 73.11 109.519 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 32.4 t -72.49 -29.16 63.39 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 115.004 -0.998 . . . . 72.44 110.881 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.459 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 74.9 mtt-85 -71.49 -24.42 61.98 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.441 0.696 . . . . 74.41 110.674 176.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.21 11.71 71.33 Favored Glycine 0 C--N 1.353 1.476 0 CA-C-O 119.448 -0.64 . . . . 75.55 112.791 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.47 HG22 ' HB3' ' C' ' 17' ' ' TYR . 72.2 p 56.71 25.67 10.41 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 125.988 1.715 . . . . 64.34 113.242 -177.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -92.02 150.9 41.33 Favored Pre-proline 0 C--O 1.241 0.635 0 C-N-CA 123.38 0.672 . . . . 73.53 109.893 173.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.803 ' HB3' ' HA ' ' E' ' 129' ' ' THR . 46.6 Cg_exo -46.12 121.33 4.33 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 123.556 2.837 . . . . 72.11 112.883 170.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -45.86 131.08 9.58 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 124.48 1.113 . . . . 61.14 111.655 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.461 HD11 HG13 ' D' ' 40' ' ' VAL . 23.7 tp -117.55 107.17 13.94 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.208 1.003 . . . . 74.23 109.209 -175.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -101.02 96.08 7.01 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 108.041 -1.096 . . . . 74.23 108.041 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.421 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 47.1 mt -61.73 116.72 5.03 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 122.787 0.435 . . . . 71.05 110.134 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.451 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -54.47 130.78 62.84 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 123.352 0.661 . . . . 74.32 112.487 -174.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 6.1 Cg_exo -73.29 109.64 2.88 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 123.286 2.657 . . . . 74.21 110.985 -178.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.07 152.9 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.877 0.871 . . . . 75.34 110.897 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -75.02 108.54 7.81 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.647 0.779 . . . . 73.54 109.021 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -58.47 -36.03 73.08 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.219 1.007 . . . . 74.22 111.803 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.28 -38.64 77.38 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.598 -1.183 . . . . 73.34 110.33 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.442 ' HA ' ' HB3' ' D' ' 138' ' ' MET . . . -70.58 -28.98 65.3 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 123.974 0.909 . . . . 75.43 112.631 -175.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 9.4 mp -66.65 -37.98 85.93 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 118.499 0.59 . . . . 71.4 111.05 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -78.24 -34.63 49.05 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.192 0.597 . . . . 75.12 110.242 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.442 ' HB3' ' HA ' ' D' ' 135' ' ' ALA . 40.8 ttm -71.69 -23.85 61.72 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.232 1.013 . . . . 72.32 111.43 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.418 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 83.9 m-20 -59.81 -41.42 91.19 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.501 0.72 . . . . 72.44 109.896 175.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -58.05 -39.07 77.52 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 124.429 1.081 . . . . 71.34 110.972 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.2 mp -77.43 -31.13 53.74 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.374 0.67 . . . . 64.31 111.492 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.418 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 11.0 pt20 -91.28 37.77 0.95 Allowed 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.342 0.592 . . . . 73.51 111.172 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.56 58.05 0.84 Allowed 'General case' 0 N--CA 1.481 1.125 0 CA-C-O 122.163 0.983 . . . . 74.31 109.335 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -145.76 -42.29 0.21 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.331 -1.304 . . . . 71.43 108.852 176.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -106.56 149.07 27.52 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.997 0.919 . . . . 75.54 109.76 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -160.84 29.25 0.32 Allowed Glycine 0 N--CA 1.467 0.747 0 CA-C-N 115.578 -0.737 . . . . 60.31 111.346 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.58 -163.93 1.01 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.343 1.057 . . . . 73.34 111.055 -176.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 100.17 -121.77 7.35 Favored Glycine 0 C--N 1.351 1.397 0 N-CA-C 110.689 -0.964 . . . . 51.12 110.689 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 6.1 m 57.22 81.52 0.14 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.079 1.352 . . . . 75.03 110.548 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -79.18 -178.03 5.96 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.461 -0.79 . . . . 74.44 110.857 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -76.23 174.49 10.07 Favored 'General case' 0 CA--C 1.553 1.092 0 N-CA-C 109.102 -0.703 . . . . 75.21 109.102 172.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -69.1 105.15 2.35 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.019 0.528 . . . . 73.33 110.401 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.31 106.09 1.04 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.695 1.598 . . . . 74.43 110.978 -173.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -102.91 140.76 36.77 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.159 0.584 . . . . 73.14 109.807 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 N-CA-C 109.137 -0.69 . . . . 75.33 109.137 -178.974 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.688 0 CA-C-O 120.072 -0.293 . . . . 50.43 113.388 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . -141.31 -57.85 0.03 OUTLIER Glycine 0 C--N 1.347 1.19 0 N-CA-C 111.255 -0.738 . . . . 71.33 111.255 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 93' ' ' PHE . . . . . 0.572 ' HB3' ' HB2' ' D' ' 54' ' ' ASP . 32.7 t80 -67.56 -36.66 81.37 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.603 0.761 . . . . 73.43 110.166 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -153.99 -156.83 0.72 Allowed 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 105.396 -2.076 . . . . 75.21 105.396 166.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.81 138.25 52.83 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.29 -1.004 . . . . 73.04 108.29 164.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.36 -103.91 0.24 Allowed Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.359 -0.448 . . . . 74.4 112.322 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 97' ' ' ILE . . . . . 0.414 HG13 ' HH ' ' D' ' 56' ' ' TYR . 37.2 pt -107.66 131.82 56.88 Favored 'Isoleucine or valine' 0 C--N 1.35 0.588 0 CA-C-O 121.672 0.749 . . . . 71.34 111.871 -166.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -147.29 -34.1 0.26 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.719 -1.128 . . . . 71.33 109.984 -177.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -105.06 90.49 3.46 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.398 0.679 . . . . 72.51 110.708 -177.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.77 169.34 9.59 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.317 1.047 . . . . 72.44 110.45 -177.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -89.88 173.03 3.64 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 122.459 2.106 . . . . 71.02 111.43 161.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 102' ' ' LEU . . . . . 0.531 HD13 ' HB2' ' D' ' 50' ' ' GLN . 23.2 tp -84.27 66.98 9.63 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 108.819 -0.808 . . . . 74.1 108.819 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 103' ' ' THR . . . . . 0.486 HG21 ' H ' ' E' ' 104' ' ' GLY 0.277 10.8 t 45.38 -74.02 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 126.6 1.96 . . . . 74.55 113.113 -166.174 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 104' ' ' GLY . . . . . 0.486 ' H ' HG21 ' E' ' 103' ' ' THR . . . -101.68 -134.97 8.66 Favored Glycine 0 C--N 1.347 1.184 0 N-CA-C 109.915 -1.274 . . . . 74.04 109.915 171.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -98.8 -17.21 18.58 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.967 0.507 . . . . 73.41 110.36 170.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -169.03 -71.59 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 106.695 -1.594 . . . . 75.44 106.695 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 107' ' ' THR . . . . . 0.431 HG21 ' OG1' ' D' ' 46' ' ' THR . 80.4 p -131.96 -51.28 0.97 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.544 -1.28 . . . . 74.15 107.544 165.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 67.58 14.78 9.66 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 125.45 1.5 . . . . 63.45 111.271 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -144.2 -36.27 0.34 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.128 0.971 . . . . 74.11 110.336 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . 69.0 127.39 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.116 1.367 . . . . 72.14 110.512 -167.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' D' ' 44' ' ' LEU . 33.6 tp -78.89 79.2 5.3 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.161 0.584 . . . . 73.31 110.607 -173.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -161.36 178.99 8.65 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.483 -0.761 . . . . 64.32 110.719 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -76.33 119.69 20.57 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.994 0.918 . . . . 73.55 110.222 -177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -91.23 141.51 28.72 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.18 -0.674 . . . . 72.13 109.18 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 35.2 p -77.87 86.75 4.09 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.249 0.62 . . . . 72.44 110.149 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . -136.2 -102.23 0.65 Allowed Glycine 0 C--N 1.343 0.919 0 CA-C-N 115.122 -0.945 . . . . 75.5 110.967 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 117' ' ' LYS . . . . . 0.471 ' HB3' ' HD3' ' E' ' 118' ' ' PRO . 12.7 tmtt? -119.86 -60.45 0.03 OUTLIER Pre-proline 0 CA--C 1.565 1.532 0 CA-C-O 118.142 -0.932 . . . . 74.0 110.485 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 118' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' E' ' 117' ' ' LYS . 1.6 Cg_endo -79.67 106.85 2.04 Favored 'Trans proline' 0 C--N 1.395 3.024 0 C-N-CA 121.833 1.689 . . . . 71.24 111.339 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -82.48 61.03 5.43 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.515 0.726 . . . . 73.3 110.096 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -78.36 153.95 31.19 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.297 -0.865 . . . . 73.24 109.443 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 121' ' ' VAL . . . . . . . . . . . . . 48.1 t 79.51 118.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 125.817 1.647 . . . . 74.12 110.395 -171.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 30.2 m -144.07 84.87 1.78 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.821 -0.807 . . . . 74.11 108.821 171.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -68.8 -38.56 80.02 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.042 1.337 . . . . 73.52 112.873 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 21.6 m -69.33 -12.64 61.83 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 113.507 0.929 . . . . 73.22 113.507 -173.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.3 10.16 9.18 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.087 0.555 . . . . 74.21 111.553 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 126' ' ' ALA . . . . . 0.541 ' HB3' HE21 ' B' ' 12' ' ' GLN . . . -136.56 101.54 4.67 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.073 0.949 . . . . 74.43 110.043 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 64.6 p -169.51 152.9 4.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.52 0.728 . . . . 74.01 110.328 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.5 -56.18 4.86 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.245 0.618 . . . . 71.32 110.513 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 129' ' ' THR . . . . . 0.803 ' HA ' ' HB3' ' D' ' 124' ' ' PRO . 24.4 m 58.6 79.25 0.22 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.766 1.226 . . . . 72.03 111.969 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -165.51 127.22 2.0 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.091 0.956 . . . . 73.11 110.197 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 131' ' ' TRP . . . . . 0.687 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 71.6 t90 -161.64 101.73 1.18 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.604 0.762 . . . . 71.21 109.684 176.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 20.9 m -147.77 113.17 5.6 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.52 1.128 . . . . 74.33 108.895 173.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 40.8 m -139.32 137.08 35.5 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 118.414 0.552 . . . . 75.14 111.06 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -116.71 93.51 0.6 Allowed Glycine 0 C--N 1.347 1.19 0 N-CA-C 110.183 -1.167 . . . . 64.41 110.183 171.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 79.7 t -64.01 101.08 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 124.012 0.925 . . . . 75.2 109.462 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -67.43 108.97 2.99 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.092 0.557 . . . . 74.31 109.983 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 12.3 t -70.28 141.07 52.43 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 123.723 0.64 . . . . 74.5 110.814 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 138' ' ' TYR . . . . . 0.42 ' HD1' ' HB2' ' A' ' 129' ' ' ALA . 92.0 m-85 -117.76 116.46 27.05 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.849 -0.797 . . . . 74.23 108.849 177.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -75.57 147.26 39.79 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.578 -0.737 . . . . 64.01 110.622 -176.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.42 -84.63 0.05 OUTLIER Glycine 0 C--N 1.344 1.002 0 N-CA-C 111.033 -0.827 . . . . 55.14 111.033 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -167.6 172.89 9.01 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.861 0.865 . . . . 75.02 110.43 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 6.8 mp -80.89 141.67 34.34 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.749 0.82 . . . . 73.55 109.067 173.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . 178.03 -119.44 0.67 Allowed Glycine 0 C--N 1.336 0.528 0 N-CA-C 110.937 -0.865 . . . . 75.13 110.937 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 13.7 p -159.74 158.27 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.01 0.924 . . . . 75.51 109.189 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 145' ' ' ASP . . . . . 0.464 ' HA ' ' ND2' ' A' ' 104' ' ' ASN . 2.8 m-20 . . . . . 0 C--O 1.251 1.164 0 N-CA-C 107.533 -1.284 . . . . 72.55 107.533 164.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.863 0 N-CA-C 113.47 0.148 . . . . 71.5 113.47 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.01 -61.91 1.9 Allowed Glycine 0 C--N 1.346 1.095 0 N-CA-C 111.886 -0.486 . . . . 73.33 111.886 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 93' ' ' PHE . . . . . 0.406 ' CD1' HG23 ' B' ' 55' ' ' VAL . 0.8 OUTLIER -70.92 -59.35 2.84 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.333 -0.618 . . . . 75.2 109.333 -178.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -103.1 -77.94 0.56 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 117.763 0.256 . . . . 75.22 110.557 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -148.25 -83.57 0.11 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.159 0.436 . . . . 75.23 112.043 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.36 89.93 0.08 OUTLIER Glycine 0 C--N 1.347 1.159 0 N-CA-C 111.312 -0.715 . . . . 55.32 111.312 -170.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 97' ' ' ILE . . . . . 0.489 HG12 ' HE1' ' B' ' 94' ' ' MET . 9.4 tt -99.67 8.47 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.325 0 C-N-CA 124.696 1.198 . . . . 75.5 108.781 171.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 30.6 t70 69.66 -77.78 0.05 Allowed 'General case' 0 C--N 1.361 1.071 0 C-N-CA 125.798 1.639 . . . . 70.21 109.194 -165.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -163.42 147.99 10.92 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.528 1.131 . . . . 73.14 108.82 176.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 100' ' ' LEU . . . . . 0.415 HD12 ' HD1' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -118.06 93.3 44.3 Favored Pre-proline 0 CA--C 1.56 1.333 0 C-N-CA 123.276 0.63 . . . . 73.52 110.819 -177.096 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -83.9 -167.21 0.42 Allowed 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 123.072 2.515 . . . . 74.22 111.089 173.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 102' ' ' LEU . . . . . . . . . . . . . 17.0 mt -150.07 80.78 1.37 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.339 0.655 . . . . 74.15 110.222 175.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 70.5 p 46.92 38.69 6.45 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.715 1.606 . . . . 74.54 113.909 169.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.31 -59.0 4.98 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 111.316 -0.714 . . . . 75.45 111.316 -174.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 105' ' ' GLN . . . . . 0.401 ' NE2' ' HB3' ' F' ' 108' ' ' HIS . 44.0 tt0 -140.08 137.24 34.39 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 124.382 1.073 . . . . 74.54 109.233 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 106' ' ' TYR . . . . . 0.488 ' CE2' ' HB ' ' B' ' 46' ' ' THR . 41.7 t80 -84.36 130.56 34.78 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 123.631 0.772 . . . . 74.24 109.253 174.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 3.8 m 68.96 159.44 0.17 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 124.596 1.185 . . . . 75.12 110.107 -177.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 108' ' ' HIS . . . . . 0.596 ' HA ' ' HB2' ' F' ' 112' ' ' ASN . 54.6 t-80 75.08 -9.75 1.33 Allowed 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 124.137 0.975 . . . . 74.23 112.107 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -79.8 -27.78 40.29 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.385 1.074 . . . . 75.31 110.331 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -157.25 -70.11 0.1 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.024 0.93 . . . . 54.12 109.302 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 10.3 tt -73.76 113.48 10.96 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.002 -1.11 . . . . 72.14 108.002 174.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 112' ' ' ASN . . . . . 0.596 ' HB2' ' HA ' ' F' ' 108' ' ' HIS . 7.2 t30 -162.83 146.05 10.97 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 123.917 0.761 . . . . 75.31 110.279 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -68.58 79.5 0.28 Allowed 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 124.568 1.147 . . . . 74.14 109.863 173.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . 0.491 ' HB2' HD21 ' F' ' 112' ' ' ASN . 22.0 tptm -162.14 164.62 27.85 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.311 0.644 . . . . 73.51 110.071 -174.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 26.9 m -71.04 76.57 0.66 Allowed 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 124.145 0.978 . . . . 73.52 109.757 171.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 171.19 40.97 0.03 OUTLIER Glycine 0 N--CA 1.464 0.561 0 CA-C-N 114.868 -1.06 . . . . 54.03 110.495 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -71.26 147.9 93.43 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.807 0.843 . . . . 75.3 110.734 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.88 -165.46 0.33 Allowed 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 122.981 2.454 . . . . 71.1 111.781 171.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -81.24 -176.72 6.13 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.626 0.77 . . . . 74.54 110.252 173.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 21.4 t80 74.62 179.03 0.2 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.336 1.054 . . . . 74.44 110.23 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 99.4 t 75.05 136.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 C-N-CA 125.018 1.327 . . . . 72.33 111.138 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 54.7 m 56.96 86.28 0.07 Allowed 'General case' 0 C--N 1.361 1.071 0 C-N-CA 124.684 1.193 . . . . 75.4 110.121 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -151.46 177.99 9.75 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.459 -0.791 . . . . 65.32 109.282 -169.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 15.4 m -68.84 86.61 0.34 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.056 0.943 . . . . 63.21 111.01 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' B' ' 130' ' ' PRO . . . -164.29 135.7 4.5 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.418 1.087 . . . . 73.15 109.129 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . 69.76 -178.39 0.22 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.74 1.216 . . . . 72.51 111.578 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 45.3 p -155.03 147.31 23.87 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.325 0.65 . . . . 63.41 110.996 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.18 115.66 23.09 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.527 -0.916 . . . . 71.24 108.527 172.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 129' ' ' THR . . . . . 0.402 HG22 ' O ' ' C' ' 122' ' ' THR . 74.4 p -81.48 -78.13 0.2 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 122.925 0.49 . . . . 62.31 110.732 -176.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -177.24 -168.91 0.21 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.874 0.87 . . . . 75.32 110.305 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 131' ' ' TRP . . . . . 0.454 ' HB2' ' HG3' ' B' ' 124' ' ' PRO . 27.7 t90 -120.58 -11.05 9.13 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.015 0.926 . . . . 75.34 110.164 168.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 35.4 t -54.48 99.83 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.699 0.8 . . . . 62.44 112.031 -169.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 133' ' ' THR . . . . . 0.466 HG22 ' HA ' ' C' ' 126' ' ' LEU . 22.8 m -76.61 -42.08 43.71 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.927 -1.033 . . . . 71.44 109.365 174.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.91 13.62 75.65 Favored Glycine 0 C--N 1.356 1.659 0 CA-C-N 114.937 -1.029 . . . . 73.45 114.096 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 10.0 p -74.45 90.54 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 CA-C-O 122.419 1.104 . . . . 73.31 110.872 -174.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -94.68 97.55 10.16 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.08 -0.964 . . . . 74.43 108.624 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 13.7 m 66.4 -87.23 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 125.116 1.366 . . . . 72.41 110.145 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -142.38 23.59 1.98 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.188 0.995 . . . . 75.43 110.007 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -144.21 170.79 15.3 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.086 0.954 . . . . 71.32 109.116 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -128.12 -113.09 1.72 Allowed Glycine 0 C--N 1.348 1.224 0 N-CA-C 111.457 -0.657 . . . . 74.23 111.457 174.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -160.27 -166.61 1.72 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.28 1.032 . . . . 74.53 109.906 -175.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.01 117.59 22.79 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.931 0.892 . . . . 70.14 109.12 171.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -89.59 61.57 3.49 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 115.756 -0.657 . . . . 70.12 112.972 -175.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 32.1 m -109.66 152.83 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.617 0.767 . . . . 75.25 110.521 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 . . . . . 0 CA--C 1.551 0.998 0 C-N-CA 124.895 1.278 . . . . 75.31 110.575 -177.157 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtm . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 109.683 -0.488 . . . . 73.22 109.683 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.1 p -164.19 -43.99 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.444 1.098 . . . . 74.45 108.425 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 63.99 16.63 10.05 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 125.22 1.408 . . . . 71.4 111.705 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -96.95 124.58 40.96 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 123.809 0.843 . . . . 73.01 108.9 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -85.27 -9.65 57.45 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.017 0.527 . . . . 73.45 110.038 175.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -88.76 14.07 11.04 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.311 1.044 . . . . 74.15 111.988 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.3 p -60.12 -71.39 0.13 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.174 0.589 . . . . 55.11 110.358 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.534 ' HG2' ' SD ' ' A' ' 9' ' ' MET . 43.2 tt0 178.56 -69.01 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 107.298 -1.371 . . . . 73.41 107.298 172.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.534 ' SD ' ' HG2' ' A' ' 8' ' ' GLU . 0.7 OUTLIER -99.85 170.66 8.38 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.767 0.827 . . . . 71.22 109.809 170.599 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.8 m -146.5 111.56 5.38 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.244 1.018 . . . . 72.33 108.459 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.436 ' CD1' HD13 ' A' ' 86' ' ' ILE . 70.4 t80 -121.13 112.46 18.71 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.228 -1.397 . . . . 74.34 107.228 167.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.534 HE22 ' HE2' ' F' ' 138' ' ' TYR . 50.4 tp60 -135.68 135.64 40.27 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.804 -1.184 . . . . 64.12 107.804 171.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.9 mt -91.57 115.83 31.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.281 -1.007 . . . . 74.13 108.281 176.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -73.88 -40.24 63.35 Favored 'General case' 0 C--O 1.242 0.708 0 O-C-N 123.388 0.43 . . . . 70.32 110.51 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.49 ' HE ' ' HB ' ' B' ' 122' ' ' THR . 26.0 ttt180 -174.86 122.65 0.24 Allowed 'General case' 0 N--CA 1.479 1.0 0 O-C-N 123.227 0.33 . . . . 72.51 110.432 -169.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 73.7 mt -106.47 136.52 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 108.723 -0.843 . . . . 73.23 108.723 172.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.464 ' HB2' ' HA2' ' B' ' 121' ' ' GLY . 26.4 p90 -166.65 177.95 6.27 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 124.206 0.941 . . . . 75.02 111.802 -172.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.6 p -110.35 118.8 37.27 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.064 -0.971 . . . . 75.43 109.386 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 35.8 mtpt -82.97 -29.33 29.12 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.066 0.46 . . . . 73.14 109.79 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.436 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 30.6 t70 -150.52 136.8 18.67 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.765 -1.107 . . . . 71.4 109.28 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 59.8 mt -135.06 138.78 48.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.904 -1.147 . . . . 75.14 107.904 174.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.4 t -150.02 124.32 9.54 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.641 0.588 . . . . 71.2 110.04 173.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.672 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.6 t80 -120.95 132.97 55.25 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 106.87 -1.529 . . . . 74.21 106.87 168.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -128.5 139.93 52.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.301 -0.629 . . . . 73.32 109.301 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.13 78.07 65.68 Favored Pre-proline 0 C--O 1.24 0.581 0 N-CA-C 106.908 -1.516 . . . . 75.31 106.908 171.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -64.18 -34.51 56.61 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.671 2.247 . . . . 73.2 112.303 -171.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -106.11 22.34 15.85 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 118.146 -0.931 . . . . 73.44 110.488 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.415 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -43.04 -56.08 6.81 Favored Pre-proline 0 N--CA 1.493 1.721 0 CA-C-O 117.923 -1.037 . . . . 54.42 113.752 -171.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 22.8 Cg_exo -65.03 -27.87 57.6 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 121.906 1.738 . . . . 64.4 113.29 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -80.65 -40.43 25.57 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.847 0.859 . . . . 71.13 110.922 -175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.667 HG22 ' HA ' ' A' ' 73' ' ' ALA . 9.3 p -78.1 -21.33 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 CA-C-N 114.935 -1.029 . . . . 72.53 112.837 -158.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -71.05 -12.14 61.35 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.168 0.587 . . . . 74.32 111.438 176.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -90.22 -18.31 25.92 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.537 1.135 . . . . 75.24 111.011 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -81.55 161.01 23.73 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.494 0.717 . . . . 73.12 112.126 -172.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.13 116.14 6.9 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 114.75 -1.113 . . . . 74.33 108.765 173.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.435 ' NE1' ' HG2' ' A' ' 124' ' ' PRO . 63.6 t-105 -80.79 80.18 7.31 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.875 0.845 . . . . 75.45 109.678 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.401 ' H ' HD23 ' A' ' 68' ' ' LEU . 9.2 tt0 -123.97 69.71 48.39 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 124.898 1.279 . . . . 73.32 108.24 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -86.4 118.25 1.59 Allowed 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.602 2.201 . . . . 73.43 112.816 -170.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -94.45 103.46 15.43 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 105.023 -2.214 . . . . 74.45 105.023 168.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.656 HG23 ' HB1' ' A' ' 66' ' ' ALA . 57.5 t -90.74 101.8 12.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 123.39 0.676 . . . . 74.22 110.334 -177.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -79.6 117.97 21.01 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.662 -0.699 . . . . 74.51 109.855 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.3 mt -97.02 107.04 19.49 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.281 -1.007 . . . . 75.22 108.281 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.528 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.7 m-20 -106.85 106.77 17.45 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.174 0.99 . . . . 74.13 108.679 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.433 HD22 HD21 ' A' ' 60' ' ' LEU . 85.3 mt -98.91 149.64 22.74 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.858 0.463 . . . . 74.15 110.631 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -154.92 148.68 25.52 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.856 -1.065 . . . . 75.05 108.696 177.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.3 m -131.51 130.89 42.94 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.583 0.753 . . . . 74.33 109.878 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.87 109.12 9.87 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.806 0.842 . . . . 63.34 109.121 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.2 p -98.7 156.95 16.58 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.214 0.606 . . . . 73.45 110.327 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.2 t -150.2 151.63 33.37 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.629 1.172 . . . . 75.04 108.609 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -100.16 111.56 23.85 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.091 -1.077 . . . . 74.3 108.091 172.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 74.1 mt -79.22 -43.03 24.64 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.136 0.574 . . . . 62.04 110.234 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.98 -177.28 5.65 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.962 -0.563 . . . . 54.24 110.708 -176.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.02 110.76 0.87 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.088 0.955 . . . . 73.03 109.883 174.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 65.1 9.59 5.65 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.529 1.132 . . . . 72.55 112.655 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.2 t -104.27 107.24 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.299 -1.0 . . . . 74.44 108.299 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -114.77 126.55 54.97 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.495 -0.928 . . . . 75.45 108.495 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -90.51 151.63 21.28 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.163 -0.681 . . . . 74.35 109.163 168.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.1 t -132.57 136.34 56.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 124.882 1.273 . . . . 52.25 107.568 170.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 52.5 t -118.01 130.12 73.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.765 -0.828 . . . . 71.03 108.765 175.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.474 HD23 HG23 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -102.32 103.47 13.92 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.643 -1.614 . . . . 73.24 106.643 176.258 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -90.21 98.77 11.97 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.16 -1.422 . . . . 72.42 107.16 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.474 HG23 HD23 ' A' ' 60' ' ' LEU . 21.5 t -100.61 132.24 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 114.757 -1.111 . . . . 71.13 108.177 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.528 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 6.8 m -125.51 146.65 49.56 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.395 -0.965 . . . . 72.51 108.395 175.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.549 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 23.2 t -145.61 117.37 2.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 124.867 1.267 . . . . 74.43 107.933 -168.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.7 m -126.2 120.55 30.36 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.129 0.422 . . . . 74.42 110.004 177.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.656 ' HB1' HG23 ' A' ' 40' ' ' VAL . . . -101.24 105.59 16.72 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.264 -1.384 . . . . 54.21 107.264 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.2 m -109.07 126.13 52.84 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.044 0.537 . . . . 73.2 110.007 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.412 HD21 ' CE3' ' A' ' 36' ' ' TRP . 35.0 mt -89.79 74.76 7.42 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 125.021 1.328 . . . . 74.11 108.671 175.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.99 -84.39 0.92 Allowed Glycine 0 C--N 1.341 0.856 0 CA-C-N 115.713 -0.676 . . . . 73.12 111.921 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -114.28 -29.0 7.06 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.787 0.835 . . . . 75.21 111.007 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -88.89 134.41 33.96 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.837 0.455 . . . . 65.44 110.211 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -80.2 136.45 36.48 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 118.019 0.372 . . . . 65.21 110.126 175.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.667 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -87.12 -58.25 2.66 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.166 0.986 . . . . 63.03 109.264 176.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -154.54 168.28 27.26 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.579 -1.191 . . . . 70.22 110.695 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 67.1 tp -124.56 147.37 48.48 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.213 1.405 . . . . 71.34 108.042 172.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.549 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 79.8 m -142.86 128.1 18.73 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.2 -1.037 . . . . 73.41 108.2 175.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -146.27 118.45 8.33 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.775 -0.454 . . . . 74.3 109.775 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.4 t -127.41 112.81 29.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.49 1.116 . . . . 64.51 108.97 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 51.7 mt-30 -86.28 84.18 7.53 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.652 -0.87 . . . . 74.12 108.652 171.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -76.78 94.92 3.93 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.506 -1.224 . . . . 73.23 109.578 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.82 144.26 18.06 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 111.87 -0.492 . . . . 64.33 111.87 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.403 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -139.03 124.18 2.75 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.265 -1.134 . . . . 73.4 110.265 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.413 HG13 ' HE1' ' A' ' 17' ' ' TYR . 48.9 mt -81.74 129.15 37.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.923 -1.14 . . . . 73.01 107.923 172.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.661 ' HB3' HD11 ' A' ' 86' ' ' ILE . 88.9 m-85 -128.5 122.99 32.43 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.189 0.996 . . . . 74.44 109.298 -174.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.0 t -89.75 93.27 9.39 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.36 1.064 . . . . 73.05 108.841 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.661 HD11 ' HB3' ' A' ' 84' ' ' PHE . 15.9 mm -120.73 132.89 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.895 0.878 . . . . 74.13 111.379 -168.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.75 167.43 28.23 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.617 0.767 . . . . 63.33 110.708 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.86 8.67 72.5 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 119.325 -0.709 . . . . 63.24 114.73 173.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.43 HG22 ' HG3' ' A' ' 9' ' ' MET . 0.2 OUTLIER -143.41 164.07 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 124.112 0.965 . . . . 65.54 109.922 174.704 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.476 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 19.8 tt0 -154.94 179.05 9.49 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.501 -0.772 . . . . 74.42 109.089 174.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.476 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 61.99 -130.03 44.44 Favored Glycine 0 C--N 1.347 1.149 0 C-N-CA 123.283 0.468 . . . . 63.51 113.792 175.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.5 p -67.92 -28.58 67.62 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.995 0.918 . . . . 55.04 111.259 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -66.59 -43.22 85.46 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.71 0.804 . . . . 62.1 110.25 177.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.574 ' HE3' HG22 ' A' ' 86' ' ' ILE . 4.3 tpt -70.84 -41.3 71.68 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.571 -0.74 . . . . 75.41 110.594 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.71 84.87 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.359 0.663 . . . . 64.43 111.136 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -71.7 -29.77 64.93 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.324 0.65 . . . . 73.51 110.75 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.8 t -71.41 -48.31 50.52 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.603 -0.517 . . . . 73.34 109.603 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 79.0 mt -80.37 -25.49 39.13 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.141 0.576 . . . . 74.15 112.494 -174.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.79 4.3 32.3 Favored Glycine 0 N--CA 1.474 1.175 0 CA-C-O 119.669 -0.517 . . . . 64.22 113.954 -173.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.2 -65.48 0.36 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 117.469 0.634 . . . . 74.31 111.33 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -67.6 -45.93 74.03 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 116.193 -0.458 . . . . 74.02 112.209 -171.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 68.6 m -66.98 -48.34 50.65 Favored Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 124.073 0.949 . . . . 73.41 112.863 -176.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -66.92 -21.02 50.73 Favored 'Trans proline' 0 C--N 1.393 2.893 0 C-N-CA 121.596 1.531 . . . . 74.4 112.562 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -71.84 -35.23 69.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.122 0.569 . . . . 54.21 110.364 174.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 38.6 mm -64.08 -42.72 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.65 0.78 . . . . 75.15 109.968 171.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.403 HD22 ' HA3' ' A' ' 82' ' ' GLY . 65.3 mt -76.17 -21.15 56.86 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.253 -0.885 . . . . 64.51 111.997 -174.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -64.31 -43.85 74.12 Favored Pre-proline 0 N--CA 1.484 1.261 0 CA-C-O 117.296 -1.335 . . . . 75.34 114.47 -172.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.78 -37.21 75.99 Favored 'Trans proline' 0 C--N 1.384 2.402 0 CA-C-N 122.04 1.764 . . . . 51.11 113.039 171.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.469 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 95.1 m-85 -77.82 -39.39 43.84 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.581 0.753 . . . . 64.55 111.777 -177.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.56 -47.07 77.09 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.592 -0.521 . . . . 75.22 109.592 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.528 ' NH1' HD13 ' C' ' 105' ' ' ILE . 29.5 ttm180 -48.19 -56.06 8.87 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 125.157 1.535 . . . . 74.45 110.32 173.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.07 -44.96 94.32 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 124.432 1.082 . . . . 65.01 112.186 -174.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.494 ' O ' ' HG3' ' A' ' 117' ' ' MET . 42.1 t -59.27 -41.42 88.84 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.893 0.745 . . . . 72.02 110.82 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.586 HD13 HD12 ' A' ' 128' ' ' LEU . 74.4 mt -64.32 -50.77 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.443 1.097 . . . . 75.3 110.561 174.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.0 m -59.56 -36.36 76.05 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.376 1.071 . . . . 75.12 111.386 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -71.38 -41.59 69.5 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 114.712 -1.131 . . . . 73.43 109.859 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.672 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 44.4 mtm -62.1 -38.37 88.62 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.731 0.413 . . . . 74.5 111.101 175.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 65.6 t -63.52 -47.38 91.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 124.325 1.05 . . . . 73.05 111.157 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.8 p -71.79 -35.27 69.95 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.007 0.523 . . . . 72.2 111.327 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.462 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 87.5 mtt-85 -68.18 -30.75 69.93 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.561 0.744 . . . . 75.42 109.886 173.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.412 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.06 14.51 48.93 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-O 118.953 -0.915 . . . . 61.01 113.218 175.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.415 HG23 ' HE ' ' B' ' 15' ' ' ARG . 1.6 t 61.54 10.21 3.13 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 127.233 2.213 . . . . 74.43 114.214 176.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -82.18 145.08 51.75 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-O 119.176 -0.44 . . . . 74.23 109.82 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.452 ' HB3' ' HA ' ' E' ' 131' ' ' TRP . 92.7 Cg_exo -48.55 149.75 6.66 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 124.039 3.16 . . . . 75.43 113.83 174.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -55.68 128.4 34.55 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 124.246 0.966 . . . . 74.42 112.021 -171.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.537 HD13 HG12 ' A' ' 40' ' ' VAL . 41.4 tp -118.99 102.54 8.84 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.432 0.693 . . . . 74.42 110.172 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.477 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 82.2 m-20 -102.77 115.38 30.47 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 107.798 -1.186 . . . . 74.1 107.798 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.586 HD12 HD13 ' A' ' 114' ' ' ILE . 10.3 mt -67.17 134.09 51.06 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.339 -0.615 . . . . 74.21 109.339 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.15 137.8 94.27 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 123.532 0.733 . . . . 63.52 111.379 -175.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.81 107.11 0.36 Allowed 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.337 2.691 . . . . 70.53 113.47 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.3 t -100.95 134.46 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.119 0.568 . . . . 74.23 111.518 -174.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.512 ' ND2' ' HB3' ' A' ' 135' ' ' ALA . 52.7 t30 -96.26 87.54 4.52 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.347 -1.297 . . . . 75.1 109.134 175.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -59.74 -25.07 64.56 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.979 0.911 . . . . 74.41 112.531 175.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.429 ' HB3' ' OD1' ' A' ' 132' ' ' ASN . 19.8 t70 -58.68 -49.94 75.69 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.651 0.78 . . . . 72.51 109.812 172.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.512 ' HB3' ' ND2' ' A' ' 132' ' ' ASN . . . -59.51 -49.6 77.16 Favored 'General case' 0 C--N 1.358 0.956 0 O-C-N 123.731 0.645 . . . . 61.32 110.727 175.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 85.7 mt -53.13 -44.65 67.89 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 124.144 0.903 . . . . 73.35 111.925 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -66.66 -45.2 79.73 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.533 -0.758 . . . . 72.25 110.467 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.497 ' HE3' HD22 ' A' ' 141' ' ' LEU . 17.4 mtp -74.0 -19.39 60.66 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.964 -0.562 . . . . 75.31 112.006 -174.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 85.8 m-20 -66.51 -37.5 85.19 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.453 0.701 . . . . 74.53 110.194 171.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -74.3 -42.72 59.05 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.766 0.826 . . . . 75.13 110.593 173.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.497 HD22 ' HE3' ' A' ' 138' ' ' MET . 40.9 tp -68.16 -49.1 63.19 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.308 1.043 . . . . 71.42 112.331 -170.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -160.4 20.15 0.15 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.151 0.58 . . . . 74.13 111.553 -172.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 77.4 mt-30 62.23 16.11 8.12 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.89 1.276 . . . . 71.52 113.304 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -74.53 109.01 7.66 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.553 0.341 . . . . 75.31 111.242 -172.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.52 178.38 9.94 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.121 0.968 . . . . 75.44 110.097 175.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 160.68 39.94 0.02 OUTLIER Glycine 0 C--N 1.342 0.895 0 N-CA-C 111.541 -0.624 . . . . 63.15 111.541 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -75.04 152.99 38.62 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.739 0.816 . . . . 74.51 110.562 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.414 ' HA3' HG23 ' C' ' 7' ' ' THR . . . -85.19 -177.56 50.78 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 116.03 -0.532 . . . . 74.23 114.052 -173.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 41.3 p -124.09 108.69 12.6 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.126 0.97 . . . . 75.43 108.434 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.424 ' HG3' HG22 ' C' ' 7' ' ' THR . 2.0 mp0 -78.76 85.89 4.74 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.459 -0.571 . . . . 71.33 109.459 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.0 86.52 1.31 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 106.53 -1.656 . . . . 72.12 106.53 171.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -85.34 143.93 28.37 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.38 -0.827 . . . . 72.05 110.333 -167.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.73 -163.17 1.0 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.372 0.669 . . . . 72.4 110.786 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -108.3 139.42 43.03 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.504 0.722 . . . . 75.11 109.444 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.934 0 C-N-CA 123.89 0.876 . . . . 73.03 109.828 176.861 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.461 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.847 0.355 . . . . 53.31 110.929 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 61.4 p -93.16 54.27 2.1 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.948 0.899 . . . . 54.33 109.836 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -122.79 -171.08 2.21 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.49 1.116 . . . . 74.54 111.252 -163.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 62.04 -81.0 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.708 1.603 . . . . 75.24 111.952 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 58.42 79.81 0.2 Allowed 'General case' 0 C--N 1.362 1.141 0 C-N-CA 124.307 1.043 . . . . 74.31 109.959 -175.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -61.52 100.34 0.14 Allowed 'General case' 0 C--N 1.353 0.754 0 CA-C-N 115.298 -0.865 . . . . 71.14 111.348 -171.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 37.4 m -66.76 151.63 47.08 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 113.866 -1.515 . . . . 62.0 111.25 -176.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.24 155.82 23.68 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.913 0.885 . . . . 75.21 110.769 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.525 ' SD ' HG22 ' B' ' 89' ' ' ILE . 11.8 tpt 66.84 163.4 0.18 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 125.634 1.574 . . . . 71.13 111.425 -169.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 9.4 t -153.92 132.26 11.98 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 107.483 -1.303 . . . . 73.55 107.483 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.425 ' HB2' ' HE2' ' B' ' 9' ' ' MET . 57.2 t80 -137.69 136.97 37.89 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.146 -0.687 . . . . 74.14 109.146 -175.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -155.72 141.5 18.02 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.373 0.669 . . . . 74.42 109.523 173.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 55.6 mt -87.72 125.16 41.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.199 -1.037 . . . . 73.33 108.199 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -89.94 -39.63 12.88 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.672 -0.695 . . . . 74.23 109.802 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.415 ' HE ' HG23 ' A' ' 122' ' ' THR . 38.6 ttt180 -171.49 143.79 1.83 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.687 -0.688 . . . . 72.21 109.725 -174.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 71.4 mt -130.25 138.14 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 107.519 -1.289 . . . . 73.14 107.519 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.433 ' HE1' HG13 ' B' ' 83' ' ' ILE . 26.7 p90 -161.66 143.37 11.42 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.248 0.547 . . . . 75.52 111.479 -172.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.538 HG23 HD11 ' B' ' 21' ' ' ILE . 21.1 m -76.44 123.26 25.73 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.946 -1.025 . . . . 74.54 108.522 171.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.407 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.8 mtpt -93.84 -26.54 16.88 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.265 0.626 . . . . 71.13 110.337 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.504 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 34.0 t70 -152.53 141.75 21.44 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.91 0.484 . . . . 75.11 110.814 -175.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.538 HD11 HG23 ' B' ' 18' ' ' THR . 32.8 mm -129.5 142.47 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.022 1.329 . . . . 74.44 108.449 174.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 46.5 m -147.58 134.27 19.97 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.846 -1.07 . . . . 73.31 109.668 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -147.16 109.05 4.4 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.752 -1.573 . . . . 71.23 106.752 167.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -120.98 114.84 22.1 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.487 -0.931 . . . . 74.34 108.487 -177.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.58 87.02 2.48 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 107.327 -1.36 . . . . 72.14 107.327 175.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.65 -37.28 22.12 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.502 2.134 . . . . 74.23 112.552 -169.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.526 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 82.4 m-20 -102.13 17.46 23.25 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.05 0.94 . . . . 73.33 110.621 -176.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -39.88 -60.74 1.28 Allowed Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 115.465 1.654 . . . . 75.53 115.465 -163.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.57 -28.48 38.02 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 121.844 1.696 . . . . 74.32 112.349 -173.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.459 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 79.1 m80 -92.83 -25.43 18.12 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.137 -0.938 . . . . 74.03 112.145 -173.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.562 HG21 ' HA ' ' B' ' 73' ' ' ALA . 6.0 p -83.02 -7.55 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 121.259 0.552 . . . . 75.43 110.725 -176.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -77.76 -9.23 58.91 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.207 0.603 . . . . 72.54 112.626 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 10.5 pt20 -67.23 -17.25 64.73 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.809 0.444 . . . . 71.11 110.582 170.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.513 ' HB2' HD13 ' B' ' 68' ' ' LEU . 30.5 mmtp -92.92 98.43 11.36 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.841 1.257 . . . . 74.24 109.23 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' F' ' 132' ' ' SER . 3.9 m-20 -100.1 78.25 2.06 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.322 0.649 . . . . 75.14 110.233 -176.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 25.2 p90 -166.06 172.46 11.35 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.575 0.75 . . . . 74.44 110.244 174.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -71.73 117.59 59.02 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 123.201 0.6 . . . . 74.33 110.104 175.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.421 ' HD3' ' HG2' ' B' ' 124' ' ' PRO . 55.8 Cg_endo -70.53 147.35 57.74 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 121.754 1.636 . . . . 72.33 110.474 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -72.47 110.0 6.56 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.22 -1.03 . . . . 73.42 108.22 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.745 HG21 ' HB1' ' B' ' 66' ' ' ALA . 59.9 t -99.32 146.05 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 114.955 -1.02 . . . . 73.24 110.44 -174.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -119.23 117.86 29.77 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.981 1.312 . . . . 73.34 108.578 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.602 HD12 HD21 ' B' ' 128' ' ' LEU . 24.2 tp -89.26 144.77 25.85 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.922 -0.399 . . . . 75.12 109.922 172.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.41 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 12.3 t70 -150.82 119.25 6.42 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.752 -0.832 . . . . 74.04 108.752 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.472 ' H ' ' HE2' ' F' ' 113' ' ' LYS . 90.5 mt -99.47 126.24 45.36 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.475 -0.565 . . . . 71.52 109.475 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -124.79 127.45 47.2 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.765 -1.198 . . . . 74.15 107.765 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.8 t -109.46 141.37 41.97 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 122.746 0.418 . . . . 74.2 110.178 -172.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.69 140.73 27.47 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.477 1.111 . . . . 74.35 108.104 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.447 ' HG ' HG23 ' B' ' 58' ' ' VAL . 14.9 m -137.92 163.8 30.57 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.764 0.426 . . . . 72.4 110.021 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 72.1 p -156.41 136.31 12.64 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.246 0.618 . . . . 73.3 109.705 174.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -91.43 134.6 34.49 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.248 -1.019 . . . . 73.04 108.248 170.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 pp -150.67 14.22 0.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.432 -0.804 . . . . 74.34 109.717 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.98 158.82 35.64 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.439 -0.801 . . . . 71.5 110.953 -174.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -83.66 127.03 33.46 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.778 -1.101 . . . . 72.14 108.897 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 64.03 4.0 1.88 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 124.472 1.109 . . . . 71.14 113.065 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 53.6 t -132.32 122.73 48.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.63 -0.878 . . . . 74.31 108.63 -173.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.43 140.62 44.49 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 108.214 -1.032 . . . . 74.13 108.214 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -99.48 101.37 12.59 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 105.442 -2.058 . . . . 74.44 105.442 172.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.447 HG23 ' HG ' ' B' ' 48' ' ' SER . 14.6 p -109.29 140.14 29.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 121.407 0.622 . . . . 72.12 109.329 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 17.0 t -114.2 144.56 21.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 124.614 1.166 . . . . 63.45 108.683 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 48.1 tp -121.12 110.36 16.12 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 107.751 -1.203 . . . . 73.34 107.751 167.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -84.25 118.36 24.12 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.673 -1.232 . . . . 74.42 107.673 171.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.4 121.24 57.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.44 -0.948 . . . . 74.31 108.44 173.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.41 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 17.8 m -108.75 135.29 50.22 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.74 0.816 . . . . 65.42 109.384 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 82.0 t -134.11 119.88 32.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.903 0.881 . . . . 73.12 109.171 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 66.6 m -109.5 138.98 45.06 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 123.659 0.783 . . . . 75.14 109.072 173.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.745 ' HB1' HG21 ' B' ' 40' ' ' VAL . . . -148.73 141.86 24.96 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.728 0.411 . . . . 73.43 109.909 178.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.516 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 35.4 p -141.68 132.68 26.07 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.607 0.763 . . . . 73.14 110.904 -176.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.513 HD13 ' HB2' ' B' ' 34' ' ' LYS . 68.8 mt -102.04 103.41 14.0 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 124.664 1.186 . . . . 71.51 109.196 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.96 -124.59 7.88 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.794 -0.639 . . . . 62.31 111.986 -175.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -96.08 2.24 53.1 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.937 0.895 . . . . 74.12 111.037 -173.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.526 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 19.9 pt-20 -130.16 149.38 51.89 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.988 0.515 . . . . 73.3 110.901 -173.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 85.9 m -73.73 123.68 24.57 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.014 -0.539 . . . . 75.32 110.673 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.562 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -76.35 -60.94 2.12 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.651 -1.159 . . . . 74.51 108.704 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -153.13 152.71 31.58 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.058 -0.974 . . . . 75.11 111.85 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 75.2 mt -121.05 110.62 16.46 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.53 -1.656 . . . . 74.51 106.53 169.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 28.9 t -119.28 121.25 39.21 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.028 -0.73 . . . . 73.14 109.028 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -138.22 128.49 26.0 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.244 0.618 . . . . 74.34 109.409 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.406 HG11 ' HA ' ' B' ' 110' ' ' ALA . 73.3 t -126.44 134.94 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.596 0.758 . . . . 70.0 109.172 175.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.504 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.3 mt-30 -108.67 107.72 18.3 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.305 -0.998 . . . . 75.31 108.305 175.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -100.8 107.81 19.46 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.753 -0.832 . . . . 74.0 108.753 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.407 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -91.73 170.01 33.16 Favored Glycine 0 C--O 1.245 0.784 0 N-CA-C 111.865 -0.494 . . . . 54.22 111.865 175.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.53 139.66 5.78 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 121.727 -0.273 . . . . 71.22 113.069 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.433 HG13 ' HE1' ' B' ' 17' ' ' TYR . 66.5 mt -98.23 110.75 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 125.019 1.327 . . . . 75.04 108.182 176.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -122.79 143.95 49.5 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.713 0.805 . . . . 74.43 110.839 -175.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 37.1 m -102.2 122.94 45.16 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.73 0.812 . . . . 70.3 109.894 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.519 ' HB ' HD13 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -131.89 122.74 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 124.911 1.284 . . . . 75.3 109.302 179.266 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.541 ' HA ' ' HB ' ' F' ' 97' ' ' ILE . . . -156.94 150.51 24.4 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.885 0.474 . . . . 62.51 111.579 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.36 -35.67 4.73 Favored Glycine 0 N--CA 1.479 1.503 0 C-N-CA 123.263 0.458 . . . . 75.22 112.394 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.525 HG22 ' SD ' ' B' ' 9' ' ' MET . 7.1 pt -63.75 160.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 124.891 1.276 . . . . 73.34 112.655 173.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -153.78 176.07 12.57 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.023 0.929 . . . . 75.41 110.317 -173.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.4 -130.86 41.2 Favored Glycine 0 C--N 1.354 1.533 0 O-C-N 123.73 0.643 . . . . 74.42 112.859 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 18.0 m -67.5 -45.29 76.26 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.678 0.791 . . . . 75.34 109.75 172.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -59.12 -23.66 62.31 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 113.556 -1.656 . . . . 74.3 112.238 -167.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.448 ' HE1' HG12 ' F' ' 97' ' ' ILE . 20.6 ttt -58.6 -70.23 0.15 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.014 1.326 . . . . 74.13 111.931 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.39 -12.8 56.08 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.803 0.441 . . . . 70.25 112.137 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -63.24 -41.78 99.11 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.355 0.662 . . . . 72.21 110.267 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -60.69 -43.64 97.5 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.855 -0.611 . . . . 72.31 111.6 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.563 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.2 pp -81.28 -23.83 37.67 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.726 0.41 . . . . 73.15 111.776 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.51 -1.61 60.46 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-O 119.784 -0.453 . . . . 65.43 113.877 -174.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.47 -55.99 0.39 Allowed 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.303 0.551 . . . . 70.42 111.891 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -69.11 -46.23 68.23 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.745 0.418 . . . . 74.25 110.33 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.563 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 79.3 m -66.19 -47.98 59.85 Favored Pre-proline 0 CA--C 1.569 1.687 0 N-CA-C 113.711 1.004 . . . . 73.4 113.711 -177.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.44 ' HG3' HG22 ' B' ' 58' ' ' VAL . 15.2 Cg_exo -65.12 -28.82 56.52 Favored 'Trans proline' 0 C--N 1.402 3.359 0 C-N-CA 122.033 1.822 . . . . 72.24 112.87 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -69.62 -29.03 66.44 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.092 0.557 . . . . 73.05 110.325 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.23 -35.69 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.339 0.656 . . . . 74.41 110.334 170.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 76.5 mt -80.26 -17.98 50.68 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.821 0.848 . . . . 74.12 112.33 -177.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -59.42 -50.71 85.89 Favored Pre-proline 0 CA--C 1.561 1.375 0 CA-C-O 117.515 -1.231 . . . . 73.02 112.898 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -54.73 -37.11 91.84 Favored 'Trans proline' 0 C--N 1.39 2.727 0 C-N-CA 122.429 2.086 . . . . 70.2 114.028 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.414 ' HE2' HG23 ' D' ' 115' ' ' THR . 55.5 m-85 -68.73 -46.69 68.24 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.376 0.671 . . . . 74.1 110.583 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.406 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -64.55 -34.72 78.91 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.592 -0.731 . . . . 63.5 110.924 176.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 31.2 ttt180 -64.99 -50.13 67.54 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.226 1.41 . . . . 73.45 110.813 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.38 -32.52 70.21 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.403 0.681 . . . . 64.51 109.933 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.547 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.9 t -67.31 -41.37 85.46 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 122.923 0.489 . . . . 71.11 110.728 177.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 49.8 mt -59.83 -54.42 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.837 0.855 . . . . 74.34 110.445 172.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 25.1 m -61.79 -29.22 70.0 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 123.757 0.661 . . . . 75.24 111.371 -177.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 44.6 t -64.5 -52.44 57.83 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 123.543 0.737 . . . . 74.5 109.839 173.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.547 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 15.6 mmt -66.02 -33.62 76.22 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.27 0.628 . . . . 72.15 111.612 -175.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.658 HG23 HD21 ' B' ' 126' ' ' LEU . 74.3 t -66.76 -44.48 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.639 1.176 . . . . 75.45 110.602 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.5 t -64.66 -32.83 74.67 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.099 -0.955 . . . . 74.22 110.567 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' B' ' 116' ' ' SER . 78.5 mtt-85 -64.67 -47.78 77.16 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 115.709 -0.678 . . . . 73.44 109.339 175.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -67.95 -5.99 42.71 Favored Glycine 0 C--N 1.358 1.772 0 O-C-N 123.735 0.647 . . . . 31.31 113.615 174.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.49 ' HB ' ' HE ' ' A' ' 15' ' ' ARG . 2.2 m 66.77 27.62 9.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.539 1.536 . . . . 74.51 110.563 175.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -84.87 156.06 61.18 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.214 0.605 . . . . 74.32 110.971 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.586 ' HG3' ' HB3' ' F' ' 131' ' ' TRP . 71.6 Cg_exo -51.89 167.86 0.41 Allowed 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 123.991 3.127 . . . . 71.22 115.219 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -63.52 112.56 2.83 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.832 -1.076 . . . . 74.4 111.605 -167.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.658 HD21 HG23 ' B' ' 118' ' ' VAL . 43.6 tp -116.56 105.82 12.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.282 0.633 . . . . 74.35 109.56 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -121.49 120.96 36.41 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.034 -1.098 . . . . 74.41 108.034 170.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.602 HD21 HD12 ' B' ' 42' ' ' LEU . 59.2 mt -74.21 143.92 44.96 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.58 0.55 . . . . 71.14 110.988 -174.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.91 141.14 63.19 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 122.961 0.504 . . . . 74.11 110.843 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.627 ' HG3' HD11 ' D' ' 16' ' ' ILE . 61.7 Cg_endo -70.14 79.98 1.02 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.334 2.689 . . . . 73.33 111.216 174.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 p -100.01 125.42 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 115.498 -0.774 . . . . 74.44 110.053 -177.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -83.06 107.69 15.82 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.677 -0.692 . . . . 74.35 110.108 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -76.56 -27.91 56.06 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.428 0.691 . . . . 74.42 110.977 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -55.43 -40.37 71.41 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.144 0.978 . . . . 71.54 112.118 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.88 -34.07 62.61 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.658 0.783 . . . . 62.44 112.25 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 5.9 mp -72.53 -35.3 68.03 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.494 0.718 . . . . 75.15 110.202 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -72.18 -36.13 69.18 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.409 -0.36 . . . . 71.53 111.092 170.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 2.4 mmt -75.06 -29.35 60.69 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 113.079 0.77 . . . . 73.52 113.079 -170.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -82.02 -39.19 23.9 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.35 0.26 . . . . 75.24 110.5 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -76.72 -47.56 21.51 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.642 0.377 . . . . 72.12 111.277 -175.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 69.9 mt -93.11 25.22 3.36 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.376 1.07 . . . . 75.54 110.715 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -72.44 171.23 12.68 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.397 0.679 . . . . 75.1 109.629 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 73.1 128.96 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.262 1.425 . . . . 75.4 111.318 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.18 159.25 42.61 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 107.131 -1.433 . . . . 73.22 107.131 -173.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.0 96.82 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.525 0.73 . . . . 71.22 110.249 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.41 -49.08 0.58 Allowed Glycine 0 C--N 1.34 0.785 0 N-CA-C 110.093 -1.203 . . . . 73.34 110.093 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 68.81 130.92 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 126.215 1.806 . . . . 74.23 113.369 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -120.18 90.75 0.48 Allowed Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.013 -0.835 . . . . 71.44 111.013 173.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 8.2 p -79.6 71.45 6.22 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.454 0.702 . . . . 72.5 110.456 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -82.67 105.89 14.07 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 107.949 -1.13 . . . . 73.15 107.949 171.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -64.94 125.26 24.33 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.059 0.944 . . . . 75.44 110.892 -173.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -121.88 127.11 50.1 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.849 0.86 . . . . 71.24 109.432 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -74.61 140.9 44.65 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 109.76 -0.459 . . . . 75.31 109.76 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -72.91 -62.55 1.42 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.522 0.729 . . . . 72.33 109.061 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.132 0 C-N-CA 124.344 1.058 . . . . 74.21 108.402 177.347 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 109.445 -0.576 . . . . 75.34 109.445 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 53.7 m -163.44 96.99 0.88 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.923 1.289 . . . . 72.53 108.517 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -110.81 150.29 29.34 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 108.801 -0.815 . . . . 74.14 108.801 168.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . 0.665 HE22 ' HG3' ' C' ' 153' ' ' GLN . 12.0 pt20 -147.81 -167.02 2.68 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.016 0.526 . . . . 75.4 111.172 -161.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -61.87 115.13 3.77 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-N 114.954 -1.021 . . . . 74.41 109.419 167.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.77 -73.41 0.23 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.913 -1.143 . . . . 74.1 107.913 -175.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' THR . . . . . 0.424 HG22 ' HG3' ' A' ' 150' ' ' GLU . 22.0 m -110.1 161.44 15.54 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 124.132 0.973 . . . . 74.24 110.275 -169.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -64.14 81.83 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.379 1.072 . . . . 74.55 108.808 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.519 ' HE1' HD12 ' C' ' 89' ' ' ILE . 59.8 ttm 60.74 113.47 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.367 1.467 . . . . 72.3 110.282 -162.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.413 HG22 ' HB3' ' A' ' 150' ' ' GLU . 16.9 m -86.2 85.63 7.35 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.246 -1.02 . . . . 75.32 108.246 172.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.406 ' HB2' ' HG2' ' C' ' 9' ' ' MET . 68.3 t80 -109.48 145.25 36.54 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.71 0.804 . . . . 72.0 109.264 -174.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -161.97 126.54 3.32 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.559 0.744 . . . . 75.32 109.591 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 48.5 mt -78.84 123.59 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 108.438 -0.949 . . . . 74.24 108.438 169.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.447 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 81.6 mm-40 -90.44 -42.12 11.07 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.644 0.777 . . . . 72.43 109.688 176.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.477 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 9.0 ptp85 -173.42 150.9 1.89 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.312 -0.858 . . . . 74.53 110.212 -178.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 74.3 mt -128.17 135.15 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 106.731 -1.581 . . . . 73.53 106.731 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -173.06 158.64 3.77 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.379 0.609 . . . . 72.41 111.724 -170.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 70.2 p -82.46 113.24 20.08 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.341 -0.845 . . . . 74.14 109.123 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.439 ' HE3' ' HB2' ' D' ' 28' ' ' ALA . 10.4 mmmm -68.61 -49.13 61.64 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.046 -1.094 . . . . 73.11 108.046 169.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.697 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 20.8 t70 -136.19 143.68 44.54 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 113.852 -1.522 . . . . 73.44 109.681 -172.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.55 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.5 mt -138.47 145.66 27.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 125.435 1.494 . . . . 75.23 107.25 175.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 41.3 t -153.17 147.75 26.12 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.463 0.649 . . . . 74.1 110.048 175.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -151.83 125.61 9.04 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.04 -1.467 . . . . 74.44 107.04 170.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -129.35 117.81 21.23 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.682 0.793 . . . . 71.05 108.867 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.22 85.62 5.62 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 107.304 -1.369 . . . . 75.41 107.304 167.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.91 -33.61 63.11 Favored 'Trans proline' 0 C--N 1.387 2.605 0 C-N-CA 123.097 2.531 . . . . 72.51 112.209 -172.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -113.6 31.51 6.45 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.861 -1.063 . . . . 73.0 109.605 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.452 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -43.91 -54.68 10.54 Favored Pre-proline 0 C--N 1.377 1.764 0 CA-C-O 117.837 -1.078 . . . . 71.01 113.383 -174.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 50.1 Cg_exo -53.28 -52.16 9.33 Favored 'Trans proline' 0 C--N 1.395 3.003 0 C-N-CA 122.001 1.801 . . . . 74.41 113.128 175.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -69.52 -32.57 71.49 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.608 -1.178 . . . . 74.4 113.2 -171.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.628 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.9 p -79.05 -24.44 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 N-CA-C 112.48 0.548 . . . . 73.51 112.48 -173.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -71.42 -17.86 62.36 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 112.349 0.5 . . . . 71.51 112.349 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -93.75 7.39 45.01 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.918 0.487 . . . . 75.01 111.759 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.687 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -94.62 158.74 15.39 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.232 0.613 . . . . 71.42 110.788 -177.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -68.22 129.65 40.55 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.057 0.943 . . . . 65.43 109.539 164.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.556 ' HZ2' HD21 ' C' ' 126' ' ' LEU . 64.0 t-105 -82.24 90.49 6.62 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.211 0.604 . . . . 74.41 110.5 -178.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -143.14 78.38 15.16 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 107.709 -1.219 . . . . 74.35 107.709 171.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -93.79 169.85 1.99 Allowed 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 122.527 2.151 . . . . 64.35 112.835 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -92.78 89.76 6.76 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 106.181 -1.785 . . . . 71.54 106.181 171.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 61.2 t -68.16 96.97 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 109.037 -0.727 . . . . 74.14 109.037 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -96.75 104.68 16.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.884 -1.053 . . . . 74.42 108.641 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.611 ' H ' HD23 ' C' ' 42' ' ' LEU . 1.8 pt? -97.07 121.14 38.62 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.788 -1.56 . . . . 74.13 106.788 168.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -119.39 141.12 49.36 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.571 -0.9 . . . . 72.1 108.571 -174.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 50.0 mt -130.97 110.74 11.47 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.32 0.648 . . . . 65.54 110.165 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -114.54 122.86 47.85 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.967 1.707 . . . . 73.13 107.469 173.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.1 t -121.8 149.28 43.55 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.029 -0.73 . . . . 73.1 109.029 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.45 153.57 32.74 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.543 0.737 . . . . 75.42 109.281 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.448 ' HG ' ' HB3' ' C' ' 98' ' ' LEU . 12.8 m -131.71 145.36 51.59 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.304 0.642 . . . . 74.13 109.414 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.3 p -144.91 127.37 15.96 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.566 -0.901 . . . . 75.21 108.566 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -80.28 117.91 21.47 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 108.717 -0.846 . . . . 72.13 108.717 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.465 HD11 HD13 ' C' ' 83' ' ' ILE . 25.6 mt -83.82 -47.18 11.39 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.585 0.707 . . . . 71.34 109.656 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.57 -166.96 2.69 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 114.486 -1.233 . . . . 63.51 110.029 -171.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -57.77 105.0 0.22 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.399 1.079 . . . . 71.33 110.535 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 60.1 22.17 11.41 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.329 1.018 . . . . 75.34 112.978 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 85.6 t -104.3 119.64 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.661 0.785 . . . . 74.41 108.989 173.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -121.28 121.31 37.42 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.821 -1.177 . . . . 75.43 107.821 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -89.93 114.43 26.23 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.033 -1.099 . . . . 71.2 108.033 168.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 97.9 t -95.14 134.94 30.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.278 -1.379 . . . . 61.34 107.278 168.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 93.8 t -121.11 138.0 52.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 108.356 -0.979 . . . . 64.45 108.356 174.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.27 101.08 8.84 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.994 -1.113 . . . . 74.33 107.994 175.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 21.0 ttm-85 -81.07 107.13 13.62 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 108.434 -0.95 . . . . 74.44 108.434 170.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.491 ' HB ' HD11 ' C' ' 114' ' ' ILE . 7.8 t -106.58 120.11 57.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 108.09 -1.078 . . . . 70.32 108.09 173.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 17.5 m -119.21 116.16 25.72 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.251 0.621 . . . . 64.02 109.572 -174.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.528 HG21 HG21 ' C' ' 114' ' ' ILE . 63.3 t -104.06 109.04 26.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 123.452 0.701 . . . . 75.55 109.114 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 3.8 m -99.4 140.1 34.08 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.668 -1.234 . . . . 64.23 107.668 170.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.41 119.42 19.62 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 106.661 -1.607 . . . . 74.25 106.661 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 44.9 m -133.29 126.02 30.54 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.579 0.549 . . . . 65.1 110.452 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.687 HD11 ' HG2' ' C' ' 34' ' ' LYS . 11.0 mt -86.78 47.08 1.44 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.766 1.226 . . . . 65.33 109.317 176.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.65 -110.8 3.84 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 111.001 -0.84 . . . . 71.03 111.001 -174.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.16 -28.87 19.73 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.093 -0.706 . . . . 75.34 109.093 173.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -62.86 120.67 11.76 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.584 1.153 . . . . 75.32 109.194 172.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 20.9 m -84.24 125.06 31.87 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 108.443 -0.947 . . . . 75.13 108.443 169.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.628 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -73.45 -62.97 1.29 Allowed 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.328 -0.99 . . . . 64.4 108.328 174.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -157.33 169.89 23.7 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-O 121.917 0.865 . . . . 73.31 110.782 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.431 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.7 tm? -123.43 147.01 47.56 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 106.388 -1.708 . . . . 74.34 106.388 166.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.431 ' N ' HD13 ' C' ' 75' ' ' LEU . 48.4 t -149.22 145.62 27.2 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.846 -1.168 . . . . 71.15 107.846 177.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -157.07 136.56 12.17 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.301 -0.629 . . . . 74.15 109.301 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.476 HG12 ' HA ' ' C' ' 110' ' ' ALA . 54.7 t -134.22 113.52 17.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.136 -1.061 . . . . 63.3 108.136 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.697 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.4 mt-30 -94.44 89.21 5.77 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.828 -0.805 . . . . 74.42 108.828 173.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -79.68 102.4 8.94 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.509 -1.223 . . . . 74.55 110.09 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.58 150.47 26.93 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 112.007 -0.437 . . . . 61.41 112.007 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.22 117.69 0.84 Allowed Glycine 0 CA--C 1.502 -0.771 0 N-CA-C 110.233 -1.147 . . . . 63.3 110.233 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.474 HD11 ' HB3' ' D' ' 29' ' ' PRO . 25.5 mm -85.23 121.15 36.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.53 -0.915 . . . . 73.51 108.53 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -129.9 117.18 19.74 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.16 -1.052 . . . . 72.22 108.16 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 53.9 p -90.45 103.5 16.18 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.954 -0.758 . . . . 63.35 108.954 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.497 HD12 ' SG ' ' C' ' 97' ' ' CYS . 25.4 mt -116.86 138.74 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.146 0.978 . . . . 74.1 110.746 -171.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.06 170.4 19.48 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.657 0.783 . . . . 73.3 110.869 175.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.83 -18.67 38.01 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-N 115.534 -0.757 . . . . 50.22 113.756 172.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.519 HD12 ' HE1' ' C' ' 9' ' ' MET . 34.8 pt -106.33 170.59 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.232 0.613 . . . . 72.3 111.261 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -160.81 158.84 29.13 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.645 0.778 . . . . 74.14 109.854 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.55 -114.76 7.1 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 123.615 0.572 . . . . 74.13 113.846 168.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 13.4 t -66.25 -35.5 80.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.635 0.774 . . . . 74.53 111.082 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.446 HE21 HG23 ' C' ' 89' ' ' ILE . 29.5 mt-30 -71.81 -42.66 66.78 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.646 0.778 . . . . 73.44 110.622 -178.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 6.2 tpt -62.5 -52.36 63.78 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 123.923 0.765 . . . . 75.33 110.024 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.87 -31.42 72.59 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.753 -0.658 . . . . 75.23 111.817 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -72.17 -34.18 68.26 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.142 0.577 . . . . 70.1 110.553 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.497 ' SG ' HD12 ' C' ' 86' ' ' ILE . 18.2 t -71.2 -41.37 70.35 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.699 -0.482 . . . . 71.34 109.699 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.448 ' HB3' ' HG ' ' C' ' 48' ' ' SER . 89.9 mt -85.05 -44.51 12.96 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.959 0.904 . . . . 72.21 112.815 -170.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.52 3.17 57.68 Favored Glycine 0 N--CA 1.472 1.072 0 CA-C-N 116.067 -0.515 . . . . 43.31 113.481 -170.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.31 -68.98 0.45 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.999 0.4 . . . . 64.2 111.096 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -60.21 -55.1 37.93 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.765 0.826 . . . . 72.14 112.475 -171.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 98.2 m -59.75 -46.74 98.45 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.794 0.838 . . . . 72.13 112.523 -177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -50.85 -35.21 48.09 Favored 'Trans proline' 0 C--N 1.395 3.018 0 C-N-CA 123.071 2.514 . . . . 75.02 115.119 169.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -66.8 -33.9 76.63 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 118.719 0.69 . . . . 74.32 111.075 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.528 HD13 ' NH1' ' A' ' 111' ' ' ARG . 42.0 mm -72.53 -34.83 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 123.004 0.521 . . . . 75.34 109.907 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 89.4 mt -84.49 -24.56 29.37 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.855 0.862 . . . . 70.5 112.326 -177.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -57.05 -52.11 76.6 Favored Pre-proline 0 N--CA 1.482 1.137 0 CA-C-O 117.334 -1.317 . . . . 71.15 113.867 -172.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.01 -34.41 80.65 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.168 1.912 . . . . 74.54 112.915 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -66.35 -47.62 72.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.483 0.713 . . . . 74.32 110.236 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.476 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -63.39 -36.88 85.2 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.855 -1.066 . . . . 73.15 110.943 177.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.2 ttt-85 -68.99 -46.57 67.71 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.409 1.484 . . . . 75.34 111.176 -175.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -67.97 -34.33 76.36 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.528 0.731 . . . . 71.35 109.486 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 12.8 t -65.86 -35.67 81.32 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.462 0.705 . . . . 74.22 111.249 177.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.528 HG21 HG21 ' C' ' 64' ' ' VAL . 85.7 mt -69.23 -58.04 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.345 0.658 . . . . 72.43 110.485 176.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 4.7 m -64.43 -28.38 69.64 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 122.707 0.403 . . . . 70.03 111.249 -173.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 42.0 t -61.6 -52.78 62.99 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 123.279 0.632 . . . . 72.52 109.37 169.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.571 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.08 -42.59 80.96 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.011 1.324 . . . . 74.43 113.002 -179.568 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 87.3 t -63.62 -45.67 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.381 1.072 . . . . 72.34 110.253 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.4 t -67.52 -29.67 69.13 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.281 -1.327 . . . . 74.13 111.429 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.487 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 87.3 mtt-85 -68.59 -39.53 80.89 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.072 -0.714 . . . . 74.43 109.072 176.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.79 12.03 58.04 Favored Glycine 0 C--N 1.354 1.535 0 CA-C-N 115.698 -0.683 . . . . 71.01 113.0 175.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 69.0 p 53.8 37.53 26.56 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 126.212 1.805 . . . . 75.33 114.146 175.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -93.99 148.03 34.52 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 107.583 -1.266 . . . . 74.14 107.583 165.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.01 169.45 0.64 Allowed 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.224 2.616 . . . . 73.0 114.168 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -59.32 123.3 16.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.159 0.984 . . . . 74.32 111.975 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.556 HD21 ' HZ2' ' C' ' 36' ' ' TRP . 3.5 mm? -116.27 86.14 2.43 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.674 -1.232 . . . . 74.13 107.674 166.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -91.46 95.17 9.82 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.727 -0.842 . . . . 74.41 108.727 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.444 ' HA ' HG23 ' F' ' 135' ' ' VAL . 8.5 mp -55.84 131.01 45.85 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.102 0.961 . . . . 73.23 111.583 -175.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.44 137.08 96.48 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-O 118.694 -0.669 . . . . 75.53 110.453 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.469 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 4.2 Cg_endo -49.52 110.91 0.41 Allowed 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.673 2.915 . . . . 73.4 113.442 178.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.9 t -100.93 114.55 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 123.142 0.577 . . . . 75.41 109.455 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -80.88 105.7 12.32 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.421 0.689 . . . . 73.32 109.418 176.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -68.8 -20.78 64.34 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.372 0.669 . . . . 75.33 112.329 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.55 -29.85 65.22 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.116 0.566 . . . . 65.51 110.554 173.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.01 -35.0 64.36 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.064 0.546 . . . . 73.21 110.004 173.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.412 ' HA ' ' ND2' ' C' ' 139' ' ' ASN . 83.1 mt -67.68 -40.28 84.42 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.82 -0.627 . . . . 71.3 110.418 175.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -72.09 -31.47 66.1 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.741 0.816 . . . . 75.32 110.488 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 23.5 ttt -60.54 -52.13 66.49 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.898 0.879 . . . . 73.34 110.524 177.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . 0.412 ' ND2' ' HA ' ' C' ' 136' ' ' LEU . 11.4 p30 -71.45 -36.02 71.08 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 116.477 -0.329 . . . . 75.41 110.882 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -64.47 -86.43 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.964 0.906 . . . . 75.23 111.354 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 54.4 tp -152.31 117.87 5.34 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.456 0.702 . . . . 74.02 109.578 -172.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -155.36 154.13 31.53 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.372 1.069 . . . . 73.12 109.7 172.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -170.52 91.3 0.17 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 107.921 -1.14 . . . . 75.23 107.921 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -54.17 132.48 43.24 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.171 0.989 . . . . 72.35 111.658 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -87.72 175.41 7.88 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.629 0.772 . . . . 61.05 111.268 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -108.76 3.32 32.14 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 116.036 -0.529 . . . . 73.13 113.071 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -89.87 149.24 22.73 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.807 0.843 . . . . 72.21 110.597 -174.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -132.74 136.68 8.87 Favored Glycine 0 C--N 1.346 1.095 0 N-CA-C 111.064 -0.814 . . . . 51.21 111.064 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 10.0 t -67.38 150.55 48.8 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.144 0.978 . . . . 73.11 110.652 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -135.92 146.32 47.21 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.15 0.5 . . . . 72.3 110.822 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.47 138.05 56.31 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.806 1.243 . . . . 75.42 109.834 170.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -144.74 -52.82 0.3 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.228 0.611 . . . . 72.43 109.809 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . 0.665 ' HG3' HE22 ' C' ' 4' ' ' GLN . 8.0 pt20 -148.49 78.17 1.41 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.05 -1.093 . . . . 75.21 108.05 -178.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -162.05 131.48 4.51 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.184 -0.916 . . . . 73.42 110.008 -177.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 N-CA-C 108.667 -0.864 . . . . 62.52 108.667 -179.784 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.13 -0.693 . . . . 75.33 109.13 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 41.1 m -90.96 90.34 7.84 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.002 -0.74 . . . . 64.11 109.002 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -82.58 -28.95 30.56 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 109.588 -0.523 . . . . 65.42 109.588 171.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -69.41 129.94 41.15 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.673 0.789 . . . . 75.31 110.157 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -144.64 172.49 12.91 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.571 0.748 . . . . 71.53 110.497 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -111.32 124.24 51.84 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 108.482 -0.933 . . . . 75.4 108.482 173.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 3.2 p -144.03 -57.64 0.38 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.391 1.077 . . . . 70.24 109.749 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' D' ' 9' ' ' MET . 24.1 tt0 -143.38 -170.49 3.29 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.881 0.872 . . . . 75.51 109.169 -176.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.449 ' H ' ' HG2' ' D' ' 8' ' ' GLU . 0.6 OUTLIER -29.25 128.02 0.1 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 126.3 1.84 . . . . 75.24 113.14 174.553 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 39.9 p -104.17 116.99 33.18 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.408 0.683 . . . . 64.14 109.525 -175.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.489 ' HA ' ' O ' ' D' ' 85' ' ' SER . 58.5 t80 -134.5 105.41 6.53 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.648 -1.242 . . . . 70.32 107.648 175.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -129.83 115.82 17.8 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.724 -0.843 . . . . 64.51 108.724 -174.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.514 HD11 HG21 ' D' ' 105' ' ' ILE . 8.1 mt -76.04 122.53 30.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 108.314 -0.995 . . . . 73.41 108.314 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -89.16 -29.05 19.6 Favored 'General case' 0 C--O 1.242 0.675 0 O-C-N 123.822 0.701 . . . . 72.34 110.982 -176.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -172.77 138.2 0.81 Allowed 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.464 0.477 . . . . 74.51 110.146 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.627 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.5 mp -120.88 135.97 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.681 -1.229 . . . . 73.44 107.681 173.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -162.4 170.14 19.3 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.207 1.003 . . . . 72.23 112.85 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.5 p -105.05 119.24 38.54 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.224 -1.353 . . . . 63.51 108.509 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -88.0 -21.29 24.9 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.035 -0.53 . . . . 75.32 109.925 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 31.8 t70 -159.9 138.61 10.6 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.182 0.993 . . . . 63.14 109.219 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.571 HG23 ' HE1' ' C' ' 117' ' ' MET . 72.5 mt -139.77 138.29 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.971 1.308 . . . . 73.35 107.802 176.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.5 t -139.69 143.35 37.05 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.104 0.962 . . . . 74.21 109.008 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.55 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 91.7 t80 -150.0 122.99 8.78 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 106.612 -1.625 . . . . 73.34 106.612 170.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.63 111.65 11.9 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.715 0.806 . . . . 62.41 109.584 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.93 84.66 4.47 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 107.665 -1.235 . . . . 70.33 107.665 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.16 -43.64 0.53 Allowed 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.415 2.077 . . . . 73.42 112.336 -171.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -93.81 10.52 32.77 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.256 1.022 . . . . 72.21 110.414 -176.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.439 ' HB2' ' HE3' ' C' ' 19' ' ' LYS . . . -31.69 -64.79 0.22 Allowed Pre-proline 0 N--CA 1.488 1.441 0 C-N-CA 127.259 2.224 . . . . 71.31 116.334 -166.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.474 ' HB3' HD11 ' C' ' 83' ' ' ILE . 93.5 Cg_endo -75.84 -21.65 14.13 Favored 'Trans proline' 0 C--N 1.38 2.222 0 CA-C-N 122.735 2.013 . . . . 74.53 114.073 -175.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -77.33 -37.29 52.79 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.377 1.071 . . . . 73.44 109.909 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.418 HG21 ' HB2' ' D' ' 68' ' ' LEU . 7.7 p -82.98 -25.57 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-N 115.452 -0.795 . . . . 72.44 111.308 -172.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -60.65 -25.78 66.58 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 122.883 0.473 . . . . 74.43 112.099 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -64.9 -8.66 16.43 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.776 1.23 . . . . 73.05 112.231 -175.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.55 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 89.6 mttt -96.41 95.01 7.75 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.2 1.4 . . . . 75.44 109.041 175.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -81.91 81.71 7.8 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.356 0.662 . . . . 74.11 111.093 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -160.78 -179.88 7.95 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.18 0.992 . . . . 72.12 109.1 166.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.422 ' NE2' ' HD2' ' D' ' 38' ' ' PRO . 35.3 tp60 -75.78 114.12 33.61 Favored Pre-proline 0 N--CA 1.477 0.9 0 CA-C-O 118.294 -0.86 . . . . 72.31 109.167 178.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.422 ' HD2' ' NE2' ' D' ' 37' ' ' GLN . 51.1 Cg_exo -53.35 134.79 58.54 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.045 2.497 . . . . 75.02 111.856 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -63.81 107.82 1.3 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 107.623 -1.251 . . . . 74.22 107.623 175.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.661 HG11 HG13 ' D' ' 64' ' ' VAL . 86.5 t -104.4 129.55 56.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 109.416 -0.587 . . . . 75.5 109.416 -176.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -105.35 112.28 25.33 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 106.348 -1.723 . . . . 73.55 106.348 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.486 HD21 ' HB2' ' D' ' 128' ' ' LEU . 64.8 tp -94.33 150.02 20.68 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.678 -1.23 . . . . 72.52 107.678 174.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -148.27 140.07 23.83 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.255 -1.017 . . . . 75.23 108.255 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.587 HD11 HG22 ' E' ' 121' ' ' VAL . 91.4 mt -130.7 145.09 51.85 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.584 0.754 . . . . 73.02 109.452 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -155.62 141.35 18.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.766 -1.198 . . . . 73.41 107.766 169.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 46' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' E' ' 106' ' ' TYR . 25.9 m -102.84 156.18 17.83 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.214 1.005 . . . . 74.22 109.292 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.09 167.13 26.7 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 126.039 1.736 . . . . 74.32 106.8 172.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 13.5 p -165.84 -164.86 0.75 Allowed 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.306 -0.627 . . . . 70.45 109.306 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 33.3 p -149.31 133.8 17.58 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 122.994 0.518 . . . . 64.22 110.129 -176.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -82.97 97.84 8.93 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 116.004 -0.544 . . . . 74.43 109.798 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 47.2 tp -140.69 112.56 7.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 106.738 -1.578 . . . . 71.52 106.738 174.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.25 -161.17 0.14 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.455 0.302 . . . . 74.41 110.751 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 68.69 23.07 7.22 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.997 0.919 . . . . 71.23 109.76 -164.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' D' ' 85' ' ' SER . 1.9 m-20 64.13 15.38 9.26 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.745 1.618 . . . . 73.32 112.011 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.26 94.88 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 109.054 -0.721 . . . . 73.43 109.054 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -122.95 127.99 49.64 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.787 -0.82 . . . . 74.45 108.787 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -94.64 119.42 33.27 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.468 -0.938 . . . . 60.33 108.468 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 73.8 t -101.33 134.45 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.853 0.861 . . . . 71.13 108.851 173.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.499 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 33.4 t -116.02 128.44 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.185 0.994 . . . . 63.44 108.745 173.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.39 111.69 24.14 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.86 -1.163 . . . . 72.44 107.86 175.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 ttt85 -85.82 106.48 17.08 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.233 -0.655 . . . . 73.54 109.233 174.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' D' ' 110' ' ' ALA . 61.1 t -105.75 130.65 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.268 1.027 . . . . 73.22 108.624 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 7.3 m -134.75 144.46 47.72 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.014 0.435 . . . . 73.44 110.964 -173.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.661 HG13 HG11 ' D' ' 40' ' ' VAL . 55.0 t -133.85 114.28 19.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 C-N-CA 125.447 1.499 . . . . 65.43 108.902 -173.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 19.2 m -106.12 93.46 4.63 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.074 -1.084 . . . . 74.43 108.074 169.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.08 144.94 27.04 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.363 0.665 . . . . 72.25 109.937 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.428 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 48.2 m -151.89 127.85 10.35 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 123.424 0.69 . . . . 75.13 110.879 -177.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.418 ' HB2' HG21 ' D' ' 31' ' ' VAL . 16.6 mt -93.45 109.31 20.9 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 107.764 -1.199 . . . . 74.32 107.764 168.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.19 -124.32 8.27 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 116.064 -0.516 . . . . 74.35 112.496 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.15 3.99 28.55 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.329 0.652 . . . . 72.45 111.775 -176.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.55 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 11.8 pt-20 -118.42 158.88 24.46 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 109.574 -0.528 . . . . 73.42 109.574 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 52.0 m -72.43 129.56 38.63 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.615 -0.72 . . . . 74.31 111.685 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.428 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -81.54 -69.19 0.63 Allowed 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.829 -1.174 . . . . 72.31 107.829 173.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -153.54 153.77 33.03 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 115.841 -0.618 . . . . 74.43 111.105 176.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 50.0 mt -119.32 109.93 16.38 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.396 -1.335 . . . . 75.41 107.396 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.537 ' SG ' HG12 ' D' ' 114' ' ' ILE . 42.0 t -120.61 136.98 54.66 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 123.544 0.737 . . . . 74.31 109.586 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -152.06 123.88 7.98 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.9 0.48 . . . . 74.0 109.794 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 88.3 t -127.58 118.52 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.926 0.89 . . . . 73.21 109.836 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.413 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.2 mt-30 -90.72 90.13 7.82 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.517 0.727 . . . . 71.24 109.251 171.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -82.77 98.74 9.26 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.723 -1.126 . . . . 74.23 109.422 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -102.19 156.4 18.55 Favored Glycine 0 N--CA 1.471 1.012 0 N-CA-C 112.077 -0.409 . . . . 60.41 112.077 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.4 150.05 13.78 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 117.2 0.5 . . . . 64.12 112.619 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 57.5 mt -90.0 132.71 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 109.082 -0.71 . . . . 73.34 109.082 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -128.98 140.46 51.64 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.305 1.042 . . . . 73.04 109.575 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 39.8 t -93.59 108.27 20.01 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 107.682 -1.229 . . . . 71.32 107.682 168.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 33.9 pt -109.13 123.9 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 N-CA-C 108.654 -0.869 . . . . 74.04 108.654 172.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.45 168.29 6.52 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.173 0.589 . . . . 62.34 111.458 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.3 19.18 72.44 Favored Glycine 0 C--N 1.347 1.165 0 O-C-N 123.683 0.614 . . . . 61.4 112.941 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.43 164.25 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.266 1.027 . . . . 74.54 109.799 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -146.68 -179.35 6.72 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.749 0.82 . . . . 73.5 110.57 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.82 -140.29 27.64 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 115.984 -0.553 . . . . 71.3 112.472 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 60.8 p -89.62 -29.83 18.57 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.366 0.666 . . . . 74.04 110.752 172.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -53.4 -33.22 53.03 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.578 1.151 . . . . 74.12 112.474 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.875 ' HE1' ' HB3' ' E' ' 100' ' ' LEU . 2.9 ppp? -60.71 -50.63 72.72 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.876 0.87 . . . . 72.24 113.197 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . 0.492 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.25 -19.4 31.66 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.061 0.544 . . . . 71.13 110.978 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -67.88 -38.37 82.94 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.674 0.79 . . . . 74.11 110.49 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 86.9 m -61.15 -33.59 73.66 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.585 0.754 . . . . 72.21 111.587 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 27.0 tp -69.54 -37.57 77.13 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.916 0.486 . . . . 75.5 111.119 -176.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.2 0.11 68.47 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-O 119.388 -0.673 . . . . 74.44 113.6 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.75 -58.32 0.77 Allowed 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 117.74 0.77 . . . . 73.42 112.932 -171.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -72.35 -43.84 63.48 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.064 0.545 . . . . 75.2 110.925 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 75.2 m -60.45 -45.48 97.38 Favored Pre-proline 0 CA--C 1.571 1.752 0 C-N-CA 124.132 0.973 . . . . 70.41 112.166 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.28 -42.05 72.33 Favored 'Trans proline' 0 C--N 1.395 3.014 0 C-N-CA 123.188 2.592 . . . . 70.04 113.836 165.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -63.38 -24.88 68.03 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.537 0.735 . . . . 74.44 110.972 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.514 HG21 HD11 ' D' ' 13' ' ' ILE . 44.8 mm -75.84 -45.5 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.798 0.839 . . . . 73.14 110.545 172.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.04 -25.79 65.54 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.477 -0.783 . . . . 75.24 111.672 -176.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -68.57 -40.01 17.26 Favored Pre-proline 0 CA--C 1.563 1.467 0 N-CA-C 114.507 1.299 . . . . 73.24 114.507 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -47.83 -46.64 20.9 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.447 2.098 . . . . 71.31 113.69 167.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . 0.438 ' OH ' ' HB3' ' B' ' 130' ' ' PRO . 99.0 m-85 -72.26 -38.46 68.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.631 0.773 . . . . 74.14 111.096 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . 0.52 ' HB3' HG22 ' D' ' 62' ' ' VAL . . . -65.93 -38.73 89.43 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.842 0.857 . . . . 75.31 110.776 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.486 HH12 ' HB3' ' D' ' 130' ' ' PRO . 24.3 ttp-105 -66.02 -48.93 69.49 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 115.104 -0.953 . . . . 75.13 110.032 175.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -56.16 -47.63 77.85 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.64 1.213 . . . . 72.21 110.977 -175.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.401 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 48.5 t -56.74 -46.26 81.48 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 124.032 0.832 . . . . 74.14 111.331 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.537 HG12 ' SG ' ' D' ' 76' ' ' CYS . 62.6 mt -63.33 -57.08 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.962 0.905 . . . . 72.02 111.096 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.414 HG23 ' HE2' ' B' ' 109' ' ' TYR . 38.8 m -52.89 -43.13 65.94 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.527 1.131 . . . . 74.25 111.273 -175.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 29.7 t -63.49 -43.42 97.31 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 114.251 -1.341 . . . . 75.04 109.925 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.486 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 71.8 mtm -69.87 -30.33 67.77 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.12 0.568 . . . . 74.2 111.763 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.441 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.4 t -64.56 -45.97 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.508 0.723 . . . . 62.34 109.916 175.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.2 p -74.53 -29.72 61.5 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.636 -0.711 . . . . 74.51 110.74 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 66.5 mtt-85 -70.65 -30.2 66.75 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.639 0.775 . . . . 73.21 109.868 173.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.62 8.97 75.59 Favored Glycine 0 C--N 1.354 1.539 0 O-C-N 123.62 0.575 . . . . 71.02 112.898 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 78.0 p 54.95 27.56 9.35 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 126.167 1.787 . . . . 73.04 113.974 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -88.67 151.04 47.29 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 109.211 -0.663 . . . . 72.52 109.211 168.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.513 ' HB3' ' HA ' ' E' ' 129' ' ' THR . 90.5 Cg_exo -48.3 133.85 25.11 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.642 2.895 . . . . 74.12 113.002 171.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -56.5 128.63 37.09 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.754 0.822 . . . . 64.03 112.006 -170.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.542 HD12 HG23 ' D' ' 40' ' ' VAL . 28.9 tp -108.93 98.23 7.74 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.612 1.165 . . . . 74.34 109.419 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -99.58 80.88 2.42 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.884 -1.154 . . . . 75.03 107.884 174.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.591 HD21 ' H ' ' D' ' 128' ' ' LEU . 0.3 OUTLIER -58.44 112.3 1.53 Allowed 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.64 -1.164 . . . . 74.12 109.686 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.6 139.48 75.6 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 125.102 1.361 . . . . 65.33 113.064 -169.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.486 ' HB3' HH12 ' D' ' 111' ' ' ARG . 96.2 Cg_endo -76.75 155.89 35.11 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.95 2.433 . . . . 73.21 112.633 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 9.6 p -148.79 143.47 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.551 -0.75 . . . . 71.33 109.568 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -81.49 105.98 13.09 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.161 -1.052 . . . . 60.31 108.161 172.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -62.43 -30.57 71.33 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.154 0.982 . . . . 64.01 110.601 -177.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -61.23 -42.5 98.72 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.641 1.176 . . . . 64.03 110.827 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.73 -34.76 76.39 Favored 'General case' 0 C--N 1.35 0.596 0 CA-C-N 114.315 -1.311 . . . . 71.34 111.11 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.699 HD12 ' HB2' ' E' ' 120' ' ' TYR . 27.6 tp -69.29 -43.79 73.13 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.978 0.911 . . . . 74.51 112.55 -176.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.466 ' O ' HD12 ' D' ' 141' ' ' LEU . 87.0 m-85 -59.11 -42.48 90.64 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 120.765 0.317 . . . . 71.32 110.617 178.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 75.8 mtm -73.69 -40.97 63.25 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.825 -0.625 . . . . 75.0 110.949 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.411 ' O ' ' HG3' ' D' ' 143' ' ' GLN . 64.2 t30 -61.69 -48.06 82.48 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.186 0.995 . . . . 73.13 110.594 -174.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -52.61 -38.67 60.58 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.648 1.179 . . . . 63.4 111.629 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.466 HD12 ' O ' ' D' ' 137' ' ' PHE . 8.9 mp -76.18 -46.81 26.66 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.667 0.787 . . . . 72.42 111.526 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -85.05 27.09 0.8 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.078 0.551 . . . . 75.54 112.424 -170.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' D' ' 139' ' ' ASN . 46.0 mt-30 -117.93 94.11 4.39 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.964 0.906 . . . . 64.05 109.548 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -140.22 21.13 2.42 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.666 -1.152 . . . . 75.22 108.862 171.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -165.22 -177.14 4.39 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.352 1.461 . . . . 64.34 109.029 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.62 163.66 39.45 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 123.3 0.375 . . . . 74.2 113.774 173.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -60.23 125.31 23.2 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.838 0.855 . . . . 72.54 111.109 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -165.17 109.63 0.37 Allowed Glycine 0 C--N 1.336 0.539 0 N-CA-C 111.102 -0.799 . . . . 63.02 111.102 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 14.8 t -74.72 -167.88 0.63 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.264 0.626 . . . . 74.01 109.654 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.62 128.79 31.79 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 109.376 -0.601 . . . . 73.32 109.376 170.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -174.16 101.52 0.1 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.92 1.688 . . . . 75.13 108.114 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -173.23 121.99 0.37 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 109.942 -0.392 . . . . 73.55 109.942 177.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -75.24 -42.83 54.35 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.283 0.633 . . . . 73.52 110.692 176.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -59.89 132.53 54.25 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.848 0.859 . . . . 73.24 110.044 172.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.874 0 C-N-CA 123.784 0.834 . . . . 74.1 109.88 -175.035 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.348 0 N-CA-C 110.95 -0.86 . . . . 71.24 110.95 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.38 -36.43 63.11 Favored Glycine 0 C--N 1.35 1.309 0 C-N-CA 122.945 0.307 . . . . 70.43 112.556 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -75.45 170.13 16.71 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.648 0.779 . . . . 73.21 110.221 175.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -79.62 18.48 0.75 Allowed 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 124.736 1.214 . . . . 75.42 112.451 -169.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt 77.25 19.04 1.34 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.698 1.199 . . . . 74.24 112.263 167.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.02 103.89 2.9 Favored Glycine 0 C--N 1.342 0.906 0 O-C-N 121.845 -0.535 . . . . 74.45 114.162 163.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 97' ' ' ILE . . . . . 0.447 HD13 ' HE3' ' D' ' 94' ' ' MET . 7.1 tt -82.25 72.81 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 CA-C-O 122.715 1.245 . . . . 71.54 108.469 166.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.6 -38.23 83.69 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.212 -0.904 . . . . 73.02 111.788 -176.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.27 81.45 1.84 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.643 0.777 . . . . 74.4 112.198 -169.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 100' ' ' LEU . . . . . 0.875 ' HB3' ' HE1' ' D' ' 94' ' ' MET . 2.2 pp -161.21 149.69 12.96 Favored Pre-proline 0 N--CA 1.481 1.116 0 C-N-CA 123.79 0.836 . . . . 75.54 111.57 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -90.15 9.24 3.33 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 123.353 2.702 . . . . 74.33 111.778 166.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 102' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 76.43 -57.52 0.55 Allowed 'General case' 0 C--N 1.363 1.178 0 C-N-CA 126.563 1.945 . . . . 75.31 110.216 -174.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 33.6 m 79.31 -52.69 0.43 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.066 1.746 . . . . 73.45 112.225 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.4 25.28 5.08 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-O 119.12 -0.822 . . . . 54.32 114.979 -174.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -70.62 79.7 0.59 Allowed 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 117.734 0.767 . . . . 74.31 109.935 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 106' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' D' ' 46' ' ' THR . 21.8 t80 62.29 102.3 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 125.575 1.55 . . . . 73.14 109.306 -175.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 107' ' ' THR . . . . . 0.427 ' OG1' ' HB ' ' D' ' 46' ' ' THR . 70.1 p -89.6 42.34 1.09 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.845 0.858 . . . . 75.03 112.013 -167.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -74.01 75.65 1.7 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.453 1.101 . . . . 75.33 109.182 -176.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -166.76 -59.73 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.482 1.113 . . . . 64.23 109.328 -170.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . 0.487 ' O ' ' HD2' ' E' ' 114' ' ' LYS . . . -100.23 -24.86 14.44 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.362 -0.835 . . . . 73.35 112.668 -168.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . 0.419 ' HA ' HD22 ' D' ' 136' ' ' LEU . 10.0 mp -89.76 -50.52 6.01 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 118.128 0.422 . . . . 75.32 111.915 -175.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 112' ' ' ASN . . . . . 0.443 ' OD1' ' HG2' ' E' ' 113' ' ' LYS . 27.2 t-20 -79.33 -85.71 0.08 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.042 0.537 . . . . 75.35 110.782 -173.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 113' ' ' LYS . . . . . 0.443 ' HG2' ' OD1' ' E' ' 112' ' ' ASN . 26.3 mmmt -83.73 106.01 15.09 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.605 0.762 . . . . 73.03 111.087 -176.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . 0.487 ' HD2' ' O ' ' E' ' 110' ' ' ALA . 2.1 mppt? -118.11 -10.46 10.32 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 107.713 -1.217 . . . . 72.45 107.713 155.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 28.2 m 58.18 -97.46 0.07 Allowed 'General case' 0 C--N 1.363 1.182 0 C-N-CA 124.897 1.279 . . . . 73.33 109.267 -169.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 44.65 -141.99 3.37 Favored Glycine 0 C--N 1.361 1.966 0 N-CA-C 115.532 0.973 . . . . 74.15 115.532 172.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.82 178.52 1.13 Allowed Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 125.021 1.328 . . . . 75.04 107.549 169.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -55.1 89.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 121.772 1.648 . . . . 75.04 111.692 162.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.53 -103.7 0.05 Allowed 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.557 1.143 . . . . 74.21 108.775 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 120' ' ' TYR . . . . . 0.699 ' HB2' HD12 ' D' ' 136' ' ' LEU . 47.8 m-85 -114.23 150.47 34.28 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.068 -1.456 . . . . 62.4 107.068 161.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 121' ' ' VAL . . . . . 0.587 HG22 HD11 ' D' ' 44' ' ' LEU . 92.3 t 56.63 -108.95 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.463 0 N-CA-C 108.362 -0.977 . . . . 74.23 108.362 -166.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 3.8 m 56.35 -75.07 0.01 OUTLIER 'General case' 0 C--N 1.363 1.166 0 C-N-CA 125.215 1.406 . . . . 53.01 111.896 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -136.17 -154.51 0.57 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.059 1.343 . . . . 65.44 108.602 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 19.2 t -157.65 169.21 25.17 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.055 0.542 . . . . 75.54 110.12 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -140.13 129.35 23.79 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.811 0.845 . . . . 72.15 110.289 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -149.48 149.9 31.49 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.32 1.048 . . . . 74.01 109.316 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 37.1 p -146.35 83.93 1.62 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.152 0.501 . . . . 73.22 110.338 -177.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -138.83 62.71 1.54 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.684 0.793 . . . . 54.11 109.417 177.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 129' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' D' ' 124' ' ' PRO . 88.9 m -89.33 122.27 32.4 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.209 -0.905 . . . . 74.24 110.928 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -157.73 105.77 2.03 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.895 0.878 . . . . 74.43 109.03 171.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 131' ' ' TRP . . . . . 0.452 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 13.3 t90 -161.87 106.13 1.23 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.888 -0.782 . . . . 73.22 108.888 175.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 59.5 m -150.57 10.82 0.66 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.34 0.656 . . . . 72.41 111.543 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 53.0 m -96.79 135.52 38.62 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.231 0.613 . . . . 75.0 111.278 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -160.62 130.98 2.51 Favored Glycine 0 C--N 1.352 1.435 0 N-CA-C 110.729 -0.948 . . . . 72.44 110.729 177.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 27.3 m -90.69 162.4 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 123.42 0.688 . . . . 73.35 111.545 -175.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -157.43 159.16 37.05 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.945 0.898 . . . . 74.41 111.164 -178.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 6.0 m 57.1 77.99 0.24 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.179 1.391 . . . . 75.21 113.103 168.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -172.0 85.75 0.08 Allowed 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.989 0.916 . . . . 73.32 108.69 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -83.34 173.11 11.85 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.45 0.7 . . . . 73.01 111.032 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 140' ' ' GLY . . . . . 0.499 ' HA2' ' HB2' ' A' ' 132' ' ' ASN . . . -121.1 49.39 0.89 Allowed Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.812 -0.631 . . . . 64.41 111.602 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . 55.29 41.63 31.08 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.649 1.18 . . . . 62.4 111.191 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 142' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' E' ' 144' ' ' VAL . 4.5 tt 72.73 -68.51 0.22 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.617 1.567 . . . . 72.21 109.848 -172.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.57 54.74 2.45 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 111.638 -0.585 . . . . 75.41 111.638 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 144' ' ' VAL . . . . . 0.439 ' HB ' HD21 ' E' ' 142' ' ' LEU . 4.6 p -96.62 131.72 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.913 0.885 . . . . 63.52 110.01 176.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 21.0 t70 . . . . . 0 C--O 1.253 1.243 0 N-CA-C 108.335 -0.987 . . . . 72.35 108.335 174.879 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.925 0 CA-C-O 119.927 -0.374 . . . . 41.15 113.177 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.53 45.43 29.24 Favored Glycine 0 C--N 1.345 1.083 0 O-C-N 123.79 0.347 . . . . 64.15 112.349 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -78.29 -50.6 11.52 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.56 0.744 . . . . 63.42 111.351 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -159.18 -55.31 0.06 Allowed 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.244 0.461 . . . . 74.42 112.244 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt 58.9 79.9 0.21 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.986 0.914 . . . . 73.41 110.511 -171.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -149.19 -34.64 0.05 OUTLIER Glycine 0 N--CA 1.469 0.842 0 CA-C-N 116.025 -0.534 . . . . 63.43 112.639 -172.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 97' ' ' ILE . . . . . 0.541 ' HB ' ' HA ' ' B' ' 87' ' ' ALA . 10.3 tt -71.72 -40.6 70.22 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 N-CA-C 108.107 -1.072 . . . . 74.22 108.107 171.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 23.5 t70 60.07 137.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 126.497 1.919 . . . . 75.11 113.692 173.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . 53.58 57.83 5.75 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.804 0.841 . . . . 71.43 111.254 176.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 100' ' ' LEU . . . . . . . . . . . . . 50.3 tp -100.52 104.84 33.29 Favored Pre-proline 0 N--CA 1.474 0.738 0 CA-C-N 115.812 -0.631 . . . . 73.43 110.814 -174.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -98.77 -172.35 0.14 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 122.98 2.453 . . . . 71.41 111.93 169.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 102' ' ' LEU . . . . . . . . . . . . . 24.4 tp -94.0 163.57 13.43 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.043 -1.095 . . . . 74.35 108.043 166.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 70.2 p -62.46 -32.41 73.29 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.454 0.702 . . . . 71.13 110.714 173.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.63 -12.85 65.95 Favored Glycine 0 C--N 1.351 1.388 0 CA-C-N 115.453 -0.794 . . . . 72.1 111.919 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -85.28 141.1 30.32 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.772 0.829 . . . . 74.02 110.525 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -121.75 -87.59 0.64 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.046 0.938 . . . . 75.21 108.843 -175.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 107' ' ' THR . . . . . 0.481 HG23 ' HB2' ' F' ' 111' ' ' LEU . 39.9 p -144.88 -158.78 0.92 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.727 1.211 . . . . 53.41 107.851 176.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 77.33 -18.53 0.49 Allowed 'General case' 0 N--CA 1.511 2.611 0 C-N-CA 124.484 1.114 . . . . 64.52 113.542 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -140.14 13.76 2.42 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.69 0.796 . . . . 75.23 110.553 -177.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -156.7 -74.73 0.1 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.955 -0.757 . . . . 72.24 108.955 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . 0.481 ' HB2' HG23 ' F' ' 107' ' ' THR . 8.9 mp -76.15 76.91 2.98 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.529 0.732 . . . . 73.43 109.712 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 112' ' ' ASN . . . . . 0.457 HD21 ' HB2' ' F' ' 117' ' ' LYS . 2.4 m-20 -121.53 102.14 8.06 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 114.969 -1.014 . . . . 63.24 109.02 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 113' ' ' LYS . . . . . 0.561 ' HB3' ' HB ' ' F' ' 121' ' ' VAL . 0.0 OUTLIER -129.27 74.06 1.56 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.524 1.13 . . . . 74.44 109.319 179.117 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -168.39 -177.02 3.05 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-N 114.575 -1.193 . . . . 74.15 108.359 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 37.2 p -51.41 -35.82 40.89 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.356 1.063 . . . . 74.4 111.8 169.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.84 86.61 0.76 Allowed Glycine 0 C--N 1.354 1.538 0 CA-C-N 115.714 -0.675 . . . . 52.32 111.761 175.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 117' ' ' LYS . . . . . 0.457 ' HB2' HD21 ' F' ' 112' ' ' ASN . 3.9 mptp? 65.0 82.39 0.21 Allowed Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 124.944 1.298 . . . . 75.32 111.212 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.74 89.6 0.63 Allowed 'Trans proline' 0 CA--C 1.558 1.716 0 C-N-CA 122.576 2.184 . . . . 74.44 111.16 174.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -78.63 -96.78 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.355 0.662 . . . . 74.11 111.501 -171.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -100.67 -55.29 2.62 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.048 -0.723 . . . . 72.41 109.048 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 121' ' ' VAL . . . . . 0.561 ' HB ' ' HB3' ' F' ' 113' ' ' LYS . 11.7 t -80.15 126.32 39.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.454 -1.313 . . . . 74.22 107.454 174.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 89.1 m -160.33 155.9 25.43 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.365 1.066 . . . . 71.13 108.556 -175.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 8.9 t70 74.85 -178.87 0.17 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.948 1.299 . . . . 71.45 110.859 170.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 7.6 m -72.14 -23.15 61.26 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.606 1.162 . . . . 72.51 113.119 -173.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . 66.16 -165.74 0.22 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.977 0.911 . . . . 74.41 110.347 -169.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.82 115.57 9.2 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.259 0.623 . . . . 65.23 111.719 -177.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 50.3 m -127.09 120.07 28.05 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.829 -1.175 . . . . 71.25 107.829 170.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -144.61 176.8 9.14 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.884 0.474 . . . . 73.51 111.318 -172.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 71.4 p 59.69 -170.31 0.14 Allowed 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 125.856 1.663 . . . . 74.35 112.47 -175.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -148.46 -179.54 7.04 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.805 0.842 . . . . 74.41 110.018 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 131' ' ' TRP . . . . . 0.586 ' HB3' ' HG3' ' B' ' 124' ' ' PRO . 47.5 t-105 -151.93 133.55 14.72 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.371 0.668 . . . . 75.4 109.292 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 132' ' ' SER . . . . . 0.425 ' HB2' ' HB3' ' B' ' 35' ' ' ASP . 34.2 t -169.4 -42.35 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 O-C-N 124.455 1.097 . . . . 75.23 109.359 -175.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 23.1 m -70.91 83.03 0.66 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.344 1.058 . . . . 71.03 111.055 -176.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -83.75 57.48 5.05 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-O 119.596 -0.558 . . . . 65.14 112.92 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 135' ' ' VAL . . . . . 0.444 HG23 ' HA ' ' C' ' 128' ' ' LEU . 94.8 t 72.67 -17.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 125.28 1.432 . . . . 74.11 113.468 175.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt 71.9 164.09 0.28 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.014 1.326 . . . . 74.4 110.139 -175.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 11.4 m -76.27 70.84 2.93 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 123.562 0.745 . . . . 74.51 112.411 -171.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 138' ' ' TYR . . . . . 0.534 ' HE2' HE22 ' A' ' 12' ' ' GLN . 63.8 m-85 51.51 24.49 2.27 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 125.989 1.716 . . . . 73.44 113.609 171.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -163.07 143.92 9.49 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.718 0.807 . . . . 74.24 108.834 -174.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -83.06 67.54 3.73 Favored Glycine 0 C--N 1.342 0.911 0 O-C-N 123.544 0.528 . . . . 61.3 112.119 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.98 154.26 41.99 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.39 0.676 . . . . 63.52 109.917 173.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 62.0 tp -64.61 123.09 18.38 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.548 0.339 . . . . 74.41 111.096 -172.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.3 103.92 1.1 Allowed Glycine 0 C--N 1.345 1.062 0 N-CA-C 110.598 -1.001 . . . . 63.2 110.598 171.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.02 97.2 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.858 0.863 . . . . 75.14 109.259 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 26.8 t70 . . . . . 0 C--O 1.249 1.063 0 C-N-CA 123.441 0.696 . . . . 74.32 109.146 -174.352 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 109.215 -0.661 . . . . 71.42 109.215 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.1 m -127.16 113.44 16.37 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.388 -0.967 . . . . 64.3 108.388 -176.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -69.48 108.78 3.92 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.721 -0.844 . . . . 71.42 108.721 175.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -70.42 107.92 4.03 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.116 0.566 . . . . 64.35 110.402 -173.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -130.92 77.11 1.77 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.747 0.819 . . . . 72.24 110.329 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -79.77 -68.57 0.66 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.746 -0.835 . . . . 74.44 108.746 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.9 t -178.74 99.48 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.019 1.328 . . . . 74.53 108.706 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.16 -171.4 3.61 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.16 0.584 . . . . 75.41 111.125 -172.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.641 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 23.3 ptt? -83.96 166.77 17.53 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.925 -0.58 . . . . 72.41 111.829 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.0 m -142.45 132.32 24.28 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.164 0.986 . . . . 74.32 109.361 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -125.32 114.43 18.89 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.847 -1.168 . . . . 71.34 107.847 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -134.38 133.4 40.55 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.254 -0.647 . . . . 75.44 109.254 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.459 HD12 HG21 ' A' ' 105' ' ' ILE . 4.7 mt -95.32 120.68 45.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 109.26 -0.644 . . . . 72.1 109.26 177.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -83.76 -39.6 19.86 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 123.554 0.534 . . . . 70.41 111.052 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -173.47 120.14 0.32 Allowed 'General case' 0 N--CA 1.472 0.675 0 O-C-N 123.393 0.433 . . . . 75.32 110.0 -170.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.491 HD13 ' HG3' ' C' ' 130' ' ' PRO . 64.7 mt -107.5 137.63 37.71 Favored 'Isoleucine or valine' 0 C--O 1.247 0.921 0 N-CA-C 108.17 -1.048 . . . . 75.12 108.17 171.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 35.9 p90 -166.4 179.27 5.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 124.304 1.003 . . . . 75.3 110.936 -170.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -111.39 120.21 41.43 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.422 0.689 . . . . 73.3 110.095 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.45 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.1 mtpt -86.08 -28.8 23.85 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.807 -0.442 . . . . 64.15 109.807 177.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.418 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 18.0 t70 -144.54 139.3 28.1 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.511 -0.768 . . . . 73.54 109.408 177.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.4 mt -139.42 140.47 37.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.405 -1.331 . . . . 64.44 107.405 172.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.5 t -153.6 125.29 7.69 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.58 0.752 . . . . 74.42 109.479 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.528 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 70.3 t80 -128.59 130.86 47.94 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 106.594 -1.632 . . . . 71.0 106.594 173.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -130.58 135.43 47.89 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.049 0.386 . . . . 71.32 110.002 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.2 76.29 12.34 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.234 1.014 . . . . 73.33 108.358 172.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.31 -34.87 9.22 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.509 2.139 . . . . 74.31 112.264 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.402 ' ND2' ' HG2' ' A' ' 71' ' ' GLU . 6.7 m-20 -91.34 11.77 22.61 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.537 -0.756 . . . . 63.1 110.74 -176.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.27 -54.12 23.66 Favored Pre-proline 0 CA--C 1.57 1.722 0 CA-C-O 118.03 -0.986 . . . . 74.44 113.035 -171.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.86 -30.41 76.86 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 122.343 2.028 . . . . 75.22 113.451 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -81.05 -43.19 19.9 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.271 0.628 . . . . 73.32 110.165 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 73' ' ' ALA . 2.0 p -77.58 -22.26 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 114.782 -1.099 . . . . 75.01 112.685 -159.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -73.28 -21.7 60.54 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.069 0.548 . . . . 73.1 111.629 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -77.96 -22.98 48.66 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.267 -0.879 . . . . 64.43 110.43 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -82.78 165.95 19.45 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.283 1.033 . . . . 74.3 111.323 -174.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -76.77 123.11 25.71 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.601 -0.727 . . . . 53.33 109.48 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -76.23 87.39 3.06 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.666 0.746 . . . . 74.44 110.329 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.94 75.96 47.21 Favored Pre-proline 0 C--O 1.242 0.663 0 N-CA-C 105.898 -1.89 . . . . 51.21 105.898 170.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.63 149.1 14.36 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.819 2.346 . . . . 53.45 112.923 -173.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -96.0 100.89 12.52 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 106.625 -1.62 . . . . 74.23 106.625 167.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 65' ' ' THR . 39.0 t -91.52 108.2 19.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 109.804 -0.443 . . . . 65.32 109.804 -176.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -102.54 114.09 28.01 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.963 -1.017 . . . . 73.12 109.178 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.598 HD11 HD13 ' A' ' 128' ' ' LEU . 6.7 tt -108.91 138.1 45.77 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.416 -0.957 . . . . 72.14 108.416 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -137.8 141.43 40.85 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.75 0.82 . . . . 63.35 109.396 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.526 HD22 HD21 ' A' ' 60' ' ' LEU . 97.3 mt -120.79 142.23 49.78 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.598 0.759 . . . . 72.32 111.337 -172.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.574 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 7.8 m-20 -134.54 137.72 44.05 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.49 -0.93 . . . . 72.4 108.49 176.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.6 m -123.48 126.81 47.42 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.36 0.664 . . . . 61.21 109.441 175.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.44 153.56 50.73 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 124.393 1.077 . . . . 75.03 108.915 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.451 ' HG ' ' HB3' ' A' ' 98' ' ' LEU . 49.8 m -126.8 159.55 33.49 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 122.962 0.505 . . . . 74.33 110.315 175.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.7 t -148.93 117.97 6.75 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.252 -1.018 . . . . 74.01 108.252 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -77.92 104.01 8.21 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.958 -0.756 . . . . 75.15 108.958 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 71.4 mt -78.63 -27.66 45.43 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.626 -0.716 . . . . 72.43 109.953 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.37 172.75 14.14 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.357 1.063 . . . . 74.31 109.093 175.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -66.44 127.98 34.39 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.582 -0.895 . . . . 53.23 108.582 169.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 69.0 12.83 8.72 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.482 1.113 . . . . 74.31 112.328 -174.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 26.6 t -127.79 112.02 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.01 0.924 . . . . 73.42 108.651 173.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -128.7 124.38 35.49 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.344 -0.614 . . . . 72.51 109.344 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -91.41 145.32 24.73 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.861 -0.792 . . . . 75.12 108.861 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.9 t -128.7 141.39 46.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.496 -0.928 . . . . 75.12 108.496 172.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 73.5 t -123.32 132.43 71.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 123.634 0.774 . . . . 74.04 109.225 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.526 HD21 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -110.07 110.14 20.94 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.22 -1.4 . . . . 74.14 107.22 175.672 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.574 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 22.0 ttp180 -93.88 100.55 12.7 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.189 -1.411 . . . . 75.03 107.189 175.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.476 HG23 HD23 ' A' ' 60' ' ' LEU . 23.1 t -95.13 124.6 47.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.228 -1.027 . . . . 61.42 108.228 174.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.9 m -121.04 122.0 39.14 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.346 -0.612 . . . . 74.11 109.346 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.526 HG23 HD12 ' A' ' 114' ' ' ILE . 86.9 t -109.58 132.43 57.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 124.49 1.116 . . . . 74.02 108.28 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 10.1 m -123.49 141.04 52.39 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.058 -1.46 . . . . 75.14 107.058 168.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.417 ' HB1' HG23 ' A' ' 40' ' ' VAL . . . -130.5 125.12 33.53 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 106.278 -1.749 . . . . 74.35 106.278 170.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.9 m -134.39 131.6 38.41 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 123.6 0.562 . . . . 75.43 111.205 -176.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.459 HD12 ' CG2' ' A' ' 31' ' ' VAL . 27.0 mt -89.82 84.79 6.27 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 108.134 -1.061 . . . . 74.44 108.134 174.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.65 -117.94 4.73 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 111.256 -0.738 . . . . 72.42 111.256 -173.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -88.18 -30.05 20.05 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 117.403 0.601 . . . . 73.12 109.588 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.402 ' HG2' ' ND2' ' A' ' 27' ' ' ASN . 22.4 tt0 -80.18 125.67 30.13 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.711 -0.477 . . . . 74.44 109.711 -175.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.2 m -80.27 134.75 36.12 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.271 0.558 . . . . 65.51 111.283 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.54 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -77.27 -60.7 2.25 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.148 -0.933 . . . . 72.23 108.96 174.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -152.14 163.61 39.01 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.786 -0.643 . . . . 73.34 111.033 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 32.0 tp -134.86 113.29 11.43 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.435 1.094 . . . . 74.05 108.611 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.479 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 70.5 m -104.88 140.26 38.4 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.92 0.888 . . . . 61.44 109.453 175.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -148.22 124.56 10.91 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.627 0.771 . . . . 55.41 109.466 172.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.0 t -133.75 112.77 17.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 124.274 1.029 . . . . 71.32 109.429 -174.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.418 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 65.4 mt-30 -84.68 89.45 7.49 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.39 -0.967 . . . . 73.04 108.39 167.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -76.4 93.83 3.55 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.896 -0.779 . . . . 71.43 108.896 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.11 148.36 21.43 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 111.551 -0.619 . . . . 65.32 111.551 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.04 122.33 1.45 Allowed Glycine 0 CA--C 1.506 -0.531 0 N-CA-C 110.801 -0.919 . . . . 72.22 110.801 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.8 mt -80.33 125.84 39.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 N-CA-C 108.305 -0.998 . . . . 74.31 108.305 171.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.598 ' HB3' HD11 ' A' ' 86' ' ' ILE . 86.3 m-85 -129.76 124.11 32.63 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.196 0.598 . . . . 65.44 109.687 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.4 m -85.5 93.65 8.82 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.777 -0.823 . . . . 71.53 108.777 172.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.598 HD11 ' HB3' ' A' ' 84' ' ' PHE . 7.9 mm -109.74 148.13 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 116.14 -0.482 . . . . 74.51 109.847 -176.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.79 171.12 19.37 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.057 0.543 . . . . 73.21 110.67 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.641 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 99.49 -34.21 5.61 Favored Glycine 0 C--N 1.344 0.973 0 O-C-N 123.853 0.721 . . . . 65.35 112.915 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.8 153.5 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.968 0.507 . . . . 71.22 111.364 -169.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.446 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 21.5 tt0 -143.89 -179.11 6.27 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.961 -1.018 . . . . 73.03 108.254 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.446 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 61.5 -133.19 47.77 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 113.784 0.274 . . . . 35.53 113.784 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.7 t -72.51 -23.22 60.99 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 122.951 0.5 . . . . 64.1 111.612 -177.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -71.73 -36.83 70.6 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.454 0.701 . . . . 75.11 110.183 177.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.485 ' HA ' ' HE1' ' A' ' 94' ' ' MET . 4.6 tpt -66.07 -49.91 65.96 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.903 -0.59 . . . . 73.23 109.881 174.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.11 -33.27 70.65 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.146 -0.934 . . . . 73.23 111.192 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.409 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 55.1 t-80 -72.26 -41.51 66.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.461 0.704 . . . . 72.13 110.898 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 46.5 t -64.25 -35.79 81.98 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 121.226 0.536 . . . . 72.22 110.189 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.451 ' HB3' ' HG ' ' A' ' 48' ' ' SER . 67.9 mt -89.54 -26.81 20.67 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.146 -0.934 . . . . 75.22 112.214 -177.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.06 4.47 45.24 Favored Glycine 0 N--CA 1.473 1.118 0 O-C-N 123.102 0.251 . . . . 73.31 113.363 -173.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.555 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -141.87 -68.46 0.38 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 122.75 0.42 . . . . 73.04 110.805 -177.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -66.88 -46.63 74.35 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 116.246 -0.434 . . . . 75.11 111.864 -171.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 92.6 m -62.3 -52.91 62.95 Favored Pre-proline 0 CA--C 1.565 1.529 0 CA-C-O 118.489 -0.767 . . . . 75.43 112.672 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -66.97 -20.27 51.18 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 121.647 1.565 . . . . 75.01 113.054 176.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -66.9 -38.87 87.04 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.187 0.595 . . . . 75.52 110.343 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.459 HG21 HD12 ' A' ' 13' ' ' ILE . 43.6 mm -68.18 -42.91 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.634 0.773 . . . . 73.24 109.63 174.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.6 mt -69.95 -28.18 65.35 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.14 -0.936 . . . . 73.03 112.297 -174.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -62.61 -44.85 88.07 Favored Pre-proline 0 N--CA 1.487 1.382 0 N-CA-C 114.033 1.123 . . . . 72.44 114.033 -171.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 85.4 Cg_exo -50.78 -39.27 57.76 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.135 1.89 . . . . 64.31 113.585 171.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -77.68 -38.95 46.4 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.343 0.657 . . . . 75.43 111.706 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.1 -49.77 70.92 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.248 0.619 . . . . 63.22 109.444 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 -49.13 -49.91 39.9 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.925 1.29 . . . . 74.03 110.741 173.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.76 -46.8 83.68 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 124.004 0.815 . . . . 73.35 111.558 -176.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 117' ' ' MET . 41.9 t -59.3 -35.56 74.02 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.446 0.698 . . . . 75.02 111.066 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.526 HD12 HG23 ' A' ' 64' ' ' VAL . 83.5 mt -70.51 -57.25 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 115.571 -0.74 . . . . 73.23 110.593 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.7 m -51.98 -39.23 59.03 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 124.586 1.154 . . . . 72.03 111.676 -174.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.3 t -66.37 -44.33 83.44 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.441 -1.254 . . . . 73.44 110.102 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.528 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 40.9 mtm -62.95 -39.76 95.61 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.561 0.344 . . . . 74.5 110.828 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.4 t -57.43 -48.38 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 O-C-N 124.018 0.824 . . . . 73.32 110.183 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 95.3 p -73.79 -33.2 64.13 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.887 -0.597 . . . . 74.41 111.711 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.407 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.2 mtt-85 -68.15 -32.46 72.75 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.293 0.637 . . . . 74.24 109.86 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.422 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.33 15.84 42.84 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 115.498 -0.774 . . . . 72.25 113.216 174.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 121' ' ' GLY . 0.8 OUTLIER 65.14 10.89 6.73 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.388 1.875 . . . . 74.22 113.234 172.578 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -83.42 144.09 45.73 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 109.506 -0.553 . . . . 75.32 109.506 175.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.534 ' HG3' ' HB3' ' E' ' 130' ' ' ALA . 82.3 Cg_exo -50.81 137.53 42.68 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.288 2.658 . . . . 63.05 112.955 175.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -55.31 128.39 33.91 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.27 0.981 . . . . 63.21 111.986 -172.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.5 tp -113.43 129.1 56.62 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.568 0.747 . . . . 73.53 109.121 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.573 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 87.1 m-20 -119.77 114.44 22.14 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.188 -1.041 . . . . 75.34 108.188 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.598 HD13 HD11 ' A' ' 42' ' ' LEU . 14.7 mt -72.86 127.41 32.47 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 109.558 -0.534 . . . . 74.44 109.558 -176.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.85 134.49 92.45 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-O 119.157 -0.449 . . . . 65.32 110.415 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.89 124.7 16.61 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.822 2.348 . . . . 71.43 112.689 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 98.8 t -101.1 128.28 53.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-N 115.745 -0.661 . . . . 73.42 109.787 -177.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -86.87 85.88 7.29 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.75 -0.833 . . . . 73.22 108.75 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -61.23 -27.43 68.43 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.425 -0.807 . . . . 75.54 111.947 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.555 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 17.2 t70 -61.71 -51.63 67.59 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.204 0.602 . . . . 74.55 109.72 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.14 86.97 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.237 0.961 . . . . 75.4 110.83 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.8 mt -61.73 -48.3 81.35 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.244 0.618 . . . . 74.45 111.457 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -66.23 -34.19 77.47 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.938 -0.393 . . . . 74.32 109.938 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.503 ' SD ' HD23 ' A' ' 141' ' ' LEU . 19.5 mmt -57.78 -45.04 86.54 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.986 0.514 . . . . 74.32 110.488 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -55.81 -33.92 64.86 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 122.738 0.415 . . . . 75.24 111.854 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -77.66 -40.89 40.12 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.64 0.776 . . . . 74.12 111.141 173.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.503 HD23 ' SD ' ' A' ' 138' ' ' MET . 46.2 tp -67.69 -55.52 12.87 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.935 0.894 . . . . 74.11 111.723 -170.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 60.8 mt-30 -169.96 -18.56 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 125.317 1.447 . . . . 65.54 110.383 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 77.56 -48.62 0.5 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.943 2.097 . . . . 72.34 111.41 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -66.96 125.0 24.57 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.397 0.679 . . . . 64.34 109.683 173.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.68 131.26 28.99 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.624 -0.88 . . . . 52.14 108.624 175.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -156.52 45.15 0.51 Allowed Glycine 0 C--N 1.339 0.75 0 N-CA-C 112.016 -0.434 . . . . 52.32 112.016 -177.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -153.16 140.96 20.09 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.3 0.64 . . . . 74.41 110.07 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 179.08 48.36 0.08 OUTLIER Glycine 0 C--N 1.341 0.845 0 CA-C-N 115.978 -0.555 . . . . 74.52 112.881 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.7 t -90.65 146.63 23.87 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 117.214 0.507 . . . . 72.21 110.063 176.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -157.56 41.57 0.3 Allowed 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 121.936 0.874 . . . . 74.1 109.459 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -93.58 118.62 31.6 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.596 -1.183 . . . . 55.53 109.869 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -174.05 97.56 0.1 Allowed 'General case' 0 C--O 1.241 0.625 0 C-N-CA 125.077 1.351 . . . . 73.51 107.919 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -86.04 134.93 33.81 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.059 0.457 . . . . 73.53 110.043 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -160.44 121.94 3.09 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.664 -1.236 . . . . 74.23 107.664 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.214 0 C-N-CA 122.946 0.498 . . . . 74.44 109.998 -175.171 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 56.0 ttm . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 109.625 -0.509 . . . . 71.12 109.625 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 14.5 t 59.14 -157.15 0.33 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.161 0.985 . . . . 65.33 110.235 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -121.19 159.22 26.34 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 108.482 -0.933 . . . . 74.51 108.482 172.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -51.37 -53.32 37.53 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.094 0.958 . . . . 72.14 112.927 -172.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 43.4 t30 57.39 92.87 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 O-C-N 124.269 0.981 . . . . 75.54 110.337 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -57.33 -68.32 0.24 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.213 1.005 . . . . 75.44 113.186 -164.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 60.7 p -106.73 20.27 19.27 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.744 0.646 . . . . 73.2 112.744 -172.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 58.79 25.28 13.31 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 122.359 1.076 . . . . 73.4 110.18 -175.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.719 ' HB3' HG21 ' B' ' 89' ' ' ILE . 22.0 ptm 52.1 176.24 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.287 2.235 . . . . 74.12 115.632 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.3 p -133.47 104.08 6.24 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 106.949 -1.5 . . . . 75.31 106.949 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.464 ' CD2' ' HG3' ' D' ' 130' ' ' PRO . 24.0 t80 -107.91 137.03 46.62 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.149 -1.056 . . . . 74.23 108.149 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.611 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 0.1 OUTLIER -141.15 118.37 11.34 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.257 -0.646 . . . . 74.44 109.257 -178.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 57.1 mt -77.89 124.35 36.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.738 -1.208 . . . . 73.1 107.738 166.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -100.29 -35.57 9.57 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.527 -0.546 . . . . 75.15 109.527 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -176.89 134.5 0.2 Allowed 'General case' 0 C--N 1.352 0.69 0 O-C-N 123.917 0.761 . . . . 74.32 109.846 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.597 HG21 ' CD1' ' B' ' 109' ' ' TYR . 78.6 mt -119.65 145.05 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.117 -1.068 . . . . 75.42 108.117 175.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -165.11 145.09 7.01 Favored 'General case' 0 C--N 1.346 0.414 0 N-CA-C 112.974 0.731 . . . . 73.43 112.974 -173.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.53 HG23 HD12 ' B' ' 21' ' ' ILE . 38.7 m -76.3 122.79 24.93 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.477 -0.783 . . . . 73.05 108.903 170.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.412 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.4 mtpt -100.12 -14.75 18.44 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.423 0.689 . . . . 75.45 111.392 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.6 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.1 t70 -158.48 141.81 15.01 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.644 0.378 . . . . 74.13 111.433 -174.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.565 HD12 ' SG ' ' B' ' 113' ' ' CYS . 29.0 mm -136.68 143.12 36.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 124.915 1.286 . . . . 74.02 108.408 174.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 68.8 m -148.4 131.84 16.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.544 -1.207 . . . . 45.34 108.484 167.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -143.71 108.79 4.98 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.719 -1.586 . . . . 73.34 106.719 168.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -124.88 112.84 17.11 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.527 -0.916 . . . . 74.41 108.527 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.6 88.29 4.12 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.749 -1.204 . . . . 61.51 107.749 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.04 -40.91 8.23 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.75 2.3 . . . . 72.1 112.772 -168.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -101.02 19.96 16.44 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.777 0.831 . . . . 73.22 110.672 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.471 ' HB1' ' HD3' ' B' ' 29' ' ' PRO . . . -39.38 -62.13 0.87 Allowed Pre-proline 0 CA--C 1.566 1.588 0 N-CA-C 114.737 1.384 . . . . 74.12 114.737 -163.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.471 ' HD3' ' HB1' ' B' ' 28' ' ' ALA . 22.9 Cg_exo -62.95 -29.41 75.86 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 122.21 1.94 . . . . 74.32 112.983 -174.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -87.97 -38.18 15.76 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.228 -0.896 . . . . 73.51 111.659 -174.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.477 HG21 HD11 ' B' ' 68' ' ' LEU . 5.7 p -72.7 -15.78 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.156 0.583 . . . . 74.32 110.927 -173.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -70.58 -10.02 58.26 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 113.693 0.997 . . . . 74.42 113.693 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -72.79 -17.16 61.6 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 120.832 0.348 . . . . 74.44 110.465 174.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -98.68 97.61 8.85 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 124.92 1.288 . . . . 71.13 110.109 -175.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -102.22 85.77 2.71 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.222 -0.659 . . . . 74.24 109.222 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 7.6 p90 -156.83 -176.47 5.99 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.958 0.903 . . . . 75.34 109.797 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -68.63 114.41 22.12 Favored Pre-proline 0 N--CA 1.472 0.658 0 C-N-CA 123.559 0.744 . . . . 74.12 110.542 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.491 ' HA ' HD21 ' B' ' 68' ' ' LEU . 27.9 Cg_endo -68.34 145.15 64.62 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 121.22 1.28 . . . . 65.4 110.693 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 9.7 tp10 -64.62 99.71 0.33 Allowed 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.235 -1.024 . . . . 61.33 108.235 170.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.591 HG12 HD13 ' B' ' 126' ' ' LEU . 53.5 t -106.79 141.71 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 123.778 0.674 . . . . 73.14 110.324 -174.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -142.27 109.37 5.53 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.374 1.069 . . . . 73.41 108.753 -172.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.459 HD12 HG21 ' B' ' 64' ' ' VAL . 38.2 tp -90.55 127.3 36.21 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.389 -0.597 . . . . 74.42 109.389 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.68 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 9.5 m-20 -122.29 116.8 24.71 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.241 1.016 . . . . 73.1 108.678 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.464 HD11 HG11 ' B' ' 131' ' ' VAL . 69.3 mt -99.39 126.74 45.34 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.42 -0.956 . . . . 75.41 108.42 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -140.68 155.52 46.47 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.293 1.037 . . . . 74.41 108.52 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' THR . . . . . 0.503 HG21 ' HB ' ' F' ' 107' ' ' THR . 1.4 t -148.18 117.83 7.05 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 121.328 0.585 . . . . 65.13 110.336 -177.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.64 125.34 53.64 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 106.726 -1.583 . . . . 73.31 106.726 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.528 ' HB2' ' HE2' ' B' ' 56' ' ' TYR . 62.0 p -139.41 177.15 8.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 119.652 -0.214 . . . . 74.5 110.886 -166.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 36.0 p -170.52 137.94 1.44 Allowed 'General case' 0 C--O 1.245 0.861 0 O-C-N 123.382 0.426 . . . . 75.4 111.16 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -76.0 126.36 30.86 Favored 'General case' 0 C--N 1.348 0.507 0 N-CA-C 108.573 -0.899 . . . . 75.41 108.573 165.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 pp -143.64 23.51 1.76 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.969 0.907 . . . . 65.44 109.092 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' B' ' 55' ' ' VAL . . . -166.25 170.89 12.74 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 123.457 0.703 . . . . 73.32 111.221 -175.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -100.76 118.02 36.02 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.666 0.787 . . . . 75.45 109.564 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 62.13 9.67 3.28 Favored 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 124.799 1.24 . . . . 64.31 112.584 -173.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.461 ' O ' ' HB1' ' B' ' 52' ' ' ALA . 74.8 t -128.75 129.96 68.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 107.631 -1.248 . . . . 74.12 107.631 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.528 ' HE2' ' HB2' ' B' ' 48' ' ' SER . 28.0 t80 -132.01 140.98 49.11 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.633 -0.877 . . . . 72.12 108.633 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -109.69 110.76 21.89 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 107.143 -1.428 . . . . 73.12 107.143 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.79 132.06 61.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 C-N-CA 123.333 0.653 . . . . 74.02 109.25 -177.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 32.7 t -111.53 113.85 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.022 -0.733 . . . . 61.43 109.022 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 60.9 tp -93.49 106.71 18.65 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.606 0.362 . . . . 62.23 110.103 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.447 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 20.9 ttm180 -86.06 108.23 18.17 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.356 0.662 . . . . 74.01 109.784 172.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 59.5 t -103.99 106.23 19.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.223 -1.029 . . . . 71.13 108.223 175.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.68 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 15.8 m -97.18 142.83 28.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.002 -0.999 . . . . 74.13 108.995 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.708 HG12 HD23 ' B' ' 126' ' ' LEU . 73.4 t -134.73 122.58 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.718 -0.845 . . . . 61.33 108.718 173.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 87.6 m -98.97 141.55 31.59 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.757 -1.201 . . . . 71.4 107.757 169.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.18 137.48 23.36 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.76 -0.459 . . . . 53.43 109.76 174.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.4 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 19.1 m -148.25 128.52 13.82 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.542 0.337 . . . . 70.32 111.489 -174.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.491 HD21 ' HA ' ' B' ' 38' ' ' PRO . 85.3 mt -93.95 99.92 12.16 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.174 -0.676 . . . . 75.51 109.174 178.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.69 -130.32 9.62 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 115.219 -0.901 . . . . 64.35 111.01 -171.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -97.18 2.0 50.49 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.087 0.955 . . . . 63.22 111.726 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -115.09 147.11 40.61 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.024 0.53 . . . . 72.15 110.569 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 49.7 m -68.92 133.06 47.7 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 123.5 0.5 . . . . 75.12 111.283 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.457 ' HA ' HG22 ' B' ' 31' ' ' VAL . . . -86.83 -60.74 1.9 Allowed 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.926 -1.138 . . . . 72.32 107.926 175.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -154.14 161.94 41.53 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 114.45 -1.25 . . . . 74.31 110.019 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -129.96 112.67 13.73 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.645 -1.613 . . . . 74.44 106.645 172.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.465 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 23.0 t -118.88 114.1 22.07 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.07 -0.715 . . . . 71.03 109.07 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -128.49 122.9 32.26 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.359 -0.978 . . . . 74.34 108.359 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 88.2 t -124.73 150.26 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.512 1.125 . . . . 63.22 108.552 -178.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.6 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 27.1 mt-30 -121.15 115.02 22.27 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.769 -0.826 . . . . 75.5 108.769 167.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -100.82 107.26 18.76 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.632 -0.877 . . . . 73.15 108.632 172.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.412 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -99.89 170.56 22.96 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 111.861 -0.496 . . . . 71.43 111.861 176.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.01 141.34 6.67 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 121.643 -0.313 . . . . 73.23 112.554 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 41.1 mt -97.77 106.61 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 108.517 -0.92 . . . . 70.11 108.517 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -116.08 135.24 54.12 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.103 0.561 . . . . 74.53 110.952 -175.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.611 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 57.7 m -95.24 129.6 42.31 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.889 0.876 . . . . 75.12 110.12 172.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.54 ' HB ' HD13 ' B' ' 89' ' ' ILE . 35.2 pt -138.39 136.61 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 124.048 0.939 . . . . 75.11 110.437 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.64 173.79 16.33 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.032 0.933 . . . . 74.03 109.787 174.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.86 -40.86 3.08 Favored Glycine 0 N--CA 1.479 1.557 0 CA-C-O 121.133 0.296 . . . . 65.41 112.823 177.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.719 HG21 ' HB3' ' B' ' 9' ' ' MET . 3.5 pt -58.8 154.76 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.474 1.11 . . . . 74.43 111.146 165.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -164.72 146.05 7.98 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.956 -1.02 . . . . 64.42 108.697 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.52 -134.8 12.28 Favored Glycine 0 C--N 1.348 1.218 0 O-C-N 123.442 0.464 . . . . 74.41 112.117 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 52.6 m -73.64 -54.22 8.65 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.757 0.823 . . . . 75.31 110.618 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.417 ' HA ' ' HB3' ' B' ' 96' ' ' HIS . 16.0 mm100 -56.52 -19.72 16.97 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.905 1.282 . . . . 74.14 113.197 -176.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.681 ' SD ' HG23 ' F' ' 97' ' ' ILE . 41.8 ttp -61.04 -70.29 0.19 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.325 1.05 . . . . 74.31 111.597 -177.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . 0.555 ' HB3' HD21 ' F' ' 102' ' ' LEU . . . -82.51 -15.11 53.63 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 111.845 0.313 . . . . 74.44 111.845 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . 0.417 ' HB3' ' HA ' ' B' ' 93' ' ' GLN . 1.4 t-80 -58.78 -34.66 71.7 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.433 0.693 . . . . 74.44 110.313 168.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.6 t -58.71 -26.0 63.47 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.554 0.742 . . . . 72.41 111.694 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.401 HD22 ' HB3' ' B' ' 56' ' ' TYR . 52.0 mt -84.41 -29.04 26.49 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.96 0.904 . . . . 75.43 112.129 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.79 -10.53 57.64 Favored Glycine 0 C--N 1.342 0.873 0 O-C-N 123.56 0.538 . . . . 73.12 113.021 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.647 ' HA ' ' HB2' ' B' ' 133' ' ' PHE . . . -124.38 -59.19 1.48 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.088 0.555 . . . . 64.34 112.167 -174.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -78.01 -48.82 15.31 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.112 0.565 . . . . 74.2 110.937 -168.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 73.5 m -61.52 -50.17 83.88 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 123.865 0.866 . . . . 74.31 112.073 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.09 -17.98 35.76 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 121.73 1.62 . . . . 72.02 112.917 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -70.86 -30.47 66.87 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.598 0.359 . . . . 72.35 110.42 173.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.425 HG22 ' NH2' ' D' ' 111' ' ' ARG . 69.5 mt -71.82 -42.42 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.18 0.592 . . . . 73.03 109.831 171.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 77.8 mt -73.89 -28.49 61.58 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.047 -0.979 . . . . 74.24 111.825 -175.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -60.12 -49.41 91.02 Favored Pre-proline 0 N--CA 1.484 1.248 0 CA-C-O 118.024 -0.988 . . . . 74.43 113.28 -172.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -54.83 -33.78 82.72 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.545 2.163 . . . . 74.12 113.598 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.597 ' CD1' HG21 ' B' ' 16' ' ' ILE . 7.7 m-30 -78.82 -40.46 32.83 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.047 0.539 . . . . 72.44 110.504 -176.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.25 -39.9 95.9 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.489 0.716 . . . . 73.14 110.136 172.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.474 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 47.1 ttt-85 -62.6 -53.3 56.64 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.429 1.491 . . . . 74.52 110.724 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -66.49 -30.54 70.9 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.461 0.705 . . . . 75.3 109.848 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.565 ' SG ' HD12 ' B' ' 21' ' ' ILE . 4.1 t -70.16 -42.36 72.59 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 122.946 0.498 . . . . 75.13 110.273 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.582 HD12 HG23 ' B' ' 64' ' ' VAL . 45.4 mt -58.79 -55.79 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.853 0.861 . . . . 73.14 110.408 173.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 9.6 m -63.7 -29.89 71.06 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.632 0.773 . . . . 74.41 111.382 -173.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.3 t -58.31 -54.94 41.28 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 108.831 -0.803 . . . . 74.34 108.831 171.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.525 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.8 mmt -64.98 -37.3 87.21 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.602 0.761 . . . . 75.43 111.4 -175.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 81.4 t -59.89 -48.82 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 124.019 0.928 . . . . 73.53 110.544 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 32.8 t -75.27 -19.85 59.48 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.899 -1.046 . . . . 73.43 111.075 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' B' ' 116' ' ' SER . 90.3 mtt-85 -68.21 -32.47 72.7 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 110.027 -0.36 . . . . 75.52 110.027 170.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . 0.43 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -79.49 -5.58 89.22 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 123.655 0.597 . . . . 64.2 112.397 169.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 6.6 m 66.39 25.57 10.31 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.624 1.57 . . . . 63.23 110.652 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -77.33 163.21 65.8 Favored Pre-proline 0 CA--C 1.555 1.148 0 CA-C-N 114.884 -1.053 . . . . 74.23 110.836 175.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.614 ' HA ' ' HB3' ' F' ' 131' ' ' TRP . 91.6 Cg_exo -48.51 144.49 13.8 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 123.312 2.675 . . . . 64.44 114.764 174.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.553 ' HB3' ' HB2' ' F' ' 130' ' ' ALA . 41.0 tp60 -54.59 118.05 3.86 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.055 0.942 . . . . 74.15 110.758 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.708 HD23 HG12 ' B' ' 64' ' ' VAL . 20.5 tp -110.04 99.36 8.47 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.14 -0.936 . . . . 74.23 109.602 -171.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -96.03 110.68 22.88 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.453 -0.573 . . . . 75.14 109.453 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.474 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 55.0 mt -77.21 126.21 30.57 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.871 -0.789 . . . . 75.43 108.871 171.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.573 ' HB3' ' HA ' ' F' ' 119' ' ' ASP . . . -76.58 154.6 83.66 Favored Pre-proline 0 CA--C 1.552 1.051 0 O-C-N 124.268 0.98 . . . . 61.42 111.706 -169.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.466 ' HG3' HD12 ' D' ' 16' ' ' ILE . 3.8 Cg_exo -77.33 87.68 1.48 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.401 2.734 . . . . 72.41 112.686 -167.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.464 HG11 HD11 ' B' ' 44' ' ' LEU . 4.6 p -92.8 122.35 44.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 115.333 -0.849 . . . . 75.0 110.517 177.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -94.67 117.25 29.83 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 107.464 -1.31 . . . . 74.41 107.464 169.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.647 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 77.1 m-85 -64.3 -15.19 59.77 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.562 0.745 . . . . 71.55 111.887 -177.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.46 -43.56 75.58 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.451 1.1 . . . . 64.42 110.858 169.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.02 -31.83 67.36 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.717 0.807 . . . . 71.33 112.055 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.543 HD12 ' HA ' ' B' ' 133' ' ' PHE . 6.7 mp -76.12 -29.42 57.85 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.545 0.738 . . . . 74.23 110.407 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -73.79 -39.97 63.76 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.759 0.423 . . . . 63.21 110.507 169.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 20.9 mmt -62.64 -35.66 80.33 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.08 0.952 . . . . 73.54 111.425 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.76 -32.61 60.03 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.563 -0.744 . . . . 64.44 110.374 -175.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -79.91 -38.74 31.86 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.299 -0.864 . . . . 64.4 110.552 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 98.5 mt -99.64 29.78 3.93 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.989 0.916 . . . . 73.44 110.647 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.23 98.29 0.22 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.558 0.743 . . . . 75.24 109.255 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -178.79 -58.43 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.587 1.155 . . . . 75.34 108.106 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -82.58 94.25 7.47 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 114.532 -1.213 . . . . 71.22 108.182 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.03 -178.01 3.49 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.916 0.887 . . . . 71.45 110.634 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -146.83 96.72 0.18 Allowed Glycine 0 C--N 1.344 0.972 0 CA-C-N 115.962 -0.563 . . . . 72.45 111.976 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -81.43 84.24 6.73 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.73 0.776 . . . . 74.42 110.673 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.67 107.65 2.22 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 115.107 -0.951 . . . . 74.22 110.731 174.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 6.2 t -119.46 129.71 54.88 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.345 0.658 . . . . 74.34 110.941 -172.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' D' ' 90' ' ' GLU . 13.8 mm-40 -91.36 134.58 34.48 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.587 -0.894 . . . . 75.43 108.587 169.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -94.84 43.89 1.1 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.666 0.786 . . . . 61.2 110.501 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 51.6 m80 69.64 121.36 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.174 1.39 . . . . 72.42 111.685 -176.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . 0.407 ' HB3' ' HA2' ' D' ' 91' ' ' GLY . 11.0 pt20 -68.5 146.11 53.43 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.483 0.713 . . . . 74.24 110.792 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -82.19 170.2 15.72 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.65 0.78 . . . . 74.43 112.015 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.156 0 CA-C-N 114.996 -1.002 . . . . 71.42 109.046 176.922 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 84.1 mtp . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 110.487 -0.19 . . . . 73.04 110.487 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 13.5 p -160.56 97.44 1.2 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.464 0.705 . . . . 73.12 109.742 174.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.82 90.68 2.92 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.582 0.706 . . . . 73.25 110.369 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -78.94 67.3 4.61 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-O 122.642 1.21 . . . . 63.32 109.956 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -69.64 127.28 32.4 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.436 -1.257 . . . . 74.34 110.855 -172.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -163.84 149.31 10.91 Favored 'General case' 0 C--O 1.245 0.854 0 C-N-CA 123.842 0.857 . . . . 74.43 110.134 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 32.4 m -83.13 82.6 8.18 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.774 -1.195 . . . . 63.05 107.774 169.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -161.29 -47.1 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.647 -0.872 . . . . 55.24 108.647 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.438 ' HE2' HG22 ' C' ' 89' ' ' ILE . 51.2 ttm 65.11 115.66 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.844 1.258 . . . . 74.33 111.611 -176.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.528 ' HB ' ' HB2' ' C' ' 87' ' ' ALA . 51.6 m -98.78 95.9 7.53 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.079 -0.711 . . . . 73.11 109.079 172.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -109.83 135.94 49.93 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.353 -0.61 . . . . 73.13 109.353 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -152.96 131.55 12.25 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 109.617 -0.512 . . . . 72.52 109.617 171.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 57.2 mt -69.88 125.96 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 108.65 -0.87 . . . . 74.43 108.65 170.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -89.93 -49.78 6.41 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.961 -0.755 . . . . 74.21 108.961 175.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.573 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -173.53 150.92 1.85 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.111 0.964 . . . . 75.22 109.973 174.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 pp -114.54 152.28 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 107.878 -1.156 . . . . 70.34 107.878 173.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.636 ' HB3' HG22 ' D' ' 122' ' ' THR . 28.2 p90 -179.56 162.46 1.11 Allowed 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.456 0.646 . . . . 73.34 110.882 -174.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.2 p -92.35 115.33 27.99 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 123.43 0.692 . . . . 74.43 109.882 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -64.43 -40.47 95.8 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.233 -1.025 . . . . 75.3 108.233 170.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -150.07 147.87 28.32 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.407 -1.269 . . . . 73.52 110.787 -174.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.536 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.6 mt -138.39 144.51 30.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 C-N-CA 125.896 1.679 . . . . 74.24 106.584 174.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 31.2 t -153.46 150.01 28.34 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 122.568 0.347 . . . . 72.41 110.481 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -155.28 137.08 14.41 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.451 1.1 . . . . 73.32 108.166 175.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -140.23 133.73 30.08 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.281 0.633 . . . . 71.2 109.433 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.79 81.41 22.87 Favored Pre-proline 0 C--O 1.241 0.621 0 N-CA-C 108.001 -1.111 . . . . 64.22 108.001 169.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.2 -30.41 74.48 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 123.017 2.478 . . . . 73.01 112.622 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . 0.47 ' OD1' ' HB ' ' C' ' 31' ' ' VAL . 5.9 p30 -117.07 34.54 5.06 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.222 0.609 . . . . 61.32 109.575 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -40.08 -57.85 2.56 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 114.148 1.166 . . . . 74.22 114.148 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -64.61 -35.39 47.82 Favored 'Trans proline' 0 C--N 1.382 2.292 0 CA-C-N 121.569 1.596 . . . . 75.44 112.64 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.596 ' HA ' HE21 ' C' ' 33' ' ' GLN . 80.5 t60 -68.71 -38.09 79.97 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.813 0.845 . . . . 74.43 112.24 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.601 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.5 p -76.34 -30.27 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 N-CA-C 112.573 0.583 . . . . 74.13 112.573 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -59.79 -34.02 72.48 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 112.447 0.536 . . . . 73.22 112.447 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . 0.596 HE21 ' HA ' ' C' ' 30' ' ' HIS . 24.7 pt20 -86.15 11.89 10.89 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.398 0.679 . . . . 73.14 112.408 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.412 ' HG2' HD11 ' C' ' 68' ' ' LEU . 1.8 ttpm? -113.95 147.85 37.86 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.877 0.871 . . . . 74.53 110.124 177.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.16 125.26 23.11 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 123.381 0.673 . . . . 71.41 110.93 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -81.55 105.81 13.01 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.927 -1.033 . . . . 73.01 110.993 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -162.78 79.44 1.77 Allowed Pre-proline 0 C--O 1.241 0.607 0 N-CA-C 107.469 -1.308 . . . . 75.21 107.469 164.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -87.04 164.52 8.67 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 122.913 2.409 . . . . 65.22 113.02 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -86.75 85.32 7.28 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 106.725 -1.583 . . . . 73.21 106.725 168.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 99.2 t -68.58 109.7 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 115.008 -0.996 . . . . 75.41 109.767 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.59 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 65.7 mttm -92.08 103.96 16.4 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.354 -0.98 . . . . 73.02 108.354 178.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 tt -89.08 123.91 33.81 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 107.057 -1.46 . . . . 65.42 107.057 174.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.604 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 17.0 t70 -128.39 139.53 52.32 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.153 0.981 . . . . 74.54 108.409 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.612 HD21 HD21 ' C' ' 60' ' ' LEU . 24.6 mt -135.3 126.41 27.96 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.438 0.695 . . . . 74.54 110.218 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -130.53 139.29 50.48 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.63 1.172 . . . . 73.3 108.193 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.0 t -144.07 139.47 28.94 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.019 0.438 . . . . 75.33 110.283 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.95 156.05 45.48 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.937 0.895 . . . . 54.13 109.608 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.42 ' HG ' ' HB3' ' C' ' 98' ' ' LEU . 2.3 m -132.43 144.18 50.31 Favored 'General case' 0 C--O 1.24 0.564 0 O-C-N 123.299 0.374 . . . . 63.24 110.034 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 22.4 p -145.12 126.07 14.48 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.916 0.886 . . . . 72.53 109.473 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -78.76 118.67 21.04 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.317 -0.623 . . . . 74.24 109.317 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.624 HD12 ' HB2' ' C' ' 57' ' ' GLU . 34.5 mt -88.45 -41.47 12.76 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.83 0.852 . . . . 73.42 110.638 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.19 -172.66 4.22 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.061 -0.972 . . . . 65.24 110.181 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.42 112.62 1.83 Allowed 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.036 0.835 . . . . 44.45 110.591 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 66.31 9.33 6.31 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.661 1.185 . . . . 62.51 112.425 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 87.0 t -106.81 107.62 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.23 0.612 . . . . 73.43 109.857 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -106.72 124.63 49.89 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.768 0.827 . . . . 74.53 109.073 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.624 ' HB2' HD12 ' C' ' 51' ' ' LEU . 30.2 tt0 -82.72 126.65 32.61 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.296 -1.002 . . . . 75.21 108.296 169.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.8 t -112.4 138.2 42.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.486 -0.931 . . . . 74.3 108.486 167.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 86.6 t -120.9 131.37 73.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 108.529 -0.915 . . . . 75.1 108.529 170.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.612 HD21 HD21 ' C' ' 44' ' ' LEU . 0.9 OUTLIER -114.22 107.23 15.33 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.676 -1.231 . . . . 74.04 107.676 172.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.9 117.74 31.18 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 114.671 -1.149 . . . . 74.53 109.153 178.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.423 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.8 t -102.07 132.37 48.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 107.838 -1.171 . . . . 65.44 107.838 172.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.604 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 29.9 m -123.31 128.02 49.35 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.099 -1.074 . . . . 71.05 108.099 175.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 85.7 t -122.95 128.75 75.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.576 -0.738 . . . . 71.33 109.34 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.59 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 25.4 m -118.32 139.24 51.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.621 -1.251 . . . . 71.44 107.621 176.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.24 113.01 15.76 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.669 -1.604 . . . . 65.45 106.669 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 65.4 m -135.62 126.21 27.05 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.672 0.607 . . . . 75.11 109.9 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.412 HD11 ' HG2' ' C' ' 34' ' ' LYS . 12.0 mt -85.98 56.06 3.81 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.224 1.41 . . . . 72.35 107.908 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.58 -107.73 3.08 Favored Glycine 0 C--N 1.341 0.851 0 N-CA-C 110.026 -1.23 . . . . 70.42 110.026 -169.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -103.59 -17.14 15.29 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.64 0.776 . . . . 73.14 110.044 173.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -68.55 99.89 1.04 Allowed 'General case' 0 C--N 1.348 0.542 0 C-N-CA 123.341 0.656 . . . . 74.5 109.44 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 50.4 m -73.36 114.83 12.01 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.169 -0.678 . . . . 71.31 109.169 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.601 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -67.84 -57.52 6.13 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.248 -1.342 . . . . 71.45 108.613 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -155.13 159.64 40.34 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.745 -1.116 . . . . 71.42 110.732 172.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -118.68 143.06 47.09 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.799 -1.556 . . . . 74.5 106.799 167.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 46.6 t -149.7 141.9 24.08 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.598 -0.89 . . . . 72.33 108.598 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -154.65 134.9 13.21 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.472 -0.566 . . . . 71.4 109.472 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' C' ' 110' ' ' ALA . 40.9 t -133.71 114.65 20.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 124.263 1.025 . . . . 74.31 108.836 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -91.27 87.64 6.57 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.654 -0.869 . . . . 73.13 108.654 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -79.86 99.11 7.38 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.408 0.683 . . . . 75.42 110.121 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.67 149.11 25.43 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 116.329 -0.396 . . . . 73.1 112.36 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.506 ' HA3' HD23 ' C' ' 106' ' ' LEU . . . -150.27 125.73 2.01 Favored Glycine 0 CA--C 1.503 -0.678 0 N-CA-C 110.508 -1.037 . . . . 50.24 110.508 -178.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.542 HD13 HD12 ' C' ' 51' ' ' LEU . 31.8 mm -93.7 125.24 46.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 108.278 -1.008 . . . . 65.21 108.278 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -133.64 121.84 22.6 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.457 0.703 . . . . 74.43 109.721 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 20.6 p -82.28 103.99 12.27 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 108.745 -0.835 . . . . 71.12 108.745 171.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.518 HG21 ' HE2' ' C' ' 94' ' ' MET . 17.8 mt -116.19 137.57 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.585 0.754 . . . . 75.52 109.74 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.528 ' HB2' ' HB ' ' C' ' 10' ' ' THR . . . -151.28 170.51 19.33 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.199 0.6 . . . . 74.2 110.639 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.34 -49.12 1.51 Allowed Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.98 -0.555 . . . . 73.02 113.371 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.663 HD13 ' HA ' ' C' ' 94' ' ' MET . 42.7 pt -91.06 171.28 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 123.445 0.698 . . . . 74.34 112.635 -167.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -157.97 157.47 33.1 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.751 -1.113 . . . . 64.13 109.508 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.66 -131.16 21.25 Favored Glycine 0 C--N 1.348 1.241 0 O-C-N 123.412 0.445 . . . . 73.32 113.805 172.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.8 p -60.46 -35.21 75.33 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.27 1.028 . . . . 74.2 111.789 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -57.72 -57.47 12.61 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.857 0.863 . . . . 73.42 110.607 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.663 ' HA ' HD13 ' C' ' 89' ' ' ILE . 4.1 tpt -55.23 -50.17 70.13 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.067 0.947 . . . . 75.11 112.505 175.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.68 -33.88 74.76 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.114 0.566 . . . . 75.15 111.253 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -73.99 -36.55 64.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.974 0.51 . . . . 75.44 110.55 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.46 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 33.7 t -69.45 -33.56 73.12 Favored 'General case' 0 C--N 1.35 0.614 0 N-CA-C 109.734 -0.469 . . . . 75.12 109.734 -177.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.42 ' HB3' ' HG ' ' C' ' 48' ' ' SER . 96.9 mt -85.78 -37.48 19.23 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.982 0.913 . . . . 71.03 111.896 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.87 3.92 45.56 Favored Glycine 0 N--CA 1.473 1.15 0 CA-C-O 119.525 -0.597 . . . . 53.2 114.58 -168.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.555 ' HA ' ' HB3' ' C' ' 133' ' ' PHE . . . -149.35 -54.46 0.17 Allowed 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.808 0.804 . . . . 71.45 112.045 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.46 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 51.3 t80 -66.6 -56.68 9.61 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.286 0.634 . . . . 75.53 112.111 -174.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 97.2 m -60.89 -47.26 96.14 Favored Pre-proline 0 CA--C 1.562 1.41 0 CA-C-O 118.787 -0.625 . . . . 74.42 112.42 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -54.54 -30.88 67.07 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 122.409 2.072 . . . . 74.22 114.318 172.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -70.72 -30.9 67.57 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.026 0.53 . . . . 64.24 111.114 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 44.5 mm -73.01 -35.3 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 109.62 -0.511 . . . . 71.53 109.62 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.506 HD23 ' HA3' ' C' ' 82' ' ' GLY . 94.7 mt -81.22 -30.97 34.06 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.971 0.908 . . . . 74.43 112.733 -175.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -55.92 -50.11 89.13 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 113.884 1.068 . . . . 74.41 113.884 -172.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.85 -36.25 95.14 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.251 1.968 . . . . 71.34 113.396 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -70.05 -44.37 69.31 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.05 0.54 . . . . 75.42 111.356 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.51 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -66.7 -33.6 76.0 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.876 -0.602 . . . . 73.24 110.713 175.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -62.63 -51.49 67.09 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.925 1.29 . . . . 75.43 110.446 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -69.37 -29.36 67.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.95 0.5 . . . . 72.31 110.377 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.9 t -69.18 -37.68 78.29 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 122.75 0.42 . . . . 73.32 110.709 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.44 ' O ' HG23 ' C' ' 118' ' ' VAL . 98.6 mt -71.65 -47.39 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 122.931 0.492 . . . . 75.42 110.054 174.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.7 m -53.23 -42.44 66.39 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.532 1.133 . . . . 71.25 111.664 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.44 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.1 t -66.68 -38.94 87.82 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.425 -0.807 . . . . 74.12 109.538 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.591 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -66.2 -39.83 89.93 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.187 0.995 . . . . 73.33 111.778 178.404 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.44 HG23 ' O ' ' C' ' 114' ' ' ILE . 61.8 t -59.04 -42.79 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 109.258 -0.645 . . . . 73.41 109.258 172.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.2 t -66.13 -38.67 88.72 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.816 -1.083 . . . . 74.03 112.248 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' C' ' 116' ' ' SER . 64.7 mtt-85 -69.58 -39.21 77.45 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.264 0.625 . . . . 73.32 110.19 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.45 3.71 84.0 Favored Glycine 0 C--N 1.351 1.361 0 CA-C-N 115.669 -0.696 . . . . 74.33 112.544 173.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.441 HG22 ' O ' ' D' ' 16' ' ' ILE . 33.6 p 58.38 30.74 20.04 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.058 1.743 . . . . 72.43 113.068 171.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -81.94 154.58 70.27 Favored Pre-proline 0 C--O 1.242 0.684 0 CA-C-N 115.703 -0.681 . . . . 73.01 109.57 175.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.48 127.76 27.32 Favored 'Trans proline' 0 C--N 1.363 1.333 0 C-N-CA 122.093 1.862 . . . . 73.12 112.022 168.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.472 ' HG2' ' HB2' ' B' ' 125' ' ' GLN . 23.6 mm-40 -53.72 154.6 3.69 Favored 'General case' 0 C--O 1.248 0.981 0 O-C-N 124.623 1.202 . . . . 74.32 113.604 -170.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.421 HD13 HG21 ' F' ' 133' ' ' THR . 21.1 tp -147.76 86.38 1.59 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-N 113.847 -1.524 . . . . 75.54 108.168 -172.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -91.97 108.63 20.07 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.787 -1.097 . . . . 73.5 108.692 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -67.81 137.99 55.79 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.513 0.725 . . . . 74.43 110.118 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.78 152.53 95.12 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 123.665 0.786 . . . . 54.02 111.106 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.491 ' HG3' HD13 ' A' ' 16' ' ' ILE . 52.1 Cg_exo -54.98 114.93 2.09 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.662 2.241 . . . . 74.54 112.272 172.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.545 ' HA ' ' HE1' ' F' ' 138' ' ' TYR . 5.0 p -98.14 125.95 51.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 123.103 0.561 . . . . 72.2 110.19 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -81.53 101.7 10.11 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.653 -0.869 . . . . 75.32 108.653 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.555 ' HB3' ' HA ' ' C' ' 100' ' ' ALA . 82.9 m-85 -67.3 -25.34 65.99 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.356 -0.838 . . . . 74.5 111.31 177.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -63.86 -36.5 84.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.324 0.649 . . . . 64.31 110.323 175.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.64 -42.1 95.69 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.647 0.779 . . . . 75.23 110.414 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 71.0 mt -72.72 -27.09 61.84 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.839 -1.073 . . . . 72.24 110.873 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -80.96 -24.0 38.39 Favored 'General case' 0 C--O 1.213 -0.864 0 C-N-CA 123.029 0.531 . . . . 74.13 110.699 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 93.1 mtp -78.7 -28.57 45.14 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 122.037 -0.414 . . . . 75.24 110.367 169.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -62.3 -33.99 75.71 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.963 1.305 . . . . 73.41 112.122 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -156.86 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.659 0 C-N-CA 123.06 0.544 . . . . 73.1 112.236 -172.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 14.4 tp 65.79 156.32 0.09 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.757 1.223 . . . . 73.03 111.794 172.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -115.66 7.67 14.81 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.513 -0.742 . . . . 75.02 110.931 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -135.13 157.29 47.3 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.747 0.819 . . . . 73.21 110.448 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -119.19 82.13 1.82 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.513 -0.921 . . . . 75.05 108.513 175.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -130.85 146.0 52.16 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.306 1.042 . . . . 64.12 109.446 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -160.12 48.44 0.39 Allowed Glycine 0 C--N 1.346 1.092 0 O-C-N 123.237 0.336 . . . . 71.4 112.927 -174.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -72.06 93.39 1.39 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.044 -0.725 . . . . 75.14 109.044 173.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -147.11 82.36 0.19 Allowed Glycine 0 C--N 1.341 0.815 0 N-CA-C 111.457 -0.657 . . . . 64.32 111.457 -175.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 9.9 t -112.89 135.54 53.54 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.24 0.616 . . . . 75.42 110.414 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -121.66 161.16 23.0 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.927 0.891 . . . . 73.41 110.115 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -84.62 137.14 33.45 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.728 0.811 . . . . 71.43 109.03 174.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -101.21 116.49 32.94 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.959 0.409 . . . . 74.13 110.594 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -124.93 109.61 13.21 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 107.934 -1.135 . . . . 74.23 107.934 169.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -69.51 158.53 35.03 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.608 0.363 . . . . 73.33 111.185 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.988 0 C-N-CA 123.634 0.773 . . . . 70.21 109.593 -174.475 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 109.822 -0.436 . . . . 75.03 109.822 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 12.6 m -90.9 -72.41 0.58 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.539 -0.911 . . . . 74.53 108.539 169.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.13 138.37 4.61 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.372 1.469 . . . . 73.41 107.634 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -163.87 77.85 0.39 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.005 0.431 . . . . 74.35 110.493 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -172.64 -64.29 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.782 0.833 . . . . 72.51 109.432 173.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -159.41 160.12 34.51 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.665 0.786 . . . . 75.12 110.0 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 32.8 m -67.43 100.71 0.87 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.572 0.749 . . . . 60.01 109.966 176.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -76.54 -163.85 0.36 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.389 0.675 . . . . 74.42 111.069 174.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.568 ' HG2' HG13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -31.5 123.17 0.26 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.51 1.524 . . . . 71.34 112.497 177.573 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 9.7 t -129.57 135.88 49.12 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.59 0.756 . . . . 74.33 109.03 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -137.4 101.16 4.43 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.371 -1.344 . . . . 71.42 107.371 175.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -125.92 124.47 40.89 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.692 0.797 . . . . 72.21 109.104 -175.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.658 HD11 HG21 ' D' ' 105' ' ' ILE . 5.4 mt -84.18 137.42 20.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.786 -0.82 . . . . 63.21 108.786 177.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -97.02 -42.5 7.87 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 122.975 0.51 . . . . 72.35 110.461 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . 0.426 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 40.8 ttt180 -174.23 142.77 0.83 Allowed 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.313 0.383 . . . . 75.43 111.383 -170.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.471 HD11 HG21 ' D' ' 13' ' ' ILE . 2.1 mp -115.55 137.75 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 105.882 -1.895 . . . . 72.43 105.882 174.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.426 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 19.0 p90 -161.54 137.0 7.64 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 123.609 0.568 . . . . 73.11 110.967 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.4 p -76.65 110.63 11.39 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.321 -0.854 . . . . 64.3 109.487 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -85.53 -9.81 56.86 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.496 -0.775 . . . . 71.32 109.712 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.635 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 17.4 t70 -169.11 143.43 3.01 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 124.896 1.278 . . . . 75.12 109.733 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.591 HG23 ' HE1' ' C' ' 117' ' ' MET . 80.4 mt -147.4 144.71 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 125.266 1.427 . . . . 74.0 107.9 177.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.8 t -147.04 145.92 29.85 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.967 0.907 . . . . 75.22 109.249 170.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.536 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 81.1 t80 -149.87 118.55 6.57 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 106.963 -1.495 . . . . 72.23 106.963 169.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -123.54 140.27 53.17 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.479 -0.563 . . . . 74.23 109.479 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.68 82.39 60.97 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 107.813 -1.18 . . . . 75.54 107.813 174.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.8 -29.24 42.51 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.924 2.416 . . . . 75.14 113.008 -170.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.402 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 38.0 m-80 -108.66 8.86 27.17 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-O 118.479 -0.772 . . . . 70.43 110.852 -177.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.406 ' HB2' ' HD3' ' D' ' 29' ' ' PRO . . . -20.05 -73.17 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 116.63 2.085 . . . . 65.11 116.63 -166.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.424 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 92.2 Cg_endo -75.5 -21.66 14.72 Favored 'Trans proline' 0 C--N 1.386 2.552 0 CA-C-N 124.056 2.484 . . . . 74.2 114.117 -176.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.412 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 5.6 t-160 -74.46 -37.93 63.08 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.257 1.023 . . . . 72.31 110.25 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.58 HG22 HD11 ' D' ' 68' ' ' LEU . 11.0 p -82.04 -20.51 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 115.953 -0.567 . . . . 74.14 111.506 -174.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.424 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 23.0 m-85 -63.75 -28.67 70.04 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 120.801 0.334 . . . . 74.0 111.819 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . 0.412 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 60.8 mt-30 -58.41 -22.27 53.48 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.71 1.204 . . . . 73.5 111.241 177.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.61 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 89.8 mttt -90.22 69.42 7.14 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.994 1.318 . . . . 73.52 110.2 177.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.73 85.45 4.74 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.411 -0.813 . . . . 62.23 110.67 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 10.2 p90 -154.07 -173.21 4.49 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.453 0.701 . . . . 63.41 109.902 172.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -63.27 112.4 6.91 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.377 1.071 . . . . 70.1 110.772 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -60.76 120.25 7.87 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.066 1.844 . . . . 75.1 110.805 172.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -67.63 104.32 1.58 Allowed 'General case' 0 C--N 1.35 0.592 0 N-CA-C 106.417 -1.697 . . . . 74.41 106.417 169.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.477 HG11 HG12 ' D' ' 64' ' ' VAL . 71.3 t -103.05 115.31 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 N-CA-C 108.792 -0.818 . . . . 74.13 108.792 -174.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -96.98 110.25 22.83 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 105.783 -1.932 . . . . 75.52 105.783 176.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.467 HD12 HG13 ' D' ' 62' ' ' VAL . 63.4 tp -94.37 138.5 32.26 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.418 -1.327 . . . . 74.3 107.418 175.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -141.75 147.92 38.15 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.528 -1.286 . . . . 71.44 107.528 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.409 HD13 ' CE2' ' D' ' 133' ' ' PHE . 73.7 mt -131.0 136.06 48.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.548 0.689 . . . . 74.53 110.874 -173.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.454 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 11.6 t70 -133.03 129.17 37.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 113.977 -1.465 . . . . 64.13 107.692 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 46' ' ' THR . . . . . 0.505 HG21 HD21 ' E' ' 111' ' ' LEU . 2.6 p -106.94 150.78 26.1 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.546 0.689 . . . . 75.24 110.094 174.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.87 166.57 29.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.233 -1.349 . . . . 74.21 107.86 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.8 p -153.52 -165.61 2.19 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.633 -0.506 . . . . 62.41 109.633 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.8 m -144.74 149.68 35.96 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.98 -0.748 . . . . 60.11 108.98 -172.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -71.65 -170.23 0.52 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.654 -0.703 . . . . 75.44 110.631 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 tm? 69.52 83.43 0.15 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 107.735 -1.209 . . . . 74.54 107.735 -165.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.6 92.27 6.54 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 114.478 -1.237 . . . . 63.12 109.395 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -164.05 75.3 0.32 Allowed 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.799 -0.815 . . . . 74.53 108.799 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 64.88 -2.62 0.67 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 125.255 1.422 . . . . 75.33 113.811 173.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 45.8 t -128.57 100.94 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 107.484 -1.302 . . . . 71.31 107.484 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -122.18 127.81 50.47 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.946 -0.761 . . . . 73.41 108.946 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -87.91 114.88 24.95 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 108.158 -1.053 . . . . 71.02 108.158 169.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 95.4 t -100.35 134.91 38.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 107.286 -1.376 . . . . 75.15 107.286 171.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 49.1 t -128.9 126.79 65.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.687 -1.227 . . . . 74.41 107.687 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.497 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -114.52 103.93 11.51 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.505 -1.294 . . . . 74.4 107.505 -176.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.662 HH21 ' HE1' ' E' ' 106' ' ' TYR . 41.1 ttm-85 -83.35 103.14 12.5 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.579 -0.897 . . . . 73.43 108.579 173.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.467 HG13 HD12 ' D' ' 42' ' ' LEU . 66.4 t -97.32 121.83 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.027 -0.731 . . . . 74.23 109.027 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 56.8 m -119.4 133.44 55.71 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.005 0.922 . . . . 74.41 109.106 -172.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.477 HG12 HG11 ' D' ' 40' ' ' VAL . 75.4 t -125.81 132.44 70.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 124.226 1.01 . . . . 74.22 108.788 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 26.7 m -127.93 93.14 3.61 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.676 -1.602 . . . . 72.0 106.676 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.83 147.24 24.62 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.704 -0.85 . . . . 71.0 108.704 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.498 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 32.5 p -149.56 133.94 17.44 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.208 0.528 . . . . 74.24 111.505 -173.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.58 HD11 HG22 ' D' ' 31' ' ' VAL . 79.4 mt -104.17 102.62 12.35 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.923 -1.035 . . . . 72.31 108.283 170.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.03 -128.96 17.49 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 115.764 -0.653 . . . . 70.4 113.154 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -84.56 3.08 38.32 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.931 0.892 . . . . 73.33 113.022 -174.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.61 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 10.5 pt-20 -137.0 154.92 50.28 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-O 121.115 0.483 . . . . 74.23 110.871 -173.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.0 m -69.18 126.56 30.17 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.583 -1.189 . . . . 73.43 111.072 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.565 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -75.65 -64.78 1.0 Allowed 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.624 -1.25 . . . . 71.51 107.624 173.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -153.24 141.84 20.88 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.266 -0.879 . . . . 75.12 111.152 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 65.9 mt -101.11 153.58 19.46 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.284 1.034 . . . . 74.42 108.771 167.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.71 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.8 t -156.82 142.19 17.42 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.123 0.569 . . . . 74.35 109.496 176.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -155.37 122.22 5.39 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.213 -0.292 . . . . 71.5 110.213 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.6 t -126.0 115.11 41.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 124.066 0.947 . . . . 73.12 109.338 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.635 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.6 mt-30 -88.72 87.64 7.32 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.6 -0.889 . . . . 75.33 108.6 171.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -83.39 100.84 10.94 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.483 -1.235 . . . . 74.44 109.083 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.37 149.01 17.74 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 112.327 -0.309 . . . . 70.3 112.327 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.37 142.97 10.49 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.77 -0.532 . . . . 65.21 111.77 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.0 mt -89.29 117.01 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 108.099 -1.074 . . . . 71.3 108.099 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.24 127.78 55.71 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.701 0.8 . . . . 74.24 110.548 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 33.6 t -84.87 122.79 29.67 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.275 -1.009 . . . . 71.42 108.275 166.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.4 HD13 ' HB2' ' D' ' 97' ' ' CYS . 3.0 tt -143.67 125.78 11.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 108.565 -0.902 . . . . 73.2 108.565 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.415 ' HB1' ' HA3' ' E' ' 96' ' ' GLY . . . -167.06 167.99 14.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.784 0.834 . . . . 74.14 110.458 -174.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.488 ' H ' ' HA3' ' E' ' 96' ' ' GLY . . . 86.56 21.13 52.43 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.447 0.467 . . . . 74.35 114.01 173.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.568 HG13 ' HG2' ' D' ' 9' ' ' MET . 0.4 OUTLIER -131.64 171.54 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.045 0.938 . . . . 75.44 108.975 177.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' B' ' 150' ' ' GLU . 7.2 tm-20 -147.62 179.92 7.34 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.645 -0.872 . . . . 62.11 108.645 -175.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' B' ' 153' ' ' GLN . . . 73.85 -136.66 22.11 Favored Glycine 0 C--N 1.347 1.16 0 C-N-CA 122.992 0.329 . . . . 74.03 112.875 172.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.6 m -91.91 -36.76 13.28 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.126 0.571 . . . . 73.22 111.242 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -65.65 -19.63 65.98 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.185 0.594 . . . . 65.15 112.46 -171.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.422 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 0.0 OUTLIER -64.51 -36.99 86.0 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.951 0.5 . . . . 74.11 112.247 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . 0.422 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.11 -14.88 45.74 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.267 0.627 . . . . 71.55 111.851 178.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -63.96 -38.84 92.57 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.52 0.728 . . . . 64.34 112.282 -176.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . 0.4 ' HB2' HD13 ' D' ' 86' ' ' ILE . 69.1 m -65.43 -49.58 68.65 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.476 0.31 . . . . 74.35 111.629 -177.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.685 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 3.6 pp -67.47 -22.16 65.49 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.05 0.389 . . . . 70.22 112.05 -176.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.93 -29.33 11.84 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-O 119.881 -0.399 . . . . 72.43 113.593 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.0 -52.89 2.3 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 117.309 0.555 . . . . 75.04 111.838 -173.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -73.71 -39.57 64.23 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 112.103 0.408 . . . . 74.41 112.103 -173.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.685 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 89.1 m -65.31 -46.76 71.31 Favored Pre-proline 0 CA--C 1.556 1.189 0 CA-C-O 118.728 -0.653 . . . . 75.21 111.692 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.497 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 50.1 Cg_exo -58.71 -35.12 99.1 Favored 'Trans proline' 0 C--N 1.389 2.692 0 C-N-CA 121.653 1.569 . . . . 65.03 112.777 168.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.47 -31.73 73.06 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.346 0.658 . . . . 71.34 111.394 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.658 HG21 HD11 ' D' ' 13' ' ' ILE . 36.5 mm -69.78 -43.67 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.533 0.733 . . . . 74.12 110.223 172.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 74.6 mt -72.81 -19.74 61.28 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.26 -0.882 . . . . 75.42 111.699 -175.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -66.32 -45.42 60.08 Favored Pre-proline 0 CA--C 1.556 1.175 0 N-CA-C 113.498 0.925 . . . . 75.2 113.498 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -49.27 -41.02 43.17 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.443 2.095 . . . . 73.44 113.86 170.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -78.97 -33.23 45.37 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.458 0.703 . . . . 73.54 112.102 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.91 -44.27 73.51 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.523 0.677 . . . . 70.45 109.506 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.425 ' NH2' HG22 ' B' ' 105' ' ' ILE . 46.5 ttp180 -66.42 -37.29 84.87 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 114.005 -1.452 . . . . 74.53 110.172 175.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . 0.444 ' HA ' ' CE2' ' B' ' 109' ' ' TYR . 8.7 tt0 -52.29 -46.86 66.08 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.732 0.813 . . . . 73.41 111.148 176.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.8 t -66.72 -47.77 71.27 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.775 -1.102 . . . . 71.34 110.71 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.71 HG12 ' SG ' ' D' ' 76' ' ' CYS . 42.6 mt -60.29 -62.77 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.978 0.511 . . . . 75.34 110.363 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 98.3 m -41.68 -46.32 3.71 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 125.709 1.603 . . . . 72.04 112.799 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 22.9 t -68.48 -45.17 73.08 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.192 -0.913 . . . . 74.13 110.67 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.1 mtm -67.44 -34.3 76.93 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.802 0.441 . . . . 71.33 111.589 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.421 HG22 ' O ' ' D' ' 114' ' ' ILE . 84.9 t -60.54 -46.81 94.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 123.797 0.839 . . . . 75.44 110.082 176.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.0 p -70.45 -28.5 65.07 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 115.785 -0.643 . . . . 71.13 110.705 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' D' ' 116' ' ' SER . 72.6 mtt-85 -71.89 -22.92 61.43 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.531 0.733 . . . . 75.22 111.251 176.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.52 12.71 68.56 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-O 119.564 -0.576 . . . . 45.23 112.709 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.636 HG22 ' HB3' ' C' ' 17' ' ' TYR . 72.6 p 60.03 11.87 2.89 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 126.735 2.014 . . . . 74.31 113.391 -174.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -81.51 149.38 64.7 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.776 -0.453 . . . . 75.33 109.776 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -48.22 120.06 4.61 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 123.095 2.53 . . . . 75.13 113.03 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.466 ' O ' ' HA ' ' E' ' 127' ' ' SER . 25.2 tt0 -42.23 119.73 1.44 Allowed 'General case' 0 C--N 1.364 1.237 0 O-C-N 124.875 1.359 . . . . 72.13 111.402 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 29.8 tp -106.48 99.61 9.18 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.309 0.644 . . . . 74.13 109.51 -171.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -97.82 97.9 9.37 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 107.449 -1.315 . . . . 70.03 107.449 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.403 HD11 HD13 ' D' ' 114' ' ' ILE . 38.8 mt -59.59 137.14 58.12 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-N 115.133 -0.939 . . . . 74.34 109.995 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.49 148.49 73.66 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 123.541 0.736 . . . . 72.3 111.184 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.464 ' HG3' ' CD2' ' B' ' 11' ' ' PHE . 32.0 Cg_endo -60.47 122.95 12.09 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.647 2.231 . . . . 75.2 111.298 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . 0.435 ' HA ' ' HE1' ' E' ' 120' ' ' TYR . 99.9 t -108.08 115.26 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.395 -0.366 . . . . 75.32 110.631 -175.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -83.64 96.55 8.71 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 107.745 -1.206 . . . . 73.53 107.745 167.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.469 ' HA ' HD12 ' D' ' 136' ' ' LEU . 28.5 m-85 -59.39 -26.86 65.47 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.047 0.939 . . . . 72.02 112.109 -174.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -49.5 -49.14 47.05 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.015 1.326 . . . . 72.4 111.13 172.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.2 -32.3 73.82 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 114.92 -1.036 . . . . 75.45 112.009 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' D' ' 133' ' ' PHE . 6.7 mp -72.05 -31.09 65.8 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 117.986 0.357 . . . . 74.53 111.108 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -78.36 -45.97 21.17 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.769 0.428 . . . . 75.34 110.684 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 79.9 mtm -67.0 -39.18 87.06 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.312 0.645 . . . . 72.2 111.464 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.539 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 6.2 m-20 -61.5 -39.26 90.33 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.888 0.475 . . . . 73.41 110.862 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -54.87 -29.53 55.68 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.309 0.644 . . . . 73.41 111.623 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.8 mp -83.0 -50.48 8.5 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.097 0.559 . . . . 74.03 111.067 173.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.539 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 10.7 pt20 -90.88 18.22 6.86 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 113.672 0.99 . . . . 62.52 113.672 -171.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . 0.53 ' HB2' ' O ' ' D' ' 139' ' ' ASN . 1.1 tm0? -121.31 91.19 3.47 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.955 -0.758 . . . . 75.41 108.955 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -145.32 -57.87 0.33 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.953 0.901 . . . . 73.11 109.296 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.53 125.88 18.8 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.449 0.7 . . . . 74.11 110.513 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.69 74.69 1.27 Allowed Glycine 0 C--N 1.345 1.048 0 N-CA-C 111.323 -0.711 . . . . 71.32 111.323 -175.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -73.51 88.21 1.63 Allowed 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.744 0.783 . . . . 74.31 110.754 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 75.87 153.02 4.17 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.227 -0.897 . . . . 64.52 112.805 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 91.1 m -146.61 118.6 8.21 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.114 0.566 . . . . 71.12 109.705 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.27 100.75 3.81 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.758 0.789 . . . . 74.32 109.169 175.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.66 112.03 6.66 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.839 -1.171 . . . . 73.32 107.839 -176.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -158.0 33.32 0.25 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.53 0.732 . . . . 75.45 110.195 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -148.79 114.82 5.76 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.515 0.726 . . . . 75.02 109.412 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -86.22 169.41 13.06 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.105 0.562 . . . . 74.1 111.146 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.847 0 N-CA-C 108.299 -1.0 . . . . 73.02 108.299 179.146 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.869 0 CA-C-O 119.455 -0.636 . . . . 50.01 111.835 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.52 -65.04 2.48 Favored Glycine 0 C--N 1.356 1.684 0 N-CA-C 111.201 -0.759 . . . . 71.34 111.201 -173.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -73.02 175.15 6.92 Favored 'General case' 0 C--O 1.249 1.03 0 C-N-CA 124.778 1.231 . . . . 73.44 109.293 166.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -66.19 117.74 8.92 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.594 -0.521 . . . . 73.22 109.594 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.08 101.41 7.85 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.048 -0.723 . . . . 71.33 109.048 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 96' ' ' GLY . . . . . 0.488 ' HA3' ' H ' ' D' ' 88' ' ' GLY . . . -125.38 -46.04 0.24 Allowed Glycine 0 C--N 1.342 0.905 0 CA-C-N 115.38 -0.827 . . . . 71.22 112.389 177.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 97' ' ' ILE . . . . . . . . . . . . . 40.7 pt -133.99 154.12 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-O 121.885 0.85 . . . . 73.03 112.389 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -162.74 -41.43 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 113.939 -1.482 . . . . 72.12 109.008 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.26 91.38 6.19 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 123.48 0.712 . . . . 75.01 109.99 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 100' ' ' LEU . . . . . 0.414 HD21 HD21 ' D' ' 98' ' ' LEU . 1.6 pp -143.13 142.44 21.73 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 123.352 0.661 . . . . 75.22 110.539 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -64.35 -26.94 63.31 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 122.811 2.341 . . . . 74.2 112.932 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 102' ' ' LEU . . . . . 0.454 ' HG ' ' H ' ' E' ' 104' ' ' GLY . 34.5 tp 70.34 168.9 0.31 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.448 1.099 . . . . 72.23 110.019 -176.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 29.3 p -78.77 -25.55 44.4 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.714 -0.616 . . . . 75.41 110.678 174.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 104' ' ' GLY . . . . . 0.454 ' H ' ' HG ' ' E' ' 102' ' ' LEU . . . 138.91 161.96 8.95 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 110.618 -0.993 . . . . 75.13 110.618 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -61.14 -37.94 84.63 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 121.392 0.615 . . . . 74.42 110.312 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 106' ' ' TYR . . . . . 0.662 ' HE1' HH21 ' D' ' 61' ' ' ARG . 48.6 t80 -132.53 9.01 4.28 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 114.766 -1.107 . . . . 75.32 110.083 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 35.0 m 69.57 160.79 0.2 Allowed 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 125.039 1.336 . . . . 71.41 111.652 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -150.75 40.22 0.73 Allowed 'General case' 0 CA--C 1.559 1.306 0 CA-C-O 122.426 1.108 . . . . 63.22 109.306 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -125.26 -170.88 2.25 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.982 0.913 . . . . 73.4 110.274 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.39 56.47 3.27 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.691 0.757 . . . . 74.52 111.031 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . 0.505 HD21 HG21 ' D' ' 46' ' ' THR . 1.6 tt -172.37 53.77 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 105.167 -2.16 . . . . 74.42 105.167 -177.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -167.79 160.82 12.82 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 113.842 -1.526 . . . . 63.44 109.131 -164.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 113' ' ' LYS . . . . . 0.425 ' HZ1' HG23 ' E' ' 115' ' ' THR . 53.7 tttm 75.49 141.78 0.07 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.674 1.19 . . . . 73.11 111.019 175.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -58.7 -23.43 59.58 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 113.469 0.915 . . . . 75.43 113.469 -173.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 115' ' ' THR . . . . . 0.425 HG23 ' HZ1' ' E' ' 113' ' ' LYS . 3.3 t -144.34 78.36 1.57 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 122.095 0.95 . . . . 63.14 109.266 178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . -79.07 169.49 54.09 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 114.728 -1.124 . . . . 62.34 112.499 173.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -76.0 127.49 85.16 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 123.681 0.793 . . . . 73.52 110.424 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.78 117.01 4.73 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.667 2.245 . . . . 74.14 111.064 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -133.78 -72.04 0.5 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.813 -0.63 . . . . 64.22 109.779 -172.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 120' ' ' TYR . . . . . 0.435 ' HE1' ' HA ' ' D' ' 131' ' ' VAL . 71.8 t80 -77.41 -57.52 3.78 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.867 -0.79 . . . . 74.34 108.867 172.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 121' ' ' VAL . . . . . . . . . . . . . 17.8 m -79.36 120.82 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-N 115.179 -0.919 . . . . 75.31 109.723 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 3.8 m -108.8 174.0 6.07 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 108.473 -0.936 . . . . 73.13 108.473 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 123' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' D' ' 40' ' ' VAL . 6.8 p-10 -76.86 -174.24 2.99 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.596 0.358 . . . . 74.24 110.875 175.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 32.7 t 62.17 35.76 15.42 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.632 0.773 . . . . 75.34 110.982 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.84 156.2 21.27 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.268 0.627 . . . . 65.45 110.95 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.5 88.73 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.035 0.934 . . . . 73.32 112.047 -169.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 127' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' D' ' 125' ' ' GLN . 7.4 p -113.22 88.8 2.92 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.47 0.708 . . . . 73.2 110.445 176.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.53 -173.76 3.88 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.539 1.136 . . . . 71.31 109.865 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 27.4 m 81.01 138.88 0.07 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 125.037 1.335 . . . . 72.33 111.32 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 130' ' ' ALA . . . . . 0.534 ' HB3' ' HG3' ' A' ' 124' ' ' PRO . . . -93.33 168.13 11.28 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.349 0.659 . . . . 70.43 110.296 177.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 131' ' ' TRP . . . . . . . . . . . . . 18.7 t90 -73.68 170.43 15.25 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 124.248 1.019 . . . . 74.33 110.481 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 43.0 p -48.49 127.64 13.54 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.747 1.219 . . . . 74.44 112.942 -173.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 15.4 t -76.65 167.42 21.87 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.871 0.869 . . . . 74.12 111.178 -177.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.15 134.02 36.67 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-N 115.788 -0.642 . . . . 54.42 112.872 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 91.9 t -79.1 77.6 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 C-N-CA 124.053 0.941 . . . . 70.02 109.952 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -86.88 -32.96 19.94 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.099 -0.955 . . . . 75.32 109.841 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 25.9 m 69.28 -81.41 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.796 1.238 . . . . 63.42 111.68 170.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 138' ' ' TYR . . . . . 0.517 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 39.6 p90 -140.86 -17.93 0.84 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.969 0.507 . . . . 73.32 111.837 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -74.95 84.62 2.24 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.021 0.528 . . . . 72.51 109.912 -173.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.53 -160.11 11.8 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.087 -0.961 . . . . 72.22 112.355 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.28 173.73 8.6 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.052 0.941 . . . . 74.03 112.019 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 42.7 tp -92.53 160.53 15.0 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.567 -1.197 . . . . 72.52 109.339 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -74.08 73.64 1.27 Allowed Glycine 0 C--N 1.352 1.456 0 O-C-N 123.291 0.37 . . . . 74.3 112.326 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.46 136.85 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.655 1.182 . . . . 75.14 109.518 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 34.8 t70 . . . . . 0 C--O 1.248 0.974 0 C-N-CA 123.384 0.674 . . . . 64.41 109.293 178.308 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.426 0 N-CA-C 111.648 -0.581 . . . . 54.15 111.648 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.92 -178.26 17.38 Favored Glycine 0 C--N 1.346 1.132 0 O-C-N 123.802 0.354 . . . . 63.43 113.725 175.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 59.96 70.31 0.64 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.246 1.018 . . . . 75.55 110.551 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -87.37 -169.46 2.62 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.919 -1.037 . . . . 75.02 109.907 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.44 32.87 1.07 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.238 0.615 . . . . 74.21 110.813 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -87.19 -47.47 4.68 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 115.406 -0.816 . . . . 73.14 112.431 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 97' ' ' ILE . . . . . 0.681 HG23 ' SD ' ' B' ' 94' ' ' MET . 55.3 mt -70.37 -45.04 76.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 123.979 0.912 . . . . 75.11 110.297 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 23.1 t70 71.42 -72.91 0.1 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.507 1.523 . . . . 74.43 111.019 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -91.4 108.64 20.03 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.904 0.882 . . . . 65.13 109.917 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 100' ' ' LEU . . . . . 0.472 HD11 HG22 ' F' ' 97' ' ' ILE . 30.5 tp -138.73 66.37 41.25 Favored Pre-proline 0 N--CA 1.488 1.446 0 C-N-CA 122.779 0.431 . . . . 74.1 111.727 -177.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.49 -34.21 3.59 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.41 2.073 . . . . 72.33 112.091 173.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 102' ' ' LEU . . . . . 0.555 HD21 ' HB3' ' B' ' 95' ' ' ALA . 1.8 tm? 53.19 74.57 0.29 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.66 1.184 . . . . 70.43 108.996 -169.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 103' ' ' THR . . . . . 0.579 HG22 ' HB2' ' F' ' 109' ' ' TYR . 56.6 p 52.29 28.74 5.94 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 125.797 1.639 . . . . 75.44 113.05 176.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.7 -149.09 19.22 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-N 115.594 -0.73 . . . . 72.11 112.953 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -88.15 32.12 0.77 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.953 0.901 . . . . 74.15 110.284 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -172.05 150.04 2.46 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.54 -0.911 . . . . 74.24 108.54 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 107' ' ' THR . . . . . 0.503 ' HB ' HG21 ' B' ' 46' ' ' THR . 15.7 m -79.87 103.05 9.5 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 109.227 -0.657 . . . . 74.45 109.227 174.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -114.95 30.43 7.36 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.546 1.139 . . . . 74.04 109.343 -175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 109' ' ' TYR . . . . . 0.579 ' HB2' HG22 ' F' ' 103' ' ' THR . 7.4 t80 -137.88 112.93 9.14 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.835 0.454 . . . . 74.11 109.883 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 62.15 -173.79 0.14 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.229 1.012 . . . . 65.45 111.612 -174.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 mp 66.29 134.94 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.111 0.965 . . . . 74.25 111.161 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 62.21 -147.85 0.38 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.081 -0.711 . . . . 74.14 109.081 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 69.62 -72.69 0.1 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.154 1.381 . . . . 74.43 110.214 177.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -71.62 133.12 45.5 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.614 -0.884 . . . . 74.04 108.614 169.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 9.7 t -60.76 120.71 10.63 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 121.193 0.521 . . . . 72.32 110.042 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . -138.6 115.15 1.12 Allowed Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.75 -0.94 . . . . 63.32 110.75 -175.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 117' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' F' ' 121' ' ' VAL . 0.5 OUTLIER -68.99 165.41 38.27 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 123.536 0.735 . . . . 73.13 109.936 -178.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -58.27 -168.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 122.098 1.865 . . . . 72.53 113.766 173.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 119' ' ' ASP . . . . . 0.575 ' HB2' ' HA ' ' F' ' 125' ' ' ALA . 8.8 t70 79.18 -78.25 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.812 1.645 . . . . 72.3 110.855 -177.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -139.85 24.51 2.39 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 122.868 0.467 . . . . 73.25 110.895 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 121' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' F' ' 117' ' ' LYS . 21.9 t 61.73 30.91 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-O 122.832 1.301 . . . . 74.51 110.039 178.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 25.6 p -103.92 -88.15 0.42 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.816 -1.083 . . . . 73.44 110.428 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -163.39 -57.85 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.098 0.559 . . . . 73.31 109.94 -175.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 14.6 m -79.05 130.92 36.03 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.326 -0.852 . . . . 64.0 109.582 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . 0.575 ' HA ' ' HB2' ' F' ' 119' ' ' ASP . . . -135.01 135.93 41.75 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 122.847 0.459 . . . . 75.35 111.377 -177.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -86.8 140.86 29.29 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.596 0.758 . . . . 73.43 110.239 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 47.7 t -148.77 -73.9 0.18 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.146 0.579 . . . . 74.31 110.574 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . 63.05 -175.24 0.15 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.193 0.997 . . . . 64.23 111.737 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 3.4 t -126.78 84.61 2.28 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.229 1.014 . . . . 72.11 109.054 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 130' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' B' ' 125' ' ' GLN . . . -84.97 73.87 10.61 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.112 -0.949 . . . . 72.33 110.006 -178.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 131' ' ' TRP . . . . . 0.614 ' HB3' ' HA ' ' B' ' 124' ' ' PRO . 82.5 t90 175.07 114.11 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.538 1.535 . . . . 74.42 107.965 173.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 7.6 t -166.97 32.97 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.406 -0.961 . . . . 71.44 108.406 172.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 133' ' ' THR . . . . . 0.421 HG21 HD13 ' C' ' 126' ' ' LEU . 1.5 m -72.98 125.0 26.58 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.954 -1.021 . . . . 74.42 110.505 -174.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -83.92 56.34 5.04 Favored Glycine 0 C--N 1.348 1.246 0 N-CA-C 112.128 -0.389 . . . . 70.24 112.128 175.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 3.9 p -91.43 91.3 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 124.061 0.944 . . . . 61.32 110.04 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 136' ' ' LYS . . . . . 0.603 ' HZ1' ' HB3' ' F' ' 136' ' ' LYS . 4.7 ttpm? -158.86 85.76 0.83 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.435 -0.802 . . . . 75.13 110.079 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 30.6 m -109.54 -71.6 0.76 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.566 -0.902 . . . . 75.33 108.566 172.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 138' ' ' TYR . . . . . 0.545 ' HE1' ' HA ' ' C' ' 131' ' ' VAL . 10.0 t80 60.83 -165.38 0.22 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.2 1.0 . . . . 74.31 111.114 175.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -68.42 -26.76 65.69 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.181 0.592 . . . . 73.32 110.496 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -172.31 -59.98 0.04 OUTLIER Glycine 0 C--N 1.346 1.095 0 CA-C-N 115.958 -0.565 . . . . 74.12 111.736 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.26 92.9 0.05 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.822 1.249 . . . . 73.54 112.502 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 60.9 tp -90.89 103.69 16.37 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.519 0.728 . . . . 75.2 110.146 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -179.87 141.98 4.93 Favored Glycine 0 C--N 1.343 0.937 0 C-N-CA 121.588 -0.339 . . . . 64.24 112.476 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 9.2 p -154.57 145.34 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.714 0.806 . . . . 72.44 109.647 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 29.8 t70 . . . . . 0 C--O 1.249 1.06 0 C-N-CA 123.324 0.65 . . . . 74.51 109.396 176.305 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 108.607 -0.886 . . . . 64.24 108.607 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -159.66 156.57 28.07 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 122.87 0.468 . . . . 74.43 110.396 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -83.95 139.31 32.66 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.012 0.925 . . . . 74.11 109.627 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -69.62 -95.62 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.31 1.044 . . . . 71.23 110.798 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.8 t30 170.94 53.92 0.0 OUTLIER 'General case' 0 C--N 1.366 1.3 0 C-N-CA 124.888 1.275 . . . . 63.53 108.205 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -148.12 -84.39 0.1 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 109.605 -0.517 . . . . 74.51 109.605 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.6 m -157.02 85.03 0.94 Allowed 'General case' 0 C--O 1.242 0.686 0 N-CA-C 107.36 -1.348 . . . . 74.32 107.36 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -93.36 144.22 25.54 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.131 -0.941 . . . . 60.13 109.512 -178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.434 ' N ' ' SD ' ' A' ' 9' ' ' MET . 1.3 mpt? -80.47 172.23 14.03 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.743 0.817 . . . . 74.4 110.661 -175.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 84.6 m -140.66 118.44 11.72 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.261 0.624 . . . . 74.14 110.486 -174.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.54 ' HE1' ' SG ' ' A' ' 102' ' ' CYS . 72.6 t80 -120.62 124.87 46.3 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.767 -1.197 . . . . 73.2 107.767 172.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -132.23 132.72 43.36 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.284 -0.635 . . . . 75.2 109.284 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.458 HG23 ' HG2' ' C' ' 130' ' ' PRO . 69.4 mt -89.69 109.63 20.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.158 -1.053 . . . . 64.45 108.158 171.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.63 -40.66 17.19 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 109.048 -0.723 . . . . 72.23 109.048 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 -168.88 122.28 0.82 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.64 0.376 . . . . 74.41 110.283 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 83.7 mt -107.07 136.71 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.776 -0.824 . . . . 74.4 108.776 170.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.443 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 22.1 p90 -164.92 169.51 16.4 Favored 'General case' 0 C--N 1.347 0.47 0 O-C-N 123.822 0.701 . . . . 61.43 111.699 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -94.47 120.6 34.96 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.116 -0.698 . . . . 70.41 109.116 172.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.443 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 34.8 mtpt -78.9 -34.88 44.35 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.164 0.507 . . . . 70.2 109.673 175.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.421 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 17.8 t70 -150.01 140.47 22.41 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.646 -1.161 . . . . 71.03 109.865 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.4 mt -130.92 139.69 50.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 124.873 1.269 . . . . 72.41 107.835 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -145.54 127.97 15.95 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.297 -1.001 . . . . 61.34 108.297 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.459 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 86.9 t80 -135.63 129.49 32.91 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.112 -1.44 . . . . 74.01 107.112 171.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -129.59 135.95 49.2 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.165 -0.679 . . . . 75.13 109.165 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.31 76.93 71.66 Favored Pre-proline 0 C--O 1.24 0.553 0 N-CA-C 105.817 -1.919 . . . . 72.15 105.817 167.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.67 -22.92 36.91 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.591 2.194 . . . . 74.52 112.027 -171.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -110.12 22.3 15.74 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.233 1.013 . . . . 65.51 109.447 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.453 ' HB2' ' HE3' ' B' ' 19' ' ' LYS . . . -46.88 -52.79 30.47 Favored Pre-proline 0 CA--C 1.568 1.654 0 CA-C-O 117.846 -1.073 . . . . 75.02 113.658 -171.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.57 -23.22 64.31 Favored 'Trans proline' 0 C--N 1.391 2.778 0 CA-C-N 121.536 1.584 . . . . 73.24 113.374 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -84.12 -39.69 19.17 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.675 0.79 . . . . 74.51 111.017 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.758 HG22 ' HA ' ' A' ' 73' ' ' ALA . 5.5 p -78.23 -23.56 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 CA-C-N 115.306 -0.861 . . . . 73.21 113.159 -157.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -70.06 -19.35 63.29 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 122.739 0.416 . . . . 74.43 110.874 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -86.81 -16.5 36.03 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.568 1.147 . . . . 74.31 110.772 177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -81.5 158.06 24.63 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.873 0.869 . . . . 74.41 111.884 -174.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.48 118.27 8.53 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 123.992 0.917 . . . . 74.11 109.413 173.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -78.55 84.92 4.65 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.661 0.743 . . . . 75.14 109.91 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -122.85 76.09 48.44 Favored Pre-proline 0 C--O 1.243 0.745 0 N-CA-C 106.799 -1.556 . . . . 74.53 106.799 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.411 ' HB2' HG22 ' A' ' 40' ' ' VAL . 83.7 Cg_endo -78.47 115.1 3.61 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 121.817 1.678 . . . . 72.32 111.363 -171.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -93.31 81.59 4.45 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 105.554 -2.017 . . . . 73.15 105.554 172.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.538 HG23 ' HB1' ' A' ' 66' ' ' ALA . 46.0 t -86.05 93.74 3.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 CA-C-N 114.532 -1.213 . . . . 61.55 109.555 -174.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.72 118.82 21.88 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.953 -1.476 . . . . 63.11 108.384 174.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.7 mt -95.39 108.55 20.75 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.435 -1.32 . . . . 75.45 107.435 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -102.61 141.18 35.85 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.387 -0.968 . . . . 75.32 108.387 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.516 HD12 HG22 ' A' ' 131' ' ' VAL . 75.5 mt -135.39 131.41 36.28 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 109.498 -0.556 . . . . 75.13 109.498 -174.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -134.03 129.56 36.27 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.448 -1.316 . . . . 71.52 107.448 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.3 m -108.54 130.97 55.28 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.876 -0.787 . . . . 53.12 108.876 172.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.72 109.37 9.11 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.819 -0.808 . . . . 73.5 108.819 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.6 p -91.28 163.42 14.24 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.318 0.647 . . . . 74.31 110.098 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.9 t -160.39 154.14 22.6 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.28 1.432 . . . . 75.41 107.328 -166.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -116.29 125.41 52.12 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.681 -0.489 . . . . 74.34 109.681 171.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.7 mt -95.02 -32.99 12.89 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.21 0.604 . . . . 74.43 110.583 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.95 -179.5 7.2 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.192 0.597 . . . . 64.14 111.39 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -63.51 123.7 19.47 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 109.346 -0.613 . . . . 70.14 109.346 174.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 70.2 -8.53 0.84 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 125.835 1.654 . . . . 64.54 112.886 -173.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.7 t -100.64 106.61 19.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 121.496 0.665 . . . . 73.43 109.301 -177.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -114.27 125.61 54.1 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.735 -1.209 . . . . 71.43 107.735 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -94.32 128.77 41.02 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.919 -0.771 . . . . 72.42 108.919 172.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.1 t -113.2 137.71 45.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.369 -0.974 . . . . 71.01 108.369 171.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.7 t -119.32 130.58 73.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.905 -0.776 . . . . 75.44 108.905 173.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.31 97.8 7.56 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 105.675 -1.972 . . . . 73.12 105.675 172.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -84.94 97.58 9.87 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.928 -1.138 . . . . 73.32 107.928 174.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 50.0 t -94.97 131.25 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 107.49 -1.3 . . . . 74.33 107.49 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.8 m -127.12 118.4 24.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.817 0.817 . . . . 74.24 110.203 175.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.595 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 91.5 t -104.33 125.49 59.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 124.56 1.144 . . . . 71.43 108.905 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.1 m -122.43 126.49 48.05 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.648 -0.871 . . . . 72.31 108.648 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.538 ' HB1' HG23 ' A' ' 40' ' ' VAL . . . -113.21 108.3 17.08 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 107.847 -1.168 . . . . 73.32 107.847 175.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.0 m -109.03 134.29 51.85 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.179 0.591 . . . . 72.21 110.037 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.459 HD13 ' HB1' ' A' ' 73' ' ' ALA . 14.4 mt -100.7 57.74 0.91 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.247 1.019 . . . . 75.21 108.341 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.46 -103.15 3.0 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 110.82 -0.912 . . . . 63.21 110.82 -169.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -96.59 -28.56 14.31 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.352 0.661 . . . . 73.45 111.428 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -102.74 123.07 45.74 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.471 0.308 . . . . 73.43 110.639 -173.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.6 m -71.5 138.42 48.92 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.514 0.726 . . . . 63.21 110.871 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.758 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -79.78 -60.06 2.49 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.317 1.047 . . . . 74.2 109.817 173.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -151.02 156.64 41.55 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 114.629 -1.169 . . . . 74.42 111.071 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 39.9 tp -126.82 115.05 18.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.633 1.173 . . . . 64.51 108.58 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.595 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 66.3 m -105.9 142.3 35.85 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.044 0.937 . . . . 72.32 109.339 175.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -146.44 121.35 9.98 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.644 -0.873 . . . . 73.22 108.644 166.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.4 t -126.09 109.81 22.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.703 -0.851 . . . . 73.52 108.703 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -85.78 82.01 8.36 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 114.379 -1.282 . . . . 72.33 108.443 174.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -76.23 95.55 3.74 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.828 -1.078 . . . . 61.14 109.164 -177.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.32 154.88 29.15 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 111.361 -0.696 . . . . 73.02 111.361 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.29 121.51 1.23 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.682 -0.967 . . . . 54.34 110.682 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.4 mt -81.68 127.1 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 107.823 -1.177 . . . . 74.12 107.823 171.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.627 ' HB3' HD11 ' A' ' 86' ' ' ILE . 71.0 m-85 -135.71 125.15 24.95 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.095 0.958 . . . . 72.24 109.561 -171.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.1 m -94.65 97.95 10.46 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 109.216 -0.661 . . . . 73.42 109.216 175.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.627 HD11 ' HB3' ' A' ' 84' ' ' PHE . 6.0 mm -108.04 156.69 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.385 0.674 . . . . 72.13 110.679 -172.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.41 162.84 8.47 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.523 1.129 . . . . 75.34 110.909 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.21 -13.94 62.81 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-N 115.951 -0.568 . . . . 73.24 114.422 174.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.46 146.6 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.824 0.85 . . . . 74.03 110.736 -177.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.403 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 50.5 mt-10 -144.16 174.76 10.6 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.296 1.038 . . . . 64.41 109.735 174.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.99 -139.01 26.42 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 116.012 -0.54 . . . . 60.21 112.618 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.7 p -69.79 -16.61 63.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 117.105 0.453 . . . . 73.12 111.501 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' C' ' 154' ' ' ASP . 48.4 mt-30 -64.57 -45.71 85.88 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.254 0.621 . . . . 74.12 109.959 170.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.469 ' HE2' HD22 ' A' ' 98' ' ' LEU . 6.1 tpt -66.75 -43.79 83.2 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.103 -0.953 . . . . 63.35 109.662 -178.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.95 -31.16 72.25 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.601 -0.727 . . . . 63.3 111.125 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -74.3 -30.3 62.01 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.667 0.787 . . . . 72.22 110.696 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.4 t -72.8 -44.54 61.38 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 109.115 -0.698 . . . . 61.14 109.115 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.469 HD22 ' HE2' ' A' ' 94' ' ' MET . 35.9 mt -84.99 -24.72 28.14 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.389 -0.823 . . . . 74.33 112.019 -174.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.01 4.45 33.89 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 119.597 -0.557 . . . . 52.03 113.947 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.581 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -147.52 -64.22 0.27 Allowed 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 117.667 0.734 . . . . 64.31 112.372 -177.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -68.16 -47.27 68.48 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 123.352 0.408 . . . . 74.35 111.697 -171.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.54 ' SG ' ' HE1' ' A' ' 11' ' ' PHE . 98.4 m -65.2 -45.83 71.87 Favored Pre-proline 0 CA--C 1.56 1.333 0 CA-C-O 117.987 -1.006 . . . . 73.22 112.316 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -54.26 -35.26 82.78 Favored 'Trans proline' 0 C--N 1.398 3.178 0 C-N-CA 122.188 1.925 . . . . 72.13 112.889 169.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -68.53 -34.25 75.54 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.531 0.732 . . . . 74.15 111.093 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.5 mm -67.88 -43.23 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.49 0.716 . . . . 73.11 110.054 172.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 55.9 mt -75.19 -20.24 59.4 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.053 -0.976 . . . . 62.23 111.877 -174.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -65.63 -45.24 67.1 Favored Pre-proline 0 N--CA 1.478 0.93 0 CA-C-O 117.05 -1.452 . . . . 75.44 113.537 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -50.72 -34.11 42.8 Favored 'Trans proline' 0 C--N 1.39 2.715 0 CA-C-N 122.182 1.815 . . . . 72.33 113.592 171.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -85.69 -36.47 20.22 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.711 0.804 . . . . 72.21 112.054 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.42 -48.25 67.84 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.968 -0.752 . . . . 64.02 108.968 175.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.407 ' NH1' HD13 ' C' ' 105' ' ' ILE . 27.9 ttm180 -47.87 -58.48 4.32 Favored 'General case' 0 C--O 1.213 -0.82 0 O-C-N 125.203 1.565 . . . . 70.43 110.677 171.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -60.79 -45.35 94.74 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 124.321 1.013 . . . . 74.44 111.792 -173.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.412 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 47.4 t -58.74 -45.9 88.62 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.045 0.841 . . . . 74.04 110.498 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.585 HD13 HD12 ' A' ' 128' ' ' LEU . 83.3 mt -61.16 -51.44 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 124.27 0.982 . . . . 64.33 110.603 175.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.2 m -58.75 -37.11 75.5 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.36 1.064 . . . . 73.21 110.687 -173.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.1 t -70.59 -44.56 67.06 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.444 -1.253 . . . . 75.33 109.866 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.439 ' HE2' ' HB2' ' A' ' 23' ' ' PHE . 10.4 mtp -59.39 -38.62 81.0 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.658 0.783 . . . . 71.23 111.774 176.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 114' ' ' ILE . 79.3 t -67.27 -46.08 84.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.211 1.004 . . . . 71.43 110.073 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.9 p -71.88 -30.63 65.61 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.828 -0.624 . . . . 64.12 111.106 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.408 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 81.7 mtt-85 -72.22 -33.69 67.78 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.675 0.79 . . . . 75.31 109.432 172.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.61 -2.17 74.32 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 115.019 -0.991 . . . . 73.21 112.962 175.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.484 HG22 HH21 ' B' ' 15' ' ' ARG . 52.1 m 76.92 19.99 1.34 Allowed 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 122.593 1.187 . . . . 74.33 111.882 168.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -93.31 148.75 36.17 Favored Pre-proline 0 C--O 1.248 1.022 0 N-CA-C 108.296 -1.002 . . . . 73.43 108.296 170.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.652 ' HB3' ' HA ' ' E' ' 131' ' ' TRP . 11.9 Cg_endo -54.47 138.96 74.9 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.494 2.129 . . . . 72.04 111.156 175.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -56.21 127.48 30.96 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.332 1.02 . . . . 75.34 112.274 -167.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.528 HD21 HG12 ' A' ' 64' ' ' VAL . 36.0 tp -113.04 97.14 6.33 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 114.454 -1.248 . . . . 74.44 109.406 -175.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -96.04 103.23 15.11 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.038 -1.467 . . . . 74.34 107.038 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.585 HD12 HD13 ' A' ' 114' ' ' ILE . 17.3 mt -55.24 136.12 49.08 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.778 0.673 . . . . 74.51 111.134 -169.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.84 137.86 97.28 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 122.755 0.422 . . . . 42.03 111.274 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.521 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 53.2 Cg_exo -55.47 114.84 2.07 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.593 2.862 . . . . 70.24 113.689 -178.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.516 HG22 HD12 ' A' ' 44' ' ' LEU . 45.1 t -104.2 133.24 48.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 CA-C-N 115.455 -0.793 . . . . 74.24 109.842 177.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 63.4 t-20 -96.97 87.12 4.16 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.515 -0.921 . . . . 71.01 108.515 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -59.68 -26.6 65.7 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.708 0.803 . . . . 74.04 113.056 175.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.581 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 8.6 t0 -63.67 -43.97 95.15 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.931 -0.766 . . . . 75.42 108.931 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.05 -35.22 80.46 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.893 -1.048 . . . . 72.31 111.476 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.415 ' HA ' ' ND2' ' A' ' 139' ' ' ASN . 77.9 mt -71.83 -40.66 68.93 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.022 0.826 . . . . 74.45 111.879 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -67.05 -42.3 85.05 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.796 -0.816 . . . . 74.12 108.796 175.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.568 ' HG3' ' HA ' ' A' ' 143' ' ' GLN . 5.4 tpt -64.09 -47.55 79.61 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 124.208 0.942 . . . . 70.1 111.336 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.687 ' HA ' ' HB2' ' A' ' 143' ' ' GLN . 23.8 p30 -66.79 -30.62 70.87 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 120.975 0.417 . . . . 74.53 110.77 -176.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -72.78 -41.52 64.93 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.296 1.038 . . . . 75.21 110.432 172.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 42.3 tp -66.52 -49.88 65.06 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.037 0.935 . . . . 75.24 110.889 -172.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 179.83 -19.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.974 0.909 . . . . 73.33 110.748 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.687 ' HB2' ' HA ' ' A' ' 139' ' ' ASN . 55.7 tt0 60.43 86.75 0.09 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.706 1.602 . . . . 75.34 111.857 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -151.52 -1.02 0.34 Allowed 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.732 -0.667 . . . . 73.42 110.561 -176.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.472 ' HB1' ' SD ' ' A' ' 138' ' ' MET . . . -144.1 -175.11 4.48 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.447 1.099 . . . . 75.14 108.99 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 168.79 -53.66 0.21 Allowed Glycine 0 C--N 1.341 0.825 0 N-CA-C 112.119 -0.393 . . . . 73.21 112.119 178.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.44 175.0 8.61 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.672 0.749 . . . . 75.42 112.016 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -161.15 -173.55 29.92 Favored Glycine 0 C--O 1.242 0.61 0 CA-C-N 114.813 -1.085 . . . . 63.35 111.429 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.6 m -148.37 159.9 43.55 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 108.121 -1.066 . . . . 74.01 108.121 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.64 178.2 8.66 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.027 0.931 . . . . 75.21 110.038 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' C' ' 147' ' ' GLU . 4.4 mp0 -76.73 94.95 3.9 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 109.32 -0.622 . . . . 65.42 109.32 172.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.458 ' HB3' ' HA3' ' C' ' 146' ' ' GLY . 46.6 t-80 -71.09 80.05 0.68 Allowed 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.212 -1.033 . . . . 71.31 108.212 170.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -170.01 108.6 0.38 Allowed 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.126 -1.064 . . . . 75.12 108.126 -172.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.464 ' HB2' ' HA ' ' C' ' 139' ' ' ASN . 2.6 m-20 -118.83 101.78 8.32 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 108.98 -0.748 . . . . 64.53 108.98 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.879 0 C-N-CA 123.74 0.816 . . . . 75.33 109.066 -178.231 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.407 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 109.452 -0.573 . . . . 75.44 109.452 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 66.2 m -149.38 163.35 37.98 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.698 1.199 . . . . 70.23 109.96 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.494 ' HB3' ' ND2' ' B' ' 6' ' ' ASN . 0.9 OUTLIER -69.05 137.21 53.38 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.141 0.976 . . . . 71.04 110.546 -172.573 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -75.9 -54.17 7.31 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.463 1.105 . . . . 72.21 112.652 -170.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -90.45 70.89 6.98 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.559 0.695 . . . . 72.03 110.592 -170.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . 0.494 ' ND2' ' HB3' ' B' ' 3' ' ' GLU . 2.7 m-80 -112.06 139.02 47.92 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.102 0.961 . . . . 74.23 109.791 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 12.7 m -68.18 -14.25 62.84 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.429 1.091 . . . . 71.42 111.72 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -57.1 -21.72 34.19 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.588 1.155 . . . . 64.41 112.089 171.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.554 ' HG3' HG23 ' B' ' 89' ' ' ILE . 1.2 tmt? 68.23 167.66 0.26 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.573 1.549 . . . . 74.12 111.804 176.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.484 ' N ' ' SD ' ' B' ' 9' ' ' MET . 9.5 t -159.89 133.59 7.16 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.844 0.857 . . . . 72.25 109.405 176.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -117.36 141.85 47.81 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 107.842 -1.17 . . . . 75.4 107.842 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -149.46 137.54 20.54 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 122.76 0.424 . . . . 74.41 110.701 176.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 44.6 mt -96.23 128.16 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.049 -1.093 . . . . 73.43 108.049 173.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -95.35 -42.03 8.72 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.524 0.515 . . . . 73.41 110.525 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.484 HH21 HG22 ' A' ' 122' ' ' THR . 22.8 ttt180 -172.93 138.69 0.8 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.737 -0.665 . . . . 73.33 109.303 -172.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.8 mt -123.31 139.88 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 106.661 -1.607 . . . . 74.2 106.661 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -164.01 145.21 8.7 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.22 0.822 . . . . 73.44 113.22 -174.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 64.0 m -76.28 120.43 21.54 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.737 -1.119 . . . . 74.52 109.094 172.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.613 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 37.0 mtpt -97.82 -22.82 16.17 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.049 0.94 . . . . 75.03 111.006 -178.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.526 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 17.8 t70 -158.53 143.25 16.07 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.185 0.594 . . . . 74.12 110.358 -175.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.595 HD13 ' SG ' ' B' ' 113' ' ' CYS . 38.9 mm -138.9 141.47 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.252 1.421 . . . . 74.1 107.849 174.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 67.8 m -145.83 138.45 25.69 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.529 0.732 . . . . 71.04 109.13 170.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.3 t80 -143.41 116.76 9.05 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.792 -1.929 . . . . 74.1 105.792 169.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -127.89 111.14 13.26 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.323 -0.992 . . . . 62.03 108.323 -176.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.477 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -110.2 87.91 6.6 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 108.211 -1.033 . . . . 73.32 108.211 175.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.07 -34.06 14.28 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.232 1.955 . . . . 74.25 111.547 -175.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -99.97 3.81 44.54 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.325 1.05 . . . . 75.23 110.902 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.524 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -24.89 -64.68 0.1 OUTLIER Pre-proline 0 N--CA 1.504 2.266 0 C-N-CA 126.606 1.962 . . . . 72.44 115.332 -172.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 7.9 Cg_exo -66.57 -42.34 9.66 Favored 'Trans proline' 0 C--N 1.388 2.63 0 C-N-CA 122.154 1.903 . . . . 74.43 112.386 -170.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -86.03 -28.19 24.31 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.651 0.78 . . . . 75.22 111.89 -171.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 p -77.59 -11.66 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 122.889 0.476 . . . . 64.33 110.696 -175.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -65.89 -20.52 66.25 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 113.101 0.778 . . . . 73.23 113.101 173.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -63.21 -25.16 68.21 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.313 0.578 . . . . 75.34 110.111 173.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.555 ' HZ3' ' HG2' ' B' ' 71' ' ' GLU . 88.4 mttt -90.83 66.98 6.12 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.307 1.043 . . . . 73.11 109.713 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -80.6 82.08 6.7 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 122.291 1.043 . . . . 75.15 109.114 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -152.83 -173.3 4.52 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.102 -0.954 . . . . 75.32 109.122 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -72.51 110.35 7.97 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 123.992 0.917 . . . . 75.42 109.631 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.532 ' HA ' HD21 ' B' ' 68' ' ' LEU . 49.2 Cg_endo -70.38 141.1 41.88 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 121.653 1.569 . . . . 74.35 109.747 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -68.12 99.97 0.95 Allowed 'General case' 0 C--O 1.242 0.687 0 N-CA-C 106.906 -1.516 . . . . 70.43 106.906 171.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.509 HG11 HD13 ' B' ' 126' ' ' LEU . 39.1 t -95.72 154.2 3.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 114.593 -1.185 . . . . 73.54 108.734 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.408 ' N ' HG13 ' B' ' 40' ' ' VAL . 53.6 tttm -143.81 117.5 9.25 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.93 -0.766 . . . . 73.33 108.93 175.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.465 HD12 HD21 ' B' ' 128' ' ' LEU . 31.1 tp -93.27 137.31 32.71 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 108.832 -0.803 . . . . 65.01 108.832 172.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -159.55 128.22 5.11 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 107.702 -1.221 . . . . 73.05 107.702 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.615 ' HB2' HD22 ' F' ' 111' ' ' LEU . 4.0 mp -108.59 151.25 26.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.879 -0.785 . . . . 72.45 108.879 -174.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.545 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.4 t70 -127.54 144.14 51.1 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.027 0.931 . . . . 73.31 109.111 -177.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 26.1 p -113.07 106.51 14.76 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.534 0.734 . . . . 64.44 110.653 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.99 136.25 52.77 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.971 -1.122 . . . . 64.11 107.971 171.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.542 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 58.0 m -142.85 177.55 8.26 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.567 0.347 . . . . 70.42 110.774 -173.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 79.4 p -159.21 139.18 11.89 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.785 0.434 . . . . 74.53 111.136 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -90.24 125.16 35.39 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 108.696 -0.853 . . . . 71.35 108.696 169.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.6 pp -140.32 17.71 2.41 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.978 0.911 . . . . 75.13 109.845 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.77 152.65 17.93 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.454 1.102 . . . . 75.33 109.078 174.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -76.98 135.43 38.7 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.279 -1.008 . . . . 74.22 108.279 164.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 70.59 -4.25 1.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.139 0.976 . . . . 71.11 113.113 172.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.425 HG13 ' HG ' ' B' ' 85' ' ' SER . 63.6 t -136.27 128.46 45.0 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 106.725 -1.583 . . . . 74.1 106.725 -175.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.542 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 4.9 t80 -122.16 169.64 10.67 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.836 0.351 . . . . 74.34 110.564 -172.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -134.72 111.45 9.98 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 107.664 -1.235 . . . . 72.45 107.664 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 61.5 t -106.75 130.67 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.056 0.942 . . . . 75.52 109.198 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.2 t -111.28 113.31 43.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 N-CA-C 109.277 -0.638 . . . . 73.45 109.277 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 63.1 tp -93.79 110.77 22.4 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 109.076 -0.713 . . . . 73.15 109.076 171.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.545 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 14.0 ttm180 -84.66 132.89 34.43 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.855 -1.165 . . . . 75.32 107.855 169.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.415 HG21 HD23 ' B' ' 44' ' ' LEU . 43.8 t -123.49 104.15 13.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.571 -1.27 . . . . 72.3 107.571 174.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 15.2 m -100.63 131.71 46.4 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.068 0.461 . . . . 75.21 110.112 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.568 HG23 HD12 ' B' ' 114' ' ' ILE . 70.3 t -122.92 126.54 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.222 1.009 . . . . 74.41 108.5 175.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.8 m -111.3 138.9 47.18 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 107.54 -1.281 . . . . 71.22 107.54 168.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.12 137.09 28.88 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.034 -0.728 . . . . 74.53 109.034 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.541 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 25.1 p -147.05 128.28 14.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.085 0.469 . . . . 64.41 111.584 -172.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.532 HD21 ' HA ' ' B' ' 38' ' ' PRO . 56.4 mt -99.03 103.79 15.76 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 124.919 1.288 . . . . 72.24 108.507 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.3 -119.04 4.82 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 115.657 -0.701 . . . . 62.54 111.824 -174.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -112.22 3.93 17.47 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.94 0.896 . . . . 73.33 111.368 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.555 ' HG2' ' HZ3' ' B' ' 34' ' ' LYS . 11.8 pt-20 -118.0 148.62 42.05 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.119 0.567 . . . . 75.11 109.672 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 99.2 m -72.63 125.66 28.02 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.8 -0.636 . . . . 62.45 111.232 -177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.541 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -71.66 -62.43 1.42 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.81 -1.181 . . . . 61.42 107.81 173.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -152.89 157.89 41.35 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.586 -1.188 . . . . 73.42 111.186 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 70.8 mt -126.08 108.5 11.42 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 106.255 -1.758 . . . . 74.51 106.255 172.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 39.3 t -119.17 113.76 21.4 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.507 -0.923 . . . . 74.12 108.507 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -128.57 124.62 36.38 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.973 -1.121 . . . . 75.33 107.973 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.491 HG12 HD11 ' B' ' 21' ' ' ILE . 67.3 t -123.63 155.84 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.855 0.862 . . . . 72.3 109.24 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.526 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.7 mt-30 -131.25 108.03 9.4 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.19 -0.67 . . . . 55.13 109.19 171.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.411 ' HB2' ' HB1' ' B' ' 110' ' ' ALA . 8.5 tp-100 -96.89 109.38 22.11 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.568 0.747 . . . . 70.43 109.518 173.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.613 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -99.64 170.61 23.25 Favored Glycine 0 N--CA 1.464 0.535 0 N-CA-C 112.021 -0.432 . . . . 73.42 112.021 174.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.97 138.78 5.12 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 112.573 -0.211 . . . . 62.5 112.573 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 49.5 mt -92.17 122.08 43.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.267 1.027 . . . . 74.12 108.764 174.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -127.45 135.21 50.1 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.002 0.921 . . . . 73.3 109.727 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.425 ' HG ' HG13 ' B' ' 55' ' ' VAL . 24.1 m -106.32 128.65 54.15 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.691 0.796 . . . . 73.11 109.5 174.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.491 ' HB ' HD11 ' B' ' 89' ' ' ILE . 1.9 pp -139.77 147.06 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.374 0.669 . . . . 72.52 111.089 -177.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.655 ' HA ' ' HB ' ' F' ' 97' ' ' ILE . . . -154.68 165.92 35.03 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.4 0.68 . . . . 75.51 111.104 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 90.8 -45.83 2.91 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 116.087 -0.506 . . . . 31.2 112.741 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.564 HD13 ' HA ' ' B' ' 94' ' ' MET . 4.0 pt -56.38 152.33 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.559 1.143 . . . . 72.34 111.426 169.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -157.94 164.09 37.2 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.536 0.734 . . . . 74.22 109.536 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.36 -111.07 3.49 Favored Glycine 0 C--N 1.355 1.631 0 O-C-N 123.197 0.31 . . . . 75.14 112.699 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 25.0 m -84.34 -43.22 14.97 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 123.695 0.798 . . . . 74.44 109.696 175.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -62.53 -24.66 67.62 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 113.758 -1.565 . . . . 75.43 111.694 -168.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.731 ' HB2' HD13 ' F' ' 97' ' ' ILE . 23.9 ptm -66.1 -65.67 0.65 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.084 0.772 . . . . 75.54 113.084 -177.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . 0.412 ' HB1' HD12 ' F' ' 102' ' ' LEU . . . -80.19 -14.4 58.48 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.21 0.448 . . . . 71.32 112.21 -175.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -61.33 -37.03 81.82 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.365 0.666 . . . . 74.15 110.554 171.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.459 ' SG ' HG21 ' B' ' 86' ' ' ILE . 43.8 t -60.13 -24.56 64.78 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.114 0.966 . . . . 73.41 112.024 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.504 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 26.7 mt -97.76 -39.13 9.19 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.124 0.969 . . . . 72.42 111.497 -177.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.26 -19.27 69.69 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 116.43 -0.35 . . . . 73.52 113.572 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.87 -48.48 1.89 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.003 0.521 . . . . 73.24 111.767 -172.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -83.05 -41.96 18.03 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 111.877 0.325 . . . . 73.23 111.877 -171.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.504 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 94.8 m -63.05 -43.23 81.15 Favored Pre-proline 0 CA--C 1.57 1.733 0 N-CA-C 113.569 0.952 . . . . 45.23 113.569 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.27 -27.62 81.52 Favored 'Trans proline' 0 C--N 1.399 3.196 0 C-N-CA 122.239 1.96 . . . . 73.24 113.674 173.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -65.01 -33.55 76.31 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.663 0.785 . . . . 74.12 110.591 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 57.4 mt -73.89 -41.7 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.883 0.873 . . . . 75.01 110.088 176.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 92.5 mt -75.94 -30.01 58.53 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.23 -0.896 . . . . 65.32 112.424 -172.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -56.98 -49.7 92.44 Favored Pre-proline 0 N--CA 1.484 1.239 0 CA-C-O 117.342 -1.313 . . . . 72.25 113.477 -172.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -50.31 -39.64 53.01 Favored 'Trans proline' 0 C--N 1.391 2.788 0 C-N-CA 122.512 2.141 . . . . 75.14 114.161 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -70.15 -47.15 62.89 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.334 0.654 . . . . 72.23 110.509 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' B' ' 80' ' ' GLN . . . -62.35 -35.53 79.41 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.37 -0.832 . . . . 65.44 111.337 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.522 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 50.2 ttt-85 -67.53 -49.73 61.97 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.134 1.374 . . . . 72.41 110.349 -177.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.6 -32.34 73.61 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.021 0.826 . . . . 71.51 109.687 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.595 ' SG ' HD13 ' B' ' 21' ' ' ILE . 3.3 t -69.56 -42.84 74.02 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.257 0.623 . . . . 65.24 110.829 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.568 HD12 HG23 ' B' ' 64' ' ' VAL . 74.9 mt -60.23 -54.52 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.392 0.677 . . . . 75.44 110.603 172.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 25.5 m -58.9 -28.69 66.43 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.503 0.721 . . . . 73.23 111.276 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 22.9 t -67.69 -53.2 29.58 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 123.203 0.601 . . . . 75.34 109.59 173.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.2 mmt -64.52 -31.89 73.3 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 122.758 0.423 . . . . 75.15 111.774 -175.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.489 HG22 HD22 ' B' ' 126' ' ' LEU . 79.8 t -69.7 -42.1 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.268 1.027 . . . . 73.04 110.562 176.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 81.5 p -72.43 -28.89 63.24 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.001 0.429 . . . . 71.25 111.087 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' B' ' 116' ' ' SER . 88.5 mtt-85 -67.93 -40.72 83.31 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.12 -0.945 . . . . 71.54 109.505 175.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.45 -6.18 61.43 Favored Glycine 0 C--N 1.352 1.467 0 O-C-N 123.764 0.665 . . . . 72.23 113.071 173.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 9.7 m 64.98 31.45 11.25 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.282 1.433 . . . . 73.12 110.298 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -89.53 164.03 31.08 Favored Pre-proline 0 CA--C 1.556 1.193 0 CA-C-N 114.22 -1.354 . . . . 75.42 111.129 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.502 ' HG3' ' HB3' ' F' ' 130' ' ' ALA . 31.1 Cg_exo -39.74 146.55 0.22 Allowed 'Trans proline' 0 C--N 1.393 2.885 0 C-N-CA 124.647 3.565 . . . . 74.11 115.86 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -61.05 112.84 2.25 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.301 0.641 . . . . 74.41 109.768 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.509 HD13 HG11 ' B' ' 40' ' ' VAL . 43.4 tp -109.93 110.72 21.76 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.424 0.69 . . . . 72.0 109.463 -174.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -107.29 117.53 34.32 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.201 -1.037 . . . . 73.02 108.201 175.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.522 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 51.4 mt -78.56 147.46 33.74 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 120.535 0.207 . . . . 64.23 110.53 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -73.13 142.11 81.97 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 123.641 0.776 . . . . 71.54 112.375 -170.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 129' ' ' ALA . 11.2 Cg_endo -85.04 104.04 0.86 Allowed 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.312 2.675 . . . . 71.3 111.192 176.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.95 134.93 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 122.83 0.452 . . . . 74.51 110.327 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -80.21 114.36 19.06 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.259 0.624 . . . . 73.4 109.432 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -54.22 -42.77 70.18 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.187 1.395 . . . . 72.31 111.453 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -52.96 -41.4 64.5 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.045 -1.434 . . . . 73.45 112.379 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.12 -32.61 73.21 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.703 0.627 . . . . 73.42 112.414 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.651 HD23 HD11 ' F' ' 111' ' ' LEU . 6.8 mp -74.16 -35.08 64.01 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.365 0.666 . . . . 74.44 110.929 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -87.4 -15.93 36.39 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.249 0.62 . . . . 74.24 111.581 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 48.1 ttm -68.11 -38.84 82.72 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.498 0.719 . . . . 74.41 110.906 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.49 ' HA ' ' HG3' ' B' ' 143' ' ' GLN . 9.8 p30 -82.71 -33.6 27.54 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.34 -0.846 . . . . 72.54 110.583 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -67.91 -31.24 70.89 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.31 0.644 . . . . 75.2 110.31 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 25.4 tp -97.74 14.61 26.3 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.82 0.848 . . . . 74.3 110.365 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 72.63 123.31 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.443 1.497 . . . . 75.44 111.915 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . 0.49 ' HG3' ' HA ' ' B' ' 139' ' ' ASN . 25.2 mt-30 -78.71 121.85 25.24 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.562 0.745 . . . . 74.04 109.717 175.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -90.86 88.04 6.89 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.102 0.561 . . . . 64.31 109.852 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . 59.25 -81.12 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.623 1.569 . . . . 73.45 113.342 171.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.99 -30.36 0.44 Allowed Glycine 0 C--N 1.342 0.864 0 N-CA-C 110.584 -1.006 . . . . 63.52 110.584 -173.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 71.93 -67.93 0.24 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.087 1.755 . . . . 74.54 111.633 175.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -129.99 147.44 18.07 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 110.949 -0.86 . . . . 70.02 110.949 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 10.8 t -157.86 22.69 0.27 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.744 0.818 . . . . 74.45 109.749 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . 0.401 ' HG2' ' NE2' ' D' ' 93' ' ' GLN . 6.6 mm-40 69.12 107.77 0.05 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.475 1.51 . . . . 64.43 109.502 -165.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -92.81 14.09 18.38 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.948 0.899 . . . . 73.43 110.01 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -148.13 130.87 16.0 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.052 0.941 . . . . 75.21 109.586 -169.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . 0.55 ' HG3' ' HG3' ' D' ' 90' ' ' GLU . 58.8 tt0 -93.9 99.61 11.93 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.802 -0.444 . . . . 71.31 109.802 178.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . 0.577 ' HB2' ' HA2' ' D' ' 91' ' ' GLY . 4.6 m-20 -116.11 158.51 23.1 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.771 0.828 . . . . 65.04 110.533 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.977 0 C-N-CA 124.489 1.116 . . . . 64.13 108.315 -179.53 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ttt . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.447 0.165 . . . . 74.3 110.799 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 43.2 m -149.54 126.35 11.12 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.613 0.765 . . . . 70.3 109.219 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . 0.498 ' HB2' ' NE2' ' A' ' 143' ' ' GLN . 14.7 mp0 -67.84 97.73 0.67 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 108.792 -0.818 . . . . 62.32 108.792 176.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -71.67 116.16 11.71 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.765 0.826 . . . . 73.35 109.587 178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -75.44 79.28 2.49 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 107.786 -1.19 . . . . 75.41 107.786 171.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 171.05 177.14 0.06 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.109 1.764 . . . . 75.21 106.758 -171.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 44.4 m -65.76 119.99 12.2 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 108.466 -0.939 . . . . 73.55 108.466 162.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -59.58 -49.17 78.82 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 124.072 0.858 . . . . 72.44 111.855 -174.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.459 ' HE3' HG21 ' C' ' 89' ' ' ILE . 50.1 ttm 64.24 116.33 0.02 OUTLIER 'General case' 0 C--N 1.357 0.907 0 O-C-N 125.119 1.512 . . . . 73.2 111.324 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 96.7 m -84.46 97.02 9.29 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.047 -1.094 . . . . 74.35 108.047 173.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.521 ' HD2' ' HG2' ' A' ' 130' ' ' PRO . 35.0 t80 -115.5 127.38 55.26 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.0 -1.111 . . . . 75.21 108.0 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -142.03 131.25 23.44 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.711 -0.848 . . . . 71.4 108.711 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 19.9 mt -84.22 134.77 26.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.723 -0.843 . . . . 73.14 108.723 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.511 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 20.9 mm-40 -91.35 -45.67 8.45 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.592 -0.892 . . . . 74.22 108.592 175.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -177.58 153.35 0.88 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.048 1.339 . . . . 75.14 109.455 175.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.441 HG21 HD23 ' C' ' 106' ' ' LEU . 75.0 mt -128.75 118.55 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.731 1.212 . . . . 63.34 108.379 177.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.483 ' HB3' HG22 ' D' ' 122' ' ' THR . 6.1 p90 -151.37 154.45 36.7 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.008 0.908 . . . . 74.21 112.249 -164.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.2 p -79.22 108.85 13.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.562 -1.199 . . . . 73.41 109.406 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' D' ' 28' ' ' ALA . 8.9 mmmm -72.83 -45.01 60.69 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 107.557 -1.275 . . . . 75.04 107.557 172.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.705 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 10.4 t70 -134.52 137.54 43.94 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 113.186 -1.825 . . . . 64.11 109.19 -174.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.4 mt -134.78 143.44 37.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 125.455 1.502 . . . . 70.22 106.969 172.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.7 t -150.01 138.0 20.24 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 109.154 -0.684 . . . . 75.31 109.154 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -139.01 128.61 24.57 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.48 -1.304 . . . . 71.33 107.48 171.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -130.18 120.19 24.14 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.534 1.134 . . . . 70.53 108.784 -174.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.14 84.0 58.66 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 106.969 -1.493 . . . . 74.5 106.969 169.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.5 -26.9 28.36 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 122.397 2.064 . . . . 64.13 111.227 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -107.39 21.83 16.89 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.486 1.114 . . . . 65.44 109.836 -176.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.82 -64.94 0.71 Allowed Pre-proline 0 CA--C 1.571 1.777 0 N-CA-C 114.466 1.284 . . . . 54.51 114.466 -165.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -67.54 -27.87 38.83 Favored 'Trans proline' 0 C--N 1.385 2.453 0 CA-C-N 122.326 1.867 . . . . 74.34 112.615 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -68.13 -37.86 81.57 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.893 0.877 . . . . 73.13 111.366 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.633 HG21 ' HA ' ' C' ' 73' ' ' ALA . 14.8 p -82.01 -24.87 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 116.184 -0.462 . . . . 71.15 111.941 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -65.72 -30.66 71.36 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 121.787 -0.57 . . . . 73.43 111.015 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -90.82 29.93 1.27 Allowed 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.109 0.964 . . . . 64.0 111.228 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.729 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 1.3 tppp? -124.74 153.38 42.49 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.457 1.103 . . . . 71.3 109.711 -177.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -67.76 129.76 40.9 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 122.994 0.518 . . . . 75.34 109.89 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 66.5 t-105 -85.0 83.44 8.06 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.8 0.84 . . . . 74.22 111.346 -173.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -131.21 78.87 71.74 Favored Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 123.739 0.816 . . . . 71.41 109.071 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -83.23 155.61 14.6 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.553 2.169 . . . . 71.11 112.428 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -88.52 100.48 13.11 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 106.749 -1.574 . . . . 74.01 106.749 168.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 57.4 t -74.64 99.42 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 109.024 -0.732 . . . . 71.24 109.024 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 32.5 mmtm -131.65 106.79 8.39 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.086 0.954 . . . . 75.44 109.472 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 pp -95.74 165.35 12.35 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.69 0.796 . . . . 73.02 109.933 175.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.583 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 19.9 t70 -139.86 143.98 37.01 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.414 1.086 . . . . 73.21 108.235 175.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 97.4 mt -128.58 112.57 14.43 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.382 0.611 . . . . 73.31 109.613 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -112.87 121.18 43.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.635 -1.617 . . . . 64.4 106.635 172.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.2 t -118.68 142.92 47.2 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.36 0.6 . . . . 75.12 109.382 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.45 151.86 49.62 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.561 1.144 . . . . 74.42 108.274 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 53.1 p -147.32 142.21 26.89 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 109.348 -0.612 . . . . 74.1 109.348 174.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 72.6 p -150.35 151.85 33.5 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.291 1.036 . . . . 64.14 108.585 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -98.87 117.22 32.87 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.925 -0.769 . . . . 73.44 108.925 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.678 HD12 ' HB2' ' C' ' 57' ' ' GLU . 61.4 mt -84.42 -37.01 21.98 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.497 0.719 . . . . 75.43 110.233 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.38 -175.76 5.6 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.169 0.988 . . . . 63.54 109.759 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -59.16 110.23 1.02 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 123.641 0.588 . . . . 72.52 110.363 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 62.85 22.72 13.58 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.287 1.035 . . . . 71.22 112.066 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 95.6 t -117.63 117.49 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.874 1.27 . . . . 62.13 107.58 173.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -127.28 125.36 40.74 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.068 0.947 . . . . 75.13 109.554 -174.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.678 ' HB2' HD12 ' C' ' 51' ' ' LEU . 40.0 tt0 -88.33 122.12 31.48 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.832 -0.803 . . . . 61.51 108.832 169.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 65.8 t -112.49 124.13 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 108.713 -0.847 . . . . 75.44 108.713 172.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.53 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 61.6 t -109.75 134.75 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.019 0.528 . . . . 64.3 109.938 176.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.47 99.56 8.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.848 -1.168 . . . . 75.4 107.848 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -80.31 106.8 12.6 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.121 -1.066 . . . . 75.14 108.121 170.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.442 HG22 ' HB3' ' C' ' 110' ' ' ALA . 22.0 t -105.15 122.5 58.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 107.866 -1.161 . . . . 74.42 107.866 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 25.1 m -113.3 138.61 49.77 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 107.415 -1.328 . . . . 74.32 107.415 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.475 HG22 HG23 ' C' ' 114' ' ' ILE . 69.1 t -134.34 111.64 14.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 108.021 -1.103 . . . . 71.33 108.021 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.401 HG23 HD22 ' C' ' 75' ' ' LEU . 4.3 m -108.22 117.4 34.05 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.707 -0.679 . . . . 74.4 109.17 -177.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.42 104.04 10.71 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.565 -0.902 . . . . 63.11 108.565 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 63.4 m -128.77 132.91 47.94 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.186 -0.672 . . . . 73.23 109.186 176.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 9.6 mt -84.68 42.32 0.9 Allowed 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 125.428 1.491 . . . . 74.35 109.889 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.22 -104.61 2.46 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 110.97 -0.852 . . . . 53.12 110.97 -172.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -89.7 -32.19 17.13 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.514 0.726 . . . . 75.3 109.945 174.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.729 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 10.7 tp10 -75.95 105.84 7.21 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 114.877 -1.056 . . . . 72.43 109.808 -178.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 61.4 m -74.21 124.52 26.55 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 118.479 0.582 . . . . 53.42 109.597 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.633 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -77.79 -53.89 6.98 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.582 -0.736 . . . . 53.54 109.111 176.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -162.03 164.13 28.42 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.827 -1.079 . . . . 75.55 110.729 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.401 HD22 HG23 ' C' ' 65' ' ' THR . 2.7 tm? -128.41 142.17 51.19 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.211 -1.774 . . . . 72.13 106.211 167.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 42.5 t -149.44 129.8 13.8 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.94 -0.763 . . . . 72.15 108.94 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -140.66 128.62 21.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.714 0.406 . . . . 72.31 110.027 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 37.3 t -125.24 115.69 44.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 124.468 1.107 . . . . 75.21 108.891 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.705 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.5 mt-30 -90.41 91.09 8.32 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.57 -0.9 . . . . 72.44 108.57 172.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -83.78 96.07 8.63 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.342 -1.299 . . . . 75.21 109.183 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -93.2 145.73 17.75 Favored Glycine 0 C--O 1.222 -0.638 0 N-CA-C 111.616 -0.594 . . . . 71.34 111.616 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.94 132.13 4.91 Favored Glycine 0 CA--C 1.503 -0.703 0 N-CA-C 110.991 -0.844 . . . . 74.43 110.991 -176.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.511 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 22.8 mm -85.66 124.46 40.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 107.467 -1.308 . . . . 74.02 107.467 174.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -129.94 118.2 21.29 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.638 0.775 . . . . 75.43 109.703 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.6 p -86.92 104.62 16.43 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.035 -0.728 . . . . 64.22 109.035 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.546 HG21 ' HE2' ' C' ' 94' ' ' MET . 19.5 mt -116.73 126.98 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.532 0.733 . . . . 73.53 110.314 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.25 169.01 18.54 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.125 0.97 . . . . 63.23 109.887 177.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.66 -17.65 57.2 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 119.365 -0.686 . . . . 53.11 114.47 174.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.642 HD13 ' HA ' ' C' ' 94' ' ' MET . 38.0 pt -119.01 166.76 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 CA-C-N 118.079 0.94 . . . . 74.12 112.493 -175.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -159.39 156.44 28.47 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.685 1.194 . . . . 75.33 109.078 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.08 -138.14 14.88 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-O 120.073 -0.293 . . . . 74.41 112.926 171.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 47.1 p -65.08 -25.18 67.68 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.796 0.838 . . . . 63.25 111.457 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -61.15 -54.24 46.87 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.166 0.986 . . . . 74.43 110.635 171.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.642 ' HA ' HD13 ' C' ' 89' ' ' ILE . 4.5 tpt -56.67 -48.61 77.23 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 124.058 0.849 . . . . 73.43 111.803 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.17 -40.96 91.76 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 123.59 0.556 . . . . 54.44 111.514 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -69.56 -30.95 68.86 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.055 0.942 . . . . 75.14 111.239 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.406 ' SG ' HD12 ' C' ' 86' ' ' ILE . 12.2 t -75.41 -35.39 61.02 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.652 -0.499 . . . . 73.41 109.652 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 96.2 mt -84.14 -32.82 24.46 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.002 0.921 . . . . 73.34 112.521 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.88 8.77 27.6 Favored Glycine 0 N--CA 1.473 1.166 0 CA-C-O 119.656 -0.525 . . . . 74.32 114.135 -170.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.75 -55.32 0.22 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 117.411 0.606 . . . . 70.23 111.644 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -71.36 -54.34 11.08 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 117.566 0.166 . . . . 75.44 111.264 -174.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.431 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 84.8 m -57.58 -50.48 87.92 Favored Pre-proline 0 CA--C 1.565 1.524 0 CA-C-O 118.182 -0.913 . . . . 55.4 111.974 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.472 ' HA ' HD12 ' C' ' 106' ' ' LEU . 38.9 Cg_exo -60.11 -28.21 86.5 Favored 'Trans proline' 0 C--N 1.4 3.256 0 C-N-CA 122.601 2.201 . . . . 75.11 113.567 174.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -68.09 -35.61 78.45 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.201 0.6 . . . . 73.03 110.778 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.407 HD13 ' NH1' ' A' ' 111' ' ' ARG . 19.9 mm -79.86 -29.62 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 109.972 -0.381 . . . . 73.04 109.972 177.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' C' ' 103' ' ' PRO . 73.9 mt -70.09 -32.08 69.96 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.406 0.683 . . . . 73.21 111.254 176.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -53.29 -53.26 58.08 Favored Pre-proline 0 N--CA 1.485 1.322 0 CA-C-O 117.228 -1.368 . . . . 72.05 114.459 -173.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.82 -36.46 96.98 Favored 'Trans proline' 0 C--N 1.391 2.783 0 C-N-CA 122.074 1.849 . . . . 54.44 113.219 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -70.17 -46.55 64.42 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.706 0.802 . . . . 72.41 110.307 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.442 ' HB3' HG22 ' C' ' 62' ' ' VAL . . . -58.61 -39.94 81.86 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 115.027 -0.988 . . . . 60.25 110.369 175.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.9 ttt-85 -65.74 -47.16 76.2 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.199 1.399 . . . . 73.51 110.757 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -69.63 -33.78 73.13 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.362 0.665 . . . . 74.34 110.055 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 40.2 t -68.68 -39.53 80.53 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.336 0.655 . . . . 64.31 111.258 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.475 HG23 HG22 ' C' ' 64' ' ' VAL . 96.7 mt -69.35 -48.19 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.572 0.749 . . . . 73.15 110.406 174.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 28.5 m -54.52 -40.16 68.35 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.561 1.144 . . . . 65.41 110.876 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.4 t -64.55 -48.05 76.48 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.002 -0.999 . . . . 52.13 109.0 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.565 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.8 -40.24 79.44 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.839 1.256 . . . . 74.24 112.672 178.433 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.424 HG23 ' O ' ' C' ' 114' ' ' ILE . 86.8 t -66.72 -41.0 87.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.531 0.732 . . . . 64.23 110.287 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 46.7 t -71.94 -27.82 63.05 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.782 0.833 . . . . 72.42 111.501 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 82.5 mtt-85 -72.52 -34.17 67.42 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.494 0.718 . . . . 74.55 109.495 175.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.24 10.39 63.81 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.388 -0.823 . . . . 74.42 112.636 173.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 72.5 p 58.7 22.9 10.47 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 126.153 1.781 . . . . 72.13 114.286 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -83.66 149.16 56.59 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 108.689 -0.856 . . . . 74.14 108.689 171.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -55.53 157.67 14.66 Favored 'Trans proline' 0 C--N 1.382 2.322 0 C-N-CA 123.073 2.516 . . . . 63.41 113.702 176.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -58.49 114.16 2.33 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.882 0.873 . . . . 72.14 112.223 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.9 tt -110.56 86.04 2.23 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 106.601 -1.629 . . . . 72.33 106.601 172.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -91.19 105.02 17.5 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.046 -0.724 . . . . 74.24 109.046 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.5 145.59 55.88 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.484 0.714 . . . . 72.51 111.983 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.22 153.15 84.24 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.575 0.75 . . . . 63.4 110.347 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.458 ' HG2' HG23 ' A' ' 13' ' ' ILE . 51.9 Cg_exo -54.71 115.68 2.58 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.892 2.395 . . . . 74.13 112.548 173.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.3 t -98.05 116.91 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.656 -0.868 . . . . 70.51 108.656 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -76.02 103.25 5.98 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.368 0.667 . . . . 75.01 110.531 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -67.18 -22.41 65.74 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.489 0.716 . . . . 75.44 112.065 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -65.46 -42.91 91.81 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.498 0.719 . . . . 72.12 110.476 175.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.08 -46.74 87.78 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 123.675 0.61 . . . . 72.14 110.354 176.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.03 -27.75 67.67 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.267 -0.878 . . . . 74.44 111.435 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -73.21 -47.94 39.26 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.262 0.625 . . . . 74.12 110.494 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 72.6 mtm -70.02 -29.36 66.39 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.267 0.556 . . . . 74.34 110.31 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . 0.464 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 6.3 t30 -57.92 -33.79 69.15 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.336 1.455 . . . . 74.25 113.718 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -159.98 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 113.283 0.846 . . . . 61.42 113.283 -168.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.435 ' HG ' ' HG2' ' C' ' 142' ' ' GLN . 40.0 tp 40.38 -85.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 125.831 1.652 . . . . 73.03 113.575 170.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . 0.435 ' HG2' ' HG ' ' C' ' 141' ' ' LEU . 9.9 pt20 -162.43 161.15 27.08 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 125.682 1.593 . . . . 75.21 107.638 176.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -78.92 81.56 5.19 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.493 0.663 . . . . 74.54 109.234 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -76.55 144.65 39.55 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.645 -1.162 . . . . 74.11 110.01 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -52.65 123.21 10.62 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.795 1.238 . . . . 75.3 112.858 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . 0.458 ' HA3' ' HB3' ' A' ' 152' ' ' HIS . . . -176.11 122.3 0.85 Allowed Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.104 -1.198 . . . . 52.14 110.104 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 151' ' ' GLU . 14.5 pt-20 -161.13 -174.92 4.59 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.214 0.606 . . . . 65.55 110.743 -172.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 89.59 71.51 1.25 Allowed Glycine 0 C--N 1.345 1.054 0 CA-C-N 115.467 -0.788 . . . . 71.02 111.68 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.25 125.17 19.56 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.057 0.543 . . . . 73.52 110.671 173.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -70.35 86.99 0.61 Allowed 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.836 -0.801 . . . . 72.11 108.836 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -84.92 78.57 9.87 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.455 -1.248 . . . . 74.52 111.018 -172.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -96.4 102.24 14.0 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.327 -0.851 . . . . 75.13 109.136 176.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . 0.403 ' HA ' ' NE2' ' A' ' 93' ' ' GLN . 24.7 tt0 -95.41 76.64 3.37 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.71 0.767 . . . . 63.41 109.31 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . 0.406 ' O ' ' HG3' ' A' ' 93' ' ' GLN . 4.5 p-10 -83.45 110.19 17.97 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.857 -1.065 . . . . 75.24 110.194 -178.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.97 0 CA-C-N 115.233 -0.894 . . . . 75.43 110.662 -177.376 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 N-CA-C 109.928 -0.397 . . . . 72.23 109.928 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 58.7 p -67.19 134.69 52.19 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.114 0.565 . . . . 53.13 110.579 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -74.7 100.07 3.87 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.605 -0.887 . . . . 75.24 108.605 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.36 83.48 0.25 Allowed 'General case' 0 CA--C 1.558 1.257 0 CA-C-O 122.741 1.258 . . . . 75.34 107.798 168.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -96.13 144.84 26.01 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.269 -1.332 . . . . 71.31 110.366 -168.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -78.51 81.91 4.81 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 123.632 0.583 . . . . 73.13 110.084 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 75.3 p -85.65 -168.33 2.18 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.178 -1.045 . . . . 73.54 108.178 169.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -60.79 88.28 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 122.892 0.477 . . . . 73.02 109.808 168.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.458 ' HG2' HG13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -34.62 122.99 0.53 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.341 1.456 . . . . 74.21 112.337 176.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 8.2 t -111.25 133.34 53.66 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 109.149 -0.685 . . . . 54.1 109.149 176.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.468 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 54.9 t80 -143.41 89.76 2.11 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.183 -1.414 . . . . 71.34 107.183 174.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -116.85 119.85 36.67 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.24 -1.022 . . . . 74.31 108.24 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 5.5 mt -75.79 121.17 27.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.061 -1.088 . . . . 75.11 108.061 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.658 ' HB2' HG23 ' D' ' 83' ' ' ILE . 10.8 mm-40 -84.9 -30.04 24.7 Favored 'General case' 0 C--O 1.242 0.674 0 O-C-N 123.802 0.688 . . . . 71.3 110.462 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -174.63 131.42 0.35 Allowed 'General case' 0 C--N 1.364 1.222 0 O-C-N 123.415 0.447 . . . . 73.12 111.149 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.419 ' N ' HD13 ' D' ' 16' ' ' ILE . 3.5 mp -108.18 135.24 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.423 -1.325 . . . . 74.44 107.423 172.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -165.84 170.57 13.71 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.744 0.783 . . . . 71.04 111.89 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -101.46 124.31 46.93 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.406 -1.27 . . . . 73.33 109.357 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.434 ' HD2' ' HA3' ' D' ' 81' ' ' GLY . 28.3 mtpt -95.28 -28.92 14.76 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.735 -0.839 . . . . 74.32 108.735 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 7.9 t70 -146.1 135.09 22.59 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 113.997 -1.456 . . . . 71.34 108.915 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.565 HG23 ' HE1' ' C' ' 117' ' ' MET . 61.9 mt -136.5 138.99 45.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.937 -1.134 . . . . 75.55 107.937 170.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.9 t -141.44 140.81 33.68 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.233 1.013 . . . . 73.34 108.52 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.49 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.2 t80 -144.71 130.44 19.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 106.059 -1.83 . . . . 74.34 106.059 168.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -134.28 138.03 44.71 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.51 -0.922 . . . . 75.41 108.51 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.14 78.12 13.94 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 107.718 -1.216 . . . . 74.24 107.718 174.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.37 -28.98 9.88 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.803 2.335 . . . . 72.42 112.688 -173.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -101.18 3.64 41.25 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.857 0.863 . . . . 74.51 110.692 -176.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.42 ' HB2' ' HE3' ' C' ' 19' ' ' LYS . . . -33.06 -64.07 0.26 Allowed Pre-proline 0 CA--C 1.566 1.56 0 N-CA-C 116.46 2.022 . . . . 74.32 116.46 -164.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.454 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 73.3 Cg_endo -74.39 -29.12 9.69 Favored 'Trans proline' 0 C--N 1.389 2.68 0 CA-C-N 123.503 2.287 . . . . 71.51 113.311 -178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -65.53 -39.73 92.1 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.649 1.18 . . . . 74.35 109.68 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.467 HG23 ' HA ' ' D' ' 73' ' ' ALA . 9.8 p -85.53 -16.39 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 CA-C-N 115.423 -0.808 . . . . 75.43 111.532 -176.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.454 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 17.7 m-85 -65.66 -20.92 66.48 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 118.05 0.386 . . . . 73.34 111.585 176.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -61.86 -23.22 66.14 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.7 0.8 . . . . 74.24 110.865 174.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.607 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 99.6 mttt -92.77 95.57 9.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.723 1.209 . . . . 72.1 110.219 178.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -94.3 94.86 8.54 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.551 0.74 . . . . 74.34 110.153 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -161.84 179.32 8.16 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.686 0.794 . . . . 73.41 110.164 166.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -58.07 111.48 3.59 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.563 1.145 . . . . 72.4 110.031 173.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.403 ' O ' HG21 ' D' ' 40' ' ' VAL . 51.3 Cg_exo -55.6 125.4 18.99 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.205 1.936 . . . . 72.55 110.288 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -72.29 107.33 4.84 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.32 -1.363 . . . . 74.3 107.32 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.648 HG22 ' HB3' ' D' ' 66' ' ' ALA . 87.5 t -113.1 103.14 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 123.308 0.38 . . . . 75.11 110.08 -168.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -87.16 119.25 27.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.796 -1.187 . . . . 71.23 107.796 172.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.78 HD21 HD13 ' D' ' 128' ' ' LEU . 57.0 tp -92.82 148.01 22.38 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.333 -0.988 . . . . 75.23 108.333 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.492 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 27.6 t70 -144.76 111.96 6.0 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.388 -1.338 . . . . 73.43 107.388 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' D' ' 62' ' ' VAL . 85.2 mt -108.11 131.83 54.21 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.062 0.545 . . . . 74.32 110.073 -173.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -132.15 133.92 44.82 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.89 -1.522 . . . . 75.02 106.89 173.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.8 t -139.24 141.79 37.85 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.833 0.825 . . . . 72.31 110.009 176.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.411 ' HA ' ' HG1' ' E' ' 107' ' ' THR . . . -154.8 161.82 41.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.391 -1.277 . . . . 64.54 107.738 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 34.0 p -133.76 158.93 42.08 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.287 -0.634 . . . . 75.22 109.287 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 78.1 p -148.72 120.21 7.95 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 109.452 -0.573 . . . . 73.51 109.452 -175.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -176.73 159.34 1.8 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.83 1.252 . . . . 74.4 108.452 172.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -55.32 -15.33 2.41 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 126.255 1.822 . . . . 75.14 113.729 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.539 ' HA ' ' CE2' ' D' ' 56' ' ' TYR . . . 78.63 89.29 0.06 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.886 1.674 . . . . 75.41 109.042 -172.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -161.66 40.39 0.14 Allowed 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.749 -1.114 . . . . 64.24 108.649 -167.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 68.8 -1.63 1.96 Allowed 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 114.232 1.197 . . . . 71.15 114.232 172.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.495 ' HB ' HD13 ' D' ' 83' ' ' ILE . 23.3 m -130.97 129.09 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 107.262 -1.384 . . . . 73.53 107.262 173.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.539 ' CE2' ' HA ' ' D' ' 52' ' ' ALA . 70.3 m-85 -141.81 130.09 22.29 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.822 -0.807 . . . . 74.11 108.822 -171.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -87.77 109.98 20.13 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.409 -0.96 . . . . 75.33 108.409 173.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.538 HG12 ' HD3' ' D' ' 103' ' ' PRO . 67.3 t -99.08 120.16 48.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 107.443 -1.317 . . . . 73.15 107.443 175.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.459 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.5 t -107.41 134.76 48.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.606 -0.887 . . . . 75.15 108.606 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.54 116.09 26.98 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.997 -0.742 . . . . 73.41 108.997 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -97.76 96.97 8.6 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.252 1.021 . . . . 74.23 109.051 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.411 HG13 HD12 ' D' ' 42' ' ' LEU . 57.7 t -94.73 109.14 21.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 108.523 -0.918 . . . . 75.43 108.523 175.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.492 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 40.6 m -106.11 132.18 52.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.957 -1.019 . . . . 70.33 109.065 -176.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.545 HG21 HD11 ' D' ' 114' ' ' ILE . 86.6 t -120.39 127.61 75.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.032 -0.729 . . . . 73.0 109.032 177.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 14.7 m -117.61 93.37 4.13 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.306 -1.368 . . . . 73.13 107.306 169.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.648 ' HB3' HG22 ' D' ' 40' ' ' VAL . . . -102.06 134.94 44.48 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.438 -0.579 . . . . 72.2 109.438 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.487 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 50.2 m -144.5 139.28 28.15 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 115.749 -0.66 . . . . 74.12 110.532 -171.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 21.1 mt -109.88 110.51 21.49 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.081 -1.451 . . . . 74.2 107.081 172.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.88 -147.34 38.08 Favored Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.956 -0.458 . . . . 73.34 111.956 -175.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.75 4.22 22.79 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.088 0.555 . . . . 73.15 112.357 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.607 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 12.3 pt-20 -119.63 161.95 19.79 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.399 0.68 . . . . 72.4 109.995 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.8 m -71.97 137.8 47.57 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.245 -0.889 . . . . 72.21 111.106 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.487 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -89.14 -65.8 0.98 Allowed 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.114 -1.439 . . . . 73.41 107.114 170.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -153.8 143.37 21.68 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.646 -1.161 . . . . 71.42 109.967 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 63.2 mt -101.53 149.24 24.3 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.047 -1.094 . . . . 75.43 108.047 167.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.606 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 35.3 t -158.92 118.91 3.14 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 117.724 0.238 . . . . 74.3 110.373 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -140.77 122.03 14.85 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.776 0.43 . . . . 63.14 110.035 -174.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 92.7 t -127.71 117.17 45.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 123.951 0.9 . . . . 74.12 109.488 -175.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.604 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.8 mt-30 -90.09 90.48 8.14 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.133 -0.691 . . . . 75.15 109.133 171.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -80.72 99.53 8.26 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.669 -1.151 . . . . 73.15 108.709 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -92.44 143.3 16.44 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 112.193 -0.363 . . . . 42.31 112.193 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.58 130.83 4.08 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 111.822 -0.511 . . . . 53.12 111.822 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.658 HG23 ' HB2' ' D' ' 14' ' ' GLN . 5.2 tp -91.22 114.43 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.554 -0.906 . . . . 74.43 108.554 174.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -111.0 130.22 55.65 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.143 0.977 . . . . 73.34 110.291 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 10.8 t -94.6 100.79 12.68 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 109.02 -0.733 . . . . 74.32 109.02 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.519 HG22 HD22 ' D' ' 98' ' ' LEU . 3.6 tt -117.73 133.61 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.611 1.165 . . . . 73.33 109.552 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.93 169.6 11.25 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.921 0.888 . . . . 64.32 110.502 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.91 21.54 55.35 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 115.88 -0.6 . . . . 61.3 113.974 174.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.458 HG13 ' HG2' ' D' ' 9' ' ' MET . 0.9 OUTLIER -142.34 168.51 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.809 0.843 . . . . 73.01 110.978 175.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.55 ' HG3' ' HG3' ' B' ' 153' ' ' GLN . 0.2 OUTLIER -149.21 -168.43 3.1 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.68 1.192 . . . . 75.53 109.744 177.404 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . 0.577 ' HA2' ' HB2' ' B' ' 154' ' ' ASP . . . 77.7 -139.4 22.89 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-N 116.156 -0.474 . . . . 73.11 112.794 174.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 11.7 m -80.23 -39.35 29.22 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.248 0.619 . . . . 75.41 109.756 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.401 ' NE2' ' HG2' ' B' ' 150' ' ' GLU . 9.7 tt0 -58.16 -36.28 72.78 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.384 1.074 . . . . 73.43 112.68 -173.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.698 ' HB2' HD11 ' E' ' 97' ' ' ILE . 0.0 OUTLIER -60.03 -48.56 81.22 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 112.807 0.669 . . . . 74.23 112.807 -172.243 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . 0.406 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.91 -26.05 25.79 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.833 0.453 . . . . 72.13 111.754 177.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -63.01 -34.25 77.15 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.587 0.755 . . . . 74.12 110.061 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 82.4 m -59.43 -50.41 74.03 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.055 0.542 . . . . 72.01 111.071 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.636 HD23 ' SG ' ' D' ' 102' ' ' CYS . 93.2 mt -69.5 -27.53 65.28 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.961 0.504 . . . . 75.33 111.95 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.82 3.71 71.16 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.488 -0.618 . . . . 70.02 113.829 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.83 -63.36 0.17 Allowed 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 117.695 0.748 . . . . 72.13 112.403 -175.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . 0.427 ' O ' HG12 ' D' ' 105' ' ' ILE . 71.1 t80 -69.01 -39.4 79.31 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.177 0.436 . . . . 75.12 112.177 -172.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.636 ' SG ' HD23 ' D' ' 98' ' ' LEU . 50.5 m -69.61 -47.07 25.85 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 123.712 0.805 . . . . 74.15 111.477 -176.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.538 ' HD3' HG12 ' D' ' 58' ' ' VAL . 28.1 Cg_endo -64.1 -26.78 65.31 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 121.421 1.414 . . . . 74.43 112.638 170.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -66.92 -31.2 71.64 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.741 0.416 . . . . 73.24 110.94 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.427 HG12 ' O ' ' D' ' 101' ' ' TYR . 41.9 mm -68.74 -39.76 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.006 0.923 . . . . 75.55 110.51 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' D' ' 103' ' ' PRO . 42.5 mt -74.31 -22.6 59.18 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.534 -0.757 . . . . 75.23 111.573 -175.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -65.28 -41.45 52.04 Favored Pre-proline 0 CA--C 1.562 1.431 0 N-CA-C 114.095 1.146 . . . . 74.54 114.095 -172.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -47.26 -48.31 15.29 Favored 'Trans proline' 0 C--N 1.389 2.669 0 C-N-CA 122.466 2.111 . . . . 73.3 113.649 169.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -73.53 -38.15 65.37 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.93 0.892 . . . . 73.1 111.26 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.39 -44.04 79.86 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.577 -0.738 . . . . 74.31 110.794 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 28.3 ttp180 -59.91 -49.01 79.39 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.21 0.944 . . . . 74.31 110.33 174.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -59.83 -46.0 90.62 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.142 0.901 . . . . 75.02 110.697 -175.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.449 ' SG ' HD11 ' D' ' 21' ' ' ILE . 42.5 t -55.04 -45.67 75.24 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 124.343 1.027 . . . . 63.15 110.309 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.558 HG22 ' SG ' ' D' ' 76' ' ' CYS . 72.4 mt -61.25 -60.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 124.067 0.854 . . . . 74.35 110.851 175.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 37.7 m -52.5 -42.77 64.57 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.032 1.333 . . . . 73.02 111.786 -172.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 33.1 t -65.72 -43.6 88.61 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.465 -1.243 . . . . 61.22 109.823 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.606 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 72.2 mtm -68.77 -28.07 66.46 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.059 0.544 . . . . 74.33 111.964 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.451 HG22 ' O ' ' D' ' 114' ' ' ILE . 92.6 t -67.23 -46.34 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.597 0.759 . . . . 74.53 109.566 176.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.7 p -73.13 -29.71 63.08 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.618 -0.719 . . . . 74.02 110.448 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 66.7 mtt-85 -69.54 -30.75 68.65 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 123.595 0.758 . . . . 73.13 109.557 172.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.65 7.23 81.75 Favored Glycine 0 C--N 1.357 1.71 0 C-N-CA 123.536 0.588 . . . . 61.11 113.0 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.483 HG22 ' HB3' ' C' ' 17' ' ' TYR . 66.4 p 55.37 38.92 31.01 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 126.402 1.881 . . . . 75.32 114.268 176.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -99.88 158.46 32.03 Favored Pre-proline 0 C--O 1.243 0.747 0 C-N-CA 123.427 0.691 . . . . 73.04 109.249 170.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.426 ' HA ' ' OG1' ' E' ' 129' ' ' THR . 97.7 Cg_exo -48.72 125.19 12.28 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.7 2.267 . . . . 73.25 112.156 168.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -47.28 126.69 9.79 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.826 1.329 . . . . 63.32 112.495 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.557 HD12 HG23 ' D' ' 40' ' ' VAL . 17.5 tp -107.21 97.75 7.48 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.9 0.88 . . . . 74.21 109.058 -176.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -99.35 99.0 9.87 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.608 -1.256 . . . . 75.11 107.608 173.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.78 HD13 HD21 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -68.47 120.24 14.22 Favored 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 108.259 -1.015 . . . . 75.22 108.259 -179.445 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.49 141.7 94.45 Favored Pre-proline 0 CA--C 1.562 1.413 0 C-N-CA 123.535 0.734 . . . . 72.52 110.914 -177.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -57.74 132.61 51.07 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 123.091 2.527 . . . . 74.34 113.388 -174.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 96.1 t -107.44 123.43 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 108.415 -0.957 . . . . 73.24 108.415 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -86.9 91.93 8.84 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.044 -1.095 . . . . 75.1 108.044 173.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -58.7 -31.61 68.41 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.397 1.079 . . . . 75.5 111.796 -174.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -63.03 -36.64 84.25 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.142 -0.936 . . . . 72.42 110.461 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.438 ' HA ' ' HE3' ' D' ' 138' ' ' MET . . . -69.79 -31.2 68.99 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.836 0.854 . . . . 72.23 111.932 -177.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 6.2 mp -71.53 -45.43 62.39 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.734 -0.469 . . . . 73.25 109.734 175.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.583 ' HA ' ' HE1' ' E' ' 109' ' ' TYR . 3.8 t80 -61.73 -36.9 82.33 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.484 -0.78 . . . . 73.22 110.083 178.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.438 ' HE3' ' HA ' ' D' ' 135' ' ' ALA . 29.1 ttm -68.71 -37.88 79.82 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.062 1.345 . . . . 73.12 110.82 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -61.9 -36.13 80.41 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.748 1.219 . . . . 63.04 111.353 -178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -68.02 -44.17 77.14 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.682 0.793 . . . . 74.41 111.172 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.6 mp -69.36 -32.27 71.22 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.392 0.677 . . . . 73.13 111.623 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -90.8 17.72 7.39 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.95 0.5 . . . . 73.44 110.819 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -118.23 45.33 2.02 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.631 -1.248 . . . . 72.43 107.631 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -145.0 179.5 7.31 Favored 'General case' 0 C--O 1.248 1.024 0 CA-C-N 113.288 -1.778 . . . . 74.42 108.404 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.35 92.69 1.44 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.374 -0.602 . . . . 72.42 109.374 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 164.7 -13.26 0.08 OUTLIER Glycine 0 C--N 1.34 0.802 0 CA-C-N 114.936 -1.029 . . . . 73.44 112.594 -176.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -60.17 104.19 0.29 Allowed 'General case' 0 C--N 1.361 1.101 0 C-N-CA 123.338 0.655 . . . . 75.05 110.651 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 178.04 51.36 0.07 OUTLIER Glycine 0 CA--C 1.506 -0.515 0 N-CA-C 110.063 -1.215 . . . . 65.5 110.063 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 5.3 t -116.61 95.38 5.01 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.953 0.901 . . . . 75.43 109.867 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.94 91.8 1.66 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 106.832 -1.544 . . . . 73.03 106.832 172.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -149.92 30.79 0.71 Allowed 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.755 1.222 . . . . 70.02 108.773 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -152.99 140.65 19.91 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.989 -1.005 . . . . 74.31 108.544 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -60.55 -64.31 1.0 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.329 1.052 . . . . 75.22 111.517 -173.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -108.56 151.27 26.33 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.116 0.966 . . . . 72.1 109.484 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 C-N-CA 123.33 0.652 . . . . 70.35 109.256 -177.704 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 CA-C-O 119.939 -0.367 . . . . 53.3 112.431 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.27 96.58 0.05 OUTLIER Glycine 0 C--N 1.354 1.531 0 CA-C-O 119.198 -0.779 . . . . 74.42 111.955 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 70.82 103.74 0.06 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 124.739 1.216 . . . . 75.33 110.094 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -78.5 178.97 7.34 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.349 1.059 . . . . 74.55 113.026 -166.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.24 133.97 21.13 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.262 1.025 . . . . 72.04 109.295 174.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 162.23 -60.73 0.28 Allowed Glycine 0 C--N 1.356 1.69 0 CA-C-O 119.962 -0.355 . . . . 73.2 113.343 -177.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 97' ' ' ILE . . . . . 0.698 HD11 ' HB2' ' D' ' 94' ' ' MET . 1.9 tt -73.33 127.63 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-O 121.437 0.637 . . . . 62.14 110.658 -175.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -140.25 -167.53 2.34 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.018 0.927 . . . . 74.03 109.74 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . 66.85 30.3 7.91 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.768 1.227 . . . . 72.45 111.172 -175.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 100' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -88.22 103.67 5.57 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 124.022 0.929 . . . . 74.04 110.804 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -87.07 -26.88 0.75 Allowed 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.065 2.51 . . . . 73.45 113.816 -175.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 102' ' ' LEU . . . . . 0.578 HD11 HG23 ' E' ' 103' ' ' THR . 2.3 pp -85.64 3.4 41.08 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.033 0.933 . . . . 75.12 111.602 -173.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 103' ' ' THR . . . . . 0.578 HG23 HD11 ' E' ' 102' ' ' LEU . 44.6 p -110.08 -14.36 14.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.522 1.129 . . . . 74.33 110.937 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . -73.18 -69.44 1.39 Allowed Glycine 0 C--N 1.352 1.425 0 O-C-N 123.074 0.234 . . . . 74.41 112.638 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -110.56 -62.51 1.52 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.399 0.679 . . . . 73.44 109.678 -176.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -165.88 144.64 6.0 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 114.734 -1.121 . . . . 75.03 108.167 -173.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 107' ' ' THR . . . . . 0.411 ' HG1' ' HA ' ' D' ' 47' ' ' ALA . 10.0 m -67.26 116.64 8.26 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.223 -0.658 . . . . 74.52 109.223 176.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -73.89 -5.02 38.53 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.339 0.656 . . . . 72.3 112.023 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 109' ' ' TYR . . . . . 0.583 ' HE1' ' HA ' ' D' ' 137' ' ' PHE . 70.7 t80 -137.53 82.03 1.9 Allowed 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 107.193 -1.41 . . . . 73.42 107.193 164.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -85.74 58.17 4.89 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.476 0.71 . . . . 74.51 111.692 -174.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . . . . . . . . . 22.9 tp 69.56 -77.86 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.518 1.527 . . . . 72.43 111.926 174.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -75.2 95.59 3.15 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.942 0.497 . . . . 75.32 110.267 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -122.85 133.74 54.42 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.481 -0.563 . . . . 72.12 109.481 173.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 15.5 ptmt -80.87 68.81 7.26 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.46 1.104 . . . . 74.44 109.887 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 46.9 p -70.68 -52.8 18.71 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.692 -1.14 . . . . 64.42 110.965 -175.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.26 -56.25 0.02 OUTLIER Glycine 0 C--N 1.34 0.765 0 CA-C-N 115.871 -0.604 . . . . 74.22 111.663 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -176.17 77.08 0.28 Allowed Pre-proline 0 CA--C 1.557 1.226 0 C-N-CA 124.032 0.933 . . . . 73.2 108.696 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.05 -33.2 12.12 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.377 2.051 . . . . 72.5 113.292 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 61.14 23.34 13.54 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 125.275 1.43 . . . . 72.24 113.149 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -108.9 157.18 18.87 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.119 -1.067 . . . . 74.34 108.119 171.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 121' ' ' VAL . . . . . 0.455 HG13 HD23 ' D' ' 42' ' ' LEU . 57.0 t 74.98 101.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.49 1.116 . . . . 73.01 109.118 -175.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 15.1 t -76.9 166.14 23.74 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.446 -0.797 . . . . 74.01 112.792 -169.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -112.58 -4.86 14.06 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.974 1.31 . . . . 63.13 110.33 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 49.4 m -144.63 125.37 14.2 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.192 0.597 . . . . 74.32 110.206 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -84.89 166.43 16.85 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.098 0.559 . . . . 74.2 110.156 173.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -116.82 32.4 6.17 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.446 0.698 . . . . 73.04 111.172 -175.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 55.0 m -136.83 120.93 17.77 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.424 0.69 . . . . 55.34 109.424 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -145.38 136.35 24.66 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.236 0.614 . . . . 71.54 109.723 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 129' ' ' THR . . . . . 0.45 HG23 ' NH2' ' B' ' 15' ' ' ARG . 61.2 p -118.66 133.52 55.8 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.954 0.902 . . . . 74.54 109.729 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.43 84.48 0.59 Allowed 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.504 0.721 . . . . 72.42 109.141 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 131' ' ' TRP . . . . . 0.652 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 1.9 t-105 -96.13 66.42 2.52 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.256 -0.884 . . . . 73.42 109.316 -171.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 57.4 m -135.31 84.03 2.06 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.55 -0.75 . . . . 75.03 109.915 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 63.0 m -145.68 104.74 3.91 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.793 0.837 . . . . 74.21 108.952 176.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -99.81 43.66 1.77 Allowed Glycine 0 C--N 1.345 1.063 0 CA-C-O 119.592 -0.56 . . . . 74.14 112.12 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 135' ' ' VAL . . . . . 0.428 HG11 ' H ' ' E' ' 137' ' ' THR . 57.9 t 63.51 -79.99 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 125.077 1.351 . . . . 63.3 111.977 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? 56.09 31.37 18.02 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.532 1.133 . . . . 75.51 112.847 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 137' ' ' THR . . . . . 0.428 ' H ' HG11 ' E' ' 135' ' ' VAL . 18.5 m -98.99 -48.9 4.71 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.217 0.451 . . . . 72.44 112.217 -175.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -97.28 -12.69 22.6 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.395 0.678 . . . . 70.22 111.724 -170.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -72.97 89.14 1.4 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.721 0.808 . . . . 61.5 111.197 -171.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -90.69 -29.22 13.97 Favored Glycine 0 C--N 1.344 0.978 0 CA-C-N 115.892 -0.594 . . . . 61.03 112.547 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -113.72 164.71 13.35 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.842 0.857 . . . . 74.11 111.321 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 49.6 tp -157.04 144.43 18.85 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.64 0.776 . . . . 74.53 109.315 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -142.57 157.92 26.83 Favored Glycine 0 C--N 1.341 0.858 0 N-CA-C 111.561 -0.615 . . . . 73.45 111.561 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.87 62.21 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.115 0.966 . . . . 75.41 108.414 170.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 30.9 t70 . . . . . 0 CA--C 1.561 1.402 0 C-N-CA 125.034 1.334 . . . . 72.44 110.985 -175.333 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.461 0 N-CA-C 111.221 -0.752 . . . . 72.11 111.221 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.78 -116.57 6.97 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-O 119.639 -0.534 . . . . 74.42 113.04 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 52.0 41.64 29.85 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.815 1.246 . . . . 73.03 111.176 -172.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -72.5 148.78 44.73 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-N 114.567 -1.197 . . . . 74.52 109.533 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -146.59 164.14 33.56 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.277 0.631 . . . . 73.44 111.079 -166.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.57 46.5 0.03 OUTLIER Glycine 0 C--N 1.345 1.063 0 N-CA-C 110.946 -0.862 . . . . 61.22 110.946 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 97' ' ' ILE . . . . . 0.731 HD13 ' HB2' ' B' ' 94' ' ' MET . 9.1 tt -141.85 -16.78 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.467 1.107 . . . . 71.13 110.074 -176.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 16.8 t70 70.87 112.49 0.06 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.035 1.334 . . . . 74.23 111.804 177.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . 70.28 -68.02 0.22 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.516 1.526 . . . . 74.01 113.46 166.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 100' ' ' LEU . . . . . 0.453 HD22 HD13 ' B' ' 98' ' ' LEU . 54.0 tp 73.39 70.05 0.26 Allowed Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 125.431 1.493 . . . . 73.25 111.803 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -93.17 135.12 1.15 Allowed 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 123.13 2.553 . . . . 75.03 112.609 173.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 102' ' ' LEU . . . . . 0.412 HD12 ' HB1' ' B' ' 95' ' ' ALA . 0.7 OUTLIER -166.27 -159.46 0.38 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.567 0.747 . . . . 72.51 110.709 177.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 103' ' ' THR . . . . . 0.407 HG21 HG21 ' F' ' 107' ' ' THR . 72.4 p -62.48 81.06 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 125.806 1.642 . . . . 64.42 112.974 -174.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.96 168.61 41.35 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 115.205 -0.907 . . . . 73.11 111.595 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 61.42 -77.33 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.669 1.188 . . . . 75.22 110.287 -172.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -150.08 136.82 19.23 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.914 0.886 . . . . 75.13 109.511 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 107' ' ' THR . . . . . 0.407 HG21 HG21 ' F' ' 103' ' ' THR . 22.6 m -77.27 130.53 37.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.487 0.715 . . . . 75.14 110.082 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -81.12 -22.29 39.19 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.425 0.69 . . . . 71.52 111.125 177.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 109' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' F' ' 115' ' ' THR . 12.6 m-30 -92.54 50.99 1.67 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.881 -1.155 . . . . 73.11 107.881 167.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.92 140.17 58.32 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 115.617 -0.72 . . . . 74.1 111.214 -175.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . 0.651 HD11 HD23 ' B' ' 136' ' ' LEU . 16.1 tp -66.08 -10.49 40.82 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-N 115.721 -0.672 . . . . 74.52 111.029 177.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -54.83 171.82 0.12 Allowed 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 125.867 1.667 . . . . 73.44 110.681 167.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -71.41 71.05 0.64 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.505 0.669 . . . . 72.22 110.785 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -145.5 -164.34 1.92 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.74 1.216 . . . . 72.23 109.617 -169.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 115' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' F' ' 109' ' ' TYR . 52.1 p -77.21 60.02 1.86 Allowed 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 124.142 0.977 . . . . 74.03 110.586 173.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . -137.79 -77.3 0.07 OUTLIER Glycine 0 C--N 1.349 1.29 0 N-CA-C 110.391 -1.084 . . . . 74.04 110.391 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -86.28 132.65 42.57 Favored Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 108.676 -0.861 . . . . 75.34 108.676 169.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 118' ' ' PRO . . . . . 0.462 ' HG3' ' OD1' ' B' ' 139' ' ' ASN . 58.7 Cg_endo -70.23 -49.41 0.5 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 121.982 1.788 . . . . 74.21 110.936 172.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -153.68 -95.99 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 107.675 -1.232 . . . . 74.21 107.675 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 50.13 -82.88 0.01 OUTLIER 'General case' 0 C--N 1.37 1.475 0 C-N-CA 125.159 1.383 . . . . 74.34 112.038 -173.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 46.6 t -72.73 90.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.691 0 N-CA-C 108.643 -0.873 . . . . 73.03 108.643 177.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 45.5 p -59.19 153.05 19.14 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.837 -1.074 . . . . 75.4 110.059 173.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -69.32 75.03 0.36 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.855 0.862 . . . . 72.12 111.229 -174.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 8.3 t -179.35 -178.49 0.49 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.447 1.899 . . . . 72.32 107.431 -176.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -137.04 -71.24 0.44 Allowed 'General case' 0 N--CA 1.481 1.109 0 O-C-N 122.106 -0.371 . . . . 71.12 110.27 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -166.65 164.11 16.79 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.394 -0.821 . . . . 73.44 109.783 -175.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 50.5 m -79.42 87.84 5.04 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.931 -0.577 . . . . 70.43 109.508 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.67 104.34 2.37 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.329 -0.851 . . . . 75.33 109.452 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 32.4 m -85.25 125.56 32.98 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.144 0.578 . . . . 74.53 110.38 -175.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 130' ' ' ALA . . . . . 0.502 ' HB3' ' HG3' ' B' ' 124' ' ' PRO . . . -74.48 149.37 40.35 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.449 0.7 . . . . 70.02 110.915 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 42.0 p-90 -106.71 150.36 26.34 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 109.273 -0.64 . . . . 74.04 109.273 175.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 22.7 t -154.92 43.83 0.49 Allowed 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.366 -0.976 . . . . 74.52 108.366 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 40.0 p -65.09 106.65 1.33 Allowed 'General case' 0 C--N 1.354 0.762 0 CA-C-N 115.179 -0.918 . . . . 70.11 109.222 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -63.38 90.62 0.08 OUTLIER Glycine 0 C--N 1.35 1.315 0 O-C-N 123.972 0.795 . . . . 72.52 112.938 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 3.8 p -63.11 97.54 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-O 121.826 0.822 . . . . 74.5 109.336 175.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -80.74 69.43 7.28 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.894 -1.048 . . . . 75.53 110.318 -170.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 33.3 m 61.17 -77.94 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.381 1.472 . . . . 55.02 111.472 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -167.58 -39.99 0.02 OUTLIER 'General case' 0 C--O 1.242 0.699 0 C-N-CA 125.186 1.395 . . . . 73.12 107.565 174.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 9.5 t30 71.56 -72.96 0.1 Allowed 'General case' 0 C--N 1.361 1.096 0 C-N-CA 125.76 1.624 . . . . 72.33 110.579 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . 172.7 174.84 40.21 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 111.678 -0.569 . . . . 71.53 111.678 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -92.18 94.65 9.3 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.488 0.715 . . . . 64.34 109.592 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -142.15 140.73 32.51 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.628 0.771 . . . . 74.44 109.422 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -108.58 119.01 5.51 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.755 -0.938 . . . . 73.5 110.755 175.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 28.9 m -90.28 142.67 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 123.057 0.543 . . . . 74.42 110.381 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 108.552 -0.907 . . . . 61.43 108.552 175.748 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.448 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.298 0.094 . . . . 54.45 110.968 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.2 t -134.15 81.1 1.89 Allowed 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.94 -1.133 . . . . 74.32 107.94 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -100.57 108.71 20.69 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.317 1.047 . . . . 72.22 109.122 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -85.58 115.35 23.22 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.794 0.838 . . . . 75.55 110.07 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -128.3 174.65 9.12 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.178 -1.045 . . . . 74.03 108.178 175.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -61.48 -27.93 68.94 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.914 0.486 . . . . 72.33 111.578 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 t -145.16 155.4 43.26 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.703 0.801 . . . . 75.31 109.77 169.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -166.22 -69.32 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 106.733 -1.58 . . . . 74.1 106.733 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.45 ' HG2' HG22 ' A' ' 89' ' ' ILE . 67.0 mtt -136.22 162.84 31.85 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.369 1.068 . . . . 73.35 108.691 169.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 87' ' ' ALA . 25.8 m -141.52 130.06 22.64 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.159 -1.052 . . . . 74.22 108.159 177.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -137.24 119.04 15.13 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.09 -1.078 . . . . 75.31 108.09 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -134.78 132.21 38.44 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.646 -0.872 . . . . 61.03 108.646 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.528 HD12 HG21 ' A' ' 105' ' ' ILE . 4.9 mt -94.33 113.36 28.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.645 -0.872 . . . . 73.25 108.645 175.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -78.43 -40.26 36.34 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 123.375 0.422 . . . . 75.1 110.006 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -170.68 124.7 0.68 Allowed 'General case' 0 C--N 1.354 0.799 0 CA-C-N 115.946 -0.57 . . . . 74.12 111.042 -173.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 81.2 mt -106.97 140.28 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 107.944 -1.132 . . . . 72.31 107.944 167.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.444 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 31.7 p90 -164.92 166.25 19.66 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.306 0.574 . . . . 74.31 111.366 -174.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -94.27 122.06 36.42 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 109.484 -0.562 . . . . 72.45 109.484 172.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 43.0 mtpt -80.11 -35.08 37.33 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.211 -0.662 . . . . 73.23 109.211 174.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -149.93 137.95 20.3 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.277 -1.329 . . . . 65.13 109.826 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.566 HG21 ' SD ' ' B' ' 117' ' ' MET . 73.1 mt -134.99 143.82 36.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 125.317 1.447 . . . . 74.35 108.008 178.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.9 t -156.71 119.93 4.16 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 123.524 0.515 . . . . 61.33 110.593 170.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.595 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.8 t80 -111.5 143.41 42.38 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.019 -1.475 . . . . 74.32 107.019 165.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -139.66 141.31 37.03 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.703 0.401 . . . . 72.12 110.669 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.19 69.92 13.01 Favored Pre-proline 0 C--O 1.242 0.692 0 N-CA-C 107.181 -1.415 . . . . 71.02 107.181 170.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.35 -8.21 19.48 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.448 2.099 . . . . 61.23 112.303 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -114.72 17.52 17.08 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 124.311 1.044 . . . . 63.01 109.246 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.507 ' HB2' ' HE3' ' B' ' 19' ' ' LYS . . . -46.24 -54.31 18.4 Favored Pre-proline 0 CA--C 1.567 1.607 0 CA-C-O 118.006 -0.997 . . . . 75.2 113.667 -169.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 39.5 Cg_exo -61.81 -24.02 76.8 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 122.016 1.81 . . . . 73.01 113.542 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -84.84 -44.86 12.86 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.757 0.823 . . . . 74.11 111.017 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.477 ' CG2' ' HA ' ' A' ' 73' ' ' ALA . 8.6 p -77.03 -21.71 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 115.346 -0.843 . . . . 74.25 112.815 -161.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -66.96 -17.24 64.82 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 116.151 -0.477 . . . . 73.21 111.471 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -91.87 -14.46 29.65 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.551 1.14 . . . . 71.25 110.87 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.476 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 19.0 mmtp -79.54 160.31 26.53 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.21 0.604 . . . . 70.33 111.549 -176.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -69.59 131.24 44.35 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.896 0.879 . . . . 72.43 109.152 173.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.48 ' CE3' HD21 ' A' ' 68' ' ' LEU . 68.6 t-105 -81.6 81.07 7.8 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.494 0.664 . . . . 73.21 110.042 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -129.08 77.76 77.31 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.552 1.141 . . . . 72.03 108.035 172.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -85.96 145.22 8.71 Favored 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.669 2.246 . . . . 62.15 113.192 -173.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -101.31 84.97 2.71 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.826 -1.176 . . . . 71.41 107.826 164.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.68 HG23 ' HB1' ' A' ' 66' ' ' ALA . 77.7 t -81.65 96.96 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 108.419 -0.956 . . . . 63.24 108.419 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -95.96 123.3 39.5 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.347 -0.612 . . . . 74.43 109.347 177.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mp -97.91 107.05 19.45 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.504 -1.295 . . . . 71.31 107.504 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -111.58 119.16 37.79 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.469 -0.937 . . . . 73.05 108.469 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.445 HD22 HD21 ' A' ' 60' ' ' LEU . 89.0 mt -112.17 139.4 47.74 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.441 0.696 . . . . 73.1 111.805 -169.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 19.4 t70 -132.29 144.09 50.35 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.78 1.232 . . . . 74.22 108.536 176.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.436 HG22 ' HG3' ' A' ' 103' ' ' PRO . 67.4 m -141.35 135.19 30.23 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.495 0.718 . . . . 72.55 109.434 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.6 123.78 10.83 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.633 0.773 . . . . 63.42 109.483 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 98' ' ' LEU . 78.9 p -97.54 162.39 13.33 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.445 0.698 . . . . 74.3 110.27 175.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.0 t -158.56 155.59 28.62 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.299 1.04 . . . . 75.11 108.53 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -102.53 115.96 31.63 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.296 -0.631 . . . . 70.24 109.296 175.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.683 HD12 ' HB2' ' A' ' 57' ' ' GLU . 56.6 mt -82.52 -40.83 20.48 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.494 0.718 . . . . 71.04 110.257 176.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.41 -174.57 5.0 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.251 -0.886 . . . . 74.14 110.713 -176.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -59.65 115.84 3.61 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.796 0.838 . . . . 72.15 110.135 176.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 71.74 -6.16 1.5 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.907 1.283 . . . . 74.44 112.843 -177.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.6 t -98.76 115.65 39.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.718 -0.845 . . . . 73.02 108.718 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -126.01 125.08 42.08 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.161 0.984 . . . . 73.34 109.061 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.683 ' HB2' HD12 ' A' ' 51' ' ' LEU . 33.2 tt0 -92.05 123.33 35.33 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.483 -0.562 . . . . 63.11 109.483 171.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.8 t -107.28 136.03 43.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.405 -0.961 . . . . 74.12 108.405 168.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.7 t -120.18 130.33 74.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.191 -1.04 . . . . 71.42 108.191 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.466 HD23 HG23 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -107.07 105.03 14.85 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.411 -1.7 . . . . 71.44 106.411 175.188 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.486 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 31.6 ttp180 -92.51 100.49 13.03 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.216 -1.402 . . . . 74.4 107.216 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.466 HG23 HD23 ' A' ' 60' ' ' LEU . 20.2 t -96.15 127.05 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 108.182 -1.044 . . . . 74.12 108.182 176.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.1 m -123.86 118.56 27.39 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.598 -0.89 . . . . 74.51 108.598 174.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.416 HG13 HD23 ' A' ' 126' ' ' LEU . 71.9 t -120.52 132.4 70.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 107.914 -1.143 . . . . 64.3 107.914 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 m -137.2 132.43 33.87 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.583 -0.895 . . . . 71.44 108.583 174.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.68 ' HB1' HG23 ' A' ' 40' ' ' VAL . . . -114.31 114.95 26.62 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.541 1.137 . . . . 75.52 108.142 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 71.2 m -120.81 134.98 55.27 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.401 0.619 . . . . 74.42 111.146 178.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.48 HD21 ' CE3' ' A' ' 36' ' ' TRP . 42.0 mt -94.91 42.27 1.09 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.402 1.481 . . . . 74.41 111.111 -176.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.61 -84.87 1.51 Allowed Glycine 0 C--N 1.339 0.698 0 CA-C-O 119.749 -0.473 . . . . 74.52 112.164 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -86.56 -30.66 21.71 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.211 0.529 . . . . 73.11 111.353 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.442 ' HB2' ' NZ ' ' A' ' 34' ' ' LYS . 4.6 tp10 -119.96 133.64 55.49 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.62 -0.881 . . . . 42.52 108.62 -174.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 73.7 m -77.71 134.37 38.13 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.111 -0.7 . . . . 74.34 109.111 170.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.477 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . . . -71.83 -64.59 0.9 Allowed 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.507 0.723 . . . . 74.21 109.45 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -159.57 166.72 30.18 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.253 -0.885 . . . . 75.0 112.039 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.7 tp -117.92 143.11 46.62 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.571 -1.195 . . . . 64.43 108.693 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.446 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 79.1 m -143.07 104.53 4.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.131 0.973 . . . . 75.4 109.622 175.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -123.1 127.69 49.07 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.539 0.736 . . . . 74.21 109.017 177.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.3 t -137.55 112.75 10.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 124.352 1.061 . . . . 74.31 109.094 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -86.21 85.65 7.34 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.781 -0.822 . . . . 72.44 108.781 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -78.37 96.26 5.29 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.948 -1.024 . . . . 71.32 110.31 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.14 155.74 30.23 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 111.724 -0.551 . . . . 73.11 111.724 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.488 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -151.51 122.3 1.33 Allowed Glycine 0 C--N 1.329 0.164 0 N-CA-C 111.703 -0.559 . . . . 62.41 111.703 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.9 mt -81.17 117.63 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.941 0.896 . . . . 74.21 108.665 171.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.546 ' HB3' HD11 ' A' ' 86' ' ' ILE . 90.8 m-85 -124.27 122.26 37.26 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.489 1.116 . . . . 74.01 109.491 -177.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.1 t -91.77 105.39 17.68 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.239 -0.652 . . . . 75.11 109.239 173.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.645 HG22 ' HE3' ' A' ' 94' ' ' MET . 1.9 mm -112.38 153.78 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.489 0.715 . . . . 74.31 109.43 -177.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.427 ' HB2' ' HB ' ' A' ' 10' ' ' THR . . . -158.23 160.61 37.31 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.557 0.743 . . . . 73.24 111.235 177.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.1 -7.62 64.58 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 119.184 -0.787 . . . . 73.44 113.928 174.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.467 ' HA ' ' HG2' ' A' ' 151' ' ' GLU . 0.1 OUTLIER -144.06 153.37 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 124.056 0.942 . . . . 74.41 111.695 -178.529 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -141.84 178.25 7.63 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.01 1.724 . . . . 72.2 108.625 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.47 -139.78 29.62 Favored Glycine 0 C--N 1.349 1.26 0 N-CA-C 114.063 0.385 . . . . 73.43 114.063 173.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.2 t -72.4 -19.38 61.61 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.258 0.623 . . . . 74.24 111.439 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.604 HE22 ' HB2' ' A' ' 151' ' ' GLU . 8.2 mt-30 -70.78 -43.82 67.94 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.992 0.917 . . . . 72.21 109.576 173.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.645 ' HE3' HG22 ' A' ' 86' ' ' ILE . 4.8 tpt -63.82 -42.31 97.69 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.085 -0.961 . . . . 74.4 109.849 174.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.3 -33.75 76.2 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.449 -0.796 . . . . 62.41 111.344 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.431 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 53.0 t-80 -71.1 -27.02 63.3 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.169 0.588 . . . . 70.4 111.193 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -78.6 -52.79 7.95 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.823 -0.436 . . . . 72.3 109.823 175.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.401 ' HB3' ' HB3' ' A' ' 48' ' ' SER . 89.6 mt -72.98 -35.24 66.84 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.789 0.835 . . . . 74.21 112.773 -171.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.08 4.0 60.55 Favored Glycine 0 N--CA 1.469 0.842 0 CA-C-N 115.97 -0.559 . . . . 64.31 113.674 -172.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.575 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -146.51 -58.45 0.29 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 117.31 0.555 . . . . 72.05 112.19 -173.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -71.83 -42.28 67.15 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.046 0.451 . . . . 74.04 110.742 -176.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 63.7 m -67.63 -49.43 40.03 Favored Pre-proline 0 CA--C 1.565 1.552 0 C-N-CA 124.733 1.213 . . . . 74.01 112.852 -175.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.436 ' HG3' HG22 ' A' ' 46' ' ' THR . 47.5 Cg_endo -65.79 -24.85 53.86 Favored 'Trans proline' 0 C--N 1.395 2.982 0 C-N-CA 122.035 1.823 . . . . 75.23 112.437 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -64.91 -37.14 86.64 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.457 0.703 . . . . 74.52 110.476 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.528 HG21 HD12 ' A' ' 13' ' ' ILE . 49.5 mm -69.02 -40.73 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.544 0.737 . . . . 73.24 110.407 174.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.488 HD22 ' HA3' ' A' ' 82' ' ' GLY . 48.3 mt -72.74 -25.18 61.11 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.475 -0.784 . . . . 74.44 112.123 -175.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -61.68 -45.09 93.15 Favored Pre-proline 0 N--CA 1.487 1.394 0 N-CA-C 113.768 1.025 . . . . 73.21 113.768 -172.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -52.05 -37.34 68.16 Favored 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 122.51 2.14 . . . . 75.53 113.876 170.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -84.09 -29.11 27.06 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.51 0.724 . . . . 74.32 112.001 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.76 -45.19 75.61 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.554 -0.906 . . . . 75.4 108.554 172.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.533 ' NH1' HD13 ' C' ' 105' ' ' ILE . 36.5 ttm180 -59.9 -40.81 90.06 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.071 -1.422 . . . . 74.31 110.515 174.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.535 ' HB2' ' HB3' ' C' ' 108' ' ' PRO . 25.7 tt0 -51.21 -54.53 24.77 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.623 1.169 . . . . 74.43 110.813 177.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.451 ' O ' ' HG3' ' A' ' 117' ' ' MET . 48.9 t -66.17 -47.21 74.72 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.435 -1.257 . . . . 64.12 111.437 -176.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.496 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 92.1 mt -58.69 -59.14 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 124.173 0.989 . . . . 73.22 110.953 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.1 m -56.82 -38.55 72.77 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.359 1.064 . . . . 74.1 111.575 -177.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.1 t -63.35 -48.82 76.39 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.892 -1.049 . . . . 61.22 110.817 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.595 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 41.2 mtm -61.46 -40.25 93.83 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.816 0.697 . . . . 74.14 111.253 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.494 HG22 ' HB3' ' A' ' 126' ' ' LEU . 82.5 t -56.77 -49.97 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 O-C-N 124.252 0.97 . . . . 75.12 110.813 175.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.6 t -68.17 -33.51 74.59 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.234 -0.893 . . . . 65.24 111.165 -177.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.536 HH12 ' HG3' ' B' ' 112' ' ' GLU . 81.8 mtt-85 -72.61 -29.43 63.48 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.537 0.735 . . . . 73.34 110.172 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.17 16.41 43.54 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-O 118.812 -0.993 . . . . 73.4 113.375 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.466 HG23 ' HE ' ' B' ' 15' ' ' ARG . 3.0 t 60.47 11.65 3.09 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 126.781 2.033 . . . . 74.41 113.66 176.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -81.88 156.66 69.86 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.708 0.803 . . . . 75.44 109.911 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.55 ' HB3' ' HA ' ' E' ' 131' ' ' TRP . 18.6 Cg_endo -60.21 129.29 29.41 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.503 2.136 . . . . 71.54 111.33 175.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -49.05 121.68 5.06 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 125.116 1.51 . . . . 73.43 112.213 -173.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.541 HD13 HG12 ' A' ' 40' ' ' VAL . 56.5 tp -108.78 102.11 11.18 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.922 -0.581 . . . . 75.53 109.662 -174.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -98.85 121.87 41.35 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.594 -1.262 . . . . 64.03 107.594 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 11.2 mt -72.02 129.88 39.61 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 110.082 -0.34 . . . . 74.35 110.082 -177.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.91 141.36 98.35 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 116.046 -0.524 . . . . 74.22 110.771 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.594 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 49.2 Cg_exo -57.7 128.74 30.37 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.284 2.656 . . . . 75.34 113.558 -176.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 85.8 t -120.58 132.3 70.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 C-N-CA 123.942 0.897 . . . . 74.13 109.824 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -96.43 95.48 8.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.752 0.821 . . . . 71.32 108.871 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -62.57 -21.09 65.33 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.941 0.897 . . . . 65.43 112.576 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.575 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 11.7 t70 -56.96 -51.03 70.81 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.55 0.74 . . . . 65.13 110.045 170.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.7 -40.49 95.22 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 124.106 0.879 . . . . 74.32 111.326 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.92 -32.07 73.47 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.463 -0.79 . . . . 73.24 111.248 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -77.3 -33.94 55.56 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.737 -0.665 . . . . 74.33 110.413 176.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.647 ' SD ' HD23 ' A' ' 141' ' ' LEU . 26.3 mmt -61.25 -28.35 69.1 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.386 0.674 . . . . 72.13 111.517 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -61.63 -29.26 69.94 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.294 1.037 . . . . 74.0 111.5 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -92.76 -41.17 10.27 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.519 0.728 . . . . 72.43 110.324 174.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.647 HD23 ' SD ' ' A' ' 138' ' ' MET . 61.4 tp -66.73 -48.66 68.48 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.272 1.029 . . . . 75.41 111.897 -166.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.438 ' NE2' ' SD ' ' A' ' 138' ' ' MET . 28.5 pt20 -143.46 24.34 1.75 Allowed 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 112.02 0.378 . . . . 73.34 112.02 -165.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -69.71 -39.95 76.58 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.044 -0.724 . . . . 75.44 109.044 168.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -155.09 -27.72 0.11 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 114.669 -1.15 . . . . 75.44 110.029 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.3 -44.9 96.44 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.469 0.708 . . . . 71.43 111.807 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 106.79 -111.59 3.57 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-O 119.694 -0.503 . . . . 71.2 112.841 174.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -176.99 162.45 2.05 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.956 0.903 . . . . 71.11 109.196 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -151.91 53.55 0.47 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.684 -0.566 . . . . 72.42 111.684 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 26.4 p -76.76 88.41 3.39 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.683 0.754 . . . . 75.22 110.434 177.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -141.46 97.06 3.09 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 107.417 -1.327 . . . . 73.03 107.417 172.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.604 ' HB2' HE22 ' A' ' 93' ' ' GLN . 11.5 tp10 -130.41 120.41 24.19 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 120.939 0.4 . . . . 73.31 110.332 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -80.2 88.96 5.45 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.149 -1.056 . . . . 74.24 108.149 173.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -70.27 74.12 0.5 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.084 0.954 . . . . 74.43 111.056 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -133.57 158.75 42.37 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.125 0.57 . . . . 65.52 110.368 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.831 0 C-N-CA 124.507 1.123 . . . . 54.45 109.359 -179.023 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptp . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 120.303 0.097 . . . . 74.01 110.802 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -75.67 101.5 5.02 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 109.02 -0.733 . . . . 73.32 109.02 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -63.49 -24.09 67.67 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.055 0.942 . . . . 74.53 112.145 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -116.8 84.95 2.23 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.918 0.887 . . . . 74.21 108.697 175.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -172.77 89.58 0.09 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.204 1.002 . . . . 73.21 108.722 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -147.49 -44.14 0.17 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.296 1.038 . . . . 54.31 108.913 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 32.9 m 69.26 103.19 0.06 Allowed 'General case' 0 C--N 1.358 0.936 0 C-N-CA 125.091 1.356 . . . . 74.22 110.867 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 72.06 137.11 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.788 1.235 . . . . 63.42 111.704 175.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.571 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 0.5 OUTLIER 66.05 165.58 0.19 Allowed 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 125.662 1.585 . . . . 74.22 112.026 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.494 ' N ' ' SD ' ' B' ' 9' ' ' MET . 78.8 m -153.22 105.93 2.93 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.181 0.992 . . . . 74.42 108.746 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -109.72 139.46 44.73 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.413 -0.958 . . . . 73.52 108.413 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -149.89 141.24 23.26 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.699 0.8 . . . . 73.12 109.272 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 19.0 mt -94.6 124.98 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 107.545 -1.28 . . . . 74.43 107.545 171.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -87.53 -48.95 7.52 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.827 -0.434 . . . . 73.03 109.827 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.466 ' HE ' HG23 ' A' ' 122' ' ' THR . 48.2 ttt180 -166.45 136.35 3.2 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.609 0.568 . . . . 71.22 109.991 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 97.7 mt -115.25 135.64 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 107.602 -1.259 . . . . 73.22 107.602 174.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -163.18 143.88 9.31 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 112.767 0.654 . . . . 71.31 112.767 -174.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 56.0 m -73.79 120.8 19.88 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.617 -1.174 . . . . 65.11 108.918 170.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.522 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.2 mtpt -98.53 -18.9 17.93 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.113 0.965 . . . . 74.23 111.897 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -166.02 144.31 5.74 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.608 0.567 . . . . 72.42 110.824 -174.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.502 HD13 ' SG ' ' B' ' 113' ' ' CYS . 45.6 mm -139.19 140.9 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.277 1.431 . . . . 74.12 108.745 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.5 t -142.71 125.8 16.34 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.649 1.18 . . . . 62.34 108.303 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.5 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 78.1 t80 -140.35 121.27 14.54 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.573 -1.269 . . . . 74.32 107.573 169.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -130.25 121.13 25.58 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.522 -0.918 . . . . 54.32 108.522 175.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.46 89.31 3.2 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 106.259 -1.756 . . . . 75.21 106.259 168.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -59.43 -36.72 93.06 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.86 2.374 . . . . 74.14 111.975 -171.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -106.47 16.54 24.54 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 118.06 -0.972 . . . . 74.3 111.611 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -30.73 -62.12 0.24 Allowed Pre-proline 0 N--CA 1.502 2.128 0 N-CA-C 115.117 1.525 . . . . 72.02 115.117 -171.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -59.5 -41.39 57.73 Favored 'Trans proline' 0 C--N 1.399 3.19 0 C-N-CA 121.951 1.767 . . . . 71.44 112.686 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -96.78 -19.35 18.98 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.079 -0.964 . . . . 72.22 113.296 -169.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.569 HG23 ' HA ' ' B' ' 73' ' ' ALA . 9.6 p -74.96 -12.93 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-O 121.155 0.502 . . . . 75.03 110.735 -176.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -77.44 -5.93 51.64 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.296 0.85 . . . . 74.23 113.296 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -68.31 -21.52 64.76 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.867 0.467 . . . . 75.45 110.433 169.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.643 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 93.8 mttt -94.33 87.1 5.09 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.254 1.021 . . . . 74.04 110.533 -175.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -86.54 90.97 8.41 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.522 -0.763 . . . . 75.31 110.346 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 34.8 p90 -173.98 -172.05 0.69 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.474 1.11 . . . . 72.44 109.3 171.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -80.15 117.61 68.38 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.101 0.561 . . . . 75.32 111.099 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.538 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 19.3 Cg_endo -64.73 147.4 89.77 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 121.74 1.627 . . . . 74.11 110.496 173.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.18 102.68 0.86 Allowed 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.728 -0.841 . . . . 73.11 108.728 174.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.79 HG21 ' HB1' ' B' ' 66' ' ' ALA . 41.8 t -99.86 145.86 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.213 -0.903 . . . . 74.52 109.875 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -140.06 127.35 21.23 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.69 1.196 . . . . 73.33 107.853 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.542 HD12 HD21 ' B' ' 128' ' ' LEU . 25.6 tp -86.4 145.29 26.92 Favored 'General case' 0 C--O 1.244 0.811 0 O-C-N 123.81 0.694 . . . . 74.04 109.211 173.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.545 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 11.4 t70 -143.95 150.07 37.76 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.992 -1.114 . . . . 75.41 107.992 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 72.5 mt -126.9 139.89 52.74 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.635 0.774 . . . . 74.01 109.458 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.422 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 29.5 t70 -132.11 151.15 51.93 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.07 0.948 . . . . 60.12 109.072 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.7 m -124.61 111.97 16.26 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.151 0.58 . . . . 71.24 110.574 -166.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.468 ' HA ' ' CE1' ' F' ' 106' ' ' TYR . . . -146.63 117.48 7.66 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 109.379 -0.6 . . . . 72.12 109.379 174.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 48.1 p -143.89 170.87 15.08 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.063 0.545 . . . . 64.21 110.08 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 64.8 p -152.04 142.55 22.66 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.422 0.289 . . . . 71.34 111.62 -173.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -96.86 94.33 7.18 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.984 -0.747 . . . . 74.32 108.984 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 pp -110.13 24.43 13.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.008 0.523 . . . . 71.41 110.611 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . 0.502 ' HB1' ' HB ' ' B' ' 55' ' ' VAL . . . -164.87 172.04 13.38 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 123.717 0.807 . . . . 70.53 111.153 172.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -97.15 124.73 41.28 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 107.922 -1.14 . . . . 53.44 107.922 172.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 66.02 4.72 3.16 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 124.362 1.065 . . . . 75.4 112.917 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.502 ' HB ' ' HB1' ' B' ' 52' ' ' ALA . 44.9 t -133.73 126.47 51.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.447 0 N-CA-C 107.041 -1.466 . . . . 73.43 107.041 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -132.7 141.19 48.46 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.794 -0.447 . . . . 74.31 109.794 -168.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -106.03 105.84 16.07 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.75 -1.204 . . . . 73.02 107.75 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 38.1 t -100.54 129.53 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.431 1.093 . . . . 74.43 109.54 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 t -118.26 114.59 45.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.629 -0.878 . . . . 73.44 108.629 173.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -100.71 108.58 20.48 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.72 -1.215 . . . . 74.34 107.72 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.422 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 31.5 ttm180 -85.98 119.7 26.57 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.288 -1.004 . . . . 74.3 108.288 173.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 31.4 t -105.18 123.94 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.92 -1.141 . . . . 75.32 107.92 175.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 45.2 m -111.02 136.78 49.51 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.89 -0.781 . . . . 73.43 108.89 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.609 HG13 HD23 ' B' ' 126' ' ' LEU . 59.4 t -129.44 114.87 32.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 124.054 0.942 . . . . 75.45 108.58 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 32.7 m -100.89 135.36 42.47 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.521 -0.918 . . . . 75.13 108.521 170.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.79 ' HB1' HG21 ' B' ' 40' ' ' VAL . . . -144.36 141.93 30.04 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.21 -0.663 . . . . 55.13 109.21 176.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.486 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 55.2 p -142.52 127.8 18.75 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 123.921 0.763 . . . . 63.23 111.324 -175.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.538 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 17.5 mt -92.93 111.79 23.52 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.056 0.943 . . . . 74.52 108.61 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.75 -123.51 19.22 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 124.054 0.846 . . . . 72.21 112.214 -175.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -97.41 3.23 51.0 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.311 0.644 . . . . 74.32 112.241 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.643 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 12.0 pt-20 -128.72 158.36 38.82 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.519 0.728 . . . . 72.21 110.063 -177.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 41.8 m -70.02 135.33 49.21 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.03 0.532 . . . . 65.54 111.041 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.569 ' HA ' HG23 ' B' ' 31' ' ' VAL . . . -87.03 -62.26 1.54 Allowed 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.78 -1.192 . . . . 73.41 107.78 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -152.23 157.04 40.88 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.161 -1.382 . . . . 74.3 110.166 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 85.5 mt -127.73 110.48 12.68 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.216 -1.772 . . . . 72.14 106.216 173.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.46 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 36.7 t -119.98 137.41 54.09 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.686 -0.857 . . . . 71.55 108.686 -177.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -153.96 136.58 15.17 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.819 -0.808 . . . . 74.12 108.819 -173.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.485 HG11 ' HA ' ' B' ' 110' ' ' ALA . 91.1 t -133.6 148.31 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.291 -1.003 . . . . 72.51 108.291 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -121.42 100.52 7.07 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 108.186 -1.042 . . . . 73.42 108.186 172.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.4 ' HB2' ' HB1' ' B' ' 110' ' ' ALA . 8.0 tp-100 -93.29 104.18 16.37 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.53 -0.915 . . . . 73.11 108.53 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.522 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -93.43 163.56 26.36 Favored Glycine 0 C--O 1.24 0.49 0 CA-C-N 115.496 -0.775 . . . . 52.32 111.681 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.13 132.67 2.67 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.617 -0.325 . . . . 74.1 112.555 -176.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 45.0 mt -91.82 123.01 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 N-CA-C 107.745 -1.205 . . . . 73.32 107.745 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -129.82 135.56 48.55 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.736 0.814 . . . . 75.34 109.935 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 58.7 m -100.42 128.25 46.53 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.76 0.824 . . . . 42.41 109.71 174.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.412 HG21 ' HE2' ' B' ' 9' ' ' MET . 1.4 pp -140.77 135.31 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 124.582 1.153 . . . . 73.41 111.029 -173.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.13 168.0 26.7 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.203 1.001 . . . . 70.24 109.557 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 91.36 -36.05 3.75 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 116.242 -0.435 . . . . 74.34 112.874 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.627 ' HB ' ' HA ' ' B' ' 94' ' ' MET . 9.0 pt -66.67 149.46 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.275 1.43 . . . . 74.32 111.81 175.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -147.45 162.02 39.88 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 124.351 1.06 . . . . 71.53 110.114 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.49 -136.04 27.66 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-N 114.432 -1.258 . . . . 72.41 113.985 175.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.9 m -66.04 -48.54 70.74 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.78 0.832 . . . . 61.3 109.759 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.477 ' HG3' ' NE2' ' B' ' 143' ' ' GLN . 10.2 tt0 -60.25 -25.6 65.81 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 113.882 -1.508 . . . . 73.3 112.059 -171.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.627 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 2.0 tmt? -59.78 -69.97 0.19 Allowed 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.349 1.06 . . . . 74.52 112.163 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . 0.47 ' HB2' ' SD ' ' B' ' 94' ' ' MET . . . -80.38 -13.57 59.04 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 122.374 0.27 . . . . 65.33 111.584 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.89 -44.74 78.49 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.21 0.604 . . . . 72.34 109.591 167.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 44.4 t -57.46 -29.09 63.93 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.814 0.845 . . . . 53.55 111.965 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 71.6 mt -72.1 -40.06 68.45 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.991 0.916 . . . . 73.2 111.494 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . 0.543 ' HA3' ' NE2' ' F' ' 108' ' ' HIS . . . -101.39 4.08 54.48 Favored Glycine 0 C--N 1.341 0.812 0 CA-C-N 116.068 -0.515 . . . . 74.33 113.768 -176.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.568 ' HB3' ' HA ' ' B' ' 134' ' ' ASP . . . -126.3 -65.4 0.98 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.385 0.674 . . . . 73.13 111.218 -176.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -74.52 -45.13 47.78 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.955 -0.566 . . . . 74.45 111.354 -172.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.425 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 79.2 m -62.66 -47.46 87.94 Favored Pre-proline 0 CA--C 1.57 1.729 0 CA-C-O 118.519 -0.753 . . . . 74.43 112.228 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.425 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 76.1 Cg_exo -57.21 -33.37 95.84 Favored 'Trans proline' 0 C--N 1.398 3.172 0 C-N-CA 122.935 2.423 . . . . 72.32 113.705 171.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -67.47 -31.01 70.87 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.225 0.61 . . . . 72.13 111.243 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.0 mt -71.62 -40.18 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.596 0.758 . . . . 74.12 110.036 173.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 83.9 mt -77.46 -30.46 53.25 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.318 -0.855 . . . . 74.02 112.023 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -58.11 -44.67 99.48 Favored Pre-proline 0 CA--C 1.561 1.374 0 C-N-CA 124.394 1.078 . . . . 74.35 113.333 -172.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -50.21 -46.73 27.2 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 122.863 2.375 . . . . 62.42 114.491 173.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -65.78 -40.73 92.28 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.202 0.601 . . . . 75.21 110.796 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.485 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -66.07 -40.65 91.06 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.159 -0.928 . . . . 70.12 111.139 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -61.22 -51.54 68.54 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.117 1.367 . . . . 73.34 110.231 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . 0.536 ' HG3' HH12 ' A' ' 120' ' ' ARG . 9.2 tp10 -61.8 -39.0 90.18 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.249 1.02 . . . . 73.03 110.396 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.51 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.1 t -68.72 -32.87 72.97 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.067 0.147 . . . . 71.02 110.764 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.524 HD13 HD13 ' B' ' 128' ' ' LEU . 50.9 mt -66.81 -53.02 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.832 0.853 . . . . 74.44 110.025 173.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.459 HG22 ' OG ' ' C' ' 119' ' ' SER . 15.3 m -59.31 -30.91 68.69 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.794 0.684 . . . . 41.33 111.027 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.497 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.1 t -64.31 -50.19 68.8 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.068 0.947 . . . . 74.2 110.174 175.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.566 ' SD ' HG21 ' A' ' 21' ' ' ILE . 33.5 mmt -62.9 -40.34 97.26 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.933 0.493 . . . . 72.24 110.889 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.482 HG13 ' HB2' ' B' ' 123' ' ' PHE . 88.0 t -65.17 -39.67 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.728 1.211 . . . . 75.04 110.786 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 36.1 t -65.89 -36.19 82.73 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.156 -0.929 . . . . 74.43 111.032 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.497 ' HG3' ' O ' ' B' ' 116' ' ' SER . 71.3 mtt-85 -70.46 -37.86 74.37 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 115.646 -0.706 . . . . 72.51 109.945 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.77 -13.65 69.22 Favored Glycine 0 C--N 1.357 1.737 0 O-C-N 123.651 0.594 . . . . 73.44 112.765 171.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 13.4 m 67.35 32.26 5.98 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.644 1.578 . . . . 74.53 110.218 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.482 ' HB2' HG13 ' B' ' 118' ' ' VAL . 52.1 m-85 -81.06 167.95 28.48 Favored Pre-proline 0 CA--C 1.558 1.252 0 CA-C-N 114.631 -1.168 . . . . 73.42 110.0 173.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -60.18 168.78 5.7 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 122.792 2.328 . . . . 74.4 113.519 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.555 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 59.9 tp60 -64.8 112.63 3.33 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 114.895 -1.048 . . . . 74.24 110.666 -174.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.609 HD23 HG13 ' B' ' 64' ' ' VAL . 23.5 tp -111.23 111.33 22.32 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 123.689 0.618 . . . . 74.42 109.353 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -123.47 134.08 53.96 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 107.895 -1.15 . . . . 72.11 107.895 170.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.542 HD21 HD12 ' B' ' 42' ' ' LEU . 74.7 mt -85.86 149.26 25.36 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 122.656 0.383 . . . . 74.51 111.251 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.02 138.38 94.98 Favored Pre-proline 0 CA--C 1.55 0.954 0 O-C-N 124.447 1.092 . . . . 54.01 110.343 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -68.19 99.37 0.58 Allowed 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.774 2.316 . . . . 72.3 111.122 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 60.8 t -89.2 110.54 21.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.188 -1.042 . . . . 73.1 108.188 176.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -89.27 94.22 9.83 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 108.389 -0.967 . . . . 75.25 108.389 174.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -60.34 -22.73 63.59 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.292 -1.322 . . . . 73.02 111.661 -175.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.568 ' HA ' ' HB3' ' B' ' 100' ' ' ALA . 13.5 m-20 -58.22 -62.61 1.71 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.073 0.549 . . . . 71.2 110.733 172.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.28 -31.31 65.48 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 123.992 0.808 . . . . 63.2 111.661 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.605 ' HG ' ' HB3' ' F' ' 120' ' ' TYR . 7.3 tt -58.33 -55.61 32.71 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.349 1.06 . . . . 72.3 110.317 178.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -83.03 -15.33 51.51 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.328 0.651 . . . . 74.34 111.961 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 62.7 mtt -78.3 -31.56 48.93 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.327 0.651 . . . . 74.51 110.872 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -78.42 -34.1 48.21 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 110.034 -0.358 . . . . 71.3 110.034 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -74.05 -40.93 62.5 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.452 -0.794 . . . . 74.01 110.448 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -100.46 7.24 44.3 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.884 0.874 . . . . 72.24 112.222 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 59.04 27.09 15.91 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.737 0.815 . . . . 74.23 112.163 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . 0.477 ' NE2' ' HG3' ' B' ' 93' ' ' GLN . 30.5 tt0 -87.49 57.75 4.58 Favored 'General case' 0 CA--C 1.554 1.129 0 CA-C-O 122.162 0.982 . . . . 74.53 108.754 176.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -84.86 151.77 24.06 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.575 -0.703 . . . . 73.34 110.521 -174.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.82 165.87 16.61 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 124.04 0.936 . . . . 73.31 111.582 175.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -126.91 -79.26 0.29 Allowed Glycine 0 C--N 1.342 0.862 0 N-CA-C 111.646 -0.581 . . . . 73.15 111.646 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 62.88 -79.87 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.61 1.164 . . . . 73.13 110.962 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 98.69 -141.11 15.39 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 111.573 -0.611 . . . . 74.03 111.573 -176.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' THR . . . . . 0.501 HG21 ' HG3' ' D' ' 90' ' ' GLU . 75.6 m -153.45 135.71 14.91 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.55 0.74 . . . . 73.54 109.273 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.67 115.36 20.89 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.944 -0.762 . . . . 74.31 108.944 169.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.35 83.19 8.04 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 106.642 -1.614 . . . . 72.22 106.642 173.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -148.93 -40.0 0.15 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.382 -0.826 . . . . 75.31 110.061 -171.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . 0.414 ' HB3' ' HA2' ' D' ' 91' ' ' GLY . 23.6 tm0? -63.98 119.07 9.39 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 109.574 -0.528 . . . . 74.22 109.574 174.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -113.26 -57.62 2.26 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.534 -0.913 . . . . 70.32 108.534 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 C-N-CA 123.787 0.835 . . . . 54.53 109.015 175.416 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 90.0 mmm . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.213 -0.662 . . . . 71.05 109.213 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 78.5 p -152.39 149.76 28.95 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.197 0.522 . . . . 73.11 110.949 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -136.11 111.39 9.07 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.723 1.209 . . . . 74.55 107.919 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -73.55 100.75 3.38 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.661 0.384 . . . . 73.24 110.189 -174.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -162.04 92.57 0.85 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.217 0.607 . . . . 72.21 110.078 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -179.64 150.92 0.43 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.635 0.774 . . . . 71.14 111.087 173.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 30.8 p -87.07 -53.32 4.94 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.293 1.037 . . . . 75.43 111.439 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -145.39 134.21 22.38 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.833 0.453 . . . . 61.24 110.946 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 21.1 ttt 45.21 109.46 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 126.678 1.991 . . . . 71.44 114.519 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.579 HG22 ' HA ' ' E' ' 141' ' ' ALA . 53.1 m -93.11 120.48 33.45 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.643 -0.873 . . . . 74.42 108.643 169.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.594 ' HD2' ' HG2' ' A' ' 130' ' ' PRO . 37.1 t80 -127.71 124.25 37.39 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.212 -1.033 . . . . 73.03 108.212 161.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -150.73 121.05 7.31 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.431 -0.951 . . . . 75.3 108.431 177.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.49 HD11 HG21 ' C' ' 105' ' ' ILE . 30.2 mt -67.79 127.6 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 123.963 0.789 . . . . 72.13 108.905 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.469 HE22 ' HG2' ' E' ' 136' ' ' LYS . 19.5 mm-40 -93.69 -37.75 11.67 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 123.506 0.504 . . . . 74.43 109.902 177.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 178.45 155.54 0.41 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.038 1.335 . . . . 74.23 109.134 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.445 ' HA ' ' HA2' ' C' ' 82' ' ' GLY . 2.8 pp -127.5 152.97 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 107.656 -1.239 . . . . 75.21 107.656 171.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.535 ' HE1' HG12 ' C' ' 83' ' ' ILE . 31.4 p90 -170.36 144.74 2.56 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 110.135 -0.32 . . . . 74.51 110.135 -174.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 66.2 p -73.08 111.77 8.5 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.976 0.51 . . . . 73.45 109.899 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.634 ' HE3' ' HB2' ' D' ' 28' ' ' ALA . 11.2 mmmm -66.91 -37.06 83.65 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.899 -0.778 . . . . 72.23 108.899 170.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.418 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.6 t70 -148.33 145.42 28.12 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.4 -1.273 . . . . 73.24 110.192 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.53 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.1 mt -136.89 144.15 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.722 1.609 . . . . 75.5 106.785 172.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.4 t -155.6 148.66 24.53 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.994 0.426 . . . . 74.44 110.337 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -151.4 127.72 10.61 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 107.255 -1.387 . . . . 74.01 107.255 173.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -135.49 112.24 10.12 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.065 0.546 . . . . 71.03 110.08 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.61 82.69 20.26 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 106.753 -1.573 . . . . 72.21 106.753 161.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.87 -25.94 32.43 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 122.626 2.217 . . . . 74.1 111.601 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -96.03 23.99 5.97 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.657 1.183 . . . . 72.22 109.618 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.423 ' HA ' HG11 ' C' ' 31' ' ' VAL . . . -44.2 -58.4 4.99 Favored Pre-proline 0 C--N 1.374 1.634 0 C-N-CA 124.999 1.32 . . . . 71.04 114.539 -163.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 19.9 Cg_exo -61.57 -42.64 31.74 Favored 'Trans proline' 0 C--N 1.386 2.532 0 CA-C-N 121.362 1.522 . . . . 71.35 111.856 -176.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -69.92 -34.39 73.41 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 114.89 -1.05 . . . . 75.25 112.541 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.562 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.9 p -79.98 -27.67 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.189 0.441 . . . . 74.15 112.189 -175.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -67.88 -34.06 75.93 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.011 0.434 . . . . 74.42 111.197 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -87.31 6.71 32.12 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.852 0.861 . . . . 74.42 111.743 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.63 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 2.5 tppp? -85.99 154.93 21.1 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.579 0.752 . . . . 74.54 111.199 -175.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -60.8 115.85 3.99 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.286 1.034 . . . . 74.41 109.929 172.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -84.36 82.79 8.23 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.984 0.914 . . . . 73.43 110.787 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -133.82 78.91 59.52 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 107.398 -1.334 . . . . 52.21 107.398 168.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -92.7 135.24 1.3 Allowed 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 123.243 2.629 . . . . 74.11 113.351 -175.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -85.64 96.89 9.82 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.981 -1.489 . . . . 72.32 106.981 169.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' C' ' 65' ' ' THR . 94.3 t -90.48 106.38 17.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 115.71 -0.677 . . . . 75.01 110.316 -175.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.08 105.04 16.93 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.172 -1.047 . . . . 62.43 108.172 173.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.431 ' H ' HD21 ' C' ' 42' ' ' LEU . 2.5 pt? -86.47 124.11 32.43 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 107.344 -1.354 . . . . 73.02 107.344 171.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.425 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 21.5 t70 -118.01 140.84 49.16 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.846 -0.798 . . . . 73.2 108.846 -176.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.557 HD13 HG12 ' C' ' 131' ' ' VAL . 51.2 mt -127.38 113.32 16.08 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.02 0.928 . . . . 75.45 109.489 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -122.48 121.3 36.24 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.266 -1.383 . . . . 64.21 107.266 174.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 6.5 t -117.17 137.03 52.6 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.058 0.456 . . . . 72.2 111.013 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.99 157.87 25.06 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.146 0.978 . . . . 71.22 108.769 175.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 60.2 p -158.58 146.35 18.07 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.14 0.576 . . . . 71.53 109.978 177.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.1 p -156.07 160.29 39.85 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.012 0.925 . . . . 72.44 109.214 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -99.59 120.08 39.1 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.569 -0.901 . . . . 73.4 108.569 172.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.575 HD12 ' HB2' ' C' ' 57' ' ' GLU . 33.6 mt -84.42 -50.8 7.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.645 0.778 . . . . 72.2 109.809 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.58 -168.25 2.86 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.845 -1.071 . . . . 75.35 109.73 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.66 118.56 9.73 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.886 -0.597 . . . . 60.32 109.904 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 68.06 -4.91 0.94 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.995 1.318 . . . . 74.42 112.109 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.0 t -99.58 116.82 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 123.741 0.816 . . . . 75.32 109.199 -174.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -124.36 129.49 50.81 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.836 1.254 . . . . 72.22 108.7 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.575 ' HB2' HD12 ' C' ' 51' ' ' LEU . 42.0 tt0 -89.72 137.1 32.62 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 108.522 -0.918 . . . . 72.44 108.522 167.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 82.2 t -123.85 140.85 46.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 108.08 -1.082 . . . . 72.52 108.08 167.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.444 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 85.3 t -122.03 146.41 27.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 108.759 -0.83 . . . . 75.25 108.759 172.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.565 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -128.76 99.8 5.47 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.91 -1.515 . . . . 74.23 106.91 177.078 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 33.3 ttm-85 -80.85 105.54 12.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.799 -1.091 . . . . 71.43 108.322 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' C' ' 43' ' ' ASP . 26.1 t -106.08 121.16 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 108.432 -0.951 . . . . 71.55 108.432 175.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 14.2 m -120.15 110.46 16.65 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.678 -0.86 . . . . 73.34 108.678 -174.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.545 HG21 HG23 ' C' ' 114' ' ' ILE . 47.6 t -98.16 109.5 23.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.95 -0.759 . . . . 74.41 108.95 177.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' C' ' 40' ' ' VAL . 32.1 m -96.5 131.73 42.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.596 -1.261 . . . . 73.15 107.596 171.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.54 118.23 19.85 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.344 -1.724 . . . . 71.23 106.344 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 29.9 m -133.25 125.74 29.99 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.089 0.243 . . . . 62.02 110.838 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.404 ' HG ' ' HB3' ' C' ' 73' ' ' ALA . 16.5 mt -87.45 49.3 1.79 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.395 1.478 . . . . 74.33 109.723 177.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.82 -115.35 5.16 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 110.533 -1.027 . . . . 65.03 110.533 -170.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -90.22 -28.37 18.9 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.796 0.838 . . . . 71.14 110.124 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.63 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 5.4 tp10 -63.68 122.09 15.52 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.804 1.242 . . . . 73.33 109.491 171.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.2 m -77.78 122.87 25.99 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.726 -0.842 . . . . 74.55 108.726 168.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.562 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -65.72 -59.39 3.96 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.307 -0.997 . . . . 62.33 108.307 171.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -165.39 164.37 19.69 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.908 -1.042 . . . . 73.23 110.658 174.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.402 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.7 tm? -120.51 141.01 50.62 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 106.354 -1.721 . . . . 63.34 106.354 166.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.436 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.6 t -146.95 110.06 4.76 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.79 -0.819 . . . . 74.13 108.79 177.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -117.44 119.74 36.01 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.08 -0.711 . . . . 75.43 109.08 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 55.1 t -117.08 114.17 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.78 -0.822 . . . . 74.15 108.78 173.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.418 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 78.2 mt-30 -90.06 87.22 6.81 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.185 -1.043 . . . . 74.3 108.185 173.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -78.42 104.48 9.05 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 115.693 -0.685 . . . . 74.43 109.325 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -83.48 179.3 52.53 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-N 116.613 -0.267 . . . . 64.25 112.717 172.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' C' ' 16' ' ' ILE . . . -178.73 136.81 3.01 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-O 119.945 -0.364 . . . . 73.33 112.719 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.535 HG12 ' HE1' ' C' ' 17' ' ' TYR . 36.6 mm -96.34 133.46 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 108.829 -0.804 . . . . 75.13 108.829 174.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -135.33 131.99 37.12 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.854 0.861 . . . . 74.43 110.308 -176.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 24.6 p -85.27 99.59 11.22 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.094 -1.076 . . . . 74.53 108.094 166.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' C' ' 10' ' ' THR . 11.7 mt -114.57 140.41 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.138 -1.06 . . . . 74.34 108.138 177.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.42 162.62 38.99 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 122.415 0.286 . . . . 75.52 111.245 -174.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.26 -35.88 3.5 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 115.917 -0.583 . . . . 52.43 113.279 172.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.621 HD13 ' HA ' ' C' ' 94' ' ' MET . 36.1 pt -88.04 165.23 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.713 0.805 . . . . 73.3 112.059 -175.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -162.24 151.73 15.94 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.941 0.896 . . . . 63.24 109.874 -177.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.98 -119.39 9.64 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 115.344 -0.844 . . . . 61.51 112.794 172.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 68.9 p -62.15 -38.16 87.95 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.004 0.922 . . . . 74.51 111.307 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.543 HE21 HG23 ' C' ' 89' ' ' ILE . 27.0 mt-30 -65.22 -52.75 52.7 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.829 0.852 . . . . 71.13 111.22 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.621 ' HA ' HD13 ' C' ' 89' ' ' ILE . 6.1 tpt -53.03 -52.9 56.95 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 124.074 0.859 . . . . 73.02 111.722 176.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.55 -35.4 80.73 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.186 0.595 . . . . 73.35 112.15 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -68.13 -35.48 78.17 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.437 0.695 . . . . 74.2 110.708 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -71.82 -37.17 70.38 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.495 -0.775 . . . . 72.5 110.433 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.57 ' HG ' ' HE1' ' C' ' 94' ' ' MET . 83.8 mt -83.59 -33.7 25.31 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.999 0.92 . . . . 74.53 112.431 -175.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -113.14 11.09 24.54 Favored Glycine 0 N--CA 1.472 1.082 0 O-C-N 123.333 0.396 . . . . 50.23 113.803 -169.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.65 -54.29 0.19 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.77 0.428 . . . . 70.44 111.257 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.422 ' HH ' ' HB3' ' A' ' 130' ' ' PRO . 64.2 t80 -75.2 -47.73 26.87 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 112.479 0.548 . . . . 75.2 112.479 -172.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.475 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 91.5 m -64.43 -49.32 72.26 Favored Pre-proline 0 CA--C 1.561 1.367 0 C-N-CA 123.499 0.72 . . . . 72.52 110.886 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.565 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 51.2 Cg_exo -57.83 -28.21 81.44 Favored 'Trans proline' 0 C--N 1.396 3.074 0 C-N-CA 122.639 2.226 . . . . 72.11 113.633 174.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -66.06 -34.88 79.08 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.189 0.596 . . . . 71.34 110.916 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.533 HD13 ' NH1' ' A' ' 111' ' ' ARG . 35.7 mm -80.75 -29.98 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 122.556 0.343 . . . . 72.11 110.089 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 mp -75.34 -25.89 58.14 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.715 0.806 . . . . 71.34 111.496 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -58.97 -51.23 83.36 Favored Pre-proline 0 C--O 1.206 -1.225 0 CA-C-O 117.476 -1.25 . . . . 75.32 112.492 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . 0.535 ' HB3' ' HB2' ' A' ' 112' ' ' GLU . 65.3 Cg_exo -47.71 -44.47 26.29 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.774 2.316 . . . . 71.1 114.817 176.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -74.2 -40.49 62.44 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.095 0.558 . . . . 74.11 111.606 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.28 -42.35 93.28 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.268 0.627 . . . . 61.45 110.153 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . 0.608 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 31.6 ttt-85 -59.89 -52.16 66.6 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.029 1.732 . . . . 72.41 110.447 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.06 -37.7 88.4 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.234 0.959 . . . . 72.03 109.967 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 38.4 t -68.78 -35.66 77.33 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.476 0.485 . . . . 61.44 111.444 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.545 HG23 HG21 ' C' ' 64' ' ' VAL . 90.9 mt -68.65 -49.58 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.283 0.633 . . . . 74.24 110.203 174.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.6 m -66.36 -28.14 68.42 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.21 0.604 . . . . 75.33 110.991 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.436 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 46.2 t -66.45 -43.05 86.64 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.071 0.949 . . . . 74.43 109.041 172.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.592 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -67.76 -34.39 76.71 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.134 0.974 . . . . 75.41 112.089 177.527 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.465 HG23 ' O ' ' C' ' 114' ' ' ILE . 88.2 t -62.6 -43.96 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.619 0.767 . . . . 74.41 108.997 172.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.459 ' OG ' HG22 ' B' ' 115' ' ' THR . 29.4 t -63.88 -39.55 94.45 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.606 -1.179 . . . . 63.35 111.786 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.504 HH12 ' HG2' ' D' ' 112' ' ' GLU . 67.0 mtt-85 -69.95 -38.31 76.09 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.578 0.751 . . . . 72.34 109.942 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.6 -1.04 88.69 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 115.426 -0.806 . . . . 70.24 112.788 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 31.5 p 61.72 30.49 18.46 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.43 1.892 . . . . 74.14 113.587 171.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -85.66 151.31 55.35 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 107.871 -1.159 . . . . 74.33 107.871 166.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.555 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 24.5 Cg_endo -63.06 157.94 46.38 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 122.354 2.036 . . . . 64.33 112.721 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 -53.06 112.71 0.91 Allowed 'General case' 0 N--CA 1.477 0.908 0 O-C-N 124.585 1.178 . . . . 75.15 112.891 -172.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.573 HD12 ' HA ' ' F' ' 133' ' ' THR . 61.0 tp -109.61 87.8 2.59 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 113.924 -1.489 . . . . 75.35 107.512 174.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -92.93 99.91 12.46 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.899 -0.778 . . . . 74.24 108.899 -174.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.608 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 4.0 mm? -56.47 125.05 20.33 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.943 0.897 . . . . 75.33 111.274 -175.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.72 152.4 95.2 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 124.212 1.005 . . . . 74.31 111.4 -175.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.424 ' HG2' HG23 ' A' ' 13' ' ' ILE . 51.2 Cg_exo -54.72 108.26 0.28 Allowed 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.979 2.453 . . . . 74.41 112.926 175.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.557 HG12 HD13 ' C' ' 44' ' ' LEU . 6.8 p -101.0 135.55 36.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.599 0.76 . . . . 75.02 109.446 175.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -97.36 101.25 12.76 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.632 0.773 . . . . 75.35 109.359 -174.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.44 ' CE1' HD11 ' C' ' 44' ' ' LEU . 66.4 m-85 -68.98 -33.79 74.25 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.63 0.772 . . . . 73.51 111.462 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -59.15 -43.41 92.05 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.92 0.888 . . . . 62.21 109.435 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.88 -41.34 95.81 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 114.691 -1.141 . . . . 61.14 111.805 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 76.4 mt -65.91 -36.05 82.32 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.308 0.643 . . . . 75.53 110.831 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -74.1 -26.57 60.43 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 115.124 -0.944 . . . . 73.5 109.955 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 28.1 ttt -75.9 -37.05 59.22 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.1 0.96 . . . . 74.23 110.705 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -66.01 -36.61 83.74 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.197 0.599 . . . . 72.41 109.934 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -52.72 -85.92 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.038 0 O-C-N 124.758 1.286 . . . . 64.15 111.234 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 39.5 tp 174.72 -37.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.402 0.681 . . . . 73.43 111.02 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -83.4 -6.27 59.41 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 115.556 -0.747 . . . . 74.14 112.837 -162.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.69 101.83 5.16 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 108.891 -0.781 . . . . 73.31 108.891 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -147.81 34.15 0.84 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.049 0.94 . . . . 72.23 108.744 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -152.22 117.61 5.29 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.137 0.575 . . . . 62.54 110.815 -172.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 165.98 52.77 0.02 OUTLIER Glycine 0 C--N 1.346 1.087 0 N-CA-C 111.642 -0.583 . . . . 62.35 111.642 176.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -111.09 171.01 7.72 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.827 0.851 . . . . 74.23 110.834 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 78.08 -146.93 31.24 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.701 -0.681 . . . . 64.22 112.104 -176.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 15.3 t -168.39 172.84 8.06 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.509 0.724 . . . . 71.24 110.097 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -64.44 142.03 58.57 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.195 0.998 . . . . 63.15 110.324 172.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.59 134.67 49.37 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 108.875 -0.787 . . . . 63.24 108.875 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -165.3 170.58 14.54 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.26 1.024 . . . . 71.21 109.861 -172.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -149.73 -36.43 0.16 Allowed 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 111.848 0.314 . . . . 75.22 111.848 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -70.74 -60.82 2.03 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.099 0.56 . . . . 75.53 109.776 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.91 0 N-CA-C 108.092 -1.077 . . . . 64.12 108.092 177.481 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 60.0 mtm . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 121.497 0.665 . . . . 75.22 109.217 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 33.9 t -88.92 141.78 28.21 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.365 0.666 . . . . 74.1 109.95 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -64.67 -57.35 9.28 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 124.022 0.826 . . . . 70.1 110.961 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -100.29 73.4 1.68 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.159 0.584 . . . . 70.55 109.924 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -156.98 150.91 24.74 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.162 -1.051 . . . . 75.43 108.162 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -73.42 83.56 1.46 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.105 -0.702 . . . . 75.31 109.105 177.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 14.9 t -162.63 173.86 13.35 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 124.522 1.129 . . . . 65.02 108.888 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.447 ' HG3' ' H ' ' D' ' 9' ' ' MET . 5.6 tp10 66.57 -153.51 0.23 Allowed 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.261 1.024 . . . . 73.42 109.613 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.472 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 24.0 ttt -31.76 127.75 0.21 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.55 1.54 . . . . 75.4 115.043 176.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 4.6 t -112.04 138.54 48.55 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.946 0.898 . . . . 64.13 108.721 169.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.416 ' HD2' HG21 ' D' ' 86' ' ' ILE . 70.8 t80 -133.75 106.06 7.14 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.085 -1.45 . . . . 73.34 107.085 174.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -124.81 127.15 46.74 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.241 -1.022 . . . . 75.53 108.241 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.424 HG22 HD11 ' D' ' 16' ' ' ILE . 26.9 mt -77.09 116.51 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 109.296 -0.631 . . . . 73.41 109.296 178.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.406 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 8.5 mm100 -84.07 -43.92 14.59 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.281 0.632 . . . . 75.0 110.385 -173.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -170.71 142.71 2.03 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.947 0.499 . . . . 72.42 110.362 -176.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.424 HD11 HG22 ' D' ' 13' ' ' ILE . 3.0 mp -115.07 148.48 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 106.872 -1.529 . . . . 73.43 106.872 172.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -169.59 168.33 9.26 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-O 121.54 0.686 . . . . 74.25 111.643 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.6 p -105.09 121.16 43.21 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 114.929 -1.032 . . . . 71.44 109.078 171.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -86.25 -25.28 25.64 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.42 0.688 . . . . 74.23 109.238 176.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.4 t70 -156.74 137.38 13.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.63 -1.168 . . . . 62.42 109.973 -175.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.592 HG23 ' HE1' ' C' ' 117' ' ' MET . 74.1 mt -140.14 141.4 33.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.218 1.407 . . . . 71.15 107.471 173.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.9 t -146.71 143.63 28.86 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.91 0.884 . . . . 72.45 109.116 173.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.53 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 84.5 t80 -146.99 133.64 19.91 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 106.581 -1.637 . . . . 74.14 106.581 172.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 48.0 mt-10 -135.27 141.77 45.79 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.96 0.904 . . . . 65.15 109.382 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.49 77.97 16.77 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 107.796 -1.187 . . . . 74.43 107.796 176.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.69 -19.42 21.31 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.666 2.244 . . . . 71.33 113.195 -173.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -108.45 -0.65 20.4 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.865 0.866 . . . . 74.4 110.707 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.634 ' HB2' ' HE3' ' C' ' 19' ' ' LYS . . . -19.51 -71.7 0.03 OUTLIER Pre-proline 0 CA--C 1.571 1.757 0 N-CA-C 116.908 2.188 . . . . 55.24 116.908 -165.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.437 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 81.4 Cg_endo -74.76 -25.1 12.71 Favored 'Trans proline' 0 C--N 1.385 2.458 0 CA-C-N 124.454 2.626 . . . . 74.44 113.84 -176.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.505 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 4.6 t-160 -69.67 -39.68 76.89 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 124.419 1.087 . . . . 75.55 110.07 178.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.591 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.8 p -82.71 -22.53 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 CA-C-N 115.666 -0.697 . . . . 74.33 111.426 -175.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.437 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 22.1 m-85 -64.25 -26.39 68.48 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 122.265 0.226 . . . . 75.21 111.221 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . 0.505 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 61.7 mt-30 -65.45 -7.08 12.39 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.834 1.253 . . . . 72.43 111.844 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.709 ' HZ1' ' HG2' ' D' ' 71' ' ' GLU . 91.6 mttt -95.71 103.86 15.76 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.152 1.381 . . . . 72.01 110.095 175.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -95.36 76.32 3.38 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.581 0.752 . . . . 73.05 110.312 -175.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 44.2 p90 -156.75 -177.78 6.86 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.8 -0.815 . . . . 75.44 108.8 168.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.401 ' OE1' ' HB3' ' E' ' 127' ' ' SER . 29.6 tp60 -65.08 117.65 41.64 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.532 1.133 . . . . 73.32 110.91 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.41 ' O ' HG23 ' D' ' 40' ' ' VAL . 74.9 Cg_exo -55.49 112.88 1.18 Allowed 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 121.807 1.672 . . . . 75.02 109.457 165.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -70.95 107.41 4.05 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.055 -1.091 . . . . 73.3 108.055 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.679 HG21 ' HB2' ' D' ' 66' ' ' ALA . 96.0 t -102.45 131.4 50.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 115.122 -0.945 . . . . 73.11 109.913 -170.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -119.45 125.13 48.18 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.715 -1.217 . . . . 74.51 107.715 170.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.456 HD12 HG13 ' D' ' 62' ' ' VAL . 51.9 tp -96.18 141.48 29.5 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.852 -0.795 . . . . 73.41 108.852 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.571 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 35.1 t70 -134.71 113.28 11.51 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.026 -1.101 . . . . 74.43 108.026 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.584 HD12 HG23 ' E' ' 121' ' ' VAL . 93.7 mt -114.49 151.7 32.85 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.295 0.638 . . . . 64.24 110.696 -177.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.536 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 13.5 t0 -152.07 143.44 23.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.19 -0.914 . . . . 72.51 108.656 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 23.9 m -105.34 141.33 37.04 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.073 -0.714 . . . . 74.21 109.073 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.538 ' HB2' ' HB ' ' D' ' 59' ' ' VAL . . . -152.86 162.5 41.21 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.214 1.006 . . . . 75.13 108.864 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 36.3 p -171.2 159.72 5.99 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.601 0.76 . . . . 75.32 110.011 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 84.6 p -154.43 169.03 24.72 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.336 1.054 . . . . 64.4 109.672 -175.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 99.38 149.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 127.847 2.459 . . . . 71.4 110.211 -175.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.523 HD22 ' N ' ' D' ' 52' ' ' ALA . 5.1 tt -65.6 158.05 28.23 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 107.804 -1.184 . . . . 72.13 107.804 173.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.523 ' N ' HD22 ' D' ' 51' ' ' LEU . . . -59.78 -123.68 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 124.608 1.163 . . . . 64.21 113.508 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 57.52 27.84 14.65 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.506 0.722 . . . . 73.41 111.59 -176.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 73.8 8.58 4.89 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.664 1.585 . . . . 73.23 112.505 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 t -108.82 99.37 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 108.773 -0.825 . . . . 73.4 108.773 -176.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.561 ' HH ' HG21 ' E' ' 97' ' ' ILE . 39.1 m-85 -133.88 129.57 36.6 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.53 -0.915 . . . . 71.12 108.53 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.583 ' HB3' HG13 ' D' ' 83' ' ' ILE . 0.0 OUTLIER -101.66 120.14 39.87 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.835 -1.172 . . . . 71.32 107.835 168.298 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.494 ' O ' ' HA2' ' D' ' 81' ' ' GLY . 79.7 t -101.02 132.9 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-N 114.472 -1.24 . . . . 64.21 109.451 -176.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.538 ' HB ' ' HB2' ' D' ' 47' ' ' ALA . 36.6 t -106.63 138.81 30.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 124.383 1.073 . . . . 75.02 108.722 178.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.569 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -120.73 118.31 29.72 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.016 -1.475 . . . . 75.4 107.016 173.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.536 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 55.3 ttm-85 -88.57 109.35 20.01 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.848 -1.168 . . . . 72.11 107.848 175.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.541 HG22 ' HB1' ' D' ' 110' ' ' ALA . 38.5 t -114.69 113.23 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.345 -0.613 . . . . 74.13 109.345 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.571 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 24.4 m -119.75 131.96 55.5 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 123.954 0.902 . . . . 73.44 108.978 -172.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.665 HG13 HG11 ' D' ' 40' ' ' VAL . 85.1 t -118.71 104.69 16.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 C-N-CA 123.294 0.638 . . . . 74.42 109.384 177.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 10.1 m -97.98 94.03 6.64 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.26 -1.385 . . . . 75.24 107.26 170.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.679 ' HB2' HG21 ' D' ' 40' ' ' VAL . . . -112.02 138.71 48.29 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.015 0.926 . . . . 74.23 108.679 -175.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.507 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 61.1 m -144.55 136.03 25.53 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.346 0.658 . . . . 74.31 111.61 -172.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.528 HD11 HG23 ' D' ' 31' ' ' VAL . 32.1 mt -100.5 106.93 18.51 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.473 1.109 . . . . 71.12 109.061 174.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.17 -126.32 8.65 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-O 119.869 -0.406 . . . . 62.11 112.807 175.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.23 5.3 52.19 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.328 0.651 . . . . 65.12 112.081 -177.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.709 ' HG2' ' HZ1' ' D' ' 34' ' ' LYS . 9.3 pt-20 -133.69 164.55 26.97 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.991 0.516 . . . . 74.41 109.965 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 21.4 m -68.02 143.69 55.44 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.994 0.917 . . . . 74.13 111.766 178.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.591 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -91.75 -69.66 0.73 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.616 -1.624 . . . . 74.12 106.616 173.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -149.22 146.89 27.83 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 114.812 -1.086 . . . . 74.33 110.059 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.422 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 82.7 mt -110.36 145.97 36.59 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.015 -1.105 . . . . 75.33 108.015 174.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.446 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 46.6 t -156.49 147.03 21.6 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.469 0.308 . . . . 71.03 110.207 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -156.63 130.52 8.39 Favored 'General case' 0 C--N 1.345 0.373 0 C-N-CA 123.274 0.63 . . . . 74.03 109.724 168.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 92.0 t -129.76 114.45 30.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 C-N-CA 124.512 1.125 . . . . 72.21 108.52 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.488 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.5 mt-30 -90.13 88.24 7.19 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.837 0.827 . . . . 73.45 109.074 173.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.7 107.2 13.31 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 113.688 -1.596 . . . . 74.43 109.912 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' D' ' 58' ' ' VAL . . . -110.85 162.22 12.58 Favored Glycine 0 N--CA 1.465 0.625 0 O-C-N 123.032 0.208 . . . . 63.34 113.397 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.09 148.9 9.15 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-O 119.366 -0.686 . . . . 52.11 112.935 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.583 HG13 ' HB3' ' D' ' 57' ' ' GLU . 3.7 mp -89.1 136.74 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.197 -1.038 . . . . 73.24 108.197 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -132.43 129.42 39.26 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.477 1.111 . . . . 73.13 108.303 176.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 30.2 p -81.53 101.89 10.24 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.043 -0.725 . . . . 75.03 109.043 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.416 HG21 ' HD2' ' D' ' 11' ' ' PHE . 2.3 pp -119.24 121.0 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 120.749 0.309 . . . . 75.31 110.757 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.16 167.93 8.49 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.481 1.112 . . . . 42.45 111.313 174.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 99.0 19.02 23.0 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 124.046 0.841 . . . . 71.34 112.626 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' D' ' 94' ' ' MET . 0.7 OUTLIER -140.18 162.16 24.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 C-N-CA 125.157 1.383 . . . . 72.43 109.461 177.617 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.501 ' HG3' HG21 ' B' ' 149' ' ' THR . 9.4 pt-20 -147.8 -174.05 4.45 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.404 0.682 . . . . 74.32 111.386 -173.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . 0.414 ' HA2' ' HB3' ' B' ' 153' ' ' GLN . . . 78.7 -146.05 29.47 Favored Glycine 0 C--N 1.349 1.255 0 C-N-CA 124.047 0.832 . . . . 61.13 112.242 -172.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 68.0 p -94.32 -39.62 10.39 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.611 0.706 . . . . 70.53 111.027 174.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -65.61 -17.82 64.87 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.363 1.065 . . . . 75.34 113.591 -171.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.71 ' HE3' ' HA ' ' E' ' 100' ' ' LEU . 0.0 OUTLIER -57.04 -30.24 64.08 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.047 0.758 . . . . 70.41 113.047 176.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . 0.437 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -80.54 -13.97 58.63 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.486 0.714 . . . . 74.54 112.351 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -63.05 -29.83 71.12 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.072 0.549 . . . . 74.54 111.084 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . 0.464 ' SG ' ' HE3' ' D' ' 9' ' ' MET . 55.5 m -62.69 -28.3 69.84 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.387 0.675 . . . . 62.33 111.488 176.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.455 HD11 HD12 ' E' ' 102' ' ' LEU . 7.1 tt -92.41 -46.93 7.43 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.601 1.16 . . . . 61.12 110.063 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.22 -15.09 65.22 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 116.2 -0.455 . . . . 71.41 114.167 -169.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.91 -52.0 1.22 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.91 0.484 . . . . 73.31 110.685 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -73.74 -39.73 64.04 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 112.272 0.471 . . . . 74.3 112.272 -174.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 92.7 m -65.15 -46.97 73.13 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-O 118.542 -0.742 . . . . 72.41 111.638 177.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.569 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 84.2 Cg_exo -54.61 -33.77 80.42 Favored 'Trans proline' 0 C--N 1.393 2.907 0 C-N-CA 122.763 2.309 . . . . 75.43 113.661 167.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.27 -32.66 74.43 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.439 0.696 . . . . 74.0 110.978 177.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 51.1 mm -74.33 -38.37 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.284 0.633 . . . . 75.42 110.244 173.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 70.6 mt -73.65 -22.9 59.83 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.521 -0.763 . . . . 64.1 111.709 -175.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -67.55 -42.01 34.18 Favored Pre-proline 0 N--CA 1.484 1.268 0 N-CA-C 113.635 0.976 . . . . 75.23 113.635 -172.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -47.15 -44.11 24.29 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.446 2.097 . . . . 73.33 113.855 167.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -79.36 -28.28 41.97 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.921 0.888 . . . . 74.41 112.252 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . 0.541 ' HB1' HG22 ' D' ' 62' ' ' VAL . . . -64.48 -47.4 79.11 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.733 0.777 . . . . 74.24 109.451 173.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -69.04 -34.29 74.96 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 113.723 -1.58 . . . . 75.33 110.385 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . 0.504 ' HG2' HH12 ' C' ' 120' ' ' ARG . 20.5 tt0 -53.42 -49.73 66.71 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.118 0.967 . . . . 74.11 110.452 175.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.426 ' O ' ' HG3' ' D' ' 117' ' ' MET . 46.1 t -67.69 -54.4 19.8 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.701 -1.136 . . . . 73.41 110.794 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.436 HG12 ' SG ' ' D' ' 76' ' ' CYS . 52.9 mt -60.28 -58.07 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.365 0.666 . . . . 74.13 111.855 -174.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 91.5 m -51.3 -41.15 60.3 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.102 0.876 . . . . 75.32 111.769 -175.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.429 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 47.2 t -66.09 -42.12 89.75 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 114.681 -1.145 . . . . 72.14 110.078 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 66.6 mtm -69.03 -30.53 68.91 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.057 0.543 . . . . 73.44 111.981 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 95.7 t -62.97 -47.21 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.682 0.793 . . . . 72.34 109.198 174.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.3 p -74.25 -26.14 60.05 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.405 -0.816 . . . . 73.13 111.206 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' D' ' 116' ' ' SER . 88.6 mtt-85 -69.77 -32.85 71.58 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.464 0.705 . . . . 74.45 109.775 174.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.84 10.95 63.48 Favored Glycine 0 C--N 1.35 1.358 0 O-C-N 123.939 0.774 . . . . 63.02 112.501 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 70.3 p 54.79 27.04 8.32 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 126.095 1.758 . . . . 74.34 113.464 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -88.85 150.93 46.65 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 109.064 -0.717 . . . . 72.41 109.064 170.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.46 ' HA ' ' OG1' ' E' ' 129' ' ' THR . 97.2 Cg_exo -46.99 122.31 6.07 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.081 2.521 . . . . 63.35 113.53 171.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -45.62 123.19 4.1 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.682 1.593 . . . . 75.13 112.174 -175.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.436 HD12 HG22 ' D' ' 40' ' ' VAL . 20.6 tp -103.08 109.79 21.48 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.629 -0.878 . . . . 64.41 108.629 -175.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -98.93 86.54 3.5 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 107.679 -1.23 . . . . 75.24 107.679 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.411 HD11 HD13 ' D' ' 114' ' ' ILE . 96.5 mt -54.38 115.04 1.88 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.026 0.53 . . . . 71.43 110.351 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.8 135.04 95.73 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 123.693 0.62 . . . . 73.5 110.557 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.62 121.81 10.45 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.545 2.163 . . . . 74.14 111.183 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 p -108.04 137.84 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.205 1.002 . . . . 74.12 108.903 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -78.27 98.4 5.89 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.176 -0.675 . . . . 74.14 109.176 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -61.43 -47.79 84.16 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.102 0.961 . . . . 75.31 111.05 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -63.06 -30.08 71.32 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.241 -0.89 . . . . 75.43 111.07 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.475 ' HA ' ' SD ' ' D' ' 138' ' ' MET . . . -58.78 -30.43 67.57 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.885 0.874 . . . . 74.21 112.714 -177.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 7.3 mp -78.71 -37.66 40.96 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.864 0.466 . . . . 75.32 111.032 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -66.27 -31.19 71.84 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 116.31 -0.405 . . . . 71.31 110.451 175.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.475 ' SD ' ' HA ' ' D' ' 135' ' ' ALA . 45.5 mtt -67.66 -46.96 70.9 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.007 0.923 . . . . 73.41 109.593 170.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -56.17 -38.42 70.9 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 125.594 1.558 . . . . 74.41 111.507 -173.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -51.23 -40.66 59.29 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.075 1.35 . . . . 74.31 111.549 176.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 mp -82.08 -49.55 10.07 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.814 0.846 . . . . 74.52 110.781 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -91.05 40.41 1.03 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 113.365 0.876 . . . . 74.05 113.365 -168.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -119.13 85.98 2.47 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 108.935 -0.765 . . . . 65.21 108.935 171.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -165.57 111.36 0.9 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.741 -1.118 . . . . 74.25 108.996 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . 65.38 24.58 12.03 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.548 1.139 . . . . 74.35 112.664 173.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -139.38 59.9 0.58 Allowed Glycine 0 N--CA 1.476 1.319 0 N-CA-C 111.558 -0.617 . . . . 73.02 111.558 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -129.08 117.06 20.23 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.999 0.92 . . . . 64.22 110.665 -175.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 141.21 101.31 0.44 Allowed Glycine 0 C--N 1.346 1.13 0 N-CA-C 111.602 -0.599 . . . . 72.52 111.602 177.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 32.3 p -129.99 151.55 50.42 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.533 1.133 . . . . 52.33 109.282 174.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -128.21 143.29 51.03 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.995 0.518 . . . . 74.41 111.343 -176.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.83 153.0 14.13 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 106.883 -1.525 . . . . 73.24 106.883 176.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -50.43 -53.85 26.39 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.887 0.875 . . . . 72.32 111.178 176.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? 59.33 88.52 0.07 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.732 1.213 . . . . 64.3 109.769 -173.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -120.01 -51.33 2.23 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.123 -0.944 . . . . 74.42 109.406 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 C-N-CA 123.971 0.908 . . . . 74.2 109.378 -178.297 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.472 0 N-CA-C 111.648 -0.581 . . . . 62.24 111.648 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 168.55 -116.01 0.64 Allowed Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.058 -0.817 . . . . 73.33 111.058 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -96.08 179.62 5.0 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.802 0.841 . . . . 73.43 109.872 175.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -89.89 -74.15 0.49 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 122.642 0.377 . . . . 71.31 111.065 -167.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -141.47 -56.62 0.48 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.691 0.796 . . . . 72.21 111.237 -173.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 127.91 75.15 0.19 Allowed Glycine 0 C--N 1.349 1.25 0 N-CA-C 111.184 -0.766 . . . . 73.25 111.184 -170.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 97' ' ' ILE . . . . . 0.561 HG21 ' HH ' ' D' ' 56' ' ' TYR . 4.3 tt -55.48 -28.31 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 125.449 1.5 . . . . 72.14 112.113 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 32.4 t70 78.58 -88.11 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 114.292 1.219 . . . . 73.32 114.292 160.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -100.75 102.41 13.5 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 118.241 0.473 . . . . 71.12 111.083 -168.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 100' ' ' LEU . . . . . 0.71 ' HA ' ' HE3' ' D' ' 94' ' ' MET . 4.2 mp -111.38 142.15 25.87 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.776 0.83 . . . . 74.31 109.144 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.46 -15.29 29.4 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 123.436 2.757 . . . . 74.24 114.929 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 102' ' ' LEU . . . . . 0.455 HD12 HD11 ' D' ' 98' ' ' LEU . 1.4 pp -108.96 -13.21 14.77 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.63 0.772 . . . . 75.22 112.906 -173.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 103' ' ' THR . . . . . 0.583 HG23 ' HB2' ' E' ' 100' ' ' LEU . 58.0 p -76.21 -36.2 58.71 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.061 0.458 . . . . 73.24 109.781 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.59 151.81 16.95 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.242 -1.143 . . . . 74.24 110.242 167.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 67.17 11.52 8.43 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.138 0.975 . . . . 75.05 111.781 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 31.1 t80 65.91 -177.16 0.19 Allowed 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 123.97 0.908 . . . . 73.15 109.84 -175.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 17.5 p -58.74 -19.45 40.39 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.455 0.702 . . . . 73.13 112.679 176.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 68.86 -76.49 0.06 Allowed 'General case' 0 C--N 1.358 0.955 0 C-N-CA 125.287 1.435 . . . . 55.14 111.556 172.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -98.16 63.2 1.57 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.652 -1.24 . . . . 74.0 107.652 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.54 156.89 15.36 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 114.968 -1.015 . . . . 71.34 110.888 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . . . . . . . . . 19.1 tp -38.71 -64.2 0.46 Allowed 'General case' 0 N--CA 1.476 0.873 0 O-C-N 125.519 1.762 . . . . 75.05 113.4 -165.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -114.41 76.24 0.98 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.463 -0.94 . . . . 63.22 108.463 174.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -140.44 -68.02 0.42 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.344 0.658 . . . . 74.01 109.556 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -147.9 43.72 1.07 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.677 -0.692 . . . . 75.42 109.924 -172.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 20.3 p -90.45 52.37 2.21 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.652 0.781 . . . . 74.45 109.984 174.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.34 -91.12 0.38 Allowed Glycine 0 C--N 1.353 1.507 0 N-CA-C 110.691 -0.964 . . . . 44.44 110.691 -172.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -127.59 96.76 32.12 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 124.256 1.022 . . . . 72.13 108.255 171.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -75.18 72.84 4.62 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 123.128 2.552 . . . . 75.32 113.055 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -95.06 177.0 6.02 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 107.989 -1.115 . . . . 50.43 107.989 173.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 60.1 t80 80.07 -46.04 0.3 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 125.461 1.504 . . . . 74.01 110.979 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 121' ' ' VAL . . . . . 0.584 HG23 HD12 ' D' ' 44' ' ' LEU . 14.6 p -63.25 -26.61 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 C-N-CA 125.234 1.414 . . . . 74.35 111.768 170.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 62.6 p -70.37 -15.42 62.85 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.418 1.087 . . . . 74.24 111.625 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -108.66 158.39 17.64 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.128 0.971 . . . . 65.4 110.548 -173.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 70.4 m -149.96 -61.14 0.21 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.994 0.917 . . . . 73.3 108.673 171.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . 60.57 -154.65 0.36 Allowed 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.088 0.868 . . . . 72.11 109.602 -172.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . 68.24 103.62 0.05 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.878 0.871 . . . . 73.24 111.867 171.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 127' ' ' SER . . . . . 0.401 ' HB3' ' OE1' ' D' ' 37' ' ' GLN . 33.3 t -162.02 132.49 4.9 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.036 0.535 . . . . 54.51 110.204 -174.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -160.38 125.23 3.81 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.184 0.516 . . . . 64.44 111.529 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 129' ' ' THR . . . . . 0.46 ' OG1' ' HA ' ' D' ' 124' ' ' PRO . 0.6 OUTLIER -148.76 170.78 17.45 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.707 1.603 . . . . 74.4 108.832 174.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 130' ' ' ALA . . . . . 0.496 ' HB2' ' HD3' ' A' ' 124' ' ' PRO . . . -119.19 21.78 12.12 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.651 -0.704 . . . . 70.21 110.266 176.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 131' ' ' TRP . . . . . 0.55 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 47.8 t90 -62.26 113.59 2.98 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 123.394 0.678 . . . . 75.35 111.306 -176.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 47.7 p -161.82 16.82 0.1 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.77 0.828 . . . . 73.1 111.631 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 2.4 p -88.5 126.85 35.45 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.831 0.452 . . . . 74.22 111.785 -176.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -92.1 -13.37 57.67 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 115.335 -0.848 . . . . 73.4 111.78 169.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 47.3 t 53.33 81.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.232 0 C-N-CA 125.804 1.642 . . . . 73.42 112.426 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 136' ' ' LYS . . . . . 0.469 ' HG2' HE22 ' C' ' 14' ' ' GLN . 21.2 mtpp -140.47 101.1 4.03 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 107.921 -1.14 . . . . 54.1 107.921 176.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 14.3 t -144.66 13.31 1.52 Allowed 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.819 0.674 . . . . 72.21 112.819 -168.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -147.82 -49.38 0.17 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.639 -0.504 . . . . 73.33 109.639 -177.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 139' ' ' ASN . . . . . 0.433 ' ND2' ' HA ' ' C' ' 10' ' ' THR . 35.0 t-20 -134.98 146.18 48.82 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.319 -0.993 . . . . 71.24 108.319 178.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.41 -92.05 1.97 Allowed Glycine 0 C--N 1.342 0.868 0 CA-C-N 116.739 -0.21 . . . . 54.52 113.379 -173.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 141' ' ' ALA . . . . . 0.579 ' HA ' HG22 ' C' ' 10' ' ' THR . . . -171.28 -174.88 1.54 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.194 1.398 . . . . 73.34 109.071 -177.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 37.8 tp -130.64 -65.9 0.78 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.72 0.408 . . . . 74.14 110.761 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . 130.02 50.56 0.11 Allowed Glycine 0 N--CA 1.472 1.067 0 N-CA-C 111.213 -0.755 . . . . 54.11 111.213 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 6.1 m -83.09 158.43 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.854 0.862 . . . . 75.04 111.291 -174.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 CA--C 1.548 0.867 0 C-N-CA 123.372 0.669 . . . . 74.14 109.453 178.362 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 CA-C-O 119.805 -0.442 . . . . 62.13 112.128 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 103.96 50.6 1.0 Allowed Glycine 0 C--N 1.35 1.325 0 N-CA-C 111.866 -0.494 . . . . 74.41 111.866 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -84.64 144.76 28.39 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.042 0.937 . . . . 75.11 109.73 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -148.46 175.89 10.76 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.115 0.966 . . . . 74.02 110.664 -176.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -127.54 145.14 50.96 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.394 1.077 . . . . 74.51 109.147 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -175.89 -66.56 0.06 OUTLIER Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.163 -0.775 . . . . 71.2 111.163 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 97' ' ' ILE . . . . . . . . . . . . . 25.0 pt -95.67 116.61 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.934 0.893 . . . . 75.52 111.468 -177.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -86.26 151.26 23.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.783 0.833 . . . . 72.42 110.157 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 99' ' ' ALA . . . . . 0.485 ' O ' ' HD3' ' F' ' 101' ' ' PRO . . . 56.6 100.7 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.773 1.229 . . . . 72.31 112.508 174.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 100' ' ' LEU . . . . . . . . . . . . . 5.4 mp -107.36 78.05 0.62 Allowed Pre-proline 0 CA--C 1.566 1.582 0 C-N-CA 124.465 1.106 . . . . 74.42 109.579 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 101' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' F' ' 99' ' ' ALA . 33.8 Cg_endo -101.21 29.5 0.1 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.707 2.938 . . . . 63.31 113.909 -167.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 71.69 -60.53 0.52 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.238 1.415 . . . . 75.32 110.61 -174.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -163.18 -42.43 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.469 1.508 . . . . 73.51 106.94 168.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . -167.41 -43.76 0.03 OUTLIER Glycine 0 C--N 1.343 0.938 0 CA-C-N 114.778 -1.101 . . . . 73.41 110.475 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -102.17 169.16 8.9 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.646 0.778 . . . . 60.1 110.306 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 106' ' ' TYR . . . . . 0.468 ' CE1' ' HA ' ' B' ' 47' ' ' ALA . 21.9 t80 -70.74 -37.07 73.42 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.876 1.27 . . . . 74.52 110.834 -175.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 14.2 m -100.77 16.25 25.64 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.254 1.022 . . . . 75.34 109.786 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 108' ' ' HIS . . . . . 0.543 ' NE2' ' HA3' ' B' ' 99' ' ' GLY . 43.7 m-70 67.0 -73.81 0.07 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.907 1.283 . . . . 74.14 109.346 -171.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -144.77 -57.73 0.35 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 107.607 -1.257 . . . . 72.34 107.607 171.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -148.39 142.14 25.63 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.977 -1.01 . . . . 75.24 110.01 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 48.1 tp -167.52 -48.49 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 106.215 -1.772 . . . . 72.13 106.215 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -91.58 164.36 13.8 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 113.659 -1.61 . . . . 71.24 107.282 158.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -60.65 133.91 56.56 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.568 0.747 . . . . 74.52 110.151 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -126.4 165.8 18.38 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 124.689 1.196 . . . . 74.44 109.437 175.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 7.8 t -73.19 91.64 1.67 Allowed 'General case' 0 CA--C 1.555 1.136 0 CA-C-O 121.75 0.786 . . . . 73.54 111.107 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.23 60.99 4.47 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.067 -0.969 . . . . 73.4 112.96 174.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -133.07 102.37 13.27 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 122.901 0.48 . . . . 73.3 109.88 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.42 102.46 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 123.07 2.514 . . . . 75.03 111.652 170.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -104.29 164.99 11.34 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.768 0.827 . . . . 71.25 110.302 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 120' ' ' TYR . . . . . 0.605 ' HB3' ' HG ' ' B' ' 136' ' ' LEU . 43.8 t80 -53.28 -44.53 68.32 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.305 1.442 . . . . 62.14 111.576 176.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 58.8 t -74.42 96.17 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 122.929 0.492 . . . . 62.5 110.149 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 5.9 t -81.26 -56.48 4.04 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 108.411 -0.959 . . . . 74.14 108.411 167.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -179.83 136.7 0.12 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.021 1.329 . . . . 75.4 108.538 172.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 55.5 m -153.33 125.93 8.2 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.562 0.745 . . . . 74.54 109.856 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -161.73 149.89 15.13 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.894 0.878 . . . . 71.43 109.461 175.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.06 141.7 28.42 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.181 0.593 . . . . 74.05 110.029 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 31.1 p -74.12 116.57 14.91 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.65 0.78 . . . . 63.33 109.647 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.51 127.88 33.6 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.628 0.771 . . . . 74.51 111.042 -177.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 39.6 p -81.62 139.53 34.95 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 122.536 0.334 . . . . 74.11 110.341 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.35 131.58 51.22 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 123.964 0.905 . . . . 54.03 110.498 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 131' ' ' TRP . . . . . 0.431 ' H ' ' HE3' ' F' ' 131' ' ' TRP . 1.0 OUTLIER -120.3 151.49 39.13 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.942 0.897 . . . . 75.05 110.222 -164.581 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 29.3 t -167.93 135.02 2.17 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.152 -0.685 . . . . 63.13 109.152 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 133' ' ' THR . . . . . 0.573 ' HA ' HD12 ' C' ' 126' ' ' LEU . 20.7 m -78.64 102.55 8.05 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.575 -0.898 . . . . 73.11 108.575 173.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -82.89 32.69 2.93 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 116.15 -0.477 . . . . 71.1 113.993 -173.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 28.0 m -70.79 126.79 31.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 108.854 -0.795 . . . . 64.04 108.854 174.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -73.65 -27.97 61.54 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 111.962 0.356 . . . . 70.22 111.962 -169.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 43.0 m -142.42 101.41 3.89 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.789 0.435 . . . . 75.45 111.028 -174.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -176.53 -54.15 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.36 1.038 . . . . 70.13 110.274 163.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -116.36 158.4 23.53 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.195 0.598 . . . . 64.21 110.758 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -73.64 136.55 22.18 Favored Glycine 0 C--N 1.346 1.11 0 N-CA-C 111.507 -0.637 . . . . 44.24 111.507 174.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -139.55 132.66 29.63 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.902 0.881 . . . . 74.21 109.55 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.93 106.68 5.12 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.48 0.712 . . . . 73.15 110.195 -176.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -83.93 62.45 4.59 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-N 115.975 -0.557 . . . . 61.32 111.837 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 16.3 m -68.39 120.26 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 C-N-CA 123.833 0.853 . . . . 71.43 110.696 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 34.1 t70 . . . . . 0 C--O 1.249 1.059 0 C-N-CA 123.385 0.674 . . . . 71.4 109.939 -176.157 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.828 -0.434 . . . . 73.51 109.828 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.7 p -131.05 115.6 16.67 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.957 -0.757 . . . . 73.02 108.957 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -131.98 42.96 3.09 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.64 0.733 . . . . 72.01 109.96 -177.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -86.66 19.42 2.91 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 115.177 -0.92 . . . . 75.44 111.731 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.455 ' HA ' ' HB3' ' A' ' 87' ' ' ALA . 26.9 t-20 -61.16 100.03 0.11 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.827 0.851 . . . . 72.41 110.048 174.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.463 ' O ' ' HA2' ' A' ' 88' ' ' GLY . 26.7 t-20 -137.86 150.73 47.39 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 108.329 -0.989 . . . . 74.2 108.329 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.4 p -54.19 80.56 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 124.686 1.194 . . . . 65.23 113.695 -173.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 172.68 115.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 128.855 2.862 . . . . 74.11 105.459 177.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.501 ' HG2' HD12 ' A' ' 89' ' ' ILE . 13.8 tmm? -71.52 145.38 49.18 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.93 0.395 . . . . 74.12 111.004 -173.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.2 m -139.39 124.95 19.32 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 124.002 0.921 . . . . 72.1 108.929 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.408 ' CD1' HD13 ' A' ' 86' ' ' ILE . 89.5 t80 -120.38 120.68 36.68 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.295 1.038 . . . . 73.2 108.761 -177.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -140.45 135.33 31.9 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.993 0.517 . . . . 74.13 109.756 173.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.617 HD12 HG21 ' A' ' 105' ' ' ILE . 3.6 mt -92.77 115.26 31.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 108.349 -0.982 . . . . 74.41 108.349 173.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.67 -40.25 29.52 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.235 -0.654 . . . . 74.12 109.235 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -176.21 122.93 0.17 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 123.146 0.279 . . . . 74.22 110.706 -171.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 79.4 mt -105.61 136.76 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.833 -0.802 . . . . 70.24 108.833 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.457 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 33.2 p90 -169.76 155.43 5.85 Favored 'General case' 0 C--N 1.346 0.42 0 O-C-N 124.197 0.936 . . . . 71.54 110.704 -173.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -83.28 121.94 27.78 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.513 -0.767 . . . . 75.12 109.475 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.457 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.5 mtpt -84.71 -26.7 27.51 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.71 -0.478 . . . . 73.01 109.71 175.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.583 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 11.0 t70 -153.49 143.44 22.07 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 114.63 -1.168 . . . . 43.4 109.837 -178.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.461 HD11 ' SD ' ' B' ' 117' ' ' MET . 91.5 mt -143.63 142.2 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.498 1.519 . . . . 63.41 107.857 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.9 t -149.97 133.22 16.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.289 0.635 . . . . 74.13 109.839 172.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -125.58 140.44 52.74 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 107.014 -1.476 . . . . 73.21 107.014 169.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -142.01 108.5 5.32 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.586 0.755 . . . . 75.34 109.042 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.57 ' HB1' ' HB3' ' A' ' 28' ' ' ALA . . . -106.96 85.65 2.03 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 106.639 -1.615 . . . . 73.15 106.639 165.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.55 -38.79 5.65 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.392 2.061 . . . . 73.42 112.177 -169.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -111.22 31.41 6.1 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.871 0.869 . . . . 64.22 108.867 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.57 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . . . -47.13 -54.72 18.98 Favored Pre-proline 0 N--CA 1.493 1.678 0 CA-C-O 117.693 -1.146 . . . . 64.15 113.72 -173.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -61.25 -28.2 84.5 Favored 'Trans proline' 0 C--N 1.401 3.334 0 C-N-CA 121.888 1.725 . . . . 74.41 112.667 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.503 ' HA ' ' NE2' ' A' ' 33' ' ' GLN . 9.0 t60 -90.64 -31.8 16.49 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.741 1.216 . . . . 54.21 112.055 -173.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.625 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.9 p -79.22 -21.4 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 120.875 0.369 . . . . 74.2 111.142 -171.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -73.58 -6.2 45.12 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 115.991 -0.55 . . . . 73.41 111.025 172.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.503 ' NE2' ' HA ' ' A' ' 30' ' ' HIS . 9.9 mt-30 -88.8 -28.98 20.07 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.925 0.89 . . . . 73.22 110.202 172.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.434 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 14.5 mmmm -77.0 157.58 31.1 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.636 0.774 . . . . 74.25 110.929 -176.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.78 119.37 9.2 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.438 0.695 . . . . 75.11 110.464 174.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.463 ' CE3' HD21 ' A' ' 68' ' ' LEU . 67.2 t-105 -81.6 87.69 6.25 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.49 0.662 . . . . 73.51 111.393 -175.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.429 ' H ' HD23 ' A' ' 68' ' ' LEU . 35.7 tt0 -124.1 82.93 56.25 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 124.652 1.181 . . . . 74.23 107.869 171.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.34 121.17 7.52 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.762 2.308 . . . . 73.2 113.257 -170.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -97.19 89.36 4.75 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.829 -0.804 . . . . 74.21 108.829 172.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.547 HG12 HD13 ' A' ' 126' ' ' LEU . 48.8 t -79.66 111.76 16.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-N 114.846 -1.07 . . . . 73.22 110.109 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -99.03 123.49 43.36 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.076 -0.713 . . . . 74.45 109.076 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 84.6 mt -99.31 108.48 21.02 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.515 0.726 . . . . 73.44 109.665 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.638 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 11.2 m-20 -104.72 106.07 16.41 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.418 -1.327 . . . . 54.33 107.418 170.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.408 HD11 ' CZ ' ' A' ' 133' ' ' PHE . 79.4 mt -106.95 117.31 33.71 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.04 -0.726 . . . . 73.12 109.04 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -122.62 130.77 53.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.882 -1.525 . . . . 60.15 106.882 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.9 m -108.35 136.0 48.73 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.69 -0.485 . . . . 70.45 109.69 177.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.38 109.93 6.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.127 0.971 . . . . 74.31 108.966 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 79.2 p -94.96 158.79 15.32 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.97 0.508 . . . . 74.5 109.955 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.0 t -148.74 119.96 7.8 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.519 -0.919 . . . . 75.12 108.519 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -81.88 115.87 21.27 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.365 -0.606 . . . . 75.1 109.365 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.0 mt -80.56 -42.42 22.39 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.532 0.733 . . . . 75.24 110.516 -176.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.67 -179.61 7.57 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.023 0.929 . . . . 74.34 110.139 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -60.73 121.48 12.37 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.673 0.789 . . . . 73.55 109.903 170.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 65.84 -2.56 0.88 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.381 1.472 . . . . 72.13 112.974 -176.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.0 t -104.68 105.1 17.94 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 N-CA-C 108.158 -1.053 . . . . 74.1 108.158 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -107.64 162.66 13.77 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.562 -0.903 . . . . 71.51 108.562 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -131.77 153.3 50.24 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 107.444 -1.317 . . . . 73.14 107.444 168.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.443 HG11 ' HD3' ' A' ' 103' ' ' PRO . 68.0 t -133.48 136.41 54.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 107.513 -1.291 . . . . 74.32 107.513 173.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.433 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 47.9 t -119.82 133.58 66.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.831 -0.803 . . . . 75.41 108.831 174.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.419 HD22 HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -104.01 100.07 9.84 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 106.564 -1.643 . . . . 74.33 106.564 177.012 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -82.97 99.21 9.66 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.867 -1.16 . . . . 74.02 107.867 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.478 HG21 ' HB1' ' A' ' 110' ' ' ALA . 47.2 t -98.96 130.57 47.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 N-CA-C 108.353 -0.98 . . . . 73.24 108.353 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.638 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 9.3 m -127.36 107.76 10.25 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.731 -0.84 . . . . 75.14 108.731 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.638 HG13 HD21 ' A' ' 126' ' ' LEU . 54.1 t -101.24 128.23 53.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 124.547 1.139 . . . . 74.24 108.275 174.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.8 m -131.44 116.89 18.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.816 -0.809 . . . . 73.52 108.816 172.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.53 119.43 39.15 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.61 -1.256 . . . . 71.14 107.61 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -127.7 142.31 51.36 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.515 0.674 . . . . 74.42 110.597 -177.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.463 HD21 ' CE3' ' A' ' 36' ' ' TRP . 50.4 mt -91.18 61.19 4.45 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.262 1.425 . . . . 72.14 107.927 170.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.2 -98.28 1.47 Allowed Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.198 -0.91 . . . . 61.14 112.684 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -88.35 -29.6 20.18 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.128 0.971 . . . . 73.11 110.287 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.434 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 5.1 tp10 -85.88 101.17 12.62 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.149 -0.932 . . . . 75.05 108.954 -174.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.4 m -68.16 124.27 22.98 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 119.291 0.951 . . . . 75.13 108.559 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.625 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -79.81 -54.52 5.76 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.17 -0.923 . . . . 74.3 108.853 -177.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -155.34 162.23 40.88 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.276 -0.874 . . . . 71.52 111.527 176.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.0 tp -131.14 118.44 20.49 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 113.765 -1.561 . . . . 72.42 107.498 175.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 85.3 m -115.3 126.89 55.02 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.595 -0.891 . . . . 74.31 108.595 175.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -139.18 115.77 10.65 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.32 -0.622 . . . . 72.4 109.32 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.4 t -125.64 112.35 30.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.42 1.088 . . . . 71.14 109.047 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 4.2 mt-30 -84.62 84.89 7.52 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.505 -0.924 . . . . 74.31 108.505 169.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -76.7 96.85 4.3 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 114.681 -1.145 . . . . 73.21 108.941 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -84.91 160.8 35.69 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.88 -0.488 . . . . 45.04 111.88 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.486 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -156.49 125.05 1.54 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.186 -1.166 . . . . 72.22 110.186 174.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.418 HG13 ' HE1' ' A' ' 17' ' ' TYR . 65.1 mt -79.79 124.66 38.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.893 -1.151 . . . . 73.32 107.893 171.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.604 ' HB3' HD11 ' A' ' 86' ' ' ILE . 96.3 m-85 -125.03 119.42 28.63 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.889 -0.782 . . . . 73.35 108.889 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.7 t -89.14 90.99 8.62 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.249 -1.019 . . . . 63.45 108.249 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 84' ' ' PHE . 13.1 mm -116.87 148.69 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 121.205 0.526 . . . . 74.24 110.816 -169.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 5' ' ' ASN . . . -163.56 171.06 16.34 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.735 -1.12 . . . . 73.51 110.114 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 6' ' ' ASN . . . 106.24 -32.89 6.89 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.239 -0.437 . . . . 72.41 112.92 177.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.501 HD12 ' HG2' ' A' ' 9' ' ' MET . 0.2 OUTLIER -121.39 169.0 13.25 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 124.278 1.031 . . . . 74.51 110.1 -175.227 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.433 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 12.6 tt0 -156.85 174.9 14.81 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 124.133 0.895 . . . . 74.54 109.07 176.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.43 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 59.73 -114.03 5.89 Favored Glycine 0 C--N 1.343 0.957 0 CA-C-N 115.69 -0.686 . . . . 70.03 114.293 176.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.4 p -71.36 -41.54 69.59 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.62 1.168 . . . . 75.43 112.217 -174.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -71.2 -34.77 71.18 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.067 0.547 . . . . 61.42 110.279 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.433 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 5.8 tpt -66.67 -42.52 86.43 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 123.469 0.481 . . . . 73.41 110.098 174.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.98 -35.08 79.51 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.373 0.669 . . . . 72.4 111.005 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.56 ' HE1' ' HG2' ' C' ' 147' ' ' GLU . 52.9 t-80 -71.71 -28.28 63.58 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.663 0.785 . . . . 71.51 110.777 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.7 t -76.19 -50.49 14.38 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.461 -0.57 . . . . 63.25 109.461 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 87.1 mt -75.98 -23.96 55.34 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.532 0.733 . . . . 75.22 112.515 -173.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.09 3.52 22.46 Favored Glycine 0 N--CA 1.473 1.139 0 CA-C-O 119.553 -0.582 . . . . 73.41 113.952 -171.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.41 -63.24 0.4 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 117.541 0.67 . . . . 72.43 111.276 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -68.62 -46.19 69.9 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.175 0.59 . . . . 74.31 111.777 -170.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 80.3 m -70.49 -47.41 18.53 Favored Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 124.235 1.014 . . . . 73.34 112.928 -176.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.443 ' HD3' HG11 ' A' ' 58' ' ' VAL . 51.5 Cg_endo -67.08 -18.66 51.59 Favored 'Trans proline' 0 C--N 1.394 2.967 0 CA-C-N 121.462 1.558 . . . . 75.13 112.461 174.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.77 -35.23 67.39 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.055 0.542 . . . . 73.44 109.74 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.617 HG21 HD12 ' A' ' 13' ' ' ILE . 39.1 mm -65.42 -44.38 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.849 0.859 . . . . 73.12 110.113 170.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.486 HD22 ' HA3' ' A' ' 82' ' ' GLY . 75.7 mt -71.49 -15.8 62.33 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.445 -0.798 . . . . 75.24 111.904 -175.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -70.03 -44.98 22.28 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 114.748 1.388 . . . . 72.31 114.748 -170.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.97 -32.14 84.66 Favored 'Trans proline' 0 C--N 1.384 2.437 0 CA-C-N 122.285 1.852 . . . . 74.43 112.314 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -76.84 -41.28 44.74 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.69 0.796 . . . . 65.13 111.65 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.478 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -66.44 -49.44 66.71 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.033 0.533 . . . . 75.3 109.749 178.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.458 ' NH1' HD13 ' C' ' 105' ' ' ILE . 30.5 ttm180 -46.8 -51.67 15.9 Favored 'General case' 0 C--N 1.353 0.761 0 O-C-N 125.258 1.599 . . . . 73.44 110.716 173.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -67.39 -43.78 80.5 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.316 1.01 . . . . 73.45 111.982 -175.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.547 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.7 t -57.68 -42.6 83.94 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.932 0.77 . . . . 74.03 110.122 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.609 HD13 HD12 ' A' ' 128' ' ' LEU . 96.5 mt -64.33 -54.84 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 114.451 -1.25 . . . . 70.2 110.253 175.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.5 m -56.59 -37.29 70.43 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.258 0.974 . . . . 72.2 111.567 -173.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.0 t -68.81 -47.9 64.92 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.664 -1.153 . . . . 74.34 110.096 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 8.6 mtp -57.12 -37.71 72.38 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.615 0.766 . . . . 75.14 111.664 175.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.3 t -67.48 -49.16 73.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.378 1.071 . . . . 75.22 110.461 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.8 p -70.44 -33.19 71.03 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.018 0.527 . . . . 75.12 111.076 -175.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.532 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.9 mtt-85 -69.48 -31.97 70.57 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.959 0.904 . . . . 75.11 109.67 172.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.84 6.08 49.74 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-O 119.304 -0.72 . . . . 73.31 113.688 174.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.553 HG21 ' HE ' ' B' ' 15' ' ' ARG . 18.1 m 73.15 7.29 5.32 Favored 'General case' 0 C--N 1.367 1.345 0 C-N-CA 125.147 1.379 . . . . 71.03 112.152 176.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -86.51 137.53 34.24 Favored Pre-proline 0 C--O 1.24 0.568 0 N-CA-C 107.197 -1.409 . . . . 71.33 107.197 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -54.67 165.87 2.25 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 123.416 2.744 . . . . 70.11 113.855 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.556 ' HG2' ' HB2' ' C' ' 15' ' ' ARG . 40.6 tp60 -52.88 117.8 3.22 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 114.534 -1.212 . . . . 75.53 111.877 -172.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.638 HD21 HG13 ' A' ' 64' ' ' VAL . 25.5 tp -113.6 114.39 26.39 Favored 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 109.175 -0.676 . . . . 71.31 109.175 173.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.414 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 5.7 m-80 -110.03 125.69 53.18 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 106.152 -1.795 . . . . 65.11 106.152 176.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.609 HD12 HD13 ' A' ' 114' ' ' ILE . 10.9 mt -72.09 144.18 48.78 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 109.173 -0.677 . . . . 65.31 109.173 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.18 138.64 91.51 Favored Pre-proline 0 N--CA 1.48 1.059 0 CA-C-O 118.864 -0.588 . . . . 73.44 111.011 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -55.09 108.17 0.29 Allowed 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.519 2.146 . . . . 75.04 111.849 168.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 75.4 t -104.18 137.17 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.078 0.951 . . . . 71.54 111.634 -173.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.433 ' ND2' ' HG2' ' C' ' 3' ' ' GLU . 50.9 t-20 -89.53 97.29 11.11 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.791 -1.095 . . . . 70.14 108.656 170.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.408 ' CZ ' HD11 ' A' ' 44' ' ' LEU . 57.2 m-85 -70.49 -18.58 62.96 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 112.827 0.677 . . . . 74.42 112.827 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -69.6 -40.02 76.9 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.45 -0.945 . . . . 63.43 108.45 174.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.07 -46.22 85.28 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.5 0.72 . . . . 72.55 110.942 174.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.425 ' HA ' ' ND2' ' A' ' 139' ' ' ASN . 56.9 mt -62.87 -33.58 75.58 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 123.748 0.655 . . . . 73.01 111.044 178.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.421 ' CE2' HD11 ' A' ' 141' ' ' LEU . 74.6 t80 -68.18 -45.02 74.6 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.507 -0.77 . . . . 74.23 109.808 176.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.406 ' HA ' ' HB3' ' A' ' 141' ' ' LEU . 74.9 mtp -64.03 -25.37 68.09 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 123.783 0.677 . . . . 75.43 112.011 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.425 ' ND2' ' HA ' ' A' ' 136' ' ' LEU . 69.6 m-20 -64.38 -53.91 41.09 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.971 -0.751 . . . . 73.51 108.971 171.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -65.6 -31.3 72.27 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 115.648 -0.706 . . . . 74.0 111.759 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.421 HD11 ' CE2' ' A' ' 137' ' ' PHE . 49.7 tp -68.37 -40.95 81.24 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.183 1.393 . . . . 74.04 111.98 -171.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -167.39 -13.42 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.141 0 O-C-N 123.682 0.614 . . . . 73.24 112.231 -173.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 59.36 80.08 0.21 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.069 0.948 . . . . 65.22 110.494 -169.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.501 ' NE2' ' HG2' ' C' ' 150' ' ' GLU . 26.0 pt20 -149.96 1.8 0.5 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.258 0.623 . . . . 74.45 111.366 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.02 164.22 17.5 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.052 0.541 . . . . 71.52 110.439 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -154.94 164.97 32.01 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.553 -0.749 . . . . 71.0 111.694 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -72.18 153.4 41.64 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.206 0.602 . . . . 55.13 109.49 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -128.75 84.76 0.32 Allowed Glycine 0 C--N 1.34 0.752 0 N-CA-C 111.429 -0.668 . . . . 44.53 111.429 -177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.1 m -73.97 148.9 41.69 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.674 0.79 . . . . 72.35 109.08 170.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.3 153.02 4.13 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.431 1.092 . . . . 63.35 113.517 -175.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -63.53 -63.45 1.17 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.33 1.052 . . . . 74.32 109.838 176.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -167.28 86.56 0.26 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.855 -1.165 . . . . 75.23 107.855 171.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -61.61 88.62 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.353 1.061 . . . . 72.35 109.591 175.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -68.59 -39.32 80.97 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.942 0.897 . . . . 74.4 111.276 -171.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.244 0 N-CA-C 108.313 -0.995 . . . . 72.13 108.313 174.518 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.418 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 109.599 -0.519 . . . . 71.52 109.599 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 14.4 t -167.7 32.15 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.407 0.683 . . . . 72.44 110.996 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -75.41 79.33 2.46 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.627 0.771 . . . . 74.12 110.368 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 64.06 -0.97 0.74 Allowed 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 124.745 1.218 . . . . 63.15 113.152 173.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -65.95 124.17 21.8 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.086 0.954 . . . . 74.2 110.273 -173.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . 0.285 30.1 p30 45.33 -68.7 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 126.026 2.079 . . . . 75.24 114.514 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 44.3 m 66.67 104.93 0.04 OUTLIER 'General case' 0 C--N 1.353 0.732 0 C-N-CA 125.29 1.436 . . . . 72.51 111.241 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -58.47 -21.91 53.0 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.468 -0.787 . . . . 74.12 111.851 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 1.4 tmt? 67.83 168.72 0.26 Allowed 'General case' 0 C--N 1.364 1.202 0 C-N-CA 125.138 1.375 . . . . 74.23 110.772 172.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.1 t -143.38 99.14 3.38 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.135 0.969 . . . . 62.33 109.373 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.452 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 54.1 t80 -112.63 141.0 46.92 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.334 -1.303 . . . . 75.23 107.684 173.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -147.55 134.14 19.85 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.764 -0.458 . . . . 73.2 109.764 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.415 HG13 ' HD3' ' D' ' 130' ' ' PRO . 41.4 mt -80.66 116.47 24.95 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 N-CA-C 107.011 -1.477 . . . . 62.34 107.011 170.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -90.06 -37.55 14.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.973 -0.751 . . . . 73.43 108.973 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.553 ' HE ' HG21 ' A' ' 122' ' ' THR . 11.7 ttt85 -168.92 151.88 5.07 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 123.611 0.569 . . . . 71.4 110.812 -177.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 53.8 mt -135.16 135.87 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 106.668 -1.604 . . . . 71.55 106.668 171.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.483 ' HE1' HG13 ' B' ' 83' ' ' ILE . 10.9 p90 -166.34 143.03 4.98 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.281 0.563 . . . . 73.01 111.79 -173.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 41.2 m -74.24 121.39 21.19 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.81 -1.086 . . . . 74.12 108.971 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.438 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.5 mtpt -98.51 -17.09 18.91 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.363 0.665 . . . . 74.52 110.979 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.416 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 3.2 t70 -163.67 145.36 9.3 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.83 0.852 . . . . 74.03 110.418 -177.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.511 HD11 HG12 ' B' ' 78' ' ' VAL . 39.4 mm -133.13 144.93 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 107.618 -1.253 . . . . 73.51 107.618 170.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 39.2 t -143.94 135.82 26.32 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.792 -0.818 . . . . 74.11 108.792 174.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.459 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.6 t80 -149.53 114.55 5.42 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 107.402 -1.333 . . . . 74.21 107.402 170.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -126.17 114.3 18.17 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.102 -1.073 . . . . 75.24 108.102 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.85 88.82 3.83 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 107.912 -1.144 . . . . 73.31 107.912 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.55 -33.33 46.33 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.723 2.282 . . . . 74.55 112.295 -172.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -106.32 7.96 31.53 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.075 0.95 . . . . 74.24 111.613 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -33.26 -64.03 0.27 Allowed Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 115.662 1.727 . . . . 74.11 115.662 -167.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -60.72 -32.58 93.23 Favored 'Trans proline' 0 C--N 1.4 3.272 0 C-N-CA 122.438 2.092 . . . . 65.34 112.914 -170.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -94.77 -39.58 10.21 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 114.664 -1.153 . . . . 75.32 111.583 -170.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.659 HG23 HD13 ' B' ' 68' ' ' LEU . 7.4 p -66.32 -19.41 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.052 0.541 . . . . 72.34 111.925 -172.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -60.47 -21.63 62.57 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.015 0.926 . . . . 75.23 113.312 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -63.9 -18.27 64.03 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.346 0.658 . . . . 75.52 111.766 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.555 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 95.6 mttt -94.06 105.29 17.29 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.256 1.022 . . . . 75.25 109.142 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -100.52 79.58 2.12 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.477 0.711 . . . . 64.43 110.441 -172.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 46.5 p90 -154.41 167.84 28.67 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.824 -1.176 . . . . 74.14 107.824 165.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 22.9 tm0? -76.51 115.44 47.64 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 107.7 -1.222 . . . . 74.3 107.7 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.27 154.38 52.84 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.982 2.455 . . . . 74.33 114.285 -170.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -66.41 115.94 6.87 Favored 'General case' 0 C--N 1.347 0.486 0 N-CA-C 108.521 -0.918 . . . . 74.21 108.521 172.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.588 HG21 ' HB1' ' B' ' 66' ' ' ALA . 57.6 t -104.27 134.86 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.36 0.6 . . . . 74.52 111.015 -172.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -106.39 103.25 12.67 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.056 -1.461 . . . . 73.24 107.056 169.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.606 HD12 HD21 ' B' ' 128' ' ' LEU . 23.8 tp -85.48 147.05 26.65 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 107.855 -1.165 . . . . 74.25 107.855 171.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.515 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 12.0 t0 -155.27 154.09 31.61 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.337 -0.616 . . . . 70.2 109.337 -176.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.515 HD11 HG13 ' B' ' 131' ' ' VAL . 97.8 mt -124.92 130.54 52.56 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.341 0.657 . . . . 63.1 110.406 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -127.93 146.94 50.48 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.259 1.424 . . . . 72.54 108.048 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 7.8 t -145.32 127.42 15.63 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.004 0.431 . . . . 72.53 110.604 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.72 116.4 10.24 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.992 -1.114 . . . . 70.55 107.992 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.488 ' HB3' ' HA ' ' B' ' 58' ' ' VAL . 56.1 p -144.69 165.07 29.1 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.094 0.405 . . . . 62.23 112.094 -173.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 67.1 p -160.96 153.05 20.01 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.337 -0.847 . . . . 65.34 110.21 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -82.57 115.03 21.36 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.875 -0.787 . . . . 72.53 108.875 166.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 pp -122.26 24.26 9.47 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.283 0.633 . . . . 74.31 110.746 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . 0.619 ' HB2' ' HB ' ' B' ' 55' ' ' VAL . . . -169.17 169.0 9.59 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.585 0.754 . . . . 72.44 111.548 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . 0.416 ' O ' HG23 ' B' ' 55' ' ' VAL . 2.8 m-20 -60.59 95.43 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.392 1.077 . . . . 73.3 112.572 -175.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 56.56 25.24 9.62 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.417 1.087 . . . . 75.54 111.866 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.619 ' HB ' ' HB2' ' B' ' 52' ' ' ALA . 89.0 t -116.93 111.79 36.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-N 114.322 -1.308 . . . . 74.4 108.117 177.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.639 ' HB2' HD11 ' F' ' 100' ' ' LEU . 8.2 t80 -101.41 138.64 38.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.099 1.36 . . . . 74.52 109.275 -174.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -116.41 114.22 23.95 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.467 -1.308 . . . . 74.02 107.467 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.488 ' HA ' ' HB3' ' B' ' 48' ' ' SER . 2.7 p -108.72 129.18 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 122.766 0.427 . . . . 75.34 110.993 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.473 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.3 t -102.33 108.48 24.07 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 N-CA-C 107.777 -1.194 . . . . 73.25 107.777 171.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 56.8 tp -95.11 102.58 14.4 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 108.516 -0.92 . . . . 73.33 108.516 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -94.05 117.88 30.73 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.588 -0.733 . . . . 75.33 109.241 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 54.1 t -105.02 128.3 58.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 108.706 -0.85 . . . . 75.34 108.706 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 14.9 m -104.88 138.4 41.19 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.998 0.519 . . . . 73.23 110.026 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.494 HG23 HD12 ' B' ' 114' ' ' ILE . 58.2 t -133.38 112.31 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.191 -1.04 . . . . 72.45 108.191 173.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.401 HG23 ' CD2' ' B' ' 75' ' ' LEU . 87.0 m -111.48 105.64 14.29 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.25 -1.019 . . . . 74.32 108.25 174.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.588 ' HB1' HG21 ' B' ' 40' ' ' VAL . . . -110.89 150.54 29.05 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.871 0.367 . . . . 74.04 110.145 -178.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.495 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 30.7 p -144.69 130.7 19.36 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.424 -0.807 . . . . 74.42 111.015 -171.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.659 HD13 HG23 ' B' ' 31' ' ' VAL . 85.8 mt -94.35 98.45 10.91 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.053 -1.092 . . . . 73.15 108.053 173.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.1 -122.55 11.48 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 115.2 -0.909 . . . . 74.44 113.992 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -82.1 2.66 30.25 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.523 0.729 . . . . 74.1 112.764 -172.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.555 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 12.4 pt-20 -143.57 159.52 42.29 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.843 0.457 . . . . 73.31 110.89 -171.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 40.0 m -69.62 133.54 47.7 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.256 -0.884 . . . . 71.41 110.325 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.495 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -84.75 -60.94 1.91 Allowed 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.03 -1.47 . . . . 62.21 107.03 172.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -154.06 162.74 40.99 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.749 -1.114 . . . . 73.21 111.541 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.401 ' CD2' HG23 ' B' ' 65' ' ' THR . 35.3 mt -123.47 112.25 17.28 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 106.129 -1.804 . . . . 74.54 106.129 169.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.548 ' SG ' ' HB2' ' B' ' 117' ' ' MET . 40.5 t -124.54 118.34 26.36 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.364 -0.606 . . . . 74.01 109.364 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -140.2 128.66 22.75 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.564 0.745 . . . . 72.51 109.208 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.511 HG12 HD11 ' B' ' 21' ' ' ILE . 42.4 t -125.5 150.7 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.801 0.84 . . . . 73.24 110.125 -175.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.416 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 22.4 mt-30 -114.94 110.48 19.69 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.56 -0.533 . . . . 73.23 109.56 171.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.458 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.1 tp-100 -99.77 102.84 14.4 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.397 -0.594 . . . . 73.53 109.397 170.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.46 160.46 29.19 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 111.011 -0.836 . . . . 60.24 111.011 174.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.66 126.54 1.62 Allowed Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.916 -0.474 . . . . 62.43 111.916 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.483 HG13 ' HE1' ' B' ' 17' ' ' TYR . 57.9 mt -88.05 122.56 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 108.224 -1.028 . . . . 75.31 108.224 175.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -135.63 140.62 44.7 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.554 0.741 . . . . 72.54 110.067 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.431 ' HG ' HG21 ' B' ' 55' ' ' VAL . 21.2 m -88.72 118.69 28.58 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.458 0.703 . . . . 51.12 109.104 170.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.588 HD11 ' HB3' ' B' ' 56' ' ' TYR . 4.0 mp -116.94 110.59 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.048 -1.464 . . . . 75.54 107.048 175.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.719 ' HA ' ' HB ' ' F' ' 97' ' ' ILE . . . -155.88 172.06 19.0 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.959 0.504 . . . . 73.42 111.14 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.02 -60.46 0.82 Allowed Glycine 0 C--N 1.344 1.012 0 N-CA-C 111.072 -0.811 . . . . 63.21 111.072 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -68.53 169.84 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 123.446 0.698 . . . . 71.43 111.876 173.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -154.52 177.9 10.67 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.319 0.648 . . . . 74.11 110.838 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.34 -126.68 8.32 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-N 115.703 -0.68 . . . . 62.13 114.145 172.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.6 m -89.73 -47.59 7.82 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.788 0.835 . . . . 72.1 109.946 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -64.33 -19.02 65.17 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.379 -1.282 . . . . 74.54 112.152 -169.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 23.9 ptt? -62.53 -37.13 84.89 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.735 0.814 . . . . 74.41 112.015 177.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.97 -13.27 59.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.414 0.686 . . . . 74.14 112.466 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . 0.557 ' HB2' HD22 ' B' ' 141' ' ' LEU . 58.0 t-80 -63.72 -32.16 73.57 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.843 0.457 . . . . 71.23 109.929 170.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -64.45 -49.47 71.34 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.51 0.724 . . . . 74.34 111.428 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.478 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.4 pp -76.95 -32.02 57.01 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.066 -0.516 . . . . 74.33 111.827 -174.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.89 -22.08 37.26 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 123.26 0.35 . . . . 64.31 113.859 -173.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.01 -59.35 1.74 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.091 0.556 . . . . 72.53 111.516 -173.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -67.23 -42.77 83.49 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.224 0.61 . . . . 74.13 111.662 -172.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.478 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 63.3 m -68.43 -49.07 32.93 Favored Pre-proline 0 CA--C 1.566 1.575 0 N-CA-C 113.413 0.894 . . . . 70.31 113.413 -175.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 35.6 Cg_exo -64.72 -28.07 60.15 Favored 'Trans proline' 0 C--N 1.39 2.757 0 C-N-CA 121.851 1.701 . . . . 74.41 113.245 177.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -58.36 -34.43 70.66 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 123.216 0.606 . . . . 73.24 111.94 174.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 58.2 mt -68.49 -35.97 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 115.387 -0.824 . . . . 75.02 110.469 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 93.8 mt -88.5 -31.65 18.61 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.312 0.856 . . . . 73.52 113.312 -170.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -53.26 -43.7 95.69 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 113.855 1.057 . . . . 73.33 113.855 -173.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -52.18 -42.41 59.75 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.893 2.395 . . . . 73.14 114.84 174.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.458 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 86.0 m-85 -68.62 -43.59 76.04 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.731 0.412 . . . . 73.11 110.749 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.14 -43.04 99.51 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.407 -0.815 . . . . 75.44 110.661 175.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.447 ' HA ' HD12 ' B' ' 128' ' ' LEU . 28.8 ttt-85 -57.74 -53.9 53.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.14 1.376 . . . . 70.21 110.902 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -66.03 -39.17 89.98 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.247 0.967 . . . . 72.53 110.669 -175.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.532 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 7.4 t -70.25 -34.26 72.62 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.869 -0.605 . . . . 71.53 110.989 -176.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.558 HD13 HD13 ' B' ' 128' ' ' LEU . 67.7 mt -60.47 -53.46 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.626 0.771 . . . . 73.3 109.652 169.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.449 HG22 ' OG ' ' C' ' 119' ' ' SER . 17.0 m -60.14 -28.56 67.99 Favored 'General case' 0 CA--C 1.551 1.011 0 O-C-N 123.807 0.692 . . . . 73.32 111.332 -177.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 29.7 m -64.47 -52.04 59.97 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 123.543 0.737 . . . . 53.53 110.656 171.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.548 ' HB2' ' SG ' ' B' ' 76' ' ' CYS . 25.2 mmt -63.21 -33.13 74.81 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.049 0.54 . . . . 75.54 111.345 -177.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.576 HG22 HD22 ' B' ' 126' ' ' LEU . 92.1 t -72.07 -38.38 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.84 1.256 . . . . 75.51 110.902 176.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 47.2 t -66.54 -34.7 78.5 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.314 -0.857 . . . . 65.13 110.53 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.547 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 74.6 mtt-85 -71.37 -37.52 71.61 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 114.788 -1.097 . . . . 74.44 109.408 177.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.49 -9.73 78.33 Favored Glycine 0 C--N 1.355 1.587 0 O-C-N 123.522 0.514 . . . . 74.5 112.69 172.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 3.2 m 69.93 20.81 6.49 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 125.487 1.515 . . . . 72.23 111.721 171.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -78.24 159.67 74.81 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.524 0.73 . . . . 75.32 111.169 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.91 172.07 0.88 Allowed 'Trans proline' 0 C--N 1.387 2.569 0 C-N-CA 123.271 2.647 . . . . 71.33 114.558 174.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.727 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 56.3 tp60 -62.75 132.51 52.47 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.482 0.919 . . . . 73.43 113.482 -166.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.576 HD22 HG22 ' B' ' 118' ' ' VAL . 59.6 tp -126.71 106.43 9.37 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.681 0.792 . . . . 74.3 109.031 176.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -112.59 119.37 37.9 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 107.639 -1.245 . . . . 64.13 107.639 170.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.606 HD21 HD12 ' B' ' 42' ' ' LEU . 31.0 mt -77.67 145.95 36.34 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 122.99 0.182 . . . . 73.14 111.39 -176.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.96 128.33 91.8 Favored Pre-proline 0 CA--C 1.546 0.812 0 O-C-N 124.366 1.041 . . . . 75.1 111.845 -175.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.495 ' HG3' HD11 ' D' ' 16' ' ' ILE . 51.3 Cg_endo -68.54 87.31 0.42 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.897 2.398 . . . . 72.35 112.033 176.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.515 HG13 HD11 ' B' ' 44' ' ' LEU . 2.5 p -90.49 109.8 21.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 108.291 -1.003 . . . . 75.15 108.291 172.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -74.78 110.12 8.82 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.726 -1.124 . . . . 74.21 108.216 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -61.69 -31.02 71.13 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.042 0.537 . . . . 73.35 111.206 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -55.73 -42.14 74.92 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.545 0.738 . . . . 62.22 111.322 171.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.2 -30.08 70.21 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 123.713 0.633 . . . . 74.2 112.03 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.3 mp -74.65 -54.44 7.43 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.284 0.564 . . . . 74.31 109.732 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -74.27 -12.78 60.65 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.075 0.95 . . . . 73.4 113.288 -173.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -21.04 61.12 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 120.871 0.367 . . . . 72.42 110.595 177.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -75.48 -33.32 60.8 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.076 0.55 . . . . 74.01 110.448 177.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . 0.423 ' HB2' HD11 ' B' ' 141' ' ' LEU . 89.3 m-85 -87.54 -49.12 7.39 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.843 -0.617 . . . . 73.24 110.769 -177.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.557 HD22 ' HB2' ' B' ' 96' ' ' HIS . 6.3 mp -100.55 10.63 40.93 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.745 0.818 . . . . 74.21 111.675 -172.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 66.89 176.27 0.24 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.717 1.207 . . . . 74.12 112.983 173.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -75.72 124.18 26.83 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.451 -0.795 . . . . 74.4 108.867 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -67.45 -52.76 35.65 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.498 0.719 . . . . 75.33 109.876 176.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -164.21 166.73 20.79 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.73 0.812 . . . . 54.12 110.809 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -173.77 40.44 0.14 Allowed Glycine 0 C--N 1.342 0.889 0 CA-C-N 116.271 -0.422 . . . . 65.0 112.279 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -94.4 149.4 21.28 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.027 0.931 . . . . 74.14 110.105 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . 0.524 ' HA3' ' HB2' ' D' ' 93' ' ' GLN . . . -137.68 -154.71 6.66 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 111.722 -0.551 . . . . 72.02 111.722 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 3.8 m 73.59 4.44 4.75 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 125.069 1.348 . . . . 74.12 111.814 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.73 -5.92 28.43 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.507 1.123 . . . . 74.44 112.566 -176.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . 0.478 ' HA ' ' HG ' ' D' ' 141' ' ' LEU . 0.3 OUTLIER -68.72 139.26 55.37 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 124.248 1.019 . . . . 74.35 110.475 178.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -127.75 -30.67 2.51 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.036 0.934 . . . . 71.43 111.487 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 68.07 97.92 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.113 1.365 . . . . 71.43 111.391 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -93.4 -62.95 1.27 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.876 -0.787 . . . . 74.55 108.876 176.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.869 0 N-CA-C 108.981 -0.748 . . . . 74.23 108.981 175.122 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 112.346 0.499 . . . . 74.45 112.346 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 63.5 m -148.79 43.33 0.98 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.462 0.648 . . . . 74.01 110.239 -169.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . 0.433 ' HG2' ' ND2' ' A' ' 132' ' ' ASN . 0.0 OUTLIER -138.5 112.9 8.78 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.485 0.714 . . . . 73.54 109.634 -179.248 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 51.37 45.25 28.24 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 125.404 1.482 . . . . 61.25 112.138 177.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -151.37 145.21 25.12 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.48 -0.782 . . . . 64.43 109.947 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.48 -44.69 50.38 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.945 -0.57 . . . . 71.12 110.399 173.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 12.8 p -144.82 -63.95 0.35 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.997 0.919 . . . . 70.41 109.087 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -153.44 -62.36 0.14 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.723 1.209 . . . . 74.34 108.606 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.455 ' HE1' HD12 ' C' ' 89' ' ' ILE . 25.9 ttt 65.74 114.38 0.03 OUTLIER 'General case' 0 C--N 1.361 1.088 0 C-N-CA 125.578 1.551 . . . . 72.14 111.693 -171.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' C' ' 87' ' ' ALA . 13.2 m -87.04 87.27 7.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.864 0.866 . . . . 75.14 109.751 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.509 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 64.0 t80 -113.57 118.61 34.9 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.539 -0.912 . . . . 73.42 108.539 177.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -135.79 125.21 24.93 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.275 -0.639 . . . . 73.53 109.275 -177.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 45.4 mt -77.16 128.16 38.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 109.466 -0.568 . . . . 70.32 109.466 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -88.69 -49.74 6.67 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.826 -0.805 . . . . 73.32 108.826 174.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.556 ' HB2' ' HG2' ' A' ' 125' ' ' GLN . 0.0 OUTLIER -174.58 149.48 1.27 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.221 1.008 . . . . 74.53 110.245 176.27 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.461 HG22 HD21 ' C' ' 106' ' ' LEU . 78.0 mt -120.57 131.59 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.503 1.121 . . . . 74.24 108.299 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.569 ' HB3' HG22 ' D' ' 122' ' ' THR . 20.8 p90 -164.44 172.19 13.7 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 121.422 0.63 . . . . 72.32 112.17 -167.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.1 p -100.38 120.3 39.76 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.268 -0.878 . . . . 72.35 109.248 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -69.29 -48.75 60.72 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 106.979 -1.489 . . . . 74.25 106.979 165.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.627 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.3 t70 -134.56 145.59 48.85 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 113.655 -1.611 . . . . 65.15 110.663 -173.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.5 mt -137.64 149.17 25.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 126.717 2.007 . . . . 74.51 105.714 172.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.1 t -156.95 149.58 23.45 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.829 -0.434 . . . . 75.35 109.829 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -155.98 129.59 8.39 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 107.265 -1.383 . . . . 74.31 107.265 174.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -132.15 132.91 43.66 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.681 -0.859 . . . . 75.41 108.681 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.33 80.55 22.6 Favored Pre-proline 0 CA--C 1.549 0.93 0 N-CA-C 106.625 -1.62 . . . . 73.13 106.625 170.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -65.25 -41.19 16.88 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.82 2.347 . . . . 71.42 111.702 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -94.82 18.37 11.92 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 114.398 -1.274 . . . . 74.1 110.779 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.41 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -41.98 -61.02 1.67 Allowed Pre-proline 0 C--N 1.369 1.427 0 C-N-CA 124.974 1.31 . . . . 75.25 114.097 -171.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -61.52 -39.48 54.89 Favored 'Trans proline' 0 C--N 1.39 2.715 0 C-N-CA 121.66 1.573 . . . . 75.31 112.15 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.465 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 85.2 t60 -71.4 -30.63 66.32 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 115.44 -0.8 . . . . 74.41 112.385 -178.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.632 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.0 p -82.96 -15.88 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 O-C-N 121.794 -0.566 . . . . 73.03 111.836 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -75.45 -20.76 58.64 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.112 0.565 . . . . 73.33 112.227 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 20.8 pt20 -94.07 8.69 40.61 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.493 0.717 . . . . 64.43 110.944 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.666 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 1.2 tppp? -99.12 161.76 13.44 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.881 0.872 . . . . 74.41 110.988 -171.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -71.49 121.79 19.29 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.403 0.681 . . . . 75.04 109.638 172.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -83.74 93.39 7.93 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.22 0.608 . . . . 74.45 111.016 -174.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -145.43 78.98 11.77 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.06 0.944 . . . . 71.22 108.494 173.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -82.45 141.33 11.2 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.695 2.263 . . . . 75.23 113.179 -173.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -87.38 88.43 7.68 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.012 -1.477 . . . . 73.44 107.012 163.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 40.3 t -83.87 111.96 20.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-N 115.117 -0.947 . . . . 74.53 110.078 -175.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.512 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 13.7 tmtt? -91.1 101.08 13.83 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 107.85 -1.167 . . . . 73.21 107.85 172.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.489 ' HB3' HG12 ' F' ' 135' ' ' VAL . 3.9 tt -87.61 121.69 30.36 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.069 -1.826 . . . . 74.44 106.069 173.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -118.31 138.35 52.45 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.428 -0.953 . . . . 72.3 108.428 -175.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.484 HD21 HD23 ' C' ' 60' ' ' LEU . 25.7 mt -132.02 111.84 11.86 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.852 0.834 . . . . 74.22 110.298 178.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -127.5 122.43 33.34 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.904 1.682 . . . . 72.55 107.268 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -123.16 125.86 45.93 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 120.99 0.424 . . . . 71.3 110.057 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.16 160.51 16.86 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.218 1.007 . . . . 62.45 109.384 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 31.1 p -151.94 146.06 25.33 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.308 0.643 . . . . 60.25 110.27 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 54.1 p -146.99 135.9 22.31 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.694 0.798 . . . . 72.14 109.351 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -78.32 117.08 19.22 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 108.856 -0.794 . . . . 72.24 108.856 175.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.679 HD12 ' HB2' ' C' ' 57' ' ' GLU . 30.8 mt -85.54 -33.28 21.79 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.899 0.88 . . . . 74.25 110.478 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.96 -174.48 3.34 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.408 1.083 . . . . 73.11 109.6 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.23 117.21 6.25 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.464 -0.789 . . . . 73.12 109.288 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 70.35 11.92 7.48 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.884 1.274 . . . . 75.12 112.044 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 30.4 t -118.32 116.27 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.196 -0.668 . . . . 75.01 109.196 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -127.46 125.12 39.95 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.017 0.927 . . . . 72.14 108.672 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.679 ' HB2' HD12 ' C' ' 51' ' ' LEU . 34.8 tt0 -85.8 142.14 29.15 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.964 -0.754 . . . . 71.1 108.964 169.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 60.1 t -128.8 122.84 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 107.817 -1.179 . . . . 64.5 107.817 167.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 68.2 t -109.64 127.56 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 109.283 -0.636 . . . . 74.12 109.283 173.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.484 HD23 HD21 ' C' ' 44' ' ' LEU . 0.1 OUTLIER -107.38 100.99 10.38 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 107.738 -1.208 . . . . 64.23 107.738 -176.544 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -82.22 106.12 13.85 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.455 0.702 . . . . 75.13 109.16 172.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.465 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.6 t -102.88 124.7 57.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.417 -1.327 . . . . 73.11 107.417 169.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 12.5 m -125.34 113.24 17.31 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.526 0.679 . . . . 62.2 109.486 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.479 HG21 HD12 ' C' ' 114' ' ' ILE . 99.5 t -102.49 111.07 30.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 124.482 1.113 . . . . 72.41 109.132 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.515 HG23 HD22 ' C' ' 75' ' ' LEU . 6.8 m -104.35 108.62 20.12 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 109.121 -0.696 . . . . 71.21 109.121 176.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.9 100.63 10.18 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.642 -0.873 . . . . 72.32 108.642 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 40.5 m -129.03 131.76 47.4 Favored 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 109.038 -0.727 . . . . 75.32 109.038 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 12.2 mt -84.91 26.51 0.83 Allowed 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 125.137 1.375 . . . . 73.21 111.3 -175.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.62 -109.49 1.06 Allowed Glycine 0 C--N 1.348 1.229 0 N-CA-C 109.486 -1.446 . . . . 60.31 109.486 -170.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.59 -31.56 16.64 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.215 -0.661 . . . . 74.21 109.215 169.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.666 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 10.0 tp10 -69.37 104.25 2.22 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 124.065 0.946 . . . . 72.11 109.964 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.1 m -78.55 123.95 27.63 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 109.384 -0.598 . . . . 72.43 109.384 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.632 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -77.42 -57.61 3.73 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.091 -1.077 . . . . 72.33 108.091 176.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . 0.438 ' HZ ' HD23 ' C' ' 126' ' ' LEU . 49.5 p90 -156.52 154.97 31.16 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.846 -1.07 . . . . 75.41 111.268 175.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.515 HD22 HG23 ' C' ' 65' ' ' THR . 2.5 tm? -113.09 145.47 40.85 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 106.094 -1.817 . . . . 74.43 106.094 163.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.437 ' SG ' HG21 ' C' ' 114' ' ' ILE . 49.6 t -151.68 125.16 8.88 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.989 -0.745 . . . . 74.31 108.989 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -131.76 136.71 47.79 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.331 -0.618 . . . . 74.15 109.331 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.504 HG12 ' HA ' ' C' ' 110' ' ' ALA . 22.7 t -132.13 113.92 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.658 -0.867 . . . . 74.3 108.658 174.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.627 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.3 mt-30 -91.73 87.96 6.5 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.017 0.927 . . . . 64.14 109.115 172.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -79.45 96.9 6.19 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.402 1.081 . . . . 53.11 110.337 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.77 144.54 22.15 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.396 -0.366 . . . . 75.44 112.694 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.407 ' HA3' HD23 ' C' ' 106' ' ' LEU . . . -147.24 128.11 2.86 Favored Glycine 0 CA--C 1.503 -0.713 0 N-CA-C 111.096 -0.802 . . . . 72.42 111.096 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 27.3 mm -95.09 123.54 47.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.248 -1.019 . . . . 75.14 108.248 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -132.23 118.68 19.83 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.517 0.727 . . . . 71.01 109.986 -173.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 56.9 m -76.41 100.8 5.32 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.464 -0.569 . . . . 71.43 109.464 170.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.517 HG21 ' HE2' ' C' ' 94' ' ' MET . 18.4 mt -114.13 131.6 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.239 0.615 . . . . 70.44 110.042 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.486 ' HB2' ' HB ' ' C' ' 10' ' ' THR . . . -153.4 169.4 23.23 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.163 0.985 . . . . 65.52 109.956 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.53 -19.2 41.78 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.936 -0.574 . . . . 75.44 113.452 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.455 HD12 ' HE1' ' C' ' 9' ' ' MET . 22.3 pt -111.03 170.5 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.051 0.54 . . . . 74.0 111.135 -175.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -166.21 149.51 7.36 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.905 0.482 . . . . 74.33 110.7 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.81 -113.15 5.06 Favored Glycine 0 C--N 1.354 1.547 0 CA-C-N 115.872 -0.604 . . . . 63.11 113.43 170.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 92' ' ' THR . . . . . 0.435 ' HA ' HD13 ' C' ' 141' ' ' LEU . 34.6 p -61.19 -43.43 98.89 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.858 0.863 . . . . 75.32 111.281 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -59.24 -42.7 91.72 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 114.965 -1.016 . . . . 74.54 110.739 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.517 ' HE2' HG21 ' C' ' 86' ' ' ILE . 6.7 tpt -68.48 -43.63 76.52 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.845 -1.07 . . . . 65.23 110.573 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.75 -36.49 79.04 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.472 0.709 . . . . 71.31 111.318 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -77.32 -31.7 54.78 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.102 0.408 . . . . 74.03 112.102 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.42 ' SG ' HD12 ' C' ' 86' ' ' ILE . 24.7 t -66.36 -43.83 84.92 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.688 -0.856 . . . . 73.14 108.688 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 43.3 mt -78.69 -28.3 45.21 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.374 -1.285 . . . . 75.44 111.104 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.61 -27.97 52.92 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 115.701 -0.681 . . . . 65.15 114.14 -172.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.422 ' HA ' ' HB3' ' C' ' 133' ' ' PHE . . . -154.83 -48.75 0.09 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.172 1.175 . . . . 72.44 114.172 -163.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -62.73 -51.86 65.52 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.686 0.616 . . . . 64.41 111.465 -173.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.509 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 57.6 m -66.52 -50.05 48.86 Favored Pre-proline 0 CA--C 1.56 1.351 0 CA-C-O 118.271 -0.871 . . . . 62.22 111.502 177.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 85.4 Cg_exo -51.56 -30.99 38.0 Favored 'Trans proline' 0 C--N 1.399 3.227 0 C-N-CA 123.029 2.486 . . . . 61.41 114.898 172.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -65.35 -43.51 90.63 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.06 0.544 . . . . 75.24 109.717 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.458 HD13 ' NH1' ' A' ' 111' ' ' ARG . 35.1 mm -72.74 -29.12 28.99 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 CA-C-N 115.663 -0.699 . . . . 75.32 110.462 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.461 HD21 HG22 ' C' ' 16' ' ' ILE . 89.0 mt -77.62 -29.68 51.96 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.815 0.846 . . . . 74.45 111.883 178.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -58.78 -50.19 89.37 Favored Pre-proline 0 N--CA 1.482 1.173 0 CA-C-O 117.448 -1.263 . . . . 74.12 114.279 -168.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.93 -32.54 92.63 Favored 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 121.832 1.688 . . . . 62.22 112.75 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -68.42 -48.26 65.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.414 0.685 . . . . 75.41 110.425 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.504 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -62.57 -35.49 79.65 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 115.952 -0.567 . . . . 75.5 111.149 176.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -63.07 -54.85 31.51 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.313 1.445 . . . . 71.31 111.374 -177.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -66.98 -30.13 70.17 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.305 0.642 . . . . 71.1 110.153 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 14.0 t -68.43 -34.5 76.09 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.456 0.702 . . . . 73.21 111.394 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.479 HD12 HG21 ' C' ' 64' ' ' VAL . 96.3 mt -74.46 -50.56 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.478 0.711 . . . . 75.4 110.298 174.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 9.1 m -66.34 -28.39 68.63 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.26 0.624 . . . . 62.44 111.602 -173.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.489 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 79.5 p -66.59 -45.36 79.48 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 109.13 -0.693 . . . . 61.54 109.13 172.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.593 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.42 -40.65 78.79 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.421 1.088 . . . . 73.52 112.478 176.384 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 62.8 t -64.73 -40.83 90.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.29 0.636 . . . . 75.13 110.609 177.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.449 ' OG ' HG22 ' B' ' 115' ' ' THR . 28.2 t -67.02 -34.63 78.15 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.05 0.94 . . . . 72.01 112.016 175.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' C' ' 116' ' ' SER . 66.0 mtt-85 -65.73 -36.3 83.19 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.237 0.615 . . . . 74.34 109.502 177.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.61 11.21 62.2 Favored Glycine 0 C--N 1.356 1.668 0 CA-C-O 119.284 -0.731 . . . . 65.13 113.322 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.446 HG22 ' HB3' ' D' ' 17' ' ' TYR . 67.6 p 59.09 21.76 9.77 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 126.139 1.776 . . . . 75.23 114.648 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -85.37 157.21 59.11 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 108.385 -0.969 . . . . 73.31 108.385 170.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.727 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 30.1 Cg_endo -61.6 168.46 8.28 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.831 2.354 . . . . 75.42 113.966 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -62.01 110.73 1.66 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.749 -1.114 . . . . 74.14 111.532 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.438 HD23 ' HZ ' ' C' ' 74' ' ' PHE . 9.5 mp -106.3 87.03 2.46 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.343 -1.354 . . . . 75.4 107.343 169.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -90.03 109.17 20.23 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.205 -1.035 . . . . 74.14 108.205 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 64.1 mt -61.04 131.29 50.13 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.529 0.732 . . . . 75.31 110.758 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.1 146.92 98.85 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 118.786 -0.626 . . . . 64.51 110.454 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -48.85 99.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.776 2.317 . . . . 75.32 112.7 172.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 58.0 t -97.4 109.03 22.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 107.494 -1.299 . . . . 74.41 107.494 172.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -86.11 101.3 12.85 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.669 -0.863 . . . . 75.22 108.669 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.422 ' HB3' ' HA ' ' C' ' 100' ' ' ALA . 73.4 m-85 -57.18 -35.62 69.81 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.011 0.925 . . . . 74.21 111.347 176.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -68.46 -25.91 65.23 Favored 'General case' 0 C--O 1.219 -0.533 0 C-N-CA 123.949 0.9 . . . . 65.52 111.942 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.55 -40.54 56.68 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.031 0.532 . . . . 74.35 110.243 171.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 79.0 mt -65.65 -36.0 82.41 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.407 -0.815 . . . . 74.25 111.096 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -83.21 -32.43 26.53 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-N 115.878 -0.601 . . . . 74.23 110.265 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 40.2 ttm -56.89 -48.64 77.71 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.683 0.793 . . . . 71.11 111.684 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -62.17 -36.53 82.14 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.274 -0.875 . . . . 74.35 111.123 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -72.14 -85.79 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 123.772 0.829 . . . . 74.12 109.902 172.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' C' ' 92' ' ' THR . 8.7 tt -102.83 131.74 49.5 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.866 1.267 . . . . 72.12 109.275 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -121.66 163.07 19.59 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.298 1.039 . . . . 74.5 110.833 -177.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -115.05 -132.56 0.33 Allowed 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 108.487 -0.931 . . . . 74.24 108.487 172.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -172.75 114.76 0.28 Allowed 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.37 0.986 . . . . 74.3 111.128 -170.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . 0.404 ' HB1' ' HA2' ' E' ' 143' ' ' GLY . . . 174.78 170.76 0.25 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 125.031 1.332 . . . . 72.23 110.278 172.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.92 172.36 21.61 Favored Glycine 0 C--N 1.351 1.394 0 N-CA-C 112.031 -0.428 . . . . 63.33 112.031 175.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . 0.56 ' HG2' ' HE1' ' A' ' 96' ' ' HIS . 20.7 tt0 -110.61 -59.17 1.99 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.424 0.689 . . . . 75.55 109.92 -178.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.4 96.08 0.16 Allowed Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.461 -0.79 . . . . 70.24 113.078 -176.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 32.0 p -73.65 -51.14 17.75 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.898 0.879 . . . . 75.34 111.992 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . 0.501 ' HG2' ' NE2' ' A' ' 144' ' ' GLN . 9.0 tp10 -151.75 149.64 29.28 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.308 0.643 . . . . 63.41 110.59 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -121.25 92.22 3.7 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.154 0.982 . . . . 71.35 109.871 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -140.22 178.99 6.9 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.032 0.933 . . . . 73.22 108.76 170.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -141.02 110.37 6.29 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.548 -0.908 . . . . 73.44 108.548 -177.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -84.78 158.15 20.79 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.043 0.537 . . . . 70.22 109.648 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.288 0 C-N-CA 124.298 1.039 . . . . 72.1 112.186 -174.784 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.451 ' SD ' ' N ' ' D' ' 1' ' ' MET . 3.2 mpp? . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.733 -0.469 . . . . 74.21 109.733 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 54.2 m -138.36 107.16 5.94 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.228 0.611 . . . . 74.44 110.005 -177.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -71.49 91.07 1.02 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.269 0.628 . . . . 74.43 109.814 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -92.38 -41.18 10.48 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.994 0.918 . . . . 70.34 109.253 -175.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 52.6 t30 73.75 153.79 0.14 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 125.094 1.357 . . . . 75.45 110.377 -173.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . 0.42 ' ND2' ' HB3' ' D' ' 90' ' ' GLU . 9.1 p30 -88.64 155.21 19.74 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.149 0.579 . . . . 74.55 110.598 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 15.2 p -140.94 -62.02 0.48 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.986 0.914 . . . . 71.44 108.922 173.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -132.55 91.61 2.95 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.569 0.748 . . . . 74.31 109.012 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -35.2 133.16 0.34 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.823 1.249 . . . . 75.11 112.796 169.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 6.2 t -133.23 135.63 45.12 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.117 0.567 . . . . 73.34 110.133 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.442 ' HD2' HG21 ' D' ' 86' ' ' ILE . 80.3 t80 -132.83 107.91 8.63 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.178 -1.416 . . . . 73.11 107.178 176.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -128.91 116.06 18.81 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.994 0.918 . . . . 74.41 108.658 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.437 HD11 HG22 ' D' ' 105' ' ' ILE . 10.7 mt -82.75 130.45 35.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 108.303 -0.999 . . . . 74.32 108.303 174.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -94.82 -34.65 12.39 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 123.621 0.575 . . . . 72.11 110.429 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -167.76 141.43 3.43 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.323 0.389 . . . . 75.1 111.015 -173.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.495 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.7 mp -122.98 134.92 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 107.292 -1.373 . . . . 75.13 107.292 171.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.446 ' HB3' HG22 ' C' ' 122' ' ' THR . 36.4 p90 -161.54 176.42 11.07 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.535 0.683 . . . . 75.43 112.372 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 53.6 p -103.47 127.22 50.9 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.422 -0.808 . . . . 75.42 109.357 173.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.442 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 32.5 mtpt -97.39 -19.22 18.62 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.027 0.531 . . . . 75.32 109.823 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.6 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 31.7 t70 -158.52 144.29 16.78 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.836 0.855 . . . . 75.33 109.876 177.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.593 HG23 ' HE1' ' C' ' 117' ' ' MET . 81.2 mt -148.59 142.91 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.624 1.569 . . . . 75.04 107.528 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.9 t -154.78 134.43 12.77 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.45 0.7 . . . . 64.53 109.419 164.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 88.8 t80 -119.75 133.92 55.43 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 105.827 -1.916 . . . . 74.55 105.827 166.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -138.69 120.59 15.46 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.349 0.659 . . . . 75.1 109.518 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.561 ' HB2' ' HB1' ' D' ' 28' ' ' ALA . . . -119.03 85.04 28.28 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 107.527 -1.286 . . . . 72.25 107.527 175.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -71.9 -29.55 15.11 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.873 2.382 . . . . 72.32 112.801 -168.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -115.27 16.58 16.83 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.077 0.951 . . . . 75.12 110.74 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.561 ' HB1' ' HB2' ' D' ' 25' ' ' ALA . . . -42.96 -58.03 4.4 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 114.887 1.44 . . . . 74.0 114.887 -161.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.31 -26.18 17.73 Favored 'Trans proline' 0 C--N 1.378 2.124 0 CA-C-N 122.356 1.877 . . . . 74.51 113.992 -175.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -74.95 -36.68 62.08 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.848 0.859 . . . . 73.12 109.887 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.472 HG13 ' HA ' ' D' ' 28' ' ' ALA . 9.8 p -83.91 -16.89 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-N 115.94 -0.573 . . . . 73.11 111.683 -172.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -68.15 -13.06 61.94 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 111.741 0.275 . . . . 74.03 111.741 175.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -69.48 -3.74 15.81 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.293 0.637 . . . . 74.52 111.3 174.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.599 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 96.5 mttt -110.69 102.88 11.4 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.276 1.43 . . . . 75.21 109.505 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -99.98 84.56 2.89 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.387 0.675 . . . . 64.04 111.125 -174.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -156.82 172.81 17.97 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 114.68 -1.145 . . . . 74.4 108.507 166.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -68.15 120.18 72.67 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-O 118.251 -0.88 . . . . 74.41 108.744 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.42 ' O ' HG21 ' D' ' 40' ' ' VAL . 81.5 Cg_exo -51.02 134.76 43.42 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 122.892 2.395 . . . . 64.41 112.124 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -69.34 110.52 4.7 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.879 -1.526 . . . . 73.43 106.879 170.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.528 HG13 HG13 ' D' ' 64' ' ' VAL . 38.4 t -107.05 108.86 26.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.84 0 CA-C-N 115.759 -0.655 . . . . 74.22 109.907 -173.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -87.95 109.27 19.68 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.603 -0.888 . . . . 73.53 108.603 168.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.409 HD11 ' O ' ' D' ' 63' ' ' THR . 58.9 tp -97.18 141.05 30.77 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.273 1.029 . . . . 62.22 109.228 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.606 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 21.5 t70 -123.94 131.9 53.64 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.385 -1.339 . . . . 74.24 107.385 173.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.595 ' HB3' HD21 ' E' ' 111' ' ' LEU . 31.9 mt -119.65 129.9 54.8 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.095 -0.706 . . . . 75.14 109.095 174.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.595 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 30.7 t70 -138.07 140.53 40.06 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 107.7 -1.222 . . . . 72.32 107.7 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 3.8 t -104.2 148.17 26.62 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.242 -0.651 . . . . 64.43 109.242 -176.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.445 ' HA ' ' HG1' ' E' ' 107' ' ' THR . . . -149.96 151.22 33.0 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.812 0.845 . . . . 70.33 109.423 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 10.1 p -171.02 152.18 3.45 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.904 0.882 . . . . 75.11 109.235 177.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 51.6 p -155.1 118.8 4.54 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.613 0.365 . . . . 74.41 110.796 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . 0.478 ' HB2' ' HA ' ' D' ' 56' ' ' TYR . 4.5 mm-40 174.93 150.96 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 126.554 1.942 . . . . 74.04 108.449 170.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 8.1 mp -99.77 98.11 8.97 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.374 0.67 . . . . 71.43 109.217 176.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . 61.2 -145.73 0.45 Allowed 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.617 0.767 . . . . 72.41 111.12 174.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 19.8 t0 74.16 6.0 4.7 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.909 1.283 . . . . 71.2 112.534 170.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.614 ' HB2' ' HB3' ' E' ' 94' ' ' PHE . 41.4 m-20 62.47 8.02 2.65 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.193 1.397 . . . . 72.33 113.639 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 50.9 t -134.39 117.63 24.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 108.767 -0.827 . . . . 74.2 108.767 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.478 ' HA ' ' HB2' ' D' ' 50' ' ' GLN . 33.4 m-85 -131.98 132.74 43.74 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 107.016 -1.476 . . . . 75.41 107.016 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -85.83 115.35 23.42 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 107.357 -1.349 . . . . 75.14 107.357 171.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 70.3 t -99.97 130.55 48.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.643 -1.162 . . . . 74.33 108.687 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.545 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 16.5 t -111.85 146.78 16.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.879 -0.786 . . . . 74.25 108.879 176.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.41 119.87 37.01 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.581 -1.266 . . . . 74.25 107.581 176.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.595 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 2.9 tmm_? -95.4 96.21 8.96 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 108.042 -1.095 . . . . 74.53 108.042 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.418 HG21 ' CD2' ' D' ' 44' ' ' LEU . 54.0 t -101.67 125.12 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.574 -0.899 . . . . 75.0 108.574 176.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 50.0 m -121.66 131.07 53.9 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 123.285 0.634 . . . . 72.12 109.526 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.528 HG13 HG13 ' D' ' 40' ' ' VAL . 83.7 t -113.86 127.06 71.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.778 -0.823 . . . . 73.43 108.778 172.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 22.4 m -119.61 92.92 3.91 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.336 -1.727 . . . . 73.41 106.336 168.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.54 143.59 30.53 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 109.652 -0.499 . . . . 71.21 109.652 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 77.9 p -147.7 137.3 22.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.238 0.542 . . . . 63.22 111.158 -173.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 26.8 mt -108.73 110.5 21.91 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.404 -1.332 . . . . 74.5 107.404 171.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.98 -134.98 20.85 Favored Glycine 0 C--N 1.342 0.909 0 O-C-N 123.589 0.556 . . . . 72.11 113.302 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.24 6.05 46.71 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.554 0.741 . . . . 73.33 112.179 -176.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.599 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 14.3 pt-20 -130.07 167.86 17.65 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.074 0.55 . . . . 74.31 110.602 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 66.0 m -71.46 138.67 49.2 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.454 -0.794 . . . . 72.33 111.217 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.77 -63.11 1.33 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.239 -1.393 . . . . 65.4 107.239 169.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -158.56 161.08 37.26 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.652 -1.158 . . . . 74.11 110.951 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 68.8 mt -131.8 112.64 12.67 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.458 1.503 . . . . 73.12 107.151 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.718 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 49.2 t -131.94 106.23 7.92 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 122.583 0.353 . . . . 72.25 110.378 -168.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -129.0 125.89 38.35 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.428 0.691 . . . . 72.22 109.657 -173.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 88.2 t -132.6 115.39 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.114 0.965 . . . . 73.24 109.822 -174.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.6 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 2.3 mp0 -90.03 87.31 6.85 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.892 0.877 . . . . 72.0 109.051 175.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -81.81 102.9 11.11 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.691 -1.14 . . . . 75.11 109.346 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -111.64 147.24 17.98 Favored Glycine 0 N--CA 1.475 1.236 0 CA-C-O 120.157 -0.246 . . . . 62.23 112.517 -178.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.91 151.91 23.1 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 117.133 0.467 . . . . 62.12 112.252 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 3.0 mp -89.74 118.22 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 108.707 -0.849 . . . . 71.51 108.707 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -115.29 150.08 36.81 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.943 0.897 . . . . 74.43 110.165 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 33.1 t -115.76 104.73 11.95 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.992 0.917 . . . . 63.11 109.152 175.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.447 HD13 HD23 ' D' ' 98' ' ' LEU . 47.2 pt -115.03 130.28 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.153 0.581 . . . . 73.53 109.838 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.87 165.29 34.98 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.587 0.755 . . . . 64.34 109.767 175.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.69 23.39 75.24 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-O 119.692 -0.504 . . . . 74.43 114.315 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.466 HG23 ' H ' ' D' ' 90' ' ' GLU . 0.1 OUTLIER -103.1 168.81 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 108.733 -0.84 . . . . 73.22 108.733 172.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.466 ' H ' HG23 ' D' ' 89' ' ' ILE . 8.8 pt-20 -135.1 178.17 7.24 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.02 0.928 . . . . 75.23 111.08 -178.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.79 -138.77 42.47 Favored Glycine 0 C--N 1.358 1.797 0 CA-C-N 115.676 -0.693 . . . . 75.11 113.068 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 65.5 p -88.31 -20.37 25.48 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.167 0.587 . . . . 65.34 110.284 170.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.739 ' HA ' ' HB3' ' D' ' 96' ' ' HIS . 25.7 tp60 -59.69 -21.42 60.56 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.186 1.395 . . . . 71.43 112.295 -175.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.463 ' HA ' ' HB ' ' D' ' 89' ' ' ILE . 16.8 ptp -57.51 -51.04 71.07 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.435 0.694 . . . . 71.12 111.856 172.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . 0.713 ' HB1' ' HB2' ' E' ' 100' ' ' LEU . . . -86.23 -22.77 26.72 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.943 0.497 . . . . 72.42 111.771 176.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . 0.739 ' HB3' ' HA ' ' D' ' 93' ' ' GLN . 19.6 t-80 -75.02 -11.27 60.06 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.184 0.593 . . . . 64.23 110.094 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 43.7 t -72.99 -51.2 19.17 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.966 0.506 . . . . 74.52 110.447 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.516 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 3.2 pp -77.64 -19.03 56.14 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.037 0.384 . . . . 73.11 112.037 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.35 -0.82 64.91 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-O 119.817 -0.435 . . . . 73.35 113.345 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.14 -66.78 0.39 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.903 0.481 . . . . 74.22 111.212 -176.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -66.84 -43.33 83.97 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.436 0.294 . . . . 72.43 111.78 -173.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.516 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 75.6 m -63.74 -47.44 81.71 Favored Pre-proline 0 CA--C 1.567 1.629 0 CA-C-O 118.289 -0.862 . . . . 75.12 112.591 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.518 ' HA ' HD12 ' D' ' 106' ' ' LEU . 27.9 Cg_exo -62.51 -28.53 77.75 Favored 'Trans proline' 0 C--N 1.399 3.233 0 C-N-CA 122.153 1.902 . . . . 75.43 112.964 170.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -67.91 -32.86 73.63 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.616 0.367 . . . . 75.44 111.068 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.437 HG22 HD11 ' D' ' 13' ' ' ILE . 48.0 mm -65.58 -34.38 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.149 0.58 . . . . 74.2 110.241 173.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' D' ' 103' ' ' PRO . 29.5 mt -77.81 -18.27 56.55 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.381 -0.827 . . . . 72.31 111.933 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.04 -41.3 10.74 Favored Pre-proline 0 N--CA 1.486 1.358 0 N-CA-C 113.91 1.078 . . . . 71.2 113.91 -173.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -50.65 -42.91 48.34 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.208 1.939 . . . . 73.43 112.721 169.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . 0.451 ' OH ' ' HB3' ' B' ' 130' ' ' PRO . 93.2 m-85 -79.49 -27.29 41.47 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.634 0.774 . . . . 74.3 111.732 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.06 -49.5 67.41 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.049 -0.722 . . . . 75.24 109.049 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -67.13 -33.37 75.29 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 113.868 -1.515 . . . . 75.34 110.864 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -53.92 -55.79 23.73 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 124.007 0.923 . . . . 70.24 110.268 174.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.406 ' O ' ' HG3' ' D' ' 117' ' ' MET . 47.2 t -62.99 -47.52 82.79 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 114.225 -1.352 . . . . 74.32 111.182 -177.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.608 HG22 ' SG ' ' D' ' 76' ' ' CYS . 68.5 mt -60.95 -61.74 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.324 0.65 . . . . 75.41 111.576 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 22.3 m -51.97 -40.42 60.86 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 124.198 0.937 . . . . 73.42 111.455 -175.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 37.5 t -60.41 -50.77 72.27 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 114.343 -1.299 . . . . 74.42 110.751 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.718 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 72.4 mtm -66.54 -30.85 71.25 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.122 0.569 . . . . 75.41 112.16 -178.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.421 HG22 ' O ' ' D' ' 114' ' ' ILE . 89.8 t -66.56 -44.34 90.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.722 0.809 . . . . 75.31 110.042 176.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 83.7 p -74.83 -28.67 60.79 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.746 -0.661 . . . . 73.3 110.56 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' D' ' 116' ' ' SER . 88.3 mtt-85 -69.84 -29.73 67.05 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.648 0.779 . . . . 70.54 109.809 173.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.46 6.98 80.88 Favored Glycine 0 C--N 1.356 1.672 0 O-C-N 123.656 0.598 . . . . 65.23 113.157 177.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.569 HG22 ' HB3' ' C' ' 17' ' ' TYR . 81.2 p 55.69 28.25 11.84 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 126.277 1.831 . . . . 75.11 113.442 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -90.9 151.34 43.34 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 123.641 0.776 . . . . 75.35 109.289 169.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -51.58 125.15 15.99 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.64 2.227 . . . . 71.34 112.211 172.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -42.89 135.64 2.95 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 126.191 1.796 . . . . 75.22 113.277 -175.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.515 HD12 HG23 ' D' ' 40' ' ' VAL . 28.7 tp -116.55 96.99 5.76 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.774 0.83 . . . . 71.52 109.78 -176.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -97.11 96.48 8.49 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 106.931 -1.507 . . . . 73.1 106.931 175.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.543 HD13 HD13 ' D' ' 114' ' ' ILE . 92.9 mt -54.13 127.25 25.95 Favored 'General case' 0 C--O 1.246 0.884 0 O-C-N 123.649 0.593 . . . . 73.15 110.397 -177.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.18 140.81 82.81 Favored Pre-proline 0 CA--C 1.551 0.982 0 O-C-N 124.185 0.928 . . . . 74.23 110.734 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.415 ' HD3' HG13 ' B' ' 13' ' ' ILE . 98.0 Cg_endo -74.22 108.4 2.66 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.566 2.177 . . . . 75.53 111.739 -170.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 59.1 t -106.48 117.25 51.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 108.186 -1.042 . . . . 74.55 108.186 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -74.28 113.14 11.14 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.698 -0.853 . . . . 70.42 108.698 169.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.434 ' CD2' ' HB2' ' D' ' 103' ' ' PRO . 2.0 m-85 -69.52 -29.03 66.55 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.239 -0.891 . . . . 72.55 110.826 -176.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -60.85 -51.12 70.65 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 108.75 -0.833 . . . . 71.22 108.75 173.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.53 -50.55 69.11 Favored 'General case' 0 C--N 1.352 0.691 0 O-C-N 124.423 1.077 . . . . 74.14 110.714 -174.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.532 HD22 ' HG ' ' E' ' 111' ' ' LEU . 33.8 tp -66.93 -39.87 87.46 Favored 'General case' 0 CA--C 1.55 0.98 0 O-C-N 123.926 0.766 . . . . 71.03 111.563 -174.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.467 ' O ' HD11 ' D' ' 141' ' ' LEU . 9.1 t80 -67.57 -41.59 83.92 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.425 -0.583 . . . . 74.34 109.425 176.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.474 ' O ' ' HG2' ' D' ' 142' ' ' GLN . 66.0 mtm -65.02 -29.29 70.19 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 116.022 -0.535 . . . . 71.33 111.315 174.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -66.57 -8.08 24.5 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 118.071 0.396 . . . . 75.13 111.732 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . 0.433 ' HD2' HD12 ' D' ' 141' ' ' LEU . 80.5 t80 -89.54 -41.97 11.71 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 121.109 0.481 . . . . 74.13 109.992 165.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.478 ' HG ' ' HA ' ' B' ' 151' ' ' GLU . 6.4 mp -76.93 -64.25 1.17 Allowed 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 124.78 1.232 . . . . 72.22 112.39 -170.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' D' ' 138' ' ' MET . 29.2 pt20 -81.18 25.32 0.49 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.729 1.212 . . . . 75.12 113.291 -176.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -114.41 84.3 2.03 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 120.944 -1.097 . . . . 71.14 108.995 -168.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -177.65 -33.52 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 113.024 -1.898 . . . . 75.5 108.302 -175.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -145.14 128.62 16.99 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.857 1.263 . . . . 73.21 108.594 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.43 -177.06 43.83 Favored Glycine 0 C--N 1.347 1.163 0 O-C-N 123.36 0.412 . . . . 74.21 113.074 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -142.68 150.44 40.18 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.433 1.093 . . . . 73.34 109.349 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -149.54 97.62 0.18 Allowed Glycine 0 C--N 1.347 1.188 0 N-CA-C 111.051 -0.82 . . . . 64.32 111.051 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 47.3 p -119.14 116.42 26.31 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.249 1.02 . . . . 64.43 109.53 -177.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.6 12.04 2.3 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 113.586 0.958 . . . . 74.44 113.586 -166.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -70.32 105.14 2.9 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.436 0.694 . . . . 73.04 110.64 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -138.14 124.09 20.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.001 0.92 . . . . 73.33 109.104 176.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -126.72 154.51 44.06 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.518 1.127 . . . . 72.41 108.691 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -62.94 144.45 56.76 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.277 0.631 . . . . 64.43 110.233 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.005 0 C-N-CA 123.361 0.664 . . . . 71.33 110.878 -177.598 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.44 0 CA-C-O 120.168 -0.24 . . . . 52.01 112.948 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 178.93 -41.79 0.08 OUTLIER Glycine 0 C--N 1.347 1.16 0 N-CA-C 112.455 -0.258 . . . . 73.13 112.455 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -108.67 -61.6 1.58 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.812 0.845 . . . . 70.54 110.543 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 94' ' ' PHE . . . . . 0.614 ' HB3' ' HB2' ' D' ' 54' ' ' ASP . 0.3 OUTLIER -148.37 -139.46 0.1 Allowed 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 109.369 -0.604 . . . . 74.43 109.369 -172.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -103.37 -73.98 0.65 Allowed 'General case' 0 N--CA 1.505 2.31 0 CA-C-N 119.388 0.995 . . . . 70.13 111.978 -169.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 146.14 33.91 0.07 OUTLIER Glycine 0 C--N 1.357 1.709 0 CA-C-O 119.757 -0.468 . . . . 74.42 113.345 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 97' ' ' ILE . . . . . 0.444 ' HB ' HD22 ' E' ' 100' ' ' LEU . 30.3 mt 57.3 -84.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.064 1.746 . . . . 75.14 111.074 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 98' ' ' ASP . . . . . 0.405 ' HB2' ' HE3' ' D' ' 94' ' ' MET . 5.5 m-20 -153.51 -74.68 0.13 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.679 0.792 . . . . 73.31 109.374 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -161.35 32.75 0.14 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.011 -0.995 . . . . 73.15 110.485 -168.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 100' ' ' LEU . . . . . 0.713 ' HB2' ' HB1' ' D' ' 95' ' ' ALA . 1.4 pt? -57.24 130.85 80.62 Favored Pre-proline 0 CA--C 1.559 1.302 0 C-N-CA 122.876 0.47 . . . . 75.35 111.397 -176.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -61.77 -20.71 70.11 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 123.22 2.613 . . . . 74.44 113.676 -172.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 102' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' E' ' 107' ' ' THR . 0.7 OUTLIER -96.77 79.96 3.01 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.433 -0.951 . . . . 74.32 108.433 174.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 103' ' ' THR . . . . . 0.571 HG22 ' HG ' ' E' ' 100' ' ' LEU . 10.9 p -137.67 15.57 2.92 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.377 1.471 . . . . 70.43 108.474 169.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 179.06 162.68 28.81 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 114.363 -1.29 . . . . 71.42 110.238 -176.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 67.11 135.48 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.909 1.284 . . . . 72.24 109.923 -166.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -70.66 89.06 0.72 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.117 -0.697 . . . . 73.24 109.117 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 107' ' ' THR . . . . . 0.498 ' HA ' HD23 ' E' ' 102' ' ' LEU . 10.0 m 67.45 150.51 0.06 Allowed 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 125.59 1.556 . . . . 75.31 113.297 176.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -129.79 116.22 18.42 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 108.19 -1.041 . . . . 73.1 108.19 171.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 80.3 119.25 0.05 Allowed 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 126.903 2.081 . . . . 74.45 111.963 -175.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.49 146.29 32.78 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 109.201 -0.666 . . . . 72.33 109.201 169.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . 0.595 HD21 ' HB3' ' D' ' 44' ' ' LEU . 32.7 tp -78.81 -48.04 15.54 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.143 0.577 . . . . 75.31 111.643 -169.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 112' ' ' ASN . . . . . 0.434 ' HB2' ' H ' ' D' ' 44' ' ' LEU . 64.5 t30 -83.57 -44.58 14.46 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.265 0.626 . . . . 74.54 109.984 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -72.48 90.25 1.31 Allowed 'General case' 0 C--N 1.358 0.939 0 N-CA-C 108.865 -0.791 . . . . 75.34 108.865 176.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -145.94 158.27 43.87 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.622 -0.717 . . . . 62.44 110.455 -165.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 40.8 p -77.32 101.11 6.15 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.517 0.727 . . . . 75.35 110.752 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.92 93.63 0.91 Allowed Glycine 0 C--N 1.346 1.102 0 CA-C-N 115.657 -0.701 . . . . 54.4 113.192 172.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -132.63 98.14 16.73 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 123.619 0.767 . . . . 73.35 109.41 176.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -67.54 -77.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.108 1.872 . . . . 72.14 110.861 172.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -146.96 131.58 17.82 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.254 1.021 . . . . 75.3 109.109 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -173.94 -54.4 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.901 0.88 . . . . 74.23 109.018 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 121' ' ' VAL . . . . . . . . . . . . . 35.8 t -70.51 -43.34 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 115.225 -0.898 . . . . 74.51 110.069 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 59.4 p -117.03 134.1 55.17 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.357 1.063 . . . . 74.15 108.969 173.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -162.07 163.86 28.45 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.546 0.738 . . . . 74.11 109.671 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 41.5 m -74.88 74.23 2.13 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.784 0.834 . . . . 73.52 110.58 176.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -134.36 169.13 17.69 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.274 1.03 . . . . 63.53 110.253 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . 68.46 74.45 0.27 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.89 1.276 . . . . 72.31 112.006 174.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 27.1 m -76.67 99.89 5.2 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.021 -0.991 . . . . 61.23 109.644 176.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.98 173.62 6.97 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.604 -0.726 . . . . 74.12 111.142 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 1.9 m -92.69 139.12 30.88 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.308 -0.627 . . . . 75.23 109.308 174.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -71.59 152.35 43.0 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.091 0.556 . . . . 55.32 110.062 173.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 131' ' ' TRP . . . . . . . . . . . . . 91.6 t90 -60.29 138.14 58.0 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.63 0.581 . . . . 73.22 110.688 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 70.3 m -161.06 137.8 8.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.281 1.032 . . . . 74.23 108.786 176.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 18.8 m -143.03 135.11 27.07 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.589 -0.523 . . . . 74.45 109.589 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -132.33 89.52 0.27 Allowed Glycine 0 C--N 1.347 1.193 0 N-CA-C 110.629 -0.989 . . . . 75.23 110.629 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 11.3 p -162.67 149.17 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.476 0.71 . . . . 74.22 109.96 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -119.75 -111.02 0.34 Allowed 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 119.159 -0.448 . . . . 75.41 111.115 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 12.9 t -173.17 172.05 3.96 Favored 'General case' 0 C--N 1.361 1.104 0 C-N-CA 122.848 0.459 . . . . 62.11 111.928 -168.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -135.7 140.24 44.28 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.942 1.297 . . . . 74.11 108.538 172.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -63.15 122.86 17.15 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.522 0.729 . . . . 61.2 110.745 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . 168.15 63.86 0.03 OUTLIER Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.276 -0.73 . . . . 60.34 111.276 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -148.88 152.21 36.05 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.853 0.861 . . . . 73.23 109.549 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 76.6 mt 66.98 94.44 0.07 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.908 1.283 . . . . 73.04 111.326 -174.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 143' ' ' GLY . . . . . 0.404 ' HA2' ' HB1' ' C' ' 145' ' ' ALA . . . -108.08 -119.22 4.33 Favored Glycine 0 C--N 1.34 0.776 0 N-CA-C 110.23 -1.148 . . . . 64.21 110.23 171.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 27.8 t -66.13 -24.56 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.386 0.674 . . . . 71.55 109.557 172.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 . . . . . 0 CA--C 1.551 1.014 0 C-N-CA 125.25 1.42 . . . . 63.44 109.861 178.029 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.485 0 N-CA-C 111.509 -0.636 . . . . 43.21 111.509 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.08 -56.8 4.86 Favored Glycine 0 C--N 1.35 1.316 0 C-N-CA 123.025 0.345 . . . . 52.13 112.483 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -79.5 71.44 6.08 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.547 1.139 . . . . 75.45 109.555 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -114.3 129.44 56.64 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.2 1.0 . . . . 75.21 109.181 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 95' ' ' LYS . . . . . 0.426 ' HD3' ' H ' ' F' ' 95' ' ' LYS . 0.0 OUTLIER -80.74 119.93 23.96 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 123.742 0.652 . . . . 74.44 110.07 175.491 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -170.19 5.33 0.04 OUTLIER Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.326 -0.708 . . . . 64.12 114.516 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 97' ' ' ILE . . . . . 0.719 ' HB ' ' HA ' ' B' ' 87' ' ' ALA . 7.2 tt -99.42 -75.15 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 118.018 0.909 . . . . 73.12 110.372 173.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 98' ' ' ASP . . . . . 0.538 ' H ' HG22 ' F' ' 97' ' ' ILE . 25.3 t70 173.24 -85.11 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.621 1.169 . . . . 72.2 108.577 -173.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.6 136.6 0.76 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.975 1.31 . . . . 74.33 108.754 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 100' ' ' LEU . . . . . 0.639 HD11 ' HB2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -147.49 75.55 11.25 Favored Pre-proline 0 CA--C 1.557 1.229 0 N-CA-C 113.183 0.809 . . . . 74.13 113.183 -176.326 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.89 27.83 0.59 Allowed 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 123.223 2.615 . . . . 73.14 112.006 170.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 102' ' ' LEU . . . . . 0.405 HD21 ' OG ' ' B' ' 48' ' ' SER . 42.2 tp 69.73 153.33 0.11 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 126.09 1.756 . . . . 75.24 111.583 -172.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 40.9 p -60.53 136.69 58.13 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.667 0.787 . . . . 71.1 110.254 170.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . -55.72 135.76 48.27 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 124.306 1.004 . . . . 73.21 115.571 -167.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 58.99 79.8 0.21 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.308 1.443 . . . . 74.12 112.625 172.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 16.8 t80 59.86 30.35 19.9 Favored 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.734 0.814 . . . . 74.11 112.386 168.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 11.3 m 56.39 57.72 4.73 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 122.09 0.948 . . . . 75.14 110.195 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -74.93 88.82 2.35 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.238 -0.892 . . . . 75.35 111.422 -174.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -127.76 -57.29 1.27 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.138 -1.06 . . . . 71.41 108.138 170.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -167.64 -28.76 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.113 -1.403 . . . . 70.41 110.203 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 tt -75.03 83.41 2.26 Favored 'General case' 0 C--N 1.359 0.989 0 C-N-CA 123.688 0.795 . . . . 71.41 109.064 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -136.31 133.48 36.93 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 106.875 -1.528 . . . . 74.23 106.875 176.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -64.32 125.88 26.0 Favored 'General case' 0 CA--C 1.551 0.986 0 O-C-N 123.246 0.341 . . . . 75.52 110.923 -172.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -178.0 -47.18 0.01 OUTLIER 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.313 1.045 . . . . 74.5 109.576 -170.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 5.4 m 66.41 149.67 0.05 Allowed 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 125.229 1.412 . . . . 73.43 111.401 -172.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.15 -60.3 2.28 Favored Glycine 0 C--N 1.346 1.087 0 N-CA-C 111.673 -0.571 . . . . 72.2 111.673 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 117' ' ' LYS . . . . . 0.414 ' HB2' ' HD3' ' F' ' 118' ' ' PRO . 12.1 mptt -70.55 -44.93 18.15 Favored Pre-proline 0 CA--C 1.556 1.181 0 CA-C-O 118.802 -0.618 . . . . 75.11 110.017 175.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 118' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' F' ' 117' ' ' LYS . 2.8 Cg_exo -79.17 124.57 6.06 Favored 'Trans proline' 0 C--N 1.391 2.795 0 C-N-CA 121.973 1.782 . . . . 73.14 110.316 160.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -83.62 -164.91 0.98 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.467 0.707 . . . . 74.23 110.071 176.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 73.83 -64.75 0.38 Allowed 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 125.307 1.443 . . . . 70.53 110.833 -173.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 28.9 t -71.39 89.06 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 124.471 1.108 . . . . 74.33 109.995 -175.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 16.2 p -142.87 -66.96 0.37 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.51 1.124 . . . . 72.32 108.905 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -172.89 123.37 0.42 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.249 1.019 . . . . 70.33 109.63 -177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 20.0 m -156.26 116.23 3.61 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.403 -0.962 . . . . 74.34 108.403 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . 65.33 13.33 8.73 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.783 0.833 . . . . 64.43 112.955 173.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.37 97.38 4.24 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 123.425 0.69 . . . . 65.43 109.279 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 14.6 m -65.1 94.64 0.15 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.124 0.97 . . . . 74.33 112.088 -170.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.29 92.93 7.04 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.038 0.935 . . . . 73.14 109.865 176.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 13.3 p -129.6 161.02 31.5 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.933 0.893 . . . . 75.31 111.034 -174.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -74.71 137.8 42.35 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.017 0.927 . . . . 71.13 112.177 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -86.77 119.16 26.7 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.505 0.722 . . . . 72.55 109.979 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 22.9 t -171.58 165.73 6.79 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.616 0.766 . . . . 70.33 110.65 174.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 16.9 p -140.25 -178.49 5.5 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.52 1.128 . . . . 74.44 110.803 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -166.05 159.05 32.22 Favored Glycine 0 C--N 1.353 1.509 0 N-CA-C 111.146 -0.782 . . . . 73.43 111.146 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 135' ' ' VAL . . . . . 0.489 HG12 ' HB3' ' C' ' 42' ' ' LEU . 60.6 t -140.07 119.06 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 123.413 0.685 . . . . 74.44 109.551 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 136' ' ' LYS . . . . . 0.462 ' HB3' ' HA ' ' C' ' 41' ' ' LYS . 54.2 tttp -79.92 -79.17 0.15 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 122.549 0.339 . . . . 73.11 110.65 172.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 91.0 m -157.17 128.95 7.08 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.51 0.724 . . . . 75.32 109.517 -168.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -79.24 76.63 5.78 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.817 -0.809 . . . . 75.21 108.817 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -162.96 130.9 3.74 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.454 -0.943 . . . . 73.12 108.454 -173.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -82.15 60.53 4.79 Favored Glycine 0 C--N 1.342 0.907 0 O-C-N 123.575 0.547 . . . . 75.2 112.499 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.0 137.18 57.88 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.244 0.617 . . . . 72.42 110.995 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -138.35 -173.03 3.42 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.051 0.94 . . . . 73.13 109.684 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.87 8.03 65.6 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 112.242 -0.343 . . . . 62.1 112.242 -176.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 96.5 t -81.25 125.4 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 124.067 0.947 . . . . 74.43 110.842 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 30.1 t70 . . . . . 0 C--O 1.245 0.868 0 C-N-CA 123.794 0.837 . . . . 73.44 108.87 173.079 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ppp? . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 110.265 -0.272 . . . . 71.41 110.265 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.3 t -165.04 126.26 2.03 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 108.494 -0.928 . . . . 72.35 108.494 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -75.16 79.26 2.3 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-O 122.163 0.982 . . . . 73.11 110.183 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -154.07 -58.0 0.12 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.069 -0.969 . . . . 71.13 109.065 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -130.4 163.87 25.95 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.805 0.842 . . . . 74.55 109.355 -175.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -55.82 109.11 0.52 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.595 0.758 . . . . 61.51 110.07 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.2 m -61.65 150.84 35.23 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 124.159 0.984 . . . . 74.31 111.09 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -49.22 128.55 16.84 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 124.273 0.983 . . . . 74.0 111.113 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.454 ' HE3' HG21 ' A' ' 89' ' ' ILE . 56.9 mtt -80.41 161.97 24.68 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.366 -0.834 . . . . 74.51 110.175 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 75.9 m -139.06 113.8 9.18 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 107.672 -1.233 . . . . 74.21 107.672 173.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -114.91 120.5 40.16 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.725 -1.213 . . . . 73.25 107.725 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -139.11 123.77 18.51 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.55 -0.907 . . . . 71.43 108.55 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.526 HD12 HG21 ' A' ' 105' ' ' ILE . 3.0 mt -88.43 119.59 35.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.624 -0.88 . . . . 73.33 108.624 177.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -91.39 -37.27 13.31 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 123.785 0.678 . . . . 74.1 110.516 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -171.17 121.49 0.54 Allowed 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.353 0.408 . . . . 74.1 109.948 -176.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.547 HD13 ' HG3' ' C' ' 130' ' ' PRO . 76.2 mt -106.72 137.18 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.201 -1.037 . . . . 73.12 108.201 171.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.501 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 37.3 p90 -164.44 175.89 9.53 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-O 122.042 0.925 . . . . 73.11 111.92 -174.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 56.2 p -102.78 111.56 23.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.677 -1.147 . . . . 75.5 108.724 176.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.501 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 34.2 mtpt -72.92 -34.32 66.54 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.283 -0.636 . . . . 75.02 109.283 175.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.475 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.1 t70 -150.35 145.79 26.33 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.965 -1.016 . . . . 73.33 110.142 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.55 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 75.5 mt -142.78 143.3 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.663 1.585 . . . . 74.51 107.43 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.4 t -154.72 131.24 10.56 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.899 0.48 . . . . 63.2 110.165 173.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.497 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 87.6 t80 -126.99 141.9 51.68 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.332 -1.358 . . . . 65.03 107.332 172.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -135.04 142.52 46.39 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.785 -0.45 . . . . 73.31 109.785 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.83 71.08 13.74 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 106.991 -1.485 . . . . 64.42 106.991 166.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -71.78 -17.84 28.93 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 122.434 2.089 . . . . 75.13 112.2 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -104.71 17.38 24.24 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-O 118.007 -0.996 . . . . 72.32 109.698 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.444 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -46.34 -55.72 13.03 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 113.674 0.99 . . . . 63.12 113.674 -169.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.444 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 32.2 Cg_exo -60.83 -26.85 83.83 Favored 'Trans proline' 0 C--N 1.388 2.616 0 C-N-CA 121.73 1.62 . . . . 63.44 113.612 178.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -81.86 -41.23 21.28 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.876 0.871 . . . . 71.24 110.522 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.546 HG22 ' HA ' ' A' ' 73' ' ' ALA . 3.8 p -74.95 -20.66 16.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 124.576 1.15 . . . . 73.43 111.787 -161.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -76.91 -21.27 55.13 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.584 0.754 . . . . 74.24 110.852 176.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -90.51 -11.94 38.71 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.697 1.199 . . . . 71.44 110.879 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -83.07 164.06 20.53 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.165 0.986 . . . . 72.41 111.44 -178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.96 118.86 17.41 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.538 0.735 . . . . 61.31 109.367 173.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.531 ' HD1' ' HB3' ' E' ' 132' ' ' SER . 71.2 t-105 -81.06 93.14 6.34 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 121.05 0.453 . . . . 75.24 110.737 -176.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -128.04 84.1 64.22 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 107.342 -1.355 . . . . 72.32 107.342 168.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -76.31 110.48 3.07 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.534 2.156 . . . . 70.33 112.443 -171.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -92.85 84.78 5.01 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 106.68 -1.6 . . . . 70.13 106.68 175.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.722 HG23 ' HB1' ' A' ' 66' ' ' ALA . 48.8 t -86.81 106.51 15.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 114.789 -1.096 . . . . 75.3 110.431 -173.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -79.01 123.47 27.33 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.19 -0.914 . . . . 74.13 109.454 171.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.8 mt -97.57 106.21 18.49 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.203 -1.036 . . . . 74.31 108.203 173.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.455 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 29.3 t70 -108.52 140.69 41.51 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.803 -1.184 . . . . 75.54 107.803 176.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.468 HD22 HD21 ' A' ' 60' ' ' LEU . 85.5 mt -136.56 150.95 48.87 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.173 0.589 . . . . 73.1 110.925 -172.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.422 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 21.8 t0 -154.77 148.98 25.98 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.931 -1.032 . . . . 71.01 109.417 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.501 HG21 ' HA2' ' A' ' 99' ' ' GLY . 89.3 m -130.86 147.44 52.51 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.614 0.766 . . . . 73.22 109.582 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -157.33 109.73 2.44 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.625 0.77 . . . . 73.34 109.661 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.3 p -93.15 154.38 18.1 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.111 0.564 . . . . 62.01 110.229 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.8 t -151.62 121.51 7.07 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.047 0.939 . . . . 73.51 109.023 -176.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -73.03 105.57 4.55 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.034 0.533 . . . . 73.34 109.679 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.494 HD13 HG22 ' A' ' 83' ' ' ILE . 60.6 mt -79.09 -38.65 35.73 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.195 0.598 . . . . 73.52 110.275 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.27 -179.88 7.93 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.925 -1.034 . . . . 71.02 109.485 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -68.46 124.93 24.9 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.012 0.525 . . . . 73.01 109.944 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 63.72 16.6 9.86 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.008 1.323 . . . . 74.42 111.717 -173.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.0 t -124.93 109.22 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.083 0.953 . . . . 65.22 108.526 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -121.9 125.62 46.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.332 -0.988 . . . . 74.43 108.332 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.486 ' HB2' HD11 ' A' ' 51' ' ' LEU . 21.7 tt0 -83.44 150.33 26.11 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.984 -1.117 . . . . 74.13 107.984 166.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.0 t -131.16 136.27 58.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 107.642 -1.244 . . . . 74.13 107.642 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.436 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 48.7 t -109.56 135.97 46.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.367 -0.975 . . . . 74.55 108.367 175.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.478 HD23 HG23 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -112.95 104.09 12.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.643 -1.614 . . . . 74.44 106.643 170.606 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.422 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 16.6 ttp180 -92.79 100.15 12.69 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.363 -1.347 . . . . 73.41 107.363 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.478 HG23 HD23 ' A' ' 60' ' ' LEU . 22.8 t -98.44 128.97 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 N-CA-C 108.235 -1.024 . . . . 74.43 108.235 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.455 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 16.8 m -120.95 112.04 18.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.524 0.678 . . . . 73.53 109.322 175.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.491 HG22 HG21 ' A' ' 114' ' ' ILE . 80.4 t -106.14 125.94 61.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 124.731 1.212 . . . . 74.34 107.883 -178.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.1 m -134.08 115.05 13.83 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 118.379 0.536 . . . . 71.25 109.848 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.722 ' HB1' HG23 ' A' ' 40' ' ' VAL . . . -100.79 121.85 42.4 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.059 -1.46 . . . . 63.41 107.059 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.1 m -121.84 135.71 54.91 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.435 0.694 . . . . 73.12 109.876 176.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.459 HD21 ' CE3' ' A' ' 36' ' ' TRP . 17.6 mt -88.13 72.1 9.18 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 107.65 -1.241 . . . . 72.42 107.65 174.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.77 -90.85 1.07 Allowed Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.218 -0.901 . . . . 64.13 111.515 -171.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -113.27 -27.03 8.12 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.165 0.586 . . . . 74.4 111.933 -174.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -85.65 129.83 34.72 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.504 -0.924 . . . . 72.34 108.504 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.3 m -72.85 125.87 28.57 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.876 -0.416 . . . . 72.34 109.876 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.546 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -71.26 -57.68 4.25 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.844 0.858 . . . . 74.15 110.319 175.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -155.06 164.5 38.8 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.261 -0.881 . . . . 74.31 111.497 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 64' ' ' VAL . 65.6 tp -118.82 140.95 49.11 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.8 -1.091 . . . . 75.33 108.202 170.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.469 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 83.2 m -140.07 96.84 3.12 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.711 0.805 . . . . 65.32 109.66 173.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -111.49 117.44 33.03 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.575 -0.528 . . . . 64.41 109.575 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.1 t -126.58 113.96 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.003 0.921 . . . . 72.4 109.845 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 53.0 mt-30 -86.3 85.58 7.34 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.774 0.83 . . . . 70.31 109.21 171.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.472 ' HG3' HD23 ' A' ' 106' ' ' LEU . 7.9 tp-100 -78.62 96.34 5.47 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.079 -0.964 . . . . 75.13 109.978 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -100.72 145.43 17.11 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.552 -0.619 . . . . 74.11 111.552 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.47 130.42 3.94 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.65 -0.98 . . . . 74.11 110.65 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.494 HG22 HD13 ' A' ' 51' ' ' LEU . 48.8 mt -79.55 126.56 39.22 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 108.501 -0.925 . . . . 74.41 108.501 174.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.555 ' HB3' HD12 ' A' ' 86' ' ' ILE . 74.0 m-85 -131.6 123.29 27.59 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.426 0.69 . . . . 72.54 109.894 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.9 t -83.44 106.23 15.02 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.237 -0.653 . . . . 75.01 109.237 171.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.555 HD12 ' HB3' ' A' ' 84' ' ' PHE . 7.7 mm -117.05 150.52 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.418 0.687 . . . . 72.34 110.157 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.96 163.38 16.04 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.571 0.544 . . . . 64.24 112.079 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.22 -19.41 46.03 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-N 115.543 -0.753 . . . . 72.2 113.124 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.454 HG21 ' HE3' ' A' ' 9' ' ' MET . 0.2 OUTLIER -134.11 148.95 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.741 0.816 . . . . 75.31 111.216 -171.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -138.05 175.24 9.75 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.942 1.297 . . . . 71.3 109.183 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.5 -123.99 33.52 Favored Glycine 0 CA--C 1.533 1.195 0 O-C-N 123.623 0.577 . . . . 34.2 114.185 175.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 38.1 p -73.2 -30.34 63.45 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.037 0.935 . . . . 65.35 110.825 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -67.66 -37.83 82.93 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.306 1.042 . . . . 64.33 110.359 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.408 ' HE3' HG21 ' A' ' 86' ' ' ILE . 5.3 tpt -68.38 -45.55 72.44 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.939 -0.573 . . . . 74.24 109.648 175.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.69 -38.1 77.5 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.187 0.929 . . . . 75.4 111.75 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -67.94 -33.91 75.58 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.31 0.644 . . . . 65.2 111.269 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.4 t -69.99 -45.11 68.0 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.019 0.437 . . . . 75.45 110.065 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.7 mt -80.79 -31.03 35.89 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.103 -0.953 . . . . 74.5 112.677 -170.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.501 ' HA2' HG21 ' A' ' 46' ' ' THR . . . -106.6 4.59 37.12 Favored Glycine 0 N--CA 1.472 1.059 0 CA-C-O 119.953 -0.36 . . . . 65.51 113.783 -173.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.608 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -136.13 -68.43 0.5 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 117.191 0.495 . . . . 61.24 111.186 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -68.22 -43.7 77.39 Favored 'General case' 0 CA--C 1.555 1.135 0 CA-C-N 116.316 -0.402 . . . . 73.45 111.914 -172.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.2 m -63.71 -51.47 65.38 Favored Pre-proline 0 CA--C 1.57 1.73 0 C-N-CA 124.247 1.019 . . . . 73.21 113.084 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.47 -19.97 48.39 Favored 'Trans proline' 0 C--N 1.397 3.084 0 C-N-CA 121.842 1.695 . . . . 74.13 113.008 173.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -67.99 -37.52 81.58 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.187 0.595 . . . . 63.33 110.519 174.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.526 HG21 HD12 ' A' ' 13' ' ' ILE . 48.7 mm -67.29 -41.45 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.529 0.732 . . . . 72.25 110.084 173.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.472 HD23 ' HG3' ' A' ' 80' ' ' GLN . 61.5 mt -73.5 -25.59 60.51 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.018 -0.992 . . . . 74.34 112.422 -174.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -61.12 -45.57 95.97 Favored Pre-proline 0 N--CA 1.486 1.354 0 N-CA-C 114.127 1.158 . . . . 75.55 114.127 -173.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -53.46 -36.46 79.77 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.265 1.977 . . . . 74.52 113.611 171.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.489 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 88.0 m-85 -83.36 -28.96 28.6 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.635 0.774 . . . . 70.43 112.252 -177.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.93 -46.77 70.57 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.414 -0.958 . . . . 73.15 108.414 172.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.506 ' NH1' HD13 ' C' ' 105' ' ' ILE . 32.0 ttm180 -58.25 -43.17 87.71 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 114.04 -1.436 . . . . 75.14 109.739 175.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 109' ' ' TYR . 11.6 tt0 -48.83 -57.94 5.6 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 125.055 1.342 . . . . 73.2 111.462 175.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.463 ' SG ' HD11 ' A' ' 21' ' ' ILE . 53.6 t -64.92 -45.19 86.91 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.428 -1.26 . . . . 65.52 111.693 -174.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.568 HD12 HD12 ' A' ' 128' ' ' LEU . 8.5 mt -58.6 -60.27 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.818 0.847 . . . . 63.53 110.554 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.9 m -50.1 -41.87 49.16 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 125.058 1.343 . . . . 65.51 112.513 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -67.97 -43.03 79.91 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.714 -1.13 . . . . 75.31 110.635 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.532 ' HE1' ' HA ' ' A' ' 114' ' ' ILE . 52.6 mtm -62.28 -39.32 92.55 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 122.807 0.443 . . . . 65.43 110.875 177.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.429 HG21 ' O ' ' A' ' 114' ' ' ILE . 94.9 t -57.58 -49.56 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 124.341 1.056 . . . . 75.13 110.232 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 81.6 p -71.61 -29.36 64.58 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.89 -0.595 . . . . 74.42 111.61 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -72.33 -29.19 63.59 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.673 0.789 . . . . 74.12 110.17 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.76 18.3 31.16 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-O 119.459 -0.634 . . . . 72.54 112.762 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.467 HG23 ' HE ' ' B' ' 15' ' ' ARG . 5.6 t 58.03 13.08 2.04 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 127.445 2.298 . . . . 61.31 114.014 178.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -78.98 150.25 74.72 Favored Pre-proline 0 C--O 1.245 0.85 0 N-CA-C 108.156 -1.053 . . . . 63.23 108.156 171.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.653 ' HB3' ' HA ' ' E' ' 131' ' ' TRP . 24.4 Cg_endo -58.61 144.25 97.64 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.278 1.985 . . . . 70.31 110.852 174.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -55.07 129.34 37.64 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 124.562 1.164 . . . . 72.42 111.698 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.9 tp -107.37 138.1 44.2 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 108.416 -0.957 . . . . 73.14 108.416 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -122.74 125.85 46.35 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.1 -1.074 . . . . 73.35 108.1 175.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.568 HD12 HD12 ' A' ' 114' ' ' ILE . 10.2 mt -73.1 126.54 30.24 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.492 -0.929 . . . . 74.34 108.492 177.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.489 ' HB2' ' HB ' ' E' ' 135' ' ' VAL . . . -57.71 134.99 82.79 Favored Pre-proline 0 CA--C 1.554 1.108 0 CA-C-O 118.974 -0.536 . . . . 72.21 110.883 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.59 116.56 2.8 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.653 2.902 . . . . 73.21 113.843 -175.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.4 t -105.87 131.94 54.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-O 121.058 0.456 . . . . 71.23 110.456 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 134' ' ' ASP . 52.0 t-20 -99.66 91.79 5.04 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.581 -1.191 . . . . 53.25 107.82 175.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -63.16 -25.83 68.53 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.715 0.806 . . . . 72.44 112.637 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.608 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 28.9 t70 -59.37 -49.56 77.34 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.286 -0.635 . . . . 74.25 109.286 171.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.37 96.54 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.326 1.017 . . . . 73.23 111.286 177.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 72.6 mt -60.7 -43.4 97.83 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.084 0.554 . . . . 72.1 111.14 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -71.23 -33.52 69.95 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.863 -0.608 . . . . 75.42 110.153 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.511 ' HB3' ' HB3' ' A' ' 143' ' ' GLN . 0.3 OUTLIER -60.1 -42.68 95.19 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.229 0.612 . . . . 63.41 110.335 177.343 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -59.83 -39.06 83.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 123.581 0.551 . . . . 72.13 111.044 177.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -72.94 -38.65 66.73 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.671 -0.695 . . . . 74.41 110.886 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 37.3 tp -69.71 -52.96 20.92 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.696 0.798 . . . . 74.55 111.483 -168.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 172.5 -16.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 123.951 0.9 . . . . 71.34 111.665 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.511 ' HB3' ' HB3' ' A' ' 138' ' ' MET . 7.5 tp60 -82.8 128.12 34.1 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.178 0.591 . . . . 75.33 111.804 -171.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -106.14 99.15 8.75 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.499 -1.297 . . . . 73.12 107.499 174.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -145.49 128.9 16.9 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.279 0.632 . . . . 54.15 109.994 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.41 159.16 44.43 Favored Glycine 0 C--N 1.343 0.928 0 O-C-N 123.672 0.608 . . . . 72.22 112.843 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.88 148.23 34.7 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.627 0.771 . . . . 75.22 111.429 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -79.34 77.49 1.84 Allowed Glycine 0 C--N 1.348 1.206 0 N-CA-C 111.298 -0.721 . . . . 73.43 111.298 176.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.7 t -116.44 134.48 54.81 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.394 0.677 . . . . 72.33 109.328 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -161.66 160.61 28.9 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.217 -0.66 . . . . 71.23 109.217 -173.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.47 173.91 10.93 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 124.012 0.925 . . . . 74.43 111.223 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.588 ' HB3' HG22 ' C' ' 10' ' ' THR . 7.2 p80 -159.88 -45.57 0.05 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.847 0.859 . . . . 63.11 111.568 -176.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 61.3 -169.26 0.17 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.325 0.65 . . . . 71.34 110.077 -164.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -99.12 -160.74 0.82 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.087 0.555 . . . . 60.25 109.521 173.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.331 0 C-N-CA 122.828 0.451 . . . . 70.14 110.457 -179.401 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.472 ' HA ' ' O ' ' F' ' 95' ' ' LYS . 52.5 ttm . . . . . 0 CA--C 1.545 0.781 0 N-CA-C 111.929 0.344 . . . . 72.4 111.929 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m -141.88 36.29 1.59 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.991 0.516 . . . . 73.41 111.388 -170.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -81.56 157.51 24.74 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.398 0.679 . . . . 72.13 111.049 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -146.59 29.4 1.03 Allowed 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.53 0.732 . . . . 75.15 109.535 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -161.36 169.28 22.32 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.019 -0.734 . . . . 72.42 109.019 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -68.72 87.17 0.34 Allowed 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.15 -0.685 . . . . 73.22 109.15 170.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.0 p -93.91 -154.54 0.41 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.053 0.941 . . . . 73.4 109.866 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -51.19 -31.77 21.31 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.465 1.106 . . . . 74.15 112.01 170.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.476 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 1.0 OUTLIER 65.45 168.51 0.2 Allowed 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 125.259 1.423 . . . . 72.53 110.97 177.376 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.467 ' N ' ' SD ' ' B' ' 9' ' ' MET . 79.3 m -149.45 108.48 3.9 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 123.987 0.915 . . . . 72.13 108.71 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.476 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 65.9 t80 -116.55 145.63 43.21 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.433 0.693 . . . . 73.0 109.363 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -158.91 141.7 14.36 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.194 -1.039 . . . . 72.4 108.194 170.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 31.6 mt -76.86 145.67 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 N-CA-C 108.267 -1.012 . . . . 74.34 108.267 170.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -109.25 -40.51 4.92 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.901 0.481 . . . . 71.02 110.183 174.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.467 ' HE ' HG23 ' A' ' 122' ' ' THR . 48.0 ttt180 -173.68 137.13 0.6 Allowed 'General case' 0 N--CA 1.476 0.871 0 O-C-N 123.73 0.644 . . . . 74.42 109.881 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 93.4 mt -114.92 138.55 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.848 1.259 . . . . 73.01 107.678 176.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -164.43 140.68 6.16 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.919 0.711 . . . . 72.23 112.919 -173.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 69.9 m -73.7 121.48 20.83 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.057 -0.974 . . . . 74.44 109.121 170.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.499 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 46.9 mtpt -98.77 -16.96 18.74 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.636 0.774 . . . . 65.02 111.764 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.571 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 34.5 t70 -169.81 144.66 2.86 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.724 0.64 . . . . 64.53 111.186 -172.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.543 HD12 ' SG ' ' B' ' 113' ' ' CYS . 30.6 mm -143.53 146.36 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.677 1.191 . . . . 75.4 110.173 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.488 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 72.4 m -144.02 139.28 28.92 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.528 1.531 . . . . 73.01 108.558 171.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.55 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 89.4 t80 -148.36 108.73 4.13 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.297 -1.742 . . . . 74.5 106.297 164.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -118.8 114.64 22.96 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.079 -1.082 . . . . 64.21 108.079 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.68 86.9 2.47 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.164 -1.421 . . . . 64.03 107.164 173.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.9 -35.52 20.65 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.883 2.389 . . . . 64.04 112.171 -171.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -103.1 16.38 26.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.977 0.911 . . . . 75.54 110.962 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.77 -58.52 4.49 Favored Pre-proline 0 N--CA 1.491 1.591 0 C-N-CA 124.985 1.314 . . . . 70.1 114.479 -168.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -57.99 -45.42 32.35 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 122.367 2.044 . . . . 74.45 113.328 -171.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -96.55 -17.24 20.6 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.172 -0.922 . . . . 73.43 112.802 -170.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.444 HG22 ' HA ' ' B' ' 73' ' ' ALA . 5.2 p -73.07 -20.32 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 118.169 0.44 . . . . 73.41 110.345 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -72.61 -1.06 14.67 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.493 0.923 . . . . 75.14 113.493 -177.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -71.56 -16.88 62.33 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 120.911 0.386 . . . . 74.42 110.097 167.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.422 ' HZ1' ' HG2' ' B' ' 71' ' ' GLU . 96.7 mttt -105.9 69.38 0.81 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.525 1.53 . . . . 74.41 110.0 -176.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -84.85 76.59 10.22 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.773 0.797 . . . . 72.04 110.492 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.424 ' O ' ' HG2' ' B' ' 124' ' ' PRO . 3.8 p90 -152.92 173.15 15.73 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.037 -1.097 . . . . 73.35 108.037 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -66.52 115.33 23.1 Favored Pre-proline 0 CA--C 1.563 1.445 0 N-CA-C 112.353 0.501 . . . . 72.12 112.353 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.411 ' HD3' ' HG2' ' B' ' 124' ' ' PRO . 60.2 Cg_endo -71.85 157.06 55.86 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.512 2.141 . . . . 64.32 111.593 176.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.68 103.96 5.16 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.252 -1.018 . . . . 75.43 108.252 169.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.538 HG22 ' HB1' ' B' ' 66' ' ' ALA . 21.5 t -96.18 157.08 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.204 1.002 . . . . 74.41 110.031 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -142.97 124.65 14.95 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.625 1.17 . . . . 75.43 107.94 172.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.466 HD11 HD12 ' B' ' 128' ' ' LEU . 21.5 tp -87.56 136.85 32.78 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 108.32 -0.992 . . . . 74.24 108.32 170.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -137.04 149.89 47.73 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.711 -0.848 . . . . 64.11 108.711 -173.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mp -128.6 150.5 50.19 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.92 0.888 . . . . 71.43 109.578 -174.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.426 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 27.2 t70 -154.55 152.15 29.72 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.57 1.148 . . . . 74.11 108.673 173.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' THR . . . . . 0.411 HG23 HD22 ' B' ' 60' ' ' LEU . 75.9 p -126.76 134.5 50.6 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 121.176 0.513 . . . . 73.12 111.474 -177.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.05 116.17 6.06 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.04 -1.467 . . . . 74.33 107.04 169.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.483 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 41.0 m -143.0 161.15 38.9 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.572 0.349 . . . . 61.34 110.741 -171.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.8 p -152.1 139.91 19.93 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.904 0.482 . . . . 71.04 111.288 -172.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -83.47 129.25 34.97 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.465 -0.939 . . . . 74.41 108.465 169.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 pp -141.84 25.05 1.99 Allowed 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.774 0.829 . . . . 74.33 109.823 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' B' ' 55' ' ' VAL . . . -161.43 148.01 14.44 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.154 -0.93 . . . . 74.02 109.789 -173.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.41 121.71 24.18 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.1 -0.704 . . . . 72.23 109.1 171.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 68.53 12.12 8.59 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 124.675 1.235 . . . . 70.34 113.03 174.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.415 ' O ' ' HB1' ' B' ' 52' ' ' ALA . 89.6 t -140.01 129.87 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 N-CA-C 107.068 -1.456 . . . . 74.42 107.068 -175.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.483 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 11.8 t80 -118.0 153.37 33.78 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.902 -0.499 . . . . 64.23 110.104 -175.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -116.3 105.77 12.92 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.63 -1.248 . . . . 75.33 107.63 176.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.43 143.41 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.859 0.864 . . . . 75.23 109.787 -176.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 22.7 t -129.83 127.06 63.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 C-N-CA 123.982 0.913 . . . . 63.53 108.756 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.411 HD22 HG23 ' B' ' 46' ' ' THR . 0.3 OUTLIER -110.53 120.41 42.32 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 107.628 -1.249 . . . . 71.22 107.628 172.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.426 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 16.7 ttm-85 -86.82 113.28 22.5 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.86 -0.793 . . . . 74.13 108.86 174.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.41 HG11 ' CD1' ' B' ' 114' ' ' ILE . 48.9 t -109.17 105.19 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.095 0.958 . . . . 74.31 108.652 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 23.9 m -107.08 148.01 29.29 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.209 1.004 . . . . 72.34 109.991 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.581 HG23 HG23 ' B' ' 114' ' ' ILE . 24.4 t -136.47 117.78 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.107 1.363 . . . . 74.24 108.797 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 85.8 m -104.96 136.53 44.27 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 108.119 -1.067 . . . . 63.14 108.119 169.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.538 ' HB1' HG22 ' B' ' 40' ' ' VAL . . . -140.2 144.65 36.69 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.801 -0.814 . . . . 71.01 108.801 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.465 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 61.2 p -144.54 133.35 22.44 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.745 0.646 . . . . 44.32 112.745 -173.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 53.0 mt -107.61 128.44 54.54 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.672 1.189 . . . . 71.23 110.506 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.76 -110.57 3.41 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 111.751 -0.539 . . . . 63.44 111.751 -173.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -116.9 1.73 12.7 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 123.536 0.734 . . . . 73.25 110.432 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.422 ' HG2' ' HZ1' ' B' ' 34' ' ' LYS . 14.0 pt-20 -115.03 158.37 22.19 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.749 -0.595 . . . . 75.11 110.218 -174.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.8 m -68.77 130.87 44.07 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 110.062 -0.348 . . . . 65.02 110.062 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.465 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -81.0 -64.82 1.11 Allowed 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.634 -1.247 . . . . 73.11 107.634 173.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -151.29 164.77 35.88 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.058 -0.974 . . . . 73.12 111.492 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 74.5 mt -127.01 131.61 50.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 105.992 -1.855 . . . . 74.25 105.992 170.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.469 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 34.2 t -131.51 149.79 52.39 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.036 -1.098 . . . . 71.25 108.036 172.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.488 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 49.7 tt0 -158.41 131.89 7.56 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.072 -0.714 . . . . 72.33 109.072 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.427 HG11 ' HA ' ' B' ' 110' ' ' ALA . 87.4 t -129.44 148.38 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.443 -0.947 . . . . 74.32 108.443 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.571 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 27.2 mt-30 -124.91 93.56 3.93 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.958 -1.127 . . . . 74.52 107.958 171.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -89.76 108.93 19.98 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.229 -0.896 . . . . 73.14 108.878 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.499 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -104.4 171.78 19.77 Favored Glycine 0 C--N 1.337 0.62 0 O-C-N 123.791 0.682 . . . . 63.42 111.867 177.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.46 137.48 4.26 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.468 -0.396 . . . . 74.42 112.47 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 51.4 mt -88.79 121.26 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 107.42 -1.326 . . . . 73.43 107.42 170.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -131.54 145.14 51.59 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.27 1.028 . . . . 63.44 108.974 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 56.4 m -89.53 121.88 32.16 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.548 0.739 . . . . 72.32 110.058 170.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.651 HG23 HD13 ' B' ' 89' ' ' ILE . 5.3 mp -125.29 108.79 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 107.472 -1.307 . . . . 74.02 107.472 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.585 ' HA ' ' HB ' ' F' ' 97' ' ' ILE . . . -144.86 166.12 26.17 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.609 0.763 . . . . 74.24 111.069 -177.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 94.37 -29.81 8.49 Favored Glycine 0 N--CA 1.482 1.739 0 CA-C-O 121.098 0.277 . . . . 54.34 113.419 176.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.651 HD13 HG23 ' B' ' 86' ' ' ILE . 0.7 OUTLIER -90.83 168.26 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 124.598 1.159 . . . . 73.11 110.999 176.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -157.16 163.47 38.85 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.649 0.78 . . . . 74.54 110.299 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.51 -113.4 4.33 Favored Glycine 0 C--N 1.356 1.641 0 C-N-CA 123.473 0.558 . . . . 63.41 112.521 171.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 31.4 m -104.22 -35.42 8.01 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.71 0.804 . . . . 55.5 109.604 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -66.3 -17.31 64.68 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.104 0.962 . . . . 74.23 111.98 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.465 ' HA ' HD11 ' B' ' 89' ' ' ILE . 21.5 ptm -61.21 -56.57 19.16 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 122.865 0.466 . . . . 74.13 111.514 173.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . 0.405 ' HA ' ' HG ' ' B' ' 98' ' ' LEU . . . -81.0 -11.47 59.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.793 0.837 . . . . 64.34 111.939 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -64.75 -36.04 83.03 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.68 0.392 . . . . 75.21 110.778 169.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.1 t -66.76 -41.13 88.27 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.748 0.419 . . . . 74.45 111.516 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.607 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.6 pp -84.19 -29.82 26.29 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.892 0.477 . . . . 74.51 111.402 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.86 -24.65 31.88 Favored Glycine 0 C--N 1.345 1.081 0 O-C-N 123.535 0.522 . . . . 73.53 113.913 -172.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.4 -48.48 2.19 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.291 0.637 . . . . 73.11 111.513 -174.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -75.94 -47.07 26.62 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.689 0.396 . . . . 72.14 111.692 -173.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.607 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 73.6 m -64.03 -42.42 69.26 Favored Pre-proline 0 CA--C 1.566 1.559 0 N-CA-C 113.6 0.963 . . . . 70.51 113.6 -177.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.55 -21.22 53.01 Favored 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 121.878 1.719 . . . . 65.3 113.806 173.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -70.13 -30.55 67.75 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 122.539 0.335 . . . . 71.22 110.772 173.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.404 HG22 ' NH2' ' D' ' 111' ' ' ARG . 84.0 mt -67.34 -40.77 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.789 0.836 . . . . 75.44 109.689 170.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 96.8 mt -76.47 -27.36 56.1 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.831 -1.077 . . . . 73.15 112.51 -174.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -55.23 -47.47 98.47 Favored Pre-proline 0 CA--C 1.567 1.597 0 CA-C-O 118.042 -0.98 . . . . 72.44 113.494 -175.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -52.45 -41.3 68.23 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 122.838 2.359 . . . . 74.54 114.711 174.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -68.83 -36.62 78.41 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.057 0.543 . . . . 75.13 110.656 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.427 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -70.5 -36.08 73.59 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.765 0.826 . . . . 75.35 111.062 174.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.553 ' HA ' HD13 ' B' ' 128' ' ' LEU . 35.4 ttt-85 -63.3 -56.05 19.68 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.167 1.387 . . . . 70.45 110.661 -178.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . 0.466 ' HG3' ' NH2' ' C' ' 120' ' ' ARG . 1.4 tm-20 -69.48 -22.53 63.61 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.762 -0.654 . . . . 75.42 109.832 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.543 ' SG ' HD12 ' B' ' 21' ' ' ILE . 4.3 t -75.97 -28.37 57.85 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 122.64 0.376 . . . . 74.43 111.138 176.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.581 HG23 HG23 ' B' ' 64' ' ' VAL . 52.3 mt -74.97 -56.22 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.515 0.726 . . . . 74.14 109.234 173.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 52.6 m -58.56 -27.95 65.07 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.185 0.994 . . . . 75.1 111.556 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 29.8 t -58.59 -53.76 54.75 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.921 0.888 . . . . 72.2 110.365 173.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.494 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.4 mmt -71.6 -32.8 68.41 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.905 0.882 . . . . 75.41 111.074 -172.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.471 HG23 HD21 ' B' ' 126' ' ' LEU . 98.7 t -64.67 -42.87 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.658 1.183 . . . . 65.13 110.459 173.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.7 t -65.93 -39.09 90.21 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.033 -0.985 . . . . 70.11 110.408 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' B' ' 116' ' ' SER . 66.4 mtt-85 -64.91 -45.44 85.89 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.518 -0.765 . . . . 74.44 109.214 174.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -64.22 -11.16 44.98 Favored Glycine 0 C--N 1.361 1.917 0 O-C-N 124.58 1.175 . . . . 74.45 113.494 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 15.8 m 66.01 29.16 10.25 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.792 1.237 . . . . 73.41 110.329 174.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -83.33 162.63 53.29 Favored Pre-proline 0 CA--C 1.552 1.036 0 CA-C-N 114.841 -1.072 . . . . 74.12 110.652 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.424 ' HG2' ' O ' ' B' ' 36' ' ' TRP . 92.0 Cg_exo -48.36 159.61 0.73 Allowed 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.786 2.991 . . . . 70.02 114.787 173.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.422 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 22.8 tp60 -60.55 113.19 2.3 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.36 -0.837 . . . . 73.11 111.484 -173.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.533 HD13 HG11 ' B' ' 40' ' ' VAL . 15.9 tp -112.23 120.08 40.54 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.843 -0.799 . . . . 75.03 108.843 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -133.0 126.53 32.15 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 107.801 -1.185 . . . . 64.31 107.801 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.553 HD13 ' HA ' ' B' ' 111' ' ' ARG . 76.1 mt -83.27 134.2 34.95 Favored 'General case' 0 C--O 1.242 0.7 0 O-C-N 123.409 0.443 . . . . 73.04 110.96 -176.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.61 143.88 90.55 Favored Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 124.58 1.175 . . . . 73.02 110.144 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -65.79 92.74 0.26 Allowed 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.68 2.253 . . . . 72.24 111.429 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.543 HG13 ' HE2' ' F' ' 120' ' ' TYR . 98.6 t -90.66 109.49 20.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.682 -1.229 . . . . 73.44 107.682 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -85.83 115.88 23.74 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 107.539 -1.282 . . . . 74.53 107.539 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -53.48 -42.83 67.66 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 124.355 1.034 . . . . 75.42 111.137 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -63.16 -42.5 99.43 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.0 0.813 . . . . 75.55 110.813 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.27 -22.78 67.07 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 112.772 0.656 . . . . 73.45 112.772 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.565 ' HG ' ' HB3' ' F' ' 120' ' ' TYR . 7.7 tt -77.32 -54.74 6.09 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.112 -0.699 . . . . 74.21 109.112 175.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -71.09 -12.64 61.62 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 114.932 -1.031 . . . . 74.34 112.18 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -65.06 -35.56 81.56 Favored 'General case' 0 C--O 1.216 -0.665 0 C-N-CA 124.015 0.926 . . . . 73.25 109.604 175.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -75.32 -31.25 60.57 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.942 0.497 . . . . 70.22 110.71 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -74.41 -48.98 24.43 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.09 0.471 . . . . 72.23 110.696 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 18.0 tp -103.79 34.57 2.95 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.126 0.97 . . . . 74.42 108.991 -173.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -68.36 152.63 45.15 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.909 -1.042 . . . . 74.12 112.332 -173.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -120.51 -5.27 9.8 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.907 0.883 . . . . 74.23 109.74 174.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 76.6 139.36 0.07 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.734 1.614 . . . . 72.52 111.82 177.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -137.42 170.04 16.76 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.542 1.137 . . . . 74.3 109.632 173.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.67 86.99 0.06 OUTLIER Glycine 0 C--N 1.341 0.85 0 N-CA-C 111.441 -0.664 . . . . 72.52 111.441 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -89.9 141.22 28.85 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.331 0.652 . . . . 73.34 109.802 175.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . 0.51 ' HA2' ' HB ' ' D' ' 7' ' ' THR . . . -77.01 66.58 2.82 Favored Glycine 0 C--N 1.351 1.395 0 O-C-N 123.937 0.773 . . . . 71.12 112.68 178.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 36.9 p -112.39 74.13 0.85 Allowed 'General case' 0 C--O 1.244 0.783 0 C-N-CA 124.628 1.171 . . . . 74.53 109.526 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 71.3 tt0 -154.46 111.32 3.33 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.306 -0.861 . . . . 72.33 110.321 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -161.83 163.6 29.26 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.635 0.774 . . . . 74.23 110.6 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 25.7 m170 -86.19 87.58 7.45 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.911 0.885 . . . . 71.31 109.509 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -124.86 27.72 6.69 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.911 0.885 . . . . 74.42 109.741 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -59.06 -27.49 65.56 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.636 1.174 . . . . 71.53 112.178 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.283 0 C-N-CA 124.987 1.315 . . . . 64.31 112.0 172.551 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.497 ' N ' ' SD ' ' C' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.547 -0.538 . . . . 75.31 109.547 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 19.4 t 56.82 54.67 6.93 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.63 1.172 . . . . 73.01 111.755 169.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.98 118.23 7.52 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 109.313 -0.625 . . . . 73.4 109.313 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -77.69 -11.75 59.9 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.345 -0.388 . . . . 64.23 111.416 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 10.1 t30 61.38 28.27 17.72 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.478 1.111 . . . . 53.5 111.287 170.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -154.11 156.46 37.29 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.297 -0.865 . . . . 61.3 108.668 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 18.1 m -160.9 87.7 0.74 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.31 -0.996 . . . . 74.43 108.31 170.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -80.92 59.7 3.86 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.982 0.513 . . . . 75.24 109.9 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.421 ' HE1' HD11 ' C' ' 89' ' ' ILE . 20.6 ttt 58.39 111.02 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.334 1.453 . . . . 74.13 111.383 -173.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.588 HG22 ' HB3' ' A' ' 152' ' ' HIS . 76.6 m -102.14 85.16 2.61 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.175 -0.676 . . . . 72.12 109.175 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -97.95 140.12 32.78 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.189 -0.914 . . . . 73.24 108.594 174.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -159.22 123.9 4.04 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 108.898 -0.779 . . . . 63.52 108.898 175.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 62.2 mt -68.56 127.16 29.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 N-CA-C 108.741 -0.837 . . . . 74.12 108.741 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -89.38 -48.35 7.4 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 109.308 -0.627 . . . . 72.42 109.308 174.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.88 148.98 0.43 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.219 1.408 . . . . 73.24 108.731 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 2.7 pp -116.59 155.2 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 106.978 -1.49 . . . . 74.31 106.978 173.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.445 ' HB3' HG22 ' D' ' 122' ' ' THR . 29.5 p90 -175.28 151.36 1.25 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.68 0.752 . . . . 74.42 111.3 -174.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 64.7 p -78.79 102.62 8.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.818 -1.083 . . . . 73.45 108.84 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 8.8 mtmt -72.8 -30.4 64.04 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.061 -0.718 . . . . 73.41 109.061 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.755 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 20.8 t70 -143.91 138.8 28.81 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.104 -0.953 . . . . 74.01 109.732 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.6 mt -137.43 143.66 33.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 106.818 -1.549 . . . . 71.32 106.818 174.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 26.1 t -155.04 141.04 18.33 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 123.76 0.663 . . . . 71.32 110.084 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -145.32 113.0 6.32 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 106.974 -1.491 . . . . 74.03 106.974 171.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -117.71 122.92 44.77 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.167 0.587 . . . . 72.55 109.99 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.35 75.79 73.56 Favored Pre-proline 0 CA--C 1.552 1.026 0 N-CA-C 107.388 -1.338 . . . . 73.23 107.388 171.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -69.82 -22.75 31.36 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 122.77 2.314 . . . . 71.25 111.511 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -101.36 12.45 37.38 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.541 1.136 . . . . 73.43 110.191 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.1 -58.14 9.55 Favored Pre-proline 0 C--N 1.375 1.715 0 C-N-CA 124.388 1.075 . . . . 72.3 113.554 -169.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -64.29 -35.95 48.45 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 121.704 1.603 . . . . 65.41 112.132 -176.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -69.82 -37.75 76.32 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.293 1.037 . . . . 74.35 112.297 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.592 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.1 p -81.29 -21.71 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 C-N-CA 122.819 0.448 . . . . 72.32 111.889 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -65.48 -26.84 68.11 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 120.681 0.277 . . . . 73.22 111.263 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -100.41 34.58 2.35 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.652 0.781 . . . . 74.23 110.279 174.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.614 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 0.6 OUTLIER -125.05 163.08 23.15 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.523 0.729 . . . . 71.35 110.23 177.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -66.58 112.99 4.42 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.532 0.733 . . . . 70.3 110.656 173.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 69.5 t-105 -76.8 81.97 3.39 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.363 0.665 . . . . 73.31 110.529 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -136.17 73.72 57.31 Favored Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 124.522 1.129 . . . . 73.11 108.465 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.31 155.48 25.25 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.702 2.268 . . . . 63.24 113.837 -171.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . 0.416 ' HB2' HD21 ' F' ' 142' ' ' LEU . 9.9 tp10 -87.4 87.71 7.49 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 105.146 -2.168 . . . . 74.53 105.146 161.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.619 ' HB ' ' HA ' ' F' ' 135' ' ' VAL . 68.7 t -76.66 98.34 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.578 0 N-CA-C 107.527 -1.286 . . . . 73.14 107.527 177.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -114.59 103.8 11.37 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.953 -1.021 . . . . 75.31 108.329 -175.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.27 160.63 18.36 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.214 0.531 . . . . 74.02 110.287 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.598 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 18.1 t70 -145.69 121.15 10.34 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.614 1.166 . . . . 73.53 108.287 -177.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 81.8 mt -125.44 111.95 15.7 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.526 0.73 . . . . 74.12 109.99 -177.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -136.52 127.06 26.9 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.439 -0.949 . . . . 70.13 108.439 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 12.4 t -115.05 146.27 41.45 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.272 0.629 . . . . 74.41 109.47 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.36 163.96 27.53 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.067 0.947 . . . . 75.44 109.304 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' C' ' 98' ' ' LEU . 3.2 m -142.89 143.71 32.16 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.805 -0.442 . . . . 73.3 109.805 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.9 t -145.2 127.81 16.12 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.0 0.92 . . . . 55.51 108.548 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -79.55 117.4 20.45 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.077 -0.712 . . . . 73.04 109.077 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.703 HD12 ' HB2' ' C' ' 57' ' ' GLU . 61.0 mt -86.39 -35.08 19.98 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.266 0.626 . . . . 74.31 111.027 -176.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.19 179.64 8.96 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.961 -1.018 . . . . 71.21 109.088 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.5 116.46 7.5 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.148 -0.686 . . . . 75.24 109.148 -178.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 68.33 18.9 9.08 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.447 1.099 . . . . 74.24 112.068 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 90.5 t -123.81 115.23 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 108.639 -0.874 . . . . 73.31 108.639 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -121.71 128.96 52.38 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.337 1.055 . . . . 73.43 109.577 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.703 ' HB2' HD12 ' C' ' 51' ' ' LEU . 44.2 tt0 -93.16 138.62 31.41 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.088 -0.708 . . . . 73.02 109.088 167.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 83.5 t -122.83 139.68 48.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.911 -1.144 . . . . 74.31 107.911 171.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 54.3 t -127.85 130.26 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 109.516 -0.55 . . . . 74.02 109.516 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.79 111.2 23.61 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.702 -1.221 . . . . 72.25 107.702 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -83.1 111.85 19.28 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 108.556 -0.905 . . . . 75.23 108.556 170.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.404 HG13 ' CD1' ' C' ' 114' ' ' ILE . 21.9 t -114.38 115.5 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 108.02 -1.104 . . . . 72.53 108.02 175.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.598 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 10.9 m -125.39 125.54 43.58 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.598 0.759 . . . . 72.4 108.956 -171.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.568 HG23 HG21 ' C' ' 114' ' ' ILE . 84.2 t -112.92 125.16 70.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 123.964 0.906 . . . . 73.02 108.89 177.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 12.5 m -104.12 138.81 40.08 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.77 -0.826 . . . . 74.21 108.77 170.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.97 101.56 5.48 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.636 -1.616 . . . . 74.54 106.636 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 41.1 m -134.02 126.46 30.26 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.537 -0.542 . . . . 74.43 109.537 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 9.7 mt -84.47 52.85 2.47 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.618 1.167 . . . . 64.3 109.213 -178.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.1 -99.83 1.93 Allowed Glycine 0 C--N 1.349 1.259 0 N-CA-C 110.515 -1.034 . . . . 72.23 110.515 -172.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . 0.522 ' HG2' HG23 ' F' ' 144' ' ' VAL . 13.9 pt-20 -101.11 -30.44 11.58 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.943 0.897 . . . . 64.44 110.439 175.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.614 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 10.1 tp10 -70.33 109.98 5.02 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.424 1.089 . . . . 72.32 109.451 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 38.9 m -83.41 124.46 30.7 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.897 0.772 . . . . 73.34 110.025 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.592 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -76.6 -57.93 3.57 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 114.398 -1.274 . . . . 72.54 109.618 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -154.65 166.26 33.96 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.025 -0.989 . . . . 73.33 110.706 174.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.41 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.4 tm? -129.23 142.56 50.82 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 105.894 -1.891 . . . . 73.22 105.894 166.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.41 ' N ' HD13 ' C' ' 75' ' ' LEU . 49.1 t -143.59 143.31 31.44 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.075 -1.083 . . . . 64.32 108.075 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -157.18 132.11 8.85 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 122.796 0.439 . . . . 74.21 109.973 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.411 HG12 ' HA ' ' C' ' 110' ' ' ALA . 55.2 t -133.85 115.41 21.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 124.748 1.219 . . . . 73.23 108.804 -176.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.755 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.2 mt-30 -96.19 90.56 5.54 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.677 0.791 . . . . 74.3 109.116 173.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.459 ' HG3' HD21 ' C' ' 106' ' ' LEU . 7.1 tp-100 -80.67 99.74 8.33 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.698 -1.137 . . . . 73.11 109.515 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.56 153.78 27.74 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.862 -0.495 . . . . 62.13 111.862 174.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.5 126.44 2.08 Favored Glycine 0 CA--C 1.501 -0.785 0 N-CA-C 110.966 -0.854 . . . . 74.24 110.966 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.497 HD13 HD12 ' C' ' 51' ' ' LEU . 13.3 mm -88.96 128.71 40.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 N-CA-C 108.891 -0.781 . . . . 75.11 108.891 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -135.87 118.39 15.88 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.379 0.671 . . . . 73.24 109.369 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.5 p -79.6 101.32 8.24 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.262 -1.014 . . . . 60.54 108.262 172.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.563 HG21 ' HE2' ' C' ' 94' ' ' MET . 21.3 mt -117.53 129.94 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.582 0.753 . . . . 73.1 110.52 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.417 ' HB2' ' HB ' ' C' ' 10' ' ' THR . . . -139.28 164.62 29.33 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.297 0.639 . . . . 73.55 110.671 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.39 -19.24 44.86 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 114.896 0.718 . . . . 72.32 114.896 170.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.717 HD13 ' HA ' ' C' ' 94' ' ' MET . 47.4 pt -108.53 167.97 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 117.593 0.697 . . . . 74.24 111.457 -176.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -159.35 177.9 10.51 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.364 -1.289 . . . . 74.5 109.263 175.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.63 -120.53 12.07 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 115.815 1.086 . . . . 75.11 115.815 173.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 46.4 p -64.91 -36.87 85.77 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.408 1.083 . . . . 75.01 111.173 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -62.23 -58.31 8.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.496 1.118 . . . . 74.31 110.538 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.717 ' HA ' HD13 ' C' ' 89' ' ' ILE . 4.6 tpt -54.15 -52.51 60.88 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 124.066 0.946 . . . . 73.54 112.243 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.96 -40.9 77.33 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 123.87 0.731 . . . . 74.32 111.235 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -68.7 -37.31 79.42 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.2 0.6 . . . . 73.42 111.222 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 35.4 t -67.6 -34.56 77.25 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.659 -0.497 . . . . 70.23 109.659 -177.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.457 ' HB3' ' OG ' ' C' ' 48' ' ' SER . 79.9 mt -88.16 -33.03 18.33 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.527 1.131 . . . . 75.31 112.173 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.5 10.91 26.02 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 114.63 0.612 . . . . 73.02 114.63 -167.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.11 -48.66 0.07 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 117.401 0.6 . . . . 70.14 111.613 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -72.74 -55.03 7.37 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.302 0.641 . . . . 74.34 111.306 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 94.4 m -63.74 -44.99 81.7 Favored Pre-proline 0 CA--C 1.562 1.419 0 CA-C-O 118.213 -0.898 . . . . 63.33 112.031 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -53.02 -31.55 54.07 Favored 'Trans proline' 0 C--N 1.394 2.962 0 C-N-CA 122.88 2.387 . . . . 74.35 114.204 170.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -67.52 -35.54 79.29 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.537 0.735 . . . . 75.13 110.373 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.506 HD13 ' NH1' ' A' ' 111' ' ' ARG . 46.0 mm -77.06 -33.26 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.375 0.67 . . . . 75.24 110.449 177.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.459 HD21 ' HG3' ' C' ' 80' ' ' GLN . 94.3 mt -82.23 -30.02 31.01 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.865 0.866 . . . . 72.44 112.034 -175.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -57.18 -49.45 93.86 Favored Pre-proline 0 N--CA 1.484 1.23 0 CA-C-O 117.891 -1.052 . . . . 73.34 113.457 -173.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.61 -40.91 81.86 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 122.561 2.174 . . . . 72.11 114.31 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . 0.475 ' OH ' ' HG2' ' A' ' 111' ' ' ARG . 89.6 m-85 -74.98 -37.56 61.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.155 0.582 . . . . 72.35 111.425 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.411 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -68.34 -34.89 76.92 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.353 -0.84 . . . . 54.03 110.498 176.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 24.2 ttt-85 -66.12 -51.24 59.8 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.604 1.561 . . . . 75.12 109.757 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -60.0 -39.53 86.1 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 124.093 0.871 . . . . 74.34 110.154 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 35.1 t -66.41 -39.86 89.23 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.461 -0.79 . . . . 74.32 110.933 -177.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.568 HG21 HG23 ' C' ' 64' ' ' VAL . 84.2 mt -69.19 -56.16 12.84 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 O-C-N 123.376 0.423 . . . . 72.15 110.565 177.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.1 m -63.21 -27.73 69.55 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 122.928 0.491 . . . . 74.1 111.066 -173.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 38.4 t -65.68 -49.34 68.91 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.383 0.673 . . . . 71.42 109.486 169.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.556 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.63 -36.63 79.1 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 124.607 1.163 . . . . 73.04 112.719 179.319 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.409 HG23 ' O ' ' C' ' 114' ' ' ILE . 76.6 t -64.23 -46.41 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.636 0.774 . . . . 74.32 108.962 175.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 39.5 t -67.3 -31.18 71.31 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.004 -0.998 . . . . 64.11 111.47 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.466 ' NH2' ' HG3' ' B' ' 112' ' ' GLU . 72.7 mtt-85 -71.17 -37.24 72.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.891 0.876 . . . . 75.54 109.566 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.46 4.3 84.45 Favored Glycine 0 C--N 1.353 1.474 0 O-C-N 123.848 0.717 . . . . 71.43 112.496 172.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 71.9 p 59.02 29.31 18.83 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.385 1.874 . . . . 75.24 113.696 172.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -85.38 143.2 38.64 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 107.018 -1.475 . . . . 73.2 107.018 166.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -48.69 143.3 16.82 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 123.088 2.525 . . . . 73.12 112.979 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.422 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 20.7 mm-40 -46.9 142.67 3.31 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 124.565 1.165 . . . . 74.42 112.786 -174.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.48 HD13 HG13 ' C' ' 40' ' ' VAL . 23.6 tp -144.88 88.49 1.9 Allowed 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.188 -1.041 . . . . 75.2 108.188 -177.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -91.85 117.2 29.56 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.502 -1.226 . . . . 63.24 109.063 -174.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -70.91 124.53 24.55 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 123.893 0.745 . . . . 74.05 109.864 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.13 145.17 85.65 Favored Pre-proline 0 CA--C 1.548 0.874 0 O-C-N 124.219 0.949 . . . . 74.43 111.333 -175.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.547 ' HG3' HD13 ' A' ' 16' ' ' ILE . 16.1 Cg_endo -55.86 108.77 0.35 Allowed 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.555 2.837 . . . . 74.22 112.081 173.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 14.0 p -98.67 152.48 4.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 109.203 -0.666 . . . . 70.52 109.203 174.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -82.97 99.17 9.64 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.163 0.985 . . . . 73.2 108.832 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -68.66 -20.44 64.45 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.091 0.556 . . . . 74.23 112.121 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.78 -32.5 67.71 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.295 0.638 . . . . 74.44 110.792 172.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . 0.564 ' HA ' ' HE3' ' C' ' 138' ' ' MET . . . -73.14 -31.65 64.41 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.329 0.652 . . . . 74.01 110.588 174.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 56.3 mt -78.8 -20.91 48.64 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.423 -0.808 . . . . 72.15 110.438 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . 0.586 ' HE2' HG12 ' E' ' 144' ' ' VAL . 69.0 t80 -82.25 -28.7 31.69 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.596 0.758 . . . . 75.41 110.582 172.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.564 ' HE3' ' HA ' ' C' ' 135' ' ' ALA . 38.0 ttm -58.87 -41.17 86.44 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.747 1.219 . . . . 74.11 112.337 -175.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -66.6 -32.68 74.17 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.162 0.585 . . . . 64.4 111.692 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -67.04 -159.99 0.02 OUTLIER 'General case' 0 CA--C 1.581 2.151 0 C-N-CA 124.013 0.925 . . . . 73.41 110.358 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 59.5 tp -169.95 145.87 3.01 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 120.874 -1.141 . . . . 72.43 108.88 -174.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -146.22 110.06 4.9 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.004 -1.11 . . . . 75.52 108.004 172.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -85.22 55.96 3.73 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.823 0.849 . . . . 75.43 111.276 -175.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -137.65 164.88 27.72 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.055 0.942 . . . . 74.41 109.141 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.16 169.82 15.4 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.166 0.986 . . . . 73.43 111.837 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -153.03 176.36 31.17 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 114.454 -1.248 . . . . 74.13 110.989 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 69.35 124.46 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.588 1.555 . . . . 74.43 111.296 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 174.08 29.82 0.03 OUTLIER Glycine 0 N--CA 1.467 0.722 0 CA-C-N 115.564 -0.744 . . . . 71.43 111.33 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 36.3 p -91.48 127.97 37.13 Favored 'General case' 0 C--N 1.348 0.505 0 C-N-CA 123.68 0.792 . . . . 73.24 111.049 -174.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -84.41 -146.07 0.09 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.439 1.095 . . . . 73.4 109.536 171.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -158.49 110.01 2.19 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 108.991 -0.744 . . . . 52.41 108.991 173.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -146.16 71.82 1.27 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 122.724 1.249 . . . . 73.03 108.02 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -62.86 116.89 5.67 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 112.97 -1.923 . . . . 74.44 109.804 172.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -104.71 -76.52 0.6 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.084 0.553 . . . . 63.02 110.405 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 N-CA-C 108.425 -0.954 . . . . 75.15 108.425 -175.406 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 53.8 ttm . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 110.236 -0.283 . . . . 74.22 110.236 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 26.4 m -110.9 105.58 14.43 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 122.159 -0.338 . . . . 64.22 111.038 -176.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.19 160.36 19.07 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.179 0.992 . . . . 75.52 109.21 173.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -121.58 78.7 1.47 Allowed 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.403 0.62 . . . . 75.45 109.649 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -64.42 -47.65 78.35 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.694 1.198 . . . . 75.13 109.683 173.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -174.83 118.84 0.2 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.396 1.078 . . . . 73.12 108.868 168.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 7' ' ' THR . . . . . 0.51 ' HB ' ' HA2' ' B' ' 148' ' ' GLY . 74.8 p -88.16 75.26 8.66 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 108.806 -0.813 . . . . 75.4 108.806 173.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -162.33 129.88 3.87 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.604 -1.18 . . . . 74.11 108.25 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.495 ' HE2' ' HB2' ' D' ' 11' ' ' PHE . 16.4 tpt -32.65 125.4 0.33 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.226 1.41 . . . . 75.12 112.975 168.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 28.9 p -108.48 118.52 36.98 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.537 0.735 . . . . 70.45 109.301 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.495 ' HB2' ' HE2' ' D' ' 9' ' ' MET . 31.2 t80 -143.04 116.41 9.06 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.444 -1.317 . . . . 75.21 107.444 176.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -141.0 153.49 45.58 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.635 0.774 . . . . 71.22 109.415 172.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 73.8 mt -102.74 120.48 52.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.087 -1.079 . . . . 74.55 108.087 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -89.05 -42.57 11.66 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.17 0.588 . . . . 74.21 110.66 -175.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -163.37 142.36 8.27 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.285 0.366 . . . . 74.12 110.496 -172.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.7 mp -124.8 135.07 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 105.579 -2.008 . . . . 61.54 105.579 174.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.432 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 34.8 p90 -162.31 172.72 15.21 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 122.12 0.962 . . . . 72.35 112.079 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.7 p -107.34 120.48 42.26 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.181 -1.372 . . . . 71.34 109.028 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.432 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 29.6 mtpt -92.02 -19.7 22.1 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.742 -0.663 . . . . 74.32 109.493 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 32.6 t70 -162.14 138.77 8.0 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.94 0.896 . . . . 73.33 109.743 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.556 HG23 ' HE1' ' C' ' 117' ' ' MET . 63.9 mt -141.81 139.64 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.809 1.244 . . . . 71.33 107.773 175.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.7 t -141.9 145.44 34.59 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.37 1.068 . . . . 75.12 108.608 170.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.519 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.0 t80 -144.95 117.66 8.67 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.143 -1.799 . . . . 74.32 106.143 167.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -125.55 118.91 26.76 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.159 0.584 . . . . 75.25 109.787 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.89 80.32 5.19 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 107.695 -1.224 . . . . 61.53 107.695 174.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.6 -19.07 16.97 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.681 2.254 . . . . 74.22 113.014 -169.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -113.49 1.42 15.02 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.599 0.76 . . . . 75.34 111.178 -177.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -27.44 -70.01 0.07 OUTLIER Pre-proline 0 CA--C 1.567 1.61 0 N-CA-C 117.481 2.4 . . . . 74.11 117.481 -167.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.464 ' HB3' HD11 ' C' ' 83' ' ' ILE . 89.4 Cg_endo -76.56 -18.01 15.8 Favored 'Trans proline' 0 C--N 1.387 2.564 0 CA-C-N 124.19 2.532 . . . . 65.11 113.971 -172.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.44 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 3.4 t-160 -78.31 -38.8 41.52 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.702 1.201 . . . . 72.11 109.699 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.422 HG22 ' HA ' ' D' ' 73' ' ' ALA . 5.1 p -83.83 -19.31 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-N 115.874 -0.603 . . . . 75.44 111.096 -175.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -64.07 -24.83 67.85 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 122.544 0.338 . . . . 75.23 111.159 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . 0.44 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 62.1 mt-30 -65.97 -9.05 26.47 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.263 1.025 . . . . 74.42 111.711 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.626 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 87.4 mttt -100.52 99.33 9.91 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.225 1.41 . . . . 73.42 109.602 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -97.33 83.2 3.25 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.254 -0.885 . . . . 74.54 110.876 -171.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -158.82 176.97 11.68 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.822 0.849 . . . . 64.23 109.402 169.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -69.94 110.96 7.6 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.353 1.061 . . . . 73.33 109.829 174.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.463 ' HB3' ' HG ' ' D' ' 68' ' ' LEU . 38.9 Cg_endo -68.81 129.63 18.98 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.014 1.809 . . . . 74.33 110.588 175.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -67.4 116.55 8.29 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 107.514 -1.291 . . . . 73.54 107.514 168.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' D' ' 66' ' ' ALA . 16.1 t -98.23 114.41 35.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 108.9 -0.778 . . . . 74.21 108.9 176.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -89.54 116.93 28.06 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.81 -0.811 . . . . 74.55 108.81 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.51 HD21 HD12 ' D' ' 128' ' ' LEU . 49.2 tp -97.27 144.43 27.07 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.065 0.459 . . . . 74.12 110.23 -176.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -135.17 139.5 44.62 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.681 -1.6 . . . . 74.34 106.681 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.417 HD13 HG13 ' D' ' 131' ' ' VAL . 45.4 mt -130.0 132.07 46.12 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.226 0.61 . . . . 64.31 110.666 -174.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -140.35 154.11 46.63 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.598 1.159 . . . . 71.44 108.317 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 46' ' ' THR . . . . . 0.56 HG22 HD22 ' E' ' 111' ' ' LEU . 2.1 p -128.61 159.69 34.76 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.597 0.713 . . . . 75.55 110.778 176.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.541 ' HB1' ' HB ' ' D' ' 59' ' ' VAL . . . -149.75 177.8 9.46 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.218 -1.356 . . . . 73.52 108.528 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 61.9 p -174.29 -162.13 0.13 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.883 0.873 . . . . 64.22 108.977 -175.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 17.3 p -147.87 129.65 15.18 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.683 -1.229 . . . . 75.41 107.683 168.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -76.68 111.59 12.34 Favored 'General case' 0 C--N 1.345 0.405 0 C-N-CA 123.3 0.64 . . . . 75.35 110.423 -172.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 tt -161.34 91.89 0.87 Allowed 'General case' 0 C--O 1.242 0.668 0 N-CA-C 106.579 -1.637 . . . . 73.11 106.579 171.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.28 83.84 7.3 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.742 -1.117 . . . . 71.21 110.789 -174.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -159.09 41.67 0.23 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.818 0.818 . . . . 70.35 108.944 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 68.82 -4.69 1.14 Allowed 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 125.928 1.691 . . . . 74.51 113.951 175.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.06 106.06 20.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.166 -1.42 . . . . 75.33 107.166 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -129.6 147.81 51.44 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.385 -0.598 . . . . 73.42 109.385 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -111.98 148.85 32.9 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.065 -1.087 . . . . 75.4 108.065 161.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 71.2 t -123.27 140.78 45.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 124.811 1.244 . . . . 75.22 107.692 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.541 ' HB ' ' HB1' ' D' ' 47' ' ' ALA . 30.3 t -125.89 137.31 58.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.727 -1.212 . . . . 72.22 107.727 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.418 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -125.74 105.4 8.95 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.511 -1.292 . . . . 73.12 107.511 -176.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 41.4 ttm-85 -85.14 102.49 13.32 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.748 0.819 . . . . 74.42 109.214 174.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.504 HG13 HD12 ' D' ' 42' ' ' LEU . 57.9 t -100.86 116.4 44.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.603 -0.888 . . . . 74.14 108.603 173.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.8 m -119.0 122.96 43.38 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.944 0.878 . . . . 73.43 110.233 -171.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 51.9 t -108.39 130.64 60.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 125.746 1.618 . . . . 74.33 109.635 -176.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 80.9 m -134.81 92.1 2.85 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.841 -1.17 . . . . 74.51 107.841 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -96.48 154.82 17.05 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.65 0.78 . . . . 44.54 109.123 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.449 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 25.2 p -149.58 135.02 18.37 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 123.648 0.592 . . . . 72.14 112.178 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' D' ' 38' ' ' PRO . 20.9 mt -105.46 102.43 11.9 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 124.81 1.244 . . . . 72.44 108.302 171.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.32 -125.4 10.6 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.572 -0.74 . . . . 72.41 113.438 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -84.97 4.96 31.22 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.554 1.142 . . . . 74.41 112.893 -174.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.626 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 12.8 pt-20 -146.32 165.75 28.35 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 120.9 0.381 . . . . 75.13 111.13 -172.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 55.7 m -64.03 135.26 56.27 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.529 -1.214 . . . . 65.34 111.435 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.449 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.46 -71.33 0.57 Allowed 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.236 -1.394 . . . . 63.32 107.236 170.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -145.11 151.95 39.29 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-O 121.179 0.514 . . . . 74.22 111.002 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 66.3 mt -117.08 152.54 34.47 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.095 1.358 . . . . 72.43 107.872 175.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.539 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 40.6 t -159.29 149.64 19.28 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.692 0.797 . . . . 75.14 108.883 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -154.91 121.71 5.45 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.48 -0.563 . . . . 75.41 109.48 170.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.58 115.82 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.64 0.776 . . . . 75.01 109.543 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.459 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.7 mt-30 -90.68 90.19 7.85 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.47 0.708 . . . . 74.0 109.415 170.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . 0.406 ' O ' HD11 ' D' ' 106' ' ' LEU . 7.8 tp-100 -80.98 101.57 9.6 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.877 -1.056 . . . . 74.04 108.897 178.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.92 143.88 15.9 Favored Glycine 0 C--N 1.338 0.693 0 N-CA-C 111.397 -0.681 . . . . 74.23 111.397 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.8 140.72 7.84 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 111.758 -0.537 . . . . 74.32 111.758 -174.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 50.8 mt -90.48 120.57 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.724 -0.843 . . . . 75.3 108.724 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -121.01 126.48 50.02 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.099 0.96 . . . . 73.12 109.521 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 44.5 p -88.86 96.6 10.76 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.913 -0.773 . . . . 74.14 108.913 173.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.56 HD13 HD23 ' D' ' 98' ' ' LEU . 37.7 pt -119.83 129.16 75.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 115.465 -0.789 . . . . 73.5 109.615 -172.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.75 167.79 7.56 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.357 0.663 . . . . 75.23 110.926 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.25 12.3 61.74 Favored Glycine 0 N--CA 1.476 1.364 0 CA-C-N 116.629 -0.26 . . . . 72.43 112.993 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.516 HG12 ' SG ' ' D' ' 97' ' ' CYS . 1.0 OUTLIER -125.34 159.93 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.892 1.277 . . . . 72.31 109.074 176.171 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -149.4 156.38 41.95 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 122.989 0.516 . . . . 64.15 110.472 -168.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.37 -131.55 10.71 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 116.003 -0.544 . . . . 75.22 114.374 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 40.0 p -84.55 -41.0 16.9 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.183 0.993 . . . . 74.24 111.067 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -66.69 -19.05 65.68 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.279 -0.873 . . . . 73.54 111.408 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.428 ' HA ' HD12 ' D' ' 89' ' ' ILE . 59.4 ttp -54.33 -57.76 10.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.954 1.301 . . . . 70.4 111.392 174.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.21 -15.18 51.46 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.308 -0.86 . . . . 71.02 111.854 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -64.01 -22.93 67.14 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.938 0.495 . . . . 75.21 111.43 172.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . 0.516 ' SG ' HG12 ' D' ' 89' ' ' ILE . 81.8 m -59.89 -46.52 89.07 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.236 0.614 . . . . 74.04 111.187 175.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.56 HD23 HD13 ' D' ' 86' ' ' ILE . 3.1 pp -94.59 -20.71 19.37 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.352 0.501 . . . . 74.23 112.352 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.98 -29.38 23.29 Favored Glycine 0 C--N 1.346 1.134 0 O-C-N 123.353 0.408 . . . . 62.01 113.396 -173.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.36 -49.18 1.08 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.809 0.444 . . . . 75.4 111.289 -174.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -74.91 -41.94 58.74 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 112.697 0.629 . . . . 73.12 112.697 -172.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 71.7 m -66.26 -44.79 59.69 Favored Pre-proline 0 CA--C 1.558 1.262 0 CA-C-O 118.558 -0.734 . . . . 55.42 111.704 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.418 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 68.6 Cg_exo -56.59 -33.73 93.76 Favored 'Trans proline' 0 C--N 1.391 2.814 0 C-N-CA 122.021 1.814 . . . . 73.43 112.909 167.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -68.32 -29.57 68.35 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.523 0.729 . . . . 73.21 111.172 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.2 mm -74.93 -37.28 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.355 0.662 . . . . 61.44 109.945 172.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.406 HD11 ' O ' ' D' ' 80' ' ' GLN . 93.3 mt -79.95 -17.76 52.16 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.472 0.709 . . . . 72.21 112.443 -177.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -68.03 -44.08 38.16 Favored Pre-proline 0 N--CA 1.486 1.348 0 CA-C-O 118.472 -0.775 . . . . 75.04 112.725 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.47 -37.11 72.38 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.368 2.046 . . . . 75.35 113.687 170.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -81.02 -32.9 33.97 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.971 0.909 . . . . 73.22 112.428 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.96 -45.21 71.27 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.177 -0.675 . . . . 74.53 109.177 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.404 ' NH2' HG22 ' B' ' 105' ' ' ILE . 43.2 ttp180 -65.51 -39.13 91.48 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 114.371 -1.286 . . . . 75.31 110.139 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -52.59 -46.32 66.9 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 123.986 0.914 . . . . 75.3 110.523 175.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.476 ' SG ' HD11 ' D' ' 21' ' ' ILE . 49.2 t -67.71 -50.28 58.32 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.903 -1.044 . . . . 74.23 110.86 -178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.534 HG12 ' SG ' ' D' ' 76' ' ' CYS . 79.3 mt -59.58 -62.14 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 123.951 0.782 . . . . 74.21 110.883 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 17.3 m -50.48 -39.65 48.75 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.949 1.299 . . . . 65.53 111.954 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.43 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 24.6 t -64.0 -48.08 77.79 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.046 -0.979 . . . . 62.51 109.977 177.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 68.6 mtm -69.35 -27.21 65.15 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.282 0.633 . . . . 72.24 112.093 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.446 HG21 ' O ' ' D' ' 114' ' ' ILE . 89.6 t -66.33 -46.07 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.407 0.683 . . . . 75.42 109.196 175.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.5 p -73.19 -28.98 62.51 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.576 -0.738 . . . . 73.34 110.698 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' D' ' 116' ' ' SER . 87.9 mtt-85 -70.86 -28.58 64.68 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.816 0.846 . . . . 74.44 110.416 173.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . 0.422 ' HA2' ' HB2' ' C' ' 17' ' ' TYR . . . -89.11 8.08 80.67 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 123.824 0.703 . . . . 70.33 112.763 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.445 HG22 ' HB3' ' C' ' 17' ' ' TYR . 47.7 p 59.09 20.47 8.38 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 126.35 1.86 . . . . 64.13 113.507 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -87.04 154.44 55.01 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 123.614 0.766 . . . . 74.41 110.106 174.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -50.3 127.44 20.1 Favored 'Trans proline' 0 C--N 1.386 2.532 0 C-N-CA 123.576 2.851 . . . . 72.52 113.013 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -52.24 128.93 26.63 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 124.522 1.139 . . . . 74.42 111.596 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.415 HD21 HG12 ' D' ' 40' ' ' VAL . 33.8 tp -107.13 97.23 7.02 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.726 -0.472 . . . . 73.21 109.726 -176.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -98.45 89.87 4.58 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 107.272 -1.381 . . . . 75.4 107.272 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.51 HD12 HD21 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -67.98 122.29 17.9 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 108.872 -0.788 . . . . 72.41 108.872 -175.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.57 142.65 87.24 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 123.798 0.839 . . . . 72.02 111.05 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.07 121.68 10.34 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.889 2.393 . . . . 75.32 112.098 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . 0.417 HG13 HD13 ' D' ' 44' ' ' LEU . 8.3 p -107.39 133.4 52.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 123.623 0.769 . . . . 75.15 109.551 -173.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -87.01 92.4 9.03 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.592 0.757 . . . . 74.13 108.96 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -53.62 -34.97 60.36 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.392 1.077 . . . . 74.45 112.81 -175.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -65.85 -37.78 87.1 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.219 0.607 . . . . 75.42 110.728 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.524 ' HA ' ' HE3' ' D' ' 138' ' ' MET . . . -64.5 -31.45 72.66 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.547 0.739 . . . . 74.12 111.091 177.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 9.0 mp -69.09 -39.3 79.09 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.959 0.904 . . . . 73.32 111.267 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -69.73 -35.3 74.89 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.007 0.523 . . . . 71.52 110.489 172.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.524 ' HE3' ' HA ' ' D' ' 135' ' ' ALA . 69.8 mtm -72.75 -23.25 60.8 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.452 0.701 . . . . 74.01 111.385 177.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.428 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 10.7 m120 -64.38 -29.82 70.87 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.31 0.644 . . . . 71.23 111.019 176.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -58.92 -37.09 75.85 Favored 'General case' 0 CA--C 1.555 1.141 0 O-C-N 123.267 0.355 . . . . 75.44 110.283 175.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 5.7 mp -83.77 -52.51 6.34 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.436 0.694 . . . . 75.44 111.646 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.428 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 15.7 pt20 -78.91 8.27 5.84 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 114.092 1.145 . . . . 72.12 114.092 -164.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' D' ' 139' ' ' ASN . 14.5 mm100 -116.04 83.11 1.89 Allowed 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 122.126 0.965 . . . . 65.1 108.793 -176.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -143.54 -55.1 0.38 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 113.665 -1.607 . . . . 71.51 106.846 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.5 92.04 0.87 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.365 -0.976 . . . . 72.21 108.365 173.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -173.23 38.42 0.14 Allowed Glycine 0 C--N 1.341 0.829 0 CA-C-N 115.945 -0.57 . . . . 73.51 111.931 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.33 169.27 17.99 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.274 1.03 . . . . 72.05 109.676 -175.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 176.81 -179.26 47.87 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 116.064 -0.516 . . . . 73.33 112.587 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 8.9 t -101.03 145.83 28.2 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.024 0.93 . . . . 71.22 110.642 -174.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -126.85 137.58 53.2 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.814 0.846 . . . . 73.33 108.898 176.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.34 104.34 2.03 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.298 -1.001 . . . . 73.22 108.298 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -101.94 86.42 2.89 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.163 0.585 . . . . 73.42 109.587 172.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -69.72 102.71 1.96 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 109.355 -0.609 . . . . 73.41 109.355 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -157.88 141.75 15.73 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.438 0.695 . . . . 62.22 109.937 -173.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.872 0 C-N-CA 123.482 0.713 . . . . 65.32 109.25 -176.005 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.534 0 N-CA-C 110.965 -0.854 . . . . 54.04 110.965 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.14 -61.81 3.81 Favored Glycine 0 C--N 1.348 1.212 0 N-CA-C 111.567 -0.613 . . . . 73.25 111.567 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -86.62 147.92 25.7 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.884 0.874 . . . . 73.24 109.42 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -112.72 -100.67 0.42 Allowed 'General case' 0 CA--C 1.549 0.929 0 CA-C-O 118.279 -0.867 . . . . 74.4 109.53 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 58.6 pttt 172.09 19.0 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 124.629 1.172 . . . . 74.5 110.902 -176.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . -148.89 76.92 0.24 Allowed Glycine 0 C--N 1.354 1.535 0 CA-C-O 119.968 -0.351 . . . . 71.44 113.554 -172.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 97' ' ' ILE . . . . . 0.431 HG12 ' O ' ' E' ' 97' ' ' ILE . 7.0 tt -167.33 18.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.708 0 C-N-CA 123.995 0.918 . . . . 73.22 110.333 169.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -70.32 178.74 2.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.911 -1.118 . . . . 75.03 110.541 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . 68.73 15.91 8.98 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.372 1.069 . . . . 72.15 111.648 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.84 113.67 22.13 Favored Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 124.292 1.037 . . . . 73.05 108.676 178.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -85.82 -9.51 7.65 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.912 2.408 . . . . 74.52 114.217 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 102' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 53.74 29.15 9.08 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 124.58 1.152 . . . . 73.43 111.758 -176.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 103' ' ' THR . . . . . 0.449 ' HB ' ' HB2' ' E' ' 108' ' ' HIS . 72.9 p 47.99 74.36 0.17 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.735 1.614 . . . . 74.54 112.371 -173.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.57 -93.5 1.89 Allowed Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.438 -0.801 . . . . 73.45 112.263 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -140.68 -60.13 0.51 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.81 0.844 . . . . 73.2 109.199 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -95.38 -77.2 0.48 Allowed 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 107.992 -1.114 . . . . 75.33 107.992 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 9.0 p -155.41 134.42 12.16 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.135 1.374 . . . . 75.31 109.172 174.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 108' ' ' HIS . . . . . 0.449 ' HB2' ' HB ' ' E' ' 103' ' ' THR . 31.2 m170 -89.57 -33.36 16.74 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.082 0.553 . . . . 74.44 110.957 171.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -102.34 119.85 39.5 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.234 0.614 . . . . 74.13 109.443 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.15 119.07 12.13 Favored 'General case' 0 C--O 1.244 0.776 0 O-C-N 124.044 0.84 . . . . 73.45 110.368 177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . 0.56 HD22 HG22 ' D' ' 46' ' ' THR . 48.4 tp -66.07 -38.49 88.42 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 123.921 0.763 . . . . 74.24 109.852 173.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -84.49 -165.83 1.28 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.829 0.852 . . . . 64.03 109.832 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 113' ' ' LYS . . . . . 0.537 ' HA ' ' HE2' ' E' ' 113' ' ' LYS . 1.0 OUTLIER 68.35 90.83 0.09 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.053 0.941 . . . . 71.1 112.616 175.564 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -128.72 163.74 24.48 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.328 1.051 . . . . 74.33 108.507 170.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 37.4 p -76.25 173.96 10.74 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.64 0.776 . . . . 64.41 110.701 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . -87.43 61.21 4.22 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 112.189 -0.365 . . . . 61.51 112.189 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 13.2 mmtm -154.3 -49.42 0.01 OUTLIER Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 124.654 1.182 . . . . 75.43 110.79 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.12 78.72 3.35 Favored 'Trans proline' 0 C--N 1.394 2.944 0 C-N-CA 122.161 1.908 . . . . 74.24 111.097 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -79.46 88.83 5.03 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.715 -0.846 . . . . 54.25 108.715 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -132.19 -45.1 0.93 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.739 -1.119 . . . . 75.34 109.577 -173.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 121' ' ' VAL . . . . . . . . . . . . . 16.9 t -92.3 50.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-O 122.467 1.127 . . . . 62.41 108.723 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 6.8 t -173.19 -42.17 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.284 -1.325 . . . . 74.3 108.857 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -82.52 91.94 6.99 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 108.96 -0.756 . . . . 72.42 108.96 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 29.5 t -107.2 -45.89 4.02 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.747 -1.115 . . . . 61.41 110.566 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . 59.19 -150.51 0.43 Allowed 'General case' 0 C--N 1.36 1.024 0 O-C-N 124.383 1.052 . . . . 74.5 108.981 -167.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . 69.82 -0.89 2.52 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 113.89 1.07 . . . . 75.43 113.89 172.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 30.8 t -89.37 133.76 34.36 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.904 0.882 . . . . 74.22 108.816 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -151.12 156.05 40.19 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 123.05 0.54 . . . . 74.21 110.474 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 14.3 t -153.08 170.85 19.46 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.751 0.821 . . . . 73.45 109.958 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 130' ' ' ALA . . . . . 0.426 ' HB1' ' HD3' ' A' ' 124' ' ' PRO . . . -155.87 31.11 0.36 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.352 1.061 . . . . 64.24 108.421 172.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 131' ' ' TRP . . . . . 0.653 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 33.1 t90 -50.67 104.0 0.07 Allowed 'General case' 0 C--N 1.371 1.533 0 C-N-CA 124.507 1.123 . . . . 74.44 111.416 -171.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 132' ' ' SER . . . . . 0.531 ' HB3' ' HD1' ' A' ' 36' ' ' TRP . 15.0 t -170.25 107.6 0.34 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.29 1.036 . . . . 74.2 108.212 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 30.9 m -145.17 137.12 25.65 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.361 0.664 . . . . 74.51 109.521 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -148.09 134.34 5.04 Favored Glycine 0 C--N 1.342 0.874 0 N-CA-C 111.827 -0.509 . . . . 74.23 111.827 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 135' ' ' VAL . . . . . 0.489 ' HB ' ' HB2' ' A' ' 129' ' ' ALA . 19.5 m -122.42 178.63 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.038 0.935 . . . . 74.52 109.357 174.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -101.09 156.2 17.55 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 110.049 -0.352 . . . . 72.31 110.049 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 95.3 m -59.28 119.28 7.1 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.834 0.854 . . . . 73.51 111.547 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 138' ' ' TYR . . . . . 0.441 ' HD2' ' HB3' ' A' ' 129' ' ' ALA . 36.5 m-85 -145.14 138.75 26.81 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.026 1.33 . . . . 75.24 108.238 171.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -130.14 -177.18 4.2 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.225 0.61 . . . . 73.21 109.975 176.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . 161.51 174.69 31.69 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 115.813 -0.631 . . . . 62.32 112.156 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.87 93.87 0.07 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.865 1.266 . . . . 73.4 111.732 178.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 36.8 tp -122.24 128.49 51.21 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.999 0.919 . . . . 74.45 108.845 172.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.51 176.36 28.52 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 115.947 -0.57 . . . . 65.33 111.757 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 144' ' ' VAL . . . . . 0.586 HG12 ' HE2' ' C' ' 137' ' ' PHE . 18.1 m -140.38 -37.62 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.944 0.898 . . . . 74.05 110.175 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 . . . . . 0 C--O 1.25 1.101 0 C-N-CA 123.65 0.78 . . . . 72.23 110.142 -177.0 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.442 0 N-CA-C 112.566 -0.213 . . . . 54.32 112.566 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.32 1.05 89.53 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-O 119.79 -0.45 . . . . 73.43 113.995 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -63.82 114.95 4.37 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.252 0.621 . . . . 75.33 109.436 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -79.18 178.58 7.95 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.586 0.754 . . . . 73.32 111.153 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 95' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' B' ' 1' ' ' MET . 32.5 tptt -142.2 131.15 23.06 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 107.391 -1.336 . . . . 72.52 107.391 171.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.47 -49.86 0.18 Allowed Glycine 0 C--N 1.347 1.178 0 O-C-N 123.484 0.49 . . . . 70.43 112.986 -172.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 97' ' ' ILE . . . . . 0.585 ' HB ' ' HA ' ' B' ' 87' ' ' ALA . 8.1 tt -83.77 -45.17 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.046 0.538 . . . . 72.42 110.342 -177.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 28.8 t70 51.56 107.0 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 126.531 1.932 . . . . 72.04 113.189 176.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . 70.51 118.2 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.566 1.147 . . . . 63.02 110.453 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 100' ' ' LEU . . . . . 0.428 ' HG ' HD11 ' F' ' 97' ' ' ILE . 3.5 mp -116.72 86.01 18.16 Favored Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 123.71 0.804 . . . . 74.21 109.571 -172.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.8 105.55 2.1 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.543 2.162 . . . . 70.34 112.019 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 102' ' ' LEU . . . . . . . . . . . . . 30.5 tp -74.5 157.96 34.62 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 109.483 -0.562 . . . . 73.24 109.483 173.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 42.4 p -73.49 81.92 1.46 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.807 0.843 . . . . 75.31 109.597 173.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.25 -157.04 44.17 Favored Glycine 0 C--N 1.343 0.965 0 CA-C-N 115.547 -0.751 . . . . 34.22 111.807 -171.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -118.96 -61.14 1.68 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.612 0.765 . . . . 75.54 109.273 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -98.91 89.88 4.45 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.307 -1.368 . . . . 74.43 107.307 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 107' ' ' THR . . . . . 0.439 HG21 ' O ' ' F' ' 111' ' ' LEU . 11.6 m 61.65 -73.0 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 126.263 1.825 . . . . 74.53 114.808 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 80.82 -44.19 0.22 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 126.74 2.016 . . . . 74.05 111.578 -172.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -68.26 171.05 7.65 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.267 0.627 . . . . 72.43 110.549 173.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.87 68.63 9.43 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.115 0.566 . . . . 74.41 110.6 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . 0.439 ' O ' HG21 ' F' ' 107' ' ' THR . 10.0 tt -150.3 108.32 3.73 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.412 -0.958 . . . . 73.22 108.412 177.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -145.44 155.56 43.2 Favored 'General case' 0 C--O 1.247 0.934 0 N-CA-C 108.431 -0.951 . . . . 75.1 108.431 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -54.01 95.11 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.991 0 O-C-N 124.681 1.238 . . . . 73.15 111.263 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -166.94 -60.32 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.176 0.99 . . . . 74.33 108.439 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 91.2 m -158.36 148.39 19.89 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.762 1.225 . . . . 74.44 108.269 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.3 148.68 50.99 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-O 119.77 -0.461 . . . . 65.22 111.983 171.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 117' ' ' LYS . . . . . 0.476 ' HA ' ' HE3' ' F' ' 117' ' ' LYS . 1.5 tpmt? -71.56 119.93 76.87 Favored Pre-proline 0 CA--C 1.55 0.961 0 CA-C-O 118.218 -0.896 . . . . 74.04 110.065 -173.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.87 82.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.394 2.93 0 C-N-CA 123.916 3.078 . . . . 74.45 114.329 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -178.61 -35.88 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 126.655 1.982 . . . . 74.13 107.696 176.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 120' ' ' TYR . . . . . 0.565 ' HB3' ' HG ' ' B' ' 136' ' ' LEU . 40.6 t80 -139.89 163.35 32.88 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.992 1.317 . . . . 73.3 108.038 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 92.3 t 68.82 105.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 124.639 1.175 . . . . 75.23 109.845 -173.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 9.8 t -153.46 -35.64 0.11 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.926 0.89 . . . . 73.01 109.266 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 19.2 t70 62.52 114.77 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.53 1.532 . . . . 74.11 112.822 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 37.5 p -132.92 21.05 4.14 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.612 1.165 . . . . 73.51 108.735 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -107.52 -37.91 6.06 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.741 0.816 . . . . 73.33 111.475 -173.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.02 85.08 0.99 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.442 0.639 . . . . 73.12 110.36 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 50.1 m -143.47 163.49 32.97 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.039 0.936 . . . . 74.03 110.028 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . 66.81 18.72 10.69 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.762 1.225 . . . . 75.53 112.388 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 4.9 t -103.11 158.89 15.99 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.488 0.715 . . . . 73.13 111.027 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -177.1 -175.39 0.58 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.336 1.454 . . . . 63.13 109.056 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 48.0 t-105 -125.02 123.75 40.51 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.654 -0.869 . . . . 73.54 108.654 171.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 51.1 m -149.83 161.91 41.33 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.663 1.185 . . . . 73.45 108.738 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 26.6 m -137.24 137.64 39.28 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.252 0.621 . . . . 74.45 109.64 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -149.27 48.72 0.59 Allowed Glycine 0 C--N 1.343 0.953 0 N-CA-C 111.422 -0.671 . . . . 72.34 111.422 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 135' ' ' VAL . . . . . 0.619 ' HA ' ' HB ' ' C' ' 40' ' ' VAL . 44.4 t -76.21 -41.97 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 109.494 -0.558 . . . . 74.12 109.494 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 136' ' ' LYS . . . . . 0.445 ' HE3' ' H ' ' F' ' 141' ' ' ALA . 36.2 ttpt 62.01 83.46 0.15 Allowed 'General case' 0 C--N 1.365 1.25 0 O-C-N 124.532 1.145 . . . . 73.41 110.693 168.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 12.3 m 67.76 172.57 0.27 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.953 0.901 . . . . 75.23 110.116 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -65.32 -36.97 85.67 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.518 -0.739 . . . . 73.55 109.663 172.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -115.31 98.63 6.87 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.796 -0.816 . . . . 72.0 108.796 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -73.19 160.85 54.12 Favored Glycine 0 C--N 1.342 0.909 0 N-CA-C 111.465 -0.654 . . . . 61.14 111.465 171.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 141' ' ' ALA . . . . . 0.445 ' H ' ' HE3' ' F' ' 136' ' ' LYS . . . -161.17 139.06 9.36 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.039 0.536 . . . . 74.04 110.07 -178.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 142' ' ' LEU . . . . . 0.416 HD21 ' HB2' ' C' ' 39' ' ' GLU . 3.0 pp -163.5 168.46 20.13 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.98 0.912 . . . . 74.15 110.543 173.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -123.87 125.56 5.89 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 109.96 -1.256 . . . . 71.11 109.96 173.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 144' ' ' VAL . . . . . 0.522 HG23 ' HG2' ' C' ' 70' ' ' GLU . 14.7 p -64.34 -30.31 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.233 0.613 . . . . 74.13 111.558 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 34.5 t70 . . . . . 0 C--O 1.246 0.92 0 N-CA-C 107.863 -1.162 . . . . 73.33 107.863 170.966 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtm . . . . . 0 N--CA 1.481 1.125 0 N-CA-C 109.644 -0.502 . . . . 61.33 109.644 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.8 m 74.84 146.63 0.09 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.284 1.433 . . . . 75.04 111.882 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -152.37 160.19 43.34 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.057 0.943 . . . . 73.21 109.694 -172.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -156.42 138.36 14.42 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 122.809 0.444 . . . . 75.14 110.485 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -68.79 89.67 0.4 Allowed 'General case' 0 C--N 1.353 0.755 0 N-CA-C 108.091 -1.077 . . . . 72.54 108.091 168.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.435 ' HB3' ' HG1' ' A' ' 149' ' ' THR . 7.5 p-10 -68.75 -177.97 1.09 Allowed 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 113.827 -1.533 . . . . 75.45 111.875 -176.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.0 m -81.0 148.66 29.64 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.806 -0.813 . . . . 73.14 108.806 172.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.49 136.33 57.94 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.39 -0.596 . . . . 74.2 109.39 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 57.9 mtm -132.4 155.94 47.57 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.759 0.824 . . . . 75.51 109.447 -177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.0 m -140.53 122.66 15.73 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.774 -0.824 . . . . 75.23 108.774 174.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -135.33 114.36 12.14 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.529 -1.286 . . . . 72.34 107.529 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -134.05 135.26 43.21 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.826 -1.176 . . . . 74.2 107.826 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.54 HD12 HG21 ' A' ' 105' ' ' ILE . 8.7 mt -93.95 114.44 30.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.381 -0.97 . . . . 75.32 108.381 174.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.473 ' NE2' HG21 ' A' ' 83' ' ' ILE . 29.0 tt0 -81.54 -30.36 33.16 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 123.731 0.644 . . . . 71.53 110.47 -177.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.459 HH22 ' HZ2' ' F' ' 131' ' ' TRP . 29.5 ttt180 -175.87 134.27 0.28 Allowed 'General case' 0 C--N 1.361 1.089 0 C-N-CA 123.13 0.572 . . . . 73.23 110.372 -175.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.584 HD13 ' HG3' ' C' ' 130' ' ' PRO . 66.2 mt -118.13 133.77 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.998 -1.112 . . . . 74.51 107.998 169.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HE1' HG13 ' A' ' 83' ' ' ILE . 24.9 p90 -164.23 149.39 10.31 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 124.098 0.874 . . . . 74.23 110.838 -174.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.0 p -75.27 130.18 38.67 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.862 -0.792 . . . . 73.23 108.862 172.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.9 mtpt -97.55 -30.05 13.1 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.778 -0.452 . . . . 74.53 109.778 175.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.44 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 7.7 t70 -143.37 141.58 30.97 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.351 -0.611 . . . . 74.24 109.351 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.477 HG22 ' SD ' ' A' ' 117' ' ' MET . 62.6 mt -142.24 146.29 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.164 1.386 . . . . 74.54 107.917 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.8 t -155.8 132.48 10.42 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.482 0.713 . . . . 65.11 109.737 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.605 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 80.5 t80 -139.08 114.65 9.85 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 107.199 -1.408 . . . . 75.24 107.199 172.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -118.24 114.36 22.89 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.996 -0.742 . . . . 74.43 108.996 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.47 79.57 1.75 Allowed Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 107.892 -1.151 . . . . 74.02 107.892 164.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.07 -26.13 21.87 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.547 2.164 . . . . 61.52 112.04 -172.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -104.49 17.9 23.24 Favored 'General case' 0 C--O 1.21 -1.02 0 CA-C-O 117.942 -1.027 . . . . 71.53 110.056 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.0 -51.96 21.19 Favored Pre-proline 0 N--CA 1.503 2.197 0 N-CA-C 114.291 1.219 . . . . 65.12 114.291 -169.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.09 -26.07 43.26 Favored 'Trans proline' 0 C--N 1.386 2.529 0 C-N-CA 121.764 1.643 . . . . 73.14 112.808 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -81.43 -43.22 19.21 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.251 1.02 . . . . 71.13 110.245 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.545 HG22 ' HA ' ' A' ' 73' ' ' ALA . 8.2 p -78.96 -21.87 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 114.762 -1.108 . . . . 71.45 112.142 -163.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -70.79 -18.17 62.76 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.579 0.351 . . . . 73.14 111.785 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -76.02 -21.32 56.99 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.682 0.793 . . . . 72.12 110.581 173.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.407 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 35.1 mmtp -83.11 154.67 24.23 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.792 0.837 . . . . 75.43 111.625 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -68.36 136.61 53.65 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.12 -0.946 . . . . 70.34 109.995 172.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.551 ' CE3' HD21 ' A' ' 68' ' ' LEU . 67.9 t-105 -82.45 86.16 6.8 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.512 0.673 . . . . 75.5 110.634 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.404 ' H ' HD23 ' A' ' 68' ' ' LEU . 29.1 tt0 -124.55 80.47 60.95 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 107.757 -1.201 . . . . 70.5 107.757 167.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.18 122.88 9.43 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.535 2.157 . . . . 64.12 112.647 -174.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -95.81 85.67 4.17 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 105.847 -1.909 . . . . 71.33 105.847 172.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.8 t -90.31 134.91 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 114.972 -1.013 . . . . 73.51 110.085 -171.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -121.5 114.78 21.73 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.168 0.987 . . . . 75.52 108.395 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 128' ' ' LEU . 2.6 tt -101.59 119.03 38.13 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.35 -0.981 . . . . 75.12 108.35 -175.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -121.43 133.49 55.07 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.162 0.985 . . . . 64.04 109.174 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.48 HD22 HD21 ' A' ' 60' ' ' LEU . 72.6 mt -121.65 131.06 53.89 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.745 0.818 . . . . 64.11 110.693 -178.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -135.66 149.21 49.22 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.071 0.948 . . . . 65.22 108.816 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.5 m -135.87 129.13 31.86 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.424 0.69 . . . . 65.41 110.099 -177.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.43 111.15 11.06 Favored 'General case' 0 C--N 1.345 0.385 0 C-N-CA 124.179 0.992 . . . . 71.42 109.512 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.0 m -90.35 159.24 16.72 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.215 -0.661 . . . . 61.22 109.215 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.9 t -158.35 117.37 3.11 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.245 -0.65 . . . . 74.23 109.245 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -76.06 106.96 7.95 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.72 -0.474 . . . . 70.13 109.72 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.4 mt -79.8 -33.55 40.36 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.402 0.681 . . . . 73.44 111.02 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.92 -174.77 4.56 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.084 0.554 . . . . 63.24 111.086 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.46 114.93 4.66 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.761 0.825 . . . . 75.45 109.362 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 64.89 18.63 11.56 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.064 1.346 . . . . 72.24 112.335 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.7 t -118.29 105.37 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.452 -0.944 . . . . 74.11 108.452 174.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -115.96 122.81 46.38 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.809 0.844 . . . . 74.42 108.724 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -86.6 148.58 25.42 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.778 -0.823 . . . . 74.2 108.778 170.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.6 t -130.33 139.37 51.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 N-CA-C 107.821 -1.178 . . . . 74.02 107.821 168.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.4 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 26.4 t -121.13 127.46 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.84 -0.8 . . . . 75.52 108.84 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.529 HD23 HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -102.23 106.75 17.62 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 106.817 -1.549 . . . . 71.33 106.817 176.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -92.76 101.82 14.22 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.865 -1.161 . . . . 71.31 107.865 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.529 HG23 HD23 ' A' ' 60' ' ' LEU . 21.9 t -96.23 126.91 48.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 N-CA-C 108.482 -0.933 . . . . 75.32 108.482 174.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.8 m -116.25 142.7 46.49 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.978 -0.749 . . . . 73.23 108.978 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.569 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 92.6 t -139.3 109.3 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 125.169 1.388 . . . . 75.41 107.749 -176.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.4 m -107.4 123.02 47.77 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.993 -0.743 . . . . 71.32 108.993 169.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.94 120.57 36.77 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.354 -0.98 . . . . 72.23 108.354 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.5 m -124.14 136.07 53.95 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.211 0.604 . . . . 64.03 110.755 -176.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.551 HD21 ' CE3' ' A' ' 36' ' ' TRP . 91.6 mt -87.75 74.99 9.02 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.354 -0.98 . . . . 75.32 108.354 174.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.47 -116.38 4.68 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 114.33 -1.305 . . . . 64.03 110.956 -169.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -91.94 -13.85 30.49 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.875 0.87 . . . . 63.42 110.743 176.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.407 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 5.9 tp10 -77.26 133.28 38.89 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.39 1.076 . . . . 75.43 108.267 173.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.6 m -87.7 127.5 35.3 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.729 0.695 . . . . 74.31 109.521 174.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.545 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -79.83 -58.85 2.98 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.53 -0.915 . . . . 73.43 108.53 173.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -162.39 165.24 26.67 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 115.458 -0.792 . . . . 74.02 111.652 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.3 tp -127.17 118.98 25.38 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.393 -1.276 . . . . 70.12 107.988 166.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.569 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.0 m -105.56 138.11 42.3 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.054 0.942 . . . . 71.24 109.257 171.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -147.92 132.75 18.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.694 -0.854 . . . . 73.32 108.694 168.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.2 t -138.7 110.85 5.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 C-N-CA 124.194 0.998 . . . . 65.22 108.461 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -84.89 85.46 7.47 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.282 -1.007 . . . . 74.02 108.282 169.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -75.92 96.99 3.85 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.096 -0.956 . . . . 74.21 109.011 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.06 160.14 34.78 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 111.513 -0.635 . . . . 75.01 111.513 178.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.9 127.68 2.01 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.773 -0.931 . . . . 62.23 110.773 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.473 HG21 ' NE2' ' A' ' 14' ' ' GLN . 63.6 mt -80.97 124.0 38.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 107.948 -1.13 . . . . 74.33 107.948 171.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.597 ' HB3' HD11 ' A' ' 86' ' ' ILE . 87.7 m-85 -125.65 127.42 46.27 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 109.003 -0.74 . . . . 72.41 109.003 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.3 t -89.3 97.57 11.27 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.955 -0.757 . . . . 64.24 108.955 173.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.597 HD11 ' HB3' ' A' ' 84' ' ' PHE . 4.7 mm -112.76 150.92 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 122.74 0.416 . . . . 75.44 110.502 -175.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.54 170.85 12.36 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.003 0.814 . . . . 73.43 110.869 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.11 -31.39 7.05 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 115.987 -0.551 . . . . 74.54 113.924 172.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.2 161.03 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.812 0.845 . . . . 73.13 108.993 176.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.557 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 17.0 tt0 -153.5 176.65 11.8 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 109.457 -0.572 . . . . 75.21 109.457 -175.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.557 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 57.5 -123.37 32.5 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 124.144 0.902 . . . . 72.23 113.921 177.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.2 t -75.23 -24.72 57.75 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.262 0.625 . . . . 64.01 111.91 -176.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -76.27 -34.79 59.12 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.42 0.688 . . . . 74.3 110.368 176.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.573 ' HE3' HG21 ' A' ' 86' ' ' ILE . 6.4 tpt -62.86 -48.68 78.0 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.383 -0.599 . . . . 75.23 109.383 171.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.71 -36.62 72.24 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.645 0.778 . . . . 53.33 110.751 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -67.96 -38.0 82.24 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.422 0.689 . . . . 74.33 111.182 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.5 t -66.38 -40.43 89.68 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.849 -0.426 . . . . 70.42 109.849 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.532 HD22 ' HE2' ' A' ' 94' ' ' MET . 53.9 mt -83.66 -25.61 30.59 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.741 0.816 . . . . 72.33 112.322 -174.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.53 3.38 34.53 Favored Glycine 0 N--CA 1.475 1.268 0 O-C-N 123.417 0.448 . . . . 73.12 113.726 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.544 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -136.8 -68.69 0.48 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.029 0.532 . . . . 70.14 110.059 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -65.82 -46.97 76.64 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.436 0.694 . . . . 74.02 111.721 -171.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 59.4 m -66.29 -50.75 47.75 Favored Pre-proline 0 CA--C 1.567 1.619 0 C-N-CA 124.464 1.105 . . . . 73.03 112.659 -175.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.96 -20.05 45.28 Favored 'Trans proline' 0 C--N 1.39 2.749 0 C-N-CA 121.841 1.694 . . . . 71.24 112.948 174.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -69.7 -35.71 75.3 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.847 0.459 . . . . 75.3 110.188 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.54 HG21 HD12 ' A' ' 13' ' ' ILE . 46.7 mm -64.25 -47.87 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.27 0.628 . . . . 73.12 109.828 171.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.5 mt -72.22 -21.7 61.36 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.116 -0.947 . . . . 74.21 112.552 -171.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -65.03 -45.46 73.44 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 114.26 1.207 . . . . 73.01 114.26 -172.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.426 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 82.8 Cg_exo -50.54 -40.95 54.29 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.055 1.837 . . . . 73.42 113.626 171.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -76.13 -38.58 56.64 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.371 0.668 . . . . 74.32 111.084 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.21 -48.12 74.46 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.347 0.659 . . . . 64.15 109.915 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.408 HH11 ' HA ' ' A' ' 108' ' ' PRO . 29.3 ttm105 -47.99 -55.91 8.92 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 125.023 1.452 . . . . 74.22 110.079 174.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -61.81 -48.34 81.02 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 124.478 1.111 . . . . 75.54 111.879 -175.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.528 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.0 t -57.05 -42.39 80.44 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 123.786 0.679 . . . . 73.23 110.57 -177.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.573 HD13 HD12 ' A' ' 128' ' ' LEU . 82.9 mt -62.95 -52.15 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 115.097 -0.956 . . . . 74.35 110.319 173.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 61.7 m -55.28 -41.08 71.79 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.047 0.939 . . . . 70.32 111.319 -175.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.8 t -68.99 -42.57 76.32 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 114.626 -1.17 . . . . 72.11 109.706 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.519 ' HE2' ' HB2' ' A' ' 23' ' ' PHE . 7.9 mtp -60.02 -42.49 94.45 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.871 0.868 . . . . 72.41 111.063 175.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.1 t -61.66 -45.84 97.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 124.278 1.031 . . . . 72.12 110.1 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.5 p -73.95 -30.51 62.58 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.271 0.628 . . . . 75.34 111.647 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 78.6 mtt-85 -72.59 -29.21 63.32 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.509 0.724 . . . . 73.33 109.594 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.07 5.42 62.77 Favored Glycine 0 C--N 1.354 1.56 0 CA-C-O 119.213 -0.771 . . . . 65.33 112.962 175.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.501 ' O ' HG23 ' A' ' 122' ' ' THR . 44.6 m 72.61 10.35 5.63 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 122.587 1.184 . . . . 74.44 111.703 173.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -86.35 144.42 38.14 Favored Pre-proline 0 C--O 1.244 0.765 0 O-C-N 121.064 -1.023 . . . . 75.21 109.151 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.416 ' HB3' ' HA ' ' E' ' 131' ' ' TRP . 72.6 Cg_exo -51.69 142.52 40.52 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.06 2.507 . . . . 74.35 112.159 174.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -57.06 136.34 56.33 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 123.999 0.812 . . . . 72.34 112.667 -170.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.477 HD21 HG12 ' A' ' 64' ' ' VAL . 35.8 tp -121.58 123.37 41.8 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.626 1.17 . . . . 74.02 108.486 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.512 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 92.2 m-20 -122.44 109.46 14.41 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.543 0.737 . . . . 71.12 109.124 -176.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.573 HD12 HD13 ' A' ' 114' ' ' ILE . 7.9 mt -70.01 116.46 10.4 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 109.217 -0.66 . . . . 75.44 109.217 -173.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.68 143.4 93.9 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 122.873 0.469 . . . . 55.43 111.57 -172.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -56.24 125.14 18.09 Favored 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.488 2.792 . . . . 72.22 114.141 -172.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 90.3 t -102.46 134.26 43.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 CA-C-N 115.335 -0.848 . . . . 73.11 110.382 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -90.54 86.54 6.44 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.709 -0.848 . . . . 71.34 108.709 176.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -63.11 -27.65 69.53 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.579 0.751 . . . . 75.42 112.029 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.544 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 18.7 t70 -66.91 -43.37 83.51 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 123.45 0.469 . . . . 75.31 109.745 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.65 -40.51 95.58 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 124.228 0.955 . . . . 71.23 111.105 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 89.3 mt -60.01 -51.94 67.5 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.275 0.63 . . . . 74.03 111.033 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -66.82 -36.43 82.35 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.686 -0.487 . . . . 71.04 109.686 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.476 ' HE2' HD23 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -57.15 -47.56 80.85 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 124.011 0.819 . . . . 74.1 110.226 -179.031 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -56.83 -42.04 78.92 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.046 0.938 . . . . 73.22 111.522 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -76.24 -30.75 58.02 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.566 -0.743 . . . . 73.41 111.17 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.476 HD23 ' HE2' ' A' ' 138' ' ' MET . 44.4 tp -67.21 -52.09 45.36 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.381 1.073 . . . . 75.44 110.998 -174.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 175.23 -13.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.14 0.976 . . . . 73.22 110.294 -175.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 75.06 -63.13 0.43 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.389 1.875 . . . . 73.34 109.795 -173.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -73.21 83.45 1.35 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.042 0.937 . . . . 75.44 109.607 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -162.99 165.17 25.22 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.452 1.101 . . . . 75.42 110.035 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -173.06 126.24 1.23 Allowed Glycine 0 C--N 1.34 0.76 0 N-CA-C 111.597 -0.601 . . . . 51.24 111.597 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -147.32 122.41 10.13 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.917 0.887 . . . . 75.4 109.078 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 179.95 53.85 0.08 OUTLIER Glycine 0 C--N 1.349 1.255 0 CA-C-N 116.308 -0.405 . . . . 61.1 112.218 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.435 ' HG1' ' HB3' ' A' ' 6' ' ' ASN . 19.0 p -129.93 142.83 50.6 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.35 -0.981 . . . . 74.02 108.35 175.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -145.94 104.47 3.85 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 108.642 -0.873 . . . . 74.43 108.642 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -166.66 38.12 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.473 0.709 . . . . 71.22 110.919 -174.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -131.32 141.44 49.93 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.722 0.409 . . . . 71.12 110.661 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -125.14 137.61 54.16 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.681 -0.859 . . . . 71.22 108.681 167.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -153.09 98.44 2.29 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.329 -0.989 . . . . 65.31 108.329 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.215 0 N-CA-C 108.447 -0.945 . . . . 74.12 108.447 -179.796 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.487 1.383 0 N-CA-C 109.699 -0.482 . . . . 74.21 109.699 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 48.5 t -154.7 112.32 3.42 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.319 1.048 . . . . 70.43 108.651 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -82.34 84.8 7.01 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.326 0.65 . . . . 71.23 110.084 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -137.26 111.26 8.3 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.878 0.871 . . . . 64.54 108.946 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -74.98 137.99 41.94 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 109.87 -0.419 . . . . 73.21 109.87 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 58.24 78.19 0.26 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.485 1.114 . . . . 73.3 110.19 -172.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.518 HG21 ' HA ' ' B' ' 89' ' ' ILE . 17.2 m -80.43 106.34 12.37 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 109.096 -0.705 . . . . 73.11 109.096 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -60.27 -29.04 68.54 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.562 1.145 . . . . 74.1 112.54 -177.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.634 ' HB3' HG23 ' B' ' 89' ' ' ILE . 25.5 ptm 51.49 -170.5 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 126.509 1.924 . . . . 70.31 113.437 -177.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.3 t -143.54 127.37 17.24 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 124.437 1.095 . . . . 72.01 108.096 171.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.401 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 75.2 t80 -123.51 146.19 48.27 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.613 0.765 . . . . 74.11 109.521 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.668 ' HG3' ' HB2' ' E' ' 125' ' ' ALA . 8.5 tt0 -149.99 131.26 14.57 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.248 0.619 . . . . 72.3 109.739 176.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 54.9 mt -80.3 122.82 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.538 -1.282 . . . . 73.12 107.538 168.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -93.58 -49.77 5.73 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.692 -0.855 . . . . 64.34 108.692 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.41 ' HE ' HG21 ' A' ' 122' ' ' THR . 26.1 ttt180 -164.14 143.57 7.75 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.767 -0.651 . . . . 73.31 110.841 -174.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 94.6 mt -124.02 141.45 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 107.039 -1.467 . . . . 74.33 107.039 173.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -165.43 138.98 4.56 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 112.886 0.699 . . . . 72.44 112.886 -174.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.6 m -73.91 119.38 18.05 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.668 0.787 . . . . 74.34 109.373 172.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.493 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.9 mtpt -96.89 -20.44 18.14 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.707 0.803 . . . . 74.11 111.678 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 34.0 t70 -160.18 149.64 17.72 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.097 0.559 . . . . 74.12 111.022 -177.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.605 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 26.9 mm -145.86 146.16 19.58 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 125.485 1.514 . . . . 75.3 108.374 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 36.3 t -155.6 145.6 21.51 Favored 'General case' 0 C--O 1.242 0.693 0 O-C-N 124.351 1.032 . . . . 73.32 110.087 169.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.44 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 87.1 t80 -151.56 108.54 3.54 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 107.457 -1.312 . . . . 74.24 107.457 169.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.18 113.53 21.69 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.243 -1.021 . . . . 74.2 108.243 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.518 ' HB3' ' HB3' ' B' ' 28' ' ' ALA . . . -107.78 86.42 2.97 Favored Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 107.888 -1.153 . . . . 74.54 107.888 174.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.2 -33.69 7.0 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.734 2.29 . . . . 72.11 112.933 -170.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -100.95 6.15 43.48 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.815 0.846 . . . . 72.11 111.389 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.518 ' HB3' ' HB3' ' B' ' 25' ' ' ALA . . . -41.39 -62.59 1.02 Allowed Pre-proline 0 N--CA 1.491 1.606 0 C-N-CA 125.436 1.494 . . . . 65.33 113.924 -168.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.37 -38.29 73.21 Favored 'Trans proline' 0 C--N 1.391 2.792 0 C-N-CA 122.89 2.393 . . . . 72.02 113.756 -172.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -93.54 -35.03 13.12 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.193 -0.912 . . . . 74.02 111.636 -171.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 4.3 p -73.14 -14.74 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.239 0.616 . . . . 75.22 111.574 -171.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -64.31 -20.46 66.1 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.445 0.698 . . . . 73.03 112.771 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -65.17 -18.18 65.09 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.146 0.578 . . . . 72.11 110.942 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.457 ' HZ3' ' HG2' ' B' ' 71' ' ' GLU . 93.0 mttt -91.2 79.61 5.69 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.787 1.235 . . . . 75.44 110.048 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -85.31 78.01 9.86 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.321 -0.854 . . . . 74.44 110.098 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 14.9 p90 -154.3 -174.68 5.06 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.952 0.901 . . . . 75.44 108.875 172.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.406 ' HB3' ' OG1' ' F' ' 129' ' ' THR . 0.0 OUTLIER -71.0 120.19 77.95 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 123.157 0.583 . . . . 70.1 111.079 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.536 ' HA ' HD21 ' B' ' 68' ' ' LEU . 58.1 Cg_endo -70.33 139.32 38.0 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 121.244 1.296 . . . . 71.24 109.513 172.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.61 101.02 1.2 Allowed 'General case' 0 C--O 1.242 0.691 0 N-CA-C 107.27 -1.381 . . . . 62.45 107.27 170.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.535 HG21 ' HB1' ' B' ' 66' ' ' ALA . 35.4 t -102.94 145.66 11.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 115.066 -0.97 . . . . 63.53 109.184 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -135.07 130.41 35.52 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.344 -0.844 . . . . 72.1 108.91 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.41 HD11 HG13 ' B' ' 62' ' ' VAL . 21.8 tp -94.09 126.97 39.63 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 124.212 0.945 . . . . 72.22 109.245 170.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -142.87 126.38 16.8 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.289 1.036 . . . . 71.12 108.466 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.498 HD21 HG21 ' B' ' 62' ' ' VAL . 4.0 mp -119.9 148.72 43.16 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.985 0.514 . . . . 72.43 110.537 -172.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.411 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 18.1 t70 -124.4 141.61 51.95 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.172 1.389 . . . . 73.13 108.097 176.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 27.4 m -113.34 104.16 12.04 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.561 -0.533 . . . . 64.01 109.561 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.59 134.43 55.05 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.088 -1.449 . . . . 74.25 107.088 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.426 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 51.9 m -142.99 162.8 34.51 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 122.493 0.317 . . . . 72.11 110.745 -175.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.9 p -152.09 135.6 16.08 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.431 0.692 . . . . 73.03 109.693 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -90.49 122.66 33.52 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 109.013 -0.736 . . . . 75.22 109.013 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 pp -143.96 25.11 1.62 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.286 -0.87 . . . . 73.11 109.589 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.97 156.76 20.19 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 123.632 0.773 . . . . 74.32 110.312 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.7 131.83 36.05 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 108.521 -0.918 . . . . 73.21 108.521 167.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 64.49 7.31 3.59 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.929 1.292 . . . . 72.42 112.215 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.696 HG21 ' HA ' ' B' ' 85' ' ' SER . 54.2 t -138.68 123.33 21.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 107.239 -1.393 . . . . 73.3 107.239 -174.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.426 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 1.5 t80 -117.26 145.45 43.93 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 108.364 -0.976 . . . . 71.32 108.364 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -100.51 103.13 14.45 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 106.547 -1.649 . . . . 71.05 106.547 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 6.8 p -102.52 132.44 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.345 -0.613 . . . . 71.32 109.345 -176.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.414 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 19.0 t -115.12 122.41 69.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 108.688 -0.856 . . . . 73.23 108.688 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 38.9 tp -103.54 105.89 16.25 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.754 -0.832 . . . . 71.22 108.754 173.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.428 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 14.4 ttm180 -84.9 110.09 18.61 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 108.588 -0.893 . . . . 74.3 108.588 174.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.498 HG21 HD21 ' B' ' 44' ' ' LEU . 61.4 t -105.03 104.7 17.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 123.572 0.749 . . . . 73.02 109.011 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 6.7 m -98.83 137.15 37.82 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.134 -0.939 . . . . 73.13 109.684 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.631 HG23 HD12 ' B' ' 114' ' ' ILE . 30.6 t -128.42 116.29 41.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 124.225 1.01 . . . . 75.21 108.524 174.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 97.0 m -101.95 136.56 41.58 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.985 -1.117 . . . . 73.51 107.985 168.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.535 ' HB1' HG21 ' B' ' 40' ' ' VAL . . . -139.87 141.22 36.61 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 109.443 -0.577 . . . . 73.43 109.443 178.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.489 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 40.9 p -148.15 130.98 16.08 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.542 0.526 . . . . 73.02 111.585 -173.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.536 HD21 ' HA ' ' B' ' 38' ' ' PRO . 75.8 mt -97.04 107.11 19.57 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.181 0.992 . . . . 71.45 108.664 176.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.58 -111.98 3.37 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 111.195 -0.762 . . . . 74.02 111.195 -172.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -117.54 1.65 12.31 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.674 0.79 . . . . 72.13 110.297 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.457 ' HG2' ' HZ3' ' B' ' 34' ' ' LYS . 12.3 pt-20 -114.43 142.15 46.73 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.768 -0.583 . . . . 73.42 110.37 -174.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 25.4 m -66.39 115.25 6.11 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.719 0.808 . . . . 64.51 111.394 -175.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.489 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -70.02 -56.34 7.2 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.992 -1.114 . . . . 74.41 107.992 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -158.37 164.47 36.29 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 114.398 -1.274 . . . . 73.32 111.151 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 67.8 mt -129.9 112.23 13.33 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 106.683 -1.599 . . . . 71.32 106.683 172.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.517 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 34.2 t -119.94 115.12 23.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.772 -0.825 . . . . 73.3 108.772 177.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -128.0 124.81 38.11 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.885 0.874 . . . . 75.32 109.044 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 73.1 t -124.49 153.17 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.227 1.011 . . . . 73.34 109.276 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.58 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.5 mt-30 -122.9 111.78 17.05 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.349 -0.982 . . . . 72.33 108.349 167.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.435 ' HG3' HD23 ' B' ' 106' ' ' LEU . 8.0 tp-100 -101.54 106.83 17.97 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.526 -0.916 . . . . 74.23 108.526 171.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.493 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -100.91 167.28 19.59 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 111.525 -0.63 . . . . 55.44 111.525 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.26 143.82 8.67 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.127 -0.559 . . . . 70.24 112.98 -174.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 79.3 mt -101.76 113.65 38.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 107.651 -1.24 . . . . 72.44 107.651 174.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . 0.406 ' O ' HG12 ' B' ' 55' ' ' VAL . 38.9 m-85 -127.49 147.46 50.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.311 0.644 . . . . 73.22 109.593 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.696 ' HA ' HG21 ' B' ' 55' ' ' VAL . 49.3 m -94.25 115.71 28.01 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.542 1.137 . . . . 62.11 110.456 177.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.628 HG21 HD12 ' B' ' 89' ' ' ILE . 3.8 mp -120.67 104.89 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 106.929 -1.508 . . . . 73.4 106.929 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.34 167.79 21.32 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.107 0.563 . . . . 74.3 110.559 -175.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.46 -45.82 3.29 Favored Glycine 0 N--CA 1.476 1.321 0 O-C-N 123.138 0.274 . . . . 70.13 113.096 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.634 HG23 ' HB3' ' B' ' 9' ' ' MET . 0.8 OUTLIER -58.03 167.74 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 124.839 1.255 . . . . 75.24 113.415 175.326 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -152.55 149.85 28.93 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.467 -1.242 . . . . 75.34 110.696 -174.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.19 -126.67 7.61 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.519 0.512 . . . . 71.42 112.236 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 20.3 m -90.1 -19.58 24.15 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.028 0.531 . . . . 64.12 110.202 175.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -53.44 -33.7 55.08 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.055 0.942 . . . . 75.11 111.368 176.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.739 ' SD ' HG23 ' F' ' 97' ' ' ILE . 11.2 ptt? -62.22 -59.42 5.06 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.259 1.024 . . . . 74.44 111.707 -174.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.85 -14.15 58.29 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.348 0.659 . . . . 70.45 111.428 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -61.87 -38.61 88.91 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.846 0.858 . . . . 64.54 110.688 170.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.7 t -68.89 -55.36 11.29 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.81 0.444 . . . . 74.31 110.615 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.625 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 1.9 pp -74.17 -18.4 60.78 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.717 0.636 . . . . 73.01 112.717 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.41 0.93 55.78 Favored Glycine 0 N--CA 1.472 1.072 0 CA-C-O 119.413 -0.659 . . . . 74.21 114.199 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.545 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -149.04 -50.86 0.15 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 117.888 0.844 . . . . 71.45 112.006 -176.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.401 ' O ' ' HB3' ' B' ' 104' ' ' ASN . 39.7 t80 -73.01 -39.58 65.9 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.333 0.653 . . . . 75.43 111.046 -177.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.625 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 82.0 m -75.13 -43.7 4.56 Favored Pre-proline 0 CA--C 1.563 1.446 0 CA-C-O 118.476 -0.773 . . . . 72.2 113.027 -175.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.7 -22.39 64.27 Favored 'Trans proline' 0 C--N 1.389 2.669 0 CA-C-N 121.185 1.459 . . . . 71.41 112.692 170.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.401 ' HB3' ' O ' ' B' ' 101' ' ' TYR . 22.8 t-20 -64.15 -37.44 87.46 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.886 0.474 . . . . 75.2 110.861 172.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.9 mt -66.37 -40.85 87.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.536 0.735 . . . . 75.31 110.09 173.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.435 HD23 ' HG3' ' B' ' 80' ' ' GLN . 88.1 mt -75.0 -28.17 60.43 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.822 0.849 . . . . 73.12 112.775 -174.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -56.16 -47.35 99.01 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 118.068 -0.968 . . . . 74.33 113.464 -173.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.513 ' HG2' ' HB2' ' D' ' 108' ' ' PRO . 85.0 Cg_exo -53.53 -42.99 61.45 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.813 2.342 . . . . 74.05 114.604 174.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.408 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 40.4 m-85 -67.62 -36.05 80.09 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.187 0.595 . . . . 73.23 110.476 -177.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.21 -39.75 74.95 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.573 0.749 . . . . 74.41 110.778 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.433 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 51.3 ttt-85 -60.79 -55.16 36.37 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.282 1.433 . . . . 74.0 111.175 -177.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -69.15 -26.15 64.73 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.618 0.574 . . . . 74.41 110.427 -177.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.498 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.8 t -70.44 -39.4 74.37 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 110.265 -0.272 . . . . 72.34 110.265 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.631 HD12 HG23 ' B' ' 64' ' ' VAL . 72.3 mt -61.44 -54.81 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 123.987 0.915 . . . . 74.03 109.762 170.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 36.7 m -59.1 -28.3 66.39 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.921 0.888 . . . . 74.14 111.263 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.475 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.8 t -68.28 -50.97 50.06 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 123.475 0.71 . . . . 73.22 109.943 175.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.4 mmt -68.22 -36.34 79.36 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.204 0.601 . . . . 75.11 111.206 -175.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.2 -43.55 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.606 1.162 . . . . 72.41 110.198 173.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 30.9 t -63.65 -34.44 77.84 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.014 -0.994 . . . . 72.45 110.581 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.528 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 81.2 mtt-85 -69.23 -34.76 75.34 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.89 -0.596 . . . . 73.23 110.297 178.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.28 -11.96 83.84 Favored Glycine 0 C--N 1.357 1.705 0 O-C-N 123.736 0.647 . . . . 64.43 112.456 170.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 16.9 m 66.92 33.63 5.79 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.769 1.628 . . . . 75.05 110.186 176.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -79.52 163.54 58.45 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 115.259 -0.882 . . . . 75.41 110.434 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -58.76 165.65 7.8 Favored 'Trans proline' 0 C--N 1.388 2.624 0 C-N-CA 122.655 2.237 . . . . 75.43 112.894 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.424 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 23.9 tp60 -63.88 112.47 2.93 Favored 'General case' 0 C--N 1.345 0.405 0 C-N-CA 123.86 0.864 . . . . 61.21 111.378 -167.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.546 HD23 HG13 ' B' ' 64' ' ' VAL . 23.3 tp -110.52 112.53 24.51 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.168 -0.924 . . . . 65.42 109.018 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.17 124.3 41.5 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 108.288 -1.005 . . . . 74.41 108.288 176.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.449 HD21 HG22 ' B' ' 64' ' ' VAL . 77.3 mt -83.59 136.62 34.17 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.691 0.396 . . . . 62.52 110.514 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.32 140.99 52.87 Favored Pre-proline 0 CA--C 1.55 0.952 0 O-C-N 123.972 0.795 . . . . 73.02 111.284 -174.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -60.02 93.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.541 2.828 . . . . 71.33 111.99 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 4.0 p -90.55 118.34 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 108.496 -0.927 . . . . 74.42 108.496 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -81.02 99.34 8.39 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.617 -0.72 . . . . 73.21 109.182 -175.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -64.41 -38.08 89.79 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.294 -0.867 . . . . 72.43 110.242 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.545 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 9.6 t70 -59.84 -50.47 73.68 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.053 -0.976 . . . . 72.43 110.331 -176.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.64 -36.77 85.34 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 124.15 0.906 . . . . 65.41 111.564 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.432 HD13 ' HB3' ' F' ' 120' ' ' TYR . 53.4 tp -59.54 -49.07 79.19 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.583 0.753 . . . . 72.15 110.602 177.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -72.04 -20.22 61.71 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.252 0.621 . . . . 72.41 111.787 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.541 ' HA ' ' HE1' ' B' ' 138' ' ' MET . 8.2 mmt -73.15 -29.26 62.74 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.931 0.492 . . . . 73.32 110.891 174.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -78.72 -36.33 43.5 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.531 0.332 . . . . 71.34 110.215 172.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -60.44 -40.07 89.77 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.109 0.563 . . . . 74.4 111.268 174.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 37.1 tp -95.52 -7.93 36.61 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.4 0.68 . . . . 71.54 111.826 -176.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 67.0 120.68 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.707 1.203 . . . . 73.43 110.722 -171.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -150.91 153.5 35.39 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.471 -0.936 . . . . 74.01 108.471 177.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.24 115.59 5.08 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.862 -0.792 . . . . 71.4 108.862 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -148.96 145.58 27.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.014 0.926 . . . . 75.24 109.065 174.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -176.55 97.02 0.11 Allowed Glycine 0 C--N 1.338 0.685 0 N-CA-C 111.078 -0.809 . . . . 43.13 111.078 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -84.44 -172.69 4.31 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.936 0.495 . . . . 74.04 111.182 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -160.19 -42.56 0.02 OUTLIER Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.497 -0.641 . . . . 61.42 111.497 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 9.1 m 49.59 59.59 4.39 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.058 1.343 . . . . 75.22 110.931 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . 0.498 ' HA ' ' HA3' ' D' ' 91' ' ' GLY . 3.4 tm-20 -80.95 113.39 19.13 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.571 -1.195 . . . . 72.11 109.694 -172.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -163.54 130.54 3.38 Favored 'General case' 0 C--O 1.239 0.524 0 O-C-N 124.038 0.836 . . . . 75.01 109.372 168.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -168.99 100.93 0.37 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 107.395 -1.335 . . . . 72.41 107.395 172.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -74.53 -33.12 62.68 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.486 0.714 . . . . 72.14 112.677 -171.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 62.26 18.89 10.56 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.286 1.035 . . . . 71.11 111.781 -173.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.247 0 C-N-CA 124.186 0.994 . . . . 73.55 108.984 -179.217 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.465 ' N ' ' SD ' ' C' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 109.339 -0.615 . . . . 73.4 109.339 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' SER . . . . . 0.485 ' HG ' HG22 ' C' ' 10' ' ' THR . 23.3 p -77.73 78.38 4.23 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.468 0.651 . . . . 65.33 109.399 174.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -70.78 86.65 0.68 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.587 -1.188 . . . . 74.34 110.499 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -124.02 134.26 53.48 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.398 1.079 . . . . 74.53 108.172 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . 0.662 ' HA ' ' HA2' ' C' ' 88' ' ' GLY . 62.6 t30 -154.77 42.35 0.47 Allowed 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 121.357 0.599 . . . . 73.44 110.376 -176.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -106.18 -79.8 0.56 Allowed 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.58 -0.526 . . . . 74.25 109.58 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 44.6 p -142.99 4.98 1.49 Allowed 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 123.769 0.827 . . . . 75.44 111.743 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -76.15 -54.87 6.18 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.796 0.838 . . . . 75.54 110.79 -167.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.501 ' HE3' HG21 ' C' ' 89' ' ' ILE . 47.6 ttm 63.03 110.59 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.335 1.454 . . . . 73.43 109.936 -165.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.485 HG22 ' HG ' ' C' ' 2' ' ' SER . 24.1 m -97.06 86.68 4.02 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.957 -0.757 . . . . 74.4 108.957 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.462 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 59.8 t80 -104.27 116.09 31.55 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.428 -0.953 . . . . 74.34 108.428 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -138.45 132.32 31.14 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 109.556 -0.535 . . . . 74.33 109.556 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 21.6 mt -77.71 128.89 38.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 O-C-N 123.957 0.786 . . . . 74.14 109.395 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.434 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.8 mm-40 -89.05 -46.57 8.75 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.471 0.709 . . . . 64.5 109.153 174.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.512 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 13.6 ptp180 -176.26 150.17 0.91 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.61 1.164 . . . . 73.14 109.63 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 76.9 mt -128.22 129.9 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.409 1.083 . . . . 74.02 108.3 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.503 ' HB3' HG22 ' D' ' 122' ' ' THR . 35.7 p90 -158.07 175.1 14.23 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.804 0.841 . . . . 73.31 110.421 -166.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.6 p -98.07 114.23 26.34 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 122.932 0.493 . . . . 73.32 109.982 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.534 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 27.9 mmtp -65.39 -30.37 71.18 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.449 -0.574 . . . . 75.3 109.449 165.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.61 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.1 t70 -162.35 146.65 12.1 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.142 -0.935 . . . . 72.15 110.651 -172.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.7 mt -138.32 147.11 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.785 1.634 . . . . 74.43 107.25 173.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 43.8 t -152.45 148.04 26.96 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 122.935 0.494 . . . . 74.44 110.535 175.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . 0.433 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 79.8 t80 -155.82 119.4 4.4 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 114.652 -1.158 . . . . 73.13 108.119 172.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -126.87 118.0 23.71 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.15 -0.685 . . . . 72.3 109.15 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.4 81.53 46.18 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 107.574 -1.269 . . . . 75.14 107.574 167.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.73 -36.05 43.01 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 122.739 2.292 . . . . 74.23 111.408 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -101.4 30.48 4.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.56 1.144 . . . . 74.32 109.535 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.24 -54.04 28.72 Favored Pre-proline 0 N--CA 1.495 1.789 0 C-N-CA 124.259 1.024 . . . . 73.51 113.297 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.46 -42.02 29.67 Favored 'Trans proline' 0 C--N 1.381 2.24 0 CA-C-N 121.17 1.454 . . . . 75.43 111.421 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -71.0 -27.75 63.92 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 114.277 -1.329 . . . . 71.41 113.042 -174.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.668 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.8 p -80.8 -28.93 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 O-C-N 122.059 -0.401 . . . . 72.33 111.664 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -65.15 -15.6 62.6 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 112.762 0.653 . . . . 75.01 112.762 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -105.32 22.46 15.37 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.947 0.899 . . . . 75.04 111.113 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.717 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -110.23 160.63 16.34 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.591 0.756 . . . . 65.52 110.562 -178.019 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -66.34 126.85 30.07 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.335 -0.617 . . . . 75.14 109.335 166.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -80.21 77.78 6.92 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.611 0.719 . . . . 65.2 109.683 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -129.02 66.44 76.31 Favored Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 123.963 0.905 . . . . 75.11 109.43 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -90.8 153.01 4.09 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.421 2.08 . . . . 52.44 112.578 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . 0.611 ' HB2' ' HE3' ' C' ' 41' ' ' LYS . 8.7 pt-20 -88.33 104.04 16.38 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.55 -1.278 . . . . 72.11 107.55 165.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.421 HG13 HD21 ' C' ' 126' ' ' LEU . 59.4 t -77.17 100.03 2.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.361 -0.977 . . . . 72.51 108.361 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.611 ' HE3' ' HB2' ' C' ' 39' ' ' GLU . 34.1 mmtp -103.59 105.57 15.84 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.421 -0.809 . . . . 75.23 109.96 -177.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mp -87.31 122.36 30.97 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 107.106 -1.442 . . . . 75.33 107.106 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.436 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 28.4 t70 -124.54 105.2 9.19 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.131 -0.692 . . . . 73.14 109.131 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.507 HD21 HG11 ' C' ' 62' ' ' VAL . 98.7 mt -94.2 141.96 27.95 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.871 0.868 . . . . 72.22 110.526 -177.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -148.46 143.64 26.87 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.255 -1.387 . . . . 73.51 107.255 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -133.93 149.55 51.29 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.883 -0.784 . . . . 74.11 108.883 175.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.77 143.55 27.6 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.443 -0.947 . . . . 72.13 108.443 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.424 ' HG ' ' HB3' ' C' ' 98' ' ' LEU . 7.0 m -132.3 150.71 52.1 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 109.908 -0.405 . . . . 74.42 109.908 -175.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.3 t -145.71 125.46 13.42 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.574 -0.898 . . . . 63.02 108.574 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -79.86 116.67 20.15 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.977 -0.749 . . . . 73.52 108.977 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.527 HD12 ' HB2' ' C' ' 57' ' ' GLU . 48.3 mt -86.04 -36.4 19.74 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.852 0.861 . . . . 74.03 110.614 -175.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.55 -172.04 3.81 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.015 0.926 . . . . 74.55 109.851 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -63.89 112.95 3.14 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.744 0.818 . . . . 64.43 109.958 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 63.99 20.8 12.36 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.641 1.176 . . . . 74.22 112.27 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 66.2 t -114.9 113.58 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.066 -1.087 . . . . 74.23 108.066 173.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -122.79 124.6 43.69 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.121 0.968 . . . . 74.0 109.673 -176.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.527 ' HB2' HD12 ' C' ' 51' ' ' LEU . 29.3 tt0 -84.46 137.74 33.19 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.501 -0.925 . . . . 65.31 108.501 168.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 92.4 t -127.21 136.37 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.544 -0.91 . . . . 75.41 108.544 172.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.433 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 58.4 t -130.08 126.06 61.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 108.931 -0.766 . . . . 74.31 108.931 177.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.503 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -102.61 98.16 8.25 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 107.162 -1.421 . . . . 75.33 107.162 -178.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -82.72 105.72 13.98 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.551 -0.907 . . . . 73.31 108.551 174.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.507 HG11 HD21 ' C' ' 44' ' ' LEU . 20.2 t -107.14 135.37 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.352 -0.981 . . . . 75.44 108.352 176.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 62.3 m -125.7 139.83 53.21 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.619 -0.882 . . . . 74.24 108.619 177.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.564 HG21 HG23 ' C' ' 114' ' ' ILE . 98.1 t -127.37 117.69 47.7 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 N-CA-C 108.744 -0.836 . . . . 74.11 108.744 173.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 19.3 m -103.81 140.16 38.03 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.114 -0.699 . . . . 73.12 109.114 171.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.39 112.35 17.45 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.61 -1.256 . . . . 74.33 107.61 174.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 30.4 m -126.67 127.67 45.52 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.008 0.432 . . . . 72.42 110.074 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.717 HD11 ' HG2' ' C' ' 34' ' ' LYS . 12.7 mt -96.96 23.37 7.27 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.96 1.304 . . . . 74.44 110.618 -174.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.74 -77.73 0.3 Allowed Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.196 -0.762 . . . . 50.33 111.196 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -117.48 -30.6 5.48 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.037 0.935 . . . . 74.1 109.418 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -79.68 122.54 26.68 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.551 1.14 . . . . 75.11 110.225 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 27.4 m -76.73 119.53 20.65 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 107.937 -1.134 . . . . 74.51 107.937 164.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.668 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -73.08 -48.51 35.27 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.385 0.612 . . . . 61.4 109.601 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -166.59 166.84 15.89 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 113.878 -1.51 . . . . 64.55 110.42 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -128.98 141.45 51.25 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.646 -1.612 . . . . 74.32 106.646 167.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 41.9 t -144.52 146.24 32.28 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.185 -1.043 . . . . 74.43 108.185 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -157.61 138.47 13.22 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.66 -0.496 . . . . 72.32 109.66 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.464 HG12 ' HA ' ' C' ' 110' ' ' ALA . 43.9 t -136.44 115.37 15.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 124.62 1.168 . . . . 64.33 108.375 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.61 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 50.9 mt-30 -90.59 86.85 6.51 Favored 'General case' 0 CA--C 1.523 -0.067 0 N-CA-C 107.922 -1.14 . . . . 62.32 107.922 168.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -80.11 99.38 7.71 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 108.573 -0.899 . . . . 75.55 108.573 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -102.34 146.09 16.75 Favored Glycine 0 C--O 1.217 -0.931 0 O-C-N 123.179 0.299 . . . . 63.33 113.193 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.13 146.18 14.37 Favored Glycine 0 C--N 1.331 0.264 0 N-CA-C 111.54 -0.624 . . . . 74.45 111.54 -176.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.515 HD13 HD12 ' C' ' 51' ' ' LEU . 30.7 mm -96.04 138.49 21.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.84 0 N-CA-C 109.389 -0.597 . . . . 74.25 109.389 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.527 ' CZ ' HD12 ' C' ' 106' ' ' LEU . 85.4 m-85 -136.36 123.08 21.11 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 123.36 0.664 . . . . 73.1 110.363 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 85' ' ' SER . . . . . 0.431 ' HB2' HD22 ' E' ' 142' ' ' LEU . 28.2 p -79.36 102.78 8.86 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 107.971 -1.122 . . . . 71.11 107.971 167.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 19.2 mt -117.21 114.94 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.949 0.899 . . . . 63.11 110.412 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -122.01 170.88 9.39 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.885 0.874 . . . . 74.11 109.131 172.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . 0.662 ' HA2' ' HA ' ' C' ' 5' ' ' ASN . . . 98.73 -22.72 39.54 Favored Glycine 0 C--N 1.341 0.809 0 N-CA-C 114.308 0.483 . . . . 63.43 114.308 170.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.697 HD13 ' HA ' ' C' ' 94' ' ' MET . 44.8 pt -122.66 162.35 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 112.613 0.597 . . . . 74.14 112.613 -172.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -159.09 156.64 29.53 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 115.011 -0.995 . . . . 72.3 109.909 175.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.13 -122.36 6.15 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 123.802 0.689 . . . . 63.13 113.008 171.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 42.3 p -67.56 -29.89 69.37 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.504 0.722 . . . . 75.44 110.958 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.61 ' HG2' HE21 ' C' ' 144' ' ' GLN . 27.5 mt-30 -64.69 -59.94 3.68 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.753 0.821 . . . . 75.25 110.489 175.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.697 ' HA ' HD13 ' C' ' 89' ' ' ILE . 5.2 tpt -46.64 -53.93 10.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.951 1.3 . . . . 73.42 112.2 173.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.09 -44.61 91.92 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.447 0.699 . . . . 73.33 111.41 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -64.12 -33.44 75.77 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.027 0.931 . . . . 75.43 111.73 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.463 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 19.4 t -68.85 -55.85 9.81 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.551 -0.907 . . . . 75.44 108.551 177.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.424 ' HB3' ' HG ' ' C' ' 48' ' ' SER . 72.7 mt -65.43 -25.61 67.6 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.611 1.164 . . . . 74.35 112.964 -175.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.16 -8.77 26.92 Favored Glycine 0 C--N 1.347 1.174 0 N-CA-C 115.035 0.774 . . . . 71.13 115.035 -171.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.09 -52.88 0.38 Allowed 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 118.213 1.007 . . . . 74.11 111.766 -175.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.463 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 73.7 t80 -70.75 -58.49 3.58 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.272 0.629 . . . . 74.11 111.498 -173.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.561 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 83.0 m -53.52 -59.07 10.35 Favored Pre-proline 0 CA--C 1.559 1.321 0 CA-C-O 117.663 -1.161 . . . . 75.31 110.968 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.561 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 82.4 Cg_exo -50.51 -34.22 41.43 Favored 'Trans proline' 0 C--N 1.395 3.012 0 C-N-CA 122.822 2.348 . . . . 65.01 114.85 -177.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -65.03 -32.32 73.99 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.442 0.697 . . . . 72.23 111.24 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 35.3 mm -72.63 -31.77 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 123.922 0.889 . . . . 72.14 110.414 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.527 HD12 ' CZ ' ' C' ' 84' ' ' PHE . 5.5 mp -90.03 -17.12 28.4 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.474 0.71 . . . . 73.31 111.734 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -55.93 -49.6 92.05 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-O 117.829 -1.081 . . . . 75.42 113.778 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -61.16 -34.68 88.67 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 121.935 1.757 . . . . 74.31 113.07 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -64.24 -46.8 82.18 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.555 0.742 . . . . 75.43 110.217 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.464 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -65.07 -36.29 83.87 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.122 -0.945 . . . . 62.55 110.723 177.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -64.96 -49.45 70.28 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.058 1.343 . . . . 74.44 110.238 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.89 -32.52 73.06 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.484 0.714 . . . . 63.44 109.625 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 9.0 t -70.24 -39.7 74.9 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 122.985 0.514 . . . . 71.31 110.964 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.564 HG23 HG21 ' C' ' 64' ' ' VAL . 96.6 mt -67.68 -48.79 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.346 0.658 . . . . 73.1 109.828 177.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 15.7 m -66.03 -29.34 69.68 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.915 -0.584 . . . . 55.33 110.755 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 30.2 t -64.77 -50.29 67.38 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.363 -0.606 . . . . 73.03 109.363 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.591 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -55.8 -46.9 77.91 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.432 1.093 . . . . 74.34 111.59 177.536 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 69.2 t -65.69 -40.48 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.874 0.87 . . . . 73.42 110.87 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 33.8 t -72.18 -29.52 64.08 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.607 0.763 . . . . 73.55 111.481 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.551 HH22 ' HG2' ' D' ' 112' ' ' GLU . 64.6 mtt-85 -74.1 -29.62 61.94 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.447 -0.797 . . . . 74.43 109.782 176.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.23 12.43 58.35 Favored Glycine 0 C--N 1.353 1.479 0 O-C-N 124.015 0.822 . . . . 44.12 112.886 172.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 69.4 p 54.16 28.34 8.9 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 126.519 1.928 . . . . 70.33 114.214 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -84.24 151.93 60.58 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 109.365 -0.605 . . . . 74.44 109.365 172.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -47.39 136.23 19.93 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.35 2.7 . . . . 73.31 113.11 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.424 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 41.9 mm-40 -53.69 110.98 0.64 Allowed 'General case' 0 N--CA 1.478 0.965 0 O-C-N 124.317 1.01 . . . . 74.04 111.839 -175.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.45 ' HA ' ' HB3' ' F' ' 132' ' ' SER . 3.9 tt -113.95 90.46 3.35 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.983 -1.117 . . . . 74.34 107.983 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -94.41 122.31 36.84 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.463 -0.94 . . . . 73.41 108.463 173.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 6.4 mp -66.73 145.18 55.81 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.174 0.921 . . . . 75.04 111.288 -171.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.8 151.9 77.06 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-N 115.602 -0.726 . . . . 64.32 110.791 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.584 ' HG3' HD13 ' A' ' 16' ' ' ILE . 21.6 Cg_exo -63.82 107.32 0.74 Allowed 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 123.062 2.508 . . . . 75.21 112.385 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.439 HG13 HD13 ' C' ' 44' ' ' LEU . 7.4 p -103.84 139.84 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 123.926 0.89 . . . . 73.33 109.096 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -94.43 104.35 16.32 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.709 0.804 . . . . 63.24 110.325 -171.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -63.4 -34.58 78.03 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.909 0.884 . . . . 74.23 112.425 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -64.99 -40.15 94.53 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.218 0.607 . . . . 61.21 110.414 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.43 -30.42 67.26 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.573 0.749 . . . . 73.0 111.177 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 91.6 mt -72.39 -40.23 67.4 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.011 0.524 . . . . 75.42 110.139 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -75.4 -18.04 60.03 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.198 -0.91 . . . . 73.4 110.226 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.704 ' HA ' ' HB2' ' C' ' 142' ' ' GLN . 47.8 ttm -65.86 -34.27 77.76 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.491 0.716 . . . . 74.3 110.363 176.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -65.8 -38.16 88.23 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.515 -0.766 . . . . 73.42 110.14 172.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -70.88 -90.15 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.054 0.942 . . . . 74.05 110.337 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mp -138.0 104.09 5.15 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.984 0.913 . . . . 75.32 109.345 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . 0.704 ' HB2' ' HA ' ' C' ' 138' ' ' MET . 5.9 tp-100 -118.87 106.46 12.52 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.062 -0.718 . . . . 71.1 109.062 173.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -149.52 3.12 0.56 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.55 0.74 . . . . 72.35 109.715 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . 0.61 HE21 ' HG2' ' C' ' 93' ' ' GLN . 1.5 tm0? -100.87 126.76 47.49 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.592 -0.892 . . . . 73.54 108.592 -178.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -131.48 13.78 5.0 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.868 0.867 . . . . 62.34 110.295 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.98 115.09 4.21 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 111.324 -0.711 . . . . 60.3 111.324 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -91.94 106.06 18.17 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 107.798 -1.186 . . . . 63.31 107.798 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -90.13 74.96 1.78 Allowed Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.818 -0.628 . . . . 60.13 112.198 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 9.1 t -73.21 119.73 17.85 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 123.454 0.702 . . . . 73.31 110.678 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -132.84 144.33 50.14 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.259 0.624 . . . . 75.02 110.168 172.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -154.4 138.06 16.07 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.925 -1.139 . . . . 72.45 107.925 166.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -155.07 93.4 1.53 Allowed 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 108.362 -0.977 . . . . 72.04 108.362 175.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -88.82 86.79 7.04 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.723 0.809 . . . . 73.52 110.165 -176.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -173.78 -178.14 1.52 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.902 1.281 . . . . 73.15 108.686 173.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.216 0 C-N-CA 124.637 1.175 . . . . 73.12 110.953 177.657 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 109.331 -0.618 . . . . 74.44 109.331 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 7.8 m -133.83 105.68 6.91 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.745 0.818 . . . . 75.34 109.109 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -148.86 100.45 3.08 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.651 0.781 . . . . 72.12 109.135 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.84 80.94 8.01 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 106.126 -1.805 . . . . 75.55 106.126 164.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -165.71 159.83 16.68 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.363 -1.289 . . . . 72.1 108.139 -169.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -72.46 80.09 1.05 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.11 -0.7 . . . . 73.13 109.11 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 14.0 t 176.37 -170.91 0.07 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 126.164 1.786 . . . . 65.35 108.243 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' D' ' 9' ' ' MET . 8.2 tp10 69.53 -169.28 0.17 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.064 0.946 . . . . 72.32 110.881 168.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.444 ' HG2' HG13 ' D' ' 89' ' ' ILE . 0.4 OUTLIER -28.96 125.44 0.11 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.836 1.654 . . . . 75.2 112.455 164.811 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 11.1 t -115.0 139.99 49.4 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.334 0.654 . . . . 74.05 109.899 -176.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -133.23 92.4 3.0 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 106.875 -1.528 . . . . 75.33 106.875 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . 0.461 HE22 ' HE2' ' E' ' 94' ' ' PHE . 41.7 mt-30 -114.19 117.35 30.92 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.629 0.772 . . . . 75.22 109.163 -175.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 9.0 mt -82.25 132.59 31.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.009 -1.108 . . . . 73.12 108.009 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -101.35 -28.59 12.52 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.624 0.77 . . . . 74.22 110.556 -174.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -173.44 133.12 0.48 Allowed 'General case' 0 C--N 1.361 1.09 0 O-C-N 123.618 0.574 . . . . 75.03 110.41 -176.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.402 ' N ' HD13 ' D' ' 16' ' ' ILE . 3.3 mp -114.04 130.47 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 107.212 -1.403 . . . . 73.2 107.212 173.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.452 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 37.4 p90 -163.65 175.79 10.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.987 0.899 . . . . 72.12 112.45 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.8 p -108.18 118.76 37.61 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 114.218 -1.356 . . . . 74.1 108.871 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.452 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 29.9 mtpt -90.52 -11.27 40.68 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.991 -0.744 . . . . 61.43 108.991 177.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.749 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 18.7 t70 -166.23 135.67 3.18 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 124.766 1.226 . . . . 75.24 109.376 -175.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.591 HG23 ' HE1' ' C' ' 117' ' ' MET . 52.8 mt -144.36 138.22 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.185 1.394 . . . . 71.33 107.937 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -145.45 138.64 26.32 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.838 0.855 . . . . 74.22 109.21 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.591 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.4 t80 -142.07 135.69 29.41 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.113 -1.44 . . . . 75.32 107.113 170.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -135.74 148.45 48.82 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 108.837 -0.801 . . . . 74.41 108.837 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' D' ' 28' ' ' ALA . . . -142.87 75.72 17.63 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 107.104 -1.443 . . . . 65.15 107.104 175.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.92 -27.81 30.17 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.777 2.318 . . . . 72.13 112.938 -169.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -108.2 1.01 21.82 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 115.415 -0.811 . . . . 75.4 110.696 -175.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' D' ' 25' ' ' ALA . . . -20.87 -73.09 0.03 OUTLIER Pre-proline 0 CA--C 1.567 1.61 0 N-CA-C 116.612 2.078 . . . . 73.54 116.612 -166.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.534 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 93.1 Cg_endo -75.15 -20.55 16.47 Favored 'Trans proline' 0 C--N 1.379 2.182 0 CA-C-N 123.962 2.451 . . . . 73.53 114.135 -173.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.466 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 5.1 t-160 -72.7 -40.63 66.06 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.877 0.871 . . . . 75.2 109.495 174.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.494 HG21 ' HA ' ' D' ' 73' ' ' ALA . 5.5 p -83.52 -20.66 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 CA-C-N 115.612 -0.722 . . . . 72.45 111.566 -173.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.415 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 22.5 m-85 -66.99 -20.65 65.92 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 111.982 0.364 . . . . 74.13 111.982 178.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . 0.466 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 62.0 mt-30 -64.03 -15.05 58.58 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.374 1.069 . . . . 73.34 110.926 176.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.642 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 93.2 mttt -92.7 96.62 10.28 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.117 1.367 . . . . 75.32 109.718 175.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -92.07 79.67 5.16 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.808 -1.087 . . . . 73.21 110.808 -172.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -158.89 171.33 20.26 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.447 -0.797 . . . . 73.54 109.727 168.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.427 HE21 ' HD2' ' D' ' 38' ' ' PRO . 31.1 tp60 -67.65 115.3 25.9 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 123.836 0.855 . . . . 75.23 109.274 177.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.427 ' HD2' HE21 ' D' ' 37' ' ' GLN . 81.3 Cg_exo -49.05 131.12 25.3 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 123.079 2.519 . . . . 73.3 112.475 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -65.04 110.37 2.46 Favored 'General case' 0 C--N 1.346 0.428 0 N-CA-C 107.008 -1.478 . . . . 73.21 107.008 171.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.653 HG11 HG13 ' D' ' 64' ' ' VAL . 96.9 t -113.05 127.19 70.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 108.517 -0.92 . . . . 73.14 108.517 -175.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.453 ' HE3' ' HB3' ' D' ' 41' ' ' LYS . 0.5 OUTLIER -120.76 129.42 53.6 Favored 'General case' 0 C--O 1.248 0.991 0 N-CA-C 106.493 -1.669 . . . . 74.32 106.493 172.414 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.549 HD12 HG13 ' D' ' 62' ' ' VAL . 33.1 tp -97.1 129.29 44.53 Favored 'General case' 0 C--O 1.238 0.477 0 O-C-N 123.931 0.77 . . . . 73.45 110.111 -172.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.578 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.2 m-20 -108.98 112.38 24.55 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.535 -1.654 . . . . 75.24 106.535 177.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.403 ' CD2' HG21 ' D' ' 62' ' ' VAL . 25.8 mt -107.23 131.95 53.62 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.374 0.606 . . . . 65.4 109.903 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.512 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.3 t70 -133.85 153.65 51.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.21 -1.359 . . . . 55.31 108.063 176.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 5.1 t -126.61 149.85 49.23 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.006 0.922 . . . . 64.13 109.047 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.478 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -148.78 141.11 24.14 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.216 -1.031 . . . . 72.4 108.216 178.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 91.3 p -155.73 -172.15 4.03 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.438 -0.949 . . . . 72.31 108.438 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 21.3 p -150.27 139.01 20.77 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 122.829 0.452 . . . . 72.34 109.847 -175.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -67.22 91.44 0.24 Allowed 'General case' 0 C--N 1.352 0.678 0 N-CA-C 108.215 -1.032 . . . . 74.55 108.215 169.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 42.7 tp -141.55 99.26 3.52 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 107.547 -1.279 . . . . 74.52 107.547 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.92 -142.13 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.614 0.766 . . . . 64.55 110.972 -175.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 70.99 12.24 7.02 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.852 1.261 . . . . 72.23 111.285 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.62 26.8 16.41 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.593 1.157 . . . . 75.02 111.024 -175.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 p -133.57 101.06 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.398 1.079 . . . . 73.33 108.217 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -118.24 144.27 45.9 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 114.634 -1.166 . . . . 75.24 108.84 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -105.43 136.26 45.31 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.428 0.632 . . . . 64.3 110.81 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 90.3 t -114.54 144.8 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-N 114.098 -1.41 . . . . 73.23 108.03 174.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 52.2 t -135.99 127.76 44.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.668 -1.234 . . . . 73.14 107.668 176.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.552 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -109.67 102.14 10.99 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 106.844 -1.539 . . . . 63.25 106.844 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.512 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.6 ttt180 -83.8 95.2 8.37 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.46 -0.941 . . . . 75.24 108.46 176.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.549 HG13 HD12 ' D' ' 42' ' ' LEU . 66.5 t -96.33 117.18 40.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.661 -1.154 . . . . 73.42 108.97 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.578 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 23.8 m -123.06 130.25 52.54 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 114.9 -1.045 . . . . 75.11 108.725 -174.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.653 HG13 HG11 ' D' ' 40' ' ' VAL . 47.2 t -111.25 121.37 63.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 C-N-CA 124.821 1.248 . . . . 73.4 108.967 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 18.4 m -100.26 110.92 23.18 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.463 -1.31 . . . . 54.4 107.463 164.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.07 138.62 54.1 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.986 -0.746 . . . . 75.13 108.986 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.449 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 80.9 p -142.07 140.67 32.62 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.347 0.594 . . . . 73.53 111.241 -175.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 35.3 mt -112.92 114.5 27.02 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 106.889 -1.522 . . . . 71.22 106.889 169.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.19 -129.2 9.23 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 123.166 0.291 . . . . 73.43 112.423 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.76 5.34 36.03 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.492 0.717 . . . . 75.52 110.901 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.642 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 12.6 pt-20 -121.97 165.15 16.43 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.469 0.708 . . . . 74.1 109.586 -177.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 72' ' ' THR . . . . . 0.412 HG22 HD22 ' D' ' 75' ' ' LEU . 94.1 m -69.26 135.26 50.26 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.803 -0.635 . . . . 75.1 111.484 177.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.494 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -82.32 -68.69 0.68 Allowed 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.595 -1.261 . . . . 75.04 107.595 170.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -149.3 161.88 41.17 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 114.974 -1.012 . . . . 71.41 110.363 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.412 HD22 HG22 ' D' ' 72' ' ' THR . 78.7 mt -120.9 120.35 35.26 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.482 1.113 . . . . 73.53 108.22 176.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.625 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 1.7 m -116.78 139.15 50.91 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.214 -1.032 . . . . 70.13 108.214 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -157.12 121.85 4.46 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.931 0.493 . . . . 70.11 109.676 173.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -136.13 119.12 22.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 123.705 0.802 . . . . 71.43 109.041 -175.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.749 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.2 mt-30 -89.04 88.59 7.63 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 108.647 -0.871 . . . . 73.43 108.647 170.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -80.27 99.19 7.73 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.371 -1.286 . . . . 74.3 108.739 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.35 142.33 15.56 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 116.316 -0.402 . . . . 71.42 112.141 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.68 140.88 11.64 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 111.117 -0.793 . . . . 64.44 111.117 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 61.3 mt -90.78 119.14 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.933 -1.136 . . . . 73.32 107.933 175.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -119.85 131.31 55.24 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.692 0.797 . . . . 72.23 110.192 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 35.4 t -107.9 100.47 9.83 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.363 -0.977 . . . . 62.23 108.363 172.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 39.9 pt -110.54 147.67 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.674 1.19 . . . . 73.41 108.807 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.7 168.56 12.45 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.792 0.682 . . . . 65.0 111.033 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.6 21.92 49.09 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.596 0.56 . . . . 65.14 114.166 174.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.444 HG13 ' HG2' ' D' ' 9' ' ' MET . 0.7 OUTLIER -138.84 161.14 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.8 0.84 . . . . 74.32 111.475 -177.645 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -149.22 -171.89 3.99 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.215 -1.357 . . . . 74.33 109.192 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' B' ' 150' ' ' GLU . . . 77.31 -140.19 24.22 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-O 119.709 -0.495 . . . . 54.12 111.934 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 81.1 p -91.87 -35.82 13.84 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 117.529 0.664 . . . . 73.21 111.268 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.544 ' HA ' ' HB3' ' D' ' 96' ' ' HIS . 27.8 tp60 -65.63 -22.03 66.62 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.203 1.001 . . . . 73.51 112.023 -172.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.475 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 0.0 OUTLIER -60.85 -43.59 98.12 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.802 0.441 . . . . 73.01 111.433 177.257 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . 0.475 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -79.59 -31.01 41.72 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.775 0.83 . . . . 62.4 110.543 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . 0.544 ' HB3' ' HA ' ' D' ' 93' ' ' GLN . 18.8 t-80 -75.06 -25.3 58.53 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 123.935 0.894 . . . . 75.12 112.153 -175.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 85.2 m -65.87 -38.27 88.35 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.56 0.695 . . . . 74.11 109.795 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.611 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 12.9 tp -77.97 -35.96 49.63 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.831 -1.077 . . . . 74.53 110.421 177.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.74 -28.45 42.63 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.434 -0.803 . . . . 62.23 115.03 -171.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.24 -47.2 2.27 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 118.295 1.047 . . . . 74.12 111.396 -175.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -74.7 -34.59 62.65 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 112.031 0.382 . . . . 74.51 112.031 -174.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.611 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 90.3 m -67.01 -47.55 52.35 Favored Pre-proline 0 CA--C 1.565 1.553 0 CA-C-O 118.46 -0.781 . . . . 75.32 112.174 177.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.552 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.5 Cg_exo -55.84 -34.27 90.92 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 122.158 1.905 . . . . 72.24 113.136 169.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -61.96 -37.34 84.38 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.482 0.713 . . . . 65.04 111.123 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 44.9 mm -68.25 -41.53 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.528 0.731 . . . . 74.15 110.601 174.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 96.6 mt -78.17 -15.13 59.11 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.742 -0.663 . . . . 72.22 112.331 -172.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -70.03 -44.09 20.63 Favored Pre-proline 0 N--CA 1.485 1.294 0 N-CA-C 113.858 1.059 . . . . 71.32 113.858 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . 0.513 ' HB2' ' HG2' ' B' ' 108' ' ' PRO . 18.8 Cg_endo -58.03 -29.24 86.2 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 121.624 1.55 . . . . 71.34 112.771 172.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -81.18 -31.23 34.1 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.782 0.833 . . . . 71.54 111.493 175.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.91 -50.28 71.48 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.792 0.837 . . . . 63.14 109.934 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -73.51 -29.47 62.5 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.198 -0.91 . . . . 74.22 110.593 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . 0.551 ' HG2' HH22 ' C' ' 120' ' ' ARG . 23.5 tt0 -53.19 -46.18 68.88 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.458 0.703 . . . . 71.34 110.479 173.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.1 t -70.38 -47.37 61.23 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.426 -0.806 . . . . 75.34 111.226 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.501 HD12 HG21 ' D' ' 64' ' ' VAL . 76.8 mt -60.12 -61.27 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.887 0.875 . . . . 74.2 111.643 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 10.3 m -50.94 -38.94 53.54 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.448 1.099 . . . . 75.24 111.638 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 23.2 t -64.27 -48.29 76.32 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.347 -0.842 . . . . 73.01 110.012 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.447 ' HE2' ' HG ' ' D' ' 76' ' ' CYS . 73.7 mtm -67.24 -29.85 69.6 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.148 0.579 . . . . 74.45 111.767 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.443 HG23 ' O ' ' D' ' 114' ' ' ILE . 76.0 t -64.84 -46.69 91.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.62 0.768 . . . . 73.44 109.39 176.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.5 p -72.87 -31.42 64.72 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.875 -0.602 . . . . 62.21 110.588 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' D' ' 116' ' ' SER . 77.6 mtt-85 -69.46 -28.87 66.47 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.775 0.83 . . . . 74.12 110.405 174.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.8 10.01 74.1 Favored Glycine 0 C--N 1.351 1.378 0 CA-C-O 119.317 -0.713 . . . . 73.45 112.647 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.503 HG22 ' HB3' ' C' ' 17' ' ' TYR . 74.5 p 52.68 37.45 23.6 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 126.12 1.768 . . . . 65.32 113.499 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -99.81 151.86 37.62 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 115.01 -0.995 . . . . 75.3 109.645 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.53 ' HB3' ' HA ' ' E' ' 129' ' ' THR . 80.3 Cg_exo -51.84 145.38 32.05 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.478 2.786 . . . . 73.11 113.194 171.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.499 ' HB3' ' HB2' ' E' ' 128' ' ' ALA . 65.1 tt0 -61.16 136.86 58.2 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.836 0.854 . . . . 73.54 112.631 -169.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.419 HD11 HG13 ' D' ' 40' ' ' VAL . 16.4 tp -124.81 99.42 6.14 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.434 1.094 . . . . 73.42 109.267 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -100.11 108.28 20.38 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 107.702 -1.222 . . . . 64.4 107.702 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 6.7 mp -70.81 116.28 10.94 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.333 -0.618 . . . . 73.44 109.333 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' E' ' 125' ' ' ALA . . . -61.11 141.38 93.84 Favored Pre-proline 0 CA--C 1.55 0.972 0 O-C-N 124.078 0.861 . . . . 63.13 111.772 -177.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.67 116.05 3.03 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.537 2.158 . . . . 71.43 110.868 175.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 13.1 p -108.62 146.53 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.811 0.845 . . . . 75.33 109.315 -172.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -73.6 104.45 4.55 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.834 -0.802 . . . . 72.41 108.834 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.694 ' HA ' HD22 ' D' ' 136' ' ' LEU . 75.3 m-85 -62.82 -36.89 84.66 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.571 0.748 . . . . 74.12 111.516 -178.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' E' ' 112' ' ' ASN . 24.8 m-20 -55.0 -38.23 67.62 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.242 0.617 . . . . 71.11 110.89 173.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.65 -18.62 59.6 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.073 0.949 . . . . 73.52 112.46 -176.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.694 HD22 ' HA ' ' D' ' 133' ' ' PHE . 3.6 mm? -59.81 -51.25 70.56 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 112.783 0.661 . . . . 73.53 112.783 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.448 ' HA ' ' HB3' ' D' ' 140' ' ' TYR . 13.5 m-85 -75.62 -30.45 59.54 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 119.708 -0.187 . . . . 74.02 111.025 176.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.504 ' HE2' ' H ' ' E' ' 114' ' ' LYS . 55.6 mtt -60.56 -34.82 74.71 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 120.879 0.371 . . . . 74.43 110.851 173.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.482 ' O ' ' HG3' ' D' ' 142' ' ' GLN . 7.1 t30 -76.59 -38.75 54.31 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.082 0.953 . . . . 74.13 109.396 176.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . 0.448 ' HB3' ' HA ' ' D' ' 137' ' ' PHE . 61.5 t80 -58.33 -38.08 76.42 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.204 1.001 . . . . 75.14 111.212 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.3 mp -61.65 -43.07 99.55 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.13 0.572 . . . . 74.12 111.1 177.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' D' ' 139' ' ' ASN . 4.1 pp0? -86.9 7.99 24.95 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.106 0.562 . . . . 74.41 111.173 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . 0.488 ' HG3' ' HB3' ' D' ' 147' ' ' GLU . 33.7 tt0 -120.19 92.81 3.86 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.875 0.87 . . . . 71.11 109.371 -171.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -145.33 84.68 1.7 Allowed 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.221 -1.029 . . . . 72.34 108.221 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . 58.75 20.9 8.34 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.584 1.154 . . . . 75.42 112.55 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -140.51 23.44 2.67 Favored Glycine 0 C--N 1.348 1.221 0 C-N-CA 123.154 0.407 . . . . 72.14 112.409 -173.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . 0.488 ' HB3' ' HG3' ' D' ' 143' ' ' GLN . 0.1 OUTLIER -90.81 -27.9 18.56 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.437 0.695 . . . . 73.23 109.643 174.145 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.57 172.84 12.17 Favored Glycine 0 C--N 1.356 1.643 0 CA-C-O 121.253 0.363 . . . . 42.02 113.059 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 47.0 p -139.08 140.87 38.15 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.515 -0.92 . . . . 61.24 108.515 174.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -130.3 119.59 23.06 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.257 -0.645 . . . . 73.33 109.257 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -95.71 38.29 1.17 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.964 0.906 . . . . 65.33 110.749 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . 0.405 ' NE2' ' HB3' ' D' ' 154' ' ' ASP . 37.3 t60 -69.7 91.82 0.63 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.491 -0.559 . . . . 75.15 109.491 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -77.41 -9.95 59.17 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.731 0.812 . . . . 74.32 112.709 -174.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . 0.405 ' HB3' ' NE2' ' D' ' 152' ' ' HIS . 34.6 t70 -70.15 81.1 0.51 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.389 0.676 . . . . 75.31 109.516 176.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.277 0 CA-C-N 114.897 -1.047 . . . . 73.33 109.423 -177.624 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.878 0 N-CA-C 112.028 -0.429 . . . . 72.14 112.028 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . -90.29 -134.89 5.85 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 111.738 -0.545 . . . . 50.32 111.738 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 59.11 80.25 0.2 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.803 1.241 . . . . 75.45 111.759 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 94' ' ' PHE . . . . . 0.461 ' HE2' HE22 ' D' ' 12' ' ' GLN . 97.5 m-85 -104.81 -160.22 0.75 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.491 0.717 . . . . 75.11 109.671 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -133.32 135.96 45.13 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 108.323 -0.991 . . . . 72.21 108.323 169.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.99 -43.06 0.18 Allowed Glycine 0 C--N 1.339 0.721 0 N-CA-C 112.18 -0.368 . . . . 64.21 112.18 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 97' ' ' ILE . . . . . 0.439 HG12 ' CD2' ' E' ' 100' ' ' LEU . 4.7 tt -103.64 80.55 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 CA-C-O 123.252 1.501 . . . . 75.03 109.502 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -108.44 -40.93 4.98 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 114.897 -1.047 . . . . 73.33 110.586 -174.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.08 75.57 9.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.571 0.748 . . . . 71.25 111.588 -173.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 100' ' ' LEU . . . . . 0.478 HD11 HD22 ' E' ' 102' ' ' LEU . 2.3 pt? -164.5 136.21 3.53 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 123.927 0.891 . . . . 73.3 109.656 170.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.77 -14.34 11.32 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.527 2.151 . . . . 74.4 112.07 168.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 102' ' ' LEU . . . . . 0.478 HD22 HD11 ' E' ' 100' ' ' LEU . 1.0 OUTLIER 53.35 51.17 15.94 Favored 'General case' 0 C--N 1.367 1.332 0 C-N-CA 125.029 1.332 . . . . 73.34 108.903 -172.518 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 65.4 p 47.61 75.64 0.13 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.813 1.245 . . . . 73.24 111.072 -173.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.91 152.64 35.55 Favored Glycine 0 C--N 1.353 1.487 0 CA-C-N 115.755 -0.657 . . . . 65.34 113.32 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 66.98 68.42 0.41 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.923 1.289 . . . . 74.52 109.86 -170.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 54.3 t80 68.85 157.19 0.14 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.788 1.235 . . . . 73.0 111.336 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 4.2 m -67.08 108.27 2.58 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 122.985 0.514 . . . . 72.1 110.817 -177.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -80.26 -65.79 0.96 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.88 0.472 . . . . 73.42 109.854 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -139.18 138.09 36.62 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.306 -0.998 . . . . 74.3 108.306 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -164.84 -46.76 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.034 0.445 . . . . 54.44 111.384 -171.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . 0.503 ' HB3' ' O ' ' D' ' 133' ' ' PHE . 5.3 mp -87.15 65.15 8.73 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.954 0.902 . . . . 74.24 108.875 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 112' ' ' ASN . . . . . 0.442 ' HB3' ' HB2' ' D' ' 137' ' ' PHE . 22.5 p-10 -157.82 177.61 11.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.148 0.979 . . . . 52.4 109.837 -177.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -157.11 -62.17 0.09 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 122.222 0.209 . . . . 75.43 111.085 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . 0.504 ' H ' ' HE2' ' D' ' 138' ' ' MET . 0.0 OUTLIER -158.74 156.22 29.44 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.955 0.502 . . . . 74.13 111.483 -172.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 29.2 m 61.14 -91.83 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 125.142 1.377 . . . . 71.24 112.942 171.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 147.12 155.66 6.64 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 110.85 -0.9 . . . . 73.3 110.85 -168.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 117' ' ' LYS . . . . . 0.414 ' N ' ' HB3' ' D' ' 138' ' ' MET . 74.7 mmtt -118.97 154.24 53.06 Favored Pre-proline 0 N--CA 1.476 0.858 0 C-N-CA 123.703 0.801 . . . . 72.32 109.505 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -72.94 -156.73 0.05 OUTLIER 'Trans proline' 0 CA--C 1.555 1.534 0 C-N-CA 122.995 2.463 . . . . 74.51 111.566 166.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -61.39 85.71 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.374 1.07 . . . . 75.44 110.613 176.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -89.84 -66.67 0.9 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.168 -0.924 . . . . 73.24 111.136 -175.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 121' ' ' VAL . . . . . 0.525 HG23 HD13 ' D' ' 136' ' ' LEU . 39.5 t -76.76 83.57 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 109.627 -0.508 . . . . 72.43 109.627 -172.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 4.2 m -147.5 7.74 0.88 Allowed 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 123.89 0.876 . . . . 73.41 109.784 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -131.05 -179.5 5.37 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.551 0.741 . . . . 74.34 111.192 -173.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 23.1 t -163.23 176.23 10.17 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.294 1.037 . . . . 64.44 109.064 175.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . 0.668 ' HB2' ' HG3' ' B' ' 12' ' ' GLN . . . -146.08 99.15 3.21 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.328 0.651 . . . . 75.23 109.785 177.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -172.67 130.52 0.54 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.163 0.985 . . . . 74.41 108.98 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 35.3 p -149.26 100.36 3.02 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.721 0.408 . . . . 73.22 109.973 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 128' ' ' ALA . . . . . 0.499 ' HB2' ' HB3' ' D' ' 125' ' ' GLN . . . -161.11 82.53 0.64 Allowed 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.124 0.97 . . . . 73.44 108.686 174.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 129' ' ' THR . . . . . 0.53 ' HA ' ' HB3' ' D' ' 124' ' ' PRO . 7.5 t -116.09 114.03 23.97 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.912 -0.585 . . . . 75.13 110.319 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -178.69 111.17 0.06 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.797 1.639 . . . . 70.31 106.576 176.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 131' ' ' TRP . . . . . 0.416 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 1.2 t-105 -162.31 56.46 0.23 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.413 0.625 . . . . 72.43 110.126 -175.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 36.2 t -137.87 95.09 2.98 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.503 -0.925 . . . . 74.22 108.503 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 23.8 m -145.79 91.35 2.08 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 122.959 0.503 . . . . 72.24 110.388 -176.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.94 87.92 0.66 Allowed Glycine 0 C--N 1.343 0.921 0 N-CA-C 111.046 -0.821 . . . . 64.33 111.046 169.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 3.4 p -55.58 132.64 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 C-N-CA 124.63 1.172 . . . . 65.42 112.598 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -126.33 120.64 30.41 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 108.168 -1.049 . . . . 71.12 108.168 174.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 1.2 p -147.95 -59.07 0.25 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.389 0.676 . . . . 73.43 110.769 -176.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -104.98 -79.07 0.56 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.436 -0.347 . . . . 73.43 110.386 -169.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -75.02 166.1 24.21 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.856 0.862 . . . . 71.24 111.308 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.34 142.0 36.54 Favored Glycine 0 C--N 1.349 1.254 0 O-C-N 123.624 0.578 . . . . 52.5 112.216 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.83 94.38 3.31 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.988 0.423 . . . . 75.24 109.868 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 142' ' ' LEU . . . . . 0.431 HD22 ' HB2' ' C' ' 85' ' ' SER . 48.2 tp -67.63 -42.72 81.89 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.288 -0.869 . . . . 74.1 109.791 172.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -156.51 143.15 9.38 Favored Glycine 0 C--N 1.33 0.23 0 N-CA-C 109.244 -1.542 . . . . 71.14 109.244 171.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 11.4 m -145.9 151.56 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 124.151 0.98 . . . . 72.54 109.355 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 36.2 t70 . . . . . 0 C--O 1.246 0.908 0 CA-C-O 118.621 -0.704 . . . . 64.44 109.717 179.173 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.772 0 N-CA-C 111.356 -0.698 . . . . 64.21 111.356 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.0 -55.46 3.67 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-O 119.979 -0.345 . . . . 43.2 113.089 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -77.38 71.91 3.89 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.747 0.819 . . . . 64.51 109.706 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -104.42 136.36 44.14 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 107.696 -1.224 . . . . 74.24 107.696 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -68.07 110.51 3.98 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.637 0.732 . . . . 75.41 112.111 -176.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -143.59 -166.0 11.06 Favored Glycine 0 C--O 1.245 0.824 0 N-CA-C 108.964 -1.655 . . . . 71.4 108.964 167.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 97' ' ' ILE . . . . . 0.739 HG23 ' SD ' ' B' ' 94' ' ' MET . 9.3 mt 71.45 -28.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.573 1.844 0 N-CA-C 114.786 1.402 . . . . 74.25 114.786 168.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 35.4 t70 81.45 -86.96 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.809 2.044 . . . . 73.44 111.434 -166.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -112.54 -46.23 3.17 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.35 0.66 . . . . 74.43 111.794 -169.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 100' ' ' LEU . . . . . 0.524 ' HB2' HG22 ' F' ' 97' ' ' ILE . 8.2 tp 75.42 74.04 0.2 Allowed Pre-proline 0 N--CA 1.479 0.996 0 C-N-CA 126.152 1.781 . . . . 75.21 112.473 -176.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -97.68 114.28 0.11 Allowed 'Trans proline' 0 CA--C 1.558 1.683 0 C-N-CA 123.13 2.553 . . . . 72.3 111.552 162.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 102' ' ' LEU . . . . . . . . . . . . . 1.7 tt -86.91 67.04 9.69 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 107.873 -1.158 . . . . 74.11 107.873 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 51.9 p 51.33 25.29 2.47 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.013 1.325 . . . . 73.52 113.284 174.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.66 49.62 4.78 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 111.955 -0.458 . . . . 62.12 111.955 -173.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 67.96 -75.51 0.06 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.494 1.517 . . . . 75.21 112.617 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -69.69 134.91 49.21 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.542 0.737 . . . . 73.32 110.052 -176.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 26.6 m -70.93 128.8 37.22 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.636 0.774 . . . . 72.53 110.581 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -76.23 -32.82 59.11 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.847 0.859 . . . . 74.12 110.377 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -65.61 119.01 10.35 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.032 -1.099 . . . . 74.52 108.032 170.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . 0.692 ' HB2' ' HB2' ' F' ' 113' ' ' LYS . . . -68.11 -5.89 20.11 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.342 0.867 . . . . 74.4 113.342 -170.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 22.7 tp 73.15 -74.07 0.09 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.986 1.314 . . . . 73.44 109.7 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -141.84 12.05 2.05 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.819 0.848 . . . . 70.24 110.358 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 113' ' ' LYS . . . . . 0.692 ' HB2' ' HB2' ' F' ' 110' ' ' ALA . 52.6 mtpt -86.1 25.69 1.12 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.468 -0.77 . . . . 74.43 112.767 -174.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 93.8 mttt 77.76 -52.34 0.52 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.28 1.432 . . . . 73.21 113.911 165.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 8.0 t -64.56 154.48 36.03 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 122.687 0.395 . . . . 72.51 110.172 171.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.95 -117.0 4.4 Favored Glycine 0 C--N 1.342 0.862 0 N-CA-C 110.32 -1.112 . . . . 70.41 110.32 -171.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 117' ' ' LYS . . . . . 0.498 ' HB2' ' HZ1' ' F' ' 117' ' ' LYS . 5.2 ttmp? -159.48 81.07 2.55 Favored Pre-proline 0 N--CA 1.482 1.129 0 C-N-CA 123.25 0.62 . . . . 75.31 109.931 176.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -88.43 23.14 0.79 Allowed 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 123.138 2.558 . . . . 63.12 112.627 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.82 84.91 0.66 Allowed 'General case' 0 C--N 1.35 0.613 0 C-N-CA 124.463 1.105 . . . . 74.45 110.804 -174.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 120' ' ' TYR . . . . . 0.432 ' HB3' HD13 ' B' ' 136' ' ' LEU . 81.9 t80 -174.27 -50.35 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.633 1.573 . . . . 74.4 106.912 -174.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 42.2 t -87.11 113.26 24.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 114.724 -1.125 . . . . 75.33 108.193 175.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 23.1 m -70.45 -14.0 62.36 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.134 0.573 . . . . 65.4 111.504 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 25.5 t70 72.03 5.91 5.45 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.548 1.139 . . . . 55.01 112.557 169.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 26.7 m -137.41 105.17 5.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.267 1.027 . . . . 61.23 109.114 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -166.51 170.33 12.92 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.686 0.794 . . . . 62.54 110.534 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . 73.74 109.37 0.07 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.601 1.56 . . . . 51.23 111.869 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 45.3 t -127.38 102.17 6.78 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.477 1.111 . . . . 71.15 108.172 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 128' ' ' ALA . . . . . 0.483 ' HB2' ' HD2' ' B' ' 38' ' ' PRO . . . -85.9 77.99 9.59 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.483 0.713 . . . . 75.44 111.895 -170.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 129' ' ' THR . . . . . 0.406 ' OG1' ' HB3' ' B' ' 37' ' ' GLN . 4.4 m -101.4 65.2 1.04 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 108.703 -0.851 . . . . 74.44 108.703 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -160.13 107.52 1.63 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.038 -0.528 . . . . 75.11 110.373 -174.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 131' ' ' TRP . . . . . 0.459 ' HZ2' HH22 ' A' ' 15' ' ' ARG . 1.3 t90 -138.59 158.29 44.53 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.866 -0.79 . . . . 70.15 108.866 -176.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 132' ' ' SER . . . . . 0.45 ' HB3' ' HA ' ' C' ' 126' ' ' LEU . 43.6 p -65.8 157.61 29.92 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.152 0.581 . . . . 72.33 111.901 177.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 14.8 t -76.64 -173.16 2.47 Favored 'General case' 0 CA--C 1.556 1.193 0 CA-C-N 115.186 -0.916 . . . . 62.32 109.664 171.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.84 77.04 0.68 Allowed Glycine 0 CA--C 1.536 1.346 0 CA-C-N 117.459 0.118 . . . . 70.54 113.166 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.79 126.83 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 108.591 -0.892 . . . . 62.12 108.591 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -140.81 -146.76 0.2 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.224 1.01 . . . . 75.41 108.675 -176.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 36.1 p -51.96 -75.12 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.648 0.779 . . . . 75.32 110.85 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -147.33 -83.92 0.11 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.574 -0.898 . . . . 74.14 108.574 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 54.2 t30 57.63 107.32 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.077 1.351 . . . . 75.54 112.4 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.21 78.27 0.97 Allowed Glycine 0 C--N 1.351 1.386 0 N-CA-C 112.265 -0.334 . . . . 72.54 112.265 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.33 152.62 41.85 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.774 0.83 . . . . 63.32 110.634 -175.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 142' ' ' LEU . . . . . 0.491 ' HG ' ' HB3' ' C' ' 39' ' ' GLU . 3.3 mp -125.0 -60.61 1.35 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.407 1.083 . . . . 75.33 108.526 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . 128.22 119.3 2.19 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-N 114.738 -1.119 . . . . 72.12 110.508 -173.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.67 -37.42 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-O 121.895 0.855 . . . . 71.21 109.763 172.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 18.3 t70 . . . . . 0 C--O 1.246 0.879 0 N-CA-C 107.381 -1.34 . . . . 71.51 107.381 175.206 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.449 ' SD ' ' HB2' ' C' ' 141' ' ' LEU . 94.6 mmm . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 108.864 -0.791 . . . . 75.35 108.864 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 m -64.38 89.27 0.06 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.319 0.58 . . . . 72.31 110.69 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.486 ' HA ' ' NE2' ' C' ' 144' ' ' GLN . 32.7 tt0 -91.21 -46.06 8.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.545 1.138 . . . . 54.51 108.93 176.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -141.32 144.15 34.44 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 113.997 -1.456 . . . . 75.12 108.781 -176.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -73.52 102.56 3.87 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 109.846 -0.427 . . . . 74.14 109.846 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -71.51 154.69 41.3 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.954 0.902 . . . . 72.4 109.954 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.1 t -61.28 157.52 16.24 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.241 1.017 . . . . 74.44 113.193 -174.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -76.37 118.8 19.44 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.254 -0.885 . . . . 73.41 110.415 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.513 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -156.31 179.86 8.83 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.136 0.975 . . . . 75.43 110.058 -178.279 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.2 m -135.35 129.11 32.91 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.489 0.716 . . . . 62.33 109.177 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.464 ' CD1' HD13 ' A' ' 86' ' ' ILE . 65.6 t80 -131.42 112.48 12.73 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.823 -1.547 . . . . 70.43 106.823 167.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -137.72 114.15 10.27 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 107.809 -1.182 . . . . 72.14 107.809 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.565 HG23 ' HG2' ' C' ' 130' ' ' PRO . 51.0 mt -69.41 114.42 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 109.034 -0.728 . . . . 75.44 109.034 177.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -78.79 -34.74 45.21 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.285 -0.635 . . . . 73.45 109.285 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.419 ' HE ' ' HB ' ' B' ' 122' ' ' THR . 14.0 ttt85 -172.63 132.52 0.58 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.973 0.509 . . . . 75.35 110.227 -174.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.513 HD11 HD13 ' A' ' 13' ' ' ILE . 80.6 mt -117.44 127.35 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.021 -1.103 . . . . 75.14 108.021 166.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.44 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 25.0 p90 -163.78 154.02 15.28 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.787 0.679 . . . . 72.52 110.827 -171.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.7 p -80.03 116.78 20.35 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 109.712 -0.477 . . . . 73.41 109.712 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.44 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 42.9 mtpt -79.11 -25.52 43.0 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.601 -0.518 . . . . 72.1 109.601 172.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.495 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.1 t70 -155.06 146.8 23.31 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 114.882 -1.054 . . . . 73.34 110.526 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 81.2 mt -141.28 141.7 30.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 C-N-CA 126.114 1.766 . . . . 73.21 107.012 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.4 t -143.72 132.76 22.88 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.218 -1.03 . . . . 64.15 108.218 170.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.592 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 85.2 t80 -139.87 141.8 36.59 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.539 -1.282 . . . . 73.12 107.539 172.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -144.37 149.41 36.09 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.773 0.829 . . . . 72.25 108.889 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.28 74.83 11.67 Favored Pre-proline 0 C--O 1.241 0.639 0 N-CA-C 106.173 -1.788 . . . . 71.21 106.173 170.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.72 -29.93 28.53 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.233 1.955 . . . . 74.14 111.88 -171.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -96.82 9.43 41.81 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.798 0.839 . . . . 75.45 111.899 -175.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.36 -58.56 7.11 Favored Pre-proline 0 CA--C 1.563 1.471 0 N-CA-C 114.4 1.259 . . . . 73.23 114.4 -166.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.84 -40.3 48.41 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.884 2.389 . . . . 72.44 114.455 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -100.16 -13.97 18.73 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.214 0.82 . . . . 74.21 113.214 -175.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 73' ' ' ALA . 3.7 p -77.27 -18.75 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-O 120.892 0.377 . . . . 74.34 110.912 -175.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -74.11 -19.96 60.41 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.393 0.677 . . . . 75.3 111.127 175.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -73.87 -28.92 61.82 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.631 0.773 . . . . 74.13 109.779 174.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -69.8 159.5 33.48 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.956 0.902 . . . . 72.01 112.119 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -68.94 123.35 20.76 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.538 -0.756 . . . . 63.34 109.234 171.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.488 ' CE3' HD21 ' A' ' 68' ' ' LEU . 71.9 t-105 -75.04 84.88 2.29 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.894 0.854 . . . . 74.43 109.841 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.426 ' H ' HD23 ' A' ' 68' ' ' LEU . 23.7 tt0 -120.48 79.63 29.44 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 125.48 1.512 . . . . 74.43 107.53 173.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.31 112.66 3.52 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.04 1.826 . . . . 64.04 112.446 -174.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.56 97.32 9.67 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 105.38 -2.082 . . . . 75.33 105.38 168.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.517 HG12 HD23 ' A' ' 126' ' ' LEU . 17.6 t -95.45 100.87 11.73 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-N 115.406 -0.815 . . . . 74.35 110.826 -170.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -77.84 114.03 16.31 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.774 -1.103 . . . . 73.32 110.027 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.3 mt -103.36 111.16 23.45 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.591 0.756 . . . . 73.52 109.671 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.611 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.8 m-20 -102.23 147.28 26.84 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.592 -0.892 . . . . 74.53 108.592 172.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.595 HD13 HG22 ' A' ' 131' ' ' VAL . 77.0 mt -131.23 141.34 50.0 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.413 0.685 . . . . 75.13 110.293 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.487 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 25.6 t70 -144.51 122.11 11.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.412 -1.267 . . . . 74.13 108.056 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.4 m -113.37 129.09 56.62 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.926 -0.768 . . . . 73.24 108.926 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.74 117.46 15.03 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.583 0.753 . . . . 63.34 109.567 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 98' ' ' LEU . 19.4 p -88.86 173.32 8.59 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 122.968 0.507 . . . . 75.12 110.552 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.6 t -163.82 145.57 9.17 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.377 1.071 . . . . 74.55 108.771 -170.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -114.9 122.7 47.12 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.272 0.629 . . . . 72.21 109.31 170.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.421 HD12 HG23 ' A' ' 83' ' ' ILE . 51.6 mt -97.65 -37.61 9.84 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.387 0.675 . . . . 75.45 109.824 178.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.1 177.45 10.79 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.874 0.87 . . . . 72.05 109.481 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -64.59 125.36 24.45 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.853 0.461 . . . . 64.11 109.986 170.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 68.22 8.75 6.77 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.139 1.376 . . . . 74.34 112.163 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 51.5 t -115.62 92.74 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 108.31 -0.996 . . . . 65.44 108.31 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -110.59 122.3 47.42 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.077 0.465 . . . . 75.12 109.751 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -93.86 147.49 23.03 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.818 0.847 . . . . 73.42 109.101 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.8 t -131.79 143.32 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 107.986 -1.116 . . . . 75.12 107.986 173.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.503 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 60.6 t -121.42 137.96 53.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 108.487 -0.931 . . . . 71.22 108.487 176.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.89 98.76 6.51 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.243 -1.392 . . . . 72.24 107.243 175.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.487 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 43.3 ttp180 -84.98 101.23 12.21 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.48 -0.933 . . . . 74.44 108.48 173.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.6 t -95.69 132.71 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 108.003 -1.11 . . . . 70.33 108.003 175.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.611 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 12.0 m -112.93 142.15 45.93 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.927 -0.768 . . . . 64.22 108.927 171.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.586 HG22 HG21 ' A' ' 114' ' ' ILE . 77.1 t -135.84 114.85 16.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 107.502 -1.296 . . . . 71.4 107.502 -176.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.4 m -121.92 107.63 12.49 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.928 -0.767 . . . . 72.01 108.928 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.421 ' HB1' HG23 ' A' ' 40' ' ' VAL . . . -102.74 111.59 23.98 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 106.703 -1.592 . . . . 72.41 106.703 -176.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 54.7 m -120.73 135.91 55.01 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.716 0.77 . . . . 73.5 111.289 -173.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.488 HD21 ' CE3' ' A' ' 36' ' ' TRP . 35.1 mt -88.86 81.66 6.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.482 1.513 . . . . 62.31 107.779 175.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.12 -99.06 1.03 Allowed Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.471 -0.786 . . . . 54.42 111.894 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -94.84 -29.58 14.65 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.274 0.63 . . . . 74.42 111.175 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -98.18 127.82 44.33 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.269 0.628 . . . . 65.14 109.892 -170.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.3 m -69.25 132.81 47.07 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 120.993 0.425 . . . . 71.43 110.406 173.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.447 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -76.93 -52.21 9.82 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.188 -0.914 . . . . 75.01 108.728 174.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -160.26 164.17 32.88 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.814 -1.085 . . . . 75.31 110.916 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.9 tp -124.31 132.07 53.55 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.414 1.086 . . . . 73.24 108.438 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.461 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 37.0 m -130.48 116.63 18.47 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.78 0.832 . . . . 73.43 109.147 175.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -131.04 116.25 17.54 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.494 -0.558 . . . . 74.02 109.494 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.0 t -124.25 114.3 40.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 124.14 0.976 . . . . 75.1 109.374 -173.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.495 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 35.4 mt-30 -85.36 83.59 7.91 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.5 -0.926 . . . . 73.32 108.5 172.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -75.77 94.55 3.3 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 114.773 -1.103 . . . . 75.14 108.564 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.24 169.49 47.88 Favored Glycine 0 C--O 1.241 0.557 0 N-CA-C 111.013 -0.835 . . . . 73.41 111.013 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.23 120.74 0.91 Allowed Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 110.87 -0.892 . . . . 74.44 110.87 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.427 HG13 ' HE1' ' A' ' 17' ' ' TYR . 51.6 mt -82.61 127.07 40.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 107.805 -1.183 . . . . 74.24 107.805 174.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.634 ' HB3' HD11 ' A' ' 86' ' ' ILE . 66.7 m-85 -128.06 123.51 34.77 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.528 -0.916 . . . . 74.55 108.528 -174.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.7 t -87.32 93.55 9.43 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.361 -0.977 . . . . 73.42 108.361 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.634 HD11 ' HB3' ' A' ' 84' ' ' PHE . 18.9 mm -117.23 147.95 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.451 0.7 . . . . 71.23 111.146 -169.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.61 173.73 11.62 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.666 0.786 . . . . 75.11 110.307 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.513 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 96.22 -33.2 5.77 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.973 -0.558 . . . . 71.21 113.022 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.42 140.12 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.602 0.761 . . . . 71.53 110.515 -173.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.463 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 11.6 mp0 -131.52 174.78 9.74 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.709 0.804 . . . . 72.33 110.02 178.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.88 -123.21 27.98 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 124.0 0.813 . . . . 71.31 114.205 173.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.9 t -71.93 -25.25 61.82 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.289 0.635 . . . . 70.02 111.354 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -75.37 -38.0 60.28 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.599 0.76 . . . . 74.53 109.527 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.584 ' HE2' HD22 ' A' ' 98' ' ' LEU . 6.1 tpt -66.5 -45.55 79.17 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.511 -0.768 . . . . 62.44 109.367 174.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.8 -37.01 77.93 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.358 -0.837 . . . . 54.54 110.883 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -68.54 -34.62 76.17 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.738 -0.664 . . . . 75.55 111.001 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.2 t -69.3 -45.61 69.16 Favored 'General case' 0 C--N 1.348 0.5 0 N-CA-C 109.445 -0.576 . . . . 72.43 109.445 178.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.584 HD22 ' HE2' ' A' ' 94' ' ' MET . 49.2 mt -80.85 -22.3 40.01 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.47 -0.787 . . . . 71.54 112.273 -172.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.13 4.14 30.08 Favored Glycine 0 N--CA 1.475 1.239 0 CA-C-O 119.677 -0.513 . . . . 72.32 114.055 -174.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.498 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -142.71 -65.91 0.39 Allowed 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 117.406 0.603 . . . . 74.54 111.192 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -69.94 -43.34 71.81 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 111.988 0.366 . . . . 74.45 111.988 -173.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 65.6 m -66.65 -47.22 56.9 Favored Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 124.044 0.937 . . . . 71.0 112.806 -176.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.412 ' HA ' ' HB2' ' A' ' 106' ' ' LEU . 52.2 Cg_endo -67.41 -23.61 43.88 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 121.77 1.646 . . . . 71.42 113.168 170.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -66.39 -38.21 87.0 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 122.604 0.362 . . . . 74.41 110.033 173.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.9 mm -65.12 -45.71 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.742 0.817 . . . . 73.53 110.276 171.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 103' ' ' PRO . 61.4 mt -72.02 -21.77 61.5 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.763 0.825 . . . . 74.01 113.074 -172.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -66.85 -44.28 51.67 Favored Pre-proline 0 N--CA 1.484 1.264 0 N-CA-C 114.057 1.132 . . . . 73.45 114.057 -169.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -54.89 -31.54 73.78 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.812 1.675 . . . . 65.44 113.714 172.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.433 ' OH ' ' HB3' ' C' ' 130' ' ' PRO . 67.8 m-85 -84.49 -37.13 21.69 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.497 0.719 . . . . 72.43 111.305 -175.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.5 -46.87 78.03 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.286 -0.635 . . . . 64.23 109.286 172.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.526 ' NH1' HD13 ' C' ' 105' ' ' ILE . 32.9 ttm180 -49.57 -52.66 28.52 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 124.884 1.365 . . . . 74.4 110.463 174.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -63.27 -45.89 89.37 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.223 0.952 . . . . 73.24 112.05 -175.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.424 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 45.1 t -58.14 -46.25 85.98 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 124.045 0.84 . . . . 74.01 110.364 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.586 HG21 HG22 ' A' ' 64' ' ' VAL . 32.5 mt -60.93 -52.5 60.93 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 115.2 -0.909 . . . . 74.22 110.632 175.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.4 m -56.21 -40.16 73.6 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.127 0.892 . . . . 71.22 111.28 -174.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 41.9 t -67.62 -42.97 81.5 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 114.772 -1.104 . . . . 74.02 110.356 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.592 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 12.9 mtp -62.5 -37.38 85.79 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.552 0.741 . . . . 73.1 111.661 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 114' ' ' ILE . 86.1 t -62.2 -53.7 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.254 1.022 . . . . 61.1 109.917 177.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.5 p -69.92 -26.71 64.28 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.95 -1.023 . . . . 61.11 111.587 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.532 ' HG2' ' HG1' ' B' ' 18' ' ' THR . 18.0 ttm-85 -75.49 -31.61 60.27 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.182 0.993 . . . . 75.43 109.083 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.88 19.82 18.96 Favored Glycine 0 C--N 1.354 1.576 0 CA-C-N 114.948 -1.024 . . . . 55.14 112.916 171.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.5 t 61.44 9.12 2.48 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 127.497 2.319 . . . . 75.11 114.03 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -78.93 140.05 57.8 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 108.409 -0.96 . . . . 74.34 108.409 175.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.08 136.06 44.94 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.857 2.372 . . . . 63.21 111.854 175.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -52.07 133.54 33.09 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.308 1.005 . . . . 73.42 113.269 -170.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.517 HD23 HG12 ' A' ' 40' ' ' VAL . 58.7 tp -112.42 137.3 50.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.406 -1.27 . . . . 70.23 108.986 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.515 HD22 ' HA ' ' C' ' 15' ' ' ARG . 83.7 m-20 -122.93 123.75 41.64 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 107.806 -1.183 . . . . 74.43 107.806 178.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.5 mt -74.78 125.6 29.13 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.122 -0.696 . . . . 74.42 109.122 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.31 135.99 96.49 Favored Pre-proline 0 CA--C 1.555 1.17 0 CA-C-O 119.186 -0.435 . . . . 75.02 111.028 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.85 131.59 46.96 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 123.284 2.656 . . . . 75.21 113.705 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.595 HG22 HD13 ' A' ' 44' ' ' LEU . 67.2 t -115.07 133.56 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.87 0.868 . . . . 74.32 110.513 -177.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -88.49 87.87 7.42 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 108.663 -0.866 . . . . 73.02 108.663 173.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -60.87 -26.9 67.74 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.001 0.92 . . . . 73.34 111.965 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.498 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 4.1 t70 -71.02 -40.77 71.59 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 123.592 0.557 . . . . 64.03 109.648 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.52 94.17 Favored 'General case' 0 C--N 1.351 0.635 0 O-C-N 123.897 0.748 . . . . 72.55 110.772 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.7 mt -58.71 -50.95 71.99 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.694 0.621 . . . . 63.54 110.59 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -63.71 -35.96 82.29 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.855 -0.611 . . . . 64.45 110.363 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.52 ' HA ' ' HB3' ' A' ' 141' ' ' LEU . 26.4 ttm -67.02 -30.69 70.86 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.253 0.621 . . . . 75.21 111.199 -176.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -59.26 -32.02 69.63 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.683 0.793 . . . . 73.11 110.927 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -83.65 -43.3 15.74 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.821 0.849 . . . . 64.43 111.075 171.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.52 ' HB3' ' HA ' ' A' ' 138' ' ' MET . 57.2 tp -59.97 -52.39 65.58 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.209 1.004 . . . . 73.13 112.202 -165.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -178.83 -15.16 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.463 0.705 . . . . 73.33 111.087 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 74.73 -34.68 0.27 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.875 1.67 . . . . 74.21 112.701 -177.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -54.33 107.75 0.31 Allowed 'General case' 0 C--N 1.354 0.762 0 C-N-CA 124.304 1.042 . . . . 73.34 108.961 172.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.459 ' HA ' ' SD ' ' A' ' 138' ' ' MET . . . -87.9 146.25 25.65 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.57 0.748 . . . . 71.33 111.158 -175.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -132.69 158.13 22.91 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 110.375 -1.09 . . . . 73.35 110.375 173.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.84 157.05 43.93 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.452 0.644 . . . . 75.55 111.486 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 175.01 168.34 35.48 Favored Glycine 0 C--O 1.24 0.517 0 CA-C-N 114.633 -1.167 . . . . 64.03 111.078 -176.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.7 t -144.42 154.87 43.41 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 122.735 0.414 . . . . 72.12 110.225 176.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -143.16 168.54 19.52 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.367 1.067 . . . . 74.33 109.467 -173.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 76.74 114.62 0.06 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.87 1.668 . . . . 65.33 111.286 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -172.73 114.51 0.28 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.529 1.131 . . . . 73.22 108.879 174.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.409 ' NE2' ' HB3' ' C' ' 139' ' ' ASN . 0.8 OUTLIER -160.15 28.86 0.17 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.152 0.581 . . . . 74.21 111.463 -173.445 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -57.19 152.48 13.63 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.891 1.276 . . . . 65.4 112.549 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 C-N-CA 123.6 0.76 . . . . 74.23 109.074 179.332 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.523 ' HE1' ' HA ' ' B' ' 1' ' ' MET . 3.1 tpt . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 110.139 -0.319 . . . . 75.24 110.139 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 69.6 m -74.89 -179.42 4.23 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.782 0.833 . . . . 73.45 111.176 174.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -82.28 85.64 6.81 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.522 0.729 . . . . 73.2 109.376 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -59.49 123.4 16.71 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.271 -1.011 . . . . 74.22 108.271 171.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -58.44 113.69 2.1 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.011 0.819 . . . . 73.44 111.839 -166.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -54.3 92.43 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.324 1.85 . . . . 75.14 113.814 -170.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 33.5 p -80.7 79.57 7.32 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.51 -0.768 . . . . 71.42 110.032 173.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 64.85 53.37 1.47 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.514 1.125 . . . . 75.24 111.141 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 14.6 ptm 54.16 -172.42 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 126.714 2.005 . . . . 73.14 114.053 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 91.5 m -151.72 111.04 3.93 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.513 1.125 . . . . 71.43 108.424 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -109.56 144.48 37.81 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.853 0.461 . . . . 75.41 109.918 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -156.69 139.97 15.63 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.888 0.875 . . . . 64.03 109.505 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.8 mt -94.08 131.47 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.258 -1.386 . . . . 74.33 107.258 169.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -93.73 -46.69 7.12 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 120.968 0.414 . . . . 73.11 109.986 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -176.74 130.9 0.19 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.22 -0.9 . . . . 70.52 109.067 -172.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.555 HG21 ' CD1' ' B' ' 109' ' ' TYR . 81.6 mt -116.2 148.37 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 108.45 -0.945 . . . . 73.02 108.45 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -165.17 147.01 7.74 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 113.059 0.763 . . . . 74.42 113.059 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.532 ' HG1' ' HG2' ' A' ' 120' ' ' ARG . 54.2 m -73.53 121.42 20.57 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.457 -1.247 . . . . 74.43 108.991 168.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -99.4 -20.79 16.3 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.499 0.719 . . . . 75.45 111.929 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -164.67 135.54 4.14 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.326 0.25 . . . . 74.03 110.742 -171.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.527 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 48.4 mm -132.57 139.11 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.871 1.268 . . . . 72.14 109.601 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.527 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 37.2 t -136.28 126.73 26.78 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.38 -1.341 . . . . 70.54 107.38 174.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.463 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.8 t80 -145.01 111.6 5.75 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 107.589 -1.263 . . . . 73.53 107.589 170.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -128.32 112.73 14.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.311 -0.996 . . . . 61.51 108.311 -173.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.62 85.06 8.73 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 107.792 -1.188 . . . . 74.41 107.792 174.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.5 -30.07 12.73 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.579 2.186 . . . . 75.33 112.256 -175.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.447 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 2.1 m-20 -98.46 10.06 41.72 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.193 0.997 . . . . 74.2 110.571 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.92 -61.89 1.35 Allowed Pre-proline 0 CA--C 1.56 1.357 0 N-CA-C 115.293 1.59 . . . . 70.04 115.293 -164.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -62.76 -27.65 75.69 Favored 'Trans proline' 0 C--N 1.391 2.765 0 C-N-CA 122.347 2.031 . . . . 71.51 112.721 -169.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -94.24 -37.89 11.31 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.704 -1.134 . . . . 74.31 111.804 -172.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.542 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.1 p -69.6 -12.22 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 122.753 0.421 . . . . 74.32 112.109 -173.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -70.38 -9.72 57.07 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 112.868 0.692 . . . . 73.24 112.868 177.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -61.92 -26.2 68.03 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.623 0.769 . . . . 72.44 110.915 171.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.551 ' HB2' HD13 ' B' ' 68' ' ' LEU . 30.4 mmtp -89.24 84.73 6.51 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.482 1.113 . . . . 74.44 110.171 -174.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -88.3 82.53 7.04 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.125 0.488 . . . . 70.22 110.834 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 26.8 p90 -160.92 -172.05 3.32 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.513 1.125 . . . . 73.52 108.966 169.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -79.59 119.29 76.4 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.152 0.581 . . . . 74.54 110.722 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.506 ' HA ' HD21 ' B' ' 68' ' ' LEU . 20.6 Cg_endo -68.59 152.02 74.89 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 121.843 1.695 . . . . 74.02 111.343 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -71.35 102.68 2.67 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.596 -0.89 . . . . 72.35 108.596 173.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.667 HG21 ' HB1' ' B' ' 66' ' ' ALA . 50.6 t -94.84 142.77 13.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 114.667 -1.151 . . . . 74.31 110.24 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -140.0 109.74 6.35 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 106.933 -1.506 . . . . 75.35 106.933 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.463 HD12 HG21 ' B' ' 64' ' ' VAL . 35.6 tp -92.61 146.08 23.94 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.949 0.9 . . . . 74.54 109.845 -173.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.581 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 16.2 m-20 -131.34 143.16 50.29 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.758 1.223 . . . . 73.43 108.62 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.479 HD12 HG21 ' F' ' 121' ' ' VAL . 98.0 mt -129.99 128.63 42.44 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.922 -1.14 . . . . 73.34 107.922 174.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -140.84 143.96 35.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.091 0.956 . . . . 74.53 108.595 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 25.8 m -118.91 102.35 8.72 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.644 -0.502 . . . . 74.04 109.644 -175.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.46 ' O ' ' HB ' ' B' ' 59' ' ' VAL . . . -125.3 115.62 20.64 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 106.672 -1.603 . . . . 42.53 106.672 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 24.2 m -142.42 -178.27 5.67 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.75 0.42 . . . . 75.4 111.401 -164.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 69.4 p -150.67 137.01 18.65 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 123.396 0.678 . . . . 72.15 109.91 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -95.17 128.47 42.03 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.7 0.4 . . . . 74.04 110.097 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 19.0 mt -92.6 -30.99 15.34 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.491 0.494 . . . . 71.44 110.234 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . 0.478 ' HB1' ' HB ' ' B' ' 55' ' ' VAL . . . -171.41 175.15 4.23 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.842 0.857 . . . . 72.24 111.418 -176.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.72 137.33 57.74 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 107.019 -1.475 . . . . 74.44 107.019 159.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 70.81 -4.1 1.8 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.421 1.088 . . . . 74.33 113.234 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.478 ' HB ' ' HB1' ' B' ' 52' ' ' ALA . 41.2 t -135.15 96.71 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 108.334 -0.987 . . . . 74.22 108.334 -178.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.493 ' HH ' HD21 ' F' ' 102' ' ' LEU . 23.5 t80 -115.9 140.71 48.98 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.73 -0.841 . . . . 74.54 108.73 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -110.44 96.84 6.45 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.149 -1.426 . . . . 71.24 107.149 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -99.85 146.77 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 115.893 -0.594 . . . . 75.42 109.999 -174.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.46 ' HB ' ' O ' ' B' ' 47' ' ' ALA . 26.9 t -127.86 143.54 40.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 123.942 0.897 . . . . 74.04 108.802 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.462 HD11 ' HE2' ' B' ' 133' ' ' PHE . 46.4 tp -119.46 114.34 22.15 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.547 -0.909 . . . . 74.44 108.547 170.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -84.39 111.92 19.88 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.377 -0.972 . . . . 75.43 108.377 171.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 20.8 t -105.78 103.37 15.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.458 -1.312 . . . . 75.03 107.458 173.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.581 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 16.8 m -103.29 131.09 50.63 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.699 -0.482 . . . . 74.13 109.699 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.544 HG23 HD12 ' B' ' 114' ' ' ILE . 88.0 t -116.84 128.12 74.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 123.377 0.671 . . . . 61.23 109.903 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 90.0 m -106.67 141.19 38.33 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.637 -1.246 . . . . 74.42 107.637 163.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.667 ' HB1' HG21 ' B' ' 40' ' ' VAL . . . -147.47 140.58 25.12 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.537 -0.912 . . . . 70.34 108.537 174.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.456 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 29.2 p -142.91 128.28 18.87 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.748 -0.66 . . . . 73.42 110.589 -171.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.551 HD13 ' HB2' ' B' ' 34' ' ' LYS . 39.0 mt -99.52 108.81 21.33 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.133 0.973 . . . . 74.32 109.668 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.66 -125.86 9.49 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 116.018 -0.537 . . . . 74.32 111.872 -175.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -96.72 2.95 52.58 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.425 0.69 . . . . 64.41 112.105 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.447 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 17.3 pt-20 -125.01 159.43 31.32 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.901 0.48 . . . . 72.41 111.3 -174.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 85.0 m -67.77 130.58 43.43 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.582 0.753 . . . . 73.33 110.329 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.542 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -84.86 -67.51 0.79 Allowed 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.598 -1.26 . . . . 72.51 107.598 170.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -147.71 156.87 43.21 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.157 -0.929 . . . . 74.44 110.988 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 89.0 mt -124.24 109.89 13.97 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 107.008 -1.479 . . . . 73.24 107.008 172.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.5 t -117.87 156.72 27.93 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.653 -0.499 . . . . 61.24 109.653 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.527 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 38.1 tt0 -165.11 139.32 4.92 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.615 -0.883 . . . . 75.31 108.615 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.437 HG11 ' HA ' ' B' ' 110' ' ' ALA . 84.5 t -133.79 145.5 33.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.879 -1.156 . . . . 75.43 107.879 173.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -125.77 93.63 3.89 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.48 -0.933 . . . . 71.13 108.48 175.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.415 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.2 tp-100 -87.77 104.91 17.01 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.395 -0.821 . . . . 73.44 109.24 -177.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.06 173.37 29.02 Favored Glycine 0 C--N 1.336 0.553 0 O-C-N 123.664 0.603 . . . . 65.04 112.168 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.39 139.65 4.64 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 121.784 -0.246 . . . . 71.21 112.785 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 52.1 mt -85.69 113.45 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 108.37 -0.974 . . . . 71.33 108.37 173.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -117.4 135.45 53.87 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.643 0.777 . . . . 73.31 109.943 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 72.4 m -94.9 105.45 17.37 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.744 0.818 . . . . 65.23 109.633 172.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.535 ' H ' HD12 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -114.3 105.15 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 124.236 1.015 . . . . 74.14 108.685 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.0 163.02 24.64 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.335 0.654 . . . . 71.42 111.523 -174.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.72 -30.76 3.43 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 114.402 0.521 . . . . 53.22 114.402 172.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.584 HD13 ' HA ' ' B' ' 94' ' ' MET . 2.0 pt -67.83 161.29 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 124.495 1.118 . . . . 64.51 111.443 172.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -148.6 171.96 15.3 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 123.863 0.865 . . . . 75.21 111.062 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.52 -130.85 11.5 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 114.557 -1.201 . . . . 62.52 113.875 173.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 24.5 m -86.59 -35.7 19.3 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.853 0.861 . . . . 74.33 109.636 174.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -65.17 -23.33 67.08 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.103 -1.408 . . . . 73.32 111.666 -170.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.584 ' HA ' HD13 ' B' ' 89' ' ' ILE . 19.0 ptt? -66.23 -51.23 59.64 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.526 -0.761 . . . . 74.11 111.761 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.74 -13.46 59.43 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.483 0.713 . . . . 75.22 111.128 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -68.91 -32.57 72.29 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.308 0.643 . . . . 64.24 110.516 169.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -65.32 -52.09 56.27 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 120.899 0.381 . . . . 74.25 110.729 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.439 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.4 pp -71.13 -22.09 62.11 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 116.049 -0.523 . . . . 72.1 111.135 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.15 4.38 44.82 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 118.764 -1.02 . . . . 61.24 115.029 -172.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.27 -45.95 0.11 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 118.557 1.178 . . . . 72.03 111.294 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -74.82 -40.77 60.87 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.093 0.557 . . . . 73.45 110.686 -176.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.439 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 74.3 m -73.46 -46.19 7.55 Favored Pre-proline 0 CA--C 1.561 1.38 0 CA-C-O 118.492 -0.766 . . . . 72.44 112.94 -177.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.64 -16.48 54.95 Favored 'Trans proline' 0 C--N 1.396 3.064 0 C-N-CA 121.9 1.734 . . . . 73.52 113.246 171.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -73.33 -32.19 64.42 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.123 0.569 . . . . 74.04 110.644 172.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 91.3 mt -70.35 -39.73 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.04 0.936 . . . . 73.42 109.758 172.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 76.1 mt -75.57 -32.22 60.29 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.88 -1.054 . . . . 74.55 111.912 -174.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -57.24 -50.11 90.04 Favored Pre-proline 0 N--CA 1.488 1.471 0 CA-C-O 117.78 -1.105 . . . . 75.31 113.451 -173.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.35 -37.44 97.57 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 121.84 1.693 . . . . 70.25 112.593 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.555 ' CD1' HG21 ' B' ' 16' ' ' ILE . 3.6 m-30 -66.37 -39.37 89.08 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.727 0.811 . . . . 73.21 110.078 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.437 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -71.12 -31.56 67.91 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.15 0.98 . . . . 70.14 111.331 175.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -69.12 -52.96 22.93 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.529 1.132 . . . . 73.42 111.068 -173.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.0 -27.33 66.47 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.52 -0.548 . . . . 74.1 109.52 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.51 ' SG ' HD13 ' B' ' 21' ' ' ILE . 31.0 t -65.29 -42.6 92.95 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 122.945 0.498 . . . . 74.25 111.256 178.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.544 HD12 HG23 ' B' ' 64' ' ' VAL . 65.0 mt -62.74 -54.16 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.209 0.604 . . . . 72.51 109.573 173.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 4.3 m -62.32 -23.22 66.64 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 124.053 0.846 . . . . 74.23 111.334 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.447 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.3 t -69.19 -50.93 43.01 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 109.072 -0.714 . . . . 64.12 109.072 174.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.0 mmt -67.86 -34.96 77.7 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.074 0.55 . . . . 72.44 111.241 -176.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.505 HG22 HD22 ' B' ' 126' ' ' LEU . 70.4 t -64.75 -43.93 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.775 1.23 . . . . 74.54 110.216 174.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 31.4 t -64.74 -34.72 78.99 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.007 -0.997 . . . . 62.12 111.291 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' B' ' 116' ' ' SER . 82.1 mtt-85 -67.84 -35.88 79.36 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-N 115.718 -0.674 . . . . 62.25 109.802 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.31 -7.04 81.92 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.595 0.559 . . . . 64.15 113.324 172.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.419 ' HB ' ' HE ' ' A' ' 15' ' ' ARG . 8.5 m 64.94 33.4 9.89 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 125.144 1.377 . . . . 74.52 110.447 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -86.21 162.8 45.06 Favored Pre-proline 0 CA--C 1.555 1.173 0 CA-C-N 114.407 -1.269 . . . . 74.15 110.395 174.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.579 ' HA ' ' HB3' ' F' ' 131' ' ' TRP . 60.1 Cg_endo -68.21 169.97 15.61 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.528 2.152 . . . . 71.01 113.415 -176.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.444 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 62.4 tp60 -64.44 115.93 5.6 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 115.224 -0.898 . . . . 75.31 111.759 -169.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.505 HD22 HG22 ' B' ' 118' ' ' VAL . 55.8 tp -109.82 98.04 7.44 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.334 -0.848 . . . . 74.42 109.357 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -103.5 103.05 12.97 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.611 -1.255 . . . . 73.11 107.611 173.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.541 HD13 HD13 ' B' ' 114' ' ' ILE . 91.0 mt -62.54 141.54 58.39 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.566 0.346 . . . . 74.1 111.14 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.3 140.28 88.07 Favored Pre-proline 0 CA--C 1.55 0.96 0 O-C-N 124.016 0.822 . . . . 53.41 111.128 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -65.92 97.35 0.34 Allowed 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.513 2.142 . . . . 74.33 111.072 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.453 ' HA ' ' HE2' ' F' ' 120' ' ' TYR . 27.4 m -90.86 112.37 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.728 0.775 . . . . 74.55 110.501 -177.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . 0.48 HD21 ' HB3' ' B' ' 135' ' ' ALA . 55.7 t30 -87.44 104.9 16.89 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.936 -1.135 . . . . 74.14 107.936 171.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.462 ' HE2' HD11 ' B' ' 60' ' ' LEU . 3.4 t80 -59.15 -34.52 72.19 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.798 1.239 . . . . 74.44 110.138 -177.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.39 -47.09 83.47 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.399 -1.273 . . . . 73.21 111.474 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.48 ' HB3' HD21 ' B' ' 132' ' ' ASN . . . -63.06 -32.02 73.29 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.442 0.697 . . . . 72.13 112.171 -176.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 6.4 tt -63.25 -45.83 89.72 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.97 0.908 . . . . 75.23 109.863 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.558 ' HA ' ' HD2' ' B' ' 140' ' ' TYR . 2.9 m-85 -77.43 -22.69 51.1 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.787 0.835 . . . . 74.45 111.96 177.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 13.1 tmm? -69.13 -35.96 76.94 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.024 0.93 . . . . 73.03 110.651 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -74.61 -29.55 61.34 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.497 -0.774 . . . . 62.4 110.965 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . 0.558 ' HD2' ' HA ' ' B' ' 137' ' ' PHE . 37.6 m-85 -63.34 -19.83 64.97 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.562 0.345 . . . . 75.55 111.345 171.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 6.8 tp -106.43 35.25 3.02 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 108.821 -0.807 . . . . 75.11 108.821 174.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 64.23 -87.49 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.814 1.645 . . . . 72.21 111.823 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -154.61 121.69 5.6 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.499 -0.926 . . . . 71.24 108.499 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -110.04 9.95 24.16 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.852 0.861 . . . . 74.34 110.562 176.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.45 175.26 10.7 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.788 0.835 . . . . 72.24 109.797 170.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 124.05 4.91 7.66 Favored Glycine 0 N--CA 1.473 1.142 0 N-CA-C 111.779 -0.529 . . . . 73.15 111.779 -174.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.44 -37.56 70.41 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.796 1.238 . . . . 74.35 110.236 169.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -110.36 -166.04 19.35 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 115.701 -0.682 . . . . 71.1 111.51 171.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 57.6 m -137.81 -79.62 0.36 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.95 -1.13 . . . . 70.04 107.95 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . 0.54 ' HA ' ' HA2' ' D' ' 88' ' ' GLY . 39.0 tt0 165.88 102.14 0.0 OUTLIER 'General case' 0 C--O 1.24 0.588 0 C-N-CA 125.485 1.514 . . . . 74.12 107.048 -171.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -67.51 -66.61 0.54 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 109.892 -0.41 . . . . 73.55 109.892 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 54.43 60.76 3.35 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.104 0.962 . . . . 72.12 111.638 170.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -113.37 137.33 51.68 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 115.335 -0.848 . . . . 73.34 109.377 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -158.35 -177.12 6.31 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.393 0.677 . . . . 74.42 110.073 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.184 0 C-N-CA 123.644 0.778 . . . . 72.24 109.219 -179.101 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.463 ' N ' ' SD ' ' C' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.484 1.226 0 N-CA-C 109.606 -0.516 . . . . 74.24 109.606 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 80.8 p 63.92 129.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 127.064 2.146 . . . . 61.43 114.211 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -57.58 -57.19 13.8 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 124.426 1.09 . . . . 74.54 110.935 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -171.62 173.26 4.72 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 123.915 0.76 . . . . 74.23 111.538 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . 0.439 ' HA ' ' HA2' ' C' ' 88' ' ' GLY . 72.6 m-20 -136.5 97.2 3.51 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.149 1.38 . . . . 75.42 107.412 171.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -144.61 155.98 43.89 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.251 0.62 . . . . 74.25 111.192 -166.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 6.5 t -76.9 75.5 3.5 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-O 122.342 1.067 . . . . 74.03 110.367 174.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -167.98 -46.85 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.588 -1.187 . . . . 74.31 108.92 -169.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.52 ' HE1' HD12 ' C' ' 89' ' ' ILE . 23.5 ttt 63.69 110.8 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.367 1.467 . . . . 75.0 110.965 -178.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.617 ' HB ' ' HB2' ' C' ' 87' ' ' ALA . 7.4 m -88.36 77.73 8.09 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.695 0.798 . . . . 73.02 109.586 -176.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -106.14 137.22 44.45 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.605 0.762 . . . . 75.5 109.354 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . 0.675 ' HB2' ' HA3' ' E' ' 140' ' ' GLY . 6.5 tp-100 -154.13 141.58 19.72 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.679 0.392 . . . . 75.42 110.11 171.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 17.1 mt -91.31 123.56 43.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 109.452 -0.573 . . . . 74.42 109.452 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -88.22 -42.89 11.99 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.127 0.571 . . . . 64.23 109.542 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.515 ' HA ' HD22 ' A' ' 127' ' ' ASN . 14.2 ptp180 -172.56 147.35 1.83 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.154 0.982 . . . . 75.34 110.307 -178.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 70.6 mt -125.03 130.79 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.104 1.362 . . . . 73.1 107.535 174.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.507 ' HB3' HG22 ' D' ' 122' ' ' THR . 31.1 p90 -162.96 173.26 13.87 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.682 0.753 . . . . 73.52 111.523 -167.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -98.36 117.28 32.42 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.982 -1.008 . . . . 63.1 109.586 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.476 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 21.4 mmtp -67.61 -48.08 67.83 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 107.904 -1.147 . . . . 63.45 107.904 168.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -139.32 144.01 38.08 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 113.85 -1.523 . . . . 73.04 109.921 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.9 mt -133.88 142.99 39.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 125.393 1.477 . . . . 74.24 107.078 173.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.0 t -152.5 146.0 24.91 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.325 0.583 . . . . 74.0 110.342 174.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -150.18 128.26 11.93 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 107.066 -1.457 . . . . 74.23 107.066 172.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -133.92 112.16 11.04 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.195 -0.668 . . . . 75.53 109.195 -177.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.56 80.81 69.32 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 107.695 -1.224 . . . . 72.25 107.695 166.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.29 -21.69 30.66 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.453 2.102 . . . . 70.23 111.609 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -100.49 15.0 29.38 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.985 1.314 . . . . 75.41 110.946 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.44 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -42.21 -56.51 5.32 Favored Pre-proline 0 N--CA 1.487 1.423 0 N-CA-C 114.385 1.254 . . . . 51.2 114.385 -169.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.44 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 36.1 Cg_exo -60.68 -41.6 45.78 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.286 1.991 . . . . 72.42 112.666 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -68.36 -39.09 81.94 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.025 -0.989 . . . . 65.34 112.059 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.711 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.1 p -79.2 -17.13 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.507 0 N-CA-C 112.841 0.682 . . . . 64.45 112.841 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -69.41 -26.85 64.83 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 112.745 0.646 . . . . 74.03 112.745 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -87.14 13.63 9.11 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.174 0.59 . . . . 70.5 111.591 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.44 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 0.7 OUTLIER -105.79 160.34 15.31 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.796 0.838 . . . . 75.51 110.756 -173.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -71.59 129.83 39.7 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.603 0.761 . . . . 71.44 109.877 173.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -82.9 90.19 6.93 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.574 0.75 . . . . 75.42 110.724 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -146.55 79.46 10.4 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 124.095 0.958 . . . . 74.41 108.845 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -86.24 158.36 9.75 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.547 2.165 . . . . 70.42 112.852 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.47 79.3 9.02 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 106.703 -1.592 . . . . 75.23 106.703 167.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 25.7 t -71.73 96.75 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.112 -0.949 . . . . 74.43 108.845 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.93 104.0 12.55 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.767 -1.568 . . . . 73.25 106.767 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 pp -85.48 145.59 27.35 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.967 -0.753 . . . . 75.02 108.967 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.418 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 22.5 t70 -128.12 115.44 18.43 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.746 -0.835 . . . . 72.44 108.746 178.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.509 HD11 HG13 ' C' ' 131' ' ' VAL . 93.0 mt -97.35 110.97 23.42 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.598 -0.519 . . . . 73.35 109.598 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -113.52 145.96 40.39 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.374 -1.343 . . . . 71.41 107.374 169.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.0 t -137.42 146.76 44.78 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.232 -0.655 . . . . 71.11 109.232 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.84 171.82 13.55 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.116 0.967 . . . . 61.05 108.8 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 32.8 p -156.15 156.03 33.53 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.284 0.633 . . . . 71.33 109.621 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -145.41 127.62 15.73 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.49 -0.93 . . . . 74.41 108.49 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -78.9 113.46 17.02 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 107.452 -1.314 . . . . 73.54 107.452 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.528 HD13 HD13 ' C' ' 83' ' ' ILE . 67.0 mt -84.61 -27.35 27.26 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.008 0.523 . . . . 72.14 110.444 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.3 -175.06 2.78 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.737 -1.12 . . . . 72.31 110.182 -176.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -64.37 104.11 0.73 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.101 -0.954 . . . . 71.04 110.343 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 65.56 21.33 11.73 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.453 1.101 . . . . 74.0 112.302 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.5 t -108.55 114.96 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 107.613 -1.254 . . . . 74.34 107.613 166.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.409 ' HB2' HD12 ' C' ' 86' ' ' ILE . 85.2 m-85 -121.63 124.39 44.21 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.343 0.657 . . . . 72.44 109.542 -177.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -82.95 143.22 30.83 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 124.542 1.137 . . . . 74.41 108.563 165.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.448 HG12 ' HD3' ' C' ' 103' ' ' PRO . 96.0 t -132.95 133.55 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.787 -0.82 . . . . 73.44 108.787 171.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.445 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 58.7 t -113.4 139.71 37.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 123.661 0.785 . . . . 74.52 109.112 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.465 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -122.63 100.73 7.07 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.045 -1.465 . . . . 65.2 107.045 173.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -82.48 107.42 15.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.193 -0.912 . . . . 74.05 109.244 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 24.4 t -107.76 114.75 47.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.885 -1.154 . . . . 65.52 107.885 173.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 21.4 m -105.1 145.51 30.43 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.195 0.998 . . . . 74.02 108.783 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.544 HG23 HG21 ' C' ' 114' ' ' ILE . 87.4 t -126.49 119.49 53.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 109.103 -0.703 . . . . 74.44 109.103 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 38.6 m -99.14 134.72 41.59 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.559 -1.274 . . . . 72.53 107.559 166.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.27 103.83 4.5 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.115 -1.068 . . . . 75.12 108.115 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 42.4 m -130.31 132.25 45.79 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 121.156 0.503 . . . . 73.25 109.862 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 12.7 mt -85.54 38.21 0.73 Allowed 'General case' 0 CA--C 1.556 1.212 0 C-N-CA 124.793 1.237 . . . . 71.31 109.87 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.49 -111.8 2.64 Favored Glycine 0 C--N 1.354 1.533 0 N-CA-C 110.217 -1.153 . . . . 64.25 110.217 -168.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -90.47 -31.22 16.88 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.151 0.981 . . . . 72.5 109.879 174.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.44 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 7.0 tp10 -67.16 101.03 0.84 Allowed 'General case' 0 C--N 1.346 0.423 0 C-N-CA 124.032 0.933 . . . . 75.11 109.793 175.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 46.4 m -72.43 116.31 12.73 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.978 -0.749 . . . . 61.0 108.978 173.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.711 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -64.44 -49.17 72.53 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.072 0.858 . . . . 73.5 109.506 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -167.54 164.73 14.79 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.133 -1.394 . . . . 74.23 110.459 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.49 138.2 53.3 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 106.38 -1.711 . . . . 73.33 106.38 164.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 51.3 t -144.89 145.71 31.7 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.777 -0.823 . . . . 73.43 108.777 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -159.94 136.89 9.31 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.796 -0.446 . . . . 64.54 109.796 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 69.1 t -131.24 124.39 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.174 0.99 . . . . 72.35 108.668 175.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -99.85 84.12 2.85 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.789 -1.189 . . . . 73.41 107.789 177.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -78.63 95.74 5.32 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.33 -0.85 . . . . 74.14 109.502 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -94.56 146.52 18.2 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 115.697 -0.683 . . . . 72.41 111.905 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.08 140.74 9.64 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.346 -0.702 . . . . 72.43 111.346 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.574 HD11 ' HB3' ' D' ' 29' ' ' PRO . 15.4 mm -97.12 133.1 40.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 109.52 -0.548 . . . . 72.11 109.52 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.43 ' HZ ' HD11 ' C' ' 106' ' ' LEU . 25.7 m-85 -135.84 147.09 48.12 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.854 0.721 . . . . 74.42 110.029 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 85' ' ' SER . . . . . 0.487 ' HB2' ' HB3' ' E' ' 141' ' ' ALA . 12.9 p -101.2 101.16 11.8 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.806 -1.183 . . . . 73.4 107.806 168.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.606 HD11 ' SG ' ' C' ' 97' ' ' CYS . 22.5 mt -116.25 129.94 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.39 0.676 . . . . 75.33 110.303 -172.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.617 ' HB2' ' HB ' ' C' ' 10' ' ' THR . . . -153.05 172.82 16.27 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.21 1.004 . . . . 74.23 109.516 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' C' ' 5' ' ' ASN . . . 95.32 -34.04 5.08 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-N 116.547 -0.297 . . . . 62.32 112.654 175.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.52 HD12 ' HE1' ' C' ' 9' ' ' MET . 33.8 pt -96.69 162.28 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.54 0.736 . . . . 75.12 111.517 -176.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -158.52 152.47 23.69 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.674 0.79 . . . . 64.14 110.417 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.58 -127.94 8.38 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-O 119.717 -0.491 . . . . 73.55 112.879 174.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -59.46 -32.91 70.67 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 123.258 0.623 . . . . 71.05 110.817 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.458 ' HB3' ' HB ' ' C' ' 89' ' ' ILE . 21.6 mt-30 -62.74 -48.95 76.99 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.357 1.063 . . . . 75.51 111.695 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.551 ' HE3' ' HA ' ' C' ' 94' ' ' MET . 4.2 tpt -55.09 -52.67 62.49 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 123.784 0.677 . . . . 72.54 110.453 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.06 -32.49 73.87 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.146 0.578 . . . . 63.51 111.955 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -70.4 -32.64 70.35 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.87 0.868 . . . . 74.21 111.153 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.606 ' SG ' HD11 ' C' ' 86' ' ' ILE . 18.7 t -72.11 -43.96 63.93 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.295 0.569 . . . . 71.33 109.622 177.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 67.6 mt -81.02 -25.3 37.29 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 114.625 -1.17 . . . . 74.33 112.121 -174.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.4 3.29 20.23 Favored Glycine 0 N--CA 1.476 1.337 0 CA-C-O 119.201 -0.777 . . . . 74.14 114.719 -172.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.99 -53.15 0.15 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 118.151 0.976 . . . . 73.11 112.559 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -70.58 -58.6 3.51 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.884 0.474 . . . . 71.31 110.404 -171.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 58.9 m -64.64 -44.18 72.98 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-O 118.494 -0.765 . . . . 72.44 112.191 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.465 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 82.7 Cg_exo -53.7 -32.87 67.26 Favored 'Trans proline' 0 C--N 1.389 2.692 0 C-N-CA 122.366 2.044 . . . . 71.45 114.021 169.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -67.55 -40.72 84.95 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 122.974 0.51 . . . . 74.43 111.028 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.526 HD13 ' NH1' ' A' ' 111' ' ' ARG . 35.8 mm -70.66 -32.57 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 C-N-CA 122.812 0.445 . . . . 71.51 110.204 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.43 HD11 ' HZ ' ' C' ' 84' ' ' PHE . 2.5 mp -83.89 -20.83 32.38 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.455 1.102 . . . . 74.44 112.105 -176.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -58.44 -47.91 97.92 Favored Pre-proline 0 CA--C 1.554 1.108 0 CA-C-O 117.811 -1.09 . . . . 72.31 113.9 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -60.14 -37.37 84.24 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 121.91 1.74 . . . . 73.21 113.044 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -68.87 -43.74 74.75 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.602 0.761 . . . . 73.44 110.309 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.11 -40.17 94.96 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.035 -0.984 . . . . 75.5 110.35 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -63.98 -48.89 74.66 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.7 1.2 . . . . 73.54 110.496 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.74 -38.91 84.16 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.136 0.575 . . . . 70.4 109.805 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . 0.44 ' O ' ' SD ' ' C' ' 117' ' ' MET . 6.8 t -63.88 -42.78 97.42 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.685 0.394 . . . . 74.12 111.136 -178.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.544 HG21 HG23 ' C' ' 64' ' ' VAL . 75.8 mt -63.27 -52.01 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 122.911 0.484 . . . . 75.21 110.244 175.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 22.0 m -63.32 -27.92 69.65 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.849 -0.614 . . . . 74.4 110.877 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 26.6 t -66.86 -52.18 46.58 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.491 0.717 . . . . 74.3 109.274 173.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.658 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.1 OUTLIER -48.76 -46.56 41.42 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.706 1.202 . . . . 75.54 112.354 175.044 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 93.4 t -67.35 -43.03 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.557 1.143 . . . . 75.1 111.004 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 15.0 t -65.72 -30.99 71.74 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.226 1.011 . . . . 75.14 111.619 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.409 HH12 ' CD ' ' D' ' 112' ' ' GLU . 70.9 mtt-85 -75.0 -39.5 61.19 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.805 0.842 . . . . 72.51 109.676 178.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.68 -2.54 64.64 Favored Glycine 0 C--N 1.356 1.645 0 CA-C-N 115.436 -0.802 . . . . 64.51 112.876 170.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.1 p 65.38 30.01 11.18 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.316 1.846 . . . . 75.15 113.533 169.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -83.81 144.28 44.89 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 108.348 -0.982 . . . . 75.11 108.348 169.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.408 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 77.8 Cg_exo -50.42 143.26 27.74 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 123.318 2.679 . . . . 74.51 113.728 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.444 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 55.5 mm-40 -51.76 119.71 4.5 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.639 1.212 . . . . 70.14 112.337 -174.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 36.6 tp -124.15 84.22 2.25 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 107.587 -1.264 . . . . 75.21 107.587 -177.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -92.68 97.68 10.94 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.377 -0.829 . . . . 73.32 108.864 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -60.36 143.82 52.17 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.47 0.708 . . . . 75.42 112.019 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.2 142.54 97.92 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-N 115.171 -0.922 . . . . 75.33 110.617 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.565 ' HG2' HG23 ' A' ' 13' ' ' ILE . 4.9 Cg_exo -67.13 152.73 79.36 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.027 1.818 . . . . 71.42 112.762 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.509 HG13 HD11 ' C' ' 44' ' ' LEU . 7.2 p -136.5 134.92 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.442 -0.799 . . . . 72.13 108.855 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -87.57 103.4 15.52 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.975 0.51 . . . . 74.42 110.254 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -61.87 -29.53 70.25 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.897 0.879 . . . . 73.23 111.82 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -56.58 -55.19 37.02 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.559 0.744 . . . . 75.23 110.061 173.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.23 -47.95 77.45 Favored 'General case' 0 C--N 1.349 0.55 0 O-C-N 124.227 0.954 . . . . 65.2 111.594 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 73.2 mt -59.02 -38.3 78.96 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.559 0.744 . . . . 73.44 111.559 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -77.56 -30.45 52.64 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.138 -0.937 . . . . 71.53 110.806 -177.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.403 ' SD ' ' N ' ' A' ' 1' ' ' MET . 25.2 mmt -70.0 -38.92 76.11 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.129 0.572 . . . . 72.14 109.882 175.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . 0.409 ' HB3' ' NE2' ' A' ' 153' ' ' GLN . 68.5 m-80 -60.56 -39.0 86.37 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.748 0.655 . . . . 64.03 110.219 173.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -72.7 -155.69 0.03 OUTLIER 'General case' 0 CA--C 1.579 2.062 0 C-N-CA 124.004 0.921 . . . . 72.23 110.217 171.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.449 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 94.4 mt 62.12 179.25 0.13 Allowed 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 124.719 1.208 . . . . 72.43 112.23 -175.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -140.72 -56.29 0.51 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.921 0.888 . . . . 75.41 109.465 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -69.32 122.09 18.2 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.107 0.963 . . . . 73.5 110.758 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . 0.486 ' NE2' ' HA ' ' A' ' 3' ' ' GLU . 34.0 tt0 -66.81 105.32 1.55 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.106 0.562 . . . . 74.55 110.163 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -152.69 112.3 3.91 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.297 0.639 . . . . 74.02 109.715 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -177.42 124.5 0.95 Allowed Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.081 -1.208 . . . . 64.35 110.081 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.78 166.44 32.23 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 117.383 0.591 . . . . 73.33 111.005 -176.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -130.59 35.91 2.39 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 116.301 -0.408 . . . . 73.1 113.214 -172.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 63.5 m -70.59 119.48 14.81 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 122.942 0.497 . . . . 75.3 109.771 171.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -150.24 141.95 23.65 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.082 0.553 . . . . 74.31 110.727 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -145.95 124.54 12.49 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 107.507 -1.294 . . . . 75.32 107.507 163.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -79.07 77.07 5.56 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.881 0.848 . . . . 71.21 110.644 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -145.81 128.78 16.47 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.122 -0.944 . . . . 71.3 108.494 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -76.25 91.67 3.23 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.3 0.64 . . . . 74.51 110.173 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.138 0 C-N-CA 124.355 1.062 . . . . 74.23 108.55 178.633 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.457 ' SD ' ' N ' ' D' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 109.621 -0.511 . . . . 74.45 109.621 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 25.5 m -73.55 85.53 1.56 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.611 0.764 . . . . 72.34 109.384 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -82.92 143.82 30.45 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.191 -0.913 . . . . 73.43 110.965 -170.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . 0.436 ' HB3' ' HG2' ' E' ' 95' ' ' LYS . 95.7 mt-30 -84.87 109.08 17.86 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.578 0.751 . . . . 74.54 109.772 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . 0.402 ' O ' ' HD3' ' E' ' 95' ' ' LYS . 6.4 p30 -94.98 131.7 40.64 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.755 0.822 . . . . 73.55 110.898 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.76 112.53 2.06 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.24 1.016 . . . . 71.23 111.066 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -141.03 149.83 42.21 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.514 1.126 . . . . 75.33 109.46 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -74.51 169.14 18.35 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.523 -0.547 . . . . 74.41 109.523 173.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.669 ' SD ' HG13 ' D' ' 89' ' ' ILE . 10.2 tpt -31.69 123.18 0.27 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.622 1.169 . . . . 73.54 114.119 177.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -119.23 131.97 55.88 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.167 0.987 . . . . 73.13 108.938 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.462 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 60.4 t80 -133.62 99.87 4.62 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.565 -1.272 . . . . 75.34 107.565 177.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -124.63 126.72 46.21 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.713 0.805 . . . . 73.53 108.868 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 11.0 mt -89.84 122.56 41.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.339 -0.985 . . . . 73.4 108.339 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -95.34 -18.94 20.36 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.37 0.668 . . . . 75.0 111.639 -171.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 179.05 124.28 0.05 Allowed 'General case' 0 C--N 1.359 0.989 0 C-N-CA 122.958 0.503 . . . . 72.34 109.818 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.54 136.34 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 106.854 -1.536 . . . . 71.42 106.854 167.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -160.6 145.08 14.14 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 123.389 0.43 . . . . 75.11 111.363 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.2 p -84.48 112.3 20.26 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.681 -0.69 . . . . 71.12 109.677 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -79.81 -18.07 51.78 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.664 -0.698 . . . . 74.45 109.377 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 4.3 t70 -157.51 147.5 20.55 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 124.803 1.241 . . . . 73.02 110.005 175.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.658 HG23 ' HE1' ' C' ' 117' ' ' MET . 69.6 mt -141.99 147.28 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.661 1.584 . . . . 74.11 107.423 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 22' ' ' SER . . . . . 0.632 ' HB3' ' HB2' ' D' ' 77' ' ' GLU . 32.8 t -155.35 144.48 20.88 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.327 1.051 . . . . 64.53 109.266 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.417 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 91.6 t80 -151.96 129.43 11.4 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.37 -1.715 . . . . 75.1 106.37 170.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -134.14 126.98 31.14 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.527 0.731 . . . . 71.34 109.248 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.43 86.41 48.38 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 107.621 -1.251 . . . . 74.44 107.621 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.48 -36.24 15.75 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.721 2.281 . . . . 70.34 112.815 -170.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -110.53 12.32 22.86 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.856 0.862 . . . . 74.45 110.359 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.41 ' O ' HG11 ' D' ' 31' ' ' VAL . . . -20.98 -70.23 0.04 OUTLIER Pre-proline 0 CA--C 1.57 1.714 0 N-CA-C 116.776 2.139 . . . . 72.2 116.776 -169.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.574 ' HB3' HD11 ' C' ' 83' ' ' ILE . 83.0 Cg_endo -76.26 -23.11 12.09 Favored 'Trans proline' 0 C--N 1.38 2.187 0 CA-C-N 123.741 2.372 . . . . 73.22 114.309 -174.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -71.24 -39.34 71.71 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.183 0.993 . . . . 74.35 109.3 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.52 HG23 ' HA ' ' D' ' 73' ' ' ALA . 9.8 p -84.0 -20.6 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.232 0 CA-C-N 114.798 -1.092 . . . . 73.03 111.825 -173.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.411 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 22.8 m-85 -67.22 -19.8 65.59 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 112.198 0.444 . . . . 74.22 112.198 177.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -63.09 -13.45 36.37 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.786 0.834 . . . . 73.2 110.958 176.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.684 ' HZ1' ' HG2' ' D' ' 71' ' ' GLU . 95.3 mttt -99.18 91.14 4.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.24 1.416 . . . . 73.12 109.804 176.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -88.25 85.45 6.91 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.271 0.558 . . . . 72.23 110.691 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 38.9 p90 -156.91 172.22 19.04 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.001 -1.111 . . . . 75.44 108.001 165.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -68.13 116.75 42.31 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 109.351 -0.611 . . . . 71.21 109.351 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -57.38 131.14 42.92 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.648 2.232 . . . . 74.54 111.752 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 22.5 tt0 -60.02 109.98 1.09 Allowed 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.837 0.711 . . . . 74.31 109.366 175.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.809 HG13 HG13 ' D' ' 64' ' ' VAL . 45.8 t -105.43 115.25 46.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 114.622 -1.172 . . . . 72.14 109.377 -177.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.31 126.36 52.14 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 106.71 -1.589 . . . . 74.3 106.71 170.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.487 HD12 HG12 ' D' ' 62' ' ' VAL . 50.1 tp -97.57 141.92 30.02 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.605 0.762 . . . . 75.43 110.046 -168.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.708 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.5 m-20 -125.05 123.92 40.83 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 107.244 -1.391 . . . . 74.54 107.244 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 88.7 mt -124.37 138.48 54.37 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.173 0.511 . . . . 73.12 111.078 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.523 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 9.5 t70 -143.18 155.35 44.52 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.434 1.494 . . . . 72.43 107.685 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.7 t -139.71 153.48 47.24 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-O 121.386 0.612 . . . . 74.42 110.074 174.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.9 170.46 18.76 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 114.588 -1.187 . . . . 63.4 109.005 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.3 p -161.55 -169.47 2.28 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.406 0.682 . . . . 74.05 109.574 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 25.0 p -149.79 126.72 11.16 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.838 -0.801 . . . . 73.03 108.838 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . 0.522 ' HB3' ' HB2' ' E' ' 102' ' ' LEU . 11.5 pm0 -72.14 96.12 1.74 Allowed 'General case' 0 C--N 1.348 0.506 0 CA-C-O 121.599 0.714 . . . . 63.33 110.066 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.45 HD13 HG13 ' D' ' 55' ' ' VAL . 1.2 tm? -142.46 104.8 4.46 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 106.025 -1.843 . . . . 74.32 106.025 177.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.447 ' HA ' ' CZ ' ' D' ' 56' ' ' TYR . . . -80.67 -154.96 0.11 Allowed 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 119.075 -0.488 . . . . 72.42 110.775 -175.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 39.0 t70 67.78 28.3 7.2 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.523 1.154 . . . . 73.03 109.226 -171.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.605 ' HB2' ' HA ' ' E' ' 93' ' ' PHE . 12.8 m-20 64.59 17.25 10.79 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 113.466 -1.697 . . . . 73.52 112.914 172.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.45 HG13 HD13 ' D' ' 51' ' ' LEU . 4.1 p -118.0 95.54 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 122.265 1.031 . . . . 73.1 108.95 175.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.447 ' CZ ' ' HA ' ' D' ' 52' ' ' ALA . 96.7 m-85 -117.46 146.56 43.41 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.12 -0.945 . . . . 72.41 109.924 -174.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -102.82 145.41 29.8 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.876 -0.602 . . . . 74.43 110.462 173.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 70.3 t -131.45 141.82 44.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 114.06 -1.427 . . . . 70.53 107.523 172.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.43 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 46.3 t -131.23 132.07 63.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 108.294 -1.002 . . . . 75.33 108.294 176.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.469 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -107.96 117.45 34.16 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 106.632 -1.618 . . . . 75.55 106.632 172.308 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.635 ' HG2' ' HG2' ' D' ' 79' ' ' GLN . 0.0 OUTLIER -101.32 97.23 7.75 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.208 -1.405 . . . . 75.44 107.208 178.312 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.487 HG12 HD12 ' D' ' 42' ' ' LEU . 54.2 t -91.08 144.25 9.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.43 -0.952 . . . . 71.22 108.43 172.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.708 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 52.2 m -138.77 135.89 35.14 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.571 -1.27 . . . . 73.33 107.571 174.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.809 HG13 HG13 ' D' ' 40' ' ' VAL . 94.9 t -117.52 127.11 75.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.976 -0.75 . . . . 73.31 108.976 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 6.0 m -111.49 93.95 4.72 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.16 -1.052 . . . . 72.23 108.16 173.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.491 ' HB3' HG21 ' D' ' 40' ' ' VAL . . . -105.29 142.29 35.31 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.002 0.521 . . . . 75.51 111.295 -177.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.437 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 42.0 m -145.52 142.27 29.05 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.153 0.581 . . . . 72.43 110.81 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.412 HD12 HG22 ' D' ' 31' ' ' VAL . 19.4 mt -108.57 109.49 20.73 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.7 -1.222 . . . . 72.21 107.7 170.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.61 -124.39 7.51 Favored Glycine 0 C--N 1.345 1.056 0 O-C-N 123.212 0.32 . . . . 61.32 112.953 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.4 5.61 37.23 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.171 0.588 . . . . 73.52 111.842 -177.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.684 ' HG2' ' HZ1' ' D' ' 34' ' ' LYS . 11.2 pt-20 -124.3 155.39 38.75 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.093 0.557 . . . . 74.41 109.986 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 75.7 m -66.32 136.53 55.94 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 122.767 0.427 . . . . 72.25 110.726 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.52 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -89.51 -64.66 1.11 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.348 -1.352 . . . . 72.42 107.348 174.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -154.96 164.13 39.33 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 114.409 -1.269 . . . . 73.3 110.68 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 62.6 mt -130.12 144.49 51.38 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 105.821 -1.918 . . . . 75.55 105.821 174.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.687 ' SG ' ' HE3' ' D' ' 117' ' ' MET . 9.1 t -152.72 106.81 3.11 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 118.812 0.733 . . . . 63.15 110.777 -173.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . 0.632 ' HB2' ' HB3' ' D' ' 22' ' ' SER . 10.9 mp0 -122.69 127.82 49.78 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.193 0.997 . . . . 71.53 109.793 -169.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 64.3 t -138.53 121.81 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 122.876 0.47 . . . . 65.53 109.741 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.635 ' HG2' ' HG2' ' D' ' 61' ' ' ARG . 43.2 mt-30 -89.99 88.58 7.36 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 108.965 -0.754 . . . . 73.14 108.965 167.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -82.58 94.58 7.54 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.236 -0.893 . . . . 64.13 108.925 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.78 173.06 37.88 Favored Glycine 0 C--O 1.242 0.623 0 CA-C-N 116.141 -0.481 . . . . 63.34 112.432 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.44 148.27 10.95 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.519 -0.34 . . . . 54.43 112.459 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.4 mt -100.44 113.67 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 108.211 -1.033 . . . . 73.22 108.211 175.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -114.24 133.51 55.58 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.969 0.908 . . . . 73.44 109.891 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 35.6 p -96.68 105.44 17.55 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.977 -0.749 . . . . 43.3 108.977 172.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.527 HG22 ' HE2' ' D' ' 9' ' ' MET . 61.7 mt -117.12 119.23 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.252 1.021 . . . . 75.44 109.25 -173.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.479 ' HA ' ' HB ' ' E' ' 97' ' ' ILE . . . -158.19 125.66 5.1 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.539 0.735 . . . . 53.42 110.569 -176.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' B' ' 150' ' ' GLU . . . 111.93 19.47 7.27 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-O 119.583 -0.565 . . . . 55.4 114.497 170.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.669 HG13 ' SD ' ' D' ' 9' ' ' MET . 0.8 OUTLIER -118.15 149.25 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 108.86 -0.793 . . . . 73.33 108.86 167.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -129.33 -179.96 5.44 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.183 0.993 . . . . 73.15 108.664 -171.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.07 -140.44 34.22 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 116.152 -0.477 . . . . 73.51 113.685 173.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 61.4 p -82.0 -33.79 29.93 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.313 0.645 . . . . 72.04 111.038 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -64.65 -26.25 68.31 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.516 0.726 . . . . 71.53 111.891 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.577 ' HA ' HD12 ' D' ' 89' ' ' ILE . 48.2 ttp -46.37 -60.46 2.32 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.913 1.285 . . . . 74.34 112.805 -176.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.68 -14.41 48.58 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.38 0.672 . . . . 63.12 112.248 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 45.2 m170 -72.05 -28.79 63.58 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.926 0.49 . . . . 73.45 110.579 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 70.9 m -62.02 -30.15 70.76 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.158 0.583 . . . . 74.45 111.078 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.2 tt -89.49 -44.98 9.75 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.827 0.851 . . . . 75.14 110.197 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.3 -13.3 74.1 Favored Glycine 0 N--CA 1.472 1.095 0 CA-C-N 115.983 -0.553 . . . . 75.45 114.331 -170.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.7 -53.16 0.81 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 117.314 0.557 . . . . 72.54 111.544 -173.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -68.37 -40.95 81.27 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 112.043 0.386 . . . . 75.22 112.043 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.467 ' SG ' HD11 ' D' ' 86' ' ' ILE . 78.2 m -66.33 -46.13 60.37 Favored Pre-proline 0 CA--C 1.562 1.415 0 CA-C-O 118.447 -0.787 . . . . 74.41 112.655 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.469 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 73.4 Cg_exo -55.08 -37.4 94.02 Favored 'Trans proline' 0 C--N 1.396 3.039 0 C-N-CA 122.152 1.901 . . . . 72.41 112.812 168.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -62.47 -36.86 83.82 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.256 0.622 . . . . 74.12 111.018 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 38.2 mm -69.98 -40.6 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.923 0.889 . . . . 73.33 110.865 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 89.4 mt -73.26 -16.89 61.38 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.877 -0.602 . . . . 72.3 111.937 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -68.53 -43.39 30.62 Favored Pre-proline 0 CA--C 1.555 1.168 0 CA-C-O 118.095 -0.955 . . . . 74.33 113.235 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . 0.402 ' HA ' ' NH2' ' D' ' 111' ' ' ARG . 58.9 Cg_exo -46.09 -43.42 20.49 Favored 'Trans proline' 0 C--N 1.382 2.322 0 C-N-CA 122.151 1.901 . . . . 72.33 113.897 167.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -77.78 -36.66 50.26 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.64 0.776 . . . . 73.32 111.769 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.84 -50.68 47.95 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.405 0.682 . . . . 64.32 110.127 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.622 HH12 ' HB3' ' D' ' 130' ' ' PRO . 36.5 ttp180 -54.92 -41.81 71.47 Favored 'General case' 0 C--O 1.211 -0.969 0 O-C-N 124.727 1.267 . . . . 75.04 111.02 172.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . 0.409 ' CD ' HH12 ' C' ' 120' ' ' ARG . 1.6 tm-20 -56.97 -53.84 53.52 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.161 0.913 . . . . 72.43 111.293 -175.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.0 t -55.02 -41.56 71.5 Favored 'General case' 0 C--N 1.348 0.523 0 O-C-N 124.469 1.106 . . . . 75.31 110.955 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.57 HG22 ' SG ' ' D' ' 76' ' ' CYS . 90.5 mt -64.22 -53.56 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.949 0.9 . . . . 74.03 110.834 177.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 93.2 m -55.45 -39.63 70.58 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.202 1.401 . . . . 71.42 110.375 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.0 t -66.97 -47.52 71.32 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.824 -1.535 . . . . 74.34 110.596 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.687 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 78.8 mtm -68.4 -25.56 65.11 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.557 0.577 . . . . 74.34 112.557 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.446 HG22 ' HB3' ' D' ' 126' ' ' LEU . 76.0 t -68.65 -45.8 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.656 0.782 . . . . 74.51 109.294 175.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 72.5 p -73.95 -27.21 60.89 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 115.536 -0.757 . . . . 75.52 110.48 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 78.0 mtt-85 -74.4 -27.3 60.57 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.694 0.798 . . . . 75.21 110.123 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.7 10.22 73.03 Favored Glycine 0 C--N 1.351 1.372 0 O-C-N 123.653 0.595 . . . . 51.12 112.704 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.507 HG22 ' HB3' ' C' ' 17' ' ' TYR . 82.5 p 51.38 37.18 18.38 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.195 1.798 . . . . 71.32 114.203 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -95.99 154.04 39.04 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.148 -0.933 . . . . 73.43 109.345 168.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -49.62 132.53 30.78 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 123.173 2.582 . . . . 74.23 112.517 168.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -50.1 128.45 19.04 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.155 0.982 . . . . 72.02 112.508 -174.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.543 HD11 HG22 ' D' ' 40' ' ' VAL . 21.4 tp -107.68 128.74 54.82 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.938 0.895 . . . . 71.33 109.066 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -129.16 99.78 5.37 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.164 -1.05 . . . . 64.35 108.164 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.48 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 2.8 mm? -64.26 121.18 13.65 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.513 0.725 . . . . 75.51 110.032 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.35 123.0 74.28 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 123.123 0.569 . . . . 73.04 111.179 -176.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.622 ' HB3' HH12 ' D' ' 111' ' ' ARG . 72.2 Cg_endo -76.41 114.77 3.95 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.542 2.161 . . . . 74.21 112.431 -176.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.25 145.22 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.806 0.842 . . . . 75.33 109.355 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -70.38 115.06 9.12 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.341 -0.615 . . . . 73.24 109.341 173.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -64.08 -22.99 67.16 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.801 0.84 . . . . 74.43 111.367 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -54.86 -40.39 69.62 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.861 1.264 . . . . 75.03 111.496 172.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.55 -58.16 9.53 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 123.922 0.764 . . . . 71.23 110.405 177.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 56.6 tp -61.62 -32.87 73.03 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.558 0.743 . . . . 75.01 111.833 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -69.4 -46.23 67.36 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.016 0.927 . . . . 74.32 110.655 -174.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 22.8 ptp -74.69 -33.96 62.55 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.866 -0.606 . . . . 74.14 110.817 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -61.29 -35.94 78.71 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.896 0.479 . . . . 62.01 110.915 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -52.59 -46.62 67.0 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 124.473 1.108 . . . . 72.24 111.381 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.27 -28.22 69.56 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.011 0.524 . . . . 73.43 111.359 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -91.74 -1.18 57.5 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.889 0.876 . . . . 65.45 113.245 -174.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.23 45.63 2.61 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.925 0.869 . . . . 64.02 111.405 -174.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . 0.428 ' O ' ' HB2' ' D' ' 150' ' ' GLU . 9.9 pt20 -150.75 -177.96 6.29 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.306 -0.861 . . . . 74.43 109.91 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . 0.507 ' HA ' ' H ' ' D' ' 150' ' ' GLU . . . -72.14 -29.06 63.67 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.748 0.819 . . . . 74.03 111.395 176.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.8 -77.04 0.97 Allowed Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.544 -0.753 . . . . 74.2 112.275 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -130.58 -21.89 2.76 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.435 1.094 . . . . 73.44 110.573 -177.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -141.4 -80.12 0.06 OUTLIER Glycine 0 C--N 1.351 1.389 0 N-CA-C 112.271 -0.331 . . . . 72.11 112.271 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 10.2 t -161.21 120.63 2.57 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.007 0.923 . . . . 75.3 109.783 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . 0.507 ' H ' ' HA ' ' D' ' 145' ' ' ALA . 37.6 mt-10 -140.86 44.71 1.81 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.098 0.959 . . . . 74.2 109.219 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . 0.612 ' HG2' ' H ' ' D' ' 152' ' ' HIS . 20.5 tt0 -73.98 -171.53 1.13 Allowed 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 123.369 0.668 . . . . 75.25 110.398 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . 0.612 ' H ' ' HG2' ' D' ' 151' ' ' GLU . 73.3 m-70 74.75 85.54 0.1 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.027 1.331 . . . . 72.14 110.258 -171.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -71.29 -57.04 4.85 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 107.409 -1.33 . . . . 74.3 107.409 166.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 61.09 -77.97 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.852 1.661 . . . . 73.13 112.335 173.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.288 0 C-N-CA 124.767 1.227 . . . . 62.45 110.344 -178.525 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 CA-C-O 119.76 -0.467 . . . . 72.33 111.994 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.81 -52.06 4.64 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-N 117.102 0.451 . . . . 51.22 112.495 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 93' ' ' PHE . . . . . 0.605 ' HA ' ' HB2' ' D' ' 54' ' ' ASP . 3.7 m-85 -70.16 94.32 0.89 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.241 0.616 . . . . 64.12 109.46 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -168.8 154.35 6.38 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.845 0.458 . . . . 75.33 112.047 176.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 95' ' ' LYS . . . . . 0.436 ' HG2' ' HB3' ' D' ' 4' ' ' GLN . 40.2 mtmt 79.82 -47.56 0.35 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.196 1.798 . . . . 71.42 112.745 171.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.14 101.47 2.18 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.243 -0.743 . . . . 75.33 111.243 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 97' ' ' ILE . . . . . 0.479 ' HB ' ' HA ' ' D' ' 87' ' ' ALA . 4.1 tt -56.35 -44.41 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.392 1.077 . . . . 74.05 111.063 175.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 24.7 t70 65.42 166.14 0.18 Allowed 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 124.488 1.115 . . . . 64.41 112.957 175.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . 65.77 8.91 5.58 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.436 1.494 . . . . 73.3 113.072 177.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 100' ' ' LEU . . . . . . . . . . . . . 37.2 tp -114.77 92.03 28.15 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 124.773 1.229 . . . . 74.3 109.574 -174.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -96.23 3.76 1.99 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.527 2.818 . . . . 71.41 113.36 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 102' ' ' LEU . . . . . 0.522 ' HB2' ' HB3' ' D' ' 50' ' ' GLN . 4.1 mm? 59.96 24.73 13.87 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.476 1.11 . . . . 74.12 111.453 -172.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 43.3 p 58.6 -68.29 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.506 1.922 . . . . 61.01 111.725 -170.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.21 153.35 8.35 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 112.188 -0.365 . . . . 74.13 112.188 173.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.09 47.54 3.29 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.576 1.15 . . . . 74.14 109.586 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 40.6 t80 73.01 165.85 0.3 Allowed 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 124.975 1.31 . . . . 75.15 111.055 173.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 27.9 m -62.8 127.09 29.63 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.932 0.893 . . . . 71.21 111.566 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -116.54 13.84 15.41 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.041 0.936 . . . . 73.43 110.946 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -101.42 -156.69 0.57 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.171 0.988 . . . . 72.04 110.801 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.54 177.73 0.13 Allowed 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.011 0.924 . . . . 72.21 113.13 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . . . . . . . . . 7.6 mp 69.32 -78.79 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.976 1.31 . . . . 63.52 109.49 -169.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -82.11 97.83 8.37 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 109.417 -0.586 . . . . 64.43 109.417 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 113' ' ' LYS . . . . . 0.564 ' HA ' ' HE2' ' E' ' 113' ' ' LYS . 7.5 mmpt? -132.33 50.51 2.23 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.974 0.892 . . . . 74.4 109.686 175.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -64.48 -45.18 88.49 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 113.788 -1.551 . . . . 71.44 109.153 172.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 43.2 p -95.01 93.27 7.29 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.314 -0.995 . . . . 64.13 108.314 167.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 137.8 -179.65 17.99 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 114.84 -1.073 . . . . 75.0 110.793 -174.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -126.15 104.61 25.7 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 123.353 0.661 . . . . 75.05 109.478 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -88.5 172.57 4.82 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.545 2.163 . . . . 74.31 112.763 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -149.57 -176.0 5.23 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.409 1.084 . . . . 75.33 108.451 168.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 36.5 t80 68.22 126.9 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.889 1.276 . . . . 65.23 111.705 175.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 121' ' ' VAL . . . . . . . . . . . . . 79.8 t 62.78 83.08 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.299 1.04 . . . . 65.33 110.21 -173.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 67.7 p -67.66 -39.94 84.53 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.224 -0.898 . . . . 73.12 108.719 169.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 123' ' ' ASP . . . . . 0.411 ' HA ' ' HB3' ' D' ' 42' ' ' LEU . 3.8 p30 -157.67 164.1 37.53 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.126 -1.397 . . . . 71.12 109.882 174.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 74.3 m -138.35 106.63 5.78 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.904 0.882 . . . . 75.23 108.909 173.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -160.1 141.56 12.58 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.836 0.855 . . . . 64.55 109.48 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -158.7 103.66 1.74 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.648 0.779 . . . . 74.54 109.377 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 33.0 p -173.06 162.66 4.61 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.065 0.946 . . . . 71.23 110.437 -178.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -159.43 123.82 3.93 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.439 0.696 . . . . 74.12 110.182 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 50.3 m -151.33 144.0 24.35 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.808 0.843 . . . . 75.25 109.865 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -93.74 155.49 17.21 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.169 -0.678 . . . . 61.44 109.169 167.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 131' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -140.11 79.76 1.73 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.305 0.574 . . . . 74.52 111.04 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 35.9 t -156.22 147.21 22.15 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.615 1.166 . . . . 73.02 108.764 173.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 5.7 p -132.53 -44.13 0.91 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.401 0.68 . . . . 65.43 110.434 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.69 61.58 2.89 Favored Glycine 0 C--N 1.346 1.11 0 N-CA-C 110.902 -0.879 . . . . 55.41 110.902 -171.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 78.7 t -63.07 117.31 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.942 0.897 . . . . 74.4 110.456 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -166.94 79.04 0.21 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.713 0.805 . . . . 74.23 109.385 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 18.2 m -93.38 -38.66 11.35 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.7 -0.482 . . . . 74.33 109.7 174.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -132.01 107.62 8.79 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.494 0.717 . . . . 65.4 110.096 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 57.32 -165.09 0.16 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 124.885 1.274 . . . . 71.23 112.979 172.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 140' ' ' GLY . . . . . 0.675 ' HA3' ' HB2' ' C' ' 12' ' ' GLN . . . 100.9 150.38 24.19 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 116.368 -0.378 . . . . 72.22 113.432 171.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 141' ' ' ALA . . . . . 0.487 ' HB3' ' HB2' ' C' ' 85' ' ' SER . . . -84.78 154.47 22.36 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.837 0.855 . . . . 71.42 110.576 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 1.5 tt -70.27 130.61 42.46 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 106.964 -1.495 . . . . 73.03 106.964 172.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -73.88 73.26 1.25 Allowed Glycine 0 C--N 1.35 1.358 0 O-C-N 123.298 0.374 . . . . 73.01 112.684 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 18.2 m -100.8 128.01 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.323 1.049 . . . . 75.45 109.821 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 119.222 -0.418 . . . . 75.21 110.849 175.756 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.68 0 N-CA-C 112.69 -0.164 . . . . 37.93 112.69 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.07 -83.4 1.18 Allowed Glycine 0 C--N 1.348 1.231 0 N-CA-C 111.758 -0.537 . . . . 73.53 111.758 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -74.02 124.0 25.42 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.564 -0.532 . . . . 72.55 109.564 173.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -107.46 140.1 40.95 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.549 0.74 . . . . 74.43 109.309 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.41 157.3 16.51 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.01 0.524 . . . . 75.54 111.099 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.63 -59.3 0.03 OUTLIER Glycine 0 C--O 1.245 0.814 0 N-CA-C 110.739 -0.944 . . . . 74.34 110.739 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 97' ' ' ILE . . . . . 0.471 HG12 ' O ' ' B' ' 89' ' ' ILE . 19.6 mt -62.7 103.19 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 108.893 -0.78 . . . . 72.41 108.893 172.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -57.57 -48.68 78.69 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.613 0.765 . . . . 70.34 111.57 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -132.67 95.54 3.62 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.504 -0.771 . . . . 74.41 109.73 -175.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 100' ' ' LEU . . . . . . . . . . . . . 46.1 tp -103.06 104.79 42.3 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 123.727 0.811 . . . . 72.45 110.571 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 101' ' ' PRO . . . . . 0.401 ' HB2' ' H ' ' F' ' 103' ' ' THR . 43.1 Cg_endo -100.88 -177.29 0.15 Allowed 'Trans proline' 0 C--N 1.366 1.466 0 C-N-CA 123.011 2.474 . . . . 74.04 112.291 161.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 102' ' ' LEU . . . . . 0.493 HD21 ' HH ' ' B' ' 56' ' ' TYR . 28.1 tp -102.66 7.44 39.85 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.785 0.834 . . . . 75.02 108.827 165.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 103' ' ' THR . . . . . 0.401 ' H ' ' HB2' ' F' ' 101' ' ' PRO . 62.5 p 55.64 36.23 26.79 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 126.335 1.854 . . . . 73.11 111.772 -175.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 124.71 168.58 12.85 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 114.808 -1.087 . . . . 61.04 111.836 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -81.96 129.28 34.73 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.274 0.63 . . . . 73.34 109.351 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 41.4 t80 71.46 157.85 0.18 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.294 1.437 . . . . 72.2 111.343 -175.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 7.3 t -71.05 142.0 50.89 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.473 0.709 . . . . 73.24 110.969 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -70.55 -49.48 47.64 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.696 -0.483 . . . . 71.03 109.696 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -77.3 90.11 3.75 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.449 -0.796 . . . . 75.34 109.009 172.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.68 134.0 50.32 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.256 0.623 . . . . 74.43 110.343 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 mp -80.16 -153.47 0.09 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.814 0.845 . . . . 75.0 110.709 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -67.34 87.28 0.18 Allowed 'General case' 0 C--N 1.356 0.882 0 N-CA-C 109.355 -0.609 . . . . 75.51 109.355 174.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -158.96 87.01 0.84 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.127 0.971 . . . . 74.25 109.127 -176.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 63.8 mttm 57.45 -89.47 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.425 1.49 . . . . 74.42 112.772 172.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 23.5 m -93.92 134.91 35.81 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.131 0.972 . . . . 74.32 110.104 -173.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 136.99 -177.58 19.62 Favored Glycine 0 C--N 1.34 0.79 0 N-CA-C 111.289 -0.724 . . . . 73.31 111.289 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.06 82.81 9.05 Favored Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 109.163 -0.68 . . . . 70.32 109.163 171.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.78 88.21 0.79 Allowed 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.774 2.316 . . . . 74.22 110.144 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -62.0 -47.64 83.88 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.601 1.16 . . . . 72.44 112.57 -175.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 120' ' ' TYR . . . . . 0.453 ' HE2' ' HA ' ' B' ' 131' ' ' VAL . 76.8 t80 -87.39 -56.88 3.17 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.234 1.013 . . . . 74.45 110.842 -171.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 121' ' ' VAL . . . . . 0.479 HG21 HD12 ' B' ' 44' ' ' LEU . 40.6 t -94.43 91.17 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 109.013 -0.736 . . . . 73.31 109.013 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 15.3 t -154.67 -6.26 0.14 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.854 0.862 . . . . 75.11 110.602 175.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -111.64 141.3 45.42 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.751 0.82 . . . . 73.31 110.682 -171.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 26.0 p -82.86 105.23 13.69 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.838 0.855 . . . . 72.02 109.908 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.18 157.57 44.71 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.791 0.836 . . . . 64.23 110.624 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . 62.37 84.27 0.14 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.625 1.17 . . . . 71.41 111.975 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 46.8 m -138.21 128.56 26.11 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.807 0.843 . . . . 73.04 109.186 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.43 167.24 12.11 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.216 0.606 . . . . 72.23 110.29 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 41.2 p -75.21 -172.67 1.78 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.725 0.81 . . . . 73.33 112.097 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.07 162.03 12.27 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 123.943 0.897 . . . . 74.23 112.734 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 131' ' ' TRP . . . . . 0.579 ' HB3' ' HA ' ' B' ' 124' ' ' PRO . 8.2 p90 -94.28 8.87 40.28 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.654 -1.157 . . . . 75.32 111.018 -178.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 15.3 m -50.1 95.35 0.01 OUTLIER 'General case' 0 C--N 1.357 0.898 0 C-N-CA 124.99 1.316 . . . . 74.04 112.433 -169.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 43.2 m -76.59 119.81 20.93 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.557 -1.202 . . . . 73.23 110.493 -176.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.39 -21.99 70.86 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.913 -0.585 . . . . 73.32 113.472 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 55.6 t -66.2 97.38 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 N-CA-C 109.225 -0.657 . . . . 73.33 109.225 173.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -63.94 -53.55 48.48 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.961 0.904 . . . . 74.43 109.755 175.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 137' ' ' THR . . . . . 0.445 HG21 ' HB2' ' F' ' 141' ' ' ALA . 8.9 t -157.69 -171.7 3.66 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 114.656 -1.156 . . . . 65.52 109.035 -177.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -76.19 -167.1 0.7 Allowed 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 124.493 1.117 . . . . 75.33 110.258 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -61.13 110.02 1.26 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.67 0.788 . . . . 74.33 110.47 175.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . 119.33 157.77 10.45 Favored Glycine 0 N--CA 1.472 1.064 0 N-CA-C 111.152 -0.779 . . . . 75.22 111.152 -173.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 141' ' ' ALA . . . . . 0.445 ' HB2' HG21 ' F' ' 137' ' ' THR . . . 62.79 35.48 13.78 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.869 0.868 . . . . 71.54 111.754 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 64.7 tp -61.78 123.58 18.36 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.871 1.268 . . . . 75.52 111.289 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.7 153.92 22.35 Favored Glycine 0 N--CA 1.476 1.324 0 O-C-N 123.231 0.332 . . . . 61.44 113.015 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 6.9 p -164.05 -34.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 124.393 1.077 . . . . 73.25 110.232 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 C--O 1.253 1.261 0 C-N-CA 124.025 0.93 . . . . 71.44 108.71 177.615 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.5 ptm . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 110.026 -0.361 . . . . 72.44 110.026 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -65.34 149.48 49.91 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.063 0.545 . . . . 73.45 110.293 176.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -70.47 -34.83 72.85 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.003 0.921 . . . . 63.05 110.841 -171.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 59.34 35.69 23.25 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 124.43 1.081 . . . . 73.41 110.186 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -68.49 107.54 2.95 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 114.626 -1.17 . . . . 75.15 111.197 -170.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -71.89 127.9 34.04 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.646 -0.706 . . . . 75.11 109.988 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.8 m -101.41 127.01 48.25 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.426 0.69 . . . . 74.51 109.425 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -66.7 -75.22 0.1 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.367 0.667 . . . . 74.22 110.058 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.534 ' HG2' HD12 ' A' ' 89' ' ' ILE . 1.3 tmt? 62.77 142.57 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 125.229 1.412 . . . . 71.11 113.182 177.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.3 m -146.1 134.02 21.35 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.855 0.862 . . . . 74.22 109.261 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.534 ' HB2' ' HE3' ' A' ' 9' ' ' MET . 66.7 t80 -129.01 120.75 26.57 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.006 -1.109 . . . . 74.25 108.006 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -147.65 108.92 4.28 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.472 -0.566 . . . . 74.51 109.472 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.6 mt -72.84 123.55 27.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 109.117 -0.698 . . . . 73.42 109.117 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -88.25 -37.55 15.96 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.167 0.587 . . . . 72.53 110.73 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -167.41 141.46 3.66 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 116.269 -0.423 . . . . 74.41 109.903 -173.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.0 mt -130.16 134.85 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 108.277 -1.008 . . . . 74.32 108.277 173.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -163.09 178.17 8.51 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 124.296 0.998 . . . . 74.34 111.434 -170.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -108.55 122.03 46.22 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.949 -0.76 . . . . 71.23 108.949 175.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.461 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 37.2 mtpt -81.38 -25.93 35.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.176 0.59 . . . . 72.53 110.338 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -160.13 152.63 20.96 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.331 -0.849 . . . . 74.12 109.186 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.467 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 73.9 mt -144.14 150.82 16.49 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 C-N-CA 125.346 1.458 . . . . 72.2 107.725 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.438 ' N ' HG23 ' A' ' 21' ' ' ILE . 47.0 t -155.35 137.5 14.71 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.467 0.707 . . . . 75.33 109.842 173.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.495 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 86.5 t80 -143.67 122.07 12.38 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.402 -1.333 . . . . 74.34 107.402 174.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -124.76 114.72 19.64 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 109.227 -0.657 . . . . 74.2 109.227 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.05 80.75 0.44 Allowed Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 105.919 -1.882 . . . . 64.54 105.919 165.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.461 ' HG2' ' ND2' ' A' ' 27' ' ' ASN . 57.7 Cg_endo -68.99 -29.02 28.28 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.784 2.322 . . . . 53.31 112.59 -162.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.461 ' ND2' ' HG2' ' A' ' 26' ' ' PRO . 1.6 m-80 -115.86 30.13 7.54 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.864 0.865 . . . . 73.0 108.822 -175.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.454 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -44.8 -58.91 4.7 Favored Pre-proline 0 CA--C 1.569 1.673 0 N-CA-C 114.703 1.371 . . . . 73.4 114.703 -165.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.454 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 38.7 Cg_exo -60.34 -31.97 93.46 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 122.06 1.84 . . . . 71.35 113.087 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.5 ' HA ' ' NE2' ' A' ' 33' ' ' GLN . 6.8 t60 -81.74 -35.2 29.97 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.308 1.043 . . . . 74.55 112.385 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.571 HG22 ' HA ' ' A' ' 73' ' ' ALA . 6.0 p -79.87 -15.1 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 121.395 0.617 . . . . 75.22 111.718 -171.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -74.9 -12.19 60.3 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 116.089 -0.505 . . . . 73.22 111.482 168.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.5 ' NE2' ' HA ' ' A' ' 30' ' ' HIS . 9.3 mt-30 -83.37 -18.0 40.36 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 124.009 0.923 . . . . 70.51 110.584 171.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.55 ' HE2' ' HB3' ' A' ' 71' ' ' GLU . 26.3 mmmt -79.33 146.19 33.05 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.361 1.065 . . . . 65.14 111.451 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -61.67 128.14 34.84 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.134 0.974 . . . . 65.33 109.74 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.517 ' CE3' HD21 ' A' ' 68' ' ' LEU . 73.5 t-105 -82.21 88.83 6.48 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 121.121 0.486 . . . . 74.54 110.617 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 17.5 tm0? -129.33 84.96 60.62 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 106.205 -1.776 . . . . 74.24 106.205 167.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.07 125.23 10.72 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.475 2.117 . . . . 74.43 112.694 -173.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -97.0 92.95 6.32 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.757 -1.201 . . . . 62.31 107.757 169.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.73 HG23 ' HB1' ' A' ' 66' ' ' ALA . 88.2 t -94.82 107.63 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.345 0.658 . . . . 73.44 110.98 -175.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -88.13 129.52 35.29 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.361 -0.836 . . . . 73.45 109.415 175.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -95.88 119.33 34.18 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.897 -1.149 . . . . 64.31 107.897 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -130.18 141.6 50.64 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 108.795 -0.817 . . . . 70.11 108.795 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.601 HD13 HG23 ' A' ' 131' ' ' VAL . 56.6 mt -140.36 146.66 38.71 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.663 0.785 . . . . 74.42 110.0 -175.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -154.88 118.32 4.51 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.591 -0.892 . . . . 61.14 108.591 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.0 m -108.59 151.59 25.91 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.696 0.798 . . . . 74.34 110.453 -173.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.673 ' HB1' HH22 ' A' ' 61' ' ' ARG . . . -145.33 154.23 42.1 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.139 0.976 . . . . 73.44 109.886 172.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.408 ' HB3' HD12 ' A' ' 98' ' ' LEU . 4.1 m -112.87 154.68 25.95 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.991 -0.744 . . . . 71.5 108.991 172.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.0 t -149.61 117.57 6.31 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.125 -1.065 . . . . 74.03 108.125 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -79.96 105.14 11.02 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.154 -0.684 . . . . 75.23 109.154 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 57' ' ' GLU . 45.9 mt -78.96 -35.68 42.73 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.094 0.558 . . . . 74.34 109.616 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.57 175.28 14.1 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.104 0.962 . . . . 65.33 109.848 176.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -65.25 124.98 23.62 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.583 -0.895 . . . . 75.23 108.583 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 66.67 11.32 8.1 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.251 1.42 . . . . 74.45 112.728 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.03 107.06 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.401 -0.962 . . . . 75.41 108.401 173.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -119.69 126.11 50.32 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.864 0.866 . . . . 74.1 109.018 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.7 ' HB2' HD12 ' A' ' 51' ' ' LEU . 32.2 tt0 -86.32 146.15 26.61 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.162 -0.681 . . . . 74.4 109.162 167.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.8 t -128.19 133.89 66.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.045 -1.095 . . . . 74.33 108.045 171.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.4 t -115.28 132.53 64.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.256 -0.646 . . . . 74.35 109.256 176.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.04 108.67 18.97 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.639 -0.874 . . . . 75.54 108.639 172.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.673 HH22 ' HB1' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -80.53 99.92 8.31 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 106.489 -1.671 . . . . 74.23 106.489 164.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.441 HG21 ' HB1' ' A' ' 110' ' ' ALA . 43.2 t -96.46 122.01 47.55 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 107.583 -1.266 . . . . 74.22 107.583 172.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.4 m -118.47 137.87 52.88 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 123.91 0.756 . . . . 74.14 109.034 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 77.0 t -140.98 139.05 34.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 125.055 1.342 . . . . 73.32 107.435 -172.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 37.1 m -137.53 130.77 30.77 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 109.411 -0.588 . . . . 75.42 109.411 171.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.73 ' HB1' HG23 ' A' ' 40' ' ' VAL . . . -114.68 120.37 39.88 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.298 -1.371 . . . . 72.31 107.298 174.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -125.93 135.45 51.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.392 0.677 . . . . 74.52 110.607 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.517 HD21 ' CE3' ' A' ' 36' ' ' TRP . 27.4 mt -92.92 84.69 4.96 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.944 1.298 . . . . 64.24 108.8 177.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.41 -100.95 1.45 Allowed Glycine 0 C--N 1.342 0.877 0 CA-C-N 115.267 -0.878 . . . . 64.52 111.782 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.33 -19.62 13.41 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.871 0.868 . . . . 73.45 109.85 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.55 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 10.0 tp10 -94.02 124.69 38.19 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.637 1.175 . . . . 71.15 109.317 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -74.41 134.51 42.4 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.207 0.458 . . . . 75.4 110.963 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.571 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -78.3 -59.31 2.83 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.721 -0.844 . . . . 74.4 108.721 174.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -159.12 161.52 36.35 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.303 -0.862 . . . . 72.23 112.139 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.7 tp -111.71 148.35 33.64 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.992 1.717 . . . . 73.12 107.645 168.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.542 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 94.6 m -140.97 136.8 32.54 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.273 1.029 . . . . 75.24 109.154 177.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 28.1 tt0 -149.29 137.96 21.05 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.076 -0.713 . . . . 73.3 109.076 172.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.6 t -141.73 115.69 4.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 123.967 0.907 . . . . 74.23 108.91 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.517 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 79.1 mt-30 -83.63 84.43 7.54 Favored 'General case' 0 C--N 1.343 0.31 0 N-CA-C 108.705 -0.85 . . . . 72.42 108.705 170.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.418 ' HG3' HD23 ' A' ' 106' ' ' LEU . 8.5 tp-100 -77.88 92.0 4.22 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.514 -0.921 . . . . 75.44 108.514 177.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.03 144.94 17.49 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 110.746 -0.942 . . . . 71.35 110.746 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.17 134.35 5.33 Favored Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 111.081 -0.808 . . . . 75.04 111.081 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.9 mt -82.07 124.77 39.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 108.416 -0.957 . . . . 75.33 108.416 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.572 ' HB3' HD11 ' A' ' 86' ' ' ILE . 92.4 m-85 -129.79 121.57 27.09 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.736 0.814 . . . . 74.34 109.029 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.4 t -86.36 103.44 14.93 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.436 -0.95 . . . . 72.22 108.436 174.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.572 HD11 ' HB3' ' A' ' 84' ' ' PHE . 3.5 mm -118.56 149.67 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 109.689 -0.486 . . . . 63.51 109.689 -177.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.53 168.14 25.67 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.061 0.544 . . . . 74.14 110.735 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 95.23 -32.35 6.27 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 116.044 -0.526 . . . . 75.21 113.061 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.534 HD12 ' HG2' ' A' ' 9' ' ' MET . 0.2 OUTLIER -122.21 141.12 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.622 0.769 . . . . 70.3 111.343 -173.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.629 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 21.7 mt-10 -142.37 173.54 11.44 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.54 1.136 . . . . 74.43 110.135 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.5 -125.33 28.68 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-O 119.771 -0.461 . . . . 64.24 112.614 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 77.3 p -76.83 -27.93 55.33 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.342 0.571 . . . . 70.12 110.616 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.548 ' HA ' ' HB ' ' C' ' 149' ' ' THR . 0.8 OUTLIER -58.98 -41.98 88.86 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.588 0.755 . . . . 74.3 109.25 175.379 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.629 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 3.0 tpt -69.98 -42.27 73.33 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 114.662 -1.153 . . . . 75.33 110.986 175.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.42 -25.21 67.06 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.09 0.956 . . . . 74.52 111.901 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -70.67 -49.36 48.11 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.806 0.442 . . . . 63.41 110.364 172.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.44 -37.46 85.93 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 123.177 0.298 . . . . 70.53 110.755 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.408 HD12 ' HB3' ' A' ' 48' ' ' SER . 52.7 mt -91.26 -30.89 16.36 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.032 0.533 . . . . 73.44 112.438 -175.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.95 4.08 33.91 Favored Glycine 0 N--CA 1.476 1.333 0 CA-C-O 119.94 -0.366 . . . . 73.02 113.752 -172.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -142.85 -61.92 0.43 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 117.006 0.403 . . . . 74.3 111.192 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -73.63 -46.28 47.79 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 112.17 0.433 . . . . 75.42 112.17 -172.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 47.5 m -64.8 -47.91 73.88 Favored Pre-proline 0 N--CA 1.49 1.539 0 CA-C-O 118.303 -0.856 . . . . 75.21 112.465 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.17 -21.11 67.74 Favored 'Trans proline' 0 C--N 1.39 2.72 0 C-N-CA 121.805 1.67 . . . . 62.33 112.786 173.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -75.41 -33.0 60.93 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.866 0.466 . . . . 74.12 109.856 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 48.4 mm -69.93 -41.49 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.381 0.672 . . . . 74.24 109.753 171.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.418 HD23 ' HG3' ' A' ' 80' ' ' GLN . 66.1 mt -72.04 -30.51 65.24 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.654 0.781 . . . . 73.04 111.807 -175.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -61.01 -40.51 74.77 Favored Pre-proline 0 N--CA 1.488 1.431 0 N-CA-C 114.401 1.259 . . . . 74.52 114.401 -171.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -51.57 -42.99 53.26 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.071 1.847 . . . . 75.13 113.462 168.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.472 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 68.4 m-85 -75.83 -35.7 59.89 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.269 0.628 . . . . 65.45 111.045 -177.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.441 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -65.81 -48.38 71.9 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.734 0.813 . . . . 73.33 109.52 176.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.522 ' NH1' HD13 ' C' ' 105' ' ' ILE . 27.8 ttm105 -51.46 -52.15 48.86 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 125.05 1.469 . . . . 75.41 110.289 174.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -62.6 -45.98 90.41 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.61 1.194 . . . . 64.24 111.78 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.53 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.3 t -60.88 -36.98 80.61 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 123.872 0.733 . . . . 74.1 110.759 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.611 HD13 HD12 ' A' ' 128' ' ' LEU . 95.6 mt -67.94 -47.2 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.127 0.971 . . . . 75.52 110.439 174.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.4 HG22 ' HE2' ' C' ' 109' ' ' TYR . 35.7 m -59.37 -39.29 82.81 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.621 1.168 . . . . 75.45 111.27 -177.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -68.68 -44.12 74.7 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.364 -1.289 . . . . 65.23 110.224 -176.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.608 ' HE3' ' HA ' ' A' ' 114' ' ' ILE . 25.6 mtm -60.48 -39.43 87.61 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.987 0.515 . . . . 64.53 110.831 177.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 114' ' ' ILE . 71.6 t -63.19 -47.85 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.296 1.038 . . . . 74.32 111.424 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.8 p -71.52 -33.36 69.13 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 116.147 -0.478 . . . . 74.33 111.178 -176.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.462 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 90.0 mtt-85 -67.96 -33.28 74.35 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.739 0.816 . . . . 74.14 109.742 173.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.411 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.14 15.12 40.67 Favored Glycine 0 C--N 1.352 1.417 0 CA-C-N 115.437 -0.801 . . . . 54.42 113.37 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.6 t 62.0 9.47 3.07 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 127.281 2.232 . . . . 71.15 114.016 173.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -81.33 138.79 48.32 Favored Pre-proline 0 C--O 1.244 0.793 0 N-CA-C 107.672 -1.232 . . . . 75.43 107.672 172.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.474 ' HB3' ' H ' ' E' ' 132' ' ' SER . 54.1 Cg_exo -53.98 142.53 64.57 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.75 2.3 . . . . 75.31 112.154 176.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -49.41 130.72 20.25 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.539 1.136 . . . . 74.34 113.779 -164.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.609 HD13 HG12 ' A' ' 40' ' ' VAL . 36.6 tp -109.27 108.62 19.28 Favored 'General case' 0 C--N 1.345 0.384 0 C-N-CA 123.169 0.588 . . . . 73.13 110.441 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.59 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 88.8 m-20 -103.26 125.76 50.08 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 107.699 -1.223 . . . . 74.03 107.699 175.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.611 HD12 HD13 ' A' ' 114' ' ' ILE . 17.8 mt -72.85 144.59 47.4 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 117.735 0.243 . . . . 71.33 110.809 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' E' ' 138' ' ' TYR . . . -70.74 133.49 86.48 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.105 0.562 . . . . 64.14 110.089 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.519 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 32.3 Cg_exo -59.97 114.4 2.07 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.576 2.85 . . . . 73.24 113.604 -173.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.601 HG23 HD13 ' A' ' 44' ' ' LEU . 45.6 t -100.23 135.64 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.372 0.669 . . . . 75.05 110.017 -177.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -101.84 89.93 3.83 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.207 -1.034 . . . . 75.44 108.207 175.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.489 ' CE1' HD11 ' A' ' 44' ' ' LEU . 44.5 m-85 -63.82 -30.79 71.84 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.814 0.846 . . . . 72.31 111.568 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.525 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 6.4 m-20 -66.08 -33.35 75.58 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.347 -0.842 . . . . 63.03 110.476 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.76 -42.25 64.23 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.155 0.582 . . . . 70.11 110.491 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.12 -49.07 79.26 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.521 0.677 . . . . 73.05 110.59 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -64.93 -36.62 84.97 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.142 -1.39 . . . . 71.15 110.071 177.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.513 ' HB2' ' O ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -69.02 -34.81 75.84 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 119.011 -0.518 . . . . 71.1 110.39 -176.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -54.74 -40.17 69.02 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.095 0.474 . . . . 72.5 110.791 176.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -68.12 -48.77 64.53 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.955 -1.02 . . . . 70.41 110.496 172.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.463 ' HB3' ' HA ' ' A' ' 138' ' ' MET . 51.8 tp -61.94 -56.07 22.97 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.894 0.878 . . . . 73.52 112.675 -168.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.423 ' HB2' ' HE1' ' A' ' 138' ' ' MET . 87.0 mt-30 -168.78 -17.25 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.614 0 C-N-CA 124.875 1.27 . . . . 75.25 110.748 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.459 ' N ' ' SD ' ' A' ' 138' ' ' MET . 33.1 tt0 72.06 -5.86 1.64 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 126.761 2.024 . . . . 75.42 112.795 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -149.98 110.56 4.25 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.052 0.541 . . . . 73.12 110.699 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -179.64 150.82 0.42 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.75 1.62 . . . . 74.4 108.181 171.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.492 ' HA2' ' H ' ' C' ' 3' ' ' GLU . . . 162.58 52.24 0.02 OUTLIER Glycine 0 C--N 1.347 1.156 0 C-N-CA 120.783 -0.722 . . . . 74.51 114.119 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.12 133.22 29.55 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.002 0.521 . . . . 64.13 109.847 176.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 135.3 30.14 0.36 Allowed Glycine 0 C--N 1.345 1.039 0 CA-C-N 115.479 -0.782 . . . . 72.5 111.427 -173.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.603 ' HA ' ' HB2' ' C' ' 145' ' ' ALA . 59.4 p -80.95 105.88 12.52 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.248 0.619 . . . . 72.24 109.906 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -153.61 135.76 14.8 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.64 0.776 . . . . 61.14 109.709 176.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -103.4 152.85 21.13 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.888 -0.782 . . . . 75.34 108.888 167.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.83 7.99 1.1 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.478 1.111 . . . . 74.54 110.301 176.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -175.29 129.08 0.28 Allowed 'General case' 0 C--N 1.356 0.876 0 C-N-CA 124.397 1.079 . . . . 74.35 108.528 177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -84.73 7.08 21.76 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.127 0.571 . . . . 62.11 111.9 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.154 0 C-N-CA 125.592 1.557 . . . . 74.32 110.662 -175.887 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 110.184 -0.302 . . . . 73.55 110.184 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 33.6 m -64.33 -25.35 68.0 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.027 0.931 . . . . 72.11 112.379 -174.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.476 ' HG2' ' HB2' ' B' ' 5' ' ' ASN . 38.9 tt0 -76.51 111.5 12.05 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.939 -0.763 . . . . 74.12 108.939 174.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -70.69 -56.08 7.25 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.448 0.699 . . . . 71.11 109.257 176.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . 0.476 ' HB2' ' HG2' ' B' ' 3' ' ' GLU . 37.4 t30 60.29 20.2 9.68 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 125.518 1.527 . . . . 75.01 112.537 176.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -72.71 104.49 3.96 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.652 0.781 . . . . 74.23 110.417 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 32.1 p -75.84 136.16 40.2 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.591 -0.731 . . . . 74.44 111.146 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -115.15 107.59 15.51 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.777 -1.194 . . . . 74.13 107.777 173.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.533 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 19.6 ptm 50.47 -167.45 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.949 1.699 . . . . 71.34 111.976 -172.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 5.5 t -153.09 138.99 18.06 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 109.147 -0.686 . . . . 73.43 109.147 166.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.451 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 68.9 t80 -134.28 137.74 44.5 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.13 0.972 . . . . 75.32 108.418 176.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -144.51 141.28 29.41 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.991 0.516 . . . . 55.32 109.938 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 66.9 mt -88.86 110.01 20.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 107.699 -1.223 . . . . 74.5 107.699 171.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -81.8 -39.1 24.57 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 123.282 0.364 . . . . 73.14 110.322 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -169.3 134.71 1.55 Allowed 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.304 0.377 . . . . 74.41 110.384 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.0 mt -114.97 142.58 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 107.247 -1.39 . . . . 71.34 107.247 171.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.425 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 40.1 p90 -169.81 162.67 9.59 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-O 122.045 0.926 . . . . 74.24 113.127 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 56.7 m -90.04 121.18 31.88 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 113.414 -1.721 . . . . 74.11 108.585 171.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.425 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 22.7 mtpp -87.29 -32.43 19.69 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.724 0.81 . . . . 74.51 110.52 178.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -158.52 143.49 16.25 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.022 -0.536 . . . . 74.44 110.89 -170.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.495 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 45.9 mm -136.3 142.88 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.466 1.506 . . . . 75.11 109.093 176.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 24.1 t -145.56 134.66 22.73 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.521 -1.218 . . . . 74.31 107.907 168.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.467 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 91.2 t80 -138.71 128.08 24.41 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.421 -1.696 . . . . 74.31 106.421 169.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -135.47 112.02 9.96 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.913 -1.143 . . . . 74.13 107.913 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.83 87.34 4.42 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 107.144 -1.428 . . . . 73.44 107.144 171.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.86 -42.01 21.48 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.654 2.236 . . . . 70.33 111.298 -174.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -97.39 5.77 49.28 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.726 -1.125 . . . . 74.43 111.65 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -29.81 -67.78 0.13 Allowed Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 115.428 1.64 . . . . 73.32 115.428 -166.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.461 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 21.3 Cg_endo -60.43 -28.49 86.84 Favored 'Trans proline' 0 C--N 1.397 3.106 0 C-N-CA 122.605 2.203 . . . . 61.42 113.03 -171.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -95.86 -39.76 9.66 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.981 -1.009 . . . . 70.32 111.996 -171.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.483 HG22 HD11 ' B' ' 68' ' ' LEU . 10.5 p -69.47 -11.76 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.22 0.608 . . . . 73.1 111.419 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -63.39 -13.18 36.95 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.269 0.628 . . . . 75.43 112.65 172.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -68.84 -13.07 62.18 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 123.874 0.87 . . . . 73.42 112.077 175.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.453 ' HB2' HD13 ' B' ' 68' ' ' LEU . 32.8 mmtp -97.41 92.71 6.09 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.494 1.118 . . . . 74.13 109.813 -174.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -92.81 80.44 4.68 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.364 0.665 . . . . 74.53 110.914 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 37.3 p90 -165.07 177.53 7.68 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.056 0.942 . . . . 73.41 110.123 170.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.57 ' HG3' ' HB2' ' F' ' 128' ' ' ALA . 42.7 tt0 -69.12 116.65 44.17 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 123.677 0.791 . . . . 74.42 109.667 173.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.429 ' HD3' ' HG2' ' B' ' 124' ' ' PRO . 34.2 Cg_endo -68.28 148.77 74.91 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 121.704 1.602 . . . . 72.31 110.727 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -71.19 104.07 2.98 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.776 -1.194 . . . . 74.35 107.776 172.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.722 HG21 ' HB1' ' B' ' 66' ' ' ALA . 32.9 t -98.09 141.51 16.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 114.705 -1.134 . . . . 71.22 109.568 -177.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -118.75 114.53 22.84 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.405 -1.702 . . . . 73.05 106.405 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.529 HD12 HD21 ' B' ' 128' ' ' LEU . 17.8 tp -89.15 132.21 34.93 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.238 -0.652 . . . . 73.32 109.238 174.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -129.41 148.2 51.3 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.871 1.268 . . . . 70.32 108.398 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.486 HD12 HD22 ' F' ' 111' ' ' LEU . 0.6 OUTLIER -142.77 151.53 41.32 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.643 0.777 . . . . 75.42 110.469 -178.43 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 19.8 t70 -148.11 139.37 23.45 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.654 1.182 . . . . 64.14 108.252 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.5 m -113.5 115.37 27.89 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.732 -0.84 . . . . 75.24 108.732 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.62 134.31 55.16 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.632 -0.877 . . . . 64.11 108.632 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.651 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 16.4 m -142.76 160.24 40.71 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.849 -0.426 . . . . 65.42 109.849 -175.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 29.5 p -166.63 136.9 3.21 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.678 0.791 . . . . 75.14 110.379 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -85.96 79.64 9.14 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 108.242 -1.021 . . . . 72.33 108.242 172.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.429 HD21 ' HB3' ' B' ' 57' ' ' GLU . 2.7 pp -93.1 6.57 47.49 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.506 -0.77 . . . . 73.31 111.02 -177.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.65 154.61 18.48 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.77 1.228 . . . . 74.3 108.773 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -75.75 129.19 36.68 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.646 0.378 . . . . 74.02 110.726 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 70.62 -3.12 2.01 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.957 1.303 . . . . 73.5 113.55 173.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 30.7 m -134.65 122.9 40.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.013 -1.106 . . . . 73.14 108.013 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.651 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 0.1 OUTLIER -99.34 156.76 16.83 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.654 0.782 . . . . 71.23 109.424 -177.087 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.429 ' HB3' HD21 ' B' ' 51' ' ' LEU . 4.5 tm-20 -121.41 97.43 5.51 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 105.728 -1.953 . . . . 75.24 105.728 166.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.522 HG22 ' HG ' ' B' ' 48' ' ' SER . 12.5 p -100.56 141.76 16.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.768 -0.827 . . . . 75.1 108.768 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.43 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 18.4 t -115.57 148.25 18.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 124.944 1.298 . . . . 73.15 108.645 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 60.1 tp -128.36 107.06 9.44 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.477 -0.935 . . . . 75.53 108.477 171.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.465 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 31.3 ttm180 -86.64 132.72 33.81 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.151 -1.055 . . . . 73.53 108.151 172.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 38.9 t -129.46 124.65 60.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 107.243 -1.391 . . . . 75.43 107.243 175.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 6.3 m -120.78 131.06 54.28 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.378 -0.601 . . . . 74.03 109.378 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.472 HG13 HD23 ' B' ' 126' ' ' LEU . 89.6 t -119.41 108.41 23.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 123.905 0.882 . . . . 65.32 109.335 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 93.9 m -90.21 138.4 31.56 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.346 -0.983 . . . . 71.53 108.346 167.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.722 ' HB1' HG21 ' B' ' 40' ' ' VAL . . . -148.25 142.47 26.13 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.234 -0.654 . . . . 75.54 109.234 175.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 17.0 p -144.28 134.69 24.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.367 -0.833 . . . . 55.33 109.973 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.483 HD11 HG22 ' B' ' 31' ' ' VAL . 62.9 mt -101.19 113.89 27.35 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.577 1.151 . . . . 73.15 110.072 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.18 -112.02 3.62 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-N 115.686 -0.688 . . . . 65.45 111.548 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.58 27.62 6.85 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.396 0.679 . . . . 63.3 109.795 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -141.23 153.27 45.17 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.192 -0.67 . . . . 73.52 109.192 176.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 56.8 m -68.17 135.2 51.71 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.225 0.536 . . . . 74.44 110.855 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.453 ' HA ' HG23 ' B' ' 31' ' ' VAL . . . -88.26 -66.01 0.96 Allowed 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.41 -1.33 . . . . 75.14 107.41 174.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -150.27 159.29 44.55 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 114.881 -1.054 . . . . 75.3 110.267 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 78.4 mt -134.07 108.53 8.39 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.396 -1.705 . . . . 74.01 106.396 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.1 t -119.82 151.53 38.7 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.104 -0.702 . . . . 71.04 109.104 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -159.23 134.39 8.29 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.511 -0.922 . . . . 73.32 108.511 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.433 HG21 HD12 ' B' ' 21' ' ' ILE . 85.4 t -128.99 143.92 39.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.997 -1.112 . . . . 74.13 107.997 175.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -122.94 96.18 4.91 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.382 -0.97 . . . . 64.12 108.382 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -91.12 102.38 15.13 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.284 -0.636 . . . . 75.23 109.284 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -94.9 165.84 25.81 Favored Glycine 0 C--N 1.339 0.749 0 O-C-N 123.58 0.55 . . . . 41.44 112.138 177.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.9 134.6 3.27 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-O 119.772 -0.46 . . . . 71.41 113.314 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.409 HD12 ' HE1' ' B' ' 17' ' ' TYR . 3.9 mp -86.12 117.82 31.47 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 107.226 -1.398 . . . . 74.24 107.226 170.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -121.84 135.94 54.92 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.592 0.757 . . . . 73.53 109.112 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 56.1 m -89.34 126.26 35.46 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.785 0.834 . . . . 72.22 109.254 173.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.557 ' HB ' HD12 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -133.65 130.3 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.079 0.951 . . . . 72.41 108.468 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.667 ' HA ' ' HB ' ' F' ' 97' ' ' ILE . . . -157.67 171.98 19.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.505 0.722 . . . . 63.23 110.645 177.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 87.18 -50.13 4.07 Favored Glycine 0 C--N 1.352 1.437 0 C-N-CA 123.608 0.623 . . . . 72.22 111.949 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.557 HD12 ' HB ' ' B' ' 86' ' ' ILE . 11.3 pt -59.08 148.08 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.981 1.313 . . . . 70.21 111.81 171.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -153.19 163.31 40.11 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.837 0.855 . . . . 71.33 109.595 -176.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.35 -121.73 6.22 Favored Glycine 0 C--N 1.351 1.371 0 C-N-CA 123.358 0.504 . . . . 53.43 112.847 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 18.8 m -73.58 -39.71 64.44 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.883 0.849 . . . . 74.2 109.909 174.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -66.68 -27.11 67.39 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 113.623 -1.626 . . . . 72.12 111.96 -167.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.641 ' HB2' HD11 ' F' ' 97' ' ' ILE . 9.6 ptm -65.95 -57.71 7.22 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.675 -0.693 . . . . 74.21 111.661 -175.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.23 -14.51 57.42 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.352 0.661 . . . . 64.21 111.89 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -61.12 -40.28 93.18 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.735 0.814 . . . . 71.31 110.906 169.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.1 t -66.36 -54.27 26.47 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.705 0.402 . . . . 75.42 111.29 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.48 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.2 pp -68.34 -25.38 65.07 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.855 0.462 . . . . 72.44 112.167 -176.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.89 2.88 58.5 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-O 119.649 -0.528 . . . . 65.34 114.2 -175.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.568 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -148.73 -55.06 0.19 Allowed 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 117.56 0.68 . . . . 65.45 112.136 -174.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -70.56 -43.34 69.7 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.426 0.69 . . . . 74.34 111.146 -176.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.48 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 56.5 m -72.86 -43.27 8.12 Favored Pre-proline 0 CA--C 1.566 1.586 0 CA-C-O 118.621 -0.704 . . . . 72.21 112.784 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.0 -30.52 93.62 Favored 'Trans proline' 0 C--N 1.396 3.058 0 C-N-CA 122.229 1.953 . . . . 73.4 113.906 170.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.15 -37.66 77.85 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.567 0.747 . . . . 72.23 111.503 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 54.9 mt -65.11 -39.08 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.882 0.873 . . . . 74.4 110.782 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.19 -23.06 54.64 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.152 -0.931 . . . . 74.13 112.215 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -60.66 -47.17 96.73 Favored Pre-proline 0 CA--C 1.567 1.606 0 N-CA-C 114.281 1.215 . . . . 75.54 114.281 -174.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -53.86 -41.74 72.25 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 122.517 2.145 . . . . 72.03 114.106 175.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -68.98 -42.17 76.91 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.4 0.68 . . . . 74.12 110.754 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.413 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -63.3 -41.05 98.92 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.321 -0.854 . . . . 71.52 110.774 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -61.35 -49.69 75.95 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.469 1.108 . . . . 74.23 110.763 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -67.3 -32.67 73.81 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.149 0.58 . . . . 72.12 110.19 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.511 ' O ' ' HG2' ' B' ' 117' ' ' MET . 9.1 t -71.11 -38.49 72.34 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 122.879 0.472 . . . . 75.31 111.082 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.426 HD12 HG23 ' B' ' 64' ' ' VAL . 81.8 mt -62.25 -56.77 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 123.684 0.794 . . . . 75.24 109.712 173.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 19.7 m -63.08 -24.74 68.04 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.763 0.825 . . . . 72.12 111.371 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.9 t -63.62 -52.45 60.79 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 109.265 -0.642 . . . . 74.33 109.265 171.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.511 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.9 mmt -66.67 -32.49 73.84 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.42 0.688 . . . . 75.31 111.357 -176.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.3 t -69.78 -40.28 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.073 0.949 . . . . 71.35 110.672 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 40.4 t -67.26 -32.07 72.84 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.304 -0.862 . . . . 72.41 110.367 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.53 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 77.8 mtt-85 -68.66 -34.6 75.99 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 115.478 -0.783 . . . . 72.52 109.851 176.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.01 -17.95 80.23 Favored Glycine 0 C--N 1.351 1.39 0 O-C-N 123.544 0.528 . . . . 52.23 112.483 170.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 18.0 m 66.93 31.23 7.23 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 123.153 1.454 . . . . 74.11 110.193 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.428 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 41.5 m-85 -78.02 167.26 37.25 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-N 114.099 -1.41 . . . . 75.42 111.168 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.608 ' HB3' ' HA ' ' F' ' 130' ' ' ALA . 50.4 Cg_exo -45.23 145.12 3.74 Favored 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 123.366 2.711 . . . . 72.12 114.566 170.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -60.09 118.38 6.24 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.083 0.953 . . . . 74.3 111.301 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.472 HD23 HG13 ' B' ' 64' ' ' VAL . 12.0 tp -110.03 119.46 39.38 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.358 1.063 . . . . 71.53 108.727 -175.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -125.0 127.85 47.64 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.265 -1.013 . . . . 61.52 108.265 174.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.529 HD21 HD12 ' B' ' 42' ' ' LEU . 43.6 mt -86.55 143.29 27.76 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.022 0.529 . . . . 75.14 110.639 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.67 132.51 94.09 Favored Pre-proline 0 CA--C 1.548 0.889 0 O-C-N 124.085 0.866 . . . . 54.1 111.014 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.26 89.34 0.32 Allowed 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.085 2.524 . . . . 71.24 111.595 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.55 113.55 26.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 CA-C-O 121.535 0.683 . . . . 72.12 109.501 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -82.44 107.85 15.41 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.665 -1.235 . . . . 75.14 107.665 171.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -67.74 -24.89 65.41 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.508 0.723 . . . . 74.13 110.294 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.568 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 25.6 t70 -62.28 -41.95 98.93 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.999 -1.001 . . . . 74.12 110.737 171.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.43 -25.68 68.12 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.911 0.757 . . . . 65.05 111.803 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.84 -55.43 29.95 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.761 -0.829 . . . . 75.3 108.761 176.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -74.82 -26.27 59.59 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.715 0.806 . . . . 63.5 111.493 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 15.7 tpt -75.55 -36.34 60.47 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.188 0.595 . . . . 74.42 110.247 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.506 ' HA ' ' HB2' ' B' ' 142' ' ' GLN . 14.6 m120 -80.77 -29.59 36.16 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.943 0.497 . . . . 73.25 110.234 175.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -73.15 -25.98 61.02 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.857 0.463 . . . . 73.23 110.914 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 18.2 tp -118.61 28.91 8.04 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-O 121.576 0.703 . . . . 73.31 109.771 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . 0.506 ' HB2' ' HA ' ' B' ' 139' ' ' ASN . 47.0 tt0 -72.18 -12.94 61.4 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.719 0.807 . . . . 71.01 111.789 -177.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -54.71 -29.2 52.55 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.919 0.887 . . . . 74.41 110.835 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -95.02 106.26 18.24 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.78 -0.822 . . . . 74.13 108.78 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -152.07 159.01 43.78 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.493 1.117 . . . . 64.24 108.756 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -162.33 6.44 0.08 OUTLIER Glycine 0 N--CA 1.471 1.029 0 CA-C-O 119.851 -0.416 . . . . 75.02 114.099 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -112.86 91.4 3.64 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.386 0.675 . . . . 73.01 109.66 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -90.47 179.77 43.48 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 115.292 -0.867 . . . . 73.14 111.054 173.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 22.1 p -136.55 126.14 25.32 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.29 0.636 . . . . 73.43 110.505 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -92.64 156.4 17.11 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.316 1.046 . . . . 72.01 109.378 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . 0.644 ' HB2' ' HB2' ' D' ' 6' ' ' ASN . 40.8 tt0 -115.7 126.65 54.37 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.059 -0.719 . . . . 75.01 109.059 172.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -147.08 54.57 1.09 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 105.803 -1.925 . . . . 63.21 105.803 172.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -70.55 115.5 9.79 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-N 115.325 -0.852 . . . . 64.12 110.516 -172.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -67.21 -32.92 74.31 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.631 -1.168 . . . . 71.52 109.968 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.225 0 C-N-CA 124.692 1.197 . . . . 62.43 107.88 171.797 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.9 ttm . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 109.277 -0.638 . . . . 51.25 109.277 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 16.5 p -91.95 88.61 6.66 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 108.906 -0.776 . . . . 73.45 108.906 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . 0.492 ' H ' ' HA2' ' A' ' 146' ' ' GLY . 32.6 mm-40 -103.62 163.25 12.43 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.866 0.466 . . . . 75.21 111.162 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -108.18 126.72 53.12 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.563 -0.903 . . . . 64.52 108.563 167.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -144.59 143.32 30.74 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.563 0.745 . . . . 74.43 109.696 -172.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -98.8 132.92 43.79 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 109.007 -0.738 . . . . 74.33 109.007 174.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 20.3 p -77.45 -54.19 6.73 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.486 1.114 . . . . 73.21 110.78 -176.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.53 -74.69 0.17 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.533 0.733 . . . . 71.42 109.985 171.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.532 ' HE3' HG21 ' C' ' 89' ' ' ILE . 56.8 ttm 50.43 113.6 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.255 1.822 . . . . 74.12 112.917 -174.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.509 ' HB ' ' HB2' ' C' ' 87' ' ' ALA . 86.3 m -83.94 76.4 10.04 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.009 -1.108 . . . . 73.53 108.009 173.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.519 ' HD2' ' HG2' ' A' ' 130' ' ' PRO . 28.9 t80 -102.85 119.63 39.18 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.335 -1.357 . . . . 75.01 107.335 176.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -137.97 133.35 33.58 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.206 -1.035 . . . . 72.15 108.206 172.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.477 HD12 HG21 ' C' ' 105' ' ' ILE . 17.3 mt -77.82 126.86 38.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 108.739 -0.838 . . . . 75.03 108.739 174.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.416 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 27.5 mm-40 -82.05 -53.36 6.17 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.259 -1.015 . . . . 74.42 108.259 173.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.59 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -172.96 146.84 1.57 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.648 0.779 . . . . 74.12 110.471 178.323 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.5 mt -116.68 132.84 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.202 1.401 . . . . 74.41 107.586 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.459 ' HB3' HG22 ' D' ' 122' ' ' THR . 39.5 p90 -161.62 156.52 23.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.372 0.606 . . . . 73.52 112.105 -164.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 42.4 p -88.18 107.65 18.89 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.511 -0.768 . . . . 71.32 109.572 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.41 ' HG2' ' CE1' ' C' ' 17' ' ' TYR . 20.6 mtmt -74.32 -29.26 61.53 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.495 -0.557 . . . . 74.42 109.495 172.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.601 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 30.7 t70 -150.21 140.91 22.65 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.309 -0.86 . . . . 63.23 110.16 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 93.7 mt -137.37 144.81 30.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 125.562 1.545 . . . . 65.01 106.943 173.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -150.26 145.51 26.24 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 123.595 0.559 . . . . 75.03 109.624 173.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -151.52 116.77 5.3 Favored 'General case' 0 C--O 1.225 -0.21 0 N-CA-C 107.987 -1.116 . . . . 75.54 107.987 171.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -121.64 121.47 37.45 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.077 0.951 . . . . 75.15 108.547 176.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.17 87.6 6.22 Favored Pre-proline 0 C--O 1.239 0.525 0 N-CA-C 106.275 -1.75 . . . . 75.04 106.275 169.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.06 -21.65 36.46 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.631 2.221 . . . . 72.23 111.828 -168.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -125.65 31.18 5.57 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.201 1.0 . . . . 74.2 109.742 -177.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.24 -61.0 2.02 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 114.644 1.35 . . . . 54.12 114.644 -169.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.11 -34.73 45.29 Favored 'Trans proline' 0 C--N 1.382 2.337 0 CA-C-N 121.848 1.696 . . . . 73.41 112.268 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -69.0 -36.7 78.12 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.773 -1.103 . . . . 75.11 111.837 -176.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.44 ' HA ' ' NZ ' ' C' ' 34' ' ' LYS . 14.5 p -80.71 -28.67 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 112.863 0.69 . . . . 75.15 112.863 -176.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -63.71 -31.42 72.59 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.718 0.407 . . . . 74.15 111.984 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -88.12 12.48 13.52 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.419 1.088 . . . . 62.04 111.803 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.768 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 10.2 ttpp -126.73 160.39 30.96 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.046 0.938 . . . . 75.01 111.434 -174.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -51.25 122.66 8.09 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.539 1.536 . . . . 74.2 112.435 178.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -86.13 82.56 8.02 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.622 0.725 . . . . 72.33 109.523 170.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -135.79 76.6 53.15 Favored Pre-proline 0 N--CA 1.472 0.662 0 N-CA-C 107.528 -1.286 . . . . 71.3 107.528 169.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -83.88 152.43 12.92 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.641 2.227 . . . . 64.41 111.703 -175.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -86.41 113.32 22.27 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.419 -1.326 . . . . 75.2 107.419 171.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.536 HG11 HG11 ' F' ' 135' ' ' VAL . 39.4 t -74.36 96.69 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.615 -0.883 . . . . 72.41 108.615 -177.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.466 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 14.2 mptt -101.04 101.47 12.24 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 106.33 -1.73 . . . . 74.52 106.33 168.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pp -105.64 162.88 13.13 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.823 0.449 . . . . 75.01 110.065 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.635 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 4.7 t70 -148.08 135.32 20.43 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.103 0.961 . . . . 70.15 108.878 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 45.5 mt -131.86 110.98 11.2 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.123 -1.066 . . . . 63.32 108.123 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -131.77 128.31 38.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.961 -1.125 . . . . 74.21 107.961 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -126.68 140.9 52.06 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 109.444 -0.576 . . . . 74.34 109.444 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.54 142.63 33.53 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.38 0.672 . . . . 70.41 109.81 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.533 ' HG ' HG21 ' C' ' 58' ' ' VAL . 20.4 m -124.34 148.5 47.44 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.331 0.653 . . . . 71.14 110.776 -175.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 21.4 p -147.38 127.11 13.41 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.134 0.974 . . . . 70.23 108.881 176.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -78.84 120.44 23.47 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.108 -0.701 . . . . 74.24 109.108 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.534 HD12 HD13 ' C' ' 83' ' ' ILE . 33.7 mt -84.07 -44.56 13.95 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.766 0.826 . . . . 73.2 109.89 -176.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.93 -174.52 4.82 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.255 -0.884 . . . . 71.3 109.789 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.44 111.52 1.42 Allowed 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.84 0.712 . . . . 71.44 110.417 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 64.91 17.09 10.89 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.763 1.225 . . . . 65.23 112.471 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.77 113.65 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.151 -1.055 . . . . 72.12 108.151 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -122.54 126.36 47.62 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.153 0.981 . . . . 64.0 109.706 -173.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.522 ' HB2' HD12 ' C' ' 51' ' ' LEU . 43.4 tt0 -89.36 132.82 34.78 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.792 -0.818 . . . . 74.02 108.792 167.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.533 HG21 ' HG ' ' C' ' 48' ' ' SER . 90.5 t -122.68 137.28 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.582 -1.266 . . . . 74.24 107.582 168.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.14 133.07 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.17 -0.678 . . . . 72.12 109.17 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.15 98.98 8.12 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.403 -1.332 . . . . 75.24 107.403 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -83.2 106.53 15.07 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.932 -0.766 . . . . 74.03 108.932 171.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 16.4 t -103.32 129.42 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 108.175 -1.046 . . . . 72.44 108.175 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.635 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 22.6 m -119.0 139.97 50.8 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.674 -0.862 . . . . 74.41 108.674 176.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.65 HG23 HG21 ' C' ' 114' ' ' ILE . 91.6 t -129.58 120.44 50.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 124.097 0.959 . . . . 65.52 108.792 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 2.0 m -115.4 109.21 17.54 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.182 -1.044 . . . . 75.23 108.182 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.44 105.52 15.67 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.945 -1.131 . . . . 73.12 107.945 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 43.0 m -131.16 128.82 40.84 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.797 -0.446 . . . . 62.11 109.797 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 16.0 mt -86.96 35.79 0.7 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.617 1.167 . . . . 73.03 110.379 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.27 -112.36 2.79 Favored Glycine 0 C--N 1.346 1.084 0 N-CA-C 110.523 -1.031 . . . . 73.35 110.523 -169.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -90.97 -26.26 19.33 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.44 0.696 . . . . 74.04 110.78 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.768 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 14.4 tp10 -68.87 118.49 11.88 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.334 -0.848 . . . . 74.24 109.095 170.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 94.9 m -87.49 120.5 28.86 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.82 -0.808 . . . . 74.33 108.82 165.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.97 -50.92 44.83 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.823 -1.08 . . . . 71.32 108.545 177.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -165.11 168.35 17.35 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 114.043 -1.435 . . . . 74.31 111.048 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.462 HD22 HG23 ' C' ' 65' ' ' THR . 2.6 tm? -127.46 140.9 51.85 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 106.269 -1.752 . . . . 74.41 106.269 166.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 51.2 t -142.83 148.39 37.0 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.656 -0.868 . . . . 74.32 108.656 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -157.81 140.13 14.45 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.708 -0.478 . . . . 74.02 109.708 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' C' ' 110' ' ' ALA . 68.9 t -136.13 115.04 15.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 124.462 1.105 . . . . 70.54 108.518 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.601 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.7 mt-30 -91.75 88.6 6.74 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.74 -0.837 . . . . 75.23 108.74 169.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -80.12 96.69 6.59 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.031 -0.986 . . . . 71.31 109.083 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.51 153.3 30.04 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 111.185 -0.766 . . . . 73.43 111.185 175.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.83 123.78 1.38 Allowed Glycine 0 CA--C 1.498 -1.011 0 N-CA-C 110.722 -0.951 . . . . 50.43 110.722 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.534 HD13 HD12 ' C' ' 51' ' ' LEU . 32.1 mm -89.96 130.48 39.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 108.758 -0.83 . . . . 75.12 108.758 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -132.03 119.35 20.91 Favored 'General case' 0 C--O 1.241 0.651 0 O-C-N 124.191 0.932 . . . . 75.54 108.49 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 21.1 p -79.36 100.48 7.62 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.656 -1.238 . . . . 71.13 107.656 171.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.442 HG21 ' HE2' ' C' ' 94' ' ' MET . 25.2 mt -115.2 129.58 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.226 0.61 . . . . 73.24 109.612 -175.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.509 ' HB2' ' HB ' ' C' ' 10' ' ' THR . . . -146.42 168.04 22.14 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.443 0.697 . . . . 72.53 110.315 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.76 -32.15 6.3 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 115.324 -0.853 . . . . 35.01 112.634 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.696 HD13 ' HA ' ' C' ' 94' ' ' MET . 37.9 pt -106.97 164.06 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.16 0.584 . . . . 74.31 111.791 -173.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -154.17 163.5 40.01 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.112 0.965 . . . . 75.25 109.189 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.97 -126.54 9.66 Favored Glycine 0 C--N 1.351 1.374 0 O-C-N 123.364 0.415 . . . . 63.3 113.923 168.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 67.2 p -69.58 -29.74 67.36 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.504 0.721 . . . . 74.04 111.223 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -63.82 -52.21 61.22 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.655 0.782 . . . . 73.4 110.157 175.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.696 ' HA ' HD13 ' C' ' 89' ' ' ILE . 4.6 tpt -53.53 -50.88 64.5 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 124.318 1.011 . . . . 72.42 111.904 173.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.35 -40.02 92.73 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.162 0.585 . . . . 74.24 111.829 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -70.6 -34.09 71.76 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.197 0.999 . . . . 73.33 111.087 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 38.5 t -69.86 -37.12 76.01 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.764 -0.653 . . . . 73.53 109.896 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.427 ' HB3' ' HG ' ' C' ' 48' ' ' SER . 90.8 mt -84.69 -32.32 23.63 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.299 1.04 . . . . 75.24 112.297 -176.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.52 11.38 28.19 Favored Glycine 0 N--CA 1.475 1.234 0 CA-C-O 119.785 -0.453 . . . . 73.04 114.102 -170.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.28 -51.58 0.11 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 117.372 0.586 . . . . 73.11 111.662 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -72.99 -49.88 26.43 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.32 0.248 . . . . 63.02 111.006 -175.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.408 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 86.0 m -64.68 -49.33 70.49 Favored Pre-proline 0 CA--C 1.561 1.39 0 CA-C-O 118.244 -0.884 . . . . 74.21 112.251 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 49.1 Cg_exo -58.75 -27.71 84.45 Favored 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 122.655 2.237 . . . . 74.23 113.547 174.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -64.51 -39.7 94.26 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.462 0.705 . . . . 75.43 110.415 174.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.522 HD13 ' NH1' ' A' ' 111' ' ' ARG . 29.2 mm -75.46 -35.73 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 O-C-N 123.267 0.355 . . . . 73.4 110.177 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 87.8 mt -74.41 -31.67 62.4 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.563 0.745 . . . . 73.14 112.223 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -55.83 -49.96 89.88 Favored Pre-proline 0 N--CA 1.484 1.26 0 CA-C-O 117.465 -1.255 . . . . 73.55 114.346 -173.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.63 -37.79 95.67 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.425 2.083 . . . . 72.1 113.445 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . 0.4 ' HE2' HG22 ' A' ' 115' ' ' THR . 52.4 m-85 -67.6 -44.27 78.49 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.624 0.77 . . . . 74.54 110.247 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.442 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -64.9 -38.69 91.81 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.963 -1.017 . . . . 70.24 110.66 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -65.04 -46.06 82.83 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.385 1.474 . . . . 74.22 110.449 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.94 -38.45 79.47 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.586 -0.734 . . . . 74.52 109.402 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 32.1 t -65.35 -36.2 83.29 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.955 0.502 . . . . 73.34 111.663 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.65 HG21 HG23 ' C' ' 64' ' ' VAL . 96.3 mt -68.85 -57.95 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.218 0.607 . . . . 74.23 110.054 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 10.8 m -65.26 -27.69 68.83 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 122.792 0.437 . . . . 71.11 111.277 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 40.8 t -64.12 -48.87 74.41 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.359 0.664 . . . . 70.45 109.242 170.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.557 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.03 -38.44 76.22 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.428 1.091 . . . . 73.22 112.351 177.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.403 HG22 ' O ' ' C' ' 114' ' ' ILE . 91.8 t -69.75 -38.44 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.019 0.928 . . . . 73.55 110.105 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 28.5 t -71.56 -27.66 63.32 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.37 1.068 . . . . 75.33 111.729 174.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' C' ' 116' ' ' SER . 76.4 mtt-85 -73.63 -40.96 63.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.582 0.753 . . . . 73.52 109.09 178.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.27 1.0 66.27 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.365 -0.834 . . . . 72.14 112.505 170.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.8 p 62.25 29.25 17.36 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.505 1.922 . . . . 64.23 113.588 170.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -80.29 151.18 72.12 Favored Pre-proline 0 C--O 1.246 0.882 0 N-CA-C 107.704 -1.221 . . . . 75.01 107.704 168.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.51 ' HG3' ' HB ' ' F' ' 129' ' ' THR . 31.4 Cg_exo -57.04 150.76 54.22 Favored 'Trans proline' 0 C--N 1.366 1.457 0 C-N-CA 122.015 1.81 . . . . 71.34 111.393 172.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' B' ' 123' ' ' PHE . 57.6 mm-40 -45.8 129.8 9.29 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.551 1.157 . . . . 75.25 112.274 -175.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 38.3 tp -136.09 86.78 2.25 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.026 -1.472 . . . . 74.42 107.026 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -92.6 122.36 34.95 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.934 -1.03 . . . . 74.11 109.267 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.57 121.88 17.32 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 108.749 -0.834 . . . . 75.23 108.749 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.14 140.66 97.95 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 123.717 0.807 . . . . 73.33 110.917 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.472 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 18.3 Cg_endo -58.8 108.64 0.43 Allowed 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.603 2.202 . . . . 75.32 112.759 177.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 26.3 t -99.9 122.0 51.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.386 -0.968 . . . . 74.12 108.386 173.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.424 ' O ' ' HG ' ' C' ' 136' ' ' LEU . 56.7 t-20 -75.0 104.53 5.62 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.377 1.071 . . . . 74.33 110.297 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -66.65 -27.05 67.37 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.835 0.854 . . . . 72.21 112.687 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -66.87 -39.44 87.54 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.565 0.746 . . . . 74.33 110.201 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.04 92.66 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.7 -0.682 . . . . 73.44 110.708 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' C' ' 132' ' ' ASN . 71.5 mt -68.17 -32.79 73.29 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.368 0.667 . . . . 74.44 111.051 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -76.87 -22.49 53.39 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.03 -0.532 . . . . 73.33 109.917 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 13.7 tpt -76.35 -35.45 58.72 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 109.858 -0.423 . . . . 74.24 109.858 173.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -64.33 -35.52 81.13 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.249 0.62 . . . . 72.43 110.536 168.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -69.85 -86.86 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.273 0.629 . . . . 73.4 110.355 174.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 4.5 tt -166.65 99.55 0.58 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.888 0.475 . . . . 71.24 110.191 -175.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -165.46 -166.81 1.03 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.61 1.164 . . . . 75.32 108.864 166.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -139.15 95.28 2.92 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.725 -0.842 . . . . 74.02 108.725 170.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -112.84 125.94 54.9 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.811 0.845 . . . . 74.14 111.02 -175.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 149' ' ' THR . . . -175.61 105.36 0.08 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.31 1.444 . . . . 72.32 108.042 171.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -141.7 55.93 0.59 Allowed Glycine 0 C--N 1.348 1.217 0 N-CA-C 113.579 0.192 . . . . 64.12 113.579 -170.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -150.17 103.16 3.15 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.03 0.532 . . . . 72.11 110.121 172.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -150.16 41.38 0.81 Allowed Glycine 0 C--N 1.343 0.959 0 N-CA-C 109.97 -1.252 . . . . 73.52 109.97 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 149' ' ' THR . . . . . 0.548 ' HB ' ' HA ' ' A' ' 93' ' ' GLN . 97.9 m -62.62 114.39 3.55 Favored 'General case' 0 C--O 1.216 -0.68 0 C-N-CA 125.62 1.568 . . . . 75.22 113.678 -169.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.29 157.59 36.0 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 120.946 0.403 . . . . 75.3 111.036 175.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.92 -18.67 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.92 1.288 . . . . 74.42 109.848 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 43.2 m80 73.35 67.85 0.11 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.083 1.753 . . . . 72.45 112.047 173.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -86.25 175.58 8.39 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.245 -0.889 . . . . 74.23 110.829 170.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -83.7 146.39 28.24 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 115.132 -0.94 . . . . 71.14 108.622 172.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.984 0 C-N-CA 123.644 0.777 . . . . 74.14 111.111 -175.353 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 51.6 mtp . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 107.603 -1.258 . . . . 74.14 107.603 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 17.5 m -59.41 -54.12 50.38 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.941 0.896 . . . . 72.32 111.464 -175.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.96 75.59 6.33 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.335 -0.848 . . . . 73.41 110.359 -171.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.27 152.96 19.28 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 108.284 -1.006 . . . . 74.42 108.284 171.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -77.72 165.31 24.38 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.321 0.582 . . . . 73.22 111.827 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . 0.644 ' HB2' ' HB2' ' B' ' 151' ' ' GLU . 65.5 t30 -72.64 158.17 36.15 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.893 -1.049 . . . . 62.31 110.029 174.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 12.4 t -136.07 -179.84 5.91 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 123.441 0.696 . . . . 70.32 109.933 -175.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.29 112.83 4.75 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 107.953 -1.129 . . . . 73.4 107.953 175.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.554 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 0.0 OUTLIER -33.59 124.06 0.43 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.73 1.612 . . . . 74.13 113.416 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 8.2 t -132.24 158.09 42.68 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.994 0.918 . . . . 73.2 109.965 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -152.14 103.99 2.93 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.209 -1.404 . . . . 73.21 107.209 -177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . 0.516 ' HB2' ' HB3' ' D' ' 85' ' ' SER . 38.2 mt-30 -112.77 114.0 26.35 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.345 -0.983 . . . . 74.41 108.345 -175.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.55 HG21 HD11 ' D' ' 16' ' ' ILE . 53.9 mt -77.91 125.13 37.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.489 -0.93 . . . . 74.15 108.489 175.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -88.77 -41.66 12.39 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 123.844 0.715 . . . . 74.35 109.861 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -177.43 136.91 0.2 Allowed 'General case' 0 N--CA 1.481 1.1 0 O-C-N 123.436 0.46 . . . . 74.11 110.864 -169.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.55 HD11 HG21 ' D' ' 13' ' ' ILE . 4.1 mp -110.98 142.72 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 107.193 -1.41 . . . . 74.53 107.193 169.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -166.35 163.42 17.51 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.868 0.842 . . . . 73.24 111.768 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 59.3 p -97.65 116.14 29.29 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.797 -1.092 . . . . 74.34 108.929 176.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.425 ' HD2' ' HA3' ' D' ' 81' ' ' GLY . 41.1 mtpt -85.39 -26.98 26.11 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.822 -0.807 . . . . 72.32 108.822 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.665 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 26.7 t70 -152.75 142.71 22.2 Favored 'General case' 0 C--N 1.35 0.597 0 C-N-CA 124.397 1.079 . . . . 72.13 109.749 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.557 HG23 ' HE1' ' C' ' 117' ' ' MET . 55.9 mt -141.96 145.65 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.865 1.266 . . . . 75.25 108.45 175.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -148.15 141.0 24.71 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.765 1.226 . . . . 74.22 109.384 174.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -144.81 129.45 18.1 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.319 -1.363 . . . . 70.04 107.319 167.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -137.44 111.56 8.42 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 123.98 0.912 . . . . 73.21 108.895 -171.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.19 86.08 1.91 Allowed Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 108.055 -1.091 . . . . 63.5 108.055 174.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -68.19 -35.67 18.67 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.808 2.338 . . . . 74.22 113.333 -165.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.465 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 50.1 m-20 -107.26 15.62 24.86 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.896 0.878 . . . . 54.2 110.813 -174.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -27.0 -71.19 0.05 OUTLIER Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 116.459 2.022 . . . . 72.32 116.459 -160.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.529 ' HB3' HD11 ' C' ' 83' ' ' ILE . 93.9 Cg_endo -74.12 -24.18 15.08 Favored 'Trans proline' 0 C--N 1.378 2.086 0 CA-C-N 123.491 2.283 . . . . 71.02 113.936 -172.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.464 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 4.8 t-160 -73.1 -40.96 64.56 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.649 0.78 . . . . 75.34 109.776 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.692 HG23 HD11 ' D' ' 68' ' ' LEU . 7.6 p -79.37 -26.58 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.506 -0.77 . . . . 72.12 111.609 -170.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -61.45 -23.69 66.03 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 122.797 0.439 . . . . 70.52 112.16 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 64.6 mt-30 -67.21 -9.07 36.51 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.698 1.199 . . . . 71.03 112.009 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -97.73 98.47 9.89 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.996 1.319 . . . . 73.34 110.182 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -88.78 88.44 7.6 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.792 0.837 . . . . 70.41 110.826 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 22.0 p90 -167.08 -177.99 3.98 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.103 0.961 . . . . 74.52 109.715 170.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.421 HE21 ' HD2' ' D' ' 38' ' ' PRO . 29.6 tp60 -80.58 115.31 54.36 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 123.551 0.74 . . . . 73.33 109.471 177.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.421 ' HD2' HE21 ' D' ' 37' ' ' GLN . 52.6 Cg_exo -58.38 142.68 97.92 Favored 'Trans proline' 0 C--N 1.386 2.501 0 C-N-CA 123.028 2.486 . . . . 73.42 112.379 177.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 14.0 mm-40 -67.18 106.46 2.02 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 107.531 -1.285 . . . . 72.11 107.531 171.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.551 HG12 HD11 ' D' ' 126' ' ' LEU . 62.4 t -106.17 116.09 49.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 O-C-N 123.729 0.643 . . . . 72.34 109.797 -178.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -98.98 152.64 19.58 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.642 -0.708 . . . . 75.25 109.569 169.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 31.9 tp -126.63 134.52 50.74 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.967 -1.015 . . . . 73.52 109.759 -173.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.546 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 13.2 t70 -130.35 113.77 14.77 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.415 -1.328 . . . . 74.34 107.415 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.683 HD12 HG21 ' E' ' 121' ' ' VAL . 94.3 mt -118.56 129.14 55.17 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.22 0.608 . . . . 73.45 109.438 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.411 ' HA ' ' HB2' ' E' ' 111' ' ' LEU . 8.5 t70 -160.03 155.76 25.86 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.633 -0.877 . . . . 73.32 108.633 172.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 46' ' ' THR . . . . . 0.45 HG23 ' HA ' ' D' ' 60' ' ' LEU . 30.4 p -123.61 168.64 12.37 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 122.167 0.984 . . . . 74.24 113.035 -170.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.13 143.97 26.33 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 113.465 -1.698 . . . . 73.34 107.208 173.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 37.2 p -144.65 152.88 41.11 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 120.58 0.229 . . . . 72.33 111.322 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 58.1 p -179.32 142.2 0.18 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.746 1.218 . . . . 74.03 109.603 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . 0.439 ' HB3' ' H ' ' D' ' 51' ' ' LEU . 0.7 OUTLIER -174.87 -98.02 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.27 1.028 . . . . 74.51 108.292 166.17 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.439 ' H ' ' HB3' ' D' ' 50' ' ' GLN . 84.6 mt -143.05 128.03 18.44 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.306 1.043 . . . . 73.1 109.291 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.33 78.03 0.74 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.764 0.825 . . . . 62.52 110.752 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . 0.463 ' HB3' ' H ' ' E' ' 92' ' ' GLY . 22.8 t70 -174.73 49.27 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.072 -1.455 . . . . 62.22 107.072 -176.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' D' ' 85' ' ' SER . 6.0 m-20 63.08 24.23 14.37 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.162 -1.381 . . . . 75.03 112.932 172.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' D' ' 50' ' ' GLN . 58.8 t -134.87 102.16 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 107.635 -1.246 . . . . 74.45 107.635 177.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -135.33 135.06 40.47 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.039 0.535 . . . . 75.31 109.856 -174.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.483 ' HG2' HG12 ' D' ' 83' ' ' ILE . 42.3 mt-10 -87.14 115.02 24.25 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.882 -1.155 . . . . 72.21 107.882 167.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 70.6 t -97.58 136.22 29.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 106.797 -1.557 . . . . 70.12 106.797 171.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.4 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.1 t -128.41 123.76 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 108.239 -1.023 . . . . 73.44 108.239 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -103.31 121.21 42.27 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.824 -1.176 . . . . 73.02 107.824 176.189 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -100.53 105.99 17.47 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.237 -1.394 . . . . 73.44 107.237 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.427 HG21 ' CD2' ' D' ' 44' ' ' LEU . 59.1 t -99.99 120.43 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 N-CA-C 108.234 -1.025 . . . . 73.35 108.234 176.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.546 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 28.2 m -120.84 140.13 52.2 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.872 -0.788 . . . . 72.43 108.872 -177.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.477 HG13 HG13 ' D' ' 40' ' ' VAL . 77.3 t -131.37 130.36 62.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 115.398 -0.819 . . . . 74.15 109.914 -173.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 10.2 m -119.84 93.03 3.93 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.409 -0.96 . . . . 74.24 108.409 172.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.505 ' HB3' HG22 ' D' ' 40' ' ' VAL . . . -100.53 146.34 27.21 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.191 0.596 . . . . 71.45 110.037 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.459 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 23.5 p -153.89 127.93 8.97 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 112.815 0.672 . . . . 64.2 112.815 -169.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.692 HD11 HG23 ' D' ' 31' ' ' VAL . 80.0 mt -96.31 102.24 14.0 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.667 0.787 . . . . 73.33 109.121 174.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.84 -132.66 11.74 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 116.286 -0.415 . . . . 72.04 112.389 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.51 2.85 56.45 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.752 0.421 . . . . 71.33 111.038 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -114.94 158.31 22.19 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.362 -0.607 . . . . 71.2 109.362 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 91.6 m -75.33 139.14 42.25 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.083 0.553 . . . . 74.21 110.722 178.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.605 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.04 -62.32 1.51 Allowed 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.548 -1.279 . . . . 74.44 107.548 175.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -158.41 149.53 20.75 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.784 -1.098 . . . . 75.41 110.864 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 74.9 mt -116.75 120.8 39.7 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.689 1.596 . . . . 72.4 107.412 174.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.541 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 38.9 t -131.97 137.34 47.87 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.855 -0.424 . . . . 73.44 109.855 -174.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' D' ' 62' ' ' VAL . 38.5 tt0 -154.24 130.84 10.67 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.702 0.401 . . . . 75.45 110.984 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 96.2 t -134.31 121.59 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.048 0.939 . . . . 71.52 109.487 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.665 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.7 mt-30 -90.2 86.35 6.5 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.677 -0.86 . . . . 74.33 108.677 169.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -80.36 101.29 8.89 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.217 -1.356 . . . . 73.44 109.073 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.425 ' HA3' ' HD2' ' D' ' 19' ' ' LYS . . . -96.85 161.07 21.78 Favored Glycine 0 N--CA 1.464 0.544 0 N-CA-C 112.479 -0.249 . . . . 70.53 112.479 178.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.03 140.72 6.63 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.729 -0.549 . . . . 74.14 111.729 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.483 HG12 ' HG2' ' D' ' 57' ' ' GLU . 50.1 mt -89.2 123.23 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.547 -1.279 . . . . 73.45 107.547 175.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -125.24 151.06 46.41 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.929 0.891 . . . . 71.45 109.768 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.516 ' HB3' ' HB2' ' D' ' 12' ' ' GLN . 33.7 t -113.19 103.76 11.66 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.324 -0.991 . . . . 71.31 108.324 173.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.586 HG23 HD12 ' D' ' 89' ' ' ILE . 3.1 mp -108.4 119.33 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 107.607 -1.257 . . . . 72.23 107.607 -176.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.33 168.69 24.59 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 123.645 0.591 . . . . 72.24 112.276 -172.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.554 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 77.83 22.59 68.82 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 115.307 -0.86 . . . . 53.21 112.957 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.586 HD12 HG23 ' D' ' 86' ' ' ILE . 0.5 OUTLIER -135.62 156.67 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.04 1.336 . . . . 73.24 108.401 176.218 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -152.08 163.85 38.47 Favored 'General case' 0 CA--C 1.561 1.379 0 N-CA-C 107.96 -1.126 . . . . 65.3 107.96 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . 0.47 ' O ' ' HE1' ' D' ' 94' ' ' MET . . . 79.19 -134.31 13.65 Favored Glycine 0 C--N 1.349 1.279 0 C-N-CA 123.545 0.593 . . . . 52.21 111.971 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 13.1 m -81.89 -25.13 35.26 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 117.964 0.882 . . . . 75.32 110.625 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -66.99 -19.04 65.65 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.634 1.174 . . . . 74.44 112.898 -174.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.512 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 0.0 OUTLIER -81.06 -43.41 19.55 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.618 0.599 . . . . 75.12 112.618 -176.348 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -78.73 -15.31 58.61 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.046 0.539 . . . . 74.55 110.614 177.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -58.9 -46.89 86.81 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.63 1.172 . . . . 75.33 110.734 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.3 m -72.23 -31.12 65.55 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.577 0.751 . . . . 73.5 111.538 -177.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.402 HD12 HG22 ' E' ' 103' ' ' THR . 2.3 tm? -64.51 -52.5 57.49 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.678 1.191 . . . . 74.34 109.457 177.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.78 -25.43 62.6 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 115.364 -0.835 . . . . 72.32 114.054 -173.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.9 -55.4 2.42 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 117.621 0.71 . . . . 73.24 112.25 -170.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -74.54 -39.76 62.14 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 111.799 0.296 . . . . 74.12 111.799 -171.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.45 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 73.8 m -63.47 -47.4 83.53 Favored Pre-proline 0 CA--C 1.569 1.708 0 CA-C-O 118.762 -0.637 . . . . 73.41 112.273 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.481 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 50.3 Cg_exo -59.72 -31.86 94.8 Favored 'Trans proline' 0 C--N 1.396 3.048 0 C-N-CA 122.656 2.237 . . . . 74.24 113.546 169.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -67.23 -28.84 68.4 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.279 0.631 . . . . 75.35 110.746 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.9 mm -74.12 -40.94 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.482 0.713 . . . . 73.34 110.227 172.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 88.3 mt -73.72 -24.92 59.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.367 0.667 . . . . 75.52 112.548 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -64.56 -44.69 75.33 Favored Pre-proline 0 N--CA 1.485 1.284 0 N-CA-C 113.766 1.024 . . . . 72.3 113.766 -171.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -55.1 -38.85 93.27 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 121.946 1.764 . . . . 74.15 113.17 173.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -73.77 -37.38 65.03 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.528 0.731 . . . . 64.5 111.074 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.62 -46.01 73.76 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.912 0.885 . . . . 73.13 110.759 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -73.8 -30.84 62.97 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-N 115.08 -0.963 . . . . 72.52 110.781 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -64.45 -46.52 82.74 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 124.105 0.878 . . . . 75.13 109.809 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.424 ' SG ' HD11 ' D' ' 21' ' ' ILE . 42.1 t -55.68 -44.84 77.7 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 124.14 0.9 . . . . 65.51 110.405 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.458 HG21 ' SG ' ' D' ' 76' ' ' CYS . 72.1 mt -62.99 -50.22 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.859 0.864 . . . . 74.14 111.064 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 63.0 m -55.27 -47.08 76.0 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.08 0.952 . . . . 65.4 110.781 -175.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.4 t -62.57 -42.18 99.39 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 113.778 -1.555 . . . . 71.15 109.967 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.541 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 74.2 mtm -70.18 -31.89 69.57 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.194 0.597 . . . . 71.43 112.047 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.435 HG22 ' O ' ' D' ' 114' ' ' ILE . 76.4 t -67.74 -42.67 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.659 0.784 . . . . 73.04 110.058 176.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.5 p -73.15 -28.05 62.02 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-N 115.628 -0.715 . . . . 74.53 110.449 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' C' ' 17' ' ' TYR . 68.8 mtt-85 -70.65 -30.41 67.02 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.426 0.69 . . . . 75.14 109.601 172.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.93 11.61 66.41 Favored Glycine 0 C--N 1.353 1.477 0 CA-C-O 119.54 -0.589 . . . . 61.43 113.587 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.459 HG22 ' HB3' ' C' ' 17' ' ' TYR . 74.2 p 58.07 21.77 8.25 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 126.122 1.769 . . . . 74.02 114.365 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -90.55 155.92 45.67 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 109.409 -0.589 . . . . 74.44 109.409 171.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.3 137.86 71.86 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 122.902 2.402 . . . . 74.11 112.076 173.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -49.35 122.17 5.82 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.05 1.34 . . . . 74.15 112.215 -175.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.551 HD11 HG12 ' D' ' 40' ' ' VAL . 37.7 tp -107.64 99.54 9.02 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.423 0.689 . . . . 74.11 110.431 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -99.33 104.59 16.49 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 106.956 -1.498 . . . . 75.11 106.956 172.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -62.9 129.25 39.61 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.038 -0.727 . . . . 73.53 109.038 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.27 134.11 90.78 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 123.854 0.862 . . . . 61.45 111.533 -170.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -68.47 111.11 2.44 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.758 2.306 . . . . 63.14 111.85 -174.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.8 m -107.99 142.25 21.14 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 CA-C-O 121.218 0.532 . . . . 75.14 109.603 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -86.42 111.66 20.73 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 107.916 -1.142 . . . . 54.3 107.916 174.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.424 ' HA ' HD12 ' D' ' 136' ' ' LEU . 60.1 m-85 -68.14 -18.19 64.56 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.269 0.628 . . . . 71.34 112.532 -174.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -63.71 -39.75 95.08 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.705 0.402 . . . . 72.31 110.127 171.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.3 -21.51 66.73 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.004 0.921 . . . . 64.35 111.79 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.567 HD23 ' HB3' ' E' ' 111' ' ' LEU . 7.3 mp -74.85 -28.24 60.59 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.801 0.84 . . . . 72.14 110.883 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -90.97 -32.12 16.08 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.734 0.413 . . . . 75.41 110.689 176.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 73.1 mtm -70.51 -22.62 62.61 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.201 0.6 . . . . 65.2 109.933 170.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.486 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 2.8 t-20 -58.62 -41.64 86.4 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 123.789 0.836 . . . . 74.32 110.137 173.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -59.31 -39.44 83.05 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 124.146 0.904 . . . . 74.33 110.709 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.1 mp -73.81 -35.35 64.86 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.596 0.758 . . . . 74.42 111.531 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.486 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 21.1 pt20 -89.23 26.69 1.57 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.315 0.578 . . . . 72.2 111.231 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -117.1 51.7 1.0 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 107.469 -1.308 . . . . 73.44 107.469 172.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.72 113.81 7.68 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 104.946 -2.242 . . . . 74.33 104.946 176.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.44 90.56 0.38 Allowed 'General case' 0 CA--C 1.542 0.635 0 O-C-N 123.771 0.67 . . . . 73.44 110.719 -171.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.59 -124.85 5.48 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 115.432 -0.804 . . . . 73.33 111.381 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -151.77 156.69 40.76 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.402 0.681 . . . . 74.12 110.797 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -173.78 -179.0 44.14 Favored Glycine 0 C--O 1.24 0.523 0 CA-C-N 114.442 -1.253 . . . . 52.54 111.244 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 26.8 m -120.57 131.48 54.68 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.754 0.822 . . . . 75.22 108.91 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -67.73 134.71 51.51 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 123.19 0.596 . . . . 70.14 109.459 174.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -72.05 142.79 49.25 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 109.453 -0.573 . . . . 74.11 109.453 174.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -66.63 94.69 0.3 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.607 -0.516 . . . . 61.44 109.607 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -67.32 95.75 0.45 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.883 0.873 . . . . 75.52 111.204 -174.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -74.86 107.77 7.16 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 114.955 -1.021 . . . . 53.42 110.194 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.142 0 C-N-CA 123.773 0.829 . . . . 74.04 109.625 -179.319 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.691 0 N-CA-C 111.767 -0.533 . . . . 74.44 111.767 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 92' ' ' GLY . . . . . 0.463 ' H ' ' HB3' ' D' ' 53' ' ' ASP . . . -93.34 -107.39 1.84 Allowed Glycine 0 C--N 1.339 0.733 0 CA-C-O 119.553 -0.582 . . . . 72.24 111.757 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -159.79 16.64 0.15 Allowed 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.459 0.911 . . . . 75.22 113.459 -173.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -152.08 172.57 16.12 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 119.152 0.887 . . . . 75.11 111.711 -177.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -130.35 131.08 45.17 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 123.235 0.614 . . . . 73.21 111.159 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.99 -57.03 0.05 OUTLIER Glycine 0 C--N 1.343 0.947 0 N-CA-C 109.06 -1.616 . . . . 74.31 109.06 168.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 97' ' ' ILE . . . . . 0.428 HG22 HD21 ' E' ' 100' ' ' LEU . 2.0 mt -114.15 109.4 28.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 C-N-CA 124.526 1.13 . . . . 73.42 108.163 175.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -92.09 -35.83 13.68 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 120.937 0.398 . . . . 73.51 109.968 174.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -125.79 132.11 52.34 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.647 0.779 . . . . 73.22 109.989 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 100' ' ' LEU . . . . . 0.463 ' HB3' ' SD ' ' D' ' 94' ' ' MET . 0.3 OUTLIER -151.33 149.29 24.19 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.081 0.952 . . . . 74.41 111.221 173.03 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -67.19 -15.25 45.76 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.574 2.183 . . . . 65.13 111.567 163.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 102' ' ' LEU . . . . . . . . . . . . . 29.5 tp 79.0 -86.34 0.02 OUTLIER 'General case' 0 C--N 1.369 1.432 0 C-N-CA 125.742 1.617 . . . . 74.31 110.066 173.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 103' ' ' THR . . . . . 0.402 HG22 HD12 ' D' ' 98' ' ' LEU . 15.0 p -138.25 7.16 2.62 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.702 1.201 . . . . 72.21 109.297 171.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.64 -164.96 45.59 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 110.823 -0.911 . . . . 74.44 110.823 -166.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -70.36 107.35 3.74 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.347 -0.983 . . . . 71.41 108.347 171.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 58.5 t80 66.49 -80.51 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.621 1.168 . . . . 73.53 109.378 -175.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 3.2 p -151.02 125.97 9.79 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.249 1.42 . . . . 74.13 107.821 167.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -88.79 -25.74 22.08 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.083 0.553 . . . . 75.12 110.838 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -87.32 -33.49 19.18 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.449 0.7 . . . . 75.13 111.44 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . 67.22 131.39 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.018 1.327 . . . . 73.11 110.799 -166.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . 0.567 ' HB3' HD23 ' D' ' 136' ' ' LEU . 11.1 mp -77.56 -76.94 0.16 Allowed 'General case' 0 N--CA 1.477 0.904 0 O-C-N 122.052 -0.405 . . . . 73.25 111.783 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -68.32 -48.81 63.92 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 123.053 0.221 . . . . 74.34 111.259 -171.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 47.0 mttp 70.58 -42.26 0.52 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 126.166 1.787 . . . . 74.42 113.419 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . 0.449 ' HD2' HG23 ' E' ' 122' ' ' THR . 22.1 tptp 77.87 -8.44 1.67 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.118 1.767 . . . . 64.12 111.822 177.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 61.7 p -77.04 -21.94 53.74 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.077 0.951 . . . . 75.34 110.632 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.96 169.65 48.41 Favored Glycine 0 C--N 1.354 1.574 0 CA-C-N 116.087 -0.506 . . . . 55.33 112.349 173.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.35 164.29 62.13 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 124.544 1.138 . . . . 74.34 111.346 -177.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.09 -167.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.393 2.872 0 C-N-CA 123.115 2.543 . . . . 73.44 113.368 175.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 23.2 t70 78.24 -51.2 0.49 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.669 1.587 . . . . 74.1 112.325 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -88.56 -113.55 0.06 Allowed 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 123.422 0.689 . . . . 75.21 111.386 -168.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 121' ' ' VAL . . . . . 0.683 HG21 HD12 ' D' ' 44' ' ' LEU . 13.4 p -94.45 43.87 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 123.57 1.653 . . . . 73.2 110.519 -172.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 122' ' ' THR . . . . . 0.449 HG23 ' HD2' ' E' ' 114' ' ' LYS . 19.5 p -144.82 -28.43 0.47 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 113.929 -1.487 . . . . 70.21 109.213 -176.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -132.62 153.49 51.0 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.642 1.177 . . . . 73.5 109.961 -172.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 65.4 m -142.61 83.75 1.83 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.159 0.984 . . . . 52.12 108.399 168.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.6 -52.49 64.94 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 115.452 -0.795 . . . . 72.33 111.143 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . 56.18 -158.84 0.23 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 124.378 1.049 . . . . 72.24 110.854 -176.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 6.6 p -171.75 118.01 0.42 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.889 0.876 . . . . 74.12 109.681 172.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -158.08 156.37 30.9 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.682 0.793 . . . . 73.45 110.613 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 8.8 t -78.42 141.31 38.41 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 115.743 -0.662 . . . . 72.35 109.629 175.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.46 174.53 10.54 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 123.239 0.615 . . . . 72.23 110.66 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 131' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -61.4 111.35 1.74 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.085 0.554 . . . . 70.14 109.901 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 132' ' ' SER . . . . . 0.474 ' H ' ' HB3' ' A' ' 124' ' ' PRO . 15.5 p -140.63 28.02 2.01 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.785 0.834 . . . . 70.22 111.34 -175.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 133' ' ' THR . . . . . 0.41 ' OG1' ' HB2' ' A' ' 124' ' ' PRO . 32.7 m -124.1 97.41 5.33 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.804 -0.443 . . . . 75.41 109.804 173.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -101.02 116.67 5.64 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 109.659 -1.376 . . . . 73.05 109.659 169.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.59 158.59 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 117.092 0.446 . . . . 75.23 110.603 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 136' ' ' LYS . . . . . 0.642 ' H ' ' HD3' ' E' ' 136' ' ' LYS . 0.4 OUTLIER -88.56 170.59 10.73 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.43 1.092 . . . . 61.53 109.745 173.614 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 15.3 t -81.65 176.46 9.62 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.12 0.568 . . . . 74.35 110.965 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 138' ' ' TYR . . . . . 0.495 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 6.2 t80 -137.69 3.27 2.49 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.332 0.653 . . . . 75.15 110.569 -177.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -69.46 166.7 18.22 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 112.313 0.486 . . . . 74.44 112.313 -174.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -89.03 150.79 21.68 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.907 -0.588 . . . . 71.22 112.785 -178.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -78.73 100.27 7.01 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.505 0.722 . . . . 54.42 110.5 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -73.1 -54.75 7.73 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.721 0.808 . . . . 73.1 109.367 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . 112.7 -164.7 12.03 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-N 115.199 -0.91 . . . . 74.14 110.89 -172.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 17.3 m -114.89 55.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-O 122.391 1.091 . . . . 71.11 110.775 -176.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 C--O 1.251 1.14 0 CA-C-N 114.615 -1.175 . . . . 75.54 109.031 175.38 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.765 0 CA-C-O 120.344 -0.142 . . . . 61.24 112.887 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . -87.0 120.04 5.37 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 111.0 -0.84 . . . . 74.55 111.0 173.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -110.63 -80.95 0.58 Allowed 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 117.324 0.562 . . . . 75.34 110.484 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -171.4 -173.83 1.31 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.067 0.947 . . . . 75.01 109.657 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -141.03 140.51 34.29 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.526 0.73 . . . . 71.42 110.716 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . 179.3 8.86 0.02 OUTLIER Glycine 0 C--N 1.356 1.682 0 CA-C-O 119.396 -0.669 . . . . 63.23 114.674 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 97' ' ' ILE . . . . . 0.667 ' HB ' ' HA ' ' B' ' 87' ' ' ALA . 17.3 tt -132.91 114.59 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-N 118.335 1.068 . . . . 72.53 108.952 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -74.76 87.44 2.22 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.188 0.595 . . . . 73.02 111.114 -169.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . 66.2 163.54 0.17 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.464 1.506 . . . . 73.3 111.712 -174.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 100' ' ' LEU . . . . . . . . . . . . . 3.6 mp -138.05 72.04 47.41 Favored Pre-proline 0 CA--C 1.553 1.06 0 N-CA-C 108.833 -0.803 . . . . 65.22 108.833 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -68.1 -3.13 10.1 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.776 2.984 . . . . 74.2 115.62 -170.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 102' ' ' LEU . . . . . . . . . . . . . 30.4 tp 58.9 44.71 16.24 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.908 0.883 . . . . 73.11 110.802 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 42.7 p 55.06 25.68 7.29 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.699 1.6 . . . . 75.21 112.844 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.03 -82.48 0.99 Allowed Glycine 0 C--N 1.351 1.386 0 CA-C-N 115.859 -0.61 . . . . 53.34 111.822 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -96.41 164.13 12.76 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.599 0.76 . . . . 75.43 110.852 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -55.5 97.38 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.183 1.393 . . . . 74.43 109.793 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 9.9 m 52.38 67.61 0.95 Allowed 'General case' 0 CA--C 1.558 1.281 0 O-C-N 124.568 1.167 . . . . 64.4 109.963 -174.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -65.81 -39.0 90.46 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.913 -0.585 . . . . 74.33 112.14 -172.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -61.95 -29.84 70.51 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.291 0.37 . . . . 72.14 110.73 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 69.86 120.88 0.03 OUTLIER 'General case' 0 C--N 1.357 0.929 0 C-N-CA 125.258 1.423 . . . . 74.13 111.571 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . 0.486 HD22 HD12 ' B' ' 44' ' ' LEU . 15.3 tp -74.04 -65.4 0.84 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.668 0.787 . . . . 74.24 110.768 -173.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -89.64 36.16 0.84 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.801 1.24 . . . . 74.4 111.51 -174.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -76.72 174.05 10.91 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.715 0.806 . . . . 75.12 112.882 -170.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -71.43 93.68 1.19 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.71 -1.132 . . . . 64.11 108.807 169.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 12.8 m -90.08 -17.65 27.33 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.452 0.701 . . . . 64.02 110.407 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 127.86 -52.26 0.83 Allowed Glycine 0 C--N 1.348 1.214 0 CA-C-O 121.212 0.34 . . . . 64.55 112.549 170.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -107.55 -175.47 0.36 Allowed Pre-proline 0 N--CA 1.478 0.961 0 N-CA-C 107.816 -1.179 . . . . 73.43 107.816 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -57.94 -37.33 96.51 Favored 'Trans proline' 0 C--N 1.375 1.945 0 CA-C-N 120.79 1.318 . . . . 71.52 110.745 158.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 61.95 -88.1 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.685 1.194 . . . . 72.04 111.178 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -157.37 149.47 22.58 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.117 0.967 . . . . 74.44 109.099 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 19.1 t 54.99 59.06 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 C-N-CA 125.195 1.398 . . . . 73.22 111.118 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 16.4 p -145.31 -59.82 0.34 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.676 -1.147 . . . . 62.35 108.594 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -138.56 140.38 39.03 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 124.932 1.293 . . . . 75.32 108.79 -176.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 20.4 m 66.25 105.16 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.068 1.347 . . . . 61.45 111.783 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -154.56 -61.27 0.12 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.387 0.675 . . . . 63.44 109.758 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -159.37 166.81 30.32 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.703 0.801 . . . . 61.14 110.267 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 27.0 p -119.26 152.29 36.94 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.681 0.792 . . . . 71.5 110.549 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 128' ' ' ALA . . . . . 0.57 ' HB2' ' HG3' ' B' ' 37' ' ' GLN . . . -88.81 149.23 23.5 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.487 0.715 . . . . 74.22 109.371 175.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 129' ' ' THR . . . . . 0.51 ' HB ' ' HG3' ' C' ' 124' ' ' PRO . 12.9 p -102.39 130.96 49.29 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.907 0.483 . . . . 73.35 109.76 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 130' ' ' ALA . . . . . 0.608 ' HA ' ' HB3' ' B' ' 124' ' ' PRO . . . -71.08 157.97 37.28 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.043 1.127 . . . . 75.44 114.043 -169.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 58.7 t-105 -92.32 102.45 14.95 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 107.476 -1.305 . . . . 74.22 107.476 168.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 68.9 m -145.59 73.72 1.36 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.43 0.692 . . . . 65.23 109.505 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 15.3 t -157.88 165.18 35.89 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.35 -0.841 . . . . 74.35 109.87 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -142.77 133.48 5.57 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 110.349 -1.101 . . . . 74.22 110.349 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 135' ' ' VAL . . . . . 0.536 HG11 HG11 ' C' ' 40' ' ' VAL . 85.3 t -74.85 -78.69 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 109.58 -0.526 . . . . 73.15 109.58 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm 57.06 165.14 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.61 1.164 . . . . 75.32 111.687 -173.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 5.6 m 68.48 159.21 0.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.141 0.976 . . . . 75.32 111.361 174.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -134.38 90.8 2.71 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.516 -0.74 . . . . 73.51 109.351 172.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -170.36 153.67 4.47 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.347 -0.842 . . . . 72.31 110.221 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -114.99 -176.4 18.71 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 111.541 -0.624 . . . . 63.31 111.541 172.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -163.57 -174.2 3.62 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.257 0.623 . . . . 71.33 110.936 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -65.76 153.63 41.26 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.198 0.999 . . . . 75.51 111.566 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -125.16 132.53 8.1 Favored Glycine 0 C--N 1.346 1.099 0 N-CA-C 110.726 -0.95 . . . . 70.21 110.726 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 18.7 t -95.66 76.02 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.08 -0.711 . . . . 73.34 109.08 -176.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--O 1.249 1.032 0 C-N-CA 123.472 0.709 . . . . 73.31 109.417 -178.179 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.496 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 109.861 -0.422 . . . . 72.13 109.861 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.2 m -124.88 122.43 37.36 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.166 0.586 . . . . 75.13 109.686 -174.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -139.77 169.86 16.94 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.025 0.93 . . . . 72.44 109.37 172.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -87.57 27.45 1.11 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.898 0.879 . . . . 70.22 112.291 -174.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -155.97 174.95 14.59 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.023 0.929 . . . . 75.54 109.733 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -65.97 97.11 0.34 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.185 0.516 . . . . 63.33 110.467 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.588 HG23 ' H ' ' A' ' 8' ' ' GLU . 2.2 m -110.46 -152.58 0.5 Allowed 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 107.666 -1.235 . . . . 71.44 107.666 176.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.588 ' H ' HG23 ' A' ' 7' ' ' THR . 10.8 pt-20 -55.66 162.36 1.72 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.998 0.919 . . . . 73.51 111.641 166.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.641 ' HE3' ' HB2' ' A' ' 11' ' ' PHE . 5.1 ppp? -84.69 177.46 8.03 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.677 -0.692 . . . . 73.02 110.989 178.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 99.4 m -145.06 114.49 7.14 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.175 0.99 . . . . 71.12 109.022 -174.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.641 ' HB2' ' HE3' ' A' ' 9' ' ' MET . 15.0 t80 -125.31 133.44 52.62 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.534 -0.913 . . . . 74.22 108.534 177.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -147.91 135.51 20.81 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.472 0.709 . . . . 72.22 109.452 171.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.795 HG22 ' HG2' ' C' ' 130' ' ' PRO . 3.9 mt -82.47 115.74 25.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.433 -0.951 . . . . 73.33 108.433 169.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.76 -41.12 19.59 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 109.451 -0.574 . . . . 64.31 109.451 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -169.51 126.74 0.91 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.629 0.372 . . . . 74.25 110.962 -175.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 86.6 mt -111.76 137.21 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.902 -0.777 . . . . 74.11 108.902 170.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.447 ' HB2' ' HA2' ' B' ' 121' ' ' GLY . 31.6 p90 -164.29 176.33 9.24 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 124.136 0.898 . . . . 73.13 111.178 -172.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.6 p -103.57 123.36 46.8 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.36 0.664 . . . . 72.55 109.289 174.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 39.5 mtpt -87.74 -27.23 22.49 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.506 -0.553 . . . . 73.43 109.506 174.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.452 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 22.3 t70 -152.25 142.05 21.98 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 114.931 -1.031 . . . . 71.45 109.418 -177.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 85.3 mt -139.63 142.24 33.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 C-N-CA 125.24 1.416 . . . . 70.05 107.409 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.8 t -149.64 123.22 9.15 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.934 0.494 . . . . 74.03 110.189 175.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.426 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 89.7 t80 -127.88 124.52 37.66 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 106.986 -1.487 . . . . 73.51 106.986 172.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 80.1 mt-10 -126.77 121.18 31.23 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.054 0.388 . . . . 75.13 110.105 -177.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.45 76.38 61.92 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 108.249 -1.019 . . . . 75.44 108.249 169.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -74.48 -23.59 14.84 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.676 2.25 . . . . 65.44 112.357 -177.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -97.43 15.57 22.73 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-O 118.198 -0.906 . . . . 71.31 109.954 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.492 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -39.94 -59.24 1.84 Allowed Pre-proline 0 CA--C 1.572 1.79 0 C-N-CA 124.703 1.201 . . . . 63.44 113.705 -168.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.492 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 32.5 Cg_exo -60.11 -35.11 93.66 Favored 'Trans proline' 0 C--N 1.387 2.601 0 C-N-CA 122.075 1.85 . . . . 75.01 113.199 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -76.38 -35.55 58.58 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.117 -0.947 . . . . 72.4 110.92 -174.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.609 HG22 ' HA ' ' A' ' 73' ' ' ALA . 5.5 p -80.61 -15.51 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.707 -0.679 . . . . 63.24 112.236 -168.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -77.11 -35.49 56.29 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.513 0.325 . . . . 73.42 110.51 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -78.19 -16.19 58.11 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.161 0.584 . . . . 75.5 111.139 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -73.33 154.6 40.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.51 0.724 . . . . 73.32 111.368 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.52 119.25 7.69 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.753 1.221 . . . . 65.24 110.331 177.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -79.67 80.76 6.02 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.709 0.766 . . . . 74.45 109.842 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -123.62 81.15 54.61 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 106.094 -1.817 . . . . 73.5 106.094 169.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -86.91 122.0 1.84 Allowed 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.695 2.264 . . . . 74.34 112.324 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -95.91 115.54 27.58 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 105.917 -1.883 . . . . 73.31 105.917 168.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.0 t -94.55 94.3 4.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 O-C-N 123.783 0.677 . . . . 65.0 109.711 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -80.19 113.55 18.45 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.922 -1.035 . . . . 74.15 109.282 175.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.522 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.6 pt? -109.81 111.64 23.21 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.549 0.69 . . . . 73.33 109.809 -177.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -101.6 137.72 39.54 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.576 1.15 . . . . 75.51 108.295 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.9 mt -126.56 120.45 29.63 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.412 0.625 . . . . 73.21 111.015 -173.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -125.17 122.12 36.16 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 114.028 -1.442 . . . . 74.4 108.047 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.426 HG22 ' HG3' ' A' ' 103' ' ' PRO . 83.8 m -122.9 135.81 54.64 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.312 0.645 . . . . 72.45 109.961 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.94 126.31 11.54 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.494 0.717 . . . . 74.41 109.734 176.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 64.7 p -96.94 172.78 7.64 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.457 0.703 . . . . 64.13 110.743 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.1 t -162.7 163.32 26.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.842 1.257 . . . . 74.02 108.871 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -110.92 116.91 32.04 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.277 0.631 . . . . 75.44 109.446 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.456 HD13 HG22 ' A' ' 83' ' ' ILE . 81.9 mt -85.91 -33.59 21.16 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.092 0.557 . . . . 75.22 110.376 175.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.9 -176.49 4.95 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.767 0.827 . . . . 72.34 110.348 -178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -62.37 118.99 8.23 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.131 0.572 . . . . 72.44 109.61 176.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 65.35 10.43 6.51 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.767 1.227 . . . . 74.33 112.438 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.38 106.65 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.772 -0.825 . . . . 73.32 108.772 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -113.99 126.42 55.11 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.991 0.916 . . . . 75.25 109.876 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -93.62 136.69 33.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.942 -0.762 . . . . 73.53 108.942 171.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.4 t -120.85 138.16 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 108.31 -0.996 . . . . 74.3 108.31 170.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.4 t -120.52 131.25 73.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.015 -0.735 . . . . 72.52 109.015 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.626 HD23 HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -109.18 105.02 14.29 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.18 -1.415 . . . . 75.34 107.18 174.784 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -88.91 100.78 13.45 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.322 -1.362 . . . . 74.4 107.322 172.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.626 HG23 HD23 ' A' ' 60' ' ' LEU . 32.0 t -94.06 126.65 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.5 -1.296 . . . . 73.21 107.5 172.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.3 m -117.61 126.59 52.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.022 -0.733 . . . . 73.12 109.022 177.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 64.0 t -115.31 126.15 72.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.087 -1.079 . . . . 73.43 108.087 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.9 m -120.68 130.5 54.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.54 -0.911 . . . . 73.5 108.54 172.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.7 123.57 29.6 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.947 -1.501 . . . . 71.11 106.947 175.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -137.27 128.92 28.62 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.23 0.538 . . . . 72.02 110.691 -174.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.543 HD12 ' CG2' ' A' ' 31' ' ' VAL . 33.5 mt -92.29 81.36 4.95 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.145 1.378 . . . . 70.35 107.913 175.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.71 -119.51 6.08 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 110.852 -0.899 . . . . 75.41 110.852 -174.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.4 -19.36 25.28 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.926 0.49 . . . . 61.24 110.201 175.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -80.92 106.69 13.13 Favored 'General case' 0 C--N 1.347 0.469 0 C-N-CA 124.035 0.934 . . . . 72.05 109.038 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.8 m -68.76 131.07 44.56 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 118.16 0.436 . . . . 65.03 109.939 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.609 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -77.66 -61.26 2.05 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.286 -1.005 . . . . 74.13 108.286 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 46.6 p90 -158.9 157.78 32.1 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.525 -0.761 . . . . 75.54 111.801 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 64' ' ' VAL . 57.1 tp -123.44 109.29 13.67 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.46 -1.245 . . . . 73.34 107.734 171.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.512 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 86.0 m -108.17 96.27 6.25 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.111 0.565 . . . . 74.52 110.301 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -111.42 115.67 29.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.9 -0.778 . . . . 74.44 108.9 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.65 133.06 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.603 0.761 . . . . 54.32 109.887 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.452 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 61.9 mt-30 -105.12 88.22 2.82 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 107.956 -1.127 . . . . 74.15 107.956 175.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -76.8 96.43 4.27 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.166 -0.924 . . . . 70.14 109.208 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.54 145.09 20.1 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 111.349 -0.701 . . . . 73.33 111.349 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.5 122.95 1.79 Allowed Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.696 -0.962 . . . . 62.23 110.696 -176.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.456 HG22 HD13 ' A' ' 51' ' ' LEU . 53.7 mt -80.77 127.29 39.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 108.151 -1.055 . . . . 63.42 108.151 170.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.448 ' HB3' ' CD1' ' A' ' 86' ' ' ILE . 92.8 m-85 -131.74 123.91 28.65 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.371 0.668 . . . . 74.33 109.4 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 t -86.43 98.0 10.77 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 108.903 -0.777 . . . . 73.42 108.903 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.453 HG21 ' HE3' ' A' ' 94' ' ' MET . 4.1 mm -112.5 149.24 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 122.857 0.463 . . . . 74.45 110.886 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.26 167.28 16.2 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.748 0.819 . . . . 61.45 110.827 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 97.44 -32.92 6.24 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 114.304 0.482 . . . . 74.21 114.304 172.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.436 HD11 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -113.01 150.33 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.411 0.684 . . . . 75.35 110.639 -174.513 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -138.8 174.58 10.37 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.379 1.072 . . . . 64.44 109.527 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.86 -133.28 40.56 Favored Glycine 0 C--N 1.345 1.07 0 O-C-N 123.792 0.683 . . . . 64.01 113.732 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 47.5 p -67.77 -25.51 65.65 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.876 0.87 . . . . 64.54 111.631 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -69.37 -42.74 74.79 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.387 0.675 . . . . 74.11 110.827 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.453 ' HE3' HG21 ' A' ' 86' ' ' ILE . 5.8 tpt -66.34 -46.72 75.85 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 116.004 -0.544 . . . . 65.44 109.897 177.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.36 -34.77 72.8 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.563 -0.744 . . . . 70.21 110.894 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -68.84 -34.29 75.24 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.651 -0.704 . . . . 75.12 111.431 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.9 t -65.76 -44.27 86.4 Favored 'General case' 0 C--N 1.348 0.516 0 N-CA-C 109.815 -0.439 . . . . 62.02 109.815 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.6 mt -84.22 -35.31 23.56 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.235 -0.893 . . . . 73.42 112.036 -170.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.86 3.93 49.25 Favored Glycine 0 N--CA 1.473 1.11 0 CA-C-O 119.713 -0.493 . . . . 74.41 114.2 -172.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.556 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -141.67 -66.57 0.41 Allowed 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 117.587 0.694 . . . . 73.43 111.537 -177.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -65.48 -44.59 86.61 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 115.968 -0.56 . . . . 71.31 111.581 -173.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.6 m -63.44 -51.08 70.22 Favored Pre-proline 0 CA--C 1.564 1.494 0 C-N-CA 124.03 0.932 . . . . 65.25 112.354 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.426 ' HG3' HG22 ' A' ' 46' ' ' THR . 34.5 Cg_endo -64.45 -27.13 62.48 Favored 'Trans proline' 0 C--N 1.395 2.985 0 C-N-CA 121.717 1.611 . . . . 73.55 113.491 173.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.456 HD22 ' HA ' ' A' ' 132' ' ' ASN . 3.0 m120 -60.88 -38.29 85.1 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 118.09 0.405 . . . . 71.35 110.613 172.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.586 HG21 HD12 ' A' ' 13' ' ' ILE . 47.3 mm -72.12 -44.21 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.467 0.707 . . . . 65.0 110.065 176.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 70.2 mt -71.75 -23.61 61.63 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.551 -0.749 . . . . 75.52 112.29 -173.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -63.98 -47.27 80.53 Favored Pre-proline 0 N--CA 1.483 1.207 0 CA-C-O 117.932 -1.033 . . . . 75.02 113.391 -172.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.414 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 83.0 Cg_exo -51.29 -36.15 56.01 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.138 1.892 . . . . 65.23 113.943 172.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -80.55 -39.37 27.87 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.396 0.678 . . . . 74.05 111.716 -177.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.78 -47.49 74.96 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 109.457 -0.572 . . . . 50.23 109.457 176.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.46 HH12 HD13 ' C' ' 105' ' ' ILE . 27.9 ttm180 -51.6 -47.07 63.72 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.85 1.26 . . . . 72.12 110.568 172.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.43 -49.12 78.14 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.033 0.833 . . . . 74.44 111.433 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.4 t -57.17 -47.19 81.84 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.084 0.865 . . . . 61.44 110.193 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.486 HD12 HD13 ' A' ' 128' ' ' LEU . 23.5 mt -56.75 -51.76 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.743 1.217 . . . . 72.51 111.124 174.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.9 m -56.23 -45.09 80.09 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.535 1.134 . . . . 74.24 111.108 -176.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.2 t -67.66 -41.05 84.4 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.41 -1.268 . . . . 73.45 110.006 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 11.6 mtp -59.66 -44.61 93.5 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.59 0.756 . . . . 75.13 111.054 176.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 82.1 t -59.33 -48.41 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 124.225 1.01 . . . . 64.12 110.543 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.9 p -71.19 -30.6 66.6 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.603 -0.726 . . . . 74.33 111.617 -176.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.451 HH12 ' HG3' ' B' ' 112' ' ' GLU . 80.3 mtt-85 -72.66 -28.31 62.64 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.98 0.512 . . . . 73.24 109.974 176.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.34 17.17 35.16 Favored Glycine 0 C--N 1.354 1.559 0 CA-C-O 119.291 -0.727 . . . . 70.12 113.432 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.411 HG23 ' HE ' ' B' ' 15' ' ' ARG . 1.4 t 59.73 9.96 1.84 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 127.202 2.201 . . . . 75.43 113.404 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -79.26 140.04 56.5 Favored Pre-proline 0 C--O 1.242 0.671 0 N-CA-C 108.311 -0.996 . . . . 73.33 108.311 175.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.473 ' HG3' ' HA ' ' E' ' 131' ' ' TRP . 89.6 Cg_exo -46.49 126.7 10.64 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 123.065 2.51 . . . . 72.23 112.268 172.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -50.67 131.6 25.66 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.599 1.187 . . . . 72.33 112.84 -168.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.4 tp -109.24 138.09 46.12 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.642 0.777 . . . . 70.05 109.858 -176.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -132.97 117.67 17.92 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.531 -0.914 . . . . 72.22 108.531 174.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.486 HD13 HD12 ' A' ' 114' ' ' ILE . 16.1 mt -72.72 135.29 45.33 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.152 -0.684 . . . . 71.13 109.152 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.443 ' HB3' HG22 ' E' ' 137' ' ' THR . . . -65.13 142.78 98.69 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 122.651 0.38 . . . . 73.25 111.254 -177.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.447 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 63.3 Cg_exo -54.17 118.39 4.95 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.421 2.748 . . . . 73.24 114.074 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 88.5 t -102.86 129.03 55.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 123.518 0.727 . . . . 74.31 110.272 178.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.471 ' ND2' ' HB3' ' A' ' 135' ' ' ALA . 56.6 t30 -96.37 92.89 6.54 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.678 0.791 . . . . 65.43 109.12 176.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -67.98 -22.84 64.99 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.55 -0.75 . . . . 71.3 111.368 177.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.556 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 13.5 t70 -54.91 -50.96 67.52 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.574 0.75 . . . . 75.13 110.105 172.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' ND2' ' A' ' 132' ' ' ASN . . . -60.91 -55.65 30.47 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 114.78 -1.1 . . . . 71.43 110.086 177.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 91.8 mt -56.82 -36.91 70.5 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 124.217 0.948 . . . . 73.31 112.479 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -68.14 -38.99 82.79 Favored 'General case' 0 C--O 1.219 -0.542 0 O-C-N 123.777 0.673 . . . . 74.5 110.257 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.434 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . 9.9 mmt -77.99 -48.94 15.07 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.364 0.505 . . . . 71.23 112.364 -175.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -60.69 -17.06 45.62 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 118.108 0.413 . . . . 73.33 111.445 173.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -84.51 -50.66 7.53 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.881 0.872 . . . . 75.0 111.22 168.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 48.9 tp -67.55 -55.22 14.31 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.46 0.704 . . . . 74.32 111.948 -167.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 170.54 -15.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 126.488 1.915 . . . . 73.01 109.68 -175.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.434 ' HA ' ' HB3' ' A' ' 138' ' ' MET . 0.0 OUTLIER 64.33 83.85 0.16 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.234 1.414 . . . . 72.41 108.917 -177.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -147.26 -178.75 6.39 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.688 0.795 . . . . 72.01 110.795 -169.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.78 96.47 2.56 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.526 0.73 . . . . 74.12 111.027 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -136.66 25.33 3.11 Favored Glycine 0 N--CA 1.473 1.138 0 N-CA-C 111.924 -0.47 . . . . 75.24 111.924 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -99.86 94.62 6.4 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.663 0.785 . . . . 74.44 109.461 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.439 ' O ' ' HG2' ' A' ' 9' ' ' MET . . . -163.71 41.98 0.32 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 110.519 -1.032 . . . . 64.54 110.519 177.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 32.6 p -135.55 95.34 3.24 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.412 1.085 . . . . 74.1 109.037 -177.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -139.16 153.4 47.93 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.576 0.751 . . . . 72.13 110.433 -175.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.407 ' HG2' ' CD2' ' A' ' 11' ' ' PHE . 37.1 mt-10 -74.43 113.21 11.4 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.949 0.9 . . . . 73.25 110.592 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -157.63 94.81 1.39 Allowed 'General case' 0 CA--C 1.554 1.098 0 CA-C-O 120.984 0.421 . . . . 74.22 111.327 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -178.11 -170.61 0.24 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.095 1.358 . . . . 74.22 108.939 170.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -115.64 133.25 56.21 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.545 0.738 . . . . 74.55 109.078 169.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.266 0 C-N-CA 124.108 0.963 . . . . 75.04 109.309 175.379 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 49.0 mtm . . . . . 0 N--CA 1.485 1.288 0 N-CA-C 109.763 -0.458 . . . . 74.21 109.763 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 59.1 m -145.81 34.26 1.03 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.706 0.803 . . . . 72.52 109.336 177.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -78.04 -170.57 1.99 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.462 1.105 . . . . 72.23 110.7 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 66.09 50.51 1.42 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.32 1.048 . . . . 75.25 110.403 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -56.55 134.25 54.13 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.687 1.195 . . . . 74.44 112.222 -176.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -77.21 146.53 36.93 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.35 0.66 . . . . 74.12 109.853 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 17.6 m -79.32 149.16 31.83 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.657 0.783 . . . . 73.13 110.281 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -70.24 80.0 0.52 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.731 -0.84 . . . . 65.12 108.731 173.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.621 ' HE3' ' SG ' ' B' ' 97' ' ' CYS . 27.0 ttt 64.78 166.8 0.17 Allowed 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 125.668 1.587 . . . . 74.01 111.59 -171.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 85.3 m -138.01 123.08 19.12 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.875 1.27 . . . . 64.42 108.13 169.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' B' ' 85' ' ' SER . 62.1 t80 -137.29 133.79 35.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.248 0.619 . . . . 71.34 109.608 177.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -150.57 140.13 21.57 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.568 0.747 . . . . 74.2 109.223 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.539 HD11 HD12 ' B' ' 105' ' ' ILE . 53.4 mt -83.16 130.27 36.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.23 -1.026 . . . . 75.12 108.23 171.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -98.78 -41.57 7.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.975 0.51 . . . . 75.11 110.4 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.411 ' HE ' HG23 ' A' ' 122' ' ' THR . 55.3 ttt180 -173.03 129.29 0.48 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.617 -0.72 . . . . 74.4 109.177 -175.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.592 HG21 ' CD1' ' B' ' 109' ' ' TYR . 75.1 mt -116.32 148.89 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.448 -0.945 . . . . 70.11 108.448 173.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -167.09 161.95 15.06 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-O 121.671 0.748 . . . . 71.24 112.016 -175.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.4 m -88.26 123.03 32.46 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.191 -1.368 . . . . 71.33 108.408 168.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.436 ' HZ2' HG22 ' B' ' 59' ' ' VAL . 43.0 mttp -80.05 -51.76 8.64 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.233 0.613 . . . . 75.11 110.593 170.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -144.85 141.77 29.39 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.283 -0.417 . . . . 64.51 110.725 -164.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.504 HD13 ' SG ' ' B' ' 113' ' ' CYS . 46.3 mm -134.95 138.66 48.73 Favored 'Isoleucine or valine' 0 C--N 1.354 0.791 0 C-N-CA 124.572 1.149 . . . . 71.42 109.726 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 40.2 t -138.32 128.47 25.76 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.923 1.289 . . . . 70.31 107.65 176.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.405 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 77.5 t80 -144.29 114.32 7.36 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 107.974 -1.121 . . . . 65.24 107.974 171.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -122.43 116.98 24.91 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.076 0.95 . . . . 74.33 108.941 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.18 86.57 3.35 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 107.595 -1.261 . . . . 72.12 107.595 169.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.86 -30.64 40.08 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.956 2.437 . . . . 71.21 112.715 -170.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -107.87 12.27 27.35 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 118.407 -0.806 . . . . 74.23 110.899 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -31.24 -73.22 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.918 0 C-N-CA 126.026 1.73 . . . . 74.32 114.604 -164.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.462 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 27.6 Cg_endo -64.06 -26.19 65.88 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 122.084 1.856 . . . . 74.14 112.954 -170.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -87.11 -41.74 13.56 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.14 -0.936 . . . . 65.44 111.383 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.54 HG22 HD11 ' B' ' 68' ' ' LEU . 8.8 p -69.18 -17.75 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.218 0.607 . . . . 71.1 111.175 -175.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -65.54 -11.09 40.6 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.128 0.788 . . . . 74.1 113.128 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.473 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.2 pt20 -63.13 -13.72 40.02 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.455 0.702 . . . . 73.4 111.446 172.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.475 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 97.9 mttt -109.06 110.3 21.53 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.779 1.632 . . . . 75.44 110.629 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -111.27 88.95 2.92 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.641 0.776 . . . . 64.22 109.822 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.594 ' HA ' ' HB1' ' F' ' 130' ' ' ALA . 33.7 p90 -167.66 172.49 9.28 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.879 0.872 . . . . 74.12 109.098 170.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -65.18 110.17 3.91 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 123.424 0.69 . . . . 74.2 110.704 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -64.83 166.3 18.63 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.051 1.834 . . . . 74.35 112.384 -177.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 33.8 tt0 -64.35 100.84 0.38 Allowed 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.509 -1.293 . . . . 62.14 107.509 168.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.474 HG11 HD13 ' B' ' 126' ' ' LEU . 54.6 t -104.32 149.31 8.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.213 -0.903 . . . . 70.01 109.125 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.511 ' HE3' ' HB2' ' B' ' 43' ' ' ASP . 12.6 ttpt -141.3 120.67 13.13 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.393 -1.336 . . . . 71.42 107.393 173.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.462 HD12 HD21 ' B' ' 128' ' ' LEU . 20.4 tp -88.53 134.62 33.81 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.614 -0.884 . . . . 74.44 108.614 174.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.511 ' HB2' ' HE3' ' B' ' 41' ' ' LYS . 2.5 t0 -142.41 146.66 35.11 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.879 -1.156 . . . . 62.42 107.879 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 mp -131.25 146.2 52.21 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.476 -0.565 . . . . 75.24 109.476 -175.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.514 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 35.0 m-20 -130.47 153.86 48.36 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.953 1.301 . . . . 73.52 108.087 170.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' THR . . . . . 0.457 HG21 HD21 ' F' ' 111' ' ' LEU . 5.9 t -139.11 130.86 27.49 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.344 0.593 . . . . 75.44 110.251 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.05 136.46 18.97 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.918 1.287 . . . . 75.53 107.662 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 19.0 m -140.8 175.22 9.79 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.923 0.489 . . . . 71.41 110.948 -170.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 58.9 p -151.66 136.94 17.55 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.725 0.41 . . . . 75.31 111.146 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -87.79 107.16 18.53 Favored 'General case' 0 C--N 1.349 0.545 0 N-CA-C 108.978 -0.749 . . . . 72.0 108.978 173.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.0 pp -125.34 15.43 8.32 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.273 -0.876 . . . . 72.01 109.717 177.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.76 151.1 14.25 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 124.439 1.096 . . . . 64.3 109.373 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -83.36 134.72 34.89 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.619 -0.882 . . . . 70.54 108.619 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.624 ' HB3' ' HB1' ' B' ' 87' ' ' ALA . 1.7 m-20 64.3 7.88 3.83 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.065 0.946 . . . . 74.52 112.275 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 86.8 t -142.03 112.17 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 107.556 -1.276 . . . . 71.53 107.556 -174.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.469 ' OH ' ' HB2' ' F' ' 102' ' ' LEU . 4.5 t80 -115.3 139.68 49.77 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 109.012 -0.736 . . . . 73.2 109.012 -171.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -101.33 104.37 15.36 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.79 -1.189 . . . . 72.52 107.79 -177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.403 HG13 ' HG3' ' B' ' 103' ' ' PRO . 60.1 t -101.58 135.87 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.775 0.83 . . . . 73.24 110.072 -174.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.436 HG22 ' HZ2' ' B' ' 19' ' ' LYS . 15.4 t -122.81 111.28 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.6 0.76 . . . . 72.14 108.956 177.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 56.5 tp -98.27 115.0 27.47 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.261 -0.644 . . . . 72.03 109.261 175.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.514 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 37.9 ttm180 -85.39 130.74 34.52 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.893 -0.78 . . . . 75.45 108.893 170.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 64.6 t -123.45 104.72 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 108.228 -1.027 . . . . 75.3 108.228 173.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 11.9 m -100.66 136.7 40.12 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.737 0.815 . . . . 75.24 109.906 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.604 HG23 HD12 ' B' ' 114' ' ' ILE . 76.8 t -121.1 125.83 74.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 123.957 0.903 . . . . 74.01 109.227 173.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.4 m -100.49 138.67 37.25 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 107.806 -1.183 . . . . 74.43 107.806 169.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.03 144.49 27.96 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.887 0.375 . . . . 72.01 111.08 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.433 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 34.9 p -151.96 128.52 10.74 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.271 -0.877 . . . . 73.24 110.568 -178.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.54 HD11 HG22 ' B' ' 31' ' ' VAL . 66.9 mt -91.76 98.3 11.53 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.654 -1.239 . . . . 65.03 107.654 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.07 -119.49 5.93 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 114.397 -1.274 . . . . 65.13 112.287 -174.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -100.91 1.39 39.82 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.622 0.769 . . . . 62.33 111.552 -174.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.475 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 14.3 pt-20 -122.02 148.55 44.69 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.705 -0.48 . . . . 74.42 109.705 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.5 m -68.46 133.72 49.06 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.119 0.485 . . . . 71.44 111.019 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.433 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -87.95 -64.4 1.15 Allowed 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.914 -1.143 . . . . 73.43 107.914 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -154.06 155.09 34.82 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.262 -1.335 . . . . 75.33 109.364 -177.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 72.4 mt -131.68 111.68 11.89 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.815 -1.55 . . . . 75.13 106.815 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 37.5 t -117.78 151.51 37.17 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.912 -0.773 . . . . 72.41 108.912 -176.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 34.9 tt0 -162.1 129.26 3.84 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.768 -0.826 . . . . 64.32 108.768 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.464 HG22 HG13 ' B' ' 114' ' ' ILE . 85.6 t -124.44 149.68 28.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 124.013 0.925 . . . . 73.22 108.535 178.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -126.51 95.83 4.48 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.181 -1.044 . . . . 74.35 108.181 171.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -90.75 107.39 19.15 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.671 -0.863 . . . . 75.04 108.671 -176.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.94 154.82 20.3 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 112.075 -0.41 . . . . 74.54 112.075 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.5 132.83 3.13 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 117.089 0.444 . . . . 71.24 112.938 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 3.7 mp -86.02 113.66 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 N-CA-C 107.941 -1.133 . . . . 74.14 107.941 170.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -121.48 153.83 37.41 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.786 0.834 . . . . 74.4 109.266 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 49.1 m -100.71 107.41 19.01 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.245 0.618 . . . . 74.25 109.868 176.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.28 102.0 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 106.676 -1.601 . . . . 71.14 106.676 175.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.624 ' HB1' ' HB3' ' B' ' 54' ' ' ASP . . . -147.77 170.84 16.73 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.24 0.616 . . . . 61.12 111.368 -169.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.39 -54.62 4.86 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-O 121.253 0.363 . . . . 63.14 112.414 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.57 HG13 ' HG3' ' B' ' 9' ' ' MET . 1.1 pp -68.4 168.57 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.242 1.017 . . . . 70.53 111.826 171.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.59 -171.3 3.63 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.168 -0.924 . . . . 73.13 110.092 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.64 -132.57 22.53 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 115.081 -0.963 . . . . 64.31 114.166 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 15.8 m -83.55 -40.97 18.44 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.953 0.901 . . . . 63.25 109.86 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.519 ' HB2' ' HG3' ' B' ' 144' ' ' GLN . 38.9 tt0 -65.49 -25.99 67.72 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 113.609 -1.632 . . . . 74.52 112.131 -165.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.643 ' HE3' ' HD2' ' F' ' 101' ' ' PRO . 0.0 OUTLIER -65.05 -40.82 95.31 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.054 0.942 . . . . 75.0 112.642 -177.728 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.23 -14.05 59.83 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.048 0.539 . . . . 75.14 112.276 -177.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -64.84 -32.44 74.15 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.833 0.453 . . . . 74.35 110.537 170.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.621 ' SG ' ' HE3' ' B' ' 9' ' ' MET . 41.2 t -66.12 -56.29 12.2 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.592 0.357 . . . . 73.23 110.889 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.431 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.5 pp -67.2 -21.71 65.76 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.711 0.404 . . . . 75.02 111.378 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.84 0.37 57.73 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-O 119.093 -0.837 . . . . 65.04 114.506 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.572 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -148.4 -56.07 0.21 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 118.39 1.095 . . . . 75.14 111.937 -177.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -68.4 -43.79 76.51 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.436 0.695 . . . . 71.13 111.393 -173.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.437 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 58.9 m -70.89 -47.42 15.41 Favored Pre-proline 0 CA--C 1.562 1.441 0 C-N-CA 123.477 0.711 . . . . 74.44 112.21 -176.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.437 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 31.9 Cg_exo -60.85 -28.32 86.22 Favored 'Trans proline' 0 C--N 1.394 2.931 0 C-N-CA 121.953 1.769 . . . . 72.35 113.346 173.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.25 -32.9 72.71 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.577 0.751 . . . . 70.22 111.849 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.539 HD12 HD11 ' B' ' 13' ' ' ILE . 70.0 mt -75.6 -34.94 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.639 0.776 . . . . 65.23 110.155 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 85.4 mt -75.44 -31.8 60.45 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.207 -0.906 . . . . 74.04 111.372 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -57.67 -48.63 96.87 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 113.885 1.068 . . . . 73.45 113.885 -173.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.8 -32.48 91.81 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 122.293 1.996 . . . . 74.54 113.211 177.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.592 ' CD1' HG21 ' B' ' 16' ' ' ILE . 5.0 m-30 -79.53 -37.69 35.96 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.315 0.646 . . . . 75.53 110.514 -176.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.46 -37.95 88.39 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.35 -0.841 . . . . 71.34 110.077 173.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.522 ' HA ' HD12 ' B' ' 128' ' ' LEU . 46.2 ttt-85 -61.02 -55.24 35.11 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.888 1.275 . . . . 74.25 110.181 177.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . 0.451 ' HG3' HH12 ' A' ' 120' ' ' ARG . 13.3 tp10 -61.24 -35.23 76.67 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.903 0.881 . . . . 73.35 110.747 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.58 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.0 t -69.13 -32.59 72.06 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 110.267 -0.271 . . . . 73.22 110.267 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.604 HD12 HG23 ' B' ' 64' ' ' VAL . 69.0 mt -71.19 -56.42 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.443 0.697 . . . . 72.3 110.411 174.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 22.7 m -58.24 -28.56 64.99 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.39 1.076 . . . . 74.4 111.416 -174.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.5 t -63.05 -57.14 11.67 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-N 115.782 -0.645 . . . . 74.12 109.574 171.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.58 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.2 mmt -64.02 -36.75 85.0 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.562 0.745 . . . . 65.42 111.254 -173.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.463 HG23 HD22 ' B' ' 126' ' ' LEU . 82.3 t -57.97 -50.08 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 124.545 1.138 . . . . 73.33 110.075 175.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 47.2 t -73.48 -20.25 60.73 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.785 -1.098 . . . . 74.33 111.496 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 90.9 mtt-85 -68.77 -31.19 70.04 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 110.149 -0.315 . . . . 74.44 110.149 173.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . 0.447 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -78.65 -4.72 87.99 Favored Glycine 0 C--N 1.355 1.607 0 O-C-N 123.62 0.575 . . . . 64.41 112.485 168.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 8.6 m 62.93 33.36 15.04 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 125.684 1.594 . . . . 65.13 110.19 -177.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -76.92 163.75 63.47 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 114.353 -1.294 . . . . 75.21 110.534 176.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.435 ' HG3' ' O ' ' B' ' 36' ' ' TRP . 36.3 Cg_endo -61.34 157.34 41.11 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 122.557 2.171 . . . . 75.34 111.63 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -63.01 130.11 43.29 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.374 0.606 . . . . 65.22 111.924 -171.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.474 HD13 HG11 ' B' ' 40' ' ' VAL . 59.9 tp -120.74 99.86 6.77 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.485 -1.234 . . . . 73.45 109.004 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -95.66 121.99 37.95 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.75 -1.204 . . . . 72.54 107.75 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' B' ' 111' ' ' ARG . 38.6 mt -79.79 132.88 36.25 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 117.831 0.287 . . . . 72.24 110.522 176.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.45 131.82 82.21 Favored Pre-proline 0 C--O 1.243 0.717 0 O-C-N 123.993 0.808 . . . . 75.01 110.91 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.541 ' HG3' HD11 ' D' ' 16' ' ' ILE . 54.0 Cg_endo -67.85 110.04 2.05 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.456 2.104 . . . . 75.33 110.698 172.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 7.7 p -88.18 141.95 13.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 N-CA-C 108.134 -1.062 . . . . 75.2 108.134 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -78.61 72.72 5.15 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 122.537 1.161 . . . . 74.34 108.645 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -65.24 -35.13 80.1 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 112.701 -2.045 . . . . 72.43 110.596 -170.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.572 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 20.6 t70 -58.44 -55.29 36.93 Favored 'General case' 0 C--N 1.349 0.554 0 CA-C-N 114.497 -1.229 . . . . 64.31 110.684 177.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.502 ' HA ' ' HB3' ' B' ' 138' ' ' MET . . . -63.49 -33.22 75.1 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 124.257 0.973 . . . . 75.15 112.057 -175.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.524 HD13 ' HB3' ' F' ' 120' ' ' TYR . 37.1 tp -55.15 -46.62 75.7 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.219 1.008 . . . . 73.42 110.918 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -92.19 -15.7 27.24 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.304 0.483 . . . . 74.11 112.304 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.502 ' HB3' ' HA ' ' B' ' 135' ' ' ALA . 59.0 ttp -64.84 -37.24 86.97 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.766 0.426 . . . . 75.52 110.594 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -76.24 -24.21 54.56 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 123.208 0.317 . . . . 73.34 111.125 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -78.09 -38.43 44.14 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 109.9 -0.407 . . . . 74.44 109.9 177.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 6.1 mp -108.85 31.85 5.35 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.966 0.906 . . . . 70.32 110.308 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -67.4 -39.43 85.57 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.374 0.669 . . . . 73.03 110.111 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -67.0 109.13 2.85 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.608 0.763 . . . . 71.12 111.187 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . 0.519 ' HG3' ' HB2' ' B' ' 93' ' ' GLN . 21.6 tm0? -164.15 -77.47 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 109.07 -0.715 . . . . 72.34 109.07 176.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -179.13 -173.79 0.3 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.802 1.241 . . . . 65.33 109.869 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -158.88 -156.18 7.93 Favored Glycine 0 C--N 1.345 1.035 0 N-CA-C 111.405 -0.678 . . . . 74.32 111.405 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -161.35 163.52 30.67 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.574 0.75 . . . . 74.42 110.803 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -103.28 -152.39 23.4 Favored Glycine 0 C--N 1.347 1.161 0 N-CA-C 111.401 -0.68 . . . . 44.33 111.401 174.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 149' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' D' ' 150' ' ' GLU . 17.9 p -124.74 -77.36 0.59 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.573 0.749 . . . . 75.22 109.769 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 178.99 117.38 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.158 0.983 . . . . 72.32 109.116 172.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.58 108.66 8.55 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.792 0.837 . . . . 73.4 110.761 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -165.27 178.97 6.54 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.133 0.973 . . . . 73.54 109.786 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -110.02 -67.3 1.0 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.022 -0.732 . . . . 74.53 109.022 172.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -174.71 -48.42 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.376 1.071 . . . . 73.34 108.472 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.132 0 CA-C-N 115.335 -0.848 . . . . 75.31 109.213 178.061 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 84.8 mtp . . . . . 0 N--CA 1.484 1.275 0 CA-C-O 121.152 0.501 . . . . 74.11 110.119 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 52.4 p -136.58 36.21 2.68 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.998 0.919 . . . . 71.54 109.399 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.61 140.83 57.26 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 114.598 -1.183 . . . . 74.21 111.636 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -151.64 139.85 20.29 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.768 0.827 . . . . 73.04 109.653 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -86.0 -12.25 50.83 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.552 0.741 . . . . 74.4 111.068 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -62.86 130.76 46.25 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.32 0.648 . . . . 75.51 110.153 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -83.89 57.98 4.43 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 122.289 1.042 . . . . 75.44 109.975 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -61.68 -43.71 98.33 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-N 114.797 -1.092 . . . . 75.51 109.882 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 18.9 ttt 61.06 113.48 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.817 1.247 . . . . 70.23 110.962 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.587 HG22 ' H ' ' E' ' 140' ' ' GLY . 19.5 m -128.42 108.41 10.54 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.039 0.447 . . . . 74.33 110.672 -174.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.48 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 75.6 t80 -97.58 145.64 26.06 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.229 1.012 . . . . 74.4 109.265 175.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 45.8 tp60 -151.81 142.87 23.16 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.268 0.627 . . . . 73.22 109.383 170.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 23.0 mt -88.18 131.9 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 108.107 -1.071 . . . . 74.43 108.107 173.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -90.26 -47.05 8.02 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.065 -0.717 . . . . 75.01 109.065 172.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -179.25 143.54 0.21 Allowed 'General case' 0 C--O 1.239 0.517 0 CA-C-N 113.914 -1.494 . . . . 75.31 108.424 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 pp -107.72 152.31 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.751 -1.203 . . . . 73.51 107.751 175.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.617 ' HB3' HG22 ' D' ' 122' ' ' THR . 23.6 p90 -173.77 142.41 0.9 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.317 0.58 . . . . 74.43 111.368 -175.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -76.27 127.11 32.23 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.294 1.038 . . . . 63.42 110.669 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -86.31 -22.23 26.87 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.58 -0.896 . . . . 60.44 108.58 168.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.625 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.2 t70 -148.53 133.42 18.05 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.759 -0.655 . . . . 61.22 109.419 -175.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 63.6 mt -136.57 137.33 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 106.035 -1.839 . . . . 71.44 106.035 170.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.3 t -155.16 151.8 28.65 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.516 0.674 . . . . 73.0 112.174 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -153.31 143.73 22.48 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 113.747 -1.57 . . . . 74.15 107.843 174.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -145.57 113.52 6.48 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.174 0.589 . . . . 74.54 110.161 -177.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.23 77.21 48.83 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 108.059 -1.089 . . . . 44.41 108.059 164.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.46 -25.31 63.26 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.708 2.272 . . . . 73.3 111.938 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -94.39 18.65 10.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.111 1.364 . . . . 74.13 111.451 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.59 -57.24 5.9 Favored Pre-proline 0 CA--C 1.559 1.294 0 N-CA-C 113.837 1.051 . . . . 73.3 113.837 -170.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -61.72 -36.74 72.89 Favored 'Trans proline' 0 C--N 1.386 2.507 0 CA-C-N 121.575 1.598 . . . . 72.4 112.468 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -70.06 -40.25 75.18 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.967 0.907 . . . . 75.44 112.39 -178.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.735 HG21 ' HA ' ' C' ' 73' ' ' ALA . 11.3 p -76.78 -26.11 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 N-CA-C 112.649 0.611 . . . . 74.12 112.649 -176.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -61.73 -29.24 69.98 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 112.933 0.716 . . . . 75.32 112.933 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -91.72 13.09 19.16 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.921 0.488 . . . . 72.1 112.073 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.675 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -97.4 163.24 12.96 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.727 0.811 . . . . 74.34 109.662 177.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.62 127.96 34.91 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.425 0.69 . . . . 63.1 109.573 170.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -84.27 83.43 7.98 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.535 0.734 . . . . 74.12 110.808 -176.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -134.9 78.93 53.09 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.77 0.828 . . . . 74.14 108.799 171.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -86.76 154.39 8.77 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.755 2.303 . . . . 73.44 112.405 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -88.68 82.06 6.92 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.126 -1.435 . . . . 64.21 107.126 166.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 44.4 t -68.82 95.97 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.663 0 N-CA-C 107.856 -1.164 . . . . 71.44 107.856 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.75 ' HZ2' ' HB2' ' C' ' 43' ' ' ASP . 0.4 OUTLIER -104.18 104.87 14.86 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.124 -1.435 . . . . 71.12 107.124 -178.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.461 HD21 HD21 ' C' ' 128' ' ' LEU . 2.2 mp -86.74 144.97 26.84 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.689 -1.226 . . . . 73.51 107.689 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.75 ' HB2' ' HZ2' ' C' ' 41' ' ' LYS . 32.6 t70 -138.26 140.97 39.87 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.176 -0.676 . . . . 73.03 109.176 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 92.8 mt -126.59 111.61 14.55 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.718 -0.845 . . . . 75.42 108.718 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -113.94 143.82 44.08 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.018 -1.475 . . . . 72.44 107.018 169.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.3 t -139.05 154.22 48.18 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 120.939 0.399 . . . . 71.23 110.034 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.82 156.26 42.98 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.172 -0.922 . . . . 74.23 108.99 175.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 30.5 p -152.66 150.45 29.48 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.27 0.628 . . . . 74.32 109.976 -175.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 49.9 p -160.56 144.85 14.05 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.201 0.6 . . . . 73.53 110.388 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -77.83 130.52 36.77 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.396 0.678 . . . . 74.24 110.176 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.732 HD12 ' HB2' ' C' ' 57' ' ' GLU . 54.0 mt -95.94 -39.75 9.63 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.521 0.729 . . . . 73.23 109.981 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.24 -171.41 2.6 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.847 0.859 . . . . 50.23 110.363 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -60.26 115.48 3.54 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.182 -0.917 . . . . 74.24 110.403 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 63.16 18.04 10.65 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.051 1.34 . . . . 65.54 111.733 177.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.8 t -121.76 117.56 52.89 Favored 'Isoleucine or valine' 0 C--N 1.354 0.763 0 C-N-CA 124.64 1.176 . . . . 54.24 108.578 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -131.14 130.35 42.96 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.313 1.045 . . . . 72.31 109.114 -176.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.732 ' HB2' HD12 ' C' ' 51' ' ' LEU . 40.0 tt0 -95.85 139.6 31.82 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.186 0.595 . . . . 73.51 109.841 173.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.01 135.01 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 108.648 -0.871 . . . . 75.31 108.648 170.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.509 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 84.3 t -113.75 144.08 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.111 0.964 . . . . 73.13 108.619 171.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.77 107.22 10.32 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.342 -0.984 . . . . 75.15 108.342 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 35.4 ttm-85 -82.08 107.63 14.93 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.517 0.727 . . . . 75.03 109.047 171.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 26.2 t -106.87 112.45 39.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.342 -0.984 . . . . 74.11 108.342 170.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 31.7 m -104.49 144.34 31.8 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.382 -0.827 . . . . 73.11 109.181 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.681 HG23 HG21 ' C' ' 114' ' ' ILE . 88.6 t -132.42 111.53 17.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 N-CA-C 107.301 -1.37 . . . . 74.41 107.301 175.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.0 m -99.11 137.27 37.87 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.908 -1.145 . . . . 71.41 107.908 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.38 104.88 5.29 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.441 -0.948 . . . . 63.34 108.441 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.9 m -129.56 132.2 46.76 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.99 0.424 . . . . 71.31 110.255 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.421 HD11 ' HG2' ' C' ' 34' ' ' LYS . 14.9 mt -85.36 36.94 0.66 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.623 1.169 . . . . 75.11 110.307 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.1 -108.05 2.64 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 110.954 -0.858 . . . . 61.42 110.954 -172.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -90.21 -31.98 16.79 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.113 0.565 . . . . 75.3 110.42 176.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -70.58 119.99 15.54 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.521 -0.918 . . . . 71.11 108.521 171.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 31.3 m -82.72 125.12 30.89 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.333 -0.988 . . . . 72.01 108.333 170.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.735 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.17 -52.6 18.29 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 109.226 -0.657 . . . . 74.4 109.226 176.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . 0.552 ' HZ ' HD23 ' C' ' 126' ' ' LEU . 33.9 p90 -165.7 169.6 14.99 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.653 -1.158 . . . . 73.43 110.913 176.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -128.48 143.25 50.95 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.422 -1.695 . . . . 73.33 106.422 167.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.513 ' SG ' HG22 ' C' ' 114' ' ' ILE . 48.6 t -150.03 122.97 8.75 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.17 -0.678 . . . . 62.12 109.17 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -137.98 134.22 34.61 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.547 -0.538 . . . . 74.24 109.547 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 71.7 t -128.75 136.76 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.093 0.957 . . . . 75.33 108.895 175.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.625 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.1 mt-30 -116.37 87.73 2.75 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.048 -1.093 . . . . 73.53 108.048 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -78.8 102.53 8.2 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.517 -1.22 . . . . 65.32 110.139 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -84.32 -179.64 51.62 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 116.511 -0.313 . . . . 63.24 112.646 173.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.46 134.42 2.27 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-O 119.96 -0.356 . . . . 74.52 112.511 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.522 HG12 ' HE1' ' C' ' 17' ' ' TYR . 33.5 mm -88.66 127.53 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.336 -0.987 . . . . 75.41 108.336 173.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -129.35 140.01 51.52 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.371 0.668 . . . . 73.01 110.595 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 57.8 m -97.42 103.51 15.45 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.551 0.74 . . . . 62.52 109.492 170.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.566 HG21 ' HE2' ' C' ' 94' ' ' MET . 51.0 mt -116.71 135.15 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.639 0.776 . . . . 75.32 109.358 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.92 164.38 30.24 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.157 0.583 . . . . 72.05 110.783 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.46 -18.2 57.9 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.711 -0.677 . . . . 63.54 114.487 172.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.658 HD13 ' HA ' ' C' ' 94' ' ' MET . 40.3 pt -119.91 173.55 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-N 118.019 0.91 . . . . 75.41 112.948 -171.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.525 ' HA ' ' HB2' ' E' ' 145' ' ' ASP . 12.1 pt-20 -161.74 178.99 8.47 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 114.028 -1.442 . . . . 71.32 109.769 174.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.96 -124.27 31.96 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 115.072 0.789 . . . . 74.2 115.072 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 4.6 m -72.28 -27.6 62.58 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.004 0.922 . . . . 73.44 111.21 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -67.15 -47.77 70.04 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.493 0.717 . . . . 73.31 109.558 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.658 ' HA ' HD13 ' C' ' 89' ' ' ILE . 4.6 tpt -55.03 -49.26 72.01 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 114.936 -1.029 . . . . 74.31 111.43 169.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.71 -33.37 68.35 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.785 0.678 . . . . 72.11 111.439 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . 0.4 ' HA ' ' CE1' ' C' ' 137' ' ' PHE . 14.6 t-80 -77.35 -36.16 53.96 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.016 0.526 . . . . 73.13 111.795 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 30.2 t -67.06 -36.58 82.34 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.999 -0.741 . . . . 64.43 108.999 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 55.6 mt -86.96 -22.51 25.54 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.522 1.129 . . . . 73.32 111.439 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.91 -29.19 23.97 Favored Glycine 0 C--N 1.346 1.093 0 O-C-N 123.489 0.493 . . . . 74.01 113.962 -172.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.35 -56.0 0.85 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.854 0.462 . . . . 63.2 111.351 -171.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -63.87 -59.0 5.07 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 123.543 0.527 . . . . 75.41 111.74 -169.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.48 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 72.9 m -58.83 -49.93 90.72 Favored Pre-proline 0 CA--C 1.559 1.309 0 CA-C-O 118.241 -0.885 . . . . 65.41 111.9 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.451 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 52.7 Cg_exo -57.94 -33.56 97.28 Favored 'Trans proline' 0 C--N 1.393 2.903 0 C-N-CA 122.122 1.882 . . . . 72.04 113.54 174.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -70.74 -28.45 64.72 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.832 0.453 . . . . 71.04 110.833 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.46 HD13 HH12 ' A' ' 111' ' ' ARG . 33.0 mm -74.75 -37.39 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.004 0.522 . . . . 74.31 109.833 173.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 82.4 mt -73.01 -25.18 60.88 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.894 0.877 . . . . 75.11 112.038 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . 0.404 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 71.7 t80 -58.23 -52.6 73.38 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 117.717 -1.135 . . . . 74.45 113.813 -174.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . 0.404 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 52.9 Cg_exo -55.3 -34.4 88.39 Favored 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 121.917 1.745 . . . . 74.14 113.258 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -74.82 -45.55 42.56 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.492 0.717 . . . . 64.41 111.264 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.77 -35.05 75.45 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.872 0.869 . . . . 71.13 110.325 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -64.23 -49.72 70.85 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.408 1.483 . . . . 75.45 110.481 178.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -68.48 -34.21 75.53 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.127 0.571 . . . . 75.0 110.571 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . 0.624 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 18.1 m -60.18 -53.61 55.67 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.973 0.509 . . . . 73.42 111.124 174.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.681 HG21 HG23 ' C' ' 64' ' ' VAL . 98.6 mt -58.98 -50.43 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 123.494 0.496 . . . . 74.23 110.02 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.3 m -50.17 -44.91 52.94 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 124.36 1.037 . . . . 75.24 111.415 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.3 t -66.32 -43.15 87.01 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.232 -0.895 . . . . 74.55 109.786 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.845 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.1 OUTLIER -60.28 -46.19 90.71 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.226 1.01 . . . . 64.23 111.664 178.018 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.497 HG23 ' O ' ' C' ' 114' ' ' ILE . 61.4 t -60.88 -43.31 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.723 0.809 . . . . 72.51 109.482 177.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 13.5 t -63.26 -39.12 93.7 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.038 -1.437 . . . . 72.21 111.993 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -71.61 -37.15 70.98 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.342 0.657 . . . . 54.54 109.883 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.2 -4.08 67.25 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.982 0.801 . . . . 61.23 112.608 172.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 24.9 p 65.61 26.19 11.6 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.527 1.931 . . . . 74.1 113.288 170.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -83.04 150.05 60.53 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 108.539 -0.912 . . . . 75.35 108.539 171.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -47.33 138.75 17.42 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 123.342 2.695 . . . . 64.35 113.02 174.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -57.26 145.78 30.73 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.196 0.935 . . . . 75.45 113.514 -171.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.552 HD23 ' HZ ' ' C' ' 74' ' ' PHE . 3.4 pp -147.47 119.12 7.99 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.182 -0.917 . . . . 75.45 109.133 173.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -113.72 115.11 27.31 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.352 -1.351 . . . . 73.24 107.352 176.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.461 HD21 HD21 ' C' ' 42' ' ' LEU . 6.0 mp -61.22 134.15 56.69 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 124.156 0.91 . . . . 73.53 111.321 -170.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.39 146.77 96.05 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 123.513 0.725 . . . . 73.33 110.59 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.795 ' HG2' HG22 ' A' ' 13' ' ' ILE . 46.0 Cg_exo -55.93 104.1 0.13 Allowed 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.584 2.189 . . . . 65.02 112.295 174.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 52.7 t -99.08 113.65 34.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.157 -1.053 . . . . 73.23 108.157 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -75.66 103.32 5.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.954 0.501 . . . . 73.22 110.124 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -62.8 -28.13 69.78 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.441 0.696 . . . . 71.51 111.185 177.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.38 -43.13 86.74 Favored 'General case' 0 C--N 1.349 0.572 0 O-C-N 123.726 0.641 . . . . 75.35 109.769 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.53 -40.31 71.67 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.186 0.994 . . . . 74.4 111.051 175.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.598 HD22 ' HH ' ' F' ' 138' ' ' TYR . 49.8 mt -76.46 -35.0 58.7 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.116 -0.947 . . . . 74.15 111.158 -176.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . 0.4 ' CE1' ' HA ' ' C' ' 96' ' ' HIS . 42.2 t80 -81.29 -21.48 39.3 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.922 0.489 . . . . 73.54 111.428 -177.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 65.3 mtt -68.47 -33.52 74.32 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.709 0.403 . . . . 63.32 109.927 172.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -61.88 -36.63 81.82 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.848 0.859 . . . . 64.11 110.118 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -69.39 -87.97 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.486 -0.779 . . . . 73.43 110.021 172.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 43.3 tp 59.32 166.25 0.06 Allowed 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 124.367 1.067 . . . . 74.4 110.994 -169.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -148.7 -80.8 0.13 Allowed 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.094 -1.003 . . . . 73.13 109.38 174.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.29 108.09 18.54 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.607 -0.886 . . . . 62.24 108.607 -172.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -73.5 93.77 2.03 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.236 1.014 . . . . 74.15 111.648 -174.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 53.18 32.48 13.35 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.957 1.303 . . . . 74.34 114.411 163.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.44 70.38 3.11 Favored Glycine 0 C--N 1.347 1.19 0 N-CA-C 110.662 -0.975 . . . . 71.11 110.662 175.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -116.34 124.86 51.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.063 0.945 . . . . 64.24 108.611 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -155.55 24.72 0.58 Allowed Glycine 0 C--N 1.34 0.797 0 N-CA-C 111.362 -0.695 . . . . 73.02 111.362 175.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 46.2 m -73.89 106.74 5.74 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.042 0.937 . . . . 72.24 110.614 -174.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -113.89 104.61 12.35 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.258 -1.015 . . . . 71.32 108.258 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -106.23 127.01 52.92 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.206 0.602 . . . . 72.41 109.511 176.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -137.37 109.78 7.41 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.371 0.605 . . . . 72.53 111.229 -168.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -103.18 138.36 40.09 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.916 -1.142 . . . . 62.22 107.916 168.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -70.54 120.61 16.43 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.084 -0.71 . . . . 61.53 109.084 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 N-CA-C 108.395 -0.965 . . . . 62.32 108.395 178.923 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.574 ' HA ' ' HA ' ' F' ' 123' ' ' ASP . 11.8 tpt . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.884 0.373 . . . . 74.44 110.074 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m -82.92 83.95 7.6 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.104 0.562 . . . . 63.14 110.66 -178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -175.3 143.07 0.64 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.679 0.792 . . . . 74.42 109.984 172.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -156.49 116.06 3.52 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.226 -1.398 . . . . 71.11 107.226 171.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -162.92 147.51 11.54 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.318 0.647 . . . . 71.44 109.451 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -75.28 124.17 26.61 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.334 -0.617 . . . . 72.45 109.334 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 45.3 p -110.65 -168.58 1.33 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.883 0.873 . . . . 72.42 109.559 176.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -72.03 -149.43 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.204 0.602 . . . . 72.03 110.508 170.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.488 ' HG2' HG13 ' D' ' 89' ' ' ILE . 0.3 OUTLIER -30.53 123.28 0.19 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 125.27 1.428 . . . . 73.55 112.761 177.467 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.414 ' HG1' ' HB2' ' D' ' 87' ' ' ALA . 27.2 p -105.38 126.96 52.7 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.303 0.641 . . . . 73.44 109.501 -177.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -142.78 104.44 4.35 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.434 -1.321 . . . . 73.24 107.434 174.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . 0.425 HE22 ' HB3' ' D' ' 85' ' ' SER . 0.4 OUTLIER -142.96 147.23 34.87 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.256 -0.646 . . . . 74.12 109.256 176.137 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mt -93.15 127.79 45.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.628 -1.249 . . . . 71.22 107.628 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.606 ' HB2' HG21 ' D' ' 83' ' ' ILE . 34.5 mt-30 -90.51 -31.02 16.93 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 123.588 0.555 . . . . 73.35 110.041 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -167.57 131.05 1.72 Allowed 'General case' 0 C--N 1.347 0.487 0 CA-C-N 115.984 -0.553 . . . . 73.54 110.259 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.541 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.8 mp -103.57 140.69 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 106.662 -1.607 . . . . 74.21 106.662 171.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -165.01 141.08 5.58 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.46 0.573 . . . . 74.13 111.981 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.7 p -84.08 114.33 21.67 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.651 -0.704 . . . . 73.31 109.772 175.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.0 mtpt -83.81 -10.25 58.19 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.309 -0.859 . . . . 74.13 110.309 175.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.634 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 14.2 t70 -166.01 144.86 5.94 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.609 1.164 . . . . 74.12 108.907 176.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.845 HG21 ' HE1' ' C' ' 117' ' ' MET . 82.6 mt -139.81 145.56 26.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 125.267 1.427 . . . . 72.32 107.428 174.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -153.41 144.36 22.84 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 123.634 0.584 . . . . 74.11 110.522 176.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -153.4 129.43 10.32 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.063 -1.458 . . . . 71.51 107.063 171.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -140.61 119.16 12.3 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.325 0.65 . . . . 71.43 110.407 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.02 90.04 3.37 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 108.132 -1.062 . . . . 63.41 108.132 170.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.97 -42.71 2.96 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 123.582 2.855 . . . . 73.13 113.072 -171.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -96.81 20.9 10.26 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.491 0.716 . . . . 72.44 110.708 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.429 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -40.13 -66.66 0.34 Allowed Pre-proline 0 CA--C 1.576 1.964 0 N-CA-C 116.109 1.892 . . . . 64.25 116.109 -155.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.483 ' HB3' HD11 ' C' ' 83' ' ' ILE . 66.9 Cg_endo -74.35 -22.49 16.3 Favored 'Trans proline' 0 C--N 1.393 2.881 0 CA-C-N 123.686 2.352 . . . . 64.33 113.712 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -70.97 -37.95 72.76 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.836 0.854 . . . . 73.53 110.079 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.52 HG22 ' HG3' ' D' ' 71' ' ' GLU . 5.1 p -83.85 -19.78 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 122.615 0.366 . . . . 63.31 111.392 -173.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.406 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 23.3 m-30 -64.12 -18.58 64.55 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 112.411 0.523 . . . . 73.42 112.411 173.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -57.6 -26.26 61.26 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.713 0.805 . . . . 64.2 110.696 172.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.458 ' CB ' ' HB3' ' D' ' 68' ' ' LEU . 28.8 mmtp -85.74 99.43 11.33 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.728 1.211 . . . . 74.33 109.233 174.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -94.58 85.11 4.42 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 122.726 0.411 . . . . 71.43 110.336 -178.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 39.6 p90 -167.68 179.73 4.69 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.216 1.006 . . . . 73.44 109.824 169.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -68.79 118.34 59.82 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.248 0.619 . . . . 74.32 110.045 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.61 124.94 16.91 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.863 2.375 . . . . 74.43 111.89 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -63.31 108.72 1.37 Allowed 'General case' 0 C--N 1.353 0.759 0 N-CA-C 109.285 -0.635 . . . . 75.03 109.285 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.696 HG22 ' HB3' ' D' ' 66' ' ' ALA . 73.4 t -100.07 131.56 47.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.258 -0.883 . . . . 61.35 108.878 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.404 ' HE2' ' HB ' ' D' ' 65' ' ' THR . 0.0 OUTLIER -111.07 149.13 31.23 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 107.815 -1.18 . . . . 75.14 107.815 169.403 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.423 HD12 HG12 ' D' ' 62' ' ' VAL . 37.1 tp -116.19 136.23 53.2 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 116.037 -0.529 . . . . 74.34 110.212 -177.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.533 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 0.6 OUTLIER -126.92 132.23 50.93 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 107.382 -1.34 . . . . 75.14 107.382 172.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.587 HD12 HG23 ' E' ' 121' ' ' VAL . 89.5 mt -125.18 130.81 52.89 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.093 0.473 . . . . 72.42 110.084 178.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -134.53 120.15 19.33 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.209 -1.404 . . . . 74.35 107.209 177.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 46' ' ' THR . . . . . 0.422 HG21 ' HG3' ' D' ' 103' ' ' PRO . 56.7 m -105.56 148.51 27.2 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.365 0.602 . . . . 63.13 110.266 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.27 -179.11 6.93 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.668 1.187 . . . . 73.53 108.721 173.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 25.8 p -159.94 -164.13 1.25 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.112 -1.44 . . . . 71.14 107.112 174.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 79.1 p -150.91 145.13 25.43 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 109.694 -0.484 . . . . 74.44 109.694 174.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . 0.425 ' HG2' ' HB2' ' D' ' 52' ' ' ALA . 49.9 tt0 72.43 123.37 0.04 OUTLIER 'General case' 0 C--N 1.362 1.127 0 O-C-N 124.793 1.308 . . . . 74.34 111.0 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.543 HD12 ' HG3' ' E' ' 105' ' ' GLN . 3.7 mm? -58.58 -52.31 66.19 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.408 0.683 . . . . 65.25 109.48 177.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.425 ' HB2' ' HG2' ' D' ' 50' ' ' GLN . . . 67.89 -177.43 0.21 Allowed 'General case' 0 C--N 1.348 0.534 0 N-CA-C 114.775 1.398 . . . . 74.5 114.775 163.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -147.56 110.3 4.71 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 113.815 -1.539 . . . . 65.32 107.471 171.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 58.21 12.66 2.0 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.907 1.683 . . . . 72.34 114.372 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 72.8 t -135.13 98.12 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 108.306 -0.998 . . . . 73.21 108.306 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.417 ' OH ' HD23 ' E' ' 100' ' ' LEU . 4.4 m-85 -138.08 131.2 30.2 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.221 -0.659 . . . . 63.14 109.221 -174.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.48 118.51 36.91 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.026 -1.101 . . . . 65.52 108.026 170.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.417 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 85.7 t -101.9 141.29 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.771 0.828 . . . . 72.43 109.33 -177.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 15.3 t -121.63 131.45 73.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 124.2 1.0 . . . . 73.25 108.747 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.19 122.94 47.22 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 107.244 -1.391 . . . . 75.12 107.244 176.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.484 ' HG2' ' HG2' ' D' ' 79' ' ' GLN . 0.0 OUTLIER -101.69 95.6 6.54 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 106.732 -1.581 . . . . 74.34 106.732 177.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.441 HG21 ' CD2' ' D' ' 44' ' ' LEU . 84.0 t -90.73 134.52 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 108.764 -0.828 . . . . 74.31 108.764 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.533 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 89.9 m -124.19 132.91 53.65 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 124.393 1.058 . . . . 73.42 109.246 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.586 HG13 HG11 ' D' ' 40' ' ' VAL . 73.5 t -127.31 130.3 70.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 124.671 1.188 . . . . 72.44 108.09 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.404 ' HB ' ' HE2' ' D' ' 41' ' ' LYS . 30.7 m -130.0 103.52 6.82 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.099 -1.074 . . . . 70.23 108.099 171.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.696 ' HB3' HG22 ' D' ' 40' ' ' VAL . . . -97.29 141.73 30.03 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.353 -0.84 . . . . 72.43 109.088 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.412 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 40.6 p -145.6 139.84 26.95 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.847 -0.615 . . . . 64.04 110.707 -172.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.462 HD11 HG23 ' D' ' 31' ' ' VAL . 31.7 mt -116.69 106.1 13.14 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.537 1.135 . . . . 71.35 108.832 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.4 -113.89 3.97 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 111.429 -0.668 . . . . 65.14 111.429 -173.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -121.06 23.2 10.73 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.531 0.732 . . . . 73.31 110.169 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.52 ' HG3' HG22 ' D' ' 31' ' ' VAL . 12.9 pt-20 -134.74 158.1 45.01 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 121.698 -0.626 . . . . 61.32 110.416 175.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 40.5 m -75.41 124.29 26.88 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.236 -0.893 . . . . 75.02 111.89 -175.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.504 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -75.32 -69.96 0.45 Allowed 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.117 -1.068 . . . . 63.02 108.117 171.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -148.08 169.22 20.45 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.222 -0.899 . . . . 73.1 110.528 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 58.3 mt -130.38 151.18 51.15 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.103 -1.814 . . . . 72.41 106.103 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.647 ' SG ' HG12 ' D' ' 114' ' ' ILE . 12.0 t -159.17 128.22 5.35 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.561 -0.533 . . . . 71.33 109.561 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -150.7 121.44 7.53 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.611 0.244 . . . . 74.12 110.545 -171.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 93.7 t -131.6 126.87 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.696 0.798 . . . . 74.31 109.918 -171.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.634 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 44.3 mt-30 -91.6 89.02 6.98 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.679 -0.86 . . . . 72.42 108.679 166.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -87.34 98.14 11.19 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.357 -0.838 . . . . 71.21 109.359 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.07 165.0 23.92 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.797 -0.638 . . . . 74.13 112.69 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.67 137.57 4.72 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 111.642 -0.583 . . . . 42.31 111.642 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.606 HG21 ' HB2' ' D' ' 14' ' ' GLN . 8.4 tp -90.66 118.32 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 CA-C-O 121.568 0.699 . . . . 74.33 109.969 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . 0.417 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 64.7 m-85 -112.99 138.91 49.15 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.624 1.17 . . . . 64.31 109.893 -178.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.425 ' HB3' HE22 ' D' ' 12' ' ' GLN . 23.7 t -115.49 104.36 11.67 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.639 -1.245 . . . . 62.25 107.639 169.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.403 HG13 HD13 ' E' ' 97' ' ' ILE . 50.2 pt -119.2 138.62 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.406 0.283 . . . . 64.41 110.466 -176.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.414 ' HB2' ' HG1' ' D' ' 10' ' ' THR . . . -150.89 169.01 22.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.432 1.093 . . . . 74.22 110.243 -175.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.63 -13.68 66.76 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 114.519 0.568 . . . . 65.04 114.519 171.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.488 HG13 ' HG2' ' D' ' 9' ' ' MET . 0.8 OUTLIER -107.74 153.79 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.424 0.69 . . . . 73.0 110.781 -179.347 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -134.52 170.34 15.91 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.682 1.193 . . . . 74.02 109.818 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . 0.412 ' O ' ' HE3' ' D' ' 94' ' ' MET . . . 74.34 -141.49 28.93 Favored Glycine 0 N--CA 1.472 1.074 0 O-C-N 123.271 0.357 . . . . 63.52 113.901 174.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 36.4 p -80.77 -43.81 19.57 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.355 0.662 . . . . 74.35 110.779 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -56.93 -26.95 60.44 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.196 0.998 . . . . 74.45 112.3 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.69 ' SD ' HD21 ' E' ' 100' ' ' LEU . 10.6 tmm? -59.15 -60.93 3.08 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 124.79 1.236 . . . . 74.42 112.103 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.91 -15.7 55.57 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.911 0.484 . . . . 64.33 111.345 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -66.35 -41.58 89.33 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.78 0.832 . . . . 74.25 109.851 175.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 73.0 m -60.65 -29.58 69.36 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.165 0.586 . . . . 73.41 111.406 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.594 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 18.5 tp -82.7 -43.26 17.07 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.06 0.544 . . . . 74.12 110.948 178.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . 0.411 ' HA3' HG23 ' E' ' 103' ' ' THR . . . -76.88 -21.83 73.29 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-N 115.682 -0.69 . . . . 74.2 113.661 -174.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -122.44 -56.55 1.79 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.241 0.616 . . . . 74.33 111.531 -174.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . 0.402 ' O ' HG12 ' D' ' 105' ' ' ILE . 31.6 t80 -73.28 -31.9 64.33 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 112.001 0.371 . . . . 74.3 112.001 -172.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.594 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 84.4 m -65.82 -49.89 56.79 Favored Pre-proline 0 CA--C 1.566 1.588 0 CA-C-O 118.309 -0.853 . . . . 74.22 112.334 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.422 ' HG3' HG21 ' D' ' 46' ' ' THR . 33.4 Cg_endo -65.13 -23.83 59.98 Favored 'Trans proline' 0 C--N 1.389 2.683 0 C-N-CA 121.753 1.635 . . . . 71.04 113.259 171.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.34 -36.28 83.62 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.694 -0.484 . . . . 73.33 109.694 174.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.405 ' O ' ' HD2' ' D' ' 108' ' ' PRO . 28.8 mm -70.13 -40.47 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.743 1.217 . . . . 74.34 111.012 175.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 55.4 mt -70.17 -20.36 63.14 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 116.017 -0.538 . . . . 63.33 111.617 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -68.84 -43.95 29.04 Favored Pre-proline 0 CA--C 1.56 1.334 0 N-CA-C 113.997 1.11 . . . . 75.34 113.997 -173.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . 0.405 ' HD2' ' O ' ' D' ' 105' ' ' ILE . 71.4 Cg_exo -45.93 -43.0 20.21 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 122.53 2.153 . . . . 71.13 113.732 168.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -80.53 -29.85 37.17 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.683 0.793 . . . . 74.51 112.206 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.93 -49.87 64.14 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.586 0.708 . . . . 74.45 109.397 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.54 HH12 ' HB3' ' D' ' 130' ' ' PRO . 34.4 ttp180 -63.0 -34.73 78.19 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 113.843 -1.526 . . . . 74.4 110.756 174.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . 0.492 ' HA ' ' CE2' ' B' ' 109' ' ' TYR . 9.5 tt0 -55.14 -54.2 46.25 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.625 0.77 . . . . 64.11 111.351 177.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.0 t -59.28 -46.24 89.06 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.726 -1.125 . . . . 75.03 110.508 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.647 HG12 ' SG ' ' D' ' 76' ' ' CYS . 74.9 mt -60.95 -56.5 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.411 1.084 . . . . 75.54 111.785 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 95.5 m -55.02 -40.95 70.75 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.823 1.249 . . . . 63.12 111.693 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 42.7 t -69.53 -27.95 65.61 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.435 -0.802 . . . . 64.2 111.327 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.55 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 76.8 mtm -84.33 -30.12 25.77 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.174 0.59 . . . . 73.22 111.873 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.4 HG22 ' O ' ' D' ' 114' ' ' ILE . 61.0 t -66.33 -39.38 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.725 0.81 . . . . 72.44 110.656 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.7 p -66.62 -27.29 67.58 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 115.652 -0.704 . . . . 73.5 110.678 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.624 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 64.3 mtt-85 -80.61 -16.25 54.56 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.775 0.83 . . . . 74.54 111.582 177.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.3 4.71 74.15 Favored Glycine 0 C--N 1.352 1.468 0 CA-C-O 119.621 -0.544 . . . . 54.21 113.156 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.617 HG22 ' HB3' ' C' ' 17' ' ' TYR . 81.0 p 56.17 27.67 11.95 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.874 1.669 . . . . 71.14 113.003 -174.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -95.08 149.62 36.5 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 123.121 0.568 . . . . 74.01 109.533 172.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -50.4 146.96 17.69 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 123.174 2.583 . . . . 73.13 113.966 171.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 41.2 tp60 -47.64 124.18 6.8 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.28 1.832 . . . . 73.43 112.911 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.458 HD12 HG23 ' D' ' 40' ' ' VAL . 13.0 tp -107.24 117.72 34.81 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.535 -0.913 . . . . 74.31 108.535 175.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -121.12 100.09 6.86 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.62 -1.252 . . . . 70.21 107.62 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.401 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 90.1 mt -65.21 120.09 12.08 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 109.411 -0.588 . . . . 72.43 109.411 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.87 122.96 69.49 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 122.839 0.455 . . . . 73.54 110.599 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.54 ' HB3' HH12 ' D' ' 111' ' ' ARG . 60.1 Cg_endo -71.42 114.31 3.89 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.395 2.063 . . . . 75.24 111.44 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 12.3 p -108.43 150.08 11.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 123.461 0.704 . . . . 75.04 109.276 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -79.03 109.53 13.43 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.116 -0.698 . . . . 74.21 109.116 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.562 ' HA ' HD12 ' D' ' 136' ' ' LEU . 1.3 m-85 -67.13 -21.43 65.84 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.725 0.81 . . . . 75.41 110.904 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -62.92 -37.69 88.01 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.844 0.857 . . . . 73.24 110.08 171.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.79 -33.62 74.17 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.682 0.793 . . . . 53.23 110.945 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.562 HD12 ' HA ' ' D' ' 133' ' ' PHE . 10.3 mp -59.34 -33.95 71.77 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.185 0.594 . . . . 75.32 110.495 175.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -77.6 -33.41 53.83 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.218 0.607 . . . . 71.32 111.763 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 45.5 mtt -58.21 -34.71 70.68 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 122.642 0.377 . . . . 74.21 110.423 176.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -51.07 -44.87 61.26 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.897 1.279 . . . . 73.33 111.796 175.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . 0.45 ' HB2' ' HB1' ' E' ' 110' ' ' ALA . 81.2 t80 -80.62 -38.74 28.71 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.634 -0.712 . . . . 74.05 110.837 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.26 -27.69 66.55 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.012 0.925 . . . . 73.11 112.153 -174.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -85.68 2.96 43.16 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.991 0.516 . . . . 74.23 111.301 177.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -118.17 44.5 2.2 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 122.968 1.366 . . . . 75.13 108.209 -173.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -173.24 -177.91 1.63 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 113.792 -1.549 . . . . 72.42 108.009 -175.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.81 82.95 1.18 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.021 -0.733 . . . . 71.41 109.021 172.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -139.88 36.55 1.81 Allowed Glycine 0 C--N 1.345 1.072 0 CA-C-N 114.569 -1.196 . . . . 75.4 110.772 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -59.11 133.71 56.34 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.251 1.02 . . . . 70.3 110.876 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 154.52 37.06 0.02 OUTLIER Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.612 -0.722 . . . . 71.2 111.406 -176.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 42.8 p -98.96 129.11 45.25 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.449 0.7 . . . . 54.53 109.805 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' B' ' 149' ' ' THR . 37.5 tt0 -122.62 117.12 25.08 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.913 0.885 . . . . 74.34 109.044 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -74.74 105.22 5.71 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.466 -0.939 . . . . 73.34 108.466 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -101.61 149.71 23.84 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.256 0.622 . . . . 75.52 111.026 -173.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -158.66 124.06 4.36 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.497 -1.297 . . . . 61.54 107.497 168.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -65.91 -39.66 90.77 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.795 0.438 . . . . 74.51 110.387 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.175 0 N-CA-C 108.48 -0.933 . . . . 73.54 108.48 170.837 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.495 0 N-CA-C 110.826 -0.91 . . . . 64.51 110.826 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.12 76.91 2.09 Favored Glycine 0 C--N 1.342 0.87 0 N-CA-C 111.408 -0.677 . . . . 75.24 111.408 173.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 66.01 -169.14 0.2 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.29 1.036 . . . . 74.34 111.509 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -103.69 175.5 5.46 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.628 0.771 . . . . 74.23 109.815 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -144.61 143.35 30.73 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.843 0.857 . . . . 73.24 109.999 166.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.34 -18.05 0.04 OUTLIER Glycine 0 C--N 1.347 1.156 0 CA-C-O 119.672 -0.516 . . . . 44.25 113.525 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 97' ' ' ILE . . . . . 0.403 HD13 HG13 ' D' ' 86' ' ' ILE . 41.5 mt -79.22 117.04 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 117.374 0.587 . . . . 74.44 110.264 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -81.61 78.87 8.31 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.103 0.961 . . . . 54.41 109.864 176.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . 64.89 149.57 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.132 1.373 . . . . 61.21 113.983 175.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 100' ' ' LEU . . . . . 0.69 HD21 ' SD ' ' D' ' 94' ' ' MET . 0.3 OUTLIER -161.32 147.69 11.31 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 123.684 0.793 . . . . 73.31 111.138 171.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -94.58 11.22 1.71 Allowed 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 123.137 2.558 . . . . 74.12 111.98 164.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 102' ' ' LEU . . . . . . . . . . . . . 28.0 mt 58.58 -164.38 0.2 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.37 1.068 . . . . 74.43 110.931 -171.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 103' ' ' THR . . . . . 0.411 HG23 ' HA3' ' D' ' 99' ' ' GLY . 23.5 p -80.76 73.88 7.72 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.022 0.529 . . . . 73.01 109.961 173.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 58.02 34.94 74.15 Favored Glycine 0 C--N 1.356 1.655 0 CA-C-N 115.888 -0.596 . . . . 63.25 114.334 176.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 105' ' ' GLN . . . . . 0.543 ' HG3' HD12 ' D' ' 51' ' ' LEU . 1.9 mp0 65.2 4.29 2.55 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.647 1.179 . . . . 74.2 113.079 -178.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -159.67 -85.4 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.162 0.585 . . . . 74.54 109.607 -177.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 2.7 p -137.75 -72.6 0.42 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.007 0.923 . . . . 75.54 108.696 170.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 11.4 m170 71.29 -54.77 0.67 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.43 1.492 . . . . 74.44 112.846 177.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -59.52 -75.24 0.06 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.122 0.969 . . . . 74.43 110.941 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . 0.45 ' HB1' ' HB2' ' D' ' 140' ' ' TYR . . . -160.55 -158.68 0.63 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.311 0.645 . . . . 63.51 109.605 -172.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . 0.473 ' HA ' HD23 ' D' ' 136' ' ' LEU . 3.2 tt 80.64 -59.58 0.28 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 125.696 1.598 . . . . 71.11 109.651 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -54.41 107.92 0.33 Allowed 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.99 0.916 . . . . 72.44 109.528 172.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -69.4 92.33 0.6 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.194 -0.912 . . . . 74.34 109.904 -175.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -84.61 78.83 9.77 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.906 -1.043 . . . . 72.22 109.1 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 24.6 m 62.78 -77.28 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 124.921 1.288 . . . . 70.03 111.794 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . -148.86 28.14 1.29 Allowed Glycine 0 C--N 1.35 1.309 0 CA-C-O 119.748 -0.473 . . . . 72.34 112.678 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -67.06 -48.82 48.57 Favored Pre-proline 0 CA--C 1.558 1.269 0 CA-C-O 118.636 -0.697 . . . . 72.31 111.034 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -86.53 131.43 3.43 Favored 'Trans proline' 0 C--N 1.393 2.883 0 C-N-CA 121.403 1.402 . . . . 71.41 111.636 171.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -66.46 -26.7 67.32 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.452 0.701 . . . . 61.41 110.024 173.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -76.76 149.02 36.33 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.048 -0.978 . . . . 75.31 109.878 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 121' ' ' VAL . . . . . 0.587 HG23 HD12 ' D' ' 44' ' ' LEU . 45.3 t 60.27 79.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.177 0.991 . . . . 71.31 110.574 176.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 13.7 t -173.34 -27.0 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.131 0.972 . . . . 75.1 109.782 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -74.9 154.58 38.13 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.546 0.738 . . . . 73.3 110.078 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 11.9 m -70.46 133.15 46.56 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.69 0.796 . . . . 75.0 111.005 -174.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.09 98.27 0.57 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.273 0.629 . . . . 53.13 109.873 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.48 111.51 9.74 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.791 0.837 . . . . 71.34 111.744 -173.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 64.1 m -139.62 166.06 25.61 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.356 1.062 . . . . 62.54 109.031 174.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.48 108.34 3.15 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.731 0.412 . . . . 75.13 110.53 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 42.5 m -150.67 141.34 22.67 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.181 0.993 . . . . 73.11 109.388 177.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -97.2 141.12 30.71 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 108.886 -0.783 . . . . 62.22 108.886 174.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 131' ' ' TRP . . . . . 0.473 ' HA ' ' HG3' ' A' ' 124' ' ' PRO . 7.0 t-105 -145.37 95.09 2.61 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.603 -0.517 . . . . 75.23 109.603 -174.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 41.7 t -159.05 138.78 11.78 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.446 0.699 . . . . 75.54 110.303 175.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 133' ' ' THR . . . . . 0.436 HG22 ' HB2' ' A' ' 124' ' ' PRO . 6.5 p -139.83 -69.01 0.41 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.545 1.138 . . . . 73.24 108.898 173.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . 64.3 55.15 25.23 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 111.572 -0.611 . . . . 73.12 111.572 -176.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 4.2 p -59.31 110.56 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.316 0 C-N-CA 123.69 0.796 . . . . 64.41 111.979 -173.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -119.01 89.79 3.2 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.335 1.054 . . . . 74.32 108.344 174.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 137' ' ' THR . . . . . 0.443 HG22 ' HB3' ' A' ' 129' ' ' ALA . 10.1 t -138.46 147.33 43.14 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.752 -0.462 . . . . 64.34 109.752 177.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 138' ' ' TYR . . . . . 0.433 ' HD2' ' HB2' ' A' ' 129' ' ' ALA . 34.3 m-85 60.31 33.34 20.87 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.096 0.959 . . . . 74.22 110.668 -172.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -131.68 142.09 49.74 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.924 0.89 . . . . 63.23 110.287 -176.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 140' ' ' GLY . . . . . 0.587 ' H ' HG22 ' C' ' 10' ' ' THR . . . 161.86 90.88 0.08 OUTLIER Glycine 0 C--N 1.354 1.572 0 N-CA-C 112.3 -0.32 . . . . 65.32 112.3 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -160.93 -171.44 3.08 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.209 1.004 . . . . 74.33 110.2 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 16.0 tp -150.09 145.8 26.56 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.117 -0.697 . . . . 74.15 109.117 176.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . 143.2 77.0 0.04 OUTLIER Glycine 0 C--N 1.346 1.129 0 N-CA-C 111.405 -0.678 . . . . 61.33 111.405 176.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 11.5 p -83.54 138.69 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.344 0.658 . . . . 74.12 110.469 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 145' ' ' ASP . . . . . 0.525 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 30.9 t70 . . . . . 0 C--O 1.248 1.021 0 N-CA-C 108.29 -1.004 . . . . 74.12 108.29 167.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.783 0 N-CA-C 112.203 -0.359 . . . . 65.52 112.203 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . -159.4 -152.59 6.53 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 110.786 -0.926 . . . . 72.41 110.786 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 56.32 69.08 0.77 Allowed 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.029 0.932 . . . . 74.41 111.425 176.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -156.29 29.36 0.34 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 113.381 0.882 . . . . 73.14 113.381 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 36.65 77.27 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 126.368 1.867 . . . . 71.04 114.133 175.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -131.12 -36.9 0.32 Allowed Glycine 0 N--CA 1.473 1.128 0 CA-C-N 115.893 -0.594 . . . . 61.14 112.457 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 97' ' ' ILE . . . . . . . . . . . . . 14.6 tt -78.74 167.5 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.225 0 C-N-CA 123.05 0.54 . . . . 74.13 109.846 176.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.87 -84.43 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.798 0.839 . . . . 73.21 112.12 -175.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -153.6 5.74 0.33 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.133 0.573 . . . . 73.04 111.526 -172.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 100' ' ' LEU . . . . . 0.405 ' N ' ' HD3' ' F' ' 101' ' ' PRO . 86.8 mt 50.0 47.25 4.53 Favored Pre-proline 0 CA--C 1.571 1.767 0 C-N-CA 124.252 1.021 . . . . 75.03 113.038 -175.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 101' ' ' PRO . . . . . 0.643 ' HD2' ' HE3' ' B' ' 94' ' ' MET . 90.5 Cg_endo -86.68 112.31 1.01 Allowed 'Trans proline' 0 C--N 1.387 2.598 0 C-N-CA 122.242 1.961 . . . . 75.24 111.745 -176.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 102' ' ' LEU . . . . . 0.469 ' HB2' ' OH ' ' B' ' 56' ' ' TYR . 22.2 tp -74.94 153.48 38.57 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 109.354 -0.61 . . . . 74.11 109.354 177.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 27.9 p -71.03 90.58 0.84 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 121.624 0.726 . . . . 75.12 110.327 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.31 -93.0 0.78 Allowed Glycine 0 C--N 1.348 1.244 0 CA-C-N 114.866 -1.061 . . . . 73.5 110.535 -171.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -172.82 -69.75 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.497 1.119 . . . . 64.32 108.403 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -85.35 104.12 14.89 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 106.877 -1.527 . . . . 75.41 106.877 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 59.5 m -62.85 101.7 0.29 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.039 0.536 . . . . 74.44 110.7 -176.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 108' ' ' HIS . . . . . 0.525 ' HA ' ' HB3' ' F' ' 112' ' ' ASN . 81.2 m-70 -92.21 19.85 6.56 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.981 0.912 . . . . 74.42 112.101 -178.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -130.82 158.91 38.87 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 109.375 -0.602 . . . . 72.11 109.375 170.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 73.08 -67.49 0.26 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.068 1.347 . . . . 75.4 112.086 174.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . 0.457 HD21 HG21 ' B' ' 46' ' ' THR . 9.3 mp -78.61 -36.88 43.55 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.83 0.852 . . . . 72.44 110.408 175.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 112' ' ' ASN . . . . . 0.525 ' HB3' ' HA ' ' F' ' 108' ' ' HIS . 23.9 t-20 -117.79 153.05 34.11 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.443 1.097 . . . . 71.44 108.299 -177.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm 57.71 31.57 20.61 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.627 0.771 . . . . 74.52 111.664 -174.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.19 59.45 5.34 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 123.142 1.448 . . . . 75.32 109.807 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 19.4 p -126.46 170.05 12.38 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 114.059 -1.428 . . . . 72.24 110.807 -172.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.21 -99.34 1.69 Allowed Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.511 -0.768 . . . . 71.44 111.826 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -77.32 163.82 62.19 Favored Pre-proline 0 CA--C 1.56 1.341 0 C-N-CA 123.742 0.817 . . . . 75.21 110.902 -177.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -40.83 117.2 0.48 Allowed 'Trans proline' 0 C--N 1.388 2.646 0 C-N-CA 124.257 3.305 . . . . 72.44 114.64 173.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -91.85 -173.6 3.55 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.584 0.754 . . . . 62.34 109.399 173.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 120' ' ' TYR . . . . . 0.524 ' HB3' HD13 ' B' ' 136' ' ' LEU . 52.4 t80 -146.53 41.78 1.15 Allowed 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.894 0.855 . . . . 75.15 109.139 -172.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 8.6 p -147.29 146.76 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 115.685 -0.689 . . . . 63.54 110.104 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 5.9 m 71.01 14.02 6.87 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.634 1.174 . . . . 72.32 112.136 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 123' ' ' ASP . . . . . 0.574 ' HA ' ' HA ' ' D' ' 1' ' ' MET . 3.9 m-20 -54.54 101.67 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.152 0.981 . . . . 73.3 111.711 -177.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 38.9 t 79.41 -44.4 0.32 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.097 1.759 . . . . 71.35 112.842 177.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . 71.14 168.9 0.32 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.086 1.354 . . . . 72.13 111.472 -171.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.62 -62.76 1.35 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.911 0.484 . . . . 75.2 110.967 -173.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 42.0 m 53.76 -148.17 0.46 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.1 0.96 . . . . 74.3 110.755 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -159.57 -91.45 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.333 0.515 . . . . 75.1 110.798 168.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 15.1 t -178.85 -177.35 0.49 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.47 0.708 . . . . 74.21 110.105 -171.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 130' ' ' ALA . . . . . 0.594 ' HB1' ' HA ' ' B' ' 36' ' ' TRP . . . -70.16 -173.2 0.65 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.151 0.98 . . . . 70.21 111.474 174.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -142.76 129.98 20.94 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 122.729 0.411 . . . . 70.44 110.08 -174.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 30.9 p -107.76 77.37 1.12 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.523 0.729 . . . . 71.01 109.726 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 15.8 p -83.89 93.84 8.11 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.525 -0.762 . . . . 61.43 110.49 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.94 7.23 29.37 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 115.817 -0.629 . . . . 72.11 114.05 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 p -69.54 92.33 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 CA-C-O 122.161 0.981 . . . . 71.31 110.086 173.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -122.85 107.53 11.97 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.151 -1.055 . . . . 75.32 108.151 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 10.4 m 64.11 -80.39 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.528 1.131 . . . . 54.45 109.806 -167.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 138' ' ' TYR . . . . . 0.598 ' HH ' HD22 ' C' ' 136' ' ' LEU . 73.9 m-85 -149.02 -170.76 3.71 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.389 1.476 . . . . 72.34 108.556 177.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -78.21 145.6 35.44 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.876 -0.416 . . . . 73.32 109.876 173.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -153.62 -107.0 0.29 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 110.859 -0.897 . . . . 71.24 110.859 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -138.29 84.14 2.01 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 108.973 -0.751 . . . . 72.31 108.973 175.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.0 176.25 7.76 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.759 0.824 . . . . 73.44 111.654 -176.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . 97.5 137.04 9.41 Favored Glycine 0 C--N 1.353 1.476 0 CA-C-N 115.567 -0.742 . . . . 72.13 111.838 -177.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 20.8 m -85.14 141.67 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.001 0.52 . . . . 75.01 111.129 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 C--O 1.254 1.305 0 C-N-CA 124.02 0.928 . . . . 73.34 109.297 176.762 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.413 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 109.487 -0.56 . . . . 73.42 109.487 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.468 ' HB2' ' HE1' ' A' ' 96' ' ' HIS . 10.9 t -129.61 98.38 4.81 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.604 0.362 . . . . 71.42 110.093 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -92.09 -173.9 3.6 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 108.611 -0.885 . . . . 75.5 108.611 170.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -93.19 53.13 1.89 Allowed 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.06 0.944 . . . . 74.11 110.586 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.509 HD21 ' HB2' ' A' ' 8' ' ' GLU . 6.5 t30 -74.7 88.81 2.24 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 108.668 -0.864 . . . . 73.05 108.668 177.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -63.39 -42.47 98.8 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 114.989 -1.005 . . . . 62.2 110.954 -176.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.9 p -77.82 73.13 4.39 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.674 0.79 . . . . 74.52 111.3 -178.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.509 ' HB2' HD21 ' A' ' 5' ' ' ASN . 3.6 mm-40 179.58 -32.32 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.691 1.597 . . . . 72.44 110.085 177.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.632 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 22.7 ptp -147.24 178.49 8.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.608 0.718 . . . . 73.04 111.962 -167.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 76.2 m -137.59 102.41 4.75 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.328 -1.306 . . . . 71.43 107.611 174.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.417 ' CD1' HD13 ' A' ' 86' ' ' ILE . 90.3 t80 -100.27 116.29 31.91 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.881 -1.155 . . . . 65.32 107.881 174.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.5 tp60 -133.99 132.91 40.68 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.541 -0.911 . . . . 74.22 108.541 174.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.2 mt -91.17 119.84 39.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.233 -1.025 . . . . 75.3 108.233 175.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.54 -41.73 21.2 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.044 -0.725 . . . . 74.22 109.044 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -170.38 131.43 0.95 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.885 0.474 . . . . 73.34 110.049 -169.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.4 mt -117.46 131.22 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 108.492 -0.929 . . . . 71.13 108.492 173.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.448 ' HE1' HG13 ' A' ' 83' ' ' ILE . 27.2 p90 -161.78 177.85 9.51 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 123.952 0.783 . . . . 74.44 111.52 -173.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.6 p -107.09 126.29 52.17 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.438 -0.579 . . . . 73.25 109.438 173.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.437 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 44.4 mtpt -86.14 -33.44 20.87 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.623 -0.51 . . . . 74.03 109.623 175.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -148.15 142.95 26.75 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.632 -1.167 . . . . 75.21 109.874 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.437 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 81.7 mt -142.02 142.3 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.821 1.249 . . . . 75.44 108.23 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -149.42 121.5 8.29 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.03 0.532 . . . . 64.25 109.797 173.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.571 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 86.0 t80 -116.37 141.94 47.5 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.315 -1.365 . . . . 72.43 107.315 168.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 26.9 mt-10 -136.39 143.14 43.84 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.998 0.519 . . . . 74.25 109.834 175.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.17 75.74 10.53 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 107.427 -1.323 . . . . 74.43 107.427 170.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.83 -33.01 44.86 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.767 2.311 . . . . 72.34 112.267 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -100.86 15.5 28.26 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 114.682 -1.145 . . . . 73.31 110.171 -176.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.562 ' HB2' ' HE3' ' B' ' 19' ' ' LYS . . . -41.18 -56.19 4.45 Favored Pre-proline 0 N--CA 1.496 1.859 0 CA-C-O 117.698 -1.144 . . . . 64.42 113.477 -170.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -61.78 -32.43 85.99 Favored 'Trans proline' 0 C--N 1.391 2.783 0 CA-C-N 121.524 1.58 . . . . 74.03 112.788 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -75.96 -46.02 31.88 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.126 -0.943 . . . . 71.15 111.096 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.759 HG22 ' HA ' ' A' ' 73' ' ' ALA . 10.0 p -76.77 -14.8 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 124.111 0.964 . . . . 75.24 112.771 -160.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -69.02 -20.09 64.13 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.842 0.457 . . . . 61.43 111.439 171.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -82.81 -22.43 34.18 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.494 1.117 . . . . 75.52 111.016 174.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.478 ' HE2' ' HB3' ' A' ' 71' ' ' GLU . 24.8 mmmt -67.1 154.61 40.81 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.235 1.014 . . . . 72.22 112.172 -178.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -74.92 125.55 29.1 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.286 -0.87 . . . . 72.04 109.259 173.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -77.71 88.33 3.97 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.605 0.717 . . . . 71.11 110.604 -174.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -117.14 83.51 15.51 Favored Pre-proline 0 N--CA 1.472 0.672 0 N-CA-C 106.313 -1.736 . . . . 71.31 106.313 170.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.8 93.85 0.87 Allowed 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 121.678 1.586 . . . . 72.54 111.151 -175.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -93.68 83.87 4.53 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 105.751 -1.944 . . . . 72.21 105.751 175.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.687 HG23 ' HB1' ' A' ' 66' ' ' ALA . 42.7 t -91.68 117.84 35.82 Favored 'Isoleucine or valine' 0 C--N 1.342 0.279 0 CA-C-N 113.573 -1.649 . . . . 61.33 110.456 -168.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.59 ' HE2' ' HB2' ' A' ' 43' ' ' ASP . 85.6 tttt -79.28 121.59 25.28 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.932 -0.766 . . . . 65.13 108.932 169.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.0 mt -101.38 106.54 17.71 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.267 -1.012 . . . . 74.33 108.267 169.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.59 ' HB2' ' HE2' ' A' ' 41' ' ' LYS . 16.5 t70 -106.1 136.8 45.15 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.167 -1.42 . . . . 74.44 107.167 175.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.701 HD22 HD23 ' A' ' 60' ' ' LEU . 87.1 mt -130.56 134.3 46.91 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.22 0.533 . . . . 64.45 110.784 -174.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.483 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 21.3 t70 -134.48 146.78 50.08 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.63 1.172 . . . . 74.44 108.331 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.8 m -136.47 127.29 27.42 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.991 0.516 . . . . 72.41 109.633 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.62 110.53 9.95 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.555 0.742 . . . . 71.15 109.987 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 61.4 p -102.17 153.98 19.44 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.773 0.429 . . . . 74.43 110.747 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.3 t -150.78 125.13 9.47 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.65 0.78 . . . . 71.44 109.044 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -72.24 105.96 4.24 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.712 -0.477 . . . . 75.32 109.712 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.743 HD12 ' HB2' ' A' ' 57' ' ' GLU . 76.3 mt -78.83 -38.49 37.9 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.051 0.54 . . . . 73.13 109.902 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.65 176.21 11.99 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.455 1.102 . . . . 74.41 109.253 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -68.13 123.19 19.99 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 108.667 -0.864 . . . . 75.14 108.667 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 66.54 20.09 10.84 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.466 1.106 . . . . 74.41 111.793 -174.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.2 t -132.17 105.19 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 107.734 -1.21 . . . . 72.35 107.734 172.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -123.15 126.4 46.94 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.716 -0.846 . . . . 73.13 108.716 -177.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.743 ' HB2' HD12 ' A' ' 51' ' ' LEU . 33.9 tt0 -84.7 149.34 25.86 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.014 -0.736 . . . . 74.34 109.014 171.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.487 HG11 ' HD3' ' A' ' 103' ' ' PRO . 73.8 t -131.48 138.68 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 C-N-CA 124.364 1.066 . . . . 74.44 108.19 169.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.41 135.74 57.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.806 -0.812 . . . . 75.05 108.806 174.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.701 HD23 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -110.19 99.35 8.43 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 106.796 -1.557 . . . . 74.34 106.796 172.037 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.483 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 30.4 ttp180 -87.11 100.56 12.74 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.086 -1.079 . . . . 62.52 108.086 173.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 32.0 t -95.29 134.56 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 108.222 -1.029 . . . . 73.12 108.222 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 9.4 m -121.89 125.14 45.75 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.078 -0.712 . . . . 65.25 109.078 174.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.465 ' O ' HD12 ' A' ' 75' ' ' LEU . 70.4 t -121.81 120.02 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 124.456 1.103 . . . . 65.24 109.156 -174.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.6 m -128.54 116.6 19.91 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.406 0.548 . . . . 73.51 109.867 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.687 ' HB1' HG23 ' A' ' 40' ' ' VAL . . . -102.94 113.07 26.22 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 107.838 -1.171 . . . . 74.42 107.838 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 46.3 m -108.89 128.52 54.99 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.21 0.604 . . . . 72.32 110.012 177.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.527 HD13 ' HB1' ' A' ' 73' ' ' ALA . 19.6 mt -95.84 77.76 3.22 Favored 'General case' 0 C--O 1.247 0.961 0 C-N-CA 124.365 1.066 . . . . 65.45 108.566 -178.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.99 -85.69 0.89 Allowed Glycine 0 C--N 1.344 0.998 0 CA-C-N 115.376 -0.829 . . . . 62.21 111.764 -174.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -112.62 -30.92 6.93 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.844 0.857 . . . . 75.42 110.354 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.478 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 7.6 tp10 -101.98 119.07 38.19 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.858 0.463 . . . . 73.22 110.26 -170.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 88.2 m -70.99 135.59 47.93 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 122.809 0.443 . . . . 62.44 111.176 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.759 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -77.06 -64.42 1.14 Allowed 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.333 1.053 . . . . 63.11 110.135 175.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -151.08 170.39 19.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.751 0.786 . . . . 71.44 112.786 -177.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 64' ' ' VAL . 62.5 tp -123.92 144.94 49.48 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 113.809 -1.541 . . . . 73.32 107.911 169.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.43 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.1 m -146.44 102.5 3.59 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.722 0.809 . . . . 73.34 109.268 176.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 37.4 tt0 -119.5 116.31 25.83 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.311 0.644 . . . . 72.52 109.276 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.463 HG12 ' HB3' ' A' ' 113' ' ' CYS . 39.4 t -127.31 113.68 33.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.221 1.008 . . . . 75.51 109.629 -174.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -85.27 87.24 7.36 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.539 -0.912 . . . . 74.22 108.539 171.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -76.44 92.8 3.43 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.453 -0.794 . . . . 74.35 109.173 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.74 146.13 19.79 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-N 115.703 -0.681 . . . . 74.23 111.467 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.27 122.67 1.68 Allowed Glycine 0 CA--C 1.503 -0.708 0 N-CA-C 110.258 -1.137 . . . . 61.45 110.258 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.47 HG23 HD11 ' A' ' 51' ' ' LEU . 49.0 mt -81.81 129.23 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.578 -1.267 . . . . 70.22 107.578 172.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.634 ' HB3' HD11 ' A' ' 86' ' ' ILE . 92.9 m-85 -130.46 134.5 47.14 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.326 -0.99 . . . . 73.41 108.326 -176.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.3 t -98.31 99.9 11.14 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.928 -1.138 . . . . 70.53 107.928 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.634 HD11 ' HB3' ' A' ' 84' ' ' PHE . 20.0 mm -120.35 129.86 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.235 0.614 . . . . 75.23 110.632 -169.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.41 173.26 12.44 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.964 0.905 . . . . 73.32 110.567 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.632 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 97.56 -32.1 7.12 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 116.309 -0.405 . . . . 63.12 112.925 175.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.39 159.98 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.942 0.897 . . . . 72.11 110.447 -176.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.483 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 19.7 tt0 -150.24 -179.29 7.07 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 108.886 -0.783 . . . . 71.41 108.886 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.483 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 59.3 -125.77 40.47 Favored Glycine 0 C--N 1.348 1.2 0 N-CA-C 114.547 0.579 . . . . 74.32 114.547 176.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.2 t -70.58 -27.14 63.89 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.116 0.566 . . . . 62.43 111.503 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -73.05 -36.14 66.84 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.96 0.904 . . . . 75.35 110.002 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.478 ' HA ' ' HE1' ' A' ' 94' ' ' MET . 4.4 tpt -65.43 -46.42 80.0 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-N 115.381 -0.827 . . . . 73.05 109.628 175.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.4 -34.71 75.81 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.447 -0.797 . . . . 75.34 111.357 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.468 ' HE1' ' HB2' ' A' ' 2' ' ' SER . 39.5 t-80 -71.92 -32.97 67.89 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.462 0.705 . . . . 71.41 111.426 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -71.64 -44.8 63.7 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.019 0.438 . . . . 73.41 109.854 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 76.2 mt -80.73 -32.37 35.73 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.496 -0.775 . . . . 73.3 112.193 -173.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.42 3.49 59.65 Favored Glycine 0 N--CA 1.469 0.856 0 CA-C-O 119.591 -0.56 . . . . 71.24 113.736 -174.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.651 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -148.16 -62.61 0.26 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.664 0.616 . . . . 70.42 112.664 -174.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -68.05 -44.59 76.04 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 120.827 0.346 . . . . 72.31 111.572 -172.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 99.3 m -69.13 -47.38 29.15 Favored Pre-proline 0 CA--C 1.563 1.457 0 C-N-CA 124.086 0.954 . . . . 61.12 112.936 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.487 ' HD3' HG11 ' A' ' 58' ' ' VAL . 44.8 Cg_endo -66.89 -19.24 52.66 Favored 'Trans proline' 0 C--N 1.395 3.025 0 CA-C-N 121.694 1.641 . . . . 64.43 112.755 173.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -70.86 -38.18 73.13 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.021 0.528 . . . . 73.41 109.951 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 38.7 mm -64.22 -42.91 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.896 0.879 . . . . 75.2 110.155 171.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.5 mt -73.92 -22.73 59.57 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.325 -0.852 . . . . 74.34 112.289 -174.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -61.57 -46.64 93.97 Favored Pre-proline 0 N--CA 1.486 1.33 0 N-CA-C 114.416 1.265 . . . . 74.13 114.416 -172.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -52.89 -35.84 72.18 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 121.784 1.656 . . . . 74.31 113.045 172.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.416 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 84.4 m-85 -79.88 -36.94 35.84 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.946 0.898 . . . . 62.21 111.877 -177.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.76 -49.6 65.42 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 109.161 -0.681 . . . . 72.34 109.161 176.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 32.5 ttm180 -50.17 -45.92 53.75 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.905 1.378 . . . . 74.43 110.218 173.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -62.94 -52.21 63.91 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.836 0.71 . . . . 61.14 111.504 -177.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.496 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 52.6 t -59.43 -34.78 72.91 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.827 0.704 . . . . 74.14 111.588 -178.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.443 HG21 HG22 ' A' ' 64' ' ' VAL . 24.4 mt -66.7 -59.27 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.691 0.796 . . . . 75.13 109.952 173.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 94.6 m -53.51 -37.65 62.98 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.829 1.252 . . . . 74.23 111.696 -174.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.2 t -69.62 -42.63 74.09 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 114.232 -1.349 . . . . 70.05 109.889 -178.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.571 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 35.3 mtm -65.69 -35.57 81.14 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.492 0.317 . . . . 73.14 110.998 176.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 114' ' ' ILE . 85.5 t -58.82 -49.42 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.892 0.877 . . . . 72.31 109.536 175.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.5 p -76.93 -27.97 55.07 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.644 -0.707 . . . . 71.23 111.725 -175.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -73.77 -28.96 61.93 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.48 0.712 . . . . 71.03 109.46 174.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.448 ' O ' HG22 ' A' ' 122' ' ' THR . . . -86.29 12.25 61.07 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.956 0.785 . . . . 73.41 112.557 171.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.3 t 63.2 11.5 5.37 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 127.127 2.171 . . . . 72.23 114.23 173.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -77.35 148.25 77.14 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 109.492 -0.559 . . . . 64.32 109.492 176.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.9 128.1 27.42 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.788 2.326 . . . . 74.42 111.93 175.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -46.85 125.43 7.36 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.804 1.315 . . . . 75.21 112.404 -171.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 61.0 tp -106.77 137.33 45.0 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.625 -0.88 . . . . 73.25 108.625 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.427 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 90.9 m-20 -129.7 113.95 15.39 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.802 -1.185 . . . . 75.41 107.802 -178.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.443 HD12 HD12 ' A' ' 114' ' ' ILE . 7.4 mt -70.57 133.08 46.41 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.951 -0.759 . . . . 74.35 108.951 -176.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.55 136.66 94.59 Favored Pre-proline 0 CA--C 1.552 1.049 0 CA-C-O 118.997 -0.525 . . . . 74.35 111.047 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -55.72 109.88 0.48 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.272 2.648 . . . . 72.31 113.558 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.441 HG22 HD13 ' A' ' 44' ' ' LEU . 58.9 t -98.43 133.05 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.07 0.462 . . . . 74.55 110.215 -175.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -92.15 80.04 5.09 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.597 -1.183 . . . . 75.34 109.049 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -57.35 -35.52 70.02 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.179 0.992 . . . . 74.25 111.615 175.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.651 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 24.1 t70 -54.29 -47.78 72.01 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 124.373 1.046 . . . . 74.54 111.095 175.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.41 -42.02 83.94 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.953 0.783 . . . . 74.15 111.083 176.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 92.5 mt -54.48 -41.28 69.34 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.067 0.547 . . . . 74.23 111.224 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.431 ' HE2' HD12 ' A' ' 141' ' ' LEU . 33.6 t80 -78.16 -39.99 39.21 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.591 -0.731 . . . . 74.41 110.253 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.573 ' SD ' HD22 ' A' ' 141' ' ' LEU . 12.6 tpt -60.81 -32.12 71.5 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.001 0.92 . . . . 75.52 111.364 -173.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -63.96 -43.35 96.08 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.209 1.003 . . . . 75.44 110.14 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -74.81 -32.76 62.07 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.885 0.874 . . . . 64.5 111.143 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.573 HD22 ' SD ' ' A' ' 138' ' ' MET . 41.7 tp -64.56 -23.35 67.24 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.462 1.105 . . . . 71.11 111.697 -171.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -141.3 28.99 1.82 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.144 0.977 . . . . 73.45 108.607 -173.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -71.81 -26.83 62.56 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 114.853 -1.067 . . . . 74.44 111.151 -176.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -137.84 -76.63 0.39 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 108.611 -0.885 . . . . 72.53 108.611 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -103.55 140.11 37.97 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.701 0.8 . . . . 74.41 109.672 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 107.78 135.17 7.61 Favored Glycine 0 C--N 1.341 0.831 0 N-CA-C 111.47 -0.652 . . . . 70.51 111.47 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -168.8 -177.93 3.2 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.461 1.104 . . . . 74.43 109.045 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 158.52 -126.95 1.77 Allowed Glycine 0 C--N 1.341 0.845 0 N-CA-C 111.892 -0.483 . . . . 62.54 111.892 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.9 t -171.78 167.12 6.44 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 123.8 0.84 . . . . 74.2 109.28 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -76.87 87.47 3.45 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.46 -0.941 . . . . 65.03 108.46 171.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.64 109.8 8.41 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.523 -0.762 . . . . 74.11 110.82 -175.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 33.1 p-80 -84.82 169.64 13.97 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.248 -0.887 . . . . 72.5 110.054 173.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -151.0 125.21 9.35 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.591 -0.892 . . . . 72.22 108.591 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -62.95 129.0 38.46 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.976 0.51 . . . . 74.44 110.857 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.936 0 O-C-N 124.048 0.843 . . . . 63.13 110.113 -177.967 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 108.638 -0.875 . . . . 74.33 108.638 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 72.9 m -147.85 -47.18 0.16 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.6 0.76 . . . . 75.43 109.844 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 66.87 146.66 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.112 1.365 . . . . 74.23 113.447 174.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.456 ' HG3' ' HA3' ' B' ' 91' ' ' GLY . 27.9 tt0 -169.73 99.63 0.31 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.513 1.125 . . . . 64.04 108.11 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -164.93 178.82 6.85 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.728 -0.471 . . . . 75.44 109.728 -175.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -64.28 105.87 0.99 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.413 0.685 . . . . 75.44 109.767 174.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 31.7 p -91.53 136.14 33.34 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.451 1.1 . . . . 63.33 111.353 -175.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -76.27 -29.92 57.63 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.89 0.876 . . . . 73.3 110.174 177.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 18.7 ptm 58.12 -179.41 0.07 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 127.325 2.25 . . . . 75.13 114.776 174.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 5.2 t -135.08 130.09 35.01 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 106.627 -1.62 . . . . 72.23 106.627 167.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.475 ' HD1' HG23 ' B' ' 86' ' ' ILE . 87.9 t80 -135.02 145.44 48.05 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.141 0.576 . . . . 71.34 110.016 -171.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -151.13 140.04 20.95 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.021 0.929 . . . . 75.24 109.121 171.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 49.8 mt -87.78 127.21 41.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.077 -1.083 . . . . 75.41 108.077 170.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -84.03 -49.21 9.14 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 109.187 -0.672 . . . . 71.13 109.187 176.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -170.31 134.54 1.19 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.314 -0.857 . . . . 75.51 110.231 -172.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.417 HD13 HD21 ' D' ' 127' ' ' ASN . 91.4 mt -114.82 137.62 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 107.673 -1.232 . . . . 74.12 107.673 175.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -161.96 142.09 10.21 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.097 0.475 . . . . 65.2 111.537 -172.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.422 HG23 HD13 ' B' ' 21' ' ' ILE . 18.9 m -77.65 126.62 31.16 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 108.57 -0.9 . . . . 61.31 108.57 171.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.562 ' HE3' ' HB2' ' A' ' 28' ' ' ALA . 42.3 mtpt -99.57 -18.35 17.41 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.969 0.907 . . . . 73.33 111.798 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -161.31 138.73 8.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.9 0.48 . . . . 73.11 110.82 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.674 HD13 ' SG ' ' B' ' 113' ' ' CYS . 47.0 mm -126.97 143.23 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.399 1.08 . . . . 75.54 108.331 168.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 27.9 t -144.79 119.81 10.03 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.227 -1.027 . . . . 63.24 108.227 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.437 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 82.9 t80 -132.1 116.46 17.06 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.808 -1.182 . . . . 72.23 107.808 173.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -123.01 113.89 19.67 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.87 0.868 . . . . 73.32 109.124 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.55 87.21 3.27 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 106.82 -1.548 . . . . 73.33 106.82 166.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.73 -26.41 45.56 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 122.559 2.173 . . . . 74.5 111.778 -173.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.446 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 72.2 m-20 -110.13 10.57 23.91 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 118.048 -0.977 . . . . 73.1 110.901 -177.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.4 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -33.71 -64.28 0.28 Allowed Pre-proline 0 N--CA 1.502 2.13 0 C-N-CA 124.955 1.302 . . . . 74.3 114.07 -171.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -64.5 -29.75 61.8 Favored 'Trans proline' 0 C--N 1.396 3.041 0 C-N-CA 122.27 1.98 . . . . 74.34 112.889 -171.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -95.14 -26.49 15.99 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.848 0.859 . . . . 73.03 111.993 -171.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.541 HG23 ' HA ' ' B' ' 73' ' ' ALA . 4.8 p -82.43 -14.57 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 C-N-CA 122.678 0.391 . . . . 72.41 110.756 -176.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -68.39 -9.88 51.28 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 113.378 0.881 . . . . 73.13 113.378 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -71.37 -13.0 61.72 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 122.907 0.483 . . . . 75.3 110.8 173.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.565 ' HZ3' ' HG2' ' B' ' 71' ' ' GLU . 89.3 mttt -103.21 81.57 1.97 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.597 1.159 . . . . 74.42 109.582 -175.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -88.48 74.86 8.48 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.453 -0.794 . . . . 62.35 110.077 -176.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -153.17 179.1 9.03 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.819 -0.628 . . . . 74.14 109.66 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.06 110.15 6.69 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.057 0.943 . . . . 74.41 109.283 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -71.54 145.97 48.5 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 121.956 1.771 . . . . 75.32 111.274 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 9.8 tp10 -64.56 102.09 0.52 Allowed 'General case' 0 C--N 1.343 0.321 0 N-CA-C 108.068 -1.086 . . . . 71.55 108.068 173.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.722 HG21 ' HB1' ' B' ' 66' ' ' ALA . 23.4 t -98.6 154.49 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 108.771 -0.826 . . . . 73.15 108.771 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -145.11 130.07 18.33 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.447 -0.946 . . . . 73.21 108.447 170.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.404 HD11 ' CG1' ' B' ' 62' ' ' VAL . 14.8 tp -86.21 138.21 32.05 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.491 -0.929 . . . . 75.24 108.491 170.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -137.0 117.02 13.29 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.933 -1.136 . . . . 64.35 107.933 -177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 4.4 mp -99.91 128.06 46.03 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.464 -0.939 . . . . 75.12 108.464 -171.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -132.17 143.87 50.27 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.325 -0.62 . . . . 73.31 109.325 175.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 18.5 p -128.91 125.86 38.46 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.472 0.709 . . . . 74.42 109.979 -174.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.419 ' O ' ' HB ' ' B' ' 59' ' ' VAL . . . -147.41 125.99 12.5 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 107.72 -1.215 . . . . 73.34 107.72 175.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.534 ' HB2' HD13 ' F' ' 102' ' ' LEU . 35.8 m -130.18 -179.01 4.99 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.085 0.554 . . . . 75.53 110.498 -176.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.8 p -152.17 135.64 16.05 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.916 -0.772 . . . . 72.2 108.916 172.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . 0.417 ' NE2' HD13 ' F' ' 100' ' ' LEU . 52.1 tt0 -91.83 119.14 31.36 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.286 -1.005 . . . . 71.5 108.286 170.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 pp -130.56 16.61 5.37 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.094 0.958 . . . . 75.33 110.077 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.19 157.8 36.51 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 123.583 0.753 . . . . 72.42 110.388 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -89.24 136.35 33.07 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 107.755 -1.202 . . . . 71.53 107.755 163.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.468 ' H ' HD12 ' F' ' 100' ' ' LEU . 5.0 m-20 71.97 4.35 4.99 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.793 1.237 . . . . 75.12 111.852 -176.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.628 HG22 ' HA ' ' B' ' 85' ' ' SER . 25.6 t -146.53 129.05 8.24 Favored 'Isoleucine or valine' 0 C--N 1.355 0.838 0 C-N-CA 124.08 0.952 . . . . 74.44 109.691 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.464 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 0.4 OUTLIER -113.53 163.53 14.8 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 108.713 -0.847 . . . . 74.41 108.713 166.38 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -119.92 107.23 12.87 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.287 -1.375 . . . . 65.22 107.287 177.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 65.8 t -100.42 125.21 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.714 0.805 . . . . 74.1 110.145 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.483 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.2 t -107.52 112.16 38.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 108.723 -0.843 . . . . 71.24 108.723 174.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 62.0 tp -93.92 112.58 24.45 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.633 -0.506 . . . . 72.41 109.633 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -95.76 106.06 18.14 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.482 0.713 . . . . 74.24 109.275 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.404 ' CG1' HD11 ' B' ' 42' ' ' LEU . 45.0 t -105.81 111.16 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 108.399 -0.963 . . . . 72.44 108.399 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 21.0 m -108.45 135.68 49.33 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.879 0.871 . . . . 71.51 109.965 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.609 HG23 HG23 ' B' ' 114' ' ' ILE . 44.4 t -129.36 115.69 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.945 1.298 . . . . 75.05 109.592 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 64.2 m -103.3 138.94 39.4 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.805 -0.813 . . . . 72.12 108.805 171.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.722 ' HB1' HG21 ' B' ' 40' ' ' VAL . . . -145.61 143.19 29.72 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.995 0.518 . . . . 74.24 109.776 176.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.508 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 67.4 p -141.5 131.81 25.07 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.546 -0.752 . . . . 71.33 110.913 -175.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.41 ' HG ' ' HB3' ' B' ' 73' ' ' ALA . 61.7 mt -100.49 111.55 23.82 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.556 1.142 . . . . 72.43 108.522 174.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.01 -128.63 11.06 Favored Glycine 0 C--N 1.342 0.887 0 O-C-N 123.436 0.46 . . . . 63.41 112.634 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -90.5 2.51 55.66 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.95 0.9 . . . . 74.33 112.207 -176.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.565 ' HG2' ' HZ3' ' B' ' 34' ' ' LYS . 12.6 pt-20 -137.84 157.25 46.81 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.768 0.427 . . . . 74.2 111.565 -169.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.5 m -69.1 128.43 36.63 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.435 -0.802 . . . . 74.03 110.938 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.541 ' HA ' HG23 ' B' ' 31' ' ' VAL . . . -79.96 -64.02 1.28 Allowed 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.565 -1.272 . . . . 74.41 107.565 174.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -150.52 158.48 44.2 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 114.83 -1.077 . . . . 75.11 111.687 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 95.8 mt -125.27 113.34 17.48 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 106.333 -1.729 . . . . 61.41 106.333 172.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.529 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 27.0 t -118.28 146.35 44.37 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.915 -1.143 . . . . 72.41 107.915 175.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -161.62 126.76 3.53 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.254 -1.017 . . . . 62.45 108.254 -176.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.2 t -124.54 148.29 28.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.007 0.923 . . . . 63.21 108.729 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -121.95 96.82 5.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.226 -1.027 . . . . 74.23 108.226 169.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -89.19 101.34 14.0 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.992 -0.744 . . . . 74.25 108.992 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.29 170.75 37.68 Favored Glycine 0 C--N 1.339 0.698 0 O-C-N 123.523 0.514 . . . . 75.24 112.017 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.99 132.76 2.5 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.512 -0.375 . . . . 74.04 112.659 -176.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 79.4 mt -91.26 111.11 23.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 108.001 -1.111 . . . . 64.21 108.001 173.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -113.34 133.8 54.95 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.104 0.562 . . . . 72.51 109.933 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.628 ' HA ' HG22 ' B' ' 55' ' ' VAL . 66.9 m -95.56 122.06 37.92 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.015 0.926 . . . . 72.32 109.319 175.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.475 HG23 ' HD1' ' B' ' 11' ' ' PHE . 0.2 OUTLIER -138.36 134.32 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.991 0.917 . . . . 74.54 110.599 -173.377 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.93 171.08 20.69 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.534 1.134 . . . . 74.35 108.191 169.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.9 -43.14 3.06 Favored Glycine 0 N--CA 1.469 0.878 0 N-CA-C 111.991 -0.444 . . . . 53.13 111.991 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.645 ' HB ' ' HA ' ' B' ' 94' ' ' MET . 9.4 pt -58.34 143.46 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.42 0.688 . . . . 73.35 110.802 171.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -161.26 152.68 18.97 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 123.858 0.724 . . . . 74.34 110.813 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.456 ' HA3' ' HG3' ' B' ' 4' ' ' GLN . . . 78.65 -133.88 13.3 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.625 -0.716 . . . . 75.5 111.854 -178.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 2.8 m -67.15 -44.03 80.82 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.666 0.787 . . . . 71.11 110.326 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -67.3 -18.93 65.38 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.048 -1.433 . . . . 74.15 111.757 -168.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.645 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 17.7 tmm? -68.14 -66.36 0.58 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.155 0.982 . . . . 73.34 111.56 -174.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . 0.42 ' O ' ' HG ' ' B' ' 98' ' ' LEU . . . -80.76 -9.36 59.81 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 120.857 0.36 . . . . 73.4 111.909 177.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -60.99 -31.74 71.34 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 122.866 0.467 . . . . 73.13 110.807 164.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.6 t -61.39 -40.45 94.39 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.831 0.852 . . . . 75.32 112.411 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' B' ' 95' ' ' ALA . 4.1 pp -69.69 -22.92 63.38 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.895 0.478 . . . . 65.33 112.001 177.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.05 -12.75 51.62 Favored Glycine 0 C--N 1.348 1.209 0 O-C-N 123.309 0.381 . . . . 75.44 113.797 -177.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.86 -57.67 1.04 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 117.364 0.582 . . . . 61.52 112.047 -173.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -75.16 -46.58 33.32 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.144 0.578 . . . . 73.54 111.615 -169.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.464 ' SG ' ' HE1' ' B' ' 56' ' ' TYR . 78.4 m -65.99 -47.18 63.93 Favored Pre-proline 0 CA--C 1.561 1.394 0 CA-C-O 118.459 -0.781 . . . . 61.44 112.595 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.96 -26.87 66.45 Favored 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 121.735 1.623 . . . . 72.41 112.746 172.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.42 -37.11 82.31 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.127 0.571 . . . . 74.23 110.868 175.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 66.7 mt -71.85 -44.49 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.758 0.823 . . . . 74.52 110.322 176.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 86.9 mt -78.47 -17.31 56.48 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.166 -0.924 . . . . 74.31 112.509 -171.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.415 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 55.4 t80 -63.33 -50.82 72.45 Favored Pre-proline 0 CA--C 1.55 0.957 0 CA-C-O 117.953 -1.022 . . . . 75.31 112.728 -176.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.58 ' HG2' ' HB2' ' D' ' 108' ' ' PRO . 93.6 Cg_exo -50.84 -42.58 50.87 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.261 1.974 . . . . 64.23 114.185 174.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -66.74 -44.44 81.5 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.361 0.665 . . . . 74.23 111.364 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.17 -37.2 83.34 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.676 -0.693 . . . . 73.23 110.995 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 60.7 ttt-85 -62.18 -51.54 67.43 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.341 1.456 . . . . 74.15 110.203 177.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -62.41 -36.8 83.48 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.238 0.961 . . . . 73.22 110.448 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.674 ' SG ' HD13 ' B' ' 21' ' ' ILE . 1.9 t -73.84 -30.2 62.55 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.018 0.127 . . . . 71.13 111.085 -177.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.609 HG23 HG23 ' B' ' 64' ' ' VAL . 41.8 mt -66.29 -55.82 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.679 0.791 . . . . 73.24 109.008 172.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.508 HG22 ' OG ' ' C' ' 119' ' ' SER . 31.9 m -62.08 -26.51 68.32 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 114.928 -1.033 . . . . 71.02 111.577 -177.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.482 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.3 t -61.65 -53.75 51.94 Favored 'General case' 0 C--N 1.347 0.458 0 N-CA-C 109.295 -0.631 . . . . 74.24 109.295 174.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.8 mmt -70.22 -30.81 67.98 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.599 0.76 . . . . 74.52 111.331 -174.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.501 HG23 HD21 ' B' ' 126' ' ' LEU . 68.8 t -66.41 -44.34 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.339 1.056 . . . . 75.11 110.271 172.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.1 t -67.28 -31.36 71.63 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.226 -0.897 . . . . 62.14 110.045 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.496 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 75.6 mtt-85 -68.44 -41.06 80.86 Favored 'General case' 0 C--O 1.211 -0.948 0 CA-C-N 115.818 -0.628 . . . . 75.21 109.561 176.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.97 -11.86 70.52 Favored Glycine 0 C--N 1.357 1.729 0 O-C-N 123.647 0.592 . . . . 71.43 112.628 171.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 11.3 m 67.11 30.74 7.2 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 125.51 1.524 . . . . 63.42 110.407 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -77.49 165.69 49.67 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-N 115.189 -0.914 . . . . 73.5 111.085 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.533 ' HG3' ' HB2' ' F' ' 131' ' ' TRP . 80.9 Cg_exo -48.23 151.07 4.65 Favored 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 123.257 2.638 . . . . 64.43 113.52 173.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.546 ' HB2' ' H ' ' C' ' 125' ' ' GLN . 29.2 tp60 -61.71 114.89 3.56 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.055 0.542 . . . . 71.41 111.572 -172.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.606 HD23 HG13 ' B' ' 64' ' ' VAL . 34.7 tp -108.79 110.35 21.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.888 -1.051 . . . . 73.14 108.656 -177.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -121.77 116.89 25.31 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.049 -1.093 . . . . 73.34 108.049 176.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.506 HD21 HG22 ' B' ' 64' ' ' VAL . 73.3 mt -75.37 144.75 42.13 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 120.909 0.385 . . . . 74.03 111.541 -175.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.453 ' H ' ' HB3' ' F' ' 126' ' ' ALA . . . -76.85 151.62 82.31 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 124.481 1.112 . . . . 72.25 110.708 -177.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.502 ' HG3' HD12 ' D' ' 16' ' ' ILE . 3.8 Cg_endo -80.23 84.53 2.0 Allowed 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.843 2.362 . . . . 74.13 110.666 -177.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 p -89.07 111.32 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 N-CA-C 108.714 -0.847 . . . . 74.52 108.714 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -80.8 107.56 13.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.521 -0.763 . . . . 65.3 109.539 -176.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -54.83 -38.28 67.19 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.764 1.226 . . . . 63.52 111.137 -177.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -58.42 -49.76 76.15 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 114.466 -1.243 . . . . 72.43 110.479 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.26 -35.25 71.47 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 123.955 0.784 . . . . 71.41 112.364 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 10.1 mp -69.28 -50.06 50.3 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.881 0.472 . . . . 72.31 110.993 -178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -68.66 -30.76 69.52 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.7 0.4 . . . . 75.31 111.423 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 10.6 tmm? -68.5 -40.33 80.91 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.517 0.727 . . . . 71.22 109.187 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.503 ' HA ' ' HB2' ' B' ' 142' ' ' GLN . 5.8 t-20 -82.51 -26.39 32.56 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.313 -0.858 . . . . 64.14 110.741 -173.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . 0.506 ' OH ' ' HG2' ' F' ' 114' ' ' LYS . 3.1 t80 -75.75 -34.5 60.29 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.44 -0.8 . . . . 70.24 110.594 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mp -104.75 18.74 21.73 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.516 0.726 . . . . 70.15 110.49 177.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . 0.503 ' HB2' ' HA ' ' B' ' 139' ' ' ASN . 15.5 tm0? -77.51 143.85 38.12 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.488 0.715 . . . . 74.13 110.314 -174.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -135.31 140.57 45.23 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.927 -1.138 . . . . 74.3 107.927 173.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 76.79 74.13 0.08 Allowed 'General case' 0 N--CA 1.481 1.093 0 O-C-N 124.837 1.335 . . . . 74.11 110.433 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -164.22 100.1 0.84 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.909 0.883 . . . . 74.43 109.489 172.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.82 23.23 2.31 Favored Glycine 0 N--CA 1.466 0.635 0 N-CA-C 110.712 -0.955 . . . . 50.11 110.712 173.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -85.65 79.8 9.22 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.106 0.962 . . . . 71.21 108.936 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -105.69 72.1 0.23 Allowed Glycine 0 C--N 1.339 0.727 0 CA-C-N 114.987 -1.006 . . . . 75.22 110.835 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 27.4 p -68.88 145.34 53.77 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.242 0.617 . . . . 72.04 110.563 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -115.95 170.42 8.5 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.726 0.811 . . . . 74.01 110.581 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -158.97 159.63 35.07 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.562 0.745 . . . . 74.03 109.115 173.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -55.06 108.64 0.43 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.221 1.009 . . . . 73.04 112.475 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -75.61 125.9 29.94 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.456 -0.942 . . . . 73.32 108.456 167.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -101.55 158.18 16.27 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.289 0.636 . . . . 73.3 111.49 -172.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 C-N-CA 124.404 1.082 . . . . 72.41 109.855 -177.224 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.55 ' N ' ' SD ' ' C' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 107.892 -1.151 . . . . 72.01 107.892 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 69.5 m -151.35 173.86 14.0 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.542 0.737 . . . . 72.33 110.72 -176.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -141.26 156.88 45.83 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.137 0.975 . . . . 74.43 110.026 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -69.26 101.59 1.53 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.498 -0.556 . . . . 73.53 109.498 176.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -77.99 144.62 36.57 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.994 0.918 . . . . 71.51 111.947 -174.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -101.97 158.54 16.07 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.576 0.75 . . . . 75.32 109.229 172.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 21.9 p -76.51 -32.86 58.55 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.819 0.847 . . . . 62.01 112.907 -171.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -85.39 73.99 10.44 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 107.966 -1.124 . . . . 71.32 107.966 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.427 ' HB3' HD22 ' E' ' 139' ' ' ASN . 17.7 ttt 41.67 113.76 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 127.127 2.171 . . . . 62.43 115.573 175.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' C' ' 87' ' ' ALA . 21.0 m -105.74 108.42 19.92 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 108.388 -0.968 . . . . 63.22 108.388 173.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -125.98 136.85 53.47 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.358 -0.608 . . . . 75.43 109.358 174.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -150.53 135.24 17.4 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.821 0.848 . . . . 73.14 108.884 169.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 53.4 mt -77.22 119.11 25.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 107.655 -1.239 . . . . 70.23 107.655 166.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -84.56 -43.08 14.84 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.7 -0.852 . . . . 75.33 108.7 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.427 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER 178.97 158.31 0.55 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.195 1.398 . . . . 73.1 109.44 176.761 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 2.0 pp -128.68 141.52 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.382 -1.34 . . . . 74.04 107.382 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -170.52 157.57 5.96 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.284 0.564 . . . . 74.44 111.694 -168.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 66.5 p -80.33 113.31 18.42 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.982 -0.554 . . . . 75.0 109.639 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -34.6 71.58 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 108.04 -1.096 . . . . 75.04 108.04 171.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.467 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.5 t70 -151.24 145.55 25.45 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.372 -1.285 . . . . 63.12 110.385 -175.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.561 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.4 mt -139.82 147.42 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.9 1.68 . . . . 73.24 106.778 175.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -159.42 150.03 19.39 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.046 0.45 . . . . 73.02 110.217 171.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -151.12 135.89 17.24 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 107.454 -1.313 . . . . 73.31 107.454 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -136.0 124.73 23.86 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.888 0.475 . . . . 75.43 109.878 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.16 75.55 77.85 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 107.76 -1.2 . . . . 54.41 107.76 162.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -74.92 -10.01 21.14 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.291 1.994 . . . . 71.35 111.677 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -106.17 13.15 29.35 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.803 1.241 . . . . 72.14 109.798 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.98 -57.0 7.78 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 115.078 1.51 . . . . 73.0 115.078 -165.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -64.34 -41.14 22.01 Favored 'Trans proline' 0 C--N 1.378 2.116 0 CA-C-N 121.813 1.683 . . . . 60.43 112.177 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -68.67 -34.31 75.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.36 1.064 . . . . 73.14 111.702 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.538 HG23 ' HA ' ' C' ' 73' ' ' ALA . 9.1 p -79.67 -27.43 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 CA-C-N 116.147 -0.479 . . . . 75.41 111.877 -178.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -69.79 -31.51 69.47 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 111.598 0.221 . . . . 74.3 111.598 174.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -96.49 30.78 2.45 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.203 0.601 . . . . 74.05 110.552 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.47 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 0.5 OUTLIER -112.75 167.44 10.48 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.315 1.046 . . . . 71.1 109.334 178.306 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -75.99 120.64 21.59 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.538 -0.541 . . . . 70.34 109.538 171.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -85.23 89.28 7.61 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.73 0.812 . . . . 74.35 110.857 -174.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -131.09 80.61 68.59 Favored Pre-proline 0 N--CA 1.481 1.109 0 C-N-CA 123.999 0.92 . . . . 74.21 108.839 167.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -71.8 111.41 3.14 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.292 1.994 . . . . 62.42 110.814 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -83.02 91.72 7.23 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 104.522 -2.399 . . . . 73.24 104.522 170.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.616 HG22 ' H ' ' F' ' 135' ' ' VAL . 62.0 t -75.28 140.59 17.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 113.623 -1.626 . . . . 75.22 110.729 -167.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -128.36 103.16 7.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.352 1.061 . . . . 71.3 108.766 171.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.54 HD11 HG13 ' F' ' 135' ' ' VAL . 87.0 mt -85.3 150.06 25.03 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.929 0.892 . . . . 74.43 108.74 174.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.414 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 31.6 t70 -143.64 141.93 30.8 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.296 0.638 . . . . 73.01 109.613 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 47.9 mt -132.42 133.18 43.58 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.192 0.997 . . . . 75.13 109.116 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -143.23 123.44 13.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.801 -1.555 . . . . 74.43 106.801 175.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 46' ' ' THR . . . . . 0.41 ' OG1' ' HG3' ' C' ' 103' ' ' PRO . 15.0 t -118.42 130.47 55.99 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.471 0.653 . . . . 72.13 109.418 176.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.35 153.41 29.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.177 -0.92 . . . . 62.33 109.095 176.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 37.2 p -146.64 143.0 28.48 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.862 -0.792 . . . . 75.51 108.862 175.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 45.9 t -156.89 135.82 11.78 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.163 0.585 . . . . 74.54 109.487 -177.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -79.48 116.82 19.93 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.764 -0.828 . . . . 74.1 108.764 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.676 HD12 ' HB2' ' C' ' 57' ' ' GLU . 63.4 mt -84.75 -34.94 22.75 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.613 0.765 . . . . 73.22 110.616 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.67 -176.02 5.63 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.143 -0.935 . . . . 72.32 109.868 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -58.44 108.61 0.65 Allowed 'General case' 0 C--O 1.242 0.674 0 O-C-N 124.122 0.889 . . . . 73.22 109.695 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . 0.563 ' HB3' ' HB3' ' C' ' 87' ' ' ALA . 16.9 m-20 66.2 24.63 10.74 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 124.311 1.007 . . . . 74.45 111.853 175.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.7 t -122.24 118.97 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 108.835 -0.802 . . . . 72.33 108.835 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -120.6 125.44 47.76 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.082 0.953 . . . . 74.32 109.997 -176.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.676 ' HB2' HD12 ' C' ' 51' ' ' LEU . 36.2 tt0 -84.71 131.99 34.51 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.531 -0.915 . . . . 73.54 108.531 166.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.52 HG12 ' HD3' ' C' ' 103' ' ' PRO . 61.3 t -122.45 123.05 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.08 -1.081 . . . . 73.14 108.08 168.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.562 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 73.5 t -108.84 145.44 15.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.19 -0.67 . . . . 71.2 109.19 174.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.06 101.27 7.44 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.651 -1.241 . . . . 75.13 107.651 174.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 35.9 ttm-85 -79.98 106.29 11.89 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.068 -1.086 . . . . 72.41 108.068 169.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.451 ' HB ' HD11 ' C' ' 114' ' ' ILE . 16.0 t -107.17 123.9 62.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.731 -1.211 . . . . 75.02 107.731 172.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 12.5 m -122.83 116.19 23.27 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.721 -0.844 . . . . 72.52 108.721 -176.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.466 HG22 HG23 ' C' ' 114' ' ' ILE . 73.8 t -111.35 110.69 33.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 124.463 1.105 . . . . 75.12 108.767 -174.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.4 m -99.67 139.28 35.56 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 115.356 -0.838 . . . . 71.21 108.88 175.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.45 105.23 6.81 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.093 -1.447 . . . . 74.42 107.093 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.0 m -123.33 135.28 54.12 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 108.179 -1.045 . . . . 71.41 108.179 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 36.2 mt -84.13 25.98 0.79 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.474 1.11 . . . . 71.01 110.714 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.76 -91.75 0.8 Allowed Glycine 0 C--N 1.357 1.722 0 N-CA-C 111.041 -0.823 . . . . 74.35 111.041 -177.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -89.11 -31.33 18.05 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.587 0.755 . . . . 73.34 110.261 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.47 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 5.6 tp10 -89.34 124.06 34.08 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.819 1.248 . . . . 74.5 109.466 173.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.0 m -80.93 126.45 31.39 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.603 -0.888 . . . . 73.41 108.603 166.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.538 ' HA ' HG23 ' C' ' 31' ' ' VAL . . . -78.47 -55.81 4.93 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.42 -0.585 . . . . 74.23 109.42 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -159.01 166.05 32.64 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.665 0.745 . . . . 74.32 112.16 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -130.05 143.14 50.63 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 106.683 -1.599 . . . . 75.24 106.683 167.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -149.87 112.08 4.65 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.661 -0.496 . . . . 74.1 109.661 179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -116.68 124.61 50.14 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.219 -0.66 . . . . 74.25 109.219 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 49.4 t -122.97 115.07 44.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.77 -0.826 . . . . 72.2 108.77 172.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.467 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.1 mt-30 -93.86 87.69 5.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.046 0.938 . . . . 74.51 109.209 175.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -80.2 101.56 8.91 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.855 -1.066 . . . . 73.43 109.976 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -100.66 150.2 18.73 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-O 121.143 0.302 . . . . 52.51 112.746 177.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.7 132.51 4.78 Favored Glycine 0 CA--C 1.501 -0.798 0 N-CA-C 110.756 -0.937 . . . . 63.32 110.756 -175.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 34.7 mm -90.87 128.14 42.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 108.531 -0.915 . . . . 73.55 108.531 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -136.15 119.39 16.68 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.609 -0.885 . . . . 73.41 108.609 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 33.3 p -78.49 102.26 7.76 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.472 -0.936 . . . . 75.13 108.472 173.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.565 HD11 ' SG ' ' C' ' 97' ' ' CYS . 5.7 mt -116.07 140.32 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 122.832 0.453 . . . . 73.25 110.073 -176.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.563 ' HB3' ' HB3' ' C' ' 54' ' ' ASP . . . -160.35 172.07 17.97 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.777 0.831 . . . . 63.31 110.732 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.99 -47.19 3.5 Favored Glycine 0 C--N 1.345 1.062 0 O-C-N 123.896 0.747 . . . . 73.54 111.61 175.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.5 HD13 ' HA ' ' C' ' 94' ' ' MET . 41.7 pt -83.1 146.77 6.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 123.64 0.776 . . . . 63.24 111.154 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -149.38 -179.13 6.83 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.907 0.883 . . . . 75.32 109.595 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.57 -126.94 30.89 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-O 119.603 -0.554 . . . . 63.03 112.107 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.6 -26.0 62.41 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.269 0.627 . . . . 62.33 111.611 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.429 ' HB3' ' HB ' ' C' ' 89' ' ' ILE . 26.5 mt-30 -65.42 -60.77 2.6 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.527 0.331 . . . . 74.21 110.266 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.5 ' HA ' HD13 ' C' ' 89' ' ' ILE . 1.8 tpt -54.93 -48.36 73.24 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 123.796 0.685 . . . . 72.04 112.152 173.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.2 -40.2 76.92 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.728 0.642 . . . . 75.24 111.608 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -83.46 -23.34 32.28 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.403 0.681 . . . . 74.41 111.638 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.565 ' SG ' HD11 ' C' ' 86' ' ' ILE . 34.3 t -69.56 -37.89 77.19 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 108.354 -0.98 . . . . 73.1 108.354 175.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.432 ' HG ' ' HE3' ' C' ' 94' ' ' MET . 76.9 mt -81.1 -31.81 34.13 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.972 -1.013 . . . . 74.13 110.801 174.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . 0.4 ' HA3' ' CE2' ' C' ' 137' ' ' PHE . . . -78.05 -28.88 55.52 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.163 -0.926 . . . . 74.34 114.755 -168.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.99 -47.57 0.09 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.469 0.544 . . . . 73.52 112.469 -167.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.46 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 70.3 t80 -56.05 -59.3 5.11 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.345 0.658 . . . . 75.42 111.772 -176.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 88.6 m -63.66 -46.01 82.7 Favored Pre-proline 0 CA--C 1.566 1.582 0 C-N-CA 124.173 0.989 . . . . 73.32 111.691 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.52 ' HD3' HG12 ' C' ' 58' ' ' VAL . 96.0 Cg_exo -49.67 -36.11 40.24 Favored 'Trans proline' 0 C--N 1.395 2.997 0 C-N-CA 123.088 2.525 . . . . 64.41 114.832 168.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -67.97 -31.98 72.08 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.477 0.711 . . . . 62.5 111.249 177.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 32.2 mm -69.66 -38.78 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 109.185 -0.672 . . . . 71.1 109.185 175.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 53.5 mt -78.82 -34.4 45.27 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.262 1.025 . . . . 71.21 112.516 -174.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -54.46 -47.11 98.64 Favored Pre-proline 0 N--CA 1.484 1.24 0 N-CA-C 114.238 1.199 . . . . 74.32 114.238 -170.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.48 -39.06 58.54 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.167 1.912 . . . . 74.14 113.345 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -68.5 -40.42 80.9 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.278 0.631 . . . . 71.23 110.793 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.28 -41.86 99.04 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.16 -0.927 . . . . 73.33 109.866 174.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -60.71 -49.35 77.86 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.936 1.294 . . . . 73.34 110.61 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.27 -40.88 90.42 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.724 0.64 . . . . 74.22 109.943 -176.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 49.4 t -68.83 -34.88 76.22 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.504 0.503 . . . . 74.44 111.986 -176.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.466 HG23 HG22 ' C' ' 64' ' ' VAL . 97.0 mt -69.43 -52.33 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.443 0.697 . . . . 75.51 110.363 175.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.4 m -67.95 -27.23 66.43 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 122.974 0.509 . . . . 63.31 111.254 -175.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 40.4 t -62.97 -47.06 84.81 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.971 0.908 . . . . 73.52 109.367 170.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.685 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.86 -38.68 91.79 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.433 1.093 . . . . 74.23 112.125 178.227 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 98.9 t -58.39 -45.79 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.462 0.705 . . . . 73.34 109.685 173.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.508 ' OG ' HG22 ' B' ' 115' ' ' THR . 28.9 t -68.76 -31.65 70.84 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.836 -1.074 . . . . 74.53 112.268 -178.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.435 HH12 ' HG2' ' D' ' 112' ' ' GLU . 73.0 mtt-85 -69.47 -40.4 77.11 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.162 -0.681 . . . . 74.2 109.162 177.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.56 -1.07 86.01 Favored Glycine 0 C--N 1.356 1.683 0 O-C-N 123.983 0.802 . . . . 62.42 112.66 172.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.3 p 65.46 25.61 11.89 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 126.819 2.048 . . . . 64.3 114.075 169.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -83.67 143.83 44.53 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 109.313 -0.625 . . . . 75.12 109.313 174.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.45 ' HG3' HG21 ' F' ' 129' ' ' THR . 78.0 Cg_exo -45.61 135.9 12.63 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 123.459 2.773 . . . . 75.04 113.055 171.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.546 ' H ' ' HB2' ' B' ' 125' ' ' GLN . 36.8 mm-40 -44.07 112.82 0.44 Allowed 'General case' 0 N--CA 1.483 1.211 0 O-C-N 124.882 1.364 . . . . 72.4 111.934 -174.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.453 HD11 ' H ' ' F' ' 135' ' ' VAL . 20.2 tp -108.18 83.94 1.86 Allowed 'General case' 0 C--O 1.239 0.525 0 N-CA-C 106.565 -1.643 . . . . 64.51 106.565 170.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -97.54 94.52 7.05 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 114.357 -1.292 . . . . 73.32 108.378 -170.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.527 ' H ' HD22 ' C' ' 128' ' ' LEU . 1.5 pt? -56.3 139.09 49.41 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.089 0.956 . . . . 73.52 111.967 -175.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.51 150.83 64.19 Favored Pre-proline 0 CA--C 1.548 0.891 0 CA-C-N 114.759 -1.109 . . . . 72.44 110.945 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.416 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 19.2 Cg_endo -60.41 113.7 1.8 Allowed 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.852 2.368 . . . . 75.42 112.674 175.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 49.0 t -99.31 118.39 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 107.676 -1.231 . . . . 64.24 107.676 171.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -71.84 103.44 3.15 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.265 0.626 . . . . 73.32 110.42 -175.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -62.64 -31.46 72.32 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.253 1.021 . . . . 73.31 111.944 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -66.36 -37.66 85.81 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.278 0.631 . . . . 74.53 110.685 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.92 86.56 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.516 0.726 . . . . 75.42 110.373 175.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 98.4 mt -64.94 -35.34 80.83 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.925 -1.034 . . . . 75.2 110.889 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . 0.4 ' CE2' ' HA3' ' C' ' 99' ' ' GLY . 3.4 t80 -81.48 -26.12 35.46 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.95 -0.568 . . . . 74.32 111.307 -179.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 37.9 ttp -67.56 -46.74 71.83 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 123.827 0.704 . . . . 74.11 109.867 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -71.5 -34.88 70.51 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 115.739 -0.664 . . . . 74.21 110.564 177.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -55.42 -84.26 0.01 OUTLIER 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.112 0.965 . . . . 72.51 110.362 174.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 38.7 tp 61.67 160.59 0.06 Allowed 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 124.623 1.169 . . . . 73.04 111.569 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.29 -73.55 0.28 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 106.671 -1.603 . . . . 75.23 106.671 173.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -148.09 119.59 7.94 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.859 -0.793 . . . . 71.21 108.859 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -77.44 118.21 19.66 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-O 121.327 0.584 . . . . 75.53 110.03 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -151.83 56.05 0.85 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.286 -1.005 . . . . 73.41 108.286 177.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.78 59.06 4.99 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 114.129 -1.396 . . . . 42.22 112.197 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -105.01 112.59 25.79 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.376 1.07 . . . . 74.31 110.045 -174.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -151.25 36.48 0.87 Allowed Glycine 0 C--N 1.341 0.837 0 O-C-N 123.617 0.573 . . . . 72.22 111.834 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 15.3 t -101.2 142.33 32.79 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.552 0.741 . . . . 72.42 110.732 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -176.86 -27.07 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.626 1.17 . . . . 74.5 109.623 176.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.58 111.15 0.74 Allowed 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 124.262 1.025 . . . . 74.24 112.03 177.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -122.06 164.25 18.02 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.725 1.21 . . . . 73.51 108.507 174.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -62.95 98.7 0.13 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 109.348 -0.612 . . . . 74.34 109.348 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.3 -52.62 61.22 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.609 0.764 . . . . 72.32 110.267 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.303 0 CA-C-N 114.852 -1.067 . . . . 71.14 109.597 177.762 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.41 ' SD ' ' N ' ' D' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.479 0.977 0 CA-C-O 119.444 -0.312 . . . . 63.43 110.963 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 37.4 p -167.36 144.54 4.52 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.872 0.469 . . . . 74.44 111.262 -173.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -91.62 161.17 15.03 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.773 1.229 . . . . 73.45 109.743 174.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -68.94 140.68 55.09 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.443 0.697 . . . . 74.32 110.228 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.87 -73.13 0.15 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.298 1.039 . . . . 65.44 110.228 -171.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -170.75 150.78 3.32 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.749 1.219 . . . . 73.13 107.748 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 14.7 t -160.34 -154.56 0.39 Allowed 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 124.095 0.958 . . . . 64.22 108.787 -174.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.495 ' HG2' ' H ' ' D' ' 9' ' ' MET . 19.3 tt0 -73.24 -169.97 0.71 Allowed 'General case' 0 CA--C 1.572 1.798 0 C-N-CA 123.807 0.843 . . . . 74.4 109.95 173.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.495 ' H ' ' HG2' ' D' ' 8' ' ' GLU . 0.1 OUTLIER -29.54 125.07 0.14 Allowed 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 125.95 1.7 . . . . 73.43 113.113 178.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 8.2 t -112.59 134.55 54.06 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.797 0.839 . . . . 75.35 109.942 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.471 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 49.9 t80 -135.3 91.01 2.68 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 106.781 -1.563 . . . . 72.54 106.781 176.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -121.2 126.8 50.54 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.474 0.71 . . . . 71.0 109.252 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.535 HD11 HG21 ' D' ' 105' ' ' ILE . 1.8 mt -96.21 132.77 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 107.84 -1.17 . . . . 73.22 107.84 178.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -104.09 -19.58 14.12 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 119.116 -0.468 . . . . 70.2 111.417 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . 0.425 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 41.1 ttt180 -172.29 131.92 0.62 Allowed 'General case' 0 C--N 1.36 1.042 0 N-CA-C 112.065 0.395 . . . . 73.33 112.065 -176.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.502 HD12 ' HG3' ' B' ' 130' ' ' PRO . 2.6 mp -110.41 134.95 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 106.842 -1.54 . . . . 64.51 106.842 170.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.425 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 22.2 p90 -158.16 140.28 14.14 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 123.521 0.513 . . . . 73.33 111.685 -177.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -78.6 113.17 16.4 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.498 -0.774 . . . . 75.35 109.668 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -85.76 -11.24 54.06 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.602 -0.726 . . . . 75.11 109.9 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.642 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.4 t70 -165.54 145.25 6.59 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.594 1.158 . . . . 53.54 109.846 177.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.685 HG21 ' HE1' ' C' ' 117' ' ' MET . 66.4 mt -148.41 148.23 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 125.622 1.569 . . . . 74.43 107.695 175.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.1 t -154.98 146.24 22.89 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.356 1.062 . . . . 74.02 109.092 171.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.561 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 92.0 t80 -143.61 126.32 16.07 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 106.669 -1.604 . . . . 71.51 106.669 169.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 47.9 mt-10 -121.16 142.73 49.61 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.549 0.74 . . . . 73.53 109.227 175.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.69 75.51 37.1 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 107.018 -1.475 . . . . 75.14 107.018 169.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -71.99 -19.93 26.09 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.453 2.102 . . . . 73.44 112.772 -171.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -110.7 3.98 19.69 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.655 0.782 . . . . 74.24 111.153 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -27.33 -70.63 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 116.805 2.15 . . . . 73.41 116.805 -167.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.32 -19.46 15.17 Favored 'Trans proline' 0 C--N 1.388 2.618 0 CA-C-N 124.036 2.477 . . . . 52.44 114.011 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -74.5 -39.6 62.32 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.045 0.938 . . . . 70.14 109.816 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.549 HG23 ' HA ' ' D' ' 73' ' ' ALA . 9.3 p -82.98 -16.25 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 CA-C-N 116.065 -0.516 . . . . 75.1 111.101 -171.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -68.42 -13.42 62.28 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.07 0.767 . . . . 75.55 113.07 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -60.34 -27.29 67.24 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.788 0.835 . . . . 73.24 110.713 173.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.555 ' HZ3' ' HG2' ' D' ' 71' ' ' GLU . 97.3 mttt -91.78 88.13 6.55 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.494 1.518 . . . . 74.31 110.179 -177.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -83.11 90.92 7.12 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.221 -0.9 . . . . 72.22 110.682 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 40.7 p90 -165.4 172.01 12.72 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.138 0.975 . . . . 75.43 109.29 166.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -70.58 111.27 9.02 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.644 0.778 . . . . 75.24 109.321 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.44 128.47 30.23 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 122.937 2.424 . . . . 63.51 112.058 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.74 113.1 5.23 Favored 'General case' 0 C--O 1.24 0.566 0 O-C-N 123.773 0.671 . . . . 74.25 109.462 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.635 HG21 ' HB3' ' D' ' 66' ' ' ALA . 78.7 t -98.53 107.13 19.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-N 115.343 -0.844 . . . . 72.54 110.102 -174.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -87.65 111.04 20.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 105.693 -1.965 . . . . 74.02 105.693 165.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 49.7 tp -95.52 143.44 26.84 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.498 -0.927 . . . . 74.32 108.498 -172.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.592 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 15.8 m-20 -120.02 117.01 26.88 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.688 -1.226 . . . . 74.42 107.688 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.641 ' HB3' HD21 ' E' ' 111' ' ' LEU . 23.4 mt -116.31 131.0 57.06 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.048 0.452 . . . . 71.4 110.014 177.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.631 ' HA ' ' HB3' ' E' ' 111' ' ' LEU . 38.4 t70 -143.99 145.2 32.06 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.246 -1.02 . . . . 73.33 108.246 171.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 46' ' ' THR . . . . . 0.717 HG22 HD22 ' E' ' 111' ' ' LEU . 22.8 p -104.6 170.57 7.81 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.105 0.562 . . . . 72.01 110.493 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -166.35 163.08 17.49 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.463 1.105 . . . . 62.55 108.621 172.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 53.7 p -155.52 153.3 30.01 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 108.147 -1.057 . . . . 65.55 108.147 169.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 68.6 p -165.78 159.33 16.02 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.631 0.772 . . . . 65.31 109.481 -174.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . 0.451 ' HB2' ' HG3' ' D' ' 57' ' ' GLU . 25.1 tp60 152.09 -91.63 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 126.781 2.033 . . . . 72.51 107.855 164.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.47 ' HB2' HG11 ' D' ' 55' ' ' VAL . 80.7 mt -151.74 133.01 14.5 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.317 1.447 . . . . 71.32 107.482 -175.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.39 78.1 3.91 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 109.111 -0.7 . . . . 63.53 109.111 173.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -166.1 42.37 0.06 Allowed 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.095 -0.957 . . . . 74.51 108.762 -171.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 66.11 -1.79 1.09 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 124.622 1.169 . . . . 73.34 113.586 178.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.47 HG11 ' HB2' ' D' ' 51' ' ' LEU . 2.3 p -109.24 94.54 3.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 107.305 -1.368 . . . . 73.52 107.305 177.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.408 ' HD2' HD11 ' D' ' 98' ' ' LEU . 5.7 m-30 -122.18 128.3 51.05 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.676 -0.861 . . . . 73.12 108.676 -171.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.451 ' HG3' ' HB2' ' D' ' 50' ' ' GLN . 31.4 mt-10 -85.89 152.99 22.53 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 107.318 -1.364 . . . . 74.21 107.318 162.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 53.3 t -130.16 138.57 53.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.302 -1.37 . . . . 72.5 107.302 165.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.462 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 32.3 t -126.11 130.12 72.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 108.249 -1.019 . . . . 71.23 108.249 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.558 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -109.02 119.96 41.1 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 106.824 -1.547 . . . . 72.44 106.824 178.722 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -99.36 97.99 8.97 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.384 -0.969 . . . . 72.2 108.384 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.4 HG21 ' CD2' ' D' ' 44' ' ' LEU . 31.9 t -101.82 117.14 46.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.291 -0.868 . . . . 74.14 108.713 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.592 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 22.6 m -126.7 119.14 26.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.382 0.673 . . . . 73.33 109.25 -173.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.573 HG11 HG13 ' D' ' 40' ' ' VAL . 55.1 t -100.89 124.16 54.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 123.715 0.806 . . . . 63.43 110.022 -177.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 28.4 m -114.69 96.19 5.61 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.239 -1.022 . . . . 75.54 108.239 170.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.635 ' HB3' HG21 ' D' ' 40' ' ' VAL . . . -106.69 142.56 36.13 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.482 -0.781 . . . . 71.51 110.076 -175.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.469 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 48.9 m -139.75 141.64 36.83 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.441 0.638 . . . . 73.44 112.258 -173.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 46.7 mt -111.57 114.71 27.96 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.32 -1.309 . . . . 73.41 107.642 170.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.52 -131.73 22.09 Favored Glycine 0 C--N 1.341 0.835 0 O-C-N 123.155 0.284 . . . . 74.13 112.768 -176.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.84 1.61 55.38 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.942 0.497 . . . . 75.41 111.41 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.555 ' HG2' ' HZ3' ' D' ' 34' ' ' LYS . 12.3 pt-20 -119.15 164.66 15.24 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.751 0.42 . . . . 75.31 110.366 -175.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 98.8 m -67.82 131.59 45.82 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.06 -0.973 . . . . 73.13 110.998 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.549 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -84.9 -63.49 1.32 Allowed 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.698 -1.223 . . . . 53.23 107.698 170.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -152.05 148.82 28.14 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 114.587 -1.188 . . . . 73.45 110.607 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.452 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 82.6 mt -109.65 154.12 23.27 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.454 1.102 . . . . 74.31 108.27 170.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.532 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 43.0 t -157.9 148.62 20.86 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.316 -0.624 . . . . 72.33 109.316 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -155.6 131.45 9.91 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.313 0.645 . . . . 75.53 109.796 174.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -135.13 113.82 16.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 108.267 -1.012 . . . . 74.54 108.267 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.642 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.8 mt-30 -89.54 83.88 6.35 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.239 -1.023 . . . . 74.41 108.239 169.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -80.31 96.87 6.77 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 113.734 -1.575 . . . . 64.32 109.377 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.25 168.51 35.23 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.689 -0.687 . . . . 73.14 112.468 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.02 138.09 4.75 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 110.707 -0.957 . . . . 73.42 110.707 173.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.99 123.97 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 N-CA-C 108.549 -0.908 . . . . 71.33 108.549 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -115.13 125.73 53.81 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.681 1.192 . . . . 73.3 110.002 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 35.0 m -87.87 95.08 9.97 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 108.513 -0.921 . . . . 55.24 108.513 168.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 37.0 pt -109.78 142.7 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.415 -0.587 . . . . 75.43 109.415 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.63 166.94 9.82 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.933 0.893 . . . . 74.25 110.378 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.23 22.75 56.46 Favored Glycine 0 C--N 1.352 1.448 0 O-C-N 123.517 0.51 . . . . 54.54 113.796 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.566 ' HB ' ' HB3' ' D' ' 94' ' ' MET . 0.2 OUTLIER -120.33 148.97 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 124.187 0.995 . . . . 75.43 109.668 -179.068 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -129.06 -178.3 4.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.79 0.836 . . . . 64.52 109.904 -175.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.58 -142.58 47.05 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.363 -0.835 . . . . 72.21 112.63 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.2 p -90.81 -14.72 31.38 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.649 0.779 . . . . 74.41 111.267 173.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -56.38 -34.1 66.37 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.356 1.062 . . . . 72.34 112.247 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.566 ' HB3' ' HB ' ' D' ' 89' ' ' ILE . 0.0 OUTLIER -62.57 -43.5 98.65 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.306 0.642 . . . . 70.12 112.049 -179.426 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . 0.453 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.05 -22.92 28.8 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.384 0.674 . . . . 65.24 111.862 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -74.93 -38.4 61.78 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.734 -0.469 . . . . 73.43 109.734 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 73.7 m -73.05 -26.7 61.38 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.493 0.717 . . . . 71.01 110.888 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.408 HD11 ' HD2' ' D' ' 56' ' ' TYR . 53.2 tp -63.89 -43.63 95.44 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.711 0.804 . . . . 75.21 110.319 175.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . 0.406 ' O ' HG21 ' D' ' 46' ' ' THR . . . -94.56 -12.05 56.28 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 119.298 -0.723 . . . . 63.1 114.381 -175.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.04 -58.34 1.88 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 118.439 1.12 . . . . 70.23 112.341 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -74.57 -41.73 60.01 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.224 0.453 . . . . 75.41 112.224 -172.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.482 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 75.5 m -61.46 -47.52 93.17 Favored Pre-proline 0 CA--C 1.568 1.636 0 C-N-CA 123.383 0.673 . . . . 70.22 111.69 178.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.558 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 53.2 Cg_exo -61.63 -31.24 86.63 Favored 'Trans proline' 0 C--N 1.39 2.718 0 C-N-CA 122.344 2.029 . . . . 73.21 113.795 170.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -63.0 -33.33 75.19 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.022 0.529 . . . . 64.2 110.843 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.535 HG21 HD11 ' D' ' 13' ' ' ILE . 47.4 mm -67.22 -42.08 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.776 0.83 . . . . 73.31 110.49 173.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 54.0 mt -76.18 -11.35 59.91 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.357 -0.838 . . . . 74.52 111.638 -175.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -70.63 -44.81 17.42 Favored Pre-proline 0 CA--C 1.558 1.282 0 N-CA-C 114.086 1.143 . . . . 72.43 114.086 -172.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . 0.58 ' HB2' ' HG2' ' B' ' 108' ' ' PRO . 29.1 Cg_endo -61.97 -32.07 84.42 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 121.649 1.566 . . . . 75.35 112.469 172.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . 0.409 ' O ' ' HB3' ' D' ' 112' ' ' GLU . 62.5 m-85 -72.82 -31.69 64.99 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.752 0.821 . . . . 74.45 111.634 175.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.98 -48.08 72.43 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.437 0.637 . . . . 75.4 109.334 175.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 33.2 ttp180 -65.66 -31.92 73.21 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.174 -1.375 . . . . 74.12 110.858 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . 0.435 ' HG2' HH12 ' C' ' 120' ' ' ARG . 16.0 tt0 -53.17 -52.63 58.17 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.343 1.057 . . . . 75.41 110.317 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.9 t -69.51 -47.59 63.31 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.511 -1.222 . . . . 74.31 111.061 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.458 HD12 HG21 ' D' ' 64' ' ' VAL . 63.4 mt -62.37 -58.23 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.346 0.658 . . . . 75.22 111.062 -176.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 86.0 m -52.84 -39.57 62.64 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.107 0.879 . . . . 74.23 111.564 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.447 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 43.4 t -65.19 -45.11 86.14 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.128 -0.942 . . . . 63.2 110.121 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.502 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 79.0 mtm -66.31 -32.87 74.54 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.198 0.599 . . . . 75.43 111.959 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.413 HG23 ' O ' ' D' ' 114' ' ' ILE . 92.5 t -62.79 -48.47 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.616 0.767 . . . . 75.15 109.794 175.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 96.4 p -71.24 -27.67 63.63 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.593 -0.731 . . . . 74.52 110.787 -178.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' D' ' 116' ' ' SER . 90.4 mtt-85 -69.64 -33.76 73.08 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.541 0.736 . . . . 74.34 109.936 174.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.46 9.16 71.71 Favored Glycine 0 C--N 1.355 1.624 0 O-C-N 123.578 0.548 . . . . 62.33 112.933 176.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 82.1 p 56.51 36.56 27.76 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.93 1.692 . . . . 74.41 113.631 177.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -98.62 149.63 35.93 Favored Pre-proline 0 C--O 1.243 0.754 0 N-CA-C 108.557 -0.905 . . . . 73.34 108.557 171.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.473 ' HB3' ' HA ' ' E' ' 129' ' ' THR . 66.7 Cg_exo -45.58 131.1 12.44 Favored 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 123.308 2.672 . . . . 73.24 112.616 172.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -52.95 130.88 34.92 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 124.344 1.027 . . . . 75.5 111.479 -172.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.453 HD12 HG22 ' D' ' 40' ' ' VAL . 10.1 tp -105.71 98.61 8.28 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.182 -0.917 . . . . 72.42 108.603 -173.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . 0.417 HD21 HD13 ' B' ' 16' ' ' ILE . 10.2 m120 -100.51 78.61 2.02 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.94 -1.133 . . . . 63.33 107.94 177.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.06 132.33 48.29 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 109.791 -0.448 . . . . 74.52 109.791 -175.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.77 144.03 97.99 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 123.815 0.846 . . . . 75.41 111.425 -174.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.65 132.63 46.67 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.635 2.223 . . . . 75.12 111.945 176.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 73.6 t -107.48 128.63 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.729 -0.841 . . . . 74.33 108.729 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -85.59 97.84 10.31 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.657 0.783 . . . . 75.21 108.997 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -62.49 -26.88 68.77 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.658 1.183 . . . . 64.32 112.229 -173.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -58.69 -41.71 86.89 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.915 0.886 . . . . 71.11 110.608 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.597 ' HA ' ' HE3' ' D' ' 138' ' ' MET . . . -61.71 -30.95 71.09 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.81 -1.087 . . . . 64.32 111.937 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.4 mp -74.43 -40.74 61.78 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.282 0.633 . . . . 74.21 111.287 -175.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -67.38 -35.49 79.44 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.805 0.442 . . . . 75.15 111.485 175.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.597 ' HE3' ' HA ' ' D' ' 135' ' ' ALA . 75.8 mtm -72.59 -38.15 67.94 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.103 0.561 . . . . 72.34 110.919 176.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.445 ' O ' ' HG3' ' D' ' 143' ' ' GLN . 66.3 t30 -71.08 -35.05 71.72 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.332 0.653 . . . . 71.31 110.262 -175.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -49.21 -41.0 35.73 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.874 1.27 . . . . 75.4 111.688 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.2 mp -73.92 -43.13 59.37 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.694 0.798 . . . . 73.3 111.768 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -91.22 27.99 1.76 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 113.194 0.813 . . . . 75.45 113.194 -169.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' D' ' 139' ' ' ASN . 46.8 mt-30 -121.44 87.25 2.72 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.276 0.56 . . . . 75.35 109.82 177.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -162.31 94.83 0.91 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.28 1.032 . . . . 62.44 109.336 -177.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.67 148.64 29.52 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.542 0.737 . . . . 74.43 110.519 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.29 102.86 1.87 Allowed Glycine 0 C--N 1.344 1.014 0 CA-C-N 115.909 -0.587 . . . . 75.42 111.768 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -68.43 137.5 54.54 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.887 0.875 . . . . 71.02 111.861 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -160.16 150.24 20.24 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 115.674 -0.693 . . . . 52.21 112.166 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 41.4 m -113.37 132.75 55.48 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.744 0.817 . . . . 74.53 109.576 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -75.63 173.56 10.89 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.193 0.597 . . . . 74.52 111.163 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -153.14 147.46 25.82 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.158 0.583 . . . . 75.14 110.391 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -136.72 121.41 18.5 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.796 0.839 . . . . 71.52 108.985 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -94.26 155.45 17.02 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.094 0.558 . . . . 70.21 109.574 171.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -162.77 147.81 11.93 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.384 -0.599 . . . . 72.22 109.384 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.285 0 C-N-CA 123.6 0.76 . . . . 72.2 109.138 -177.715 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.519 0 N-CA-C 111.823 -0.511 . . . . 73.24 111.823 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.52 -155.95 42.23 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 113.887 0.315 . . . . 73.2 113.887 175.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -121.09 169.05 10.89 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.422 1.089 . . . . 75.33 111.019 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -93.81 -169.57 2.13 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.952 0.901 . . . . 75.44 111.304 -174.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -158.16 101.02 1.73 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.686 -1.228 . . . . 62.13 107.686 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . -177.48 -52.85 0.07 OUTLIER Glycine 0 C--N 1.346 1.114 0 O-C-N 123.106 0.254 . . . . 55.41 112.809 -176.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 97' ' ' ILE . . . . . . . . . . . . . 4.0 tt -83.12 101.73 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 CA-C-O 122.177 0.989 . . . . 72.32 110.689 -177.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -155.66 89.17 1.16 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 114.763 -1.108 . . . . 74.41 108.063 171.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 99' ' ' ALA . . . . . 0.524 ' H ' HD22 ' E' ' 100' ' ' LEU . . . -166.41 25.73 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.308 1.043 . . . . 71.52 109.673 -177.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 100' ' ' LEU . . . . . 0.524 HD22 ' H ' ' E' ' 99' ' ' ALA . 2.1 pt? -151.93 152.32 29.72 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 123.645 0.778 . . . . 74.52 110.289 -173.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -84.9 152.5 11.27 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 122.454 2.103 . . . . 72.42 110.496 161.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 102' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -72.72 83.59 1.17 Allowed 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 109.323 -0.621 . . . . 71.42 109.323 178.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 103' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' E' ' 107' ' ' THR . 48.4 p 54.41 15.75 1.08 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 126.356 1.862 . . . . 72.45 113.452 -174.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.65 -168.43 29.19 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.778 -0.529 . . . . 75.23 111.778 -173.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -66.5 -43.45 85.32 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.59 0.756 . . . . 61.21 111.433 -176.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -153.91 59.57 0.73 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 108.289 -1.004 . . . . 72.32 108.289 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 107' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' E' ' 103' ' ' THR . 18.2 m 54.14 79.14 0.14 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.843 1.257 . . . . 74.11 111.4 176.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -61.4 -33.11 73.13 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.985 -1.007 . . . . 72.11 112.562 -169.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -70.12 -46.3 65.09 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.458 0.474 . . . . 74.15 110.255 174.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' E' ' 113' ' ' LYS . . . 62.03 115.82 0.02 OUTLIER 'General case' 0 C--N 1.357 0.896 0 O-C-N 124.614 1.197 . . . . 75.5 110.03 -165.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . 0.717 HD22 HG22 ' D' ' 46' ' ' THR . 52.5 tp -51.74 -57.32 9.6 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.041 0.936 . . . . 72.02 112.714 -168.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -107.9 72.16 0.84 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 107.588 -1.264 . . . . 74.52 107.588 171.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 113' ' ' LYS . . . . . 0.453 ' HB2' ' HB3' ' E' ' 110' ' ' ALA . 21.6 tptm -79.44 86.76 5.11 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.807 -0.442 . . . . 75.21 109.807 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . 0.571 ' HD3' ' HB2' ' E' ' 117' ' ' LYS . 36.4 ttmt -168.3 109.22 0.54 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.252 -0.886 . . . . 74.24 108.743 175.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 77.5 p -100.17 -16.0 17.94 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.422 0.689 . . . . 73.11 111.984 -175.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . -95.24 -30.21 8.39 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 116.338 -0.392 . . . . 74.51 113.301 -175.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 117' ' ' LYS . . . . . 0.571 ' HB2' ' HD3' ' E' ' 114' ' ' LYS . 63.1 mttp -131.96 164.48 42.72 Favored Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 123.469 0.707 . . . . 62.31 110.328 -178.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.98 179.28 6.23 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.475 2.116 . . . . 62.31 111.888 165.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -150.67 -162.82 1.63 Allowed 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 108.411 -0.959 . . . . 74.01 108.411 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -50.15 -32.56 16.44 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 125.159 1.384 . . . . 64.34 111.568 173.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 121' ' ' VAL . . . . . . . . . . . . . 48.0 t -77.15 83.35 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 C-N-CA 123.932 0.893 . . . . 74.14 110.464 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 1.8 p -157.37 147.66 20.92 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.559 1.544 . . . . 74.11 108.286 175.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -139.17 128.57 24.25 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.399 -0.593 . . . . 71.32 109.399 174.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 54.3 m -145.72 19.59 1.48 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.764 1.225 . . . . 70.33 108.921 170.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -108.2 -17.56 13.99 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.915 0.886 . . . . 75.14 111.087 -173.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.25 139.62 41.22 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.422 -0.584 . . . . 62.0 109.422 171.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 38.5 p -155.8 87.3 1.07 Allowed 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.348 0.594 . . . . 74.43 110.109 -175.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -128.73 66.14 1.42 Allowed 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.73 0.776 . . . . 74.31 108.99 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 129' ' ' THR . . . . . 0.473 ' HA ' ' HB3' ' D' ' 124' ' ' PRO . 8.1 t -88.26 119.35 28.58 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.98 -1.009 . . . . 74.45 110.449 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -167.03 98.54 0.53 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.9 0.88 . . . . 73.11 109.731 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 131' ' ' TRP . . . . . . . . . . . . . 68.2 t90 -164.52 109.32 0.96 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.881 0.872 . . . . 75.11 109.274 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 19.3 p 179.13 87.07 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.546 1.138 . . . . 72.44 109.813 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 16.9 m -149.98 142.15 24.08 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.271 -0.64 . . . . 74.32 109.271 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -171.2 122.95 1.0 Allowed Glycine 0 C--N 1.343 0.963 0 N-CA-C 110.473 -1.051 . . . . 64.21 110.473 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 31.1 m -120.5 144.73 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.713 0.805 . . . . 73.12 110.699 -175.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -138.08 45.5 2.11 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.797 0.808 . . . . 75.25 108.883 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 24.4 p -72.58 -28.79 63.02 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.815 -0.63 . . . . 55.44 109.97 173.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -119.18 170.93 8.66 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.665 1.186 . . . . 75.42 109.61 173.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 139' ' ' ASN . . . . . 0.427 HD22 ' HB3' ' C' ' 9' ' ' MET . 51.8 t30 -120.04 -92.26 0.54 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.476 0.71 . . . . 74.53 110.006 -176.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . 172.13 179.35 42.98 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 112.295 -0.322 . . . . 74.3 112.295 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -163.19 -160.32 0.6 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.577 1.151 . . . . 74.4 109.585 -174.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 142' ' ' LEU . . . . . 0.458 HD11 ' HD1' ' C' ' 101' ' ' TYR . 92.3 mt 74.14 22.37 2.33 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 125.419 1.488 . . . . 72.42 111.84 174.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -86.77 108.05 3.28 Favored Glycine 0 C--N 1.344 0.996 0 N-CA-C 111.173 -0.771 . . . . 72.35 111.173 174.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 27.3 m -81.46 146.25 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 123.16 0.584 . . . . 73.31 110.919 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 29.1 t70 . . . . . 0 C--O 1.252 1.191 0 C-N-CA 124.218 1.007 . . . . 70.34 110.591 179.946 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.415 0 N-CA-C 112.301 -0.32 . . . . 65.11 112.301 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . -143.61 152.07 23.84 Favored Glycine 0 C--N 1.343 0.939 0 N-CA-C 110.319 -1.112 . . . . 71.34 110.319 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -107.22 -66.2 1.04 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.079 0.552 . . . . 73.53 110.64 -174.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -109.22 -102.93 0.38 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.468 0.307 . . . . 72.33 111.502 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -148.06 -63.56 0.26 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.149 0.58 . . . . 71.44 111.146 -162.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . 170.52 72.08 0.04 OUTLIER Glycine 0 C--N 1.34 0.799 0 CA-C-N 115.11 -0.95 . . . . 71.22 110.793 -170.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 97' ' ' ILE . . . . . 0.452 HD11 HG12 ' B' ' 86' ' ' ILE . 5.2 tt -48.65 -46.15 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 124.998 1.319 . . . . 61.04 111.445 177.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 t0 174.18 -72.02 0.01 OUTLIER 'General case' 0 C--N 1.355 0.812 0 C-N-CA 125.612 1.565 . . . . 72.13 107.843 175.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -175.69 -20.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.166 0.986 . . . . 72.11 111.089 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 100' ' ' LEU . . . . . 0.468 HD12 ' H ' ' B' ' 54' ' ' ASP . 2.7 mp 61.36 92.54 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.445 0 C-N-CA 125.743 1.617 . . . . 65.43 110.881 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 101' ' ' PRO . . . . . 0.542 ' HD3' ' HE3' ' B' ' 94' ' ' MET . 95.5 Cg_endo -93.64 89.54 0.15 Allowed 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.257 2.638 . . . . 73.43 110.289 175.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 102' ' ' LEU . . . . . 0.534 HD13 ' HB2' ' B' ' 48' ' ' SER . 32.6 tp -66.02 161.73 20.92 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 114.727 -1.124 . . . . 74.21 109.963 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 39.2 p -79.08 52.72 1.32 Allowed 'General case' 0 CA--C 1.564 1.484 0 C-N-CA 124.548 1.139 . . . . 75.31 111.673 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.71 -72.16 2.82 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 111.237 -0.745 . . . . 70.51 111.237 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -174.0 -67.07 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 106.689 -1.597 . . . . 74.54 106.689 177.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -81.26 120.28 24.71 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 106.561 -1.644 . . . . 74.41 106.561 168.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 35.6 m -61.64 110.15 1.41 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.576 0.35 . . . . 74.14 110.725 -173.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -86.65 48.2 1.6 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.354 1.062 . . . . 73.04 109.928 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -169.94 90.27 0.18 Allowed 'General case' 0 C--O 1.239 0.547 0 N-CA-C 106.474 -1.676 . . . . 61.31 106.474 -178.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.02 171.13 8.62 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.232 0.613 . . . . 72.12 111.789 -172.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.79 90.67 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 114.556 -1.202 . . . . 63.5 110.223 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 5.0 t30 71.85 7.39 5.86 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.183 1.393 . . . . 70.44 111.549 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -130.25 149.41 51.95 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.164 -0.96 . . . . 72.42 112.82 -168.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . 0.506 ' HG2' ' OH ' ' B' ' 140' ' ' TYR . 0.0 OUTLIER -141.36 39.16 1.73 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.642 1.577 . . . . 73.45 107.544 167.181 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 12.0 m 75.3 83.04 0.1 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.369 1.468 . . . . 74.31 109.274 -165.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . -115.26 -159.13 12.07 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 115.742 -0.663 . . . . 74.41 112.286 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 117' ' ' LYS . . . . . 0.534 ' HZ1' ' HB3' ' F' ' 117' ' ' LYS . 10.1 mtpm? -142.46 -57.67 0.02 OUTLIER Pre-proline 0 CA--C 1.564 1.484 0 C-N-CA 124.048 0.939 . . . . 75.5 110.472 177.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 118' ' ' PRO . . . . . 0.441 ' HD3' ' HB2' ' F' ' 117' ' ' LYS . 18.8 Cg_endo -92.97 45.5 0.34 Allowed 'Trans proline' 0 C--N 1.393 2.879 0 C-N-CA 122.364 2.042 . . . . 71.44 112.458 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -69.59 171.12 9.43 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.639 0.776 . . . . 72.15 111.895 -174.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -50.44 -53.55 28.69 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.437 1.095 . . . . 74.54 110.971 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 48.2 t -82.99 83.99 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 108.589 -0.893 . . . . 61.52 108.589 175.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 10.1 t -90.26 -14.0 34.21 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 114.679 -1.146 . . . . 73.02 111.265 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -124.68 172.77 9.01 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.753 0.821 . . . . 73.11 109.953 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 22.6 m -63.98 -34.91 79.05 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.842 -0.617 . . . . 64.54 110.683 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . 72.19 -63.47 0.43 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.219 1.808 . . . . 73.23 111.412 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 126' ' ' ALA . . . . . 0.453 ' HB3' ' H ' ' B' ' 129' ' ' ALA . . . -77.18 95.32 4.26 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.944 0.898 . . . . 61.14 110.339 176.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 58.9 p -98.81 125.49 44.19 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.472 -0.936 . . . . 73.32 108.472 172.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.81 -164.73 0.31 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.706 0.802 . . . . 72.55 110.588 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 129' ' ' THR . . . . . 0.512 HG23 ' HB3' ' B' ' 125' ' ' GLN . 13.2 t -123.15 -179.13 4.18 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.791 -0.818 . . . . 72.24 108.791 170.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.66 164.87 25.49 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 123.033 0.533 . . . . 71.4 111.084 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 131' ' ' TRP . . . . . 0.533 ' HB2' ' HG3' ' B' ' 124' ' ' PRO . 27.3 t90 -79.92 83.22 5.87 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.31 -0.996 . . . . 71.22 108.31 174.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 14.8 p -109.03 48.6 0.86 Allowed 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.069 0.947 . . . . 71.34 109.422 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 24.4 m -78.62 122.05 25.45 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.761 -1.109 . . . . 74.34 110.296 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -78.85 -85.51 0.54 Allowed Glycine 0 C--N 1.348 1.226 0 O-C-N 123.654 0.596 . . . . 63.23 112.039 176.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 135' ' ' VAL . . . . . 0.616 ' H ' HG22 ' C' ' 40' ' ' VAL . 48.0 t 59.33 19.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 C-N-CA 124.897 1.279 . . . . 71.3 110.971 -177.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -85.71 73.22 10.45 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 122.095 0.95 . . . . 75.12 110.62 -176.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 2.0 m -132.61 29.74 4.17 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 114.137 -1.392 . . . . 75.24 107.308 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -152.49 148.54 27.53 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-N 114.516 -1.22 . . . . 72.31 108.456 -170.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -59.68 111.56 1.48 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.5 0.72 . . . . 72.31 110.268 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . 133.6 20.48 0.88 Allowed Glycine 0 CA--C 1.532 1.147 0 CA-C-N 115.36 -0.836 . . . . 54.24 111.772 -172.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.66 134.42 40.59 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.686 0.794 . . . . 75.21 110.521 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -146.89 158.31 43.88 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.306 0.642 . . . . 74.05 110.44 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -131.65 116.24 1.86 Allowed Glycine 0 C--N 1.345 1.065 0 N-CA-C 110.403 -1.079 . . . . 45.34 110.403 174.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 48.5 t -105.4 133.53 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 117.536 0.668 . . . . 72.2 109.746 -177.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 . . . . . 0 C--O 1.254 1.318 0 N-CA-C 108.587 -0.894 . . . . 75.31 108.587 174.075 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.462 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.492 -0.558 . . . . 75.23 109.492 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.6 m -72.39 93.29 1.51 Allowed 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.536 0.734 . . . . 70.54 109.801 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -144.91 156.89 44.24 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 122.905 0.482 . . . . 74.01 110.292 -176.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -67.94 160.61 28.22 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.543 1.137 . . . . 74.35 112.122 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -152.77 155.18 36.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.699 0.799 . . . . 75.51 109.173 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -57.33 134.72 56.24 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.13 0.972 . . . . 74.24 110.886 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -109.11 79.95 1.27 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 122.746 1.26 . . . . 74.53 109.405 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -128.07 28.78 5.49 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 114.466 -1.243 . . . . 71.44 109.971 -175.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.451 ' N ' ' SD ' ' A' ' 9' ' ' MET . 1.0 OUTLIER -71.02 160.31 33.16 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.973 0.909 . . . . 74.23 110.995 -179.411 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.7 m -140.25 111.89 7.39 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.352 -1.351 . . . . 73.23 107.352 172.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -129.49 113.91 15.46 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.068 -1.086 . . . . 75.03 108.068 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -134.08 118.44 17.74 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.016 -0.735 . . . . 75.1 109.016 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.4 mt -80.69 119.82 31.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 109.362 -0.607 . . . . 71.23 109.362 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -85.83 -38.78 17.76 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 123.607 0.567 . . . . 71.43 110.163 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -173.52 129.26 0.43 Allowed 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.599 -0.273 . . . . 74.55 110.365 -170.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.467 HD13 ' HG3' ' C' ' 130' ' ' PRO . 87.0 mt -119.79 134.02 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 108.235 -1.024 . . . . 62.51 108.235 173.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.428 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 36.8 p90 -162.27 168.1 22.87 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 124.036 0.835 . . . . 75.22 110.87 -170.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -89.78 119.49 30.21 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.665 -0.865 . . . . 73.11 108.665 172.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.428 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 32.8 mtpt -78.97 -26.33 43.44 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.736 -0.468 . . . . 74.24 109.736 172.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -159.08 146.31 17.31 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.292 1.037 . . . . 72.34 109.614 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.8 mt -135.85 146.36 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.092 1.357 . . . . 73.14 107.836 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.0 t -148.01 131.95 17.15 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 109.059 -0.719 . . . . 70.43 109.059 171.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.594 ' HB2' ' HE1' ' A' ' 117' ' ' MET . 89.3 t80 -137.09 127.75 27.02 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 106.988 -1.486 . . . . 73.55 106.988 171.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -134.5 129.18 34.76 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.009 0.523 . . . . 74.41 109.856 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.93 75.21 79.84 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.479 -1.304 . . . . 73.43 107.479 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.49 -28.0 32.67 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.713 2.275 . . . . 62.21 112.377 -172.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -104.8 15.38 27.96 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.203 -0.908 . . . . 75.41 110.154 -177.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.5 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -43.85 -56.41 7.48 Favored Pre-proline 0 N--CA 1.494 1.763 0 N-CA-C 113.996 1.11 . . . . 71.22 113.996 -169.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 70.8 Cg_exo -54.98 -35.22 89.38 Favored 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 122.515 2.143 . . . . 72.4 113.607 176.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.419 ' HA ' ' NE2' ' A' ' 33' ' ' GLN . 1.9 m-70 -78.36 -42.47 30.36 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.508 0.723 . . . . 73.22 110.042 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.567 HG22 ' HA ' ' A' ' 73' ' ' ALA . 1.1 p -67.05 -27.57 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 114.593 -1.185 . . . . 74.42 111.951 -159.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -72.99 -29.33 62.96 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.952 -0.567 . . . . 74.11 110.767 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.419 ' NE2' ' HA ' ' A' ' 30' ' ' HIS . 38.9 mt-30 -75.1 -24.29 58.08 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.239 1.016 . . . . 73.25 110.888 178.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -77.24 152.28 34.76 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.853 0.861 . . . . 65.33 110.707 -175.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.83 118.29 7.0 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.752 0.657 . . . . 54.33 109.623 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -83.82 85.06 7.35 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.679 0.752 . . . . 74.45 110.991 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -121.01 84.05 38.69 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 107.001 -1.481 . . . . 74.52 107.001 170.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.45 116.89 4.63 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.361 2.041 . . . . 62.45 111.982 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -96.38 101.79 13.48 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.319 -0.993 . . . . 75.31 108.319 174.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 t -97.39 108.1 21.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 114.818 -1.083 . . . . 70.14 110.796 -169.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -83.65 119.94 25.37 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.747 0.819 . . . . 72.5 109.035 170.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.6 tp -97.25 106.53 18.88 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.371 -0.974 . . . . 74.33 108.371 175.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.455 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.4 m-20 -107.92 148.52 29.53 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.373 1.069 . . . . 72.34 108.77 176.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.556 HD12 HG22 ' A' ' 131' ' ' VAL . 92.6 mt -137.68 154.91 49.62 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.306 0.642 . . . . 64.31 111.246 -175.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.6 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 6.8 m-20 -137.72 141.29 41.02 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.166 -1.379 . . . . 64.24 108.113 175.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.3 m -141.0 123.16 15.64 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.249 -0.649 . . . . 64.1 109.249 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.75 138.16 23.06 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.505 0.722 . . . . 64.33 109.511 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.8 m -90.57 165.77 13.57 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.078 0.551 . . . . 75.25 109.56 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.2 t -154.69 119.48 4.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.398 -0.964 . . . . 71.44 108.398 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -85.15 103.33 14.04 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.953 -1.129 . . . . 72.11 107.953 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.437 HD13 ' HB2' ' A' ' 57' ' ' GLU . 83.4 mt -77.9 -40.1 40.97 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.12 0.568 . . . . 74.24 109.474 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.35 -178.41 6.96 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.0 -1.0 . . . . 71.01 109.731 178.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -61.7 115.85 4.31 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.475 -0.784 . . . . 73.12 109.358 172.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 72.05 -4.19 2.04 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 125.178 1.391 . . . . 74.44 113.427 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.1 t -100.94 104.59 16.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.477 -0.935 . . . . 75.33 108.477 175.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -115.18 123.31 48.56 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.622 -0.881 . . . . 72.14 108.622 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.437 ' HB2' HD13 ' A' ' 51' ' ' LEU . 32.4 tt0 -89.58 151.59 21.85 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 123.396 0.679 . . . . 74.43 109.313 166.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.418 HG11 ' HD3' ' A' ' 103' ' ' PRO . 83.2 t -130.03 138.03 55.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.983 -1.117 . . . . 75.33 107.983 168.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.1 t -114.3 132.51 63.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 CA-C-O 121.232 0.539 . . . . 74.25 109.749 174.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.483 HD21 HD23 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -113.68 110.3 19.98 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 106.313 -1.736 . . . . 73.51 106.313 174.326 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.616 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 16.8 ttp180 -101.31 107.07 18.33 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.878 -1.156 . . . . 74.43 107.878 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.422 HG23 HD23 ' A' ' 60' ' ' LEU . 36.1 t -93.67 123.61 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 108.585 -0.894 . . . . 74.23 108.585 176.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 22.1 m -114.7 111.88 21.97 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.212 -0.662 . . . . 74.33 109.212 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.509 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 81.7 t -103.02 120.9 53.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 124.539 1.135 . . . . 73.14 109.004 177.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.421 ' HG1' HD12 ' A' ' 75' ' ' LEU . 18.5 m -115.39 129.48 56.59 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.859 -0.793 . . . . 72.24 108.859 166.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.6 129.2 56.65 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.266 -1.383 . . . . 74.51 107.266 171.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.1 m -125.04 171.14 10.49 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.504 0.668 . . . . 73.13 109.936 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.7 mt -130.09 62.4 1.56 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 105.781 -1.933 . . . . 75.22 105.781 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.96 -103.52 2.01 Favored Glycine 0 C--N 1.338 0.648 0 CA-C-N 115.559 -0.746 . . . . 63.43 111.257 -173.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -91.16 -27.18 18.69 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.846 0.459 . . . . 71.52 111.708 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -97.44 123.84 41.42 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.802 0.441 . . . . 75.24 109.937 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 57.6 m -70.61 134.55 47.7 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.975 0.417 . . . . 71.55 110.391 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.567 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -79.26 -59.12 2.89 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.252 -0.885 . . . . 71.34 109.66 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -156.47 166.11 34.36 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.93 -1.032 . . . . 74.15 110.93 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.421 HD12 ' HG1' ' A' ' 65' ' ' THR . 35.7 tp -135.46 114.11 11.81 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.366 1.066 . . . . 74.43 108.848 176.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.509 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 57.4 m -107.02 139.91 40.67 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.09 0.956 . . . . 70.11 108.917 174.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -149.95 117.81 6.26 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.592 -0.521 . . . . 72.11 109.592 175.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.5 t -127.59 114.5 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.835 0.854 . . . . 73.42 109.859 -175.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.616 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 10.4 mt-30 -86.77 81.18 8.27 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.548 -0.908 . . . . 75.01 108.548 174.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -76.57 95.94 4.02 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.59 -0.732 . . . . 74.12 109.407 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.85 146.48 16.38 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 111.351 -0.7 . . . . 64.1 111.351 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.29 134.05 6.49 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.104 -0.798 . . . . 51.13 111.104 -176.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.9 mt -81.24 125.57 39.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 108.777 -0.823 . . . . 75.54 108.777 173.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.683 ' HB3' HD11 ' A' ' 86' ' ' ILE . 82.0 m-85 -127.68 128.03 44.75 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.981 0.912 . . . . 74.15 109.202 -174.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.1 t -94.89 101.04 12.81 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.194 -1.039 . . . . 74.24 108.194 175.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.683 HD11 ' HB3' ' A' ' 84' ' ' PHE . 5.8 mm -113.5 153.52 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 122.4 0.28 . . . . 74.53 111.11 -171.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.06 167.5 12.51 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.546 1.139 . . . . 61.41 110.248 175.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.87 2.16 64.97 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-O 119.372 -0.682 . . . . 74.21 114.724 169.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.07 161.49 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 123.965 0.906 . . . . 74.01 110.554 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.505 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 18.1 tt0 -153.61 175.56 13.08 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 109.574 -0.528 . . . . 63.45 109.574 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.505 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 53.74 -121.23 17.22 Favored Glycine 0 C--N 1.349 1.299 0 O-C-N 124.099 0.874 . . . . 63.32 114.34 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.9 t -69.25 -30.35 68.45 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.028 0.931 . . . . 71.14 111.941 -176.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -74.42 -36.64 63.44 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.146 0.579 . . . . 75.41 110.459 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.465 ' HE3' HG21 ' A' ' 86' ' ' ILE . 4.9 tpt -65.26 -44.56 87.69 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.442 0.464 . . . . 74.52 110.405 175.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.62 -41.66 86.45 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.318 -0.855 . . . . 60.52 111.208 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.425 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 54.8 t-80 -78.58 -25.55 45.33 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.419 -0.809 . . . . 73.11 111.508 -177.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 44.0 t -69.95 -42.91 72.59 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.265 0.555 . . . . 75.44 109.962 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 88.0 mt -81.85 -40.97 21.68 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.846 -1.07 . . . . 74.51 111.732 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.32 3.16 81.91 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 116.035 -0.529 . . . . 71.11 114.284 -170.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.637 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -146.93 -58.76 0.28 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.54 0.67 . . . . 64.24 112.007 -171.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -67.65 -45.29 75.73 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-N 116.006 -0.543 . . . . 73.44 111.049 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.401 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 88.3 m -63.45 -52.34 60.83 Favored Pre-proline 0 CA--C 1.566 1.573 0 N-CA-C 113.435 0.902 . . . . 74.33 113.435 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.418 ' HD3' HG11 ' A' ' 58' ' ' VAL . 44.3 Cg_endo -65.7 -20.6 59.35 Favored 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 122.051 1.834 . . . . 71.44 113.052 177.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -63.83 -43.69 95.45 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 120.99 0.424 . . . . 72.21 110.043 172.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.401 ' HB ' ' O ' ' A' ' 102' ' ' CYS . 31.2 mm -61.74 -38.15 79.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 124.405 1.082 . . . . 75.41 110.673 174.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 78.0 mt -77.64 -22.46 50.66 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.079 0.952 . . . . 74.32 112.96 -173.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -70.3 -41.94 14.84 Favored Pre-proline 0 CA--C 1.557 1.245 0 N-CA-C 114.434 1.272 . . . . 74.24 114.434 -170.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -54.12 -39.39 86.07 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 121.902 1.734 . . . . 75.12 112.742 173.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -74.55 -40.81 61.45 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.748 0.819 . . . . 72.41 111.484 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.66 -49.01 74.91 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.974 0.509 . . . . 70.35 110.241 177.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.494 HH12 HD13 ' C' ' 105' ' ' ILE . 29.7 ttm180 -52.04 -48.88 64.36 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.719 1.262 . . . . 74.33 110.491 176.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -61.95 -50.51 71.82 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 124.204 0.94 . . . . 75.4 111.63 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.447 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 44.9 t -54.3 -44.75 72.24 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.361 1.038 . . . . 72.45 110.691 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.598 HD13 HD12 ' A' ' 128' ' ' LEU . 96.9 mt -63.05 -55.06 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 114.968 -1.014 . . . . 75.22 111.14 176.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 91.4 m -52.83 -43.44 66.0 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.12 0.968 . . . . 74.32 111.53 -175.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 22.9 t -68.0 -44.21 77.09 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.382 -1.281 . . . . 74.52 109.782 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.594 ' HE1' ' HB2' ' A' ' 23' ' ' PHE . 11.1 mtp -57.45 -42.45 82.51 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.887 0.875 . . . . 73.1 111.596 175.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.3 t -59.72 -49.27 84.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.4 1.08 . . . . 75.45 110.274 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -72.42 -27.66 62.48 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.855 -0.612 . . . . 71.24 111.775 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 116' ' ' SER . 50.3 mtt-85 -70.77 -31.43 68.21 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.363 0.665 . . . . 72.34 109.932 175.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.48 18.2 25.57 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.572 -0.74 . . . . 74.35 113.073 175.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.444 HG23 ' HE ' ' B' ' 15' ' ' ARG . 2.5 t 59.61 11.57 2.44 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 126.952 2.101 . . . . 74.14 113.225 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -79.07 139.31 56.78 Favored Pre-proline 0 C--O 1.245 0.858 0 N-CA-C 108.271 -1.011 . . . . 65.4 108.271 174.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.517 ' HB3' ' H ' ' E' ' 132' ' ' SER . 91.6 Cg_exo -48.58 135.79 27.0 Favored 'Trans proline' 0 C--N 1.365 1.438 0 C-N-CA 123.249 2.633 . . . . 74.3 112.519 173.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -58.8 127.5 32.5 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 124.292 0.995 . . . . 70.44 111.988 -166.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.0 tp -110.22 134.61 52.06 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 123.974 0.91 . . . . 73.0 108.859 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.493 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 85.6 m-20 -129.02 122.22 29.58 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.823 -0.806 . . . . 64.03 108.823 178.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.598 HD12 HD13 ' A' ' 114' ' ' ILE . 6.2 mt -74.15 148.04 42.1 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.481 -0.562 . . . . 71.31 109.481 -176.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.664 ' HB3' ' HA ' ' E' ' 137' ' ' THR . . . -79.38 142.73 58.79 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 119.34 -0.362 . . . . 64.54 111.042 -179.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.487 ' HB3' ' OH ' ' C' ' 101' ' ' TYR . 53.3 Cg_exo -56.22 121.66 10.39 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 123.446 2.764 . . . . 73.45 113.774 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.556 HG22 HD12 ' A' ' 44' ' ' LEU . 57.7 t -102.35 121.03 52.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-N 115.485 -0.779 . . . . 75.52 109.265 176.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.415 ' ND2' ' HB2' ' A' ' 135' ' ' ALA . 46.5 t30 -91.15 81.31 5.57 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.618 -0.882 . . . . 74.11 108.618 176.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -59.29 -31.58 69.26 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 114.893 -1.049 . . . . 74.22 111.578 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.637 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 13.9 t70 -55.22 -47.84 74.75 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.966 0.906 . . . . 74.43 109.937 178.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.415 ' HB2' ' ND2' ' A' ' 132' ' ' ASN . . . -72.75 -42.43 64.05 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.384 -0.825 . . . . 73.4 111.694 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.451 ' HA ' HD22 ' A' ' 139' ' ' ASN . 76.1 mt -65.22 -42.15 93.75 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.034 0.534 . . . . 73.11 112.323 -174.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.57 ' HE2' HD11 ' A' ' 141' ' ' LEU . 25.3 t80 -71.05 -33.49 70.33 Favored 'General case' 0 C--O 1.212 -0.915 0 N-CA-C 109.349 -0.611 . . . . 63.24 109.349 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.618 ' HG3' ' HB3' ' A' ' 144' ' ' GLN . 7.2 tpt -72.85 -36.68 67.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.552 0.341 . . . . 65.33 110.894 -173.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.578 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 17.1 p30 -75.29 -25.81 58.24 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 110.224 -0.287 . . . . 75.24 110.224 174.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -76.92 -32.87 57.69 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.18 0.592 . . . . 71.32 111.112 172.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.57 HD11 ' HE2' ' A' ' 137' ' ' PHE . 50.2 tp -62.33 -48.79 78.29 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.712 1.205 . . . . 72.14 111.168 -171.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -165.92 18.04 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.126 -0.943 . . . . 74.54 109.95 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.578 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 0.6 OUTLIER 54.49 83.8 0.07 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.017 0.927 . . . . 70.12 109.012 -167.065 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.618 ' HB3' ' HG3' ' A' ' 138' ' ' MET . 30.3 tp60 -128.16 124.61 37.26 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.726 -0.67 . . . . 74.45 109.257 -178.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -151.54 -178.1 6.49 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.338 1.055 . . . . 62.34 109.191 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 78.16 69.52 1.39 Allowed Glycine 0 C--N 1.341 0.837 0 N-CA-C 111.749 -0.54 . . . . 72.02 111.749 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.22 147.05 48.64 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.029 0.531 . . . . 70.13 111.065 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.01 89.88 1.53 Allowed Glycine 0 C--N 1.336 0.583 0 N-CA-C 109.721 -1.352 . . . . 54.33 109.721 170.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.5 m -72.81 76.95 1.14 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.703 0.763 . . . . 74.43 110.415 -176.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -165.27 40.27 0.07 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 106.983 -1.488 . . . . 65.4 106.983 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -76.7 131.02 38.55 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 115.032 -0.985 . . . . 72.03 109.863 -176.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -126.27 37.05 4.4 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 123.969 0.793 . . . . 74.23 109.317 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -65.8 103.27 0.87 Allowed 'General case' 0 C--N 1.351 0.653 0 N-CA-C 109.06 -0.719 . . . . 65.12 109.06 170.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -73.26 114.52 11.54 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 114.766 -1.106 . . . . 74.31 109.508 -178.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.324 0 CA-C-O 118.126 -0.94 . . . . 63.41 108.673 178.33 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 58.0 ttp . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 109.855 -0.424 . . . . 74.42 109.855 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 43.0 t -157.21 -84.19 0.05 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.812 0.845 . . . . 73.55 109.582 176.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -159.31 106.39 1.74 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.365 0.666 . . . . 71.5 109.545 177.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -144.99 152.54 40.32 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.55 0.74 . . . . 75.12 109.954 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . 0.647 ' H ' ' HB3' ' D' ' 147' ' ' GLU . 39.9 t30 -154.2 141.12 19.22 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.658 1.183 . . . . 70.21 109.244 -174.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -151.44 100.3 2.71 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.875 -1.158 . . . . 72.3 107.875 169.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 40.6 p -83.56 70.0 10.19 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 123.523 0.729 . . . . 74.01 110.408 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -75.59 104.14 6.01 Favored 'General case' 0 C--N 1.348 0.525 0 N-CA-C 107.226 -1.398 . . . . 74.01 107.226 169.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.609 ' HB3' HG23 ' B' ' 89' ' ' ILE . 21.4 ptm 54.71 -176.29 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.766 1.626 . . . . 74.43 113.225 -174.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 90.7 m -148.29 124.76 10.99 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.536 -1.283 . . . . 74.33 107.536 169.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -113.54 145.03 41.87 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.997 -0.742 . . . . 75.55 108.997 173.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.483 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -155.66 139.76 16.46 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.314 -0.624 . . . . 74.21 109.314 172.513 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.434 HD11 HD12 ' B' ' 105' ' ' ILE . 50.4 mt -82.07 132.25 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 108.022 -1.103 . . . . 72.23 108.022 168.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -100.61 -43.73 6.07 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.528 -0.545 . . . . 73.3 109.528 178.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.444 ' HE ' HG23 ' A' ' 122' ' ' THR . 55.0 ttt180 -173.27 134.22 0.53 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.473 -0.785 . . . . 75.32 108.907 -174.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.582 HG21 ' CD1' ' B' ' 109' ' ' TYR . 88.8 mt -121.1 148.37 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 108.596 -0.89 . . . . 74.33 108.596 177.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -162.39 142.87 9.99 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 112.857 0.688 . . . . 74.41 112.857 -175.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.3 m -73.15 117.14 14.52 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.686 -1.143 . . . . 73.32 108.445 167.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.442 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 42.3 mtpt -91.43 -33.76 15.11 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.076 0.551 . . . . 71.52 110.294 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.595 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 19.3 t70 -149.79 136.21 19.09 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.093 -0.503 . . . . 61.52 110.811 -167.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 43.9 mm -134.92 139.55 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.793 1.237 . . . . 74.31 108.033 174.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 47.0 t -144.21 115.1 7.81 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.256 -1.016 . . . . 74.22 108.256 177.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' B' ' 75' ' ' LEU . 77.9 t80 -126.4 130.47 50.79 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 107.715 -1.217 . . . . 64.12 107.715 171.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -140.24 120.69 14.08 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.863 0.865 . . . . 52.21 108.744 175.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.98 85.58 6.66 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 107.257 -1.386 . . . . 61.35 107.257 170.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.7 -26.57 53.16 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.799 2.333 . . . . 63.34 112.313 -173.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -108.5 5.24 25.02 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.469 -0.787 . . . . 72.41 111.078 -177.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -30.23 -67.18 0.15 Allowed Pre-proline 0 N--CA 1.498 1.959 0 C-N-CA 125.447 1.499 . . . . 54.52 114.868 -167.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -61.95 -28.37 80.76 Favored 'Trans proline' 0 C--N 1.392 2.838 0 C-N-CA 122.043 1.828 . . . . 70.11 113.0 -170.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -94.03 -34.72 12.91 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.092 -0.958 . . . . 72.41 111.871 -172.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.599 HG21 HD11 ' B' ' 68' ' ' LEU . 9.9 p -72.19 -15.23 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 122.659 0.383 . . . . 74.53 111.202 -176.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -68.36 -9.81 50.67 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.557 0.743 . . . . 72.4 112.573 177.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.473 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.2 pt20 -67.0 -20.47 65.88 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.036 0.534 . . . . 74.01 110.808 174.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.473 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 99.5 mttt -103.03 110.78 22.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.991 1.316 . . . . 75.33 110.116 -175.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -112.92 97.31 6.46 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.692 0.397 . . . . 74.15 110.529 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 35.1 p90 -167.49 -171.31 1.64 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.439 1.096 . . . . 65.3 108.943 170.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 13.0 pm0 -71.36 111.39 10.01 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.482 0.713 . . . . 75.31 110.416 176.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.489 ' HA ' HD21 ' B' ' 68' ' ' LEU . 15.2 Cg_endo -65.61 152.14 82.62 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 121.204 1.27 . . . . 75.5 110.452 177.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 32.0 tt0 -69.72 99.85 1.4 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.787 -1.19 . . . . 71.4 107.787 173.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.596 HG21 ' HB1' ' B' ' 66' ' ' ALA . 31.7 t -101.73 142.04 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 O-C-N 123.655 0.597 . . . . 73.34 110.134 -171.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -126.91 107.67 10.3 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.519 1.128 . . . . 63.41 108.51 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 17.9 tp -87.25 125.57 34.28 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.39 -0.966 . . . . 73.42 108.39 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -137.45 111.39 8.3 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.842 -1.17 . . . . 74.41 107.842 -170.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mp -100.99 140.65 34.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.039 0.536 . . . . 73.13 109.737 -175.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -142.96 145.33 32.89 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.107 0.963 . . . . 74.1 109.846 -177.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 4.0 t -126.37 104.62 8.27 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.701 0.8 . . . . 74.11 109.177 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.76 113.91 23.23 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.341 -1.355 . . . . 62.4 107.341 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 30.9 p -146.51 164.7 31.69 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.583 0.353 . . . . 75.52 111.819 -167.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 55.0 p -151.39 142.94 23.59 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.201 0.601 . . . . 60.23 110.83 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' F' ' 100' ' ' LEU . 62.1 tt0 -82.6 111.83 18.93 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 109.315 -0.624 . . . . 73.54 109.315 172.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 pp -121.64 21.81 10.75 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.336 -0.847 . . . . 74.01 109.851 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . 0.457 ' HB2' ' HB ' ' B' ' 55' ' ' VAL . . . -168.04 148.37 4.95 Favored 'General case' 0 C--N 1.361 1.079 0 C-N-CA 123.401 0.68 . . . . 64.43 111.743 176.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.62 141.26 46.56 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 107.609 -1.256 . . . . 64.2 107.609 158.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.62 ' HB2' ' HB3' ' F' ' 93' ' ' PHE . 24.2 m-20 70.05 -2.49 2.05 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.692 1.197 . . . . 75.4 112.472 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.457 ' HB ' ' HB2' ' B' ' 52' ' ' ALA . 24.8 t -141.08 127.47 20.29 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 CA-C-N 118.755 0.707 . . . . 70.54 109.821 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.461 ' HD2' HG23 ' B' ' 58' ' ' VAL . 14.9 t80 -115.67 138.48 51.05 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 106.976 -1.49 . . . . 73.12 106.976 171.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -100.88 99.89 10.44 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 106.958 -1.497 . . . . 73.31 106.958 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.461 HG23 ' HD2' ' B' ' 56' ' ' TYR . 32.3 t -96.11 127.35 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.152 -0.931 . . . . 74.14 109.589 -173.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 17.5 t -114.9 112.44 40.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 109.149 -0.686 . . . . 74.15 109.149 175.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 63.4 tp -94.2 107.25 19.2 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 116.018 -0.537 . . . . 74.51 109.586 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -85.68 108.58 18.09 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.954 -0.758 . . . . 72.34 108.954 171.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.405 HG11 ' CD1' ' B' ' 114' ' ' ILE . 39.8 t -104.38 103.17 14.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 106.842 -1.54 . . . . 73.01 106.842 175.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 25.6 m -99.46 141.57 32.07 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.176 -0.92 . . . . 74.34 109.506 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.529 HG23 HD12 ' B' ' 114' ' ' ILE . 41.5 t -133.77 118.29 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.128 0.971 . . . . 75.11 109.425 175.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 40.5 m -105.3 139.65 39.62 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.162 -1.421 . . . . 72.41 107.162 172.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.596 ' HB1' HG21 ' B' ' 40' ' ' VAL . . . -146.06 141.02 27.19 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.537 0.608 . . . . 54.23 110.536 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.506 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 19.8 m -143.12 128.37 18.75 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.452 0.47 . . . . 73.24 112.018 -172.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.599 HD11 HG21 ' B' ' 31' ' ' VAL . 90.4 mt -95.1 117.74 30.72 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.673 0.789 . . . . 75.03 109.007 176.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.51 -110.59 3.09 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.948 -0.861 . . . . 70.41 110.948 -172.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.22 6.38 8.47 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.771 0.829 . . . . 74.55 109.698 177.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.45 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 12.6 pt-20 -113.75 148.34 36.66 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.039 0.536 . . . . 75.51 109.627 -175.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 27.7 m -66.1 120.75 13.73 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.787 0.435 . . . . 73.41 110.966 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.506 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -73.53 -63.8 1.12 Allowed 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.612 -1.255 . . . . 72.55 107.612 172.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -152.59 161.82 42.06 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 114.405 -1.271 . . . . 65.44 111.087 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 58.1 mt -123.26 112.34 17.52 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 105.328 -2.101 . . . . 74.43 105.328 171.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.524 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 47.5 t -120.43 139.94 52.11 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.612 -0.884 . . . . 71.43 108.612 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -157.09 135.47 11.31 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.273 -0.64 . . . . 72.22 109.273 -174.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.427 HG11 ' HA ' ' B' ' 110' ' ' ALA . 62.6 t -132.88 147.54 31.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.097 -0.956 . . . . 74.21 108.798 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.595 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 17.9 mt-30 -123.68 106.95 10.95 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.073 -1.084 . . . . 65.33 108.073 168.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.424 ' O ' HD13 ' B' ' 106' ' ' LEU . 8.2 tp-100 -97.03 104.39 16.4 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.356 -0.979 . . . . 73.13 108.356 176.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.442 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -94.77 167.57 27.05 Favored Glycine 0 C--N 1.338 0.649 0 O-C-N 123.543 0.527 . . . . 65.43 111.969 175.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.15 138.52 5.26 Favored Glycine 0 C--N 1.341 0.826 0 C-N-CA 121.156 -0.545 . . . . 70.42 114.053 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.422 HG22 HG13 ' B' ' 55' ' ' VAL . 70.3 mt -86.37 114.36 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 124.862 1.265 . . . . 70.01 108.184 169.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -126.31 133.4 51.4 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.278 0.631 . . . . 75.22 110.514 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 58.3 m -89.39 106.06 18.2 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.573 0.749 . . . . 74.21 110.767 175.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.584 HG21 HD13 ' B' ' 89' ' ' ILE . 54.9 mt -116.95 104.74 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 125.274 1.43 . . . . 72.42 108.395 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.12 166.7 23.47 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.938 0.895 . . . . 54.4 110.648 -174.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.6 -53.17 2.7 Favored Glycine 0 N--CA 1.476 1.36 0 O-C-N 123.111 0.257 . . . . 62.1 112.635 177.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.609 HG23 ' HB3' ' B' ' 9' ' ' MET . 0.5 OUTLIER -62.5 166.38 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 124.283 1.033 . . . . 74.5 112.271 171.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -159.79 151.9 20.68 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.108 -0.951 . . . . 73.15 110.41 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.67 -127.7 9.02 Favored Glycine 0 C--N 1.354 1.562 0 CA-C-N 116.365 -0.379 . . . . 63.15 113.179 174.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.6 m -79.8 -39.31 31.12 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.995 0.903 . . . . 71.14 110.292 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -60.77 -34.38 74.39 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 113.217 -1.81 . . . . 74.53 111.731 -168.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.533 ' SD ' ' N ' ' B' ' 95' ' ' ALA . 2.1 ppp? -65.72 -46.09 80.22 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.091 -0.959 . . . . 72.25 111.822 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . 0.533 ' N ' ' SD ' ' B' ' 94' ' ' MET . . . -79.44 -12.45 59.89 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.472 0.709 . . . . 70.31 112.724 -175.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -62.4 -34.74 77.33 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 110.18 -0.304 . . . . 64.24 110.18 167.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -68.67 -51.18 44.67 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.944 0.498 . . . . 71.45 111.049 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.49 ' HG ' ' HA ' ' B' ' 95' ' ' ALA . 4.2 pp -70.82 -27.81 64.15 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.636 0.375 . . . . 75.44 111.687 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.1 3.82 67.15 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-O 119.142 -0.81 . . . . 72.42 114.185 -174.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.42 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -153.95 -51.88 0.1 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 117.948 0.874 . . . . 74.51 112.257 -178.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -71.52 -40.36 70.18 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.051 0.54 . . . . 74.3 111.263 -175.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.48 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 72.3 m -68.87 -48.51 29.42 Favored Pre-proline 0 CA--C 1.56 1.337 0 CA-C-O 118.544 -0.741 . . . . 75.11 111.493 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.5 -32.72 64.47 Favored 'Trans proline' 0 C--N 1.399 3.189 0 C-N-CA 122.636 2.224 . . . . 74.11 113.627 169.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -61.94 -34.84 76.82 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.366 0.666 . . . . 74.35 111.47 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.434 HD12 HD11 ' B' ' 13' ' ' ILE . 72.4 mt -75.99 -41.45 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.765 0.826 . . . . 73.14 110.195 176.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.424 HD13 ' O ' ' B' ' 80' ' ' GLN . 78.2 mt -71.29 -25.0 62.25 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 114.718 -1.128 . . . . 75.2 111.207 -176.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -62.63 -52.14 67.2 Favored Pre-proline 0 CA--C 1.552 1.024 0 CA-C-O 117.363 -1.304 . . . . 73.2 113.2 -172.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -54.06 -40.26 82.18 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.266 1.977 . . . . 72.33 113.023 177.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.582 ' CD1' HG21 ' B' ' 16' ' ' ILE . 5.2 m-30 -65.92 -44.13 86.05 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.981 -1.009 . . . . 73.02 110.495 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.427 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -70.81 -37.16 73.22 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.889 0.876 . . . . 73.34 111.456 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.648 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 52.4 ttt-85 -65.73 -54.88 21.28 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.243 1.417 . . . . 74.22 110.815 -176.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -73.23 -18.06 61.28 Favored 'General case' 0 CA--C 1.551 0.982 0 O-C-N 123.898 0.749 . . . . 74.14 110.06 -177.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.467 ' O ' ' HG2' ' B' ' 117' ' ' MET . 15.6 t -72.8 -42.1 64.24 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 122.739 0.416 . . . . 73.44 109.93 172.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.529 HD12 HG23 ' B' ' 64' ' ' VAL . 75.3 mt -57.52 -54.32 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 123.637 0.775 . . . . 73.31 109.704 171.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 21.3 m -59.43 -29.91 68.11 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 124.34 1.025 . . . . 72.23 111.517 -177.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.6 t -68.39 -47.83 66.32 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.004 0.522 . . . . 73.2 110.357 174.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.6 mmt -69.66 -30.14 67.76 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.83 0.452 . . . . 71.45 111.115 -176.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.545 HG22 HD22 ' B' ' 126' ' ' LEU . 91.0 t -67.68 -41.87 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.194 0.998 . . . . 75.55 109.861 172.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.8 t -66.86 -29.72 69.7 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.206 -0.906 . . . . 73.42 111.058 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' B' ' 116' ' ' SER . 84.5 mtt-85 -72.11 -35.2 69.11 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 123.116 0.566 . . . . 64.43 109.66 176.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.3 -9.85 81.41 Favored Glycine 0 C--N 1.354 1.562 0 O-C-N 123.531 0.519 . . . . 73.43 112.42 170.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.2 m 69.95 25.52 4.87 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 125.444 1.497 . . . . 72.54 110.643 174.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -78.38 165.26 51.33 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 124.043 0.937 . . . . 75.13 111.764 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.04 163.77 4.04 Favored 'Trans proline' 0 C--N 1.392 2.851 0 C-N-CA 123.313 2.675 . . . . 75.31 113.673 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -64.83 113.59 3.91 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.128 -0.942 . . . . 71.04 112.175 -171.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.545 HD22 HG22 ' B' ' 118' ' ' VAL . 48.6 tp -112.57 88.63 2.87 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 115.829 -0.623 . . . . 74.44 109.774 177.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -93.92 110.13 21.82 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.763 -1.199 . . . . 70.35 107.763 169.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.648 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 74.1 mt -65.46 146.32 55.02 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.331 0.253 . . . . 71.33 111.047 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.74 144.94 98.9 Favored Pre-proline 0 CA--C 1.55 0.964 0 O-C-N 124.406 1.066 . . . . 74.32 112.387 -173.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -68.11 84.47 0.44 Allowed 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.919 2.413 . . . . 62.31 111.61 173.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 19.8 m -101.28 126.92 55.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-O 121.2 0.524 . . . . 74.2 109.976 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -87.0 104.99 16.84 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 108.04 -1.096 . . . . 73.53 108.04 172.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -53.61 -38.61 64.18 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.455 1.102 . . . . 74.51 110.225 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.42 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 7.6 t70 -61.83 -44.43 96.86 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.33 -1.305 . . . . 73.52 111.046 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.53 -39.57 88.33 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.645 0.778 . . . . 75.33 112.561 -173.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.63 -45.81 81.62 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.906 0.483 . . . . 75.04 110.392 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -79.6 -17.09 54.65 Favored 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 115.423 -0.808 . . . . 75.55 111.377 -176.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 57.7 ttm -63.91 -27.19 68.98 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.387 1.075 . . . . 74.1 111.7 -175.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.436 ' HB2' ' HH ' ' F' ' 109' ' ' TYR . 32.7 m-80 -73.16 -22.52 60.49 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.24 0.616 . . . . 74.04 111.052 -177.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . 0.447 ' HB2' ' CE2' ' F' ' 109' ' ' TYR . 46.6 t80 -67.21 -40.32 86.4 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.852 0.861 . . . . 72.51 109.827 175.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 mp -91.15 -5.67 54.68 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.113 -0.949 . . . . 74.22 110.855 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 70.66 169.3 0.31 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.189 1.395 . . . . 71.55 111.364 -177.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -70.2 115.86 9.89 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.832 -0.622 . . . . 75.05 109.51 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.28 -57.3 6.92 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.263 -0.643 . . . . 72.13 109.263 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . 63.08 -175.1 0.15 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.476 1.111 . . . . 72.54 112.04 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 155.69 -177.38 32.85 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 116.647 -0.251 . . . . 62.05 113.028 175.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -138.12 132.46 32.03 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.446 0.698 . . . . 71.22 110.338 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -138.81 49.54 0.83 Allowed Glycine 0 C--N 1.343 0.926 0 N-CA-C 110.646 -0.982 . . . . 64.33 110.646 176.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 22.0 p -76.23 170.26 16.65 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.764 0.826 . . . . 74.21 112.463 -175.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 63.31 -93.24 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.0 1.32 . . . . 62.11 111.324 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 40.21 83.47 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.797 1.239 . . . . 52.33 112.626 -167.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -76.66 127.34 32.59 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.026 -0.534 . . . . 73.25 110.606 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -165.83 126.63 1.83 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.78 1.232 . . . . 73.31 107.786 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -67.33 138.56 56.89 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.669 -0.493 . . . . 73.35 109.669 176.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 C-N-CA 123.833 0.853 . . . . 55.4 108.803 -176.404 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.409 ' N ' ' SD ' ' C' ' 1' ' ' MET . 2.9 mpp? . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 108.758 -0.83 . . . . 74.51 108.758 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 37.1 p -170.26 35.8 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.986 0.914 . . . . 74.03 109.557 178.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -68.11 101.99 1.25 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.02 -0.991 . . . . 73.03 109.828 -174.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -75.93 114.79 14.96 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.101 -0.954 . . . . 75.41 109.607 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -148.41 1.64 0.62 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.419 0.526 . . . . 72.01 112.419 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . 0.584 ' HB2' HE21 ' C' ' 153' ' ' GLN . 94.5 m-20 -135.34 96.38 3.46 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.952 0.501 . . . . 74.54 110.221 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 39.7 p -120.39 101.13 7.58 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.979 -0.748 . . . . 72.34 108.979 170.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -126.92 156.16 41.92 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.992 -0.744 . . . . 73.31 108.992 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.463 ' HE3' HG22 ' C' ' 89' ' ' ILE . 53.2 ttm 64.43 112.23 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.522 1.529 . . . . 75.04 110.781 -172.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.585 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 28.4 m -89.88 76.09 7.16 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 107.441 -1.318 . . . . 74.11 107.441 166.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -88.52 117.55 27.54 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.1 -1.444 . . . . 74.33 107.1 174.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -140.49 114.8 9.26 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.891 -1.151 . . . . 74.03 107.891 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 37.6 mt -72.31 131.75 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.639 -0.875 . . . . 75.15 108.639 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -86.59 -49.47 7.52 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.352 -0.61 . . . . 71.15 109.352 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.573 HH21 ' HD2' ' D' ' 32' ' ' PHE . 0.0 OUTLIER -178.36 151.83 0.64 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.48 1.112 . . . . 75.4 109.104 173.213 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 pp -109.43 151.7 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 107.653 -1.24 . . . . 74.44 107.653 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.565 ' HE1' HG12 ' C' ' 83' ' ' ILE . 49.2 p90 -172.28 153.35 2.98 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.145 0.43 . . . . 64.53 111.245 -176.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.2 p -85.31 111.59 20.02 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.704 -0.68 . . . . 74.3 111.533 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.455 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 31.2 mmtp -65.52 -33.07 75.06 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.382 0.673 . . . . 74.55 110.733 170.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -151.79 146.28 25.6 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.7 -1.136 . . . . 71.21 109.756 -177.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 80.8 mt -142.84 139.81 27.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 106.37 -1.715 . . . . 74.04 106.37 171.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.4 t -154.27 147.53 24.85 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.452 0.644 . . . . 73.14 109.901 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -146.94 136.33 22.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 106.811 -1.551 . . . . 71.12 106.811 172.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -137.94 133.44 33.75 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.502 -0.925 . . . . 62.41 108.502 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.11 77.65 6.11 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 108.197 -1.038 . . . . 71.33 108.197 172.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.34 -27.8 28.05 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.761 2.308 . . . . 70.24 111.144 177.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -99.08 14.33 29.66 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.773 -1.103 . . . . 73.54 111.052 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.59 -55.39 12.41 Favored Pre-proline 0 N--CA 1.49 1.525 0 C-N-CA 124.429 1.092 . . . . 75.35 113.11 -177.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.55 -46.47 20.62 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.062 1.842 . . . . 73.43 112.316 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -69.71 -32.51 71.13 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.567 -1.197 . . . . 73.24 112.534 -174.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.1 p -79.5 -29.27 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 111.991 0.367 . . . . 75.24 111.991 -176.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -63.75 -32.28 73.73 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.704 0.401 . . . . 74.3 111.838 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -88.62 17.3 5.58 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.211 0.604 . . . . 72.44 111.621 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.416 ' HG2' HD11 ' C' ' 68' ' ' LEU . 2.4 ttpm? -120.33 152.06 38.37 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.076 0.951 . . . . 75.12 110.552 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -59.27 129.46 42.16 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.368 1.067 . . . . 75.41 111.361 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -85.49 85.7 7.41 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.973 0.909 . . . . 72.33 110.749 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -131.53 78.36 71.47 Favored Pre-proline 0 N--CA 1.479 1.008 0 N-CA-C 107.118 -1.438 . . . . 70.53 107.118 171.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -93.44 143.4 2.0 Allowed 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.538 2.158 . . . . 75.4 113.312 -175.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -85.5 98.21 10.48 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 106.686 -1.598 . . . . 74.45 106.686 159.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 94.7 t -76.48 99.52 2.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.14 -1.059 . . . . 75.32 108.14 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -90.8 100.72 13.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.148 -1.797 . . . . 75.22 106.148 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.507 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.5 pt? -97.44 162.0 13.52 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 115.626 -0.716 . . . . 74.52 109.587 -174.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.805 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 25.6 m-20 -142.32 146.26 34.83 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.744 0.818 . . . . 74.5 110.055 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.464 HD13 HG13 ' C' ' 131' ' ' VAL . 95.1 mt -134.53 111.12 9.83 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.771 0.828 . . . . 74.04 108.949 174.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -116.43 142.87 46.29 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.27 1.428 . . . . 73.24 107.277 173.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.6 t -152.69 152.67 31.99 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.752 -0.462 . . . . 74.13 109.752 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.82 157.63 38.19 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.466 0.706 . . . . 70.23 109.988 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.415 ' HG ' ' HB3' ' C' ' 98' ' ' LEU . 6.2 m -130.01 144.59 51.41 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.134 0.574 . . . . 70.52 109.629 176.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 37.8 p -145.29 127.48 15.71 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.672 0.789 . . . . 60.03 109.438 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -75.99 120.65 21.61 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.475 0.71 . . . . 74.14 110.51 -177.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.654 HD12 ' HB2' ' C' ' 57' ' ' GLU . 40.6 mt -91.42 -31.06 16.16 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.427 0.691 . . . . 71.4 110.661 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.55 -177.41 5.92 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.778 0.831 . . . . 73.44 110.375 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -65.24 119.71 11.41 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.769 -0.65 . . . . 73.23 110.116 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 65.94 11.56 7.79 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.902 1.281 . . . . 73.13 112.126 -175.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.3 t -116.23 111.59 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.051 -0.722 . . . . 72.31 109.051 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -123.0 124.2 42.6 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.965 -1.124 . . . . 74.42 107.965 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.654 ' HB2' HD12 ' C' ' 51' ' ' LEU . 40.1 tt0 -85.78 137.96 32.42 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.773 -0.825 . . . . 74.31 108.773 170.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.66 138.43 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 108.27 -1.011 . . . . 55.33 108.27 170.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.439 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 44.9 t -127.07 133.74 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 109.283 -0.636 . . . . 74.43 109.283 174.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.485 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -117.56 105.24 11.86 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.669 -1.234 . . . . 72.21 107.669 -177.886 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 16.9 ttm-85 -81.62 108.36 15.12 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.599 0.76 . . . . 75.11 109.505 171.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 44.0 t -104.78 119.06 53.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 108.015 -1.106 . . . . 74.42 108.015 171.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.805 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 79.2 m -114.66 145.41 42.05 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.056 0.942 . . . . 71.41 108.95 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.466 HG22 HG23 ' C' ' 114' ' ' ILE . 35.7 t -135.45 112.43 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.69 1.196 . . . . 73.14 108.314 178.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.7 m -101.77 122.66 44.37 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.309 -0.997 . . . . 74.53 108.309 168.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.6 119.24 38.93 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.148 -1.427 . . . . 74.01 107.148 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 32.2 m -141.25 129.01 21.64 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.109 0.255 . . . . 74.44 110.343 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.416 HD11 ' HG2' ' C' ' 34' ' ' LYS . 23.0 mt -86.56 44.08 1.12 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.506 1.122 . . . . 73.42 109.914 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.95 -104.96 2.54 Favored Glycine 0 C--N 1.344 1.019 0 N-CA-C 110.275 -1.13 . . . . 74.12 110.275 -172.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -90.85 -31.52 16.42 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.57 0.748 . . . . 72.22 109.438 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -65.91 121.56 15.35 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.71 1.204 . . . . 64.55 110.478 174.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 52.2 m -83.87 120.27 25.87 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.973 -0.751 . . . . 74.42 108.973 167.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.603 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.94 -55.07 8.12 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 123.945 0.778 . . . . 54.04 108.944 174.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -162.03 162.5 28.86 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 115.446 -0.797 . . . . 74.13 110.316 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.413 HD11 ' N ' ' C' ' 76' ' ' CYS . 2.9 tm? -114.33 142.65 46.04 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 106.491 -1.67 . . . . 71.31 106.491 163.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.413 ' N ' HD11 ' C' ' 75' ' ' LEU . 46.1 t -145.06 143.49 30.46 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.29 -1.004 . . . . 61.14 108.29 175.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -156.98 130.01 7.8 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.465 -0.569 . . . . 74.13 109.465 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 86.0 t -130.96 122.19 51.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.504 -0.924 . . . . 75.03 108.504 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -99.05 88.46 3.97 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.839 -1.171 . . . . 75.25 107.839 177.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -79.36 100.17 7.48 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.972 -1.013 . . . . 74.15 109.633 -175.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -82.09 174.55 53.7 Favored Glycine 0 C--O 1.237 0.316 0 CA-C-N 115.923 -0.58 . . . . 54.24 112.301 174.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.79 126.67 1.17 Allowed Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 111.786 -0.526 . . . . 72.24 111.786 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.565 HG12 ' HE1' ' C' ' 17' ' ' TYR . 31.7 mm -87.13 126.45 40.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.241 -1.022 . . . . 75.24 108.241 174.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -127.93 118.56 23.83 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.534 0.734 . . . . 72.23 109.431 -177.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 28.5 p -84.67 102.11 12.69 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.588 -0.893 . . . . 74.31 108.588 169.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 29.6 mt -115.43 118.59 59.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.692 1.197 . . . . 62.41 109.702 -175.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.585 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -124.96 170.1 11.44 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.712 0.805 . . . . 74.35 109.898 174.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.98 -39.64 2.68 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 116.432 -0.349 . . . . 65.53 113.616 171.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.647 HD13 ' HA ' ' C' ' 94' ' ' MET . 39.8 pt -103.93 165.33 3.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 123.283 0.633 . . . . 71.02 111.574 -171.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -159.92 154.35 23.84 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.254 -0.884 . . . . 74.34 109.195 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.2 -120.41 17.94 Favored Glycine 0 C--N 1.346 1.084 0 O-C-N 123.534 0.521 . . . . 63.25 113.579 174.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 35.1 p -61.6 -40.63 95.49 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.574 0.75 . . . . 75.3 111.831 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -63.49 -49.58 73.04 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.837 0.455 . . . . 75.41 110.908 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.647 ' HA ' HD13 ' C' ' 89' ' ' ILE . 6.2 tpt -52.36 -54.06 36.66 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 124.239 0.962 . . . . 75.32 111.909 174.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.63 -42.33 96.68 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.292 0.567 . . . . 73.13 111.639 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -65.4 -31.77 73.05 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.729 1.211 . . . . 74.41 111.037 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 48.7 t -76.63 -27.67 55.78 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.286 -0.87 . . . . 71.1 110.864 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.441 ' HG ' ' HE1' ' C' ' 94' ' ' MET . 94.3 mt -94.53 -32.14 13.6 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.672 0.789 . . . . 72.13 112.975 -172.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.03 -8.0 37.19 Favored Glycine 0 N--CA 1.473 1.123 0 CA-C-O 119.963 -0.354 . . . . 55.01 113.7 -173.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.23 -54.42 1.11 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.853 0.461 . . . . 73.41 110.874 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.487 ' OH ' ' HB3' ' A' ' 130' ' ' PRO . 52.2 t80 -73.4 -49.84 24.98 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.898 -0.592 . . . . 71.42 112.0 -170.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 68.0 m -63.23 -47.74 84.44 Favored Pre-proline 0 CA--C 1.557 1.228 0 CA-C-O 118.64 -0.695 . . . . 74.43 111.55 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.485 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 78.1 Cg_exo -56.43 -31.8 86.89 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.453 2.102 . . . . 73.24 113.594 170.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -68.02 -32.48 72.89 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.971 0.508 . . . . 74.21 110.726 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.494 HD13 HH12 ' A' ' 111' ' ' ARG . 10.0 mm -72.62 -41.68 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 109.509 -0.552 . . . . 65.44 109.509 174.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 85.0 mt -74.48 -23.62 58.9 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.899 0.88 . . . . 73.23 112.238 -175.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . 0.401 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 53.7 t80 -59.77 -53.43 65.62 Favored Pre-proline 0 N--CA 1.48 1.027 0 CA-C-O 117.431 -1.271 . . . . 65.42 113.445 -174.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . 0.401 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 51.1 Cg_exo -56.29 -36.59 97.13 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 121.84 1.693 . . . . 75.3 113.155 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -67.4 -47.53 70.03 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.27 0.628 . . . . 74.34 111.271 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.2 -38.93 88.33 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.176 0.99 . . . . 74.41 110.601 177.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -64.72 -47.26 78.93 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.165 1.386 . . . . 75.13 110.178 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -67.48 -34.03 76.32 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 123.861 0.726 . . . . 54.51 110.062 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.6 t -72.11 -34.58 68.72 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.933 0.493 . . . . 73.33 111.052 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.466 HG23 HG22 ' C' ' 64' ' ' VAL . 65.2 mt -73.91 -50.36 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 122.856 0.462 . . . . 72.13 110.34 176.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.1 m -65.71 -28.43 69.06 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.101 0.56 . . . . 72.03 110.872 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 29.3 t -62.85 -49.18 75.89 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 108.951 -0.759 . . . . 75.24 108.951 169.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.569 ' HG3' HD12 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.64 -36.47 78.72 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.322 1.049 . . . . 74.44 112.629 179.04 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 92.3 t -62.65 -49.25 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.544 0.737 . . . . 74.53 109.603 175.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.2 t -65.44 -32.91 74.78 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.978 -1.01 . . . . 72.13 111.552 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.502 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 76.5 mtt-85 -67.18 -37.6 83.97 Favored 'General case' 0 C--O 1.214 -0.8 0 C-N-CA 123.448 0.699 . . . . 73.14 109.465 176.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.84 8.15 70.98 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.31 -0.717 . . . . 72.32 113.249 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.404 HG22 ' HB3' ' D' ' 17' ' ' TYR . 81.0 p 55.6 33.66 21.62 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.05 1.74 . . . . 73.51 113.124 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -93.28 145.7 30.52 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 108.431 -0.951 . . . . 74.5 108.431 171.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -51.32 148.58 18.77 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 123.72 2.946 . . . . 73.12 114.249 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -55.43 112.47 1.12 Allowed 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.274 0.984 . . . . 71.14 112.261 -176.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.506 HD12 HG21 ' F' ' 133' ' ' THR . 53.8 tp -110.49 86.87 2.39 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.481 -1.236 . . . . 73.21 107.805 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -91.6 101.62 14.25 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.555 -0.906 . . . . 74.33 108.555 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.9 127.84 33.35 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.898 0.879 . . . . 75.21 110.393 -174.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.72 151.48 94.71 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 123.916 0.886 . . . . 62.34 111.811 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.467 ' HG3' HD13 ' A' ' 16' ' ' ILE . 51.6 Cg_exo -52.95 107.93 0.23 Allowed 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.017 2.478 . . . . 72.31 112.995 175.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.464 HG13 HD13 ' C' ' 44' ' ' LEU . 6.3 p -101.56 124.25 55.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 109.254 -0.647 . . . . 74.21 109.254 175.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -85.54 104.65 15.5 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.176 0.59 . . . . 63.35 109.686 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -66.05 -22.41 66.43 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.948 -0.569 . . . . 72.21 111.493 176.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -71.18 -36.57 72.02 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.566 0.541 . . . . 73.33 109.802 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.71 -43.35 99.02 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.441 -0.8 . . . . 71.45 110.22 172.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.418 ' HA ' ' HB3' ' C' ' 139' ' ' ASN . 73.5 mt -71.3 -25.74 62.56 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.855 0.862 . . . . 63.32 111.537 178.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -75.09 -41.88 57.82 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.313 0.645 . . . . 73.43 110.01 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 73.5 mtm -69.1 -32.7 72.3 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.599 -0.728 . . . . 72.43 109.888 172.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . 0.418 ' HB3' ' HA ' ' C' ' 136' ' ' LEU . 8.0 t30 -64.02 -34.47 78.09 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.035 1.334 . . . . 70.2 113.511 -175.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . 0.527 ' HD1' ' N ' ' C' ' 141' ' ' LEU . 0.8 OUTLIER -67.15 -151.22 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 118.661 0.664 . . . . 73.54 111.463 -176.082 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.527 ' N ' ' HD1' ' C' ' 140' ' ' TYR . 3.8 pp -67.04 13.8 0.06 Allowed 'General case' 0 CA--C 1.573 1.847 0 O-C-N 120.186 -1.571 . . . . 75.4 113.829 175.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -78.47 125.8 29.87 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.318 1.047 . . . . 74.31 109.693 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -114.89 71.42 0.76 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.797 0.839 . . . . 73.2 111.244 -175.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . 0.436 ' HB3' ' H ' ' C' ' 145' ' ' ALA . 0.9 OUTLIER -172.3 -101.56 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 107.972 -1.121 . . . . 72.13 107.972 170.031 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . 0.436 ' H ' ' HB3' ' C' ' 144' ' ' GLN . . . 173.57 -178.76 0.09 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.739 1.615 . . . . 71.31 108.608 -176.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -164.24 -82.86 0.05 OUTLIER Glycine 0 C--N 1.338 0.652 0 N-CA-C 109.916 -1.274 . . . . 63.34 109.916 177.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 61.29 -81.5 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 125.286 1.434 . . . . 73.12 111.824 174.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -115.49 109.11 2.0 Allowed Glycine 0 C--N 1.351 1.408 0 N-CA-C 111.667 -0.573 . . . . 74.15 111.667 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 3.3 t -159.38 100.4 1.5 Allowed 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.778 0.831 . . . . 72.43 109.412 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -176.27 135.84 0.27 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.304 1.041 . . . . 74.45 109.52 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -133.93 22.57 3.86 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.66 0.784 . . . . 74.23 112.184 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . 0.411 ' O ' ' HB3' ' A' ' 132' ' ' ASN . 20.9 t60 -66.1 98.85 0.47 Allowed 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 122.935 0.494 . . . . 73.14 110.015 175.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . 0.584 HE21 ' HB2' ' C' ' 6' ' ' ASN . 19.5 pt20 -132.3 73.69 1.54 Allowed 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.596 0.713 . . . . 74.33 112.643 -174.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.39 120.33 42.09 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.46 0.704 . . . . 71.15 109.247 169.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.327 0 C-N-CA 124.568 1.147 . . . . 71.44 109.588 -177.466 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.949 0.404 . . . . 73.04 110.136 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 29.7 t -146.13 -160.64 1.18 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 107.685 -1.228 . . . . 63.14 107.685 177.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . 0.659 ' HG2' ' HA3' ' D' ' 91' ' ' GLY . 34.4 mt-10 66.14 25.62 10.71 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.941 0.896 . . . . 74.04 111.712 170.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -139.81 151.23 45.57 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.764 1.226 . . . . 72.3 108.81 -174.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 59.72 93.15 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.465 1.106 . . . . 70.54 111.375 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . 0.504 HD21 ' HA ' ' D' ' 89' ' ' ILE . 23.6 m120 -115.69 108.25 16.14 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.008 -0.738 . . . . 75.33 109.008 178.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 29.8 m -58.47 159.18 6.61 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.455 1.102 . . . . 71.33 110.238 172.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -49.85 92.67 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.651 0.781 . . . . 73.31 110.454 175.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.452 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 0.0 OUTLIER -34.18 121.11 0.46 Allowed 'General case' 0 C--N 1.359 0.982 0 C-N-CA 125.852 1.661 . . . . 71.43 112.101 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 5.6 t -108.14 145.01 34.76 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 123.342 0.657 . . . . 71.42 109.5 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -152.88 103.25 2.74 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.734 -1.21 . . . . 73.02 107.734 -175.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -112.68 128.67 56.46 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.252 -1.018 . . . . 75.53 108.252 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.448 HG21 HD13 ' D' ' 16' ' ' ILE . 12.8 mt -94.24 134.97 29.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.173 -1.047 . . . . 65.11 108.173 175.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -106.34 -33.45 7.76 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 122.779 0.431 . . . . 75.31 111.629 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -169.32 127.0 0.95 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 120.592 0.234 . . . . 72.52 111.594 -166.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.448 HD13 HG21 ' D' ' 13' ' ' ILE . 2.5 mp -107.22 134.46 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 107.67 -1.233 . . . . 75.51 107.67 168.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' C' ' 120' ' ' ARG . 39.4 p90 -163.73 150.39 11.88 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-O 121.821 0.82 . . . . 75.41 111.873 175.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.4 p -85.89 126.3 33.96 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.684 -1.144 . . . . 74.22 109.199 176.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -99.37 -14.22 19.27 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.349 -0.611 . . . . 73.5 109.349 175.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.67 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.2 t70 -160.02 136.87 9.2 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.309 1.044 . . . . 72.11 109.032 176.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.569 HD12 ' HG3' ' C' ' 117' ' ' MET . 65.7 mt -137.67 144.66 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.626 1.17 . . . . 74.41 108.121 174.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.1 t -146.62 139.28 25.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.185 0.994 . . . . 73.22 108.955 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.452 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 77.5 t80 -150.31 123.24 8.73 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.753 -1.573 . . . . 75.42 106.753 167.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -127.38 129.67 48.0 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.15 -0.685 . . . . 75.11 109.15 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.1 79.49 14.32 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 107.57 -1.27 . . . . 73.33 107.57 169.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.75 -35.06 13.38 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.375 2.05 . . . . 74.44 112.151 -171.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -104.99 6.51 33.52 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.101 0.96 . . . . 75.03 110.515 -174.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -23.65 -77.75 0.02 OUTLIER Pre-proline 0 CA--C 1.567 1.613 0 N-CA-C 117.428 2.381 . . . . 72.51 117.428 -169.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.455 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 87.1 Cg_endo -75.29 -17.48 18.9 Favored 'Trans proline' 0 C--N 1.388 2.652 0 CA-C-N 124.643 2.694 . . . . 73.41 113.224 -170.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.472 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 6.4 t-160 -70.88 -43.71 67.84 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.949 -0.76 . . . . 72.34 108.949 172.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.459 HG22 ' HA ' ' D' ' 73' ' ' ALA . 4.8 p -83.88 -19.62 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 CA-C-N 115.748 -0.66 . . . . 74.23 111.517 -170.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.573 ' HD2' HH21 ' C' ' 15' ' ' ARG . 22.7 m-85 -67.4 -20.72 65.57 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 120.914 0.388 . . . . 63.34 111.416 177.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . 0.472 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 58.8 mt-30 -64.31 -18.33 64.51 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.103 0.961 . . . . 64.23 111.083 174.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.519 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 92.7 mttt -92.19 81.54 5.01 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.747 1.219 . . . . 75.43 108.784 174.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -83.43 79.7 9.33 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 122.074 0.94 . . . . 75.1 111.062 -174.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -152.93 -174.91 5.1 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.092 -0.958 . . . . 65.14 109.041 169.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -77.21 114.59 41.52 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 123.516 0.726 . . . . 73.44 110.43 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -53.94 119.98 7.17 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 122.53 2.154 . . . . 74.22 110.764 172.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -67.2 108.83 2.84 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.76 -1.2 . . . . 74.0 107.76 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.676 HG11 HG13 ' D' ' 64' ' ' VAL . 93.9 t -100.88 132.51 46.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 CA-C-N 115.419 -0.809 . . . . 73.5 109.823 -171.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -115.24 118.94 34.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.569 -1.271 . . . . 75.54 107.569 173.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.679 HD12 HG13 ' D' ' 62' ' ' VAL . 37.9 tp -97.39 137.58 36.16 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.27 0.557 . . . . 64.34 110.131 -178.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.407 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 6.5 m-20 -133.66 122.19 23.08 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.028 1.331 . . . . 73.24 108.083 -175.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 89.1 mt -119.8 144.58 47.24 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.814 0.445 . . . . 74.42 110.759 -176.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.474 ' HB2' ' HB3' ' D' ' 61' ' ' ARG . 11.7 m-20 -142.13 134.61 28.05 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.218 1.007 . . . . 72.21 109.061 176.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 46' ' ' THR . . . . . 0.428 HG23 ' HA2' ' D' ' 99' ' ' GLY . 59.1 m -104.15 139.05 39.76 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.154 -1.054 . . . . 64.1 108.154 168.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.42 141.05 21.72 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.585 -1.265 . . . . 72.32 107.585 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 30.8 p -158.98 151.48 21.6 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 109.806 -0.442 . . . . 75.53 109.806 -175.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.409 ' O ' ' HG2' ' D' ' 50' ' ' GLN . 65.4 p -160.51 116.47 2.32 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 123.63 0.581 . . . . 55.45 110.791 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' D' ' 49' ' ' SER . 50.9 mm-40 -166.6 129.29 1.86 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 126.289 1.836 . . . . 72.34 106.809 175.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 40.9 tp -79.3 97.17 6.18 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 117.92 0.327 . . . . 71.1 110.583 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . 54.58 -151.36 0.37 Allowed 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 124.735 1.214 . . . . 72.41 112.609 171.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 19.9 t70 73.62 -0.64 3.3 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 124.919 1.288 . . . . 63.52 112.345 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' D' ' 85' ' ' SER . 80.9 m-20 64.66 26.32 13.15 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.681 1.192 . . . . 73.11 113.396 176.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 9.0 m -129.64 110.2 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.402 -0.962 . . . . 74.23 108.402 169.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.405 ' HA ' ' HB2' ' D' ' 50' ' ' GLN . 46.5 m-85 -126.88 132.58 50.89 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 109.31 -0.626 . . . . 73.2 109.31 -175.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -87.28 112.43 22.04 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.594 -0.891 . . . . 71.34 108.594 175.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.584 HG12 ' HD3' ' D' ' 103' ' ' PRO . 84.8 t -101.13 116.9 45.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.322 -0.992 . . . . 70.0 108.322 176.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.471 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 26.3 t -102.71 129.36 54.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 108.777 -0.823 . . . . 71.11 108.777 176.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.31 122.78 48.48 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.41 -0.959 . . . . 74.43 108.41 -178.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.474 ' HB3' ' HB2' ' D' ' 45' ' ' ASP . 49.3 ttp180 -98.53 101.47 12.91 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.996 -0.742 . . . . 75.35 108.996 173.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.679 HG13 HD12 ' D' ' 42' ' ' LEU . 61.9 t -98.24 113.64 33.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 114.898 -1.046 . . . . 73.31 108.678 173.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.407 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 11.0 m -122.44 124.22 43.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.356 -0.838 . . . . 73.21 109.706 -172.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.676 HG13 HG11 ' D' ' 40' ' ' VAL . 39.9 t -109.15 123.24 64.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 C-N-CA 125.409 1.484 . . . . 64.05 108.774 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 20.4 m -113.52 101.27 9.19 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.902 -1.147 . . . . 65.23 107.902 169.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.47 142.95 41.53 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.636 -0.711 . . . . 75.22 109.105 -173.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.451 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 17.1 p -149.72 134.0 17.32 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.746 0.647 . . . . 73.1 112.746 -171.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 34.3 mt -109.06 112.01 23.96 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.797 1.239 . . . . 71.21 107.733 173.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.5 -140.41 22.7 Favored Glycine 0 C--N 1.344 1.004 0 O-C-N 123.286 0.367 . . . . 50.5 112.545 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.29 6.64 42.11 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.348 0.659 . . . . 63.01 111.799 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.519 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 11.1 pt-20 -132.35 173.99 10.71 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.885 0.474 . . . . 72.5 110.611 -178.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 31.2 m -73.6 140.03 45.94 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.452 -0.794 . . . . 71.41 111.775 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.459 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -87.25 -67.19 0.84 Allowed 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.404 -1.332 . . . . 75.51 107.404 169.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -148.41 148.75 30.68 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.52 -1.218 . . . . 72.53 110.26 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 78.6 mt -103.41 150.38 23.89 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.73 1.212 . . . . 74.53 108.197 169.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.539 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.9 t -158.12 140.58 14.45 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.359 -0.608 . . . . 73.33 109.359 176.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -155.54 127.62 7.61 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.106 0.562 . . . . 73.33 109.698 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.93 114.97 34.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 123.126 0.57 . . . . 75.15 109.553 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.67 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.0 mt-30 -90.71 85.67 6.13 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.872 0.844 . . . . 75.34 109.394 171.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -81.18 101.44 9.67 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 113.818 -1.537 . . . . 74.4 109.726 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.42 143.89 17.56 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 112.273 -0.331 . . . . 72.31 112.273 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.65 134.0 6.57 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 111.855 -0.498 . . . . 74.04 111.855 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.411 HG13 ' HE1' ' D' ' 17' ' ' TYR . 61.6 mt -89.23 103.17 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 107.925 -1.139 . . . . 72.24 107.925 175.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -108.78 144.11 37.05 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.807 0.843 . . . . 73.22 110.641 -177.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' D' ' 54' ' ' ASP . 16.4 p -116.46 137.34 52.24 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.679 0.792 . . . . 63.23 110.097 171.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.446 HG12 HD11 ' D' ' 89' ' ' ILE . 6.3 tt -145.24 138.68 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.394 0.678 . . . . 73.4 110.81 -163.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.428 ' HA ' ' CG2' ' E' ' 97' ' ' ILE . . . -168.26 170.76 9.83 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.425 0.69 . . . . 73.41 111.645 175.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 93.61 7.58 61.56 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 115.748 -0.66 . . . . 53.43 112.793 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.504 ' HA ' HD21 ' D' ' 6' ' ' ASN . 1.4 pp -140.1 149.96 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.542 1.137 . . . . 74.1 110.225 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.9 173.26 17.26 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.746 0.819 . . . . 72.32 110.456 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . 0.659 ' HA3' ' HG2' ' D' ' 3' ' ' GLU . . . 79.86 -118.26 4.68 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 114.781 0.673 . . . . 64.41 114.781 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 54.2 p -90.08 -44.67 9.66 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.384 0.674 . . . . 63.31 111.388 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.447 ' NE2' HG21 ' D' ' 89' ' ' ILE . 12.8 pt20 -66.86 -23.61 66.04 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 113.177 0.806 . . . . 71.44 113.177 -172.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 21.7 ptm -56.72 -51.31 69.33 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 113.851 1.056 . . . . 74.12 113.851 -174.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.9 -12.85 59.71 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.577 0.751 . . . . 65.34 112.411 -168.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -61.8 -37.62 85.05 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.942 0.497 . . . . 74.25 110.53 171.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 61.8 m -66.72 -25.48 66.54 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.876 -0.602 . . . . 72.03 111.943 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.443 HD22 HG23 ' D' ' 86' ' ' ILE . 89.6 mt -92.84 -39.34 11.25 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.815 0.846 . . . . 73.05 111.281 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . 0.428 ' HA2' HG23 ' D' ' 46' ' ' THR . . . -90.53 -1.85 73.9 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.622 -0.717 . . . . 73.45 113.54 -171.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.23 -49.64 0.13 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.157 0.429 . . . . 72.34 112.157 -173.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -73.63 -42.99 60.73 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 118.168 0.44 . . . . 72.55 111.958 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.439 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 89.8 m -60.27 -48.83 93.07 Favored Pre-proline 0 CA--C 1.562 1.425 0 CA-C-O 118.964 -0.541 . . . . 75.44 112.091 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.584 ' HD3' HG12 ' D' ' 58' ' ' VAL . 37.6 Cg_endo -65.54 -24.88 55.7 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 121.924 1.749 . . . . 64.13 112.835 173.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -67.98 -31.13 70.63 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.561 0.344 . . . . 75.2 110.262 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 37.5 mm -73.02 -38.92 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.025 0.93 . . . . 73.32 110.829 173.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' D' ' 103' ' ' PRO . 71.6 mt -69.76 -26.92 64.53 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.333 0.653 . . . . 70.05 111.899 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -62.82 -41.61 72.85 Favored Pre-proline 0 CA--C 1.554 1.132 0 N-CA-C 113.93 1.085 . . . . 74.41 113.93 -170.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -47.12 -45.43 21.54 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.205 1.937 . . . . 75.22 114.087 167.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -79.9 -32.69 40.22 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.678 0.791 . . . . 75.1 111.961 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.39 -36.14 66.0 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.236 0.614 . . . . 75.21 110.153 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.493 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.8 ttp180 -66.18 -45.1 82.02 Favored 'General case' 0 C--O 1.208 -1.116 0 CA-C-N 114.839 -1.073 . . . . 73.25 109.305 171.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -55.05 -48.56 73.29 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.958 0.903 . . . . 75.5 111.302 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.469 ' SG ' HD11 ' D' ' 21' ' ' ILE . 46.0 t -58.35 -45.8 87.49 Favored 'General case' 0 C--N 1.347 0.487 0 O-C-N 124.22 0.95 . . . . 74.23 111.032 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.539 HG12 ' SG ' ' D' ' 76' ' ' CYS . 45.1 mt -64.06 -55.04 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.111 0.565 . . . . 75.15 110.915 177.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.2 m -50.71 -40.66 54.8 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.354 1.462 . . . . 71.5 111.455 -176.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 34.4 t -66.66 -47.85 71.22 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.912 -1.04 . . . . 61.45 110.434 177.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.418 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 64.2 mtm -69.57 -29.5 67.06 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.495 0.554 . . . . 74.34 112.495 -175.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.402 HG22 ' O ' ' D' ' 114' ' ' ILE . 86.4 t -67.82 -44.44 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.503 0.721 . . . . 74.03 109.471 176.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 65.9 p -71.66 -28.44 63.75 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 115.626 -0.716 . . . . 74.42 110.048 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' D' ' 116' ' ' SER . 92.7 mtt-85 -71.79 -30.05 65.12 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.82 0.848 . . . . 74.45 110.191 173.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.85 8.64 77.18 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 123.642 0.588 . . . . 71.32 112.748 176.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 82.0 p 54.91 31.12 15.2 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 126.165 1.786 . . . . 63.45 113.99 178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -95.27 153.19 39.72 Favored Pre-proline 0 C--O 1.245 0.819 0 N-CA-C 107.702 -1.222 . . . . 73.43 107.702 168.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.49 150.33 60.75 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.657 2.238 . . . . 74.25 112.314 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -59.15 122.02 12.76 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.768 0.827 . . . . 73.44 111.829 -169.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 19.8 tp -107.42 100.68 10.09 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.066 0.947 . . . . 75.42 109.087 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -100.04 104.97 16.59 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.214 -1.032 . . . . 74.01 108.214 172.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.493 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 2.9 mm? -66.57 115.73 6.76 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 109.183 -0.673 . . . . 72.02 109.183 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.446 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -57.24 129.48 79.61 Favored Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 123.294 0.638 . . . . 54.43 112.087 -172.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 1.2 Cg_endo -79.05 117.09 3.8 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.068 2.512 . . . . 74.24 111.243 -175.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 14.8 p -127.03 149.21 31.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 123.697 0.799 . . . . 73.11 109.126 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -69.75 113.73 7.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.908 -0.775 . . . . 75.42 108.908 172.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -60.59 -34.03 73.61 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.898 0.879 . . . . 74.34 111.213 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -63.63 -33.64 76.07 Favored 'General case' 0 C--O 1.213 -0.844 0 O-C-N 124.051 0.845 . . . . 71.44 110.861 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.98 -28.7 69.99 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.616 0.766 . . . . 73.23 112.134 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.43 HD23 ' HB2' ' E' ' 112' ' ' ASN . 9.4 mp -71.21 -40.53 71.09 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.311 0.644 . . . . 73.23 110.712 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -76.6 -37.49 56.36 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.079 0.952 . . . . 73.42 109.107 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.499 ' HG2' ' HG2' ' D' ' 142' ' ' GLN . 24.3 ttm -68.78 -32.64 72.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.878 1.271 . . . . 72.21 110.034 -176.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -66.93 -8.29 28.38 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.186 0.994 . . . . 73.52 111.507 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . 0.543 ' HB2' ' HH ' ' E' ' 109' ' ' TYR . 36.5 t80 -85.51 -38.96 17.97 Favored 'General case' 0 CA--C 1.552 1.029 0 O-C-N 121.34 -0.85 . . . . 74.51 109.997 170.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.5 mp -83.22 -67.43 0.79 Allowed 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 123.756 0.822 . . . . 72.54 112.456 -175.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.499 ' HG2' ' HG2' ' D' ' 138' ' ' MET . 7.4 pt20 -79.98 38.61 0.41 Allowed 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 123.708 0.803 . . . . 75.11 112.922 -172.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -130.13 93.04 3.4 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.586 -0.696 . . . . 74.34 109.837 -165.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -147.62 171.41 15.65 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.484 1.114 . . . . 63.34 108.122 177.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.99 92.67 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.283 0.633 . . . . 74.52 111.241 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -168.04 44.78 0.24 Allowed Glycine 0 C--N 1.34 0.791 0 N-CA-C 110.771 -0.932 . . . . 71.14 110.771 -177.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . 0.647 ' HB3' ' H ' ' B' ' 5' ' ' ASN . 0.0 OUTLIER -113.72 -25.69 8.56 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.841 1.256 . . . . 74.22 111.218 -177.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 73.97 -114.39 4.54 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 111.173 -0.771 . . . . 71.52 111.173 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 12.8 t -171.05 18.03 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.039 0.935 . . . . 74.03 109.86 177.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -121.91 149.0 44.04 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.178 0.513 . . . . 75.14 111.783 -169.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -100.07 143.05 30.72 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.16 -1.422 . . . . 71.14 107.16 159.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -67.15 125.09 24.94 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.401 0.62 . . . . 73.14 112.465 -170.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -133.89 166.23 23.17 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.436 1.494 . . . . 70.01 108.241 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -61.09 90.61 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 CA-C-O 121.899 0.857 . . . . 73.43 111.725 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.211 0 C-N-CA 124.066 0.946 . . . . 74.42 108.859 -176.262 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.055 0 N-CA-C 110.779 -0.928 . . . . 72.23 110.779 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . -143.95 36.67 1.49 Allowed Glycine 0 C--N 1.343 0.94 0 CA-C-N 117.108 0.454 . . . . 74.53 113.49 -175.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -78.38 74.96 4.91 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 106.948 -1.501 . . . . 72.33 106.948 167.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -81.78 -101.96 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.62 -0.718 . . . . 74.24 110.193 -171.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -146.7 -60.16 0.29 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.498 0.666 . . . . 72.44 110.492 -166.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 152.4 122.29 0.95 Allowed Glycine 0 CA--C 1.519 0.301 0 N-CA-C 109.198 -1.561 . . . . 74.31 109.198 -171.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 97' ' ' ILE . . . . . 0.428 ' CG2' ' HA ' ' D' ' 87' ' ' ALA . 3.9 pt -81.11 48.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 124.111 0.964 . . . . 65.32 112.505 -177.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 t70 56.78 92.45 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.109 1.364 . . . . 75.12 110.836 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . 61.89 -168.56 0.18 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.874 0.87 . . . . 72.22 110.448 -172.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.83 72.21 3.64 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 109.033 -0.728 . . . . 75.51 109.033 175.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -80.04 71.06 7.25 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 122.877 2.385 . . . . 71.13 112.14 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 102' ' ' LEU . . . . . . . . . . . . . 1.8 tt -88.58 67.76 8.55 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 108.837 -0.801 . . . . 72.21 108.837 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 47.3 p 51.18 30.35 5.63 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.278 1.431 . . . . 62.45 113.07 176.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.38 -138.06 13.65 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 110.675 -0.97 . . . . 40.13 110.675 -171.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -94.9 -4.61 46.59 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.385 0.674 . . . . 75.35 111.032 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -164.09 148.9 10.23 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.753 1.221 . . . . 72.42 108.72 -174.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 8.3 m -77.41 88.75 3.79 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.436 -0.579 . . . . 73.15 109.436 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -66.19 -27.67 68.17 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.227 -0.897 . . . . 63.04 110.91 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 109' ' ' TYR . . . . . 0.543 ' HH ' ' HB2' ' D' ' 140' ' ' TYR . 9.9 t80 -68.54 99.28 0.96 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 107.385 -1.339 . . . . 74.23 107.385 166.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.46 145.6 45.61 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 122.758 0.423 . . . . 73.2 110.991 -177.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 mp -78.38 87.39 4.41 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.75 0.82 . . . . 74.42 109.9 -171.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 112' ' ' ASN . . . . . 0.43 ' HB2' HD23 ' D' ' 136' ' ' LEU . 66.8 t30 63.77 84.95 0.14 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.087 1.355 . . . . 61.24 111.672 176.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -124.61 -51.06 1.73 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.211 1.005 . . . . 73.23 108.483 175.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -71.89 114.17 9.7 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.638 -0.875 . . . . 72.32 108.638 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 39.4 m -79.1 129.68 34.7 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.923 0.889 . . . . 71.42 110.263 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 140.98 39.76 0.08 OUTLIER Glycine 0 N--CA 1.469 0.891 0 N-CA-C 110.912 -0.875 . . . . 64.22 110.912 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -137.3 141.11 32.86 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.047 0.939 . . . . 73.5 109.558 -172.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -37.56 134.74 0.52 Allowed 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 124.022 3.148 . . . . 72.41 113.697 167.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -59.86 114.79 2.98 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.486 1.114 . . . . 75.44 113.0 -165.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -120.76 -75.47 0.59 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.965 0.906 . . . . 62.13 108.907 172.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 121' ' ' VAL . . . . . 0.522 HG11 HD23 ' D' ' 42' ' ' LEU . 37.2 t -130.3 70.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 108.562 -0.903 . . . . 70.25 108.562 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 6.8 p -128.92 153.44 47.51 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.26 -0.882 . . . . 74.14 109.937 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 29.0 t70 62.78 -86.12 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 124.808 1.243 . . . . 74.41 111.879 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 79.5 p -157.65 176.69 12.29 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.056 0.942 . . . . 73.21 108.891 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -132.62 -78.7 0.5 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.692 0.397 . . . . 65.2 110.009 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -117.66 173.18 6.88 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.331 0.653 . . . . 62.41 110.896 -175.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 127' ' ' SER . . . . . 0.597 ' HB2' HG23 ' E' ' 129' ' ' THR . 24.6 p -103.75 -76.48 0.59 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.648 0.779 . . . . 73.25 110.183 176.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . 58.9 27.26 15.96 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.967 0.907 . . . . 74.54 111.358 -173.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 129' ' ' THR . . . . . 0.597 HG23 ' HB2' ' E' ' 127' ' ' SER . 5.4 t -89.36 117.48 28.32 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.773 0.829 . . . . 74.33 111.393 -175.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -167.82 94.63 0.41 Allowed 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.091 0.956 . . . . 74.11 108.985 174.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 131' ' ' TRP . . . . . 0.403 ' HA ' ' HG3' ' A' ' 124' ' ' PRO . 19.5 t90 -143.99 112.34 6.42 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.679 -0.86 . . . . 74.42 108.679 176.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 132' ' ' SER . . . . . 0.517 ' H ' ' HB3' ' A' ' 124' ' ' PRO . 44.9 p -167.77 114.75 0.73 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.877 1.271 . . . . 72.55 108.844 178.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 133' ' ' THR . . . . . 0.45 HG23 ' HB2' ' A' ' 124' ' ' PRO . 0.2 OUTLIER -149.99 161.62 41.97 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.847 0.459 . . . . 65.21 111.027 -179.465 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -148.45 111.57 0.54 Allowed Glycine 0 C--N 1.345 1.063 0 N-CA-C 110.586 -1.006 . . . . 75.23 110.586 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.9 115.17 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.394 0.678 . . . . 75.32 109.467 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -95.33 25.46 4.37 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.687 0.795 . . . . 75.33 111.185 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 137' ' ' THR . . . . . 0.664 ' HA ' ' HB3' ' A' ' 129' ' ' ALA . 45.8 p 48.3 -97.88 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.118 1.367 . . . . 73.33 112.05 -168.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -172.15 -38.4 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.482 1.113 . . . . 72.45 109.385 176.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -136.83 -170.27 2.66 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.647 1.179 . . . . 72.21 108.866 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -70.08 81.27 0.35 Allowed Glycine 0 C--N 1.348 1.213 0 O-C-N 123.621 0.575 . . . . 72.41 111.986 174.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.54 76.13 3.25 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.641 0.776 . . . . 73.3 109.913 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 92.7 mt -80.1 156.32 27.1 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.824 -0.626 . . . . 75.43 111.74 -173.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.98 49.95 0.78 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 109.392 -1.483 . . . . 71.11 109.392 174.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 14.5 p -112.31 147.56 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.411 0.684 . . . . 75.51 109.608 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 CA--C 1.55 0.952 0 C-N-CA 123.458 0.703 . . . . 72.31 110.447 175.422 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.639 0 CA-C-O 119.567 -0.574 . . . . 61.01 112.061 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.44 62.38 3.28 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 116.843 0.321 . . . . 52.42 112.744 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 93' ' ' PHE . . . . . 0.62 ' HB3' ' HB2' ' B' ' 54' ' ' ASP . 17.9 t80 -83.03 -37.03 24.47 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.149 0.58 . . . . 74.32 109.617 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.25 -57.5 1.39 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.949 0.5 . . . . 74.01 110.251 -173.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -164.74 -68.44 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.347 0.259 . . . . 73.13 110.994 177.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.53 138.18 4.46 Favored Glycine 0 C--N 1.348 1.234 0 C-N-CA 121.818 -0.229 . . . . 71.15 113.179 -172.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 97' ' ' ILE . . . . . 0.439 HD11 ' HB2' ' B' ' 94' ' ' MET . 9.8 tt -166.4 138.97 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.457 1.503 . . . . 71.44 107.308 176.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -56.81 -51.89 67.19 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 112.922 0.712 . . . . 72.51 112.922 -167.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -177.04 148.17 0.61 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.652 1.181 . . . . 73.33 107.841 -177.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 100' ' ' LEU . . . . . 0.496 ' HA ' ' HE1' ' B' ' 94' ' ' MET . 5.1 mp -112.37 96.38 35.43 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-N 117.931 0.332 . . . . 73.14 110.751 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -93.14 -172.53 0.35 Allowed 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 123.101 2.534 . . . . 73.03 110.221 163.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 102' ' ' LEU . . . . . . . . . . . . . 44.9 tp -95.63 -59.63 1.83 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 107.922 -1.14 . . . . 74.52 107.922 168.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.94 -55.7 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.113 1.365 . . . . 72.12 108.619 170.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . -147.82 -162.38 10.05 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.77 -0.65 . . . . 63.23 112.255 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -71.6 84.33 0.86 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.508 0.723 . . . . 72.51 110.186 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 53.3 t80 48.27 82.19 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.764 1.626 . . . . 73.14 112.528 177.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 7.8 t -116.36 144.13 44.66 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.576 0.75 . . . . 72.41 109.992 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -98.92 -59.0 1.81 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.17 -0.678 . . . . 74.53 109.17 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 109' ' ' TYR . . . . . 0.447 ' CE2' ' HB2' ' B' ' 140' ' ' TYR . 70.5 t80 63.95 102.75 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.524 1.129 . . . . 72.31 109.828 -172.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 62.72 -137.91 0.42 Allowed 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 124.101 0.96 . . . . 74.12 109.448 -168.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 85.8 mt 72.75 -69.98 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 125.118 1.367 . . . . 74.12 112.734 174.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -87.41 34.45 0.7 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.424 1.09 . . . . 73.31 112.723 -171.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 113' ' ' LYS . . . . . 0.512 ' HZ1' ' HB3' ' F' ' 113' ' ' LYS . 7.3 ttpm? 67.34 -71.5 0.1 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.064 1.346 . . . . 72.01 111.624 -177.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt 50.54 -66.16 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 127.798 2.439 . . . . 74.25 115.7 175.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 21.5 m -61.97 -32.09 72.51 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.039 0.936 . . . . 75.41 111.979 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 131.78 -56.25 0.74 Allowed Glycine 0 C--N 1.345 1.042 0 N-CA-C 112.064 -0.414 . . . . 63.34 112.064 175.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -122.68 96.93 44.94 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 123.284 0.634 . . . . 75.02 109.996 -176.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.45 104.59 1.93 Allowed 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.17 1.914 . . . . 72.14 111.097 173.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -75.62 69.71 2.37 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.954 0.883 . . . . 73.45 110.153 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 28.7 t80 173.25 -179.24 0.08 Allowed 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 126.99 2.116 . . . . 74.23 107.071 -174.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 98.3 t 75.05 -79.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 124.619 1.168 . . . . 74.25 111.515 172.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 31.4 p -88.43 96.59 10.66 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.317 0.647 . . . . 62.44 110.606 -174.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -159.84 102.69 1.49 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.342 -0.614 . . . . 63.04 109.342 177.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 23.1 t 63.15 7.8 2.97 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.496 1.118 . . . . 64.4 112.206 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -89.33 104.9 17.42 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.075 0.95 . . . . 65.23 110.421 -167.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . 62.27 18.59 10.31 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.644 1.178 . . . . 72.13 112.48 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 16.1 m -76.95 89.35 3.51 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.644 0.778 . . . . 74.21 110.547 -176.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -159.53 -63.91 0.07 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.715 0.806 . . . . 74.41 109.277 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 92.0 m 65.07 124.44 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.187 1.395 . . . . 71.23 113.432 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -161.61 154.41 20.49 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 114.717 -1.129 . . . . 65.12 109.037 169.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 51.8 t90 -143.48 22.1 1.84 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.284 1.033 . . . . 73.34 108.325 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 14.1 m -67.15 88.08 0.17 Allowed 'General case' 0 C--N 1.352 0.701 0 CA-C-O 121.438 0.637 . . . . 74.15 110.003 -178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 133' ' ' THR . . . . . 0.506 HG21 HD12 ' C' ' 126' ' ' LEU . 21.4 m -73.87 92.39 2.06 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.658 -1.155 . . . . 72.44 108.453 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -82.7 36.58 2.65 Favored Glycine 0 C--N 1.355 1.612 0 CA-C-N 116.089 -0.505 . . . . 71.4 113.089 -175.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 15.0 p -75.22 136.45 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.519 0.727 . . . . 72.41 109.649 -177.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -118.39 179.85 3.99 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.607 -0.516 . . . . 75.33 109.607 175.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 10.2 t -66.69 168.14 9.94 Favored 'General case' 0 C--O 1.25 1.079 0 CA-C-N 115.675 -0.693 . . . . 74.33 109.517 169.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -64.36 118.51 8.8 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.175 -1.046 . . . . 72.32 108.175 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -63.75 119.25 9.58 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.998 0.919 . . . . 74.15 112.016 -167.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.88 11.21 29.7 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 115.796 -0.638 . . . . 74.41 112.778 178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.35 -41.69 47.39 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.477 -0.564 . . . . 53.44 109.477 174.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 2.1 tm? 68.12 -71.75 0.11 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.556 1.542 . . . . 74.43 109.608 -176.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.84 -168.1 11.74 Favored Glycine 0 C--N 1.342 0.881 0 N-CA-C 111.228 -0.749 . . . . 62.22 111.228 173.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 99.1 t -120.47 -55.64 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.681 0.793 . . . . 64.52 109.031 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 . . . . . 0 N--CA 1.48 1.051 0 C-N-CA 123.675 0.79 . . . . 75.04 110.237 179.028 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtp . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 109.066 -0.716 . . . . 73.21 109.066 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.1 p -164.68 16.78 0.05 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.863 1.265 . . . . 74.41 109.377 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -124.63 -165.75 1.42 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.787 0.835 . . . . 72.3 110.311 -166.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -151.3 73.16 1.08 Allowed 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 122.1 0.952 . . . . 72.14 109.94 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -83.01 97.93 9.0 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.244 -0.889 . . . . 74.13 109.7 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.632 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 7.1 p30 -87.98 108.92 19.44 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.279 0.562 . . . . 61.42 109.86 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.5 m -143.62 -135.77 0.09 Allowed 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 107.908 -1.145 . . . . 74.45 107.908 -176.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -88.79 55.58 3.42 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.394 0.997 . . . . 74.21 109.426 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.2 mpt? 63.17 170.07 0.15 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.758 1.223 . . . . 75.42 112.038 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 58.5 m -140.56 114.7 9.15 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.08 -1.452 . . . . 74.14 107.08 167.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -131.66 118.82 20.55 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.047 -0.724 . . . . 74.43 109.047 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.495 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 0.0 OUTLIER -136.98 131.7 33.3 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 106.603 -1.628 . . . . 75.24 106.603 175.171 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.554 HD12 HG21 ' A' ' 105' ' ' ILE . 6.4 mt -94.38 107.54 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.496 -0.928 . . . . 75.41 108.496 173.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.96 -40.31 68.75 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.519 -0.919 . . . . 74.43 108.519 -176.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 -173.89 122.85 0.33 Allowed 'General case' 0 C--N 1.351 0.655 0 CA-C-N 115.949 -0.569 . . . . 75.44 110.527 -169.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.565 HD13 ' HG3' ' C' ' 130' ' ' PRO . 65.0 mt -106.49 134.72 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 107.979 -1.119 . . . . 74.31 107.979 169.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.481 ' HE1' HG13 ' A' ' 83' ' ' ILE . 30.9 p90 -164.5 178.79 7.14 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 124.165 0.916 . . . . 74.24 110.807 -172.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.1 p -109.47 124.15 50.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.624 -0.716 . . . . 60.22 109.316 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.407 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 42.7 mtpt -86.46 -30.73 21.81 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.66 -0.496 . . . . 75.54 109.66 175.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 31.9 t70 -149.6 145.59 26.86 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.065 -0.97 . . . . 53.22 109.739 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.3 mt -141.02 146.02 24.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 C-N-CA 125.086 1.354 . . . . 74.41 107.835 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.2 t -152.15 137.7 17.76 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.55 0.74 . . . . 72.33 109.791 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.487 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 92.2 t80 -144.42 132.49 21.6 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.993 -1.484 . . . . 75.2 106.993 173.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -133.05 111.75 11.23 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.869 -0.789 . . . . 74.24 108.869 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.511 ' HB1' ' HB3' ' A' ' 28' ' ' ALA . . . -104.36 81.92 0.57 Allowed Pre-proline 0 C--O 1.245 0.817 0 N-CA-C 106.415 -1.698 . . . . 72.33 106.415 161.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.56 -29.05 25.46 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.282 1.988 . . . . 73.13 111.281 -172.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -111.45 19.1 18.53 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-N 114.451 -1.25 . . . . 71.44 109.297 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.511 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . . . -44.83 -49.35 28.17 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 113.633 0.975 . . . . 72.04 113.633 -171.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -59.82 -39.62 70.71 Favored 'Trans proline' 0 C--N 1.392 2.858 0 C-N-CA 121.686 1.591 . . . . 75.12 112.744 176.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.417 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 3.7 m-70 -76.72 -38.04 55.0 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.223 -1.353 . . . . 74.14 110.588 -173.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.443 HG11 ' O ' ' A' ' 28' ' ' ALA . 3.6 p -72.6 -25.68 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 124.563 1.145 . . . . 75.03 111.281 -163.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -76.21 -18.82 58.88 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.557 0.743 . . . . 74.41 110.98 176.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -85.11 -28.21 25.74 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.171 0.989 . . . . 74.54 110.258 173.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 1.3 mmmp? -79.35 159.69 27.04 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.291 1.036 . . . . 74.35 111.735 -173.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.85 119.74 9.96 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.853 0.861 . . . . 65.31 110.353 176.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -82.47 85.18 6.98 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.543 0.687 . . . . 72.03 110.16 -178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.483 ' H ' HD23 ' A' ' 68' ' ' LEU . 8.3 tp-100 -121.07 76.05 30.32 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.673 1.189 . . . . 75.34 108.263 172.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.53 113.11 2.81 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.599 2.199 . . . . 72.31 112.622 -171.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -94.69 92.17 6.88 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.585 -1.265 . . . . 73.3 107.585 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.617 HG23 ' HB1' ' A' ' 66' ' ' ALA . 61.5 t -89.44 106.38 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.718 -1.128 . . . . 64.24 111.037 -173.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -86.45 140.43 29.98 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.372 0.669 . . . . 74.13 110.561 171.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.9 mt -106.67 106.21 16.61 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.038 -1.097 . . . . 74.12 108.038 171.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -107.4 108.59 20.02 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.691 1.196 . . . . 71.2 108.157 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.543 HD12 HG22 ' A' ' 131' ' ' VAL . 83.7 mt -104.25 155.07 19.04 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.692 0.758 . . . . 64.23 112.249 -170.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.451 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 17.3 t70 -158.2 139.45 13.36 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 113.705 -1.589 . . . . 64.52 108.357 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.8 m -138.87 122.25 17.16 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.163 -0.681 . . . . 75.53 109.163 175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.86 111.8 11.91 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.56 0.744 . . . . 71.44 109.213 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 p -91.66 153.1 19.91 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.384 0.674 . . . . 71.32 110.342 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.2 t -149.64 121.21 8.0 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.711 0.804 . . . . 63.24 109.454 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -71.35 112.48 7.52 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.56 -0.533 . . . . 75.43 109.56 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.677 HD12 ' HB2' ' A' ' 57' ' ' GLU . 46.8 mt -81.28 -43.76 18.69 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.128 0.571 . . . . 75.44 109.76 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.77 178.76 8.58 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.282 -0.872 . . . . 74.53 110.074 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.32 129.43 39.89 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 109.311 -0.626 . . . . 74.12 109.311 175.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 63.18 18.75 11.21 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.368 1.067 . . . . 72.03 111.262 -175.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.2 t -130.85 102.53 6.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.821 0 C-N-CA 124.374 1.069 . . . . 74.14 108.576 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -113.74 123.19 49.28 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.524 -1.287 . . . . 74.51 107.524 175.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.677 ' HB2' HD12 ' A' ' 51' ' ' LEU . 32.8 tt0 -85.46 151.38 24.02 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.686 -0.857 . . . . 73.12 108.686 173.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.401 HG11 ' HD3' ' A' ' 103' ' ' PRO . 70.2 t -130.3 135.57 60.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.137 -1.06 . . . . 73.11 108.137 169.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.2 t -117.49 128.35 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.748 -0.834 . . . . 75.21 108.748 173.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.95 100.03 9.55 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 106.769 -1.567 . . . . 72.3 106.769 176.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.504 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 21.0 ttp180 -86.83 101.61 13.51 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.617 -0.883 . . . . 73.4 108.617 173.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 37.3 t -97.85 126.95 50.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 107.442 -1.318 . . . . 74.42 107.442 173.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.6 m -124.05 123.48 40.45 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.499 -0.926 . . . . 75.22 108.499 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.644 HG13 HD21 ' A' ' 126' ' ' LEU . 69.3 t -117.09 135.42 57.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 124.843 1.257 . . . . 75.51 108.472 -174.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.6 m -136.47 127.93 28.54 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 109.657 -0.498 . . . . 65.13 109.657 169.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.617 ' HB1' HG23 ' A' ' 40' ' ' VAL . . . -106.05 128.3 53.76 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 107.025 -1.472 . . . . 75.23 107.025 172.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.1 m -132.21 129.82 40.2 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.05 0.54 . . . . 63.21 110.884 -175.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 37' ' ' GLN . 17.2 mt -89.92 51.48 2.08 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.355 1.462 . . . . 73.44 109.917 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.3 -86.37 1.12 Allowed Glycine 0 C--N 1.349 1.271 0 CA-C-N 116.228 -0.442 . . . . 55.15 113.097 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.42 -28.94 20.58 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.504 0.722 . . . . 73.33 111.044 -177.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -111.69 135.79 51.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.067 0.947 . . . . 71.24 109.181 -174.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.6 m -76.64 134.03 39.42 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.392 -0.596 . . . . 74.14 109.392 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.432 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -77.55 -60.2 2.46 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.436 0.694 . . . . 75.33 109.69 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -153.38 163.22 40.3 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.092 -0.958 . . . . 70.44 111.027 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.1 tp -126.1 142.63 51.44 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.057 1.343 . . . . 74.03 108.277 173.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.572 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.2 m -137.77 139.49 40.1 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.784 1.234 . . . . 73.25 108.318 176.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -148.7 124.34 10.44 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.955 -0.757 . . . . 72.41 108.955 169.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.5 t -128.66 119.87 51.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 109.041 -0.725 . . . . 71.13 109.041 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.504 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 51.9 mt-30 -92.97 85.5 5.15 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.286 -1.005 . . . . 75.3 108.286 172.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -76.2 94.78 3.58 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 114.363 -1.29 . . . . 63.33 109.183 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.0 145.47 19.27 Favored Glycine 0 C--N 1.341 0.828 0 N-CA-C 111.399 -0.681 . . . . 72.4 111.399 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.12 122.93 1.9 Allowed Glycine 0 CA--C 1.507 -0.415 0 N-CA-C 110.455 -1.058 . . . . 61.23 110.455 -176.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.481 HG13 ' HE1' ' A' ' 17' ' ' TYR . 53.0 mt -80.36 115.83 23.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 107.93 -1.137 . . . . 74.13 107.93 173.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.632 ' HB3' HD11 ' A' ' 86' ' ' ILE . 98.3 m-85 -120.3 123.78 43.98 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.92 -0.77 . . . . 74.43 108.92 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.495 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 17.8 m -86.33 94.28 9.31 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.631 -0.878 . . . . 74.01 108.631 176.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.632 HD11 ' HB3' ' A' ' 84' ' ' PHE . 6.3 mm -109.48 147.98 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 122.151 0.181 . . . . 63.42 110.598 -175.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -172.33 177.84 2.98 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.386 1.075 . . . . 71.25 109.566 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.632 ' HA2' ' HA ' ' A' ' 6' ' ' ASN . . . 93.88 -24.09 27.97 Favored Glycine 0 N--CA 1.467 0.75 0 CA-C-O 120.246 -0.197 . . . . 53.22 113.192 176.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.54 170.16 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.816 0.846 . . . . 75.41 110.87 -176.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 13.1 tt0 -155.55 179.15 9.45 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.337 -0.847 . . . . 75.04 109.478 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.404 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 59.53 -122.0 28.61 Favored Glycine 0 C--N 1.347 1.165 0 C-N-CA 123.531 0.586 . . . . 74.34 114.033 177.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.8 p -73.04 -30.81 64.0 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.032 0.933 . . . . 65.54 111.887 -176.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -71.19 -37.21 72.13 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.136 0.574 . . . . 74.05 110.189 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.424 ' HE1' ' HG ' ' A' ' 98' ' ' LEU . 4.9 tpt -66.47 -46.44 76.37 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.726 -0.67 . . . . 72.34 109.997 175.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.1 -35.6 75.58 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.654 -0.703 . . . . 65.42 110.798 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -71.12 -35.11 71.64 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.232 0.613 . . . . 74.13 111.327 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -65.12 -44.01 90.11 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 109.437 -0.579 . . . . 73.54 109.437 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.424 ' HG ' ' HE1' ' A' ' 94' ' ' MET . 33.0 mt -82.75 -27.53 31.02 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.213 -0.903 . . . . 75.0 112.534 -175.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.07 4.29 38.52 Favored Glycine 0 N--CA 1.473 1.16 0 CA-C-O 119.689 -0.506 . . . . 73.15 114.124 -171.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.419 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -145.93 -67.67 0.29 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 117.388 0.594 . . . . 75.14 111.503 -176.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -66.97 -47.76 70.58 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 112.506 0.558 . . . . 64.3 112.506 -172.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 86.6 m -64.55 -48.44 74.35 Favored Pre-proline 0 CA--C 1.561 1.397 0 CA-C-O 118.364 -0.827 . . . . 72.51 112.635 -177.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.401 ' HD3' HG11 ' A' ' 58' ' ' VAL . 32.5 Cg_endo -64.42 -24.08 64.45 Favored 'Trans proline' 0 C--N 1.395 2.999 0 C-N-CA 121.671 1.58 . . . . 73.14 112.797 172.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -67.7 -36.67 81.07 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.179 0.592 . . . . 72.31 110.38 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.554 HG21 HD12 ' A' ' 13' ' ' ILE . 44.2 mm -69.37 -42.5 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.635 0.774 . . . . 75.01 110.133 173.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.2 mt -72.41 -23.88 61.16 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.153 -0.931 . . . . 75.52 112.068 -174.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -66.41 -41.33 40.64 Favored Pre-proline 0 N--CA 1.484 1.262 0 N-CA-C 114.306 1.225 . . . . 74.41 114.306 -171.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -50.0 -44.39 37.57 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 121.92 1.746 . . . . 72.22 113.214 168.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -74.67 -36.37 62.8 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.627 0.771 . . . . 74.21 111.709 -177.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.19 -46.65 64.17 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.345 0.658 . . . . 52.13 109.846 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.506 ' NH1' HD13 ' C' ' 105' ' ' ILE . 33.2 ttm105 -49.72 -54.8 16.69 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.812 1.32 . . . . 72.54 109.994 173.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -63.06 -44.26 96.31 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.156 0.91 . . . . 73.41 111.798 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.449 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.6 t -61.79 -31.89 72.14 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.919 0.487 . . . . 73.54 111.432 -179.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.556 HD13 HD12 ' A' ' 128' ' ' LEU . 71.1 mt -71.49 -54.95 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.602 0.761 . . . . 75.15 109.657 172.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 46.2 m -56.32 -35.12 67.21 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.039 1.336 . . . . 72.14 111.605 -173.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.5 t -69.81 -44.24 70.41 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 114.956 -1.02 . . . . 74.25 109.734 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.513 ' HE3' ' HA ' ' A' ' 114' ' ' ILE . 51.7 mtm -63.42 -38.83 92.67 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.886 0.474 . . . . 74.14 110.715 177.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.9 t -61.51 -47.85 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 124.399 1.08 . . . . 74.14 110.475 178.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.8 p -74.24 -34.38 63.62 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.124 0.569 . . . . 60.42 111.393 -175.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.521 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.1 mtt-85 -70.7 -27.22 63.83 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.744 0.818 . . . . 75.44 109.696 174.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.52 7.24 62.06 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.361 -0.836 . . . . 75.24 112.714 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 122' ' ' THR . 36.0 m 72.88 9.21 5.49 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 124.625 1.17 . . . . 70.13 112.083 173.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -83.91 139.91 40.21 Favored Pre-proline 0 C--O 1.244 0.794 0 O-C-N 121.225 -0.922 . . . . 71.43 108.785 173.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.674 ' HB3' ' HA ' ' E' ' 131' ' ' TRP . 9.2 Cg_endo -56.31 141.5 88.79 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.282 1.988 . . . . 75.13 110.85 174.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.649 ' HB3' ' HE1' ' E' ' 131' ' ' TRP . 26.2 tt0 -56.57 140.43 46.57 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 124.324 1.015 . . . . 72.55 113.08 -165.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.644 HD21 HG13 ' A' ' 64' ' ' VAL . 31.6 tp -119.56 105.29 11.08 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 113.665 -1.607 . . . . 74.55 109.424 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -99.28 118.85 36.87 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 107.941 -1.133 . . . . 75.54 107.941 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.556 HD12 HD13 ' A' ' 114' ' ' ILE . 11.9 mt -70.75 147.14 49.31 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.616 0.573 . . . . 74.1 110.012 -174.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.55 132.52 95.42 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 123.043 0.537 . . . . 71.41 110.329 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -62.87 116.85 3.81 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.794 2.329 . . . . 71.11 112.221 -176.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.543 HG22 HD12 ' A' ' 44' ' ' LEU . 87.3 t -99.04 130.46 47.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 C-N-CA 123.131 0.572 . . . . 74.1 110.549 -172.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -90.76 89.06 7.33 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 108.324 -0.991 . . . . 65.04 108.324 174.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -65.03 -23.17 67.12 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.512 0.725 . . . . 74.33 112.373 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.419 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 4.0 m-20 -68.31 -39.37 82.03 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.484 0.714 . . . . 64.34 110.29 174.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.88 83.94 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.237 0.615 . . . . 63.24 110.309 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 60.3 mt -65.54 -41.32 93.19 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.033 0.533 . . . . 65.34 111.052 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -63.34 -45.17 92.49 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.432 -0.803 . . . . 71.04 109.808 178.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.579 ' HE1' ' HB2' ' A' ' 147' ' ' GLU . 17.3 mmt -61.71 -43.88 98.0 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 123.819 0.699 . . . . 73.55 111.025 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -53.98 -43.36 69.92 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.37 0.668 . . . . 74.43 111.141 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -69.06 -43.36 74.78 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.675 0.79 . . . . 75.13 111.237 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.405 HD23 ' SD ' ' A' ' 138' ' ' MET . 60.6 tp -65.96 -50.94 62.58 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.248 1.019 . . . . 74.43 112.238 -168.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -175.9 -19.03 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.55 0.74 . . . . 73.25 111.034 -174.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.46 90.59 0.06 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.703 1.601 . . . . 71.14 109.493 -176.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -149.17 143.11 25.74 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.111 0.564 . . . . 73.33 109.544 -176.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.92 103.5 2.67 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.89 0.744 . . . . 74.52 109.833 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -169.18 -156.36 10.61 Favored Glycine 0 C--N 1.338 0.667 0 O-C-N 123.598 0.561 . . . . 75.44 112.582 -177.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.594 ' HG3' HG23 ' A' ' 149' ' ' THR . 10.3 tp10 70.87 -70.91 0.14 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.542 1.537 . . . . 71.24 110.388 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 59.75 40.84 97.15 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 114.375 0.51 . . . . 72.32 114.375 169.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.594 HG23 ' HG3' ' A' ' 147' ' ' GLU . 22.6 p -61.69 -19.03 61.91 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.892 0.877 . . . . 75.42 113.25 -177.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.94 118.54 12.29 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.566 -0.901 . . . . 72.51 108.566 172.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -167.22 146.83 5.26 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.668 1.187 . . . . 73.41 108.325 175.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -116.01 38.82 3.23 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.573 1.149 . . . . 73.43 109.794 -176.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -49.56 -82.76 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.673 1.189 . . . . 71.53 112.617 -172.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.6 t70 177.7 70.04 0.01 OUTLIER 'General case' 0 C--O 1.245 0.829 0 N-CA-C 107.586 -1.265 . . . . 73.34 107.586 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.192 0 CA-C-N 115.051 -0.977 . . . . 75.24 108.714 178.676 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.428 ' H3 ' HG21 ' E' ' 122' ' ' THR . 49.0 ttp . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 108.732 -0.84 . . . . 72.14 108.732 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 20.4 t 70.35 155.51 0.14 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 125.111 1.364 . . . . 72.15 111.092 -177.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.551 ' HG3' ' H ' ' B' ' 5' ' ' ASN . 12.1 tp10 67.8 139.92 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 124.744 1.218 . . . . 74.02 111.662 -177.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.83 12.81 4.39 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.093 0.957 . . . . 71.02 112.662 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . 0.551 ' H ' ' HG3' ' B' ' 3' ' ' GLU . 1.6 m-20 61.63 63.69 1.13 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.393 1.077 . . . . 75.05 110.647 174.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -66.5 135.34 54.08 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 115.717 -0.674 . . . . 65.11 111.935 -172.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.462 ' HB ' ' HE1' ' E' ' 120' ' ' TYR . 9.1 t -172.01 158.55 4.74 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 124.702 1.201 . . . . 73.21 108.91 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -65.14 144.35 57.28 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 108.827 -0.805 . . . . 75.34 108.827 167.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.565 ' HE2' ' HB2' ' B' ' 11' ' ' PHE . 26.3 ttt 66.3 166.83 0.21 Allowed 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 124.785 1.234 . . . . 73.21 112.109 -176.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 41.7 m -142.39 101.98 4.0 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 107.262 -1.384 . . . . 60.51 107.262 172.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.565 ' HB2' ' HE2' ' B' ' 9' ' ' MET . 43.0 t80 -123.54 132.96 54.04 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.547 -0.909 . . . . 74.54 108.547 175.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -157.8 140.34 14.64 Favored 'General case' 0 C--O 1.244 0.768 0 O-C-N 123.768 0.667 . . . . 73.22 109.621 171.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.556 HD13 HD11 ' B' ' 16' ' ' ILE . 41.2 mt -67.81 131.52 33.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 114.774 -1.103 . . . . 74.44 109.624 177.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . 0.433 ' OE1' ' HA3' ' F' ' 92' ' ' GLY . 30.6 mm-40 -94.9 -45.41 7.3 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.984 -0.747 . . . . 70.45 108.984 173.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.507 ' HE ' HG21 ' A' ' 122' ' ' THR . 16.4 ttt180 -169.96 131.68 1.06 Allowed 'General case' 0 C--N 1.353 0.725 0 CA-C-N 115.494 -0.775 . . . . 74.24 110.301 -174.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.556 HD11 HD13 ' B' ' 13' ' ' ILE . 93.9 mt -115.11 146.0 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 108.057 -1.09 . . . . 72.31 108.057 174.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -168.31 149.65 5.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 112.813 0.672 . . . . 72.12 112.813 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 46.4 m -76.84 123.82 26.8 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 114.834 -1.075 . . . . 74.31 109.61 170.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.566 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.4 mtpt -96.6 -17.65 20.27 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.602 0.761 . . . . 73.41 111.326 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -164.31 141.84 6.78 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 123.649 0.593 . . . . 41.33 110.406 -174.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.617 HD11 ' SG ' ' B' ' 113' ' ' CYS . 30.5 mm -130.9 144.35 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.062 0.945 . . . . 74.21 108.957 170.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 34.7 t -149.59 140.96 23.24 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.961 -1.018 . . . . 75.03 109.032 174.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -148.2 124.83 11.09 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.07 -1.456 . . . . 74.41 107.07 169.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -132.18 112.92 12.7 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.527 0.731 . . . . 75.22 109.233 -177.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.8 87.69 3.84 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.469 -1.308 . . . . 73.21 107.469 171.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.3 -27.28 34.63 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.532 2.155 . . . . 72.22 112.081 -172.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.505 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 78.6 m-20 -110.4 9.71 23.42 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.069 0.948 . . . . 70.2 110.911 -177.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -30.64 -66.35 0.17 Allowed Pre-proline 0 N--CA 1.493 1.68 0 C-N-CA 125.668 1.587 . . . . 75.54 115.23 -167.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -58.51 -36.27 97.61 Favored 'Trans proline' 0 C--N 1.398 3.173 0 C-N-CA 122.13 1.887 . . . . 72.2 113.266 -174.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -86.63 -37.66 17.83 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.168 -0.924 . . . . 74.41 111.79 -171.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.52 HG22 HD11 ' B' ' 68' ' ' LEU . 8.7 p -71.06 -9.21 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.371 0.668 . . . . 75.51 111.64 -174.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -72.87 -9.52 58.78 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.112 0.565 . . . . 74.2 112.301 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -67.97 -28.89 67.84 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.232 0.613 . . . . 61.11 110.221 171.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.423 ' HB3' ' HB3' ' B' ' 68' ' ' LEU . 30.5 mmtp -81.55 102.19 10.45 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.573 1.149 . . . . 75.14 108.941 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -107.38 87.95 2.62 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 120.956 0.408 . . . . 70.21 110.857 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -169.61 172.08 7.13 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.772 1.229 . . . . 71.01 108.64 169.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.7 117.74 53.71 Favored Pre-proline 0 N--CA 1.479 1.0 0 N-CA-C 109.021 -0.733 . . . . 75.54 109.021 175.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.497 ' HA ' HD21 ' B' ' 68' ' ' LEU . 16.8 Cg_endo -60.52 150.21 82.65 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.245 1.963 . . . . 73.53 112.546 -176.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -70.64 112.31 6.78 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.087 -1.079 . . . . 72.23 108.087 172.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.413 HG12 HD13 ' B' ' 126' ' ' LEU . 59.9 t -105.53 146.79 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 115.361 -0.836 . . . . 72.02 110.818 -172.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -129.78 106.44 8.7 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 106.933 -1.506 . . . . 74.44 106.933 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.476 HD12 HG21 ' B' ' 64' ' ' VAL . 23.6 tp -90.38 125.48 35.56 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.621 -0.511 . . . . 73.53 109.621 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -130.92 155.71 46.31 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.521 1.128 . . . . 71.42 108.112 -178.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.2 162.91 34.28 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.439 0.695 . . . . 63.42 111.547 -173.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.656 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 8.7 m-20 -138.5 126.11 22.08 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.753 1.221 . . . . 74.15 109.394 175.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' THR . . . . . 0.414 HG22 ' HZ ' ' B' ' 137' ' ' PHE . 7.8 t -114.98 111.14 20.68 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.544 0.687 . . . . 75.25 109.902 174.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.41 141.85 21.64 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.812 0.845 . . . . 75.34 109.013 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.466 ' OG ' HD12 ' F' ' 102' ' ' LEU . 79.0 p -142.07 172.22 12.99 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.571 0.348 . . . . 72.03 111.183 -176.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 54.4 p -151.27 141.37 22.17 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.387 0.675 . . . . 75.35 110.407 -174.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . 0.471 ' HB2' ' CE1' ' B' ' 56' ' ' TYR . 43.5 tt0 -85.98 103.71 14.94 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 109.218 -0.66 . . . . 72.53 109.218 173.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 pp -126.07 24.94 6.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.352 -0.84 . . . . 72.34 109.027 174.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.85 157.67 24.36 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.535 -1.211 . . . . 73.44 109.7 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -83.18 104.47 13.39 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.524 0.73 . . . . 75.35 111.575 -167.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 58.16 23.97 10.81 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 124.696 1.198 . . . . 74.51 111.534 -172.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 85.9 t -131.13 115.85 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 113.788 -1.551 . . . . 60.41 107.288 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.471 ' CE1' ' HB2' ' B' ' 50' ' ' GLN . 0.2 OUTLIER -104.78 140.92 37.38 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.107 0.563 . . . . 74.13 109.769 -174.167 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -100.18 97.64 8.42 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.481 -1.303 . . . . 75.01 107.481 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.404 ' HA ' ' HB3' ' B' ' 48' ' ' SER . 55.3 t -93.06 126.97 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 123.642 0.777 . . . . 74.42 110.078 -177.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.415 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 20.3 t -107.22 142.77 19.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 123.453 0.701 . . . . 74.33 109.426 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.459 HD12 ' HB3' ' B' ' 103' ' ' PRO . 52.7 tp -129.73 108.8 10.46 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.253 -1.017 . . . . 74.54 108.253 171.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.656 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 37.9 ttm180 -87.06 115.34 24.38 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.063 -1.088 . . . . 74.12 108.063 171.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 25.1 t -103.89 119.4 52.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.548 -1.279 . . . . 71.11 107.548 173.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 24.4 m -119.83 128.81 54.04 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.207 -0.664 . . . . 73.34 109.207 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.546 HG22 HG23 ' B' ' 114' ' ' ILE . 84.9 t -117.96 109.55 27.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 123.975 0.91 . . . . 73.11 109.102 -175.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 99.5 m -89.13 138.04 31.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.676 -1.231 . . . . 71.45 107.676 168.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.41 141.09 25.61 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.191 -0.67 . . . . 71.05 109.191 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.409 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 31.9 p -145.28 138.07 26.15 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.522 0.514 . . . . 73.13 111.221 -173.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.52 HD11 HG22 ' B' ' 31' ' ' VAL . 77.7 mt -110.97 102.21 10.71 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.487 1.115 . . . . 74.01 109.159 176.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.77 -137.45 19.47 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.129 -0.788 . . . . 64.33 111.129 -172.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -92.54 3.14 56.11 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 117.405 0.602 . . . . 70.4 110.613 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.505 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 16.7 pt-20 -113.68 151.87 31.23 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.013 0.525 . . . . 74.44 109.654 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 60.7 m -72.88 133.23 44.32 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.119 -0.491 . . . . 73.31 110.216 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.515 ' HA ' HG23 ' B' ' 31' ' ' VAL . . . -84.23 -64.57 1.14 Allowed 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.883 -1.155 . . . . 63.31 107.883 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -155.36 158.88 39.4 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.45 -1.25 . . . . 71.52 110.581 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 53.4 mt -132.35 108.89 9.49 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 106.432 -1.692 . . . . 74.14 106.432 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 48.5 t -119.5 116.34 25.89 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.076 -0.713 . . . . 74.34 109.076 -177.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.401 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 43.9 tt0 -124.67 121.76 35.61 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.761 -0.829 . . . . 74.1 108.761 -175.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' B' ' 110' ' ' ALA . 79.4 t -126.41 135.37 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.89 0.876 . . . . 75.33 109.014 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -107.7 119.77 40.36 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.073 -1.084 . . . . 74.31 108.073 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -110.03 106.01 15.35 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.659 -0.867 . . . . 73.32 108.659 174.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.566 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -98.94 160.81 20.13 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.189 -0.764 . . . . 74.24 111.189 174.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.32 126.2 1.7 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 112.18 -0.368 . . . . 72.41 112.18 -174.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -85.39 114.17 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 N-CA-C 107.718 -1.215 . . . . 74.1 107.718 173.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -129.75 143.66 50.92 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.043 0.937 . . . . 73.03 109.774 -175.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.3 m -88.98 123.3 33.18 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.47 -0.567 . . . . 73.33 109.47 172.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.55 HG22 HD13 ' B' ' 89' ' ' ILE . 4.2 mp -122.98 115.64 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 N-CA-C 108.159 -1.052 . . . . 75.11 108.159 177.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.592 ' HA ' ' HB ' ' F' ' 97' ' ' ILE . . . -154.91 172.64 17.71 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.786 0.835 . . . . 73.0 110.389 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.73 -37.93 3.25 Favored Glycine 0 N--CA 1.481 1.669 0 C-N-CA 123.042 0.353 . . . . 64.13 113.942 172.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.55 HD13 HG22 ' B' ' 86' ' ' ILE . 0.8 OUTLIER -81.15 169.14 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 124.433 1.093 . . . . 73.41 111.87 176.304 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -154.06 175.18 13.73 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.282 -0.872 . . . . 65.53 110.349 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.1 -136.87 27.41 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.802 -0.635 . . . . 72.41 113.221 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.4 m -93.82 -29.16 15.48 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.01 0.524 . . . . 73.13 110.907 -177.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -56.19 -29.55 61.05 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.916 0.887 . . . . 72.13 111.224 175.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.485 ' HG2' HD12 ' F' ' 97' ' ' ILE . 0.7 OUTLIER -66.8 -57.2 7.53 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.612 1.565 . . . . 75.31 112.592 -179.237 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . 0.413 ' N ' ' SD ' ' B' ' 94' ' ' MET . . . -78.41 -15.12 59.01 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 111.958 0.355 . . . . 72.34 111.958 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -59.51 -30.03 68.28 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.834 0.854 . . . . 74.35 110.499 169.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.411 ' SG ' ' HE3' ' B' ' 9' ' ' MET . 41.9 t -63.48 -55.38 24.59 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.072 0.549 . . . . 74.21 111.774 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.487 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.6 pp -69.45 -31.96 70.6 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.631 0.372 . . . . 73.53 111.961 -174.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.02 -23.77 51.0 Favored Glycine 0 C--N 1.348 1.207 0 O-C-N 123.379 0.424 . . . . 62.42 113.567 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.6 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -125.43 -59.28 1.39 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.054 0.542 . . . . 71.1 112.002 -169.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -64.48 -43.74 93.19 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.266 0.626 . . . . 74.15 111.798 -174.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 79.8 m -65.59 -48.13 65.88 Favored Pre-proline 0 CA--C 1.566 1.58 0 CA-C-O 118.309 -0.853 . . . . 64.13 112.201 -176.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.459 ' HB3' HD12 ' B' ' 60' ' ' LEU . 85.8 Cg_exo -53.47 -34.55 72.4 Favored 'Trans proline' 0 C--N 1.397 3.122 0 C-N-CA 122.557 2.171 . . . . 70.23 113.829 170.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.476 HD22 ' HB2' ' B' ' 134' ' ' ASP . 90.9 m-20 -65.4 -29.47 70.18 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.14 0.576 . . . . 75.13 111.941 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.415 HG22 ' NH2' ' D' ' 111' ' ' ARG . 62.6 mt -71.56 -41.54 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.085 0.554 . . . . 73.52 109.858 174.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.4 mt -78.3 -29.87 48.06 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 114.79 -1.096 . . . . 74.43 112.453 -169.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.522 ' HB2' ' HE1' ' B' ' 133' ' ' PHE . 47.9 t80 -55.67 -49.6 91.82 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-O 117.739 -1.124 . . . . 74.33 113.304 -174.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -48.12 -47.51 19.23 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 122.907 2.405 . . . . 54.31 114.695 176.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -65.01 -46.27 82.1 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.137 0.575 . . . . 75.43 110.931 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.512 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -62.41 -39.54 93.61 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.204 -0.907 . . . . 63.42 110.698 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.461 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 52.3 ttt-85 -62.92 -47.06 84.9 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.552 1.541 . . . . 74.41 111.213 -176.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.23 -34.95 73.49 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.598 0.561 . . . . 72.53 110.09 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.617 ' SG ' HD11 ' B' ' 21' ' ' ILE . 8.8 t -68.58 -36.61 78.96 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.612 -0.267 . . . . 75.24 111.082 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.546 HG23 HG22 ' B' ' 64' ' ' VAL . 85.0 mt -59.49 -53.65 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.745 0.818 . . . . 73.44 109.897 169.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 54.5 m -57.13 -32.54 66.46 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.654 0.781 . . . . 73.22 111.546 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.477 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 42.8 t -63.79 -49.8 71.5 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.666 0.786 . . . . 72.33 109.891 174.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.554 ' HE2' HG22 ' B' ' 21' ' ' ILE . 12.5 mmt -70.67 -30.76 67.45 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.096 0.558 . . . . 73.24 111.54 -175.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.482 HG23 ' O ' ' B' ' 114' ' ' ILE . 95.3 t -66.35 -41.74 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.667 0.787 . . . . 75.14 109.704 173.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.2 t -65.83 -32.22 73.62 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.879 -1.055 . . . . 64.42 110.804 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.478 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 88.1 mtt-85 -70.02 -34.71 73.64 Favored 'General case' 0 C--O 1.206 -1.23 0 CA-C-N 115.782 -0.644 . . . . 74.2 110.179 176.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.05 -13.89 82.77 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.428 0.455 . . . . 71.52 112.364 170.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.6 m 69.55 24.1 5.73 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 125.125 1.37 . . . . 72.11 110.519 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.483 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 71.5 m-85 -77.57 159.05 77.87 Favored Pre-proline 0 N--CA 1.477 0.91 0 CA-C-N 114.875 -1.057 . . . . 74.14 110.366 175.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.14 158.56 4.99 Favored 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 123.204 2.603 . . . . 62.25 113.794 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.433 HE21 ' ND2' ' B' ' 127' ' ' ASN . 42.6 tp60 -62.14 126.35 27.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.71 0.804 . . . . 74.41 112.459 -170.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.447 HD23 HG12 ' B' ' 64' ' ' VAL . 39.6 tp -109.81 101.13 10.02 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-N 115.225 -0.898 . . . . 63.25 109.131 178.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . 0.433 ' ND2' HE21 ' B' ' 125' ' ' GLN . 21.6 m-80 -99.25 105.69 17.74 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 107.187 -1.412 . . . . 71.24 107.187 167.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.461 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 46.8 mt -63.64 127.88 33.34 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.332 -0.618 . . . . 75.21 109.332 175.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.01 148.47 92.47 Favored Pre-proline 0 CA--C 1.553 1.078 0 O-C-N 123.775 0.672 . . . . 60.52 111.225 -175.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -69.57 90.3 0.5 Allowed 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.872 2.381 . . . . 72.2 111.863 -174.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 81.9 t -95.45 109.75 23.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.611 -0.885 . . . . 73.22 108.611 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -83.75 109.05 17.19 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.549 -1.278 . . . . 71.55 107.549 171.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.522 ' HE1' ' HB2' ' B' ' 107' ' ' PHE . 47.9 m-85 -67.61 -24.34 65.47 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.442 0.697 . . . . 61.13 110.521 -176.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.6 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 7.9 t70 -62.81 -37.79 88.13 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.34 -1.3 . . . . 74.43 110.989 177.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.11 -30.06 71.15 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.057 0.943 . . . . 73.42 112.52 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.62 -49.24 41.94 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 109.848 -0.427 . . . . 75.24 109.848 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.455 ' HA ' ' HD2' ' B' ' 140' ' ' TYR . 60.6 m-85 -67.41 -26.68 66.55 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 115.631 -0.713 . . . . 75.12 111.489 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 54.3 ttm -61.35 -27.29 68.4 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.508 1.123 . . . . 63.04 112.008 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -74.05 -40.96 62.47 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.49 0.316 . . . . 74.42 110.359 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . 0.455 ' HD2' ' HA ' ' B' ' 137' ' ' PHE . 53.2 m-85 -72.11 -32.91 67.41 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.711 -0.677 . . . . 73.23 110.649 -176.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 76.4 mt -103.93 36.36 2.36 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.109 -0.951 . . . . 73.43 111.267 -172.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -65.72 155.72 35.2 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.644 0.378 . . . . 71.3 110.699 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 65.72 65.53 0.54 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.362 1.065 . . . . 74.21 108.708 -172.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -153.36 106.22 2.93 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.141 -1.39 . . . . 70.53 107.552 -175.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -139.92 164.49 29.86 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.133 0.573 . . . . 71.34 111.447 -172.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -177.78 159.78 25.83 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 114.939 -1.028 . . . . 72.51 110.658 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -153.63 152.69 31.14 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.519 0.728 . . . . 73.5 109.703 -173.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.61 173.54 46.86 Favored Glycine 0 C--N 1.351 1.377 0 O-C-N 123.749 0.656 . . . . 73.43 113.211 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 9.5 t -145.61 -35.84 0.29 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.203 0.601 . . . . 61.33 110.807 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -68.15 100.74 1.05 Allowed 'General case' 0 C--O 1.244 0.791 0 CA-C-O 121.765 0.793 . . . . 74.25 110.977 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.09 153.17 22.4 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.965 -1.016 . . . . 75.11 110.256 171.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . 0.401 ' HB3' ' HA3' ' E' ' 116' ' ' GLY . 59.3 m80 -138.13 87.02 2.21 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.104 -0.702 . . . . 74.24 109.104 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -114.98 134.13 55.45 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.359 0.664 . . . . 75.25 110.382 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . 0.408 ' HB3' ' HB ' ' E' ' 115' ' ' THR . 38.2 t70 -131.7 97.16 4.13 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.415 -0.958 . . . . 55.1 108.415 170.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 C-N-CA 123.946 0.898 . . . . 71.43 108.897 -176.324 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.412 ' SD ' ' N ' ' C' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 121.285 0.564 . . . . 73.21 110.112 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 18.0 t -84.85 102.65 13.25 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 108.597 -0.89 . . . . 73.12 108.597 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -69.0 -59.39 3.08 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.057 0.943 . . . . 65.21 113.517 -165.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 55.58 45.98 23.79 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.983 0.913 . . . . 73.42 110.907 -172.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -76.61 69.09 2.98 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 122.732 1.253 . . . . 73.31 110.828 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -75.64 -44.5 42.31 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.448 -1.251 . . . . 73.43 110.366 -174.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 7.5 p -88.66 75.01 8.31 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 121.781 0.8 . . . . 74.53 109.542 172.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -170.46 -45.38 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.132 -1.394 . . . . 73.24 108.553 175.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.466 ' HE1' HD12 ' C' ' 89' ' ' ILE . 21.4 ttt 62.6 115.39 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.353 1.461 . . . . 72.53 111.159 -171.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 49.6 m -111.83 114.17 26.96 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 108.411 -0.959 . . . . 74.32 108.411 173.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -123.42 117.82 26.04 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 107.317 -1.364 . . . . 74.0 107.317 167.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . 0.551 HE22 HG22 ' E' ' 135' ' ' VAL . 5.9 tp60 -141.27 136.03 31.23 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 120.919 0.39 . . . . 74.43 110.177 175.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.444 HG12 ' HE2' ' C' ' 84' ' ' PHE . 16.2 mt -75.92 120.11 25.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 115.083 -0.962 . . . . 73.25 108.407 174.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.525 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.0 mm-40 -87.88 -39.08 15.1 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 123.639 0.587 . . . . 75.44 109.486 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.3 ptt-85 177.96 153.86 0.31 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.513 1.125 . . . . 74.25 110.392 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 70.7 mt -135.05 125.69 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.179 1.391 . . . . 74.3 107.262 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.442 ' HB3' HG22 ' D' ' 122' ' ' THR . 29.8 p90 -164.42 158.68 18.73 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.229 0.538 . . . . 75.42 111.408 -166.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.7 p -87.8 109.63 19.88 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.455 -0.793 . . . . 74.23 110.164 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.463 ' HD2' ' HB2' ' D' ' 28' ' ' ALA . 13.8 mtmt -82.39 -16.68 48.2 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 110.069 -0.345 . . . . 74.42 110.069 172.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.677 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.4 t70 -153.7 139.01 17.53 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.862 -0.608 . . . . 71.44 109.911 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.6 mt -141.57 145.75 24.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 106.57 -1.641 . . . . 74.3 106.57 173.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.4 t -157.23 144.99 18.98 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.262 0.553 . . . . 74.12 110.2 173.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -142.93 129.68 20.4 Favored 'General case' 0 C--O 1.225 -0.208 0 N-CA-C 107.054 -1.462 . . . . 74.11 107.054 170.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -135.73 112.56 10.2 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.24 -0.652 . . . . 73.25 109.24 -175.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.25 85.73 5.77 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 106.981 -1.488 . . . . 42.34 106.981 168.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.26 -19.96 37.81 Favored 'Trans proline' 0 C--N 1.383 2.38 0 C-N-CA 122.69 2.26 . . . . 64.22 111.874 -174.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -120.02 31.01 6.71 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.332 1.053 . . . . 74.43 109.022 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.56 -60.63 2.77 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 114.24 1.2 . . . . 73.25 114.24 -170.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.21 -32.71 41.84 Favored 'Trans proline' 0 C--N 1.379 2.152 0 CA-C-N 121.34 1.514 . . . . 75.15 111.926 -177.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.472 ' HA ' HE21 ' C' ' 33' ' ' GLN . 81.4 t60 -69.32 -38.34 78.18 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.662 -1.153 . . . . 73.13 111.986 -177.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.598 HG21 ' HA ' ' C' ' 73' ' ' ALA . 13.9 p -79.08 -29.55 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 112.075 0.398 . . . . 73.13 112.075 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -62.61 -30.01 71.03 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.013 0.525 . . . . 62.13 112.383 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . 0.472 HE21 ' HA ' ' C' ' 30' ' ' HIS . 29.3 pt20 -88.59 7.13 34.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.201 0.6 . . . . 72.34 111.949 178.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.42 ' HG2' HD11 ' C' ' 68' ' ' LEU . 2.8 ttpm? -114.71 143.2 45.43 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.659 0.783 . . . . 65.42 110.076 175.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.66 131.79 49.06 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.559 1.144 . . . . 72.11 111.985 -175.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.406 ' HZ2' HD22 ' C' ' 126' ' ' LEU . 75.3 t-105 -74.41 87.58 2.05 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.653 1.181 . . . . 73.32 111.683 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -132.91 73.05 76.27 Favored Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 124.253 1.021 . . . . 75.32 108.732 169.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -91.39 148.92 3.57 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.816 2.344 . . . . 73.42 112.598 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -88.25 81.12 7.38 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 107.268 -1.382 . . . . 72.11 107.268 164.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.54 113.3 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 CA-C-N 114.911 -1.041 . . . . 73.34 109.964 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -94.02 101.31 13.35 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.561 -0.903 . . . . 73.42 108.561 175.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' F' ' 138' ' ' TYR . 4.7 tt -87.81 129.82 35.07 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 106.97 -1.493 . . . . 74.55 106.97 176.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.523 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 14.2 t70 -128.93 140.56 51.61 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.08 0.952 . . . . 64.41 109.477 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.494 HD22 HG21 ' C' ' 62' ' ' VAL . 45.5 mt -125.95 111.12 14.4 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.616 -0.883 . . . . 73.4 108.616 172.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -122.46 121.32 36.33 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 107.74 -1.207 . . . . 73.31 107.74 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.3 t -121.32 144.18 48.78 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.324 -0.621 . . . . 65.23 109.324 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.99 151.56 42.62 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.907 0.883 . . . . 74.45 108.729 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 56.7 p -138.06 143.4 40.47 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 122.863 0.465 . . . . 71.25 110.304 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 78.9 p -145.41 153.52 41.29 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.545 0.738 . . . . 75.4 110.006 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -81.94 118.02 22.63 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 109.035 -0.728 . . . . 75.14 109.035 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.564 HD13 ' HB2' ' C' ' 57' ' ' GLU . 87.5 mt -82.89 -53.14 6.08 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.32 0.648 . . . . 55.42 109.288 174.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.15 -172.59 3.52 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 114.206 -1.361 . . . . 74.14 109.14 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.44 107.73 1.44 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.702 0.801 . . . . 74.03 110.068 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 70.69 12.62 7.27 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.367 1.467 . . . . 63.52 112.683 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 90.4 t -110.55 118.92 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.064 -0.717 . . . . 72.42 109.064 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -121.5 129.98 53.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.621 1.169 . . . . 72.54 109.343 -174.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.564 ' HB2' HD13 ' C' ' 51' ' ' LEU . 44.8 tt0 -96.77 115.09 26.84 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.208 -0.664 . . . . 74.31 109.208 170.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 89.1 t -96.76 116.01 37.76 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 N-CA-C 107.894 -1.151 . . . . 74.14 107.894 169.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.441 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 61.0 t -103.76 131.53 52.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.882 -0.785 . . . . 74.42 108.882 173.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.424 HD23 HD23 ' C' ' 44' ' ' LEU . 0.1 OUTLIER -104.47 98.51 8.27 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 107.709 -1.219 . . . . 74.24 107.709 172.727 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -82.44 106.78 14.59 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.525 -0.917 . . . . 75.41 108.525 172.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.494 HG21 HD22 ' C' ' 44' ' ' LEU . 12.8 t -104.61 125.19 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.906 -0.775 . . . . 64.1 108.906 177.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.523 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 89.9 m -110.23 130.7 55.5 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.94 -0.763 . . . . 54.32 108.94 178.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.66 HG23 HG21 ' C' ' 114' ' ' ILE . 97.4 t -124.37 109.05 21.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.506 -0.924 . . . . 52.34 108.506 174.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.8 m -101.56 141.89 33.75 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.824 -0.806 . . . . 72.41 108.824 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.21 117.96 18.92 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.266 -1.012 . . . . 73.51 108.266 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 37.3 m -140.03 125.99 19.64 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.201 0.313 . . . . 72.31 111.297 -177.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.42 HD11 ' HG2' ' C' ' 34' ' ' LYS . 21.2 mt -87.9 46.63 1.4 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.728 1.211 . . . . 70.34 110.138 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.94 -114.45 4.65 Favored Glycine 0 C--N 1.344 1.011 0 N-CA-C 110.519 -1.033 . . . . 64.55 110.519 -170.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.18 -12.53 37.88 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.25 0.62 . . . . 73.4 110.395 174.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -75.27 121.33 22.02 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 124.359 1.064 . . . . 72.12 109.678 174.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.1 m -82.58 115.9 21.75 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 108.685 -0.858 . . . . 71.01 108.685 165.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.598 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -69.96 -48.57 57.83 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.148 -1.056 . . . . 64.33 108.148 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -168.22 172.11 8.85 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 114.316 -1.311 . . . . 73.14 111.27 175.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.407 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.9 tm? -127.56 144.51 51.06 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 106.667 -1.605 . . . . 72.31 106.667 166.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.407 ' N ' HD13 ' C' ' 75' ' ' LEU . 54.1 t -145.86 145.86 30.9 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.71 -0.848 . . . . 73.05 108.71 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -158.81 140.28 13.31 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.762 -0.459 . . . . 75.45 109.762 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' C' ' 110' ' ' ALA . 27.0 t -135.81 114.39 15.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 124.65 1.18 . . . . 73.32 107.875 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.677 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.4 mt-30 -94.27 89.07 5.79 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.951 -0.759 . . . . 75.55 108.951 171.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -79.96 96.47 6.42 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.576 -1.193 . . . . 74.45 109.108 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -82.78 145.09 23.42 Favored Glycine 0 C--N 1.343 0.945 0 N-CA-C 111.425 -0.67 . . . . 70.53 111.425 177.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.05 117.68 1.09 Allowed Glycine 0 CA--C 1.507 -0.42 0 N-CA-C 111.028 -0.829 . . . . 73.44 111.028 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 15.5 mm -86.01 131.44 34.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.859 -0.793 . . . . 74.35 108.859 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.444 ' HE2' HG12 ' C' ' 13' ' ' ILE . 94.6 m-85 -137.8 120.54 16.31 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.667 0.787 . . . . 75.42 109.913 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 17.1 p -79.9 100.51 8.09 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 108.282 -1.007 . . . . 64.42 108.282 170.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.559 HG23 ' HE1' ' C' ' 94' ' ' MET . 15.6 mt -114.3 140.28 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 123.168 0.587 . . . . 73.3 109.698 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.96 158.27 36.28 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.512 1.125 . . . . 74.32 109.315 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.01 -18.54 57.25 Favored Glycine 0 C--O 1.246 0.903 0 N-CA-C 115.761 1.064 . . . . 62.02 115.761 166.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.466 HD12 ' HE1' ' C' ' 9' ' ' MET . 13.5 pt -106.98 170.53 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 117.315 0.558 . . . . 74.0 111.225 -179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -157.68 151.19 23.74 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.328 0.651 . . . . 74.02 110.65 -175.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.73 -121.99 10.02 Favored Glycine 0 C--N 1.348 1.213 0 O-C-N 123.929 0.768 . . . . 73.24 113.647 171.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.1 p -62.16 -30.56 71.14 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.836 0.855 . . . . 73.44 111.617 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -69.98 -49.94 46.65 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.315 1.046 . . . . 72.3 111.137 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.559 ' HE1' HG23 ' C' ' 86' ' ' ILE . 0.4 OUTLIER -60.04 -46.28 90.04 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 124.105 0.878 . . . . 74.22 110.429 176.749 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.39 90.92 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.477 0.711 . . . . 64.34 111.226 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -69.44 -35.88 76.11 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.221 0.609 . . . . 75.02 110.697 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.491 ' SG ' HD12 ' C' ' 86' ' ' ILE . 33.8 t -66.83 -51.28 57.51 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.871 0.732 . . . . 74.04 109.291 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 68.7 mt -74.85 -35.52 62.37 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.354 1.062 . . . . 75.34 113.063 -177.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.37 -14.05 33.97 Favored Glycine 0 N--CA 1.473 1.135 0 N-CA-C 115.032 0.773 . . . . 63.41 115.032 -165.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' C' ' 137' ' ' PHE . . . -138.01 -49.05 0.56 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 117.854 0.827 . . . . 60.41 111.944 -173.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -73.12 -49.95 25.51 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.951 0.901 . . . . 75.41 111.633 -172.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 84.5 m -67.25 -47.49 49.71 Favored Pre-proline 0 CA--C 1.564 1.516 0 C-N-CA 123.478 0.711 . . . . 74.14 112.233 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -58.19 -27.8 81.74 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 122.464 2.109 . . . . 74.4 113.552 175.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -65.68 -38.27 88.79 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.188 0.595 . . . . 61.2 110.543 176.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.506 HD13 ' NH1' ' A' ' 111' ' ' ARG . 30.1 mm -71.01 -36.94 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 116.029 -0.532 . . . . 75.02 109.732 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 6.1 mp -79.19 -25.5 42.75 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.431 1.092 . . . . 75.41 112.768 -176.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . 0.41 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 56.6 t80 -57.23 -50.71 86.62 Favored Pre-proline 0 N--CA 1.479 0.997 0 CA-C-O 117.849 -1.072 . . . . 73.44 113.394 -172.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 38.7 Cg_exo -60.71 -34.21 92.19 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.016 1.81 . . . . 72.52 113.158 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -64.7 -47.87 76.75 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.226 0.61 . . . . 71.12 110.633 177.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.433 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -66.73 -35.51 80.29 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.775 -0.648 . . . . 54.54 110.788 177.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -61.31 -53.13 60.64 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.246 1.418 . . . . 74.42 110.593 -178.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . 0.41 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.7 tm-20 -66.07 -34.31 77.78 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.403 -0.817 . . . . 74.21 110.28 -178.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.0 t -67.06 -39.17 86.82 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.06 0.544 . . . . 74.21 111.099 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.66 HG21 HG23 ' C' ' 64' ' ' VAL . 87.1 mt -69.17 -50.78 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.371 0.669 . . . . 74.15 110.579 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.2 m -64.14 -28.69 69.94 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 123.486 0.491 . . . . 70.44 110.476 -176.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.4 t -64.44 -51.82 61.21 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 123.57 0.748 . . . . 71.52 109.704 171.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.562 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -50.33 -47.92 55.63 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 124.361 1.064 . . . . 73.03 112.013 177.101 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 91.8 t -67.95 -38.83 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 124.228 1.011 . . . . 73.43 111.12 -177.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 77.6 p -72.7 -30.44 64.21 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.188 0.595 . . . . 73.53 111.44 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' C' ' 116' ' ' SER . 86.8 mtt-85 -67.82 -39.83 83.86 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.239 1.016 . . . . 72.12 110.252 175.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.84 7.23 59.66 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-N 115.295 -0.866 . . . . 62.51 112.659 174.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 29.9 p 62.59 26.87 15.93 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.567 1.947 . . . . 75.11 113.46 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -87.3 152.29 52.41 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 107.821 -1.177 . . . . 71.15 107.821 166.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.17 169.11 6.61 Favored 'Trans proline' 0 C--N 1.369 1.653 0 C-N-CA 122.783 2.322 . . . . 72.32 113.383 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' B' ' 123' ' ' PHE . 57.4 mm-40 -59.86 113.46 2.29 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.405 -1.27 . . . . 74.03 112.485 -177.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.406 HD22 ' HZ2' ' C' ' 36' ' ' TRP . 63.6 mt -107.33 87.92 2.61 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.965 -1.124 . . . . 65.25 107.965 168.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -89.94 112.65 24.1 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.925 -1.139 . . . . 75.44 107.925 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.449 HD12 HD13 ' C' ' 114' ' ' ILE . 40.2 mt -64.73 129.64 40.56 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 123.434 0.459 . . . . 72.4 110.686 -175.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.53 150.65 93.75 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.571 0.748 . . . . 64.52 110.468 178.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.565 ' HG3' HD13 ' A' ' 16' ' ' ILE . 26.8 Cg_exo -59.81 105.39 0.27 Allowed 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.34 2.027 . . . . 72.3 112.268 174.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 35.7 t -99.52 117.36 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 108.12 -1.067 . . . . 65.43 108.12 176.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -77.08 103.37 6.97 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.826 0.85 . . . . 74.33 110.515 -172.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -65.78 -24.98 67.05 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.63 -0.714 . . . . 75.34 111.654 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -67.1 -40.07 86.83 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.327 0.651 . . . . 74.43 109.973 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.8 -45.79 91.01 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.362 0.665 . . . . 64.34 110.509 174.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 81.2 mt -69.34 -23.46 63.77 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.043 -0.98 . . . . 74.25 111.388 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . 0.444 ' HB2' ' HB3' ' C' ' 100' ' ' ALA . 79.1 t80 -75.64 -58.03 3.53 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 116.313 -0.403 . . . . 74.13 110.104 176.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 52.5 mtm -61.29 -27.07 68.21 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.554 0.742 . . . . 65.23 111.256 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -49.94 -35.51 24.31 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.674 1.59 . . . . 72.1 113.074 174.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . 0.437 ' HE1' ' HG2' ' C' ' 142' ' ' GLN . 0.0 OUTLIER -70.38 -153.67 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.684 0 C-N-CA 122.587 0.355 . . . . 74.44 111.321 -177.286 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 59.8 tp -78.45 83.69 4.65 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.497 -0.752 . . . . 73.14 108.985 171.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . 0.437 ' HG2' ' HE1' ' C' ' 140' ' ' TYR . 0.5 OUTLIER -109.32 103.45 12.4 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 107.152 -1.425 . . . . 73.32 107.152 176.11 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . 0.545 ' HA ' HE21 ' C' ' 143' ' ' GLN . 0.0 OUTLIER -85.93 -46.96 10.07 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.453 -0.339 . . . . 73.22 110.781 -175.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -105.82 105.29 15.26 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.188 0.518 . . . . 73.01 112.049 -170.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -107.85 -157.23 0.61 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.324 1.05 . . . . 75.51 108.364 167.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 118.17 118.72 2.87 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-O 119.597 -0.557 . . . . 74.52 111.988 174.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.24 178.33 6.54 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.942 0.897 . . . . 73.22 112.404 -177.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 89.08 120.52 1.83 Allowed Glycine 0 C--N 1.352 1.466 0 N-CA-C 111.287 -0.725 . . . . 72.04 111.287 -175.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 14.6 t -152.56 162.31 41.39 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 117.501 0.65 . . . . 72.33 111.317 -174.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -70.98 139.07 50.45 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.745 0.818 . . . . 74.13 110.445 174.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.34 156.02 25.69 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.4 -0.963 . . . . 74.32 108.4 175.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -69.85 134.34 48.38 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 109.658 -0.497 . . . . 74.24 109.658 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -81.52 -57.21 3.57 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.483 0.313 . . . . 75.04 111.018 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -156.69 163.19 39.57 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.479 0.712 . . . . 63.24 109.159 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.403 0 C-N-CA 123.487 0.715 . . . . 74.4 109.29 176.246 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 80.4 mtp . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 109.707 -0.479 . . . . 74.23 109.707 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -127.01 117.45 22.5 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.504 0.722 . . . . 73.14 109.284 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.19 103.88 5.53 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.82 -0.807 . . . . 75.25 108.82 174.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -69.83 113.5 7.13 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.103 0.561 . . . . 74.22 109.74 -173.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . 0.451 ' HB3' ' HG2' ' E' ' 95' ' ' LYS . 34.4 t30 -134.69 132.49 38.94 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.448 0.699 . . . . 74.11 109.417 176.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.96 130.94 34.55 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.592 0.757 . . . . 72.45 109.555 178.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 9.3 t -150.58 179.64 8.0 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 124.071 0.948 . . . . 74.1 108.535 176.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -54.66 103.57 0.09 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.356 0.662 . . . . 75.14 110.812 175.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -32.52 122.51 0.34 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 125.289 1.436 . . . . 75.51 111.751 175.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 24.3 m -114.57 129.1 56.63 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.168 -0.679 . . . . 74.22 109.168 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.497 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 50.6 t80 -133.98 98.61 4.2 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.457 -1.312 . . . . 72.4 107.457 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -132.51 127.97 36.33 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.257 -0.646 . . . . 72.14 109.257 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 6.1 mt -83.88 127.22 39.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 108.572 -0.899 . . . . 72.31 108.572 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.516 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 75.1 mm-40 -81.96 -35.21 29.25 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.478 0.711 . . . . 73.32 110.302 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -171.25 133.8 0.87 Allowed 'General case' 0 C--N 1.357 0.914 0 O-C-N 123.737 0.648 . . . . 74.31 110.7 -175.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.459 ' N ' HD13 ' D' ' 16' ' ' ILE . 3.4 mp -105.57 141.85 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 107.144 -1.428 . . . . 72.34 107.144 171.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -166.72 152.92 8.45 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.438 0.637 . . . . 74.11 111.7 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 71.3 p -89.14 117.29 28.03 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 114.882 -1.054 . . . . 73.32 109.702 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -86.56 -29.74 22.42 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.652 -0.704 . . . . 63.54 109.371 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.594 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.6 t70 -150.87 142.15 23.28 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.815 -1.084 . . . . 65.31 109.589 176.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.562 HG23 ' HE1' ' C' ' 117' ' ' MET . 76.7 mt -140.73 141.07 32.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 C-N-CA 125.367 1.467 . . . . 72.02 107.402 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.7 t -147.21 144.29 28.81 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.681 0.793 . . . . 73.24 109.54 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.492 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.6 t80 -147.51 134.42 20.2 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 107.301 -1.37 . . . . 75.43 107.301 168.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.636 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 43.6 mt-10 -133.33 148.69 51.89 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.13 0.972 . . . . 74.1 108.954 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.73 80.07 6.92 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 107.44 -1.319 . . . . 55.23 107.44 171.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -67.46 -52.38 0.59 Allowed 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.545 2.163 . . . . 72.52 112.385 -174.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -87.61 19.63 3.31 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.457 0.703 . . . . 73.11 111.05 -176.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.463 ' HB2' ' HD2' ' C' ' 19' ' ' LYS . . . -48.26 -61.09 3.45 Favored Pre-proline 0 CA--C 1.556 1.201 0 N-CA-C 114.826 1.417 . . . . 73.22 114.826 -164.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.52 ' HB3' HD11 ' C' ' 83' ' ' ILE . 60.2 Cg_endo -68.13 -20.5 43.7 Favored 'Trans proline' 0 C--N 1.388 2.617 0 CA-C-N 121.704 1.644 . . . . 73.42 113.288 -173.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.402 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 6.1 t-160 -81.83 -40.72 22.09 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.987 -1.006 . . . . 75.03 110.795 177.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -83.12 -16.06 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 O-C-N 122.246 -0.284 . . . . 73.43 111.424 -169.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -62.58 -16.85 58.45 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 112.529 0.566 . . . . 75.45 112.529 170.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . 0.402 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 56.8 mt-30 -69.12 -7.68 38.36 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.717 0.807 . . . . 73.14 111.424 174.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.587 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 91.4 mttt -106.27 100.57 10.1 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.797 1.239 . . . . 72.23 109.638 -178.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -97.86 92.77 5.99 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.775 0.83 . . . . 72.03 110.327 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -167.09 -178.34 4.12 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.033 0.933 . . . . 74.31 109.918 171.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -69.64 113.14 14.99 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.132 0.973 . . . . 74.03 109.841 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -58.84 125.89 19.56 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.46 2.106 . . . . 64.12 111.239 176.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -76.75 114.09 15.12 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.085 -1.08 . . . . 72.32 108.085 173.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.569 HG12 HD21 ' D' ' 126' ' ' LEU . 9.0 t -112.69 129.79 67.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.886 -0.597 . . . . 75.31 110.341 -171.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.59 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 72.0 mmtt -88.6 108.51 19.48 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.979 -1.119 . . . . 74.3 107.979 168.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 42.5 tp -98.52 121.08 40.02 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.785 -0.82 . . . . 74.34 108.785 173.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.497 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 8.8 t0 -120.38 143.99 48.14 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.009 -1.478 . . . . 70.21 107.009 177.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 58.1 mt -133.84 129.67 36.8 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.495 0.718 . . . . 74.52 109.577 -175.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.422 ' HB2' ' HB3' ' D' ' 61' ' ' ARG . 54.0 m-20 -134.56 145.67 48.93 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.708 -1.219 . . . . 72.22 107.708 173.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 7.1 t -105.03 161.15 14.46 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.788 -0.819 . . . . 72.21 108.788 169.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.625 ' HB1' ' HB ' ' D' ' 59' ' ' VAL . . . -149.83 152.68 35.53 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.945 0.898 . . . . 74.32 108.649 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' E' ' 105' ' ' GLN . 5.2 p -161.31 177.82 9.8 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.35 0.66 . . . . 65.44 110.037 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 49.3 p -164.06 160.21 21.4 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 111.963 0.357 . . . . 63.45 111.963 -176.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . 0.655 ' HG2' HD21 ' D' ' 51' ' ' LEU . 40.8 tt0 69.84 152.07 0.1 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 126.181 1.792 . . . . 74.34 111.483 -176.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.655 HD21 ' HG2' ' D' ' 50' ' ' GLN . 2.6 pt? -59.45 -34.44 72.53 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.749 -0.463 . . . . 75.04 109.749 174.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . 68.36 93.79 0.07 Allowed 'General case' 0 C--N 1.361 1.103 0 C-N-CA 125.38 1.472 . . . . 74.23 113.302 164.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.38 78.24 9.78 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 124.274 1.03 . . . . 74.35 108.712 174.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.4 ' HA ' ' HE1' ' D' ' 56' ' ' TYR . 61.8 m-20 66.67 7.2 4.99 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 125.035 1.334 . . . . 64.25 113.36 -177.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 15.7 t -124.26 98.65 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 107.89 -1.152 . . . . 74.25 107.89 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.548 ' HH ' HD12 ' E' ' 100' ' ' LEU . 30.2 m-85 -115.63 135.01 54.48 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.075 0.55 . . . . 74.4 109.742 -174.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.442 ' HG2' HD12 ' D' ' 83' ' ' ILE . 39.4 mt-10 -90.62 114.06 26.24 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.068 -1.086 . . . . 73.24 108.068 162.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 88.7 t -103.19 140.08 22.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.849 -1.167 . . . . 74.32 107.849 168.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.625 ' HB ' ' HB1' ' D' ' 47' ' ' ALA . 41.7 t -133.56 146.97 31.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 107.625 -1.25 . . . . 73.13 107.625 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.63 115.91 20.19 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.63 -1.248 . . . . 64.12 107.63 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.422 ' HB3' ' HB2' ' D' ' 45' ' ' ASP . 24.8 ttm-85 -93.07 98.56 11.41 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.046 -1.094 . . . . 74.22 108.046 175.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.457 HG22 ' HB1' ' D' ' 110' ' ' ALA . 49.4 t -99.12 112.72 32.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.785 -0.82 . . . . 75.51 108.785 176.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 63.9 m -105.72 134.21 49.2 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.75 -1.114 . . . . 74.54 109.206 -175.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.464 HG22 HD12 ' D' ' 114' ' ' ILE . 71.5 t -131.63 119.75 43.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 124.287 1.035 . . . . 74.14 108.556 -177.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.59 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 24.1 m -126.49 90.76 3.23 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.757 -1.201 . . . . 75.0 107.757 177.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -97.37 146.43 25.18 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.831 -0.622 . . . . 73.41 110.136 -174.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.473 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 31.4 p -147.31 139.93 24.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 123.871 0.732 . . . . 75.14 110.97 -173.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 24.0 mt -112.08 112.89 24.84 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 107.755 -1.202 . . . . 75.22 107.755 171.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.73 -114.29 3.8 Favored Glycine 0 C--N 1.347 1.14 0 N-CA-C 113.692 0.237 . . . . 62.43 113.692 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.06 12.53 11.95 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.345 0.658 . . . . 64.53 110.487 -178.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.587 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 10.9 pt-20 -130.52 162.37 29.41 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.024 0.53 . . . . 73.14 109.63 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -71.89 130.41 40.95 Favored 'General case' 0 C--O 1.243 0.721 0 O-C-N 123.809 0.693 . . . . 70.33 110.71 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.473 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -81.68 -65.24 1.04 Allowed 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.648 -1.241 . . . . 65.25 107.648 172.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -151.61 150.22 30.04 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.132 -0.94 . . . . 73.53 111.125 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.636 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 63.4 mt -108.55 153.94 22.65 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.516 1.126 . . . . 75.12 108.765 171.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.491 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.2 t -160.33 142.53 12.94 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.086 0.555 . . . . 63.22 109.796 174.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -154.9 126.15 7.27 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.943 -0.392 . . . . 75.44 109.943 171.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.0 t -125.76 117.03 48.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 123.771 0.828 . . . . 73.35 109.187 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.594 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.6 mt-30 -90.23 86.94 6.65 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.816 -0.809 . . . . 75.52 108.816 172.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.14 110.5 15.61 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.181 -1.372 . . . . 73.05 109.342 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.39 173.03 17.5 Favored Glycine 0 C--N 1.338 0.659 0 O-C-N 123.067 0.23 . . . . 45.24 113.468 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.74 152.83 14.6 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 115.735 -0.233 . . . . 73.44 112.937 177.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 19.3 mm -90.19 115.72 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 107.997 -1.112 . . . . 75.52 107.997 173.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -112.65 135.08 53.8 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.759 0.823 . . . . 74.22 110.326 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 39.3 t -102.11 106.96 17.91 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.817 -0.808 . . . . 74.54 108.817 172.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 42.9 pt -121.34 132.84 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.104 -0.702 . . . . 75.05 109.104 173.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.87 165.61 22.66 Favored 'General case' 0 C--O 1.243 0.744 0 O-C-N 123.448 0.468 . . . . 73.23 111.796 -173.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.27 -4.63 83.19 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.15 -0.932 . . . . 64.02 114.015 177.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -104.57 163.34 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 121.365 0.602 . . . . 74.12 110.665 -177.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.445 ' HG2' ' H ' ' D' ' 91' ' ' GLY . 29.6 tt0 -148.05 174.34 12.02 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 114.453 -1.249 . . . . 74.33 108.639 -173.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . 0.445 ' H ' ' HG2' ' D' ' 90' ' ' GLU . . . 77.6 -140.9 24.91 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 123.218 0.437 . . . . 74.03 112.628 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 60.8 p -90.48 -29.64 17.8 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.212 0.605 . . . . 74.01 110.838 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.486 ' HA ' ' HB3' ' D' ' 96' ' ' HIS . 20.7 pt20 -64.63 -23.66 67.33 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.744 0.818 . . . . 74.24 112.401 -173.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.587 ' SD ' HD23 ' E' ' 100' ' ' LEU . 0.0 OUTLIER -64.78 -43.37 93.47 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.101 0.56 . . . . 74.2 111.327 178.054 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . 0.482 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.15 -17.33 37.55 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.477 0.711 . . . . 75.13 111.406 177.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . 0.486 ' HB3' ' HA ' ' D' ' 93' ' ' GLN . 78.1 t60 -73.89 -37.58 64.64 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.67 0.788 . . . . 74.53 110.608 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 71.1 m -60.71 -34.91 75.09 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.947 0.499 . . . . 64.3 110.74 174.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.407 HD21 ' HA ' ' D' ' 98' ' ' LEU . 1.1 tm? -75.42 -43.45 49.82 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.264 1.026 . . . . 74.14 110.508 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.4 -26.68 60.93 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 115.565 -0.743 . . . . 74.3 114.06 -173.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.534 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -122.37 -59.02 1.67 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.026 0.53 . . . . 71.42 112.028 -169.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -71.04 -37.81 72.55 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 112.13 0.418 . . . . 74.22 112.13 -170.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.497 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 73.9 m -66.58 -47.76 56.28 Favored Pre-proline 0 CA--C 1.568 1.657 0 CA-C-O 118.723 -0.656 . . . . 71.13 111.943 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 51.8 Cg_exo -58.9 -33.3 98.57 Favored 'Trans proline' 0 C--N 1.394 2.948 0 C-N-CA 122.052 1.834 . . . . 75.3 113.372 170.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -64.22 -35.13 79.79 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.802 0.441 . . . . 75.42 110.849 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 24.1 mm -63.91 -39.52 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.08 0.952 . . . . 72.14 110.71 173.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 85.7 mt -78.13 -14.59 59.41 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.474 -0.784 . . . . 74.34 112.222 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -72.16 -40.68 7.76 Favored Pre-proline 0 N--CA 1.486 1.334 0 N-CA-C 113.497 0.925 . . . . 71.55 113.497 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -47.68 -49.06 14.22 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.351 2.034 . . . . 65.45 113.298 166.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -71.6 -35.15 70.41 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.43 0.692 . . . . 74.42 111.535 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . 0.457 ' HB1' HG22 ' D' ' 62' ' ' VAL . . . -64.81 -57.46 8.83 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.713 0.805 . . . . 73.44 110.185 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.415 ' NH2' HG22 ' B' ' 105' ' ' ILE . 39.5 ttp180 -56.72 -42.2 78.77 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 114.332 -1.304 . . . . 71.44 110.761 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -56.78 -54.62 44.26 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.891 0.744 . . . . 74.25 110.727 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.4 t -54.87 -45.32 74.58 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.291 0.995 . . . . 74.5 110.867 -177.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.491 HG12 ' SG ' ' D' ' 76' ' ' CYS . 85.1 mt -61.16 -58.54 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.67 0.788 . . . . 73.05 110.923 176.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.7 m -51.87 -43.87 63.46 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.932 1.293 . . . . 75.03 111.598 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 33.3 t -63.79 -44.72 92.53 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 114.505 -1.225 . . . . 73.35 109.826 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 68.1 mtm -69.82 -30.88 68.5 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.034 0.534 . . . . 71.11 111.613 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 80.3 t -64.4 -45.96 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.582 0.753 . . . . 75.44 109.573 175.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 95.2 p -74.4 -28.32 61.04 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.451 -0.795 . . . . 75.13 110.722 -178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' D' ' 116' ' ' SER . 69.4 mtt-85 -70.26 -27.12 64.19 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.53 0.732 . . . . 73.01 109.932 173.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.75 10.5 67.44 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 123.804 0.69 . . . . 72.33 112.887 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.442 HG22 ' HB3' ' C' ' 17' ' ' TYR . 68.8 p 53.79 29.41 9.63 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 126.113 1.765 . . . . 73.2 113.561 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -92.47 158.49 38.53 Favored Pre-proline 0 C--O 1.242 0.688 0 CA-C-N 115.449 -0.796 . . . . 71.14 109.737 171.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -48.16 119.96 4.48 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.768 2.312 . . . . 74.41 112.113 169.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -46.54 124.51 5.99 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 124.72 1.262 . . . . 74.32 111.757 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.569 HD21 HG12 ' D' ' 40' ' ' VAL . 33.7 tp -107.5 98.69 8.27 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.962 0.41 . . . . 74.12 111.042 -173.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . 0.431 ' HB2' ' HB2' ' E' ' 126' ' ' ALA . 83.4 m-20 -97.98 96.85 8.44 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 107.11 -1.441 . . . . 75.43 107.11 173.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.05 132.56 54.33 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.519 -0.764 . . . . 75.13 109.481 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.16 136.72 96.82 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 122.714 0.405 . . . . 71.31 110.45 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.538 ' HD3' HG13 ' B' ' 13' ' ' ILE . 93.8 Cg_endo -79.55 145.79 18.72 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.577 2.184 . . . . 75.14 111.864 -174.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 9.0 p -141.24 141.1 31.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 109.003 -0.74 . . . . 73.43 109.003 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -78.95 108.61 12.55 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.676 -0.861 . . . . 74.34 108.676 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.401 ' HA ' HD23 ' D' ' 136' ' ' LEU . 1.7 m-85 -62.69 -28.3 69.84 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.391 0.676 . . . . 72.42 110.346 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.534 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 5.6 t70 -60.53 -38.01 83.04 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.715 -1.129 . . . . 73.42 110.403 175.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.427 ' HA ' ' HE2' ' D' ' 138' ' ' MET . . . -64.92 -32.46 74.19 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.807 0.843 . . . . 73.44 111.911 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' D' ' 133' ' ' PHE . 2.7 mm? -74.62 -46.97 34.91 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.75 0.42 . . . . 73.15 111.347 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.526 ' HE1' ' HB2' ' E' ' 108' ' ' HIS . 69.1 m-85 -70.0 -27.94 65.1 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 116.721 -0.218 . . . . 74.42 111.555 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.427 ' HE2' ' HA ' ' D' ' 135' ' ' ALA . 69.6 mtm -72.04 -37.2 69.75 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.456 0.303 . . . . 75.32 110.58 167.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.48 ' O ' ' HG3' ' D' ' 143' ' ' GLN . 0.1 OUTLIER -54.81 -40.52 69.6 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.075 0.95 . . . . 73.22 110.337 -178.447 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -57.3 -34.42 68.69 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.096 0.872 . . . . 75.21 111.849 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.2 mp -80.96 -29.48 35.35 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.892 0.877 . . . . 73.15 110.685 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -83.7 33.14 0.47 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.234 1.014 . . . . 72.24 111.778 -177.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' D' ' 139' ' ' ASN . 23.7 mt-30 -119.16 55.78 0.93 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 122.061 0.934 . . . . 74.15 109.141 -173.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -168.64 -60.02 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.028 -1.442 . . . . 74.3 108.573 -177.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.58 158.6 35.89 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.938 -1.028 . . . . 73.44 109.817 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.88 -27.92 0.02 OUTLIER Glycine 0 C--N 1.345 1.063 0 O-C-N 123.34 0.4 . . . . 73.35 112.572 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.35 89.79 0.08 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.535 1.534 . . . . 75.2 110.91 176.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -81.46 83.11 1.52 Allowed Glycine 0 C--N 1.346 1.097 0 CA-C-N 116.337 -0.392 . . . . 63.5 113.901 -174.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 7.6 t -119.04 120.95 38.73 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.896 -0.779 . . . . 75.44 108.896 172.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -117.59 147.42 42.86 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.838 0.455 . . . . 72.21 111.051 -176.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -132.8 79.04 1.83 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 106.999 -1.482 . . . . 74.21 106.999 170.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -152.07 -172.43 4.22 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.67 0.788 . . . . 75.23 109.746 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -66.72 91.45 0.19 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.885 -0.413 . . . . 75.24 109.885 174.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -65.48 129.12 38.6 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.994 0.918 . . . . 71.12 110.327 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.217 0 C-N-CA 123.255 0.622 . . . . 72.4 109.98 -179.635 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.927 0 CA-C-O 119.922 -0.376 . . . . 75.52 112.597 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.67 44.44 89.6 Favored Glycine 0 C--N 1.357 1.698 0 CA-C-N 116.627 0.214 . . . . 74.41 112.888 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 56.66 -159.15 0.24 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.382 1.073 . . . . 74.52 110.442 -172.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -110.03 -161.55 0.76 Allowed 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.18 -0.95 . . . . 72.21 110.399 -172.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 95' ' ' LYS . . . . . 0.451 ' HG2' ' HB3' ' D' ' 5' ' ' ASN . 0.9 OUTLIER -71.25 109.55 5.35 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.828 -0.804 . . . . 75.4 108.828 171.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . -51.51 139.03 27.55 Favored Glycine 0 C--N 1.356 1.692 0 O-C-N 125.361 1.663 . . . . 72.14 113.499 -177.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 97' ' ' ILE . . . . . 0.436 HD11 ' HB2' ' D' ' 94' ' ' MET . 29.9 mt -51.2 -40.98 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.469 0.708 . . . . 74.31 111.57 -177.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 35.9 t70 76.0 -50.45 0.61 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.559 1.543 . . . . 54.53 113.268 169.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.34 -52.34 63.83 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.895 1.278 . . . . 74.35 112.512 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 100' ' ' LEU . . . . . 0.587 HD23 ' SD ' ' D' ' 94' ' ' MET . 3.6 pp -74.27 139.85 75.85 Favored Pre-proline 0 CA--C 1.549 0.916 0 O-C-N 123.099 0.25 . . . . 74.12 110.562 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 101' ' ' PRO . . . . . 0.498 ' HD2' HG22 ' E' ' 103' ' ' THR . 40.6 Cg_endo -94.9 24.27 0.37 Allowed 'Trans proline' 0 C--N 1.366 1.448 0 C-N-CA 123.127 2.551 . . . . 72.32 110.343 155.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 102' ' ' LEU . . . . . . . . . . . . . 1.4 tt 58.26 84.07 0.11 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.049 1.74 . . . . 74.43 109.689 -166.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 103' ' ' THR . . . . . 0.498 HG22 ' HD2' ' E' ' 101' ' ' PRO . 23.4 p -74.18 125.73 29.02 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.396 1.078 . . . . 65.42 111.663 -176.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.27 78.83 0.13 Allowed Glycine 0 C--N 1.355 1.594 0 O-C-N 123.974 0.796 . . . . 61.44 112.758 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 105' ' ' GLN . . . . . 0.411 ' HB3' ' O ' ' D' ' 48' ' ' SER . 22.6 mp0 -67.1 -60.84 2.28 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.933 0.493 . . . . 74.14 110.792 -172.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 106' ' ' TYR . . . . . 0.454 ' HA ' ' HA ' ' D' ' 47' ' ' ALA . 58.1 t80 -83.07 94.43 7.8 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.613 -0.884 . . . . 73.55 108.613 174.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 46.5 m 63.78 105.5 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.699 1.2 . . . . 63.42 110.963 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 108' ' ' HIS . . . . . 0.526 ' HB2' ' HE1' ' D' ' 137' ' ' PHE . 18.3 m-70 -66.09 -39.27 89.87 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 115.324 -0.853 . . . . 73.43 111.031 -170.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -138.97 -76.28 0.36 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.813 0.845 . . . . 64.12 109.001 173.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . 0.55 ' HB1' ' HE2' ' E' ' 114' ' ' LYS . . . -163.38 151.39 13.39 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.451 1.1 . . . . 73.24 108.578 176.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . 0.505 HD12 ' HE2' ' D' ' 137' ' ' PHE . 55.5 tp -131.0 -75.53 0.53 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.964 0.505 . . . . 73.43 110.363 -172.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -57.36 -50.57 72.52 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.378 0.671 . . . . 72.32 112.127 -168.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -113.61 84.23 1.98 Allowed 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.255 -0.646 . . . . 74.33 109.255 176.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . 0.55 ' HE2' ' HB1' ' E' ' 110' ' ' ALA . 0.0 OUTLIER -84.81 122.76 29.6 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.662 -0.699 . . . . 72.12 109.19 168.554 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' E' E ' 115' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' B' ' 154' ' ' ASP . 23.3 p -73.88 80.49 1.64 Allowed 'General case' 0 CA--C 1.543 0.706 0 O-C-N 124.114 0.884 . . . . 74.42 109.877 174.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 116' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' B' ' 152' ' ' HIS . . . -122.6 83.77 0.36 Allowed Glycine 0 C--N 1.341 0.848 0 CA-C-N 114.553 -1.203 . . . . 65.22 110.225 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 117' ' ' LYS . . . . . 0.59 ' HB3' ' HD2' ' E' ' 118' ' ' PRO . 46.6 mtmt 67.97 177.82 0.05 OUTLIER Pre-proline 0 CA--C 1.563 1.454 0 C-N-CA 124.766 1.227 . . . . 74.44 108.958 -159.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 118' ' ' PRO . . . . . 0.59 ' HD2' ' HB3' ' E' ' 117' ' ' LYS . 16.2 Cg_exo -27.4 -52.64 0.11 Allowed 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 123.891 3.061 . . . . 73.21 116.113 172.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -160.37 169.91 22.13 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 120.86 0.362 . . . . 75.24 110.937 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 120' ' ' TYR . . . . . 0.462 ' HE1' ' HB ' ' B' ' 7' ' ' THR . 55.8 t80 -150.36 -29.26 0.22 Allowed 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.355 1.062 . . . . 74.34 110.174 174.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 121' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.36 82.79 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 123.114 0.566 . . . . 63.11 110.278 -178.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 122' ' ' THR . . . . . 0.428 HG21 ' H3 ' ' B' ' 1' ' ' MET . 44.8 m -159.52 126.19 4.52 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.682 1.193 . . . . 73.13 108.732 166.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -172.2 165.79 6.02 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.123 0.889 . . . . 74.42 109.315 170.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 23.2 m -68.69 132.97 47.75 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.53 0.732 . . . . 70.42 110.649 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -84.11 157.68 21.65 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.587 0.755 . . . . 75.34 110.991 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 126' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' D' ' 127' ' ' ASN . . . -81.33 120.34 24.81 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.642 -0.708 . . . . 73.34 112.493 -170.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 39.5 m -138.29 -69.07 0.44 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.89 -0.781 . . . . 73.41 108.89 167.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . 56.26 21.81 5.65 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.193 0.997 . . . . 61.02 112.749 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 12.9 t -127.92 165.55 19.99 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.109 0.564 . . . . 73.45 111.153 -172.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -136.83 169.82 17.12 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.034 0.934 . . . . 72.41 110.406 -176.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 131' ' ' TRP . . . . . 0.674 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 29.6 t90 -114.32 103.2 10.83 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.723 -0.843 . . . . 74.44 108.723 173.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 55.0 m -151.77 66.84 0.87 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.621 0.768 . . . . 72.01 110.384 177.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 91.4 m -139.92 133.15 29.78 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.061 0.545 . . . . 73.22 109.712 173.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -162.99 148.93 16.11 Favored Glycine 0 C--N 1.342 0.882 0 N-CA-C 111.276 -0.73 . . . . 65.33 111.276 175.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 135' ' ' VAL . . . . . 0.551 HG22 HE22 ' C' ' 12' ' ' GLN . 29.2 m -87.8 -174.71 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.547 0.739 . . . . 74.13 110.546 176.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -97.92 156.61 16.53 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.201 0.6 . . . . 73.5 110.215 171.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 7.2 t -70.14 131.21 43.92 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.24 0.543 . . . . 71.44 111.872 -177.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -110.12 112.38 24.32 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.529 -1.286 . . . . 72.42 107.529 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -151.34 -55.34 0.14 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.206 0.602 . . . . 73.11 109.915 175.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . 63.03 28.6 72.35 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 120.88 0.156 . . . . 74.12 112.902 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -91.36 152.86 20.26 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.682 0.793 . . . . 60.35 110.359 -176.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 47.9 tp -91.93 -5.2 53.59 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.732 0.813 . . . . 74.33 110.027 174.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.08 164.26 35.62 Favored Glycine 0 C--N 1.351 1.386 0 N-CA-C 111.818 -0.513 . . . . 64.44 111.818 -173.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 42.1 t -117.94 -65.11 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 109.741 -0.466 . . . . 74.24 109.741 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 31.3 t70 . . . . . 0 C--O 1.249 1.054 0 C-N-CA 123.753 0.821 . . . . 64.11 109.01 -176.413 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.869 0 N-CA-C 112.192 -0.363 . . . . 71.24 112.192 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' F' F ' 92' ' ' GLY . . . . . 0.433 ' HA3' ' OE1' ' B' ' 14' ' ' GLN . . . 160.1 172.27 27.1 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-O 119.588 -0.562 . . . . 71.31 112.444 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 57.22 83.83 0.1 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.367 1.067 . . . . 74.44 110.869 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -120.82 -172.52 2.4 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.609 -0.723 . . . . 70.32 110.357 -173.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -141.96 89.78 2.21 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.82 -1.178 . . . . 75.34 107.82 172.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -157.53 11.1 0.25 Allowed Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.488 -0.778 . . . . 62.14 114.231 -174.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 97' ' ' ILE . . . . . 0.592 ' HB ' ' HA ' ' B' ' 87' ' ' ALA . 15.5 tt -124.46 157.2 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 109.282 -0.636 . . . . 75.0 109.282 174.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -75.96 -91.15 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 123.825 0.85 . . . . 75.42 111.356 -175.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -153.28 124.98 7.74 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 107.923 -1.14 . . . . 75.32 107.923 -176.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 100' ' ' LEU . . . . . 0.432 ' HB2' ' CE1' ' B' ' 56' ' ' TYR . 2.9 mp -98.86 106.09 35.33 Favored Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 123.43 0.692 . . . . 75.33 111.421 -164.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -89.88 152.27 4.96 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.74 2.293 . . . . 62.2 113.455 178.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 102' ' ' LEU . . . . . 0.466 HD12 ' OG ' ' B' ' 48' ' ' SER . 4.3 mm? -101.93 22.66 12.65 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.048 0.939 . . . . 72.24 109.777 167.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 72.9 p 51.16 29.87 5.16 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.788 1.635 . . . . 74.44 112.61 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 141.21 -87.46 0.19 Allowed Glycine 0 C--N 1.345 1.041 0 N-CA-C 110.139 -1.184 . . . . 74.42 110.139 -175.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -152.24 -62.72 0.17 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.103 -1.073 . . . . 71.54 108.103 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -126.22 78.35 1.76 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.134 -1.062 . . . . 74.31 108.134 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 29.2 m 58.72 113.48 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 124.722 1.209 . . . . 73.32 113.525 169.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -66.91 -26.52 66.9 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.939 0.496 . . . . 73.11 110.87 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -95.38 -109.78 0.14 Allowed 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 123.534 0.734 . . . . 74.15 109.82 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -178.48 154.93 0.83 Allowed 'General case' 0 C--N 1.362 1.113 0 C-N-CA 125.117 1.367 . . . . 71.34 108.925 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 53.8 tp -124.21 -46.75 1.92 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.131 0.572 . . . . 74.15 109.544 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -74.28 98.6 3.25 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.142 0.577 . . . . 75.45 110.58 174.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -133.21 165.32 25.06 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.892 0.877 . . . . 74.43 109.559 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . 0.515 ' HG3' ' H ' ' F' ' 116' ' ' GLY . 18.9 ptpt -144.07 -28.84 0.5 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.979 0.511 . . . . 75.13 111.943 -174.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 2.0 m 63.56 18.73 11.28 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.251 1.02 . . . . 75.23 111.342 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 116' ' ' GLY . . . . . 0.515 ' H ' ' HG3' ' F' ' 114' ' ' LYS . . . 72.3 -76.64 0.76 Allowed Glycine 0 C--N 1.353 1.481 0 N-CA-C 110.624 -0.991 . . . . 54.42 110.624 -168.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -86.7 110.74 34.7 Favored Pre-proline 0 CA--C 1.546 0.817 0 N-CA-C 107.592 -1.262 . . . . 74.12 107.592 169.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 118' ' ' PRO . . . . . 0.424 ' HB2' ' HA ' ' F' ' 122' ' ' THR . 30.7 Cg_exo -62.24 107.37 0.56 Allowed 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 123.056 2.504 . . . . 72.34 112.943 -176.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -71.69 -66.96 0.57 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.256 -0.884 . . . . 61.22 108.68 170.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -97.13 161.95 13.59 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.141 -1.059 . . . . 72.44 108.141 165.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 13.3 t 61.08 34.86 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 122.701 1.239 . . . . 73.34 108.874 -171.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 122' ' ' THR . . . . . 0.424 ' HA ' ' HB2' ' F' ' 118' ' ' PRO . 11.1 t -83.37 173.84 11.2 Favored 'General case' 0 C--O 1.245 0.858 0 CA-C-N 114.79 -1.095 . . . . 71.15 110.825 -178.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.64 129.36 40.19 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.421 0.688 . . . . 64.21 110.221 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 18.8 p -155.27 124.04 6.1 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 124.114 0.966 . . . . 74.53 109.272 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . 64.46 -104.05 0.11 Allowed 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.364 1.066 . . . . 65.03 110.593 -177.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . 53.99 20.2 2.34 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.744 1.218 . . . . 73.42 114.213 176.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 21.0 m -110.77 114.42 27.76 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.245 0.618 . . . . 74.04 110.139 -176.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -164.79 140.63 5.7 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.243 0.617 . . . . 64.1 110.632 177.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 13.4 t -91.7 -164.94 1.25 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.889 0.876 . . . . 75.11 109.199 175.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -126.21 136.12 52.44 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.337 0.655 . . . . 71.24 110.327 176.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 21.3 m95 57.91 -102.73 0.16 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.09 1.356 . . . . 75.24 112.582 175.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 15.4 m 57.44 31.7 20.64 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.043 0.937 . . . . 71.24 110.517 -167.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 133' ' ' THR . . . . . 0.425 HG22 ' HB ' ' F' ' 135' ' ' VAL . 29.7 m -82.55 120.11 25.1 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 114.739 -1.119 . . . . 74.5 110.406 -174.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.29 -49.6 72.88 Favored Glycine 0 C--N 1.355 1.606 0 O-C-N 123.747 0.655 . . . . 73.13 112.487 177.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 135' ' ' VAL . . . . . 0.531 HG21 ' HH ' ' F' ' 138' ' ' TYR . 6.3 p 45.01 32.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 C-N-CA 126.424 1.89 . . . . 72.43 113.162 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -75.56 -68.21 0.59 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.363 -0.835 . . . . 63.31 111.544 -171.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 16.8 p -104.46 134.77 47.09 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.464 0.705 . . . . 73.31 110.7 -174.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 138' ' ' TYR . . . . . 0.531 ' HH ' HG21 ' F' ' 135' ' ' VAL . 59.7 m-85 -108.55 86.81 2.36 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.954 0.902 . . . . 73.34 109.029 -176.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -165.16 129.28 2.39 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.729 0.812 . . . . 72.42 109.295 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -120.61 50.37 0.83 Allowed Glycine 0 C--N 1.342 0.877 0 N-CA-C 111.065 -0.814 . . . . 60.23 111.065 176.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.06 151.31 44.68 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.987 0.515 . . . . 54.24 111.754 -177.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 2.3 pp -149.44 171.94 15.76 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.528 0.731 . . . . 73.31 110.768 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -171.06 66.42 0.15 Allowed Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.408 -0.814 . . . . 54.41 111.163 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 90.8 t -58.44 126.16 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 123.988 0.915 . . . . 73.42 110.185 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 19.2 t70 . . . . . 0 C--O 1.252 1.198 0 N-CA-C 108.541 -0.911 . . . . 71.5 108.541 -177.458 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 109.482 -0.562 . . . . 72.25 109.482 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.1 m -109.95 124.68 51.83 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.77 0.828 . . . . 73.33 109.711 177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.93 147.21 34.87 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 106.894 -1.521 . . . . 74.45 106.894 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -70.86 90.18 0.79 Allowed 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.214 0.606 . . . . 73.24 109.822 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -75.33 84.83 2.48 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.461 -0.94 . . . . 75.15 108.461 174.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.439 ' ND2' ' HG2' ' A' ' 8' ' ' GLU . 4.3 p-10 -65.4 157.89 28.11 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.522 1.129 . . . . 75.12 111.205 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.6 t -71.05 81.99 0.68 Allowed 'General case' 0 CA--C 1.557 1.224 0 CA-C-O 122.191 0.996 . . . . 74.4 112.305 -171.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.439 ' HG2' ' ND2' ' A' ' 6' ' ' ASN . 72.4 mm-40 -105.7 -20.62 13.4 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.523 1.129 . . . . 73.04 109.648 170.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -62.59 150.01 41.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.255 1.022 . . . . 74.41 111.545 -170.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 63.0 m -140.7 126.85 19.64 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 106.496 -1.668 . . . . 75.14 106.496 172.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -137.45 125.21 22.45 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.845 -0.798 . . . . 75.55 108.845 -173.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -145.73 129.69 17.37 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.259 -0.645 . . . . 71.41 109.259 173.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.0 mt -84.77 126.18 40.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.505 -0.924 . . . . 73.24 108.505 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -93.04 -41.23 10.09 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.172 0.589 . . . . 71.53 110.347 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -172.73 121.49 0.41 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.62 -0.718 . . . . 74.44 109.969 -173.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 80.1 mt -105.4 132.43 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 107.373 -1.343 . . . . 70.22 107.373 172.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.467 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 28.2 p90 -162.98 164.02 25.86 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 123.687 0.617 . . . . 74.25 111.445 -172.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.422 HG23 ' HB3' ' B' ' 120' ' ' ARG . 68.7 p -90.37 122.19 33.02 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.779 -0.452 . . . . 61.03 109.779 174.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.467 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.1 mtpt -83.24 -33.55 26.05 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.055 0.542 . . . . 71.14 109.922 175.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -148.49 142.06 25.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.112 -0.949 . . . . 65.02 109.06 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.7 mt -135.47 145.9 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.778 1.231 . . . . 74.42 107.845 175.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -151.19 131.16 13.35 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.215 0.606 . . . . 71.15 109.999 172.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.445 ' HB2' ' HE2' ' A' ' 117' ' ' MET . 90.6 t80 -131.37 133.1 44.95 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 106.781 -1.563 . . . . 75.22 106.781 171.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -135.67 125.97 26.5 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.627 -0.509 . . . . 74.44 109.627 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.82 79.21 4.41 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 106.16 -1.793 . . . . 75.03 106.16 163.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -65.7 -35.53 36.61 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.455 2.103 . . . . 74.01 112.027 -167.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -107.81 27.07 9.57 Favored 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 124.461 1.104 . . . . 73.52 109.261 -172.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.452 ' HB2' ' HE3' ' B' ' 19' ' ' LYS . . . -46.09 -54.94 14.85 Favored Pre-proline 0 CA--C 1.568 1.652 0 N-CA-C 114.723 1.379 . . . . 63.33 114.723 -165.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.443 ' HG3' ' HG3' ' B' ' 57' ' ' GLU . 28.0 Cg_exo -62.5 -25.85 76.0 Favored 'Trans proline' 0 C--N 1.39 2.736 0 CA-C-N 121.904 1.716 . . . . 74.02 113.26 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.483 ' O ' ' HG2' ' A' ' 33' ' ' GLN . 2.5 m-70 -86.83 -34.32 19.54 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.614 0.765 . . . . 62.3 110.479 -178.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.519 HG22 ' HA ' ' A' ' 73' ' ' ALA . 3.7 p -74.75 -12.04 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 C-N-CA 123.204 0.602 . . . . 75.41 111.894 -164.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -91.78 -18.44 23.87 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.44 0.696 . . . . 73.32 111.291 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 29.9 pt20 -96.98 -11.55 24.43 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.251 0.62 . . . . 74.42 110.251 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 14.3 mmmm -76.93 156.36 32.08 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.407 0.683 . . . . 74.31 111.106 177.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.06 119.3 10.54 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.467 0.707 . . . . 74.44 110.005 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.4 ' CE3' HD21 ' A' ' 68' ' ' LEU . 60.9 t-105 -76.89 84.74 3.45 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-O 121.596 0.713 . . . . 75.41 109.798 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -116.17 79.2 8.41 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 106.246 -1.761 . . . . 72.54 106.246 172.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -81.12 106.62 1.78 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.436 2.091 . . . . 72.24 112.188 -172.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -95.87 88.64 4.99 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 122.6 1.19 . . . . 71.41 107.859 174.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.629 HG23 ' HB1' ' A' ' 66' ' ' ALA . 61.6 t -86.85 101.55 11.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 114.474 -1.239 . . . . 74.22 110.237 -174.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.611 ' HZ2' ' HB2' ' A' ' 43' ' ' ASP . 56.3 tttm -82.32 118.66 23.32 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.994 -1.003 . . . . 72.21 109.121 171.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.3 mp -95.56 108.16 20.39 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.633 -1.247 . . . . 75.04 107.633 173.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.611 ' HB2' ' HZ2' ' A' ' 41' ' ' LYS . 18.5 t70 -105.93 150.67 25.44 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.267 -1.012 . . . . 64.42 108.267 176.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.463 HD22 HD21 ' A' ' 60' ' ' LEU . 67.1 mt -133.29 158.77 42.11 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.406 0.682 . . . . 75.11 110.766 -177.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 25.5 t70 -160.14 121.7 3.17 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.579 -1.191 . . . . 75.2 108.037 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.6 m -112.27 126.51 55.32 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 122.838 0.455 . . . . 75.24 110.196 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.46 112.91 11.32 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.776 0.83 . . . . 74.1 109.493 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.1 p -89.41 177.19 6.64 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.94 0.496 . . . . 55.24 109.867 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.452 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 26.0 t -165.38 153.31 11.21 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.284 1.034 . . . . 73.23 109.112 -168.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -113.73 131.1 56.31 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 109.034 -0.728 . . . . 74.12 109.034 172.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.531 HD12 HG22 ' A' ' 83' ' ' ILE . 80.5 mt -110.48 -34.45 6.31 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.5 0.72 . . . . 74.24 111.4 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.424 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -157.82 -171.23 3.46 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 123.536 0.734 . . . . 74.14 110.537 -177.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -70.59 119.09 14.23 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.533 -0.914 . . . . 75.41 108.533 172.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 65.54 10.72 6.88 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.361 1.065 . . . . 74.34 112.107 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.424 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 57.2 t -116.21 112.6 40.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 107.835 -1.172 . . . . 62.32 107.835 175.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -126.7 126.33 43.32 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.892 0.877 . . . . 73.34 109.036 -176.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 37.8 tt0 -86.65 149.11 25.14 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.512 -0.551 . . . . 75.24 109.512 175.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.1 t -130.77 142.13 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 108.062 -1.088 . . . . 74.14 108.062 173.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.507 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 52.5 t -123.48 133.02 70.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.434 -0.95 . . . . 71.4 108.434 175.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.463 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -113.57 106.81 14.98 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.506 -1.294 . . . . 75.2 107.506 173.129 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.459 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 24.8 ttp180 -93.63 100.59 12.81 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.856 -1.164 . . . . 73.31 107.856 175.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.6 t -94.57 122.92 46.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 107.562 -1.273 . . . . 74.3 107.562 174.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.4 m -116.77 107.61 14.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.567 0.698 . . . . 64.24 109.426 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.616 HG13 HD21 ' A' ' 126' ' ' LEU . 58.0 t -104.38 133.91 47.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 C-N-CA 124.788 1.235 . . . . 73.1 107.871 -178.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.0 m -135.44 136.4 41.32 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.697 -0.853 . . . . 75.03 108.697 170.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.629 ' HB1' HG23 ' A' ' 40' ' ' VAL . . . -116.19 130.89 57.01 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.487 -1.301 . . . . 73.01 107.487 171.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.7 m -124.79 169.76 11.7 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.102 -0.703 . . . . 71.13 109.102 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.4 HD21 ' CE3' ' A' ' 36' ' ' TRP . 62.7 mt -124.09 42.95 3.12 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.754 1.222 . . . . 73.4 108.265 -176.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.22 -89.66 1.58 Allowed Glycine 0 C--N 1.34 0.756 0 CA-C-N 114.725 -1.125 . . . . 72.42 111.34 -172.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.43 -19.53 19.81 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.74 0.816 . . . . 72.3 112.539 -173.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -121.49 132.78 54.91 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 109.693 -0.484 . . . . 75.23 109.693 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.0 m -72.18 137.13 46.7 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 122.449 0.3 . . . . 70.44 110.469 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.519 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -79.17 -62.24 1.76 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.721 -0.672 . . . . 70.12 109.609 176.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -157.07 168.4 27.58 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.164 -0.925 . . . . 73.02 111.614 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 64' ' ' VAL . 61.4 tp -125.41 141.97 51.76 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.939 1.296 . . . . 73.23 108.434 171.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.424 ' HB3' HG22 ' A' ' 114' ' ' ILE . 77.7 m -143.15 99.15 3.39 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.487 1.115 . . . . 72.41 109.289 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -124.25 117.55 24.81 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.711 -0.848 . . . . 74.03 108.711 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.7 t -130.65 128.86 63.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 123.84 0.856 . . . . 74.52 109.613 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.459 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 77.3 mt-30 -96.95 90.9 5.37 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.557 0.743 . . . . 74.41 109.151 169.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -77.59 94.16 4.32 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.79 -0.819 . . . . 72.44 108.79 174.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.507 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.84 172.35 49.86 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.986 -0.846 . . . . 72.45 110.986 175.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.08 126.36 1.2 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.16 -0.776 . . . . 74.0 111.16 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.531 HG22 HD12 ' A' ' 51' ' ' LEU . 50.0 mt -81.59 126.48 39.85 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 108.66 -0.867 . . . . 72.42 108.66 174.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.564 ' HB3' HD11 ' A' ' 86' ' ' ILE . 91.8 m-85 -132.23 121.0 22.96 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.15 0.58 . . . . 73.4 109.961 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.3 m -84.97 97.44 9.8 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.903 -0.777 . . . . 75.3 108.903 174.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.564 HD11 ' HB3' ' A' ' 84' ' ' PHE . 3.5 mm -108.28 153.89 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 122.949 0.5 . . . . 72.11 109.994 -178.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.417 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -165.27 166.03 19.1 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.943 0.497 . . . . 74.23 111.261 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.45 -21.85 42.39 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 116.113 -0.494 . . . . 42.0 114.003 174.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.95 147.61 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.176 0.59 . . . . 72.54 111.535 -172.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -134.28 175.54 9.41 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.91 1.284 . . . . 74.31 109.439 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.62 -124.64 36.28 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.854 0.721 . . . . 64.11 113.828 175.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.0 t -71.19 -29.56 65.33 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.328 0.651 . . . . 62.41 111.741 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -69.33 -43.89 72.77 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.94 0.496 . . . . 70.22 110.324 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.411 ' HE1' ' HG ' ' A' ' 98' ' ' LEU . 2.5 tpt -66.79 -40.3 88.08 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.819 -0.628 . . . . 75.42 110.457 177.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.13 -32.59 74.36 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.236 0.614 . . . . 74.24 110.846 176.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -73.14 -30.94 63.96 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.343 0.657 . . . . 72.24 110.934 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.8 t -73.1 -51.6 17.4 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 109.27 -0.641 . . . . 64.24 109.27 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.411 ' HG ' ' HE1' ' A' ' 94' ' ' MET . 77.2 mt -76.9 -26.9 54.68 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.427 0.691 . . . . 73.11 112.258 -174.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.81 3.56 34.04 Favored Glycine 0 N--CA 1.468 0.815 0 CA-C-O 119.492 -0.616 . . . . 63.55 114.033 -171.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.556 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -148.72 -60.34 0.23 Allowed 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 117.671 0.736 . . . . 64.1 112.323 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.416 ' O ' HG12 ' A' ' 105' ' ' ILE . 73.5 t80 -66.44 -45.54 79.51 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.858 0.463 . . . . 75.54 111.509 -175.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 85.9 m -67.51 -46.79 47.85 Favored Pre-proline 0 CA--C 1.564 1.484 0 C-N-CA 124.381 1.072 . . . . 72.34 111.818 -179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -55.76 -34.17 90.13 Favored 'Trans proline' 0 C--N 1.397 3.126 0 C-N-CA 122.615 2.21 . . . . 75.13 113.523 168.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -63.42 -39.77 95.39 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.777 0.831 . . . . 74.32 110.499 176.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 101' ' ' TYR . 49.8 mm -66.41 -40.08 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.562 0.745 . . . . 74.44 110.212 174.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 68.9 mt -77.69 -22.38 50.58 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.244 -0.889 . . . . 62.21 112.5 -172.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -65.3 -42.33 58.13 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 114.291 1.219 . . . . 73.22 114.291 -172.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -53.2 -38.05 80.92 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 121.974 1.782 . . . . 72.1 113.12 171.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -82.03 -30.2 31.58 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.514 0.725 . . . . 74.15 111.651 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.85 -48.21 72.38 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.941 -0.763 . . . . 72.12 108.941 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.495 ' HG2' ' OH ' ' C' ' 109' ' ' TYR . 31.5 ttm180 -60.81 -39.86 90.54 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 113.741 -1.572 . . . . 71.52 110.088 176.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -52.46 -56.37 15.54 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.376 1.07 . . . . 74.14 110.727 176.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 45.1 t -60.17 -47.82 84.31 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 113.945 -1.48 . . . . 65.24 111.206 -175.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.594 HD13 HD12 ' A' ' 128' ' ' LEU . 96.1 mt -63.22 -59.85 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.714 0.806 . . . . 74.31 110.926 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 92.4 m -49.1 -42.5 39.23 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 124.338 1.024 . . . . 74.23 112.226 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.3 t -68.9 -46.75 67.54 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.745 -1.116 . . . . 61.32 110.582 -178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.445 ' HE2' ' HB2' ' A' ' 23' ' ' PHE . 9.9 mtp -53.67 -44.34 69.61 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.917 0.887 . . . . 72.44 111.226 175.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 114' ' ' ILE . 97.0 t -59.63 -49.71 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-N 114.726 -1.125 . . . . 60.23 110.772 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.4 p -70.9 -28.55 64.62 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.98 -0.554 . . . . 72.52 111.62 -177.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.483 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.4 mtt-85 -71.03 -29.9 65.94 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.674 0.79 . . . . 75.52 110.123 176.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.07 23.05 10.0 Favored Glycine 0 C--N 1.352 1.46 0 CA-C-O 118.957 -0.913 . . . . 64.3 113.407 176.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.428 HG23 ' HE ' ' B' ' 15' ' ' ARG . 4.1 t 57.36 10.71 0.97 Allowed 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 127.047 2.139 . . . . 54.32 113.853 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -81.17 144.02 53.61 Favored Pre-proline 0 C--O 1.242 0.709 0 N-CA-C 108.392 -0.966 . . . . 73.22 108.392 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.496 ' HB3' ' N ' ' E' ' 132' ' ' SER . 83.0 Cg_exo -49.15 146.57 12.59 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 123.138 2.559 . . . . 73.14 111.94 173.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -59.74 133.24 55.92 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.105 0.478 . . . . 74.11 111.595 -174.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.616 HD21 HG13 ' A' ' 64' ' ' VAL . 28.1 tp -118.03 110.1 17.26 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.658 1.183 . . . . 75.13 108.753 176.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.453 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 72.3 m-20 -100.44 126.39 46.83 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.525 -1.287 . . . . 75.21 107.525 172.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.594 HD12 HD13 ' A' ' 114' ' ' ILE . 13.5 mt -73.27 141.37 47.22 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 123.125 0.266 . . . . 74.33 110.303 -178.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.59 135.65 95.78 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.299 0.64 . . . . 72.13 110.822 177.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.74 120.69 8.44 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 123.307 2.671 . . . . 75.53 112.833 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 84.4 t -103.4 136.77 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.538 0.735 . . . . 72.05 110.809 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.463 ' ND2' ' HB3' ' A' ' 135' ' ' ALA . 37.2 t30 -94.61 90.38 6.12 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 108.327 -0.99 . . . . 75.13 108.327 172.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -63.44 -28.67 70.13 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.091 0.957 . . . . 74.2 112.561 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.556 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 7.9 m-20 -63.41 -35.79 81.57 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.122 0.569 . . . . 73.11 110.626 176.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.463 ' HB3' ' ND2' ' A' ' 132' ' ' ASN . . . -65.19 -48.93 71.71 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 123.549 0.531 . . . . 74.34 110.053 171.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 62.3 mt -56.67 -39.29 73.49 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.808 0.843 . . . . 71.0 111.329 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -65.66 -48.35 72.42 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.301 -0.863 . . . . 73.22 110.252 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 90.7 mmm -63.17 -27.72 69.56 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.571 0.544 . . . . 72.3 111.434 -177.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -67.89 -54.56 17.85 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.161 -0.681 . . . . 74.42 109.161 171.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -56.53 -30.42 63.03 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-O 121.088 0.47 . . . . 75.33 111.968 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 28.8 tp -64.34 -48.35 75.88 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.597 1.159 . . . . 72.51 111.72 -176.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -154.97 29.88 0.41 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 114.554 1.316 . . . . 71.31 114.554 -171.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -73.56 -67.34 0.6 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.987 -0.746 . . . . 74.45 108.987 172.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -133.03 153.23 51.69 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.029 0.932 . . . . 54.42 109.126 173.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -78.06 79.55 4.52 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.441 0.696 . . . . 72.23 109.6 176.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.41 -61.69 0.65 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 111.041 -0.824 . . . . 75.31 111.041 -177.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -90.16 65.52 6.43 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.67 0.788 . . . . 74.33 110.235 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -88.77 66.47 3.13 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 110.35 -1.1 . . . . 72.21 110.35 175.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.6 m -73.24 140.92 47.21 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.252 0.621 . . . . 74.2 110.442 -175.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -78.62 73.6 5.17 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.349 1.06 . . . . 74.41 110.792 -177.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -162.97 153.6 16.63 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.762 1.225 . . . . 74.33 109.481 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 178.58 -174.02 0.16 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.042 0.937 . . . . 70.33 110.273 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -59.46 128.9 39.34 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.194 0.998 . . . . 75.42 108.637 168.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.459 ' HB3' HD21 ' E' ' 139' ' ' ASN . 1.3 p-10 -50.12 99.87 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.175 1.39 . . . . 75.21 112.755 -175.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.257 0 CA-C-N 114.517 -1.22 . . . . 72.44 108.974 178.358 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.413 ' SD ' ' N ' ' B' ' 1' ' ' MET . 3.0 mpp? . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 109.366 -0.605 . . . . 73.24 109.366 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 61.9 p -75.51 137.1 40.67 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.657 0.783 . . . . 62.13 109.343 176.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -98.16 138.01 36.09 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 109.452 -0.573 . . . . 75.24 109.452 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -93.82 44.94 1.13 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.797 0.839 . . . . 74.3 109.013 177.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -91.36 78.89 5.67 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.939 0.896 . . . . 71.02 108.956 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -84.25 139.84 32.07 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.201 -0.909 . . . . 73.31 111.068 -170.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.7 t -139.73 138.18 35.73 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.858 0.863 . . . . 72.15 108.68 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 63.74 35.23 11.46 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.459 1.104 . . . . 63.45 109.49 -174.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.56 ' HE3' ' SG ' ' B' ' 97' ' ' CYS . 25.6 ttt 65.65 165.98 0.18 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 125.343 1.457 . . . . 75.33 112.766 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 89.5 m -151.05 128.12 11.12 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.965 1.306 . . . . 74.01 107.694 171.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.46 ' CE1' ' HE2' ' B' ' 101' ' ' TYR . 0.1 OUTLIER -146.86 135.54 22.11 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.304 0.573 . . . . 74.44 110.252 179.115 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.484 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -131.09 130.05 42.67 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.819 1.248 . . . . 75.11 109.212 -179.575 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 69.4 mt -73.24 127.49 35.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 108.357 -0.979 . . . . 73.24 108.357 170.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -92.42 -43.67 9.09 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 123.744 0.652 . . . . 75.34 109.595 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.428 ' HE ' HG23 ' A' ' 122' ' ' THR . 45.6 ttt180 -174.27 135.84 0.46 Allowed 'General case' 0 C--N 1.352 0.71 0 CA-C-N 115.703 -0.68 . . . . 70.41 109.932 -173.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.547 HG23 ' CE1' ' B' ' 109' ' ' TYR . 80.7 mt -122.84 138.8 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.065 -1.087 . . . . 73.31 108.065 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -164.15 157.33 17.95 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.127 0.788 . . . . 73.42 113.127 -171.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 53.5 m -83.66 119.48 24.81 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.366 -1.288 . . . . 75.35 108.864 171.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.452 ' HE3' ' HB2' ' A' ' 28' ' ' ALA . 39.6 mtpt -91.81 -24.98 19.21 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.658 0.783 . . . . 71.23 111.522 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -159.57 142.76 14.25 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 123.387 0.429 . . . . 72.11 111.02 -175.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.564 HD13 ' SG ' ' B' ' 113' ' ' CYS . 48.6 mm -134.37 144.19 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.939 1.295 . . . . 75.35 108.321 171.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 29.5 t -147.68 134.45 20.04 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.221 1.009 . . . . 63.44 108.35 171.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -134.87 131.89 37.91 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.979 -1.489 . . . . 74.1 106.979 167.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -132.69 125.39 30.18 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.177 -1.046 . . . . 74.21 108.177 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.505 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -114.75 87.37 14.55 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 106.899 -1.519 . . . . 61.43 106.899 164.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.39 -35.04 74.89 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.554 2.17 . . . . 74.21 111.228 -173.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -110.29 14.93 22.59 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.47 -1.241 . . . . 53.24 110.742 -175.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.505 ' HB1' ' HB2' ' B' ' 25' ' ' ALA . . . -31.63 -66.3 0.19 Allowed Pre-proline 0 N--CA 1.493 1.715 0 C-N-CA 125.951 1.701 . . . . 75.42 115.278 -172.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.496 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 24.8 Cg_exo -60.83 -36.51 83.62 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 122.457 2.105 . . . . 75.11 113.269 -167.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -93.31 -32.22 14.39 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.403 0.52 . . . . 74.11 112.403 -174.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.605 HG21 HD11 ' B' ' 68' ' ' LEU . 7.2 p -67.6 -11.69 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-N 118.209 0.458 . . . . 75.22 111.534 -173.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -74.1 -15.09 61.06 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.868 0.867 . . . . 75.41 112.976 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -61.54 -28.91 69.66 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.476 0.655 . . . . 55.24 109.543 172.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -88.91 105.17 17.58 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.894 1.278 . . . . 75.12 109.451 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -113.43 99.18 7.57 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.625 -0.88 . . . . 65.13 108.625 172.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 11.2 p90 -160.71 -172.78 3.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.368 -0.975 . . . . 75.24 108.368 170.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -73.84 107.3 3.32 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.353 0.661 . . . . 74.34 111.014 175.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' F' ' 129' ' ' THR . 37.9 Cg_endo -68.11 143.65 60.36 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 121.533 1.488 . . . . 74.12 110.5 178.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.23 101.46 1.19 Allowed 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.543 -0.91 . . . . 75.32 108.543 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.703 HG21 ' HB1' ' B' ' 66' ' ' ALA . 33.9 t -91.78 144.71 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 114.245 -1.343 . . . . 74.43 109.695 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.61 ' HZ1' ' HB2' ' B' ' 43' ' ' ASP . 0.5 OUTLIER -144.15 119.65 10.35 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.067 -1.827 . . . . 75.01 106.067 -175.243 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.43 HD12 HD21 ' B' ' 128' ' ' LEU . 20.9 tp -95.06 147.23 23.64 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.625 0.77 . . . . 74.52 109.362 -174.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.61 ' HB2' ' HZ1' ' B' ' 41' ' ' LYS . 13.0 t70 -140.62 134.29 30.25 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.692 -1.225 . . . . 75.12 107.692 -175.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 64.3 mt -128.0 126.27 41.02 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.632 -0.877 . . . . 73.22 108.632 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.579 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 19.5 t70 -126.1 119.79 28.48 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.369 1.067 . . . . 75.0 108.612 -173.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.8 p -110.29 102.95 11.57 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.33 0.652 . . . . 74.23 111.516 -169.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.73 136.83 51.11 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.135 0.974 . . . . 71.25 108.554 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.1 p -139.86 175.86 9.23 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.418 0.687 . . . . 73.02 109.721 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 75.3 p -157.12 140.15 15.34 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.093 0.557 . . . . 75.15 110.337 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . 0.51 ' HB2' HD22 ' F' ' 102' ' ' LEU . 63.2 tt0 -94.87 128.46 41.65 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.617 -0.883 . . . . 74.13 108.617 172.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.91 16.41 2.48 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.72 0.808 . . . . 73.1 110.923 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . 0.737 ' HB2' ' HB ' ' B' ' 55' ' ' VAL . . . -173.67 165.12 4.49 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.819 1.248 . . . . 73.34 109.73 173.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.45 119.24 13.41 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.884 -0.784 . . . . 72.22 108.884 176.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 69.16 -5.63 1.05 Allowed 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 124.687 1.195 . . . . 74.53 113.145 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.737 ' HB ' ' HB2' ' B' ' 52' ' ' ALA . 44.4 t -119.57 97.49 5.26 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.226 -1.028 . . . . 75.13 108.226 -172.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.64 ' HE1' HD12 ' B' ' 86' ' ' ILE . 54.4 p90 -99.23 -176.86 3.43 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 114.556 -1.202 . . . . 73.45 109.207 177.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.443 ' HG3' ' HG3' ' A' ' 29' ' ' PRO . 5.5 tm-20 -138.69 107.2 5.85 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 106.383 -1.71 . . . . 74.3 106.383 173.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 14.8 p -101.0 135.03 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 109.863 -0.421 . . . . 74.24 109.863 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 29.9 t -109.38 115.23 49.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 123.754 0.821 . . . . 61.34 108.955 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 54.5 tp -93.89 101.13 13.2 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.378 -0.971 . . . . 64.21 108.378 170.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.579 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 14.1 ttm-85 -87.33 116.82 25.69 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.681 -0.859 . . . . 74.35 108.681 172.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.37 125.9 66.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.029 -1.1 . . . . 72.23 108.029 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 8.7 m -121.84 131.67 54.17 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.242 -0.651 . . . . 73.13 109.242 178.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.509 HG23 HD12 ' B' ' 114' ' ' ILE . 56.7 t -115.88 125.2 72.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 124.569 1.148 . . . . 75.11 109.131 176.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 88.9 m -105.06 138.72 40.82 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.463 -0.94 . . . . 75.23 108.463 164.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.703 ' HB1' HG21 ' B' ' 40' ' ' VAL . . . -142.19 144.27 33.32 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 107.96 -1.126 . . . . 73.43 107.96 174.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.465 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 49.6 p -144.7 134.26 23.34 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.388 0.43 . . . . 72.23 111.978 -171.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.605 HD11 HG21 ' B' ' 31' ' ' VAL . 70.6 mt -102.61 99.57 9.58 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.487 -0.931 . . . . 73.23 108.487 175.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.05 -134.3 14.18 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.991 -0.549 . . . . 73.22 112.364 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -82.32 3.55 27.29 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.26 0.624 . . . . 75.13 112.515 -177.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -128.76 150.68 50.19 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.789 0.435 . . . . 72.11 111.767 -174.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 68.3 m -68.7 128.43 36.62 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.418 -0.81 . . . . 71.24 110.36 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.502 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . . . -80.14 -59.28 2.77 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.366 -0.976 . . . . 75.21 108.366 176.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -152.51 157.85 41.71 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 114.701 -1.136 . . . . 74.11 111.437 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 98.2 mt -125.15 113.58 17.88 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.682 1.593 . . . . 75.35 107.262 171.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.9 t -118.39 140.14 50.31 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.177 -1.045 . . . . 75.44 108.177 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -151.22 127.64 10.68 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.813 -0.81 . . . . 74.54 108.813 -174.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.438 HG21 HD12 ' B' ' 21' ' ' ILE . 90.4 t -124.44 147.71 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 123.942 0.897 . . . . 73.34 108.83 177.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -120.74 106.38 11.64 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.477 -1.305 . . . . 74.14 107.477 168.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -98.41 101.3 12.7 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.504 -1.295 . . . . 54.13 107.504 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.4 159.57 22.56 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 111.062 -0.815 . . . . 71.25 111.062 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.9 132.61 3.12 Favored Glycine 0 C--O 1.239 0.446 0 C-N-CA 121.718 -0.277 . . . . 72.42 112.411 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 54.6 mt -91.66 108.13 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 108.497 -0.927 . . . . 72.22 108.497 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -119.47 143.89 47.28 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.159 -1.052 . . . . 75.35 108.159 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 15.8 m -115.17 114.23 25.0 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.476 -0.935 . . . . 75.13 108.476 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.64 HD12 ' HE1' ' B' ' 56' ' ' TYR . 0.2 OUTLIER -115.56 142.22 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.359 -0.978 . . . . 73.34 108.359 178.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.38 168.6 26.83 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.981 0.512 . . . . 65.1 110.622 -177.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.86 -44.92 2.69 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.966 -0.561 . . . . 72.03 111.895 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.414 HD12 ' HB2' ' B' ' 94' ' ' MET . 1.0 OUTLIER -81.74 157.25 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.5 1.12 . . . . 75.22 111.261 178.131 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.5 ' HA ' ' SD ' ' B' ' 94' ' ' MET . 9.7 mp0 -145.9 177.95 8.55 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.483 1.113 . . . . 73.01 109.605 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.62 -125.42 23.07 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.127 -0.942 . . . . 73.42 113.81 173.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 27.2 m -79.27 -45.39 19.83 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.703 0.801 . . . . 75.34 110.724 -178.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -67.47 -28.91 68.25 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 113.953 -1.476 . . . . 74.3 111.886 -166.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.5 ' SD ' ' HA ' ' B' ' 90' ' ' GLU . 26.9 ptt? -64.34 -47.49 79.15 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.227 0.611 . . . . 72.53 111.373 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . 0.458 ' HA ' ' HG ' ' B' ' 98' ' ' LEU . . . -81.0 -13.34 58.96 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.996 0.919 . . . . 63.44 112.186 -175.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -64.74 -32.13 73.67 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.655 0.382 . . . . 72.0 110.277 170.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.56 ' SG ' ' HE3' ' B' ' 9' ' ' MET . 48.0 t -67.51 -30.92 70.72 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.584 0.754 . . . . 64.31 111.53 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.744 HD21 HD11 ' F' ' 100' ' ' LEU . 4.0 pp -101.38 -24.48 14.19 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 112.942 0.719 . . . . 73.5 112.942 -175.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.76 -26.24 61.09 Favored Glycine 0 C--N 1.338 0.671 0 O-C-N 123.584 0.553 . . . . 65.24 112.736 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.08 -49.75 0.33 Allowed 'General case' 0 C--O 1.242 0.671 0 N-CA-C 112.568 0.581 . . . . 74.45 112.568 -165.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.46 ' HE2' ' CE1' ' B' ' 11' ' ' PHE . 16.0 t80 -68.02 -48.75 64.83 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.69 0.796 . . . . 74.34 112.155 -174.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 98.1 m -73.69 -37.94 3.74 Favored Pre-proline 0 CA--C 1.557 1.238 0 N-CA-C 112.627 0.603 . . . . 74.54 112.627 -177.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -51.43 -31.49 38.87 Favored 'Trans proline' 0 C--N 1.387 2.553 0 C-N-CA 122.399 2.066 . . . . 73.52 114.181 162.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -68.89 -25.41 64.59 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 122.767 0.427 . . . . 74.44 111.504 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.497 HG23 ' NH2' ' D' ' 111' ' ' ARG . 71.5 mt -69.05 -39.8 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 121.336 0.589 . . . . 74.21 109.413 170.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.461 ' CD2' HG21 ' B' ' 16' ' ' ILE . 70.3 mt -77.09 -24.6 51.8 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.689 1.196 . . . . 72.43 111.893 -177.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -59.18 -53.71 63.58 Favored Pre-proline 0 N--CA 1.484 1.248 0 N-CA-C 113.822 1.045 . . . . 72.21 113.822 -171.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.16 -30.56 55.26 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 121.62 1.547 . . . . 75.21 111.98 -177.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.547 ' CE1' HG23 ' B' ' 16' ' ' ILE . 2.4 m-30 -64.54 -47.8 77.46 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.02 0.928 . . . . 73.5 110.058 176.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.18 -40.57 97.9 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.026 0.93 . . . . 71.55 110.747 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.4 ttt-85 -64.69 -46.34 82.79 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.225 1.41 . . . . 75.3 110.861 -175.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.38 -35.06 77.15 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 123.776 0.673 . . . . 64.22 109.454 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.564 ' SG ' HD13 ' B' ' 21' ' ' ILE . 4.4 t -68.99 -35.51 76.8 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.891 0.476 . . . . 74.34 111.157 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.509 HD12 HG23 ' B' ' 64' ' ' VAL . 49.2 mt -62.89 -56.88 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.649 0.78 . . . . 72.43 109.339 173.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 18.1 m -59.63 -28.21 67.02 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.941 0.896 . . . . 55.03 111.459 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.461 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.7 t -66.25 -51.45 57.42 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.981 0.912 . . . . 54.41 110.3 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.5 mmt -70.14 -29.98 67.03 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.183 0.593 . . . . 73.12 111.245 -176.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.614 HG23 HD21 ' B' ' 126' ' ' LEU . 77.6 t -67.95 -41.86 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.513 1.125 . . . . 72.43 110.389 172.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.7 t -67.69 -32.03 72.41 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.604 -0.726 . . . . 75.31 110.341 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' B' ' 116' ' ' SER . 70.3 mtt-85 -69.74 -42.59 73.74 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 115.688 -0.687 . . . . 73.41 109.162 175.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.12 -10.82 62.81 Favored Glycine 0 C--N 1.358 1.801 0 O-C-N 123.736 0.648 . . . . 75.53 112.639 172.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 8.9 m 68.75 23.1 7.11 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 125.762 1.625 . . . . 72.11 110.973 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -78.96 164.26 55.96 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 124.019 0.927 . . . . 74.52 111.341 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -45.28 147.56 2.35 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 123.839 3.026 . . . . 73.52 114.85 172.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.435 ' O ' ' HA ' ' F' ' 129' ' ' THR . 54.4 tp60 -59.95 113.29 2.23 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.272 1.029 . . . . 72.01 112.512 -172.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.614 HD21 HG23 ' B' ' 118' ' ' VAL . 28.5 tp -107.71 104.72 14.3 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.151 0.58 . . . . 74.34 109.457 -172.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -111.49 120.9 43.7 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.442 -0.947 . . . . 74.22 108.442 175.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.43 HD21 HD12 ' B' ' 42' ' ' LEU . 57.9 mt -78.14 149.29 33.82 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 110.296 -0.261 . . . . 74.43 110.296 175.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' F' ' 124' ' ' SER . . . -72.61 143.39 84.9 Favored Pre-proline 0 CA--C 1.55 0.961 0 O-C-N 123.503 0.502 . . . . 54.03 111.238 -178.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.61 81.76 0.76 Allowed 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 123.345 2.697 . . . . 70.42 112.191 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.17 110.68 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 121.402 0.62 . . . . 73.35 109.423 177.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -86.17 111.61 20.54 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.692 -1.225 . . . . 65.14 107.692 171.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -64.26 -29.92 70.99 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.564 -0.744 . . . . 75.33 110.931 -171.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -61.71 -33.42 73.99 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.936 0.895 . . . . 74.42 111.546 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.82 -47.59 82.78 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 124.008 0.818 . . . . 72.34 111.018 175.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.565 HD23 HD22 ' F' ' 111' ' ' LEU . 7.1 mp -63.76 -39.73 94.97 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.029 0.532 . . . . 74.31 110.826 -177.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.456 ' HE1' HD12 ' F' ' 111' ' ' LEU . 5.7 m-85 -64.68 -44.2 91.12 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.268 0.627 . . . . 73.41 110.48 174.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.521 ' O ' ' HB3' ' B' ' 142' ' ' GLN . 48.3 tpp -74.72 -13.06 60.56 Favored 'General case' 0 C--O 1.208 -1.083 0 CA-C-N 115.555 -0.748 . . . . 74.43 110.977 -176.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.74 -34.01 62.45 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 118.399 0.545 . . . . 75.21 110.242 174.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -90.88 -26.43 19.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.397 0.679 . . . . 75.34 110.858 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 96.0 mt -108.37 22.85 15.37 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.012 0.925 . . . . 73.31 111.237 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . 0.521 ' HB3' ' O ' ' B' ' 138' ' ' MET . 13.6 pt20 -79.63 177.9 8.54 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.54 0.686 . . . . 75.3 111.791 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -152.17 -171.0 3.8 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.663 -1.153 . . . . 73.42 109.019 175.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -66.05 -16.01 63.55 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.424 0.69 . . . . 70.24 111.654 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.71 103.38 0.11 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.247 1.019 . . . . 74.43 111.373 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.07 34.95 0.03 OUTLIER Glycine 0 C--N 1.342 0.864 0 CA-C-N 115.336 -0.847 . . . . 75.43 111.083 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -147.26 142.37 27.13 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.358 1.063 . . . . 75.43 109.735 -174.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 116.02 76.97 0.65 Allowed Glycine 0 C--N 1.352 1.467 0 O-C-N 123.428 0.455 . . . . 75.02 112.731 177.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 8.8 t -148.07 127.7 13.31 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.662 -0.866 . . . . 72.12 108.662 172.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -161.33 122.61 2.85 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.492 -0.559 . . . . 63.31 109.492 -173.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -160.49 96.84 1.18 Allowed 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.443 0.697 . . . . 74.31 109.175 167.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -80.16 72.74 6.98 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.508 0.723 . . . . 74.42 111.706 -176.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -154.79 113.73 3.62 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.284 0.634 . . . . 72.13 109.482 176.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -81.29 -32.12 33.31 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.673 0.789 . . . . 74.21 111.07 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.406 0 C-N-CA 123.615 0.766 . . . . 73.33 109.157 179.062 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.475 ' N ' ' SD ' ' C' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.954 0 CA-C-O 121.674 0.75 . . . . 71.44 110.755 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 30.8 t -161.28 109.8 1.54 Allowed 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.336 -0.987 . . . . 72.42 108.336 175.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -78.99 -174.67 4.15 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.426 0.69 . . . . 74.11 111.647 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -136.18 124.37 23.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.986 0.915 . . . . 70.51 109.691 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -149.8 153.39 36.72 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.869 0.868 . . . . 71.32 108.878 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -62.55 -40.86 98.19 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.659 0.784 . . . . 73.24 109.892 174.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 4.9 t -108.81 77.43 1.07 Allowed 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 122.573 1.177 . . . . 72.14 108.766 171.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -97.89 -60.7 1.51 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.751 -1.113 . . . . 65.41 109.911 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.595 ' HE1' HD12 ' C' ' 89' ' ' ILE . 54.5 ttm 63.26 114.97 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.547 1.539 . . . . 75.24 111.354 -171.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 20.2 m -103.78 95.44 6.03 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.585 -0.894 . . . . 72.32 108.585 171.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -110.74 139.96 45.56 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.799 0.839 . . . . 64.24 109.074 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -151.59 124.62 8.66 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.989 -0.745 . . . . 64.35 108.989 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.416 ' HB ' HG13 ' E' ' 135' ' ' VAL . 53.0 mt -70.11 135.0 29.1 Favored 'Isoleucine or valine' 0 C--N 1.349 0.586 0 N-CA-C 108.45 -0.945 . . . . 74.11 108.45 174.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -97.5 -47.71 5.56 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.273 -0.64 . . . . 73.31 109.273 176.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.453 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 11.8 ptm180 -179.01 143.02 0.2 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.288 1.035 . . . . 74.34 109.255 -176.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.31 146.8 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 107.363 -1.347 . . . . 75.11 107.363 171.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.419 ' HB3' HG22 ' D' ' 122' ' ' THR . 28.6 p90 -170.78 154.58 4.4 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.201 0.524 . . . . 64.51 111.943 -168.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.0 p -81.01 109.24 15.4 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.216 -0.902 . . . . 71.44 108.848 173.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -77.3 -29.78 53.84 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.186 -0.672 . . . . 74.5 109.186 173.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.664 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 22.5 t70 -146.07 143.77 29.6 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.905 -1.043 . . . . 73.45 109.663 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 99.3 mt -137.92 145.34 29.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 125.237 1.415 . . . . 73.35 107.389 173.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.3 t -152.91 146.05 24.67 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.129 0.571 . . . . 73.55 109.723 175.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -147.48 118.58 7.74 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 107.861 -1.162 . . . . 71.32 107.861 170.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -120.79 113.48 20.23 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.073 0.949 . . . . 75.12 108.981 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.63 87.81 7.02 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 106.446 -1.687 . . . . 73.14 106.446 169.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.89 -42.67 23.35 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.845 2.363 . . . . 72.12 112.042 -170.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -113.06 35.53 3.89 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.759 -1.109 . . . . 72.1 109.239 -177.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.474 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -43.92 -53.27 13.34 Favored Pre-proline 0 C--N 1.373 1.604 0 C-N-CA 124.915 1.286 . . . . 73.32 114.113 -176.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.96 -50.88 7.91 Favored 'Trans proline' 0 C--N 1.39 2.749 0 C-N-CA 121.521 1.481 . . . . 74.32 111.906 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -70.04 -28.07 65.17 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.309 -1.314 . . . . 74.1 113.016 -173.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.654 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.0 p -77.79 -23.88 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 112.235 0.458 . . . . 64.22 112.235 -175.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -71.9 -21.27 61.66 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 112.118 0.414 . . . . 71.32 112.118 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -93.54 16.35 13.89 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.027 0.531 . . . . 75.4 111.016 175.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.757 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -104.17 154.01 20.27 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.748 0.819 . . . . 75.42 109.974 176.111 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -72.4 130.78 41.5 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.31 0.644 . . . . 74.34 109.711 171.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -85.39 90.24 7.89 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.819 0.848 . . . . 74.1 112.2 -171.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -145.7 77.52 12.32 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 124.675 1.19 . . . . 75.34 108.907 170.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -91.53 165.77 3.47 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.758 2.305 . . . . 71.14 113.562 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -87.97 100.56 13.0 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.969 -1.122 . . . . 72.52 107.969 166.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 42.0 t -79.89 98.59 3.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.549 -0.908 . . . . 70.41 108.549 177.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -93.06 102.52 14.85 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.068 -1.456 . . . . 75.52 107.068 175.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 tt -87.78 138.21 31.66 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 106.817 -1.549 . . . . 70.35 106.817 176.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.454 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 36.0 t70 -131.56 134.71 46.36 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.053 0.941 . . . . 65.13 108.85 -175.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 96.2 mt -128.54 114.48 16.79 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.602 0.761 . . . . 72.14 110.018 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -117.12 120.75 39.29 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.671 -1.233 . . . . 71.14 107.671 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 10.1 t -118.24 149.24 41.45 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 109.778 -0.453 . . . . 75.22 109.778 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.17 149.12 26.72 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.572 0.749 . . . . 75.03 109.359 174.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.48 ' HG ' ' HB3' ' C' ' 98' ' ' LEU . 14.3 m -123.77 152.53 42.09 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.122 -0.696 . . . . 64.24 109.122 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 72.9 p -154.61 127.37 8.11 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.506 -0.924 . . . . 75.5 108.506 177.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -79.62 117.7 20.78 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.994 -0.743 . . . . 74.44 108.994 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.731 HD12 ' HB2' ' C' ' 57' ' ' GLU . 41.5 mt -83.55 -44.76 14.3 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.492 0.717 . . . . 75.0 110.273 -176.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.99 -176.55 4.72 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.449 -0.796 . . . . 64.31 109.691 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.08 107.77 0.59 Allowed 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.786 -1.097 . . . . 73.31 110.505 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . 0.441 ' HB2' HG11 ' E' ' 144' ' ' VAL . 1.3 m-20 64.38 25.31 13.38 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.452 1.101 . . . . 75.21 112.113 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 87.9 t -119.05 114.77 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.328 -0.989 . . . . 75.04 108.328 174.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -117.81 125.55 50.78 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.354 1.062 . . . . 75.11 109.291 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.731 ' HB2' HD12 ' C' ' 51' ' ' LEU . 37.4 tt0 -91.17 117.71 29.84 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.246 -0.65 . . . . 64.22 109.246 168.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.8 t -99.61 142.02 15.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.083 -1.08 . . . . 75.23 108.083 169.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 90.5 t -127.4 144.08 38.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.786 -0.82 . . . . 75.04 108.786 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.401 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -130.37 99.02 4.87 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 107.848 -1.168 . . . . 74.05 107.848 177.61 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -82.52 110.78 17.93 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.369 0.668 . . . . 75.22 109.41 171.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.404 HG13 ' CD1' ' C' ' 114' ' ' ILE . 39.6 t -108.52 122.77 63.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.698 -0.853 . . . . 73.33 108.698 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 16.8 m -126.1 127.48 45.86 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.449 0.7 . . . . 74.42 109.521 -176.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.423 HG22 HG23 ' C' ' 114' ' ' ILE . 60.2 t -114.36 112.11 38.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 124.165 0.986 . . . . 72.54 108.893 178.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 11.2 m -98.12 135.86 39.18 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.457 -1.312 . . . . 75.33 107.457 171.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.71 118.22 17.86 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.225 -1.398 . . . . 62.02 107.225 -175.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.5 m -133.9 130.89 38.43 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.194 0.521 . . . . 73.11 110.545 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.757 HD11 ' HG2' ' C' ' 34' ' ' LYS . 14.2 mt -88.48 39.48 0.91 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.624 1.169 . . . . 74.33 109.626 174.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.91 -106.22 2.66 Favored Glycine 0 C--N 1.353 1.474 0 CA-C-N 115.823 -0.626 . . . . 63.44 111.701 -173.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -90.24 -30.05 17.79 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.792 -0.818 . . . . 71.13 108.792 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -65.76 121.05 14.14 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 114.713 -1.131 . . . . 75.14 109.435 169.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 89.8 m -83.97 120.65 26.36 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.124 -1.065 . . . . 73.32 108.124 164.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.654 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -67.41 -58.57 4.52 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 123.945 0.778 . . . . 51.12 109.139 175.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -165.13 176.57 8.39 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 121.984 0.897 . . . . 72.41 111.078 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.424 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.1 tm? -134.84 145.35 48.23 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 105.766 -1.939 . . . . 74.42 105.766 170.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.469 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.2 t -147.82 141.88 25.99 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.878 -1.156 . . . . 73.15 107.878 174.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -150.88 131.54 13.97 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.473 -0.566 . . . . 75.22 109.473 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 75.8 t -131.76 114.05 24.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.345 -0.983 . . . . 75.24 108.345 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.664 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.7 mt-30 -90.49 86.14 6.34 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.417 -0.957 . . . . 72.32 108.417 173.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -79.01 102.15 8.19 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.225 -1.352 . . . . 75.24 108.88 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.9 159.44 32.9 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 111.475 -0.65 . . . . 62.51 111.475 172.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.69 116.73 0.73 Allowed Glycine 0 CA--C 1.507 -0.428 0 N-CA-C 111.317 -0.713 . . . . 75.21 111.317 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.622 HD11 ' HB3' ' D' ' 29' ' ' PRO . 17.2 mm -84.4 132.42 31.61 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 N-CA-C 108.778 -0.823 . . . . 74.45 108.778 178.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.401 ' HD2' ' HA ' ' C' ' 13' ' ' ILE . 66.0 m-85 -135.66 139.07 43.44 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.483 0.713 . . . . 75.44 109.837 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 21.7 p -99.01 104.0 16.0 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.809 -1.182 . . . . 72.34 107.809 169.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 46.1 mt -115.72 132.62 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.898 0.879 . . . . 74.25 109.128 -176.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.83 164.46 33.58 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 122.902 0.481 . . . . 75.45 111.187 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.83 -41.75 2.71 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 115.353 -0.84 . . . . 75.32 113.392 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.595 HD12 ' HE1' ' C' ' 9' ' ' MET . 39.7 pt -85.98 168.84 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.274 0.629 . . . . 75.44 111.787 -174.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -164.5 168.23 18.58 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.981 1.312 . . . . 71.42 108.339 176.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.22 -119.46 11.7 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.805 -0.441 . . . . 62.51 112.982 171.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 69.9 p -69.0 -41.78 77.36 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.134 0.574 . . . . 73.34 110.644 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -61.93 -46.51 89.01 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.519 0.728 . . . . 72.11 110.9 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.533 ' HA ' HD13 ' C' ' 89' ' ' ILE . 5.4 tpt -59.74 -51.45 69.69 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 123.734 0.646 . . . . 74.32 111.579 177.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.26 -40.88 97.67 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.68 0.612 . . . . 55.53 111.319 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -72.36 -34.54 68.06 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.901 -1.045 . . . . 71.04 111.119 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -65.11 -42.5 93.89 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.317 0.58 . . . . 65.12 109.885 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.48 ' HB3' ' HG ' ' C' ' 48' ' ' SER . 97.3 mt -79.44 -37.24 37.49 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.798 -1.092 . . . . 64.45 112.78 -175.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.78 11.66 45.81 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-O 119.429 -0.65 . . . . 74.52 114.597 -167.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' C' ' 137' ' ' PHE . . . -155.95 -56.67 0.09 Allowed 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 117.827 0.814 . . . . 72.22 111.385 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -63.7 -56.17 17.72 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.617 0.767 . . . . 70.4 111.815 -175.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.426 ' O ' HD13 ' C' ' 106' ' ' LEU . 85.5 m -65.25 -47.3 71.38 Favored Pre-proline 0 CA--C 1.561 1.397 0 C-N-CA 123.925 0.89 . . . . 71.12 112.371 -177.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.401 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 53.7 Cg_exo -55.66 -30.53 75.71 Favored 'Trans proline' 0 C--N 1.397 3.092 0 C-N-CA 122.44 2.093 . . . . 65.51 113.628 173.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -70.18 -28.71 65.54 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.289 0.636 . . . . 74.03 111.116 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.454 HD13 HH12 ' A' ' 111' ' ' ARG . 33.8 mm -77.91 -32.27 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 123.163 0.585 . . . . 73.34 109.971 175.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.426 HD13 ' O ' ' C' ' 102' ' ' CYS . 7.3 mp -78.4 -27.55 46.75 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.05 0.94 . . . . 62.15 111.578 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -56.82 -49.81 91.7 Favored Pre-proline 0 N--CA 1.48 1.069 0 CA-C-O 117.556 -1.212 . . . . 75.44 113.672 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -50.91 -40.68 57.83 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.72 2.28 . . . . 64.44 114.674 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . 0.495 ' OH ' ' HG2' ' A' ' 111' ' ' ARG . 89.2 m-85 -79.15 -37.44 38.47 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.263 0.625 . . . . 73.41 111.455 -175.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.64 96.26 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.436 -0.802 . . . . 75.45 109.956 173.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 34.6 ttt-85 -62.97 -50.9 68.98 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.579 1.551 . . . . 75.41 110.394 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -60.67 -40.8 93.44 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.094 0.871 . . . . 74.33 110.126 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 31.8 t -72.33 -32.18 66.29 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.709 -0.678 . . . . 65.32 111.212 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.469 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 44.2 mt -69.1 -53.35 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.905 -0.406 . . . . 75.14 109.905 174.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 22.5 m -62.62 -28.98 70.27 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.442 0.697 . . . . 74.11 111.196 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 37.6 t -67.51 -49.21 64.48 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.254 0.622 . . . . 72.04 109.348 173.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.554 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.39 -39.79 84.48 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 124.432 1.093 . . . . 72.22 112.402 179.838 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.425 HG21 ' O ' ' C' ' 114' ' ' ILE . 93.7 t -65.23 -43.99 95.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.73 0.812 . . . . 74.12 110.223 176.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 22.0 t -66.07 -29.87 70.28 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.067 -0.97 . . . . 72.33 111.577 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 88.1 mtt-85 -73.02 -39.82 65.68 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.603 0.761 . . . . 72.14 109.506 177.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.61 -0.79 68.99 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 123.895 0.747 . . . . 63.41 112.522 171.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.429 HG21 ' HB3' ' D' ' 17' ' ' TYR . 32.0 p 63.4 32.17 14.66 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.823 2.049 . . . . 75.0 113.384 170.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -83.98 149.83 57.16 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 108.027 -1.101 . . . . 64.31 108.027 166.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.06 161.06 5.37 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 123.3 2.667 . . . . 73.12 113.96 176.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -58.55 113.57 2.06 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.751 0.82 . . . . 74.34 112.222 -172.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 50.8 tp -109.35 87.83 2.59 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.924 -1.034 . . . . 73.34 108.254 173.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -90.2 106.7 18.66 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.175 -1.046 . . . . 73.21 108.175 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 86.5 mt -64.45 129.25 39.16 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.41 0.684 . . . . 71.23 110.618 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.07 151.2 96.11 Favored Pre-proline 0 CA--C 1.553 1.076 0 O-C-N 124.34 1.025 . . . . 73.55 111.089 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.87 116.71 3.4 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.15 2.566 . . . . 55.42 112.853 177.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 28.9 t -99.35 133.22 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.042 -0.725 . . . . 72.24 109.042 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -87.64 96.47 10.44 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.745 0.818 . . . . 71.11 109.169 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -68.92 -24.58 64.31 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.396 0.679 . . . . 75.44 112.085 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -66.13 -41.15 90.88 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 109.076 -0.713 . . . . 75.35 109.076 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.79 -39.98 95.91 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.303 -0.862 . . . . 72.11 110.819 175.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 77.2 mt -67.6 -26.23 66.16 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.551 -0.75 . . . . 74.4 111.012 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . 0.516 ' HB2' ' HB3' ' C' ' 100' ' ' ALA . 34.5 t80 -78.8 -27.01 44.39 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 120.613 0.244 . . . . 72.12 110.878 176.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 62.7 mtt -65.59 -36.88 85.05 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.352 -0.61 . . . . 71.32 109.352 170.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -71.79 -33.39 68.53 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.858 0.863 . . . . 75.34 111.743 173.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -51.23 -83.49 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.512 1.125 . . . . 73.0 110.701 176.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 33.9 tp -133.36 92.64 3.03 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.253 -0.647 . . . . 63.15 109.253 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -77.88 82.32 4.26 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.458 -0.941 . . . . 74.51 108.458 172.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -141.4 -14.03 0.88 Allowed 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.066 -1.424 . . . . 73.12 108.88 178.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -147.32 168.53 21.53 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 123.852 0.861 . . . . 64.14 110.957 -171.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.74 -179.06 6.94 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.714 1.205 . . . . 63.42 109.075 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 165.22 101.01 0.15 Allowed Glycine 0 C--N 1.342 0.867 0 N-CA-C 111.499 -0.64 . . . . 51.03 111.499 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.44 127.61 12.05 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.324 -0.991 . . . . 73.25 108.324 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -169.95 58.17 0.19 Allowed Glycine 0 C--N 1.344 0.974 0 N-CA-C 111.789 -0.524 . . . . 74.31 111.789 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 13.2 p -67.46 95.9 0.48 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.359 0.664 . . . . 74.35 110.66 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -90.87 -171.77 3.13 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.461 1.104 . . . . 71.31 110.006 176.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -141.71 141.39 33.3 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.141 -1.059 . . . . 74.41 108.141 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -156.09 77.01 0.94 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.967 0.907 . . . . 72.01 110.092 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -78.67 171.44 15.14 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 115.2 -0.909 . . . . 75.13 111.113 174.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -165.96 98.17 0.64 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.155 -0.684 . . . . 75.44 109.155 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.318 -0.849 . . . . 73.21 109.212 -175.771 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 109.868 -0.419 . . . . 74.23 109.868 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 38.0 m -149.87 106.89 3.57 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.081 0.952 . . . . 64.41 108.86 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.42 79.33 1.2 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 109.475 -0.565 . . . . 73.42 109.475 -176.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -136.75 46.84 2.19 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 107.428 -1.323 . . . . 72.44 107.428 167.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -127.37 127.41 44.16 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.306 -0.861 . . . . 65.13 109.455 -176.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -93.57 -31.8 14.38 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.022 0.929 . . . . 74.43 109.749 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 6.3 m -71.96 161.25 31.2 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 123.92 0.888 . . . . 73.22 110.13 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 73.15 122.71 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.185 1.394 . . . . 75.3 111.014 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -33.76 123.14 0.45 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.613 1.165 . . . . 72.23 111.736 172.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.424 HG21 ' HB2' ' D' ' 87' ' ' ALA . 10.2 t -119.18 140.74 49.69 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.941 0.4 . . . . 74.32 110.286 -176.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -133.37 111.2 10.58 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.642 -1.244 . . . . 74.11 107.642 173.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -136.4 139.64 42.61 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.086 0.954 . . . . 64.54 108.655 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.54 HG21 HD11 ' D' ' 16' ' ' ILE . 7.4 mt -100.2 142.02 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 108.717 -0.846 . . . . 75.32 108.717 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -103.45 -34.6 8.65 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.324 0.65 . . . . 75.53 111.483 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -169.42 137.13 1.8 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.015 0.376 . . . . 74.25 112.015 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.54 HD11 HG21 ' D' ' 13' ' ' ILE . 3.5 mp -115.66 140.09 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 107.216 -1.402 . . . . 75.21 107.216 170.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.429 ' HB3' HG21 ' C' ' 122' ' ' THR . 38.3 p90 -168.72 171.08 8.92 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.977 0.911 . . . . 75.23 110.15 176.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -98.41 117.83 33.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.888 -1.051 . . . . 74.11 109.089 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.426 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 22.4 mtpt -85.79 -25.8 26.15 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.721 -0.844 . . . . 65.01 108.721 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.625 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 26.6 t70 -155.68 136.87 13.83 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.648 -1.16 . . . . 75.21 109.576 -178.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.554 HG23 ' HE1' ' C' ' 117' ' ' MET . 67.9 mt -136.59 146.84 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.326 1.05 . . . . 74.54 109.019 174.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -145.5 141.25 28.13 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.608 1.163 . . . . 72.21 109.515 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.491 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.1 t80 -145.67 134.52 22.44 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 106.415 -1.698 . . . . 74.21 106.415 165.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 50.0 mt-10 -135.03 144.99 47.6 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.94 0.896 . . . . 74.34 109.366 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.96 79.77 8.32 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 107.037 -1.468 . . . . 75.54 107.037 170.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.16 -15.49 28.73 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.821 2.347 . . . . 73.43 112.232 -175.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -114.78 16.38 17.38 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 124.383 1.073 . . . . 73.23 110.588 -174.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.55 -65.11 0.98 Allowed Pre-proline 0 CA--C 1.562 1.412 0 N-CA-C 115.067 1.506 . . . . 61.13 115.067 -159.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.622 ' HB3' HD11 ' C' ' 83' ' ' ILE . 57.4 Cg_endo -69.96 -22.98 30.42 Favored 'Trans proline' 0 C--N 1.392 2.833 0 CA-C-N 122.51 1.932 . . . . 73.22 113.484 -177.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -69.47 -44.63 70.79 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.275 1.03 . . . . 74.54 110.498 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' D' ' 73' ' ' ALA . 5.7 p -85.0 -18.52 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 123.192 0.597 . . . . 73.4 111.613 -170.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -60.9 -23.55 65.31 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 112.447 0.536 . . . . 74.02 112.447 172.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -63.8 -22.73 67.05 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.434 0.694 . . . . 63.21 110.919 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.545 ' NZ ' ' HB3' ' D' ' 71' ' ' GLU . 90.9 mttt -85.59 104.78 15.65 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.489 1.115 . . . . 73.42 109.599 176.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -102.09 90.56 3.99 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.379 -0.6 . . . . 64.52 109.379 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 35.4 p90 -165.42 -168.44 1.36 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.882 0.873 . . . . 75.11 109.624 171.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.404 HE21 ' HD2' ' D' ' 38' ' ' PRO . 27.3 tp60 -72.7 117.17 57.05 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.8 0.84 . . . . 74.43 110.497 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.404 ' HD2' HE21 ' D' ' 37' ' ' GLN . 53.0 Cg_exo -56.88 110.63 0.62 Allowed 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 121.788 1.659 . . . . 64.23 109.862 168.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -67.79 109.61 3.44 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.048 -1.093 . . . . 74.22 108.048 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.656 HG11 HG13 ' D' ' 64' ' ' VAL . 92.3 t -106.62 122.68 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.4 -0.364 . . . . 71.44 110.397 -170.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.458 ' HB3' ' HZ1' ' D' ' 41' ' ' LYS . 0.0 OUTLIER -106.95 119.29 38.97 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.726 -1.583 . . . . 71.31 106.726 172.856 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 45.3 tp -95.11 141.91 28.19 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.334 -0.987 . . . . 75.24 108.334 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -136.53 125.3 23.97 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.229 -1.397 . . . . 73.21 107.229 -177.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.411 ' CD2' HG21 ' D' ' 62' ' ' VAL . 83.6 mt -120.08 142.13 49.15 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.143 0.577 . . . . 74.11 110.491 -175.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -146.38 143.22 28.92 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.344 1.458 . . . . 74.02 107.612 174.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 46' ' ' THR . . . . . 0.433 ' HB ' HD21 ' E' ' 111' ' ' LEU . 15.2 t -103.95 165.37 11.09 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.983 -0.747 . . . . 72.21 108.983 176.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.584 ' HB1' ' HB ' ' D' ' 59' ' ' VAL . . . -151.37 147.44 26.92 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.258 -1.386 . . . . 65.51 107.258 175.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 6.4 p -167.69 -170.61 1.43 Allowed 'General case' 0 C--O 1.246 0.899 0 C-N-CA 123.753 0.821 . . . . 70.21 108.879 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 27.8 p -148.5 119.27 7.55 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.167 0.587 . . . . 63.2 109.432 -173.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . 0.495 ' HB3' ' HB2' ' E' ' 102' ' ' LEU . 29.2 pt20 -79.12 -28.04 42.91 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.279 0.632 . . . . 75.53 111.282 -177.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 57.0 tp -69.51 85.0 0.43 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.906 0.882 . . . . 74.3 109.528 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -177.84 161.73 1.63 Allowed 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.301 1.041 . . . . 64.21 110.578 -175.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -116.59 92.87 4.0 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.424 -0.954 . . . . 51.22 108.424 171.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' D' ' 85' ' ' SER . 3.5 m-20 68.82 5.46 4.99 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 114.05 1.13 . . . . 55.52 114.05 169.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 89.8 t -134.18 100.54 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.001 -1.111 . . . . 70.31 108.001 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.423 ' HH ' HD21 ' E' ' 100' ' ' LEU . 40.9 m-85 -117.84 138.47 52.07 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.034 0.934 . . . . 74.44 109.891 -170.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.667 ' HG2' HG13 ' D' ' 83' ' ' ILE . 33.8 mt-10 -87.95 108.34 19.15 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 108.521 -0.918 . . . . 72.2 108.521 170.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 97.4 t -101.08 123.79 54.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.77 -0.826 . . . . 64.23 108.77 175.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.584 ' HB ' ' HB1' ' D' ' 47' ' ' ALA . 21.3 t -114.24 130.86 67.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.994 -1.113 . . . . 74.34 107.994 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.558 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -105.35 119.81 40.01 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.792 -1.188 . . . . 71.52 107.792 -178.563 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -98.6 99.79 10.96 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.237 -1.024 . . . . 64.53 108.237 177.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.411 HG21 ' CD2' ' D' ' 44' ' ' LEU . 58.3 t -105.86 118.46 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 108.66 -0.867 . . . . 74.35 108.66 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.0 m -125.45 130.59 52.13 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.593 -0.73 . . . . 63.44 109.751 -170.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.656 HG13 HG11 ' D' ' 40' ' ' VAL . 70.3 t -113.22 130.6 66.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 124.845 1.258 . . . . 73.22 109.445 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 37.3 m -119.55 93.49 4.09 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.218 -1.401 . . . . 74.22 107.218 167.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.71 138.13 36.32 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.787 -0.82 . . . . 74.52 108.787 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.507 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 66.9 m -143.43 132.29 22.73 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.193 0.521 . . . . 75.54 111.232 -175.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 35.6 mt -95.55 99.26 11.16 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.482 -1.303 . . . . 64.12 107.482 173.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.57 -137.36 17.37 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.578 -0.737 . . . . 74.12 112.619 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.44 5.26 31.84 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.611 0.764 . . . . 74.14 111.95 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.545 ' HB3' ' NZ ' ' D' ' 34' ' ' LYS . 5.4 tp10 -136.6 145.67 45.17 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.194 0.998 . . . . 72.22 109.599 -169.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 91.8 m -59.83 135.95 57.85 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.741 1.217 . . . . 53.22 112.522 -175.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.507 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.6 -65.62 1.0 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.301 -1.37 . . . . 74.12 107.301 170.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -152.57 158.26 42.23 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 114.542 -1.208 . . . . 75.13 110.045 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.447 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 76.0 mt -116.84 155.02 29.73 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.867 1.267 . . . . 73.52 108.269 171.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.561 ' SG ' HG12 ' D' ' 114' ' ' ILE . 49.1 t -154.42 147.71 24.9 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.059 -0.719 . . . . 70.0 109.059 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -157.43 123.78 4.88 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.818 0.447 . . . . 64.11 110.129 174.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 50.2 t -124.3 116.93 49.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 123.523 0.729 . . . . 72.24 109.118 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.625 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.9 mt-30 -93.25 85.1 4.92 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.938 0.875 . . . . 72.55 109.08 171.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -80.4 102.64 9.74 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 113.713 -1.585 . . . . 71.33 109.465 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.84 150.83 21.31 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 116.742 -0.208 . . . . 73.5 113.219 -178.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.58 137.24 5.58 Favored Glycine 0 C--N 1.34 0.791 0 N-CA-C 112.092 -0.403 . . . . 52.24 112.092 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.667 HG13 ' HG2' ' D' ' 57' ' ' GLU . 2.6 mp -91.15 112.84 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 107.775 -1.194 . . . . 65.13 107.775 174.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -115.33 145.29 42.64 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.69 0.796 . . . . 73.43 109.669 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' D' ' 54' ' ' ASP . 39.8 m -116.29 107.78 15.27 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.836 0.854 . . . . 63.41 109.766 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.452 HD13 HD22 ' D' ' 98' ' ' LEU . 46.9 pt -116.8 129.35 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.387 0.675 . . . . 73.42 109.391 176.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.424 ' HB2' HG21 ' D' ' 10' ' ' THR . . . -143.49 158.18 43.85 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.675 0.79 . . . . 71.44 110.149 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.07 23.64 44.18 Favored Glycine 0 C--N 1.347 1.16 0 O-C-N 123.709 0.631 . . . . 73.4 114.247 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.423 HD11 ' HG3' ' D' ' 94' ' ' MET . 0.7 OUTLIER -134.85 160.94 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.476 0.71 . . . . 70.33 110.726 178.254 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.13 160.2 40.48 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.137 0.898 . . . . 75.14 111.019 -171.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.67 -141.35 36.52 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.194 -0.912 . . . . 71.54 113.945 175.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.5 p -78.41 -32.31 48.62 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.138 0.575 . . . . 74.23 110.739 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -56.46 -33.58 66.06 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.881 0.873 . . . . 74.23 111.266 177.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.537 ' SD ' HG21 ' E' ' 97' ' ' ILE . 40.0 ttp -62.44 -62.19 1.93 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.146 1.378 . . . . 71.22 112.165 177.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.28 -15.09 51.54 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.066 0.546 . . . . 53.32 112.176 -171.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -70.83 -26.59 63.35 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.109 0.564 . . . . 74.22 110.088 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.7 t -66.41 -45.65 79.21 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.273 0.629 . . . . 75.42 110.947 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.604 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 4.3 pp -74.35 -23.08 58.97 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 116.608 -0.269 . . . . 74.42 111.207 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.82 -28.59 34.44 Favored Glycine 0 C--N 1.348 1.23 0 O-C-N 123.458 0.474 . . . . 73.34 112.958 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.24 -57.37 2.01 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 117.332 0.566 . . . . 62.11 112.233 -170.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -72.48 -37.64 68.39 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.524 0.329 . . . . 74.24 111.833 -174.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.604 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 88.6 m -65.35 -46.62 70.81 Favored Pre-proline 0 CA--C 1.566 1.592 0 CA-C-O 118.775 -0.631 . . . . 73.41 112.198 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.558 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 76.2 Cg_exo -57.61 -31.3 91.4 Favored 'Trans proline' 0 C--N 1.394 2.923 0 C-N-CA 122.622 2.215 . . . . 74.34 113.902 168.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -65.57 -28.55 69.23 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.092 0.557 . . . . 61.43 111.186 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.4 mm -73.32 -35.29 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.316 0.646 . . . . 75.05 110.332 174.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 68.3 mt -77.1 -18.24 58.1 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.352 -0.84 . . . . 74.14 111.891 -177.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -70.46 -39.91 10.5 Favored Pre-proline 0 CA--C 1.557 1.218 0 N-CA-C 114.353 1.242 . . . . 74.4 114.353 -171.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.79 -44.9 45.15 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.962 1.775 . . . . 71.33 112.68 169.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -71.83 -32.58 67.69 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.845 0.858 . . . . 71.12 111.554 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.99 -50.52 64.01 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.467 0.707 . . . . 55.34 110.237 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.497 ' NH2' HG23 ' B' ' 105' ' ' ILE . 31.3 ttp180 -60.22 -43.06 96.31 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 124.353 1.033 . . . . 72.22 110.031 176.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -57.0 -52.77 63.94 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.102 0.876 . . . . 63.31 111.455 -176.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.437 ' O ' ' HG3' ' D' ' 117' ' ' MET . 43.2 t -57.06 -44.17 82.76 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 124.177 0.923 . . . . 73.3 110.598 -177.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.561 HG12 ' SG ' ' D' ' 76' ' ' CYS . 83.7 mt -60.62 -54.95 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.743 0.817 . . . . 73.31 110.696 175.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 77.2 m -53.43 -43.74 68.23 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.382 1.473 . . . . 62.2 111.055 -175.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -65.36 -45.9 82.31 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.403 -1.272 . . . . 72.04 109.805 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.448 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 71.2 mtm -70.87 -26.97 63.48 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.0 0.52 . . . . 73.43 112.391 -177.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.432 HG23 ' O ' ' D' ' 114' ' ' ILE . 71.0 t -68.64 -46.16 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.216 0.606 . . . . 70.51 109.419 175.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 81.5 p -70.75 -29.69 66.0 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.588 -0.733 . . . . 72.45 110.463 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -70.83 -34.15 71.41 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.815 0.846 . . . . 72.55 110.0 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.7 6.17 71.06 Favored Glycine 0 C--N 1.355 1.625 0 O-C-N 123.681 0.613 . . . . 53.14 113.203 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.419 HG22 ' HB3' ' C' ' 17' ' ' TYR . 65.3 p 56.18 28.94 13.87 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 126.39 1.876 . . . . 72.53 113.349 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -92.79 148.93 36.94 Favored Pre-proline 0 C--O 1.241 0.655 0 N-CA-C 108.598 -0.89 . . . . 75.54 108.598 167.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.35 125.96 13.04 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 123.318 2.679 . . . . 71.04 112.466 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -47.91 124.9 8.05 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 124.607 1.192 . . . . 74.54 112.149 -173.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.655 HD12 HG23 ' D' ' 40' ' ' VAL . 16.6 tp -106.49 106.1 16.46 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.165 0.986 . . . . 75.03 109.682 -176.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -109.47 83.01 1.68 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.322 1.049 . . . . 73.44 108.532 175.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.476 ' HA ' ' HB1' ' E' ' 125' ' ' ALA . 3.6 pp -62.98 141.91 58.57 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.958 0.503 . . . . 64.34 110.393 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.24 139.86 90.14 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 122.74 0.416 . . . . 75.42 111.609 -173.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.51 144.73 36.54 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.682 2.255 . . . . 75.51 111.365 176.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.99 145.59 23.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.815 0 C-N-CA 122.977 0.511 . . . . 71.22 110.129 -177.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -78.71 112.28 15.67 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.508 0.723 . . . . 71.42 109.24 176.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -65.57 -26.0 67.66 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.968 0.907 . . . . 74.23 112.146 -176.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -51.8 -47.02 64.43 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 124.384 1.052 . . . . 74.21 109.624 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.85 -43.5 98.25 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-N 113.846 -1.524 . . . . 73.31 111.705 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 7.0 mp -58.65 -35.83 73.16 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 124.51 1.124 . . . . 73.41 113.002 -171.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -69.76 -41.83 74.67 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.961 0.504 . . . . 74.25 110.896 178.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 70.9 mtm -74.65 -20.18 59.98 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.476 -0.783 . . . . 73.44 110.858 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.405 ' O ' ' HG2' ' D' ' 143' ' ' GLN . 76.3 m-20 -78.23 -30.42 48.74 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.107 0.963 . . . . 73.44 111.385 178.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -55.62 -33.95 64.46 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.02 0.928 . . . . 73.44 112.596 -177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.1 mp -71.41 -29.42 64.9 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.46 0.704 . . . . 72.33 110.696 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -82.53 -4.44 57.58 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.369 0.668 . . . . 73.34 112.09 -173.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' D' ' 139' ' ' ASN . 0.8 OUTLIER -123.35 83.24 2.1 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.857 0.863 . . . . 74.11 109.062 -173.639 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -164.94 173.73 11.3 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.677 1.191 . . . . 72.23 108.579 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.75 -65.82 0.62 Allowed 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 109.284 -0.636 . . . . 73.12 109.284 175.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 51.9 -95.38 0.01 OUTLIER Glycine 0 C--N 1.363 2.081 0 O-C-N 124.404 1.065 . . . . 71.45 112.384 -177.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -136.73 104.67 5.59 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 107.476 -1.305 . . . . 70.54 107.476 163.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 154.4 85.53 0.05 OUTLIER Glycine 0 C--N 1.339 0.748 0 O-C-N 123.721 0.638 . . . . 72.43 111.732 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 31.7 m -81.68 85.34 6.59 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.182 -0.674 . . . . 72.03 109.182 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -91.36 71.9 6.1 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.901 -0.778 . . . . 71.42 108.901 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.38 91.55 0.56 Allowed 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 115.225 -0.898 . . . . 74.21 109.385 176.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -73.07 90.99 1.56 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.717 -0.846 . . . . 75.1 108.717 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -70.24 132.76 46.22 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.086 -0.961 . . . . 74.24 110.163 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -91.67 152.92 20.01 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.516 -0.92 . . . . 71.35 108.516 174.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.262 0 CA-C-O 118.505 -0.759 . . . . 73.51 110.982 -178.052 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.838 0 N-CA-C 112.729 -0.149 . . . . 72.04 112.729 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.02 104.94 0.89 Allowed Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.383 -0.676 . . . . 62.25 112.163 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 49.1 t80 67.6 55.55 0.62 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.416 1.086 . . . . 74.31 109.921 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 73.07 132.56 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 125.926 1.69 . . . . 64.23 113.164 174.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 95' ' ' LYS . . . . . 0.425 ' HE2' ' HB2' ' E' ' 95' ' ' LYS . 0.0 OUTLIER -156.17 156.22 33.83 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-O 121.153 0.502 . . . . 74.35 110.383 167.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.48 -36.76 0.16 Allowed Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.105 -1.198 . . . . 73.34 110.105 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 97' ' ' ILE . . . . . 0.537 HG21 ' SD ' ' D' ' 94' ' ' MET . 86.4 mt -86.18 114.89 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.282 1.433 . . . . 62.33 107.819 173.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -100.29 0.89 41.04 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.687 0.795 . . . . 72.11 111.414 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -162.02 116.18 1.87 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.227 1.011 . . . . 72.41 109.439 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 100' ' ' LEU . . . . . 0.488 HD21 HG23 ' E' ' 97' ' ' ILE . 0.7 OUTLIER -112.52 99.4 47.17 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 123.255 0.622 . . . . 75.35 109.337 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -94.89 100.82 0.11 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 123.532 2.821 . . . . 75.11 110.413 165.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 102' ' ' LEU . . . . . 0.495 ' HB2' ' HB3' ' D' ' 50' ' ' GLN . 4.0 tt -79.79 73.12 6.54 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.543 0.737 . . . . 74.21 110.679 -169.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 62.6 p 51.29 12.02 0.13 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 125.994 1.718 . . . . 74.45 114.091 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 140.11 -65.09 0.52 Allowed Glycine 0 C--N 1.342 0.878 0 N-CA-C 109.738 -1.345 . . . . 54.13 109.738 -168.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -173.31 -38.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.836 1.255 . . . . 73.51 110.059 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -148.27 -160.57 1.19 Allowed 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 106.983 -1.488 . . . . 71.42 106.983 -172.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 16.0 m -52.14 88.19 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.727 1.211 . . . . 73.41 111.634 169.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 -79.21 -33.87 43.4 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.113 -0.949 . . . . 70.11 109.259 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -116.73 117.98 31.29 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.897 -1.149 . . . . 74.23 107.897 -178.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.98 142.53 58.4 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.03 0.832 . . . . 71.1 111.224 -177.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . 0.494 ' O ' HG22 ' E' ' 121' ' ' VAL . 5.5 mp -93.64 17.16 12.22 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.115 -0.948 . . . . 74.12 110.115 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -130.7 -164.77 1.47 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.588 1.155 . . . . 75.42 108.854 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -105.95 116.01 31.22 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.161 -0.681 . . . . 72.55 109.161 169.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -75.77 -23.65 55.94 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.723 0.809 . . . . 63.43 111.045 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 8.4 t -144.02 -45.45 0.26 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.992 0.517 . . . . 73.22 110.517 173.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 122.47 131.52 3.89 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-O 119.464 -0.631 . . . . 45.13 111.954 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -176.2 -58.89 0.0 OUTLIER Pre-proline 0 CA--C 1.564 1.494 0 C-N-CA 125.533 1.533 . . . . 75.15 108.938 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -81.94 -38.81 0.19 Allowed 'Trans proline' 0 C--N 1.397 3.112 0 C-N-CA 121.765 1.643 . . . . 75.44 112.475 175.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 54.3 38.52 29.54 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.87 1.268 . . . . 75.41 113.397 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -61.26 -38.08 85.44 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.08 0.552 . . . . 74.15 110.211 170.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 121' ' ' VAL . . . . . 0.494 HG22 ' O ' ' E' ' 111' ' ' LEU . 41.9 t -93.51 85.06 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.621 -1.251 . . . . 71.53 107.621 171.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 26.3 m -75.89 150.64 37.54 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.399 -1.273 . . . . 73.04 110.332 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -87.48 45.86 1.32 Allowed 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.989 0.899 . . . . 62.52 110.437 174.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 35.0 t -159.84 139.05 11.0 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.719 1.207 . . . . 72.2 108.201 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . 0.476 ' HB1' ' HA ' ' D' ' 128' ' ' LEU . . . -146.06 159.86 42.69 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.351 0.66 . . . . 73.43 110.511 -175.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.36 125.34 26.72 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.242 0.617 . . . . 62.4 109.787 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 42.0 t -161.53 166.88 26.4 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.56 0.744 . . . . 55.32 109.787 -178.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.72 170.16 15.39 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.624 0.77 . . . . 61.0 110.924 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 2.1 p -125.56 10.66 7.88 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.039 0.935 . . . . 75.13 111.006 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -144.22 146.18 32.52 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.257 0.623 . . . . 72.22 110.728 -175.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 131' ' ' TRP . . . . . . . . . . . . . 39.5 t-105 -162.4 169.69 20.06 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 124.045 0.938 . . . . 74.44 109.68 177.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 132' ' ' SER . . . . . 0.496 ' N ' ' HB3' ' A' ' 124' ' ' PRO . 24.1 m 74.16 105.47 0.07 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.758 1.623 . . . . 74.54 111.171 178.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 87.9 m -65.65 -31.84 73.08 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.325 1.05 . . . . 74.02 111.822 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.9 78.93 1.26 Allowed Glycine 0 C--N 1.342 0.883 0 N-CA-C 110.507 -1.037 . . . . 73.32 110.507 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 135' ' ' VAL . . . . . 0.416 HG13 ' HB ' ' C' ' 13' ' ' ILE . 58.2 t -73.49 126.63 34.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 123.579 0.751 . . . . 71.24 110.672 -175.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -114.06 177.42 4.65 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.352 1.061 . . . . 74.15 109.77 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 3.7 m -93.26 18.62 9.25 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.352 0.661 . . . . 75.31 110.391 176.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 71.5 t80 65.48 -76.7 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.152 1.381 . . . . 74.3 111.457 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 139' ' ' ASN . . . . . 0.459 HD21 ' HB3' ' A' ' 154' ' ' ASP . 6.2 t30 -90.13 -50.09 6.2 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.473 0.709 . . . . 74.34 109.231 177.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.03 164.96 54.81 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.793 -0.639 . . . . 72.1 113.015 -175.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -110.07 172.6 6.77 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.858 0.863 . . . . 73.34 109.985 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 46.2 tp -86.1 139.44 31.11 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.606 0.363 . . . . 73.44 110.196 175.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -97.1 -107.32 2.47 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-O 119.418 -0.657 . . . . 73.33 111.509 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 144' ' ' VAL . . . . . 0.441 HG11 ' HB2' ' C' ' 54' ' ' ASP . 40.4 t 58.97 84.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.562 1.145 . . . . 75.31 109.565 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 32.8 t70 . . . . . 0 C--O 1.252 1.194 0 C-N-CA 123.388 0.675 . . . . 73.11 110.895 -174.16 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.43 0 N-CA-C 111.593 -0.603 . . . . 64.33 111.593 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.35 39.35 3.12 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 114.344 0.498 . . . . 75.34 114.344 -174.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -89.91 89.46 7.74 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.535 -0.913 . . . . 75.34 108.535 172.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -113.53 173.66 6.3 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.367 1.067 . . . . 74.0 111.173 -174.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -130.31 153.8 48.29 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.076 0.95 . . . . 74.44 110.744 -175.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -166.94 -59.18 0.03 OUTLIER Glycine 0 C--N 1.352 1.454 0 O-C-N 123.545 0.528 . . . . 71.12 112.017 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 97' ' ' ILE . . . . . 0.525 HG22 ' HB2' ' F' ' 100' ' ' LEU . 37.0 mt -67.61 131.97 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 124.298 1.039 . . . . 75.51 109.291 173.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -85.62 7.0 24.93 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.239 0.829 . . . . 61.31 113.239 -176.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -158.16 -84.87 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 118.408 0.549 . . . . 73.22 111.47 -175.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 100' ' ' LEU . . . . . 0.744 HD11 HD21 ' B' ' 98' ' ' LEU . 38.5 tp 56.77 84.27 0.21 Allowed Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 124.812 1.245 . . . . 74.04 111.497 -175.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -90.47 6.77 3.92 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.853 2.369 . . . . 74.34 113.127 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 102' ' ' LEU . . . . . 0.51 HD22 ' HB2' ' B' ' 50' ' ' GLN . 3.6 mm? 60.71 14.13 4.83 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.913 0.885 . . . . 75.14 111.089 -176.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 9.2 p 45.5 36.39 2.46 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.951 1.7 . . . . 74.12 113.307 -171.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.71 172.93 16.08 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 116.251 -0.431 . . . . 75.5 112.376 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -67.69 -51.92 43.9 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.234 1.014 . . . . 75.13 110.824 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -110.6 141.94 43.12 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.196 -1.039 . . . . 74.51 108.196 175.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 32.4 m -72.47 118.01 14.84 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.33 0.652 . . . . 73.15 110.552 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -81.86 50.29 1.51 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.199 0.999 . . . . 75.44 110.397 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -169.19 45.79 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 106.395 -1.706 . . . . 73.12 106.395 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.49 147.49 47.73 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.877 -1.056 . . . . 73.04 109.636 176.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . 0.565 HD22 HD23 ' B' ' 136' ' ' LEU . 5.7 mp -79.61 3.74 18.09 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.374 0.67 . . . . 74.33 112.32 -171.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -152.92 -65.91 0.16 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.392 0.677 . . . . 72.2 109.428 177.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt 58.18 -96.06 0.06 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.283 1.033 . . . . 74.13 109.433 -172.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -169.19 -33.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 126.261 1.825 . . . . 75.03 108.637 171.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 8.9 m -88.7 16.61 6.46 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 124.086 0.954 . . . . 63.03 110.115 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.39 119.9 18.66 Favored Glycine 0 C--N 1.356 1.692 0 CA-C-N 116.338 -0.392 . . . . 63.42 112.604 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.34 159.39 83.6 Favored Pre-proline 0 N--CA 1.476 0.838 0 CA-C-O 117.503 -1.237 . . . . 72.31 109.148 175.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -24.2 103.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.398 3.143 1 C-N-CA 125.574 4.183 . . . . 72.3 114.438 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -89.69 -177.95 5.4 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.592 1.157 . . . . 73.12 112.214 -168.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -121.38 -8.08 9.18 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 115.045 -0.979 . . . . 73.35 110.903 -178.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 13.6 p -77.94 -29.62 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 122.749 0.42 . . . . 61.43 110.953 -176.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 43.8 p 56.26 -170.37 0.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 125.964 1.706 . . . . 73.53 112.569 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -53.52 -67.72 0.23 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.593 0.757 . . . . 72.12 111.079 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 124' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' B' ' 129' ' ' ALA . 23.3 t -173.28 -22.3 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.208 0.603 . . . . 75.41 110.303 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . 56.55 29.63 15.84 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.526 1.131 . . . . 75.24 110.909 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.74 74.17 6.63 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.962 -1.017 . . . . 75.15 110.6 -170.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 21.8 m -86.09 59.52 5.68 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.223 -0.899 . . . . 73.31 110.157 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -155.73 4.36 0.19 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.196 0.999 . . . . 74.34 110.826 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 129' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' B' ' 125' ' ' GLN . 16.5 p -75.56 91.8 2.86 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.805 0.842 . . . . 62.31 111.26 -177.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -150.75 147.4 27.27 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.508 1.123 . . . . 71.52 109.313 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 35.3 t90 -124.33 -69.71 0.79 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.024 0.53 . . . . 75.33 111.15 -178.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 53.7 m -64.01 112.8 3.12 Favored 'General case' 0 C--N 1.363 1.192 0 CA-C-O 121.094 0.473 . . . . 74.21 111.512 -173.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 9.0 t -124.26 -174.27 2.96 Favored 'General case' 0 C--O 1.244 0.763 0 C-N-CA 124.476 1.11 . . . . 65.14 108.992 175.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.13 69.79 2.44 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 120.377 -0.124 . . . . 72.53 113.139 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 6.1 m -85.36 87.82 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-O 122.178 0.99 . . . . 75.31 109.549 173.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.52 -172.95 3.84 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.133 -0.939 . . . . 74.13 109.771 174.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 32.5 m -59.59 127.28 31.22 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.441 -0.948 . . . . 75.23 108.441 172.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -61.86 86.63 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 O-C-N 124.321 1.013 . . . . 75.34 112.184 -170.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -173.63 142.82 0.97 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.186 -1.37 . . . . 72.41 108.454 -173.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -82.77 143.96 22.71 Favored Glycine 0 C--N 1.342 0.878 0 N-CA-C 112.053 -0.419 . . . . 71.43 112.053 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -150.82 -92.63 0.06 Allowed 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.258 -1.015 . . . . 75.12 108.258 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 19.1 mt -155.26 88.66 1.17 Allowed 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 107.276 -1.379 . . . . 75.11 107.276 165.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.92 73.07 1.98 Allowed Glycine 0 C--N 1.348 1.236 0 N-CA-C 111.654 -0.579 . . . . 70.3 111.654 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 29.9 m -114.19 138.54 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.53 1.132 . . . . 71.33 110.998 -171.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 C--O 1.248 0.99 0 C-N-CA 124.048 0.939 . . . . 62.44 109.256 168.207 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.7 ttm . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 107.73 -1.211 . . . . 72.41 107.73 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.0 m -58.88 95.79 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.623 0.769 . . . . 71.45 112.45 -167.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -77.49 151.18 34.74 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.829 0.852 . . . . 70.0 110.833 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.1 134.34 43.17 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.012 0.925 . . . . 75.35 109.604 177.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -80.14 147.35 31.4 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.152 0.581 . . . . 72.35 109.964 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -88.44 147.73 24.55 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.993 0.517 . . . . 65.1 110.03 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -113.69 -8.1 13.27 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.72 0.808 . . . . 74.12 110.675 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -106.11 79.54 1.41 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.594 0.758 . . . . 74.22 110.434 -174.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -123.28 174.24 7.42 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.901 0.88 . . . . 55.31 109.987 175.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.3 m -141.21 116.07 9.76 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.404 1.082 . . . . 75.24 108.218 169.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -120.96 119.77 33.54 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.978 0.911 . . . . 65.43 109.211 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -135.25 132.47 37.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.006 0.923 . . . . 73.44 108.586 174.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.531 HD12 HG21 ' A' ' 105' ' ' ILE . 4.8 mt -96.17 114.47 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 108.617 -0.883 . . . . 73.3 108.617 173.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -78.32 -32.95 49.52 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.014 0.525 . . . . 75.1 110.249 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -171.85 148.69 2.37 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 123.378 0.424 . . . . 75.14 110.144 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.2 mt -133.12 135.26 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 124.632 1.173 . . . . 73.45 108.502 173.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -163.2 171.74 15.81 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 123.982 0.801 . . . . 75.32 112.104 -171.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -101.78 124.39 47.34 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.366 -0.976 . . . . 72.21 108.366 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -85.91 -35.69 20.36 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.039 0.447 . . . . 74.25 109.889 175.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.518 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 19.7 t70 -146.66 138.96 24.9 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.15 -0.932 . . . . 74.11 109.401 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 81.0 mt -129.11 140.32 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.009 -1.108 . . . . 71.2 108.009 174.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.7 t -138.87 123.67 18.71 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.365 0.666 . . . . 72.11 109.279 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 86.9 t80 -133.59 129.38 36.89 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.265 -1.754 . . . . 74.33 106.265 170.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -139.17 124.45 19.11 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.955 -1.128 . . . . 74.13 107.955 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.7 89.26 7.42 Favored Pre-proline 0 C--O 1.241 0.658 0 N-CA-C 107.886 -1.153 . . . . 71.44 107.886 175.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -52.31 -53.39 7.0 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 123.684 2.923 . . . . 72.24 113.504 -169.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.26 41.27 2.83 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.779 -0.823 . . . . 74.53 108.779 -173.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.433 ' O ' HG11 ' A' ' 31' ' ' VAL . . . -44.66 -59.13 4.34 Favored Pre-proline 0 N--CA 1.495 1.789 0 CA-C-O 117.584 -1.198 . . . . 71.21 113.968 -171.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.431 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 20.9 Cg_exo -62.37 -22.54 74.22 Favored 'Trans proline' 0 C--N 1.389 2.669 0 CA-C-N 121.952 1.733 . . . . 74.5 112.618 -177.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -94.47 -28.36 15.5 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.613 1.165 . . . . 72.21 111.244 -173.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.433 HG11 ' O ' ' A' ' 28' ' ' ALA . 5.9 p -80.05 -17.09 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 122.698 0.399 . . . . 62.13 111.877 -170.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -78.23 -24.12 47.11 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.393 0.677 . . . . 75.24 111.206 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -92.56 -16.08 26.15 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.782 0.833 . . . . 75.35 110.687 176.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -67.57 157.81 33.5 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.29 0.636 . . . . 74.04 111.156 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -67.54 116.63 8.48 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.401 -0.963 . . . . 72.42 108.401 171.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.42 ' CE3' HD21 ' A' ' 68' ' ' LEU . 73.7 t-105 -83.8 82.13 8.46 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.092 0.557 . . . . 72.53 110.372 -175.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -115.16 81.78 8.33 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 107.572 -1.27 . . . . 74.51 107.572 168.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -86.53 121.34 1.88 Allowed 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.424 2.083 . . . . 73.4 112.499 -173.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.577 ' HG3' ' HZ3' ' E' ' 136' ' ' LYS . 37.1 tt0 -94.95 95.45 8.64 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.069 -1.456 . . . . 75.31 107.069 168.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.731 HG23 ' HB1' ' A' ' 66' ' ' ALA . 48.0 t -85.71 104.38 13.41 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-N 115.727 -0.67 . . . . 74.23 109.554 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.543 ' HB2' ' HZ2' ' A' ' 41' ' ' LYS . 7.1 mtmp? -79.18 121.44 25.03 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.025 -1.102 . . . . 73.32 108.025 173.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tt -96.19 105.12 17.13 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 105.841 -1.911 . . . . 75.52 105.841 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -112.39 145.25 40.44 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 107.907 -1.146 . . . . 73.41 107.907 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.492 HD11 HG22 ' A' ' 131' ' ' VAL . 90.1 mt -136.82 146.98 46.3 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.913 0.485 . . . . 74.12 112.094 -171.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -155.09 117.52 4.25 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.906 -1.043 . . . . 73.12 108.765 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.404 HG22 ' HG3' ' A' ' 103' ' ' PRO . 54.3 m -117.5 126.9 53.4 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.068 0.547 . . . . 71.31 109.997 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.52 127.15 23.42 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.179 0.591 . . . . 75.23 109.94 176.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 61.7 p -101.82 170.72 7.97 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.943 0.897 . . . . 64.33 111.391 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 94.5 p -150.17 124.4 9.48 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.94 0.896 . . . . 53.1 109.382 -173.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -78.88 103.7 9.0 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.187 -0.671 . . . . 73.31 109.187 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.42 HD13 ' HB2' ' A' ' 57' ' ' GLU . 69.9 mt -79.39 -26.8 41.87 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.512 0.725 . . . . 75.52 110.848 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.14 -175.08 2.51 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.918 0.887 . . . . 73.4 110.049 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.92 112.33 2.27 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 109.152 -0.684 . . . . 70.22 109.152 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 68.21 6.33 5.21 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.745 1.218 . . . . 75.22 112.884 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.6 t -105.16 116.23 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.014 -1.106 . . . . 62.43 108.014 173.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -132.25 127.33 35.49 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.302 -0.999 . . . . 73.1 108.302 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.42 ' HB2' HD13 ' A' ' 51' ' ' LEU . 23.9 tt0 -88.55 143.37 27.0 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 108.036 -1.098 . . . . 74.22 108.036 167.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.6 t -118.51 134.67 61.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.049 -1.093 . . . . 74.14 108.049 170.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.8 t -117.72 124.46 73.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 108.607 -0.886 . . . . 73.55 108.607 174.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.23 119.68 39.49 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.535 -1.283 . . . . 72.22 107.535 175.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 46.3 ttp85 -109.48 100.98 9.98 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.559 -1.274 . . . . 74.24 107.559 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 43.7 t -96.23 103.0 14.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 114.204 -1.362 . . . . 71.21 107.909 -178.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.8 m -96.27 107.45 19.8 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 122.066 0.936 . . . . 75.52 108.918 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.427 ' O ' HD12 ' A' ' 75' ' ' LEU . 43.4 t -104.72 135.91 40.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 114.599 -1.182 . . . . 74.03 108.592 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 35.7 m -138.1 126.43 23.17 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.497 -0.557 . . . . 75.32 109.497 173.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.731 ' HB1' HG23 ' A' ' 40' ' ' VAL . . . -105.31 130.34 53.45 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.326 -1.361 . . . . 70.34 107.326 173.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 54.9 m -136.52 134.15 37.23 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.7 0.625 . . . . 74.41 110.507 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.42 HD21 ' CE3' ' A' ' 36' ' ' TRP . 23.7 mt -87.25 69.12 10.01 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 107.532 -1.284 . . . . 75.03 107.532 174.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.26 -100.83 1.3 Allowed Glycine 0 C--N 1.346 1.117 0 CA-C-N 114.307 -1.315 . . . . 74.22 111.939 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -91.14 -27.54 18.47 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.931 0.892 . . . . 75.42 111.604 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -91.33 123.02 34.45 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.485 -0.561 . . . . 74.35 109.485 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.9 m -71.49 129.96 40.07 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.029 0.443 . . . . 74.12 110.431 172.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.33 -52.2 8.41 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.389 1.075 . . . . 75.12 109.162 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -160.47 160.49 32.11 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.225 -0.898 . . . . 73.22 111.615 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 64' ' ' VAL . 63.9 tp -112.68 143.53 43.74 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.806 1.242 . . . . 74.31 108.132 166.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 88.5 m -143.75 98.81 3.3 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.86 0.864 . . . . 74.21 109.651 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 35.0 tt0 -122.37 116.12 23.48 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.915 -0.772 . . . . 64.05 108.915 -176.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.6 t -124.38 122.28 63.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 121.441 0.638 . . . . 64.41 109.885 -177.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -99.75 82.07 2.55 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.298 -1.319 . . . . 71.12 108.019 -178.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -76.02 94.47 3.43 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.038 -0.983 . . . . 74.14 109.11 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.05 150.99 21.8 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.664 -0.698 . . . . 75.41 111.383 177.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.76 132.68 3.35 Favored Glycine 0 CA--C 1.507 -0.446 0 N-CA-C 111.017 -0.833 . . . . 61.11 111.017 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.7 mt -81.41 127.07 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.384 -0.969 . . . . 71.1 108.384 175.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.554 ' HB3' HD11 ' A' ' 86' ' ' ILE . 95.8 m-85 -124.81 120.02 30.52 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.311 1.044 . . . . 72.35 108.618 -177.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.9 m -92.67 99.2 11.94 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.346 -1.353 . . . . 64.14 107.346 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.554 HD11 ' HB3' ' A' ' 84' ' ' PHE . 10.9 mm -117.15 145.99 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 122.787 0.435 . . . . 73.31 110.118 -174.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.91 169.95 17.41 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.688 0.617 . . . . 74.43 110.859 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.45 -15.12 63.36 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.702 -0.681 . . . . 63.51 112.824 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.45 164.54 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 124.188 0.995 . . . . 73.31 110.412 -177.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.605 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 13.8 tt0 -154.8 -177.74 6.72 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 109.402 -0.592 . . . . 74.12 109.402 173.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.537 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 67.53 -122.14 16.84 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 123.208 0.433 . . . . 65.44 113.513 176.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.5 t -74.36 -28.94 61.36 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.711 0.804 . . . . 73.22 111.522 -176.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -73.64 -37.29 65.38 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.518 0.727 . . . . 75.0 109.582 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.605 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 3.2 tpt -66.24 -42.79 88.09 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.237 -0.892 . . . . 73.23 110.053 175.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.18 88.82 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.362 -0.835 . . . . 50.41 111.109 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.473 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 55.8 t-80 -74.9 -20.53 59.68 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.014 0.526 . . . . 73.43 111.163 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.5 t -78.21 -49.01 14.57 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.785 -0.572 . . . . 75.15 109.539 174.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 76.1 mt -78.81 -31.44 45.9 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.245 0.618 . . . . 75.22 112.575 -172.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.35 4.41 51.36 Favored Glycine 0 N--CA 1.47 0.953 0 CA-C-O 119.649 -0.528 . . . . 75.15 113.583 -174.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.537 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -144.47 -63.64 0.36 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.448 0.624 . . . . 65.21 112.009 -175.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -69.61 -47.1 64.63 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 112.083 0.401 . . . . 73.14 112.083 -172.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 88.8 m -65.78 -47.13 66.26 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.401 1.08 . . . . 60.33 112.966 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.404 ' HG3' HG22 ' A' ' 46' ' ' THR . 37.8 Cg_endo -65.0 -24.81 59.75 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 122.023 1.815 . . . . 74.24 112.955 173.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -68.83 -33.69 74.25 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.13 0.572 . . . . 73.31 110.505 174.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.531 HG21 HD12 ' A' ' 13' ' ' ILE . 43.8 mm -68.3 -42.44 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.77 0.828 . . . . 73.52 110.4 172.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.8 mt -74.25 -25.01 59.38 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.054 -0.976 . . . . 75.44 112.089 -174.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -64.69 -40.87 52.73 Favored Pre-proline 0 CA--C 1.558 1.282 0 N-CA-C 114.49 1.293 . . . . 75.42 114.49 -171.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -52.55 -42.05 64.33 Favored 'Trans proline' 0 C--N 1.385 2.452 0 CA-C-N 121.966 1.738 . . . . 73.34 113.23 170.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -73.43 -40.28 64.36 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.533 0.733 . . . . 75.2 111.318 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.52 -46.59 82.25 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.483 0.713 . . . . 65.32 110.106 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.541 ' NH1' HD13 ' C' ' 105' ' ' ILE . 29.8 ttm180 -52.06 -50.43 61.51 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.959 1.304 . . . . 74.54 110.869 174.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -62.6 -47.79 82.26 Favored 'General case' 0 C--N 1.346 0.429 0 O-C-N 124.431 1.082 . . . . 70.15 111.436 -175.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.414 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 49.7 t -57.51 -42.76 83.42 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 124.173 0.921 . . . . 74.45 110.455 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.588 HD13 HD12 ' A' ' 128' ' ' LEU . 96.6 mt -60.97 -50.13 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.488 1.115 . . . . 73.14 110.607 175.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.0 m -61.33 -39.31 90.08 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.015 0.926 . . . . 74.13 111.379 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -69.89 -43.11 72.45 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.98 -1.009 . . . . 71.21 109.813 -177.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 6.9 mtp -56.97 -43.95 82.14 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.774 0.83 . . . . 75.01 111.129 174.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.8 t -62.07 -47.11 94.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.556 1.142 . . . . 74.3 111.101 179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.7 p -73.95 -29.38 61.98 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 122.906 0.483 . . . . 75.42 111.654 -176.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.444 ' NH1' ' HA ' ' B' ' 113' ' ' CYS . 68.4 mtt-85 -71.62 -30.93 66.33 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.214 0.606 . . . . 70.14 109.627 174.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.92 14.24 44.34 Favored Glycine 0 C--N 1.35 1.33 0 CA-C-N 115.413 -0.812 . . . . 74.32 112.976 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.477 HG23 ' HE ' ' B' ' 15' ' ' ARG . 3.2 t 57.31 13.8 1.88 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 127.156 2.183 . . . . 71.31 113.605 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -77.47 142.14 66.52 Favored Pre-proline 0 C--O 1.244 0.774 0 N-CA-C 108.903 -0.777 . . . . 73.32 108.903 175.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.545 ' HB3' ' HA ' ' E' ' 131' ' ' TRP . 41.5 Cg_exo -43.84 128.25 6.88 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 123.612 2.875 . . . . 74.51 112.622 170.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -55.35 131.88 46.76 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.22 0.95 . . . . 65.41 112.375 -167.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.623 HD13 HG12 ' A' ' 40' ' ' VAL . 42.6 tp -112.62 117.16 31.51 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.751 1.22 . . . . 75.24 109.932 -174.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -121.14 104.61 9.9 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.028 -0.73 . . . . 72.23 109.028 -174.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.588 HD12 HD13 ' A' ' 114' ' ' ILE . 79.2 mt -61.81 144.69 54.42 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.367 0.667 . . . . 73.34 112.336 -173.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.405 ' H ' HG23 ' E' ' 135' ' ' VAL . . . -70.98 144.84 90.82 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.299 0.64 . . . . 72.32 110.304 177.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.432 ' HA ' HH22 ' A' ' 111' ' ' ARG . 24.8 Cg_exo -64.05 117.51 4.52 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.834 2.356 . . . . 71.34 112.599 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.492 HG22 HD11 ' A' ' 44' ' ' LEU . 87.9 t -100.22 132.6 45.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-N 116.126 -0.488 . . . . 73.22 110.299 -179.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.432 ' OD1' ' HB3' ' A' ' 134' ' ' ASP . 63.7 t30 -97.59 92.94 6.15 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.725 -1.213 . . . . 74.12 107.725 172.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -65.3 -25.18 67.52 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.577 0.751 . . . . 64.32 111.355 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.537 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 1.1 t70 -54.74 -48.27 72.79 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.958 0.903 . . . . 72.32 110.291 168.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.514 ' HB3' ' HB2' ' C' ' 2' ' ' SER . . . -62.81 -45.41 92.77 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.571 0.748 . . . . 44.12 111.711 177.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.45 HD23 ' HE2' ' C' ' 1' ' ' MET . 95.5 mt -61.74 -35.98 79.66 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.365 0.666 . . . . 74.24 111.396 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -75.04 -35.68 61.89 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.504 -0.771 . . . . 73.43 109.858 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.602 ' SD ' HD22 ' A' ' 141' ' ' LEU . 17.8 mmt -57.99 -40.62 81.16 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 123.575 0.547 . . . . 73.13 111.464 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -49.77 -38.54 34.46 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.793 0.837 . . . . 74.41 111.966 177.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -88.83 -37.56 15.28 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.193 0.997 . . . . 73.44 111.514 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.602 HD22 ' SD ' ' A' ' 138' ' ' MET . 41.2 tp -62.65 -54.19 43.19 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.734 0.814 . . . . 75.42 111.954 -169.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -169.82 -14.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 124.709 1.203 . . . . 75.31 110.746 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 14.3 tm0? 65.73 62.8 0.62 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.037 1.335 . . . . 72.14 108.674 -175.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -148.65 169.48 20.28 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.422 -0.808 . . . . 75.34 111.887 -173.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.36 167.36 18.6 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.542 -1.208 . . . . 73.15 110.888 170.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 139.53 93.75 0.26 Allowed Glycine 0 C--N 1.347 1.171 0 N-CA-C 110.946 -0.861 . . . . 70.01 110.946 -178.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -137.41 -85.29 0.31 Allowed 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 108.347 -0.983 . . . . 65.13 108.347 -176.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 64.65 63.97 3.89 Favored Glycine 0 C--N 1.355 1.618 0 N-CA-C 114.703 0.641 . . . . 63.2 114.703 171.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.7 t -84.85 161.81 19.76 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.626 0.37 . . . . 74.01 111.141 175.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -151.48 126.93 10.03 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.558 0.743 . . . . 74.2 109.05 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.51 102.7 3.91 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.875 0.87 . . . . 74.5 111.112 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.546 ' HA ' ' SD ' ' C' ' 138' ' ' MET . 10.8 m170 -148.99 128.66 13.22 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.429 0.692 . . . . 74.45 111.131 175.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -113.47 21.36 15.22 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.656 1.183 . . . . 62.24 110.189 173.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -108.22 140.57 41.26 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.64 0.776 . . . . 72.2 109.225 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.291 0 C-N-CA 124.0 0.92 . . . . 71.41 109.291 179.621 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.472 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 109.538 -0.542 . . . . 70.25 109.538 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 25.9 p -168.19 99.66 0.44 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.879 0.872 . . . . 75.43 109.287 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.484 ' H ' ' HB3' ' F' ' 99' ' ' ALA . 7.8 tp10 -123.75 173.52 8.08 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.365 0.666 . . . . 63.5 109.588 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.445 ' H ' ' HG3' ' B' ' 3' ' ' GLU . 17.2 mm-40 -76.26 -90.09 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.693 0.797 . . . . 73.21 112.044 -164.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -169.0 153.54 5.66 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.145 0.978 . . . . 72.51 109.176 -175.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . 0.487 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 57.5 t30 -162.95 129.95 3.53 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.044 -1.095 . . . . 72.3 108.044 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 19.0 p -105.77 177.72 4.77 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.368 0.667 . . . . 74.13 112.121 -173.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 80.08 -43.73 0.26 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 126.621 1.968 . . . . 73.01 112.463 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.579 ' HE3' ' SG ' ' B' ' 97' ' ' CYS . 11.8 ptm 65.12 171.41 0.21 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 126.605 1.962 . . . . 71.03 115.442 172.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 5.0 t -135.79 126.93 28.04 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.46 -1.245 . . . . 75.52 107.701 168.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.411 ' HB2' ' HE2' ' B' ' 9' ' ' MET . 59.0 t80 -130.82 144.18 51.27 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.909 0.484 . . . . 75.41 110.132 -176.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.414 ' HB3' ' HE2' ' F' ' 94' ' ' PHE . 59.0 tt0 -150.28 141.92 23.58 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 108.693 -0.855 . . . . 72.31 108.693 169.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.482 HD12 HD11 ' B' ' 16' ' ' ILE . 63.1 mt -81.44 125.2 39.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.527 -1.286 . . . . 73.1 107.527 171.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . 0.543 ' HB2' HG23 ' B' ' 83' ' ' ILE . 9.3 mm100 -90.16 -39.06 13.07 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.785 -0.45 . . . . 65.43 109.785 -176.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.477 ' HE ' HG23 ' A' ' 122' ' ' THR . 43.2 ttt180 -176.97 134.48 0.2 Allowed 'General case' 0 N--CA 1.477 0.917 0 O-C-N 123.919 0.762 . . . . 75.15 109.81 176.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.551 ' HB ' ' ND2' ' D' ' 127' ' ' ASN . 96.7 mt -115.63 141.37 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 107.851 -1.166 . . . . 71.41 107.851 173.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -168.44 151.35 5.41 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-O 121.386 0.613 . . . . 74.44 111.568 -174.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 89.5 m -79.06 126.9 31.3 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.953 -1.021 . . . . 71.4 109.24 172.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -89.61 -42.74 11.22 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.73 0.412 . . . . 70.01 110.071 169.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.478 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.1 t70 -140.65 136.82 33.07 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.573 -0.285 . . . . 75.43 110.541 -169.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.575 HD13 ' SG ' ' B' ' 113' ' ' CYS . 46.6 mm -126.18 137.09 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.015 0.926 . . . . 74.01 108.772 169.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.486 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 47.7 t -140.52 131.62 26.34 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.686 1.194 . . . . 75.23 107.866 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 80.2 t80 -143.68 121.81 12.18 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.319 -1.734 . . . . 73.0 106.319 170.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -126.71 113.59 16.87 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.117 -1.068 . . . . 75.22 108.117 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.464 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -106.7 87.21 2.66 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 106.633 -1.617 . . . . 65.1 106.633 167.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.66 -27.85 52.69 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.327 2.018 . . . . 74.21 110.962 -172.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.415 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 67.5 m-20 -109.82 11.49 24.31 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.507 1.123 . . . . 71.4 110.939 -177.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.464 ' HB1' ' HB2' ' B' ' 25' ' ' ALA . . . -30.48 -64.34 0.21 Allowed Pre-proline 0 N--CA 1.5 2.049 0 C-N-CA 125.517 1.527 . . . . 64.51 114.699 -172.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.422 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 14.3 Cg_exo -60.48 -34.8 92.52 Favored 'Trans proline' 0 C--N 1.395 3.015 0 C-N-CA 122.729 2.286 . . . . 72.42 112.199 -170.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.412 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 80.5 m80 -92.52 -39.76 11.19 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 114.442 -1.253 . . . . 73.44 112.39 -170.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -69.76 -12.66 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.032 0.533 . . . . 74.33 111.808 -171.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -69.76 -6.7 33.82 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.651 0.78 . . . . 74.45 112.92 173.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.42 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 29.4 pt20 -67.9 -22.11 65.1 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.816 0.447 . . . . 74.44 110.168 169.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.508 ' HZ1' ' HG2' ' B' ' 71' ' ' GLU . 92.6 mttt -101.43 92.79 5.08 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.672 1.189 . . . . 74.31 109.869 -176.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -99.17 82.5 2.72 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.623 0.769 . . . . 73.15 110.057 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -157.01 -177.97 7.02 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.733 0.813 . . . . 72.03 109.61 172.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.706 ' HG3' ' HB ' ' F' ' 129' ' ' THR . 26.9 tt0 -66.86 114.77 19.41 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.63 0.772 . . . . 64.01 110.588 175.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.528 ' HA ' HD21 ' B' ' 68' ' ' LEU . 41.8 Cg_endo -66.3 144.36 74.02 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 121.597 1.531 . . . . 73.55 110.678 172.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -71.4 113.3 8.29 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.525 -0.917 . . . . 73.24 108.525 172.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.582 HG12 HD13 ' B' ' 126' ' ' LEU . 57.4 t -106.5 150.41 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.063 0.945 . . . . 73.52 111.378 -170.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -138.0 119.29 14.66 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.925 1.29 . . . . 74.04 107.854 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.473 HD12 HG21 ' B' ' 64' ' ' VAL . 23.3 tp -85.43 138.62 32.13 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.359 -0.978 . . . . 74.44 108.359 173.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -140.05 112.38 7.77 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.858 -1.164 . . . . 73.02 107.858 -171.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 88.4 mt -103.1 139.57 38.45 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.275 0.63 . . . . 74.12 110.778 -171.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -148.28 146.02 28.43 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.126 1.37 . . . . 74.22 107.638 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.4 t -151.24 110.91 4.02 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 121.432 0.634 . . . . 74.13 111.737 -177.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.63 148.53 40.88 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.346 1.058 . . . . 74.2 108.367 175.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 20.8 p -142.8 177.18 8.51 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.429 0.691 . . . . 72.14 111.109 -172.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 58.7 p -156.2 134.6 11.52 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.314 1.045 . . . . 72.3 108.675 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -92.17 111.05 22.46 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.158 -1.053 . . . . 73.45 108.158 172.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 pp -120.53 17.31 12.09 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.945 0.898 . . . . 64.24 110.955 -175.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . 0.456 ' HB1' ' HB ' ' B' ' 55' ' ' VAL . . . -162.3 150.86 14.88 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.321 1.048 . . . . 70.13 109.3 175.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -67.15 116.58 8.11 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.578 0.351 . . . . 53.24 110.341 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 72.35 -3.61 2.25 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.422 1.489 . . . . 64.34 112.357 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.551 HG23 ' HB3' ' F' ' 93' ' ' PHE . 44.0 t -119.32 102.15 12.48 Favored 'Isoleucine or valine' 0 C--N 1.347 0.483 0 N-CA-C 107.45 -1.315 . . . . 61.44 107.45 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.497 ' CE2' ' HB ' ' B' ' 58' ' ' VAL . 0.1 OUTLIER -94.31 -177.96 4.44 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.736 -0.838 . . . . 75.34 108.736 -178.055 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.512 ' HG2' ' HB ' ' B' ' 83' ' ' ILE . 4.2 tm-20 -142.34 118.54 10.76 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 107.218 -1.401 . . . . 75.13 107.218 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.497 ' HB ' ' CE2' ' B' ' 56' ' ' TYR . 12.0 p -111.09 148.19 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-O 121.094 0.473 . . . . 74.12 110.938 -178.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.459 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 28.7 t -119.02 134.36 62.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.052 -1.092 . . . . 73.14 108.052 171.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 59.1 tp -114.21 103.39 11.06 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 108.291 -1.003 . . . . 73.34 108.291 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -84.81 109.48 18.12 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.593 0.711 . . . . 74.14 109.241 175.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 56.1 t -107.06 103.44 15.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 107.769 -1.197 . . . . 72.42 107.769 174.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.9 m -102.21 132.69 47.98 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.738 -0.664 . . . . 74.45 109.567 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.584 HG23 HD12 ' B' ' 114' ' ' ILE . 82.6 t -116.76 117.31 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.138 0.975 . . . . 73.13 109.362 174.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 10.6 m -87.23 140.42 29.56 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.126 -1.064 . . . . 73.24 108.126 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.9 140.39 23.38 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 118.045 0.384 . . . . 71.33 110.413 175.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.405 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 52.6 p -146.44 133.13 19.93 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.058 0.456 . . . . 64.3 111.598 -175.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.528 HD21 ' HA ' ' B' ' 38' ' ' PRO . 72.9 mt -100.11 100.96 11.89 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.341 1.056 . . . . 75.35 108.661 176.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.58 -134.73 24.46 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.992 -0.549 . . . . 72.13 112.248 -176.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -83.01 4.28 26.66 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.755 0.822 . . . . 75.51 113.033 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.508 ' HG2' ' HZ1' ' B' ' 34' ' ' LYS . 12.0 pt-20 -127.1 150.91 49.26 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.851 0.296 . . . . 74.01 110.49 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 85.8 m -69.4 135.84 50.85 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 123.533 0.521 . . . . 72.35 110.464 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.405 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -85.88 -63.64 1.29 Allowed 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.414 -1.328 . . . . 72.0 107.414 175.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -151.92 162.87 40.37 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.326 -1.306 . . . . 70.14 110.58 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 52.0 mt -132.32 110.42 10.57 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 105.443 -2.058 . . . . 73.31 105.443 175.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 34.4 t -116.96 145.32 43.71 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.323 -0.991 . . . . 75.34 108.323 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.486 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.9 tt0 -155.1 132.03 10.79 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.306 -0.998 . . . . 73.43 108.306 -177.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.433 HG21 HD12 ' B' ' 21' ' ' ILE . 94.7 t -127.26 143.53 40.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.973 -1.121 . . . . 55.33 107.973 174.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.478 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 26.2 mt-30 -119.6 86.99 2.65 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.092 -1.077 . . . . 74.12 108.092 174.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.46 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.5 tp-100 -82.95 102.84 11.97 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 114.738 -1.119 . . . . 74.42 109.281 -177.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -87.74 162.71 33.1 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-N 115.893 -0.594 . . . . 62.21 111.634 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.9 125.76 1.34 Allowed Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.544 -1.022 . . . . 63.32 110.544 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.543 HG23 ' HB2' ' B' ' 14' ' ' GLN . 18.8 tt -95.68 131.01 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 108.57 -0.9 . . . . 74.22 108.57 175.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -137.0 141.25 42.54 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.604 0.762 . . . . 74.53 109.437 -175.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.2 m -88.77 106.93 18.68 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.658 -0.867 . . . . 72.51 108.658 172.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.489 HG21 HD12 ' F' ' 97' ' ' ILE . 23.8 mm -97.37 109.66 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 107.873 -1.158 . . . . 74.02 107.873 -173.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.31 172.14 18.69 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.025 0.441 . . . . 75.43 111.58 -172.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 83.28 -47.11 3.76 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.506 -0.77 . . . . 73.3 112.631 -178.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.54 HG21 ' HB3' ' B' ' 9' ' ' MET . 1.0 OUTLIER -78.52 159.43 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 109.743 -0.465 . . . . 74.21 109.743 168.647 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -165.75 145.16 6.33 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 123.556 0.535 . . . . 74.32 110.86 -171.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.97 -100.54 2.7 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-O 120.174 -0.237 . . . . 74.32 113.347 175.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.1 m -95.96 -54.9 3.16 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 122.08 0.943 . . . . 73.22 110.12 -175.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -67.58 -18.23 64.92 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 113.52 -1.673 . . . . 61.44 111.383 -171.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.656 ' HB2' HD13 ' F' ' 97' ' ' ILE . 22.6 ptt? -61.42 -44.25 97.45 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.836 0.854 . . . . 74.52 113.057 -176.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.02 -11.72 60.01 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.049 0.54 . . . . 71.21 112.142 -175.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -63.79 -38.56 91.57 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.129 0.572 . . . . 64.32 110.359 168.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.579 ' SG ' ' HE3' ' B' ' 9' ' ' MET . 41.5 t -58.75 -52.67 64.7 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.258 0.551 . . . . 74.02 111.164 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.8 pp -83.44 -27.19 29.7 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.525 -0.761 . . . . 73.4 112.146 -174.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.21 -16.62 62.37 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-O 120.016 -0.324 . . . . 72.22 113.338 -176.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.408 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -136.82 -58.13 0.72 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.784 0.434 . . . . 71.42 112.093 -170.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -66.37 -43.53 85.69 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.125 0.57 . . . . 75.31 112.196 -173.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 59.7 m -71.38 -44.81 13.39 Favored Pre-proline 0 CA--C 1.562 1.437 0 CA-C-O 118.567 -0.73 . . . . 75.23 112.33 -175.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -59.17 -31.83 96.06 Favored 'Trans proline' 0 C--N 1.394 2.934 0 C-N-CA 121.887 1.725 . . . . 71.15 113.247 168.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -62.11 -36.81 82.87 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.192 0.597 . . . . 72.4 110.303 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 59.1 mt -65.39 -40.86 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.489 0.716 . . . . 73.35 110.433 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 94.7 mt -76.26 -24.88 54.51 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.698 -0.683 . . . . 75.12 112.668 -173.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -62.32 -45.04 89.93 Favored Pre-proline 0 CA--C 1.566 1.587 0 CA-C-O 117.78 -1.105 . . . . 72.43 113.691 -173.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -52.3 -43.33 54.55 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.516 2.144 . . . . 73.22 113.371 173.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.46 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 95.3 m-85 -64.17 -45.24 89.29 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.285 0.634 . . . . 74.44 110.149 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.87 82.37 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.457 -0.792 . . . . 62.14 111.049 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.499 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 65.0 ttt-85 -64.56 -61.34 2.27 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.454 1.102 . . . . 72.1 110.989 -175.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -67.44 -25.85 66.11 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 123.505 0.503 . . . . 73.14 111.032 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.575 ' SG ' HD13 ' B' ' 21' ' ' ILE . 3.9 t -66.19 -40.75 90.63 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 109.681 -0.488 . . . . 74.51 109.681 176.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.584 HD12 HG23 ' B' ' 64' ' ' VAL . 70.3 mt -62.9 -54.47 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.784 0.834 . . . . 71.44 110.418 172.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 6.3 m -60.89 -30.68 70.3 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.886 0.875 . . . . 72.21 111.68 -173.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 44.4 t -65.41 -48.63 72.17 Favored 'General case' 0 C--N 1.347 0.5 0 C-N-CA 123.6 0.76 . . . . 73.35 110.191 174.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.54 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.4 mmt -68.35 -29.74 68.54 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.032 0.533 . . . . 74.55 111.194 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.5 t -65.37 -44.36 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.442 1.097 . . . . 74.25 110.02 173.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 40.5 t -68.72 -29.92 68.44 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.241 -0.89 . . . . 64.44 111.174 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' B' ' 116' ' ' SER . 88.7 mtt-85 -65.14 -39.7 93.37 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 108.934 -0.765 . . . . 70.51 108.934 174.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.0 -5.28 75.09 Favored Glycine 0 C--N 1.356 1.675 0 O-C-N 123.651 0.595 . . . . 62.11 113.558 172.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 8.0 m 67.58 31.11 6.31 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.136 1.374 . . . . 74.04 111.006 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -91.68 160.45 36.38 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-N 114.821 -1.081 . . . . 74.2 111.143 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.451 ' HG3' ' HB2' ' F' ' 131' ' ' TRP . 82.3 Cg_exo -51.31 157.72 4.33 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.838 3.025 . . . . 75.34 115.598 177.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.59 ' O ' ' HA ' ' F' ' 129' ' ' THR . 55.1 tp60 -58.26 113.91 2.16 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.257 1.423 . . . . 74.51 111.529 -177.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.582 HD13 HG12 ' B' ' 40' ' ' VAL . 32.5 tp -106.96 102.37 11.73 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.075 0.464 . . . . 74.33 109.771 -172.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . 0.432 HD22 ' HG3' ' B' ' 125' ' ' GLN . 29.2 m-80 -101.07 117.88 35.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.271 0.629 . . . . 71.34 109.431 -177.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.499 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 69.4 mt -85.89 135.9 33.5 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 109.886 -0.413 . . . . 73.21 109.886 172.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.34 138.43 74.94 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 123.494 0.718 . . . . 61.23 110.807 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.432 ' HG3' HD11 ' D' ' 16' ' ' ILE . 21.3 Cg_endo -60.19 101.99 0.17 Allowed 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 123.207 2.605 . . . . 75.31 111.946 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 18.1 m -90.15 109.95 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 122.013 0.911 . . . . 73.35 109.38 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -88.2 85.95 7.01 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.068 -0.969 . . . . 75.24 109.402 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -53.53 -33.62 55.2 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 114.569 -1.196 . . . . 75.05 111.641 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.408 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 6.0 m-20 -52.76 -52.68 55.52 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.362 1.065 . . . . 73.15 111.87 177.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.475 ' HA ' ' HB3' ' B' ' 138' ' ' MET . . . -69.86 -32.33 70.64 Favored 'General case' 0 C--O 1.218 -0.559 0 O-C-N 124.025 0.828 . . . . 75.12 110.96 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.515 HD13 ' HH ' ' F' ' 120' ' ' TYR . 3.4 tt -57.41 -42.43 82.27 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.927 0.891 . . . . 74.5 110.248 -178.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -81.67 -36.68 28.49 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.116 0.566 . . . . 75.52 111.525 174.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.475 ' HB3' ' HA ' ' B' ' 135' ' ' ALA . 26.7 ttt -68.18 -19.86 64.82 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.677 0.791 . . . . 74.52 111.771 -174.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -74.76 -22.3 58.86 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.93 0.492 . . . . 71.41 110.754 178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -90.09 -34.36 15.94 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.147 0.579 . . . . 75.44 110.186 174.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 7.6 mp -100.16 32.69 2.88 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.971 0.908 . . . . 75.44 110.724 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.8 110.15 9.99 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.146 0.579 . . . . 71.54 110.332 -173.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -156.56 179.74 8.97 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.661 1.184 . . . . 73.35 110.09 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 68.12 107.24 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.698 1.599 . . . . 74.03 111.007 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.95 0.72 1.99 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.036 0.934 . . . . 74.33 111.203 174.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.22 78.79 1.08 Allowed Glycine 0 C--N 1.354 1.574 0 O-C-N 123.488 0.492 . . . . 45.2 112.209 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -111.29 162.54 14.9 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.348 1.059 . . . . 74.23 110.553 -175.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -78.37 141.37 24.77 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 115.301 -0.863 . . . . 61.43 112.096 176.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 41.5 m -143.54 143.36 31.5 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.937 0.895 . . . . 64.14 109.058 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 75.27 133.27 0.05 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.271 1.428 . . . . 75.21 112.575 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -158.38 130.0 6.65 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 124.469 1.107 . . . . 74.03 108.631 171.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -114.97 154.48 28.69 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.713 0.805 . . . . 62.34 110.368 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -153.88 93.55 1.66 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.342 1.057 . . . . 73.15 109.017 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -169.76 152.57 4.59 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.687 0.795 . . . . 75.52 109.719 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 C-N-CA 123.967 0.907 . . . . 73.45 108.571 176.665 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.45 ' HE2' HD23 ' A' ' 136' ' ' LEU . 40.3 mtp . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 121.728 0.775 . . . . 72.02 109.663 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 2' ' ' SER . . . . . 0.514 ' HB2' ' HB3' ' A' ' 135' ' ' ALA . 19.9 m -144.43 -131.61 0.08 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.604 -1.18 . . . . 60.04 108.376 -167.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . 0.477 ' HA ' ' HB2' ' C' ' 154' ' ' ASP . 10.2 pt-20 -119.09 140.93 49.27 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 106.749 -1.574 . . . . 74.0 106.749 153.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . 0.622 ' HG2' ' HA ' ' C' ' 154' ' ' ASP . 13.8 mm-40 -75.25 98.38 3.76 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.33 -0.619 . . . . 71.1 109.33 174.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -59.67 -60.12 4.35 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 124.226 0.954 . . . . 73.35 109.624 172.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -76.95 178.54 6.85 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.244 0.618 . . . . 75.31 109.599 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 5.1 t -51.02 142.72 11.57 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.396 1.078 . . . . 74.22 112.111 176.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -63.5 -76.4 0.07 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.911 0.884 . . . . 54.53 110.998 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 47.2 ttm 56.7 113.22 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.679 1.192 . . . . 75.11 111.31 -173.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 11.9 m -86.38 74.69 9.92 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.781 -0.822 . . . . 63.54 108.781 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.619 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 69.1 t80 -90.89 121.44 32.74 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.828 -1.078 . . . . 75.23 108.094 178.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -136.81 122.69 20.06 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.641 -0.874 . . . . 70.24 108.641 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.535 HD11 HG21 ' C' ' 105' ' ' ILE . 46.5 mt -83.05 126.78 40.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 109.279 -0.637 . . . . 74.15 109.279 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.406 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 27.7 mm-40 -87.06 -44.27 11.69 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.852 -0.796 . . . . 73.11 108.852 174.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 179.96 151.06 0.4 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.032 1.333 . . . . 75.44 109.462 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 83.7 mt -123.44 128.44 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 107.877 -1.157 . . . . 72.54 107.877 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.588 ' HB3' HG22 ' D' ' 122' ' ' THR . 35.5 p90 -161.27 149.92 16.01 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.318 0.58 . . . . 75.01 111.56 -167.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.7 p -80.61 119.72 23.62 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.35 -0.841 . . . . 74.3 110.575 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp -71.88 -36.62 70.14 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.619 -0.882 . . . . 73.42 108.619 169.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -148.85 148.43 29.89 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-N 115.092 -0.958 . . . . 72.21 110.006 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.1 mt -140.64 140.47 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 106.347 -1.724 . . . . 72.24 106.347 175.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 28.3 t -154.12 146.64 24.07 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.204 0.526 . . . . 74.12 110.526 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -155.17 129.37 8.9 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 107.013 -1.477 . . . . 75.51 107.013 172.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -137.69 123.96 20.55 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.247 0.619 . . . . 73.42 109.544 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -121.38 84.13 41.04 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 107.145 -1.428 . . . . 71.11 107.145 166.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.47 -24.07 43.01 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 122.422 2.081 . . . . 74.1 111.578 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -104.0 17.27 24.45 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.36 1.064 . . . . 74.21 110.516 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.53 -57.1 10.54 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 113.526 0.936 . . . . 75.4 113.526 -171.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -63.04 -39.16 41.51 Favored 'Trans proline' 0 C--N 1.393 2.884 0 C-N-CA 122.112 1.874 . . . . 70.31 111.962 -176.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -69.26 -37.06 77.75 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.367 -1.288 . . . . 73.24 111.996 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.686 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.8 p -82.55 -21.03 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 N-CA-C 112.907 0.706 . . . . 62.41 112.907 -176.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -66.28 -29.22 69.4 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 120.856 0.36 . . . . 73.21 111.652 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -94.96 14.18 22.55 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.848 0.859 . . . . 74.21 111.371 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -104.55 158.26 16.61 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.708 0.803 . . . . 75.45 109.668 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -70.25 115.38 9.37 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.672 0.789 . . . . 75.24 110.158 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -80.6 91.57 5.84 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.243 1.017 . . . . 72.25 111.333 -171.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . 0.432 ' H ' HD23 ' C' ' 68' ' ' LEU . 0.2 OUTLIER -139.58 73.72 34.89 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.368 1.067 . . . . 74.03 109.206 169.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -79.85 149.13 20.3 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.282 1.988 . . . . 72.13 112.192 -174.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -86.91 93.19 9.25 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.637 -1.616 . . . . 74.51 106.637 165.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.454 HG13 HG13 ' F' ' 135' ' ' VAL . 56.2 t -68.3 102.84 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 108.429 -0.952 . . . . 75.01 108.429 177.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -109.81 102.5 11.28 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.149 -1.056 . . . . 70.32 108.149 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.474 HD23 ' HB ' ' F' ' 135' ' ' VAL . 4.2 pp -87.96 139.57 30.38 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.011 -1.107 . . . . 71.2 108.011 172.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -139.86 118.64 12.42 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.148 -0.686 . . . . 75.42 109.148 -175.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 92.7 mt -111.95 138.95 47.88 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.77 0.828 . . . . 61.43 111.369 -171.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -147.62 127.08 13.17 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.788 1.235 . . . . 74.04 107.96 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 8.7 t -120.64 145.02 47.84 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 109.447 -0.575 . . . . 61.22 109.447 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.39 150.55 40.81 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.473 0.709 . . . . 75.01 109.781 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.507 ' HG ' HG21 ' C' ' 58' ' ' VAL . 32.8 m -141.64 155.0 45.73 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.053 0.541 . . . . 74.52 110.74 -177.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 61.7 p -151.85 129.86 11.81 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.082 0.953 . . . . 75.44 109.06 178.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -73.71 117.44 15.48 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.04 -0.726 . . . . 74.35 109.04 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.669 HD12 ' HB2' ' C' ' 57' ' ' GLU . 71.1 mt -86.89 -43.56 12.34 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.41 0.684 . . . . 73.32 109.976 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.26 -173.93 4.52 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.341 -0.845 . . . . 64.1 110.249 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.3 107.74 0.81 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.011 0.924 . . . . 72.05 110.217 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 66.37 22.05 10.84 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.221 1.008 . . . . 75.13 111.026 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 96.0 t -119.39 119.31 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.025 0.93 . . . . 71.44 108.732 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -127.15 126.82 43.56 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.289 1.036 . . . . 72.42 108.988 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.669 ' HB2' HD12 ' C' ' 51' ' ' LEU . 35.9 tt0 -83.9 126.19 32.74 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.402 -0.962 . . . . 73.23 108.402 168.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.507 HG21 ' HG ' ' C' ' 48' ' ' SER . 88.6 t -118.05 137.09 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.25 -0.648 . . . . 71.43 109.25 173.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.428 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 44.8 t -128.67 145.26 35.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.096 0.958 . . . . 73.02 108.869 177.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.435 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -126.72 104.35 8.03 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.476 -1.305 . . . . 75.41 107.476 177.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -81.98 106.17 13.68 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.285 -1.006 . . . . 75.44 108.285 171.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 23.2 t -104.65 133.57 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.907 -1.145 . . . . 72.13 107.907 172.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 84.9 m -126.97 136.74 52.68 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.385 -0.969 . . . . 71.41 108.385 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.455 HG22 HD12 ' C' ' 114' ' ' ILE . 85.2 t -122.56 114.12 41.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 109.422 -0.584 . . . . 74.34 109.422 173.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 18.7 m -98.54 137.34 37.34 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.716 -0.846 . . . . 74.1 108.716 172.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.79 113.81 17.12 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.14 -1.43 . . . . 72.35 107.14 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 44.0 m -136.76 128.61 29.15 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.464 0.477 . . . . 75.25 110.17 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.432 HD23 ' H ' ' C' ' 37' ' ' GLN . 49.8 mt -84.41 29.05 0.61 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.151 1.38 . . . . 73.32 111.265 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.64 -91.04 0.75 Allowed Glycine 0 C--N 1.35 1.345 0 N-CA-C 111.169 -0.772 . . . . 72.31 111.169 -175.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -90.67 -33.7 15.71 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.55 0.74 . . . . 71.15 109.27 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -88.87 122.18 31.99 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.597 1.159 . . . . 74.22 110.463 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 89.1 m -81.73 129.09 34.6 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.482 -0.562 . . . . 73.12 109.482 169.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.686 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -80.72 -58.45 3.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.791 0.836 . . . . 74.14 110.059 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -157.12 167.98 28.8 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.85 0.833 . . . . 75.32 111.224 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -131.51 137.35 48.5 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 106.655 -1.609 . . . . 75.52 106.655 166.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 41.8 t -137.07 149.32 47.32 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.582 -0.896 . . . . 54.45 108.582 176.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -157.78 133.65 9.27 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.44 -0.578 . . . . 73.12 109.44 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 73.7 t -132.75 132.46 59.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 124.143 0.977 . . . . 75.04 108.889 174.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -104.39 87.13 2.65 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.295 -1.002 . . . . 74.0 108.295 173.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -79.39 97.92 6.54 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.349 -0.841 . . . . 71.43 109.145 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -83.72 177.86 52.39 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 115.781 -0.645 . . . . 63.1 112.293 175.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 178.18 134.27 2.04 Favored Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 111.356 -0.698 . . . . 74.41 111.356 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.406 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 35.4 mm -88.7 125.81 41.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.361 -0.977 . . . . 75.54 108.361 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -130.3 117.86 20.44 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.47 0.708 . . . . 74.42 109.37 -178.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 11.4 p -85.01 102.19 12.99 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 108.466 -0.939 . . . . 72.23 108.466 172.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.501 HG21 ' HE2' ' C' ' 94' ' ' MET . 24.4 mt -114.29 129.54 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.814 0.845 . . . . 70.53 109.949 -175.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.86 171.15 14.86 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.654 0.782 . . . . 61.13 110.385 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.81 -35.06 4.62 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 116.26 -0.427 . . . . 55.44 113.075 176.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.692 HD13 ' HA ' ' C' ' 94' ' ' MET . 27.7 pt -108.12 171.71 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.251 0.62 . . . . 74.41 111.709 -171.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -167.19 156.93 10.79 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.801 0.84 . . . . 72.24 109.923 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.07 -115.62 6.24 Favored Glycine 0 C--N 1.349 1.304 0 O-C-N 123.324 0.39 . . . . 61.1 113.535 171.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 58.3 p -64.22 -40.07 95.28 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 123.688 0.795 . . . . 72.22 110.953 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -68.37 -47.66 66.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.899 0.88 . . . . 74.32 111.097 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.692 ' HA ' HD13 ' C' ' 89' ' ' ILE . 5.2 tpt -53.86 -49.86 67.55 Favored 'General case' 0 C--N 1.352 0.694 0 O-C-N 123.875 0.734 . . . . 63.02 111.705 173.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.69 -38.76 89.01 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 123.637 0.585 . . . . 73.11 111.032 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . 0.471 ' O ' ' HB2' ' C' ' 100' ' ' ALA . 44.5 t-80 -71.59 -19.68 62.1 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.553 1.141 . . . . 75.13 111.483 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 9.3 t -82.2 -51.96 7.44 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.517 -0.92 . . . . 73.31 108.517 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.11 -30.11 69.19 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.841 -1.072 . . . . 74.13 112.978 -172.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.94 11.28 29.54 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-O 119.45 -0.639 . . . . 63.3 113.64 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.545 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -151.34 -61.14 0.18 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 117.535 0.667 . . . . 64.0 112.222 -176.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -74.04 -53.31 10.28 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.422 0.689 . . . . 74.41 112.14 -169.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.619 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 34.5 m -58.56 -49.18 94.88 Favored Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.15 0.98 . . . . 73.2 111.924 176.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 77.1 Cg_exo -53.83 -35.76 80.44 Favored 'Trans proline' 0 C--N 1.402 3.384 0 C-N-CA 122.686 2.257 . . . . 73.13 113.24 173.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -68.76 -33.15 73.4 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.418 0.687 . . . . 74.45 111.708 -176.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.541 HD13 ' NH1' ' A' ' 111' ' ' ARG . 31.4 mm -70.11 -43.03 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 122.332 0.253 . . . . 71.32 110.691 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 1.7 pp -95.93 -3.56 45.01 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.372 0.878 . . . . 74.43 113.372 -176.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . 0.497 ' HZ ' HD23 ' C' ' 128' ' ' LEU . 56.0 t80 -55.06 -48.15 96.76 Favored Pre-proline 0 N--CA 1.485 1.317 0 CA-C-O 117.742 -1.123 . . . . 74.52 113.578 172.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -60.94 -30.67 90.4 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 121.738 1.626 . . . . 73.25 112.979 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -68.66 -43.05 77.01 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.371 0.669 . . . . 74.32 109.479 176.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.54 -39.34 94.16 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.041 -0.981 . . . . 75.34 110.625 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -61.87 -52.77 62.75 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.382 1.073 . . . . 74.33 110.191 176.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -67.22 -28.37 68.01 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.596 0.759 . . . . 72.11 110.383 -174.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . 0.49 ' O ' ' SD ' ' C' ' 117' ' ' MET . 8.2 t -71.05 -49.2 47.32 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 122.997 0.519 . . . . 70.12 110.334 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.455 HD12 HG22 ' C' ' 64' ' ' VAL . 86.8 mt -59.77 -47.28 91.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 123.29 0.636 . . . . 75.04 110.167 174.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 99.4 m -63.53 -31.05 72.1 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.812 0.845 . . . . 63.53 111.109 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 25.2 t -65.51 -48.42 72.59 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 108.808 -0.812 . . . . 73.13 108.808 171.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.906 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.2 OUTLIER -56.29 -43.19 78.6 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.953 0.901 . . . . 75.24 112.485 178.441 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.434 HG21 ' O ' ' C' ' 114' ' ' ILE . 87.9 t -69.33 -41.89 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.869 0.868 . . . . 74.05 110.26 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 30.6 t -64.1 -37.8 88.75 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.111 -0.949 . . . . 73.43 111.454 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.535 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 60.3 mtt-85 -69.64 -40.14 76.69 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.149 -0.932 . . . . 73.31 110.222 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.64 2.26 64.03 Favored Glycine 0 C--N 1.355 1.631 0 O-C-N 123.796 0.685 . . . . 74.21 112.847 174.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 44.2 p 60.94 28.19 18.0 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.952 1.701 . . . . 71.02 113.098 168.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -83.23 144.08 46.27 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.12 -1.067 . . . . 75.12 108.12 169.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -44.75 141.93 5.4 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.791 2.994 . . . . 74.44 114.071 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.507 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 13.3 mm-40 -59.22 124.75 21.02 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.908 0.755 . . . . 75.21 112.802 -170.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 40.1 tp -121.38 103.26 8.82 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.268 -1.012 . . . . 72.41 108.268 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -96.19 116.0 28.31 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.387 -0.824 . . . . 74.42 109.658 -176.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.497 HD23 ' HZ ' ' C' ' 107' ' ' PHE . 0.9 OUTLIER -71.59 117.4 13.1 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.588 0.755 . . . . 75.22 109.027 -178.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.74 159.15 70.98 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 123.95 0.9 . . . . 73.11 111.654 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -55.49 100.74 0.08 OUTLIER 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.726 2.284 . . . . 73.14 113.199 174.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.9 t -99.56 111.09 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 108.218 -1.03 . . . . 63.12 108.218 172.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -86.06 104.38 15.61 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.407 0.683 . . . . 73.43 110.722 -175.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -64.51 -23.76 67.38 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.164 0.986 . . . . 72.43 112.041 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.545 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 2.4 t70 -65.25 -36.67 84.84 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.766 0.826 . . . . 62.3 109.753 178.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.4 -19.32 33.73 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.382 -1.281 . . . . 63.51 111.614 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 36.0 mt -82.88 -22.35 34.0 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 120.895 0.378 . . . . 74.31 110.697 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -75.1 -15.58 60.6 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.473 0.709 . . . . 65.13 110.469 177.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.546 ' SD ' ' HA ' ' A' ' 152' ' ' HIS . 48.2 ttp -43.92 -60.71 1.71 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.796 1.639 . . . . 75.22 112.325 173.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -72.87 -33.21 65.93 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.909 -1.041 . . . . 71.13 111.191 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -71.05 -155.98 0.03 OUTLIER 'General case' 0 CA--C 1.574 1.881 0 C-N-CA 123.635 0.774 . . . . 74.35 111.206 -175.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.565 HD21 ' HG2' ' C' ' 143' ' ' GLN . 32.2 tp 58.87 -85.23 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.013 1.325 . . . . 70.4 111.352 -176.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 175.96 -44.91 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.215 1.406 . . . . 71.22 108.425 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . 0.565 ' HG2' HD21 ' C' ' 141' ' ' LEU . 11.0 pt20 -83.61 168.83 15.99 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.305 -0.861 . . . . 71.44 110.907 179.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . 0.443 ' NE2' ' H ' ' C' ' 145' ' ' ALA . 0.0 OUTLIER -147.6 141.57 25.91 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 106.281 -1.748 . . . . 71.45 106.281 172.647 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . 0.443 ' H ' ' NE2' ' C' ' 144' ' ' GLN . . . 70.65 59.99 0.21 Allowed 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.527 1.131 . . . . 74.1 109.333 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.82 -140.85 1.17 Allowed Glycine 0 C--N 1.349 1.261 0 CA-C-N 114.155 -1.384 . . . . 73.15 112.033 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.22 -172.15 3.8 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.035 0.534 . . . . 72.33 110.992 -176.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -160.28 64.9 0.28 Allowed Glycine 0 C--N 1.342 0.895 0 N-CA-C 110.203 -1.159 . . . . 72.44 110.203 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 10.5 t -64.73 139.92 58.81 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-O 121.254 0.55 . . . . 73.34 111.525 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.95 131.01 54.08 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.917 0.887 . . . . 75.33 109.032 -178.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . 0.515 ' HG2' ' H ' ' C' ' 152' ' ' HIS . 30.7 tt0 -172.98 -173.34 0.94 Allowed 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 107.859 -1.163 . . . . 75.25 107.859 -174.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . 0.515 ' H ' ' HG2' ' C' ' 151' ' ' GLU . 86.5 m-70 80.27 -177.31 0.07 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.167 1.387 . . . . 73.31 111.526 170.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.12 159.87 37.66 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.2 -1.407 . . . . 74.43 107.2 -176.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . 0.622 ' HA ' ' HG2' ' C' ' 4' ' ' GLN . 12.2 t70 -52.85 102.44 0.05 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.513 1.125 . . . . 63.2 111.549 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.274 0 N-CA-C 107.843 -1.169 . . . . 61.25 107.843 177.636 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.476 ' HE3' ' HB2' ' E' ' 98' ' ' ASP . 23.7 ptt? . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 109.457 -0.571 . . . . 63.2 109.457 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 47.2 t 61.57 100.51 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.891 1.276 . . . . 63.42 110.652 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -78.65 77.47 5.13 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-O 121.723 0.773 . . . . 74.22 110.562 -176.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . 0.537 ' HB2' ' HD2' ' E' ' 95' ' ' LYS . 74.2 mm-40 -138.53 128.77 25.77 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 106.68 -1.6 . . . . 74.32 106.68 175.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -169.68 -44.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.88 0.472 . . . . 74.23 110.372 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -75.96 98.71 4.33 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.592 0.757 . . . . 74.44 109.882 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 7' ' ' THR . . . . . 0.402 HG22 ' HE1' ' E' ' 94' ' ' PHE . 6.6 t -166.36 165.0 17.48 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.128 0.971 . . . . 71.23 109.409 179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -71.25 113.11 7.95 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.686 0.795 . . . . 75.13 109.897 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -31.74 123.76 0.27 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 125.717 1.607 . . . . 75.25 113.253 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 15.1 t -113.46 130.92 56.21 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 122.959 0.504 . . . . 73.43 109.644 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -138.64 93.88 2.77 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.397 -1.335 . . . . 73.44 107.397 174.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -124.3 126.11 45.49 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.754 -0.832 . . . . 72.04 108.754 -177.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 mt -82.41 121.35 35.44 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 N-CA-C 108.773 -0.825 . . . . 75.04 108.773 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -85.26 -29.66 24.44 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.282 1.033 . . . . 74.31 110.303 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -170.14 142.11 2.22 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 123.625 0.578 . . . . 74.51 110.426 -177.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.432 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.9 mp -118.24 130.4 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 105.503 -2.036 . . . . 74.03 105.503 170.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -159.99 141.92 12.98 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 118.701 0.682 . . . . 74.24 111.359 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 71.3 p -78.36 110.8 13.73 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.882 -1.054 . . . . 64.45 109.176 174.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -78.41 -24.76 46.06 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.562 -0.744 . . . . 75.01 109.253 176.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.703 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 2.8 t70 -149.97 147.96 28.5 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.665 1.186 . . . . 71.34 110.02 174.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.906 HG21 ' HE1' ' C' ' 117' ' ' MET . 83.1 mt -139.51 146.51 25.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 126.07 1.748 . . . . 73.31 107.598 174.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 39.9 t -155.86 145.38 21.0 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.167 0.587 . . . . 75.12 110.428 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.502 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 79.7 t80 -151.98 139.88 20.01 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.703 -1.591 . . . . 75.33 106.703 171.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 40.6 mt-10 -142.99 146.3 33.77 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.404 0.681 . . . . 73.42 109.604 -175.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.75 85.57 6.55 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.039 0.935 . . . . 75.34 108.573 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.87 -36.9 21.72 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.348 2.699 . . . . 63.44 112.935 -177.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.434 ' ND2' ' HB2' ' D' ' 71' ' ' GLU . 67.9 m-20 -103.66 16.17 27.06 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.14 -0.936 . . . . 75.04 110.749 -173.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -34.06 -66.2 0.23 Allowed Pre-proline 0 CA--C 1.571 1.761 0 N-CA-C 116.292 1.96 . . . . 73.54 116.292 -162.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.82 -21.96 13.88 Favored 'Trans proline' 0 C--N 1.386 2.529 0 CA-C-N 123.977 2.456 . . . . 75.43 114.165 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -70.51 -41.81 72.12 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.712 1.205 . . . . 73.31 110.306 178.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.622 HG22 HD11 ' D' ' 68' ' ' LEU . 13.4 p -82.53 -20.53 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-N 115.233 -0.894 . . . . 71.22 111.56 -173.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 19.5 m-30 -62.41 -29.04 70.21 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 112.299 0.481 . . . . 72.3 112.299 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -63.87 -14.66 55.14 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.42 1.088 . . . . 73.32 111.567 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.518 ' HZ3' ' HG2' ' D' ' 71' ' ' GLU . 94.2 mttt -93.6 109.36 20.98 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.829 1.252 . . . . 74.11 110.1 175.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -102.94 92.89 4.76 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.175 0.59 . . . . 74.41 111.059 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 42.4 p90 -168.46 -177.28 3.12 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.838 1.255 . . . . 73.21 108.421 168.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.442 ' HB2' ' HB3' ' E' ' 128' ' ' ALA . 61.0 tp60 -74.02 118.32 68.54 Favored Pre-proline 0 N--CA 1.479 0.985 0 CA-C-O 119.09 -0.481 . . . . 71.24 109.834 177.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -58.95 137.39 79.54 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.332 2.021 . . . . 72.41 111.195 174.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 25.5 mt-10 -62.81 106.9 0.87 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.447 -0.946 . . . . 73.12 108.447 174.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.492 HG13 HG13 ' D' ' 64' ' ' VAL . 57.2 t -99.96 108.48 22.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.374 -0.602 . . . . 74.33 109.374 -175.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -86.76 109.69 19.41 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.387 -1.338 . . . . 73.44 107.387 169.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.497 HD12 HG12 ' D' ' 62' ' ' VAL . 40.4 tp -96.08 123.31 39.64 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.5 -0.926 . . . . 74.32 108.5 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -118.86 143.91 46.69 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 106.282 -1.747 . . . . 75.01 106.282 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.533 ' H ' ' HB3' ' E' ' 112' ' ' ASN . 94.9 mt -136.73 148.23 47.18 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.419 0.688 . . . . 65.15 109.159 -174.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.746 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.8 t70 -145.38 136.32 24.64 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.426 -0.953 . . . . 72.12 108.426 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.3 t -102.43 158.42 16.22 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.967 -1.123 . . . . 74.41 107.967 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.572 ' HB2' ' HB ' ' D' ' 59' ' ' VAL . . . -161.9 165.92 26.95 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.995 0.518 . . . . 74.33 109.731 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.4 p -170.7 -159.79 0.18 Allowed 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.681 1.192 . . . . 75.52 108.201 -175.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 50.4 m -143.46 150.16 38.61 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.119 0.485 . . . . 64.33 110.295 -175.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -78.73 168.88 19.09 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.706 -1.134 . . . . 74.24 110.192 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 tt 63.76 105.04 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.231 -1.026 . . . . 74.32 108.231 -174.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.39 -77.68 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.179 0.592 . . . . 74.23 112.064 -171.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 12.2 t70 60.87 7.93 1.66 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.783 1.233 . . . . 71.42 113.277 175.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 61.38 17.09 8.03 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.803 1.241 . . . . 75.24 112.445 -173.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 47.6 t -118.05 100.18 9.56 Favored 'Isoleucine or valine' 0 C--N 1.35 0.588 0 N-CA-C 107.452 -1.314 . . . . 65.54 107.452 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.715 ' HH ' HG13 ' E' ' 97' ' ' ILE . 24.0 m-85 -119.82 129.93 54.67 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 107.908 -1.145 . . . . 75.25 107.908 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -111.02 118.33 35.76 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.059 -1.46 . . . . 75.52 107.059 165.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.404 HG12 ' O ' ' D' ' 47' ' ' ALA . 72.1 t -100.29 134.98 38.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.382 -0.97 . . . . 75.14 108.382 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' D' ' 47' ' ' ALA . 24.8 t -114.97 137.97 46.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.341 -0.985 . . . . 72.23 108.341 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.518 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -115.08 118.61 33.86 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.382 -1.34 . . . . 72.43 107.382 174.339 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.746 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 45.3 ttm-85 -95.54 99.31 11.21 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.831 -1.174 . . . . 73.04 107.831 171.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.497 HG12 HD12 ' D' ' 42' ' ' LEU . 94.8 t -89.25 128.98 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 106.746 -1.576 . . . . 64.41 106.746 169.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 5.3 m -129.56 126.07 37.69 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.64 -0.874 . . . . 74.34 108.64 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.492 HG13 HG13 ' D' ' 40' ' ' VAL . 55.6 t -108.41 132.0 57.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 108.049 -1.093 . . . . 73.54 108.049 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 49.5 m -126.69 90.86 3.24 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.322 -1.362 . . . . 72.15 107.322 171.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -104.35 139.07 39.84 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.28 -0.873 . . . . 73.13 109.838 -176.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.483 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 77.4 p -144.17 128.95 18.31 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-O 121.07 0.462 . . . . 75.4 112.233 -172.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.622 HD11 HG22 ' D' ' 31' ' ' VAL . 43.9 mt -92.4 104.08 16.45 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.956 -1.498 . . . . 74.35 106.956 170.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.15 -145.85 38.52 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 123.674 0.608 . . . . 64.22 111.998 -172.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.69 2.93 31.23 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 112.503 0.556 . . . . 75.23 112.503 -177.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.518 ' HG2' ' HZ3' ' D' ' 34' ' ' LYS . 13.1 pt-20 -117.21 146.55 43.17 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 117.924 0.329 . . . . 75.32 110.163 -176.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 98.8 m -63.99 121.07 13.24 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 124.002 0.814 . . . . 74.52 111.108 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.483 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -76.86 -71.89 0.37 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.157 -1.423 . . . . 71.23 107.157 170.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -147.43 141.11 25.6 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.672 -0.695 . . . . 75.51 111.201 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.454 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 56.1 mt -103.96 149.53 25.05 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.218 -1.401 . . . . 74.44 107.218 166.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.68 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 6.3 t -157.94 106.23 2.02 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.081 0.401 . . . . 74.14 110.087 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -120.37 122.22 40.3 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.011 0.524 . . . . 74.41 110.204 -176.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 98.2 t -123.84 117.68 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.607 0.763 . . . . 75.12 109.42 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.703 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.1 mt-30 -88.68 83.37 6.74 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.482 -0.933 . . . . 72.54 108.482 168.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -80.53 96.54 6.83 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.172 -1.376 . . . . 75.44 109.316 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.61 161.87 28.78 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 111.765 -0.534 . . . . 74.43 111.765 177.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.21 134.55 3.36 Favored Glycine 0 C--N 1.332 0.315 0 N-CA-C 111.624 -0.59 . . . . 75.42 111.624 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 48.4 mt -90.03 117.45 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 108.687 -0.857 . . . . 73.42 108.687 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -115.64 125.94 53.53 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.473 1.109 . . . . 73.23 109.804 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 53.6 p -84.2 104.13 13.98 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.736 -0.839 . . . . 72.11 108.736 171.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 45.3 mt -115.61 122.6 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.403 0.681 . . . . 74.21 109.492 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.08 168.43 25.55 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.659 1.183 . . . . 73.12 109.595 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.28 22.66 43.55 Favored Glycine 0 N--CA 1.476 1.325 0 N-CA-C 114.364 0.505 . . . . 71.33 114.364 172.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.579 HD12 ' HA ' ' D' ' 94' ' ' MET . 1.0 OUTLIER -136.63 172.42 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 124.349 1.06 . . . . 73.45 109.569 -179.318 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -153.17 -170.76 3.71 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.854 0.462 . . . . 74.43 110.583 177.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.49 -141.66 30.11 Favored Glycine 0 C--N 1.349 1.281 0 CA-C-N 116.011 -0.54 . . . . 54.13 112.383 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 11.2 t -89.91 -20.91 22.81 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.364 0.666 . . . . 75.04 109.878 170.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -58.63 -30.93 67.66 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.692 1.197 . . . . 75.24 112.03 -176.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.579 ' HA ' HD12 ' D' ' 89' ' ' ILE . 12.5 ptp -53.48 -54.12 41.69 Favored 'General case' 0 CA--C 1.55 0.968 0 O-C-N 123.817 0.698 . . . . 74.32 111.905 177.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . 0.412 ' N ' ' HG3' ' D' ' 94' ' ' MET . . . -87.38 -15.48 37.71 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.051 0.94 . . . . 75.23 112.071 -176.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -66.1 -39.11 89.72 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.628 0.771 . . . . 73.5 110.319 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 75.0 m -63.97 -38.9 92.75 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.423 -0.808 . . . . 73.51 110.987 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.532 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 6.2 tt -71.96 -39.51 69.31 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 115.389 -0.823 . . . . 74.44 110.666 -176.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.21 -27.51 52.19 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-O 119.793 -0.449 . . . . 73.44 114.212 -173.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.7 -51.89 2.25 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 122.985 0.514 . . . . 61.54 112.019 -172.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -73.64 -39.97 64.1 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.057 0.543 . . . . 73.13 111.526 -171.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.532 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 85.7 m -63.04 -47.98 85.2 Favored Pre-proline 0 CA--C 1.563 1.466 0 CA-C-O 118.4 -0.809 . . . . 74.54 112.345 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.518 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 53.1 Cg_exo -58.19 -36.76 97.53 Favored 'Trans proline' 0 C--N 1.396 3.058 0 C-N-CA 122.231 1.954 . . . . 73.03 112.963 168.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -62.33 -33.82 75.44 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.424 0.69 . . . . 72.44 111.535 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.0 mm -69.68 -39.27 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.665 0.786 . . . . 64.33 110.888 175.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 77.3 mt -73.86 -21.48 60.09 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.645 -0.707 . . . . 73.12 112.091 -175.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -66.78 -41.18 36.24 Favored Pre-proline 0 CA--C 1.56 1.364 0 CA-C-O 117.718 -1.134 . . . . 74.1 113.909 -172.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -45.63 -48.19 12.43 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 122.516 2.144 . . . . 74.41 113.75 168.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -72.2 -40.78 67.61 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.864 0.865 . . . . 75.44 111.771 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.01 -44.04 90.5 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.622 0.769 . . . . 71.32 110.933 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -61.99 -46.96 86.94 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.685 -1.143 . . . . 75.41 110.364 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -61.49 -44.9 96.25 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.976 0.91 . . . . 73.3 111.327 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.535 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 51.9 t -56.01 -46.59 78.71 Favored 'General case' 0 C--N 1.349 0.565 0 O-C-N 124.086 0.866 . . . . 75.31 110.472 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.557 HG12 ' SG ' ' D' ' 76' ' ' CYS . 69.8 mt -63.29 -48.84 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 114.956 -1.02 . . . . 71.42 111.472 176.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 86.1 m -56.05 -44.11 78.54 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 124.029 0.932 . . . . 74.41 111.123 -172.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.455 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 40.6 t -65.16 -41.47 94.65 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.386 -1.279 . . . . 73.33 110.467 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.68 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 75.5 mtm -71.29 -29.64 65.3 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.961 0.504 . . . . 73.44 111.754 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.471 HG21 ' HB3' ' D' ' 126' ' ' LEU . 75.1 t -65.47 -43.35 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.008 0.923 . . . . 75.23 109.606 175.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 96.3 p -74.74 -24.45 58.72 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.613 -0.721 . . . . 62.43 110.902 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' D' ' 116' ' ' SER . 92.5 mtt-85 -70.08 -31.37 68.92 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.876 0.47 . . . . 75.31 110.107 172.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.92 10.24 68.96 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 123.581 0.55 . . . . 75.51 112.901 174.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.588 HG22 ' HB3' ' C' ' 17' ' ' TYR . 50.3 p 60.51 12.16 3.4 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 126.844 2.057 . . . . 64.14 114.411 -178.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -79.46 155.31 76.48 Favored Pre-proline 0 N--CA 1.48 1.031 0 CA-C-O 118.966 -0.54 . . . . 74.32 110.629 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -47.53 122.89 7.35 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.307 2.672 . . . . 71.45 111.474 173.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -50.27 132.33 24.22 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 124.759 1.287 . . . . 75.21 111.592 -171.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.471 ' HB3' HG21 ' D' ' 118' ' ' VAL . 48.7 tp -106.39 98.53 8.2 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 121.635 0.731 . . . . 75.23 109.968 -173.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . 0.551 ' ND2' ' HB ' ' B' ' 16' ' ' ILE . 6.9 m120 -99.08 89.32 4.22 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 106.269 -1.752 . . . . 74.11 106.269 174.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 87.7 mt -55.79 113.47 1.49 Allowed 'General case' 0 C--N 1.357 0.903 0 O-C-N 123.739 0.649 . . . . 73.3 109.518 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.91 123.03 82.55 Favored Pre-proline 0 CA--C 1.547 0.862 0 O-C-N 123.829 0.705 . . . . 73.52 109.393 -175.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.21 136.04 33.39 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.641 2.228 . . . . 74.22 112.4 -168.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.43 143.37 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.201 1.0 . . . . 75.31 109.079 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -73.99 115.2 13.18 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.226 0.61 . . . . 74.13 109.395 177.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -60.36 -38.59 84.34 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.384 1.074 . . . . 75.41 111.845 -175.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.44 -26.51 63.69 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.651 -0.704 . . . . 61.44 111.055 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.83 -30.38 70.99 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.869 0.468 . . . . 74.44 111.287 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 45.9 tp -75.87 -37.75 58.6 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.741 0.816 . . . . 74.24 110.511 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -64.72 -51.3 63.11 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.907 0.483 . . . . 73.34 110.967 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 75.3 mtm -62.55 -39.32 93.24 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.32 0.648 . . . . 75.23 110.642 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.479 ' O ' ' HG3' ' D' ' 143' ' ' GLN . 3.2 t-20 -52.46 -49.76 64.0 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 124.087 0.867 . . . . 74.42 110.257 173.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . 0.435 ' HE1' ' HG2' ' E' ' 114' ' ' LYS . 59.5 t80 -60.12 -42.9 95.74 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.451 1.094 . . . . 60.4 112.621 -177.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.4 -29.93 70.23 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.898 0.479 . . . . 63.13 111.191 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -92.24 25.33 2.96 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.329 1.052 . . . . 73.24 111.833 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' D' ' 139' ' ' ASN . 97.1 mt-30 -120.06 94.35 4.36 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.82 0.848 . . . . 72.24 109.67 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -143.82 41.84 1.44 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.892 0.877 . . . . 73.11 109.132 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . 70.15 -0.08 2.93 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 125.235 1.414 . . . . 71.41 113.254 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.26 -34.06 42.31 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 111.712 -0.555 . . . . 61.43 111.712 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.71 -66.42 0.9 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.757 0.823 . . . . 71.02 110.683 178.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 58.34 29.15 62.82 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 123.341 0.401 . . . . 72.43 113.547 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 20.8 m -85.73 99.78 11.56 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.7 0.8 . . . . 74.1 110.792 -172.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -90.07 98.73 11.94 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.45 0.7 . . . . 71.52 109.443 176.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -135.49 132.62 37.56 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.505 0.722 . . . . 71.32 110.868 -177.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 26.5 p-80 -159.62 148.13 17.59 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.742 1.217 . . . . 75.33 108.399 170.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -90.81 148.31 22.62 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.854 -0.795 . . . . 71.13 108.854 172.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.86 115.75 5.14 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.506 0.722 . . . . 75.15 109.167 173.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.221 0 C-N-CA 123.749 0.819 . . . . 71.41 109.628 -173.019 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.569 0 N-CA-C 111.838 -0.505 . . . . 72.33 111.838 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.85 -37.63 60.85 Favored Glycine 0 C--N 1.355 1.623 0 C-N-CA 122.987 0.327 . . . . 72.43 112.803 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -81.76 98.4 8.42 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 109.482 -0.562 . . . . 74.12 109.482 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 94' ' ' PHE . . . . . 0.402 ' HE1' HG22 ' D' ' 7' ' ' THR . 54.8 p90 -97.81 167.11 11.14 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.622 -0.881 . . . . 73.5 108.622 166.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 95' ' ' LYS . . . . . 0.674 ' HE2' ' HB3' ' E' ' 98' ' ' ASP . 12.2 tmtt? -81.69 134.61 35.48 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.304 0.642 . . . . 65.1 110.202 -177.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . -148.0 -70.35 0.01 OUTLIER Glycine 0 C--N 1.343 0.947 0 N-CA-C 110.542 -1.023 . . . . 72.03 110.542 172.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 97' ' ' ILE . . . . . 0.715 HG13 ' HH ' ' D' ' 56' ' ' TYR . 36.9 pt -102.32 120.86 52.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 CA-C-O 121.71 0.767 . . . . 71.41 110.523 178.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 98' ' ' ASP . . . . . 0.674 ' HB3' ' HE2' ' E' ' 95' ' ' LYS . 7.0 p-10 -116.67 -11.01 11.05 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.1 0.96 . . . . 73.55 112.153 -173.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.82 102.94 4.4 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.228 -0.656 . . . . 74.14 109.228 -174.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 100' ' ' LEU . . . . . 0.514 HD23 HD11 ' E' ' 97' ' ' ILE . 5.7 mp -117.69 143.31 32.14 Favored Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 108.909 -0.774 . . . . 71.5 108.909 176.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.38 -47.94 23.24 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 123.034 2.489 . . . . 74.15 113.464 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 102' ' ' LEU . . . . . 0.45 HD13 HD12 ' D' ' 98' ' ' LEU . 3.8 pp -75.37 -21.5 58.27 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.811 0.671 . . . . 73.12 112.811 -174.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 60.9 p -76.25 1.09 16.96 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.558 0.343 . . . . 61.14 111.531 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.58 -40.08 78.13 Favored Glycine 0 C--N 1.35 1.336 0 N-CA-C 111.458 -0.657 . . . . 73.14 111.458 165.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -164.05 -82.07 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.466 0.706 . . . . 73.23 109.921 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -173.17 151.53 2.1 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.339 1.056 . . . . 74.23 108.637 -174.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 8.4 t -69.93 132.94 46.74 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.287 0.635 . . . . 75.44 110.757 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -60.66 -50.09 74.91 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.574 0.75 . . . . 75.14 110.964 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -81.95 108.4 15.42 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.727 -0.842 . . . . 74.45 108.727 169.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.29 168.91 14.89 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.811 0.445 . . . . 64.44 110.362 173.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . . . . . . . . . 26.3 tp -49.22 -65.08 0.63 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.027 1.331 . . . . 74.24 112.366 -174.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 112' ' ' ASN . . . . . 0.533 ' HB3' ' H ' ' D' ' 44' ' ' LEU . 6.5 t30 -115.65 95.54 5.19 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 107.734 -1.209 . . . . 74.22 107.734 170.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -152.82 177.53 10.63 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 107.508 -1.293 . . . . 74.24 107.508 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . 0.435 ' HG2' ' HE1' ' D' ' 140' ' ' TYR . 58.6 tptt 63.3 -179.93 0.15 Allowed 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.389 0.676 . . . . 75.42 109.905 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 21.2 m 73.39 157.05 0.18 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.034 0.934 . . . . 74.11 110.456 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.41 -60.52 8.79 Favored Glycine 0 C--N 1.353 1.476 0 N-CA-C 111.71 -0.556 . . . . 63.44 111.71 172.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -142.04 113.07 6.3 Favored Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 124.423 1.089 . . . . 75.24 108.263 171.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -82.05 74.28 5.3 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 123.04 2.493 . . . . 75.41 111.587 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -89.2 26.03 1.73 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.909 0.884 . . . . 73.01 111.362 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -65.06 -36.23 83.67 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.359 1.063 . . . . 74.41 110.242 173.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 121' ' ' VAL . . . . . . . . . . . . . 33.3 m -82.4 -26.52 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 115.176 -0.92 . . . . 73.34 111.151 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 14.9 m -85.54 73.4 10.48 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-O 121.75 0.786 . . . . 65.53 109.812 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -83.69 -60.97 1.95 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.972 -1.013 . . . . 74.5 109.6 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 19.2 t -159.04 -179.11 7.74 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.1 -0.955 . . . . 71.42 109.52 -177.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -144.48 -177.73 5.63 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.007 0.923 . . . . 73.42 109.592 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -153.19 172.0 17.62 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.766 0.426 . . . . 72.13 111.958 -171.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 19.6 m 61.94 30.22 18.02 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.368 1.467 . . . . 72.23 113.103 175.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 128' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' D' ' 37' ' ' GLN . . . -68.68 102.12 1.44 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.596 -0.729 . . . . 72.4 109.173 171.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 51.3 m -148.17 145.78 28.45 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.427 0.691 . . . . 74.2 109.928 -176.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.36 154.05 42.32 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.865 0.866 . . . . 64.32 111.179 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 131' ' ' TRP . . . . . 0.545 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 13.8 p90 -130.18 109.76 11.06 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 121.472 0.653 . . . . 75.2 110.394 178.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 132' ' ' SER . . . . . 0.496 ' H ' ' HB3' ' A' ' 124' ' ' PRO . 32.4 t -165.3 114.47 1.04 Allowed 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.991 -1.115 . . . . 74.43 107.991 175.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 133' ' ' THR . . . . . 0.404 ' OG1' ' HB2' ' A' ' 124' ' ' PRO . 63.5 m -142.23 -51.0 0.39 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.509 0.724 . . . . 74.41 109.235 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 134' ' ' GLY . . . . . 0.47 ' O ' HD12 ' A' ' 126' ' ' LEU . . . 70.75 -98.83 0.71 Allowed Glycine 0 C--N 1.349 1.276 0 CA-C-N 115.269 -0.878 . . . . 54.11 112.28 178.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 135' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 129' ' ' ALA . 2.7 p -174.76 -49.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.712 1.205 . . . . 75.33 109.243 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 136' ' ' LYS . . . . . 0.577 ' HZ3' ' HG3' ' A' ' 39' ' ' GLU . 23.5 ttpp 67.7 -69.71 0.13 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.898 1.679 . . . . 74.24 112.413 -178.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 18.5 m -68.99 92.03 0.5 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.572 0.749 . . . . 75.33 110.956 -174.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -104.19 -61.6 1.42 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.731 1.212 . . . . 74.31 109.582 176.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -65.81 -69.46 0.3 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.178 0.991 . . . . 73.04 110.995 -171.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . 77.28 -78.65 1.42 Allowed Glycine 0 CA--C 1.531 1.074 0 CA-C-N 116.583 -0.28 . . . . 72.13 112.751 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -124.48 179.1 5.08 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.768 0.827 . . . . 74.1 110.533 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 36.3 tp -130.14 141.81 50.65 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.516 0.726 . . . . 74.05 109.466 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.8 41.89 1.34 Allowed Glycine 0 C--N 1.351 1.382 0 O-C-N 123.26 0.35 . . . . 74.14 113.036 -176.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 12.3 p -105.94 113.64 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 CA-C-O 121.271 0.558 . . . . 75.21 110.056 174.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 37.5 t70 . . . . . 0 CA--C 1.554 1.107 0 C-N-CA 125.55 1.54 . . . . 74.33 111.362 174.54 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.306 0 N-CA-C 112.301 -0.32 . . . . 54.34 112.301 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.28 -58.01 4.51 Favored Glycine 0 C--N 1.351 1.372 0 N-CA-C 111.529 -0.629 . . . . 73.24 111.529 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 93' ' ' PHE . . . . . 0.551 ' HB3' HG23 ' B' ' 55' ' ' VAL . 49.6 m-85 -71.12 109.34 5.13 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.211 1.004 . . . . 65.05 110.536 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 94' ' ' PHE . . . . . 0.414 ' HE2' ' HB3' ' B' ' 12' ' ' GLN . 52.0 p90 -108.74 159.39 16.79 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.303 0.641 . . . . 73.51 110.373 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -130.15 154.41 47.55 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.616 0.366 . . . . 75.25 110.853 -173.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . 160.65 48.27 0.02 OUTLIER Glycine 0 C--N 1.351 1.396 0 CA-C-O 120.948 0.193 . . . . 74.31 113.447 177.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 97' ' ' ILE . . . . . 0.656 HD13 ' HB2' ' B' ' 94' ' ' MET . 18.8 tt -133.15 -30.99 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.806 0.842 . . . . 72.51 108.79 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 30.0 t70 70.38 -71.39 0.13 Allowed 'General case' 0 C--N 1.359 1.004 0 C-N-CA 126.357 1.863 . . . . 64.03 113.444 171.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 99' ' ' ALA . . . . . 0.484 ' HB3' ' H ' ' B' ' 3' ' ' GLU . . . -82.32 26.04 0.57 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.356 1.062 . . . . 61.23 113.607 -167.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 100' ' ' LEU . . . . . 0.445 HD11 ' H ' ' F' ' 102' ' ' LEU . 36.6 tp -100.89 100.74 13.52 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 123.677 0.791 . . . . 75.05 110.647 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 101' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' F' ' 99' ' ' ALA . 42.9 Cg_endo -97.42 13.7 0.84 Allowed 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.589 2.859 . . . . 73.42 112.224 166.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 102' ' ' LEU . . . . . 0.445 ' H ' HD11 ' F' ' 100' ' ' LEU . 29.7 tp 71.0 142.72 0.05 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.775 1.63 . . . . 71.41 111.601 -177.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 103' ' ' THR . . . . . 0.443 ' H ' HD12 ' F' ' 102' ' ' LEU . 17.5 m -73.4 73.63 1.37 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.539 1.136 . . . . 75.03 110.977 -177.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 57.69 20.85 41.04 Favored Glycine 0 C--N 1.352 1.448 0 N-CA-C 115.555 0.982 . . . . 75.31 115.555 176.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 61.41 19.42 10.24 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.757 0.823 . . . . 75.2 112.222 -176.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -168.65 118.87 0.74 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.488 -1.301 . . . . 74.11 107.488 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 16.5 m -75.51 84.92 2.59 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 121.189 0.519 . . . . 74.41 110.631 -177.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -100.75 105.02 16.31 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.796 0.839 . . . . 75.21 109.905 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -167.06 -59.71 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 107.476 -1.305 . . . . 75.42 107.476 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -125.85 -166.12 1.52 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 114.388 -1.278 . . . . 65.23 109.199 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 8.2 mp 71.01 -67.46 0.25 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 125.237 1.415 . . . . 75.13 109.195 -171.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -61.86 126.95 29.14 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.612 -0.884 . . . . 74.55 108.612 165.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -66.42 98.35 0.48 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 122.231 1.015 . . . . 72.54 110.784 -174.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -82.38 -78.75 0.2 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.241 -1.345 . . . . 72.01 110.151 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 31.9 m -156.75 -44.72 0.07 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.85 0.86 . . . . 72.31 109.047 -172.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.37 158.06 31.89 Favored Glycine 0 C--N 1.355 1.628 0 CA-C-N 115.371 -0.831 . . . . 65.01 113.394 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -74.83 126.41 88.41 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 123.127 0.571 . . . . 72.02 110.999 -173.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 118' ' ' PRO . . . . . 0.446 ' HB2' ' HB ' ' F' ' 121' ' ' VAL . 95.8 Cg_endo -81.39 92.68 1.02 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 123.112 2.541 . . . . 63.25 111.623 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.68 -76.46 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.525 1.13 . . . . 64.34 113.086 -174.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 120' ' ' TYR . . . . . 0.515 ' HH ' HD13 ' B' ' 136' ' ' LEU . 32.1 p90 -88.89 -14.72 36.12 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.298 0.239 . . . . 73.14 110.542 -178.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 121' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' F' ' 118' ' ' PRO . 25.7 t -76.45 84.86 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 109.017 -0.735 . . . . 73.22 109.017 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 5.6 t -99.06 -49.1 4.62 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.21 -0.905 . . . . 73.04 110.361 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -178.82 -54.85 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.349 1.06 . . . . 61.41 109.877 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 32.1 t 179.25 -48.52 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.022 1.329 . . . . 63.45 107.981 -174.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . 64.92 -79.59 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.481 1.512 . . . . 63.43 111.659 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -81.34 97.22 7.6 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.882 0.473 . . . . 50.14 110.314 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 35.4 p -87.05 -49.57 7.24 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.498 0.719 . . . . 72.55 110.251 176.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . 55.74 32.56 19.69 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.733 1.213 . . . . 63.15 111.303 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 129' ' ' THR . . . . . 0.706 ' HB ' ' HG3' ' B' ' 37' ' ' GLN . 20.4 m -91.04 100.68 13.5 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.481 -0.781 . . . . 54.51 111.429 -170.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -142.93 147.45 35.27 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.013 0.925 . . . . 72.43 109.752 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 131' ' ' TRP . . . . . 0.451 ' HB2' ' HG3' ' B' ' 124' ' ' PRO . 8.5 t90 -106.89 140.32 39.89 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 109.13 -0.693 . . . . 74.24 109.13 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 33.7 t -83.79 157.66 21.99 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.887 -0.412 . . . . 72.24 109.887 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 14.2 t -65.76 163.93 15.66 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.146 0.578 . . . . 74.32 110.961 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.2 160.67 26.79 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 123.649 0.593 . . . . 54.23 112.929 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 135' ' ' VAL . . . . . 0.474 ' HB ' HD23 ' C' ' 42' ' ' LEU . 21.7 m -77.73 75.27 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-O 122.628 1.204 . . . . 62.32 110.892 -175.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 136' ' ' LYS . . . . . 0.547 ' HZ3' ' HB3' ' F' ' 136' ' ' LYS . 0.0 OUTLIER -77.68 88.69 3.95 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.521 -1.218 . . . . 72.33 108.823 -175.094 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 10.8 m -139.91 -38.85 0.46 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.53 1.132 . . . . 71.34 109.028 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -81.55 -171.24 3.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.86 0.864 . . . . 74.53 111.354 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -66.19 88.64 0.12 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.717 0.807 . . . . 70.14 109.843 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.91 54.93 0.08 OUTLIER Glycine 0 C--O 1.239 0.438 0 N-CA-C 109.535 -1.426 . . . . 74.2 109.535 -176.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.03 144.59 45.35 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.957 0.903 . . . . 72.42 110.62 -169.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 pp -141.29 167.05 23.11 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 123.971 0.908 . . . . 75.32 109.836 172.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.02 105.81 2.19 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.014 -0.834 . . . . 74.02 111.014 173.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.63 -50.73 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.725 0.81 . . . . 75.14 110.076 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 C--O 1.248 1.004 0 N-CA-C 108.296 -1.001 . . . . 61.2 108.296 176.926 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 mmt . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.363 -0.606 . . . . 72.44 109.363 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -131.21 123.25 28.06 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.779 0.832 . . . . 74.23 109.423 -174.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -147.1 92.98 2.19 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.532 0.682 . . . . 53.43 110.866 -171.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -171.92 127.9 0.6 Allowed 'General case' 0 C--O 1.239 0.516 0 N-CA-C 106.861 -1.533 . . . . 72.13 106.861 176.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -70.09 91.12 0.68 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.131 0.491 . . . . 74.54 109.915 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -58.62 -56.04 27.3 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.831 1.252 . . . . 71.33 110.506 -177.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.497 HG21 HG23 ' A' ' 89' ' ' ILE . 6.0 t -153.58 152.03 30.44 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.328 -0.851 . . . . 61.31 110.345 -174.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -84.58 179.34 7.41 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.648 -0.706 . . . . 74.35 109.424 175.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.552 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 2.8 ppp? -145.28 175.18 10.48 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.122 0.569 . . . . 71.21 111.515 -172.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.4 m -140.88 129.7 23.02 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.388 1.075 . . . . 75.04 108.19 173.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -119.99 117.5 28.19 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.95 1.3 . . . . 72.13 108.337 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -133.89 109.8 9.29 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.619 -0.882 . . . . 74.21 108.619 -178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.8 mt -74.17 122.17 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.749 -0.834 . . . . 73.11 108.749 174.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -92.91 -42.17 9.64 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.088 0.555 . . . . 72.42 110.818 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -170.68 121.8 0.59 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 110.05 -0.352 . . . . 74.22 110.05 -175.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 98.1 mt -105.71 126.14 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 107.57 -1.27 . . . . 74.3 107.57 172.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.489 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 28.3 p90 -162.11 157.11 22.85 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 123.736 0.647 . . . . 75.11 110.896 -171.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.1 p -85.01 117.09 23.77 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 109.408 -0.59 . . . . 72.41 109.408 174.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.489 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.0 mtpt -78.19 -31.31 49.47 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.407 -0.59 . . . . 71.33 109.407 174.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 30.4 t70 -150.25 145.82 26.43 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.759 -1.109 . . . . 62.13 110.68 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.401 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 75.0 mt -138.92 145.41 27.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 C-N-CA 125.395 1.478 . . . . 74.5 107.951 176.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.3 t -149.26 133.05 16.95 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.833 0.853 . . . . 73.54 109.538 173.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -130.54 139.39 50.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.087 -1.449 . . . . 74.14 107.087 169.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -135.12 134.11 39.9 Favored 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 123.068 0.547 . . . . 73.24 109.621 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.524 ' HB1' ' HB1' ' A' ' 28' ' ' ALA . . . -147.8 71.57 11.45 Favored Pre-proline 0 C--O 1.243 0.738 0 N-CA-C 105.829 -1.915 . . . . 73.43 105.829 169.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.78 -30.99 10.9 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.142 1.895 . . . . 75.12 111.389 -177.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -94.03 12.97 24.41 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 118.35 -0.833 . . . . 70.52 109.91 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.524 ' HB1' ' HB1' ' A' ' 25' ' ' ALA . . . -42.91 -59.08 3.28 Favored Pre-proline 0 CA--C 1.573 1.844 0 CA-C-O 118.146 -0.931 . . . . 73.13 112.919 -173.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -63.46 -15.02 45.91 Favored 'Trans proline' 0 C--N 1.395 2.995 0 C-N-CA 122.541 2.16 . . . . 71.51 113.956 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -92.29 -42.65 9.71 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.868 0.867 . . . . 73.01 110.154 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.535 HG21 HD12 ' A' ' 68' ' ' LEU . 4.3 p -79.32 -13.48 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-N 114.02 -1.446 . . . . 60.3 112.617 -161.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -72.42 -15.38 61.83 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.186 0.594 . . . . 74.23 110.968 173.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -87.46 -12.56 45.71 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.352 1.061 . . . . 74.25 111.15 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -82.46 155.71 24.47 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.646 0.778 . . . . 63.12 111.394 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.98 128.53 36.31 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.49 0.716 . . . . 72.33 109.457 170.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.469 ' CE3' HD21 ' A' ' 68' ' ' LEU . 49.9 t-105 -81.04 76.34 7.99 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.848 0.832 . . . . 74.42 110.266 -177.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.3 tm0? -126.8 81.88 68.39 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 105.025 -2.213 . . . . 74.44 105.025 168.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -83.68 144.98 11.42 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.347 2.031 . . . . 73.43 112.141 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -96.46 84.11 3.64 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.457 -1.312 . . . . 64.33 107.457 173.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.404 HG22 ' HB1' ' A' ' 66' ' ' ALA . 43.3 t -88.13 94.44 4.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 CA-C-N 115.537 -0.756 . . . . 71.34 109.819 -175.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -92.93 134.12 35.43 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.056 -0.974 . . . . 71.42 109.978 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.1 mt -103.66 108.95 20.46 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.477 -0.935 . . . . 75.35 108.477 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.599 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 10.2 m-20 -101.63 107.92 19.31 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.367 -1.346 . . . . 74.11 107.367 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.471 HD22 HD21 ' A' ' 60' ' ' LEU . 86.8 mt -103.52 135.53 44.94 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.448 0.642 . . . . 73.32 111.279 -174.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 24.8 t70 -132.55 143.45 49.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.334 -1.303 . . . . 74.02 108.254 178.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.6 m -127.25 133.4 50.21 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.663 0.785 . . . . 73.31 108.963 175.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.77 147.71 52.32 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 124.547 1.139 . . . . 71.12 108.502 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.433 ' HG ' ' HB3' ' A' ' 98' ' ' LEU . 68.1 m -131.68 156.51 45.76 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 122.747 0.419 . . . . 73.21 109.883 174.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.9 t -154.31 118.89 4.87 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.257 -1.016 . . . . 73.21 108.257 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -72.87 107.48 5.3 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 108.544 -0.91 . . . . 74.33 108.544 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.5 mt -79.95 -36.62 35.96 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.987 -0.552 . . . . 75.24 110.454 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.55 -174.02 4.81 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.272 0.629 . . . . 62.44 110.869 -177.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -65.29 119.84 11.67 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.203 0.601 . . . . 61.41 109.634 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 65.73 5.61 3.45 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.988 1.315 . . . . 73.52 112.532 -175.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.5 t -107.12 111.12 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 109.108 -0.701 . . . . 73.23 109.108 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -121.23 124.58 45.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.108 -1.071 . . . . 72.05 108.108 176.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -87.78 143.63 27.05 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.677 -0.86 . . . . 72.02 108.677 170.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.419 HG11 ' HD3' ' A' ' 103' ' ' PRO . 96.9 t -126.4 137.58 57.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 107.873 -1.158 . . . . 71.43 107.873 170.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.441 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 44.7 t -119.27 130.75 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.473 -0.936 . . . . 74.25 108.473 174.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.484 HD23 HG23 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -104.74 105.91 16.19 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 105.957 -1.868 . . . . 74.31 105.957 173.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.565 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 28.6 ttp180 -92.88 99.98 12.53 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.345 -1.354 . . . . 72.41 107.345 176.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.484 HG23 HD23 ' A' ' 60' ' ' LEU . 29.5 t -94.93 129.24 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 107.705 -1.22 . . . . 74.54 107.705 176.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.3 m -121.71 114.58 21.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.887 -0.783 . . . . 72.12 108.887 176.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 90.6 t -102.06 106.89 20.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.32 -0.993 . . . . 73.13 108.32 177.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.9 m -103.3 132.68 49.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.43 -0.952 . . . . 70.34 108.43 172.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.404 ' HB1' HG22 ' A' ' 40' ' ' VAL . . . -137.98 118.26 13.65 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.527 -0.545 . . . . 74.31 109.527 178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.0 m -123.24 138.2 54.69 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.368 0.667 . . . . 63.35 110.521 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.535 HD12 HG21 ' A' ' 31' ' ' VAL . 22.0 mt -92.32 86.31 5.67 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.973 1.309 . . . . 70.42 108.396 172.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.5 -95.75 0.89 Allowed Glycine 0 C--N 1.339 0.705 0 O-C-N 123.393 0.433 . . . . 74.01 112.34 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.85 -26.17 13.23 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.634 0.773 . . . . 70.15 110.752 -177.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -104.07 126.19 50.99 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.398 0.679 . . . . 74.41 110.4 -174.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.1 m -63.62 125.94 25.92 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 123.561 0.538 . . . . 64.14 110.75 173.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.492 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -72.63 -60.26 2.32 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.818 -0.808 . . . . 72.55 108.818 174.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -160.31 168.17 25.88 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.652 0.739 . . . . 74.53 111.757 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 64' ' ' VAL . 65.1 tp -127.2 143.11 51.32 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.003 1.321 . . . . 71.1 107.739 169.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.555 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 70.9 m -144.76 98.28 3.16 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.386 0.674 . . . . 63.02 109.777 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 33.9 tt0 -118.64 116.93 27.61 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.673 -0.491 . . . . 74.34 109.673 -176.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.0 t -125.33 110.87 25.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 123.836 0.855 . . . . 75.13 109.022 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.434 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 51.9 mt-30 -84.9 82.51 8.41 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.231 -1.026 . . . . 65.43 108.231 172.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -76.07 94.43 3.45 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 114.474 -1.239 . . . . 71.35 108.574 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.46 163.34 40.73 Favored Glycine 0 C--O 1.24 0.474 0 N-CA-C 111.011 -0.836 . . . . 61.44 111.011 177.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.83 121.71 1.05 Allowed Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 110.371 -1.092 . . . . 74.51 110.371 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.8 mt -81.49 122.65 36.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.499 -1.297 . . . . 73.44 107.499 173.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.542 ' HB3' HD11 ' A' ' 86' ' ' ILE . 93.3 m-85 -128.19 121.17 28.8 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.359 0.664 . . . . 74.11 109.513 -178.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.1 t -85.25 98.1 10.31 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.418 -0.956 . . . . 74.35 108.418 173.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.542 HD11 ' HB3' ' A' ' 84' ' ' PHE . 4.2 mm -107.87 147.95 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.418 -0.586 . . . . 75.33 109.418 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.53 170.1 23.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.647 -0.706 . . . . 74.43 110.121 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 100.15 -34.17 5.73 Favored Glycine 0 C--N 1.341 0.818 0 O-C-N 123.613 0.571 . . . . 73.34 113.574 176.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.52 HG22 ' HB3' ' A' ' 9' ' ' MET . 0.2 OUTLIER -127.5 146.34 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 122.928 0.491 . . . . 71.01 111.739 -169.259 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.24 175.17 9.49 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.658 1.183 . . . . 65.43 109.335 175.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.26 -131.29 27.32 Favored Glycine 0 C--N 1.352 1.443 0 O-C-N 123.46 0.475 . . . . 75.41 113.611 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.9 t -72.8 -21.53 60.97 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.23 0.612 . . . . 73.42 111.212 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -73.64 -42.39 61.47 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.606 0.762 . . . . 71.41 109.387 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.3 tpt -66.55 -42.52 87.02 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 115.596 -0.729 . . . . 74.31 110.262 173.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.54 -29.2 70.4 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.385 -0.825 . . . . 72.43 111.13 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.461 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 60.4 t-80 -71.53 -35.27 70.61 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.98 -0.555 . . . . 74.44 110.926 176.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.9 t -71.89 -44.16 64.2 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 110.005 -0.368 . . . . 72.23 110.005 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.433 ' HB3' ' HG ' ' A' ' 48' ' ' SER . 55.6 mt -82.38 -32.07 29.38 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.66 0.615 . . . . 74.42 112.66 -173.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.89 4.36 42.07 Favored Glycine 0 N--CA 1.472 1.034 0 CA-C-O 119.89 -0.395 . . . . 71.42 113.639 -172.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.562 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -140.49 -68.6 0.41 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 117.014 0.407 . . . . 62.32 110.759 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -67.97 -45.33 74.46 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 116.01 -0.541 . . . . 74.43 112.266 -168.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 82.4 m -67.19 -48.42 48.16 Favored Pre-proline 0 CA--C 1.559 1.296 0 CA-C-O 118.065 -0.969 . . . . 75.34 112.783 -176.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.419 ' HD3' HG11 ' A' ' 58' ' ' VAL . 41.0 Cg_endo -66.51 -18.72 54.72 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 121.576 1.517 . . . . 74.22 112.682 173.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -76.12 -34.62 59.47 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.923 0.489 . . . . 74.11 110.529 173.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.2 mm -64.35 -43.84 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.448 0.699 . . . . 73.32 109.447 170.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.2 mt -73.36 -23.48 60.21 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.045 -0.98 . . . . 74.2 112.522 -174.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -63.61 -45.64 82.88 Favored Pre-proline 0 N--CA 1.485 1.279 0 N-CA-C 114.331 1.234 . . . . 75.25 114.331 -172.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -52.95 -36.53 75.58 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 121.985 1.79 . . . . 73.14 113.47 172.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -79.08 -39.36 33.98 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.559 0.744 . . . . 74.12 111.352 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.45 -49.53 73.33 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.252 0.621 . . . . 64.03 109.369 175.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.47 ' NH1' HD13 ' C' ' 105' ' ' ILE . 27.4 ttm180 -49.96 -50.5 46.56 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 125.137 1.523 . . . . 72.0 111.084 175.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -65.24 -47.85 75.37 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 124.374 1.046 . . . . 75.24 111.747 -176.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.519 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 53.7 t -56.0 -42.01 75.75 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.135 0.897 . . . . 54.11 110.468 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.534 HD12 HG23 ' A' ' 64' ' ' VAL . 68.8 mt -62.66 -53.69 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 114.736 -1.12 . . . . 75.44 110.616 174.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 33.1 m -55.87 -36.86 68.04 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.679 0.791 . . . . 74.24 111.027 -175.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.7 t -68.68 -46.9 67.86 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.582 -1.19 . . . . 72.21 110.186 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.6 mtp -59.94 -42.29 93.7 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.605 0.762 . . . . 73.34 111.897 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.5 t -63.76 -44.16 98.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 124.254 1.022 . . . . 71.24 110.252 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 99.4 p -73.23 -32.3 64.67 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.803 -0.635 . . . . 71.33 111.108 -176.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -67.78 -33.38 74.72 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.469 0.708 . . . . 71.51 109.738 173.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.54 15.05 37.67 Favored Glycine 0 C--N 1.354 1.562 0 CA-C-N 115.585 -0.734 . . . . 53.11 113.578 175.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.419 HG23 ' HE ' ' B' ' 15' ' ' ARG . 2.4 t 59.9 11.54 2.63 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 127.26 2.224 . . . . 73.51 114.488 174.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -79.76 140.01 54.56 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 107.96 -1.126 . . . . 72.51 107.96 175.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -43.15 133.56 6.21 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 123.529 2.819 . . . . 74.4 112.647 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -52.36 131.0 32.71 Favored 'General case' 0 C--N 1.363 1.164 0 O-C-N 123.93 0.769 . . . . 71.35 112.474 -169.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.489 HD21 HG12 ' A' ' 64' ' ' VAL . 22.3 tp -120.22 115.73 24.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.688 1.195 . . . . 74.24 109.303 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.54 ' HB2' HG21 ' E' ' 135' ' ' VAL . 35.9 m-80 -109.17 128.04 54.7 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 105.715 -1.957 . . . . 63.44 105.715 173.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.494 HD12 HD13 ' A' ' 114' ' ' ILE . 15.4 mt -71.7 147.44 47.41 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 118.29 0.496 . . . . 74.21 110.926 -175.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.33 137.6 86.53 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 122.98 0.512 . . . . 65.14 110.677 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.2 124.21 15.65 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 123.132 2.555 . . . . 63.34 113.329 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 68.6 t -109.43 128.6 65.3 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 C-N-CA 123.78 0.832 . . . . 75.21 110.388 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -92.18 84.3 5.22 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.466 -0.939 . . . . 74.01 108.466 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -60.83 -29.67 69.64 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.884 0.874 . . . . 74.43 111.587 177.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.562 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 5.5 t70 -64.24 -42.24 96.62 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 124.007 0.817 . . . . 70.41 109.559 178.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.92 -40.18 87.56 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.125 0.891 . . . . 75.4 111.275 176.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.64 -42.86 99.48 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 123.779 0.674 . . . . 75.33 111.016 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -71.32 -36.56 71.63 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 116.014 -0.539 . . . . 73.4 109.834 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.515 ' HG2' ' HA ' ' A' ' 143' ' ' GLN . 33.4 ttm -64.7 -27.97 69.28 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.51 0.506 . . . . 75.24 111.374 -174.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -58.33 -42.94 87.9 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.432 0.693 . . . . 74.15 110.668 172.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -78.05 -30.28 49.72 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 125.012 1.325 . . . . 65.04 111.403 176.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.466 ' HB3' ' HA ' ' A' ' 138' ' ' MET . 51.9 tp -68.28 -51.2 47.58 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.215 1.006 . . . . 63.14 111.508 -175.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 169.99 -18.81 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 125.002 1.321 . . . . 75.14 111.238 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.515 ' HA ' ' HG2' ' A' ' 138' ' ' MET . 0.0 OUTLIER 49.39 72.82 0.28 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.695 1.598 . . . . 75.25 111.273 -173.191 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -160.63 -54.06 0.05 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.632 -0.713 . . . . 74.45 109.261 177.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.59 155.39 48.38 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-N 115.463 -0.789 . . . . 73.1 110.614 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 174.59 124.36 0.79 Allowed Glycine 0 C--N 1.346 1.095 0 O-C-N 123.73 0.644 . . . . 52.0 112.713 176.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -145.3 -171.07 3.58 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.786 1.234 . . . . 72.05 108.33 170.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 120.95 65.57 0.25 Allowed Glycine 0 C--N 1.349 1.302 0 N-CA-C 112.47 -0.252 . . . . 63.42 112.47 177.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.8 t -153.26 152.81 31.58 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.319 0.647 . . . . 75.23 110.722 175.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -175.79 150.24 1.01 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.545 1.138 . . . . 74.02 109.156 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.64 124.65 52.31 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.81 -0.811 . . . . 75.14 108.81 172.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -158.32 117.73 3.18 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.162 1.385 . . . . 74.1 107.726 177.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -146.16 161.54 39.99 Favored 'General case' 0 C--O 1.24 0.572 0 O-C-N 123.79 0.681 . . . . 75.51 110.763 -175.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -116.67 -62.31 1.6 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.32 1.048 . . . . 71.02 108.553 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.918 0 C-N-CA 124.244 1.018 . . . . 71.22 108.686 179.39 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.698 ' SD ' ' HD2' ' F' ' 95' ' ' LYS . 57.2 mtm . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 109.12 -0.696 . . . . 72.0 109.12 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.2 t -103.47 93.48 4.97 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 109.053 -0.721 . . . . 73.44 109.053 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 68.8 80.26 0.2 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.754 1.222 . . . . 75.23 111.531 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -136.73 78.5 1.7 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.522 1.129 . . . . 64.42 108.553 170.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -152.78 123.49 7.34 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.423 -0.954 . . . . 75.12 108.423 -178.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -126.36 121.27 32.06 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.466 0.707 . . . . 72.13 109.239 -176.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 13.3 t -75.9 160.86 29.48 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.218 0.607 . . . . 74.33 110.705 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 61.94 27.83 16.92 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.376 1.071 . . . . 71.32 110.576 -173.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.518 ' HB3' HG22 ' B' ' 89' ' ' ILE . 20.7 ptm 49.43 -174.44 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 127.037 2.135 . . . . 70.3 112.71 -170.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -147.68 140.03 24.47 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 108.425 -0.954 . . . . 72.3 108.425 169.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -138.35 140.46 39.47 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.741 -0.837 . . . . 75.51 108.741 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -151.5 140.02 20.59 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 109.087 -0.708 . . . . 72.32 109.087 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.573 HD13 ' HD3' ' D' ' 130' ' ' PRO . 33.8 mt -75.1 133.0 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 107.535 -1.283 . . . . 61.4 107.535 167.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -98.43 -43.76 6.78 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.054 -0.721 . . . . 75.12 109.054 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.419 ' HE ' HG23 ' A' ' 122' ' ' THR . 52.0 ttt180 -172.88 131.72 0.52 Allowed 'General case' 0 C--N 1.348 0.536 0 CA-C-N 115.723 -0.671 . . . . 72.23 109.69 -177.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.561 HG21 ' CD1' ' B' ' 109' ' ' TYR . 58.6 mt -115.63 144.13 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.108 -1.071 . . . . 74.12 108.108 173.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -164.69 145.58 7.82 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.489 0.661 . . . . 75.22 111.931 -175.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.1 m -72.91 118.17 15.53 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.405 -1.27 . . . . 71.33 108.086 169.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -94.59 -23.29 17.7 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.509 0.724 . . . . 74.24 111.02 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -161.48 143.47 11.76 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.986 0.179 . . . . 74.21 110.9 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.517 HD13 ' SG ' ' B' ' 113' ' ' CYS . 47.1 mm -136.1 143.92 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.536 1.135 . . . . 75.25 109.536 176.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 68.9 m -141.27 132.58 26.63 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.962 1.705 . . . . 63.11 107.208 169.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 88.0 t80 -142.87 109.26 5.33 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.483 -1.673 . . . . 72.2 106.483 166.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -119.53 111.54 18.22 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.501 -0.925 . . . . 75.42 108.501 -176.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.56 86.47 1.78 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 106.566 -1.642 . . . . 71.2 106.566 173.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.28 -35.7 8.13 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.464 2.11 . . . . 73.15 112.199 -165.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -106.93 21.02 18.2 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.1 -0.954 . . . . 71.32 109.663 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.417 ' HB1' ' HD3' ' B' ' 29' ' ' PRO . . . -42.66 -62.33 1.31 Allowed Pre-proline 0 N--CA 1.487 1.424 0 C-N-CA 125.221 1.408 . . . . 73.35 114.722 -165.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.417 ' HD3' ' HB1' ' B' ' 28' ' ' ALA . 16.6 Cg_exo -61.81 -30.18 84.05 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 122.08 1.854 . . . . 74.33 112.375 -171.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -96.04 -27.99 14.84 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.564 -1.198 . . . . 74.31 111.983 -169.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.441 HG21 ' HA ' ' B' ' 73' ' ' ALA . 6.4 p -81.81 -10.02 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 120.775 0.322 . . . . 72.12 111.043 -176.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -70.57 -19.96 62.83 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.383 0.673 . . . . 74.23 112.678 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -65.92 -12.78 57.3 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.144 0.497 . . . . 74.51 111.229 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -97.36 92.26 5.89 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.053 1.341 . . . . 73.13 109.744 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -97.38 78.92 2.73 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.755 -0.657 . . . . 73.15 109.622 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 15.1 p90 -153.8 -173.24 4.5 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.092 0.557 . . . . 74.44 110.017 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -73.03 109.47 6.33 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 124.143 0.977 . . . . 74.45 110.088 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.493 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 55.6 Cg_endo -72.91 132.24 18.1 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 121.199 1.266 . . . . 70.02 111.317 175.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -65.6 104.86 1.09 Allowed 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.184 0.594 . . . . 72.22 109.809 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.563 HG21 ' HB1' ' B' ' 66' ' ' ALA . 74.8 t -99.5 143.38 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 114.355 -1.293 . . . . 72.33 111.221 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -124.09 132.05 53.61 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 106.949 -1.5 . . . . 73.43 106.949 173.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.408 HD12 HG21 ' B' ' 64' ' ' VAL . 17.1 tp -102.06 124.98 48.6 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.073 -1.084 . . . . 70.22 108.073 172.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -124.85 139.59 53.7 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.615 -1.254 . . . . 73.44 107.615 -175.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mp -122.3 138.25 54.57 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.837 0.855 . . . . 65.42 109.453 -171.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.552 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 9.8 t70 -135.22 146.85 49.05 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.715 1.206 . . . . 74.4 108.442 173.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.1 m -126.74 103.42 7.53 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.919 -0.771 . . . . 74.14 108.919 -176.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.75 117.89 31.52 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 108.625 -0.879 . . . . 63.41 108.625 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 51.7 p -144.6 161.04 40.14 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 122.429 0.291 . . . . 75.42 110.752 -176.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.7 p -159.45 138.88 11.35 Favored 'General case' 0 C--O 1.244 0.799 0 O-C-N 123.444 0.465 . . . . 74.0 111.211 -174.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . 0.447 ' HG3' HD11 ' F' ' 100' ' ' LEU . 61.0 tt0 -78.37 104.57 9.04 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 108.845 -0.798 . . . . 72.23 108.845 171.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 3.0 pp -122.53 11.31 9.88 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.647 -0.706 . . . . 72.32 109.928 175.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.07 158.49 43.09 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 115.702 -0.681 . . . . 63.41 110.49 -174.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.93 107.74 17.86 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.418 1.087 . . . . 72.23 110.883 -172.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 62.53 18.63 10.6 Favored 'General case' 0 N--CA 1.501 2.122 0 C-N-CA 124.275 1.03 . . . . 71.15 111.589 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 90.3 t -135.6 121.63 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.372 1.469 . . . . 62.32 107.248 -174.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -113.43 139.25 49.07 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.69 -0.856 . . . . 75.32 108.69 -172.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -104.51 101.29 10.96 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 106.578 -1.638 . . . . 62.52 106.578 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -104.04 133.66 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.201 0.601 . . . . 73.43 109.491 -177.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.486 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 25.8 t -118.4 122.11 68.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 C-N-CA 124.183 0.993 . . . . 74.42 108.437 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.45 109.94 21.78 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 107.796 -1.187 . . . . 72.11 107.796 174.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.552 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 39.2 ttm180 -85.85 112.23 20.94 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.889 -0.782 . . . . 71.24 108.889 175.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 61.7 t -105.37 103.59 15.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.42 -0.956 . . . . 73.4 108.42 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 7.5 m -99.44 131.39 45.48 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.427 -0.806 . . . . 74.41 109.648 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.577 HG23 HD12 ' B' ' 114' ' ' ILE . 72.4 t -120.05 133.14 67.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 123.758 0.823 . . . . 65.34 110.042 176.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 72.6 m -110.76 147.35 34.63 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 108.355 -0.98 . . . . 75.34 108.355 167.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.563 ' HB1' HG21 ' B' ' 40' ' ' VAL . . . -144.5 133.19 22.28 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.446 0.698 . . . . 62.23 109.359 173.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.457 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 16.6 m -133.98 126.38 30.15 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 123.418 0.449 . . . . 74.22 110.675 -174.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.493 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 60.4 mt -99.08 101.29 12.61 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.841 -1.17 . . . . 75.23 107.841 174.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.82 -144.82 24.33 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 115.747 -0.661 . . . . 74.43 111.54 -173.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -82.41 2.36 32.91 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.017 0.927 . . . . 72.33 112.652 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -123.34 158.83 30.18 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.638 0.775 . . . . 70.55 110.354 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 92.4 m -81.35 126.16 31.26 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.683 0.793 . . . . 74.14 110.689 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.457 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -77.67 -57.85 3.59 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.321 1.049 . . . . 71.43 108.96 174.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -143.99 162.41 36.26 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 122.249 1.023 . . . . 73.44 111.937 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 84.4 mt -126.76 147.5 49.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 112.886 -1.961 . . . . 75.41 106.554 171.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 32.5 t -149.45 150.85 33.01 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.006 -1.109 . . . . 70.24 108.006 174.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -161.84 125.15 3.1 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.207 -1.034 . . . . 74.41 108.207 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.439 HG11 ' HA ' ' B' ' 110' ' ' ALA . 84.6 t -122.94 146.6 27.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.542 -0.911 . . . . 72.41 108.542 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -117.72 107.53 14.29 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.012 -1.107 . . . . 74.12 108.012 169.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -99.43 100.62 11.69 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.224 -1.028 . . . . 72.12 108.224 175.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -96.22 162.2 22.67 Favored Glycine 0 C--N 1.336 0.55 0 O-C-N 123.785 0.678 . . . . 55.03 111.599 177.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.9 131.98 2.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.695 -0.288 . . . . 70.31 112.642 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 47.0 mt -85.54 115.03 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 N-CA-C 107.612 -1.255 . . . . 73.21 107.612 171.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -127.32 140.95 51.85 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.832 0.853 . . . . 73.42 109.621 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 56.1 m -95.19 123.26 38.59 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.381 0.672 . . . . 75.34 110.191 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.699 HG23 HD13 ' B' ' 89' ' ' ILE . 2.4 mp -127.63 113.07 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 108.018 -1.104 . . . . 71.14 108.018 -178.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.82 155.46 35.84 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.176 0.59 . . . . 71.24 110.812 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 102.02 -34.15 5.93 Favored Glycine 0 N--CA 1.48 1.571 0 C-N-CA 123.786 0.707 . . . . 74.24 112.496 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.699 HD13 HG23 ' B' ' 86' ' ' ILE . 0.9 OUTLIER -80.74 167.63 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 124.509 1.124 . . . . 64.42 112.345 178.804 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.447 ' HA ' ' HB2' ' F' ' 98' ' ' ASP . 44.3 tt0 -156.59 148.98 23.37 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.819 0.848 . . . . 71.13 110.655 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.15 -134.16 12.34 Favored Glycine 0 C--N 1.356 1.673 0 C-N-CA 123.013 0.34 . . . . 70.5 113.655 172.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.5 m -64.64 -48.47 74.71 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.42 1.088 . . . . 63.44 110.255 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -66.28 -24.7 66.61 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 113.437 -1.711 . . . . 74.21 111.466 -170.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.8 -65.7 0.65 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.637 1.175 . . . . 74.1 112.215 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.52 -13.24 59.93 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.686 0.395 . . . . 72.24 111.983 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -59.82 -36.07 76.03 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.286 0.634 . . . . 75.32 110.402 168.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.4 t -65.16 -55.43 18.68 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.215 0.606 . . . . 74.12 111.524 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.623 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.6 pp -76.49 -18.25 58.86 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 112.646 0.61 . . . . 75.3 112.646 -177.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.93 -19.6 30.8 Favored Glycine 0 C--N 1.348 1.239 0 CA-C-O 119.766 -0.463 . . . . 54.2 113.861 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.72 -51.94 1.06 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 117.324 0.562 . . . . 73.13 111.49 -173.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -70.17 -40.15 74.87 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.414 0.686 . . . . 75.41 111.244 -175.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.623 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 81.8 m -70.99 -48.83 13.64 Favored Pre-proline 0 CA--C 1.56 1.36 0 CA-C-O 118.443 -0.789 . . . . 72.23 112.086 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.431 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 84.2 Cg_exo -54.14 -29.12 54.53 Favored 'Trans proline' 0 C--N 1.393 2.906 0 C-N-CA 122.49 2.127 . . . . 70.21 114.029 169.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -64.75 -33.31 75.68 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.4 0.68 . . . . 71.21 111.488 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 65.0 mt -72.89 -39.12 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.772 0.829 . . . . 75.04 110.122 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 71.2 mt -75.33 -34.18 61.19 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.737 -1.119 . . . . 74.22 111.722 -174.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -57.73 -47.34 99.11 Favored Pre-proline 0 N--CA 1.487 1.377 0 CA-C-O 117.559 -1.21 . . . . 71.32 113.776 -171.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -54.94 -35.93 90.78 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.21 1.94 . . . . 73.33 113.299 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.561 ' CD1' HG21 ' B' ' 16' ' ' ILE . 5.0 m-30 -76.03 -40.43 53.47 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.827 -0.624 . . . . 75.04 110.364 -176.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.439 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -63.04 -42.76 99.83 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.486 -0.779 . . . . 74.05 110.257 174.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 28.4 ttt-85 -60.47 -49.61 76.89 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.075 1.35 . . . . 74.1 110.819 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -69.32 -31.5 70.0 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.885 0.741 . . . . 74.52 109.998 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.531 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.9 t -68.51 -40.54 80.78 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 122.915 0.486 . . . . 54.41 110.316 177.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.577 HD12 HG23 ' B' ' 64' ' ' VAL . 81.8 mt -62.37 -54.82 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.63 0.772 . . . . 74.31 110.128 174.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.9 m -61.18 -27.95 68.78 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 123.916 0.76 . . . . 73.02 111.068 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.461 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.3 t -64.92 -53.27 49.12 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 123.208 0.603 . . . . 73.03 109.555 173.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.531 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.1 mmt -65.92 -33.8 76.66 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.27 0.628 . . . . 74.21 111.573 -175.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.438 HG22 HD22 ' B' ' 126' ' ' LEU . 78.2 t -68.3 -41.72 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.732 1.213 . . . . 62.44 110.604 176.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 39.0 t -67.11 -31.15 71.43 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.227 -0.897 . . . . 74.11 110.785 175.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.519 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 82.0 mtt-85 -69.55 -37.78 77.17 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 123.237 0.615 . . . . 75.41 110.001 176.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.31 -11.42 71.38 Favored Glycine 0 C--N 1.353 1.515 0 O-C-N 123.429 0.456 . . . . 64.13 112.749 170.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 10.1 m 67.93 26.93 7.36 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 125.804 1.641 . . . . 75.23 110.204 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -78.07 164.99 53.76 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-N 114.964 -1.016 . . . . 75.3 111.448 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -47.54 154.48 1.7 Allowed 'Trans proline' 0 C--N 1.393 2.911 0 C-N-CA 123.429 2.753 . . . . 72.5 114.351 171.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.671 ' HB3' ' HB3' ' F' ' 130' ' ' ALA . 0.0 OUTLIER -62.37 115.95 4.64 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.003 0.921 . . . . 62.24 111.595 -175.508 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.451 HD13 HG12 ' B' ' 40' ' ' VAL . 37.8 tp -109.57 108.13 18.46 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.546 -0.752 . . . . 72.14 109.392 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -114.35 120.51 40.63 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 107.73 -1.211 . . . . 73.33 107.73 169.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.472 HD13 HD13 ' B' ' 114' ' ' ILE . 87.9 mt -74.98 130.13 38.83 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 122.873 0.469 . . . . 75.44 110.32 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.11 136.24 90.94 Favored Pre-proline 0 CA--C 1.55 0.971 0 O-C-N 124.393 1.058 . . . . 65.4 110.77 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.03 94.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.711 2.274 . . . . 75.33 111.907 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 19.5 m -90.61 110.44 22.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.847 0.832 . . . . 75.14 109.201 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . 0.439 ' ND2' ' HB1' ' B' ' 135' ' ' ALA . 13.2 p-10 -85.77 106.02 16.71 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.542 -0.91 . . . . 74.11 108.542 174.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.427 ' HD1' HD21 ' F' ' 111' ' ' LEU . 15.0 m-85 -58.51 -33.28 69.66 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.116 -1.402 . . . . 74.43 109.843 176.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -56.36 -36.39 68.76 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 113.419 -1.719 . . . . 64.54 111.791 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.439 ' HB1' ' ND2' ' B' ' 132' ' ' ASN . . . -57.88 -35.31 70.81 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.951 0.9 . . . . 62.04 112.183 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.26 -49.16 72.99 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 123.761 0.663 . . . . 75.14 109.612 175.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -71.1 -23.39 62.1 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.368 0.667 . . . . 75.24 112.611 -177.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.474 ' HG2' ' NE2' ' B' ' 143' ' ' GLN . 60.7 mtt -65.34 -37.39 86.92 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.638 0.775 . . . . 73.04 111.298 177.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -106.53 -31.93 8.3 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.504 -0.771 . . . . 72.13 111.314 -167.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -76.46 -48.6 19.07 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.287 0.635 . . . . 74.25 109.794 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 6.4 mp -89.91 -7.68 53.6 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.783 0.433 . . . . 62.13 111.051 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 60.11 123.74 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.202 1.401 . . . . 74.43 112.876 -177.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . 0.474 ' NE2' ' HG2' ' B' ' 138' ' ' MET . 25.0 mt-30 -113.53 -65.4 1.19 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.661 -0.866 . . . . 71.32 108.661 170.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 55.7 86.27 0.06 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.65 1.18 . . . . 72.44 109.602 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.0 -23.47 64.11 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.567 0.747 . . . . 73.45 112.953 -171.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.23 24.49 54.43 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-O 119.735 -0.481 . . . . 74.42 112.746 -174.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 64.48 -78.46 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.972 1.309 . . . . 70.11 110.642 -175.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.17 7.53 2.24 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-O 119.437 -0.646 . . . . 73.34 112.906 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 7.7 m 59.79 81.94 0.16 Allowed 'General case' 0 C--N 1.357 0.922 0 C-N-CA 124.536 1.135 . . . . 75.03 110.757 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -79.47 156.82 27.67 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.329 0.652 . . . . 75.43 110.824 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -145.57 -176.79 5.26 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.059 0.944 . . . . 74.43 109.37 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . 0.706 ' HB3' ' HB3' ' D' ' 90' ' ' GLU . 5.0 p80 -155.85 86.15 1.04 Allowed 'General case' 0 C--N 1.355 0.806 0 CA-C-O 121.536 0.684 . . . . 72.35 111.546 174.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -75.29 -45.46 39.72 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.955 -0.757 . . . . 74.22 108.955 165.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -105.99 172.71 6.66 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.641 1.176 . . . . 75.32 110.885 -173.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . 0.476 ' HB3' ' HB1' ' E' ' 99' ' ' ALA . . . . . . . . 0 C--O 1.248 1.014 0 C-N-CA 124.171 0.988 . . . . 75.15 109.45 -177.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.82 0.343 . . . . 74.3 110.144 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 2' ' ' SER . . . . . 0.479 ' HB3' ' HG3' ' E' ' 136' ' ' LYS . 73.5 m -147.12 170.87 16.27 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.445 1.098 . . . . 71.53 109.24 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -66.19 88.42 0.12 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 108.739 -0.837 . . . . 75.11 108.739 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -136.08 88.88 2.43 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.825 -1.079 . . . . 72.41 108.894 -170.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -166.66 137.5 3.32 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.658 0.783 . . . . 74.25 109.094 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -141.64 169.51 17.46 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.223 1.009 . . . . 70.43 108.519 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 46.1 m -46.26 -44.04 16.07 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.541 1.137 . . . . 74.44 111.435 174.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -161.85 158.48 25.57 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.415 -1.266 . . . . 73.44 108.245 173.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 20.7 ttt 64.94 111.87 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.01 1.324 . . . . 72.24 110.894 -173.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.463 ' HB ' ' HB1' ' C' ' 87' ' ' ALA . 23.3 m -101.26 79.05 1.95 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.262 1.025 . . . . 62.3 108.461 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -99.07 130.45 45.4 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.325 -0.991 . . . . 71.22 108.325 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . 0.425 HE21 ' HB ' ' E' ' 135' ' ' VAL . 60.7 tp60 -150.3 126.05 10.37 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 109.045 -0.724 . . . . 75.2 109.045 174.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.633 ' HB ' HG22 ' E' ' 135' ' ' VAL . 59.5 mt -64.79 134.69 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 107.88 -1.156 . . . . 75.23 107.88 168.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.421 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 31.5 mm-40 -102.73 -39.22 7.12 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.847 0.459 . . . . 74.33 109.822 176.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -178.6 142.31 0.23 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.506 1.123 . . . . 74.32 109.448 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 35.1 mm -119.84 117.8 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 108.128 -1.064 . . . . 72.33 108.128 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.554 ' HB3' HG22 ' D' ' 122' ' ' THR . 41.2 p90 -145.4 162.03 38.26 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.489 0.661 . . . . 74.02 112.031 -167.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.4 p -93.72 115.36 27.79 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.112 -0.949 . . . . 73.23 109.086 175.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.406 ' HG2' ' HE2' ' C' ' 17' ' ' TYR . 77.6 mttt -77.59 -45.31 25.62 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.477 -0.935 . . . . 75.25 108.477 170.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.677 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 26.4 t70 -131.08 135.65 47.72 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 113.662 -1.608 . . . . 64.32 109.435 -171.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.411 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 77.5 mt -138.09 142.02 36.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 106.423 -1.695 . . . . 73.14 106.423 174.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.0 t -154.32 145.62 22.96 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.401 0.619 . . . . 71.13 110.326 177.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -149.68 126.03 10.81 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 106.745 -1.576 . . . . 64.4 106.745 170.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -131.63 116.54 17.5 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.478 0.711 . . . . 73.33 109.521 -175.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.54 78.34 62.59 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 124.021 0.928 . . . . 63.13 108.502 172.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.73 -25.99 39.4 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 122.431 2.087 . . . . 75.42 111.037 174.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -97.67 14.04 28.17 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.127 0.971 . . . . 73.55 110.937 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.65 -55.15 24.74 Favored Pre-proline 0 N--CA 1.491 1.602 0 CA-C-O 117.96 -1.019 . . . . 43.43 113.502 -172.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.13 -43.79 39.35 Favored 'Trans proline' 0 C--N 1.391 2.815 0 C-N-CA 121.836 1.691 . . . . 64.04 112.077 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -68.78 -32.94 73.05 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.271 -1.331 . . . . 73.03 112.649 -174.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.59 HG21 ' HA ' ' C' ' 73' ' ' ALA . 12.9 p -80.81 -27.19 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 N-CA-C 112.146 0.425 . . . . 72.22 112.146 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -64.86 -27.73 69.07 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 122.893 0.477 . . . . 74.42 111.834 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -88.86 8.37 29.54 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.619 0.767 . . . . 74.14 111.504 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.498 ' HG2' HD11 ' C' ' 68' ' ' LEU . 1.0 OUTLIER -114.69 152.16 32.44 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.014 0.926 . . . . 75.3 110.258 -179.467 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -62.77 128.65 36.91 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.238 0.615 . . . . 64.53 111.12 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 65.8 t-105 -85.05 95.86 9.23 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.298 -0.865 . . . . 74.35 111.121 -174.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . 0.402 ' H ' HD23 ' C' ' 68' ' ' LEU . 34.5 tt0 -144.43 75.44 15.05 Favored Pre-proline 0 CA--C 1.549 0.918 0 N-CA-C 108.132 -1.062 . . . . 72.3 108.132 172.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -87.52 162.35 8.06 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.602 2.201 . . . . 74.43 112.686 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -90.08 108.1 19.53 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.407 -1.27 . . . . 72.22 107.692 171.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.45 96.99 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 109.078 -0.712 . . . . 73.43 109.078 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.655 ' HE3' ' HA3' ' F' ' 140' ' ' GLY . 0.8 OUTLIER -101.48 101.98 12.66 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.021 -1.103 . . . . 73.14 108.021 176.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.612 HD22 HG12 ' C' ' 62' ' ' VAL . 1.9 tt -103.65 127.44 51.1 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 107.3 -1.37 . . . . 75.3 107.3 177.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -119.56 117.85 29.46 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.575 0.75 . . . . 70.13 109.008 174.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -99.97 109.27 21.62 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.725 -0.843 . . . . 73.31 108.725 173.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -121.65 121.04 36.46 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.869 -1.16 . . . . 75.45 107.869 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.1 t -124.91 148.01 48.54 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.146 0.498 . . . . 73.43 110.309 -176.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.65 151.07 35.56 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.144 0.977 . . . . 72.14 108.733 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.428 ' HG ' ' HB3' ' C' ' 98' ' ' LEU . 14.4 m -123.1 150.41 43.22 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 123.715 0.806 . . . . 64.0 109.386 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 25.8 t -147.64 126.4 12.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.481 0.712 . . . . 70.34 109.319 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -76.86 117.56 18.59 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.206 -0.664 . . . . 74.34 109.206 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.596 HD12 ' HB2' ' C' ' 57' ' ' GLU . 50.3 mt -84.1 -43.64 14.84 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.618 0.767 . . . . 75.0 110.413 -175.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.47 -176.14 4.92 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.985 -1.007 . . . . 74.24 109.815 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.71 109.86 2.17 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.967 0.907 . . . . 71.41 110.4 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 65.27 19.98 11.79 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.923 1.289 . . . . 73.54 112.385 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 57.7 t -113.25 110.01 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 108.362 -0.977 . . . . 71.14 108.362 172.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -112.4 124.89 53.5 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.438 1.095 . . . . 75.31 109.794 -177.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.596 ' HB2' HD12 ' C' ' 51' ' ' LEU . 43.1 tt0 -91.24 142.66 27.48 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.759 -0.83 . . . . 75.24 108.759 170.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 82.8 t -124.81 139.4 51.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.995 -1.113 . . . . 73.23 107.995 167.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.06 130.07 72.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.975 -0.75 . . . . 74.34 108.975 173.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.542 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -110.48 111.73 23.17 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.218 -1.401 . . . . 72.13 107.218 178.545 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -90.67 107.24 19.04 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.303 -0.999 . . . . 74.35 108.303 173.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.612 HG12 HD22 ' C' ' 42' ' ' LEU . 38.9 t -101.32 118.89 48.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.949 -1.13 . . . . 74.34 107.949 173.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 26.0 m -118.7 137.48 53.29 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.984 -0.747 . . . . 73.42 108.984 -175.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.413 HG22 HG22 ' C' ' 114' ' ' ILE . 84.8 t -132.02 120.39 43.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 124.02 0.928 . . . . 75.14 109.046 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 10.0 m -113.17 130.31 56.25 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.349 -0.982 . . . . 74.23 108.349 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.88 115.71 24.36 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.16 -1.052 . . . . 73.21 108.16 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 54.5 m -134.02 130.21 37.22 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.431 0.457 . . . . 64.32 110.342 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.498 HD11 ' HG2' ' C' ' 34' ' ' LYS . 39.2 mt -85.84 39.34 0.8 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.699 1.2 . . . . 75.55 109.687 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.43 -102.48 2.2 Favored Glycine 0 C--N 1.348 1.24 0 N-CA-C 110.19 -1.164 . . . . 64.21 110.19 -170.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -89.79 -30.72 17.78 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.753 0.821 . . . . 72.43 110.397 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.401 ' HG2' HD12 ' C' ' 68' ' ' LEU . 4.3 tp10 -69.7 121.36 17.03 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 123.95 0.9 . . . . 74.35 109.788 176.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -81.19 117.28 21.59 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.262 -1.014 . . . . 71.31 108.262 165.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.59 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.91 -50.8 21.48 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.654 -0.869 . . . . 73.51 108.654 176.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . 0.462 ' HZ ' HD22 ' C' ' 126' ' ' LEU . 31.3 p90 -164.86 164.49 20.91 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.284 -1.326 . . . . 74.15 110.723 177.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -121.62 144.57 48.67 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 105.965 -1.865 . . . . 64.13 105.965 164.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.401 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.9 t -149.13 137.73 21.07 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.085 -1.08 . . . . 64.3 108.085 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -155.69 132.74 10.7 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.892 -0.41 . . . . 75.32 109.892 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 92.8 t -126.02 135.93 62.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.122 0.969 . . . . 64.51 109.037 174.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.677 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.7 mt-30 -109.99 96.2 6.08 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.069 0.948 . . . . 74.13 108.925 171.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -80.66 102.31 9.78 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.501 -1.227 . . . . 61.25 109.189 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.41 148.85 25.51 Favored Glycine 0 C--N 1.342 0.898 0 N-CA-C 111.181 -0.767 . . . . 70.14 111.181 174.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.74 119.23 1.04 Allowed Glycine 0 N--CA 1.465 0.591 0 CA-C-N 117.419 0.609 . . . . 55.42 111.98 -176.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.457 HG12 ' HE1' ' C' ' 17' ' ' TYR . 22.8 mm -86.75 129.12 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.024 -0.732 . . . . 73.14 109.024 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -133.41 126.64 31.69 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.912 0.885 . . . . 74.04 109.227 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 10.2 p -87.49 101.67 13.82 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.881 -1.155 . . . . 53.3 107.881 168.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 7.7 mt -117.27 124.87 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.648 0.779 . . . . 75.5 110.317 -174.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.463 ' HB1' ' HB ' ' C' ' 10' ' ' THR . . . -142.5 171.31 14.23 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.098 0.959 . . . . 64.53 109.2 177.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.21 -25.36 12.63 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-O 119.701 -0.499 . . . . 62.14 114.091 174.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.639 HD13 ' HA ' ' C' ' 94' ' ' MET . 37.7 pt -106.63 164.09 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 123.366 0.667 . . . . 72.33 111.393 -178.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -156.04 154.84 31.65 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.639 0.776 . . . . 73.24 110.127 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.41 -117.85 8.72 Favored Glycine 0 C--N 1.351 1.383 0 O-C-N 123.724 0.64 . . . . 71.2 113.411 169.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 17.7 m -62.19 -38.36 88.83 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.006 0.922 . . . . 74.32 111.134 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.433 HE21 HG23 ' C' ' 89' ' ' ILE . 28.7 mt-30 -67.43 -51.25 53.95 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.947 0.899 . . . . 74.33 111.239 -177.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.639 ' HA ' HD13 ' C' ' 89' ' ' ILE . 5.3 tpt -55.55 -50.72 69.29 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 124.176 0.923 . . . . 75.4 111.431 174.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.32 -43.36 92.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.377 0.671 . . . . 74.51 111.801 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -70.93 -36.49 72.65 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.684 0.794 . . . . 75.31 111.288 -175.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -64.23 -36.79 85.23 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.601 -0.727 . . . . 62.1 110.394 177.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.495 ' HG ' ' HE1' ' C' ' 94' ' ' MET . 91.7 mt -83.65 -37.56 22.66 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.295 1.038 . . . . 75.22 112.752 -176.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.87 -13.62 36.66 Favored Glycine 0 N--CA 1.475 1.279 0 N-CA-C 113.996 0.359 . . . . 72.41 113.996 -168.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.17 -54.32 1.19 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 117.014 0.407 . . . . 71.32 111.488 -175.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -70.72 -52.05 23.42 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 116.251 -0.431 . . . . 75.42 111.781 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.407 ' O ' HD11 ' C' ' 106' ' ' LEU . 96.9 m -64.18 -48.67 76.33 Favored Pre-proline 0 CA--C 1.559 1.309 0 CA-C-O 118.101 -0.952 . . . . 63.43 112.487 -177.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.542 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 50.4 Cg_exo -57.46 -27.3 75.59 Favored 'Trans proline' 0 C--N 1.393 2.891 0 C-N-CA 122.228 1.952 . . . . 71.13 113.373 175.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.43 -38.02 80.81 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.413 0.685 . . . . 73.12 109.878 177.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.47 HD13 ' NH1' ' A' ' 111' ' ' ARG . 47.3 mm -72.47 -34.28 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.684 0.794 . . . . 74.14 110.338 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.407 HD11 ' O ' ' C' ' 102' ' ' CYS . 7.3 mp -80.52 -24.19 39.53 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.906 0.883 . . . . 72.23 112.259 -177.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -58.86 -50.73 86.4 Favored Pre-proline 0 N--CA 1.481 1.081 0 CA-C-O 117.335 -1.317 . . . . 75.0 113.968 -172.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -59.53 -37.34 89.49 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 121.968 1.779 . . . . 74.11 113.206 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -65.2 -47.27 77.49 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.643 0.777 . . . . 74.1 110.392 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.96 -34.25 77.97 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 114.48 -1.236 . . . . 74.44 111.329 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -67.3 -50.19 61.24 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.205 1.402 . . . . 73.41 110.701 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -65.76 -35.26 80.21 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 123.805 0.69 . . . . 74.31 109.696 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 18.9 t -67.83 -29.49 68.65 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.305 0.642 . . . . 54.2 111.964 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.427 ' CD1' HG13 ' C' ' 62' ' ' VAL . 65.4 mt -79.07 -53.51 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 123.15 0.58 . . . . 74.13 110.678 174.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 17.8 m -61.91 -28.36 69.47 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.283 0.633 . . . . 74.31 111.162 -175.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.6 t -65.52 -50.07 66.59 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.676 0.791 . . . . 74.1 109.568 171.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.614 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.69 -40.35 87.57 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.464 1.105 . . . . 75.12 112.519 -179.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.42 -42.61 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.752 0.821 . . . . 73.1 109.995 175.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 39.7 t -71.45 -27.6 63.38 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.082 -0.963 . . . . 71.13 111.776 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' C' ' 116' ' ' SER . 79.9 mtt-85 -72.88 -41.83 64.26 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.002 -0.74 . . . . 73.21 109.002 176.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.88 -3.33 63.68 Favored Glycine 0 C--N 1.357 1.733 0 CA-C-N 115.419 -0.81 . . . . 73.42 112.901 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 26.1 p 62.32 30.49 17.47 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.632 1.973 . . . . 63.43 112.823 172.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -83.75 145.84 48.19 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 108.504 -0.924 . . . . 73.52 108.504 169.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -46.01 140.51 10.26 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 124.013 3.142 . . . . 71.34 114.898 176.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.463 ' HB2' ' HD1' ' F' ' 131' ' ' TRP . 24.0 mm-40 -60.24 134.6 57.21 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.659 1.184 . . . . 72.0 113.116 -174.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.462 HD22 ' HZ ' ' C' ' 74' ' ' PHE . 0.8 OUTLIER -141.53 98.7 3.4 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 114.791 -1.095 . . . . 74.53 108.567 174.429 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -91.5 102.82 15.48 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.412 -0.959 . . . . 74.25 108.412 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -57.58 129.93 44.08 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.62 1.168 . . . . 75.21 112.498 -167.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.68 144.53 98.92 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.096 0.958 . . . . 74.14 111.6 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.19 123.62 12.85 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.948 2.432 . . . . 75.4 112.918 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 24.2 t -115.5 121.4 67.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 108.49 -0.929 . . . . 75.31 108.49 175.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.455 HD22 ' HB3' ' C' ' 134' ' ' ASP . 57.3 t30 -75.13 107.47 7.24 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.587 0.755 . . . . 74.52 111.276 -175.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -65.37 -18.35 65.25 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.77 0.828 . . . . 74.23 112.994 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.455 ' HB3' HD22 ' C' ' 132' ' ' ASN . 9.9 t70 -65.52 -43.09 91.13 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.143 0.577 . . . . 71.52 109.846 172.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.09 -42.43 96.93 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.52 -0.764 . . . . 65.24 110.656 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 76.3 mt -70.64 -24.54 62.73 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.164 -0.925 . . . . 73.51 111.844 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -66.13 -35.8 81.45 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.26 0.624 . . . . 74.21 110.868 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 59.8 mtt -57.21 -28.25 62.7 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.211 1.004 . . . . 65.34 112.211 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -68.46 -28.31 66.92 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.893 1.277 . . . . 75.53 114.245 -176.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -158.01 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.486 0 N-CA-C 115.529 1.678 . . . . 71.23 115.529 -168.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 5.1 mp -126.97 133.7 50.54 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.386 -0.968 . . . . 71.15 108.386 175.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . 0.582 ' HG3' ' H ' ' C' ' 144' ' ' GLN . 55.5 tp60 -170.61 136.53 1.26 Allowed 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.094 0.871 . . . . 73.41 109.25 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -79.81 -7.39 58.65 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.732 0.813 . . . . 75.21 111.135 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . 0.582 ' H ' ' HG3' ' C' ' 142' ' ' GLN . 9.2 tp-100 -106.08 122.79 46.88 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.295 1.038 . . . . 65.23 108.56 170.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.52 -35.82 81.19 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.333 0.587 . . . . 71.24 109.958 174.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 128.06 -152.66 19.12 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 114.857 -1.065 . . . . 75.34 110.72 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -161.38 -55.99 0.05 OUTLIER 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.103 -0.702 . . . . 71.54 109.103 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 76.61 160.79 10.94 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 114.952 -1.022 . . . . 54.5 111.812 -171.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 7.8 t -162.08 142.77 10.41 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.308 0.643 . . . . 74.54 109.702 177.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -90.83 67.17 6.15 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 107.472 -1.307 . . . . 73.13 107.472 169.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -92.81 115.61 28.27 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.394 -0.821 . . . . 74.44 109.073 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . 0.468 ' CE1' ' SD ' ' A' ' 138' ' ' MET . 11.1 p80 -171.9 139.65 1.17 Allowed 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.44 -0.948 . . . . 74.43 108.44 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . 0.432 ' HB3' ' O ' ' E' ' 144' ' ' VAL . 3.7 tp-100 -161.95 143.53 11.06 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.693 -0.484 . . . . 75.22 109.693 177.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -108.02 163.92 12.73 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.101 0.56 . . . . 75.25 110.383 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.844 0 N-CA-C 108.0 -1.111 . . . . 72.35 108.0 171.48 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.6 ttm . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 110.209 -0.293 . . . . 73.14 110.209 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 34.3 t -159.04 -37.56 0.06 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.405 0.682 . . . . 73.33 110.575 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 65.44 160.08 0.12 Allowed 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 124.819 1.248 . . . . 73.21 112.855 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -169.54 166.3 10.12 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.405 0.682 . . . . 72.11 111.22 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -96.06 12.11 31.77 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.662 0.785 . . . . 73.33 111.57 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -64.26 122.1 15.84 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.119 0.568 . . . . 70.14 111.475 -176.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 13.3 t -76.74 -21.69 54.91 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.082 0.953 . . . . 72.15 111.361 -177.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -68.73 144.36 54.41 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 107.636 -1.246 . . . . 75.05 107.636 172.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.62 ' HG2' HG13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -27.3 122.6 0.09 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 126.147 1.779 . . . . 75.5 114.28 -167.842 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 13.0 t -120.81 138.58 53.97 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.15 0.58 . . . . 74.41 109.836 -176.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.424 ' HD2' HG22 ' D' ' 86' ' ' ILE . 84.9 t80 -134.84 101.93 5.08 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 107.861 -1.163 . . . . 73.43 107.861 176.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -127.5 120.07 27.46 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.421 -0.955 . . . . 60.34 108.421 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 10.5 mt -80.25 133.01 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 109.341 -0.614 . . . . 64.13 109.341 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -89.82 -40.58 12.36 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.829 0.852 . . . . 65.1 110.805 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -167.69 137.77 2.76 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.351 -0.386 . . . . 73.24 110.385 -175.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.415 ' N ' HD13 ' D' ' 16' ' ' ILE . 3.9 mp -110.17 137.26 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 107.048 -1.464 . . . . 73.42 107.048 169.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -164.31 142.49 7.04 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.372 0.533 . . . . 75.43 111.457 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 67.9 p -77.95 121.0 23.6 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.866 -0.606 . . . . 73.5 109.749 176.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.486 ' HD2' ' HA3' ' D' ' 81' ' ' GLY . 34.9 mtpt -96.08 -13.89 23.31 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.297 0.639 . . . . 74.1 109.909 -178.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.6 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.4 t70 -163.79 139.7 6.51 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.352 1.061 . . . . 71.41 108.915 177.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.614 HG23 ' HE1' ' C' ' 117' ' ' MET . 76.8 mt -141.9 147.41 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.614 1.166 . . . . 74.21 108.488 177.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 74.3 m -148.85 142.01 24.99 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.0 1.72 . . . . 72.41 108.155 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 83.0 t80 -145.86 113.53 6.38 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 105.012 -2.218 . . . . 74.14 105.012 166.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -131.07 110.04 10.92 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.79 0.436 . . . . 63.41 110.254 -168.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.35 82.06 11.5 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 107.92 -1.141 . . . . 74.52 107.92 176.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.74 -17.6 17.85 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.57 2.18 . . . . 73.05 112.361 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 76.8 m-20 -107.48 9.08 29.69 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.84 0.856 . . . . 72.53 110.735 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -33.31 -67.82 0.18 Allowed Pre-proline 0 CA--C 1.572 1.808 0 N-CA-C 115.976 1.843 . . . . 65.13 115.976 -165.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.455 ' HB3' HD11 ' C' ' 83' ' ' ILE . 88.6 Cg_endo -77.79 -15.19 15.26 Favored 'Trans proline' 0 C--N 1.385 2.495 0 CA-C-N 124.077 2.492 . . . . 72.13 114.014 -176.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.41 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 7.2 t-160 -72.99 -40.99 64.79 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.652 1.181 . . . . 75.44 109.399 173.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.562 HG23 ' HA ' ' D' ' 73' ' ' ALA . 8.7 p -86.08 -19.69 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 CA-C-N 115.018 -0.992 . . . . 64.53 111.473 -175.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -67.66 -19.66 65.22 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 117.837 0.29 . . . . 75.21 111.658 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -67.28 -14.14 62.64 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.711 0.804 . . . . 70.3 110.832 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.571 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 93.1 mttt -103.22 69.1 1.0 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.958 1.303 . . . . 73.31 109.255 177.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -84.07 74.6 10.25 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-O 122.314 1.054 . . . . 72.25 110.489 -176.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 4.7 p90 -142.8 -165.05 1.97 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.587 -0.733 . . . . 73.41 109.311 175.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -64.5 108.51 1.99 Allowed Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 124.163 0.985 . . . . 74.54 111.027 177.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -72.24 126.89 12.12 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.168 1.912 . . . . 72.42 110.747 176.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.91 111.83 11.69 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.915 -1.142 . . . . 74.22 107.915 176.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.611 HG11 HG13 ' D' ' 64' ' ' VAL . 65.9 t -108.61 137.01 42.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 C-N-CA 123.846 0.858 . . . . 65.44 108.911 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 29.7 mmtm -126.85 134.47 50.51 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.456 0.702 . . . . 74.4 109.796 170.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 20.7 tp -96.68 147.68 23.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.255 -0.884 . . . . 74.3 109.971 -175.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.537 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 19.9 t70 -139.98 112.48 7.86 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.83 -1.174 . . . . 73.24 107.83 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' E' ' 111' ' ' LEU . 96.0 mt -115.08 132.73 56.51 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.391 0.677 . . . . 74.52 109.817 -172.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.569 ' HB2' ' HB3' ' D' ' 61' ' ' ARG . 3.5 m-20 -132.49 151.28 51.96 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.816 1.246 . . . . 75.43 108.658 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 20.5 p -107.88 146.48 32.26 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.368 0.667 . . . . 74.12 110.47 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.654 ' HB2' ' HB ' ' D' ' 59' ' ' VAL . . . -149.37 163.39 37.88 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.126 0.97 . . . . 61.21 109.217 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 61.6 p -167.41 -171.8 1.79 Allowed 'General case' 0 CA--C 1.542 0.642 0 O-C-N 123.798 0.686 . . . . 73.44 110.917 -173.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.47 ' HB2' ' HB3' ' D' ' 57' ' ' GLU . 49.0 m -147.14 144.06 28.72 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.814 1.245 . . . . 63.24 108.331 174.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . 0.453 ' HA ' HD21 ' E' ' 102' ' ' LEU . 23.8 pt20 -79.19 -164.97 0.69 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.446 1.098 . . . . 74.42 111.722 -174.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 tm? 83.72 112.02 0.06 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 125.798 1.639 . . . . 72.41 109.308 -176.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.41 110.22 22.28 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.734 0.813 . . . . 53.31 112.415 -171.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -161.63 23.75 0.12 Allowed 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 120.731 0.3 . . . . 61.14 110.889 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 65.68 7.68 4.66 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 124.376 1.07 . . . . 73.25 112.015 -171.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.49 HG23 ' HA3' ' E' ' 92' ' ' GLY . 11.7 t -113.13 99.2 8.17 Favored 'Isoleucine or valine' 0 C--N 1.349 0.571 0 N-CA-C 107.422 -1.325 . . . . 75.34 107.422 177.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -127.84 131.79 49.46 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 120.596 0.236 . . . . 73.53 110.443 -173.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.47 ' HB3' ' HB2' ' D' ' 49' ' ' SER . 35.6 tp10 -87.6 138.49 31.42 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.651 -0.87 . . . . 74.11 108.651 174.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 78.7 t -136.25 138.33 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 C-N-CA 124.846 1.258 . . . . 73.12 107.909 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.654 ' HB ' ' HB2' ' D' ' 47' ' ' ALA . 21.5 t -132.94 120.24 40.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.424 -0.954 . . . . 75.54 108.424 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.49 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -93.2 124.84 37.46 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.112 -1.07 . . . . 74.13 108.112 174.149 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.569 ' HB3' ' HB2' ' D' ' 45' ' ' ASP . 1.5 tmm_? -100.27 104.65 16.14 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.095 -1.076 . . . . 73.11 108.095 174.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.435 HG11 HD12 ' D' ' 114' ' ' ILE . 82.8 t -103.1 121.5 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 123.923 0.889 . . . . 72.3 108.734 175.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.537 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 60.3 m -120.82 133.69 55.31 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.617 0.722 . . . . 74.12 109.47 175.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.611 HG13 HG11 ' D' ' 40' ' ' VAL . 34.5 t -110.26 119.69 59.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 114.457 -1.247 . . . . 74.42 108.662 174.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 15.6 m -109.04 91.86 3.81 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.21 -1.404 . . . . 65.21 107.21 171.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.63 147.19 25.07 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.513 -0.767 . . . . 73.32 109.372 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 53.8 p -156.28 132.86 10.2 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 123.513 0.508 . . . . 63.41 111.092 -173.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 21.5 mt -104.62 112.22 25.22 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.077 -1.083 . . . . 74.42 108.077 170.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.34 -115.94 4.41 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.926 -0.579 . . . . 72.42 111.737 -172.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -115.91 4.53 13.86 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 117.381 0.591 . . . . 72.41 111.388 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.571 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 12.5 pt-20 -114.25 154.86 27.2 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.49 0.316 . . . . 72.55 110.656 -175.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 95.3 m -63.12 120.06 10.74 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 123.975 0.797 . . . . 73.24 111.144 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.562 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -76.18 -67.37 0.69 Allowed 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.02 -1.474 . . . . 64.04 107.02 167.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -154.23 142.95 20.9 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.997 -0.547 . . . . 75.31 110.997 176.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 57.8 mt -106.12 107.95 19.21 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 107.249 -1.389 . . . . 73.14 107.249 170.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.666 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 17.5 t -118.45 107.78 14.22 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.023 -0.732 . . . . 75.4 109.023 -172.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' D' ' 62' ' ' VAL . 34.4 tt0 -128.9 131.37 47.58 Favored 'General case' 0 C--O 1.22 -0.487 0 C-N-CA 123.265 0.626 . . . . 74.52 110.088 -171.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 86.3 t -134.43 116.18 21.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 123.734 0.814 . . . . 74.13 108.928 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.6 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 78.6 mt-30 -88.88 84.43 6.65 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.177 -1.045 . . . . 71.45 108.177 171.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -82.32 108.05 15.46 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 113.998 -1.456 . . . . 73.53 109.52 -176.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.486 ' HA3' ' HD2' ' D' ' 19' ' ' LYS . . . -99.61 172.95 25.45 Favored Glycine 0 C--O 1.241 0.558 0 O-C-N 123.374 0.421 . . . . 34.22 112.893 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.63 144.26 6.53 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.513 -0.344 . . . . 64.24 112.865 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 54.7 mt -90.11 128.08 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.019 -1.104 . . . . 74.42 108.019 172.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -124.57 140.27 53.1 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.914 0.886 . . . . 75.55 110.771 -175.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 7.1 m -98.83 98.73 9.79 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.387 1.075 . . . . 70.15 108.92 172.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.639 HG12 HD21 ' D' ' 98' ' ' LEU . 2.6 pp -115.96 132.87 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 109.26 -0.645 . . . . 75.3 109.26 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.92 168.19 19.71 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.234 1.014 . . . . 71.52 109.404 -177.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.523 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 90.74 -21.55 32.62 Favored Glycine 0 N--CA 1.477 1.381 0 C-N-CA 123.221 0.439 . . . . 42.32 113.91 175.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.62 HG13 ' HG2' ' D' ' 9' ' ' MET . 1.0 OUTLIER -101.03 155.85 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.864 0.865 . . . . 74.43 109.374 172.517 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.706 ' HB3' ' HB3' ' B' ' 152' ' ' HIS . 30.7 mt-10 -144.4 175.11 10.35 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.286 1.034 . . . . 71.22 110.457 -176.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.26 -140.56 23.05 Favored Glycine 0 C--N 1.357 1.732 0 N-CA-C 114.68 0.632 . . . . 75.24 114.68 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 86.2 m -79.79 -38.35 33.27 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.974 0.91 . . . . 73.33 111.046 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -60.72 -36.37 78.68 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.365 1.066 . . . . 74.12 111.198 -174.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.596 ' HB2' HD12 ' E' ' 97' ' ' ILE . 0.0 OUTLIER -68.07 -37.53 81.37 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.973 0.731 . . . . 73.2 112.973 -172.219 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.58 -25.35 33.36 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.383 0.673 . . . . 75.21 109.927 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -66.89 -27.39 67.47 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.099 0.96 . . . . 73.33 110.302 174.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 94.8 m -62.21 -42.83 99.65 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.383 0.673 . . . . 73.42 111.387 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.639 HD21 HG12 ' D' ' 86' ' ' ILE . 86.9 mt -70.71 -22.24 62.47 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.586 0.355 . . . . 73.0 111.361 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.63 14.02 56.44 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-O 119.499 -0.612 . . . . 64.41 113.28 176.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.506 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -155.98 -66.11 0.11 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 118.277 1.039 . . . . 73.03 112.355 -177.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -65.43 -51.63 58.87 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.12 0.568 . . . . 75.02 111.632 -172.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.412 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 78.8 m -60.89 -47.01 96.87 Favored Pre-proline 0 CA--C 1.565 1.554 0 C-N-CA 123.772 0.829 . . . . 72.31 112.359 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.49 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.7 Cg_exo -54.32 -40.01 84.54 Favored 'Trans proline' 0 C--N 1.394 2.955 0 C-N-CA 122.388 2.059 . . . . 60.12 113.678 168.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . 0.424 ' HB2' ' HB2' ' D' ' 133' ' ' PHE . 2.6 t-20 -61.98 -33.5 74.43 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.458 0.703 . . . . 75.31 111.325 -178.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 43.6 mm -72.85 -36.12 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.361 1.064 . . . . 74.42 110.76 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 91.1 mt -71.93 -19.06 61.97 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.907 -0.588 . . . . 74.42 111.629 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -65.96 -44.42 61.37 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-O 117.782 -1.104 . . . . 74.4 113.335 -173.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.89 -42.12 31.57 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 122.343 2.028 . . . . 75.04 113.964 168.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -79.52 -32.35 42.32 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.687 0.795 . . . . 74.51 111.921 -177.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.94 -44.69 65.58 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.415 0.626 . . . . 73.53 109.996 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.58 HH12 ' HB3' ' D' ' 130' ' ' PRO . 37.4 ttp180 -65.67 -35.65 81.39 Favored 'General case' 0 C--O 1.206 -1.216 0 CA-C-N 114.012 -1.449 . . . . 74.03 110.365 174.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . 0.499 ' HA ' ' CE2' ' B' ' 109' ' ' TYR . 6.1 tt0 -52.86 -51.21 61.91 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.845 0.858 . . . . 73.44 111.151 176.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.453 ' O ' ' HG3' ' D' ' 117' ' ' MET . 43.8 t -63.7 -45.04 91.82 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.527 -1.215 . . . . 75.32 110.717 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.595 HG22 ' SG ' ' D' ' 76' ' ' CYS . 31.5 mt -60.55 -64.42 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.392 0.677 . . . . 72.24 111.269 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.441 HG21 ' OD1' ' D' ' 127' ' ' ASN . 85.4 m -40.54 -46.89 2.59 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.027 1.731 . . . . 75.43 112.63 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -62.95 -48.14 80.19 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 114.867 -1.061 . . . . 74.21 110.657 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.666 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 71.6 mtm -67.24 -31.46 71.83 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.42 0.688 . . . . 64.31 112.296 -178.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.456 HG21 ' HB3' ' D' ' 126' ' ' LEU . 87.2 t -65.53 -45.06 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.765 0.826 . . . . 75.53 109.946 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 56.0 p -70.38 -33.05 70.96 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 115.289 -0.869 . . . . 72.45 110.363 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 51.8 mtt-85 -67.36 -35.07 78.63 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.872 0.869 . . . . 75.14 110.576 175.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.21 11.19 61.31 Favored Glycine 0 C--N 1.355 1.6 0 CA-C-O 119.581 -0.566 . . . . 72.35 114.082 -178.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.554 HG22 ' HB3' ' C' ' 17' ' ' TYR . 66.9 p 57.2 30.25 18.06 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 126.2 1.8 . . . . 65.13 114.073 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -97.87 149.36 35.64 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.147 0.579 . . . . 75.21 109.781 170.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -45.17 120.99 3.36 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 123.75 2.967 . . . . 74.24 112.832 169.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' E' ' 127' ' ' SER . 46.3 tt0 -48.54 122.75 5.81 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 124.539 1.149 . . . . 74.1 111.876 -174.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.456 ' HB3' HG21 ' D' ' 118' ' ' VAL . 22.5 tp -105.44 106.59 17.16 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.45 0.7 . . . . 73.22 109.598 -174.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . 0.441 ' OD1' HG21 ' D' ' 115' ' ' THR . 93.0 m-20 -106.53 89.87 3.16 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.288 1.035 . . . . 73.45 108.936 175.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.409 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 37.6 mt -57.39 117.88 4.57 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.048 0.939 . . . . 75.54 110.498 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.43 123.81 78.07 Favored Pre-proline 0 CA--C 1.56 1.338 0 C-N-CA 122.679 0.391 . . . . 74.41 111.176 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.58 ' HB3' HH12 ' D' ' 111' ' ' ARG . 76.6 Cg_endo -75.54 141.31 24.97 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 122.603 2.202 . . . . 71.1 111.876 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.87 152.22 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.574 0.75 . . . . 74.34 109.748 -175.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -68.58 103.9 1.82 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.382 0.673 . . . . 75.52 110.391 176.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.424 ' HB2' ' HB2' ' D' ' 104' ' ' ASN . 3.7 m-30 -62.36 -24.48 67.38 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.097 0.959 . . . . 75.22 112.639 -177.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.506 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 4.5 t70 -62.28 -40.11 95.18 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.797 0.685 . . . . 73.31 109.858 -178.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.449 ' HA ' ' HE3' ' D' ' 138' ' ' MET . . . -71.52 -34.56 70.18 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.179 -0.919 . . . . 72.42 111.539 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 10.2 mp -65.76 -47.56 74.82 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 122.925 0.49 . . . . 65.24 110.621 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -68.69 -31.19 70.12 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 124.064 0.946 . . . . 73.04 109.893 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.449 ' HE3' ' HA ' ' D' ' 135' ' ' ALA . 32.8 ttm -66.3 -41.64 89.45 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.306 1.042 . . . . 74.11 110.668 177.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.408 ' HB3' HE21 ' D' ' 143' ' ' GLN . 32.8 m-80 -80.08 -16.58 54.71 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.547 -0.752 . . . . 72.42 111.988 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -54.93 -39.9 69.35 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.648 0.779 . . . . 74.45 110.559 173.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.8 mp -68.12 -33.58 74.76 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 114.763 -1.108 . . . . 74.24 110.96 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -87.28 4.59 42.15 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.239 1.016 . . . . 55.2 112.159 -174.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . 0.408 HE21 ' HB3' ' D' ' 139' ' ' ASN . 78.0 mt-30 -120.06 95.25 4.68 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.965 0.906 . . . . 73.11 109.262 -176.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -142.69 -168.18 2.7 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.661 0.784 . . . . 74.52 110.484 -175.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.03 -18.31 63.19 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.523 1.129 . . . . 74.44 113.144 -176.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.64 9.47 43.22 Favored Glycine 0 C--N 1.352 1.465 0 O-C-N 123.396 0.435 . . . . 71.44 113.306 175.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.25 139.42 39.2 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 106.952 -1.499 . . . . 74.01 106.952 174.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . 0.426 ' HA2' ' HE2' ' E' ' 117' ' ' LYS . . . -156.67 42.01 0.55 Allowed Glycine 0 C--N 1.351 1.392 0 N-CA-C 114.339 0.496 . . . . 74.44 114.339 -174.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 13.1 t -93.71 173.37 7.72 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 117.582 0.691 . . . . 72.42 110.161 173.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -156.25 150.05 25.0 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.833 0.853 . . . . 74.34 109.575 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -169.04 175.42 5.78 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.406 0.622 . . . . 74.44 111.481 171.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -126.12 137.43 53.6 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.496 1.118 . . . . 74.32 108.039 167.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -148.82 146.27 27.91 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.645 0.378 . . . . 75.22 111.17 -170.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 65.45 150.46 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.114 1.366 . . . . 74.23 113.502 171.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.057 0 C-N-CA 124.434 1.094 . . . . 62.12 108.85 176.482 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 CA-C-O 120.037 -0.313 . . . . 73.41 113.461 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' E' E ' 92' ' ' GLY . . . . . 0.49 ' HA3' HG23 ' D' ' 55' ' ' VAL . . . -158.42 -73.98 0.02 OUTLIER Glycine 0 C--N 1.342 0.9 0 N-CA-C 111.435 -0.666 . . . . 74.21 111.435 -177.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -166.01 172.32 11.57 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 112.854 0.687 . . . . 74.34 112.854 -172.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 5.1 t80 61.08 -94.39 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 126.216 1.806 . . . . 75.14 111.421 177.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 95' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' E' ' 95' ' ' LYS . 39.0 mtmt -149.53 -80.92 0.12 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.409 0.623 . . . . 74.32 110.862 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 141.3 75.67 0.04 OUTLIER Glycine 0 C--N 1.345 1.042 0 N-CA-C 109.586 -1.406 . . . . 65.14 109.586 -166.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 97' ' ' ILE . . . . . 0.596 HD12 ' HB2' ' D' ' 94' ' ' MET . 1.5 tt -37.01 105.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 126.659 1.983 . . . . 74.21 113.908 -176.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 25.4 t70 52.41 -92.09 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.909 1.684 . . . . 63.03 112.284 172.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 99' ' ' ALA . . . . . 0.476 ' HB1' ' HB3' ' B' ' 155' ' ' ALA . . . -161.38 40.22 0.14 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.678 0.791 . . . . 74.34 109.885 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 100' ' ' LEU . . . . . . . . . . . . . 12.8 tp -69.57 101.72 0.35 Allowed Pre-proline 0 N--CA 1.484 1.27 0 C-N-CA 124.913 1.285 . . . . 64.44 111.684 -178.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -100.23 -2.78 0.63 Allowed 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 123.236 2.624 . . . . 73.14 113.595 -175.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 102' ' ' LEU . . . . . 0.453 HD21 ' HA ' ' D' ' 50' ' ' GLN . 4.0 mm? 62.22 167.14 0.11 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 125.227 1.411 . . . . 73.25 112.313 -168.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 74.0 p -83.23 -43.62 15.89 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.545 -0.752 . . . . 75.3 109.508 175.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 168.71 -177.67 42.49 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-N 115.094 -0.957 . . . . 72.01 112.019 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -76.06 105.29 7.02 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.593 -0.892 . . . . 72.2 108.593 175.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 106' ' ' TYR . . . . . 0.437 ' HA ' ' HA ' ' D' ' 47' ' ' ALA . 59.3 t80 72.01 132.59 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.903 1.281 . . . . 75.2 110.972 -176.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 8.3 t -124.62 157.26 35.92 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.453 0.701 . . . . 74.53 110.089 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -97.73 18.27 16.05 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.007 0.923 . . . . 72.32 110.634 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -80.58 71.27 7.44 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 108.785 -0.82 . . . . 72.41 108.785 166.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.09 138.62 38.85 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.408 -1.269 . . . . 75.23 110.207 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' D' ' 44' ' ' LEU . 5.8 mp -65.09 -33.21 75.47 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.211 0.605 . . . . 71.21 110.096 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -98.38 95.48 7.38 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.552 -0.907 . . . . 70.43 108.552 171.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -103.59 77.89 1.53 Allowed 'General case' 0 C--O 1.242 0.69 0 N-CA-C 106.596 -1.631 . . . . 72.01 106.596 175.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -63.95 116.75 6.14 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 114.795 -1.093 . . . . 74.31 111.399 -175.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 5.5 m -140.51 5.67 2.04 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.909 0.884 . . . . 71.12 109.642 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.04 -29.24 12.56 Favored Glycine 0 C--N 1.35 1.341 0 N-CA-C 111.958 -0.457 . . . . 72.42 111.958 -175.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 117' ' ' LYS . . . . . 0.426 ' HE2' ' HA2' ' D' ' 148' ' ' GLY . 0.7 OUTLIER -68.93 131.2 91.07 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 108.573 -0.899 . . . . 75.33 108.573 174.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.18 112.4 0.92 Allowed 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.838 2.359 . . . . 74.12 111.474 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -60.89 154.71 21.5 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.734 0.814 . . . . 72.04 111.089 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -82.76 -2.23 53.79 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.925 -0.58 . . . . 75.01 111.055 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 121' ' ' VAL . . . . . . . . . . . . . 35.0 t -68.3 132.72 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 123.638 0.775 . . . . 73.5 109.553 172.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 29.6 m -62.56 138.23 58.44 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 122.811 0.444 . . . . 71.14 109.824 173.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -58.2 147.74 29.33 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.311 0.577 . . . . 65.22 111.126 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 4.6 m -88.57 42.83 1.09 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.017 -0.992 . . . . 65.25 111.117 -171.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -73.85 -159.62 0.08 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.728 1.211 . . . . 74.31 110.568 173.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . 65.56 54.28 1.13 Allowed 'General case' 0 C--N 1.356 0.891 0 CA-C-O 121.863 0.839 . . . . 74.52 110.31 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 127' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' D' ' 125' ' ' GLN . 4.7 p -122.72 113.82 19.72 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.93 -1.032 . . . . 72.33 109.779 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.81 99.68 1.07 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.426 1.09 . . . . 75.52 111.267 -174.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 32.7 p -87.94 74.53 8.95 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.923 0.889 . . . . 74.1 112.854 -171.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -166.68 109.31 0.71 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 107.667 -1.235 . . . . 73.44 107.667 170.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 131' ' ' TRP . . . . . . . . . . . . . 8.0 t-105 -148.64 158.33 44.06 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.419 0.525 . . . . 75.13 112.419 -175.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 14.4 t 70.36 104.09 0.06 Allowed 'General case' 0 C--N 1.357 0.922 0 C-N-CA 126.384 1.873 . . . . 64.11 110.998 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 29.1 m -79.52 -20.39 47.31 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.623 0.769 . . . . 71.54 109.959 169.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.2 -135.33 13.77 Favored Glycine 0 C--N 1.342 0.904 0 N-CA-C 109.46 -1.456 . . . . 75.44 109.46 -164.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 135' ' ' VAL . . . . . 0.633 HG22 ' HB ' ' C' ' 13' ' ' ILE . 77.0 t -141.07 -63.13 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.231 0.612 . . . . 71.04 110.232 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 136' ' ' LYS . . . . . 0.479 ' HG3' ' HB3' ' C' ' 2' ' ' SER . 4.2 mtmt 62.95 -160.21 0.31 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 124.068 0.855 . . . . 74.45 110.514 -171.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 7.6 t -134.63 150.64 50.69 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.851 -0.531 . . . . 74.53 110.542 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -64.15 -36.28 83.51 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.204 1.002 . . . . 64.34 110.677 172.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -160.57 126.65 4.04 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.014 0.926 . . . . 73.1 108.583 173.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -115.07 123.19 5.87 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.979 -0.448 . . . . 74.41 111.979 -177.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -159.5 145.94 16.4 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.412 0.685 . . . . 74.5 109.921 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 6.2 mp -86.02 123.45 31.35 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.688 -0.856 . . . . 73.3 108.688 175.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -81.69 -107.47 0.37 Allowed Glycine 0 CA--C 1.532 1.135 0 N-CA-C 112.158 -0.377 . . . . 74.54 112.158 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 144' ' ' VAL . . . . . 0.432 ' O ' ' HB3' ' C' ' 153' ' ' GLN . 10.5 p -171.63 172.7 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 124.799 1.24 . . . . 75.41 108.049 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 N--CA 1.49 1.563 0 CA-C-N 118.656 0.662 . . . . 73.11 110.441 174.808 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.914 0 CA-C-O 119.874 -0.403 . . . . 72.24 112.847 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . -132.92 59.72 0.68 Allowed Glycine 0 C--N 1.352 1.463 0 N-CA-C 111.366 -0.693 . . . . 60.12 111.366 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -93.81 90.31 6.49 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.734 0.814 . . . . 64.33 109.373 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -159.79 148.65 17.62 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.35 0.66 . . . . 74.24 110.346 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 95' ' ' LYS . . . . . 0.698 ' HD2' ' SD ' ' B' ' 1' ' ' MET . 0.7 OUTLIER -63.73 97.7 0.16 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.403 1.081 . . . . 75.11 111.772 -173.156 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -149.81 -6.02 0.2 Allowed Glycine 0 CA--C 1.535 1.317 0 CA-C-N 115.327 -0.851 . . . . 65.41 113.424 174.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 97' ' ' ILE . . . . . 0.445 HG22 ' HB2' ' F' ' 100' ' ' LEU . 8.8 tp -81.63 165.89 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 123.489 0.716 . . . . 51.45 110.863 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 98' ' ' ASP . . . . . 0.447 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 22.2 t70 -93.53 -79.0 0.42 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.707 0.803 . . . . 71.25 110.17 173.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.31 78.7 1.86 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 108.85 -0.796 . . . . 65.42 108.85 -178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 100' ' ' LEU . . . . . 0.447 HD11 ' HG3' ' B' ' 50' ' ' GLN . 1.7 tm? -55.63 -43.2 99.04 Favored Pre-proline 0 N--CA 1.491 1.616 0 C-N-CA 124.768 1.227 . . . . 75.14 113.444 -171.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.65 133.52 20.55 Favored 'Trans proline' 0 C--N 1.381 2.249 0 CA-C-N 121.071 1.418 . . . . 74.3 110.032 167.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 102' ' ' LEU . . . . . . . . . . . . . 61.1 mt -58.19 102.0 0.09 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.886 0.474 . . . . 70.0 110.648 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 6.3 t -54.56 137.52 43.04 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 125.261 1.424 . . . . 73.42 112.529 -174.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.92 -78.68 0.61 Allowed Glycine 0 C--N 1.341 0.86 0 N-CA-C 111.377 -0.689 . . . . 71.22 111.377 -176.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -159.67 167.85 27.4 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.885 0.474 . . . . 74.34 110.023 -171.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -38.06 94.31 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.569 1.948 . . . . 75.45 111.641 168.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 19.3 m 50.05 73.27 0.27 Allowed 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 124.688 1.195 . . . . 73.44 110.669 -173.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -65.3 -33.82 76.88 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 114.754 -1.112 . . . . 73.01 112.138 -173.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -71.0 -24.45 62.39 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.029 0.532 . . . . 74.21 111.137 176.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 62.94 94.38 0.05 OUTLIER 'General case' 0 C--N 1.356 0.86 0 C-N-CA 125.052 1.341 . . . . 73.24 112.196 174.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . 0.427 HD21 ' HD1' ' B' ' 133' ' ' PHE . 21.5 tp -65.3 -58.77 5.1 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.62 0.724 . . . . 73.01 109.182 173.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -153.88 75.89 1.04 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 106.167 -1.79 . . . . 75.33 106.167 170.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -86.26 -17.93 33.4 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.898 -1.046 . . . . 74.24 110.652 -176.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -125.87 156.85 38.99 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.07 0.948 . . . . 74.42 110.223 177.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 41.0 p -69.32 -20.79 63.87 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.642 0.777 . . . . 75.53 111.257 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.54 76.71 1.57 Allowed Glycine 0 C--N 1.346 1.104 0 N-CA-C 111.117 -0.793 . . . . 65.1 111.117 172.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 117' ' ' LYS . . . . . 0.481 ' HG3' ' HB ' ' F' ' 121' ' ' VAL . 0.0 OUTLIER -58.84 124.11 71.67 Favored Pre-proline 0 CA--C 1.562 1.434 0 C-N-CA 123.376 0.67 . . . . 72.32 111.243 174.204 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -64.23 -26.09 64.61 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.64 2.894 . . . . 65.34 115.684 -169.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -158.42 -54.87 0.07 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 120.916 0.389 . . . . 75.4 111.377 -169.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -70.11 171.93 8.83 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.009 0.923 . . . . 75.42 110.913 -176.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 121' ' ' VAL . . . . . 0.481 ' HB ' ' HG3' ' F' ' 117' ' ' LYS . 62.1 t 62.31 87.36 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.393 1.077 . . . . 74.34 109.55 -178.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 13.0 t -113.52 -166.84 1.13 Allowed 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.954 -1.021 . . . . 74.33 109.88 -172.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -58.14 -30.42 66.33 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.268 1.027 . . . . 64.44 111.576 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 55.3 m -65.66 93.1 0.16 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.739 0.815 . . . . 62.13 110.41 175.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -144.17 -177.67 5.57 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.659 1.184 . . . . 72.23 109.279 -178.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 126' ' ' ALA . . . . . 0.525 ' O ' ' HB ' ' B' ' 40' ' ' VAL . . . -75.0 106.3 6.43 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.004 0.522 . . . . 72.43 110.338 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 66.5 m -139.43 93.38 2.67 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.426 -0.953 . . . . 71.32 108.426 174.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -158.74 149.24 19.9 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.477 0.711 . . . . 70.54 109.915 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 15.6 p -77.66 -78.18 0.14 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.864 -0.791 . . . . 62.44 108.864 170.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 130' ' ' ALA . . . . . 0.671 ' HB3' ' HB3' ' B' ' 125' ' ' GLN . . . 45.09 61.0 2.71 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.145 0.978 . . . . 74.32 110.968 -171.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 131' ' ' TRP . . . . . 0.463 ' HD1' ' HB2' ' C' ' 125' ' ' GLN . 9.7 t90 -154.61 18.06 0.46 Allowed 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.621 -1.172 . . . . 74.43 109.166 -176.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 57.2 p -64.34 -21.06 66.49 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.356 0.663 . . . . 75.2 111.843 -176.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 34.0 m -73.91 83.43 1.7 Allowed 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 121.256 0.55 . . . . 74.23 109.691 170.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.89 94.89 0.89 Allowed Glycine 0 C--N 1.351 1.39 0 N-CA-C 109.872 -1.291 . . . . 74.53 109.872 173.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 59.2 t -59.3 113.94 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 123.813 0.845 . . . . 74.33 111.228 -172.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 136' ' ' LYS . . . . . 0.412 ' HD3' ' H ' ' F' ' 136' ' ' LYS . 0.2 OUTLIER -128.45 -164.63 1.4 Allowed 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.558 1.143 . . . . 62.12 108.967 -175.645 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 5.4 t -57.96 132.58 53.85 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.219 0.607 . . . . 62.32 110.196 170.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -70.6 125.67 27.46 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.577 0.751 . . . . 73.11 111.627 -170.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -163.79 152.7 13.9 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.185 -1.042 . . . . 74.41 108.185 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 140' ' ' GLY . . . . . 0.655 ' HA3' ' HE3' ' C' ' 41' ' ' LYS . . . -132.08 -112.87 1.44 Allowed Glycine 0 C--N 1.337 0.634 0 CA-C-O 119.025 -0.875 . . . . 70.02 111.343 173.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . 70.12 -65.58 0.31 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.181 1.392 . . . . 72.34 110.561 -174.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 38.7 tp 64.47 -82.28 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.484 1.513 . . . . 64.21 111.399 174.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.99 59.52 6.91 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 111.377 -0.689 . . . . 63.13 111.377 -174.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 3.4 p -60.44 106.17 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 C-N-CA 123.777 0.831 . . . . 73.23 111.032 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 35.6 t70 . . . . . 0 C--O 1.244 0.797 0 C-N-CA 124.224 1.009 . . . . 74.33 108.521 -178.612 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 ttp . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 109.387 -0.597 . . . . 74.32 109.387 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.8 m -55.02 120.07 6.37 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.181 0.992 . . . . 74.44 111.004 174.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -151.4 119.41 6.24 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.421 0.688 . . . . 73.32 110.584 -177.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -122.59 -34.72 3.2 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.788 0.835 . . . . 75.2 109.596 166.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 61.3 t30 55.57 61.04 3.01 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 124.31 1.044 . . . . 74.55 110.13 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -159.39 154.61 25.29 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.817 -0.628 . . . . 73.41 110.518 -172.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.4 t -70.14 -9.24 54.99 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.408 1.083 . . . . 74.21 112.509 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.13 158.6 10.99 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.567 0.747 . . . . 74.3 111.704 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 41.1 mtt -46.72 144.33 2.38 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.538 1.935 . . . . 74.23 112.55 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.0 m -141.27 126.67 18.72 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.889 0.875 . . . . 72.44 109.586 -178.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -125.32 113.09 17.13 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.554 -0.906 . . . . 65.23 108.554 170.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -135.72 136.66 41.01 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.508 -0.923 . . . . 74.14 108.508 170.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.501 HD12 HG21 ' A' ' 105' ' ' ILE . 5.2 mt -93.35 117.15 36.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 108.762 -0.829 . . . . 75.13 108.762 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.03 -42.36 32.7 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.948 0.78 . . . . 72.35 109.32 -177.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -173.69 121.41 0.32 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 110.276 -0.268 . . . . 73.25 110.276 -171.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.443 HD13 ' HG3' ' C' ' 130' ' ' PRO . 65.8 mt -106.26 133.92 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.767 -0.827 . . . . 74.13 108.767 173.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.438 ' HE1' HG13 ' A' ' 83' ' ' ILE . 31.4 p90 -164.12 158.09 18.87 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 124.011 0.819 . . . . 74.32 111.33 -174.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.6 p -86.78 117.0 25.24 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.291 -0.633 . . . . 63.22 109.291 172.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.434 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 38.5 mtpt -75.82 -34.13 60.13 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.415 -0.587 . . . . 73.43 109.415 175.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 23.4 t70 -149.59 142.85 25.13 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.607 -1.179 . . . . 72.33 110.064 -178.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 76.1 mt -137.34 144.88 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.762 1.225 . . . . 65.15 108.119 175.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.5 t -148.92 138.3 21.71 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.667 0.787 . . . . 74.32 109.034 171.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.551 ' HB2' ' HE1' ' A' ' 117' ' ' MET . 91.5 t80 -135.22 134.61 40.22 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.572 -1.64 . . . . 75.13 106.572 169.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -133.3 137.54 46.03 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.347 0.659 . . . . 73.45 109.542 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.94 76.64 11.38 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 106.582 -1.636 . . . . 71.31 106.582 171.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.75 -28.59 36.74 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.316 2.011 . . . . 71.15 111.199 -178.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -97.99 11.23 38.19 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.067 -0.969 . . . . 71.21 111.189 -175.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.428 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -44.87 -59.61 3.96 Favored Pre-proline 0 CA--C 1.564 1.51 0 N-CA-C 114.2 1.185 . . . . 71.14 114.2 -165.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HG3' ' HZ1' ' B' ' 19' ' ' LYS . 31.7 Cg_exo -58.78 -36.85 96.41 Favored 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 122.015 1.81 . . . . 72.35 113.675 -171.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -99.39 -12.47 20.24 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.491 0.716 . . . . 75.3 112.863 -175.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.608 HG22 ' HA ' ' A' ' 73' ' ' ALA . 3.6 p -77.07 -23.49 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-N 118.073 0.397 . . . . 74.43 110.396 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -71.46 -18.47 62.31 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.514 0.726 . . . . 74.3 111.328 173.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -80.03 -27.58 39.45 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.496 0.719 . . . . 74.11 110.543 175.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.501 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 12.7 mmmm -72.87 152.64 41.39 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.942 0.897 . . . . 75.15 111.371 -175.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.25 123.45 18.69 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.547 0.739 . . . . 74.33 109.322 174.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -76.97 81.35 3.51 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.75 0.786 . . . . 74.42 110.116 -175.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.461 ' H ' HD22 ' A' ' 68' ' ' LEU . 19.5 tm0? -115.64 78.77 6.99 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 106.478 -1.675 . . . . 61.2 106.478 172.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -84.63 112.5 1.57 Allowed 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.224 1.95 . . . . 63.4 111.62 -172.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -92.88 88.09 6.06 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.445 -1.687 . . . . 74.13 106.445 171.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.51 HG23 ' HB1' ' A' ' 66' ' ' ALA . 48.7 t -88.15 102.92 13.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 114.332 -1.304 . . . . 70.15 110.392 -173.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -78.12 115.66 18.01 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.682 -1.145 . . . . 74.42 109.181 172.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.449 HD11 ' HB3' ' A' ' 128' ' ' LEU . 3.6 tt -96.89 107.49 20.0 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 106.504 -1.665 . . . . 74.44 106.504 176.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -104.94 147.19 28.05 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.407 1.083 . . . . 72.13 108.739 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.554 HD22 HD21 ' A' ' 60' ' ' LEU . 87.5 mt -133.58 138.9 46.25 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.198 0.599 . . . . 62.15 110.891 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.555 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 24.2 t70 -136.62 144.82 44.27 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.105 1.362 . . . . 53.41 107.847 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.9 m -139.11 126.83 21.97 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.808 0.443 . . . . 74.33 110.354 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.2 127.01 32.85 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.867 0.867 . . . . 73.4 109.931 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.451 ' HG ' ' HB3' ' A' ' 98' ' ' LEU . 49.7 m -112.73 161.42 16.89 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.486 0.66 . . . . 62.32 111.185 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 90.0 p -149.12 162.12 40.6 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.344 1.458 . . . . 74.1 107.654 175.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -113.46 107.45 15.85 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.806 -0.812 . . . . 72.04 108.806 169.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.3 mt -79.4 -29.3 41.94 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.7 -0.682 . . . . 65.25 111.523 -175.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.67 -172.47 3.12 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.128 0.571 . . . . 74.42 111.352 -177.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -61.47 112.5 2.22 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.992 0.917 . . . . 55.43 109.751 174.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 69.89 2.0 3.69 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.955 1.702 . . . . 75.31 112.703 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.68 108.11 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.661 -0.65 . . . . 73.53 109.645 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -114.49 126.24 54.72 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.609 1.164 . . . . 75.22 108.31 177.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -91.71 139.9 30.23 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 108.46 -0.941 . . . . 73.13 108.46 171.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.45 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 98.1 t -123.5 139.64 49.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.196 -1.039 . . . . 71.45 108.196 170.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.426 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 50.3 t -120.04 132.64 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.424 -0.954 . . . . 63.32 108.424 174.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.554 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -111.94 104.5 12.78 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.751 -1.574 . . . . 73.21 106.751 170.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.555 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 13.3 ttp180 -94.28 100.49 12.53 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.443 -1.317 . . . . 72.13 107.443 176.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.472 HG23 HD23 ' A' ' 60' ' ' LEU . 36.0 t -93.72 123.99 46.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.663 -1.236 . . . . 73.34 107.663 177.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 m -118.68 115.72 25.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.829 0.823 . . . . 74.12 109.448 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.546 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 91.8 t -104.2 128.92 57.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 C-N-CA 124.866 1.266 . . . . 73.15 108.98 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.1 m -125.4 128.56 48.3 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 108.586 -0.894 . . . . 73.34 108.586 171.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.51 ' HB1' HG23 ' A' ' 40' ' ' VAL . . . -118.12 129.28 55.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.818 -1.178 . . . . 75.22 107.818 175.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.7 m -135.57 139.08 43.61 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.595 0.712 . . . . 74.22 110.655 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.461 HD22 ' H ' ' A' ' 37' ' ' GLN . 59.4 mt -95.86 62.63 2.28 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.373 1.869 . . . . 75.2 108.701 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.11 -84.63 0.92 Allowed Glycine 0 CA--C 1.529 0.955 0 CA-C-N 115.806 -0.634 . . . . 30.15 112.275 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.35 -26.79 11.84 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.542 0.737 . . . . 61.23 111.737 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.501 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 2.9 tp10 -95.66 112.86 24.49 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.702 0.801 . . . . 75.35 109.641 -174.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.9 m -67.96 129.97 41.53 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.933 0.788 . . . . 73.25 110.124 176.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.608 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -76.78 -60.64 2.27 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.34 -0.846 . . . . 72.43 109.173 177.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -159.09 170.45 21.99 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.48 -0.782 . . . . 74.53 111.489 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.4 tp -140.75 113.32 8.1 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.885 1.274 . . . . 74.05 108.457 176.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.546 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 58.9 m -105.63 141.66 36.7 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.181 0.993 . . . . 70.31 108.85 176.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -148.3 116.75 6.56 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.449 -0.575 . . . . 70.33 109.449 173.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.5 t -127.05 112.82 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.713 0.805 . . . . 73.21 109.38 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -84.82 83.36 8.07 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.181 -1.044 . . . . 74.34 108.181 170.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -76.17 92.17 3.22 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.191 -1.04 . . . . 74.44 108.191 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.93 164.91 41.27 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.777 -0.929 . . . . 70.31 110.777 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.25 122.01 1.06 Allowed Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.132 -1.187 . . . . 74.44 110.132 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.438 HG13 ' HE1' ' A' ' 17' ' ' TYR . 57.0 mt -81.13 125.92 39.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 107.654 -1.239 . . . . 71.34 107.654 171.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.599 ' HB3' HD11 ' A' ' 86' ' ' ILE . 87.7 m-85 -127.25 136.92 52.65 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.518 0.727 . . . . 74.21 109.285 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.5 p -100.38 90.98 4.5 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.695 0.798 . . . . 74.5 109.023 174.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 84' ' ' PHE . 14.7 mm -111.12 147.45 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 114.859 -1.064 . . . . 75.31 110.638 -173.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.85 167.38 18.82 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.581 0.352 . . . . 73.13 111.754 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.96 1.67 88.72 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 115.145 0.818 . . . . 75.21 115.145 172.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.2 172.13 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.642 0.777 . . . . 73.54 110.179 177.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.489 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 0.6 OUTLIER -160.64 177.78 10.15 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.25 -0.886 . . . . 74.53 109.607 176.231 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.9 -116.36 8.61 Favored Glycine 0 C--N 1.351 1.391 0 O-C-N 123.793 0.683 . . . . 75.11 113.786 172.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.4 p -64.2 -41.15 97.19 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.762 1.225 . . . . 73.44 111.528 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -74.38 -36.87 63.56 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.045 0.538 . . . . 71.11 111.323 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.494 ' HA ' ' HE1' ' A' ' 94' ' ' MET . 4.8 tpt -68.16 -45.92 72.2 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.55 -0.537 . . . . 71.52 109.55 177.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.88 -32.18 73.38 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.181 -0.918 . . . . 74.34 110.781 176.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -73.69 -38.04 65.02 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.105 0.562 . . . . 75.24 110.342 176.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.8 t -67.92 -39.31 83.56 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.619 -0.511 . . . . 63.34 109.619 -178.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.451 ' HB3' ' HG ' ' A' ' 48' ' ' SER . 78.8 mt -85.68 -28.1 24.92 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.679 0.792 . . . . 73.0 111.975 -177.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -114.7 4.48 22.88 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 114.508 0.563 . . . . 72.31 114.508 -170.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.447 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -143.31 -62.19 0.41 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 117.72 0.76 . . . . 73.02 110.958 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -62.84 -57.78 9.68 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.961 0.904 . . . . 74.33 111.593 -173.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 82.6 m -64.43 -46.78 78.12 Favored Pre-proline 0 CA--C 1.558 1.269 0 CA-C-O 117.895 -1.05 . . . . 73.35 113.102 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.7 -20.25 59.43 Favored 'Trans proline' 0 C--N 1.396 3.059 0 CA-C-N 121.446 1.552 . . . . 65.35 112.896 174.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -76.58 -32.32 58.05 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.952 0.501 . . . . 61.41 109.883 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.501 HG21 HD12 ' A' ' 13' ' ' ILE . 46.2 mm -67.0 -45.19 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.445 0.698 . . . . 74.34 109.7 169.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 59.1 mt -73.14 -22.97 60.41 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.788 -1.096 . . . . 74.22 111.946 -174.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -65.3 -44.49 68.55 Favored Pre-proline 0 N--CA 1.481 1.076 0 CA-C-O 117.296 -1.335 . . . . 75.3 113.78 -172.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 77.8 Cg_exo -54.33 -36.69 87.75 Favored 'Trans proline' 0 C--N 1.387 2.553 0 CA-C-N 121.96 1.736 . . . . 72.41 113.383 171.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.451 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 93.3 m-85 -76.49 -39.2 53.83 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.187 0.595 . . . . 73.41 111.5 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.97 -47.07 75.79 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.519 0.728 . . . . 73.4 109.346 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -51.44 -52.66 44.4 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 125.546 1.538 . . . . 74.55 110.016 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -61.93 -47.74 83.57 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.554 1.159 . . . . 72.42 111.853 -175.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.51 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 49.9 t -55.91 -45.16 78.77 Favored 'General case' 0 C--N 1.351 0.631 0 O-C-N 124.498 1.124 . . . . 61.15 110.242 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.55 HD13 HD12 ' A' ' 128' ' ' LEU . 84.2 mt -62.35 -53.14 51.39 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 CA-C-N 114.844 -1.071 . . . . 74.31 110.804 175.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 38.5 m -57.73 -37.35 73.43 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.263 1.025 . . . . 74.03 110.964 -173.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.6 t -69.26 -46.24 67.76 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.766 -1.106 . . . . 72.31 109.818 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.551 ' HE1' ' HB2' ' A' ' 23' ' ' PHE . 9.0 mtp -58.84 -37.31 76.17 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.796 0.839 . . . . 72.24 111.837 176.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 114' ' ' ILE . 74.2 t -67.27 -45.61 85.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 124.183 0.993 . . . . 70.02 110.284 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 94.2 p -73.63 -28.04 61.58 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 116.248 -0.433 . . . . 74.44 110.772 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -70.38 -33.97 72.03 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.698 0.799 . . . . 74.43 109.376 172.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.439 ' O ' HG22 ' A' ' 122' ' ' THR . . . -81.99 8.13 61.17 Favored Glycine 0 C--N 1.353 1.502 0 CA-C-N 115.095 -0.957 . . . . 73.52 112.767 172.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.4 t 65.14 11.47 7.2 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 127.42 2.288 . . . . 60.31 113.888 171.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -79.38 143.81 60.68 Favored Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 108.962 -0.755 . . . . 74.32 108.962 177.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -48.05 143.54 13.8 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.372 2.715 . . . . 55.24 113.285 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -53.13 116.09 2.21 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.835 1.254 . . . . 73.32 113.283 -165.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.541 HD21 HG12 ' A' ' 64' ' ' VAL . 55.6 tp -110.71 96.06 5.94 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.159 0.584 . . . . 75.02 109.625 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.632 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 1.0 OUTLIER -100.31 113.51 26.28 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 106.287 -1.745 . . . . 75.44 106.287 175.566 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.55 HD12 HD13 ' A' ' 114' ' ' ILE . 16.2 mt -65.65 130.57 43.74 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 123.553 0.533 . . . . 63.44 109.751 -174.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.73 139.11 97.56 Favored Pre-proline 0 CA--C 1.554 1.128 0 CA-C-O 118.767 -0.635 . . . . 72.23 110.755 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.528 ' HD2' HE21 ' C' ' 12' ' ' GLN . 75.6 Cg_exo -50.31 140.51 34.06 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 123.617 2.878 . . . . 72.25 113.686 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.538 HG22 HD12 ' A' ' 44' ' ' LEU . 70.9 t -115.6 132.34 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 122.95 0.5 . . . . 75.11 110.082 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -93.06 79.77 4.56 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.201 -1.037 . . . . 70.22 108.201 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.447 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 84.8 m-85 -58.42 -25.0 61.66 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.977 0.911 . . . . 75.14 111.791 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -67.97 -49.67 60.3 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.223 1.009 . . . . 75.23 110.594 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.57 92.66 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.076 0.86 . . . . 73.23 110.194 177.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.42 ' HA ' HD22 ' A' ' 139' ' ' ASN . 88.7 mt -62.46 -36.62 83.02 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 114.727 -1.124 . . . . 74.11 111.312 178.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -67.32 -42.72 83.16 Favored 'General case' 0 C--O 1.216 -0.67 0 O-C-N 123.789 0.681 . . . . 71.12 110.109 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.459 ' HA ' ' HE3' ' A' ' 138' ' ' MET . 22.5 mmt -59.99 -51.78 68.21 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 123.656 0.597 . . . . 72.02 111.208 -175.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.42 HD22 ' HA ' ' A' ' 136' ' ' LEU . 12.1 p30 -70.55 -30.24 66.91 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.245 0.218 . . . . 75.32 111.436 -177.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -74.73 -32.36 62.1 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.354 0.662 . . . . 73.34 111.126 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 59.8 tp -65.14 -50.39 66.22 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.998 0.919 . . . . 74.22 109.608 -175.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 174.86 -13.36 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.224 0 O-C-N 124.698 1.249 . . . . 74.43 110.909 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.4 ' HG2' ' HG2' ' A' ' 144' ' ' GLN . 36.0 tt0 68.73 154.33 0.11 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.048 1.339 . . . . 75.21 110.46 -172.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.4 ' HG2' ' HG2' ' A' ' 143' ' ' GLN . 14.0 mm100 67.37 -79.79 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.701 1.2 . . . . 74.43 110.869 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.84 143.76 47.71 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.619 0.767 . . . . 73.15 110.694 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -176.18 44.86 0.11 Allowed Glycine 0 C--N 1.336 0.534 0 N-CA-C 110.857 -0.897 . . . . 45.34 110.857 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -69.16 144.25 53.86 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.245 1.018 . . . . 73.41 111.018 -174.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -79.48 96.42 1.51 Allowed Glycine 0 C--N 1.345 1.035 0 CA-C-N 116.058 -0.519 . . . . 55.24 113.128 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.1 t -70.04 131.66 44.68 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-O 121.233 0.539 . . . . 63.13 111.139 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -136.54 171.9 13.81 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.916 1.287 . . . . 71.3 108.988 -178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 69.32 0.52 2.91 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 124.501 1.121 . . . . 71.1 111.928 175.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -103.75 97.45 7.46 Favored 'General case' 0 C--O 1.216 -0.681 0 N-CA-C 107.309 -1.367 . . . . 75.33 107.309 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.47 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 22.9 mt-30 64.08 168.39 0.16 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.399 1.08 . . . . 74.4 112.988 175.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.4 t70 179.81 96.25 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.46 -1.311 . . . . 72.14 107.46 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.479 0 C-N-CA 124.109 0.964 . . . . 74.4 108.999 -175.899 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.415 ' HB3' ' O ' ' B' ' 143' ' ' GLN . 1.2 tmt? . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 109.403 -0.591 . . . . 73.22 109.403 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 36.0 t -162.08 122.11 2.49 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.3 1.04 . . . . 72.52 108.275 174.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 59.86 73.31 0.49 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.775 1.23 . . . . 75.14 111.102 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -80.58 -55.87 4.55 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.285 -0.87 . . . . 73.11 108.962 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -85.74 116.67 24.14 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.265 1.026 . . . . 64.04 108.775 167.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -162.02 -58.74 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 108.399 -0.963 . . . . 70.34 108.399 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 40.3 p -88.96 144.15 26.37 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.433 -0.803 . . . . 75.54 109.721 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -68.96 -32.85 72.74 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.985 0.514 . . . . 74.21 110.901 176.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.527 ' HG3' HG13 ' B' ' 89' ' ' ILE . 26.9 ttt 63.44 165.16 0.12 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.88 1.672 . . . . 71.43 112.148 -177.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.8 m -140.84 125.69 18.14 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.936 -1.135 . . . . 62.14 107.936 167.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.431 ' HB2' ' HE3' ' B' ' 9' ' ' MET . 55.4 t80 -136.18 142.07 44.1 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.705 0.802 . . . . 74.55 108.975 177.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -156.11 141.44 17.56 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 109.124 -0.695 . . . . 75.22 109.124 170.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.586 ' HB ' ' HB1' ' E' ' 126' ' ' ALA . 61.6 mt -80.77 134.23 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.033 -1.099 . . . . 74.1 108.033 175.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -99.98 -50.61 3.94 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.591 0.357 . . . . 75.31 110.224 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -167.47 129.72 1.62 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.255 -0.646 . . . . 72.25 109.255 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.558 HG21 ' CD1' ' B' ' 109' ' ' TYR . 86.8 mt -115.32 149.6 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 108.539 -0.912 . . . . 74.3 108.539 175.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.598 ' HE2' ' HZ3' ' B' ' 19' ' ' LYS . 20.7 p90 -167.41 162.85 14.88 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.63 0.728 . . . . 74.34 111.492 -173.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 55.4 m -90.19 124.29 34.72 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 114.342 -1.299 . . . . 75.35 108.307 170.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.598 ' HZ3' ' HE2' ' B' ' 17' ' ' TYR . 35.3 mttp -85.96 -45.56 11.37 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.944 0.898 . . . . 72.5 110.343 172.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 24.4 t70 -144.64 142.76 30.36 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.519 -0.309 . . . . 61.04 110.91 -167.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.448 HD13 ' SG ' ' B' ' 113' ' ' CYS . 46.4 mm -136.25 142.76 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.628 1.171 . . . . 72.1 109.116 177.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.403 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 29.4 m -138.17 135.37 35.6 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.102 1.361 . . . . 75.22 108.029 168.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 80.9 t80 -142.12 108.42 5.27 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 105.659 -1.978 . . . . 73.45 105.659 164.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -118.95 112.18 19.28 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.315 -0.994 . . . . 74.21 108.315 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.01 87.08 4.34 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 107.029 -1.471 . . . . 72.24 107.029 171.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.91 -26.63 21.93 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 122.24 1.96 . . . . 74.33 111.911 -172.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.55 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 75.2 m-20 -107.99 14.62 25.09 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.537 1.135 . . . . 64.52 110.453 -176.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.98 -55.27 9.58 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 125.339 1.456 . . . . 70.43 114.832 -167.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -55.46 -44.68 46.21 Favored 'Trans proline' 0 C--N 1.4 3.239 0 C-N-CA 122.054 1.836 . . . . 73.12 113.348 -175.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -98.03 -16.79 19.48 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.899 1.074 . . . . 75.12 113.899 -171.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.455 HG23 ' HA ' ' B' ' 73' ' ' ALA . 9.5 p -76.1 -8.72 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-N 118.811 0.732 . . . . 75.4 112.05 -172.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -80.45 -1.62 42.37 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.897 0.479 . . . . 74.13 112.187 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -64.01 -25.19 68.01 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.086 0.554 . . . . 55.32 110.304 166.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.496 ' HB2' HD13 ' B' ' 68' ' ' LEU . 31.1 mmtp -90.96 107.94 19.53 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.988 1.315 . . . . 71.32 108.979 -178.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -115.89 86.09 2.41 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.384 0.611 . . . . 72.23 110.806 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 37.4 p90 -163.97 160.51 21.99 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.325 1.45 . . . . 73.34 107.78 171.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -62.75 116.18 22.1 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 108.376 -0.972 . . . . 73.42 108.376 172.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.01 157.54 58.91 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.042 1.828 . . . . 72.3 111.665 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -69.13 115.32 8.28 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 108.233 -1.025 . . . . 62.32 108.233 172.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.659 HG21 ' HB1' ' B' ' 66' ' ' ALA . 60.8 t -106.21 129.45 59.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 O-C-N 124.146 0.904 . . . . 71.02 110.602 -173.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.483 ' HE3' ' HB2' ' B' ' 43' ' ' ASP . 18.7 ttpt -106.48 120.5 42.08 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.509 -0.923 . . . . 75.54 108.509 168.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 16.1 tp -88.03 134.16 33.8 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.585 -0.894 . . . . 72.41 108.585 173.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.484 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 9.4 t0 -134.66 112.11 10.54 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.094 -1.076 . . . . 72.04 108.094 -172.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.417 HD12 HG11 ' B' ' 131' ' ' VAL . 78.4 mt -107.35 150.88 26.23 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.094 0.558 . . . . 74.24 110.306 -173.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.528 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.2 t70 -151.66 139.27 19.67 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.607 0.763 . . . . 74.3 109.686 -173.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 4.7 t -114.55 103.66 11.24 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-O 121.694 0.759 . . . . 73.13 109.68 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.28 118.67 30.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.555 -0.906 . . . . 73.43 108.555 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 54.0 p -145.77 172.35 13.43 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 122.086 -0.383 . . . . 71.43 111.563 -175.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 24.4 p -159.62 137.39 10.03 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.684 0.793 . . . . 74.23 110.702 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . 0.479 ' HB2' ' CE2' ' B' ' 56' ' ' TYR . 58.8 tt0 -84.98 105.71 15.95 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 108.566 -0.901 . . . . 75.31 108.566 170.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 pp -123.72 14.12 9.35 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.1 -0.954 . . . . 74.04 110.161 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.67 142.98 12.73 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.6 -1.182 . . . . 73.45 108.571 -176.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -75.99 117.25 17.51 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.642 0.777 . . . . 73.44 109.982 -172.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 66.12 5.21 3.45 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 125.566 1.547 . . . . 75.12 112.758 -176.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.423 HG23 ' HG ' ' B' ' 85' ' ' SER . 61.9 t -125.07 96.64 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.422 -1.325 . . . . 74.23 107.422 -175.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.479 ' CE2' ' HB2' ' B' ' 50' ' ' GLN . 1.8 t80 -94.27 140.24 30.03 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.97 -0.752 . . . . 75.54 108.97 -172.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -106.47 105.09 14.96 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.524 -1.287 . . . . 70.41 107.524 -177.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -103.11 129.08 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.331 1.052 . . . . 75.45 109.718 -174.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 16.3 t -115.84 112.44 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.762 -0.829 . . . . 75.33 108.762 176.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -94.18 110.31 22.04 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.751 -1.203 . . . . 74.04 107.751 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.528 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 7.1 tmm_? -91.19 124.67 35.58 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.758 -0.83 . . . . 72.54 108.758 176.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 19.3 t -111.63 135.35 51.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.66 -1.237 . . . . 74.51 107.66 173.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 22.9 m -128.64 128.52 44.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.81 0.814 . . . . 72.13 109.274 171.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.483 HG23 HD12 ' B' ' 114' ' ' ILE . 79.6 t -107.09 114.84 47.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 114.09 -1.414 . . . . 63.04 108.584 172.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 88.6 m -96.03 135.93 37.16 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.017 -1.105 . . . . 73.41 108.017 165.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.659 ' HB1' HG21 ' B' ' 40' ' ' VAL . . . -148.35 141.82 25.35 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.207 -0.664 . . . . 73.04 109.207 177.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.542 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 18.5 p -143.61 134.87 25.85 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.646 -0.707 . . . . 65.04 111.207 -172.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.521 ' HG ' ' HB3' ' B' ' 73' ' ' ALA . 85.2 mt -106.88 104.01 13.59 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.925 1.29 . . . . 74.13 110.733 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.44 -125.08 7.15 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-O 120.118 -0.268 . . . . 73.4 112.781 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -91.01 3.54 54.44 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.456 0.703 . . . . 64.43 111.77 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.55 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 13.1 pt-20 -135.2 146.68 48.92 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.066 0.546 . . . . 74.33 110.945 -170.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 49.1 m -71.91 130.54 41.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.843 -0.617 . . . . 73.33 110.842 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.542 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -79.33 -65.48 0.99 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.881 -1.054 . . . . 70.01 108.306 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -151.18 152.02 32.73 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.221 -0.899 . . . . 75.52 111.459 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 78.4 mt -118.99 109.39 15.89 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 105.928 -1.878 . . . . 74.43 105.928 168.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.6 t -117.29 135.43 53.83 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.877 -1.156 . . . . 64.4 107.877 -178.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.403 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 38.1 tt0 -149.5 135.96 19.23 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.725 -0.843 . . . . 73.22 108.725 -172.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -131.16 143.2 41.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.845 -0.798 . . . . 72.12 108.845 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -116.56 96.69 5.62 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.811 -1.181 . . . . 74.31 107.811 171.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.422 ' HB2' ' HB1' ' B' ' 110' ' ' ALA . 7.6 tp-100 -90.89 100.02 12.95 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.95 -0.759 . . . . 74.3 108.95 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.74 142.26 16.15 Favored Glycine 0 C--N 1.344 1.027 0 O-C-N 123.624 0.578 . . . . 74.23 111.705 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.432 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -142.67 125.93 2.75 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.643 -0.583 . . . . 71.44 111.643 -176.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 40.8 mt -84.93 115.73 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 107.517 -1.29 . . . . 74.33 107.517 171.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -128.93 146.26 51.0 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.583 0.753 . . . . 65.43 109.913 -177.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.423 ' HG ' HG23 ' B' ' 55' ' ' VAL . 44.4 m -94.0 110.09 21.8 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.374 0.67 . . . . 65.3 109.36 172.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 4.7 mp -112.91 111.42 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 108.154 -1.054 . . . . 75.52 108.154 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.676 ' HA ' ' HB ' ' F' ' 97' ' ' ILE . . . -155.51 169.24 24.73 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.11 0.564 . . . . 75.32 111.325 178.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.12 -67.63 0.85 Allowed Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.525 -0.63 . . . . 65.04 111.525 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.527 HG13 ' HG3' ' B' ' 9' ' ' MET . 0.9 OUTLIER -52.69 159.05 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 124.338 1.055 . . . . 72.24 111.759 168.333 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -151.46 145.77 25.45 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 112.624 0.602 . . . . 75.35 112.624 -171.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.428 ' O ' ' HG2' ' B' ' 94' ' ' MET . . . 70.09 -111.88 4.06 Favored Glycine 0 C--N 1.358 1.781 0 CA-C-N 115.453 -0.794 . . . . 70.31 113.985 173.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 8.9 m -73.44 -38.03 65.64 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 122.081 0.943 . . . . 70.44 109.625 177.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -69.63 -27.73 65.31 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 113.404 -1.725 . . . . 74.23 110.903 -170.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.44 ' HB2' HD13 ' F' ' 97' ' ' ILE . 25.1 ptt? -81.45 -43.91 18.2 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.345 0.658 . . . . 73.44 112.687 -173.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.3 -11.29 59.94 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.598 0.759 . . . . 72.42 112.19 -173.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -61.25 -35.31 76.91 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.505 0.322 . . . . 74.43 110.259 165.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.3 t -61.34 -61.09 2.79 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.812 0.445 . . . . 62.55 111.282 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.55 HD13 HD12 ' F' ' 102' ' ' LEU . 0.4 OUTLIER -71.56 -15.82 62.29 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 113.004 0.742 . . . . 74.34 113.004 -178.529 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.31 -2.45 59.02 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.689 -0.506 . . . . 71.14 113.532 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.83 -59.87 0.18 Allowed 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.405 0.603 . . . . 61.44 111.881 -174.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -67.61 -48.25 67.34 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.077 0.951 . . . . 72.54 111.784 -173.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.5 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 63.6 m -65.0 -48.69 70.78 Favored Pre-proline 0 CA--C 1.563 1.47 0 C-N-CA 123.802 0.841 . . . . 75.1 111.509 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.5 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 74.6 Cg_exo -57.33 -29.49 84.32 Favored 'Trans proline' 0 C--N 1.4 3.26 0 C-N-CA 122.731 2.287 . . . . 75.33 113.991 170.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -67.7 -30.35 69.84 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.032 0.933 . . . . 72.42 110.682 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.511 HD12 HD11 ' B' ' 13' ' ' ILE . 62.2 mt -76.04 -41.29 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.466 0.706 . . . . 75.0 110.135 175.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.432 HD21 ' HA3' ' B' ' 82' ' ' GLY . 80.9 mt -71.86 -34.22 69.04 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.801 -1.091 . . . . 75.14 111.912 -175.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -59.49 -47.62 97.47 Favored Pre-proline 0 CA--C 1.56 1.327 0 CA-C-O 117.513 -1.232 . . . . 74.0 113.167 -170.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -56.2 -36.72 96.99 Favored 'Trans proline' 0 C--N 1.392 2.849 0 C-N-CA 122.363 2.042 . . . . 75.3 113.229 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.558 ' CD1' HG21 ' B' ' 16' ' ' ILE . 4.0 m-30 -70.68 -42.62 70.48 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.526 0.731 . . . . 72.23 109.978 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' B' ' 80' ' ' GLN . . . -66.76 -36.53 82.64 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.009 -0.996 . . . . 71.14 110.91 176.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.474 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 50.4 ttt-85 -64.36 -48.91 73.69 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.231 1.413 . . . . 75.31 110.749 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -70.07 -31.62 69.32 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.549 0.739 . . . . 61.24 109.768 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.508 ' O ' ' HG2' ' B' ' 117' ' ' MET . 11.5 t -67.29 -38.64 85.34 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 123.017 0.527 . . . . 75.02 110.515 177.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.483 HD12 HG23 ' B' ' 64' ' ' VAL . 63.5 mt -63.36 -55.71 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.971 0.908 . . . . 72.2 110.141 174.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.401 HG22 ' OG ' ' C' ' 119' ' ' SER . 24.2 m -60.97 -30.41 70.23 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 124.136 0.898 . . . . 73.14 111.268 -175.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.464 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 29.8 t -60.49 -52.29 65.83 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.469 0.708 . . . . 74.15 109.235 173.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.508 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.6 mmt -65.85 -35.82 81.72 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.28 0.632 . . . . 73.42 111.414 -175.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.6 t -63.75 -44.59 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 124.144 0.978 . . . . 63.42 110.655 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.3 t -67.55 -32.59 73.46 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.713 -1.13 . . . . 75.15 111.294 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.51 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 77.3 mtt-85 -66.55 -43.46 85.01 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.572 -0.74 . . . . 74.1 109.507 175.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.68 -7.79 66.05 Favored Glycine 0 C--N 1.352 1.444 0 O-C-N 123.801 0.688 . . . . 74.44 113.259 175.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.58 HG21 HD21 ' C' ' 127' ' ' ASN . 7.4 m 63.94 29.98 14.33 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.897 1.279 . . . . 71.51 110.662 177.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -83.14 159.47 62.33 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.138 0.975 . . . . 74.15 111.062 176.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.472 ' HA ' ' HB2' ' F' ' 131' ' ' TRP . 87.2 Cg_exo -48.76 149.12 7.87 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.489 2.793 . . . . 72.14 114.65 177.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.407 HE21 ' ND2' ' B' ' 127' ' ' ASN . 65.9 tp60 -59.49 114.34 2.65 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 124.382 1.051 . . . . 73.33 111.613 -171.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 21.2 tp -111.66 102.07 10.41 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.891 0.876 . . . . 75.01 109.88 -178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . 0.407 ' ND2' HE21 ' B' ' 125' ' ' GLN . 58.2 m-80 -107.58 119.01 38.24 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 107.793 -1.188 . . . . 72.41 107.793 167.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.474 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 42.1 mt -69.01 148.54 49.95 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 123.159 0.287 . . . . 75.31 110.711 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.36 147.5 97.08 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.429 0.692 . . . . 64.12 110.589 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.12 92.49 0.1 Allowed 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.505 2.137 . . . . 74.42 112.111 173.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.417 HG11 HD12 ' B' ' 44' ' ' LEU . 69.7 t -90.17 110.83 22.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 109.321 -0.622 . . . . 74.33 109.321 177.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -96.75 105.19 17.27 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.34 -0.985 . . . . 65.01 108.34 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -65.46 -27.94 68.86 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.145 0.978 . . . . 63.15 111.302 -176.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -54.17 -43.59 70.77 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.504 1.122 . . . . 73.35 110.909 176.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.84 -42.28 98.84 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.812 0.845 . . . . 60.33 111.846 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 9.2 mp -61.22 -47.07 87.79 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.315 0.646 . . . . 74.0 110.926 -176.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -78.64 -47.04 17.84 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.957 -0.565 . . . . 72.11 111.915 -177.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 88.5 mtp -67.78 -36.32 80.25 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 122.856 0.462 . . . . 73.21 112.022 -173.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -76.81 -21.2 55.44 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.521 0.329 . . . . 75.2 111.029 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -76.62 -39.23 53.11 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.855 -0.424 . . . . 75.44 109.855 171.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 11.1 mp -81.01 11.09 4.3 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.085 0.954 . . . . 73.43 111.727 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 72.55 150.75 0.1 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.56 1.544 . . . . 73.11 111.766 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' B' ' 1' ' ' MET . 49.6 mt-30 -84.01 -53.86 5.26 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.502 0.721 . . . . 70.21 109.886 177.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 54.47 86.42 0.05 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.832 1.253 . . . . 72.45 109.64 -178.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -141.76 135.77 30.07 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.161 0.584 . . . . 72.41 109.636 -175.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.18 -161.55 27.4 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 123.482 0.489 . . . . 70.31 111.972 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 70.38 100.62 0.06 Allowed 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.503 1.121 . . . . 75.42 111.476 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . 0.449 ' HA2' ' OD1' ' D' ' 5' ' ' ASN . . . -109.73 74.85 0.21 Allowed Glycine 0 C--N 1.347 1.182 0 CA-C-N 115.445 -0.798 . . . . 73.23 111.933 177.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 36.9 p -67.11 154.68 40.64 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.243 0.544 . . . . 73.35 112.011 -176.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -119.63 177.56 4.9 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.828 1.251 . . . . 74.11 109.384 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.28 -121.38 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 107.529 -1.285 . . . . 72.24 107.529 -177.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -144.82 133.88 22.69 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.524 1.129 . . . . 73.44 108.001 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -76.63 80.86 3.28 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.996 0.518 . . . . 73.01 109.622 174.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -56.24 120.26 7.28 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.05 0.94 . . . . 72.4 111.305 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . 0.451 ' HA ' ' HE3' ' D' ' 1' ' ' MET . . . . . . . . 0 C--O 1.249 1.064 0 C-N-CA 123.618 0.767 . . . . 75.43 110.289 -176.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 109.171 -0.677 . . . . 75.31 109.171 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -50.58 -56.61 10.94 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.324 1.449 . . . . 74.03 111.049 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . 0.407 ' HB3' ' H ' ' C' ' 4' ' ' GLN . 1.9 tm-20 -175.35 -83.78 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 104.199 -2.519 . . . . 73.22 104.199 172.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . 0.407 ' H ' ' HB3' ' C' ' 3' ' ' GLU . 52.7 mt-30 -147.01 124.64 11.78 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 107.283 -1.377 . . . . 73.24 107.283 168.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . 0.429 ' ND2' ' HB1' ' C' ' 87' ' ' ALA . 48.9 t30 -75.63 122.14 23.5 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.748 0.419 . . . . 53.51 110.657 -174.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -80.88 97.82 7.58 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.842 0.857 . . . . 75.32 110.632 -174.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 8.5 t -171.34 149.85 2.82 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.069 0.947 . . . . 75.13 110.016 174.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -101.45 72.0 1.38 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.676 0.79 . . . . 64.34 108.954 -177.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 9.3 ttt 65.69 122.57 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.662 1.585 . . . . 72.33 113.113 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 32.0 m -133.38 119.03 19.15 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 124.103 0.961 . . . . 74.22 108.828 170.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.416 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 55.7 t80 -109.18 136.24 48.98 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.713 -0.847 . . . . 75.14 108.713 169.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . 0.794 ' HG2' ' HA ' ' E' ' 136' ' ' LYS . 1.3 tp60 -157.91 144.23 17.55 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.3 0.375 . . . . 75.24 110.54 168.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 57.2 mt -82.65 135.07 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 115.467 -0.788 . . . . 72.34 109.384 175.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.482 HE22 ' HB2' ' E' ' 136' ' ' LYS . 29.8 mm-40 -98.92 -46.47 5.61 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.475 0.71 . . . . 65.13 109.706 172.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.632 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -170.69 146.16 2.61 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.603 0.761 . . . . 74.31 110.746 174.037 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 36.3 mm -115.64 139.23 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 106.467 -1.679 . . . . 70.41 106.467 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.46 ' HB3' HG22 ' D' ' 122' ' ' THR . 19.3 p90 -169.45 157.78 7.53 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.896 0.855 . . . . 72.32 111.987 -171.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.6 p -82.9 102.87 11.96 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.222 -1.354 . . . . 74.43 109.422 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.432 ' HE3' ' HB2' ' D' ' 28' ' ' ALA . 11.2 mmmm -65.14 -34.36 78.21 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.381 0.61 . . . . 74.14 109.392 171.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.591 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.5 t70 -153.4 145.7 23.93 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.63 -1.168 . . . . 74.42 109.24 -175.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.5 mt -140.85 145.77 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.615 1.566 . . . . 74.02 107.098 176.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.6 t -156.27 150.57 25.5 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.179 0.514 . . . . 61.13 110.266 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -149.37 131.74 15.62 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.168 -1.419 . . . . 74.1 107.168 174.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -133.92 111.8 10.74 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.108 -0.701 . . . . 72.33 109.108 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.66 82.14 67.45 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 107.657 -1.238 . . . . 70.32 107.657 170.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.84 -44.97 18.37 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.552 2.168 . . . . 71.54 111.276 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -92.89 21.06 5.96 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.472 -1.24 . . . . 75.4 111.082 -176.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.44 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -46.62 -58.3 7.07 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 124.226 1.01 . . . . 75.41 113.471 -172.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -60.94 -38.95 65.11 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 121.679 1.586 . . . . 63.43 112.44 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -69.24 -39.38 78.55 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.348 -0.842 . . . . 73.54 111.419 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.646 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.5 p -78.46 -17.29 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 C-N-CA 123.009 0.524 . . . . 73.31 112.308 -171.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -70.81 -15.54 62.66 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 112.194 0.442 . . . . 74.53 112.194 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -109.17 19.68 19.19 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.13 0.572 . . . . 72.55 111.09 174.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.651 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -92.85 158.7 15.72 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.385 0.674 . . . . 72.15 109.757 173.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.56 125.33 23.91 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.34 0.656 . . . . 52.3 109.377 167.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 62.3 t-105 -85.37 80.25 9.2 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.164 0.586 . . . . 74.23 110.364 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -121.79 76.92 38.56 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 124.368 1.067 . . . . 75.01 108.316 170.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.605 ' HG2' HG21 ' F' ' 133' ' ' THR . 1.9 Cg_endo -85.35 119.45 2.03 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 123.553 2.835 . . . . 55.23 112.608 -170.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -87.35 94.62 9.73 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.468 -1.242 . . . . 70.34 108.487 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.02 110.12 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 113.869 -1.514 . . . . 75.22 110.526 -172.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.52 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 18.2 tptm -92.2 105.47 17.68 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.45 -0.945 . . . . 74.31 108.45 169.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 pp -86.9 128.89 35.06 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 106.64 -1.615 . . . . 74.32 106.64 169.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.529 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 16.3 t70 -125.78 105.31 8.87 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 108.897 -0.779 . . . . 75.43 108.897 -172.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.457 HD21 HG11 ' C' ' 62' ' ' VAL . 96.1 mt -96.27 130.85 43.26 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.356 0.662 . . . . 64.11 110.521 -174.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -144.58 125.71 14.6 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.731 1.212 . . . . 73.12 107.938 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.1 t -121.86 151.74 40.34 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 109.621 -0.511 . . . . 73.4 109.621 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.93 148.24 31.58 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 124.355 1.062 . . . . 74.3 108.354 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.408 ' HG ' ' HB3' ' C' ' 98' ' ' LEU . 13.6 m -143.43 143.77 31.75 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.332 -0.618 . . . . 74.52 109.332 -178.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 65.0 p -145.22 136.36 24.88 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.931 0.892 . . . . 73.54 109.34 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -79.07 117.69 20.34 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 109.016 -0.735 . . . . 75.23 109.016 176.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.652 HD12 ' HB2' ' C' ' 57' ' ' GLU . 68.4 mt -84.25 -38.91 19.92 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.483 0.713 . . . . 65.52 110.19 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.22 -169.48 3.06 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.349 -0.841 . . . . 75.44 110.273 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.02 104.27 0.1 Allowed 'General case' 0 N--CA 1.481 1.088 0 O-C-N 124.185 0.928 . . . . 51.5 110.985 176.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 60.25 35.74 20.85 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 124.603 1.19 . . . . 73.15 111.338 174.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.4 t -127.7 119.24 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.867 -1.16 . . . . 72.11 107.867 174.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -123.63 124.13 42.1 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.961 0.905 . . . . 75.52 109.602 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.652 ' HB2' HD12 ' C' ' 51' ' ' LEU . 39.0 tt0 -85.51 132.11 34.25 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.471 -0.937 . . . . 74.35 108.471 167.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 51.5 t -118.82 143.71 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.32 -0.622 . . . . 71.31 109.32 171.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 90.3 t -124.33 140.54 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 C-N-CA 125.226 1.41 . . . . 75.24 108.433 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.4 HD13 ' CZ ' ' C' ' 133' ' ' PHE . 0.0 OUTLIER -121.14 96.96 5.3 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.184 -1.413 . . . . 75.1 107.184 173.833 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -82.2 105.91 13.67 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.465 -0.939 . . . . 74.51 108.465 173.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.457 HG11 HD21 ' C' ' 44' ' ' LEU . 28.6 t -105.38 129.01 58.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.769 -1.197 . . . . 75.42 107.769 173.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.529 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 69.5 m -116.42 125.06 51.49 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.499 -0.926 . . . . 64.54 108.499 175.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.422 HG21 HG23 ' C' ' 114' ' ' ILE . 68.0 t -103.83 110.25 29.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.2 -0.667 . . . . 70.22 109.2 170.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 7.4 m -96.48 131.97 42.52 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.83 -1.544 . . . . 75.21 106.83 170.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.75 113.39 14.66 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 106.682 -1.599 . . . . 72.23 106.682 -176.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 36.8 m -134.04 126.97 31.28 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-O 121.0 0.429 . . . . 75.24 110.144 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 16.2 mt -85.09 36.9 0.64 Allowed 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 125.829 1.652 . . . . 72.41 110.482 177.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.5 -92.62 1.04 Allowed Glycine 0 C--N 1.358 1.8 0 N-CA-C 111.085 -0.806 . . . . 74.2 111.085 176.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -90.33 -19.61 23.84 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.424 1.09 . . . . 73.14 110.697 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -103.54 124.13 48.21 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 125.335 1.454 . . . . 74.24 109.293 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 83.5 m -78.78 123.94 27.7 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.042 0.837 . . . . 72.4 109.222 167.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.646 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -70.55 -59.03 3.08 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.957 0.786 . . . . 74.51 109.335 174.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -162.54 173.77 13.54 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-O 121.468 0.651 . . . . 64.23 110.953 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.43 HD23 HG21 ' C' ' 65' ' ' THR . 2.7 tm? -138.0 104.16 5.17 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 106.435 -1.691 . . . . 64.34 106.435 175.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 49.3 t -108.21 145.42 34.28 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.26 -1.015 . . . . 71.31 108.26 176.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -154.25 128.79 9.23 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.304 -0.628 . . . . 75.25 109.304 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 69.1 t -126.91 136.2 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.011 0.924 . . . . 74.45 109.025 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.591 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.1 mt-30 -105.03 90.2 3.37 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.165 -1.05 . . . . 71.23 108.165 170.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -80.33 98.85 7.62 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.475 -0.784 . . . . 74.01 109.862 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.47 170.28 48.39 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 116.255 -0.429 . . . . 71.32 112.274 176.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.94 119.75 0.78 Allowed Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.82 -0.912 . . . . 64.2 110.82 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.536 HD11 ' HB3' ' D' ' 29' ' ' PRO . 36.0 mm -82.02 124.96 39.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.741 -0.837 . . . . 71.02 108.741 176.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -126.7 119.06 26.03 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 124.059 0.849 . . . . 72.03 108.779 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 12.4 p -80.65 99.21 8.04 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.895 -1.15 . . . . 74.55 107.895 172.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.64 HG21 ' HE2' ' C' ' 94' ' ' MET . 20.9 mt -118.14 123.87 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 109.403 -0.591 . . . . 74.55 109.403 -177.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.429 ' HB1' ' ND2' ' C' ' 5' ' ' ASN . . . -127.59 155.22 44.2 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.903 0.705 . . . . 63.04 112.903 -171.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.88 -28.13 6.79 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.13 -0.941 . . . . 63.3 115.14 168.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.711 HD13 ' HA ' ' C' ' 94' ' ' MET . 37.5 pt -96.16 159.04 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-O 121.726 0.774 . . . . 75.14 112.232 -175.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -149.41 -173.08 4.29 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 113.781 -1.554 . . . . 74.45 108.069 171.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.74 -128.22 46.15 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.494 0.496 . . . . 55.43 113.973 171.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 10.2 t -74.08 -32.13 63.12 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.142 0.977 . . . . 71.33 112.571 -174.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -65.88 -52.72 47.77 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.186 0.595 . . . . 75.44 109.987 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.711 ' HA ' HD13 ' C' ' 89' ' ' ILE . 4.6 tpt -54.72 -48.75 72.13 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 124.149 0.905 . . . . 75.31 111.632 173.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.43 -38.14 76.82 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.988 0.805 . . . . 71.12 111.388 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -80.42 -29.58 37.65 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.31 0.644 . . . . 74.41 111.805 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 35.0 t -70.35 -34.79 73.05 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.999 -0.741 . . . . 74.23 108.999 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.408 ' HB3' ' HG ' ' C' ' 48' ' ' SER . 69.3 mt -87.36 -28.8 21.99 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.035 1.334 . . . . 75.41 111.123 176.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.42 -28.07 41.24 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 115.804 -0.635 . . . . 63.53 114.397 -170.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.487 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -139.21 -52.33 0.55 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 111.934 0.346 . . . . 63.33 111.934 -169.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -64.73 -53.65 43.81 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 123.293 0.371 . . . . 74.23 110.988 -173.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.416 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 94.9 m -59.23 -49.93 90.24 Favored Pre-proline 0 CA--C 1.564 1.5 0 CA-C-O 118.173 -0.918 . . . . 72.55 111.976 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -53.79 -33.25 69.93 Favored 'Trans proline' 0 C--N 1.397 3.125 0 C-N-CA 122.666 2.244 . . . . 72.35 114.628 171.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -67.1 -32.3 73.37 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 122.86 0.464 . . . . 71.34 110.958 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 44.0 mm -72.87 -40.71 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.041 0.536 . . . . 74.42 109.637 176.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 76.0 mt -78.9 -27.01 43.85 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.144 0.978 . . . . 71.11 112.272 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -56.43 -49.41 93.63 Favored Pre-proline 0 CA--C 1.56 1.328 0 N-CA-C 114.547 1.314 . . . . 71.52 114.547 -173.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -60.84 -38.65 68.54 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 122.022 1.815 . . . . 74.21 112.67 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -67.93 -41.06 83.13 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.451 -0.795 . . . . 72.42 110.119 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.9 -42.69 99.87 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.784 0.834 . . . . 75.11 109.929 175.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -57.76 -55.65 32.16 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.329 1.052 . . . . 72.34 110.377 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -66.07 -30.59 71.13 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.16 0.584 . . . . 75.31 110.426 -174.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . 0.415 ' SG ' HG12 ' C' ' 21' ' ' ILE . 21.4 t -72.54 -33.89 67.15 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 122.94 0.496 . . . . 74.01 111.453 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.422 HG23 HG21 ' C' ' 64' ' ' VAL . 96.3 mt -75.15 -49.58 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 123.554 0.742 . . . . 74.34 110.144 175.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 13.5 m -67.14 -28.95 68.56 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.249 1.02 . . . . 71.14 110.819 -175.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.445 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 27.2 t -63.07 -50.07 72.05 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 108.612 -0.884 . . . . 71.53 108.612 170.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.546 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.52 -35.44 77.72 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.585 1.154 . . . . 75.12 112.602 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 93.3 t -63.36 -47.01 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.61 0.764 . . . . 73.53 109.706 173.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.401 ' OG ' HG22 ' B' ' 115' ' ' THR . 46.5 t -68.53 -28.94 67.43 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.813 -1.085 . . . . 73.11 111.506 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' C' ' 116' ' ' SER . 86.5 mtt-85 -72.06 -42.45 66.22 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.031 -0.729 . . . . 74.55 109.031 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.65 -0.82 60.04 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 115.588 -0.733 . . . . 70.03 112.686 170.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.409 HG21 ' HB3' ' D' ' 17' ' ' TYR . 32.8 p 61.59 32.68 18.57 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.493 1.917 . . . . 73.52 113.375 171.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -83.34 155.19 66.53 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 108.638 -0.875 . . . . 73.14 108.638 170.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -50.63 159.42 2.23 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.994 2.462 . . . . 73.33 113.947 171.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -51.01 138.79 18.82 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.815 1.246 . . . . 74.41 112.292 -176.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.438 HD11 HG23 ' F' ' 133' ' ' THR . 50.7 tp -149.1 86.2 1.49 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.123 -0.695 . . . . 71.45 109.123 178.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . 0.58 HD21 HG21 ' B' ' 122' ' ' THR . 83.6 m-20 -91.64 123.29 34.93 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.219 -0.9 . . . . 74.11 108.707 175.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.08 119.81 15.74 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.403 -0.962 . . . . 75.43 108.403 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.29 143.57 95.45 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 123.768 0.827 . . . . 75.14 110.923 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.451 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 8.5 Cg_endo -51.71 98.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.128 2.552 . . . . 72.13 113.014 174.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 60.2 t -98.29 111.7 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.489 -1.301 . . . . 75.24 107.489 173.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -74.03 102.82 4.3 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.048 0.539 . . . . 71.43 110.566 -174.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.4 ' CZ ' HD13 ' C' ' 60' ' ' LEU . 81.0 m-85 -62.18 -25.26 67.68 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.841 0.856 . . . . 74.43 111.454 176.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.487 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 23.9 t70 -62.17 -49.96 73.71 Favored 'General case' 0 C--N 1.347 0.485 0 O-C-N 123.881 0.738 . . . . 62.15 109.713 177.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.16 -43.05 92.09 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 124.176 0.922 . . . . 43.54 111.654 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 79.7 mt -64.28 -39.89 94.85 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.953 -1.021 . . . . 73.54 111.428 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -82.45 -23.6 34.7 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.256 -0.429 . . . . 74.54 111.468 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.482 ' HG2' ' O ' ' C' ' 134' ' ' ASP . 22.2 mmt -63.81 -30.19 71.31 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 110.024 -0.362 . . . . 72.14 110.024 174.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -61.47 -41.88 97.92 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.035 0.934 . . . . 74.32 110.699 173.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -69.75 -83.35 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 115.315 -0.857 . . . . 65.25 109.745 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 15.0 tp -140.03 132.7 28.89 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.292 -1.003 . . . . 75.11 108.292 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -121.57 13.77 10.94 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.611 0.967 . . . . 74.14 113.611 -163.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 -88.37 139.79 30.13 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 109.69 -0.485 . . . . 74.3 109.69 177.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -170.84 174.46 4.84 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.631 0.772 . . . . 74.45 111.642 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -136.68 93.26 2.84 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 106.929 -1.508 . . . . 74.14 106.929 162.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -82.94 47.34 3.8 Favored Glycine 0 N--CA 1.476 1.357 0 C-N-CA 123.298 0.475 . . . . 74.12 113.953 -173.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -164.24 112.8 1.15 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.172 1.389 . . . . 74.41 107.885 177.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -110.82 178.84 19.91 Favored Glycine 0 C--N 1.339 0.705 0 CA-C-N 116.253 -0.43 . . . . 53.33 113.649 -175.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 1.4 p -156.14 111.04 2.88 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.131 1.373 . . . . 74.54 109.617 -176.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.58 158.94 16.71 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 107.906 -1.146 . . . . 74.4 107.906 171.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -120.62 -68.45 0.91 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.72 -0.845 . . . . 72.52 108.72 172.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -156.52 138.93 14.84 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.388 1.075 . . . . 75.41 110.008 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -144.37 161.66 38.43 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.582 1.153 . . . . 71.31 109.584 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -76.13 170.67 15.85 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.308 0.643 . . . . 75.01 111.472 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.188 0 C-N-CA 124.024 0.93 . . . . 75.32 109.814 178.4 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.451 ' HE3' ' HA ' ' B' ' 155' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.483 1.197 0 CA-C-O 120.856 0.36 . . . . 72.54 110.198 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 39.5 t -148.49 118.14 7.04 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.622 -0.881 . . . . 71.43 108.622 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -70.82 176.74 4.03 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.438 0.695 . . . . 73.11 111.354 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . 0.432 ' NE2' ' HA ' ' E' ' 97' ' ' ILE . 20.8 mm-40 -99.27 105.59 17.62 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.305 0.642 . . . . 74.23 109.829 -175.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . 0.449 ' OD1' ' HA2' ' B' ' 148' ' ' GLY . 16.1 t30 -111.23 133.99 53.16 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.1 0.96 . . . . 72.51 109.884 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -60.25 -41.66 93.67 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.388 1.075 . . . . 74.01 111.713 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.81 -16.16 60.13 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.496 0.554 . . . . 72.25 112.496 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' D' ' 5' ' ' ASN . 30.8 tt0 -72.87 -30.32 63.88 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 118.679 -0.677 . . . . 75.2 110.889 174.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -29.15 123.68 0.13 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 125.483 1.74 . . . . 74.22 113.746 -169.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 7.4 p -118.83 142.36 47.8 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.361 1.064 . . . . 64.42 109.806 -173.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -142.67 102.34 4.03 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.078 -1.082 . . . . 73.41 108.078 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -119.55 126.29 50.87 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.46 0.704 . . . . 74.14 109.465 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mt -91.79 137.89 21.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 123.657 0.783 . . . . 55.43 109.203 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.424 ' NE2' HG23 ' D' ' 83' ' ' ILE . 51.2 mt-30 -110.92 -44.41 3.62 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.191 0.596 . . . . 55.51 111.678 -176.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -169.03 122.98 0.82 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.822 -0.172 . . . . 72.0 110.566 -168.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.1 mp -103.82 137.17 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 107.287 -1.375 . . . . 73.14 107.287 166.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.409 ' HB3' HG21 ' C' ' 122' ' ' THR . 41.5 p90 -158.33 146.62 18.62 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.228 0.611 . . . . 73.44 110.804 174.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -76.88 114.53 15.75 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.398 -0.819 . . . . 61.02 109.034 173.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -81.12 -21.13 40.09 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.586 -0.733 . . . . 54.5 109.896 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 7.3 t70 -162.12 142.67 10.29 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.941 1.297 . . . . 71.31 109.225 -176.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.546 HG23 ' HE1' ' C' ' 117' ' ' MET . 79.5 mt -142.94 148.73 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 124.889 1.276 . . . . 73.34 108.549 176.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.3 t -150.28 145.3 26.1 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.052 1.341 . . . . 64.51 108.352 172.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.519 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.5 t80 -151.69 136.18 16.92 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.497 -1.668 . . . . 75.33 106.497 171.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.509 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 48.0 mt-10 -138.97 148.55 43.64 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.335 0.654 . . . . 74.33 109.819 -176.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.68 78.43 9.1 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 107.718 -1.216 . . . . 74.41 107.718 175.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.6 -31.31 8.86 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.514 2.142 . . . . 74.52 112.827 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -94.46 -1.48 53.48 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.368 0.667 . . . . 71.31 111.096 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.432 ' HB2' ' HE3' ' C' ' 19' ' ' LYS . . . -24.55 -66.96 0.07 OUTLIER Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 126.841 2.057 . . . . 71.24 116.356 -164.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.536 ' HB3' HD11 ' C' ' 83' ' ' ILE . 86.4 Cg_endo -77.71 -20.7 11.83 Favored 'Trans proline' 0 C--N 1.385 2.472 0 CA-C-N 123.046 2.124 . . . . 75.11 113.92 -176.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.506 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 3.9 t-160 -73.25 -39.24 65.61 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.055 0.942 . . . . 75.43 109.365 174.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.566 HG21 ' HA ' ' D' ' 73' ' ' ALA . 5.6 p -83.57 -24.12 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 CA-C-N 115.627 -0.715 . . . . 73.41 111.14 -172.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -63.83 -29.31 70.52 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.085 0.469 . . . . 75.14 111.207 176.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . 0.506 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 69.5 mt-30 -56.87 -29.3 62.81 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.547 -1.206 . . . . 71.34 110.493 176.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.552 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 98.4 mttt -84.42 71.48 10.7 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.731 1.212 . . . . 75.45 109.498 169.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -76.85 92.92 3.66 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.185 -0.916 . . . . 71.22 109.676 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -164.91 -165.82 0.96 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.128 0.971 . . . . 73.31 109.964 173.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -77.68 115.02 46.43 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.471 1.108 . . . . 74.41 110.965 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' HG2' ' D' ' 124' ' ' PRO . 24.0 Cg_exo -64.73 130.45 26.3 Favored 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 122.649 2.233 . . . . 71.31 111.203 173.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 30.0 mm-40 -67.52 109.6 3.3 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 108.122 -1.066 . . . . 75.14 108.122 171.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.663 HG11 HG13 ' D' ' 64' ' ' VAL . 45.7 t -99.16 128.07 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.774 -0.824 . . . . 75.33 108.774 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.02 127.87 48.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.605 -1.628 . . . . 65.5 106.605 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.549 HD21 HD11 ' D' ' 128' ' ' LEU . 55.4 tp -95.82 145.64 25.19 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.533 0.733 . . . . 73.51 110.522 -173.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.499 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 10.1 t70 -142.47 111.9 6.65 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 106.486 -1.672 . . . . 71.25 106.486 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.409 ' HB3' HD23 ' E' ' 111' ' ' LEU . 79.1 mt -109.71 145.27 36.86 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.256 0.55 . . . . 75.02 110.87 -174.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.69 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.0 t70 -137.33 149.88 47.35 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.71 1.204 . . . . 71.32 108.378 177.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 46' ' ' THR . . . . . 0.461 ' HB ' HG23 ' E' ' 107' ' ' THR . 30.2 m -120.92 144.16 48.59 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.82 -0.807 . . . . 60.43 108.82 173.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.535 ' HB2' ' HB ' ' D' ' 59' ' ' VAL . . . -147.23 170.31 17.51 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.931 1.292 . . . . 73.41 107.653 -177.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 10.0 p -168.38 165.32 12.79 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.692 0.397 . . . . 60.14 110.7 -172.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 12.0 p -169.68 165.95 9.94 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.646 0.778 . . . . 74.4 110.152 -173.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . 0.411 ' HB2' ' HA ' ' D' ' 56' ' ' TYR . 69.1 mm-40 79.93 157.55 0.16 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.193 1.797 . . . . 74.13 111.255 -176.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.634 ' H ' HD23 ' D' ' 51' ' ' LEU . 1.1 pt? -63.5 133.15 53.37 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.391 -1.277 . . . . 71.12 111.444 -177.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.66 82.4 7.89 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.387 1.075 . . . . 73.04 111.951 -167.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -150.72 74.37 1.17 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.864 0.84 . . . . 72.02 109.202 175.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.543 ' O ' ' HA ' ' D' ' 85' ' ' SER . 68.0 m-20 62.84 -9.15 0.11 Allowed 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 125.856 1.663 . . . . 75.31 114.74 -176.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 40.4 t -135.62 96.04 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 119.316 0.962 . . . . 73.21 108.557 -173.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.411 ' HA ' ' HB2' ' D' ' 50' ' ' GLN . 1.3 p90 -152.51 161.27 42.81 Favored 'General case' 0 C--O 1.247 0.921 0 CA-C-N 114.299 -1.319 . . . . 71.2 108.649 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.52 ' HG2' HG12 ' D' ' 83' ' ' ILE . 36.1 mt-10 -89.77 143.74 26.55 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 114.934 -1.03 . . . . 74.2 110.323 177.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 91.6 t -116.75 139.67 42.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 113.251 -1.795 . . . . 74.31 106.902 167.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' D' ' 47' ' ' ALA . 41.5 t -129.22 129.87 67.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.426 -0.953 . . . . 74.15 108.426 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.521 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -110.95 120.64 43.07 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.251 -1.389 . . . . 73.22 107.251 173.849 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.69 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 7.3 ttm180 -102.03 100.88 11.19 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.091 -1.077 . . . . 75.52 108.091 175.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.424 HG12 HD12 ' D' ' 42' ' ' LEU . 49.0 t -92.12 122.84 43.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.299 -1.0 . . . . 72.32 108.299 173.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 17.5 m -122.05 129.13 52.14 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.745 -0.835 . . . . 73.41 108.745 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.663 HG13 HG11 ' D' ' 40' ' ' VAL . 67.5 t -118.8 121.02 65.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 124.281 1.032 . . . . 73.11 109.186 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 49.8 m -106.84 114.61 28.8 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.155 -1.424 . . . . 75.44 107.155 164.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.594 ' HB3' HG22 ' D' ' 40' ' ' VAL . . . -119.86 142.84 48.29 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.553 0.741 . . . . 64.25 109.25 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.508 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 68.6 p -147.32 130.92 16.83 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.141 0.422 . . . . 71.12 112.141 -170.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 18.7 mt -93.84 105.95 17.95 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.15 0.98 . . . . 63.22 108.38 175.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.08 -116.28 4.29 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 110.94 -0.864 . . . . 70.43 110.94 -174.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.51 4.95 16.44 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.312 0.645 . . . . 60.43 111.955 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.552 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 10.3 pt-20 -115.9 155.43 27.97 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.604 0.361 . . . . 72.15 110.842 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 61.7 m -64.91 119.85 11.46 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.924 0.889 . . . . 75.41 112.209 -177.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.566 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -79.24 -69.8 0.55 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.623 -1.251 . . . . 75.43 107.623 171.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -145.6 149.52 34.7 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 114.988 -1.005 . . . . 73.34 110.704 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.509 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 65.6 mt -112.54 152.97 28.21 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.906 1.282 . . . . 74.41 107.957 172.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.731 ' SG ' HG12 ' D' ' 114' ' ' ILE . 53.3 t -158.35 144.91 17.43 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.784 0.434 . . . . 74.11 110.058 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -155.65 125.89 6.68 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.042 0.537 . . . . 73.43 109.757 173.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 87.7 t -131.26 115.42 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.759 0.824 . . . . 74.44 109.231 -177.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.516 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.7 mt-30 -88.63 85.16 6.75 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.636 -0.876 . . . . 70.2 108.636 170.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -81.05 98.86 8.17 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 113.998 -1.456 . . . . 74.33 109.377 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.51 162.16 24.37 Favored Glycine 0 N--CA 1.465 0.596 0 N-CA-C 112.295 -0.322 . . . . 75.04 112.295 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.87 136.94 4.49 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.676 -0.569 . . . . 74.24 111.676 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.52 HG12 ' HG2' ' D' ' 57' ' ' GLU . 44.2 mt -90.76 105.59 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.779 -0.823 . . . . 73.22 108.779 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -107.93 141.75 39.09 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.727 0.811 . . . . 73.13 109.821 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' D' ' 54' ' ' ASP . 3.9 t -115.73 110.36 19.01 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 109.078 -0.712 . . . . 55.14 109.078 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 44.2 pt -126.67 134.33 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 123.531 0.732 . . . . 74.54 110.942 -174.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.95 170.36 17.87 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.888 0.875 . . . . 71.43 110.813 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.3 23.81 53.3 Favored Glycine 0 C--N 1.355 1.602 0 O-C-N 123.424 0.452 . . . . 71.34 113.171 173.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.553 HG22 HE21 ' D' ' 93' ' ' GLN . 0.7 OUTLIER -140.82 144.86 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.449 0.7 . . . . 75.0 110.327 179.016 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -131.65 175.92 8.76 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.406 1.082 . . . . 73.44 110.492 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.82 -128.22 10.94 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 115.628 -0.715 . . . . 73.13 113.518 173.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 9.7 t -87.0 -38.39 16.63 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.233 0.613 . . . . 70.22 110.903 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.553 HE21 HG22 ' D' ' 89' ' ' ILE . 13.8 pt20 -69.05 -22.07 64.05 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.261 0.625 . . . . 75.34 112.666 -171.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -64.49 -49.63 70.6 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.078 0.466 . . . . 74.54 111.081 177.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.09 -13.82 49.13 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.868 0.867 . . . . 73.12 110.965 -177.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -75.49 -22.83 56.85 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.061 0.545 . . . . 74.43 109.677 175.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 75.3 m -71.33 -50.98 26.9 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.077 0.551 . . . . 72.54 110.749 176.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 pp -67.03 -28.1 67.95 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.854 0.461 . . . . 72.33 111.772 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.15 -20.64 48.65 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.609 -0.551 . . . . 65.33 113.584 -178.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.52 -57.31 1.21 Allowed 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 117.794 0.797 . . . . 64.05 112.689 -170.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -68.94 -39.04 79.8 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 122.907 0.483 . . . . 74.51 111.281 -173.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 91.9 m -68.29 -47.09 38.82 Favored Pre-proline 0 CA--C 1.57 1.723 0 CA-C-O 118.401 -0.809 . . . . 73.42 111.767 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.521 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 86.4 Cg_exo -54.98 -33.31 82.46 Favored 'Trans proline' 0 C--N 1.402 3.355 0 C-N-CA 122.605 2.204 . . . . 75.31 113.685 166.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -65.86 -29.06 69.45 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.967 0.507 . . . . 71.24 111.139 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.1 mm -79.33 -33.66 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.901 0.88 . . . . 65.45 110.689 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 89.7 mt -75.1 -24.13 58.05 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.057 0.543 . . . . 72.32 112.147 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -67.37 -39.29 19.45 Favored Pre-proline 0 CA--C 1.562 1.437 0 CA-C-O 117.742 -1.123 . . . . 73.05 113.751 -172.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -50.48 -44.19 40.9 Favored 'Trans proline' 0 C--N 1.389 2.661 0 C-N-CA 122.182 1.921 . . . . 75.13 113.419 168.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -77.37 -35.49 54.47 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.778 0.831 . . . . 75.12 111.566 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.26 -47.51 67.53 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.546 0.738 . . . . 74.33 109.757 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.479 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 34.8 ttp180 -59.27 -43.67 92.49 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-N 114.643 -1.162 . . . . 74.21 110.254 172.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.13 -50.35 69.48 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 124.022 0.826 . . . . 61.21 111.365 -176.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.457 ' O ' ' HG3' ' D' ' 117' ' ' MET . 42.5 t -56.77 -44.58 81.97 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 124.453 1.096 . . . . 74.42 110.549 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.731 HG12 ' SG ' ' D' ' 76' ' ' CYS . 76.7 mt -62.71 -52.6 57.6 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 C-N-CA 124.159 0.984 . . . . 75.1 110.941 176.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 91.9 m -53.39 -45.58 69.33 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.502 1.521 . . . . 74.51 110.337 -175.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -64.94 -45.82 84.16 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.514 -1.676 . . . . 75.12 110.072 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 71.8 mtm -68.99 -30.13 68.48 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.824 0.449 . . . . 73.53 111.964 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.44 HG23 ' O ' ' D' ' 114' ' ' ILE . 78.6 t -67.07 -46.03 85.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.793 0.837 . . . . 74.41 109.218 176.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 83.4 p -72.61 -28.42 62.76 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 115.737 -0.665 . . . . 75.34 110.682 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 55.0 mtt-85 -74.61 -31.04 61.89 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.68 0.792 . . . . 75.3 110.165 175.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.94 4.41 85.37 Favored Glycine 0 C--N 1.354 1.574 0 O-C-N 123.466 0.479 . . . . 62.01 112.629 177.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.46 HG22 ' HB3' ' C' ' 17' ' ' TYR . 43.5 p 58.9 32.1 21.93 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 126.152 1.781 . . . . 64.52 112.67 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -96.83 150.11 36.52 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 115.392 -0.822 . . . . 73.33 109.786 170.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.525 ' HB3' ' HA ' ' E' ' 129' ' ' THR . 22.5 Cg_exo -43.29 122.82 3.15 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 124.042 3.161 . . . . 73.23 114.121 172.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -52.44 123.18 10.31 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.858 1.263 . . . . 72.54 112.049 -173.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.474 HD11 HG13 ' D' ' 40' ' ' VAL . 28.1 tp -107.63 112.46 25.19 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.299 1.04 . . . . 75.15 109.655 -176.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -116.07 79.63 1.33 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.505 -0.924 . . . . 74.41 108.505 176.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.549 HD11 HD21 ' D' ' 42' ' ' LEU . 0.3 OUTLIER -58.42 119.7 7.44 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 123.153 0.581 . . . . 75.44 109.918 -174.159 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -54.32 130.04 60.93 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 124.233 1.013 . . . . 63.33 112.317 -175.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.464 ' HG3' HH12 ' D' ' 111' ' ' ARG . 1.6 Cg_endo -76.59 118.19 4.79 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.481 2.121 . . . . 74.53 111.134 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 12.8 p -108.47 152.07 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.531 0.733 . . . . 74.05 109.51 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -72.99 102.21 3.42 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.414 -0.587 . . . . 73.3 109.414 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -60.81 -32.55 71.9 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.766 0.826 . . . . 74.35 111.205 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -56.83 -39.48 74.28 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.535 1.134 . . . . 73.43 110.263 176.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.35 -42.65 87.79 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 114.872 -1.058 . . . . 74.43 111.145 176.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 10.6 mp -53.71 -41.54 67.08 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 123.165 0.586 . . . . 75.11 111.979 -177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -69.75 -49.99 47.73 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.929 0.491 . . . . 73.12 111.522 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 16.8 ptp -66.4 -32.1 73.27 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 119.695 -0.193 . . . . 75.15 111.128 -175.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -66.71 -33.58 75.96 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.237 1.015 . . . . 74.22 111.023 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -68.52 -46.16 70.32 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.124 0.57 . . . . 73.11 110.35 175.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.6 mp -73.41 -30.34 63.18 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.173 0.589 . . . . 73.54 112.25 -175.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -89.74 4.5 49.46 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 122.991 0.516 . . . . 71.43 111.849 -175.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -118.61 95.89 5.05 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.772 0.796 . . . . 73.34 110.85 -176.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -138.36 20.18 2.75 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 114.014 -1.448 . . . . 72.13 107.169 172.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.03 -44.47 18.01 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-N 114.623 -1.172 . . . . 64.05 110.619 -176.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 67.72 31.3 75.7 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.938 -0.574 . . . . 74.34 112.389 -177.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -84.91 88.52 7.43 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.791 0.836 . . . . 73.14 109.279 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -160.28 109.78 0.41 Allowed Glycine 0 C--N 1.345 1.042 0 CA-C-N 115.974 -0.557 . . . . 74.13 111.921 -177.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 14.9 t -154.07 135.76 14.41 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.41 0.684 . . . . 75.55 109.642 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -147.04 132.21 18.35 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.993 0.917 . . . . 74.31 109.735 174.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -135.76 143.51 45.3 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.267 1.027 . . . . 71.41 109.015 173.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -162.35 53.46 0.22 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.165 -1.42 . . . . 74.15 107.165 175.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -65.29 128.18 34.77 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 114.913 -1.039 . . . . 71.31 111.772 -173.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -143.8 116.34 8.63 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.567 1.147 . . . . 74.45 108.295 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.013 0 N-CA-C 109.373 -0.603 . . . . 73.45 109.373 177.405 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.673 0 N-CA-C 111.973 -0.451 . . . . 64.23 111.973 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.93 60.24 6.69 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.672 0.278 . . . . 74.23 112.441 -177.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -81.26 74.94 8.24 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.575 0.75 . . . . 70.31 109.74 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 67.06 173.47 0.26 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.937 1.295 . . . . 75.01 112.305 173.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -108.1 -52.41 2.77 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 112.812 0.671 . . . . 75.45 112.812 -166.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 118.14 94.14 1.66 Allowed Glycine 0 C--N 1.342 0.891 0 N-CA-C 111.099 -0.8 . . . . 71.1 111.099 -171.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 97' ' ' ILE . . . . . 0.517 HG13 HD12 ' E' ' 100' ' ' LEU . 26.2 pt -72.88 131.62 34.59 Favored 'Isoleucine or valine' 0 C--N 1.357 0.932 0 N-CA-C 107.8 -1.185 . . . . 75.02 107.8 172.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -105.06 167.92 9.39 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.18 -0.464 . . . . 73.3 110.585 -167.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . 71.07 23.99 4.04 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.3 1.44 . . . . 62.53 111.188 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 100' ' ' LEU . . . . . 0.517 HD12 HG13 ' E' ' 97' ' ' ILE . 69.5 mt -76.11 118.33 70.47 Favored Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 123.291 0.636 . . . . 73.2 110.916 176.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -92.33 0.07 4.05 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.557 2.171 . . . . 73.41 111.36 163.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.23 71.66 0.56 Allowed 'General case' 0 C--N 1.363 1.156 0 C-N-CA 125.381 1.472 . . . . 73.2 108.513 -168.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 103' ' ' THR . . . . . 0.64 ' HB ' ' HA ' ' E' ' 107' ' ' THR . 28.5 m 61.65 -73.18 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.522 1.529 . . . . 65.11 111.211 -170.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . -157.89 51.19 0.41 Allowed Glycine 0 C--N 1.35 1.308 0 N-CA-C 111.984 -0.446 . . . . 74.21 111.984 175.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 69.75 97.13 0.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 125.126 1.37 . . . . 65.21 110.037 -175.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 53.2 t80 61.81 37.94 15.14 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.212 1.005 . . . . 74.31 110.206 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 107' ' ' THR . . . . . 0.64 ' HA ' ' HB ' ' E' ' 103' ' ' THR . 28.3 m 77.73 -55.8 0.51 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.922 1.689 . . . . 74.32 111.773 -177.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 78.68 -59.56 0.41 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 125.814 1.646 . . . . 71.41 112.191 176.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -68.29 127.07 31.62 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.726 0.411 . . . . 73.11 110.269 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.35 137.91 58.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.422 0.689 . . . . 61.04 109.773 173.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . 0.442 HD21 ' HG1' ' D' ' 46' ' ' THR . 47.1 tp -79.57 67.93 5.46 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 121.967 0.889 . . . . 72.34 109.783 -178.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 172.79 -59.68 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 106.018 -1.845 . . . . 75.32 106.018 -174.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 18.1 tptp 65.44 128.72 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 126.294 1.837 . . . . 74.2 111.488 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -72.33 82.63 1.04 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.06 0.544 . . . . 75.15 110.225 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 13.3 t -122.79 -16.87 7.01 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.61 0.764 . . . . 72.41 110.799 -175.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 161.3 -88.32 0.11 Allowed Glycine 0 C--N 1.351 1.373 0 N-CA-C 112.491 -0.244 . . . . 73.13 112.491 175.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 32.9 pttt -156.21 141.81 12.67 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 123.788 0.835 . . . . 71.23 109.634 -175.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -96.75 68.09 0.13 Allowed 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.49 2.793 . . . . 72.35 113.656 -174.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -61.47 -45.45 94.22 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 123.826 0.85 . . . . 71.55 111.229 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -67.33 -26.92 66.74 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 114.89 -1.05 . . . . 74.33 112.017 -176.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 121' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.89 -12.24 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 C-N-CA 123.653 0.781 . . . . 75.02 110.452 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 28.2 p 74.05 -49.0 0.67 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 127.395 2.278 . . . . 50.32 112.691 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 15.9 t70 71.57 -80.41 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.732 1.213 . . . . 74.04 111.064 171.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 15.8 m -92.74 81.48 4.72 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.59 0.756 . . . . 70.42 109.253 177.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -155.0 155.94 35.08 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.896 -0.593 . . . . 74.55 110.516 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 126' ' ' ALA . . . . . 0.586 ' HB1' ' HB ' ' B' ' 13' ' ' ILE . . . 64.38 86.07 0.13 Allowed 'General case' 0 CA--C 1.551 1.014 0 O-C-N 124.809 1.318 . . . . 62.3 112.607 173.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 30.8 t -156.92 162.67 39.64 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.692 0.797 . . . . 55.04 109.881 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -141.58 110.74 6.29 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.898 0.879 . . . . 70.34 109.684 -173.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 129' ' ' THR . . . . . 0.525 ' HA ' ' HB3' ' D' ' 124' ' ' PRO . 3.6 t -96.73 124.89 40.85 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.526 0.731 . . . . 74.1 111.634 -176.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -166.34 117.35 0.99 Allowed 'General case' 0 C--N 1.357 0.928 0 C-N-CA 124.423 1.089 . . . . 74.32 109.454 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 131' ' ' TRP . . . . . 0.401 ' HE1' ' HB ' ' D' ' 122' ' ' THR . 8.8 t90 -152.01 -174.39 4.85 Favored 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 124.075 0.95 . . . . 74.52 109.173 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 23.7 t 83.35 95.0 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.464 1.906 . . . . 72.4 109.743 176.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.48 37.69 0.2 Allowed 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 125.007 1.323 . . . . 64.33 109.636 -176.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.12 90.02 0.5 Allowed Glycine 0 C--N 1.352 1.466 0 CA-C-N 115.56 -0.746 . . . . 72.32 112.195 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 29.9 m -71.1 122.15 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 C-N-CA 123.555 0.742 . . . . 73.12 111.127 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 136' ' ' LYS . . . . . 0.794 ' HA ' ' HG2' ' C' ' 12' ' ' GLN . 35.3 ttpt -145.39 16.8 1.5 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.405 0.621 . . . . 74.31 110.588 177.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 137' ' ' THR . . . . . 0.634 ' HA ' HG13 ' E' ' 144' ' ' VAL . 1.1 p -151.92 107.59 3.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.255 1.022 . . . . 75.24 109.059 174.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -138.24 5.99 2.55 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.918 0.887 . . . . 62.5 110.131 176.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -134.36 126.1 28.94 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.332 -0.988 . . . . 75.42 108.332 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -103.31 28.35 16.05 Favored Glycine 0 C--N 1.345 1.07 0 O-C-N 123.705 0.628 . . . . 73.44 112.904 -176.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.49 -55.74 9.38 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.404 0.682 . . . . 73.04 110.245 176.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 67.7 tp -174.97 -48.86 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.565 1.546 . . . . 74.13 106.91 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -131.92 -171.18 12.76 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 114.441 -1.254 . . . . 54.14 111.329 173.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 144' ' ' VAL . . . . . 0.634 HG13 ' HA ' ' E' ' 137' ' ' THR . 22.3 m -132.2 162.91 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.656 1.183 . . . . 75.05 110.995 -175.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 28.1 t70 . . . . . 0 C--O 1.254 1.34 0 C-N-CA 125.14 1.376 . . . . 75.04 107.527 174.486 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.671 0 N-CA-C 111.899 -0.481 . . . . 72.22 111.899 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . -121.23 114.66 2.64 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 111.851 -0.5 . . . . 65.22 111.851 -173.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -150.21 18.26 0.85 Allowed 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 112.886 0.699 . . . . 74.15 112.886 -174.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -166.45 146.39 5.97 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.517 0.327 . . . . 70.11 110.944 173.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -122.44 145.14 48.57 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.805 0.842 . . . . 74.41 109.094 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . 163.45 -24.33 0.19 Allowed Glycine 0 C--N 1.347 1.193 0 CA-C-O 119.442 -0.643 . . . . 63.32 114.472 173.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 97' ' ' ILE . . . . . 0.676 ' HB ' ' HA ' ' B' ' 87' ' ' ALA . 13.2 tt -109.75 140.96 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-N 117.883 0.841 . . . . 72.3 109.75 -177.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -87.92 118.38 27.42 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.918 -0.401 . . . . 53.42 109.918 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . 58.94 -75.86 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.601 1.56 . . . . 71.41 113.617 172.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 100' ' ' LEU . . . . . 0.674 HD21 HD11 ' F' ' 97' ' ' ILE . 29.6 tp 68.17 83.07 0.18 Allowed Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.49 1.516 . . . . 75.23 110.797 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -88.32 40.2 0.55 Allowed 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 123.619 2.879 . . . . 72.0 112.369 177.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 102' ' ' LEU . . . . . 0.55 HD12 HD13 ' B' ' 98' ' ' LEU . 68.4 tp 65.92 -80.61 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.516 1.127 . . . . 74.02 108.494 -165.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 4.7 p -163.59 -50.56 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.424 2.29 . . . . 73.53 105.0 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 177.24 -157.19 21.82 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 113.629 -1.623 . . . . 64.13 110.134 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -70.96 103.82 2.78 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.2 0.6 . . . . 74.04 110.426 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 42.8 t80 63.28 14.76 8.08 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 125.49 1.516 . . . . 75.33 112.137 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 29.8 m 68.35 119.26 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.42 1.088 . . . . 75.24 110.168 -169.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -70.71 83.76 0.63 Allowed 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.715 0.769 . . . . 74.44 109.1 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 78.9 t80 180.0 -50.32 0.01 OUTLIER 'General case' 0 C--O 1.241 0.61 0 N-CA-C 106.032 -1.84 . . . . 73.13 106.032 -170.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 67.36 120.84 0.03 OUTLIER 'General case' 0 C--N 1.36 1.045 0 O-C-N 125.463 1.727 . . . . 72.05 111.268 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 16.4 tp -85.87 20.72 2.12 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-O 121.664 0.745 . . . . 75.05 110.942 -175.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -92.38 19.85 6.74 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.883 1.273 . . . . 73.41 111.002 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -67.73 102.24 1.18 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.65 0.78 . . . . 71.24 109.42 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . 0.642 ' HA ' HG21 ' F' ' 122' ' ' THR . 37.0 mtmt -141.95 166.85 23.57 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.882 0.873 . . . . 74.51 110.905 -177.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 20.2 m 58.39 72.67 0.51 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.376 1.47 . . . . 73.33 112.684 170.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.93 -25.1 2.24 Favored Glycine 0 C--N 1.354 1.532 0 N-CA-C 115.1 0.8 . . . . 74.53 115.1 170.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -68.07 -46.72 41.47 Favored Pre-proline 0 CA--C 1.562 1.409 0 C-N-CA 123.691 0.796 . . . . 74.01 111.442 -176.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -89.62 -156.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.39 2.724 0 C-N-CA 122.2 1.934 . . . . 74.22 111.372 170.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -151.61 167.63 27.51 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.385 0.674 . . . . 74.02 109.614 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 74.5 t80 74.23 -67.93 0.24 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.5 1.52 . . . . 73.31 112.088 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.8 -40.5 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.727 0.811 . . . . 71.5 111.402 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 122' ' ' THR . . . . . 0.642 HG21 ' HA ' ' F' ' 114' ' ' LYS . 73.2 p -105.75 11.92 31.51 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.558 0.743 . . . . 73.12 111.378 -178.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -116.2 -65.5 1.18 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.426 0.69 . . . . 75.53 109.978 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 30.0 p -92.05 137.96 31.93 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.556 0.743 . . . . 75.51 109.535 178.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -121.48 -85.31 0.66 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.547 0.739 . . . . 63.15 109.935 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -177.23 -172.04 0.37 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.344 1.058 . . . . 73.45 110.006 -174.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 48.8 p -75.14 144.96 42.55 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 109.086 -0.709 . . . . 72.14 109.086 169.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.41 -33.04 73.03 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.851 0.86 . . . . 55.24 112.858 -173.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 129' ' ' THR . . . . . 0.519 HG21 ' H ' ' F' ' 130' ' ' ALA . 1.7 m 59.1 -154.94 0.36 Allowed 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 108.881 -0.785 . . . . 75.45 108.881 -176.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 130' ' ' ALA . . . . . 0.519 ' H ' HG21 ' F' ' 129' ' ' THR . . . -166.35 176.14 7.69 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 119.437 1.017 . . . . 65.23 111.486 176.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 131' ' ' TRP . . . . . 0.472 ' HB2' ' HA ' ' B' ' 124' ' ' PRO . 0.6 OUTLIER -142.26 95.51 2.81 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.155 0.982 . . . . 73.41 109.638 170.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 65.0 m -145.65 -66.25 0.31 Allowed 'General case' 0 C--O 1.239 0.527 0 N-CA-C 106.541 -1.651 . . . . 74.41 106.541 165.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 133' ' ' THR . . . . . 0.605 HG21 ' HG2' ' C' ' 38' ' ' PRO . 62.8 m 62.97 -79.55 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.941 0 O-C-N 124.634 1.209 . . . . 74.13 110.778 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.42 158.09 33.78 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 112.641 -0.184 . . . . 73.42 112.641 177.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 7.5 p -147.24 130.2 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 C-N-CA 123.723 0.809 . . . . 74.31 108.999 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -72.66 -55.85 6.21 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.323 0.649 . . . . 75.11 109.766 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 10.4 t -171.47 -147.87 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 106.7 -1.593 . . . . 72.53 106.7 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -56.96 -42.09 79.52 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 118.979 0.809 . . . . 75.15 110.45 173.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -107.81 148.82 29.01 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.907 0.883 . . . . 75.3 109.9 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -87.7 128.54 9.07 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.227 -0.749 . . . . 74.35 111.227 171.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -91.6 102.81 15.46 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.439 -0.578 . . . . 72.44 109.439 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 71.6 mt -65.82 81.28 0.07 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.967 0.907 . . . . 63.33 110.999 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -132.21 47.05 1.03 Allowed Glycine 0 C--N 1.341 0.828 0 N-CA-C 110.976 -0.85 . . . . 74.24 110.976 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 53.6 t -67.3 93.66 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 124.269 1.028 . . . . 71.14 109.96 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 34.0 t70 . . . . . 0 C--O 1.249 1.057 0 CA-C-N 114.607 -1.179 . . . . 73.14 110.205 -177.233 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptm . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 110.257 -0.275 . . . . 72.53 110.257 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.3 t -170.07 110.33 0.41 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.875 0.87 . . . . 62.13 108.963 177.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -82.26 88.66 6.51 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.597 0.713 . . . . 71.41 110.187 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -75.19 118.46 18.14 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.201 -1.363 . . . . 75.11 109.313 177.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.408 HD21 ' N ' ' A' ' 5' ' ' ASN . 0.8 OUTLIER -76.59 74.38 3.29 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.86 0.864 . . . . 74.31 110.241 -176.889 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -175.58 -160.53 0.08 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.85 1.66 . . . . 71.0 107.95 -174.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.8 p -91.5 2.21 56.59 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 112.707 0.632 . . . . 74.05 112.707 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -76.05 112.61 12.67 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.211 -1.033 . . . . 75.15 108.211 174.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.623 ' HB3' HG23 ' A' ' 89' ' ' ILE . 4.8 ppp? -139.88 179.2 6.74 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.09 -0.959 . . . . 73.14 110.418 -170.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.2 m -136.26 115.26 12.3 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.475 0.71 . . . . 65.33 109.375 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.457 ' HB2' ' HE3' ' A' ' 9' ' ' MET . 62.0 t80 -110.24 121.39 45.16 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.737 -1.209 . . . . 74.01 107.737 173.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -133.92 134.62 42.84 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.148 -0.686 . . . . 74.54 109.148 176.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.402 HG21 HD12 ' A' ' 13' ' ' ILE . 47.8 mt -92.55 114.09 28.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 108.252 -1.018 . . . . 72.34 108.252 175.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -83.95 -35.46 23.98 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 123.399 0.437 . . . . 74.22 110.533 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -175.93 121.73 0.18 Allowed 'General case' 0 C--N 1.351 0.652 0 N-CA-C 109.553 -0.536 . . . . 73.5 109.553 -168.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.532 HD13 ' HG3' ' C' ' 130' ' ' PRO . 78.7 mt -109.42 135.75 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 107.832 -1.173 . . . . 74.34 107.832 171.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -161.83 177.1 10.17 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 124.021 0.826 . . . . 74.41 111.66 -174.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.5 p -102.49 118.64 37.29 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.942 -0.762 . . . . 65.52 108.942 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -75.95 -35.87 59.52 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.229 -0.441 . . . . 74.54 110.002 172.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 18.2 t70 -145.51 144.46 30.56 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.654 -0.703 . . . . 72.12 109.787 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.403 HG22 ' SD ' ' A' ' 117' ' ' MET . 57.4 mt -140.5 141.66 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 107.563 -1.273 . . . . 74.33 107.563 175.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.5 t -154.54 139.85 17.64 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.714 -0.476 . . . . 71.35 109.714 170.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.66 ' HB2' ' HE2' ' A' ' 117' ' ' MET . 80.6 t80 -142.33 116.15 9.26 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.221 -1.4 . . . . 71.13 107.221 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -118.32 134.28 55.18 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.809 0.443 . . . . 71.44 109.991 -176.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.8 74.34 58.3 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 107.651 -1.24 . . . . 71.0 107.651 172.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.07 -27.23 20.59 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.528 2.152 . . . . 73.41 111.964 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -99.2 9.82 42.67 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.067 -0.97 . . . . 74.14 110.587 -177.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.483 ' O ' HG11 ' A' ' 31' ' ' VAL . . . -45.82 -60.32 3.59 Favored Pre-proline 0 C--N 1.371 1.529 0 C-N-CA 124.295 1.038 . . . . 73.23 113.724 -166.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -60.07 -31.31 93.21 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 121.755 1.636 . . . . 74.34 113.027 -171.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.52 -15.73 18.55 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.515 -0.766 . . . . 75.2 112.25 -175.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.627 HG22 ' HA ' ' A' ' 73' ' ' ALA . 4.8 p -77.04 -24.71 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-N 117.945 0.339 . . . . 74.34 110.391 -176.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -69.02 -22.34 64.06 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.92 -0.582 . . . . 75.24 110.583 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -74.68 -21.57 59.33 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.042 0.937 . . . . 74.43 111.437 176.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -81.93 161.42 23.09 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.208 0.603 . . . . 73.24 110.521 -177.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -63.11 117.52 6.62 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.244 0.618 . . . . 73.14 109.389 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.447 ' CE3' HD21 ' A' ' 68' ' ' LEU . 71.7 t-105 -81.32 89.05 6.06 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.629 0.728 . . . . 75.45 110.684 -178.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.46 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -145.85 74.54 13.39 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 125.061 1.344 . . . . 75.3 108.569 172.728 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.0 149.79 17.76 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.924 2.416 . . . . 75.11 113.618 -171.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -97.92 97.79 9.24 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 107.108 -1.441 . . . . 75.32 107.108 167.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.725 HG23 ' HB1' ' A' ' 66' ' ' ALA . 59.4 t -83.03 94.71 3.25 Favored 'Isoleucine or valine' 0 C--N 1.345 0.382 0 CA-C-O 121.699 0.762 . . . . 74.11 109.303 176.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -78.02 117.12 19.03 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.299 -1.773 . . . . 73.41 109.456 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.5 tp -97.79 106.68 19.03 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.842 -0.617 . . . . 70.34 109.542 -175.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.649 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 2.0 m-20 -104.86 145.26 30.64 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.498 1.119 . . . . 72.44 108.51 172.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.7 mt -137.84 148.1 45.12 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.677 0.791 . . . . 73.54 109.626 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -148.55 142.22 25.54 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.507 1.123 . . . . 63.52 108.269 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.7 m -140.81 136.42 32.42 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.198 0.599 . . . . 75.42 110.129 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.99 130.22 9.62 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.687 0.795 . . . . 64.22 109.508 174.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 68.4 p -90.45 -179.52 5.61 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.71 0.804 . . . . 75.21 110.6 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.511 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 39.1 t -159.63 141.04 12.84 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.855 0.862 . . . . 54.21 109.149 -177.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -93.44 107.84 19.62 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.434 -0.95 . . . . 72.45 108.434 171.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' A' ' 57' ' ' GLU . 53.6 mt -84.79 -43.57 14.1 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.004 0.522 . . . . 74.51 109.731 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.07 -173.34 4.53 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.26 -0.882 . . . . 52.41 110.041 -177.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -70.05 118.33 12.75 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.641 0.776 . . . . 72.01 109.295 176.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 64.18 14.26 8.48 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.152 1.381 . . . . 72.23 112.237 -174.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.0 t -117.41 110.26 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 108.664 -0.865 . . . . 74.44 108.664 176.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -121.99 124.66 44.52 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.198 0.999 . . . . 73.15 109.066 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.511 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 30.6 tt0 -86.12 152.85 22.52 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.763 -0.828 . . . . 55.15 108.763 169.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 77.2 t -132.03 138.79 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 N-CA-C 108.232 -1.025 . . . . 75.01 108.232 167.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.428 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 51.1 t -113.93 134.81 55.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.262 -0.644 . . . . 74.44 109.262 174.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.62 105.32 12.93 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.408 -1.331 . . . . 73.53 107.408 168.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 42.0 ttp180 -93.67 101.99 14.15 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.95 -1.13 . . . . 71.03 107.95 177.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.5 t -93.72 132.27 38.34 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 108.174 -1.047 . . . . 74.34 108.174 176.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.649 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 24.2 m -120.27 139.39 52.78 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.563 -0.902 . . . . 75.22 108.563 172.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.671 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.2 t -142.51 109.11 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 124.878 1.271 . . . . 74.33 107.692 -169.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.3 m -115.17 124.18 50.8 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 109.351 -0.611 . . . . 74.55 109.351 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.725 ' HB1' HG23 ' A' ' 40' ' ' VAL . . . -103.38 120.65 41.21 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.478 -1.675 . . . . 64.22 106.478 172.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 59.5 m -129.16 134.74 48.16 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.024 0.44 . . . . 72.24 110.496 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.46 HD23 ' H ' ' A' ' 37' ' ' GLN . 32.9 mt -88.46 64.39 7.47 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.338 -1.356 . . . . 75.34 107.338 174.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.26 -109.11 2.72 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 114.74 -1.118 . . . . 62.12 111.954 -174.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -86.93 -21.45 26.25 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.793 0.837 . . . . 73.42 109.133 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 9.5 tp10 -77.9 133.0 38.18 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.001 0.92 . . . . 74.42 108.857 172.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.4 m -89.03 129.07 35.73 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.799 0.727 . . . . 71.31 109.469 167.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.627 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -78.4 -59.58 2.72 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.019 -0.734 . . . . 72.31 109.019 173.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -159.47 169.63 23.48 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.443 -0.799 . . . . 73.54 110.892 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.417 HD11 ' H ' ' A' ' 76' ' ' CYS . 20.0 tp -132.44 142.17 49.14 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.484 -1.234 . . . . 74.23 107.939 174.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.671 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 64.6 m -137.32 132.96 34.38 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.773 1.229 . . . . 71.22 108.155 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -145.94 119.51 9.12 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.258 -0.645 . . . . 74.52 109.258 173.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.3 t -127.91 110.51 22.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.51 1.124 . . . . 74.24 108.7 -176.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 18.3 mt-30 -85.33 82.58 8.28 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.105 -1.072 . . . . 71.35 108.105 172.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -75.23 92.94 2.77 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.308 -0.86 . . . . 74.51 108.924 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -97.47 146.16 18.14 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 115.407 -0.815 . . . . 50.3 111.19 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.88 133.31 5.64 Favored Glycine 0 CA--C 1.505 -0.584 0 N-CA-C 110.64 -0.984 . . . . 65.54 110.64 -176.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.408 HG23 HD12 ' A' ' 51' ' ' LEU . 43.6 mt -81.59 126.41 39.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 108.43 -0.952 . . . . 75.43 108.43 173.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.589 ' HB3' HD11 ' A' ' 86' ' ' ILE . 84.7 m-85 -130.1 120.87 25.31 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.207 1.003 . . . . 63.14 109.036 -176.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.9 t -89.39 101.54 14.22 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.987 -0.746 . . . . 74.33 108.987 176.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.688 HG22 ' HE3' ' A' ' 94' ' ' MET . 2.2 mm -113.45 137.81 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 122.789 0.436 . . . . 74.32 110.068 -175.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.9 167.24 25.32 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.755 0.822 . . . . 72.03 110.243 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.29 -31.8 8.14 Favored Glycine 0 C--N 1.352 1.426 0 N-CA-C 114.176 0.43 . . . . 74.01 114.176 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.623 HG23 ' HB3' ' A' ' 9' ' ' MET . 0.2 OUTLIER -131.51 163.08 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 123.331 0.652 . . . . 73.41 112.486 -166.477 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.76 175.11 13.67 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 114.454 -1.248 . . . . 75.12 109.105 175.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.02 -132.45 19.29 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 116.168 -0.469 . . . . 65.43 112.781 176.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.0 p -68.59 -30.63 69.42 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.503 0.721 . . . . 51.22 112.526 -177.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -66.38 -42.41 87.99 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 120.861 0.362 . . . . 75.13 110.12 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.688 ' HE3' HG22 ' A' ' 86' ' ' ILE . 6.1 tpt -68.87 -47.8 65.0 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.428 -0.806 . . . . 74.11 110.078 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.47 -41.34 72.82 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.623 0.769 . . . . 71.35 111.048 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -65.93 -37.38 85.89 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.473 -0.785 . . . . 72.42 111.422 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.7 t -66.52 -44.66 81.89 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.744 -0.465 . . . . 64.41 109.744 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.564 HD22 ' HE2' ' A' ' 94' ' ' MET . 70.8 mt -78.04 -29.71 49.51 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.342 -0.844 . . . . 75.53 112.37 -171.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.34 0.22 43.63 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-O 119.592 -0.56 . . . . 62.23 114.488 -172.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.492 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -139.83 -63.41 0.5 Allowed 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 117.726 0.763 . . . . 53.22 111.406 -175.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -68.67 -43.92 75.17 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 116.067 -0.515 . . . . 74.42 111.851 -174.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.454 ' SG ' ' HE1' ' A' ' 11' ' ' PHE . 77.6 m -66.19 -49.6 54.46 Favored Pre-proline 0 CA--C 1.564 1.495 0 C-N-CA 124.218 1.007 . . . . 74.11 112.452 -176.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.39 -22.91 59.16 Favored 'Trans proline' 0 C--N 1.394 2.929 0 C-N-CA 121.751 1.634 . . . . 72.51 112.684 174.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -68.43 -37.17 80.03 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.248 0.619 . . . . 71.12 110.245 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.3 mm -65.46 -40.07 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.649 0.78 . . . . 74.04 110.233 172.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.7 mt -78.3 -19.12 54.25 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.032 0.933 . . . . 72.01 112.526 -174.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -70.63 -41.91 13.31 Favored Pre-proline 0 CA--C 1.559 1.29 0 N-CA-C 114.351 1.241 . . . . 74.24 114.351 -171.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.0 -37.23 78.45 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 121.901 1.734 . . . . 73.04 112.657 172.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -80.44 -36.01 34.18 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.857 0.863 . . . . 70.41 111.611 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.45 -51.2 64.29 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.073 0.549 . . . . 70.13 109.701 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.428 ' NH1' HD13 ' C' ' 105' ' ' ILE . 30.3 ttm180 -47.57 -53.28 14.99 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 124.862 1.351 . . . . 72.2 110.277 173.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -62.01 -45.98 91.23 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 124.433 1.083 . . . . 71.51 111.859 -174.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.609 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.3 t -57.2 -45.91 83.36 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.84 0.713 . . . . 73.12 110.352 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.496 HD12 HG22 ' A' ' 64' ' ' VAL . 56.0 mt -61.8 -52.71 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 115.113 -0.948 . . . . 75.3 110.739 176.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 47.9 m -54.17 -42.33 69.51 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.219 1.008 . . . . 74.35 111.401 -174.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.3 t -69.05 -44.79 71.93 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.736 -1.12 . . . . 74.52 110.355 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.66 ' HE2' ' HB2' ' A' ' 23' ' ' PHE . 8.9 mtp -56.04 -43.58 77.97 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.762 0.825 . . . . 74.31 111.082 176.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.4 t -59.71 -48.96 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.711 1.204 . . . . 74.03 110.465 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.0 p -72.47 -27.41 62.27 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.137 0.575 . . . . 71.33 111.632 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.474 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.3 mtt-85 -72.37 -29.05 63.42 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.46 0.704 . . . . 72.54 109.942 175.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.56 18.05 36.12 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-O 119.165 -0.797 . . . . 74.32 113.32 172.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.423 HG23 ' NE ' ' B' ' 15' ' ' ARG . 1.5 t 60.41 9.82 2.18 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 127.227 2.211 . . . . 73.21 113.76 177.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -80.79 142.66 52.92 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 108.161 -1.051 . . . . 74.35 108.161 172.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.573 ' HB3' ' HA ' ' E' ' 131' ' ' TRP . 11.7 Cg_endo -55.49 147.16 59.54 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.74 2.293 . . . . 72.33 112.768 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -54.28 129.0 33.69 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 124.65 1.219 . . . . 73.25 112.63 -172.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.423 HD23 HG12 ' A' ' 40' ' ' VAL . 31.3 tp -117.42 105.94 12.67 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.032 0.933 . . . . 74.31 109.901 -177.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -99.93 113.02 25.29 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.306 -0.998 . . . . 63.01 108.306 176.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.405 HD12 ' CD1' ' A' ' 114' ' ' ILE . 18.4 mt -67.64 154.48 41.38 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 120.714 0.292 . . . . 74.43 110.984 -175.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.22 136.37 93.77 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 123.535 0.734 . . . . 74.54 111.377 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -62.45 112.1 1.49 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.547 2.165 . . . . 75.14 111.528 173.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 90.7 t -101.88 139.98 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 121.126 0.489 . . . . 74.11 111.17 -173.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.407 ' OD1' ' HB3' ' A' ' 134' ' ' ASP . 46.4 t-20 -90.63 86.68 6.45 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.285 -1.325 . . . . 72.53 109.024 176.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -62.87 -23.99 67.59 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 112.804 0.668 . . . . 75.24 112.804 172.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.492 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 21.8 t70 -65.61 -37.89 87.9 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.028 0.531 . . . . 74.21 109.639 175.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.15 -50.04 51.4 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.822 0.849 . . . . 53.3 110.294 174.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.04 -41.98 75.87 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.416 0.687 . . . . 73.23 111.435 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -71.07 -41.68 70.37 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.767 -0.651 . . . . 75.32 110.094 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -36.25 80.36 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 123.712 0.632 . . . . 73.21 109.856 -175.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 143' ' ' GLN . 81.8 m-20 -56.27 -31.36 63.53 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.397 1.079 . . . . 65.25 111.925 176.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -87.92 -44.5 11.0 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.589 0.755 . . . . 73.43 110.463 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.0 tp -48.83 -40.85 30.92 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.12 1.768 . . . . 74.23 113.271 -168.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -147.49 30.27 0.92 Allowed 'General case' 0 CA--C 1.549 0.907 0 CA-C-O 120.973 0.416 . . . . 71.34 111.219 -169.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.486 ' HB2' ' O ' ' A' ' 139' ' ' ASN . 20.5 tt0 -61.9 -62.04 2.07 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.357 0.598 . . . . 74.02 110.398 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -134.77 15.02 3.64 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.304 1.042 . . . . 72.02 109.504 176.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.59 -167.8 2.43 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.282 1.033 . . . . 71.02 109.5 -171.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 136.82 84.38 0.15 Allowed Glycine 0 C--N 1.343 0.919 0 N-CA-C 110.294 -1.122 . . . . 73.34 110.294 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -74.11 74.99 1.76 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.986 0.915 . . . . 62.34 110.859 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -81.26 57.65 4.87 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.825 -0.625 . . . . 74.11 112.07 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.6 t -120.55 137.92 54.13 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 124.519 1.127 . . . . 74.21 109.669 -174.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -131.61 159.09 39.28 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.586 -0.894 . . . . 73.14 108.586 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -138.55 134.19 33.54 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.259 0.624 . . . . 75.44 109.794 174.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -98.34 -28.1 13.81 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.754 0.821 . . . . 74.15 110.116 177.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -63.92 93.85 0.09 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.34 0.656 . . . . 74.41 110.538 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -76.16 87.92 3.04 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.14 0.976 . . . . 65.51 109.544 178.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 CA-C-N 114.933 -1.031 . . . . 72.11 109.387 -175.735 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 40.0 mtm . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 108.673 -0.862 . . . . 71.22 108.673 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 46.1 p -99.87 -45.8 5.59 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.528 0.731 . . . . 63.5 111.119 -176.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 54.32 48.85 19.81 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.252 1.021 . . . . 74.53 109.982 -176.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.526 ' HG2' ' H ' ' B' ' 5' ' ' ASN . 42.3 tt0 -159.72 -171.12 3.15 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 114.203 -1.362 . . . . 73.44 108.298 -167.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . 0.526 ' H ' ' HG2' ' B' ' 4' ' ' GLN . 1.3 m-20 -61.82 96.52 0.07 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.046 0.938 . . . . 75.12 109.236 174.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -136.87 178.78 6.81 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 108.489 -0.93 . . . . 73.31 108.489 -174.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.421 ' OG1' ' HA ' ' B' ' 89' ' ' ILE . 7.5 t -71.68 92.65 1.19 Allowed 'General case' 0 CA--C 1.553 1.094 0 CA-C-O 122.701 1.239 . . . . 73.01 111.201 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -90.2 -11.1 42.03 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 114.34 -1.3 . . . . 71.41 110.061 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.467 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 18.2 ptm 59.35 171.64 0.07 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 127.315 2.246 . . . . 70.41 114.197 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 54.9 m -135.41 122.71 21.74 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.71 -1.218 . . . . 72.32 107.71 172.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -111.69 142.27 44.23 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.811 -0.811 . . . . 74.22 108.811 -177.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -150.08 120.52 7.4 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.72 0.408 . . . . 73.41 110.092 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.1 mt -77.96 126.83 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.368 -0.975 . . . . 72.53 108.368 171.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -98.27 -40.07 8.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.066 0.546 . . . . 73.13 109.838 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.423 ' NE ' HG23 ' A' ' 122' ' ' THR . 50.8 ttt180 -173.09 134.96 0.57 Allowed 'General case' 0 C--N 1.353 0.745 0 O-C-N 123.554 0.534 . . . . 72.42 109.686 -173.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.2 mt -122.06 143.79 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 107.119 -1.437 . . . . 75.24 107.119 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -169.25 153.48 5.41 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.599 0.592 . . . . 75.54 112.599 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.584 HG23 HD11 ' B' ' 21' ' ' ILE . 30.6 m -82.05 118.58 23.13 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.03 -0.986 . . . . 74.02 109.778 176.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.407 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 44.4 mtpt -95.81 -18.01 20.72 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.437 0.695 . . . . 75.13 111.521 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.522 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 28.8 t70 -155.09 140.04 17.31 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.47 0.481 . . . . 72.44 110.916 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.584 HD11 HG23 ' B' ' 18' ' ' THR . 32.3 mm -129.25 144.38 38.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 N-CA-C 107.763 -1.199 . . . . 75.4 107.763 172.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 46.6 t -147.82 132.76 18.12 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.381 -1.282 . . . . 74.52 108.296 169.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.3 t80 -145.29 118.02 8.67 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 107.189 -1.411 . . . . 73.54 107.189 168.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -119.84 133.68 55.5 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.664 -0.865 . . . . 63.11 108.664 173.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.485 ' CB ' ' HB1' ' B' ' 28' ' ' ALA . . . -117.32 82.15 14.42 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 106.51 -1.663 . . . . 70.45 106.51 166.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.2 -24.96 27.06 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.885 2.39 . . . . 75.34 111.96 -171.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -114.41 9.67 16.87 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.908 0.883 . . . . 63.43 110.751 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.523 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -30.8 -64.99 0.2 Allowed Pre-proline 0 N--CA 1.494 1.736 0 C-N-CA 125.992 1.717 . . . . 70.24 114.812 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 14.6 Cg_exo -64.09 -36.72 46.46 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 122.398 2.065 . . . . 73.53 112.338 -166.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.45 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 77.5 m80 -95.98 -18.63 20.11 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.006 -0.997 . . . . 74.2 112.321 -173.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 3.6 p -83.17 -10.33 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 117.991 0.36 . . . . 74.54 110.654 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -76.06 -3.49 36.19 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 112.843 0.683 . . . . 75.33 112.843 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.8 pt20 -78.98 -5.01 52.79 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.8 0.44 . . . . 75.32 110.223 169.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.481 ' HZ1' ' HG2' ' B' ' 71' ' ' GLU . 89.8 mttt -107.22 87.57 2.54 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.832 1.253 . . . . 72.43 110.395 -177.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -93.37 87.57 5.66 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.135 -0.939 . . . . 71.23 110.318 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 18.6 p90 -162.97 -171.24 2.6 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.416 0.686 . . . . 72.54 110.04 172.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.466 ' H ' ' NE2' ' B' ' 37' ' ' GLN . 0.0 OUTLIER -79.1 111.82 23.09 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 124.367 1.067 . . . . 71.23 110.295 178.47 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.84 141.03 36.36 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 121.879 1.719 . . . . 75.21 111.522 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.64 108.07 2.76 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 109.626 -0.509 . . . . 64.43 109.626 176.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.724 HG21 ' HB1' ' B' ' 66' ' ' ALA . 88.0 t -99.21 149.29 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 115.045 -0.979 . . . . 72.02 110.554 -175.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -135.46 129.67 33.54 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.354 1.462 . . . . 71.45 107.541 172.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.491 HD12 HD21 ' B' ' 128' ' ' LEU . 20.5 tp -97.04 140.82 30.99 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.449 -0.945 . . . . 74.04 108.449 170.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.624 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 7.2 t70 -137.93 141.0 40.6 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.222 -1.399 . . . . 73.12 107.222 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 49.3 mt -137.61 126.71 24.39 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.42 -0.585 . . . . 75.32 109.42 -170.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -124.57 139.95 53.4 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.023 1.329 . . . . 72.11 108.753 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.12 105.61 11.17 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 109.084 -0.71 . . . . 63.13 109.084 -172.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.76 152.01 50.7 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.034 0.933 . . . . 53.5 109.208 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 29.5 p -149.72 -169.54 3.4 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.932 -0.48 . . . . 73.42 110.94 -175.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 50.9 p -155.23 136.16 13.7 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.884 0.874 . . . . 74.24 109.183 170.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . 0.4 ' HB2' ' HE2' ' B' ' 56' ' ' TYR . 43.4 tt0 -91.26 112.24 24.07 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.566 -1.272 . . . . 74.44 107.566 168.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 pp -131.17 17.23 5.02 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.119 0.567 . . . . 74.11 110.474 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.26 152.15 21.93 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.691 -0.686 . . . . 71.54 110.568 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -72.38 117.35 13.93 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.242 -0.89 . . . . 73.32 109.168 172.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 65.65 13.79 9.13 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.075 0.95 . . . . 72.22 112.979 172.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.5 t -137.3 123.52 27.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.794 -1.558 . . . . 73.43 106.794 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.539 ' HB2' HD13 ' B' ' 86' ' ' ILE . 16.2 t80 -124.4 140.34 53.04 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.473 -0.566 . . . . 75.2 109.473 -167.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -108.96 106.13 15.96 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 107.843 -1.169 . . . . 73.14 107.843 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 94.5 t -100.78 138.28 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.652 0.781 . . . . 75.03 109.703 -176.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 24.1 t -122.79 110.77 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.029 0.932 . . . . 73.32 109.255 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -95.19 112.29 24.02 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.997 -1.112 . . . . 74.13 107.997 174.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -85.18 118.79 24.95 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 108.487 -0.931 . . . . 74.53 108.487 174.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 23.0 t -105.63 131.87 53.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 107.848 -1.167 . . . . 65.51 107.848 171.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.624 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 19.9 m -121.18 139.13 53.78 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.924 -1.139 . . . . 74.21 107.924 173.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.55 HG11 HD23 ' B' ' 126' ' ' LEU . 80.8 t -130.12 130.91 66.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.242 0.544 . . . . 64.45 109.707 175.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.4 m -106.57 144.57 33.05 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.727 -1.124 . . . . 75.42 108.871 168.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.724 ' HB1' HG21 ' B' ' 40' ' ' VAL . . . -148.97 136.47 20.31 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.895 -1.15 . . . . 72.35 107.895 171.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 15.6 m -137.65 128.07 26.46 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.585 0.553 . . . . 71.23 111.436 -173.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.414 ' HG ' ' HB3' ' B' ' 73' ' ' ALA . 44.8 mt -94.56 105.2 17.15 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.569 -0.9 . . . . 73.44 108.569 176.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.62 -120.42 5.13 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.881 -0.599 . . . . 61.32 111.873 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.42 10.75 25.32 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.506 0.722 . . . . 74.0 110.972 -178.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.481 ' HG2' ' HZ1' ' B' ' 34' ' ' LYS . 12.1 pt-20 -129.25 156.01 44.66 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.382 0.673 . . . . 73.44 109.734 -177.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 32.3 m -65.18 136.25 56.44 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 123.544 0.528 . . . . 71.11 110.433 176.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.414 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . . . -89.27 -60.72 1.87 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 107.397 -1.335 . . . . 71.32 107.397 172.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -155.39 163.51 39.98 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 114.169 -1.378 . . . . 74.22 110.891 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 93.1 mt -136.42 113.54 10.57 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.156 1.383 . . . . 73.21 107.696 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.543 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 39.2 t -121.73 117.26 26.18 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.758 -0.46 . . . . 73.31 109.758 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.466 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 37.9 tt0 -124.54 123.21 39.6 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.6 1.16 . . . . 70.04 108.993 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 96.8 t -128.84 130.42 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.583 0.753 . . . . 75.11 110.272 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.522 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 26.3 mt-30 -100.01 119.84 38.89 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.135 -1.061 . . . . 64.11 108.135 171.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.505 ' HB2' ' HB1' ' B' ' 110' ' ' ALA . 7.9 tp-100 -108.9 109.05 20.05 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.224 -1.028 . . . . 73.23 108.224 176.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.407 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -104.84 170.24 17.77 Favored Glycine 0 C--N 1.335 0.5 0 O-C-N 123.883 0.739 . . . . 73.3 112.115 177.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.22 144.63 7.64 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.201 -0.523 . . . . 75.33 113.321 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 3.2 mp -85.64 117.41 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 107.607 -1.257 . . . . 74.24 107.607 172.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -121.93 134.59 54.84 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.836 0.854 . . . . 73.12 109.152 176.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 49.1 m -88.87 113.51 24.49 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.473 -0.936 . . . . 74.23 108.473 174.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.539 HD13 ' HB2' ' B' ' 56' ' ' TYR . 1.0 OUTLIER -121.99 105.1 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.096 0.958 . . . . 75.41 108.536 -174.676 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.535 ' HA ' ' HB ' ' F' ' 97' ' ' ILE . . . -151.22 170.42 19.52 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.041 0.448 . . . . 63.44 110.338 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 97.83 -57.5 1.1 Allowed Glycine 0 C--N 1.339 0.725 0 N-CA-C 110.069 -1.212 . . . . 75.22 110.069 -170.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.498 HD12 ' HB2' ' B' ' 94' ' ' MET . 1.0 OUTLIER -67.18 156.53 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 124.019 0.928 . . . . 73.41 111.845 175.425 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -155.5 147.14 23.05 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.765 0.826 . . . . 74.14 109.368 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.95 -123.91 7.94 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 123.328 0.392 . . . . 72.24 113.323 174.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.0 m -84.08 -44.71 13.79 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.801 0.81 . . . . 73.54 110.217 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -64.96 -19.92 66.21 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 113.877 -1.511 . . . . 74.45 111.8 -169.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.498 ' HB2' HD12 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -74.73 -41.9 59.28 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.557 0.743 . . . . 74.54 111.422 -178.559 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.81 -15.19 59.26 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.448 0.699 . . . . 64.21 111.4 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -66.02 -37.81 86.82 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.725 0.81 . . . . 72.31 110.149 170.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 37.2 t -64.75 -62.87 1.31 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.435 0.636 . . . . 74.24 110.81 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.608 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.4 pp -70.09 -20.74 63.19 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 116.065 -0.516 . . . . 73.23 112.298 -176.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.15 -2.08 64.45 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-O 119.435 -0.647 . . . . 72.25 114.43 -177.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.532 ' HB1' ' HB2' ' B' ' 134' ' ' ASP . . . -148.88 -49.57 0.15 Allowed 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 117.714 0.757 . . . . 75.54 111.611 -175.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.538 ' HH ' ' HB2' ' D' ' 130' ' ' PRO . 46.7 t80 -71.81 -44.97 63.03 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.666 0.786 . . . . 74.22 111.087 -177.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.608 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 80.7 m -66.01 -47.81 62.16 Favored Pre-proline 0 CA--C 1.562 1.404 0 CA-C-O 118.734 -0.65 . . . . 75.21 111.818 178.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -51.01 -37.63 57.32 Favored 'Trans proline' 0 C--N 1.388 2.652 0 C-N-CA 122.796 2.33 . . . . 65.35 113.866 169.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.55 -32.28 73.69 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.58 0.752 . . . . 74.2 111.406 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.0 mt -74.53 -37.69 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.631 0.772 . . . . 72.22 110.403 176.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 80.4 mt -75.45 -29.65 59.73 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.808 0.843 . . . . 73.15 111.961 -176.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -57.64 -47.99 98.0 Favored Pre-proline 0 CA--C 1.561 1.385 0 CA-C-O 117.777 -1.106 . . . . 74.35 113.201 -174.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -47.13 -45.87 20.56 Favored 'Trans proline' 0 C--N 1.387 2.599 0 C-N-CA 122.976 2.451 . . . . 74.21 114.664 174.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -72.36 -41.91 65.88 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.079 0.552 . . . . 73.42 111.032 -175.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.505 ' HB1' ' HB2' ' B' ' 80' ' ' GLN . . . -64.61 -40.68 95.93 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 122.599 0.36 . . . . 73.25 110.503 176.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 53.2 ttt-85 -60.16 -50.54 73.26 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.351 1.461 . . . . 72.33 110.734 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -68.38 -32.53 72.68 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.629 0.772 . . . . 74.15 109.98 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.502 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.6 t -69.96 -41.15 74.89 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.961 0.504 . . . . 63.12 110.577 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.543 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 73.6 mt -57.77 -53.77 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.391 1.077 . . . . 72.5 110.132 172.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.429 HG22 ' OG ' ' C' ' 119' ' ' SER . 17.7 m -60.78 -30.42 70.03 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.166 0.586 . . . . 73.14 111.138 -177.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.0 t -63.37 -50.48 69.74 Favored 'General case' 0 C--N 1.348 0.537 0 C-N-CA 123.041 0.536 . . . . 74.14 109.559 173.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.7 mmt -65.51 -32.66 74.38 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.439 0.696 . . . . 73.41 111.459 -176.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.426 HG23 ' O ' ' B' ' 114' ' ' ILE . 97.5 t -68.8 -42.69 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.733 0.813 . . . . 72.24 110.345 174.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.3 t -62.91 -35.1 78.95 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.326 -0.852 . . . . 52.1 110.838 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.609 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 77.0 mtt-85 -70.18 -38.53 75.4 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 114.679 -1.146 . . . . 74.35 110.096 177.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.39 -7.73 68.98 Favored Glycine 0 C--N 1.352 1.429 0 O-C-N 123.845 0.715 . . . . 71.24 112.839 173.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 16.8 m 66.94 24.92 9.51 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 125.118 1.367 . . . . 70.34 110.329 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -85.07 163.23 46.62 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 123.861 0.864 . . . . 71.42 111.145 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.21 166.76 1.5 Allowed 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 123.339 2.693 . . . . 73.32 114.524 175.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -65.05 114.64 4.74 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.329 1.051 . . . . 75.54 111.353 -172.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.55 HD23 HG11 ' B' ' 64' ' ' VAL . 26.4 tp -112.4 107.1 15.78 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.032 -0.729 . . . . 72.24 109.032 174.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -121.55 127.11 50.62 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.133 -1.062 . . . . 63.53 108.133 171.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.491 HD21 HD12 ' B' ' 42' ' ' LEU . 84.0 mt -77.56 138.58 39.25 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 123.427 0.454 . . . . 72.35 110.267 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.05 147.26 98.91 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.714 0.805 . . . . 63.02 111.066 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.27 81.01 0.29 Allowed 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.261 2.64 . . . . 72.11 111.678 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 4.1 p -96.51 112.24 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 115.259 -0.882 . . . . 74.43 109.545 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -78.85 114.65 17.96 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.302 -0.999 . . . . 73.53 108.302 172.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -56.88 -38.27 72.53 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.121 0.968 . . . . 75.33 110.775 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.532 ' HB2' ' HB1' ' B' ' 100' ' ' ALA . 27.7 t70 -65.92 -36.2 82.71 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 114.481 -1.236 . . . . 71.45 111.187 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.23 -37.76 86.64 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.986 0.514 . . . . 75.44 111.038 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.6 mp -69.58 -35.31 75.24 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.615 0.766 . . . . 74.33 110.047 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -69.03 -34.08 74.65 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.962 -0.563 . . . . 75.11 110.643 173.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.481 ' HE1' ' HG2' ' B' ' 143' ' ' GLN . 91.5 mtp -72.92 -20.32 61.09 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.265 1.026 . . . . 74.23 111.472 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.403 ' HB3' HG21 ' B' ' 149' ' ' THR . 1.0 OUTLIER -72.47 -39.82 67.42 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.592 -0.522 . . . . 72.31 109.592 176.229 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -77.8 -35.49 51.35 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 120.949 0.404 . . . . 74.32 110.07 175.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 28.9 tp -76.75 -7.31 55.15 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.547 0.739 . . . . 72.35 110.88 -175.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 69.22 -71.19 0.12 Allowed 'General case' 0 C--N 1.363 1.167 0 C-N-CA 125.743 1.617 . . . . 71.14 110.039 -176.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . 0.481 ' HG2' ' HE1' ' B' ' 138' ' ' MET . 57.6 tp60 70.54 -66.19 0.3 Allowed 'General case' 0 C--N 1.361 1.067 0 C-N-CA 125.907 1.683 . . . . 72.4 111.178 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -68.69 150.71 47.61 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.489 0.715 . . . . 74.23 110.238 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.62 98.6 0.05 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.05 0.94 . . . . 72.12 109.606 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 140.43 -134.93 6.74 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 110.286 -1.126 . . . . 74.23 110.286 -173.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -171.3 -63.41 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.681 0.792 . . . . 63.54 109.3 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 82.49 -62.44 4.59 Favored Glycine 0 C--N 1.35 1.33 0 CA-C-N 115.698 -0.683 . . . . 54.11 112.964 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 149' ' ' THR . . . . . 0.403 HG21 ' HB3' ' B' ' 139' ' ' ASN . 65.8 p -74.05 134.94 43.01 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.893 0.877 . . . . 73.34 110.871 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.2 146.27 28.62 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.053 -1.091 . . . . 74.35 108.053 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 60.79 20.67 10.78 Favored 'General case' 0 CA--C 1.575 1.905 0 C-N-CA 124.203 1.001 . . . . 73.54 111.85 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -148.34 53.95 1.02 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.246 1.418 . . . . 75.22 107.356 174.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -73.3 -76.51 0.12 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.184 -1.371 . . . . 74.23 110.352 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . 0.469 ' HA ' ' HB1' ' F' ' 110' ' ' ALA . 4.4 p30 -148.29 170.48 17.81 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.424 0.69 . . . . 75.01 110.303 -173.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.3 0 C-N-CA 124.038 0.935 . . . . 65.24 109.522 -179.445 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 87.7 mmm . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 110.07 -0.345 . . . . 73.31 110.07 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 73.0 p -76.87 90.48 3.5 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.556 0.693 . . . . 64.3 109.677 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -89.96 113.0 24.58 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.868 -1.06 . . . . 73.41 111.775 -172.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -136.09 155.61 49.94 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.715 1.206 . . . . 74.51 108.267 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . 0.558 ' HB3' ' HG2' ' C' ' 8' ' ' GLU . 33.8 t-20 -89.19 -81.23 0.28 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.594 -0.891 . . . . 75.14 108.594 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 154.32 -52.03 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 127.328 2.251 . . . . 74.52 106.864 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 80.9 p -124.54 56.34 1.29 Allowed 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.292 -0.867 . . . . 71.32 110.767 -175.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.6 ' HG3' ' H ' ' C' ' 155' ' ' ALA . 7.7 mm-40 -64.48 -33.67 76.43 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.109 0.481 . . . . 73.11 110.978 173.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.429 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 16.6 ttt 65.34 113.7 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.165 1.786 . . . . 72.11 111.601 -174.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 99.3 m -123.43 106.75 10.9 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 124.158 0.983 . . . . 74.32 108.594 176.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -105.48 128.59 53.64 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.396 -0.964 . . . . 73.34 108.396 174.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -141.71 122.51 14.39 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.015 0.526 . . . . 75.45 109.675 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 55.5 mt -71.88 120.49 20.28 Favored 'Isoleucine or valine' 0 C--N 1.35 0.624 0 N-CA-C 108.586 -0.894 . . . . 74.4 108.586 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -84.72 -45.28 12.58 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.545 -0.909 . . . . 73.22 108.545 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 178.15 165.71 0.74 Allowed 'General case' 0 C--N 1.353 0.724 0 CA-C-N 114.34 -1.3 . . . . 75.35 109.848 -176.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.5 ' HA ' ' HA2' ' C' ' 82' ' ' GLY . 2.8 pp -130.53 150.13 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 106.476 -1.676 . . . . 75.23 106.476 168.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.47 ' HB3' HG22 ' D' ' 122' ' ' THR . 19.2 p90 -178.35 141.38 0.23 Allowed 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 118.852 0.751 . . . . 72.24 110.777 -176.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 69.6 p -72.44 119.83 17.2 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.976 0.91 . . . . 72.14 110.116 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -73.16 -44.07 60.56 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.211 -1.033 . . . . 73.44 108.211 169.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 26.9 t70 -134.49 141.89 46.88 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 113.577 -1.647 . . . . 70.41 109.772 -169.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.564 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.6 mt -144.77 143.8 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 106.92 -1.511 . . . . 73.41 106.92 176.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.3 t -156.38 150.92 25.69 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.161 0.505 . . . . 71.01 110.306 176.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -152.83 123.43 7.28 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 107.065 -1.458 . . . . 74.54 107.065 172.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.0 113.46 14.0 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.245 0.618 . . . . 75.23 109.765 -174.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.11 82.7 67.95 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 107.666 -1.235 . . . . 70.43 107.666 167.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.2 -24.82 31.81 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.783 2.322 . . . . 61.34 112.04 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -106.9 26.03 10.58 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.132 1.373 . . . . 62.31 110.315 178.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.66 -52.25 18.71 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 113.915 1.08 . . . . 60.14 113.915 -174.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.97 -42.64 29.25 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 121.75 1.633 . . . . 74.05 112.251 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -68.32 -33.89 75.13 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.611 -1.177 . . . . 75.23 111.897 -175.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.698 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.1 p -80.23 -25.27 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 N-CA-C 112.757 0.651 . . . . 73.11 112.757 177.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -69.48 -28.98 66.54 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.55 -0.719 . . . . 70.22 112.184 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -89.4 35.04 0.81 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.378 0.671 . . . . 65.4 110.346 176.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.414 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.5 OUTLIER -125.69 165.34 18.76 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.77 0.828 . . . . 74.13 110.856 -174.439 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -78.39 124.19 27.84 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 115.459 -0.791 . . . . 74.1 109.709 169.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -85.38 96.06 9.44 Favored 'General case' 0 C--O 1.242 0.674 0 O-C-N 123.514 0.509 . . . . 74.31 110.18 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -150.38 76.77 8.34 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 107.106 -1.442 . . . . 74.35 107.106 169.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -90.95 164.95 3.89 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.733 2.289 . . . . 70.52 113.025 -175.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -88.6 82.51 6.88 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.147 -1.427 . . . . 72.54 107.147 170.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 56.5 t -73.93 114.96 14.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 114.809 -1.087 . . . . 75.23 109.344 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -135.53 125.24 25.37 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.274 -0.875 . . . . 75.43 109.427 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.426 HD23 HD22 ' C' ' 128' ' ' LEU . 3.8 pp -89.3 159.59 17.31 Favored 'General case' 0 C--O 1.246 0.913 0 N-CA-C 108.71 -0.848 . . . . 73.45 108.71 165.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.521 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 17.5 t70 -134.33 134.21 41.55 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.636 -1.246 . . . . 75.22 107.636 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.438 HD13 HG23 ' C' ' 131' ' ' VAL . 78.6 mt -123.54 110.98 15.72 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.602 0.715 . . . . 74.33 110.341 -176.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -120.76 129.73 53.73 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 106.543 -1.651 . . . . 72.42 106.543 173.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.8 t -129.95 150.67 51.13 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.624 -0.509 . . . . 73.43 109.624 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.24 149.78 29.81 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.342 0.657 . . . . 74.12 110.274 -177.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 32.9 p -125.59 150.3 47.63 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.697 0.799 . . . . 73.21 109.744 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 36.1 t -145.44 126.6 14.72 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.84 -1.17 . . . . 72.34 107.84 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -81.89 117.32 22.05 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.94 -0.763 . . . . 74.24 108.94 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.542 HD12 ' HB2' ' C' ' 57' ' ' GLU . 51.0 mt -86.23 -43.15 13.2 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.862 0.865 . . . . 73.01 110.081 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.47 -177.31 5.7 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 114.501 -1.227 . . . . 74.54 108.777 176.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -66.76 116.94 8.2 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.242 -0.651 . . . . 72.02 109.242 -177.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 68.62 21.84 7.8 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.824 1.25 . . . . 74.2 112.887 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.3 t -126.81 110.76 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 108.873 -0.788 . . . . 75.23 108.873 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -117.99 125.37 50.26 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.853 0.861 . . . . 75.13 110.583 -174.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.542 ' HB2' HD12 ' C' ' 51' ' ' LEU . 28.4 tt0 -83.11 109.99 17.63 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.238 1.015 . . . . 74.04 108.543 168.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 77.5 t -99.18 139.04 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.341 -0.985 . . . . 75.12 108.341 169.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.0 t -134.1 132.83 56.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 108.779 -0.822 . . . . 75.34 108.779 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -112.63 105.06 13.15 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.628 -1.249 . . . . 75.44 107.628 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 30.4 ttm-85 -81.13 111.23 17.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.766 0.826 . . . . 71.44 109.216 171.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 24.6 t -111.28 113.54 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 108.12 -1.067 . . . . 72.11 108.12 173.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 22.0 m -116.21 123.25 47.3 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.925 0.89 . . . . 73.53 109.603 -174.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.502 HG21 HG21 ' C' ' 114' ' ' ILE . 71.6 t -100.99 120.12 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 122.965 0.506 . . . . 65.41 109.786 177.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 3.8 m -107.29 110.03 21.95 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.174 -1.047 . . . . 72.41 108.174 172.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.37 115.86 28.76 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.337 -0.986 . . . . 70.12 108.337 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -138.38 127.51 24.22 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.008 0.523 . . . . 72.42 110.097 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.414 HD11 ' HG2' ' C' ' 34' ' ' LYS . 16.9 mt -83.07 32.52 0.44 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.586 1.554 . . . . 73.33 111.276 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.68 -109.22 2.79 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 110.454 -1.058 . . . . 64.22 110.454 -171.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -89.94 -19.74 24.16 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.611 0.764 . . . . 73.2 110.366 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -87.43 121.12 29.45 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.51 1.124 . . . . 72.34 108.765 174.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 88.7 m -75.48 131.3 40.03 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.856 -0.794 . . . . 74.23 108.856 168.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.698 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.43 -61.1 2.02 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.05 -0.722 . . . . 74.41 109.05 171.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -162.57 155.14 19.27 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.365 -0.834 . . . . 74.54 109.918 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -114.38 135.81 53.68 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.979 -1.489 . . . . 74.44 106.979 167.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 49.8 t -142.13 148.03 37.65 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.321 -0.992 . . . . 70.21 108.321 -175.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -154.99 131.11 10.24 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.166 0.586 . . . . 74.2 109.703 177.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 68.8 t -125.23 132.03 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 108.273 -1.01 . . . . 74.11 108.273 167.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -107.83 90.81 3.41 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.96 -1.126 . . . . 72.33 107.96 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -78.4 108.6 11.87 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 114.876 -1.056 . . . . 74.44 109.072 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.71 171.87 54.14 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 111.778 -0.529 . . . . 70.01 111.778 173.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' C' ' 16' ' ' ILE . . . 179.18 116.28 0.5 Allowed Glycine 0 CA--C 1.508 -0.403 0 N-CA-C 110.055 -1.218 . . . . 72.23 110.055 -178.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.428 HG12 ' HA ' ' C' ' 57' ' ' GLU . 66.9 mt -105.93 136.29 40.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 123.607 0.763 . . . . 74.43 109.234 -173.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -137.34 126.58 24.66 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.426 1.09 . . . . 75.55 109.274 -171.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 70.8 m -78.52 101.25 7.27 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.362 -0.977 . . . . 72.21 108.362 168.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.53 HG21 ' HE2' ' C' ' 94' ' ' MET . 21.2 mt -116.21 126.84 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.183 -0.673 . . . . 73.54 109.183 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -135.92 168.33 19.54 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 122.937 0.495 . . . . 75.01 110.649 -177.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.84 -49.96 3.67 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.868 0.73 . . . . 71.33 112.479 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.418 HD12 ' HE1' ' C' ' 9' ' ' MET . 26.5 pt -82.19 161.19 3.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 123.296 0.639 . . . . 71.41 111.671 -175.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -156.63 156.13 32.98 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.477 -0.783 . . . . 74.12 110.113 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.5 -113.6 5.99 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 124.069 0.856 . . . . 62.52 113.744 171.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 9.6 t -64.85 -36.18 83.51 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.828 0.851 . . . . 73.43 111.65 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -68.3 -44.06 76.28 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.585 0.754 . . . . 73.21 109.722 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.53 ' HE2' HG21 ' C' ' 86' ' ' ILE . 5.9 tpt -64.42 -47.26 79.82 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.777 -1.101 . . . . 73.05 110.372 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.84 -39.51 81.48 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.029 0.932 . . . . 71.32 111.034 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -65.35 -32.39 74.01 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.244 -0.889 . . . . 71.04 111.602 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.413 ' SG ' HD12 ' C' ' 86' ' ' ILE . 22.1 t -75.49 -45.32 39.08 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 109.644 -0.502 . . . . 53.32 109.644 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 61.4 mt -74.21 -32.7 63.14 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.21 1.004 . . . . 72.14 112.786 -172.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.71 11.77 30.06 Favored Glycine 0 N--CA 1.473 1.104 0 CA-C-O 119.646 -0.53 . . . . 62.54 114.361 -170.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.411 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -153.26 -56.91 0.12 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 117.677 0.739 . . . . 73.41 111.967 -176.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -70.61 -48.33 55.64 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.037 0.535 . . . . 72.32 111.426 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 70.7 m -69.77 -47.4 24.15 Favored Pre-proline 0 CA--C 1.563 1.472 0 C-N-CA 123.958 0.903 . . . . 72.34 111.92 -176.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.481 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 77.8 Cg_exo -56.67 -26.29 64.54 Favored 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.407 2.072 . . . . 74.25 113.924 172.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -66.99 -37.96 85.15 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.981 0.513 . . . . 74.44 110.606 175.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.428 HD13 ' NH1' ' A' ' 111' ' ' ARG . 44.5 mm -73.85 -35.81 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.189 0.596 . . . . 71.15 109.928 177.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.23 -28.6 47.93 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.132 0.973 . . . . 74.45 112.744 -176.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -57.29 -51.39 82.07 Favored Pre-proline 0 N--CA 1.486 1.331 0 N-CA-C 113.951 1.093 . . . . 73.33 113.951 -172.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -58.51 -36.75 97.01 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 121.722 1.614 . . . . 74.33 113.239 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -67.97 -46.58 70.98 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.265 0.626 . . . . 75.43 110.918 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.66 -36.86 79.75 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.233 1.013 . . . . 72.42 110.78 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . 0.5 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 38.9 ttt-85 -62.61 -55.52 26.34 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.294 1.438 . . . . 63.54 110.408 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -64.69 -35.77 82.12 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 123.853 0.72 . . . . 73.35 110.203 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 14.0 t -66.22 -33.79 76.54 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.055 0.542 . . . . 73.5 111.313 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.502 HG21 HG21 ' C' ' 64' ' ' VAL . 96.0 mt -72.07 -52.21 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 122.833 0.453 . . . . 71.52 109.806 172.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -61.65 -28.97 69.76 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.141 0.576 . . . . 72.15 111.634 -173.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 25.9 t -66.13 -47.08 75.28 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.782 0.833 . . . . 75.3 108.967 173.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.598 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.3 -40.99 92.51 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.473 1.109 . . . . 74.43 111.757 176.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.428 HG21 ' O ' ' C' ' 114' ' ' ILE . 64.1 t -61.18 -44.6 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.655 0.782 . . . . 64.33 109.33 176.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.429 ' OG ' HG22 ' B' ' 115' ' ' THR . 30.1 t -66.69 -34.59 78.19 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 114.989 -1.005 . . . . 75.12 112.037 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.441 ' NH1' ' HA ' ' D' ' 113' ' ' CYS . 68.3 mtt-85 -69.81 -39.4 76.54 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.329 0.652 . . . . 74.02 109.585 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.28 6.48 71.89 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 123.853 0.721 . . . . 75.22 112.696 173.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.9 p 58.42 31.79 21.35 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.394 1.878 . . . . 74.33 113.204 171.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -87.2 150.64 49.93 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 108.678 -0.86 . . . . 73.51 108.678 168.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -44.41 147.05 1.73 Allowed 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 124.575 3.517 . . . . 73.24 115.73 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -51.83 117.18 2.54 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.356 1.062 . . . . 74.23 112.008 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 52.6 tp -107.71 90.57 3.34 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.607 0.718 . . . . 75.21 109.401 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -96.91 95.35 7.78 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.403 -0.817 . . . . 72.43 109.254 -175.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.5 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 90.6 mt -62.32 146.91 49.83 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.524 0.73 . . . . 73.23 112.096 -174.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.56 147.93 64.65 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 123.819 0.848 . . . . 71.41 110.791 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.532 ' HG3' HD13 ' A' ' 16' ' ' ILE . 43.9 Cg_exo -57.63 116.1 2.99 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 123.218 2.612 . . . . 72.44 112.279 175.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.438 HG23 HD13 ' C' ' 44' ' ' LEU . 60.5 t -100.02 132.93 44.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 110.243 -0.28 . . . . 73.42 110.243 176.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -94.99 92.32 6.81 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.888 0.875 . . . . 72.52 108.953 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -66.65 -26.99 67.32 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.503 0.721 . . . . 74.01 111.851 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.411 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 15.8 t70 -66.03 -41.21 91.21 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.552 0.741 . . . . 74.34 110.18 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.37 -42.3 96.27 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.774 0.829 . . . . 73.03 110.746 176.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 79.5 mt -66.1 -36.02 82.07 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.443 -0.799 . . . . 64.03 111.08 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -70.98 -33.7 70.68 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.754 0.822 . . . . 73.52 110.135 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 35.5 ttm -66.5 -39.56 88.75 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.445 1.098 . . . . 71.34 110.077 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -71.56 -36.98 71.11 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.358 -0.837 . . . . 72.41 110.827 171.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -72.17 -153.02 0.02 OUTLIER 'General case' 0 CA--C 1.57 1.716 0 C-N-CA 123.637 0.775 . . . . 71.51 109.767 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 57.25 -144.22 0.65 Allowed 'General case' 0 CA--C 1.566 1.593 0 C-N-CA 124.221 1.008 . . . . 70.05 109.137 -175.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -168.15 -64.37 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 107.196 -1.409 . . . . 73.34 107.196 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -88.31 111.04 21.25 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 115.845 -0.616 . . . . 74.54 109.739 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -71.81 97.27 1.77 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.418 -0.81 . . . . 74.21 108.962 172.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -132.79 128.06 35.95 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.747 -1.205 . . . . 73.41 107.747 176.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -150.29 120.14 1.1 Allowed Glycine 0 C--N 1.334 0.433 0 N-CA-C 110.918 -0.873 . . . . 73.44 110.918 -175.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -157.48 -171.01 3.42 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.98 0.912 . . . . 64.54 109.07 -175.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 91.6 155.54 31.85 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 112.063 -0.415 . . . . 73.32 112.063 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 9.9 t -113.21 163.6 14.58 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.97 0.508 . . . . 74.34 111.242 -175.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -153.87 79.87 1.14 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.375 -1.343 . . . . 74.23 107.375 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -134.87 -9.31 2.37 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.639 -0.71 . . . . 74.42 112.226 -172.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -161.72 156.77 23.39 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.168 -0.678 . . . . 72.51 109.168 -172.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . 0.473 ' HB3' HD21 ' E' ' 142' ' ' LEU . 26.6 mt-30 -112.81 110.45 20.57 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.67 0.788 . . . . 63.41 110.15 -178.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -155.6 -84.36 0.06 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.964 0.505 . . . . 75.41 109.874 174.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . 0.6 ' H ' ' HG3' ' C' ' 8' ' ' GLU . . . . . . . . 0 C--O 1.252 1.232 0 C-N-CA 124.447 1.099 . . . . 55.0 108.546 -177.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.422 ' SD ' ' N ' ' D' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 109.993 -0.373 . . . . 72.51 109.993 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 40.8 t 70.82 154.22 0.13 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.842 1.257 . . . . 63.54 109.976 -168.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 67.5 128.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.728 1.211 . . . . 73.34 112.402 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -90.6 151.25 21.39 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.391 1.077 . . . . 73.41 108.316 175.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -63.64 -28.65 70.06 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 122.84 0.456 . . . . 71.52 110.88 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 55.2 28.57 11.3 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 124.357 1.063 . . . . 74.41 112.179 174.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.0 t -63.96 164.97 9.51 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.852 0.861 . . . . 72.34 110.931 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.44 154.14 39.33 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 109.472 -0.566 . . . . 74.14 109.472 169.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.604 ' HG2' HG13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -32.87 124.5 0.36 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.973 1.309 . . . . 64.04 112.38 179.457 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 10.2 t -148.25 158.23 43.96 Favored 'General case' 0 C--O 1.247 0.951 0 C-N-CA 123.681 0.792 . . . . 74.52 109.223 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.41 ' HD2' HG22 ' D' ' 86' ' ' ILE . 84.7 t80 -156.35 120.11 4.36 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.097 -1.075 . . . . 62.42 108.097 -175.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -132.81 116.59 16.72 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.486 0.714 . . . . 72.4 109.376 -177.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 63.8 mt -78.92 129.06 38.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 115.288 -0.869 . . . . 74.42 108.932 176.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -99.2 -44.57 6.21 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.716 0.406 . . . . 75.23 110.98 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -167.84 147.41 4.89 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.265 0.226 . . . . 70.34 111.181 -174.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.0 mp -125.56 140.48 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 106.031 -1.84 . . . . 74.12 106.031 172.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -164.28 146.97 9.09 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 124.038 0.836 . . . . 75.42 110.614 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.1 p -85.01 112.87 20.99 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.396 -0.82 . . . . 74.22 109.622 176.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -83.76 -18.92 36.16 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.394 0.678 . . . . 73.33 109.661 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.672 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 30.6 t70 -159.8 131.73 6.27 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.976 0.91 . . . . 73.12 109.694 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.598 HG23 ' HE1' ' C' ' 117' ' ' MET . 77.3 mt -134.94 142.43 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 107.375 -1.342 . . . . 74.24 107.375 171.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 22' ' ' SER . . . . . 0.419 ' HB3' ' HB2' ' D' ' 77' ' ' GLU . 33.8 t -142.67 143.88 32.51 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.794 1.237 . . . . 75.21 107.961 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.564 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.9 t80 -152.69 117.91 5.22 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.279 -1.378 . . . . 75.45 107.279 172.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -130.28 113.1 13.98 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.717 0.807 . . . . 74.31 109.112 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.517 ' HB2' ' HB1' ' D' ' 28' ' ' ALA . . . -105.3 90.55 3.96 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 107.912 -1.144 . . . . 45.51 107.912 172.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.8 -30.47 9.36 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.977 2.452 . . . . 73.33 112.733 -172.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -109.57 7.64 24.7 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.593 0.757 . . . . 61.55 111.439 -171.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.517 ' HB1' ' HB2' ' D' ' 25' ' ' ALA . . . -44.45 -60.58 2.78 Favored Pre-proline 0 CA--C 1.558 1.25 0 N-CA-C 115.298 1.592 . . . . 64.22 115.298 -158.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.82 -34.54 23.88 Favored 'Trans proline' 0 C--N 1.377 2.035 0 CA-C-N 122.474 1.919 . . . . 71.34 113.873 -172.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -86.19 -21.34 27.55 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 116.637 -0.256 . . . . 74.51 110.497 -175.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.473 HG12 ' O ' ' D' ' 28' ' ' ALA . 1.8 p -83.1 -21.1 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.068 0.547 . . . . 74.24 110.307 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -57.88 -23.6 53.85 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.601 0.76 . . . . 72.1 112.864 174.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -59.31 -27.38 65.82 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.839 0.856 . . . . 70.54 111.167 176.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.498 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 96.7 mttt -83.92 90.79 7.45 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.697 1.199 . . . . 74.32 109.749 177.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -83.45 92.7 7.63 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.935 -1.03 . . . . 64.34 111.46 -175.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 44.6 p90 -167.8 172.68 8.93 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.247 1.019 . . . . 75.15 109.234 166.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -64.19 114.83 15.37 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 108.518 -0.919 . . . . 71.12 108.518 173.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.421 ' O ' HG23 ' D' ' 40' ' ' VAL . 53.3 Cg_exo -54.25 119.35 6.2 Favored 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 122.762 2.308 . . . . 74.52 110.457 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.47 111.05 3.38 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.991 -0.744 . . . . 73.44 108.991 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.626 HG11 HG13 ' D' ' 64' ' ' VAL . 88.3 t -99.07 140.86 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 113.983 -1.462 . . . . 73.31 108.6 -175.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -124.6 122.95 38.99 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.012 -1.477 . . . . 73.22 107.012 171.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 64.3 tp -97.17 138.54 34.52 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.757 0.823 . . . . 75.53 109.863 -170.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.732 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 9.0 m-20 -125.64 114.01 18.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.728 -1.124 . . . . 73.32 108.033 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 90.5 mt -109.23 135.27 50.6 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.091 -0.707 . . . . 73.34 109.091 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -146.04 154.03 41.41 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.388 1.075 . . . . 73.02 108.477 -177.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 8.8 t -117.96 150.84 38.57 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.294 0.569 . . . . 74.15 110.274 -177.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.07 170.35 19.61 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.415 1.486 . . . . 74.41 107.777 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 72.1 p -171.13 -171.33 0.95 Allowed 'General case' 0 C--O 1.243 0.724 0 CA-C-O 121.174 0.512 . . . . 65.3 110.925 -177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 36.4 m -147.42 119.62 8.32 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 106.239 -1.763 . . . . 64.25 106.239 172.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -83.62 130.47 34.98 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.108 0.563 . . . . 75.15 111.479 -169.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -159.1 99.25 1.5 Allowed 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.257 -1.757 . . . . 75.24 106.257 170.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.61 83.05 1.54 Allowed 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 121.751 0.786 . . . . 74.32 112.128 -171.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -145.49 19.32 1.52 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.936 1.294 . . . . 73.44 108.2 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' D' ' 85' ' ' SER . 1.0 OUTLIER 71.17 5.63 5.53 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 125.24 1.416 . . . . 71.34 113.112 -176.737 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 16.4 m -122.44 112.22 33.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 107.933 -1.136 . . . . 74.54 107.933 175.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.557 ' HB2' HD11 ' D' ' 98' ' ' LEU . 9.8 m-85 -134.88 133.12 39.33 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 106.746 -1.575 . . . . 72.41 106.746 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.462 ' HB3' HG13 ' D' ' 83' ' ' ILE . 7.4 pt-20 -86.92 122.67 31.1 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.708 -0.849 . . . . 72.12 108.708 173.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 78.3 t -101.06 141.44 17.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.421 -1.263 . . . . 73.31 108.272 177.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.559 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 36.3 t -128.18 123.97 61.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 108.181 -1.044 . . . . 73.12 108.181 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.493 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -95.09 109.11 21.21 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 106.828 -1.545 . . . . 75.34 106.828 177.763 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.49 95.3 10.21 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.388 -1.708 . . . . 73.13 106.388 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.448 HG22 HD22 ' D' ' 60' ' ' LEU . 44.9 t -97.69 145.13 9.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 115.406 -0.816 . . . . 74.01 109.057 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.732 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 52.7 m -141.21 143.12 34.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.939 -1.028 . . . . 74.12 108.683 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.626 HG13 HG11 ' D' ' 40' ' ' VAL . 12.3 t -133.6 115.69 22.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 123.796 0.838 . . . . 71.32 108.784 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 17.2 m -106.68 94.77 5.3 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.796 -0.816 . . . . 73.32 108.796 171.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.603 ' HB3' HG21 ' D' ' 40' ' ' VAL . . . -99.07 145.85 26.69 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 109.595 -0.52 . . . . 61.34 109.595 176.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.403 ' HA ' ' N ' ' D' ' 73' ' ' ALA . 22.7 p -153.4 137.63 16.54 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.737 -0.665 . . . . 63.52 111.257 -171.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 22.1 mt -107.54 116.4 31.87 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.898 1.279 . . . . 74.13 108.225 173.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.26 -133.54 18.33 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-N 116.161 -0.472 . . . . 70.25 112.081 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -94.57 3.57 54.94 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.148 0.579 . . . . 74.42 111.551 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.498 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 15.7 pt-20 -124.39 167.43 14.39 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.729 0.412 . . . . 64.43 110.249 -176.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 12.0 m -68.1 144.91 54.85 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 124.137 0.898 . . . . 75.41 111.731 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.403 ' N ' ' HA ' ' D' ' 67' ' ' SER . . . -99.54 -59.91 1.63 Allowed 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.308 -1.367 . . . . 64.52 107.308 168.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -157.97 158.95 35.91 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.476 -1.238 . . . . 74.23 110.306 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 51.2 mt -124.73 145.39 49.72 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 107.137 -1.431 . . . . 74.53 107.137 176.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.663 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 45.6 t -156.49 109.45 2.61 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 117.884 0.311 . . . . 63.44 110.738 -171.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' D' ' 22' ' ' SER . 12.1 mp0 -124.5 127.69 47.84 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.079 0.952 . . . . 74.35 109.384 -173.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 87.1 t -135.47 115.17 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.125 0.57 . . . . 74.14 109.887 -178.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.672 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.9 mt-30 -88.68 84.75 6.72 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.428 -0.953 . . . . 74.34 108.428 170.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -83.1 96.92 8.53 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 113.736 -1.574 . . . . 75.11 109.604 -176.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -100.02 170.53 22.8 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.538 -0.301 . . . . 74.52 113.678 -175.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.78 148.5 8.36 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-O 119.243 -0.754 . . . . 73.12 112.675 177.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.462 HG13 ' HB3' ' D' ' 57' ' ' GLU . 3.4 mp -89.32 126.3 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.099 -1.075 . . . . 74.34 108.099 176.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -123.37 149.77 44.54 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.97 0.908 . . . . 74.32 110.239 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' D' ' 54' ' ' ASP . 31.2 t -115.44 111.71 21.19 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.884 0.874 . . . . 74.31 109.073 176.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.411 HD12 ' HB2' ' D' ' 98' ' ' LEU . 46.0 pt -114.88 140.07 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.966 0.906 . . . . 72.25 108.985 177.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.58 ' HA ' HG12 ' E' ' 97' ' ' ILE . . . -162.16 161.92 28.21 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.062 0.458 . . . . 73.15 111.917 177.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.93 8.89 81.78 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.065 -0.971 . . . . 73.44 115.099 167.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.604 HG13 ' HG2' ' D' ' 9' ' ' MET . 0.5 OUTLIER -98.77 171.69 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 N-CA-C 107.986 -1.116 . . . . 74.21 107.986 174.773 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.454 ' H ' HG22 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -138.96 175.3 9.67 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.87 -0.519 . . . . 71.24 110.85 -177.57 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.8 -133.12 29.41 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 114.876 -1.057 . . . . 65.44 112.805 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -92.08 -29.99 16.25 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.639 0.776 . . . . 63.25 111.057 175.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -68.8 -15.5 63.52 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.234 0.613 . . . . 74.04 112.359 -173.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.542 ' HA ' ' HB ' ' D' ' 89' ' ' ILE . 0.0 OUTLIER -59.21 -37.74 78.2 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.708 0.633 . . . . 70.42 112.708 173.538 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . 0.503 ' HB1' HD23 ' E' ' 102' ' ' LEU . . . -83.73 -16.97 42.88 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.399 0.68 . . . . 74.34 111.481 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -66.62 -38.2 86.44 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.935 0.894 . . . . 74.33 111.154 -178.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 63.8 m -59.91 -30.47 69.06 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.623 0.769 . . . . 74.12 111.96 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.608 HD22 HD22 ' E' ' 102' ' ' LEU . 14.5 tp -79.53 -42.58 24.82 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.047 -0.979 . . . . 72.05 110.45 -177.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.08 -18.52 69.36 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 115.739 -0.664 . . . . 72.52 113.794 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.16 -63.08 1.37 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.06 0.544 . . . . 73.44 112.289 -170.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -70.59 -31.88 69.04 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 112.236 0.458 . . . . 75.33 112.236 -174.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.428 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 87.4 m -68.32 -49.5 32.4 Favored Pre-proline 0 CA--C 1.568 1.669 0 CA-C-O 118.531 -0.747 . . . . 71.41 112.114 177.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.493 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 51.7 Cg_exo -60.46 -27.36 84.71 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 122.273 1.982 . . . . 73.51 113.373 169.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -64.76 -36.07 83.13 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.325 0.65 . . . . 65.04 110.532 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 31.1 mm -66.5 -43.14 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.724 0.81 . . . . 74.44 110.371 172.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 75.0 mt -75.52 -12.37 60.21 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.8 0.84 . . . . 75.34 112.979 -173.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -75.47 -45.9 4.36 Favored Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 113.559 0.948 . . . . 75.44 113.559 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.53 -33.57 78.83 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 121.871 1.714 . . . . 71.34 112.578 169.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -76.65 -32.06 57.74 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.468 0.707 . . . . 75.53 111.793 176.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.96 85.98 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.836 -0.431 . . . . 70.2 109.836 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' D' ' 111' ' ' ARG . 9.6 ptt-85 -76.61 -29.11 56.39 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 123.313 0.383 . . . . 73.32 110.697 178.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -51.13 -43.34 61.16 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.851 0.834 . . . . 74.33 109.878 172.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.441 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 18.8 t -72.8 -60.93 1.99 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.071 -1.422 . . . . 65.04 109.927 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.474 ' O ' HG23 ' D' ' 118' ' ' VAL . 80.4 mt -53.5 -56.7 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 124.77 1.228 . . . . 74.44 112.873 -174.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 28.7 m -48.72 -38.35 21.26 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.873 0.869 . . . . 74.43 111.545 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 12.7 t -69.02 -47.59 65.06 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.741 -1.118 . . . . 74.22 110.25 -178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.663 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 4.0 mpp? -63.14 -32.59 74.01 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 117.973 0.351 . . . . 63.53 111.65 178.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.474 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.2 t -62.24 -49.47 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 123.397 0.679 . . . . 73.45 109.927 176.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.7 p -71.92 -29.07 63.92 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.776 -0.647 . . . . 73.12 110.768 -177.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.4 mtt-85 -71.36 -30.41 66.13 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.746 0.818 . . . . 73.42 110.367 175.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.61 8.41 75.31 Favored Glycine 0 C--N 1.355 1.591 0 CA-C-O 119.367 -0.685 . . . . 52.23 112.82 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.47 HG22 ' HB3' ' C' ' 17' ' ' TYR . 74.7 p 51.75 56.8 7.3 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.497 1.519 . . . . 71.52 112.274 -175.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -120.74 148.28 47.9 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 108.518 -0.919 . . . . 73.15 108.518 169.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -50.28 141.13 32.53 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 123.167 2.578 . . . . 70.4 112.668 174.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -55.4 140.54 39.58 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.383 1.073 . . . . 74.52 113.2 -167.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.502 HD23 HG22 ' D' ' 40' ' ' VAL . 13.4 tp -126.8 98.55 5.41 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.008 0.923 . . . . 73.3 109.328 -178.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -102.1 103.0 13.54 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.163 -1.051 . . . . 63.42 108.163 175.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.403 HD22 HD11 ' D' ' 126' ' ' LEU . 79.4 mt -62.08 121.92 14.25 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 123.59 0.556 . . . . 73.11 110.412 -178.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.89 128.95 91.31 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.811 0.844 . . . . 72.11 110.977 -175.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.538 ' HB2' ' HH ' ' B' ' 101' ' ' TYR . 4.1 Cg_endo -79.99 105.61 1.82 Allowed 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.905 2.403 . . . . 60.11 111.938 -170.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -107.79 124.62 64.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.015 -1.105 . . . . 75.21 108.015 172.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -68.2 117.06 9.53 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.932 -0.766 . . . . 75.54 108.932 175.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.568 ' HA ' HD22 ' D' ' 136' ' ' LEU . 1.5 m-85 -61.94 -21.4 64.75 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.025 1.33 . . . . 62.45 112.048 -171.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -53.07 -35.21 59.3 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.195 1.398 . . . . 65.44 111.481 173.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.31 -31.0 69.18 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.265 1.026 . . . . 74.51 112.404 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.568 HD22 ' HA ' ' D' ' 133' ' ' PHE . 3.5 mm? -72.83 -35.8 67.35 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.09 0.556 . . . . 72.24 110.586 177.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -78.39 -31.18 48.2 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.738 -0.665 . . . . 75.45 110.782 177.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 70.8 mtm -73.94 -26.15 60.35 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.883 0.473 . . . . 72.0 110.798 172.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.505 ' O ' ' HG2' ' D' ' 143' ' ' GLN . 6.7 t30 -51.35 -43.61 61.84 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.348 0.659 . . . . 73.23 109.759 173.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -52.81 -41.67 64.39 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.906 1.282 . . . . 72.14 112.222 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.4 mp -72.87 -38.86 66.87 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.19 0.596 . . . . 75.31 111.509 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -89.43 40.61 1.0 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.409 0.683 . . . . 75.51 112.191 -174.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' D' ' 139' ' ' ASN . 24.1 mm-40 -117.92 76.62 1.08 Allowed 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.557 -0.905 . . . . 73.2 108.557 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . 0.555 ' HG2' ' H ' ' D' ' 145' ' ' ALA . 44.2 tt0 -169.83 -150.67 0.08 Allowed 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 106.72 -1.585 . . . . 74.54 106.72 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . 0.555 ' H ' ' HG2' ' D' ' 144' ' ' GLN . . . -78.05 10.54 2.82 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 119.112 0.869 . . . . 71.14 112.13 175.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.5 60.65 4.0 Favored Glycine 0 C--N 1.355 1.607 0 C-N-CA 123.507 0.575 . . . . 73.22 112.269 172.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -79.08 173.85 12.16 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.343 1.057 . . . . 72.3 109.533 173.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -161.87 104.33 0.24 Allowed Glycine 0 C--N 1.335 0.499 0 N-CA-C 111.757 -0.537 . . . . 72.11 111.757 -175.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 3.8 t -77.37 71.18 3.84 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.997 0.919 . . . . 73.44 110.226 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -74.38 100.31 3.75 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.842 -0.799 . . . . 71.22 108.842 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -104.77 103.49 13.12 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.67 0.788 . . . . 70.41 109.699 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -151.44 82.13 1.3 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.276 -1.009 . . . . 73.44 108.276 171.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -140.44 121.98 15.16 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.949 -1.023 . . . . 73.34 109.212 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -94.83 122.35 37.36 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.938 -1.134 . . . . 75.11 107.938 170.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.942 0 C-N-CA 123.392 0.677 . . . . 74.23 110.286 -177.084 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.677 0 CA-C-O 120.124 -0.265 . . . . 74.05 112.488 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . -136.36 151.45 20.82 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 111.124 -0.791 . . . . 61.44 111.124 177.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -96.51 98.6 10.35 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.34 -1.356 . . . . 75.21 107.34 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -104.38 -22.31 13.35 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.898 0.879 . . . . 74.01 113.083 -165.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm 72.28 158.84 0.2 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.93 1.292 . . . . 73.52 112.854 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 177.54 -48.94 0.1 Allowed Glycine 0 C--N 1.343 0.944 0 N-CA-C 111.464 -0.654 . . . . 63.12 111.464 -177.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 97' ' ' ILE . . . . . 0.58 HG12 ' HA ' ' D' ' 87' ' ' ALA . 29.4 pt -132.81 96.27 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-O 122.884 1.326 . . . . 65.51 110.141 177.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -107.14 -170.91 1.78 Allowed 'General case' 0 C--O 1.244 0.81 0 CA-C-N 114.95 -1.023 . . . . 75.02 108.67 170.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . 63.65 15.14 8.7 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.943 0.897 . . . . 71.03 112.254 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 100' ' ' LEU . . . . . . . . . . . . . 4.0 pp -85.16 114.97 59.14 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 108.596 -0.89 . . . . 74.22 108.596 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -87.85 0.89 6.96 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.784 2.323 . . . . 73.32 112.454 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 102' ' ' LEU . . . . . 0.608 HD22 HD22 ' D' ' 98' ' ' LEU . 97.0 mt 59.04 29.78 19.43 Favored 'General case' 0 C--N 1.368 1.389 0 C-N-CA 124.248 1.019 . . . . 64.35 110.918 -173.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 70.2 p 53.27 22.27 2.64 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.931 1.692 . . . . 74.44 112.539 -175.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 150.31 145.42 4.12 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 109.181 -1.567 . . . . 64.44 109.181 -172.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -77.38 33.11 0.16 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.391 1.076 . . . . 74.41 112.859 -169.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -165.06 -64.99 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 106.41 -1.7 . . . . 74.51 106.41 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -177.11 142.07 0.35 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.732 2.013 . . . . 70.23 107.512 169.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -74.14 -38.0 63.89 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.662 -0.496 . . . . 74.51 109.662 172.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -134.76 126.61 29.3 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.595 1.158 . . . . 73.15 108.36 177.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.23 -174.54 3.11 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 123.568 0.747 . . . . 72.35 111.526 -172.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . . . . . . . . . 4.7 mp -83.89 177.86 8.14 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.741 1.216 . . . . 75.11 110.352 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 112' ' ' ASN . . . . . 0.598 ' HA ' HG21 ' E' ' 121' ' ' VAL . 5.6 m-20 58.88 95.78 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.209 1.004 . . . . 73.14 111.462 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -70.07 127.69 33.72 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 108.217 -1.031 . . . . 74.1 108.217 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . 0.438 ' HD2' ' N ' ' E' ' 114' ' ' LYS . 10.6 mptt -80.03 -39.59 29.56 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.837 -0.801 . . . . 74.45 108.837 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 12.4 t -158.94 153.28 24.02 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 114.494 -1.23 . . . . 74.12 109.006 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 144.06 -98.4 0.21 Allowed Glycine 0 C--N 1.338 0.653 0 N-CA-C 111.893 -0.483 . . . . 72.24 111.893 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 117' ' ' LYS . . . . . 0.549 ' HD2' ' HD2' ' E' ' 118' ' ' PRO . 24.1 tptm -104.88 119.65 52.67 Favored Pre-proline 0 CA--C 1.548 0.873 0 N-CA-C 108.966 -0.753 . . . . 75.44 108.966 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 118' ' ' PRO . . . . . 0.549 ' HD2' ' HD2' ' E' ' 117' ' ' LYS . 52.8 Cg_endo -65.62 -177.9 0.82 Allowed 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.181 2.587 . . . . 72.43 113.551 -177.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 78.2 -36.15 0.2 Allowed 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 126.027 1.731 . . . . 71.11 112.701 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -64.23 124.02 20.62 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.794 0.838 . . . . 75.22 111.931 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 121' ' ' VAL . . . . . 0.598 HG21 ' HA ' ' E' ' 112' ' ' ASN . 61.7 t 68.81 100.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.55 1.54 . . . . 75.51 111.233 -177.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 35.4 p -105.54 171.13 7.49 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 124.428 1.091 . . . . 74.15 109.223 170.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.92 -87.69 0.09 Allowed 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 112.243 0.46 . . . . 71.54 112.243 -174.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 22.0 t -85.57 84.38 7.62 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.504 0.722 . . . . 64.23 109.766 -174.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -153.12 26.18 0.54 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.946 0.898 . . . . 73.43 110.401 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -135.67 130.16 33.87 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.115 0.566 . . . . 54.55 109.9 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 47.9 t 69.24 156.92 0.14 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.259 1.424 . . . . 74.32 112.298 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -157.12 15.03 0.27 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.806 0.842 . . . . 73.41 110.376 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 44.6 m -111.24 134.58 52.73 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.408 0.683 . . . . 73.44 110.45 -173.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.08 -169.63 2.12 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.339 1.055 . . . . 73.34 111.856 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 131' ' ' TRP . . . . . 0.573 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 0.9 OUTLIER -135.29 97.28 3.67 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 124.13 0.972 . . . . 72.34 108.554 -178.702 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 20.7 m -128.15 100.72 5.97 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.788 -0.57 . . . . 64.3 110.639 -173.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 22.8 m -142.28 106.11 4.71 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 107.664 -1.235 . . . . 72.42 107.664 171.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.61 -36.07 58.79 Favored Glycine 0 C--N 1.35 1.355 0 O-C-N 123.514 0.509 . . . . 71.42 112.931 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 63.8 t 65.21 -70.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 125.589 1.555 . . . . 75.41 111.694 -176.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 59.06 41.27 20.98 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.93 1.292 . . . . 75.12 110.706 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 40.2 p 52.44 28.61 6.05 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.563 1.545 . . . . 73.22 112.986 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 30.0 t80 57.89 29.26 17.3 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-O 122.363 1.078 . . . . 73.33 110.673 174.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -152.17 166.29 32.17 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 115.302 -0.863 . . . . 74.22 109.34 -173.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.07 81.17 0.25 Allowed Glycine 0 C--N 1.343 0.921 0 CA-C-N 116.503 -0.317 . . . . 64.23 112.323 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -79.28 168.0 20.15 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 124.046 0.938 . . . . 73.41 111.003 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 142' ' ' LEU . . . . . 0.473 HD21 ' HB3' ' C' ' 153' ' ' GLN . 3.8 mm? -72.01 160.56 32.3 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.76 -0.654 . . . . 74.12 110.421 177.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.34 73.19 1.83 Allowed Glycine 0 C--N 1.346 1.131 0 O-C-N 123.534 0.522 . . . . 75.03 112.009 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 6.7 m -109.79 100.81 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 124.031 0.932 . . . . 74.2 109.438 -177.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 33.1 t70 . . . . . 0 C--O 1.25 1.124 0 N-CA-C 108.754 -0.832 . . . . 72.21 108.754 -176.575 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.463 0 N-CA-C 111.841 -0.504 . . . . 74.33 111.841 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . -90.41 54.78 3.52 Favored Glycine 0 C--N 1.351 1.363 0 C-N-CA 122.867 0.27 . . . . 52.12 113.246 -175.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -137.74 112.71 9.06 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.996 0.919 . . . . 74.43 109.368 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -89.58 154.53 19.91 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.344 1.058 . . . . 75.43 109.657 175.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.06 168.24 14.86 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.941 0.496 . . . . 74.41 110.117 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . 140.77 31.57 0.16 Allowed Glycine 0 C--N 1.344 1.02 0 CA-C-N 116.302 -0.408 . . . . 74.33 113.298 177.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 97' ' ' ILE . . . . . 0.535 ' HB ' ' HA ' ' B' ' 87' ' ' ALA . 15.0 tt -104.24 -40.77 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 109.022 -0.732 . . . . 74.1 109.022 170.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 30.5 t70 58.19 109.03 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.615 1.566 . . . . 73.21 112.848 174.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . 68.79 110.69 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.44 1.096 . . . . 74.22 111.828 174.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 100' ' ' LEU . . . . . . . . . . . . . 5.4 mp -114.18 86.98 12.5 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 123.016 0.526 . . . . 73.51 109.665 174.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -86.49 -3.84 8.43 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.917 2.412 . . . . 74.02 112.031 168.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 102' ' ' LEU . . . . . 0.416 HD13 HD12 ' B' ' 98' ' ' LEU . 2.2 mm? 57.17 -95.78 0.06 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.526 1.53 . . . . 74.51 110.623 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 3.3 t -167.82 94.37 0.41 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.391 1.077 . . . . 73.41 108.67 174.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.47 -74.17 1.95 Allowed Glycine 0 C--N 1.344 1.014 0 CA-C-N 115.255 -0.884 . . . . 54.51 111.663 -174.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.21 -56.7 1.9 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.605 1.162 . . . . 74.1 107.985 176.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -166.66 165.11 16.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.758 1.223 . . . . 74.14 108.793 -177.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 28.8 m -45.47 102.26 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.104 1.362 . . . . 73.14 111.936 177.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -136.15 131.39 34.64 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 124.107 0.963 . . . . 74.11 108.494 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -142.97 -77.64 0.24 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 107.685 -1.228 . . . . 73.41 107.685 173.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' B' ' 154' ' ' ASP . . . -153.64 -52.24 0.1 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.159 -1.052 . . . . 71.42 108.159 176.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 43.2 tp 58.74 -88.57 0.02 OUTLIER 'General case' 0 C--N 1.359 0.982 0 C-N-CA 125.33 1.452 . . . . 74.34 110.884 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 112' ' ' ASN . . . . . 0.474 HD21 ' HA ' ' B' ' 43' ' ' ASP . 2.9 t30 -169.35 15.14 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.981 0.912 . . . . 71.31 108.976 -172.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -79.94 127.3 32.1 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 123.277 0.631 . . . . 71.43 110.666 -171.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 50.9 tptt 58.92 40.72 22.24 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.477 1.111 . . . . 73.42 109.043 -175.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 3.2 m 63.53 33.0 13.81 Favored 'General case' 0 CA--C 1.557 1.231 0 CA-C-N 114.361 -1.29 . . . . 70.33 109.821 -176.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.66 74.14 1.58 Allowed Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.178 -0.919 . . . . 63.41 112.352 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -76.28 134.25 70.72 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 123.602 0.761 . . . . 74.04 111.091 -174.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 118' ' ' PRO . . . . . 0.47 ' HG2' ' HB3' ' F' ' 120' ' ' TYR . 66.9 Cg_endo -84.94 31.51 0.49 Allowed 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 123.368 2.712 . . . . 75.3 111.167 166.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 9.4 t70 56.57 40.84 29.24 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 125.895 1.678 . . . . 75.32 110.598 -171.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 120' ' ' TYR . . . . . 0.47 ' HB3' ' HG2' ' F' ' 118' ' ' PRO . 38.5 t80 -148.97 147.48 28.65 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 114.887 -1.051 . . . . 75.45 109.401 -173.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 99.1 t 65.27 104.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 125.184 1.394 . . . . 73.23 111.431 -175.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 32.2 m -95.92 136.72 35.98 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.145 -0.687 . . . . 63.42 109.145 173.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -83.45 -11.65 57.27 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.968 0.907 . . . . 63.41 112.544 -170.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 15.1 m -68.96 -9.98 55.01 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.851 0.86 . . . . 72.31 112.445 -177.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.87 -24.62 67.81 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.761 0.825 . . . . 74.55 111.85 174.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -83.06 -21.5 33.75 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.799 0.84 . . . . 64.31 111.937 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 41.3 m -81.64 98.02 8.17 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.388 0.675 . . . . 71.34 110.609 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -142.97 143.52 31.98 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.785 0.834 . . . . 72.13 109.949 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 26.0 m -73.76 98.73 2.99 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.832 0.853 . . . . 75.01 108.902 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -151.06 90.32 1.6 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.946 -0.57 . . . . 72.34 110.487 -174.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 64.2 t90 -151.29 153.31 34.58 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.337 0.655 . . . . 75.53 109.577 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 70.7 m -153.21 151.28 29.91 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.756 1.223 . . . . 70.35 109.799 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 14.4 t -87.82 -174.95 4.96 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.867 0.867 . . . . 73.33 109.925 174.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.28 -94.24 0.15 Allowed Glycine 0 C--N 1.348 1.199 0 CA-C-O 120.064 -0.298 . . . . 60.23 112.471 175.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 12.3 p -163.55 151.26 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.096 0.558 . . . . 72.22 109.644 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -123.09 130.49 52.85 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 107.758 -1.201 . . . . 73.54 107.758 168.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 88.0 m 68.26 120.26 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.557 1.143 . . . . 65.34 109.832 -167.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -60.4 -30.91 69.9 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.354 0.662 . . . . 72.04 111.323 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 66.08 96.08 0.05 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.274 1.43 . . . . 73.42 111.373 174.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -123.17 10.17 8.81 Favored Glycine 0 N--CA 1.472 1.063 0 N-CA-C 111.936 -0.466 . . . . 50.45 111.936 174.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.24 -63.98 1.21 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.718 0.807 . . . . 72.2 110.104 -177.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 45.2 tp 49.85 80.27 0.07 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.314 1.446 . . . . 63.11 111.939 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -104.09 121.89 7.18 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 111.233 -0.747 . . . . 62.4 111.233 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.84 -26.43 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.006 0.523 . . . . 73.31 111.211 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 27.5 t70 . . . . . 0 C--O 1.251 1.132 0 C-N-CA 124.402 1.081 . . . . 73.42 108.928 177.713 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 120.738 0.304 . . . . 74.43 110.548 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.5 t -159.77 173.62 15.73 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.221 1.008 . . . . 73.44 109.121 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -88.84 122.55 32.35 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 108.434 -0.95 . . . . 72.21 108.434 169.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -99.34 112.06 24.31 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.638 -0.875 . . . . 75.34 108.638 175.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -72.32 139.74 48.13 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.117 0.967 . . . . 74.32 110.522 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -81.36 138.46 35.63 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.091 0.556 . . . . 74.35 111.329 -176.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.9 p -121.86 -34.44 3.37 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.421 1.088 . . . . 60.42 109.517 176.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -105.5 -78.61 0.57 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.838 0.855 . . . . 73.12 109.802 175.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 68.9 mtm -148.13 159.56 43.81 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.177 1.391 . . . . 73.02 108.105 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 79.2 m -153.93 118.79 5.0 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.994 0.518 . . . . 74.35 110.845 176.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.405 ' CD1' HD13 ' A' ' 86' ' ' ILE . 93.9 t80 -99.36 114.58 27.54 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 106.359 -1.719 . . . . 74.22 106.359 161.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -133.32 112.5 11.69 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.189 -0.671 . . . . 73.43 109.189 -177.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.781 HG22 ' HG2' ' C' ' 130' ' ' PRO . 41.3 mt -83.65 113.96 23.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 107.745 -1.206 . . . . 75.43 107.745 169.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -94.77 -28.72 15.13 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 109.705 -0.48 . . . . 65.45 109.705 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -166.37 139.96 4.09 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 122.741 0.416 . . . . 75.34 111.101 -177.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.571 HD12 ' HG3' ' C' ' 130' ' ' PRO . 95.5 mt -128.45 138.45 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.687 1.195 . . . . 73.01 107.828 169.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.46 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 32.5 p90 -163.74 174.88 11.09 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.735 0.647 . . . . 75.23 111.395 -175.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.0 p -101.17 121.89 42.65 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.196 -0.668 . . . . 72.13 109.196 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 35.5 mtpt -81.5 -38.2 26.68 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.129 0.49 . . . . 72.2 109.908 175.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 21.0 t70 -142.59 144.24 32.77 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.825 -1.079 . . . . 74.31 110.17 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.6 HD13 ' SD ' ' B' ' 117' ' ' MET . 97.4 mt -144.03 144.75 22.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 125.581 1.552 . . . . 70.32 107.43 176.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.4 t -159.13 142.85 14.99 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 122.917 0.487 . . . . 64.14 110.22 168.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -136.84 143.74 43.26 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 107.427 -1.323 . . . . 73.42 107.427 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -137.84 127.0 24.42 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.841 0.456 . . . . 74.32 110.387 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.21 66.31 9.28 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 125.382 1.473 . . . . 72.44 108.236 167.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.89 -34.25 30.69 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.25 1.967 . . . . 73.33 110.804 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.417 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 20.0 p-10 -89.96 24.68 2.35 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 114.175 -1.375 . . . . 55.55 111.292 174.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.87 -49.8 71.89 Favored Pre-proline 0 CA--C 1.571 1.773 0 CA-C-O 118.44 -0.79 . . . . 55.32 112.659 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.48 -26.79 70.21 Favored 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 121.718 1.612 . . . . 61.41 113.765 175.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 27' ' ' ASN . 16.9 m-70 -77.33 -49.04 15.83 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.664 0.745 . . . . 74.53 110.564 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.682 HG22 ' HA ' ' A' ' 73' ' ' ALA . 9.9 p -72.4 -25.61 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 CA-C-N 114.302 -1.317 . . . . 75.54 112.741 -167.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -64.72 -19.75 65.95 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 122.875 0.47 . . . . 74.51 111.882 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -86.47 -31.39 21.37 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.426 1.091 . . . . 71.34 110.129 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.509 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 4.0 tmtp? -68.97 142.9 54.54 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.138 0.975 . . . . 71.2 109.642 -174.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.509 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 10.2 m-20 -53.23 124.03 13.45 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.566 1.146 . . . . 73.33 110.922 176.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -85.13 85.07 7.5 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 121.629 0.728 . . . . 74.2 110.722 -175.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -130.96 76.97 76.14 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 107.137 -1.431 . . . . 72.42 107.137 167.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -85.55 133.43 4.49 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.281 1.988 . . . . 75.2 112.432 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -97.06 90.7 5.26 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.061 -1.459 . . . . 72.11 107.061 166.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.766 HG23 ' HB1' ' A' ' 66' ' ' ALA . 62.1 t -77.69 93.12 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 108.581 -0.896 . . . . 74.42 108.581 175.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.458 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -90.35 127.12 36.09 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.903 -1.044 . . . . 74.35 109.168 177.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.517 HD22 HG12 ' A' ' 62' ' ' VAL . 3.7 tt -108.48 123.05 48.29 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.205 -1.035 . . . . 74.34 108.205 -171.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.514 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 10.8 m-20 -113.24 114.69 27.08 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.471 1.108 . . . . 74.22 109.514 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 45.7 mt -99.38 146.96 25.74 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.068 0.547 . . . . 73.11 112.033 -178.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -148.02 146.9 29.09 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.079 1.351 . . . . 64.43 108.46 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 84.4 m -134.61 140.82 46.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.276 0.63 . . . . 72.33 110.169 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.07 154.04 49.29 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.662 1.185 . . . . 75.32 109.339 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.5 p -130.43 155.46 46.39 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.21 0.604 . . . . 62.43 109.63 173.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.7 t -149.09 120.21 7.75 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.217 1.007 . . . . 74.34 108.371 -176.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -73.27 111.11 8.09 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.382 -0.599 . . . . 64.44 109.382 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.703 HD12 ' HB2' ' A' ' 57' ' ' GLU . 52.6 mt -84.81 -30.45 24.56 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.215 0.606 . . . . 73.33 110.072 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.74 177.02 10.3 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.667 1.187 . . . . 74.2 109.596 177.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -63.67 125.06 23.07 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.581 -0.896 . . . . 72.33 108.581 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 60.0 18.92 8.04 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.129 0.972 . . . . 71.14 112.72 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.5 t -126.05 110.43 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 107.824 -1.176 . . . . 75.21 107.824 173.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -123.52 127.86 48.94 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.849 0.86 . . . . 74.3 109.008 -175.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.703 ' HB2' HD12 ' A' ' 51' ' ' LEU . 31.5 tt0 -84.55 139.32 32.21 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.487 -0.931 . . . . 74.53 108.487 165.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.442 HG11 ' HD3' ' A' ' 103' ' ' PRO . 72.0 t -120.71 136.41 57.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.936 -1.135 . . . . 70.4 107.936 169.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.11 131.97 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.687 -0.857 . . . . 74.5 108.687 174.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.59 107.22 17.95 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.8 -1.556 . . . . 74.2 106.8 173.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -92.97 99.84 12.4 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.192 -1.04 . . . . 62.43 108.192 176.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.517 HG12 HD22 ' A' ' 42' ' ' LEU . 40.4 t -95.91 124.75 48.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 114.256 -1.338 . . . . 72.11 107.648 176.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.514 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 5.0 m -115.61 136.88 52.63 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.91 -1.144 . . . . 74.42 107.91 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.552 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 71.8 t -137.91 126.2 31.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 107.487 -1.301 . . . . 65.25 107.487 -172.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.458 ' HB ' ' HD2' ' A' ' 41' ' ' LYS . 27.5 m -137.72 131.69 31.71 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.984 -0.747 . . . . 73.34 108.984 169.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.766 ' HB1' HG23 ' A' ' 40' ' ' VAL . . . -105.56 120.76 42.45 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 107.618 -1.253 . . . . 72.02 107.618 174.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.3 m -118.02 126.47 52.36 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.744 0.418 . . . . 71.21 110.006 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.2 mt -90.54 66.51 6.3 Favored 'General case' 0 C--O 1.248 1.011 0 C-N-CA 125.046 1.339 . . . . 74.54 108.68 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.05 -86.74 0.78 Allowed Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.796 -0.638 . . . . 70.2 111.842 -176.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -108.95 -29.19 8.72 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.004 0.922 . . . . 73.43 110.902 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -89.3 113.57 24.85 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.663 -0.865 . . . . 72.31 108.663 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.2 m -69.0 130.37 42.58 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.81 0.732 . . . . 72.31 109.203 174.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.682 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -75.99 -58.65 3.16 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.387 -0.824 . . . . 60.34 109.884 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -159.33 163.68 35.44 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.723 -1.126 . . . . 72.2 110.691 177.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.2 tp -124.27 135.57 53.49 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.483 1.113 . . . . 75.41 108.705 172.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.552 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 68.6 m -133.5 133.11 41.81 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.54 1.136 . . . . 72.35 109.133 175.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -145.36 123.05 11.83 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.872 -0.788 . . . . 72.13 108.872 172.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.7 t -131.09 125.12 57.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 123.947 0.899 . . . . 75.14 108.948 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 53.8 mt-30 -99.67 91.63 4.96 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.919 0.887 . . . . 71.53 108.879 173.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -78.66 97.98 6.03 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.969 -1.014 . . . . 73.53 109.625 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.54 150.65 23.57 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 111.54 -0.624 . . . . 74.43 111.54 177.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.48 125.82 2.08 Favored Glycine 0 CA--C 1.508 -0.384 0 N-CA-C 110.665 -0.974 . . . . 74.02 110.665 -177.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.2 mt -84.59 112.87 22.36 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 N-CA-C 109.052 -0.721 . . . . 70.24 109.052 176.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.648 ' HB3' HD11 ' A' ' 86' ' ' ILE . 81.7 m-85 -121.77 118.69 29.65 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.093 0.957 . . . . 75.33 108.752 -177.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.5 t -92.75 95.87 9.82 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.771 -1.196 . . . . 70.3 107.771 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.648 HD11 ' HB3' ' A' ' 84' ' ' PHE . 11.9 mm -112.72 142.73 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.902 -0.59 . . . . 72.5 110.109 -172.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.9 164.87 30.9 Favored 'General case' 0 C--O 1.241 0.615 0 O-C-N 123.584 0.553 . . . . 73.41 112.25 -172.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.77 6.65 85.15 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 114.852 -1.067 . . . . 64.51 114.191 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.423 HD11 ' HE3' ' A' ' 94' ' ' MET . 0.2 OUTLIER -134.11 165.23 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.159 0.984 . . . . 75.15 108.89 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -159.27 175.95 12.77 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 109.451 -0.574 . . . . 73.15 109.451 175.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.01 -117.19 8.42 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.007 0.813 . . . . 62.02 114.323 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 t -70.12 -31.08 68.44 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.279 1.032 . . . . 74.42 111.755 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -74.61 -39.72 61.99 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 123.181 0.592 . . . . 71.3 110.713 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.423 ' HE3' HD11 ' A' ' 89' ' ' ILE . 3.9 tpt -68.13 -40.8 82.4 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.311 0.382 . . . . 74.12 110.111 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.88 98.13 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.329 -0.85 . . . . 75.04 110.745 175.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -68.4 -31.93 71.62 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.076 -0.511 . . . . 73.52 111.632 179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 48.5 t -69.46 -44.97 70.14 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 110.062 -0.347 . . . . 63.12 110.062 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 65.0 mt -83.12 -26.68 30.77 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.38 0.672 . . . . 73.04 111.961 -174.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.23 3.35 37.71 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-O 119.525 -0.597 . . . . 63.1 114.15 -173.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.553 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -142.38 -68.44 0.37 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 117.684 0.742 . . . . 74.03 111.646 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -69.38 -41.93 75.83 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 112.465 0.543 . . . . 63.41 112.465 -170.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 70.1 m -66.46 -50.08 49.29 Favored Pre-proline 0 CA--C 1.568 1.659 0 CA-C-O 118.53 -0.747 . . . . 73.43 111.93 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.442 ' HD3' HG11 ' A' ' 58' ' ' VAL . 37.8 Cg_endo -65.86 -21.02 58.12 Favored 'Trans proline' 0 C--N 1.395 3.019 0 C-N-CA 121.781 1.654 . . . . 73.13 113.288 172.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -66.25 -42.91 87.89 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.161 0.584 . . . . 72.5 109.812 172.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.42 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 39.7 mm -62.01 -43.39 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.899 0.879 . . . . 72.34 110.318 174.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.7 mt -72.04 -24.13 61.49 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.398 -0.819 . . . . 74.24 112.627 -173.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -62.93 -44.89 86.6 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 114.339 1.237 . . . . 73.4 114.339 -172.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 92.5 Cg_exo -50.06 -40.98 50.13 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.203 1.935 . . . . 70.14 114.083 171.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -76.92 -39.56 50.39 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.619 0.768 . . . . 75.5 111.049 -177.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.37 -47.24 82.89 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.648 0.779 . . . . 74.22 110.016 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.477 ' NH1' HD13 ' C' ' 105' ' ' ILE . 29.7 ttm180 -49.4 -55.93 11.36 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 125.023 1.452 . . . . 75.24 110.142 172.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -60.89 -45.48 94.4 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.496 1.122 . . . . 74.14 111.664 -174.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 45.1 t -56.91 -45.32 82.72 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.026 0.829 . . . . 73.14 110.434 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.564 HD13 HD12 ' A' ' 128' ' ' LEU . 66.2 mt -63.27 -51.62 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 115.077 -0.965 . . . . 74.14 110.535 175.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 50.6 m -55.54 -41.48 73.26 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.113 0.965 . . . . 71.22 111.246 -174.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -69.78 -42.85 73.26 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.498 -1.228 . . . . 71.45 109.913 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.515 ' SD ' HG22 ' A' ' 21' ' ' ILE . 10.2 mtp -58.79 -41.73 87.39 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.642 0.777 . . . . 75.54 111.19 175.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 114' ' ' ILE . 83.1 t -65.08 -48.13 85.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.384 1.074 . . . . 75.23 110.329 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.3 p -71.62 -30.94 66.34 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.911 -0.586 . . . . 75.03 111.298 -176.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.464 HH12 ' HG3' ' B' ' 112' ' ' GLU . 64.8 mtt-85 -72.4 -30.25 64.48 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.554 0.742 . . . . 73.15 109.197 173.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.43 -2.6 74.91 Favored Glycine 0 C--N 1.356 1.643 0 O-C-N 123.88 0.737 . . . . 73.15 112.921 174.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 92.2 m 71.68 26.59 3.07 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 122.912 1.339 . . . . 75.11 111.288 174.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -98.26 145.08 29.23 Favored Pre-proline 0 C--O 1.244 0.801 0 N-CA-C 108.51 -0.922 . . . . 72.3 108.51 170.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.608 ' HB3' ' H ' ' E' ' 132' ' ' SER . 61.2 Cg_exo -43.98 132.68 8.44 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.389 2.726 . . . . 75.21 112.891 174.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -52.93 123.2 10.9 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 124.162 0.914 . . . . 74.35 112.399 -170.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.414 HD23 HG12 ' A' ' 40' ' ' VAL . 45.5 tp -109.24 100.68 9.78 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.908 0.883 . . . . 70.53 110.207 -174.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.463 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 88.9 m-20 -97.78 113.06 24.76 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.63 -1.248 . . . . 74.15 107.63 174.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.564 HD12 HD13 ' A' ' 114' ' ' ILE . 19.1 mt -65.21 147.68 53.02 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 123.58 0.55 . . . . 74.12 110.46 -175.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.76 134.74 88.05 Favored Pre-proline 0 CA--C 1.549 0.933 0 CA-C-O 118.914 -0.565 . . . . 72.54 111.158 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.49 120.93 9.17 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.256 2.637 . . . . 74.21 113.337 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 64.7 t -107.31 130.44 59.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 123.644 0.778 . . . . 74.43 110.37 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -92.51 92.22 7.97 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.051 -1.092 . . . . 75.24 108.051 173.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -62.64 -29.4 70.6 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.88 0.872 . . . . 73.31 112.22 176.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.553 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 6.7 m-20 -70.86 -25.48 62.84 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.291 0.636 . . . . 73.43 111.131 177.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.01 -40.96 37.32 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.239 0.616 . . . . 60.41 110.233 172.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.61 -44.69 96.53 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.207 0.603 . . . . 74.41 110.938 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -73.83 -29.29 62.06 Favored 'General case' 0 C--O 1.216 -0.708 0 CA-C-N 115.073 -0.967 . . . . 73.12 109.74 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.719 ' HE3' ' HB2' ' A' ' 145' ' ' ALA . 3.2 tpt -55.94 -41.44 74.65 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.623 0.769 . . . . 75.53 111.02 178.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -58.04 -34.43 70.06 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 124.167 0.917 . . . . 70.41 111.289 178.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -90.19 -30.28 17.69 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.804 1.242 . . . . 73.33 111.507 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.416 HD23 ' HE1' ' A' ' 138' ' ' MET . 51.4 tp -68.26 -50.53 53.2 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.91 0.884 . . . . 73.21 111.18 -168.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 174.1 -15.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 124.381 1.05 . . . . 75.44 110.653 177.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 70.02 -50.12 0.64 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.565 1.146 . . . . 73.3 111.225 -166.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -71.15 95.09 1.2 Allowed 'General case' 0 C--N 1.358 0.937 0 C-N-CA 123.068 0.547 . . . . 72.42 110.366 170.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.719 ' HB2' ' HE3' ' A' ' 138' ' ' MET . . . -177.56 171.88 1.86 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.698 1.599 . . . . 70.24 108.344 170.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -127.26 -115.02 1.9 Allowed Glycine 0 C--N 1.339 0.719 0 N-CA-C 112.29 -0.324 . . . . 74.32 112.29 -177.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -146.3 160.75 41.6 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.079 0.952 . . . . 73.42 110.263 -173.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -165.44 135.47 3.73 Favored Glycine 0 C--N 1.339 0.695 0 CA-C-N 115.802 -0.635 . . . . 65.14 111.559 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.8 t -133.63 156.09 48.5 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.686 0.794 . . . . 72.3 109.572 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -88.69 151.58 22.35 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.121 0.568 . . . . 73.2 110.956 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -108.99 90.34 3.26 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 107.733 -1.21 . . . . 63.44 107.733 163.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -72.39 98.37 2.23 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.999 -1.111 . . . . 75.15 107.999 173.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 19.1 tm0? -59.86 104.37 0.29 Allowed 'General case' 0 C--N 1.352 0.698 0 N-CA-C 108.192 -1.04 . . . . 65.31 108.192 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -76.5 143.82 40.2 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 123.774 0.671 . . . . 72.11 109.549 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 C-N-CA 123.3 0.64 . . . . 71.3 110.166 -178.596 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptp . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 109.911 -0.403 . . . . 64.53 109.911 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.9 t 70.0 173.33 0.3 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.751 1.22 . . . . 71.54 110.705 -172.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -82.59 72.98 9.66 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.645 0.736 . . . . 75.42 110.441 -176.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -97.96 -3.97 37.27 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.808 -1.087 . . . . 73.34 111.267 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 65.44 63.79 0.62 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.535 1.134 . . . . 75.23 110.009 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -112.79 142.81 44.99 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.57 -1.195 . . . . 72.01 108.215 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 13.4 t -65.04 -16.86 63.92 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.419 0.687 . . . . 64.04 111.264 175.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 68.02 -105.85 0.08 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.279 1.432 . . . . 75.21 109.45 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.638 ' HG2' HG22 ' B' ' 89' ' ' ILE . 0.1 OUTLIER 55.17 170.0 0.02 OUTLIER 'General case' 0 CA--C 1.57 1.713 0 C-N-CA 124.753 1.221 . . . . 74.24 111.701 -174.623 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.535 ' HB ' ' HB2' ' B' ' 87' ' ' ALA . 85.2 m -154.41 102.26 2.41 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.11 -1.07 . . . . 74.34 108.11 168.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.427 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 50.9 t80 -119.9 134.35 55.27 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.068 -1.086 . . . . 73.21 108.068 173.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.401 ' HG3' ' HB2' ' D' ' 129' ' ' ALA . 12.2 tt0 -164.01 142.12 7.3 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 123.702 0.626 . . . . 71.31 110.791 169.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.473 HD11 HD12 ' B' ' 105' ' ' ILE . 37.8 mt -80.07 132.4 31.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.021 -0.991 . . . . 74.45 109.43 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -99.12 -38.72 8.82 Favored 'General case' 0 C--O 1.242 0.662 0 O-C-N 123.816 0.697 . . . . 74.02 110.299 178.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -173.46 137.18 0.63 Allowed 'General case' 0 C--N 1.349 0.583 0 O-C-N 123.747 0.654 . . . . 72.24 109.8 -175.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.407 HD11 HD12 ' B' ' 13' ' ' ILE . 96.6 mt -120.31 143.43 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 107.577 -1.268 . . . . 72.41 107.577 174.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -162.9 139.48 7.44 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.696 0.628 . . . . 75.43 112.696 -173.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.9 m -73.96 118.01 16.43 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.042 0.937 . . . . 63.12 109.499 172.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.454 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.6 mtpt -98.15 -9.98 24.89 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.932 0.893 . . . . 71.13 112.045 -176.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.449 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 16.1 t70 -174.27 144.6 0.95 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.168 0.587 . . . . 64.5 110.745 -176.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.557 HD13 ' SG ' ' B' ' 113' ' ' CYS . 43.8 mm -138.28 148.67 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 125.047 1.339 . . . . 64.4 108.792 175.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.497 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 38.9 t -148.68 139.99 23.3 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 125.159 1.384 . . . . 63.14 108.214 172.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.48 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 81.2 t80 -152.85 113.7 4.13 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.375 -1.343 . . . . 75.44 107.375 171.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -121.18 119.09 31.32 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.953 0.901 . . . . 72.52 108.712 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.477 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -107.45 87.12 3.11 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 107.194 -1.41 . . . . 72.14 107.194 167.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.68 -34.44 31.97 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.987 2.458 . . . . 73.02 111.662 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -101.84 3.39 39.25 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.44 1.096 . . . . 70.15 110.375 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.516 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -30.0 -65.06 0.19 Allowed Pre-proline 0 N--CA 1.499 1.997 0 C-N-CA 126.331 1.853 . . . . 71.33 114.886 -172.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.516 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 28.8 Cg_exo -57.69 -48.07 18.53 Favored 'Trans proline' 0 C--N 1.391 2.802 0 C-N-CA 122.934 2.423 . . . . 63.53 113.462 -166.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -96.36 -15.37 21.89 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.297 -0.865 . . . . 75.23 112.648 -172.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 3.4 p -73.76 -17.7 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-N 118.657 0.662 . . . . 75.23 110.647 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -68.62 -6.32 25.08 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 113.764 1.024 . . . . 70.12 113.764 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -71.24 -13.53 61.94 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 120.991 0.424 . . . . 74.0 110.747 172.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.699 ' HZ1' ' HG2' ' B' ' 71' ' ' GLU . 91.1 mttt -98.62 88.0 3.96 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.729 1.212 . . . . 75.11 110.049 -177.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.45 77.92 9.92 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.989 -1.005 . . . . 71.34 110.99 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -158.37 164.58 36.18 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.881 0.873 . . . . 75.44 108.721 169.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.54 117.4 60.34 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 108.181 -1.044 . . . . 73.13 108.181 177.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.425 ' O ' HG23 ' B' ' 40' ' ' VAL . 31.8 Cg_endo -65.98 147.56 84.8 Favored 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 122.207 1.938 . . . . 75.31 112.231 -177.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -69.93 114.17 7.86 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 109.004 -0.739 . . . . 75.2 109.004 178.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.609 ' HB ' ' HB3' ' F' ' 126' ' ' ALA . 77.7 t -111.04 138.06 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 114.998 -1.001 . . . . 74.22 111.939 -172.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.566 ' HE2' ' HD3' ' F' ' 114' ' ' LYS . 44.4 tttp -107.27 126.97 53.12 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 126.017 1.727 . . . . 73.41 107.503 174.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.615 HD12 HD21 ' B' ' 128' ' ' LEU . 15.6 tp -103.01 127.3 50.3 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.729 -0.841 . . . . 74.45 108.729 174.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -143.8 136.13 26.85 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 106.999 -1.482 . . . . 44.11 106.999 -177.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.7 mp -127.05 149.24 50.0 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.952 -0.758 . . . . 74.34 108.952 -171.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.567 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 7.6 t70 -125.77 146.29 49.84 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.772 1.229 . . . . 54.34 109.255 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 26.9 m -124.84 105.64 9.41 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.495 0.718 . . . . 74.22 109.643 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.7 120.45 39.39 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.366 -1.346 . . . . 71.51 107.366 176.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.705 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 25.1 m -135.41 161.57 35.06 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.495 0.318 . . . . 75.53 111.506 -168.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 42.0 p -165.15 139.29 4.88 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.322 0.649 . . . . 74.45 111.06 -177.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -87.57 96.65 10.48 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 108.782 -0.822 . . . . 74.41 108.782 171.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 pp -107.53 14.78 25.46 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.801 0.44 . . . . 74.24 110.688 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.98 143.75 22.83 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.775 0.83 . . . . 74.12 109.56 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -74.06 132.13 42.02 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.646 -0.872 . . . . 74.41 108.646 170.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 67.76 1.9 2.83 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.946 1.298 . . . . 61.45 113.442 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.46 HG21 ' HD2' ' F' ' 93' ' ' PHE . 58.2 t -140.08 128.28 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 107.851 -1.166 . . . . 72.24 107.851 -172.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.705 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 6.7 t80 -115.38 154.26 29.52 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.797 -0.565 . . . . 72.33 109.566 -176.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -124.24 117.67 25.08 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 107.739 -1.208 . . . . 61.0 107.739 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 p -118.71 127.8 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.881 0.873 . . . . 70.42 109.363 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.414 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.9 t -103.77 112.33 36.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 108.072 -1.085 . . . . 75.0 108.072 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -103.18 108.68 19.98 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.473 -0.936 . . . . 71.41 108.473 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.567 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 6.2 ttm180 -85.12 135.4 33.99 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.131 -0.941 . . . . 74.03 109.238 174.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.484 ' HB ' HD11 ' B' ' 114' ' ' ILE . 17.5 t -122.57 117.13 51.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.14 -1.059 . . . . 53.23 108.14 169.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 17.3 m -109.78 133.36 53.23 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.874 0.87 . . . . 74.1 109.786 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.611 HG22 HG21 ' B' ' 114' ' ' ILE . 55.4 t -115.78 114.5 46.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 125.308 1.443 . . . . 73.32 109.139 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 41.4 m -91.79 138.09 31.84 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.698 -1.223 . . . . 73.13 107.698 166.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.515 ' HB1' HG21 ' B' ' 40' ' ' VAL . . . -148.78 143.01 26.08 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 117.943 0.338 . . . . 64.2 110.467 178.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 73.7 p -147.96 133.42 18.64 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 123.768 0.667 . . . . 74.24 111.032 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.561 HD13 ' HB2' ' B' ' 34' ' ' LYS . 54.0 mt -93.89 108.73 20.49 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.171 0.988 . . . . 74.43 108.508 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.87 -116.64 4.39 Favored Glycine 0 C--N 1.342 0.861 0 N-CA-C 111.469 -0.652 . . . . 42.41 111.469 -175.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -111.62 -0.08 16.21 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.054 0.942 . . . . 72.44 110.645 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.699 ' HG2' ' HZ1' ' B' ' 34' ' ' LYS . 9.8 pt-20 -116.77 154.37 30.79 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.328 -0.619 . . . . 72.42 109.328 -178.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 39.4 m -62.81 141.4 58.64 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.972 0.509 . . . . 63.51 111.285 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.443 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . . . -97.78 -64.06 1.07 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.658 -1.238 . . . . 74.32 107.658 172.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -151.88 154.4 36.07 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.639 -1.164 . . . . 73.23 109.949 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 88.5 mt -130.44 112.87 13.64 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 106.916 -1.513 . . . . 73.14 106.916 175.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.1 t -117.63 156.19 28.59 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.134 -0.691 . . . . 62.2 109.134 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.497 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.0 tt0 -161.93 129.63 4.03 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.649 0.78 . . . . 75.23 108.997 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.415 HG22 HG13 ' B' ' 114' ' ' ILE . 94.2 t -126.41 150.13 31.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.125 -1.065 . . . . 75.15 108.125 175.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.6 mt-30 -124.86 97.95 5.49 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.181 -1.044 . . . . 74.24 108.181 170.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -93.26 103.14 15.42 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.676 -0.693 . . . . 73.11 109.255 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.454 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -94.19 172.32 31.91 Favored Glycine 0 C--O 1.243 0.675 0 CA-C-N 115.824 -0.626 . . . . 62.24 111.862 176.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.91 142.71 6.88 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.808 -0.517 . . . . 71.1 111.808 -178.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 16.3 tt -107.54 116.86 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 C-N-CA 123.997 0.919 . . . . 74.21 108.661 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -123.3 134.7 54.04 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.089 0.955 . . . . 75.31 109.578 -172.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.0 m -89.12 130.83 35.49 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.024 0.53 . . . . 65.12 109.592 174.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.496 ' HB ' HD13 ' B' ' 89' ' ' ILE . 0.1 OUTLIER -135.75 139.55 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.14 0.976 . . . . 72.44 109.114 -178.472 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.535 ' HB2' ' HB ' ' B' ' 10' ' ' THR . . . -157.9 169.39 24.69 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.98 0.912 . . . . 73.35 110.426 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.31 -41.47 3.0 Favored Glycine 0 C--N 1.352 1.449 0 C-N-CA 123.718 0.675 . . . . 71.4 113.35 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.638 HG22 ' HG2' ' B' ' 9' ' ' MET . 9.5 pt -65.5 153.29 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.388 1.475 . . . . 72.12 113.052 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -151.36 172.37 16.03 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.515 1.126 . . . . 64.35 110.049 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.73 -133.72 32.28 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-N 116.231 -0.44 . . . . 43.44 114.0 177.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.0 m -80.73 -47.27 14.2 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.972 0.909 . . . . 74.44 110.888 -175.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -65.51 -20.73 66.46 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.818 -1.083 . . . . 74.35 111.259 -172.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.597 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 11.0 ttt -52.47 -70.22 0.09 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.29 1.436 . . . . 71.02 112.428 174.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . 0.425 ' HB3' HD22 ' F' ' 102' ' ' LEU . . . -78.9 -12.74 60.04 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.427 -0.351 . . . . 61.21 111.489 -175.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -61.87 -41.58 98.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.215 0.606 . . . . 74.42 110.713 167.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 t -64.06 -28.08 69.55 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.291 0.636 . . . . 72.21 112.346 -176.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.707 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.5 pp -103.23 -17.72 15.21 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.352 0.661 . . . . 73.32 111.501 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.11 -4.09 41.58 Favored Glycine 0 N--CA 1.478 1.48 0 N-CA-C 114.201 0.44 . . . . 51.22 114.201 -173.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.87 -49.71 0.52 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.459 0.704 . . . . 73.1 110.362 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -71.15 -39.02 72.19 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 122.7 0.4 . . . . 74.02 111.648 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.707 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 84.5 m -67.72 -47.45 44.48 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-O 118.493 -0.765 . . . . 73.21 111.717 177.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.44 -34.4 41.49 Favored 'Trans proline' 0 C--N 1.394 2.928 0 C-N-CA 122.66 2.24 . . . . 75.32 114.244 167.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -67.41 -35.6 79.59 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.043 0.937 . . . . 73.43 110.563 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.473 HD12 HD11 ' B' ' 13' ' ' ILE . 79.6 mt -68.58 -40.45 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.759 0.824 . . . . 75.34 110.164 173.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 95.5 mt -75.72 -20.97 57.97 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.971 -1.013 . . . . 73.12 112.191 -174.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -61.68 -50.29 82.7 Favored Pre-proline 0 CA--C 1.561 1.376 0 CA-C-O 118.012 -0.994 . . . . 63.34 112.8 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -50.9 -40.38 57.92 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 122.633 2.222 . . . . 64.34 114.145 173.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -67.97 -44.57 76.39 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.518 0.727 . . . . 74.42 110.879 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.67 -34.86 79.29 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.248 0.619 . . . . 74.14 110.829 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.491 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 31.5 ttt180 -66.35 -52.63 45.04 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.219 1.407 . . . . 74.25 110.094 -175.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . 0.464 ' HG3' HH12 ' A' ' 120' ' ' ARG . 12.3 tp10 -65.0 -33.43 76.03 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.033 0.933 . . . . 74.31 110.647 176.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.557 ' SG ' HD13 ' B' ' 21' ' ' ILE . 1.9 t -70.57 -32.57 70.01 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 122.439 -0.163 . . . . 73.4 110.967 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.611 HG21 HG22 ' B' ' 64' ' ' VAL . 66.3 mt -70.56 -57.9 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.277 0.631 . . . . 63.51 109.445 173.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 13.3 m -61.54 -22.96 65.61 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 124.205 0.94 . . . . 72.31 111.346 -173.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.3 t -62.04 -52.7 62.9 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 123.444 0.698 . . . . 74.24 109.851 170.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.6 ' SD ' HD13 ' A' ' 21' ' ' ILE . 12.7 mmt -68.44 -33.39 74.12 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.862 0.865 . . . . 63.33 111.113 -175.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.554 HG23 HD21 ' B' ' 126' ' ' LEU . 86.4 t -65.45 -43.96 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.806 1.242 . . . . 71.04 110.135 173.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.5 t -63.83 -34.87 78.9 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.73 -1.123 . . . . 73.53 110.564 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' B' ' 116' ' ' SER . 77.4 mtt-85 -69.24 -33.31 73.09 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.05 -0.977 . . . . 73.55 110.373 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.37 -15.75 81.25 Favored Glycine 0 C--N 1.356 1.686 0 O-C-N 123.57 0.544 . . . . 73.43 112.389 170.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 15.7 m 65.33 37.91 6.08 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.715 1.606 . . . . 71.42 110.261 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -81.5 156.92 70.66 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 114.61 -1.177 . . . . 74.53 109.53 172.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -50.91 163.83 0.71 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.38 2.72 . . . . 74.33 114.48 175.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -59.4 118.25 5.78 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 115.481 -0.782 . . . . 70.53 111.342 -171.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.554 HD21 HG23 ' B' ' 118' ' ' VAL . 54.8 tp -107.62 95.21 5.54 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.614 -0.884 . . . . 70.02 108.614 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -96.55 106.4 18.66 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.998 -1.112 . . . . 73.44 107.998 172.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.615 HD21 HD12 ' B' ' 42' ' ' LEU . 30.4 mt -67.05 134.84 52.68 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 110.135 -0.32 . . . . 71.4 110.135 175.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.71 131.46 94.9 Favored Pre-proline 0 CA--C 1.549 0.914 0 O-C-N 124.106 0.879 . . . . 74.32 110.713 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -61.75 90.79 0.11 Allowed 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.087 2.525 . . . . 64.14 111.618 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 p -90.35 111.69 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.591 -0.731 . . . . 74.22 109.493 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -79.47 113.69 17.81 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.671 -1.233 . . . . 55.24 107.671 171.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -65.4 -40.0 92.89 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.706 0.802 . . . . 75.31 110.182 -177.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -57.23 -28.18 62.67 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 114.03 -1.441 . . . . 73.34 111.129 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.436 ' O ' ' HG2' ' B' ' 138' ' ' MET . . . -71.1 -39.26 72.22 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 124.023 0.929 . . . . 62.31 111.715 177.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 mp -64.19 -38.35 90.75 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 122.179 -0.326 . . . . 73.51 110.391 178.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -74.71 -35.98 62.7 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.289 0.636 . . . . 75.12 111.766 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.436 ' HG2' ' O ' ' B' ' 135' ' ' ALA . 18.3 ptm -68.89 -36.09 77.64 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 110.02 -0.363 . . . . 73.52 110.02 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -80.78 -23.77 39.07 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.652 0.781 . . . . 74.22 111.12 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -71.85 -42.31 67.06 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.927 0.491 . . . . 73.24 109.911 175.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 10.3 mp -85.33 1.32 48.94 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.48 0.712 . . . . 71.31 111.185 175.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 64.37 85.49 0.14 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.446 1.498 . . . . 75.25 111.593 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -155.85 91.99 1.33 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 105.5 -2.037 . . . . 75.13 105.5 172.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -127.25 86.11 2.45 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.779 0.832 . . . . 75.2 109.859 -169.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . 61.56 -152.69 0.37 Allowed 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 124.254 1.022 . . . . 71.33 112.104 172.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 101.54 165.82 27.38 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-O 119.598 -0.557 . . . . 73.42 112.154 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 68.6 104.47 0.05 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.78 1.232 . . . . 72.14 111.759 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 156.93 49.99 0.01 OUTLIER Glycine 0 C--N 1.343 0.941 0 N-CA-C 111.247 -0.741 . . . . 50.45 111.247 177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 70.8 p -87.43 179.28 6.6 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.706 0.802 . . . . 71.23 111.194 -172.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 74.49 126.98 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.907 1.683 . . . . 75.14 109.852 -171.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -165.19 132.89 3.08 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.466 1.107 . . . . 71.21 108.108 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 29.5 t60 -113.1 -72.39 0.71 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 107.747 -1.205 . . . . 73.24 107.747 172.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -176.21 -79.53 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.442 1.097 . . . . 73.54 109.414 172.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -142.32 101.95 4.0 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.75 1.22 . . . . 73.24 107.827 -178.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.561 1.378 0 O-C-N 124.508 1.13 . . . . 70.31 110.732 -175.133 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 43.8 ttm . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 109.742 -0.466 . . . . 74.14 109.742 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 72.0 m -159.03 92.9 1.12 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.691 0.796 . . . . 71.44 110.036 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.73 152.52 42.7 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.586 -0.733 . . . . 71.33 109.23 170.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -147.09 152.53 38.66 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.216 0.532 . . . . 74.33 110.844 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -121.64 30.88 6.5 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 106.958 -1.497 . . . . 75.44 106.958 168.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -70.78 149.8 46.5 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-N 114.818 -1.083 . . . . 72.1 110.299 -172.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 39.6 p -126.46 109.36 12.1 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.01 0.924 . . . . 74.2 110.019 -172.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -173.84 -44.47 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.635 0.774 . . . . 63.15 111.138 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.474 ' H ' ' HA3' ' C' ' 88' ' ' GLY . 12.2 ttt 57.05 110.41 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.046 1.738 . . . . 73.45 111.871 -164.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 88.5 m -126.95 114.47 17.88 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.368 1.067 . . . . 74.23 108.252 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.476 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 78.8 t80 -107.98 129.42 55.12 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.959 -0.756 . . . . 74.14 108.959 177.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -140.42 128.45 22.13 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.136 -0.69 . . . . 72.04 109.136 174.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 50.2 mt -76.77 128.85 37.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 108.809 -0.811 . . . . 75.23 108.809 172.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -90.15 -49.59 6.48 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.934 -0.765 . . . . 73.23 108.934 172.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.463 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -176.46 153.52 1.18 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.431 1.092 . . . . 73.33 110.049 179.213 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 84.3 mt -127.7 134.92 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.087 1.355 . . . . 73.52 107.71 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.513 ' HE2' ' HD3' ' C' ' 19' ' ' LYS . 42.4 p90 -163.72 174.2 11.94 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.439 0.695 . . . . 64.52 110.288 -164.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.7 p -105.92 116.16 31.46 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 122.988 0.515 . . . . 71.15 109.838 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.513 ' HD3' ' HE2' ' C' ' 17' ' ' TYR . 30.8 mmtp -65.78 -37.97 87.74 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.947 -0.76 . . . . 75.53 108.947 167.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.421 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 13.1 t70 -149.56 147.19 27.87 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 114.482 -1.235 . . . . 73.33 110.4 -174.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.504 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 91.5 mt -139.36 146.11 26.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 106.505 -1.665 . . . . 75.23 106.505 173.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 18.2 t -157.35 148.13 21.37 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 121.064 0.459 . . . . 72.0 110.32 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -156.2 108.56 2.58 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.635 -1.246 . . . . 74.45 107.635 174.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -117.29 112.02 20.18 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 122.92 0.488 . . . . 73.41 110.065 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -121.47 83.05 40.33 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.63 1.172 . . . . 75.21 107.951 169.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.66 -17.82 25.87 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.684 2.256 . . . . 64.53 111.385 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -102.8 12.26 36.45 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.543 1.137 . . . . 74.04 110.543 -178.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.99 -57.9 5.47 Favored Pre-proline 0 C--N 1.374 1.646 0 C-N-CA 124.761 1.224 . . . . 61.15 113.687 -169.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -60.25 -46.62 17.61 Favored 'Trans proline' 0 C--N 1.385 2.484 0 CA-C-N 121.427 1.545 . . . . 75.44 113.143 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -69.41 -29.41 67.14 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.155 -0.929 . . . . 72.25 111.899 -174.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.616 HG22 ' HA ' ' C' ' 73' ' ' ALA . 6.7 p -83.14 -21.14 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 N-CA-C 113.286 0.847 . . . . 63.41 113.286 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -67.9 -18.02 64.66 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 112.517 0.562 . . . . 75.04 112.517 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -100.12 16.25 24.72 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.875 0.87 . . . . 75.14 111.253 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.474 ' HZ2' ' HA ' ' C' ' 31' ' ' VAL . 0.1 OUTLIER -100.59 155.54 17.81 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.474 0.71 . . . . 74.23 110.339 -174.428 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.32 125.07 25.56 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.089 0.556 . . . . 75.33 110.303 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.1 t-105 -83.03 87.97 6.88 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.731 0.812 . . . . 74.22 110.627 -173.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -139.54 75.95 31.31 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 123.932 0.893 . . . . 74.52 108.891 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -82.83 145.03 12.54 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.224 1.949 . . . . 73.32 112.056 -175.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -86.15 89.1 7.73 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 104.849 -2.278 . . . . 74.01 104.849 168.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 58.1 t -78.64 98.33 2.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 114.996 -1.002 . . . . 73.45 109.175 -175.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -97.5 102.31 14.05 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.548 -0.908 . . . . 73.4 108.548 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 pp -87.31 123.5 32.36 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.446 -1.316 . . . . 73.43 107.446 171.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -130.46 143.42 50.75 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.393 -0.966 . . . . 74.4 108.393 -172.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.444 HD11 ' CE1' ' C' ' 133' ' ' PHE . 91.9 mt -131.6 112.64 12.78 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.959 0.504 . . . . 72.21 110.959 -171.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -115.03 126.72 55.05 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 107.46 -1.311 . . . . 74.41 107.46 169.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -116.2 153.93 30.97 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 109.091 -0.707 . . . . 65.43 109.091 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.72 133.4 23.7 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.763 -0.828 . . . . 63.33 108.763 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.428 ' HG ' ' HB3' ' C' ' 98' ' ' LEU . 32.9 p -144.87 144.79 31.3 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.834 0.453 . . . . 74.44 110.154 -174.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 62.9 p -149.07 152.65 36.56 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.658 0.783 . . . . 73.24 109.872 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -85.43 117.99 24.68 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.043 -1.095 . . . . 74.14 108.043 173.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.682 HD12 ' HB2' ' C' ' 57' ' ' GLU . 31.9 mt -84.64 -40.2 17.73 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.595 0.758 . . . . 75.1 109.689 -176.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.31 -173.73 4.56 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.707 -1.133 . . . . 73.12 109.119 175.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -62.43 126.65 28.07 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.445 -0.798 . . . . 75.44 109.565 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 66.13 -0.72 1.33 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.847 1.259 . . . . 55.14 112.965 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 45.7 t -118.29 111.39 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 109.367 -0.605 . . . . 74.53 109.367 -176.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -113.32 166.62 11.3 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.973 0.909 . . . . 74.34 109.751 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.682 ' HB2' HD12 ' C' ' 51' ' ' LEU . 41.4 tt0 -127.86 144.55 51.09 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.174 0.99 . . . . 73.33 108.734 171.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 82.6 t -131.23 133.73 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 108.182 -1.044 . . . . 70.33 108.182 167.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.451 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 60.2 t -120.25 130.1 74.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 107.66 -1.237 . . . . 71.45 107.66 176.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.443 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -113.18 97.36 6.45 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.742 -1.207 . . . . 64.45 107.742 -176.678 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 7.9 ttm-85 -81.84 110.45 17.15 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.961 -0.755 . . . . 75.32 108.961 173.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.499 ' HB ' HD11 ' C' ' 114' ' ' ILE . 19.4 t -106.68 123.86 61.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.074 -1.084 . . . . 71.11 108.074 173.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 59.6 m -115.03 132.11 56.71 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.026 -1.102 . . . . 72.4 108.026 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.556 HG21 HG23 ' C' ' 114' ' ' ILE . 89.0 t -121.28 116.95 51.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 109.141 -0.689 . . . . 75.24 109.141 176.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 12.5 m -101.76 139.04 37.95 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.635 -0.876 . . . . 73.11 108.635 173.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.57 105.72 4.58 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.607 -0.886 . . . . 62.12 108.607 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 36.9 m -127.04 133.54 50.47 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.356 0.662 . . . . 72.11 109.705 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 11.3 mt -91.04 15.0 12.43 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.988 1.315 . . . . 74.24 111.474 -176.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 145.25 -110.46 0.55 Allowed Glycine 0 C--N 1.351 1.377 0 N-CA-C 110.026 -1.229 . . . . 70.34 110.026 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -88.74 -27.25 21.3 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.523 0.729 . . . . 72.34 109.088 169.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -74.55 119.47 18.79 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 124.438 1.095 . . . . 74.21 109.492 175.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 53.4 m -84.29 124.41 31.22 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.994 -0.743 . . . . 75.31 108.994 169.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.616 ' HA ' HG22 ' C' ' 31' ' ' VAL . . . -70.07 -54.86 11.24 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.462 0.705 . . . . 74.51 109.457 176.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -163.85 163.24 23.86 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.101 -0.954 . . . . 73.04 110.906 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -126.94 141.25 51.85 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 106.635 -1.617 . . . . 74.54 106.635 167.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.442 ' SG ' HG21 ' C' ' 114' ' ' ILE . 48.9 t -141.17 150.72 43.12 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.976 -0.749 . . . . 72.12 108.976 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -158.18 136.45 10.89 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.321 0.648 . . . . 72.3 109.853 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -135.82 114.21 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 124.496 1.118 . . . . 64.1 108.201 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.419 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 68.7 mt-30 -94.19 88.25 5.54 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.562 -0.903 . . . . 74.5 108.562 173.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -81.01 95.51 6.83 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.243 -0.89 . . . . 75.22 109.743 -176.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -83.58 149.1 25.53 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 116.016 -0.538 . . . . 52.13 112.23 178.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.08 125.49 1.79 Allowed Glycine 0 CA--C 1.505 -0.586 0 N-CA-C 111.143 -0.783 . . . . 71.44 111.143 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.523 HD13 ' HB3' ' D' ' 29' ' ' PRO . 26.4 mm -85.29 130.8 35.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 N-CA-C 108.475 -0.935 . . . . 73.23 108.475 175.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -135.75 118.76 16.38 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.474 0.71 . . . . 74.23 109.977 -178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 64.7 m -76.87 102.44 6.34 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.898 -0.778 . . . . 64.53 108.898 171.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.569 HG21 ' HE2' ' C' ' 94' ' ' MET . 22.3 mt -116.95 137.87 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 108.69 -0.855 . . . . 74.12 108.69 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -145.44 169.82 17.59 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.355 0.662 . . . . 64.52 109.309 176.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . 0.474 ' HA3' ' H ' ' C' ' 9' ' ' MET . . . 91.62 -15.5 61.37 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 114.881 0.713 . . . . 75.11 114.881 169.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.712 HD13 ' HA ' ' C' ' 94' ' ' MET . 27.6 pt -117.14 169.66 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-N 117.762 0.781 . . . . 74.02 111.561 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -159.97 152.03 20.51 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.289 -0.869 . . . . 73.11 109.995 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.67 -126.86 9.28 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 123.524 0.515 . . . . 70.44 113.345 172.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 35.5 p -67.37 -26.01 66.25 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.129 0.971 . . . . 74.0 111.828 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -65.57 -52.92 48.7 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.692 0.797 . . . . 70.31 109.711 174.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.712 ' HA ' HD13 ' C' ' 89' ' ' ILE . 5.5 tpt -54.14 -48.7 70.55 Favored 'General case' 0 C--N 1.353 0.72 0 CA-C-N 114.916 -1.038 . . . . 73.2 112.096 172.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.84 83.07 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.313 0.645 . . . . 61.22 111.181 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -68.05 -34.23 76.06 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.257 -0.883 . . . . 74.32 111.342 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.404 ' SG ' HD12 ' C' ' 86' ' ' ILE . 33.7 t -72.86 -42.08 64.08 Favored 'General case' 0 C--N 1.347 0.488 0 N-CA-C 109.392 -0.595 . . . . 74.22 109.392 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.428 ' HB3' ' HG ' ' C' ' 48' ' ' SER . 92.3 mt -77.46 -28.79 52.47 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.959 0.904 . . . . 71.31 112.518 -175.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -114.44 11.1 21.73 Favored Glycine 0 N--CA 1.477 1.423 0 CA-C-O 119.597 -0.557 . . . . 55.25 114.27 -170.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.22 -55.05 0.12 Allowed 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 117.52 0.66 . . . . 73.24 111.846 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -70.4 -55.25 9.53 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.061 0.544 . . . . 73.32 111.705 -173.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.476 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 50.3 m -68.31 -43.92 34.63 Favored Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 123.764 0.826 . . . . 73.04 112.454 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.443 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 72.6 Cg_exo -55.62 -27.58 61.15 Favored 'Trans proline' 0 C--N 1.399 3.188 0 C-N-CA 122.402 2.068 . . . . 71.13 114.182 172.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -67.67 -35.42 78.82 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.328 0.651 . . . . 72.1 110.75 176.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.477 HD13 ' NH1' ' A' ' 111' ' ' ARG . 49.7 mm -75.71 -32.42 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.358 0.663 . . . . 74.43 110.212 177.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.75 -28.79 55.86 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.867 0.867 . . . . 73.35 111.79 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -56.78 -48.78 96.69 Favored Pre-proline 0 N--CA 1.482 1.175 0 N-CA-C 114.458 1.281 . . . . 73.53 114.458 -173.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.63 -38.69 92.64 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 121.895 1.73 . . . . 73.0 113.119 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -67.54 -43.56 80.41 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.832 0.853 . . . . 74.14 110.671 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.414 ' O ' HG13 ' C' ' 114' ' ' ILE . . . -65.22 -39.6 92.98 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.548 -0.751 . . . . 75.24 110.338 176.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -59.65 -49.89 75.97 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.205 1.402 . . . . 74.23 110.527 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.74 -37.8 88.83 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 123.944 0.778 . . . . 75.42 109.727 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.7 t -69.54 -33.13 72.35 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.176 0.59 . . . . 72.43 111.593 -176.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.556 HG23 HG21 ' C' ' 64' ' ' VAL . 88.2 mt -71.98 -51.91 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.236 0.614 . . . . 73.3 109.54 176.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.2 m -67.24 -29.23 68.81 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 123.695 0.622 . . . . 75.42 111.193 -175.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 48.3 t -63.47 -46.53 85.8 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.523 0.729 . . . . 74.34 109.077 172.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.576 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.53 -35.46 81.03 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.018 0.927 . . . . 75.54 112.32 178.105 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.447 HG13 ' HB2' ' C' ' 123' ' ' PHE . 95.4 t -68.85 -36.63 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.346 0.658 . . . . 61.21 109.71 174.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.0 t -71.13 -32.31 68.83 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.18 0.992 . . . . 71.03 111.447 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' C' ' 116' ' ' SER . 81.2 mtt-85 -73.3 -39.19 65.52 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.17 -0.678 . . . . 73.05 109.17 177.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.49 -3.72 78.59 Favored Glycine 0 C--N 1.353 1.488 0 O-C-N 123.928 0.767 . . . . 51.33 112.663 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 25.7 p 63.11 28.66 16.11 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 126.797 2.039 . . . . 64.55 113.627 170.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.447 ' HB2' HG13 ' C' ' 118' ' ' VAL . 94.8 m-85 -82.62 161.22 59.58 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.663 0.785 . . . . 74.44 109.077 169.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -51.91 140.94 47.51 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.815 2.343 . . . . 74.51 112.817 172.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -55.35 109.17 0.5 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.312 1.045 . . . . 75.13 112.323 -175.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 56.4 tp -112.02 88.43 2.81 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.318 -0.623 . . . . 74.31 109.318 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -90.54 123.04 33.89 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.783 -0.821 . . . . 73.24 108.783 177.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.67 140.55 51.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.659 0.784 . . . . 73.51 110.781 -176.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.529 ' HB3' HG12 ' F' ' 135' ' ' VAL . . . -76.95 155.17 82.91 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 115.33 -0.85 . . . . 71.24 111.058 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.781 ' HG2' HG22 ' A' ' 13' ' ' ILE . 39.6 Cg_exo -55.55 106.99 0.21 Allowed 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.995 2.463 . . . . 70.12 112.132 173.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 18.3 t -99.6 120.59 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 108.361 -0.977 . . . . 74.33 108.361 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -79.53 100.9 7.96 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.82 0.848 . . . . 75.55 109.751 -176.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.444 ' CE1' HD11 ' C' ' 44' ' ' LEU . 93.6 m-85 -66.47 -29.13 69.19 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.826 0.85 . . . . 70.34 112.48 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -64.28 -42.79 96.25 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.341 0.657 . . . . 70.02 109.605 176.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.42 -36.38 81.15 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.229 -0.896 . . . . 75.4 110.858 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.443 ' HA ' HD22 ' C' ' 139' ' ' ASN . 54.0 mt -66.63 -38.9 87.88 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.902 0.481 . . . . 74.52 110.779 177.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -73.69 -26.99 60.99 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.367 -0.833 . . . . 74.15 110.41 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 47.2 ttm -66.07 -48.78 69.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.039 0.936 . . . . 62.31 110.651 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . 0.443 HD22 ' HA ' ' C' ' 136' ' ' LEU . 10.9 p30 -71.36 -34.37 70.41 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 116.287 -0.415 . . . . 64.21 110.907 176.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -71.7 -155.72 0.03 OUTLIER 'General case' 0 CA--C 1.579 2.083 0 C-N-CA 123.316 0.646 . . . . 74.23 109.679 169.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.457 ' HG ' ' H ' ' C' ' 143' ' ' GLN . 22.0 tp 65.26 161.3 0.13 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.791 1.237 . . . . 73.21 111.034 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -131.48 16.18 4.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.049 -1.032 . . . . 74.41 111.078 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . 0.457 ' H ' ' HG ' ' C' ' 141' ' ' LEU . 4.6 tp60 -155.21 -157.74 0.77 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 108.908 -0.775 . . . . 73.05 108.908 -172.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -149.12 171.37 16.53 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.457 0.703 . . . . 64.02 110.023 175.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -127.23 145.18 50.86 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.291 1.036 . . . . 61.42 109.368 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -167.24 74.17 0.14 Allowed Glycine 0 C--N 1.342 0.887 0 N-CA-C 111.118 -0.793 . . . . 62.41 111.118 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -152.73 91.69 1.58 Allowed 'General case' 0 C--O 1.24 0.59 0 N-CA-C 109.11 -0.7 . . . . 74.14 109.11 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -91.66 130.89 10.51 Favored Glycine 0 C--N 1.344 1.024 0 N-CA-C 111.077 -0.809 . . . . 61.32 111.077 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 2.3 t -151.48 128.84 11.29 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.568 0.747 . . . . 75.32 110.03 -174.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -138.46 70.45 1.38 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.337 0.655 . . . . 74.02 110.678 -171.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -159.73 148.29 17.5 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.583 0.353 . . . . 74.04 111.438 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -170.86 31.02 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.03 1.332 . . . . 74.44 109.982 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -67.19 97.98 0.57 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.553 0.741 . . . . 74.12 110.829 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -94.11 124.73 38.31 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.473 -0.936 . . . . 70.01 108.473 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.185 0 C-N-CA 123.562 0.745 . . . . 55.42 109.458 -175.124 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.411 ' HE2' ' HA ' ' D' ' 1' ' ' MET . 4.3 mmt . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 110.152 -0.314 . . . . 74.45 110.152 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 68.4 p -78.54 73.57 5.09 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.483 0.713 . . . . 73.3 109.397 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.55 147.69 41.54 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.989 0.915 . . . . 73.31 111.703 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -158.2 129.9 6.74 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.721 0.808 . . . . 70.24 109.921 -176.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -143.49 144.39 31.96 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.272 1.029 . . . . 74.12 109.465 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -76.37 111.89 12.3 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.376 0.67 . . . . 74.42 110.303 -177.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 13.3 p -137.29 156.07 48.7 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.406 1.082 . . . . 75.42 109.326 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -74.31 176.64 6.51 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 109.454 -0.573 . . . . 74.33 109.454 175.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 18.3 121.13 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 127.179 2.192 . . . . 71.12 115.853 -165.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -139.09 150.76 46.08 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.731 -0.668 . . . . 75.03 110.855 -175.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.437 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 69.8 t80 -138.91 106.3 5.54 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 106.418 -1.697 . . . . 74.45 106.418 175.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . 0.48 ' HB2' ' OG ' ' D' ' 85' ' ' SER . 41.9 mt-30 -119.6 116.89 26.94 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.409 -0.589 . . . . 65.33 109.409 -175.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 63.1 mt -78.94 118.77 26.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.29 -1.004 . . . . 73.01 108.29 174.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.506 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 8.5 mm-40 -95.84 -39.71 9.69 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.433 0.293 . . . . 71.23 110.474 -174.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -173.36 137.87 0.68 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.699 0.4 . . . . 74.33 110.166 -176.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.5 mp -115.09 142.4 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 107.195 -1.409 . . . . 65.11 107.195 172.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -163.12 147.27 11.08 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.305 0.642 . . . . 73.44 110.866 175.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.6 p -82.59 114.39 20.95 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.059 -0.973 . . . . 74.33 109.39 175.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -87.24 -15.76 37.23 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.919 0.888 . . . . 72.32 109.634 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.671 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.9 t70 -163.34 130.85 3.54 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.81 1.244 . . . . 75.41 109.081 -177.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.576 HG23 ' HE1' ' C' ' 117' ' ' MET . 76.2 mt -134.56 142.86 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.225 -1.028 . . . . 72.51 108.225 173.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.9 t -143.17 137.25 28.91 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.502 1.121 . . . . 64.31 108.556 172.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.504 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.1 t80 -135.44 121.44 19.96 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.134 -1.802 . . . . 75.23 106.134 166.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 40.5 mt-10 -127.08 110.49 12.98 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.662 0.785 . . . . 73.35 109.054 -177.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.99 89.14 3.45 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 107.761 -1.199 . . . . 51.24 107.761 171.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -71.46 -37.74 5.28 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.596 2.197 . . . . 75.11 112.314 -174.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -99.44 4.55 46.19 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.085 0.954 . . . . 74.42 110.367 -174.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.403 ' HB2' ' HD3' ' D' ' 29' ' ' PRO . . . -25.14 -70.22 0.05 OUTLIER Pre-proline 0 CA--C 1.564 1.514 0 C-N-CA 127.471 2.309 . . . . 74.24 116.62 -166.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.523 ' HB3' HD13 ' C' ' 83' ' ' ILE . 76.7 Cg_endo -76.99 -19.76 13.58 Favored 'Trans proline' 0 C--N 1.382 2.291 0 CA-C-N 123.293 2.212 . . . . 72.43 113.95 -171.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -78.56 -38.55 40.05 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.274 1.03 . . . . 72.24 109.922 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.717 HG22 ' HA ' ' D' ' 73' ' ' ALA . 11.1 p -82.8 -19.53 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 CA-C-N 115.61 -0.723 . . . . 65.24 111.574 -171.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -62.9 -23.39 67.33 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 112.558 0.577 . . . . 74.44 112.558 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -57.1 -31.1 64.92 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.346 1.058 . . . . 74.54 110.668 177.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.549 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 86.3 mttt -84.92 78.93 9.8 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.905 1.282 . . . . 73.5 110.047 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -79.87 83.79 5.75 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 121.684 0.754 . . . . 70.44 110.698 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -157.77 -179.08 7.81 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.508 -0.923 . . . . 73.41 108.508 167.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -64.02 114.48 13.89 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 123.771 0.828 . . . . 74.24 110.693 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.479 ' O ' HG21 ' D' ' 40' ' ' VAL . 60.5 Cg_exo -56.46 122.69 12.24 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 121.897 1.732 . . . . 72.34 110.677 171.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -66.43 110.58 3.17 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 107.391 -1.337 . . . . 74.34 107.391 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.666 HG23 HD12 ' D' ' 126' ' ' LEU . 85.2 t -100.82 136.71 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.987 0.915 . . . . 74.54 110.845 -170.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -111.0 119.34 38.73 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.507 -0.923 . . . . 72.51 108.507 167.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 63.2 tp -96.94 143.23 28.01 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.194 -0.669 . . . . 73.2 109.194 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.596 ' HA ' HD21 ' E' ' 112' ' ' ASN . 31.5 t70 -142.15 144.14 33.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.041 -0.981 . . . . 63.05 108.575 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.69 ' HB2' ' HB3' ' E' ' 111' ' ' LEU . 72.8 mt -134.65 133.89 40.58 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.393 -0.965 . . . . 65.43 108.393 -177.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 16.4 t70 -134.04 151.18 51.32 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.847 1.259 . . . . 74.15 107.764 177.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.22 163.58 14.19 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.506 0.67 . . . . 72.43 111.396 -175.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -167.25 147.7 5.48 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 113.84 -1.527 . . . . 75.43 107.382 169.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 29.0 p -161.36 147.47 14.26 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.835 -0.431 . . . . 55.43 109.835 171.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.573 ' HA ' HD21 ' E' ' 102' ' ' LEU . 35.4 p -177.88 128.99 0.14 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.441 0.696 . . . . 75.21 110.233 -176.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . 0.481 ' HB2' ' H ' ' D' ' 57' ' ' GLU . 10.7 tm0? -160.76 -85.46 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 106.736 -1.579 . . . . 74.13 106.736 171.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 80.0 mt -138.15 -160.36 1.05 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.962 1.305 . . . . 71.15 107.545 170.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.546 ' HA ' ' HE2' ' D' ' 56' ' ' TYR . . . -133.38 78.45 1.78 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.566 -0.902 . . . . 55.12 108.566 170.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -163.97 50.58 0.14 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.646 -0.706 . . . . 73.33 109.496 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' D' ' 85' ' ' SER . 0.0 OUTLIER 72.88 -6.05 1.76 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 126.2 1.8 . . . . 74.01 113.419 177.126 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.96 105.52 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 108.869 -0.789 . . . . 75.22 108.869 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.546 ' HE2' ' HA ' ' D' ' 52' ' ' ALA . 47.0 m-85 -132.19 131.62 42.37 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.228 0.611 . . . . 74.44 110.478 -174.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.679 ' HG2' HG13 ' D' ' 83' ' ' ILE . 53.4 mt-10 -90.11 111.68 22.89 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.897 -0.779 . . . . 73.34 108.897 168.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 84.1 t -100.85 135.91 34.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 O-C-N 124.112 0.882 . . . . 73.3 109.379 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.524 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 47.2 t -122.78 133.96 67.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.033 1.333 . . . . 71.34 108.199 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.45 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -113.82 117.44 31.45 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.506 -1.294 . . . . 75.23 107.506 174.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.417 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 50.0 ttm-85 -93.87 95.02 8.83 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.419 -1.326 . . . . 74.14 107.419 174.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 49.0 t -91.11 144.13 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.44 -0.948 . . . . 73.23 108.44 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 36.0 m -139.87 141.25 36.61 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.036 -0.727 . . . . 71.32 109.036 -176.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.629 HG13 HG11 ' D' ' 40' ' ' VAL . 50.5 t -132.97 128.66 56.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 124.465 1.106 . . . . 75.14 108.49 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 56.6 m -125.01 93.37 3.87 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.371 -1.344 . . . . 65.4 107.371 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -95.71 154.59 17.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.941 -0.763 . . . . 75.54 108.941 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 28.7 p -153.37 132.56 12.67 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 123.331 0.394 . . . . 75.1 110.878 -173.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.508 HD11 HG21 ' D' ' 31' ' ' VAL . 52.1 mt -105.42 112.42 25.52 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.167 -1.049 . . . . 73.21 108.167 174.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.88 -133.42 15.3 Favored Glycine 0 C--N 1.345 1.057 0 O-C-N 123.38 0.425 . . . . 74.34 112.563 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.77 2.5 56.72 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.969 0.507 . . . . 75.4 111.758 -178.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.549 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 12.3 pt-20 -123.3 160.89 25.73 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.207 0.603 . . . . 74.54 110.528 -176.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 94.6 m -64.59 140.51 58.87 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.108 0.963 . . . . 72.34 110.992 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.717 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -92.33 -62.49 1.39 Allowed 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.855 -1.165 . . . . 74.14 107.855 172.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.84 165.78 35.55 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 114.347 -1.297 . . . . 73.32 109.937 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 87.5 mt -132.32 153.02 51.14 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.616 1.566 . . . . 74.44 107.257 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.637 ' SG ' HG12 ' D' ' 114' ' ' ILE . 53.0 t -158.61 145.1 17.2 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.747 0.419 . . . . 52.13 110.168 -177.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -154.54 126.8 7.84 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 123.103 0.561 . . . . 73.54 110.168 172.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 95.3 t -128.76 116.69 42.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 124.033 0.933 . . . . 75.1 109.059 -178.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.671 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.5 mt-30 -87.98 86.32 7.11 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.899 0.857 . . . . 74.53 108.863 168.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -82.46 97.9 8.63 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 113.831 -1.531 . . . . 73.11 109.394 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -96.2 166.62 24.58 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-N 116.48 -0.327 . . . . 71.11 112.706 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.7 153.26 12.97 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-O 119.837 -0.424 . . . . 74.22 112.783 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.679 HG13 ' HG2' ' D' ' 57' ' ' GLU . 3.0 mp -94.24 128.6 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 108.083 -1.08 . . . . 72.14 108.083 176.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -131.35 124.59 30.7 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.165 -1.05 . . . . 73.42 108.165 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.48 ' OG ' ' HB2' ' D' ' 12' ' ' GLN . 51.4 p -95.92 126.43 41.17 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 109.06 -0.719 . . . . 75.12 109.06 174.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 31.2 pt -133.61 129.39 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.452 -0.944 . . . . 74.43 108.452 -170.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.07 167.93 28.98 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.263 0.225 . . . . 63.1 111.18 -171.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.03 23.43 71.77 Favored Glycine 0 C--N 1.353 1.485 0 O-C-N 124.122 0.888 . . . . 74.02 114.484 171.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.641 HD11 ' HA ' ' D' ' 94' ' ' MET . 0.7 OUTLIER -133.54 155.45 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.158 0.583 . . . . 74.42 110.593 177.637 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.33 177.19 8.1 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.824 -1.08 . . . . 73.22 109.506 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.79 -140.78 25.49 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 123.29 0.368 . . . . 74.15 113.108 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 81.8 p -77.32 -43.09 34.3 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.772 0.829 . . . . 63.03 111.107 -175.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -57.96 -33.36 68.76 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.34 1.056 . . . . 75.32 111.771 -177.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.847 ' HE3' ' HB ' ' E' ' 97' ' ' ILE . 1.6 tmt? -47.56 -60.66 2.38 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.522 1.529 . . . . 74.44 112.729 -176.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.15 -15.7 46.19 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.204 0.601 . . . . 72.02 112.034 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -76.95 -17.52 58.85 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 122.859 0.464 . . . . 74.11 111.895 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 71.5 m -60.7 -44.26 96.77 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.586 0.354 . . . . 75.44 111.135 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.508 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 4.3 pp -79.27 -30.35 43.0 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.1 0.56 . . . . 75.25 111.816 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.55 -29.09 25.24 Favored Glycine 0 C--N 1.35 1.335 0 O-C-N 123.247 0.342 . . . . 61.24 113.669 -172.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.42 -57.12 2.02 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.447 0.699 . . . . 70.25 111.336 -171.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -72.87 -38.96 66.83 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 112.225 0.454 . . . . 61.45 112.225 -171.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.508 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 72.1 m -66.97 -46.1 53.58 Favored Pre-proline 0 CA--C 1.567 1.609 0 CA-C-O 118.679 -0.677 . . . . 75.13 111.937 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.45 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.4 Cg_exo -59.54 -32.0 95.46 Favored 'Trans proline' 0 C--N 1.393 2.913 0 C-N-CA 122.016 1.81 . . . . 73.51 112.911 169.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -64.63 -29.02 70.02 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.076 0.55 . . . . 71.41 111.125 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.404 ' O ' ' HD2' ' D' ' 108' ' ' PRO . 46.2 mm -78.23 -33.86 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.812 0.845 . . . . 74.22 110.786 174.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 65.3 mt -74.63 -18.79 60.49 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.24 0.616 . . . . 74.13 111.752 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -66.28 -45.81 60.63 Favored Pre-proline 0 CA--C 1.559 1.315 0 CA-C-O 118.195 -0.907 . . . . 75.31 113.306 -176.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' D' ' 105' ' ' ILE . 81.7 Cg_exo -52.37 -42.57 59.95 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.371 2.047 . . . . 74.23 114.323 171.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -71.99 -40.44 68.55 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.554 0.742 . . . . 70.35 111.49 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.03 -44.72 91.71 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.623 -0.717 . . . . 74.41 109.912 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.508 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 27.3 ttp180 -57.72 -49.1 77.66 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.74 1.275 . . . . 73.24 110.311 178.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -58.71 -49.02 79.12 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.373 1.045 . . . . 74.34 110.45 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 43.1 t -57.26 -45.64 83.8 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 124.031 0.832 . . . . 74.11 111.186 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.637 HG12 ' SG ' ' D' ' 76' ' ' CYS . 89.0 mt -61.17 -55.94 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.772 0.829 . . . . 74.32 110.673 175.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 90.7 m -52.86 -42.3 65.1 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 124.764 1.226 . . . . 74.32 111.088 -174.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.419 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 29.9 t -66.69 -43.14 85.18 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.492 -1.231 . . . . 74.12 109.863 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.6 mtm -70.69 -26.93 63.65 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.056 0.543 . . . . 74.14 111.941 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.459 HG22 ' HB3' ' D' ' 126' ' ' LEU . 79.8 t -64.73 -47.75 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.384 0.674 . . . . 71.42 109.38 173.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.9 p -72.82 -28.94 62.86 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.569 -0.741 . . . . 75.01 110.559 -178.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' D' ' 116' ' ' SER . 76.4 mtt-85 -71.16 -27.17 63.34 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.757 0.823 . . . . 73.14 110.097 173.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.46 8.87 79.11 Favored Glycine 0 C--N 1.351 1.398 0 CA-C-O 119.354 -0.692 . . . . 63.11 112.615 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 69.7 p 55.88 40.81 30.54 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.781 1.632 . . . . 64.54 113.761 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -105.93 152.95 40.4 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 109.001 -0.74 . . . . 75.33 109.001 170.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -48.91 133.46 28.08 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.024 2.483 . . . . 73.4 112.141 171.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -55.78 128.6 35.7 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 124.308 1.005 . . . . 75.04 112.389 -170.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.666 HD12 HG23 ' D' ' 40' ' ' VAL . 14.2 tp -111.23 102.57 10.98 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.139 0.976 . . . . 70.41 108.973 -176.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -100.9 104.39 15.59 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.647 -1.242 . . . . 53.1 107.647 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.508 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.2 mm? -64.32 114.75 4.47 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.189 0.595 . . . . 75.4 109.806 -177.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.401 ' HB2' ' HG3' ' B' ' 12' ' ' GLN . . . -62.14 132.76 93.94 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 123.105 0.562 . . . . 75.34 111.023 -174.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -61.43 116.66 3.55 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.06 2.507 . . . . 73.32 112.357 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . 0.419 HG11 HG21 ' E' ' 121' ' ' VAL . 7.2 p -110.54 136.1 47.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 N-CA-C 108.901 -0.777 . . . . 73.41 108.901 176.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -80.65 113.13 18.63 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.798 -0.816 . . . . 55.21 108.798 176.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -62.17 -40.02 94.63 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.027 0.931 . . . . 71.22 110.952 -177.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -51.59 -33.2 31.69 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.856 1.262 . . . . 73.21 112.481 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.26 -35.63 81.45 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.461 0.704 . . . . 73.14 111.572 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.483 ' HB3' ' HB1' ' E' ' 110' ' ' ALA . 2.5 mm? -75.33 -28.89 59.81 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.224 0.61 . . . . 74.25 111.389 178.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -75.54 -37.4 60.04 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.831 0.453 . . . . 73.31 110.649 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 73.7 mtm -71.43 -25.8 62.47 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.033 0.533 . . . . 73.35 110.297 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.504 ' O ' ' HG2' ' D' ' 143' ' ' GLN . 5.4 t30 -67.29 -43.93 80.5 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.267 0.627 . . . . 74.15 109.6 169.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . 0.441 ' HD1' ' HG2' ' E' ' 114' ' ' LYS . 90.2 t80 -57.94 -43.32 86.29 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.841 0.857 . . . . 74.31 111.938 -176.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.59 -35.46 81.07 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.927 -0.578 . . . . 71.52 111.355 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -91.36 30.72 1.24 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 122.978 0.511 . . . . 62.42 111.273 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' D' ' 139' ' ' ASN . 16.2 mm100 -118.22 52.29 1.03 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.266 1.026 . . . . 62.43 108.338 174.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -167.77 154.08 7.71 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-N 114.292 -1.322 . . . . 72.12 108.693 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.1 86.6 0.06 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.435 0.694 . . . . 73.14 110.218 174.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -164.63 40.86 0.3 Allowed Glycine 0 C--N 1.338 0.688 0 CA-C-N 114.987 -1.006 . . . . 73.33 111.075 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -89.18 161.37 16.49 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.907 0.883 . . . . 72.03 109.991 -178.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.49 75.72 0.66 Allowed Glycine 0 C--N 1.343 0.932 0 N-CA-C 110.76 -0.936 . . . . 71.23 110.76 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 3.3 t -141.33 100.58 3.82 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.999 0.92 . . . . 74.41 109.628 -176.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -170.33 149.42 3.39 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.332 1.053 . . . . 72.43 110.033 -176.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -143.89 89.46 2.05 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.084 0.953 . . . . 73.3 108.72 172.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -84.61 86.62 7.29 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.771 0.796 . . . . 75.45 109.133 170.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -136.99 111.96 8.94 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.557 0.743 . . . . 74.01 109.829 -176.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -132.57 158.81 41.23 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.316 1.046 . . . . 75.23 109.449 176.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.14 0 N-CA-C 108.671 -0.863 . . . . 74.1 108.671 177.486 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.948 0 N-CA-C 112.273 -0.331 . . . . 44.33 112.273 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.3 -87.84 0.5 Allowed Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.131 -0.788 . . . . 64.11 111.131 -172.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -172.76 173.89 3.77 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.959 1.304 . . . . 72.21 109.835 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 51.3 t80 67.92 -72.04 0.1 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.903 1.681 . . . . 75.25 112.897 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm 77.21 106.28 0.08 Allowed 'General case' 0 C--N 1.363 1.181 0 C-N-CA 125.774 1.629 . . . . 70.54 109.452 -173.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 96' ' ' GLY . . . . . 0.421 ' H ' ' HB3' ' D' ' 54' ' ' ASP . . . -131.87 -69.28 0.09 OUTLIER Glycine 0 C--N 1.337 0.602 0 N-CA-C 111.566 -0.614 . . . . 62.11 111.566 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 97' ' ' ILE . . . . . 0.847 ' HB ' ' HE3' ' D' ' 94' ' ' MET . 34.9 pt -123.66 131.65 72.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.516 0.727 . . . . 75.45 109.333 177.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -122.32 -47.1 2.14 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.228 0.611 . . . . 75.35 111.391 -172.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.14 79.77 6.65 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.331 0.586 . . . . 75.33 111.247 -173.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 100' ' ' LEU . . . . . 0.483 HD21 ' HH ' ' D' ' 56' ' ' TYR . 2.0 pp -140.83 150.31 59.31 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 124.343 1.057 . . . . 74.44 109.123 172.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.03 -3.33 13.11 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 122.487 2.125 . . . . 71.43 113.059 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 102' ' ' LEU . . . . . 0.573 HD21 ' HA ' ' D' ' 49' ' ' SER . 25.0 tp 61.48 27.24 16.83 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.342 1.057 . . . . 74.53 109.872 -178.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 17.3 p 49.17 36.9 9.84 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.385 1.474 . . . . 72.34 112.452 -175.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.7 24.33 67.65 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.626 -0.716 . . . . 74.14 113.494 176.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 105' ' ' GLN . . . . . 0.526 ' HG3' HD22 ' E' ' 102' ' ' LEU . 1.4 mp0 59.99 10.69 2.3 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 125.112 1.365 . . . . 74.33 113.378 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -150.29 -40.19 0.13 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 122.104 -0.373 . . . . 74.34 110.294 -170.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 7.3 m 66.94 -78.42 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.272 1.029 . . . . 63.41 109.648 -176.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 76.1 -52.76 0.61 Allowed 'General case' 0 C--N 1.36 1.052 0 C-N-CA 126.016 1.726 . . . . 73.23 112.946 173.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -59.23 149.98 26.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.664 0.786 . . . . 75.01 112.602 -171.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . 0.483 ' HB1' ' HB3' ' D' ' 136' ' ' LEU . . . 70.07 -151.67 0.11 Allowed 'General case' 0 CA--C 1.554 1.108 0 O-C-N 124.429 1.08 . . . . 75.31 111.321 174.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . 0.69 ' HB3' ' HB2' ' D' ' 44' ' ' LEU . 7.1 mp 73.78 -1.51 3.04 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.652 1.581 . . . . 61.45 113.424 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 112' ' ' ASN . . . . . 0.596 HD21 ' HA ' ' D' ' 43' ' ' ASP . 20.6 t-20 -176.88 -58.0 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.644 1.178 . . . . 73.02 107.909 -177.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -103.97 -159.0 0.69 Allowed 'General case' 0 C--O 1.243 0.723 0 CA-C-N 114.062 -1.427 . . . . 71.5 109.599 -176.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . 0.441 ' HG2' ' HD1' ' D' ' 140' ' ' TYR . 49.1 tptt 65.45 38.61 5.56 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 122.435 1.112 . . . . 75.1 109.213 -175.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 115' ' ' THR . . . . . 0.454 ' HB ' HD22 ' D' ' 139' ' ' ASN . 9.0 t -164.42 -43.44 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.412 -1.267 . . . . 72.15 109.671 -177.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 149.01 -96.06 0.17 Allowed Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.518 -1.033 . . . . 63.01 110.518 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -92.83 157.22 39.87 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 123.774 0.829 . . . . 74.11 110.632 -172.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -83.6 17.27 1.71 Allowed 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.66 2.906 . . . . 73.53 113.045 172.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -60.31 -30.19 69.34 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.983 0.913 . . . . 75.14 112.573 -174.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -75.83 -54.83 6.3 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.013 0.525 . . . . 75.23 110.956 -177.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 121' ' ' VAL . . . . . 0.419 HG21 HG11 ' D' ' 131' ' ' VAL . 8.5 p -71.19 -39.79 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.356 0.662 . . . . 72.13 110.803 -177.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 33.7 m -99.63 78.98 2.2 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.377 1.071 . . . . 73.02 108.15 176.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -96.19 107.88 20.27 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.666 -1.235 . . . . 71.3 107.666 171.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 21.6 p -77.85 116.92 18.73 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.961 -0.563 . . . . 73.12 110.628 -174.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -151.91 -161.09 1.25 Allowed 'General case' 0 C--O 1.246 0.918 0 C-N-CA 125.028 1.331 . . . . 71.41 107.891 172.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . 66.1 -178.24 0.19 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.845 0.858 . . . . 70.12 110.999 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 33.0 p -157.49 -74.75 0.09 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 110.023 -0.362 . . . . 72.32 110.023 175.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . 56.03 27.37 11.22 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.969 0.907 . . . . 75.23 111.756 -175.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 24.1 p -79.84 89.93 5.27 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 124.294 1.038 . . . . 74.11 110.932 -173.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -149.8 96.75 2.51 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.832 0.853 . . . . 62.22 108.918 176.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 131' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -149.36 98.3 2.77 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.902 0.881 . . . . 72.51 108.879 177.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 132' ' ' SER . . . . . 0.608 ' H ' ' HB3' ' A' ' 124' ' ' PRO . 32.5 t -174.88 103.08 0.09 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.108 1.363 . . . . 65.02 108.026 176.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 30.6 m -119.8 105.5 11.18 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.653 0.381 . . . . 72.32 110.739 -178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.23 87.21 1.0 Allowed Glycine 0 C--N 1.34 0.8 0 N-CA-C 109.653 -1.379 . . . . 71.01 109.653 167.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 82.6 t -59.68 -56.99 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.553 0.741 . . . . 75.2 109.978 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 65.9 -7.28 0.38 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.088 1.355 . . . . 73.32 113.96 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 137' ' ' THR . . . . . 0.617 HG23 ' H ' ' E' ' 139' ' ' ASN . 30.0 m 69.86 148.61 0.07 Allowed 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 124.956 1.303 . . . . 63.11 111.039 -168.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -55.08 -34.99 64.09 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.55 0.69 . . . . 75.5 110.181 171.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 139' ' ' ASN . . . . . 0.617 ' H ' HG23 ' E' ' 137' ' ' THR . 24.7 t-20 -91.31 85.29 5.78 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 107.808 -1.182 . . . . 64.04 107.808 167.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.57 138.36 35.77 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 115.323 -0.853 . . . . 72.15 112.934 -174.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.89 141.32 58.81 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.237 0.615 . . . . 70.04 111.094 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 89.9 mt -59.89 137.43 58.07 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.365 0.666 . . . . 73.34 110.778 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -72.65 74.2 0.93 Allowed Glycine 0 C--N 1.348 1.235 0 O-C-N 123.946 0.779 . . . . 63.13 112.001 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 13.0 m -88.83 84.69 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.191 0.996 . . . . 70.23 110.003 -174.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 16.1 t70 . . . . . 0 C--O 1.252 1.199 0 N-CA-C 108.25 -1.019 . . . . 74.0 108.25 -175.263 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.796 0 N-CA-C 112.079 -0.408 . . . . 64.13 112.079 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.26 -53.92 40.62 Favored Glycine 0 C--N 1.355 1.603 0 N-CA-C 114.146 0.418 . . . . 64.43 114.146 -172.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 93' ' ' PHE . . . . . 0.46 ' HD2' HG21 ' B' ' 55' ' ' VAL . 86.6 m-85 -70.73 97.52 1.38 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.799 0.84 . . . . 64.51 110.671 -178.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 94' ' ' PHE . . . . . 0.414 ' CD2' HG22 ' B' ' 10' ' ' THR . 70.4 t80 -95.18 160.42 14.56 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.453 0.701 . . . . 74.4 109.381 175.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -136.3 149.84 48.62 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.179 0.592 . . . . 62.22 112.451 -173.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.72 51.35 0.01 OUTLIER Glycine 0 C--N 1.351 1.413 0 CA-C-N 115.443 -0.799 . . . . 73.15 112.309 174.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 97' ' ' ILE . . . . . 0.512 ' HB ' ' HA ' ' B' ' 87' ' ' ALA . 7.2 tt -152.48 -20.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 124.502 1.121 . . . . 64.54 109.828 -177.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 33.6 t70 65.93 -96.33 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.891 1.676 . . . . 75.14 112.009 177.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -98.78 144.13 28.35 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.635 0.774 . . . . 74.04 109.951 -172.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 100' ' ' LEU . . . . . . . . . . . . . 3.0 mp -128.19 86.17 58.65 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 123.198 0.599 . . . . 74.32 109.726 -177.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.92 -61.36 0.25 Allowed 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.632 2.221 . . . . 75.53 112.141 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 102' ' ' LEU . . . . . 0.425 HD22 ' HB3' ' B' ' 95' ' ' ALA . 2.2 tm? 56.55 94.53 0.02 OUTLIER 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.908 1.283 . . . . 72.34 109.824 -173.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 32.0 p 66.14 -63.69 0.23 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.384 1.874 . . . . 74.0 111.752 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 178.17 -38.46 0.08 OUTLIER Glycine 0 C--N 1.339 0.731 0 N-CA-C 110.959 -0.856 . . . . 65.13 110.959 173.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -170.97 -51.68 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.222 1.009 . . . . 73.11 109.493 -175.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -131.21 118.57 20.61 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.694 0.797 . . . . 74.11 109.384 -174.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 27.9 m -64.81 121.28 14.22 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.734 0.814 . . . . 74.33 110.656 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -128.31 7.46 5.92 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.533 0.733 . . . . 73.42 110.795 -177.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -82.15 73.11 9.2 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.723 0.809 . . . . 75.33 109.53 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 60.31 -167.92 0.17 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.179 0.992 . . . . 75.31 110.031 -170.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 86.2 mt 53.6 74.2 0.33 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.666 0.787 . . . . 72.41 111.204 176.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -160.07 -64.0 0.07 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.477 -0.783 . . . . 71.13 109.961 -171.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 113' ' ' LYS . . . . . 0.567 ' HE3' ' HB ' ' F' ' 115' ' ' THR . 54.3 pttt -175.3 -165.76 0.19 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.065 0.946 . . . . 73.34 110.187 -172.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . 0.566 ' HD3' ' HE2' ' B' ' 41' ' ' LYS . 53.7 mtmt -93.12 31.23 1.48 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.795 0.838 . . . . 74.52 111.322 178.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 115' ' ' THR . . . . . 0.567 ' HB ' ' HE3' ' F' ' 113' ' ' LYS . 57.4 m -130.43 148.62 52.26 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.464 1.106 . . . . 62.21 108.881 175.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.46 -136.07 13.12 Favored Glycine 0 C--N 1.341 0.859 0 N-CA-C 110.61 -0.996 . . . . 73.53 110.61 -175.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -128.24 84.14 64.1 Favored Pre-proline 0 CA--C 1.551 1.004 0 CA-C-N 117.392 0.596 . . . . 75.23 110.123 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -90.75 112.54 0.4 Allowed 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 123.914 3.076 . . . . 72.4 110.378 172.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -125.19 171.57 10.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.408 0.683 . . . . 75.14 110.658 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 28.6 t80 74.58 -70.59 0.15 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.541 1.536 . . . . 75.4 110.966 175.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 99.7 t -129.45 114.21 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 123.466 0.706 . . . . 73.42 109.325 175.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 14.8 t -169.61 20.53 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.564 0.746 . . . . 72.54 110.361 176.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -123.16 -173.0 2.62 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.382 0.673 . . . . 75.43 111.353 -165.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 124' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' B' ' 41' ' ' LYS . 28.1 t -83.37 140.72 32.24 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 115.172 -0.922 . . . . 74.04 109.531 170.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -163.74 -34.52 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.604 0.762 . . . . 74.22 110.212 -176.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 126' ' ' ALA . . . . . 0.609 ' HB3' ' HB ' ' B' ' 40' ' ' VAL . . . -62.9 108.97 1.31 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.519 0.728 . . . . 52.04 111.626 -175.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 15.5 p -147.63 62.98 1.14 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.703 1.201 . . . . 63.31 108.381 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.84 -84.06 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.86 -1.064 . . . . 64.14 110.823 -173.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 14.8 m -154.71 140.36 17.98 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.803 0.441 . . . . 75.51 110.166 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.99 167.29 19.5 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.384 1.074 . . . . 71.22 112.144 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -137.11 132.72 34.46 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.826 0.85 . . . . 64.13 108.85 176.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 21.3 t -162.16 76.8 0.48 Allowed 'General case' 0 C--O 1.238 0.49 0 O-C-N 123.957 0.786 . . . . 75.15 109.122 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 53.8 m -146.98 120.05 8.81 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.883 -0.784 . . . . 75.42 108.883 177.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.49 83.7 1.11 Allowed Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.694 -0.563 . . . . 70.43 111.694 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 135' ' ' VAL . . . . . 0.529 HG12 ' HB3' ' C' ' 129' ' ' ALA . 21.7 t -73.85 86.44 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 N-CA-C 108.31 -0.996 . . . . 75.34 108.31 176.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -107.88 106.08 16.19 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.593 1.157 . . . . 73.13 109.728 -173.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 82.2 p 51.82 -80.61 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 126.602 1.961 . . . . 72.25 112.937 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -156.66 133.86 10.54 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.346 1.058 . . . . 70.42 109.326 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -178.36 -62.43 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.083 0.953 . . . . 74.32 109.309 174.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . 74.7 -91.4 0.77 Allowed Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.136 -0.938 . . . . 71.15 112.197 -175.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -171.82 167.1 6.41 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.64 1.176 . . . . 61.32 109.363 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 4.7 pp -79.22 138.2 37.73 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 107.908 -1.145 . . . . 71.31 107.908 169.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.93 170.19 54.57 Favored Glycine 0 C--N 1.342 0.885 0 O-C-N 123.229 0.33 . . . . 74.43 112.92 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 40.9 t -69.11 -52.73 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 108.33 -0.989 . . . . 74.02 108.33 175.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 31.2 t70 . . . . . 0 C--O 1.247 0.937 0 CA-C-N 114.401 -1.272 . . . . 71.43 108.841 173.047 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.8 m . . . . . 0 CA--C 1.534 0.357 0 N-CA-C 106.942 -1.503 . . . . 75.44 106.942 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -137.32 121.11 17.48 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.752 -1.203 . . . . 72.45 107.752 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -143.02 110.82 5.91 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.157 -0.683 . . . . 62.25 109.157 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.9 mt -70.39 114.39 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.317 -0.623 . . . . 72.13 109.317 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -82.18 -39.93 22.47 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.653 0.595 . . . . 70.1 110.206 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -175.06 122.42 0.23 Allowed 'General case' 0 N--CA 1.481 1.098 0 O-C-N 123.608 0.568 . . . . 72.42 110.862 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 97.0 mt -106.21 136.0 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.378 -0.971 . . . . 73.15 108.378 171.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.532 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 30.7 p90 -166.78 164.93 16.54 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 123.843 0.714 . . . . 72.05 111.196 -174.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.3 p -88.33 124.0 33.47 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.77 -0.456 . . . . 55.15 109.77 175.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -90.85 -36.94 13.91 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.891 -0.781 . . . . 73.24 108.891 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.713 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 24.7 t70 -138.8 136.84 36.09 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.982 -1.008 . . . . 63.4 109.125 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 76.4 mt -130.88 142.62 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.804 1.242 . . . . 71.32 107.818 173.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.2 t -149.44 116.6 6.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.394 0.678 . . . . 65.13 109.983 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.707 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.1 t80 -122.79 136.69 54.95 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.472 -1.307 . . . . 63.23 107.472 168.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -133.47 129.55 37.37 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.196 0.598 . . . . 73.22 110.088 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.47 69.87 12.65 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 105.852 -1.907 . . . . 14.42 105.852 167.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.07 -16.58 17.83 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.325 2.017 . . . . 52.53 111.124 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -94.71 9.43 38.94 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.651 1.18 . . . . 74.5 110.369 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -47.66 -58.53 7.4 Favored Pre-proline 0 CA--C 1.569 1.698 0 C-N-CA 124.785 1.234 . . . . 73.25 113.853 -165.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.478 ' HB3' HD11 ' B' ' 51' ' ' LEU . 69.4 Cg_exo -51.85 -44.56 44.17 Favored 'Trans proline' 0 C--N 1.398 3.152 0 C-N-CA 122.715 2.277 . . . . 73.21 113.856 -173.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -96.18 -13.03 23.81 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.485 -0.78 . . . . 72.11 112.205 -174.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.472 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.4 p -77.45 -15.86 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 120.869 0.366 . . . . 74.51 110.708 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -77.41 -22.39 51.63 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.299 0.64 . . . . 74.12 110.904 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -77.62 -23.79 49.73 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.921 0.889 . . . . 75.2 110.283 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 71' ' ' GLU . 30.3 mmmt -65.64 144.93 56.63 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.22 1.008 . . . . 72.32 111.94 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -60.47 117.72 5.61 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.661 -0.866 . . . . 70.25 108.661 168.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.415 ' CE3' HD21 ' A' ' 68' ' ' LEU . 70.6 t-105 -75.6 84.68 2.65 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.676 0.75 . . . . 74.51 110.022 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.74 78.32 74.0 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 105.882 -1.896 . . . . 63.45 105.882 169.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -81.93 140.67 11.52 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.665 2.243 . . . . 73.44 111.908 -173.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -97.66 83.78 3.27 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.072 -1.455 . . . . 63.33 107.072 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 66' ' ' ALA . 58.0 t -81.96 119.16 30.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 CA-C-N 114.745 -1.116 . . . . 63.25 109.549 -174.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.437 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 74.0 mttt -113.86 113.57 25.06 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.237 1.015 . . . . 74.31 108.467 -170.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -98.43 121.16 40.02 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 108.294 -1.002 . . . . 71.33 108.294 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -130.43 138.57 50.39 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.39 1.076 . . . . 70.22 108.265 -176.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.525 HD22 HD21 ' A' ' 60' ' ' LEU . 88.3 mt -128.89 140.14 51.82 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.939 0.496 . . . . 53.02 110.95 -173.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.52 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 27.7 t70 -142.9 146.19 33.8 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.465 1.106 . . . . 74.02 108.742 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.2 m -131.8 128.85 39.63 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.117 0.567 . . . . 74.45 110.076 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.71 110.04 10.11 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.66 0.784 . . . . 62.13 109.151 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.4 p -90.68 161.23 15.47 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 109.512 -0.551 . . . . 51.01 109.512 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.4 t -152.97 121.17 6.21 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.966 0.906 . . . . 54.21 108.702 -172.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -79.72 104.23 10.17 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.589 -0.893 . . . . 73.43 108.589 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.6 mt -81.83 -35.58 29.25 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.893 0.477 . . . . 53.31 109.96 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.45 -176.47 5.08 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.628 0.771 . . . . 32.31 110.391 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.68 113.95 4.1 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.501 0.72 . . . . 74.2 110.181 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 66.27 17.89 10.8 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.629 1.172 . . . . 52.13 111.609 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.5 t -119.69 106.85 19.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 107.73 -1.211 . . . . 63.31 107.73 173.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -123.12 125.49 45.25 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.29 -1.004 . . . . 64.42 108.29 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -86.35 139.48 30.93 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.46 -0.941 . . . . 74.32 108.46 168.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.1 t -120.17 140.93 42.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.02 -1.104 . . . . 71.31 108.02 171.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.8 t -121.07 130.26 74.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.515 -0.92 . . . . 73.31 108.515 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.525 HD21 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -105.13 107.88 19.1 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.875 -1.528 . . . . 71.33 106.875 177.386 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.52 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 32.1 ttp180 -92.35 99.66 12.38 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.224 -1.399 . . . . 75.25 107.224 174.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.27 127.98 47.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 107.689 -1.226 . . . . 74.11 107.689 174.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.411 HG23 ' HB2' ' A' ' 77' ' ' GLU . 7.5 m -121.05 125.08 46.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.402 0.62 . . . . 53.43 109.672 175.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.663 HG11 HD21 ' A' ' 126' ' ' LEU . 58.9 t -116.23 125.12 73.15 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 C-N-CA 124.962 1.305 . . . . 73.11 107.567 177.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.437 ' HB ' ' HD2' ' A' ' 41' ' ' LYS . 13.8 m -127.75 127.07 42.98 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.155 0.889 . . . . 61.13 109.629 172.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.485 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -118.07 126.46 52.32 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.346 -0.983 . . . . 71.25 108.346 178.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 35.2 m -130.24 132.82 46.13 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.461 0.704 . . . . 61.23 110.352 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.415 HD21 ' CE3' ' A' ' 36' ' ' TRP . 12.6 mt -93.08 70.35 4.52 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 125.26 1.424 . . . . 73.01 109.058 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.8 -107.03 2.36 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-N 115.595 -0.73 . . . . 51.45 111.404 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.1 -26.77 17.31 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.551 0.74 . . . . 54.14 111.216 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.42 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 6.3 tp10 -93.81 123.9 37.46 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.587 0.755 . . . . 71.31 109.001 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 89.8 m -75.82 136.79 40.21 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 117.744 0.247 . . . . 65.43 110.57 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.472 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -74.34 -64.83 0.94 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.763 -0.828 . . . . 41.03 108.763 174.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.452 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 31.6 p90 -158.94 170.31 22.38 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.325 -0.852 . . . . 61.42 112.002 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 64' ' ' VAL . 57.2 tp -125.28 135.83 52.9 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.91 1.284 . . . . 64.14 107.831 167.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.45 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 73.7 m -135.4 97.75 3.78 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.692 0.797 . . . . 64.41 110.249 174.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.411 ' HB2' HG23 ' A' ' 63' ' ' THR . 34.9 tt0 -117.66 118.26 31.61 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.112 0.965 . . . . 72.15 108.543 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.9 t -127.68 121.82 57.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 109.134 -0.691 . . . . 62.4 109.134 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.713 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.2 mt-30 -92.79 86.37 5.49 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.275 -0.875 . . . . 72.14 108.865 173.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 -76.71 99.37 5.06 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 113.786 -1.552 . . . . 73.24 109.469 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.14 159.73 32.85 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 111.419 -0.672 . . . . 34.22 111.419 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.437 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -161.02 122.45 1.12 Allowed Glycine 0 CA--C 1.498 -0.987 0 N-CA-C 110.336 -1.106 . . . . 55.31 110.336 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.6 mt -78.72 124.65 37.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 N-CA-C 107.337 -1.357 . . . . 74.41 107.337 173.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -123.79 160.04 28.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.884 -0.784 . . . . 72.12 108.884 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.6 t -117.75 101.57 8.43 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.349 -1.352 . . . . 54.4 107.349 173.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.0 mm -107.72 145.4 15.03 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 O-C-N 123.736 0.647 . . . . 75.44 110.249 -176.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.51 177.25 8.28 Favored 'General case' 0 C--O 1.231 0.116 0 O-C-N 123.761 0.663 . . . . 73.43 110.971 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.93 -27.18 11.61 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-N 116.061 -0.518 . . . . 53.1 113.047 176.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.45 148.19 24.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 C-N-CA 123.772 0.829 . . . . 70.24 110.808 -171.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.599 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 2.3 mp0 -135.9 175.42 9.61 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.915 0.886 . . . . 73.53 109.952 176.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.12 -119.77 9.88 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-N 115.341 -0.845 . . . . 74.52 113.497 174.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.5 p -73.2 -30.21 63.37 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.114 0.966 . . . . 54.12 110.448 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -74.66 -36.52 62.83 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.14 -0.937 . . . . 62.23 109.852 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.599 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 2.6 tpt -61.22 -44.78 96.72 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.295 0.638 . . . . 73.41 109.75 172.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.4 -29.48 69.0 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.269 -0.878 . . . . 55.51 111.271 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.506 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 54.0 t-80 -71.88 -27.66 63.01 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.288 0.635 . . . . 73.12 111.068 176.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 37.1 t -79.55 -60.73 2.24 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.147 -0.686 . . . . 73.15 109.147 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 78.5 mt -67.92 -34.15 76.06 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.03 0.932 . . . . 71.51 113.196 -172.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.87 3.46 52.5 Favored Glycine 0 N--CA 1.47 0.963 0 CA-C-O 119.688 -0.506 . . . . 73.4 113.775 -173.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.563 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -140.14 -70.47 0.39 Allowed 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 117.348 0.574 . . . . 62.15 111.332 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -67.69 -39.19 84.46 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 111.879 0.325 . . . . 64.22 111.879 -171.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 63.5 m -66.68 -53.35 28.87 Favored Pre-proline 0 CA--C 1.564 1.492 0 C-N-CA 124.566 1.146 . . . . 65.05 112.164 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.431 ' HA ' HD12 ' A' ' 106' ' ' LEU . 58.2 Cg_endo -68.35 -18.89 44.2 Favored 'Trans proline' 0 C--N 1.399 3.219 0 C-N-CA 121.965 1.777 . . . . 73.11 112.616 175.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 0.1 OUTLIER -67.4 -47.24 70.87 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.934 -0.765 . . . . 72.05 108.934 174.74 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.3 mm -59.56 -33.45 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.758 1.223 . . . . 71.04 111.299 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.437 HD21 ' HA3' ' A' ' 82' ' ' GLY . 49.3 mt -79.86 -18.8 49.85 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.315 0.646 . . . . 71.04 112.153 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -66.51 -40.55 34.14 Favored Pre-proline 0 CA--C 1.558 1.251 0 N-CA-C 114.737 1.384 . . . . 75.03 114.737 -172.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.5 -37.71 94.72 Favored 'Trans proline' 0 C--N 1.389 2.69 0 C-N-CA 121.998 1.798 . . . . 74.43 112.757 173.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -82.32 -35.2 28.16 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.098 -0.955 . . . . 75.43 111.022 -175.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.73 -49.39 73.24 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.157 -0.683 . . . . 64.04 109.157 174.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.518 ' NH1' HD12 ' C' ' 105' ' ' ILE . 32.3 ttm180 -49.86 -55.14 15.43 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 125.19 1.556 . . . . 64.13 110.511 174.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.85 -42.57 94.79 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.25 0.969 . . . . 64.32 111.686 -173.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 117' ' ' MET . 48.7 t -60.45 -40.79 92.44 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 123.5 0.5 . . . . 53.54 110.795 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.464 HG21 HG21 ' A' ' 64' ' ' VAL . 63.2 mt -64.58 -50.34 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.224 1.01 . . . . 75.4 110.597 174.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.446 HG21 ' HE2' ' C' ' 109' ' ' TYR . 82.9 m -58.03 -44.62 87.44 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.367 1.067 . . . . 74.4 111.245 -174.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 24.0 t -65.69 -40.74 92.64 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.329 -1.305 . . . . 74.22 110.21 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.707 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 38.0 mtm -64.07 -41.28 97.39 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.61 0.364 . . . . 73.13 111.034 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.409 HG13 ' HB2' ' A' ' 123' ' ' PHE . 79.3 t -61.58 -45.37 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 O-C-N 124.051 0.844 . . . . 65.0 110.587 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.3 p -71.91 -32.76 67.69 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.014 0.525 . . . . 73.21 111.273 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.463 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.5 mtt-85 -69.96 -30.88 68.35 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.271 0.629 . . . . 73.21 109.704 174.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.99 12.72 57.16 Favored Glycine 0 C--N 1.355 1.604 0 O-C-N 123.905 0.753 . . . . 51.25 112.861 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.402 HG21 ' HE ' ' B' ' 15' ' ' ARG . 1.5 t 62.19 14.19 6.46 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.153 2.181 . . . . 74.15 113.615 172.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.409 ' HB2' HG13 ' A' ' 118' ' ' VAL . 98.1 m-85 -80.49 149.35 68.26 Favored Pre-proline 0 C--O 1.244 0.813 0 N-CA-C 107.068 -1.456 . . . . 71.22 107.068 169.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.63 142.88 81.3 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.163 1.909 . . . . 50.41 111.396 176.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -55.53 122.63 11.71 Favored 'General case' 0 C--N 1.352 0.705 0 O-C-N 124.246 0.966 . . . . 63.02 111.481 -169.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.663 HD21 HG11 ' A' ' 64' ' ' VAL . 22.6 tp -106.15 121.15 43.59 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 108.35 -0.982 . . . . 73.31 108.35 -176.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.588 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 88.6 m-20 -117.74 124.28 48.08 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.657 -1.238 . . . . 71.33 107.657 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 9.6 mt -74.24 140.3 44.92 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.966 -0.753 . . . . 74.3 108.966 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.62 140.16 89.36 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-O 119.251 -0.404 . . . . 61.2 111.025 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -56.09 115.68 2.64 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 123.392 2.728 . . . . 72.31 113.343 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.414 HG21 HD11 ' A' ' 44' ' ' LEU . 92.0 t -102.72 123.38 56.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-N 115.421 -0.809 . . . . 73.44 109.517 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -87.24 90.72 8.46 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 107.778 -1.193 . . . . 71.45 107.778 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.412 ' CZ ' HD13 ' A' ' 44' ' ' LEU . 29.3 m-85 -63.58 -28.6 70.04 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.396 0.678 . . . . 60.4 111.465 177.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.563 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 14.8 t70 -61.7 -39.39 91.33 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.486 0.715 . . . . 75.43 110.11 175.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.5 -40.17 89.09 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.728 0.811 . . . . 62.33 110.651 173.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.97 -38.74 89.67 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.259 0.623 . . . . 73.53 111.352 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.502 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 60.1 t80 . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 109.79 -0.448 . . . . 74.31 109.79 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.449 ' HG3' HG13 ' B' ' 89' ' ' ILE . 24.6 ttt . . . . . 0 CA--C 1.562 1.413 0 CA-C-O 121.628 0.728 . . . . 73.22 111.564 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.406 ' N ' ' HG2' ' B' ' 9' ' ' MET . 2.6 t -138.75 126.58 22.26 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.691 1.196 . . . . 54.22 108.46 169.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -127.9 137.41 52.3 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.286 -1.005 . . . . 74.12 108.286 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -151.86 109.71 3.67 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.624 0.369 . . . . 71.43 110.359 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.431 HD13 HD11 ' B' ' 16' ' ' ILE . 47.4 mt -60.84 144.65 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 108.853 -0.795 . . . . 73.3 108.853 172.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -110.04 -45.21 3.64 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.684 -0.487 . . . . 75.52 109.684 176.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.402 ' HE ' HG21 ' A' ' 122' ' ' THR . 50.0 ttt180 -167.45 132.66 1.98 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.386 -0.598 . . . . 61.4 109.386 -173.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.431 HD11 HD13 ' B' ' 13' ' ' ILE . 96.4 mt -118.88 147.93 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 107.494 -1.299 . . . . 74.4 107.494 177.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -169.91 163.89 9.6 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.836 0.827 . . . . 73.2 112.139 -174.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 82.7 m -92.49 122.74 35.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.627 -1.624 . . . . 63.35 108.237 171.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -80.05 -49.94 11.07 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.571 0.748 . . . . 64.34 110.732 170.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -144.99 139.46 27.5 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 122.113 -0.367 . . . . 73.2 111.185 -168.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.462 HD11 ' SG ' ' B' ' 113' ' ' CYS . 49.5 mm -128.86 141.77 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.247 1.019 . . . . 74.0 109.911 173.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -144.82 133.35 22.02 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.69 1.196 . . . . 71.12 108.002 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -143.6 109.9 5.41 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.016 -1.105 . . . . 73.02 108.016 173.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -117.97 114.86 23.8 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.562 0.745 . . . . 72.03 109.039 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.25 88.31 2.47 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 106.431 -1.692 . . . . 75.11 106.431 170.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -72.02 -31.8 11.87 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.092 2.528 . . . . 72.11 113.256 -168.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -109.42 25.72 11.47 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.307 0.643 . . . . 74.53 109.268 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.532 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -44.36 -58.41 5.1 Favored Pre-proline 0 CA--C 1.564 1.487 0 N-CA-C 114.633 1.346 . . . . 74.13 114.633 -163.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 24.6 Cg_exo -61.3 -35.94 81.83 Favored 'Trans proline' 0 C--N 1.393 2.889 0 C-N-CA 122.078 1.852 . . . . 75.34 112.962 -174.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -95.08 -25.18 16.56 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.478 -0.783 . . . . 72.54 112.47 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.536 HG22 HD12 ' B' ' 68' ' ' LEU . 4.5 p -71.15 -14.25 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-O 121.332 0.587 . . . . 65.13 110.14 -175.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -73.31 -2.66 22.95 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.265 1.026 . . . . 74.34 112.459 174.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -68.63 -19.64 64.43 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.435 0.694 . . . . 73.24 110.116 169.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.573 ' HB2' HD13 ' B' ' 68' ' ' LEU . 29.4 mmtp -98.31 102.62 14.42 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 125.497 1.519 . . . . 74.4 108.884 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -99.8 77.35 2.04 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.807 0.443 . . . . 74.03 110.639 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 43.6 p90 -160.99 167.97 25.45 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.976 0.91 . . . . 74.52 109.581 169.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.46 113.97 22.45 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 107.328 -1.36 . . . . 73.04 107.328 176.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.92 163.92 15.22 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.809 2.339 . . . . 64.21 113.709 -173.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -71.21 103.95 2.95 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.388 -0.967 . . . . 44.43 108.388 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.555 HG11 HD11 ' B' ' 126' ' ' LEU . 49.0 t -94.33 146.5 6.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 114.996 -1.002 . . . . 64.35 110.253 -176.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -149.14 125.96 11.17 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.24 1.016 . . . . 74.3 108.282 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.441 HD11 ' CG1' ' B' ' 62' ' ' VAL . 16.3 tp -89.65 137.95 31.89 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.061 0.545 . . . . 75.33 109.768 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -139.56 113.29 8.57 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.441 1.096 . . . . 64.31 108.309 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 91.3 mt -99.69 152.46 20.05 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.751 0.82 . . . . 71.34 109.636 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.789 ' HB3' ' HD2' ' B' ' 61' ' ' ARG . 31.7 t70 -156.03 151.59 27.04 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 107.324 -1.362 . . . . 72.02 107.324 173.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' THR . . . . . 0.45 HG22 ' HA ' ' B' ' 60' ' ' LEU . 0.9 OUTLIER -143.83 146.45 33.07 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.664 0.745 . . . . 74.31 112.315 -170.888 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.11 153.2 41.91 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.931 1.292 . . . . 63.32 108.359 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.487 ' HB2' ' CE2' ' B' ' 56' ' ' TYR . 74.4 p -145.7 176.05 9.93 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.565 0.579 . . . . 73.43 112.565 -174.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 65.5 p -162.01 139.29 8.46 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.688 1.195 . . . . 75.13 109.869 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -90.79 109.93 21.13 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.284 -0.635 . . . . 71.22 109.284 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' A' ' 29' ' ' PRO . 39.3 mt -86.56 -23.34 25.85 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.763 0.425 . . . . 71.41 110.531 175.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.543 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -163.1 167.42 22.28 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.452 0.701 . . . . 71.51 111.08 -176.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -82.17 138.49 34.69 Favored 'General case' 0 C--O 1.248 0.99 0 N-CA-C 107.291 -1.374 . . . . 71.14 107.291 161.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 78.17 -5.35 2.09 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 125.758 1.623 . . . . 73.5 112.258 -175.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 50.1 t -144.34 117.97 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.539 0.735 . . . . 71.21 109.044 -175.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.487 ' CE2' ' HB2' ' B' ' 48' ' ' SER . 26.9 t80 -126.61 151.58 47.8 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.195 0.598 . . . . 75.41 110.002 -173.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -116.26 121.0 40.73 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 107.755 -1.202 . . . . 74.31 107.755 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 12.9 p -127.48 147.93 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.128 0.571 . . . . 72.43 109.984 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 17.4 t -125.37 116.26 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.73 0.812 . . . . 64.2 109.808 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.45 ' HA ' HG22 ' B' ' 46' ' ' THR . 58.0 tp -94.72 105.27 17.21 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.051 -0.722 . . . . 74.32 109.051 170.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.789 ' HD2' ' HB3' ' B' ' 45' ' ' ASP . 1.7 tmt_? -86.54 120.46 27.89 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.709 -1.219 . . . . 72.43 107.709 172.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.441 ' CG1' HD11 ' B' ' 42' ' ' LEU . 32.3 t -114.81 133.04 62.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.284 -1.006 . . . . 52.15 108.284 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 24.7 m -131.03 131.81 44.54 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.325 0.583 . . . . 75.23 109.628 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.7 HG11 HD21 ' B' ' 126' ' ' LEU . 97.2 t -111.54 118.74 58.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 C-N-CA 124.419 1.087 . . . . 74.03 108.338 176.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 68.5 m -92.51 130.94 38.03 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.114 -1.069 . . . . 70.24 108.114 168.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.39 134.34 27.19 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.863 -0.792 . . . . 72.33 108.863 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.492 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 18.8 p -144.63 133.26 22.2 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 123.736 0.648 . . . . 63.22 110.803 -175.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.573 HD13 ' HB2' ' B' ' 34' ' ' LYS . 78.4 mt -99.45 103.05 14.79 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.47 1.108 . . . . 75.5 110.056 176.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.7 -111.7 3.41 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.797 -0.521 . . . . 63.31 111.797 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -115.19 1.32 13.81 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.256 0.622 . . . . 74.32 110.706 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.53 ' HG3' HG23 ' B' ' 31' ' ' VAL . 18.2 pt-20 -115.47 143.1 45.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.415 0.686 . . . . 75.12 109.396 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 63.4 m -69.11 132.13 46.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 121.235 0.54 . . . . 73.22 110.999 -178.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.492 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -83.31 -63.03 1.44 Allowed 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.819 -1.178 . . . . 72.22 107.819 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -153.87 152.36 30.55 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.523 -1.217 . . . . 74.54 110.358 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -125.79 111.85 15.36 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.427 -1.694 . . . . 75.15 106.427 170.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.49 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 49.5 t -117.42 134.63 54.62 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.909 -1.145 . . . . 73.34 107.909 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -146.09 126.36 13.92 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.427 -0.953 . . . . 73.24 108.427 -173.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 66.1 t -123.08 148.02 27.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.259 -1.015 . . . . 62.54 108.259 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -120.46 106.96 12.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.083 -1.451 . . . . 54.24 107.083 168.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -100.82 103.07 14.27 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.609 -0.885 . . . . 75.53 108.609 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.59 158.8 18.59 Favored Glycine 0 C--N 1.342 0.885 0 O-C-N 123.762 0.664 . . . . 74.34 111.548 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.44 142.45 7.86 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 117.314 0.557 . . . . 72.15 113.414 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 3.8 mp -90.34 124.68 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 107.941 -1.133 . . . . 75.42 107.941 170.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -129.59 153.35 48.15 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.315 1.046 . . . . 75.44 109.28 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 30.3 m -107.76 109.1 20.58 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.742 0.817 . . . . 73.12 109.191 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.598 HG22 HD11 ' B' ' 89' ' ' ILE . 4.0 mp -111.74 108.52 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.756 1.223 . . . . 63.04 107.93 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.98 158.43 43.92 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.048 0.539 . . . . 64.44 111.22 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.73 -56.14 0.88 Allowed Glycine 0 C--N 1.349 1.261 0 C-N-CA 123.292 0.472 . . . . 73.42 112.668 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.598 HD11 HG22 ' B' ' 86' ' ' ILE . 0.6 OUTLIER -56.22 166.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 124.528 1.131 . . . . 64.43 113.035 173.238 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -158.42 160.03 36.39 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.078 -0.964 . . . . 64.23 110.057 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.08 -109.92 3.81 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 112.166 -0.373 . . . . 54.11 112.166 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 80.0 m -99.94 -42.42 6.78 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.482 0.713 . . . . 73.24 110.677 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.405 ' HA ' ' HB3' ' B' ' 96' ' ' HIS . 2.8 mp0 -65.66 -19.14 65.79 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.207 1.003 . . . . 71.04 112.448 -173.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.456 ' HA ' HD13 ' B' ' 89' ' ' ILE . 20.3 ptm -61.69 -66.07 0.59 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.102 0.561 . . . . 64.03 111.613 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 95' ' ' ALA . . . . . 0.435 ' H ' ' HG3' ' B' ' 94' ' ' MET . . . -79.69 -14.26 58.89 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.801 0.44 . . . . 53.5 111.621 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 96' ' ' HIS . . . . . 0.405 ' HB3' ' HA ' ' B' ' 93' ' ' GLN . 35.7 t-80 -63.32 -34.9 78.7 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.278 0.631 . . . . 61.24 110.888 171.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 48.7 t -66.72 -44.21 82.2 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.819 0.447 . . . . 63.21 111.594 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.55 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 1.5 pp -80.23 -30.18 38.54 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.098 0.559 . . . . 74.13 111.464 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.51 -30.57 44.34 Favored Glycine 0 C--N 1.342 0.866 0 O-C-N 123.601 0.563 . . . . 72.41 113.601 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.41 -53.95 1.47 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.324 0.65 . . . . 62.25 111.967 -169.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -67.79 -37.46 82.08 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.333 0.653 . . . . 72.32 112.197 -174.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.55 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 79.9 m -71.14 -43.56 13.13 Favored Pre-proline 0 CA--C 1.563 1.456 0 CA-C-O 118.383 -0.818 . . . . 64.1 112.367 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -50.89 -36.88 54.38 Favored 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 122.366 2.044 . . . . 74.21 113.402 166.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -67.42 -29.75 69.32 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.2 0.6 . . . . 45.24 111.865 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.406 ' O ' ' HD2' ' B' ' 108' ' ' PRO . 74.9 mt -69.49 -41.57 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.314 0.646 . . . . 74.14 109.691 171.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.6 mt -76.85 -21.57 54.82 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.962 -1.017 . . . . 64.12 112.028 -174.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -59.15 -49.76 91.3 Favored Pre-proline 0 N--CA 1.485 1.314 0 CA-C-O 118.165 -0.921 . . . . 72.22 113.021 -176.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.406 ' HD2' ' O ' ' B' ' 105' ' ' ILE . 86.9 Cg_exo -53.17 -43.04 60.48 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 122.715 2.277 . . . . 75.15 114.224 175.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -67.29 -41.27 85.7 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.396 0.678 . . . . 51.23 110.565 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.32 -38.45 91.1 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.601 -0.727 . . . . 61.34 110.689 175.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.0 ttt-85 -64.93 -47.12 78.84 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.529 1.532 . . . . 61.42 110.831 -176.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -70.87 -34.0 71.17 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.988 0.515 . . . . 65.03 109.855 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.528 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.9 t -66.23 -34.66 78.52 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 123.352 0.408 . . . . 75.22 110.741 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.49 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 51.8 mt -65.46 -55.71 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.924 0.889 . . . . 64.42 109.858 173.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 10.2 m -63.35 -24.83 68.02 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.479 0.712 . . . . 74.34 111.496 -175.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.437 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 36.4 t -64.24 -50.15 69.11 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 123.385 0.674 . . . . 72.35 109.251 173.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.528 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.2 mmt -69.5 -34.35 74.18 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.305 0.642 . . . . 74.35 110.826 -176.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 114' ' ' ILE . 85.5 t -62.26 -43.73 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.88 0.872 . . . . 74.21 110.082 173.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 48.3 t -66.25 -31.89 72.98 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.027 -0.988 . . . . 71.23 111.041 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' B' ' 116' ' ' SER . 86.4 mtt-85 -68.95 -39.77 79.33 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.488 -0.778 . . . . 73.03 110.5 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.08 -14.26 81.98 Favored Glycine 0 C--N 1.354 1.531 0 O-C-N 123.698 0.624 . . . . 62.24 112.222 172.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 7.5 m 65.58 37.15 6.11 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.595 1.558 . . . . 63.33 110.058 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.432 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 57.5 m-85 -85.22 159.54 56.37 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 114.576 -1.193 . . . . 74.53 110.051 173.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -47.89 159.79 0.56 Allowed 'Trans proline' 0 C--N 1.385 2.458 0 C-N-CA 123.851 3.034 . . . . 74.34 115.249 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.446 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 60.0 tp60 -61.3 118.19 6.58 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 115.112 -0.949 . . . . 63.22 111.762 -173.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.7 HD21 HG11 ' B' ' 64' ' ' VAL . 32.8 tp -110.85 103.33 11.83 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.556 -0.747 . . . . 61.4 110.052 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -108.1 114.9 29.15 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 107.908 -1.145 . . . . 72.43 107.908 169.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.44 HD21 ' CG2' ' B' ' 64' ' ' VAL . 41.9 mt -70.42 140.94 52.15 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.272 0.358 . . . . 64.44 110.352 176.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.47 145.79 98.99 Favored Pre-proline 0 CA--C 1.551 1.01 0 O-C-N 123.7 0.625 . . . . 73.5 110.529 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -60.88 92.05 0.1 OUTLIER 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.827 2.352 . . . . 72.33 111.74 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 94.7 t -99.23 112.51 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 123.24 0.616 . . . . 61.01 109.778 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 46.6 t30 . . . . . 0 CA--C 1.541 0.618 0 C-N-CA 123.943 0.897 . . . . 70.53 109.141 173.254 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 58.5 t80 . . . . . 0 C--O 1.238 0.497 0 N-CA-C 109.118 -0.697 . . . . 65.45 109.118 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -141.33 118.09 11.05 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.206 0.603 . . . . 74.51 109.698 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 60.4 mt -73.52 134.13 30.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 109.018 -0.734 . . . . 72.4 109.018 173.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.433 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.3 mm-40 -96.79 -49.97 4.86 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 108.998 -0.742 . . . . 52.22 108.998 171.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.588 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -178.2 146.0 0.38 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.32 1.048 . . . . 74.03 110.477 179.871 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 4.9 mp -109.7 124.84 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 107.549 -1.278 . . . . 72.42 107.549 172.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.477 ' HB3' HG23 ' D' ' 122' ' ' THR . 44.1 p90 -147.74 170.52 17.39 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.584 0.707 . . . . 74.25 111.712 -171.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 18' ' ' THR . . . . . 0.411 HG21 HD11 ' C' ' 21' ' ' ILE . 75.5 p -102.7 108.17 19.32 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.493 -0.776 . . . . 73.23 109.936 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.562 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 26.7 mtpt -78.66 -23.15 45.89 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 109.468 -0.567 . . . . 74.42 109.468 174.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.485 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 10.5 t70 -148.51 138.88 22.59 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.699 0.8 . . . . 55.21 109.774 176.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.476 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 82.7 mt -136.89 140.17 43.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 106.314 -1.736 . . . . 54.33 106.314 169.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.9 t -153.18 143.92 22.75 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.457 0.703 . . . . 63.43 109.949 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -156.22 109.25 2.65 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 107.657 -1.238 . . . . 74.12 107.657 172.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -116.34 111.49 20.17 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.477 -0.564 . . . . 75.21 109.477 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.79 79.64 31.95 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 108.006 -1.109 . . . . 53.2 108.006 170.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.05 -17.04 25.26 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.614 2.209 . . . . 64.11 111.399 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -105.01 11.99 32.78 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.762 1.225 . . . . 70.22 110.274 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.475 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -50.96 -54.05 41.44 Favored Pre-proline 0 C--N 1.371 1.501 0 C-N-CA 124.351 1.06 . . . . 64.02 113.742 -169.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.6 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 12.4 Cg_endo -56.92 -52.7 6.22 Favored 'Trans proline' 0 C--N 1.391 2.789 0 C-N-CA 121.658 1.572 . . . . 74.14 111.67 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.453 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 85.4 t60 -67.77 -28.64 67.78 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.659 0.784 . . . . 62.31 112.654 -172.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.735 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.6 p -77.43 -19.68 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 N-CA-C 112.43 0.53 . . . . 73.52 112.43 -174.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -71.66 -13.52 61.77 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.856 0.687 . . . . 72.03 112.856 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 28.1 pt20 -99.18 6.34 46.43 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.188 0.595 . . . . 52.1 111.68 175.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.82 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -94.48 150.91 19.79 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.778 0.831 . . . . 55.43 110.442 -178.338 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.16 119.78 11.49 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.343 0.657 . . . . 64.33 109.277 169.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -82.89 92.37 7.28 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.557 0.743 . . . . 64.3 112.053 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -142.9 79.99 14.2 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 124.606 1.162 . . . . 74.3 107.895 169.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -87.29 163.06 8.41 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.732 2.288 . . . . 73.15 111.235 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -85.57 76.06 10.06 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.306 -1.368 . . . . 62.44 107.306 173.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 p -62.75 97.34 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 114.603 -1.18 . . . . 62.05 108.735 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -107.56 102.96 12.18 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 113.627 -1.624 . . . . 73.44 107.442 -171.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -88.3 129.36 35.4 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.017 -1.105 . . . . 70.52 108.017 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.437 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 15.4 t70 -124.62 139.04 54.24 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.95 -0.759 . . . . 75.21 108.95 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.449 HD22 HD21 ' C' ' 60' ' ' LEU . 79.0 mt -130.43 110.65 11.63 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.083 0.953 . . . . 51.2 108.568 175.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -124.22 119.77 30.31 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.175 -1.417 . . . . 75.13 107.175 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.1 t -119.91 145.32 46.82 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 109.621 -0.511 . . . . 70.54 109.621 -176.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.54 162.13 36.65 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.912 0.885 . . . . 54.42 108.931 176.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.409 ' OG ' ' HB3' ' C' ' 98' ' ' LEU . 5.4 m -129.12 164.08 24.11 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 109.468 -0.568 . . . . 61.22 109.468 174.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -148.65 125.61 11.3 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.675 -1.231 . . . . 72.31 107.675 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -84.21 114.83 22.09 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.897 -1.149 . . . . 65.52 107.897 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.597 HD11 ' HB2' ' C' ' 57' ' ' GLU . 50.1 mt -88.71 -42.67 11.82 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.4 0.68 . . . . 73.41 109.782 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.04 -171.22 3.85 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 115.081 -0.963 . . . . 63.52 109.967 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.37 113.32 2.85 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 114.92 -1.036 . . . . 55.42 109.307 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 63.86 15.29 8.99 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.037 0.935 . . . . 75.51 112.387 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 85.1 t -111.71 115.88 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.136 -1.061 . . . . 62.33 108.136 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -125.14 124.73 42.44 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.804 0.841 . . . . 63.11 109.185 -177.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.597 ' HB2' HD11 ' C' ' 51' ' ' LEU . 38.7 tt0 -83.74 133.63 34.78 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.238 -1.023 . . . . 74.21 108.238 164.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -118.94 135.61 58.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 108.247 -1.02 . . . . 73.42 108.247 168.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.413 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 57.3 t -119.75 141.93 37.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 123.644 0.778 . . . . 72.12 109.128 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.449 HD21 HD22 ' C' ' 44' ' ' LEU . 0.0 OUTLIER -123.11 102.01 7.73 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.713 -1.217 . . . . 75.44 107.713 177.586 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -81.87 106.97 14.21 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.687 -0.857 . . . . 73.51 108.687 172.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 11.0 t -109.86 113.91 45.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.24 -1.022 . . . . 70.53 108.24 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 26.8 m -111.98 132.13 54.97 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.197 -0.668 . . . . 73.42 109.197 -177.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.561 HG23 HD13 ' C' ' 114' ' ' ILE . 50.6 t -118.32 114.71 45.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.774 -0.824 . . . . 73.14 108.774 171.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.432 HG23 HD23 ' C' ' 75' ' ' LEU . 7.4 m -99.19 139.17 35.25 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.285 -1.006 . . . . 53.22 108.285 172.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.6 109.82 8.35 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.638 -0.875 . . . . 64.32 108.638 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 36.5 m -136.94 131.75 33.45 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.874 0.47 . . . . 54.24 110.293 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.82 HD13 ' HG2' ' C' ' 34' ' ' LYS . 1.6 mt -93.16 50.34 1.51 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.214 1.006 . . . . 64.35 108.572 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.32 -119.95 6.46 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 110.3 -1.12 . . . . 75.45 110.3 -171.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -90.48 -11.94 38.77 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.239 0.616 . . . . 63.15 109.836 172.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -71.58 119.53 15.87 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.753 0.821 . . . . 75.21 109.239 172.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 30.9 m -79.27 125.1 29.05 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.071 -0.714 . . . . 64.12 109.071 170.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.735 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -82.43 -53.92 5.61 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.39 -1.337 . . . . 75.33 107.39 168.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 74' ' ' PHE . . . . . 0.429 ' HZ ' HD13 ' C' ' 126' ' ' LEU . 32.7 p90 -169.77 168.56 8.88 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 114.73 -1.123 . . . . 74.11 110.41 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.432 HD23 HG23 ' C' ' 65' ' ' THR . 3.1 tm? -130.44 144.93 51.71 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 106.14 -1.8 . . . . 75.54 106.14 169.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.417 ' N ' HD13 ' C' ' 75' ' ' LEU . 49.2 t -150.17 146.21 26.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.739 0.416 . . . . 72.12 109.991 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -157.68 137.47 12.26 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.701 0.8 . . . . 75.21 109.673 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.562 HG21 ' HB3' ' C' ' 113' ' ' CYS . 24.2 t -134.34 113.51 17.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 124.562 1.145 . . . . 72.21 107.923 174.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.485 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 69.3 mt-30 -91.55 88.42 6.76 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.966 -1.124 . . . . 61.52 107.966 174.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -79.27 96.86 6.06 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.821 -1.081 . . . . 75.2 109.195 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -92.56 145.79 17.82 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 111.27 -0.732 . . . . 61.43 111.27 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.85 132.75 4.01 Favored Glycine 0 CA--C 1.501 -0.787 0 N-CA-C 110.898 -0.881 . . . . 74.21 110.898 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.433 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 26.5 mm -89.48 132.0 35.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 N-CA-C 109.174 -0.676 . . . . 73.14 109.174 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -134.51 119.27 18.27 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.727 0.811 . . . . 74.0 109.376 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 27.8 m -81.8 102.07 10.57 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.202 -1.036 . . . . 73.14 108.202 171.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.608 HG21 ' HE1' ' C' ' 94' ' ' MET . 27.5 mt -116.22 131.6 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.732 0.813 . . . . 53.13 109.481 -176.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.03 169.45 17.57 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.756 0.423 . . . . 74.31 110.956 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.21 -29.48 5.59 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 115.817 -0.629 . . . . 43.01 113.971 171.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.431 HD11 HG21 ' C' ' 86' ' ' ILE . 39.5 pt -96.95 171.79 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.338 0.655 . . . . 65.31 110.933 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -166.23 -179.15 4.91 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.198 0.999 . . . . 75.12 109.256 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.29 -119.9 13.71 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 123.925 0.766 . . . . 64.54 114.116 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 26.1 p -73.93 -30.83 62.77 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.696 0.798 . . . . 62.24 112.105 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -63.47 -48.24 78.48 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.944 0.498 . . . . 74.24 109.709 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.608 ' HE1' HG21 ' C' ' 86' ' ' ILE . 5.4 tpt -63.99 -48.08 77.83 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-N 115.547 -0.751 . . . . 75.44 110.501 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.4 -35.23 73.58 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.287 0.635 . . . . 34.25 111.486 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 17.5 t60 -83.74 -28.84 27.94 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.956 0.502 . . . . 70.24 110.954 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.559 ' SG ' HD13 ' C' ' 86' ' ' ILE . 18.8 t -68.34 -38.58 81.61 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.688 -0.856 . . . . 75.13 108.688 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.409 ' HB3' ' OG ' ' C' ' 48' ' ' SER . 53.9 mt -83.63 -33.34 25.31 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.523 -1.217 . . . . 54.33 110.857 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.27 -24.38 63.67 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.297 -0.865 . . . . 54.21 114.28 -169.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.36 -52.54 0.11 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.802 0.667 . . . . 72.42 112.802 -164.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -57.02 -57.54 12.11 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 123.999 0.812 . . . . 70.02 111.177 -176.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.403 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 95.3 m -64.28 -49.11 74.38 Favored Pre-proline 0 CA--C 1.564 1.486 0 C-N-CA 124.151 0.981 . . . . 71.22 112.422 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 74.8 Cg_exo -53.43 -32.89 64.6 Favored 'Trans proline' 0 C--N 1.402 3.359 0 C-N-CA 122.701 2.267 . . . . 74.13 113.889 173.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -67.97 -31.47 71.21 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.608 0.763 . . . . 70.43 110.694 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.518 HD12 ' NH1' ' A' ' 111' ' ' ARG . 25.7 mm -74.74 -35.62 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 122.899 0.48 . . . . 71.22 109.85 175.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.95 -27.74 57.66 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.781 0.832 . . . . 75.45 111.443 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -58.77 -50.93 85.37 Favored Pre-proline 0 N--CA 1.483 1.18 0 N-CA-C 114.552 1.316 . . . . 74.34 114.552 -171.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -58.69 -38.05 91.11 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 121.967 1.778 . . . . 72.33 112.873 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.446 ' HE2' HG21 ' A' ' 115' ' ' THR . 52.4 m-85 -67.25 -45.22 77.34 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.844 0.858 . . . . 73.55 110.3 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.08 86.3 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.162 -0.927 . . . . 72.32 110.907 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 41.8 ttt-85 -67.84 -43.87 78.52 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.883 1.273 . . . . 74.03 110.259 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 112' ' ' GLU . . . . . 0.403 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.1 tm-20 -66.29 -39.95 89.7 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.293 0.637 . . . . 45.11 109.591 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.562 ' HB3' HG21 ' C' ' 78' ' ' VAL . 28.6 m -59.91 -48.93 79.67 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.584 0.753 . . . . 73.3 111.996 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.561 HD13 HG23 ' C' ' 64' ' ' VAL . 71.0 mt -64.09 -52.32 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 123.439 0.462 . . . . 64.24 110.85 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 14.2 m -66.7 -29.07 68.97 Favored 'General case' 0 CA--C 1.556 1.181 0 O-C-N 123.462 0.476 . . . . 73.13 110.746 -175.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 39.2 t -63.91 -46.38 85.07 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.3 -0.63 . . . . 72.22 109.3 170.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.591 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.17 -41.01 96.03 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.469 1.107 . . . . 73.1 112.215 179.286 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.476 HG23 ' O ' ' C' ' 114' ' ' ILE . 92.6 t -64.81 -41.23 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.938 0.895 . . . . 71.33 109.572 176.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 11.6 t -67.12 -29.95 69.83 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.813 1.245 . . . . 75.23 112.129 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.439 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 75.3 mtt-85 -74.16 -41.3 61.71 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.575 0.75 . . . . 70.44 109.668 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.06 -0.42 60.67 Favored Glycine 0 C--N 1.354 1.572 0 O-C-N 123.719 0.637 . . . . 60.42 112.608 169.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 31.0 p 63.84 30.67 14.4 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.989 2.115 . . . . 64.34 113.025 169.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -82.33 156.44 68.82 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 107.916 -1.142 . . . . 64.53 107.916 167.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.446 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 12.8 Cg_endo -57.19 157.05 22.51 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.479 2.119 . . . . 53.32 112.845 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' B' ' 123' ' ' PHE . 53.8 mm-40 -56.02 112.78 1.29 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.21 0.944 . . . . 63.55 111.601 -176.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.429 HD13 ' HZ ' ' C' ' 74' ' ' PHE . 5.2 tt -116.75 85.15 2.26 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.476 -1.305 . . . . 71.22 107.476 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -95.28 122.17 37.7 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.691 -0.855 . . . . 74.13 108.691 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.79 144.38 37.18 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.589 0.556 . . . . 75.43 109.872 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.89 148.42 98.84 Favored Pre-proline 0 CA--C 1.55 0.958 0 O-C-N 124.076 0.86 . . . . 74.13 111.125 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.84 108.53 0.39 Allowed 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.798 2.332 . . . . 55.3 112.22 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 43.3 t -99.6 112.68 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.46 -0.941 . . . . 73.02 108.46 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -77.74 104.95 8.59 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.141 -0.689 . . . . 70.2 109.141 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -63.39 -35.52 80.68 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.664 0.785 . . . . 74.21 111.575 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.08 -21.51 65.88 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.931 0.892 . . . . 44.13 111.839 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.52 -47.31 33.75 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.96 0.904 . . . . 75.11 109.296 172.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 35.0 mt -65.79 -43.52 88.48 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.824 -0.625 . . . . 72.31 111.087 -176.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 24.5 t80 . . . . . 0 CA--C 1.542 0.664 0 CA-C-N 115.039 -0.982 . . . . 74.15 110.495 -177.139 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 59.2 m . . . . . 0 C--O 1.241 0.645 0 N-CA-C 109.939 -0.393 . . . . 74.41 109.939 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.59 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 47.3 t80 -142.94 91.65 2.32 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.023 -1.102 . . . . 75.33 108.023 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -113.24 123.74 50.87 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.517 -0.92 . . . . 70.42 108.517 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 12.4 mt -79.28 128.34 38.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.347 -0.982 . . . . 72.12 108.347 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -85.57 -43.19 13.72 Favored 'General case' 0 C--O 1.239 0.538 0 O-C-N 123.638 0.587 . . . . 73.43 109.817 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -171.09 131.62 0.8 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.799 -0.637 . . . . 71.51 110.575 -171.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 4.0 mp -106.46 141.48 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 107.348 -1.353 . . . . 72.04 107.348 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -167.01 145.51 5.06 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.648 0.592 . . . . 71.31 111.819 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -76.86 116.34 17.44 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.492 -0.776 . . . . 74.55 109.573 175.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.6 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 43.0 mtpt -88.92 -13.02 40.04 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.45 0.7 . . . . 70.22 110.439 178.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.645 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 25.3 t70 -162.55 141.63 9.07 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.099 0.96 . . . . 64.44 109.699 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.591 HG21 ' HE2' ' C' ' 117' ' ' MET . 98.4 mt -141.28 141.35 30.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 125.278 1.431 . . . . 72.35 107.884 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 41.1 t -149.3 141.38 23.91 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.667 1.187 . . . . 62.24 108.109 173.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.476 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 81.2 t80 -152.54 125.72 8.62 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 106.562 -1.644 . . . . 75.3 106.562 171.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -129.42 145.64 51.39 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.286 -0.635 . . . . 74.12 109.286 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.76 80.46 65.85 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 107.263 -1.384 . . . . 64.1 107.263 174.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.61 -38.54 31.64 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 123.513 2.809 . . . . 63.15 113.419 -169.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 42.2 m-20 -106.94 12.38 28.83 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 118.762 -0.637 . . . . 54.22 110.959 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.562 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -27.63 -69.42 0.08 OUTLIER Pre-proline 0 CA--C 1.571 1.772 0 N-CA-C 116.742 2.127 . . . . 72.01 116.742 -164.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.45 -18.69 13.69 Favored 'Trans proline' 0 C--N 1.385 2.483 0 CA-C-N 123.661 2.343 . . . . 74.44 114.212 -174.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -74.49 -38.66 62.82 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.295 1.038 . . . . 72.01 109.103 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.487 HG12 ' O ' ' D' ' 28' ' ' ALA . 4.3 p -84.76 -20.66 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 CA-C-N 115.328 -0.851 . . . . 71.43 111.676 -174.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.505 ' HD2' HH21 ' C' ' 15' ' ' ARG . 20.6 m-85 -67.6 -18.54 65.02 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 122.586 0.354 . . . . 75.34 111.945 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -65.29 -16.84 63.99 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.203 1.001 . . . . 64.01 111.06 175.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.404 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 96.4 mttt -97.42 90.26 5.0 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 125.086 1.354 . . . . 74.54 110.463 -178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -90.67 93.22 9.16 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.954 0.502 . . . . 63.54 109.772 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 20.5 p90 -162.47 -170.39 2.42 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.874 0.87 . . . . 70.14 109.466 168.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -67.98 109.78 4.47 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.707 1.203 . . . . 61.12 110.898 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -58.54 122.27 11.38 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.27 1.98 . . . . 74.14 110.565 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 39' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 0.2 OUTLIER -66.68 107.21 2.06 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 106.983 -1.488 . . . . 75.31 106.983 175.289 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.601 HG22 ' HB2' ' D' ' 66' ' ' ALA . 93.8 t -111.67 142.93 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.876 -0.787 . . . . 51.02 108.876 -174.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -129.76 123.87 32.07 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.369 -0.974 . . . . 61.53 108.369 168.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.587 HD11 HG13 ' D' ' 62' ' ' VAL . 51.5 tp -95.73 125.98 40.68 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.001 -0.74 . . . . 75.24 109.001 174.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -124.9 111.11 15.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.787 -1.56 . . . . 72.23 106.787 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.538 HD22 HG22 ' D' ' 62' ' ' VAL . 62.0 mt -97.58 164.53 12.39 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.932 -1.031 . . . . 72.43 108.958 177.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -164.4 144.93 7.98 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.979 -1.119 . . . . 72.51 107.979 167.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 70.4 p -102.62 151.14 22.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.735 0.779 . . . . 74.13 109.769 -176.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.54 161.72 41.1 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 106.686 -1.598 . . . . 42.55 106.686 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 12.8 p . . . . . 0 C--O 1.238 0.464 0 C-N-CA 122.786 0.434 . . . . 53.41 110.255 -176.866 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 54' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' D' ' 85' ' ' SER . 6.5 m-20 . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 112.836 0.68 . . . . 70.14 112.836 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.87 117.81 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 108.239 -1.023 . . . . 74.22 108.239 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -135.13 125.55 26.59 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.626 -0.879 . . . . 72.14 108.626 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -90.0 129.97 36.26 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 106.857 -1.534 . . . . 73.34 106.857 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 83.3 t -132.96 131.26 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 124.097 0.959 . . . . 65.35 108.631 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.485 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 32.3 t -119.94 144.51 28.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 C-N-CA 124.642 1.177 . . . . 74.43 108.853 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.6 108.94 12.06 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.389 -1.337 . . . . 55.1 107.389 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 ttt85 -85.41 106.01 16.47 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.144 -0.687 . . . . 71.42 109.144 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.587 HG13 HD11 ' D' ' 42' ' ' LEU . 59.7 t -108.1 118.29 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 123.95 0.9 . . . . 61.42 109.07 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 17.0 m -128.71 131.14 47.91 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.613 0.57 . . . . 41.11 109.948 -171.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.57 HG13 HG13 ' D' ' 40' ' ' VAL . 90.9 t -113.78 135.3 53.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 124.536 1.134 . . . . 72.54 109.545 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 7.1 m -121.01 94.72 4.43 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.921 -1.14 . . . . 64.2 107.921 171.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.601 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -109.42 142.08 40.91 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.614 0.366 . . . . 74.33 110.711 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.525 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 49.6 m -148.61 132.72 17.29 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.069 0.947 . . . . 75.12 110.561 -171.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.2 mt -98.34 105.71 17.9 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.967 -1.123 . . . . 75.3 107.967 173.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.07 -120.39 5.19 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 115.506 -0.77 . . . . 54.4 112.391 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.12 6.7 27.12 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.592 0.757 . . . . 54.04 111.383 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 71' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 10.9 pt-20 -127.6 159.59 34.19 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.258 0.623 . . . . 72.43 109.321 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 93.9 m -70.34 136.92 50.16 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.335 0.654 . . . . 65.44 111.961 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.525 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -91.75 -70.52 0.68 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.19 -1.411 . . . . 53.2 107.19 174.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -146.35 148.09 32.0 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.092 -0.958 . . . . 74.13 110.414 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 73.6 mt -116.17 153.52 31.68 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.757 1.223 . . . . 75.52 107.741 171.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.615 ' SG ' HG12 ' D' ' 114' ' ' ILE . 34.6 t -154.35 146.66 23.87 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.584 -0.524 . . . . 53.31 109.584 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -157.4 122.21 4.43 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.728 0.411 . . . . 74.12 110.625 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 94.8 t -132.79 115.46 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.106 0.962 . . . . 53.33 109.277 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.645 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.0 mt-30 -89.3 88.51 7.53 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.693 -0.854 . . . . 71.24 108.693 172.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -83.01 103.59 12.57 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.338 -1.301 . . . . 65.31 109.528 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -102.83 167.84 17.69 Favored Glycine 0 N--CA 1.468 0.825 0 O-C-N 123.219 0.324 . . . . 64.41 113.055 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.16 143.07 6.07 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 112.447 -0.261 . . . . 63.15 112.447 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 2.5 mp -91.29 127.34 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.218 -1.03 . . . . 74.33 108.218 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -122.41 134.86 54.6 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.538 1.135 . . . . 55.33 109.532 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 34.1 t -84.96 103.53 14.09 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 108.287 -1.005 . . . . 74.14 108.287 171.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.572 HG22 HD11 ' D' ' 89' ' ' ILE . 15.1 mt -109.54 131.9 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.569 -0.9 . . . . 62.25 108.569 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.65 164.02 14.49 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.706 0.629 . . . . 54.43 111.281 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.71 21.59 74.27 Favored Glycine 0 C--N 1.353 1.473 0 O-C-N 123.918 0.761 . . . . 73.34 114.619 170.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.572 HD11 HG22 ' D' ' 86' ' ' ILE . 1.0 OUTLIER -133.27 140.91 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.306 1.042 . . . . 63.22 109.457 177.889 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 32.0 mp0 -129.56 175.79 8.5 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 123.962 0.905 . . . . 73.11 109.601 -175.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.64 -137.8 23.04 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.219 -0.901 . . . . 64.54 112.458 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 45.5 p -66.46 -45.6 79.22 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.692 0.797 . . . . 71.21 111.035 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -58.84 -28.5 66.11 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.009 1.324 . . . . 75.23 112.331 -175.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.523 ' HA ' HD13 ' D' ' 89' ' ' ILE . 26.4 ttt -49.17 -63.54 1.07 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.98 1.312 . . . . 63.12 112.508 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.91 -16.43 35.97 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.333 0.653 . . . . 65.12 111.81 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -72.78 -21.8 60.94 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.715 0.406 . . . . 65.21 111.625 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 75.3 m -56.99 -50.98 71.06 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 123.467 0.479 . . . . 72.21 111.654 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 pp -68.42 -18.23 64.39 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.266 0.627 . . . . 74.54 112.586 -176.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.83 -2.22 42.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 114.775 0.67 . . . . 71.33 114.775 -174.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.42 -54.29 0.29 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 118.011 0.905 . . . . 71.2 111.459 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -73.49 -51.1 18.28 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.039 0.535 . . . . 75.21 111.287 -172.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.59 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 35.1 m -61.18 -44.83 95.0 Favored Pre-proline 0 CA--C 1.566 1.573 0 C-N-CA 123.914 0.886 . . . . 61.25 112.44 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.429 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 50.0 Cg_exo -58.35 -36.45 97.6 Favored 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 122.331 2.021 . . . . 75.14 113.468 169.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -64.19 -31.11 72.19 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.279 0.632 . . . . 73.23 110.997 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 33.1 mm -67.54 -38.55 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.046 0.938 . . . . 64.24 110.623 174.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' D' ' 103' ' ' PRO . 60.5 mt -73.31 -20.47 60.79 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.261 -0.881 . . . . 75.34 111.895 -175.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -67.44 -41.74 33.74 Favored Pre-proline 0 CA--C 1.556 1.195 0 N-CA-C 114.274 1.212 . . . . 72.32 114.274 -172.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -45.42 -44.97 16.18 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.508 2.139 . . . . 54.35 113.584 169.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -78.18 -35.03 49.24 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.829 0.852 . . . . 64.52 111.496 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 110' ' ' ALA . . . . . 0.475 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -62.25 -56.15 21.42 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.652 0.781 . . . . 74.12 110.339 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.432 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 40.3 ttp180 -58.19 -42.88 87.06 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 114.038 -1.437 . . . . 75.11 110.574 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -55.29 -52.64 62.77 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.084 0.865 . . . . 72.33 110.481 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.4 t -56.27 -45.63 80.03 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.306 1.004 . . . . 54.23 111.13 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.615 HG12 ' SG ' ' D' ' 76' ' ' CYS . 42.3 mt -62.02 -57.36 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.379 -0.828 . . . . 75.31 111.1 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 30.2 m -55.35 -38.58 68.97 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.537 1.135 . . . . 62.03 111.124 -174.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 22.6 t -60.4 -50.96 71.52 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.62 -1.173 . . . . 63.24 109.662 176.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.72 -32.4 72.15 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.628 0.771 . . . . 63.42 112.178 -176.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.481 HG23 ' O ' ' D' ' 114' ' ' ILE . 84.0 t -60.44 -46.41 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.746 0.819 . . . . 73.11 109.519 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 32.4 t -72.49 -29.16 63.39 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 115.004 -0.998 . . . . 72.44 110.881 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.462 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 74.9 mtt-85 -71.49 -24.42 61.98 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.441 0.696 . . . . 72.13 110.674 176.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.21 11.71 71.33 Favored Glycine 0 C--N 1.353 1.476 0 CA-C-O 119.448 -0.64 . . . . 75.55 112.791 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.477 HG23 ' HB3' ' C' ' 17' ' ' TYR . 72.2 p 56.71 25.67 10.41 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 125.988 1.715 . . . . 64.34 113.242 -177.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -92.02 150.9 41.33 Favored Pre-proline 0 C--O 1.241 0.635 0 C-N-CA 123.38 0.672 . . . . 64.1 109.893 173.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -46.12 121.33 4.33 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 123.556 2.837 . . . . 64.14 112.883 170.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -45.86 131.08 9.58 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 124.48 1.113 . . . . 61.14 111.655 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 23.7 tp -117.55 107.17 13.94 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.208 1.003 . . . . 74.23 109.209 -175.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -101.02 96.08 7.01 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 108.041 -1.096 . . . . 74.23 108.041 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.432 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 47.1 mt -61.73 116.72 5.03 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 122.787 0.435 . . . . 71.05 110.134 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.484 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -54.47 130.78 62.84 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 123.352 0.661 . . . . 74.32 112.487 -174.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 6.1 Cg_exo -73.29 109.64 2.88 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 123.286 2.657 . . . . 74.21 110.985 -178.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.07 152.9 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.877 0.871 . . . . 75.34 110.897 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -75.02 108.54 7.81 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.647 0.779 . . . . 62.44 109.021 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 N--CA 1.488 1.437 0 C-N-CA 124.219 1.007 . . . . 73.12 111.803 179.979 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.8 m . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 108.459 -0.941 . . . . 65.35 108.459 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -121.13 112.46 18.71 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.228 -1.397 . . . . 74.34 107.228 167.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -135.68 135.64 40.27 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.804 -1.184 . . . . 62.21 107.804 171.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.9 mt -91.57 115.83 31.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.281 -1.007 . . . . 74.13 108.281 176.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -73.88 -40.24 63.35 Favored 'General case' 0 C--O 1.242 0.708 0 O-C-N 123.388 0.43 . . . . 70.32 110.51 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.506 ' HE ' ' HB ' ' B' ' 122' ' ' THR . 26.0 ttt180 -174.86 122.65 0.24 Allowed 'General case' 0 N--CA 1.479 1.0 0 O-C-N 123.227 0.33 . . . . 72.51 110.432 -169.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 73.7 mt -106.47 136.52 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 108.723 -0.843 . . . . 72.45 108.723 172.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.473 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 26.4 p90 -166.65 177.95 6.27 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 124.206 0.941 . . . . 75.02 111.802 -172.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.6 p -110.35 118.8 37.27 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.064 -0.971 . . . . 64.4 109.386 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.473 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 35.8 mtpt -82.97 -29.33 29.12 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.066 0.46 . . . . 61.21 109.79 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 30.6 t70 -150.52 136.8 18.67 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.765 -1.107 . . . . 71.14 109.28 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.406 HG23 HG22 ' A' ' 78' ' ' VAL . 59.8 mt -135.06 138.78 48.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.904 -1.147 . . . . 64.31 107.904 174.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.4 t -150.02 124.32 9.54 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.641 0.588 . . . . 71.2 110.04 173.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.7 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.6 t80 -120.95 132.97 55.25 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 106.87 -1.529 . . . . 74.14 106.87 168.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -128.5 139.93 52.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.301 -0.629 . . . . 63.13 109.301 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.13 78.07 65.68 Favored Pre-proline 0 C--O 1.24 0.581 0 N-CA-C 106.908 -1.516 . . . . 75.31 106.908 171.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -64.18 -34.51 56.61 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.671 2.247 . . . . 73.2 112.303 -171.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -106.11 22.34 15.85 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 118.146 -0.931 . . . . 73.44 110.488 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.428 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -43.04 -56.08 6.81 Favored Pre-proline 0 N--CA 1.493 1.721 0 CA-C-O 117.923 -1.037 . . . . 51.42 113.752 -171.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.428 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 22.8 Cg_exo -65.03 -27.87 57.6 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 121.906 1.738 . . . . 64.4 113.29 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -80.65 -40.43 25.57 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.847 0.859 . . . . 71.13 110.922 -175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.809 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.3 p -78.1 -21.33 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 CA-C-N 114.935 -1.029 . . . . 72.53 112.837 -158.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -71.05 -12.14 61.35 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.168 0.587 . . . . 74.32 111.438 176.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -90.22 -18.31 25.92 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.537 1.135 . . . . 62.12 111.011 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -81.55 161.01 23.73 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.494 0.717 . . . . 72.41 112.126 -172.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.13 116.14 6.9 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 114.75 -1.113 . . . . 74.33 108.765 173.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.43 ' CE3' HD21 ' A' ' 68' ' ' LEU . 63.6 t-105 -80.79 80.18 7.31 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.875 0.845 . . . . 73.41 109.678 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.427 ' H ' HD22 ' A' ' 68' ' ' LEU . 51.2 tt0 -123.97 69.71 48.39 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 124.898 1.279 . . . . 73.32 108.24 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -86.4 118.25 1.59 Allowed 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.602 2.201 . . . . 73.43 112.816 -170.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -94.45 103.46 15.43 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 105.023 -2.214 . . . . 74.45 105.023 168.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.458 ' CG1' HG13 ' A' ' 64' ' ' VAL . 57.5 t -90.74 101.8 12.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 123.39 0.676 . . . . 74.22 110.334 -177.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -79.6 117.97 21.01 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.662 -0.699 . . . . 74.51 109.855 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.3 mt -97.02 107.04 19.49 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.281 -1.007 . . . . 74.34 108.281 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.532 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.7 m-20 -106.85 106.77 17.45 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.174 0.99 . . . . 74.13 108.679 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.446 HD11 HG21 ' A' ' 131' ' ' VAL . 85.3 mt -98.91 149.64 22.74 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.858 0.463 . . . . 62.31 110.631 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -154.92 148.68 25.52 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.856 -1.065 . . . . 75.05 108.696 177.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.3 m -131.51 130.89 42.94 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.583 0.753 . . . . 74.33 109.878 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.87 109.12 9.87 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.806 0.842 . . . . 55.04 109.121 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.2 p -98.7 156.95 16.58 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.214 0.606 . . . . 64.31 110.327 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.2 t -150.2 151.63 33.37 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.629 1.172 . . . . 75.04 108.609 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -100.16 111.56 23.85 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.091 -1.077 . . . . 72.12 108.091 172.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 74.1 mt -79.22 -43.03 24.64 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.136 0.574 . . . . 53.33 110.234 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.98 -177.28 5.65 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.962 -0.563 . . . . 54.24 110.708 -176.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.02 110.76 0.87 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.088 0.955 . . . . 73.03 109.883 174.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 65.1 9.59 5.65 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.529 1.132 . . . . 72.55 112.655 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.2 t -104.27 107.24 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.299 -1.0 . . . . 63.52 108.299 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -114.77 126.55 54.97 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.495 -0.928 . . . . 75.45 108.495 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -90.51 151.63 21.28 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.163 -0.681 . . . . 64.35 109.163 168.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.409 HG11 ' HD3' ' A' ' 103' ' ' PRO . 55.1 t -132.57 136.34 56.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 124.882 1.273 . . . . 42.42 107.568 170.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 52.5 t -118.01 130.12 73.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.765 -0.828 . . . . 45.4 108.765 175.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.442 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -102.32 103.47 13.92 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.643 -1.614 . . . . 73.24 106.643 176.258 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -90.21 98.77 11.97 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.16 -1.422 . . . . 72.42 107.16 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.61 132.24 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 114.757 -1.111 . . . . 71.13 108.177 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 6.8 m -125.51 146.65 49.56 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.395 -0.965 . . . . 61.22 108.395 175.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 23.2 t -145.61 117.37 2.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 124.867 1.267 . . . . 64.4 107.933 -168.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.7 m -126.2 120.55 30.36 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.129 0.422 . . . . 74.32 110.004 177.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.42 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -101.24 105.59 16.72 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.264 -1.384 . . . . 54.21 107.264 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.2 m -109.07 126.13 52.84 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.044 0.537 . . . . 73.2 110.007 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.43 HD21 ' CE3' ' A' ' 36' ' ' TRP . 35.0 mt -89.79 74.76 7.42 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 125.021 1.328 . . . . 74.11 108.671 175.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.99 -84.39 0.92 Allowed Glycine 0 C--N 1.341 0.856 0 CA-C-N 115.713 -0.676 . . . . 72.02 111.921 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -114.28 -29.0 7.06 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.787 0.835 . . . . 53.44 111.007 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -88.89 134.41 33.96 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.837 0.455 . . . . 65.44 110.211 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -80.2 136.45 36.48 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 118.019 0.372 . . . . 65.21 110.126 175.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.809 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -87.12 -58.25 2.66 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.166 0.986 . . . . 63.03 109.264 176.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -154.54 168.28 27.26 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.579 -1.191 . . . . 64.13 110.695 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 64' ' ' VAL . 67.1 tp -124.56 147.37 48.48 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.213 1.405 . . . . 64.3 108.042 172.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.56 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 79.8 m -142.86 128.1 18.73 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.2 -1.037 . . . . 73.41 108.2 175.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -146.27 118.45 8.33 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.775 -0.454 . . . . 74.3 109.775 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.406 HG22 HG23 ' A' ' 21' ' ' ILE . 39.4 t -127.41 112.81 29.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.49 1.116 . . . . 64.51 108.97 -176.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 51.7 mt-30 -86.28 84.18 7.53 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.652 -0.87 . . . . 74.12 108.652 171.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -76.78 94.92 3.93 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.506 -1.224 . . . . 73.23 109.578 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.82 144.26 18.06 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 111.87 -0.492 . . . . 64.33 111.87 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.494 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.03 124.18 2.75 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.265 -1.134 . . . . 71.22 110.265 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.422 HG13 ' HE1' ' A' ' 17' ' ' TYR . 48.9 mt -81.74 129.15 37.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.923 -1.14 . . . . 73.01 107.923 172.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.653 ' HB3' HD11 ' A' ' 86' ' ' ILE . 88.9 m-85 -128.5 122.99 32.43 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.189 0.996 . . . . 74.44 109.298 -174.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.0 t -89.75 93.27 9.39 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.36 1.064 . . . . 73.05 108.841 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.653 HD11 ' HB3' ' A' ' 84' ' ' PHE . 15.9 mm -120.73 132.89 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.895 0.878 . . . . 74.13 111.379 -168.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.75 167.43 28.23 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.617 0.767 . . . . 62.21 110.708 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.86 8.67 72.5 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 119.325 -0.709 . . . . 63.24 114.73 173.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.47 HD11 HG22 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -143.41 164.07 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 124.112 0.965 . . . . 60.42 109.922 174.704 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.473 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 19.8 tt0 -154.94 179.05 9.49 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.501 -0.772 . . . . 62.22 109.089 174.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.473 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 61.99 -130.03 44.44 Favored Glycine 0 C--N 1.347 1.149 0 C-N-CA 123.283 0.468 . . . . 63.22 113.792 175.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.5 p -67.92 -28.58 67.62 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.995 0.918 . . . . 55.04 111.259 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -66.59 -43.22 85.46 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.71 0.804 . . . . 62.1 110.25 177.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.3 tpt -70.84 -41.3 71.68 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.571 -0.74 . . . . 75.41 110.594 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.71 84.87 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.359 0.663 . . . . 64.43 111.136 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.415 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 61.0 t-80 -71.7 -29.77 64.93 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.324 0.65 . . . . 73.51 110.75 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.8 t -71.41 -48.31 50.52 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.603 -0.517 . . . . 61.34 109.603 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 79.0 mt -80.37 -25.49 39.13 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.141 0.576 . . . . 74.15 112.494 -174.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.79 4.3 32.3 Favored Glycine 0 N--CA 1.474 1.175 0 CA-C-O 119.669 -0.517 . . . . 44.03 113.954 -173.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -144.2 -65.48 0.36 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 117.469 0.634 . . . . 74.31 111.33 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -67.6 -45.93 74.03 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 116.193 -0.458 . . . . 74.02 112.209 -171.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 68.6 m -66.98 -48.34 50.65 Favored Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 124.073 0.949 . . . . 73.41 112.863 -176.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HD3' HG11 ' A' ' 58' ' ' VAL . 46.0 Cg_endo -66.92 -21.02 50.73 Favored 'Trans proline' 0 C--N 1.393 2.893 0 C-N-CA 121.596 1.531 . . . . 72.52 112.562 173.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -71.84 -35.23 69.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.122 0.569 . . . . 54.21 110.364 174.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 38.6 mm -64.08 -42.72 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.65 0.78 . . . . 74.35 109.968 171.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.494 HD21 ' HA3' ' A' ' 82' ' ' GLY . 65.3 mt -76.17 -21.15 56.86 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.253 -0.885 . . . . 64.24 111.997 -174.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -64.31 -43.85 74.12 Favored Pre-proline 0 N--CA 1.484 1.261 0 CA-C-O 117.296 -1.335 . . . . 73.42 114.47 -172.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.78 -37.21 75.99 Favored 'Trans proline' 0 C--N 1.384 2.402 0 CA-C-N 122.04 1.764 . . . . 51.11 113.039 171.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -77.82 -39.39 43.84 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.581 0.753 . . . . 54.31 111.777 -177.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.56 -47.07 77.09 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.592 -0.521 . . . . 75.22 109.592 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.486 ' NH1' HD12 ' C' ' 105' ' ' ILE . 29.5 ttm180 -48.19 -56.06 8.87 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 125.157 1.535 . . . . 72.04 110.32 173.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.07 -44.96 94.32 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 124.432 1.082 . . . . 65.01 112.186 -174.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 117' ' ' MET . 42.1 t -59.27 -41.42 88.84 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.893 0.745 . . . . 72.02 110.82 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 118' ' ' VAL . 74.4 mt -64.32 -50.77 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.443 1.097 . . . . 75.3 110.561 174.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.0 m -59.56 -36.36 76.05 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.376 1.071 . . . . 75.12 111.386 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -71.38 -41.59 69.5 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 114.712 -1.131 . . . . 73.43 109.859 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.7 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 44.4 mtm -62.1 -38.37 88.62 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.731 0.413 . . . . 63.34 111.101 175.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 114' ' ' ILE . 65.6 t -63.52 -47.38 91.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 124.325 1.05 . . . . 72.51 111.157 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.8 p -71.79 -35.27 69.95 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.007 0.523 . . . . 72.2 111.327 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.467 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 87.5 mtt-85 -68.18 -30.75 69.93 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.561 0.744 . . . . 74.25 109.886 173.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.447 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.06 14.51 48.93 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-O 118.953 -0.915 . . . . 52.14 113.218 175.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.6 t 61.54 10.21 3.13 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 127.233 2.213 . . . . 74.43 114.214 176.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -82.18 145.08 51.75 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-O 119.176 -0.44 . . . . 74.23 109.82 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.427 ' HG2' ' NE1' ' A' ' 36' ' ' TRP . 92.7 Cg_exo -48.55 149.75 6.66 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 124.039 3.16 . . . . 75.43 113.83 174.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -55.68 128.4 34.55 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 124.246 0.966 . . . . 64.14 112.021 -171.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.457 HD11 HG11 ' A' ' 40' ' ' VAL . 41.4 tp -118.99 102.54 8.84 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.432 0.693 . . . . 74.42 110.172 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -102.77 115.38 30.47 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 107.798 -1.186 . . . . 71.12 107.798 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.3 mt -67.17 134.09 51.06 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.339 -0.615 . . . . 73.2 109.339 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.424 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -61.15 137.8 94.27 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 123.532 0.733 . . . . 52.03 111.379 -175.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 32.4 Cg_exo -59.81 107.11 0.36 Allowed 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.337 2.691 . . . . 70.53 113.47 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.446 HG21 HD11 ' A' ' 44' ' ' LEU . 58.3 t -100.95 134.46 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.119 0.568 . . . . 52.02 111.518 -174.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.448 ' ND2' ' HB2' ' A' ' 135' ' ' ALA . 52.7 t30 -96.26 87.54 4.52 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.347 -1.297 . . . . 73.42 109.134 175.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -59.74 -25.07 64.56 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.979 0.911 . . . . 74.33 112.531 175.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.436 ' HB3' ' OD1' ' A' ' 132' ' ' ASN . 19.8 t70 -58.68 -49.94 75.69 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.651 0.78 . . . . 65.52 109.812 172.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.448 ' HB2' ' ND2' ' A' ' 132' ' ' ASN . . . -59.51 -49.6 77.16 Favored 'General case' 0 C--N 1.358 0.956 0 O-C-N 123.731 0.645 . . . . 54.12 110.727 175.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 85.7 mt -53.13 -44.65 67.89 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 124.144 0.903 . . . . 71.04 111.925 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 82.7 t80 . . . . . 0 N--CA 1.47 0.536 0 CA-C-N 115.533 -0.758 . . . . 72.25 110.467 179.643 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.523 ' SD ' HG23 ' B' ' 89' ' ' ILE . 11.8 tpt . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 121.459 0.647 . . . . 53.51 111.425 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 9.4 t -153.92 132.26 11.98 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 107.483 -1.303 . . . . 63.35 107.483 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -137.69 136.97 37.89 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.146 -0.687 . . . . 74.14 109.146 -175.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -155.72 141.5 18.02 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.373 0.669 . . . . 74.42 109.523 173.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 55.6 mt -87.72 125.16 41.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.199 -1.037 . . . . 62.4 108.199 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -89.94 -39.63 12.88 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.672 -0.695 . . . . 72.44 109.802 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.44 ' HE ' HG21 ' A' ' 122' ' ' THR . 38.6 ttt180 -171.49 143.79 1.83 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.687 -0.688 . . . . 62.32 109.725 -174.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 71.4 mt -130.25 138.14 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 107.519 -1.289 . . . . 73.14 107.519 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.421 ' HE1' HG13 ' B' ' 83' ' ' ILE . 26.7 p90 -161.66 143.37 11.42 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.248 0.547 . . . . 75.52 111.479 -172.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.697 HG21 HD11 ' B' ' 21' ' ' ILE . 21.1 m -76.44 123.26 25.73 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.946 -1.025 . . . . 73.1 108.522 171.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.43 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.8 mtpt -93.84 -26.54 16.88 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.265 0.626 . . . . 71.13 110.337 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 34.0 t70 -152.53 141.75 21.44 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.91 0.484 . . . . 75.11 110.814 -175.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.697 HD11 HG21 ' B' ' 18' ' ' THR . 32.8 mm -129.5 142.47 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.022 1.329 . . . . 72.51 108.449 174.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 46.5 m -147.58 134.27 19.97 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.846 -1.07 . . . . 71.22 109.668 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -147.16 109.05 4.4 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.752 -1.573 . . . . 70.52 106.752 167.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -120.98 114.84 22.1 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.487 -0.931 . . . . 65.34 108.487 -177.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.58 87.02 2.48 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 107.327 -1.36 . . . . 63.21 107.327 175.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.65 -37.28 22.12 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.502 2.134 . . . . 74.23 112.552 -169.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -102.13 17.46 23.25 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.05 0.94 . . . . 73.13 110.621 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.422 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -39.88 -60.74 1.28 Allowed Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 115.465 1.654 . . . . 75.53 115.465 -163.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 12.6 Cg_exo -67.57 -28.48 38.02 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 121.844 1.696 . . . . 72.34 112.349 -173.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.458 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 79.1 m80 -92.83 -25.43 18.12 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.137 -0.938 . . . . 74.03 112.145 -173.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.585 HG21 ' HA ' ' B' ' 73' ' ' ALA . 6.0 p -83.02 -7.55 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 121.259 0.552 . . . . 75.43 110.725 -176.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -77.76 -9.23 58.91 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.207 0.603 . . . . 72.13 112.626 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 10.5 pt20 -67.23 -17.25 64.73 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.809 0.444 . . . . 71.11 110.582 170.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.538 ' HB2' HD13 ' B' ' 68' ' ' LEU . 30.5 mmtp -92.92 98.43 11.36 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.841 1.257 . . . . 74.24 109.23 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -100.1 78.25 2.06 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.322 0.649 . . . . 75.14 110.233 -176.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 25.2 p90 -166.06 172.46 11.35 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.575 0.75 . . . . 65.14 110.244 174.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -71.73 117.59 59.02 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 123.201 0.6 . . . . 73.32 110.104 175.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.42 ' HD3' ' HG2' ' B' ' 124' ' ' PRO . 55.8 Cg_endo -70.53 147.35 57.74 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 121.754 1.636 . . . . 72.33 110.474 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -72.47 110.0 6.56 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.22 -1.03 . . . . 65.24 108.22 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.479 HG21 HD13 ' B' ' 126' ' ' LEU . 59.9 t -99.32 146.05 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 114.955 -1.02 . . . . 73.24 110.44 -174.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -119.23 117.86 29.77 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.981 1.312 . . . . 70.04 108.578 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.629 HD13 HD22 ' B' ' 128' ' ' LEU . 24.2 tp -89.26 144.77 25.85 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.922 -0.399 . . . . 61.14 109.922 172.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.412 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 12.3 t70 -150.82 119.25 6.42 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.752 -0.832 . . . . 74.04 108.752 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 90.5 mt -99.47 126.24 45.36 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.475 -0.565 . . . . 71.42 109.475 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -124.79 127.45 47.2 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.765 -1.198 . . . . 74.15 107.765 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.8 t -109.46 141.37 41.97 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 122.746 0.418 . . . . 74.2 110.178 -172.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.69 140.73 27.47 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.477 1.111 . . . . 74.35 108.104 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 14.9 m -137.92 163.8 30.57 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.764 0.426 . . . . 72.4 110.021 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 72.1 p -156.41 136.31 12.64 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.246 0.618 . . . . 73.3 109.705 174.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -91.43 134.6 34.49 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.248 -1.019 . . . . 73.04 108.248 170.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 pp -150.67 14.22 0.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.432 -0.804 . . . . 74.34 109.717 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.98 158.82 35.64 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.439 -0.801 . . . . 45.02 110.953 -174.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -83.66 127.03 33.46 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.778 -1.101 . . . . 70.31 108.897 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 64.03 4.0 1.88 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 124.472 1.109 . . . . 63.23 113.065 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 53.6 t -132.32 122.73 48.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.63 -0.878 . . . . 74.31 108.63 -173.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.43 140.62 44.49 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 108.214 -1.032 . . . . 73.13 108.214 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -99.48 101.37 12.59 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 105.442 -2.058 . . . . 63.54 105.442 172.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.512 HG21 ' HG3' ' B' ' 103' ' ' PRO . 14.6 p -109.29 140.14 29.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 121.407 0.622 . . . . 72.12 109.329 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.418 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 17.0 t -114.2 144.56 21.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 124.614 1.166 . . . . 61.03 108.683 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 48.1 tp -121.12 110.36 16.12 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 107.751 -1.203 . . . . 73.34 107.751 167.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -84.25 118.36 24.12 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.673 -1.232 . . . . 73.3 107.673 171.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.4 121.24 57.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.44 -0.948 . . . . 71.5 108.44 173.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 17.8 m -108.75 135.29 50.22 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.74 0.816 . . . . 64.42 109.384 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.537 HG11 HD21 ' B' ' 126' ' ' LEU . 82.0 t -134.11 119.88 32.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.903 0.881 . . . . 73.12 109.171 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 66.6 m -109.5 138.98 45.06 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 123.659 0.783 . . . . 75.14 109.072 173.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.469 ' HB2' HG22 ' B' ' 40' ' ' VAL . . . -148.73 141.86 24.96 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.728 0.411 . . . . 73.43 109.909 178.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.554 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 35.4 p -141.68 132.68 26.07 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.607 0.763 . . . . 71.43 110.904 -176.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.538 HD13 ' HB2' ' B' ' 34' ' ' LYS . 68.8 mt -102.04 103.41 14.0 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 124.664 1.186 . . . . 61.22 109.196 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.96 -124.59 7.88 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.794 -0.639 . . . . 62.14 111.986 -175.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -96.08 2.24 53.1 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.937 0.895 . . . . 74.12 111.037 -173.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -130.16 149.38 51.89 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.988 0.515 . . . . 73.3 110.901 -173.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 85.9 m -73.73 123.68 24.57 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.014 -0.539 . . . . 75.32 110.673 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.585 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -76.35 -60.94 2.12 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.651 -1.159 . . . . 74.51 108.704 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -153.13 152.71 31.58 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.058 -0.974 . . . . 75.11 111.85 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 75.2 mt -121.05 110.62 16.46 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.53 -1.656 . . . . 55.22 106.53 169.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 28.9 t -119.28 121.25 39.21 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.028 -0.73 . . . . 62.4 109.028 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -138.22 128.49 26.0 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.244 0.618 . . . . 64.54 109.409 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 73.3 t -126.44 134.94 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.596 0.758 . . . . 62.23 109.172 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.502 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.3 mt-30 -108.67 107.72 18.3 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.305 -0.998 . . . . 73.44 108.305 175.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.425 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 7.8 tp-100 -100.8 107.81 19.46 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.753 -0.832 . . . . 74.0 108.753 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.43 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -91.73 170.01 33.16 Favored Glycine 0 C--O 1.245 0.784 0 N-CA-C 111.865 -0.494 . . . . 54.22 111.865 175.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.53 139.66 5.78 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 121.727 -0.273 . . . . 71.22 113.069 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.421 HG13 ' HE1' ' B' ' 17' ' ' TYR . 66.5 mt -98.23 110.75 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 125.019 1.327 . . . . 71.23 108.182 176.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -122.79 143.95 49.5 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.713 0.805 . . . . 74.43 110.839 -175.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 37.1 m -102.2 122.94 45.16 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.73 0.812 . . . . 70.3 109.894 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.566 ' HB ' HD11 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -131.89 122.74 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 124.911 1.284 . . . . 75.3 109.302 179.266 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.94 150.51 24.4 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.885 0.474 . . . . 61.54 111.579 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.36 -35.67 4.73 Favored Glycine 0 N--CA 1.479 1.503 0 C-N-CA 123.263 0.458 . . . . 75.22 112.394 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.566 HD11 ' HB ' ' B' ' 86' ' ' ILE . 7.1 pt -63.75 160.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 124.891 1.276 . . . . 65.21 112.655 173.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -153.78 176.07 12.57 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.023 0.929 . . . . 64.22 110.317 -173.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.4 -130.86 41.2 Favored Glycine 0 C--N 1.354 1.533 0 O-C-N 123.73 0.643 . . . . 63.13 112.859 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 18.0 m -67.5 -45.29 76.26 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.678 0.791 . . . . 63.44 109.75 172.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -59.12 -23.66 62.31 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 113.556 -1.656 . . . . 74.3 112.238 -167.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 20.6 ttt -58.6 -70.23 0.15 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.014 1.326 . . . . 74.13 111.931 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.39 -12.8 56.08 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.803 0.441 . . . . 70.25 112.137 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -63.24 -41.78 99.11 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.355 0.662 . . . . 72.21 110.267 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -60.69 -43.64 97.5 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.855 -0.611 . . . . 72.31 111.6 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.562 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.2 pp -81.28 -23.83 37.67 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.726 0.41 . . . . 52.42 111.776 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.51 -1.61 60.46 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-O 119.784 -0.453 . . . . 62.01 113.877 -174.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.47 -55.99 0.39 Allowed 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.303 0.551 . . . . 64.21 111.891 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -69.11 -46.23 68.23 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.745 0.418 . . . . 54.33 110.33 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.562 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 79.3 m -66.19 -47.98 59.85 Favored Pre-proline 0 CA--C 1.569 1.687 0 N-CA-C 113.711 1.004 . . . . 60.03 113.711 -177.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.512 ' HG3' HG21 ' B' ' 58' ' ' VAL . 15.2 Cg_exo -65.12 -28.82 56.52 Favored 'Trans proline' 0 C--N 1.402 3.359 0 C-N-CA 122.033 1.822 . . . . 72.24 112.87 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -69.62 -29.03 66.44 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.092 0.557 . . . . 71.23 110.325 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.23 -35.69 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.339 0.656 . . . . 64.14 110.334 170.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 76.5 mt -80.26 -17.98 50.68 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.821 0.848 . . . . 73.21 112.33 -177.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -59.42 -50.71 85.89 Favored Pre-proline 0 CA--C 1.561 1.375 0 CA-C-O 117.515 -1.231 . . . . 73.02 112.898 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -54.73 -37.11 91.84 Favored 'Trans proline' 0 C--N 1.39 2.727 0 C-N-CA 122.429 2.086 . . . . 70.2 114.028 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -68.73 -46.69 68.24 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.376 0.671 . . . . 72.51 110.583 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.425 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -64.55 -34.72 78.91 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.592 -0.731 . . . . 62.3 110.924 176.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 31.2 ttt180 -64.99 -50.13 67.54 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.226 1.41 . . . . 73.45 110.813 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.38 -32.52 70.21 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.403 0.681 . . . . 55.01 109.933 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.56 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.9 t -67.31 -41.37 85.46 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 122.923 0.489 . . . . 65.54 110.728 177.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 49.8 mt -59.83 -54.42 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.837 0.855 . . . . 71.43 110.445 172.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 25.1 m -61.79 -29.22 70.0 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 123.757 0.661 . . . . 75.24 111.371 -177.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 44.6 t -64.5 -52.44 57.83 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 123.543 0.737 . . . . 74.5 109.839 173.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 15.6 mmt -66.02 -33.62 76.22 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.27 0.628 . . . . 64.22 111.612 -175.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.504 HG21 HD23 ' B' ' 126' ' ' LEU . 74.3 t -66.76 -44.48 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.639 1.176 . . . . 75.45 110.602 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.5 t -64.66 -32.83 74.67 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.099 -0.955 . . . . 65.45 110.567 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' B' ' 116' ' ' SER . 78.5 mtt-85 -64.67 -47.78 77.16 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 115.709 -0.678 . . . . 72.13 109.339 175.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 121' ' ' GLY . . . . . 0.468 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -67.95 -5.99 42.71 Favored Glycine 0 C--N 1.358 1.772 0 O-C-N 123.735 0.647 . . . . 22.41 113.615 174.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.506 ' HB ' ' HE ' ' A' ' 15' ' ' ARG . 2.2 m 66.77 27.62 9.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.539 1.536 . . . . 74.51 110.563 175.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -84.87 156.06 61.18 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.214 0.605 . . . . 74.32 110.971 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.42 ' HG2' ' HD3' ' B' ' 38' ' ' PRO . 71.6 Cg_exo -51.89 167.86 0.41 Allowed 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 123.991 3.127 . . . . 71.22 115.219 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -63.52 112.56 2.83 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.832 -1.076 . . . . 74.15 111.605 -167.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.537 HD21 HG11 ' B' ' 64' ' ' VAL . 43.6 tp -116.56 105.82 12.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.282 0.633 . . . . 74.23 109.56 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -121.49 120.96 36.41 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.034 -1.098 . . . . 72.21 108.034 170.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.629 HD22 HD13 ' B' ' 42' ' ' LEU . 59.2 mt -74.21 143.92 44.96 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.58 0.55 . . . . 63.03 110.988 -174.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.91 141.14 63.19 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 122.961 0.504 . . . . 73.11 110.843 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.655 ' HG3' HD11 ' D' ' 16' ' ' ILE . 61.7 Cg_endo -70.14 79.98 1.02 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.334 2.689 . . . . 73.33 111.216 174.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 p -100.01 125.42 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 115.498 -0.774 . . . . 74.44 110.053 -177.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 60.3 t30 . . . . . 0 CA--C 1.539 0.556 0 CA-C-N 115.677 -0.692 . . . . 72.12 110.108 -177.403 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 68.3 t80 . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 109.264 -0.643 . . . . 72.0 109.264 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -161.97 126.54 3.32 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.559 0.744 . . . . 74.03 109.591 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 48.5 mt -78.84 123.59 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 108.438 -0.949 . . . . 74.24 108.438 169.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.445 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 14.4 mm100 -90.44 -42.12 11.07 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.644 0.777 . . . . 65.11 109.688 176.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -173.42 150.9 1.89 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.312 -0.858 . . . . 73.43 110.212 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 74.3 mt -128.17 135.15 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 106.731 -1.581 . . . . 72.41 106.731 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -173.06 158.64 3.77 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.379 0.609 . . . . 61.11 111.724 -170.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 70.2 p -82.46 113.24 20.08 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.341 -0.845 . . . . 71.04 109.123 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.603 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 10.4 mmmm -68.61 -49.13 61.64 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.046 -1.094 . . . . 73.11 108.046 169.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.704 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 20.8 t70 -136.19 143.68 44.54 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 113.852 -1.522 . . . . 73.44 109.681 -172.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.552 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.5 mt -138.47 145.66 27.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 125.435 1.494 . . . . 75.23 107.25 175.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 41.3 t -153.17 147.75 26.12 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.463 0.649 . . . . 62.03 110.048 175.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -151.83 125.61 9.04 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.04 -1.467 . . . . 74.44 107.04 170.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -129.35 117.81 21.23 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.682 0.793 . . . . 71.05 108.867 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.22 85.62 5.62 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 107.304 -1.369 . . . . 75.41 107.304 167.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.91 -33.61 63.11 Favored 'Trans proline' 0 C--N 1.387 2.605 0 C-N-CA 123.097 2.531 . . . . 64.23 112.209 -172.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -113.6 31.51 6.45 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.861 -1.063 . . . . 70.44 109.605 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.414 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -43.91 -54.68 10.54 Favored Pre-proline 0 C--N 1.377 1.764 0 CA-C-O 117.837 -1.078 . . . . 54.12 113.383 -174.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 50.1 Cg_exo -53.28 -52.16 9.33 Favored 'Trans proline' 0 C--N 1.395 3.003 0 C-N-CA 122.001 1.801 . . . . 63.01 113.128 175.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -69.52 -32.57 71.49 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.608 -1.178 . . . . 74.4 113.2 -171.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.622 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.9 p -79.05 -24.44 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 N-CA-C 112.48 0.548 . . . . 73.51 112.48 -173.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -71.42 -17.86 62.36 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 112.349 0.5 . . . . 71.51 112.349 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -93.75 7.39 45.01 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.918 0.487 . . . . 71.12 111.759 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.696 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -94.62 158.74 15.39 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.232 0.613 . . . . 71.42 110.788 -177.804 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -68.22 129.65 40.55 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.057 0.943 . . . . 65.43 109.539 164.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 36' ' ' TRP . . . . . 0.567 ' HZ2' HD21 ' C' ' 126' ' ' LEU . 64.0 t-105 -82.24 90.49 6.62 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.211 0.604 . . . . 74.41 110.5 -178.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -143.14 78.38 15.16 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 107.709 -1.219 . . . . 74.35 107.709 171.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -93.79 169.85 1.99 Allowed 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 122.527 2.151 . . . . 64.35 112.835 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -92.78 89.76 6.76 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 106.181 -1.785 . . . . 63.43 106.181 171.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 61.2 t -68.16 96.97 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 109.037 -0.727 . . . . 74.14 109.037 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -96.75 104.68 16.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.884 -1.053 . . . . 74.42 108.641 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.682 ' H ' HD23 ' C' ' 42' ' ' LEU . 1.8 pt? -97.07 121.14 38.62 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.788 -1.56 . . . . 62.24 106.788 168.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -119.39 141.12 49.36 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.571 -0.9 . . . . 72.1 108.571 -174.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 50.0 mt -130.97 110.74 11.47 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.32 0.648 . . . . 65.54 110.165 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -114.54 122.86 47.85 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.967 1.707 . . . . 73.13 107.469 173.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.1 t -121.8 149.28 43.55 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.029 -0.73 . . . . 71.13 109.029 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.45 153.57 32.74 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.543 0.737 . . . . 51.32 109.281 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.456 ' OG ' ' HB3' ' C' ' 98' ' ' LEU . 12.8 m -131.71 145.36 51.59 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.304 0.642 . . . . 74.13 109.414 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.3 p -144.91 127.37 15.96 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.566 -0.901 . . . . 74.32 108.566 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -80.28 117.91 21.47 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 108.717 -0.846 . . . . 72.13 108.717 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.616 HD11 HD12 ' C' ' 83' ' ' ILE . 25.6 mt -83.82 -47.18 11.39 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.585 0.707 . . . . 71.34 109.656 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.57 -166.96 2.69 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 114.486 -1.233 . . . . 44.31 110.029 -171.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -57.77 105.0 0.22 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.399 1.079 . . . . 71.33 110.535 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 60.1 22.17 11.41 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.329 1.018 . . . . 71.52 112.978 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 85.6 t -104.3 119.64 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.661 0.785 . . . . 74.41 108.989 173.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -121.28 121.31 37.42 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.821 -1.177 . . . . 74.35 107.821 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -89.93 114.43 26.23 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.033 -1.099 . . . . 62.11 108.033 168.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 97.9 t -95.14 134.94 30.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.278 -1.379 . . . . 61.34 107.278 168.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 93.8 t -121.11 138.0 52.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 108.356 -0.979 . . . . 54.1 108.356 174.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.27 101.08 8.84 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.994 -1.113 . . . . 71.11 107.994 175.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 21.0 ttm-85 -81.07 107.13 13.62 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 108.434 -0.95 . . . . 74.44 108.434 170.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.49 ' HB ' HD11 ' C' ' 114' ' ' ILE . 7.8 t -106.58 120.11 57.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 108.09 -1.078 . . . . 70.32 108.09 173.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 17.5 m -119.21 116.16 25.72 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.251 0.621 . . . . 64.02 109.572 -174.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.475 HG21 HG21 ' C' ' 114' ' ' ILE . 63.3 t -104.06 109.04 26.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 123.452 0.701 . . . . 61.53 109.114 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 3.8 m -99.4 140.1 34.08 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.668 -1.234 . . . . 64.23 107.668 170.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.41 119.42 19.62 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 106.661 -1.607 . . . . 74.25 106.661 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 44.9 m -133.29 126.02 30.54 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.579 0.549 . . . . 61.43 110.452 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.696 HD13 ' HG2' ' C' ' 34' ' ' LYS . 11.0 mt -86.78 47.08 1.44 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.766 1.226 . . . . 62.11 109.317 176.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.65 -110.8 3.84 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 111.001 -0.84 . . . . 71.03 111.001 -174.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.16 -28.87 19.73 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.093 -0.706 . . . . 75.14 109.093 173.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -62.86 120.67 11.76 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.584 1.153 . . . . 72.14 109.194 172.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 20.9 m -84.24 125.06 31.87 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 108.443 -0.947 . . . . 75.13 108.443 169.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.622 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -73.45 -62.97 1.29 Allowed 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.328 -0.99 . . . . 64.4 108.328 174.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -157.33 169.89 23.7 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-O 121.917 0.865 . . . . 73.31 110.782 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.442 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.7 tm? -123.43 147.01 47.56 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 106.388 -1.708 . . . . 73.33 106.388 166.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.442 ' N ' HD13 ' C' ' 75' ' ' LEU . 48.4 t -149.22 145.62 27.2 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.846 -1.168 . . . . 54.53 107.846 177.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -157.07 136.56 12.17 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.301 -0.629 . . . . 74.15 109.301 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.474 HG11 ' HA ' ' C' ' 110' ' ' ALA . 54.7 t -134.22 113.52 17.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.136 -1.061 . . . . 63.3 108.136 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.704 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.4 mt-30 -94.44 89.21 5.77 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.828 -0.805 . . . . 71.03 108.828 173.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -79.68 102.4 8.94 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.509 -1.223 . . . . 74.55 110.09 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.58 150.47 26.93 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 112.007 -0.437 . . . . 61.41 112.007 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.404 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -152.22 117.69 0.84 Allowed Glycine 0 CA--C 1.502 -0.771 0 N-CA-C 110.233 -1.147 . . . . 63.3 110.233 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.616 HD12 HD11 ' C' ' 51' ' ' LEU . 25.5 mm -85.23 121.15 36.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.53 -0.915 . . . . 53.13 108.53 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -129.9 117.18 19.74 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.16 -1.052 . . . . 53.43 108.16 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 53.9 p -90.45 103.5 16.18 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.954 -0.758 . . . . 63.35 108.954 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.541 HD13 ' SG ' ' C' ' 97' ' ' CYS . 25.4 mt -116.86 138.74 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.146 0.978 . . . . 74.1 110.746 -171.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.06 170.4 19.48 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.657 0.783 . . . . 62.54 110.869 175.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.83 -18.67 38.01 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-N 115.534 -0.757 . . . . 42.14 113.756 172.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 34.8 pt -106.33 170.59 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.232 0.613 . . . . 64.13 111.261 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -160.81 158.84 29.13 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.645 0.778 . . . . 74.14 109.854 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.55 -114.76 7.1 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 123.615 0.572 . . . . 61.23 113.846 168.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 13.4 t -66.25 -35.5 80.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.635 0.774 . . . . 74.53 111.082 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -71.81 -42.66 66.78 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.646 0.778 . . . . 73.44 110.622 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 6.2 tpt -62.5 -52.36 63.78 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 123.923 0.765 . . . . 54.25 110.024 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.87 -31.42 72.59 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.753 -0.658 . . . . 60.43 111.817 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -72.17 -34.18 68.26 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.142 0.577 . . . . 70.1 110.553 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.541 ' SG ' HD13 ' C' ' 86' ' ' ILE . 18.2 t -71.2 -41.37 70.35 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.699 -0.482 . . . . 61.54 109.699 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.456 ' HB3' ' OG ' ' C' ' 48' ' ' SER . 89.9 mt -85.05 -44.51 12.96 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.959 0.904 . . . . 72.01 112.815 -170.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.52 3.17 57.68 Favored Glycine 0 N--CA 1.472 1.072 0 CA-C-N 116.067 -0.515 . . . . 43.31 113.481 -170.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.31 -68.98 0.45 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.999 0.4 . . . . 64.2 111.096 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -60.21 -55.1 37.93 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.765 0.826 . . . . 72.14 112.475 -171.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 98.2 m -59.75 -46.74 98.45 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.794 0.838 . . . . 72.13 112.523 -177.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -50.85 -35.21 48.09 Favored 'Trans proline' 0 C--N 1.395 3.018 0 C-N-CA 123.071 2.514 . . . . 63.04 115.119 169.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -66.8 -33.9 76.63 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 118.719 0.69 . . . . 74.32 111.075 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.486 HD12 ' NH1' ' A' ' 111' ' ' ARG . 42.0 mm -72.53 -34.83 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 123.004 0.521 . . . . 75.34 109.907 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.404 HD21 ' HA3' ' C' ' 82' ' ' GLY . 89.4 mt -84.49 -24.56 29.37 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.855 0.862 . . . . 70.5 112.326 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -57.05 -52.11 76.6 Favored Pre-proline 0 N--CA 1.482 1.137 0 CA-C-O 117.334 -1.317 . . . . 71.15 113.867 -172.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.01 -34.41 80.65 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.168 1.912 . . . . 64.31 112.915 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -66.35 -47.62 72.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.483 0.713 . . . . 72.24 110.236 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.474 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -63.39 -36.88 85.2 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.855 -1.066 . . . . 73.15 110.943 177.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.2 ttt-85 -68.99 -46.57 67.71 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.409 1.484 . . . . 75.34 111.176 -175.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -67.97 -34.33 76.36 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.528 0.731 . . . . 65.11 109.486 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 12.8 t -65.86 -35.67 81.32 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.462 0.705 . . . . 65.02 111.249 177.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.49 HD11 ' HB ' ' C' ' 62' ' ' VAL . 85.7 mt -69.23 -58.04 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.345 0.658 . . . . 72.11 110.485 176.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 4.7 m -64.43 -28.38 69.64 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 122.707 0.403 . . . . 70.03 111.249 -173.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 42.0 t -61.6 -52.78 62.99 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 123.279 0.632 . . . . 51.21 109.37 169.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.549 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.08 -42.59 80.96 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.011 1.324 . . . . 74.43 113.002 -179.568 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.468 HG11 HD23 ' C' ' 126' ' ' LEU . 87.3 t -63.62 -45.67 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.381 1.072 . . . . 64.51 110.253 177.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.4 t -67.52 -29.67 69.13 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.281 -1.327 . . . . 71.31 111.429 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.48 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 87.3 mtt-85 -68.59 -39.53 80.89 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.072 -0.714 . . . . 64.45 109.072 176.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.79 12.03 58.04 Favored Glycine 0 C--N 1.354 1.535 0 CA-C-N 115.698 -0.683 . . . . 70.21 113.0 175.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 69.0 p 53.8 37.53 26.56 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 126.212 1.805 . . . . 75.33 114.146 175.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -93.99 148.03 34.52 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 107.583 -1.266 . . . . 74.11 107.583 165.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.01 169.45 0.64 Allowed 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.224 2.616 . . . . 73.0 114.168 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -59.32 123.3 16.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.159 0.984 . . . . 74.04 111.975 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.567 HD21 ' HZ2' ' C' ' 36' ' ' TRP . 3.5 mm? -116.27 86.14 2.43 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.674 -1.232 . . . . 71.44 107.674 166.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -91.46 95.17 9.82 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.727 -0.842 . . . . 53.13 108.727 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 8.5 mp -55.84 131.01 45.85 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.102 0.961 . . . . 73.11 111.583 -175.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.44 137.08 96.48 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-O 118.694 -0.669 . . . . 62.11 110.453 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -49.52 110.91 0.41 Allowed 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.673 2.915 . . . . 73.35 113.442 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.9 t -100.93 114.55 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 123.142 0.577 . . . . 75.32 109.455 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -80.88 105.7 12.32 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.421 0.689 . . . . 72.54 109.418 176.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -68.8 -20.78 64.34 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.372 0.669 . . . . 51.3 112.329 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.55 -29.85 65.22 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.116 0.566 . . . . 65.51 110.554 173.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.01 -35.0 64.36 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.064 0.546 . . . . 70.2 110.004 173.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 83.1 mt -67.68 -40.28 84.42 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.82 -0.627 . . . . 71.3 110.418 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 55.9 t80 . . . . . 0 N--CA 1.473 0.717 0 C-N-CA 123.741 0.816 . . . . 75.32 110.488 179.793 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 C--O 1.242 0.687 0 N-CA-C 109.525 -0.546 . . . . 64.14 109.525 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.483 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 58.5 t80 -134.5 105.41 6.53 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.648 -1.242 . . . . 62.22 107.648 175.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -129.83 115.82 17.8 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.724 -0.843 . . . . 61.43 108.724 -174.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 8.1 mt -76.04 122.53 30.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 108.314 -0.995 . . . . 72.23 108.314 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -89.16 -29.05 19.6 Favored 'General case' 0 C--O 1.242 0.675 0 O-C-N 123.822 0.701 . . . . 62.14 110.982 -176.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -172.77 138.2 0.81 Allowed 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.464 0.477 . . . . 51.31 110.146 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.655 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.5 mp -120.88 135.97 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.681 -1.229 . . . . 73.44 107.681 173.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -162.4 170.14 19.3 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.207 1.003 . . . . 71.13 112.85 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.5 p -105.05 119.24 38.54 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.224 -1.353 . . . . 63.51 108.509 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -88.0 -21.29 24.9 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.035 -0.53 . . . . 73.2 109.925 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.412 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 31.8 t70 -159.9 138.61 10.6 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.182 0.993 . . . . 63.14 109.219 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.549 HG21 ' HE2' ' C' ' 117' ' ' MET . 72.5 mt -139.77 138.29 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.971 1.308 . . . . 73.35 107.802 176.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.5 t -139.69 143.35 37.05 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.104 0.962 . . . . 74.21 109.008 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.552 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 91.7 t80 -150.0 122.99 8.78 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 106.612 -1.625 . . . . 62.12 106.612 170.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.63 111.65 11.9 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.715 0.806 . . . . 62.41 109.584 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.93 84.66 4.47 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 107.665 -1.235 . . . . 70.33 107.665 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.16 -43.64 0.53 Allowed 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.415 2.077 . . . . 61.14 112.336 -171.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -93.81 10.52 32.77 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.256 1.022 . . . . 71.42 110.414 -176.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.603 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -31.69 -64.79 0.22 Allowed Pre-proline 0 N--CA 1.488 1.441 0 C-N-CA 127.259 2.224 . . . . 61.11 116.334 -166.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.84 -21.65 14.13 Favored 'Trans proline' 0 C--N 1.38 2.222 0 CA-C-N 122.735 2.013 . . . . 74.53 114.073 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -77.33 -37.29 52.79 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.377 1.071 . . . . 73.44 109.909 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.438 HG12 ' O ' ' D' ' 28' ' ' ALA . 7.7 p -82.98 -25.57 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-N 115.452 -0.795 . . . . 63.21 111.308 -172.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -60.65 -25.78 66.58 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 122.883 0.473 . . . . 74.43 112.099 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -64.9 -8.66 16.43 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.776 1.23 . . . . 63.01 112.231 -175.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -96.41 95.01 7.75 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.2 1.4 . . . . 71.21 109.041 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -81.91 81.71 7.8 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.356 0.662 . . . . 74.11 111.093 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -160.78 -179.88 7.95 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.18 0.992 . . . . 72.12 109.1 166.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -75.78 114.12 33.61 Favored Pre-proline 0 N--CA 1.477 0.9 0 CA-C-O 118.294 -0.86 . . . . 64.13 109.167 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.35 134.79 58.54 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.045 2.497 . . . . 74.33 111.856 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -63.81 107.82 1.3 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 107.623 -1.251 . . . . 74.22 107.623 175.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.664 HG13 HG13 ' D' ' 64' ' ' VAL . 86.5 t -104.4 129.55 56.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 109.416 -0.587 . . . . 73.31 109.416 -176.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -105.35 112.28 25.33 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 106.348 -1.723 . . . . 62.23 106.348 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.489 HD22 ' HB2' ' D' ' 128' ' ' LEU . 64.8 tp -94.33 150.02 20.68 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.678 -1.23 . . . . 54.23 107.678 174.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -148.27 140.07 23.83 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.255 -1.017 . . . . 75.23 108.255 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.506 HD22 HG22 ' D' ' 62' ' ' VAL . 91.4 mt -130.7 145.09 51.85 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.584 0.754 . . . . 73.02 109.452 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -155.62 141.35 18.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.766 -1.198 . . . . 73.41 107.766 169.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 25.9 m -102.84 156.18 17.83 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.214 1.005 . . . . 64.24 109.292 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.09 167.13 26.7 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 126.039 1.736 . . . . 74.32 106.8 172.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 13.5 p . . . . . 0 C--O 1.244 0.783 0 N-CA-C 109.306 -0.627 . . . . 62.32 109.306 -179.79 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 54' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' D' ' 85' ' ' SER . 1.9 m-20 . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 112.011 0.374 . . . . 63.13 112.011 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.26 94.88 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 109.054 -0.721 . . . . 73.2 109.054 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -122.95 127.99 49.64 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.787 -0.82 . . . . 70.03 108.787 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -94.64 119.42 33.27 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.468 -0.938 . . . . 60.33 108.468 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 73.8 t -101.33 134.45 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.853 0.861 . . . . 71.13 108.851 173.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.515 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 33.4 t -116.02 128.44 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.185 0.994 . . . . 63.21 108.745 173.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.39 111.69 24.14 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.86 -1.163 . . . . 72.44 107.86 175.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 ttt85 -85.82 106.48 17.08 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.233 -0.655 . . . . 42.53 109.233 174.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.506 HG22 HD22 ' D' ' 44' ' ' LEU . 61.1 t -105.75 130.65 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.268 1.027 . . . . 44.33 108.624 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 7.3 m -134.75 144.46 47.72 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.014 0.435 . . . . 71.53 110.964 -173.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.664 HG13 HG13 ' D' ' 40' ' ' VAL . 55.0 t -133.85 114.28 19.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 C-N-CA 125.447 1.499 . . . . 60.12 108.902 -173.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 19.2 m -106.12 93.46 4.63 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.074 -1.084 . . . . 74.43 108.074 169.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.08 144.94 27.04 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.363 0.665 . . . . 72.25 109.937 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.496 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 48.2 m -151.89 127.85 10.35 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 123.424 0.69 . . . . 75.13 110.879 -177.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.437 ' HB2' HG22 ' D' ' 31' ' ' VAL . 16.6 mt -93.45 109.31 20.9 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 107.764 -1.199 . . . . 61.22 107.764 168.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.19 -124.32 8.27 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 116.064 -0.516 . . . . 54.55 112.496 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.15 3.99 28.55 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.329 0.652 . . . . 72.45 111.775 -176.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -118.42 158.88 24.46 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 109.574 -0.528 . . . . 60.43 109.574 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 52.0 m -72.43 129.56 38.63 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.615 -0.72 . . . . 73.13 111.685 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.496 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -81.54 -69.19 0.63 Allowed 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.829 -1.174 . . . . 72.31 107.829 173.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -153.54 153.77 33.03 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 115.841 -0.618 . . . . 74.43 111.105 176.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 50.0 mt -119.32 109.93 16.38 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.396 -1.335 . . . . 74.33 107.396 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.543 ' SG ' HG12 ' D' ' 114' ' ' ILE . 42.0 t -120.61 136.98 54.66 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 123.544 0.737 . . . . 70.14 109.586 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -152.06 123.88 7.98 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.9 0.48 . . . . 70.23 109.794 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 88.3 t -127.58 118.52 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.926 0.89 . . . . 71.22 109.836 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.412 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.2 mt-30 -90.72 90.13 7.82 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.517 0.727 . . . . 71.24 109.251 171.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -82.77 98.74 9.26 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.723 -1.126 . . . . 52.24 109.422 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -102.19 156.4 18.55 Favored Glycine 0 N--CA 1.471 1.012 0 N-CA-C 112.077 -0.409 . . . . 44.25 112.077 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.4 150.05 13.78 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 117.2 0.5 . . . . 64.12 112.619 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 57.5 mt -90.0 132.71 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 109.082 -0.71 . . . . 64.21 109.082 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -128.98 140.46 51.64 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.305 1.042 . . . . 64.42 109.575 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 39.8 t -93.59 108.27 20.01 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 107.682 -1.229 . . . . 71.32 107.682 168.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 33.9 pt -109.13 123.9 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 N-CA-C 108.654 -0.869 . . . . 74.04 108.654 172.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.45 168.29 6.52 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.173 0.589 . . . . 62.34 111.458 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.3 19.18 72.44 Favored Glycine 0 C--N 1.347 1.165 0 O-C-N 123.683 0.614 . . . . 61.4 112.941 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.43 164.25 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.266 1.027 . . . . 74.54 109.799 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -146.68 -179.35 6.72 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.749 0.82 . . . . 73.21 110.57 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.82 -140.29 27.64 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 115.984 -0.553 . . . . 71.3 112.472 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 60.8 p -89.62 -29.83 18.57 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.366 0.666 . . . . 74.04 110.752 172.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -53.4 -33.22 53.03 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.578 1.151 . . . . 74.12 112.474 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.492 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 2.9 ppp? -60.71 -50.63 72.72 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.876 0.87 . . . . 72.24 113.197 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 95' ' ' ALA . . . . . 0.492 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.25 -19.4 31.66 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.061 0.544 . . . . 65.24 110.978 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -67.88 -38.37 82.94 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.674 0.79 . . . . 74.11 110.49 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 86.9 m -61.15 -33.59 73.66 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.585 0.754 . . . . 72.21 111.587 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 27.0 tp -69.54 -37.57 77.13 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.916 0.486 . . . . 75.5 111.119 -176.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.2 0.11 68.47 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-O 119.388 -0.673 . . . . 74.44 113.6 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.75 -58.32 0.77 Allowed 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 117.74 0.77 . . . . 62.33 112.932 -171.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -72.35 -43.84 63.48 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.064 0.545 . . . . 63.12 110.925 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.483 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 75.2 m -60.45 -45.48 97.38 Favored Pre-proline 0 CA--C 1.571 1.752 0 C-N-CA 124.132 0.973 . . . . 70.41 112.166 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.401 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 73.5 Cg_exo -55.28 -42.05 72.33 Favored 'Trans proline' 0 C--N 1.395 3.014 0 C-N-CA 123.188 2.592 . . . . 70.04 113.836 165.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -63.38 -24.88 68.03 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.537 0.735 . . . . 55.24 110.972 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 44.8 mm -75.84 -45.5 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.798 0.839 . . . . 73.14 110.545 172.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.04 -25.79 65.54 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.477 -0.783 . . . . 75.24 111.672 -176.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -68.57 -40.01 17.26 Favored Pre-proline 0 CA--C 1.563 1.467 0 N-CA-C 114.507 1.299 . . . . 72.42 114.507 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -47.83 -46.64 20.9 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.447 2.098 . . . . 71.31 113.69 167.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 109' ' ' TYR . . . . . 0.428 ' OH ' ' HB3' ' B' ' 130' ' ' PRO . 99.0 m-85 -72.26 -38.46 68.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.631 0.773 . . . . 74.14 111.096 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 110' ' ' ALA . . . . . 0.417 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -65.93 -38.73 89.43 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.842 0.857 . . . . 72.21 110.776 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.485 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 24.3 ttp-105 -66.02 -48.93 69.49 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 115.104 -0.953 . . . . 73.25 110.032 175.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -56.16 -47.63 77.85 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.64 1.213 . . . . 54.44 110.977 -175.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.5 t -56.74 -46.26 81.48 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 124.032 0.832 . . . . 74.14 111.331 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.543 HG12 ' SG ' ' D' ' 76' ' ' CYS . 62.6 mt -63.33 -57.08 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.962 0.905 . . . . 60.22 111.096 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 38.8 m -52.89 -43.13 65.94 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.527 1.131 . . . . 54.1 111.273 -175.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 29.7 t -63.49 -43.42 97.31 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 114.251 -1.341 . . . . 64.14 109.925 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.8 mtm -69.87 -30.33 67.77 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.12 0.568 . . . . 74.2 111.763 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.4 t -64.56 -45.97 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.508 0.723 . . . . 62.34 109.916 175.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.2 p -74.53 -29.72 61.5 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.636 -0.711 . . . . 60.15 110.74 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 66.5 mtt-85 -70.65 -30.2 66.75 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.639 0.775 . . . . 73.21 109.868 173.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.62 8.97 75.59 Favored Glycine 0 C--N 1.354 1.539 0 O-C-N 123.62 0.575 . . . . 71.02 112.898 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 78.0 p 54.95 27.56 9.35 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 126.167 1.787 . . . . 73.04 113.974 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -88.67 151.04 47.29 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 109.211 -0.663 . . . . 72.52 109.211 168.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -48.3 133.85 25.11 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.642 2.895 . . . . 72.34 113.002 171.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -56.5 128.63 37.09 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.754 0.822 . . . . 55.42 112.006 -170.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.594 HD13 HG21 ' D' ' 40' ' ' VAL . 28.9 tp -108.93 98.23 7.74 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.612 1.165 . . . . 74.34 109.419 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -99.58 80.88 2.42 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.884 -1.154 . . . . 72.12 107.884 174.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.665 ' H ' HD23 ' D' ' 128' ' ' LEU . 0.3 OUTLIER -58.44 112.3 1.53 Allowed 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.64 -1.164 . . . . 74.12 109.686 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.6 139.48 75.6 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 125.102 1.361 . . . . 65.33 113.064 -169.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.48 ' HB3' HH12 ' D' ' 111' ' ' ARG . 96.2 Cg_endo -76.75 155.89 35.11 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.95 2.433 . . . . 73.21 112.633 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 9.6 p -148.79 143.47 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.551 -0.75 . . . . 63.44 109.568 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -81.49 105.98 13.09 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.161 -1.052 . . . . 60.31 108.161 172.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 . . . . . 0 N--CA 1.483 1.18 0 C-N-CA 124.154 0.982 . . . . 64.01 110.601 -177.801 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.0 m . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 109.361 -0.607 . . . . 74.32 109.361 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.431 ' CD1' HD12 ' A' ' 86' ' ' ILE . 46.7 t80 -125.32 114.43 18.89 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.847 -1.168 . . . . 64.24 107.847 175.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -134.38 133.4 40.55 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.254 -0.647 . . . . 75.44 109.254 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.498 ' CD1' HG21 ' A' ' 105' ' ' ILE . 4.7 mt -95.32 120.68 45.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 109.26 -0.644 . . . . 63.04 109.26 177.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -83.76 -39.6 19.86 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 123.554 0.534 . . . . 70.41 111.052 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -173.47 120.14 0.32 Allowed 'General case' 0 N--CA 1.472 0.675 0 O-C-N 123.393 0.433 . . . . 74.5 110.0 -170.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.518 HD12 ' HG3' ' C' ' 130' ' ' PRO . 64.7 mt -107.5 137.63 37.71 Favored 'Isoleucine or valine' 0 C--O 1.247 0.921 0 N-CA-C 108.17 -1.048 . . . . 75.12 108.17 171.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.458 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 35.9 p90 -166.4 179.27 5.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 124.304 1.003 . . . . 75.3 110.936 -170.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -111.39 120.21 41.43 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.422 0.689 . . . . 65.3 110.095 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.1 mtpt -86.08 -28.8 23.85 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.807 -0.442 . . . . 64.15 109.807 177.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 18.0 t70 -144.54 139.3 28.1 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.511 -0.768 . . . . 73.54 109.408 177.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.4 mt -139.42 140.47 37.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.405 -1.331 . . . . 40.34 107.405 172.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.5 t -153.6 125.29 7.69 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.58 0.752 . . . . 72.15 109.479 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.557 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 70.3 t80 -128.59 130.86 47.94 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 106.594 -1.632 . . . . 71.0 106.594 173.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -130.58 135.43 47.89 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.049 0.386 . . . . 71.32 110.002 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.2 76.29 12.34 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.234 1.014 . . . . 73.33 108.358 172.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.31 -34.87 9.22 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.509 2.139 . . . . 73.32 112.264 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -91.34 11.77 22.61 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.537 -0.756 . . . . 63.1 110.74 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.449 ' HA ' HG12 ' A' ' 31' ' ' VAL . . . -47.27 -54.12 23.66 Favored Pre-proline 0 CA--C 1.57 1.722 0 CA-C-O 118.03 -0.986 . . . . 74.44 113.035 -171.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 51.9 Cg_exo -55.86 -30.41 76.86 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 122.343 2.028 . . . . 75.22 113.451 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -81.05 -43.19 19.9 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.271 0.628 . . . . 73.32 110.165 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.566 HG21 ' HA ' ' A' ' 73' ' ' ALA . 2.0 p -77.58 -22.26 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 114.782 -1.099 . . . . 75.01 112.685 -159.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -73.28 -21.7 60.54 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.069 0.548 . . . . 54.22 111.629 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -77.96 -22.98 48.66 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.267 -0.879 . . . . 64.43 110.43 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -82.78 165.95 19.45 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.283 1.033 . . . . 71.33 111.323 -174.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -76.77 123.11 25.71 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.601 -0.727 . . . . 53.33 109.48 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -76.23 87.39 3.06 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.666 0.746 . . . . 74.44 110.329 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.94 75.96 47.21 Favored Pre-proline 0 C--O 1.242 0.663 0 N-CA-C 105.898 -1.89 . . . . 41.12 105.898 170.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.63 149.1 14.36 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.819 2.346 . . . . 53.45 112.923 -173.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -96.0 100.89 12.52 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 106.625 -1.62 . . . . 70.14 106.625 167.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 65' ' ' THR . 39.0 t -91.52 108.2 19.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 109.804 -0.443 . . . . 65.32 109.804 -176.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -102.54 114.09 28.01 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.963 -1.017 . . . . 73.12 109.178 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.617 HD11 HD13 ' A' ' 128' ' ' LEU . 6.7 tt -108.91 138.1 45.77 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.416 -0.957 . . . . 65.51 108.416 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -137.8 141.43 40.85 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.75 0.82 . . . . 63.35 109.396 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.604 HD22 HD21 ' A' ' 60' ' ' LEU . 97.3 mt -120.79 142.23 49.78 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.598 0.759 . . . . 53.34 111.337 -172.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.577 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 7.8 m-20 -134.54 137.72 44.05 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.49 -0.93 . . . . 72.4 108.49 176.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.5 HG21 ' HA2' ' A' ' 99' ' ' GLY . 74.6 m -123.48 126.81 47.42 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.36 0.664 . . . . 61.21 109.441 175.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.44 153.56 50.73 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 124.393 1.077 . . . . 74.41 108.915 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.8 m -126.8 159.55 33.49 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 122.962 0.505 . . . . 74.33 110.315 175.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.7 t -148.93 117.97 6.75 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.252 -1.018 . . . . 73.42 108.252 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -77.92 104.01 8.21 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.958 -0.756 . . . . 75.15 108.958 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 71.4 mt -78.63 -27.66 45.43 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.626 -0.716 . . . . 72.43 109.953 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.473 ' HB3' ' CG2' ' A' ' 55' ' ' VAL . . . -163.37 172.75 14.14 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.357 1.063 . . . . 62.25 109.093 175.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -66.44 127.98 34.39 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.582 -0.895 . . . . 44.5 108.582 169.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 69.0 12.83 8.72 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.482 1.113 . . . . 74.31 112.328 -174.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.473 ' CG2' ' HB3' ' A' ' 52' ' ' ALA . 26.6 t -127.79 112.02 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.01 0.924 . . . . 73.42 108.651 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -128.7 124.38 35.49 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.344 -0.614 . . . . 63.03 109.344 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -91.41 145.32 24.73 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.861 -0.792 . . . . 75.12 108.861 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.9 t -128.7 141.39 46.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.496 -0.928 . . . . 71.04 108.496 172.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 73.5 t -123.32 132.43 71.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 123.634 0.774 . . . . 73.25 109.225 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.604 HD21 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -110.07 110.14 20.94 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.22 -1.4 . . . . 65.43 107.22 175.672 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.577 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 22.0 ttp180 -93.88 100.55 12.7 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.189 -1.411 . . . . 74.42 107.189 175.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.1 t -95.13 124.6 47.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.228 -1.027 . . . . 61.35 108.228 174.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.9 m -121.04 122.0 39.14 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.346 -0.612 . . . . 74.11 109.346 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.512 HG21 HG21 ' A' ' 114' ' ' ILE . 86.9 t -109.58 132.43 57.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 124.49 1.116 . . . . 62.11 108.28 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 10.1 m -123.49 141.04 52.39 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.058 -1.46 . . . . 75.14 107.058 168.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.5 125.12 33.53 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 106.278 -1.749 . . . . 74.35 106.278 170.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.9 m -134.39 131.6 38.41 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 123.6 0.562 . . . . 61.24 111.205 -176.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.0 mt -89.82 84.79 6.27 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 108.134 -1.061 . . . . 71.33 108.134 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.65 -117.94 4.73 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 111.256 -0.738 . . . . 72.42 111.256 -173.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -88.18 -30.05 20.05 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 117.403 0.601 . . . . 73.12 109.588 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -80.18 125.67 30.13 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.711 -0.477 . . . . 72.22 109.711 -175.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.2 m -80.27 134.75 36.12 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.271 0.558 . . . . 64.32 111.283 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.566 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -77.27 -60.7 2.25 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.148 -0.933 . . . . 54.21 108.96 174.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -152.14 163.61 39.01 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.786 -0.643 . . . . 72.42 111.033 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 32.0 tp -134.86 113.29 11.43 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.435 1.094 . . . . 74.05 108.611 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.476 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 70.5 m -104.88 140.26 38.4 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.92 0.888 . . . . 61.44 109.453 175.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -148.22 124.56 10.91 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.627 0.771 . . . . 53.43 109.466 172.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.0 t -133.75 112.77 17.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 124.274 1.029 . . . . 71.32 109.429 -174.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 65.4 mt-30 -84.68 89.45 7.49 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.39 -0.967 . . . . 73.04 108.39 167.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -76.4 93.83 3.55 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.896 -0.779 . . . . 70.13 108.896 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.11 148.36 21.43 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 111.551 -0.619 . . . . 65.32 111.551 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.04 122.33 1.45 Allowed Glycine 0 CA--C 1.506 -0.531 0 N-CA-C 110.801 -0.919 . . . . 60.43 110.801 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.8 mt -80.33 125.84 39.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 N-CA-C 108.305 -0.998 . . . . 74.31 108.305 171.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.815 ' HB3' HD11 ' A' ' 86' ' ' ILE . 86.3 m-85 -129.76 124.11 32.63 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.196 0.598 . . . . 65.44 109.687 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.4 m -85.5 93.65 8.82 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.777 -0.823 . . . . 71.53 108.777 172.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.815 HD11 ' HB3' ' A' ' 84' ' ' PHE . 7.9 mm -109.74 148.13 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 116.14 -0.482 . . . . 74.51 109.847 -176.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.79 171.12 19.37 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.057 0.543 . . . . 73.21 110.67 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.49 -34.21 5.61 Favored Glycine 0 C--N 1.344 0.973 0 O-C-N 123.853 0.721 . . . . 65.35 112.915 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.565 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -122.8 153.5 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.968 0.507 . . . . 71.22 111.364 -169.398 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.438 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 21.5 tt0 -143.89 -179.11 6.27 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.961 -1.018 . . . . 64.24 108.254 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.438 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 61.5 -133.19 47.77 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 113.784 0.274 . . . . 10.14 113.784 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.7 t -72.51 -23.22 60.99 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 122.951 0.5 . . . . 53.14 111.612 -177.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -71.73 -36.83 70.6 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.454 0.701 . . . . 75.11 110.183 177.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.415 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 4.6 tpt -66.07 -49.91 65.96 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.903 -0.59 . . . . 73.23 109.881 174.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.11 -33.27 70.65 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.146 -0.934 . . . . 73.23 111.192 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -72.26 -41.51 66.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.461 0.704 . . . . 72.13 110.898 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 46.5 t -64.25 -35.79 81.98 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 121.226 0.536 . . . . 72.22 110.189 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.9 mt -89.54 -26.81 20.67 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.146 -0.934 . . . . 63.44 112.214 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.5 ' HA2' HG21 ' A' ' 46' ' ' THR . . . -104.06 4.47 45.24 Favored Glycine 0 N--CA 1.473 1.118 0 O-C-N 123.102 0.251 . . . . 62.5 113.363 -173.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.595 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -141.87 -68.46 0.38 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 122.75 0.42 . . . . 63.35 110.805 -177.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -66.88 -46.63 74.35 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 116.246 -0.434 . . . . 75.11 111.864 -171.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 92.6 m -62.3 -52.91 62.95 Favored Pre-proline 0 CA--C 1.565 1.529 0 CA-C-O 118.489 -0.767 . . . . 72.34 112.672 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.431 ' HA ' ' HB2' ' A' ' 106' ' ' LEU . 44.5 Cg_endo -66.97 -20.27 51.18 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 121.647 1.565 . . . . 75.01 113.054 176.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -66.9 -38.87 87.04 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.187 0.595 . . . . 75.52 110.343 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.498 HG21 ' CD1' ' A' ' 13' ' ' ILE . 43.6 mm -68.18 -42.91 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.634 0.773 . . . . 73.24 109.63 174.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 103' ' ' PRO . 54.6 mt -69.95 -28.18 65.35 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.14 -0.936 . . . . 62.01 112.297 -174.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -62.61 -44.85 88.07 Favored Pre-proline 0 N--CA 1.487 1.382 0 N-CA-C 114.033 1.123 . . . . 71.13 114.033 -171.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.401 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 85.4 Cg_exo -50.78 -39.27 57.76 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.135 1.89 . . . . 64.31 113.585 171.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -77.68 -38.95 46.4 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.343 0.657 . . . . 74.4 111.706 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.1 -49.77 70.92 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.248 0.619 . . . . 63.22 109.444 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.407 HH12 HD12 ' C' ' 105' ' ' ILE . 31.7 ttm180 -49.13 -49.91 39.9 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.925 1.29 . . . . 73.52 110.741 173.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.76 -46.8 83.68 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 124.004 0.815 . . . . 73.35 111.558 -176.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.442 ' O ' ' HG3' ' A' ' 117' ' ' MET . 41.9 t -59.3 -35.56 74.02 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.446 0.698 . . . . 63.32 111.066 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.512 HG21 HG21 ' A' ' 64' ' ' VAL . 83.5 mt -70.51 -57.25 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 115.571 -0.74 . . . . 62.51 110.593 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.7 m -51.98 -39.23 59.03 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 124.586 1.154 . . . . 72.03 111.676 -174.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.3 t -66.37 -44.33 83.44 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.441 -1.254 . . . . 73.44 110.102 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.557 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 40.9 mtm -62.95 -39.76 95.61 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.561 0.344 . . . . 74.44 110.828 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.4 t -57.43 -48.38 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 O-C-N 124.018 0.824 . . . . 65.51 110.183 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 95.3 p -73.79 -33.2 64.13 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.887 -0.597 . . . . 74.41 111.711 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.411 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.2 mtt-85 -68.15 -32.46 72.75 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.293 0.637 . . . . 64.42 109.86 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.33 15.84 42.84 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 115.498 -0.774 . . . . 72.25 113.216 174.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 121' ' ' GLY . 0.8 OUTLIER 65.14 10.89 6.73 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.388 1.875 . . . . 42.5 113.234 172.578 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -83.42 144.09 45.73 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 109.506 -0.553 . . . . 75.32 109.506 175.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -50.81 137.53 42.68 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.288 2.658 . . . . 63.05 112.955 175.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -55.31 128.39 33.91 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.27 0.981 . . . . 63.21 111.986 -172.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.5 tp -113.43 129.1 56.62 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.568 0.747 . . . . 65.11 109.121 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.559 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 87.1 m-20 -119.77 114.44 22.14 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.188 -1.041 . . . . 75.34 108.188 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.617 HD13 HD11 ' A' ' 42' ' ' LEU . 14.7 mt -72.86 127.41 32.47 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 109.558 -0.534 . . . . 52.22 109.558 -176.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.85 134.49 92.45 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-O 119.157 -0.449 . . . . 65.32 110.415 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.89 124.7 16.61 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.822 2.348 . . . . 71.43 112.689 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.567 HG21 HD11 ' A' ' 44' ' ' LEU . 98.8 t -101.1 128.28 53.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-N 115.745 -0.661 . . . . 73.42 109.787 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -86.87 85.88 7.29 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.75 -0.833 . . . . 73.22 108.75 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -61.23 -27.43 68.43 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.425 -0.807 . . . . 72.14 111.947 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.595 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 17.2 t70 -61.71 -51.63 67.59 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.204 0.602 . . . . 74.55 109.72 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.14 86.97 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.237 0.961 . . . . 64.2 110.83 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.8 mt -61.73 -48.3 81.35 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.244 0.618 . . . . 71.22 111.457 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 31.6 t80 . . . . . 0 N--CA 1.473 0.698 0 N-CA-C 109.938 -0.393 . . . . 74.32 109.938 178.601 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.738 ' HB3' HG23 ' B' ' 89' ' ' ILE . 22.0 ptm . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 115.632 1.715 . . . . 71.34 115.632 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.3 p -133.47 104.08 6.24 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 106.949 -1.5 . . . . 71.32 106.949 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.473 ' CD2' ' HG3' ' D' ' 130' ' ' PRO . 24.0 t80 -107.91 137.03 46.62 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.149 -1.056 . . . . 65.12 108.149 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.618 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 7.9 tp60 -141.15 118.37 11.34 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.257 -0.646 . . . . 74.44 109.257 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 57.1 mt -77.89 124.35 36.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.738 -1.208 . . . . 73.1 107.738 166.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -100.29 -35.57 9.57 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.527 -0.546 . . . . 74.04 109.527 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -176.89 134.5 0.2 Allowed 'General case' 0 C--N 1.352 0.69 0 O-C-N 123.917 0.761 . . . . 74.32 109.846 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.535 HG21 ' CD1' ' B' ' 109' ' ' TYR . 78.6 mt -119.65 145.05 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.117 -1.068 . . . . 75.42 108.117 175.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -165.11 145.09 7.01 Favored 'General case' 0 C--N 1.346 0.414 0 N-CA-C 112.974 0.731 . . . . 73.43 112.974 -173.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 38.7 m -76.3 122.79 24.93 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.477 -0.783 . . . . 72.11 108.903 170.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.433 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.4 mtpt -100.12 -14.75 18.44 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.423 0.689 . . . . 75.45 111.392 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.6 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.1 t70 -158.48 141.81 15.01 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.644 0.378 . . . . 71.35 111.433 -174.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.722 HD11 ' SG ' ' B' ' 113' ' ' CYS . 29.0 mm -136.68 143.12 36.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 124.915 1.286 . . . . 64.33 108.408 174.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 68.8 m -148.4 131.84 16.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.544 -1.207 . . . . 45.34 108.484 167.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -143.71 108.79 4.98 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.719 -1.586 . . . . 63.01 106.719 168.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -124.88 112.84 17.11 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.527 -0.916 . . . . 71.35 108.527 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.6 88.29 4.12 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.749 -1.204 . . . . 61.43 107.749 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.04 -40.91 8.23 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.75 2.3 . . . . 72.1 112.772 -168.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -101.02 19.96 16.44 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.777 0.831 . . . . 54.11 110.672 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.483 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -39.38 -62.13 0.87 Allowed Pre-proline 0 CA--C 1.566 1.588 0 N-CA-C 114.737 1.384 . . . . 40.22 114.737 -163.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 22.9 Cg_exo -62.95 -29.41 75.86 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 122.21 1.94 . . . . 74.32 112.983 -174.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -87.97 -38.18 15.76 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.228 -0.896 . . . . 73.51 111.659 -174.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.668 HG22 HD12 ' B' ' 68' ' ' LEU . 5.7 p -72.7 -15.78 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.156 0.583 . . . . 52.33 110.927 -173.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -70.58 -10.02 58.26 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 113.693 0.997 . . . . 74.42 113.693 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -72.79 -17.16 61.6 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 120.832 0.348 . . . . 65.51 110.465 174.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -98.68 97.61 8.85 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 124.92 1.288 . . . . 64.41 110.109 -175.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -102.22 85.77 2.71 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.222 -0.659 . . . . 74.24 109.222 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 7.6 p90 -156.83 -176.47 5.99 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.958 0.903 . . . . 75.2 109.797 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -68.63 114.41 22.12 Favored Pre-proline 0 N--CA 1.472 0.658 0 C-N-CA 123.559 0.744 . . . . 64.42 110.542 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.421 ' O ' HG23 ' B' ' 40' ' ' VAL . 27.9 Cg_endo -68.34 145.15 64.62 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 121.22 1.28 . . . . 65.4 110.693 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 9.7 tp10 -64.62 99.71 0.33 Allowed 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.235 -1.024 . . . . 61.33 108.235 170.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.508 HG11 HD11 ' B' ' 126' ' ' LEU . 53.5 t -106.79 141.71 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 123.778 0.674 . . . . 64.25 110.324 -174.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.402 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 54.3 tttm -142.27 109.37 5.53 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.374 1.069 . . . . 73.14 108.753 -172.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.418 HD13 HD22 ' B' ' 128' ' ' LEU . 38.2 tp -90.55 127.3 36.21 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.389 -0.597 . . . . 74.42 109.389 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.682 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 9.5 m-20 -122.29 116.8 24.71 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.241 1.016 . . . . 73.1 108.678 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.515 HD11 HG11 ' B' ' 131' ' ' VAL . 69.3 mt -99.39 126.74 45.34 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.42 -0.956 . . . . 75.41 108.42 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -140.68 155.52 46.47 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.293 1.037 . . . . 74.41 108.52 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.4 t -148.18 117.83 7.05 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 121.328 0.585 . . . . 52.04 110.336 -177.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.64 125.34 53.64 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 106.726 -1.583 . . . . 64.35 106.726 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.546 ' HB2' ' HE2' ' B' ' 56' ' ' TYR . 62.0 p -139.41 177.15 8.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 119.652 -0.214 . . . . 74.41 110.886 -166.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 36.0 p -170.52 137.94 1.44 Allowed 'General case' 0 C--O 1.245 0.861 0 O-C-N 123.382 0.426 . . . . 75.4 111.16 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -76.0 126.36 30.86 Favored 'General case' 0 C--N 1.348 0.507 0 N-CA-C 108.573 -0.899 . . . . 71.01 108.573 165.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 pp -143.64 23.51 1.76 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.969 0.907 . . . . 64.21 109.092 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' B' ' 55' ' ' VAL . . . -166.25 170.89 12.74 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 123.457 0.703 . . . . 73.32 111.221 -175.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -100.76 118.02 36.02 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.666 0.787 . . . . 75.45 109.564 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 62.13 9.67 3.28 Favored 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 124.799 1.24 . . . . 50.34 112.584 -173.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.45 ' O ' ' HB3' ' B' ' 52' ' ' ALA . 74.8 t -128.75 129.96 68.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 107.631 -1.248 . . . . 74.12 107.631 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.546 ' HE2' ' HB2' ' B' ' 48' ' ' SER . 28.0 t80 -132.01 140.98 49.11 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.633 -0.877 . . . . 72.12 108.633 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -109.69 110.76 21.89 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 107.143 -1.428 . . . . 73.12 107.143 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.79 132.06 61.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 C-N-CA 123.333 0.653 . . . . 71.52 109.25 -177.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 32.7 t -111.53 113.85 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.022 -0.733 . . . . 61.43 109.022 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 60.9 tp -93.49 106.71 18.65 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.606 0.362 . . . . 62.23 110.103 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.445 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 20.9 ttm180 -86.06 108.23 18.17 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.356 0.662 . . . . 54.43 109.784 172.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.414 HG13 HD11 ' B' ' 42' ' ' LEU . 59.5 t -103.99 106.23 19.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.223 -1.029 . . . . 54.31 108.223 175.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.682 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 15.8 m -97.18 142.83 28.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.002 -0.999 . . . . 74.13 108.995 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.891 HG11 HD21 ' B' ' 126' ' ' LEU . 73.4 t -134.73 122.58 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.718 -0.845 . . . . 61.33 108.718 173.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 87.6 m -98.97 141.55 31.59 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.757 -1.201 . . . . 61.53 107.757 169.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.18 137.48 23.36 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.76 -0.459 . . . . 53.21 109.76 174.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.461 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 19.1 m -148.25 128.52 13.82 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.542 0.337 . . . . 70.32 111.489 -174.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.668 HD12 HG22 ' B' ' 31' ' ' VAL . 85.3 mt -93.95 99.92 12.16 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.174 -0.676 . . . . 61.53 109.174 178.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.69 -130.32 9.62 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 115.219 -0.901 . . . . 64.35 111.01 -171.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -97.18 2.0 50.49 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.087 0.955 . . . . 63.22 111.726 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -115.09 147.11 40.61 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.024 0.53 . . . . 65.14 110.569 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 49.7 m -68.92 133.06 47.7 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 123.5 0.5 . . . . 75.12 111.283 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.512 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -86.83 -60.74 1.9 Allowed 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.926 -1.138 . . . . 72.32 107.926 175.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -154.14 161.94 41.53 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 114.45 -1.25 . . . . 74.0 110.019 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -129.96 112.67 13.73 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.645 -1.613 . . . . 74.43 106.645 172.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.469 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 23.0 t -118.88 114.1 22.07 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.07 -0.715 . . . . 63.34 109.07 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -128.49 122.9 32.26 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.359 -0.978 . . . . 73.13 108.359 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 88.2 t -124.73 150.26 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.512 1.125 . . . . 53.24 108.552 -178.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.6 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 27.1 mt-30 -121.15 115.02 22.27 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.769 -0.826 . . . . 64.11 108.769 167.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -100.82 107.26 18.76 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.632 -0.877 . . . . 73.15 108.632 172.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.433 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -99.89 170.56 22.96 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 111.861 -0.496 . . . . 71.43 111.861 176.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.01 141.34 6.67 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 121.643 -0.313 . . . . 73.23 112.554 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 41.1 mt -97.77 106.61 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 108.517 -0.92 . . . . 70.11 108.517 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -116.08 135.24 54.12 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.103 0.561 . . . . 74.41 110.952 -175.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.618 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 57.7 m -95.24 129.6 42.31 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.889 0.876 . . . . 54.01 110.12 172.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.568 ' HB ' HD11 ' B' ' 89' ' ' ILE . 35.2 pt -138.39 136.61 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 124.048 0.939 . . . . 75.11 110.437 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.64 173.79 16.33 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.032 0.933 . . . . 74.03 109.787 174.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.86 -40.86 3.08 Favored Glycine 0 N--CA 1.479 1.557 0 CA-C-O 121.133 0.296 . . . . 65.41 112.823 177.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.738 HG23 ' HB3' ' B' ' 9' ' ' MET . 3.5 pt -58.8 154.76 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.474 1.11 . . . . 74.24 111.146 165.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -164.72 146.05 7.98 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.956 -1.02 . . . . 61.31 108.697 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.52 -134.8 12.28 Favored Glycine 0 C--N 1.348 1.218 0 O-C-N 123.442 0.464 . . . . 63.11 112.117 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 52.6 m -73.64 -54.22 8.65 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.757 0.823 . . . . 72.22 110.618 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.437 ' HA ' ' HB3' ' B' ' 96' ' ' HIS . 16.0 mm100 -56.52 -19.72 16.97 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.905 1.282 . . . . 74.14 113.197 -176.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.527 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 41.8 ttp -61.04 -70.29 0.19 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.325 1.05 . . . . 62.14 111.597 -177.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.51 -15.11 53.63 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 111.845 0.313 . . . . 74.44 111.845 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' HIS . . . . . 0.437 ' HB3' ' HA ' ' B' ' 93' ' ' GLN . 1.4 t-80 -58.78 -34.66 71.7 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.433 0.693 . . . . 71.51 110.313 168.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.6 t -58.71 -26.0 63.47 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.554 0.742 . . . . 72.41 111.694 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.401 HD22 ' HB3' ' B' ' 56' ' ' TYR . 52.0 mt -84.41 -29.04 26.49 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.96 0.904 . . . . 70.45 112.129 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.79 -10.53 57.64 Favored Glycine 0 C--N 1.342 0.873 0 O-C-N 123.56 0.538 . . . . 43.23 113.021 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.38 -59.19 1.48 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.088 0.555 . . . . 44.41 112.167 -174.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -78.01 -48.82 15.31 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.112 0.565 . . . . 74.2 110.937 -168.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 73.5 m -61.52 -50.17 83.88 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 123.865 0.866 . . . . 74.15 112.073 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.09 -17.98 35.76 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 121.73 1.62 . . . . 63.0 112.917 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -70.86 -30.47 66.87 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.598 0.359 . . . . 72.21 110.42 173.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.437 HG23 ' NH2' ' D' ' 111' ' ' ARG . 69.5 mt -71.82 -42.42 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.18 0.592 . . . . 72.12 109.831 171.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 77.8 mt -73.89 -28.49 61.58 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.047 -0.979 . . . . 64.43 111.825 -175.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -60.12 -49.41 91.02 Favored Pre-proline 0 N--CA 1.484 1.248 0 CA-C-O 118.024 -0.988 . . . . 74.43 113.28 -172.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -54.83 -33.78 82.72 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.545 2.163 . . . . 74.12 113.598 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.535 ' CD1' HG21 ' B' ' 16' ' ' ILE . 7.7 m-30 -78.82 -40.46 32.83 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.047 0.539 . . . . 71.32 110.504 -176.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.25 -39.9 95.9 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.489 0.716 . . . . 61.13 110.136 172.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.463 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 47.1 ttt-85 -62.6 -53.3 56.64 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.429 1.491 . . . . 71.41 110.724 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -66.49 -30.54 70.9 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.461 0.705 . . . . 75.3 109.848 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.722 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.1 t -70.16 -42.36 72.59 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 122.946 0.498 . . . . 75.13 110.273 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.479 ' O ' HG23 ' B' ' 118' ' ' VAL . 45.4 mt -58.79 -55.79 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.853 0.861 . . . . 61.51 110.408 173.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 9.6 m -63.7 -29.89 71.06 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.632 0.773 . . . . 74.41 111.382 -173.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.3 t -58.31 -54.94 41.28 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 108.831 -0.803 . . . . 73.05 108.831 171.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.529 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.8 mmt -64.98 -37.3 87.21 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.602 0.761 . . . . 75.43 111.4 -175.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.479 HG23 ' O ' ' B' ' 114' ' ' ILE . 81.4 t -59.89 -48.82 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 124.019 0.928 . . . . 73.23 110.544 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 32.8 t -75.27 -19.85 59.48 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.899 -1.046 . . . . 73.43 111.075 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' B' ' 116' ' ' SER . 90.3 mtt-85 -68.21 -32.47 72.7 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 110.027 -0.36 . . . . 75.52 110.027 170.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 121' ' ' GLY . . . . . 0.433 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -79.49 -5.58 89.22 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 123.655 0.597 . . . . 60.33 112.397 169.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 6.6 m 66.39 25.57 10.31 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.624 1.57 . . . . 60.11 110.652 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -77.33 163.21 65.8 Favored Pre-proline 0 CA--C 1.555 1.148 0 CA-C-N 114.884 -1.053 . . . . 74.23 110.836 175.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -48.51 144.49 13.8 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 123.312 2.675 . . . . 63.31 114.764 174.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.471 ' HB2' ' HG2' ' C' ' 125' ' ' GLN . 41.0 tp60 -54.59 118.05 3.86 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.055 0.942 . . . . 31.21 110.758 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.891 HD21 HG11 ' B' ' 64' ' ' VAL . 20.5 tp -110.04 99.36 8.47 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.14 -0.936 . . . . 74.23 109.602 -171.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 127' ' ' ASN . . . . . 0.413 HD21 ' HG3' ' B' ' 125' ' ' GLN . 43.8 m-80 -96.03 110.68 22.88 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.453 -0.573 . . . . 75.14 109.453 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.463 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 55.0 mt -77.21 126.21 30.57 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.871 -0.789 . . . . 75.31 108.871 171.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.58 154.6 83.66 Favored Pre-proline 0 CA--C 1.552 1.051 0 O-C-N 124.268 0.98 . . . . 34.04 111.706 -169.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.492 ' HG3' HD13 ' D' ' 16' ' ' ILE . 3.8 Cg_exo -77.33 87.68 1.48 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.401 2.734 . . . . 72.41 112.686 -167.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.515 HG11 HD11 ' B' ' 44' ' ' LEU . 4.6 p -92.8 122.35 44.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 115.333 -0.849 . . . . 65.12 110.517 177.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 9.0 p30 . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 107.464 -1.31 . . . . 74.41 107.464 169.03 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 59.7 t80 . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 109.353 -0.61 . . . . 65.33 109.353 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -152.96 131.55 12.25 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 109.617 -0.512 . . . . 72.52 109.617 171.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 57.2 mt -69.88 125.96 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 108.65 -0.87 . . . . 74.43 108.65 170.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -89.93 -49.78 6.41 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.961 -0.755 . . . . 64.23 108.961 175.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.559 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -173.53 150.92 1.85 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.111 0.964 . . . . 75.22 109.973 174.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 pp -114.54 152.28 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 107.878 -1.156 . . . . 60.3 107.878 173.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.638 ' HB3' HG23 ' D' ' 122' ' ' THR . 28.2 p90 -179.56 162.46 1.11 Allowed 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.456 0.646 . . . . 73.34 110.882 -174.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.2 p -92.35 115.33 27.99 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 123.43 0.692 . . . . 74.43 109.882 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.401 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 19.6 mmtp -64.43 -40.47 95.8 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.233 -1.025 . . . . 75.22 108.233 170.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -150.07 147.87 28.32 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.407 -1.269 . . . . 73.52 110.787 -174.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.54 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.6 mt -138.39 144.51 30.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 C-N-CA 125.896 1.679 . . . . 74.24 106.584 174.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 31.2 t -153.46 150.01 28.34 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 122.568 0.347 . . . . 54.23 110.481 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -155.28 137.08 14.41 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.451 1.1 . . . . 73.32 108.166 175.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -140.23 133.73 30.08 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.281 0.633 . . . . 71.2 109.433 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.79 81.41 22.87 Favored Pre-proline 0 C--O 1.241 0.621 0 N-CA-C 108.001 -1.111 . . . . 64.22 108.001 169.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.2 -30.41 74.48 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 123.017 2.478 . . . . 54.02 112.622 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 27' ' ' ASN . . . . . 0.479 ' OD1' ' HB ' ' C' ' 31' ' ' VAL . 5.9 p30 -117.07 34.54 5.06 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.222 0.609 . . . . 54.33 109.575 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -40.08 -57.85 2.56 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 114.148 1.166 . . . . 74.22 114.148 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -64.61 -35.39 47.82 Favored 'Trans proline' 0 C--N 1.382 2.292 0 CA-C-N 121.569 1.596 . . . . 43.2 112.64 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -68.71 -38.09 79.97 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.813 0.845 . . . . 73.13 112.24 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.623 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.5 p -76.34 -30.27 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 N-CA-C 112.573 0.583 . . . . 74.13 112.573 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -59.79 -34.02 72.48 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 112.447 0.536 . . . . 73.22 112.447 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -86.15 11.89 10.89 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.398 0.679 . . . . 71.3 112.408 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.429 ' HG2' HD13 ' C' ' 68' ' ' LEU . 1.8 ttpm? -113.95 147.85 37.86 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.877 0.871 . . . . 74.53 110.124 177.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.16 125.26 23.11 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 123.381 0.673 . . . . 71.41 110.93 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -81.55 105.81 13.01 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.927 -1.033 . . . . 63.04 110.993 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -162.78 79.44 1.77 Allowed Pre-proline 0 C--O 1.241 0.607 0 N-CA-C 107.469 -1.308 . . . . 75.21 107.469 164.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -87.04 164.52 8.67 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 122.913 2.409 . . . . 43.24 113.02 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -86.75 85.32 7.28 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 106.725 -1.583 . . . . 73.21 106.725 168.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 99.2 t -68.58 109.7 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 115.008 -0.996 . . . . 64.34 109.767 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.582 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 65.7 mttm -92.08 103.96 16.4 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.354 -0.98 . . . . 73.02 108.354 178.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 tt -89.08 123.91 33.81 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 107.057 -1.46 . . . . 51.52 107.057 174.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.609 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 17.0 t70 -128.39 139.53 52.32 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.153 0.981 . . . . 74.54 108.409 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.522 HD22 HD21 ' C' ' 60' ' ' LEU . 24.6 mt -135.3 126.41 27.96 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.438 0.695 . . . . 72.33 110.218 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -130.53 139.29 50.48 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.63 1.172 . . . . 61.11 108.193 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.0 t -144.07 139.47 28.94 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.019 0.438 . . . . 75.33 110.283 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.95 156.05 45.48 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.937 0.895 . . . . 54.13 109.608 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 2.3 m -132.43 144.18 50.31 Favored 'General case' 0 C--O 1.24 0.564 0 O-C-N 123.299 0.374 . . . . 54.14 110.034 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 22.4 p -145.12 126.07 14.48 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.916 0.886 . . . . 72.32 109.473 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -78.76 118.67 21.04 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.317 -0.623 . . . . 73.04 109.317 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' C' ' 57' ' ' GLU . 34.5 mt -88.45 -41.47 12.76 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.83 0.852 . . . . 73.42 110.638 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.19 -172.66 4.22 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.061 -0.972 . . . . 62.54 110.181 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.42 112.62 1.83 Allowed 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.036 0.835 . . . . 44.45 110.591 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 66.31 9.33 6.31 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.661 1.185 . . . . 62.23 112.425 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 87.0 t -106.81 107.62 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.23 0.612 . . . . 61.33 109.857 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -106.72 124.63 49.89 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.768 0.827 . . . . 74.53 109.073 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.56 ' HB2' HD11 ' C' ' 51' ' ' LEU . 30.2 tt0 -82.72 126.65 32.61 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.296 -1.002 . . . . 75.21 108.296 169.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.8 t -112.4 138.2 42.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.486 -0.931 . . . . 72.4 108.486 167.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 86.6 t -120.9 131.37 73.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 108.529 -0.915 . . . . 53.42 108.529 170.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.522 HD21 HD22 ' C' ' 44' ' ' LEU . 0.9 OUTLIER -114.22 107.23 15.33 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.676 -1.231 . . . . 74.04 107.676 172.633 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.414 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 0.0 OUTLIER -95.9 117.74 31.18 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 114.671 -1.149 . . . . 74.42 109.153 178.083 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 10.8 t -102.07 132.37 48.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 107.838 -1.171 . . . . 65.44 107.838 172.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.609 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 29.9 m -123.31 128.02 49.35 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.099 -1.074 . . . . 71.05 108.099 175.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.409 HG23 HD13 ' C' ' 114' ' ' ILE . 85.7 t -122.95 128.75 75.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.576 -0.738 . . . . 71.33 109.34 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 25.4 m -118.32 139.24 51.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.621 -1.251 . . . . 71.44 107.621 176.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.24 113.01 15.76 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.669 -1.604 . . . . 65.45 106.669 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 65.4 m -135.62 126.21 27.05 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.672 0.607 . . . . 60.14 109.9 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.429 HD13 ' HG2' ' C' ' 34' ' ' LYS . 12.0 mt -85.98 56.06 3.81 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.224 1.41 . . . . 72.34 107.908 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.58 -107.73 3.08 Favored Glycine 0 C--N 1.341 0.851 0 N-CA-C 110.026 -1.23 . . . . 64.11 110.026 -169.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -103.59 -17.14 15.29 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.64 0.776 . . . . 72.22 110.044 173.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -68.55 99.89 1.04 Allowed 'General case' 0 C--N 1.348 0.542 0 C-N-CA 123.341 0.656 . . . . 64.22 109.44 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 50.4 m -73.36 114.83 12.01 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.169 -0.678 . . . . 71.31 109.169 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.623 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -67.84 -57.52 6.13 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.248 -1.342 . . . . 42.22 108.613 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -155.13 159.64 40.34 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.745 -1.116 . . . . 71.42 110.732 172.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.417 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -118.68 143.06 47.09 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.799 -1.556 . . . . 73.24 106.799 167.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.417 ' N ' HD13 ' C' ' 75' ' ' LEU . 46.6 t -149.7 141.9 24.08 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.598 -0.89 . . . . 72.33 108.598 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -154.65 134.9 13.21 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.472 -0.566 . . . . 71.4 109.472 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.48 HG11 ' HA ' ' C' ' 110' ' ' ALA . 40.9 t -133.71 114.65 20.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 124.263 1.025 . . . . 73.53 108.836 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.414 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 53.4 mt-30 -91.27 87.64 6.57 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.654 -0.869 . . . . 65.14 108.654 174.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.439 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.4 tp-100 -79.86 99.11 7.38 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.408 0.683 . . . . 72.24 110.121 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.67 149.11 25.43 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 116.329 -0.396 . . . . 55.35 112.36 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.538 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.27 125.73 2.01 Favored Glycine 0 CA--C 1.503 -0.678 0 N-CA-C 110.508 -1.037 . . . . 43.42 110.508 -178.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.538 HD12 HD11 ' C' ' 51' ' ' LEU . 31.8 mm -93.7 125.24 46.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 108.278 -1.008 . . . . 63.11 108.278 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -133.64 121.84 22.6 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.457 0.703 . . . . 74.43 109.721 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 20.6 p -82.28 103.99 12.27 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 108.745 -0.835 . . . . 71.12 108.745 171.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.612 HG21 ' HE3' ' C' ' 94' ' ' MET . 17.8 mt -116.19 137.57 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.585 0.754 . . . . 74.14 109.74 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.28 170.51 19.33 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.199 0.6 . . . . 74.2 110.639 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.34 -49.12 1.51 Allowed Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.98 -0.555 . . . . 73.02 113.371 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.599 HD11 ' HE3' ' C' ' 94' ' ' MET . 42.7 pt -91.06 171.28 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 123.445 0.698 . . . . 74.34 112.635 -167.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -157.97 157.47 33.1 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.751 -1.113 . . . . 41.13 109.508 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.66 -131.16 21.25 Favored Glycine 0 C--N 1.348 1.241 0 O-C-N 123.412 0.445 . . . . 73.32 113.805 172.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.8 p -60.46 -35.21 75.33 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.27 1.028 . . . . 61.13 111.789 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -57.72 -57.47 12.61 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.857 0.863 . . . . 64.1 110.607 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.612 ' HE3' HG21 ' C' ' 86' ' ' ILE . 4.1 tpt -55.23 -50.17 70.13 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.067 0.947 . . . . 75.11 112.505 175.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.68 -33.88 74.76 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.114 0.566 . . . . 74.11 111.253 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -73.99 -36.55 64.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.974 0.51 . . . . 72.23 110.55 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.466 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 33.7 t -69.45 -33.56 73.12 Favored 'General case' 0 C--N 1.35 0.614 0 N-CA-C 109.734 -0.469 . . . . 75.12 109.734 -177.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 96.9 mt -85.78 -37.48 19.23 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.982 0.913 . . . . 65.2 111.896 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.87 3.92 45.56 Favored Glycine 0 N--CA 1.473 1.15 0 CA-C-O 119.525 -0.597 . . . . 53.2 114.58 -168.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.543 ' HA ' ' HB3' ' C' ' 133' ' ' PHE . . . -149.35 -54.46 0.17 Allowed 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.808 0.804 . . . . 63.42 112.045 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.466 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 51.3 t80 -66.6 -56.68 9.61 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.286 0.634 . . . . 75.43 112.111 -174.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 97.2 m -60.89 -47.26 96.14 Favored Pre-proline 0 CA--C 1.562 1.41 0 CA-C-O 118.787 -0.625 . . . . 74.13 112.42 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -54.54 -30.88 67.07 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 122.409 2.072 . . . . 74.22 114.318 172.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -70.72 -30.9 67.57 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.026 0.53 . . . . 54.52 111.114 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.407 HD12 HH12 ' A' ' 111' ' ' ARG . 44.5 mm -73.01 -35.3 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 109.62 -0.511 . . . . 71.5 109.62 175.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.538 HD21 ' HA3' ' C' ' 82' ' ' GLY . 94.7 mt -81.22 -30.97 34.06 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.971 0.908 . . . . 74.35 112.733 -175.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -55.92 -50.11 89.13 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 113.884 1.068 . . . . 74.41 113.884 -172.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.85 -36.25 95.14 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.251 1.968 . . . . 71.34 113.396 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -70.05 -44.37 69.31 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.05 0.54 . . . . 64.23 111.356 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.48 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -66.7 -33.6 76.0 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.876 -0.602 . . . . 45.14 110.713 175.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -62.63 -51.49 67.09 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.925 1.29 . . . . 75.43 110.446 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -69.37 -29.36 67.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.95 0.5 . . . . 71.52 110.377 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.9 t -69.18 -37.68 78.29 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 122.75 0.42 . . . . 63.43 110.709 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.447 ' O ' HG23 ' C' ' 118' ' ' VAL . 98.6 mt -71.65 -47.39 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 122.931 0.492 . . . . 73.53 110.054 174.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.7 m -53.23 -42.44 66.39 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.532 1.133 . . . . 71.02 111.664 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.428 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.1 t -66.68 -38.94 87.82 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.425 -0.807 . . . . 74.12 109.538 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.541 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -66.2 -39.83 89.93 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.187 0.995 . . . . 73.33 111.778 178.404 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.447 HG23 ' O ' ' C' ' 114' ' ' ILE . 61.8 t -59.04 -42.79 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 109.258 -0.645 . . . . 62.23 109.258 172.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.2 t -66.13 -38.67 88.72 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.816 -1.083 . . . . 74.03 112.248 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' C' ' 116' ' ' SER . 64.7 mtt-85 -69.58 -39.21 77.45 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.264 0.625 . . . . 71.42 110.19 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.45 3.71 84.0 Favored Glycine 0 C--N 1.351 1.361 0 CA-C-N 115.669 -0.696 . . . . 74.33 112.544 173.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 33.6 p 58.38 30.74 20.04 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.058 1.743 . . . . 72.43 113.068 171.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -81.94 154.58 70.27 Favored Pre-proline 0 C--O 1.242 0.684 0 CA-C-N 115.703 -0.681 . . . . 73.01 109.57 175.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.48 127.76 27.32 Favored 'Trans proline' 0 C--N 1.363 1.333 0 C-N-CA 122.093 1.862 . . . . 73.12 112.022 168.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.471 ' HG2' ' HB2' ' B' ' 125' ' ' GLN . 23.6 mm-40 -53.72 154.6 3.69 Favored 'General case' 0 C--O 1.248 0.981 0 O-C-N 124.623 1.202 . . . . 73.22 113.604 -170.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 21.1 tp -147.76 86.38 1.59 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-N 113.847 -1.524 . . . . 75.54 108.168 -172.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -91.97 108.63 20.07 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.787 -1.097 . . . . 70.14 108.692 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -67.81 137.99 55.79 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.513 0.725 . . . . 74.43 110.118 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.78 152.53 95.12 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 123.665 0.786 . . . . 51.25 111.106 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.518 ' HG3' HD12 ' A' ' 16' ' ' ILE . 52.1 Cg_exo -54.98 114.93 2.09 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.662 2.241 . . . . 74.54 112.272 172.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 131' ' ' VAL . . . . . 0.477 HG11 HD11 ' C' ' 44' ' ' LEU . 5.0 p -98.14 125.95 51.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 123.103 0.561 . . . . 45.13 110.19 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -81.53 101.7 10.11 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.653 -0.869 . . . . 75.32 108.653 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 133' ' ' PHE . . . . . 0.543 ' HB3' ' HA ' ' C' ' 100' ' ' ALA . 82.9 m-85 -67.3 -25.34 65.99 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.356 -0.838 . . . . 55.3 111.31 177.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -63.86 -36.5 84.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.324 0.649 . . . . 64.31 110.323 175.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.64 -42.1 95.69 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.647 0.779 . . . . 63.44 110.414 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 71.0 mt -72.72 -27.09 61.84 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.839 -1.073 . . . . 72.24 110.873 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 70.9 t80 . . . . . 0 C--O 1.213 -0.864 0 C-N-CA 123.029 0.531 . . . . 65.44 110.699 177.853 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 C--O 1.244 0.808 0 N-CA-C 109.03 -0.73 . . . . 74.33 109.03 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.419 ' HZ ' ' HG ' ' D' ' 102' ' ' CYS . 59.7 t80 -137.4 101.16 4.43 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.371 -1.344 . . . . 71.42 107.371 175.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -125.92 124.47 40.89 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.692 0.797 . . . . 72.21 109.104 -175.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.602 HD13 HG21 ' D' ' 105' ' ' ILE . 5.4 mt -84.18 137.42 20.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.786 -0.82 . . . . 60.21 108.786 177.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -97.02 -42.5 7.87 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 122.975 0.51 . . . . 72.03 110.461 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.42 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 40.8 ttt180 -174.23 142.77 0.83 Allowed 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.313 0.383 . . . . 71.33 111.383 -170.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.492 HD13 ' HG3' ' B' ' 130' ' ' PRO . 2.1 mp -115.55 137.75 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 105.882 -1.895 . . . . 72.43 105.882 174.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.42 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 19.0 p90 -161.54 137.0 7.64 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 123.609 0.568 . . . . 73.11 110.967 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.4 p -76.65 110.63 11.39 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.321 -0.854 . . . . 64.3 109.487 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -85.53 -9.81 56.86 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.496 -0.775 . . . . 71.32 109.712 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.636 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 17.4 t70 -169.11 143.43 3.01 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 124.896 1.278 . . . . 61.34 109.733 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.541 HG21 ' HE2' ' C' ' 117' ' ' MET . 80.4 mt -147.4 144.71 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 125.266 1.427 . . . . 70.44 107.9 177.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.8 t -147.04 145.92 29.85 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.967 0.907 . . . . 73.1 109.249 170.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.54 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 81.1 t80 -149.87 118.55 6.57 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 106.963 -1.495 . . . . 71.52 106.963 169.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -123.54 140.27 53.17 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.479 -0.563 . . . . 74.23 109.479 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.68 82.39 60.97 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 107.813 -1.18 . . . . 75.54 107.813 174.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.8 -29.24 42.51 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.924 2.416 . . . . 73.54 113.008 -170.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.41 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 38.0 m-80 -108.66 8.86 27.17 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-O 118.479 -0.772 . . . . 70.43 110.852 -177.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.426 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -20.05 -73.17 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 116.63 2.085 . . . . 60.1 116.63 -166.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.437 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 92.2 Cg_endo -75.5 -21.66 14.72 Favored 'Trans proline' 0 C--N 1.386 2.552 0 CA-C-N 124.056 2.484 . . . . 60.15 114.117 -176.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -74.46 -37.93 63.08 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.257 1.023 . . . . 72.31 110.25 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.651 HG22 HD12 ' D' ' 68' ' ' LEU . 11.0 p -82.04 -20.51 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 115.953 -0.567 . . . . 62.42 111.506 -174.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.437 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 23.0 m-85 -63.75 -28.67 70.04 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 120.801 0.334 . . . . 72.44 111.819 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -58.41 -22.27 53.48 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.71 1.204 . . . . 73.5 111.241 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -90.22 69.42 7.14 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.994 1.318 . . . . 73.52 110.2 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.73 85.45 4.74 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.411 -0.813 . . . . 61.22 110.67 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 10.2 p90 -154.07 -173.21 4.49 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.453 0.701 . . . . 63.21 109.902 172.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -63.27 112.4 6.91 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.377 1.071 . . . . 64.51 110.772 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -60.76 120.25 7.87 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.066 1.844 . . . . 75.1 110.805 172.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -67.63 104.32 1.58 Allowed 'General case' 0 C--N 1.35 0.592 0 N-CA-C 106.417 -1.697 . . . . 74.01 106.417 169.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.586 HG13 HG13 ' D' ' 64' ' ' VAL . 71.3 t -103.05 115.31 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 N-CA-C 108.792 -0.818 . . . . 74.13 108.792 -174.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -96.98 110.25 22.83 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 105.783 -1.932 . . . . 75.52 105.783 176.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.475 HD11 HG13 ' D' ' 62' ' ' VAL . 63.4 tp -94.37 138.5 32.26 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.418 -1.327 . . . . 74.3 107.418 175.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -141.75 147.92 38.15 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.528 -1.286 . . . . 71.44 107.528 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.42 ' CD2' HG22 ' D' ' 62' ' ' VAL . 73.7 mt -131.0 136.06 48.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.548 0.689 . . . . 74.53 110.874 -173.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 11.6 t70 -133.03 129.17 37.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 113.977 -1.465 . . . . 53.31 107.692 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 2.6 p -106.94 150.78 26.1 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.546 0.689 . . . . 65.01 110.094 174.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.87 166.57 29.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.233 -1.349 . . . . 51.13 107.86 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.8 p . . . . . 0 C--O 1.241 0.614 0 N-CA-C 109.633 -0.506 . . . . 62.41 109.633 -179.962 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 113.811 1.041 . . . . 70.13 113.811 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 45.8 t -128.57 100.94 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 107.484 -1.302 . . . . 71.31 107.484 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -122.18 127.81 50.47 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.946 -0.761 . . . . 61.14 108.946 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -87.91 114.88 24.95 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 108.158 -1.053 . . . . 71.02 108.158 169.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 95.4 t -100.35 134.91 38.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 107.286 -1.376 . . . . 72.54 107.286 171.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 49.1 t -128.9 126.79 65.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.687 -1.227 . . . . 74.41 107.687 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.522 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -114.52 103.93 11.51 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.505 -1.294 . . . . 74.4 107.505 -176.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.446 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 41.1 ttm-85 -83.35 103.14 12.5 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.579 -0.897 . . . . 65.41 108.579 173.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.475 HG13 HD11 ' D' ' 42' ' ' LEU . 66.4 t -97.32 121.83 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.027 -0.731 . . . . 74.14 109.027 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 56.8 m -119.4 133.44 55.71 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.005 0.922 . . . . 70.43 109.106 -172.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.586 HG13 HG13 ' D' ' 40' ' ' VAL . 75.4 t -125.81 132.44 70.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 124.226 1.01 . . . . 54.33 108.788 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 26.7 m -127.93 93.14 3.61 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.676 -1.602 . . . . 72.0 106.676 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.83 147.24 24.62 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.704 -0.85 . . . . 71.0 108.704 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.551 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 32.5 p -149.56 133.94 17.44 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.208 0.528 . . . . 74.24 111.505 -173.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.651 HD12 HG22 ' D' ' 31' ' ' VAL . 79.4 mt -104.17 102.62 12.35 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.923 -1.035 . . . . 65.52 108.283 170.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.03 -128.96 17.49 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 115.764 -0.653 . . . . 63.31 113.154 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -84.56 3.08 38.32 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.931 0.892 . . . . 61.42 113.022 -174.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -137.0 154.92 50.28 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-O 121.115 0.483 . . . . 74.23 110.871 -173.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.0 m -69.18 126.56 30.17 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.583 -1.189 . . . . 73.43 111.072 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.577 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -75.65 -64.78 1.0 Allowed 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.624 -1.25 . . . . 71.51 107.624 173.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -153.24 141.84 20.88 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.266 -0.879 . . . . 75.12 111.152 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 65.9 mt -101.11 153.58 19.46 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.284 1.034 . . . . 60.43 108.771 167.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.716 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.8 t -156.82 142.19 17.42 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.123 0.569 . . . . 54.14 109.496 176.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -155.37 122.22 5.39 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.213 -0.292 . . . . 65.34 110.213 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.6 t -126.0 115.11 41.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 124.066 0.947 . . . . 72.41 109.338 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.636 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.6 mt-30 -88.72 87.64 7.32 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.6 -0.889 . . . . 75.33 108.6 171.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -83.39 100.84 10.94 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.483 -1.235 . . . . 74.44 109.083 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.37 149.01 17.74 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 112.327 -0.309 . . . . 70.3 112.327 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.37 142.97 10.49 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.77 -0.532 . . . . 52.3 111.77 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.0 mt -89.29 117.01 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 108.099 -1.074 . . . . 65.42 108.099 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.24 127.78 55.71 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.701 0.8 . . . . 74.24 110.548 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 33.6 t -84.87 122.79 29.67 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.275 -1.009 . . . . 61.12 108.275 166.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.474 HD12 ' HB2' ' D' ' 97' ' ' CYS . 3.0 tt -143.67 125.78 11.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 108.565 -0.902 . . . . 44.32 108.565 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.06 167.99 14.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.784 0.834 . . . . 51.43 110.458 -174.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.56 21.13 52.43 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.447 0.467 . . . . 74.35 114.01 173.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.64 171.54 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.045 0.938 . . . . 70.42 108.975 177.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -147.62 179.92 7.34 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.645 -0.872 . . . . 62.01 108.645 -175.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.85 -136.66 22.11 Favored Glycine 0 C--N 1.347 1.16 0 C-N-CA 122.992 0.329 . . . . 74.03 112.875 172.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.6 m -91.91 -36.76 13.28 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.126 0.571 . . . . 63.21 111.242 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -65.65 -19.63 65.98 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.185 0.594 . . . . 65.15 112.46 -171.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.422 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 0.0 OUTLIER -64.51 -36.99 86.0 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.951 0.5 . . . . 74.11 112.247 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 95' ' ' ALA . . . . . 0.422 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.11 -14.88 45.74 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.267 0.627 . . . . 64.23 111.851 178.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -63.96 -38.84 92.57 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.52 0.728 . . . . 64.34 112.282 -176.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 97' ' ' CYS . . . . . 0.474 ' HB2' HD12 ' D' ' 86' ' ' ILE . 69.1 m -65.43 -49.58 68.65 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.476 0.31 . . . . 74.35 111.629 -177.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.684 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 3.6 pp -67.47 -22.16 65.49 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.05 0.389 . . . . 70.22 112.05 -176.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.93 -29.33 11.84 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-O 119.881 -0.399 . . . . 72.43 113.593 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.0 -52.89 2.3 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 117.309 0.555 . . . . 32.24 111.838 -173.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -73.71 -39.57 64.23 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 112.103 0.408 . . . . 74.41 112.103 -173.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.684 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 89.1 m -65.31 -46.76 71.31 Favored Pre-proline 0 CA--C 1.556 1.189 0 CA-C-O 118.728 -0.653 . . . . 54.21 111.692 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.522 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 50.1 Cg_exo -58.71 -35.12 99.1 Favored 'Trans proline' 0 C--N 1.389 2.692 0 C-N-CA 121.653 1.569 . . . . 52.31 112.777 168.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.47 -31.73 73.06 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.346 0.658 . . . . 71.34 111.394 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.602 HG21 HD13 ' D' ' 13' ' ' ILE . 36.5 mm -69.78 -43.67 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.533 0.733 . . . . 74.12 110.223 172.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 74.6 mt -72.81 -19.74 61.28 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.26 -0.882 . . . . 72.24 111.699 -175.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -66.32 -45.42 60.08 Favored Pre-proline 0 CA--C 1.556 1.175 0 N-CA-C 113.498 0.925 . . . . 72.12 113.498 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -49.27 -41.02 43.17 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.443 2.095 . . . . 70.11 113.86 170.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -78.97 -33.23 45.37 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.458 0.703 . . . . 70.01 112.102 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.91 -44.27 73.51 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.523 0.677 . . . . 70.45 109.506 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.437 ' NH2' HG23 ' B' ' 105' ' ' ILE . 46.5 ttp180 -66.42 -37.29 84.87 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 114.005 -1.452 . . . . 70.5 110.172 175.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 112' ' ' GLU . . . . . 0.428 ' HA ' ' CE2' ' B' ' 109' ' ' TYR . 8.7 tt0 -52.29 -46.86 66.08 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.732 0.813 . . . . 73.41 111.148 176.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.8 t -66.72 -47.77 71.27 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.775 -1.102 . . . . 64.25 110.71 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.716 HG12 ' SG ' ' D' ' 76' ' ' CYS . 42.6 mt -60.29 -62.77 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.978 0.511 . . . . 53.42 110.363 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 98.3 m -41.68 -46.32 3.71 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 125.709 1.603 . . . . 63.23 112.799 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 22.9 t -68.48 -45.17 73.08 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.192 -0.913 . . . . 74.13 110.67 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.1 mtm -67.44 -34.3 76.93 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.802 0.441 . . . . 71.33 111.589 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.484 HG23 ' O ' ' D' ' 114' ' ' ILE . 84.9 t -60.54 -46.81 94.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 123.797 0.839 . . . . 71.33 110.082 176.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.0 p -70.45 -28.5 65.07 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 115.785 -0.643 . . . . 71.13 110.705 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' D' ' 116' ' ' SER . 72.6 mtt-85 -71.89 -22.92 61.43 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.531 0.733 . . . . 75.22 111.251 176.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.52 12.71 68.56 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-O 119.564 -0.576 . . . . 45.23 112.709 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.638 HG23 ' HB3' ' C' ' 17' ' ' TYR . 72.6 p 60.03 11.87 2.89 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 126.735 2.014 . . . . 61.11 113.391 -174.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -81.51 149.38 64.7 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.776 -0.453 . . . . 75.33 109.776 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -48.22 120.06 4.61 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 123.095 2.53 . . . . 54.11 113.03 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -42.23 119.73 1.44 Allowed 'General case' 0 C--N 1.364 1.237 0 O-C-N 124.875 1.359 . . . . 72.13 111.402 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.484 HD13 HG21 ' D' ' 40' ' ' VAL . 29.8 tp -106.48 99.61 9.18 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.309 0.644 . . . . 60.42 109.51 -171.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -97.82 97.9 9.37 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 107.449 -1.315 . . . . 65.14 107.449 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.4 HD11 HD12 ' D' ' 114' ' ' ILE . 38.8 mt -59.59 137.14 58.12 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-N 115.133 -0.939 . . . . 73.42 109.995 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.49 148.49 73.66 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 123.541 0.736 . . . . 72.3 111.184 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.473 ' HG3' ' CD2' ' B' ' 11' ' ' PHE . 32.0 Cg_endo -60.47 122.95 12.09 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.647 2.231 . . . . 74.42 111.298 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 99.9 t -108.08 115.26 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.395 -0.366 . . . . 75.32 110.631 -175.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -83.64 96.55 8.71 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 107.745 -1.206 . . . . 55.01 107.745 167.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 . . . . . 0 N--CA 1.489 1.501 0 C-N-CA 124.047 0.939 . . . . 45.22 112.109 -174.635 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 84.6 m . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 120.934 0.397 . . . . 74.14 110.486 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.807 ' HE1' ' HG ' ' A' ' 102' ' ' CYS . 72.6 t80 -120.62 124.87 46.3 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.767 -1.197 . . . . 62.04 107.767 172.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -132.23 132.72 43.36 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.284 -0.635 . . . . 75.2 109.284 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.471 HG21 ' HG2' ' C' ' 130' ' ' PRO . 69.4 mt -89.69 109.63 20.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.158 -1.053 . . . . 64.02 108.158 171.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.63 -40.66 17.19 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 109.048 -0.723 . . . . 72.23 109.048 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 -168.88 122.28 0.82 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.64 0.376 . . . . 63.41 110.283 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 83.7 mt -107.07 136.71 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.776 -0.824 . . . . 74.4 108.776 170.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.454 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 22.1 p90 -164.92 169.51 16.4 Favored 'General case' 0 C--N 1.347 0.47 0 O-C-N 123.822 0.701 . . . . 52.33 111.699 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -94.47 120.6 34.96 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.116 -0.698 . . . . 70.41 109.116 172.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.454 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 34.8 mtpt -78.9 -34.88 44.35 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.164 0.507 . . . . 70.2 109.673 175.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 17.8 t70 -150.01 140.47 22.41 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.646 -1.161 . . . . 64.22 109.865 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.4 mt -130.92 139.69 50.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 124.873 1.269 . . . . 65.45 107.835 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -145.54 127.97 15.95 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.297 -1.001 . . . . 61.34 108.297 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.464 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 86.9 t80 -135.63 129.49 32.91 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.112 -1.44 . . . . 74.01 107.112 171.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -129.59 135.95 49.2 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.165 -0.679 . . . . 72.44 109.165 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.31 76.93 71.66 Favored Pre-proline 0 C--O 1.24 0.553 0 N-CA-C 105.817 -1.919 . . . . 72.15 105.817 167.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.67 -22.92 36.91 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.591 2.194 . . . . 53.45 112.027 -171.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -110.12 22.3 15.74 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.233 1.013 . . . . 65.51 109.447 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.478 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -46.88 -52.79 30.47 Favored Pre-proline 0 CA--C 1.568 1.654 0 CA-C-O 117.846 -1.073 . . . . 75.02 113.658 -171.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.57 -23.22 64.31 Favored 'Trans proline' 0 C--N 1.391 2.778 0 CA-C-N 121.536 1.584 . . . . 64.03 113.374 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -84.12 -39.69 19.17 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.675 0.79 . . . . 74.51 111.017 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.893 HG21 ' HA ' ' A' ' 73' ' ' ALA . 5.5 p -78.23 -23.56 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 CA-C-N 115.306 -0.861 . . . . 72.35 113.159 -157.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -70.06 -19.35 63.29 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 122.739 0.416 . . . . 74.43 110.874 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -86.81 -16.5 36.03 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.568 1.147 . . . . 74.31 110.772 177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -81.5 158.06 24.63 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.873 0.869 . . . . 72.31 111.884 -174.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.48 118.27 8.53 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 123.992 0.917 . . . . 72.13 109.413 173.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -78.55 84.92 4.65 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.661 0.743 . . . . 75.14 109.91 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -122.85 76.09 48.44 Favored Pre-proline 0 C--O 1.243 0.745 0 N-CA-C 106.799 -1.556 . . . . 53.31 106.799 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.44 ' HB2' HG23 ' A' ' 40' ' ' VAL . 83.7 Cg_endo -78.47 115.1 3.61 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 121.817 1.678 . . . . 72.32 111.363 -171.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -93.31 81.59 4.45 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 105.554 -2.017 . . . . 70.23 105.554 172.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.44 HG23 ' HB2' ' A' ' 38' ' ' PRO . 46.0 t -86.05 93.74 3.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 CA-C-N 114.532 -1.213 . . . . 61.55 109.555 -174.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.72 118.82 21.88 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.953 -1.476 . . . . 53.51 108.384 174.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.7 mt -95.39 108.55 20.75 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.435 -1.32 . . . . 75.45 107.435 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -102.61 141.18 35.85 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.387 -0.968 . . . . 75.32 108.387 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.55 HD11 HG21 ' A' ' 131' ' ' VAL . 75.5 mt -135.39 131.41 36.28 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 109.498 -0.556 . . . . 72.41 109.498 -174.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -134.03 129.56 36.27 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.448 -1.316 . . . . 61.31 107.448 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.485 HG21 ' HA2' ' A' ' 99' ' ' GLY . 85.3 m -108.54 130.97 55.28 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.876 -0.787 . . . . 51.42 108.876 172.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.72 109.37 9.11 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.819 -0.808 . . . . 51.22 108.819 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.6 p -91.28 163.42 14.24 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.318 0.647 . . . . 74.31 110.098 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.9 t -160.39 154.14 22.6 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.28 1.432 . . . . 75.41 107.328 -166.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -116.29 125.41 52.12 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.681 -0.489 . . . . 70.12 109.681 171.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.7 mt -95.02 -32.99 12.89 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.21 0.604 . . . . 54.41 110.583 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.95 -179.5 7.2 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.192 0.597 . . . . 64.14 111.39 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -63.51 123.7 19.47 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 109.346 -0.613 . . . . 64.03 109.346 174.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 70.2 -8.53 0.84 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 125.835 1.654 . . . . 64.4 112.886 -173.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.7 t -100.64 106.61 19.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 121.496 0.665 . . . . 73.43 109.301 -177.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -114.27 125.61 54.1 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.735 -1.209 . . . . 71.43 107.735 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -94.32 128.77 41.02 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.919 -0.771 . . . . 72.42 108.919 172.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.1 t -113.2 137.71 45.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.369 -0.974 . . . . 71.01 108.369 171.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.7 t -119.32 130.58 73.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.905 -0.776 . . . . 75.44 108.905 173.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.31 97.8 7.56 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 105.675 -1.972 . . . . 73.12 105.675 172.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -84.94 97.58 9.87 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.928 -1.138 . . . . 73.13 107.928 174.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 50.0 t -94.97 131.25 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 107.49 -1.3 . . . . 74.33 107.49 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.8 m -127.12 118.4 24.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.817 0.817 . . . . 74.24 110.203 175.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.597 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 91.5 t -104.33 125.49 59.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 124.56 1.144 . . . . 43.0 108.905 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.1 m -122.43 126.49 48.05 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.648 -0.871 . . . . 42.04 108.648 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.404 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -113.21 108.3 17.08 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 107.847 -1.168 . . . . 63.42 107.847 175.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.0 m -109.03 134.29 51.85 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.179 0.591 . . . . 72.21 110.037 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.4 mt -100.7 57.74 0.91 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.247 1.019 . . . . 62.41 108.341 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.46 -103.15 3.0 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 110.82 -0.912 . . . . 45.41 110.82 -169.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -96.59 -28.56 14.31 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.352 0.661 . . . . 73.45 111.428 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -102.74 123.07 45.74 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.471 0.308 . . . . 71.33 110.639 -173.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.6 m -71.5 138.42 48.92 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.514 0.726 . . . . 63.21 110.871 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.893 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -79.78 -60.06 2.49 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.317 1.047 . . . . 74.2 109.817 173.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -151.02 156.64 41.55 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 114.629 -1.169 . . . . 73.45 111.071 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 39.9 tp -126.82 115.05 18.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.633 1.173 . . . . 61.23 108.58 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.597 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 66.3 m -105.9 142.3 35.85 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.044 0.937 . . . . 72.32 109.339 175.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -146.44 121.35 9.98 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.644 -0.873 . . . . 53.32 108.644 166.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.4 t -126.09 109.81 22.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.703 -0.851 . . . . 73.52 108.703 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -85.78 82.01 8.36 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 114.379 -1.282 . . . . 72.33 108.443 174.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -76.23 95.55 3.74 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.828 -1.078 . . . . 61.14 109.164 -177.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.32 154.88 29.15 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 111.361 -0.696 . . . . 41.02 111.361 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.29 121.51 1.23 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.682 -0.967 . . . . 30.3 110.682 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.4 mt -81.68 127.1 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 107.823 -1.177 . . . . 74.12 107.823 171.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.844 ' HB3' HD11 ' A' ' 86' ' ' ILE . 71.0 m-85 -135.71 125.15 24.95 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.095 0.958 . . . . 72.24 109.561 -171.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.1 m -94.65 97.95 10.46 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 109.216 -0.661 . . . . 73.42 109.216 175.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.844 HD11 ' HB3' ' A' ' 84' ' ' PHE . 6.0 mm -108.04 156.69 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.385 0.674 . . . . 62.11 110.679 -172.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.41 162.84 8.47 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.523 1.129 . . . . 74.23 110.909 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.21 -13.94 62.81 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-N 115.951 -0.568 . . . . 25.4 114.422 174.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.482 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -133.46 146.6 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.824 0.85 . . . . 41.53 110.736 -177.108 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -144.16 174.76 10.6 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.296 1.038 . . . . 64.41 109.735 174.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.99 -139.01 26.42 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 116.012 -0.54 . . . . 60.21 112.618 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.7 p -69.79 -16.61 63.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 117.105 0.453 . . . . 73.12 111.501 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.57 -45.71 85.88 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.254 0.621 . . . . 74.12 109.959 170.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.403 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 6.1 tpt -66.75 -43.79 83.2 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.103 -0.953 . . . . 63.35 109.662 -178.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.95 -31.16 72.25 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.601 -0.727 . . . . 63.3 111.125 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.441 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 57.8 t-80 -74.3 -30.3 62.01 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.667 0.787 . . . . 63.44 110.696 176.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.4 t -72.8 -44.54 61.38 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 109.115 -0.698 . . . . 60.01 109.115 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 94' ' ' MET . 35.9 mt -84.99 -24.72 28.14 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.389 -0.823 . . . . 72.13 112.019 -174.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.485 ' HA2' HG21 ' A' ' 46' ' ' THR . . . -108.01 4.45 33.89 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 119.597 -0.557 . . . . 45.13 113.947 -174.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.562 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -147.52 -64.22 0.27 Allowed 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 117.667 0.734 . . . . 62.4 112.372 -177.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -68.16 -47.27 68.48 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 123.352 0.408 . . . . 74.35 111.697 -171.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.807 ' HG ' ' HE1' ' A' ' 11' ' ' PHE . 98.4 m -65.2 -45.83 71.87 Favored Pre-proline 0 CA--C 1.56 1.333 0 CA-C-O 117.987 -1.006 . . . . 70.0 112.316 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -54.26 -35.26 82.78 Favored 'Trans proline' 0 C--N 1.398 3.178 0 C-N-CA 122.188 1.925 . . . . 72.13 112.889 169.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -68.53 -34.25 75.54 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.531 0.732 . . . . 64.43 111.093 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.5 mm -67.88 -43.23 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.49 0.716 . . . . 53.42 110.054 172.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 55.9 mt -75.19 -20.24 59.4 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.053 -0.976 . . . . 61.33 111.877 -174.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -65.63 -45.24 67.1 Favored Pre-proline 0 N--CA 1.478 0.93 0 CA-C-O 117.05 -1.452 . . . . 72.11 113.537 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -50.72 -34.11 42.8 Favored 'Trans proline' 0 C--N 1.39 2.715 0 CA-C-N 122.182 1.815 . . . . 44.51 113.592 171.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -85.69 -36.47 20.22 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.711 0.804 . . . . 72.21 112.054 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.42 -48.25 67.84 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.968 -0.752 . . . . 64.02 108.968 175.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.453 ' NH1' HD12 ' C' ' 105' ' ' ILE . 27.9 ttm180 -47.87 -58.48 4.32 Favored 'General case' 0 C--O 1.213 -0.82 0 O-C-N 125.203 1.565 . . . . 61.31 110.677 171.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -60.79 -45.35 94.74 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 124.321 1.013 . . . . 74.44 111.792 -173.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.416 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 47.4 t -58.74 -45.9 88.62 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.045 0.841 . . . . 71.34 110.498 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.505 HG21 HG21 ' A' ' 64' ' ' VAL . 83.3 mt -61.16 -51.44 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 124.27 0.982 . . . . 64.33 110.603 175.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.2 m -58.75 -37.11 75.5 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.36 1.064 . . . . 73.21 110.687 -173.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.1 t -70.59 -44.56 67.06 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.444 -1.253 . . . . 54.44 109.866 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.4 mtp -59.39 -38.62 81.0 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.658 0.783 . . . . 63.41 111.774 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 114' ' ' ILE . 79.3 t -67.27 -46.08 84.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.211 1.004 . . . . 70.02 110.073 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.9 p -71.88 -30.63 65.61 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.828 -0.624 . . . . 55.14 111.106 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.413 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 81.7 mtt-85 -72.22 -33.69 67.78 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.675 0.79 . . . . 75.31 109.432 172.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.61 -2.17 74.32 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 115.019 -0.991 . . . . 73.21 112.962 175.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.529 HG22 HH21 ' B' ' 15' ' ' ARG . 52.1 m 76.92 19.99 1.34 Allowed 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 122.593 1.187 . . . . 74.33 111.882 168.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -93.31 148.75 36.17 Favored Pre-proline 0 C--O 1.248 1.022 0 N-CA-C 108.296 -1.002 . . . . 71.42 108.296 170.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -54.47 138.96 74.9 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.494 2.129 . . . . 72.04 111.156 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -56.21 127.48 30.96 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.332 1.02 . . . . 75.34 112.274 -167.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.542 HD21 HG11 ' A' ' 64' ' ' VAL . 36.0 tp -113.04 97.14 6.33 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 114.454 -1.248 . . . . 74.44 109.406 -175.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -96.04 103.23 15.11 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.038 -1.467 . . . . 74.34 107.038 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 17.3 mt -55.24 136.12 49.08 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.778 0.673 . . . . 74.51 111.134 -169.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.84 137.86 97.28 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 122.755 0.422 . . . . 42.03 111.274 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.537 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 53.2 Cg_exo -55.47 114.84 2.07 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.593 2.862 . . . . 64.43 113.689 -178.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.55 HG21 HD11 ' A' ' 44' ' ' LEU . 45.1 t -104.2 133.24 48.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 CA-C-N 115.455 -0.793 . . . . 70.45 109.842 177.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 63.4 t-20 -96.97 87.12 4.16 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.515 -0.921 . . . . 55.13 108.515 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -59.68 -26.6 65.7 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.708 0.803 . . . . 73.24 113.056 175.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.562 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 8.6 t0 -63.67 -43.97 95.15 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.931 -0.766 . . . . 74.34 108.931 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.05 -35.22 80.46 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.893 -1.048 . . . . 61.34 111.476 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 77.9 mt -71.83 -40.66 68.93 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.022 0.826 . . . . 74.45 111.879 -177.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 59.8 t80 . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 108.796 -0.816 . . . . 74.12 108.796 175.688 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.582 ' HG3' HG23 ' B' ' 89' ' ' ILE . 1.2 tmt? . . . . . 0 N--CA 1.486 1.354 0 N-CA-C 111.804 0.298 . . . . 72.42 111.804 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.484 ' N ' ' SD ' ' B' ' 9' ' ' MET . 9.5 t -159.89 133.59 7.16 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.844 0.857 . . . . 61.25 109.405 176.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -117.36 141.85 47.81 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 107.842 -1.17 . . . . 72.15 107.842 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -149.46 137.54 20.54 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 122.76 0.424 . . . . 74.41 110.701 176.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 44.6 mt -96.23 128.16 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.049 -1.093 . . . . 73.43 108.049 173.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -95.35 -42.03 8.72 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.524 0.515 . . . . 64.34 110.525 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.529 HH21 HG22 ' A' ' 122' ' ' THR . 22.8 ttt180 -172.93 138.69 0.8 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.737 -0.665 . . . . 70.45 109.303 -172.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.8 mt -123.31 139.88 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 106.661 -1.607 . . . . 52.33 106.661 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -164.01 145.21 8.7 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.22 0.822 . . . . 73.44 113.22 -174.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 64.0 m -76.28 120.43 21.54 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.737 -1.119 . . . . 61.12 109.094 172.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.637 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 37.0 mtpt -97.82 -22.82 16.17 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.049 0.94 . . . . 55.21 111.006 -178.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 17.8 t70 -158.53 143.25 16.07 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.185 0.594 . . . . 74.12 110.358 -175.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.464 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 38.9 mm -138.9 141.47 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.252 1.421 . . . . 63.13 107.849 174.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 67.8 m -145.83 138.45 25.69 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.529 0.732 . . . . 71.04 109.13 170.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.3 t80 -143.41 116.76 9.05 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.792 -1.929 . . . . 74.1 105.792 169.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -127.89 111.14 13.26 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.323 -0.992 . . . . 62.03 108.323 -176.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.607 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -110.2 87.91 6.6 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 108.211 -1.033 . . . . 73.32 108.211 175.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.07 -34.06 14.28 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.232 1.955 . . . . 74.25 111.547 -175.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -99.97 3.81 44.54 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.325 1.05 . . . . 72.35 110.902 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.607 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -24.89 -64.68 0.1 OUTLIER Pre-proline 0 N--CA 1.504 2.266 0 C-N-CA 126.606 1.962 . . . . 72.44 115.332 -172.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 7.9 Cg_exo -66.57 -42.34 9.66 Favored 'Trans proline' 0 C--N 1.388 2.63 0 C-N-CA 122.154 1.903 . . . . 70.52 112.386 -170.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -86.03 -28.19 24.31 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.651 0.78 . . . . 75.22 111.89 -171.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.523 HG22 HD12 ' B' ' 68' ' ' LEU . 4.8 p -77.59 -11.66 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 122.889 0.476 . . . . 53.41 110.696 -175.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -65.89 -20.52 66.25 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 113.101 0.778 . . . . 65.15 113.101 173.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -63.21 -25.16 68.21 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.313 0.578 . . . . 62.54 110.111 173.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -90.83 66.98 6.12 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.307 1.043 . . . . 72.54 109.713 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -80.6 82.08 6.7 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 122.291 1.043 . . . . 75.15 109.114 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -152.83 -173.3 4.52 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.102 -0.954 . . . . 75.32 109.122 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -72.51 110.35 7.97 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 123.992 0.917 . . . . 75.42 109.631 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.409 ' O ' HG23 ' B' ' 40' ' ' VAL . 49.2 Cg_endo -70.38 141.1 41.88 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 121.653 1.569 . . . . 71.01 109.747 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -68.12 99.97 0.95 Allowed 'General case' 0 C--O 1.242 0.687 0 N-CA-C 106.906 -1.516 . . . . 63.42 106.906 171.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.667 HG11 HD11 ' B' ' 126' ' ' LEU . 39.1 t -95.72 154.2 3.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 114.593 -1.185 . . . . 73.44 108.734 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -143.81 117.5 9.25 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.93 -0.766 . . . . 73.13 108.93 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.495 HD13 HD22 ' B' ' 128' ' ' LEU . 31.1 tp -93.27 137.31 32.71 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 108.832 -0.803 . . . . 65.01 108.832 172.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -159.55 128.22 5.11 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 107.702 -1.221 . . . . 73.05 107.702 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.461 HD23 HG22 ' B' ' 62' ' ' VAL . 4.0 mp -108.59 151.25 26.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.879 -0.785 . . . . 72.45 108.879 -174.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.55 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.4 t70 -127.54 144.14 51.1 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.027 0.931 . . . . 73.31 109.111 -177.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 26.1 p -113.07 106.51 14.76 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.534 0.734 . . . . 64.44 110.653 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.99 136.25 52.77 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.971 -1.122 . . . . 51.43 107.971 171.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.571 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 58.0 m -142.85 177.55 8.26 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.567 0.347 . . . . 62.14 110.774 -173.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 79.4 p -159.21 139.18 11.89 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.785 0.434 . . . . 61.41 111.136 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -90.24 125.16 35.39 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 108.696 -0.853 . . . . 52.53 108.696 169.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.6 pp -140.32 17.71 2.41 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.978 0.911 . . . . 74.22 109.845 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.77 152.65 17.93 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.454 1.102 . . . . 75.33 109.078 174.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -76.98 135.43 38.7 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.279 -1.008 . . . . 74.22 108.279 164.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 70.59 -4.25 1.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.139 0.976 . . . . 71.11 113.113 172.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 63.6 t -136.27 128.46 45.0 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 106.725 -1.583 . . . . 62.04 106.725 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.571 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 4.9 t80 -122.16 169.64 10.67 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.836 0.351 . . . . 64.3 110.564 -172.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -134.72 111.45 9.98 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 107.664 -1.235 . . . . 72.45 107.664 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 61.5 t -106.75 130.67 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.056 0.942 . . . . 75.52 109.198 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.2 t -111.28 113.31 43.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 N-CA-C 109.277 -0.638 . . . . 73.45 109.277 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' B' ' 103' ' ' PRO . 63.1 tp -93.79 110.77 22.4 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 109.076 -0.713 . . . . 62.23 109.076 171.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.55 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 14.0 ttm180 -84.66 132.89 34.43 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.855 -1.165 . . . . 74.51 107.855 169.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.461 HG22 HD23 ' B' ' 44' ' ' LEU . 43.8 t -123.49 104.15 13.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.571 -1.27 . . . . 71.43 107.571 174.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 15.2 m -100.63 131.71 46.4 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.068 0.461 . . . . 52.43 110.112 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.616 HG11 HD21 ' B' ' 126' ' ' LEU . 70.3 t -122.92 126.54 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.222 1.009 . . . . 63.14 108.5 175.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.8 m -111.3 138.9 47.18 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 107.54 -1.281 . . . . 71.22 107.54 168.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.12 137.09 28.88 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.034 -0.728 . . . . 74.53 109.034 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.569 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 25.1 p -147.05 128.28 14.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.085 0.469 . . . . 64.41 111.584 -172.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.523 HD12 HG22 ' B' ' 31' ' ' VAL . 56.4 mt -99.03 103.79 15.76 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 124.919 1.288 . . . . 72.24 108.507 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.3 -119.04 4.82 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 115.657 -0.701 . . . . 62.54 111.824 -174.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -112.22 3.93 17.47 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.94 0.896 . . . . 73.33 111.368 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -118.0 148.62 42.05 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.119 0.567 . . . . 75.11 109.672 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 99.2 m -72.63 125.66 28.02 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.8 -0.636 . . . . 62.45 111.232 -177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.569 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -71.66 -62.43 1.42 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.81 -1.181 . . . . 61.42 107.81 173.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -152.89 157.89 41.35 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.586 -1.188 . . . . 70.13 111.186 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 70.8 mt -126.08 108.5 11.42 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 106.255 -1.758 . . . . 72.25 106.255 172.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 39.3 t -119.17 113.76 21.4 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.507 -0.923 . . . . 74.12 108.507 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -128.57 124.62 36.38 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.973 -1.121 . . . . 75.33 107.973 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 67.3 t -123.63 155.84 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.855 0.862 . . . . 64.13 109.24 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.53 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.7 mt-30 -131.25 108.03 9.4 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.19 -0.67 . . . . 55.13 109.19 171.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 8.5 tp-100 -96.89 109.38 22.11 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.568 0.747 . . . . 61.53 109.518 173.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.637 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -99.64 170.61 23.25 Favored Glycine 0 N--CA 1.464 0.535 0 N-CA-C 112.021 -0.432 . . . . 73.42 112.021 174.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.97 138.78 5.12 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 112.573 -0.211 . . . . 51.42 112.573 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 49.5 mt -92.17 122.08 43.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.267 1.027 . . . . 71.25 108.764 174.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -127.45 135.21 50.1 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.002 0.921 . . . . 70.1 109.727 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 24.1 m -106.32 128.65 54.15 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.691 0.796 . . . . 73.11 109.5 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.626 ' HB ' HD11 ' B' ' 89' ' ' ILE . 1.9 pp -139.77 147.06 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.374 0.669 . . . . 72.52 111.089 -177.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.68 165.92 35.03 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.4 0.68 . . . . 62.04 111.104 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 90.8 -45.83 2.91 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 116.087 -0.506 . . . . 31.2 112.741 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.626 HD11 ' HB ' ' B' ' 86' ' ' ILE . 4.0 pt -56.38 152.33 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.559 1.143 . . . . 72.34 111.426 169.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -157.94 164.09 37.2 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.536 0.734 . . . . 74.22 109.536 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.36 -111.07 3.49 Favored Glycine 0 C--N 1.355 1.631 0 O-C-N 123.197 0.31 . . . . 53.34 112.699 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 25.0 m -84.34 -43.22 14.97 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 123.695 0.798 . . . . 73.43 109.696 175.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -62.53 -24.66 67.62 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 113.758 -1.565 . . . . 75.43 111.694 -168.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.566 ' HA ' HD12 ' B' ' 89' ' ' ILE . 23.9 ptm -66.1 -65.67 0.65 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.084 0.772 . . . . 75.54 113.084 -177.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.19 -14.4 58.48 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.21 0.448 . . . . 61.1 112.21 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -61.33 -37.03 81.82 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.365 0.666 . . . . 74.15 110.554 171.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 97' ' ' CYS . . . . . 0.456 ' SG ' HG21 ' B' ' 86' ' ' ILE . 43.8 t -60.13 -24.56 64.78 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.114 0.966 . . . . 52.24 112.024 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.501 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 26.7 mt -97.76 -39.13 9.19 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.124 0.969 . . . . 72.42 111.497 -177.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.26 -19.27 69.69 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 116.43 -0.35 . . . . 73.52 113.572 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.87 -48.48 1.89 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.003 0.521 . . . . 73.24 111.767 -172.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -83.05 -41.96 18.03 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 111.877 0.325 . . . . 72.43 111.877 -171.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.501 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 94.8 m -63.05 -43.23 81.15 Favored Pre-proline 0 CA--C 1.57 1.733 0 N-CA-C 113.569 0.952 . . . . 45.23 113.569 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.424 ' HB3' HD13 ' B' ' 60' ' ' LEU . 51.5 Cg_exo -58.27 -27.62 81.52 Favored 'Trans proline' 0 C--N 1.399 3.196 0 C-N-CA 122.239 1.96 . . . . 73.24 113.674 173.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -65.01 -33.55 76.31 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.663 0.785 . . . . 72.23 110.591 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 57.4 mt -73.89 -41.7 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.883 0.873 . . . . 75.01 110.088 176.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 92.5 mt -75.94 -30.01 58.53 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.23 -0.896 . . . . 60.12 112.424 -172.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -56.98 -49.7 92.44 Favored Pre-proline 0 N--CA 1.484 1.239 0 CA-C-O 117.342 -1.313 . . . . 64.13 113.477 -172.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -50.31 -39.64 53.01 Favored 'Trans proline' 0 C--N 1.391 2.788 0 C-N-CA 122.512 2.141 . . . . 74.11 114.161 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -70.15 -47.15 62.89 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.334 0.654 . . . . 72.23 110.509 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -62.35 -35.53 79.41 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.37 -0.832 . . . . 65.44 111.337 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.533 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 50.2 ttt-85 -67.53 -49.73 61.97 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.134 1.374 . . . . 72.41 110.349 -177.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.6 -32.34 73.61 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.021 0.826 . . . . 60.33 109.687 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.51 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.3 t -69.56 -42.84 74.02 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.257 0.623 . . . . 65.24 110.829 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.424 HD13 HG23 ' B' ' 64' ' ' VAL . 74.9 mt -60.23 -54.52 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.392 0.677 . . . . 72.25 110.603 172.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 25.5 m -58.9 -28.69 66.43 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.503 0.721 . . . . 70.44 111.276 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 22.9 t -67.69 -53.2 29.58 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 123.203 0.601 . . . . 71.43 109.59 173.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.51 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.2 mmt -64.52 -31.89 73.3 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 122.758 0.423 . . . . 75.15 111.774 -175.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.8 t -69.7 -42.1 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.268 1.027 . . . . 73.04 110.562 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 81.5 p -72.43 -28.89 63.24 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.001 0.429 . . . . 52.42 111.087 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' B' ' 116' ' ' SER . 88.5 mtt-85 -67.93 -40.72 83.31 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.12 -0.945 . . . . 71.54 109.505 175.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.45 -6.18 61.43 Favored Glycine 0 C--N 1.352 1.467 0 O-C-N 123.764 0.665 . . . . 64.13 113.071 173.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 9.7 m 64.98 31.45 11.25 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.282 1.433 . . . . 73.12 110.298 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -89.53 164.03 31.08 Favored Pre-proline 0 CA--C 1.556 1.193 0 CA-C-N 114.22 -1.354 . . . . 63.11 111.129 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -39.74 146.55 0.22 Allowed 'Trans proline' 0 C--N 1.393 2.885 0 C-N-CA 124.647 3.565 . . . . 50.32 115.86 174.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -61.05 112.84 2.25 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.301 0.641 . . . . 74.41 109.768 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.667 HD11 HG11 ' B' ' 40' ' ' VAL . 43.4 tp -109.93 110.72 21.76 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.424 0.69 . . . . 70.34 109.463 -174.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -107.29 117.53 34.32 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.201 -1.037 . . . . 73.02 108.201 175.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.533 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 51.4 mt -78.56 147.46 33.74 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 120.535 0.207 . . . . 54.52 110.53 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 129' ' ' ALA . . . . . 0.441 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -73.13 142.11 81.97 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 123.641 0.776 . . . . 71.54 112.375 -170.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' B' ' 129' ' ' ALA . 11.2 Cg_endo -85.04 104.04 0.86 Allowed 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.312 2.675 . . . . 41.11 111.192 176.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.95 134.93 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 122.83 0.452 . . . . 74.51 110.327 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 41.0 t30 . . . . . 0 N--CA 1.474 0.756 0 C-N-CA 123.259 0.624 . . . . 73.4 109.432 177.926 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.537 ' HD2' ' HG2' ' A' ' 130' ' ' PRO . 35.0 t80 . . . . . 0 C--O 1.239 0.53 0 N-CA-C 108.0 -1.111 . . . . 75.21 108.0 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -142.03 131.25 23.44 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.711 -0.848 . . . . 71.4 108.711 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 19.9 mt -84.22 134.77 26.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.723 -0.843 . . . . 73.14 108.723 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.499 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 11.1 mm100 -91.35 -45.67 8.45 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.592 -0.892 . . . . 74.22 108.592 175.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -177.58 153.35 0.88 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.048 1.339 . . . . 73.24 109.455 175.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.491 HG23 HD23 ' C' ' 106' ' ' LEU . 75.0 mt -128.75 118.55 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.731 1.212 . . . . 62.34 108.379 177.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.511 ' HB3' HG23 ' D' ' 122' ' ' THR . 6.1 p90 -151.37 154.45 36.7 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.008 0.908 . . . . 72.45 112.249 -164.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.2 p -79.22 108.85 13.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.562 -1.199 . . . . 71.15 109.406 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -72.83 -45.01 60.69 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 107.557 -1.275 . . . . 53.41 107.557 172.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.71 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 10.4 t70 -134.52 137.54 43.94 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 113.186 -1.825 . . . . 64.11 109.19 -174.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.4 mt -134.78 143.44 37.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 125.455 1.502 . . . . 70.22 106.969 172.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.7 t -150.01 138.0 20.24 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 109.154 -0.684 . . . . 75.31 109.154 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -139.01 128.61 24.57 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.48 -1.304 . . . . 71.33 107.48 171.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -130.18 120.19 24.14 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.534 1.134 . . . . 70.53 108.784 -174.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.14 84.0 58.66 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 106.969 -1.493 . . . . 74.5 106.969 169.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.5 -26.9 28.36 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 122.397 2.064 . . . . 64.13 111.227 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -107.39 21.83 16.89 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.486 1.114 . . . . 65.44 109.836 -176.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.82 -64.94 0.71 Allowed Pre-proline 0 CA--C 1.571 1.777 0 N-CA-C 114.466 1.284 . . . . 32.11 114.466 -165.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -67.54 -27.87 38.83 Favored 'Trans proline' 0 C--N 1.385 2.453 0 CA-C-N 122.326 1.867 . . . . 74.34 112.615 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -68.13 -37.86 81.57 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.893 0.877 . . . . 73.13 111.366 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.632 HG21 ' HA ' ' C' ' 73' ' ' ALA . 14.8 p -82.01 -24.87 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 116.184 -0.462 . . . . 71.15 111.941 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -65.72 -30.66 71.36 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 121.787 -0.57 . . . . 71.35 111.015 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -90.82 29.93 1.27 Allowed 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.109 0.964 . . . . 64.0 111.228 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -124.74 153.38 42.49 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.457 1.103 . . . . 71.3 109.711 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -67.76 129.76 40.9 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 122.994 0.518 . . . . 75.34 109.89 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 66.5 t-105 -85.0 83.44 8.06 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.8 0.84 . . . . 74.13 111.346 -173.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -131.21 78.87 71.74 Favored Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 123.739 0.816 . . . . 71.41 109.071 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -83.23 155.61 14.6 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.553 2.169 . . . . 71.11 112.428 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -88.52 100.48 13.11 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 106.749 -1.574 . . . . 72.51 106.749 168.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 57.4 t -74.64 99.42 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 109.024 -0.732 . . . . 53.51 109.024 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 32.5 mmtm -131.65 106.79 8.39 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.086 0.954 . . . . 61.02 109.472 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 pp -95.74 165.35 12.35 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.69 0.796 . . . . 72.11 109.933 175.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 19.9 t70 -139.86 143.98 37.01 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.414 1.086 . . . . 73.21 108.235 175.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 97.4 mt -128.58 112.57 14.43 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.382 0.611 . . . . 61.2 109.613 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -112.87 121.18 43.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.635 -1.617 . . . . 64.4 106.635 172.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.2 t -118.68 142.92 47.2 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.36 0.6 . . . . 75.12 109.382 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.45 151.86 49.62 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.561 1.144 . . . . 70.41 108.274 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 53.1 p -147.32 142.21 26.89 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 109.348 -0.612 . . . . 64.42 109.348 174.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 72.6 p -150.35 151.85 33.5 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.291 1.036 . . . . 64.14 108.585 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -98.87 117.22 32.87 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.925 -0.769 . . . . 71.04 108.925 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.654 HD11 ' HB2' ' C' ' 57' ' ' GLU . 61.4 mt -84.42 -37.01 21.98 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.497 0.719 . . . . 75.43 110.233 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.38 -175.76 5.6 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.169 0.988 . . . . 63.31 109.759 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -59.16 110.23 1.02 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 123.641 0.588 . . . . 72.52 110.363 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 62.85 22.72 13.58 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.287 1.035 . . . . 71.22 112.066 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 95.6 t -117.63 117.49 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.874 1.27 . . . . 51.04 107.58 173.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -127.28 125.36 40.74 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.068 0.947 . . . . 72.14 109.554 -174.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.654 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.0 tt0 -88.33 122.12 31.48 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.832 -0.803 . . . . 61.04 108.832 169.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 65.8 t -112.49 124.13 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 108.713 -0.847 . . . . 75.44 108.713 172.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.538 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 61.6 t -109.75 134.75 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.019 0.528 . . . . 53.13 109.938 176.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.47 99.56 8.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.848 -1.168 . . . . 75.4 107.848 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -80.31 106.8 12.6 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.121 -1.066 . . . . 75.14 108.121 170.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.15 122.5 58.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 107.866 -1.161 . . . . 74.42 107.866 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 25.1 m -113.3 138.61 49.77 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 107.415 -1.328 . . . . 61.33 107.415 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.426 HG21 HG21 ' C' ' 114' ' ' ILE . 69.1 t -134.34 111.64 14.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 108.021 -1.103 . . . . 62.51 108.021 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.457 HG23 HD23 ' C' ' 75' ' ' LEU . 4.3 m -108.22 117.4 34.05 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.707 -0.679 . . . . 73.41 109.17 -177.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.42 104.04 10.71 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.565 -0.902 . . . . 62.42 108.565 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 63.4 m -128.77 132.91 47.94 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.186 -0.672 . . . . 65.44 109.186 176.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 9.6 mt -84.68 42.32 0.9 Allowed 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 125.428 1.491 . . . . 70.22 109.889 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.22 -104.61 2.46 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 110.97 -0.852 . . . . 53.12 110.97 -172.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -89.7 -32.19 17.13 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.514 0.726 . . . . 75.3 109.945 174.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -75.95 105.84 7.21 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 114.877 -1.056 . . . . 71.54 109.808 -178.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 61.4 m -74.21 124.52 26.55 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 118.479 0.582 . . . . 53.42 109.597 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.632 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -77.79 -53.89 6.98 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.582 -0.736 . . . . 53.54 109.111 176.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -162.03 164.13 28.42 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.827 -1.079 . . . . 75.55 110.729 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.457 HD23 HG23 ' C' ' 65' ' ' THR . 2.7 tm? -128.41 142.17 51.19 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.211 -1.774 . . . . 61.12 106.211 167.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 42.5 t -149.44 129.8 13.8 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.94 -0.763 . . . . 72.15 108.94 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -140.66 128.62 21.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.714 0.406 . . . . 72.31 110.027 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 37.3 t -125.24 115.69 44.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 124.468 1.107 . . . . 73.04 108.891 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.71 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.5 mt-30 -90.41 91.09 8.32 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.57 -0.9 . . . . 72.44 108.57 172.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -83.78 96.07 8.63 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.342 -1.299 . . . . 75.21 109.183 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -93.2 145.73 17.75 Favored Glycine 0 C--O 1.222 -0.638 0 N-CA-C 111.616 -0.594 . . . . 70.02 111.616 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.94 132.13 4.91 Favored Glycine 0 CA--C 1.503 -0.703 0 N-CA-C 110.991 -0.844 . . . . 74.43 110.991 -176.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.499 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 22.8 mm -85.66 124.46 40.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 107.467 -1.308 . . . . 74.02 107.467 174.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -129.94 118.2 21.29 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.638 0.775 . . . . 73.01 109.703 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.6 p -86.92 104.62 16.43 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.035 -0.728 . . . . 64.22 109.035 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.53 HD13 ' SG ' ' C' ' 97' ' ' CYS . 19.5 mt -116.73 126.98 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.532 0.733 . . . . 63.34 110.314 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.25 169.01 18.54 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.125 0.97 . . . . 63.23 109.887 177.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.66 -17.65 57.2 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 119.365 -0.686 . . . . 53.11 114.47 174.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' C' ' 94' ' ' MET . 38.0 pt -119.01 166.76 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 CA-C-N 118.079 0.94 . . . . 74.12 112.493 -175.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -159.39 156.44 28.47 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.685 1.194 . . . . 72.12 109.078 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.08 -138.14 14.88 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-O 120.073 -0.293 . . . . 74.41 112.926 171.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 47.1 p -65.08 -25.18 67.68 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.796 0.838 . . . . 63.25 111.457 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -61.15 -54.24 46.87 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.166 0.986 . . . . 74.43 110.635 171.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.587 ' HE3' ' HA ' ' C' ' 94' ' ' MET . 4.5 tpt -56.67 -48.61 77.23 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 124.058 0.849 . . . . 62.44 111.803 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.17 -40.96 91.76 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 123.59 0.556 . . . . 43.12 111.514 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -69.56 -30.95 68.86 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.055 0.942 . . . . 75.14 111.239 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.53 ' SG ' HD13 ' C' ' 86' ' ' ILE . 12.2 t -75.41 -35.39 61.02 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.652 -0.499 . . . . 70.11 109.652 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 96.2 mt -84.14 -32.82 24.46 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.002 0.921 . . . . 71.33 112.521 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.88 8.77 27.6 Favored Glycine 0 N--CA 1.473 1.166 0 CA-C-O 119.656 -0.525 . . . . 71.43 114.135 -170.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.75 -55.32 0.22 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 117.411 0.606 . . . . 53.25 111.644 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -71.36 -54.34 11.08 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 117.566 0.166 . . . . 74.13 111.264 -174.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.45 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 84.8 m -57.58 -50.48 87.92 Favored Pre-proline 0 CA--C 1.565 1.524 0 CA-C-O 118.182 -0.913 . . . . 55.4 111.974 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.464 ' HA ' HD12 ' C' ' 106' ' ' LEU . 38.9 Cg_exo -60.11 -28.21 86.5 Favored 'Trans proline' 0 C--N 1.4 3.256 0 C-N-CA 122.601 2.201 . . . . 75.11 113.567 174.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -68.09 -35.61 78.45 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.201 0.6 . . . . 55.21 110.778 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.453 HD12 ' NH1' ' A' ' 111' ' ' ARG . 19.9 mm -79.86 -29.62 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 109.972 -0.381 . . . . 70.35 109.972 177.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.491 HD23 HG23 ' C' ' 16' ' ' ILE . 73.9 mt -70.09 -32.08 69.96 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.406 0.683 . . . . 73.21 111.254 176.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -53.29 -53.26 58.08 Favored Pre-proline 0 N--CA 1.485 1.322 0 CA-C-O 117.228 -1.368 . . . . 71.41 114.459 -173.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.82 -36.46 96.98 Favored 'Trans proline' 0 C--N 1.391 2.783 0 C-N-CA 122.074 1.849 . . . . 54.44 113.219 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -70.17 -46.55 64.42 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.706 0.802 . . . . 71.33 110.307 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.94 81.86 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 115.027 -0.988 . . . . 60.25 110.369 175.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.9 ttt-85 -65.74 -47.16 76.2 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.199 1.399 . . . . 64.32 110.757 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -69.63 -33.78 73.13 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.362 0.665 . . . . 74.34 110.055 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 40.2 t -68.68 -39.53 80.53 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.336 0.655 . . . . 61.44 111.258 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.441 ' O ' HG23 ' C' ' 118' ' ' VAL . 96.7 mt -69.35 -48.19 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.572 0.749 . . . . 73.15 110.406 174.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 28.5 m -54.52 -40.16 68.35 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.561 1.144 . . . . 62.42 110.876 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.4 t -64.55 -48.05 76.48 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.002 -0.999 . . . . 52.13 109.0 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.52 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.8 -40.24 79.44 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.839 1.256 . . . . 74.24 112.672 178.433 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.441 HG23 ' O ' ' C' ' 114' ' ' ILE . 86.8 t -66.72 -41.0 87.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.531 0.732 . . . . 54.31 110.287 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 46.7 t -71.94 -27.82 63.05 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.782 0.833 . . . . 62.4 111.501 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 82.5 mtt-85 -72.52 -34.17 67.42 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.494 0.718 . . . . 74.55 109.495 175.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.24 10.39 63.81 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.388 -0.823 . . . . 74.42 112.636 173.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 72.5 p 58.7 22.9 10.47 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 126.153 1.781 . . . . 62.1 114.286 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -83.66 149.16 56.59 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 108.689 -0.856 . . . . 72.21 108.689 171.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -55.53 157.67 14.66 Favored 'Trans proline' 0 C--N 1.382 2.322 0 C-N-CA 123.073 2.516 . . . . 61.32 113.702 176.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -58.49 114.16 2.33 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.882 0.873 . . . . 72.14 112.223 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.9 tt -110.56 86.04 2.23 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 106.601 -1.629 . . . . 62.33 106.601 172.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -91.19 105.02 17.5 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.046 -0.724 . . . . 74.24 109.046 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.5 145.59 55.88 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.484 0.714 . . . . 72.51 111.983 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.22 153.15 84.24 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.575 0.75 . . . . 62.31 110.347 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.471 ' HG2' HG21 ' A' ' 13' ' ' ILE . 51.9 Cg_exo -54.71 115.68 2.58 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.892 2.395 . . . . 74.13 112.548 173.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.3 t -98.05 116.91 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.656 -0.868 . . . . 70.51 108.656 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -76.02 103.25 5.98 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.368 0.667 . . . . 75.01 110.531 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -67.18 -22.41 65.74 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.489 0.716 . . . . 74.24 112.065 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -65.46 -42.91 91.81 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.498 0.719 . . . . 72.12 110.476 175.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.08 -46.74 87.78 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 123.675 0.61 . . . . 64.03 110.354 176.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.03 -27.75 67.67 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.267 -0.878 . . . . 74.44 111.435 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 88.2 t80 . . . . . 0 N--CA 1.472 0.647 0 C-N-CA 123.262 0.625 . . . . 53.11 110.494 -179.821 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 8.2 t . . . . . 0 C--O 1.24 0.563 0 N-CA-C 109.149 -0.685 . . . . 54.01 109.149 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.465 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 54.9 t80 -143.41 89.76 2.11 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.183 -1.414 . . . . 71.34 107.183 174.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -116.85 119.85 36.67 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.24 -1.022 . . . . 64.32 108.24 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 5.5 mt -75.79 121.17 27.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.061 -1.088 . . . . 75.11 108.061 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 14' ' ' GLN . . . . . 0.684 ' HB2' HG23 ' D' ' 83' ' ' ILE . 10.8 mm-40 -84.9 -30.04 24.7 Favored 'General case' 0 C--O 1.242 0.674 0 O-C-N 123.802 0.688 . . . . 71.3 110.462 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -174.63 131.42 0.35 Allowed 'General case' 0 C--N 1.364 1.222 0 O-C-N 123.415 0.447 . . . . 72.2 111.149 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.412 ' N ' HD12 ' D' ' 16' ' ' ILE . 3.5 mp -108.18 135.24 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.423 -1.325 . . . . 73.04 107.423 172.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -165.84 170.57 13.71 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.744 0.783 . . . . 71.04 111.89 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -101.46 124.31 46.93 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.406 -1.27 . . . . 63.43 109.357 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.461 ' HD2' ' HA3' ' D' ' 81' ' ' GLY . 28.3 mtpt -95.28 -28.92 14.76 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.735 -0.839 . . . . 71.33 108.735 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.607 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 7.9 t70 -146.1 135.09 22.59 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 113.997 -1.456 . . . . 63.13 108.915 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.52 HG21 ' HE2' ' C' ' 117' ' ' MET . 61.9 mt -136.5 138.99 45.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.937 -1.134 . . . . 72.43 107.937 170.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.9 t -141.44 140.81 33.68 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.233 1.013 . . . . 73.34 108.52 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.49 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.2 t80 -144.71 130.44 19.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 106.059 -1.83 . . . . 73.31 106.059 168.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -134.28 138.03 44.71 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.51 -0.922 . . . . 63.24 108.51 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.421 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -144.14 78.12 13.94 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 107.718 -1.216 . . . . 74.24 107.718 174.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.37 -28.98 9.88 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.803 2.335 . . . . 72.42 112.688 -173.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -101.18 3.64 41.25 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.857 0.863 . . . . 74.51 110.692 -176.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.481 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -33.06 -64.07 0.26 Allowed Pre-proline 0 CA--C 1.566 1.56 0 N-CA-C 116.46 2.022 . . . . 74.32 116.46 -164.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.451 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 73.3 Cg_endo -74.39 -29.12 9.69 Favored 'Trans proline' 0 C--N 1.389 2.68 0 CA-C-N 123.503 2.287 . . . . 71.51 113.311 -178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -65.53 -39.73 92.1 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.649 1.18 . . . . 74.35 109.68 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.519 HG22 HD12 ' D' ' 68' ' ' LEU . 9.8 p -85.53 -16.39 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 CA-C-N 115.423 -0.808 . . . . 70.04 111.532 -176.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.451 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 17.7 m-85 -65.66 -20.92 66.48 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 118.05 0.386 . . . . 73.34 111.585 176.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -61.86 -23.22 66.14 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.7 0.8 . . . . 74.24 110.865 174.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -92.77 95.57 9.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.723 1.209 . . . . 62.44 110.219 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -94.3 94.86 8.54 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.551 0.74 . . . . 74.34 110.153 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -161.84 179.32 8.16 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.686 0.794 . . . . 72.34 110.164 166.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -58.07 111.48 3.59 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.563 1.145 . . . . 72.4 110.031 173.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.419 ' O ' HG23 ' D' ' 40' ' ' VAL . 51.3 Cg_exo -55.6 125.4 18.99 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.205 1.936 . . . . 72.55 110.288 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -72.29 107.33 4.84 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.32 -1.363 . . . . 74.3 107.32 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.879 HG13 HG13 ' D' ' 64' ' ' VAL . 87.5 t -113.1 103.14 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 123.308 0.38 . . . . 73.14 110.08 -168.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -87.16 119.25 27.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.796 -1.187 . . . . 71.23 107.796 172.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.794 HD22 HD11 ' D' ' 128' ' ' LEU . 57.0 tp -92.82 148.01 22.38 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.333 -0.988 . . . . 75.23 108.333 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.5 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 27.6 t70 -144.76 111.96 6.0 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.388 -1.338 . . . . 70.44 107.388 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' D' ' 62' ' ' VAL . 85.2 mt -108.11 131.83 54.21 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.062 0.545 . . . . 74.31 110.073 -173.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -132.15 133.92 44.82 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.89 -1.522 . . . . 75.02 106.89 173.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.8 t -139.24 141.79 37.85 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.833 0.825 . . . . 72.31 110.009 176.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.8 161.82 41.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.391 -1.277 . . . . 64.54 107.738 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 34.0 p . . . . . 0 C--N 1.322 -0.617 0 N-CA-C 109.287 -0.634 . . . . 73.04 109.287 177.755 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.506 2.333 0 N-CA-C 114.232 1.197 . . . . 42.04 114.232 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.539 ' HB ' HD11 ' D' ' 83' ' ' ILE . 23.3 m -130.97 129.09 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 107.262 -1.384 . . . . 61.32 107.262 173.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -141.81 130.09 22.29 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.822 -0.807 . . . . 72.33 108.822 -171.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -87.77 109.98 20.13 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.409 -0.96 . . . . 75.33 108.409 173.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.507 HG11 ' HD3' ' D' ' 103' ' ' PRO . 67.3 t -99.08 120.16 48.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 107.443 -1.317 . . . . 73.15 107.443 175.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.457 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.5 t -107.41 134.76 48.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.606 -0.887 . . . . 75.15 108.606 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.54 116.09 26.98 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.997 -0.742 . . . . 72.14 108.997 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -97.76 96.97 8.6 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.252 1.021 . . . . 70.23 109.051 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.603 HG13 HD11 ' D' ' 42' ' ' LEU . 57.7 t -94.73 109.14 21.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 108.523 -0.918 . . . . 60.01 108.523 175.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 40.6 m -106.11 132.18 52.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.957 -1.019 . . . . 63.52 109.065 -176.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.879 HG13 HG13 ' D' ' 40' ' ' VAL . 86.6 t -120.39 127.61 75.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.032 -0.729 . . . . 45.54 109.032 177.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 14.7 m -117.61 93.37 4.13 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.306 -1.368 . . . . 73.13 107.306 169.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.566 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -102.06 134.94 44.48 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.438 -0.579 . . . . 72.2 109.438 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.534 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 50.2 m -144.5 139.28 28.15 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 115.749 -0.66 . . . . 71.22 110.532 -171.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.519 HD12 HG22 ' D' ' 31' ' ' VAL . 21.1 mt -109.88 110.51 21.49 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.081 -1.451 . . . . 71.22 107.081 172.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.88 -147.34 38.08 Favored Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.956 -0.458 . . . . 73.34 111.956 -175.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.75 4.22 22.79 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.088 0.555 . . . . 42.41 112.357 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -119.63 161.95 19.79 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.399 0.68 . . . . 72.4 109.995 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.8 m -71.97 137.8 47.57 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.245 -0.889 . . . . 72.21 111.106 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.534 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -89.14 -65.8 0.98 Allowed 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.114 -1.439 . . . . 73.22 107.114 170.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -153.8 143.37 21.68 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.646 -1.161 . . . . 71.42 109.967 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 63.2 mt -101.53 149.24 24.3 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.047 -1.094 . . . . 75.43 108.047 167.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.574 ' SG ' HG23 ' D' ' 114' ' ' ILE . 35.3 t -158.92 118.91 3.14 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 117.724 0.238 . . . . 74.3 110.373 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -140.77 122.03 14.85 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.776 0.43 . . . . 63.14 110.035 -174.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 92.7 t -127.71 117.17 45.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 123.951 0.9 . . . . 74.12 109.488 -175.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.607 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.8 mt-30 -90.09 90.48 8.14 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.133 -0.691 . . . . 74.51 109.133 171.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -80.72 99.53 8.26 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.669 -1.151 . . . . 64.34 108.709 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.461 ' HA3' ' HD2' ' D' ' 19' ' ' LYS . . . -92.44 143.3 16.44 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 112.193 -0.363 . . . . 42.31 112.193 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.58 130.83 4.08 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 111.822 -0.511 . . . . 53.12 111.822 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.684 HG23 ' HB2' ' D' ' 14' ' ' GLN . 5.2 tp -91.22 114.43 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.554 -0.906 . . . . 71.25 108.554 174.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -111.0 130.22 55.65 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.143 0.977 . . . . 73.34 110.291 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 10.8 t -94.6 100.79 12.68 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 109.02 -0.733 . . . . 74.32 109.02 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.513 HG21 HD21 ' D' ' 98' ' ' LEU . 3.6 tt -117.73 133.61 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.611 1.165 . . . . 70.11 109.552 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.93 169.6 11.25 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.921 0.888 . . . . 64.32 110.502 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.91 21.54 55.35 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 115.88 -0.6 . . . . 61.3 113.974 174.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.34 168.51 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.809 0.843 . . . . 72.24 110.978 175.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.21 -168.43 3.1 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.68 1.192 . . . . 75.53 109.744 177.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.7 -139.4 22.89 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-N 116.156 -0.474 . . . . 73.11 112.794 174.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 11.7 m -80.23 -39.35 29.22 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.248 0.619 . . . . 75.41 109.756 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -58.16 -36.28 72.78 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.384 1.074 . . . . 70.24 112.68 -173.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.406 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 0.0 OUTLIER -60.03 -48.56 81.22 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 112.807 0.669 . . . . 74.23 112.807 -172.243 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 95' ' ' ALA . . . . . 0.406 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.91 -26.05 25.79 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.833 0.453 . . . . 64.54 111.754 177.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -63.01 -34.25 77.15 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.587 0.755 . . . . 74.12 110.061 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 82.4 m -59.43 -50.41 74.03 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.055 0.542 . . . . 63.14 111.071 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.645 HD23 ' SG ' ' D' ' 102' ' ' CYS . 93.2 mt -69.5 -27.53 65.28 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.961 0.504 . . . . 74.14 111.95 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.82 3.71 71.16 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.488 -0.618 . . . . 54.2 113.829 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.83 -63.36 0.17 Allowed 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 117.695 0.748 . . . . 72.01 112.403 -175.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 101' ' ' TYR . . . . . 0.442 ' O ' HG12 ' D' ' 105' ' ' ILE . 71.1 t80 -69.01 -39.4 79.31 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.177 0.436 . . . . 75.12 112.177 -172.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.645 ' SG ' HD23 ' D' ' 98' ' ' LEU . 50.5 m -69.61 -47.07 25.85 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 123.712 0.805 . . . . 74.15 111.477 -176.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.507 ' HD3' HG11 ' D' ' 58' ' ' VAL . 28.1 Cg_endo -64.1 -26.78 65.31 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 121.421 1.414 . . . . 54.34 112.638 170.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -66.92 -31.2 71.64 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.741 0.416 . . . . 72.42 110.94 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.442 HG12 ' O ' ' D' ' 101' ' ' TYR . 41.9 mm -68.74 -39.76 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.006 0.923 . . . . 75.55 110.51 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' D' ' 103' ' ' PRO . 42.5 mt -74.31 -22.6 59.18 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.534 -0.757 . . . . 71.11 111.573 -175.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -65.28 -41.45 52.04 Favored Pre-proline 0 CA--C 1.562 1.431 0 N-CA-C 114.095 1.146 . . . . 74.42 114.095 -172.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -47.26 -48.31 15.29 Favored 'Trans proline' 0 C--N 1.389 2.669 0 C-N-CA 122.466 2.111 . . . . 73.3 113.649 169.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -73.53 -38.15 65.37 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.93 0.892 . . . . 70.51 111.26 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.39 -44.04 79.86 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.577 -0.738 . . . . 74.31 110.794 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 28.3 ttp180 -59.91 -49.01 79.39 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.21 0.944 . . . . 73.23 110.33 174.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -59.83 -46.0 90.62 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.142 0.901 . . . . 75.02 110.697 -175.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.4 ' O ' ' HG3' ' D' ' 117' ' ' MET . 42.5 t -55.04 -45.67 75.24 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 124.343 1.027 . . . . 45.1 110.309 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.574 HG23 ' SG ' ' D' ' 76' ' ' CYS . 72.4 mt -61.25 -60.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 124.067 0.854 . . . . 74.35 110.851 175.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 37.7 m -52.5 -42.77 64.57 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.032 1.333 . . . . 62.45 111.786 -172.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 33.1 t -65.72 -43.6 88.61 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.465 -1.243 . . . . 60.12 109.823 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 72.2 mtm -68.77 -28.07 66.46 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.059 0.544 . . . . 73.13 111.964 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.465 HG23 ' O ' ' D' ' 114' ' ' ILE . 92.6 t -67.23 -46.34 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.597 0.759 . . . . 73.42 109.566 176.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.7 p -73.13 -29.71 63.08 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.618 -0.719 . . . . 63.42 110.448 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 66.7 mtt-85 -69.54 -30.75 68.65 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 123.595 0.758 . . . . 71.53 109.557 172.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.65 7.23 81.75 Favored Glycine 0 C--N 1.357 1.71 0 C-N-CA 123.536 0.588 . . . . 61.11 113.0 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.511 HG23 ' HB3' ' C' ' 17' ' ' TYR . 66.4 p 55.37 38.92 31.01 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 126.402 1.881 . . . . 64.35 114.268 176.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -99.88 158.46 32.03 Favored Pre-proline 0 C--O 1.243 0.747 0 C-N-CA 123.427 0.691 . . . . 71.15 109.249 170.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_exo -48.72 125.19 12.28 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.7 2.267 . . . . 73.25 112.156 168.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -47.28 126.69 9.79 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.826 1.329 . . . . 63.32 112.495 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.679 HD13 HG21 ' D' ' 40' ' ' VAL . 17.5 tp -107.21 97.75 7.48 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.9 0.88 . . . . 74.21 109.058 -176.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -99.35 99.0 9.87 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.608 -1.256 . . . . 72.13 107.608 173.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.794 HD11 HD22 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -68.47 120.24 14.22 Favored 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 108.259 -1.015 . . . . 60.02 108.259 -179.445 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.49 141.7 94.45 Favored Pre-proline 0 CA--C 1.562 1.413 0 C-N-CA 123.535 0.734 . . . . 72.52 110.914 -177.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -57.74 132.61 51.07 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 123.091 2.527 . . . . 72.44 113.388 -174.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 96.1 t -107.44 123.43 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 108.415 -0.957 . . . . 73.1 108.415 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -86.9 91.93 8.84 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.044 -1.095 . . . . 41.02 108.044 173.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 . . . . . 0 N--CA 1.484 1.275 0 C-N-CA 124.397 1.079 . . . . 75.5 111.796 -174.349 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 25.8 m . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 108.159 -1.052 . . . . 74.22 108.159 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -137.24 119.04 15.13 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.09 -1.078 . . . . 64.41 108.09 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -134.78 132.21 38.44 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.646 -0.872 . . . . 61.03 108.646 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.517 ' CD1' HG21 ' A' ' 105' ' ' ILE . 4.9 mt -94.33 113.36 28.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.645 -0.872 . . . . 73.21 108.645 175.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -78.43 -40.26 36.34 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 123.375 0.422 . . . . 75.1 110.006 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -170.68 124.7 0.68 Allowed 'General case' 0 C--N 1.354 0.799 0 CA-C-N 115.946 -0.57 . . . . 74.12 111.042 -173.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.412 HD12 ' HG3' ' C' ' 130' ' ' PRO . 81.2 mt -106.97 140.28 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 107.944 -1.132 . . . . 64.11 107.944 167.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.521 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 31.7 p90 -164.92 166.25 19.66 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.306 0.574 . . . . 64.53 111.366 -174.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -94.27 122.06 36.42 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 109.484 -0.562 . . . . 54.54 109.484 172.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.455 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 43.0 mtpt -80.11 -35.08 37.33 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.211 -0.662 . . . . 72.14 109.211 174.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -149.93 137.95 20.3 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.277 -1.329 . . . . 65.13 109.826 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.547 HG21 ' SD ' ' B' ' 117' ' ' MET . 73.1 mt -134.99 143.82 36.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 125.317 1.447 . . . . 74.35 108.008 178.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.9 t -156.71 119.93 4.16 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 123.524 0.515 . . . . 61.33 110.593 170.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.628 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.8 t80 -111.5 143.41 42.38 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.019 -1.475 . . . . 74.15 107.019 165.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -139.66 141.31 37.03 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.703 0.401 . . . . 72.12 110.669 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.19 69.92 13.01 Favored Pre-proline 0 C--O 1.242 0.692 0 N-CA-C 107.181 -1.415 . . . . 64.3 107.181 170.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.35 -8.21 19.48 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.448 2.099 . . . . 61.23 112.303 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -114.72 17.52 17.08 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 124.311 1.044 . . . . 62.44 109.246 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.517 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -46.24 -54.31 18.4 Favored Pre-proline 0 CA--C 1.567 1.607 0 CA-C-O 118.006 -0.997 . . . . 75.2 113.667 -169.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -61.81 -24.02 76.8 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 122.016 1.81 . . . . 73.01 113.542 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -84.84 -44.86 12.86 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.757 0.823 . . . . 72.41 111.017 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.927 HG21 ' HA ' ' A' ' 73' ' ' ALA . 8.6 p -77.03 -21.71 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 115.346 -0.843 . . . . 74.25 112.815 -161.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -66.96 -17.24 64.82 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 116.151 -0.477 . . . . 73.21 111.471 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -91.87 -14.46 29.65 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.551 1.14 . . . . 52.51 110.87 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.496 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 19.0 mmtp -79.54 160.31 26.53 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.21 0.604 . . . . 70.33 111.549 -176.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -69.59 131.24 44.35 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.896 0.879 . . . . 72.43 109.152 173.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.496 ' CE3' HD21 ' A' ' 68' ' ' LEU . 68.6 t-105 -81.6 81.07 7.8 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.494 0.664 . . . . 72.54 110.042 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -129.08 77.76 77.31 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.552 1.141 . . . . 72.03 108.035 172.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -85.96 145.22 8.71 Favored 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.669 2.246 . . . . 62.15 113.192 -173.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -101.31 84.97 2.71 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.826 -1.176 . . . . 71.41 107.826 164.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.679 HG11 HD11 ' A' ' 126' ' ' LEU . 77.7 t -81.65 96.96 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 108.419 -0.956 . . . . 61.44 108.419 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -95.96 123.3 39.5 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.347 -0.612 . . . . 74.43 109.347 177.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mp -97.91 107.05 19.45 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.504 -1.295 . . . . 65.44 107.504 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -111.58 119.16 37.79 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.469 -0.937 . . . . 54.31 108.469 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.498 HD22 HD21 ' A' ' 60' ' ' LEU . 89.0 mt -112.17 139.4 47.74 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.441 0.696 . . . . 73.1 111.805 -169.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.482 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 19.4 t70 -132.29 144.09 50.35 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.78 1.232 . . . . 41.54 108.536 176.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.4 m -141.35 135.19 30.23 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.495 0.718 . . . . 72.55 109.434 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.6 123.78 10.83 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.633 0.773 . . . . 63.42 109.483 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.419 ' HB3' ' HB3' ' A' ' 98' ' ' LEU . 78.9 p -97.54 162.39 13.33 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.445 0.698 . . . . 50.14 110.27 175.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.0 t -158.56 155.59 28.62 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.299 1.04 . . . . 72.25 108.53 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -102.53 115.96 31.63 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.296 -0.631 . . . . 70.24 109.296 175.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.634 HD11 ' HB2' ' A' ' 57' ' ' GLU . 56.6 mt -82.52 -40.83 20.48 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.494 0.718 . . . . 64.14 110.257 176.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.41 -174.57 5.0 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.251 -0.886 . . . . 65.11 110.713 -176.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -59.65 115.84 3.61 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.796 0.838 . . . . 72.15 110.135 176.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 71.74 -6.16 1.5 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.907 1.283 . . . . 74.44 112.843 -177.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.6 t -98.76 115.65 39.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.718 -0.845 . . . . 63.43 108.718 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -126.01 125.08 42.08 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.161 0.984 . . . . 61.52 109.061 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.634 ' HB2' HD11 ' A' ' 51' ' ' LEU . 33.2 tt0 -92.05 123.33 35.33 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.483 -0.562 . . . . 63.11 109.483 171.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.8 t -107.28 136.03 43.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.405 -0.961 . . . . 64.22 108.405 168.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.7 t -120.18 130.33 74.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.191 -1.04 . . . . 71.42 108.191 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.498 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -107.07 105.03 14.85 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.411 -1.7 . . . . 71.44 106.411 175.188 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.482 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 31.6 ttp180 -92.51 100.49 13.03 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.216 -1.402 . . . . 74.4 107.216 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.2 t -96.15 127.05 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 108.182 -1.044 . . . . 62.54 108.182 176.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.1 m -123.86 118.56 27.39 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.598 -0.89 . . . . 74.51 108.598 174.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.597 HG11 HD21 ' A' ' 126' ' ' LEU . 71.9 t -120.52 132.4 70.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 107.914 -1.143 . . . . 64.3 107.914 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 m -137.2 132.43 33.87 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.583 -0.895 . . . . 71.32 108.583 174.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.561 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -114.31 114.95 26.62 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.541 1.137 . . . . 62.42 108.142 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 71.2 m -120.81 134.98 55.27 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.401 0.619 . . . . 74.42 111.146 178.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.496 HD21 ' CE3' ' A' ' 36' ' ' TRP . 42.0 mt -94.91 42.27 1.09 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.402 1.481 . . . . 74.41 111.111 -176.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.61 -84.87 1.51 Allowed Glycine 0 C--N 1.339 0.698 0 CA-C-O 119.749 -0.473 . . . . 33.1 112.164 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -86.56 -30.66 21.71 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.211 0.529 . . . . 73.11 111.353 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.449 ' HB2' ' NZ ' ' A' ' 34' ' ' LYS . 4.6 tp10 -119.96 133.64 55.49 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.62 -0.881 . . . . 42.44 108.62 -174.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 73.7 m -77.71 134.37 38.13 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.111 -0.7 . . . . 64.31 109.111 170.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.927 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -71.83 -64.59 0.9 Allowed 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.507 0.723 . . . . 74.21 109.45 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -159.57 166.72 30.18 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.253 -0.885 . . . . 75.0 112.039 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.7 tp -117.92 143.11 46.62 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.571 -1.195 . . . . 64.43 108.693 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.446 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 79.1 m -143.07 104.53 4.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.131 0.973 . . . . 75.4 109.622 175.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -123.1 127.69 49.07 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.539 0.736 . . . . 74.21 109.017 177.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.3 t -137.55 112.75 10.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 124.352 1.061 . . . . 62.21 109.094 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -86.21 85.65 7.34 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.781 -0.822 . . . . 65.22 108.781 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -78.37 96.26 5.29 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.948 -1.024 . . . . 64.42 110.31 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.14 155.74 30.23 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 111.724 -0.551 . . . . 73.11 111.724 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.508 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -151.51 122.3 1.33 Allowed Glycine 0 C--N 1.329 0.164 0 N-CA-C 111.703 -0.559 . . . . 62.41 111.703 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.9 mt -81.17 117.63 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.941 0.896 . . . . 71.23 108.665 171.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.695 ' HB3' HD11 ' A' ' 86' ' ' ILE . 90.8 m-85 -124.27 122.26 37.26 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.489 1.116 . . . . 62.34 109.491 -177.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.1 t -91.77 105.39 17.68 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.239 -0.652 . . . . 75.11 109.239 173.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.695 HD11 ' HB3' ' A' ' 84' ' ' PHE . 1.9 mm -112.38 153.78 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.489 0.715 . . . . 72.5 109.43 -177.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.426 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -158.23 160.61 37.31 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.557 0.743 . . . . 73.24 111.235 177.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.1 -7.62 64.58 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 119.184 -0.787 . . . . 73.44 113.928 174.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.06 153.37 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 124.056 0.942 . . . . 73.55 111.695 -178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -141.84 178.25 7.63 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.01 1.724 . . . . 63.55 108.625 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.47 -139.78 29.62 Favored Glycine 0 C--N 1.349 1.26 0 N-CA-C 114.063 0.385 . . . . 73.43 114.063 173.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.2 t -72.4 -19.38 61.61 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.258 0.623 . . . . 64.44 111.439 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -70.78 -43.82 67.94 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.992 0.917 . . . . 72.21 109.576 173.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.8 tpt -63.82 -42.31 97.69 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.085 -0.961 . . . . 72.12 109.849 174.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.3 -33.75 76.2 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.449 -0.796 . . . . 62.41 111.344 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.463 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 53.0 t-80 -71.1 -27.02 63.3 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.169 0.588 . . . . 61.21 111.193 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -78.6 -52.79 7.95 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.823 -0.436 . . . . 72.3 109.823 175.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 48' ' ' SER . 89.6 mt -72.98 -35.24 66.84 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.789 0.835 . . . . 55.31 112.773 -171.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.08 4.0 60.55 Favored Glycine 0 N--CA 1.469 0.842 0 CA-C-N 115.97 -0.559 . . . . 64.31 113.674 -172.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.561 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -146.51 -58.45 0.29 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 117.31 0.555 . . . . 53.42 112.19 -173.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.409 ' O ' HG12 ' A' ' 105' ' ' ILE . 41.6 t80 -71.83 -42.28 67.15 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.046 0.451 . . . . 74.04 110.742 -176.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 63.7 m -67.63 -49.43 40.03 Favored Pre-proline 0 CA--C 1.565 1.552 0 C-N-CA 124.733 1.213 . . . . 74.01 112.852 -175.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.407 ' HA ' HD12 ' A' ' 106' ' ' LEU . 47.5 Cg_endo -65.79 -24.85 53.86 Favored 'Trans proline' 0 C--N 1.395 2.982 0 C-N-CA 122.035 1.823 . . . . 74.01 112.437 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -64.91 -37.14 86.64 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.457 0.703 . . . . 74.52 110.476 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.517 HG21 ' CD1' ' A' ' 13' ' ' ILE . 49.5 mm -69.02 -40.73 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.544 0.737 . . . . 72.23 110.407 174.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.508 HD21 ' HA3' ' A' ' 82' ' ' GLY . 48.3 mt -72.74 -25.18 61.11 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.475 -0.784 . . . . 62.1 112.123 -175.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -61.68 -45.09 93.15 Favored Pre-proline 0 N--CA 1.487 1.394 0 N-CA-C 113.768 1.025 . . . . 65.33 113.768 -172.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -52.05 -37.34 68.16 Favored 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 122.51 2.14 . . . . 75.53 113.876 170.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -84.09 -29.11 27.06 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.51 0.724 . . . . 74.32 112.001 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.76 -45.19 75.61 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.554 -0.906 . . . . 75.4 108.554 172.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.558 ' NH1' HD12 ' C' ' 105' ' ' ILE . 36.5 ttm180 -59.9 -40.81 90.06 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.071 -1.422 . . . . 74.31 110.515 174.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' C' ' 108' ' ' PRO . 25.7 tt0 -51.21 -54.53 24.77 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.623 1.169 . . . . 74.43 110.813 177.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 117' ' ' MET . 48.9 t -66.17 -47.21 74.72 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.435 -1.257 . . . . 64.12 111.437 -176.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 118' ' ' VAL . 92.1 mt -58.69 -59.14 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 124.173 0.989 . . . . 73.22 110.953 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.1 m -56.82 -38.55 72.77 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.359 1.064 . . . . 74.1 111.575 -177.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.1 t -63.35 -48.82 76.39 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.892 -1.049 . . . . 61.22 110.817 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.628 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 41.2 mtm -61.46 -40.25 93.83 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.816 0.697 . . . . 71.23 111.253 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 126' ' ' LEU . 82.5 t -56.77 -49.97 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 O-C-N 124.252 0.97 . . . . 54.51 110.813 175.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.6 t -68.17 -33.51 74.59 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.234 -0.893 . . . . 65.24 111.165 -177.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.55 HH12 ' HG3' ' B' ' 112' ' ' GLU . 81.8 mtt-85 -72.61 -29.43 63.48 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.537 0.735 . . . . 73.34 110.172 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.452 ' O ' HG22 ' A' ' 122' ' ' THR . . . -86.17 16.41 43.54 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-O 118.812 -0.993 . . . . 73.02 113.375 175.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.475 HG21 ' HE ' ' B' ' 15' ' ' ARG . 3.0 t 60.47 11.65 3.09 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 126.781 2.033 . . . . 74.41 113.66 176.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -81.88 156.66 69.86 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.708 0.803 . . . . 75.44 109.911 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.21 129.29 29.41 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.503 2.136 . . . . 71.31 111.33 175.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -49.05 121.68 5.06 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 125.116 1.51 . . . . 73.43 112.213 -173.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.679 HD11 HG11 ' A' ' 40' ' ' VAL . 56.5 tp -108.78 102.11 11.18 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.922 -0.581 . . . . 72.41 109.662 -174.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -98.85 121.87 41.35 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.594 -1.262 . . . . 64.03 107.594 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 11.2 mt -72.02 129.88 39.61 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 110.082 -0.34 . . . . 74.35 110.082 -177.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -64.91 141.36 98.35 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 116.046 -0.524 . . . . 74.22 110.771 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.613 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 49.2 Cg_exo -57.7 128.74 30.37 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.284 2.656 . . . . 75.34 113.558 -176.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 85.8 t -120.58 132.3 70.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 C-N-CA 123.942 0.897 . . . . 64.45 109.824 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -96.43 95.48 8.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.752 0.821 . . . . 63.13 108.871 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -62.57 -21.09 65.33 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.941 0.897 . . . . 65.43 112.576 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.561 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 11.7 t70 -56.96 -51.03 70.81 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.55 0.74 . . . . 65.13 110.045 170.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.7 -40.49 95.22 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 124.106 0.879 . . . . 74.32 111.326 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.92 -32.07 73.47 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.463 -0.79 . . . . 73.24 111.248 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 62.6 t80 . . . . . 0 N--CA 1.469 0.522 0 CA-C-N 115.737 -0.665 . . . . 74.33 110.413 176.409 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.578 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 0.5 OUTLIER . . . . . 0 CA--C 1.563 1.461 0 CA-C-O 121.232 0.539 . . . . 74.22 112.026 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.494 ' N ' ' SD ' ' B' ' 9' ' ' MET . 78.8 m -153.22 105.93 2.93 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.181 0.992 . . . . 74.42 108.746 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -109.72 139.46 44.73 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.413 -0.958 . . . . 73.52 108.413 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -149.89 141.24 23.26 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.699 0.8 . . . . 73.12 109.272 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 19.0 mt -94.6 124.98 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 107.545 -1.28 . . . . 60.43 107.545 171.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -87.53 -48.95 7.52 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.827 -0.434 . . . . 73.03 109.827 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.475 ' HE ' HG21 ' A' ' 122' ' ' THR . 48.2 ttt180 -166.45 136.35 3.2 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.609 0.568 . . . . 62.52 109.991 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 97.7 mt -115.25 135.64 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 107.602 -1.259 . . . . 63.13 107.602 174.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -163.18 143.88 9.31 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 112.767 0.654 . . . . 60.35 112.767 -174.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 56.0 m -73.79 120.8 19.88 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.617 -1.174 . . . . 65.11 108.918 170.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.552 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.2 mtpt -98.53 -18.9 17.93 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.113 0.965 . . . . 73.31 111.897 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -166.02 144.31 5.74 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.608 0.567 . . . . 64.23 110.824 -174.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.453 ' HB ' ' H ' ' A' ' 23' ' ' PHE . 45.6 mm -139.19 140.9 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.277 1.431 . . . . 70.12 108.745 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.5 t -142.71 125.8 16.34 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.649 1.18 . . . . 62.23 108.303 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.518 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 78.1 t80 -140.35 121.27 14.54 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.573 -1.269 . . . . 74.32 107.573 169.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -130.25 121.13 25.58 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.522 -0.918 . . . . 54.32 108.522 175.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.683 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -105.46 89.31 3.2 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 106.259 -1.756 . . . . 61.14 106.259 168.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -59.43 -36.72 93.06 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.86 2.374 . . . . 62.01 111.975 -171.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -106.47 16.54 24.54 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 118.06 -0.972 . . . . 74.3 111.611 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.683 ' HB2' ' HB3' ' B' ' 25' ' ' ALA . . . -30.73 -62.12 0.24 Allowed Pre-proline 0 N--CA 1.502 2.128 0 N-CA-C 115.117 1.525 . . . . 53.31 115.117 -171.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 17.4 Cg_exo -59.5 -41.39 57.73 Favored 'Trans proline' 0 C--N 1.399 3.19 0 C-N-CA 121.951 1.767 . . . . 63.15 112.686 -173.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -96.78 -19.35 18.98 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.079 -0.964 . . . . 72.11 113.296 -169.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.543 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.6 p -74.96 -12.93 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-O 121.155 0.502 . . . . 75.03 110.735 -176.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -77.44 -5.93 51.64 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.296 0.85 . . . . 74.23 113.296 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -68.31 -21.52 64.76 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.867 0.467 . . . . 75.45 110.433 169.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -94.33 87.1 5.09 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.254 1.021 . . . . 74.04 110.533 -175.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -86.54 90.97 8.41 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.522 -0.763 . . . . 75.31 110.346 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 34.8 p90 -173.98 -172.05 0.69 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.474 1.11 . . . . 72.44 109.3 171.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -80.15 117.61 68.38 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.101 0.561 . . . . 75.32 111.099 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.525 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 19.3 Cg_endo -64.73 147.4 89.77 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 121.74 1.627 . . . . 74.11 110.496 173.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.18 102.68 0.86 Allowed 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.728 -0.841 . . . . 73.11 108.728 174.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.68 HG11 HD11 ' B' ' 126' ' ' LEU . 41.8 t -99.86 145.86 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.213 -0.903 . . . . 54.21 109.875 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -140.06 127.35 21.23 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.69 1.196 . . . . 73.33 107.853 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.541 HD13 HD22 ' B' ' 128' ' ' LEU . 25.6 tp -86.4 145.29 26.92 Favored 'General case' 0 C--O 1.244 0.811 0 O-C-N 123.81 0.694 . . . . 73.0 109.211 173.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.558 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 11.4 t70 -143.95 150.07 37.76 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.992 -1.114 . . . . 61.0 107.992 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.4 HD11 HG11 ' B' ' 131' ' ' VAL . 72.5 mt -126.9 139.89 52.74 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.635 0.774 . . . . 61.21 109.458 -175.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 29.5 t70 -132.11 151.15 51.93 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.07 0.948 . . . . 60.12 109.072 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.7 m -124.61 111.97 16.26 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.151 0.58 . . . . 71.24 110.574 -166.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.63 117.48 7.66 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 109.379 -0.6 . . . . 72.12 109.379 174.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 48.1 p -143.89 170.87 15.08 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.063 0.545 . . . . 60.4 110.08 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 64.8 p -152.04 142.55 22.66 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.422 0.289 . . . . 54.12 111.62 -173.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -96.86 94.33 7.18 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.984 -0.747 . . . . 71.3 108.984 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 pp -110.13 24.43 13.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.008 0.523 . . . . 64.44 110.611 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.469 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -164.87 172.04 13.38 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 123.717 0.807 . . . . 41.21 111.153 172.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -97.15 124.73 41.28 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 107.922 -1.14 . . . . 40.23 107.922 172.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 66.02 4.72 3.16 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 124.362 1.065 . . . . 75.4 112.917 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 44.9 t -133.73 126.47 51.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.447 0 N-CA-C 107.041 -1.466 . . . . 55.51 107.041 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -132.7 141.19 48.46 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.794 -0.447 . . . . 74.31 109.794 -168.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -106.03 105.84 16.07 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.75 -1.204 . . . . 73.02 107.75 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 38.1 t -100.54 129.53 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.431 1.093 . . . . 53.54 109.54 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 t -118.26 114.59 45.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.629 -0.878 . . . . 70.15 108.629 173.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -100.71 108.58 20.48 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.72 -1.215 . . . . 71.34 107.72 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.417 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 31.5 ttm180 -85.98 119.7 26.57 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.288 -1.004 . . . . 70.11 108.288 173.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 31.4 t -105.18 123.94 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.92 -1.141 . . . . 75.32 107.92 175.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.558 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 45.2 m -111.02 136.78 49.51 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.89 -0.781 . . . . 73.43 108.89 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.677 HG11 HD21 ' B' ' 126' ' ' LEU . 59.4 t -129.44 114.87 32.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 124.054 0.942 . . . . 75.45 108.58 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 32.7 m -100.89 135.36 42.47 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.521 -0.918 . . . . 74.53 108.521 170.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.36 141.93 30.04 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.21 -0.663 . . . . 55.13 109.21 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.536 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 55.2 p -142.52 127.8 18.75 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 123.921 0.763 . . . . 63.23 111.324 -175.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 17.5 mt -92.93 111.79 23.52 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.056 0.943 . . . . 74.52 108.61 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.75 -123.51 19.22 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 124.054 0.846 . . . . 63.0 112.214 -175.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -97.41 3.23 51.0 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.311 0.644 . . . . 74.32 112.241 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -128.72 158.36 38.82 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.519 0.728 . . . . 72.21 110.063 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 41.8 m -70.02 135.33 49.21 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.03 0.532 . . . . 63.01 111.041 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.543 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -87.03 -62.26 1.54 Allowed 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.78 -1.192 . . . . 73.41 107.78 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -152.23 157.04 40.88 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.161 -1.382 . . . . 73.22 110.166 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 85.5 mt -127.73 110.48 12.68 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.216 -1.772 . . . . 61.21 106.216 173.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.469 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 36.7 t -119.98 137.41 54.09 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.686 -0.857 . . . . 61.22 108.686 -177.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -153.96 136.58 15.17 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.819 -0.808 . . . . 74.12 108.819 -173.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.421 HG21 ' HB3' ' B' ' 113' ' ' CYS . 91.1 t -133.6 148.31 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.291 -1.003 . . . . 72.51 108.291 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -121.42 100.52 7.07 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 108.186 -1.042 . . . . 73.42 108.186 172.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.432 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 8.0 tp-100 -93.29 104.18 16.37 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.53 -0.915 . . . . 72.42 108.53 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.552 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -93.43 163.56 26.36 Favored Glycine 0 C--O 1.24 0.49 0 CA-C-N 115.496 -0.775 . . . . 52.32 111.681 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.13 132.67 2.67 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.617 -0.325 . . . . 74.1 112.555 -176.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 45.0 mt -91.82 123.01 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 N-CA-C 107.745 -1.205 . . . . 64.34 107.745 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -129.82 135.56 48.55 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.736 0.814 . . . . 75.34 109.935 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 58.7 m -100.42 128.25 46.53 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.76 0.824 . . . . 35.12 109.71 174.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.447 ' HB ' HD11 ' B' ' 89' ' ' ILE . 1.4 pp -140.77 135.31 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 124.582 1.153 . . . . 73.34 111.029 -173.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.13 168.0 26.7 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.203 1.001 . . . . 70.24 109.557 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 91.36 -36.05 3.75 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 116.242 -0.435 . . . . 74.34 112.874 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.599 ' HB ' ' HA ' ' B' ' 94' ' ' MET . 9.0 pt -66.67 149.46 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.275 1.43 . . . . 74.24 111.81 175.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -147.45 162.02 39.88 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 124.351 1.06 . . . . 71.53 110.114 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.49 -136.04 27.66 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-N 114.432 -1.258 . . . . 72.41 113.985 175.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.9 m -66.04 -48.54 70.74 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.78 0.832 . . . . 61.3 109.759 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -60.25 -25.6 65.81 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 113.882 -1.508 . . . . 73.3 112.059 -171.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.599 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 2.0 tmt? -59.78 -69.97 0.19 Allowed 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.349 1.06 . . . . 65.42 112.163 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 95' ' ' ALA . . . . . 0.442 ' HB2' ' SD ' ' B' ' 94' ' ' MET . . . -80.38 -13.57 59.04 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 122.374 0.27 . . . . 61.14 111.584 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.89 -44.74 78.49 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.21 0.604 . . . . 70.03 109.591 167.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 44.4 t -57.46 -29.09 63.93 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.814 0.845 . . . . 53.55 111.965 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 71.6 mt -72.1 -40.06 68.45 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.991 0.916 . . . . 73.2 111.494 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.39 4.08 54.48 Favored Glycine 0 C--N 1.341 0.812 0 CA-C-N 116.068 -0.515 . . . . 74.33 113.768 -176.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.3 -65.4 0.98 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.385 0.674 . . . . 40.44 111.218 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -74.52 -45.13 47.78 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.955 -0.566 . . . . 74.33 111.354 -172.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.448 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 79.2 m -62.66 -47.46 87.94 Favored Pre-proline 0 CA--C 1.57 1.729 0 CA-C-O 118.519 -0.753 . . . . 74.43 112.228 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.448 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 76.1 Cg_exo -57.21 -33.37 95.84 Favored 'Trans proline' 0 C--N 1.398 3.172 0 C-N-CA 122.935 2.423 . . . . 72.32 113.705 171.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -67.47 -31.01 70.87 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.225 0.61 . . . . 72.13 111.243 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.0 mt -71.62 -40.18 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.596 0.758 . . . . 71.32 110.036 173.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 83.9 mt -77.46 -30.46 53.25 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.318 -0.855 . . . . 63.11 112.023 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -58.11 -44.67 99.48 Favored Pre-proline 0 CA--C 1.561 1.374 0 C-N-CA 124.394 1.078 . . . . 74.35 113.333 -172.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -50.21 -46.73 27.2 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 122.863 2.375 . . . . 52.24 114.491 173.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -65.78 -40.73 92.28 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.202 0.601 . . . . 52.32 110.796 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.432 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -66.07 -40.65 91.06 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.159 -0.928 . . . . 70.12 111.139 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -61.22 -51.54 68.54 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.117 1.367 . . . . 73.34 110.231 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.55 ' HG3' HH12 ' A' ' 120' ' ' ARG . 9.2 tp10 -61.8 -39.0 90.18 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.249 1.02 . . . . 72.11 110.396 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.521 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.1 t -68.72 -32.87 72.97 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.067 0.147 . . . . 55.41 110.764 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.469 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 50.9 mt -66.81 -53.02 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.832 0.853 . . . . 74.44 110.025 173.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.483 HG21 ' OG ' ' C' ' 119' ' ' SER . 15.3 m -59.31 -30.91 68.69 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.794 0.684 . . . . 41.33 111.027 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.497 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.1 t -64.31 -50.19 68.8 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.068 0.947 . . . . 74.2 110.174 175.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.547 ' SD ' HG21 ' A' ' 21' ' ' ILE . 33.5 mmt -62.9 -40.34 97.26 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.933 0.493 . . . . 72.24 110.889 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.41 HG23 ' O ' ' B' ' 114' ' ' ILE . 88.0 t -65.17 -39.67 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.728 1.211 . . . . 62.12 110.786 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 36.1 t -65.89 -36.19 82.73 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.156 -0.929 . . . . 70.22 111.032 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.497 ' HG3' ' O ' ' B' ' 116' ' ' SER . 71.3 mtt-85 -70.46 -37.86 74.37 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 115.646 -0.706 . . . . 72.51 109.945 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.77 -13.65 69.22 Favored Glycine 0 C--N 1.357 1.737 0 O-C-N 123.651 0.594 . . . . 73.44 112.765 171.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 13.4 m 67.35 32.26 5.98 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.644 1.578 . . . . 72.21 110.218 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -81.06 167.95 28.48 Favored Pre-proline 0 CA--C 1.558 1.252 0 CA-C-N 114.631 -1.168 . . . . 72.13 110.0 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -60.18 168.78 5.7 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 122.792 2.328 . . . . 70.51 113.519 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.605 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 59.9 tp60 -64.8 112.63 3.33 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 114.895 -1.048 . . . . 72.14 110.666 -174.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.68 HD11 HG11 ' B' ' 40' ' ' VAL . 23.5 tp -111.23 111.33 22.32 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 123.689 0.618 . . . . 74.42 109.353 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -123.47 134.08 53.96 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 107.895 -1.15 . . . . 72.11 107.895 170.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.541 HD22 HD13 ' B' ' 42' ' ' LEU . 74.7 mt -85.86 149.26 25.36 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 122.656 0.383 . . . . 74.51 111.251 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 129' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -67.02 138.38 94.98 Favored Pre-proline 0 CA--C 1.55 0.954 0 O-C-N 124.447 1.092 . . . . 54.01 110.343 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' B' ' 129' ' ' ALA . 11.5 Cg_exo -68.19 99.37 0.58 Allowed 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.774 2.316 . . . . 72.3 111.122 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.4 HG11 HD11 ' B' ' 44' ' ' LEU . 60.8 t -89.2 110.54 21.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.188 -1.042 . . . . 65.03 108.188 176.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 . . . . . 0 C--O 1.243 0.721 0 N-CA-C 108.389 -0.967 . . . . 75.25 108.389 174.914 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.613 ' HD2' ' HG2' ' A' ' 130' ' ' PRO . 37.1 t80 . . . . . 0 C--O 1.239 0.505 0 N-CA-C 108.212 -1.033 . . . . 71.13 108.212 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -150.73 121.05 7.31 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.431 -0.951 . . . . 75.3 108.431 177.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.422 ' CD1' HG21 ' C' ' 105' ' ' ILE . 30.2 mt -67.79 127.6 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 123.963 0.789 . . . . 72.13 108.905 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -93.69 -37.75 11.67 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 123.506 0.504 . . . . 74.43 109.902 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 178.45 155.54 0.41 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.038 1.335 . . . . 72.33 109.134 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.434 ' HA ' ' HA2' ' C' ' 82' ' ' GLY . 2.8 pp -127.5 152.97 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 107.656 -1.239 . . . . 73.3 107.656 171.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.536 ' HE1' HG12 ' C' ' 83' ' ' ILE . 31.4 p90 -170.36 144.74 2.56 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 110.135 -0.32 . . . . 62.24 110.135 -174.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 66.2 p -73.08 111.77 8.5 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.976 0.51 . . . . 73.45 109.899 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.716 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 11.2 mmmm -66.91 -37.06 83.65 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.899 -0.778 . . . . 65.15 108.899 170.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.6 t70 -148.33 145.42 28.12 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.4 -1.273 . . . . 73.24 110.192 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.533 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.1 mt -136.89 144.15 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.722 1.609 . . . . 75.5 106.785 172.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.4 t -155.6 148.66 24.53 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.994 0.426 . . . . 55.51 110.337 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -151.4 127.72 10.61 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 107.255 -1.387 . . . . 63.01 107.255 173.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -135.49 112.24 10.12 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.065 0.546 . . . . 71.03 110.08 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.61 82.69 20.26 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 106.753 -1.573 . . . . 72.21 106.753 161.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.87 -25.94 32.43 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 122.626 2.217 . . . . 53.41 111.601 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -96.03 23.99 5.97 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.657 1.183 . . . . 72.22 109.618 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.2 -58.4 4.99 Favored Pre-proline 0 C--N 1.374 1.634 0 C-N-CA 124.999 1.32 . . . . 65.55 114.539 -163.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -61.57 -42.64 31.74 Favored 'Trans proline' 0 C--N 1.386 2.532 0 CA-C-N 121.362 1.522 . . . . 71.2 111.856 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -69.92 -34.39 73.41 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 114.89 -1.05 . . . . 75.25 112.541 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.553 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.9 p -79.98 -27.67 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.189 0.441 . . . . 74.15 112.189 -175.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -67.88 -34.06 75.93 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.011 0.434 . . . . 72.52 111.197 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -87.31 6.71 32.12 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.852 0.861 . . . . 73.02 111.743 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -85.99 154.93 21.1 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.579 0.752 . . . . 74.54 111.199 -175.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -60.8 115.85 3.99 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.286 1.034 . . . . 61.12 109.929 172.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -84.36 82.79 8.23 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.984 0.914 . . . . 73.43 110.787 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -133.82 78.91 59.52 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 107.398 -1.334 . . . . 44.42 107.398 168.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -92.7 135.24 1.3 Allowed 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 123.243 2.629 . . . . 70.21 113.351 -175.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 39' ' ' GLU . . . . . 0.405 ' HB3' ' HE3' ' C' ' 41' ' ' LYS . 4.4 mp0 -85.64 96.89 9.82 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.981 -1.489 . . . . 72.32 106.981 169.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' C' ' 65' ' ' THR . 94.3 t -90.48 106.38 17.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 115.71 -0.677 . . . . 74.12 110.316 -175.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' C' ' 39' ' ' GLU . 0.2 OUTLIER -95.08 105.04 16.93 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.172 -1.047 . . . . 62.42 108.172 173.039 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.501 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.5 pt? -86.47 124.11 32.43 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 107.344 -1.354 . . . . 72.12 107.344 171.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.426 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 21.5 t70 -118.01 140.84 49.16 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.846 -0.798 . . . . 73.2 108.846 -176.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.643 HD11 HG11 ' C' ' 131' ' ' VAL . 51.2 mt -127.38 113.32 16.08 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.02 0.928 . . . . 74.01 109.489 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -122.48 121.3 36.24 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.266 -1.383 . . . . 64.21 107.266 174.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 6.5 t -117.17 137.03 52.6 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.058 0.456 . . . . 72.2 111.013 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.99 157.87 25.06 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.146 0.978 . . . . 71.22 108.769 175.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 60.2 p -158.58 146.35 18.07 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.14 0.576 . . . . 54.01 109.978 177.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.1 p -156.07 160.29 39.85 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.012 0.925 . . . . 72.33 109.214 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -99.59 120.08 39.1 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.569 -0.901 . . . . 65.44 108.569 172.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' C' ' 57' ' ' GLU . 33.6 mt -84.42 -50.8 7.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.645 0.778 . . . . 70.41 109.809 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.58 -168.25 2.86 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.845 -1.071 . . . . 71.22 109.73 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.66 118.56 9.73 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.886 -0.597 . . . . 60.32 109.904 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 68.06 -4.91 0.94 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.995 1.318 . . . . 65.21 112.109 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.0 t -99.58 116.82 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 123.741 0.816 . . . . 73.43 109.199 -174.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -124.36 129.49 50.81 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.836 1.254 . . . . 72.22 108.7 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.577 ' HB2' HD11 ' C' ' 51' ' ' LEU . 42.0 tt0 -89.72 137.1 32.62 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 108.522 -0.918 . . . . 61.4 108.522 167.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 82.2 t -123.85 140.85 46.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 108.08 -1.082 . . . . 64.41 108.08 167.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.467 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 85.3 t -122.03 146.41 27.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 108.759 -0.83 . . . . 63.55 108.759 172.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.58 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -128.76 99.8 5.47 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.91 -1.515 . . . . 73.11 106.91 177.078 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 33.3 ttm-85 -80.85 105.54 12.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.799 -1.091 . . . . 71.43 108.322 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 26.1 t -106.08 121.16 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 108.432 -0.951 . . . . 71.55 108.432 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 14.2 m -120.15 110.46 16.65 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.678 -0.86 . . . . 61.02 108.678 -174.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.549 HG21 HG21 ' C' ' 114' ' ' ILE . 47.6 t -98.16 109.5 23.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.95 -0.759 . . . . 54.23 108.95 177.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' C' ' 40' ' ' VAL . 32.1 m -96.5 131.73 42.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.596 -1.261 . . . . 73.15 107.596 171.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.54 118.23 19.85 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.344 -1.724 . . . . 71.23 106.344 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 29.9 m -133.25 125.74 29.99 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.089 0.243 . . . . 44.45 110.838 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 16.5 mt -87.45 49.3 1.79 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.395 1.478 . . . . 64.24 109.723 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.82 -115.35 5.16 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 110.533 -1.027 . . . . 42.53 110.533 -170.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -90.22 -28.37 18.9 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.796 0.838 . . . . 71.14 110.124 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -63.68 122.09 15.52 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.804 1.242 . . . . 63.52 109.491 171.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.2 m -77.78 122.87 25.99 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.726 -0.842 . . . . 73.32 108.726 168.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.553 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -65.72 -59.39 3.96 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.307 -0.997 . . . . 62.33 108.307 171.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -165.39 164.37 19.69 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.908 -1.042 . . . . 63.32 110.658 174.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.424 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.7 tm? -120.51 141.01 50.62 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 106.354 -1.721 . . . . 61.22 106.354 166.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.436 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.6 t -146.95 110.06 4.76 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.79 -0.819 . . . . 74.13 108.79 177.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -117.44 119.74 36.01 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.08 -0.711 . . . . 75.43 109.08 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 55.1 t -117.08 114.17 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.78 -0.822 . . . . 73.41 108.78 173.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.409 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 78.2 mt-30 -90.06 87.22 6.81 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.185 -1.043 . . . . 74.3 108.185 173.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -78.42 104.48 9.05 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 115.693 -0.685 . . . . 44.2 109.325 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -83.48 179.3 52.53 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-N 116.613 -0.267 . . . . 43.25 112.717 172.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' C' ' 16' ' ' ILE . . . -178.73 136.81 3.01 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-O 119.945 -0.364 . . . . 61.44 112.719 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.536 HG12 ' HE1' ' C' ' 17' ' ' TYR . 36.6 mm -96.34 133.46 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 108.829 -0.804 . . . . 64.1 108.829 174.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -135.33 131.99 37.12 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.854 0.861 . . . . 62.42 110.308 -176.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 24.6 p -85.27 99.59 11.22 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.094 -1.076 . . . . 74.53 108.094 166.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.668 HG21 ' HE1' ' C' ' 94' ' ' MET . 11.7 mt -114.57 140.41 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.138 -1.06 . . . . 74.34 108.138 177.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.42 162.62 38.99 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 122.415 0.286 . . . . 74.05 111.245 -174.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.26 -35.88 3.5 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 115.917 -0.583 . . . . 31.44 113.279 172.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' C' ' 94' ' ' MET . 36.1 pt -88.04 165.23 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.713 0.805 . . . . 73.3 112.059 -175.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -162.24 151.73 15.94 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.941 0.896 . . . . 63.24 109.874 -177.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.98 -119.39 9.64 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 115.344 -0.844 . . . . 61.51 112.794 172.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 68.9 p -62.15 -38.16 87.95 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.004 0.922 . . . . 74.51 111.307 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -65.22 -52.75 52.7 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.829 0.852 . . . . 63.32 111.22 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.668 ' HE1' HG21 ' C' ' 86' ' ' ILE . 6.1 tpt -53.03 -52.9 56.95 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 124.074 0.859 . . . . 73.02 111.722 176.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.55 -35.4 80.73 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.186 0.595 . . . . 71.43 112.15 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -68.13 -35.48 78.17 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.437 0.695 . . . . 73.05 110.708 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -71.82 -37.17 70.38 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.495 -0.775 . . . . 53.35 110.433 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 83.8 mt -83.59 -33.7 25.31 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.999 0.92 . . . . 44.02 112.431 -175.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -113.14 11.09 24.54 Favored Glycine 0 N--CA 1.472 1.082 0 O-C-N 123.333 0.396 . . . . 40.43 113.803 -169.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.65 -54.29 0.19 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.77 0.428 . . . . 70.44 111.257 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -75.2 -47.73 26.87 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 112.479 0.548 . . . . 71.44 112.479 -172.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.491 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 91.5 m -64.43 -49.32 72.26 Favored Pre-proline 0 CA--C 1.561 1.367 0 C-N-CA 123.499 0.72 . . . . 72.52 110.886 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.58 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 51.2 Cg_exo -57.83 -28.21 81.44 Favored 'Trans proline' 0 C--N 1.396 3.074 0 C-N-CA 122.639 2.226 . . . . 72.11 113.633 174.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -66.06 -34.88 79.08 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.189 0.596 . . . . 71.34 110.916 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.558 HD12 ' NH1' ' A' ' 111' ' ' ARG . 35.7 mm -80.75 -29.98 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 122.556 0.343 . . . . 72.11 110.089 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 mp -75.34 -25.89 58.14 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.715 0.806 . . . . 63.4 111.496 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -58.97 -51.23 83.36 Favored Pre-proline 0 C--O 1.206 -1.225 0 CA-C-O 117.476 -1.25 . . . . 75.32 112.492 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 108' ' ' PRO . . . . . 0.571 ' HB3' ' HB2' ' A' ' 112' ' ' GLU . 65.3 Cg_exo -47.71 -44.47 26.29 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.774 2.316 . . . . 71.1 114.817 176.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -74.2 -40.49 62.44 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.095 0.558 . . . . 74.11 111.606 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.28 -42.35 93.28 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.268 0.627 . . . . 61.45 110.153 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 111' ' ' ARG . . . . . 0.616 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 31.6 ttt-85 -59.89 -52.16 66.6 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.029 1.732 . . . . 72.41 110.447 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.06 -37.7 88.4 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.234 0.959 . . . . 65.22 109.967 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 38.4 t -68.78 -35.66 77.33 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.476 0.485 . . . . 60.31 111.444 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.549 HG21 HG21 ' C' ' 64' ' ' VAL . 90.9 mt -68.65 -49.58 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.283 0.633 . . . . 73.13 110.203 174.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.6 m -66.36 -28.14 68.42 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.21 0.604 . . . . 75.33 110.991 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.426 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 46.2 t -66.45 -43.05 86.64 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.071 0.949 . . . . 54.12 109.041 172.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.564 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -67.76 -34.39 76.71 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.134 0.974 . . . . 72.24 112.089 177.527 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.48 HG23 ' O ' ' C' ' 114' ' ' ILE . 88.2 t -62.6 -43.96 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.619 0.767 . . . . 72.12 108.997 172.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.483 ' OG ' HG21 ' B' ' 115' ' ' THR . 29.4 t -63.88 -39.55 94.45 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.606 -1.179 . . . . 55.33 111.786 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.519 HH12 ' HG2' ' D' ' 112' ' ' GLU . 67.0 mtt-85 -69.95 -38.31 76.09 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.578 0.751 . . . . 72.34 109.942 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.6 -1.04 88.69 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 115.426 -0.806 . . . . 63.25 112.788 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.498 HG21 ' O ' ' D' ' 16' ' ' ILE . 31.5 p 61.72 30.49 18.46 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.43 1.892 . . . . 74.14 113.587 171.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.47 ' HB2' HG13 ' C' ' 118' ' ' VAL . 93.7 m-85 -85.66 151.31 55.35 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 107.871 -1.159 . . . . 64.1 107.871 166.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.605 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 24.5 Cg_endo -63.06 157.94 46.38 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 122.354 2.036 . . . . 64.04 112.721 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 -53.06 112.71 0.91 Allowed 'General case' 0 N--CA 1.477 0.908 0 O-C-N 124.585 1.178 . . . . 75.15 112.891 -172.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 61.0 tp -109.61 87.8 2.59 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 113.924 -1.489 . . . . 74.53 107.512 174.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -92.93 99.91 12.46 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.899 -0.778 . . . . 74.24 108.899 -174.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.616 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 4.0 mm? -56.47 125.05 20.33 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.943 0.897 . . . . 75.33 111.274 -175.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.72 152.4 95.2 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 124.212 1.005 . . . . 74.31 111.4 -175.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.452 ' HG2' HG21 ' A' ' 13' ' ' ILE . 51.2 Cg_exo -54.72 108.26 0.28 Allowed 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.979 2.453 . . . . 74.41 112.926 175.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 131' ' ' VAL . . . . . 0.643 HG11 HD11 ' C' ' 44' ' ' LEU . 6.8 p -101.0 135.55 36.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.599 0.76 . . . . 75.02 109.446 175.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -97.36 101.25 12.76 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.632 0.773 . . . . 72.22 109.359 -174.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 133' ' ' PHE . . . . . 0.451 ' CE1' HD13 ' C' ' 44' ' ' LEU . 66.4 m-85 -68.98 -33.79 74.25 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.63 0.772 . . . . 73.51 111.462 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -59.15 -43.41 92.05 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.92 0.888 . . . . 62.21 109.435 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.88 -41.34 95.81 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 114.691 -1.141 . . . . 54.44 111.805 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 76.4 mt -65.91 -36.05 82.32 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.308 0.643 . . . . 64.32 110.831 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 18.0 t80 . . . . . 0 CA--C 1.554 1.108 0 CA-C-N 115.124 -0.944 . . . . 73.5 109.955 177.051 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 4.6 t . . . . . 0 C--O 1.243 0.724 0 N-CA-C 108.721 -0.844 . . . . 55.24 108.721 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.429 ' HD2' HG22 ' D' ' 86' ' ' ILE . 70.8 t80 -133.75 106.06 7.14 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.085 -1.45 . . . . 71.02 107.085 174.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -124.81 127.15 46.74 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.241 -1.022 . . . . 73.12 108.241 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.6 HG21 HD11 ' D' ' 16' ' ' ILE . 26.9 mt -77.09 116.51 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 109.296 -0.631 . . . . 65.03 109.296 178.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -84.07 -43.92 14.59 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.281 0.632 . . . . 75.0 110.385 -173.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -170.71 142.71 2.03 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.947 0.499 . . . . 72.42 110.362 -176.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.6 HD11 HG21 ' D' ' 13' ' ' ILE . 3.0 mp -115.07 148.48 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 106.872 -1.529 . . . . 72.14 106.872 172.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -169.59 168.33 9.26 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-O 121.54 0.686 . . . . 74.25 111.643 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.6 p -105.09 121.16 43.21 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 114.929 -1.032 . . . . 71.44 109.078 171.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -86.25 -25.28 25.64 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.42 0.688 . . . . 74.23 109.238 176.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.4 t70 -156.74 137.38 13.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.63 -1.168 . . . . 62.42 109.973 -175.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.564 HG21 ' HE2' ' C' ' 117' ' ' MET . 74.1 mt -140.14 141.4 33.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.218 1.407 . . . . 64.44 107.471 173.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.9 t -146.71 143.63 28.86 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.91 0.884 . . . . 54.11 109.116 173.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.533 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 84.5 t80 -146.99 133.64 19.91 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 106.581 -1.637 . . . . 70.04 106.581 172.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 48.0 mt-10 -135.27 141.77 45.79 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.96 0.904 . . . . 65.15 109.382 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.49 77.97 16.77 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 107.796 -1.187 . . . . 63.32 107.796 176.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.69 -19.42 21.31 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.666 2.244 . . . . 63.52 113.195 -173.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -108.45 -0.65 20.4 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.865 0.866 . . . . 71.5 110.707 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.716 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -19.51 -71.7 0.03 OUTLIER Pre-proline 0 CA--C 1.571 1.757 0 N-CA-C 116.908 2.188 . . . . 55.24 116.908 -165.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.431 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 81.4 Cg_endo -74.76 -25.1 12.71 Favored 'Trans proline' 0 C--N 1.385 2.458 0 CA-C-N 124.454 2.626 . . . . 74.44 113.84 -176.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -69.67 -39.68 76.89 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 124.419 1.087 . . . . 75.55 110.07 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.8 p -82.71 -22.53 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 CA-C-N 115.666 -0.697 . . . . 62.24 111.426 -175.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.431 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 22.1 m-85 -64.25 -26.39 68.48 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 122.265 0.226 . . . . 72.5 111.221 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -65.45 -7.08 12.39 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.834 1.253 . . . . 72.43 111.844 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.506 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 91.6 mttt -95.71 103.86 15.76 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.152 1.381 . . . . 63.31 110.095 175.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -95.36 76.32 3.38 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.581 0.752 . . . . 55.21 110.312 -175.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 44.2 p90 -156.75 -177.78 6.86 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.8 -0.815 . . . . 75.15 108.8 168.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -65.08 117.65 41.64 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.532 1.133 . . . . 73.32 110.91 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.438 ' O ' HG23 ' D' ' 40' ' ' VAL . 74.9 Cg_exo -55.49 112.88 1.18 Allowed 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 121.807 1.672 . . . . 75.02 109.457 165.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -70.95 107.41 4.05 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.055 -1.091 . . . . 73.02 108.055 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.656 HG13 HG13 ' D' ' 64' ' ' VAL . 96.0 t -102.45 131.4 50.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 115.122 -0.945 . . . . 43.35 109.913 -170.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -119.45 125.13 48.18 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.715 -1.217 . . . . 74.12 107.715 170.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.555 HD11 HG13 ' D' ' 62' ' ' VAL . 51.9 tp -96.18 141.48 29.5 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.852 -0.795 . . . . 62.45 108.852 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.58 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 35.1 t70 -134.71 113.28 11.51 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.026 -1.101 . . . . 71.31 108.026 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' D' ' 62' ' ' VAL . 93.7 mt -114.49 151.7 32.85 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.295 0.638 . . . . 62.53 110.696 -177.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.542 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 13.5 t0 -152.07 143.44 23.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.19 -0.914 . . . . 72.51 108.656 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 23.9 m -105.34 141.33 37.04 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.073 -0.714 . . . . 64.12 109.073 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.54 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.86 162.5 41.21 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.214 1.006 . . . . 75.13 108.864 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 36.3 p . . . . . 0 C--O 1.243 0.722 0 C-N-CA 123.601 0.76 . . . . 34.51 110.011 175.507 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 112.505 0.557 . . . . 64.43 112.505 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 t -108.82 99.37 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 108.773 -0.825 . . . . 73.4 108.773 -176.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -133.88 129.57 36.6 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.53 -0.915 . . . . 62.11 108.53 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.604 ' HB3' HG13 ' D' ' 83' ' ' ILE . 0.0 OUTLIER -101.66 120.14 39.87 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.835 -1.172 . . . . 71.32 107.835 168.298 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.485 ' O ' ' HA2' ' D' ' 81' ' ' GLY . 79.7 t -101.02 132.9 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-N 114.472 -1.24 . . . . 55.45 109.451 -176.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 36.6 t -106.63 138.81 30.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 124.383 1.073 . . . . 73.31 108.722 178.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.561 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -120.73 118.31 29.72 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.016 -1.475 . . . . 55.11 107.016 173.842 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.542 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 55.3 ttm-85 -88.57 109.35 20.01 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.848 -1.168 . . . . 71.34 107.848 175.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.555 HG13 HD11 ' D' ' 42' ' ' LEU . 38.5 t -114.69 113.23 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.345 -0.613 . . . . 74.13 109.345 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.58 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 24.4 m -119.75 131.96 55.5 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 123.954 0.902 . . . . 71.51 108.978 -172.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.656 HG13 HG13 ' D' ' 40' ' ' VAL . 85.1 t -118.71 104.69 16.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 C-N-CA 123.294 0.638 . . . . 74.42 109.384 177.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 10.1 m -97.98 94.03 6.64 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.26 -1.385 . . . . 75.24 107.26 170.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.02 138.71 48.29 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.015 0.926 . . . . 74.23 108.679 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.546 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 61.1 m -144.55 136.03 25.53 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.346 0.658 . . . . 63.54 111.61 -172.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.509 HD12 HG22 ' D' ' 31' ' ' VAL . 32.1 mt -100.5 106.93 18.51 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.473 1.109 . . . . 71.12 109.061 174.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.17 -126.32 8.65 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-O 119.869 -0.406 . . . . 62.11 112.807 175.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.23 5.3 52.19 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.328 0.651 . . . . 65.12 112.081 -177.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 71' ' ' GLU . . . . . 0.506 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 9.3 pt-20 -133.69 164.55 26.97 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.991 0.516 . . . . 73.34 109.965 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 21.4 m -68.02 143.69 55.44 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.994 0.917 . . . . 74.13 111.766 178.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.551 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -91.75 -69.66 0.73 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.616 -1.624 . . . . 65.23 106.616 173.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -149.22 146.89 27.83 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 114.812 -1.086 . . . . 71.43 110.059 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 82.7 mt -110.36 145.97 36.59 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.015 -1.105 . . . . 75.33 108.015 174.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.454 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 46.6 t -156.49 147.03 21.6 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.469 0.308 . . . . 71.03 110.207 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -156.63 130.52 8.39 Favored 'General case' 0 C--N 1.345 0.373 0 C-N-CA 123.274 0.63 . . . . 52.31 109.724 168.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 78' ' ' VAL . . . . . 0.409 HG22 HG23 ' D' ' 21' ' ' ILE . 92.0 t -129.76 114.45 30.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 C-N-CA 124.512 1.125 . . . . 55.42 108.52 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.486 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.5 mt-30 -90.13 88.24 7.19 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.837 0.827 . . . . 72.15 109.074 173.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.7 107.2 13.31 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 113.688 -1.596 . . . . 63.43 109.912 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' D' ' 58' ' ' VAL . . . -110.85 162.22 12.58 Favored Glycine 0 N--CA 1.465 0.625 0 O-C-N 123.032 0.208 . . . . 63.34 113.397 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.09 148.9 9.15 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-O 119.366 -0.686 . . . . 52.11 112.935 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.604 HG13 ' HB3' ' D' ' 57' ' ' GLU . 3.7 mp -89.1 136.74 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.197 -1.038 . . . . 73.24 108.197 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -132.43 129.42 39.26 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.477 1.111 . . . . 73.13 108.303 176.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 30.2 p -81.53 101.89 10.24 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.043 -0.725 . . . . 74.21 109.043 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.429 HG22 ' HD2' ' D' ' 11' ' ' PHE . 2.3 pp -119.24 121.0 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 120.749 0.309 . . . . 71.21 110.757 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.16 167.93 8.49 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.481 1.112 . . . . 42.45 111.313 174.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.0 19.02 23.0 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 124.046 0.841 . . . . 71.34 112.626 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.609 HD13 ' HB2' ' D' ' 94' ' ' MET . 0.7 OUTLIER -140.18 162.16 24.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 C-N-CA 125.157 1.383 . . . . 72.43 109.461 177.617 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -147.8 -174.05 4.45 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.404 0.682 . . . . 73.11 111.386 -173.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.7 -146.05 29.47 Favored Glycine 0 C--N 1.349 1.255 0 C-N-CA 124.047 0.832 . . . . 61.13 112.242 -172.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 68.0 p -94.32 -39.62 10.39 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.611 0.706 . . . . 42.12 111.027 174.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -65.61 -17.82 64.87 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.363 1.065 . . . . 75.34 113.591 -171.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.609 ' HB2' HD13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -57.04 -30.24 64.08 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.047 0.758 . . . . 54.44 113.047 176.517 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 95' ' ' ALA . . . . . 0.437 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -80.54 -13.97 58.63 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.486 0.714 . . . . 72.32 112.351 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -63.05 -29.83 71.12 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.072 0.549 . . . . 74.54 111.084 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 55.5 m -62.69 -28.3 69.84 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.387 0.675 . . . . 43.3 111.488 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.1 tt -92.41 -46.93 7.43 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.601 1.16 . . . . 51.15 110.063 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.22 -15.09 65.22 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 116.2 -0.455 . . . . 71.41 114.167 -169.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.91 -52.0 1.22 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.91 0.484 . . . . 51.14 110.685 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 101' ' ' TYR . . . . . 0.415 ' O ' HG12 ' D' ' 105' ' ' ILE . 61.8 t80 -73.74 -39.73 64.04 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 112.272 0.471 . . . . 64.53 112.272 -174.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 92.7 m -65.15 -46.97 73.13 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-O 118.542 -0.742 . . . . 72.41 111.638 177.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.561 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 84.2 Cg_exo -54.61 -33.77 80.42 Favored 'Trans proline' 0 C--N 1.393 2.907 0 C-N-CA 122.763 2.309 . . . . 75.43 113.661 167.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.27 -32.66 74.43 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.439 0.696 . . . . 72.31 110.978 177.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.415 HG12 ' O ' ' D' ' 101' ' ' TYR . 51.1 mm -74.33 -38.37 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.284 0.633 . . . . 75.31 110.244 173.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 70.6 mt -73.65 -22.9 59.83 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.521 -0.763 . . . . 63.55 111.709 -175.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -67.55 -42.01 34.18 Favored Pre-proline 0 N--CA 1.484 1.268 0 N-CA-C 113.635 0.976 . . . . 75.23 113.635 -172.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -47.15 -44.11 24.29 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.446 2.097 . . . . 73.33 113.855 167.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -79.36 -28.28 41.97 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.921 0.888 . . . . 74.41 112.252 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 110' ' ' ALA . . . . . 0.505 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -64.48 -47.4 79.11 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.733 0.777 . . . . 74.24 109.451 173.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -69.04 -34.29 74.96 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 113.723 -1.58 . . . . 72.45 110.385 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 112' ' ' GLU . . . . . 0.519 ' HG2' HH12 ' C' ' 120' ' ' ARG . 20.5 tt0 -53.42 -49.73 66.71 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.118 0.967 . . . . 64.32 110.452 175.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.428 ' O ' ' HG3' ' D' ' 117' ' ' MET . 46.1 t -67.69 -54.4 19.8 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.701 -1.136 . . . . 73.41 110.794 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.493 HG21 HG21 ' D' ' 64' ' ' VAL . 52.9 mt -60.28 -58.07 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.365 0.666 . . . . 54.42 111.855 -174.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 91.5 m -51.3 -41.15 60.3 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.102 0.876 . . . . 75.32 111.769 -175.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 47.2 t -66.09 -42.12 89.75 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 114.681 -1.145 . . . . 72.14 110.078 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 66.6 mtm -69.03 -30.53 68.91 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.057 0.543 . . . . 61.43 111.981 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.437 HG23 ' O ' ' D' ' 114' ' ' ILE . 95.7 t -62.97 -47.21 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.682 0.793 . . . . 72.34 109.198 174.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.3 p -74.25 -26.14 60.05 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.405 -0.816 . . . . 73.13 111.206 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' D' ' 116' ' ' SER . 88.6 mtt-85 -69.77 -32.85 71.58 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.464 0.705 . . . . 74.45 109.775 174.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.84 10.95 63.48 Favored Glycine 0 C--N 1.35 1.358 0 O-C-N 123.939 0.774 . . . . 40.31 112.501 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 70.3 p 54.79 27.04 8.32 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 126.095 1.758 . . . . 71.13 113.464 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -88.85 150.93 46.65 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 109.064 -0.717 . . . . 71.34 109.064 170.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -46.99 122.31 6.07 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.081 2.521 . . . . 54.42 113.53 171.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -45.62 123.19 4.1 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.682 1.593 . . . . 75.13 112.174 -175.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.432 ' HB3' HG21 ' D' ' 118' ' ' VAL . 20.6 tp -103.08 109.79 21.48 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.629 -0.878 . . . . 61.03 108.629 -175.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -98.93 86.54 3.5 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 107.679 -1.23 . . . . 63.14 107.679 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 96.5 mt -54.38 115.04 1.88 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.026 0.53 . . . . 63.31 110.351 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.8 135.04 95.73 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 123.693 0.62 . . . . 73.5 110.557 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.62 121.81 10.45 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.545 2.163 . . . . 72.11 111.183 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 p -108.04 137.84 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.205 1.002 . . . . 74.12 108.903 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -78.27 98.4 5.89 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.176 -0.675 . . . . 74.14 109.176 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 . . . . . 0 N--CA 1.475 0.804 0 C-N-CA 124.102 0.961 . . . . 75.31 111.05 -178.432 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.2 m . . . . . 0 CA--C 1.536 0.432 0 N-CA-C 108.929 -0.767 . . . . 72.1 108.929 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -120.38 120.68 36.68 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.295 1.038 . . . . 73.2 108.761 -177.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -140.45 135.33 31.9 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.993 0.517 . . . . 73.41 109.756 173.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.441 ' CD1' HG21 ' A' ' 105' ' ' ILE . 3.6 mt -92.77 115.26 31.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 108.349 -0.982 . . . . 74.13 108.349 173.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.67 -40.25 29.52 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.235 -0.654 . . . . 74.12 109.235 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -176.21 122.93 0.17 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 123.146 0.279 . . . . 62.32 110.706 -171.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 79.4 mt -105.61 136.76 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.833 -0.802 . . . . 51.41 108.833 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.467 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 33.2 p90 -169.76 155.43 5.85 Favored 'General case' 0 C--N 1.346 0.42 0 O-C-N 124.197 0.936 . . . . 71.54 110.704 -173.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -83.28 121.94 27.78 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.513 -0.767 . . . . 74.54 109.475 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.467 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.5 mtpt -84.71 -26.7 27.51 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.71 -0.478 . . . . 73.01 109.71 175.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.598 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 11.0 t70 -153.49 143.44 22.07 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 114.63 -1.168 . . . . 42.32 109.837 -178.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.485 HD13 ' SD ' ' B' ' 117' ' ' MET . 91.5 mt -143.63 142.2 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.498 1.519 . . . . 63.41 107.857 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.9 t -149.97 133.22 16.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.289 0.635 . . . . 74.13 109.839 172.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -125.58 140.44 52.74 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 107.014 -1.476 . . . . 70.43 107.014 169.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -142.01 108.5 5.32 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.586 0.755 . . . . 75.34 109.042 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -106.96 85.65 2.03 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 106.639 -1.615 . . . . 64.33 106.639 165.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.55 -38.79 5.65 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.392 2.061 . . . . 53.12 112.177 -169.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -111.22 31.41 6.1 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.871 0.869 . . . . 63.23 108.867 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.521 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -47.13 -54.72 18.98 Favored Pre-proline 0 N--CA 1.493 1.678 0 CA-C-O 117.693 -1.146 . . . . 61.5 113.72 -173.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -61.25 -28.2 84.5 Favored 'Trans proline' 0 C--N 1.401 3.334 0 C-N-CA 121.888 1.725 . . . . 54.42 112.667 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -90.64 -31.8 16.49 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.741 1.216 . . . . 52.34 112.055 -173.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.647 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.9 p -79.22 -21.4 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 120.875 0.369 . . . . 74.2 111.142 -171.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -73.58 -6.2 45.12 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 115.991 -0.55 . . . . 73.41 111.025 172.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -88.8 -28.98 20.07 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.925 0.89 . . . . 63.33 110.202 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.429 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 14.5 mmmm -77.0 157.58 31.1 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.636 0.774 . . . . 72.14 110.929 -176.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.78 119.37 9.2 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.438 0.695 . . . . 71.31 110.464 174.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.452 ' CE3' HD21 ' A' ' 68' ' ' LEU . 67.2 t-105 -81.6 87.69 6.25 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.49 0.662 . . . . 73.51 111.393 -175.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.533 ' H ' HD22 ' A' ' 68' ' ' LEU . 35.7 tt0 -124.1 82.93 56.25 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 124.652 1.181 . . . . 70.25 107.869 171.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.34 121.17 7.52 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.762 2.308 . . . . 63.24 113.257 -170.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -97.19 89.36 4.75 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.829 -0.804 . . . . 74.21 108.829 172.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.571 HG21 HD13 ' A' ' 126' ' ' LEU . 48.8 t -79.66 111.76 16.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-N 114.846 -1.07 . . . . 73.22 110.109 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -99.03 123.49 43.36 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.076 -0.713 . . . . 74.45 109.076 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 84.6 mt -99.31 108.48 21.02 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.515 0.726 . . . . 62.1 109.665 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.632 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 11.2 m-20 -104.72 106.07 16.41 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.418 -1.327 . . . . 44.43 107.418 170.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.41 HD13 ' CZ ' ' A' ' 133' ' ' PHE . 79.4 mt -106.95 117.31 33.71 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.04 -0.726 . . . . 72.43 109.04 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -122.62 130.77 53.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.882 -1.525 . . . . 60.15 106.882 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.4 HG21 ' HA2' ' A' ' 99' ' ' GLY . 99.9 m -108.35 136.0 48.73 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.69 -0.485 . . . . 70.45 109.69 177.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.38 109.93 6.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.127 0.971 . . . . 50.33 108.966 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 79.2 p -94.96 158.79 15.32 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.97 0.508 . . . . 74.5 109.955 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.0 t -148.74 119.96 7.8 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.519 -0.919 . . . . 51.41 108.519 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -81.88 115.87 21.27 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.365 -0.606 . . . . 72.31 109.365 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.0 mt -80.56 -42.42 22.39 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.532 0.733 . . . . 75.24 110.516 -176.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.67 -179.61 7.57 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.023 0.929 . . . . 74.32 110.139 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -60.73 121.48 12.37 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.673 0.789 . . . . 73.55 109.903 170.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 65.84 -2.56 0.88 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.381 1.472 . . . . 54.22 112.974 -176.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.0 t -104.68 105.1 17.94 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 N-CA-C 108.158 -1.053 . . . . 70.12 108.158 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -107.64 162.66 13.77 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.562 -0.903 . . . . 53.1 108.562 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -131.77 153.3 50.24 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 107.444 -1.317 . . . . 72.13 107.444 168.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.452 HG11 ' HD3' ' A' ' 103' ' ' PRO . 68.0 t -133.48 136.41 54.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 107.513 -1.291 . . . . 64.4 107.513 173.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.452 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 47.9 t -119.82 133.58 66.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.831 -0.803 . . . . 75.41 108.831 174.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.417 HD22 HG22 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -104.01 100.07 9.84 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 106.564 -1.643 . . . . 63.21 106.564 177.012 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -82.97 99.21 9.66 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.867 -1.16 . . . . 72.14 107.867 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.461 HG21 ' HB1' ' A' ' 110' ' ' ALA . 47.2 t -98.96 130.57 47.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 N-CA-C 108.353 -0.98 . . . . 73.24 108.353 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.632 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 9.3 m -127.36 107.76 10.25 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.731 -0.84 . . . . 75.14 108.731 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.57 HG11 HD21 ' A' ' 126' ' ' LEU . 54.1 t -101.24 128.23 53.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 124.547 1.139 . . . . 74.24 108.275 174.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.8 m -131.44 116.89 18.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.816 -0.809 . . . . 55.51 108.816 172.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.53 119.43 39.15 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.61 -1.256 . . . . 52.41 107.61 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -127.7 142.31 51.36 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.515 0.674 . . . . 74.42 110.597 -177.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.533 HD22 ' H ' ' A' ' 37' ' ' GLN . 50.4 mt -91.18 61.19 4.45 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.262 1.425 . . . . 72.14 107.927 170.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.2 -98.28 1.47 Allowed Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.198 -0.91 . . . . 60.03 112.684 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -88.35 -29.6 20.18 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.128 0.971 . . . . 73.11 110.287 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.429 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 5.1 tp10 -85.88 101.17 12.62 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.149 -0.932 . . . . 72.14 108.954 -174.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.4 m -68.16 124.27 22.98 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 119.291 0.951 . . . . 75.13 108.559 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.647 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -79.81 -54.52 5.76 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.17 -0.923 . . . . 74.3 108.853 -177.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.437 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 54.5 p90 -155.34 162.23 40.88 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.276 -0.874 . . . . 71.4 111.527 176.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 64' ' ' VAL . 45.0 tp -131.14 118.44 20.49 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 113.765 -1.561 . . . . 63.43 107.498 175.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.437 ' HG ' ' HD1' ' A' ' 74' ' ' PHE . 85.3 m -115.3 126.89 55.02 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.595 -0.891 . . . . 74.31 108.595 175.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -139.18 115.77 10.65 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.32 -0.622 . . . . 72.21 109.32 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.4 t -125.64 112.35 30.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.42 1.088 . . . . 71.14 109.047 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.598 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 19.2 mt-30 -84.62 84.89 7.52 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.505 -0.924 . . . . 74.21 108.505 169.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -76.7 96.85 4.3 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 114.681 -1.145 . . . . 72.51 108.941 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -84.91 160.8 35.69 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.88 -0.488 . . . . 45.04 111.88 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.506 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -156.49 125.05 1.54 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.186 -1.166 . . . . 72.22 110.186 174.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.409 HG13 ' HE1' ' A' ' 17' ' ' TYR . 65.1 mt -79.79 124.66 38.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.893 -1.151 . . . . 73.32 107.893 171.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.625 ' HB3' HD11 ' A' ' 86' ' ' ILE . 96.3 m-85 -125.03 119.42 28.63 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.889 -0.782 . . . . 72.01 108.889 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.7 t -89.14 90.99 8.62 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.249 -1.019 . . . . 63.45 108.249 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.625 HD11 ' HB3' ' A' ' 84' ' ' PHE . 13.1 mm -116.87 148.69 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 121.205 0.526 . . . . 74.24 110.816 -169.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.56 171.06 16.34 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.735 -1.12 . . . . 73.51 110.114 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 106.24 -32.89 6.89 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.239 -0.437 . . . . 70.44 112.92 177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.593 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -121.39 169.0 13.25 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 124.278 1.031 . . . . 74.3 110.1 -175.227 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.406 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 12.6 tt0 -156.85 174.9 14.81 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 124.133 0.895 . . . . 74.54 109.07 176.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.73 -114.03 5.89 Favored Glycine 0 C--N 1.343 0.957 0 CA-C-N 115.69 -0.686 . . . . 41.04 114.293 176.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.4 p -71.36 -41.54 69.59 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.62 1.168 . . . . 73.34 112.217 -174.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -71.2 -34.77 71.18 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.067 0.547 . . . . 61.42 110.279 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.406 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 5.8 tpt -66.67 -42.52 86.43 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 123.469 0.481 . . . . 64.52 110.098 174.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.98 -35.08 79.51 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.373 0.669 . . . . 72.4 111.005 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.426 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 52.9 t-80 -71.71 -28.28 63.58 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.663 0.785 . . . . 71.22 110.777 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.7 t -76.19 -50.49 14.38 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.461 -0.57 . . . . 63.25 109.461 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 87.1 mt -75.98 -23.96 55.34 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.532 0.733 . . . . 63.54 112.515 -173.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.4 ' HA2' HG21 ' A' ' 46' ' ' THR . . . -115.09 3.52 22.46 Favored Glycine 0 N--CA 1.473 1.139 0 CA-C-O 119.553 -0.582 . . . . 73.41 113.952 -171.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -143.41 -63.24 0.4 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 117.541 0.67 . . . . 72.43 111.276 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -68.62 -46.19 69.9 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.175 0.59 . . . . 73.4 111.777 -170.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 80.3 m -70.49 -47.41 18.53 Favored Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 124.235 1.014 . . . . 53.51 112.928 -176.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.452 ' HD3' HG11 ' A' ' 58' ' ' VAL . 51.5 Cg_endo -67.08 -18.66 51.59 Favored 'Trans proline' 0 C--N 1.394 2.967 0 CA-C-N 121.462 1.558 . . . . 53.45 112.461 174.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -72.77 -35.23 67.39 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.055 0.542 . . . . 73.44 109.74 174.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.441 HG21 ' CD1' ' A' ' 13' ' ' ILE . 39.1 mm -65.42 -44.38 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.849 0.859 . . . . 55.51 110.113 170.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.506 HD21 ' HA3' ' A' ' 82' ' ' GLY . 75.7 mt -71.49 -15.8 62.33 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.445 -0.798 . . . . 75.24 111.904 -175.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -70.03 -44.98 22.28 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 114.748 1.388 . . . . 72.31 114.748 -170.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.97 -32.14 84.66 Favored 'Trans proline' 0 C--N 1.384 2.437 0 CA-C-N 122.285 1.852 . . . . 63.32 112.314 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -76.84 -41.28 44.74 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.69 0.796 . . . . 65.13 111.65 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.461 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -66.44 -49.44 66.71 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.033 0.533 . . . . 74.34 109.749 178.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.487 ' NH1' HD12 ' C' ' 105' ' ' ILE . 30.5 ttm180 -46.8 -51.67 15.9 Favored 'General case' 0 C--N 1.353 0.761 0 O-C-N 125.258 1.599 . . . . 73.44 110.716 173.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -67.39 -43.78 80.5 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.316 1.01 . . . . 73.45 111.982 -175.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.554 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.7 t -57.68 -42.6 83.94 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.932 0.77 . . . . 74.03 110.122 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.487 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.5 mt -64.33 -54.84 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 114.451 -1.25 . . . . 53.01 110.253 175.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.5 m -56.59 -37.29 70.43 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.258 0.974 . . . . 65.3 111.567 -173.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.0 t -68.81 -47.9 64.92 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.664 -1.153 . . . . 71.11 110.096 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 8.6 mtp -57.12 -37.71 72.38 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.615 0.766 . . . . 55.24 111.664 175.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 114' ' ' ILE . 70.3 t -67.48 -49.16 73.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.378 1.071 . . . . 71.24 110.461 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.8 p -70.44 -33.19 71.03 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.018 0.527 . . . . 75.12 111.076 -175.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.541 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.9 mtt-85 -69.48 -31.97 70.57 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.959 0.904 . . . . 74.2 109.67 172.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.84 6.08 49.74 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-O 119.304 -0.72 . . . . 73.05 113.688 174.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.53 HG21 ' HE ' ' B' ' 15' ' ' ARG . 18.1 m 73.15 7.29 5.32 Favored 'General case' 0 C--N 1.367 1.345 0 C-N-CA 125.147 1.379 . . . . 71.03 112.152 176.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -86.51 137.53 34.24 Favored Pre-proline 0 C--O 1.24 0.568 0 N-CA-C 107.197 -1.409 . . . . 71.33 107.197 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -54.67 165.87 2.25 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 123.416 2.744 . . . . 63.21 113.855 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.573 ' HG2' ' HB2' ' C' ' 15' ' ' ARG . 40.6 tp60 -52.88 117.8 3.22 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 114.534 -1.212 . . . . 75.53 111.877 -172.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.571 HD13 HG21 ' A' ' 40' ' ' VAL . 25.5 tp -113.6 114.39 26.39 Favored 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 109.175 -0.676 . . . . 62.42 109.175 173.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.486 HD21 ' HA ' ' C' ' 15' ' ' ARG . 5.7 m-80 -110.03 125.69 53.18 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 106.152 -1.795 . . . . 63.52 106.152 176.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.473 HD11 HD12 ' A' ' 114' ' ' ILE . 10.9 mt -72.09 144.18 48.78 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 109.173 -0.677 . . . . 65.31 109.173 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.51 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -60.18 138.64 91.51 Favored Pre-proline 0 N--CA 1.48 1.059 0 CA-C-O 118.864 -0.588 . . . . 73.44 111.011 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -55.09 108.17 0.29 Allowed 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.519 2.146 . . . . 63.34 111.849 168.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 129' ' ' ALA . 75.4 t -104.18 137.17 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.078 0.951 . . . . 71.54 111.634 -173.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -89.53 97.29 11.11 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.791 -1.095 . . . . 64.4 108.656 170.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.41 ' CZ ' HD13 ' A' ' 44' ' ' LEU . 57.2 m-85 -70.49 -18.58 62.96 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 112.827 0.677 . . . . 74.42 112.827 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -69.6 -40.02 76.9 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.45 -0.945 . . . . 52.11 108.45 174.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.07 -46.22 85.28 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.5 0.72 . . . . 63.31 110.942 174.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 56.9 mt -62.87 -33.58 75.58 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 123.748 0.655 . . . . 73.01 111.044 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.421 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 74.6 t80 . . . . . 0 C--O 1.218 -0.588 0 CA-C-N 115.507 -0.77 . . . . 72.43 109.808 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 1.4 tmt? . . . . . 0 CA--C 1.552 1.055 0 CA-C-O 120.801 0.334 . . . . 74.0 110.772 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.1 t -143.38 99.14 3.38 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.135 0.969 . . . . 62.33 109.373 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.474 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 54.1 t80 -112.63 141.0 46.92 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.334 -1.303 . . . . 75.23 107.684 173.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -147.55 134.14 19.85 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.764 -0.458 . . . . 64.55 109.764 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.473 HD11 HD13 ' B' ' 105' ' ' ILE . 41.4 mt -80.66 116.47 24.95 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 N-CA-C 107.011 -1.477 . . . . 55.13 107.011 170.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -90.06 -37.55 14.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.973 -0.751 . . . . 73.43 108.973 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.53 ' HE ' HG21 ' A' ' 122' ' ' THR . 11.7 ttt85 -168.92 151.88 5.07 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 123.611 0.569 . . . . 71.12 110.812 -177.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 53.8 mt -135.16 135.87 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 106.668 -1.604 . . . . 71.55 106.668 171.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.471 ' HE1' HG13 ' B' ' 83' ' ' ILE . 10.9 p90 -166.34 143.03 4.98 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.281 0.563 . . . . 73.01 111.79 -173.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 41.2 m -74.24 121.39 21.19 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.81 -1.086 . . . . 74.12 108.971 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.466 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.5 mtpt -98.51 -17.09 18.91 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.363 0.665 . . . . 72.11 110.979 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 3.2 t70 -163.67 145.36 9.3 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.83 0.852 . . . . 74.03 110.418 -177.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.404 HD13 HG13 ' B' ' 78' ' ' VAL . 39.4 mm -133.13 144.93 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 107.618 -1.253 . . . . 73.51 107.618 170.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 39.2 t -143.94 135.82 26.32 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.792 -0.818 . . . . 74.11 108.792 174.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.478 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.6 t80 -149.53 114.55 5.42 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 107.402 -1.333 . . . . 44.2 107.402 170.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -126.17 114.3 18.17 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.102 -1.073 . . . . 75.24 108.102 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.602 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -106.85 88.82 3.83 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 107.912 -1.144 . . . . 61.34 107.912 175.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.55 -33.33 46.33 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.723 2.282 . . . . 71.54 112.295 -172.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -106.32 7.96 31.53 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.075 0.95 . . . . 74.24 111.613 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.602 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -33.26 -64.03 0.27 Allowed Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 115.662 1.727 . . . . 74.11 115.662 -167.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.435 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 19.9 Cg_exo -60.72 -32.58 93.23 Favored 'Trans proline' 0 C--N 1.4 3.272 0 C-N-CA 122.438 2.092 . . . . 54.31 112.914 -170.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -94.77 -39.58 10.21 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 114.664 -1.153 . . . . 75.32 111.583 -170.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.706 HG22 HD12 ' B' ' 68' ' ' LEU . 7.4 p -66.32 -19.41 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.052 0.541 . . . . 62.14 111.925 -172.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -60.47 -21.63 62.57 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.015 0.926 . . . . 64.35 113.312 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -63.9 -18.27 64.03 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.346 0.658 . . . . 75.52 111.766 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.446 ' HB2' HD13 ' B' ' 68' ' ' LEU . 95.6 mttt -94.06 105.29 17.29 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.256 1.022 . . . . 75.25 109.142 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -100.52 79.58 2.12 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.477 0.711 . . . . 64.43 110.441 -172.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 46.5 p90 -154.41 167.84 28.67 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.824 -1.176 . . . . 74.14 107.824 165.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 22.9 tm0? -76.51 115.44 47.64 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 107.7 -1.222 . . . . 74.3 107.7 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.27 154.38 52.84 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.982 2.455 . . . . 71.14 114.285 -170.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -66.41 115.94 6.87 Favored 'General case' 0 C--N 1.347 0.486 0 N-CA-C 108.521 -0.918 . . . . 74.21 108.521 172.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.431 HG13 HG13 ' B' ' 64' ' ' VAL . 57.6 t -104.27 134.86 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.36 0.6 . . . . 74.52 111.015 -172.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -106.39 103.25 12.67 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.056 -1.461 . . . . 65.4 107.056 169.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.646 HD13 HD22 ' B' ' 128' ' ' LEU . 23.8 tp -85.48 147.05 26.65 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 107.855 -1.165 . . . . 73.25 107.855 171.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.517 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 12.0 t0 -155.27 154.09 31.61 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.337 -0.616 . . . . 61.05 109.337 -176.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.566 HD11 HG11 ' B' ' 131' ' ' VAL . 97.8 mt -124.92 130.54 52.56 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.341 0.657 . . . . 42.0 110.406 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -127.93 146.94 50.48 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.259 1.424 . . . . 72.54 108.048 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 7.8 t -145.32 127.42 15.63 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.004 0.431 . . . . 72.53 110.604 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.72 116.4 10.24 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.992 -1.114 . . . . 53.33 107.992 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.515 ' HB3' ' HA ' ' B' ' 58' ' ' VAL . 56.1 p -144.69 165.07 29.1 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.094 0.405 . . . . 45.12 112.094 -173.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 67.1 p -160.96 153.05 20.01 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.337 -0.847 . . . . 61.04 110.21 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -82.57 115.03 21.36 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.875 -0.787 . . . . 72.53 108.875 166.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 pp -122.26 24.26 9.47 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.283 0.633 . . . . 62.13 110.746 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.611 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -169.17 169.0 9.59 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.585 0.754 . . . . 72.44 111.548 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' ASP . . . . . 0.427 ' O ' HG23 ' B' ' 55' ' ' VAL . 2.8 m-20 -60.59 95.43 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.392 1.077 . . . . 64.45 112.572 -175.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 56.56 25.24 9.62 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.417 1.087 . . . . 75.54 111.866 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 89.0 t -116.93 111.79 36.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-N 114.322 -1.308 . . . . 71.12 108.117 177.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.588 ' HB3' HD13 ' B' ' 86' ' ' ILE . 8.2 t80 -101.41 138.64 38.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.099 1.36 . . . . 74.52 109.275 -174.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -116.41 114.22 23.95 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.467 -1.308 . . . . 63.22 107.467 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.515 ' HA ' ' HB3' ' B' ' 48' ' ' SER . 2.7 p -108.72 129.18 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 122.766 0.427 . . . . 75.34 110.993 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.482 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.3 t -102.33 108.48 24.07 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 N-CA-C 107.777 -1.194 . . . . 73.25 107.777 171.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 56.8 tp -95.11 102.58 14.4 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 108.516 -0.92 . . . . 53.13 108.516 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -94.05 117.88 30.73 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.588 -0.733 . . . . 74.4 109.241 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 54.1 t -105.02 128.3 58.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 108.706 -0.85 . . . . 74.23 108.706 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 14.9 m -104.88 138.4 41.19 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.998 0.519 . . . . 53.14 110.026 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.821 HG11 HD21 ' B' ' 126' ' ' LEU . 58.2 t -133.38 112.31 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.191 -1.04 . . . . 52.25 108.191 173.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.425 HG23 ' CD2' ' B' ' 75' ' ' LEU . 87.0 m -111.48 105.64 14.29 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.25 -1.019 . . . . 74.32 108.25 174.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.89 150.54 29.05 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.871 0.367 . . . . 63.53 110.145 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.522 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 30.7 p -144.69 130.7 19.36 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.424 -0.807 . . . . 74.42 111.015 -171.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.706 HD12 HG22 ' B' ' 31' ' ' VAL . 85.8 mt -94.35 98.45 10.91 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.053 -1.092 . . . . 71.34 108.053 173.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.1 -122.55 11.48 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 115.2 -0.909 . . . . 74.44 113.992 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -82.1 2.66 30.25 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.523 0.729 . . . . 71.11 112.764 -172.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -143.57 159.52 42.29 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.843 0.457 . . . . 73.31 110.89 -171.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 40.0 m -69.62 133.54 47.7 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.256 -0.884 . . . . 71.41 110.325 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.548 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -84.75 -60.94 1.91 Allowed 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.03 -1.47 . . . . 61.14 107.03 172.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -154.06 162.74 40.99 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.749 -1.114 . . . . 73.21 111.541 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.425 ' CD2' HG23 ' B' ' 65' ' ' THR . 35.3 mt -123.47 112.25 17.28 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 106.129 -1.804 . . . . 74.54 106.129 169.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' B' ' 117' ' ' MET . 40.5 t -124.54 118.34 26.36 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.364 -0.606 . . . . 74.01 109.364 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -140.2 128.66 22.75 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.564 0.745 . . . . 72.51 109.208 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.404 HG13 HD13 ' B' ' 21' ' ' ILE . 42.4 t -125.5 150.7 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.801 0.84 . . . . 73.24 110.125 -175.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.415 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 22.4 mt-30 -114.94 110.48 19.69 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.56 -0.533 . . . . 73.23 109.56 171.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.448 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.1 tp-100 -99.77 102.84 14.4 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.397 -0.594 . . . . 72.21 109.397 170.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.46 160.46 29.19 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 111.011 -0.836 . . . . 60.24 111.011 174.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.66 126.54 1.62 Allowed Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.916 -0.474 . . . . 61.41 111.916 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.471 HG13 ' HE1' ' B' ' 17' ' ' TYR . 57.9 mt -88.05 122.56 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 108.224 -1.028 . . . . 62.22 108.224 175.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -135.63 140.62 44.7 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.554 0.741 . . . . 72.54 110.067 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 21.2 m -88.72 118.69 28.58 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.458 0.703 . . . . 51.12 109.104 170.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.588 HD13 ' HB3' ' B' ' 56' ' ' TYR . 4.0 mp -116.94 110.59 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.048 -1.464 . . . . 52.54 107.048 175.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.88 172.06 19.0 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.959 0.504 . . . . 73.42 111.14 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.02 -60.46 0.82 Allowed Glycine 0 C--N 1.344 1.012 0 N-CA-C 111.072 -0.811 . . . . 63.21 111.072 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.421 HD13 ' HB2' ' B' ' 94' ' ' MET . 0.9 OUTLIER -68.53 169.84 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 123.446 0.698 . . . . 63.34 111.876 173.232 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -154.52 177.9 10.67 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.319 0.648 . . . . 74.11 110.838 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.34 -126.68 8.32 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-N 115.703 -0.68 . . . . 62.13 114.145 172.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.6 m -89.73 -47.59 7.82 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.788 0.835 . . . . 72.1 109.946 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -64.33 -19.02 65.17 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.379 -1.282 . . . . 71.34 112.152 -169.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.421 ' HB2' HD13 ' B' ' 89' ' ' ILE . 23.9 ptt? -62.53 -37.13 84.89 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.735 0.814 . . . . 74.41 112.015 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.97 -13.27 59.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.414 0.686 . . . . 53.22 112.466 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -63.72 -32.16 73.57 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.843 0.457 . . . . 71.23 109.929 170.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -64.45 -49.47 71.34 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.51 0.724 . . . . 65.01 111.428 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.47 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.4 pp -76.95 -32.02 57.01 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.066 -0.516 . . . . 74.33 111.827 -174.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.89 -22.08 37.26 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 123.26 0.35 . . . . 64.31 113.859 -173.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.01 -59.35 1.74 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.091 0.556 . . . . 72.53 111.516 -173.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -67.23 -42.77 83.49 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.224 0.61 . . . . 74.13 111.662 -172.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.474 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 63.3 m -68.43 -49.07 32.93 Favored Pre-proline 0 CA--C 1.566 1.575 0 N-CA-C 113.413 0.894 . . . . 70.31 113.413 -175.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.429 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 35.6 Cg_exo -64.72 -28.07 60.15 Favored 'Trans proline' 0 C--N 1.39 2.757 0 C-N-CA 121.851 1.701 . . . . 72.43 113.245 177.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -58.36 -34.43 70.66 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 123.216 0.606 . . . . 73.24 111.94 174.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.473 HD13 HD11 ' B' ' 13' ' ' ILE . 58.2 mt -68.49 -35.97 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 115.387 -0.824 . . . . 73.33 110.469 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 93.8 mt -88.5 -31.65 18.61 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.312 0.856 . . . . 51.33 113.312 -170.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -53.26 -43.7 95.69 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 113.855 1.057 . . . . 73.33 113.855 -173.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -52.18 -42.41 59.75 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.893 2.395 . . . . 72.31 114.84 174.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.448 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 86.0 m-85 -68.62 -43.59 76.04 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.731 0.412 . . . . 72.52 110.749 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.14 -43.04 99.51 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.407 -0.815 . . . . 61.24 110.661 175.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 28.8 ttt-85 -57.74 -53.9 53.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.14 1.376 . . . . 64.43 110.902 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -66.03 -39.17 89.98 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.247 0.967 . . . . 72.53 110.669 -175.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.541 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 7.4 t -70.25 -34.26 72.62 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.869 -0.605 . . . . 51.4 110.989 -176.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.498 HD13 HG23 ' B' ' 64' ' ' VAL . 67.7 mt -60.47 -53.46 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.626 0.771 . . . . 72.23 109.652 169.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.461 HG21 ' OG ' ' C' ' 119' ' ' SER . 17.0 m -60.14 -28.56 67.99 Favored 'General case' 0 CA--C 1.551 1.011 0 O-C-N 123.807 0.692 . . . . 73.13 111.332 -177.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 29.7 m -64.47 -52.04 59.97 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 123.543 0.737 . . . . 53.53 110.656 171.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.545 ' HB2' ' SG ' ' B' ' 76' ' ' CYS . 25.2 mmt -63.21 -33.13 74.81 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.049 0.54 . . . . 75.54 111.345 -177.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 92.1 t -72.07 -38.38 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.84 1.256 . . . . 75.51 110.902 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 47.2 t -66.54 -34.7 78.5 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.314 -0.857 . . . . 65.13 110.53 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.554 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 74.6 mtt-85 -71.37 -37.52 71.61 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 114.788 -1.097 . . . . 74.44 109.408 177.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.49 -9.73 78.33 Favored Glycine 0 C--N 1.355 1.587 0 O-C-N 123.522 0.514 . . . . 74.5 112.69 172.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 3.2 m 69.93 20.81 6.49 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 125.487 1.515 . . . . 72.23 111.721 171.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -78.24 159.67 74.81 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.524 0.73 . . . . 75.32 111.169 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.91 172.07 0.88 Allowed 'Trans proline' 0 C--N 1.387 2.569 0 C-N-CA 123.271 2.647 . . . . 71.33 114.558 174.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.759 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 10.6 tp-100 -62.75 132.51 52.47 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.482 0.919 . . . . 73.43 113.482 -166.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.821 HD21 HG11 ' B' ' 64' ' ' VAL . 59.6 tp -126.71 106.43 9.37 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.681 0.792 . . . . 72.11 109.031 176.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -112.59 119.37 37.9 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 107.639 -1.245 . . . . 64.13 107.639 170.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.646 HD22 HD13 ' B' ' 42' ' ' LEU . 31.0 mt -77.67 145.95 36.34 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 122.99 0.182 . . . . 71.22 111.39 -176.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.96 128.33 91.8 Favored Pre-proline 0 CA--C 1.546 0.812 0 O-C-N 124.366 1.041 . . . . 72.52 111.845 -175.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.485 ' HG3' HD11 ' D' ' 16' ' ' ILE . 51.3 Cg_endo -68.54 87.31 0.42 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.897 2.398 . . . . 52.15 112.033 176.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.566 HG11 HD11 ' B' ' 44' ' ' LEU . 2.5 p -90.49 109.8 21.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 108.291 -1.003 . . . . 75.15 108.291 172.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 37.0 t30 . . . . . 0 CA--C 1.533 0.289 0 CA-C-N 114.726 -1.124 . . . . 64.51 108.216 178.066 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.51 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 64.0 t80 . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 108.539 -0.912 . . . . 73.42 108.539 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -135.79 125.21 24.93 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.275 -0.639 . . . . 64.33 109.275 -177.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 45.4 mt -77.16 128.16 38.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 109.466 -0.568 . . . . 70.32 109.466 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -88.69 -49.74 6.67 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.826 -0.805 . . . . 72.41 108.826 174.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.573 ' HB2' ' HG2' ' A' ' 125' ' ' GLN . 0.0 OUTLIER -174.58 149.48 1.27 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.221 1.008 . . . . 74.35 110.245 176.27 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.497 HG23 HD23 ' C' ' 106' ' ' LEU . 78.0 mt -120.57 131.59 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.503 1.121 . . . . 74.24 108.299 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.609 ' HB3' HG23 ' D' ' 122' ' ' THR . 20.8 p90 -164.44 172.19 13.7 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 121.422 0.63 . . . . 64.34 112.17 -167.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.1 p -100.38 120.3 39.76 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.268 -0.878 . . . . 72.35 109.248 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -69.29 -48.75 60.72 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 106.979 -1.489 . . . . 63.12 106.979 165.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.629 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.3 t70 -134.56 145.59 48.85 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 113.655 -1.611 . . . . 61.05 110.663 -173.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.406 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.5 mt -137.64 149.17 25.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 126.717 2.007 . . . . 72.35 105.714 172.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.1 t -156.95 149.58 23.45 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.829 -0.434 . . . . 74.53 109.829 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -155.98 129.59 8.39 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 107.265 -1.383 . . . . 74.31 107.265 174.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -132.15 132.91 43.66 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.681 -0.859 . . . . 74.25 108.681 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.33 80.55 22.6 Favored Pre-proline 0 CA--C 1.549 0.93 0 N-CA-C 106.625 -1.62 . . . . 73.13 106.625 170.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -65.25 -41.19 16.88 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.82 2.347 . . . . 63.04 111.702 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -94.82 18.37 11.92 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 114.398 -1.274 . . . . 63.11 110.779 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.98 -61.02 1.67 Allowed Pre-proline 0 C--N 1.369 1.427 0 C-N-CA 124.974 1.31 . . . . 61.42 114.097 -171.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -61.52 -39.48 54.89 Favored 'Trans proline' 0 C--N 1.39 2.715 0 C-N-CA 121.66 1.573 . . . . 75.31 112.15 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.48 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 85.2 t60 -71.4 -30.63 66.32 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 115.44 -0.8 . . . . 73.24 112.385 -178.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.728 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.0 p -82.96 -15.88 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 O-C-N 121.794 -0.566 . . . . 65.21 111.836 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -75.45 -20.76 58.64 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.112 0.565 . . . . 73.33 112.227 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 20.8 pt20 -94.07 8.69 40.61 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.493 0.717 . . . . 64.43 110.944 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -99.12 161.76 13.44 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.881 0.872 . . . . 71.01 110.988 -171.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -71.49 121.79 19.29 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.403 0.681 . . . . 75.04 109.638 172.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -83.74 93.39 7.93 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.22 0.608 . . . . 74.45 111.016 -174.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 37' ' ' GLN . . . . . 0.414 ' H ' HD22 ' C' ' 68' ' ' LEU . 52.9 tt0 -145.43 78.98 11.77 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.06 0.944 . . . . 71.22 108.494 173.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -82.45 141.33 11.2 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.695 2.263 . . . . 74.51 113.179 -173.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -87.38 88.43 7.68 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.012 -1.477 . . . . 64.21 107.012 163.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 40.3 t -83.87 111.96 20.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-N 115.117 -0.947 . . . . 74.53 110.078 -175.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.489 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 13.7 tmtt? -91.1 101.08 13.83 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 107.85 -1.167 . . . . 72.13 107.85 172.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.9 tt -87.61 121.69 30.36 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.069 -1.826 . . . . 70.44 106.069 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -118.31 138.35 52.45 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.428 -0.953 . . . . 60.0 108.428 -175.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.537 HD22 HD21 ' C' ' 60' ' ' LEU . 25.7 mt -132.02 111.84 11.86 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.852 0.834 . . . . 74.22 110.298 178.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -127.5 122.43 33.34 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.904 1.682 . . . . 72.55 107.268 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -123.16 125.86 45.93 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 120.99 0.424 . . . . 52.12 110.057 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.16 160.51 16.86 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.218 1.007 . . . . 62.23 109.384 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 31.1 p -151.94 146.06 25.33 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.308 0.643 . . . . 54.44 110.27 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 54.1 p -146.99 135.9 22.31 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.694 0.798 . . . . 72.14 109.351 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -78.32 117.08 19.22 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 108.856 -0.794 . . . . 71.15 108.856 175.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.707 HD11 ' HB2' ' C' ' 57' ' ' GLU . 30.8 mt -85.54 -33.28 21.79 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.899 0.88 . . . . 74.25 110.478 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.96 -174.48 3.34 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.408 1.083 . . . . 73.11 109.6 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.23 117.21 6.25 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.464 -0.789 . . . . 73.12 109.288 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 70.35 11.92 7.48 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.884 1.274 . . . . 72.3 112.044 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 30.4 t -118.32 116.27 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.196 -0.668 . . . . 60.35 109.196 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -127.46 125.12 39.95 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.017 0.927 . . . . 64.24 108.672 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.707 ' HB2' HD11 ' C' ' 51' ' ' LEU . 34.8 tt0 -85.8 142.14 29.15 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.964 -0.754 . . . . 71.1 108.964 169.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 60.1 t -128.8 122.84 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 107.817 -1.179 . . . . 64.5 107.817 167.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 68.2 t -109.64 127.56 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 109.283 -0.636 . . . . 70.44 109.283 173.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.537 HD21 HD22 ' C' ' 44' ' ' LEU . 0.1 OUTLIER -107.38 100.99 10.38 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 107.738 -1.208 . . . . 61.12 107.738 -176.544 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -82.22 106.12 13.85 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.455 0.702 . . . . 75.13 109.16 172.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.443 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.6 t -102.88 124.7 57.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.417 -1.327 . . . . 64.54 107.417 169.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 12.5 m -125.34 113.24 17.31 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.526 0.679 . . . . 62.2 109.486 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.428 HG21 HG21 ' C' ' 114' ' ' ILE . 99.5 t -102.49 111.07 30.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 124.482 1.113 . . . . 64.14 109.132 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.517 HG23 HD23 ' C' ' 75' ' ' LEU . 6.8 m -104.35 108.62 20.12 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 109.121 -0.696 . . . . 71.21 109.121 176.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.9 100.63 10.18 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.642 -0.873 . . . . 65.32 108.642 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 40.5 m -129.03 131.76 47.4 Favored 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 109.038 -0.727 . . . . 75.32 109.038 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.414 HD22 ' H ' ' C' ' 37' ' ' GLN . 12.2 mt -84.91 26.51 0.83 Allowed 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 125.137 1.375 . . . . 62.02 111.3 -175.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.62 -109.49 1.06 Allowed Glycine 0 C--N 1.348 1.229 0 N-CA-C 109.486 -1.446 . . . . 60.31 109.486 -170.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.59 -31.56 16.64 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.215 -0.661 . . . . 74.21 109.215 169.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -69.37 104.25 2.22 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 124.065 0.946 . . . . 72.11 109.964 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.1 m -78.55 123.95 27.63 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 109.384 -0.598 . . . . 72.43 109.384 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.728 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -77.42 -57.61 3.73 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.091 -1.077 . . . . 71.13 108.091 176.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 74' ' ' PHE . . . . . 0.435 ' HZ ' HD22 ' C' ' 126' ' ' LEU . 49.5 p90 -156.52 154.97 31.16 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.846 -1.07 . . . . 74.22 111.268 175.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.517 HD23 HG23 ' C' ' 65' ' ' THR . 2.5 tm? -113.09 145.47 40.85 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 106.094 -1.817 . . . . 74.43 106.094 163.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.449 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.6 t -151.68 125.16 8.88 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.989 -0.745 . . . . 74.31 108.989 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -131.76 136.71 47.79 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.331 -0.618 . . . . 74.15 109.331 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.466 HG11 ' HA ' ' C' ' 110' ' ' ALA . 22.7 t -132.13 113.92 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.658 -0.867 . . . . 74.3 108.658 174.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.629 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.3 mt-30 -91.73 87.96 6.5 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.017 0.927 . . . . 62.41 109.115 172.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -79.45 96.9 6.19 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.402 1.081 . . . . 53.11 110.337 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.77 144.54 22.15 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.396 -0.366 . . . . 72.22 112.694 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.425 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.24 128.11 2.86 Favored Glycine 0 CA--C 1.503 -0.713 0 N-CA-C 111.096 -0.802 . . . . 72.42 111.096 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.42 HD11 ' HB3' ' D' ' 29' ' ' PRO . 27.3 mm -95.09 123.54 47.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.248 -1.019 . . . . 75.14 108.248 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -132.23 118.68 19.83 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.517 0.727 . . . . 62.04 109.986 -173.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 56.9 m -76.41 100.8 5.32 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.464 -0.569 . . . . 71.12 109.464 170.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.576 HD13 ' SG ' ' C' ' 97' ' ' CYS . 18.4 mt -114.13 131.6 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.239 0.615 . . . . 70.44 110.042 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.4 169.4 23.23 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.163 0.985 . . . . 54.53 109.956 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.53 -19.2 41.78 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.936 -0.574 . . . . 63.54 113.452 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 22.3 pt -111.03 170.5 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.051 0.54 . . . . 63.51 111.135 -175.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -166.21 149.51 7.36 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.905 0.482 . . . . 74.3 110.7 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.81 -113.15 5.06 Favored Glycine 0 C--N 1.354 1.547 0 CA-C-N 115.872 -0.604 . . . . 63.11 113.43 170.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 34.6 p -61.19 -43.43 98.89 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.858 0.863 . . . . 75.11 111.281 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -59.24 -42.7 91.72 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 114.965 -1.016 . . . . 74.54 110.739 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.502 ' HE1' HG21 ' C' ' 86' ' ' ILE . 6.7 tpt -68.48 -43.63 76.52 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.845 -1.07 . . . . 64.25 110.573 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.75 -36.49 79.04 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.472 0.709 . . . . 71.31 111.318 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 96' ' ' HIS . . . . . 0.402 ' HE1' ' HA ' ' C' ' 134' ' ' ASP . 33.2 t60 -77.32 -31.7 54.78 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.102 0.408 . . . . 74.03 112.102 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.576 ' SG ' HD13 ' C' ' 86' ' ' ILE . 24.7 t -66.36 -43.83 84.92 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.688 -0.856 . . . . 63.42 108.688 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 43.3 mt -78.69 -28.3 45.21 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.374 -1.285 . . . . 73.33 111.104 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.61 -27.97 52.92 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 115.701 -0.681 . . . . 65.15 114.14 -172.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.83 -48.75 0.09 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.172 1.175 . . . . 72.44 114.172 -163.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -62.73 -51.86 65.52 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.686 0.616 . . . . 61.12 111.465 -173.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.51 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 57.6 m -66.52 -50.05 48.86 Favored Pre-proline 0 CA--C 1.56 1.351 0 CA-C-O 118.271 -0.871 . . . . 52.44 111.502 177.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.504 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 85.4 Cg_exo -51.56 -30.99 38.0 Favored 'Trans proline' 0 C--N 1.399 3.227 0 C-N-CA 123.029 2.486 . . . . 61.12 114.898 172.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -65.35 -43.51 90.63 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.06 0.544 . . . . 60.34 109.717 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.487 HD12 ' NH1' ' A' ' 111' ' ' ARG . 35.1 mm -72.74 -29.12 28.99 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 CA-C-N 115.663 -0.699 . . . . 73.35 110.462 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.497 HD23 HG23 ' C' ' 16' ' ' ILE . 89.0 mt -77.62 -29.68 51.96 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.815 0.846 . . . . 71.45 111.883 178.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -58.78 -50.19 89.37 Favored Pre-proline 0 N--CA 1.482 1.173 0 CA-C-O 117.448 -1.263 . . . . 74.12 114.279 -168.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.93 -32.54 92.63 Favored 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 121.832 1.688 . . . . 62.22 112.75 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -68.42 -48.26 65.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.414 0.685 . . . . 75.41 110.425 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.466 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -62.57 -35.49 79.65 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 115.952 -0.567 . . . . 25.45 111.149 176.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -63.07 -54.85 31.51 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.313 1.445 . . . . 63.15 111.374 -177.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -66.98 -30.13 70.17 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.305 0.642 . . . . 71.1 110.153 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 14.0 t -68.43 -34.5 76.09 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.456 0.702 . . . . 70.31 111.394 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.449 HG23 ' SG ' ' C' ' 76' ' ' CYS . 96.3 mt -74.46 -50.56 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.478 0.711 . . . . 75.4 110.298 174.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 9.1 m -66.34 -28.39 68.63 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.26 0.624 . . . . 62.44 111.602 -173.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 79.5 p -66.59 -45.36 79.48 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 109.13 -0.693 . . . . 54.41 109.13 172.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.576 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.42 -40.65 78.79 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.421 1.088 . . . . 65.55 112.478 176.384 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.411 HG23 ' O ' ' C' ' 114' ' ' ILE . 62.8 t -64.73 -40.83 90.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.29 0.636 . . . . 61.15 110.609 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.461 ' OG ' HG21 ' B' ' 115' ' ' THR . 28.2 t -67.02 -34.63 78.15 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.05 0.94 . . . . 70.2 112.016 175.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' C' ' 116' ' ' SER . 66.0 mtt-85 -65.73 -36.3 83.19 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.237 0.615 . . . . 73.33 109.502 177.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.61 11.21 62.2 Favored Glycine 0 C--N 1.356 1.668 0 CA-C-O 119.284 -0.731 . . . . 65.13 113.322 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.425 HG23 ' HB3' ' D' ' 17' ' ' TYR . 67.6 p 59.09 21.76 9.77 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 126.139 1.776 . . . . 43.53 114.648 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -85.37 157.21 59.11 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 108.385 -0.969 . . . . 73.31 108.385 170.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.759 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 30.1 Cg_endo -61.6 168.46 8.28 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.831 2.354 . . . . 74.41 113.966 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -62.01 110.73 1.66 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.749 -1.114 . . . . 74.14 111.532 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.435 HD22 ' HZ ' ' C' ' 74' ' ' PHE . 9.5 mp -106.3 87.03 2.46 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.343 -1.354 . . . . 74.25 107.343 169.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -90.03 109.17 20.23 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.205 -1.035 . . . . 74.14 108.205 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 64.1 mt -61.04 131.29 50.13 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.529 0.732 . . . . 74.35 110.758 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.1 146.92 98.85 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 118.786 -0.626 . . . . 61.34 110.454 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -48.85 99.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.776 2.317 . . . . 75.32 112.7 172.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 58.0 t -97.4 109.03 22.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 107.494 -1.299 . . . . 64.41 107.494 172.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -86.11 101.3 12.85 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.669 -0.863 . . . . 75.22 108.669 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -57.18 -35.62 69.81 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.011 0.925 . . . . 74.21 111.347 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 134' ' ' ASP . . . . . 0.402 ' HA ' ' HE1' ' C' ' 96' ' ' HIS . 9.1 m-20 -68.46 -25.91 65.23 Favored 'General case' 0 C--O 1.219 -0.533 0 C-N-CA 123.949 0.9 . . . . 65.52 111.942 -177.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.55 -40.54 56.68 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.031 0.532 . . . . 73.42 110.243 171.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 79.0 mt -65.65 -36.0 82.41 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.407 -0.815 . . . . 74.02 111.096 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 2.1 t80 . . . . . 0 C--O 1.211 -0.939 0 CA-C-N 115.878 -0.601 . . . . 74.23 110.265 179.376 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 C--O 1.242 0.666 0 CA-C-O 120.983 0.421 . . . . 73.34 110.133 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.451 ' HD2' HG22 ' D' ' 86' ' ' ILE . 80.3 t80 -132.83 107.91 8.63 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.178 -1.416 . . . . 73.11 107.178 176.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -128.91 116.06 18.81 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.994 0.918 . . . . 74.41 108.658 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 10.7 mt -82.75 130.45 35.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 108.303 -0.999 . . . . 70.12 108.303 174.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -94.82 -34.65 12.39 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 123.621 0.575 . . . . 71.14 110.429 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -167.76 141.43 3.43 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.323 0.389 . . . . 75.1 111.015 -173.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.485 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.7 mp -122.98 134.92 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 107.292 -1.373 . . . . 72.02 107.292 171.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.448 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 36.4 p90 -161.54 176.42 11.07 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.535 0.683 . . . . 64.53 112.372 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 53.6 p -103.47 127.22 50.9 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.422 -0.808 . . . . 72.52 109.357 173.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.448 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 32.5 mtpt -97.39 -19.22 18.62 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.027 0.531 . . . . 75.32 109.823 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.599 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 31.7 t70 -158.52 144.29 16.78 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.836 0.855 . . . . 73.24 109.876 177.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.576 HD13 ' HE3' ' C' ' 117' ' ' MET . 81.2 mt -148.59 142.91 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.624 1.569 . . . . 75.04 107.528 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.9 t -154.78 134.43 12.77 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.45 0.7 . . . . 63.35 109.419 164.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 88.8 t80 -119.75 133.92 55.43 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 105.827 -1.916 . . . . 62.35 105.827 166.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -138.69 120.59 15.46 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.349 0.659 . . . . 75.1 109.518 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.551 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -119.03 85.04 28.28 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 107.527 -1.286 . . . . 72.25 107.527 175.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -71.9 -29.55 15.11 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.873 2.382 . . . . 72.32 112.801 -168.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -115.27 16.58 16.83 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.077 0.951 . . . . 75.12 110.74 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.551 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -42.96 -58.03 4.4 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 114.887 1.44 . . . . 74.0 114.887 -161.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.42 ' HB3' HD11 ' C' ' 83' ' ' ILE . 89.6 Cg_endo -72.31 -26.18 17.73 Favored 'Trans proline' 0 C--N 1.378 2.124 0 CA-C-N 122.356 1.877 . . . . 74.51 113.992 -175.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -74.95 -36.68 62.08 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.848 0.859 . . . . 72.32 109.887 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.432 HG12 ' O ' ' D' ' 28' ' ' ALA . 9.8 p -83.91 -16.89 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-N 115.94 -0.573 . . . . 73.11 111.683 -172.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -68.15 -13.06 61.94 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 111.741 0.275 . . . . 74.03 111.741 175.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -69.48 -3.74 15.81 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.293 0.637 . . . . 74.52 111.3 174.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -110.69 102.88 11.4 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.276 1.43 . . . . 75.21 109.505 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -99.98 84.56 2.89 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.387 0.675 . . . . 54.11 111.125 -174.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -156.82 172.81 17.97 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 114.68 -1.145 . . . . 65.5 108.507 166.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -68.15 120.18 72.67 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-O 118.251 -0.88 . . . . 74.41 108.744 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -51.02 134.76 43.42 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 122.892 2.395 . . . . 61.12 112.124 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -69.34 110.52 4.7 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.879 -1.526 . . . . 73.43 106.879 170.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.722 HG13 HG13 ' D' ' 64' ' ' VAL . 38.4 t -107.05 108.86 26.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.84 0 CA-C-N 115.759 -0.655 . . . . 52.2 109.907 -173.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -87.95 109.27 19.68 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.603 -0.888 . . . . 73.31 108.603 168.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.447 HD12 ' O ' ' D' ' 63' ' ' THR . 58.9 tp -97.18 141.05 30.77 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.273 1.029 . . . . 62.22 109.228 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.614 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 21.5 t70 -123.94 131.9 53.64 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.385 -1.339 . . . . 73.34 107.385 173.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.433 ' CD2' HG22 ' D' ' 62' ' ' VAL . 31.9 mt -119.65 129.9 54.8 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.095 -0.706 . . . . 74.13 109.095 174.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.6 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 30.7 t70 -138.07 140.53 40.06 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 107.7 -1.222 . . . . 72.32 107.7 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 3.8 t -104.2 148.17 26.62 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.242 -0.651 . . . . 63.12 109.242 -176.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.96 151.22 33.0 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.812 0.845 . . . . 52.54 109.423 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.443 ' HB3' HG22 ' D' ' 58' ' ' VAL . 10.1 p . . . . . 0 C--O 1.243 0.759 0 C-N-CA 123.904 0.882 . . . . 75.11 109.235 177.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 . . . . . 0 N--CA 1.486 1.353 0 N-CA-C 113.639 0.978 . . . . 63.43 113.639 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 50.9 t -134.39 117.63 24.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 108.767 -0.827 . . . . 74.2 108.767 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -131.98 132.74 43.74 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 107.016 -1.476 . . . . 75.41 107.016 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -85.83 115.35 23.42 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 107.357 -1.349 . . . . 75.14 107.357 171.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.443 HG22 ' HB3' ' D' ' 48' ' ' SER . 70.3 t -99.97 130.55 48.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.643 -1.162 . . . . 74.33 108.687 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.547 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 16.5 t -111.85 146.78 16.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.879 -0.786 . . . . 62.41 108.879 176.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.41 119.87 37.01 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.581 -1.266 . . . . 73.34 107.581 176.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.6 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 2.9 tmm_? -95.4 96.21 8.96 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 108.042 -1.095 . . . . 74.53 108.042 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.443 HG13 HD11 ' D' ' 42' ' ' LEU . 54.0 t -101.67 125.12 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.574 -0.899 . . . . 71.42 108.574 176.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.614 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 50.0 m -121.66 131.07 53.9 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 123.285 0.634 . . . . 52.54 109.526 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.722 HG13 HG13 ' D' ' 40' ' ' VAL . 83.7 t -113.86 127.06 71.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.778 -0.823 . . . . 73.43 108.778 172.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 22.4 m -119.61 92.92 3.91 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.336 -1.727 . . . . 72.43 106.336 168.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.54 143.59 30.53 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 109.652 -0.499 . . . . 71.21 109.652 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 77.9 p -147.7 137.3 22.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.238 0.542 . . . . 63.22 111.158 -173.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 26.8 mt -108.73 110.5 21.91 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.404 -1.332 . . . . 74.5 107.404 171.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.98 -134.98 20.85 Favored Glycine 0 C--N 1.342 0.909 0 O-C-N 123.589 0.556 . . . . 61.44 113.302 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.24 6.05 46.71 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.554 0.741 . . . . 73.33 112.179 -176.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -130.07 167.86 17.65 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.074 0.55 . . . . 74.31 110.602 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 66.0 m -71.46 138.67 49.2 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.454 -0.794 . . . . 72.11 111.217 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.427 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -89.77 -63.11 1.33 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.239 -1.393 . . . . 65.4 107.239 169.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -158.56 161.08 37.26 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.652 -1.158 . . . . 74.11 110.951 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 68.8 mt -131.8 112.64 12.67 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.458 1.503 . . . . 63.14 107.151 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.623 ' SG ' HG23 ' D' ' 114' ' ' ILE . 49.2 t -131.94 106.23 7.92 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 122.583 0.353 . . . . 54.35 110.378 -168.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -129.0 125.89 38.35 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.428 0.691 . . . . 42.33 109.657 -173.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 88.2 t -132.6 115.39 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.114 0.965 . . . . 73.24 109.822 -174.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.599 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 2.3 mp0 -90.03 87.31 6.85 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.892 0.877 . . . . 53.23 109.051 175.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -81.81 102.9 11.11 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.691 -1.14 . . . . 70.04 109.346 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -111.64 147.24 17.98 Favored Glycine 0 N--CA 1.475 1.236 0 CA-C-O 120.157 -0.246 . . . . 44.33 112.517 -178.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.91 151.91 23.1 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 117.133 0.467 . . . . 51.41 112.252 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 3.0 mp -89.74 118.22 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 108.707 -0.849 . . . . 71.43 108.707 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -115.29 150.08 36.81 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.943 0.897 . . . . 65.44 110.165 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 33.1 t -115.76 104.73 11.95 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.992 0.917 . . . . 60.42 109.152 175.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.495 HD11 HD23 ' D' ' 98' ' ' LEU . 47.2 pt -115.03 130.28 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.153 0.581 . . . . 62.21 109.838 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.87 165.29 34.98 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.587 0.755 . . . . 64.34 109.767 175.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.69 23.39 75.24 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-O 119.692 -0.504 . . . . 74.43 114.315 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.453 HG22 ' H ' ' D' ' 90' ' ' GLU . 0.1 OUTLIER -103.1 168.81 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 108.733 -0.84 . . . . 73.22 108.733 172.728 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.453 ' H ' HG22 ' D' ' 89' ' ' ILE . 8.8 pt-20 -135.1 178.17 7.24 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.02 0.928 . . . . 75.23 111.08 -178.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.79 -138.77 42.47 Favored Glycine 0 C--N 1.358 1.797 0 CA-C-N 115.676 -0.693 . . . . 64.22 113.068 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 65.5 p -88.31 -20.37 25.48 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.167 0.587 . . . . 64.13 110.284 170.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.751 ' HA ' ' HB3' ' D' ' 96' ' ' HIS . 25.7 tp60 -59.69 -21.42 60.56 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.186 1.395 . . . . 54.32 112.295 -175.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.425 ' HA ' ' HB ' ' D' ' 89' ' ' ILE . 16.8 ptp -57.51 -51.04 71.07 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.435 0.694 . . . . 71.12 111.856 172.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.23 -22.77 26.72 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.943 0.497 . . . . 72.42 111.771 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 96' ' ' HIS . . . . . 0.751 ' HB3' ' HA ' ' D' ' 93' ' ' GLN . 19.6 t-80 -75.02 -11.27 60.06 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.184 0.593 . . . . 54.22 110.094 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 43.7 t -72.99 -51.2 19.17 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.966 0.506 . . . . 73.41 110.447 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.517 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 3.2 pp -77.64 -19.03 56.14 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.037 0.384 . . . . 55.54 112.037 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.35 -0.82 64.91 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-O 119.817 -0.435 . . . . 73.35 113.345 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.14 -66.78 0.39 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.903 0.481 . . . . 64.02 111.212 -176.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -66.84 -43.33 83.97 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.436 0.294 . . . . 72.43 111.78 -173.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.517 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 75.6 m -63.74 -47.44 81.71 Favored Pre-proline 0 CA--C 1.567 1.629 0 CA-C-O 118.289 -0.862 . . . . 75.12 112.591 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.598 ' HA ' HD12 ' D' ' 106' ' ' LEU . 27.9 Cg_exo -62.51 -28.53 77.75 Favored 'Trans proline' 0 C--N 1.399 3.233 0 C-N-CA 122.153 1.902 . . . . 53.33 112.964 170.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -67.91 -32.86 73.63 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.616 0.367 . . . . 75.44 111.068 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 48.0 mm -65.58 -34.38 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.149 0.58 . . . . 74.2 110.241 173.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.598 HD12 ' HA ' ' D' ' 103' ' ' PRO . 29.5 mt -77.81 -18.27 56.55 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.381 -0.827 . . . . 72.31 111.933 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.04 -41.3 10.74 Favored Pre-proline 0 N--CA 1.486 1.358 0 N-CA-C 113.91 1.078 . . . . 71.2 113.91 -173.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -50.65 -42.91 48.34 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.208 1.939 . . . . 64.22 112.721 169.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 109' ' ' TYR . . . . . 0.455 ' OH ' ' HB3' ' B' ' 130' ' ' PRO . 93.2 m-85 -79.49 -27.29 41.47 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.634 0.774 . . . . 74.3 111.732 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.06 -49.5 67.41 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.049 -0.722 . . . . 75.24 109.049 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -67.13 -33.37 75.29 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 113.868 -1.515 . . . . 51.44 110.864 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -53.92 -55.79 23.73 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 124.007 0.923 . . . . 70.24 110.268 174.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.408 ' O ' ' HG3' ' D' ' 117' ' ' MET . 47.2 t -62.99 -47.52 82.79 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 114.225 -1.352 . . . . 74.32 111.182 -177.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.623 HG23 ' SG ' ' D' ' 76' ' ' CYS . 68.5 mt -60.95 -61.74 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.324 0.65 . . . . 73.02 111.576 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 22.3 m -51.97 -40.42 60.86 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 124.198 0.937 . . . . 73.42 111.455 -175.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 37.5 t -60.41 -50.77 72.27 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 114.343 -1.299 . . . . 74.42 110.751 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.408 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 72.4 mtm -66.54 -30.85 71.25 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.122 0.569 . . . . 75.41 112.16 -178.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.8 t -66.56 -44.34 90.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.722 0.809 . . . . 73.14 110.042 176.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 83.7 p -74.83 -28.67 60.79 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.746 -0.661 . . . . 73.3 110.56 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' D' ' 116' ' ' SER . 88.3 mtt-85 -69.84 -29.73 67.05 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.648 0.779 . . . . 61.45 109.809 173.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.46 6.98 80.88 Favored Glycine 0 C--N 1.356 1.672 0 O-C-N 123.656 0.598 . . . . 60.3 113.157 177.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.609 HG23 ' HB3' ' C' ' 17' ' ' TYR . 81.2 p 55.69 28.25 11.84 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 126.277 1.831 . . . . 61.44 113.442 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -90.9 151.34 43.34 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 123.641 0.776 . . . . 75.35 109.289 169.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -51.58 125.15 15.99 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.64 2.227 . . . . 65.42 112.211 172.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -42.89 135.64 2.95 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 126.191 1.796 . . . . 75.22 113.277 -175.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.655 HD13 HG21 ' D' ' 40' ' ' VAL . 28.7 tp -116.55 96.99 5.76 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.774 0.83 . . . . 55.4 109.78 -176.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -97.11 96.48 8.49 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 106.931 -1.507 . . . . 53.33 106.931 175.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.496 HD11 HD12 ' D' ' 114' ' ' ILE . 92.9 mt -54.13 127.25 25.95 Favored 'General case' 0 C--O 1.246 0.884 0 O-C-N 123.649 0.593 . . . . 73.15 110.397 -177.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.18 140.81 82.81 Favored Pre-proline 0 CA--C 1.551 0.982 0 O-C-N 124.185 0.928 . . . . 74.23 110.734 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.404 ' HD3' HG13 ' B' ' 13' ' ' ILE . 98.0 Cg_endo -74.22 108.4 2.66 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.566 2.177 . . . . 74.22 111.739 -170.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 59.1 t -106.48 117.25 51.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 108.186 -1.042 . . . . 71.43 108.186 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -74.28 113.14 11.14 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.698 -0.853 . . . . 54.5 108.698 169.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 133' ' ' PHE . . . . . 0.439 ' CD2' ' HB2' ' D' ' 103' ' ' PRO . 2.0 m-85 . . . . . 0 N--CA 1.471 0.594 0 CA-C-N 115.239 -0.891 . . . . 72.55 110.826 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 75.9 m . . . . . 0 N--CA 1.457 -0.118 0 N-CA-C 107.672 -1.233 . . . . 74.21 107.672 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -114.91 120.5 40.16 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.725 -1.213 . . . . 73.25 107.725 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -139.11 123.77 18.51 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.55 -0.907 . . . . 71.43 108.55 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.453 HG21 ' HG3' ' C' ' 130' ' ' PRO . 3.0 mt -88.43 119.59 35.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.624 -0.88 . . . . 73.12 108.624 177.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -91.39 -37.27 13.31 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 123.785 0.678 . . . . 74.1 110.516 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -171.17 121.49 0.54 Allowed 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.353 0.408 . . . . 74.1 109.948 -176.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 76.2 mt -106.72 137.18 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.201 -1.037 . . . . 53.5 108.201 171.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.511 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 37.3 p90 -164.44 175.89 9.53 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-O 122.042 0.925 . . . . 73.11 111.92 -174.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 56.2 p -102.78 111.56 23.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.677 -1.147 . . . . 75.5 108.724 176.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.511 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 34.2 mtpt -72.92 -34.32 66.54 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.283 -0.636 . . . . 75.02 109.283 175.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.1 t70 -150.35 145.79 26.33 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.965 -1.016 . . . . 64.41 110.142 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.56 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 75.5 mt -142.78 143.3 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.663 1.585 . . . . 61.15 107.43 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.4 t -154.72 131.24 10.56 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.899 0.48 . . . . 63.2 110.165 173.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.513 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 87.6 t80 -126.99 141.9 51.68 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.332 -1.358 . . . . 65.03 107.332 172.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HB3' ' HD3' ' A' ' 26' ' ' PRO . 30.2 mt-10 -135.04 142.52 46.39 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.785 -0.45 . . . . 73.31 109.785 175.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.83 71.08 13.74 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 106.991 -1.485 . . . . 33.34 106.991 166.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.404 ' HD3' ' HB3' ' A' ' 24' ' ' GLU . 65.1 Cg_endo -71.78 -17.84 28.93 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 122.434 2.089 . . . . 75.13 112.2 -175.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -104.71 17.38 24.24 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-O 118.007 -0.996 . . . . 62.4 109.698 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.449 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -46.34 -55.72 13.03 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 113.674 0.99 . . . . 50.42 113.674 -169.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 32.2 Cg_exo -60.83 -26.85 83.83 Favored 'Trans proline' 0 C--N 1.388 2.616 0 C-N-CA 121.73 1.62 . . . . 63.12 113.612 178.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -81.86 -41.23 21.28 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.876 0.871 . . . . 71.24 110.522 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.574 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.8 p -74.95 -20.66 16.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 124.576 1.15 . . . . 73.43 111.787 -161.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -76.91 -21.27 55.13 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.584 0.754 . . . . 74.24 110.852 176.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -90.51 -11.94 38.71 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.697 1.199 . . . . 71.44 110.879 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -83.07 164.06 20.53 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.165 0.986 . . . . 72.41 111.44 -178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.96 118.86 17.41 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.538 0.735 . . . . 55.55 109.367 173.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.45 ' CE3' HD21 ' A' ' 68' ' ' LEU . 71.2 t-105 -81.06 93.14 6.34 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 121.05 0.453 . . . . 75.24 110.737 -176.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -128.04 84.1 64.22 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 107.342 -1.355 . . . . 72.32 107.342 168.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -76.31 110.48 3.07 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.534 2.156 . . . . 54.11 112.443 -171.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -92.85 84.78 5.01 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 106.68 -1.6 . . . . 70.13 106.68 175.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.568 HG22 ' HB2' ' A' ' 66' ' ' ALA . 48.8 t -86.81 106.51 15.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 114.789 -1.096 . . . . 75.3 110.431 -173.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -79.01 123.47 27.33 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.19 -0.914 . . . . 71.51 109.454 171.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.8 mt -97.57 106.21 18.49 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.203 -1.036 . . . . 74.31 108.203 173.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.472 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 29.3 t70 -108.52 140.69 41.51 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.803 -1.184 . . . . 74.21 107.803 176.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.521 HD11 HG21 ' A' ' 131' ' ' VAL . 85.5 mt -136.56 150.95 48.87 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.173 0.589 . . . . 61.35 110.925 -172.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 21.8 t0 -154.77 148.98 25.98 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.931 -1.032 . . . . 71.01 109.417 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.455 HG21 ' HA2' ' A' ' 99' ' ' GLY . 89.3 m -130.86 147.44 52.51 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.614 0.766 . . . . 43.52 109.582 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -157.33 109.73 2.44 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.625 0.77 . . . . 73.34 109.661 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.3 p -93.15 154.38 18.1 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.111 0.564 . . . . 43.31 110.229 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.8 t -151.62 121.51 7.07 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.047 0.939 . . . . 64.14 109.023 -176.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -73.03 105.57 4.55 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.034 0.533 . . . . 60.44 109.679 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' ' 57' ' ' GLU . 60.6 mt -79.09 -38.65 35.73 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.195 0.598 . . . . 73.52 110.275 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.27 -179.88 7.93 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.925 -1.034 . . . . 65.2 109.485 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -68.46 124.93 24.9 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.012 0.525 . . . . 72.34 109.944 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 63.72 16.6 9.86 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.008 1.323 . . . . 74.42 111.717 -173.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.0 t -124.93 109.22 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.083 0.953 . . . . 64.5 108.526 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -121.9 125.62 46.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.332 -0.988 . . . . 72.4 108.332 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.442 ' HB2' HD11 ' A' ' 51' ' ' LEU . 21.7 tt0 -83.44 150.33 26.11 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.984 -1.117 . . . . 74.13 107.984 166.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.0 t -131.16 136.27 58.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 107.642 -1.244 . . . . 72.43 107.642 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.441 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 48.7 t -109.56 135.97 46.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.367 -0.975 . . . . 50.23 108.367 175.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.491 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -112.95 104.09 12.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.643 -1.614 . . . . 74.44 106.643 170.606 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.425 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 16.6 ttp180 -92.79 100.15 12.69 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.363 -1.347 . . . . 63.35 107.363 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.8 t -98.44 128.97 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 N-CA-C 108.235 -1.024 . . . . 74.43 108.235 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 16.8 m -120.95 112.04 18.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.524 0.678 . . . . 73.53 109.322 175.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 80.4 t -106.14 125.94 61.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 124.731 1.212 . . . . 65.13 107.883 -178.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.1 m -134.08 115.05 13.83 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 118.379 0.536 . . . . 71.25 109.848 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.568 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -100.79 121.85 42.4 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.059 -1.46 . . . . 44.52 107.059 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.1 m -121.84 135.71 54.91 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.435 0.694 . . . . 55.14 109.876 176.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.45 HD21 ' CE3' ' A' ' 36' ' ' TRP . 17.6 mt -88.13 72.1 9.18 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 107.65 -1.241 . . . . 54.24 107.65 174.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.77 -90.85 1.07 Allowed Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.218 -0.901 . . . . 52.41 111.515 -171.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -113.27 -27.03 8.12 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.165 0.586 . . . . 74.4 111.933 -174.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -85.65 129.83 34.72 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.504 -0.924 . . . . 71.42 108.504 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.3 m -72.85 125.87 28.57 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.876 -0.416 . . . . 64.12 109.876 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.574 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -71.26 -57.68 4.25 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.844 0.858 . . . . 54.01 110.319 175.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -155.06 164.5 38.8 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.261 -0.881 . . . . 74.31 111.497 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 64' ' ' VAL . 65.6 tp -118.82 140.95 49.11 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.8 -1.091 . . . . 75.01 108.202 170.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.487 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 83.2 m -140.07 96.84 3.12 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.711 0.805 . . . . 65.32 109.66 173.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -111.49 117.44 33.03 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.575 -0.528 . . . . 64.41 109.575 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.1 t -126.58 113.96 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.003 0.921 . . . . 72.4 109.845 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 53.0 mt-30 -86.3 85.58 7.34 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.774 0.83 . . . . 63.13 109.21 171.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.437 ' HG3' HD22 ' A' ' 106' ' ' LEU . 61.2 tp60 -78.62 96.34 5.47 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.079 -0.964 . . . . 75.13 109.978 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -100.72 145.43 17.11 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.552 -0.619 . . . . 72.11 111.552 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.47 130.42 3.94 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.65 -0.98 . . . . 74.11 110.65 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 48.8 mt -79.55 126.56 39.22 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 108.501 -0.925 . . . . 71.02 108.501 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.504 ' HB3' HD11 ' A' ' 86' ' ' ILE . 74.0 m-85 -131.6 123.29 27.59 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.426 0.69 . . . . 43.34 109.894 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.9 t -83.44 106.23 15.02 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.237 -0.653 . . . . 65.32 109.237 171.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.504 HD11 ' HB3' ' A' ' 84' ' ' PHE . 7.7 mm -117.05 150.52 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.418 0.687 . . . . 71.35 110.157 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.96 163.38 16.04 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.571 0.544 . . . . 64.24 112.079 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.22 -19.41 46.03 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-N 115.543 -0.753 . . . . 72.2 113.124 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.424 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -134.11 148.95 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.741 0.816 . . . . 72.15 111.216 -171.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -138.05 175.24 9.75 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.942 1.297 . . . . 71.3 109.183 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.5 -123.99 33.52 Favored Glycine 0 CA--C 1.533 1.195 0 O-C-N 123.623 0.577 . . . . 32.22 114.185 175.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 38.1 p -73.2 -30.34 63.45 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.037 0.935 . . . . 65.35 110.825 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -67.66 -37.83 82.93 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.306 1.042 . . . . 60.53 110.359 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 5.3 tpt -68.38 -45.55 72.44 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.939 -0.573 . . . . 74.24 109.648 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.69 -38.1 77.5 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.187 0.929 . . . . 75.4 111.75 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.467 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 58.9 t-80 -67.94 -33.91 75.58 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.31 0.644 . . . . 65.2 111.269 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.4 t -69.99 -45.11 68.0 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.019 0.437 . . . . 75.45 110.065 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.7 mt -80.79 -31.03 35.89 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.103 -0.953 . . . . 73.11 112.677 -170.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.455 ' HA2' HG21 ' A' ' 46' ' ' THR . . . -106.6 4.59 37.12 Favored Glycine 0 N--CA 1.472 1.059 0 CA-C-O 119.953 -0.36 . . . . 65.51 113.783 -173.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.571 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -136.13 -68.43 0.5 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 117.191 0.495 . . . . 61.24 111.186 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -68.22 -43.7 77.39 Favored 'General case' 0 CA--C 1.555 1.135 0 CA-C-N 116.316 -0.402 . . . . 73.41 111.914 -172.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.2 m -63.71 -51.47 65.38 Favored Pre-proline 0 CA--C 1.57 1.73 0 C-N-CA 124.247 1.019 . . . . 71.54 113.084 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.47 -19.97 48.39 Favored 'Trans proline' 0 C--N 1.397 3.084 0 C-N-CA 121.842 1.695 . . . . 62.22 113.008 173.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -67.99 -37.52 81.58 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.187 0.595 . . . . 63.33 110.519 174.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.439 HG21 HD13 ' A' ' 13' ' ' ILE . 48.7 mm -67.29 -41.45 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.529 0.732 . . . . 65.24 110.084 173.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.437 HD22 ' HG3' ' A' ' 80' ' ' GLN . 61.5 mt -73.5 -25.59 60.51 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.018 -0.992 . . . . 63.11 112.422 -174.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -61.12 -45.57 95.97 Favored Pre-proline 0 N--CA 1.486 1.354 0 N-CA-C 114.127 1.158 . . . . 75.55 114.127 -173.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -53.46 -36.46 79.77 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.265 1.977 . . . . 74.52 113.611 171.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.426 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 88.0 m-85 -83.36 -28.96 28.6 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.635 0.774 . . . . 64.13 112.252 -177.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.93 -46.77 70.57 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.414 -0.958 . . . . 41.43 108.414 172.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.476 ' HG2' ' OH ' ' C' ' 109' ' ' TYR . 32.0 ttm180 -58.25 -43.17 87.71 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 114.04 -1.436 . . . . 75.14 109.739 175.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 109' ' ' TYR . 11.6 tt0 -48.83 -57.94 5.6 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 125.055 1.342 . . . . 73.2 111.462 175.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 117' ' ' MET . 53.6 t -64.92 -45.19 86.91 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.428 -1.26 . . . . 65.52 111.693 -174.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.632 HD13 HD11 ' A' ' 128' ' ' LEU . 8.5 mt -58.6 -60.27 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.818 0.847 . . . . 63.53 110.554 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.9 m -50.1 -41.87 49.16 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 125.058 1.343 . . . . 65.51 112.513 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -67.97 -43.03 79.91 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.714 -1.13 . . . . 75.31 110.635 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.513 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 52.6 mtm -62.28 -39.32 92.55 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 122.807 0.443 . . . . 65.43 110.875 177.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 114' ' ' ILE . 94.9 t -57.58 -49.56 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 124.341 1.056 . . . . 75.13 110.232 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 81.6 p -71.61 -29.36 64.58 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.89 -0.595 . . . . 64.51 111.61 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -72.33 -29.19 63.59 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.673 0.789 . . . . 74.12 110.17 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.76 18.3 31.16 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-O 119.459 -0.634 . . . . 72.54 112.762 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.47 HG21 ' HE ' ' B' ' 15' ' ' ARG . 5.6 t 58.03 13.08 2.04 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 127.445 2.298 . . . . 61.31 114.014 178.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -78.98 150.25 74.72 Favored Pre-proline 0 C--O 1.245 0.85 0 N-CA-C 108.156 -1.053 . . . . 63.23 108.156 171.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -58.61 144.25 97.64 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.278 1.985 . . . . 55.25 110.852 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -55.07 129.34 37.64 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 124.562 1.164 . . . . 72.42 111.698 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.9 tp -107.37 138.1 44.2 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 108.416 -0.957 . . . . 71.43 108.416 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -122.74 125.85 46.35 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.1 -1.074 . . . . 73.35 108.1 175.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.632 HD11 HD13 ' A' ' 114' ' ' ILE . 10.2 mt -73.1 126.54 30.24 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.492 -0.929 . . . . 74.14 108.492 177.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.71 134.99 82.79 Favored Pre-proline 0 CA--C 1.554 1.108 0 CA-C-O 118.974 -0.536 . . . . 50.14 110.883 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.59 116.56 2.8 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.653 2.902 . . . . 73.21 113.843 -175.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.521 HG21 HD11 ' A' ' 44' ' ' LEU . 61.4 t -105.87 131.94 54.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-O 121.058 0.456 . . . . 71.23 110.456 177.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.453 ' OD1' ' HB3' ' A' ' 134' ' ' ASP . 52.0 t-20 -99.66 91.79 5.04 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.581 -1.191 . . . . 53.25 107.82 175.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.402 ' CZ ' HD13 ' A' ' 44' ' ' LEU . 92.2 m-85 -63.16 -25.83 68.53 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.715 0.806 . . . . 72.44 112.637 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.571 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 28.9 t70 -59.37 -49.56 77.34 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.286 -0.635 . . . . 74.25 109.286 171.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.37 96.54 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.326 1.017 . . . . 73.23 111.286 177.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 72.6 mt -60.7 -43.4 97.83 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.084 0.554 . . . . 72.1 111.14 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 39.3 t80 . . . . . 0 CA--C 1.539 0.548 0 CA-C-N 115.863 -0.608 . . . . 73.22 110.153 178.878 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.49 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 1.0 OUTLIER . . . . . 0 CA--C 1.565 1.539 0 CA-C-O 120.905 0.383 . . . . 72.53 110.97 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.467 ' N ' ' SD ' ' B' ' 9' ' ' MET . 79.3 m -149.45 108.48 3.9 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 123.987 0.915 . . . . 65.13 108.71 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.477 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 65.9 t80 -116.55 145.63 43.21 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.433 0.693 . . . . 53.35 109.363 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -158.91 141.7 14.36 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.194 -1.039 . . . . 72.4 108.194 170.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.461 HD13 HD11 ' B' ' 16' ' ' ILE . 31.6 mt -76.86 145.67 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 N-CA-C 108.267 -1.012 . . . . 64.45 108.267 170.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -109.25 -40.51 4.92 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.901 0.481 . . . . 70.52 110.183 174.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.47 ' HE ' HG21 ' A' ' 122' ' ' THR . 48.0 ttt180 -173.68 137.13 0.6 Allowed 'General case' 0 N--CA 1.476 0.871 0 O-C-N 123.73 0.644 . . . . 74.42 109.881 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.461 HD11 HD13 ' B' ' 13' ' ' ILE . 93.4 mt -114.92 138.55 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.848 1.259 . . . . 64.33 107.678 176.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -164.43 140.68 6.16 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.919 0.711 . . . . 70.4 112.919 -173.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 69.9 m -73.7 121.48 20.83 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.057 -0.974 . . . . 74.44 109.121 170.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.523 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 46.9 mtpt -98.77 -16.96 18.74 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.636 0.774 . . . . 65.02 111.764 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.572 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 34.5 t70 -169.81 144.66 2.86 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.724 0.64 . . . . 63.33 111.186 -172.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.525 HD11 ' SG ' ' B' ' 113' ' ' CYS . 30.6 mm -143.53 146.36 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.677 1.191 . . . . 75.4 110.173 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.501 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 72.4 m -144.02 139.28 28.92 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.528 1.531 . . . . 63.41 108.558 171.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.56 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 89.4 t80 -148.36 108.73 4.13 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.297 -1.742 . . . . 72.41 106.297 164.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -118.8 114.64 22.96 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.079 -1.082 . . . . 64.21 108.079 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.465 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -106.68 86.9 2.47 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.164 -1.421 . . . . 64.03 107.164 173.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.9 -35.52 20.65 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.883 2.389 . . . . 54.22 112.171 -171.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -103.1 16.38 26.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.977 0.911 . . . . 75.54 110.962 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.465 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -43.77 -58.52 4.49 Favored Pre-proline 0 N--CA 1.491 1.591 0 C-N-CA 124.985 1.314 . . . . 70.1 114.479 -168.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 33.9 Cg_exo -57.99 -45.42 32.35 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 122.367 2.044 . . . . 72.31 113.328 -171.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -96.55 -17.24 20.6 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.172 -0.922 . . . . 73.43 112.802 -170.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.584 HG21 ' HA ' ' B' ' 73' ' ' ALA . 5.2 p -73.07 -20.32 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 118.169 0.44 . . . . 73.41 110.345 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -72.61 -1.06 14.67 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.493 0.923 . . . . 74.21 113.493 -177.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -71.56 -16.88 62.33 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 120.911 0.386 . . . . 74.42 110.097 167.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -105.9 69.38 0.81 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.525 1.53 . . . . 74.41 110.0 -176.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -84.85 76.59 10.22 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.773 0.797 . . . . 72.04 110.492 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.444 ' O ' ' HG2' ' B' ' 124' ' ' PRO . 3.8 p90 -152.92 173.15 15.73 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.037 -1.097 . . . . 72.32 108.037 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -66.52 115.33 23.1 Favored Pre-proline 0 CA--C 1.563 1.445 0 N-CA-C 112.353 0.501 . . . . 72.12 112.353 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.413 ' HD3' ' HG2' ' B' ' 124' ' ' PRO . 60.2 Cg_endo -71.85 157.06 55.86 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.512 2.141 . . . . 64.12 111.593 176.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.68 103.96 5.16 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.252 -1.018 . . . . 75.43 108.252 169.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.671 HG11 HD11 ' B' ' 126' ' ' LEU . 21.5 t -96.18 157.08 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.204 1.002 . . . . 74.03 110.031 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -142.97 124.65 14.95 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.625 1.17 . . . . 75.43 107.94 172.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.59 HD13 HD22 ' B' ' 128' ' ' LEU . 21.5 tp -87.56 136.85 32.78 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 108.32 -0.992 . . . . 74.23 108.32 170.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -137.04 149.89 47.73 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.711 -0.848 . . . . 64.11 108.711 -173.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mp -128.6 150.5 50.19 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.92 0.888 . . . . 71.43 109.578 -174.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 27.2 t70 -154.55 152.15 29.72 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.57 1.148 . . . . 63.41 108.673 173.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' THR . . . . . 0.42 HG22 HD22 ' B' ' 60' ' ' LEU . 75.9 p -126.76 134.5 50.6 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 121.176 0.513 . . . . 73.12 111.474 -177.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.05 116.17 6.06 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.04 -1.467 . . . . 74.33 107.04 169.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.506 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 41.0 m -143.0 161.15 38.9 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.572 0.349 . . . . 61.34 110.741 -171.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.8 p -152.1 139.91 19.93 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.904 0.482 . . . . 33.13 111.288 -172.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -83.47 129.25 34.97 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.465 -0.939 . . . . 74.41 108.465 169.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 pp -141.84 25.05 1.99 Allowed 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.774 0.829 . . . . 74.33 109.823 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' B' ' 55' ' ' VAL . . . -161.43 148.01 14.44 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.154 -0.93 . . . . 62.14 109.789 -173.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.41 121.71 24.18 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.1 -0.704 . . . . 72.23 109.1 171.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 68.53 12.12 8.59 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 124.675 1.235 . . . . 50.12 113.03 174.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.407 ' O ' ' HB3' ' B' ' 52' ' ' ALA . 89.6 t -140.01 129.87 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 N-CA-C 107.068 -1.456 . . . . 74.34 107.068 -175.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.506 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 11.8 t80 -118.0 153.37 33.78 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.902 -0.499 . . . . 54.11 110.104 -175.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -116.3 105.77 12.92 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.63 -1.248 . . . . 61.22 107.63 176.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.43 143.41 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.859 0.864 . . . . 63.54 109.787 -176.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 22.7 t -129.83 127.06 63.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 C-N-CA 123.982 0.913 . . . . 63.53 108.756 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.42 HD22 HG22 ' B' ' 46' ' ' THR . 0.3 OUTLIER -110.53 120.41 42.32 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 107.628 -1.249 . . . . 54.05 107.628 172.766 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.428 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 16.7 ttm-85 -86.82 113.28 22.5 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.86 -0.793 . . . . 64.11 108.86 174.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.17 105.19 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.095 0.958 . . . . 73.21 108.652 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 23.9 m -107.08 148.01 29.29 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.209 1.004 . . . . 51.32 109.991 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.551 HG11 HD21 ' B' ' 126' ' ' LEU . 24.4 t -136.47 117.78 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.107 1.363 . . . . 74.24 108.797 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 85.8 m -104.96 136.53 44.27 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 108.119 -1.067 . . . . 63.14 108.119 169.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.2 144.65 36.69 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.801 -0.814 . . . . 64.42 108.801 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.489 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 61.2 p -144.54 133.35 22.44 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.745 0.646 . . . . 22.11 112.745 -173.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 53.0 mt -107.61 128.44 54.54 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.672 1.189 . . . . 61.32 110.506 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.76 -110.57 3.41 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 111.751 -0.539 . . . . 51.54 111.751 -173.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -116.9 1.73 12.7 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 123.536 0.734 . . . . 73.25 110.432 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -115.03 158.37 22.19 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.749 -0.595 . . . . 75.11 110.218 -174.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.8 m -68.77 130.87 44.07 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 110.062 -0.348 . . . . 65.02 110.062 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.584 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -81.0 -64.82 1.11 Allowed 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.634 -1.247 . . . . 73.11 107.634 173.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -151.29 164.77 35.88 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.058 -0.974 . . . . 64.24 111.492 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 74.5 mt -127.01 131.61 50.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 105.992 -1.855 . . . . 70.1 105.992 170.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 34.2 t -131.51 149.79 52.39 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.036 -1.098 . . . . 64.14 108.036 172.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.501 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 49.7 tt0 -158.41 131.89 7.56 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.072 -0.714 . . . . 70.02 109.072 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.411 HG11 ' HA ' ' B' ' 110' ' ' ALA . 87.4 t -129.44 148.38 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.443 -0.947 . . . . 74.15 108.443 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.572 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 27.2 mt-30 -124.91 93.56 3.93 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.958 -1.127 . . . . 73.11 107.958 171.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.412 ' HG3' HD22 ' B' ' 106' ' ' LEU . 61.5 tp60 -89.76 108.93 19.98 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.229 -0.896 . . . . 64.33 108.878 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.523 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -104.4 171.78 19.77 Favored Glycine 0 C--N 1.337 0.62 0 O-C-N 123.791 0.682 . . . . 63.42 111.867 177.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.46 137.48 4.26 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.468 -0.396 . . . . 74.42 112.47 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 51.4 mt -88.79 121.26 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 107.42 -1.326 . . . . 73.43 107.42 170.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -131.54 145.14 51.59 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.27 1.028 . . . . 61.04 108.974 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 56.4 m -89.53 121.88 32.16 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.548 0.739 . . . . 72.32 110.058 170.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.691 HG22 HD11 ' B' ' 89' ' ' ILE . 5.3 mp -125.29 108.79 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 107.472 -1.307 . . . . 74.02 107.472 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.86 166.12 26.17 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.609 0.763 . . . . 74.24 111.069 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 94.37 -29.81 8.49 Favored Glycine 0 N--CA 1.482 1.739 0 CA-C-O 121.098 0.277 . . . . 45.2 113.419 176.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.691 HD11 HG22 ' B' ' 86' ' ' ILE . 0.7 OUTLIER -90.83 168.26 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 124.598 1.159 . . . . 71.11 110.999 176.801 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -157.16 163.47 38.85 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.649 0.78 . . . . 35.42 110.299 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.51 -113.4 4.33 Favored Glycine 0 C--N 1.356 1.641 0 C-N-CA 123.473 0.558 . . . . 63.41 112.521 171.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 31.4 m -104.22 -35.42 8.01 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.71 0.804 . . . . 55.5 109.604 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -66.3 -17.31 64.68 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.104 0.962 . . . . 74.21 111.98 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.478 ' HA ' HD13 ' B' ' 89' ' ' ILE . 21.5 ptm -61.21 -56.57 19.16 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 122.865 0.466 . . . . 74.13 111.514 173.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 95' ' ' ALA . . . . . 0.403 ' HA ' ' HG ' ' B' ' 98' ' ' LEU . . . -81.0 -11.47 59.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.793 0.837 . . . . 63.14 111.939 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -64.75 -36.04 83.03 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.68 0.392 . . . . 64.2 110.778 169.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.1 t -66.76 -41.13 88.27 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.748 0.419 . . . . 74.45 111.516 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.603 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.6 pp -84.19 -29.82 26.29 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.892 0.477 . . . . 73.24 111.402 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.86 -24.65 31.88 Favored Glycine 0 C--N 1.345 1.081 0 O-C-N 123.535 0.522 . . . . 62.03 113.913 -172.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.4 -48.48 2.19 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.291 0.637 . . . . 72.33 111.513 -174.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -75.94 -47.07 26.62 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.689 0.396 . . . . 72.14 111.692 -173.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.603 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 73.6 m -64.03 -42.42 69.26 Favored Pre-proline 0 CA--C 1.566 1.559 0 N-CA-C 113.6 0.963 . . . . 70.51 113.6 -177.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.55 -21.22 53.01 Favored 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 121.878 1.719 . . . . 65.3 113.806 173.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -70.13 -30.55 67.75 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 122.539 0.335 . . . . 63.5 110.772 173.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.473 HG23 ' NH2' ' D' ' 111' ' ' ARG . 84.0 mt -67.34 -40.77 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.789 0.836 . . . . 75.44 109.689 170.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.412 HD22 ' HG3' ' B' ' 80' ' ' GLN . 96.8 mt -76.47 -27.36 56.1 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.831 -1.077 . . . . 63.23 112.51 -174.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -55.23 -47.47 98.47 Favored Pre-proline 0 CA--C 1.567 1.597 0 CA-C-O 118.042 -0.98 . . . . 72.13 113.494 -175.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -52.45 -41.3 68.23 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 122.838 2.359 . . . . 74.22 114.711 174.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -68.83 -36.62 78.41 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.057 0.543 . . . . 62.51 110.656 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.411 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -70.5 -36.08 73.59 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.765 0.826 . . . . 75.35 111.062 174.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.553 ' HA ' HD12 ' B' ' 128' ' ' LEU . 35.4 ttt-85 -63.3 -56.05 19.68 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.167 1.387 . . . . 70.45 110.661 -178.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.465 ' HG3' ' NH2' ' C' ' 120' ' ' ARG . 1.4 tm-20 -69.48 -22.53 63.61 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.762 -0.654 . . . . 75.42 109.832 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.525 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.3 t -75.97 -28.37 57.85 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 122.64 0.376 . . . . 73.21 111.138 176.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.481 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 52.3 mt -74.97 -56.22 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.515 0.726 . . . . 74.14 109.234 173.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 52.6 m -58.56 -27.95 65.07 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.185 0.994 . . . . 70.22 111.556 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.485 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 29.8 t -58.59 -53.76 54.75 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.921 0.888 . . . . 52.3 110.365 173.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.4 mmt -71.6 -32.8 68.41 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.905 0.882 . . . . 74.0 111.074 -172.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.426 HG21 ' CD2' ' B' ' 126' ' ' LEU . 98.7 t -64.67 -42.87 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.658 1.183 . . . . 65.13 110.459 173.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.7 t -65.93 -39.09 90.21 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.033 -0.985 . . . . 70.11 110.408 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' B' ' 116' ' ' SER . 66.4 mtt-85 -64.91 -45.44 85.89 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.518 -0.765 . . . . 74.44 109.214 174.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 121' ' ' GLY . . . . . 0.506 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -64.22 -11.16 44.98 Favored Glycine 0 C--N 1.361 1.917 0 O-C-N 124.58 1.175 . . . . 74.45 113.494 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 15.8 m 66.01 29.16 10.25 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.792 1.237 . . . . 52.31 110.329 174.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -83.33 162.63 53.29 Favored Pre-proline 0 CA--C 1.552 1.036 0 CA-C-N 114.841 -1.072 . . . . 74.12 110.652 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.444 ' HG2' ' O ' ' B' ' 36' ' ' TRP . 92.0 Cg_exo -48.36 159.61 0.73 Allowed 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.786 2.991 . . . . 70.02 114.787 173.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.423 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 6.7 tp-100 -60.55 113.19 2.3 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.36 -0.837 . . . . 73.11 111.484 -173.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.671 HD11 HG11 ' B' ' 40' ' ' VAL . 15.9 tp -112.23 120.08 40.54 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.843 -0.799 . . . . 75.03 108.843 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -133.0 126.53 32.15 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 107.801 -1.185 . . . . 55.31 107.801 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.59 HD22 HD13 ' B' ' 42' ' ' LEU . 76.1 mt -83.27 134.2 34.95 Favored 'General case' 0 C--O 1.242 0.7 0 O-C-N 123.409 0.443 . . . . 72.23 110.96 -176.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.61 143.88 90.55 Favored Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 124.58 1.175 . . . . 24.23 110.144 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -65.79 92.74 0.26 Allowed 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.68 2.253 . . . . 72.24 111.429 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 98.6 t -90.66 109.49 20.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.682 -1.229 . . . . 73.44 107.682 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 . . . . . 0 C--O 1.245 0.821 0 N-CA-C 107.539 -1.282 . . . . 74.53 107.539 177.15 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 65.0 t80 . . . . . 0 C--O 1.237 0.425 0 N-CA-C 108.594 -0.891 . . . . 73.24 108.594 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -159.22 123.9 4.04 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 108.898 -0.779 . . . . 63.52 108.898 175.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 62.2 mt -68.56 127.16 29.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 N-CA-C 108.741 -0.837 . . . . 74.12 108.741 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -89.38 -48.35 7.4 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 109.308 -0.627 . . . . 72.42 109.308 174.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.88 148.98 0.43 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.219 1.408 . . . . 71.2 108.731 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 2.7 pp -116.59 155.2 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 106.978 -1.49 . . . . 73.33 106.978 173.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.441 ' HB3' HG23 ' D' ' 122' ' ' THR . 29.5 p90 -175.28 151.36 1.25 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.68 0.752 . . . . 74.42 111.3 -174.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 64.7 p -78.79 102.62 8.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.818 -1.083 . . . . 73.45 108.84 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 8.8 mtmt -72.8 -30.4 64.04 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.061 -0.718 . . . . 72.23 109.061 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.762 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 20.8 t70 -143.91 138.8 28.81 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.104 -0.953 . . . . 63.11 109.732 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.52 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.6 mt -137.43 143.66 33.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 106.818 -1.549 . . . . 71.32 106.818 174.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 26.1 t -155.04 141.04 18.33 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 123.76 0.663 . . . . 71.04 110.084 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -145.32 113.0 6.32 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 106.974 -1.491 . . . . 74.03 106.974 171.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -117.71 122.92 44.77 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.167 0.587 . . . . 72.55 109.99 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.35 75.79 73.56 Favored Pre-proline 0 CA--C 1.552 1.026 0 N-CA-C 107.388 -1.338 . . . . 73.23 107.388 171.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -69.82 -22.75 31.36 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 122.77 2.314 . . . . 65.0 111.511 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -101.36 12.45 37.38 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.541 1.136 . . . . 73.43 110.191 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.446 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -49.1 -58.14 9.55 Favored Pre-proline 0 C--N 1.375 1.715 0 C-N-CA 124.388 1.075 . . . . 50.32 113.554 -169.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.446 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 18.4 Cg_exo -64.29 -35.95 48.45 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 121.704 1.603 . . . . 60.31 112.132 -176.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -69.82 -37.75 76.32 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.293 1.037 . . . . 74.35 112.297 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.614 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.1 p -81.29 -21.71 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 C-N-CA 122.819 0.448 . . . . 72.32 111.889 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -65.48 -26.84 68.11 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 120.681 0.277 . . . . 72.34 111.263 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -100.41 34.58 2.35 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.652 0.781 . . . . 73.45 110.279 174.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -125.05 163.08 23.15 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.523 0.729 . . . . 71.35 110.23 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -66.58 112.99 4.42 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.532 0.733 . . . . 70.3 110.656 173.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 69.5 t-105 -76.8 81.97 3.39 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.363 0.665 . . . . 72.33 110.529 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 37' ' ' GLN . . . . . 0.451 ' H ' HD22 ' C' ' 68' ' ' LEU . 96.8 mt-30 -136.17 73.72 57.31 Favored Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 124.522 1.129 . . . . 62.13 108.465 174.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.31 155.48 25.25 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.702 2.268 . . . . 53.23 113.837 -171.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -87.4 87.71 7.49 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 105.146 -2.168 . . . . 71.41 105.146 161.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.505 HG11 HD11 ' C' ' 126' ' ' LEU . 68.7 t -76.66 98.34 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.578 0 N-CA-C 107.527 -1.286 . . . . 73.14 107.527 177.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -114.59 103.8 11.37 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.953 -1.021 . . . . 71.34 108.329 -175.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.27 160.63 18.36 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.214 0.531 . . . . 62.24 110.287 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.611 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 18.1 t70 -145.69 121.15 10.34 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.614 1.166 . . . . 73.53 108.287 -177.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.522 HD21 HG13 ' C' ' 62' ' ' VAL . 81.8 mt -125.44 111.95 15.7 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.526 0.73 . . . . 72.45 109.99 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -136.52 127.06 26.9 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.439 -0.949 . . . . 70.13 108.439 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 12.4 t -115.05 146.27 41.45 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.272 0.629 . . . . 74.41 109.47 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.36 163.96 27.53 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.067 0.947 . . . . 55.34 109.304 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.465 ' OG ' ' HB3' ' C' ' 98' ' ' LEU . 3.2 m -142.89 143.71 32.16 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.805 -0.442 . . . . 73.3 109.805 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.9 t -145.2 127.81 16.12 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.0 0.92 . . . . 42.21 108.548 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -79.55 117.4 20.45 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.077 -0.712 . . . . 73.04 109.077 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.632 HD11 ' HB2' ' C' ' 57' ' ' GLU . 61.0 mt -86.39 -35.08 19.98 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.266 0.626 . . . . 74.23 111.027 -176.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.19 179.64 8.96 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.961 -1.018 . . . . 22.41 109.088 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.5 116.46 7.5 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.148 -0.686 . . . . 75.24 109.148 -178.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 68.33 18.9 9.08 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.447 1.099 . . . . 74.24 112.068 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 90.5 t -123.81 115.23 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 108.639 -0.874 . . . . 73.31 108.639 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -121.71 128.96 52.38 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.337 1.055 . . . . 71.52 109.577 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.632 ' HB2' HD11 ' C' ' 51' ' ' LEU . 44.2 tt0 -93.16 138.62 31.41 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.088 -0.708 . . . . 71.22 109.088 167.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 83.5 t -122.83 139.68 48.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.911 -1.144 . . . . 74.31 107.911 171.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 54.3 t -127.85 130.26 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 109.516 -0.55 . . . . 71.54 109.516 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.79 111.2 23.61 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.702 -1.221 . . . . 60.54 107.702 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -83.1 111.85 19.28 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 108.556 -0.905 . . . . 75.23 108.556 170.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.522 HG13 HD21 ' C' ' 44' ' ' LEU . 21.9 t -114.38 115.5 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 108.02 -1.104 . . . . 61.43 108.02 175.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 10.9 m -125.39 125.54 43.58 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.598 0.759 . . . . 64.23 108.956 -171.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.638 HG23 HD13 ' C' ' 114' ' ' ILE . 84.2 t -112.92 125.16 70.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 123.964 0.906 . . . . 72.52 108.89 177.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 12.5 m -104.12 138.81 40.08 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.77 -0.826 . . . . 53.44 108.77 170.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.97 101.56 5.48 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.636 -1.616 . . . . 64.42 106.636 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 41.1 m -134.02 126.46 30.26 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.537 -0.542 . . . . 74.43 109.537 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.451 HD22 ' H ' ' C' ' 37' ' ' GLN . 9.7 mt -84.47 52.85 2.47 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.618 1.167 . . . . 64.3 109.213 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.1 -99.83 1.93 Allowed Glycine 0 C--N 1.349 1.259 0 N-CA-C 110.515 -1.034 . . . . 70.4 110.515 -172.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -101.11 -30.44 11.58 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.943 0.897 . . . . 64.44 110.439 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -70.33 109.98 5.02 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.424 1.089 . . . . 62.35 109.451 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 38.9 m -83.41 124.46 30.7 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.897 0.772 . . . . 73.34 110.025 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.614 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -76.6 -57.93 3.57 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 114.398 -1.274 . . . . 72.43 109.618 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -154.65 166.26 33.96 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.025 -0.989 . . . . 73.33 110.706 174.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.432 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.4 tm? -129.23 142.56 50.82 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 105.894 -1.891 . . . . 71.05 105.894 166.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.432 ' N ' HD13 ' C' ' 75' ' ' LEU . 49.1 t -143.59 143.31 31.44 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.075 -1.083 . . . . 43.42 108.075 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -157.18 132.11 8.85 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 122.796 0.439 . . . . 74.21 109.973 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.434 HG11 ' HA ' ' C' ' 110' ' ' ALA . 55.2 t -133.85 115.41 21.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 124.748 1.219 . . . . 73.23 108.804 -176.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.762 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.2 mt-30 -96.19 90.56 5.54 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.677 0.791 . . . . 74.3 109.116 173.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.484 ' HG3' HD22 ' C' ' 106' ' ' LEU . 60.0 tp60 -80.67 99.74 8.33 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.698 -1.137 . . . . 65.31 109.515 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.56 153.78 27.74 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.862 -0.495 . . . . 62.13 111.862 174.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.5 126.44 2.08 Favored Glycine 0 CA--C 1.501 -0.785 0 N-CA-C 110.966 -0.854 . . . . 74.24 110.966 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.482 HD12 HD11 ' C' ' 51' ' ' LEU . 13.3 mm -88.96 128.71 40.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 N-CA-C 108.891 -0.781 . . . . 73.44 108.891 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -135.87 118.39 15.88 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.379 0.671 . . . . 73.24 109.369 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.5 p -79.6 101.32 8.24 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.262 -1.014 . . . . 32.2 108.262 172.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.651 HG21 ' HE1' ' C' ' 94' ' ' MET . 21.3 mt -117.53 129.94 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.582 0.753 . . . . 73.1 110.52 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.28 164.62 29.33 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.297 0.639 . . . . 73.55 110.671 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.39 -19.24 44.86 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 114.896 0.718 . . . . 72.32 114.896 170.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' C' ' 94' ' ' MET . 47.4 pt -108.53 167.97 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 117.593 0.697 . . . . 74.24 111.457 -176.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -159.35 177.9 10.51 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.364 -1.289 . . . . 74.5 109.263 175.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.63 -120.53 12.07 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 115.815 1.086 . . . . 62.21 115.815 173.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 46.4 p -64.91 -36.87 85.77 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.408 1.083 . . . . 71.32 111.173 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -62.23 -58.31 8.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.496 1.118 . . . . 74.31 110.538 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.651 ' HE1' HG21 ' C' ' 86' ' ' ILE . 4.6 tpt -54.15 -52.51 60.88 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 124.066 0.946 . . . . 73.54 112.243 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.96 -40.9 77.33 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 123.87 0.731 . . . . 74.32 111.235 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -68.7 -37.31 79.42 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.2 0.6 . . . . 65.35 111.222 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.477 ' SG ' HD13 ' C' ' 86' ' ' ILE . 35.4 t -67.6 -34.56 77.25 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.659 -0.497 . . . . 70.23 109.659 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.465 ' HB3' ' OG ' ' C' ' 48' ' ' SER . 79.9 mt -88.16 -33.03 18.33 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.527 1.131 . . . . 74.2 112.173 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.5 10.91 26.02 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 114.63 0.612 . . . . 73.02 114.63 -167.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.11 -48.66 0.07 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 117.401 0.6 . . . . 55.51 111.613 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -72.74 -55.03 7.37 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.302 0.641 . . . . 74.34 111.306 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 94.4 m -63.74 -44.99 81.7 Favored Pre-proline 0 CA--C 1.562 1.419 0 CA-C-O 118.213 -0.898 . . . . 63.25 112.031 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -53.02 -31.55 54.07 Favored 'Trans proline' 0 C--N 1.394 2.962 0 C-N-CA 122.88 2.387 . . . . 72.32 114.204 170.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -67.52 -35.54 79.29 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.537 0.735 . . . . 75.13 110.373 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.468 HD12 ' NH1' ' A' ' 111' ' ' ARG . 46.0 mm -77.06 -33.26 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.375 0.67 . . . . 75.24 110.449 177.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.484 HD22 ' HG3' ' C' ' 80' ' ' GLN . 94.3 mt -82.23 -30.02 31.01 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.865 0.866 . . . . 72.44 112.034 -175.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -57.18 -49.45 93.86 Favored Pre-proline 0 N--CA 1.484 1.23 0 CA-C-O 117.891 -1.052 . . . . 73.34 113.457 -173.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.61 -40.91 81.86 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 122.561 2.174 . . . . 71.1 114.31 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.476 ' OH ' ' HG2' ' A' ' 111' ' ' ARG . 89.6 m-85 -74.98 -37.56 61.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.155 0.582 . . . . 72.35 111.425 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.434 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -68.34 -34.89 76.92 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.353 -0.84 . . . . 54.03 110.498 176.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 24.2 ttt-85 -66.12 -51.24 59.8 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.604 1.561 . . . . 74.32 109.757 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -60.0 -39.53 86.1 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 124.093 0.871 . . . . 74.34 110.154 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 35.1 t -66.41 -39.86 89.23 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.461 -0.79 . . . . 74.32 110.933 -177.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.638 HD13 HG23 ' C' ' 64' ' ' VAL . 84.2 mt -69.19 -56.16 12.84 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 O-C-N 123.376 0.423 . . . . 71.05 110.565 177.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.1 m -63.21 -27.73 69.55 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 122.928 0.491 . . . . 74.1 111.066 -173.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 38.4 t -65.68 -49.34 68.91 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.383 0.673 . . . . 71.42 109.486 169.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.509 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.63 -36.63 79.1 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 124.607 1.163 . . . . 72.4 112.719 179.319 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.435 HG23 ' O ' ' C' ' 114' ' ' ILE . 76.6 t -64.23 -46.41 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.636 0.774 . . . . 65.23 108.962 175.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 39.5 t -67.3 -31.18 71.31 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.004 -0.998 . . . . 61.45 111.47 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.465 ' NH2' ' HG3' ' B' ' 112' ' ' GLU . 72.7 mtt-85 -71.17 -37.24 72.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.891 0.876 . . . . 75.54 109.566 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.46 4.3 84.45 Favored Glycine 0 C--N 1.353 1.474 0 O-C-N 123.848 0.717 . . . . 62.14 112.496 172.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 71.9 p 59.02 29.31 18.83 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.385 1.874 . . . . 75.24 113.696 172.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -85.38 143.2 38.64 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 107.018 -1.475 . . . . 73.2 107.018 166.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -48.69 143.3 16.82 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 123.088 2.525 . . . . 73.12 112.979 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.423 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 12.6 mm100 -46.9 142.67 3.31 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 124.565 1.165 . . . . 74.42 112.786 -174.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.505 HD11 HG11 ' C' ' 40' ' ' VAL . 23.6 tp -144.88 88.49 1.9 Allowed 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.188 -1.041 . . . . 74.43 108.188 -177.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -91.85 117.2 29.56 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.502 -1.226 . . . . 63.24 109.063 -174.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.402 HD21 HG21 ' C' ' 64' ' ' VAL . 4.1 mm? -70.91 124.53 24.55 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 123.893 0.745 . . . . 73.11 109.864 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.13 145.17 85.65 Favored Pre-proline 0 CA--C 1.548 0.874 0 O-C-N 124.219 0.949 . . . . 74.11 111.333 -175.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.453 ' HG3' HG21 ' A' ' 13' ' ' ILE . 16.1 Cg_endo -55.86 108.77 0.35 Allowed 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.555 2.837 . . . . 73.22 112.081 173.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 14.0 p -98.67 152.48 4.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 109.203 -0.666 . . . . 70.52 109.203 174.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -82.97 99.17 9.64 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.163 0.985 . . . . 73.2 108.832 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -68.66 -20.44 64.45 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.091 0.556 . . . . 74.23 112.121 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.78 -32.5 67.71 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.295 0.638 . . . . 72.21 110.792 172.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.14 -31.65 64.41 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.329 0.652 . . . . 74.01 110.588 174.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 56.3 mt -78.8 -20.91 48.64 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.423 -0.808 . . . . 72.15 110.438 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 69.0 t80 . . . . . 0 CA--C 1.548 0.88 0 C-N-CA 123.596 0.758 . . . . 73.5 110.582 172.976 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 28.9 p . . . . . 0 CA--C 1.545 0.776 0 N-CA-C 109.301 -0.629 . . . . 70.41 109.301 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -143.04 116.41 9.06 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.444 -1.317 . . . . 75.21 107.444 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -141.0 153.49 45.58 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.635 0.774 . . . . 63.21 109.415 172.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.523 HG21 HD11 ' D' ' 16' ' ' ILE . 73.8 mt -102.74 120.48 52.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.087 -1.079 . . . . 74.55 108.087 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -89.05 -42.57 11.66 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.17 0.588 . . . . 74.21 110.66 -175.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -163.37 142.36 8.27 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.285 0.366 . . . . 63.11 110.496 -172.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.523 HD11 HG21 ' D' ' 13' ' ' ILE . 2.7 mp -124.8 135.07 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 105.579 -2.008 . . . . 41.51 105.579 174.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.437 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 34.8 p90 -162.31 172.72 15.21 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 122.12 0.962 . . . . 72.35 112.079 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 18' ' ' THR . . . . . 0.49 HG21 HD11 ' D' ' 21' ' ' ILE . 75.7 p -107.34 120.48 42.26 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.181 -1.372 . . . . 63.11 109.028 178.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.437 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 29.6 mtpt -92.02 -19.7 22.1 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.742 -0.663 . . . . 74.32 109.493 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.456 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 32.6 t70 -162.14 138.77 8.0 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.94 0.896 . . . . 73.33 109.743 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.509 HG21 ' HE2' ' C' ' 117' ' ' MET . 63.9 mt -141.81 139.64 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.809 1.244 . . . . 71.33 107.773 175.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.7 t -141.9 145.44 34.59 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.37 1.068 . . . . 75.12 108.608 170.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.52 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.0 t80 -144.95 117.66 8.67 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.143 -1.799 . . . . 74.13 106.143 167.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -125.55 118.91 26.76 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.159 0.584 . . . . 64.21 109.787 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.496 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -113.89 80.32 5.19 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 107.695 -1.224 . . . . 61.53 107.695 174.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.6 -19.07 16.97 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.681 2.254 . . . . 54.1 113.014 -169.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -113.49 1.42 15.02 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.599 0.76 . . . . 75.34 111.178 -177.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.496 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -27.44 -70.01 0.07 OUTLIER Pre-proline 0 CA--C 1.567 1.61 0 N-CA-C 117.481 2.4 . . . . 61.32 117.481 -167.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.56 -18.01 15.8 Favored 'Trans proline' 0 C--N 1.387 2.564 0 CA-C-N 124.19 2.532 . . . . 65.11 113.971 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -78.31 -38.8 41.52 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.702 1.201 . . . . 72.11 109.699 175.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.428 HG21 ' HA ' ' D' ' 73' ' ' ALA . 5.1 p -83.83 -19.31 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-N 115.874 -0.603 . . . . 71.43 111.096 -175.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -64.07 -24.83 67.85 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 122.544 0.338 . . . . 75.23 111.159 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -65.97 -9.05 26.47 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.263 1.025 . . . . 74.42 111.711 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -100.52 99.33 9.91 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.225 1.41 . . . . 70.33 109.602 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -97.33 83.2 3.25 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.254 -0.885 . . . . 74.54 110.876 -171.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -158.82 176.97 11.68 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.822 0.849 . . . . 64.23 109.402 169.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -69.94 110.96 7.6 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.353 1.061 . . . . 73.14 109.829 174.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.454 ' HB3' ' HG ' ' D' ' 68' ' ' LEU . 38.9 Cg_endo -68.81 129.63 18.98 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.014 1.809 . . . . 74.33 110.588 175.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -67.4 116.55 8.29 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 107.514 -1.291 . . . . 73.54 107.514 168.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.562 ' CG1' HG13 ' D' ' 64' ' ' VAL . 16.1 t -98.23 114.41 35.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 108.9 -0.778 . . . . 74.21 108.9 176.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -89.54 116.93 28.06 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.81 -0.811 . . . . 73.04 108.81 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.497 HD22 HD11 ' D' ' 128' ' ' LEU . 49.2 tp -97.27 144.43 27.07 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.065 0.459 . . . . 74.12 110.23 -176.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -135.17 139.5 44.62 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.681 -1.6 . . . . 74.34 106.681 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.443 HD11 HG11 ' D' ' 131' ' ' VAL . 45.4 mt -130.0 132.07 46.12 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.226 0.61 . . . . 63.53 110.666 -174.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -140.35 154.11 46.63 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.598 1.159 . . . . 71.44 108.317 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 2.1 p -128.61 159.69 34.76 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.597 0.713 . . . . 75.55 110.778 176.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.544 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.75 177.8 9.46 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.218 -1.356 . . . . 61.1 108.528 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 61.9 p . . . . . 0 N--CA 1.476 0.866 0 C-N-CA 123.883 0.873 . . . . 64.22 108.977 -175.187 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.497 1.899 0 N-CA-C 113.951 1.093 . . . . 74.51 113.951 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.06 106.06 20.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.166 -1.42 . . . . 60.22 107.166 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -129.6 147.81 51.44 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.385 -0.598 . . . . 73.31 109.385 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -111.98 148.85 32.9 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.065 -1.087 . . . . 63.42 108.065 161.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 71.2 t -123.27 140.78 45.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 124.811 1.244 . . . . 70.22 107.692 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 30.3 t -125.89 137.31 58.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.727 -1.212 . . . . 55.54 107.727 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.434 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -125.74 105.4 8.95 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.511 -1.292 . . . . 73.12 107.511 -176.764 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 41.4 ttm-85 -85.14 102.49 13.32 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.748 0.819 . . . . 74.42 109.214 174.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.491 HG13 HD11 ' D' ' 42' ' ' LEU . 57.9 t -100.86 116.4 44.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.603 -0.888 . . . . 74.14 108.603 173.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.8 m -119.0 122.96 43.38 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.944 0.878 . . . . 72.52 110.233 -171.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.562 HG13 ' CG1' ' D' ' 40' ' ' VAL . 51.9 t -108.39 130.64 60.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 125.746 1.618 . . . . 61.22 109.635 -176.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 80.9 m -134.81 92.1 2.85 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.841 -1.17 . . . . 74.51 107.841 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -96.48 154.82 17.05 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.65 0.78 . . . . 44.32 109.123 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.481 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 25.2 p -149.58 135.02 18.37 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 123.648 0.592 . . . . 72.14 112.178 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.454 ' HG ' ' HB3' ' D' ' 38' ' ' PRO . 20.9 mt -105.46 102.43 11.9 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 124.81 1.244 . . . . 72.44 108.302 171.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.32 -125.4 10.6 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.572 -0.74 . . . . 72.41 113.438 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -84.97 4.96 31.22 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.554 1.142 . . . . 74.41 112.893 -174.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -146.32 165.75 28.35 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 120.9 0.381 . . . . 75.13 111.13 -172.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 55.7 m -64.03 135.26 56.27 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.529 -1.214 . . . . 65.34 111.435 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.481 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.46 -71.33 0.57 Allowed 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.236 -1.394 . . . . 63.32 107.236 170.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -145.11 151.95 39.29 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-O 121.179 0.514 . . . . 74.22 111.002 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 66.3 mt -117.08 152.54 34.47 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.095 1.358 . . . . 72.43 107.872 175.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.546 ' SG ' HG12 ' D' ' 114' ' ' ILE . 40.6 t -159.29 149.64 19.28 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.692 0.797 . . . . 63.13 108.883 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -154.91 121.71 5.45 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.48 -0.563 . . . . 75.41 109.48 170.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.58 115.82 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.64 0.776 . . . . 75.01 109.543 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.456 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.7 mt-30 -90.68 90.19 7.85 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.47 0.708 . . . . 74.0 109.415 170.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 80' ' ' GLN . . . . . 0.427 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.8 tp-100 -80.98 101.57 9.6 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.877 -1.056 . . . . 74.04 108.897 178.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.92 143.88 15.9 Favored Glycine 0 C--N 1.338 0.693 0 N-CA-C 111.397 -0.681 . . . . 60.21 111.397 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.8 140.72 7.84 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 111.758 -0.537 . . . . 74.32 111.758 -174.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 50.8 mt -90.48 120.57 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.724 -0.843 . . . . 60.51 108.724 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -121.01 126.48 50.02 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.099 0.96 . . . . 73.12 109.521 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 44.5 p -88.86 96.6 10.76 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.913 -0.773 . . . . 74.14 108.913 173.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.56 HD11 HD23 ' D' ' 98' ' ' LEU . 37.7 pt -119.83 129.16 75.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 115.465 -0.789 . . . . 53.25 109.615 -172.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.75 167.79 7.56 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.357 0.663 . . . . 75.23 110.926 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.25 12.3 61.74 Favored Glycine 0 N--CA 1.476 1.364 0 CA-C-N 116.629 -0.26 . . . . 72.43 112.993 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.511 HG12 ' SG ' ' D' ' 97' ' ' CYS . 1.0 OUTLIER -125.34 159.93 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.892 1.277 . . . . 63.33 109.074 176.171 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -149.4 156.38 41.95 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 122.989 0.516 . . . . 64.15 110.472 -168.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.37 -131.55 10.71 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 116.003 -0.544 . . . . 75.22 114.374 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 40.0 p -84.55 -41.0 16.9 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.183 0.993 . . . . 62.43 111.067 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -66.69 -19.05 65.68 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.279 -0.873 . . . . 73.54 111.408 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.45 ' HA ' HD13 ' D' ' 89' ' ' ILE . 59.4 ttp -54.33 -57.76 10.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.954 1.301 . . . . 70.4 111.392 174.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.21 -15.18 51.46 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.308 -0.86 . . . . 71.02 111.854 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -64.01 -22.93 67.14 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.938 0.495 . . . . 75.21 111.43 172.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 97' ' ' CYS . . . . . 0.511 ' SG ' HG12 ' D' ' 89' ' ' ILE . 81.8 m -59.89 -46.52 89.07 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.236 0.614 . . . . 74.04 111.187 175.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.56 HD23 HD11 ' D' ' 86' ' ' ILE . 3.1 pp -94.59 -20.71 19.37 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.352 0.501 . . . . 71.22 112.352 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.98 -29.38 23.29 Favored Glycine 0 C--N 1.346 1.134 0 O-C-N 123.353 0.408 . . . . 62.01 113.396 -173.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.36 -49.18 1.08 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.809 0.444 . . . . 75.4 111.289 -174.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -74.91 -41.94 58.74 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 112.697 0.629 . . . . 65.31 112.697 -172.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 71.7 m -66.26 -44.79 59.69 Favored Pre-proline 0 CA--C 1.558 1.262 0 CA-C-O 118.558 -0.734 . . . . 55.42 111.704 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.434 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 68.6 Cg_exo -56.59 -33.73 93.76 Favored 'Trans proline' 0 C--N 1.391 2.814 0 C-N-CA 122.021 1.814 . . . . 65.13 112.909 167.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -68.32 -29.57 68.35 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.523 0.729 . . . . 73.21 111.172 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.2 mm -74.93 -37.28 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.355 0.662 . . . . 61.44 109.945 172.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.427 HD13 ' O ' ' D' ' 80' ' ' GLN . 93.3 mt -79.95 -17.76 52.16 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.472 0.709 . . . . 72.14 112.443 -177.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -68.03 -44.08 38.16 Favored Pre-proline 0 N--CA 1.486 1.348 0 CA-C-O 118.472 -0.775 . . . . 75.04 112.725 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.47 -37.11 72.38 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.368 2.046 . . . . 73.22 113.687 170.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -81.02 -32.9 33.97 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.971 0.909 . . . . 73.1 112.428 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.96 -45.21 71.27 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.177 -0.675 . . . . 62.44 109.177 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.473 ' NH2' HG23 ' B' ' 105' ' ' ILE . 43.2 ttp180 -65.51 -39.13 91.48 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 114.371 -1.286 . . . . 71.35 110.139 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -52.59 -46.32 66.9 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 123.986 0.914 . . . . 64.11 110.523 175.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.2 t -67.71 -50.28 58.32 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.903 -1.044 . . . . 74.23 110.86 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.546 HG12 ' SG ' ' D' ' 76' ' ' CYS . 79.3 mt -59.58 -62.14 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 123.951 0.782 . . . . 73.44 110.883 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 17.3 m -50.48 -39.65 48.75 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.949 1.299 . . . . 65.53 111.954 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 24.6 t -64.0 -48.08 77.79 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.046 -0.979 . . . . 62.51 109.977 177.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 68.6 mtm -69.35 -27.21 65.15 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.282 0.633 . . . . 72.24 112.093 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.467 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.6 t -66.33 -46.07 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.407 0.683 . . . . 75.42 109.196 175.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.5 p -73.19 -28.98 62.51 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.576 -0.738 . . . . 73.34 110.698 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' D' ' 116' ' ' SER . 87.9 mtt-85 -70.86 -28.58 64.68 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.816 0.846 . . . . 74.44 110.416 173.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 121' ' ' GLY . . . . . 0.421 ' HA2' ' HB2' ' C' ' 17' ' ' TYR . . . -89.11 8.08 80.67 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 123.824 0.703 . . . . 70.33 112.763 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.441 HG23 ' HB3' ' C' ' 17' ' ' TYR . 47.7 p 59.09 20.47 8.38 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 126.35 1.86 . . . . 64.13 113.507 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -87.04 154.44 55.01 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 123.614 0.766 . . . . 74.41 110.106 174.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -50.3 127.44 20.1 Favored 'Trans proline' 0 C--N 1.386 2.532 0 C-N-CA 123.576 2.851 . . . . 65.02 113.013 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -52.24 128.93 26.63 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 124.522 1.139 . . . . 74.42 111.596 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 33.8 tp -107.13 97.23 7.02 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.726 -0.472 . . . . 65.34 109.726 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -98.45 89.87 4.58 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 107.272 -1.381 . . . . 75.4 107.272 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.497 HD11 HD22 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -67.98 122.29 17.9 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 108.872 -0.788 . . . . 72.41 108.872 -175.597 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.57 142.65 87.24 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 123.798 0.839 . . . . 53.13 111.05 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.07 121.68 10.34 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.889 2.393 . . . . 75.32 112.098 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 131' ' ' VAL . . . . . 0.443 HG11 HD11 ' D' ' 44' ' ' LEU . 8.3 p -107.39 133.4 52.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 123.623 0.769 . . . . 73.32 109.551 -173.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -87.01 92.4 9.03 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.592 0.757 . . . . 62.21 108.96 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 N--CA 1.486 1.368 0 C-N-CA 124.392 1.077 . . . . 74.45 112.81 -175.683 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.0 m . . . . . 0 N--CA 1.467 0.4 0 N-CA-C 108.774 -0.824 . . . . 75.23 108.774 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -135.33 114.36 12.14 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.529 -1.286 . . . . 72.34 107.529 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -134.05 135.26 43.21 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.826 -1.176 . . . . 72.14 107.826 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.441 HD13 HG21 ' A' ' 105' ' ' ILE . 8.7 mt -93.95 114.44 30.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.381 -0.97 . . . . 63.04 108.381 174.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -81.54 -30.36 33.16 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 123.731 0.644 . . . . 71.53 110.47 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -175.87 134.27 0.28 Allowed 'General case' 0 C--N 1.361 1.089 0 C-N-CA 123.13 0.572 . . . . 55.53 110.372 -175.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.546 HD12 ' HG3' ' C' ' 130' ' ' PRO . 66.2 mt -118.13 133.77 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.998 -1.112 . . . . 74.51 107.998 169.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.456 ' HE1' HG13 ' A' ' 83' ' ' ILE . 24.9 p90 -164.23 149.39 10.31 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 124.098 0.874 . . . . 74.23 110.838 -174.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.0 p -75.27 130.18 38.67 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.862 -0.792 . . . . 73.23 108.862 172.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.446 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.9 mtpt -97.55 -30.05 13.1 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.778 -0.452 . . . . 74.53 109.778 175.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.434 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 7.7 t70 -143.37 141.58 30.97 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.351 -0.611 . . . . 74.24 109.351 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.442 HG23 ' SD ' ' A' ' 117' ' ' MET . 62.6 mt -142.24 146.29 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.164 1.386 . . . . 64.4 107.917 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.8 t -155.8 132.48 10.42 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.482 0.713 . . . . 65.11 109.737 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.605 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 80.5 t80 -139.08 114.65 9.85 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 107.199 -1.408 . . . . 75.24 107.199 172.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -118.24 114.36 22.89 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.996 -0.742 . . . . 74.43 108.996 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.47 79.57 1.75 Allowed Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 107.892 -1.151 . . . . 74.02 107.892 164.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.07 -26.13 21.87 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.547 2.164 . . . . 61.52 112.04 -172.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -104.49 17.9 23.24 Favored 'General case' 0 C--O 1.21 -1.02 0 CA-C-O 117.942 -1.027 . . . . 71.53 110.056 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.415 ' HA ' HG12 ' A' ' 31' ' ' VAL . . . -45.0 -51.96 21.19 Favored Pre-proline 0 N--CA 1.503 2.197 0 N-CA-C 114.291 1.219 . . . . 34.11 114.291 -169.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.09 -26.07 43.26 Favored 'Trans proline' 0 C--N 1.386 2.529 0 C-N-CA 121.764 1.643 . . . . 73.14 112.808 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -81.43 -43.22 19.21 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.251 1.02 . . . . 71.13 110.245 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.714 HG21 ' HA ' ' A' ' 73' ' ' ALA . 8.2 p -78.96 -21.87 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 114.762 -1.108 . . . . 71.13 112.142 -163.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -70.79 -18.17 62.76 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.579 0.351 . . . . 73.14 111.785 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -76.02 -21.32 56.99 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.682 0.793 . . . . 70.35 110.581 173.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.406 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 35.1 mmtp -83.11 154.67 24.23 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.792 0.837 . . . . 72.03 111.625 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -68.36 136.61 53.65 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.12 -0.946 . . . . 70.34 109.995 172.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.535 ' CE3' HD21 ' A' ' 68' ' ' LEU . 67.9 t-105 -82.45 86.16 6.8 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.512 0.673 . . . . 75.41 110.634 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.41 ' H ' HD22 ' A' ' 68' ' ' LEU . 29.1 tt0 -124.55 80.47 60.95 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 107.757 -1.201 . . . . 55.32 107.757 167.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.18 122.88 9.43 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.535 2.157 . . . . 64.12 112.647 -174.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -95.81 85.67 4.17 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 105.847 -1.909 . . . . 64.14 105.847 172.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.8 t -90.31 134.91 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 114.972 -1.013 . . . . 73.51 110.085 -171.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -121.5 114.78 21.73 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.168 0.987 . . . . 75.52 108.395 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 128' ' ' LEU . 2.6 tt -101.59 119.03 38.13 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.35 -0.981 . . . . 72.5 108.35 -175.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -121.43 133.49 55.07 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.162 0.985 . . . . 64.04 109.174 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.565 HD22 HD21 ' A' ' 60' ' ' LEU . 72.6 mt -121.65 131.06 53.89 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.745 0.818 . . . . 61.04 110.693 -178.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -135.66 149.21 49.22 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.071 0.948 . . . . 64.12 108.816 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.5 m -135.87 129.13 31.86 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.424 0.69 . . . . 54.54 110.099 -177.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.43 111.15 11.06 Favored 'General case' 0 C--N 1.345 0.385 0 C-N-CA 124.179 0.992 . . . . 65.22 109.512 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.0 m -90.35 159.24 16.72 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.215 -0.661 . . . . 52.21 109.215 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.9 t -158.35 117.37 3.11 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.245 -0.65 . . . . 74.23 109.245 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -76.06 106.96 7.95 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.72 -0.474 . . . . 70.13 109.72 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.4 mt -79.8 -33.55 40.36 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.402 0.681 . . . . 73.44 111.02 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.92 -174.77 4.56 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.084 0.554 . . . . 50.2 111.086 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.46 114.93 4.66 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.761 0.825 . . . . 75.45 109.362 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 64.89 18.63 11.56 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.064 1.346 . . . . 72.24 112.335 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.7 t -118.29 105.37 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.452 -0.944 . . . . 74.11 108.452 174.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -115.96 122.81 46.38 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.809 0.844 . . . . 74.42 108.724 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -86.6 148.58 25.42 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.778 -0.823 . . . . 74.2 108.778 170.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.6 t -130.33 139.37 51.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 N-CA-C 107.821 -1.178 . . . . 74.02 107.821 168.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.421 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 26.4 t -121.13 127.46 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.84 -0.8 . . . . 62.5 108.84 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.565 HD21 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -102.23 106.75 17.62 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 106.817 -1.549 . . . . 71.33 106.817 176.925 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -92.76 101.82 14.22 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.865 -1.161 . . . . 53.4 107.865 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.23 126.91 48.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 N-CA-C 108.482 -0.933 . . . . 61.23 108.482 174.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.8 m -116.25 142.7 46.49 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.978 -0.749 . . . . 70.55 108.978 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.573 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 92.6 t -139.3 109.3 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 125.169 1.388 . . . . 75.41 107.749 -176.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.4 m -107.4 123.02 47.77 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.993 -0.743 . . . . 71.32 108.993 169.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.94 120.57 36.77 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.354 -0.98 . . . . 53.25 108.354 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.5 m -124.14 136.07 53.95 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.211 0.604 . . . . 52.33 110.755 -176.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.662 HD12 HG22 ' A' ' 31' ' ' VAL . 91.6 mt -87.75 74.99 9.02 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.354 -0.98 . . . . 75.3 108.354 174.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.47 -116.38 4.68 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 114.33 -1.305 . . . . 35.32 110.956 -169.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -91.94 -13.85 30.49 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.875 0.87 . . . . 63.42 110.743 176.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.406 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 5.9 tp10 -77.26 133.28 38.89 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.39 1.076 . . . . 75.43 108.267 173.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.6 m -87.7 127.5 35.3 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.729 0.695 . . . . 74.31 109.521 174.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.714 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -79.83 -58.85 2.98 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.53 -0.915 . . . . 73.43 108.53 173.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -162.39 165.24 26.67 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 115.458 -0.792 . . . . 63.54 111.652 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.3 tp -127.17 118.98 25.38 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.393 -1.276 . . . . 65.01 107.988 166.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.573 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.0 m -105.56 138.11 42.3 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.054 0.942 . . . . 71.24 109.257 171.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -147.92 132.75 18.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.694 -0.854 . . . . 73.32 108.694 168.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.2 t -138.7 110.85 5.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 C-N-CA 124.194 0.998 . . . . 65.15 108.461 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -84.89 85.46 7.47 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.282 -1.007 . . . . 74.02 108.282 169.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -75.92 96.99 3.85 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.096 -0.956 . . . . 64.2 109.011 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.06 160.14 34.78 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 111.513 -0.635 . . . . 75.01 111.513 178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.9 127.68 2.01 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.773 -0.931 . . . . 62.23 110.773 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.456 HG13 ' HE1' ' A' ' 17' ' ' TYR . 63.6 mt -80.97 124.0 38.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 107.948 -1.13 . . . . 74.33 107.948 171.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.81 ' HB3' HD11 ' A' ' 86' ' ' ILE . 87.7 m-85 -125.65 127.42 46.27 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 109.003 -0.74 . . . . 72.41 109.003 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.3 t -89.3 97.57 11.27 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.955 -0.757 . . . . 64.24 108.955 173.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.81 HD11 ' HB3' ' A' ' 84' ' ' PHE . 4.7 mm -112.76 150.92 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 122.74 0.416 . . . . 75.44 110.502 -175.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.54 170.85 12.36 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.003 0.814 . . . . 65.33 110.869 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.11 -31.39 7.05 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 115.987 -0.551 . . . . 74.54 113.924 172.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.602 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.2 161.03 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.812 0.845 . . . . 73.13 108.993 176.884 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.554 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 17.0 tt0 -153.5 176.65 11.8 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 109.457 -0.572 . . . . 75.21 109.457 -175.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.554 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 57.5 -123.37 32.5 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 124.144 0.902 . . . . 72.23 113.921 177.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.2 t -75.23 -24.72 57.75 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.262 0.625 . . . . 61.33 111.91 -176.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -76.27 -34.79 59.12 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.42 0.688 . . . . 74.3 110.368 176.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.435 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 6.4 tpt -62.86 -48.68 78.0 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.383 -0.599 . . . . 75.23 109.383 171.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.71 -36.62 72.24 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.645 0.778 . . . . 41.54 110.751 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -67.96 -38.0 82.24 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.422 0.689 . . . . 74.33 111.182 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.5 t -66.38 -40.43 89.68 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.849 -0.426 . . . . 70.42 109.849 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 94' ' ' MET . 53.9 mt -83.66 -25.61 30.59 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.741 0.816 . . . . 60.35 112.322 -174.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.53 3.38 34.53 Favored Glycine 0 N--CA 1.475 1.268 0 O-C-N 123.417 0.448 . . . . 73.12 113.726 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.546 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -136.8 -68.69 0.48 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.029 0.532 . . . . 60.05 110.059 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -65.82 -46.97 76.64 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.436 0.694 . . . . 74.02 111.721 -171.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 59.4 m -66.29 -50.75 47.75 Favored Pre-proline 0 CA--C 1.567 1.619 0 C-N-CA 124.464 1.105 . . . . 72.24 112.659 -175.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.96 -20.05 45.28 Favored 'Trans proline' 0 C--N 1.39 2.749 0 C-N-CA 121.841 1.694 . . . . 71.24 112.948 174.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -69.7 -35.71 75.3 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.847 0.459 . . . . 74.55 110.188 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.441 HG21 HD13 ' A' ' 13' ' ' ILE . 46.7 mm -64.25 -47.87 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.27 0.628 . . . . 73.12 109.828 171.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.5 mt -72.22 -21.7 61.36 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.116 -0.947 . . . . 74.21 112.552 -171.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -65.03 -45.46 73.44 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 114.26 1.207 . . . . 61.22 114.26 -172.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.425 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 82.8 Cg_exo -50.54 -40.95 54.29 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.055 1.837 . . . . 53.24 113.626 171.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -76.13 -38.58 56.64 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.371 0.668 . . . . 74.32 111.084 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.21 -48.12 74.46 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.347 0.659 . . . . 60.12 109.915 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.438 ' NH1' HG23 ' C' ' 105' ' ' ILE . 29.3 ttm105 -47.99 -55.91 8.92 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 125.023 1.452 . . . . 74.22 110.079 174.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -61.81 -48.34 81.02 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 124.478 1.111 . . . . 74.4 111.879 -175.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.531 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.0 t -57.05 -42.39 80.44 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 123.786 0.679 . . . . 73.23 110.57 -177.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 118' ' ' VAL . 82.9 mt -62.95 -52.15 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 115.097 -0.956 . . . . 74.35 110.319 173.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.426 HG21 ' HE2' ' C' ' 109' ' ' TYR . 61.7 m -55.28 -41.08 71.79 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.047 0.939 . . . . 70.32 111.319 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.8 t -68.99 -42.57 76.32 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 114.626 -1.17 . . . . 51.45 109.706 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.513 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 7.9 mtp -60.02 -42.49 94.45 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.871 0.868 . . . . 72.41 111.063 175.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 114' ' ' ILE . 70.1 t -61.66 -45.84 97.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 124.278 1.031 . . . . 54.12 110.1 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.5 p -73.95 -30.51 62.58 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.271 0.628 . . . . 75.34 111.647 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 78.6 mtt-85 -72.59 -29.21 63.32 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.509 0.724 . . . . 70.44 109.594 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.07 5.42 62.77 Favored Glycine 0 C--N 1.354 1.56 0 CA-C-O 119.213 -0.771 . . . . 65.33 112.962 175.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.593 HG21 ' HE ' ' B' ' 15' ' ' ARG . 44.6 m 72.61 10.35 5.63 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 122.587 1.184 . . . . 73.42 111.703 173.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -86.35 144.42 38.14 Favored Pre-proline 0 C--O 1.244 0.765 0 O-C-N 121.064 -1.023 . . . . 64.25 109.151 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -51.69 142.52 40.52 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.06 2.507 . . . . 74.35 112.159 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -57.06 136.34 56.33 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 123.999 0.812 . . . . 72.34 112.667 -170.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.445 HD21 HG11 ' A' ' 64' ' ' VAL . 35.8 tp -121.58 123.37 41.8 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.626 1.17 . . . . 74.02 108.486 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.499 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 92.2 m-20 -122.44 109.46 14.41 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.543 0.737 . . . . 71.12 109.124 -176.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.511 ' HB3' HD11 ' A' ' 42' ' ' LEU . 7.9 mt -70.01 116.46 10.4 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 109.217 -0.66 . . . . 63.23 109.217 -173.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.68 143.4 93.9 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 122.873 0.469 . . . . 53.14 111.57 -172.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -56.24 125.14 18.09 Favored 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.488 2.792 . . . . 63.44 114.141 -172.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.493 HG21 HD11 ' A' ' 44' ' ' LEU . 90.3 t -102.46 134.26 43.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 CA-C-N 115.335 -0.848 . . . . 71.24 110.382 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -90.54 86.54 6.44 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.709 -0.848 . . . . 71.34 108.709 176.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -63.11 -27.65 69.53 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.579 0.751 . . . . 75.42 112.029 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.546 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 18.7 t70 -66.91 -43.37 83.51 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 123.45 0.469 . . . . 62.4 109.745 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.65 -40.51 95.58 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 124.228 0.955 . . . . 71.23 111.105 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 89.3 mt -60.01 -51.94 67.5 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.275 0.63 . . . . 65.42 111.033 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 25.1 t80 . . . . . 0 N--CA 1.47 0.538 0 N-CA-C 109.686 -0.487 . . . . 71.04 109.686 -179.823 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.644 ' HB3' HG23 ' B' ' 89' ' ' ILE . 25.5 ptm . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 113.437 0.903 . . . . 70.31 113.437 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.3 t -143.54 127.37 17.24 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 124.437 1.095 . . . . 70.51 108.096 171.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.402 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 75.2 t80 -123.51 146.19 48.27 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.613 0.765 . . . . 73.52 109.521 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.432 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 8.5 tt0 -149.99 131.26 14.57 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.248 0.619 . . . . 62.31 109.739 176.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 54.9 mt -80.3 122.82 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.538 -1.282 . . . . 71.41 107.538 168.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -93.58 -49.77 5.73 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.692 -0.855 . . . . 64.34 108.692 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.593 ' HE ' HG21 ' A' ' 122' ' ' THR . 26.1 ttt180 -164.14 143.57 7.75 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.767 -0.651 . . . . 54.14 110.841 -174.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 94.6 mt -124.02 141.45 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 107.039 -1.467 . . . . 74.33 107.039 173.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -165.43 138.98 4.56 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 112.886 0.699 . . . . 71.42 112.886 -174.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.6 m -73.91 119.38 18.05 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.668 0.787 . . . . 74.34 109.373 172.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.522 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.9 mtpt -96.89 -20.44 18.14 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.707 0.803 . . . . 74.11 111.678 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.578 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 34.0 t70 -160.18 149.64 17.72 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.097 0.559 . . . . 74.12 111.022 -177.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.605 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 26.9 mm -145.86 146.16 19.58 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 125.485 1.514 . . . . 73.45 108.374 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 36.3 t -155.6 145.6 21.51 Favored 'General case' 0 C--O 1.242 0.693 0 O-C-N 124.351 1.032 . . . . 70.14 110.087 169.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.44 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.1 t80 -151.56 108.54 3.54 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 107.457 -1.312 . . . . 73.12 107.457 169.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.18 113.53 21.69 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.243 -1.021 . . . . 74.2 108.243 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.64 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -107.78 86.42 2.97 Favored Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 107.888 -1.153 . . . . 74.54 107.888 174.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.2 -33.69 7.0 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.734 2.29 . . . . 72.11 112.933 -170.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -100.95 6.15 43.48 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.815 0.846 . . . . 72.11 111.389 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.64 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -41.39 -62.59 1.02 Allowed Pre-proline 0 N--CA 1.491 1.606 0 C-N-CA 125.436 1.494 . . . . 45.11 113.924 -168.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 52.8 Cg_exo -52.37 -38.29 73.21 Favored 'Trans proline' 0 C--N 1.391 2.792 0 C-N-CA 122.89 2.393 . . . . 63.14 113.756 -172.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -93.54 -35.03 13.12 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.193 -0.912 . . . . 74.02 111.636 -171.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.508 HG22 HD12 ' B' ' 68' ' ' LEU . 4.3 p -73.14 -14.74 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.239 0.616 . . . . 65.45 111.574 -171.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -64.31 -20.46 66.1 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.445 0.698 . . . . 70.41 112.771 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -65.17 -18.18 65.09 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.146 0.578 . . . . 52.25 110.942 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.452 ' HB2' HD13 ' B' ' 68' ' ' LEU . 93.0 mttt -91.2 79.61 5.69 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.787 1.235 . . . . 75.44 110.048 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -85.31 78.01 9.86 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.321 -0.854 . . . . 74.44 110.098 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 14.9 p90 -154.3 -174.68 5.06 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.952 0.901 . . . . 72.14 108.875 172.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -71.0 120.19 77.95 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 123.157 0.583 . . . . 70.1 111.079 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.33 139.32 38.0 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 121.244 1.296 . . . . 41.44 109.513 172.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.61 101.02 1.2 Allowed 'General case' 0 C--O 1.242 0.691 0 N-CA-C 107.27 -1.381 . . . . 62.45 107.27 170.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.689 HG11 HD11 ' B' ' 126' ' ' LEU . 35.4 t -102.94 145.66 11.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 115.066 -0.97 . . . . 63.53 109.184 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -135.07 130.41 35.52 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.344 -0.844 . . . . 72.1 108.91 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.527 HD11 HG13 ' B' ' 62' ' ' VAL . 21.8 tp -94.09 126.97 39.63 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 124.212 0.945 . . . . 60.54 109.245 170.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -142.87 126.38 16.8 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.289 1.036 . . . . 71.12 108.466 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.546 HD23 HG22 ' B' ' 62' ' ' VAL . 4.0 mp -119.9 148.72 43.16 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.985 0.514 . . . . 72.43 110.537 -172.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.409 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 18.1 t70 -124.4 141.61 51.95 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.172 1.389 . . . . 73.04 108.097 176.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 27.4 m -113.34 104.16 12.04 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.561 -0.533 . . . . 52.13 109.561 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.59 134.43 55.05 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.088 -1.449 . . . . 74.25 107.088 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.45 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 51.9 m -142.99 162.8 34.51 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 122.493 0.317 . . . . 72.11 110.745 -175.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.9 p -152.09 135.6 16.08 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.431 0.692 . . . . 65.43 109.693 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -90.49 122.66 33.52 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 109.013 -0.736 . . . . 75.22 109.013 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 pp -143.96 25.11 1.62 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.286 -0.87 . . . . 63.54 109.589 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.97 156.76 20.19 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 123.632 0.773 . . . . 73.23 110.312 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.7 131.83 36.05 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 108.521 -0.918 . . . . 73.21 108.521 167.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 64.49 7.31 3.59 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.929 1.292 . . . . 72.42 112.215 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.7 HG22 ' HA ' ' B' ' 85' ' ' SER . 54.2 t -138.68 123.33 21.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 107.239 -1.393 . . . . 64.3 107.239 -174.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.45 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 1.5 t80 -117.26 145.45 43.93 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 108.364 -0.976 . . . . 55.12 108.364 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -100.51 103.13 14.45 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 106.547 -1.649 . . . . 44.01 106.547 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 6.8 p -102.52 132.44 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.345 -0.613 . . . . 71.32 109.345 -176.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.419 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 19.0 t -115.12 122.41 69.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 108.688 -0.856 . . . . 33.35 108.688 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 38.9 tp -103.54 105.89 16.25 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.754 -0.832 . . . . 71.22 108.754 173.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.432 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 14.4 ttm180 -84.9 110.09 18.61 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 108.588 -0.893 . . . . 74.3 108.588 174.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.546 HG22 HD23 ' B' ' 44' ' ' LEU . 61.4 t -105.03 104.7 17.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 123.572 0.749 . . . . 60.51 109.011 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 6.7 m -98.83 137.15 37.82 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.134 -0.939 . . . . 73.13 109.684 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.651 HG11 HD21 ' B' ' 126' ' ' LEU . 30.6 t -128.42 116.29 41.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 124.225 1.01 . . . . 62.11 108.524 174.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 97.0 m -101.95 136.56 41.58 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.985 -1.117 . . . . 73.51 107.985 168.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.87 141.22 36.61 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 109.443 -0.577 . . . . 73.33 109.443 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.521 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 40.9 p -148.15 130.98 16.08 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.542 0.526 . . . . 73.02 111.585 -173.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.508 HD12 HG22 ' B' ' 31' ' ' VAL . 75.8 mt -97.04 107.11 19.57 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.181 0.992 . . . . 71.45 108.664 176.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.58 -111.98 3.37 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 111.195 -0.762 . . . . 41.22 111.195 -172.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -117.54 1.65 12.31 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.674 0.79 . . . . 72.13 110.297 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -114.43 142.15 46.73 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.768 -0.583 . . . . 62.35 110.37 -174.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 25.4 m -66.39 115.25 6.11 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.719 0.808 . . . . 54.41 111.394 -175.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.521 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -70.02 -56.34 7.2 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.992 -1.114 . . . . 74.41 107.992 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -158.37 164.47 36.29 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 114.398 -1.274 . . . . 64.3 111.151 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 67.8 mt -129.9 112.23 13.33 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 106.683 -1.599 . . . . 70.02 106.683 172.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.519 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 34.2 t -119.94 115.12 23.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.772 -0.825 . . . . 72.41 108.772 177.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -128.0 124.81 38.11 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.885 0.874 . . . . 70.04 109.044 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 73.1 t -124.49 153.17 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.227 1.011 . . . . 73.02 109.276 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.578 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.5 mt-30 -122.9 111.78 17.05 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.349 -0.982 . . . . 72.33 108.349 167.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.461 ' HG3' HD22 ' B' ' 106' ' ' LEU . 8.0 tp-100 -101.54 106.83 17.97 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.526 -0.916 . . . . 74.23 108.526 171.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.522 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -100.91 167.28 19.59 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 111.525 -0.63 . . . . 55.44 111.525 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.26 143.82 8.67 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.127 -0.559 . . . . 70.24 112.98 -174.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 79.3 mt -101.76 113.65 38.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 107.651 -1.24 . . . . 72.44 107.651 174.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' PHE . . . . . 0.428 ' O ' HG13 ' B' ' 55' ' ' VAL . 38.9 m-85 -127.49 147.46 50.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.311 0.644 . . . . 73.22 109.593 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.7 ' HA ' HG22 ' B' ' 55' ' ' VAL . 49.3 m -94.25 115.71 28.01 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.542 1.137 . . . . 61.51 110.456 177.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.602 HG22 HD11 ' B' ' 89' ' ' ILE . 3.8 mp -120.67 104.89 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 106.929 -1.508 . . . . 73.4 106.929 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.34 167.79 21.32 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.107 0.563 . . . . 74.3 110.559 -175.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.46 -45.82 3.29 Favored Glycine 0 N--CA 1.476 1.321 0 O-C-N 123.138 0.274 . . . . 70.13 113.096 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.644 HG23 ' HB3' ' B' ' 9' ' ' MET . 0.8 OUTLIER -58.03 167.74 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 124.839 1.255 . . . . 71.01 113.415 175.326 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -152.55 149.85 28.93 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.467 -1.242 . . . . 75.23 110.696 -174.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.19 -126.67 7.61 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.519 0.512 . . . . 21.11 112.236 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 20.3 m -90.1 -19.58 24.15 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.028 0.531 . . . . 64.12 110.202 175.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -53.44 -33.7 55.08 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.055 0.942 . . . . 75.11 111.368 176.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -62.22 -59.42 5.06 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.259 1.024 . . . . 74.44 111.707 -174.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.85 -14.15 58.29 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.348 0.659 . . . . 70.45 111.428 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -61.87 -38.61 88.91 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.846 0.858 . . . . 61.24 110.688 170.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.7 t -68.89 -55.36 11.29 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.81 0.444 . . . . 61.13 110.615 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.616 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 1.9 pp -74.17 -18.4 60.78 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.717 0.636 . . . . 73.01 112.717 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.41 0.93 55.78 Favored Glycine 0 N--CA 1.472 1.072 0 CA-C-O 119.413 -0.659 . . . . 65.31 114.199 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.04 -50.86 0.15 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 117.888 0.844 . . . . 71.45 112.006 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.405 ' O ' ' HB3' ' B' ' 104' ' ' ASN . 39.7 t80 -73.01 -39.58 65.9 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.333 0.653 . . . . 75.43 111.046 -177.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.616 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 82.0 m -75.13 -43.7 4.56 Favored Pre-proline 0 CA--C 1.563 1.446 0 CA-C-O 118.476 -0.773 . . . . 63.24 113.027 -175.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.7 -22.39 64.27 Favored 'Trans proline' 0 C--N 1.389 2.669 0 CA-C-N 121.185 1.459 . . . . 71.41 112.692 170.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 104' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' B' ' 101' ' ' TYR . 22.8 t-20 -64.15 -37.44 87.46 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.886 0.474 . . . . 75.2 110.861 172.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.9 mt -66.37 -40.85 87.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.536 0.735 . . . . 71.13 110.09 173.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.461 HD22 ' HG3' ' B' ' 80' ' ' GLN . 88.1 mt -75.0 -28.17 60.43 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.822 0.849 . . . . 64.35 112.775 -174.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -56.16 -47.35 99.01 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 118.068 -0.968 . . . . 71.33 113.464 -173.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.538 ' HG2' ' HB2' ' D' ' 108' ' ' PRO . 85.0 Cg_exo -53.53 -42.99 61.45 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.813 2.342 . . . . 71.21 114.604 174.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.412 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 40.4 m-85 -67.62 -36.05 80.09 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.187 0.595 . . . . 73.23 110.476 -177.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.21 -39.75 74.95 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.573 0.749 . . . . 72.45 110.778 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.419 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 51.3 ttt-85 -60.79 -55.16 36.37 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.282 1.433 . . . . 74.0 111.175 -177.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -69.15 -26.15 64.73 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.618 0.574 . . . . 74.11 110.427 -177.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.528 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.8 t -70.44 -39.4 74.37 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 110.265 -0.272 . . . . 72.34 110.265 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.519 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 72.3 mt -61.44 -54.81 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 123.987 0.915 . . . . 70.42 109.762 170.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 36.7 m -59.1 -28.3 66.39 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.921 0.888 . . . . 73.52 111.263 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.8 t -68.28 -50.97 50.06 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 123.475 0.71 . . . . 73.22 109.943 175.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.501 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.4 mmt -68.22 -36.34 79.36 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.204 0.601 . . . . 73.43 111.206 -175.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.2 -43.55 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.606 1.162 . . . . 62.42 110.198 173.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 30.9 t -63.65 -34.44 77.84 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.014 -0.994 . . . . 72.45 110.581 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.531 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 81.2 mtt-85 -69.23 -34.76 75.34 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.89 -0.596 . . . . 63.34 110.297 178.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -75.28 -11.96 83.84 Favored Glycine 0 C--N 1.357 1.705 0 O-C-N 123.736 0.647 . . . . 41.34 112.456 170.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 16.9 m 66.92 33.63 5.79 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.769 1.628 . . . . 43.22 110.186 176.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -79.52 163.54 58.45 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 115.259 -0.882 . . . . 61.31 110.434 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -58.76 165.65 7.8 Favored 'Trans proline' 0 C--N 1.388 2.624 0 C-N-CA 122.655 2.237 . . . . 63.25 112.894 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.422 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 23.9 tp60 -63.88 112.47 2.93 Favored 'General case' 0 C--N 1.345 0.405 0 C-N-CA 123.86 0.864 . . . . 52.21 111.378 -167.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.689 HD11 HG11 ' B' ' 40' ' ' VAL . 23.3 tp -110.52 112.53 24.51 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.168 -0.924 . . . . 62.23 109.018 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.17 124.3 41.5 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 108.288 -1.005 . . . . 74.41 108.288 176.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.419 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 77.3 mt -83.59 136.62 34.17 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.691 0.396 . . . . 62.52 110.514 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.32 140.99 52.87 Favored Pre-proline 0 CA--C 1.55 0.952 0 O-C-N 123.972 0.795 . . . . 60.01 111.284 -174.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -60.02 93.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.541 2.828 . . . . 71.33 111.99 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 4.0 p -90.55 118.34 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 108.496 -0.927 . . . . 72.53 108.496 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 . . . . . 0 C--O 1.242 0.662 0 CA-C-N 115.617 -0.72 . . . . 73.21 109.182 -175.975 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.465 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 59.8 t80 . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 108.428 -0.953 . . . . 73.5 108.428 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -138.45 132.32 31.14 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 109.556 -0.535 . . . . 74.33 109.556 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 21.6 mt -77.71 128.89 38.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 O-C-N 123.957 0.786 . . . . 52.52 109.395 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.431 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 11.6 mm100 -89.05 -46.57 8.75 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.471 0.709 . . . . 64.32 109.153 174.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.499 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 13.6 ptp180 -176.26 150.17 0.91 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.61 1.164 . . . . 72.44 109.63 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 76.9 mt -128.22 129.9 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.409 1.083 . . . . 73.25 108.3 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.539 ' HB3' HG23 ' D' ' 122' ' ' THR . 35.7 p90 -158.07 175.1 14.23 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.804 0.841 . . . . 73.31 110.421 -166.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.6 p -98.07 114.23 26.34 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 122.932 0.493 . . . . 43.13 109.982 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.538 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 27.9 mmtp -65.39 -30.37 71.18 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.449 -0.574 . . . . 70.44 109.449 165.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.605 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.1 t70 -162.35 146.65 12.1 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.142 -0.935 . . . . 72.15 110.651 -172.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.598 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.7 mt -138.32 147.11 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.785 1.634 . . . . 74.43 107.25 173.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 43.8 t -152.45 148.04 26.96 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 122.935 0.494 . . . . 74.44 110.535 175.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.416 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 79.8 t80 -155.82 119.4 4.4 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 114.652 -1.158 . . . . 73.13 108.119 172.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -126.87 118.0 23.71 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.15 -0.685 . . . . 62.04 109.15 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.4 81.53 46.18 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 107.574 -1.269 . . . . 63.11 107.574 167.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.73 -36.05 43.01 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 122.739 2.292 . . . . 74.23 111.408 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -101.4 30.48 4.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.56 1.144 . . . . 73.25 109.535 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.24 -54.04 28.72 Favored Pre-proline 0 N--CA 1.495 1.789 0 C-N-CA 124.259 1.024 . . . . 73.51 113.297 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.46 -42.02 29.67 Favored 'Trans proline' 0 C--N 1.381 2.24 0 CA-C-N 121.17 1.454 . . . . 61.41 111.421 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -71.0 -27.75 63.92 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 114.277 -1.329 . . . . 64.22 113.042 -174.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.569 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.8 p -80.8 -28.93 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 O-C-N 122.059 -0.401 . . . . 41.12 111.664 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -65.15 -15.6 62.6 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 112.762 0.653 . . . . 75.01 112.762 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -105.32 22.46 15.37 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.947 0.899 . . . . 73.4 111.113 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.692 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -110.23 160.63 16.34 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.591 0.756 . . . . 64.22 110.562 -178.019 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -66.34 126.85 30.07 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.335 -0.617 . . . . 75.14 109.335 166.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -80.21 77.78 6.92 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.611 0.719 . . . . 63.31 109.683 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -129.02 66.44 76.31 Favored Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 123.963 0.905 . . . . 75.11 109.43 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -90.8 153.01 4.09 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.421 2.08 . . . . 51.44 112.578 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 39' ' ' GLU . . . . . 0.612 ' HB2' ' HE3' ' C' ' 41' ' ' LYS . 8.7 pt-20 -88.33 104.04 16.38 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.55 -1.278 . . . . 72.11 107.55 165.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.461 HG11 HD21 ' C' ' 126' ' ' LEU . 59.4 t -77.17 100.03 2.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.361 -0.977 . . . . 61.22 108.361 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.612 ' HE3' ' HB2' ' C' ' 39' ' ' GLU . 34.1 mmtp -103.59 105.57 15.84 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.421 -0.809 . . . . 75.23 109.96 -177.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mp -87.31 122.36 30.97 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 107.106 -1.442 . . . . 72.53 107.106 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.436 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 28.4 t70 -124.54 105.2 9.19 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.131 -0.692 . . . . 73.14 109.131 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.515 HD11 HG11 ' C' ' 131' ' ' VAL . 98.7 mt -94.2 141.96 27.95 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.871 0.868 . . . . 71.21 110.526 -177.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -148.46 143.64 26.87 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.255 -1.387 . . . . 73.51 107.255 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 46' ' ' THR . . . . . 0.436 HG21 ' HA2' ' C' ' 99' ' ' GLY . 10.0 t -133.93 149.55 51.29 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.883 -0.784 . . . . 63.02 108.883 175.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.77 143.55 27.6 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.443 -0.947 . . . . 72.13 108.443 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 7.0 m -132.3 150.71 52.1 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 109.908 -0.405 . . . . 61.21 109.908 -175.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.3 t -145.71 125.46 13.42 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.574 -0.898 . . . . 60.14 108.574 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -79.86 116.67 20.15 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.977 -0.749 . . . . 73.52 108.977 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.561 HD11 HD12 ' C' ' 83' ' ' ILE . 48.3 mt -86.04 -36.4 19.74 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.852 0.861 . . . . 74.03 110.614 -175.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.55 -172.04 3.81 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.015 0.926 . . . . 45.03 109.851 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -63.89 112.95 3.14 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.744 0.818 . . . . 64.43 109.958 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 63.99 20.8 12.36 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.641 1.176 . . . . 74.22 112.27 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 66.2 t -114.9 113.58 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.066 -1.087 . . . . 74.23 108.066 173.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -122.79 124.6 43.69 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.121 0.968 . . . . 73.2 109.673 -176.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.45 ' HB2' HD11 ' C' ' 51' ' ' LEU . 29.3 tt0 -84.46 137.74 33.19 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.501 -0.925 . . . . 65.31 108.501 168.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 92.4 t -127.21 136.37 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.544 -0.91 . . . . 54.5 108.544 172.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.472 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 58.4 t -130.08 126.06 61.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 108.931 -0.766 . . . . 73.42 108.931 177.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.518 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -102.61 98.16 8.25 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 107.162 -1.421 . . . . 75.33 107.162 -178.498 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.415 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 6.2 tmm_? -82.72 105.72 13.98 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.551 -0.907 . . . . 73.21 108.551 174.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 20.2 t -107.14 135.37 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.352 -0.981 . . . . 75.44 108.352 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 62.3 m -125.7 139.83 53.21 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.619 -0.882 . . . . 71.23 108.619 177.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.472 HG21 HG21 ' C' ' 114' ' ' ILE . 98.1 t -127.37 117.69 47.7 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 N-CA-C 108.744 -0.836 . . . . 74.11 108.744 173.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 19.3 m -103.81 140.16 38.03 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.114 -0.699 . . . . 73.12 109.114 171.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.39 112.35 17.45 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.61 -1.256 . . . . 74.33 107.61 174.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 30.4 m -126.67 127.67 45.52 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.008 0.432 . . . . 72.42 110.074 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.692 HD13 ' HG2' ' C' ' 34' ' ' LYS . 12.7 mt -96.96 23.37 7.27 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.96 1.304 . . . . 74.44 110.618 -174.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.74 -77.73 0.3 Allowed Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.196 -0.762 . . . . 50.33 111.196 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -117.48 -30.6 5.48 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.037 0.935 . . . . 74.01 109.418 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -79.68 122.54 26.68 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.551 1.14 . . . . 75.11 110.225 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 27.4 m -76.73 119.53 20.65 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 107.937 -1.134 . . . . 63.14 107.937 164.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.569 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -73.08 -48.51 35.27 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.385 0.612 . . . . 61.4 109.601 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -166.59 166.84 15.89 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 113.878 -1.51 . . . . 64.55 110.42 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -128.98 141.45 51.25 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.646 -1.612 . . . . 74.32 106.646 167.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 41.9 t -144.52 146.24 32.28 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.185 -1.043 . . . . 74.43 108.185 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -157.61 138.47 13.22 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.66 -0.496 . . . . 64.52 109.66 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 43.9 t -136.44 115.37 15.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 124.62 1.168 . . . . 62.13 108.375 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.605 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 45.9 mt-30 -90.59 86.85 6.51 Favored 'General case' 0 CA--C 1.523 -0.067 0 N-CA-C 107.922 -1.14 . . . . 62.32 107.922 168.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -80.11 99.38 7.71 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 108.573 -0.899 . . . . 73.54 108.573 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -102.34 146.09 16.75 Favored Glycine 0 C--O 1.217 -0.931 0 O-C-N 123.179 0.299 . . . . 61.24 113.193 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.13 146.18 14.37 Favored Glycine 0 C--N 1.331 0.264 0 N-CA-C 111.54 -0.624 . . . . 74.45 111.54 -176.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.561 HD12 HD11 ' C' ' 51' ' ' LEU . 30.7 mm -96.04 138.49 21.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.84 0 N-CA-C 109.389 -0.597 . . . . 74.25 109.389 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.553 ' CZ ' HD11 ' C' ' 106' ' ' LEU . 85.4 m-85 -136.36 123.08 21.11 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 123.36 0.664 . . . . 73.1 110.363 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 28.2 p -79.36 102.78 8.86 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 107.971 -1.122 . . . . 71.11 107.971 167.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.407 HG21 ' HE1' ' C' ' 94' ' ' MET . 19.2 mt -117.21 114.94 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.949 0.899 . . . . 62.2 110.412 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -122.01 170.88 9.39 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.885 0.874 . . . . 65.25 109.131 172.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.73 -22.72 39.54 Favored Glycine 0 C--N 1.341 0.809 0 N-CA-C 114.308 0.483 . . . . 63.43 114.308 170.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' C' ' 94' ' ' MET . 44.8 pt -122.66 162.35 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 112.613 0.597 . . . . 74.14 112.613 -172.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -159.09 156.64 29.53 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 115.011 -0.995 . . . . 72.3 109.909 175.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.13 -122.36 6.15 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 123.802 0.689 . . . . 63.13 113.008 171.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 42.3 p -67.56 -29.89 69.37 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.504 0.722 . . . . 73.12 110.958 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -64.69 -59.94 3.68 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.753 0.821 . . . . 73.54 110.489 175.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.493 ' HE3' ' HA ' ' C' ' 94' ' ' MET . 5.2 tpt -46.64 -53.93 10.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.951 1.3 . . . . 72.04 112.2 173.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.09 -44.61 91.92 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.447 0.699 . . . . 73.33 111.41 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -64.12 -33.44 75.77 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.027 0.931 . . . . 75.21 111.73 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.478 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 19.4 t -68.85 -55.85 9.81 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.551 -0.907 . . . . 75.44 108.551 177.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 72.7 mt -65.43 -25.61 67.6 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.611 1.164 . . . . 73.22 112.964 -175.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 99' ' ' GLY . . . . . 0.436 ' HA2' HG21 ' C' ' 46' ' ' THR . . . -109.16 -8.77 26.92 Favored Glycine 0 C--N 1.347 1.174 0 N-CA-C 115.035 0.774 . . . . 41.13 115.035 -171.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.09 -52.88 0.38 Allowed 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 118.213 1.007 . . . . 74.11 111.766 -175.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.478 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 73.7 t80 -70.75 -58.49 3.58 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.272 0.629 . . . . 74.11 111.498 -173.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.569 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 83.0 m -53.52 -59.07 10.35 Favored Pre-proline 0 CA--C 1.559 1.321 0 CA-C-O 117.663 -1.161 . . . . 72.44 110.968 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.569 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 82.4 Cg_exo -50.51 -34.22 41.43 Favored 'Trans proline' 0 C--N 1.395 3.012 0 C-N-CA 122.822 2.348 . . . . 64.02 114.85 -177.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -65.03 -32.32 73.99 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.442 0.697 . . . . 70.52 111.24 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.438 HG23 ' NH1' ' A' ' 111' ' ' ARG . 35.3 mm -72.63 -31.77 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 123.922 0.889 . . . . 72.14 110.414 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.553 HD11 ' CZ ' ' C' ' 84' ' ' PHE . 5.5 mp -90.03 -17.12 28.4 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.474 0.71 . . . . 73.31 111.734 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -55.93 -49.6 92.05 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-O 117.829 -1.081 . . . . 61.13 113.778 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -61.16 -34.68 88.67 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 121.935 1.757 . . . . 74.21 113.07 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.426 ' HE2' HG21 ' A' ' 115' ' ' THR . 59.9 m-85 -64.24 -46.8 82.18 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.555 0.742 . . . . 75.43 110.217 175.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.07 -36.29 83.87 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.122 -0.945 . . . . 62.55 110.723 177.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -64.96 -49.45 70.28 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.058 1.343 . . . . 61.43 110.238 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.89 -32.52 73.06 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.484 0.714 . . . . 63.44 109.625 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 9.0 t -70.24 -39.7 74.9 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 122.985 0.514 . . . . 71.31 110.964 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.472 HG21 HG21 ' C' ' 64' ' ' VAL . 96.6 mt -67.68 -48.79 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.346 0.658 . . . . 73.1 109.828 177.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 15.7 m -66.03 -29.34 69.68 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.915 -0.584 . . . . 55.33 110.755 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 30.2 t -64.77 -50.29 67.38 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.363 -0.606 . . . . 73.03 109.363 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.465 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -55.8 -46.9 77.91 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.432 1.093 . . . . 65.24 111.59 177.536 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 69.2 t -65.69 -40.48 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.874 0.87 . . . . 73.42 110.87 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 33.8 t -72.18 -29.52 64.08 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.607 0.763 . . . . 73.55 111.481 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.584 HH22 ' HG2' ' D' ' 112' ' ' GLU . 64.6 mtt-85 -74.1 -29.62 61.94 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.447 -0.797 . . . . 71.51 109.782 176.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.23 12.43 58.35 Favored Glycine 0 C--N 1.353 1.479 0 O-C-N 124.015 0.822 . . . . 24.34 112.886 172.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.43 HG23 ' HB3' ' D' ' 17' ' ' TYR . 69.4 p 54.16 28.34 8.9 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 126.519 1.928 . . . . 70.33 114.214 176.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -84.24 151.93 60.58 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 109.365 -0.605 . . . . 74.44 109.365 172.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -47.39 136.23 19.93 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.35 2.7 . . . . 71.41 113.11 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.422 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 41.9 mm-40 -53.69 110.98 0.64 Allowed 'General case' 0 N--CA 1.478 0.965 0 O-C-N 124.317 1.01 . . . . 74.04 111.839 -175.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.461 HD21 HG11 ' C' ' 40' ' ' VAL . 3.9 tt -113.95 90.46 3.35 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.983 -1.117 . . . . 65.42 107.983 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -94.41 122.31 36.84 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.463 -0.94 . . . . 73.41 108.463 173.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 6.4 mp -66.73 145.18 55.81 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.174 0.921 . . . . 75.04 111.288 -171.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.8 151.9 77.06 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-N 115.602 -0.726 . . . . 64.32 110.791 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.546 ' HG3' HD12 ' A' ' 16' ' ' ILE . 21.6 Cg_exo -63.82 107.32 0.74 Allowed 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 123.062 2.508 . . . . 60.43 112.385 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 131' ' ' VAL . . . . . 0.515 HG11 HD11 ' C' ' 44' ' ' LEU . 7.4 p -103.84 139.84 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 123.926 0.89 . . . . 73.33 109.096 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -94.43 104.35 16.32 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.709 0.804 . . . . 63.24 110.325 -171.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -63.4 -34.58 78.03 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.909 0.884 . . . . 74.23 112.425 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -64.99 -40.15 94.53 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.218 0.607 . . . . 61.21 110.414 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.43 -30.42 67.26 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.573 0.749 . . . . 65.51 111.177 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 91.6 mt -72.39 -40.23 67.4 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.011 0.524 . . . . 75.42 110.139 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 25.8 t80 . . . . . 0 CA--C 1.546 0.825 0 CA-C-N 115.198 -0.91 . . . . 73.4 110.226 178.615 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 C--O 1.242 0.67 0 CA-C-O 120.98 0.419 . . . . 74.05 109.899 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -133.23 92.4 3.0 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 106.875 -1.528 . . . . 75.33 106.875 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -114.19 117.35 30.92 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.629 0.772 . . . . 74.45 109.163 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 9.0 mt -82.25 132.59 31.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.009 -1.108 . . . . 55.03 108.009 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -101.35 -28.59 12.52 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.624 0.77 . . . . 74.1 110.556 -174.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -173.44 133.12 0.48 Allowed 'General case' 0 C--N 1.361 1.09 0 O-C-N 123.618 0.574 . . . . 75.03 110.41 -176.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.413 HD12 ' N ' ' D' ' 16' ' ' ILE . 3.3 mp -114.04 130.47 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 107.212 -1.403 . . . . 63.15 107.212 173.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.458 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 37.4 p90 -163.65 175.79 10.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.987 0.899 . . . . 72.12 112.45 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.8 p -108.18 118.76 37.61 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 114.218 -1.356 . . . . 72.32 108.871 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.458 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 29.9 mtpt -90.52 -11.27 40.68 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.991 -0.744 . . . . 55.23 108.991 177.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.751 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 18.7 t70 -166.23 135.67 3.18 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 124.766 1.226 . . . . 75.24 109.376 -175.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.465 HD13 ' HE3' ' C' ' 117' ' ' MET . 52.8 mt -144.36 138.22 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.185 1.394 . . . . 63.43 107.937 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -145.45 138.64 26.32 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.838 0.855 . . . . 74.22 109.21 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.598 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.4 t80 -142.07 135.69 29.41 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.113 -1.44 . . . . 75.32 107.113 170.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -135.74 148.45 48.82 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 108.837 -0.801 . . . . 72.22 108.837 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -142.87 75.72 17.63 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 107.104 -1.443 . . . . 65.15 107.104 175.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.92 -27.81 30.17 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.777 2.318 . . . . 70.14 112.938 -169.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -108.2 1.01 21.82 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 115.415 -0.811 . . . . 64.3 110.696 -175.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.476 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -20.87 -73.09 0.03 OUTLIER Pre-proline 0 CA--C 1.567 1.61 0 N-CA-C 116.612 2.078 . . . . 73.54 116.612 -166.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.538 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 93.1 Cg_endo -75.15 -20.55 16.47 Favored 'Trans proline' 0 C--N 1.379 2.182 0 CA-C-N 123.962 2.451 . . . . 73.34 114.135 -173.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -72.7 -40.63 66.06 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.877 0.871 . . . . 62.43 109.495 174.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.476 HG12 ' O ' ' D' ' 28' ' ' ALA . 5.5 p -83.52 -20.66 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 CA-C-N 115.612 -0.722 . . . . 72.45 111.566 -173.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.4 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 22.5 m-85 -66.99 -20.65 65.92 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 111.982 0.364 . . . . 73.35 111.982 178.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -64.03 -15.05 58.58 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.374 1.069 . . . . 73.34 110.926 176.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -92.7 96.62 10.28 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.117 1.367 . . . . 75.32 109.718 175.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -92.07 79.67 5.16 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.808 -1.087 . . . . 51.14 110.808 -172.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -158.89 171.33 20.26 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.447 -0.797 . . . . 73.54 109.727 168.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -67.65 115.3 25.9 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 123.836 0.855 . . . . 75.23 109.274 177.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -49.05 131.12 25.3 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 123.079 2.519 . . . . 52.21 112.475 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -65.04 110.37 2.46 Favored 'General case' 0 C--N 1.346 0.428 0 N-CA-C 107.008 -1.478 . . . . 73.21 107.008 171.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.709 HG13 HG13 ' D' ' 64' ' ' VAL . 96.9 t -113.05 127.19 70.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 108.517 -0.92 . . . . 73.14 108.517 -175.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.466 ' HE3' ' HB3' ' D' ' 41' ' ' LYS . 0.5 OUTLIER -120.76 129.42 53.6 Favored 'General case' 0 C--O 1.248 0.991 0 N-CA-C 106.493 -1.669 . . . . 63.23 106.493 172.414 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.631 HD11 HG13 ' D' ' 62' ' ' VAL . 33.1 tp -97.1 129.29 44.53 Favored 'General case' 0 C--O 1.238 0.477 0 O-C-N 123.931 0.77 . . . . 73.45 110.111 -172.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.601 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.2 m-20 -108.98 112.38 24.55 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.535 -1.654 . . . . 64.12 106.535 177.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.411 ' CD2' HG22 ' D' ' 62' ' ' VAL . 25.8 mt -107.23 131.95 53.62 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.374 0.606 . . . . 65.4 109.903 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.3 t70 -133.85 153.65 51.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.21 -1.359 . . . . 53.43 108.063 176.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 5.1 t -126.61 149.85 49.23 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.006 0.922 . . . . 64.13 109.047 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.478 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -148.78 141.11 24.14 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.216 -1.031 . . . . 63.03 108.216 178.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 91.3 p . . . . . 0 C--O 1.243 0.723 0 N-CA-C 108.438 -0.949 . . . . 72.31 108.438 178.775 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 121.213 0.53 . . . . 75.02 111.024 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 p -133.57 101.06 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.398 1.079 . . . . 64.25 108.217 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -118.24 144.27 45.9 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 114.634 -1.166 . . . . 75.24 108.84 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -105.43 136.26 45.31 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.428 0.632 . . . . 64.3 110.81 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 90.3 t -114.54 144.8 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-N 114.098 -1.41 . . . . 71.42 108.03 174.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 52.2 t -135.99 127.76 44.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.668 -1.234 . . . . 71.52 107.668 176.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.535 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -109.67 102.14 10.99 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 106.844 -1.539 . . . . 63.25 106.844 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.507 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.6 ttt180 -83.8 95.2 8.37 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.46 -0.941 . . . . 75.24 108.46 176.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.631 HG13 HD11 ' D' ' 42' ' ' LEU . 66.5 t -96.33 117.18 40.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.661 -1.154 . . . . 73.42 108.97 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.601 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 23.8 m -123.06 130.25 52.54 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 114.9 -1.045 . . . . 75.11 108.725 -174.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.709 HG13 HG13 ' D' ' 40' ' ' VAL . 47.2 t -111.25 121.37 63.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 C-N-CA 124.821 1.248 . . . . 73.4 108.967 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 18.4 m -100.26 110.92 23.18 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.463 -1.31 . . . . 52.53 107.463 164.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.07 138.62 54.1 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.986 -0.746 . . . . 63.41 108.986 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.482 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 80.9 p -142.07 140.67 32.62 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.347 0.594 . . . . 73.53 111.241 -175.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.427 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 35.3 mt -112.92 114.5 27.02 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 106.889 -1.522 . . . . 64.5 106.889 169.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.19 -129.2 9.23 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 123.166 0.291 . . . . 73.43 112.423 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.76 5.34 36.03 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.492 0.717 . . . . 72.04 110.901 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -121.97 165.15 16.43 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.469 0.708 . . . . 61.44 109.586 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 94.1 m -69.26 135.26 50.26 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.803 -0.635 . . . . 75.1 111.484 177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.482 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -82.32 -68.69 0.68 Allowed 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.595 -1.261 . . . . 75.04 107.595 170.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -149.3 161.88 41.17 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 114.974 -1.012 . . . . 71.41 110.363 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 78.7 mt -120.9 120.35 35.26 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.482 1.113 . . . . 73.14 108.22 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.658 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 1.7 m -116.78 139.15 50.91 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.214 -1.032 . . . . 70.13 108.214 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -157.12 121.85 4.46 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.931 0.493 . . . . 70.11 109.676 173.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -136.13 119.12 22.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 123.705 0.802 . . . . 52.1 109.041 -175.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.751 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.2 mt-30 -89.04 88.59 7.63 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 108.647 -0.871 . . . . 73.43 108.647 170.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -80.27 99.19 7.73 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.371 -1.286 . . . . 70.32 108.739 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.35 142.33 15.56 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 116.316 -0.402 . . . . 71.42 112.141 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.68 140.88 11.64 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 111.117 -0.793 . . . . 61.52 111.117 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 61.3 mt -90.78 119.14 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.933 -1.136 . . . . 72.23 107.933 175.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -119.85 131.31 55.24 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.692 0.797 . . . . 71.11 110.192 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 35.4 t -107.9 100.47 9.83 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.363 -0.977 . . . . 62.23 108.363 172.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 39.9 pt -110.54 147.67 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.674 1.19 . . . . 73.41 108.807 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.7 168.56 12.45 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.792 0.682 . . . . 64.12 111.033 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.6 21.92 49.09 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.596 0.56 . . . . 54.34 114.166 174.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -138.84 161.14 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.8 0.84 . . . . 72.34 111.475 -177.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -149.22 -171.89 3.99 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.215 -1.357 . . . . 74.33 109.192 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.31 -140.19 24.22 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-O 119.709 -0.495 . . . . 50.51 111.934 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 81.1 p -91.87 -35.82 13.84 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 117.529 0.664 . . . . 73.21 111.268 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.568 ' HA ' ' HB3' ' D' ' 96' ' ' HIS . 27.8 tp60 -65.63 -22.03 66.62 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.203 1.001 . . . . 71.24 112.023 -172.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.475 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 0.0 OUTLIER -60.85 -43.59 98.12 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.802 0.441 . . . . 71.12 111.433 177.257 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 95' ' ' ALA . . . . . 0.475 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -79.59 -31.01 41.72 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.775 0.83 . . . . 62.4 110.543 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 96' ' ' HIS . . . . . 0.568 ' HB3' ' HA ' ' D' ' 93' ' ' GLN . 18.8 t-80 -75.06 -25.3 58.53 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 123.935 0.894 . . . . 75.12 112.153 -175.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 85.2 m -65.87 -38.27 88.35 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.56 0.695 . . . . 74.11 109.795 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.614 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 12.9 tp -77.97 -35.96 49.63 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.831 -1.077 . . . . 72.34 110.421 177.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.74 -28.45 42.63 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.434 -0.803 . . . . 62.23 115.03 -171.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.24 -47.2 2.27 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 118.295 1.047 . . . . 74.12 111.396 -175.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -74.7 -34.59 62.65 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 112.031 0.382 . . . . 72.42 112.031 -174.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.614 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 90.3 m -67.01 -47.55 52.35 Favored Pre-proline 0 CA--C 1.565 1.553 0 CA-C-O 118.46 -0.781 . . . . 75.32 112.174 177.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.535 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.5 Cg_exo -55.84 -34.27 90.92 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 122.158 1.905 . . . . 63.44 113.136 169.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -61.96 -37.34 84.38 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.482 0.713 . . . . 65.04 111.123 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 44.9 mm -68.25 -41.53 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.528 0.731 . . . . 74.15 110.601 174.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 96.6 mt -78.17 -15.13 59.11 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.742 -0.663 . . . . 70.14 112.331 -172.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -70.03 -44.09 20.63 Favored Pre-proline 0 N--CA 1.485 1.294 0 N-CA-C 113.858 1.059 . . . . 61.21 113.858 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 108' ' ' PRO . . . . . 0.538 ' HB2' ' HG2' ' B' ' 108' ' ' PRO . 18.8 Cg_endo -58.03 -29.24 86.2 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 121.624 1.55 . . . . 65.31 112.771 172.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -81.18 -31.23 34.1 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.782 0.833 . . . . 71.54 111.493 175.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.91 -50.28 71.48 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.792 0.837 . . . . 34.44 109.934 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -73.51 -29.47 62.5 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.198 -0.91 . . . . 74.12 110.593 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 112' ' ' GLU . . . . . 0.584 ' HG2' HH22 ' C' ' 120' ' ' ARG . 23.5 tt0 -53.19 -46.18 68.88 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.458 0.703 . . . . 65.34 110.479 173.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.1 t -70.38 -47.37 61.23 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.426 -0.806 . . . . 43.44 111.226 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.449 ' O ' HG23 ' D' ' 118' ' ' VAL . 76.8 mt -60.12 -61.27 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.887 0.875 . . . . 74.2 111.643 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 10.3 m -50.94 -38.94 53.54 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.448 1.099 . . . . 75.24 111.638 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -64.27 -48.29 76.32 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.347 -0.842 . . . . 64.03 110.012 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 73.7 mtm -67.24 -29.85 69.6 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.148 0.579 . . . . 74.42 111.767 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.449 HG23 ' O ' ' D' ' 114' ' ' ILE . 76.0 t -64.84 -46.69 91.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.62 0.768 . . . . 73.34 109.39 176.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.5 p -72.87 -31.42 64.72 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.875 -0.602 . . . . 62.21 110.588 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 77.6 mtt-85 -69.46 -28.87 66.47 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.775 0.83 . . . . 72.31 110.405 174.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.8 10.01 74.1 Favored Glycine 0 C--N 1.351 1.378 0 CA-C-O 119.317 -0.713 . . . . 71.24 112.647 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.539 HG23 ' HB3' ' C' ' 17' ' ' TYR . 74.5 p 52.68 37.45 23.6 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 126.12 1.768 . . . . 65.32 113.499 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -99.81 151.86 37.62 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 115.01 -0.995 . . . . 75.3 109.645 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -51.84 145.38 32.05 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.478 2.786 . . . . 73.11 113.194 171.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -61.16 136.86 58.2 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.836 0.854 . . . . 73.54 112.631 -169.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.442 HD13 HG21 ' D' ' 40' ' ' VAL . 16.4 tp -124.81 99.42 6.14 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.434 1.094 . . . . 65.53 109.267 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -100.11 108.28 20.38 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 107.702 -1.222 . . . . 64.4 107.702 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 6.7 mp -70.81 116.28 10.94 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.333 -0.618 . . . . 73.34 109.333 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.11 141.38 93.84 Favored Pre-proline 0 CA--C 1.55 0.972 0 O-C-N 124.078 0.861 . . . . 62.44 111.772 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.67 116.05 3.03 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.537 2.158 . . . . 60.12 110.868 175.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 13.1 p -108.62 146.53 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.811 0.845 . . . . 65.31 109.315 -172.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -73.6 104.45 4.55 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.834 -0.802 . . . . 72.41 108.834 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 . . . . . 0 N--CA 1.471 0.601 0 C-N-CA 123.571 0.748 . . . . 74.12 111.516 -178.543 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.2 m . . . . . 0 CA--C 1.535 0.379 0 N-CA-C 109.177 -0.675 . . . . 62.33 109.177 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -131.42 112.48 12.73 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.823 -1.547 . . . . 64.25 106.823 167.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -137.72 114.15 10.27 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 107.809 -1.182 . . . . 72.14 107.809 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.618 HG21 ' HG2' ' C' ' 130' ' ' PRO . 51.0 mt -69.41 114.42 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 109.034 -0.728 . . . . 74.3 109.034 177.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -78.79 -34.74 45.21 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.285 -0.635 . . . . 73.23 109.285 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.43 ' HE ' ' HB ' ' B' ' 122' ' ' THR . 14.0 ttt85 -172.63 132.52 0.58 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.973 0.509 . . . . 72.05 110.227 -174.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.455 HD11 HD13 ' A' ' 13' ' ' ILE . 80.6 mt -117.44 127.35 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.021 -1.103 . . . . 75.14 108.021 166.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 25.0 p90 -163.78 154.02 15.28 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.787 0.679 . . . . 62.33 110.827 -171.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.7 p -80.03 116.78 20.35 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 109.712 -0.477 . . . . 73.41 109.712 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.45 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 42.9 mtpt -79.11 -25.52 43.0 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.601 -0.518 . . . . 72.1 109.601 172.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.495 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.1 t70 -155.06 146.8 23.31 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 114.882 -1.054 . . . . 55.22 110.526 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.485 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 81.2 mt -141.28 141.7 30.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 C-N-CA 126.114 1.766 . . . . 72.41 107.012 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.4 t -143.72 132.76 22.88 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.218 -1.03 . . . . 64.15 108.218 170.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.539 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 85.2 t80 -139.87 141.8 36.59 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.539 -1.282 . . . . 73.12 107.539 172.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -144.37 149.41 36.09 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.773 0.829 . . . . 72.25 108.889 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.28 74.83 11.67 Favored Pre-proline 0 C--O 1.241 0.639 0 N-CA-C 106.173 -1.788 . . . . 43.23 106.173 170.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.72 -29.93 28.53 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.233 1.955 . . . . 71.14 111.88 -171.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -96.82 9.43 41.81 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.798 0.839 . . . . 73.32 111.899 -175.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.464 ' HA ' HG12 ' A' ' 31' ' ' VAL . . . -47.36 -58.56 7.11 Favored Pre-proline 0 CA--C 1.563 1.471 0 N-CA-C 114.4 1.259 . . . . 41.32 114.4 -166.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 71.8 Cg_exo -49.84 -40.3 48.41 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.884 2.389 . . . . 71.44 114.455 -177.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -100.16 -13.97 18.73 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.214 0.82 . . . . 72.45 113.214 -175.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.597 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.7 p -77.27 -18.75 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-O 120.892 0.377 . . . . 74.34 110.912 -175.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -74.11 -19.96 60.41 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.393 0.677 . . . . 75.3 111.127 175.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -73.87 -28.92 61.82 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.631 0.773 . . . . 74.13 109.779 174.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -69.8 159.5 33.48 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.956 0.902 . . . . 65.32 112.119 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -68.94 123.35 20.76 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.538 -0.756 . . . . 45.41 109.234 171.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.494 ' CE3' HD21 ' A' ' 68' ' ' LEU . 71.9 t-105 -75.04 84.88 2.29 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.894 0.854 . . . . 74.43 109.841 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.433 ' H ' HD22 ' A' ' 68' ' ' LEU . 23.7 tt0 -120.48 79.63 29.44 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 125.48 1.512 . . . . 74.41 107.53 173.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.31 112.66 3.52 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.04 1.826 . . . . 64.04 112.446 -174.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.56 97.32 9.67 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 105.38 -2.082 . . . . 75.33 105.38 168.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.435 HG11 HD21 ' A' ' 126' ' ' LEU . 17.6 t -95.45 100.87 11.73 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-N 115.406 -0.815 . . . . 74.35 110.826 -170.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -77.84 114.03 16.31 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.774 -1.103 . . . . 71.24 110.027 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.3 mt -103.36 111.16 23.45 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.591 0.756 . . . . 53.31 109.671 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.598 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.8 m-20 -102.23 147.28 26.84 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.592 -0.892 . . . . 74.3 108.592 172.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.612 HD11 HG21 ' A' ' 131' ' ' VAL . 77.0 mt -131.23 141.34 50.0 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.413 0.685 . . . . 75.13 110.293 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 25.6 t70 -144.51 122.11 11.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.412 -1.267 . . . . 74.13 108.056 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.4 m -113.37 129.09 56.62 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.926 -0.768 . . . . 73.24 108.926 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.74 117.46 15.03 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.583 0.753 . . . . 33.33 109.567 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.43 ' HB3' ' HB3' ' A' ' 98' ' ' LEU . 19.4 p -88.86 173.32 8.59 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 122.968 0.507 . . . . 75.12 110.552 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.6 t -163.82 145.57 9.17 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.377 1.071 . . . . 74.55 108.771 -170.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -114.9 122.7 47.12 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.272 0.629 . . . . 64.34 109.31 170.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.6 mt -97.65 -37.61 9.84 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.387 0.675 . . . . 73.13 109.824 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.474 ' HB3' ' CG2' ' A' ' 55' ' ' VAL . . . -153.1 177.45 10.79 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.874 0.87 . . . . 60.11 109.481 177.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -64.59 125.36 24.45 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.853 0.461 . . . . 64.11 109.986 170.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 68.22 8.75 6.77 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.139 1.376 . . . . 71.34 112.163 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.474 ' CG2' ' HB3' ' A' ' 52' ' ' ALA . 51.5 t -115.62 92.74 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 108.31 -0.996 . . . . 65.44 108.31 176.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -110.59 122.3 47.42 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.077 0.465 . . . . 75.12 109.751 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -93.86 147.49 23.03 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.818 0.847 . . . . 65.5 109.101 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.8 t -131.79 143.32 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 107.986 -1.116 . . . . 75.12 107.986 173.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.526 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 60.6 t -121.42 137.96 53.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 108.487 -0.931 . . . . 71.22 108.487 176.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.89 98.76 6.51 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.243 -1.392 . . . . 72.24 107.243 175.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.486 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 43.3 ttp180 -84.98 101.23 12.21 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.48 -0.933 . . . . 74.44 108.48 173.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.6 t -95.69 132.71 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 108.003 -1.11 . . . . 70.33 108.003 175.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.598 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 12.0 m -112.93 142.15 45.93 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.927 -0.768 . . . . 64.22 108.927 171.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.604 HG21 HG21 ' A' ' 114' ' ' ILE . 77.1 t -135.84 114.85 16.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 107.502 -1.296 . . . . 71.4 107.502 -176.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.4 m -121.92 107.63 12.49 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.928 -0.767 . . . . 72.01 108.928 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.74 111.59 23.98 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 106.703 -1.592 . . . . 72.41 106.703 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 54.7 m -120.73 135.91 55.01 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.716 0.77 . . . . 70.41 111.289 -173.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.509 HD12 HG22 ' A' ' 31' ' ' VAL . 35.1 mt -88.86 81.66 6.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.482 1.513 . . . . 62.31 107.779 175.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.12 -99.06 1.03 Allowed Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.471 -0.786 . . . . 54.42 111.894 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -94.84 -29.58 14.65 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.274 0.63 . . . . 74.42 111.175 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -98.18 127.82 44.33 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.269 0.628 . . . . 65.14 109.892 -170.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.3 m -69.25 132.81 47.07 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 120.993 0.425 . . . . 45.35 110.406 173.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.597 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -76.93 -52.21 9.82 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.188 -0.914 . . . . 71.13 108.728 174.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -160.26 164.17 32.88 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.814 -1.085 . . . . 75.31 110.916 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.9 tp -124.31 132.07 53.55 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.414 1.086 . . . . 54.22 108.438 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.462 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 37.0 m -130.48 116.63 18.47 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.78 0.832 . . . . 64.42 109.147 175.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -131.04 116.25 17.54 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.494 -0.558 . . . . 74.02 109.494 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.0 t -124.25 114.3 40.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 124.14 0.976 . . . . 63.2 109.374 -173.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.495 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 35.4 mt-30 -85.36 83.59 7.91 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.5 -0.926 . . . . 73.32 108.5 172.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -75.77 94.55 3.3 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 114.773 -1.103 . . . . 73.55 108.564 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.24 169.49 47.88 Favored Glycine 0 C--O 1.241 0.557 0 N-CA-C 111.013 -0.835 . . . . 73.41 111.013 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.23 120.74 0.91 Allowed Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 110.87 -0.892 . . . . 74.44 110.87 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.425 HG13 ' HE1' ' A' ' 17' ' ' TYR . 51.6 mt -82.61 127.07 40.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 107.805 -1.183 . . . . 64.45 107.805 174.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.692 ' HB3' HD11 ' A' ' 86' ' ' ILE . 66.7 m-85 -128.06 123.51 34.77 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.528 -0.916 . . . . 60.45 108.528 -174.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.7 t -87.32 93.55 9.43 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.361 -0.977 . . . . 73.42 108.361 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.692 HD11 ' HB3' ' A' ' 84' ' ' PHE . 18.9 mm -117.23 147.95 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.451 0.7 . . . . 71.23 111.146 -169.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.61 173.73 11.62 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.666 0.786 . . . . 75.11 110.307 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.22 -33.2 5.77 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.973 -0.558 . . . . 71.21 113.022 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.56 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -124.42 140.12 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.602 0.761 . . . . 71.53 110.515 -173.286 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.452 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 11.6 mp0 -131.52 174.78 9.74 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.709 0.804 . . . . 72.33 110.02 178.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.88 -123.21 27.98 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 124.0 0.813 . . . . 71.31 114.205 173.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.9 t -71.93 -25.25 61.82 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.289 0.635 . . . . 65.12 111.354 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -75.37 -38.0 60.28 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.599 0.76 . . . . 54.42 109.527 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.452 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 6.1 tpt -66.5 -45.55 79.17 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.511 -0.768 . . . . 55.35 109.367 174.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.8 -37.01 77.93 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.358 -0.837 . . . . 53.22 110.883 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -68.54 -34.62 76.17 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.738 -0.664 . . . . 75.55 111.001 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.2 t -69.3 -45.61 69.16 Favored 'General case' 0 C--N 1.348 0.5 0 N-CA-C 109.445 -0.576 . . . . 72.43 109.445 178.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 94' ' ' MET . 49.2 mt -80.85 -22.3 40.01 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.47 -0.787 . . . . 33.41 112.273 -172.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.13 4.14 30.08 Favored Glycine 0 N--CA 1.475 1.239 0 CA-C-O 119.677 -0.513 . . . . 64.15 114.055 -174.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.484 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -142.71 -65.91 0.39 Allowed 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 117.406 0.603 . . . . 74.54 111.192 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -69.94 -43.34 71.81 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 111.988 0.366 . . . . 74.45 111.988 -173.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 65.6 m -66.65 -47.22 56.9 Favored Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 124.044 0.937 . . . . 71.0 112.806 -176.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.458 ' HA ' ' HB2' ' A' ' 106' ' ' LEU . 52.2 Cg_endo -67.41 -23.61 43.88 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 121.77 1.646 . . . . 64.42 113.168 170.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -66.39 -38.21 87.0 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 122.604 0.362 . . . . 64.21 110.033 173.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.9 mm -65.12 -45.71 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.742 0.817 . . . . 63.01 110.276 171.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 103' ' ' PRO . 61.4 mt -72.02 -21.77 61.5 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.763 0.825 . . . . 74.01 113.074 -172.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -66.85 -44.28 51.67 Favored Pre-proline 0 N--CA 1.484 1.264 0 N-CA-C 114.057 1.132 . . . . 73.45 114.057 -169.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -54.89 -31.54 73.78 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.812 1.675 . . . . 51.11 113.714 172.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.443 ' OH ' ' HB3' ' C' ' 130' ' ' PRO . 67.8 m-85 -84.49 -37.13 21.69 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.497 0.719 . . . . 71.11 111.305 -175.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.5 -46.87 78.03 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.286 -0.635 . . . . 54.34 109.286 172.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.545 ' NH1' HD12 ' C' ' 105' ' ' ILE . 32.9 ttm180 -49.57 -52.66 28.52 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 124.884 1.365 . . . . 74.4 110.463 174.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -63.27 -45.89 89.37 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.223 0.952 . . . . 73.13 112.05 -175.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.428 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 45.1 t -58.14 -46.25 85.98 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 124.045 0.84 . . . . 73.12 110.364 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.604 HG21 HG21 ' A' ' 64' ' ' VAL . 32.5 mt -60.93 -52.5 60.93 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 115.2 -0.909 . . . . 64.44 110.632 175.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.4 m -56.21 -40.16 73.6 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.127 0.892 . . . . 71.22 111.28 -174.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.516 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 41.9 t -67.62 -42.97 81.5 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 114.772 -1.104 . . . . 54.31 110.356 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.9 mtp -62.5 -37.38 85.79 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.552 0.741 . . . . 73.1 111.661 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 114' ' ' ILE . 86.1 t -62.2 -53.7 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.254 1.022 . . . . 41.42 109.917 177.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.5 p -69.92 -26.71 64.28 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.95 -1.023 . . . . 54.55 111.587 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.516 ' HB2' ' O ' ' A' ' 116' ' ' SER . 18.0 ttm-85 -75.49 -31.61 60.27 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.182 0.993 . . . . 71.44 109.083 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.437 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.88 19.82 18.96 Favored Glycine 0 C--N 1.354 1.576 0 CA-C-N 114.948 -1.024 . . . . 34.13 112.916 171.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.5 t 61.44 9.12 2.48 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 127.497 2.319 . . . . 75.11 114.03 175.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -78.93 140.05 57.8 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 108.409 -0.96 . . . . 74.34 108.409 175.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.08 136.06 44.94 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.857 2.372 . . . . 54.41 111.854 175.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -52.07 133.54 33.09 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.308 1.005 . . . . 73.42 113.269 -170.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.435 HD21 HG11 ' A' ' 40' ' ' VAL . 58.7 tp -112.42 137.3 50.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.406 -1.27 . . . . 65.03 108.986 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -122.93 123.75 41.64 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 107.806 -1.183 . . . . 74.43 107.806 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.453 HD11 HD13 ' A' ' 114' ' ' ILE . 7.5 mt -74.78 125.6 29.13 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.122 -0.696 . . . . 60.12 109.122 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.31 135.99 96.49 Favored Pre-proline 0 CA--C 1.555 1.17 0 CA-C-O 119.186 -0.435 . . . . 75.02 111.028 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.85 131.59 46.96 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 123.284 2.656 . . . . 75.12 113.705 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.612 HG21 HD11 ' A' ' 44' ' ' LEU . 67.2 t -115.07 133.56 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.87 0.868 . . . . 74.32 110.513 -177.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -88.49 87.87 7.42 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 108.663 -0.866 . . . . 63.54 108.663 173.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -60.87 -26.9 67.74 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.001 0.92 . . . . 72.32 111.965 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.484 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 4.1 t70 -71.02 -40.77 71.59 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 123.592 0.557 . . . . 51.25 109.648 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.52 94.17 Favored 'General case' 0 C--N 1.351 0.635 0 O-C-N 123.897 0.748 . . . . 60.02 110.772 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.7 mt -58.71 -50.95 71.99 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.694 0.621 . . . . 63.54 110.59 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 53.9 t80 . . . . . 0 N--CA 1.474 0.74 0 CA-C-N 115.855 -0.611 . . . . 64.45 110.363 178.979 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 14.6 ptm . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 114.053 1.131 . . . . 63.31 114.053 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 91.5 m -151.72 111.04 3.93 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.513 1.125 . . . . 71.43 108.424 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -109.56 144.48 37.81 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.853 0.461 . . . . 71.24 109.918 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -156.69 139.97 15.63 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.888 0.875 . . . . 44.51 109.505 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.8 mt -94.08 131.47 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.258 -1.386 . . . . 73.42 107.258 169.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -93.73 -46.69 7.12 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 120.968 0.414 . . . . 73.11 109.986 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -176.74 130.9 0.19 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.22 -0.9 . . . . 70.52 109.067 -172.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.513 HG21 ' CD1' ' B' ' 109' ' ' TYR . 81.6 mt -116.2 148.37 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 108.45 -0.945 . . . . 64.23 108.45 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -165.17 147.01 7.74 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 113.059 0.763 . . . . 73.35 113.059 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.2 m -73.53 121.42 20.57 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.457 -1.247 . . . . 74.43 108.991 168.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.414 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.9 mtpt -99.4 -20.79 16.3 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.499 0.719 . . . . 75.45 111.929 -177.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -164.67 135.54 4.14 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.326 0.25 . . . . 63.44 110.742 -171.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 48.4 mm -132.57 139.11 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.871 1.268 . . . . 63.42 109.601 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 37.2 t -136.28 126.73 26.78 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.38 -1.341 . . . . 70.54 107.38 174.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.485 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.8 t80 -145.01 111.6 5.75 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 107.589 -1.263 . . . . 73.53 107.589 170.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -128.32 112.73 14.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.311 -0.996 . . . . 61.51 108.311 -173.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.62 85.06 8.73 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 107.792 -1.188 . . . . 63.11 107.792 174.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.5 -30.07 12.73 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.579 2.186 . . . . 72.22 112.256 -175.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.451 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 2.1 m-20 -98.46 10.06 41.72 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.193 0.997 . . . . 71.13 110.571 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.469 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -41.92 -61.89 1.35 Allowed Pre-proline 0 CA--C 1.56 1.357 0 N-CA-C 115.293 1.59 . . . . 53.42 115.293 -164.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.409 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 15.5 Cg_exo -62.76 -27.65 75.69 Favored 'Trans proline' 0 C--N 1.391 2.765 0 C-N-CA 122.347 2.031 . . . . 71.51 112.721 -169.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -94.24 -37.89 11.31 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.704 -1.134 . . . . 71.53 111.804 -172.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.589 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.1 p -69.6 -12.22 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 122.753 0.421 . . . . 74.32 112.109 -173.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -70.38 -9.72 57.07 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 112.868 0.692 . . . . 73.24 112.868 177.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -61.92 -26.2 68.03 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.623 0.769 . . . . 62.33 110.915 171.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.614 ' HB2' HD13 ' B' ' 68' ' ' LEU . 30.4 mmtp -89.24 84.73 6.51 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.482 1.113 . . . . 54.24 110.171 -174.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -88.3 82.53 7.04 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.125 0.488 . . . . 70.22 110.834 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 26.8 p90 -160.92 -172.05 3.32 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.513 1.125 . . . . 72.12 108.966 169.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -79.59 119.29 76.4 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.152 0.581 . . . . 74.54 110.722 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.473 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 20.6 Cg_endo -68.59 152.02 74.89 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 121.843 1.695 . . . . 74.02 111.343 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -71.35 102.68 2.67 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.596 -0.89 . . . . 72.35 108.596 173.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.425 HG11 HD11 ' B' ' 126' ' ' LEU . 50.6 t -94.84 142.77 13.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 114.667 -1.151 . . . . 74.31 110.24 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -140.0 109.74 6.35 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 106.933 -1.506 . . . . 75.35 106.933 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.484 HD13 HD22 ' B' ' 128' ' ' LEU . 35.6 tp -92.61 146.08 23.94 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.949 0.9 . . . . 74.54 109.845 -173.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.598 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 16.2 m-20 -131.34 143.16 50.29 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.758 1.223 . . . . 65.44 108.62 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 98.0 mt -129.99 128.63 42.44 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.922 -1.14 . . . . 73.34 107.922 174.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -140.84 143.96 35.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.091 0.956 . . . . 71.0 108.595 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 25.8 m -118.91 102.35 8.72 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.644 -0.502 . . . . 74.04 109.644 -175.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' B' ' 59' ' ' VAL . . . -125.3 115.62 20.64 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 106.672 -1.603 . . . . 42.53 106.672 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 24.2 m -142.42 -178.27 5.67 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.75 0.42 . . . . 63.3 111.401 -164.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 69.4 p -150.67 137.01 18.65 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 123.396 0.678 . . . . 44.34 109.91 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -95.17 128.47 42.03 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.7 0.4 . . . . 60.44 110.097 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 19.0 mt -92.6 -30.99 15.34 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.491 0.494 . . . . 64.22 110.234 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.495 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -171.41 175.15 4.23 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.842 0.857 . . . . 72.24 111.418 -176.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.72 137.33 57.74 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 107.019 -1.475 . . . . 74.44 107.019 159.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 70.81 -4.1 1.8 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.421 1.088 . . . . 74.33 113.234 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 41.2 t -135.15 96.71 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 108.334 -0.987 . . . . 74.22 108.334 -178.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -115.9 140.71 48.98 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.73 -0.841 . . . . 73.43 108.73 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -110.44 96.84 6.45 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.149 -1.426 . . . . 71.24 107.149 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -99.85 146.77 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 115.893 -0.594 . . . . 72.34 109.999 -174.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' B' ' 47' ' ' ALA . 26.9 t -127.86 143.54 40.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 123.942 0.897 . . . . 60.44 108.802 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 46.4 tp -119.46 114.34 22.15 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.547 -0.909 . . . . 74.44 108.547 170.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -84.39 111.92 19.88 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.377 -0.972 . . . . 75.43 108.377 171.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.414 ' CG1' HD11 ' B' ' 42' ' ' LEU . 20.8 t -105.78 103.37 15.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.458 -1.312 . . . . 75.03 107.458 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.598 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 16.8 m -103.29 131.09 50.63 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.699 -0.482 . . . . 73.42 109.699 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.592 HG11 HD21 ' B' ' 126' ' ' LEU . 88.0 t -116.84 128.12 74.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 123.377 0.671 . . . . 54.2 109.903 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 90.0 m -106.67 141.19 38.33 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.637 -1.246 . . . . 74.42 107.637 163.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -147.47 140.58 25.12 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.537 -0.912 . . . . 53.33 108.537 174.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.49 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 29.2 p -142.91 128.28 18.87 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.748 -0.66 . . . . 73.25 110.589 -171.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.614 HD13 ' HB2' ' B' ' 34' ' ' LYS . 39.0 mt -99.52 108.81 21.33 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.133 0.973 . . . . 65.4 109.668 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.66 -125.86 9.49 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 116.018 -0.537 . . . . 74.32 111.872 -175.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -96.72 2.95 52.58 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.425 0.69 . . . . 64.34 112.105 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.451 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 17.3 pt-20 -125.01 159.43 31.32 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.901 0.48 . . . . 60.35 111.3 -174.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 85.0 m -67.77 130.58 43.43 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.582 0.753 . . . . 64.34 110.329 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.589 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -84.86 -67.51 0.79 Allowed 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.598 -1.26 . . . . 64.41 107.598 170.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -147.71 156.87 43.21 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.157 -0.929 . . . . 64.43 110.988 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 89.0 mt -124.24 109.89 13.97 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 107.008 -1.479 . . . . 70.05 107.008 172.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.5 t -117.87 156.72 27.93 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.653 -0.499 . . . . 32.11 109.653 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 38.1 tt0 -165.11 139.32 4.92 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.615 -0.883 . . . . 75.31 108.615 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.42 HG22 HD12 ' B' ' 21' ' ' ILE . 84.5 t -133.79 145.5 33.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.879 -1.156 . . . . 63.44 107.879 173.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -125.77 93.63 3.89 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.48 -0.933 . . . . 70.32 108.48 175.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.418 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.2 tp-100 -87.77 104.91 17.01 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.395 -0.821 . . . . 73.44 109.24 -177.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.414 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -97.06 173.37 29.02 Favored Glycine 0 C--N 1.336 0.553 0 O-C-N 123.664 0.603 . . . . 65.04 112.168 175.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.39 139.65 4.64 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 121.784 -0.246 . . . . 35.23 112.785 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 52.1 mt -85.69 113.45 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 108.37 -0.974 . . . . 71.33 108.37 173.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -117.4 135.45 53.87 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.643 0.777 . . . . 73.31 109.943 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 72.4 m -94.9 105.45 17.37 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.744 0.818 . . . . 65.23 109.633 172.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.637 ' HB ' HD11 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -114.3 105.15 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 124.236 1.015 . . . . 74.14 108.685 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.0 163.02 24.64 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.335 0.654 . . . . 71.42 111.523 -174.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.72 -30.76 3.43 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 114.402 0.521 . . . . 53.22 114.402 172.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.637 HD11 ' HB ' ' B' ' 86' ' ' ILE . 2.0 pt -67.83 161.29 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 124.495 1.118 . . . . 64.51 111.443 172.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -148.6 171.96 15.3 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 123.863 0.865 . . . . 75.21 111.062 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.52 -130.85 11.5 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 114.557 -1.201 . . . . 62.52 113.875 173.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 24.5 m -86.59 -35.7 19.3 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.853 0.861 . . . . 63.5 109.636 174.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -65.17 -23.33 67.08 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.103 -1.408 . . . . 71.24 111.666 -170.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.598 ' HA ' HD12 ' B' ' 89' ' ' ILE . 19.0 ptt? -66.23 -51.23 59.64 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.526 -0.761 . . . . 73.2 111.761 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.74 -13.46 59.43 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.483 0.713 . . . . 55.35 111.128 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -68.91 -32.57 72.29 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.308 0.643 . . . . 64.24 110.516 169.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -65.32 -52.09 56.27 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 120.899 0.381 . . . . 61.25 110.729 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.432 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.4 pp -71.13 -22.09 62.11 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 116.049 -0.523 . . . . 44.53 111.135 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.15 4.38 44.82 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 118.764 -1.02 . . . . 53.12 115.029 -172.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.27 -45.95 0.11 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 118.557 1.178 . . . . 72.03 111.294 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -74.82 -40.77 60.87 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.093 0.557 . . . . 73.45 110.686 -176.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.432 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 74.3 m -73.46 -46.19 7.55 Favored Pre-proline 0 CA--C 1.561 1.38 0 CA-C-O 118.492 -0.766 . . . . 65.2 112.94 -177.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.64 -16.48 54.95 Favored 'Trans proline' 0 C--N 1.396 3.064 0 C-N-CA 121.9 1.734 . . . . 73.52 113.246 171.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -73.33 -32.19 64.42 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.123 0.569 . . . . 74.04 110.644 172.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.475 HG23 ' NH2' ' D' ' 111' ' ' ARG . 91.3 mt -70.35 -39.73 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.04 0.936 . . . . 73.42 109.758 172.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 76.1 mt -75.57 -32.22 60.29 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.88 -1.054 . . . . 72.0 111.912 -174.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -57.24 -50.11 90.04 Favored Pre-proline 0 N--CA 1.488 1.471 0 CA-C-O 117.78 -1.105 . . . . 75.31 113.451 -173.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.35 -37.44 97.57 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 121.84 1.693 . . . . 63.41 112.593 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.513 ' CD1' HG21 ' B' ' 16' ' ' ILE . 3.6 m-30 -66.37 -39.37 89.08 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.727 0.811 . . . . 72.42 110.078 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.12 -31.56 67.91 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.15 0.98 . . . . 65.13 111.331 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -69.12 -52.96 22.93 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.529 1.132 . . . . 71.24 111.068 -173.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.0 -27.33 66.47 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.52 -0.548 . . . . 74.1 109.52 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.485 ' O ' ' HG2' ' B' ' 117' ' ' MET . 31.0 t -65.29 -42.6 92.95 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 122.945 0.498 . . . . 54.21 111.256 178.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.562 HD13 HG23 ' B' ' 64' ' ' VAL . 65.0 mt -62.74 -54.16 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.209 0.604 . . . . 62.34 109.573 173.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 4.3 m -62.32 -23.22 66.64 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 124.053 0.846 . . . . 73.13 111.334 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.447 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.3 t -69.19 -50.93 43.01 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 109.072 -0.714 . . . . 44.4 109.072 174.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.0 mmt -67.86 -34.96 77.7 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.074 0.55 . . . . 61.0 111.241 -176.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 70.4 t -64.75 -43.93 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.775 1.23 . . . . 72.53 110.216 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 31.4 t -64.74 -34.72 78.99 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.007 -0.997 . . . . 62.12 111.291 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' B' ' 116' ' ' SER . 82.1 mtt-85 -67.84 -35.88 79.36 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-N 115.718 -0.674 . . . . 62.25 109.802 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.31 -7.04 81.92 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.595 0.559 . . . . 64.15 113.324 172.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.43 ' HB ' ' HE ' ' A' ' 15' ' ' ARG . 8.5 m 64.94 33.4 9.89 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 125.144 1.377 . . . . 74.52 110.447 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -86.21 162.8 45.06 Favored Pre-proline 0 CA--C 1.555 1.173 0 CA-C-N 114.407 -1.269 . . . . 74.15 110.395 174.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.21 169.97 15.61 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.528 2.152 . . . . 71.01 113.415 -176.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.488 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 62.4 tp60 -64.44 115.93 5.6 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 115.224 -0.898 . . . . 75.31 111.759 -169.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.592 HD21 HG11 ' B' ' 64' ' ' VAL . 55.8 tp -109.82 98.04 7.44 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.334 -0.848 . . . . 70.12 109.357 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 127' ' ' ASN . . . . . 0.415 ' ND2' ' HG3' ' B' ' 125' ' ' GLN . 40.7 m-80 -103.5 103.05 12.97 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.611 -1.255 . . . . 73.11 107.611 173.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.484 HD22 HD13 ' B' ' 42' ' ' LEU . 91.0 mt -62.54 141.54 58.39 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.566 0.346 . . . . 74.1 111.14 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.3 140.28 88.07 Favored Pre-proline 0 CA--C 1.55 0.96 0 O-C-N 124.016 0.822 . . . . 53.41 111.128 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -65.92 97.35 0.34 Allowed 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.513 2.142 . . . . 74.33 111.072 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 27.4 m -90.86 112.37 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.728 0.775 . . . . 55.41 110.501 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 55.7 t30 . . . . . 0 C--O 1.24 0.595 0 N-CA-C 107.936 -1.135 . . . . 73.32 107.936 171.44 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 71.0 t80 . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 109.354 -0.61 . . . . 75.5 109.354 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -154.13 141.58 19.72 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.679 0.392 . . . . 75.42 110.11 171.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 17.1 mt -91.31 123.56 43.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 109.452 -0.573 . . . . 65.53 109.452 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -88.22 -42.89 11.99 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.127 0.571 . . . . 44.34 109.542 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -172.56 147.35 1.83 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.154 0.982 . . . . 70.24 110.307 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 70.6 mt -125.03 130.79 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.104 1.362 . . . . 73.1 107.535 174.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.529 ' HB3' HG23 ' D' ' 122' ' ' THR . 31.1 p90 -162.96 173.26 13.87 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.682 0.753 . . . . 73.52 111.523 -167.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -98.36 117.28 32.42 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.982 -1.008 . . . . 60.31 109.586 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.491 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 21.4 mmtp -67.61 -48.08 67.83 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 107.904 -1.147 . . . . 63.45 107.904 168.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -139.32 144.01 38.08 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 113.85 -1.523 . . . . 73.04 109.921 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.425 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.9 mt -133.88 142.99 39.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 125.393 1.477 . . . . 74.24 107.078 173.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.0 t -152.5 146.0 24.91 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.325 0.583 . . . . 72.21 110.342 174.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -150.18 128.26 11.93 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 107.066 -1.457 . . . . 74.23 107.066 172.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -133.92 112.16 11.04 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.195 -0.668 . . . . 64.41 109.195 -177.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.56 80.81 69.32 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 107.695 -1.224 . . . . 61.13 107.695 166.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.29 -21.69 30.66 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.453 2.102 . . . . 70.23 111.609 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -100.49 15.0 29.38 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.985 1.314 . . . . 75.41 110.946 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.436 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -42.21 -56.51 5.32 Favored Pre-proline 0 N--CA 1.487 1.423 0 N-CA-C 114.385 1.254 . . . . 43.54 114.385 -169.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.436 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 36.1 Cg_exo -60.68 -41.6 45.78 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.286 1.991 . . . . 52.11 112.666 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -68.36 -39.09 81.94 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.025 -0.989 . . . . 62.32 112.059 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.758 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.1 p -79.2 -17.13 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.507 0 N-CA-C 112.841 0.682 . . . . 63.44 112.841 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -69.41 -26.85 64.83 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 112.745 0.646 . . . . 71.44 112.745 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -87.14 13.63 9.11 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.174 0.59 . . . . 65.31 111.591 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.79 160.34 15.31 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.796 0.838 . . . . 74.33 110.756 -173.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -71.59 129.83 39.7 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.603 0.761 . . . . 71.44 109.877 173.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -82.9 90.19 6.93 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.574 0.75 . . . . 72.24 110.724 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 37' ' ' GLN . . . . . 0.443 ' H ' HD22 ' C' ' 68' ' ' LEU . 52.6 tt0 -146.55 79.46 10.4 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 124.095 0.958 . . . . 74.41 108.845 173.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -86.24 158.36 9.75 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.547 2.165 . . . . 70.42 112.852 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.47 79.3 9.02 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 106.703 -1.592 . . . . 70.44 106.703 167.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 25.7 t -71.73 96.75 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.112 -0.949 . . . . 73.15 108.845 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.93 104.0 12.55 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.767 -1.568 . . . . 73.25 106.767 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 pp -85.48 145.59 27.35 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.967 -0.753 . . . . 72.52 108.967 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.406 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 22.5 t70 -128.12 115.44 18.43 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.746 -0.835 . . . . 70.15 108.746 178.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.524 HD11 HG11 ' C' ' 131' ' ' VAL . 93.0 mt -97.35 110.97 23.42 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.598 -0.519 . . . . 73.13 109.598 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -113.52 145.96 40.39 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.374 -1.343 . . . . 71.41 107.374 169.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.0 t -137.42 146.76 44.78 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.232 -0.655 . . . . 71.11 109.232 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.84 171.82 13.55 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.116 0.967 . . . . 61.05 108.8 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 32.8 p -156.15 156.03 33.53 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.284 0.633 . . . . 42.11 109.621 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -145.41 127.62 15.73 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.49 -0.93 . . . . 74.41 108.49 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -78.9 113.46 17.02 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 107.452 -1.314 . . . . 73.32 107.452 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.63 HD11 HD12 ' C' ' 83' ' ' ILE . 67.0 mt -84.61 -27.35 27.26 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.008 0.523 . . . . 72.04 110.444 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.3 -175.06 2.78 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.737 -1.12 . . . . 71.22 110.182 -176.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -64.37 104.11 0.73 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.101 -0.954 . . . . 64.35 110.343 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 65.56 21.33 11.73 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.453 1.101 . . . . 71.35 112.302 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.5 t -108.55 114.96 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 107.613 -1.254 . . . . 74.32 107.613 166.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -121.63 124.39 44.21 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.343 0.657 . . . . 54.11 109.542 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.433 ' HB2' HD11 ' C' ' 51' ' ' LEU . 26.3 tt0 -82.95 143.22 30.83 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 124.542 1.137 . . . . 74.41 108.563 165.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.445 HG11 ' HD3' ' C' ' 103' ' ' PRO . 96.0 t -132.95 133.55 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.787 -0.82 . . . . 73.44 108.787 171.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.45 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 58.7 t -113.4 139.71 37.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 123.661 0.785 . . . . 74.52 109.112 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.465 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -122.63 100.73 7.07 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.045 -1.465 . . . . 65.2 107.045 173.902 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -82.48 107.42 15.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.193 -0.912 . . . . 72.33 109.244 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 24.4 t -107.76 114.75 47.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.885 -1.154 . . . . 65.52 107.885 173.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.406 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 21.4 m -105.1 145.51 30.43 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.195 0.998 . . . . 74.02 108.783 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.54 HG21 HG21 ' C' ' 114' ' ' ILE . 87.4 t -126.49 119.49 53.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 109.103 -0.703 . . . . 71.41 109.103 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 38.6 m -99.14 134.72 41.59 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.559 -1.274 . . . . 72.53 107.559 166.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.27 103.83 4.5 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.115 -1.068 . . . . 71.33 108.115 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 42.4 m -130.31 132.25 45.79 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 121.156 0.503 . . . . 73.25 109.862 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.443 HD22 ' H ' ' C' ' 37' ' ' GLN . 12.7 mt -85.54 38.21 0.73 Allowed 'General case' 0 CA--C 1.556 1.212 0 C-N-CA 124.793 1.237 . . . . 62.42 109.87 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.49 -111.8 2.64 Favored Glycine 0 C--N 1.354 1.533 0 N-CA-C 110.217 -1.153 . . . . 64.25 110.217 -168.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -90.47 -31.22 16.88 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.151 0.981 . . . . 72.5 109.879 174.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -67.16 101.03 0.84 Allowed 'General case' 0 C--N 1.346 0.423 0 C-N-CA 124.032 0.933 . . . . 75.11 109.793 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 46.4 m -72.43 116.31 12.73 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.978 -0.749 . . . . 45.23 108.978 173.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.758 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -64.44 -49.17 72.53 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.072 0.858 . . . . 73.5 109.506 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -167.54 164.73 14.79 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.133 -1.394 . . . . 65.34 110.459 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.49 138.2 53.3 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 106.38 -1.711 . . . . 35.55 106.38 164.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 51.3 t -144.89 145.71 31.7 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.777 -0.823 . . . . 73.43 108.777 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -159.94 136.89 9.31 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.796 -0.446 . . . . 64.54 109.796 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 69.1 t -131.24 124.39 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.174 0.99 . . . . 63.31 108.668 175.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -99.85 84.12 2.85 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.789 -1.189 . . . . 73.41 107.789 177.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -78.63 95.74 5.32 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.33 -0.85 . . . . 63.03 109.502 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -94.56 146.52 18.2 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 115.697 -0.683 . . . . 72.41 111.905 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.08 140.74 9.64 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.346 -0.702 . . . . 72.43 111.346 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.63 HD12 HD11 ' C' ' 51' ' ' LEU . 15.4 mm -97.12 133.1 40.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 109.52 -0.548 . . . . 71.15 109.52 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.435 ' HZ ' HD11 ' C' ' 106' ' ' LEU . 25.7 m-85 -135.84 147.09 48.12 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.854 0.721 . . . . 74.42 110.029 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 12.9 p -101.2 101.16 11.8 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.806 -1.183 . . . . 65.34 107.806 168.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.629 HD13 ' SG ' ' C' ' 97' ' ' CYS . 22.5 mt -116.25 129.94 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.39 0.676 . . . . 72.5 110.303 -172.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.05 172.82 16.27 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.21 1.004 . . . . 74.23 109.516 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.32 -34.04 5.08 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-N 116.547 -0.297 . . . . 62.32 112.654 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.457 ' HB ' ' HB3' ' C' ' 93' ' ' GLN . 33.8 pt -96.69 162.28 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.54 0.736 . . . . 74.01 111.517 -176.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -158.52 152.47 23.69 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.674 0.79 . . . . 54.24 110.417 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.58 -127.94 8.38 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-O 119.717 -0.491 . . . . 31.44 112.879 174.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -59.46 -32.91 70.67 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 123.258 0.623 . . . . 71.05 110.817 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 93' ' ' GLN . . . . . 0.457 ' HB3' ' HB ' ' C' ' 89' ' ' ILE . 92.9 mt-30 -62.74 -48.95 76.99 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.357 1.063 . . . . 64.31 111.695 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.547 ' HE3' ' HA ' ' C' ' 94' ' ' MET . 4.2 tpt -55.09 -52.67 62.49 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 123.784 0.677 . . . . 72.54 110.453 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.06 -32.49 73.87 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.146 0.578 . . . . 33.42 111.955 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -70.4 -32.64 70.35 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.87 0.868 . . . . 74.21 111.153 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.629 ' SG ' HD13 ' C' ' 86' ' ' ILE . 18.7 t -72.11 -43.96 63.93 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.295 0.569 . . . . 71.33 109.622 177.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 67.6 mt -81.02 -25.3 37.29 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 114.625 -1.17 . . . . 44.33 112.121 -174.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.4 3.29 20.23 Favored Glycine 0 N--CA 1.476 1.337 0 CA-C-O 119.201 -0.777 . . . . 41.14 114.719 -172.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.99 -53.15 0.15 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 118.151 0.976 . . . . 73.11 112.559 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -70.58 -58.6 3.51 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.884 0.474 . . . . 64.11 110.404 -171.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 58.9 m -64.64 -44.18 72.98 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-O 118.494 -0.765 . . . . 72.4 112.191 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.465 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 82.7 Cg_exo -53.7 -32.87 67.26 Favored 'Trans proline' 0 C--N 1.389 2.692 0 C-N-CA 122.366 2.044 . . . . 71.45 114.021 169.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -67.55 -40.72 84.95 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 122.974 0.51 . . . . 65.41 111.028 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.545 HD12 ' NH1' ' A' ' 111' ' ' ARG . 35.8 mm -70.66 -32.57 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 C-N-CA 122.812 0.445 . . . . 63.24 110.204 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.435 HD11 ' HZ ' ' C' ' 84' ' ' PHE . 2.5 mp -83.89 -20.83 32.38 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.455 1.102 . . . . 74.44 112.105 -176.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -58.44 -47.91 97.92 Favored Pre-proline 0 CA--C 1.554 1.108 0 CA-C-O 117.811 -1.09 . . . . 72.31 113.9 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -60.14 -37.37 84.24 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 121.91 1.74 . . . . 73.21 113.044 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -68.87 -43.74 74.75 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.602 0.761 . . . . 73.44 110.309 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.11 -40.17 94.96 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.035 -0.984 . . . . 51.1 110.35 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -63.98 -48.89 74.66 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.7 1.2 . . . . 73.54 110.496 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.74 -38.91 84.16 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.136 0.575 . . . . 70.4 109.805 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.44 ' O ' ' SD ' ' C' ' 117' ' ' MET . 6.8 t -63.88 -42.78 97.42 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.685 0.394 . . . . 71.12 111.136 -178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.54 HG21 HG21 ' C' ' 64' ' ' VAL . 75.8 mt -63.27 -52.01 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 122.911 0.484 . . . . 71.42 110.244 175.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 22.0 m -63.32 -27.92 69.65 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.849 -0.614 . . . . 74.14 110.877 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 26.6 t -66.86 -52.18 46.58 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.491 0.717 . . . . 72.13 109.274 173.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.635 ' HE2' HD13 ' D' ' 21' ' ' ILE . 0.1 OUTLIER -48.76 -46.56 41.42 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.706 1.202 . . . . 75.54 112.354 175.044 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 93.4 t -67.35 -43.03 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.557 1.143 . . . . 75.1 111.004 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 15.0 t -65.72 -30.99 71.74 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.226 1.011 . . . . 75.14 111.619 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.42 HH12 ' CD ' ' D' ' 112' ' ' GLU . 70.9 mtt-85 -75.0 -39.5 61.19 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.805 0.842 . . . . 71.41 109.676 178.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.68 -2.54 64.64 Favored Glycine 0 C--N 1.356 1.645 0 CA-C-N 115.436 -0.802 . . . . 64.51 112.876 170.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.1 p 65.38 30.01 11.18 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.316 1.846 . . . . 75.15 113.533 169.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -83.81 144.28 44.89 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 108.348 -0.982 . . . . 75.11 108.348 169.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.488 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 77.8 Cg_exo -50.42 143.26 27.74 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 123.318 2.679 . . . . 72.4 113.728 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.441 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 55.5 mm-40 -51.76 119.71 4.5 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.639 1.212 . . . . 52.53 112.337 -174.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 36.6 tp -124.15 84.22 2.25 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 107.587 -1.264 . . . . 75.21 107.587 -177.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 127' ' ' ASN . . . . . 0.401 ' HB2' HG23 ' B' ' 122' ' ' THR . 20.0 m120 -92.68 97.68 10.94 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.377 -0.829 . . . . 73.32 108.864 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -60.36 143.82 52.17 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.47 0.708 . . . . 75.42 112.019 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.2 142.54 97.92 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-N 115.171 -0.922 . . . . 74.11 110.617 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.618 ' HG2' HG21 ' A' ' 13' ' ' ILE . 4.9 Cg_exo -67.13 152.73 79.36 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.027 1.818 . . . . 71.42 112.762 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 131' ' ' VAL . . . . . 0.524 HG11 HD11 ' C' ' 44' ' ' LEU . 7.2 p -136.5 134.92 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.442 -0.799 . . . . 55.32 108.855 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -87.57 103.4 15.52 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.975 0.51 . . . . 74.42 110.254 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -61.87 -29.53 70.25 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.897 0.879 . . . . 73.23 111.82 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -56.58 -55.19 37.02 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.559 0.744 . . . . 73.42 110.061 173.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.23 -47.95 77.45 Favored 'General case' 0 C--N 1.349 0.55 0 O-C-N 124.227 0.954 . . . . 61.01 111.594 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 73.2 mt -59.02 -38.3 78.96 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.559 0.744 . . . . 54.44 111.559 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 39.8 t80 . . . . . 0 N--CA 1.471 0.624 0 CA-C-N 115.138 -0.937 . . . . 65.02 110.806 -177.271 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 C--O 1.242 0.694 0 N-CA-C 108.938 -0.764 . . . . 61.15 108.938 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.478 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 60.4 t80 -133.62 99.87 4.62 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.565 -1.272 . . . . 75.34 107.565 177.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -124.63 126.72 46.21 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.713 0.805 . . . . 73.53 108.868 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.421 HG21 HD11 ' D' ' 16' ' ' ILE . 11.0 mt -89.84 122.56 41.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.339 -0.985 . . . . 61.15 108.339 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -95.34 -18.94 20.36 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.37 0.668 . . . . 75.0 111.639 -171.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 179.05 124.28 0.05 Allowed 'General case' 0 C--N 1.359 0.989 0 C-N-CA 122.958 0.503 . . . . 72.34 109.818 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.421 HD11 HG21 ' D' ' 13' ' ' ILE . 3.7 mp -103.54 136.34 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 106.854 -1.536 . . . . 71.4 106.854 167.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -160.6 145.08 14.14 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 123.389 0.43 . . . . 74.34 111.363 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.2 p -84.48 112.3 20.26 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.681 -0.69 . . . . 64.44 109.677 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -79.81 -18.07 51.78 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.664 -0.698 . . . . 64.02 109.377 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.523 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 4.3 t70 -157.51 147.5 20.55 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 124.803 1.241 . . . . 65.44 110.005 175.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.635 HD13 ' HE2' ' C' ' 117' ' ' MET . 69.6 mt -141.99 147.28 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.661 1.584 . . . . 62.22 107.423 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 22' ' ' SER . . . . . 0.646 ' HB3' ' HB2' ' D' ' 77' ' ' GLU . 32.8 t -155.35 144.48 20.88 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.327 1.051 . . . . 64.53 109.266 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.425 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 91.6 t80 -151.96 129.43 11.4 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.37 -1.715 . . . . 75.1 106.37 170.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -134.14 126.98 31.14 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.527 0.731 . . . . 62.32 109.248 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.43 86.41 48.38 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 107.621 -1.251 . . . . 74.24 107.621 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.48 -36.24 15.75 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.721 2.281 . . . . 70.03 112.815 -170.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -110.53 12.32 22.86 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.856 0.862 . . . . 74.45 110.359 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.461 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -20.98 -70.23 0.04 OUTLIER Pre-proline 0 CA--C 1.57 1.714 0 N-CA-C 116.776 2.139 . . . . 65.31 116.776 -169.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.499 ' HB3' HD11 ' C' ' 83' ' ' ILE . 83.0 Cg_endo -76.26 -23.11 12.09 Favored 'Trans proline' 0 C--N 1.38 2.187 0 CA-C-N 123.741 2.372 . . . . 61.51 114.309 -174.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -71.24 -39.34 71.71 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.183 0.993 . . . . 74.35 109.3 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.576 HG21 ' HA ' ' D' ' 73' ' ' ALA . 9.8 p -84.0 -20.6 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.232 0 CA-C-N 114.798 -1.092 . . . . 61.13 111.825 -173.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.406 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 22.8 m-85 -67.22 -19.8 65.59 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 112.198 0.444 . . . . 72.43 112.198 177.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -63.09 -13.45 36.37 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.786 0.834 . . . . 62.44 110.958 176.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -99.18 91.14 4.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.24 1.416 . . . . 73.12 109.804 176.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -88.25 85.45 6.91 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.271 0.558 . . . . 72.23 110.691 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 38.9 p90 -156.91 172.22 19.04 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.001 -1.111 . . . . 75.44 108.001 165.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -68.13 116.75 42.31 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 109.351 -0.611 . . . . 63.52 109.351 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -57.38 131.14 42.92 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.648 2.232 . . . . 74.54 111.752 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 39' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 22.5 tt0 -60.02 109.98 1.09 Allowed 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.837 0.711 . . . . 72.21 109.366 175.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.845 HG13 HG13 ' D' ' 64' ' ' VAL . 45.8 t -105.43 115.25 46.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 114.622 -1.172 . . . . 62.55 109.377 -177.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.31 126.36 52.14 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 106.71 -1.589 . . . . 70.34 106.71 170.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.508 HD11 HG13 ' D' ' 62' ' ' VAL . 50.1 tp -97.57 141.92 30.02 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.605 0.762 . . . . 51.34 110.046 -168.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.764 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.5 m-20 -125.05 123.92 40.83 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 107.244 -1.391 . . . . 74.54 107.244 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 88.7 mt -124.37 138.48 54.37 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.173 0.511 . . . . 72.22 111.078 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 9.5 t70 -143.18 155.35 44.52 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.434 1.494 . . . . 64.22 107.685 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.7 t -139.71 153.48 47.24 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-O 121.386 0.612 . . . . 72.32 110.074 174.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.9 170.46 18.76 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 114.588 -1.187 . . . . 63.4 109.005 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.3 p . . . . . 0 C--O 1.24 0.597 0 C-N-CA 123.406 0.682 . . . . 74.05 109.574 -177.394 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 112.914 0.709 . . . . 73.25 112.914 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 4.1 p -118.0 95.54 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 122.265 1.031 . . . . 73.1 108.95 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -117.46 146.56 43.41 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.12 -0.945 . . . . 65.32 109.924 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -102.82 145.41 29.8 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.876 -0.602 . . . . 65.1 110.462 173.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 70.3 t -131.45 141.82 44.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 114.06 -1.427 . . . . 70.53 107.523 172.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.441 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 46.3 t -131.23 132.07 63.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 108.294 -1.002 . . . . 75.33 108.294 176.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.484 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -107.96 117.45 34.16 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 106.632 -1.618 . . . . 71.31 106.632 172.308 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.662 ' HG2' ' HG2' ' D' ' 79' ' ' GLN . 0.0 OUTLIER -101.32 97.23 7.75 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.208 -1.405 . . . . 65.31 107.208 178.312 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.508 HG13 HD11 ' D' ' 42' ' ' LEU . 54.2 t -91.08 144.25 9.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.43 -0.952 . . . . 71.22 108.43 172.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.764 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 52.2 m -138.77 135.89 35.14 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.571 -1.27 . . . . 73.33 107.571 174.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.845 HG13 HG13 ' D' ' 40' ' ' VAL . 94.9 t -117.52 127.11 75.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.976 -0.75 . . . . 73.31 108.976 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 6.0 m -111.49 93.95 4.72 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.16 -1.052 . . . . 72.23 108.16 173.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.567 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -105.29 142.29 35.31 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.002 0.521 . . . . 52.31 111.295 -177.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.505 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 42.0 m -145.52 142.27 29.05 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.153 0.581 . . . . 61.22 110.81 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.512 HD12 HG22 ' D' ' 31' ' ' VAL . 19.4 mt -108.57 109.49 20.73 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.7 -1.222 . . . . 72.02 107.7 170.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.61 -124.39 7.51 Favored Glycine 0 C--N 1.345 1.056 0 O-C-N 123.212 0.32 . . . . 61.32 112.953 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.4 5.61 37.23 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.171 0.588 . . . . 73.52 111.842 -177.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -124.3 155.39 38.75 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.093 0.557 . . . . 74.41 109.986 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 75.7 m -66.32 136.53 55.94 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 122.767 0.427 . . . . 64.4 110.726 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.576 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.51 -64.66 1.11 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.348 -1.352 . . . . 52.23 107.348 174.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -154.96 164.13 39.33 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 114.409 -1.269 . . . . 73.3 110.68 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 62.6 mt -130.12 144.49 51.38 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 105.821 -1.918 . . . . 75.55 105.821 174.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.59 ' SG ' HG23 ' D' ' 114' ' ' ILE . 9.1 t -152.72 106.81 3.11 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 118.812 0.733 . . . . 63.15 110.777 -173.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 77' ' ' GLU . . . . . 0.646 ' HB2' ' HB3' ' D' ' 22' ' ' SER . 10.9 mp0 -122.69 127.82 49.78 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.193 0.997 . . . . 71.53 109.793 -169.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 64.3 t -138.53 121.81 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 122.876 0.47 . . . . 61.02 109.741 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.662 ' HG2' ' HG2' ' D' ' 61' ' ' ARG . 43.2 mt-30 -89.99 88.58 7.36 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 108.965 -0.754 . . . . 71.31 108.965 167.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 80' ' ' GLN . . . . . 0.414 ' O ' HD13 ' D' ' 106' ' ' LEU . 6.9 tp-100 -82.58 94.58 7.54 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.236 -0.893 . . . . 64.13 108.925 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.78 173.06 37.88 Favored Glycine 0 C--O 1.242 0.623 0 CA-C-N 116.141 -0.481 . . . . 63.34 112.432 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.44 148.27 10.95 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.519 -0.34 . . . . 42.14 112.459 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.4 mt -100.44 113.67 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 108.211 -1.033 . . . . 73.22 108.211 175.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -114.24 133.51 55.58 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.969 0.908 . . . . 72.23 109.891 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 35.6 p -96.68 105.44 17.55 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.977 -0.749 . . . . 43.3 108.977 172.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.504 HD11 ' SG ' ' D' ' 102' ' ' CYS . 61.7 mt -117.12 119.23 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.252 1.021 . . . . 54.24 109.25 -173.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.19 125.66 5.1 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.539 0.735 . . . . 53.42 110.569 -176.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.93 19.47 7.27 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-O 119.583 -0.565 . . . . 55.4 114.497 170.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.615 HD13 ' HA ' ' D' ' 94' ' ' MET . 0.8 OUTLIER -118.15 149.25 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 108.86 -0.793 . . . . 72.03 108.86 167.413 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -129.33 -179.96 5.44 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.183 0.993 . . . . 73.15 108.664 -171.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.07 -140.44 34.22 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 116.152 -0.477 . . . . 73.51 113.685 173.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 61.4 p -82.0 -33.79 29.93 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.313 0.645 . . . . 72.04 111.038 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -64.65 -26.25 68.31 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.516 0.726 . . . . 71.53 111.891 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.615 ' HA ' HD13 ' D' ' 89' ' ' ILE . 48.2 ttp -46.37 -60.46 2.32 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.913 1.285 . . . . 74.34 112.805 -176.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.68 -14.41 48.58 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.38 0.672 . . . . 62.13 112.248 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 45.2 m170 -72.05 -28.79 63.58 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.926 0.49 . . . . 73.45 110.579 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 70.9 m -62.02 -30.15 70.76 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.158 0.583 . . . . 73.44 111.078 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.2 tt -89.49 -44.98 9.75 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.827 0.851 . . . . 72.01 110.197 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.3 -13.3 74.1 Favored Glycine 0 N--CA 1.472 1.095 0 CA-C-N 115.983 -0.553 . . . . 53.05 114.331 -170.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.7 -53.16 0.81 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 117.314 0.557 . . . . 72.41 111.544 -173.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -68.37 -40.95 81.27 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 112.043 0.386 . . . . 74.33 112.043 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.504 ' SG ' HD11 ' D' ' 86' ' ' ILE . 78.2 m -66.33 -46.13 60.37 Favored Pre-proline 0 CA--C 1.562 1.415 0 CA-C-O 118.447 -0.787 . . . . 65.43 112.655 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.484 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 73.4 Cg_exo -55.08 -37.4 94.02 Favored 'Trans proline' 0 C--N 1.396 3.039 0 C-N-CA 122.152 1.901 . . . . 72.31 112.812 168.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -62.47 -36.86 83.82 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.256 0.622 . . . . 63.44 111.018 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 38.2 mm -69.98 -40.6 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.923 0.889 . . . . 73.33 110.865 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.414 HD13 ' O ' ' D' ' 80' ' ' GLN . 89.4 mt -73.26 -16.89 61.38 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.877 -0.602 . . . . 72.3 111.937 -176.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -68.53 -43.39 30.62 Favored Pre-proline 0 CA--C 1.555 1.168 0 CA-C-O 118.095 -0.955 . . . . 70.43 113.235 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -46.09 -43.42 20.49 Favored 'Trans proline' 0 C--N 1.382 2.322 0 C-N-CA 122.151 1.901 . . . . 55.01 113.897 167.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -77.78 -36.66 50.26 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.64 0.776 . . . . 71.13 111.769 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.84 -50.68 47.95 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.405 0.682 . . . . 64.32 110.127 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.619 HH12 ' HB3' ' D' ' 130' ' ' PRO . 36.5 ttp180 -54.92 -41.81 71.47 Favored 'General case' 0 C--O 1.211 -0.969 0 O-C-N 124.727 1.267 . . . . 75.04 111.02 172.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 112' ' ' GLU . . . . . 0.42 ' CD ' HH12 ' C' ' 120' ' ' ARG . 1.6 tm-20 -56.97 -53.84 53.52 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.161 0.913 . . . . 71.23 111.293 -175.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.0 t -55.02 -41.56 71.5 Favored 'General case' 0 C--N 1.348 0.523 0 O-C-N 124.469 1.106 . . . . 71.3 110.955 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.59 HG23 ' SG ' ' D' ' 76' ' ' CYS . 90.5 mt -64.22 -53.56 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.949 0.9 . . . . 74.03 110.834 177.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 93.2 m -55.45 -39.63 70.58 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.202 1.401 . . . . 71.42 110.375 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.0 t -66.97 -47.52 71.32 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.824 -1.535 . . . . 74.34 110.596 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.422 ' HE2' ' HA ' ' D' ' 114' ' ' ILE . 78.8 mtm -68.4 -25.56 65.11 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.557 0.577 . . . . 74.34 112.557 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' D' ' 126' ' ' LEU . 76.0 t -68.65 -45.8 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.656 0.782 . . . . 74.51 109.294 175.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 72.5 p -73.95 -27.21 60.89 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 115.536 -0.757 . . . . 75.52 110.48 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 78.0 mtt-85 -74.4 -27.3 60.57 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.694 0.798 . . . . 75.21 110.123 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.7 10.22 73.03 Favored Glycine 0 C--N 1.351 1.372 0 O-C-N 123.653 0.595 . . . . 51.12 112.704 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.529 HG23 ' HB3' ' C' ' 17' ' ' TYR . 82.5 p 51.38 37.18 18.38 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.195 1.798 . . . . 71.32 114.203 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -95.99 154.04 39.04 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.148 -0.933 . . . . 72.22 109.345 168.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -49.62 132.53 30.78 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 123.173 2.582 . . . . 74.23 112.517 168.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -50.1 128.45 19.04 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.155 0.982 . . . . 65.13 112.508 -174.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.569 HD13 HG21 ' D' ' 40' ' ' VAL . 21.4 tp -107.68 128.74 54.82 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.938 0.895 . . . . 62.33 109.066 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -129.16 99.78 5.37 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.164 -1.05 . . . . 64.35 108.164 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.492 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 2.8 mm? -64.26 121.18 13.65 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.513 0.725 . . . . 73.34 110.032 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.35 123.0 74.28 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 123.123 0.569 . . . . 64.4 111.179 -176.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.619 ' HB3' HH12 ' D' ' 111' ' ' ARG . 72.2 Cg_endo -76.41 114.77 3.95 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.542 2.161 . . . . 63.5 112.431 -176.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.25 145.22 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.806 0.842 . . . . 63.42 109.355 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -70.38 115.06 9.12 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.341 -0.615 . . . . 73.24 109.341 173.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 . . . . . 0 N--CA 1.482 1.157 0 C-N-CA 123.801 0.84 . . . . 62.11 111.367 -179.69 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.3 m . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 109.261 -0.644 . . . . 72.11 109.261 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -129.01 120.75 26.57 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.006 -1.109 . . . . 74.25 108.006 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -147.65 108.92 4.28 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.472 -0.566 . . . . 74.51 109.472 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.485 ' CD1' HG21 ' A' ' 105' ' ' ILE . 12.6 mt -72.84 123.55 27.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 109.117 -0.698 . . . . 61.33 109.117 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -88.25 -37.55 15.96 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.167 0.587 . . . . 72.53 110.73 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -167.41 141.46 3.66 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 116.269 -0.423 . . . . 74.41 109.903 -173.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.0 mt -130.16 134.85 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 108.277 -1.008 . . . . 74.32 108.277 173.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -163.09 178.17 8.51 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 124.296 0.998 . . . . 74.34 111.434 -170.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -108.55 122.03 46.22 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.949 -0.76 . . . . 71.23 108.949 175.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.481 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 37.2 mtpt -81.38 -25.93 35.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.176 0.59 . . . . 61.31 110.338 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -160.13 152.63 20.96 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.331 -0.849 . . . . 74.12 109.186 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 73.9 mt -144.14 150.82 16.49 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 C-N-CA 125.346 1.458 . . . . 63.34 107.725 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.0 t -155.35 137.5 14.71 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.467 0.707 . . . . 75.12 109.842 173.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.494 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 86.5 t80 -143.67 122.07 12.38 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.402 -1.333 . . . . 74.24 107.402 174.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -124.76 114.72 19.64 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 109.227 -0.657 . . . . 73.44 109.227 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.05 80.75 0.44 Allowed Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 105.919 -1.882 . . . . 64.54 105.919 165.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.99 -29.02 28.28 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.784 2.322 . . . . 53.31 112.59 -162.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -115.86 30.13 7.54 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.864 0.865 . . . . 72.32 108.822 -175.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.457 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -44.8 -58.91 4.7 Favored Pre-proline 0 CA--C 1.569 1.673 0 N-CA-C 114.703 1.371 . . . . 73.4 114.703 -165.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 38.7 Cg_exo -60.34 -31.97 93.46 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 122.06 1.84 . . . . 63.12 113.087 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -81.74 -35.2 29.97 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.308 1.043 . . . . 74.55 112.385 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.837 HG21 ' HA ' ' A' ' 73' ' ' ALA . 6.0 p -79.87 -15.1 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 121.395 0.617 . . . . 64.41 111.718 -171.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -74.9 -12.19 60.3 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 116.089 -0.505 . . . . 73.22 111.482 168.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -83.37 -18.0 40.36 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 124.009 0.923 . . . . 65.03 110.584 171.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.538 ' HE2' ' HB3' ' A' ' 71' ' ' GLU . 26.3 mmmt -79.33 146.19 33.05 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.361 1.065 . . . . 65.14 111.451 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -61.67 128.14 34.84 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.134 0.974 . . . . 65.33 109.74 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.493 ' CE3' HD21 ' A' ' 68' ' ' LEU . 73.5 t-105 -82.21 88.83 6.48 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 121.121 0.486 . . . . 52.32 110.617 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 17.5 tm0? -129.33 84.96 60.62 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 106.205 -1.776 . . . . 74.14 106.205 167.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.07 125.23 10.72 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.475 2.117 . . . . 53.31 112.694 -173.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -97.0 92.95 6.32 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.757 -1.201 . . . . 62.31 107.757 169.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.666 HG11 HD11 ' A' ' 126' ' ' LEU . 88.2 t -94.82 107.63 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.345 0.658 . . . . 62.14 110.98 -175.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -88.13 129.52 35.29 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.361 -0.836 . . . . 73.45 109.415 175.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -95.88 119.33 34.18 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.897 -1.149 . . . . 64.31 107.897 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -130.18 141.6 50.64 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 108.795 -0.817 . . . . 52.34 108.795 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.664 HD11 HG21 ' A' ' 131' ' ' VAL . 56.6 mt -140.36 146.66 38.71 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.663 0.785 . . . . 74.42 110.0 -175.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -154.88 118.32 4.51 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.591 -0.892 . . . . 52.21 108.591 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.0 m -108.59 151.59 25.91 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.696 0.798 . . . . 74.34 110.453 -173.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.686 ' HB2' HH22 ' A' ' 61' ' ' ARG . . . -145.33 154.23 42.1 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.139 0.976 . . . . 72.13 109.886 172.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.419 ' HB3' HD13 ' A' ' 98' ' ' LEU . 4.1 m -112.87 154.68 25.95 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.991 -0.744 . . . . 71.23 108.991 172.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.0 t -149.61 117.57 6.31 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.125 -1.065 . . . . 74.03 108.125 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -79.96 105.14 11.02 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.154 -0.684 . . . . 75.23 109.154 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.608 HD11 ' HB2' ' A' ' 57' ' ' GLU . 45.9 mt -78.96 -35.68 42.73 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.094 0.558 . . . . 73.54 109.616 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.46 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -155.57 175.28 14.1 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.104 0.962 . . . . 60.3 109.848 176.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -65.25 124.98 23.62 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.583 -0.895 . . . . 75.23 108.583 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 66.67 11.32 8.1 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.251 1.42 . . . . 54.12 112.728 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 41.8 t -124.03 107.06 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.401 -0.962 . . . . 73.24 108.401 173.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -119.69 126.11 50.32 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.864 0.866 . . . . 73.35 109.018 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.608 ' HB2' HD11 ' A' ' 51' ' ' LEU . 32.2 tt0 -86.32 146.15 26.61 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.162 -0.681 . . . . 74.4 109.162 167.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.8 t -128.19 133.89 66.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.045 -1.095 . . . . 71.2 108.045 171.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.401 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 46.4 t -115.28 132.53 64.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.256 -0.646 . . . . 74.35 109.256 176.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.04 108.67 18.97 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.639 -0.874 . . . . 75.54 108.639 172.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.686 HH22 ' HB2' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -80.53 99.92 8.31 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 106.489 -1.671 . . . . 74.23 106.489 164.768 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.2 t -96.46 122.01 47.55 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 107.583 -1.266 . . . . 74.22 107.583 172.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.4 m -118.47 137.87 52.88 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 123.91 0.756 . . . . 73.11 109.034 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 77.0 t -140.98 139.05 34.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 125.055 1.342 . . . . 73.32 107.435 -172.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 37.1 m -137.53 130.77 30.77 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 109.411 -0.588 . . . . 72.44 109.411 171.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.489 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -114.68 120.37 39.88 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.298 -1.371 . . . . 72.31 107.298 174.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -125.93 135.45 51.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.392 0.677 . . . . 64.21 110.607 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.535 HD12 HG22 ' A' ' 31' ' ' VAL . 27.4 mt -92.92 84.69 4.96 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.944 1.298 . . . . 64.24 108.8 177.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.41 -100.95 1.45 Allowed Glycine 0 C--N 1.342 0.877 0 CA-C-N 115.267 -0.878 . . . . 64.52 111.782 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.33 -19.62 13.41 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.871 0.868 . . . . 73.45 109.85 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.538 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 10.0 tp10 -94.02 124.69 38.19 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.637 1.175 . . . . 71.15 109.317 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -74.41 134.51 42.4 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.207 0.458 . . . . 73.14 110.963 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.837 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -78.3 -59.31 2.83 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.721 -0.844 . . . . 74.4 108.721 174.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -159.12 161.52 36.35 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.303 -0.862 . . . . 64.52 112.139 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.431 HD12 ' O ' ' A' ' 64' ' ' VAL . 38.7 tp -111.71 148.35 33.64 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.992 1.717 . . . . 54.44 107.645 168.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.55 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 94.6 m -140.97 136.8 32.54 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.273 1.029 . . . . 75.24 109.154 177.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -149.29 137.96 21.05 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.076 -0.713 . . . . 73.15 109.076 172.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.6 t -141.73 115.69 4.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 123.967 0.907 . . . . 71.51 108.91 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.525 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 79.1 mt-30 -83.63 84.43 7.54 Favored 'General case' 0 C--N 1.343 0.31 0 N-CA-C 108.705 -0.85 . . . . 63.02 108.705 170.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.42 ' HG3' HD22 ' A' ' 106' ' ' LEU . 8.5 tp-100 -77.88 92.0 4.22 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.514 -0.921 . . . . 75.44 108.514 177.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -95.03 144.94 17.49 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 110.746 -0.942 . . . . 71.35 110.746 178.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.17 134.35 5.33 Favored Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 111.081 -0.808 . . . . 74.52 111.081 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.9 mt -82.07 124.77 39.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 108.416 -0.957 . . . . 75.33 108.416 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.801 ' HB3' HD11 ' A' ' 86' ' ' ILE . 92.4 m-85 -129.79 121.57 27.09 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.736 0.814 . . . . 65.35 109.029 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.4 t -86.36 103.44 14.93 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.436 -0.95 . . . . 61.11 108.436 174.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.801 HD11 ' HB3' ' A' ' 84' ' ' PHE . 3.5 mm -118.56 149.67 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 109.689 -0.486 . . . . 63.51 109.689 -177.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.53 168.14 25.67 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.061 0.544 . . . . 74.14 110.735 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.23 -32.35 6.27 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 116.044 -0.526 . . . . 72.15 113.061 178.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.587 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -122.21 141.12 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.622 0.769 . . . . 70.3 111.343 -173.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.628 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 21.7 mt-10 -142.37 173.54 11.44 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.54 1.136 . . . . 74.43 110.135 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.5 -125.33 28.68 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-O 119.771 -0.461 . . . . 64.24 112.614 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 77.3 p -76.83 -27.93 55.33 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.342 0.571 . . . . 70.12 110.616 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.506 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 0.8 OUTLIER -58.98 -41.98 88.86 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.588 0.755 . . . . 74.3 109.25 175.379 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.628 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 3.0 tpt -69.98 -42.27 73.33 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 114.662 -1.153 . . . . 75.33 110.986 175.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.42 -25.21 67.06 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.09 0.956 . . . . 74.52 111.901 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -70.67 -49.36 48.11 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.806 0.442 . . . . 63.41 110.364 172.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.44 -37.46 85.93 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 123.177 0.298 . . . . 65.4 110.755 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.419 HD13 ' HB3' ' A' ' 48' ' ' SER . 52.7 mt -91.26 -30.89 16.36 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.032 0.533 . . . . 73.44 112.438 -175.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.95 4.08 33.91 Favored Glycine 0 N--CA 1.476 1.333 0 CA-C-O 119.94 -0.366 . . . . 71.14 113.752 -172.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.468 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -142.85 -61.92 0.43 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 117.006 0.403 . . . . 74.3 111.192 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.41 ' O ' HG12 ' A' ' 105' ' ' ILE . 45.6 t80 -73.63 -46.28 47.79 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 112.17 0.433 . . . . 72.51 112.17 -172.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 47.5 m -64.8 -47.91 73.88 Favored Pre-proline 0 N--CA 1.49 1.539 0 CA-C-O 118.303 -0.856 . . . . 75.21 112.465 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.17 -21.11 67.74 Favored 'Trans proline' 0 C--N 1.39 2.72 0 C-N-CA 121.805 1.67 . . . . 54.1 112.786 173.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -75.41 -33.0 60.93 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.866 0.466 . . . . 74.12 109.856 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.485 HG21 ' CD1' ' A' ' 13' ' ' ILE . 48.4 mm -69.93 -41.49 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.381 0.672 . . . . 61.43 109.753 171.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.42 HD22 ' HG3' ' A' ' 80' ' ' GLN . 66.1 mt -72.04 -30.51 65.24 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.654 0.781 . . . . 73.04 111.807 -175.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -61.01 -40.51 74.77 Favored Pre-proline 0 N--CA 1.488 1.431 0 N-CA-C 114.401 1.259 . . . . 74.52 114.401 -171.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -51.57 -42.99 53.26 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.071 1.847 . . . . 75.13 113.462 168.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -75.83 -35.7 59.89 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.269 0.628 . . . . 65.45 111.045 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.81 -48.38 71.9 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.734 0.813 . . . . 73.33 109.52 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.539 ' NH1' HD12 ' C' ' 105' ' ' ILE . 27.8 ttm105 -51.46 -52.15 48.86 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 125.05 1.469 . . . . 75.41 110.289 174.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -62.6 -45.98 90.41 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.61 1.194 . . . . 64.24 111.78 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.533 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.3 t -60.88 -36.98 80.61 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 123.872 0.733 . . . . 34.42 110.759 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.493 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.6 mt -67.94 -47.2 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.127 0.971 . . . . 72.52 110.439 174.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.434 HG21 ' HE2' ' C' ' 109' ' ' TYR . 35.7 m -59.37 -39.29 82.81 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.621 1.168 . . . . 75.45 111.27 -177.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -68.68 -44.12 74.7 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.364 -1.289 . . . . 64.2 110.224 -176.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.483 ' HG3' ' O ' ' A' ' 113' ' ' CYS . 25.6 mtm -60.48 -39.43 87.61 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.987 0.515 . . . . 45.2 110.831 177.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 114' ' ' ILE . 71.6 t -63.19 -47.85 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.296 1.038 . . . . 74.32 111.424 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.8 p -71.52 -33.36 69.13 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 116.147 -0.478 . . . . 73.0 111.178 -176.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.47 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 90.0 mtt-85 -67.96 -33.28 74.35 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.739 0.816 . . . . 65.52 109.742 173.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.446 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.14 15.12 40.67 Favored Glycine 0 C--N 1.352 1.417 0 CA-C-N 115.437 -0.801 . . . . 32.1 113.37 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.6 t 62.0 9.47 3.07 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 127.281 2.232 . . . . 71.15 114.016 173.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -81.33 138.79 48.32 Favored Pre-proline 0 C--O 1.244 0.793 0 N-CA-C 107.672 -1.232 . . . . 73.51 107.672 172.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -53.98 142.53 64.57 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.75 2.3 . . . . 75.31 112.154 176.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -49.41 130.72 20.25 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.539 1.136 . . . . 71.34 113.779 -164.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.666 HD11 HG11 ' A' ' 40' ' ' VAL . 36.6 tp -109.27 108.62 19.28 Favored 'General case' 0 C--N 1.345 0.384 0 C-N-CA 123.169 0.588 . . . . 70.14 110.441 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.576 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 88.8 m-20 -103.26 125.76 50.08 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 107.699 -1.223 . . . . 74.03 107.699 175.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.47 ' H ' ' HG3' ' A' ' 111' ' ' ARG . 17.8 mt -72.85 144.59 47.4 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 117.735 0.243 . . . . 65.21 110.809 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -70.74 133.49 86.48 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.105 0.562 . . . . 64.14 110.089 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.53 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 32.3 Cg_exo -59.97 114.4 2.07 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.576 2.85 . . . . 62.31 113.604 -173.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.664 HG21 HD11 ' A' ' 44' ' ' LEU . 45.6 t -100.23 135.64 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.372 0.669 . . . . 71.03 110.017 -177.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -101.84 89.93 3.83 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.207 -1.034 . . . . 75.44 108.207 175.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.496 ' CE1' HD13 ' A' ' 44' ' ' LEU . 44.5 m-85 -63.82 -30.79 71.84 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.814 0.846 . . . . 64.22 111.568 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.468 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 6.4 m-20 -66.08 -33.35 75.58 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.347 -0.842 . . . . 43.31 110.476 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.76 -42.25 64.23 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.155 0.582 . . . . 70.11 110.491 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.12 -49.07 79.26 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.521 0.677 . . . . 63.04 110.59 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 59.8 t80 . . . . . 0 CA--C 1.536 0.405 0 CA-C-N 114.142 -1.39 . . . . 71.15 110.071 177.919 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.554 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 19.6 ptm . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 111.976 0.361 . . . . 54.34 111.976 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 5.5 t -153.09 138.99 18.06 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 109.147 -0.686 . . . . 71.44 109.147 166.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.539 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 68.9 t80 -134.28 137.74 44.5 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.13 0.972 . . . . 75.32 108.418 176.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -144.51 141.28 29.41 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.991 0.516 . . . . 55.32 109.938 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 66.9 mt -88.86 110.01 20.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 107.699 -1.223 . . . . 74.5 107.699 171.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -81.8 -39.1 24.57 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 123.282 0.364 . . . . 72.41 110.322 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -169.3 134.71 1.55 Allowed 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.304 0.377 . . . . 74.41 110.384 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.0 mt -114.97 142.58 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 107.247 -1.39 . . . . 70.41 107.247 171.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.434 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 40.1 p90 -169.81 162.67 9.59 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-O 122.045 0.926 . . . . 74.24 113.127 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 56.7 m -90.04 121.18 31.88 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 113.414 -1.721 . . . . 74.11 108.585 171.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.434 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 22.7 mtpp -87.29 -32.43 19.69 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.724 0.81 . . . . 73.42 110.52 178.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -158.52 143.49 16.25 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.022 -0.536 . . . . 74.44 110.89 -170.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 45.9 mm -136.3 142.88 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.466 1.506 . . . . 72.15 109.093 176.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 24.1 t -145.56 134.66 22.73 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.521 -1.218 . . . . 74.31 107.907 168.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.484 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 91.2 t80 -138.71 128.08 24.41 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.421 -1.696 . . . . 74.31 106.421 169.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -135.47 112.02 9.96 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.913 -1.143 . . . . 74.13 107.913 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.576 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -108.83 87.34 4.42 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 107.144 -1.428 . . . . 71.41 107.144 171.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.86 -42.01 21.48 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.654 2.236 . . . . 70.33 111.298 -174.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -97.39 5.77 49.28 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.726 -1.125 . . . . 71.2 111.65 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.576 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -29.81 -67.78 0.13 Allowed Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 115.428 1.64 . . . . 72.04 115.428 -166.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.481 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 21.3 Cg_endo -60.43 -28.49 86.84 Favored 'Trans proline' 0 C--N 1.397 3.106 0 C-N-CA 122.605 2.203 . . . . 53.13 113.03 -171.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -95.86 -39.76 9.66 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.981 -1.009 . . . . 63.41 111.996 -171.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.445 HG22 HD12 ' B' ' 68' ' ' LEU . 10.5 p -69.47 -11.76 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.22 0.608 . . . . 70.12 111.419 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -63.39 -13.18 36.95 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.269 0.628 . . . . 75.43 112.65 172.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -68.84 -13.07 62.18 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 123.874 0.87 . . . . 73.42 112.077 175.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.581 ' HB2' HD13 ' B' ' 68' ' ' LEU . 32.8 mmtp -97.41 92.71 6.09 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.494 1.118 . . . . 74.13 109.813 -174.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -92.81 80.44 4.68 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.364 0.665 . . . . 74.53 110.914 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 37.3 p90 -165.07 177.53 7.68 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.056 0.942 . . . . 64.1 110.123 170.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -69.12 116.65 44.17 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 123.677 0.791 . . . . 61.23 109.667 173.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.431 ' HD3' ' HG2' ' B' ' 124' ' ' PRO . 34.2 Cg_endo -68.28 148.77 74.91 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 121.704 1.602 . . . . 72.31 110.727 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -71.19 104.07 2.98 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.776 -1.194 . . . . 74.35 107.776 172.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.524 HG11 HD11 ' B' ' 126' ' ' LEU . 32.9 t -98.09 141.51 16.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 114.705 -1.134 . . . . 71.22 109.568 -177.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -118.75 114.53 22.84 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.405 -1.702 . . . . 72.22 106.405 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.587 HD13 HD22 ' B' ' 128' ' ' LEU . 17.8 tp -89.15 132.21 34.93 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.238 -0.652 . . . . 73.32 109.238 174.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -129.41 148.2 51.3 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.871 1.268 . . . . 70.32 108.398 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.77 151.53 41.32 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.643 0.777 . . . . 75.42 110.469 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 19.8 t70 -148.11 139.37 23.45 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.654 1.182 . . . . 64.14 108.252 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.5 m -113.5 115.37 27.89 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.732 -0.84 . . . . 61.22 108.732 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.62 134.31 55.16 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.632 -0.877 . . . . 62.33 108.632 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.673 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 16.4 m -142.76 160.24 40.71 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.849 -0.426 . . . . 65.42 109.849 -175.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 29.5 p -166.63 136.9 3.21 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.678 0.791 . . . . 75.14 110.379 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -85.96 79.64 9.14 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 108.242 -1.021 . . . . 72.33 108.242 172.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.426 HD21 ' HB3' ' B' ' 57' ' ' GLU . 2.7 pp -93.1 6.57 47.49 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.506 -0.77 . . . . 73.31 111.02 -177.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.405 ' HB3' HG23 ' B' ' 55' ' ' VAL . . . -162.65 154.61 18.48 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.77 1.228 . . . . 74.3 108.773 173.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -75.75 129.19 36.68 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.646 0.378 . . . . 74.02 110.726 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 70.62 -3.12 2.01 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.957 1.303 . . . . 73.34 113.55 173.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.405 HG23 ' HB3' ' B' ' 52' ' ' ALA . 30.7 m -134.65 122.9 40.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.013 -1.106 . . . . 61.22 108.013 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.673 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 0.1 OUTLIER -99.34 156.76 16.83 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.654 0.782 . . . . 63.33 109.424 -177.087 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.426 ' HB3' HD21 ' B' ' 51' ' ' LEU . 4.5 tm-20 -121.41 97.43 5.51 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 105.728 -1.953 . . . . 72.22 105.728 166.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 12.5 p -100.56 141.76 16.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.768 -0.827 . . . . 75.1 108.768 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.436 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 18.4 t -115.57 148.25 18.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 124.944 1.298 . . . . 73.15 108.645 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 60.1 tp -128.36 107.06 9.44 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.477 -0.935 . . . . 75.53 108.477 171.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.468 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 31.3 ttm180 -86.64 132.72 33.81 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.151 -1.055 . . . . 73.53 108.151 172.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 38.9 t -129.46 124.65 60.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 107.243 -1.391 . . . . 75.43 107.243 175.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 6.3 m -120.78 131.06 54.28 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.378 -0.601 . . . . 72.41 109.378 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.663 HG11 HD21 ' B' ' 126' ' ' LEU . 89.6 t -119.41 108.41 23.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 123.905 0.882 . . . . 65.32 109.335 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 93.9 m -90.21 138.4 31.56 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.346 -0.983 . . . . 71.53 108.346 167.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.25 142.47 26.13 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.234 -0.654 . . . . 74.1 109.234 175.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.429 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 17.0 p -144.28 134.69 24.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.367 -0.833 . . . . 55.33 109.973 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.581 HD13 ' HB2' ' B' ' 34' ' ' LYS . 62.9 mt -101.19 113.89 27.35 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.577 1.151 . . . . 73.15 110.072 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.18 -112.02 3.62 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-N 115.686 -0.688 . . . . 65.45 111.548 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.58 27.62 6.85 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.396 0.679 . . . . 63.3 109.795 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -141.23 153.27 45.17 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.192 -0.67 . . . . 73.52 109.192 176.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 56.8 m -68.17 135.2 51.71 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.225 0.536 . . . . 51.33 110.855 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.429 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -88.26 -66.01 0.96 Allowed 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.41 -1.33 . . . . 75.14 107.41 174.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -150.27 159.29 44.55 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 114.881 -1.054 . . . . 73.41 110.267 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 78.4 mt -134.07 108.53 8.39 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.396 -1.705 . . . . 74.01 106.396 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.1 t -119.82 151.53 38.7 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.104 -0.702 . . . . 71.04 109.104 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -159.23 134.39 8.29 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.511 -0.922 . . . . 71.24 108.511 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' B' ' 113' ' ' CYS . 85.4 t -128.99 143.92 39.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.997 -1.112 . . . . 74.13 107.997 175.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -122.94 96.18 4.91 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.382 -0.97 . . . . 62.02 108.382 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -91.12 102.38 15.13 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.284 -0.636 . . . . 75.23 109.284 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -94.9 165.84 25.81 Favored Glycine 0 C--N 1.339 0.749 0 O-C-N 123.58 0.55 . . . . 41.44 112.138 177.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.9 134.6 3.27 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-O 119.772 -0.46 . . . . 71.41 113.314 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.413 HD12 ' HE1' ' B' ' 17' ' ' TYR . 3.9 mp -86.12 117.82 31.47 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 107.226 -1.398 . . . . 70.21 107.226 170.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -121.84 135.94 54.92 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.592 0.757 . . . . 73.53 109.112 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 56.1 m -89.34 126.26 35.46 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.785 0.834 . . . . 72.22 109.254 173.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.569 ' HB ' HD11 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -133.65 130.3 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.079 0.951 . . . . 72.41 108.468 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' B' ' 9' ' ' MET . . . -157.67 171.98 19.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.505 0.722 . . . . 50.22 110.645 177.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.554 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 87.18 -50.13 4.07 Favored Glycine 0 C--N 1.352 1.437 0 C-N-CA 123.608 0.623 . . . . 52.42 111.949 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.569 HD11 ' HB ' ' B' ' 86' ' ' ILE . 11.3 pt -59.08 148.08 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.981 1.313 . . . . 45.31 111.81 171.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -153.19 163.31 40.11 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.837 0.855 . . . . 71.33 109.595 -176.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.35 -121.73 6.22 Favored Glycine 0 C--N 1.351 1.371 0 C-N-CA 123.358 0.504 . . . . 53.43 112.847 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 18.8 m -73.58 -39.71 64.44 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.883 0.849 . . . . 74.2 109.909 174.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -66.68 -27.11 67.39 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 113.623 -1.626 . . . . 71.41 111.96 -167.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.441 ' HA ' HD12 ' B' ' 89' ' ' ILE . 9.6 ptm -65.95 -57.71 7.22 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.675 -0.693 . . . . 74.04 111.661 -175.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.23 -14.51 57.42 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.352 0.661 . . . . 44.23 111.89 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -61.12 -40.28 93.18 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.735 0.814 . . . . 71.31 110.906 169.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.1 t -66.36 -54.27 26.47 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.705 0.402 . . . . 72.41 111.29 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.472 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.2 pp -68.34 -25.38 65.07 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.855 0.462 . . . . 72.44 112.167 -176.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.89 2.88 58.5 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-O 119.649 -0.528 . . . . 65.34 114.2 -175.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.73 -55.06 0.19 Allowed 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 117.56 0.68 . . . . 65.45 112.136 -174.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -70.56 -43.34 69.7 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.426 0.69 . . . . 74.34 111.146 -176.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.539 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 56.5 m -72.86 -43.27 8.12 Favored Pre-proline 0 CA--C 1.566 1.586 0 CA-C-O 118.621 -0.704 . . . . 55.41 112.784 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.0 -30.52 93.62 Favored 'Trans proline' 0 C--N 1.396 3.058 0 C-N-CA 122.229 1.953 . . . . 73.02 113.906 170.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.15 -37.66 77.85 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.567 0.747 . . . . 72.23 111.503 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 54.9 mt -65.11 -39.08 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.882 0.873 . . . . 73.12 110.782 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.19 -23.06 54.64 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.152 -0.931 . . . . 64.24 112.215 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -60.66 -47.17 96.73 Favored Pre-proline 0 CA--C 1.567 1.606 0 N-CA-C 114.281 1.215 . . . . 75.54 114.281 -174.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -53.86 -41.74 72.25 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 122.517 2.145 . . . . 65.35 114.106 175.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -68.98 -42.17 76.91 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.4 0.68 . . . . 74.12 110.754 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.05 98.92 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.321 -0.854 . . . . 31.43 110.774 177.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -61.35 -49.69 75.95 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.469 1.108 . . . . 70.32 110.763 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -67.3 -32.67 73.81 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.149 0.58 . . . . 72.12 110.19 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.509 ' O ' ' HG2' ' B' ' 117' ' ' MET . 9.1 t -71.11 -38.49 72.34 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 122.879 0.472 . . . . 73.43 111.082 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.415 HD13 HG23 ' B' ' 64' ' ' VAL . 81.8 mt -62.25 -56.77 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 123.684 0.794 . . . . 65.14 109.712 173.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 19.7 m -63.08 -24.74 68.04 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.763 0.825 . . . . 72.12 111.371 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.455 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.9 t -63.62 -52.45 60.79 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 109.265 -0.642 . . . . 74.33 109.265 171.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.9 mmt -66.67 -32.49 73.84 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.42 0.688 . . . . 61.15 111.357 -176.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.463 HG21 HD22 ' B' ' 126' ' ' LEU . 93.3 t -69.78 -40.28 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.073 0.949 . . . . 71.35 110.672 175.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 40.4 t -67.26 -32.07 72.84 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.304 -0.862 . . . . 72.14 110.367 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.533 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 77.8 mtt-85 -68.66 -34.6 75.99 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 115.478 -0.783 . . . . 65.42 109.851 176.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.01 -17.95 80.23 Favored Glycine 0 C--N 1.351 1.39 0 O-C-N 123.544 0.528 . . . . 52.23 112.483 170.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 18.0 m 66.93 31.23 7.23 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 123.153 1.454 . . . . 74.11 110.193 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.432 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 41.5 m-85 -78.02 167.26 37.25 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-N 114.099 -1.41 . . . . 75.42 111.168 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.431 ' HG2' ' HD3' ' B' ' 38' ' ' PRO . 50.4 Cg_exo -45.23 145.12 3.74 Favored 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 123.366 2.711 . . . . 72.12 114.566 170.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.406 ' HB2' ' H ' ' C' ' 125' ' ' GLN . 9.3 tp-100 -60.09 118.38 6.24 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.083 0.953 . . . . 72.11 111.301 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.663 HD21 HG11 ' B' ' 64' ' ' VAL . 12.0 tp -110.03 119.46 39.38 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.358 1.063 . . . . 62.51 108.727 -175.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -125.0 127.85 47.64 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.265 -1.013 . . . . 61.52 108.265 174.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.587 HD22 HD13 ' B' ' 42' ' ' LEU . 43.6 mt -86.55 143.29 27.76 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.022 0.529 . . . . 73.54 110.639 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.67 132.51 94.09 Favored Pre-proline 0 CA--C 1.548 0.889 0 O-C-N 124.085 0.866 . . . . 54.1 111.014 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.26 89.34 0.32 Allowed 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.085 2.524 . . . . 65.4 111.595 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.55 113.55 26.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 CA-C-O 121.535 0.683 . . . . 61.34 109.501 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 58.9 t30 . . . . . 0 C--O 1.237 0.401 0 N-CA-C 107.665 -1.235 . . . . 72.42 107.665 171.562 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.53 ' HD2' ' HG2' ' A' ' 130' ' ' PRO . 28.9 t80 . . . . . 0 C--O 1.24 0.558 0 N-CA-C 107.335 -1.357 . . . . 73.31 107.335 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -137.97 133.35 33.58 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.206 -1.035 . . . . 54.24 108.206 172.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.485 HD13 HD11 ' C' ' 16' ' ' ILE . 17.3 mt -77.82 126.86 38.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 108.739 -0.838 . . . . 63.43 108.739 174.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.412 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 13.4 mm100 -82.05 -53.36 6.17 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.259 -1.015 . . . . 73.34 108.259 173.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.576 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -172.96 146.84 1.57 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.648 0.779 . . . . 74.12 110.471 178.323 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.485 HD11 HD13 ' C' ' 13' ' ' ILE . 72.5 mt -116.68 132.84 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.202 1.401 . . . . 74.41 107.586 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.442 ' HB3' HG23 ' D' ' 122' ' ' THR . 39.5 p90 -161.62 156.52 23.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.372 0.606 . . . . 63.34 112.105 -164.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 42.4 p -88.18 107.65 18.89 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.511 -0.768 . . . . 54.34 109.572 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.41 ' HG2' ' CE1' ' C' ' 17' ' ' TYR . 20.6 mtmt -74.32 -29.26 61.53 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.495 -0.557 . . . . 74.42 109.495 172.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.603 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 30.7 t70 -150.21 140.91 22.65 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.309 -0.86 . . . . 55.51 110.16 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 93.7 mt -137.37 144.81 30.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 125.562 1.545 . . . . 62.42 106.943 173.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -150.26 145.51 26.24 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 123.595 0.559 . . . . 75.03 109.624 173.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -151.52 116.77 5.3 Favored 'General case' 0 C--O 1.225 -0.21 0 N-CA-C 107.987 -1.116 . . . . 75.54 107.987 171.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -121.64 121.47 37.45 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.077 0.951 . . . . 72.11 108.547 176.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.17 87.6 6.22 Favored Pre-proline 0 C--O 1.239 0.525 0 N-CA-C 106.275 -1.75 . . . . 75.04 106.275 169.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.06 -21.65 36.46 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.631 2.221 . . . . 72.23 111.828 -168.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -125.65 31.18 5.57 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.201 1.0 . . . . 74.2 109.742 -177.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.24 -61.0 2.02 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 114.644 1.35 . . . . 53.13 114.644 -169.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.11 -34.73 45.29 Favored 'Trans proline' 0 C--N 1.382 2.337 0 CA-C-N 121.848 1.696 . . . . 73.14 112.268 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -69.0 -36.7 78.12 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.773 -1.103 . . . . 75.11 111.837 -176.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.593 ' HA ' ' HZ2' ' C' ' 34' ' ' LYS . 14.5 p -80.71 -28.67 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 112.863 0.69 . . . . 75.15 112.863 -176.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -63.71 -31.42 72.59 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.718 0.407 . . . . 71.14 111.984 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -88.12 12.48 13.52 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.419 1.088 . . . . 54.15 111.803 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.63 ' HZ3' ' HG2' ' C' ' 71' ' ' GLU . 10.2 ttpp -126.73 160.39 30.96 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.046 0.938 . . . . 75.01 111.434 -174.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -51.25 122.66 8.09 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.539 1.536 . . . . 74.2 112.435 178.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -86.13 82.56 8.02 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.622 0.725 . . . . 72.31 109.523 170.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -135.79 76.6 53.15 Favored Pre-proline 0 N--CA 1.472 0.662 0 N-CA-C 107.528 -1.286 . . . . 45.31 107.528 169.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -83.88 152.43 12.92 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.641 2.227 . . . . 61.25 111.703 -175.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -86.41 113.32 22.27 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.419 -1.326 . . . . 64.04 107.419 171.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 39.4 t -74.36 96.69 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.615 -0.883 . . . . 51.33 108.615 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.476 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 14.2 mptt -101.04 101.47 12.24 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 106.33 -1.73 . . . . 74.52 106.33 168.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pp -105.64 162.88 13.13 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.823 0.449 . . . . 75.01 110.065 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.634 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 4.7 t70 -148.08 135.32 20.43 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.103 0.961 . . . . 63.34 108.878 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 45.5 mt -131.86 110.98 11.2 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.123 -1.066 . . . . 63.32 108.123 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -131.77 128.31 38.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.961 -1.125 . . . . 74.21 107.961 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -126.68 140.9 52.06 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 109.444 -0.576 . . . . 74.34 109.444 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.54 142.63 33.53 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.38 0.672 . . . . 70.14 109.81 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 20.4 m -124.34 148.5 47.44 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.331 0.653 . . . . 43.45 110.776 -175.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 21.4 p -147.38 127.11 13.41 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.134 0.974 . . . . 63.54 108.881 176.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -78.84 120.44 23.47 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.108 -0.701 . . . . 74.24 109.108 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' C' ' 57' ' ' GLU . 33.7 mt -84.07 -44.56 13.95 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.766 0.826 . . . . 73.2 109.89 -176.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.93 -174.52 4.82 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.255 -0.884 . . . . 41.22 109.789 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.44 111.52 1.42 Allowed 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.84 0.712 . . . . 71.44 110.417 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 64.91 17.09 10.89 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.763 1.225 . . . . 55.33 112.471 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.77 113.65 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.151 -1.055 . . . . 71.02 108.151 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -122.54 126.36 47.62 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.153 0.981 . . . . 64.0 109.706 -173.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.499 ' HB2' HD11 ' C' ' 51' ' ' LEU . 43.4 tt0 -89.36 132.82 34.78 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.792 -0.818 . . . . 64.05 108.792 167.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 90.5 t -122.68 137.28 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.582 -1.266 . . . . 62.4 107.582 168.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.14 133.07 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.17 -0.678 . . . . 72.12 109.17 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.15 98.98 8.12 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.403 -1.332 . . . . 75.24 107.403 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -83.2 106.53 15.07 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.932 -0.766 . . . . 64.43 108.932 171.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 16.4 t -103.32 129.42 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 108.175 -1.046 . . . . 62.52 108.175 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.634 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 22.6 m -119.0 139.97 50.8 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.674 -0.862 . . . . 64.1 108.674 176.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.633 HG21 HG21 ' C' ' 114' ' ' ILE . 91.6 t -129.58 120.44 50.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 124.097 0.959 . . . . 65.52 108.792 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.494 HG23 HD23 ' C' ' 75' ' ' LEU . 2.0 m -115.4 109.21 17.54 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.182 -1.044 . . . . 71.02 108.182 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.44 105.52 15.67 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.945 -1.131 . . . . 30.32 107.945 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 43.0 m -131.16 128.82 40.84 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.797 -0.446 . . . . 51.12 109.797 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.413 HD12 ' HG2' ' C' ' 71' ' ' GLU . 16.0 mt -86.96 35.79 0.7 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.617 1.167 . . . . 72.15 110.379 -177.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.27 -112.36 2.79 Favored Glycine 0 C--N 1.346 1.084 0 N-CA-C 110.523 -1.031 . . . . 55.35 110.523 -169.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -90.97 -26.26 19.33 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.44 0.696 . . . . 74.04 110.78 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 71' ' ' GLU . . . . . 0.63 ' HG2' ' HZ3' ' C' ' 34' ' ' LYS . 14.4 tp10 -68.87 118.49 11.88 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.334 -0.848 . . . . 74.24 109.095 170.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 94.9 m -87.49 120.5 28.86 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.82 -0.808 . . . . 74.33 108.82 165.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.97 -50.92 44.83 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.823 -1.08 . . . . 71.32 108.545 177.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -165.11 168.35 17.35 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 114.043 -1.435 . . . . 53.01 111.048 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.494 HD23 HG23 ' C' ' 65' ' ' THR . 2.6 tm? -127.46 140.9 51.85 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 106.269 -1.752 . . . . 74.41 106.269 166.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 51.2 t -142.83 148.39 37.0 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.656 -0.868 . . . . 74.32 108.656 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -157.81 140.13 14.45 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.708 -0.478 . . . . 71.14 109.708 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.408 HG11 ' HA ' ' C' ' 110' ' ' ALA . 68.9 t -136.13 115.04 15.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 124.462 1.105 . . . . 44.21 108.518 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.603 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.7 mt-30 -91.75 88.6 6.74 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.74 -0.837 . . . . 73.11 108.74 169.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -80.12 96.69 6.59 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.031 -0.986 . . . . 63.11 109.083 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.51 153.3 30.04 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 111.185 -0.766 . . . . 54.53 111.185 175.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.83 123.78 1.38 Allowed Glycine 0 CA--C 1.498 -1.011 0 N-CA-C 110.722 -0.951 . . . . 50.43 110.722 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.502 HD11 ' HB3' ' D' ' 29' ' ' PRO . 32.1 mm -89.96 130.48 39.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 108.758 -0.83 . . . . 63.25 108.758 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -132.03 119.35 20.91 Favored 'General case' 0 C--O 1.241 0.651 0 O-C-N 124.191 0.932 . . . . 75.54 108.49 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 21.1 p -79.36 100.48 7.62 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.656 -1.238 . . . . 71.02 107.656 171.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.431 HD13 ' SG ' ' C' ' 97' ' ' CYS . 25.2 mt -115.2 129.58 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.226 0.61 . . . . 73.21 109.612 -175.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.42 168.04 22.14 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.443 0.697 . . . . 72.53 110.315 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.76 -32.15 6.3 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 115.324 -0.853 . . . . 35.01 112.634 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.425 HD11 ' HE3' ' C' ' 94' ' ' MET . 37.9 pt -106.97 164.06 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.16 0.584 . . . . 70.22 111.791 -173.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -154.17 163.5 40.01 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.112 0.965 . . . . 64.23 109.189 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.97 -126.54 9.66 Favored Glycine 0 C--N 1.351 1.374 0 O-C-N 123.364 0.415 . . . . 63.3 113.923 168.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 67.2 p -69.58 -29.74 67.36 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.504 0.721 . . . . 74.04 111.223 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -63.82 -52.21 61.22 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.655 0.782 . . . . 73.4 110.157 175.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.509 ' HE3' ' HA ' ' C' ' 94' ' ' MET . 4.6 tpt -53.53 -50.88 64.5 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 124.318 1.011 . . . . 72.4 111.904 173.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.35 -40.02 92.73 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.162 0.585 . . . . 74.24 111.829 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -70.6 -34.09 71.76 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.197 0.999 . . . . 73.33 111.087 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.431 ' SG ' HD13 ' C' ' 86' ' ' ILE . 38.5 t -69.86 -37.12 76.01 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.764 -0.653 . . . . 60.14 109.896 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 90.8 mt -84.69 -32.32 23.63 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.299 1.04 . . . . 75.24 112.297 -176.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.52 11.38 28.19 Favored Glycine 0 N--CA 1.475 1.234 0 CA-C-O 119.785 -0.453 . . . . 73.04 114.102 -170.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.28 -51.58 0.11 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 117.372 0.586 . . . . 73.11 111.662 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -72.99 -49.88 26.43 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.32 0.248 . . . . 63.02 111.006 -175.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.432 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 86.0 m -64.68 -49.33 70.49 Favored Pre-proline 0 CA--C 1.561 1.39 0 CA-C-O 118.244 -0.884 . . . . 73.21 112.251 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.432 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 49.1 Cg_exo -58.75 -27.71 84.45 Favored 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 122.655 2.237 . . . . 65.02 113.547 174.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -64.51 -39.7 94.26 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.462 0.705 . . . . 55.03 110.415 174.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.539 HD12 ' NH1' ' A' ' 111' ' ' ARG . 29.2 mm -75.46 -35.73 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 O-C-N 123.267 0.355 . . . . 73.4 110.177 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 87.8 mt -74.41 -31.67 62.4 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.563 0.745 . . . . 71.23 112.223 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -55.83 -49.96 89.88 Favored Pre-proline 0 N--CA 1.484 1.26 0 CA-C-O 117.465 -1.255 . . . . 73.55 114.346 -173.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.63 -37.79 95.67 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.425 2.083 . . . . 72.1 113.445 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.434 ' HE2' HG21 ' A' ' 115' ' ' THR . 52.4 m-85 -67.6 -44.27 78.49 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.624 0.77 . . . . 74.54 110.247 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.408 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -64.9 -38.69 91.81 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.963 -1.017 . . . . 70.24 110.66 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -65.04 -46.06 82.83 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.385 1.474 . . . . 63.44 110.449 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.94 -38.45 79.47 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.586 -0.734 . . . . 52.13 109.402 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 32.1 t -65.35 -36.2 83.29 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.955 0.502 . . . . 60.44 111.663 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.633 HG21 HG21 ' C' ' 64' ' ' VAL . 96.3 mt -68.85 -57.95 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.218 0.607 . . . . 74.23 110.054 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 10.8 m -65.26 -27.69 68.83 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 122.792 0.437 . . . . 71.11 111.277 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.419 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 40.8 t -64.12 -48.87 74.41 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.359 0.664 . . . . 44.42 109.242 170.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.548 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.03 -38.44 76.22 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.428 1.091 . . . . 73.22 112.351 177.876 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.462 HG23 ' O ' ' C' ' 114' ' ' ILE . 91.8 t -69.75 -38.44 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.019 0.928 . . . . 73.33 110.105 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 28.5 t -71.56 -27.66 63.32 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.37 1.068 . . . . 61.44 111.729 174.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' C' ' 116' ' ' SER . 76.4 mtt-85 -73.63 -40.96 63.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.582 0.753 . . . . 43.44 109.09 178.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.27 1.0 66.27 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.365 -0.834 . . . . 72.14 112.505 170.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.439 HG21 ' O ' ' D' ' 16' ' ' ILE . 30.8 p 62.25 29.25 17.36 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.505 1.922 . . . . 64.23 113.588 170.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -80.29 151.18 72.12 Favored Pre-proline 0 C--O 1.246 0.882 0 N-CA-C 107.704 -1.221 . . . . 74.11 107.704 168.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.04 150.76 54.22 Favored 'Trans proline' 0 C--N 1.366 1.457 0 C-N-CA 122.015 1.81 . . . . 53.15 111.393 172.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' B' ' 123' ' ' PHE . 8.5 mm100 -45.8 129.8 9.29 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.551 1.157 . . . . 62.15 112.274 -175.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 38.3 tp -136.09 86.78 2.25 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.026 -1.472 . . . . 74.42 107.026 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -92.6 122.36 34.95 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.934 -1.03 . . . . 72.21 109.267 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.57 121.88 17.32 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 108.749 -0.834 . . . . 74.44 108.749 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.14 140.66 97.95 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 123.717 0.807 . . . . 73.33 110.917 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.8 108.64 0.43 Allowed 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.603 2.202 . . . . 73.41 112.759 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 26.3 t -99.9 122.0 51.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.386 -0.968 . . . . 52.11 108.386 173.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 132' ' ' ASN . . . . . 0.425 ' O ' ' HG ' ' C' ' 136' ' ' LEU . 56.7 t-20 -75.0 104.53 5.62 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.377 1.071 . . . . 74.33 110.297 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -66.65 -27.05 67.37 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.835 0.854 . . . . 72.21 112.687 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -66.87 -39.44 87.54 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.565 0.746 . . . . 72.25 110.201 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.04 92.66 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.7 -0.682 . . . . 73.44 110.708 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 136' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' C' ' 132' ' ' ASN . 71.5 mt -68.17 -32.79 73.29 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.368 0.667 . . . . 62.01 111.051 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 25.2 t80 . . . . . 0 CA--C 1.542 0.667 0 CA-C-N 116.03 -0.532 . . . . 73.33 109.917 177.663 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 8.2 t . . . . . 0 C--O 1.243 0.733 0 CA-C-O 121.237 0.541 . . . . 70.03 109.965 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.57 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 62.6 t80 -152.14 103.99 2.93 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.209 -1.404 . . . . 73.21 107.209 -177.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 12' ' ' GLN . . . . . 0.521 ' HB2' ' HB3' ' D' ' 85' ' ' SER . 38.2 mt-30 -112.77 114.0 26.35 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.345 -0.983 . . . . 74.41 108.345 -175.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.496 HG21 HD11 ' D' ' 16' ' ' ILE . 53.9 mt -77.91 125.13 37.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.489 -0.93 . . . . 64.43 108.489 175.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -88.77 -41.66 12.39 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 123.844 0.715 . . . . 74.35 109.861 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -177.43 136.91 0.2 Allowed 'General case' 0 N--CA 1.481 1.1 0 O-C-N 123.436 0.46 . . . . 74.11 110.864 -169.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.496 HD11 HG21 ' D' ' 13' ' ' ILE . 4.1 mp -110.98 142.72 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 107.193 -1.41 . . . . 74.53 107.193 169.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -166.35 163.42 17.51 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.868 0.842 . . . . 72.52 111.768 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 59.3 p -97.65 116.14 29.29 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.797 -1.092 . . . . 74.34 108.929 176.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.455 ' HD2' ' HA3' ' D' ' 81' ' ' GLY . 41.1 mtpt -85.39 -26.98 26.11 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.822 -0.807 . . . . 71.45 108.822 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.666 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 26.7 t70 -152.75 142.71 22.2 Favored 'General case' 0 C--N 1.35 0.597 0 C-N-CA 124.397 1.079 . . . . 71.52 109.749 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.548 HG21 ' HE2' ' C' ' 117' ' ' MET . 55.9 mt -141.96 145.65 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.865 1.266 . . . . 71.54 108.45 175.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -148.15 141.0 24.71 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.765 1.226 . . . . 44.51 109.384 174.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 23' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -144.81 129.45 18.1 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.319 -1.363 . . . . 63.03 107.319 167.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -137.44 111.56 8.42 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 123.98 0.912 . . . . 73.21 108.895 -171.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.19 86.08 1.91 Allowed Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 108.055 -1.091 . . . . 63.5 108.055 174.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -68.19 -35.67 18.67 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.808 2.338 . . . . 72.41 113.333 -165.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.486 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 50.1 m-20 -107.26 15.62 24.86 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.896 0.878 . . . . 54.2 110.813 -174.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.469 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -27.0 -71.19 0.05 OUTLIER Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 116.459 2.022 . . . . 54.34 116.459 -160.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.502 ' HB3' HD11 ' C' ' 83' ' ' ILE . 93.9 Cg_endo -74.12 -24.18 15.08 Favored 'Trans proline' 0 C--N 1.378 2.086 0 CA-C-N 123.491 2.283 . . . . 65.1 113.936 -172.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -73.1 -40.96 64.56 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.649 0.78 . . . . 70.13 109.776 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.608 HG22 HD12 ' D' ' 68' ' ' LEU . 7.6 p -79.37 -26.58 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.506 -0.77 . . . . 72.12 111.609 -170.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -61.45 -23.69 66.03 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 122.797 0.439 . . . . 65.41 112.16 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -67.21 -9.07 36.51 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.698 1.199 . . . . 71.03 112.009 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -97.73 98.47 9.89 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.996 1.319 . . . . 73.12 110.182 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -88.78 88.44 7.6 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.792 0.837 . . . . 70.41 110.826 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 22.0 p90 -167.08 -177.99 3.98 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.103 0.961 . . . . 74.52 109.715 170.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -80.58 115.31 54.36 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 123.551 0.74 . . . . 70.51 109.471 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.38 142.68 97.92 Favored 'Trans proline' 0 C--N 1.386 2.501 0 C-N-CA 123.028 2.486 . . . . 72.44 112.379 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 39' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 14.0 mm-40 -67.18 106.46 2.02 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 107.531 -1.285 . . . . 72.11 107.531 171.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.625 HG13 HG13 ' D' ' 64' ' ' VAL . 62.4 t -106.17 116.09 49.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 O-C-N 123.729 0.643 . . . . 72.34 109.797 -178.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -98.98 152.64 19.58 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.642 -0.708 . . . . 45.34 109.569 169.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.444 HD11 HG13 ' D' ' 62' ' ' VAL . 31.9 tp -126.63 134.52 50.74 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.967 -1.015 . . . . 73.14 109.759 -173.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.551 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 13.2 t70 -130.35 113.77 14.77 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.415 -1.328 . . . . 74.22 107.415 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.437 ' CD2' HG22 ' D' ' 62' ' ' VAL . 94.3 mt -118.56 129.14 55.17 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.22 0.608 . . . . 70.33 109.438 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -160.03 155.76 25.86 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.633 -0.877 . . . . 73.32 108.633 172.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 46' ' ' THR . . . . . 0.499 HG22 ' HA ' ' D' ' 60' ' ' LEU . 30.4 p -123.61 168.64 12.37 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 122.167 0.984 . . . . 74.24 113.035 -170.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.13 143.97 26.33 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 113.465 -1.698 . . . . 60.22 107.208 173.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 37.2 p . . . . . 0 C--O 1.242 0.678 0 CA-C-O 120.58 0.229 . . . . 72.33 111.322 -178.675 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 54' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' D' ' 85' ' ' SER . 6.0 m-20 . . . . . 0 N--CA 1.485 1.322 0 N-CA-C 112.932 0.715 . . . . 75.03 112.932 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 58.8 t -134.87 102.16 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 107.635 -1.246 . . . . 74.45 107.635 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -135.33 135.06 40.47 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.039 0.535 . . . . 75.31 109.856 -174.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.514 ' HG2' HG12 ' D' ' 83' ' ' ILE . 42.3 mt-10 -87.14 115.02 24.25 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.882 -1.155 . . . . 64.04 107.882 167.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 70.6 t -97.58 136.22 29.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 106.797 -1.557 . . . . 70.12 106.797 171.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.426 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.1 t -128.41 123.76 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 108.239 -1.023 . . . . 73.33 108.239 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.499 ' HA ' HG22 ' D' ' 46' ' ' THR . 0.2 OUTLIER -103.31 121.21 42.27 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.824 -1.176 . . . . 60.51 107.824 176.189 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -100.53 105.99 17.47 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.237 -1.394 . . . . 61.5 107.237 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.444 HG13 HD11 ' D' ' 42' ' ' LEU . 59.1 t -99.99 120.43 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 N-CA-C 108.234 -1.025 . . . . 73.35 108.234 176.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 28.2 m -120.84 140.13 52.2 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.872 -0.788 . . . . 72.43 108.872 -177.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.625 HG13 HG13 ' D' ' 40' ' ' VAL . 77.3 t -131.37 130.36 62.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 115.398 -0.819 . . . . 74.15 109.914 -173.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 10.2 m -119.84 93.03 3.93 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.409 -0.96 . . . . 70.03 108.409 172.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.509 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -100.53 146.34 27.21 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.191 0.596 . . . . 63.13 110.037 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.521 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 23.5 p -153.89 127.93 8.97 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 112.815 0.672 . . . . 64.2 112.815 -169.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.608 HD12 HG22 ' D' ' 31' ' ' VAL . 80.0 mt -96.31 102.24 14.0 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.667 0.787 . . . . 70.24 109.121 174.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.84 -132.66 11.74 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 116.286 -0.415 . . . . 72.04 112.389 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.51 2.85 56.45 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.752 0.421 . . . . 71.33 111.038 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -114.94 158.31 22.19 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.362 -0.607 . . . . 71.2 109.362 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 91.6 m -75.33 139.14 42.25 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.083 0.553 . . . . 72.13 110.722 178.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.607 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.04 -62.32 1.51 Allowed 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.548 -1.279 . . . . 74.44 107.548 175.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -158.41 149.53 20.75 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.784 -1.098 . . . . 75.41 110.864 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 74.9 mt -116.75 120.8 39.7 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.689 1.596 . . . . 72.01 107.412 174.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.532 ' SG ' HG23 ' D' ' 114' ' ' ILE . 38.9 t -131.97 137.34 47.87 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.855 -0.424 . . . . 70.44 109.855 -174.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 77' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' D' ' 62' ' ' VAL . 38.5 tt0 -154.24 130.84 10.67 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.702 0.401 . . . . 72.42 110.984 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 78' ' ' VAL . . . . . 0.413 HG22 HG23 ' D' ' 21' ' ' ILE . 96.2 t -134.31 121.59 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.048 0.939 . . . . 71.52 109.487 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.666 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.7 mt-30 -90.2 86.35 6.5 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.677 -0.86 . . . . 71.44 108.677 169.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -80.36 101.29 8.89 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.217 -1.356 . . . . 65.13 109.073 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.455 ' HA3' ' HD2' ' D' ' 19' ' ' LYS . . . -96.85 161.07 21.78 Favored Glycine 0 N--CA 1.464 0.544 0 N-CA-C 112.479 -0.249 . . . . 70.53 112.479 178.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.03 140.72 6.63 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.729 -0.549 . . . . 74.14 111.729 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.514 HG12 ' HG2' ' D' ' 57' ' ' GLU . 50.1 mt -89.2 123.23 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.547 -1.279 . . . . 54.02 107.547 175.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -125.24 151.06 46.41 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.929 0.891 . . . . 71.45 109.768 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.521 ' HB3' ' HB2' ' D' ' 12' ' ' GLN . 33.7 t -113.19 103.76 11.66 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.324 -0.991 . . . . 71.31 108.324 173.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.63 HG22 HD11 ' D' ' 89' ' ' ILE . 3.1 mp -108.4 119.33 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 107.607 -1.257 . . . . 72.23 107.607 -176.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.33 168.69 24.59 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 123.645 0.591 . . . . 71.21 112.276 -172.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.83 22.59 68.82 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 115.307 -0.86 . . . . 53.21 112.957 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.63 HD11 HG22 ' D' ' 86' ' ' ILE . 0.5 OUTLIER -135.62 156.67 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.04 1.336 . . . . 55.01 108.401 176.218 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -152.08 163.85 38.47 Favored 'General case' 0 CA--C 1.561 1.379 0 N-CA-C 107.96 -1.126 . . . . 43.23 107.96 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.19 -134.31 13.65 Favored Glycine 0 C--N 1.349 1.279 0 C-N-CA 123.545 0.593 . . . . 51.51 111.971 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 13.1 m -81.89 -25.13 35.26 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 117.964 0.882 . . . . 75.32 110.625 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -66.99 -19.04 65.65 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.634 1.174 . . . . 74.44 112.898 -174.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.512 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 0.0 OUTLIER -81.06 -43.41 19.55 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.618 0.599 . . . . 75.12 112.618 -176.348 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 95' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -78.73 -15.31 58.61 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.046 0.539 . . . . 54.22 110.614 177.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -58.9 -46.89 86.81 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.63 1.172 . . . . 71.42 110.734 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 97' ' ' CYS . . . . . 0.406 ' HB2' HG21 ' D' ' 86' ' ' ILE . 51.3 m -72.23 -31.12 65.55 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.577 0.751 . . . . 73.5 111.538 -177.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -64.51 -52.5 57.49 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.678 1.191 . . . . 70.32 109.457 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.78 -25.43 62.6 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 115.364 -0.835 . . . . 72.32 114.054 -173.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.9 -55.4 2.42 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 117.621 0.71 . . . . 65.13 112.25 -170.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -74.54 -39.76 62.14 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 111.799 0.296 . . . . 73.22 111.799 -171.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.57 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 73.8 m -63.47 -47.4 83.53 Favored Pre-proline 0 CA--C 1.569 1.708 0 CA-C-O 118.762 -0.637 . . . . 63.25 112.273 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.489 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 50.3 Cg_exo -59.72 -31.86 94.8 Favored 'Trans proline' 0 C--N 1.396 3.048 0 C-N-CA 122.656 2.237 . . . . 72.53 113.546 169.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -67.23 -28.84 68.4 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.279 0.631 . . . . 73.34 110.746 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.9 mm -74.12 -40.94 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.482 0.713 . . . . 73.32 110.227 172.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 88.3 mt -73.72 -24.92 59.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.367 0.667 . . . . 75.52 112.548 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -64.56 -44.69 75.33 Favored Pre-proline 0 N--CA 1.485 1.284 0 N-CA-C 113.766 1.024 . . . . 72.3 113.766 -171.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -55.1 -38.85 93.27 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 121.946 1.764 . . . . 74.15 113.17 173.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -73.77 -37.38 65.03 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.528 0.731 . . . . 51.12 111.074 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.62 -46.01 73.76 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.912 0.885 . . . . 73.13 110.759 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -73.8 -30.84 62.97 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-N 115.08 -0.963 . . . . 61.31 110.781 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -64.45 -46.52 82.74 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 124.105 0.878 . . . . 71.14 109.809 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.1 t -55.68 -44.84 77.7 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 124.14 0.9 . . . . 64.01 110.405 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.532 HG23 ' SG ' ' D' ' 76' ' ' CYS . 72.1 mt -62.99 -50.22 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.859 0.864 . . . . 64.44 111.064 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 63.0 m -55.27 -47.08 76.0 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.08 0.952 . . . . 64.33 110.781 -175.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.4 t -62.57 -42.18 99.39 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 113.778 -1.555 . . . . 62.44 109.967 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.2 mtm -70.18 -31.89 69.57 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.194 0.597 . . . . 71.43 112.047 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.505 HG23 ' O ' ' D' ' 114' ' ' ILE . 76.4 t -67.74 -42.67 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.659 0.784 . . . . 73.04 110.058 176.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.5 p -73.15 -28.05 62.02 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-N 115.628 -0.715 . . . . 65.53 110.449 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' C' ' 17' ' ' TYR . 68.8 mtt-85 -70.65 -30.41 67.02 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.426 0.69 . . . . 61.34 109.601 172.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.93 11.61 66.41 Favored Glycine 0 C--N 1.353 1.477 0 CA-C-O 119.54 -0.589 . . . . 61.12 113.587 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.442 HG23 ' HB3' ' C' ' 17' ' ' TYR . 74.2 p 58.07 21.77 8.25 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 126.122 1.769 . . . . 74.02 114.365 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -90.55 155.92 45.67 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 109.409 -0.589 . . . . 72.22 109.409 171.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.3 137.86 71.86 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 122.902 2.402 . . . . 71.1 112.076 173.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -49.35 122.17 5.82 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.05 1.34 . . . . 74.15 112.215 -175.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.436 ' HB3' HG21 ' D' ' 118' ' ' VAL . 37.7 tp -107.64 99.54 9.02 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.423 0.689 . . . . 74.11 110.431 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -99.33 104.59 16.49 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 106.956 -1.498 . . . . 75.11 106.956 172.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.428 HD21 HG21 ' D' ' 114' ' ' ILE . 3.0 mm? -62.9 129.25 39.61 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.038 -0.727 . . . . 73.53 109.038 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.27 134.11 90.78 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 123.854 0.862 . . . . 60.41 111.533 -170.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -68.47 111.11 2.44 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.758 2.306 . . . . 60.15 111.85 -174.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.8 m -107.99 142.25 21.14 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 CA-C-O 121.218 0.532 . . . . 62.12 109.603 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -86.42 111.66 20.73 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 107.916 -1.142 . . . . 54.3 107.916 174.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 . . . . . 0 N--CA 1.483 1.221 0 C-N-CA 123.269 0.628 . . . . 70.11 112.532 -174.518 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 99.4 m . . . . . 0 CA--C 1.544 0.724 0 N-CA-C 109.022 -0.733 . . . . 51.44 109.022 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.536 ' CD1' HD12 ' A' ' 86' ' ' ILE . 15.0 t80 -125.31 133.44 52.62 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.534 -0.913 . . . . 53.54 108.534 177.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -147.91 135.51 20.81 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.472 0.709 . . . . 70.32 109.452 171.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.611 HG21 ' HG2' ' C' ' 130' ' ' PRO . 3.9 mt -82.47 115.74 25.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.433 -0.951 . . . . 64.13 108.433 169.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.76 -41.12 19.59 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 109.451 -0.574 . . . . 53.3 109.451 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.426 ' NH2' ' HB ' ' B' ' 122' ' ' THR . 23.1 ttt180 -169.51 126.74 0.91 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.629 0.372 . . . . 74.25 110.962 -175.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.407 HD12 ' HG3' ' C' ' 130' ' ' PRO . 86.6 mt -111.76 137.21 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.902 -0.777 . . . . 74.11 108.902 170.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HB2' ' HA2' ' B' ' 121' ' ' GLY . 31.6 p90 -164.29 176.33 9.24 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 124.136 0.898 . . . . 53.2 111.178 -172.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.6 p -103.57 123.36 46.8 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.36 0.664 . . . . 64.53 109.289 174.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.482 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 39.5 mtpt -87.74 -27.23 22.49 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.506 -0.553 . . . . 73.43 109.506 174.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.449 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 22.3 t70 -152.25 142.05 21.98 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 114.931 -1.031 . . . . 71.45 109.418 -177.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 85.3 mt -139.63 142.24 33.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 C-N-CA 125.24 1.416 . . . . 70.05 107.409 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.8 t -149.64 123.22 9.15 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.934 0.494 . . . . 74.03 110.189 175.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.424 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 89.7 t80 -127.88 124.52 37.66 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 106.986 -1.487 . . . . 73.51 106.986 172.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 80.1 mt-10 -126.77 121.18 31.23 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.054 0.388 . . . . 75.13 110.105 -177.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.45 76.38 61.92 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 108.249 -1.019 . . . . 74.12 108.249 169.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -74.48 -23.59 14.84 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.676 2.25 . . . . 65.44 112.357 -177.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -97.43 15.57 22.73 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-O 118.198 -0.906 . . . . 64.22 109.954 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.593 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -39.94 -59.24 1.84 Allowed Pre-proline 0 CA--C 1.572 1.79 0 C-N-CA 124.703 1.201 . . . . 63.44 113.705 -168.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 32.5 Cg_exo -60.11 -35.11 93.66 Favored 'Trans proline' 0 C--N 1.387 2.601 0 C-N-CA 122.075 1.85 . . . . 75.01 113.199 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -76.38 -35.55 58.58 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.117 -0.947 . . . . 72.13 110.92 -174.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.752 HG21 ' HA ' ' A' ' 73' ' ' ALA . 5.5 p -80.61 -15.51 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.707 -0.679 . . . . 63.24 112.236 -168.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -77.11 -35.49 56.29 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.513 0.325 . . . . 71.44 110.51 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -78.19 -16.19 58.11 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.161 0.584 . . . . 75.5 111.139 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -73.33 154.6 40.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.51 0.724 . . . . 63.43 111.368 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.52 119.25 7.69 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.753 1.221 . . . . 65.24 110.331 177.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -79.67 80.76 6.02 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.709 0.766 . . . . 74.45 109.842 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -123.62 81.15 54.61 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 106.094 -1.817 . . . . 73.5 106.094 169.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -86.91 122.0 1.84 Allowed 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.695 2.264 . . . . 60.31 112.324 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -95.91 115.54 27.58 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 105.917 -1.883 . . . . 73.31 105.917 168.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.0 t -94.55 94.3 4.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 O-C-N 123.783 0.677 . . . . 65.0 109.711 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -80.19 113.55 18.45 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.922 -1.035 . . . . 64.14 109.282 175.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.594 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.6 pt? -109.81 111.64 23.21 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.549 0.69 . . . . 73.33 109.809 -177.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -101.6 137.72 39.54 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.576 1.15 . . . . 75.51 108.295 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.494 HD11 HG21 ' A' ' 131' ' ' VAL . 67.9 mt -126.56 120.45 29.63 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.412 0.625 . . . . 62.04 111.015 -173.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -125.17 122.12 36.16 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 114.028 -1.442 . . . . 74.4 108.047 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 83.8 m -122.9 135.81 54.64 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.312 0.645 . . . . 72.45 109.961 177.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.94 126.31 11.54 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.494 0.717 . . . . 61.31 109.734 176.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 64.7 p -96.94 172.78 7.64 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.457 0.703 . . . . 64.13 110.743 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.1 t -162.7 163.32 26.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.842 1.257 . . . . 53.24 108.871 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -110.92 116.91 32.04 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.277 0.631 . . . . 75.44 109.446 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.9 mt -85.91 -33.59 21.16 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.092 0.557 . . . . 75.22 110.376 175.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.9 -176.49 4.95 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.767 0.827 . . . . 72.34 110.348 -178.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -62.37 118.99 8.23 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.131 0.572 . . . . 63.1 109.61 176.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 65.35 10.43 6.51 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.767 1.227 . . . . 74.33 112.438 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.38 106.65 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.772 -0.825 . . . . 73.32 108.772 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -113.99 126.42 55.11 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.991 0.916 . . . . 75.25 109.876 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -93.62 136.69 33.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.942 -0.762 . . . . 71.21 108.942 171.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.4 t -120.85 138.16 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 108.31 -0.996 . . . . 61.03 108.31 170.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.4 t -120.52 131.25 73.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.015 -0.735 . . . . 72.52 109.015 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.485 HD21 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -109.18 105.02 14.29 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.18 -1.415 . . . . 73.45 107.18 174.784 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -88.91 100.78 13.45 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.322 -1.362 . . . . 60.13 107.322 172.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.0 t -94.06 126.65 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.5 -1.296 . . . . 53.44 107.5 172.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.3 m -117.61 126.59 52.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.022 -0.733 . . . . 61.52 109.022 177.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.52 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 64.0 t -115.31 126.15 72.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.087 -1.079 . . . . 65.21 108.087 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.9 m -120.68 130.5 54.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.54 -0.911 . . . . 73.5 108.54 172.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.7 123.57 29.6 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.947 -1.501 . . . . 71.11 106.947 175.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -137.27 128.92 28.62 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.23 0.538 . . . . 72.02 110.691 -174.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.699 HD12 HG22 ' A' ' 31' ' ' VAL . 33.5 mt -92.29 81.36 4.95 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.145 1.378 . . . . 64.25 107.913 175.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.71 -119.51 6.08 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 110.852 -0.899 . . . . 73.24 110.852 -174.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.4 -19.36 25.28 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.926 0.49 . . . . 53.3 110.201 175.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -80.92 106.69 13.13 Favored 'General case' 0 C--N 1.347 0.469 0 C-N-CA 124.035 0.934 . . . . 72.05 109.038 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.8 m -68.76 131.07 44.56 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 118.16 0.436 . . . . 62.54 109.939 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.752 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -77.66 -61.26 2.05 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.286 -1.005 . . . . 71.53 108.286 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 46.6 p90 -158.9 157.78 32.1 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.525 -0.761 . . . . 75.54 111.801 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 64' ' ' VAL . 57.1 tp -123.44 109.29 13.67 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.46 -1.245 . . . . 73.34 107.734 171.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.52 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 86.0 m -108.17 96.27 6.25 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.111 0.565 . . . . 52.32 110.301 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -111.42 115.67 29.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.9 -0.778 . . . . 70.43 108.9 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.65 133.06 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.603 0.761 . . . . 53.05 109.887 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 61.9 mt-30 -105.12 88.22 2.82 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 107.956 -1.127 . . . . 74.15 107.956 175.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -76.8 96.43 4.27 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.166 -0.924 . . . . 70.14 109.208 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.54 145.09 20.1 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 111.349 -0.701 . . . . 73.33 111.349 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.5 122.95 1.79 Allowed Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.696 -0.962 . . . . 62.23 110.696 -176.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.441 HG13 ' HE1' ' A' ' 17' ' ' TYR . 53.7 mt -80.77 127.29 39.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 108.151 -1.055 . . . . 63.42 108.151 170.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.802 ' HB3' HD11 ' A' ' 86' ' ' ILE . 92.8 m-85 -131.74 123.91 28.65 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.371 0.668 . . . . 74.33 109.4 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 t -86.43 98.0 10.77 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 108.903 -0.777 . . . . 72.21 108.903 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.802 HD11 ' HB3' ' A' ' 84' ' ' PHE . 4.1 mm -112.5 149.24 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 122.857 0.463 . . . . 74.45 110.886 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.26 167.28 16.2 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.748 0.819 . . . . 52.05 110.827 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.44 -32.92 6.24 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 114.304 0.482 . . . . 74.21 114.304 172.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.671 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -113.01 150.33 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.411 0.684 . . . . 61.51 110.639 -174.513 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -138.8 174.58 10.37 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.379 1.072 . . . . 64.44 109.527 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.86 -133.28 40.56 Favored Glycine 0 C--N 1.345 1.07 0 O-C-N 123.792 0.683 . . . . 64.01 113.732 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 47.5 p -67.77 -25.51 65.65 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.876 0.87 . . . . 64.54 111.631 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -69.37 -42.74 74.79 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.387 0.675 . . . . 74.11 110.827 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 5.8 tpt -66.34 -46.72 75.85 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 116.004 -0.544 . . . . 60.51 109.897 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.36 -34.77 72.8 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.563 -0.744 . . . . 64.4 110.894 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -68.84 -34.29 75.24 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.651 -0.704 . . . . 72.44 111.431 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.9 t -65.76 -44.27 86.4 Favored 'General case' 0 C--N 1.348 0.516 0 N-CA-C 109.815 -0.439 . . . . 60.53 109.815 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.6 mt -84.22 -35.31 23.56 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.235 -0.893 . . . . 73.42 112.036 -170.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.86 3.93 49.25 Favored Glycine 0 N--CA 1.473 1.11 0 CA-C-O 119.713 -0.493 . . . . 73.53 114.2 -172.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.52 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -141.67 -66.57 0.41 Allowed 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 117.587 0.694 . . . . 73.43 111.537 -177.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -65.48 -44.59 86.61 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 115.968 -0.56 . . . . 71.31 111.581 -173.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.6 m -63.44 -51.08 70.22 Favored Pre-proline 0 CA--C 1.564 1.494 0 C-N-CA 124.03 0.932 . . . . 65.25 112.354 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.45 -27.13 62.48 Favored 'Trans proline' 0 C--N 1.395 2.985 0 C-N-CA 121.717 1.611 . . . . 73.34 113.491 173.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.511 HD21 ' HA ' ' A' ' 132' ' ' ASN . 3.0 m120 -60.88 -38.29 85.1 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 118.09 0.405 . . . . 71.35 110.613 172.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.506 HG21 ' CD1' ' A' ' 13' ' ' ILE . 47.3 mm -72.12 -44.21 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.467 0.707 . . . . 63.01 110.065 176.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 70.2 mt -71.75 -23.61 61.63 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.551 -0.749 . . . . 64.24 112.29 -173.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -63.98 -47.27 80.53 Favored Pre-proline 0 N--CA 1.483 1.207 0 CA-C-O 117.932 -1.033 . . . . 75.02 113.391 -172.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.412 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 83.0 Cg_exo -51.29 -36.15 56.01 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.138 1.892 . . . . 65.23 113.943 172.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -80.55 -39.37 27.87 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.396 0.678 . . . . 65.03 111.716 -177.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.78 -47.49 74.96 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 109.457 -0.572 . . . . 40.32 109.457 176.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.614 HH12 HD12 ' C' ' 105' ' ' ILE . 27.9 ttm180 -51.6 -47.07 63.72 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.85 1.26 . . . . 72.12 110.568 172.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.43 -49.12 78.14 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.033 0.833 . . . . 55.25 111.433 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.4 t -57.17 -47.19 81.84 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.084 0.865 . . . . 50.42 110.193 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.527 HD13 HD11 ' A' ' 128' ' ' LEU . 23.5 mt -56.75 -51.76 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.743 1.217 . . . . 72.51 111.124 174.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.9 m -56.23 -45.09 80.09 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.535 1.134 . . . . 73.14 111.108 -176.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.2 t -67.66 -41.05 84.4 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.41 -1.268 . . . . 72.22 110.006 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 11.6 mtp -59.66 -44.61 93.5 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.59 0.756 . . . . 71.53 111.054 176.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 114' ' ' ILE . 82.1 t -59.33 -48.41 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 124.225 1.01 . . . . 62.23 110.543 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.9 p -71.19 -30.6 66.6 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.603 -0.726 . . . . 63.22 111.617 -176.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.468 HH12 ' HG3' ' B' ' 112' ' ' GLU . 80.3 mtt-85 -72.66 -28.31 62.64 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.98 0.512 . . . . 73.24 109.974 176.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.436 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.34 17.17 35.16 Favored Glycine 0 C--N 1.354 1.559 0 CA-C-O 119.291 -0.727 . . . . 64.24 113.432 174.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.4 t 59.73 9.96 1.84 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 127.202 2.201 . . . . 74.42 113.404 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -79.26 140.04 56.5 Favored Pre-proline 0 C--O 1.242 0.671 0 N-CA-C 108.311 -0.996 . . . . 73.33 108.311 175.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -46.49 126.7 10.64 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 123.065 2.51 . . . . 60.4 112.268 172.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -50.67 131.6 25.66 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.599 1.187 . . . . 72.32 112.84 -168.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.4 tp -109.24 138.09 46.12 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.642 0.777 . . . . 70.05 109.858 -176.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -132.97 117.67 17.92 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.531 -0.914 . . . . 64.01 108.531 174.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.527 HD11 HD13 ' A' ' 114' ' ' ILE . 16.1 mt -72.72 135.29 45.33 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.152 -0.684 . . . . 63.24 109.152 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.13 142.78 98.69 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 122.651 0.38 . . . . 73.25 111.254 -177.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.464 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 63.3 Cg_exo -54.17 118.39 4.95 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.421 2.748 . . . . 73.24 114.074 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.494 HG21 HD11 ' A' ' 44' ' ' LEU . 88.5 t -102.86 129.03 55.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 123.518 0.727 . . . . 64.43 110.272 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.511 ' HA ' HD21 ' A' ' 104' ' ' ASN . 56.6 t30 -96.37 92.89 6.54 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.678 0.791 . . . . 63.14 109.12 176.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -67.98 -22.84 64.99 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.55 -0.75 . . . . 71.14 111.368 177.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.52 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 13.5 t70 -54.91 -50.96 67.52 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.574 0.75 . . . . 75.13 110.105 172.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.91 -55.65 30.47 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 114.78 -1.1 . . . . 71.43 110.086 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 91.8 mt -56.82 -36.91 70.5 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 124.217 0.948 . . . . 71.33 112.479 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 81.8 t80 . . . . . 0 C--O 1.219 -0.542 0 O-C-N 123.777 0.673 . . . . 63.34 110.257 178.288 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.57 ' HG3' HG13 ' B' ' 89' ' ' ILE . 27.0 ttt . . . . . 0 CA--C 1.566 1.571 0 CA-C-O 121.454 0.645 . . . . 74.01 111.59 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.415 ' N ' ' HG2' ' B' ' 9' ' ' MET . 85.3 m -138.01 123.08 19.12 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.875 1.27 . . . . 61.33 108.13 169.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.636 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 62.1 t80 -137.29 133.79 35.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.248 0.619 . . . . 71.34 109.608 177.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -150.57 140.13 21.57 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.568 0.747 . . . . 74.04 109.223 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.505 HD11 HD13 ' B' ' 105' ' ' ILE . 53.4 mt -83.16 130.27 36.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.23 -1.026 . . . . 53.14 108.23 171.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -98.78 -41.57 7.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.975 0.51 . . . . 75.11 110.4 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -173.03 129.29 0.48 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.617 -0.72 . . . . 74.22 109.177 -175.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.557 HG21 ' CD1' ' B' ' 109' ' ' TYR . 75.1 mt -116.32 148.89 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.448 -0.945 . . . . 61.45 108.448 173.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -167.09 161.95 15.06 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-O 121.671 0.748 . . . . 71.24 112.016 -175.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.4 m -88.26 123.03 32.46 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.191 -1.368 . . . . 64.02 108.408 168.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.543 ' HZ2' ' HA3' ' B' ' 81' ' ' GLY . 43.0 mttp -80.05 -51.76 8.64 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.233 0.613 . . . . 75.11 110.593 170.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -144.85 141.77 29.39 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.283 -0.417 . . . . 61.43 110.725 -164.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.507 HD11 ' SG ' ' B' ' 113' ' ' CYS . 46.3 mm -134.95 138.66 48.73 Favored 'Isoleucine or valine' 0 C--N 1.354 0.791 0 C-N-CA 124.572 1.149 . . . . 70.43 109.726 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.42 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 40.2 t -138.32 128.47 25.76 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.923 1.289 . . . . 62.14 107.65 176.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.416 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 77.5 t80 -144.29 114.32 7.36 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 107.974 -1.121 . . . . 53.52 107.974 171.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -122.43 116.98 24.91 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.076 0.95 . . . . 65.44 108.941 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.18 86.57 3.35 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 107.595 -1.261 . . . . 72.12 107.595 169.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.86 -30.64 40.08 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.956 2.437 . . . . 71.21 112.715 -170.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -107.87 12.27 27.35 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 118.407 -0.806 . . . . 74.23 110.899 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.421 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -31.24 -73.22 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.918 0 C-N-CA 126.026 1.73 . . . . 74.24 114.604 -164.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.482 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 27.6 Cg_endo -64.06 -26.19 65.88 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 122.084 1.856 . . . . 74.14 112.954 -170.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -87.11 -41.74 13.56 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.14 -0.936 . . . . 62.24 111.383 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.498 HG22 HD12 ' B' ' 68' ' ' LEU . 8.8 p -69.18 -17.75 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.218 0.607 . . . . 55.43 111.175 -175.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -65.54 -11.09 40.6 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.128 0.788 . . . . 74.1 113.128 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.501 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.2 pt20 -63.13 -13.72 40.02 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.455 0.702 . . . . 71.32 111.446 172.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.501 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 97.9 mttt -109.06 110.3 21.53 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.779 1.632 . . . . 74.12 110.629 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -111.27 88.95 2.92 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.641 0.776 . . . . 64.22 109.822 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.448 ' O ' ' HG3' ' B' ' 124' ' ' PRO . 33.7 p90 -167.66 172.49 9.28 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.879 0.872 . . . . 74.12 109.098 170.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -65.18 110.17 3.91 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 123.424 0.69 . . . . 54.33 110.704 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.414 ' O ' HG23 ' B' ' 40' ' ' VAL . 18.0 Cg_endo -64.83 166.3 18.63 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.051 1.834 . . . . 73.15 112.384 -177.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 33.8 tt0 -64.35 100.84 0.38 Allowed 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.509 -1.293 . . . . 54.31 107.509 168.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.689 HG11 HD11 ' B' ' 126' ' ' LEU . 54.6 t -104.32 149.31 8.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.213 -0.903 . . . . 70.01 109.125 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.504 ' HE3' ' HB2' ' B' ' 43' ' ' ASP . 12.6 ttpt -141.3 120.67 13.13 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.393 -1.336 . . . . 52.31 107.393 173.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.524 HD13 HD22 ' B' ' 128' ' ' LEU . 20.4 tp -88.53 134.62 33.81 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.614 -0.884 . . . . 73.24 108.614 174.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.504 ' HB2' ' HE3' ' B' ' 41' ' ' LYS . 2.5 t0 -142.41 146.66 35.11 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.879 -1.156 . . . . 62.42 107.879 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 mp -131.25 146.2 52.21 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.476 -0.565 . . . . 65.11 109.476 -175.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.519 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 35.0 m-20 -130.47 153.86 48.36 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.953 1.301 . . . . 73.52 108.087 170.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 5.9 t -139.11 130.86 27.49 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.344 0.593 . . . . 64.03 110.251 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.05 136.46 18.97 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.918 1.287 . . . . 75.53 107.662 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 19.0 m -140.8 175.22 9.79 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.923 0.489 . . . . 71.41 110.948 -170.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 58.9 p -151.66 136.94 17.55 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.725 0.41 . . . . 75.24 111.146 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -87.79 107.16 18.53 Favored 'General case' 0 C--N 1.349 0.545 0 N-CA-C 108.978 -0.749 . . . . 72.0 108.978 173.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.0 pp -125.34 15.43 8.32 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.273 -0.876 . . . . 62.13 109.717 177.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.76 151.1 14.25 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 124.439 1.096 . . . . 64.3 109.373 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -83.36 134.72 34.89 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.619 -0.882 . . . . 70.54 108.619 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' HB3' ' HB2' ' B' ' 87' ' ' ALA . 1.7 m-20 64.3 7.88 3.83 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.065 0.946 . . . . 74.52 112.275 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 86.8 t -142.03 112.17 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 107.556 -1.276 . . . . 71.53 107.556 -174.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -115.3 139.68 49.77 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 109.012 -0.736 . . . . 72.43 109.012 -171.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -101.33 104.37 15.36 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.79 -1.189 . . . . 72.52 107.79 -177.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.58 135.87 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.775 0.83 . . . . 72.42 110.072 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 15.4 t -122.81 111.28 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.6 0.76 . . . . 72.14 108.956 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 56.5 tp -98.27 115.0 27.47 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.261 -0.644 . . . . 72.03 109.261 175.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.519 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 37.9 ttm180 -85.39 130.74 34.52 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.893 -0.78 . . . . 75.45 108.893 170.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 64.6 t -123.45 104.72 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 108.228 -1.027 . . . . 74.35 108.228 173.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 11.9 m -100.66 136.7 40.12 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.737 0.815 . . . . 75.24 109.906 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.742 HG11 HD21 ' B' ' 126' ' ' LEU . 76.8 t -121.1 125.83 74.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 123.957 0.903 . . . . 74.01 109.227 173.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.4 m -100.49 138.67 37.25 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 107.806 -1.183 . . . . 74.43 107.806 169.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.03 144.49 27.96 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.887 0.375 . . . . 72.01 111.08 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.482 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 34.9 p -151.96 128.52 10.74 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.271 -0.877 . . . . 73.24 110.568 -178.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.498 HD12 HG22 ' B' ' 31' ' ' VAL . 66.9 mt -91.76 98.3 11.53 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.654 -1.239 . . . . 65.03 107.654 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.07 -119.49 5.93 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 114.397 -1.274 . . . . 65.13 112.287 -174.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -100.91 1.39 39.82 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.622 0.769 . . . . 62.33 111.552 -174.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -122.02 148.55 44.69 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.705 -0.48 . . . . 74.42 109.705 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.5 m -68.46 133.72 49.06 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.119 0.485 . . . . 71.44 111.019 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.482 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -87.95 -64.4 1.15 Allowed 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.914 -1.143 . . . . 73.43 107.914 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 74' ' ' PHE . . . . . 0.438 ' CZ ' HD22 ' B' ' 126' ' ' LEU . 43.0 p90 -154.06 155.09 34.82 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.262 -1.335 . . . . 63.31 109.364 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 72.4 mt -131.68 111.68 11.89 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.815 -1.55 . . . . 75.13 106.815 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 37.5 t -117.78 151.51 37.17 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.912 -0.773 . . . . 72.41 108.912 -176.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.42 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 34.9 tt0 -162.1 129.26 3.84 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.768 -0.826 . . . . 64.32 108.768 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 85.6 t -124.44 149.68 28.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 124.013 0.925 . . . . 73.22 108.535 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -126.51 95.83 4.48 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.181 -1.044 . . . . 71.03 108.181 171.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -90.75 107.39 19.15 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.671 -0.863 . . . . 75.04 108.671 -176.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.543 ' HA3' ' HZ2' ' B' ' 19' ' ' LYS . . . -97.94 154.82 20.3 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 112.075 -0.41 . . . . 74.54 112.075 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.5 132.83 3.13 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 117.089 0.444 . . . . 70.13 112.938 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 3.7 mp -86.02 113.66 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 N-CA-C 107.941 -1.133 . . . . 64.34 107.941 170.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -121.48 153.83 37.41 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.786 0.834 . . . . 74.4 109.266 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 49.1 m -100.71 107.41 19.01 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.245 0.618 . . . . 62.54 109.868 176.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.28 102.0 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 106.676 -1.601 . . . . 71.14 106.676 175.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.679 ' HB2' ' HB3' ' B' ' 54' ' ' ASP . . . -147.77 170.84 16.73 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.24 0.616 . . . . 53.53 111.368 -169.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.39 -54.62 4.86 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-O 121.253 0.363 . . . . 63.14 112.414 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.57 HG13 ' HG3' ' B' ' 9' ' ' MET . 1.1 pp -68.4 168.57 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.242 1.017 . . . . 65.23 111.826 171.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.59 -171.3 3.63 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.168 -0.924 . . . . 73.13 110.092 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.64 -132.57 22.53 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 115.081 -0.963 . . . . 64.31 114.166 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 15.8 m -83.55 -40.97 18.44 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.953 0.901 . . . . 63.25 109.86 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -65.49 -25.99 67.72 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 113.609 -1.632 . . . . 74.52 112.131 -165.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.467 ' HB2' HD13 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -65.05 -40.82 95.31 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.054 0.942 . . . . 71.42 112.642 -177.728 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.23 -14.05 59.83 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.048 0.539 . . . . 75.14 112.276 -177.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -64.84 -32.44 74.15 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.833 0.453 . . . . 73.34 110.537 170.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.2 t -66.12 -56.29 12.2 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.592 0.357 . . . . 70.45 110.889 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.415 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.5 pp -67.2 -21.71 65.76 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.711 0.404 . . . . 75.02 111.378 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.84 0.37 57.73 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-O 119.093 -0.837 . . . . 65.04 114.506 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.4 -56.07 0.21 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 118.39 1.095 . . . . 53.34 111.937 -177.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -68.4 -43.79 76.51 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.436 0.695 . . . . 70.44 111.393 -173.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.636 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 58.9 m -70.89 -47.42 15.41 Favored Pre-proline 0 CA--C 1.562 1.441 0 C-N-CA 123.477 0.711 . . . . 71.23 112.21 -176.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 31.9 Cg_exo -60.85 -28.32 86.22 Favored 'Trans proline' 0 C--N 1.394 2.931 0 C-N-CA 121.953 1.769 . . . . 72.35 113.346 173.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.25 -32.9 72.71 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.577 0.751 . . . . 70.22 111.849 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.505 HD13 HD11 ' B' ' 13' ' ' ILE . 70.0 mt -75.6 -34.94 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.639 0.776 . . . . 63.44 110.155 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 85.4 mt -75.44 -31.8 60.45 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.207 -0.906 . . . . 45.14 111.372 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -57.67 -48.63 96.87 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 113.885 1.068 . . . . 52.01 113.885 -173.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.8 -32.48 91.81 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 122.293 1.996 . . . . 74.2 113.211 177.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.557 ' CD1' HG21 ' B' ' 16' ' ' ILE . 5.0 m-30 -79.53 -37.69 35.96 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.315 0.646 . . . . 75.53 110.514 -176.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.46 -37.95 88.39 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.35 -0.841 . . . . 71.34 110.077 173.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.486 ' HA ' HD12 ' B' ' 128' ' ' LEU . 46.2 ttt-85 -61.02 -55.24 35.11 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.888 1.275 . . . . 74.25 110.181 177.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.468 ' HG3' HH12 ' A' ' 120' ' ' ARG . 13.3 tp10 -61.24 -35.23 76.67 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.903 0.881 . . . . 73.35 110.747 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.592 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.0 t -69.13 -32.59 72.06 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 110.267 -0.271 . . . . 73.0 110.267 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.548 HD13 HG23 ' B' ' 64' ' ' VAL . 69.0 mt -71.19 -56.42 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.443 0.697 . . . . 72.3 110.411 174.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 22.7 m -58.24 -28.56 64.99 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.39 1.076 . . . . 74.4 111.416 -174.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.5 t -63.05 -57.14 11.67 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-N 115.782 -0.645 . . . . 74.12 109.574 171.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.592 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.2 mmt -64.02 -36.75 85.0 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.562 0.745 . . . . 64.24 111.254 -173.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.479 HG21 HD23 ' B' ' 126' ' ' LEU . 82.3 t -57.97 -50.08 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 124.545 1.138 . . . . 61.32 110.075 175.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 47.2 t -73.48 -20.25 60.73 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.785 -1.098 . . . . 74.33 111.496 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.456 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 90.9 mtt-85 -68.77 -31.19 70.04 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 110.149 -0.315 . . . . 71.22 110.149 173.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 121' ' ' GLY . . . . . 0.45 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -78.65 -4.72 87.99 Favored Glycine 0 C--N 1.355 1.607 0 O-C-N 123.62 0.575 . . . . 52.0 112.485 168.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.426 ' HB ' ' NH2' ' A' ' 15' ' ' ARG . 8.6 m 62.93 33.36 15.04 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 125.684 1.594 . . . . 63.22 110.19 -177.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -76.92 163.75 63.47 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 114.353 -1.294 . . . . 72.0 110.534 176.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.448 ' HG3' ' O ' ' B' ' 36' ' ' TRP . 36.3 Cg_endo -61.34 157.34 41.11 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 122.557 2.171 . . . . 75.34 111.63 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -63.01 130.11 43.29 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.374 0.606 . . . . 60.23 111.924 -171.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.742 HD21 HG11 ' B' ' 64' ' ' VAL . 59.9 tp -120.74 99.86 6.77 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.485 -1.234 . . . . 54.52 109.004 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -95.66 121.99 37.95 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.75 -1.204 . . . . 70.01 107.75 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.524 HD22 HD13 ' B' ' 42' ' ' LEU . 38.6 mt -79.79 132.88 36.25 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 117.831 0.287 . . . . 52.2 110.522 176.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.45 131.82 82.21 Favored Pre-proline 0 C--O 1.243 0.717 0 O-C-N 123.993 0.808 . . . . 62.25 110.91 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.582 ' HG3' HD11 ' D' ' 16' ' ' ILE . 54.0 Cg_endo -67.85 110.04 2.05 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.456 2.104 . . . . 75.33 110.698 172.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 7.7 p -88.18 141.95 13.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 N-CA-C 108.134 -1.062 . . . . 75.2 108.134 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 61.1 t30 . . . . . 0 CA--C 1.547 0.83 0 CA-C-O 122.537 1.161 . . . . 62.54 108.645 -179.452 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.479 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 75.6 t80 . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 109.265 -0.643 . . . . 74.4 109.265 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 45.8 tp60 -151.81 142.87 23.16 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.268 0.627 . . . . 72.11 109.383 170.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 23.0 mt -88.18 131.9 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 108.107 -1.071 . . . . 74.43 108.107 173.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -90.26 -47.05 8.02 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.065 -0.717 . . . . 75.01 109.065 172.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -179.25 143.54 0.21 Allowed 'General case' 0 C--O 1.239 0.517 0 CA-C-N 113.914 -1.494 . . . . 75.31 108.424 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 pp -107.72 152.31 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.751 -1.203 . . . . 73.51 107.751 175.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.6 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 23.6 p90 -173.77 142.41 0.9 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.317 0.58 . . . . 74.43 111.368 -175.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -76.27 127.11 32.23 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.294 1.038 . . . . 63.42 110.669 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -86.31 -22.23 26.87 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.58 -0.896 . . . . 60.44 108.58 168.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.627 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.2 t70 -148.53 133.42 18.05 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.759 -0.655 . . . . 61.02 109.419 -175.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 63.6 mt -136.57 137.33 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 106.035 -1.839 . . . . 71.44 106.035 170.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.3 t -155.16 151.8 28.65 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.516 0.674 . . . . 61.25 112.174 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -153.31 143.73 22.48 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 113.747 -1.57 . . . . 73.23 107.843 174.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -145.57 113.52 6.48 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.174 0.589 . . . . 43.12 110.161 -177.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.23 77.21 48.83 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 108.059 -1.089 . . . . 44.21 108.059 164.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.46 -25.31 63.26 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.708 2.272 . . . . 73.3 111.938 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -94.39 18.65 10.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.111 1.364 . . . . 52.15 111.451 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.59 -57.24 5.9 Favored Pre-proline 0 CA--C 1.559 1.294 0 N-CA-C 113.837 1.051 . . . . 41.4 113.837 -170.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -61.72 -36.74 72.89 Favored 'Trans proline' 0 C--N 1.386 2.507 0 CA-C-N 121.575 1.598 . . . . 45.54 112.468 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -70.06 -40.25 75.18 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.967 0.907 . . . . 75.44 112.39 -178.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.777 HG21 ' HA ' ' C' ' 73' ' ' ALA . 11.3 p -76.78 -26.11 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 N-CA-C 112.649 0.611 . . . . 74.12 112.649 -176.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -61.73 -29.24 69.98 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 112.933 0.716 . . . . 71.12 112.933 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -91.72 13.09 19.16 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.921 0.488 . . . . 72.1 112.073 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.4 163.24 12.96 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.727 0.811 . . . . 74.11 109.662 177.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.62 127.96 34.91 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.425 0.69 . . . . 63.1 109.573 170.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -84.27 83.43 7.98 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.535 0.734 . . . . 74.12 110.808 -176.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -134.9 78.93 53.09 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.77 0.828 . . . . 74.14 108.799 171.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -86.76 154.39 8.77 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.755 2.303 . . . . 54.52 112.405 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -88.68 82.06 6.92 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.126 -1.435 . . . . 64.21 107.126 166.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 44.4 t -68.82 95.97 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.663 0 N-CA-C 107.856 -1.164 . . . . 64.0 107.856 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.414 ' NZ ' ' HB2' ' C' ' 43' ' ' ASP . 0.4 OUTLIER -104.18 104.87 14.86 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.124 -1.435 . . . . 60.44 107.124 -178.765 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.477 HD23 HD23 ' C' ' 128' ' ' LEU . 2.2 mp -86.74 144.97 26.84 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.689 -1.226 . . . . 73.51 107.689 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.534 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 32.6 t70 -138.26 140.97 39.87 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.176 -0.676 . . . . 64.55 109.176 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 92.8 mt -126.59 111.61 14.55 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.718 -0.845 . . . . 75.42 108.718 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -113.94 143.82 44.08 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.018 -1.475 . . . . 72.44 107.018 169.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.3 t -139.05 154.22 48.18 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 120.939 0.399 . . . . 63.44 110.034 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.82 156.26 42.98 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.172 -0.922 . . . . 74.23 108.99 175.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 30.5 p -152.66 150.45 29.48 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.27 0.628 . . . . 74.32 109.976 -175.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 49.9 p -160.56 144.85 14.05 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.201 0.6 . . . . 73.53 110.388 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -77.83 130.52 36.77 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.396 0.678 . . . . 53.43 110.176 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.703 HD11 ' HB2' ' C' ' 57' ' ' GLU . 54.0 mt -95.94 -39.75 9.63 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.521 0.729 . . . . 73.23 109.981 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.24 -171.41 2.6 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.847 0.859 . . . . 50.23 110.363 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -60.26 115.48 3.54 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.182 -0.917 . . . . 74.24 110.403 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 63.16 18.04 10.65 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.051 1.34 . . . . 65.54 111.733 177.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.8 t -121.76 117.56 52.89 Favored 'Isoleucine or valine' 0 C--N 1.354 0.763 0 C-N-CA 124.64 1.176 . . . . 43.33 108.578 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -131.14 130.35 42.96 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.313 1.045 . . . . 63.23 109.114 -176.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.703 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.0 tt0 -95.85 139.6 31.82 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.186 0.595 . . . . 73.51 109.841 173.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.01 135.01 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 108.648 -0.871 . . . . 45.45 108.648 170.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.535 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 84.3 t -113.75 144.08 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.111 0.964 . . . . 73.13 108.619 171.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.77 107.22 10.32 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.342 -0.984 . . . . 60.22 108.342 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 35.4 ttm-85 -82.08 107.63 14.93 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.517 0.727 . . . . 75.03 109.047 171.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 26.2 t -106.87 112.45 39.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.342 -0.984 . . . . 72.23 108.342 170.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 31.7 m -104.49 144.34 31.8 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.382 -0.827 . . . . 54.41 109.181 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.641 HG21 HG21 ' C' ' 114' ' ' ILE . 88.6 t -132.42 111.53 17.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 N-CA-C 107.301 -1.37 . . . . 74.41 107.301 175.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.0 m -99.11 137.27 37.87 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.908 -1.145 . . . . 71.41 107.908 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.38 104.88 5.29 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.441 -0.948 . . . . 52.44 108.441 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.9 m -129.56 132.2 46.76 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.99 0.424 . . . . 71.31 110.255 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 14.9 mt -85.36 36.94 0.66 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.623 1.169 . . . . 75.11 110.307 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.1 -108.05 2.64 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 110.954 -0.858 . . . . 50.22 110.954 -172.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -90.21 -31.98 16.79 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.113 0.565 . . . . 75.3 110.42 176.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -70.58 119.99 15.54 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.521 -0.918 . . . . 71.11 108.521 171.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 31.3 m -82.72 125.12 30.89 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.333 -0.988 . . . . 72.01 108.333 170.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.777 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.17 -52.6 18.29 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 109.226 -0.657 . . . . 71.41 109.226 176.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 74' ' ' PHE . . . . . 0.564 ' HZ ' HD21 ' C' ' 126' ' ' LEU . 33.9 p90 -165.7 169.6 14.99 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.653 -1.158 . . . . 72.1 110.913 176.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.413 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -128.48 143.25 50.95 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.422 -1.695 . . . . 53.21 106.422 167.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.546 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.6 t -150.03 122.97 8.75 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.17 -0.678 . . . . 62.12 109.17 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -137.98 134.22 34.61 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.547 -0.538 . . . . 74.24 109.547 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.512 HG21 ' HB3' ' C' ' 113' ' ' CYS . 71.7 t -128.75 136.76 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.093 0.957 . . . . 75.33 108.895 175.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.627 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.1 mt-30 -116.37 87.73 2.75 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.048 -1.093 . . . . 72.12 108.048 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -78.8 102.53 8.2 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.517 -1.22 . . . . 65.32 110.139 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -84.32 -179.64 51.62 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 116.511 -0.313 . . . . 63.24 112.646 173.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.46 134.42 2.27 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-O 119.96 -0.356 . . . . 74.52 112.511 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.517 HG12 ' HE1' ' C' ' 17' ' ' TYR . 33.5 mm -88.66 127.53 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.336 -0.987 . . . . 75.41 108.336 173.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -129.35 140.01 51.52 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.371 0.668 . . . . 73.01 110.595 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 57.8 m -97.42 103.51 15.45 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.551 0.74 . . . . 54.02 109.492 170.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.66 HG21 ' HE1' ' C' ' 94' ' ' MET . 51.0 mt -116.71 135.15 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.639 0.776 . . . . 74.31 109.358 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.92 164.38 30.24 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.157 0.583 . . . . 72.05 110.783 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.46 -18.2 57.9 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.711 -0.677 . . . . 63.13 114.487 172.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' C' ' 94' ' ' MET . 40.3 pt -119.91 173.55 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-N 118.019 0.91 . . . . 73.51 112.948 -171.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -161.74 178.99 8.47 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 114.028 -1.442 . . . . 54.43 109.769 174.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.96 -124.27 31.96 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 115.072 0.789 . . . . 74.2 115.072 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 4.6 m -72.28 -27.6 62.58 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.004 0.922 . . . . 70.34 111.21 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -67.15 -47.77 70.04 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.493 0.717 . . . . 73.03 109.558 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.66 ' HE1' HG21 ' C' ' 86' ' ' ILE . 4.6 tpt -55.03 -49.26 72.01 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 114.936 -1.029 . . . . 72.24 111.43 169.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.71 -33.37 68.35 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.785 0.678 . . . . 72.11 111.439 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -77.35 -36.16 53.96 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.016 0.526 . . . . 73.13 111.795 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.4 ' SG ' HD13 ' C' ' 86' ' ' ILE . 30.2 t -67.06 -36.58 82.34 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.999 -0.741 . . . . 64.43 108.999 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 55.6 mt -86.96 -22.51 25.54 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.522 1.129 . . . . 73.32 111.439 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.91 -29.19 23.97 Favored Glycine 0 C--N 1.346 1.093 0 O-C-N 123.489 0.493 . . . . 71.32 113.962 -172.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.35 -56.0 0.85 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.854 0.462 . . . . 34.14 111.351 -171.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -63.87 -59.0 5.07 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 123.543 0.527 . . . . 70.03 111.74 -169.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.479 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 72.9 m -58.83 -49.93 90.72 Favored Pre-proline 0 CA--C 1.559 1.309 0 CA-C-O 118.241 -0.885 . . . . 54.1 111.9 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 52.7 Cg_exo -57.94 -33.56 97.28 Favored 'Trans proline' 0 C--N 1.393 2.903 0 C-N-CA 122.122 1.882 . . . . 32.13 113.54 174.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -70.74 -28.45 64.72 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.832 0.453 . . . . 71.04 110.833 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.614 HD12 HH12 ' A' ' 111' ' ' ARG . 33.0 mm -74.75 -37.39 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.004 0.522 . . . . 74.31 109.833 173.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 82.4 mt -73.01 -25.18 60.88 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.894 0.877 . . . . 54.13 112.038 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 107' ' ' PHE . . . . . 0.411 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 71.7 t80 -58.23 -52.6 73.38 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 117.717 -1.135 . . . . 74.2 113.813 -174.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 108' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 52.9 Cg_exo -55.3 -34.4 88.39 Favored 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 121.917 1.745 . . . . 74.14 113.258 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -74.82 -45.55 42.56 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.492 0.717 . . . . 63.11 111.264 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.77 -35.05 75.45 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.872 0.869 . . . . 71.13 110.325 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -64.23 -49.72 70.85 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.408 1.483 . . . . 75.14 110.481 178.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -68.48 -34.21 75.53 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.127 0.571 . . . . 75.0 110.571 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.634 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 18.1 m -60.18 -53.61 55.67 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.973 0.509 . . . . 72.23 111.124 174.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.641 HG21 HG21 ' C' ' 64' ' ' VAL . 98.6 mt -58.98 -50.43 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 123.494 0.496 . . . . 74.02 110.02 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.3 m -50.17 -44.91 52.94 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 124.36 1.037 . . . . 71.4 111.415 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.3 t -66.32 -43.15 87.01 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.232 -0.895 . . . . 53.32 109.786 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.8 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.1 OUTLIER -60.28 -46.19 90.71 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.226 1.01 . . . . 53.11 111.664 178.018 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.517 HG23 ' O ' ' C' ' 114' ' ' ILE . 61.4 t -60.88 -43.31 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.723 0.809 . . . . 61.3 109.482 177.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 13.5 t -63.26 -39.12 93.7 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.038 -1.437 . . . . 62.43 111.993 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -71.61 -37.15 70.98 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.342 0.657 . . . . 54.22 109.883 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.2 -4.08 67.25 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.982 0.801 . . . . 60.05 112.608 172.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.407 HG21 ' O ' ' D' ' 16' ' ' ILE . 24.9 p 65.61 26.19 11.6 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.527 1.931 . . . . 74.1 113.288 170.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -83.04 150.05 60.53 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 108.539 -0.912 . . . . 75.35 108.539 171.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -47.33 138.75 17.42 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 123.342 2.695 . . . . 54.33 113.02 174.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -57.26 145.78 30.73 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.196 0.935 . . . . 73.02 113.514 -171.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.564 HD21 ' HZ ' ' C' ' 74' ' ' PHE . 3.4 pp -147.47 119.12 7.99 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.182 -0.917 . . . . 62.31 109.133 173.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -113.72 115.11 27.31 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.352 -1.351 . . . . 73.24 107.352 176.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.477 HD23 HD23 ' C' ' 42' ' ' LEU . 6.0 mp -61.22 134.15 56.69 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 124.156 0.91 . . . . 70.44 111.321 -170.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.39 146.77 96.05 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 123.513 0.725 . . . . 73.33 110.59 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.611 ' HG2' HG21 ' A' ' 13' ' ' ILE . 46.0 Cg_exo -55.93 104.1 0.13 Allowed 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.584 2.189 . . . . 62.21 112.295 174.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 52.7 t -99.08 113.65 34.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.157 -1.053 . . . . 55.24 108.157 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -75.66 103.32 5.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.954 0.501 . . . . 53.13 110.124 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -62.8 -28.13 69.78 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.441 0.696 . . . . 71.51 111.185 177.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.38 -43.13 86.74 Favored 'General case' 0 C--N 1.349 0.572 0 O-C-N 123.726 0.641 . . . . 54.04 109.769 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.53 -40.31 71.67 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.186 0.994 . . . . 63.42 111.051 175.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 49.8 mt -76.46 -35.0 58.7 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.116 -0.947 . . . . 74.15 111.158 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 42.2 t80 . . . . . 0 N--CA 1.478 0.941 0 C-N-CA 122.922 0.489 . . . . 72.52 111.428 -177.745 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 27.2 p . . . . . 0 N--CA 1.464 0.246 0 N-CA-C 109.501 -0.555 . . . . 73.44 109.501 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -142.78 104.44 4.35 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.434 -1.321 . . . . 71.5 107.434 174.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.96 147.23 34.87 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.256 -0.646 . . . . 74.12 109.256 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mt -93.15 127.79 45.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.628 -1.249 . . . . 71.22 107.628 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 14' ' ' GLN . . . . . 0.628 ' HB2' HG23 ' D' ' 83' ' ' ILE . 34.5 mt-30 -90.51 -31.02 16.93 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 123.588 0.555 . . . . 73.35 110.041 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -167.57 131.05 1.72 Allowed 'General case' 0 C--N 1.347 0.487 0 CA-C-N 115.984 -0.553 . . . . 73.34 110.259 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.582 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.8 mp -103.57 140.69 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 106.662 -1.607 . . . . 71.45 106.662 171.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -165.01 141.08 5.58 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.46 0.573 . . . . 74.13 111.981 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.7 p -84.08 114.33 21.67 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.651 -0.704 . . . . 73.31 109.772 175.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.0 mtpt -83.81 -10.25 58.19 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.309 -0.859 . . . . 74.11 110.309 175.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.638 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 14.2 t70 -166.01 144.86 5.94 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.609 1.164 . . . . 43.14 108.907 176.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.8 HD13 ' HE3' ' C' ' 117' ' ' MET . 82.6 mt -139.81 145.56 26.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 125.267 1.427 . . . . 71.11 107.428 174.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -153.41 144.36 22.84 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 123.634 0.584 . . . . 73.23 110.522 176.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.402 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 73.7 t80 -153.4 129.43 10.32 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.063 -1.458 . . . . 71.51 107.063 171.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -140.61 119.16 12.3 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.325 0.65 . . . . 71.43 110.407 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.02 90.04 3.37 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 108.132 -1.062 . . . . 63.41 108.132 170.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.97 -42.71 2.96 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 123.582 2.855 . . . . 53.21 113.072 -171.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.417 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 13.3 m120 -96.81 20.9 10.26 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.491 0.716 . . . . 65.33 110.708 -176.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.6 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -40.13 -66.66 0.34 Allowed Pre-proline 0 CA--C 1.576 1.964 0 N-CA-C 116.109 1.892 . . . . 55.23 116.109 -155.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.516 ' HB3' HD11 ' C' ' 83' ' ' ILE . 66.9 Cg_endo -74.35 -22.49 16.3 Favored 'Trans proline' 0 C--N 1.393 2.881 0 CA-C-N 123.686 2.352 . . . . 55.33 113.712 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -70.97 -37.95 72.76 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.836 0.854 . . . . 73.53 110.079 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.524 HG23 ' HG3' ' D' ' 71' ' ' GLU . 5.1 p -83.85 -19.78 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 122.615 0.366 . . . . 60.54 111.392 -173.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.41 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 23.3 m-30 -64.12 -18.58 64.55 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 112.411 0.523 . . . . 73.22 112.411 173.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -57.6 -26.26 61.26 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.713 0.805 . . . . 64.2 110.696 172.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.456 ' CB ' ' HB3' ' D' ' 68' ' ' LEU . 28.8 mmtp -85.74 99.43 11.33 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.728 1.211 . . . . 74.33 109.233 174.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -94.58 85.11 4.42 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 122.726 0.411 . . . . 71.43 110.336 -178.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 39.6 p90 -167.68 179.73 4.69 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.216 1.006 . . . . 73.23 109.824 169.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -68.79 118.34 59.82 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.248 0.619 . . . . 74.32 110.045 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.61 124.94 16.91 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.863 2.375 . . . . 74.43 111.89 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -63.31 108.72 1.37 Allowed 'General case' 0 C--N 1.353 0.759 0 N-CA-C 109.285 -0.635 . . . . 75.03 109.285 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.703 HG13 HG13 ' D' ' 64' ' ' VAL . 73.4 t -100.07 131.56 47.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.258 -0.883 . . . . 61.12 108.878 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.07 149.13 31.23 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 107.815 -1.18 . . . . 43.13 107.815 169.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.453 HD11 HG13 ' D' ' 62' ' ' VAL . 37.1 tp -116.19 136.23 53.2 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 116.037 -0.529 . . . . 74.34 110.212 -177.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.56 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 0.6 OUTLIER -126.92 132.23 50.93 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 107.382 -1.34 . . . . 74.43 107.382 172.721 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.458 ' CD2' HG22 ' D' ' 62' ' ' VAL . 89.5 mt -125.18 130.81 52.89 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.093 0.473 . . . . 72.42 110.084 178.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -134.53 120.15 19.33 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.209 -1.404 . . . . 73.22 107.209 177.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 46' ' ' THR . . . . . 0.406 HG21 ' HG3' ' D' ' 103' ' ' PRO . 56.7 m -105.56 148.51 27.2 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.365 0.602 . . . . 63.13 110.266 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.27 -179.11 6.93 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.668 1.187 . . . . 73.53 108.721 173.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 25.8 p . . . . . 0 C--N 1.317 -0.824 0 N-CA-C 107.112 -1.44 . . . . 71.14 107.112 174.337 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 54' ' ' ASP . . . . . 0.598 ' N ' ' HH ' ' D' ' 56' ' ' TYR . 6.1 m-20 . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 114.372 1.249 . . . . 72.34 114.372 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 72.8 t -135.13 98.12 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 108.306 -0.998 . . . . 62.12 108.306 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.598 ' HH ' ' N ' ' D' ' 54' ' ' ASP . 4.4 m-85 -138.08 131.2 30.2 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.221 -0.659 . . . . 63.14 109.221 -174.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.48 118.51 36.91 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.026 -1.101 . . . . 65.33 108.026 170.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.405 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 85.7 t -101.9 141.29 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.771 0.828 . . . . 52.45 109.33 -177.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 15.3 t -121.63 131.45 73.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 124.2 1.0 . . . . 71.35 108.747 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.403 HD21 HD22 ' D' ' 44' ' ' LEU . 0.2 OUTLIER -106.19 122.94 47.22 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 107.244 -1.391 . . . . 74.52 107.244 176.186 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.499 ' HG2' ' HG2' ' D' ' 79' ' ' GLN . 0.0 OUTLIER -101.69 95.6 6.54 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 106.732 -1.581 . . . . 64.52 106.732 177.854 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.458 HG22 ' CD2' ' D' ' 44' ' ' LEU . 84.0 t -90.73 134.52 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 108.764 -0.828 . . . . 64.15 108.764 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.56 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 89.9 m -124.19 132.91 53.65 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 124.393 1.058 . . . . 73.42 109.246 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.703 HG13 HG13 ' D' ' 40' ' ' VAL . 73.5 t -127.31 130.3 70.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 124.671 1.188 . . . . 71.3 108.09 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 30.7 m -130.0 103.52 6.82 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.099 -1.074 . . . . 70.23 108.099 171.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.679 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -97.29 141.73 30.03 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.353 -0.84 . . . . 64.14 109.088 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.441 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 40.6 p -145.6 139.84 26.95 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.847 -0.615 . . . . 64.04 110.707 -172.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.456 ' HB3' ' CB ' ' D' ' 34' ' ' LYS . 31.7 mt -116.69 106.1 13.14 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.537 1.135 . . . . 61.21 108.832 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.4 -113.89 3.97 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 111.429 -0.668 . . . . 40.4 111.429 -173.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -121.06 23.2 10.73 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.531 0.732 . . . . 60.42 110.169 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 71' ' ' GLU . . . . . 0.524 ' HG3' HG23 ' D' ' 31' ' ' VAL . 12.9 pt-20 -134.74 158.1 45.01 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 121.698 -0.626 . . . . 61.32 110.416 175.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 40.5 m -75.41 124.29 26.88 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.236 -0.893 . . . . 75.02 111.89 -175.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.491 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -75.32 -69.96 0.45 Allowed 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.117 -1.068 . . . . 63.02 108.117 171.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -148.08 169.22 20.45 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.222 -0.899 . . . . 73.1 110.528 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 58.3 mt -130.38 151.18 51.15 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.103 -1.814 . . . . 52.41 106.103 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.661 ' SG ' HG12 ' D' ' 114' ' ' ILE . 12.0 t -159.17 128.22 5.35 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.561 -0.533 . . . . 71.33 109.561 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -150.7 121.44 7.53 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.611 0.244 . . . . 70.31 110.545 -171.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 93.7 t -131.6 126.87 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.696 0.798 . . . . 74.31 109.918 -171.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.638 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 44.3 mt-30 -91.6 89.02 6.98 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.679 -0.86 . . . . 72.41 108.679 166.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -87.34 98.14 11.19 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.357 -0.838 . . . . 64.23 109.359 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.07 165.0 23.92 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.797 -0.638 . . . . 74.13 112.69 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.67 137.57 4.72 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 111.642 -0.583 . . . . 42.31 111.642 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.628 HG23 ' HB2' ' D' ' 14' ' ' GLN . 8.4 tp -90.66 118.32 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 CA-C-O 121.568 0.699 . . . . 74.33 109.969 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.405 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 64.7 m-85 -112.99 138.91 49.15 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.624 1.17 . . . . 64.31 109.893 -178.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 23.7 t -115.49 104.36 11.67 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.639 -1.245 . . . . 42.43 107.639 169.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 50.2 pt -119.2 138.62 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.406 0.283 . . . . 62.41 110.466 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.89 169.01 22.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.432 1.093 . . . . 72.43 110.243 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.63 -13.68 66.76 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 114.519 0.568 . . . . 65.04 114.519 171.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.458 HD13 ' HG2' ' D' ' 94' ' ' MET . 0.8 OUTLIER -107.74 153.79 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.424 0.69 . . . . 73.0 110.781 -179.347 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -134.52 170.34 15.91 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.682 1.193 . . . . 65.14 109.818 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.34 -141.49 28.93 Favored Glycine 0 N--CA 1.472 1.074 0 O-C-N 123.271 0.357 . . . . 63.52 113.901 174.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 36.4 p -80.77 -43.81 19.57 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.355 0.662 . . . . 71.03 110.779 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -56.93 -26.95 60.44 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.196 0.998 . . . . 65.4 112.3 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.458 ' HG2' HD13 ' D' ' 89' ' ' ILE . 10.6 tmm? -59.15 -60.93 3.08 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 124.79 1.236 . . . . 74.42 112.103 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.91 -15.7 55.57 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.911 0.484 . . . . 64.33 111.345 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -66.35 -41.58 89.33 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.78 0.832 . . . . 74.25 109.851 175.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 73.0 m -60.65 -29.58 69.36 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.165 0.586 . . . . 43.55 111.406 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.594 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 18.5 tp -82.7 -43.26 17.07 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.06 0.544 . . . . 72.12 110.948 178.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.88 -21.83 73.29 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-N 115.682 -0.69 . . . . 74.2 113.661 -174.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -122.44 -56.55 1.79 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.241 0.616 . . . . 62.43 111.531 -174.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 101' ' ' TYR . . . . . 0.42 ' O ' HG12 ' D' ' 105' ' ' ILE . 31.6 t80 -73.28 -31.9 64.33 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 112.001 0.371 . . . . 74.3 112.001 -172.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.594 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 84.4 m -65.82 -49.89 56.79 Favored Pre-proline 0 CA--C 1.566 1.588 0 CA-C-O 118.309 -0.853 . . . . 74.22 112.334 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.406 ' HG3' HG21 ' D' ' 46' ' ' THR . 33.4 Cg_endo -65.13 -23.83 59.98 Favored 'Trans proline' 0 C--N 1.389 2.683 0 C-N-CA 121.753 1.635 . . . . 65.55 113.259 171.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.34 -36.28 83.62 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.694 -0.484 . . . . 72.33 109.694 174.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.42 HG12 ' O ' ' D' ' 101' ' ' TYR . 28.8 mm -70.13 -40.47 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.743 1.217 . . . . 74.24 111.012 175.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 55.4 mt -70.17 -20.36 63.14 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 116.017 -0.538 . . . . 63.33 111.617 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -68.84 -43.95 29.04 Favored Pre-proline 0 CA--C 1.56 1.334 0 N-CA-C 113.997 1.11 . . . . 75.34 113.997 -173.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 108' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' D' ' 105' ' ' ILE . 71.4 Cg_exo -45.93 -43.0 20.21 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 122.53 2.153 . . . . 62.34 113.732 168.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -80.53 -29.85 37.17 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.683 0.793 . . . . 74.51 112.206 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.93 -49.87 64.14 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.586 0.708 . . . . 74.45 109.397 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.541 HH12 ' HB3' ' D' ' 130' ' ' PRO . 34.4 ttp180 -63.0 -34.73 78.19 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 113.843 -1.526 . . . . 74.4 110.756 174.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 112' ' ' GLU . . . . . 0.482 ' HA ' ' CE2' ' B' ' 109' ' ' TYR . 9.5 tt0 -55.14 -54.2 46.25 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.625 0.77 . . . . 55.3 111.351 177.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.0 t -59.28 -46.24 89.06 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.726 -1.125 . . . . 75.03 110.508 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.661 HG12 ' SG ' ' D' ' 76' ' ' CYS . 74.9 mt -60.95 -56.5 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.411 1.084 . . . . 75.54 111.785 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 95.5 m -55.02 -40.95 70.75 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.823 1.249 . . . . 54.4 111.693 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 42.7 t -69.53 -27.95 65.61 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.435 -0.802 . . . . 33.34 111.327 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.602 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 76.8 mtm -84.33 -30.12 25.77 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.174 0.59 . . . . 73.22 111.873 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.421 HG23 ' O ' ' D' ' 114' ' ' ILE . 61.0 t -66.33 -39.38 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.725 0.81 . . . . 72.44 110.656 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.7 p -66.62 -27.29 67.58 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 115.652 -0.704 . . . . 72.43 110.678 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.634 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 64.3 mtt-85 -80.61 -16.25 54.56 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.775 0.83 . . . . 74.54 111.582 177.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.3 4.71 74.15 Favored Glycine 0 C--N 1.352 1.468 0 CA-C-O 119.621 -0.544 . . . . 54.21 113.156 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.555 HG23 ' HB3' ' C' ' 17' ' ' TYR . 81.0 p 56.17 27.67 11.95 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.874 1.669 . . . . 71.14 113.003 -174.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -95.08 149.62 36.5 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 123.121 0.568 . . . . 64.35 109.533 172.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -50.4 146.96 17.69 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 123.174 2.583 . . . . 70.43 113.966 171.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 41.2 tp60 -47.64 124.18 6.8 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.28 1.832 . . . . 73.43 112.911 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.561 HD13 HG21 ' D' ' 40' ' ' VAL . 13.0 tp -107.24 117.72 34.81 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.535 -0.913 . . . . 74.31 108.535 175.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -121.12 100.09 6.86 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.62 -1.252 . . . . 70.21 107.62 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.405 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 90.1 mt -65.21 120.09 12.08 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 109.411 -0.588 . . . . 72.43 109.411 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.87 122.96 69.49 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 122.839 0.455 . . . . 72.3 110.599 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.541 ' HB3' HH12 ' D' ' 111' ' ' ARG . 60.1 Cg_endo -71.42 114.31 3.89 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.395 2.063 . . . . 70.44 111.44 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 12.3 p -108.43 150.08 11.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 123.461 0.704 . . . . 73.0 109.276 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -79.03 109.53 13.43 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.116 -0.698 . . . . 73.03 109.116 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 . . . . . 0 N--CA 1.483 1.208 0 C-N-CA 123.725 0.81 . . . . 75.41 110.904 179.111 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 76.2 m . . . . . 0 C--O 1.239 0.552 0 N-CA-C 107.611 -1.255 . . . . 71.43 107.611 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -100.27 116.29 31.91 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.881 -1.155 . . . . 64.01 107.881 174.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.5 tp60 -133.99 132.91 40.68 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.541 -0.911 . . . . 74.22 108.541 174.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.2 mt -91.17 119.84 39.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.233 -1.025 . . . . 75.3 108.233 175.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.54 -41.73 21.2 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.044 -0.725 . . . . 74.22 109.044 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -170.38 131.43 0.95 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.885 0.474 . . . . 72.03 110.049 -169.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.4 mt -117.46 131.22 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 108.492 -0.929 . . . . 64.2 108.492 173.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.452 ' HE1' HG13 ' A' ' 83' ' ' ILE . 27.2 p90 -161.78 177.85 9.51 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 123.952 0.783 . . . . 72.15 111.52 -173.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.6 p -107.09 126.29 52.17 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.438 -0.579 . . . . 63.44 109.438 173.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.448 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 44.4 mtpt -86.14 -33.44 20.87 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.623 -0.51 . . . . 74.03 109.623 175.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -148.15 142.95 26.75 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.632 -1.167 . . . . 61.02 109.874 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.458 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 81.7 mt -142.02 142.3 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.821 1.249 . . . . 53.4 108.23 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -149.42 121.5 8.29 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.03 0.532 . . . . 64.25 109.797 173.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.594 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 86.0 t80 -116.37 141.94 47.5 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.315 -1.365 . . . . 72.01 107.315 168.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 26.9 mt-10 -136.39 143.14 43.84 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.998 0.519 . . . . 74.25 109.834 175.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.17 75.74 10.53 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 107.427 -1.323 . . . . 73.45 107.427 170.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.83 -33.01 44.86 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.767 2.311 . . . . 71.05 112.267 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -100.86 15.5 28.26 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 114.682 -1.145 . . . . 71.32 110.171 -176.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.59 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -41.18 -56.19 4.45 Favored Pre-proline 0 N--CA 1.496 1.859 0 CA-C-O 117.698 -1.144 . . . . 53.03 113.477 -170.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -61.78 -32.43 85.99 Favored 'Trans proline' 0 C--N 1.391 2.783 0 CA-C-N 121.524 1.58 . . . . 74.03 112.788 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -75.96 -46.02 31.88 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.126 -0.943 . . . . 71.15 111.096 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.836 HG21 ' HA ' ' A' ' 73' ' ' ALA . 10.0 p -76.77 -14.8 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 124.111 0.964 . . . . 74.54 112.771 -160.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -69.02 -20.09 64.13 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.842 0.457 . . . . 55.4 111.439 171.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -82.81 -22.43 34.18 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.494 1.117 . . . . 75.52 111.016 174.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 71' ' ' GLU . 24.8 mmmt -67.1 154.61 40.81 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.235 1.014 . . . . 71.1 112.172 -178.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -74.92 125.55 29.1 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.286 -0.87 . . . . 72.04 109.259 173.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -77.71 88.33 3.97 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.605 0.717 . . . . 71.11 110.604 -174.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -117.14 83.51 15.51 Favored Pre-proline 0 N--CA 1.472 0.672 0 N-CA-C 106.313 -1.736 . . . . 64.12 106.313 170.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.8 93.85 0.87 Allowed 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 121.678 1.586 . . . . 71.52 111.151 -175.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -93.68 83.87 4.53 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 105.751 -1.944 . . . . 72.21 105.751 175.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 66' ' ' ALA . 42.7 t -91.68 117.84 35.82 Favored 'Isoleucine or valine' 0 C--N 1.342 0.279 0 CA-C-N 113.573 -1.649 . . . . 61.33 110.456 -168.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.601 ' HE2' ' HB2' ' A' ' 43' ' ' ASP . 85.6 tttt -79.28 121.59 25.28 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.932 -0.766 . . . . 43.21 108.932 169.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.0 mt -101.38 106.54 17.71 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.267 -1.012 . . . . 74.33 108.267 169.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.601 ' HB2' ' HE2' ' A' ' 41' ' ' LYS . 16.5 t70 -106.1 136.8 45.15 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.167 -1.42 . . . . 74.44 107.167 175.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.587 HD22 HD21 ' A' ' 60' ' ' LEU . 87.1 mt -130.56 134.3 46.91 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.22 0.533 . . . . 64.45 110.784 -174.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 21.3 t70 -134.48 146.78 50.08 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.63 1.172 . . . . 74.44 108.331 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.8 m -136.47 127.29 27.42 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.991 0.516 . . . . 53.11 109.633 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.62 110.53 9.95 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.555 0.742 . . . . 54.44 109.987 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 61.4 p -102.17 153.98 19.44 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.773 0.429 . . . . 74.43 110.747 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.3 t -150.78 125.13 9.47 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.65 0.78 . . . . 51.02 109.044 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -72.24 105.96 4.24 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.712 -0.477 . . . . 64.22 109.712 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.632 HD11 ' HB2' ' A' ' 57' ' ' GLU . 76.3 mt -78.83 -38.49 37.9 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.051 0.54 . . . . 65.33 109.902 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.65 176.21 11.99 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.455 1.102 . . . . 54.34 109.253 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -68.13 123.19 19.99 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 108.667 -0.864 . . . . 75.14 108.667 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 66.54 20.09 10.84 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.466 1.106 . . . . 71.44 111.793 -174.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.2 t -132.17 105.19 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 107.734 -1.21 . . . . 72.35 107.734 172.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -123.15 126.4 46.94 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.716 -0.846 . . . . 71.11 108.716 -177.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.632 ' HB2' HD11 ' A' ' 51' ' ' LEU . 33.9 tt0 -84.7 149.34 25.86 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.014 -0.736 . . . . 71.25 109.014 171.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.516 HG11 ' HD3' ' A' ' 103' ' ' PRO . 73.8 t -131.48 138.68 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 C-N-CA 124.364 1.066 . . . . 74.1 108.19 169.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.41 135.74 57.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.806 -0.812 . . . . 54.25 108.806 174.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.587 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -110.19 99.35 8.43 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 106.796 -1.557 . . . . 74.34 106.796 172.037 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.473 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 30.4 ttp180 -87.11 100.56 12.74 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.086 -1.079 . . . . 62.52 108.086 173.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 32.0 t -95.29 134.56 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 108.222 -1.029 . . . . 61.14 108.222 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.548 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 9.4 m -121.89 125.14 45.75 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.078 -0.712 . . . . 65.25 109.078 174.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.477 ' O ' HD12 ' A' ' 75' ' ' LEU . 70.4 t -121.81 120.02 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 124.456 1.103 . . . . 50.44 109.156 -174.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.6 m -128.54 116.6 19.91 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.406 0.548 . . . . 71.22 109.867 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.444 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -102.94 113.07 26.22 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 107.838 -1.171 . . . . 65.1 107.838 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 46.3 m -108.89 128.52 54.99 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.21 0.604 . . . . 72.32 110.012 177.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.432 HD11 ' HB2' ' A' ' 73' ' ' ALA . 19.6 mt -95.84 77.76 3.22 Favored 'General case' 0 C--O 1.247 0.961 0 C-N-CA 124.365 1.066 . . . . 22.5 108.566 -178.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.99 -85.69 0.89 Allowed Glycine 0 C--N 1.344 0.998 0 CA-C-N 115.376 -0.829 . . . . 62.21 111.764 -174.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -112.62 -30.92 6.93 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.844 0.857 . . . . 70.53 110.354 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.474 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 7.6 tp10 -101.98 119.07 38.19 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.858 0.463 . . . . 62.21 110.26 -170.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 88.2 m -70.99 135.59 47.93 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 122.809 0.443 . . . . 43.33 111.176 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.836 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -77.06 -64.42 1.14 Allowed 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.333 1.053 . . . . 50.31 110.135 175.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -151.08 170.39 19.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.751 0.786 . . . . 63.44 112.786 -177.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 64' ' ' VAL . 62.5 tp -123.92 144.94 49.48 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 113.809 -1.541 . . . . 71.13 107.911 169.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.44 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.1 m -146.44 102.5 3.59 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.722 0.809 . . . . 72.34 109.268 176.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 37.4 tt0 -119.5 116.31 25.83 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.311 0.644 . . . . 72.52 109.276 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 113' ' ' CYS . 39.4 t -127.31 113.68 33.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.221 1.008 . . . . 41.14 109.629 -174.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -85.27 87.24 7.36 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.539 -0.912 . . . . 74.22 108.539 171.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -76.44 92.8 3.43 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.453 -0.794 . . . . 74.35 109.173 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.74 146.13 19.79 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-N 115.703 -0.681 . . . . 74.23 111.467 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.27 122.67 1.68 Allowed Glycine 0 CA--C 1.503 -0.708 0 N-CA-C 110.258 -1.137 . . . . 61.45 110.258 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.492 HG23 HD12 ' A' ' 51' ' ' LEU . 49.0 mt -81.81 129.23 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.578 -1.267 . . . . 70.22 107.578 172.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.638 ' HB3' HD11 ' A' ' 86' ' ' ILE . 92.9 m-85 -130.46 134.5 47.14 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.326 -0.99 . . . . 71.1 108.326 -176.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.3 t -98.31 99.9 11.14 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.928 -1.138 . . . . 52.15 107.928 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.638 HD11 ' HB3' ' A' ' 84' ' ' PHE . 20.0 mm -120.35 129.86 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.235 0.614 . . . . 75.23 110.632 -169.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.41 173.26 12.44 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.964 0.905 . . . . 64.31 110.567 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.56 -32.1 7.12 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 116.309 -0.405 . . . . 63.12 112.925 175.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -122.39 159.98 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.942 0.897 . . . . 71.54 110.447 -176.056 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.464 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 19.7 tt0 -150.24 -179.29 7.07 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 108.886 -0.783 . . . . 63.21 108.886 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.464 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 59.3 -125.77 40.47 Favored Glycine 0 C--N 1.348 1.2 0 N-CA-C 114.547 0.579 . . . . 74.32 114.547 176.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.2 t -70.58 -27.14 63.89 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.116 0.566 . . . . 54.21 111.503 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -73.05 -36.14 66.84 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.96 0.904 . . . . 75.35 110.002 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.4 tpt -65.43 -46.42 80.0 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-N 115.381 -0.827 . . . . 73.05 109.628 175.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.4 -34.71 75.81 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.447 -0.797 . . . . 75.34 111.357 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.441 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 39.5 t-80 -71.92 -32.97 67.89 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.462 0.705 . . . . 61.12 111.426 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -71.64 -44.8 63.7 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.019 0.438 . . . . 73.25 109.854 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 76.2 mt -80.73 -32.37 35.73 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.496 -0.775 . . . . 73.3 112.193 -173.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.42 3.49 59.65 Favored Glycine 0 N--CA 1.469 0.856 0 CA-C-O 119.591 -0.56 . . . . 44.12 113.736 -174.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.676 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.16 -62.61 0.26 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.664 0.616 . . . . 64.22 112.664 -174.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -68.05 -44.59 76.04 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 120.827 0.346 . . . . 65.55 111.572 -172.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 99.3 m -69.13 -47.38 29.15 Favored Pre-proline 0 CA--C 1.563 1.457 0 C-N-CA 124.086 0.954 . . . . 55.15 112.936 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.516 ' HD3' HG11 ' A' ' 58' ' ' VAL . 44.8 Cg_endo -66.89 -19.24 52.66 Favored 'Trans proline' 0 C--N 1.395 3.025 0 CA-C-N 121.694 1.641 . . . . 34.13 112.755 173.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -70.86 -38.18 73.13 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.021 0.528 . . . . 73.41 109.951 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 38.7 mm -64.22 -42.91 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.896 0.879 . . . . 72.23 110.155 171.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.408 ' HB2' ' HA ' ' A' ' 103' ' ' PRO . 49.5 mt -73.92 -22.73 59.57 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.325 -0.852 . . . . 74.34 112.289 -174.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -61.57 -46.64 93.97 Favored Pre-proline 0 N--CA 1.486 1.33 0 N-CA-C 114.416 1.265 . . . . 74.13 114.416 -172.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -52.89 -35.84 72.18 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 121.784 1.656 . . . . 74.31 113.045 172.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -79.88 -36.94 35.84 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.946 0.898 . . . . 60.11 111.877 -177.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.76 -49.6 65.42 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 109.161 -0.681 . . . . 53.34 109.161 176.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.4 HH12 HD12 ' C' ' 105' ' ' ILE . 32.5 ttm180 -50.17 -45.92 53.75 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.905 1.378 . . . . 72.32 110.218 173.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -62.94 -52.21 63.91 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.836 0.71 . . . . 54.0 111.504 -177.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.498 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 52.6 t -59.43 -34.78 72.91 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.827 0.704 . . . . 73.32 111.588 -178.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.572 HD13 HD11 ' A' ' 128' ' ' LEU . 24.4 mt -66.7 -59.27 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.691 0.796 . . . . 72.22 109.952 173.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 94.6 m -53.51 -37.65 62.98 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.829 1.252 . . . . 74.13 111.696 -174.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.2 t -69.62 -42.63 74.09 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 114.232 -1.349 . . . . 60.21 109.889 -178.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.594 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 35.3 mtm -65.69 -35.57 81.14 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.492 0.317 . . . . 63.05 110.998 176.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 114' ' ' ILE . 85.5 t -58.82 -49.42 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.892 0.877 . . . . 72.31 109.536 175.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.5 p -76.93 -27.97 55.07 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.644 -0.707 . . . . 71.23 111.725 -175.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -73.77 -28.96 61.93 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.48 0.712 . . . . 45.43 109.46 174.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.461 ' O ' HG22 ' A' ' 122' ' ' THR . . . -86.29 12.25 61.07 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.956 0.785 . . . . 73.41 112.557 171.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.3 t 63.2 11.5 5.37 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 127.127 2.171 . . . . 72.23 114.23 173.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -77.35 148.25 77.14 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 109.492 -0.559 . . . . 64.32 109.492 176.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.9 128.1 27.42 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.788 2.326 . . . . 74.14 111.93 175.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -46.85 125.43 7.36 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.804 1.315 . . . . 63.33 112.404 -171.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 61.0 tp -106.77 137.33 45.0 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.625 -0.88 . . . . 70.45 108.625 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -129.7 113.95 15.39 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.802 -1.185 . . . . 72.13 107.802 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.572 HD11 HD13 ' A' ' 114' ' ' ILE . 7.4 mt -70.57 133.08 46.41 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.951 -0.759 . . . . 74.35 108.951 -176.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.55 136.66 94.59 Favored Pre-proline 0 CA--C 1.552 1.049 0 CA-C-O 118.997 -0.525 . . . . 43.31 111.047 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -55.72 109.88 0.48 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.272 2.648 . . . . 72.31 113.558 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.488 HG21 HD11 ' A' ' 44' ' ' LEU . 58.9 t -98.43 133.05 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.07 0.462 . . . . 74.55 110.215 -175.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -92.15 80.04 5.09 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.597 -1.183 . . . . 75.34 109.049 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -57.35 -35.52 70.02 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.179 0.992 . . . . 74.25 111.615 175.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.676 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 24.1 t70 -54.29 -47.78 72.01 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 124.373 1.046 . . . . 74.54 111.095 175.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.41 -42.02 83.94 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.953 0.783 . . . . 72.03 111.083 176.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 92.5 mt -54.48 -41.28 69.34 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.067 0.547 . . . . 74.13 111.224 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 33.6 t80 . . . . . 0 CA--C 1.541 0.624 0 CA-C-N 115.591 -0.731 . . . . 74.41 110.253 176.527 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 18.7 ptm . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 114.776 1.398 . . . . 75.13 114.776 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 5.2 t -135.08 130.09 35.01 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 106.627 -1.62 . . . . 63.1 106.627 167.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.47 ' HD1' HG22 ' B' ' 86' ' ' ILE . 87.9 t80 -135.02 145.44 48.05 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.141 0.576 . . . . 71.34 110.016 -171.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -151.13 140.04 20.95 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.021 0.929 . . . . 74.41 109.121 171.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 49.8 mt -87.78 127.21 41.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.077 -1.083 . . . . 65.43 108.077 170.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -84.03 -49.21 9.14 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 109.187 -0.672 . . . . 65.23 109.187 176.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.401 ' HE ' ' CG2' ' A' ' 122' ' ' THR . 48.4 ttt180 -170.31 134.54 1.19 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.314 -0.857 . . . . 72.13 110.231 -172.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 91.4 mt -114.82 137.62 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 107.673 -1.232 . . . . 73.55 107.673 175.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -161.96 142.09 10.21 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.097 0.475 . . . . 65.2 111.537 -172.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.605 HG21 HD11 ' B' ' 21' ' ' ILE . 18.9 m -77.65 126.62 31.16 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 108.57 -0.9 . . . . 55.31 108.57 171.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.59 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 42.3 mtpt -99.57 -18.35 17.41 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.969 0.907 . . . . 73.33 111.798 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -161.31 138.73 8.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.9 0.48 . . . . 73.11 110.82 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.605 HD11 HG21 ' B' ' 18' ' ' THR . 47.0 mm -126.97 143.23 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.399 1.08 . . . . 43.23 108.331 168.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 27.9 t -144.79 119.81 10.03 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.227 -1.027 . . . . 63.24 108.227 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.458 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 82.9 t80 -132.1 116.46 17.06 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.808 -1.182 . . . . 72.23 107.808 173.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -123.01 113.89 19.67 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.87 0.868 . . . . 73.32 109.124 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -107.55 87.21 3.27 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 106.82 -1.548 . . . . 64.43 106.82 166.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.73 -26.41 45.56 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 122.559 2.173 . . . . 64.33 111.778 -173.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.446 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 72.2 m-20 -110.13 10.57 23.91 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 118.048 -0.977 . . . . 72.34 110.901 -177.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.473 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -33.71 -64.28 0.28 Allowed Pre-proline 0 N--CA 1.502 2.13 0 C-N-CA 124.955 1.302 . . . . 74.3 114.07 -171.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 11.9 Cg_exo -64.5 -29.75 61.8 Favored 'Trans proline' 0 C--N 1.396 3.041 0 C-N-CA 122.27 1.98 . . . . 74.34 112.889 -171.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -95.14 -26.49 15.99 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.848 0.859 . . . . 73.03 111.993 -171.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.487 HG21 ' HA ' ' B' ' 73' ' ' ALA . 4.8 p -82.43 -14.57 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 C-N-CA 122.678 0.391 . . . . 71.13 110.756 -176.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -68.39 -9.88 51.28 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 113.378 0.881 . . . . 65.52 113.378 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -71.37 -13.0 61.72 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 122.907 0.483 . . . . 75.3 110.8 173.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.427 ' HB2' HD13 ' B' ' 68' ' ' LEU . 89.3 mttt -103.21 81.57 1.97 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.597 1.159 . . . . 74.42 109.582 -175.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -88.48 74.86 8.48 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.453 -0.794 . . . . 62.35 110.077 -176.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -153.17 179.1 9.03 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.819 -0.628 . . . . 73.34 109.66 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -71.06 110.15 6.69 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.057 0.943 . . . . 74.11 109.283 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -71.54 145.97 48.5 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 121.956 1.771 . . . . 75.32 111.274 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 9.8 tp10 -64.56 102.09 0.52 Allowed 'General case' 0 C--N 1.343 0.321 0 N-CA-C 108.068 -1.086 . . . . 60.33 108.068 173.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.678 HG11 HD11 ' B' ' 126' ' ' LEU . 23.4 t -98.6 154.49 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 108.771 -0.826 . . . . 73.14 108.771 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -145.11 130.07 18.33 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.447 -0.946 . . . . 71.11 108.447 170.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.534 HD11 ' CG1' ' B' ' 62' ' ' VAL . 14.8 tp -86.21 138.21 32.05 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.491 -0.929 . . . . 63.34 108.491 170.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -137.0 117.02 13.29 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.933 -1.136 . . . . 64.35 107.933 -177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 4.4 mp -99.91 128.06 46.03 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.464 -0.939 . . . . 75.12 108.464 -171.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -132.17 143.87 50.27 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.325 -0.62 . . . . 73.31 109.325 175.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 18.5 p -128.91 125.86 38.46 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.472 0.709 . . . . 71.13 109.979 -174.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.415 ' O ' ' HB ' ' B' ' 59' ' ' VAL . . . -147.41 125.99 12.5 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 107.72 -1.215 . . . . 73.34 107.72 175.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 35.8 m -130.18 -179.01 4.99 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.085 0.554 . . . . 75.53 110.498 -176.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.8 p -152.17 135.64 16.05 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.916 -0.772 . . . . 72.2 108.916 172.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -91.83 119.14 31.36 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.286 -1.005 . . . . 71.5 108.286 170.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 pp -130.56 16.61 5.37 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.094 0.958 . . . . 53.44 110.077 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.19 157.8 36.51 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 123.583 0.753 . . . . 72.42 110.388 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -89.24 136.35 33.07 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 107.755 -1.202 . . . . 71.53 107.755 163.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 71.97 4.35 4.99 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.793 1.237 . . . . 73.14 111.852 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.625 HG22 ' HA ' ' B' ' 85' ' ' SER . 25.6 t -146.53 129.05 8.24 Favored 'Isoleucine or valine' 0 C--N 1.355 0.838 0 C-N-CA 124.08 0.952 . . . . 74.44 109.691 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.468 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 0.4 OUTLIER -113.53 163.53 14.8 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 108.713 -0.847 . . . . 74.41 108.713 166.38 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -119.92 107.23 12.87 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.287 -1.375 . . . . 61.3 107.287 177.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 65.8 t -100.42 125.21 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.714 0.805 . . . . 24.31 110.145 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.494 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.2 t -107.52 112.16 38.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 108.723 -0.843 . . . . 71.24 108.723 174.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 62.0 tp -93.92 112.58 24.45 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.633 -0.506 . . . . 71.5 109.633 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -95.76 106.06 18.14 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.482 0.713 . . . . 74.24 109.275 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.534 ' CG1' HD11 ' B' ' 42' ' ' LEU . 45.0 t -105.81 111.16 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 108.399 -0.963 . . . . 60.34 108.399 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 21.0 m -108.45 135.68 49.33 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.879 0.871 . . . . 71.51 109.965 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.739 HG11 HD21 ' B' ' 126' ' ' LEU . 44.4 t -129.36 115.69 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.945 1.298 . . . . 75.05 109.592 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 64.2 m -103.3 138.94 39.4 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.805 -0.813 . . . . 72.12 108.805 171.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -145.61 143.19 29.72 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.995 0.518 . . . . 64.32 109.776 176.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.549 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 67.4 p -141.5 131.81 25.07 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.546 -0.752 . . . . 71.33 110.913 -175.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.427 HD13 ' HB2' ' B' ' 34' ' ' LYS . 61.7 mt -100.49 111.55 23.82 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.556 1.142 . . . . 72.43 108.522 174.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.01 -128.63 11.06 Favored Glycine 0 C--N 1.342 0.887 0 O-C-N 123.436 0.46 . . . . 44.51 112.634 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -90.5 2.51 55.66 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.95 0.9 . . . . 73.25 112.207 -176.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.446 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 12.6 pt-20 -137.84 157.25 46.81 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.768 0.427 . . . . 74.2 111.565 -169.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.5 m -69.1 128.43 36.63 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.435 -0.802 . . . . 61.43 110.938 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.549 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -79.96 -64.02 1.28 Allowed 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.565 -1.272 . . . . 74.41 107.565 174.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -150.52 158.48 44.2 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 114.83 -1.077 . . . . 74.32 111.687 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 95.8 mt -125.27 113.34 17.48 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 106.333 -1.729 . . . . 61.41 106.333 172.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 27.0 t -118.28 146.35 44.37 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.915 -1.143 . . . . 40.23 107.915 175.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -161.62 126.76 3.53 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.254 -1.017 . . . . 62.45 108.254 -176.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.2 t -124.54 148.29 28.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.007 0.923 . . . . 54.43 108.729 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -121.95 96.82 5.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.226 -1.027 . . . . 74.23 108.226 169.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.429 ' HG3' HD22 ' B' ' 106' ' ' LEU . 53.8 tp60 -89.19 101.34 14.0 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.992 -0.744 . . . . 74.25 108.992 177.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.29 170.75 37.68 Favored Glycine 0 C--N 1.339 0.698 0 O-C-N 123.523 0.514 . . . . 72.42 112.017 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.99 132.76 2.5 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.512 -0.375 . . . . 64.53 112.659 -176.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 79.4 mt -91.26 111.11 23.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 108.001 -1.111 . . . . 62.32 108.001 173.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -113.34 133.8 54.95 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.104 0.562 . . . . 72.51 109.933 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.625 ' HA ' HG22 ' B' ' 55' ' ' VAL . 66.9 m -95.56 122.06 37.92 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.015 0.926 . . . . 70.25 109.319 175.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.47 HG22 ' HD1' ' B' ' 11' ' ' PHE . 0.2 OUTLIER -138.36 134.32 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.991 0.917 . . . . 74.54 110.599 -173.377 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.93 171.08 20.69 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.534 1.134 . . . . 64.32 108.191 169.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.9 -43.14 3.06 Favored Glycine 0 N--CA 1.469 0.878 0 N-CA-C 111.991 -0.444 . . . . 42.1 111.991 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.628 ' HB ' ' HA ' ' B' ' 94' ' ' MET . 9.4 pt -58.34 143.46 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.42 0.688 . . . . 73.32 110.802 171.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -161.26 152.68 18.97 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 123.858 0.724 . . . . 73.14 110.813 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.65 -133.88 13.3 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.625 -0.716 . . . . 75.5 111.854 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 2.8 m -67.15 -44.03 80.82 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.666 0.787 . . . . 65.41 110.326 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -67.3 -18.93 65.38 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.048 -1.433 . . . . 74.15 111.757 -168.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.628 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 17.7 tmm? -68.14 -66.36 0.58 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.155 0.982 . . . . 72.41 111.56 -174.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 95' ' ' ALA . . . . . 0.408 ' O ' ' HG ' ' B' ' 98' ' ' LEU . . . -80.76 -9.36 59.81 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 120.857 0.36 . . . . 71.41 111.909 177.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -60.99 -31.74 71.34 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 122.866 0.467 . . . . 53.23 110.807 164.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.6 t -61.39 -40.45 94.39 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.831 0.852 . . . . 75.32 112.411 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' B' ' 95' ' ' ALA . 4.1 pp -69.69 -22.92 63.38 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.895 0.478 . . . . 65.33 112.001 177.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.05 -12.75 51.62 Favored Glycine 0 C--N 1.348 1.209 0 O-C-N 123.309 0.381 . . . . 75.44 113.797 -177.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.86 -57.67 1.04 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 117.364 0.582 . . . . 44.23 112.047 -173.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -75.16 -46.58 33.32 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.144 0.578 . . . . 73.31 111.615 -169.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.468 ' SG ' ' HE1' ' B' ' 56' ' ' TYR . 78.4 m -65.99 -47.18 63.93 Favored Pre-proline 0 CA--C 1.561 1.394 0 CA-C-O 118.459 -0.781 . . . . 61.01 112.595 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.96 -26.87 66.45 Favored 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 121.735 1.623 . . . . 71.3 112.746 172.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.42 -37.11 82.31 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.127 0.571 . . . . 73.33 110.868 175.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 66.7 mt -71.85 -44.49 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.758 0.823 . . . . 72.34 110.322 176.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.429 HD22 ' HG3' ' B' ' 80' ' ' GLN . 86.9 mt -78.47 -17.31 56.48 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.166 -0.924 . . . . 73.44 112.509 -171.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.422 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 55.4 t80 -63.33 -50.82 72.45 Favored Pre-proline 0 CA--C 1.55 0.957 0 CA-C-O 117.953 -1.022 . . . . 75.31 112.728 -176.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.597 ' HG2' ' HB2' ' D' ' 108' ' ' PRO . 93.6 Cg_exo -50.84 -42.58 50.87 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.261 1.974 . . . . 64.03 114.185 174.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -66.74 -44.44 81.5 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.361 0.665 . . . . 74.23 111.364 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.17 -37.2 83.34 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.676 -0.693 . . . . 73.23 110.995 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 60.7 ttt-85 -62.18 -51.54 67.43 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.341 1.456 . . . . 63.2 110.203 177.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -62.41 -36.8 83.48 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.238 0.961 . . . . 73.22 110.448 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.537 ' SG ' HD11 ' B' ' 21' ' ' ILE . 1.9 t -73.84 -30.2 62.55 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.018 0.127 . . . . 71.13 111.085 -177.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.569 HD13 HG23 ' B' ' 64' ' ' VAL . 41.8 mt -66.29 -55.82 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.679 0.791 . . . . 73.24 109.008 172.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.531 HG21 ' OG ' ' C' ' 119' ' ' SER . 31.9 m -62.08 -26.51 68.32 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 114.928 -1.033 . . . . 71.02 111.577 -177.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.3 t -61.65 -53.75 51.94 Favored 'General case' 0 C--N 1.347 0.458 0 N-CA-C 109.295 -0.631 . . . . 74.24 109.295 174.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.8 mmt -70.22 -30.81 67.98 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.599 0.76 . . . . 74.52 111.331 -174.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 68.8 t -66.41 -44.34 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.339 1.056 . . . . 52.2 110.271 172.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.1 t -67.28 -31.36 71.63 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.226 -0.897 . . . . 62.14 110.045 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.498 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 75.6 mtt-85 -68.44 -41.06 80.86 Favored 'General case' 0 C--O 1.211 -0.948 0 CA-C-N 115.818 -0.628 . . . . 73.23 109.561 176.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.97 -11.86 70.52 Favored Glycine 0 C--N 1.357 1.729 0 O-C-N 123.647 0.592 . . . . 71.43 112.628 171.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 11.3 m 67.11 30.74 7.2 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 125.51 1.524 . . . . 54.13 110.407 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -77.49 165.69 49.67 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-N 115.189 -0.914 . . . . 73.0 111.085 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -48.23 151.07 4.65 Favored 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 123.257 2.638 . . . . 41.42 113.52 173.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.563 ' HB2' ' H ' ' C' ' 125' ' ' GLN . 29.2 tp60 -61.71 114.89 3.56 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.055 0.542 . . . . 71.41 111.572 -172.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.739 HD21 HG11 ' B' ' 64' ' ' VAL . 34.7 tp -108.79 110.35 21.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.888 -1.051 . . . . 73.14 108.656 -177.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -121.77 116.89 25.31 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.049 -1.093 . . . . 73.34 108.049 176.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 73.3 mt -75.37 144.75 42.13 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 120.909 0.385 . . . . 73.1 111.541 -175.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.85 151.62 82.31 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 124.481 1.112 . . . . 72.25 110.708 -177.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.439 ' HG3' HD13 ' D' ' 16' ' ' ILE . 3.8 Cg_endo -80.23 84.53 2.0 Allowed 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.843 2.362 . . . . 74.13 110.666 -177.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 p -89.07 111.32 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 N-CA-C 108.714 -0.847 . . . . 74.52 108.714 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 43.5 t30 . . . . . 0 N--CA 1.472 0.628 0 CA-C-N 115.521 -0.763 . . . . 61.02 109.539 -176.951 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 61.7 t80 . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.358 -0.608 . . . . 75.43 109.358 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -150.53 135.24 17.4 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.821 0.848 . . . . 53.23 108.884 169.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 53.4 mt -77.22 119.11 25.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 107.655 -1.239 . . . . 70.23 107.655 166.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -84.56 -43.08 14.84 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.7 -0.852 . . . . 75.33 108.7 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.97 158.31 0.55 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.195 1.398 . . . . 71.04 109.44 176.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.427 ' O ' HD12 ' C' ' 16' ' ' ILE . 2.0 pp -128.68 141.52 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.382 -1.34 . . . . 74.04 107.382 175.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.443 ' HB3' HG23 ' D' ' 122' ' ' THR . 17.7 p90 -170.52 157.57 5.96 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.284 0.564 . . . . 73.04 111.694 -168.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 66.5 p -80.33 113.31 18.42 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.982 -0.554 . . . . 75.0 109.639 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -34.6 71.58 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 108.04 -1.096 . . . . 75.04 108.04 171.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.5 t70 -151.24 145.55 25.45 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.372 -1.285 . . . . 53.22 110.385 -175.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.577 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.4 mt -139.82 147.42 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.9 1.68 . . . . 73.24 106.778 175.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -159.42 150.03 19.39 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.046 0.45 . . . . 73.02 110.217 171.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -151.12 135.89 17.24 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 107.454 -1.313 . . . . 61.3 107.454 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -136.0 124.73 23.86 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.888 0.475 . . . . 75.43 109.878 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.16 75.55 77.85 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 107.76 -1.2 . . . . 54.41 107.76 162.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -74.92 -10.01 21.14 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.291 1.994 . . . . 64.22 111.677 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -106.17 13.15 29.35 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.803 1.241 . . . . 71.12 109.798 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.98 -57.0 7.78 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 115.078 1.51 . . . . 73.0 115.078 -165.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -64.34 -41.14 22.01 Favored 'Trans proline' 0 C--N 1.378 2.116 0 CA-C-N 121.813 1.683 . . . . 60.43 112.177 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -68.67 -34.31 75.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.36 1.064 . . . . 52.3 111.702 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.93 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.1 p -79.67 -27.43 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 CA-C-N 116.147 -0.479 . . . . 60.32 111.877 -178.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -69.79 -31.51 69.47 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 111.598 0.221 . . . . 63.32 111.598 174.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -96.49 30.78 2.45 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.203 0.601 . . . . 72.11 110.552 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.75 167.44 10.48 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.315 1.046 . . . . 71.1 109.334 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -75.99 120.64 21.59 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.538 -0.541 . . . . 70.34 109.538 171.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -85.23 89.28 7.61 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.73 0.812 . . . . 74.35 110.857 -174.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -131.09 80.61 68.59 Favored Pre-proline 0 N--CA 1.481 1.109 0 C-N-CA 123.999 0.92 . . . . 71.45 108.839 167.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -71.8 111.41 3.14 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.292 1.994 . . . . 62.42 110.814 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -83.02 91.72 7.23 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 104.522 -2.399 . . . . 73.24 104.522 170.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.487 HG21 HD11 ' C' ' 126' ' ' LEU . 62.0 t -75.28 140.59 17.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 113.623 -1.626 . . . . 74.43 110.729 -167.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -128.36 103.16 7.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.352 1.061 . . . . 71.3 108.766 171.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 87.0 mt -85.3 150.06 25.03 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.929 0.892 . . . . 74.43 108.74 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.426 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 31.6 t70 -143.64 141.93 30.8 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.296 0.638 . . . . 63.21 109.613 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 47.9 mt -132.42 133.18 43.58 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.192 0.997 . . . . 62.23 109.116 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -143.23 123.44 13.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.801 -1.555 . . . . 74.43 106.801 175.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 46' ' ' THR . . . . . 0.429 ' OG1' ' HG3' ' C' ' 103' ' ' PRO . 15.0 t -118.42 130.47 55.99 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.471 0.653 . . . . 72.13 109.418 176.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.35 153.41 29.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.177 -0.92 . . . . 53.4 109.095 176.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 37.2 p -146.64 143.0 28.48 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.862 -0.792 . . . . 75.51 108.862 175.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 45.9 t -156.89 135.82 11.78 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.163 0.585 . . . . 70.1 109.487 -177.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -79.48 116.82 19.93 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.764 -0.828 . . . . 72.22 108.764 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.602 HD11 ' HB2' ' C' ' 57' ' ' GLU . 63.4 mt -84.75 -34.94 22.75 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.613 0.765 . . . . 73.22 110.616 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.67 -176.02 5.63 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.143 -0.935 . . . . 44.3 109.868 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -58.44 108.61 0.65 Allowed 'General case' 0 C--O 1.242 0.674 0 O-C-N 124.122 0.889 . . . . 73.22 109.695 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 54' ' ' ASP . . . . . 0.585 ' HB3' ' HB2' ' C' ' 87' ' ' ALA . 16.9 m-20 66.2 24.63 10.74 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 124.311 1.007 . . . . 74.45 111.853 175.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.7 t -122.24 118.97 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 108.835 -0.802 . . . . 43.1 108.835 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -120.6 125.44 47.76 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.082 0.953 . . . . 73.34 109.997 -176.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.602 ' HB2' HD11 ' C' ' 51' ' ' LEU . 36.2 tt0 -84.71 131.99 34.51 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.531 -0.915 . . . . 73.51 108.531 166.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.484 HG11 ' HD3' ' C' ' 103' ' ' PRO . 61.3 t -122.45 123.05 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.08 -1.081 . . . . 73.14 108.08 168.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.574 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 73.5 t -108.84 145.44 15.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.19 -0.67 . . . . 65.01 109.19 174.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.06 101.27 7.44 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.651 -1.241 . . . . 75.13 107.651 174.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 35.9 ttm-85 -79.98 106.29 11.89 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.068 -1.086 . . . . 72.41 108.068 169.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.446 ' HB ' HD11 ' C' ' 114' ' ' ILE . 16.0 t -107.17 123.9 62.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.731 -1.211 . . . . 54.45 107.731 172.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 12.5 m -122.83 116.19 23.27 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.721 -0.844 . . . . 55.45 108.721 -176.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.415 HG21 HG21 ' C' ' 114' ' ' ILE . 73.8 t -111.35 110.69 33.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 124.463 1.105 . . . . 41.53 108.767 -174.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.4 m -99.67 139.28 35.56 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 115.356 -0.838 . . . . 71.21 108.88 175.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.45 105.23 6.81 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.093 -1.447 . . . . 74.42 107.093 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.0 m -123.33 135.28 54.12 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 108.179 -1.045 . . . . 45.02 108.179 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 36.2 mt -84.13 25.98 0.79 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.474 1.11 . . . . 63.25 110.714 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.76 -91.75 0.8 Allowed Glycine 0 C--N 1.357 1.722 0 N-CA-C 111.041 -0.823 . . . . 72.43 111.041 -177.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -89.11 -31.33 18.05 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.587 0.755 . . . . 73.34 110.261 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -89.34 124.06 34.08 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.819 1.248 . . . . 74.5 109.466 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.0 m -80.93 126.45 31.39 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.603 -0.888 . . . . 73.41 108.603 166.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.93 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -78.47 -55.81 4.93 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.42 -0.585 . . . . 72.14 109.42 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -159.01 166.05 32.64 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.665 0.745 . . . . 62.41 112.16 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.413 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.1 tm? -130.05 143.14 50.63 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 106.683 -1.599 . . . . 75.24 106.683 167.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.413 ' N ' HD13 ' C' ' 75' ' ' LEU . 48.5 t -149.87 112.08 4.65 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.661 -0.496 . . . . 52.03 109.661 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -116.68 124.61 50.14 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.219 -0.66 . . . . 54.41 109.219 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 49.4 t -122.97 115.07 44.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.77 -0.826 . . . . 72.2 108.77 172.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.468 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.1 mt-30 -93.86 87.69 5.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.046 0.938 . . . . 74.41 109.209 175.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -80.2 101.56 8.91 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.855 -1.066 . . . . 63.31 109.976 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -100.66 150.2 18.73 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-O 121.143 0.302 . . . . 35.01 112.746 177.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.7 132.51 4.78 Favored Glycine 0 CA--C 1.501 -0.798 0 N-CA-C 110.756 -0.937 . . . . 45.55 110.756 -175.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 34.7 mm -90.87 128.14 42.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 108.531 -0.915 . . . . 73.13 108.531 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -136.15 119.39 16.68 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.609 -0.885 . . . . 71.03 108.609 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 33.3 p -78.49 102.26 7.76 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.472 -0.936 . . . . 75.13 108.472 173.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.549 HD13 ' SG ' ' C' ' 97' ' ' CYS . 5.7 mt -116.07 140.32 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 122.832 0.453 . . . . 63.1 110.073 -176.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' C' ' 54' ' ' ASP . . . -160.35 172.07 17.97 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.777 0.831 . . . . 60.04 110.732 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.99 -47.19 3.5 Favored Glycine 0 C--N 1.345 1.062 0 O-C-N 123.896 0.747 . . . . 73.54 111.61 175.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.423 HD11 ' HE3' ' C' ' 94' ' ' MET . 41.7 pt -83.1 146.77 6.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 123.64 0.776 . . . . 63.1 111.154 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -149.38 -179.13 6.83 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.907 0.883 . . . . 75.32 109.595 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.57 -126.94 30.89 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-O 119.603 -0.554 . . . . 63.03 112.107 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.6 -26.0 62.41 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.269 0.627 . . . . 50.53 111.611 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 93' ' ' GLN . . . . . 0.419 ' HB3' ' HB ' ' C' ' 89' ' ' ILE . 97.8 mt-30 -65.42 -60.77 2.6 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.527 0.331 . . . . 74.21 110.266 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.423 ' HE3' HD11 ' C' ' 89' ' ' ILE . 1.8 tpt -54.93 -48.36 73.24 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 123.796 0.685 . . . . 65.1 112.152 173.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.2 -40.2 76.92 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.728 0.642 . . . . 75.24 111.608 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -83.46 -23.34 32.28 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.403 0.681 . . . . 71.1 111.638 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.549 ' SG ' HD13 ' C' ' 86' ' ' ILE . 34.3 t -69.56 -37.89 77.19 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 108.354 -0.98 . . . . 73.1 108.354 175.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.421 ' HG ' ' HE2' ' C' ' 94' ' ' MET . 76.9 mt -81.1 -31.81 34.13 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.972 -1.013 . . . . 74.13 110.801 174.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 99' ' ' GLY . . . . . 0.418 ' HA3' ' CE2' ' C' ' 137' ' ' PHE . . . -78.05 -28.88 55.52 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.163 -0.926 . . . . 74.34 114.755 -168.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.99 -47.57 0.09 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.469 0.544 . . . . 73.52 112.469 -167.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.47 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 70.3 t80 -56.05 -59.3 5.11 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.345 0.658 . . . . 73.32 111.772 -176.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 88.6 m -63.66 -46.01 82.7 Favored Pre-proline 0 CA--C 1.566 1.582 0 C-N-CA 124.173 0.989 . . . . 73.32 111.691 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.484 ' HD3' HG11 ' C' ' 58' ' ' VAL . 96.0 Cg_exo -49.67 -36.11 40.24 Favored 'Trans proline' 0 C--N 1.395 2.997 0 C-N-CA 123.088 2.525 . . . . 35.33 114.832 168.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -67.97 -31.98 72.08 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.477 0.711 . . . . 62.02 111.249 177.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.4 HD12 HH12 ' A' ' 111' ' ' ARG . 32.2 mm -69.66 -38.78 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 109.185 -0.672 . . . . 64.14 109.185 175.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 53.5 mt -78.82 -34.4 45.27 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.262 1.025 . . . . 71.21 112.516 -174.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -54.46 -47.11 98.64 Favored Pre-proline 0 N--CA 1.484 1.24 0 N-CA-C 114.238 1.199 . . . . 74.32 114.238 -170.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.48 -39.06 58.54 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.167 1.912 . . . . 72.53 113.345 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -68.5 -40.42 80.9 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.278 0.631 . . . . 64.41 110.793 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.28 -41.86 99.04 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.16 -0.927 . . . . 73.33 109.866 174.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 111' ' ' ARG . . . . . 0.407 ' HA ' HD21 ' C' ' 128' ' ' LEU . 56.2 ttt180 -60.71 -49.35 77.86 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.936 1.294 . . . . 73.34 110.61 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.27 -40.88 90.42 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.724 0.64 . . . . 74.22 109.943 -176.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 49.4 t -68.83 -34.88 76.22 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.504 0.503 . . . . 74.44 111.986 -176.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.446 HD11 ' HB ' ' C' ' 62' ' ' VAL . 97.0 mt -69.43 -52.33 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.443 0.697 . . . . 72.12 110.363 175.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.4 m -67.95 -27.23 66.43 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 122.974 0.509 . . . . 53.14 111.254 -175.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 40.4 t -62.97 -47.06 84.81 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.971 0.908 . . . . 63.44 109.367 170.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.553 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.86 -38.68 91.79 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.433 1.093 . . . . 74.23 112.125 178.227 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 98.9 t -58.39 -45.79 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.462 0.705 . . . . 60.43 109.685 173.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.531 ' OG ' HG21 ' B' ' 115' ' ' THR . 28.9 t -68.76 -31.65 70.84 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.836 -1.074 . . . . 71.44 112.268 -178.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.446 HH12 ' HG2' ' D' ' 112' ' ' GLU . 73.0 mtt-85 -69.47 -40.4 77.11 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.162 -0.681 . . . . 65.02 109.162 177.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.56 -1.07 86.01 Favored Glycine 0 C--N 1.356 1.683 0 O-C-N 123.983 0.802 . . . . 62.42 112.66 172.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.3 p 65.46 25.61 11.89 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 126.819 2.048 . . . . 50.24 114.075 169.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -83.67 143.83 44.53 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 109.313 -0.625 . . . . 75.12 109.313 174.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.408 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 78.0 Cg_exo -45.61 135.9 12.63 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 123.459 2.773 . . . . 75.04 113.055 171.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.563 ' H ' ' HB2' ' B' ' 125' ' ' GLN . 36.8 mm-40 -44.07 112.82 0.44 Allowed 'General case' 0 N--CA 1.483 1.211 0 O-C-N 124.882 1.364 . . . . 72.4 111.934 -174.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.487 HD11 HG21 ' C' ' 40' ' ' VAL . 20.2 tp -108.18 83.94 1.86 Allowed 'General case' 0 C--O 1.239 0.525 0 N-CA-C 106.565 -1.643 . . . . 63.4 106.565 170.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -97.54 94.52 7.05 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 114.357 -1.292 . . . . 73.32 108.378 -170.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.577 HD23 ' H ' ' C' ' 128' ' ' LEU . 1.5 pt? -56.3 139.09 49.41 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.089 0.956 . . . . 65.02 111.967 -175.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.51 150.83 64.19 Favored Pre-proline 0 CA--C 1.548 0.891 0 CA-C-N 114.759 -1.109 . . . . 64.14 110.945 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.41 113.7 1.8 Allowed 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.852 2.368 . . . . 75.42 112.674 175.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 49.0 t -99.31 118.39 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 107.676 -1.231 . . . . 64.24 107.676 171.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -71.84 103.44 3.15 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.265 0.626 . . . . 61.24 110.42 -175.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -62.64 -31.46 72.32 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.253 1.021 . . . . 73.31 111.944 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -66.36 -37.66 85.81 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.278 0.631 . . . . 74.53 110.685 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.92 86.56 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.516 0.726 . . . . 64.0 110.373 175.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 98.4 mt -64.94 -35.34 80.83 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.925 -1.034 . . . . 72.22 110.889 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 137' ' ' PHE . . . . . 0.418 ' CE2' ' HA3' ' C' ' 99' ' ' GLY . 3.4 t80 . . . . . 0 C--O 1.238 0.463 0 CA-C-N 115.95 -0.568 . . . . 74.32 111.307 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 8.2 t . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 120.975 0.417 . . . . 60.34 109.942 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.531 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 49.9 t80 -135.3 91.01 2.68 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 106.781 -1.563 . . . . 65.34 106.781 176.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -121.2 126.8 50.54 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.474 0.71 . . . . 63.42 109.252 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mt -96.21 132.77 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 107.84 -1.17 . . . . 73.22 107.84 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -104.09 -19.58 14.12 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 119.116 -0.468 . . . . 70.2 111.417 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.416 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 41.1 ttt180 -172.29 131.92 0.62 Allowed 'General case' 0 C--N 1.36 1.042 0 N-CA-C 112.065 0.395 . . . . 73.33 112.065 -176.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.439 HD13 ' HG3' ' B' ' 130' ' ' PRO . 2.6 mp -110.41 134.95 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 106.842 -1.54 . . . . 64.51 106.842 170.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.416 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 22.2 p90 -158.16 140.28 14.14 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 123.521 0.513 . . . . 64.31 111.685 -177.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -78.6 113.17 16.4 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.498 -0.774 . . . . 75.35 109.668 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -85.76 -11.24 54.06 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.602 -0.726 . . . . 75.11 109.9 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.651 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.4 t70 -165.54 145.25 6.59 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.594 1.158 . . . . 53.41 109.846 177.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.553 HD13 ' HE3' ' C' ' 117' ' ' MET . 66.4 mt -148.41 148.23 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 125.622 1.569 . . . . 74.43 107.695 175.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.1 t -154.98 146.24 22.89 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.356 1.062 . . . . 53.3 109.092 171.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.577 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 92.0 t80 -143.61 126.32 16.07 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 106.669 -1.604 . . . . 71.51 106.669 169.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 47.9 mt-10 -121.16 142.73 49.61 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.549 0.74 . . . . 73.53 109.227 175.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.433 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -138.69 75.51 37.1 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 107.018 -1.475 . . . . 60.01 107.018 169.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -71.99 -19.93 26.09 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.453 2.102 . . . . 72.54 112.772 -171.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -110.7 3.98 19.69 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.655 0.782 . . . . 74.24 111.153 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.452 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -27.33 -70.63 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 116.805 2.15 . . . . 64.24 116.805 -167.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.32 -19.46 15.17 Favored 'Trans proline' 0 C--N 1.388 2.618 0 CA-C-N 124.036 2.477 . . . . 52.44 114.011 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -74.5 -39.6 62.32 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.045 0.938 . . . . 53.52 109.816 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' D' ' 73' ' ' ALA . 9.3 p -82.98 -16.25 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 CA-C-N 116.065 -0.516 . . . . 75.1 111.101 -171.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -68.42 -13.42 62.28 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.07 0.767 . . . . 75.55 113.07 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -60.34 -27.29 67.24 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.788 0.835 . . . . 72.4 110.713 173.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -91.78 88.13 6.55 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.494 1.518 . . . . 71.14 110.179 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -83.11 90.92 7.12 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.221 -0.9 . . . . 72.22 110.682 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 40.7 p90 -165.4 172.01 12.72 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.138 0.975 . . . . 75.43 109.29 166.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -70.58 111.27 9.02 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.644 0.778 . . . . 62.01 109.321 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.44 128.47 30.23 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 122.937 2.424 . . . . 63.51 112.058 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.74 113.1 5.23 Favored 'General case' 0 C--O 1.24 0.566 0 O-C-N 123.773 0.671 . . . . 74.25 109.462 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.925 HG13 HG13 ' D' ' 64' ' ' VAL . 78.7 t -98.53 107.13 19.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-N 115.343 -0.844 . . . . 72.54 110.102 -174.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -87.65 111.04 20.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 105.693 -1.965 . . . . 64.11 105.693 165.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.441 HD11 HG13 ' D' ' 62' ' ' VAL . 49.7 tp -95.52 143.44 26.84 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.498 -0.927 . . . . 64.51 108.498 -172.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.613 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 15.8 m-20 -120.02 117.01 26.88 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.688 -1.226 . . . . 74.42 107.688 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.404 ' CD2' HG22 ' D' ' 62' ' ' VAL . 23.4 mt -116.31 131.0 57.06 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.048 0.452 . . . . 65.12 110.014 177.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -143.99 145.2 32.06 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.246 -1.02 . . . . 71.34 108.246 171.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 46' ' ' THR . . . . . 0.409 HG21 ' O ' ' D' ' 99' ' ' GLY . 22.8 p -104.6 170.57 7.81 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.105 0.562 . . . . 64.43 110.493 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -166.35 163.08 17.49 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.463 1.105 . . . . 62.55 108.621 172.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 53.7 p . . . . . 0 C--O 1.245 0.861 0 N-CA-C 108.147 -1.057 . . . . 61.42 108.147 169.62 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.498 1.95 0 N-CA-C 113.586 0.958 . . . . 73.34 113.586 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 p -109.24 94.54 3.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 107.305 -1.368 . . . . 51.21 107.305 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -122.18 128.3 51.05 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.676 -0.861 . . . . 73.12 108.676 -171.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -85.89 152.99 22.53 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 107.318 -1.364 . . . . 73.14 107.318 162.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 53.3 t -130.16 138.57 53.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.302 -1.37 . . . . 64.1 107.302 165.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.471 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 32.3 t -126.11 130.12 72.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 108.249 -1.019 . . . . 71.23 108.249 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.595 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -109.02 119.96 41.1 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 106.824 -1.547 . . . . 72.44 106.824 178.722 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -99.36 97.99 8.97 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.384 -0.969 . . . . 72.01 108.384 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.441 HG13 HD11 ' D' ' 42' ' ' LEU . 31.9 t -101.82 117.14 46.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.291 -0.868 . . . . 74.14 108.713 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.613 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 22.6 m -126.7 119.14 26.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.382 0.673 . . . . 73.33 109.25 -173.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.925 HG13 HG13 ' D' ' 40' ' ' VAL . 55.1 t -100.89 124.16 54.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 123.715 0.806 . . . . 63.43 110.022 -177.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 28.4 m -114.69 96.19 5.61 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.239 -1.022 . . . . 71.23 108.239 170.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.604 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -106.69 142.56 36.13 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.482 -0.781 . . . . 71.51 110.076 -175.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.52 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 48.9 m -139.75 141.64 36.83 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.441 0.638 . . . . 73.44 112.258 -173.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.442 HD12 HG22 ' D' ' 31' ' ' VAL . 46.7 mt -111.57 114.71 27.96 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.32 -1.309 . . . . 73.41 107.642 170.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.52 -131.73 22.09 Favored Glycine 0 C--N 1.341 0.835 0 O-C-N 123.155 0.284 . . . . 60.42 112.768 -176.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.84 1.61 55.38 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.942 0.497 . . . . 75.41 111.41 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -119.15 164.66 15.24 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.751 0.42 . . . . 71.31 110.366 -175.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 98.8 m -67.82 131.59 45.82 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.06 -0.973 . . . . 73.13 110.998 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.581 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -84.9 -63.49 1.32 Allowed 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.698 -1.223 . . . . 51.41 107.698 170.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -152.05 148.82 28.14 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 114.587 -1.188 . . . . 62.13 110.607 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.446 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 82.6 mt -109.65 154.12 23.27 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.454 1.102 . . . . 74.3 108.27 170.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.542 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 43.0 t -157.9 148.62 20.86 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.316 -0.624 . . . . 52.41 109.316 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -155.6 131.45 9.91 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.313 0.645 . . . . 41.44 109.796 174.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -135.13 113.82 16.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 108.267 -1.012 . . . . 74.54 108.267 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.651 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.8 mt-30 -89.54 83.88 6.35 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.239 -1.023 . . . . 74.41 108.239 169.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -80.31 96.87 6.77 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 113.734 -1.575 . . . . 64.32 109.377 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.25 168.51 35.23 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.689 -0.687 . . . . 73.14 112.468 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.02 138.09 4.75 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 110.707 -0.957 . . . . 53.11 110.707 173.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.99 123.97 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 N-CA-C 108.549 -0.908 . . . . 60.41 108.549 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -115.13 125.73 53.81 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.681 1.192 . . . . 72.31 110.002 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 35.0 m -87.87 95.08 9.97 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 108.513 -0.921 . . . . 41.45 108.513 168.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 37.0 pt -109.78 142.7 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.415 -0.587 . . . . 75.43 109.415 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.63 166.94 9.82 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.933 0.893 . . . . 64.24 110.378 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.23 22.75 56.46 Favored Glycine 0 C--N 1.352 1.448 0 O-C-N 123.517 0.51 . . . . 52.35 113.796 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.581 ' HB ' ' HB3' ' D' ' 94' ' ' MET . 0.2 OUTLIER -120.33 148.97 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 124.187 0.995 . . . . 75.43 109.668 -179.068 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -129.06 -178.3 4.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.79 0.836 . . . . 64.52 109.904 -175.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.58 -142.58 47.05 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.363 -0.835 . . . . 53.14 112.63 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.2 p -90.81 -14.72 31.38 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.649 0.779 . . . . 74.41 111.267 173.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -56.38 -34.1 66.37 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.356 1.062 . . . . 72.34 112.247 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.581 ' HB3' ' HB ' ' D' ' 89' ' ' ILE . 0.0 OUTLIER -62.57 -43.5 98.65 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.306 0.642 . . . . 64.13 112.049 -179.426 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 95' ' ' ALA . . . . . 0.453 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.05 -22.92 28.8 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.384 0.674 . . . . 54.0 111.862 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -74.93 -38.4 61.78 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.734 -0.469 . . . . 73.43 109.734 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 73.7 m -73.05 -26.7 61.38 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.493 0.717 . . . . 70.41 110.888 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 53.2 tp -63.89 -43.63 95.44 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.711 0.804 . . . . 65.32 110.319 175.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 99' ' ' GLY . . . . . 0.409 ' O ' HG21 ' D' ' 46' ' ' THR . . . -94.56 -12.05 56.28 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 119.298 -0.723 . . . . 62.32 114.381 -175.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.04 -58.34 1.88 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 118.439 1.12 . . . . 70.23 112.341 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -74.57 -41.73 60.01 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.224 0.453 . . . . 75.41 112.224 -172.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.531 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 75.5 m -61.46 -47.52 93.17 Favored Pre-proline 0 CA--C 1.568 1.636 0 C-N-CA 123.383 0.673 . . . . 70.22 111.69 178.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.595 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 53.2 Cg_exo -61.63 -31.24 86.63 Favored 'Trans proline' 0 C--N 1.39 2.718 0 C-N-CA 122.344 2.029 . . . . 65.12 113.795 170.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -63.0 -33.33 75.19 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.022 0.529 . . . . 64.2 110.843 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.4 mm -67.22 -42.08 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.776 0.83 . . . . 73.31 110.49 173.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 54.0 mt -76.18 -11.35 59.91 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.357 -0.838 . . . . 73.23 111.638 -175.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -70.63 -44.81 17.42 Favored Pre-proline 0 CA--C 1.558 1.282 0 N-CA-C 114.086 1.143 . . . . 72.43 114.086 -172.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 108' ' ' PRO . . . . . 0.597 ' HB2' ' HG2' ' B' ' 108' ' ' PRO . 29.1 Cg_endo -61.97 -32.07 84.42 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 121.649 1.566 . . . . 75.35 112.469 172.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 109' ' ' TYR . . . . . 0.415 ' O ' ' HB3' ' D' ' 112' ' ' GLU . 62.5 m-85 -72.82 -31.69 64.99 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.752 0.821 . . . . 73.22 111.634 175.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.98 -48.08 72.43 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.437 0.637 . . . . 75.4 109.334 175.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 33.2 ttp180 -65.66 -31.92 73.21 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.174 -1.375 . . . . 54.21 110.858 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 112' ' ' GLU . . . . . 0.446 ' HG2' HH12 ' C' ' 120' ' ' ARG . 16.0 tt0 -53.17 -52.63 58.17 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.343 1.057 . . . . 72.4 110.317 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.9 t -69.51 -47.59 63.31 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.511 -1.222 . . . . 74.31 111.061 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.52 HG21 HG21 ' D' ' 64' ' ' VAL . 63.4 mt -62.37 -58.23 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.346 0.658 . . . . 75.22 111.062 -176.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 86.0 m -52.84 -39.57 62.64 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.107 0.879 . . . . 74.23 111.564 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 43.4 t -65.19 -45.11 86.14 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.128 -0.942 . . . . 52.0 110.121 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.452 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 79.0 mtm -66.31 -32.87 74.54 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.198 0.599 . . . . 75.43 111.959 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.428 HG23 ' O ' ' D' ' 114' ' ' ILE . 92.5 t -62.79 -48.47 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.616 0.767 . . . . 75.15 109.794 175.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 96.4 p -71.24 -27.67 63.63 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.593 -0.731 . . . . 74.45 110.787 -178.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' D' ' 116' ' ' SER . 90.4 mtt-85 -69.64 -33.76 73.08 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.541 0.736 . . . . 72.24 109.936 174.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.46 9.16 71.71 Favored Glycine 0 C--N 1.355 1.624 0 O-C-N 123.578 0.548 . . . . 62.33 112.933 176.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.443 HG23 ' HB3' ' C' ' 17' ' ' TYR . 82.1 p 56.51 36.56 27.76 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.93 1.692 . . . . 74.11 113.631 177.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -98.62 149.63 35.93 Favored Pre-proline 0 C--O 1.243 0.754 0 N-CA-C 108.557 -0.905 . . . . 73.34 108.557 171.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -45.58 131.1 12.44 Favored 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 123.308 2.672 . . . . 63.22 112.616 172.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -52.95 130.88 34.92 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 124.344 1.027 . . . . 75.5 111.479 -172.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.516 HD13 HG21 ' D' ' 40' ' ' VAL . 10.1 tp -105.71 98.61 8.28 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.182 -0.917 . . . . 72.42 108.603 -173.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -100.51 78.61 2.02 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.94 -1.133 . . . . 63.33 107.94 177.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.06 132.33 48.29 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 109.791 -0.448 . . . . 52.3 109.791 -175.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.77 144.03 97.99 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 123.815 0.846 . . . . 75.41 111.425 -174.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.65 132.63 46.67 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.635 2.223 . . . . 65.45 111.945 176.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 73.6 t -107.48 128.63 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.729 -0.841 . . . . 73.34 108.729 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -85.59 97.84 10.31 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.657 0.783 . . . . 70.21 108.997 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 . . . . . 0 N--CA 1.487 1.424 0 C-N-CA 124.658 1.183 . . . . 51.35 112.229 -173.621 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.7 m . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 107.352 -1.351 . . . . 72.34 107.352 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -129.49 113.91 15.46 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.068 -1.086 . . . . 64.42 108.068 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -134.08 118.44 17.74 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.016 -0.735 . . . . 65.35 109.016 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.471 HG21 ' HG2' ' C' ' 130' ' ' PRO . 43.4 mt -80.69 119.82 31.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 109.362 -0.607 . . . . 64.11 109.362 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -85.83 -38.78 17.76 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 123.607 0.567 . . . . 60.32 110.163 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -173.52 129.26 0.43 Allowed 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.599 -0.273 . . . . 65.21 110.365 -170.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.497 HD12 ' HG3' ' C' ' 130' ' ' PRO . 87.0 mt -119.79 134.02 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 108.235 -1.024 . . . . 53.2 108.235 173.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.435 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 36.8 p90 -162.27 168.1 22.87 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 124.036 0.835 . . . . 73.43 110.87 -170.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -89.78 119.49 30.21 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.665 -0.865 . . . . 62.31 108.665 172.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 32.8 mtpt -78.97 -26.33 43.44 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.736 -0.468 . . . . 74.24 109.736 172.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -159.08 146.31 17.31 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.292 1.037 . . . . 62.12 109.614 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.8 mt -135.85 146.36 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.092 1.357 . . . . 72.04 107.836 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.0 t -148.01 131.95 17.15 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 109.059 -0.719 . . . . 64.33 109.059 171.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 89.3 t80 -137.09 127.75 27.02 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 106.988 -1.486 . . . . 72.32 106.988 171.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -134.5 129.18 34.76 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.009 0.523 . . . . 74.41 109.856 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.93 75.21 79.84 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.479 -1.304 . . . . 73.43 107.479 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.49 -28.0 32.67 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.713 2.275 . . . . 54.34 112.377 -172.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -104.8 15.38 27.96 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.203 -0.908 . . . . 75.41 110.154 -177.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.563 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -43.85 -56.41 7.48 Favored Pre-proline 0 N--CA 1.494 1.763 0 N-CA-C 113.996 1.11 . . . . 71.21 113.996 -169.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 70.8 Cg_exo -54.98 -35.22 89.38 Favored 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 122.515 2.143 . . . . 71.04 113.607 176.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -78.36 -42.47 30.36 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.508 0.723 . . . . 73.22 110.042 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.1 p -67.05 -27.57 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 114.593 -1.185 . . . . 74.42 111.951 -159.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -72.99 -29.33 62.96 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.952 -0.567 . . . . 74.11 110.767 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -75.1 -24.29 58.08 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.239 1.016 . . . . 71.14 110.888 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -77.24 152.28 34.76 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.853 0.861 . . . . 35.34 110.707 -175.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.83 118.29 7.0 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.752 0.657 . . . . 54.33 109.623 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -83.82 85.06 7.35 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.679 0.752 . . . . 72.35 110.991 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -121.01 84.05 38.69 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 107.001 -1.481 . . . . 74.52 107.001 170.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.45 116.89 4.63 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.361 2.041 . . . . 62.45 111.982 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -96.38 101.79 13.48 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.319 -0.993 . . . . 75.31 108.319 174.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 t -97.39 108.1 21.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 114.818 -1.083 . . . . 70.14 110.796 -169.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -83.65 119.94 25.37 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.747 0.819 . . . . 72.5 109.035 170.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.6 tp -97.25 106.53 18.88 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.371 -0.974 . . . . 54.41 108.371 175.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.472 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.4 m-20 -107.92 148.52 29.53 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.373 1.069 . . . . 72.22 108.77 176.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.728 HD11 HG21 ' A' ' 131' ' ' VAL . 92.6 mt -137.68 154.91 49.62 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.306 0.642 . . . . 42.03 111.246 -175.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.606 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 6.8 m-20 -137.72 141.29 41.02 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.166 -1.379 . . . . 61.53 108.113 175.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.3 m -141.0 123.16 15.64 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.249 -0.649 . . . . 64.1 109.249 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.75 138.16 23.06 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.505 0.722 . . . . 64.33 109.511 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.8 m -90.57 165.77 13.57 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.078 0.551 . . . . 75.25 109.56 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.2 t -154.69 119.48 4.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.398 -0.964 . . . . 54.21 108.398 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -85.15 103.33 14.04 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.953 -1.129 . . . . 72.11 107.953 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 57' ' ' GLU . 83.4 mt -77.9 -40.1 40.97 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.12 0.568 . . . . 62.43 109.474 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.35 -178.41 6.96 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.0 -1.0 . . . . 71.01 109.731 178.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -61.7 115.85 4.31 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.475 -0.784 . . . . 73.12 109.358 172.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 72.05 -4.19 2.04 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 125.178 1.391 . . . . 74.44 113.427 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.1 t -100.94 104.59 16.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.477 -0.935 . . . . 75.33 108.477 175.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -115.18 123.31 48.56 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.622 -0.881 . . . . 72.14 108.622 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.466 ' HB2' HD11 ' A' ' 51' ' ' LEU . 32.4 tt0 -89.58 151.59 21.85 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 123.396 0.679 . . . . 54.3 109.313 166.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.457 HG11 ' HD3' ' A' ' 103' ' ' PRO . 83.2 t -130.03 138.03 55.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.983 -1.117 . . . . 64.32 107.983 168.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.1 t -114.3 132.51 63.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 CA-C-O 121.232 0.539 . . . . 60.11 109.749 174.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.546 HD21 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -113.68 110.3 19.98 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 106.313 -1.736 . . . . 72.01 106.313 174.326 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.606 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 16.8 ttp180 -101.31 107.07 18.33 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.878 -1.156 . . . . 73.22 107.878 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 36.1 t -93.67 123.61 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 108.585 -0.894 . . . . 64.22 108.585 176.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.472 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 22.1 m -114.7 111.88 21.97 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.212 -0.662 . . . . 72.32 109.212 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.528 HG21 HG21 ' A' ' 114' ' ' ILE . 81.7 t -103.02 120.9 53.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 124.539 1.135 . . . . 53.44 109.004 177.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.5 m -115.39 129.48 56.59 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.859 -0.793 . . . . 72.24 108.859 166.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.6 129.2 56.65 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.266 -1.383 . . . . 73.11 107.266 171.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.1 m -125.04 171.14 10.49 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.504 0.668 . . . . 73.13 109.936 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.7 mt -130.09 62.4 1.56 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 105.781 -1.933 . . . . 65.21 105.781 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.96 -103.52 2.01 Favored Glycine 0 C--N 1.338 0.648 0 CA-C-N 115.559 -0.746 . . . . 63.43 111.257 -173.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -91.16 -27.18 18.69 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.846 0.459 . . . . 71.52 111.708 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -97.44 123.84 41.42 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.802 0.441 . . . . 75.24 109.937 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 57.6 m -70.61 134.55 47.7 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.975 0.417 . . . . 71.55 110.391 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.581 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -79.26 -59.12 2.89 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.252 -0.885 . . . . 71.34 109.66 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -156.47 166.11 34.36 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.93 -1.032 . . . . 74.15 110.93 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.7 tp -135.46 114.11 11.81 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.366 1.066 . . . . 74.33 108.848 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.508 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 57.4 m -107.02 139.91 40.67 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.09 0.956 . . . . 70.11 108.917 174.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -149.95 117.81 6.26 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.592 -0.521 . . . . 72.11 109.592 175.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.5 t -127.59 114.5 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.835 0.854 . . . . 73.42 109.859 -175.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.604 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 10.4 mt-30 -86.77 81.18 8.27 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.548 -0.908 . . . . 64.4 108.548 174.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -76.57 95.94 4.02 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.59 -0.732 . . . . 74.12 109.407 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.85 146.48 16.38 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 111.351 -0.7 . . . . 64.1 111.351 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.29 134.05 6.49 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.104 -0.798 . . . . 51.13 111.104 -176.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.9 mt -81.24 125.57 39.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 108.777 -0.823 . . . . 71.43 108.777 173.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.812 ' HB3' HD11 ' A' ' 86' ' ' ILE . 82.0 m-85 -127.68 128.03 44.75 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.981 0.912 . . . . 74.15 109.202 -174.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.1 t -94.89 101.04 12.81 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.194 -1.039 . . . . 54.54 108.194 175.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.812 HD11 ' HB3' ' A' ' 84' ' ' PHE . 5.8 mm -113.5 153.52 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 122.4 0.28 . . . . 74.53 111.11 -171.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.06 167.5 12.51 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.546 1.139 . . . . 61.41 110.248 175.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.87 2.16 64.97 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-O 119.372 -0.682 . . . . 74.21 114.724 169.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.07 161.49 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 123.965 0.906 . . . . 74.01 110.554 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.475 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 18.1 tt0 -153.61 175.56 13.08 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 109.574 -0.528 . . . . 63.3 109.574 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.475 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 53.74 -121.23 17.22 Favored Glycine 0 C--N 1.349 1.299 0 O-C-N 124.099 0.874 . . . . 63.32 114.34 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.9 t -69.25 -30.35 68.45 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.028 0.931 . . . . 71.14 111.941 -176.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -74.42 -36.64 63.44 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.146 0.579 . . . . 62.42 110.459 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.411 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 4.9 tpt -65.26 -44.56 87.69 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.442 0.464 . . . . 74.52 110.405 175.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.62 -41.66 86.45 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.318 -0.855 . . . . 60.52 111.208 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.517 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 54.8 t-80 -78.58 -25.55 45.33 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.419 -0.809 . . . . 73.11 111.508 -177.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 44.0 t -69.95 -42.91 72.59 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.265 0.555 . . . . 75.44 109.962 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 88.0 mt -81.85 -40.97 21.68 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.846 -1.07 . . . . 74.51 111.732 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.32 3.16 81.91 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 116.035 -0.529 . . . . 71.11 114.284 -170.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.669 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -146.93 -58.76 0.28 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.54 0.67 . . . . 64.24 112.007 -171.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -67.65 -45.29 75.73 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-N 116.006 -0.543 . . . . 73.44 111.049 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.406 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 88.3 m -63.45 -52.34 60.83 Favored Pre-proline 0 CA--C 1.566 1.573 0 N-CA-C 113.435 0.902 . . . . 63.13 113.435 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.457 ' HD3' HG11 ' A' ' 58' ' ' VAL . 44.3 Cg_endo -65.7 -20.6 59.35 Favored 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 122.051 1.834 . . . . 55.5 113.052 177.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -63.83 -43.69 95.45 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 120.99 0.424 . . . . 72.21 110.043 172.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' A' ' 102' ' ' CYS . 31.2 mm -61.74 -38.15 79.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 124.405 1.082 . . . . 75.41 110.673 174.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 103' ' ' PRO . 78.0 mt -77.64 -22.46 50.66 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.079 0.952 . . . . 74.03 112.96 -173.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -70.3 -41.94 14.84 Favored Pre-proline 0 CA--C 1.557 1.245 0 N-CA-C 114.434 1.272 . . . . 74.24 114.434 -170.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -54.12 -39.39 86.07 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 121.902 1.734 . . . . 75.12 112.742 173.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -74.55 -40.81 61.45 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.748 0.819 . . . . 72.22 111.484 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.66 -49.01 74.91 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.974 0.509 . . . . 70.35 110.241 177.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.654 HH12 HD12 ' C' ' 105' ' ' ILE . 29.7 ttm180 -52.04 -48.88 64.36 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.719 1.262 . . . . 74.05 110.491 176.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -61.95 -50.51 71.82 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 124.204 0.94 . . . . 75.4 111.63 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.451 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 44.9 t -54.3 -44.75 72.24 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.361 1.038 . . . . 53.55 110.691 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.528 HG21 HG21 ' A' ' 64' ' ' VAL . 96.9 mt -63.05 -55.06 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 114.968 -1.014 . . . . 75.22 111.14 176.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 91.4 m -52.83 -43.44 66.0 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.12 0.968 . . . . 63.02 111.53 -175.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -68.0 -44.21 77.09 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.382 -1.281 . . . . 74.52 109.782 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 11.1 mtp -57.45 -42.45 82.51 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.887 0.875 . . . . 73.1 111.596 175.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 114' ' ' ILE . 72.3 t -59.72 -49.27 84.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.4 1.08 . . . . 73.53 110.274 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -72.42 -27.66 62.48 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.855 -0.612 . . . . 71.24 111.775 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 50.3 mtt-85 -70.77 -31.43 68.21 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.363 0.665 . . . . 72.34 109.932 175.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.422 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.48 18.2 25.57 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.572 -0.74 . . . . 63.21 113.073 175.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 121' ' ' GLY . 2.5 t 59.61 11.57 2.44 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 126.952 2.101 . . . . 71.21 113.225 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -79.07 139.31 56.78 Favored Pre-proline 0 C--O 1.245 0.858 0 N-CA-C 108.271 -1.011 . . . . 55.3 108.271 174.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -48.58 135.79 27.0 Favored 'Trans proline' 0 C--N 1.365 1.438 0 C-N-CA 123.249 2.633 . . . . 74.3 112.519 173.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -58.8 127.5 32.5 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 124.292 0.995 . . . . 70.44 111.988 -166.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.0 tp -110.22 134.61 52.06 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 123.974 0.91 . . . . 72.14 108.859 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -129.02 122.22 29.58 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.823 -0.806 . . . . 44.2 108.823 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.2 mt -74.15 148.04 42.1 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.481 -0.562 . . . . 71.31 109.481 -176.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.38 142.73 58.79 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 119.34 -0.362 . . . . 44.23 111.042 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.507 ' HB3' ' OH ' ' C' ' 101' ' ' TYR . 53.3 Cg_exo -56.22 121.66 10.39 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 123.446 2.764 . . . . 73.45 113.774 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.728 HG21 HD11 ' A' ' 44' ' ' LEU . 57.7 t -102.35 121.03 52.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-N 115.485 -0.779 . . . . 74.14 109.265 176.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -91.15 81.31 5.57 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.618 -0.882 . . . . 74.11 108.618 176.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -59.29 -31.58 69.26 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 114.893 -1.049 . . . . 73.42 111.578 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.669 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 13.9 t70 -55.22 -47.84 74.75 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.966 0.906 . . . . 74.43 109.937 178.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.75 -42.43 64.05 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.384 -0.825 . . . . 73.4 111.694 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 76.1 mt -65.22 -42.15 93.75 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.034 0.534 . . . . 70.51 112.323 -174.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.418 ' HB3' ' HB2' ' A' ' 100' ' ' ALA . 25.3 t80 . . . . . 0 C--O 1.212 -0.915 0 N-CA-C 109.349 -0.611 . . . . 62.33 109.349 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.606 ' HB3' HG23 ' B' ' 89' ' ' ILE . 21.4 ptm . . . . . 0 N--CA 1.484 1.226 0 CA-C-O 122.035 0.922 . . . . 70.41 113.225 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 90.7 m -148.29 124.76 10.99 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.536 -1.283 . . . . 74.25 107.536 169.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -113.54 145.03 41.87 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.997 -0.742 . . . . 75.31 108.997 173.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -155.66 139.76 16.46 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.314 -0.624 . . . . 74.21 109.314 172.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.443 HD13 HD11 ' B' ' 16' ' ' ILE . 50.4 mt -82.07 132.25 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 108.022 -1.103 . . . . 65.24 108.022 168.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -100.61 -43.73 6.07 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.528 -0.545 . . . . 64.32 109.528 178.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.401 ' HE ' HG21 ' A' ' 122' ' ' THR . 55.0 ttt180 -173.27 134.22 0.53 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.473 -0.785 . . . . 75.32 108.907 -174.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.521 HG21 ' CD1' ' B' ' 109' ' ' TYR . 88.8 mt -121.1 148.37 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 108.596 -0.89 . . . . 74.33 108.596 177.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -162.39 142.87 9.99 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 112.857 0.688 . . . . 74.41 112.857 -175.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.3 m -73.15 117.14 14.52 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.686 -1.143 . . . . 64.45 108.445 167.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.466 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 42.3 mtpt -91.43 -33.76 15.11 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.076 0.551 . . . . 71.52 110.294 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.594 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 19.3 t70 -149.79 136.21 19.09 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.093 -0.503 . . . . 61.52 110.811 -167.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 43.9 mm -134.92 139.55 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.793 1.237 . . . . 74.31 108.033 174.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 47.0 t -144.21 115.1 7.81 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.256 -1.016 . . . . 74.22 108.256 177.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' B' ' 75' ' ' LEU . 77.9 t80 -126.4 130.47 50.79 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 107.715 -1.217 . . . . 64.12 107.715 171.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -140.24 120.69 14.08 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.863 0.865 . . . . 52.21 108.744 175.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.496 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -111.98 85.58 6.66 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 107.257 -1.386 . . . . 54.33 107.257 170.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.7 -26.57 53.16 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.799 2.333 . . . . 61.05 112.313 -173.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -108.5 5.24 25.02 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.469 -0.787 . . . . 64.23 111.078 -177.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.52 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -30.23 -67.18 0.15 Allowed Pre-proline 0 N--CA 1.498 1.959 0 C-N-CA 125.447 1.499 . . . . 51.03 114.868 -167.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 21.1 Cg_exo -61.95 -28.37 80.76 Favored 'Trans proline' 0 C--N 1.392 2.838 0 C-N-CA 122.043 1.828 . . . . 62.42 113.0 -170.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -94.03 -34.72 12.91 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.092 -0.958 . . . . 72.41 111.871 -172.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.682 HG22 HD12 ' B' ' 68' ' ' LEU . 9.9 p -72.19 -15.23 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 122.659 0.383 . . . . 72.34 111.202 -176.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -68.36 -9.81 50.67 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.557 0.743 . . . . 61.13 112.573 177.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.503 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.2 pt20 -67.0 -20.47 65.88 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.036 0.534 . . . . 32.01 110.808 174.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.503 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 99.5 mttt -103.03 110.78 22.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.991 1.316 . . . . 72.34 110.116 -175.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -112.92 97.31 6.46 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.692 0.397 . . . . 74.12 110.529 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 35.1 p90 -167.49 -171.31 1.64 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.439 1.096 . . . . 54.44 108.943 170.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 13.0 pm0 -71.36 111.39 10.01 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.482 0.713 . . . . 75.31 110.416 176.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.521 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 15.2 Cg_endo -65.61 152.14 82.62 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 121.204 1.27 . . . . 75.5 110.452 177.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 32.0 tt0 -69.72 99.85 1.4 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.787 -1.19 . . . . 71.23 107.787 173.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.472 HG23 ' O ' ' B' ' 38' ' ' PRO . 31.7 t -101.73 142.04 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 O-C-N 123.655 0.597 . . . . 73.34 110.134 -171.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -126.91 107.67 10.3 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.519 1.128 . . . . 62.41 108.51 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 17.9 tp -87.25 125.57 34.28 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.39 -0.966 . . . . 65.23 108.39 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -137.45 111.39 8.3 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.842 -1.17 . . . . 74.41 107.842 -170.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mp -100.99 140.65 34.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.039 0.536 . . . . 70.33 109.737 -175.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -142.96 145.33 32.89 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.107 0.963 . . . . 74.1 109.846 -177.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 4.0 t -126.37 104.62 8.27 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.701 0.8 . . . . 63.54 109.177 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.76 113.91 23.23 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.341 -1.355 . . . . 62.22 107.341 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 30.9 p -146.51 164.7 31.69 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.583 0.353 . . . . 73.01 111.819 -167.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 55.0 p -151.39 142.94 23.59 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.201 0.601 . . . . 52.41 110.83 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -82.6 111.83 18.93 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 109.315 -0.624 . . . . 73.4 109.315 172.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 pp -121.64 21.81 10.75 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.336 -0.847 . . . . 72.13 109.851 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -168.04 148.37 4.95 Favored 'General case' 0 C--N 1.361 1.079 0 C-N-CA 123.401 0.68 . . . . 64.43 111.743 176.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.62 141.26 46.56 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 107.609 -1.256 . . . . 64.2 107.609 158.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 70.05 -2.49 2.05 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.692 1.197 . . . . 75.4 112.472 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.443 HG11 HG23 ' B' ' 83' ' ' ILE . 24.8 t -141.08 127.47 20.29 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 CA-C-N 118.755 0.707 . . . . 70.54 109.821 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.475 ' HD2' HG22 ' B' ' 58' ' ' VAL . 14.9 t80 -115.67 138.48 51.05 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 106.976 -1.49 . . . . 73.12 106.976 171.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -100.88 99.89 10.44 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 106.958 -1.497 . . . . 71.33 106.958 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.475 HG22 ' HD2' ' B' ' 56' ' ' TYR . 32.3 t -96.11 127.35 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.152 -0.931 . . . . 62.43 109.589 -173.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.414 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 17.5 t -114.9 112.44 40.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 109.149 -0.686 . . . . 74.15 109.149 175.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 63.4 tp -94.2 107.25 19.2 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 116.018 -0.537 . . . . 73.41 109.586 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -85.68 108.58 18.09 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.954 -0.758 . . . . 62.53 108.954 171.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 39.8 t -104.38 103.17 14.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 106.842 -1.54 . . . . 73.01 106.842 175.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 25.6 m -99.46 141.57 32.07 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.176 -0.92 . . . . 74.34 109.506 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.642 HG11 HD21 ' B' ' 126' ' ' LEU . 41.5 t -133.77 118.29 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.128 0.971 . . . . 75.11 109.425 175.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 40.5 m -105.3 139.65 39.62 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.162 -1.421 . . . . 72.41 107.162 172.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -146.06 141.02 27.19 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.537 0.608 . . . . 54.23 110.536 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.559 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 19.8 m -143.12 128.37 18.75 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.452 0.47 . . . . 73.24 112.018 -172.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.682 HD12 HG22 ' B' ' 31' ' ' VAL . 90.4 mt -95.1 117.74 30.72 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.673 0.789 . . . . 73.23 109.007 176.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.51 -110.59 3.09 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.948 -0.861 . . . . 44.14 110.948 -172.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.22 6.38 8.47 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.771 0.829 . . . . 74.55 109.698 177.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -113.75 148.34 36.66 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.039 0.536 . . . . 75.51 109.627 -175.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 27.7 m -66.1 120.75 13.73 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.787 0.435 . . . . 73.41 110.966 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.631 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -73.53 -63.8 1.12 Allowed 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.612 -1.255 . . . . 70.34 107.612 172.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 74' ' ' PHE . . . . . 0.402 ' HZ ' HD22 ' B' ' 126' ' ' LEU . 39.4 p90 -152.59 161.82 42.06 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 114.405 -1.271 . . . . 62.23 111.087 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 58.1 mt -123.26 112.34 17.52 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 105.328 -2.101 . . . . 50.42 105.328 171.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.525 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 47.5 t -120.43 139.94 52.11 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.612 -0.884 . . . . 71.43 108.612 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -157.09 135.47 11.31 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.273 -0.64 . . . . 55.25 109.273 -174.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 62.6 t -132.88 147.54 31.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.097 -0.956 . . . . 74.21 108.798 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.594 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 17.9 mt-30 -123.68 106.95 10.95 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.073 -1.084 . . . . 65.33 108.073 168.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.446 ' O ' HD13 ' B' ' 106' ' ' LEU . 8.2 tp-100 -97.03 104.39 16.4 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.356 -0.979 . . . . 73.13 108.356 176.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.466 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -94.77 167.57 27.05 Favored Glycine 0 C--N 1.338 0.649 0 O-C-N 123.543 0.527 . . . . 65.43 111.969 175.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.15 138.52 5.26 Favored Glycine 0 C--N 1.341 0.826 0 C-N-CA 121.156 -0.545 . . . . 70.42 114.053 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.443 HG23 HG11 ' B' ' 55' ' ' VAL . 70.3 mt -86.37 114.36 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 124.862 1.265 . . . . 62.42 108.184 169.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -126.31 133.4 51.4 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.278 0.631 . . . . 74.54 110.514 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 58.3 m -89.39 106.06 18.2 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.573 0.749 . . . . 71.14 110.767 175.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.59 HG22 HD11 ' B' ' 89' ' ' ILE . 54.9 mt -116.95 104.74 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 125.274 1.43 . . . . 72.31 108.395 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.12 166.7 23.47 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.938 0.895 . . . . 54.4 110.648 -174.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.6 -53.17 2.7 Favored Glycine 0 N--CA 1.476 1.36 0 O-C-N 123.111 0.257 . . . . 53.13 112.635 177.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.606 HG23 ' HB3' ' B' ' 9' ' ' MET . 0.5 OUTLIER -62.5 166.38 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 124.283 1.033 . . . . 74.5 112.271 171.978 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -159.79 151.9 20.68 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.108 -0.951 . . . . 73.15 110.41 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.67 -127.7 9.02 Favored Glycine 0 C--N 1.354 1.562 0 CA-C-N 116.365 -0.379 . . . . 30.22 113.179 174.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.6 m -79.8 -39.31 31.12 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.995 0.903 . . . . 71.14 110.292 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -60.77 -34.38 74.39 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 113.217 -1.81 . . . . 74.53 111.731 -168.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.533 ' SD ' ' N ' ' B' ' 95' ' ' ALA . 2.1 ppp? -65.72 -46.09 80.22 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.091 -0.959 . . . . 72.2 111.822 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 95' ' ' ALA . . . . . 0.533 ' N ' ' SD ' ' B' ' 94' ' ' MET . . . -79.44 -12.45 59.89 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.472 0.709 . . . . 63.11 112.724 -175.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -62.4 -34.74 77.33 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 110.18 -0.304 . . . . 64.24 110.18 167.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -68.67 -51.18 44.67 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.944 0.498 . . . . 34.03 111.049 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.511 ' HG ' ' HA ' ' B' ' 95' ' ' ALA . 4.2 pp -70.82 -27.81 64.15 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.636 0.375 . . . . 75.44 111.687 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.1 3.82 67.15 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-O 119.142 -0.81 . . . . 72.42 114.185 -174.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.95 -51.88 0.1 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 117.948 0.874 . . . . 74.51 112.257 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -71.52 -40.36 70.18 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.051 0.54 . . . . 72.13 111.263 -175.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.475 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 72.3 m -68.87 -48.51 29.42 Favored Pre-proline 0 CA--C 1.56 1.337 0 CA-C-O 118.544 -0.741 . . . . 74.22 111.493 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 89.1 Cg_exo -53.5 -32.72 64.47 Favored 'Trans proline' 0 C--N 1.399 3.189 0 C-N-CA 122.636 2.224 . . . . 74.11 113.627 169.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -61.94 -34.84 76.82 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.366 0.666 . . . . 74.35 111.47 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.439 HD13 HD11 ' B' ' 13' ' ' ILE . 72.4 mt -75.99 -41.45 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.765 0.826 . . . . 73.14 110.195 176.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.446 HD13 ' O ' ' B' ' 80' ' ' GLN . 78.2 mt -71.29 -25.0 62.25 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 114.718 -1.128 . . . . 75.2 111.207 -176.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -62.63 -52.14 67.2 Favored Pre-proline 0 CA--C 1.552 1.024 0 CA-C-O 117.363 -1.304 . . . . 73.2 113.2 -172.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -54.06 -40.26 82.18 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.266 1.977 . . . . 72.33 113.023 177.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.521 ' CD1' HG21 ' B' ' 16' ' ' ILE . 5.2 m-30 -65.92 -44.13 86.05 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.981 -1.009 . . . . 73.02 110.495 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.81 -37.16 73.22 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.889 0.876 . . . . 73.34 111.456 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.659 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 52.4 ttt-85 -65.73 -54.88 21.28 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.243 1.417 . . . . 71.24 110.815 -176.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -73.23 -18.06 61.28 Favored 'General case' 0 CA--C 1.551 0.982 0 O-C-N 123.898 0.749 . . . . 61.32 110.06 -177.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.47 ' O ' ' HG2' ' B' ' 117' ' ' MET . 15.6 t -72.8 -42.1 64.24 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 122.739 0.416 . . . . 73.44 109.93 172.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.525 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 75.3 mt -57.52 -54.32 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 123.637 0.775 . . . . 73.31 109.704 171.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.41 HG21 ' OG ' ' C' ' 119' ' ' SER . 21.3 m -59.43 -29.91 68.11 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 124.34 1.025 . . . . 72.23 111.517 -177.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.6 t -68.39 -47.83 66.32 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.004 0.522 . . . . 71.21 110.357 174.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.6 mmt -69.66 -30.14 67.76 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.83 0.452 . . . . 71.45 111.115 -176.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.406 HG23 ' O ' ' B' ' 114' ' ' ILE . 91.0 t -67.68 -41.87 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.194 0.998 . . . . 74.44 109.861 172.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.8 t -66.86 -29.72 69.7 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.206 -0.906 . . . . 73.42 111.058 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' B' ' 116' ' ' SER . 84.5 mtt-85 -72.11 -35.2 69.11 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 123.116 0.566 . . . . 64.34 109.66 176.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.3 -9.85 81.41 Favored Glycine 0 C--N 1.354 1.562 0 O-C-N 123.531 0.519 . . . . 73.43 112.42 170.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.2 m 69.95 25.52 4.87 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 125.444 1.497 . . . . 71.55 110.643 174.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -78.38 165.26 51.33 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 124.043 0.937 . . . . 75.13 111.764 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.04 163.77 4.04 Favored 'Trans proline' 0 C--N 1.392 2.851 0 C-N-CA 123.313 2.675 . . . . 75.14 113.673 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -64.83 113.59 3.91 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.128 -0.942 . . . . 71.04 112.175 -171.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.642 HD21 HG11 ' B' ' 64' ' ' VAL . 48.6 tp -112.57 88.63 2.87 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 115.829 -0.623 . . . . 74.44 109.774 177.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -93.92 110.13 21.82 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.763 -1.199 . . . . 70.35 107.763 169.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.659 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 74.1 mt -65.46 146.32 55.02 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.331 0.253 . . . . 71.33 111.047 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.74 144.94 98.9 Favored Pre-proline 0 CA--C 1.55 0.964 0 O-C-N 124.406 1.066 . . . . 65.05 112.387 -173.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -68.11 84.47 0.44 Allowed 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.919 2.413 . . . . 62.31 111.61 173.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 19.8 m -101.28 126.92 55.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-O 121.2 0.524 . . . . 73.54 109.976 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 54.4 t30 . . . . . 0 C--O 1.244 0.785 0 N-CA-C 108.04 -1.096 . . . . 73.53 108.04 172.113 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 29.6 t80 . . . . . 0 C--O 1.24 0.561 0 N-CA-C 107.1 -1.444 . . . . 73.43 107.1 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -140.49 114.8 9.26 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.891 -1.151 . . . . 73.31 107.891 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 37.6 mt -72.31 131.75 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.639 -0.875 . . . . 74.44 108.639 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -86.59 -49.47 7.52 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.352 -0.61 . . . . 71.15 109.352 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.577 HH21 ' HD2' ' D' ' 32' ' ' PHE . 0.0 OUTLIER -178.36 151.83 0.64 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.48 1.112 . . . . 71.34 109.104 173.213 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 pp -109.43 151.7 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 107.653 -1.24 . . . . 64.21 107.653 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.561 ' HE1' HG12 ' C' ' 83' ' ' ILE . 49.2 p90 -172.28 153.35 2.98 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.145 0.43 . . . . 64.53 111.245 -176.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.2 p -85.31 111.59 20.02 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.704 -0.68 . . . . 72.33 111.533 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.463 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 31.2 mmtp -65.52 -33.07 75.06 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.382 0.673 . . . . 74.55 110.733 170.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -151.79 146.28 25.6 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.7 -1.136 . . . . 71.21 109.756 -177.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.467 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 80.8 mt -142.84 139.81 27.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 106.37 -1.715 . . . . 73.14 106.37 171.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.4 t -154.27 147.53 24.85 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.452 0.644 . . . . 73.14 109.901 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -146.94 136.33 22.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 106.811 -1.551 . . . . 71.12 106.811 172.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -137.94 133.44 33.75 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.502 -0.925 . . . . 62.41 108.502 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.11 77.65 6.11 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 108.197 -1.038 . . . . 62.24 108.197 172.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.34 -27.8 28.05 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.761 2.308 . . . . 63.32 111.144 177.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -99.08 14.33 29.66 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.773 -1.103 . . . . 73.54 111.052 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.463 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -45.59 -55.39 12.41 Favored Pre-proline 0 N--CA 1.49 1.525 0 C-N-CA 124.429 1.092 . . . . 75.35 113.11 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 32.4 Cg_exo -59.55 -46.47 20.62 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.062 1.842 . . . . 73.43 112.316 -177.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -69.71 -32.51 71.13 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.567 -1.197 . . . . 73.24 112.534 -174.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.642 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.1 p -79.5 -29.27 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 111.991 0.367 . . . . 75.24 111.991 -176.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -63.75 -32.28 73.73 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.704 0.401 . . . . 74.3 111.838 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -88.62 17.3 5.58 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.211 0.604 . . . . 72.44 111.621 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.408 ' HG2' HD13 ' C' ' 68' ' ' LEU . 2.4 ttpm? -120.33 152.06 38.37 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.076 0.951 . . . . 74.34 110.552 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -59.27 129.46 42.16 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.368 1.067 . . . . 65.31 111.361 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -85.49 85.7 7.41 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.973 0.909 . . . . 72.33 110.749 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 16.6 tm0? -131.53 78.36 71.47 Favored Pre-proline 0 N--CA 1.479 1.008 0 N-CA-C 107.118 -1.438 . . . . 63.5 107.118 171.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -93.44 143.4 2.0 Allowed 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.538 2.158 . . . . 75.4 113.312 -175.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -85.5 98.21 10.48 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 106.686 -1.598 . . . . 74.45 106.686 159.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 94.7 t -76.48 99.52 2.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.14 -1.059 . . . . 75.32 108.14 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -90.8 100.72 13.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.148 -1.797 . . . . 71.32 106.148 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.585 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.5 pt? -97.44 162.0 13.52 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 115.626 -0.716 . . . . 74.52 109.587 -174.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.82 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 25.6 m-20 -142.32 146.26 34.83 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.744 0.818 . . . . 74.5 110.055 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.527 HD11 HG11 ' C' ' 131' ' ' VAL . 95.1 mt -134.53 111.12 9.83 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.771 0.828 . . . . 74.04 108.949 174.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.401 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 5.7 t70 -116.43 142.87 46.29 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.27 1.428 . . . . 73.24 107.277 173.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.6 t -152.69 152.67 31.99 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.752 -0.462 . . . . 74.13 109.752 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.82 157.63 38.19 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.466 0.706 . . . . 63.52 109.988 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 6.2 m -130.01 144.59 51.41 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.134 0.574 . . . . 61.14 109.629 176.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 37.8 p -145.29 127.48 15.71 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.672 0.789 . . . . 53.53 109.438 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -75.99 120.65 21.61 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.475 0.71 . . . . 74.03 110.51 -177.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' C' ' 57' ' ' GLU . 40.6 mt -91.42 -31.06 16.16 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.427 0.691 . . . . 44.33 110.661 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.55 -177.41 5.92 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.778 0.831 . . . . 72.22 110.375 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -65.24 119.71 11.41 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.769 -0.65 . . . . 73.23 110.116 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 65.94 11.56 7.79 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.902 1.281 . . . . 73.13 112.126 -175.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.3 t -116.23 111.59 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.051 -0.722 . . . . 61.14 109.051 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -123.0 124.2 42.6 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.965 -1.124 . . . . 74.42 107.965 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.577 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.1 tt0 -85.78 137.96 32.42 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.773 -0.825 . . . . 74.31 108.773 170.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.66 138.43 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 108.27 -1.011 . . . . 54.21 108.27 170.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 44.9 t -127.07 133.74 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 109.283 -0.636 . . . . 74.43 109.283 174.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.486 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -117.56 105.24 11.86 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.669 -1.234 . . . . 70.43 107.669 -177.886 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.401 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 16.9 ttm-85 -81.62 108.36 15.12 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.599 0.76 . . . . 75.11 109.505 171.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 44.0 t -104.78 119.06 53.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 108.015 -1.106 . . . . 74.13 108.015 171.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.82 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 79.2 m -114.66 145.41 42.05 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.056 0.942 . . . . 71.41 108.95 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 35.7 t -135.45 112.43 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.69 1.196 . . . . 73.14 108.314 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.7 m -101.77 122.66 44.37 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.309 -0.997 . . . . 72.15 108.309 168.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.6 119.24 38.93 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.148 -1.427 . . . . 74.01 107.148 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 32.2 m -141.25 129.01 21.64 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.109 0.255 . . . . 74.13 110.343 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.408 HD13 ' HG2' ' C' ' 34' ' ' LYS . 23.0 mt -86.56 44.08 1.12 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.506 1.122 . . . . 73.42 109.914 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.95 -104.96 2.54 Favored Glycine 0 C--N 1.344 1.019 0 N-CA-C 110.275 -1.13 . . . . 74.12 110.275 -172.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -90.85 -31.52 16.42 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.57 0.748 . . . . 72.22 109.438 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -65.91 121.56 15.35 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.71 1.204 . . . . 54.43 110.478 174.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 52.2 m -83.87 120.27 25.87 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.973 -0.751 . . . . 45.44 108.973 167.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.642 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.94 -55.07 8.12 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 123.945 0.778 . . . . 54.04 108.944 174.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -162.03 162.5 28.86 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 115.446 -0.797 . . . . 74.13 110.316 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.434 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.9 tm? -114.33 142.65 46.04 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 106.491 -1.67 . . . . 65.04 106.491 163.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.434 ' N ' HD13 ' C' ' 75' ' ' LEU . 46.1 t -145.06 143.49 30.46 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.29 -1.004 . . . . 34.53 108.29 175.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -156.98 130.01 7.8 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.465 -0.569 . . . . 74.13 109.465 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 86.0 t -130.96 122.19 51.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.504 -0.924 . . . . 61.55 108.504 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -99.05 88.46 3.97 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.839 -1.171 . . . . 75.25 107.839 177.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 65.3 tp60 -79.36 100.17 7.48 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.972 -1.013 . . . . 74.15 109.633 -175.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -82.09 174.55 53.7 Favored Glycine 0 C--O 1.237 0.316 0 CA-C-N 115.923 -0.58 . . . . 52.22 112.301 174.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.79 126.67 1.17 Allowed Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 111.786 -0.526 . . . . 72.24 111.786 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.561 HG12 ' HE1' ' C' ' 17' ' ' TYR . 31.7 mm -87.13 126.45 40.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.241 -1.022 . . . . 75.24 108.241 174.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -127.93 118.56 23.83 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.534 0.734 . . . . 63.24 109.431 -177.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 28.5 p -84.67 102.11 12.69 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.588 -0.893 . . . . 74.21 108.588 169.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 29.6 mt -115.43 118.59 59.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.692 1.197 . . . . 54.14 109.702 -175.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -124.96 170.1 11.44 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.712 0.805 . . . . 74.35 109.898 174.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.98 -39.64 2.68 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 116.432 -0.349 . . . . 65.53 113.616 171.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 39.8 pt -103.93 165.33 3.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 123.283 0.633 . . . . 70.2 111.574 -171.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -159.92 154.35 23.84 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.254 -0.884 . . . . 74.22 109.195 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.2 -120.41 17.94 Favored Glycine 0 C--N 1.346 1.084 0 O-C-N 123.534 0.521 . . . . 63.25 113.579 174.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 35.1 p -61.6 -40.63 95.49 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.574 0.75 . . . . 72.2 111.831 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -63.49 -49.58 73.04 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.837 0.455 . . . . 75.41 110.908 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 6.2 tpt -52.36 -54.06 36.66 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 124.239 0.962 . . . . 65.43 111.909 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.63 -42.33 96.68 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.292 0.567 . . . . 73.13 111.639 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -65.4 -31.77 73.05 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.729 1.211 . . . . 61.44 111.037 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 48.7 t -76.63 -27.67 55.78 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.286 -0.87 . . . . 61.31 110.864 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 94.3 mt -94.53 -32.14 13.6 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.672 0.789 . . . . 72.13 112.975 -172.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.03 -8.0 37.19 Favored Glycine 0 N--CA 1.473 1.123 0 CA-C-O 119.963 -0.354 . . . . 41.32 113.7 -173.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.23 -54.42 1.11 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.853 0.461 . . . . 70.34 110.874 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.507 ' OH ' ' HB3' ' A' ' 130' ' ' PRO . 52.2 t80 -73.4 -49.84 24.98 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.898 -0.592 . . . . 64.22 112.0 -170.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.401 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 68.0 m -63.23 -47.74 84.44 Favored Pre-proline 0 CA--C 1.557 1.228 0 CA-C-O 118.64 -0.695 . . . . 74.43 111.55 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.486 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 78.1 Cg_exo -56.43 -31.8 86.89 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.453 2.102 . . . . 72.05 113.594 170.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -68.02 -32.48 72.89 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.971 0.508 . . . . 74.21 110.726 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.654 HD12 HH12 ' A' ' 111' ' ' ARG . 10.0 mm -72.62 -41.68 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 109.509 -0.552 . . . . 65.44 109.509 174.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 85.0 mt -74.48 -23.62 58.9 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.899 0.88 . . . . 73.23 112.238 -175.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 107' ' ' PHE . . . . . 0.401 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 53.7 t80 -59.77 -53.43 65.62 Favored Pre-proline 0 N--CA 1.48 1.027 0 CA-C-O 117.431 -1.271 . . . . 62.14 113.445 -174.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 108' ' ' PRO . . . . . 0.401 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 51.1 Cg_exo -56.29 -36.59 97.13 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 121.84 1.693 . . . . 74.2 113.155 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -67.4 -47.53 70.03 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.27 0.628 . . . . 74.34 111.271 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.2 -38.93 88.33 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.176 0.99 . . . . 71.41 110.601 177.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -64.72 -47.26 78.93 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.165 1.386 . . . . 73.04 110.178 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -67.48 -34.03 76.32 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 123.861 0.726 . . . . 54.51 110.062 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.6 t -72.11 -34.58 68.72 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.933 0.493 . . . . 71.31 111.052 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.413 HG23 ' SG ' ' C' ' 76' ' ' CYS . 65.2 mt -73.91 -50.36 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 122.856 0.462 . . . . 62.25 110.34 176.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.1 m -65.71 -28.43 69.06 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.101 0.56 . . . . 64.54 110.872 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 29.3 t -62.85 -49.18 75.89 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 108.951 -0.759 . . . . 72.3 108.951 169.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.528 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.64 -36.47 78.72 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.322 1.049 . . . . 74.14 112.629 179.04 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.4 HG23 ' O ' ' C' ' 114' ' ' ILE . 92.3 t -62.65 -49.25 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.544 0.737 . . . . 63.11 109.603 175.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.41 ' OG ' HG21 ' B' ' 115' ' ' THR . 29.2 t -65.44 -32.91 74.78 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.978 -1.01 . . . . 72.13 111.552 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.492 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 76.5 mtt-85 -67.18 -37.6 83.97 Favored 'General case' 0 C--O 1.214 -0.8 0 C-N-CA 123.448 0.699 . . . . 71.33 109.465 176.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.84 8.15 70.98 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.31 -0.717 . . . . 72.32 113.249 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.409 HG23 ' HB3' ' D' ' 17' ' ' TYR . 81.0 p 55.6 33.66 21.62 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.05 1.74 . . . . 73.51 113.124 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -93.28 145.7 30.52 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 108.431 -0.951 . . . . 74.5 108.431 171.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -51.32 148.58 18.77 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 123.72 2.946 . . . . 62.24 114.249 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -55.43 112.47 1.12 Allowed 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.274 0.984 . . . . 60.11 112.261 -176.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 53.8 tp -110.49 86.87 2.39 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.481 -1.236 . . . . 73.02 107.805 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -91.6 101.62 14.25 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.555 -0.906 . . . . 74.33 108.555 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.9 127.84 33.35 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.898 0.879 . . . . 75.21 110.393 -174.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.72 151.48 94.71 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 123.916 0.886 . . . . 34.33 111.811 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.497 ' HG3' HD12 ' A' ' 16' ' ' ILE . 51.6 Cg_exo -52.95 107.93 0.23 Allowed 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.017 2.478 . . . . 63.24 112.995 175.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 131' ' ' VAL . . . . . 0.527 HG11 HD11 ' C' ' 44' ' ' LEU . 6.3 p -101.56 124.25 55.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 109.254 -0.647 . . . . 65.43 109.254 175.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -85.54 104.65 15.5 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.176 0.59 . . . . 63.35 109.686 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -66.05 -22.41 66.43 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.948 -0.569 . . . . 71.14 111.493 176.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -71.18 -36.57 72.02 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.566 0.541 . . . . 71.42 109.802 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.71 -43.35 99.02 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.441 -0.8 . . . . 71.33 110.22 172.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 73.5 mt -71.3 -25.74 62.56 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.855 0.862 . . . . 63.32 111.537 178.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 40.2 t80 . . . . . 0 N--CA 1.472 0.667 0 C-N-CA 123.313 0.645 . . . . 73.43 110.01 -179.272 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 5.6 t . . . . . 0 C--O 1.243 0.76 0 N-CA-C 109.5 -0.555 . . . . 71.32 109.5 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.415 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 54.8 t80 -152.88 103.25 2.74 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.734 -1.21 . . . . 73.02 107.734 -175.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -112.68 128.67 56.46 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.252 -1.018 . . . . 75.53 108.252 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 12.8 mt -94.24 134.97 29.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.173 -1.047 . . . . 64.11 108.173 175.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -106.34 -33.45 7.76 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 122.779 0.431 . . . . 75.31 111.629 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -169.32 127.0 0.95 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 120.592 0.234 . . . . 61.02 111.594 -166.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.22 134.46 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 107.67 -1.233 . . . . 72.11 107.67 168.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' C' ' 120' ' ' ARG . 39.4 p90 -163.73 150.39 11.88 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-O 121.821 0.82 . . . . 72.53 111.873 175.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 18' ' ' THR . . . . . 0.4 HG21 HD11 ' D' ' 21' ' ' ILE . 81.4 p -85.89 126.3 33.96 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.684 -1.144 . . . . 63.41 109.199 176.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -99.37 -14.22 19.27 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.349 -0.611 . . . . 73.5 109.349 175.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.675 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.2 t70 -160.02 136.87 9.2 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.309 1.044 . . . . 63.34 109.032 176.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.528 HG21 ' HE2' ' C' ' 117' ' ' MET . 65.7 mt -137.67 144.66 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.626 1.17 . . . . 73.33 108.121 174.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.1 t -146.62 139.28 25.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.185 0.994 . . . . 72.44 108.955 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.467 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 77.5 t80 -150.31 123.24 8.73 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.753 -1.573 . . . . 60.25 106.753 167.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -127.38 129.67 48.0 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.15 -0.685 . . . . 75.11 109.15 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.441 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -118.1 79.49 14.32 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 107.57 -1.27 . . . . 44.23 107.57 169.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.75 -35.06 13.38 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.375 2.05 . . . . 74.44 112.151 -171.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -104.99 6.51 33.52 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.101 0.96 . . . . 64.02 110.515 -174.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.496 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -23.65 -77.75 0.02 OUTLIER Pre-proline 0 CA--C 1.567 1.613 0 N-CA-C 117.428 2.381 . . . . 51.45 117.428 -169.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.463 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 87.1 Cg_endo -75.29 -17.48 18.9 Favored 'Trans proline' 0 C--N 1.388 2.652 0 CA-C-N 124.643 2.694 . . . . 73.41 113.224 -170.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -70.88 -43.71 67.84 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.949 -0.76 . . . . 63.23 108.949 172.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.496 HG12 ' O ' ' D' ' 28' ' ' ALA . 4.8 p -83.88 -19.62 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 CA-C-N 115.748 -0.66 . . . . 73.44 111.517 -170.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.577 ' HD2' HH21 ' C' ' 15' ' ' ARG . 22.7 m-85 -67.4 -20.72 65.57 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 120.914 0.388 . . . . 62.41 111.416 177.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -64.31 -18.33 64.51 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.103 0.961 . . . . 64.23 111.083 174.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -92.19 81.54 5.01 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.747 1.219 . . . . 72.25 108.784 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -83.43 79.7 9.33 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 122.074 0.94 . . . . 75.1 111.062 -174.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -152.93 -174.91 5.1 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.092 -0.958 . . . . 65.14 109.041 169.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -77.21 114.59 41.52 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 123.516 0.726 . . . . 63.34 110.43 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -53.94 119.98 7.17 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 122.53 2.154 . . . . 61.31 110.764 172.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -67.2 108.83 2.84 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.76 -1.2 . . . . 74.0 107.76 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.749 HG13 HG13 ' D' ' 64' ' ' VAL . 93.9 t -100.88 132.51 46.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 CA-C-N 115.419 -0.809 . . . . 73.5 109.823 -171.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -115.24 118.94 34.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.569 -1.271 . . . . 73.21 107.569 173.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.621 HD11 HG13 ' D' ' 62' ' ' VAL . 37.9 tp -97.39 137.58 36.16 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.27 0.557 . . . . 64.34 110.131 -178.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.42 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 6.5 m-20 -133.66 122.19 23.08 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.028 1.331 . . . . 60.03 108.083 -175.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.416 ' CD2' HG22 ' D' ' 62' ' ' VAL . 89.1 mt -119.8 144.58 47.24 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.814 0.445 . . . . 74.42 110.759 -176.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.48 ' HB2' ' HB3' ' D' ' 61' ' ' ARG . 11.7 m-20 -142.13 134.61 28.05 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.218 1.007 . . . . 72.21 109.061 176.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 46' ' ' THR . . . . . 0.451 HG21 ' HA2' ' D' ' 99' ' ' GLY . 59.1 m -104.15 139.05 39.76 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.154 -1.054 . . . . 64.1 108.154 168.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.42 141.05 21.72 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.585 -1.265 . . . . 50.21 107.585 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 30.8 p . . . . . 0 C--O 1.243 0.731 0 N-CA-C 109.806 -0.442 . . . . 75.53 109.806 -175.962 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 54' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' D' ' 85' ' ' SER . 80.9 m-20 . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 113.396 0.887 . . . . 71.54 113.396 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 9.0 m -129.64 110.2 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.402 -0.962 . . . . 74.23 108.402 169.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -126.88 132.58 50.89 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 109.31 -0.626 . . . . 73.2 109.31 -175.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -87.28 112.43 22.04 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.594 -0.891 . . . . 61.15 108.594 175.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.581 HG11 ' HD3' ' D' ' 103' ' ' PRO . 84.8 t -101.13 116.9 45.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.322 -0.992 . . . . 70.0 108.322 176.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.479 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 26.3 t -102.71 129.36 54.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 108.777 -0.823 . . . . 61.35 108.777 176.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' D' ' 79' ' ' GLN . 0.1 OUTLIER -110.31 122.78 48.48 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.41 -0.959 . . . . 74.43 108.41 -178.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.48 ' HB3' ' HB2' ' D' ' 45' ' ' ASP . 49.3 ttp180 -98.53 101.47 12.91 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.996 -0.742 . . . . 75.35 108.996 173.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.621 HG13 HD11 ' D' ' 42' ' ' LEU . 61.9 t -98.24 113.64 33.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 114.898 -1.046 . . . . 62.23 108.678 173.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.42 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 11.0 m -122.44 124.22 43.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.356 -0.838 . . . . 73.21 109.706 -172.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.749 HG13 HG13 ' D' ' 40' ' ' VAL . 39.9 t -109.15 123.24 64.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 C-N-CA 125.409 1.484 . . . . 62.03 108.774 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 20.4 m -113.52 101.27 9.19 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.902 -1.147 . . . . 62.31 107.902 169.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.47 142.95 41.53 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.636 -0.711 . . . . 75.22 109.105 -173.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.473 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 17.1 p -149.72 134.0 17.32 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.746 0.647 . . . . 73.1 112.746 -171.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.449 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 34.3 mt -109.06 112.01 23.96 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.797 1.239 . . . . 50.45 107.733 173.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.5 -140.41 22.7 Favored Glycine 0 C--N 1.344 1.004 0 O-C-N 123.286 0.367 . . . . 43.33 112.545 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.29 6.64 42.11 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.348 0.659 . . . . 63.01 111.799 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -132.35 173.99 10.71 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.885 0.474 . . . . 72.5 110.611 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 31.2 m -73.6 140.03 45.94 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.452 -0.794 . . . . 71.41 111.775 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.473 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.25 -67.19 0.84 Allowed 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.404 -1.332 . . . . 75.51 107.404 169.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -148.41 148.75 30.68 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.52 -1.218 . . . . 72.53 110.26 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 78.6 mt -103.41 150.38 23.89 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.73 1.212 . . . . 70.31 108.197 169.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.539 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.9 t -158.12 140.58 14.45 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.359 -0.608 . . . . 73.33 109.359 176.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -155.54 127.62 7.61 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.106 0.562 . . . . 61.42 109.698 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.93 114.97 34.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 123.126 0.57 . . . . 62.04 109.553 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.675 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.0 mt-30 -90.71 85.67 6.13 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.872 0.844 . . . . 72.34 109.394 171.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -81.18 101.44 9.67 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 113.818 -1.537 . . . . 74.4 109.726 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.42 143.89 17.56 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 112.273 -0.331 . . . . 72.31 112.273 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.65 134.0 6.57 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 111.855 -0.498 . . . . 74.04 111.855 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 61.6 mt -89.23 103.17 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 107.925 -1.139 . . . . 72.24 107.925 175.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -108.78 144.11 37.05 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.807 0.843 . . . . 73.22 110.641 -177.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' D' ' 54' ' ' ASP . 16.4 p -116.46 137.34 52.24 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.679 0.792 . . . . 55.44 110.097 171.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.449 HG12 HD11 ' D' ' 89' ' ' ILE . 6.3 tt -145.24 138.68 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.394 0.678 . . . . 60.15 110.81 -163.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.26 170.76 9.83 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.425 0.69 . . . . 61.43 111.645 175.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.61 7.58 61.56 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 115.748 -0.66 . . . . 45.51 112.793 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.449 HD11 HG12 ' D' ' 86' ' ' ILE . 1.4 pp -140.1 149.96 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.542 1.137 . . . . 45.43 110.225 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.9 173.26 17.26 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.746 0.819 . . . . 72.32 110.456 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.86 -118.26 4.68 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 114.781 0.673 . . . . 64.41 114.781 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 54.2 p -90.08 -44.67 9.66 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.384 0.674 . . . . 63.13 111.388 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -66.86 -23.61 66.04 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 113.177 0.806 . . . . 71.44 113.177 -172.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 21.7 ptm -56.72 -51.31 69.33 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 113.851 1.056 . . . . 73.41 113.851 -174.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.9 -12.85 59.71 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.577 0.751 . . . . 65.34 112.411 -168.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -61.8 -37.62 85.05 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.942 0.497 . . . . 74.25 110.53 171.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 61.8 m -66.72 -25.48 66.54 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.876 -0.602 . . . . 72.03 111.943 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.444 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 89.6 mt -92.84 -39.34 11.25 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.815 0.846 . . . . 73.05 111.281 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 99' ' ' GLY . . . . . 0.451 ' HA2' HG21 ' D' ' 46' ' ' THR . . . -90.53 -1.85 73.9 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.622 -0.717 . . . . 44.3 113.54 -171.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.23 -49.64 0.13 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.157 0.429 . . . . 72.34 112.157 -173.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -73.63 -42.99 60.73 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 118.168 0.44 . . . . 72.55 111.958 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 89.8 m -60.27 -48.83 93.07 Favored Pre-proline 0 CA--C 1.562 1.425 0 CA-C-O 118.964 -0.541 . . . . 75.44 112.091 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.581 ' HD3' HG11 ' D' ' 58' ' ' VAL . 37.6 Cg_endo -65.54 -24.88 55.7 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 121.924 1.749 . . . . 63.33 112.835 173.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -67.98 -31.13 70.63 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.561 0.344 . . . . 65.21 110.262 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 37.5 mm -73.02 -38.92 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.025 0.93 . . . . 73.03 110.829 173.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' D' ' 103' ' ' PRO . 71.6 mt -69.76 -26.92 64.53 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.333 0.653 . . . . 70.05 111.899 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -62.82 -41.61 72.85 Favored Pre-proline 0 CA--C 1.554 1.132 0 N-CA-C 113.93 1.085 . . . . 74.41 113.93 -170.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -47.12 -45.43 21.54 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.205 1.937 . . . . 73.3 114.087 167.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -79.9 -32.69 40.22 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.678 0.791 . . . . 72.42 111.961 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.39 -36.14 66.0 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.236 0.614 . . . . 75.21 110.153 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.505 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.8 ttp180 -66.18 -45.1 82.02 Favored 'General case' 0 C--O 1.208 -1.116 0 CA-C-N 114.839 -1.073 . . . . 73.25 109.305 171.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -55.05 -48.56 73.29 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.958 0.903 . . . . 72.3 111.302 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.417 ' O ' ' HG3' ' D' ' 117' ' ' MET . 46.0 t -58.35 -45.8 87.49 Favored 'General case' 0 C--N 1.347 0.487 0 O-C-N 124.22 0.95 . . . . 74.23 111.032 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.539 HG12 ' SG ' ' D' ' 76' ' ' CYS . 45.1 mt -64.06 -55.04 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.111 0.565 . . . . 72.23 110.915 177.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.2 m -50.71 -40.66 54.8 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.354 1.462 . . . . 71.5 111.455 -176.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 34.4 t -66.66 -47.85 71.22 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.912 -1.04 . . . . 55.33 110.434 177.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.417 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 64.2 mtm -69.57 -29.5 67.06 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.495 0.554 . . . . 74.14 112.495 -175.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.419 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.4 t -67.82 -44.44 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.503 0.721 . . . . 62.31 109.471 176.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 65.9 p -71.66 -28.44 63.75 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 115.626 -0.716 . . . . 74.42 110.048 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' D' ' 116' ' ' SER . 92.7 mtt-85 -71.79 -30.05 65.12 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.82 0.848 . . . . 73.14 110.191 173.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.85 8.64 77.18 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 123.642 0.588 . . . . 71.32 112.748 176.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.411 HG23 ' HB3' ' C' ' 17' ' ' TYR . 82.0 p 54.91 31.12 15.2 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 126.165 1.786 . . . . 44.44 113.99 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -95.27 153.19 39.72 Favored Pre-proline 0 C--O 1.245 0.819 0 N-CA-C 107.702 -1.222 . . . . 61.2 107.702 168.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.49 150.33 60.75 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.657 2.238 . . . . 54.25 112.314 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -59.15 122.02 12.76 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.768 0.827 . . . . 72.44 111.829 -169.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.444 HD13 HG21 ' D' ' 40' ' ' VAL . 19.8 tp -107.42 100.68 10.09 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.066 0.947 . . . . 44.52 109.087 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -100.04 104.97 16.59 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.214 -1.032 . . . . 71.32 108.214 172.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.505 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 2.9 mm? -66.57 115.73 6.76 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 109.183 -0.673 . . . . 64.4 109.183 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.475 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -57.24 129.48 79.61 Favored Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 123.294 0.638 . . . . 34.5 112.087 -172.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 1.2 Cg_endo -79.05 117.09 3.8 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.068 2.512 . . . . 74.24 111.243 -175.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 14.8 p -127.03 149.21 31.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 123.697 0.799 . . . . 73.11 109.126 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -69.75 113.73 7.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.908 -0.775 . . . . 70.21 108.908 172.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 . . . . . 0 N--CA 1.481 1.121 0 C-N-CA 123.898 0.879 . . . . 73.1 111.213 -178.637 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 58.5 m . . . . . 0 C--O 1.235 0.295 0 N-CA-C 107.08 -1.452 . . . . 62.52 107.08 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -131.66 118.82 20.55 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.047 -0.724 . . . . 74.43 109.047 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.486 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 0.0 OUTLIER -136.98 131.7 33.3 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 106.603 -1.628 . . . . 75.24 106.603 175.171 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.462 ' CD1' HG21 ' A' ' 105' ' ' ILE . 6.4 mt -94.38 107.54 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.496 -0.928 . . . . 73.04 108.496 173.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.96 -40.31 68.75 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.519 -0.919 . . . . 74.43 108.519 -176.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 -173.89 122.85 0.33 Allowed 'General case' 0 C--N 1.351 0.655 0 CA-C-N 115.949 -0.569 . . . . 54.51 110.527 -169.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.572 HD12 ' HG3' ' C' ' 130' ' ' PRO . 65.0 mt -106.49 134.72 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 107.979 -1.119 . . . . 72.33 107.979 169.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.5 ' HE1' HG13 ' A' ' 83' ' ' ILE . 30.9 p90 -164.5 178.79 7.14 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 124.165 0.916 . . . . 74.24 110.807 -172.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.1 p -109.47 124.15 50.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.624 -0.716 . . . . 60.22 109.316 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.414 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 42.7 mtpt -86.46 -30.73 21.81 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.66 -0.496 . . . . 75.54 109.66 175.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.46 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 31.9 t70 -149.6 145.59 26.86 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.065 -0.97 . . . . 52.44 109.739 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.3 mt -141.02 146.02 24.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 C-N-CA 125.086 1.354 . . . . 74.41 107.835 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.2 t -152.15 137.7 17.76 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.55 0.74 . . . . 41.15 109.791 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.502 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 92.2 t80 -144.42 132.49 21.6 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.993 -1.484 . . . . 71.4 106.993 173.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -133.05 111.75 11.23 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.869 -0.789 . . . . 74.24 108.869 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -104.36 81.92 0.57 Allowed Pre-proline 0 C--O 1.245 0.817 0 N-CA-C 106.415 -1.698 . . . . 65.3 106.415 161.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.56 -29.05 25.46 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.282 1.988 . . . . 72.24 111.281 -172.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -111.45 19.1 18.53 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-N 114.451 -1.25 . . . . 52.23 109.297 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.49 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -44.83 -49.35 28.17 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 113.633 0.975 . . . . 55.34 113.633 -171.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -59.82 -39.62 70.71 Favored 'Trans proline' 0 C--N 1.392 2.858 0 C-N-CA 121.686 1.591 . . . . 75.12 112.744 176.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.432 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 3.2 m80 -76.72 -38.04 55.0 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.223 -1.353 . . . . 62.32 110.588 -173.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.473 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.6 p -72.6 -25.68 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 124.563 1.145 . . . . 63.21 111.281 -163.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -76.21 -18.82 58.88 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.557 0.743 . . . . 74.41 110.98 176.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -85.11 -28.21 25.74 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.171 0.989 . . . . 71.41 110.258 173.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 1.3 mmmp? -79.35 159.69 27.04 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.291 1.036 . . . . 55.45 111.735 -173.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.85 119.74 9.96 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.853 0.861 . . . . 65.31 110.353 176.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -82.47 85.18 6.98 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.543 0.687 . . . . 64.5 110.16 -178.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.504 ' H ' HD22 ' A' ' 68' ' ' LEU . 8.3 tp-100 -121.07 76.05 30.32 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.673 1.189 . . . . 75.34 108.263 172.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.53 113.11 2.81 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.599 2.199 . . . . 71.21 112.622 -171.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -94.69 92.17 6.88 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.585 -1.265 . . . . 73.3 107.585 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.496 HG22 ' HB2' ' A' ' 66' ' ' ALA . 61.5 t -89.44 106.38 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.718 -1.128 . . . . 63.2 111.037 -173.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -86.45 140.43 29.98 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.372 0.669 . . . . 62.41 110.561 171.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.9 mt -106.67 106.21 16.61 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.038 -1.097 . . . . 74.12 108.038 171.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -107.4 108.59 20.02 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.691 1.196 . . . . 70.2 108.157 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.55 HD11 HG21 ' A' ' 131' ' ' VAL . 83.7 mt -104.25 155.07 19.04 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.692 0.758 . . . . 64.23 112.249 -170.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 17.3 t70 -158.2 139.45 13.36 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 113.705 -1.589 . . . . 64.52 108.357 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.8 m -138.87 122.25 17.16 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.163 -0.681 . . . . 75.53 109.163 175.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.86 111.8 11.91 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.56 0.744 . . . . 62.42 109.213 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 p -91.66 153.1 19.91 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.384 0.674 . . . . 71.32 110.342 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.2 t -149.64 121.21 8.0 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.711 0.804 . . . . 63.24 109.454 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -71.35 112.48 7.52 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.56 -0.533 . . . . 74.11 109.56 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' A' ' 57' ' ' GLU . 46.8 mt -81.28 -43.76 18.69 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.128 0.571 . . . . 63.51 109.76 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.77 178.76 8.58 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.282 -0.872 . . . . 74.53 110.074 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.32 129.43 39.89 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 109.311 -0.626 . . . . 74.12 109.311 175.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 63.18 18.75 11.21 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.368 1.067 . . . . 72.03 111.262 -175.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.2 t -130.85 102.53 6.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.821 0 C-N-CA 124.374 1.069 . . . . 74.14 108.576 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -113.74 123.19 49.28 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.524 -1.287 . . . . 74.34 107.524 175.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.554 ' HB2' HD11 ' A' ' 51' ' ' LEU . 32.8 tt0 -85.46 151.38 24.02 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.686 -0.857 . . . . 73.12 108.686 173.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.423 HG11 ' HD3' ' A' ' 103' ' ' PRO . 70.2 t -130.3 135.57 60.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.137 -1.06 . . . . 73.11 108.137 169.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.2 t -117.49 128.35 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.748 -0.834 . . . . 75.21 108.748 173.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.95 100.03 9.55 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 106.769 -1.567 . . . . 53.15 106.769 176.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.495 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 21.0 ttp180 -86.83 101.61 13.51 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.617 -0.883 . . . . 72.41 108.617 173.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 37.3 t -97.85 126.95 50.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 107.442 -1.318 . . . . 71.0 107.442 173.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.6 m -124.05 123.48 40.45 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.499 -0.926 . . . . 51.31 108.499 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.591 HG11 HD21 ' A' ' 126' ' ' LEU . 69.3 t -117.09 135.42 57.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 124.843 1.257 . . . . 63.52 108.472 -174.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 30.6 m -136.47 127.93 28.54 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 109.657 -0.498 . . . . 64.13 109.657 169.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.496 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -106.05 128.3 53.76 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 107.025 -1.472 . . . . 75.23 107.025 172.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.1 m -132.21 129.82 40.2 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.05 0.54 . . . . 61.04 110.884 -175.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.504 HD22 ' H ' ' A' ' 37' ' ' GLN . 17.2 mt -89.92 51.48 2.08 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.355 1.462 . . . . 64.24 109.917 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.3 -86.37 1.12 Allowed Glycine 0 C--N 1.349 1.271 0 CA-C-N 116.228 -0.442 . . . . 55.15 113.097 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.42 -28.94 20.58 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.504 0.722 . . . . 73.33 111.044 -177.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -111.69 135.79 51.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.067 0.947 . . . . 64.11 109.181 -174.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.6 m -76.64 134.03 39.42 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.392 -0.596 . . . . 64.41 109.392 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.473 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -77.55 -60.2 2.46 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.436 0.694 . . . . 43.11 109.69 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -153.38 163.22 40.3 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.092 -0.958 . . . . 61.41 111.027 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.401 HD12 ' H ' ' A' ' 76' ' ' CYS . 28.1 tp -126.1 142.63 51.44 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.057 1.343 . . . . 74.03 108.277 173.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.571 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.2 m -137.77 139.49 40.1 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.784 1.234 . . . . 73.25 108.318 176.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -148.7 124.34 10.44 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.955 -0.757 . . . . 72.3 108.955 169.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.5 t -128.66 119.87 51.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 109.041 -0.725 . . . . 71.13 109.041 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.495 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 51.9 mt-30 -92.97 85.5 5.15 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.286 -1.005 . . . . 75.21 108.286 172.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -76.2 94.78 3.58 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 114.363 -1.29 . . . . 61.2 109.183 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.0 145.47 19.27 Favored Glycine 0 C--N 1.341 0.828 0 N-CA-C 111.399 -0.681 . . . . 72.4 111.399 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.12 122.93 1.9 Allowed Glycine 0 CA--C 1.507 -0.415 0 N-CA-C 110.455 -1.058 . . . . 51.11 110.455 -176.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.5 HG13 ' HE1' ' A' ' 17' ' ' TYR . 53.0 mt -80.36 115.83 23.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 107.93 -1.137 . . . . 74.13 107.93 173.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.807 ' HB3' HD11 ' A' ' 86' ' ' ILE . 98.3 m-85 -120.3 123.78 43.98 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.92 -0.77 . . . . 74.35 108.92 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.486 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 17.8 m -86.33 94.28 9.31 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.631 -0.878 . . . . 33.43 108.631 176.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.807 HD11 ' HB3' ' A' ' 84' ' ' PHE . 6.3 mm -109.48 147.98 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 122.151 0.181 . . . . 63.42 110.598 -175.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.432 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -172.33 177.84 2.98 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.386 1.075 . . . . 71.11 109.566 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.88 -24.09 27.97 Favored Glycine 0 N--CA 1.467 0.75 0 CA-C-O 120.246 -0.197 . . . . 51.1 113.192 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.485 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -129.54 170.16 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.816 0.846 . . . . 71.12 110.87 -176.921 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -155.55 179.15 9.45 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.337 -0.847 . . . . 72.05 109.478 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.53 -122.0 28.61 Favored Glycine 0 C--N 1.347 1.165 0 C-N-CA 123.531 0.586 . . . . 52.31 114.033 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.8 p -73.04 -30.81 64.0 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.032 0.933 . . . . 65.54 111.887 -176.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -71.19 -37.21 72.13 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.136 0.574 . . . . 74.05 110.189 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.403 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 4.9 tpt -66.47 -46.44 76.37 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.726 -0.67 . . . . 72.34 109.997 175.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.1 -35.6 75.58 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.654 -0.703 . . . . 53.1 110.798 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -71.12 -35.11 71.64 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.232 0.613 . . . . 73.03 111.327 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -65.12 -44.01 90.11 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 109.437 -0.579 . . . . 62.25 109.437 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.403 ' HG ' ' HE2' ' A' ' 94' ' ' MET . 33.0 mt -82.75 -27.53 31.02 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.213 -0.903 . . . . 73.35 112.534 -175.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.07 4.29 38.52 Favored Glycine 0 N--CA 1.473 1.16 0 CA-C-O 119.689 -0.506 . . . . 73.15 114.124 -171.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.93 -67.67 0.29 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 117.388 0.594 . . . . 54.01 111.503 -176.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -66.97 -47.76 70.58 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 112.506 0.558 . . . . 64.3 112.506 -172.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 86.6 m -64.55 -48.44 74.35 Favored Pre-proline 0 CA--C 1.561 1.397 0 CA-C-O 118.364 -0.827 . . . . 72.51 112.635 -177.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.423 ' HD3' HG11 ' A' ' 58' ' ' VAL . 32.5 Cg_endo -64.42 -24.08 64.45 Favored 'Trans proline' 0 C--N 1.395 2.999 0 C-N-CA 121.671 1.58 . . . . 71.51 112.797 172.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -67.7 -36.67 81.07 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.179 0.592 . . . . 71.04 110.38 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.462 HG21 ' CD1' ' A' ' 13' ' ' ILE . 44.2 mm -69.37 -42.5 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.635 0.774 . . . . 71.4 110.133 173.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.2 mt -72.41 -23.88 61.16 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.153 -0.931 . . . . 72.42 112.068 -174.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -66.41 -41.33 40.64 Favored Pre-proline 0 N--CA 1.484 1.262 0 N-CA-C 114.306 1.225 . . . . 74.21 114.306 -171.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -50.0 -44.39 37.57 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 121.92 1.746 . . . . 65.33 113.214 168.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -74.67 -36.37 62.8 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.627 0.771 . . . . 74.21 111.709 -177.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.19 -46.65 64.17 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.345 0.658 . . . . 44.41 109.846 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.535 ' NH1' HD12 ' C' ' 105' ' ' ILE . 33.2 ttm105 -49.72 -54.8 16.69 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.812 1.32 . . . . 71.23 109.994 173.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -63.06 -44.26 96.31 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.156 0.91 . . . . 71.54 111.798 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.453 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.6 t -61.79 -31.89 72.14 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.919 0.487 . . . . 73.54 111.432 -179.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.498 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 71.1 mt -71.49 -54.95 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.602 0.761 . . . . 75.15 109.657 172.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 46.2 m -56.32 -35.12 67.21 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.039 1.336 . . . . 72.11 111.605 -173.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.5 t -69.81 -44.24 70.41 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 114.956 -1.02 . . . . 74.25 109.734 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.502 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 51.7 mtm -63.42 -38.83 92.67 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.886 0.474 . . . . 74.14 110.715 177.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 114' ' ' ILE . 84.9 t -61.51 -47.85 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 124.399 1.08 . . . . 62.21 110.475 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.8 p -74.24 -34.38 63.62 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.124 0.569 . . . . 54.13 111.393 -175.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.524 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.1 mtt-85 -70.7 -27.22 63.83 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.744 0.818 . . . . 75.44 109.696 174.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.52 7.24 62.06 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.361 -0.836 . . . . 75.24 112.714 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.461 HG21 ' HE ' ' B' ' 15' ' ' ARG . 36.0 m 72.88 9.21 5.49 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 124.625 1.17 . . . . 70.13 112.083 173.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -83.91 139.91 40.21 Favored Pre-proline 0 C--O 1.244 0.794 0 O-C-N 121.225 -0.922 . . . . 71.35 108.785 173.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -56.31 141.5 88.79 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.282 1.988 . . . . 75.13 110.85 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -56.57 140.43 46.57 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 124.324 1.015 . . . . 72.55 113.08 -165.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.591 HD21 HG11 ' A' ' 64' ' ' VAL . 31.6 tp -119.56 105.29 11.08 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 113.665 -1.607 . . . . 71.32 109.424 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -99.28 118.85 36.87 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 107.941 -1.133 . . . . 75.54 107.941 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 11.9 mt -70.75 147.14 49.31 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.616 0.573 . . . . 72.04 110.012 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -64.55 132.52 95.42 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 123.043 0.537 . . . . 41.13 110.329 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 25.8 Cg_exo -62.87 116.85 3.81 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.794 2.329 . . . . 45.23 112.221 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.55 HG21 HD11 ' A' ' 44' ' ' LEU . 87.3 t -99.04 130.46 47.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 C-N-CA 123.131 0.572 . . . . 73.42 110.549 -172.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -90.76 89.06 7.33 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 108.324 -0.991 . . . . 54.04 108.324 174.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -65.03 -23.17 67.12 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.512 0.725 . . . . 74.33 112.373 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.31 -39.37 82.03 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.484 0.714 . . . . 64.34 110.29 174.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.88 83.94 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.237 0.615 . . . . 60.51 110.309 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 60.3 mt -65.54 -41.32 93.19 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.033 0.533 . . . . 65.34 111.052 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.7 t80 . . . . . 0 N--CA 1.47 0.561 0 CA-C-N 115.432 -0.803 . . . . 71.04 109.808 178.414 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.533 ' HG3' HG13 ' B' ' 89' ' ' ILE . 26.3 ttt . . . . . 0 CA--C 1.562 1.435 0 CA-C-O 121.789 0.804 . . . . 60.1 112.109 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 41.7 m -142.39 101.98 4.0 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 107.262 -1.384 . . . . 60.3 107.262 172.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -123.54 132.96 54.04 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.547 -0.909 . . . . 74.54 108.547 175.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -157.8 140.34 14.64 Favored 'General case' 0 C--O 1.244 0.768 0 O-C-N 123.768 0.667 . . . . 73.22 109.621 171.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.591 HD13 HD11 ' B' ' 16' ' ' ILE . 41.2 mt -67.81 131.52 33.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 114.774 -1.103 . . . . 64.1 109.624 177.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -94.9 -45.41 7.3 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.984 -0.747 . . . . 41.41 108.984 173.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.461 ' HE ' HG21 ' A' ' 122' ' ' THR . 16.4 ttt180 -169.96 131.68 1.06 Allowed 'General case' 0 C--N 1.353 0.725 0 CA-C-N 115.494 -0.775 . . . . 72.15 110.301 -174.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.591 HD11 HD13 ' B' ' 13' ' ' ILE . 93.9 mt -115.11 146.0 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 108.057 -1.09 . . . . 64.0 108.057 174.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -168.31 149.65 5.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 112.813 0.672 . . . . 71.33 112.813 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 46.4 m -76.84 123.82 26.8 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 114.834 -1.075 . . . . 74.11 109.61 170.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.589 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.4 mtpt -96.6 -17.65 20.27 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.602 0.761 . . . . 62.01 111.326 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -164.31 141.84 6.78 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 123.649 0.593 . . . . 35.25 110.406 -174.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.456 HD12 ' SG ' ' B' ' 113' ' ' CYS . 30.5 mm -130.9 144.35 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.062 0.945 . . . . 74.21 108.957 170.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 34.7 t -149.59 140.96 23.24 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.961 -1.018 . . . . 75.03 109.032 174.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.416 ' HB2' ' HB3' ' B' ' 117' ' ' MET . 91.5 t80 -148.2 124.83 11.09 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.07 -1.456 . . . . 71.51 107.07 169.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -132.18 112.92 12.7 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.527 0.731 . . . . 70.34 109.233 -177.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.568 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -107.8 87.69 3.84 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.469 -1.308 . . . . 71.15 107.469 171.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.3 -27.28 34.63 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.532 2.155 . . . . 72.22 112.081 -172.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -110.4 9.71 23.42 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.069 0.948 . . . . 70.2 110.911 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.568 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -30.64 -66.35 0.17 Allowed Pre-proline 0 N--CA 1.493 1.68 0 C-N-CA 125.668 1.587 . . . . 42.55 115.23 -167.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.507 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 28.8 Cg_exo -58.51 -36.27 97.61 Favored 'Trans proline' 0 C--N 1.398 3.173 0 C-N-CA 122.13 1.887 . . . . 72.2 113.266 -174.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -86.63 -37.66 17.83 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.168 -0.924 . . . . 71.14 111.79 -171.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.493 HG21 ' HA ' ' B' ' 73' ' ' ALA . 8.7 p -71.06 -9.21 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.371 0.668 . . . . 71.12 111.64 -174.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -72.87 -9.52 58.78 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.112 0.565 . . . . 71.41 112.301 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -67.97 -28.89 67.84 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.232 0.613 . . . . 61.11 110.221 171.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.44 ' HB2' HD13 ' B' ' 68' ' ' LEU . 30.5 mmtp -81.55 102.19 10.45 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.573 1.149 . . . . 52.34 108.941 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -107.38 87.95 2.62 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 120.956 0.408 . . . . 70.21 110.857 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -169.61 172.08 7.13 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.772 1.229 . . . . 71.01 108.64 169.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.7 117.74 53.71 Favored Pre-proline 0 N--CA 1.479 1.0 0 N-CA-C 109.021 -0.733 . . . . 73.04 109.021 175.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.432 ' O ' HG23 ' B' ' 40' ' ' VAL . 16.8 Cg_endo -60.52 150.21 82.65 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.245 1.963 . . . . 73.53 112.546 -176.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -70.64 112.31 6.78 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.087 -1.079 . . . . 72.23 108.087 172.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 38' ' ' PRO . 59.9 t -105.53 146.79 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 115.361 -0.836 . . . . 72.02 110.818 -172.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -129.78 106.44 8.7 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 106.933 -1.506 . . . . 74.44 106.933 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.44 HD13 HG22 ' B' ' 64' ' ' VAL . 23.6 tp -90.38 125.48 35.56 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.621 -0.511 . . . . 73.53 109.621 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -130.92 155.71 46.31 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.521 1.128 . . . . 71.42 108.112 -178.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.2 162.91 34.28 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.439 0.695 . . . . 62.53 111.547 -173.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.661 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 8.7 m-20 -138.5 126.11 22.08 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.753 1.221 . . . . 74.15 109.394 175.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 7.8 t -114.98 111.14 20.68 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.544 0.687 . . . . 64.13 109.902 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.41 141.85 21.64 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.812 0.845 . . . . 75.34 109.013 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.434 ' HB3' ' HA ' ' B' ' 58' ' ' VAL . 79.0 p -142.07 172.22 12.99 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.571 0.348 . . . . 72.03 111.183 -176.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 54.4 p -151.27 141.37 22.17 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.387 0.675 . . . . 75.35 110.407 -174.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' GLN . . . . . 0.466 ' HB2' ' CE1' ' B' ' 56' ' ' TYR . 43.5 tt0 -85.98 103.71 14.94 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 109.218 -0.66 . . . . 72.53 109.218 173.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 pp -126.07 24.94 6.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.352 -0.84 . . . . 72.23 109.027 174.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.85 157.67 24.36 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.535 -1.211 . . . . 53.55 109.7 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -83.18 104.47 13.39 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.524 0.73 . . . . 75.35 111.575 -167.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 58.16 23.97 10.81 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 124.696 1.198 . . . . 71.43 111.534 -172.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 85.9 t -131.13 115.85 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 113.788 -1.551 . . . . 60.41 107.288 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.466 ' CE1' ' HB2' ' B' ' 50' ' ' GLN . 0.2 OUTLIER -104.78 140.92 37.38 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.107 0.563 . . . . 61.51 109.769 -174.167 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -100.18 97.64 8.42 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.481 -1.303 . . . . 64.15 107.481 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.434 ' HA ' ' HB3' ' B' ' 48' ' ' SER . 55.3 t -93.06 126.97 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 123.642 0.777 . . . . 70.44 110.078 -177.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.429 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 20.3 t -107.22 142.77 19.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 123.453 0.701 . . . . 74.33 109.426 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.471 HD13 ' HB3' ' B' ' 103' ' ' PRO . 52.7 tp -129.73 108.8 10.46 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.253 -1.017 . . . . 74.54 108.253 171.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.661 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 37.9 ttm180 -87.06 115.34 24.38 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.063 -1.088 . . . . 72.05 108.063 171.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 25.1 t -103.89 119.4 52.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.548 -1.279 . . . . 71.11 107.548 173.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 24.4 m -119.83 128.81 54.04 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.207 -0.664 . . . . 73.34 109.207 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.587 HG11 HD21 ' B' ' 126' ' ' LEU . 84.9 t -117.96 109.55 27.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 123.975 0.91 . . . . 62.44 109.102 -175.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 99.5 m -89.13 138.04 31.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.676 -1.231 . . . . 71.45 107.676 168.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.41 141.09 25.61 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.191 -0.67 . . . . 71.05 109.191 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.46 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 31.9 p -145.28 138.07 26.15 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.522 0.514 . . . . 71.31 111.221 -173.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' B' ' 34' ' ' LYS . 77.7 mt -110.97 102.21 10.71 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.487 1.115 . . . . 71.32 109.159 176.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.77 -137.45 19.47 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.129 -0.788 . . . . 52.03 111.129 -172.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -92.54 3.14 56.11 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 117.405 0.602 . . . . 70.4 110.613 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -113.68 151.87 31.23 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.013 0.525 . . . . 74.44 109.654 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 60.7 m -72.88 133.23 44.32 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.119 -0.491 . . . . 54.51 110.216 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.493 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -84.23 -64.57 1.14 Allowed 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.883 -1.155 . . . . 54.34 107.883 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -155.36 158.88 39.4 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.45 -1.25 . . . . 71.52 110.581 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 53.4 mt -132.35 108.89 9.49 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 106.432 -1.692 . . . . 74.12 106.432 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 48.5 t -119.5 116.34 25.89 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.076 -0.713 . . . . 74.34 109.076 -177.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.411 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 43.9 tt0 -124.67 121.76 35.61 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.761 -0.829 . . . . 74.03 108.761 -175.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 79.4 t -126.41 135.37 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.89 0.876 . . . . 74.23 109.014 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -107.7 119.77 40.36 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.073 -1.084 . . . . 74.31 108.073 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.432 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 8.0 tp-100 -110.03 106.01 15.35 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.659 -0.867 . . . . 73.32 108.659 174.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.589 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -98.94 160.81 20.13 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.189 -0.764 . . . . 45.43 111.189 174.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.32 126.2 1.7 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 112.18 -0.368 . . . . 53.02 112.18 -174.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -85.39 114.17 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 N-CA-C 107.718 -1.215 . . . . 74.1 107.718 173.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -129.75 143.66 50.92 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.043 0.937 . . . . 73.03 109.774 -175.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.3 m -88.98 123.3 33.18 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.47 -0.567 . . . . 55.22 109.47 172.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.567 HG22 HD11 ' B' ' 89' ' ' ILE . 4.2 mp -122.98 115.64 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 N-CA-C 108.159 -1.052 . . . . 75.11 108.159 177.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.91 172.64 17.71 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.786 0.835 . . . . 73.0 110.389 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.402 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 88.73 -37.93 3.25 Favored Glycine 0 N--CA 1.481 1.669 0 C-N-CA 123.042 0.353 . . . . 62.11 113.942 172.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.567 HD11 HG22 ' B' ' 86' ' ' ILE . 0.8 OUTLIER -81.15 169.14 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 124.433 1.093 . . . . 73.41 111.87 176.304 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -154.06 175.18 13.73 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.282 -0.872 . . . . 65.53 110.349 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.1 -136.87 27.41 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.802 -0.635 . . . . 4.04 113.221 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.4 m -93.82 -29.16 15.48 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.01 0.524 . . . . 64.12 110.907 -177.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -56.19 -29.55 61.05 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.916 0.887 . . . . 72.13 111.224 175.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.413 ' SD ' ' N ' ' B' ' 95' ' ' ALA . 0.7 OUTLIER -66.8 -57.2 7.53 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.612 1.565 . . . . 75.31 112.592 -179.237 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 95' ' ' ALA . . . . . 0.413 ' N ' ' SD ' ' B' ' 94' ' ' MET . . . -78.41 -15.12 59.01 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 111.958 0.355 . . . . 51.05 111.958 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -59.51 -30.03 68.28 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.834 0.854 . . . . 64.35 110.499 169.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -63.48 -55.38 24.59 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.072 0.549 . . . . 65.42 111.774 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.487 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.6 pp -69.45 -31.96 70.6 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.631 0.372 . . . . 73.53 111.961 -174.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.02 -23.77 51.0 Favored Glycine 0 C--N 1.348 1.207 0 O-C-N 123.379 0.424 . . . . 35.14 113.567 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.43 -59.28 1.39 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.054 0.542 . . . . 71.1 112.002 -169.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -64.48 -43.74 93.19 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.266 0.626 . . . . 74.15 111.798 -174.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 79.8 m -65.59 -48.13 65.88 Favored Pre-proline 0 CA--C 1.566 1.58 0 CA-C-O 118.309 -0.853 . . . . 63.22 112.201 -176.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.471 ' HB3' HD13 ' B' ' 60' ' ' LEU . 85.8 Cg_exo -53.47 -34.55 72.4 Favored 'Trans proline' 0 C--N 1.397 3.122 0 C-N-CA 122.557 2.171 . . . . 70.23 113.829 170.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -65.4 -29.47 70.18 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.14 0.576 . . . . 70.55 111.941 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.418 HG23 ' NH2' ' D' ' 111' ' ' ARG . 62.6 mt -71.56 -41.54 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.085 0.554 . . . . 65.43 109.858 174.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.4 mt -78.3 -29.87 48.06 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 114.79 -1.096 . . . . 53.24 112.453 -169.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -55.67 -49.6 91.82 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-O 117.739 -1.124 . . . . 73.2 113.304 -174.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -48.12 -47.51 19.23 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 122.907 2.405 . . . . 53.23 114.695 176.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -65.01 -46.27 82.1 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.137 0.575 . . . . 75.43 110.931 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.432 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -62.41 -39.54 93.61 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.204 -0.907 . . . . 63.42 110.698 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.51 HH22 HD21 ' B' ' 127' ' ' ASN . 52.3 ttt-85 -62.92 -47.06 84.9 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.552 1.541 . . . . 74.41 111.213 -176.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.23 -34.95 73.49 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.598 0.561 . . . . 72.53 110.09 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.524 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 8.8 t -68.58 -36.61 78.96 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.612 -0.267 . . . . 71.14 111.082 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.522 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 85.0 mt -59.49 -53.65 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.745 0.818 . . . . 73.44 109.897 169.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 54.5 m -57.13 -32.54 66.46 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.654 0.781 . . . . 70.31 111.546 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.475 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 42.8 t -63.79 -49.8 71.5 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.666 0.786 . . . . 64.42 109.891 174.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.524 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.5 mmt -70.67 -30.76 67.45 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.096 0.558 . . . . 73.24 111.54 -175.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.483 HG23 ' O ' ' B' ' 114' ' ' ILE . 95.3 t -66.35 -41.74 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.667 0.787 . . . . 72.52 109.704 173.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.2 t -65.83 -32.22 73.62 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.879 -1.055 . . . . 53.11 110.804 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' B' ' 116' ' ' SER . 88.1 mtt-85 -70.02 -34.71 73.64 Favored 'General case' 0 C--O 1.206 -1.23 0 CA-C-N 115.782 -0.644 . . . . 74.15 110.179 176.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.05 -13.89 82.77 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.428 0.455 . . . . 71.52 112.364 170.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.6 m 69.55 24.1 5.73 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 125.125 1.37 . . . . 21.33 110.519 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.487 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 71.5 m-85 -77.57 159.05 77.87 Favored Pre-proline 0 N--CA 1.477 0.91 0 CA-C-N 114.875 -1.057 . . . . 73.13 110.366 175.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.14 158.56 4.99 Favored 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 123.204 2.603 . . . . 53.32 113.794 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -62.14 126.35 27.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.71 0.804 . . . . 73.34 112.459 -170.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.587 HD21 HG11 ' B' ' 64' ' ' VAL . 39.6 tp -109.81 101.13 10.02 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-N 115.225 -0.898 . . . . 61.23 109.131 178.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 127' ' ' ASN . . . . . 0.51 HD21 HH22 ' B' ' 111' ' ' ARG . 6.9 m120 -99.25 105.69 17.74 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 107.187 -1.412 . . . . 61.53 107.187 167.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.467 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 46.8 mt -63.64 127.88 33.34 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.332 -0.618 . . . . 71.54 109.332 175.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.01 148.47 92.47 Favored Pre-proline 0 CA--C 1.553 1.078 0 O-C-N 123.775 0.672 . . . . 60.34 111.225 -175.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -69.57 90.3 0.5 Allowed 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.872 2.381 . . . . 65.04 111.863 -174.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 81.9 t -95.45 109.75 23.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.611 -0.885 . . . . 73.22 108.611 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 41.7 t30 . . . . . 0 C--O 1.24 0.6 0 N-CA-C 107.549 -1.278 . . . . 62.25 107.549 171.691 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 66.6 t80 . . . . . 0 N--CA 1.471 0.586 0 N-CA-C 107.317 -1.364 . . . . 72.35 107.317 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -141.27 136.03 31.23 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 120.919 0.39 . . . . 71.03 110.177 175.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.44 HG12 ' HE2' ' C' ' 84' ' ' PHE . 16.2 mt -75.92 120.11 25.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 115.083 -0.962 . . . . 72.44 108.407 174.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.523 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.0 mm-40 -87.88 -39.08 15.1 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 123.639 0.587 . . . . 75.44 109.486 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.3 ptt-85 177.96 153.86 0.31 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.513 1.125 . . . . 63.0 110.392 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 70.7 mt -135.05 125.69 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.179 1.391 . . . . 74.3 107.262 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.408 ' HB3' HG23 ' D' ' 122' ' ' THR . 29.8 p90 -164.42 158.68 18.73 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.229 0.538 . . . . 62.01 111.408 -166.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.7 p -87.8 109.63 19.88 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.455 -0.793 . . . . 54.51 110.164 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.534 ' HD2' ' HB3' ' D' ' 28' ' ' ALA . 13.8 mtmt -82.39 -16.68 48.2 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 110.069 -0.345 . . . . 74.42 110.069 172.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.684 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.4 t70 -153.7 139.01 17.53 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.862 -0.608 . . . . 71.44 109.911 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.6 mt -141.57 145.75 24.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 106.57 -1.641 . . . . 73.24 106.57 173.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.4 t -157.23 144.99 18.98 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.262 0.553 . . . . 74.12 110.2 173.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -142.93 129.68 20.4 Favored 'General case' 0 C--O 1.225 -0.208 0 N-CA-C 107.054 -1.462 . . . . 74.11 107.054 170.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -135.73 112.56 10.2 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.24 -0.652 . . . . 73.25 109.24 -175.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.25 85.73 5.77 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 106.981 -1.488 . . . . 24.55 106.981 168.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.26 -19.96 37.81 Favored 'Trans proline' 0 C--N 1.383 2.38 0 C-N-CA 122.69 2.26 . . . . 63.55 111.874 -174.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -120.02 31.01 6.71 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.332 1.053 . . . . 74.43 109.022 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.56 -60.63 2.77 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 114.24 1.2 . . . . 53.3 114.24 -170.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.21 -32.71 41.84 Favored 'Trans proline' 0 C--N 1.379 2.152 0 CA-C-N 121.34 1.514 . . . . 75.15 111.926 -177.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -69.32 -38.34 78.18 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.662 -1.153 . . . . 60.11 111.986 -177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' C' ' 73' ' ' ALA . 13.9 p -79.08 -29.55 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 112.075 0.398 . . . . 73.13 112.075 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -62.61 -30.01 71.03 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.013 0.525 . . . . 62.13 112.383 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -88.59 7.13 34.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.201 0.6 . . . . 71.01 111.949 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.403 ' HG2' HD13 ' C' ' 68' ' ' LEU . 2.8 ttpm? -114.71 143.2 45.43 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.659 0.783 . . . . 61.03 110.076 175.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.66 131.79 49.06 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.559 1.144 . . . . 72.11 111.985 -175.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 36' ' ' TRP . . . . . 0.42 ' HZ2' HD21 ' C' ' 126' ' ' LEU . 75.3 t-105 -74.41 87.58 2.05 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.653 1.181 . . . . 64.51 111.683 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 37' ' ' GLN . . . . . 0.424 ' H ' HD22 ' C' ' 68' ' ' LEU . 47.2 mt-30 -132.91 73.05 76.27 Favored Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 124.253 1.021 . . . . 75.32 108.732 169.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -91.39 148.92 3.57 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.816 2.344 . . . . 61.32 112.598 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -88.25 81.12 7.38 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 107.268 -1.382 . . . . 72.11 107.268 164.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.54 113.3 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 CA-C-N 114.911 -1.041 . . . . 73.34 109.964 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -94.02 101.31 13.35 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.561 -0.903 . . . . 72.11 108.561 175.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 tt -87.81 129.82 35.07 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 106.97 -1.493 . . . . 74.55 106.97 176.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 14.2 t70 -128.93 140.56 51.61 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.08 0.952 . . . . 64.41 109.477 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.447 HD23 HG22 ' C' ' 62' ' ' VAL . 45.5 mt -125.95 111.12 14.4 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.616 -0.883 . . . . 70.51 108.616 172.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -122.46 121.32 36.33 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 107.74 -1.207 . . . . 54.34 107.74 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.3 t -121.32 144.18 48.78 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.324 -0.621 . . . . 61.14 109.324 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.99 151.56 42.62 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.907 0.883 . . . . 74.45 108.729 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 56.7 p -138.06 143.4 40.47 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 122.863 0.465 . . . . 71.25 110.304 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 78.9 p -145.41 153.52 41.29 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.545 0.738 . . . . 74.23 110.006 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -81.94 118.02 22.63 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 109.035 -0.728 . . . . 75.14 109.035 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.651 HD11 ' HB2' ' C' ' 57' ' ' GLU . 87.5 mt -82.89 -53.14 6.08 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.32 0.648 . . . . 42.21 109.288 174.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.15 -172.59 3.52 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 114.206 -1.361 . . . . 24.44 109.14 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.44 107.73 1.44 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.702 0.801 . . . . 74.03 110.068 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 70.69 12.62 7.27 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.367 1.467 . . . . 63.52 112.683 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 90.4 t -110.55 118.92 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.064 -0.717 . . . . 72.42 109.064 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -121.5 129.98 53.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.621 1.169 . . . . 72.54 109.343 -174.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.651 ' HB2' HD11 ' C' ' 51' ' ' LEU . 44.8 tt0 -96.77 115.09 26.84 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.208 -0.664 . . . . 74.31 109.208 170.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 89.1 t -96.76 116.01 37.76 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 N-CA-C 107.894 -1.151 . . . . 62.2 107.894 169.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.46 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 61.0 t -103.76 131.53 52.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.882 -0.785 . . . . 74.42 108.882 173.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.47 98.51 8.27 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 107.709 -1.219 . . . . 64.04 107.709 172.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -82.44 106.78 14.59 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.525 -0.917 . . . . 75.41 108.525 172.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.448 ' HB ' HD11 ' C' ' 114' ' ' ILE . 12.8 t -104.61 125.19 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.906 -0.775 . . . . 64.1 108.906 177.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 89.9 m -110.23 130.7 55.5 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.94 -0.763 . . . . 54.32 108.94 178.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.668 HG21 HG21 ' C' ' 114' ' ' ILE . 97.4 t -124.37 109.05 21.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.506 -0.924 . . . . 52.34 108.506 174.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.8 m -101.56 141.89 33.75 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.824 -0.806 . . . . 72.41 108.824 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.21 117.96 18.92 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.266 -1.012 . . . . 73.51 108.266 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 37.3 m -140.03 125.99 19.64 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.201 0.313 . . . . 62.31 111.297 -177.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.424 HD22 ' H ' ' C' ' 37' ' ' GLN . 21.2 mt -87.9 46.63 1.4 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.728 1.211 . . . . 70.34 110.138 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.94 -114.45 4.65 Favored Glycine 0 C--N 1.344 1.011 0 N-CA-C 110.519 -1.033 . . . . 64.55 110.519 -170.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.18 -12.53 37.88 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.25 0.62 . . . . 73.4 110.395 174.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -75.27 121.33 22.02 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 124.359 1.064 . . . . 71.22 109.678 174.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.1 m -82.58 115.9 21.75 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 108.685 -0.858 . . . . 62.01 108.685 165.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.618 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -69.96 -48.57 57.83 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.148 -1.056 . . . . 64.33 108.148 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -168.22 172.11 8.85 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 114.316 -1.311 . . . . 73.14 111.27 175.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.438 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.9 tm? -127.56 144.51 51.06 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 106.667 -1.605 . . . . 72.31 106.667 166.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.438 ' N ' HD13 ' C' ' 75' ' ' LEU . 54.1 t -145.86 145.86 30.9 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.71 -0.848 . . . . 71.45 108.71 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -158.81 140.28 13.31 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.762 -0.459 . . . . 63.02 109.762 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 27.0 t -135.81 114.39 15.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 124.65 1.18 . . . . 73.32 107.875 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.684 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.4 mt-30 -94.27 89.07 5.79 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.951 -0.759 . . . . 75.22 108.951 171.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -79.96 96.47 6.42 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.576 -1.193 . . . . 74.45 109.108 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -82.78 145.09 23.42 Favored Glycine 0 C--N 1.343 0.945 0 N-CA-C 111.425 -0.67 . . . . 70.53 111.425 177.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.05 117.68 1.09 Allowed Glycine 0 CA--C 1.507 -0.42 0 N-CA-C 111.028 -0.829 . . . . 73.44 111.028 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.523 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 15.5 mm -86.01 131.44 34.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.859 -0.793 . . . . 74.14 108.859 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.44 ' HE2' HG12 ' C' ' 13' ' ' ILE . 94.6 m-85 -137.8 120.54 16.31 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.667 0.787 . . . . 75.42 109.913 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 17.1 p -79.9 100.51 8.09 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 108.282 -1.007 . . . . 64.42 108.282 170.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.545 HD13 ' SG ' ' C' ' 97' ' ' CYS . 15.6 mt -114.3 140.28 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 123.168 0.587 . . . . 71.5 109.698 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.96 158.27 36.28 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.512 1.125 . . . . 74.32 109.315 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.01 -18.54 57.25 Favored Glycine 0 C--O 1.246 0.903 0 N-CA-C 115.761 1.064 . . . . 62.02 115.761 166.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 13.5 pt -106.98 170.53 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 117.315 0.558 . . . . 63.34 111.225 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -157.68 151.19 23.74 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.328 0.651 . . . . 74.02 110.65 -175.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.73 -121.99 10.02 Favored Glycine 0 C--N 1.348 1.213 0 O-C-N 123.929 0.768 . . . . 25.12 113.647 171.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.1 p -62.16 -30.56 71.14 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.836 0.855 . . . . 71.14 111.617 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -69.98 -49.94 46.65 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.315 1.046 . . . . 72.3 111.137 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.04 -46.28 90.04 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 124.105 0.878 . . . . 73.14 110.429 176.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.39 90.92 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.477 0.711 . . . . 64.34 111.226 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -69.44 -35.88 76.11 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.221 0.609 . . . . 75.02 110.697 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.545 ' SG ' HD13 ' C' ' 86' ' ' ILE . 33.8 t -66.83 -51.28 57.51 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.871 0.732 . . . . 74.04 109.291 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 68.7 mt -74.85 -35.52 62.37 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.354 1.062 . . . . 64.33 113.063 -177.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.37 -14.05 33.97 Favored Glycine 0 N--CA 1.473 1.135 0 N-CA-C 115.032 0.773 . . . . 63.41 115.032 -165.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.507 ' HB2' ' HB2' ' C' ' 137' ' ' PHE . . . -138.01 -49.05 0.56 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 117.854 0.827 . . . . 60.41 111.944 -173.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -73.12 -49.95 25.51 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.951 0.901 . . . . 73.3 111.633 -172.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.402 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 84.5 m -67.25 -47.49 49.71 Favored Pre-proline 0 CA--C 1.564 1.516 0 C-N-CA 123.478 0.711 . . . . 72.03 112.233 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 52.9 Cg_exo -58.19 -27.8 81.74 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 122.464 2.109 . . . . 74.4 113.552 175.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -65.68 -38.27 88.79 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.188 0.595 . . . . 61.2 110.543 176.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.535 HD12 ' NH1' ' A' ' 111' ' ' ARG . 30.1 mm -71.01 -36.94 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 116.029 -0.532 . . . . 75.02 109.732 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 6.1 mp -79.19 -25.5 42.75 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.431 1.092 . . . . 75.41 112.768 -176.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 107' ' ' PHE . . . . . 0.403 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 56.6 t80 -57.23 -50.71 86.62 Favored Pre-proline 0 N--CA 1.479 0.997 0 CA-C-O 117.849 -1.072 . . . . 72.25 113.394 -172.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 108' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 38.7 Cg_exo -60.71 -34.21 92.19 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.016 1.81 . . . . 72.52 113.158 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -64.7 -47.87 76.75 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.226 0.61 . . . . 43.31 110.633 177.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.73 -35.51 80.29 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.775 -0.648 . . . . 54.54 110.788 177.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -61.31 -53.13 60.64 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.246 1.418 . . . . 74.42 110.593 -178.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 112' ' ' GLU . . . . . 0.405 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.7 tm-20 -66.07 -34.31 77.78 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.403 -0.817 . . . . 70.23 110.28 -178.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.0 t -67.06 -39.17 86.82 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.06 0.544 . . . . 65.32 111.099 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.668 HG21 HG21 ' C' ' 64' ' ' VAL . 87.1 mt -69.17 -50.78 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.371 0.669 . . . . 74.15 110.579 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.2 m -64.14 -28.69 69.94 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 123.486 0.491 . . . . 70.44 110.476 -176.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.4 t -64.44 -51.82 61.21 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 123.57 0.748 . . . . 62.51 109.704 171.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.43 ' CE ' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -50.33 -47.92 55.63 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 124.361 1.064 . . . . 73.03 112.013 177.101 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 91.8 t -67.95 -38.83 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 124.228 1.011 . . . . 53.43 111.12 -177.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 77.6 p -72.7 -30.44 64.21 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.188 0.595 . . . . 73.53 111.44 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' C' ' 116' ' ' SER . 86.8 mtt-85 -67.82 -39.83 83.86 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.239 1.016 . . . . 72.12 110.252 175.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.84 7.23 59.66 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-N 115.295 -0.866 . . . . 44.15 112.659 174.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 29.9 p 62.59 26.87 15.93 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.567 1.947 . . . . 75.11 113.46 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -87.3 152.29 52.41 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 107.821 -1.177 . . . . 71.14 107.821 166.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.17 169.11 6.61 Favored 'Trans proline' 0 C--N 1.369 1.653 0 C-N-CA 122.783 2.322 . . . . 65.13 113.383 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' B' ' 123' ' ' PHE . 57.4 mm-40 -59.86 113.46 2.29 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.405 -1.27 . . . . 70.31 112.485 -177.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.42 HD21 ' HZ2' ' C' ' 36' ' ' TRP . 63.6 mt -107.33 87.92 2.61 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.965 -1.124 . . . . 65.25 107.965 168.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -89.94 112.65 24.1 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.925 -1.139 . . . . 75.44 107.925 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 40.2 mt -64.73 129.64 40.56 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 123.434 0.459 . . . . 70.25 110.686 -175.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.53 150.65 93.75 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.571 0.748 . . . . 64.42 110.468 178.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.572 ' HG3' HD12 ' A' ' 16' ' ' ILE . 26.8 Cg_exo -59.81 105.39 0.27 Allowed 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.34 2.027 . . . . 72.3 112.268 174.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 35.7 t -99.52 117.36 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 108.12 -1.067 . . . . 52.24 108.12 176.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -77.08 103.37 6.97 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.826 0.85 . . . . 71.33 110.515 -172.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -65.78 -24.98 67.05 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.63 -0.714 . . . . 72.43 111.654 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -67.1 -40.07 86.83 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.327 0.651 . . . . 74.43 109.973 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.8 -45.79 91.01 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.362 0.665 . . . . 64.34 110.509 174.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 81.2 mt -69.34 -23.46 63.77 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.043 -0.98 . . . . 74.11 111.388 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 137' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' C' ' 100' ' ' ALA . 79.1 t80 . . . . . 0 C--O 1.217 -0.61 0 CA-C-N 116.313 -0.403 . . . . 72.21 110.104 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 24.3 m . . . . . 0 C--O 1.235 0.3 0 N-CA-C 109.168 -0.679 . . . . 74.22 109.168 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.496 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 50.6 t80 -133.98 98.61 4.2 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.457 -1.312 . . . . 64.0 107.457 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -132.51 127.97 36.33 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.257 -0.646 . . . . 71.2 109.257 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 6.1 mt -83.88 127.22 39.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 108.572 -0.899 . . . . 64.34 108.572 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 14' ' ' GLN . . . . . 0.505 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 16.0 mm100 -81.96 -35.21 29.25 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.478 0.711 . . . . 73.32 110.302 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -171.25 133.8 0.87 Allowed 'General case' 0 C--N 1.357 0.914 0 O-C-N 123.737 0.648 . . . . 74.2 110.7 -175.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.434 HD12 ' N ' ' D' ' 16' ' ' ILE . 3.4 mp -105.57 141.85 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 107.144 -1.428 . . . . 72.34 107.144 171.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -166.72 152.92 8.45 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.438 0.637 . . . . 74.11 111.7 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 71.3 p -89.14 117.29 28.03 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 114.882 -1.054 . . . . 72.11 109.702 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -86.56 -29.74 22.42 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.652 -0.704 . . . . 60.41 109.371 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.6 t70 -150.87 142.15 23.28 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.815 -1.084 . . . . 65.31 109.589 176.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.43 HG21 ' CE ' ' C' ' 117' ' ' MET . 76.7 mt -140.73 141.07 32.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 C-N-CA 125.367 1.467 . . . . 72.02 107.402 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.7 t -147.21 144.29 28.81 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.681 0.793 . . . . 53.41 109.54 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.494 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.6 t80 -147.51 134.42 20.2 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 107.301 -1.37 . . . . 72.43 107.301 168.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.636 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 43.6 mt-10 -133.33 148.69 51.89 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.13 0.972 . . . . 74.1 108.954 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.418 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -150.73 80.07 6.92 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 107.44 -1.319 . . . . 55.23 107.44 171.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -67.46 -52.38 0.59 Allowed 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.545 2.163 . . . . 72.52 112.385 -174.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -87.61 19.63 3.31 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.457 0.703 . . . . 72.43 111.05 -176.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.534 ' HB3' ' HD2' ' C' ' 19' ' ' LYS . . . -48.26 -61.09 3.45 Favored Pre-proline 0 CA--C 1.556 1.201 0 N-CA-C 114.826 1.417 . . . . 25.21 114.826 -164.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.464 ' HB3' HD11 ' C' ' 83' ' ' ILE . 60.2 Cg_endo -68.13 -20.5 43.7 Favored 'Trans proline' 0 C--N 1.388 2.617 0 CA-C-N 121.704 1.644 . . . . 73.41 113.288 -173.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -81.83 -40.72 22.09 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.987 -1.006 . . . . 61.53 110.795 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.434 HG22 HD12 ' D' ' 68' ' ' LEU . 9.8 p -83.12 -16.06 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 O-C-N 122.246 -0.284 . . . . 73.43 111.424 -169.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -62.58 -16.85 58.45 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 112.529 0.566 . . . . 75.45 112.529 170.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -69.12 -7.68 38.36 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.717 0.807 . . . . 73.14 111.424 174.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -106.27 100.57 10.1 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.797 1.239 . . . . 72.02 109.638 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -97.86 92.77 5.99 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.775 0.83 . . . . 72.03 110.327 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -167.09 -178.34 4.12 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.033 0.933 . . . . 74.31 109.918 171.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -69.64 113.14 14.99 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.132 0.973 . . . . 74.03 109.841 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -58.84 125.89 19.56 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.46 2.106 . . . . 53.42 111.239 176.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -76.75 114.09 15.12 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.085 -1.08 . . . . 62.41 108.085 173.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.549 ' CG1' HG13 ' D' ' 64' ' ' VAL . 9.0 t -112.69 129.79 67.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.886 -0.597 . . . . 74.33 110.341 -171.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.591 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 72.0 mmtt -88.6 108.51 19.48 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.979 -1.119 . . . . 74.3 107.979 168.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.484 HD11 HG13 ' D' ' 62' ' ' VAL . 42.5 tp -98.52 121.08 40.02 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.785 -0.82 . . . . 64.21 108.785 173.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.503 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 8.8 t0 -120.38 143.99 48.14 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.009 -1.478 . . . . 70.21 107.009 177.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 58.1 mt -133.84 129.67 36.8 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.495 0.718 . . . . 74.52 109.577 -175.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.424 ' HB2' ' HB3' ' D' ' 61' ' ' ARG . 54.0 m-20 -134.56 145.67 48.93 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.708 -1.219 . . . . 72.22 107.708 173.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 7.1 t -105.03 161.15 14.46 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.788 -0.819 . . . . 72.21 108.788 169.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.64 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.83 152.68 35.53 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.945 0.898 . . . . 74.32 108.649 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.471 0.579 0 C-N-CA 123.35 0.66 . . . . 65.44 110.037 -179.704 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 54' ' ' ASP . . . . . 0.417 ' HA ' ' HE1' ' D' ' 56' ' ' TYR . 61.8 m-20 . . . . . 0 N--CA 1.487 1.391 0 N-CA-C 113.36 0.874 . . . . 64.25 113.36 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 15.7 t -124.26 98.65 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 107.89 -1.152 . . . . 74.25 107.89 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.417 ' HE1' ' HA ' ' D' ' 54' ' ' ASP . 30.2 m-85 -115.63 135.01 54.48 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.075 0.55 . . . . 74.4 109.742 -174.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.45 ' HG2' HD13 ' D' ' 83' ' ' ILE . 39.4 mt-10 -90.62 114.06 26.24 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.068 -1.086 . . . . 73.24 108.068 162.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 88.7 t -103.19 140.08 22.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.849 -1.167 . . . . 73.41 107.849 168.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.64 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 41.7 t -133.56 146.97 31.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 107.625 -1.25 . . . . 62.35 107.625 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.63 115.91 20.19 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.63 -1.248 . . . . 55.21 107.63 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.424 ' HB3' ' HB2' ' D' ' 45' ' ' ASP . 24.8 ttm-85 -93.07 98.56 11.41 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.046 -1.094 . . . . 71.34 108.046 175.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.484 HG13 HD11 ' D' ' 42' ' ' LEU . 49.4 t -99.12 112.72 32.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.785 -0.82 . . . . 70.03 108.785 176.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 63.9 m -105.72 134.21 49.2 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.75 -1.114 . . . . 74.54 109.206 -175.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.549 HG13 ' CG1' ' D' ' 40' ' ' VAL . 71.5 t -131.63 119.75 43.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 124.287 1.035 . . . . 73.24 108.556 -177.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.591 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 24.1 m -126.49 90.76 3.23 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.757 -1.201 . . . . 75.0 107.757 177.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -97.37 146.43 25.18 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.831 -0.622 . . . . 73.41 110.136 -174.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.519 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 31.4 p -147.31 139.93 24.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 123.871 0.732 . . . . 75.14 110.97 -173.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.434 HD12 HG22 ' D' ' 31' ' ' VAL . 24.0 mt -112.08 112.89 24.84 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 107.755 -1.202 . . . . 75.22 107.755 171.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.73 -114.29 3.8 Favored Glycine 0 C--N 1.347 1.14 0 N-CA-C 113.692 0.237 . . . . 62.43 113.692 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.06 12.53 11.95 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.345 0.658 . . . . 63.15 110.487 -178.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -130.52 162.37 29.41 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.024 0.53 . . . . 73.14 109.63 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -71.89 130.41 40.95 Favored 'General case' 0 C--O 1.243 0.721 0 O-C-N 123.809 0.693 . . . . 45.32 110.71 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.519 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -81.68 -65.24 1.04 Allowed 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.648 -1.241 . . . . 65.25 107.648 172.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -151.61 150.22 30.04 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.132 -0.94 . . . . 73.53 111.125 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.636 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 63.4 mt -108.55 153.94 22.65 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.516 1.126 . . . . 75.12 108.765 171.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.504 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.2 t -160.33 142.53 12.94 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.086 0.555 . . . . 63.22 109.796 174.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -154.9 126.15 7.27 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.943 -0.392 . . . . 72.43 109.943 171.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.0 t -125.76 117.03 48.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 123.771 0.828 . . . . 53.11 109.187 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.597 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.6 mt-30 -90.23 86.94 6.65 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.816 -0.809 . . . . 75.52 108.816 172.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.14 110.5 15.61 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.181 -1.372 . . . . 71.35 109.342 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -108.39 173.03 17.5 Favored Glycine 0 C--N 1.338 0.659 0 O-C-N 123.067 0.23 . . . . 45.24 113.468 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.74 152.83 14.6 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 115.735 -0.233 . . . . 73.44 112.937 177.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 19.3 mm -90.19 115.72 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 107.997 -1.112 . . . . 74.22 107.997 173.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -112.65 135.08 53.8 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.759 0.823 . . . . 61.24 110.326 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 39.3 t -102.11 106.96 17.91 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.817 -0.808 . . . . 74.54 108.817 172.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 42.9 pt -121.34 132.84 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.104 -0.702 . . . . 64.34 109.104 173.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.87 165.61 22.66 Favored 'General case' 0 C--O 1.243 0.744 0 O-C-N 123.448 0.468 . . . . 53.31 111.796 -173.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.27 -4.63 83.19 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.15 -0.932 . . . . 64.02 114.015 177.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.459 HD12 ' H ' ' D' ' 89' ' ' ILE . 0.5 OUTLIER -104.57 163.34 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 121.365 0.602 . . . . 64.31 110.665 -177.56 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' D' ' 91' ' ' GLY . 29.6 tt0 -148.05 174.34 12.02 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 114.453 -1.249 . . . . 74.33 108.639 -173.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 91' ' ' GLY . . . . . 0.449 ' H ' ' HG2' ' D' ' 90' ' ' GLU . . . 77.6 -140.9 24.91 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 123.218 0.437 . . . . 74.03 112.628 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 60.8 p -90.48 -29.64 17.8 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.212 0.605 . . . . 74.01 110.838 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.51 ' HA ' ' HB3' ' D' ' 96' ' ' HIS . 20.7 pt20 -64.63 -23.66 67.33 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.744 0.818 . . . . 74.24 112.401 -173.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.482 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 0.0 OUTLIER -64.78 -43.37 93.47 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.101 0.56 . . . . 32.43 111.327 178.054 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 95' ' ' ALA . . . . . 0.482 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.15 -17.33 37.55 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.477 0.711 . . . . 74.25 111.406 177.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 96' ' ' HIS . . . . . 0.51 ' HB3' ' HA ' ' D' ' 93' ' ' GLN . 78.1 t60 -73.89 -37.58 64.64 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.67 0.788 . . . . 74.53 110.608 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 71.1 m -60.71 -34.91 75.09 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.947 0.499 . . . . 62.4 110.74 174.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.432 ' HA ' HD22 ' D' ' 98' ' ' LEU . 1.1 tm? -75.42 -43.45 49.82 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.264 1.026 . . . . 71.31 110.508 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.4 -26.68 60.93 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 115.565 -0.743 . . . . 74.3 114.06 -173.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -122.37 -59.02 1.67 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.026 0.53 . . . . 71.42 112.028 -169.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -71.04 -37.81 72.55 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 112.13 0.418 . . . . 70.31 112.13 -170.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.496 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 73.9 m -66.58 -47.76 56.28 Favored Pre-proline 0 CA--C 1.568 1.657 0 CA-C-O 118.723 -0.656 . . . . 71.13 111.943 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 51.8 Cg_exo -58.9 -33.3 98.57 Favored 'Trans proline' 0 C--N 1.394 2.948 0 C-N-CA 122.052 1.834 . . . . 75.23 113.372 170.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -64.22 -35.13 79.79 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.802 0.441 . . . . 75.42 110.849 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 24.1 mm -63.91 -39.52 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.08 0.952 . . . . 72.14 110.71 173.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 85.7 mt -78.13 -14.59 59.41 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.474 -0.784 . . . . 74.34 112.222 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -72.16 -40.68 7.76 Favored Pre-proline 0 N--CA 1.486 1.334 0 N-CA-C 113.497 0.925 . . . . 71.55 113.497 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -47.68 -49.06 14.22 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.351 2.034 . . . . 65.45 113.298 166.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -71.6 -35.15 70.41 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.43 0.692 . . . . 74.05 111.535 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.81 -57.46 8.83 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.713 0.805 . . . . 73.44 110.185 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.418 ' NH2' HG23 ' B' ' 105' ' ' ILE . 39.5 ttp180 -56.72 -42.2 78.77 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 114.332 -1.304 . . . . 71.44 110.761 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -56.78 -54.62 44.26 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.891 0.744 . . . . 74.25 110.727 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.4 t -54.87 -45.32 74.58 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.291 0.995 . . . . 62.14 110.867 -177.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.504 HG12 ' SG ' ' D' ' 76' ' ' CYS . 85.1 mt -61.16 -58.54 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.67 0.788 . . . . 54.51 110.923 176.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.7 m -51.87 -43.87 63.46 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.932 1.293 . . . . 75.03 111.598 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.411 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 33.3 t -63.79 -44.72 92.53 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 114.505 -1.225 . . . . 73.35 109.826 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 68.1 mtm -69.82 -30.88 68.5 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.034 0.534 . . . . 62.05 111.613 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.478 HG23 ' O ' ' D' ' 114' ' ' ILE . 80.3 t -64.4 -45.96 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.582 0.753 . . . . 75.44 109.573 175.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 95.2 p -74.4 -28.32 61.04 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.451 -0.795 . . . . 75.13 110.722 -178.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' D' ' 116' ' ' SER . 69.4 mtt-85 -70.26 -27.12 64.19 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.53 0.732 . . . . 71.31 109.932 173.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.75 10.5 67.44 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 123.804 0.69 . . . . 72.33 112.887 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.408 HG23 ' HB3' ' C' ' 17' ' ' TYR . 68.8 p 53.79 29.41 9.63 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 126.113 1.765 . . . . 64.51 113.561 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -92.47 158.49 38.53 Favored Pre-proline 0 C--O 1.242 0.688 0 CA-C-N 115.449 -0.796 . . . . 71.14 109.737 171.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -48.16 119.96 4.48 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.768 2.312 . . . . 74.41 112.113 169.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -46.54 124.51 5.99 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 124.72 1.262 . . . . 74.32 111.757 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.413 HD21 HG11 ' D' ' 40' ' ' VAL . 33.7 tp -107.5 98.69 8.27 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.962 0.41 . . . . 52.4 111.042 -173.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -97.98 96.85 8.44 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 107.11 -1.441 . . . . 72.44 107.11 173.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.05 132.56 54.33 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.519 -0.764 . . . . 44.14 109.481 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.16 136.72 96.82 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 122.714 0.405 . . . . 61.15 110.45 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.542 ' HD3' HG13 ' B' ' 13' ' ' ILE . 93.8 Cg_endo -79.55 145.79 18.72 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.577 2.184 . . . . 75.14 111.864 -174.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 9.0 p -141.24 141.1 31.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 109.003 -0.74 . . . . 73.43 109.003 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -78.95 108.61 12.55 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.676 -0.861 . . . . 62.51 108.676 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 . . . . . 0 N--CA 1.484 1.232 0 C-N-CA 123.391 0.676 . . . . 65.32 110.346 178.261 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 63.0 m . . . . . 0 CA--C 1.532 0.273 0 N-CA-C 106.496 -1.668 . . . . 53.03 106.496 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -137.45 125.21 22.45 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.845 -0.798 . . . . 75.55 108.845 -173.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -145.73 129.69 17.37 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.259 -0.645 . . . . 71.41 109.259 173.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.4 HD13 HD11 ' A' ' 16' ' ' ILE . 7.0 mt -84.77 126.18 40.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.505 -0.924 . . . . 73.11 108.505 175.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -93.04 -41.23 10.09 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.172 0.589 . . . . 64.33 110.347 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -172.73 121.49 0.41 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.62 -0.718 . . . . 74.43 109.969 -173.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.4 HD11 HD13 ' A' ' 13' ' ' ILE . 80.1 mt -105.4 132.43 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 107.373 -1.343 . . . . 61.52 107.373 172.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.478 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 28.2 p90 -162.98 164.02 25.86 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 123.687 0.617 . . . . 74.25 111.445 -172.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.7 p -90.37 122.19 33.02 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.779 -0.452 . . . . 61.03 109.779 174.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.478 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.1 mtpt -83.24 -33.55 26.05 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.055 0.542 . . . . 71.12 109.922 175.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -148.49 142.06 25.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.112 -0.949 . . . . 65.02 109.06 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.7 mt -135.47 145.9 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.778 1.231 . . . . 74.42 107.845 175.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -151.19 131.16 13.35 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.215 0.606 . . . . 71.15 109.999 172.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.449 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 90.6 t80 -131.37 133.1 44.95 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 106.781 -1.563 . . . . 75.22 106.781 171.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -135.67 125.97 26.5 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.627 -0.509 . . . . 74.23 109.627 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.82 79.21 4.41 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 106.16 -1.793 . . . . 75.03 106.16 163.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -65.7 -35.53 36.61 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.455 2.103 . . . . 74.01 112.027 -167.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -107.81 27.07 9.57 Favored 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 124.461 1.104 . . . . 73.52 109.261 -172.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.47 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -46.09 -54.94 14.85 Favored Pre-proline 0 CA--C 1.568 1.652 0 N-CA-C 114.723 1.379 . . . . 55.0 114.723 -165.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.453 ' HG3' ' HG3' ' B' ' 57' ' ' GLU . 28.0 Cg_exo -62.5 -25.85 76.0 Favored 'Trans proline' 0 C--N 1.39 2.736 0 CA-C-N 121.904 1.716 . . . . 74.02 113.26 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.505 ' O ' ' HG2' ' A' ' 33' ' ' GLN . 2.5 m-70 -86.83 -34.32 19.54 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.614 0.765 . . . . 54.31 110.479 -178.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.532 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.7 p -74.75 -12.04 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 C-N-CA 123.204 0.602 . . . . 71.2 111.894 -164.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -91.78 -18.44 23.87 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.44 0.696 . . . . 65.24 111.291 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 3.6 pt20 -96.98 -11.55 24.43 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.251 0.62 . . . . 72.33 110.251 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 14.3 mmmm -76.93 156.36 32.08 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.407 0.683 . . . . 65.53 111.106 177.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.06 119.3 10.54 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.467 0.707 . . . . 53.14 110.005 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.9 t-105 -76.89 84.74 3.45 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-O 121.596 0.713 . . . . 64.34 109.798 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -116.17 79.2 8.41 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 106.246 -1.761 . . . . 71.43 106.246 172.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -81.12 106.62 1.78 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.436 2.091 . . . . 63.51 112.188 -172.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -95.87 88.64 4.99 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 122.6 1.19 . . . . 71.33 107.859 174.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.556 HG22 ' HB2' ' A' ' 66' ' ' ALA . 61.6 t -86.85 101.55 11.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 114.474 -1.239 . . . . 73.43 110.237 -174.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -82.32 118.66 23.32 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.994 -1.003 . . . . 62.02 109.121 171.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.3 mp -95.56 108.16 20.39 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.633 -1.247 . . . . 71.51 107.633 173.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -105.93 150.67 25.44 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.267 -1.012 . . . . 64.42 108.267 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.511 HD22 HD21 ' A' ' 60' ' ' LEU . 67.1 mt -133.29 158.77 42.11 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.406 0.682 . . . . 75.11 110.766 -177.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 25.5 t70 -160.14 121.7 3.17 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.579 -1.191 . . . . 72.33 108.037 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.437 HG21 ' HA2' ' A' ' 99' ' ' GLY . 41.6 m -112.27 126.51 55.32 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 122.838 0.455 . . . . 73.05 110.196 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.46 112.91 11.32 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.776 0.83 . . . . 74.1 109.493 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.1 p -89.41 177.19 6.64 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.94 0.496 . . . . 52.52 109.867 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.441 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 26.0 t -165.38 153.31 11.21 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.284 1.034 . . . . 73.23 109.112 -168.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -113.73 131.1 56.31 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 109.034 -0.728 . . . . 73.24 109.034 172.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.419 HD12 HG23 ' A' ' 83' ' ' ILE . 80.5 mt -110.48 -34.45 6.31 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.5 0.72 . . . . 74.24 111.4 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.539 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -157.82 -171.23 3.46 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 123.536 0.734 . . . . 70.41 110.537 -177.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -70.59 119.09 14.23 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.533 -0.914 . . . . 75.41 108.533 172.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 65.54 10.72 6.88 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.361 1.065 . . . . 54.24 112.107 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 57.2 t -116.21 112.6 40.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 107.835 -1.172 . . . . 62.32 107.835 175.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -126.7 126.33 43.32 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.892 0.877 . . . . 72.4 109.036 -176.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 37.8 tt0 -86.65 149.11 25.14 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.512 -0.551 . . . . 63.51 109.512 175.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.409 HG21 ' CB ' ' A' ' 102' ' ' CYS . 91.1 t -130.77 142.13 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 108.062 -1.088 . . . . 73.45 108.062 173.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.53 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 52.5 t -123.48 133.02 70.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.434 -0.95 . . . . 65.14 108.434 175.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.511 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -113.57 106.81 14.98 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.506 -1.294 . . . . 75.2 107.506 173.129 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.455 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 24.8 ttp180 -93.63 100.59 12.81 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.856 -1.164 . . . . 71.13 107.856 175.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.6 t -94.57 122.92 46.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 107.562 -1.273 . . . . 74.3 107.562 174.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.4 m -116.77 107.61 14.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.567 0.698 . . . . 63.35 109.426 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.536 HG11 HD21 ' A' ' 126' ' ' LEU . 58.0 t -104.38 133.91 47.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 C-N-CA 124.788 1.235 . . . . 54.33 107.871 -178.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.0 m -135.44 136.4 41.32 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.697 -0.853 . . . . 75.03 108.697 170.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.556 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -116.19 130.89 57.01 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.487 -1.301 . . . . 73.01 107.487 171.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.7 m -124.79 169.76 11.7 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.102 -0.703 . . . . 54.34 109.102 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.7 mt -124.09 42.95 3.12 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.754 1.222 . . . . 73.4 108.265 -176.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.22 -89.66 1.58 Allowed Glycine 0 C--N 1.34 0.756 0 CA-C-N 114.725 -1.125 . . . . 42.5 111.34 -172.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.43 -19.53 19.81 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.74 0.816 . . . . 72.3 112.539 -173.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -121.49 132.78 54.91 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 109.693 -0.484 . . . . 75.23 109.693 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.0 m -72.18 137.13 46.7 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 122.449 0.3 . . . . 63.05 110.469 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.532 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -79.17 -62.24 1.76 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.721 -0.672 . . . . 70.12 109.609 176.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -157.07 168.4 27.58 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.164 -0.925 . . . . 70.13 111.614 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 64' ' ' VAL . 61.4 tp -125.41 141.97 51.76 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.939 1.296 . . . . 73.23 108.434 171.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.459 ' SG ' HG22 ' A' ' 118' ' ' VAL . 77.7 m -143.15 99.15 3.39 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.487 1.115 . . . . 72.41 109.289 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -124.25 117.55 24.81 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.711 -0.848 . . . . 70.12 108.711 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.7 t -130.65 128.86 63.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 123.84 0.856 . . . . 74.52 109.613 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.455 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 77.3 mt-30 -96.95 90.9 5.37 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.557 0.743 . . . . 74.41 109.151 169.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -77.59 94.16 4.32 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.79 -0.819 . . . . 72.32 108.79 174.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.84 172.35 49.86 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.986 -0.846 . . . . 72.45 110.986 175.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.08 126.36 1.2 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.16 -0.776 . . . . 74.0 111.16 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.419 HG23 HD12 ' A' ' 51' ' ' LEU . 50.0 mt -81.59 126.48 39.85 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 108.66 -0.867 . . . . 72.42 108.66 174.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.721 ' HB3' HD11 ' A' ' 86' ' ' ILE . 91.8 m-85 -132.23 121.0 22.96 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.15 0.58 . . . . 73.4 109.961 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.3 m -84.97 97.44 9.8 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.903 -0.777 . . . . 75.3 108.903 174.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.721 HD11 ' HB3' ' A' ' 84' ' ' PHE . 3.5 mm -108.28 153.89 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 122.949 0.5 . . . . 62.31 109.994 -178.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -165.27 166.03 19.1 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.943 0.497 . . . . 74.23 111.261 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.45 -21.85 42.39 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 116.113 -0.494 . . . . 41.35 114.003 174.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.467 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -133.95 147.61 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.176 0.59 . . . . 64.45 111.535 -172.187 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -134.28 175.54 9.41 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.91 1.284 . . . . 71.32 109.439 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.62 -124.64 36.28 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.854 0.721 . . . . 54.11 113.828 175.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.0 t -71.19 -29.56 65.33 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.328 0.651 . . . . 62.41 111.741 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -69.33 -43.89 72.77 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.94 0.496 . . . . 52.1 110.324 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.5 tpt -66.79 -40.3 88.08 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.819 -0.628 . . . . 75.42 110.457 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.13 -32.59 74.36 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.236 0.614 . . . . 43.24 110.846 176.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -73.14 -30.94 63.96 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.343 0.657 . . . . 45.32 110.934 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.8 t -73.1 -51.6 17.4 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 109.27 -0.641 . . . . 64.24 109.27 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.2 mt -76.9 -26.9 54.68 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.427 0.691 . . . . 73.11 112.258 -174.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.437 ' HA2' HG21 ' A' ' 46' ' ' THR . . . -107.81 3.56 34.04 Favored Glycine 0 N--CA 1.468 0.815 0 CA-C-O 119.492 -0.616 . . . . 22.2 114.033 -171.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.477 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.72 -60.34 0.23 Allowed 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 117.671 0.736 . . . . 64.1 112.323 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.428 ' O ' HG12 ' A' ' 105' ' ' ILE . 73.5 t80 -66.44 -45.54 79.51 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.858 0.463 . . . . 75.54 111.509 -175.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.409 ' CB ' HG21 ' A' ' 58' ' ' VAL . 85.9 m -67.51 -46.79 47.85 Favored Pre-proline 0 CA--C 1.564 1.484 0 C-N-CA 124.381 1.072 . . . . 72.34 111.818 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -55.76 -34.17 90.13 Favored 'Trans proline' 0 C--N 1.397 3.126 0 C-N-CA 122.615 2.21 . . . . 61.1 113.523 168.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.403 ' HB3' ' O ' ' A' ' 101' ' ' TYR . 26.7 t-20 -63.42 -39.77 95.39 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.777 0.831 . . . . 61.01 110.499 176.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 101' ' ' TYR . 49.8 mm -66.41 -40.08 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.562 0.745 . . . . 74.44 110.212 174.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 68.9 mt -77.69 -22.38 50.58 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.244 -0.889 . . . . 62.21 112.5 -172.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -65.3 -42.33 58.13 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 114.291 1.219 . . . . 71.14 114.291 -172.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -53.2 -38.05 80.92 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 121.974 1.782 . . . . 72.1 113.12 171.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -82.03 -30.2 31.58 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.514 0.725 . . . . 70.32 111.651 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.85 -48.21 72.38 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.941 -0.763 . . . . 72.12 108.941 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.605 HH12 HD12 ' C' ' 105' ' ' ILE . 31.5 ttm180 -60.81 -39.86 90.54 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 113.741 -1.572 . . . . 71.52 110.088 176.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.4 ' HB2' ' HB3' ' C' ' 108' ' ' PRO . 14.5 tt0 -52.46 -56.37 15.54 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.376 1.07 . . . . 54.22 110.727 176.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 45.1 t -60.17 -47.82 84.31 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 113.945 -1.48 . . . . 45.05 111.206 -175.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.1 mt -63.22 -59.85 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.714 0.806 . . . . 73.34 110.926 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 92.4 m -49.1 -42.5 39.23 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 124.338 1.024 . . . . 74.23 112.226 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.3 t -68.9 -46.75 67.54 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.745 -1.116 . . . . 53.45 110.582 -178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.449 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 9.9 mtp -53.67 -44.34 69.61 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.917 0.887 . . . . 72.44 111.226 175.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 114' ' ' ILE . 97.0 t -59.63 -49.71 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-N 114.726 -1.125 . . . . 60.23 110.772 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.4 p -70.9 -28.55 64.62 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.98 -0.554 . . . . 71.42 111.62 -177.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.489 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.4 mtt-85 -71.03 -29.9 65.94 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.674 0.79 . . . . 75.52 110.123 176.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.409 ' O ' HG22 ' A' ' 122' ' ' THR . . . -86.07 23.05 10.0 Favored Glycine 0 C--N 1.352 1.46 0 CA-C-O 118.957 -0.913 . . . . 55.41 113.407 176.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.409 HG22 ' O ' ' A' ' 121' ' ' GLY . 4.1 t 57.36 10.71 0.97 Allowed 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 127.047 2.139 . . . . 54.32 113.853 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -81.17 144.02 53.61 Favored Pre-proline 0 C--O 1.242 0.709 0 N-CA-C 108.392 -0.966 . . . . 73.22 108.392 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -49.15 146.57 12.59 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 123.138 2.559 . . . . 72.13 111.94 173.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -59.74 133.24 55.92 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.105 0.478 . . . . 64.21 111.595 -174.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.536 HD21 HG11 ' A' ' 64' ' ' VAL . 28.1 tp -118.03 110.1 17.26 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.658 1.183 . . . . 75.13 108.753 176.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.438 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 72.3 m-20 -100.44 126.39 46.83 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.525 -1.287 . . . . 75.21 107.525 172.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 13.5 mt -73.27 141.37 47.22 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 123.125 0.266 . . . . 74.33 110.303 -178.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -65.59 135.65 95.78 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.299 0.64 . . . . 63.44 110.822 177.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 36.3 Cg_exo -61.74 120.69 8.44 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 123.307 2.671 . . . . 65.32 112.833 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.499 HG21 HD11 ' A' ' 44' ' ' LEU . 84.4 t -103.4 136.77 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.538 0.735 . . . . 62.03 110.809 -178.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.479 ' ND2' ' HB2' ' A' ' 135' ' ' ALA . 37.2 t30 -94.61 90.38 6.12 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 108.327 -0.99 . . . . 75.13 108.327 172.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.438 ' CE1' HD13 ' A' ' 44' ' ' LEU . 93.5 m-85 -63.44 -28.67 70.13 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.091 0.957 . . . . 74.2 112.561 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.477 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 7.9 m-20 -63.41 -35.79 81.57 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.122 0.569 . . . . 72.53 110.626 176.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.479 ' HB2' ' ND2' ' A' ' 132' ' ' ASN . . . -65.19 -48.93 71.71 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 123.549 0.531 . . . . 74.34 110.053 171.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 62.3 mt -56.67 -39.29 73.49 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.808 0.843 . . . . 61.42 111.329 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.456 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 84.8 t80 . . . . . 0 C--N 1.349 0.569 0 CA-C-N 115.301 -0.863 . . . . 73.22 110.252 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 25.6 ttt . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 112.766 0.654 . . . . 75.33 112.766 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 89.5 m -151.05 128.12 11.12 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.965 1.306 . . . . 74.01 107.694 171.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.46 ' CE1' ' HE2' ' B' ' 101' ' ' TYR . 0.1 OUTLIER -146.86 135.54 22.11 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.304 0.573 . . . . 71.4 110.252 179.115 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -131.09 130.05 42.67 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.819 1.248 . . . . 75.11 109.212 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 69.4 mt -73.24 127.49 35.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 108.357 -0.979 . . . . 71.51 108.357 170.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -92.42 -43.67 9.09 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 123.744 0.652 . . . . 75.34 109.595 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -174.27 135.84 0.46 Allowed 'General case' 0 C--N 1.352 0.71 0 CA-C-N 115.703 -0.68 . . . . 70.41 109.932 -173.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.486 HG21 ' CE1' ' B' ' 109' ' ' TYR . 80.7 mt -122.84 138.8 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.065 -1.087 . . . . 51.14 108.065 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -164.15 157.33 17.95 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.127 0.788 . . . . 72.44 113.127 -171.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 53.5 m -83.66 119.48 24.81 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.366 -1.288 . . . . 72.14 108.864 171.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.47 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 39.6 mtpt -91.81 -24.98 19.21 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.658 0.783 . . . . 71.23 111.522 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -159.57 142.76 14.25 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 123.387 0.429 . . . . 71.13 111.02 -175.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.422 HD11 ' SG ' ' B' ' 113' ' ' CYS . 48.6 mm -134.37 144.19 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.939 1.295 . . . . 63.43 108.321 171.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 29.5 t -147.68 134.45 20.04 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.221 1.009 . . . . 63.44 108.35 171.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -134.87 131.89 37.91 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.979 -1.489 . . . . 74.1 106.979 167.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -132.69 125.39 30.18 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.177 -1.046 . . . . 54.13 108.177 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.572 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -114.75 87.37 14.55 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 106.899 -1.519 . . . . 61.43 106.899 164.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.39 -35.04 74.89 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.554 2.17 . . . . 72.14 111.228 -173.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -110.29 14.93 22.59 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.47 -1.241 . . . . 53.13 110.742 -175.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.593 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -31.63 -66.3 0.19 Allowed Pre-proline 0 N--CA 1.493 1.715 0 C-N-CA 125.951 1.701 . . . . 62.41 115.278 -172.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 24.8 Cg_exo -60.83 -36.51 83.62 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 122.457 2.105 . . . . 71.31 113.269 -167.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -93.31 -32.22 14.39 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.403 0.52 . . . . 74.11 112.403 -174.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.673 HG22 HD12 ' B' ' 68' ' ' LEU . 7.2 p -67.6 -11.69 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-N 118.209 0.458 . . . . 74.24 111.534 -173.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -74.1 -15.09 61.06 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.868 0.867 . . . . 75.41 112.976 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -61.54 -28.91 69.66 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.476 0.655 . . . . 42.34 109.543 172.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -88.91 105.17 17.58 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.894 1.278 . . . . 70.45 109.451 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -113.43 99.18 7.57 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.625 -0.88 . . . . 65.13 108.625 172.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 11.2 p90 -160.71 -172.78 3.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.368 -0.975 . . . . 75.24 108.368 170.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -73.84 107.3 3.32 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.353 0.661 . . . . 74.34 111.014 175.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.11 143.65 60.36 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 121.533 1.488 . . . . 74.12 110.5 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.23 101.46 1.19 Allowed 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.543 -0.91 . . . . 74.44 108.543 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.423 HG11 HD11 ' B' ' 126' ' ' LEU . 33.9 t -91.78 144.71 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 114.245 -1.343 . . . . 74.43 109.695 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.15 119.65 10.35 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.067 -1.827 . . . . 43.15 106.067 -175.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 20.9 tp -95.06 147.23 23.64 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.625 0.77 . . . . 74.52 109.362 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.564 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 13.0 t70 -140.62 134.29 30.25 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.692 -1.225 . . . . 62.24 107.692 -175.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 64.3 mt -128.0 126.27 41.02 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.632 -0.877 . . . . 53.23 108.632 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 19.5 t70 -126.1 119.79 28.48 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.369 1.067 . . . . 74.32 108.612 -173.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.8 p -110.29 102.95 11.57 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.33 0.652 . . . . 74.14 111.516 -169.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.73 136.83 51.11 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.135 0.974 . . . . 44.54 108.554 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.1 p -139.86 175.86 9.23 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.418 0.687 . . . . 60.14 109.721 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 75.3 p -157.12 140.15 15.34 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.093 0.557 . . . . 75.15 110.337 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -94.87 128.46 41.65 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.617 -0.883 . . . . 74.13 108.617 172.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.91 16.41 2.48 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.72 0.808 . . . . 55.42 110.923 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.74 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -173.67 165.12 4.49 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.819 1.248 . . . . 73.13 109.73 173.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.45 119.24 13.41 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.884 -0.784 . . . . 54.52 108.884 176.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 69.16 -5.63 1.05 Allowed 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 124.687 1.195 . . . . 63.13 113.145 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.74 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 44.4 t -119.57 97.49 5.26 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.226 -1.028 . . . . 75.13 108.226 -172.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.64 ' HE1' HD12 ' B' ' 86' ' ' ILE . 54.4 p90 -99.23 -176.86 3.43 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 114.556 -1.202 . . . . 73.45 109.207 177.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.453 ' HG3' ' HG3' ' A' ' 29' ' ' PRO . 5.5 tm-20 -138.69 107.2 5.85 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 106.383 -1.71 . . . . 70.45 106.383 173.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 14.8 p -101.0 135.03 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 109.863 -0.421 . . . . 74.24 109.863 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 29.9 t -109.38 115.23 49.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 123.754 0.821 . . . . 53.44 108.955 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 54.5 tp -93.89 101.13 13.2 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.378 -0.971 . . . . 52.51 108.378 170.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.586 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 14.1 ttm-85 -87.33 116.82 25.69 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.681 -0.859 . . . . 74.35 108.681 172.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.37 125.9 66.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.029 -1.1 . . . . 72.23 108.029 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.564 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 8.7 m -121.84 131.67 54.17 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.242 -0.651 . . . . 73.13 109.242 178.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.707 HG11 HD21 ' B' ' 126' ' ' LEU . 56.7 t -115.88 125.2 72.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 124.569 1.148 . . . . 75.11 109.131 176.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 88.9 m -105.06 138.72 40.82 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.463 -0.94 . . . . 71.25 108.463 164.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.19 144.27 33.32 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 107.96 -1.126 . . . . 71.12 107.96 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.51 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 49.6 p -144.7 134.26 23.34 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.388 0.43 . . . . 64.41 111.978 -171.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.673 HD12 HG22 ' B' ' 31' ' ' VAL . 70.6 mt -102.61 99.57 9.58 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.487 -0.931 . . . . 73.23 108.487 175.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.05 -134.3 14.18 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.991 -0.549 . . . . 73.22 112.364 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -82.32 3.55 27.29 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.26 0.624 . . . . 75.13 112.515 -177.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -128.76 150.68 50.19 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.789 0.435 . . . . 72.05 111.767 -174.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 68.3 m -68.7 128.43 36.62 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.418 -0.81 . . . . 71.24 110.36 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.51 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -80.14 -59.28 2.77 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.366 -0.976 . . . . 62.5 108.366 176.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -152.51 157.85 41.71 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 114.701 -1.136 . . . . 74.11 111.437 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 98.2 mt -125.15 113.58 17.88 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.682 1.593 . . . . 75.35 107.262 171.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.9 t -118.39 140.14 50.31 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.177 -1.045 . . . . 75.44 108.177 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -151.22 127.64 10.68 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.813 -0.81 . . . . 72.34 108.813 -174.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 90.4 t -124.44 147.71 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 123.942 0.897 . . . . 42.05 108.83 177.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -120.74 106.38 11.64 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.477 -1.305 . . . . 74.14 107.477 168.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 48.1 tp60 -98.41 101.3 12.7 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.504 -1.295 . . . . 45.22 107.504 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.4 159.57 22.56 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 111.062 -0.815 . . . . 71.25 111.062 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.9 132.61 3.12 Favored Glycine 0 C--O 1.239 0.446 0 C-N-CA 121.718 -0.277 . . . . 72.42 112.411 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 54.6 mt -91.66 108.13 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 108.497 -0.927 . . . . 72.22 108.497 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -119.47 143.89 47.28 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.159 -1.052 . . . . 75.35 108.159 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 15.8 m -115.17 114.23 25.0 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.476 -0.935 . . . . 75.13 108.476 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.64 HD12 ' HE1' ' B' ' 56' ' ' TYR . 0.2 OUTLIER -115.56 142.22 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.359 -0.978 . . . . 61.4 108.359 178.559 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.38 168.6 26.83 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.981 0.512 . . . . 65.1 110.622 -177.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.86 -44.92 2.69 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.966 -0.561 . . . . 72.03 111.895 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.455 HD13 ' HB2' ' B' ' 94' ' ' MET . 1.0 OUTLIER -81.74 157.25 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.5 1.12 . . . . 63.03 111.261 178.131 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.47 ' HA ' ' SD ' ' B' ' 94' ' ' MET . 9.7 mp0 -145.9 177.95 8.55 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.483 1.113 . . . . 73.01 109.605 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.62 -125.42 23.07 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.127 -0.942 . . . . 73.42 113.81 173.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 27.2 m -79.27 -45.39 19.83 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.703 0.801 . . . . 51.22 110.724 -178.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -67.47 -28.91 68.25 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 113.953 -1.476 . . . . 52.34 111.886 -166.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.47 ' SD ' ' HA ' ' B' ' 90' ' ' GLU . 26.9 ptt? -64.34 -47.49 79.15 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.227 0.611 . . . . 72.53 111.373 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 95' ' ' ALA . . . . . 0.477 ' HA ' ' HG ' ' B' ' 98' ' ' LEU . . . -81.0 -13.34 58.96 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.996 0.919 . . . . 41.24 112.186 -175.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -64.74 -32.13 73.67 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.655 0.382 . . . . 72.0 110.277 170.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 97' ' ' CYS . . . . . 0.408 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 48.0 t -67.51 -30.92 70.72 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.584 0.754 . . . . 64.31 111.53 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.477 ' HG ' ' HA ' ' B' ' 95' ' ' ALA . 4.0 pp -101.38 -24.48 14.19 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 112.942 0.719 . . . . 73.5 112.942 -175.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.76 -26.24 61.09 Favored Glycine 0 C--N 1.338 0.671 0 O-C-N 123.584 0.553 . . . . 40.4 112.736 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.08 -49.75 0.33 Allowed 'General case' 0 C--O 1.242 0.671 0 N-CA-C 112.568 0.581 . . . . 53.33 112.568 -165.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.46 ' HE2' ' CE1' ' B' ' 11' ' ' PHE . 16.0 t80 -68.02 -48.75 64.83 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.69 0.796 . . . . 64.02 112.155 -174.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 98.1 m -73.69 -37.94 3.74 Favored Pre-proline 0 CA--C 1.557 1.238 0 N-CA-C 112.627 0.603 . . . . 41.43 112.627 -177.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -51.43 -31.49 38.87 Favored 'Trans proline' 0 C--N 1.387 2.553 0 C-N-CA 122.399 2.066 . . . . 72.45 114.181 162.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -68.89 -25.41 64.59 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 122.767 0.427 . . . . 74.44 111.504 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.497 HG23 ' NH2' ' D' ' 111' ' ' ARG . 71.5 mt -69.05 -39.8 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 121.336 0.589 . . . . 71.54 109.413 170.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.457 ' CD2' HG23 ' B' ' 16' ' ' ILE . 70.3 mt -77.09 -24.6 51.8 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.689 1.196 . . . . 72.43 111.893 -177.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -59.18 -53.71 63.58 Favored Pre-proline 0 N--CA 1.484 1.248 0 N-CA-C 113.822 1.045 . . . . 65.14 113.822 -171.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.16 -30.56 55.26 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 121.62 1.547 . . . . 75.21 111.98 -177.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.486 ' CE1' HG21 ' B' ' 16' ' ' ILE . 2.4 m-30 -64.54 -47.8 77.46 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.02 0.928 . . . . 72.53 110.058 176.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.18 -40.57 97.9 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.026 0.93 . . . . 71.55 110.747 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.4 ttt-85 -64.69 -46.34 82.79 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.225 1.41 . . . . 74.42 110.861 -175.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.38 -35.06 77.15 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 123.776 0.673 . . . . 64.22 109.454 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.496 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.4 t -68.99 -35.51 76.8 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.891 0.476 . . . . 44.31 111.157 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.446 HD13 HG23 ' B' ' 64' ' ' VAL . 49.2 mt -62.89 -56.88 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.649 0.78 . . . . 72.43 109.339 173.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 18.1 m -59.63 -28.21 67.02 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.941 0.896 . . . . 55.03 111.459 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.7 t -66.25 -51.45 57.42 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.981 0.912 . . . . 54.04 110.3 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.496 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.5 mmt -70.14 -29.98 67.03 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.183 0.593 . . . . 73.12 111.245 -176.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 77.6 t -67.95 -41.86 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.513 1.125 . . . . 72.21 110.389 172.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.7 t -67.69 -32.03 72.41 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.604 -0.726 . . . . 75.31 110.341 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' B' ' 116' ' ' SER . 70.3 mtt-85 -69.74 -42.59 73.74 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 115.688 -0.687 . . . . 73.41 109.162 175.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.12 -10.82 62.81 Favored Glycine 0 C--N 1.358 1.801 0 O-C-N 123.736 0.648 . . . . 75.53 112.639 172.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 8.9 m 68.75 23.1 7.11 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 125.762 1.625 . . . . 63.33 110.973 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -78.96 164.26 55.96 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 124.019 0.927 . . . . 73.24 111.341 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -45.28 147.56 2.35 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 123.839 3.026 . . . . 72.01 114.85 172.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -59.95 113.29 2.23 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.272 1.029 . . . . 72.01 112.512 -172.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.707 HD21 HG11 ' B' ' 64' ' ' VAL . 28.5 tp -107.71 104.72 14.3 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.151 0.58 . . . . 73.4 109.457 -172.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -111.49 120.9 43.7 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.442 -0.947 . . . . 74.22 108.442 175.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.437 HD21 ' CG2' ' B' ' 64' ' ' VAL . 57.9 mt -78.14 149.29 33.82 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 110.296 -0.261 . . . . 74.43 110.296 175.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.61 143.39 84.9 Favored Pre-proline 0 CA--C 1.55 0.961 0 O-C-N 123.503 0.502 . . . . 43.14 111.238 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.61 81.76 0.76 Allowed 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 123.345 2.697 . . . . 70.42 112.191 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.17 110.68 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 121.402 0.62 . . . . 61.32 109.423 177.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 107.692 -1.225 . . . . 65.14 107.692 171.279 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 88.2 t80 . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 109.074 -0.713 . . . . 63.12 109.074 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -151.59 124.62 8.66 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.989 -0.745 . . . . 64.35 108.989 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.417 ' HA ' ' HD2' ' C' ' 84' ' ' PHE . 53.0 mt -70.11 135.0 29.1 Favored 'Isoleucine or valine' 0 C--N 1.349 0.586 0 N-CA-C 108.45 -0.945 . . . . 72.03 108.45 174.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -97.5 -47.71 5.56 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.273 -0.64 . . . . 73.31 109.273 176.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.438 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 11.8 ptm180 -179.01 143.02 0.2 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.288 1.035 . . . . 74.34 109.255 -176.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.406 ' O ' HD12 ' C' ' 16' ' ' ILE . 2.4 pp -120.31 146.8 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 107.363 -1.347 . . . . 73.02 107.363 171.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.457 ' HB3' HG23 ' D' ' 122' ' ' THR . 28.6 p90 -170.78 154.58 4.4 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.201 0.524 . . . . 64.51 111.943 -168.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.0 p -81.01 109.24 15.4 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.216 -0.902 . . . . 71.44 108.848 173.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -77.3 -29.78 53.84 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.186 -0.672 . . . . 74.5 109.186 173.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.665 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 22.5 t70 -146.07 143.77 29.6 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.905 -1.043 . . . . 73.45 109.663 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 99.3 mt -137.92 145.34 29.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 125.237 1.415 . . . . 73.25 107.389 173.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.3 t -152.91 146.05 24.67 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.129 0.571 . . . . 73.55 109.723 175.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -147.48 118.58 7.74 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 107.861 -1.162 . . . . 62.31 107.861 170.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -120.79 113.48 20.23 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.073 0.949 . . . . 75.12 108.981 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.63 87.81 7.02 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 106.446 -1.687 . . . . 73.14 106.446 169.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.89 -42.67 23.35 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.845 2.363 . . . . 72.12 112.042 -170.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -113.06 35.53 3.89 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.759 -1.109 . . . . 71.12 109.239 -177.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.463 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -43.92 -53.27 13.34 Favored Pre-proline 0 C--N 1.373 1.604 0 C-N-CA 124.915 1.286 . . . . 61.22 114.113 -176.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.96 -50.88 7.91 Favored 'Trans proline' 0 C--N 1.39 2.749 0 C-N-CA 121.521 1.481 . . . . 74.32 111.906 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -70.04 -28.07 65.17 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.309 -1.314 . . . . 74.1 113.016 -173.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.723 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.0 p -77.79 -23.88 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 112.235 0.458 . . . . 64.22 112.235 -175.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -71.9 -21.27 61.66 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 112.118 0.414 . . . . 71.32 112.118 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -93.54 16.35 13.89 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.027 0.531 . . . . 75.4 111.016 175.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.794 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -104.17 154.01 20.27 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.748 0.819 . . . . 55.22 109.974 176.111 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -72.4 130.78 41.5 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.31 0.644 . . . . 64.03 109.711 171.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -85.39 90.24 7.89 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.819 0.848 . . . . 74.1 112.2 -171.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -145.7 77.52 12.32 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 124.675 1.19 . . . . 74.54 108.907 170.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -91.53 165.77 3.47 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.758 2.305 . . . . 71.14 113.562 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 39' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' C' ' 67' ' ' SER . 7.4 pt-20 -87.97 100.56 13.0 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.969 -1.122 . . . . 72.52 107.969 166.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 42.0 t -79.89 98.59 3.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.549 -0.908 . . . . 61.52 108.549 177.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -93.06 102.52 14.85 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.068 -1.456 . . . . 71.12 107.068 175.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 tt -87.78 138.21 31.66 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 106.817 -1.549 . . . . 70.35 106.817 176.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.467 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 36.0 t70 -131.56 134.71 46.36 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.053 0.941 . . . . 65.13 108.85 -175.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 96.2 mt -128.54 114.48 16.79 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.602 0.761 . . . . 62.44 110.018 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -117.12 120.75 39.29 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.671 -1.233 . . . . 71.14 107.671 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 10.1 t -118.24 149.24 41.45 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 109.778 -0.453 . . . . 53.52 109.778 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.17 149.12 26.72 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.572 0.749 . . . . 75.03 109.359 174.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 14.3 m -123.77 152.53 42.09 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.122 -0.696 . . . . 53.44 109.122 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 72.9 p -154.61 127.37 8.11 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.506 -0.924 . . . . 70.51 108.506 177.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -79.62 117.7 20.78 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.994 -0.743 . . . . 63.44 108.994 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.675 HD11 ' HB2' ' C' ' 57' ' ' GLU . 41.5 mt -83.55 -44.76 14.3 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.492 0.717 . . . . 75.0 110.273 -176.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.99 -176.55 4.72 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.449 -0.796 . . . . 44.21 109.691 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.08 107.77 0.59 Allowed 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.786 -1.097 . . . . 72.12 110.505 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 64.38 25.31 13.38 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.452 1.101 . . . . 75.21 112.113 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 87.9 t -119.05 114.77 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.328 -0.989 . . . . 73.14 108.328 174.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -117.81 125.55 50.78 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.354 1.062 . . . . 74.53 109.291 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.675 ' HB2' HD11 ' C' ' 51' ' ' LEU . 37.4 tt0 -91.17 117.71 29.84 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.246 -0.65 . . . . 64.22 109.246 168.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.8 t -99.61 142.02 15.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.083 -1.08 . . . . 65.35 108.083 169.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 90.5 t -127.4 144.08 38.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.786 -0.82 . . . . 72.21 108.786 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.42 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -130.37 99.02 4.87 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 107.848 -1.168 . . . . 73.02 107.848 177.61 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -82.52 110.78 17.93 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.369 0.668 . . . . 72.22 109.41 171.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 39.6 t -108.52 122.77 63.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.698 -0.853 . . . . 73.33 108.698 178.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 16.8 m -126.1 127.48 45.86 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.449 0.7 . . . . 65.11 109.521 -176.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 60.2 t -114.36 112.11 38.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 124.165 0.986 . . . . 72.01 108.893 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 11.2 m -98.12 135.86 39.18 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.457 -1.312 . . . . 75.33 107.457 171.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.71 118.22 17.86 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.225 -1.398 . . . . 62.02 107.225 -175.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 67' ' ' SER . . . . . 0.41 ' O ' ' HG2' ' C' ' 39' ' ' GLU . 50.5 m -133.9 130.89 38.43 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.194 0.521 . . . . 73.11 110.545 178.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.794 HD13 ' HG2' ' C' ' 34' ' ' LYS . 14.2 mt -88.48 39.48 0.91 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.624 1.169 . . . . 72.31 109.626 174.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.91 -106.22 2.66 Favored Glycine 0 C--N 1.353 1.474 0 CA-C-N 115.823 -0.626 . . . . 63.44 111.701 -173.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -90.24 -30.05 17.79 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.792 -0.818 . . . . 71.13 108.792 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -65.76 121.05 14.14 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 114.713 -1.131 . . . . 73.1 109.435 169.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 89.8 m -83.97 120.65 26.36 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.124 -1.065 . . . . 71.24 108.124 164.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.723 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -67.41 -58.57 4.52 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 123.945 0.778 . . . . 51.12 109.139 175.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -165.13 176.57 8.39 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 121.984 0.897 . . . . 72.41 111.078 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.452 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.1 tm? -134.84 145.35 48.23 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 105.766 -1.939 . . . . 74.42 105.766 170.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.473 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.2 t -147.82 141.88 25.99 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.878 -1.156 . . . . 73.15 107.878 174.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -150.88 131.54 13.97 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.473 -0.566 . . . . 42.13 109.473 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 75.8 t -131.76 114.05 24.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.345 -0.983 . . . . 75.24 108.345 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.665 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.7 mt-30 -90.49 86.14 6.34 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.417 -0.957 . . . . 71.14 108.417 173.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -79.01 102.15 8.19 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.225 -1.352 . . . . 75.24 108.88 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.9 159.44 32.9 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 111.475 -0.65 . . . . 62.51 111.475 172.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.69 116.73 0.73 Allowed Glycine 0 CA--C 1.507 -0.428 0 N-CA-C 111.317 -0.713 . . . . 75.21 111.317 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.503 HD12 HD11 ' C' ' 51' ' ' LEU . 17.2 mm -84.4 132.42 31.61 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 N-CA-C 108.778 -0.823 . . . . 63.32 108.778 178.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.417 ' HD2' ' HA ' ' C' ' 13' ' ' ILE . 66.0 m-85 -135.66 139.07 43.44 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.483 0.713 . . . . 75.44 109.837 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 21.7 p -99.01 104.0 16.0 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.809 -1.182 . . . . 72.34 107.809 169.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.418 HG21 HD11 ' C' ' 89' ' ' ILE . 46.1 mt -115.72 132.62 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.898 0.879 . . . . 73.31 109.128 -176.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.83 164.46 33.58 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 122.902 0.481 . . . . 61.0 111.187 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.83 -41.75 2.71 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 115.353 -0.84 . . . . 75.32 113.392 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' C' ' 94' ' ' MET . 39.7 pt -85.98 168.84 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.274 0.629 . . . . 75.44 111.787 -174.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -164.5 168.23 18.58 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.981 1.312 . . . . 71.42 108.339 176.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.22 -119.46 11.7 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.805 -0.441 . . . . 62.51 112.982 171.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 69.9 p -69.0 -41.78 77.36 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.134 0.574 . . . . 73.34 110.644 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -61.93 -46.51 89.01 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.519 0.728 . . . . 72.11 110.9 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.434 ' HE3' ' HA ' ' C' ' 94' ' ' MET . 5.4 tpt -59.74 -51.45 69.69 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 123.734 0.646 . . . . 63.12 111.579 177.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.26 -40.88 97.67 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.68 0.612 . . . . 55.53 111.319 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -72.36 -34.54 68.06 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.901 -1.045 . . . . 71.04 111.119 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -65.11 -42.5 93.89 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.317 0.58 . . . . 65.12 109.885 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.44 -37.24 37.49 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.798 -1.092 . . . . 64.45 112.78 -175.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.78 11.66 45.81 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-O 119.429 -0.65 . . . . 42.31 114.597 -167.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.548 ' HB2' ' HB2' ' C' ' 137' ' ' PHE . . . -155.95 -56.67 0.09 Allowed 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 117.827 0.814 . . . . 65.3 111.385 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -63.7 -56.17 17.72 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.617 0.767 . . . . 70.4 111.815 -175.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.467 ' O ' HD13 ' C' ' 106' ' ' LEU . 85.5 m -65.25 -47.3 71.38 Favored Pre-proline 0 CA--C 1.561 1.397 0 C-N-CA 123.925 0.89 . . . . 62.12 112.371 -177.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.42 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 53.7 Cg_exo -55.66 -30.53 75.71 Favored 'Trans proline' 0 C--N 1.397 3.092 0 C-N-CA 122.44 2.093 . . . . 52.24 113.628 173.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -70.18 -28.71 65.54 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.289 0.636 . . . . 64.22 111.116 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.605 HD12 HH12 ' A' ' 111' ' ' ARG . 33.8 mm -77.91 -32.27 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 123.163 0.585 . . . . 71.35 109.971 175.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.467 HD13 ' O ' ' C' ' 102' ' ' CYS . 7.3 mp -78.4 -27.55 46.75 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.05 0.94 . . . . 55.41 111.578 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -56.82 -49.81 91.7 Favored Pre-proline 0 N--CA 1.48 1.069 0 CA-C-O 117.556 -1.212 . . . . 74.02 113.672 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 108' ' ' PRO . . . . . 0.4 ' HB3' ' HB2' ' A' ' 112' ' ' GLU . 97.3 Cg_exo -50.91 -40.68 57.83 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.72 2.28 . . . . 64.44 114.674 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.494 ' OH ' ' HG2' ' A' ' 111' ' ' ARG . 89.2 m-85 -79.15 -37.44 38.47 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.263 0.625 . . . . 71.21 111.455 -175.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.64 96.26 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.436 -0.802 . . . . 75.45 109.956 173.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 34.6 ttt-85 -62.97 -50.9 68.98 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.579 1.551 . . . . 75.41 110.394 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -60.67 -40.8 93.44 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.094 0.871 . . . . 72.13 110.126 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 31.8 t -72.33 -32.18 66.29 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.709 -0.678 . . . . 62.44 111.212 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.473 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 44.2 mt -69.1 -53.35 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.905 -0.406 . . . . 73.31 109.905 174.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 22.5 m -62.62 -28.98 70.27 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.442 0.697 . . . . 73.44 111.196 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 37.6 t -67.51 -49.21 64.48 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.254 0.622 . . . . 62.12 109.348 173.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.525 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.39 -39.79 84.48 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 124.432 1.093 . . . . 64.34 112.402 179.838 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.417 HG23 ' O ' ' C' ' 114' ' ' ILE . 93.7 t -65.23 -43.99 95.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.73 0.812 . . . . 62.15 110.223 176.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 22.0 t -66.07 -29.87 70.28 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.067 -0.97 . . . . 43.31 111.577 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.41 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 88.1 mtt-85 -73.02 -39.82 65.68 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.603 0.761 . . . . 72.14 109.506 177.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.61 -0.79 68.99 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 123.895 0.747 . . . . 63.41 112.522 171.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.0 p 63.4 32.17 14.66 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.823 2.049 . . . . 75.0 113.384 170.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -83.98 149.83 57.16 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 108.027 -1.101 . . . . 64.23 108.027 166.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.06 161.06 5.37 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 123.3 2.667 . . . . 62.51 113.96 176.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -58.55 113.57 2.06 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.751 0.82 . . . . 72.21 112.222 -172.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 50.8 tp -109.35 87.83 2.59 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.924 -1.034 . . . . 61.4 108.254 173.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -90.2 106.7 18.66 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.175 -1.046 . . . . 73.21 108.175 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 86.5 mt -64.45 129.25 39.16 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.41 0.684 . . . . 61.44 110.618 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.07 151.2 96.11 Favored Pre-proline 0 CA--C 1.553 1.076 0 O-C-N 124.34 1.025 . . . . 73.55 111.089 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.87 116.71 3.4 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.15 2.566 . . . . 55.42 112.853 177.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 28.9 t -99.35 133.22 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.042 -0.725 . . . . 72.24 109.042 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -87.64 96.47 10.44 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.745 0.818 . . . . 63.45 109.169 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -68.92 -24.58 64.31 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.396 0.679 . . . . 75.44 112.085 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -66.13 -41.15 90.88 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 109.076 -0.713 . . . . 61.01 109.076 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.79 -39.98 95.91 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.303 -0.862 . . . . 72.11 110.819 175.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 77.2 mt -67.6 -26.23 66.16 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.551 -0.75 . . . . 64.13 111.012 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 137' ' ' PHE . . . . . 0.548 ' HB2' ' HB2' ' C' ' 100' ' ' ALA . 34.5 t80 . . . . . 0 CA--C 1.546 0.804 0 CA-C-O 120.613 0.244 . . . . 70.22 110.878 176.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.421 HG22 ' HB3' ' D' ' 87' ' ' ALA . 10.2 t . . . . . 0 N--CA 1.47 0.565 0 CA-C-O 120.941 0.4 . . . . 33.54 110.286 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -133.37 111.2 10.58 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.642 -1.244 . . . . 74.11 107.642 173.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -136.4 139.64 42.61 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.086 0.954 . . . . 63.2 108.655 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.506 HG21 HD11 ' D' ' 16' ' ' ILE . 7.4 mt -100.2 142.02 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 108.717 -0.846 . . . . 61.1 108.717 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -103.45 -34.6 8.65 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.324 0.65 . . . . 75.53 111.483 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -169.42 137.13 1.8 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.015 0.376 . . . . 72.14 112.015 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.506 HD11 HG21 ' D' ' 13' ' ' ILE . 3.5 mp -115.66 140.09 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 107.216 -1.402 . . . . 65.55 107.216 170.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.43 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 38.3 p90 -168.72 171.08 8.92 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.977 0.911 . . . . 73.31 110.15 176.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -98.41 117.83 33.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.888 -1.051 . . . . 71.25 109.089 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.43 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 22.4 mtpt -85.79 -25.8 26.15 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.721 -0.844 . . . . 65.01 108.721 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.629 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 26.6 t70 -155.68 136.87 13.83 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.648 -1.16 . . . . 74.0 109.576 -178.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.525 HG21 ' HE2' ' C' ' 117' ' ' MET . 67.9 mt -136.59 146.84 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.326 1.05 . . . . 71.15 109.019 174.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -145.5 141.25 28.13 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.608 1.163 . . . . 72.21 109.515 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.492 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.1 t80 -145.67 134.52 22.44 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 106.415 -1.698 . . . . 72.03 106.415 165.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.45 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 50.0 mt-10 -135.03 144.99 47.6 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.94 0.896 . . . . 74.34 109.366 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.96 79.77 8.32 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 107.037 -1.468 . . . . 75.54 107.037 170.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.16 -15.49 28.73 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.821 2.347 . . . . 71.51 112.232 -175.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.415 ' ND2' ' HB ' ' D' ' 72' ' ' THR . 40.5 m-20 -114.78 16.38 17.38 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 124.383 1.073 . . . . 73.23 110.588 -174.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.55 -65.11 0.98 Allowed Pre-proline 0 CA--C 1.562 1.412 0 N-CA-C 115.067 1.506 . . . . 61.13 115.067 -159.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.501 ' HB3' HD11 ' C' ' 83' ' ' ILE . 57.4 Cg_endo -69.96 -22.98 30.42 Favored 'Trans proline' 0 C--N 1.392 2.833 0 CA-C-N 122.51 1.932 . . . . 62.12 113.484 -177.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -69.47 -44.63 70.79 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.275 1.03 . . . . 70.42 110.498 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.463 HG21 ' HA ' ' D' ' 73' ' ' ALA . 5.7 p -85.0 -18.52 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 123.192 0.597 . . . . 72.34 111.613 -170.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -60.9 -23.55 65.31 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 112.447 0.536 . . . . 54.54 112.447 172.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -63.8 -22.73 67.05 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.434 0.694 . . . . 55.42 110.919 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.594 ' HZ1' ' HB3' ' D' ' 71' ' ' GLU . 90.9 mttt -85.59 104.78 15.65 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.489 1.115 . . . . 72.12 109.599 176.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -102.09 90.56 3.99 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.379 -0.6 . . . . 63.34 109.379 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 35.4 p90 -165.42 -168.44 1.36 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.882 0.873 . . . . 75.11 109.624 171.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -72.7 117.17 57.05 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.8 0.84 . . . . 65.24 110.497 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.88 110.63 0.62 Allowed 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 121.788 1.659 . . . . 64.23 109.862 168.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -67.79 109.61 3.44 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.048 -1.093 . . . . 74.22 108.048 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.683 HG21 HD13 ' D' ' 126' ' ' LEU . 92.3 t -106.62 122.68 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.4 -0.364 . . . . 71.44 110.397 -170.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 119.29 38.97 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.726 -1.583 . . . . 71.31 106.726 172.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.499 HD11 HG13 ' D' ' 62' ' ' VAL . 45.3 tp -95.11 141.91 28.19 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.334 -0.987 . . . . 75.24 108.334 178.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -136.53 125.3 23.97 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.229 -1.397 . . . . 73.21 107.229 -177.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.426 ' CD2' HG22 ' D' ' 62' ' ' VAL . 83.6 mt -120.08 142.13 49.15 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.143 0.577 . . . . 74.11 110.491 -175.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -146.38 143.22 28.92 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.344 1.458 . . . . 74.02 107.612 174.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 15.2 t -103.95 165.37 11.09 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.983 -0.747 . . . . 63.22 108.983 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.596 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.37 147.44 26.92 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.258 -1.386 . . . . 65.51 107.258 175.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 6.4 p . . . . . 0 C--O 1.246 0.899 0 C-N-CA 123.753 0.821 . . . . 62.23 108.879 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 54' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' D' ' 85' ' ' SER . 3.5 m-20 . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 114.05 1.13 . . . . 55.52 114.05 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 89.8 t -134.18 100.54 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.001 -1.111 . . . . 62.31 108.001 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -117.84 138.47 52.07 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.034 0.934 . . . . 51.5 109.891 -170.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.672 ' HG2' HG13 ' D' ' 83' ' ' ILE . 33.8 mt-10 -87.95 108.34 19.15 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 108.521 -0.918 . . . . 72.2 108.521 170.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 97.4 t -101.08 123.79 54.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.77 -0.826 . . . . 55.31 108.77 175.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 21.3 t -114.24 130.86 67.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.994 -1.113 . . . . 74.34 107.994 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.583 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -105.35 119.81 40.01 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.792 -1.188 . . . . 71.52 107.792 -178.563 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -98.6 99.79 10.96 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.237 -1.024 . . . . 64.53 108.237 177.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.499 HG13 HD11 ' D' ' 42' ' ' LEU . 58.3 t -105.86 118.46 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 108.66 -0.867 . . . . 74.35 108.66 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.0 m -125.45 130.59 52.13 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.593 -0.73 . . . . 63.44 109.751 -170.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.661 HG13 HG13 ' D' ' 40' ' ' VAL . 70.3 t -113.22 130.6 66.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 124.845 1.258 . . . . 73.22 109.445 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 37.3 m -119.55 93.49 4.09 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.218 -1.401 . . . . 62.41 107.218 167.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.71 138.13 36.32 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.787 -0.82 . . . . 54.51 108.787 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.546 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 66.9 m -143.43 132.29 22.73 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.193 0.521 . . . . 75.54 111.232 -175.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.436 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 35.6 mt -95.55 99.26 11.16 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.482 -1.303 . . . . 51.41 107.482 173.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.57 -137.36 17.37 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.578 -0.737 . . . . 74.12 112.619 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.44 5.26 31.84 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.611 0.764 . . . . 73.43 111.95 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 71' ' ' GLU . . . . . 0.594 ' HB3' ' HZ1' ' D' ' 34' ' ' LYS . 5.4 tp10 -136.6 145.67 45.17 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.194 0.998 . . . . 72.22 109.599 -169.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 72' ' ' THR . . . . . 0.415 ' HB ' ' ND2' ' D' ' 27' ' ' ASN . 91.8 m -59.83 135.95 57.85 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.741 1.217 . . . . 53.22 112.522 -175.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.546 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.6 -65.62 1.0 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.301 -1.37 . . . . 74.12 107.301 170.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -152.57 158.26 42.23 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 114.542 -1.208 . . . . 53.24 110.045 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 76.0 mt -116.84 155.02 29.73 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.867 1.267 . . . . 73.52 108.269 171.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.574 ' SG ' HG12 ' D' ' 114' ' ' ILE . 49.1 t -154.42 147.71 24.9 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.059 -0.719 . . . . 63.42 109.059 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -157.43 123.78 4.88 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.818 0.447 . . . . 64.11 110.129 174.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 50.2 t -124.3 116.93 49.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 123.523 0.729 . . . . 62.2 109.118 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.629 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.9 mt-30 -93.25 85.1 4.92 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.938 0.875 . . . . 62.3 109.08 171.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -80.4 102.64 9.74 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 113.713 -1.585 . . . . 71.33 109.465 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.84 150.83 21.31 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 116.742 -0.208 . . . . 73.5 113.219 -178.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.58 137.24 5.58 Favored Glycine 0 C--N 1.34 0.791 0 N-CA-C 112.092 -0.403 . . . . 52.24 112.092 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.672 HG13 ' HG2' ' D' ' 57' ' ' GLU . 2.6 mp -91.15 112.84 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 107.775 -1.194 . . . . 65.13 107.775 174.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -115.33 145.29 42.64 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.69 0.796 . . . . 62.32 109.669 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' D' ' 54' ' ' ASP . 39.8 m -116.29 107.78 15.27 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.836 0.854 . . . . 63.41 109.766 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.488 HD11 HD23 ' D' ' 98' ' ' LEU . 46.9 pt -116.8 129.35 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.387 0.675 . . . . 73.42 109.391 176.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.421 ' HB3' HG22 ' D' ' 10' ' ' THR . . . -143.49 158.18 43.85 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.675 0.79 . . . . 71.44 110.149 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.07 23.64 44.18 Favored Glycine 0 C--N 1.347 1.16 0 O-C-N 123.709 0.631 . . . . 73.4 114.247 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.432 HD13 ' HG3' ' D' ' 94' ' ' MET . 0.7 OUTLIER -134.85 160.94 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.476 0.71 . . . . 62.45 110.726 178.254 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.13 160.2 40.48 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.137 0.898 . . . . 75.14 111.019 -171.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.67 -141.35 36.52 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.194 -0.912 . . . . 71.54 113.945 175.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.5 p -78.41 -32.31 48.62 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.138 0.575 . . . . 74.23 110.739 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -56.46 -33.58 66.06 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.881 0.873 . . . . 74.23 111.266 177.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.432 ' HG3' HD13 ' D' ' 89' ' ' ILE . 40.0 ttp -62.44 -62.19 1.93 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.146 1.378 . . . . 71.22 112.165 177.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.28 -15.09 51.54 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.066 0.546 . . . . 51.11 112.176 -171.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -70.83 -26.59 63.35 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.109 0.564 . . . . 74.22 110.088 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.7 t -66.41 -45.65 79.21 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.273 0.629 . . . . 75.42 110.947 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.599 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 4.3 pp -74.35 -23.08 58.97 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 116.608 -0.269 . . . . 74.42 111.207 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.82 -28.59 34.44 Favored Glycine 0 C--N 1.348 1.23 0 O-C-N 123.458 0.474 . . . . 55.01 112.958 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.24 -57.37 2.01 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 117.332 0.566 . . . . 50.22 112.233 -170.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -72.48 -37.64 68.39 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.524 0.329 . . . . 74.24 111.833 -174.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.599 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 88.6 m -65.35 -46.62 70.81 Favored Pre-proline 0 CA--C 1.566 1.592 0 CA-C-O 118.775 -0.631 . . . . 73.41 112.198 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.583 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 76.2 Cg_exo -57.61 -31.3 91.4 Favored 'Trans proline' 0 C--N 1.394 2.923 0 C-N-CA 122.622 2.215 . . . . 73.44 113.902 168.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -65.57 -28.55 69.23 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.092 0.557 . . . . 61.43 111.186 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.4 mm -73.32 -35.29 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.316 0.646 . . . . 75.05 110.332 174.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 68.3 mt -77.1 -18.24 58.1 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.352 -0.84 . . . . 74.14 111.891 -177.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 107' ' ' PHE . . . . . 0.421 ' HE2' ' HA ' ' D' ' 130' ' ' PRO . 8.4 t80 -70.46 -39.91 10.5 Favored Pre-proline 0 CA--C 1.557 1.218 0 N-CA-C 114.353 1.242 . . . . 71.52 114.353 -171.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.79 -44.9 45.15 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.962 1.775 . . . . 60.33 112.68 169.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -71.83 -32.58 67.69 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.845 0.858 . . . . 71.12 111.554 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.99 -50.52 64.01 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.467 0.707 . . . . 32.33 110.237 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.497 ' NH2' HG23 ' B' ' 105' ' ' ILE . 31.3 ttp180 -60.22 -43.06 96.31 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 124.353 1.033 . . . . 63.24 110.031 176.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -57.0 -52.77 63.94 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.102 0.876 . . . . 55.22 111.455 -176.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.437 ' O ' ' HG3' ' D' ' 117' ' ' MET . 43.2 t -57.06 -44.17 82.76 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 124.177 0.923 . . . . 73.3 110.598 -177.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.574 HG12 ' SG ' ' D' ' 76' ' ' CYS . 83.7 mt -60.62 -54.95 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.743 0.817 . . . . 64.04 110.696 175.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 77.2 m -53.43 -43.74 68.23 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.382 1.473 . . . . 62.01 111.055 -175.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -65.36 -45.9 82.31 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.403 -1.272 . . . . 72.04 109.805 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.437 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 71.2 mtm -70.87 -26.97 63.48 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.0 0.52 . . . . 73.43 112.391 -177.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.467 HG21 ' HB3' ' D' ' 126' ' ' LEU . 71.0 t -68.64 -46.16 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.216 0.606 . . . . 70.51 109.419 175.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 81.5 p -70.75 -29.69 66.0 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.588 -0.733 . . . . 72.45 110.463 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -70.83 -34.15 71.41 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.815 0.846 . . . . 64.35 110.0 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.7 6.17 71.06 Favored Glycine 0 C--N 1.355 1.625 0 O-C-N 123.681 0.613 . . . . 51.13 113.203 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.457 HG23 ' HB3' ' C' ' 17' ' ' TYR . 65.3 p 56.18 28.94 13.87 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 126.39 1.876 . . . . 72.53 113.349 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -92.79 148.93 36.94 Favored Pre-proline 0 C--O 1.241 0.655 0 N-CA-C 108.598 -0.89 . . . . 75.54 108.598 167.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.35 125.96 13.04 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 123.318 2.679 . . . . 71.04 112.466 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -47.91 124.9 8.05 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 124.607 1.192 . . . . 74.54 112.149 -173.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.683 HD13 HG21 ' D' ' 40' ' ' VAL . 16.6 tp -106.49 106.1 16.46 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.165 0.986 . . . . 75.03 109.682 -176.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -109.47 83.01 1.68 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.322 1.049 . . . . 73.44 108.532 175.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.452 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.6 pp -62.98 141.91 58.57 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.958 0.503 . . . . 64.34 110.393 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.24 139.86 90.14 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 122.74 0.416 . . . . 75.42 111.609 -173.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.421 ' HA ' ' HE2' ' D' ' 107' ' ' PHE . 74.3 Cg_endo -73.51 144.73 36.54 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.682 2.255 . . . . 72.32 111.365 176.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.99 145.59 23.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.815 0 C-N-CA 122.977 0.511 . . . . 70.33 110.129 -177.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -78.71 112.28 15.67 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.508 0.723 . . . . 71.42 109.24 176.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 . . . . . 0 N--CA 1.48 1.039 0 C-N-CA 123.968 0.907 . . . . 74.23 112.146 -176.489 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.3 m . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 108.218 -1.03 . . . . 74.5 108.218 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -120.96 119.77 33.54 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.978 0.911 . . . . 65.43 109.211 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -135.25 132.47 37.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.006 0.923 . . . . 73.44 108.586 174.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.466 ' CD1' HG21 ' A' ' 105' ' ' ILE . 4.8 mt -96.17 114.47 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 108.617 -0.883 . . . . 62.32 108.617 173.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -78.32 -32.95 49.52 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.014 0.525 . . . . 70.2 110.249 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -171.85 148.69 2.37 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 123.378 0.424 . . . . 64.34 110.144 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.2 mt -133.12 135.26 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 124.632 1.173 . . . . 65.34 108.502 173.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -163.2 171.74 15.81 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 123.982 0.801 . . . . 75.32 112.104 -171.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -101.78 124.39 47.34 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.366 -0.976 . . . . 72.21 108.366 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.532 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 44.2 mtpt -85.91 -35.69 20.36 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.039 0.447 . . . . 74.25 109.889 175.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.528 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 19.7 t70 -146.66 138.96 24.9 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.15 -0.932 . . . . 74.11 109.401 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 81.0 mt -129.11 140.32 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.009 -1.108 . . . . 71.14 108.009 174.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.7 t -138.87 123.67 18.71 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.365 0.666 . . . . 72.11 109.279 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 86.9 t80 -133.59 129.38 36.89 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.265 -1.754 . . . . 74.33 106.265 170.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -139.17 124.45 19.11 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.955 -1.128 . . . . 74.13 107.955 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.7 89.26 7.42 Favored Pre-proline 0 C--O 1.241 0.658 0 N-CA-C 107.886 -1.153 . . . . 71.44 107.886 175.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -52.31 -53.39 7.0 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 123.684 2.923 . . . . 72.24 113.504 -169.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.26 41.27 2.83 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.779 -0.823 . . . . 74.53 108.779 -173.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -44.66 -59.13 4.34 Favored Pre-proline 0 N--CA 1.495 1.789 0 CA-C-O 117.584 -1.198 . . . . 71.21 113.968 -171.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 20.9 Cg_exo -62.37 -22.54 74.22 Favored 'Trans proline' 0 C--N 1.389 2.669 0 CA-C-N 121.952 1.733 . . . . 74.5 112.618 -177.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -94.47 -28.36 15.5 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.613 1.165 . . . . 72.21 111.244 -173.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 28' ' ' ALA . 5.9 p -80.05 -17.09 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 122.698 0.399 . . . . 34.3 111.877 -170.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -78.23 -24.12 47.11 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.393 0.677 . . . . 75.24 111.206 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -92.56 -16.08 26.15 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.782 0.833 . . . . 75.35 110.687 176.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -67.57 157.81 33.5 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.29 0.636 . . . . 63.02 111.156 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -67.54 116.63 8.48 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.401 -0.963 . . . . 72.42 108.401 171.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.421 ' CE3' HD21 ' A' ' 68' ' ' LEU . 73.7 t-105 -83.8 82.13 8.46 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.092 0.557 . . . . 72.25 110.372 -175.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -115.16 81.78 8.33 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 107.572 -1.27 . . . . 73.42 107.572 168.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -86.53 121.34 1.88 Allowed 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.424 2.083 . . . . 73.4 112.499 -173.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -94.95 95.45 8.64 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.069 -1.456 . . . . 64.43 107.069 168.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.559 HG11 HD11 ' A' ' 126' ' ' LEU . 48.0 t -85.71 104.38 13.41 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-N 115.727 -0.67 . . . . 74.23 109.554 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -79.18 121.44 25.03 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.025 -1.102 . . . . 40.03 108.025 173.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tt -96.19 105.12 17.13 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 105.841 -1.911 . . . . 63.03 105.841 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -112.39 145.25 40.44 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 107.907 -1.146 . . . . 73.41 107.907 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.552 HD11 HG21 ' A' ' 131' ' ' VAL . 90.1 mt -136.82 146.98 46.3 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.913 0.485 . . . . 72.22 112.094 -171.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -155.09 117.52 4.25 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.906 -1.043 . . . . 73.12 108.765 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.3 m -117.5 126.9 53.4 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.068 0.547 . . . . 64.2 109.997 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.52 127.15 23.42 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.179 0.591 . . . . 54.53 109.94 176.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 61.7 p -101.82 170.72 7.97 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.943 0.897 . . . . 64.33 111.391 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 94.5 p -150.17 124.4 9.48 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.94 0.896 . . . . 53.1 109.382 -173.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -78.88 103.7 9.0 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.187 -0.671 . . . . 63.1 109.187 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 57' ' ' GLU . 69.9 mt -79.39 -26.8 41.87 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.512 0.725 . . . . 71.01 110.848 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.14 -175.08 2.51 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.918 0.887 . . . . 72.04 110.049 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.92 112.33 2.27 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 109.152 -0.684 . . . . 70.22 109.152 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 68.21 6.33 5.21 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.745 1.218 . . . . 75.22 112.884 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.6 t -105.16 116.23 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.014 -1.106 . . . . 61.23 108.014 173.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -132.25 127.33 35.49 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.302 -0.999 . . . . 73.1 108.302 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.445 ' HB2' HD11 ' A' ' 51' ' ' LEU . 23.9 tt0 -88.55 143.37 27.0 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 108.036 -1.098 . . . . 74.22 108.036 167.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.6 t -118.51 134.67 61.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.049 -1.093 . . . . 74.14 108.049 170.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.411 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 42.8 t -117.72 124.46 73.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 108.607 -0.886 . . . . 73.55 108.607 174.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.23 119.68 39.49 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.535 -1.283 . . . . 63.21 107.535 175.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 46.3 ttp85 -109.48 100.98 9.98 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.559 -1.274 . . . . 63.41 107.559 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.7 t -96.23 103.0 14.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 114.204 -1.362 . . . . 71.21 107.909 -178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.8 m -96.27 107.45 19.8 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 122.066 0.936 . . . . 71.1 108.918 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.556 HG11 HD21 ' A' ' 126' ' ' LEU . 43.4 t -104.72 135.91 40.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 114.599 -1.182 . . . . 73.21 108.592 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 35.7 m -138.1 126.43 23.17 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.497 -0.557 . . . . 75.32 109.497 173.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.547 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -105.31 130.34 53.45 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.326 -1.361 . . . . 70.34 107.326 173.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 54.9 m -136.52 134.15 37.23 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.7 0.625 . . . . 74.41 110.507 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.421 HD21 ' CE3' ' A' ' 36' ' ' TRP . 23.7 mt -87.25 69.12 10.01 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 107.532 -1.284 . . . . 75.01 107.532 174.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.26 -100.83 1.3 Allowed Glycine 0 C--N 1.346 1.117 0 CA-C-N 114.307 -1.315 . . . . 74.22 111.939 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -91.14 -27.54 18.47 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.931 0.892 . . . . 75.42 111.604 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -91.33 123.02 34.45 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.485 -0.561 . . . . 74.35 109.485 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.9 m -71.49 129.96 40.07 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.029 0.443 . . . . 44.51 110.431 172.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.33 -52.2 8.41 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.389 1.075 . . . . 75.12 109.162 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -160.47 160.49 32.11 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.225 -0.898 . . . . 73.22 111.615 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 64' ' ' VAL . 63.9 tp -112.68 143.53 43.74 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.806 1.242 . . . . 62.5 108.132 166.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.425 ' HB3' HG23 ' A' ' 114' ' ' ILE . 88.5 m -143.75 98.81 3.3 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.86 0.864 . . . . 74.21 109.651 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -122.37 116.12 23.48 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.915 -0.772 . . . . 61.04 108.915 -176.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.6 t -124.38 122.28 63.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 121.441 0.638 . . . . 64.41 109.885 -177.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -99.75 82.07 2.55 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.298 -1.319 . . . . 71.12 108.019 -178.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -76.02 94.47 3.43 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.038 -0.983 . . . . 74.14 109.11 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.05 150.99 21.8 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.664 -0.698 . . . . 72.12 111.383 177.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.76 132.68 3.35 Favored Glycine 0 CA--C 1.507 -0.446 0 N-CA-C 111.017 -0.833 . . . . 31.02 111.017 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.7 mt -81.41 127.07 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.384 -0.969 . . . . 63.43 108.384 175.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.602 ' HB3' HD11 ' A' ' 86' ' ' ILE . 95.8 m-85 -124.81 120.02 30.52 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.311 1.044 . . . . 62.54 108.618 -177.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.9 m -92.67 99.2 11.94 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.346 -1.353 . . . . 64.14 107.346 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.602 HD11 ' HB3' ' A' ' 84' ' ' PHE . 10.9 mm -117.15 145.99 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 122.787 0.435 . . . . 55.12 110.118 -174.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.91 169.95 17.41 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.688 0.617 . . . . 60.41 110.859 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.45 -15.12 63.36 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.702 -0.681 . . . . 53.35 112.824 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.45 164.54 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 124.188 0.995 . . . . 64.23 110.412 -177.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.591 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 13.8 tt0 -154.8 -177.74 6.72 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 109.402 -0.592 . . . . 74.12 109.402 173.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.528 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 67.53 -122.14 16.84 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 123.208 0.433 . . . . 65.44 113.513 176.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.5 t -74.36 -28.94 61.36 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.711 0.804 . . . . 73.22 111.522 -176.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -73.64 -37.29 65.38 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.518 0.727 . . . . 73.45 109.582 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.591 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 3.2 tpt -66.24 -42.79 88.09 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.237 -0.892 . . . . 72.21 110.053 175.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.18 88.82 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.362 -0.835 . . . . 50.41 111.109 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.534 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 55.8 t-80 -74.9 -20.53 59.68 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.014 0.526 . . . . 73.43 111.163 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.5 t -78.21 -49.01 14.57 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.785 -0.572 . . . . 75.15 109.539 174.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 76.1 mt -78.81 -31.44 45.9 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.245 0.618 . . . . 74.03 112.575 -172.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.35 4.41 51.36 Favored Glycine 0 N--CA 1.47 0.953 0 CA-C-O 119.649 -0.528 . . . . 75.15 113.583 -174.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -144.47 -63.64 0.36 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.448 0.624 . . . . 63.22 112.009 -175.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -69.61 -47.1 64.63 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 112.083 0.401 . . . . 73.14 112.083 -172.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 88.8 m -65.78 -47.13 66.26 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.401 1.08 . . . . 60.33 112.966 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.0 -24.81 59.75 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 122.023 1.815 . . . . 44.24 112.955 173.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -68.83 -33.69 74.25 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.13 0.572 . . . . 73.31 110.505 174.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.466 HG21 ' CD1' ' A' ' 13' ' ' ILE . 43.8 mm -68.3 -42.44 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.77 0.828 . . . . 72.0 110.4 172.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.8 mt -74.25 -25.01 59.38 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.054 -0.976 . . . . 70.31 112.089 -174.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -64.69 -40.87 52.73 Favored Pre-proline 0 CA--C 1.558 1.282 0 N-CA-C 114.49 1.293 . . . . 72.33 114.49 -171.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -52.55 -42.05 64.33 Favored 'Trans proline' 0 C--N 1.385 2.452 0 CA-C-N 121.966 1.738 . . . . 62.22 113.23 170.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -73.43 -40.28 64.36 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.533 0.733 . . . . 75.2 111.318 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.52 -46.59 82.25 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.483 0.713 . . . . 65.32 110.106 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.535 ' NH1' HD12 ' C' ' 105' ' ' ILE . 29.8 ttm180 -52.06 -50.43 61.51 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.959 1.304 . . . . 74.54 110.869 174.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -62.6 -47.79 82.26 Favored 'General case' 0 C--N 1.346 0.429 0 O-C-N 124.431 1.082 . . . . 70.15 111.436 -175.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.416 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 49.7 t -57.51 -42.76 83.42 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 124.173 0.921 . . . . 64.13 110.455 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.461 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.6 mt -60.97 -50.13 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.488 1.115 . . . . 52.13 110.607 175.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.0 m -61.33 -39.31 90.08 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.015 0.926 . . . . 74.13 111.379 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -69.89 -43.11 72.45 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.98 -1.009 . . . . 71.21 109.813 -177.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 6.9 mtp -56.97 -43.95 82.14 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.774 0.83 . . . . 75.01 111.129 174.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 114' ' ' ILE . 68.8 t -62.07 -47.11 94.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.556 1.142 . . . . 70.01 111.101 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.7 p -73.95 -29.38 61.98 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 122.906 0.483 . . . . 31.03 111.654 -176.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.448 ' NH1' ' HA ' ' B' ' 113' ' ' CYS . 68.4 mtt-85 -71.62 -30.93 66.33 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.214 0.606 . . . . 53.32 109.627 174.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.92 14.24 44.34 Favored Glycine 0 C--N 1.35 1.33 0 CA-C-N 115.413 -0.812 . . . . 72.43 112.976 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.532 HG21 ' HE ' ' B' ' 15' ' ' ARG . 3.2 t 57.31 13.8 1.88 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 127.156 2.183 . . . . 60.11 113.605 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -77.47 142.14 66.52 Favored Pre-proline 0 C--O 1.244 0.774 0 N-CA-C 108.903 -0.777 . . . . 73.32 108.903 175.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -43.84 128.25 6.88 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 123.612 2.875 . . . . 74.51 112.622 170.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -55.35 131.88 46.76 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.22 0.95 . . . . 65.41 112.375 -167.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.559 HD11 HG11 ' A' ' 40' ' ' VAL . 42.6 tp -112.62 117.16 31.51 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.751 1.22 . . . . 71.31 109.932 -174.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -121.14 104.61 9.9 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.028 -0.73 . . . . 72.23 109.028 -174.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 111' ' ' ARG . 79.2 mt -61.81 144.69 54.42 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.367 0.667 . . . . 53.35 112.336 -173.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.98 144.84 90.82 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.299 0.64 . . . . 72.32 110.304 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.406 ' HA ' HH22 ' A' ' 111' ' ' ARG . 24.8 Cg_exo -64.05 117.51 4.52 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.834 2.356 . . . . 64.12 112.599 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.552 HG21 HD11 ' A' ' 44' ' ' LEU . 87.9 t -100.22 132.6 45.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-N 116.126 -0.488 . . . . 61.23 110.299 -179.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.437 ' OD1' ' HB3' ' A' ' 134' ' ' ASP . 63.7 t30 -97.59 92.94 6.15 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.725 -1.213 . . . . 70.25 107.725 172.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.41 ' CE1' HD13 ' A' ' 44' ' ' LEU . 86.0 m-85 -65.3 -25.18 67.52 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.577 0.751 . . . . 62.24 111.355 177.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.459 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 1.1 t70 -54.74 -48.27 72.79 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.958 0.903 . . . . 72.32 110.291 168.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.409 ' HB2' HD22 ' A' ' 132' ' ' ASN . . . -62.81 -45.41 92.77 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.571 0.748 . . . . 44.12 111.711 177.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.74 -35.98 79.66 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.365 0.666 . . . . 74.24 111.396 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 42.4 t80 . . . . . 0 CA--C 1.538 0.517 0 CA-C-N 115.504 -0.771 . . . . 64.32 109.858 177.939 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.548 ' HB3' HG23 ' B' ' 89' ' ' ILE . 11.8 ptm . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 115.442 1.645 . . . . 71.03 115.442 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 5.0 t -135.79 126.93 28.04 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.46 -1.245 . . . . 72.33 107.701 168.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -130.82 144.18 51.27 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.909 0.484 . . . . 71.25 110.132 -176.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -150.28 141.92 23.58 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 108.693 -0.855 . . . . 64.2 108.693 169.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 63.1 mt -81.44 125.2 39.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.527 -1.286 . . . . 73.1 107.527 171.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 14' ' ' GLN . . . . . 0.562 ' HB2' HG23 ' B' ' 83' ' ' ILE . 9.3 mm100 -90.16 -39.06 13.07 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.785 -0.45 . . . . 65.43 109.785 -176.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.532 ' HE ' HG21 ' A' ' 122' ' ' THR . 43.2 ttt180 -176.97 134.48 0.2 Allowed 'General case' 0 N--CA 1.477 0.917 0 O-C-N 123.919 0.762 . . . . 73.51 109.81 176.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.63 141.37 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 107.851 -1.166 . . . . 54.13 107.851 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -168.44 151.35 5.41 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-O 121.386 0.613 . . . . 73.45 111.568 -174.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 89.5 m -79.06 126.9 31.3 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.953 -1.021 . . . . 60.2 109.24 172.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -89.61 -42.74 11.22 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.73 0.412 . . . . 70.01 110.071 169.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.1 t70 -140.65 136.82 33.07 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.573 -0.285 . . . . 75.43 110.541 -169.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.45 HD11 ' SG ' ' B' ' 113' ' ' CYS . 46.6 mm -126.18 137.09 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.015 0.926 . . . . 70.11 108.772 169.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.488 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 47.7 t -140.52 131.62 26.34 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.686 1.194 . . . . 75.23 107.866 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 80.2 t80 -143.68 121.81 12.18 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.319 -1.734 . . . . 73.0 106.319 170.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -126.71 113.59 16.87 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.117 -1.068 . . . . 62.51 108.117 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -106.7 87.21 2.66 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 106.633 -1.617 . . . . 65.1 106.633 167.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.66 -27.85 52.69 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.327 2.018 . . . . 74.21 110.962 -172.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.417 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 67.5 m-20 -109.82 11.49 24.31 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.507 1.123 . . . . 63.25 110.939 -177.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' B' ' 25' ' ' ALA . . . -30.48 -64.34 0.21 Allowed Pre-proline 0 N--CA 1.5 2.049 0 C-N-CA 125.517 1.527 . . . . 64.51 114.699 -172.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 14.3 Cg_exo -60.48 -34.8 92.52 Favored 'Trans proline' 0 C--N 1.395 3.015 0 C-N-CA 122.729 2.286 . . . . 70.31 112.199 -170.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.41 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 80.5 m80 -92.52 -39.76 11.19 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 114.442 -1.253 . . . . 71.24 112.39 -170.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.549 HG22 HD12 ' B' ' 68' ' ' LEU . 8.7 p -69.76 -12.66 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.032 0.533 . . . . 74.33 111.808 -171.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -69.76 -6.7 33.82 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.651 0.78 . . . . 71.44 112.92 173.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.452 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 29.4 pt20 -67.9 -22.11 65.1 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.816 0.447 . . . . 73.54 110.168 169.027 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.452 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 92.6 mttt -101.43 92.79 5.08 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.672 1.189 . . . . 74.31 109.869 -176.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -99.17 82.5 2.72 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.623 0.769 . . . . 63.53 110.057 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -157.01 -177.97 7.02 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.733 0.813 . . . . 52.4 109.61 172.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -66.86 114.77 19.41 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.63 0.772 . . . . 50.11 110.588 175.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.419 ' O ' HG23 ' B' ' 40' ' ' VAL . 41.8 Cg_endo -66.3 144.36 74.02 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 121.597 1.531 . . . . 73.55 110.678 172.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -71.4 113.3 8.29 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.525 -0.917 . . . . 70.22 108.525 172.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.494 HG11 HD11 ' B' ' 126' ' ' LEU . 57.4 t -106.5 150.41 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.063 0.945 . . . . 71.5 111.378 -170.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -138.0 119.29 14.66 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.925 1.29 . . . . 72.3 107.854 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.479 HD13 HD22 ' B' ' 128' ' ' LEU . 23.3 tp -85.43 138.62 32.13 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.359 -0.978 . . . . 34.31 108.359 173.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -140.05 112.38 7.77 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.858 -1.164 . . . . 45.24 107.858 -171.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 88.4 mt -103.1 139.57 38.45 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.275 0.63 . . . . 74.12 110.778 -171.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -148.28 146.02 28.43 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.126 1.37 . . . . 65.25 107.638 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.4 t -151.24 110.91 4.02 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 121.432 0.634 . . . . 65.32 111.737 -177.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.63 148.53 40.88 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.346 1.058 . . . . 74.2 108.367 175.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 20.8 p -142.8 177.18 8.51 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.429 0.691 . . . . 72.14 111.109 -172.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 58.7 p -156.2 134.6 11.52 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.314 1.045 . . . . 72.3 108.675 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -92.17 111.05 22.46 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.158 -1.053 . . . . 73.45 108.158 172.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 pp -120.53 17.31 12.09 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.945 0.898 . . . . 64.24 110.955 -175.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -162.3 150.86 14.88 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.321 1.048 . . . . 70.13 109.3 175.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -67.15 116.58 8.11 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.578 0.351 . . . . 53.24 110.341 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 72.35 -3.61 2.25 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.422 1.489 . . . . 61.12 112.357 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 44.0 t -119.32 102.15 12.48 Favored 'Isoleucine or valine' 0 C--N 1.347 0.483 0 N-CA-C 107.45 -1.315 . . . . 44.21 107.45 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.503 ' CE2' ' HB ' ' B' ' 58' ' ' VAL . 0.1 OUTLIER -94.31 -177.96 4.44 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.736 -0.838 . . . . 75.34 108.736 -178.055 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.519 ' HG2' ' HB ' ' B' ' 83' ' ' ILE . 4.2 tm-20 -142.34 118.54 10.76 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 107.218 -1.401 . . . . 75.13 107.218 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.503 ' HB ' ' CE2' ' B' ' 56' ' ' TYR . 12.0 p -111.09 148.19 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-O 121.094 0.473 . . . . 72.23 110.938 -178.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.474 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 28.7 t -119.02 134.36 62.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.052 -1.092 . . . . 73.14 108.052 171.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 59.1 tp -114.21 103.39 11.06 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 108.291 -1.003 . . . . 51.12 108.291 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -84.81 109.48 18.12 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.593 0.711 . . . . 74.14 109.241 175.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.433 HG13 HD11 ' B' ' 42' ' ' LEU . 56.1 t -107.06 103.44 15.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 107.769 -1.197 . . . . 51.53 107.769 174.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.9 m -102.21 132.69 47.98 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.738 -0.664 . . . . 72.22 109.567 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.894 HG11 HD21 ' B' ' 126' ' ' LEU . 82.6 t -116.76 117.31 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.138 0.975 . . . . 73.13 109.362 174.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 10.6 m -87.23 140.42 29.56 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.126 -1.064 . . . . 71.23 108.126 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.9 140.39 23.38 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 118.045 0.384 . . . . 65.54 110.413 175.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.462 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 52.6 p -146.44 133.13 19.93 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.058 0.456 . . . . 43.45 111.598 -175.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.549 HD12 HG22 ' B' ' 31' ' ' VAL . 72.9 mt -100.11 100.96 11.89 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.341 1.056 . . . . 75.35 108.661 176.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.58 -134.73 24.46 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.992 -0.549 . . . . 72.13 112.248 -176.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -83.01 4.28 26.66 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.755 0.822 . . . . 64.53 113.033 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.417 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 12.0 pt-20 -127.1 150.91 49.26 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.851 0.296 . . . . 74.01 110.49 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 85.8 m -69.4 135.84 50.85 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 123.533 0.521 . . . . 72.12 110.464 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.494 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -85.88 -63.64 1.29 Allowed 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.414 -1.328 . . . . 72.0 107.414 175.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -151.92 162.87 40.37 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.326 -1.306 . . . . 70.14 110.58 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 52.0 mt -132.32 110.42 10.57 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 105.443 -2.058 . . . . 73.31 105.443 175.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 34.4 t -116.96 145.32 43.71 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.323 -0.991 . . . . 75.34 108.323 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.488 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.9 tt0 -155.1 132.03 10.79 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.306 -0.998 . . . . 73.43 108.306 -177.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.47 HG21 ' HB3' ' B' ' 113' ' ' CYS . 94.7 t -127.26 143.53 40.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.973 -1.121 . . . . 43.1 107.973 174.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.486 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 26.2 mt-30 -119.6 86.99 2.65 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.092 -1.077 . . . . 60.03 108.092 174.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.462 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.5 tp-100 -82.95 102.84 11.97 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 114.738 -1.119 . . . . 74.42 109.281 -177.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -87.74 162.71 33.1 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-N 115.893 -0.594 . . . . 62.21 111.634 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.9 125.76 1.34 Allowed Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.544 -1.022 . . . . 62.34 110.544 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.562 HG23 ' HB2' ' B' ' 14' ' ' GLN . 18.8 tt -95.68 131.01 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 108.57 -0.9 . . . . 74.22 108.57 175.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -137.0 141.25 42.54 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.604 0.762 . . . . 74.53 109.437 -175.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.2 m -88.77 106.93 18.68 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.658 -0.867 . . . . 72.51 108.658 172.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 23.8 mm -97.37 109.66 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 107.873 -1.158 . . . . 73.22 107.873 -173.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.31 172.14 18.69 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.025 0.441 . . . . 75.43 111.58 -172.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 83.28 -47.11 3.76 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.506 -0.77 . . . . 73.3 112.631 -178.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.548 HG23 ' HB3' ' B' ' 9' ' ' MET . 1.0 OUTLIER -78.52 159.43 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 109.743 -0.465 . . . . 74.21 109.743 168.647 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -165.75 145.16 6.33 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 123.556 0.535 . . . . 74.32 110.86 -171.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.97 -100.54 2.7 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-O 120.174 -0.237 . . . . 73.02 113.347 175.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.1 m -95.96 -54.9 3.16 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 122.08 0.943 . . . . 71.34 110.12 -175.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -67.58 -18.23 64.92 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 113.52 -1.673 . . . . 61.44 111.383 -171.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 22.6 ptt? -61.42 -44.25 97.45 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.836 0.854 . . . . 74.52 113.057 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.02 -11.72 60.01 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.049 0.54 . . . . 71.21 112.142 -175.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -63.79 -38.56 91.57 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.129 0.572 . . . . 64.32 110.359 168.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.5 t -58.75 -52.67 64.7 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.258 0.551 . . . . 74.02 111.164 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.8 pp -83.44 -27.19 29.7 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.525 -0.761 . . . . 73.4 112.146 -174.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.21 -16.62 62.37 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-O 120.016 -0.324 . . . . 72.22 113.338 -176.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.82 -58.13 0.72 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.784 0.434 . . . . 70.14 112.093 -170.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -66.37 -43.53 85.69 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.125 0.57 . . . . 74.13 112.196 -173.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.4 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 59.7 m -71.38 -44.81 13.39 Favored Pre-proline 0 CA--C 1.562 1.437 0 CA-C-O 118.567 -0.73 . . . . 74.2 112.33 -175.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.4 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 50.1 Cg_exo -59.17 -31.83 96.06 Favored 'Trans proline' 0 C--N 1.394 2.934 0 C-N-CA 121.887 1.725 . . . . 65.3 113.247 168.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -62.11 -36.81 82.87 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.192 0.597 . . . . 72.4 110.303 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 59.1 mt -65.39 -40.86 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.489 0.716 . . . . 73.35 110.433 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 94.7 mt -76.26 -24.88 54.51 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.698 -0.683 . . . . 71.22 112.668 -173.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -62.32 -45.04 89.93 Favored Pre-proline 0 CA--C 1.566 1.587 0 CA-C-O 117.78 -1.105 . . . . 72.41 113.691 -173.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -52.3 -43.33 54.55 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.516 2.144 . . . . 73.22 113.371 173.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.462 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 95.3 m-85 -64.17 -45.24 89.29 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.285 0.634 . . . . 74.44 110.149 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.87 82.37 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.457 -0.792 . . . . 33.31 111.049 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.491 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 65.0 ttt-85 -64.56 -61.34 2.27 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.454 1.102 . . . . 72.1 110.989 -175.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -67.44 -25.85 66.11 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 123.505 0.503 . . . . 45.44 111.032 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.552 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.9 t -66.19 -40.75 90.63 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 109.681 -0.488 . . . . 63.5 109.681 176.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.549 HD13 HG23 ' B' ' 64' ' ' VAL . 70.3 mt -62.9 -54.47 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.784 0.834 . . . . 60.32 110.418 172.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 6.3 m -60.89 -30.68 70.3 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.886 0.875 . . . . 52.43 111.68 -173.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.454 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 44.4 t -65.41 -48.63 72.17 Favored 'General case' 0 C--N 1.347 0.5 0 C-N-CA 123.6 0.76 . . . . 73.35 110.191 174.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.552 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.4 mmt -68.35 -29.74 68.54 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.032 0.533 . . . . 60.32 111.194 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.428 HG23 ' O ' ' B' ' 114' ' ' ILE . 69.5 t -65.37 -44.36 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.442 1.097 . . . . 74.25 110.02 173.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 40.5 t -68.72 -29.92 68.44 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.241 -0.89 . . . . 64.44 111.174 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' B' ' 116' ' ' SER . 88.7 mtt-85 -65.14 -39.7 93.37 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 108.934 -0.765 . . . . 54.44 108.934 174.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.0 -5.28 75.09 Favored Glycine 0 C--N 1.356 1.675 0 O-C-N 123.651 0.595 . . . . 51.05 113.558 172.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 8.0 m 67.58 31.11 6.31 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.136 1.374 . . . . 73.1 111.006 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -91.68 160.45 36.38 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-N 114.821 -1.081 . . . . 73.41 111.143 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -51.31 157.72 4.33 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.838 3.025 . . . . 75.34 115.598 177.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.494 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 55.1 tp60 -58.26 113.91 2.16 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.257 1.423 . . . . 74.51 111.529 -177.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.894 HD21 HG11 ' B' ' 64' ' ' VAL . 32.5 tp -106.96 102.37 11.73 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.075 0.464 . . . . 74.33 109.771 -172.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 127' ' ' ASN . . . . . 0.489 HD21 ' HG3' ' B' ' 125' ' ' GLN . 29.2 m-80 -101.07 117.88 35.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.271 0.629 . . . . 71.34 109.431 -177.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.491 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 69.4 mt -85.89 135.9 33.5 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 109.886 -0.413 . . . . 73.21 109.886 172.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.34 138.43 74.94 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 123.494 0.718 . . . . 41.05 110.807 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.492 ' HG3' HD11 ' D' ' 16' ' ' ILE . 21.3 Cg_endo -60.19 101.99 0.17 Allowed 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 123.207 2.605 . . . . 61.21 111.946 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 18.1 m -90.15 109.95 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 122.013 0.911 . . . . 65.12 109.38 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 . . . . . 0 C--O 1.242 0.701 0 CA-C-N 115.068 -0.969 . . . . 75.24 109.402 -178.46 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.869 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 69.1 t80 . . . . . 0 C--O 1.237 0.422 0 N-CA-C 108.094 -1.076 . . . . 74.23 108.094 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -136.81 122.69 20.06 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.641 -0.874 . . . . 70.24 108.641 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.432 HD11 HG21 ' C' ' 105' ' ' ILE . 46.5 mt -83.05 126.78 40.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 109.279 -0.637 . . . . 45.11 109.279 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.409 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 13.7 mm100 -87.06 -44.27 11.69 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.852 -0.796 . . . . 72.31 108.852 174.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 179.96 151.06 0.4 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.032 1.333 . . . . 74.12 109.462 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 83.7 mt -123.44 128.44 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 107.877 -1.157 . . . . 70.21 107.877 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.608 ' HB3' HG23 ' D' ' 122' ' ' THR . 35.5 p90 -161.27 149.92 16.01 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.318 0.58 . . . . 75.01 111.56 -167.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.7 p -80.61 119.72 23.62 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.35 -0.841 . . . . 74.3 110.575 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp -71.88 -36.62 70.14 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.619 -0.882 . . . . 73.42 108.619 169.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -148.85 148.43 29.89 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-N 115.092 -0.958 . . . . 72.21 110.006 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.1 mt -140.64 140.47 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 106.347 -1.724 . . . . 54.11 106.347 175.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 28.3 t -154.12 146.64 24.07 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.204 0.526 . . . . 74.12 110.526 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -155.17 129.37 8.9 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 107.013 -1.477 . . . . 74.04 107.013 172.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -137.69 123.96 20.55 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.247 0.619 . . . . 73.35 109.544 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -121.38 84.13 41.04 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 107.145 -1.428 . . . . 71.11 107.145 166.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.47 -24.07 43.01 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 122.422 2.081 . . . . 74.1 111.578 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -104.0 17.27 24.45 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.36 1.064 . . . . 74.21 110.516 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.42 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -47.53 -57.1 10.54 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 113.526 0.936 . . . . 75.4 113.526 -171.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.42 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 21.7 Cg_exo -63.04 -39.16 41.51 Favored 'Trans proline' 0 C--N 1.393 2.884 0 C-N-CA 122.112 1.874 . . . . 64.02 111.962 -176.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -69.26 -37.06 77.75 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.367 -1.288 . . . . 73.24 111.996 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.766 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.8 p -82.55 -21.03 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 N-CA-C 112.907 0.706 . . . . 62.41 112.907 -176.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -66.28 -29.22 69.4 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 120.856 0.36 . . . . 71.44 111.652 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -94.96 14.18 22.55 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.848 0.859 . . . . 71.54 111.371 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -104.55 158.26 16.61 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.708 0.803 . . . . 62.25 109.668 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -70.25 115.38 9.37 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.672 0.789 . . . . 75.24 110.158 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -80.6 91.57 5.84 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.243 1.017 . . . . 72.22 111.333 -171.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 37' ' ' GLN . . . . . 0.477 ' H ' HD22 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -139.58 73.72 34.89 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.368 1.067 . . . . 74.03 109.206 169.967 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -79.85 149.13 20.3 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.282 1.988 . . . . 71.01 112.192 -174.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -86.91 93.19 9.25 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.637 -1.616 . . . . 64.13 106.637 165.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.405 HG13 HD21 ' C' ' 126' ' ' LEU . 56.2 t -68.3 102.84 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 108.429 -0.952 . . . . 71.3 108.429 177.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -109.81 102.5 11.28 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.149 -1.056 . . . . 64.42 108.149 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 pp -87.96 139.57 30.38 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.011 -1.107 . . . . 62.4 108.011 172.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -139.86 118.64 12.42 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.148 -0.686 . . . . 75.42 109.148 -175.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 92.7 mt -111.95 138.95 47.88 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.77 0.828 . . . . 53.51 111.369 -171.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -147.62 127.08 13.17 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.788 1.235 . . . . 74.04 107.96 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 8.7 t -120.64 145.02 47.84 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 109.447 -0.575 . . . . 61.22 109.447 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.39 150.55 40.81 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.473 0.709 . . . . 75.01 109.781 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 32.8 m -141.64 155.0 45.73 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.053 0.541 . . . . 74.35 110.74 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 61.7 p -151.85 129.86 11.81 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.082 0.953 . . . . 63.54 109.06 178.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -73.71 117.44 15.48 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.04 -0.726 . . . . 72.04 109.04 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' C' ' 57' ' ' GLU . 71.1 mt -86.89 -43.56 12.34 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.41 0.684 . . . . 73.23 109.976 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.26 -173.93 4.52 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.341 -0.845 . . . . 61.55 110.249 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.3 107.74 0.81 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.011 0.924 . . . . 72.05 110.217 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 66.37 22.05 10.84 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.221 1.008 . . . . 75.13 111.026 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 96.0 t -119.39 119.31 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.025 0.93 . . . . 65.31 108.732 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -127.15 126.82 43.56 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.289 1.036 . . . . 72.42 108.988 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.629 ' HB2' HD11 ' C' ' 51' ' ' LEU . 35.9 tt0 -83.9 126.19 32.74 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.402 -0.962 . . . . 73.23 108.402 168.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 88.6 t -118.05 137.09 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.25 -0.648 . . . . 62.13 109.25 173.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.459 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 44.8 t -128.67 145.26 35.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.096 0.958 . . . . 73.02 108.869 177.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.455 HD11 ' CZ ' ' C' ' 133' ' ' PHE . 0.0 OUTLIER -126.72 104.35 8.03 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.476 -1.305 . . . . 75.41 107.476 177.783 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -81.98 106.17 13.68 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.285 -1.006 . . . . 75.44 108.285 171.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 23.2 t -104.65 133.57 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.907 -1.145 . . . . 72.13 107.907 172.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 84.9 m -126.97 136.74 52.68 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.385 -0.969 . . . . 62.35 108.385 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.496 HG23 HD13 ' C' ' 114' ' ' ILE . 85.2 t -122.56 114.12 41.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 109.422 -0.584 . . . . 62.42 109.422 173.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 18.7 m -98.54 137.34 37.34 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.716 -0.846 . . . . 74.1 108.716 172.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.79 113.81 17.12 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.14 -1.43 . . . . 70.31 107.14 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 44.0 m -136.76 128.61 29.15 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.464 0.477 . . . . 75.25 110.17 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.477 HD22 ' H ' ' C' ' 37' ' ' GLN . 49.8 mt -84.41 29.05 0.61 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.151 1.38 . . . . 61.52 111.265 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.64 -91.04 0.75 Allowed Glycine 0 C--N 1.35 1.345 0 N-CA-C 111.169 -0.772 . . . . 71.13 111.169 -175.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -90.67 -33.7 15.71 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.55 0.74 . . . . 71.15 109.27 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -88.87 122.18 31.99 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.597 1.159 . . . . 74.22 110.463 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 89.1 m -81.73 129.09 34.6 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.482 -0.562 . . . . 63.43 109.482 169.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.766 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -80.72 -58.45 3.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.791 0.836 . . . . 74.14 110.059 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -157.12 167.98 28.8 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.85 0.833 . . . . 75.32 111.224 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -131.51 137.35 48.5 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 106.655 -1.609 . . . . 53.21 106.655 166.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.604 ' SG ' HG23 ' C' ' 114' ' ' ILE . 41.8 t -137.07 149.32 47.32 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.582 -0.896 . . . . 54.45 108.582 176.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -157.78 133.65 9.27 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.44 -0.578 . . . . 71.3 109.44 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 73.7 t -132.75 132.46 59.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 124.143 0.977 . . . . 75.04 108.889 174.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -104.39 87.13 2.65 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.295 -1.002 . . . . 74.0 108.295 173.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -79.39 97.92 6.54 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.349 -0.841 . . . . 70.33 109.145 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -83.72 177.86 52.39 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 115.781 -0.645 . . . . 41.43 112.293 175.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 178.18 134.27 2.04 Favored Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 111.356 -0.698 . . . . 74.41 111.356 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.409 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 35.4 mm -88.7 125.81 41.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.361 -0.977 . . . . 71.23 108.361 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -130.3 117.86 20.44 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.47 0.708 . . . . 74.1 109.37 -178.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 11.4 p -85.01 102.19 12.99 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 108.466 -0.939 . . . . 72.23 108.466 172.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.435 HG21 ' HE1' ' C' ' 94' ' ' MET . 24.4 mt -114.29 129.54 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.814 0.845 . . . . 62.41 109.949 -175.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.86 171.15 14.86 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.654 0.782 . . . . 54.12 110.385 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.81 -35.06 4.62 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 116.26 -0.427 . . . . 50.44 113.075 176.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 27.7 pt -108.12 171.71 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.251 0.62 . . . . 65.41 111.709 -171.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -167.19 156.93 10.79 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.801 0.84 . . . . 71.34 109.923 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.07 -115.62 6.24 Favored Glycine 0 C--N 1.349 1.304 0 O-C-N 123.324 0.39 . . . . 61.1 113.535 171.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 58.3 p -64.22 -40.07 95.28 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 123.688 0.795 . . . . 72.22 110.953 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -68.37 -47.66 66.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.899 0.88 . . . . 74.32 111.097 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.529 ' HE3' ' HA ' ' C' ' 94' ' ' MET . 5.2 tpt -53.86 -49.86 67.55 Favored 'General case' 0 C--N 1.352 0.694 0 O-C-N 123.875 0.734 . . . . 54.14 111.705 173.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.69 -38.76 89.01 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 123.637 0.585 . . . . 72.11 111.032 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 96' ' ' HIS . . . . . 0.543 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 44.5 t-80 -71.59 -19.68 62.1 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.553 1.141 . . . . 75.13 111.483 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 9.3 t -82.2 -51.96 7.44 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.517 -0.92 . . . . 73.31 108.517 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.11 -30.11 69.19 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.841 -1.072 . . . . 64.1 112.978 -172.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.94 11.28 29.54 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-O 119.45 -0.639 . . . . 63.3 113.64 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -151.34 -61.14 0.18 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 117.535 0.667 . . . . 35.54 112.222 -176.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -74.04 -53.31 10.28 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.422 0.689 . . . . 74.41 112.14 -169.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.869 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 34.5 m -58.56 -49.18 94.88 Favored Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.15 0.98 . . . . 71.24 111.924 176.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.521 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 77.1 Cg_exo -53.83 -35.76 80.44 Favored 'Trans proline' 0 C--N 1.402 3.384 0 C-N-CA 122.686 2.257 . . . . 61.24 113.24 173.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -68.76 -33.15 73.4 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.418 0.687 . . . . 60.24 111.708 -176.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.535 HD12 ' NH1' ' A' ' 111' ' ' ARG . 31.4 mm -70.11 -43.03 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 122.332 0.253 . . . . 53.01 110.691 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.403 ' HA ' ' CD1' ' C' ' 109' ' ' TYR . 1.7 pp -95.93 -3.56 45.01 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.372 0.878 . . . . 74.43 113.372 -176.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 107' ' ' PHE . . . . . 0.504 ' HZ ' HD22 ' C' ' 128' ' ' LEU . 56.0 t80 -55.06 -48.15 96.76 Favored Pre-proline 0 N--CA 1.485 1.317 0 CA-C-O 117.742 -1.123 . . . . 74.22 113.578 172.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -60.94 -30.67 90.4 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 121.738 1.626 . . . . 73.25 112.979 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.403 ' CD1' ' HA ' ' C' ' 106' ' ' LEU . 19.3 m-85 -68.66 -43.05 77.01 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.371 0.669 . . . . 73.01 109.479 176.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.54 -39.34 94.16 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.041 -0.981 . . . . 74.31 110.625 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -61.87 -52.77 62.75 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.382 1.073 . . . . 70.45 110.191 176.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -67.22 -28.37 68.01 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.596 0.759 . . . . 72.11 110.383 -174.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.49 ' O ' ' SD ' ' C' ' 117' ' ' MET . 8.2 t -71.05 -49.2 47.32 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 122.997 0.519 . . . . 70.12 110.334 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.604 HG23 ' SG ' ' C' ' 76' ' ' CYS . 86.8 mt -59.77 -47.28 91.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 123.29 0.636 . . . . 74.15 110.167 174.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 99.4 m -63.53 -31.05 72.1 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.812 0.845 . . . . 61.42 111.109 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 25.2 t -65.51 -48.42 72.59 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 108.808 -0.812 . . . . 73.13 108.808 171.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.901 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.2 OUTLIER -56.29 -43.19 78.6 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.953 0.901 . . . . 75.24 112.485 178.441 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.426 HG23 ' O ' ' C' ' 114' ' ' ILE . 87.9 t -69.33 -41.89 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.869 0.868 . . . . 74.05 110.26 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 30.6 t -64.1 -37.8 88.75 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.111 -0.949 . . . . 73.43 111.454 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.535 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 60.3 mtt-85 -69.64 -40.14 76.69 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.149 -0.932 . . . . 61.44 110.222 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.64 2.26 64.03 Favored Glycine 0 C--N 1.355 1.631 0 O-C-N 123.796 0.685 . . . . 74.21 112.847 174.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 44.2 p 60.94 28.19 18.0 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.952 1.701 . . . . 70.04 113.098 168.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -83.23 144.08 46.27 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.12 -1.067 . . . . 62.21 108.12 169.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -44.75 141.93 5.4 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.791 2.994 . . . . 72.14 114.071 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.494 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 13.3 mm-40 -59.22 124.75 21.02 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.908 0.755 . . . . 75.21 112.802 -170.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.405 HD21 HG13 ' C' ' 40' ' ' VAL . 40.1 tp -121.38 103.26 8.82 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.268 -1.012 . . . . 72.41 108.268 -176.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -96.19 116.0 28.31 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.387 -0.824 . . . . 74.42 109.658 -176.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.504 HD22 ' HZ ' ' C' ' 107' ' ' PHE . 0.9 OUTLIER -71.59 117.4 13.1 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.588 0.755 . . . . 75.22 109.027 -178.838 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.74 159.15 70.98 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 123.95 0.9 . . . . 73.11 111.654 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -55.49 100.74 0.08 OUTLIER 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.726 2.284 . . . . 63.31 113.199 174.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.9 t -99.56 111.09 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 108.218 -1.03 . . . . 63.12 108.218 172.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -86.06 104.38 15.61 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.407 0.683 . . . . 73.43 110.722 -175.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 133' ' ' PHE . . . . . 0.455 ' CZ ' HD11 ' C' ' 60' ' ' LEU . 82.9 m-85 -64.51 -23.76 67.38 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.164 0.986 . . . . 72.43 112.041 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 134' ' ' ASP . . . . . 0.457 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 2.4 t70 -65.25 -36.67 84.84 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.766 0.826 . . . . 62.3 109.753 178.208 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.4 -19.32 33.73 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.382 -1.281 . . . . 55.34 111.614 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 36.0 mt -82.88 -22.35 34.0 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 120.895 0.378 . . . . 62.21 110.697 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 38.0 t80 . . . . . 0 CA--C 1.554 1.119 0 C-N-CA 123.473 0.709 . . . . 65.13 110.469 177.371 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 C--O 1.244 0.765 0 N-CA-C 109.644 -0.502 . . . . 73.32 109.644 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.572 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 51.0 t80 -138.64 93.88 2.77 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.397 -1.335 . . . . 73.44 107.397 174.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -124.3 126.11 45.49 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.754 -0.832 . . . . 72.04 108.754 -177.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 mt -82.41 121.35 35.44 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 N-CA-C 108.773 -0.825 . . . . 73.31 108.773 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -85.26 -29.66 24.44 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.282 1.033 . . . . 74.31 110.303 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -170.14 142.11 2.22 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 123.625 0.578 . . . . 72.15 110.426 -177.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.492 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.9 mp -118.24 130.4 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 105.503 -2.036 . . . . 71.23 105.503 170.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.4 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 25.2 p90 -159.99 141.92 12.98 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 118.701 0.682 . . . . 74.24 111.359 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 71.3 p -78.36 110.8 13.73 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.882 -1.054 . . . . 61.12 109.176 174.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.4 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 31.7 mtpt -78.41 -24.76 46.06 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.562 -0.744 . . . . 75.01 109.253 176.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.707 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 2.8 t70 -149.97 147.96 28.5 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.665 1.186 . . . . 71.34 110.02 174.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.901 HG21 ' HE2' ' C' ' 117' ' ' MET . 83.1 mt -139.51 146.51 25.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 126.07 1.748 . . . . 73.11 107.598 174.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 39.9 t -155.86 145.38 21.0 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.167 0.587 . . . . 75.12 110.428 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.513 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 79.7 t80 -151.98 139.88 20.01 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.703 -1.591 . . . . 74.42 106.703 171.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.441 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 40.6 mt-10 -142.99 146.3 33.77 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.404 0.681 . . . . 72.13 109.604 -175.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.75 85.57 6.55 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.039 0.935 . . . . 53.52 108.573 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.87 -36.9 21.72 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.348 2.699 . . . . 61.23 112.935 -177.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -103.66 16.17 27.06 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.14 -0.936 . . . . 74.11 110.749 -173.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -34.06 -66.2 0.23 Allowed Pre-proline 0 CA--C 1.571 1.761 0 N-CA-C 116.292 1.96 . . . . 73.54 116.292 -162.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.406 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 95.7 Cg_endo -75.82 -21.96 13.88 Favored 'Trans proline' 0 C--N 1.386 2.529 0 CA-C-N 123.977 2.456 . . . . 75.11 114.165 -178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -70.51 -41.81 72.12 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.712 1.205 . . . . 73.31 110.306 178.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.63 HG21 ' HA ' ' D' ' 73' ' ' ALA . 13.4 p -82.53 -20.53 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-N 115.233 -0.894 . . . . 63.31 111.56 -173.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.406 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.5 m-30 -62.41 -29.04 70.21 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 112.299 0.481 . . . . 65.22 112.299 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -63.87 -14.66 55.14 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.42 1.088 . . . . 73.32 111.567 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -93.6 109.36 20.98 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.829 1.252 . . . . 74.11 110.1 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -102.94 92.89 4.76 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.175 0.59 . . . . 53.44 111.059 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 42.4 p90 -168.46 -177.28 3.12 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.838 1.255 . . . . 65.35 108.421 168.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 61.0 tp60 -74.02 118.32 68.54 Favored Pre-proline 0 N--CA 1.479 0.985 0 CA-C-O 119.09 -0.481 . . . . 65.52 109.834 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -58.95 137.39 79.54 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.332 2.021 . . . . 70.31 111.195 174.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 39' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 25.5 mt-10 -62.81 106.9 0.87 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.447 -0.946 . . . . 73.12 108.447 174.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.668 HG13 HG13 ' D' ' 64' ' ' VAL . 57.2 t -99.96 108.48 22.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.374 -0.602 . . . . 55.1 109.374 -175.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -86.76 109.69 19.41 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.387 -1.338 . . . . 73.44 107.387 169.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.592 HD11 HG13 ' D' ' 62' ' ' VAL . 40.4 tp -96.08 123.31 39.64 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.5 -0.926 . . . . 74.32 108.5 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -118.86 143.91 46.69 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 106.282 -1.747 . . . . 63.02 106.282 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.404 ' CD2' HG22 ' D' ' 62' ' ' VAL . 94.9 mt -136.73 148.23 47.18 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.419 0.688 . . . . 65.15 109.159 -174.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.755 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.8 t70 -145.38 136.32 24.64 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.426 -0.953 . . . . 72.12 108.426 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.3 t -102.43 158.42 16.22 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.967 -1.123 . . . . 74.41 107.967 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -161.9 165.92 26.95 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.995 0.518 . . . . 72.53 109.731 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.4 p . . . . . 0 C--O 1.242 0.69 0 C-N-CA 124.681 1.192 . . . . 75.52 108.201 -175.762 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 112.445 0.535 . . . . 75.24 112.445 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 47.6 t -118.05 100.18 9.56 Favored 'Isoleucine or valine' 0 C--N 1.35 0.588 0 N-CA-C 107.452 -1.314 . . . . 65.54 107.452 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -119.82 129.93 54.67 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 107.908 -1.145 . . . . 75.25 107.908 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -111.02 118.33 35.76 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.059 -1.46 . . . . 75.52 107.059 165.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 72.1 t -100.29 134.98 38.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.382 -0.97 . . . . 75.14 108.382 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.58 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 24.8 t -114.97 137.97 46.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.341 -0.985 . . . . 65.42 108.341 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.524 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -115.08 118.61 33.86 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.382 -1.34 . . . . 62.25 107.382 174.339 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.755 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 45.3 ttm-85 -95.54 99.31 11.21 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.831 -1.174 . . . . 73.04 107.831 171.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.592 HG13 HD11 ' D' ' 42' ' ' LEU . 94.8 t -89.25 128.98 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 106.746 -1.576 . . . . 64.15 106.746 169.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 5.3 m -129.56 126.07 37.69 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.64 -0.874 . . . . 74.34 108.64 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.668 HG13 HG13 ' D' ' 40' ' ' VAL . 55.6 t -108.41 132.0 57.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 108.049 -1.093 . . . . 73.54 108.049 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 49.5 m -126.69 90.86 3.24 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.322 -1.362 . . . . 65.33 107.322 171.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -104.35 139.07 39.84 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.28 -0.873 . . . . 73.13 109.838 -176.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.551 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 77.4 p -144.17 128.95 18.31 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-O 121.07 0.462 . . . . 75.4 112.233 -172.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.602 HD12 HG22 ' D' ' 31' ' ' VAL . 43.9 mt -92.4 104.08 16.45 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.956 -1.498 . . . . 74.35 106.956 170.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.15 -145.85 38.52 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 123.674 0.608 . . . . 34.01 111.998 -172.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.69 2.93 31.23 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 112.503 0.556 . . . . 75.23 112.503 -177.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -117.21 146.55 43.17 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 117.924 0.329 . . . . 74.1 110.163 -176.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 98.8 m -63.99 121.07 13.24 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 124.002 0.814 . . . . 74.52 111.108 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.63 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -76.86 -71.89 0.37 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.157 -1.423 . . . . 33.51 107.157 170.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -147.43 141.11 25.6 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.672 -0.695 . . . . 75.51 111.201 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.441 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 56.1 mt -103.96 149.53 25.05 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.218 -1.401 . . . . 73.21 107.218 166.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.578 ' SG ' HG12 ' D' ' 114' ' ' ILE . 6.3 t -157.94 106.23 2.02 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.081 0.401 . . . . 74.14 110.087 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -120.37 122.22 40.3 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.011 0.524 . . . . 74.41 110.204 -176.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 98.2 t -123.84 117.68 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.607 0.763 . . . . 54.44 109.42 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.707 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.1 mt-30 -88.68 83.37 6.74 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.482 -0.933 . . . . 72.54 108.482 168.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 80' ' ' GLN . . . . . 0.415 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.2 tp-100 -80.53 96.54 6.83 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.172 -1.376 . . . . 64.13 109.316 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.61 161.87 28.78 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 111.765 -0.534 . . . . 74.43 111.765 177.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.21 134.55 3.36 Favored Glycine 0 C--N 1.332 0.315 0 N-CA-C 111.624 -0.59 . . . . 75.42 111.624 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 48.4 mt -90.03 117.45 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 108.687 -0.857 . . . . 73.42 108.687 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -115.64 125.94 53.53 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.473 1.109 . . . . 61.04 109.804 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 53.6 p -84.2 104.13 13.98 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.736 -0.839 . . . . 72.11 108.736 171.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 45.3 mt -115.61 122.6 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.403 0.681 . . . . 74.21 109.492 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.08 168.43 25.55 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.659 1.183 . . . . 73.12 109.595 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.28 22.66 43.55 Favored Glycine 0 N--CA 1.476 1.325 0 N-CA-C 114.364 0.505 . . . . 65.21 114.364 172.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' D' ' 94' ' ' MET . 1.0 OUTLIER -136.63 172.42 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 124.349 1.06 . . . . 64.41 109.569 -179.318 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -153.17 -170.76 3.71 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.854 0.462 . . . . 73.14 110.583 177.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.49 -141.66 30.11 Favored Glycine 0 C--N 1.349 1.281 0 CA-C-N 116.011 -0.54 . . . . 54.13 112.383 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 11.2 t -89.91 -20.91 22.81 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.364 0.666 . . . . 75.04 109.878 170.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -58.63 -30.93 67.66 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.692 1.197 . . . . 71.32 112.03 -176.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.693 ' HA ' HD12 ' D' ' 89' ' ' ILE . 12.5 ptp -53.48 -54.12 41.69 Favored 'General case' 0 CA--C 1.55 0.968 0 O-C-N 123.817 0.698 . . . . 65.41 111.905 177.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 95' ' ' ALA . . . . . 0.438 ' H ' ' HG3' ' D' ' 94' ' ' MET . . . -87.38 -15.48 37.71 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.051 0.94 . . . . 44.04 112.071 -176.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -66.1 -39.11 89.72 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.628 0.771 . . . . 73.5 110.319 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 75.0 m -63.97 -38.9 92.75 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.423 -0.808 . . . . 44.33 110.987 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.532 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 6.2 tt -71.96 -39.51 69.31 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 115.389 -0.823 . . . . 74.44 110.666 -176.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.21 -27.51 52.19 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-O 119.793 -0.449 . . . . 61.54 114.212 -173.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.7 -51.89 2.25 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 122.985 0.514 . . . . 61.54 112.019 -172.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 101' ' ' TYR . . . . . 0.4 ' O ' HG12 ' D' ' 105' ' ' ILE . 70.1 t80 -73.64 -39.97 64.1 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.057 0.543 . . . . 72.31 111.526 -171.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.572 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 85.7 m -63.04 -47.98 85.2 Favored Pre-proline 0 CA--C 1.563 1.466 0 CA-C-O 118.4 -0.809 . . . . 54.5 112.345 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.524 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 53.1 Cg_exo -58.19 -36.76 97.53 Favored 'Trans proline' 0 C--N 1.396 3.058 0 C-N-CA 122.231 1.954 . . . . 70.12 112.963 168.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -62.33 -33.82 75.44 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.424 0.69 . . . . 64.24 111.535 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.4 HG12 ' O ' ' D' ' 101' ' ' TYR . 46.0 mm -69.68 -39.27 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.665 0.786 . . . . 64.33 110.888 175.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.415 HD13 ' O ' ' D' ' 80' ' ' GLN . 77.3 mt -73.86 -21.48 60.09 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.645 -0.707 . . . . 64.25 112.091 -175.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -66.78 -41.18 36.24 Favored Pre-proline 0 CA--C 1.56 1.364 0 CA-C-O 117.718 -1.134 . . . . 73.33 113.909 -172.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -45.63 -48.19 12.43 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 122.516 2.144 . . . . 74.12 113.75 168.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -72.2 -40.78 67.61 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.864 0.865 . . . . 75.44 111.771 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.01 -44.04 90.5 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.622 0.769 . . . . 63.14 110.933 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -61.99 -46.96 86.94 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.685 -1.143 . . . . 75.41 110.364 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -61.49 -44.9 96.25 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.976 0.91 . . . . 63.33 111.327 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.535 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 51.9 t -56.01 -46.59 78.71 Favored 'General case' 0 C--N 1.349 0.565 0 O-C-N 124.086 0.866 . . . . 73.44 110.472 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.578 HG12 ' SG ' ' D' ' 76' ' ' CYS . 69.8 mt -63.29 -48.84 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 114.956 -1.02 . . . . 71.42 111.472 176.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 86.1 m -56.05 -44.11 78.54 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 124.029 0.932 . . . . 72.54 111.123 -172.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 40.6 t -65.16 -41.47 94.65 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.386 -1.279 . . . . 71.23 110.467 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.447 ' HE2' ' HA ' ' D' ' 114' ' ' ILE . 75.5 mtm -71.29 -29.64 65.3 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.961 0.504 . . . . 73.44 111.754 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.517 HG23 ' O ' ' D' ' 114' ' ' ILE . 75.1 t -65.47 -43.35 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.008 0.923 . . . . 73.0 109.606 175.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 96.3 p -74.74 -24.45 58.72 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.613 -0.721 . . . . 62.01 110.902 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' D' ' 116' ' ' SER . 92.5 mtt-85 -70.08 -31.37 68.92 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.876 0.47 . . . . 70.33 110.107 172.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.92 10.24 68.96 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 123.581 0.55 . . . . 63.45 112.901 174.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.608 HG23 ' HB3' ' C' ' 17' ' ' TYR . 50.3 p 60.51 12.16 3.4 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 126.844 2.057 . . . . 64.14 114.411 -178.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -79.46 155.31 76.48 Favored Pre-proline 0 N--CA 1.48 1.031 0 CA-C-O 118.966 -0.54 . . . . 74.32 110.629 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -47.53 122.89 7.35 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.307 2.672 . . . . 51.12 111.474 173.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -50.27 132.33 24.22 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 124.759 1.287 . . . . 73.33 111.592 -171.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.482 HD13 HG21 ' D' ' 40' ' ' VAL . 48.7 tp -106.39 98.53 8.2 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 121.635 0.731 . . . . 75.23 109.968 -173.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -99.08 89.32 4.22 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 106.269 -1.752 . . . . 74.11 106.269 174.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 87.7 mt -55.79 113.47 1.49 Allowed 'General case' 0 C--N 1.357 0.903 0 O-C-N 123.739 0.649 . . . . 73.3 109.518 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.91 123.03 82.55 Favored Pre-proline 0 CA--C 1.547 0.862 0 O-C-N 123.829 0.705 . . . . 72.34 109.393 -175.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.21 136.04 33.39 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.641 2.228 . . . . 74.14 112.4 -168.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.43 143.37 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.201 1.0 . . . . 73.35 109.079 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -73.99 115.2 13.18 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.226 0.61 . . . . 74.13 109.395 177.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 . . . . . 0 N--CA 1.483 1.181 0 C-N-CA 124.384 1.074 . . . . 75.41 111.845 -175.969 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.4 m . . . . . 0 CA--C 1.541 0.622 0 N-CA-C 108.19 -1.041 . . . . 62.5 108.19 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -119.99 117.5 28.19 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.95 1.3 . . . . 72.13 108.337 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -133.89 109.8 9.29 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.619 -0.882 . . . . 71.4 108.619 -178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.8 mt -74.17 122.17 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.749 -0.834 . . . . 73.11 108.749 174.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -92.91 -42.17 9.64 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.088 0.555 . . . . 72.42 110.818 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -170.68 121.8 0.59 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 110.05 -0.352 . . . . 71.03 110.05 -175.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.401 HD12 ' HG3' ' C' ' 130' ' ' PRO . 98.1 mt -105.71 126.14 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 107.57 -1.27 . . . . 74.3 107.57 172.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.502 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 28.3 p90 -162.11 157.11 22.85 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 123.736 0.647 . . . . 75.11 110.896 -171.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.1 p -85.01 117.09 23.77 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 109.408 -0.59 . . . . 44.15 109.408 174.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.0 mtpt -78.19 -31.31 49.47 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.407 -0.59 . . . . 71.33 109.407 174.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 30.4 t70 -150.25 145.82 26.43 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.759 -1.109 . . . . 61.24 110.68 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 75.0 mt -138.92 145.41 27.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 C-N-CA 125.395 1.478 . . . . 61.42 107.951 176.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.3 t -149.26 133.05 16.95 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.833 0.853 . . . . 73.54 109.538 173.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -130.54 139.39 50.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.087 -1.449 . . . . 74.14 107.087 169.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -135.12 134.11 39.9 Favored 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 123.068 0.547 . . . . 55.2 109.621 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.8 71.57 11.45 Favored Pre-proline 0 C--O 1.243 0.738 0 N-CA-C 105.829 -1.915 . . . . 73.43 105.829 169.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.78 -30.99 10.9 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.142 1.895 . . . . 74.44 111.389 -177.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -94.03 12.97 24.41 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 118.35 -0.833 . . . . 70.52 109.91 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.559 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -42.91 -59.08 3.28 Favored Pre-proline 0 CA--C 1.573 1.844 0 CA-C-O 118.146 -0.931 . . . . 72.11 112.919 -173.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 20.5 Cg_exo -63.46 -15.02 45.91 Favored 'Trans proline' 0 C--N 1.395 2.995 0 C-N-CA 122.541 2.16 . . . . 52.51 113.956 -178.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -92.29 -42.65 9.71 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.868 0.867 . . . . 71.14 110.154 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.72 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.3 p -79.32 -13.48 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-N 114.02 -1.446 . . . . 54.43 112.617 -161.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -72.42 -15.38 61.83 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.186 0.594 . . . . 52.15 110.968 173.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -87.46 -12.56 45.71 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.352 1.061 . . . . 74.25 111.15 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -82.46 155.71 24.47 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.646 0.778 . . . . 63.12 111.394 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.98 128.53 36.31 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.49 0.716 . . . . 72.33 109.457 170.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.444 ' CE3' HD21 ' A' ' 68' ' ' LEU . 49.9 t-105 -81.04 76.34 7.99 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.848 0.832 . . . . 74.42 110.266 -177.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.3 tm0? -126.8 81.88 68.39 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 105.025 -2.213 . . . . 64.14 105.025 168.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -83.68 144.98 11.42 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.347 2.031 . . . . 73.43 112.141 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -96.46 84.11 3.64 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.457 -1.312 . . . . 64.33 107.457 173.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.423 HG13 HG13 ' A' ' 64' ' ' VAL . 43.3 t -88.13 94.44 4.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 CA-C-N 115.537 -0.756 . . . . 71.34 109.819 -175.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -92.93 134.12 35.43 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.056 -0.974 . . . . 62.04 109.978 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.1 mt -103.66 108.95 20.46 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.477 -0.935 . . . . 71.03 108.477 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.605 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 10.2 m-20 -101.63 107.92 19.31 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.367 -1.346 . . . . 60.41 107.367 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.594 HD11 HG21 ' A' ' 131' ' ' VAL . 86.8 mt -103.52 135.53 44.94 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.448 0.642 . . . . 70.5 111.279 -174.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 24.8 t70 -132.55 143.45 49.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.334 -1.303 . . . . 61.31 108.254 178.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.6 m -127.25 133.4 50.21 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.663 0.785 . . . . 55.43 108.963 175.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.77 147.71 52.32 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 124.547 1.139 . . . . 71.12 108.502 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.1 m -131.68 156.51 45.76 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 122.747 0.419 . . . . 73.21 109.883 174.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.9 t -154.31 118.89 4.87 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.257 -1.016 . . . . 73.21 108.257 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -72.87 107.48 5.3 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 108.544 -0.91 . . . . 74.33 108.544 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.5 mt -79.95 -36.62 35.96 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.987 -0.552 . . . . 64.24 110.454 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.55 -174.02 4.81 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.272 0.629 . . . . 44.04 110.869 -177.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -65.29 119.84 11.67 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.203 0.601 . . . . 54.11 109.634 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 65.73 5.61 3.45 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.988 1.315 . . . . 55.33 112.532 -175.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.5 t -107.12 111.12 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 109.108 -0.701 . . . . 73.23 109.108 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -121.23 124.58 45.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.108 -1.071 . . . . 72.05 108.108 176.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -87.78 143.63 27.05 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.677 -0.86 . . . . 72.02 108.677 170.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.458 HG11 ' HD3' ' A' ' 103' ' ' PRO . 96.9 t -126.4 137.58 57.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 107.873 -1.158 . . . . 71.15 107.873 170.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.458 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 44.7 t -119.27 130.75 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.473 -0.936 . . . . 74.25 108.473 174.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.548 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -104.74 105.91 16.19 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 105.957 -1.868 . . . . 65.45 105.957 173.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.568 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 28.6 ttp180 -92.88 99.98 12.53 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.345 -1.354 . . . . 72.41 107.345 176.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.5 t -94.93 129.24 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 107.705 -1.22 . . . . 70.1 107.705 176.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.605 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.3 m -121.71 114.58 21.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.887 -0.783 . . . . 72.12 108.887 176.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 90.6 t -102.06 106.89 20.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.32 -0.993 . . . . 73.13 108.32 177.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.9 m -103.3 132.68 49.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.43 -0.952 . . . . 64.14 108.43 172.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.98 118.26 13.65 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.527 -0.545 . . . . 74.31 109.527 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.0 m -123.24 138.2 54.69 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.368 0.667 . . . . 63.35 110.521 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.698 HD12 HG22 ' A' ' 31' ' ' VAL . 22.0 mt -92.32 86.31 5.67 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.973 1.309 . . . . 70.42 108.396 172.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.5 -95.75 0.89 Allowed Glycine 0 C--N 1.339 0.705 0 O-C-N 123.393 0.433 . . . . 74.01 112.34 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.85 -26.17 13.23 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.634 0.773 . . . . 70.15 110.752 -177.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -104.07 126.19 50.99 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.398 0.679 . . . . 55.02 110.4 -174.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.1 m -63.62 125.94 25.92 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 123.561 0.538 . . . . 51.54 110.75 173.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.72 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -72.63 -60.26 2.32 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.818 -0.808 . . . . 71.55 108.818 174.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -160.31 168.17 25.88 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.652 0.739 . . . . 55.44 111.757 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 64' ' ' VAL . 65.1 tp -127.2 143.11 51.32 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.003 1.321 . . . . 63.22 107.739 169.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.563 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 70.9 m -144.76 98.28 3.16 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.386 0.674 . . . . 63.02 109.777 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -118.64 116.93 27.61 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.673 -0.491 . . . . 74.34 109.673 -176.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.0 t -125.33 110.87 25.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 123.836 0.855 . . . . 75.13 109.022 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 51.9 mt-30 -84.9 82.51 8.41 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.231 -1.026 . . . . 55.03 108.231 172.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -76.07 94.43 3.45 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 114.474 -1.239 . . . . 71.35 108.574 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.46 163.34 40.73 Favored Glycine 0 C--O 1.24 0.474 0 N-CA-C 111.011 -0.836 . . . . 61.44 111.011 177.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.83 121.71 1.05 Allowed Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 110.371 -1.092 . . . . 32.31 110.371 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.8 mt -81.49 122.65 36.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.499 -1.297 . . . . 70.25 107.499 173.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.703 ' HB3' HD11 ' A' ' 86' ' ' ILE . 93.3 m-85 -128.19 121.17 28.8 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.359 0.664 . . . . 73.13 109.513 -178.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.1 t -85.25 98.1 10.31 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.418 -0.956 . . . . 74.35 108.418 173.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.703 HD11 ' HB3' ' A' ' 84' ' ' PHE . 4.2 mm -107.87 147.95 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.418 -0.586 . . . . 75.33 109.418 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.53 170.1 23.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.647 -0.706 . . . . 74.43 110.121 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.15 -34.17 5.73 Favored Glycine 0 C--N 1.341 0.818 0 O-C-N 123.613 0.571 . . . . 73.34 113.574 176.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.57 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -127.5 146.34 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 122.928 0.491 . . . . 71.01 111.739 -169.259 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.24 175.17 9.49 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.658 1.183 . . . . 65.43 109.335 175.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.26 -131.29 27.32 Favored Glycine 0 C--N 1.352 1.443 0 O-C-N 123.46 0.475 . . . . 51.41 113.611 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.9 t -72.8 -21.53 60.97 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.23 0.612 . . . . 54.2 111.212 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -73.64 -42.39 61.47 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.606 0.762 . . . . 70.23 109.387 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.3 tpt -66.55 -42.52 87.02 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 115.596 -0.729 . . . . 72.4 110.262 173.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.54 -29.2 70.4 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.385 -0.825 . . . . 72.43 111.13 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.488 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 60.4 t-80 -71.53 -35.27 70.61 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.98 -0.555 . . . . 74.44 110.926 176.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.9 t -71.89 -44.16 64.2 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 110.005 -0.368 . . . . 52.3 110.005 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.6 mt -82.38 -32.07 29.38 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.66 0.615 . . . . 73.04 112.66 -173.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.89 4.36 42.07 Favored Glycine 0 N--CA 1.472 1.034 0 CA-C-O 119.89 -0.395 . . . . 71.42 113.639 -172.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.538 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -140.49 -68.6 0.41 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 117.014 0.407 . . . . 55.23 110.759 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -67.97 -45.33 74.46 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 116.01 -0.541 . . . . 73.31 112.266 -168.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 82.4 m -67.19 -48.42 48.16 Favored Pre-proline 0 CA--C 1.559 1.296 0 CA-C-O 118.065 -0.969 . . . . 62.42 112.783 -176.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.458 ' HD3' HG11 ' A' ' 58' ' ' VAL . 41.0 Cg_endo -66.51 -18.72 54.72 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 121.576 1.517 . . . . 74.22 112.682 173.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -76.12 -34.62 59.47 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.923 0.489 . . . . 74.11 110.529 173.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.2 mm -64.35 -43.84 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.448 0.699 . . . . 71.51 109.447 170.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.2 mt -73.36 -23.48 60.21 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.045 -0.98 . . . . 73.24 112.522 -174.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -63.61 -45.64 82.88 Favored Pre-proline 0 N--CA 1.485 1.279 0 N-CA-C 114.331 1.234 . . . . 75.25 114.331 -172.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -52.95 -36.53 75.58 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 121.985 1.79 . . . . 73.14 113.47 172.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -79.08 -39.36 33.98 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.559 0.744 . . . . 71.12 111.352 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.45 -49.53 73.33 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.252 0.621 . . . . 63.22 109.369 175.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.47 ' NH1' HD12 ' C' ' 105' ' ' ILE . 27.4 ttm180 -49.96 -50.5 46.56 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 125.137 1.523 . . . . 71.32 111.084 175.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -65.24 -47.85 75.37 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 124.374 1.046 . . . . 75.24 111.747 -176.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.525 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 53.7 t -56.0 -42.01 75.75 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.135 0.897 . . . . 54.11 110.468 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.556 HG21 HG21 ' A' ' 64' ' ' VAL . 68.8 mt -62.66 -53.69 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 114.736 -1.12 . . . . 72.1 110.616 174.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.404 HG21 ' HE2' ' C' ' 109' ' ' TYR . 33.1 m -55.87 -36.86 68.04 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.679 0.791 . . . . 72.33 111.027 -175.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.7 t -68.68 -46.9 67.86 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.582 -1.19 . . . . 72.21 110.186 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.6 mtp -59.94 -42.29 93.7 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.605 0.762 . . . . 73.34 111.897 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 114' ' ' ILE . 84.5 t -63.76 -44.16 98.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 124.254 1.022 . . . . 64.45 110.252 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 99.4 p -73.23 -32.3 64.67 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.803 -0.635 . . . . 65.13 111.108 -176.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -67.78 -33.38 74.72 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.469 0.708 . . . . 70.33 109.738 173.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.54 15.05 37.67 Favored Glycine 0 C--N 1.354 1.562 0 CA-C-N 115.585 -0.734 . . . . 41.41 113.578 175.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.4 t 59.9 11.54 2.63 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 127.26 2.224 . . . . 62.34 114.488 174.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -79.76 140.01 54.56 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 107.96 -1.126 . . . . 72.3 107.96 175.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -43.15 133.56 6.21 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 123.529 2.819 . . . . 72.33 112.647 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -52.36 131.0 32.71 Favored 'General case' 0 C--N 1.363 1.164 0 O-C-N 123.93 0.769 . . . . 71.35 112.474 -169.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.419 HD21 HG11 ' A' ' 64' ' ' VAL . 22.3 tp -120.22 115.73 24.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.688 1.195 . . . . 63.51 109.303 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -109.17 128.04 54.7 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 105.715 -1.957 . . . . 63.44 105.715 173.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.454 ' H ' ' HG3' ' A' ' 111' ' ' ARG . 15.4 mt -71.7 147.44 47.41 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 118.29 0.496 . . . . 64.12 110.926 -175.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.33 137.6 86.53 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 122.98 0.512 . . . . 50.23 110.677 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.2 124.21 15.65 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 123.132 2.555 . . . . 62.5 113.329 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.594 HG21 HD11 ' A' ' 44' ' ' LEU . 68.6 t -109.43 128.6 65.3 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 C-N-CA 123.78 0.832 . . . . 53.22 110.388 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -92.18 84.3 5.22 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.466 -0.939 . . . . 73.24 108.466 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -60.83 -29.67 69.64 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.884 0.874 . . . . 74.43 111.587 177.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.538 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 5.5 t70 -64.24 -42.24 96.62 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 124.007 0.817 . . . . 70.41 109.559 178.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.92 -40.18 87.56 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.125 0.891 . . . . 50.53 111.275 176.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.64 -42.86 99.48 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 123.779 0.674 . . . . 75.33 111.016 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 69.2 t80 . . . . . 0 C--N 1.346 0.445 0 CA-C-N 116.014 -0.539 . . . . 61.15 109.834 174.742 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.529 ' HB3' HG23 ' B' ' 89' ' ' ILE . 20.7 ptm . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 121.433 0.635 . . . . 65.22 112.71 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -147.68 140.03 24.47 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 108.425 -0.954 . . . . 71.02 108.425 169.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -138.35 140.46 39.47 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.741 -0.837 . . . . 74.45 108.741 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -151.5 140.02 20.59 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 109.087 -0.708 . . . . 72.32 109.087 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.459 HD13 HD11 ' B' ' 16' ' ' ILE . 33.8 mt -75.1 133.0 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 107.535 -1.283 . . . . 51.33 107.535 167.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -98.43 -43.76 6.78 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.054 -0.721 . . . . 74.43 109.054 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -172.88 131.72 0.52 Allowed 'General case' 0 C--N 1.348 0.536 0 CA-C-N 115.723 -0.671 . . . . 62.41 109.69 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.507 HG21 ' CD1' ' B' ' 109' ' ' TYR . 58.6 mt -115.63 144.13 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.108 -1.071 . . . . 72.14 108.108 173.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -164.69 145.58 7.82 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.489 0.661 . . . . 75.22 111.931 -175.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.1 m -72.91 118.17 15.53 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.405 -1.27 . . . . 71.33 108.086 169.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -94.59 -23.29 17.7 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.509 0.724 . . . . 65.11 111.02 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -161.48 143.47 11.76 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.986 0.179 . . . . 60.21 110.9 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.448 HD11 ' SG ' ' B' ' 113' ' ' CYS . 47.1 mm -136.1 143.92 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.536 1.135 . . . . 61.43 109.536 176.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 68.9 m -141.27 132.58 26.63 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.962 1.705 . . . . 63.11 107.208 169.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 88.0 t80 -142.87 109.26 5.33 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.483 -1.673 . . . . 72.2 106.483 166.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 38.8 mt-10 -119.53 111.54 18.22 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.501 -0.925 . . . . 75.42 108.501 -176.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.56 86.47 1.78 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 106.566 -1.642 . . . . 71.2 106.566 173.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.28 -35.7 8.13 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.464 2.11 . . . . 73.15 112.199 -165.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -106.93 21.02 18.2 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.1 -0.954 . . . . 64.32 109.663 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.436 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -42.66 -62.33 1.31 Allowed Pre-proline 0 N--CA 1.487 1.424 0 C-N-CA 125.221 1.408 . . . . 64.43 114.722 -165.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.436 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 16.6 Cg_exo -61.81 -30.18 84.05 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 122.08 1.854 . . . . 74.33 112.375 -171.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -96.04 -27.99 14.84 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.564 -1.198 . . . . 74.31 111.983 -169.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' B' ' 73' ' ' ALA . 6.4 p -81.81 -10.02 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 120.775 0.322 . . . . 72.12 111.043 -176.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -70.57 -19.96 62.83 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.383 0.673 . . . . 65.22 112.678 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -65.92 -12.78 57.3 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.144 0.497 . . . . 72.24 111.229 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -97.36 92.26 5.89 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.053 1.341 . . . . 65.21 109.744 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -97.38 78.92 2.73 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.755 -0.657 . . . . 73.15 109.622 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 15.1 p90 -153.8 -173.24 4.5 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.092 0.557 . . . . 62.14 110.017 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -73.03 109.47 6.33 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 124.143 0.977 . . . . 72.14 110.088 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.476 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 55.6 Cg_endo -72.91 132.24 18.1 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 121.199 1.266 . . . . 70.02 111.317 175.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -65.6 104.86 1.09 Allowed 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.184 0.594 . . . . 64.01 109.809 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.461 HG11 HD11 ' B' ' 126' ' ' LEU . 74.8 t -99.5 143.38 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 114.355 -1.293 . . . . 71.32 111.221 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -124.09 132.05 53.61 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 106.949 -1.5 . . . . 73.43 106.949 173.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.453 HD13 HD22 ' B' ' 128' ' ' LEU . 17.1 tp -102.06 124.98 48.6 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.073 -1.084 . . . . 52.11 108.073 172.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -124.85 139.59 53.7 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.615 -1.254 . . . . 72.24 107.615 -175.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mp -122.3 138.25 54.57 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.837 0.855 . . . . 65.42 109.453 -171.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.553 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 9.8 t70 -135.22 146.85 49.05 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.715 1.206 . . . . 74.4 108.442 173.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.1 m -126.74 103.42 7.53 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.919 -0.771 . . . . 74.14 108.919 -176.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.75 117.89 31.52 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 108.625 -0.879 . . . . 61.25 108.625 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 51.7 p -144.6 161.04 40.14 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 122.429 0.291 . . . . 75.42 110.752 -176.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.7 p -159.45 138.88 11.35 Favored 'General case' 0 C--O 1.244 0.799 0 O-C-N 123.444 0.465 . . . . 74.0 111.211 -174.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -78.37 104.57 9.04 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 108.845 -0.798 . . . . 70.35 108.845 171.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 3.0 pp -122.53 11.31 9.88 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.647 -0.706 . . . . 44.41 109.928 175.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.07 158.49 43.09 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 115.702 -0.681 . . . . 61.23 110.49 -174.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.93 107.74 17.86 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.418 1.087 . . . . 72.23 110.883 -172.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 62.53 18.63 10.6 Favored 'General case' 0 N--CA 1.501 2.122 0 C-N-CA 124.275 1.03 . . . . 71.12 111.589 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 90.3 t -135.6 121.63 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.372 1.469 . . . . 61.3 107.248 -174.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -113.43 139.25 49.07 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.69 -0.856 . . . . 75.32 108.69 -172.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -104.51 101.29 10.96 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 106.578 -1.638 . . . . 42.43 106.578 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -104.04 133.66 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.201 0.601 . . . . 73.43 109.491 -177.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.505 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 25.8 t -118.4 122.11 68.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 C-N-CA 124.183 0.993 . . . . 73.15 108.437 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.45 109.94 21.78 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 107.796 -1.187 . . . . 72.11 107.796 174.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.553 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 39.2 ttm180 -85.85 112.23 20.94 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.889 -0.782 . . . . 53.13 108.889 175.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.447 HG13 HD11 ' B' ' 42' ' ' LEU . 61.7 t -105.37 103.59 15.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.42 -0.956 . . . . 73.4 108.42 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 7.5 m -99.44 131.39 45.48 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.427 -0.806 . . . . 73.53 109.648 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.664 HG11 HD21 ' B' ' 126' ' ' LEU . 72.4 t -120.05 133.14 67.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 123.758 0.823 . . . . 65.34 110.042 176.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 72.6 m -110.76 147.35 34.63 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 108.355 -0.98 . . . . 65.31 108.355 167.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.442 ' HB2' HG22 ' B' ' 40' ' ' VAL . . . -144.5 133.19 22.28 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.446 0.698 . . . . 62.23 109.359 173.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.463 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 16.6 m -133.98 126.38 30.15 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 123.418 0.449 . . . . 55.32 110.675 -174.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.476 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 60.4 mt -99.08 101.29 12.61 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.841 -1.17 . . . . 73.25 107.841 174.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.82 -144.82 24.33 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 115.747 -0.661 . . . . 74.43 111.54 -173.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -82.41 2.36 32.91 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.017 0.927 . . . . 71.43 112.652 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -123.34 158.83 30.18 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.638 0.775 . . . . 70.34 110.354 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 92.4 m -81.35 126.16 31.26 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.683 0.793 . . . . 63.43 110.689 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.468 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -77.67 -57.85 3.59 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.321 1.049 . . . . 71.43 108.96 174.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -143.99 162.41 36.26 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 122.249 1.023 . . . . 73.34 111.937 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.4 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 84.4 mt -126.76 147.5 49.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 112.886 -1.961 . . . . 65.03 106.554 171.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 32.5 t -149.45 150.85 33.01 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.006 -1.109 . . . . 53.5 108.006 174.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 35.7 tt0 -161.84 125.15 3.1 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.207 -1.034 . . . . 74.41 108.207 178.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 84.6 t -122.94 146.6 27.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.542 -0.911 . . . . 63.01 108.542 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -117.72 107.53 14.29 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.012 -1.107 . . . . 73.33 108.012 169.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -99.43 100.62 11.69 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.224 -1.028 . . . . 72.12 108.224 175.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -96.22 162.2 22.67 Favored Glycine 0 C--N 1.336 0.55 0 O-C-N 123.785 0.678 . . . . 53.34 111.599 177.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.9 131.98 2.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.695 -0.288 . . . . 64.32 112.642 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 47.0 mt -85.54 115.03 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 N-CA-C 107.612 -1.255 . . . . 65.24 107.612 171.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -127.32 140.95 51.85 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.832 0.853 . . . . 60.2 109.621 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 56.1 m -95.19 123.26 38.59 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.381 0.672 . . . . 75.34 110.191 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.727 HG22 HD11 ' B' ' 89' ' ' ILE . 2.4 mp -127.63 113.07 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 108.018 -1.104 . . . . 44.44 108.018 -178.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.82 155.46 35.84 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.176 0.59 . . . . 52.44 110.812 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 102.02 -34.15 5.93 Favored Glycine 0 N--CA 1.48 1.571 0 C-N-CA 123.786 0.707 . . . . 73.0 112.496 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.727 HD11 HG22 ' B' ' 86' ' ' ILE . 0.9 OUTLIER -80.74 167.63 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 124.509 1.124 . . . . 63.13 112.345 178.804 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -156.59 148.98 23.37 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.819 0.848 . . . . 71.13 110.655 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.15 -134.16 12.34 Favored Glycine 0 C--N 1.356 1.673 0 C-N-CA 123.013 0.34 . . . . 70.5 113.655 172.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.5 m -64.64 -48.47 74.71 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.42 1.088 . . . . 44.11 110.255 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -66.28 -24.7 66.61 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 113.437 -1.711 . . . . 74.21 111.466 -170.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.8 -65.7 0.65 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.637 1.175 . . . . 73.44 112.215 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.52 -13.24 59.93 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.686 0.395 . . . . 42.41 111.983 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -59.82 -36.07 76.03 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.286 0.634 . . . . 75.32 110.402 168.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.4 t -65.16 -55.43 18.68 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.215 0.606 . . . . 74.12 111.524 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.619 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.6 pp -76.49 -18.25 58.86 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 112.646 0.61 . . . . 75.3 112.646 -177.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.93 -19.6 30.8 Favored Glycine 0 C--N 1.348 1.239 0 CA-C-O 119.766 -0.463 . . . . 52.03 113.861 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.72 -51.94 1.06 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 117.324 0.562 . . . . 52.22 111.49 -173.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -70.17 -40.15 74.87 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.414 0.686 . . . . 71.51 111.244 -175.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.619 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 81.8 m -70.99 -48.83 13.64 Favored Pre-proline 0 CA--C 1.56 1.36 0 CA-C-O 118.443 -0.789 . . . . 72.23 112.086 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 84.2 Cg_exo -54.14 -29.12 54.53 Favored 'Trans proline' 0 C--N 1.393 2.906 0 C-N-CA 122.49 2.127 . . . . 62.54 114.029 169.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -64.75 -33.31 75.68 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.4 0.68 . . . . 71.21 111.488 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.425 HG23 ' NH2' ' D' ' 111' ' ' ARG . 65.0 mt -72.89 -39.12 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.772 0.829 . . . . 75.04 110.122 175.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 71.2 mt -75.33 -34.18 61.19 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.737 -1.119 . . . . 64.33 111.722 -174.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -57.73 -47.34 99.11 Favored Pre-proline 0 N--CA 1.487 1.377 0 CA-C-O 117.559 -1.21 . . . . 62.11 113.776 -171.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -54.94 -35.93 90.78 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.21 1.94 . . . . 43.54 113.299 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.507 ' CD1' HG21 ' B' ' 16' ' ' ILE . 5.0 m-30 -76.03 -40.43 53.47 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.827 -0.624 . . . . 75.04 110.364 -176.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.04 -42.76 99.83 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.486 -0.779 . . . . 54.2 110.257 174.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 28.4 ttt-85 -60.47 -49.61 76.89 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.075 1.35 . . . . 74.1 110.819 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -69.32 -31.5 70.0 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.885 0.741 . . . . 74.52 109.998 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.533 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.9 t -68.51 -40.54 80.78 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 122.915 0.486 . . . . 54.41 110.316 177.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.501 HD13 HG23 ' B' ' 64' ' ' VAL . 81.8 mt -62.37 -54.82 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.63 0.772 . . . . 74.31 110.128 174.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.9 m -61.18 -27.95 68.78 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 123.916 0.76 . . . . 73.02 111.068 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.3 t -64.92 -53.27 49.12 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 123.208 0.603 . . . . 50.1 109.555 173.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.533 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.1 mmt -65.92 -33.8 76.66 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.27 0.628 . . . . 73.14 111.573 -175.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 78.2 t -68.3 -41.72 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.732 1.213 . . . . 61.12 110.604 176.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 39.0 t -67.11 -31.15 71.43 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.227 -0.897 . . . . 72.51 110.785 175.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.525 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 82.0 mtt-85 -69.55 -37.78 77.17 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 123.237 0.615 . . . . 75.41 110.001 176.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.31 -11.42 71.38 Favored Glycine 0 C--N 1.353 1.515 0 O-C-N 123.429 0.456 . . . . 64.13 112.749 170.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 10.1 m 67.93 26.93 7.36 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 125.804 1.641 . . . . 55.4 110.204 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -78.07 164.99 53.76 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-N 114.964 -1.016 . . . . 75.3 111.448 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -47.54 154.48 1.7 Allowed 'Trans proline' 0 C--N 1.393 2.911 0 C-N-CA 123.429 2.753 . . . . 72.42 114.351 171.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.528 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -62.37 115.95 4.64 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.003 0.921 . . . . 53.31 111.595 -175.508 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.664 HD21 HG11 ' B' ' 64' ' ' VAL . 37.8 tp -109.57 108.13 18.46 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.546 -0.752 . . . . 72.14 109.392 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -114.35 120.51 40.63 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 107.73 -1.211 . . . . 61.13 107.73 169.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.456 HD21 HG21 ' B' ' 64' ' ' VAL . 87.9 mt -74.98 130.13 38.83 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 122.873 0.469 . . . . 64.24 110.32 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.11 136.24 90.94 Favored Pre-proline 0 CA--C 1.55 0.971 0 O-C-N 124.393 1.058 . . . . 64.45 110.77 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.03 94.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.711 2.274 . . . . 61.33 111.907 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 19.5 m -90.61 110.44 22.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.847 0.832 . . . . 75.14 109.201 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 108.542 -0.91 . . . . 74.11 108.542 174.501 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 56.1 t80 . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 108.325 -0.991 . . . . 61.53 108.325 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -150.3 126.05 10.37 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 109.045 -0.724 . . . . 75.2 109.045 174.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 59.5 mt -64.79 134.69 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 107.88 -1.156 . . . . 75.23 107.88 168.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.423 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 31.5 mm-40 -102.73 -39.22 7.12 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.847 0.459 . . . . 74.33 109.822 176.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -178.6 142.31 0.23 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.506 1.123 . . . . 74.32 109.448 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 35.1 mm -119.84 117.8 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 108.128 -1.064 . . . . 72.33 108.128 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.559 ' HB3' HG23 ' D' ' 122' ' ' THR . 41.2 p90 -145.4 162.03 38.26 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.489 0.661 . . . . 74.02 112.031 -167.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.4 p -93.72 115.36 27.79 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.112 -0.949 . . . . 61.32 109.086 175.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.416 ' HG2' ' HE2' ' C' ' 17' ' ' TYR . 77.6 mttt -77.59 -45.31 25.62 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.477 -0.935 . . . . 75.25 108.477 170.193 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.675 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 26.4 t70 -131.08 135.65 47.72 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 113.662 -1.608 . . . . 64.32 109.435 -171.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 77.5 mt -138.09 142.02 36.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 106.423 -1.695 . . . . 73.14 106.423 174.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.0 t -154.32 145.62 22.96 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.401 0.619 . . . . 71.13 110.326 177.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -149.68 126.03 10.81 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 106.745 -1.576 . . . . 64.13 106.745 170.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -131.63 116.54 17.5 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.478 0.711 . . . . 73.33 109.521 -175.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.54 78.34 62.59 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 124.021 0.928 . . . . 62.14 108.502 172.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.73 -25.99 39.4 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 122.431 2.087 . . . . 62.24 111.037 174.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -97.67 14.04 28.17 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.127 0.971 . . . . 72.42 110.937 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.413 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -49.65 -55.15 24.74 Favored Pre-proline 0 N--CA 1.491 1.602 0 CA-C-O 117.96 -1.019 . . . . 43.43 113.502 -172.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.413 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 37.5 Cg_exo -59.13 -43.79 39.35 Favored 'Trans proline' 0 C--N 1.391 2.815 0 C-N-CA 121.836 1.691 . . . . 62.14 112.077 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -68.78 -32.94 73.05 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.271 -1.331 . . . . 73.03 112.649 -174.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.607 HG21 ' HA ' ' C' ' 73' ' ' ALA . 12.9 p -80.81 -27.19 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 N-CA-C 112.146 0.425 . . . . 41.22 112.146 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -64.86 -27.73 69.07 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 122.893 0.477 . . . . 64.52 111.834 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -88.86 8.37 29.54 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.619 0.767 . . . . 74.14 111.504 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.464 ' HG2' HD13 ' C' ' 68' ' ' LEU . 1.0 OUTLIER -114.69 152.16 32.44 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.014 0.926 . . . . 75.3 110.258 -179.467 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -62.77 128.65 36.91 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.238 0.615 . . . . 64.53 111.12 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 65.8 t-105 -85.05 95.86 9.23 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.298 -0.865 . . . . 74.35 111.121 -174.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 37' ' ' GLN . . . . . 0.456 ' H ' HD22 ' C' ' 68' ' ' LEU . 34.5 tt0 -144.43 75.44 15.05 Favored Pre-proline 0 CA--C 1.549 0.918 0 N-CA-C 108.132 -1.062 . . . . 53.43 108.132 172.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -87.52 162.35 8.06 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.602 2.201 . . . . 74.43 112.686 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -90.08 108.1 19.53 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.407 -1.27 . . . . 72.22 107.692 171.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.45 96.99 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 109.078 -0.712 . . . . 63.23 109.078 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.48 101.98 12.66 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.021 -1.103 . . . . 53.12 108.021 176.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.554 HD21 HG13 ' C' ' 62' ' ' VAL . 1.9 tt -103.65 127.44 51.1 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 107.3 -1.37 . . . . 74.23 107.3 177.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -119.56 117.85 29.46 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.575 0.75 . . . . 53.45 109.008 174.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -99.97 109.27 21.62 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.725 -0.843 . . . . 72.21 108.725 173.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -121.65 121.04 36.46 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.869 -1.16 . . . . 75.45 107.869 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.1 t -124.91 148.01 48.54 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.146 0.498 . . . . 73.43 110.309 -176.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.65 151.07 35.56 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.144 0.977 . . . . 72.14 108.733 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 14.4 m -123.1 150.41 43.22 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 123.715 0.806 . . . . 64.0 109.386 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 25.8 t -147.64 126.4 12.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.481 0.712 . . . . 70.34 109.319 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -76.86 117.56 18.59 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.206 -0.664 . . . . 74.34 109.206 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.532 HD11 ' HB2' ' C' ' 57' ' ' GLU . 50.3 mt -84.1 -43.64 14.84 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.618 0.767 . . . . 71.04 110.413 -175.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.47 -176.14 4.92 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.985 -1.007 . . . . 74.24 109.815 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.71 109.86 2.17 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.967 0.907 . . . . 71.41 110.4 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 65.27 19.98 11.79 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.923 1.289 . . . . 73.54 112.385 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 57.7 t -113.25 110.01 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 108.362 -0.977 . . . . 71.14 108.362 172.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -112.4 124.89 53.5 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.438 1.095 . . . . 70.14 109.794 -177.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.532 ' HB2' HD11 ' C' ' 51' ' ' LEU . 43.1 tt0 -91.24 142.66 27.48 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.759 -0.83 . . . . 75.24 108.759 170.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 82.8 t -124.81 139.4 51.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.995 -1.113 . . . . 53.22 107.995 167.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.06 130.07 72.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.975 -0.75 . . . . 74.34 108.975 173.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.541 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -110.48 111.73 23.17 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.218 -1.401 . . . . 72.12 107.218 178.545 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -90.67 107.24 19.04 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.303 -0.999 . . . . 52.33 108.303 173.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.554 HG13 HD21 ' C' ' 42' ' ' LEU . 38.9 t -101.32 118.89 48.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.949 -1.13 . . . . 74.34 107.949 173.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 26.0 m -118.7 137.48 53.29 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.984 -0.747 . . . . 61.14 108.984 -175.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.458 HG23 HD13 ' C' ' 114' ' ' ILE . 84.8 t -132.02 120.39 43.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 124.02 0.928 . . . . 75.14 109.046 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 10.0 m -113.17 130.31 56.25 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.349 -0.982 . . . . 60.02 108.349 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.88 115.71 24.36 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.16 -1.052 . . . . 73.21 108.16 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 54.5 m -134.02 130.21 37.22 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.431 0.457 . . . . 54.42 110.342 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.464 HD13 ' HG2' ' C' ' 34' ' ' LYS . 39.2 mt -85.84 39.34 0.8 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.699 1.2 . . . . 75.55 109.687 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.43 -102.48 2.2 Favored Glycine 0 C--N 1.348 1.24 0 N-CA-C 110.19 -1.164 . . . . 64.21 110.19 -170.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -89.79 -30.72 17.78 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.753 0.821 . . . . 72.43 110.397 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 71' ' ' GLU . . . . . 0.441 ' HG2' HD12 ' C' ' 68' ' ' LEU . 4.3 tp10 -69.7 121.36 17.03 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 123.95 0.9 . . . . 74.33 109.788 176.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -81.19 117.28 21.59 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.262 -1.014 . . . . 61.54 108.262 165.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.607 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.91 -50.8 21.48 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.654 -0.869 . . . . 73.51 108.654 176.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 74' ' ' PHE . . . . . 0.488 ' HZ ' HD21 ' C' ' 126' ' ' LEU . 31.3 p90 -164.86 164.49 20.91 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.284 -1.326 . . . . 62.52 110.723 177.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.42 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.0 tm? -121.62 144.57 48.67 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 105.965 -1.865 . . . . 61.15 105.965 164.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.527 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.9 t -149.13 137.73 21.07 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.085 -1.08 . . . . 63.34 108.085 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -155.69 132.74 10.7 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.892 -0.41 . . . . 62.34 109.892 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 92.8 t -126.02 135.93 62.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.122 0.969 . . . . 64.51 109.037 174.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.675 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.7 mt-30 -109.99 96.2 6.08 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.069 0.948 . . . . 73.34 108.925 171.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -80.66 102.31 9.78 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.501 -1.227 . . . . 51.35 109.189 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.41 148.85 25.51 Favored Glycine 0 C--N 1.342 0.898 0 N-CA-C 111.181 -0.767 . . . . 43.24 111.181 174.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.74 119.23 1.04 Allowed Glycine 0 N--CA 1.465 0.591 0 CA-C-N 117.419 0.609 . . . . 42.14 111.98 -176.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.446 HG12 ' HE1' ' C' ' 17' ' ' TYR . 22.8 mm -86.75 129.12 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.024 -0.732 . . . . 72.43 109.024 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -133.41 126.64 31.69 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.912 0.885 . . . . 74.04 109.227 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 10.2 p -87.49 101.67 13.82 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.881 -1.155 . . . . 52.21 107.881 168.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 7.7 mt -117.27 124.87 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.648 0.779 . . . . 75.5 110.317 -174.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.5 171.31 14.23 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.098 0.959 . . . . 64.23 109.2 177.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.21 -25.36 12.63 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-O 119.701 -0.499 . . . . 62.14 114.091 174.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.569 HD11 ' HE3' ' C' ' 94' ' ' MET . 37.7 pt -106.63 164.09 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 123.366 0.667 . . . . 72.33 111.393 -178.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -156.04 154.84 31.65 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.639 0.776 . . . . 73.24 110.127 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.41 -117.85 8.72 Favored Glycine 0 C--N 1.351 1.383 0 O-C-N 123.724 0.64 . . . . 61.11 113.411 169.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 17.7 m -62.19 -38.36 88.83 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.006 0.922 . . . . 73.42 111.134 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -67.43 -51.25 53.95 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.947 0.899 . . . . 74.33 111.239 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.569 ' HE3' HD11 ' C' ' 89' ' ' ILE . 5.3 tpt -55.55 -50.72 69.29 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 124.176 0.923 . . . . 62.12 111.431 174.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.32 -43.36 92.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.377 0.671 . . . . 74.51 111.801 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -70.93 -36.49 72.65 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.684 0.794 . . . . 75.31 111.288 -175.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -64.23 -36.79 85.23 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.601 -0.727 . . . . 61.33 110.394 177.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.505 ' HG ' ' HE2' ' C' ' 94' ' ' MET . 91.7 mt -83.65 -37.56 22.66 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.295 1.038 . . . . 63.35 112.752 -176.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.87 -13.62 36.66 Favored Glycine 0 N--CA 1.475 1.279 0 N-CA-C 113.996 0.359 . . . . 72.41 113.996 -168.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.17 -54.32 1.19 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 117.014 0.407 . . . . 50.14 111.488 -175.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -70.72 -52.05 23.42 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 116.251 -0.431 . . . . 75.42 111.781 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.436 ' O ' HD13 ' C' ' 106' ' ' LEU . 96.9 m -64.18 -48.67 76.33 Favored Pre-proline 0 CA--C 1.559 1.309 0 CA-C-O 118.101 -0.952 . . . . 42.4 112.487 -177.366 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.541 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 50.4 Cg_exo -57.46 -27.3 75.59 Favored 'Trans proline' 0 C--N 1.393 2.891 0 C-N-CA 122.228 1.952 . . . . 61.14 113.373 175.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.43 -38.02 80.81 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.413 0.685 . . . . 73.12 109.878 177.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.47 HD12 ' NH1' ' A' ' 111' ' ' ARG . 47.3 mm -72.47 -34.28 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.684 0.794 . . . . 74.14 110.338 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.436 HD13 ' O ' ' C' ' 102' ' ' CYS . 7.3 mp -80.52 -24.19 39.53 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.906 0.883 . . . . 53.32 112.259 -177.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -58.86 -50.73 86.4 Favored Pre-proline 0 N--CA 1.481 1.081 0 CA-C-O 117.335 -1.317 . . . . 75.0 113.968 -172.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -59.53 -37.34 89.49 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 121.968 1.779 . . . . 74.11 113.206 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.404 ' HE2' HG21 ' A' ' 115' ' ' THR . 58.6 m-85 -65.2 -47.27 77.49 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.643 0.777 . . . . 64.35 110.392 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.96 -34.25 77.97 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 114.48 -1.236 . . . . 60.14 111.329 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -67.3 -50.19 61.24 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.205 1.402 . . . . 73.41 110.701 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -65.76 -35.26 80.21 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 123.805 0.69 . . . . 74.31 109.696 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 18.9 t -67.83 -29.49 68.65 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.305 0.642 . . . . 41.41 111.964 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.527 HG23 ' SG ' ' C' ' 76' ' ' CYS . 65.4 mt -79.07 -53.51 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 123.15 0.58 . . . . 74.13 110.678 174.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 17.8 m -61.91 -28.36 69.47 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.283 0.633 . . . . 71.31 111.162 -175.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.6 t -65.52 -50.07 66.59 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.676 0.791 . . . . 74.1 109.568 171.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.495 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.69 -40.35 87.57 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.464 1.105 . . . . 65.43 112.519 -179.669 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.42 -42.61 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.752 0.821 . . . . 71.1 109.995 175.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 39.7 t -71.45 -27.6 63.38 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.082 -0.963 . . . . 71.13 111.776 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' C' ' 116' ' ' SER . 79.9 mtt-85 -72.88 -41.83 64.26 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.002 -0.74 . . . . 73.13 109.002 176.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.88 -3.33 63.68 Favored Glycine 0 C--N 1.357 1.733 0 CA-C-N 115.419 -0.81 . . . . 65.32 112.901 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 26.1 p 62.32 30.49 17.47 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.632 1.973 . . . . 63.43 112.823 172.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -83.75 145.84 48.19 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 108.504 -0.924 . . . . 53.42 108.504 169.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -46.01 140.51 10.26 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 124.013 3.142 . . . . 64.34 114.898 176.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -60.24 134.6 57.21 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.659 1.184 . . . . 72.0 113.116 -174.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.488 HD21 ' HZ ' ' C' ' 74' ' ' PHE . 0.8 OUTLIER -141.53 98.7 3.4 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 114.791 -1.095 . . . . 74.53 108.567 174.429 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -91.5 102.82 15.48 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.412 -0.959 . . . . 74.25 108.412 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.467 ' H ' HD22 ' C' ' 128' ' ' LEU . 2.7 mm? -57.58 129.93 44.08 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.62 1.168 . . . . 75.12 112.498 -167.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.68 144.53 98.92 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.096 0.958 . . . . 74.14 111.6 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.401 ' HG3' HD12 ' A' ' 16' ' ' ILE . 24.1 Cg_exo -62.19 123.62 12.85 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.948 2.432 . . . . 62.22 112.918 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 24.2 t -115.5 121.4 67.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 108.49 -0.929 . . . . 75.31 108.49 175.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -75.13 107.47 7.24 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.587 0.755 . . . . 64.1 111.276 -175.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -65.37 -18.35 65.25 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.77 0.828 . . . . 52.11 112.994 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -65.52 -43.09 91.13 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.143 0.577 . . . . 71.52 109.846 172.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.09 -42.43 96.93 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.52 -0.764 . . . . 65.24 110.656 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 76.3 mt -70.64 -24.54 62.73 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.164 -0.925 . . . . 73.01 111.844 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 83.4 t80 . . . . . 0 N--CA 1.47 0.568 0 C-N-CA 123.26 0.624 . . . . 74.21 110.868 -178.496 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 C--O 1.243 0.748 0 N-CA-C 109.836 -0.431 . . . . 74.41 109.836 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.431 ' HD2' HG22 ' D' ' 86' ' ' ILE . 84.9 t80 -134.84 101.93 5.08 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 107.861 -1.163 . . . . 52.41 107.861 176.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -127.5 120.07 27.46 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.421 -0.955 . . . . 55.43 108.421 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 10.5 mt -80.25 133.01 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 109.341 -0.614 . . . . 63.5 109.341 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -89.82 -40.58 12.36 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.829 0.852 . . . . 54.45 110.805 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -167.69 137.77 2.76 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.351 -0.386 . . . . 73.24 110.385 -175.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.9 mp -110.17 137.26 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 107.048 -1.464 . . . . 61.14 107.048 169.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -164.31 142.49 7.04 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.372 0.533 . . . . 71.41 111.457 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 67.9 p -77.95 121.0 23.6 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.866 -0.606 . . . . 73.5 109.749 176.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.518 ' HD2' ' HA3' ' D' ' 81' ' ' GLY . 34.9 mtpt -96.08 -13.89 23.31 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.297 0.639 . . . . 71.21 109.909 -178.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.4 t70 -163.79 139.7 6.51 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.352 1.061 . . . . 71.41 108.915 177.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.495 HG21 ' HE2' ' C' ' 117' ' ' MET . 76.8 mt -141.9 147.41 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.614 1.166 . . . . 55.14 108.488 177.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 74.3 m -148.85 142.01 24.99 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.0 1.72 . . . . 72.41 108.155 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 83.0 t80 -145.86 113.53 6.38 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 105.012 -2.218 . . . . 73.03 105.012 166.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -131.07 110.04 10.92 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.79 0.436 . . . . 63.41 110.254 -168.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.35 82.06 11.5 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 107.92 -1.141 . . . . 63.24 107.92 176.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.74 -17.6 17.85 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.57 2.18 . . . . 71.23 112.361 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.422 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 76.8 m-20 -107.48 9.08 29.69 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.84 0.856 . . . . 72.53 110.735 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.412 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -33.31 -67.82 0.18 Allowed Pre-proline 0 CA--C 1.572 1.808 0 N-CA-C 115.976 1.843 . . . . 51.43 115.976 -165.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.79 -15.19 15.26 Favored 'Trans proline' 0 C--N 1.385 2.495 0 CA-C-N 124.077 2.492 . . . . 65.24 114.014 -176.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 30' ' ' HIS . . . . . 0.422 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 7.2 t-160 -72.99 -40.99 64.79 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.652 1.181 . . . . 71.23 109.399 173.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.568 HG22 HD12 ' D' ' 68' ' ' LEU . 8.7 p -86.08 -19.69 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 CA-C-N 115.018 -0.992 . . . . 63.43 111.473 -175.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -67.66 -19.66 65.22 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 117.837 0.29 . . . . 75.21 111.658 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -67.28 -14.14 62.64 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.711 0.804 . . . . 70.3 110.832 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -103.22 69.1 1.0 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.958 1.303 . . . . 72.22 109.255 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -84.07 74.6 10.25 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-O 122.314 1.054 . . . . 72.25 110.489 -176.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 4.7 p90 -142.8 -165.05 1.97 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.587 -0.733 . . . . 73.41 109.311 175.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -64.5 108.51 1.99 Allowed Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 124.163 0.985 . . . . 72.44 111.027 177.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -72.24 126.89 12.12 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.168 1.912 . . . . 51.53 110.747 176.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.91 111.83 11.69 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.915 -1.142 . . . . 74.22 107.915 176.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.676 HG13 HG13 ' D' ' 64' ' ' VAL . 65.9 t -108.61 137.01 42.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 C-N-CA 123.846 0.858 . . . . 65.44 108.911 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 29.7 mmtm -126.85 134.47 50.51 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.456 0.702 . . . . 74.4 109.796 170.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.733 HD11 HG13 ' D' ' 62' ' ' VAL . 20.7 tp -96.68 147.68 23.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.255 -0.884 . . . . 63.04 109.971 -175.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.549 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 19.9 t70 -139.98 112.48 7.86 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.83 -1.174 . . . . 73.24 107.83 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.0 mt -115.08 132.73 56.51 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.391 0.677 . . . . 73.12 109.817 -172.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.577 ' HB2' ' HB3' ' D' ' 61' ' ' ARG . 3.5 m-20 -132.49 151.28 51.96 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.816 1.246 . . . . 75.43 108.658 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 46' ' ' THR . . . . . 0.414 HG21 ' O ' ' D' ' 99' ' ' GLY . 20.5 p -107.88 146.48 32.26 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.368 0.667 . . . . 71.43 110.47 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.639 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.37 163.39 37.88 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.126 0.97 . . . . 61.21 109.217 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 61.6 p . . . . . 0 CA--C 1.542 0.642 0 O-C-N 123.798 0.686 . . . . 73.44 110.917 -173.748 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 . . . . . 0 N--CA 1.499 2.019 0 N-CA-C 112.015 0.376 . . . . 73.25 112.015 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 11.7 t -113.13 99.2 8.17 Favored 'Isoleucine or valine' 0 C--N 1.349 0.571 0 N-CA-C 107.422 -1.325 . . . . 63.31 107.422 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -127.84 131.79 49.46 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 120.596 0.236 . . . . 73.53 110.443 -173.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -87.6 138.49 31.42 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.651 -0.87 . . . . 74.11 108.651 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 78.7 t -136.25 138.33 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 C-N-CA 124.846 1.258 . . . . 63.1 107.909 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.639 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 21.5 t -132.94 120.24 40.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.424 -0.954 . . . . 53.12 108.424 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.539 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -93.2 124.84 37.46 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.112 -1.07 . . . . 73.02 108.112 174.149 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.591 ' HG2' ' HG2' ' D' ' 79' ' ' GLN . 1.5 tmm_? -100.27 104.65 16.14 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.095 -1.076 . . . . 62.02 108.095 174.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.733 HG13 HD11 ' D' ' 42' ' ' LEU . 82.8 t -103.1 121.5 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 123.923 0.889 . . . . 71.14 108.734 175.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.549 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 60.3 m -120.82 133.69 55.31 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.617 0.722 . . . . 73.31 109.47 175.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.676 HG13 HG13 ' D' ' 40' ' ' VAL . 34.5 t -110.26 119.69 59.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 114.457 -1.247 . . . . 74.42 108.662 174.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 15.6 m -109.04 91.86 3.81 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.21 -1.404 . . . . 63.24 107.21 171.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.63 147.19 25.07 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.513 -0.767 . . . . 71.41 109.372 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.423 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 53.8 p -156.28 132.86 10.2 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 123.513 0.508 . . . . 63.41 111.092 -173.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.568 HD12 HG22 ' D' ' 31' ' ' VAL . 21.5 mt -104.62 112.22 25.22 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.077 -1.083 . . . . 52.32 108.077 170.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.34 -115.94 4.41 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.926 -0.579 . . . . 72.42 111.737 -172.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -115.91 4.53 13.86 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 117.381 0.591 . . . . 65.34 111.388 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -114.25 154.86 27.2 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.49 0.316 . . . . 70.34 110.656 -175.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 95.3 m -63.12 120.06 10.74 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 123.975 0.797 . . . . 73.24 111.144 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.548 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -76.18 -67.37 0.69 Allowed 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.02 -1.474 . . . . 52.12 107.02 167.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 74' ' ' PHE . . . . . 0.402 ' HD1' ' HB2' ' D' ' 76' ' ' CYS . 53.2 p90 -154.23 142.95 20.9 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.997 -0.547 . . . . 71.41 110.997 176.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 57.8 mt -106.12 107.95 19.21 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 107.249 -1.389 . . . . 71.1 107.249 170.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.612 ' SG ' HG23 ' D' ' 114' ' ' ILE . 17.5 t -118.45 107.78 14.22 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.023 -0.732 . . . . 41.04 109.023 -172.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -128.9 131.37 47.58 Favored 'General case' 0 C--O 1.22 -0.487 0 C-N-CA 123.265 0.626 . . . . 74.52 110.088 -171.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 78' ' ' VAL . . . . . 0.446 HG21 ' HB3' ' D' ' 113' ' ' CYS . 86.3 t -134.43 116.18 21.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 123.734 0.814 . . . . 74.13 108.928 178.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.604 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 78.6 mt-30 -88.88 84.43 6.65 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.177 -1.045 . . . . 71.45 108.177 171.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -82.32 108.05 15.46 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 113.998 -1.456 . . . . 64.0 109.52 -176.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.518 ' HA3' ' HD2' ' D' ' 19' ' ' LYS . . . -99.61 172.95 25.45 Favored Glycine 0 C--O 1.241 0.558 0 O-C-N 123.374 0.421 . . . . 34.22 112.893 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.63 144.26 6.53 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.513 -0.344 . . . . 51.43 112.865 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 54.7 mt -90.11 128.08 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.019 -1.104 . . . . 74.42 108.019 172.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -124.57 140.27 53.1 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.914 0.886 . . . . 75.55 110.771 -175.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 7.1 m -98.83 98.73 9.79 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.387 1.075 . . . . 62.55 108.92 172.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.664 HG12 HD21 ' D' ' 98' ' ' LEU . 2.6 pp -115.96 132.87 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 109.26 -0.645 . . . . 75.2 109.26 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.92 168.19 19.71 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.234 1.014 . . . . 51.11 109.404 -177.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.74 -21.55 32.62 Favored Glycine 0 N--CA 1.477 1.381 0 C-N-CA 123.221 0.439 . . . . 42.32 113.91 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.433 HD13 ' HB2' ' D' ' 94' ' ' MET . 1.0 OUTLIER -101.03 155.85 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.864 0.865 . . . . 65.41 109.374 172.517 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -144.4 175.11 10.35 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.286 1.034 . . . . 63.42 110.457 -176.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.26 -140.56 23.05 Favored Glycine 0 C--N 1.357 1.732 0 N-CA-C 114.68 0.632 . . . . 72.11 114.68 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 86.2 m -79.79 -38.35 33.27 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.974 0.91 . . . . 73.33 111.046 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -60.72 -36.37 78.68 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.365 1.066 . . . . 53.54 111.198 -174.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.433 ' HB2' HD13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -68.07 -37.53 81.37 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.973 0.731 . . . . 73.2 112.973 -172.219 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.58 -25.35 33.36 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.383 0.673 . . . . 71.23 109.927 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -66.89 -27.39 67.47 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.099 0.96 . . . . 73.33 110.302 174.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 94.8 m -62.21 -42.83 99.65 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.383 0.673 . . . . 73.42 111.387 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.664 HD21 HG12 ' D' ' 86' ' ' ILE . 86.9 mt -70.71 -22.24 62.47 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.586 0.355 . . . . 73.0 111.361 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 99' ' ' GLY . . . . . 0.414 ' O ' HG21 ' D' ' 46' ' ' THR . . . -102.63 14.02 56.44 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-O 119.499 -0.612 . . . . 64.41 113.28 176.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.98 -66.11 0.11 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 118.277 1.039 . . . . 62.03 112.355 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -65.43 -51.63 58.87 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.12 0.568 . . . . 75.02 111.632 -172.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.429 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 78.8 m -60.89 -47.01 96.87 Favored Pre-proline 0 CA--C 1.565 1.554 0 C-N-CA 123.772 0.829 . . . . 71.11 112.359 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.539 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.7 Cg_exo -54.32 -40.01 84.54 Favored 'Trans proline' 0 C--N 1.394 2.955 0 C-N-CA 122.388 2.059 . . . . 60.12 113.678 168.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 104' ' ' ASN . . . . . 0.418 ' HB2' ' HB2' ' D' ' 133' ' ' PHE . 56.1 t30 -61.98 -33.5 74.43 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.458 0.703 . . . . 64.12 111.325 -178.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.404 HG13 ' CZ ' ' D' ' 11' ' ' PHE . 43.6 mm -72.85 -36.12 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.361 1.064 . . . . 72.13 110.76 175.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 91.1 mt -71.93 -19.06 61.97 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.907 -0.588 . . . . 74.42 111.629 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -65.96 -44.42 61.37 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-O 117.782 -1.104 . . . . 72.12 113.335 -173.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.89 -42.12 31.57 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 122.343 2.028 . . . . 75.04 113.964 168.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -79.52 -32.35 42.32 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.687 0.795 . . . . 64.33 111.921 -177.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.94 -44.69 65.58 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.415 0.626 . . . . 73.53 109.996 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.577 HH12 ' HB3' ' D' ' 130' ' ' PRO . 37.4 ttp180 -65.67 -35.65 81.39 Favored 'General case' 0 C--O 1.206 -1.216 0 CA-C-N 114.012 -1.449 . . . . 74.03 110.365 174.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 112' ' ' GLU . . . . . 0.473 ' HA ' ' CE2' ' B' ' 109' ' ' TYR . 6.1 tt0 -52.86 -51.21 61.91 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.845 0.858 . . . . 73.44 111.151 176.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.456 ' O ' ' HG3' ' D' ' 117' ' ' MET . 43.8 t -63.7 -45.04 91.82 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.527 -1.215 . . . . 75.32 110.717 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.612 HG23 ' SG ' ' D' ' 76' ' ' CYS . 31.5 mt -60.55 -64.42 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.392 0.677 . . . . 65.51 111.269 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.4 m -40.54 -46.89 2.59 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.027 1.731 . . . . 71.14 112.63 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -62.95 -48.14 80.19 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 114.867 -1.061 . . . . 72.44 110.657 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.456 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 71.6 mtm -67.24 -31.46 71.83 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.42 0.688 . . . . 64.31 112.296 -178.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.485 HG21 ' HB3' ' D' ' 126' ' ' LEU . 87.2 t -65.53 -45.06 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.765 0.826 . . . . 52.33 109.946 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 56.0 p -70.38 -33.05 70.96 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 115.289 -0.869 . . . . 44.21 110.363 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 51.8 mtt-85 -67.36 -35.07 78.63 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.872 0.869 . . . . 75.14 110.576 175.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.21 11.19 61.31 Favored Glycine 0 C--N 1.355 1.6 0 CA-C-O 119.581 -0.566 . . . . 51.22 114.082 -178.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.559 HG23 ' HB3' ' C' ' 17' ' ' TYR . 66.9 p 57.2 30.25 18.06 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 126.2 1.8 . . . . 65.13 114.073 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -97.87 149.36 35.64 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.147 0.579 . . . . 75.21 109.781 170.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -45.17 120.99 3.36 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 123.75 2.967 . . . . 74.24 112.832 169.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -48.54 122.75 5.81 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 124.539 1.149 . . . . 74.1 111.876 -174.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.485 ' HB3' HG21 ' D' ' 118' ' ' VAL . 22.5 tp -105.44 106.59 17.16 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.45 0.7 . . . . 70.11 109.598 -174.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -106.53 89.87 3.16 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.288 1.035 . . . . 73.45 108.936 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.42 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 37.6 mt -57.39 117.88 4.57 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.048 0.939 . . . . 75.54 110.498 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.43 123.81 78.07 Favored Pre-proline 0 CA--C 1.56 1.338 0 C-N-CA 122.679 0.391 . . . . 55.11 111.176 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.577 ' HB3' HH12 ' D' ' 111' ' ' ARG . 76.6 Cg_endo -75.54 141.31 24.97 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 122.603 2.202 . . . . 71.1 111.876 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.87 152.22 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.574 0.75 . . . . 63.52 109.748 -175.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -68.58 103.9 1.82 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.382 0.673 . . . . 70.31 110.391 176.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 133' ' ' PHE . . . . . 0.418 ' HB2' ' HB2' ' D' ' 104' ' ' ASN . 3.7 m-30 . . . . . 0 N--CA 1.486 1.349 0 C-N-CA 124.097 0.959 . . . . 70.45 112.639 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.0 m . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 109.586 -0.524 . . . . 61.01 109.586 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -125.32 113.09 17.13 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.554 -0.906 . . . . 63.42 108.554 170.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -135.72 136.66 41.01 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.508 -0.923 . . . . 54.45 108.508 170.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.471 ' CD1' HG21 ' A' ' 105' ' ' ILE . 5.2 mt -93.35 117.15 36.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 108.762 -0.829 . . . . 74.21 108.762 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.03 -42.36 32.7 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.948 0.78 . . . . 72.35 109.32 -177.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -173.69 121.41 0.32 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 110.276 -0.268 . . . . 73.25 110.276 -171.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 65.8 mt -106.26 133.92 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.767 -0.827 . . . . 74.13 108.767 173.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.513 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 31.4 p90 -164.12 158.09 18.87 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 124.011 0.819 . . . . 74.32 111.33 -174.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.6 p -86.78 117.0 25.24 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.291 -0.633 . . . . 61.3 109.291 172.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.445 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 38.5 mtpt -75.82 -34.13 60.13 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.415 -0.587 . . . . 73.43 109.415 175.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 23.4 t70 -149.59 142.85 25.13 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.607 -1.179 . . . . 72.33 110.064 -178.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 76.1 mt -137.34 144.88 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.762 1.225 . . . . 60.14 108.119 175.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.5 t -148.92 138.3 21.71 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.667 0.787 . . . . 72.55 109.034 171.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.505 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 91.5 t80 -135.22 134.61 40.22 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.572 -1.64 . . . . 75.13 106.572 169.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -133.3 137.54 46.03 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.347 0.659 . . . . 71.13 109.542 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.94 76.64 11.38 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 106.582 -1.636 . . . . 63.32 106.582 171.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.75 -28.59 36.74 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.316 2.011 . . . . 63.25 111.199 -178.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -97.99 11.23 38.19 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.067 -0.969 . . . . 64.22 111.189 -175.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.439 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -44.87 -59.61 3.96 Favored Pre-proline 0 CA--C 1.564 1.51 0 N-CA-C 114.2 1.185 . . . . 70.31 114.2 -165.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.78 -36.85 96.41 Favored 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 122.015 1.81 . . . . 63.22 113.675 -171.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -99.39 -12.47 20.24 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.491 0.716 . . . . 60.25 112.863 -175.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.775 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.6 p -77.07 -23.49 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-N 118.073 0.397 . . . . 74.43 110.396 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -71.46 -18.47 62.31 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.514 0.726 . . . . 62.45 111.328 173.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -80.03 -27.58 39.45 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.496 0.719 . . . . 74.11 110.543 175.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.494 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 12.7 mmmm -72.87 152.64 41.39 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.942 0.897 . . . . 73.23 111.371 -175.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.25 123.45 18.69 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.547 0.739 . . . . 74.33 109.322 174.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -76.97 81.35 3.51 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.75 0.786 . . . . 74.42 110.116 -175.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.442 ' H ' HD22 ' A' ' 68' ' ' LEU . 19.5 tm0? -115.64 78.77 6.99 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 106.478 -1.675 . . . . 54.12 106.478 172.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -84.63 112.5 1.57 Allowed 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.224 1.95 . . . . 44.41 111.62 -172.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -92.88 88.09 6.06 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.445 -1.687 . . . . 61.45 106.445 171.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.7 t -88.15 102.92 13.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 114.332 -1.304 . . . . 63.14 110.392 -173.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -78.12 115.66 18.01 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.682 -1.145 . . . . 63.5 109.181 172.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 128' ' ' LEU . 3.6 tt -96.89 107.49 20.0 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 106.504 -1.665 . . . . 73.02 106.504 176.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -104.94 147.19 28.05 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.407 1.083 . . . . 72.13 108.739 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.761 HD11 HG21 ' A' ' 131' ' ' VAL . 87.5 mt -133.58 138.9 46.25 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.198 0.599 . . . . 51.23 110.891 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.561 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 24.2 t70 -136.62 144.82 44.27 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.105 1.362 . . . . 53.41 107.847 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.9 m -139.11 126.83 21.97 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.808 0.443 . . . . 72.13 110.354 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.2 127.01 32.85 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.867 0.867 . . . . 73.4 109.931 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.7 m -112.73 161.42 16.89 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.486 0.66 . . . . 62.32 111.185 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 90.0 p -149.12 162.12 40.6 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.344 1.458 . . . . 73.23 107.654 175.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -113.46 107.45 15.85 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.806 -0.812 . . . . 71.11 108.806 169.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.3 mt -79.4 -29.3 41.94 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.7 -0.682 . . . . 65.25 111.523 -175.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.67 -172.47 3.12 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.128 0.571 . . . . 74.04 111.352 -177.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -61.47 112.5 2.22 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.992 0.917 . . . . 45.23 109.751 174.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 69.89 2.0 3.69 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.955 1.702 . . . . 75.31 112.703 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.68 108.11 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.661 -0.65 . . . . 72.34 109.645 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -114.49 126.24 54.72 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.609 1.164 . . . . 75.22 108.31 177.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -91.71 139.9 30.23 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 108.46 -0.941 . . . . 72.45 108.46 171.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.446 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 98.1 t -123.5 139.64 49.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.196 -1.039 . . . . 71.45 108.196 170.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.449 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 50.3 t -120.04 132.64 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.424 -0.954 . . . . 43.23 108.424 174.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.667 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -111.94 104.5 12.78 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.751 -1.574 . . . . 72.01 106.751 170.947 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.561 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 13.3 ttp180 -94.28 100.49 12.53 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.443 -1.317 . . . . 63.23 107.443 176.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 36.0 t -93.72 123.99 46.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.663 -1.236 . . . . 63.41 107.663 177.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 m -118.68 115.72 25.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.829 0.823 . . . . 71.31 109.448 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.604 HG11 HD21 ' A' ' 126' ' ' LEU . 91.8 t -104.2 128.92 57.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 C-N-CA 124.866 1.266 . . . . 73.15 108.98 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.1 m -125.4 128.56 48.3 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 108.586 -0.894 . . . . 73.11 108.586 171.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.12 129.28 55.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.818 -1.178 . . . . 70.25 107.818 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.7 m -135.57 139.08 43.61 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.595 0.712 . . . . 74.22 110.655 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.442 HD22 ' H ' ' A' ' 37' ' ' GLN . 59.4 mt -95.86 62.63 2.28 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.373 1.869 . . . . 64.21 108.701 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.11 -84.63 0.92 Allowed Glycine 0 CA--C 1.529 0.955 0 CA-C-N 115.806 -0.634 . . . . 21.52 112.275 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.35 -26.79 11.84 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.542 0.737 . . . . 60.12 111.737 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.494 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 2.9 tp10 -95.66 112.86 24.49 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.702 0.801 . . . . 72.41 109.641 -174.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.9 m -67.96 129.97 41.53 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.933 0.788 . . . . 72.35 110.124 176.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.775 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -76.78 -60.64 2.27 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.34 -0.846 . . . . 72.43 109.173 177.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.415 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 51.9 p90 -159.09 170.45 21.99 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.48 -0.782 . . . . 72.31 111.489 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.4 tp -140.75 113.32 8.1 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.885 1.274 . . . . 74.05 108.457 176.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.541 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 58.9 m -105.63 141.66 36.7 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.181 0.993 . . . . 70.31 108.85 176.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -148.3 116.75 6.56 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.449 -0.575 . . . . 70.33 109.449 173.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.5 t -127.05 112.82 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.713 0.805 . . . . 43.53 109.38 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -84.82 83.36 8.07 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.181 -1.044 . . . . 73.43 108.181 170.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -76.17 92.17 3.22 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.191 -1.04 . . . . 74.44 108.191 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.93 164.91 41.27 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.777 -0.929 . . . . 70.31 110.777 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.25 122.01 1.06 Allowed Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.132 -1.187 . . . . 54.31 110.132 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.443 HG13 ' HE1' ' A' ' 17' ' ' TYR . 57.0 mt -81.13 125.92 39.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 107.654 -1.239 . . . . 54.31 107.654 171.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.573 ' HB3' HD11 ' A' ' 86' ' ' ILE . 87.7 m-85 -127.25 136.92 52.65 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.518 0.727 . . . . 72.34 109.285 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.5 p -100.38 90.98 4.5 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.695 0.798 . . . . 61.51 109.023 174.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.573 HD11 ' HB3' ' A' ' 84' ' ' PHE . 14.7 mm -111.12 147.45 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 114.859 -1.064 . . . . 75.21 110.638 -173.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.85 167.38 18.82 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.581 0.352 . . . . 61.21 111.754 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.96 1.67 88.72 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 115.145 0.818 . . . . 75.21 115.145 172.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.2 172.13 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.642 0.777 . . . . 73.54 110.179 177.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 0.6 OUTLIER -160.64 177.78 10.15 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.25 -0.886 . . . . 74.53 109.607 176.231 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.9 -116.36 8.61 Favored Glycine 0 C--N 1.351 1.391 0 O-C-N 123.793 0.683 . . . . 75.11 113.786 172.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.4 p -64.2 -41.15 97.19 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.762 1.225 . . . . 72.24 111.528 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -74.38 -36.87 63.56 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.045 0.538 . . . . 65.53 111.323 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.478 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 4.8 tpt -68.16 -45.92 72.2 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.55 -0.537 . . . . 71.52 109.55 177.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.88 -32.18 73.38 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.181 -0.918 . . . . 74.34 110.781 176.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -73.69 -38.04 65.02 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.105 0.562 . . . . 63.31 110.342 176.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.412 ' SG ' HG21 ' A' ' 86' ' ' ILE . 50.8 t -67.92 -39.31 83.56 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.619 -0.511 . . . . 63.34 109.619 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 78.8 mt -85.68 -28.1 24.92 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.679 0.792 . . . . 73.0 111.975 -177.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -114.7 4.48 22.88 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 114.508 0.563 . . . . 72.31 114.508 -170.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -143.31 -62.19 0.41 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 117.72 0.76 . . . . 65.11 110.958 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -62.84 -57.78 9.68 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.961 0.904 . . . . 71.44 111.593 -173.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 82.6 m -64.43 -46.78 78.12 Favored Pre-proline 0 CA--C 1.558 1.269 0 CA-C-O 117.895 -1.05 . . . . 73.35 113.102 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.7 -20.25 59.43 Favored 'Trans proline' 0 C--N 1.396 3.059 0 CA-C-N 121.446 1.552 . . . . 61.35 112.896 174.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -76.58 -32.32 58.05 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.952 0.501 . . . . 53.25 109.883 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.471 HG21 ' CD1' ' A' ' 13' ' ' ILE . 46.2 mm -67.0 -45.19 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.445 0.698 . . . . 74.34 109.7 169.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 59.1 mt -73.14 -22.97 60.41 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.788 -1.096 . . . . 60.52 111.946 -174.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -65.3 -44.49 68.55 Favored Pre-proline 0 N--CA 1.481 1.076 0 CA-C-O 117.296 -1.335 . . . . 75.3 113.78 -172.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 77.8 Cg_exo -54.33 -36.69 87.75 Favored 'Trans proline' 0 C--N 1.387 2.553 0 CA-C-N 121.96 1.736 . . . . 71.1 113.383 171.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -76.49 -39.2 53.83 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.187 0.595 . . . . 73.41 111.5 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.97 -47.07 75.79 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.519 0.728 . . . . 73.4 109.346 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -51.44 -52.66 44.4 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 125.546 1.538 . . . . 74.55 110.016 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -61.93 -47.74 83.57 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.554 1.159 . . . . 72.42 111.853 -175.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.516 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 49.9 t -55.91 -45.16 78.77 Favored 'General case' 0 C--N 1.351 0.631 0 O-C-N 124.498 1.124 . . . . 54.32 110.242 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.508 HG21 HG21 ' A' ' 64' ' ' VAL . 84.2 mt -62.35 -53.14 51.39 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 CA-C-N 114.844 -1.071 . . . . 74.31 110.804 175.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 38.5 m -57.73 -37.35 73.43 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.263 1.025 . . . . 62.42 110.964 -173.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.6 t -69.26 -46.24 67.76 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.766 -1.106 . . . . 72.31 109.818 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.505 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 9.0 mtp -58.84 -37.31 76.17 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.796 0.839 . . . . 64.44 111.837 176.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 114' ' ' ILE . 74.2 t -67.27 -45.61 85.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 124.183 0.993 . . . . 62.31 110.284 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 94.2 p -73.63 -28.04 61.58 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 116.248 -0.433 . . . . 72.14 110.772 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -70.38 -33.97 72.03 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.698 0.799 . . . . 74.14 109.376 172.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 122' ' ' THR . . . -81.99 8.13 61.17 Favored Glycine 0 C--N 1.353 1.502 0 CA-C-N 115.095 -0.957 . . . . 71.04 112.767 172.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.4 t 65.14 11.47 7.2 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 127.42 2.288 . . . . 54.41 113.888 171.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -79.38 143.81 60.68 Favored Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 108.962 -0.755 . . . . 65.5 108.962 177.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -48.05 143.54 13.8 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.372 2.715 . . . . 55.24 113.285 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -53.13 116.09 2.21 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.835 1.254 . . . . 73.32 113.283 -165.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.604 HD21 HG11 ' A' ' 64' ' ' VAL . 55.6 tp -110.71 96.06 5.94 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.159 0.584 . . . . 75.02 109.625 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.646 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 1.0 OUTLIER -100.31 113.51 26.28 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 106.287 -1.745 . . . . 73.32 106.287 175.566 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.442 ' HB3' HD11 ' A' ' 42' ' ' LEU . 16.2 mt -65.65 130.57 43.74 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 123.553 0.533 . . . . 61.3 109.751 -174.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.73 139.11 97.56 Favored Pre-proline 0 CA--C 1.554 1.128 0 CA-C-O 118.767 -0.635 . . . . 60.1 110.755 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.31 140.51 34.06 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 123.617 2.878 . . . . 63.45 113.686 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.761 HG21 HD11 ' A' ' 44' ' ' LEU . 70.9 t -115.6 132.34 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 122.95 0.5 . . . . 75.11 110.082 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -93.06 79.77 4.56 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.201 -1.037 . . . . 70.22 108.201 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.454 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 84.8 m-85 -58.42 -25.0 61.66 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.977 0.911 . . . . 75.14 111.791 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -67.97 -49.67 60.3 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.223 1.009 . . . . 65.31 110.594 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.57 92.66 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.076 0.86 . . . . 71.44 110.194 177.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.7 mt -62.46 -36.62 83.02 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 114.727 -1.124 . . . . 64.0 111.312 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.1 t80 . . . . . 0 C--O 1.216 -0.67 0 O-C-N 123.789 0.681 . . . . 71.12 110.109 177.042 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.531 ' HG3' HG13 ' B' ' 89' ' ' ILE . 26.9 ttt . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 121.698 0.761 . . . . 60.42 112.148 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.8 m -140.84 125.69 18.14 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.936 -1.135 . . . . 62.14 107.936 167.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -136.18 142.07 44.1 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.705 0.802 . . . . 70.31 108.975 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -156.11 141.44 17.56 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 109.124 -0.695 . . . . 73.24 109.124 170.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.475 HD11 HD13 ' B' ' 105' ' ' ILE . 61.6 mt -80.77 134.23 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.033 -1.099 . . . . 55.12 108.033 175.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -99.98 -50.61 3.94 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.591 0.357 . . . . 70.32 110.224 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.434 ' HE ' HG21 ' A' ' 122' ' ' THR . 46.2 ttt180 -167.47 129.72 1.62 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.255 -0.646 . . . . 72.25 109.255 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.488 HG21 ' CD1' ' B' ' 109' ' ' TYR . 86.8 mt -115.32 149.6 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 108.539 -0.912 . . . . 74.3 108.539 175.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -167.41 162.85 14.88 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.63 0.728 . . . . 71.1 111.492 -173.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.443 ' H ' ' HA2' ' A' ' 121' ' ' GLY . 55.4 m -90.19 124.29 34.72 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 114.342 -1.299 . . . . 75.35 108.307 170.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -85.96 -45.56 11.37 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.944 0.898 . . . . 72.5 110.343 172.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.437 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 24.4 t70 -144.64 142.76 30.36 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.519 -0.309 . . . . 61.04 110.91 -167.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 46.4 mm -136.25 142.76 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.628 1.171 . . . . 72.1 109.116 177.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 29.4 m -138.17 135.37 35.6 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.102 1.361 . . . . 75.22 108.029 168.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 80.9 t80 -142.12 108.42 5.27 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 105.659 -1.978 . . . . 63.35 105.659 164.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -118.95 112.18 19.28 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.315 -0.994 . . . . 73.5 108.315 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.446 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -109.01 87.08 4.34 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 107.029 -1.471 . . . . 72.24 107.029 171.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.91 -26.63 21.93 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 122.24 1.96 . . . . 72.25 111.911 -172.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.409 ' OD1' ' HB2' ' B' ' 71' ' ' GLU . 15.4 m120 -107.99 14.62 25.09 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.537 1.135 . . . . 64.52 110.453 -176.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.513 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -43.98 -55.27 9.58 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 125.339 1.456 . . . . 61.25 114.832 -167.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -55.46 -44.68 46.21 Favored 'Trans proline' 0 C--N 1.4 3.239 0 C-N-CA 122.054 1.836 . . . . 61.44 113.348 -175.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -98.03 -16.79 19.48 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.899 1.074 . . . . 75.12 113.899 -171.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.404 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.5 p -76.1 -8.72 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-N 118.811 0.732 . . . . 75.4 112.05 -172.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -80.45 -1.62 42.37 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.897 0.479 . . . . 74.13 112.187 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -64.01 -25.19 68.01 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.086 0.554 . . . . 55.32 110.304 166.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.605 ' HB2' HD13 ' B' ' 68' ' ' LEU . 31.1 mmtp -90.96 107.94 19.53 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.988 1.315 . . . . 52.4 108.979 -178.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -115.89 86.09 2.41 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.384 0.611 . . . . 72.23 110.806 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 37.4 p90 -163.97 160.51 21.99 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.325 1.45 . . . . 72.2 107.78 171.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -62.75 116.18 22.1 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 108.376 -0.972 . . . . 73.42 108.376 172.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.01 157.54 58.91 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.042 1.828 . . . . 72.3 111.665 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -69.13 115.32 8.28 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 108.233 -1.025 . . . . 62.32 108.233 172.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.57 HG13 HG13 ' B' ' 64' ' ' VAL . 60.8 t -106.21 129.45 59.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 O-C-N 124.146 0.904 . . . . 62.12 110.602 -173.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.487 ' HE3' ' HB2' ' B' ' 43' ' ' ASP . 18.7 ttpt -106.48 120.5 42.08 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.509 -0.923 . . . . 70.54 108.509 168.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 16.1 tp -88.03 134.16 33.8 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.585 -0.894 . . . . 71.42 108.585 173.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 9.4 t0 -134.66 112.11 10.54 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.094 -1.076 . . . . 72.04 108.094 -172.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.433 HD11 HG11 ' B' ' 131' ' ' VAL . 78.4 mt -107.35 150.88 26.23 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.094 0.558 . . . . 71.2 110.306 -173.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.2 t70 -151.66 139.27 19.67 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.607 0.763 . . . . 63.14 109.686 -173.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 4.7 t -114.55 103.66 11.24 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-O 121.694 0.759 . . . . 73.13 109.68 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.28 118.67 30.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.555 -0.906 . . . . 73.43 108.555 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 54.0 p -145.77 172.35 13.43 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 122.086 -0.383 . . . . 61.13 111.563 -175.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 24.4 p -159.62 137.39 10.03 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.684 0.793 . . . . 74.23 110.702 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' GLN . . . . . 0.48 ' HB2' ' CE2' ' B' ' 56' ' ' TYR . 58.8 tt0 -84.98 105.71 15.95 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 108.566 -0.901 . . . . 61.42 108.566 170.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 pp -123.72 14.12 9.35 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.1 -0.954 . . . . 74.04 110.161 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.67 142.98 12.73 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.6 -1.182 . . . . 71.32 108.571 -176.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -75.99 117.25 17.51 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.642 0.777 . . . . 73.44 109.982 -172.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 66.12 5.21 3.45 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 125.566 1.547 . . . . 75.12 112.758 -176.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.9 t -125.07 96.64 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.422 -1.325 . . . . 65.13 107.422 -175.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.48 ' CE2' ' HB2' ' B' ' 50' ' ' GLN . 1.8 t80 -94.27 140.24 30.03 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.97 -0.752 . . . . 75.54 108.97 -172.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -106.47 105.09 14.96 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.524 -1.287 . . . . 70.41 107.524 -177.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -103.11 129.08 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.331 1.052 . . . . 73.1 109.718 -174.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.405 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 16.3 t -115.84 112.44 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.762 -0.829 . . . . 75.33 108.762 176.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -94.18 110.31 22.04 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.751 -1.203 . . . . 74.04 107.751 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.535 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 7.1 tmm_? -91.19 124.67 35.58 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.758 -0.83 . . . . 72.54 108.758 176.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 19.3 t -111.63 135.35 51.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.66 -1.237 . . . . 72.53 107.66 173.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 22.9 m -128.64 128.52 44.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.81 0.814 . . . . 72.13 109.274 171.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.57 HG13 HG13 ' B' ' 40' ' ' VAL . 79.6 t -107.09 114.84 47.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 114.09 -1.414 . . . . 44.33 108.584 172.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 88.6 m -96.03 135.93 37.16 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.017 -1.105 . . . . 73.41 108.017 165.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.35 141.82 25.35 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.207 -0.664 . . . . 63.14 109.207 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.572 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 18.5 p -143.61 134.87 25.85 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.646 -0.707 . . . . 65.04 111.207 -172.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.605 HD13 ' HB2' ' B' ' 34' ' ' LYS . 85.2 mt -106.88 104.01 13.59 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.925 1.29 . . . . 72.11 110.733 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.44 -125.08 7.15 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-O 120.118 -0.268 . . . . 73.4 112.781 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -91.01 3.54 54.44 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.456 0.703 . . . . 64.43 111.77 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.409 ' HB2' ' OD1' ' B' ' 27' ' ' ASN . 13.1 pt-20 -135.2 146.68 48.92 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.066 0.546 . . . . 74.33 110.945 -170.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 49.1 m -71.91 130.54 41.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.843 -0.617 . . . . 73.33 110.842 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.572 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -79.33 -65.48 0.99 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.881 -1.054 . . . . 70.01 108.306 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -151.18 152.02 32.73 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.221 -0.899 . . . . 75.52 111.459 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 78.4 mt -118.99 109.39 15.89 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 105.928 -1.878 . . . . 52.23 105.928 168.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.6 t -117.29 135.43 53.83 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.877 -1.156 . . . . 62.23 107.877 -178.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.416 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 38.1 tt0 -149.5 135.96 19.23 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.725 -0.843 . . . . 73.22 108.725 -172.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.416 HG21 ' HB3' ' B' ' 113' ' ' CYS . 58.0 t -131.16 143.2 41.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.845 -0.798 . . . . 63.22 108.845 175.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -116.56 96.69 5.62 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.811 -1.181 . . . . 74.31 107.811 171.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 7.6 tp-100 -90.89 100.02 12.95 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.95 -0.759 . . . . 60.13 108.95 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.74 142.26 16.15 Favored Glycine 0 C--N 1.344 1.027 0 O-C-N 123.624 0.578 . . . . 74.23 111.705 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.45 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -142.67 125.93 2.75 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.643 -0.583 . . . . 71.44 111.643 -176.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 40.8 mt -84.93 115.73 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 107.517 -1.29 . . . . 63.13 107.517 171.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -128.93 146.26 51.0 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.583 0.753 . . . . 65.43 109.913 -177.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 44.4 m -94.0 110.09 21.8 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.374 0.67 . . . . 64.22 109.36 172.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 4.7 mp -112.91 111.42 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 108.154 -1.054 . . . . 75.52 108.154 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.51 169.24 24.73 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.11 0.564 . . . . 72.31 111.325 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.12 -67.63 0.85 Allowed Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.525 -0.63 . . . . 65.04 111.525 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.531 HG13 ' HG3' ' B' ' 9' ' ' MET . 0.9 OUTLIER -52.69 159.05 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 124.338 1.055 . . . . 65.35 111.759 168.333 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -151.46 145.77 25.45 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 112.624 0.602 . . . . 75.35 112.624 -171.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 91' ' ' GLY . . . . . 0.442 ' O ' ' HG2' ' B' ' 94' ' ' MET . . . 70.09 -111.88 4.06 Favored Glycine 0 C--N 1.358 1.781 0 CA-C-N 115.453 -0.794 . . . . 70.31 113.985 173.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 8.9 m -73.44 -38.03 65.64 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 122.081 0.943 . . . . 70.44 109.625 177.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -69.63 -27.73 65.31 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 113.404 -1.725 . . . . 74.23 110.903 -170.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' B' ' 91' ' ' GLY . 25.1 ptt? -81.45 -43.91 18.2 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.345 0.658 . . . . 63.34 112.687 -173.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.3 -11.29 59.94 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.598 0.759 . . . . 62.21 112.19 -173.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -61.25 -35.31 76.91 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.505 0.322 . . . . 74.43 110.259 165.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.3 t -61.34 -61.09 2.79 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.812 0.445 . . . . 62.55 111.282 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.56 -15.82 62.29 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 113.004 0.742 . . . . 74.21 113.004 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.31 -2.45 59.02 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.689 -0.506 . . . . 71.14 113.532 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.83 -59.87 0.18 Allowed 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.405 0.603 . . . . 54.4 111.881 -174.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -67.61 -48.25 67.34 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.077 0.951 . . . . 63.34 111.784 -173.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.523 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 63.6 m -65.0 -48.69 70.78 Favored Pre-proline 0 CA--C 1.563 1.47 0 C-N-CA 123.802 0.841 . . . . 73.32 111.509 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.523 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 74.6 Cg_exo -57.33 -29.49 84.32 Favored 'Trans proline' 0 C--N 1.4 3.26 0 C-N-CA 122.731 2.287 . . . . 75.24 113.991 170.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -67.7 -30.35 69.84 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.032 0.933 . . . . 65.1 110.682 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.475 HD13 HD11 ' B' ' 13' ' ' ILE . 62.2 mt -76.04 -41.29 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.466 0.706 . . . . 72.42 110.135 175.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.45 HD21 ' HA3' ' B' ' 82' ' ' GLY . 80.9 mt -71.86 -34.22 69.04 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.801 -1.091 . . . . 75.14 111.912 -175.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -59.49 -47.62 97.47 Favored Pre-proline 0 CA--C 1.56 1.327 0 CA-C-O 117.513 -1.232 . . . . 73.25 113.167 -170.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -56.2 -36.72 96.99 Favored 'Trans proline' 0 C--N 1.392 2.849 0 C-N-CA 122.363 2.042 . . . . 75.3 113.229 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.488 ' CD1' HG21 ' B' ' 16' ' ' ILE . 4.0 m-30 -70.68 -42.62 70.48 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.526 0.731 . . . . 61.54 109.978 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -66.76 -36.53 82.64 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.009 -0.996 . . . . 71.14 110.91 176.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.473 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 50.4 ttt-85 -64.36 -48.91 73.69 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.231 1.413 . . . . 75.31 110.749 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -70.07 -31.62 69.32 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.549 0.739 . . . . 44.11 109.768 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.511 ' O ' ' HG2' ' B' ' 117' ' ' MET . 11.5 t -67.29 -38.64 85.34 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 123.017 0.527 . . . . 75.02 110.515 177.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.454 HD13 HG23 ' B' ' 64' ' ' VAL . 63.5 mt -63.36 -55.71 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.971 0.908 . . . . 70.04 110.141 174.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.425 HG21 ' OG ' ' C' ' 119' ' ' SER . 24.2 m -60.97 -30.41 70.23 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 124.136 0.898 . . . . 64.02 111.268 -175.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 29.8 t -60.49 -52.29 65.83 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.469 0.708 . . . . 74.15 109.235 173.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.511 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.6 mmt -65.85 -35.82 81.72 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.28 0.632 . . . . 73.42 111.414 -175.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.6 t -63.75 -44.59 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 124.144 0.978 . . . . 52.24 110.655 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.3 t -67.55 -32.59 73.46 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.713 -1.13 . . . . 75.15 111.294 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.516 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 77.3 mtt-85 -66.55 -43.46 85.01 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.572 -0.74 . . . . 71.43 109.507 175.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.68 -7.79 66.05 Favored Glycine 0 C--N 1.352 1.444 0 O-C-N 123.801 0.688 . . . . 74.44 113.259 175.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 7.4 m 63.94 29.98 14.33 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.897 1.279 . . . . 71.51 110.662 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.408 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 37.0 m-85 -83.14 159.47 62.33 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.138 0.975 . . . . 74.15 111.062 176.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -48.76 149.12 7.87 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.489 2.793 . . . . 34.04 114.65 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 65.9 tp60 -59.49 114.34 2.65 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 124.382 1.051 . . . . 73.33 111.613 -171.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.465 HD21 HG11 ' B' ' 64' ' ' VAL . 21.2 tp -111.66 102.07 10.41 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.891 0.876 . . . . 75.01 109.88 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -107.58 119.01 38.24 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 107.793 -1.188 . . . . 72.41 107.793 167.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.473 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 42.1 mt -69.01 148.54 49.95 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 123.159 0.287 . . . . 75.31 110.711 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.36 147.5 97.08 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.429 0.692 . . . . 64.12 110.589 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.12 92.49 0.1 Allowed 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.505 2.137 . . . . 74.42 112.111 173.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.433 HG11 HD11 ' B' ' 44' ' ' LEU . 69.7 t -90.17 110.83 22.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 109.321 -0.622 . . . . 72.14 109.321 177.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 108.34 -0.985 . . . . 65.01 108.34 176.477 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.412 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 55.7 t80 . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 108.713 -0.847 . . . . 75.14 108.713 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.91 144.23 17.55 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.3 0.375 . . . . 75.24 110.54 168.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 57.2 mt -82.65 135.07 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 115.467 -0.788 . . . . 64.2 109.384 175.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -98.92 -46.47 5.61 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.475 0.71 . . . . 65.13 109.706 172.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.646 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -170.69 146.16 2.61 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.603 0.761 . . . . 74.31 110.746 174.037 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 36.3 mm -115.64 139.23 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 106.467 -1.679 . . . . 70.41 106.467 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.532 ' HB3' HG23 ' D' ' 122' ' ' THR . 19.3 p90 -169.45 157.78 7.53 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.896 0.855 . . . . 72.2 111.987 -171.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.6 p -82.9 102.87 11.96 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.222 -1.354 . . . . 74.43 109.422 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.642 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 11.2 mmmm -65.14 -34.36 78.21 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.381 0.61 . . . . 74.01 109.392 171.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.593 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.5 t70 -153.4 145.7 23.93 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.63 -1.168 . . . . 74.42 109.24 -175.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.525 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.5 mt -140.85 145.77 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.615 1.566 . . . . 52.54 107.098 176.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.6 t -156.27 150.57 25.5 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.179 0.514 . . . . 61.13 110.266 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -149.37 131.74 15.62 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.168 -1.419 . . . . 74.1 107.168 174.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -133.92 111.8 10.74 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.108 -0.701 . . . . 72.33 109.108 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.66 82.14 67.45 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 107.657 -1.238 . . . . 70.32 107.657 170.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.84 -44.97 18.37 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.552 2.168 . . . . 71.54 111.276 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -92.89 21.06 5.96 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.472 -1.24 . . . . 75.4 111.082 -176.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.423 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -46.62 -58.3 7.07 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 124.226 1.01 . . . . 62.31 113.471 -172.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -60.94 -38.95 65.11 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 121.679 1.586 . . . . 63.31 112.44 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -69.24 -39.38 78.55 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.348 -0.842 . . . . 73.54 111.419 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.71 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.5 p -78.46 -17.29 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 C-N-CA 123.009 0.524 . . . . 62.21 112.308 -171.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -70.81 -15.54 62.66 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 112.194 0.442 . . . . 74.53 112.194 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -109.17 19.68 19.19 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.13 0.572 . . . . 72.55 111.09 174.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.85 158.7 15.72 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.385 0.674 . . . . 71.14 109.757 173.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.56 125.33 23.91 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.34 0.656 . . . . 52.3 109.377 167.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 62.3 t-105 -85.37 80.25 9.2 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.164 0.586 . . . . 73.53 110.364 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -121.79 76.92 38.56 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 124.368 1.067 . . . . 73.33 108.316 170.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -85.35 119.45 2.03 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 123.553 2.835 . . . . 55.23 112.608 -170.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -87.35 94.62 9.73 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.468 -1.242 . . . . 70.34 108.487 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.02 110.12 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 113.869 -1.514 . . . . 61.11 110.526 -172.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.516 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 18.2 tptm -92.2 105.47 17.68 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.45 -0.945 . . . . 55.51 108.45 169.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 pp -86.9 128.89 35.06 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 106.64 -1.615 . . . . 74.3 106.64 169.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.532 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 16.3 t70 -125.78 105.31 8.87 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 108.897 -0.779 . . . . 75.43 108.897 -172.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 96.1 mt -96.27 130.85 43.26 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.356 0.662 . . . . 64.11 110.521 -174.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -144.58 125.71 14.6 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.731 1.212 . . . . 73.12 107.938 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.1 t -121.86 151.74 40.34 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 109.621 -0.511 . . . . 73.4 109.621 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.93 148.24 31.58 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 124.355 1.062 . . . . 74.23 108.354 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 13.6 m -143.43 143.77 31.75 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.332 -0.618 . . . . 74.52 109.332 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 65.0 p -145.22 136.36 24.88 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.931 0.892 . . . . 73.54 109.34 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -79.07 117.69 20.34 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 109.016 -0.735 . . . . 75.23 109.016 176.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.631 HD11 ' HB2' ' C' ' 57' ' ' GLU . 68.4 mt -84.25 -38.91 19.92 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.483 0.713 . . . . 61.2 110.19 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.22 -169.48 3.06 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.349 -0.841 . . . . 74.03 110.273 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.02 104.27 0.1 Allowed 'General case' 0 N--CA 1.481 1.088 0 O-C-N 124.185 0.928 . . . . 51.5 110.985 176.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 60.25 35.74 20.85 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 124.603 1.19 . . . . 73.15 111.338 174.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.4 t -127.7 119.24 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.867 -1.16 . . . . 72.11 107.867 174.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -123.63 124.13 42.1 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.961 0.905 . . . . 73.43 109.602 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.631 ' HB2' HD11 ' C' ' 51' ' ' LEU . 39.0 tt0 -85.51 132.11 34.25 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.471 -0.937 . . . . 74.35 108.471 167.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 51.5 t -118.82 143.71 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.32 -0.622 . . . . 52.02 109.32 171.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 90.3 t -124.33 140.54 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 C-N-CA 125.226 1.41 . . . . 53.41 108.433 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.403 HD11 ' CZ ' ' C' ' 133' ' ' PHE . 0.0 OUTLIER -121.14 96.96 5.3 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.184 -1.413 . . . . 75.1 107.184 173.833 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -82.2 105.91 13.67 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.465 -0.939 . . . . 74.25 108.465 173.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.415 ' HB ' HD11 ' C' ' 114' ' ' ILE . 28.6 t -105.38 129.01 58.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.769 -1.197 . . . . 75.42 107.769 173.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 69.5 m -116.42 125.06 51.49 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.499 -0.926 . . . . 62.01 108.499 175.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.45 HG21 HG21 ' C' ' 114' ' ' ILE . 68.0 t -103.83 110.25 29.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.2 -0.667 . . . . 70.22 109.2 170.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 7.4 m -96.48 131.97 42.52 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.83 -1.544 . . . . 73.31 106.83 170.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.75 113.39 14.66 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 106.682 -1.599 . . . . 72.23 106.682 -176.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 36.8 m -134.04 126.97 31.28 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-O 121.0 0.429 . . . . 75.24 110.144 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 16.2 mt -85.09 36.9 0.64 Allowed 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 125.829 1.652 . . . . 43.22 110.482 177.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.5 -92.62 1.04 Allowed Glycine 0 C--N 1.358 1.8 0 N-CA-C 111.085 -0.806 . . . . 74.2 111.085 176.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -90.33 -19.61 23.84 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.424 1.09 . . . . 73.14 110.697 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -103.54 124.13 48.21 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 125.335 1.454 . . . . 73.51 109.293 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 83.5 m -78.78 123.94 27.7 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.042 0.837 . . . . 72.4 109.222 167.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.71 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -70.55 -59.03 3.08 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.957 0.786 . . . . 74.51 109.335 174.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -162.54 173.77 13.54 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-O 121.468 0.651 . . . . 64.2 110.953 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.434 HD23 HG23 ' C' ' 65' ' ' THR . 2.7 tm? -138.0 104.16 5.17 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 106.435 -1.691 . . . . 64.34 106.435 175.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 49.3 t -108.21 145.42 34.28 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.26 -1.015 . . . . 71.31 108.26 176.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -154.25 128.79 9.23 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.304 -0.628 . . . . 75.25 109.304 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 69.1 t -126.91 136.2 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.011 0.924 . . . . 74.32 109.025 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.593 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 47.9 mt-30 -105.03 90.2 3.37 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.165 -1.05 . . . . 62.44 108.165 170.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -80.33 98.85 7.62 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.475 -0.784 . . . . 71.11 109.862 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.47 170.28 48.39 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 116.255 -0.429 . . . . 44.45 112.274 176.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.94 119.75 0.78 Allowed Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.82 -0.912 . . . . 54.51 110.82 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.448 HD12 HD11 ' C' ' 51' ' ' LEU . 36.0 mm -82.02 124.96 39.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.741 -0.837 . . . . 64.01 108.741 176.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -126.7 119.06 26.03 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 124.059 0.849 . . . . 64.24 108.779 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 12.4 p -80.65 99.21 8.04 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.895 -1.15 . . . . 74.55 107.895 172.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.562 HG21 ' HE3' ' C' ' 94' ' ' MET . 20.9 mt -118.14 123.87 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 109.403 -0.591 . . . . 74.55 109.403 -177.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.59 155.22 44.2 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.903 0.705 . . . . 54.32 112.903 -171.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.88 -28.13 6.79 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.13 -0.941 . . . . 50.52 115.14 168.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.643 HD11 ' HE3' ' C' ' 94' ' ' MET . 37.5 pt -96.16 159.04 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-O 121.726 0.774 . . . . 75.14 112.232 -175.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -149.41 -173.08 4.29 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 113.781 -1.554 . . . . 74.45 108.069 171.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.74 -128.22 46.15 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.494 0.496 . . . . 55.43 113.973 171.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 10.2 t -74.08 -32.13 63.12 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.142 0.977 . . . . 61.24 112.571 -174.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -65.88 -52.72 47.77 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.186 0.595 . . . . 75.44 109.987 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.643 ' HE3' HD11 ' C' ' 89' ' ' ILE . 4.6 tpt -54.72 -48.75 72.13 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 124.149 0.905 . . . . 75.31 111.632 173.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.43 -38.14 76.82 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.988 0.805 . . . . 71.12 111.388 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -80.42 -29.58 37.65 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.31 0.644 . . . . 74.41 111.805 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.413 ' SG ' HD13 ' C' ' 86' ' ' ILE . 35.0 t -70.35 -34.79 73.05 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.999 -0.741 . . . . 73.44 108.999 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 69.3 mt -87.36 -28.8 21.99 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.035 1.334 . . . . 62.41 111.123 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.42 -28.07 41.24 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 115.804 -0.635 . . . . 52.22 114.397 -170.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -139.21 -52.33 0.55 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 111.934 0.346 . . . . 63.1 111.934 -169.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -64.73 -53.65 43.81 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 123.293 0.371 . . . . 73.42 110.988 -173.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.412 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 94.9 m -59.23 -49.93 90.24 Favored Pre-proline 0 CA--C 1.564 1.5 0 CA-C-O 118.173 -0.918 . . . . 72.55 111.976 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -53.79 -33.25 69.93 Favored 'Trans proline' 0 C--N 1.397 3.125 0 C-N-CA 122.666 2.244 . . . . 72.35 114.628 171.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -67.1 -32.3 73.37 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 122.86 0.464 . . . . 71.12 110.958 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 44.0 mm -72.87 -40.71 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.041 0.536 . . . . 72.23 109.637 176.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 76.0 mt -78.9 -27.01 43.85 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.144 0.978 . . . . 71.11 112.272 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -56.43 -49.41 93.63 Favored Pre-proline 0 CA--C 1.56 1.328 0 N-CA-C 114.547 1.314 . . . . 71.23 114.547 -173.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -60.84 -38.65 68.54 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 122.022 1.815 . . . . 63.45 112.67 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -67.93 -41.06 83.13 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.451 -0.795 . . . . 72.14 110.119 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.9 -42.69 99.87 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.784 0.834 . . . . 75.11 109.929 175.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -57.76 -55.65 32.16 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.329 1.052 . . . . 72.34 110.377 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -66.07 -30.59 71.13 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.16 0.584 . . . . 75.31 110.426 -174.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.401 ' SG ' HG12 ' C' ' 21' ' ' ILE . 21.4 t -72.54 -33.89 67.15 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 122.94 0.496 . . . . 74.01 111.453 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.45 HG21 HG21 ' C' ' 64' ' ' VAL . 96.3 mt -75.15 -49.58 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 123.554 0.742 . . . . 74.34 110.144 175.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 13.5 m -67.14 -28.95 68.56 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.249 1.02 . . . . 71.14 110.819 -175.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 27.2 t -63.07 -50.07 72.05 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 108.612 -0.884 . . . . 71.53 108.612 170.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.534 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.52 -35.44 77.72 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.585 1.154 . . . . 73.33 112.602 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 93.3 t -63.36 -47.01 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.61 0.764 . . . . 63.3 109.706 173.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.425 ' OG ' HG21 ' B' ' 115' ' ' THR . 46.5 t -68.53 -28.94 67.43 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.813 -1.085 . . . . 63.42 111.506 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' C' ' 116' ' ' SER . 86.5 mtt-85 -72.06 -42.45 66.22 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.031 -0.729 . . . . 72.33 109.031 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.65 -0.82 60.04 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 115.588 -0.733 . . . . 70.03 112.686 170.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.8 p 61.59 32.68 18.57 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.493 1.917 . . . . 73.52 113.375 171.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -83.34 155.19 66.53 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 108.638 -0.875 . . . . 73.14 108.638 170.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -50.63 159.42 2.23 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.994 2.462 . . . . 71.34 113.947 171.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' B' ' 123' ' ' PHE . 2.9 mm-40 -51.01 138.79 18.82 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.815 1.246 . . . . 74.41 112.292 -176.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 50.7 tp -149.1 86.2 1.49 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.123 -0.695 . . . . 42.34 109.123 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -91.64 123.29 34.93 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.219 -0.9 . . . . 74.11 108.707 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.08 119.81 15.74 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.403 -0.962 . . . . 75.43 108.403 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.29 143.57 95.45 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 123.768 0.827 . . . . 75.14 110.923 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -51.71 98.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.128 2.552 . . . . 62.42 113.014 174.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 60.2 t -98.29 111.7 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.489 -1.301 . . . . 74.12 107.489 173.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -74.03 102.82 4.3 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.048 0.539 . . . . 52.24 110.566 -174.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 133' ' ' PHE . . . . . 0.403 ' CZ ' HD11 ' C' ' 60' ' ' LEU . 81.0 m-85 -62.18 -25.26 67.68 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.841 0.856 . . . . 74.12 111.454 176.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 134' ' ' ASP . . . . . 0.454 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 23.9 t70 -62.17 -49.96 73.71 Favored 'General case' 0 C--N 1.347 0.485 0 O-C-N 123.881 0.738 . . . . 62.15 109.713 177.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.16 -43.05 92.09 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 124.176 0.922 . . . . 43.54 111.654 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 79.7 mt -64.28 -39.89 94.85 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.953 -1.021 . . . . 73.54 111.428 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 27.3 t80 . . . . . 0 CA--C 1.543 0.689 0 CA-C-N 116.256 -0.429 . . . . 74.54 111.468 -177.954 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 109.806 -0.442 . . . . 64.42 109.806 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.404 ' HD2' HG22 ' D' ' 86' ' ' ILE . 82.0 t80 -142.67 102.34 4.03 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.078 -1.082 . . . . 73.41 108.078 176.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -119.55 126.29 50.87 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.46 0.704 . . . . 74.14 109.465 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mt -91.79 137.89 21.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 123.657 0.783 . . . . 54.11 109.203 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -110.92 -44.41 3.62 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.191 0.596 . . . . 55.51 111.678 -176.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -169.03 122.98 0.82 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.822 -0.172 . . . . 64.11 110.566 -168.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.1 mp -103.82 137.17 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 107.287 -1.375 . . . . 73.14 107.287 166.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -158.33 146.62 18.62 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.228 0.611 . . . . 73.44 110.804 174.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -76.88 114.53 15.75 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.398 -0.819 . . . . 61.02 109.034 173.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -81.12 -21.13 40.09 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.586 -0.733 . . . . 53.12 109.896 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 7.3 t70 -162.12 142.67 10.29 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.941 1.297 . . . . 71.31 109.225 -176.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.534 HG21 ' HE2' ' C' ' 117' ' ' MET . 79.5 mt -142.94 148.73 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 124.889 1.276 . . . . 73.12 108.549 176.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.3 t -150.28 145.3 26.1 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.052 1.341 . . . . 51.13 108.352 172.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.525 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.5 t80 -151.69 136.18 16.92 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.497 -1.668 . . . . 75.33 106.497 171.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.508 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 48.0 mt-10 -138.97 148.55 43.64 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.335 0.654 . . . . 74.33 109.819 -176.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.68 78.43 9.1 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 107.718 -1.216 . . . . 74.22 107.718 175.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.6 -31.31 8.86 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.514 2.142 . . . . 74.52 112.827 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -94.46 -1.48 53.48 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.368 0.667 . . . . 71.31 111.096 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.642 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -24.55 -66.96 0.07 OUTLIER Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 126.841 2.057 . . . . 71.24 116.356 -164.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.71 -20.7 11.83 Favored 'Trans proline' 0 C--N 1.385 2.472 0 CA-C-N 123.046 2.124 . . . . 55.32 113.92 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -73.25 -39.24 65.61 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.055 0.942 . . . . 75.43 109.365 174.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.517 HG22 HD12 ' D' ' 68' ' ' LEU . 5.6 p -83.57 -24.12 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 CA-C-N 115.627 -0.715 . . . . 60.41 111.14 -172.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -63.83 -29.31 70.52 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.085 0.469 . . . . 75.14 111.207 176.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -56.87 -29.3 62.81 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.547 -1.206 . . . . 71.22 110.493 176.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -84.42 71.48 10.7 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.731 1.212 . . . . 74.31 109.498 169.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -76.85 92.92 3.66 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.185 -0.916 . . . . 71.22 109.676 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -164.91 -165.82 0.96 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.128 0.971 . . . . 73.31 109.964 173.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -77.68 115.02 46.43 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.471 1.108 . . . . 73.12 110.965 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.73 130.45 26.3 Favored 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 122.649 2.233 . . . . 71.31 111.203 173.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 39' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 30.0 mm-40 -67.52 109.6 3.3 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 108.122 -1.066 . . . . 63.44 108.122 171.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.66 HG13 HG13 ' D' ' 64' ' ' VAL . 45.7 t -99.16 128.07 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.774 -0.824 . . . . 75.33 108.774 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.02 127.87 48.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.605 -1.628 . . . . 63.32 106.605 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.613 HD11 HG13 ' D' ' 62' ' ' VAL . 55.4 tp -95.82 145.64 25.19 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.533 0.733 . . . . 72.41 110.522 -173.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.512 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 10.1 t70 -142.47 111.9 6.65 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 106.486 -1.672 . . . . 71.25 106.486 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 79.1 mt -109.71 145.27 36.86 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.256 0.55 . . . . 55.45 110.87 -174.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.701 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.0 t70 -137.33 149.88 47.35 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.71 1.204 . . . . 71.32 108.378 177.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 30.2 m -120.92 144.16 48.59 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.82 -0.807 . . . . 60.43 108.82 173.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.546 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -147.23 170.31 17.51 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.931 1.292 . . . . 24.33 107.653 -177.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.469 0.478 0 C-N-CA 122.692 0.397 . . . . 60.14 110.7 -172.139 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' D' D ' 54' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' D' ' 85' ' ' SER . 68.0 m-20 . . . . . 0 N--CA 1.498 1.952 0 N-CA-C 114.74 1.385 . . . . 62.24 114.74 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 40.4 t -135.62 96.04 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 119.316 0.962 . . . . 62.52 108.557 -173.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -152.51 161.27 42.81 Favored 'General case' 0 C--O 1.247 0.921 0 CA-C-N 114.299 -1.319 . . . . 61.52 108.649 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.545 ' HG2' HG12 ' D' ' 83' ' ' ILE . 36.1 mt-10 -89.77 143.74 26.55 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 114.934 -1.03 . . . . 74.2 110.323 177.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.431 HG11 ' HD3' ' D' ' 103' ' ' PRO . 91.6 t -116.75 139.67 42.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 113.251 -1.795 . . . . 52.33 106.902 167.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 41.5 t -129.22 129.87 67.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.426 -0.953 . . . . 74.15 108.426 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.537 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -110.95 120.64 43.07 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.251 -1.389 . . . . 73.22 107.251 173.849 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.701 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 7.3 ttm180 -102.03 100.88 11.19 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.091 -1.077 . . . . 75.52 108.091 175.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.613 HG13 HD11 ' D' ' 42' ' ' LEU . 49.0 t -92.12 122.84 43.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.299 -1.0 . . . . 64.54 108.299 173.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 17.5 m -122.05 129.13 52.14 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.745 -0.835 . . . . 73.41 108.745 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.66 HG13 HG13 ' D' ' 40' ' ' VAL . 67.5 t -118.8 121.02 65.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 124.281 1.032 . . . . 73.11 109.186 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 49.8 m -106.84 114.61 28.8 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.155 -1.424 . . . . 75.44 107.155 164.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.55 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -119.86 142.84 48.29 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.553 0.741 . . . . 64.25 109.25 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.561 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 68.6 p -147.32 130.92 16.83 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.141 0.422 . . . . 71.12 112.141 -170.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.517 HD12 HG22 ' D' ' 31' ' ' VAL . 18.7 mt -93.84 105.95 17.95 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.15 0.98 . . . . 61.51 108.38 175.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.08 -116.28 4.29 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 110.94 -0.864 . . . . 70.43 110.94 -174.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.51 4.95 16.44 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.312 0.645 . . . . 54.42 111.955 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -115.9 155.43 27.97 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.604 0.361 . . . . 70.55 110.842 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 61.7 m -64.91 119.85 11.46 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.924 0.889 . . . . 75.41 112.209 -177.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.561 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -79.24 -69.8 0.55 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.623 -1.251 . . . . 72.44 107.623 171.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -145.6 149.52 34.7 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 114.988 -1.005 . . . . 73.34 110.704 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 65.6 mt -112.54 152.97 28.21 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.906 1.282 . . . . 74.41 107.957 172.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.745 ' SG ' HG12 ' D' ' 114' ' ' ILE . 53.3 t -158.35 144.91 17.43 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.784 0.434 . . . . 53.01 110.058 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -155.65 125.89 6.68 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.042 0.537 . . . . 73.43 109.757 173.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 87.7 t -131.26 115.42 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.759 0.824 . . . . 73.41 109.231 -177.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.518 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.7 mt-30 -88.63 85.16 6.75 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.636 -0.876 . . . . 70.2 108.636 170.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -81.05 98.86 8.17 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 113.998 -1.456 . . . . 64.54 109.377 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.51 162.16 24.37 Favored Glycine 0 N--CA 1.465 0.596 0 N-CA-C 112.295 -0.322 . . . . 63.12 112.295 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.87 136.94 4.49 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.676 -0.569 . . . . 74.24 111.676 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.545 HG12 ' HG2' ' D' ' 57' ' ' GLU . 44.2 mt -90.76 105.59 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.779 -0.823 . . . . 73.22 108.779 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -107.93 141.75 39.09 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.727 0.811 . . . . 73.13 109.821 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' D' ' 54' ' ' ASP . 3.9 t -115.73 110.36 19.01 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 109.078 -0.712 . . . . 52.31 109.078 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.404 HG22 ' HD2' ' D' ' 11' ' ' PHE . 44.2 pt -126.67 134.33 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 123.531 0.732 . . . . 74.54 110.942 -174.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.95 170.36 17.87 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.888 0.875 . . . . 65.13 110.813 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.3 23.81 53.3 Favored Glycine 0 C--N 1.355 1.602 0 O-C-N 123.424 0.452 . . . . 71.34 113.171 173.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -140.82 144.86 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.449 0.7 . . . . 75.0 110.327 179.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -131.65 175.92 8.76 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.406 1.082 . . . . 73.44 110.492 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.82 -128.22 10.94 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 115.628 -0.715 . . . . 73.13 113.518 173.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 9.7 t -87.0 -38.39 16.63 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.233 0.613 . . . . 70.22 110.903 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -69.05 -22.07 64.05 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.261 0.625 . . . . 75.34 112.666 -171.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -64.49 -49.63 70.6 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.078 0.466 . . . . 74.12 111.081 177.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.09 -13.82 49.13 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.868 0.867 . . . . 70.23 110.965 -177.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -75.49 -22.83 56.85 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.061 0.545 . . . . 74.43 109.677 175.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 75.3 m -71.33 -50.98 26.9 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.077 0.551 . . . . 72.35 110.749 176.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 pp -67.03 -28.1 67.95 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.854 0.461 . . . . 64.25 111.772 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.15 -20.64 48.65 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.609 -0.551 . . . . 53.43 113.584 -178.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.52 -57.31 1.21 Allowed 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 117.794 0.797 . . . . 64.05 112.689 -170.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -68.94 -39.04 79.8 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 122.907 0.483 . . . . 74.51 111.281 -173.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 91.9 m -68.29 -47.09 38.82 Favored Pre-proline 0 CA--C 1.57 1.723 0 CA-C-O 118.401 -0.809 . . . . 73.42 111.767 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.537 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 86.4 Cg_exo -54.98 -33.31 82.46 Favored 'Trans proline' 0 C--N 1.402 3.355 0 C-N-CA 122.605 2.204 . . . . 72.04 113.685 166.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -65.86 -29.06 69.45 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.967 0.507 . . . . 54.44 111.139 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.1 mm -79.33 -33.66 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.901 0.88 . . . . 52.43 110.689 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 89.7 mt -75.1 -24.13 58.05 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.057 0.543 . . . . 72.32 112.147 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -67.37 -39.29 19.45 Favored Pre-proline 0 CA--C 1.562 1.437 0 CA-C-O 117.742 -1.123 . . . . 70.41 113.751 -172.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -50.48 -44.19 40.9 Favored 'Trans proline' 0 C--N 1.389 2.661 0 C-N-CA 122.182 1.921 . . . . 73.53 113.419 168.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -77.37 -35.49 54.47 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.778 0.831 . . . . 75.12 111.566 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.26 -47.51 67.53 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.546 0.738 . . . . 74.33 109.757 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.489 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 34.8 ttp180 -59.27 -43.67 92.49 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-N 114.643 -1.162 . . . . 71.25 110.254 172.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.13 -50.35 69.48 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 124.022 0.826 . . . . 52.35 111.365 -176.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.461 ' O ' ' HG3' ' D' ' 117' ' ' MET . 42.5 t -56.77 -44.58 81.97 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 124.453 1.096 . . . . 71.15 110.549 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.745 HG12 ' SG ' ' D' ' 76' ' ' CYS . 76.7 mt -62.71 -52.6 57.6 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 C-N-CA 124.159 0.984 . . . . 72.05 110.941 176.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 91.9 m -53.39 -45.58 69.33 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.502 1.521 . . . . 74.51 110.337 -175.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -64.94 -45.82 84.16 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.514 -1.676 . . . . 75.12 110.072 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.461 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 71.8 mtm -68.99 -30.13 68.48 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.824 0.449 . . . . 73.53 111.964 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.437 HG23 ' O ' ' D' ' 114' ' ' ILE . 78.6 t -67.07 -46.03 85.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.793 0.837 . . . . 74.41 109.218 176.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 83.4 p -72.61 -28.42 62.76 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 115.737 -0.665 . . . . 75.34 110.682 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 55.0 mtt-85 -74.61 -31.04 61.89 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.68 0.792 . . . . 75.3 110.165 175.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.94 4.41 85.37 Favored Glycine 0 C--N 1.354 1.574 0 O-C-N 123.466 0.479 . . . . 41.44 112.629 177.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.532 HG23 ' HB3' ' C' ' 17' ' ' TYR . 43.5 p 58.9 32.1 21.93 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 126.152 1.781 . . . . 64.52 112.67 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -96.83 150.11 36.52 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 115.392 -0.822 . . . . 73.33 109.786 170.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -43.29 122.82 3.15 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 124.042 3.161 . . . . 65.21 114.121 172.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -52.44 123.18 10.31 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.858 1.263 . . . . 72.54 112.049 -173.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.515 HD13 HG21 ' D' ' 40' ' ' VAL . 28.1 tp -107.63 112.46 25.19 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.299 1.04 . . . . 75.15 109.655 -176.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -116.07 79.63 1.33 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.505 -0.924 . . . . 62.23 108.505 176.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.516 HD11 HD22 ' D' ' 42' ' ' LEU . 0.3 OUTLIER -58.42 119.7 7.44 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 123.153 0.581 . . . . 53.54 109.918 -174.159 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -54.32 130.04 60.93 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 124.233 1.013 . . . . 54.31 112.317 -175.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.467 ' HG3' HH12 ' D' ' 111' ' ' ARG . 1.6 Cg_endo -76.59 118.19 4.79 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.481 2.121 . . . . 74.53 111.134 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 12.8 p -108.47 152.07 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.531 0.733 . . . . 74.05 109.51 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -72.99 102.21 3.42 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.414 -0.587 . . . . 73.3 109.414 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 . . . . . 0 N--CA 1.487 1.39 0 C-N-CA 123.766 0.826 . . . . 64.44 111.205 -179.141 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.2 m . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 109.375 -0.602 . . . . 65.33 109.375 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.455 ' HE1' ' SG ' ' A' ' 102' ' ' CYS . 62.0 t80 -110.24 121.39 45.16 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.737 -1.209 . . . . 74.01 107.737 173.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -133.92 134.62 42.84 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.148 -0.686 . . . . 71.41 109.148 176.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.426 HG21 ' HG2' ' C' ' 130' ' ' PRO . 47.8 mt -92.55 114.09 28.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 108.252 -1.018 . . . . 63.32 108.252 175.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -83.95 -35.46 23.98 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 123.399 0.437 . . . . 74.22 110.533 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -175.93 121.73 0.18 Allowed 'General case' 0 C--N 1.351 0.652 0 N-CA-C 109.553 -0.536 . . . . 73.5 109.553 -168.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.555 HD12 ' HG3' ' C' ' 130' ' ' PRO . 78.7 mt -109.42 135.75 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 107.832 -1.173 . . . . 63.14 107.832 171.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.434 ' CE2' ' HB1' ' B' ' 28' ' ' ALA . 31.3 p90 -161.83 177.1 10.17 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 124.021 0.826 . . . . 73.2 111.66 -174.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.5 p -102.49 118.64 37.29 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.942 -0.762 . . . . 61.34 108.942 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.1 mtpt -75.95 -35.87 59.52 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.229 -0.441 . . . . 72.25 110.002 172.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 18.2 t70 -145.51 144.46 30.56 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.654 -0.703 . . . . 55.01 109.787 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 57.4 mt -140.5 141.66 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 107.563 -1.273 . . . . 74.2 107.563 175.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.5 t -154.54 139.85 17.64 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.714 -0.476 . . . . 64.54 109.714 170.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.516 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 80.6 t80 -142.33 116.15 9.26 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.221 -1.4 . . . . 71.13 107.221 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -118.32 134.28 55.18 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.809 0.443 . . . . 71.44 109.991 -176.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.8 74.34 58.3 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 107.651 -1.24 . . . . 55.15 107.651 172.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.07 -27.23 20.59 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.528 2.152 . . . . 43.21 111.964 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -99.2 9.82 42.67 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.067 -0.97 . . . . 73.33 110.587 -177.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.483 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -45.82 -60.32 3.59 Favored Pre-proline 0 C--N 1.371 1.529 0 C-N-CA 124.295 1.038 . . . . 35.24 113.724 -166.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 23.4 Cg_exo -60.07 -31.31 93.21 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 121.755 1.636 . . . . 72.14 113.027 -171.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.52 -15.73 18.55 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.515 -0.766 . . . . 75.2 112.25 -175.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.78 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.8 p -77.04 -24.71 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-N 117.945 0.339 . . . . 73.21 110.391 -176.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -69.02 -22.34 64.06 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.92 -0.582 . . . . 75.24 110.583 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -74.68 -21.57 59.33 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.042 0.937 . . . . 74.43 111.437 176.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -81.93 161.42 23.09 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.208 0.603 . . . . 73.11 110.521 -177.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -63.11 117.52 6.62 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.244 0.618 . . . . 73.14 109.389 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.423 ' CE3' HD21 ' A' ' 68' ' ' LEU . 71.7 t-105 -81.32 89.05 6.06 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.629 0.728 . . . . 75.45 110.684 -178.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.465 ' H ' HD22 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -145.85 74.54 13.39 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 125.061 1.344 . . . . 74.3 108.569 172.728 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.0 149.79 17.76 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.924 2.416 . . . . 72.22 113.618 -171.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -97.92 97.79 9.24 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 107.108 -1.441 . . . . 55.44 107.108 167.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' A' ' 66' ' ' ALA . 59.4 t -83.03 94.71 3.25 Favored 'Isoleucine or valine' 0 C--N 1.345 0.382 0 CA-C-O 121.699 0.762 . . . . 74.11 109.303 176.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -78.02 117.12 19.03 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.299 -1.773 . . . . 73.41 109.456 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.5 tp -97.79 106.68 19.03 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.842 -0.617 . . . . 63.43 109.542 -175.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.673 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 2.0 m-20 -104.86 145.26 30.64 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.498 1.119 . . . . 72.44 108.51 172.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.463 HD11 HG21 ' A' ' 131' ' ' VAL . 95.7 mt -137.84 148.1 45.12 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.677 0.791 . . . . 73.54 109.626 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -148.55 142.22 25.54 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.507 1.123 . . . . 42.22 108.269 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.7 m -140.81 136.42 32.42 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.198 0.599 . . . . 75.42 110.129 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.99 130.22 9.62 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.687 0.795 . . . . 42.05 109.508 174.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 68.4 p -90.45 -179.52 5.61 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.71 0.804 . . . . 41.03 110.6 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.513 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 39.1 t -159.63 141.04 12.84 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.855 0.862 . . . . 54.01 109.149 -177.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -93.44 107.84 19.62 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.434 -0.95 . . . . 72.45 108.434 171.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 57' ' ' GLU . 53.6 mt -84.79 -43.57 14.1 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.004 0.522 . . . . 65.12 109.731 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.07 -173.34 4.53 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.26 -0.882 . . . . 52.41 110.041 -177.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -70.05 118.33 12.75 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.641 0.776 . . . . 72.01 109.295 176.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 64.18 14.26 8.48 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.152 1.381 . . . . 72.23 112.237 -174.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.0 t -117.41 110.26 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 108.664 -0.865 . . . . 71.24 108.664 176.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -121.99 124.66 44.52 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.198 0.999 . . . . 72.42 109.066 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 30.6 tt0 -86.12 152.85 22.52 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.763 -0.828 . . . . 55.15 108.763 169.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 77.2 t -132.03 138.79 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 N-CA-C 108.232 -1.025 . . . . 65.13 108.232 167.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.43 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 51.1 t -113.93 134.81 55.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.262 -0.644 . . . . 73.4 109.262 174.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.62 105.32 12.93 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.408 -1.331 . . . . 73.53 107.408 168.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 42.0 ttp180 -93.67 101.99 14.15 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.95 -1.13 . . . . 65.02 107.95 177.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.5 t -93.72 132.27 38.34 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 108.174 -1.047 . . . . 64.44 108.174 176.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.673 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 24.2 m -120.27 139.39 52.78 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.563 -0.902 . . . . 75.22 108.563 172.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.67 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.2 t -142.51 109.11 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 124.878 1.271 . . . . 72.42 107.692 -169.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.3 m -115.17 124.18 50.8 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 109.351 -0.611 . . . . 74.55 109.351 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.514 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -103.38 120.65 41.21 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.478 -1.675 . . . . 64.22 106.478 172.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 59.5 m -129.16 134.74 48.16 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.024 0.44 . . . . 72.24 110.496 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.465 HD22 ' H ' ' A' ' 37' ' ' GLN . 32.9 mt -88.46 64.39 7.47 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.338 -1.356 . . . . 75.34 107.338 174.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.26 -109.11 2.72 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 114.74 -1.118 . . . . 62.12 111.954 -174.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -86.93 -21.45 26.25 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.793 0.837 . . . . 73.42 109.133 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 9.5 tp10 -77.9 133.0 38.18 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.001 0.92 . . . . 70.34 108.857 172.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.4 m -89.03 129.07 35.73 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.799 0.727 . . . . 71.31 109.469 167.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.78 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -78.4 -59.58 2.72 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.019 -0.734 . . . . 72.31 109.019 173.071 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -159.47 169.63 23.48 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.443 -0.799 . . . . 65.22 110.892 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.426 HD12 ' H ' ' A' ' 76' ' ' CYS . 20.0 tp -132.44 142.17 49.14 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.484 -1.234 . . . . 72.24 107.939 174.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.67 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 64.6 m -137.32 132.96 34.38 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.773 1.229 . . . . 65.22 108.155 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -145.94 119.51 9.12 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.258 -0.645 . . . . 44.54 109.258 173.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.3 t -127.91 110.51 22.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.51 1.124 . . . . 62.05 108.7 -176.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 68.3 mt-30 -85.33 82.58 8.28 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.105 -1.072 . . . . 71.35 108.105 172.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -75.23 92.94 2.77 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.308 -0.86 . . . . 74.51 108.924 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -97.47 146.16 18.14 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 115.407 -0.815 . . . . 42.32 111.19 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.88 133.31 5.64 Favored Glycine 0 CA--C 1.505 -0.584 0 N-CA-C 110.64 -0.984 . . . . 40.34 110.64 -176.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.424 HG23 HD12 ' A' ' 51' ' ' LEU . 43.6 mt -81.59 126.41 39.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 108.43 -0.952 . . . . 64.03 108.43 173.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.743 ' HB3' HD11 ' A' ' 86' ' ' ILE . 84.7 m-85 -130.1 120.87 25.31 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.207 1.003 . . . . 61.01 109.036 -176.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.9 t -89.39 101.54 14.22 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.987 -0.746 . . . . 74.33 108.987 176.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.743 HD11 ' HB3' ' A' ' 84' ' ' PHE . 2.2 mm -113.45 137.81 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 122.789 0.436 . . . . 73.53 110.068 -175.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.9 167.24 25.32 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.755 0.822 . . . . 71.43 110.243 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.29 -31.8 8.14 Favored Glycine 0 C--N 1.352 1.426 0 N-CA-C 114.176 0.43 . . . . 74.01 114.176 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.545 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -131.51 163.08 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 123.331 0.652 . . . . 73.41 112.486 -166.477 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.76 175.11 13.67 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 114.454 -1.248 . . . . 61.23 109.105 175.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.02 -132.45 19.29 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 116.168 -0.469 . . . . 65.43 112.781 176.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.0 p -68.59 -30.63 69.42 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.503 0.721 . . . . 43.11 112.526 -177.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -66.38 -42.41 87.99 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 120.861 0.362 . . . . 73.14 110.12 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.431 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 6.1 tpt -68.87 -47.8 65.0 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.428 -0.806 . . . . 45.25 110.078 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.47 -41.34 72.82 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.623 0.769 . . . . 70.13 111.048 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -65.93 -37.38 85.89 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.473 -0.785 . . . . 72.42 111.422 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.7 t -66.52 -44.66 81.89 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.744 -0.465 . . . . 43.2 109.744 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 48' ' ' SER . 70.8 mt -78.04 -29.71 49.51 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.342 -0.844 . . . . 75.53 112.37 -171.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.34 0.22 43.63 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-O 119.592 -0.56 . . . . 62.23 114.488 -172.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.455 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -139.83 -63.41 0.5 Allowed 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 117.726 0.763 . . . . 32.03 111.406 -175.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -68.67 -43.92 75.17 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 116.067 -0.515 . . . . 74.42 111.851 -174.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.455 ' SG ' ' HE1' ' A' ' 11' ' ' PHE . 77.6 m -66.19 -49.6 54.46 Favored Pre-proline 0 CA--C 1.564 1.495 0 C-N-CA 124.218 1.007 . . . . 71.53 112.452 -176.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.39 -22.91 59.16 Favored 'Trans proline' 0 C--N 1.394 2.929 0 C-N-CA 121.751 1.634 . . . . 72.51 112.684 174.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -68.43 -37.17 80.03 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.248 0.619 . . . . 71.12 110.245 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.3 mm -65.46 -40.07 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.649 0.78 . . . . 72.45 110.233 172.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.7 mt -78.3 -19.12 54.25 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.032 0.933 . . . . 64.21 112.526 -174.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -70.63 -41.91 13.31 Favored Pre-proline 0 CA--C 1.559 1.29 0 N-CA-C 114.351 1.241 . . . . 74.24 114.351 -171.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.0 -37.23 78.45 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 121.901 1.734 . . . . 73.04 112.657 172.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -80.44 -36.01 34.18 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.857 0.863 . . . . 70.41 111.611 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.45 -51.2 64.29 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.073 0.549 . . . . 54.12 109.701 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.423 ' NH1' HD12 ' C' ' 105' ' ' ILE . 30.3 ttm180 -47.57 -53.28 14.99 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 124.862 1.351 . . . . 72.2 110.277 173.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -62.01 -45.98 91.23 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 124.433 1.083 . . . . 71.51 111.859 -174.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.614 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.3 t -57.2 -45.91 83.36 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.84 0.713 . . . . 73.12 110.352 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 118' ' ' VAL . 56.0 mt -61.8 -52.71 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 115.113 -0.948 . . . . 75.3 110.739 176.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 47.9 m -54.17 -42.33 69.51 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.219 1.008 . . . . 74.35 111.401 -174.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.3 t -69.05 -44.79 71.93 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.736 -1.12 . . . . 63.34 110.355 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.516 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 8.9 mtp -56.04 -43.58 77.97 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.762 0.825 . . . . 64.33 111.082 176.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 114' ' ' ILE . 73.4 t -59.71 -48.96 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.711 1.204 . . . . 71.45 110.465 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.0 p -72.47 -27.41 62.27 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.137 0.575 . . . . 71.33 111.632 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.475 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.3 mtt-85 -72.37 -29.05 63.42 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.46 0.704 . . . . 72.54 109.942 175.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.436 ' O ' HG22 ' A' ' 122' ' ' THR . . . -86.56 18.05 36.12 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-O 119.165 -0.797 . . . . 74.32 113.32 172.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.5 t 60.41 9.82 2.18 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 127.227 2.211 . . . . 73.21 113.76 177.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -80.79 142.66 52.92 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 108.161 -1.051 . . . . 71.54 108.161 172.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.49 147.16 59.54 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.74 2.293 . . . . 70.33 112.768 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -54.28 129.0 33.69 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 124.65 1.219 . . . . 65.41 112.63 -172.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 31.3 tp -117.42 105.94 12.67 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.032 0.933 . . . . 61.41 109.901 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -99.93 113.02 25.29 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.306 -0.998 . . . . 63.01 108.306 176.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.434 HD11 HD13 ' A' ' 114' ' ' ILE . 18.4 mt -67.64 154.48 41.38 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 120.714 0.292 . . . . 74.43 110.984 -175.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.22 136.37 93.77 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 123.535 0.734 . . . . 74.54 111.377 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -62.45 112.1 1.49 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.547 2.165 . . . . 75.14 111.528 173.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.463 HG21 HD11 ' A' ' 44' ' ' LEU . 90.7 t -101.88 139.98 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 121.126 0.489 . . . . 70.14 111.17 -173.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.411 ' OD1' ' HB3' ' A' ' 134' ' ' ASP . 46.4 t-20 -90.63 86.68 6.45 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.285 -1.325 . . . . 72.53 109.024 176.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -62.87 -23.99 67.59 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 112.804 0.668 . . . . 75.24 112.804 172.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.455 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 21.8 t70 -65.61 -37.89 87.9 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.028 0.531 . . . . 74.21 109.639 175.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.15 -50.04 51.4 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.822 0.849 . . . . 53.3 110.294 174.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.04 -41.98 75.87 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.416 0.687 . . . . 65.14 111.435 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.5 t80 . . . . . 0 N--CA 1.467 0.399 0 CA-C-N 115.767 -0.651 . . . . 74.33 110.094 179.415 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.454 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 18.2 ptm . . . . . 0 N--CA 1.487 1.383 0 N-CA-C 114.197 1.184 . . . . 64.23 114.197 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 54.9 m -135.41 122.71 21.74 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.71 -1.218 . . . . 72.32 107.71 172.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -111.69 142.27 44.23 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.811 -0.811 . . . . 74.22 108.811 -177.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -150.08 120.52 7.4 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.72 0.408 . . . . 72.14 110.092 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.1 mt -77.96 126.83 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.368 -0.975 . . . . 72.53 108.368 171.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -98.27 -40.07 8.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.066 0.546 . . . . 73.13 109.838 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -173.09 134.96 0.57 Allowed 'General case' 0 C--N 1.353 0.745 0 O-C-N 123.554 0.534 . . . . 70.12 109.686 -173.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.2 mt -122.06 143.79 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 107.119 -1.437 . . . . 73.3 107.119 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -169.25 153.48 5.41 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.599 0.592 . . . . 75.54 112.599 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.665 HG21 HD11 ' B' ' 21' ' ' ILE . 30.6 m -82.05 118.58 23.13 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.03 -0.986 . . . . 54.41 109.778 176.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.437 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 44.4 mtpt -95.81 -18.01 20.72 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.437 0.695 . . . . 72.05 111.521 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 28.8 t70 -155.09 140.04 17.31 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.47 0.481 . . . . 72.2 110.916 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.665 HD11 HG21 ' B' ' 18' ' ' THR . 32.3 mm -129.25 144.38 38.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 N-CA-C 107.763 -1.199 . . . . 75.4 107.763 172.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.47 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 46.6 t -147.82 132.76 18.12 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.381 -1.282 . . . . 74.52 108.296 169.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.3 t80 -145.29 118.02 8.67 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 107.189 -1.411 . . . . 73.54 107.189 168.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -119.84 133.68 55.5 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.664 -0.865 . . . . 63.11 108.664 173.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.672 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -117.32 82.15 14.42 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 106.51 -1.663 . . . . 70.45 106.51 166.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.2 -24.96 27.06 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.885 2.39 . . . . 75.34 111.96 -171.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -114.41 9.67 16.87 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.908 0.883 . . . . 63.43 110.751 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.672 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -30.8 -64.99 0.2 Allowed Pre-proline 0 N--CA 1.494 1.736 0 C-N-CA 125.992 1.717 . . . . 70.24 114.812 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 14.6 Cg_exo -64.09 -36.72 46.46 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 122.398 2.065 . . . . 64.22 112.338 -166.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.454 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 77.5 m80 -95.98 -18.63 20.11 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.006 -0.997 . . . . 65.54 112.321 -173.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 3.6 p -83.17 -10.33 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 117.991 0.36 . . . . 50.34 110.654 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -76.06 -3.49 36.19 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 112.843 0.683 . . . . 75.33 112.843 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.8 pt20 -78.98 -5.01 52.79 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.8 0.44 . . . . 75.32 110.223 169.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -107.22 87.57 2.54 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.832 1.253 . . . . 64.23 110.395 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -93.37 87.57 5.66 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.135 -0.939 . . . . 71.23 110.318 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 18.6 p90 -162.97 -171.24 2.6 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.416 0.686 . . . . 72.54 110.04 172.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -79.1 111.82 23.09 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 124.367 1.067 . . . . 71.23 110.295 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.84 141.03 36.36 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 121.879 1.719 . . . . 75.21 111.522 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.64 108.07 2.76 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 109.626 -0.509 . . . . 64.43 109.626 176.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 88.0 t -99.21 149.29 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 115.045 -0.979 . . . . 72.02 110.554 -175.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -135.46 129.67 33.54 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.354 1.462 . . . . 71.45 107.541 172.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.44 HD13 HD22 ' B' ' 128' ' ' LEU . 20.5 tp -97.04 140.82 30.99 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.449 -0.945 . . . . 74.04 108.449 170.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.639 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 7.2 t70 -137.93 141.0 40.6 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.222 -1.399 . . . . 73.12 107.222 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 49.3 mt -137.61 126.71 24.39 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.42 -0.585 . . . . 73.43 109.42 -170.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -124.57 139.95 53.4 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.023 1.329 . . . . 72.11 108.753 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.12 105.61 11.17 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 109.084 -0.71 . . . . 63.13 109.084 -172.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.76 152.01 50.7 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.034 0.933 . . . . 40.11 109.208 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 29.5 p -149.72 -169.54 3.4 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.932 -0.48 . . . . 73.42 110.94 -175.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 50.9 p -155.23 136.16 13.7 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.884 0.874 . . . . 63.21 109.183 170.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -91.26 112.24 24.07 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.566 -1.272 . . . . 72.52 107.566 168.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 pp -131.17 17.23 5.02 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.119 0.567 . . . . 62.01 110.474 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.26 152.15 21.93 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.691 -0.686 . . . . 71.54 110.568 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -72.38 117.35 13.93 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.242 -0.89 . . . . 73.32 109.168 172.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 65.65 13.79 9.13 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.075 0.95 . . . . 64.53 112.979 172.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.5 t -137.3 123.52 27.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.794 -1.558 . . . . 73.43 106.794 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.583 ' HB2' HD11 ' B' ' 86' ' ' ILE . 16.2 t80 -124.4 140.34 53.04 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.473 -0.566 . . . . 74.52 109.473 -167.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -108.96 106.13 15.96 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 107.843 -1.169 . . . . 63.32 107.843 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 94.5 t -100.78 138.28 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.652 0.781 . . . . 73.23 109.703 -176.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 24.1 t -122.79 110.77 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.029 0.932 . . . . 73.32 109.255 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -95.19 112.29 24.02 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.997 -1.112 . . . . 74.13 107.997 174.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -85.18 118.79 24.95 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 108.487 -0.931 . . . . 74.53 108.487 174.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 23.0 t -105.63 131.87 53.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 107.848 -1.167 . . . . 65.51 107.848 171.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.639 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 19.9 m -121.18 139.13 53.78 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.924 -1.139 . . . . 74.21 107.924 173.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.821 HG11 HD21 ' B' ' 126' ' ' LEU . 80.8 t -130.12 130.91 66.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.242 0.544 . . . . 63.21 109.707 175.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.4 m -106.57 144.57 33.05 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.727 -1.124 . . . . 70.11 108.871 168.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.97 136.47 20.31 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.895 -1.15 . . . . 72.35 107.895 171.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 15.6 m -137.65 128.07 26.46 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.585 0.553 . . . . 71.23 111.436 -173.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.465 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 44.8 mt -94.56 105.2 17.15 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.569 -0.9 . . . . 62.51 108.569 176.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.62 -120.42 5.13 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.881 -0.599 . . . . 50.54 111.873 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.42 10.75 25.32 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.506 0.722 . . . . 74.0 110.972 -178.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -129.25 156.01 44.66 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.382 0.673 . . . . 73.44 109.734 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 32.3 m -65.18 136.25 56.44 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 123.544 0.528 . . . . 63.24 110.433 176.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.465 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -89.27 -60.72 1.87 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 107.397 -1.335 . . . . 71.32 107.397 172.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -155.39 163.51 39.98 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 114.169 -1.378 . . . . 73.1 110.891 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 93.1 mt -136.42 113.54 10.57 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.156 1.383 . . . . 71.3 107.696 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.541 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 39.2 t -121.73 117.26 26.18 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.758 -0.46 . . . . 73.31 109.758 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.47 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 37.9 tt0 -124.54 123.21 39.6 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.6 1.16 . . . . 52.13 108.993 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 96.8 t -128.84 130.42 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.583 0.753 . . . . 64.12 110.272 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.518 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 26.3 mt-30 -100.01 119.84 38.89 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.135 -1.061 . . . . 64.11 108.135 171.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.561 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 7.9 tp-100 -108.9 109.05 20.05 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.224 -1.028 . . . . 73.23 108.224 176.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.437 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -104.84 170.24 17.77 Favored Glycine 0 C--N 1.335 0.5 0 O-C-N 123.883 0.739 . . . . 53.44 112.115 177.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.22 144.63 7.64 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.201 -0.523 . . . . 63.21 113.321 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 3.2 mp -85.64 117.41 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 107.607 -1.257 . . . . 73.13 107.607 172.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -121.93 134.59 54.84 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.836 0.854 . . . . 73.12 109.152 176.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 49.1 m -88.87 113.51 24.49 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.473 -0.936 . . . . 74.23 108.473 174.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.583 HD11 ' HB2' ' B' ' 56' ' ' TYR . 1.0 OUTLIER -121.99 105.1 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.096 0.958 . . . . 65.5 108.536 -174.676 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.22 170.42 19.52 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.041 0.448 . . . . 63.44 110.338 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 97.83 -57.5 1.1 Allowed Glycine 0 C--N 1.339 0.725 0 N-CA-C 110.069 -1.212 . . . . 75.22 110.069 -170.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' B' ' 94' ' ' MET . 1.0 OUTLIER -67.18 156.53 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 124.019 0.928 . . . . 73.41 111.845 175.425 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -155.5 147.14 23.05 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.765 0.826 . . . . 74.14 109.368 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.95 -123.91 7.94 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 123.328 0.392 . . . . 72.24 113.323 174.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.0 m -84.08 -44.71 13.79 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.801 0.81 . . . . 63.11 110.217 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -64.96 -19.92 66.21 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 113.877 -1.511 . . . . 74.45 111.8 -169.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.527 ' HB2' HD13 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -74.73 -41.9 59.28 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.557 0.743 . . . . 74.54 111.422 -178.559 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.81 -15.19 59.26 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.448 0.699 . . . . 64.21 111.4 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -66.02 -37.81 86.82 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.725 0.81 . . . . 63.01 110.149 170.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 37.2 t -64.75 -62.87 1.31 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.435 0.636 . . . . 65.43 110.81 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.595 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.4 pp -70.09 -20.74 63.19 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 116.065 -0.516 . . . . 73.23 112.298 -176.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.15 -2.08 64.45 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-O 119.435 -0.647 . . . . 51.01 114.43 -177.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.88 -49.57 0.15 Allowed 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 117.714 0.757 . . . . 75.54 111.611 -175.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -71.81 -44.97 63.03 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.666 0.786 . . . . 63.43 111.087 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 80.7 m -66.01 -47.81 62.16 Favored Pre-proline 0 CA--C 1.562 1.404 0 CA-C-O 118.734 -0.65 . . . . 75.21 111.818 178.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 76.2 Cg_exo -51.01 -37.63 57.32 Favored 'Trans proline' 0 C--N 1.388 2.652 0 C-N-CA 122.796 2.33 . . . . 65.35 113.866 169.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.55 -32.28 73.69 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.58 0.752 . . . . 65.12 111.406 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.0 mt -74.53 -37.69 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.631 0.772 . . . . 64.23 110.403 176.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 80.4 mt -75.45 -29.65 59.73 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.808 0.843 . . . . 71.01 111.961 -176.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -57.64 -47.99 98.0 Favored Pre-proline 0 CA--C 1.561 1.385 0 CA-C-O 117.777 -1.106 . . . . 74.35 113.201 -174.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.429 ' HB3' ' HB2' ' D' ' 112' ' ' GLU . 68.4 Cg_exo -47.13 -45.87 20.56 Favored 'Trans proline' 0 C--N 1.387 2.599 0 C-N-CA 122.976 2.451 . . . . 74.21 114.664 174.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -72.36 -41.91 65.88 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.079 0.552 . . . . 73.42 111.032 -175.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.561 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -64.61 -40.68 95.93 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 122.599 0.36 . . . . 73.13 110.503 176.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 53.2 ttt-85 -60.16 -50.54 73.26 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.351 1.461 . . . . 72.33 110.734 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -68.38 -32.53 72.68 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.629 0.772 . . . . 73.41 109.98 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.572 ' SG ' HD11 ' B' ' 21' ' ' ILE . 5.6 t -69.96 -41.15 74.89 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.961 0.504 . . . . 53.12 110.577 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.541 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 73.6 mt -57.77 -53.77 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.391 1.077 . . . . 53.13 110.132 172.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.441 HG21 ' OG ' ' C' ' 119' ' ' SER . 17.7 m -60.78 -30.42 70.03 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.166 0.586 . . . . 63.3 111.138 -177.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.0 t -63.37 -50.48 69.74 Favored 'General case' 0 C--N 1.348 0.537 0 C-N-CA 123.041 0.536 . . . . 74.14 109.559 173.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.508 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.7 mmt -65.51 -32.66 74.38 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.439 0.696 . . . . 73.41 111.459 -176.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.411 HG23 ' O ' ' B' ' 114' ' ' ILE . 97.5 t -68.8 -42.69 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.733 0.813 . . . . 72.24 110.345 174.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.3 t -62.91 -35.1 78.95 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.326 -0.852 . . . . 44.24 110.838 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.614 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 77.0 mtt-85 -70.18 -38.53 75.4 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 114.679 -1.146 . . . . 74.2 110.096 177.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.39 -7.73 68.98 Favored Glycine 0 C--N 1.352 1.429 0 O-C-N 123.845 0.715 . . . . 71.24 112.839 173.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 16.8 m 66.94 24.92 9.51 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 125.118 1.367 . . . . 63.13 110.329 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -85.07 163.23 46.62 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 123.861 0.864 . . . . 71.42 111.145 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.21 166.76 1.5 Allowed 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 123.339 2.693 . . . . 73.32 114.524 175.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -65.05 114.64 4.74 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.329 1.051 . . . . 64.24 111.353 -172.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.821 HD21 HG11 ' B' ' 64' ' ' VAL . 26.4 tp -112.4 107.1 15.78 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.032 -0.729 . . . . 54.51 109.032 174.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -121.55 127.11 50.62 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.133 -1.062 . . . . 63.53 108.133 171.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.49 HD21 HG21 ' B' ' 64' ' ' VAL . 84.0 mt -77.56 138.58 39.25 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 123.427 0.454 . . . . 70.35 110.267 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.05 147.26 98.91 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.714 0.805 . . . . 50.12 111.066 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.27 81.01 0.29 Allowed 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.261 2.64 . . . . 61.03 111.678 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 4.1 p -96.51 112.24 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 115.259 -0.882 . . . . 54.15 109.545 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 37.6 t30 . . . . . 0 C--O 1.236 0.344 0 N-CA-C 108.302 -0.999 . . . . 73.3 108.302 172.436 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 75.2 t80 . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 108.396 -0.964 . . . . 70.23 108.396 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -141.71 122.51 14.39 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.015 0.526 . . . . 73.41 109.675 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.411 ' HA ' ' HD2' ' C' ' 84' ' ' PHE . 55.5 mt -71.88 120.49 20.28 Favored 'Isoleucine or valine' 0 C--N 1.35 0.624 0 N-CA-C 108.586 -0.894 . . . . 64.44 108.586 171.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -84.72 -45.28 12.58 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.545 -0.909 . . . . 73.22 108.545 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 178.15 165.71 0.74 Allowed 'General case' 0 C--N 1.353 0.724 0 CA-C-N 114.34 -1.3 . . . . 75.35 109.848 -176.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.496 ' HA ' ' HA2' ' C' ' 82' ' ' GLY . 2.8 pp -130.53 150.13 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 106.476 -1.676 . . . . 74.23 106.476 168.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.452 ' HB3' HG23 ' D' ' 122' ' ' THR . 19.2 p90 -178.35 141.38 0.23 Allowed 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 118.852 0.751 . . . . 72.24 110.777 -176.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 18' ' ' THR . . . . . 0.406 HG21 ' SG ' ' C' ' 113' ' ' CYS . 69.6 p -72.44 119.83 17.2 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.976 0.91 . . . . 64.12 110.116 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -73.16 -44.07 60.56 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.211 -1.033 . . . . 73.44 108.211 169.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 26.9 t70 -134.49 141.89 46.88 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 113.577 -1.647 . . . . 62.55 109.772 -169.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.567 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.6 mt -144.77 143.8 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 106.92 -1.511 . . . . 73.25 106.92 176.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.3 t -156.38 150.92 25.69 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.161 0.505 . . . . 64.11 110.306 176.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -152.83 123.43 7.28 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 107.065 -1.458 . . . . 72.31 107.065 172.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.0 113.46 14.0 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.245 0.618 . . . . 72.14 109.765 -174.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.11 82.7 67.95 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 107.666 -1.235 . . . . 40.21 107.666 167.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.2 -24.82 31.81 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.783 2.322 . . . . 54.52 112.04 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -106.9 26.03 10.58 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.132 1.373 . . . . 54.54 110.315 178.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.66 -52.25 18.71 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 113.915 1.08 . . . . 60.14 113.915 -174.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.97 -42.64 29.25 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 121.75 1.633 . . . . 74.05 112.251 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -68.32 -33.89 75.13 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.611 -1.177 . . . . 75.23 111.897 -175.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.716 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.1 p -80.23 -25.27 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 N-CA-C 112.757 0.651 . . . . 73.11 112.757 177.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -69.48 -28.98 66.54 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.55 -0.719 . . . . 70.22 112.184 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -89.4 35.04 0.81 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.378 0.671 . . . . 65.4 110.346 176.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.69 165.34 18.76 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.77 0.828 . . . . 70.12 110.856 -174.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -78.39 124.19 27.84 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 115.459 -0.791 . . . . 74.1 109.709 169.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -85.38 96.06 9.44 Favored 'General case' 0 C--O 1.242 0.674 0 O-C-N 123.514 0.509 . . . . 72.2 110.18 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -150.38 76.77 8.34 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 107.106 -1.442 . . . . 74.22 107.106 169.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -90.95 164.95 3.89 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.733 2.289 . . . . 65.11 113.025 -175.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -88.6 82.51 6.88 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.147 -1.427 . . . . 72.54 107.147 170.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 56.5 t -73.93 114.96 14.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 114.809 -1.087 . . . . 53.54 109.344 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -135.53 125.24 25.37 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.274 -0.875 . . . . 75.43 109.427 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.424 HD23 HD22 ' C' ' 128' ' ' LEU . 3.8 pp -89.3 159.59 17.31 Favored 'General case' 0 C--O 1.246 0.913 0 N-CA-C 108.71 -0.848 . . . . 73.45 108.71 165.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.525 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 17.5 t70 -134.33 134.21 41.55 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.636 -1.246 . . . . 75.22 107.636 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.439 HD11 HG21 ' C' ' 131' ' ' VAL . 78.6 mt -123.54 110.98 15.72 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.602 0.715 . . . . 74.33 110.341 -176.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -120.76 129.73 53.73 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 106.543 -1.651 . . . . 71.32 106.543 173.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.8 t -129.95 150.67 51.13 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.624 -0.509 . . . . 72.21 109.624 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.24 149.78 29.81 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.342 0.657 . . . . 54.14 110.274 -177.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 32.9 p -125.59 150.3 47.63 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.697 0.799 . . . . 72.33 109.744 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 36.1 t -145.44 126.6 14.72 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.84 -1.17 . . . . 72.34 107.84 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -81.89 117.32 22.05 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.94 -0.763 . . . . 65.34 108.94 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.497 HD11 ' HB2' ' C' ' 57' ' ' GLU . 51.0 mt -86.23 -43.15 13.2 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.862 0.865 . . . . 73.01 110.081 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.47 -177.31 5.7 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 114.501 -1.227 . . . . 74.54 108.777 176.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -66.76 116.94 8.2 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.242 -0.651 . . . . 62.23 109.242 -177.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 68.62 21.84 7.8 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.824 1.25 . . . . 74.2 112.887 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.3 t -126.81 110.76 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 108.873 -0.788 . . . . 75.23 108.873 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -117.99 125.37 50.26 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.853 0.861 . . . . 73.01 110.583 -174.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.497 ' HB2' HD11 ' C' ' 51' ' ' LEU . 28.4 tt0 -83.11 109.99 17.63 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.238 1.015 . . . . 74.04 108.543 168.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 77.5 t -99.18 139.04 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.341 -0.985 . . . . 61.54 108.341 169.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.0 t -134.1 132.83 56.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 108.779 -0.822 . . . . 74.32 108.779 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -112.63 105.06 13.15 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.628 -1.249 . . . . 73.42 107.628 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 30.4 ttm-85 -81.13 111.23 17.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.766 0.826 . . . . 62.12 109.216 171.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 24.6 t -111.28 113.54 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 108.12 -1.067 . . . . 72.11 108.12 173.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 22.0 m -116.21 123.25 47.3 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.925 0.89 . . . . 73.53 109.603 -174.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.529 HG23 HD13 ' C' ' 114' ' ' ILE . 71.6 t -100.99 120.12 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 122.965 0.506 . . . . 61.53 109.786 177.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 3.8 m -107.29 110.03 21.95 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.174 -1.047 . . . . 72.41 108.174 172.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.37 115.86 28.76 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.337 -0.986 . . . . 70.12 108.337 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -138.38 127.51 24.22 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.008 0.523 . . . . 72.42 110.097 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 16.9 mt -83.07 32.52 0.44 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.586 1.554 . . . . 64.01 111.276 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.68 -109.22 2.79 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 110.454 -1.058 . . . . 61.1 110.454 -171.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -89.94 -19.74 24.16 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.611 0.764 . . . . 73.2 110.366 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -87.43 121.12 29.45 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.51 1.124 . . . . 53.4 108.765 174.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 88.7 m -75.48 131.3 40.03 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.856 -0.794 . . . . 74.23 108.856 168.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.716 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.43 -61.1 2.02 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.05 -0.722 . . . . 74.41 109.05 171.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -162.57 155.14 19.27 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.365 -0.834 . . . . 74.54 109.918 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -114.38 135.81 53.68 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.979 -1.489 . . . . 62.04 106.979 167.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 49.8 t -142.13 148.03 37.65 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.321 -0.992 . . . . 62.41 108.321 -175.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -154.99 131.11 10.24 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.166 0.586 . . . . 74.2 109.703 177.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 68.8 t -125.23 132.03 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 108.273 -1.01 . . . . 73.53 108.273 167.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -107.83 90.81 3.41 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.96 -1.126 . . . . 53.23 107.96 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -78.4 108.6 11.87 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 114.876 -1.056 . . . . 74.44 109.072 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.71 171.87 54.14 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 111.778 -0.529 . . . . 70.01 111.778 173.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' C' ' 16' ' ' ILE . . . 179.18 116.28 0.5 Allowed Glycine 0 CA--C 1.508 -0.403 0 N-CA-C 110.055 -1.218 . . . . 72.23 110.055 -178.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.423 HG12 ' HA ' ' C' ' 57' ' ' GLU . 66.9 mt -105.93 136.29 40.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 123.607 0.763 . . . . 62.24 109.234 -173.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.411 ' HD2' ' HA ' ' C' ' 13' ' ' ILE . 64.3 m-85 -137.34 126.58 24.66 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.426 1.09 . . . . 63.22 109.274 -171.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 70.8 m -78.52 101.25 7.27 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.362 -0.977 . . . . 72.21 108.362 168.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.474 HD13 ' SG ' ' C' ' 97' ' ' CYS . 21.2 mt -116.21 126.84 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.183 -0.673 . . . . 73.4 109.183 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.92 168.33 19.54 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 122.937 0.495 . . . . 75.01 110.649 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.84 -49.96 3.67 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.868 0.73 . . . . 71.33 112.479 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.44 HD11 HG21 ' C' ' 86' ' ' ILE . 26.5 pt -82.19 161.19 3.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 123.296 0.639 . . . . 54.24 111.671 -175.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -156.63 156.13 32.98 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.477 -0.783 . . . . 74.12 110.113 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.5 -113.6 5.99 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 124.069 0.856 . . . . 50.11 113.744 171.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 9.6 t -64.85 -36.18 83.51 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.828 0.851 . . . . 65.01 111.65 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -68.3 -44.06 76.28 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.585 0.754 . . . . 72.31 109.722 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.465 ' HE1' HG21 ' C' ' 86' ' ' ILE . 5.9 tpt -64.42 -47.26 79.82 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.777 -1.101 . . . . 62.2 110.372 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.84 -39.51 81.48 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.029 0.932 . . . . 71.32 111.034 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -65.35 -32.39 74.01 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.244 -0.889 . . . . 63.35 111.602 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.474 ' SG ' HD13 ' C' ' 86' ' ' ILE . 22.1 t -75.49 -45.32 39.08 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 109.644 -0.502 . . . . 52.02 109.644 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 61.4 mt -74.21 -32.7 63.14 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.21 1.004 . . . . 63.24 112.786 -172.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.71 11.77 30.06 Favored Glycine 0 N--CA 1.473 1.104 0 CA-C-O 119.646 -0.53 . . . . 62.54 114.361 -170.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.26 -56.91 0.12 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 117.677 0.739 . . . . 73.41 111.967 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -70.61 -48.33 55.64 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.037 0.535 . . . . 72.3 111.426 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.415 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 70.7 m -69.77 -47.4 24.15 Favored Pre-proline 0 CA--C 1.563 1.472 0 C-N-CA 123.958 0.903 . . . . 63.51 111.92 -176.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.464 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 77.8 Cg_exo -56.67 -26.29 64.54 Favored 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.407 2.072 . . . . 74.25 113.924 172.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -66.99 -37.96 85.15 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.981 0.513 . . . . 74.44 110.606 175.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.423 HD12 ' NH1' ' A' ' 111' ' ' ARG . 44.5 mm -73.85 -35.81 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.189 0.596 . . . . 71.15 109.928 177.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.23 -28.6 47.93 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.132 0.973 . . . . 74.45 112.744 -176.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -57.29 -51.39 82.07 Favored Pre-proline 0 N--CA 1.486 1.331 0 N-CA-C 113.951 1.093 . . . . 73.33 113.951 -172.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -58.51 -36.75 97.01 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 121.722 1.614 . . . . 74.33 113.239 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -67.97 -46.58 70.98 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.265 0.626 . . . . 73.33 110.918 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.66 -36.86 79.75 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.233 1.013 . . . . 61.45 110.78 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 111' ' ' ARG . . . . . 0.502 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 38.9 ttt-85 -62.61 -55.52 26.34 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.294 1.438 . . . . 62.54 110.408 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -64.69 -35.77 82.12 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 123.853 0.72 . . . . 71.42 110.203 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.406 ' SG ' HG21 ' C' ' 18' ' ' THR . 14.0 t -66.22 -33.79 76.54 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.055 0.542 . . . . 73.5 111.313 -177.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.529 HD13 HG23 ' C' ' 64' ' ' VAL . 96.0 mt -72.07 -52.21 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 122.833 0.453 . . . . 63.43 109.806 172.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -61.65 -28.97 69.76 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.141 0.576 . . . . 72.15 111.634 -173.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 25.9 t -66.13 -47.08 75.28 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.782 0.833 . . . . 54.13 108.967 173.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.623 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.3 -40.99 92.51 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.473 1.109 . . . . 74.43 111.757 176.779 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.436 HG23 ' O ' ' C' ' 114' ' ' ILE . 64.1 t -61.18 -44.6 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.655 0.782 . . . . 64.33 109.33 176.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.441 ' OG ' HG21 ' B' ' 115' ' ' THR . 30.1 t -66.69 -34.59 78.19 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 114.989 -1.005 . . . . 73.54 112.037 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.423 ' NH1' ' HA ' ' D' ' 113' ' ' CYS . 68.3 mtt-85 -69.81 -39.4 76.54 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.329 0.652 . . . . 70.05 109.585 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.28 6.48 71.89 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 123.853 0.721 . . . . 75.22 112.696 173.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.9 p 58.42 31.79 21.35 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.394 1.878 . . . . 63.03 113.204 171.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -87.2 150.64 49.93 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 108.678 -0.86 . . . . 73.51 108.678 168.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -44.41 147.05 1.73 Allowed 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 124.575 3.517 . . . . 73.24 115.73 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -51.83 117.18 2.54 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.356 1.062 . . . . 74.1 112.008 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 52.6 tp -107.71 90.57 3.34 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.607 0.718 . . . . 74.21 109.401 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -96.91 95.35 7.78 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.403 -0.817 . . . . 62.53 109.254 -175.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.502 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 90.6 mt -62.32 146.91 49.83 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.524 0.73 . . . . 64.4 112.096 -174.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.56 147.93 64.65 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 123.819 0.848 . . . . 63.35 110.791 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.555 ' HG3' HD12 ' A' ' 16' ' ' ILE . 43.9 Cg_exo -57.63 116.1 2.99 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 123.218 2.612 . . . . 63.34 112.279 175.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 131' ' ' VAL . . . . . 0.439 HG21 HD11 ' C' ' 44' ' ' LEU . 60.5 t -100.02 132.93 44.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 110.243 -0.28 . . . . 73.42 110.243 176.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -94.99 92.32 6.81 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.888 0.875 . . . . 62.43 108.953 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -66.65 -26.99 67.32 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.503 0.721 . . . . 74.01 111.851 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -66.03 -41.21 91.21 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.552 0.741 . . . . 74.34 110.18 178.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.37 -42.3 96.27 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.774 0.829 . . . . 71.32 110.746 176.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 79.5 mt -66.1 -36.02 82.07 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.443 -0.799 . . . . 53.54 111.08 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 63.2 t80 . . . . . 0 N--CA 1.476 0.851 0 C-N-CA 123.754 0.822 . . . . 73.52 110.135 177.598 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.247 0.951 0 N-CA-C 109.223 -0.658 . . . . 64.43 109.223 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -156.35 120.11 4.36 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.097 -1.075 . . . . 62.42 108.097 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -132.81 116.59 16.72 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.486 0.714 . . . . 72.4 109.376 -177.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 63.8 mt -78.92 129.06 38.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 115.288 -0.869 . . . . 74.42 108.932 176.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -99.2 -44.57 6.21 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.716 0.406 . . . . 73.32 110.98 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -167.84 147.41 4.89 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.265 0.226 . . . . 64.44 111.181 -174.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.0 mp -125.56 140.48 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 106.031 -1.84 . . . . 74.11 106.031 172.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -164.28 146.97 9.09 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 124.038 0.836 . . . . 75.42 110.614 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.1 p -85.01 112.87 20.99 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.396 -0.82 . . . . 63.11 109.622 176.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -83.76 -18.92 36.16 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.394 0.678 . . . . 73.33 109.661 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.674 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 30.6 t70 -159.8 131.73 6.27 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.976 0.91 . . . . 73.12 109.694 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.623 HG21 ' HE2' ' C' ' 117' ' ' MET . 77.3 mt -134.94 142.43 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 107.375 -1.342 . . . . 70.42 107.375 171.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 22' ' ' SER . . . . . 0.427 ' HB3' ' HB2' ' D' ' 77' ' ' GLU . 33.8 t -142.67 143.88 32.51 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.794 1.237 . . . . 62.03 107.961 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.567 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.9 t80 -152.69 117.91 5.22 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.279 -1.378 . . . . 71.04 107.279 172.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -130.28 113.1 13.98 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.717 0.807 . . . . 74.31 109.112 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.611 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -105.3 90.55 3.96 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 107.912 -1.144 . . . . 45.51 107.912 172.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.8 -30.47 9.36 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.977 2.452 . . . . 70.12 112.733 -172.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -109.57 7.64 24.7 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.593 0.757 . . . . 44.23 111.439 -171.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.611 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -44.45 -60.58 2.78 Favored Pre-proline 0 CA--C 1.558 1.25 0 N-CA-C 115.298 1.592 . . . . 64.22 115.298 -158.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.82 -34.54 23.88 Favored 'Trans proline' 0 C--N 1.377 2.035 0 CA-C-N 122.474 1.919 . . . . 64.01 113.873 -172.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -86.19 -21.34 27.55 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 116.637 -0.256 . . . . 74.51 110.497 -175.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.443 HG12 ' O ' ' D' ' 28' ' ' ALA . 1.8 p -83.1 -21.1 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.068 0.547 . . . . 53.11 110.307 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -57.88 -23.6 53.85 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.601 0.76 . . . . 72.1 112.864 174.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -59.31 -27.38 65.82 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.839 0.856 . . . . 70.54 111.167 176.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -83.92 90.79 7.45 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.697 1.199 . . . . 62.14 109.749 177.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -83.45 92.7 7.63 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.935 -1.03 . . . . 64.34 111.46 -175.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 44.6 p90 -167.8 172.68 8.93 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.247 1.019 . . . . 72.41 109.234 166.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -64.19 114.83 15.37 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 108.518 -0.919 . . . . 71.12 108.518 173.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.415 ' O ' HG23 ' D' ' 40' ' ' VAL . 53.3 Cg_exo -54.25 119.35 6.2 Favored 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 122.762 2.308 . . . . 74.52 110.457 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.47 111.05 3.38 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.991 -0.744 . . . . 64.25 108.991 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.655 HG13 HG13 ' D' ' 64' ' ' VAL . 88.3 t -99.07 140.86 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 113.983 -1.462 . . . . 73.31 108.6 -175.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -124.6 122.95 38.99 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.012 -1.477 . . . . 73.22 107.012 171.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 64.3 tp -97.17 138.54 34.52 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.757 0.823 . . . . 75.53 109.863 -170.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.762 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 9.0 m-20 -125.64 114.01 18.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.728 -1.124 . . . . 53.41 108.033 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 90.5 mt -109.23 135.27 50.6 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.091 -0.707 . . . . 54.42 109.091 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -146.04 154.03 41.41 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.388 1.075 . . . . 73.02 108.477 -177.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 8.8 t -117.96 150.84 38.57 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.294 0.569 . . . . 74.15 110.274 -177.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.07 170.35 19.61 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.415 1.486 . . . . 74.13 107.777 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 72.1 p . . . . . 0 C--O 1.243 0.724 0 CA-C-O 121.174 0.512 . . . . 65.3 110.925 -177.311 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 54' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' D' ' 85' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 N-CA-C 113.112 0.782 . . . . 71.34 113.112 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 16.4 m -122.44 112.22 33.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 107.933 -1.136 . . . . 72.35 107.933 175.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.578 ' HB2' HD11 ' D' ' 98' ' ' LEU . 9.8 m-85 -134.88 133.12 39.33 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 106.746 -1.575 . . . . 71.1 106.746 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.471 ' HB3' HG13 ' D' ' 83' ' ' ILE . 7.4 pt-20 -86.92 122.67 31.1 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.708 -0.849 . . . . 71.43 108.708 173.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 78.3 t -101.06 141.44 17.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.421 -1.263 . . . . 54.54 108.272 177.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.574 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 36.3 t -128.18 123.97 61.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 108.181 -1.044 . . . . 54.21 108.181 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.514 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -95.09 109.11 21.21 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 106.828 -1.545 . . . . 75.34 106.828 177.763 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.49 95.3 10.21 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.388 -1.708 . . . . 73.13 106.388 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.48 HG21 ' CB ' ' D' ' 110' ' ' ALA . 44.9 t -97.69 145.13 9.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 115.406 -0.816 . . . . 74.01 109.057 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.762 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 52.7 m -141.21 143.12 34.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.939 -1.028 . . . . 74.12 108.683 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.655 HG13 HG13 ' D' ' 40' ' ' VAL . 12.3 t -133.6 115.69 22.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 123.796 0.838 . . . . 70.45 108.784 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 17.2 m -106.68 94.77 5.3 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.796 -0.816 . . . . 63.34 108.796 171.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.625 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -99.07 145.85 26.69 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 109.595 -0.52 . . . . 54.3 109.595 176.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 22.7 p -153.4 137.63 16.54 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.737 -0.665 . . . . 63.52 111.257 -171.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.428 ' HB2' HG22 ' D' ' 31' ' ' VAL . 22.1 mt -107.54 116.4 31.87 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.898 1.279 . . . . 71.45 108.225 173.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.26 -133.54 18.33 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-N 116.161 -0.472 . . . . 42.01 112.081 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -94.57 3.57 54.94 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.148 0.579 . . . . 64.22 111.551 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -124.39 167.43 14.39 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.729 0.412 . . . . 64.43 110.249 -176.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 12.0 m -68.1 144.91 54.85 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 124.137 0.898 . . . . 74.45 111.731 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.54 -59.91 1.63 Allowed 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.308 -1.367 . . . . 60.22 107.308 168.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 74' ' ' PHE . . . . . 0.426 ' CE1' HG22 ' D' ' 118' ' ' VAL . 54.1 p90 -157.97 158.95 35.91 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.476 -1.238 . . . . 74.23 110.306 178.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 51.2 mt -124.73 145.39 49.72 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 107.137 -1.431 . . . . 74.53 107.137 176.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.447 ' SG ' HG12 ' D' ' 114' ' ' ILE . 45.6 t -156.49 109.45 2.61 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 117.884 0.311 . . . . 55.21 110.738 -171.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 77' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' D' ' 22' ' ' SER . 12.1 mp0 -124.5 127.69 47.84 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.079 0.952 . . . . 74.35 109.384 -173.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 87.1 t -135.47 115.17 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.125 0.57 . . . . 73.45 109.887 -178.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.674 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.9 mt-30 -88.68 84.75 6.72 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.428 -0.953 . . . . 70.33 108.428 170.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 80' ' ' GLN . . . . . 0.403 ' O ' HD13 ' D' ' 106' ' ' LEU . 6.7 tp-100 -83.1 96.92 8.53 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 113.736 -1.574 . . . . 71.41 109.604 -176.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -100.02 170.53 22.8 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.538 -0.301 . . . . 74.52 113.678 -175.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.78 148.5 8.36 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-O 119.243 -0.754 . . . . 71.14 112.675 177.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.471 HG13 ' HB3' ' D' ' 57' ' ' GLU . 3.4 mp -89.32 126.3 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.099 -1.075 . . . . 71.03 108.099 176.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -123.37 149.77 44.54 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.97 0.908 . . . . 73.11 110.239 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' D' ' 54' ' ' ASP . 31.2 t -115.44 111.71 21.19 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.884 0.874 . . . . 64.43 109.073 176.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.407 HD13 ' HB2' ' D' ' 98' ' ' LEU . 46.0 pt -114.88 140.07 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.966 0.906 . . . . 72.25 108.985 177.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.16 161.92 28.21 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.062 0.458 . . . . 51.4 111.917 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.93 8.89 81.78 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.065 -0.971 . . . . 73.44 115.099 167.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.506 ' HB ' ' HA ' ' D' ' 94' ' ' MET . 0.5 OUTLIER -98.77 171.69 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 N-CA-C 107.986 -1.116 . . . . 73.33 107.986 174.773 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.428 ' H ' HG22 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -138.96 175.3 9.67 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.87 -0.519 . . . . 64.42 110.85 -177.57 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.8 -133.12 29.41 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 114.876 -1.057 . . . . 34.0 112.805 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -92.08 -29.99 16.25 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.639 0.776 . . . . 44.21 111.057 175.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -68.8 -15.5 63.52 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.234 0.613 . . . . 73.33 112.359 -173.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.506 ' HA ' ' HB ' ' D' ' 89' ' ' ILE . 0.0 OUTLIER -59.21 -37.74 78.2 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.708 0.633 . . . . 70.42 112.708 173.538 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.73 -16.97 42.88 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.399 0.68 . . . . 62.23 111.481 177.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -66.62 -38.2 86.44 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.935 0.894 . . . . 74.33 111.154 -178.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 63.8 m -59.91 -30.47 69.06 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.623 0.769 . . . . 74.12 111.96 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' D' ' 56' ' ' TYR . 14.5 tp -79.53 -42.58 24.82 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.047 -0.979 . . . . 61.15 110.45 -177.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.08 -18.52 69.36 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 115.739 -0.664 . . . . 72.52 113.794 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.16 -63.08 1.37 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.06 0.544 . . . . 63.54 112.289 -170.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -70.59 -31.88 69.04 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 112.236 0.458 . . . . 75.33 112.236 -174.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.454 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 87.4 m -68.32 -49.5 32.4 Favored Pre-proline 0 CA--C 1.568 1.669 0 CA-C-O 118.531 -0.747 . . . . 53.0 112.114 177.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.514 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 51.7 Cg_exo -60.46 -27.36 84.71 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 122.273 1.982 . . . . 63.35 113.373 169.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -64.76 -36.07 83.13 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.325 0.65 . . . . 41.33 110.532 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 31.1 mm -66.5 -43.14 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.724 0.81 . . . . 61.21 110.371 172.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.403 HD13 ' O ' ' D' ' 80' ' ' GLN . 75.0 mt -75.52 -12.37 60.21 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.8 0.84 . . . . 75.34 112.979 -173.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -75.47 -45.9 4.36 Favored Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 113.559 0.948 . . . . 75.15 113.559 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.53 -33.57 78.83 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 121.871 1.714 . . . . 71.34 112.578 169.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -76.65 -32.06 57.74 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.468 0.707 . . . . 75.53 111.793 176.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 110' ' ' ALA . . . . . 0.48 ' CB ' HG21 ' D' ' 62' ' ' VAL . . . -64.2 -45.96 85.98 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.836 -0.431 . . . . 70.2 109.836 177.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' D' ' 111' ' ' ARG . 9.6 ptt-85 -76.61 -29.11 56.39 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 123.313 0.383 . . . . 73.32 110.697 178.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 112' ' ' GLU . . . . . 0.429 ' HB2' ' HB3' ' B' ' 108' ' ' PRO . 23.0 tt0 -51.13 -43.34 61.16 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.851 0.834 . . . . 74.33 109.878 172.039 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.423 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 18.8 t -72.8 -60.93 1.99 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.071 -1.422 . . . . 63.11 109.927 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.688 ' HA ' ' HE1' ' D' ' 117' ' ' MET . 80.4 mt -53.5 -56.7 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 124.77 1.228 . . . . 74.44 112.873 -174.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 28.7 m -48.72 -38.35 21.26 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.873 0.869 . . . . 74.43 111.545 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 12.7 t -69.02 -47.59 65.06 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.741 -1.118 . . . . 70.44 110.25 -178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.688 ' HE1' ' HA ' ' D' ' 114' ' ' ILE . 4.0 mpp? -63.14 -32.59 74.01 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 117.973 0.351 . . . . 63.53 111.65 178.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.484 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.2 t -62.24 -49.47 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 123.397 0.679 . . . . 73.45 109.927 176.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.7 p -71.92 -29.07 63.92 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.776 -0.647 . . . . 73.12 110.768 -177.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.4 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 86.4 mtt-85 -71.36 -30.41 66.13 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.746 0.818 . . . . 73.42 110.367 175.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.61 8.41 75.31 Favored Glycine 0 C--N 1.355 1.591 0 CA-C-O 119.367 -0.685 . . . . 52.23 112.82 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.452 HG23 ' HB3' ' C' ' 17' ' ' TYR . 74.7 p 51.75 56.8 7.3 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.497 1.519 . . . . 71.52 112.274 -175.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -120.74 148.28 47.9 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 108.518 -0.919 . . . . 71.02 108.518 169.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -50.28 141.13 32.53 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 123.167 2.578 . . . . 63.45 112.668 174.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -55.4 140.54 39.58 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.383 1.073 . . . . 74.52 113.2 -167.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.465 HD22 HG21 ' D' ' 40' ' ' VAL . 13.4 tp -126.8 98.55 5.41 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.008 0.923 . . . . 73.3 109.328 -178.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -102.1 103.0 13.54 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.163 -1.051 . . . . 54.03 108.163 175.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.08 121.92 14.25 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 123.59 0.556 . . . . 62.24 110.412 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.89 128.95 91.31 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.811 0.844 . . . . 72.11 110.977 -175.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -79.99 105.61 1.82 Allowed 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.905 2.403 . . . . 44.24 111.938 -170.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -107.79 124.62 64.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.015 -1.105 . . . . 75.21 108.015 172.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -68.2 117.06 9.53 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.932 -0.766 . . . . 75.54 108.932 175.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 133' ' ' PHE . . . . . 0.418 ' HD1' ' H ' ' D' ' 133' ' ' PHE . 1.5 m-85 . . . . . 0 N--CA 1.486 1.354 0 C-N-CA 125.025 1.33 . . . . 62.45 112.048 -171.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 79.2 m . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 120.568 0.223 . . . . 74.35 110.845 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.402 ' HZ ' HG13 ' A' ' 105' ' ' ILE . 93.9 t80 -99.36 114.58 27.54 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 106.359 -1.719 . . . . 74.22 106.359 161.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -133.32 112.5 11.69 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.189 -0.671 . . . . 73.43 109.189 -177.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.658 HG21 ' HG2' ' C' ' 130' ' ' PRO . 41.3 mt -83.65 113.96 23.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 107.745 -1.206 . . . . 74.41 107.745 169.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -94.77 -28.72 15.13 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 109.705 -0.48 . . . . 65.45 109.705 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.416 ' NH2' ' HB ' ' B' ' 122' ' ' THR . 20.2 ttt180 -166.37 139.96 4.09 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 122.741 0.416 . . . . 43.11 111.101 -177.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.571 HD12 ' HG3' ' C' ' 130' ' ' PRO . 95.5 mt -128.45 138.45 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.687 1.195 . . . . 64.13 107.828 169.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.468 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 32.5 p90 -163.74 174.88 11.09 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.735 0.647 . . . . 71.43 111.395 -175.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.0 p -101.17 121.89 42.65 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.196 -0.668 . . . . 63.22 109.196 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.468 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 35.5 mtpt -81.5 -38.2 26.68 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.129 0.49 . . . . 63.33 109.908 175.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.494 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 21.0 t70 -142.59 144.24 32.77 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.825 -1.079 . . . . 74.31 110.17 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.574 HD13 ' SD ' ' B' ' 117' ' ' MET . 97.4 mt -144.03 144.75 22.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 125.581 1.552 . . . . 63.32 107.43 176.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.4 t -159.13 142.85 14.99 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 122.917 0.487 . . . . 64.14 110.22 168.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -136.84 143.74 43.26 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 107.427 -1.323 . . . . 72.41 107.427 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -137.84 127.0 24.42 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.841 0.456 . . . . 74.32 110.387 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.21 66.31 9.28 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 125.382 1.473 . . . . 72.44 108.236 167.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.89 -34.25 30.69 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.25 1.967 . . . . 73.33 110.804 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.418 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 20.0 p-10 -89.96 24.68 2.35 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 114.175 -1.375 . . . . 55.55 111.292 174.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.87 -49.8 71.89 Favored Pre-proline 0 CA--C 1.571 1.773 0 CA-C-O 118.44 -0.79 . . . . 55.32 112.659 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.48 -26.79 70.21 Favored 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 121.718 1.612 . . . . 53.41 113.765 175.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.418 ' HB2' ' HB2' ' A' ' 27' ' ' ASN . 16.9 m-70 -77.33 -49.04 15.83 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.664 0.745 . . . . 71.53 110.564 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.804 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.9 p -72.4 -25.61 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 CA-C-N 114.302 -1.317 . . . . 62.52 112.741 -167.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -64.72 -19.75 65.95 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 122.875 0.47 . . . . 70.03 111.882 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -86.47 -31.39 21.37 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.426 1.091 . . . . 64.22 110.129 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.52 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 4.0 tmtp? -68.97 142.9 54.54 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.138 0.975 . . . . 71.2 109.642 -174.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.52 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 10.2 m-20 -53.23 124.03 13.45 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.566 1.146 . . . . 73.33 110.922 176.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -85.13 85.07 7.5 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 121.629 0.728 . . . . 74.2 110.722 -175.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -130.96 76.97 76.14 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 107.137 -1.431 . . . . 71.5 107.137 167.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -85.55 133.43 4.49 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.281 1.988 . . . . 75.2 112.432 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -97.06 90.7 5.26 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.061 -1.459 . . . . 72.11 107.061 166.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.678 HG22 ' HB2' ' A' ' 66' ' ' ALA . 62.1 t -77.69 93.12 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 108.581 -0.896 . . . . 63.22 108.581 175.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.489 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -90.35 127.12 36.09 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.903 -1.044 . . . . 74.35 109.168 177.933 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.679 HD21 HG13 ' A' ' 62' ' ' VAL . 3.7 tt -108.48 123.05 48.29 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.205 -1.035 . . . . 74.34 108.205 -171.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.51 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 10.8 m-20 -113.24 114.69 27.08 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.471 1.108 . . . . 74.22 109.514 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.459 HD22 HD21 ' A' ' 60' ' ' LEU . 45.7 mt -99.38 146.96 25.74 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.068 0.547 . . . . 53.13 112.033 -178.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -148.02 146.9 29.09 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.079 1.351 . . . . 64.43 108.46 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 84.4 m -134.61 140.82 46.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.276 0.63 . . . . 63.32 110.169 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.07 154.04 49.29 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.662 1.185 . . . . 73.12 109.339 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.5 p -130.43 155.46 46.39 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.21 0.604 . . . . 62.43 109.63 173.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.7 t -149.09 120.21 7.75 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.217 1.007 . . . . 74.34 108.371 -176.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -73.27 111.11 8.09 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.382 -0.599 . . . . 61.55 109.382 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.612 HD11 ' HB2' ' A' ' 57' ' ' GLU . 52.6 mt -84.81 -30.45 24.56 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.215 0.606 . . . . 73.33 110.072 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.42 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -161.74 177.02 10.3 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.667 1.187 . . . . 74.04 109.596 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -63.67 125.06 23.07 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.581 -0.896 . . . . 72.33 108.581 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 60.0 18.92 8.04 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.129 0.972 . . . . 71.14 112.72 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 49.5 t -126.05 110.43 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 107.824 -1.176 . . . . 75.21 107.824 173.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -123.52 127.86 48.94 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.849 0.86 . . . . 74.11 109.008 -175.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.612 ' HB2' HD11 ' A' ' 51' ' ' LEU . 31.5 tt0 -84.55 139.32 32.21 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.487 -0.931 . . . . 74.53 108.487 165.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.48 HG11 ' HD3' ' A' ' 103' ' ' PRO . 72.0 t -120.71 136.41 57.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.936 -1.135 . . . . 62.11 107.936 169.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.11 131.97 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.687 -0.857 . . . . 72.21 108.687 174.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.459 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -107.59 107.22 17.95 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.8 -1.556 . . . . 63.12 106.8 173.974 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -92.97 99.84 12.4 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.192 -1.04 . . . . 55.21 108.192 176.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.679 HG13 HD21 ' A' ' 42' ' ' LEU . 40.4 t -95.91 124.75 48.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 114.256 -1.338 . . . . 62.2 107.648 176.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 5.0 m -115.61 136.88 52.63 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.91 -1.144 . . . . 74.42 107.91 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 71.8 t -137.91 126.2 31.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 107.487 -1.301 . . . . 63.23 107.487 -172.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.489 ' HB ' ' HD2' ' A' ' 41' ' ' LYS . 27.5 m -137.72 131.69 31.71 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.984 -0.747 . . . . 73.34 108.984 169.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.678 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -105.56 120.76 42.45 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 107.618 -1.253 . . . . 72.02 107.618 174.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.3 m -118.02 126.47 52.36 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.744 0.418 . . . . 71.21 110.006 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.2 mt -90.54 66.51 6.3 Favored 'General case' 0 C--O 1.248 1.011 0 C-N-CA 125.046 1.339 . . . . 74.12 108.68 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.05 -86.74 0.78 Allowed Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.796 -0.638 . . . . 70.2 111.842 -176.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -108.95 -29.19 8.72 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.004 0.922 . . . . 64.33 110.902 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -89.3 113.57 24.85 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.663 -0.865 . . . . 72.31 108.663 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.2 m -69.0 130.37 42.58 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.81 0.732 . . . . 44.41 109.203 174.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.804 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -75.99 -58.65 3.16 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.387 -0.824 . . . . 53.34 109.884 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -159.33 163.68 35.44 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.723 -1.126 . . . . 72.11 110.691 177.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.2 tp -124.27 135.57 53.49 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.483 1.113 . . . . 72.44 108.705 172.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.551 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 68.6 m -133.5 133.11 41.81 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.54 1.136 . . . . 63.14 109.133 175.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -145.36 123.05 11.83 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.872 -0.788 . . . . 72.05 108.872 172.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.7 t -131.09 125.12 57.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 123.947 0.899 . . . . 75.14 108.948 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.494 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 53.8 mt-30 -99.67 91.63 4.96 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.919 0.887 . . . . 71.53 108.879 173.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -78.66 97.98 6.03 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.969 -1.014 . . . . 73.53 109.625 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.54 150.65 23.57 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 111.54 -0.624 . . . . 74.04 111.54 177.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.48 125.82 2.08 Favored Glycine 0 CA--C 1.508 -0.384 0 N-CA-C 110.665 -0.974 . . . . 74.02 110.665 -177.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.2 mt -84.59 112.87 22.36 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 N-CA-C 109.052 -0.721 . . . . 63.35 109.052 176.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.659 ' HB3' HD11 ' A' ' 86' ' ' ILE . 81.7 m-85 -121.77 118.69 29.65 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.093 0.957 . . . . 70.25 108.752 -177.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.5 t -92.75 95.87 9.82 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.771 -1.196 . . . . 61.24 107.771 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.659 HD11 ' HB3' ' A' ' 84' ' ' PHE . 11.9 mm -112.72 142.73 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.902 -0.59 . . . . 72.43 110.109 -172.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.9 164.87 30.9 Favored 'General case' 0 C--O 1.241 0.615 0 O-C-N 123.584 0.553 . . . . 64.23 112.25 -172.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.77 6.65 85.15 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 114.852 -1.067 . . . . 63.0 114.191 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.436 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -134.11 165.23 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.159 0.984 . . . . 74.41 108.89 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -159.27 175.95 12.77 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 109.451 -0.574 . . . . 65.23 109.451 175.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.01 -117.19 8.42 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.007 0.813 . . . . 62.02 114.323 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 t -70.12 -31.08 68.44 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.279 1.032 . . . . 72.1 111.755 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -74.61 -39.72 61.99 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 123.181 0.592 . . . . 71.3 110.713 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.9 tpt -68.13 -40.8 82.4 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.311 0.382 . . . . 72.32 110.111 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.88 98.13 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.329 -0.85 . . . . 55.45 110.745 175.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.435 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 54.5 t-80 -68.4 -31.93 71.62 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.076 -0.511 . . . . 73.52 111.632 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.496 ' SG ' HG21 ' A' ' 86' ' ' ILE . 48.5 t -69.46 -44.97 70.14 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 110.062 -0.347 . . . . 34.23 110.062 -178.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 65.0 mt -83.12 -26.68 30.77 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.38 0.672 . . . . 55.44 111.961 -174.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.23 3.35 37.71 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-O 119.525 -0.597 . . . . 61.5 114.15 -173.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.493 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -142.38 -68.44 0.37 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 117.684 0.742 . . . . 73.32 111.646 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -69.38 -41.93 75.83 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 112.465 0.543 . . . . 63.41 112.465 -170.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 70.1 m -66.46 -50.08 49.29 Favored Pre-proline 0 CA--C 1.568 1.659 0 CA-C-O 118.53 -0.747 . . . . 64.01 111.93 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.48 ' HD3' HG11 ' A' ' 58' ' ' VAL . 37.8 Cg_endo -65.86 -21.02 58.12 Favored 'Trans proline' 0 C--N 1.395 3.019 0 C-N-CA 121.781 1.654 . . . . 54.54 113.288 172.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -66.25 -42.91 87.89 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.161 0.584 . . . . 72.5 109.812 172.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.419 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 39.7 mm -62.01 -43.39 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.899 0.879 . . . . 64.03 110.318 174.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.7 mt -72.04 -24.13 61.49 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.398 -0.819 . . . . 61.13 112.627 -173.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -62.93 -44.89 86.6 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 114.339 1.237 . . . . 73.4 114.339 -172.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.419 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 92.5 Cg_exo -50.06 -40.98 50.13 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.203 1.935 . . . . 70.14 114.083 171.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -76.92 -39.56 50.39 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.619 0.768 . . . . 75.5 111.049 -177.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.37 -47.24 82.89 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.648 0.779 . . . . 74.22 110.016 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.463 ' NH1' HD12 ' C' ' 105' ' ' ILE . 29.7 ttm180 -49.4 -55.93 11.36 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 125.023 1.452 . . . . 64.43 110.142 172.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -60.89 -45.48 94.4 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.496 1.122 . . . . 74.14 111.664 -174.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.402 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 45.1 t -56.91 -45.32 82.72 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.026 0.829 . . . . 73.14 110.434 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 118' ' ' VAL . 66.2 mt -63.27 -51.62 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 115.077 -0.965 . . . . 73.21 110.535 175.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 50.6 m -55.54 -41.48 73.26 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.113 0.965 . . . . 71.12 111.246 -174.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -69.78 -42.85 73.26 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.498 -1.228 . . . . 63.21 109.913 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.498 ' SD ' HG23 ' A' ' 21' ' ' ILE . 10.2 mtp -58.79 -41.73 87.39 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.642 0.777 . . . . 75.54 111.19 175.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 114' ' ' ILE . 83.1 t -65.08 -48.13 85.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.384 1.074 . . . . 74.3 110.329 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.3 p -71.62 -30.94 66.34 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.911 -0.586 . . . . 53.22 111.298 -176.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.478 HH12 ' HG3' ' B' ' 112' ' ' GLU . 64.8 mtt-85 -72.4 -30.25 64.48 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.554 0.742 . . . . 63.42 109.197 173.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.43 -2.6 74.91 Favored Glycine 0 C--N 1.356 1.643 0 O-C-N 123.88 0.737 . . . . 73.15 112.921 174.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.514 HG21 ' HE ' ' B' ' 15' ' ' ARG . 92.2 m 71.68 26.59 3.07 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 122.912 1.339 . . . . 75.11 111.288 174.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -98.26 145.08 29.23 Favored Pre-proline 0 C--O 1.244 0.801 0 N-CA-C 108.51 -0.922 . . . . 72.3 108.51 170.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -43.98 132.68 8.44 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.389 2.726 . . . . 75.21 112.891 174.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -52.93 123.2 10.9 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 124.162 0.914 . . . . 74.35 112.399 -170.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 45.5 tp -109.24 100.68 9.78 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.908 0.883 . . . . 62.51 110.207 -174.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.434 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 88.9 m-20 -97.78 113.06 24.76 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.63 -1.248 . . . . 74.15 107.63 174.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 19.1 mt -65.21 147.68 53.02 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 123.58 0.55 . . . . 74.12 110.46 -175.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.76 134.74 88.05 Favored Pre-proline 0 CA--C 1.549 0.933 0 CA-C-O 118.914 -0.565 . . . . 52.51 111.158 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.49 120.93 9.17 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.256 2.637 . . . . 74.21 113.337 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.434 HG21 HD11 ' A' ' 44' ' ' LEU . 64.7 t -107.31 130.44 59.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 123.644 0.778 . . . . 74.34 110.37 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -92.51 92.22 7.97 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.051 -1.092 . . . . 75.24 108.051 173.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -62.64 -29.4 70.6 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.88 0.872 . . . . 73.31 112.22 176.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.493 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 6.7 m-20 -70.86 -25.48 62.84 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.291 0.636 . . . . 73.15 111.131 177.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.01 -40.96 37.32 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.239 0.616 . . . . 43.34 110.233 172.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.61 -44.69 96.53 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.207 0.603 . . . . 74.41 110.938 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.3 t80 . . . . . 0 C--O 1.216 -0.708 0 CA-C-N 115.073 -0.967 . . . . 73.12 109.74 179.199 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.659 ' HG2' HG23 ' B' ' 89' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.57 1.713 0 CA-C-O 121.318 0.58 . . . . 53.13 111.701 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 85.2 m -154.41 102.26 2.41 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.11 -1.07 . . . . 74.34 108.11 168.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.428 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 50.9 t80 -119.9 134.35 55.27 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.068 -1.086 . . . . 72.11 108.068 173.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -164.01 142.12 7.3 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 123.702 0.626 . . . . 60.52 110.791 169.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.52 HD13 HD11 ' B' ' 16' ' ' ILE . 37.8 mt -80.07 132.4 31.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.021 -0.991 . . . . 74.45 109.43 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -99.12 -38.72 8.82 Favored 'General case' 0 C--O 1.242 0.662 0 O-C-N 123.816 0.697 . . . . 70.43 110.299 178.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.514 ' HE ' HG21 ' A' ' 122' ' ' THR . 40.3 ttt180 -173.46 137.18 0.63 Allowed 'General case' 0 C--N 1.349 0.583 0 O-C-N 123.747 0.654 . . . . 72.24 109.8 -175.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.52 HD11 HD13 ' B' ' 13' ' ' ILE . 96.6 mt -120.31 143.43 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 107.577 -1.268 . . . . 64.22 107.577 174.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -162.9 139.48 7.44 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.696 0.628 . . . . 75.43 112.696 -173.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.9 m -73.96 118.01 16.43 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.042 0.937 . . . . 53.43 109.499 172.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.474 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.6 mtpt -98.15 -9.98 24.89 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.932 0.893 . . . . 71.13 112.045 -176.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 16.1 t70 -174.27 144.6 0.95 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.168 0.587 . . . . 52.43 110.745 -176.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.507 HD11 ' SG ' ' B' ' 113' ' ' CYS . 43.8 mm -138.28 148.67 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 125.047 1.339 . . . . 64.4 108.792 175.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.51 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 38.9 t -148.68 139.99 23.3 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 125.159 1.384 . . . . 52.33 108.214 172.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.498 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 81.2 t80 -152.85 113.7 4.13 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.375 -1.343 . . . . 75.44 107.375 171.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -121.18 119.09 31.32 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.953 0.901 . . . . 72.52 108.712 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.637 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -107.45 87.12 3.11 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 107.194 -1.41 . . . . 72.14 107.194 167.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.68 -34.44 31.97 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.987 2.458 . . . . 71.13 111.662 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -101.84 3.39 39.25 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.44 1.096 . . . . 70.15 110.375 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.637 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -30.0 -65.06 0.19 Allowed Pre-proline 0 N--CA 1.499 1.997 0 C-N-CA 126.331 1.853 . . . . 44.11 114.886 -172.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 28.8 Cg_exo -57.69 -48.07 18.53 Favored 'Trans proline' 0 C--N 1.391 2.802 0 C-N-CA 122.934 2.423 . . . . 50.42 113.462 -166.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -96.36 -15.37 21.89 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.297 -0.865 . . . . 73.21 112.648 -172.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.421 HG22 HD12 ' B' ' 68' ' ' LEU . 3.4 p -73.76 -17.7 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-N 118.657 0.662 . . . . 64.13 110.647 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -68.62 -6.32 25.08 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 113.764 1.024 . . . . 70.12 113.764 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -71.24 -13.53 61.94 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 120.991 0.424 . . . . 71.03 110.747 172.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.59 ' HB2' HD13 ' B' ' 68' ' ' LEU . 91.1 mttt -98.62 88.0 3.96 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.729 1.212 . . . . 54.42 110.049 -177.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.45 77.92 9.92 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.989 -1.005 . . . . 70.22 110.99 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.405 ' O ' ' HG2' ' B' ' 124' ' ' PRO . 38.5 p90 -158.37 164.58 36.18 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.881 0.873 . . . . 65.54 108.721 169.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -73.54 117.4 60.34 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 108.181 -1.044 . . . . 73.13 108.181 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.442 ' O ' HG23 ' B' ' 40' ' ' VAL . 31.8 Cg_endo -65.98 147.56 84.8 Favored 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 122.207 1.938 . . . . 75.31 112.231 -177.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -69.93 114.17 7.86 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 109.004 -0.739 . . . . 75.2 109.004 178.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.547 HG21 HD13 ' B' ' 126' ' ' LEU . 77.7 t -111.04 138.06 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 114.998 -1.001 . . . . 74.22 111.939 -172.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.478 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 44.4 tttp -107.27 126.97 53.12 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 126.017 1.727 . . . . 71.53 107.503 174.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.747 HD13 HD22 ' B' ' 128' ' ' LEU . 15.6 tp -103.01 127.3 50.3 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.729 -0.841 . . . . 74.02 108.729 174.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -143.8 136.13 26.85 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 106.999 -1.482 . . . . 44.11 106.999 -177.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.7 mp -127.05 149.24 50.0 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.952 -0.758 . . . . 74.34 108.952 -171.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.577 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 7.6 t70 -125.77 146.29 49.84 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.772 1.229 . . . . 54.34 109.255 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 26.9 m -124.84 105.64 9.41 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.495 0.718 . . . . 72.21 109.643 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.7 120.45 39.39 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.366 -1.346 . . . . 71.51 107.366 176.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.721 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 25.1 m -135.41 161.57 35.06 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.495 0.318 . . . . 75.53 111.506 -168.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 42.0 p -165.15 139.29 4.88 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.322 0.649 . . . . 74.45 111.06 -177.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -87.57 96.65 10.48 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 108.782 -0.822 . . . . 74.41 108.782 171.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 pp -107.53 14.78 25.46 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.801 0.44 . . . . 65.14 110.688 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.98 143.75 22.83 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.775 0.83 . . . . 63.54 109.56 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -74.06 132.13 42.02 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.646 -0.872 . . . . 74.41 108.646 170.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 67.76 1.9 2.83 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.946 1.298 . . . . 51.23 113.442 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 58.2 t -140.08 128.28 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 107.851 -1.166 . . . . 72.24 107.851 -172.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.721 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 6.7 t80 -115.38 154.26 29.52 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.797 -0.565 . . . . 71.21 109.566 -176.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -124.24 117.67 25.08 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 107.739 -1.208 . . . . 61.0 107.739 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 p -118.71 127.8 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.881 0.873 . . . . 70.42 109.363 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.41 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.9 t -103.77 112.33 36.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 108.072 -1.085 . . . . 62.25 108.072 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -103.18 108.68 19.98 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.473 -0.936 . . . . 71.41 108.473 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.577 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 6.2 ttm180 -85.12 135.4 33.99 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.131 -0.941 . . . . 73.32 109.238 174.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.466 ' CG1' HD11 ' B' ' 42' ' ' LEU . 17.5 t -122.57 117.13 51.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.14 -1.059 . . . . 52.13 108.14 169.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 17.3 m -109.78 133.36 53.23 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.874 0.87 . . . . 63.23 109.786 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.557 HG21 HG21 ' B' ' 114' ' ' ILE . 55.4 t -115.78 114.5 46.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 125.308 1.443 . . . . 65.14 109.139 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 41.4 m -91.79 138.09 31.84 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.698 -1.223 . . . . 72.12 107.698 166.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.538 ' HB2' HG22 ' B' ' 40' ' ' VAL . . . -148.78 143.01 26.08 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 117.943 0.338 . . . . 64.2 110.467 178.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 73.7 p -147.96 133.42 18.64 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 123.768 0.667 . . . . 74.24 111.032 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.59 HD13 ' HB2' ' B' ' 34' ' ' LYS . 54.0 mt -93.89 108.73 20.49 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.171 0.988 . . . . 74.43 108.508 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.87 -116.64 4.39 Favored Glycine 0 C--N 1.342 0.861 0 N-CA-C 111.469 -0.652 . . . . 42.41 111.469 -175.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -111.62 -0.08 16.21 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.054 0.942 . . . . 72.44 110.645 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.426 ' HG2' ' NZ ' ' B' ' 34' ' ' LYS . 9.8 pt-20 -116.77 154.37 30.79 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.328 -0.619 . . . . 72.01 109.328 -178.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 39.4 m -62.81 141.4 58.64 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.972 0.509 . . . . 63.51 111.285 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.435 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -97.78 -64.06 1.07 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.658 -1.238 . . . . 74.32 107.658 172.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -151.88 154.4 36.07 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.639 -1.164 . . . . 73.23 109.949 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 88.5 mt -130.44 112.87 13.64 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 106.916 -1.513 . . . . 55.25 106.916 175.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.1 t -117.63 156.19 28.59 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.134 -0.691 . . . . 62.2 109.134 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.51 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.0 tt0 -161.93 129.63 4.03 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.649 0.78 . . . . 75.23 108.997 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 94.2 t -126.41 150.13 31.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.125 -1.065 . . . . 75.15 108.125 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.444 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.6 mt-30 -124.86 97.95 5.49 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.181 -1.044 . . . . 74.24 108.181 170.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -93.26 103.14 15.42 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.676 -0.693 . . . . 73.11 109.255 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.474 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -94.19 172.32 31.91 Favored Glycine 0 C--O 1.243 0.675 0 CA-C-N 115.824 -0.626 . . . . 62.0 111.862 176.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.91 142.71 6.88 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.808 -0.517 . . . . 71.1 111.808 -178.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 16.3 tt -107.54 116.86 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 C-N-CA 123.997 0.919 . . . . 74.21 108.661 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -123.3 134.7 54.04 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.089 0.955 . . . . 62.41 109.578 -172.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.0 m -89.12 130.83 35.49 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.024 0.53 . . . . 64.21 109.592 174.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.551 ' HB ' HD11 ' B' ' 89' ' ' ILE . 0.1 OUTLIER -135.75 139.55 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.14 0.976 . . . . 72.44 109.114 -178.472 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.534 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -157.9 169.39 24.69 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.98 0.912 . . . . 73.35 110.426 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.31 -41.47 3.0 Favored Glycine 0 C--N 1.352 1.449 0 C-N-CA 123.718 0.675 . . . . 65.24 113.35 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.659 HG23 ' HG2' ' B' ' 9' ' ' MET . 9.5 pt -65.5 153.29 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.388 1.475 . . . . 72.12 113.052 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -151.36 172.37 16.03 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.515 1.126 . . . . 64.35 110.049 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.73 -133.72 32.28 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-N 116.231 -0.44 . . . . 30.11 114.0 177.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.0 m -80.73 -47.27 14.2 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.972 0.909 . . . . 74.44 110.888 -175.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -65.51 -20.73 66.46 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.818 -1.083 . . . . 74.13 111.259 -172.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.576 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 11.0 ttt -52.47 -70.22 0.09 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.29 1.436 . . . . 70.52 112.428 174.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.9 -12.74 60.04 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.427 -0.351 . . . . 51.45 111.489 -175.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -61.87 -41.58 98.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.215 0.606 . . . . 60.12 110.713 167.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 t -64.06 -28.08 69.55 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.291 0.636 . . . . 43.41 112.346 -176.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.714 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.5 pp -103.23 -17.72 15.21 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.352 0.661 . . . . 73.32 111.501 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.11 -4.09 41.58 Favored Glycine 0 N--CA 1.478 1.48 0 N-CA-C 114.201 0.44 . . . . 51.22 114.201 -173.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.87 -49.71 0.52 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.459 0.704 . . . . 63.43 110.362 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -71.15 -39.02 72.19 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 122.7 0.4 . . . . 71.43 111.648 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.714 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 84.5 m -67.72 -47.45 44.48 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-O 118.493 -0.765 . . . . 71.21 111.717 177.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.44 -34.4 41.49 Favored 'Trans proline' 0 C--N 1.394 2.928 0 C-N-CA 122.66 2.24 . . . . 75.32 114.244 167.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -67.41 -35.6 79.59 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.043 0.937 . . . . 73.43 110.563 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.467 HD13 HD11 ' B' ' 13' ' ' ILE . 79.6 mt -68.58 -40.45 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.759 0.824 . . . . 63.5 110.164 173.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 95.5 mt -75.72 -20.97 57.97 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.971 -1.013 . . . . 73.12 112.191 -174.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -61.68 -50.29 82.7 Favored Pre-proline 0 CA--C 1.561 1.376 0 CA-C-O 118.012 -0.994 . . . . 51.33 112.8 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -50.9 -40.38 57.92 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 122.633 2.222 . . . . 63.01 114.145 173.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -67.97 -44.57 76.39 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.518 0.727 . . . . 72.21 110.879 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.67 -34.86 79.29 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.248 0.619 . . . . 63.42 110.829 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.495 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 31.5 ttt180 -66.35 -52.63 45.04 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.219 1.407 . . . . 71.34 110.094 -175.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.478 ' HG3' HH12 ' A' ' 120' ' ' ARG . 12.3 tp10 -65.0 -33.43 76.03 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.033 0.933 . . . . 74.31 110.647 176.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.507 ' SG ' HD11 ' B' ' 21' ' ' ILE . 1.9 t -70.57 -32.57 70.01 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 122.439 -0.163 . . . . 63.44 110.967 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.557 HG21 HG21 ' B' ' 64' ' ' VAL . 66.3 mt -70.56 -57.9 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.277 0.631 . . . . 63.51 109.445 173.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 13.3 m -61.54 -22.96 65.61 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 124.205 0.94 . . . . 64.31 111.346 -173.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.3 t -62.04 -52.7 62.9 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 123.444 0.698 . . . . 73.14 109.851 170.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.574 ' SD ' HD13 ' A' ' 21' ' ' ILE . 12.7 mmt -68.44 -33.39 74.12 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.862 0.865 . . . . 63.33 111.113 -175.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.413 HG21 HD23 ' B' ' 126' ' ' LEU . 86.4 t -65.45 -43.96 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.806 1.242 . . . . 71.04 110.135 173.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.5 t -63.83 -34.87 78.9 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.73 -1.123 . . . . 73.53 110.564 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' B' ' 116' ' ' SER . 77.4 mtt-85 -69.24 -33.31 73.09 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.05 -0.977 . . . . 72.43 110.373 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.37 -15.75 81.25 Favored Glycine 0 C--N 1.356 1.686 0 O-C-N 123.57 0.544 . . . . 73.43 112.389 170.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.416 ' HB ' ' NH2' ' A' ' 15' ' ' ARG . 15.7 m 65.33 37.91 6.08 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.715 1.606 . . . . 71.42 110.261 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -81.5 156.92 70.66 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 114.61 -1.177 . . . . 71.15 109.53 172.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.405 ' HG2' ' O ' ' B' ' 36' ' ' TRP . 88.1 Cg_exo -50.91 163.83 0.71 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.38 2.72 . . . . 74.33 114.48 175.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -59.4 118.25 5.78 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 115.481 -0.782 . . . . 60.45 111.342 -171.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.547 HD13 HG21 ' B' ' 40' ' ' VAL . 54.8 tp -107.62 95.21 5.54 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.614 -0.884 . . . . 70.02 108.614 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -96.55 106.4 18.66 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.998 -1.112 . . . . 73.23 107.998 172.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.747 HD22 HD13 ' B' ' 42' ' ' LEU . 30.4 mt -67.05 134.84 52.68 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 110.135 -0.32 . . . . 61.3 110.135 175.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.71 131.46 94.9 Favored Pre-proline 0 CA--C 1.549 0.914 0 O-C-N 124.106 0.879 . . . . 74.32 110.713 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -61.75 90.79 0.11 Allowed 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.087 2.525 . . . . 64.14 111.618 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 p -90.35 111.69 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.591 -0.731 . . . . 73.14 109.493 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 44.5 t30 . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 107.671 -1.233 . . . . 55.24 107.671 171.984 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.525 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 78.8 t80 . . . . . 0 C--O 1.237 0.438 0 N-CA-C 108.959 -0.756 . . . . 73.34 108.959 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -140.42 128.45 22.13 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.136 -0.69 . . . . 72.04 109.136 174.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 50.2 mt -76.77 128.85 37.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 108.809 -0.811 . . . . 70.53 108.809 172.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -90.15 -49.59 6.48 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.934 -0.765 . . . . 55.32 108.934 172.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.434 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -176.46 153.52 1.18 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.431 1.092 . . . . 62.21 110.049 179.213 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 84.3 mt -127.7 134.92 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.087 1.355 . . . . 71.41 107.71 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.516 ' HE2' ' HD3' ' C' ' 19' ' ' LYS . 42.4 p90 -163.72 174.2 11.94 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.439 0.695 . . . . 64.52 110.288 -164.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.7 p -105.92 116.16 31.46 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 122.988 0.515 . . . . 71.15 109.838 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.516 ' HD3' ' HE2' ' C' ' 17' ' ' TYR . 30.8 mmtp -65.78 -37.97 87.74 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.947 -0.76 . . . . 75.53 108.947 167.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.434 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 13.1 t70 -149.56 147.19 27.87 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 114.482 -1.235 . . . . 73.33 110.4 -174.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.507 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 91.5 mt -139.36 146.11 26.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 106.505 -1.665 . . . . 75.23 106.505 173.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 18.2 t -157.35 148.13 21.37 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 121.064 0.459 . . . . 54.24 110.32 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -156.2 108.56 2.58 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.635 -1.246 . . . . 74.45 107.635 174.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -117.29 112.02 20.18 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 122.92 0.488 . . . . 73.41 110.065 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -121.47 83.05 40.33 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.63 1.172 . . . . 75.21 107.951 169.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.66 -17.82 25.87 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.684 2.256 . . . . 64.53 111.385 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -102.8 12.26 36.45 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.543 1.137 . . . . 74.04 110.543 -178.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.99 -57.9 5.47 Favored Pre-proline 0 C--N 1.374 1.646 0 C-N-CA 124.761 1.224 . . . . 53.41 113.687 -169.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -60.25 -46.62 17.61 Favored 'Trans proline' 0 C--N 1.385 2.484 0 CA-C-N 121.427 1.545 . . . . 73.14 113.143 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -69.41 -29.41 67.14 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.155 -0.929 . . . . 70.02 111.899 -174.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.851 HG21 ' HA ' ' C' ' 73' ' ' ALA . 6.7 p -83.14 -21.14 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 N-CA-C 113.286 0.847 . . . . 63.41 113.286 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -67.9 -18.02 64.66 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 112.517 0.562 . . . . 75.04 112.517 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -100.12 16.25 24.72 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.875 0.87 . . . . 75.14 111.253 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.59 155.54 17.81 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.474 0.71 . . . . 73.32 110.339 -174.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.32 125.07 25.56 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.089 0.556 . . . . 75.33 110.303 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.1 t-105 -83.03 87.97 6.88 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.731 0.812 . . . . 72.42 110.627 -173.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -139.54 75.95 31.31 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 123.932 0.893 . . . . 64.1 108.891 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -82.83 145.03 12.54 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.224 1.949 . . . . 73.32 112.056 -175.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -86.15 89.1 7.73 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 104.849 -2.278 . . . . 74.01 104.849 168.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 58.1 t -78.64 98.33 2.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 114.996 -1.002 . . . . 61.13 109.175 -175.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -97.5 102.31 14.05 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.548 -0.908 . . . . 73.4 108.548 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.411 HD12 ' O ' ' C' ' 42' ' ' LEU . 3.1 pp -87.31 123.5 32.36 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.446 -1.316 . . . . 70.33 107.446 171.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -130.46 143.42 50.75 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.393 -0.966 . . . . 74.4 108.393 -172.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.459 HD13 ' CE1' ' C' ' 133' ' ' PHE . 91.9 mt -131.6 112.64 12.78 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.959 0.504 . . . . 61.14 110.959 -171.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -115.03 126.72 55.05 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 107.46 -1.311 . . . . 74.41 107.46 169.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -116.2 153.93 30.97 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 109.091 -0.707 . . . . 65.43 109.091 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.72 133.4 23.7 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.763 -0.828 . . . . 63.33 108.763 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 32.9 p -144.87 144.79 31.3 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.834 0.453 . . . . 73.54 110.154 -174.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 62.9 p -149.07 152.65 36.56 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.658 0.783 . . . . 72.11 109.872 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -85.43 117.99 24.68 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.043 -1.095 . . . . 71.34 108.043 173.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.698 HD11 ' HB2' ' C' ' 57' ' ' GLU . 31.9 mt -84.64 -40.2 17.73 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.595 0.758 . . . . 73.31 109.689 -176.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.31 -173.73 4.56 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.707 -1.133 . . . . 60.12 109.119 175.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -62.43 126.65 28.07 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.445 -0.798 . . . . 75.44 109.565 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 66.13 -0.72 1.33 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.847 1.259 . . . . 55.14 112.965 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 45.7 t -118.29 111.39 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 109.367 -0.605 . . . . 74.53 109.367 -176.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -113.32 166.62 11.3 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.973 0.909 . . . . 74.31 109.751 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.698 ' HB2' HD11 ' C' ' 51' ' ' LEU . 41.4 tt0 -127.86 144.55 51.09 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.174 0.99 . . . . 72.11 108.734 171.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 82.6 t -131.23 133.73 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 108.182 -1.044 . . . . 70.33 108.182 167.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.488 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 60.2 t -120.25 130.1 74.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 107.66 -1.237 . . . . 71.45 107.66 176.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.454 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -113.18 97.36 6.45 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.742 -1.207 . . . . 51.41 107.742 -176.678 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 7.9 ttm-85 -81.84 110.45 17.15 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.961 -0.755 . . . . 75.32 108.961 173.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.509 ' HB ' HD11 ' C' ' 114' ' ' ILE . 19.4 t -106.68 123.86 61.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.074 -1.084 . . . . 63.41 108.074 173.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 59.6 m -115.03 132.11 56.71 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.026 -1.102 . . . . 72.4 108.026 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.491 HG21 HG21 ' C' ' 114' ' ' ILE . 89.0 t -121.28 116.95 51.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 109.141 -0.689 . . . . 75.24 109.141 176.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 12.5 m -101.76 139.04 37.95 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.635 -0.876 . . . . 73.11 108.635 173.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.57 105.72 4.58 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.607 -0.886 . . . . 62.12 108.607 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 36.9 m -127.04 133.54 50.47 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.356 0.662 . . . . 71.35 109.705 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 11.3 mt -91.04 15.0 12.43 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.988 1.315 . . . . 64.41 111.474 -176.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 145.25 -110.46 0.55 Allowed Glycine 0 C--N 1.351 1.377 0 N-CA-C 110.026 -1.229 . . . . 44.23 110.026 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -88.74 -27.25 21.3 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.523 0.729 . . . . 72.34 109.088 169.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -74.55 119.47 18.79 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 124.438 1.095 . . . . 74.21 109.492 175.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 53.4 m -84.29 124.41 31.22 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.994 -0.743 . . . . 75.31 108.994 169.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.851 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -70.07 -54.86 11.24 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.462 0.705 . . . . 52.03 109.457 176.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -163.85 163.24 23.86 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.101 -0.954 . . . . 73.04 110.906 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.41 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.5 tm? -126.94 141.25 51.85 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 106.635 -1.617 . . . . 64.11 106.635 167.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.45 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.9 t -141.17 150.72 43.12 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.976 -0.749 . . . . 52.03 108.976 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -158.18 136.45 10.89 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.321 0.648 . . . . 65.33 109.853 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -135.82 114.21 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 124.496 1.118 . . . . 64.1 108.201 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.415 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 68.7 mt-30 -94.19 88.25 5.54 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.562 -0.903 . . . . 74.5 108.562 173.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -81.01 95.51 6.83 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.243 -0.89 . . . . 75.22 109.743 -176.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -83.58 149.1 25.53 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 116.016 -0.538 . . . . 31.25 112.23 178.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.08 125.49 1.79 Allowed Glycine 0 CA--C 1.505 -0.586 0 N-CA-C 111.143 -0.783 . . . . 71.44 111.143 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.581 HD11 ' HB3' ' D' ' 29' ' ' PRO . 26.4 mm -85.29 130.8 35.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 N-CA-C 108.475 -0.935 . . . . 64.15 108.475 175.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -135.75 118.76 16.38 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.474 0.71 . . . . 74.23 109.977 -178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 64.7 m -76.87 102.44 6.34 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.898 -0.778 . . . . 64.53 108.898 171.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.632 HG21 ' HE1' ' C' ' 94' ' ' MET . 22.3 mt -116.95 137.87 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 108.69 -0.855 . . . . 74.12 108.69 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.44 169.82 17.59 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.355 0.662 . . . . 64.52 109.309 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.62 -15.5 61.37 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 114.881 0.713 . . . . 75.11 114.881 169.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.449 HD11 ' HE1' ' C' ' 94' ' ' MET . 27.6 pt -117.14 169.66 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-N 117.762 0.781 . . . . 74.02 111.561 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -159.97 152.03 20.51 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.289 -0.869 . . . . 73.11 109.995 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.67 -126.86 9.28 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 123.524 0.515 . . . . 70.44 113.345 172.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 35.5 p -67.37 -26.01 66.25 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.129 0.971 . . . . 61.54 111.828 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -65.57 -52.92 48.7 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.692 0.797 . . . . 70.31 109.711 174.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.632 ' HE1' HG21 ' C' ' 86' ' ' ILE . 5.5 tpt -54.14 -48.7 70.55 Favored 'General case' 0 C--N 1.353 0.72 0 CA-C-N 114.916 -1.038 . . . . 73.2 112.096 172.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.84 83.07 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.313 0.645 . . . . 61.22 111.181 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -68.05 -34.23 76.06 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.257 -0.883 . . . . 74.32 111.342 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.448 ' SG ' HD13 ' C' ' 86' ' ' ILE . 33.7 t -72.86 -42.08 64.08 Favored 'General case' 0 C--N 1.347 0.488 0 N-CA-C 109.392 -0.595 . . . . 74.22 109.392 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 92.3 mt -77.46 -28.79 52.47 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.959 0.904 . . . . 63.25 112.518 -175.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -114.44 11.1 21.73 Favored Glycine 0 N--CA 1.477 1.423 0 CA-C-O 119.597 -0.557 . . . . 55.25 114.27 -170.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.22 -55.05 0.12 Allowed 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 117.52 0.66 . . . . 55.44 111.846 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -70.4 -55.25 9.53 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.061 0.544 . . . . 73.32 111.705 -173.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.525 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 50.3 m -68.31 -43.92 34.63 Favored Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 123.764 0.826 . . . . 70.25 112.454 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.454 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 72.6 Cg_exo -55.62 -27.58 61.15 Favored 'Trans proline' 0 C--N 1.399 3.188 0 C-N-CA 122.402 2.068 . . . . 71.13 114.182 172.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -67.67 -35.42 78.82 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.328 0.651 . . . . 72.1 110.75 176.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.463 HD12 ' NH1' ' A' ' 111' ' ' ARG . 49.7 mm -75.71 -32.42 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.358 0.663 . . . . 74.43 110.212 177.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.75 -28.79 55.86 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.867 0.867 . . . . 54.24 111.79 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -56.78 -48.78 96.69 Favored Pre-proline 0 N--CA 1.482 1.175 0 N-CA-C 114.458 1.281 . . . . 71.13 114.458 -173.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.63 -38.69 92.64 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 121.895 1.73 . . . . 73.0 113.119 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -67.54 -43.56 80.41 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.832 0.853 . . . . 74.14 110.671 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.402 ' O ' HG13 ' C' ' 114' ' ' ILE . . . -65.22 -39.6 92.98 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.548 -0.751 . . . . 75.24 110.338 176.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -59.65 -49.89 75.97 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.205 1.402 . . . . 73.43 110.527 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.74 -37.8 88.83 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 123.944 0.778 . . . . 75.42 109.727 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.7 t -69.54 -33.13 72.35 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.176 0.59 . . . . 72.43 111.593 -176.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.509 HD11 ' HB ' ' C' ' 62' ' ' VAL . 88.2 mt -71.98 -51.91 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.236 0.614 . . . . 53.03 109.54 176.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.2 m -67.24 -29.23 68.81 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 123.695 0.622 . . . . 75.42 111.193 -175.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 48.3 t -63.47 -46.53 85.8 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.523 0.729 . . . . 74.34 109.077 172.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.532 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.53 -35.46 81.03 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.018 0.927 . . . . 62.53 112.32 178.105 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' C' ' 123' ' ' PHE . 95.4 t -68.85 -36.63 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.346 0.658 . . . . 53.21 109.71 174.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.0 t -71.13 -32.31 68.83 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.18 0.992 . . . . 64.43 111.447 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' C' ' 116' ' ' SER . 81.2 mtt-85 -73.3 -39.19 65.52 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.17 -0.678 . . . . 53.04 109.17 177.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.49 -3.72 78.59 Favored Glycine 0 C--N 1.353 1.488 0 O-C-N 123.928 0.767 . . . . 51.33 112.663 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 25.7 p 63.11 28.66 16.11 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 126.797 2.039 . . . . 64.55 113.627 170.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.427 ' HB2' HG13 ' C' ' 118' ' ' VAL . 94.8 m-85 -82.62 161.22 59.58 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.663 0.785 . . . . 72.33 109.077 169.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -51.91 140.94 47.51 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.815 2.343 . . . . 74.51 112.817 172.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -55.35 109.17 0.5 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.312 1.045 . . . . 71.11 112.323 -175.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 56.4 tp -112.02 88.43 2.81 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.318 -0.623 . . . . 71.0 109.318 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -90.54 123.04 33.89 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.783 -0.821 . . . . 73.24 108.783 177.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.67 140.55 51.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.659 0.784 . . . . 73.51 110.781 -176.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.95 155.17 82.91 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 115.33 -0.85 . . . . 71.24 111.058 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.658 ' HG2' HG21 ' A' ' 13' ' ' ILE . 39.6 Cg_exo -55.55 106.99 0.21 Allowed 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.995 2.463 . . . . 61.43 112.132 173.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 18.3 t -99.6 120.59 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 108.361 -0.977 . . . . 74.33 108.361 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 132' ' ' ASN . . . . . 0.406 ' O ' ' HG ' ' C' ' 136' ' ' LEU . 56.5 t-20 -79.53 100.9 7.96 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.82 0.848 . . . . 75.55 109.751 -176.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 133' ' ' PHE . . . . . 0.459 ' CE1' HD13 ' C' ' 44' ' ' LEU . 93.6 m-85 -66.47 -29.13 69.19 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.826 0.85 . . . . 63.24 112.48 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -64.28 -42.79 96.25 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.341 0.657 . . . . 65.22 109.605 176.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.42 -36.38 81.15 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.229 -0.896 . . . . 75.4 110.858 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 136' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' C' ' 132' ' ' ASN . 54.0 mt -66.63 -38.9 87.88 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.902 0.481 . . . . 73.45 110.779 177.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 38.1 t80 . . . . . 0 CA--C 1.546 0.817 0 CA-C-N 115.367 -0.833 . . . . 65.14 110.41 179.524 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 C--O 1.244 0.785 0 CA-C-O 121.296 0.57 . . . . 63.34 110.855 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.438 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 69.8 t80 -138.91 106.3 5.54 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 106.418 -1.697 . . . . 74.45 106.418 175.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 12' ' ' GLN . . . . . 0.483 ' HB2' ' OG ' ' D' ' 85' ' ' SER . 41.9 mt-30 -119.6 116.89 26.94 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.409 -0.589 . . . . 65.33 109.409 -175.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.556 HG21 HD11 ' D' ' 16' ' ' ILE . 63.1 mt -78.94 118.77 26.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.29 -1.004 . . . . 53.43 108.29 174.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 14' ' ' GLN . . . . . 0.486 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 8.5 mm-40 -95.84 -39.71 9.69 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.433 0.293 . . . . 62.11 110.474 -174.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -173.36 137.87 0.68 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.699 0.4 . . . . 74.33 110.166 -176.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.556 HD11 HG21 ' D' ' 13' ' ' ILE . 3.5 mp -115.09 142.4 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 107.195 -1.409 . . . . 65.11 107.195 172.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -163.12 147.27 11.08 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.305 0.642 . . . . 61.23 110.866 175.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.6 p -82.59 114.39 20.95 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.059 -0.973 . . . . 74.33 109.39 175.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -87.24 -15.76 37.23 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.919 0.888 . . . . 64.34 109.634 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.675 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.9 t70 -163.34 130.85 3.54 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.81 1.244 . . . . 63.23 109.081 -177.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.532 HG21 ' HE2' ' C' ' 117' ' ' MET . 76.2 mt -134.56 142.86 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.225 -1.028 . . . . 72.51 108.225 173.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.9 t -143.17 137.25 28.91 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.502 1.121 . . . . 54.33 108.556 172.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.507 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.1 t80 -135.44 121.44 19.96 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.134 -1.802 . . . . 75.23 106.134 166.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 40.5 mt-10 -127.08 110.49 12.98 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.662 0.785 . . . . 73.35 109.054 -177.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.99 89.14 3.45 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 107.761 -1.199 . . . . 40.42 107.761 171.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -71.46 -37.74 5.28 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.596 2.197 . . . . 71.0 112.314 -174.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -99.44 4.55 46.19 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.085 0.954 . . . . 74.42 110.367 -174.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.404 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -25.14 -70.22 0.05 OUTLIER Pre-proline 0 CA--C 1.564 1.514 0 C-N-CA 127.471 2.309 . . . . 74.24 116.62 -166.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.581 ' HB3' HD11 ' C' ' 83' ' ' ILE . 76.7 Cg_endo -76.99 -19.76 13.58 Favored 'Trans proline' 0 C--N 1.382 2.291 0 CA-C-N 123.293 2.212 . . . . 72.43 113.95 -171.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -78.56 -38.55 40.05 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.274 1.03 . . . . 72.24 109.922 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.746 HG21 ' HA ' ' D' ' 73' ' ' ALA . 11.1 p -82.8 -19.53 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 CA-C-N 115.61 -0.723 . . . . 65.24 111.574 -171.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -62.9 -23.39 67.33 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 112.558 0.577 . . . . 74.44 112.558 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -57.1 -31.1 64.92 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.346 1.058 . . . . 74.54 110.668 177.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -84.92 78.93 9.8 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.905 1.282 . . . . 71.21 110.047 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -79.87 83.79 5.75 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 121.684 0.754 . . . . 70.44 110.698 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -157.77 -179.08 7.81 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.508 -0.923 . . . . 73.41 108.508 167.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -64.02 114.48 13.89 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 123.771 0.828 . . . . 71.34 110.693 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.434 ' O ' HG23 ' D' ' 40' ' ' VAL . 60.5 Cg_exo -56.46 122.69 12.24 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 121.897 1.732 . . . . 72.34 110.677 171.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -66.43 110.58 3.17 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 107.391 -1.337 . . . . 74.34 107.391 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.728 HG21 HD13 ' D' ' 126' ' ' LEU . 85.2 t -100.82 136.71 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.987 0.915 . . . . 74.54 110.845 -170.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -111.0 119.34 38.73 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.507 -0.923 . . . . 60.31 108.507 167.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 63.2 tp -96.94 143.23 28.01 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.194 -0.669 . . . . 73.2 109.194 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.509 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 31.5 t70 -142.15 144.14 33.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.041 -0.981 . . . . 61.12 108.575 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 72.8 mt -134.65 133.89 40.58 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.393 -0.965 . . . . 65.43 108.393 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 16.4 t70 -134.04 151.18 51.32 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.847 1.259 . . . . 70.13 107.764 177.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.22 163.58 14.19 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.506 0.67 . . . . 72.43 111.396 -175.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -167.25 147.7 5.48 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 113.84 -1.527 . . . . 75.43 107.382 169.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 29.0 p . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.835 -0.431 . . . . 54.45 109.835 171.877 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' D' D ' 54' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' D' ' 85' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 113.419 0.896 . . . . 61.2 113.419 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.96 105.52 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 108.869 -0.789 . . . . 64.43 108.869 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -132.19 131.62 42.37 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.228 0.611 . . . . 74.44 110.478 -174.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.699 ' HG2' HG13 ' D' ' 83' ' ' ILE . 53.4 mt-10 -90.11 111.68 22.89 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.897 -0.779 . . . . 73.34 108.897 168.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 84.1 t -100.85 135.91 34.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 O-C-N 124.112 0.882 . . . . 73.3 109.379 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.527 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 47.2 t -122.78 133.96 67.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.033 1.333 . . . . 54.24 108.199 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.475 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -113.82 117.44 31.45 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.506 -1.294 . . . . 70.41 107.506 174.908 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.416 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 50.0 ttm-85 -93.87 95.02 8.83 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.419 -1.326 . . . . 70.11 107.419 174.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 49.0 t -91.11 144.13 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.44 -0.948 . . . . 72.33 108.44 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 36.0 m -139.87 141.25 36.61 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.036 -0.727 . . . . 62.13 109.036 -176.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.644 HG13 HG13 ' D' ' 40' ' ' VAL . 50.5 t -132.97 128.66 56.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 124.465 1.106 . . . . 75.14 108.49 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 56.6 m -125.01 93.37 3.87 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.371 -1.344 . . . . 65.4 107.371 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -95.71 154.59 17.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.941 -0.763 . . . . 74.42 108.941 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 28.7 p -153.37 132.56 12.67 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 123.331 0.394 . . . . 75.1 110.878 -173.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.496 HD12 HG22 ' D' ' 31' ' ' VAL . 52.1 mt -105.42 112.42 25.52 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.167 -1.049 . . . . 73.21 108.167 174.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.88 -133.42 15.3 Favored Glycine 0 C--N 1.345 1.057 0 O-C-N 123.38 0.425 . . . . 74.34 112.563 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.77 2.5 56.72 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.969 0.507 . . . . 75.4 111.758 -178.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -123.3 160.89 25.73 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.207 0.603 . . . . 74.54 110.528 -176.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 94.6 m -64.59 140.51 58.87 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.108 0.963 . . . . 72.34 110.992 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.746 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -92.33 -62.49 1.39 Allowed 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.855 -1.165 . . . . 74.14 107.855 172.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.84 165.78 35.55 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 114.347 -1.297 . . . . 64.14 109.937 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 87.5 mt -132.32 153.02 51.14 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.616 1.566 . . . . 54.35 107.257 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.652 ' SG ' HG12 ' D' ' 114' ' ' ILE . 53.0 t -158.61 145.1 17.2 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.747 0.419 . . . . 52.13 110.168 -177.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -154.54 126.8 7.84 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 123.103 0.561 . . . . 73.11 110.168 172.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 95.3 t -128.76 116.69 42.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 124.033 0.933 . . . . 75.1 109.059 -178.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.675 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.5 mt-30 -87.98 86.32 7.11 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.899 0.857 . . . . 64.53 108.863 168.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -82.46 97.9 8.63 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 113.831 -1.531 . . . . 73.11 109.394 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -96.2 166.62 24.58 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-N 116.48 -0.327 . . . . 60.11 112.706 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.7 153.26 12.97 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-O 119.837 -0.424 . . . . 63.22 112.783 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.699 HG13 ' HG2' ' D' ' 57' ' ' GLU . 3.0 mp -94.24 128.6 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 108.083 -1.08 . . . . 71.13 108.083 176.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -131.35 124.59 30.7 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.165 -1.05 . . . . 73.42 108.165 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' D' ' 54' ' ' ASP . 51.4 p -95.92 126.43 41.17 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 109.06 -0.719 . . . . 75.12 109.06 174.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 31.2 pt -133.61 129.39 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.452 -0.944 . . . . 74.43 108.452 -170.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.07 167.93 28.98 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.263 0.225 . . . . 63.1 111.18 -171.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.03 23.43 71.77 Favored Glycine 0 C--N 1.353 1.485 0 O-C-N 124.122 0.888 . . . . 74.02 114.484 171.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.673 HD13 ' HA ' ' D' ' 94' ' ' MET . 0.7 OUTLIER -133.54 155.45 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.158 0.583 . . . . 70.54 110.593 177.637 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.33 177.19 8.1 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.824 -1.08 . . . . 73.22 109.506 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.79 -140.78 25.49 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 123.29 0.368 . . . . 42.12 113.108 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 81.8 p -77.32 -43.09 34.3 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.772 0.829 . . . . 50.34 111.107 -175.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -57.96 -33.36 68.76 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.34 1.056 . . . . 74.21 111.771 -177.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.673 ' HA ' HD13 ' D' ' 89' ' ' ILE . 1.6 tmt? -47.56 -60.66 2.38 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.522 1.529 . . . . 74.44 112.729 -176.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.15 -15.7 46.19 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.204 0.601 . . . . 60.11 112.034 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -76.95 -17.52 58.85 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 122.859 0.464 . . . . 71.24 111.895 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 71.5 m -60.7 -44.26 96.77 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.586 0.354 . . . . 75.44 111.135 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.504 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 4.3 pp -79.27 -30.35 43.0 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.1 0.56 . . . . 75.25 111.816 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.55 -29.09 25.24 Favored Glycine 0 C--N 1.35 1.335 0 O-C-N 123.247 0.342 . . . . 55.44 113.669 -172.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.42 -57.12 2.02 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.447 0.699 . . . . 61.11 111.336 -171.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -72.87 -38.96 66.83 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 112.225 0.454 . . . . 61.4 112.225 -171.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.504 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 72.1 m -66.97 -46.1 53.58 Favored Pre-proline 0 CA--C 1.567 1.609 0 CA-C-O 118.679 -0.677 . . . . 71.44 111.937 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.475 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.4 Cg_exo -59.54 -32.0 95.46 Favored 'Trans proline' 0 C--N 1.393 2.913 0 C-N-CA 122.016 1.81 . . . . 73.51 112.911 169.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -64.63 -29.02 70.02 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.076 0.55 . . . . 71.22 111.125 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.407 ' O ' ' HD2' ' D' ' 108' ' ' PRO . 46.2 mm -78.23 -33.86 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.812 0.845 . . . . 73.1 110.786 174.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 65.3 mt -74.63 -18.79 60.49 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.24 0.616 . . . . 74.13 111.752 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -66.28 -45.81 60.63 Favored Pre-proline 0 CA--C 1.559 1.315 0 CA-C-O 118.195 -0.907 . . . . 75.31 113.306 -176.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 108' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' D' ' 105' ' ' ILE . 81.7 Cg_exo -52.37 -42.57 59.95 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.371 2.047 . . . . 72.32 114.323 171.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -71.99 -40.44 68.55 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.554 0.742 . . . . 70.35 111.49 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.03 -44.72 91.71 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.623 -0.717 . . . . 73.55 109.912 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.522 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 27.3 ttp180 -57.72 -49.1 77.66 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.74 1.275 . . . . 70.41 110.311 178.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -58.71 -49.02 79.12 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.373 1.045 . . . . 74.34 110.45 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 43.1 t -57.26 -45.64 83.8 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 124.031 0.832 . . . . 54.01 111.186 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.652 HG12 ' SG ' ' D' ' 76' ' ' CYS . 89.0 mt -61.17 -55.94 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.772 0.829 . . . . 74.32 110.673 175.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 90.7 m -52.86 -42.3 65.1 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 124.764 1.226 . . . . 72.25 111.088 -174.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 29.9 t -66.69 -43.14 85.18 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.492 -1.231 . . . . 44.44 109.863 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.6 mtm -70.69 -26.93 63.65 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.056 0.543 . . . . 32.03 111.941 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.472 HG21 ' HB3' ' D' ' 126' ' ' LEU . 79.8 t -64.73 -47.75 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.384 0.674 . . . . 71.42 109.38 173.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.9 p -72.82 -28.94 62.86 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.569 -0.741 . . . . 75.01 110.559 -178.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' D' ' 116' ' ' SER . 76.4 mtt-85 -71.16 -27.17 63.34 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.757 0.823 . . . . 73.14 110.097 173.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.46 8.87 79.11 Favored Glycine 0 C--N 1.351 1.398 0 CA-C-O 119.354 -0.692 . . . . 34.24 112.615 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.404 HG23 ' HB3' ' C' ' 17' ' ' TYR . 69.7 p 55.88 40.81 30.54 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.781 1.632 . . . . 64.54 113.761 177.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -105.93 152.95 40.4 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 109.001 -0.74 . . . . 75.33 109.001 170.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -48.91 133.46 28.08 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.024 2.483 . . . . 73.4 112.141 171.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -55.78 128.6 35.7 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 124.308 1.005 . . . . 75.04 112.389 -170.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.728 HD13 HG21 ' D' ' 40' ' ' VAL . 14.2 tp -111.23 102.57 10.98 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.139 0.976 . . . . 70.41 108.973 -176.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -100.9 104.39 15.59 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.647 -1.242 . . . . 53.1 107.647 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.522 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.2 mm? -64.32 114.75 4.47 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.189 0.595 . . . . 75.4 109.806 -177.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.14 132.76 93.94 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 123.105 0.562 . . . . 75.34 111.023 -174.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -61.43 116.66 3.55 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.06 2.507 . . . . 73.32 112.357 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p -110.54 136.1 47.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 N-CA-C 108.901 -0.777 . . . . 73.41 108.901 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -80.65 113.13 18.63 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.798 -0.816 . . . . 55.21 108.798 176.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 124.027 0.931 . . . . 71.22 110.952 -177.326 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 mmt . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 108.773 -0.825 . . . . 74.34 108.773 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.0 m -143.44 97.4 3.07 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.004 0.521 . . . . 72.34 109.828 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -67.63 118.09 10.45 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.108 0.563 . . . . 75.53 109.587 176.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -108.61 81.6 1.49 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.585 0.754 . . . . 74.13 109.669 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -76.86 142.29 40.27 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.512 -0.767 . . . . 75.12 109.986 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -87.89 116.02 25.76 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.751 0.82 . . . . 74.32 108.907 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.0 p -126.62 161.78 27.25 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.026 0.93 . . . . 74.43 110.797 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 66.2 45.19 2.36 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.073 1.349 . . . . 74.43 112.201 172.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -83.94 167.49 16.91 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.657 0.741 . . . . 62.3 111.542 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.8 m -140.12 126.03 19.55 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 106.942 -1.503 . . . . 75.44 106.942 164.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -137.32 121.11 17.48 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.752 -1.203 . . . . 72.45 107.752 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -143.02 110.82 5.91 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.157 -0.683 . . . . 62.25 109.157 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.9 mt -70.39 114.39 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.317 -0.623 . . . . 72.13 109.317 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -82.18 -39.93 22.47 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.653 0.595 . . . . 70.1 110.206 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -175.06 122.42 0.23 Allowed 'General case' 0 N--CA 1.481 1.098 0 O-C-N 123.608 0.568 . . . . 72.42 110.862 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 97.0 mt -106.21 136.0 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.378 -0.971 . . . . 73.15 108.378 171.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.532 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 30.7 p90 -166.78 164.93 16.54 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 123.843 0.714 . . . . 72.05 111.196 -174.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.3 p -88.33 124.0 33.47 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.77 -0.456 . . . . 55.15 109.77 175.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -90.85 -36.94 13.91 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.891 -0.781 . . . . 73.24 108.891 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.713 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 24.7 t70 -138.8 136.84 36.09 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.982 -1.008 . . . . 63.4 109.125 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 76.4 mt -130.88 142.62 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.804 1.242 . . . . 71.32 107.818 173.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.2 t -149.44 116.6 6.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.394 0.678 . . . . 65.13 109.983 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.707 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.1 t80 -122.79 136.69 54.95 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.472 -1.307 . . . . 63.23 107.472 168.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -133.47 129.55 37.37 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.196 0.598 . . . . 73.22 110.088 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.47 69.87 12.65 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 105.852 -1.907 . . . . 14.42 105.852 167.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.07 -16.58 17.83 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.325 2.017 . . . . 52.53 111.124 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -94.71 9.43 38.94 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.651 1.18 . . . . 74.5 110.369 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -47.66 -58.53 7.4 Favored Pre-proline 0 CA--C 1.569 1.698 0 C-N-CA 124.785 1.234 . . . . 73.25 113.853 -165.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.478 ' HB3' HD11 ' B' ' 51' ' ' LEU . 69.4 Cg_exo -51.85 -44.56 44.17 Favored 'Trans proline' 0 C--N 1.398 3.152 0 C-N-CA 122.715 2.277 . . . . 73.21 113.856 -173.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -96.18 -13.03 23.81 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.485 -0.78 . . . . 72.11 112.205 -174.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.472 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.4 p -77.45 -15.86 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 120.869 0.366 . . . . 74.51 110.708 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -77.41 -22.39 51.63 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.299 0.64 . . . . 74.12 110.904 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -77.62 -23.79 49.73 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.921 0.889 . . . . 75.2 110.283 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 71' ' ' GLU . 30.3 mmmt -65.64 144.93 56.63 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.22 1.008 . . . . 72.32 111.94 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -60.47 117.72 5.61 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.661 -0.866 . . . . 70.25 108.661 168.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.415 ' CE3' HD21 ' A' ' 68' ' ' LEU . 70.6 t-105 -75.6 84.68 2.65 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.676 0.75 . . . . 74.51 110.022 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.74 78.32 74.0 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 105.882 -1.896 . . . . 63.45 105.882 169.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -81.93 140.67 11.52 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.665 2.243 . . . . 73.44 111.908 -173.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -97.66 83.78 3.27 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.072 -1.455 . . . . 63.33 107.072 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 66' ' ' ALA . 58.0 t -81.96 119.16 30.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 CA-C-N 114.745 -1.116 . . . . 63.25 109.549 -174.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.437 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 74.0 mttt -113.86 113.57 25.06 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.237 1.015 . . . . 74.31 108.467 -170.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -98.43 121.16 40.02 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 108.294 -1.002 . . . . 71.33 108.294 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -130.43 138.57 50.39 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.39 1.076 . . . . 70.22 108.265 -176.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.525 HD22 HD21 ' A' ' 60' ' ' LEU . 88.3 mt -128.89 140.14 51.82 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.939 0.496 . . . . 53.02 110.95 -173.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.52 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 27.7 t70 -142.9 146.19 33.8 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.465 1.106 . . . . 74.02 108.742 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.2 m -131.8 128.85 39.63 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.117 0.567 . . . . 74.45 110.076 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.71 110.04 10.11 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.66 0.784 . . . . 62.13 109.151 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.4 p -90.68 161.23 15.47 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 109.512 -0.551 . . . . 51.01 109.512 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.4 t -152.97 121.17 6.21 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.966 0.906 . . . . 54.21 108.702 -172.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -79.72 104.23 10.17 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.589 -0.893 . . . . 73.43 108.589 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.6 mt -81.83 -35.58 29.25 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.893 0.477 . . . . 53.31 109.96 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.45 -176.47 5.08 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.628 0.771 . . . . 32.31 110.391 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.68 113.95 4.1 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.501 0.72 . . . . 74.2 110.181 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 66.27 17.89 10.8 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.629 1.172 . . . . 52.13 111.609 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.5 t -119.69 106.85 19.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 107.73 -1.211 . . . . 63.31 107.73 173.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -123.12 125.49 45.25 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.29 -1.004 . . . . 64.42 108.29 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -86.35 139.48 30.93 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.46 -0.941 . . . . 74.32 108.46 168.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.1 t -120.17 140.93 42.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.02 -1.104 . . . . 71.31 108.02 171.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.8 t -121.07 130.26 74.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.515 -0.92 . . . . 73.31 108.515 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.525 HD21 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -105.13 107.88 19.1 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.875 -1.528 . . . . 71.33 106.875 177.386 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.52 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 32.1 ttp180 -92.35 99.66 12.38 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.224 -1.399 . . . . 75.25 107.224 174.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.27 127.98 47.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 107.689 -1.226 . . . . 74.11 107.689 174.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.411 HG23 ' HB2' ' A' ' 77' ' ' GLU . 7.5 m -121.05 125.08 46.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.402 0.62 . . . . 53.43 109.672 175.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.663 HG11 HD21 ' A' ' 126' ' ' LEU . 58.9 t -116.23 125.12 73.15 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 C-N-CA 124.962 1.305 . . . . 73.11 107.567 177.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.437 ' HB ' ' HD2' ' A' ' 41' ' ' LYS . 13.8 m -127.75 127.07 42.98 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.155 0.889 . . . . 61.13 109.629 172.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.485 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -118.07 126.46 52.32 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.346 -0.983 . . . . 71.25 108.346 178.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 35.2 m -130.24 132.82 46.13 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.461 0.704 . . . . 61.23 110.352 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.415 HD21 ' CE3' ' A' ' 36' ' ' TRP . 12.6 mt -93.08 70.35 4.52 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 125.26 1.424 . . . . 73.01 109.058 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.8 -107.03 2.36 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-N 115.595 -0.73 . . . . 51.45 111.404 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.1 -26.77 17.31 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.551 0.74 . . . . 54.14 111.216 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.42 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 6.3 tp10 -93.81 123.9 37.46 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.587 0.755 . . . . 71.31 109.001 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 89.8 m -75.82 136.79 40.21 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 117.744 0.247 . . . . 65.43 110.57 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.472 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -74.34 -64.83 0.94 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.763 -0.828 . . . . 41.03 108.763 174.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.452 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 31.6 p90 -158.94 170.31 22.38 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.325 -0.852 . . . . 61.42 112.002 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 64' ' ' VAL . 57.2 tp -125.28 135.83 52.9 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.91 1.284 . . . . 64.14 107.831 167.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.45 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 73.7 m -135.4 97.75 3.78 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.692 0.797 . . . . 64.41 110.249 174.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.411 ' HB2' HG23 ' A' ' 63' ' ' THR . 34.9 tt0 -117.66 118.26 31.61 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.112 0.965 . . . . 72.15 108.543 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.9 t -127.68 121.82 57.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 109.134 -0.691 . . . . 62.4 109.134 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.713 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.2 mt-30 -92.79 86.37 5.49 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.275 -0.875 . . . . 72.14 108.865 173.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 -76.71 99.37 5.06 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 113.786 -1.552 . . . . 73.24 109.469 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.14 159.73 32.85 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 111.419 -0.672 . . . . 34.22 111.419 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.437 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -161.02 122.45 1.12 Allowed Glycine 0 CA--C 1.498 -0.987 0 N-CA-C 110.336 -1.106 . . . . 55.31 110.336 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.6 mt -78.72 124.65 37.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 N-CA-C 107.337 -1.357 . . . . 74.41 107.337 173.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -123.79 160.04 28.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.884 -0.784 . . . . 72.12 108.884 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.6 t -117.75 101.57 8.43 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.349 -1.352 . . . . 54.4 107.349 173.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.0 mm -107.72 145.4 15.03 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 O-C-N 123.736 0.647 . . . . 75.44 110.249 -176.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.51 177.25 8.28 Favored 'General case' 0 C--O 1.231 0.116 0 O-C-N 123.761 0.663 . . . . 73.43 110.971 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.93 -27.18 11.61 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-N 116.061 -0.518 . . . . 53.1 113.047 176.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.45 148.19 24.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 C-N-CA 123.772 0.829 . . . . 70.24 110.808 -171.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.599 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 2.3 mp0 -135.9 175.42 9.61 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.915 0.886 . . . . 73.53 109.952 176.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.12 -119.77 9.88 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-N 115.341 -0.845 . . . . 74.52 113.497 174.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.5 p -73.2 -30.21 63.37 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.114 0.966 . . . . 54.12 110.448 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -74.66 -36.52 62.83 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.14 -0.937 . . . . 62.23 109.852 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.599 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 2.6 tpt -61.22 -44.78 96.72 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.295 0.638 . . . . 73.41 109.75 172.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.4 -29.48 69.0 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.269 -0.878 . . . . 55.51 111.271 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.506 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 54.0 t-80 -71.88 -27.66 63.01 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.288 0.635 . . . . 73.12 111.068 176.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 37.1 t -79.55 -60.73 2.24 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.147 -0.686 . . . . 73.15 109.147 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 78.5 mt -67.92 -34.15 76.06 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.03 0.932 . . . . 71.51 113.196 -172.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.87 3.46 52.5 Favored Glycine 0 N--CA 1.47 0.963 0 CA-C-O 119.688 -0.506 . . . . 73.4 113.775 -173.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.563 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -140.14 -70.47 0.39 Allowed 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 117.348 0.574 . . . . 62.15 111.332 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -67.69 -39.19 84.46 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 111.879 0.325 . . . . 64.22 111.879 -171.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 63.5 m -66.68 -53.35 28.87 Favored Pre-proline 0 CA--C 1.564 1.492 0 C-N-CA 124.566 1.146 . . . . 65.05 112.164 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.431 ' HA ' HD12 ' A' ' 106' ' ' LEU . 58.2 Cg_endo -68.35 -18.89 44.2 Favored 'Trans proline' 0 C--N 1.399 3.219 0 C-N-CA 121.965 1.777 . . . . 73.11 112.616 175.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.449 ' ND2' ' HA ' ' E' ' 145' ' ' ASP . 0.1 OUTLIER -67.4 -47.24 70.87 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.934 -0.765 . . . . 72.05 108.934 174.74 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.3 mm -59.56 -33.45 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.758 1.223 . . . . 71.04 111.299 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.437 HD21 ' HA3' ' A' ' 82' ' ' GLY . 49.3 mt -79.86 -18.8 49.85 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.315 0.646 . . . . 71.04 112.153 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -66.51 -40.55 34.14 Favored Pre-proline 0 CA--C 1.558 1.251 0 N-CA-C 114.737 1.384 . . . . 75.03 114.737 -172.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.5 -37.71 94.72 Favored 'Trans proline' 0 C--N 1.389 2.69 0 C-N-CA 121.998 1.798 . . . . 74.43 112.757 173.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -82.32 -35.2 28.16 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.098 -0.955 . . . . 75.43 111.022 -175.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.73 -49.39 73.24 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.157 -0.683 . . . . 64.04 109.157 174.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.518 ' NH1' HD12 ' C' ' 105' ' ' ILE . 32.3 ttm180 -49.86 -55.14 15.43 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 125.19 1.556 . . . . 64.13 110.511 174.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.85 -42.57 94.79 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.25 0.969 . . . . 64.32 111.686 -173.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 117' ' ' MET . 48.7 t -60.45 -40.79 92.44 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 123.5 0.5 . . . . 53.54 110.795 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.464 HG21 HG21 ' A' ' 64' ' ' VAL . 63.2 mt -64.58 -50.34 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.224 1.01 . . . . 75.4 110.597 174.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.446 HG21 ' HE2' ' C' ' 109' ' ' TYR . 82.9 m -58.03 -44.62 87.44 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.367 1.067 . . . . 74.4 111.245 -174.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 24.0 t -65.69 -40.74 92.64 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.329 -1.305 . . . . 74.22 110.21 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.707 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 38.0 mtm -64.07 -41.28 97.39 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.61 0.364 . . . . 73.13 111.034 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.409 HG13 ' HB2' ' A' ' 123' ' ' PHE . 79.3 t -61.58 -45.37 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 O-C-N 124.051 0.844 . . . . 65.0 110.587 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.3 p -71.91 -32.76 67.69 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.014 0.525 . . . . 73.21 111.273 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.463 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.5 mtt-85 -69.96 -30.88 68.35 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.271 0.629 . . . . 73.21 109.704 174.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.99 12.72 57.16 Favored Glycine 0 C--N 1.355 1.604 0 O-C-N 123.905 0.753 . . . . 51.25 112.861 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.402 HG21 ' HE ' ' B' ' 15' ' ' ARG . 1.5 t 62.19 14.19 6.46 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.153 2.181 . . . . 74.15 113.615 172.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.409 ' HB2' HG13 ' A' ' 118' ' ' VAL . 98.1 m-85 -80.49 149.35 68.26 Favored Pre-proline 0 C--O 1.244 0.813 0 N-CA-C 107.068 -1.456 . . . . 71.22 107.068 169.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.687 ' HB3' ' HA ' ' E' ' 131' ' ' TRP . 12.2 Cg_endo -55.63 142.88 81.3 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.163 1.909 . . . . 50.41 111.396 176.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -55.53 122.63 11.71 Favored 'General case' 0 C--N 1.352 0.705 0 O-C-N 124.246 0.966 . . . . 63.02 111.481 -169.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.663 HD21 HG11 ' A' ' 64' ' ' VAL . 22.6 tp -106.15 121.15 43.59 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 108.35 -0.982 . . . . 73.31 108.35 -176.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.588 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 88.6 m-20 -117.74 124.28 48.08 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.657 -1.238 . . . . 71.33 107.657 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 9.6 mt -74.24 140.3 44.92 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.966 -0.753 . . . . 74.3 108.966 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.421 ' HB3' ' HD1' ' E' ' 138' ' ' TYR . . . -69.62 140.16 89.36 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-O 119.251 -0.404 . . . . 61.2 111.025 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -56.09 115.68 2.64 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 123.392 2.728 . . . . 72.31 113.343 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.414 HG21 HD11 ' A' ' 44' ' ' LEU . 92.0 t -102.72 123.38 56.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-N 115.421 -0.809 . . . . 73.44 109.517 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -87.24 90.72 8.46 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 107.778 -1.193 . . . . 71.45 107.778 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.412 ' CZ ' HD13 ' A' ' 44' ' ' LEU . 29.3 m-85 -63.58 -28.6 70.04 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.396 0.678 . . . . 60.4 111.465 177.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.563 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 14.8 t70 -61.7 -39.39 91.33 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.486 0.715 . . . . 75.43 110.11 175.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.5 -40.17 89.09 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.728 0.811 . . . . 62.33 110.651 173.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.97 -38.74 89.67 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.259 0.623 . . . . 73.53 111.352 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.502 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 60.1 t80 -74.51 -39.73 62.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.79 -0.448 . . . . 74.31 109.79 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.491 ' HE3' HD23 ' A' ' 141' ' ' LEU . 1.9 tpt -54.46 -35.86 63.48 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.273 1.029 . . . . 74.14 111.027 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -56.23 -55.33 34.58 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.915 0.886 . . . . 73.11 110.851 176.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -71.0 -31.5 68.05 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.625 0.77 . . . . 72.11 111.253 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.491 HD23 ' HE3' ' A' ' 138' ' ' MET . 32.0 tp -68.13 -52.77 31.05 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.09 0.556 . . . . 64.22 111.37 -170.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 179.18 -15.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 113.681 0.993 . . . . 63.52 113.681 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 58.99 56.0 4.21 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.556 0.742 . . . . 72.14 111.348 -173.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -164.18 100.89 0.85 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.381 0.672 . . . . 74.42 110.185 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -167.95 135.6 2.26 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.71 1.204 . . . . 64.44 108.525 175.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -168.14 125.92 1.35 Allowed Glycine 0 C--N 1.348 1.196 0 C-N-CA 121.631 -0.319 . . . . 71.33 113.006 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.629 ' HA ' ' HA3' ' C' ' 148' ' ' GLY . 42.5 mt-10 -132.75 147.81 52.32 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.544 1.137 . . . . 75.1 109.227 173.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 140.26 117.19 1.39 Allowed Glycine 0 C--N 1.341 0.851 0 N-CA-C 111.428 -0.669 . . . . 61.11 111.428 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.442 HG22 ' O ' ' C' ' 147' ' ' GLU . 5.1 t -149.88 65.74 0.98 Allowed 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.408 -0.96 . . . . 60.21 108.408 170.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -66.92 98.67 0.57 Allowed 'General case' 0 C--N 1.35 0.592 0 CA-C-N 114.59 -1.186 . . . . 73.35 110.466 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -104.64 127.91 52.53 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.469 -0.937 . . . . 64.05 108.469 171.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -83.19 100.74 10.76 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.338 -0.616 . . . . 71.24 109.338 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -118.63 102.53 8.94 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.773 0.829 . . . . 71.03 108.808 173.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -163.54 133.06 4.09 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.462 0.705 . . . . 71.31 109.859 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.941 0 C-N-CA 124.158 0.983 . . . . 53.12 108.732 178.867 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 110.06 -0.348 . . . . 75.12 110.06 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 74.9 m -93.32 78.18 4.48 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 123.433 0.693 . . . . 65.43 109.767 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -175.23 32.11 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.225 -0.898 . . . . 70.15 110.795 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -132.98 -179.72 5.66 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.795 0.438 . . . . 72.01 110.761 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -90.95 95.87 10.34 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.679 0.792 . . . . 55.53 109.274 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ASN . . . . . 0.59 ' HB3' ' HB2' ' B' ' 154' ' ' ASP . 63.4 t30 -151.61 170.29 20.05 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.718 0.807 . . . . 73.05 109.144 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 45.8 p -56.96 134.99 56.11 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.364 1.066 . . . . 64.11 111.087 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -70.94 127.3 32.13 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.204 1.001 . . . . 71.31 110.536 -171.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.449 ' HG3' HG13 ' B' ' 89' ' ' ILE . 24.6 ttt 65.97 166.94 0.2 Allowed 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 124.725 1.21 . . . . 73.22 111.564 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.406 ' N ' ' HG2' ' B' ' 9' ' ' MET . 2.6 t -138.75 126.58 22.26 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.691 1.196 . . . . 54.22 108.46 169.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -127.9 137.41 52.3 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.286 -1.005 . . . . 74.12 108.286 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.403 ' OE1' ' HB2' ' E' ' 126' ' ' ALA . 7.2 tp-100 -151.86 109.71 3.67 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.624 0.369 . . . . 71.43 110.359 -176.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.431 HD13 HD11 ' B' ' 16' ' ' ILE . 47.4 mt -60.84 144.65 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 108.853 -0.795 . . . . 73.3 108.853 172.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -110.04 -45.21 3.64 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.684 -0.487 . . . . 75.52 109.684 176.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.402 ' HE ' HG21 ' A' ' 122' ' ' THR . 50.0 ttt180 -167.45 132.66 1.98 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.386 -0.598 . . . . 61.4 109.386 -173.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.431 HD11 HD13 ' B' ' 13' ' ' ILE . 96.4 mt -118.88 147.93 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 107.494 -1.299 . . . . 74.4 107.494 177.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -169.91 163.89 9.6 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.836 0.827 . . . . 73.2 112.139 -174.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 82.7 m -92.49 122.74 35.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.627 -1.624 . . . . 63.35 108.237 171.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -80.05 -49.94 11.07 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.571 0.748 . . . . 64.34 110.732 170.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -144.99 139.46 27.5 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 122.113 -0.367 . . . . 73.2 111.185 -168.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.462 HD11 ' SG ' ' B' ' 113' ' ' CYS . 49.5 mm -128.86 141.77 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.247 1.019 . . . . 74.0 109.911 173.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -144.82 133.35 22.02 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.69 1.196 . . . . 71.12 108.002 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -143.6 109.9 5.41 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.016 -1.105 . . . . 73.02 108.016 173.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -117.97 114.86 23.8 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.562 0.745 . . . . 72.03 109.039 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.25 88.31 2.47 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 106.431 -1.692 . . . . 75.11 106.431 170.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -72.02 -31.8 11.87 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.092 2.528 . . . . 72.11 113.256 -168.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -109.42 25.72 11.47 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.307 0.643 . . . . 74.53 109.268 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.532 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -44.36 -58.41 5.1 Favored Pre-proline 0 CA--C 1.564 1.487 0 N-CA-C 114.633 1.346 . . . . 74.13 114.633 -163.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 24.6 Cg_exo -61.3 -35.94 81.83 Favored 'Trans proline' 0 C--N 1.393 2.889 0 C-N-CA 122.078 1.852 . . . . 75.34 112.962 -174.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -95.08 -25.18 16.56 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.478 -0.783 . . . . 72.54 112.47 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.536 HG22 HD12 ' B' ' 68' ' ' LEU . 4.5 p -71.15 -14.25 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-O 121.332 0.587 . . . . 65.13 110.14 -175.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -73.31 -2.66 22.95 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.265 1.026 . . . . 74.34 112.459 174.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -68.63 -19.64 64.43 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.435 0.694 . . . . 73.24 110.116 169.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.573 ' HB2' HD13 ' B' ' 68' ' ' LEU . 29.4 mmtp -98.31 102.62 14.42 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 125.497 1.519 . . . . 74.4 108.884 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -99.8 77.35 2.04 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.807 0.443 . . . . 74.03 110.639 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 43.6 p90 -160.99 167.97 25.45 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.976 0.91 . . . . 74.52 109.581 169.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.46 113.97 22.45 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 107.328 -1.36 . . . . 73.04 107.328 176.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.92 163.92 15.22 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.809 2.339 . . . . 64.21 113.709 -173.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -71.21 103.95 2.95 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.388 -0.967 . . . . 44.43 108.388 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.555 HG11 HD11 ' B' ' 126' ' ' LEU . 49.0 t -94.33 146.5 6.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 114.996 -1.002 . . . . 64.35 110.253 -176.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -149.14 125.96 11.17 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.24 1.016 . . . . 74.3 108.282 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.441 HD11 ' CG1' ' B' ' 62' ' ' VAL . 16.3 tp -89.65 137.95 31.89 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.061 0.545 . . . . 75.33 109.768 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -139.56 113.29 8.57 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.441 1.096 . . . . 64.31 108.309 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 91.3 mt -99.69 152.46 20.05 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.751 0.82 . . . . 71.34 109.636 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.789 ' HB3' ' HD2' ' B' ' 61' ' ' ARG . 31.7 t70 -156.03 151.59 27.04 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 107.324 -1.362 . . . . 72.02 107.324 173.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' THR . . . . . 0.485 ' HB ' ' CE2' ' F' ' 106' ' ' TYR . 0.9 OUTLIER -143.83 146.45 33.07 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.664 0.745 . . . . 74.31 112.315 -170.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.11 153.2 41.91 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.931 1.292 . . . . 63.32 108.359 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.487 ' HB2' ' CE2' ' B' ' 56' ' ' TYR . 74.4 p -145.7 176.05 9.93 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.565 0.579 . . . . 73.43 112.565 -174.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 65.5 p -162.01 139.29 8.46 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.688 1.195 . . . . 75.13 109.869 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -90.79 109.93 21.13 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.284 -0.635 . . . . 71.22 109.284 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' A' ' 29' ' ' PRO . 39.3 mt -86.56 -23.34 25.85 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.763 0.425 . . . . 71.41 110.531 175.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.543 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -163.1 167.42 22.28 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.452 0.701 . . . . 71.51 111.08 -176.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -82.17 138.49 34.69 Favored 'General case' 0 C--O 1.248 0.99 0 N-CA-C 107.291 -1.374 . . . . 71.14 107.291 161.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 78.17 -5.35 2.09 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 125.758 1.623 . . . . 73.5 112.258 -175.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 50.1 t -144.34 117.97 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.539 0.735 . . . . 71.21 109.044 -175.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.487 ' CE2' ' HB2' ' B' ' 48' ' ' SER . 26.9 t80 -126.61 151.58 47.8 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.195 0.598 . . . . 75.41 110.002 -173.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -116.26 121.0 40.73 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 107.755 -1.202 . . . . 74.31 107.755 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 12.9 p -127.48 147.93 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.128 0.571 . . . . 72.43 109.984 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 17.4 t -125.37 116.26 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.73 0.812 . . . . 64.2 109.808 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.45 ' HA ' HG22 ' B' ' 46' ' ' THR . 58.0 tp -94.72 105.27 17.21 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.051 -0.722 . . . . 74.32 109.051 170.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.789 ' HD2' ' HB3' ' B' ' 45' ' ' ASP . 1.7 tmt_? -86.54 120.46 27.89 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.709 -1.219 . . . . 72.43 107.709 172.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.441 ' CG1' HD11 ' B' ' 42' ' ' LEU . 32.3 t -114.81 133.04 62.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.284 -1.006 . . . . 52.15 108.284 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 24.7 m -131.03 131.81 44.54 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.325 0.583 . . . . 75.23 109.628 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.7 HG11 HD21 ' B' ' 126' ' ' LEU . 97.2 t -111.54 118.74 58.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 C-N-CA 124.419 1.087 . . . . 74.03 108.338 176.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 68.5 m -92.51 130.94 38.03 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.114 -1.069 . . . . 70.24 108.114 168.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.39 134.34 27.19 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.863 -0.792 . . . . 72.33 108.863 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.492 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 18.8 p -144.63 133.26 22.2 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 123.736 0.648 . . . . 63.22 110.803 -175.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.573 HD13 ' HB2' ' B' ' 34' ' ' LYS . 78.4 mt -99.45 103.05 14.79 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.47 1.108 . . . . 75.5 110.056 176.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.7 -111.7 3.41 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.797 -0.521 . . . . 63.31 111.797 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -115.19 1.32 13.81 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.256 0.622 . . . . 74.32 110.706 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.53 ' HG3' HG23 ' B' ' 31' ' ' VAL . 18.2 pt-20 -115.47 143.1 45.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.415 0.686 . . . . 75.12 109.396 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 63.4 m -69.11 132.13 46.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 121.235 0.54 . . . . 73.22 110.999 -178.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.492 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -83.31 -63.03 1.44 Allowed 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.819 -1.178 . . . . 72.22 107.819 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -153.87 152.36 30.55 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.523 -1.217 . . . . 74.54 110.358 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -125.79 111.85 15.36 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.427 -1.694 . . . . 75.15 106.427 170.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.49 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 49.5 t -117.42 134.63 54.62 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.909 -1.145 . . . . 73.34 107.909 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -146.09 126.36 13.92 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.427 -0.953 . . . . 73.24 108.427 -173.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 66.1 t -123.08 148.02 27.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.259 -1.015 . . . . 62.54 108.259 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -120.46 106.96 12.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.083 -1.451 . . . . 54.24 107.083 168.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -100.82 103.07 14.27 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.609 -0.885 . . . . 75.53 108.609 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.59 158.8 18.59 Favored Glycine 0 C--N 1.342 0.885 0 O-C-N 123.762 0.664 . . . . 74.34 111.548 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.44 142.45 7.86 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 117.314 0.557 . . . . 72.15 113.414 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 3.8 mp -90.34 124.68 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 107.941 -1.133 . . . . 75.42 107.941 170.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -129.59 153.35 48.15 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.315 1.046 . . . . 75.44 109.28 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 30.3 m -107.76 109.1 20.58 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.742 0.817 . . . . 73.12 109.191 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.598 HG22 HD11 ' B' ' 89' ' ' ILE . 4.0 mp -111.74 108.52 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.756 1.223 . . . . 63.04 107.93 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.98 158.43 43.92 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.048 0.539 . . . . 64.44 111.22 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.73 -56.14 0.88 Allowed Glycine 0 C--N 1.349 1.261 0 C-N-CA 123.292 0.472 . . . . 73.42 112.668 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.598 HD11 HG22 ' B' ' 86' ' ' ILE . 0.6 OUTLIER -56.22 166.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 124.528 1.131 . . . . 64.43 113.035 173.238 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -158.42 160.03 36.39 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.078 -0.964 . . . . 64.23 110.057 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.08 -109.92 3.81 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 112.166 -0.373 . . . . 54.11 112.166 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 80.0 m -99.94 -42.42 6.78 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.482 0.713 . . . . 73.24 110.677 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.405 ' HA ' ' HB3' ' B' ' 96' ' ' HIS . 2.8 mp0 -65.66 -19.14 65.79 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.207 1.003 . . . . 71.04 112.448 -173.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.456 ' HA ' HD13 ' B' ' 89' ' ' ILE . 20.3 ptm -61.69 -66.07 0.59 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.102 0.561 . . . . 64.03 111.613 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.435 ' H ' ' HG3' ' B' ' 94' ' ' MET . . . -79.69 -14.26 58.89 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.801 0.44 . . . . 53.5 111.621 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.405 ' HB3' ' HA ' ' B' ' 93' ' ' GLN . 35.7 t-80 -63.32 -34.9 78.7 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.278 0.631 . . . . 61.24 110.888 171.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 48.7 t -66.72 -44.21 82.2 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.819 0.447 . . . . 63.21 111.594 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.55 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 1.5 pp -80.23 -30.18 38.54 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.098 0.559 . . . . 74.13 111.464 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.51 -30.57 44.34 Favored Glycine 0 C--N 1.342 0.866 0 O-C-N 123.601 0.563 . . . . 72.41 113.601 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.41 -53.95 1.47 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.324 0.65 . . . . 62.25 111.967 -169.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -67.79 -37.46 82.08 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.333 0.653 . . . . 72.32 112.197 -174.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.55 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 79.9 m -71.14 -43.56 13.13 Favored Pre-proline 0 CA--C 1.563 1.456 0 CA-C-O 118.383 -0.818 . . . . 64.1 112.367 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -50.89 -36.88 54.38 Favored 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 122.366 2.044 . . . . 74.21 113.402 166.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -67.42 -29.75 69.32 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.2 0.6 . . . . 45.24 111.865 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.406 ' O ' ' HD2' ' B' ' 108' ' ' PRO . 74.9 mt -69.49 -41.57 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.314 0.646 . . . . 74.14 109.691 171.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.6 mt -76.85 -21.57 54.82 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.962 -1.017 . . . . 64.12 112.028 -174.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -59.15 -49.76 91.3 Favored Pre-proline 0 N--CA 1.485 1.314 0 CA-C-O 118.165 -0.921 . . . . 72.22 113.021 -176.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.406 ' HD2' ' O ' ' B' ' 105' ' ' ILE . 86.9 Cg_exo -53.17 -43.04 60.48 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 122.715 2.277 . . . . 75.15 114.224 175.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -67.29 -41.27 85.7 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.396 0.678 . . . . 51.23 110.565 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.32 -38.45 91.1 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.601 -0.727 . . . . 61.34 110.689 175.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.0 ttt-85 -64.93 -47.12 78.84 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.529 1.532 . . . . 61.42 110.831 -176.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -70.87 -34.0 71.17 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.988 0.515 . . . . 65.03 109.855 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.528 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.9 t -66.23 -34.66 78.52 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 123.352 0.408 . . . . 75.22 110.741 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.49 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 51.8 mt -65.46 -55.71 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.924 0.889 . . . . 64.42 109.858 173.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 10.2 m -63.35 -24.83 68.02 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.479 0.712 . . . . 74.34 111.496 -175.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.437 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 36.4 t -64.24 -50.15 69.11 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 123.385 0.674 . . . . 72.35 109.251 173.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.528 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.2 mmt -69.5 -34.35 74.18 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.305 0.642 . . . . 74.35 110.826 -176.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 114' ' ' ILE . 85.5 t -62.26 -43.73 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.88 0.872 . . . . 74.21 110.082 173.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 48.3 t -66.25 -31.89 72.98 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.027 -0.988 . . . . 71.23 111.041 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' B' ' 116' ' ' SER . 86.4 mtt-85 -68.95 -39.77 79.33 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.488 -0.778 . . . . 73.03 110.5 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.08 -14.26 81.98 Favored Glycine 0 C--N 1.354 1.531 0 O-C-N 123.698 0.624 . . . . 62.24 112.222 172.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 7.5 m 65.58 37.15 6.11 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.595 1.558 . . . . 63.33 110.058 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.432 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 57.5 m-85 -85.22 159.54 56.37 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 114.576 -1.193 . . . . 74.53 110.051 173.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.45 ' HG3' ' HB2' ' F' ' 131' ' ' TRP . 86.6 Cg_exo -47.89 159.79 0.56 Allowed 'Trans proline' 0 C--N 1.385 2.458 0 C-N-CA 123.851 3.034 . . . . 74.34 115.249 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.446 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 60.0 tp60 -61.3 118.19 6.58 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 115.112 -0.949 . . . . 63.22 111.762 -173.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.7 HD21 HG11 ' B' ' 64' ' ' VAL . 32.8 tp -110.85 103.33 11.83 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.556 -0.747 . . . . 61.4 110.052 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -108.1 114.9 29.15 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 107.908 -1.145 . . . . 72.43 107.908 169.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.44 HD21 ' CG2' ' B' ' 64' ' ' VAL . 41.9 mt -70.42 140.94 52.15 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.272 0.358 . . . . 64.44 110.352 176.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.47 145.79 98.99 Favored Pre-proline 0 CA--C 1.551 1.01 0 O-C-N 123.7 0.625 . . . . 73.5 110.529 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.477 ' HD2' ' HB1' ' F' ' 125' ' ' ALA . 39.3 Cg_exo -60.88 92.05 0.1 OUTLIER 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.827 2.352 . . . . 72.33 111.74 174.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 94.7 t -99.23 112.51 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 123.24 0.616 . . . . 61.01 109.778 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -79.2 113.74 17.58 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.943 0.897 . . . . 70.53 109.141 173.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -62.56 -36.01 81.3 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.134 0.974 . . . . 70.3 110.76 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -55.31 -45.6 76.29 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.37 1.044 . . . . 73.33 110.912 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -50.74 -39.74 52.83 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.347 1.03 . . . . 71.51 113.594 -170.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 5.5 mp -72.0 -42.08 66.86 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.617 0.367 . . . . 45.24 111.053 -176.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -74.91 -25.88 59.24 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 116.381 -0.372 . . . . 73.42 111.666 175.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -73.21 -37.92 66.27 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.433 0.693 . . . . 61.41 109.81 -177.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -75.23 -22.83 57.62 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 116.253 -0.43 . . . . 45.13 110.491 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -82.76 -23.54 33.9 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.256 0.622 . . . . 75.11 111.037 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 24.4 tp -117.31 25.08 10.71 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.648 0.779 . . . . 72.12 109.398 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -71.65 -47.07 56.83 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.586 0.754 . . . . 73.13 110.093 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -70.97 90.77 0.84 Allowed 'General case' 0 C--N 1.354 0.769 0 N-CA-C 107.649 -1.241 . . . . 74.51 107.649 177.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -167.7 -51.57 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.243 -0.89 . . . . 52.23 109.375 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . 68.88 168.44 0.28 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.918 1.287 . . . . 72.32 111.551 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 162.31 68.27 0.02 OUTLIER Glycine 0 C--N 1.343 0.949 0 N-CA-C 111.961 -0.456 . . . . 64.45 111.961 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -83.18 97.32 8.77 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.187 -0.671 . . . . 53.42 109.187 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.76 179.05 38.55 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 115.895 -0.593 . . . . 40.11 113.559 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 27.7 m -98.2 144.5 27.59 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 109.078 -0.712 . . . . 21.32 109.078 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -66.35 92.38 0.19 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.709 0.804 . . . . 72.23 110.417 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -158.27 114.71 2.79 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.958 1.303 . . . . 75.14 107.52 176.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -84.75 140.98 30.86 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 122.292 0.237 . . . . 72.02 110.489 -175.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -85.55 -163.84 0.92 Allowed 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 109.296 -0.631 . . . . 75.44 109.296 171.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' ASP . . . . . 0.59 ' HB2' ' HB3' ' B' ' 6' ' ' ASN . 18.3 p-10 -135.99 179.05 6.58 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.067 0.547 . . . . 74.43 110.712 177.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-N 114.959 -1.019 . . . . 73.41 110.171 -179.95 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.473 0.707 0 CA-C-O 119.538 -0.267 . . . . 70.14 111.434 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 31.9 t -171.53 30.9 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.622 0.369 . . . . 73.1 111.617 -172.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -80.73 80.91 7.11 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.379 0.609 . . . . 73.22 110.066 -177.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -113.67 16.36 18.63 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.803 0.841 . . . . 62.21 110.637 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -81.9 102.44 10.89 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.94 0.896 . . . . 71.3 109.45 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -113.27 99.43 7.8 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.631 0.773 . . . . 73.52 110.062 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 31.4 p -127.65 -175.52 3.49 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.242 1.017 . . . . 72.31 109.854 174.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -69.35 137.26 52.75 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.86 -1.163 . . . . 71.41 107.86 165.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.492 ' HE3' HG21 ' C' ' 89' ' ' ILE . 55.6 ttm 61.5 111.58 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.046 1.338 . . . . 75.2 111.284 -172.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.461 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 58.0 m -103.15 80.37 1.84 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 106.942 -1.503 . . . . 54.33 106.942 172.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -92.26 126.86 37.52 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 114.96 -1.018 . . . . 65.45 109.118 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -141.33 118.09 11.05 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.206 0.603 . . . . 74.51 109.698 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 60.4 mt -73.52 134.13 30.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 109.018 -0.734 . . . . 72.4 109.018 173.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.433 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.3 mm-40 -96.79 -49.97 4.86 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 108.998 -0.742 . . . . 52.22 108.998 171.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.588 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -178.2 146.0 0.38 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.32 1.048 . . . . 74.03 110.477 179.871 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 4.9 mp -109.7 124.84 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 107.549 -1.278 . . . . 72.42 107.549 172.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.477 ' HB3' HG23 ' D' ' 122' ' ' THR . 44.1 p90 -147.74 170.52 17.39 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.584 0.707 . . . . 74.25 111.712 -171.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 18' ' ' THR . . . . . 0.411 HG21 HD11 ' C' ' 21' ' ' ILE . 75.5 p -102.7 108.17 19.32 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.493 -0.776 . . . . 73.23 109.936 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.562 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 26.7 mtpt -78.66 -23.15 45.89 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 109.468 -0.567 . . . . 74.42 109.468 174.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.485 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 10.5 t70 -148.51 138.88 22.59 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.699 0.8 . . . . 55.21 109.774 176.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.476 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 82.7 mt -136.89 140.17 43.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 106.314 -1.736 . . . . 54.33 106.314 169.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.9 t -153.18 143.92 22.75 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.457 0.703 . . . . 63.43 109.949 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -156.22 109.25 2.65 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 107.657 -1.238 . . . . 74.12 107.657 172.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -116.34 111.49 20.17 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.477 -0.564 . . . . 75.21 109.477 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.79 79.64 31.95 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 108.006 -1.109 . . . . 53.2 108.006 170.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.05 -17.04 25.26 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.614 2.209 . . . . 64.11 111.399 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -105.01 11.99 32.78 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.762 1.225 . . . . 70.22 110.274 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.475 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -50.96 -54.05 41.44 Favored Pre-proline 0 C--N 1.371 1.501 0 C-N-CA 124.351 1.06 . . . . 64.02 113.742 -169.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.6 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 12.4 Cg_endo -56.92 -52.7 6.22 Favored 'Trans proline' 0 C--N 1.391 2.789 0 C-N-CA 121.658 1.572 . . . . 74.14 111.67 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.453 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 85.4 t60 -67.77 -28.64 67.78 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.659 0.784 . . . . 62.31 112.654 -172.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.735 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.6 p -77.43 -19.68 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 N-CA-C 112.43 0.53 . . . . 73.52 112.43 -174.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -71.66 -13.52 61.77 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.856 0.687 . . . . 72.03 112.856 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 28.1 pt20 -99.18 6.34 46.43 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.188 0.595 . . . . 52.1 111.68 175.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.82 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -94.48 150.91 19.79 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.778 0.831 . . . . 55.43 110.442 -178.338 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.16 119.78 11.49 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.343 0.657 . . . . 64.33 109.277 169.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -82.89 92.37 7.28 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.557 0.743 . . . . 64.3 112.053 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -142.9 79.99 14.2 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 124.606 1.162 . . . . 74.3 107.895 169.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -87.29 163.06 8.41 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.732 2.288 . . . . 73.15 111.235 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -85.57 76.06 10.06 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.306 -1.368 . . . . 62.44 107.306 173.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 p -62.75 97.34 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 114.603 -1.18 . . . . 62.05 108.735 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -107.56 102.96 12.18 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 113.627 -1.624 . . . . 73.44 107.442 -171.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -88.3 129.36 35.4 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.017 -1.105 . . . . 70.52 108.017 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.437 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 15.4 t70 -124.62 139.04 54.24 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.95 -0.759 . . . . 75.21 108.95 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.449 HD22 HD21 ' C' ' 60' ' ' LEU . 79.0 mt -130.43 110.65 11.63 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.083 0.953 . . . . 51.2 108.568 175.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -124.22 119.77 30.31 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.175 -1.417 . . . . 75.13 107.175 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.1 t -119.91 145.32 46.82 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 109.621 -0.511 . . . . 70.54 109.621 -176.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.54 162.13 36.65 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.912 0.885 . . . . 54.42 108.931 176.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.409 ' OG ' ' HB3' ' C' ' 98' ' ' LEU . 5.4 m -129.12 164.08 24.11 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 109.468 -0.568 . . . . 61.22 109.468 174.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -148.65 125.61 11.3 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.675 -1.231 . . . . 72.31 107.675 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -84.21 114.83 22.09 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.897 -1.149 . . . . 65.52 107.897 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.597 HD11 ' HB2' ' C' ' 57' ' ' GLU . 50.1 mt -88.71 -42.67 11.82 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.4 0.68 . . . . 73.41 109.782 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.04 -171.22 3.85 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 115.081 -0.963 . . . . 63.52 109.967 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.37 113.32 2.85 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 114.92 -1.036 . . . . 55.42 109.307 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 63.86 15.29 8.99 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.037 0.935 . . . . 75.51 112.387 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 85.1 t -111.71 115.88 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.136 -1.061 . . . . 62.33 108.136 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -125.14 124.73 42.44 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.804 0.841 . . . . 63.11 109.185 -177.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.597 ' HB2' HD11 ' C' ' 51' ' ' LEU . 38.7 tt0 -83.74 133.63 34.78 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.238 -1.023 . . . . 74.21 108.238 164.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -118.94 135.61 58.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 108.247 -1.02 . . . . 73.42 108.247 168.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.413 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 57.3 t -119.75 141.93 37.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 123.644 0.778 . . . . 72.12 109.128 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.449 HD21 HD22 ' C' ' 44' ' ' LEU . 0.0 OUTLIER -123.11 102.01 7.73 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.713 -1.217 . . . . 75.44 107.713 177.586 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -81.87 106.97 14.21 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.687 -0.857 . . . . 73.51 108.687 172.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 11.0 t -109.86 113.91 45.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.24 -1.022 . . . . 70.53 108.24 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 26.8 m -111.98 132.13 54.97 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.197 -0.668 . . . . 73.42 109.197 -177.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.561 HG23 HD13 ' C' ' 114' ' ' ILE . 50.6 t -118.32 114.71 45.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.774 -0.824 . . . . 73.14 108.774 171.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.432 HG23 HD23 ' C' ' 75' ' ' LEU . 7.4 m -99.19 139.17 35.25 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.285 -1.006 . . . . 53.22 108.285 172.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.6 109.82 8.35 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.638 -0.875 . . . . 64.32 108.638 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 36.5 m -136.94 131.75 33.45 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.874 0.47 . . . . 54.24 110.293 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.82 HD13 ' HG2' ' C' ' 34' ' ' LYS . 1.6 mt -93.16 50.34 1.51 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.214 1.006 . . . . 64.35 108.572 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.32 -119.95 6.46 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 110.3 -1.12 . . . . 75.45 110.3 -171.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -90.48 -11.94 38.77 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.239 0.616 . . . . 63.15 109.836 172.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -71.58 119.53 15.87 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.753 0.821 . . . . 75.21 109.239 172.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 30.9 m -79.27 125.1 29.05 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.071 -0.714 . . . . 64.12 109.071 170.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.735 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -82.43 -53.92 5.61 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.39 -1.337 . . . . 75.33 107.39 168.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 74' ' ' PHE . . . . . 0.429 ' HZ ' HD13 ' C' ' 126' ' ' LEU . 32.7 p90 -169.77 168.56 8.88 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 114.73 -1.123 . . . . 74.11 110.41 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.432 HD23 HG23 ' C' ' 65' ' ' THR . 3.1 tm? -130.44 144.93 51.71 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 106.14 -1.8 . . . . 75.54 106.14 169.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.417 ' N ' HD13 ' C' ' 75' ' ' LEU . 49.2 t -150.17 146.21 26.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.739 0.416 . . . . 72.12 109.991 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -157.68 137.47 12.26 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.701 0.8 . . . . 75.21 109.673 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.562 HG21 ' HB3' ' C' ' 113' ' ' CYS . 24.2 t -134.34 113.51 17.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 124.562 1.145 . . . . 72.21 107.923 174.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.485 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 69.3 mt-30 -91.55 88.42 6.76 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.966 -1.124 . . . . 61.52 107.966 174.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -79.27 96.86 6.06 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.821 -1.081 . . . . 75.2 109.195 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -92.56 145.79 17.82 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 111.27 -0.732 . . . . 61.43 111.27 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.85 132.75 4.01 Favored Glycine 0 CA--C 1.501 -0.787 0 N-CA-C 110.898 -0.881 . . . . 74.21 110.898 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.433 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 26.5 mm -89.48 132.0 35.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 N-CA-C 109.174 -0.676 . . . . 73.14 109.174 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -134.51 119.27 18.27 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.727 0.811 . . . . 74.0 109.376 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 27.8 m -81.8 102.07 10.57 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.202 -1.036 . . . . 73.14 108.202 171.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.608 HG21 ' HE1' ' C' ' 94' ' ' MET . 27.5 mt -116.22 131.6 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.732 0.813 . . . . 53.13 109.481 -176.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.461 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -142.03 169.45 17.57 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.756 0.423 . . . . 74.31 110.956 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.21 -29.48 5.59 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 115.817 -0.629 . . . . 43.01 113.971 171.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.492 HG21 ' HE3' ' C' ' 9' ' ' MET . 39.5 pt -96.95 171.79 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.338 0.655 . . . . 65.31 110.933 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -166.23 -179.15 4.91 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.198 0.999 . . . . 75.12 109.256 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.29 -119.9 13.71 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 123.925 0.766 . . . . 64.54 114.116 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 92' ' ' THR . . . . . 0.689 ' HB ' HD12 ' C' ' 141' ' ' LEU . 26.1 p -73.93 -30.83 62.77 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.696 0.798 . . . . 62.24 112.105 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -63.47 -48.24 78.48 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.944 0.498 . . . . 74.24 109.709 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.608 ' HE1' HG21 ' C' ' 86' ' ' ILE . 5.4 tpt -63.99 -48.08 77.83 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-N 115.547 -0.751 . . . . 75.44 110.501 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.4 -35.23 73.58 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.287 0.635 . . . . 34.25 111.486 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 17.5 t60 -83.74 -28.84 27.94 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.956 0.502 . . . . 70.24 110.954 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.559 ' SG ' HD13 ' C' ' 86' ' ' ILE . 18.8 t -68.34 -38.58 81.61 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.688 -0.856 . . . . 75.13 108.688 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.409 ' HB3' ' OG ' ' C' ' 48' ' ' SER . 53.9 mt -83.63 -33.34 25.31 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.523 -1.217 . . . . 54.33 110.857 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.27 -24.38 63.67 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.297 -0.865 . . . . 54.21 114.28 -169.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.36 -52.54 0.11 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.802 0.667 . . . . 72.42 112.802 -164.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -57.02 -57.54 12.11 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 123.999 0.812 . . . . 70.02 111.177 -176.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.403 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 95.3 m -64.28 -49.11 74.38 Favored Pre-proline 0 CA--C 1.564 1.486 0 C-N-CA 124.151 0.981 . . . . 71.22 112.422 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 74.8 Cg_exo -53.43 -32.89 64.6 Favored 'Trans proline' 0 C--N 1.402 3.359 0 C-N-CA 122.701 2.267 . . . . 74.13 113.889 173.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -67.97 -31.47 71.21 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.608 0.763 . . . . 70.43 110.694 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.518 HD12 ' NH1' ' A' ' 111' ' ' ARG . 25.7 mm -74.74 -35.62 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 122.899 0.48 . . . . 71.22 109.85 175.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.95 -27.74 57.66 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.781 0.832 . . . . 75.45 111.443 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -58.77 -50.93 85.37 Favored Pre-proline 0 N--CA 1.483 1.18 0 N-CA-C 114.552 1.316 . . . . 74.34 114.552 -171.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -58.69 -38.05 91.11 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 121.967 1.778 . . . . 72.33 112.873 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.446 ' HE2' HG21 ' A' ' 115' ' ' THR . 52.4 m-85 -67.25 -45.22 77.34 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.844 0.858 . . . . 73.55 110.3 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.08 86.3 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.162 -0.927 . . . . 72.32 110.907 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 41.8 ttt-85 -67.84 -43.87 78.52 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.883 1.273 . . . . 74.03 110.259 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 112' ' ' GLU . . . . . 0.403 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.1 tm-20 -66.29 -39.95 89.7 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.293 0.637 . . . . 45.11 109.591 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.562 ' HB3' HG21 ' C' ' 78' ' ' VAL . 28.6 m -59.91 -48.93 79.67 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.584 0.753 . . . . 73.3 111.996 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.561 HD13 HG23 ' C' ' 64' ' ' VAL . 71.0 mt -64.09 -52.32 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 123.439 0.462 . . . . 64.24 110.85 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 14.2 m -66.7 -29.07 68.97 Favored 'General case' 0 CA--C 1.556 1.181 0 O-C-N 123.462 0.476 . . . . 73.13 110.746 -175.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 39.2 t -63.91 -46.38 85.07 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.3 -0.63 . . . . 72.22 109.3 170.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.591 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.17 -41.01 96.03 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.469 1.107 . . . . 73.1 112.215 179.286 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.476 HG23 ' O ' ' C' ' 114' ' ' ILE . 92.6 t -64.81 -41.23 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.938 0.895 . . . . 71.33 109.572 176.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 11.6 t -67.12 -29.95 69.83 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.813 1.245 . . . . 75.23 112.129 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.439 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 75.3 mtt-85 -74.16 -41.3 61.71 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.575 0.75 . . . . 70.44 109.668 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.06 -0.42 60.67 Favored Glycine 0 C--N 1.354 1.572 0 O-C-N 123.719 0.637 . . . . 60.42 112.608 169.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.412 ' O ' HG21 ' F' ' 129' ' ' THR . 31.0 p 63.84 30.67 14.4 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.989 2.115 . . . . 64.34 113.025 169.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -82.33 156.44 68.82 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 107.916 -1.142 . . . . 64.53 107.916 167.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.446 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 12.8 Cg_endo -57.19 157.05 22.51 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.479 2.119 . . . . 53.32 112.845 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' B' ' 123' ' ' PHE . 53.8 mm-40 -56.02 112.78 1.29 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.21 0.944 . . . . 63.55 111.601 -176.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.507 ' HA ' HG23 ' F' ' 133' ' ' THR . 5.2 tt -116.75 85.15 2.26 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.476 -1.305 . . . . 71.22 107.476 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -95.28 122.17 37.7 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.691 -0.855 . . . . 74.13 108.691 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.79 144.38 37.18 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.589 0.556 . . . . 75.43 109.872 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.89 148.42 98.84 Favored Pre-proline 0 CA--C 1.55 0.958 0 O-C-N 124.076 0.86 . . . . 74.13 111.125 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.84 108.53 0.39 Allowed 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.798 2.332 . . . . 55.3 112.22 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 43.3 t -99.6 112.68 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.46 -0.941 . . . . 73.02 108.46 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -77.74 104.95 8.59 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.141 -0.689 . . . . 70.2 109.141 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -63.39 -35.52 80.68 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.664 0.785 . . . . 74.21 111.575 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.08 -21.51 65.88 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.931 0.892 . . . . 44.13 111.839 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.52 -47.31 33.75 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.96 0.904 . . . . 75.11 109.296 172.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 35.0 mt -65.79 -43.52 88.48 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.824 -0.625 . . . . 72.31 111.087 -176.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -77.67 -16.33 58.58 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.039 -0.982 . . . . 74.15 110.495 -177.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 50.4 ttm -59.75 -30.62 68.98 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.731 0.813 . . . . 73.13 110.967 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -68.65 -42.83 77.43 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.8 -1.091 . . . . 62.12 110.353 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -72.71 -87.03 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 123.856 0.862 . . . . 73.24 111.805 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.689 HD12 ' HB ' ' C' ' 92' ' ' THR . 4.2 mm? 52.15 -99.79 0.09 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.443 1.097 . . . . 64.1 111.174 -168.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 176.9 -67.06 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.72 1.208 . . . . 72.12 108.233 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -91.28 131.57 36.71 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.135 -0.691 . . . . 72.34 109.135 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -88.27 85.9 6.98 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 107.383 -1.34 . . . . 74.3 107.383 174.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -171.68 114.46 0.36 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.284 1.034 . . . . 53.03 108.834 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -165.96 13.98 0.08 OUTLIER Glycine 0 C--N 1.344 1.007 0 O-C-N 123.316 0.385 . . . . 40.31 113.197 -176.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 147' ' ' GLU . . . . . 0.442 ' O ' HG22 ' A' ' 149' ' ' THR . 1.0 OUTLIER -73.58 161.06 30.75 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.713 0.805 . . . . 75.14 110.667 176.109 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 148' ' ' GLY . . . . . 0.629 ' HA3' ' HA ' ' A' ' 147' ' ' GLU . . . -160.4 -108.04 0.23 Allowed Glycine 0 C--N 1.339 0.7 0 N-CA-C 110.945 -0.862 . . . . 61.34 110.945 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 56.3 p 48.89 80.78 0.06 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.621 1.168 . . . . 63.02 112.192 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -146.31 141.66 27.51 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.303 -1.369 . . . . 73.34 107.303 177.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.05 120.26 9.35 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.989 -0.745 . . . . 74.41 108.989 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -153.41 119.68 5.49 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.317 -0.623 . . . . 74.24 109.317 -172.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.19 73.89 5.77 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 109.183 -0.673 . . . . 52.34 109.183 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -176.22 169.16 2.8 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.688 1.195 . . . . 71.01 109.293 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.366 0 N-CA-C 107.997 -1.112 . . . . 73.32 107.997 176.613 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 56.0 ttm . . . . . 0 N--CA 1.484 1.263 0 N-CA-C 109.437 -0.579 . . . . 74.21 109.437 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 16.1 m 64.03 20.67 12.3 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.868 1.267 . . . . 61.34 110.722 -171.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -177.07 165.98 2.38 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 125.47 1.508 . . . . 65.12 108.545 -173.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -81.19 -13.33 58.71 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.74 0.416 . . . . 70.51 111.155 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -68.77 103.12 1.68 Allowed 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.999 -0.741 . . . . 72.25 108.999 175.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 6' ' ' ASN . . . . . 0.502 ' HB3' ' HB2' ' D' ' 9' ' ' MET . 57.7 m-20 -67.29 -46.93 72.13 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.962 0.905 . . . . 74.1 110.033 -176.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 21.3 m 64.89 -73.61 0.06 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.612 1.565 . . . . 61.21 113.207 169.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -93.57 0.69 56.71 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.64 0.776 . . . . 65.23 112.308 -174.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.507 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 0.0 OUTLIER -32.14 126.51 0.26 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 125.193 1.397 . . . . 64.23 113.253 174.565 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 59.2 m -127.68 132.84 49.62 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.308 0.643 . . . . 74.41 109.939 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.59 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 47.3 t80 -142.94 91.65 2.32 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.023 -1.102 . . . . 75.33 108.023 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -113.24 123.74 50.87 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.517 -0.92 . . . . 70.42 108.517 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 12.4 mt -79.28 128.34 38.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.347 -0.982 . . . . 72.12 108.347 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -85.57 -43.19 13.72 Favored 'General case' 0 C--O 1.239 0.538 0 O-C-N 123.638 0.587 . . . . 73.43 109.817 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -171.09 131.62 0.8 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.799 -0.637 . . . . 71.51 110.575 -171.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 4.0 mp -106.46 141.48 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 107.348 -1.353 . . . . 72.04 107.348 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -167.01 145.51 5.06 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.648 0.592 . . . . 71.31 111.819 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -76.86 116.34 17.44 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.492 -0.776 . . . . 74.55 109.573 175.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.6 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 43.0 mtpt -88.92 -13.02 40.04 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.45 0.7 . . . . 70.22 110.439 178.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.645 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 25.3 t70 -162.55 141.63 9.07 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.099 0.96 . . . . 64.44 109.699 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.591 HG21 ' HE2' ' C' ' 117' ' ' MET . 98.4 mt -141.28 141.35 30.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 125.278 1.431 . . . . 72.35 107.884 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 41.1 t -149.3 141.38 23.91 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.667 1.187 . . . . 62.24 108.109 173.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.476 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 81.2 t80 -152.54 125.72 8.62 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 106.562 -1.644 . . . . 75.3 106.562 171.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -129.42 145.64 51.39 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.286 -0.635 . . . . 74.12 109.286 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.76 80.46 65.85 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 107.263 -1.384 . . . . 64.1 107.263 174.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.61 -38.54 31.64 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 123.513 2.809 . . . . 63.15 113.419 -169.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 42.2 m-20 -106.94 12.38 28.83 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 118.762 -0.637 . . . . 54.22 110.959 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.562 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -27.63 -69.42 0.08 OUTLIER Pre-proline 0 CA--C 1.571 1.772 0 N-CA-C 116.742 2.127 . . . . 72.01 116.742 -164.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.45 -18.69 13.69 Favored 'Trans proline' 0 C--N 1.385 2.483 0 CA-C-N 123.661 2.343 . . . . 74.44 114.212 -174.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -74.49 -38.66 62.82 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.295 1.038 . . . . 72.01 109.103 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.487 HG12 ' O ' ' D' ' 28' ' ' ALA . 4.3 p -84.76 -20.66 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 CA-C-N 115.328 -0.851 . . . . 71.43 111.676 -174.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.505 ' HD2' HH21 ' C' ' 15' ' ' ARG . 20.6 m-85 -67.6 -18.54 65.02 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 122.586 0.354 . . . . 75.34 111.945 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -65.29 -16.84 63.99 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.203 1.001 . . . . 64.01 111.06 175.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.404 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 96.4 mttt -97.42 90.26 5.0 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 125.086 1.354 . . . . 74.54 110.463 -178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -90.67 93.22 9.16 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.954 0.502 . . . . 63.54 109.772 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 20.5 p90 -162.47 -170.39 2.42 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.874 0.87 . . . . 70.14 109.466 168.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -67.98 109.78 4.47 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.707 1.203 . . . . 61.12 110.898 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -58.54 122.27 11.38 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.27 1.98 . . . . 74.14 110.565 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 0.2 OUTLIER -66.68 107.21 2.06 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 106.983 -1.488 . . . . 75.31 106.983 175.289 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.601 HG22 ' HB2' ' D' ' 66' ' ' ALA . 93.8 t -111.67 142.93 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.876 -0.787 . . . . 51.02 108.876 -174.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -129.76 123.87 32.07 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.369 -0.974 . . . . 61.53 108.369 168.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.587 HD11 HG13 ' D' ' 62' ' ' VAL . 51.5 tp -95.73 125.98 40.68 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.001 -0.74 . . . . 75.24 109.001 174.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -124.9 111.11 15.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.787 -1.56 . . . . 72.23 106.787 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.538 HD22 HG22 ' D' ' 62' ' ' VAL . 62.0 mt -97.58 164.53 12.39 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.932 -1.031 . . . . 72.43 108.958 177.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -164.4 144.93 7.98 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.979 -1.119 . . . . 72.51 107.979 167.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 46' ' ' THR . . . . . 0.493 HG23 HD22 ' E' ' 111' ' ' LEU . 70.4 p -102.62 151.14 22.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.735 0.779 . . . . 74.13 109.769 -176.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.54 161.72 41.1 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 106.686 -1.598 . . . . 42.55 106.686 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 12.8 p -175.32 -176.95 0.97 Allowed 'General case' 0 C--O 1.238 0.464 0 C-N-CA 122.786 0.434 . . . . 53.41 110.255 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 57.9 p -148.47 119.01 7.41 Favored 'General case' 0 C--O 1.247 0.95 0 N-CA-C 107.667 -1.234 . . . . 70.32 107.667 174.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 50' ' ' GLN . . . . . 0.571 ' HB2' HD13 ' E' ' 102' ' ' LEU . 51.2 tt0 -72.11 86.02 1.04 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.323 -1.308 . . . . 73.0 108.896 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -80.85 -37.13 30.46 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.762 -1.199 . . . . 64.41 107.762 177.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . 68.38 -175.48 0.2 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.949 1.3 . . . . 60.34 112.175 175.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 25.0 t70 52.21 55.1 9.68 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.36 1.064 . . . . 71.42 109.677 -168.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.573 ' HB2' ' HB3' ' E' ' 93' ' ' PHE . 6.5 m-20 67.03 3.98 3.38 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 114.007 -1.451 . . . . 70.14 112.836 175.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.87 117.81 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 108.239 -1.023 . . . . 74.22 108.239 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -135.13 125.55 26.59 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.626 -0.879 . . . . 72.14 108.626 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -90.0 129.97 36.26 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 106.857 -1.534 . . . . 73.34 106.857 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 83.3 t -132.96 131.26 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 124.097 0.959 . . . . 65.35 108.631 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.485 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 32.3 t -119.94 144.51 28.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 C-N-CA 124.642 1.177 . . . . 74.43 108.853 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.6 108.94 12.06 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.389 -1.337 . . . . 55.1 107.389 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 ttt85 -85.41 106.01 16.47 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.144 -0.687 . . . . 71.42 109.144 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.587 HG13 HD11 ' D' ' 42' ' ' LEU . 59.7 t -108.1 118.29 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 123.95 0.9 . . . . 61.42 109.07 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 17.0 m -128.71 131.14 47.91 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.613 0.57 . . . . 41.11 109.948 -171.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.57 HG13 HG13 ' D' ' 40' ' ' VAL . 90.9 t -113.78 135.3 53.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 124.536 1.134 . . . . 72.54 109.545 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 7.1 m -121.01 94.72 4.43 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.921 -1.14 . . . . 64.2 107.921 171.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.601 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -109.42 142.08 40.91 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.614 0.366 . . . . 74.33 110.711 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.525 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 49.6 m -148.61 132.72 17.29 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.069 0.947 . . . . 75.12 110.561 -171.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.2 mt -98.34 105.71 17.9 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.967 -1.123 . . . . 75.3 107.967 173.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.07 -120.39 5.19 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 115.506 -0.77 . . . . 54.4 112.391 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.12 6.7 27.12 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.592 0.757 . . . . 54.04 111.383 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 71' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 10.9 pt-20 -127.6 159.59 34.19 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.258 0.623 . . . . 72.43 109.321 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 93.9 m -70.34 136.92 50.16 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.335 0.654 . . . . 65.44 111.961 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.525 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -91.75 -70.52 0.68 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.19 -1.411 . . . . 53.2 107.19 174.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -146.35 148.09 32.0 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.092 -0.958 . . . . 74.13 110.414 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 73.6 mt -116.17 153.52 31.68 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.757 1.223 . . . . 75.52 107.741 171.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.615 ' SG ' HG12 ' D' ' 114' ' ' ILE . 34.6 t -154.35 146.66 23.87 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.584 -0.524 . . . . 53.31 109.584 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -157.4 122.21 4.43 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.728 0.411 . . . . 74.12 110.625 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 94.8 t -132.79 115.46 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.106 0.962 . . . . 53.33 109.277 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.645 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.0 mt-30 -89.3 88.51 7.53 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.693 -0.854 . . . . 71.24 108.693 172.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -83.01 103.59 12.57 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.338 -1.301 . . . . 65.31 109.528 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -102.83 167.84 17.69 Favored Glycine 0 N--CA 1.468 0.825 0 O-C-N 123.219 0.324 . . . . 64.41 113.055 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.16 143.07 6.07 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 112.447 -0.261 . . . . 63.15 112.447 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 2.5 mp -91.29 127.34 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.218 -1.03 . . . . 74.33 108.218 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -122.41 134.86 54.6 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.538 1.135 . . . . 55.33 109.532 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 34.1 t -84.96 103.53 14.09 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 108.287 -1.005 . . . . 74.14 108.287 171.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.572 HG22 HD11 ' D' ' 89' ' ' ILE . 15.1 mt -109.54 131.9 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.569 -0.9 . . . . 62.25 108.569 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.65 164.02 14.49 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.706 0.629 . . . . 54.43 111.281 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 76.71 21.59 74.27 Favored Glycine 0 C--N 1.353 1.473 0 O-C-N 123.918 0.761 . . . . 73.34 114.619 170.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.572 HD11 HG22 ' D' ' 86' ' ' ILE . 1.0 OUTLIER -133.27 140.91 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.306 1.042 . . . . 63.22 109.457 177.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 32.0 mp0 -129.56 175.79 8.5 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 123.962 0.905 . . . . 73.11 109.601 -175.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.64 -137.8 23.04 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.219 -0.901 . . . . 64.54 112.458 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 45.5 p -66.46 -45.6 79.22 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.692 0.797 . . . . 71.21 111.035 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -58.84 -28.5 66.11 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.009 1.324 . . . . 75.23 112.331 -175.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.523 ' HA ' HD13 ' D' ' 89' ' ' ILE . 26.4 ttt -49.17 -63.54 1.07 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.98 1.312 . . . . 63.12 112.508 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.91 -16.43 35.97 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.333 0.653 . . . . 65.12 111.81 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -72.78 -21.8 60.94 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.715 0.406 . . . . 65.21 111.625 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 75.3 m -56.99 -50.98 71.06 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 123.467 0.479 . . . . 72.21 111.654 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 pp -68.42 -18.23 64.39 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.266 0.627 . . . . 74.54 112.586 -176.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 99' ' ' GLY . . . . . 0.486 ' HA3' HG21 ' E' ' 103' ' ' THR . . . -104.83 -2.22 42.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 114.775 0.67 . . . . 71.33 114.775 -174.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.42 -54.29 0.29 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 118.011 0.905 . . . . 71.2 111.459 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -73.49 -51.1 18.28 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.039 0.535 . . . . 75.21 111.287 -172.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.59 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 35.1 m -61.18 -44.83 95.0 Favored Pre-proline 0 CA--C 1.566 1.573 0 C-N-CA 123.914 0.886 . . . . 61.25 112.44 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.429 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 50.0 Cg_exo -58.35 -36.45 97.6 Favored 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 122.331 2.021 . . . . 75.14 113.468 169.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -64.19 -31.11 72.19 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.279 0.632 . . . . 73.23 110.997 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 33.1 mm -67.54 -38.55 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.046 0.938 . . . . 64.24 110.623 174.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' D' ' 103' ' ' PRO . 60.5 mt -73.31 -20.47 60.79 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.261 -0.881 . . . . 75.34 111.895 -175.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -67.44 -41.74 33.74 Favored Pre-proline 0 CA--C 1.556 1.195 0 N-CA-C 114.274 1.212 . . . . 72.32 114.274 -172.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -45.42 -44.97 16.18 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.508 2.139 . . . . 54.35 113.584 169.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -78.18 -35.03 49.24 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.829 0.852 . . . . 64.52 111.496 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 110' ' ' ALA . . . . . 0.475 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -62.25 -56.15 21.42 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.652 0.781 . . . . 74.12 110.339 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.432 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 40.3 ttp180 -58.19 -42.88 87.06 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 114.038 -1.437 . . . . 75.11 110.574 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -55.29 -52.64 62.77 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.084 0.865 . . . . 72.33 110.481 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.4 t -56.27 -45.63 80.03 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.306 1.004 . . . . 54.23 111.13 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.615 HG12 ' SG ' ' D' ' 76' ' ' CYS . 42.3 mt -62.02 -57.36 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.379 -0.828 . . . . 75.31 111.1 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 30.2 m -55.35 -38.58 68.97 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.537 1.135 . . . . 62.03 111.124 -174.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 22.6 t -60.4 -50.96 71.52 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.62 -1.173 . . . . 63.24 109.662 176.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.72 -32.4 72.15 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.628 0.771 . . . . 63.42 112.178 -176.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.481 HG23 ' O ' ' D' ' 114' ' ' ILE . 84.0 t -60.44 -46.41 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.746 0.819 . . . . 73.11 109.519 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 32.4 t -72.49 -29.16 63.39 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 115.004 -0.998 . . . . 72.44 110.881 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.462 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 74.9 mtt-85 -71.49 -24.42 61.98 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.441 0.696 . . . . 72.13 110.674 176.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.21 11.71 71.33 Favored Glycine 0 C--N 1.353 1.476 0 CA-C-O 119.448 -0.64 . . . . 75.55 112.791 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.477 HG23 ' HB3' ' C' ' 17' ' ' TYR . 72.2 p 56.71 25.67 10.41 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 125.988 1.715 . . . . 64.34 113.242 -177.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -92.02 150.9 41.33 Favored Pre-proline 0 C--O 1.241 0.635 0 C-N-CA 123.38 0.672 . . . . 64.1 109.893 173.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.773 ' HB3' ' HA ' ' E' ' 129' ' ' THR . 46.6 Cg_exo -46.12 121.33 4.33 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 123.556 2.837 . . . . 64.14 112.883 170.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -45.86 131.08 9.58 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 124.48 1.113 . . . . 61.14 111.655 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 23.7 tp -117.55 107.17 13.94 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.208 1.003 . . . . 74.23 109.209 -175.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 127' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' E' ' 126' ' ' ALA . 82.2 m-20 -101.02 96.08 7.01 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 108.041 -1.096 . . . . 74.23 108.041 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.432 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 47.1 mt -61.73 116.72 5.03 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 122.787 0.435 . . . . 71.05 110.134 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.484 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -54.47 130.78 62.84 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 123.352 0.661 . . . . 74.32 112.487 -174.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 6.1 Cg_exo -73.29 109.64 2.88 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 123.286 2.657 . . . . 74.21 110.985 -178.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.07 152.9 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.877 0.871 . . . . 75.34 110.897 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -75.02 108.54 7.81 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.647 0.779 . . . . 62.44 109.021 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -58.47 -36.03 73.08 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.219 1.007 . . . . 73.12 111.803 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.28 -38.64 77.38 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.598 -1.183 . . . . 62.32 110.33 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.463 ' HA ' ' HB3' ' D' ' 138' ' ' MET . . . -70.58 -28.98 65.3 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 123.974 0.909 . . . . 63.32 112.631 -175.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 9.4 mp -66.65 -37.98 85.93 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 118.499 0.59 . . . . 61.03 111.05 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -78.24 -34.63 49.05 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.192 0.597 . . . . 65.24 110.242 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.463 ' HB3' ' HA ' ' D' ' 135' ' ' ALA . 40.8 ttm -71.69 -23.85 61.72 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.232 1.013 . . . . 71.32 111.43 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.411 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 83.9 m-20 -59.81 -41.42 91.19 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.501 0.72 . . . . 72.44 109.896 175.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -58.05 -39.07 77.52 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 124.429 1.081 . . . . 71.21 110.972 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.2 mp -77.43 -31.13 53.74 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.374 0.67 . . . . 64.31 111.492 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 142' ' ' GLN . . . . . 0.411 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 11.0 pt20 -91.28 37.77 0.95 Allowed 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.342 0.592 . . . . 60.02 111.172 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.56 58.05 0.84 Allowed 'General case' 0 N--CA 1.481 1.125 0 CA-C-O 122.163 0.983 . . . . 74.31 109.335 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -145.76 -42.29 0.21 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.331 -1.304 . . . . 71.43 108.852 176.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -106.56 149.07 27.52 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.997 0.919 . . . . 71.52 109.76 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -160.84 29.25 0.32 Allowed Glycine 0 N--CA 1.467 0.747 0 CA-C-N 115.578 -0.737 . . . . 53.15 111.346 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.58 -163.93 1.01 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.343 1.057 . . . . 73.34 111.055 -176.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 100.17 -121.77 7.35 Favored Glycine 0 C--N 1.351 1.397 0 N-CA-C 110.689 -0.964 . . . . 51.12 110.689 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 6.1 m 57.22 81.52 0.14 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.079 1.352 . . . . 75.03 110.548 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -79.18 -178.03 5.96 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.461 -0.79 . . . . 73.32 110.857 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -76.23 174.49 10.07 Favored 'General case' 0 CA--C 1.553 1.092 0 N-CA-C 109.102 -0.703 . . . . 75.21 109.102 172.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -69.1 105.15 2.35 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.019 0.528 . . . . 62.11 110.401 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.31 106.09 1.04 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.695 1.598 . . . . 74.22 110.978 -173.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -102.91 140.76 36.77 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.159 0.584 . . . . 72.4 109.807 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 N-CA-C 109.137 -0.69 . . . . 73.0 109.137 -178.974 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.688 0 CA-C-O 120.072 -0.293 . . . . 50.43 113.388 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . -141.31 -57.85 0.03 OUTLIER Glycine 0 C--N 1.347 1.19 0 N-CA-C 111.255 -0.738 . . . . 71.33 111.255 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 93' ' ' PHE . . . . . 0.573 ' HB3' ' HB2' ' D' ' 54' ' ' ASP . 32.7 t80 -67.56 -36.66 81.37 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.603 0.761 . . . . 73.43 110.166 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -153.99 -156.83 0.72 Allowed 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 105.396 -2.076 . . . . 75.21 105.396 166.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.81 138.25 52.83 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.29 -1.004 . . . . 71.32 108.29 164.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.36 -103.91 0.24 Allowed Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.359 -0.448 . . . . 74.4 112.322 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 97' ' ' ILE . . . . . . . . . . . . . 37.2 pt -107.66 131.82 56.88 Favored 'Isoleucine or valine' 0 C--N 1.35 0.588 0 CA-C-O 121.672 0.749 . . . . 71.34 111.871 -166.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -147.29 -34.1 0.26 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.719 -1.128 . . . . 71.33 109.984 -177.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -105.06 90.49 3.46 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.398 0.679 . . . . 51.32 110.708 -177.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.77 169.34 9.59 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.317 1.047 . . . . 72.44 110.45 -177.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -89.88 173.03 3.64 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 122.459 2.106 . . . . 71.02 111.43 161.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 102' ' ' LEU . . . . . 0.571 HD13 ' HB2' ' D' ' 50' ' ' GLN . 23.2 tp -84.27 66.98 9.63 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 108.819 -0.808 . . . . 63.44 108.819 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 103' ' ' THR . . . . . 0.505 HG23 ' H ' ' E' ' 104' ' ' GLY 0.277 10.8 t 45.38 -74.02 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 126.6 1.96 . . . . 63.32 113.113 -166.174 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 104' ' ' GLY . . . . . 0.505 ' H ' HG23 ' E' ' 103' ' ' THR . . . -101.68 -134.97 8.66 Favored Glycine 0 C--N 1.347 1.184 0 N-CA-C 109.915 -1.274 . . . . 74.04 109.915 171.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -98.8 -17.21 18.58 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.967 0.507 . . . . 73.41 110.36 170.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -169.03 -71.59 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 106.695 -1.594 . . . . 75.44 106.695 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 107' ' ' THR . . . . . 0.454 HG22 ' OG1' ' D' ' 46' ' ' THR . 80.4 p -131.96 -51.28 0.97 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.544 -1.28 . . . . 74.15 107.544 165.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 67.58 14.78 9.66 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 125.45 1.5 . . . . 63.34 111.271 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -144.2 -36.27 0.34 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.128 0.971 . . . . 64.3 110.336 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . 69.0 127.39 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.116 1.367 . . . . 72.14 110.512 -167.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 111' ' ' LEU . . . . . 0.494 HD23 ' HB3' ' D' ' 44' ' ' LEU . 33.6 tp -78.89 79.2 5.3 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.161 0.584 . . . . 71.21 110.607 -173.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -161.36 178.99 8.65 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.483 -0.761 . . . . 63.44 110.719 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -76.33 119.69 20.57 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.994 0.918 . . . . 73.4 110.222 -177.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -91.23 141.51 28.72 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.18 -0.674 . . . . 54.21 109.18 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 35.2 p -77.87 86.75 4.09 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.249 0.62 . . . . 62.04 110.149 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . -136.2 -102.23 0.65 Allowed Glycine 0 C--N 1.343 0.919 0 CA-C-N 115.122 -0.945 . . . . 70.44 110.967 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 117' ' ' LYS . . . . . 0.471 ' HB3' ' HD3' ' E' ' 118' ' ' PRO . 12.7 tmtt? -119.86 -60.45 0.03 OUTLIER Pre-proline 0 CA--C 1.565 1.532 0 CA-C-O 118.142 -0.932 . . . . 74.0 110.485 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 118' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' E' ' 117' ' ' LYS . 1.6 Cg_endo -79.67 106.85 2.04 Favored 'Trans proline' 0 C--N 1.395 3.024 0 C-N-CA 121.833 1.689 . . . . 71.24 111.339 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -82.48 61.03 5.43 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.515 0.726 . . . . 73.3 110.096 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -78.36 153.95 31.19 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.297 -0.865 . . . . 73.24 109.443 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 121' ' ' VAL . . . . . . . . . . . . . 48.1 t 79.51 118.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 125.817 1.647 . . . . 74.12 110.395 -171.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 30.2 m -144.07 84.87 1.78 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.821 -0.807 . . . . 74.11 108.821 171.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -68.8 -38.56 80.02 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.042 1.337 . . . . 73.52 112.873 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 21.6 m -69.33 -12.64 61.83 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 113.507 0.929 . . . . 72.13 113.507 -173.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.3 10.16 9.18 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.087 0.555 . . . . 51.13 111.553 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 126' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' D' ' 127' ' ' ASN . . . -136.56 101.54 4.67 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.073 0.949 . . . . 74.43 110.043 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 64.6 p -169.51 152.9 4.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.52 0.728 . . . . 74.01 110.328 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.5 -56.18 4.86 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.245 0.618 . . . . 71.32 110.513 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 129' ' ' THR . . . . . 0.773 ' HA ' ' HB3' ' D' ' 124' ' ' PRO . 24.4 m 58.6 79.25 0.22 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.766 1.226 . . . . 55.05 111.969 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -165.51 127.22 2.0 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.091 0.956 . . . . 73.11 110.197 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 131' ' ' TRP . . . . . 0.687 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 71.6 t90 -161.64 101.73 1.18 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.604 0.762 . . . . 63.42 109.684 176.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 20.9 m -147.77 113.17 5.6 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.52 1.128 . . . . 74.33 108.895 173.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 40.8 m -139.32 137.08 35.5 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 118.414 0.552 . . . . 75.14 111.06 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -116.71 93.51 0.6 Allowed Glycine 0 C--N 1.347 1.19 0 N-CA-C 110.183 -1.167 . . . . 50.13 110.183 171.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 79.7 t -64.01 101.08 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 124.012 0.925 . . . . 75.2 109.462 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -67.43 108.97 2.99 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.092 0.557 . . . . 73.51 109.983 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 12.3 t -70.28 141.07 52.43 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 123.723 0.64 . . . . 74.5 110.814 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 138' ' ' TYR . . . . . 0.421 ' HD1' ' HB3' ' A' ' 129' ' ' ALA . 92.0 m-85 -117.76 116.46 27.05 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.849 -0.797 . . . . 74.23 108.849 177.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -75.57 147.26 39.79 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.578 -0.737 . . . . 62.12 110.622 -176.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.42 -84.63 0.05 OUTLIER Glycine 0 C--N 1.344 1.002 0 N-CA-C 111.033 -0.827 . . . . 53.23 111.033 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -167.6 172.89 9.01 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.861 0.865 . . . . 75.02 110.43 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 6.8 mp -80.89 141.67 34.34 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.749 0.82 . . . . 73.55 109.067 173.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . 178.03 -119.44 0.67 Allowed Glycine 0 C--N 1.336 0.528 0 N-CA-C 110.937 -0.865 . . . . 75.13 110.937 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 13.7 p -159.74 158.27 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.01 0.924 . . . . 72.2 109.189 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 145' ' ' ASP . . . . . 0.449 ' HA ' ' ND2' ' A' ' 104' ' ' ASN . 2.8 m-20 . . . . . 0 C--O 1.251 1.164 0 N-CA-C 107.533 -1.284 . . . . 72.55 107.533 164.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.863 0 N-CA-C 113.47 0.148 . . . . 42.32 113.47 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.01 -61.91 1.9 Allowed Glycine 0 C--N 1.346 1.095 0 N-CA-C 111.886 -0.486 . . . . 63.14 111.886 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 93' ' ' PHE . . . . . 0.414 ' CD1' HG21 ' B' ' 55' ' ' VAL . 0.8 OUTLIER -70.92 -59.35 2.84 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.333 -0.618 . . . . 75.2 109.333 -178.701 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -103.1 -77.94 0.56 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 117.763 0.256 . . . . 74.22 110.557 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -148.25 -83.57 0.11 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.159 0.436 . . . . 74.43 112.043 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.36 89.93 0.08 OUTLIER Glycine 0 C--N 1.347 1.159 0 N-CA-C 111.312 -0.715 . . . . 50.32 111.312 -170.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 97' ' ' ILE . . . . . 0.4 HD11 ' HB2' ' B' ' 94' ' ' MET . 9.4 tt -99.67 8.47 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.325 0 C-N-CA 124.696 1.198 . . . . 74.2 108.781 171.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 30.6 t70 69.66 -77.78 0.05 Allowed 'General case' 0 C--N 1.361 1.071 0 C-N-CA 125.798 1.639 . . . . 65.55 109.194 -165.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -163.42 147.99 10.92 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.528 1.131 . . . . 73.14 108.82 176.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 100' ' ' LEU . . . . . 0.422 HD13 ' HD1' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -118.06 93.3 44.3 Favored Pre-proline 0 CA--C 1.56 1.333 0 C-N-CA 123.276 0.63 . . . . 73.52 110.819 -177.096 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -83.9 -167.21 0.42 Allowed 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 123.072 2.515 . . . . 54.14 111.089 173.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 102' ' ' LEU . . . . . 0.405 HD13 ' CD1' ' F' ' 106' ' ' TYR . 17.0 mt -150.07 80.78 1.37 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.339 0.655 . . . . 74.15 110.222 175.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 70.5 p 46.92 38.69 6.45 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.715 1.606 . . . . 74.54 113.909 169.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.31 -59.0 4.98 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 111.316 -0.714 . . . . 42.21 111.316 -174.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -140.08 137.24 34.39 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 124.382 1.073 . . . . 74.54 109.233 177.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 106' ' ' TYR . . . . . 0.485 ' CE2' ' HB ' ' B' ' 46' ' ' THR . 41.7 t80 -84.36 130.56 34.78 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 123.631 0.772 . . . . 74.01 109.253 174.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 3.8 m 68.96 159.44 0.17 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 124.596 1.185 . . . . 75.12 110.107 -177.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 108' ' ' HIS . . . . . 0.589 ' HA ' ' HB2' ' F' ' 112' ' ' ASN . 54.6 t-80 75.08 -9.75 1.33 Allowed 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 124.137 0.975 . . . . 65.44 112.107 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -79.8 -27.78 40.29 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.385 1.074 . . . . 75.31 110.331 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -157.25 -70.11 0.1 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.024 0.93 . . . . 41.11 109.302 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 10.3 tt -73.76 113.48 10.96 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.002 -1.11 . . . . 72.11 108.002 174.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 112' ' ' ASN . . . . . 0.589 ' HB2' ' HA ' ' F' ' 108' ' ' HIS . 20.2 t-20 -162.83 146.05 10.97 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 123.917 0.761 . . . . 75.31 110.279 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -68.58 79.5 0.28 Allowed 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 124.568 1.147 . . . . 74.14 109.863 173.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -162.14 164.62 27.85 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.311 0.644 . . . . 73.51 110.071 -174.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 26.9 m -71.04 76.57 0.66 Allowed 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 124.145 0.978 . . . . 52.2 109.757 171.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 171.19 40.97 0.03 OUTLIER Glycine 0 N--CA 1.464 0.561 0 CA-C-N 114.868 -1.06 . . . . 54.03 110.495 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -71.26 147.9 93.43 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.807 0.843 . . . . 75.3 110.734 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.88 -165.46 0.33 Allowed 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 122.981 2.454 . . . . 65.34 111.781 171.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -81.24 -176.72 6.13 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.626 0.77 . . . . 74.54 110.252 173.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 21.4 t80 74.62 179.03 0.2 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.336 1.054 . . . . 74.44 110.23 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 99.4 t 75.05 136.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 C-N-CA 125.018 1.327 . . . . 72.33 111.138 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 54.7 m 56.96 86.28 0.07 Allowed 'General case' 0 C--N 1.361 1.071 0 C-N-CA 124.684 1.193 . . . . 75.4 110.121 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -151.46 177.99 9.75 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.459 -0.791 . . . . 65.32 109.282 -169.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 15.4 m -68.84 86.61 0.34 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.056 0.943 . . . . 63.21 111.01 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 125' ' ' ALA . . . . . 0.477 ' HB1' ' HD2' ' B' ' 130' ' ' PRO . . . -164.29 135.7 4.5 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.418 1.087 . . . . 73.15 109.129 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . 69.76 -178.39 0.22 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.74 1.216 . . . . 65.14 111.578 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 45.3 p -155.03 147.31 23.87 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.325 0.65 . . . . 33.21 110.996 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.18 115.66 23.09 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.527 -0.916 . . . . 64.15 108.527 172.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 129' ' ' THR . . . . . 0.412 HG21 ' O ' ' C' ' 122' ' ' THR . 74.4 p -81.48 -78.13 0.2 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 122.925 0.49 . . . . 53.51 110.732 -176.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -177.24 -168.91 0.21 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.874 0.87 . . . . 73.23 110.305 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 131' ' ' TRP . . . . . 0.45 ' HB2' ' HG3' ' B' ' 124' ' ' PRO . 27.7 t90 -120.58 -11.05 9.13 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.015 0.926 . . . . 75.34 110.164 168.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 35.4 t -54.48 99.83 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.699 0.8 . . . . 43.53 112.031 -169.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 133' ' ' THR . . . . . 0.507 HG23 ' HA ' ' C' ' 126' ' ' LEU . 22.8 m -76.61 -42.08 43.71 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.927 -1.033 . . . . 71.44 109.365 174.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.91 13.62 75.65 Favored Glycine 0 C--N 1.356 1.659 0 CA-C-N 114.937 -1.029 . . . . 73.45 114.096 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 10.0 p -74.45 90.54 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 CA-C-O 122.419 1.104 . . . . 53.24 110.872 -174.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -94.68 97.55 10.16 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.08 -0.964 . . . . 74.43 108.624 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 13.7 m 66.4 -87.23 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 125.116 1.366 . . . . 72.41 110.145 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -142.38 23.59 1.98 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.188 0.995 . . . . 75.43 110.007 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -144.21 170.79 15.3 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.086 0.954 . . . . 70.32 109.116 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -128.12 -113.09 1.72 Allowed Glycine 0 C--N 1.348 1.224 0 N-CA-C 111.457 -0.657 . . . . 53.31 111.457 174.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -160.27 -166.61 1.72 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.28 1.032 . . . . 63.11 109.906 -175.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.01 117.59 22.79 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.931 0.892 . . . . 61.31 109.12 171.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -89.59 61.57 3.49 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 115.756 -0.657 . . . . 55.13 112.972 -175.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 32.1 m -109.66 152.83 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.617 0.767 . . . . 75.25 110.521 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 . . . . . 0 CA--C 1.551 0.998 0 C-N-CA 124.895 1.278 . . . . 73.43 110.575 -177.157 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtm . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 109.683 -0.488 . . . . 73.22 109.683 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.1 p -164.19 -43.99 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.444 1.098 . . . . 74.45 108.425 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 63.99 16.63 10.05 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 125.22 1.408 . . . . 71.4 111.705 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -96.95 124.58 40.96 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 123.809 0.843 . . . . 71.13 108.9 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -85.27 -9.65 57.45 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.017 0.527 . . . . 71.43 110.038 175.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -88.76 14.07 11.04 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.311 1.044 . . . . 73.32 111.988 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.3 p -60.12 -71.39 0.13 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.174 0.589 . . . . 53.22 110.358 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.524 ' HG2' ' SD ' ' A' ' 9' ' ' MET . 43.2 tt0 178.56 -69.01 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 107.298 -1.371 . . . . 73.41 107.298 172.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.524 ' SD ' ' HG2' ' A' ' 8' ' ' GLU . 0.7 OUTLIER -99.85 170.66 8.38 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.767 0.827 . . . . 71.22 109.809 170.599 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.8 m -146.5 111.56 5.38 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.244 1.018 . . . . 65.35 108.459 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -121.13 112.46 18.71 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.228 -1.397 . . . . 74.34 107.228 167.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -135.68 135.64 40.27 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.804 -1.184 . . . . 62.21 107.804 171.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.9 mt -91.57 115.83 31.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.281 -1.007 . . . . 74.13 108.281 176.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -73.88 -40.24 63.35 Favored 'General case' 0 C--O 1.242 0.708 0 O-C-N 123.388 0.43 . . . . 70.32 110.51 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.506 ' HE ' ' HB ' ' B' ' 122' ' ' THR . 26.0 ttt180 -174.86 122.65 0.24 Allowed 'General case' 0 N--CA 1.479 1.0 0 O-C-N 123.227 0.33 . . . . 72.51 110.432 -169.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 73.7 mt -106.47 136.52 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 108.723 -0.843 . . . . 72.45 108.723 172.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.473 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 26.4 p90 -166.65 177.95 6.27 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 124.206 0.941 . . . . 75.02 111.802 -172.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.6 p -110.35 118.8 37.27 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.064 -0.971 . . . . 64.4 109.386 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.473 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 35.8 mtpt -82.97 -29.33 29.12 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.066 0.46 . . . . 61.21 109.79 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 30.6 t70 -150.52 136.8 18.67 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.765 -1.107 . . . . 71.14 109.28 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.406 HG23 HG22 ' A' ' 78' ' ' VAL . 59.8 mt -135.06 138.78 48.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.904 -1.147 . . . . 64.31 107.904 174.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.4 t -150.02 124.32 9.54 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.641 0.588 . . . . 71.2 110.04 173.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.7 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.6 t80 -120.95 132.97 55.25 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 106.87 -1.529 . . . . 74.14 106.87 168.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -128.5 139.93 52.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.301 -0.629 . . . . 63.13 109.301 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.13 78.07 65.68 Favored Pre-proline 0 C--O 1.24 0.581 0 N-CA-C 106.908 -1.516 . . . . 75.31 106.908 171.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -64.18 -34.51 56.61 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.671 2.247 . . . . 73.2 112.303 -171.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -106.11 22.34 15.85 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 118.146 -0.931 . . . . 73.44 110.488 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.428 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -43.04 -56.08 6.81 Favored Pre-proline 0 N--CA 1.493 1.721 0 CA-C-O 117.923 -1.037 . . . . 51.42 113.752 -171.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.428 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 22.8 Cg_exo -65.03 -27.87 57.6 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 121.906 1.738 . . . . 64.4 113.29 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -80.65 -40.43 25.57 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.847 0.859 . . . . 71.13 110.922 -175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.809 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.3 p -78.1 -21.33 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 CA-C-N 114.935 -1.029 . . . . 72.53 112.837 -158.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -71.05 -12.14 61.35 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.168 0.587 . . . . 74.32 111.438 176.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -90.22 -18.31 25.92 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.537 1.135 . . . . 62.12 111.011 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -81.55 161.01 23.73 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.494 0.717 . . . . 72.41 112.126 -172.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.13 116.14 6.9 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 114.75 -1.113 . . . . 74.33 108.765 173.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.43 ' CE3' HD21 ' A' ' 68' ' ' LEU . 63.6 t-105 -80.79 80.18 7.31 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.875 0.845 . . . . 73.41 109.678 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.427 ' H ' HD22 ' A' ' 68' ' ' LEU . 51.2 tt0 -123.97 69.71 48.39 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 124.898 1.279 . . . . 73.32 108.24 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -86.4 118.25 1.59 Allowed 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.602 2.201 . . . . 73.43 112.816 -170.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -94.45 103.46 15.43 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 105.023 -2.214 . . . . 74.45 105.023 168.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.458 ' CG1' HG13 ' A' ' 64' ' ' VAL . 57.5 t -90.74 101.8 12.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 123.39 0.676 . . . . 74.22 110.334 -177.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -79.6 117.97 21.01 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.662 -0.699 . . . . 74.51 109.855 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.3 mt -97.02 107.04 19.49 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.281 -1.007 . . . . 74.34 108.281 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.532 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.7 m-20 -106.85 106.77 17.45 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.174 0.99 . . . . 74.13 108.679 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.446 HD11 HG21 ' A' ' 131' ' ' VAL . 85.3 mt -98.91 149.64 22.74 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.858 0.463 . . . . 62.31 110.631 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -154.92 148.68 25.52 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.856 -1.065 . . . . 75.05 108.696 177.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.3 m -131.51 130.89 42.94 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.583 0.753 . . . . 74.33 109.878 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.87 109.12 9.87 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.806 0.842 . . . . 55.04 109.121 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.2 p -98.7 156.95 16.58 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.214 0.606 . . . . 64.31 110.327 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.2 t -150.2 151.63 33.37 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.629 1.172 . . . . 75.04 108.609 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -100.16 111.56 23.85 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.091 -1.077 . . . . 72.12 108.091 172.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 74.1 mt -79.22 -43.03 24.64 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.136 0.574 . . . . 53.33 110.234 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.98 -177.28 5.65 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.962 -0.563 . . . . 54.24 110.708 -176.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.02 110.76 0.87 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.088 0.955 . . . . 73.03 109.883 174.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 65.1 9.59 5.65 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.529 1.132 . . . . 72.55 112.655 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.2 t -104.27 107.24 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.299 -1.0 . . . . 63.52 108.299 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -114.77 126.55 54.97 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.495 -0.928 . . . . 75.45 108.495 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -90.51 151.63 21.28 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.163 -0.681 . . . . 64.35 109.163 168.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.409 HG11 ' HD3' ' A' ' 103' ' ' PRO . 55.1 t -132.57 136.34 56.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 124.882 1.273 . . . . 42.42 107.568 170.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 52.5 t -118.01 130.12 73.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.765 -0.828 . . . . 45.4 108.765 175.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.442 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -102.32 103.47 13.92 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.643 -1.614 . . . . 73.24 106.643 176.258 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -90.21 98.77 11.97 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.16 -1.422 . . . . 72.42 107.16 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.61 132.24 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 114.757 -1.111 . . . . 71.13 108.177 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 6.8 m -125.51 146.65 49.56 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.395 -0.965 . . . . 61.22 108.395 175.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 23.2 t -145.61 117.37 2.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 124.867 1.267 . . . . 64.4 107.933 -168.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.7 m -126.2 120.55 30.36 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.129 0.422 . . . . 74.32 110.004 177.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.42 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -101.24 105.59 16.72 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.264 -1.384 . . . . 54.21 107.264 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.2 m -109.07 126.13 52.84 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.044 0.537 . . . . 73.2 110.007 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.43 HD21 ' CE3' ' A' ' 36' ' ' TRP . 35.0 mt -89.79 74.76 7.42 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 125.021 1.328 . . . . 74.11 108.671 175.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.99 -84.39 0.92 Allowed Glycine 0 C--N 1.341 0.856 0 CA-C-N 115.713 -0.676 . . . . 72.02 111.921 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -114.28 -29.0 7.06 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.787 0.835 . . . . 53.44 111.007 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -88.89 134.41 33.96 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.837 0.455 . . . . 65.44 110.211 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -80.2 136.45 36.48 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 118.019 0.372 . . . . 65.21 110.126 175.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.809 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -87.12 -58.25 2.66 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.166 0.986 . . . . 63.03 109.264 176.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -154.54 168.28 27.26 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.579 -1.191 . . . . 64.13 110.695 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 64' ' ' VAL . 67.1 tp -124.56 147.37 48.48 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.213 1.405 . . . . 64.3 108.042 172.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.56 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 79.8 m -142.86 128.1 18.73 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.2 -1.037 . . . . 73.41 108.2 175.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -146.27 118.45 8.33 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.775 -0.454 . . . . 74.3 109.775 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.406 HG22 HG23 ' A' ' 21' ' ' ILE . 39.4 t -127.41 112.81 29.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.49 1.116 . . . . 64.51 108.97 -176.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 51.7 mt-30 -86.28 84.18 7.53 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.652 -0.87 . . . . 74.12 108.652 171.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -76.78 94.92 3.93 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.506 -1.224 . . . . 73.23 109.578 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.82 144.26 18.06 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 111.87 -0.492 . . . . 64.33 111.87 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.494 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.03 124.18 2.75 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.265 -1.134 . . . . 71.22 110.265 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.422 HG13 ' HE1' ' A' ' 17' ' ' TYR . 48.9 mt -81.74 129.15 37.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.923 -1.14 . . . . 73.01 107.923 172.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.653 ' HB3' HD11 ' A' ' 86' ' ' ILE . 88.9 m-85 -128.5 122.99 32.43 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.189 0.996 . . . . 74.44 109.298 -174.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.0 t -89.75 93.27 9.39 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.36 1.064 . . . . 73.05 108.841 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.653 HD11 ' HB3' ' A' ' 84' ' ' PHE . 15.9 mm -120.73 132.89 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.895 0.878 . . . . 74.13 111.379 -168.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.75 167.43 28.23 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.617 0.767 . . . . 62.21 110.708 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.86 8.67 72.5 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 119.325 -0.709 . . . . 63.24 114.73 173.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.47 HD11 HG22 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -143.41 164.07 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 124.112 0.965 . . . . 60.42 109.922 174.704 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.473 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 19.8 tt0 -154.94 179.05 9.49 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.501 -0.772 . . . . 62.22 109.089 174.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.473 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 61.99 -130.03 44.44 Favored Glycine 0 C--N 1.347 1.149 0 C-N-CA 123.283 0.468 . . . . 63.22 113.792 175.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.5 p -67.92 -28.58 67.62 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.995 0.918 . . . . 55.04 111.259 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -66.59 -43.22 85.46 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.71 0.804 . . . . 62.1 110.25 177.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.3 tpt -70.84 -41.3 71.68 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.571 -0.74 . . . . 75.41 110.594 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.71 84.87 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.359 0.663 . . . . 64.43 111.136 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.415 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 61.0 t-80 -71.7 -29.77 64.93 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.324 0.65 . . . . 73.51 110.75 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.8 t -71.41 -48.31 50.52 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.603 -0.517 . . . . 61.34 109.603 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 79.0 mt -80.37 -25.49 39.13 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.141 0.576 . . . . 74.15 112.494 -174.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.79 4.3 32.3 Favored Glycine 0 N--CA 1.474 1.175 0 CA-C-O 119.669 -0.517 . . . . 44.03 113.954 -173.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -144.2 -65.48 0.36 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 117.469 0.634 . . . . 74.31 111.33 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -67.6 -45.93 74.03 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 116.193 -0.458 . . . . 74.02 112.209 -171.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 68.6 m -66.98 -48.34 50.65 Favored Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 124.073 0.949 . . . . 73.41 112.863 -176.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HD3' HG11 ' A' ' 58' ' ' VAL . 46.0 Cg_endo -66.92 -21.02 50.73 Favored 'Trans proline' 0 C--N 1.393 2.893 0 C-N-CA 121.596 1.531 . . . . 72.52 112.562 173.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -71.84 -35.23 69.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.122 0.569 . . . . 54.21 110.364 174.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 38.6 mm -64.08 -42.72 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.65 0.78 . . . . 74.35 109.968 171.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.494 HD21 ' HA3' ' A' ' 82' ' ' GLY . 65.3 mt -76.17 -21.15 56.86 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.253 -0.885 . . . . 64.24 111.997 -174.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -64.31 -43.85 74.12 Favored Pre-proline 0 N--CA 1.484 1.261 0 CA-C-O 117.296 -1.335 . . . . 73.42 114.47 -172.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.78 -37.21 75.99 Favored 'Trans proline' 0 C--N 1.384 2.402 0 CA-C-N 122.04 1.764 . . . . 51.11 113.039 171.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -77.82 -39.39 43.84 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.581 0.753 . . . . 54.31 111.777 -177.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.56 -47.07 77.09 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.592 -0.521 . . . . 75.22 109.592 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.486 ' NH1' HD12 ' C' ' 105' ' ' ILE . 29.5 ttm180 -48.19 -56.06 8.87 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 125.157 1.535 . . . . 72.04 110.32 173.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.07 -44.96 94.32 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 124.432 1.082 . . . . 65.01 112.186 -174.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 117' ' ' MET . 42.1 t -59.27 -41.42 88.84 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.893 0.745 . . . . 72.02 110.82 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 118' ' ' VAL . 74.4 mt -64.32 -50.77 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.443 1.097 . . . . 75.3 110.561 174.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.0 m -59.56 -36.36 76.05 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.376 1.071 . . . . 75.12 111.386 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -71.38 -41.59 69.5 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 114.712 -1.131 . . . . 73.43 109.859 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.7 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 44.4 mtm -62.1 -38.37 88.62 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.731 0.413 . . . . 63.34 111.101 175.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 114' ' ' ILE . 65.6 t -63.52 -47.38 91.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 124.325 1.05 . . . . 72.51 111.157 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.8 p -71.79 -35.27 69.95 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.007 0.523 . . . . 72.2 111.327 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.467 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 87.5 mtt-85 -68.18 -30.75 69.93 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.561 0.744 . . . . 74.25 109.886 173.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.447 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.06 14.51 48.93 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-O 118.953 -0.915 . . . . 52.14 113.218 175.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.6 t 61.54 10.21 3.13 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 127.233 2.213 . . . . 74.43 114.214 176.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -82.18 145.08 51.75 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-O 119.176 -0.44 . . . . 74.23 109.82 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.427 ' HG2' ' NE1' ' A' ' 36' ' ' TRP . 92.7 Cg_exo -48.55 149.75 6.66 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 124.039 3.16 . . . . 75.43 113.83 174.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -55.68 128.4 34.55 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 124.246 0.966 . . . . 64.14 112.021 -171.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.457 HD11 HG11 ' A' ' 40' ' ' VAL . 41.4 tp -118.99 102.54 8.84 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.432 0.693 . . . . 74.42 110.172 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -102.77 115.38 30.47 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 107.798 -1.186 . . . . 71.12 107.798 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.3 mt -67.17 134.09 51.06 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.339 -0.615 . . . . 73.2 109.339 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.424 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -61.15 137.8 94.27 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 123.532 0.733 . . . . 52.03 111.379 -175.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 32.4 Cg_exo -59.81 107.11 0.36 Allowed 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.337 2.691 . . . . 70.53 113.47 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.446 HG21 HD11 ' A' ' 44' ' ' LEU . 58.3 t -100.95 134.46 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.119 0.568 . . . . 52.02 111.518 -174.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.503 ' HB2' ' HA2' ' E' ' 140' ' ' GLY . 52.7 t30 -96.26 87.54 4.52 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.347 -1.297 . . . . 73.42 109.134 175.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -59.74 -25.07 64.56 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.979 0.911 . . . . 74.33 112.531 175.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.436 ' HB3' ' OD1' ' A' ' 132' ' ' ASN . 19.8 t70 -58.68 -49.94 75.69 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.651 0.78 . . . . 65.52 109.812 172.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.448 ' HB2' ' ND2' ' A' ' 132' ' ' ASN . . . -59.51 -49.6 77.16 Favored 'General case' 0 C--N 1.358 0.956 0 O-C-N 123.731 0.645 . . . . 54.12 110.727 175.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 85.7 mt -53.13 -44.65 67.89 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 124.144 0.903 . . . . 71.04 111.925 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -66.66 -45.2 79.73 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.533 -0.758 . . . . 72.25 110.467 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.478 ' HA ' ' HB3' ' A' ' 141' ' ' LEU . 17.4 mtp -74.0 -19.39 60.66 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.964 -0.562 . . . . 75.31 112.006 -174.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 85.8 m-20 -66.51 -37.5 85.19 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.453 0.701 . . . . 74.53 110.194 171.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -74.3 -42.72 59.05 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.766 0.826 . . . . 63.42 110.593 173.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.478 ' HB3' ' HA ' ' A' ' 138' ' ' MET . 40.9 tp -68.16 -49.1 63.19 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.308 1.043 . . . . 71.42 112.331 -170.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.407 ' HG3' ' HB2' ' A' ' 144' ' ' GLN . 19.8 pt20 -160.4 20.15 0.15 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.151 0.58 . . . . 74.13 111.553 -172.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 77.4 mt-30 62.23 16.11 8.12 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.89 1.276 . . . . 71.52 113.304 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.407 ' HB2' ' HG3' ' A' ' 142' ' ' GLN . 33.1 tt0 -74.53 109.01 7.66 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.553 0.341 . . . . 75.31 111.242 -172.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.52 178.38 9.94 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.121 0.968 . . . . 61.35 110.097 175.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 160.68 39.94 0.02 OUTLIER Glycine 0 C--N 1.342 0.895 0 N-CA-C 111.541 -0.624 . . . . 63.15 111.541 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -75.04 152.99 38.62 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.739 0.816 . . . . 74.51 110.562 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.422 ' HA3' HG23 ' C' ' 7' ' ' THR . . . -85.19 -177.56 50.78 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 116.03 -0.532 . . . . 74.23 114.052 -173.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 41.3 p -124.09 108.69 12.6 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.126 0.97 . . . . 75.43 108.434 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.444 ' HB3' HG23 ' C' ' 10' ' ' THR . 2.0 mp0 -78.76 85.89 4.74 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.459 -0.571 . . . . 71.33 109.459 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.0 86.52 1.31 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 106.53 -1.656 . . . . 72.12 106.53 171.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -85.34 143.93 28.37 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.38 -0.827 . . . . 70.55 110.333 -167.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -100.73 -163.17 1.0 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.372 0.669 . . . . 72.4 110.786 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -108.3 139.42 43.03 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.504 0.722 . . . . 64.43 109.444 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.934 0 C-N-CA 123.89 0.876 . . . . 73.03 109.828 176.861 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.438 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.847 0.355 . . . . 53.02 110.929 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 61.4 p -93.16 54.27 2.1 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.948 0.899 . . . . 54.33 109.836 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -122.79 -171.08 2.21 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.49 1.116 . . . . 74.54 111.252 -163.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 62.04 -81.0 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.708 1.603 . . . . 75.24 111.952 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 58.42 79.81 0.2 Allowed 'General case' 0 C--N 1.362 1.141 0 C-N-CA 124.307 1.043 . . . . 74.14 109.959 -175.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -61.52 100.34 0.14 Allowed 'General case' 0 C--N 1.353 0.754 0 CA-C-N 115.298 -0.865 . . . . 71.14 111.348 -171.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 37.4 m -66.76 151.63 47.08 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 113.866 -1.515 . . . . 61.12 111.25 -176.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.24 155.82 23.68 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.913 0.885 . . . . 74.4 110.769 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.523 ' SD ' HG23 ' B' ' 89' ' ' ILE . 11.8 tpt 66.84 163.4 0.18 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 125.634 1.574 . . . . 53.51 111.425 -169.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 9.4 t -153.92 132.26 11.98 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 107.483 -1.303 . . . . 63.35 107.483 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -137.69 136.97 37.89 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.146 -0.687 . . . . 74.14 109.146 -175.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -155.72 141.5 18.02 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.373 0.669 . . . . 74.42 109.523 173.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 55.6 mt -87.72 125.16 41.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.199 -1.037 . . . . 62.4 108.199 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -89.94 -39.63 12.88 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.672 -0.695 . . . . 72.44 109.802 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.44 ' HE ' HG21 ' A' ' 122' ' ' THR . 38.6 ttt180 -171.49 143.79 1.83 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.687 -0.688 . . . . 62.32 109.725 -174.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 71.4 mt -130.25 138.14 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 107.519 -1.289 . . . . 73.14 107.519 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.421 ' HE1' HG13 ' B' ' 83' ' ' ILE . 26.7 p90 -161.66 143.37 11.42 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.248 0.547 . . . . 75.52 111.479 -172.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.697 HG21 HD11 ' B' ' 21' ' ' ILE . 21.1 m -76.44 123.26 25.73 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.946 -1.025 . . . . 73.1 108.522 171.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.43 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.8 mtpt -93.84 -26.54 16.88 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.265 0.626 . . . . 71.13 110.337 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 34.0 t70 -152.53 141.75 21.44 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.91 0.484 . . . . 75.11 110.814 -175.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.697 HD11 HG21 ' B' ' 18' ' ' THR . 32.8 mm -129.5 142.47 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.022 1.329 . . . . 72.51 108.449 174.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 46.5 m -147.58 134.27 19.97 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.846 -1.07 . . . . 71.22 109.668 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -147.16 109.05 4.4 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.752 -1.573 . . . . 70.52 106.752 167.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -120.98 114.84 22.1 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.487 -0.931 . . . . 65.34 108.487 -177.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.58 87.02 2.48 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 107.327 -1.36 . . . . 63.21 107.327 175.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.65 -37.28 22.12 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.502 2.134 . . . . 74.23 112.552 -169.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -102.13 17.46 23.25 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.05 0.94 . . . . 73.13 110.621 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.422 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -39.88 -60.74 1.28 Allowed Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 115.465 1.654 . . . . 75.53 115.465 -163.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 12.6 Cg_exo -67.57 -28.48 38.02 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 121.844 1.696 . . . . 72.34 112.349 -173.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.458 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 79.1 m80 -92.83 -25.43 18.12 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.137 -0.938 . . . . 74.03 112.145 -173.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.585 HG21 ' HA ' ' B' ' 73' ' ' ALA . 6.0 p -83.02 -7.55 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 121.259 0.552 . . . . 75.43 110.725 -176.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -77.76 -9.23 58.91 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.207 0.603 . . . . 72.13 112.626 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 10.5 pt20 -67.23 -17.25 64.73 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.809 0.444 . . . . 71.11 110.582 170.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.538 ' HB2' HD13 ' B' ' 68' ' ' LEU . 30.5 mmtp -92.92 98.43 11.36 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.841 1.257 . . . . 74.24 109.23 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' F' ' 132' ' ' SER . 3.9 m-20 -100.1 78.25 2.06 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.322 0.649 . . . . 75.14 110.233 -176.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 25.2 p90 -166.06 172.46 11.35 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.575 0.75 . . . . 65.14 110.244 174.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -71.73 117.59 59.02 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 123.201 0.6 . . . . 73.32 110.104 175.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.42 ' HD3' ' HG2' ' B' ' 124' ' ' PRO . 55.8 Cg_endo -70.53 147.35 57.74 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 121.754 1.636 . . . . 72.33 110.474 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -72.47 110.0 6.56 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.22 -1.03 . . . . 65.24 108.22 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.479 HG21 HD13 ' B' ' 126' ' ' LEU . 59.9 t -99.32 146.05 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 114.955 -1.02 . . . . 73.24 110.44 -174.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -119.23 117.86 29.77 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.981 1.312 . . . . 70.04 108.578 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.629 HD13 HD22 ' B' ' 128' ' ' LEU . 24.2 tp -89.26 144.77 25.85 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.922 -0.399 . . . . 61.14 109.922 172.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.412 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 12.3 t70 -150.82 119.25 6.42 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.752 -0.832 . . . . 74.04 108.752 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.51 ' H ' ' HE2' ' F' ' 113' ' ' LYS . 90.5 mt -99.47 126.24 45.36 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.475 -0.565 . . . . 71.42 109.475 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -124.79 127.45 47.2 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.765 -1.198 . . . . 74.15 107.765 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.8 t -109.46 141.37 41.97 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 122.746 0.418 . . . . 74.2 110.178 -172.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.69 140.73 27.47 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.477 1.111 . . . . 74.35 108.104 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 14.9 m -137.92 163.8 30.57 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.764 0.426 . . . . 72.4 110.021 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 72.1 p -156.41 136.31 12.64 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.246 0.618 . . . . 73.3 109.705 174.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -91.43 134.6 34.49 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.248 -1.019 . . . . 73.04 108.248 170.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 pp -150.67 14.22 0.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.432 -0.804 . . . . 74.34 109.717 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.98 158.82 35.64 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.439 -0.801 . . . . 45.02 110.953 -174.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -83.66 127.03 33.46 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.778 -1.101 . . . . 70.31 108.897 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 64.03 4.0 1.88 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 124.472 1.109 . . . . 63.23 113.065 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 53.6 t -132.32 122.73 48.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.63 -0.878 . . . . 74.31 108.63 -173.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.43 140.62 44.49 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 108.214 -1.032 . . . . 73.13 108.214 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -99.48 101.37 12.59 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 105.442 -2.058 . . . . 63.54 105.442 172.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.512 HG21 ' HG3' ' B' ' 103' ' ' PRO . 14.6 p -109.29 140.14 29.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 121.407 0.622 . . . . 72.12 109.329 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.418 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 17.0 t -114.2 144.56 21.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 124.614 1.166 . . . . 61.03 108.683 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 48.1 tp -121.12 110.36 16.12 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 107.751 -1.203 . . . . 73.34 107.751 167.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -84.25 118.36 24.12 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.673 -1.232 . . . . 73.3 107.673 171.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.4 121.24 57.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.44 -0.948 . . . . 71.5 108.44 173.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 17.8 m -108.75 135.29 50.22 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.74 0.816 . . . . 64.42 109.384 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.537 HG11 HD21 ' B' ' 126' ' ' LEU . 82.0 t -134.11 119.88 32.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.903 0.881 . . . . 73.12 109.171 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 66.6 m -109.5 138.98 45.06 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 123.659 0.783 . . . . 75.14 109.072 173.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.469 ' HB2' HG22 ' B' ' 40' ' ' VAL . . . -148.73 141.86 24.96 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.728 0.411 . . . . 73.43 109.909 178.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.554 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 35.4 p -141.68 132.68 26.07 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.607 0.763 . . . . 71.43 110.904 -176.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.538 HD13 ' HB2' ' B' ' 34' ' ' LYS . 68.8 mt -102.04 103.41 14.0 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 124.664 1.186 . . . . 61.22 109.196 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.96 -124.59 7.88 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.794 -0.639 . . . . 62.14 111.986 -175.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -96.08 2.24 53.1 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.937 0.895 . . . . 74.12 111.037 -173.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -130.16 149.38 51.89 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.988 0.515 . . . . 73.3 110.901 -173.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 85.9 m -73.73 123.68 24.57 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.014 -0.539 . . . . 75.32 110.673 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.585 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -76.35 -60.94 2.12 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.651 -1.159 . . . . 74.51 108.704 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -153.13 152.71 31.58 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.058 -0.974 . . . . 75.11 111.85 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 75.2 mt -121.05 110.62 16.46 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.53 -1.656 . . . . 55.22 106.53 169.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 28.9 t -119.28 121.25 39.21 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.028 -0.73 . . . . 62.4 109.028 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -138.22 128.49 26.0 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.244 0.618 . . . . 64.54 109.409 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 73.3 t -126.44 134.94 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.596 0.758 . . . . 62.23 109.172 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.502 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.3 mt-30 -108.67 107.72 18.3 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.305 -0.998 . . . . 73.44 108.305 175.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.425 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 7.8 tp-100 -100.8 107.81 19.46 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.753 -0.832 . . . . 74.0 108.753 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.43 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -91.73 170.01 33.16 Favored Glycine 0 C--O 1.245 0.784 0 N-CA-C 111.865 -0.494 . . . . 54.22 111.865 175.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.53 139.66 5.78 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 121.727 -0.273 . . . . 71.22 113.069 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.421 HG13 ' HE1' ' B' ' 17' ' ' TYR . 66.5 mt -98.23 110.75 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 125.019 1.327 . . . . 71.23 108.182 176.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -122.79 143.95 49.5 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.713 0.805 . . . . 74.43 110.839 -175.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 37.1 m -102.2 122.94 45.16 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.73 0.812 . . . . 70.3 109.894 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.566 ' HB ' HD11 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -131.89 122.74 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 124.911 1.284 . . . . 75.3 109.302 179.266 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.532 ' HA ' ' HB ' ' F' ' 97' ' ' ILE . . . -156.94 150.51 24.4 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.885 0.474 . . . . 61.54 111.579 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.36 -35.67 4.73 Favored Glycine 0 N--CA 1.479 1.503 0 C-N-CA 123.263 0.458 . . . . 75.22 112.394 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.566 HD11 ' HB ' ' B' ' 86' ' ' ILE . 7.1 pt -63.75 160.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 124.891 1.276 . . . . 65.21 112.655 173.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -153.78 176.07 12.57 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.023 0.929 . . . . 64.22 110.317 -173.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.4 -130.86 41.2 Favored Glycine 0 C--N 1.354 1.533 0 O-C-N 123.73 0.643 . . . . 63.13 112.859 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 18.0 m -67.5 -45.29 76.26 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.678 0.791 . . . . 63.44 109.75 172.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -59.12 -23.66 62.31 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 113.556 -1.656 . . . . 74.3 112.238 -167.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.446 ' HG3' HD11 ' F' ' 97' ' ' ILE . 20.6 ttt -58.6 -70.23 0.15 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.014 1.326 . . . . 74.13 111.931 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.39 -12.8 56.08 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.803 0.441 . . . . 70.25 112.137 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -63.24 -41.78 99.11 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.355 0.662 . . . . 72.21 110.267 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -60.69 -43.64 97.5 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.855 -0.611 . . . . 72.31 111.6 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.562 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.2 pp -81.28 -23.83 37.67 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.726 0.41 . . . . 52.42 111.776 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.51 -1.61 60.46 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-O 119.784 -0.453 . . . . 62.01 113.877 -174.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.47 -55.99 0.39 Allowed 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.303 0.551 . . . . 64.21 111.891 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -69.11 -46.23 68.23 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.745 0.418 . . . . 54.33 110.33 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.562 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 79.3 m -66.19 -47.98 59.85 Favored Pre-proline 0 CA--C 1.569 1.687 0 N-CA-C 113.711 1.004 . . . . 60.03 113.711 -177.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.512 ' HG3' HG21 ' B' ' 58' ' ' VAL . 15.2 Cg_exo -65.12 -28.82 56.52 Favored 'Trans proline' 0 C--N 1.402 3.359 0 C-N-CA 122.033 1.822 . . . . 72.24 112.87 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -69.62 -29.03 66.44 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.092 0.557 . . . . 71.23 110.325 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.23 -35.69 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.339 0.656 . . . . 64.14 110.334 170.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 76.5 mt -80.26 -17.98 50.68 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.821 0.848 . . . . 73.21 112.33 -177.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -59.42 -50.71 85.89 Favored Pre-proline 0 CA--C 1.561 1.375 0 CA-C-O 117.515 -1.231 . . . . 73.02 112.898 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -54.73 -37.11 91.84 Favored 'Trans proline' 0 C--N 1.39 2.727 0 C-N-CA 122.429 2.086 . . . . 70.2 114.028 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -68.73 -46.69 68.24 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.376 0.671 . . . . 72.51 110.583 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.425 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -64.55 -34.72 78.91 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.592 -0.731 . . . . 62.3 110.924 176.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 31.2 ttt180 -64.99 -50.13 67.54 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.226 1.41 . . . . 73.45 110.813 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.38 -32.52 70.21 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.403 0.681 . . . . 55.01 109.933 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.56 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.9 t -67.31 -41.37 85.46 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 122.923 0.489 . . . . 65.54 110.728 177.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 49.8 mt -59.83 -54.42 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.837 0.855 . . . . 71.43 110.445 172.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 25.1 m -61.79 -29.22 70.0 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 123.757 0.661 . . . . 75.24 111.371 -177.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 44.6 t -64.5 -52.44 57.83 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 123.543 0.737 . . . . 74.5 109.839 173.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 15.6 mmt -66.02 -33.62 76.22 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.27 0.628 . . . . 64.22 111.612 -175.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.504 HG21 HD23 ' B' ' 126' ' ' LEU . 74.3 t -66.76 -44.48 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.639 1.176 . . . . 75.45 110.602 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.5 t -64.66 -32.83 74.67 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.099 -0.955 . . . . 65.45 110.567 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' B' ' 116' ' ' SER . 78.5 mtt-85 -64.67 -47.78 77.16 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 115.709 -0.678 . . . . 72.13 109.339 175.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.468 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -67.95 -5.99 42.71 Favored Glycine 0 C--N 1.358 1.772 0 O-C-N 123.735 0.647 . . . . 22.41 113.615 174.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.506 ' HB ' ' HE ' ' A' ' 15' ' ' ARG . 2.2 m 66.77 27.62 9.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.539 1.536 . . . . 74.51 110.563 175.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -84.87 156.06 61.18 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.214 0.605 . . . . 74.32 110.971 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.581 ' HG3' ' HB3' ' F' ' 131' ' ' TRP . 71.6 Cg_exo -51.89 167.86 0.41 Allowed 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 123.991 3.127 . . . . 71.22 115.219 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -63.52 112.56 2.83 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.832 -1.076 . . . . 74.15 111.605 -167.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.537 HD21 HG11 ' B' ' 64' ' ' VAL . 43.6 tp -116.56 105.82 12.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.282 0.633 . . . . 74.23 109.56 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -121.49 120.96 36.41 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.034 -1.098 . . . . 72.21 108.034 170.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.629 HD22 HD13 ' B' ' 42' ' ' LEU . 59.2 mt -74.21 143.92 44.96 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.58 0.55 . . . . 63.03 110.988 -174.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.91 141.14 63.19 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 122.961 0.504 . . . . 73.11 110.843 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.655 ' HG3' HD11 ' D' ' 16' ' ' ILE . 61.7 Cg_endo -70.14 79.98 1.02 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.334 2.689 . . . . 73.33 111.216 174.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 p -100.01 125.42 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 115.498 -0.774 . . . . 74.44 110.053 -177.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -83.06 107.69 15.82 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.677 -0.692 . . . . 72.12 110.108 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -76.56 -27.91 56.06 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.428 0.691 . . . . 73.14 110.977 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -55.43 -40.37 71.41 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.144 0.978 . . . . 71.54 112.118 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.88 -34.07 62.61 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.658 0.783 . . . . 62.33 112.25 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.401 HD21 HG23 ' F' ' 121' ' ' VAL . 5.9 mp -72.53 -35.3 68.03 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.494 0.718 . . . . 72.22 110.202 -178.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -72.18 -36.13 69.18 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.409 -0.36 . . . . 64.24 111.092 170.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 2.4 mmt -75.06 -29.35 60.69 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 113.079 0.77 . . . . 73.52 113.079 -170.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -82.02 -39.19 23.9 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.35 0.26 . . . . 75.24 110.5 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -76.72 -47.56 21.51 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.642 0.377 . . . . 72.12 111.277 -175.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 69.9 mt -93.11 25.22 3.36 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.376 1.07 . . . . 72.54 110.715 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -72.44 171.23 12.68 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.397 0.679 . . . . 75.1 109.629 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 73.1 128.96 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.262 1.425 . . . . 75.4 111.318 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.18 159.25 42.61 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 107.131 -1.433 . . . . 73.22 107.131 -173.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.0 96.82 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.525 0.73 . . . . 62.55 110.249 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.41 -49.08 0.58 Allowed Glycine 0 C--N 1.34 0.785 0 N-CA-C 110.093 -1.203 . . . . 63.24 110.093 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 68.81 130.92 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 126.215 1.806 . . . . 74.23 113.369 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -120.18 90.75 0.48 Allowed Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.013 -0.835 . . . . 71.44 111.013 173.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 8.2 p -79.6 71.45 6.22 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.454 0.702 . . . . 71.52 110.456 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -82.67 105.89 14.07 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 107.949 -1.13 . . . . 73.15 107.949 171.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -64.94 125.26 24.33 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.059 0.944 . . . . 75.44 110.892 -173.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -121.88 127.11 50.1 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.849 0.86 . . . . 71.24 109.432 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -74.61 140.9 44.65 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 109.76 -0.459 . . . . 75.31 109.76 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -72.91 -62.55 1.42 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.522 0.729 . . . . 72.33 109.061 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.132 0 C-N-CA 124.344 1.058 . . . . 74.21 108.402 177.347 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 109.445 -0.576 . . . . 75.34 109.445 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 53.7 m -163.44 96.99 0.88 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.923 1.289 . . . . 41.33 108.517 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -110.81 150.29 29.34 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 108.801 -0.815 . . . . 74.14 108.801 168.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -147.81 -167.02 2.68 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.016 0.526 . . . . 74.44 111.172 -161.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -61.87 115.13 3.77 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-N 114.954 -1.021 . . . . 74.41 109.419 167.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -145.77 -73.41 0.23 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.913 -1.143 . . . . 74.1 107.913 -175.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.437 HG21 ' HG3' ' A' ' 150' ' ' GLU . 22.0 m -110.1 161.44 15.54 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 124.132 0.973 . . . . 62.1 110.275 -169.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -64.14 81.83 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.379 1.072 . . . . 74.55 108.808 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.408 ' HG2' ' HB2' ' C' ' 11' ' ' PHE . 59.8 ttm 60.74 113.47 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.367 1.467 . . . . 72.3 110.282 -162.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.444 HG23 ' HB3' ' A' ' 150' ' ' GLU . 16.9 m -86.2 85.63 7.35 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.246 -1.02 . . . . 75.32 108.246 172.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.408 ' HB2' ' HG2' ' C' ' 9' ' ' MET . 68.3 t80 -109.48 145.25 36.54 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.71 0.804 . . . . 72.0 109.264 -174.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -161.97 126.54 3.32 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.559 0.744 . . . . 74.03 109.591 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 48.5 mt -78.84 123.59 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 108.438 -0.949 . . . . 74.24 108.438 169.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.445 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 81.6 mm-40 -90.44 -42.12 11.07 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.644 0.777 . . . . 65.11 109.688 176.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -173.42 150.9 1.89 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.312 -0.858 . . . . 73.43 110.212 -178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 74.3 mt -128.17 135.15 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 106.731 -1.581 . . . . 72.41 106.731 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -173.06 158.64 3.77 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.379 0.609 . . . . 61.11 111.724 -170.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 70.2 p -82.46 113.24 20.08 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.341 -0.845 . . . . 71.04 109.123 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.603 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 10.4 mmmm -68.61 -49.13 61.64 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.046 -1.094 . . . . 73.11 108.046 169.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.704 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 20.8 t70 -136.19 143.68 44.54 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 113.852 -1.522 . . . . 73.44 109.681 -172.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.552 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.5 mt -138.47 145.66 27.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 125.435 1.494 . . . . 75.23 107.25 175.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 41.3 t -153.17 147.75 26.12 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.463 0.649 . . . . 62.03 110.048 175.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -151.83 125.61 9.04 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.04 -1.467 . . . . 74.44 107.04 170.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -129.35 117.81 21.23 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.682 0.793 . . . . 71.05 108.867 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.22 85.62 5.62 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 107.304 -1.369 . . . . 75.41 107.304 167.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.91 -33.61 63.11 Favored 'Trans proline' 0 C--N 1.387 2.605 0 C-N-CA 123.097 2.531 . . . . 64.23 112.209 -172.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -113.6 31.51 6.45 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.861 -1.063 . . . . 70.44 109.605 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.414 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -43.91 -54.68 10.54 Favored Pre-proline 0 C--N 1.377 1.764 0 CA-C-O 117.837 -1.078 . . . . 54.12 113.383 -174.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 50.1 Cg_exo -53.28 -52.16 9.33 Favored 'Trans proline' 0 C--N 1.395 3.003 0 C-N-CA 122.001 1.801 . . . . 63.01 113.128 175.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -69.52 -32.57 71.49 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.608 -1.178 . . . . 74.4 113.2 -171.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.622 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.9 p -79.05 -24.44 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 N-CA-C 112.48 0.548 . . . . 73.51 112.48 -173.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -71.42 -17.86 62.36 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 112.349 0.5 . . . . 71.51 112.349 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -93.75 7.39 45.01 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.918 0.487 . . . . 71.12 111.759 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.696 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -94.62 158.74 15.39 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.232 0.613 . . . . 71.42 110.788 -177.804 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -68.22 129.65 40.55 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.057 0.943 . . . . 65.43 109.539 164.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.567 ' HZ2' HD21 ' C' ' 126' ' ' LEU . 64.0 t-105 -82.24 90.49 6.62 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.211 0.604 . . . . 74.41 110.5 -178.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -143.14 78.38 15.16 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 107.709 -1.219 . . . . 74.35 107.709 171.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -93.79 169.85 1.99 Allowed 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 122.527 2.151 . . . . 64.35 112.835 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -92.78 89.76 6.76 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 106.181 -1.785 . . . . 63.43 106.181 171.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 61.2 t -68.16 96.97 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 109.037 -0.727 . . . . 74.14 109.037 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -96.75 104.68 16.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.884 -1.053 . . . . 74.42 108.641 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.682 ' H ' HD23 ' C' ' 42' ' ' LEU . 1.8 pt? -97.07 121.14 38.62 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.788 -1.56 . . . . 62.24 106.788 168.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -119.39 141.12 49.36 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.571 -0.9 . . . . 72.1 108.571 -174.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 50.0 mt -130.97 110.74 11.47 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.32 0.648 . . . . 65.54 110.165 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -114.54 122.86 47.85 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.967 1.707 . . . . 73.13 107.469 173.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.1 t -121.8 149.28 43.55 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.029 -0.73 . . . . 71.13 109.029 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.45 153.57 32.74 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.543 0.737 . . . . 51.32 109.281 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.456 ' OG ' ' HB3' ' C' ' 98' ' ' LEU . 12.8 m -131.71 145.36 51.59 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.304 0.642 . . . . 74.13 109.414 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.3 p -144.91 127.37 15.96 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.566 -0.901 . . . . 74.32 108.566 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -80.28 117.91 21.47 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 108.717 -0.846 . . . . 72.13 108.717 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.616 HD11 HD12 ' C' ' 83' ' ' ILE . 25.6 mt -83.82 -47.18 11.39 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.585 0.707 . . . . 71.34 109.656 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.57 -166.96 2.69 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 114.486 -1.233 . . . . 44.31 110.029 -171.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -57.77 105.0 0.22 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.399 1.079 . . . . 71.33 110.535 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 60.1 22.17 11.41 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.329 1.018 . . . . 71.52 112.978 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 85.6 t -104.3 119.64 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.661 0.785 . . . . 74.41 108.989 173.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -121.28 121.31 37.42 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.821 -1.177 . . . . 74.35 107.821 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -89.93 114.43 26.23 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.033 -1.099 . . . . 62.11 108.033 168.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 97.9 t -95.14 134.94 30.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.278 -1.379 . . . . 61.34 107.278 168.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 93.8 t -121.11 138.0 52.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 108.356 -0.979 . . . . 54.1 108.356 174.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.27 101.08 8.84 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.994 -1.113 . . . . 71.11 107.994 175.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 21.0 ttm-85 -81.07 107.13 13.62 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 108.434 -0.95 . . . . 74.44 108.434 170.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.49 ' HB ' HD11 ' C' ' 114' ' ' ILE . 7.8 t -106.58 120.11 57.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 108.09 -1.078 . . . . 70.32 108.09 173.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 17.5 m -119.21 116.16 25.72 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.251 0.621 . . . . 64.02 109.572 -174.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.475 HG21 HG21 ' C' ' 114' ' ' ILE . 63.3 t -104.06 109.04 26.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 123.452 0.701 . . . . 61.53 109.114 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 3.8 m -99.4 140.1 34.08 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.668 -1.234 . . . . 64.23 107.668 170.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.41 119.42 19.62 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 106.661 -1.607 . . . . 74.25 106.661 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 44.9 m -133.29 126.02 30.54 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.579 0.549 . . . . 61.43 110.452 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.696 HD13 ' HG2' ' C' ' 34' ' ' LYS . 11.0 mt -86.78 47.08 1.44 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.766 1.226 . . . . 62.11 109.317 176.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.65 -110.8 3.84 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 111.001 -0.84 . . . . 71.03 111.001 -174.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.16 -28.87 19.73 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.093 -0.706 . . . . 75.14 109.093 173.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -62.86 120.67 11.76 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.584 1.153 . . . . 72.14 109.194 172.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 20.9 m -84.24 125.06 31.87 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 108.443 -0.947 . . . . 75.13 108.443 169.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.622 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -73.45 -62.97 1.29 Allowed 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.328 -0.99 . . . . 64.4 108.328 174.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -157.33 169.89 23.7 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-O 121.917 0.865 . . . . 73.31 110.782 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.442 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.7 tm? -123.43 147.01 47.56 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 106.388 -1.708 . . . . 73.33 106.388 166.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.442 ' N ' HD13 ' C' ' 75' ' ' LEU . 48.4 t -149.22 145.62 27.2 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.846 -1.168 . . . . 54.53 107.846 177.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -157.07 136.56 12.17 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.301 -0.629 . . . . 74.15 109.301 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.474 HG11 ' HA ' ' C' ' 110' ' ' ALA . 54.7 t -134.22 113.52 17.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.136 -1.061 . . . . 63.3 108.136 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.704 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.4 mt-30 -94.44 89.21 5.77 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.828 -0.805 . . . . 71.03 108.828 173.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -79.68 102.4 8.94 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.509 -1.223 . . . . 74.55 110.09 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.58 150.47 26.93 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 112.007 -0.437 . . . . 61.41 112.007 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.404 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -152.22 117.69 0.84 Allowed Glycine 0 CA--C 1.502 -0.771 0 N-CA-C 110.233 -1.147 . . . . 63.3 110.233 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.616 HD12 HD11 ' C' ' 51' ' ' LEU . 25.5 mm -85.23 121.15 36.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.53 -0.915 . . . . 53.13 108.53 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -129.9 117.18 19.74 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.16 -1.052 . . . . 53.43 108.16 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 53.9 p -90.45 103.5 16.18 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.954 -0.758 . . . . 63.35 108.954 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.541 HD13 ' SG ' ' C' ' 97' ' ' CYS . 25.4 mt -116.86 138.74 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.146 0.978 . . . . 74.1 110.746 -171.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.06 170.4 19.48 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.657 0.783 . . . . 62.54 110.869 175.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.83 -18.67 38.01 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-N 115.534 -0.757 . . . . 42.14 113.756 172.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 34.8 pt -106.33 170.59 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.232 0.613 . . . . 64.13 111.261 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -160.81 158.84 29.13 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.645 0.778 . . . . 74.14 109.854 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.55 -114.76 7.1 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 123.615 0.572 . . . . 61.23 113.846 168.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 13.4 t -66.25 -35.5 80.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.635 0.774 . . . . 74.53 111.082 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -71.81 -42.66 66.78 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.646 0.778 . . . . 73.44 110.622 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 6.2 tpt -62.5 -52.36 63.78 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 123.923 0.765 . . . . 54.25 110.024 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.87 -31.42 72.59 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.753 -0.658 . . . . 60.43 111.817 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -72.17 -34.18 68.26 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.142 0.577 . . . . 70.1 110.553 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.541 ' SG ' HD13 ' C' ' 86' ' ' ILE . 18.2 t -71.2 -41.37 70.35 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.699 -0.482 . . . . 61.54 109.699 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.456 ' HB3' ' OG ' ' C' ' 48' ' ' SER . 89.9 mt -85.05 -44.51 12.96 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.959 0.904 . . . . 72.01 112.815 -170.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.52 3.17 57.68 Favored Glycine 0 N--CA 1.472 1.072 0 CA-C-N 116.067 -0.515 . . . . 43.31 113.481 -170.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.31 -68.98 0.45 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.999 0.4 . . . . 64.2 111.096 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -60.21 -55.1 37.93 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.765 0.826 . . . . 72.14 112.475 -171.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 98.2 m -59.75 -46.74 98.45 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.794 0.838 . . . . 72.13 112.523 -177.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -50.85 -35.21 48.09 Favored 'Trans proline' 0 C--N 1.395 3.018 0 C-N-CA 123.071 2.514 . . . . 63.04 115.119 169.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -66.8 -33.9 76.63 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 118.719 0.69 . . . . 74.32 111.075 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.486 HD12 ' NH1' ' A' ' 111' ' ' ARG . 42.0 mm -72.53 -34.83 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 123.004 0.521 . . . . 75.34 109.907 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.404 HD21 ' HA3' ' C' ' 82' ' ' GLY . 89.4 mt -84.49 -24.56 29.37 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.855 0.862 . . . . 70.5 112.326 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -57.05 -52.11 76.6 Favored Pre-proline 0 N--CA 1.482 1.137 0 CA-C-O 117.334 -1.317 . . . . 71.15 113.867 -172.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.01 -34.41 80.65 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.168 1.912 . . . . 64.31 112.915 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -66.35 -47.62 72.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.483 0.713 . . . . 72.24 110.236 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.474 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -63.39 -36.88 85.2 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.855 -1.066 . . . . 73.15 110.943 177.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.2 ttt-85 -68.99 -46.57 67.71 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.409 1.484 . . . . 75.34 111.176 -175.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -67.97 -34.33 76.36 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.528 0.731 . . . . 65.11 109.486 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 12.8 t -65.86 -35.67 81.32 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.462 0.705 . . . . 65.02 111.249 177.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.49 HD11 ' HB ' ' C' ' 62' ' ' VAL . 85.7 mt -69.23 -58.04 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.345 0.658 . . . . 72.11 110.485 176.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 4.7 m -64.43 -28.38 69.64 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 122.707 0.403 . . . . 70.03 111.249 -173.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 42.0 t -61.6 -52.78 62.99 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 123.279 0.632 . . . . 51.21 109.37 169.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.549 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.08 -42.59 80.96 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.011 1.324 . . . . 74.43 113.002 -179.568 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.468 HG11 HD23 ' C' ' 126' ' ' LEU . 87.3 t -63.62 -45.67 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.381 1.072 . . . . 64.51 110.253 177.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.4 t -67.52 -29.67 69.13 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.281 -1.327 . . . . 71.31 111.429 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.48 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 87.3 mtt-85 -68.59 -39.53 80.89 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.072 -0.714 . . . . 64.45 109.072 176.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.79 12.03 58.04 Favored Glycine 0 C--N 1.354 1.535 0 CA-C-N 115.698 -0.683 . . . . 70.21 113.0 175.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 69.0 p 53.8 37.53 26.56 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 126.212 1.805 . . . . 75.33 114.146 175.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -93.99 148.03 34.52 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 107.583 -1.266 . . . . 74.11 107.583 165.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.01 169.45 0.64 Allowed 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.224 2.616 . . . . 73.0 114.168 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -59.32 123.3 16.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.159 0.984 . . . . 74.04 111.975 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.567 HD21 ' HZ2' ' C' ' 36' ' ' TRP . 3.5 mm? -116.27 86.14 2.43 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.674 -1.232 . . . . 71.44 107.674 166.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -91.46 95.17 9.82 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.727 -0.842 . . . . 53.13 108.727 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.466 ' HA ' HG21 ' F' ' 135' ' ' VAL . 8.5 mp -55.84 131.01 45.85 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.102 0.961 . . . . 73.11 111.583 -175.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.44 137.08 96.48 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-O 118.694 -0.669 . . . . 62.11 110.453 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -49.52 110.91 0.41 Allowed 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.673 2.915 . . . . 73.35 113.442 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.9 t -100.93 114.55 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 123.142 0.577 . . . . 75.32 109.455 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -80.88 105.7 12.32 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.421 0.689 . . . . 72.54 109.418 176.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -68.8 -20.78 64.34 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.372 0.669 . . . . 51.3 112.329 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.55 -29.85 65.22 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.116 0.566 . . . . 65.51 110.554 173.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.01 -35.0 64.36 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.064 0.546 . . . . 70.2 110.004 173.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 83.1 mt -67.68 -40.28 84.42 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.82 -0.627 . . . . 71.3 110.418 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -72.09 -31.47 66.1 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.741 0.816 . . . . 75.32 110.488 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 23.5 ttt -60.54 -52.13 66.49 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.898 0.879 . . . . 55.25 110.524 177.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -71.45 -36.02 71.08 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 116.477 -0.329 . . . . 61.34 110.882 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -64.47 -86.43 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.964 0.906 . . . . 73.31 111.354 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 54.4 tp -152.31 117.87 5.34 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.456 0.702 . . . . 74.02 109.578 -172.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -155.36 154.13 31.53 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.372 1.069 . . . . 71.22 109.7 172.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -170.52 91.3 0.17 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 107.921 -1.14 . . . . 73.44 107.921 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -54.17 132.48 43.24 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.171 0.989 . . . . 70.45 111.658 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -87.72 175.41 7.88 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.629 0.772 . . . . 43.03 111.268 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -108.76 3.32 32.14 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 116.036 -0.529 . . . . 73.13 113.071 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -89.87 149.24 22.73 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.807 0.843 . . . . 64.3 110.597 -174.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -132.74 136.68 8.87 Favored Glycine 0 C--N 1.346 1.095 0 N-CA-C 111.064 -0.814 . . . . 51.21 111.064 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 10.0 t -67.38 150.55 48.8 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.144 0.978 . . . . 71.2 110.652 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -135.92 146.32 47.21 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.15 0.5 . . . . 72.3 110.822 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.47 138.05 56.31 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.806 1.243 . . . . 74.21 109.834 170.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -144.74 -52.82 0.3 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.228 0.611 . . . . 72.43 109.809 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -148.49 78.17 1.41 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.05 -1.093 . . . . 75.21 108.05 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -162.05 131.48 4.51 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.184 -0.916 . . . . 73.42 110.008 -177.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 N-CA-C 108.667 -0.864 . . . . 62.52 108.667 -179.784 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.13 -0.693 . . . . 74.31 109.13 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 41.1 m -90.96 90.34 7.84 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.002 -0.74 . . . . 63.13 109.002 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -82.58 -28.95 30.56 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 109.588 -0.523 . . . . 65.42 109.588 171.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -69.41 129.94 41.15 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.673 0.789 . . . . 70.42 110.157 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -144.64 172.49 12.91 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.571 0.748 . . . . 53.4 110.497 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -111.32 124.24 51.84 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 108.482 -0.933 . . . . 75.4 108.482 173.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 3.2 p -144.03 -57.64 0.38 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.391 1.077 . . . . 70.24 109.749 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.479 ' HG2' ' H ' ' D' ' 9' ' ' MET . 24.1 tt0 -143.38 -170.49 3.29 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.881 0.872 . . . . 72.54 109.169 -176.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.479 ' H ' ' HG2' ' D' ' 8' ' ' GLU . 0.6 OUTLIER -29.25 128.02 0.1 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 126.3 1.84 . . . . 71.22 113.14 174.553 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 39.9 p -104.17 116.99 33.18 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.408 0.683 . . . . 64.14 109.525 -175.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.483 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 58.5 t80 -134.5 105.41 6.53 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.648 -1.242 . . . . 62.22 107.648 175.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -129.83 115.82 17.8 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.724 -0.843 . . . . 61.43 108.724 -174.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 8.1 mt -76.04 122.53 30.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 108.314 -0.995 . . . . 72.23 108.314 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -89.16 -29.05 19.6 Favored 'General case' 0 C--O 1.242 0.675 0 O-C-N 123.822 0.701 . . . . 62.14 110.982 -176.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -172.77 138.2 0.81 Allowed 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.464 0.477 . . . . 51.31 110.146 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.655 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.5 mp -120.88 135.97 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.681 -1.229 . . . . 73.44 107.681 173.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -162.4 170.14 19.3 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.207 1.003 . . . . 71.13 112.85 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.5 p -105.05 119.24 38.54 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.224 -1.353 . . . . 63.51 108.509 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -88.0 -21.29 24.9 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.035 -0.53 . . . . 73.2 109.925 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.412 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 31.8 t70 -159.9 138.61 10.6 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.182 0.993 . . . . 63.14 109.219 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.549 HG21 ' HE2' ' C' ' 117' ' ' MET . 72.5 mt -139.77 138.29 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.971 1.308 . . . . 73.35 107.802 176.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.5 t -139.69 143.35 37.05 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.104 0.962 . . . . 74.21 109.008 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.552 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 91.7 t80 -150.0 122.99 8.78 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 106.612 -1.625 . . . . 62.12 106.612 170.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.63 111.65 11.9 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.715 0.806 . . . . 62.41 109.584 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.93 84.66 4.47 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 107.665 -1.235 . . . . 70.33 107.665 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.16 -43.64 0.53 Allowed 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.415 2.077 . . . . 61.14 112.336 -171.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -93.81 10.52 32.77 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.256 1.022 . . . . 71.42 110.414 -176.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.603 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -31.69 -64.79 0.22 Allowed Pre-proline 0 N--CA 1.488 1.441 0 C-N-CA 127.259 2.224 . . . . 61.11 116.334 -166.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.84 -21.65 14.13 Favored 'Trans proline' 0 C--N 1.38 2.222 0 CA-C-N 122.735 2.013 . . . . 74.53 114.073 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -77.33 -37.29 52.79 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.377 1.071 . . . . 73.44 109.909 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.438 HG12 ' O ' ' D' ' 28' ' ' ALA . 7.7 p -82.98 -25.57 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-N 115.452 -0.795 . . . . 63.21 111.308 -172.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -60.65 -25.78 66.58 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 122.883 0.473 . . . . 74.43 112.099 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -64.9 -8.66 16.43 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.776 1.23 . . . . 63.01 112.231 -175.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -96.41 95.01 7.75 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.2 1.4 . . . . 71.21 109.041 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -81.91 81.71 7.8 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.356 0.662 . . . . 74.11 111.093 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -160.78 -179.88 7.95 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.18 0.992 . . . . 72.12 109.1 166.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.426 ' NE2' ' HD2' ' D' ' 38' ' ' PRO . 35.3 tp60 -75.78 114.12 33.61 Favored Pre-proline 0 N--CA 1.477 0.9 0 CA-C-O 118.294 -0.86 . . . . 64.13 109.167 178.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.426 ' HD2' ' NE2' ' D' ' 37' ' ' GLN . 51.1 Cg_exo -53.35 134.79 58.54 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.045 2.497 . . . . 74.33 111.856 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -63.81 107.82 1.3 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 107.623 -1.251 . . . . 74.22 107.623 175.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.664 HG13 HG13 ' D' ' 64' ' ' VAL . 86.5 t -104.4 129.55 56.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 109.416 -0.587 . . . . 73.31 109.416 -176.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -105.35 112.28 25.33 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 106.348 -1.723 . . . . 62.23 106.348 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.489 HD22 ' HB2' ' D' ' 128' ' ' LEU . 64.8 tp -94.33 150.02 20.68 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.678 -1.23 . . . . 54.23 107.678 174.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -148.27 140.07 23.83 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.255 -1.017 . . . . 75.23 108.255 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.582 HD12 HG22 ' E' ' 121' ' ' VAL . 91.4 mt -130.7 145.09 51.85 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.584 0.754 . . . . 73.02 109.452 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -155.62 141.35 18.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.766 -1.198 . . . . 73.41 107.766 169.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 46' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' E' ' 106' ' ' TYR . 25.9 m -102.84 156.18 17.83 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.214 1.005 . . . . 64.24 109.292 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.09 167.13 26.7 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 126.039 1.736 . . . . 74.32 106.8 172.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 13.5 p -165.84 -164.86 0.75 Allowed 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.306 -0.627 . . . . 62.32 109.306 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 33.3 p -149.31 133.8 17.58 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 122.994 0.518 . . . . 54.25 110.129 -176.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -82.97 97.84 8.93 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 116.004 -0.544 . . . . 62.41 109.798 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 47.2 tp -140.69 112.56 7.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 106.738 -1.578 . . . . 71.52 106.738 174.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.25 -161.17 0.14 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.455 0.302 . . . . 54.32 110.751 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 68.69 23.07 7.22 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.997 0.919 . . . . 71.23 109.76 -164.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' D' ' 85' ' ' SER . 1.9 m-20 64.13 15.38 9.26 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.745 1.618 . . . . 63.13 112.011 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.26 94.88 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 109.054 -0.721 . . . . 73.2 109.054 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -122.95 127.99 49.64 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.787 -0.82 . . . . 70.03 108.787 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -94.64 119.42 33.27 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.468 -0.938 . . . . 60.33 108.468 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 73.8 t -101.33 134.45 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.853 0.861 . . . . 71.13 108.851 173.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.515 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 33.4 t -116.02 128.44 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.185 0.994 . . . . 63.21 108.745 173.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.39 111.69 24.14 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.86 -1.163 . . . . 72.44 107.86 175.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 ttt85 -85.82 106.48 17.08 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.233 -0.655 . . . . 42.53 109.233 174.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.506 HG22 HD22 ' D' ' 44' ' ' LEU . 61.1 t -105.75 130.65 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.268 1.027 . . . . 44.33 108.624 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 7.3 m -134.75 144.46 47.72 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.014 0.435 . . . . 71.53 110.964 -173.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.664 HG13 HG13 ' D' ' 40' ' ' VAL . 55.0 t -133.85 114.28 19.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 C-N-CA 125.447 1.499 . . . . 60.12 108.902 -173.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 19.2 m -106.12 93.46 4.63 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.074 -1.084 . . . . 74.43 108.074 169.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.08 144.94 27.04 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.363 0.665 . . . . 72.25 109.937 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.496 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 48.2 m -151.89 127.85 10.35 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 123.424 0.69 . . . . 75.13 110.879 -177.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.437 ' HB2' HG22 ' D' ' 31' ' ' VAL . 16.6 mt -93.45 109.31 20.9 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 107.764 -1.199 . . . . 61.22 107.764 168.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.19 -124.32 8.27 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 116.064 -0.516 . . . . 54.55 112.496 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.15 3.99 28.55 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.329 0.652 . . . . 72.45 111.775 -176.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -118.42 158.88 24.46 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 109.574 -0.528 . . . . 60.43 109.574 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 52.0 m -72.43 129.56 38.63 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.615 -0.72 . . . . 73.13 111.685 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.496 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -81.54 -69.19 0.63 Allowed 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.829 -1.174 . . . . 72.31 107.829 173.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -153.54 153.77 33.03 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 115.841 -0.618 . . . . 74.43 111.105 176.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 50.0 mt -119.32 109.93 16.38 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.396 -1.335 . . . . 74.33 107.396 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.543 ' SG ' HG12 ' D' ' 114' ' ' ILE . 42.0 t -120.61 136.98 54.66 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 123.544 0.737 . . . . 70.14 109.586 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -152.06 123.88 7.98 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.9 0.48 . . . . 70.23 109.794 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 88.3 t -127.58 118.52 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.926 0.89 . . . . 71.22 109.836 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.412 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.2 mt-30 -90.72 90.13 7.82 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.517 0.727 . . . . 71.24 109.251 171.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -82.77 98.74 9.26 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.723 -1.126 . . . . 52.24 109.422 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -102.19 156.4 18.55 Favored Glycine 0 N--CA 1.471 1.012 0 N-CA-C 112.077 -0.409 . . . . 44.25 112.077 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.4 150.05 13.78 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 117.2 0.5 . . . . 64.12 112.619 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 57.5 mt -90.0 132.71 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 109.082 -0.71 . . . . 64.21 109.082 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -128.98 140.46 51.64 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.305 1.042 . . . . 64.42 109.575 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 39.8 t -93.59 108.27 20.01 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 107.682 -1.229 . . . . 71.32 107.682 168.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 33.9 pt -109.13 123.9 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 N-CA-C 108.654 -0.869 . . . . 74.04 108.654 172.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.45 168.29 6.52 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.173 0.589 . . . . 62.34 111.458 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.3 19.18 72.44 Favored Glycine 0 C--N 1.347 1.165 0 O-C-N 123.683 0.614 . . . . 61.4 112.941 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.43 164.25 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.266 1.027 . . . . 74.54 109.799 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -146.68 -179.35 6.72 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.749 0.82 . . . . 73.21 110.57 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.82 -140.29 27.64 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 115.984 -0.553 . . . . 71.3 112.472 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 60.8 p -89.62 -29.83 18.57 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.366 0.666 . . . . 74.04 110.752 172.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -53.4 -33.22 53.03 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.578 1.151 . . . . 74.12 112.474 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.633 ' HE1' ' HB3' ' E' ' 100' ' ' LEU . 2.9 ppp? -60.71 -50.63 72.72 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.876 0.87 . . . . 72.24 113.197 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 95' ' ' ALA . . . . . 0.492 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.25 -19.4 31.66 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.061 0.544 . . . . 65.24 110.978 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -67.88 -38.37 82.94 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.674 0.79 . . . . 74.11 110.49 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 86.9 m -61.15 -33.59 73.66 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.585 0.754 . . . . 72.21 111.587 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 27.0 tp -69.54 -37.57 77.13 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.916 0.486 . . . . 75.5 111.119 -176.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.2 0.11 68.47 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-O 119.388 -0.673 . . . . 74.44 113.6 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.75 -58.32 0.77 Allowed 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 117.74 0.77 . . . . 62.33 112.932 -171.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -72.35 -43.84 63.48 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.064 0.545 . . . . 63.12 110.925 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.483 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 75.2 m -60.45 -45.48 97.38 Favored Pre-proline 0 CA--C 1.571 1.752 0 C-N-CA 124.132 0.973 . . . . 70.41 112.166 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.401 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 73.5 Cg_exo -55.28 -42.05 72.33 Favored 'Trans proline' 0 C--N 1.395 3.014 0 C-N-CA 123.188 2.592 . . . . 70.04 113.836 165.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -63.38 -24.88 68.03 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.537 0.735 . . . . 55.24 110.972 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 44.8 mm -75.84 -45.5 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.798 0.839 . . . . 73.14 110.545 172.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.04 -25.79 65.54 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.477 -0.783 . . . . 75.24 111.672 -176.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -68.57 -40.01 17.26 Favored Pre-proline 0 CA--C 1.563 1.467 0 N-CA-C 114.507 1.299 . . . . 72.42 114.507 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -47.83 -46.64 20.9 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.447 2.098 . . . . 71.31 113.69 167.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 109' ' ' TYR . . . . . 0.428 ' OH ' ' HB3' ' B' ' 130' ' ' PRO . 99.0 m-85 -72.26 -38.46 68.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.631 0.773 . . . . 74.14 111.096 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 110' ' ' ALA . . . . . 0.417 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -65.93 -38.73 89.43 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.842 0.857 . . . . 72.21 110.776 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.485 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 24.3 ttp-105 -66.02 -48.93 69.49 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 115.104 -0.953 . . . . 73.25 110.032 175.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -56.16 -47.63 77.85 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.64 1.213 . . . . 54.44 110.977 -175.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.5 t -56.74 -46.26 81.48 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 124.032 0.832 . . . . 74.14 111.331 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.543 HG12 ' SG ' ' D' ' 76' ' ' CYS . 62.6 mt -63.33 -57.08 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.962 0.905 . . . . 60.22 111.096 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 38.8 m -52.89 -43.13 65.94 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.527 1.131 . . . . 54.1 111.273 -175.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 29.7 t -63.49 -43.42 97.31 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 114.251 -1.341 . . . . 64.14 109.925 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.8 mtm -69.87 -30.33 67.77 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.12 0.568 . . . . 74.2 111.763 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.4 t -64.56 -45.97 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.508 0.723 . . . . 62.34 109.916 175.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.2 p -74.53 -29.72 61.5 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.636 -0.711 . . . . 60.15 110.74 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 66.5 mtt-85 -70.65 -30.2 66.75 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.639 0.775 . . . . 73.21 109.868 173.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.62 8.97 75.59 Favored Glycine 0 C--N 1.354 1.539 0 O-C-N 123.62 0.575 . . . . 71.02 112.898 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 78.0 p 54.95 27.56 9.35 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 126.167 1.787 . . . . 73.04 113.974 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -88.67 151.04 47.29 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 109.211 -0.663 . . . . 72.52 109.211 168.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.495 ' HB3' ' HA ' ' E' ' 129' ' ' THR . 90.5 Cg_exo -48.3 133.85 25.11 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.642 2.895 . . . . 72.34 113.002 171.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -56.5 128.63 37.09 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.754 0.822 . . . . 55.42 112.006 -170.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.594 HD13 HG21 ' D' ' 40' ' ' VAL . 28.9 tp -108.93 98.23 7.74 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.612 1.165 . . . . 74.34 109.419 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -99.58 80.88 2.42 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.884 -1.154 . . . . 72.12 107.884 174.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.665 ' H ' HD23 ' D' ' 128' ' ' LEU . 0.3 OUTLIER -58.44 112.3 1.53 Allowed 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.64 -1.164 . . . . 74.12 109.686 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.6 139.48 75.6 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 125.102 1.361 . . . . 65.33 113.064 -169.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.48 ' HB3' HH12 ' D' ' 111' ' ' ARG . 96.2 Cg_endo -76.75 155.89 35.11 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.95 2.433 . . . . 73.21 112.633 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 9.6 p -148.79 143.47 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.551 -0.75 . . . . 63.44 109.568 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -81.49 105.98 13.09 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.161 -1.052 . . . . 60.31 108.161 172.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -62.43 -30.57 71.33 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.154 0.982 . . . . 64.01 110.601 -177.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -61.23 -42.5 98.72 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.641 1.176 . . . . 64.03 110.827 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.73 -34.76 76.39 Favored 'General case' 0 C--N 1.35 0.596 0 CA-C-N 114.315 -1.311 . . . . 71.34 111.11 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.725 HD13 ' HB2' ' E' ' 120' ' ' TYR . 27.6 tp -69.29 -43.79 73.13 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.978 0.911 . . . . 74.22 112.55 -176.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.487 ' O ' HD13 ' D' ' 141' ' ' LEU . 87.0 m-85 -59.11 -42.48 90.64 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 120.765 0.317 . . . . 71.32 110.617 178.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 75.8 mtm -73.69 -40.97 63.25 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.825 -0.625 . . . . 55.2 110.949 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.406 ' O ' ' HG3' ' D' ' 143' ' ' GLN . 64.2 t30 -61.69 -48.06 82.48 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.186 0.995 . . . . 72.43 110.594 -174.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -52.61 -38.67 60.58 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.648 1.179 . . . . 63.31 111.629 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.487 HD13 ' O ' ' D' ' 137' ' ' PHE . 8.9 mp -76.18 -46.81 26.66 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.667 0.787 . . . . 72.42 111.526 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -85.05 27.09 0.8 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.078 0.551 . . . . 75.54 112.424 -170.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 143' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' D' ' 139' ' ' ASN . 46.0 mt-30 -117.93 94.11 4.39 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.964 0.906 . . . . 55.42 109.548 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -140.22 21.13 2.42 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.666 -1.152 . . . . 73.1 108.862 171.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -165.22 -177.14 4.39 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.352 1.461 . . . . 61.5 109.029 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.62 163.66 39.45 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 123.3 0.375 . . . . 74.2 113.774 173.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -60.23 125.31 23.2 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.838 0.855 . . . . 72.54 111.109 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -165.17 109.63 0.37 Allowed Glycine 0 C--N 1.336 0.539 0 N-CA-C 111.102 -0.799 . . . . 42.33 111.102 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 14.8 t -74.72 -167.88 0.63 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.264 0.626 . . . . 74.01 109.654 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.62 128.79 31.79 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 109.376 -0.601 . . . . 72.51 109.376 170.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -174.16 101.52 0.1 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.92 1.688 . . . . 74.43 108.114 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 152' ' ' HIS . . . . . 0.402 ' CD2' ' HB3' ' D' ' 154' ' ' ASP . 2.2 t60 -173.23 121.99 0.37 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 109.942 -0.392 . . . . 71.1 109.942 177.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -75.24 -42.83 54.35 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.283 0.633 . . . . 72.23 110.692 176.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 154' ' ' ASP . . . . . 0.402 ' HB3' ' CD2' ' D' ' 152' ' ' HIS . 1.9 t70 -59.89 132.53 54.25 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.848 0.859 . . . . 73.24 110.044 172.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.874 0 C-N-CA 123.784 0.834 . . . . 74.1 109.88 -175.035 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.348 0 N-CA-C 110.95 -0.86 . . . . 71.24 110.95 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.38 -36.43 63.11 Favored Glycine 0 C--N 1.35 1.309 0 C-N-CA 122.945 0.307 . . . . 70.43 112.556 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -75.45 170.13 16.71 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.648 0.779 . . . . 73.21 110.221 175.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -79.62 18.48 0.75 Allowed 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 124.736 1.214 . . . . 75.42 112.451 -169.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt 77.25 19.04 1.34 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.698 1.199 . . . . 74.24 112.263 167.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.02 103.89 2.9 Favored Glycine 0 C--N 1.342 0.906 0 O-C-N 121.845 -0.535 . . . . 71.24 114.162 163.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 97' ' ' ILE . . . . . . . . . . . . . 7.1 tt -82.25 72.81 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 CA-C-O 122.715 1.245 . . . . 71.54 108.469 166.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.6 -38.23 83.69 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.212 -0.904 . . . . 73.02 111.788 -176.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.27 81.45 1.84 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.643 0.777 . . . . 72.44 112.198 -169.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 100' ' ' LEU . . . . . 0.633 ' HB3' ' HE1' ' D' ' 94' ' ' MET . 2.2 pp -161.21 149.69 12.96 Favored Pre-proline 0 N--CA 1.481 1.116 0 C-N-CA 123.79 0.836 . . . . 72.43 111.57 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -90.15 9.24 3.33 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 123.353 2.702 . . . . 64.33 111.778 166.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 102' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 76.43 -57.52 0.55 Allowed 'General case' 0 C--N 1.363 1.178 0 C-N-CA 126.563 1.945 . . . . 75.31 110.216 -174.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 33.6 m 79.31 -52.69 0.43 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.066 1.746 . . . . 73.33 112.225 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.4 25.28 5.08 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-O 119.12 -0.822 . . . . 54.32 114.979 -174.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -70.62 79.7 0.59 Allowed 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 117.734 0.767 . . . . 74.31 109.935 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 106' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' D' ' 46' ' ' THR . 21.8 t80 62.29 102.3 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 125.575 1.55 . . . . 73.14 109.306 -175.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 107' ' ' THR . . . . . 0.432 ' OG1' ' HB ' ' D' ' 46' ' ' THR . 70.1 p -89.6 42.34 1.09 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.845 0.858 . . . . 60.14 112.013 -167.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -74.01 75.65 1.7 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.453 1.101 . . . . 75.33 109.182 -176.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -166.76 -59.73 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.482 1.113 . . . . 64.23 109.328 -170.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 110' ' ' ALA . . . . . 0.497 ' O ' ' HD2' ' E' ' 114' ' ' LYS . . . -100.23 -24.86 14.44 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.362 -0.835 . . . . 72.15 112.668 -168.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 111' ' ' LEU . . . . . . . . . . . . . 10.0 mp -89.76 -50.52 6.01 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 118.128 0.422 . . . . 74.32 111.915 -175.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 112' ' ' ASN . . . . . 0.452 ' OD1' ' HG2' ' E' ' 113' ' ' LYS . 27.2 t-20 -79.33 -85.71 0.08 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.042 0.537 . . . . 75.35 110.782 -173.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 113' ' ' LYS . . . . . 0.452 ' HG2' ' OD1' ' E' ' 112' ' ' ASN . 26.3 mmmt -83.73 106.01 15.09 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.605 0.762 . . . . 62.15 111.087 -176.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 114' ' ' LYS . . . . . 0.497 ' HD2' ' O ' ' E' ' 110' ' ' ALA . 2.1 mppt? -118.11 -10.46 10.32 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 107.713 -1.217 . . . . 65.05 107.713 155.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 28.2 m 58.18 -97.46 0.07 Allowed 'General case' 0 C--N 1.363 1.182 0 C-N-CA 124.897 1.279 . . . . 73.33 109.267 -169.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 44.65 -141.99 3.37 Favored Glycine 0 C--N 1.361 1.966 0 N-CA-C 115.532 0.973 . . . . 64.14 115.532 172.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.82 178.52 1.13 Allowed Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 125.021 1.328 . . . . 75.04 107.549 169.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -55.1 89.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 121.772 1.648 . . . . 74.22 111.692 162.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.53 -103.7 0.05 Allowed 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.557 1.143 . . . . 74.21 108.775 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 120' ' ' TYR . . . . . 0.725 ' HB2' HD13 ' D' ' 136' ' ' LEU . 47.8 m-85 -114.23 150.47 34.28 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.068 -1.456 . . . . 62.14 107.068 161.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 121' ' ' VAL . . . . . 0.582 HG22 HD12 ' D' ' 44' ' ' LEU . 92.3 t 56.63 -108.95 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.463 0 N-CA-C 108.362 -0.977 . . . . 53.02 108.362 -166.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 122' ' ' THR . . . . . 0.409 ' N ' HG12 ' E' ' 121' ' ' VAL . 3.8 m 56.35 -75.07 0.01 OUTLIER 'General case' 0 C--N 1.363 1.166 0 C-N-CA 125.215 1.406 . . . . 53.01 111.896 -175.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -136.17 -154.51 0.57 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.059 1.343 . . . . 65.44 108.602 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 19.2 t -157.65 169.21 25.17 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.055 0.542 . . . . 65.25 110.12 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -140.13 129.35 23.79 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.811 0.845 . . . . 64.23 110.289 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -149.48 149.9 31.49 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.32 1.048 . . . . 63.11 109.316 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 37.1 p -146.35 83.93 1.62 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.152 0.501 . . . . 70.1 110.338 -177.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -138.83 62.71 1.54 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.684 0.793 . . . . 34.51 109.417 177.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 129' ' ' THR . . . . . 0.495 ' HA ' ' HB3' ' D' ' 124' ' ' PRO . 88.9 m -89.33 122.27 32.4 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.209 -0.905 . . . . 74.24 110.928 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -157.73 105.77 2.03 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.895 0.878 . . . . 73.31 109.03 171.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 131' ' ' TRP . . . . . 0.423 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 13.3 t90 -161.87 106.13 1.23 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.888 -0.782 . . . . 55.53 108.888 175.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 59.5 m -150.57 10.82 0.66 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.34 0.656 . . . . 72.41 111.543 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 53.0 m -96.79 135.52 38.62 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.231 0.613 . . . . 65.04 111.278 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -160.62 130.98 2.51 Favored Glycine 0 C--N 1.352 1.435 0 N-CA-C 110.729 -0.948 . . . . 72.44 110.729 177.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 27.3 m -90.69 162.4 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 123.42 0.688 . . . . 64.23 111.545 -175.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -157.43 159.16 37.05 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.945 0.898 . . . . 74.41 111.164 -178.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 6.0 m 57.1 77.99 0.24 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.179 1.391 . . . . 75.21 113.103 168.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -172.0 85.75 0.08 Allowed 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.989 0.916 . . . . 73.32 108.69 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -83.34 173.11 11.85 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.45 0.7 . . . . 73.01 111.032 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 140' ' ' GLY . . . . . 0.503 ' HA2' ' HB2' ' A' ' 132' ' ' ASN . . . -121.1 49.39 0.89 Allowed Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.812 -0.631 . . . . 31.14 111.602 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . 55.29 41.63 31.08 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.649 1.18 . . . . 62.4 111.191 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 142' ' ' LEU . . . . . 0.455 HD22 ' HB ' ' E' ' 144' ' ' VAL . 4.5 tt 72.73 -68.51 0.22 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.617 1.567 . . . . 72.21 109.848 -172.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.57 54.74 2.45 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 111.638 -0.585 . . . . 75.41 111.638 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 144' ' ' VAL . . . . . 0.455 ' HB ' HD22 ' E' ' 142' ' ' LEU . 4.6 p -96.62 131.72 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.913 0.885 . . . . 63.52 110.01 176.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 21.0 t70 . . . . . 0 C--O 1.253 1.243 0 N-CA-C 108.335 -0.987 . . . . 72.35 108.335 174.879 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.925 0 CA-C-O 119.927 -0.374 . . . . 24.25 113.177 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.53 45.43 29.24 Favored Glycine 0 C--N 1.345 1.083 0 O-C-N 123.79 0.347 . . . . 14.14 112.349 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -78.29 -50.6 11.52 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.56 0.744 . . . . 55.21 111.351 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -159.18 -55.31 0.06 Allowed 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.244 0.461 . . . . 74.1 112.244 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt 58.9 79.9 0.21 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.986 0.914 . . . . 73.41 110.511 -171.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -149.19 -34.64 0.05 OUTLIER Glycine 0 N--CA 1.469 0.842 0 CA-C-N 116.025 -0.534 . . . . 63.43 112.639 -172.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 97' ' ' ILE . . . . . 0.532 ' HB ' ' HA ' ' B' ' 87' ' ' ALA . 10.3 tt -71.72 -40.6 70.22 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 N-CA-C 108.107 -1.072 . . . . 74.22 108.107 171.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 23.5 t70 60.07 137.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 126.497 1.919 . . . . 75.11 113.692 173.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . 53.58 57.83 5.75 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.804 0.841 . . . . 71.43 111.254 176.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 100' ' ' LEU . . . . . 0.407 HD22 HG21 ' F' ' 97' ' ' ILE . 50.3 tp -100.52 104.84 33.29 Favored Pre-proline 0 N--CA 1.474 0.738 0 CA-C-N 115.812 -0.631 . . . . 73.43 110.814 -174.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -98.77 -172.35 0.14 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 122.98 2.453 . . . . 71.41 111.93 169.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 102' ' ' LEU . . . . . . . . . . . . . 24.4 tp -94.0 163.57 13.43 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.043 -1.095 . . . . 74.35 108.043 166.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 70.2 p -62.46 -32.41 73.29 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.454 0.702 . . . . 63.35 110.714 173.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.63 -12.85 65.95 Favored Glycine 0 C--N 1.351 1.388 0 CA-C-N 115.453 -0.794 . . . . 72.1 111.919 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -85.28 141.1 30.32 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.772 0.829 . . . . 74.02 110.525 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -121.75 -87.59 0.64 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.046 0.938 . . . . 71.4 108.843 -175.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 107' ' ' THR . . . . . 0.479 HG22 ' HB2' ' F' ' 111' ' ' LEU . 39.9 p -144.88 -158.78 0.92 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.727 1.211 . . . . 53.15 107.851 176.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 45.6 m80 77.33 -18.53 0.49 Allowed 'General case' 0 N--CA 1.511 2.611 0 C-N-CA 124.484 1.114 . . . . 64.13 113.542 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -140.14 13.76 2.42 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.69 0.796 . . . . 64.43 110.553 -177.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -156.7 -74.73 0.1 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.955 -0.757 . . . . 72.24 108.955 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 111' ' ' LEU . . . . . 0.479 ' HB2' HG22 ' F' ' 107' ' ' THR . 8.9 mp -76.15 76.91 2.98 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.529 0.732 . . . . 62.21 109.712 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 112' ' ' ASN . . . . . 0.519 HD22 ' HB2' ' F' ' 117' ' ' LYS . 2.4 m-20 -121.53 102.14 8.06 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 114.969 -1.014 . . . . 63.14 109.02 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 113' ' ' LYS . . . . . 0.569 ' HB3' ' HB ' ' F' ' 121' ' ' VAL . 0.0 OUTLIER -129.27 74.06 1.56 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.524 1.13 . . . . 54.11 109.319 179.117 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -168.39 -177.02 3.05 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-N 114.575 -1.193 . . . . 72.4 108.359 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 37.2 p -51.41 -35.82 40.89 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.356 1.063 . . . . 70.12 111.8 169.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.84 86.61 0.76 Allowed Glycine 0 C--N 1.354 1.538 0 CA-C-N 115.714 -0.675 . . . . 52.32 111.761 175.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 117' ' ' LYS . . . . . 0.519 ' HB2' HD22 ' F' ' 112' ' ' ASN . 3.9 mptp? 65.0 82.39 0.21 Allowed Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 124.944 1.298 . . . . 72.4 111.212 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.74 89.6 0.63 Allowed 'Trans proline' 0 CA--C 1.558 1.716 0 C-N-CA 122.576 2.184 . . . . 72.54 111.16 174.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -78.63 -96.78 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.355 0.662 . . . . 74.11 111.501 -171.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -100.67 -55.29 2.62 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.048 -0.723 . . . . 72.41 109.048 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 121' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' F' ' 113' ' ' LYS . 11.7 t -80.15 126.32 39.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.454 -1.313 . . . . 74.22 107.454 174.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 89.1 m -160.33 155.9 25.43 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.365 1.066 . . . . 32.31 108.556 -175.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 8.9 t70 74.85 -178.87 0.17 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.948 1.299 . . . . 71.45 110.859 170.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 7.6 m -72.14 -23.15 61.26 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.606 1.162 . . . . 55.24 113.119 -173.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . 66.16 -165.74 0.22 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.977 0.911 . . . . 45.2 110.347 -169.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.82 115.57 9.2 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.259 0.623 . . . . 50.1 111.719 -177.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 50.3 m -127.09 120.07 28.05 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.829 -1.175 . . . . 71.25 107.829 170.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -144.61 176.8 9.14 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.884 0.474 . . . . 73.44 111.318 -172.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 71.4 p 59.69 -170.31 0.14 Allowed 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 125.856 1.663 . . . . 74.35 112.47 -175.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -148.46 -179.54 7.04 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.805 0.842 . . . . 74.41 110.018 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 131' ' ' TRP . . . . . 0.581 ' HB3' ' HG3' ' B' ' 124' ' ' PRO . 47.5 t-105 -151.93 133.55 14.72 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.371 0.668 . . . . 61.41 109.292 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 132' ' ' SER . . . . . 0.408 ' HB2' ' HB3' ' B' ' 35' ' ' ASP . 34.2 t -169.4 -42.35 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 O-C-N 124.455 1.097 . . . . 75.23 109.359 -175.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 23.1 m -70.91 83.03 0.66 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.344 1.058 . . . . 71.03 111.055 -176.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -83.75 57.48 5.05 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-O 119.596 -0.558 . . . . 65.14 112.92 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 135' ' ' VAL . . . . . 0.466 HG21 ' HA ' ' C' ' 128' ' ' LEU . 94.8 t 72.67 -17.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 125.28 1.432 . . . . 65.13 113.468 175.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt 71.9 164.09 0.28 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.014 1.326 . . . . 71.02 110.139 -175.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 11.4 m -76.27 70.84 2.93 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 123.562 0.745 . . . . 64.15 112.411 -171.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 51.51 24.49 2.27 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 125.989 1.716 . . . . 64.43 113.609 171.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -163.07 143.92 9.49 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.718 0.807 . . . . 74.24 108.834 -174.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -83.06 67.54 3.73 Favored Glycine 0 C--N 1.342 0.911 0 O-C-N 123.544 0.528 . . . . 51.4 112.119 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.98 154.26 41.99 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.39 0.676 . . . . 63.52 109.917 173.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 62.0 tp -64.61 123.09 18.38 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.548 0.339 . . . . 74.3 111.096 -172.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.3 103.92 1.1 Allowed Glycine 0 C--N 1.345 1.062 0 N-CA-C 110.598 -1.001 . . . . 62.54 110.598 171.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.02 97.2 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.858 0.863 . . . . 74.52 109.259 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 26.8 t70 . . . . . 0 C--O 1.249 1.063 0 C-N-CA 123.441 0.696 . . . . 74.32 109.146 -174.352 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 109.215 -0.661 . . . . 71.42 109.215 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.1 m -127.16 113.44 16.37 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.388 -0.967 . . . . 64.3 108.388 -176.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -69.48 108.78 3.92 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.721 -0.844 . . . . 71.42 108.721 175.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -70.42 107.92 4.03 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.116 0.566 . . . . 61.15 110.402 -173.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -130.92 77.11 1.77 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.747 0.819 . . . . 72.24 110.329 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -79.77 -68.57 0.66 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.746 -0.835 . . . . 72.21 108.746 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.9 t -178.74 99.48 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.019 1.328 . . . . 74.53 108.706 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.16 -171.4 3.61 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.16 0.584 . . . . 75.41 111.125 -172.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.654 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 23.3 ptt? -83.96 166.77 17.53 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.925 -0.58 . . . . 72.41 111.829 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.0 m -142.45 132.32 24.28 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.164 0.986 . . . . 74.32 109.361 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.431 ' CD1' HD12 ' A' ' 86' ' ' ILE . 46.7 t80 -125.32 114.43 18.89 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.847 -1.168 . . . . 64.24 107.847 175.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -134.38 133.4 40.55 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.254 -0.647 . . . . 75.44 109.254 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.498 ' CD1' HG21 ' A' ' 105' ' ' ILE . 4.7 mt -95.32 120.68 45.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 109.26 -0.644 . . . . 63.04 109.26 177.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -83.76 -39.6 19.86 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 123.554 0.534 . . . . 70.41 111.052 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -173.47 120.14 0.32 Allowed 'General case' 0 N--CA 1.472 0.675 0 O-C-N 123.393 0.433 . . . . 74.5 110.0 -170.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.518 HD12 ' HG3' ' C' ' 130' ' ' PRO . 64.7 mt -107.5 137.63 37.71 Favored 'Isoleucine or valine' 0 C--O 1.247 0.921 0 N-CA-C 108.17 -1.048 . . . . 75.12 108.17 171.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.458 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 35.9 p90 -166.4 179.27 5.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 124.304 1.003 . . . . 75.3 110.936 -170.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -111.39 120.21 41.43 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.422 0.689 . . . . 65.3 110.095 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.1 mtpt -86.08 -28.8 23.85 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.807 -0.442 . . . . 64.15 109.807 177.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 18.0 t70 -144.54 139.3 28.1 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.511 -0.768 . . . . 73.54 109.408 177.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.4 mt -139.42 140.47 37.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.405 -1.331 . . . . 40.34 107.405 172.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.5 t -153.6 125.29 7.69 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.58 0.752 . . . . 72.15 109.479 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.557 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 70.3 t80 -128.59 130.86 47.94 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 106.594 -1.632 . . . . 71.0 106.594 173.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -130.58 135.43 47.89 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.049 0.386 . . . . 71.32 110.002 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.2 76.29 12.34 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.234 1.014 . . . . 73.33 108.358 172.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.31 -34.87 9.22 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.509 2.139 . . . . 73.32 112.264 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -91.34 11.77 22.61 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.537 -0.756 . . . . 63.1 110.74 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.449 ' HA ' HG12 ' A' ' 31' ' ' VAL . . . -47.27 -54.12 23.66 Favored Pre-proline 0 CA--C 1.57 1.722 0 CA-C-O 118.03 -0.986 . . . . 74.44 113.035 -171.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 51.9 Cg_exo -55.86 -30.41 76.86 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 122.343 2.028 . . . . 75.22 113.451 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -81.05 -43.19 19.9 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.271 0.628 . . . . 73.32 110.165 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.566 HG21 ' HA ' ' A' ' 73' ' ' ALA . 2.0 p -77.58 -22.26 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 114.782 -1.099 . . . . 75.01 112.685 -159.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -73.28 -21.7 60.54 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.069 0.548 . . . . 54.22 111.629 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -77.96 -22.98 48.66 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.267 -0.879 . . . . 64.43 110.43 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -82.78 165.95 19.45 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.283 1.033 . . . . 71.33 111.323 -174.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -76.77 123.11 25.71 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.601 -0.727 . . . . 53.33 109.48 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -76.23 87.39 3.06 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.666 0.746 . . . . 74.44 110.329 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.94 75.96 47.21 Favored Pre-proline 0 C--O 1.242 0.663 0 N-CA-C 105.898 -1.89 . . . . 41.12 105.898 170.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.63 149.1 14.36 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.819 2.346 . . . . 53.45 112.923 -173.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -96.0 100.89 12.52 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 106.625 -1.62 . . . . 70.14 106.625 167.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 65' ' ' THR . 39.0 t -91.52 108.2 19.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 109.804 -0.443 . . . . 65.32 109.804 -176.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -102.54 114.09 28.01 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.963 -1.017 . . . . 73.12 109.178 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.617 HD11 HD13 ' A' ' 128' ' ' LEU . 6.7 tt -108.91 138.1 45.77 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.416 -0.957 . . . . 65.51 108.416 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -137.8 141.43 40.85 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.75 0.82 . . . . 63.35 109.396 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.604 HD22 HD21 ' A' ' 60' ' ' LEU . 97.3 mt -120.79 142.23 49.78 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.598 0.759 . . . . 53.34 111.337 -172.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.577 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 7.8 m-20 -134.54 137.72 44.05 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.49 -0.93 . . . . 72.4 108.49 176.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.5 HG21 ' HA2' ' A' ' 99' ' ' GLY . 74.6 m -123.48 126.81 47.42 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.36 0.664 . . . . 61.21 109.441 175.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.44 153.56 50.73 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 124.393 1.077 . . . . 74.41 108.915 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.8 m -126.8 159.55 33.49 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 122.962 0.505 . . . . 74.33 110.315 175.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.7 t -148.93 117.97 6.75 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.252 -1.018 . . . . 73.42 108.252 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -77.92 104.01 8.21 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.958 -0.756 . . . . 75.15 108.958 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 71.4 mt -78.63 -27.66 45.43 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.626 -0.716 . . . . 72.43 109.953 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.473 ' HB3' ' CG2' ' A' ' 55' ' ' VAL . . . -163.37 172.75 14.14 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.357 1.063 . . . . 62.25 109.093 175.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -66.44 127.98 34.39 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.582 -0.895 . . . . 44.5 108.582 169.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 69.0 12.83 8.72 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.482 1.113 . . . . 74.31 112.328 -174.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.473 ' CG2' ' HB3' ' A' ' 52' ' ' ALA . 26.6 t -127.79 112.02 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.01 0.924 . . . . 73.42 108.651 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -128.7 124.38 35.49 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.344 -0.614 . . . . 63.03 109.344 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -91.41 145.32 24.73 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.861 -0.792 . . . . 75.12 108.861 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.9 t -128.7 141.39 46.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.496 -0.928 . . . . 71.04 108.496 172.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 73.5 t -123.32 132.43 71.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 123.634 0.774 . . . . 73.25 109.225 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.604 HD21 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -110.07 110.14 20.94 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.22 -1.4 . . . . 65.43 107.22 175.672 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.577 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 22.0 ttp180 -93.88 100.55 12.7 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.189 -1.411 . . . . 74.42 107.189 175.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.1 t -95.13 124.6 47.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.228 -1.027 . . . . 61.35 108.228 174.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.9 m -121.04 122.0 39.14 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.346 -0.612 . . . . 74.11 109.346 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.512 HG21 HG21 ' A' ' 114' ' ' ILE . 86.9 t -109.58 132.43 57.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 124.49 1.116 . . . . 62.11 108.28 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 10.1 m -123.49 141.04 52.39 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.058 -1.46 . . . . 75.14 107.058 168.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.5 125.12 33.53 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 106.278 -1.749 . . . . 74.35 106.278 170.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.9 m -134.39 131.6 38.41 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 123.6 0.562 . . . . 61.24 111.205 -176.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.0 mt -89.82 84.79 6.27 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 108.134 -1.061 . . . . 71.33 108.134 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.65 -117.94 4.73 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 111.256 -0.738 . . . . 72.42 111.256 -173.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -88.18 -30.05 20.05 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 117.403 0.601 . . . . 73.12 109.588 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -80.18 125.67 30.13 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.711 -0.477 . . . . 72.22 109.711 -175.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.2 m -80.27 134.75 36.12 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.271 0.558 . . . . 64.32 111.283 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.566 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -77.27 -60.7 2.25 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.148 -0.933 . . . . 54.21 108.96 174.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -152.14 163.61 39.01 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.786 -0.643 . . . . 72.42 111.033 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 32.0 tp -134.86 113.29 11.43 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.435 1.094 . . . . 74.05 108.611 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.476 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 70.5 m -104.88 140.26 38.4 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.92 0.888 . . . . 61.44 109.453 175.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -148.22 124.56 10.91 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.627 0.771 . . . . 53.43 109.466 172.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.0 t -133.75 112.77 17.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 124.274 1.029 . . . . 71.32 109.429 -174.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 65.4 mt-30 -84.68 89.45 7.49 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.39 -0.967 . . . . 73.04 108.39 167.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -76.4 93.83 3.55 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.896 -0.779 . . . . 70.13 108.896 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.11 148.36 21.43 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 111.551 -0.619 . . . . 65.32 111.551 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.04 122.33 1.45 Allowed Glycine 0 CA--C 1.506 -0.531 0 N-CA-C 110.801 -0.919 . . . . 60.43 110.801 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.8 mt -80.33 125.84 39.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 N-CA-C 108.305 -0.998 . . . . 74.31 108.305 171.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.815 ' HB3' HD11 ' A' ' 86' ' ' ILE . 86.3 m-85 -129.76 124.11 32.63 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.196 0.598 . . . . 65.44 109.687 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.4 m -85.5 93.65 8.82 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.777 -0.823 . . . . 71.53 108.777 172.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.815 HD11 ' HB3' ' A' ' 84' ' ' PHE . 7.9 mm -109.74 148.13 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 116.14 -0.482 . . . . 74.51 109.847 -176.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.79 171.12 19.37 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.057 0.543 . . . . 73.21 110.67 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.654 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 99.49 -34.21 5.61 Favored Glycine 0 C--N 1.344 0.973 0 O-C-N 123.853 0.721 . . . . 65.35 112.915 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.565 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -122.8 153.5 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.968 0.507 . . . . 71.22 111.364 -169.398 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.438 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 21.5 tt0 -143.89 -179.11 6.27 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.961 -1.018 . . . . 64.24 108.254 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.438 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 61.5 -133.19 47.77 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 113.784 0.274 . . . . 10.14 113.784 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.7 t -72.51 -23.22 60.99 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 122.951 0.5 . . . . 53.14 111.612 -177.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -71.73 -36.83 70.6 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.454 0.701 . . . . 75.11 110.183 177.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.415 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 4.6 tpt -66.07 -49.91 65.96 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.903 -0.59 . . . . 73.23 109.881 174.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.11 -33.27 70.65 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.146 -0.934 . . . . 73.23 111.192 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -72.26 -41.51 66.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.461 0.704 . . . . 72.13 110.898 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 46.5 t -64.25 -35.79 81.98 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 121.226 0.536 . . . . 72.22 110.189 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.9 mt -89.54 -26.81 20.67 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.146 -0.934 . . . . 63.44 112.214 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.5 ' HA2' HG21 ' A' ' 46' ' ' THR . . . -104.06 4.47 45.24 Favored Glycine 0 N--CA 1.473 1.118 0 O-C-N 123.102 0.251 . . . . 62.5 113.363 -173.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.595 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -141.87 -68.46 0.38 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 122.75 0.42 . . . . 63.35 110.805 -177.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -66.88 -46.63 74.35 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 116.246 -0.434 . . . . 75.11 111.864 -171.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 92.6 m -62.3 -52.91 62.95 Favored Pre-proline 0 CA--C 1.565 1.529 0 CA-C-O 118.489 -0.767 . . . . 72.34 112.672 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.431 ' HA ' ' HB2' ' A' ' 106' ' ' LEU . 44.5 Cg_endo -66.97 -20.27 51.18 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 121.647 1.565 . . . . 75.01 113.054 176.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -66.9 -38.87 87.04 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.187 0.595 . . . . 75.52 110.343 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.498 HG21 ' CD1' ' A' ' 13' ' ' ILE . 43.6 mm -68.18 -42.91 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.634 0.773 . . . . 73.24 109.63 174.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 103' ' ' PRO . 54.6 mt -69.95 -28.18 65.35 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.14 -0.936 . . . . 62.01 112.297 -174.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -62.61 -44.85 88.07 Favored Pre-proline 0 N--CA 1.487 1.382 0 N-CA-C 114.033 1.123 . . . . 71.13 114.033 -171.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.401 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 85.4 Cg_exo -50.78 -39.27 57.76 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.135 1.89 . . . . 64.31 113.585 171.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -77.68 -38.95 46.4 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.343 0.657 . . . . 74.4 111.706 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.1 -49.77 70.92 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.248 0.619 . . . . 63.22 109.444 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.407 HH12 HD12 ' C' ' 105' ' ' ILE . 31.7 ttm180 -49.13 -49.91 39.9 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.925 1.29 . . . . 73.52 110.741 173.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.76 -46.8 83.68 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 124.004 0.815 . . . . 73.35 111.558 -176.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.442 ' O ' ' HG3' ' A' ' 117' ' ' MET . 41.9 t -59.3 -35.56 74.02 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.446 0.698 . . . . 63.32 111.066 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.512 HG21 HG21 ' A' ' 64' ' ' VAL . 83.5 mt -70.51 -57.25 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 115.571 -0.74 . . . . 62.51 110.593 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.7 m -51.98 -39.23 59.03 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 124.586 1.154 . . . . 72.03 111.676 -174.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.3 t -66.37 -44.33 83.44 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.441 -1.254 . . . . 73.44 110.102 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.557 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 40.9 mtm -62.95 -39.76 95.61 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.561 0.344 . . . . 74.44 110.828 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.4 t -57.43 -48.38 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 O-C-N 124.018 0.824 . . . . 65.51 110.183 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 95.3 p -73.79 -33.2 64.13 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.887 -0.597 . . . . 74.41 111.711 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.411 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.2 mtt-85 -68.15 -32.46 72.75 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.293 0.637 . . . . 64.42 109.86 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.33 15.84 42.84 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 115.498 -0.774 . . . . 72.25 113.216 174.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 121' ' ' GLY . 0.8 OUTLIER 65.14 10.89 6.73 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.388 1.875 . . . . 42.5 113.234 172.578 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -83.42 144.09 45.73 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 109.506 -0.553 . . . . 75.32 109.506 175.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.567 ' HG3' ' HB3' ' E' ' 130' ' ' ALA . 82.3 Cg_exo -50.81 137.53 42.68 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.288 2.658 . . . . 63.05 112.955 175.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -55.31 128.39 33.91 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.27 0.981 . . . . 63.21 111.986 -172.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.5 tp -113.43 129.1 56.62 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.568 0.747 . . . . 65.11 109.121 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.559 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 87.1 m-20 -119.77 114.44 22.14 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.188 -1.041 . . . . 75.34 108.188 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.617 HD13 HD11 ' A' ' 42' ' ' LEU . 14.7 mt -72.86 127.41 32.47 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 109.558 -0.534 . . . . 52.22 109.558 -176.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.85 134.49 92.45 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-O 119.157 -0.449 . . . . 65.32 110.415 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.89 124.7 16.61 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.822 2.348 . . . . 71.43 112.689 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.567 HG21 HD11 ' A' ' 44' ' ' LEU . 98.8 t -101.1 128.28 53.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-N 115.745 -0.661 . . . . 73.42 109.787 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -86.87 85.88 7.29 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.75 -0.833 . . . . 73.22 108.75 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -61.23 -27.43 68.43 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.425 -0.807 . . . . 72.14 111.947 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.595 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 17.2 t70 -61.71 -51.63 67.59 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.204 0.602 . . . . 74.55 109.72 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.14 86.97 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.237 0.961 . . . . 64.2 110.83 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.8 mt -61.73 -48.3 81.35 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.244 0.618 . . . . 71.22 111.457 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -66.23 -34.19 77.47 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.938 -0.393 . . . . 74.32 109.938 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.498 ' SD ' HD23 ' A' ' 141' ' ' LEU . 19.5 mmt -57.78 -45.04 86.54 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.986 0.514 . . . . 61.42 110.488 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -55.81 -33.92 64.86 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 122.738 0.415 . . . . 54.05 111.854 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -77.66 -40.89 40.12 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.64 0.776 . . . . 74.12 111.141 173.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.498 HD23 ' SD ' ' A' ' 138' ' ' MET . 46.2 tp -67.69 -55.52 12.87 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.935 0.894 . . . . 74.11 111.723 -170.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 60.8 mt-30 -169.96 -18.56 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 125.317 1.447 . . . . 64.41 110.383 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 77.56 -48.62 0.5 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.943 2.097 . . . . 72.34 111.41 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -66.96 125.0 24.57 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.397 0.679 . . . . 64.34 109.683 173.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.68 131.26 28.99 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.624 -0.88 . . . . 34.35 108.624 175.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -156.52 45.15 0.51 Allowed Glycine 0 C--N 1.339 0.75 0 N-CA-C 112.016 -0.434 . . . . 50.23 112.016 -177.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -153.16 140.96 20.09 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.3 0.64 . . . . 73.41 110.07 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 179.08 48.36 0.08 OUTLIER Glycine 0 C--N 1.341 0.845 0 CA-C-N 115.978 -0.555 . . . . 51.53 112.881 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.7 t -90.65 146.63 23.87 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 117.214 0.507 . . . . 72.21 110.063 176.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -157.56 41.57 0.3 Allowed 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 121.936 0.874 . . . . 62.54 109.459 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -93.58 118.62 31.6 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.596 -1.183 . . . . 51.03 109.869 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -174.05 97.56 0.1 Allowed 'General case' 0 C--O 1.241 0.625 0 C-N-CA 125.077 1.351 . . . . 73.43 107.919 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -86.04 134.93 33.81 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.059 0.457 . . . . 73.53 110.043 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -160.44 121.94 3.09 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.664 -1.236 . . . . 74.23 107.664 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.214 0 C-N-CA 122.946 0.498 . . . . 74.44 109.998 -175.171 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 56.0 ttm . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 109.625 -0.509 . . . . 62.13 109.625 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 14.5 t 59.14 -157.15 0.33 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.161 0.985 . . . . 55.23 110.235 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -121.19 159.22 26.34 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 108.482 -0.933 . . . . 74.51 108.482 172.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -51.37 -53.32 37.53 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.094 0.958 . . . . 71.02 112.927 -172.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 57.39 92.87 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 O-C-N 124.269 0.981 . . . . 75.54 110.337 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -57.33 -68.32 0.24 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.213 1.005 . . . . 75.44 113.186 -164.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 60.7 p -106.73 20.27 19.27 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.744 0.646 . . . . 73.2 112.744 -172.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 58.79 25.28 13.31 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 122.359 1.076 . . . . 73.4 110.18 -175.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.738 ' HB3' HG23 ' B' ' 89' ' ' ILE . 22.0 ptm 52.1 176.24 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.287 2.235 . . . . 71.34 115.632 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.3 p -133.47 104.08 6.24 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 106.949 -1.5 . . . . 71.32 106.949 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.473 ' CD2' ' HG3' ' D' ' 130' ' ' PRO . 24.0 t80 -107.91 137.03 46.62 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.149 -1.056 . . . . 65.12 108.149 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.618 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 7.9 tp60 -141.15 118.37 11.34 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.257 -0.646 . . . . 74.44 109.257 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 57.1 mt -77.89 124.35 36.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.738 -1.208 . . . . 73.1 107.738 166.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -100.29 -35.57 9.57 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.527 -0.546 . . . . 74.04 109.527 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -176.89 134.5 0.2 Allowed 'General case' 0 C--N 1.352 0.69 0 O-C-N 123.917 0.761 . . . . 74.32 109.846 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.535 HG21 ' CD1' ' B' ' 109' ' ' TYR . 78.6 mt -119.65 145.05 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.117 -1.068 . . . . 75.42 108.117 175.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -165.11 145.09 7.01 Favored 'General case' 0 C--N 1.346 0.414 0 N-CA-C 112.974 0.731 . . . . 73.43 112.974 -173.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 38.7 m -76.3 122.79 24.93 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.477 -0.783 . . . . 72.11 108.903 170.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.433 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.4 mtpt -100.12 -14.75 18.44 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.423 0.689 . . . . 75.45 111.392 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.6 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.1 t70 -158.48 141.81 15.01 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.644 0.378 . . . . 71.35 111.433 -174.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.722 HD11 ' SG ' ' B' ' 113' ' ' CYS . 29.0 mm -136.68 143.12 36.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 124.915 1.286 . . . . 64.33 108.408 174.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 68.8 m -148.4 131.84 16.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.544 -1.207 . . . . 45.34 108.484 167.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -143.71 108.79 4.98 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.719 -1.586 . . . . 63.01 106.719 168.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -124.88 112.84 17.11 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.527 -0.916 . . . . 71.35 108.527 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.6 88.29 4.12 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.749 -1.204 . . . . 61.43 107.749 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.04 -40.91 8.23 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.75 2.3 . . . . 72.1 112.772 -168.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -101.02 19.96 16.44 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.777 0.831 . . . . 54.11 110.672 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.483 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -39.38 -62.13 0.87 Allowed Pre-proline 0 CA--C 1.566 1.588 0 N-CA-C 114.737 1.384 . . . . 40.22 114.737 -163.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 22.9 Cg_exo -62.95 -29.41 75.86 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 122.21 1.94 . . . . 74.32 112.983 -174.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -87.97 -38.18 15.76 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.228 -0.896 . . . . 73.51 111.659 -174.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.668 HG22 HD12 ' B' ' 68' ' ' LEU . 5.7 p -72.7 -15.78 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.156 0.583 . . . . 52.33 110.927 -173.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -70.58 -10.02 58.26 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 113.693 0.997 . . . . 74.42 113.693 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -72.79 -17.16 61.6 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 120.832 0.348 . . . . 65.51 110.465 174.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -98.68 97.61 8.85 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 124.92 1.288 . . . . 64.41 110.109 -175.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -102.22 85.77 2.71 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.222 -0.659 . . . . 74.24 109.222 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 7.6 p90 -156.83 -176.47 5.99 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.958 0.903 . . . . 75.2 109.797 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -68.63 114.41 22.12 Favored Pre-proline 0 N--CA 1.472 0.658 0 C-N-CA 123.559 0.744 . . . . 64.42 110.542 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.421 ' O ' HG23 ' B' ' 40' ' ' VAL . 27.9 Cg_endo -68.34 145.15 64.62 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 121.22 1.28 . . . . 65.4 110.693 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 9.7 tp10 -64.62 99.71 0.33 Allowed 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.235 -1.024 . . . . 61.33 108.235 170.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.508 HG11 HD11 ' B' ' 126' ' ' LEU . 53.5 t -106.79 141.71 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 123.778 0.674 . . . . 64.25 110.324 -174.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.402 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 54.3 tttm -142.27 109.37 5.53 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.374 1.069 . . . . 73.14 108.753 -172.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.418 HD13 HD22 ' B' ' 128' ' ' LEU . 38.2 tp -90.55 127.3 36.21 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.389 -0.597 . . . . 74.42 109.389 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.682 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 9.5 m-20 -122.29 116.8 24.71 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.241 1.016 . . . . 73.1 108.678 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.515 HD11 HG11 ' B' ' 131' ' ' VAL . 69.3 mt -99.39 126.74 45.34 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.42 -0.956 . . . . 75.41 108.42 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -140.68 155.52 46.47 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.293 1.037 . . . . 74.41 108.52 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' THR . . . . . 0.486 HG23 ' HB ' ' F' ' 107' ' ' THR . 1.4 t -148.18 117.83 7.05 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 121.328 0.585 . . . . 52.04 110.336 -177.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.64 125.34 53.64 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 106.726 -1.583 . . . . 64.35 106.726 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.546 ' HB2' ' HE2' ' B' ' 56' ' ' TYR . 62.0 p -139.41 177.15 8.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 119.652 -0.214 . . . . 74.41 110.886 -166.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 36.0 p -170.52 137.94 1.44 Allowed 'General case' 0 C--O 1.245 0.861 0 O-C-N 123.382 0.426 . . . . 75.4 111.16 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -76.0 126.36 30.86 Favored 'General case' 0 C--N 1.348 0.507 0 N-CA-C 108.573 -0.899 . . . . 71.01 108.573 165.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 pp -143.64 23.51 1.76 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.969 0.907 . . . . 64.21 109.092 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' B' ' 55' ' ' VAL . . . -166.25 170.89 12.74 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 123.457 0.703 . . . . 73.32 111.221 -175.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -100.76 118.02 36.02 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.666 0.787 . . . . 75.45 109.564 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 62.13 9.67 3.28 Favored 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 124.799 1.24 . . . . 50.34 112.584 -173.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.45 ' O ' ' HB3' ' B' ' 52' ' ' ALA . 74.8 t -128.75 129.96 68.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 107.631 -1.248 . . . . 74.12 107.631 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.546 ' HE2' ' HB2' ' B' ' 48' ' ' SER . 28.0 t80 -132.01 140.98 49.11 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.633 -0.877 . . . . 72.12 108.633 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -109.69 110.76 21.89 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 107.143 -1.428 . . . . 73.12 107.143 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.79 132.06 61.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 C-N-CA 123.333 0.653 . . . . 71.52 109.25 -177.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 32.7 t -111.53 113.85 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.022 -0.733 . . . . 61.43 109.022 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 60.9 tp -93.49 106.71 18.65 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.606 0.362 . . . . 62.23 110.103 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.445 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 20.9 ttm180 -86.06 108.23 18.17 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.356 0.662 . . . . 54.43 109.784 172.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.414 HG13 HD11 ' B' ' 42' ' ' LEU . 59.5 t -103.99 106.23 19.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.223 -1.029 . . . . 54.31 108.223 175.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.682 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 15.8 m -97.18 142.83 28.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.002 -0.999 . . . . 74.13 108.995 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.891 HG11 HD21 ' B' ' 126' ' ' LEU . 73.4 t -134.73 122.58 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.718 -0.845 . . . . 61.33 108.718 173.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 87.6 m -98.97 141.55 31.59 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.757 -1.201 . . . . 61.53 107.757 169.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.18 137.48 23.36 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.76 -0.459 . . . . 53.21 109.76 174.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.461 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 19.1 m -148.25 128.52 13.82 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.542 0.337 . . . . 70.32 111.489 -174.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.668 HD12 HG22 ' B' ' 31' ' ' VAL . 85.3 mt -93.95 99.92 12.16 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.174 -0.676 . . . . 61.53 109.174 178.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.69 -130.32 9.62 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 115.219 -0.901 . . . . 64.35 111.01 -171.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -97.18 2.0 50.49 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.087 0.955 . . . . 63.22 111.726 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -115.09 147.11 40.61 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.024 0.53 . . . . 65.14 110.569 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 49.7 m -68.92 133.06 47.7 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 123.5 0.5 . . . . 75.12 111.283 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.512 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -86.83 -60.74 1.9 Allowed 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.926 -1.138 . . . . 72.32 107.926 175.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -154.14 161.94 41.53 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 114.45 -1.25 . . . . 74.0 110.019 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -129.96 112.67 13.73 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.645 -1.613 . . . . 74.43 106.645 172.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.469 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 23.0 t -118.88 114.1 22.07 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.07 -0.715 . . . . 63.34 109.07 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -128.49 122.9 32.26 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.359 -0.978 . . . . 73.13 108.359 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 88.2 t -124.73 150.26 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.512 1.125 . . . . 53.24 108.552 -178.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.6 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 27.1 mt-30 -121.15 115.02 22.27 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.769 -0.826 . . . . 64.11 108.769 167.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -100.82 107.26 18.76 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.632 -0.877 . . . . 73.15 108.632 172.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.433 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -99.89 170.56 22.96 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 111.861 -0.496 . . . . 71.43 111.861 176.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.01 141.34 6.67 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 121.643 -0.313 . . . . 73.23 112.554 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 41.1 mt -97.77 106.61 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 108.517 -0.92 . . . . 70.11 108.517 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -116.08 135.24 54.12 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.103 0.561 . . . . 74.41 110.952 -175.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.618 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 57.7 m -95.24 129.6 42.31 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.889 0.876 . . . . 54.01 110.12 172.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.568 ' HB ' HD11 ' B' ' 89' ' ' ILE . 35.2 pt -138.39 136.61 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 124.048 0.939 . . . . 75.11 110.437 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.64 173.79 16.33 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.032 0.933 . . . . 74.03 109.787 174.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.86 -40.86 3.08 Favored Glycine 0 N--CA 1.479 1.557 0 CA-C-O 121.133 0.296 . . . . 65.41 112.823 177.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.738 HG23 ' HB3' ' B' ' 9' ' ' MET . 3.5 pt -58.8 154.76 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.474 1.11 . . . . 74.24 111.146 165.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -164.72 146.05 7.98 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.956 -1.02 . . . . 61.31 108.697 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.52 -134.8 12.28 Favored Glycine 0 C--N 1.348 1.218 0 O-C-N 123.442 0.464 . . . . 63.11 112.117 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 52.6 m -73.64 -54.22 8.65 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.757 0.823 . . . . 72.22 110.618 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.437 ' HA ' ' HB3' ' B' ' 96' ' ' HIS . 16.0 mm100 -56.52 -19.72 16.97 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.905 1.282 . . . . 74.14 113.197 -176.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.688 ' SD ' HG23 ' F' ' 97' ' ' ILE . 41.8 ttp -61.04 -70.29 0.19 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.325 1.05 . . . . 62.14 111.597 -177.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.591 ' HB1' HD23 ' F' ' 102' ' ' LEU . . . -82.51 -15.11 53.63 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 111.845 0.313 . . . . 74.44 111.845 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.437 ' HB3' ' HA ' ' B' ' 93' ' ' GLN . 1.4 t-80 -58.78 -34.66 71.7 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.433 0.693 . . . . 71.51 110.313 168.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.6 t -58.71 -26.0 63.47 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.554 0.742 . . . . 72.41 111.694 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.401 HD22 ' HB3' ' B' ' 56' ' ' TYR . 52.0 mt -84.41 -29.04 26.49 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.96 0.904 . . . . 70.45 112.129 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.79 -10.53 57.64 Favored Glycine 0 C--N 1.342 0.873 0 O-C-N 123.56 0.538 . . . . 43.23 113.021 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.675 ' HA ' ' HB2' ' B' ' 133' ' ' PHE . . . -124.38 -59.19 1.48 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.088 0.555 . . . . 44.41 112.167 -174.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -78.01 -48.82 15.31 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.112 0.565 . . . . 74.2 110.937 -168.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 73.5 m -61.52 -50.17 83.88 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 123.865 0.866 . . . . 74.15 112.073 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.09 -17.98 35.76 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 121.73 1.62 . . . . 63.0 112.917 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -70.86 -30.47 66.87 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.598 0.359 . . . . 72.21 110.42 173.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.437 HG23 ' NH2' ' D' ' 111' ' ' ARG . 69.5 mt -71.82 -42.42 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.18 0.592 . . . . 72.12 109.831 171.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 77.8 mt -73.89 -28.49 61.58 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.047 -0.979 . . . . 64.43 111.825 -175.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -60.12 -49.41 91.02 Favored Pre-proline 0 N--CA 1.484 1.248 0 CA-C-O 118.024 -0.988 . . . . 74.43 113.28 -172.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -54.83 -33.78 82.72 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.545 2.163 . . . . 74.12 113.598 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.535 ' CD1' HG21 ' B' ' 16' ' ' ILE . 7.7 m-30 -78.82 -40.46 32.83 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.047 0.539 . . . . 71.32 110.504 -176.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.25 -39.9 95.9 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.489 0.716 . . . . 61.13 110.136 172.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.463 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 47.1 ttt-85 -62.6 -53.3 56.64 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.429 1.491 . . . . 71.41 110.724 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -66.49 -30.54 70.9 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.461 0.705 . . . . 75.3 109.848 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.722 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.1 t -70.16 -42.36 72.59 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 122.946 0.498 . . . . 75.13 110.273 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.479 ' O ' HG23 ' B' ' 118' ' ' VAL . 45.4 mt -58.79 -55.79 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.853 0.861 . . . . 61.51 110.408 173.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 9.6 m -63.7 -29.89 71.06 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.632 0.773 . . . . 74.41 111.382 -173.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.3 t -58.31 -54.94 41.28 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 108.831 -0.803 . . . . 73.05 108.831 171.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.529 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.8 mmt -64.98 -37.3 87.21 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.602 0.761 . . . . 75.43 111.4 -175.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.479 HG23 ' O ' ' B' ' 114' ' ' ILE . 81.4 t -59.89 -48.82 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 124.019 0.928 . . . . 73.23 110.544 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 32.8 t -75.27 -19.85 59.48 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.899 -1.046 . . . . 73.43 111.075 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' B' ' 116' ' ' SER . 90.3 mtt-85 -68.21 -32.47 72.7 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 110.027 -0.36 . . . . 75.52 110.027 170.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.433 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -79.49 -5.58 89.22 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 123.655 0.597 . . . . 60.33 112.397 169.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 6.6 m 66.39 25.57 10.31 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.624 1.57 . . . . 60.11 110.652 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -77.33 163.21 65.8 Favored Pre-proline 0 CA--C 1.555 1.148 0 CA-C-N 114.884 -1.053 . . . . 74.23 110.836 175.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.552 ' HA ' ' HB3' ' F' ' 131' ' ' TRP . 91.6 Cg_exo -48.51 144.49 13.8 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 123.312 2.675 . . . . 63.31 114.764 174.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.533 ' HB3' ' HB3' ' F' ' 130' ' ' ALA . 41.0 tp60 -54.59 118.05 3.86 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.055 0.942 . . . . 31.21 110.758 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.891 HD21 HG11 ' B' ' 64' ' ' VAL . 20.5 tp -110.04 99.36 8.47 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.14 -0.936 . . . . 74.23 109.602 -171.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 127' ' ' ASN . . . . . 0.413 HD21 ' HG3' ' B' ' 125' ' ' GLN . 43.8 m-80 -96.03 110.68 22.88 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.453 -0.573 . . . . 75.14 109.453 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.463 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 55.0 mt -77.21 126.21 30.57 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.871 -0.789 . . . . 75.31 108.871 171.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.558 ' HB3' ' HA ' ' F' ' 119' ' ' ASP . . . -76.58 154.6 83.66 Favored Pre-proline 0 CA--C 1.552 1.051 0 O-C-N 124.268 0.98 . . . . 34.04 111.706 -169.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.492 ' HG3' HD13 ' D' ' 16' ' ' ILE . 3.8 Cg_exo -77.33 87.68 1.48 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.401 2.734 . . . . 72.41 112.686 -167.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.515 HG11 HD11 ' B' ' 44' ' ' LEU . 4.6 p -92.8 122.35 44.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 115.333 -0.849 . . . . 65.12 110.517 177.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -94.67 117.25 29.83 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 107.464 -1.31 . . . . 74.41 107.464 169.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.675 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 77.1 m-85 -64.3 -15.19 59.77 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.562 0.745 . . . . 71.33 111.887 -177.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.46 -43.56 75.58 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.451 1.1 . . . . 64.35 110.858 169.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.02 -31.83 67.36 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.717 0.807 . . . . 71.33 112.055 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.561 HD13 ' HA ' ' B' ' 133' ' ' PHE . 6.7 mp -76.12 -29.42 57.85 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.545 0.738 . . . . 74.23 110.407 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -73.79 -39.97 63.76 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.759 0.423 . . . . 53.03 110.507 169.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 20.9 mmt -62.64 -35.66 80.33 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.08 0.952 . . . . 73.54 111.425 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.76 -32.61 60.03 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.563 -0.744 . . . . 63.1 110.374 -175.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -79.91 -38.74 31.86 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.299 -0.864 . . . . 64.4 110.552 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 98.5 mt -99.64 29.78 3.93 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.989 0.916 . . . . 73.44 110.647 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.23 98.29 0.22 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.558 0.743 . . . . 75.24 109.255 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -178.79 -58.43 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.587 1.155 . . . . 75.34 108.106 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -82.58 94.25 7.47 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 114.532 -1.213 . . . . 71.22 108.182 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.03 -178.01 3.49 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.916 0.887 . . . . 71.45 110.634 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -146.83 96.72 0.18 Allowed Glycine 0 C--N 1.344 0.972 0 CA-C-N 115.962 -0.563 . . . . 72.45 111.976 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -81.43 84.24 6.73 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.73 0.776 . . . . 74.42 110.673 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.67 107.65 2.22 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 115.107 -0.951 . . . . 71.54 110.731 174.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 6.2 t -119.46 129.71 54.88 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.345 0.658 . . . . 73.55 110.941 -172.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 150' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' D' ' 90' ' ' GLU . 13.8 mm-40 -91.36 134.58 34.48 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.587 -0.894 . . . . 75.43 108.587 169.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -94.84 43.89 1.1 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.666 0.786 . . . . 61.2 110.501 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 51.6 m80 69.64 121.36 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.174 1.39 . . . . 72.42 111.685 -176.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 153' ' ' GLN . . . . . 0.418 ' HB3' ' HA2' ' D' ' 91' ' ' GLY . 11.0 pt20 -68.5 146.11 53.43 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.483 0.713 . . . . 74.24 110.792 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -82.19 170.2 15.72 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.65 0.78 . . . . 74.31 112.015 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.156 0 CA-C-N 114.996 -1.002 . . . . 71.42 109.046 176.922 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 84.1 mtp . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 110.487 -0.19 . . . . 73.04 110.487 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 13.5 p -160.56 97.44 1.2 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.464 0.705 . . . . 73.12 109.742 174.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.82 90.68 2.92 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.582 0.706 . . . . 73.25 110.369 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -78.94 67.3 4.61 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-O 122.642 1.21 . . . . 63.32 109.956 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -69.64 127.28 32.4 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.436 -1.257 . . . . 74.34 110.855 -172.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -163.84 149.31 10.91 Favored 'General case' 0 C--O 1.245 0.854 0 C-N-CA 123.842 0.857 . . . . 64.24 110.134 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 32.4 m -83.13 82.6 8.18 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.774 -1.195 . . . . 63.05 107.774 169.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -161.29 -47.1 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.647 -0.872 . . . . 55.24 108.647 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.637 ' HE3' HG21 ' C' ' 89' ' ' ILE . 51.2 ttm 65.11 115.66 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.844 1.258 . . . . 72.14 111.611 -176.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 51.6 m -98.78 95.9 7.53 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.079 -0.711 . . . . 51.3 109.079 172.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -109.83 135.94 49.93 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.353 -0.61 . . . . 65.33 109.353 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -152.96 131.55 12.25 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 109.617 -0.512 . . . . 72.52 109.617 171.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 57.2 mt -69.88 125.96 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 108.65 -0.87 . . . . 74.43 108.65 170.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -89.93 -49.78 6.41 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.961 -0.755 . . . . 64.23 108.961 175.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.559 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -173.53 150.92 1.85 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.111 0.964 . . . . 75.22 109.973 174.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 pp -114.54 152.28 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 107.878 -1.156 . . . . 60.3 107.878 173.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.638 ' HB3' HG23 ' D' ' 122' ' ' THR . 28.2 p90 -179.56 162.46 1.11 Allowed 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.456 0.646 . . . . 73.34 110.882 -174.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.2 p -92.35 115.33 27.99 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 123.43 0.692 . . . . 74.43 109.882 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.401 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 19.6 mmtp -64.43 -40.47 95.8 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.233 -1.025 . . . . 75.22 108.233 170.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -150.07 147.87 28.32 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.407 -1.269 . . . . 73.52 110.787 -174.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.54 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.6 mt -138.39 144.51 30.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 C-N-CA 125.896 1.679 . . . . 74.24 106.584 174.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 31.2 t -153.46 150.01 28.34 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 122.568 0.347 . . . . 54.23 110.481 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -155.28 137.08 14.41 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.451 1.1 . . . . 73.32 108.166 175.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -140.23 133.73 30.08 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.281 0.633 . . . . 71.2 109.433 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.79 81.41 22.87 Favored Pre-proline 0 C--O 1.241 0.621 0 N-CA-C 108.001 -1.111 . . . . 64.22 108.001 169.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.2 -30.41 74.48 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 123.017 2.478 . . . . 54.02 112.622 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 27' ' ' ASN . . . . . 0.479 ' OD1' ' HB ' ' C' ' 31' ' ' VAL . 5.9 p30 -117.07 34.54 5.06 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.222 0.609 . . . . 54.33 109.575 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -40.08 -57.85 2.56 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 114.148 1.166 . . . . 74.22 114.148 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -64.61 -35.39 47.82 Favored 'Trans proline' 0 C--N 1.382 2.292 0 CA-C-N 121.569 1.596 . . . . 43.2 112.64 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -68.71 -38.09 79.97 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.813 0.845 . . . . 73.13 112.24 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.623 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.5 p -76.34 -30.27 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 N-CA-C 112.573 0.583 . . . . 74.13 112.573 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -59.79 -34.02 72.48 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 112.447 0.536 . . . . 73.22 112.447 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -86.15 11.89 10.89 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.398 0.679 . . . . 71.3 112.408 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.429 ' HG2' HD13 ' C' ' 68' ' ' LEU . 1.8 ttpm? -113.95 147.85 37.86 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.877 0.871 . . . . 74.53 110.124 177.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.16 125.26 23.11 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 123.381 0.673 . . . . 71.41 110.93 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -81.55 105.81 13.01 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.927 -1.033 . . . . 63.04 110.993 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -162.78 79.44 1.77 Allowed Pre-proline 0 C--O 1.241 0.607 0 N-CA-C 107.469 -1.308 . . . . 75.21 107.469 164.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -87.04 164.52 8.67 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 122.913 2.409 . . . . 43.24 113.02 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -86.75 85.32 7.28 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 106.725 -1.583 . . . . 73.21 106.725 168.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 99.2 t -68.58 109.7 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 115.008 -0.996 . . . . 64.34 109.767 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.582 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 65.7 mttm -92.08 103.96 16.4 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.354 -0.98 . . . . 73.02 108.354 178.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 tt -89.08 123.91 33.81 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 107.057 -1.46 . . . . 51.52 107.057 174.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.609 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 17.0 t70 -128.39 139.53 52.32 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.153 0.981 . . . . 74.54 108.409 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.522 HD22 HD21 ' C' ' 60' ' ' LEU . 24.6 mt -135.3 126.41 27.96 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.438 0.695 . . . . 72.33 110.218 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -130.53 139.29 50.48 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.63 1.172 . . . . 61.11 108.193 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.0 t -144.07 139.47 28.94 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.019 0.438 . . . . 75.33 110.283 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.95 156.05 45.48 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.937 0.895 . . . . 54.13 109.608 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 2.3 m -132.43 144.18 50.31 Favored 'General case' 0 C--O 1.24 0.564 0 O-C-N 123.299 0.374 . . . . 54.14 110.034 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 22.4 p -145.12 126.07 14.48 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.916 0.886 . . . . 72.32 109.473 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -78.76 118.67 21.04 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.317 -0.623 . . . . 73.04 109.317 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' C' ' 57' ' ' GLU . 34.5 mt -88.45 -41.47 12.76 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.83 0.852 . . . . 73.42 110.638 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.19 -172.66 4.22 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.061 -0.972 . . . . 62.54 110.181 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.42 112.62 1.83 Allowed 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.036 0.835 . . . . 44.45 110.591 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 66.31 9.33 6.31 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.661 1.185 . . . . 62.23 112.425 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 87.0 t -106.81 107.62 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.23 0.612 . . . . 61.33 109.857 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -106.72 124.63 49.89 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.768 0.827 . . . . 74.53 109.073 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.56 ' HB2' HD11 ' C' ' 51' ' ' LEU . 30.2 tt0 -82.72 126.65 32.61 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.296 -1.002 . . . . 75.21 108.296 169.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.8 t -112.4 138.2 42.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.486 -0.931 . . . . 72.4 108.486 167.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 86.6 t -120.9 131.37 73.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 108.529 -0.915 . . . . 53.42 108.529 170.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.522 HD21 HD22 ' C' ' 44' ' ' LEU . 0.9 OUTLIER -114.22 107.23 15.33 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.676 -1.231 . . . . 74.04 107.676 172.633 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.414 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 0.0 OUTLIER -95.9 117.74 31.18 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 114.671 -1.149 . . . . 74.42 109.153 178.083 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 10.8 t -102.07 132.37 48.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 107.838 -1.171 . . . . 65.44 107.838 172.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.609 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 29.9 m -123.31 128.02 49.35 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.099 -1.074 . . . . 71.05 108.099 175.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.409 HG23 HD13 ' C' ' 114' ' ' ILE . 85.7 t -122.95 128.75 75.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.576 -0.738 . . . . 71.33 109.34 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 25.4 m -118.32 139.24 51.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.621 -1.251 . . . . 71.44 107.621 176.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.24 113.01 15.76 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.669 -1.604 . . . . 65.45 106.669 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 65.4 m -135.62 126.21 27.05 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.672 0.607 . . . . 60.14 109.9 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.429 HD13 ' HG2' ' C' ' 34' ' ' LYS . 12.0 mt -85.98 56.06 3.81 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.224 1.41 . . . . 72.34 107.908 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.58 -107.73 3.08 Favored Glycine 0 C--N 1.341 0.851 0 N-CA-C 110.026 -1.23 . . . . 64.11 110.026 -169.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -103.59 -17.14 15.29 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.64 0.776 . . . . 72.22 110.044 173.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -68.55 99.89 1.04 Allowed 'General case' 0 C--N 1.348 0.542 0 C-N-CA 123.341 0.656 . . . . 64.22 109.44 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 50.4 m -73.36 114.83 12.01 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.169 -0.678 . . . . 71.31 109.169 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.623 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -67.84 -57.52 6.13 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.248 -1.342 . . . . 42.22 108.613 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -155.13 159.64 40.34 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.745 -1.116 . . . . 71.42 110.732 172.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.417 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -118.68 143.06 47.09 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.799 -1.556 . . . . 73.24 106.799 167.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.417 ' N ' HD13 ' C' ' 75' ' ' LEU . 46.6 t -149.7 141.9 24.08 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.598 -0.89 . . . . 72.33 108.598 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -154.65 134.9 13.21 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.472 -0.566 . . . . 71.4 109.472 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.48 HG11 ' HA ' ' C' ' 110' ' ' ALA . 40.9 t -133.71 114.65 20.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 124.263 1.025 . . . . 73.53 108.836 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.414 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 53.4 mt-30 -91.27 87.64 6.57 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.654 -0.869 . . . . 65.14 108.654 174.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.439 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.4 tp-100 -79.86 99.11 7.38 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.408 0.683 . . . . 72.24 110.121 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.67 149.11 25.43 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 116.329 -0.396 . . . . 55.35 112.36 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.538 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.27 125.73 2.01 Favored Glycine 0 CA--C 1.503 -0.678 0 N-CA-C 110.508 -1.037 . . . . 43.42 110.508 -178.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.538 HD12 HD11 ' C' ' 51' ' ' LEU . 31.8 mm -93.7 125.24 46.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 108.278 -1.008 . . . . 63.11 108.278 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -133.64 121.84 22.6 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.457 0.703 . . . . 74.43 109.721 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 20.6 p -82.28 103.99 12.27 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 108.745 -0.835 . . . . 71.12 108.745 171.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.612 HG21 ' HE3' ' C' ' 94' ' ' MET . 17.8 mt -116.19 137.57 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.585 0.754 . . . . 74.14 109.74 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.538 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -151.28 170.51 19.33 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.199 0.6 . . . . 74.2 110.639 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.34 -49.12 1.51 Allowed Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.98 -0.555 . . . . 73.02 113.371 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.637 HG21 ' HE3' ' C' ' 9' ' ' MET . 42.7 pt -91.06 171.28 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 123.445 0.698 . . . . 74.34 112.635 -167.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -157.97 157.47 33.1 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.751 -1.113 . . . . 41.13 109.508 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.66 -131.16 21.25 Favored Glycine 0 C--N 1.348 1.241 0 O-C-N 123.412 0.445 . . . . 73.32 113.805 172.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.8 p -60.46 -35.21 75.33 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.27 1.028 . . . . 61.13 111.789 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -57.72 -57.47 12.61 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.857 0.863 . . . . 64.1 110.607 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.612 ' HE3' HG21 ' C' ' 86' ' ' ILE . 4.1 tpt -55.23 -50.17 70.13 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.067 0.947 . . . . 75.11 112.505 175.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.68 -33.88 74.76 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.114 0.566 . . . . 74.11 111.253 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -73.99 -36.55 64.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.974 0.51 . . . . 72.23 110.55 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.466 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 33.7 t -69.45 -33.56 73.12 Favored 'General case' 0 C--N 1.35 0.614 0 N-CA-C 109.734 -0.469 . . . . 75.12 109.734 -177.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 96.9 mt -85.78 -37.48 19.23 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.982 0.913 . . . . 65.2 111.896 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.87 3.92 45.56 Favored Glycine 0 N--CA 1.473 1.15 0 CA-C-O 119.525 -0.597 . . . . 53.2 114.58 -168.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.543 ' HA ' ' HB3' ' C' ' 133' ' ' PHE . . . -149.35 -54.46 0.17 Allowed 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.808 0.804 . . . . 63.42 112.045 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.466 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 51.3 t80 -66.6 -56.68 9.61 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.286 0.634 . . . . 75.43 112.111 -174.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 97.2 m -60.89 -47.26 96.14 Favored Pre-proline 0 CA--C 1.562 1.41 0 CA-C-O 118.787 -0.625 . . . . 74.13 112.42 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -54.54 -30.88 67.07 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 122.409 2.072 . . . . 74.22 114.318 172.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -70.72 -30.9 67.57 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.026 0.53 . . . . 54.52 111.114 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.407 HD12 HH12 ' A' ' 111' ' ' ARG . 44.5 mm -73.01 -35.3 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 109.62 -0.511 . . . . 71.5 109.62 175.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.538 HD21 ' HA3' ' C' ' 82' ' ' GLY . 94.7 mt -81.22 -30.97 34.06 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.971 0.908 . . . . 74.35 112.733 -175.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -55.92 -50.11 89.13 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 113.884 1.068 . . . . 74.41 113.884 -172.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.85 -36.25 95.14 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.251 1.968 . . . . 71.34 113.396 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -70.05 -44.37 69.31 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.05 0.54 . . . . 64.23 111.356 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.48 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -66.7 -33.6 76.0 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.876 -0.602 . . . . 45.14 110.713 175.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -62.63 -51.49 67.09 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.925 1.29 . . . . 75.43 110.446 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -69.37 -29.36 67.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.95 0.5 . . . . 71.52 110.377 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.9 t -69.18 -37.68 78.29 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 122.75 0.42 . . . . 63.43 110.709 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.447 ' O ' HG23 ' C' ' 118' ' ' VAL . 98.6 mt -71.65 -47.39 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 122.931 0.492 . . . . 73.53 110.054 174.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.7 m -53.23 -42.44 66.39 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.532 1.133 . . . . 71.02 111.664 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.428 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.1 t -66.68 -38.94 87.82 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.425 -0.807 . . . . 74.12 109.538 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.541 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -66.2 -39.83 89.93 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.187 0.995 . . . . 73.33 111.778 178.404 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.447 HG23 ' O ' ' C' ' 114' ' ' ILE . 61.8 t -59.04 -42.79 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 109.258 -0.645 . . . . 62.23 109.258 172.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.2 t -66.13 -38.67 88.72 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.816 -1.083 . . . . 74.03 112.248 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' C' ' 116' ' ' SER . 64.7 mtt-85 -69.58 -39.21 77.45 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.264 0.625 . . . . 71.42 110.19 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.45 3.71 84.0 Favored Glycine 0 C--N 1.351 1.361 0 CA-C-N 115.669 -0.696 . . . . 74.33 112.544 173.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 33.6 p 58.38 30.74 20.04 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.058 1.743 . . . . 72.43 113.068 171.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -81.94 154.58 70.27 Favored Pre-proline 0 C--O 1.242 0.684 0 CA-C-N 115.703 -0.681 . . . . 73.01 109.57 175.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.48 127.76 27.32 Favored 'Trans proline' 0 C--N 1.363 1.333 0 C-N-CA 122.093 1.862 . . . . 73.12 112.022 168.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.471 ' HG2' ' HB2' ' B' ' 125' ' ' GLN . 23.6 mm-40 -53.72 154.6 3.69 Favored 'General case' 0 C--O 1.248 0.981 0 O-C-N 124.623 1.202 . . . . 73.22 113.604 -170.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.424 HD13 HG21 ' F' ' 133' ' ' THR . 21.1 tp -147.76 86.38 1.59 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-N 113.847 -1.524 . . . . 75.54 108.168 -172.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -91.97 108.63 20.07 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.787 -1.097 . . . . 70.14 108.692 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -67.81 137.99 55.79 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.513 0.725 . . . . 74.43 110.118 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.78 152.53 95.12 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 123.665 0.786 . . . . 51.25 111.106 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.518 ' HG3' HD12 ' A' ' 16' ' ' ILE . 52.1 Cg_exo -54.98 114.93 2.09 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.662 2.241 . . . . 74.54 112.272 172.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.54 ' HA ' ' HE1' ' F' ' 138' ' ' TYR . 5.0 p -98.14 125.95 51.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 123.103 0.561 . . . . 45.13 110.19 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -81.53 101.7 10.11 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.653 -0.869 . . . . 75.32 108.653 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.543 ' HB3' ' HA ' ' C' ' 100' ' ' ALA . 82.9 m-85 -67.3 -25.34 65.99 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.356 -0.838 . . . . 55.3 111.31 177.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -63.86 -36.5 84.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.324 0.649 . . . . 64.31 110.323 175.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.64 -42.1 95.69 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.647 0.779 . . . . 63.44 110.414 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 71.0 mt -72.72 -27.09 61.84 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.839 -1.073 . . . . 72.24 110.873 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -80.96 -24.0 38.39 Favored 'General case' 0 C--O 1.213 -0.864 0 C-N-CA 123.029 0.531 . . . . 65.44 110.699 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 93.1 mtp -78.7 -28.57 45.14 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 122.037 -0.414 . . . . 75.24 110.367 169.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -62.3 -33.99 75.71 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.963 1.305 . . . . 73.41 112.122 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -156.86 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.659 0 C-N-CA 123.06 0.544 . . . . 73.1 112.236 -172.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.435 ' HG ' ' H ' ' C' ' 143' ' ' GLN . 14.4 tp 65.79 156.32 0.09 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.757 1.223 . . . . 73.03 111.794 172.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -115.66 7.67 14.81 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.513 -0.742 . . . . 75.02 110.931 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 143' ' ' GLN . . . . . 0.435 ' H ' ' HG ' ' C' ' 141' ' ' LEU . 54.6 mt-30 -135.13 157.29 47.3 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.747 0.819 . . . . 73.21 110.448 -178.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -119.19 82.13 1.82 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.513 -0.921 . . . . 75.05 108.513 175.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -130.85 146.0 52.16 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.306 1.042 . . . . 61.4 109.446 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -160.12 48.44 0.39 Allowed Glycine 0 C--N 1.346 1.092 0 O-C-N 123.237 0.336 . . . . 60.54 112.927 -174.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -72.06 93.39 1.39 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.044 -0.725 . . . . 75.14 109.044 173.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -147.11 82.36 0.19 Allowed Glycine 0 C--N 1.341 0.815 0 N-CA-C 111.457 -0.657 . . . . 53.14 111.457 -175.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 9.9 t -112.89 135.54 53.54 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.24 0.616 . . . . 75.42 110.414 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -121.66 161.16 23.0 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.927 0.891 . . . . 61.44 110.115 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -84.62 137.14 33.45 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.728 0.811 . . . . 65.3 109.03 174.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -101.21 116.49 32.94 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.959 0.409 . . . . 74.13 110.594 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -124.93 109.61 13.21 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 107.934 -1.135 . . . . 74.23 107.934 169.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -69.51 158.53 35.03 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.608 0.363 . . . . 73.33 111.185 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.988 0 C-N-CA 123.634 0.773 . . . . 70.21 109.593 -174.475 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 109.822 -0.436 . . . . 75.03 109.822 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 12.6 m -90.9 -72.41 0.58 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.539 -0.911 . . . . 74.53 108.539 169.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.13 138.37 4.61 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.372 1.469 . . . . 64.12 107.634 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -163.87 77.85 0.39 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.005 0.431 . . . . 74.35 110.493 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -172.64 -64.29 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.782 0.833 . . . . 72.51 109.432 173.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -159.41 160.12 34.51 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.665 0.786 . . . . 72.42 110.0 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 32.8 m -67.43 100.71 0.87 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.572 0.749 . . . . 60.01 109.966 176.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -76.54 -163.85 0.36 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.389 0.675 . . . . 74.42 111.069 174.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.591 ' HG2' HG13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -31.5 123.17 0.26 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.51 1.524 . . . . 63.23 112.497 177.573 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 9.7 t -129.57 135.88 49.12 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.59 0.756 . . . . 74.33 109.03 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.419 ' HZ ' ' HG ' ' D' ' 102' ' ' CYS . 59.7 t80 -137.4 101.16 4.43 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.371 -1.344 . . . . 71.42 107.371 175.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -125.92 124.47 40.89 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.692 0.797 . . . . 72.21 109.104 -175.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.602 HD13 HG21 ' D' ' 105' ' ' ILE . 5.4 mt -84.18 137.42 20.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.786 -0.82 . . . . 60.21 108.786 177.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -97.02 -42.5 7.87 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 122.975 0.51 . . . . 72.03 110.461 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.42 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 40.8 ttt180 -174.23 142.77 0.83 Allowed 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.313 0.383 . . . . 71.33 111.383 -170.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.492 HD13 ' HG3' ' B' ' 130' ' ' PRO . 2.1 mp -115.55 137.75 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 105.882 -1.895 . . . . 72.43 105.882 174.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.42 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 19.0 p90 -161.54 137.0 7.64 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 123.609 0.568 . . . . 73.11 110.967 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.4 p -76.65 110.63 11.39 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.321 -0.854 . . . . 64.3 109.487 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -85.53 -9.81 56.86 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.496 -0.775 . . . . 71.32 109.712 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.636 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 17.4 t70 -169.11 143.43 3.01 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 124.896 1.278 . . . . 61.34 109.733 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.541 HG21 ' HE2' ' C' ' 117' ' ' MET . 80.4 mt -147.4 144.71 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 125.266 1.427 . . . . 70.44 107.9 177.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.8 t -147.04 145.92 29.85 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.967 0.907 . . . . 73.1 109.249 170.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.54 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 81.1 t80 -149.87 118.55 6.57 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 106.963 -1.495 . . . . 71.52 106.963 169.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -123.54 140.27 53.17 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.479 -0.563 . . . . 74.23 109.479 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.68 82.39 60.97 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 107.813 -1.18 . . . . 75.54 107.813 174.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.8 -29.24 42.51 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.924 2.416 . . . . 73.54 113.008 -170.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.41 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 38.0 m-80 -108.66 8.86 27.17 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-O 118.479 -0.772 . . . . 70.43 110.852 -177.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.426 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -20.05 -73.17 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 116.63 2.085 . . . . 60.1 116.63 -166.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.437 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 92.2 Cg_endo -75.5 -21.66 14.72 Favored 'Trans proline' 0 C--N 1.386 2.552 0 CA-C-N 124.056 2.484 . . . . 60.15 114.117 -176.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -74.46 -37.93 63.08 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.257 1.023 . . . . 72.31 110.25 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.651 HG22 HD12 ' D' ' 68' ' ' LEU . 11.0 p -82.04 -20.51 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 115.953 -0.567 . . . . 62.42 111.506 -174.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.437 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 23.0 m-85 -63.75 -28.67 70.04 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 120.801 0.334 . . . . 72.44 111.819 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -58.41 -22.27 53.48 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.71 1.204 . . . . 73.5 111.241 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -90.22 69.42 7.14 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.994 1.318 . . . . 73.52 110.2 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.73 85.45 4.74 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.411 -0.813 . . . . 61.22 110.67 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 10.2 p90 -154.07 -173.21 4.49 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.453 0.701 . . . . 63.21 109.902 172.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -63.27 112.4 6.91 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.377 1.071 . . . . 64.51 110.772 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -60.76 120.25 7.87 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.066 1.844 . . . . 75.1 110.805 172.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -67.63 104.32 1.58 Allowed 'General case' 0 C--N 1.35 0.592 0 N-CA-C 106.417 -1.697 . . . . 74.01 106.417 169.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.586 HG13 HG13 ' D' ' 64' ' ' VAL . 71.3 t -103.05 115.31 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 N-CA-C 108.792 -0.818 . . . . 74.13 108.792 -174.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -96.98 110.25 22.83 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 105.783 -1.932 . . . . 75.52 105.783 176.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.475 HD11 HG13 ' D' ' 62' ' ' VAL . 63.4 tp -94.37 138.5 32.26 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.418 -1.327 . . . . 74.3 107.418 175.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -141.75 147.92 38.15 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.528 -1.286 . . . . 71.44 107.528 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.42 ' CD2' HG22 ' D' ' 62' ' ' VAL . 73.7 mt -131.0 136.06 48.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.548 0.689 . . . . 74.53 110.874 -173.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 11.6 t70 -133.03 129.17 37.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 113.977 -1.465 . . . . 53.31 107.692 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 46' ' ' THR . . . . . 0.52 HG23 HD22 ' E' ' 111' ' ' LEU . 2.6 p -106.94 150.78 26.1 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.546 0.689 . . . . 65.01 110.094 174.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.87 166.57 29.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.233 -1.349 . . . . 51.13 107.86 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.8 p -153.52 -165.61 2.19 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.633 -0.506 . . . . 62.41 109.633 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.8 m -144.74 149.68 35.96 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.98 -0.748 . . . . 50.51 108.98 -172.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -71.65 -170.23 0.52 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.654 -0.703 . . . . 74.34 110.631 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 tm? 69.52 83.43 0.15 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 107.735 -1.209 . . . . 74.54 107.735 -165.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.6 92.27 6.54 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 114.478 -1.237 . . . . 63.12 109.395 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -164.05 75.3 0.32 Allowed 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.799 -0.815 . . . . 74.53 108.799 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 64.88 -2.62 0.67 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 125.255 1.422 . . . . 70.13 113.811 173.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 45.8 t -128.57 100.94 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 107.484 -1.302 . . . . 71.31 107.484 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -122.18 127.81 50.47 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.946 -0.761 . . . . 61.14 108.946 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -87.91 114.88 24.95 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 108.158 -1.053 . . . . 71.02 108.158 169.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 95.4 t -100.35 134.91 38.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 107.286 -1.376 . . . . 72.54 107.286 171.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 49.1 t -128.9 126.79 65.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.687 -1.227 . . . . 74.41 107.687 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.522 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -114.52 103.93 11.51 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.505 -1.294 . . . . 74.4 107.505 -176.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.677 HH21 ' HE1' ' E' ' 106' ' ' TYR . 41.1 ttm-85 -83.35 103.14 12.5 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.579 -0.897 . . . . 65.41 108.579 173.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.475 HG13 HD11 ' D' ' 42' ' ' LEU . 66.4 t -97.32 121.83 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.027 -0.731 . . . . 74.14 109.027 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 56.8 m -119.4 133.44 55.71 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.005 0.922 . . . . 70.43 109.106 -172.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.586 HG13 HG13 ' D' ' 40' ' ' VAL . 75.4 t -125.81 132.44 70.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 124.226 1.01 . . . . 54.33 108.788 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 26.7 m -127.93 93.14 3.61 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.676 -1.602 . . . . 72.0 106.676 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.83 147.24 24.62 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.704 -0.85 . . . . 71.0 108.704 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.551 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 32.5 p -149.56 133.94 17.44 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.208 0.528 . . . . 74.24 111.505 -173.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.651 HD12 HG22 ' D' ' 31' ' ' VAL . 79.4 mt -104.17 102.62 12.35 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.923 -1.035 . . . . 65.52 108.283 170.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.03 -128.96 17.49 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 115.764 -0.653 . . . . 63.31 113.154 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -84.56 3.08 38.32 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.931 0.892 . . . . 61.42 113.022 -174.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -137.0 154.92 50.28 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-O 121.115 0.483 . . . . 74.23 110.871 -173.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.0 m -69.18 126.56 30.17 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.583 -1.189 . . . . 73.43 111.072 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.577 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -75.65 -64.78 1.0 Allowed 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.624 -1.25 . . . . 71.51 107.624 173.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -153.24 141.84 20.88 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.266 -0.879 . . . . 75.12 111.152 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 65.9 mt -101.11 153.58 19.46 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.284 1.034 . . . . 60.43 108.771 167.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.716 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.8 t -156.82 142.19 17.42 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.123 0.569 . . . . 54.14 109.496 176.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -155.37 122.22 5.39 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.213 -0.292 . . . . 65.34 110.213 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.6 t -126.0 115.11 41.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 124.066 0.947 . . . . 72.41 109.338 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.636 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.6 mt-30 -88.72 87.64 7.32 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.6 -0.889 . . . . 75.33 108.6 171.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -83.39 100.84 10.94 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.483 -1.235 . . . . 74.44 109.083 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.37 149.01 17.74 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 112.327 -0.309 . . . . 70.3 112.327 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.37 142.97 10.49 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.77 -0.532 . . . . 52.3 111.77 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.0 mt -89.29 117.01 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 108.099 -1.074 . . . . 65.42 108.099 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.24 127.78 55.71 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.701 0.8 . . . . 74.24 110.548 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 33.6 t -84.87 122.79 29.67 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.275 -1.009 . . . . 61.12 108.275 166.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.474 HD12 ' HB2' ' D' ' 97' ' ' CYS . 3.0 tt -143.67 125.78 11.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 108.565 -0.902 . . . . 44.32 108.565 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.406 ' HB1' ' HA3' ' E' ' 96' ' ' GLY . . . -167.06 167.99 14.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.784 0.834 . . . . 51.43 110.458 -174.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.525 ' H ' ' HA3' ' E' ' 96' ' ' GLY . . . 86.56 21.13 52.43 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.447 0.467 . . . . 74.35 114.01 173.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.591 HG13 ' HG2' ' D' ' 9' ' ' MET . 0.4 OUTLIER -131.64 171.54 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.045 0.938 . . . . 70.42 108.975 177.762 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' B' ' 150' ' ' GLU . 7.2 tm-20 -147.62 179.92 7.34 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.645 -0.872 . . . . 62.01 108.645 -175.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 91' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' B' ' 153' ' ' GLN . . . 73.85 -136.66 22.11 Favored Glycine 0 C--N 1.347 1.16 0 C-N-CA 122.992 0.329 . . . . 74.03 112.875 172.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.6 m -91.91 -36.76 13.28 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.126 0.571 . . . . 63.21 111.242 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -65.65 -19.63 65.98 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.185 0.594 . . . . 65.15 112.46 -171.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.422 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 0.0 OUTLIER -64.51 -36.99 86.0 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.951 0.5 . . . . 74.11 112.247 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 95' ' ' ALA . . . . . 0.422 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.11 -14.88 45.74 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.267 0.627 . . . . 64.23 111.851 178.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -63.96 -38.84 92.57 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.52 0.728 . . . . 64.34 112.282 -176.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 97' ' ' CYS . . . . . 0.474 ' HB2' HD12 ' D' ' 86' ' ' ILE . 69.1 m -65.43 -49.58 68.65 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.476 0.31 . . . . 74.35 111.629 -177.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.684 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 3.6 pp -67.47 -22.16 65.49 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.05 0.389 . . . . 70.22 112.05 -176.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.93 -29.33 11.84 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-O 119.881 -0.399 . . . . 72.43 113.593 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.0 -52.89 2.3 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 117.309 0.555 . . . . 32.24 111.838 -173.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -73.71 -39.57 64.23 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 112.103 0.408 . . . . 74.41 112.103 -173.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.684 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 89.1 m -65.31 -46.76 71.31 Favored Pre-proline 0 CA--C 1.556 1.189 0 CA-C-O 118.728 -0.653 . . . . 54.21 111.692 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.522 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 50.1 Cg_exo -58.71 -35.12 99.1 Favored 'Trans proline' 0 C--N 1.389 2.692 0 C-N-CA 121.653 1.569 . . . . 52.31 112.777 168.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.47 -31.73 73.06 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.346 0.658 . . . . 71.34 111.394 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.602 HG21 HD13 ' D' ' 13' ' ' ILE . 36.5 mm -69.78 -43.67 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.533 0.733 . . . . 74.12 110.223 172.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 74.6 mt -72.81 -19.74 61.28 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.26 -0.882 . . . . 72.24 111.699 -175.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -66.32 -45.42 60.08 Favored Pre-proline 0 CA--C 1.556 1.175 0 N-CA-C 113.498 0.925 . . . . 72.12 113.498 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -49.27 -41.02 43.17 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.443 2.095 . . . . 70.11 113.86 170.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -78.97 -33.23 45.37 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.458 0.703 . . . . 70.01 112.102 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.91 -44.27 73.51 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.523 0.677 . . . . 70.45 109.506 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.437 ' NH2' HG23 ' B' ' 105' ' ' ILE . 46.5 ttp180 -66.42 -37.29 84.87 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 114.005 -1.452 . . . . 70.5 110.172 175.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 112' ' ' GLU . . . . . 0.428 ' HA ' ' CE2' ' B' ' 109' ' ' TYR . 8.7 tt0 -52.29 -46.86 66.08 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.732 0.813 . . . . 73.41 111.148 176.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.8 t -66.72 -47.77 71.27 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.775 -1.102 . . . . 64.25 110.71 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.716 HG12 ' SG ' ' D' ' 76' ' ' CYS . 42.6 mt -60.29 -62.77 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.978 0.511 . . . . 53.42 110.363 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 98.3 m -41.68 -46.32 3.71 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 125.709 1.603 . . . . 63.23 112.799 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 22.9 t -68.48 -45.17 73.08 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.192 -0.913 . . . . 74.13 110.67 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.1 mtm -67.44 -34.3 76.93 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.802 0.441 . . . . 71.33 111.589 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.484 HG23 ' O ' ' D' ' 114' ' ' ILE . 84.9 t -60.54 -46.81 94.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 123.797 0.839 . . . . 71.33 110.082 176.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.0 p -70.45 -28.5 65.07 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 115.785 -0.643 . . . . 71.13 110.705 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' D' ' 116' ' ' SER . 72.6 mtt-85 -71.89 -22.92 61.43 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.531 0.733 . . . . 75.22 111.251 176.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.52 12.71 68.56 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-O 119.564 -0.576 . . . . 45.23 112.709 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.638 HG23 ' HB3' ' C' ' 17' ' ' TYR . 72.6 p 60.03 11.87 2.89 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 126.735 2.014 . . . . 61.11 113.391 -174.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -81.51 149.38 64.7 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.776 -0.453 . . . . 75.33 109.776 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -48.22 120.06 4.61 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 123.095 2.53 . . . . 54.11 113.03 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.479 ' O ' ' HA ' ' E' ' 127' ' ' SER . 25.2 tt0 -42.23 119.73 1.44 Allowed 'General case' 0 C--N 1.364 1.237 0 O-C-N 124.875 1.359 . . . . 72.13 111.402 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.484 HD13 HG21 ' D' ' 40' ' ' VAL . 29.8 tp -106.48 99.61 9.18 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.309 0.644 . . . . 60.42 109.51 -171.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -97.82 97.9 9.37 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 107.449 -1.315 . . . . 65.14 107.449 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.4 HD11 HD12 ' D' ' 114' ' ' ILE . 38.8 mt -59.59 137.14 58.12 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-N 115.133 -0.939 . . . . 73.42 109.995 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.49 148.49 73.66 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 123.541 0.736 . . . . 72.3 111.184 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.473 ' HG3' ' CD2' ' B' ' 11' ' ' PHE . 32.0 Cg_endo -60.47 122.95 12.09 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.647 2.231 . . . . 74.42 111.298 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 131' ' ' VAL . . . . . 0.424 ' HA ' ' HE1' ' E' ' 120' ' ' TYR . 99.9 t -108.08 115.26 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.395 -0.366 . . . . 75.32 110.631 -175.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -83.64 96.55 8.71 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 107.745 -1.206 . . . . 55.01 107.745 167.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.482 ' HA ' HD13 ' D' ' 136' ' ' LEU . 28.5 m-85 -59.39 -26.86 65.47 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.047 0.939 . . . . 45.22 112.109 -174.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -49.5 -49.14 47.05 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.015 1.326 . . . . 72.4 111.13 172.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.2 -32.3 73.82 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 114.92 -1.036 . . . . 75.45 112.009 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' D' ' 133' ' ' PHE . 6.7 mp -72.05 -31.09 65.8 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 117.986 0.357 . . . . 73.11 111.108 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -78.36 -45.97 21.17 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.769 0.428 . . . . 75.33 110.684 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 79.9 mtm -67.0 -39.18 87.06 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.312 0.645 . . . . 51.32 111.464 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.546 ' O ' ' HB2' ' D' ' 143' ' ' GLN . 6.2 m-20 -61.5 -39.26 90.33 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.888 0.475 . . . . 73.41 110.862 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -54.87 -29.53 55.68 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.309 0.644 . . . . 73.41 111.623 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.8 mp -83.0 -50.48 8.5 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.097 0.559 . . . . 73.42 111.067 173.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 142' ' ' GLN . . . . . 0.537 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 10.7 pt20 -90.88 18.22 6.86 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 113.672 0.99 . . . . 62.52 113.672 -171.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 143' ' ' GLN . . . . . 0.546 ' HB2' ' O ' ' D' ' 139' ' ' ASN . 1.1 tm0? -121.31 91.19 3.47 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.955 -0.758 . . . . 71.03 108.955 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -145.32 -57.87 0.33 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.953 0.901 . . . . 61.43 109.296 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.53 125.88 18.8 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.449 0.7 . . . . 74.11 110.513 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.69 74.69 1.27 Allowed Glycine 0 C--N 1.345 1.048 0 N-CA-C 111.323 -0.711 . . . . 71.32 111.323 -175.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -73.51 88.21 1.63 Allowed 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.744 0.783 . . . . 64.53 110.754 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 75.87 153.02 4.17 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.227 -0.897 . . . . 64.52 112.805 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 91.1 m -146.61 118.6 8.21 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.114 0.566 . . . . 71.12 109.705 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.27 100.75 3.81 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.758 0.789 . . . . 72.11 109.169 175.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.66 112.03 6.66 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.839 -1.171 . . . . 73.23 107.839 -176.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -158.0 33.32 0.25 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.53 0.732 . . . . 75.45 110.195 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -148.79 114.82 5.76 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.515 0.726 . . . . 73.34 109.412 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -86.22 169.41 13.06 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.105 0.562 . . . . 54.1 111.146 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.847 0 N-CA-C 108.299 -1.0 . . . . 37.81 108.299 179.146 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.869 0 CA-C-O 119.455 -0.636 . . . . 23.02 111.835 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.52 -65.04 2.48 Favored Glycine 0 C--N 1.356 1.684 0 N-CA-C 111.201 -0.759 . . . . 45.12 111.201 -173.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -73.02 175.15 6.92 Favored 'General case' 0 C--O 1.249 1.03 0 C-N-CA 124.778 1.231 . . . . 72.24 109.293 166.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -66.19 117.74 8.92 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.594 -0.521 . . . . 73.22 109.594 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.08 101.41 7.85 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.048 -0.723 . . . . 63.23 109.048 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 96' ' ' GLY . . . . . 0.525 ' HA3' ' H ' ' D' ' 88' ' ' GLY . . . -125.38 -46.04 0.24 Allowed Glycine 0 C--N 1.342 0.905 0 CA-C-N 115.38 -0.827 . . . . 31.24 112.389 177.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 97' ' ' ILE . . . . . . . . . . . . . 40.7 pt -133.99 154.12 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-O 121.885 0.85 . . . . 73.03 112.389 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -162.74 -41.43 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 113.939 -1.482 . . . . 72.12 109.008 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.26 91.38 6.19 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 123.48 0.712 . . . . 75.01 109.99 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pp -143.13 142.44 21.73 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 123.352 0.661 . . . . 72.14 110.539 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -64.35 -26.94 63.31 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 122.811 2.341 . . . . 74.2 112.932 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 102' ' ' LEU . . . . . 0.493 ' HG ' ' H ' ' E' ' 104' ' ' GLY . 34.5 tp 70.34 168.9 0.31 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.448 1.099 . . . . 71.44 110.019 -176.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 29.3 p -78.77 -25.55 44.4 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.714 -0.616 . . . . 75.41 110.678 174.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 104' ' ' GLY . . . . . 0.493 ' H ' ' HG ' ' E' ' 102' ' ' LEU . . . 138.91 161.96 8.95 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 110.618 -0.993 . . . . 74.22 110.618 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -61.14 -37.94 84.63 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 121.392 0.615 . . . . 74.42 110.312 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 106' ' ' TYR . . . . . 0.677 ' HE1' HH21 ' D' ' 61' ' ' ARG . 48.6 t80 -132.53 9.01 4.28 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 114.766 -1.107 . . . . 73.42 110.083 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 35.0 m 69.57 160.79 0.2 Allowed 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 125.039 1.336 . . . . 62.41 111.652 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -150.75 40.22 0.73 Allowed 'General case' 0 CA--C 1.559 1.306 0 CA-C-O 122.426 1.108 . . . . 53.45 109.306 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -125.26 -170.88 2.25 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.982 0.913 . . . . 73.4 110.274 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.39 56.47 3.27 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.691 0.757 . . . . 73.22 111.031 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 111' ' ' LEU . . . . . 0.52 HD22 HG23 ' D' ' 46' ' ' THR . 1.6 tt -172.37 53.77 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 105.167 -2.16 . . . . 63.51 105.167 -177.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -167.79 160.82 12.82 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 113.842 -1.526 . . . . 63.44 109.131 -164.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 53.7 tttm 75.49 141.78 0.07 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.674 1.19 . . . . 64.23 111.019 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -58.7 -23.43 59.58 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 113.469 0.915 . . . . 75.43 113.469 -173.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 3.3 t -144.34 78.36 1.57 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 122.095 0.95 . . . . 63.14 109.266 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . -79.07 169.49 54.09 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 114.728 -1.124 . . . . 62.34 112.499 173.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -76.0 127.49 85.16 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 123.681 0.793 . . . . 73.52 110.424 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.78 117.01 4.73 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.667 2.245 . . . . 74.14 111.064 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -133.78 -72.04 0.5 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.813 -0.63 . . . . 64.22 109.779 -172.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 120' ' ' TYR . . . . . 0.424 ' HE1' ' HA ' ' D' ' 131' ' ' VAL . 71.8 t80 -77.41 -57.52 3.78 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.867 -0.79 . . . . 72.23 108.867 172.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 121' ' ' VAL . . . . . . . . . . . . . 17.8 m -79.36 120.82 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-N 115.179 -0.919 . . . . 71.44 109.723 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 3.8 m -108.8 174.0 6.07 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 108.473 -0.936 . . . . 70.35 108.473 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 123' ' ' ASP . . . . . 0.472 ' HA ' ' O ' ' D' ' 40' ' ' VAL . 6.8 p-10 -76.86 -174.24 2.99 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.596 0.358 . . . . 74.24 110.875 175.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 32.7 t 62.17 35.76 15.42 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.632 0.773 . . . . 64.33 110.982 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.84 156.2 21.27 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.268 0.627 . . . . 65.45 110.95 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.5 88.73 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.035 0.934 . . . . 73.32 112.047 -169.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 127' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' D' ' 125' ' ' GLN . 7.4 p -113.22 88.8 2.92 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.47 0.708 . . . . 62.14 110.445 176.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.53 -173.76 3.88 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.539 1.136 . . . . 71.31 109.865 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 27.4 m 81.01 138.88 0.07 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 125.037 1.335 . . . . 72.33 111.32 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 130' ' ' ALA . . . . . 0.567 ' HB3' ' HG3' ' A' ' 124' ' ' PRO . . . -93.33 168.13 11.28 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.349 0.659 . . . . 62.15 110.296 177.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 131' ' ' TRP . . . . . 0.409 ' O ' ' HB3' ' A' ' 124' ' ' PRO . 18.7 t90 -73.68 170.43 15.25 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 124.248 1.019 . . . . 73.24 110.481 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 43.0 p -48.49 127.64 13.54 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.747 1.219 . . . . 74.44 112.942 -173.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 15.4 t -76.65 167.42 21.87 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.871 0.869 . . . . 74.12 111.178 -177.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.15 134.02 36.67 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-N 115.788 -0.642 . . . . 54.42 112.872 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 91.9 t -79.1 77.6 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 C-N-CA 124.053 0.941 . . . . 65.45 109.952 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -86.88 -32.96 19.94 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.099 -0.955 . . . . 74.03 109.841 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 25.9 m 69.28 -81.41 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.796 1.238 . . . . 63.42 111.68 170.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 138' ' ' TYR . . . . . 0.529 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 39.6 p90 -140.86 -17.93 0.84 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.969 0.507 . . . . 73.32 111.837 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -74.95 84.62 2.24 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.021 0.528 . . . . 72.51 109.912 -173.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.53 -160.11 11.8 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.087 -0.961 . . . . 72.22 112.355 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.28 173.73 8.6 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.052 0.941 . . . . 51.13 112.019 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 42.7 tp -92.53 160.53 15.0 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.567 -1.197 . . . . 72.44 109.339 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -74.08 73.64 1.27 Allowed Glycine 0 C--N 1.352 1.456 0 O-C-N 123.291 0.37 . . . . 74.3 112.326 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.46 136.85 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.655 1.182 . . . . 74.12 109.518 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 34.8 t70 . . . . . 0 C--O 1.248 0.974 0 C-N-CA 123.384 0.674 . . . . 64.41 109.293 178.308 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.426 0 N-CA-C 111.648 -0.581 . . . . 35.54 111.648 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.92 -178.26 17.38 Favored Glycine 0 C--N 1.346 1.132 0 O-C-N 123.802 0.354 . . . . 43.25 113.725 175.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 59.96 70.31 0.64 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.246 1.018 . . . . 75.55 110.551 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -87.37 -169.46 2.62 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.919 -1.037 . . . . 74.4 109.907 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.44 32.87 1.07 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.238 0.615 . . . . 74.21 110.813 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -87.19 -47.47 4.68 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 115.406 -0.816 . . . . 73.14 112.431 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 97' ' ' ILE . . . . . 0.688 HG23 ' SD ' ' B' ' 94' ' ' MET . 55.3 mt -70.37 -45.04 76.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 123.979 0.912 . . . . 64.21 110.297 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 23.1 t70 71.42 -72.91 0.1 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.507 1.523 . . . . 74.43 111.019 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -91.4 108.64 20.03 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.904 0.882 . . . . 65.13 109.917 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 100' ' ' LEU . . . . . 0.491 HD13 HG21 ' F' ' 97' ' ' ILE . 30.5 tp -138.73 66.37 41.25 Favored Pre-proline 0 N--CA 1.488 1.446 0 C-N-CA 122.779 0.431 . . . . 74.1 111.727 -177.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.49 -34.21 3.59 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.41 2.073 . . . . 64.44 112.091 173.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 102' ' ' LEU . . . . . 0.591 HD23 ' HB1' ' B' ' 95' ' ' ALA . 1.8 tm? 53.19 74.57 0.29 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.66 1.184 . . . . 70.24 108.996 -169.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 103' ' ' THR . . . . . 0.619 HG21 ' HB2' ' F' ' 109' ' ' TYR . 56.6 p 52.29 28.74 5.94 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 125.797 1.639 . . . . 64.32 113.05 176.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.7 -149.09 19.22 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-N 115.594 -0.73 . . . . 72.11 112.953 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -88.15 32.12 0.77 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.953 0.901 . . . . 74.15 110.284 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -172.05 150.04 2.46 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.54 -0.911 . . . . 72.23 108.54 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 107' ' ' THR . . . . . 0.486 ' HB ' HG23 ' B' ' 46' ' ' THR . 15.7 m -79.87 103.05 9.5 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 109.227 -0.657 . . . . 74.45 109.227 174.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -114.95 30.43 7.36 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.546 1.139 . . . . 74.04 109.343 -175.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 109' ' ' TYR . . . . . 0.619 ' HB2' HG21 ' F' ' 103' ' ' THR . 7.4 t80 -137.88 112.93 9.14 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.835 0.454 . . . . 74.11 109.883 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 62.15 -173.79 0.14 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.229 1.012 . . . . 65.45 111.612 -174.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 mp 66.29 134.94 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.111 0.965 . . . . 71.43 111.161 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 62.21 -147.85 0.38 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.081 -0.711 . . . . 71.22 109.081 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 69.62 -72.69 0.1 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.154 1.381 . . . . 64.41 110.214 177.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -71.62 133.12 45.5 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.614 -0.884 . . . . 73.41 108.614 169.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 9.7 t -60.76 120.71 10.63 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 121.193 0.521 . . . . 72.32 110.042 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . -138.6 115.15 1.12 Allowed Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.75 -0.94 . . . . 63.32 110.75 -175.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 117' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' F' ' 121' ' ' VAL . 0.5 OUTLIER -68.99 165.41 38.27 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 123.536 0.735 . . . . 63.1 109.936 -178.738 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -58.27 -168.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 122.098 1.865 . . . . 54.22 113.766 173.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 119' ' ' ASP . . . . . 0.571 ' HB2' ' HA ' ' F' ' 125' ' ' ALA . 8.8 t70 79.18 -78.25 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.812 1.645 . . . . 72.3 110.855 -177.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -139.85 24.51 2.39 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 122.868 0.467 . . . . 72.42 110.895 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 121' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' F' ' 117' ' ' LYS . 21.9 t 61.73 30.91 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-O 122.832 1.301 . . . . 74.51 110.039 178.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 25.6 p -103.92 -88.15 0.42 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.816 -1.083 . . . . 73.44 110.428 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -163.39 -57.85 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.098 0.559 . . . . 73.31 109.94 -175.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 14.6 m -79.05 130.92 36.03 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.326 -0.852 . . . . 52.12 109.582 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 125' ' ' ALA . . . . . 0.571 ' HA ' ' HB2' ' F' ' 119' ' ' ASP . . . -135.01 135.93 41.75 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 122.847 0.459 . . . . 75.35 111.377 -177.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -86.8 140.86 29.29 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.596 0.758 . . . . 73.43 110.239 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 47.7 t -148.77 -73.9 0.18 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.146 0.579 . . . . 74.31 110.574 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . 63.05 -175.24 0.15 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.193 0.997 . . . . 60.15 111.737 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 3.4 t -126.78 84.61 2.28 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.229 1.014 . . . . 72.11 109.054 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 130' ' ' ALA . . . . . 0.533 ' HB3' ' HB3' ' B' ' 125' ' ' GLN . . . -84.97 73.87 10.61 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.112 -0.949 . . . . 62.11 110.006 -178.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 131' ' ' TRP . . . . . 0.552 ' HB3' ' HA ' ' B' ' 124' ' ' PRO . 82.5 t90 175.07 114.11 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.538 1.535 . . . . 74.42 107.965 173.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 7.6 t -166.97 32.97 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.406 -0.961 . . . . 70.33 108.406 172.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 133' ' ' THR . . . . . 0.424 HG21 HD13 ' C' ' 126' ' ' LEU . 1.5 m -72.98 125.0 26.58 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.954 -1.021 . . . . 65.22 110.505 -174.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -83.92 56.34 5.04 Favored Glycine 0 C--N 1.348 1.246 0 N-CA-C 112.128 -0.389 . . . . 70.24 112.128 175.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 3.9 p -91.43 91.3 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 124.061 0.944 . . . . 54.54 110.04 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -158.86 85.76 0.83 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.435 -0.802 . . . . 75.13 110.079 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 30.6 m -109.54 -71.6 0.76 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.566 -0.902 . . . . 75.33 108.566 172.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 138' ' ' TYR . . . . . 0.54 ' HE1' ' HA ' ' C' ' 131' ' ' VAL . 10.0 t80 60.83 -165.38 0.22 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.2 1.0 . . . . 72.22 111.114 175.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -68.42 -26.76 65.69 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.181 0.592 . . . . 71.41 110.496 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -172.31 -59.98 0.04 OUTLIER Glycine 0 C--N 1.346 1.095 0 CA-C-N 115.958 -0.565 . . . . 74.12 111.736 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.26 92.9 0.05 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.822 1.249 . . . . 73.54 112.502 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 60.9 tp -90.89 103.69 16.37 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.519 0.728 . . . . 73.31 110.146 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -179.87 141.98 4.93 Favored Glycine 0 C--N 1.343 0.937 0 C-N-CA 121.588 -0.339 . . . . 64.24 112.476 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 9.2 p -154.57 145.34 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.714 0.806 . . . . 61.42 109.647 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 29.8 t70 . . . . . 0 C--O 1.249 1.06 0 C-N-CA 123.324 0.65 . . . . 74.51 109.396 176.305 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 108.607 -0.886 . . . . 61.52 108.607 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -159.66 156.57 28.07 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 122.87 0.468 . . . . 74.43 110.396 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -83.95 139.31 32.66 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.012 0.925 . . . . 74.11 109.627 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -69.62 -95.62 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.31 1.044 . . . . 71.23 110.798 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.8 t30 170.94 53.92 0.0 OUTLIER 'General case' 0 C--N 1.366 1.3 0 C-N-CA 124.888 1.275 . . . . 54.31 108.205 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -148.12 -84.39 0.1 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 109.605 -0.517 . . . . 74.51 109.605 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.6 m -157.02 85.03 0.94 Allowed 'General case' 0 C--O 1.242 0.686 0 N-CA-C 107.36 -1.348 . . . . 74.32 107.36 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -93.36 144.22 25.54 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.131 -0.941 . . . . 60.13 109.512 -178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.434 ' N ' ' SD ' ' A' ' 9' ' ' MET . 1.3 mpt? -80.47 172.23 14.03 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.743 0.817 . . . . 74.4 110.661 -175.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 84.6 m -140.66 118.44 11.72 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.261 0.624 . . . . 74.14 110.486 -174.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.807 ' HE1' ' HG ' ' A' ' 102' ' ' CYS . 72.6 t80 -120.62 124.87 46.3 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.767 -1.197 . . . . 62.04 107.767 172.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -132.23 132.72 43.36 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.284 -0.635 . . . . 75.2 109.284 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.471 HG21 ' HG2' ' C' ' 130' ' ' PRO . 69.4 mt -89.69 109.63 20.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.158 -1.053 . . . . 64.02 108.158 171.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.63 -40.66 17.19 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 109.048 -0.723 . . . . 72.23 109.048 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 -168.88 122.28 0.82 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.64 0.376 . . . . 63.41 110.283 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 83.7 mt -107.07 136.71 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.776 -0.824 . . . . 74.4 108.776 170.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.454 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 22.1 p90 -164.92 169.51 16.4 Favored 'General case' 0 C--N 1.347 0.47 0 O-C-N 123.822 0.701 . . . . 52.33 111.699 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -94.47 120.6 34.96 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.116 -0.698 . . . . 70.41 109.116 172.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.454 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 34.8 mtpt -78.9 -34.88 44.35 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.164 0.507 . . . . 70.2 109.673 175.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 17.8 t70 -150.01 140.47 22.41 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.646 -1.161 . . . . 64.22 109.865 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.4 mt -130.92 139.69 50.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 124.873 1.269 . . . . 65.45 107.835 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -145.54 127.97 15.95 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.297 -1.001 . . . . 61.34 108.297 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.464 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 86.9 t80 -135.63 129.49 32.91 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.112 -1.44 . . . . 74.01 107.112 171.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -129.59 135.95 49.2 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.165 -0.679 . . . . 72.44 109.165 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.31 76.93 71.66 Favored Pre-proline 0 C--O 1.24 0.553 0 N-CA-C 105.817 -1.919 . . . . 72.15 105.817 167.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.67 -22.92 36.91 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.591 2.194 . . . . 53.45 112.027 -171.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -110.12 22.3 15.74 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.233 1.013 . . . . 65.51 109.447 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.478 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -46.88 -52.79 30.47 Favored Pre-proline 0 CA--C 1.568 1.654 0 CA-C-O 117.846 -1.073 . . . . 75.02 113.658 -171.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.57 -23.22 64.31 Favored 'Trans proline' 0 C--N 1.391 2.778 0 CA-C-N 121.536 1.584 . . . . 64.03 113.374 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -84.12 -39.69 19.17 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.675 0.79 . . . . 74.51 111.017 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.893 HG21 ' HA ' ' A' ' 73' ' ' ALA . 5.5 p -78.23 -23.56 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 CA-C-N 115.306 -0.861 . . . . 72.35 113.159 -157.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -70.06 -19.35 63.29 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 122.739 0.416 . . . . 74.43 110.874 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -86.81 -16.5 36.03 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.568 1.147 . . . . 74.31 110.772 177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -81.5 158.06 24.63 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.873 0.869 . . . . 72.31 111.884 -174.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.48 118.27 8.53 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 123.992 0.917 . . . . 72.13 109.413 173.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -78.55 84.92 4.65 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.661 0.743 . . . . 75.14 109.91 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -122.85 76.09 48.44 Favored Pre-proline 0 C--O 1.243 0.745 0 N-CA-C 106.799 -1.556 . . . . 53.31 106.799 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.44 ' HB2' HG23 ' A' ' 40' ' ' VAL . 83.7 Cg_endo -78.47 115.1 3.61 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 121.817 1.678 . . . . 72.32 111.363 -171.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -93.31 81.59 4.45 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 105.554 -2.017 . . . . 70.23 105.554 172.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.44 HG23 ' HB2' ' A' ' 38' ' ' PRO . 46.0 t -86.05 93.74 3.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 CA-C-N 114.532 -1.213 . . . . 61.55 109.555 -174.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.72 118.82 21.88 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.953 -1.476 . . . . 53.51 108.384 174.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.7 mt -95.39 108.55 20.75 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.435 -1.32 . . . . 75.45 107.435 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -102.61 141.18 35.85 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.387 -0.968 . . . . 75.32 108.387 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.55 HD11 HG21 ' A' ' 131' ' ' VAL . 75.5 mt -135.39 131.41 36.28 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 109.498 -0.556 . . . . 72.41 109.498 -174.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -134.03 129.56 36.27 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.448 -1.316 . . . . 61.31 107.448 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.485 HG21 ' HA2' ' A' ' 99' ' ' GLY . 85.3 m -108.54 130.97 55.28 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.876 -0.787 . . . . 51.42 108.876 172.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.72 109.37 9.11 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.819 -0.808 . . . . 51.22 108.819 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.6 p -91.28 163.42 14.24 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.318 0.647 . . . . 74.31 110.098 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.9 t -160.39 154.14 22.6 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.28 1.432 . . . . 75.41 107.328 -166.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -116.29 125.41 52.12 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.681 -0.489 . . . . 70.12 109.681 171.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.7 mt -95.02 -32.99 12.89 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.21 0.604 . . . . 54.41 110.583 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.95 -179.5 7.2 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.192 0.597 . . . . 64.14 111.39 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -63.51 123.7 19.47 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 109.346 -0.613 . . . . 64.03 109.346 174.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 70.2 -8.53 0.84 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 125.835 1.654 . . . . 64.4 112.886 -173.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.7 t -100.64 106.61 19.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 121.496 0.665 . . . . 73.43 109.301 -177.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -114.27 125.61 54.1 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.735 -1.209 . . . . 71.43 107.735 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -94.32 128.77 41.02 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.919 -0.771 . . . . 72.42 108.919 172.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.1 t -113.2 137.71 45.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.369 -0.974 . . . . 71.01 108.369 171.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.7 t -119.32 130.58 73.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.905 -0.776 . . . . 75.44 108.905 173.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.31 97.8 7.56 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 105.675 -1.972 . . . . 73.12 105.675 172.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -84.94 97.58 9.87 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.928 -1.138 . . . . 73.13 107.928 174.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 50.0 t -94.97 131.25 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 107.49 -1.3 . . . . 74.33 107.49 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.8 m -127.12 118.4 24.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.817 0.817 . . . . 74.24 110.203 175.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.597 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 91.5 t -104.33 125.49 59.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 124.56 1.144 . . . . 43.0 108.905 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.1 m -122.43 126.49 48.05 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.648 -0.871 . . . . 42.04 108.648 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.404 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -113.21 108.3 17.08 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 107.847 -1.168 . . . . 63.42 107.847 175.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.0 m -109.03 134.29 51.85 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.179 0.591 . . . . 72.21 110.037 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.4 mt -100.7 57.74 0.91 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.247 1.019 . . . . 62.41 108.341 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.46 -103.15 3.0 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 110.82 -0.912 . . . . 45.41 110.82 -169.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -96.59 -28.56 14.31 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.352 0.661 . . . . 73.45 111.428 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -102.74 123.07 45.74 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.471 0.308 . . . . 71.33 110.639 -173.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.6 m -71.5 138.42 48.92 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.514 0.726 . . . . 63.21 110.871 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.893 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -79.78 -60.06 2.49 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.317 1.047 . . . . 74.2 109.817 173.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -151.02 156.64 41.55 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 114.629 -1.169 . . . . 73.45 111.071 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 39.9 tp -126.82 115.05 18.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.633 1.173 . . . . 61.23 108.58 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.597 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 66.3 m -105.9 142.3 35.85 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.044 0.937 . . . . 72.32 109.339 175.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -146.44 121.35 9.98 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.644 -0.873 . . . . 53.32 108.644 166.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.4 t -126.09 109.81 22.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.703 -0.851 . . . . 73.52 108.703 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -85.78 82.01 8.36 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 114.379 -1.282 . . . . 72.33 108.443 174.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -76.23 95.55 3.74 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.828 -1.078 . . . . 61.14 109.164 -177.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.32 154.88 29.15 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 111.361 -0.696 . . . . 41.02 111.361 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.29 121.51 1.23 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.682 -0.967 . . . . 30.3 110.682 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.4 mt -81.68 127.1 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 107.823 -1.177 . . . . 74.12 107.823 171.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.844 ' HB3' HD11 ' A' ' 86' ' ' ILE . 71.0 m-85 -135.71 125.15 24.95 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.095 0.958 . . . . 72.24 109.561 -171.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.1 m -94.65 97.95 10.46 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 109.216 -0.661 . . . . 73.42 109.216 175.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.844 HD11 ' HB3' ' A' ' 84' ' ' PHE . 6.0 mm -108.04 156.69 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.385 0.674 . . . . 62.11 110.679 -172.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.41 162.84 8.47 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.523 1.129 . . . . 74.23 110.909 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.21 -13.94 62.81 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-N 115.951 -0.568 . . . . 25.4 114.422 174.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.482 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -133.46 146.6 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.824 0.85 . . . . 41.53 110.736 -177.108 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -144.16 174.76 10.6 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.296 1.038 . . . . 64.41 109.735 174.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.99 -139.01 26.42 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 116.012 -0.54 . . . . 60.21 112.618 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.7 p -69.79 -16.61 63.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 117.105 0.453 . . . . 73.12 111.501 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' C' ' 154' ' ' ASP . 48.4 mt-30 -64.57 -45.71 85.88 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.254 0.621 . . . . 74.12 109.959 170.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.403 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 6.1 tpt -66.75 -43.79 83.2 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.103 -0.953 . . . . 63.35 109.662 -178.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.95 -31.16 72.25 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.601 -0.727 . . . . 63.3 111.125 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.441 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 57.8 t-80 -74.3 -30.3 62.01 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.667 0.787 . . . . 63.44 110.696 176.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.4 t -72.8 -44.54 61.38 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 109.115 -0.698 . . . . 60.01 109.115 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 94' ' ' MET . 35.9 mt -84.99 -24.72 28.14 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.389 -0.823 . . . . 72.13 112.019 -174.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.485 ' HA2' HG21 ' A' ' 46' ' ' THR . . . -108.01 4.45 33.89 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 119.597 -0.557 . . . . 45.13 113.947 -174.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.562 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -147.52 -64.22 0.27 Allowed 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 117.667 0.734 . . . . 62.4 112.372 -177.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -68.16 -47.27 68.48 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 123.352 0.408 . . . . 74.35 111.697 -171.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.807 ' HG ' ' HE1' ' A' ' 11' ' ' PHE . 98.4 m -65.2 -45.83 71.87 Favored Pre-proline 0 CA--C 1.56 1.333 0 CA-C-O 117.987 -1.006 . . . . 70.0 112.316 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -54.26 -35.26 82.78 Favored 'Trans proline' 0 C--N 1.398 3.178 0 C-N-CA 122.188 1.925 . . . . 72.13 112.889 169.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -68.53 -34.25 75.54 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.531 0.732 . . . . 64.43 111.093 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.5 mm -67.88 -43.23 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.49 0.716 . . . . 53.42 110.054 172.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 55.9 mt -75.19 -20.24 59.4 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.053 -0.976 . . . . 61.33 111.877 -174.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -65.63 -45.24 67.1 Favored Pre-proline 0 N--CA 1.478 0.93 0 CA-C-O 117.05 -1.452 . . . . 72.11 113.537 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -50.72 -34.11 42.8 Favored 'Trans proline' 0 C--N 1.39 2.715 0 CA-C-N 122.182 1.815 . . . . 44.51 113.592 171.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -85.69 -36.47 20.22 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.711 0.804 . . . . 72.21 112.054 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.42 -48.25 67.84 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.968 -0.752 . . . . 64.02 108.968 175.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.453 ' NH1' HD12 ' C' ' 105' ' ' ILE . 27.9 ttm180 -47.87 -58.48 4.32 Favored 'General case' 0 C--O 1.213 -0.82 0 O-C-N 125.203 1.565 . . . . 61.31 110.677 171.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -60.79 -45.35 94.74 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 124.321 1.013 . . . . 74.44 111.792 -173.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.416 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 47.4 t -58.74 -45.9 88.62 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.045 0.841 . . . . 71.34 110.498 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.505 HG21 HG21 ' A' ' 64' ' ' VAL . 83.3 mt -61.16 -51.44 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 124.27 0.982 . . . . 64.33 110.603 175.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.2 m -58.75 -37.11 75.5 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.36 1.064 . . . . 73.21 110.687 -173.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.1 t -70.59 -44.56 67.06 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.444 -1.253 . . . . 54.44 109.866 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.4 mtp -59.39 -38.62 81.0 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.658 0.783 . . . . 63.41 111.774 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 114' ' ' ILE . 79.3 t -67.27 -46.08 84.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.211 1.004 . . . . 70.02 110.073 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.9 p -71.88 -30.63 65.61 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.828 -0.624 . . . . 55.14 111.106 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.413 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 81.7 mtt-85 -72.22 -33.69 67.78 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.675 0.79 . . . . 75.31 109.432 172.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.61 -2.17 74.32 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 115.019 -0.991 . . . . 73.21 112.962 175.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.529 HG22 HH21 ' B' ' 15' ' ' ARG . 52.1 m 76.92 19.99 1.34 Allowed 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 122.593 1.187 . . . . 74.33 111.882 168.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -93.31 148.75 36.17 Favored Pre-proline 0 C--O 1.248 1.022 0 N-CA-C 108.296 -1.002 . . . . 71.42 108.296 170.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.659 ' HB3' ' HA ' ' E' ' 131' ' ' TRP . 11.9 Cg_endo -54.47 138.96 74.9 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.494 2.129 . . . . 72.04 111.156 175.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -56.21 127.48 30.96 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.332 1.02 . . . . 75.34 112.274 -167.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.542 HD21 HG11 ' A' ' 64' ' ' VAL . 36.0 tp -113.04 97.14 6.33 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 114.454 -1.248 . . . . 74.44 109.406 -175.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -96.04 103.23 15.11 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.038 -1.467 . . . . 74.34 107.038 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 17.3 mt -55.24 136.12 49.08 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.778 0.673 . . . . 74.51 111.134 -169.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.84 137.86 97.28 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 122.755 0.422 . . . . 42.03 111.274 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.537 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 53.2 Cg_exo -55.47 114.84 2.07 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.593 2.862 . . . . 64.43 113.689 -178.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.55 HG21 HD11 ' A' ' 44' ' ' LEU . 45.1 t -104.2 133.24 48.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 CA-C-N 115.455 -0.793 . . . . 70.45 109.842 177.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 63.4 t-20 -96.97 87.12 4.16 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.515 -0.921 . . . . 55.13 108.515 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -59.68 -26.6 65.7 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.708 0.803 . . . . 73.24 113.056 175.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.562 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 8.6 t0 -63.67 -43.97 95.15 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.931 -0.766 . . . . 74.34 108.931 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.05 -35.22 80.46 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.893 -1.048 . . . . 61.34 111.476 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.418 ' HA ' ' ND2' ' A' ' 139' ' ' ASN . 77.9 mt -71.83 -40.66 68.93 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.022 0.826 . . . . 74.45 111.879 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -67.05 -42.3 85.05 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.796 -0.816 . . . . 74.12 108.796 175.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.569 ' HG3' ' HA ' ' A' ' 143' ' ' GLN . 5.4 tpt -64.09 -47.55 79.61 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 124.208 0.942 . . . . 70.1 111.336 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.69 ' HA ' ' HB2' ' A' ' 143' ' ' GLN . 23.8 p30 -66.79 -30.62 70.87 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 120.975 0.417 . . . . 74.53 110.77 -176.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -72.78 -41.52 64.93 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.296 1.038 . . . . 75.21 110.432 172.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 42.3 tp -66.52 -49.88 65.06 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.037 0.935 . . . . 75.24 110.889 -172.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 179.83 -19.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.974 0.909 . . . . 55.22 110.748 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.69 ' HB2' ' HA ' ' A' ' 139' ' ' ASN . 55.7 tt0 60.43 86.75 0.09 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.706 1.602 . . . . 75.34 111.857 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -151.52 -1.02 0.34 Allowed 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.732 -0.667 . . . . 73.42 110.561 -176.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.483 ' HB3' ' SD ' ' A' ' 138' ' ' MET . . . -144.1 -175.11 4.48 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.447 1.099 . . . . 73.1 108.99 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 168.79 -53.66 0.21 Allowed Glycine 0 C--N 1.341 0.825 0 N-CA-C 112.119 -0.393 . . . . 73.21 112.119 178.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.44 175.0 8.61 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.672 0.749 . . . . 75.42 112.016 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -161.15 -173.55 29.92 Favored Glycine 0 C--O 1.242 0.61 0 CA-C-N 114.813 -1.085 . . . . 63.35 111.429 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.6 m -148.37 159.9 43.55 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 108.121 -1.066 . . . . 74.01 108.121 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.64 178.2 8.66 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.027 0.931 . . . . 75.21 110.038 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.557 ' HA ' ' HA ' ' C' ' 147' ' ' GLU . 4.4 mp0 -76.73 94.95 3.9 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 109.32 -0.622 . . . . 65.42 109.32 172.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.459 ' HB3' ' HA3' ' C' ' 146' ' ' GLY . 46.6 t-80 -71.09 80.05 0.68 Allowed 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.212 -1.033 . . . . 71.31 108.212 170.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -170.01 108.6 0.38 Allowed 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.126 -1.064 . . . . 64.11 108.126 -172.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.432 ' HB2' ' HA ' ' C' ' 139' ' ' ASN . 2.6 m-20 -118.83 101.78 8.32 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 108.98 -0.748 . . . . 64.23 108.98 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.879 0 C-N-CA 123.74 0.816 . . . . 75.33 109.066 -178.231 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 109.452 -0.573 . . . . 75.44 109.452 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 66.2 m -149.38 163.35 37.98 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.698 1.199 . . . . 70.23 109.96 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.05 137.21 53.38 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.141 0.976 . . . . 65.11 110.546 -172.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -75.9 -54.17 7.31 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.463 1.105 . . . . 71.45 112.652 -170.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -90.45 70.89 6.98 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.559 0.695 . . . . 72.03 110.592 -170.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -112.06 139.02 47.92 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.102 0.961 . . . . 73.12 109.791 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 12.7 m -68.18 -14.25 62.84 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.429 1.091 . . . . 64.12 111.72 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -57.1 -21.72 34.19 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.588 1.155 . . . . 64.41 112.089 171.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.582 ' HG3' HG23 ' B' ' 89' ' ' ILE . 1.2 tmt? 68.23 167.66 0.26 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.573 1.549 . . . . 72.42 111.804 176.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.484 ' N ' ' SD ' ' B' ' 9' ' ' MET . 9.5 t -159.89 133.59 7.16 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.844 0.857 . . . . 61.25 109.405 176.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -117.36 141.85 47.81 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 107.842 -1.17 . . . . 72.15 107.842 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -149.46 137.54 20.54 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 122.76 0.424 . . . . 74.41 110.701 176.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 44.6 mt -96.23 128.16 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.049 -1.093 . . . . 73.43 108.049 173.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -95.35 -42.03 8.72 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.524 0.515 . . . . 64.34 110.525 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.529 HH21 HG22 ' A' ' 122' ' ' THR . 22.8 ttt180 -172.93 138.69 0.8 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.737 -0.665 . . . . 70.45 109.303 -172.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.8 mt -123.31 139.88 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 106.661 -1.607 . . . . 52.33 106.661 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -164.01 145.21 8.7 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.22 0.822 . . . . 73.44 113.22 -174.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 64.0 m -76.28 120.43 21.54 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.737 -1.119 . . . . 61.12 109.094 172.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.637 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 37.0 mtpt -97.82 -22.82 16.17 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.049 0.94 . . . . 55.21 111.006 -178.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 17.8 t70 -158.53 143.25 16.07 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.185 0.594 . . . . 74.12 110.358 -175.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.464 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 38.9 mm -138.9 141.47 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.252 1.421 . . . . 63.13 107.849 174.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 67.8 m -145.83 138.45 25.69 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.529 0.732 . . . . 71.04 109.13 170.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.3 t80 -143.41 116.76 9.05 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.792 -1.929 . . . . 74.1 105.792 169.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -127.89 111.14 13.26 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.323 -0.992 . . . . 62.03 108.323 -176.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.607 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -110.2 87.91 6.6 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 108.211 -1.033 . . . . 73.32 108.211 175.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.07 -34.06 14.28 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.232 1.955 . . . . 74.25 111.547 -175.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -99.97 3.81 44.54 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.325 1.05 . . . . 72.35 110.902 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.607 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -24.89 -64.68 0.1 OUTLIER Pre-proline 0 N--CA 1.504 2.266 0 C-N-CA 126.606 1.962 . . . . 72.44 115.332 -172.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 7.9 Cg_exo -66.57 -42.34 9.66 Favored 'Trans proline' 0 C--N 1.388 2.63 0 C-N-CA 122.154 1.903 . . . . 70.52 112.386 -170.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -86.03 -28.19 24.31 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.651 0.78 . . . . 75.22 111.89 -171.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.523 HG22 HD12 ' B' ' 68' ' ' LEU . 4.8 p -77.59 -11.66 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 122.889 0.476 . . . . 53.41 110.696 -175.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -65.89 -20.52 66.25 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 113.101 0.778 . . . . 65.15 113.101 173.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -63.21 -25.16 68.21 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.313 0.578 . . . . 62.54 110.111 173.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -90.83 66.98 6.12 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.307 1.043 . . . . 72.54 109.713 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -80.6 82.08 6.7 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 122.291 1.043 . . . . 75.15 109.114 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -152.83 -173.3 4.52 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.102 -0.954 . . . . 75.32 109.122 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -72.51 110.35 7.97 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 123.992 0.917 . . . . 75.42 109.631 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.409 ' O ' HG23 ' B' ' 40' ' ' VAL . 49.2 Cg_endo -70.38 141.1 41.88 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 121.653 1.569 . . . . 71.01 109.747 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -68.12 99.97 0.95 Allowed 'General case' 0 C--O 1.242 0.687 0 N-CA-C 106.906 -1.516 . . . . 63.42 106.906 171.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.667 HG11 HD11 ' B' ' 126' ' ' LEU . 39.1 t -95.72 154.2 3.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 114.593 -1.185 . . . . 73.44 108.734 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -143.81 117.5 9.25 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.93 -0.766 . . . . 73.13 108.93 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.495 HD13 HD22 ' B' ' 128' ' ' LEU . 31.1 tp -93.27 137.31 32.71 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 108.832 -0.803 . . . . 65.01 108.832 172.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -159.55 128.22 5.11 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 107.702 -1.221 . . . . 73.05 107.702 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.651 ' HB2' HD23 ' F' ' 111' ' ' LEU . 4.0 mp -108.59 151.25 26.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.879 -0.785 . . . . 72.45 108.879 -174.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.55 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.4 t70 -127.54 144.14 51.1 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.027 0.931 . . . . 73.31 109.111 -177.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 26.1 p -113.07 106.51 14.76 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.534 0.734 . . . . 64.44 110.653 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.99 136.25 52.77 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.971 -1.122 . . . . 51.43 107.971 171.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.571 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 58.0 m -142.85 177.55 8.26 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.567 0.347 . . . . 62.14 110.774 -173.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 79.4 p -159.21 139.18 11.89 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.785 0.434 . . . . 61.41 111.136 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -90.24 125.16 35.39 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 108.696 -0.853 . . . . 52.53 108.696 169.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.6 pp -140.32 17.71 2.41 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.978 0.911 . . . . 74.22 109.845 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.77 152.65 17.93 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.454 1.102 . . . . 75.33 109.078 174.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -76.98 135.43 38.7 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.279 -1.008 . . . . 74.22 108.279 164.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 70.59 -4.25 1.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.139 0.976 . . . . 71.11 113.113 172.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 63.6 t -136.27 128.46 45.0 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 106.725 -1.583 . . . . 62.04 106.725 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.571 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 4.9 t80 -122.16 169.64 10.67 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.836 0.351 . . . . 64.3 110.564 -172.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -134.72 111.45 9.98 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 107.664 -1.235 . . . . 72.45 107.664 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 61.5 t -106.75 130.67 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.056 0.942 . . . . 75.52 109.198 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.2 t -111.28 113.31 43.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 N-CA-C 109.277 -0.638 . . . . 73.45 109.277 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' B' ' 103' ' ' PRO . 63.1 tp -93.79 110.77 22.4 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 109.076 -0.713 . . . . 62.23 109.076 171.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.55 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 14.0 ttm180 -84.66 132.89 34.43 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.855 -1.165 . . . . 74.51 107.855 169.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.461 HG22 HD23 ' B' ' 44' ' ' LEU . 43.8 t -123.49 104.15 13.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.571 -1.27 . . . . 71.43 107.571 174.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 15.2 m -100.63 131.71 46.4 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.068 0.461 . . . . 52.43 110.112 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.616 HG11 HD21 ' B' ' 126' ' ' LEU . 70.3 t -122.92 126.54 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.222 1.009 . . . . 63.14 108.5 175.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.8 m -111.3 138.9 47.18 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 107.54 -1.281 . . . . 71.22 107.54 168.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.12 137.09 28.88 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.034 -0.728 . . . . 74.53 109.034 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.569 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 25.1 p -147.05 128.28 14.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.085 0.469 . . . . 64.41 111.584 -172.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.523 HD12 HG22 ' B' ' 31' ' ' VAL . 56.4 mt -99.03 103.79 15.76 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 124.919 1.288 . . . . 72.24 108.507 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.3 -119.04 4.82 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 115.657 -0.701 . . . . 62.54 111.824 -174.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -112.22 3.93 17.47 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.94 0.896 . . . . 73.33 111.368 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -118.0 148.62 42.05 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.119 0.567 . . . . 75.11 109.672 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 99.2 m -72.63 125.66 28.02 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.8 -0.636 . . . . 62.45 111.232 -177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.569 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -71.66 -62.43 1.42 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.81 -1.181 . . . . 61.42 107.81 173.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -152.89 157.89 41.35 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.586 -1.188 . . . . 70.13 111.186 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 70.8 mt -126.08 108.5 11.42 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 106.255 -1.758 . . . . 72.25 106.255 172.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 39.3 t -119.17 113.76 21.4 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.507 -0.923 . . . . 74.12 108.507 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -128.57 124.62 36.38 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.973 -1.121 . . . . 75.33 107.973 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 67.3 t -123.63 155.84 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.855 0.862 . . . . 64.13 109.24 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.53 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.7 mt-30 -131.25 108.03 9.4 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.19 -0.67 . . . . 55.13 109.19 171.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 8.5 tp-100 -96.89 109.38 22.11 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.568 0.747 . . . . 61.53 109.518 173.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.637 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -99.64 170.61 23.25 Favored Glycine 0 N--CA 1.464 0.535 0 N-CA-C 112.021 -0.432 . . . . 73.42 112.021 174.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.97 138.78 5.12 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 112.573 -0.211 . . . . 51.42 112.573 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 49.5 mt -92.17 122.08 43.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.267 1.027 . . . . 71.25 108.764 174.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -127.45 135.21 50.1 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.002 0.921 . . . . 70.1 109.727 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 24.1 m -106.32 128.65 54.15 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.691 0.796 . . . . 73.11 109.5 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.626 ' HB ' HD11 ' B' ' 89' ' ' ILE . 1.9 pp -139.77 147.06 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.374 0.669 . . . . 72.52 111.089 -177.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.648 ' HA ' ' HB ' ' F' ' 97' ' ' ILE . . . -154.68 165.92 35.03 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.4 0.68 . . . . 62.04 111.104 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 90.8 -45.83 2.91 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 116.087 -0.506 . . . . 31.2 112.741 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.626 HD11 ' HB ' ' B' ' 86' ' ' ILE . 4.0 pt -56.38 152.33 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.559 1.143 . . . . 72.34 111.426 169.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -157.94 164.09 37.2 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.536 0.734 . . . . 74.22 109.536 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.36 -111.07 3.49 Favored Glycine 0 C--N 1.355 1.631 0 O-C-N 123.197 0.31 . . . . 53.34 112.699 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 25.0 m -84.34 -43.22 14.97 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 123.695 0.798 . . . . 73.43 109.696 175.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -62.53 -24.66 67.62 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 113.758 -1.565 . . . . 75.43 111.694 -168.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.766 ' HB2' HD11 ' F' ' 97' ' ' ILE . 23.9 ptm -66.1 -65.67 0.65 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.084 0.772 . . . . 75.54 113.084 -177.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.44 ' HB1' HD13 ' F' ' 102' ' ' LEU . . . -80.19 -14.4 58.48 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.21 0.448 . . . . 61.1 112.21 -175.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -61.33 -37.03 81.82 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.365 0.666 . . . . 74.15 110.554 171.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' CYS . . . . . 0.456 ' SG ' HG21 ' B' ' 86' ' ' ILE . 43.8 t -60.13 -24.56 64.78 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.114 0.966 . . . . 52.24 112.024 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.501 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 26.7 mt -97.76 -39.13 9.19 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.124 0.969 . . . . 72.42 111.497 -177.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.26 -19.27 69.69 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 116.43 -0.35 . . . . 73.52 113.572 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.87 -48.48 1.89 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.003 0.521 . . . . 73.24 111.767 -172.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -83.05 -41.96 18.03 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 111.877 0.325 . . . . 72.43 111.877 -171.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.501 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 94.8 m -63.05 -43.23 81.15 Favored Pre-proline 0 CA--C 1.57 1.733 0 N-CA-C 113.569 0.952 . . . . 45.23 113.569 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.424 ' HB3' HD13 ' B' ' 60' ' ' LEU . 51.5 Cg_exo -58.27 -27.62 81.52 Favored 'Trans proline' 0 C--N 1.399 3.196 0 C-N-CA 122.239 1.96 . . . . 73.24 113.674 173.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -65.01 -33.55 76.31 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.663 0.785 . . . . 72.23 110.591 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 57.4 mt -73.89 -41.7 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.883 0.873 . . . . 75.01 110.088 176.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 92.5 mt -75.94 -30.01 58.53 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.23 -0.896 . . . . 60.12 112.424 -172.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -56.98 -49.7 92.44 Favored Pre-proline 0 N--CA 1.484 1.239 0 CA-C-O 117.342 -1.313 . . . . 64.13 113.477 -172.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -50.31 -39.64 53.01 Favored 'Trans proline' 0 C--N 1.391 2.788 0 C-N-CA 122.512 2.141 . . . . 74.11 114.161 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -70.15 -47.15 62.89 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.334 0.654 . . . . 72.23 110.509 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -62.35 -35.53 79.41 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.37 -0.832 . . . . 65.44 111.337 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.533 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 50.2 ttt-85 -67.53 -49.73 61.97 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.134 1.374 . . . . 72.41 110.349 -177.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.6 -32.34 73.61 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.021 0.826 . . . . 60.33 109.687 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.51 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.3 t -69.56 -42.84 74.02 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.257 0.623 . . . . 65.24 110.829 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.424 HD13 HG23 ' B' ' 64' ' ' VAL . 74.9 mt -60.23 -54.52 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.392 0.677 . . . . 72.25 110.603 172.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 25.5 m -58.9 -28.69 66.43 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.503 0.721 . . . . 70.44 111.276 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 22.9 t -67.69 -53.2 29.58 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 123.203 0.601 . . . . 71.43 109.59 173.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.51 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.2 mmt -64.52 -31.89 73.3 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 122.758 0.423 . . . . 75.15 111.774 -175.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.8 t -69.7 -42.1 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.268 1.027 . . . . 73.04 110.562 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 81.5 p -72.43 -28.89 63.24 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.001 0.429 . . . . 52.42 111.087 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' B' ' 116' ' ' SER . 88.5 mtt-85 -67.93 -40.72 83.31 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.12 -0.945 . . . . 71.54 109.505 175.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.45 -6.18 61.43 Favored Glycine 0 C--N 1.352 1.467 0 O-C-N 123.764 0.665 . . . . 64.13 113.071 173.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 9.7 m 64.98 31.45 11.25 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.282 1.433 . . . . 73.12 110.298 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -89.53 164.03 31.08 Favored Pre-proline 0 CA--C 1.556 1.193 0 CA-C-N 114.22 -1.354 . . . . 63.11 111.129 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.532 ' HG3' ' HB2' ' F' ' 130' ' ' ALA . 31.1 Cg_exo -39.74 146.55 0.22 Allowed 'Trans proline' 0 C--N 1.393 2.885 0 C-N-CA 124.647 3.565 . . . . 50.32 115.86 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -61.05 112.84 2.25 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.301 0.641 . . . . 74.41 109.768 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.667 HD11 HG11 ' B' ' 40' ' ' VAL . 43.4 tp -109.93 110.72 21.76 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.424 0.69 . . . . 70.34 109.463 -174.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -107.29 117.53 34.32 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.201 -1.037 . . . . 73.02 108.201 175.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.533 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 51.4 mt -78.56 147.46 33.74 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 120.535 0.207 . . . . 54.52 110.53 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.441 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -73.13 142.11 81.97 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 123.641 0.776 . . . . 71.54 112.375 -170.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' B' ' 129' ' ' ALA . 11.2 Cg_endo -85.04 104.04 0.86 Allowed 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.312 2.675 . . . . 41.11 111.192 176.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.95 134.93 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 122.83 0.452 . . . . 74.51 110.327 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -80.21 114.36 19.06 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.259 0.624 . . . . 73.4 109.432 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -54.22 -42.77 70.18 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.187 1.395 . . . . 63.52 111.453 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -52.96 -41.4 64.5 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.045 -1.434 . . . . 72.42 112.379 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.12 -32.61 73.21 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.703 0.627 . . . . 44.33 112.414 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.701 HD22 HD11 ' F' ' 111' ' ' LEU . 6.8 mp -74.16 -35.08 64.01 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.365 0.666 . . . . 73.42 110.929 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -87.4 -15.93 36.39 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.249 0.62 . . . . 74.24 111.581 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 48.1 ttm -68.11 -38.84 82.72 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.498 0.719 . . . . 74.41 110.906 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.499 ' HA ' ' HG3' ' B' ' 143' ' ' GLN . 9.8 p30 -82.71 -33.6 27.54 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.34 -0.846 . . . . 64.31 110.583 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -67.91 -31.24 70.89 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.31 0.644 . . . . 74.32 110.31 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 25.4 tp -97.74 14.61 26.3 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.82 0.848 . . . . 43.0 110.365 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 72.63 123.31 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.443 1.497 . . . . 74.2 111.915 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 143' ' ' GLN . . . . . 0.499 ' HG3' ' HA ' ' B' ' 139' ' ' ASN . 25.2 mt-30 -78.71 121.85 25.24 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.562 0.745 . . . . 74.04 109.717 175.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -90.86 88.04 6.89 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.102 0.561 . . . . 64.31 109.852 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . 59.25 -81.12 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.623 1.569 . . . . 73.45 113.342 171.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.99 -30.36 0.44 Allowed Glycine 0 C--N 1.342 0.864 0 N-CA-C 110.584 -1.006 . . . . 63.52 110.584 -173.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 71.93 -67.93 0.24 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.087 1.755 . . . . 74.54 111.633 175.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -129.99 147.44 18.07 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 110.949 -0.86 . . . . 54.43 110.949 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 10.8 t -157.86 22.69 0.27 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.744 0.818 . . . . 71.22 109.749 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 69.12 107.77 0.05 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.475 1.51 . . . . 61.21 109.502 -165.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -92.81 14.09 18.38 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.948 0.899 . . . . 71.54 110.01 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -148.13 130.87 16.0 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.052 0.941 . . . . 73.34 109.586 -169.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 153' ' ' GLN . . . . . 0.543 ' HG3' ' HG3' ' D' ' 90' ' ' GLU . 58.8 tt0 -93.9 99.61 11.93 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.802 -0.444 . . . . 71.31 109.802 178.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 154' ' ' ASP . . . . . 0.604 ' HB2' ' HA2' ' D' ' 91' ' ' GLY . 4.6 m-20 -116.11 158.51 23.1 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.771 0.828 . . . . 65.04 110.533 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.977 0 C-N-CA 124.489 1.116 . . . . 64.13 108.315 -179.53 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ttt . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.447 0.165 . . . . 73.34 110.799 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 43.2 m -149.54 126.35 11.12 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.613 0.765 . . . . 45.32 109.219 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 3' ' ' GLU . . . . . 0.505 ' HB2' ' NE2' ' A' ' 143' ' ' GLN . 14.7 mp0 -67.84 97.73 0.67 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 108.792 -0.818 . . . . 52.05 108.792 176.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 4' ' ' GLN . . . . . 0.429 HE21 ' HG3' ' C' ' 8' ' ' GLU . 50.5 mt-30 -71.67 116.16 11.71 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.765 0.826 . . . . 73.35 109.587 178.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -75.44 79.28 2.49 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 107.786 -1.19 . . . . 55.14 107.786 171.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 171.05 177.14 0.06 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.109 1.764 . . . . 75.21 106.758 -171.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 44.4 m -65.76 119.99 12.2 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 108.466 -0.939 . . . . 73.55 108.466 162.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.429 ' HG3' HE21 ' C' ' 4' ' ' GLN . 34.9 tt0 -59.58 -49.17 78.82 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 124.072 0.858 . . . . 62.12 111.855 -174.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.583 ' HE2' HG21 ' C' ' 89' ' ' ILE . 50.1 ttm 64.24 116.33 0.02 OUTLIER 'General case' 0 C--N 1.357 0.907 0 O-C-N 125.119 1.512 . . . . 64.43 111.324 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 96.7 m -84.46 97.02 9.29 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.047 -1.094 . . . . 74.35 108.047 173.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.537 ' HD2' ' HG2' ' A' ' 130' ' ' PRO . 35.0 t80 -115.5 127.38 55.26 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.0 -1.111 . . . . 75.21 108.0 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 12' ' ' GLN . . . . . 0.418 HE22 ' HE3' ' E' ' 136' ' ' LYS . 29.1 tt0 -142.03 131.25 23.44 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.711 -0.848 . . . . 71.4 108.711 177.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 19.9 mt -84.22 134.77 26.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.723 -0.843 . . . . 73.14 108.723 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.499 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 11.1 mm100 -91.35 -45.67 8.45 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.592 -0.892 . . . . 74.22 108.592 175.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -177.58 153.35 0.88 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.048 1.339 . . . . 73.24 109.455 175.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.491 HG23 HD23 ' C' ' 106' ' ' LEU . 75.0 mt -128.75 118.55 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.731 1.212 . . . . 62.34 108.379 177.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.511 ' HB3' HG23 ' D' ' 122' ' ' THR . 6.1 p90 -151.37 154.45 36.7 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.008 0.908 . . . . 72.45 112.249 -164.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.2 p -79.22 108.85 13.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.562 -1.199 . . . . 71.15 109.406 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -72.83 -45.01 60.69 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 107.557 -1.275 . . . . 53.41 107.557 172.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.71 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 10.4 t70 -134.52 137.54 43.94 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 113.186 -1.825 . . . . 64.11 109.19 -174.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.4 mt -134.78 143.44 37.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 125.455 1.502 . . . . 70.22 106.969 172.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.7 t -150.01 138.0 20.24 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 109.154 -0.684 . . . . 75.31 109.154 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -139.01 128.61 24.57 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.48 -1.304 . . . . 71.33 107.48 171.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -130.18 120.19 24.14 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.534 1.134 . . . . 70.53 108.784 -174.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.14 84.0 58.66 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 106.969 -1.493 . . . . 74.5 106.969 169.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.5 -26.9 28.36 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 122.397 2.064 . . . . 64.13 111.227 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -107.39 21.83 16.89 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.486 1.114 . . . . 65.44 109.836 -176.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.82 -64.94 0.71 Allowed Pre-proline 0 CA--C 1.571 1.777 0 N-CA-C 114.466 1.284 . . . . 32.11 114.466 -165.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -67.54 -27.87 38.83 Favored 'Trans proline' 0 C--N 1.385 2.453 0 CA-C-N 122.326 1.867 . . . . 74.34 112.615 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -68.13 -37.86 81.57 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.893 0.877 . . . . 73.13 111.366 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.632 HG21 ' HA ' ' C' ' 73' ' ' ALA . 14.8 p -82.01 -24.87 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 116.184 -0.462 . . . . 71.15 111.941 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -65.72 -30.66 71.36 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 121.787 -0.57 . . . . 71.35 111.015 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -90.82 29.93 1.27 Allowed 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.109 0.964 . . . . 64.0 111.228 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -124.74 153.38 42.49 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.457 1.103 . . . . 71.3 109.711 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -67.76 129.76 40.9 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 122.994 0.518 . . . . 75.34 109.89 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 66.5 t-105 -85.0 83.44 8.06 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.8 0.84 . . . . 74.13 111.346 -173.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -131.21 78.87 71.74 Favored Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 123.739 0.816 . . . . 71.41 109.071 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -83.23 155.61 14.6 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.553 2.169 . . . . 71.11 112.428 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -88.52 100.48 13.11 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 106.749 -1.574 . . . . 72.51 106.749 168.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 57.4 t -74.64 99.42 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 109.024 -0.732 . . . . 53.51 109.024 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 32.5 mmtm -131.65 106.79 8.39 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.086 0.954 . . . . 61.02 109.472 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 pp -95.74 165.35 12.35 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.69 0.796 . . . . 72.11 109.933 175.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 19.9 t70 -139.86 143.98 37.01 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.414 1.086 . . . . 73.21 108.235 175.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 97.4 mt -128.58 112.57 14.43 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.382 0.611 . . . . 61.2 109.613 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -112.87 121.18 43.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.635 -1.617 . . . . 64.4 106.635 172.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.2 t -118.68 142.92 47.2 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.36 0.6 . . . . 75.12 109.382 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.45 151.86 49.62 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.561 1.144 . . . . 70.41 108.274 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 53.1 p -147.32 142.21 26.89 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 109.348 -0.612 . . . . 64.42 109.348 174.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 72.6 p -150.35 151.85 33.5 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.291 1.036 . . . . 64.14 108.585 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -98.87 117.22 32.87 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.925 -0.769 . . . . 71.04 108.925 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.654 HD11 ' HB2' ' C' ' 57' ' ' GLU . 61.4 mt -84.42 -37.01 21.98 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.497 0.719 . . . . 75.43 110.233 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.38 -175.76 5.6 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.169 0.988 . . . . 63.31 109.759 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -59.16 110.23 1.02 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 123.641 0.588 . . . . 72.52 110.363 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 62.85 22.72 13.58 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.287 1.035 . . . . 71.22 112.066 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 95.6 t -117.63 117.49 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.874 1.27 . . . . 51.04 107.58 173.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -127.28 125.36 40.74 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.068 0.947 . . . . 72.14 109.554 -174.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.654 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.0 tt0 -88.33 122.12 31.48 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.832 -0.803 . . . . 61.04 108.832 169.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 65.8 t -112.49 124.13 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 108.713 -0.847 . . . . 75.44 108.713 172.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.538 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 61.6 t -109.75 134.75 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.019 0.528 . . . . 53.13 109.938 176.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.47 99.56 8.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.848 -1.168 . . . . 75.4 107.848 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -80.31 106.8 12.6 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.121 -1.066 . . . . 75.14 108.121 170.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.15 122.5 58.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 107.866 -1.161 . . . . 74.42 107.866 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 25.1 m -113.3 138.61 49.77 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 107.415 -1.328 . . . . 61.33 107.415 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.426 HG21 HG21 ' C' ' 114' ' ' ILE . 69.1 t -134.34 111.64 14.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 108.021 -1.103 . . . . 62.51 108.021 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.457 HG23 HD23 ' C' ' 75' ' ' LEU . 4.3 m -108.22 117.4 34.05 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.707 -0.679 . . . . 73.41 109.17 -177.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.42 104.04 10.71 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.565 -0.902 . . . . 62.42 108.565 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 63.4 m -128.77 132.91 47.94 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.186 -0.672 . . . . 65.44 109.186 176.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 9.6 mt -84.68 42.32 0.9 Allowed 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 125.428 1.491 . . . . 70.22 109.889 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.22 -104.61 2.46 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 110.97 -0.852 . . . . 53.12 110.97 -172.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -89.7 -32.19 17.13 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.514 0.726 . . . . 75.3 109.945 174.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -75.95 105.84 7.21 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 114.877 -1.056 . . . . 71.54 109.808 -178.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 61.4 m -74.21 124.52 26.55 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 118.479 0.582 . . . . 53.42 109.597 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.632 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -77.79 -53.89 6.98 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.582 -0.736 . . . . 53.54 109.111 176.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -162.03 164.13 28.42 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.827 -1.079 . . . . 75.55 110.729 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.457 HD23 HG23 ' C' ' 65' ' ' THR . 2.7 tm? -128.41 142.17 51.19 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.211 -1.774 . . . . 61.12 106.211 167.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 42.5 t -149.44 129.8 13.8 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.94 -0.763 . . . . 72.15 108.94 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -140.66 128.62 21.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.714 0.406 . . . . 72.31 110.027 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 37.3 t -125.24 115.69 44.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 124.468 1.107 . . . . 73.04 108.891 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.71 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.5 mt-30 -90.41 91.09 8.32 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.57 -0.9 . . . . 72.44 108.57 172.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -83.78 96.07 8.63 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.342 -1.299 . . . . 75.21 109.183 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -93.2 145.73 17.75 Favored Glycine 0 C--O 1.222 -0.638 0 N-CA-C 111.616 -0.594 . . . . 70.02 111.616 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.94 132.13 4.91 Favored Glycine 0 CA--C 1.503 -0.703 0 N-CA-C 110.991 -0.844 . . . . 74.43 110.991 -176.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.499 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 22.8 mm -85.66 124.46 40.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 107.467 -1.308 . . . . 74.02 107.467 174.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -129.94 118.2 21.29 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.638 0.775 . . . . 73.01 109.703 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.6 p -86.92 104.62 16.43 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.035 -0.728 . . . . 64.22 109.035 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.53 HD13 ' SG ' ' C' ' 97' ' ' CYS . 19.5 mt -116.73 126.98 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.532 0.733 . . . . 63.34 110.314 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.25 169.01 18.54 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.125 0.97 . . . . 63.23 109.887 177.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.66 -17.65 57.2 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 119.365 -0.686 . . . . 53.11 114.47 174.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.583 HG21 ' HE2' ' C' ' 9' ' ' MET . 38.0 pt -119.01 166.76 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 CA-C-N 118.079 0.94 . . . . 74.12 112.493 -175.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -159.39 156.44 28.47 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.685 1.194 . . . . 72.12 109.078 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.08 -138.14 14.88 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-O 120.073 -0.293 . . . . 74.41 112.926 171.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 47.1 p -65.08 -25.18 67.68 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.796 0.838 . . . . 63.25 111.457 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -61.15 -54.24 46.87 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.166 0.986 . . . . 74.43 110.635 171.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.587 ' HE3' ' HA ' ' C' ' 94' ' ' MET . 4.5 tpt -56.67 -48.61 77.23 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 124.058 0.849 . . . . 62.44 111.803 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.17 -40.96 91.76 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 123.59 0.556 . . . . 43.12 111.514 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -69.56 -30.95 68.86 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.055 0.942 . . . . 75.14 111.239 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.53 ' SG ' HD13 ' C' ' 86' ' ' ILE . 12.2 t -75.41 -35.39 61.02 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.652 -0.499 . . . . 70.11 109.652 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 96.2 mt -84.14 -32.82 24.46 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.002 0.921 . . . . 71.33 112.521 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.88 8.77 27.6 Favored Glycine 0 N--CA 1.473 1.166 0 CA-C-O 119.656 -0.525 . . . . 71.43 114.135 -170.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.75 -55.32 0.22 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 117.411 0.606 . . . . 53.25 111.644 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -71.36 -54.34 11.08 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 117.566 0.166 . . . . 74.13 111.264 -174.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.45 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 84.8 m -57.58 -50.48 87.92 Favored Pre-proline 0 CA--C 1.565 1.524 0 CA-C-O 118.182 -0.913 . . . . 55.4 111.974 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.464 ' HA ' HD12 ' C' ' 106' ' ' LEU . 38.9 Cg_exo -60.11 -28.21 86.5 Favored 'Trans proline' 0 C--N 1.4 3.256 0 C-N-CA 122.601 2.201 . . . . 75.11 113.567 174.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -68.09 -35.61 78.45 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.201 0.6 . . . . 55.21 110.778 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.453 HD12 ' NH1' ' A' ' 111' ' ' ARG . 19.9 mm -79.86 -29.62 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 109.972 -0.381 . . . . 70.35 109.972 177.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.491 HD23 HG23 ' C' ' 16' ' ' ILE . 73.9 mt -70.09 -32.08 69.96 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.406 0.683 . . . . 73.21 111.254 176.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -53.29 -53.26 58.08 Favored Pre-proline 0 N--CA 1.485 1.322 0 CA-C-O 117.228 -1.368 . . . . 71.41 114.459 -173.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.82 -36.46 96.98 Favored 'Trans proline' 0 C--N 1.391 2.783 0 C-N-CA 122.074 1.849 . . . . 54.44 113.219 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -70.17 -46.55 64.42 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.706 0.802 . . . . 71.33 110.307 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.94 81.86 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 115.027 -0.988 . . . . 60.25 110.369 175.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.9 ttt-85 -65.74 -47.16 76.2 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.199 1.399 . . . . 64.32 110.757 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -69.63 -33.78 73.13 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.362 0.665 . . . . 74.34 110.055 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 40.2 t -68.68 -39.53 80.53 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.336 0.655 . . . . 61.44 111.258 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.441 ' O ' HG23 ' C' ' 118' ' ' VAL . 96.7 mt -69.35 -48.19 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.572 0.749 . . . . 73.15 110.406 174.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 28.5 m -54.52 -40.16 68.35 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.561 1.144 . . . . 62.42 110.876 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.4 t -64.55 -48.05 76.48 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.002 -0.999 . . . . 52.13 109.0 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.52 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.8 -40.24 79.44 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.839 1.256 . . . . 74.24 112.672 178.433 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.441 HG23 ' O ' ' C' ' 114' ' ' ILE . 86.8 t -66.72 -41.0 87.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.531 0.732 . . . . 54.31 110.287 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 46.7 t -71.94 -27.82 63.05 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.782 0.833 . . . . 62.4 111.501 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 82.5 mtt-85 -72.52 -34.17 67.42 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.494 0.718 . . . . 74.55 109.495 175.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.24 10.39 63.81 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.388 -0.823 . . . . 74.42 112.636 173.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 72.5 p 58.7 22.9 10.47 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 126.153 1.781 . . . . 62.1 114.286 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -83.66 149.16 56.59 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 108.689 -0.856 . . . . 72.21 108.689 171.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -55.53 157.67 14.66 Favored 'Trans proline' 0 C--N 1.382 2.322 0 C-N-CA 123.073 2.516 . . . . 61.32 113.702 176.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -58.49 114.16 2.33 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.882 0.873 . . . . 72.14 112.223 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.9 tt -110.56 86.04 2.23 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 106.601 -1.629 . . . . 62.33 106.601 172.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -91.19 105.02 17.5 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.046 -0.724 . . . . 74.24 109.046 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.5 145.59 55.88 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.484 0.714 . . . . 72.51 111.983 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.22 153.15 84.24 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.575 0.75 . . . . 62.31 110.347 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.471 ' HG2' HG21 ' A' ' 13' ' ' ILE . 51.9 Cg_exo -54.71 115.68 2.58 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.892 2.395 . . . . 74.13 112.548 173.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.3 t -98.05 116.91 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.656 -0.868 . . . . 70.51 108.656 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -76.02 103.25 5.98 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.368 0.667 . . . . 75.01 110.531 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -67.18 -22.41 65.74 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.489 0.716 . . . . 74.24 112.065 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -65.46 -42.91 91.81 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.498 0.719 . . . . 72.12 110.476 175.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.08 -46.74 87.78 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 123.675 0.61 . . . . 64.03 110.354 176.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.03 -27.75 67.67 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.267 -0.878 . . . . 74.44 111.435 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -73.21 -47.94 39.26 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.262 0.625 . . . . 53.11 110.494 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 72.6 mtm -70.02 -29.36 66.39 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.267 0.556 . . . . 74.34 110.31 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 139' ' ' ASN . . . . . 0.432 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 6.3 t30 -57.92 -33.79 69.15 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.336 1.455 . . . . 72.42 113.718 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -159.98 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 113.283 0.846 . . . . 61.42 113.283 -168.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.435 ' HG ' ' HG2' ' C' ' 142' ' ' GLN . 40.0 tp 40.38 -85.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 125.831 1.652 . . . . 73.03 113.575 170.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.435 ' HG2' ' HG ' ' C' ' 141' ' ' LEU . 9.9 pt20 -162.43 161.15 27.08 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 125.682 1.593 . . . . 75.21 107.638 176.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -78.92 81.56 5.19 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.493 0.663 . . . . 62.22 109.234 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -76.55 144.65 39.55 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.645 -1.162 . . . . 63.31 110.01 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -52.65 123.21 10.62 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.795 1.238 . . . . 72.3 112.858 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 146' ' ' GLY . . . . . 0.459 ' HA3' ' HB3' ' A' ' 152' ' ' HIS . . . -176.11 122.3 0.85 Allowed Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.104 -1.198 . . . . 51.33 110.104 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 147' ' ' GLU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 151' ' ' GLU . 14.5 pt-20 -161.13 -174.92 4.59 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.214 0.606 . . . . 65.55 110.743 -172.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 89.59 71.51 1.25 Allowed Glycine 0 C--N 1.345 1.054 0 CA-C-N 115.467 -0.788 . . . . 71.02 111.68 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.25 125.17 19.56 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.057 0.543 . . . . 73.52 110.671 173.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -70.35 86.99 0.61 Allowed 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.836 -0.801 . . . . 72.11 108.836 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -84.92 78.57 9.87 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.455 -1.248 . . . . 61.24 111.018 -172.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -96.4 102.24 14.0 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.327 -0.851 . . . . 75.13 109.136 176.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 153' ' ' GLN . . . . . 0.4 ' HA ' ' NE2' ' A' ' 93' ' ' GLN . 24.7 tt0 -95.41 76.64 3.37 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.71 0.767 . . . . 63.41 109.31 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 154' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 93' ' ' GLN . 4.5 p-10 -83.45 110.19 17.97 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.857 -1.065 . . . . 74.02 110.194 -178.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.97 0 CA-C-N 115.233 -0.894 . . . . 75.43 110.662 -177.376 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 N-CA-C 109.928 -0.397 . . . . 71.24 109.928 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 58.7 p -67.19 134.69 52.19 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.114 0.565 . . . . 53.13 110.579 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -74.7 100.07 3.87 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.605 -0.887 . . . . 62.31 108.605 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -68.36 83.48 0.25 Allowed 'General case' 0 CA--C 1.558 1.257 0 CA-C-O 122.741 1.258 . . . . 71.23 107.798 168.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -96.13 144.84 26.01 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.269 -1.332 . . . . 45.42 110.366 -168.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -78.51 81.91 4.81 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 123.632 0.583 . . . . 62.22 110.084 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 75.3 p -85.65 -168.33 2.18 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.178 -1.045 . . . . 41.42 108.178 169.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -60.79 88.28 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 122.892 0.477 . . . . 73.02 109.808 168.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.48 ' HG2' HG13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -34.62 122.99 0.53 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.341 1.456 . . . . 74.21 112.337 176.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 8.2 t -111.25 133.34 53.66 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 109.149 -0.685 . . . . 54.01 109.149 176.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.465 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 54.9 t80 -143.41 89.76 2.11 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.183 -1.414 . . . . 71.34 107.183 174.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -116.85 119.85 36.67 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.24 -1.022 . . . . 64.32 108.24 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 5.5 mt -75.79 121.17 27.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.061 -1.088 . . . . 75.11 108.061 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 14' ' ' GLN . . . . . 0.684 ' HB2' HG23 ' D' ' 83' ' ' ILE . 10.8 mm-40 -84.9 -30.04 24.7 Favored 'General case' 0 C--O 1.242 0.674 0 O-C-N 123.802 0.688 . . . . 71.3 110.462 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -174.63 131.42 0.35 Allowed 'General case' 0 C--N 1.364 1.222 0 O-C-N 123.415 0.447 . . . . 72.2 111.149 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.412 ' N ' HD12 ' D' ' 16' ' ' ILE . 3.5 mp -108.18 135.24 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.423 -1.325 . . . . 73.04 107.423 172.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -165.84 170.57 13.71 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.744 0.783 . . . . 71.04 111.89 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -101.46 124.31 46.93 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.406 -1.27 . . . . 63.43 109.357 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.461 ' HD2' ' HA3' ' D' ' 81' ' ' GLY . 28.3 mtpt -95.28 -28.92 14.76 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.735 -0.839 . . . . 71.33 108.735 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.607 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 7.9 t70 -146.1 135.09 22.59 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 113.997 -1.456 . . . . 63.13 108.915 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.52 HG21 ' HE2' ' C' ' 117' ' ' MET . 61.9 mt -136.5 138.99 45.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.937 -1.134 . . . . 72.43 107.937 170.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.9 t -141.44 140.81 33.68 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.233 1.013 . . . . 73.34 108.52 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.49 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.2 t80 -144.71 130.44 19.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 106.059 -1.83 . . . . 73.31 106.059 168.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -134.28 138.03 44.71 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.51 -0.922 . . . . 63.24 108.51 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.421 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -144.14 78.12 13.94 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 107.718 -1.216 . . . . 74.24 107.718 174.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.37 -28.98 9.88 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.803 2.335 . . . . 72.42 112.688 -173.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -101.18 3.64 41.25 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.857 0.863 . . . . 74.51 110.692 -176.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.481 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -33.06 -64.07 0.26 Allowed Pre-proline 0 CA--C 1.566 1.56 0 N-CA-C 116.46 2.022 . . . . 74.32 116.46 -164.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.451 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 73.3 Cg_endo -74.39 -29.12 9.69 Favored 'Trans proline' 0 C--N 1.389 2.68 0 CA-C-N 123.503 2.287 . . . . 71.51 113.311 -178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -65.53 -39.73 92.1 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.649 1.18 . . . . 74.35 109.68 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.519 HG22 HD12 ' D' ' 68' ' ' LEU . 9.8 p -85.53 -16.39 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 CA-C-N 115.423 -0.808 . . . . 70.04 111.532 -176.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.451 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 17.7 m-85 -65.66 -20.92 66.48 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 118.05 0.386 . . . . 73.34 111.585 176.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -61.86 -23.22 66.14 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.7 0.8 . . . . 74.24 110.865 174.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -92.77 95.57 9.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.723 1.209 . . . . 62.44 110.219 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -94.3 94.86 8.54 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.551 0.74 . . . . 74.34 110.153 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -161.84 179.32 8.16 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.686 0.794 . . . . 72.34 110.164 166.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -58.07 111.48 3.59 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.563 1.145 . . . . 72.4 110.031 173.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.419 ' O ' HG23 ' D' ' 40' ' ' VAL . 51.3 Cg_exo -55.6 125.4 18.99 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.205 1.936 . . . . 72.55 110.288 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -72.29 107.33 4.84 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.32 -1.363 . . . . 74.3 107.32 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.879 HG13 HG13 ' D' ' 64' ' ' VAL . 87.5 t -113.1 103.14 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 123.308 0.38 . . . . 73.14 110.08 -168.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -87.16 119.25 27.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.796 -1.187 . . . . 71.23 107.796 172.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.794 HD22 HD11 ' D' ' 128' ' ' LEU . 57.0 tp -92.82 148.01 22.38 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.333 -0.988 . . . . 75.23 108.333 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.5 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 27.6 t70 -144.76 111.96 6.0 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.388 -1.338 . . . . 70.44 107.388 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' D' ' 62' ' ' VAL . 85.2 mt -108.11 131.83 54.21 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.062 0.545 . . . . 74.31 110.073 -173.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -132.15 133.92 44.82 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.89 -1.522 . . . . 75.02 106.89 173.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.8 t -139.24 141.79 37.85 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.833 0.825 . . . . 72.31 110.009 176.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.8 161.82 41.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.391 -1.277 . . . . 64.54 107.738 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 34.0 p -133.76 158.93 42.08 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.287 -0.634 . . . . 73.04 109.287 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 78.1 p -148.72 120.21 7.95 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 109.452 -0.573 . . . . 72.3 109.452 -175.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 15.0 tm0? -176.73 159.34 1.8 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.83 1.252 . . . . 74.4 108.452 172.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -55.32 -15.33 2.41 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 126.255 1.822 . . . . 71.12 113.729 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.562 ' HA ' ' CE2' ' D' ' 56' ' ' TYR . . . 78.63 89.29 0.06 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.886 1.674 . . . . 75.41 109.042 -172.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -161.66 40.39 0.14 Allowed 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.749 -1.114 . . . . 64.24 108.649 -167.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 68.8 -1.63 1.96 Allowed 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 114.232 1.197 . . . . 42.04 114.232 172.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.539 ' HB ' HD11 ' D' ' 83' ' ' ILE . 23.3 m -130.97 129.09 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 107.262 -1.384 . . . . 61.32 107.262 173.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.562 ' CE2' ' HA ' ' D' ' 52' ' ' ALA . 70.3 m-85 -141.81 130.09 22.29 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.822 -0.807 . . . . 72.33 108.822 -171.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -87.77 109.98 20.13 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.409 -0.96 . . . . 75.33 108.409 173.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.507 HG11 ' HD3' ' D' ' 103' ' ' PRO . 67.3 t -99.08 120.16 48.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 107.443 -1.317 . . . . 73.15 107.443 175.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.457 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.5 t -107.41 134.76 48.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.606 -0.887 . . . . 75.15 108.606 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.54 116.09 26.98 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.997 -0.742 . . . . 72.14 108.997 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -97.76 96.97 8.6 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.252 1.021 . . . . 70.23 109.051 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.603 HG13 HD11 ' D' ' 42' ' ' LEU . 57.7 t -94.73 109.14 21.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 108.523 -0.918 . . . . 60.01 108.523 175.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 40.6 m -106.11 132.18 52.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.957 -1.019 . . . . 63.52 109.065 -176.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.879 HG13 HG13 ' D' ' 40' ' ' VAL . 86.6 t -120.39 127.61 75.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.032 -0.729 . . . . 45.54 109.032 177.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 14.7 m -117.61 93.37 4.13 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.306 -1.368 . . . . 73.13 107.306 169.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.566 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -102.06 134.94 44.48 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.438 -0.579 . . . . 72.2 109.438 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.534 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 50.2 m -144.5 139.28 28.15 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 115.749 -0.66 . . . . 71.22 110.532 -171.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.519 HD12 HG22 ' D' ' 31' ' ' VAL . 21.1 mt -109.88 110.51 21.49 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.081 -1.451 . . . . 71.22 107.081 172.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.88 -147.34 38.08 Favored Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.956 -0.458 . . . . 73.34 111.956 -175.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.75 4.22 22.79 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.088 0.555 . . . . 42.41 112.357 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -119.63 161.95 19.79 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.399 0.68 . . . . 72.4 109.995 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.8 m -71.97 137.8 47.57 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.245 -0.889 . . . . 72.21 111.106 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.534 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -89.14 -65.8 0.98 Allowed 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.114 -1.439 . . . . 73.22 107.114 170.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -153.8 143.37 21.68 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.646 -1.161 . . . . 71.42 109.967 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 63.2 mt -101.53 149.24 24.3 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.047 -1.094 . . . . 75.43 108.047 167.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.574 ' SG ' HG23 ' D' ' 114' ' ' ILE . 35.3 t -158.92 118.91 3.14 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 117.724 0.238 . . . . 74.3 110.373 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -140.77 122.03 14.85 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.776 0.43 . . . . 63.14 110.035 -174.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 92.7 t -127.71 117.17 45.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 123.951 0.9 . . . . 74.12 109.488 -175.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.607 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.8 mt-30 -90.09 90.48 8.14 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.133 -0.691 . . . . 74.51 109.133 171.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -80.72 99.53 8.26 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.669 -1.151 . . . . 64.34 108.709 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.461 ' HA3' ' HD2' ' D' ' 19' ' ' LYS . . . -92.44 143.3 16.44 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 112.193 -0.363 . . . . 42.31 112.193 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.58 130.83 4.08 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 111.822 -0.511 . . . . 53.12 111.822 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.684 HG23 ' HB2' ' D' ' 14' ' ' GLN . 5.2 tp -91.22 114.43 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.554 -0.906 . . . . 71.25 108.554 174.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -111.0 130.22 55.65 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.143 0.977 . . . . 73.34 110.291 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 10.8 t -94.6 100.79 12.68 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 109.02 -0.733 . . . . 74.32 109.02 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.513 HG21 HD21 ' D' ' 98' ' ' LEU . 3.6 tt -117.73 133.61 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.611 1.165 . . . . 70.11 109.552 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.93 169.6 11.25 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.921 0.888 . . . . 64.32 110.502 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.91 21.54 55.35 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 115.88 -0.6 . . . . 61.3 113.974 174.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.48 HG13 ' HG2' ' D' ' 9' ' ' MET . 0.9 OUTLIER -142.34 168.51 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.809 0.843 . . . . 72.24 110.978 175.603 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.543 ' HG3' ' HG3' ' B' ' 153' ' ' GLN . 0.2 OUTLIER -149.21 -168.43 3.1 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.68 1.192 . . . . 75.53 109.744 177.404 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 91' ' ' GLY . . . . . 0.604 ' HA2' ' HB2' ' B' ' 154' ' ' ASP . . . 77.7 -139.4 22.89 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-N 116.156 -0.474 . . . . 73.11 112.794 174.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 11.7 m -80.23 -39.35 29.22 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.248 0.619 . . . . 75.41 109.756 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -58.16 -36.28 72.78 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.384 1.074 . . . . 70.24 112.68 -173.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.644 ' HB2' HD11 ' E' ' 97' ' ' ILE . 0.0 OUTLIER -60.03 -48.56 81.22 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 112.807 0.669 . . . . 74.23 112.807 -172.243 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 95' ' ' ALA . . . . . 0.406 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.91 -26.05 25.79 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.833 0.453 . . . . 64.54 111.754 177.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -63.01 -34.25 77.15 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.587 0.755 . . . . 74.12 110.061 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 82.4 m -59.43 -50.41 74.03 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.055 0.542 . . . . 63.14 111.071 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.645 HD23 ' SG ' ' D' ' 102' ' ' CYS . 93.2 mt -69.5 -27.53 65.28 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.961 0.504 . . . . 74.14 111.95 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.82 3.71 71.16 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.488 -0.618 . . . . 54.2 113.829 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.83 -63.36 0.17 Allowed 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 117.695 0.748 . . . . 72.01 112.403 -175.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 101' ' ' TYR . . . . . 0.442 ' O ' HG12 ' D' ' 105' ' ' ILE . 71.1 t80 -69.01 -39.4 79.31 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.177 0.436 . . . . 75.12 112.177 -172.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.645 ' SG ' HD23 ' D' ' 98' ' ' LEU . 50.5 m -69.61 -47.07 25.85 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 123.712 0.805 . . . . 74.15 111.477 -176.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.507 ' HD3' HG11 ' D' ' 58' ' ' VAL . 28.1 Cg_endo -64.1 -26.78 65.31 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 121.421 1.414 . . . . 54.34 112.638 170.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -66.92 -31.2 71.64 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.741 0.416 . . . . 72.42 110.94 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.442 HG12 ' O ' ' D' ' 101' ' ' TYR . 41.9 mm -68.74 -39.76 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.006 0.923 . . . . 75.55 110.51 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' D' ' 103' ' ' PRO . 42.5 mt -74.31 -22.6 59.18 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.534 -0.757 . . . . 71.11 111.573 -175.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -65.28 -41.45 52.04 Favored Pre-proline 0 CA--C 1.562 1.431 0 N-CA-C 114.095 1.146 . . . . 74.42 114.095 -172.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -47.26 -48.31 15.29 Favored 'Trans proline' 0 C--N 1.389 2.669 0 C-N-CA 122.466 2.111 . . . . 73.3 113.649 169.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -73.53 -38.15 65.37 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.93 0.892 . . . . 70.51 111.26 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.39 -44.04 79.86 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.577 -0.738 . . . . 74.31 110.794 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 28.3 ttp180 -59.91 -49.01 79.39 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.21 0.944 . . . . 73.23 110.33 174.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -59.83 -46.0 90.62 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.142 0.901 . . . . 75.02 110.697 -175.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.4 ' O ' ' HG3' ' D' ' 117' ' ' MET . 42.5 t -55.04 -45.67 75.24 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 124.343 1.027 . . . . 45.1 110.309 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.574 HG23 ' SG ' ' D' ' 76' ' ' CYS . 72.4 mt -61.25 -60.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 124.067 0.854 . . . . 74.35 110.851 175.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 37.7 m -52.5 -42.77 64.57 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.032 1.333 . . . . 62.45 111.786 -172.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 33.1 t -65.72 -43.6 88.61 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.465 -1.243 . . . . 60.12 109.823 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 72.2 mtm -68.77 -28.07 66.46 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.059 0.544 . . . . 73.13 111.964 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.465 HG23 ' O ' ' D' ' 114' ' ' ILE . 92.6 t -67.23 -46.34 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.597 0.759 . . . . 73.42 109.566 176.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.7 p -73.13 -29.71 63.08 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.618 -0.719 . . . . 63.42 110.448 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 66.7 mtt-85 -69.54 -30.75 68.65 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 123.595 0.758 . . . . 71.53 109.557 172.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.65 7.23 81.75 Favored Glycine 0 C--N 1.357 1.71 0 C-N-CA 123.536 0.588 . . . . 61.11 113.0 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.511 HG23 ' HB3' ' C' ' 17' ' ' TYR . 66.4 p 55.37 38.92 31.01 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 126.402 1.881 . . . . 64.35 114.268 176.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -99.88 158.46 32.03 Favored Pre-proline 0 C--O 1.243 0.747 0 C-N-CA 123.427 0.691 . . . . 71.15 109.249 170.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.451 ' HA ' ' OG1' ' E' ' 129' ' ' THR . 97.7 Cg_exo -48.72 125.19 12.28 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.7 2.267 . . . . 73.25 112.156 168.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -47.28 126.69 9.79 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.826 1.329 . . . . 63.32 112.495 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.679 HD13 HG21 ' D' ' 40' ' ' VAL . 17.5 tp -107.21 97.75 7.48 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.9 0.88 . . . . 74.21 109.058 -176.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -99.35 99.0 9.87 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.608 -1.256 . . . . 72.13 107.608 173.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.794 HD11 HD22 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -68.47 120.24 14.22 Favored 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 108.259 -1.015 . . . . 60.02 108.259 -179.445 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.49 141.7 94.45 Favored Pre-proline 0 CA--C 1.562 1.413 0 C-N-CA 123.535 0.734 . . . . 72.52 110.914 -177.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -57.74 132.61 51.07 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 123.091 2.527 . . . . 72.44 113.388 -174.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 96.1 t -107.44 123.43 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 108.415 -0.957 . . . . 73.1 108.415 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -86.9 91.93 8.84 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.044 -1.095 . . . . 41.02 108.044 173.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -58.7 -31.61 68.41 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.397 1.079 . . . . 75.5 111.796 -174.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -63.03 -36.64 84.25 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.142 -0.936 . . . . 72.42 110.461 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.79 -31.2 68.99 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.836 0.854 . . . . 72.23 111.932 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 6.2 mp -71.53 -45.43 62.39 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.734 -0.469 . . . . 72.4 109.734 175.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.579 ' HA ' ' HE1' ' E' ' 109' ' ' TYR . 3.8 t80 -61.73 -36.9 82.33 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.484 -0.78 . . . . 72.45 110.083 178.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 29.1 ttm -68.71 -37.88 79.82 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.062 1.345 . . . . 64.45 110.82 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -61.9 -36.13 80.41 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.748 1.219 . . . . 63.04 111.353 -178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -68.02 -44.17 77.14 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.682 0.793 . . . . 74.41 111.172 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.409 HD13 ' O ' ' D' ' 137' ' ' PHE . 10.6 mp -69.36 -32.27 71.22 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.392 0.677 . . . . 63.4 111.623 -177.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -90.8 17.72 7.39 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.95 0.5 . . . . 71.33 110.819 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -118.23 45.33 2.02 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.631 -1.248 . . . . 72.43 107.631 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -145.0 179.5 7.31 Favored 'General case' 0 C--O 1.248 1.024 0 CA-C-N 113.288 -1.778 . . . . 74.42 108.404 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.35 92.69 1.44 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.374 -0.602 . . . . 64.52 109.374 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 164.7 -13.26 0.08 OUTLIER Glycine 0 C--N 1.34 0.802 0 CA-C-N 114.936 -1.029 . . . . 73.44 112.594 -176.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -60.17 104.19 0.29 Allowed 'General case' 0 C--N 1.361 1.101 0 C-N-CA 123.338 0.655 . . . . 73.24 110.651 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 178.04 51.36 0.07 OUTLIER Glycine 0 CA--C 1.506 -0.515 0 N-CA-C 110.063 -1.215 . . . . 65.5 110.063 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 5.3 t -116.61 95.38 5.01 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.953 0.901 . . . . 60.13 109.867 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.94 91.8 1.66 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 106.832 -1.544 . . . . 73.03 106.832 172.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -149.92 30.79 0.71 Allowed 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.755 1.222 . . . . 70.02 108.773 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -152.99 140.65 19.91 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.989 -1.005 . . . . 74.14 108.544 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -60.55 -64.31 1.0 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.329 1.052 . . . . 73.21 111.517 -173.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -108.56 151.27 26.33 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.116 0.966 . . . . 65.23 109.484 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 C-N-CA 123.33 0.652 . . . . 70.24 109.256 -177.704 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 CA-C-O 119.939 -0.367 . . . . 43.21 112.431 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.27 96.58 0.05 OUTLIER Glycine 0 C--N 1.354 1.531 0 CA-C-O 119.198 -0.779 . . . . 74.42 111.955 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 93' ' ' PHE . . . . . 0.411 ' CD2' HG11 ' D' ' 55' ' ' VAL . 3.1 m-85 70.82 103.74 0.06 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 124.739 1.216 . . . . 75.33 110.094 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -78.5 178.97 7.34 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.349 1.059 . . . . 73.23 113.026 -166.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.24 133.97 21.13 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.262 1.025 . . . . 71.32 109.295 174.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 162.23 -60.73 0.28 Allowed Glycine 0 C--N 1.356 1.69 0 CA-C-O 119.962 -0.355 . . . . 73.2 113.343 -177.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 97' ' ' ILE . . . . . 0.644 HD11 ' HB2' ' D' ' 94' ' ' MET . 1.9 tt -73.33 127.63 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-O 121.437 0.637 . . . . 60.21 110.658 -175.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -140.25 -167.53 2.34 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.018 0.927 . . . . 74.03 109.74 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . 66.85 30.3 7.91 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.768 1.227 . . . . 41.51 111.172 -175.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 100' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -88.22 103.67 5.57 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 124.022 0.929 . . . . 73.23 110.804 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -87.07 -26.88 0.75 Allowed 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.065 2.51 . . . . 73.45 113.816 -175.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 102' ' ' LEU . . . . . 0.573 HD12 HG23 ' E' ' 103' ' ' THR . 2.3 pp -85.64 3.4 41.08 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.033 0.933 . . . . 75.02 111.602 -173.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 103' ' ' THR . . . . . 0.573 HG23 HD12 ' E' ' 102' ' ' LEU . 44.6 p -110.08 -14.36 14.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.522 1.129 . . . . 74.33 110.937 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . -73.18 -69.44 1.39 Allowed Glycine 0 C--N 1.352 1.425 0 O-C-N 123.074 0.234 . . . . 74.41 112.638 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -110.56 -62.51 1.52 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.399 0.679 . . . . 73.44 109.678 -176.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -165.88 144.64 6.0 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 114.734 -1.121 . . . . 71.22 108.167 -173.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 10.0 m -67.26 116.64 8.26 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.223 -0.658 . . . . 74.13 109.223 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -73.89 -5.02 38.53 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.339 0.656 . . . . 44.35 112.023 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 109' ' ' TYR . . . . . 0.579 ' HE1' ' HA ' ' D' ' 137' ' ' PHE . 70.7 t80 -137.53 82.03 1.9 Allowed 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 107.193 -1.41 . . . . 73.42 107.193 164.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -85.74 58.17 4.89 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.476 0.71 . . . . 74.51 111.692 -174.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 111' ' ' LEU . . . . . . . . . . . . . 22.9 tp 69.56 -77.86 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.518 1.527 . . . . 72.43 111.926 174.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -75.2 95.59 3.15 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.942 0.497 . . . . 75.32 110.267 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -122.85 133.74 54.42 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.481 -0.563 . . . . 64.3 109.481 173.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 114' ' ' LYS . . . . . 0.405 ' H ' ' HG2' ' E' ' 114' ' ' LYS . 15.5 ptmt -80.87 68.81 7.26 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.46 1.104 . . . . 74.44 109.887 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 46.9 p -70.68 -52.8 18.71 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.692 -1.14 . . . . 54.33 110.965 -175.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.26 -56.25 0.02 OUTLIER Glycine 0 C--N 1.34 0.765 0 CA-C-N 115.871 -0.604 . . . . 55.41 111.663 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -176.17 77.08 0.28 Allowed Pre-proline 0 CA--C 1.557 1.226 0 C-N-CA 124.032 0.933 . . . . 73.2 108.696 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.05 -33.2 12.12 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.377 2.051 . . . . 72.5 113.292 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 61.14 23.34 13.54 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 125.275 1.43 . . . . 72.24 113.149 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -108.9 157.18 18.87 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.119 -1.067 . . . . 74.34 108.119 171.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 121' ' ' VAL . . . . . 0.465 HG13 HD23 ' D' ' 42' ' ' LEU . 57.0 t 74.98 101.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.49 1.116 . . . . 71.43 109.118 -175.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 15.1 t -76.9 166.14 23.74 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.446 -0.797 . . . . 61.34 112.792 -169.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -112.58 -4.86 14.06 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.974 1.31 . . . . 63.13 110.33 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 49.4 m -144.63 125.37 14.2 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.192 0.597 . . . . 74.32 110.206 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -84.89 166.43 16.85 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.098 0.559 . . . . 74.2 110.156 173.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -116.82 32.4 6.17 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.446 0.698 . . . . 71.14 111.172 -175.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 55.0 m -136.83 120.93 17.77 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.424 0.69 . . . . 55.34 109.424 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -145.38 136.35 24.66 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.236 0.614 . . . . 70.42 109.723 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 129' ' ' THR . . . . . 0.46 HG22 ' NH2' ' B' ' 15' ' ' ARG . 61.2 p -118.66 133.52 55.8 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.954 0.902 . . . . 74.54 109.729 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.43 84.48 0.59 Allowed 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.504 0.721 . . . . 72.34 109.141 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 131' ' ' TRP . . . . . 0.659 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 1.9 t-105 -96.13 66.42 2.52 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.256 -0.884 . . . . 73.42 109.316 -171.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 57.4 m -135.31 84.03 2.06 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.55 -0.75 . . . . 75.03 109.915 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 63.0 m -145.68 104.74 3.91 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.793 0.837 . . . . 73.42 108.952 176.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -99.81 43.66 1.77 Allowed Glycine 0 C--N 1.345 1.063 0 CA-C-O 119.592 -0.56 . . . . 74.14 112.12 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 135' ' ' VAL . . . . . 0.473 HG12 ' H ' ' E' ' 137' ' ' THR . 57.9 t 63.51 -79.99 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 125.077 1.351 . . . . 63.3 111.977 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 136' ' ' LYS . . . . . 0.418 ' HE3' HE22 ' C' ' 12' ' ' GLN . 8.0 mmpt? 56.09 31.37 18.02 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.532 1.133 . . . . 62.54 112.847 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 137' ' ' THR . . . . . 0.473 ' H ' HG12 ' E' ' 135' ' ' VAL . 18.5 m -98.99 -48.9 4.71 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.217 0.451 . . . . 54.11 112.217 -175.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -97.28 -12.69 22.6 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.395 0.678 . . . . 64.31 111.724 -170.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -72.97 89.14 1.4 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.721 0.808 . . . . 61.5 111.197 -171.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -90.69 -29.22 13.97 Favored Glycine 0 C--N 1.344 0.978 0 CA-C-N 115.892 -0.594 . . . . 61.03 112.547 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -113.72 164.71 13.35 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.842 0.857 . . . . 60.3 111.321 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 49.6 tp -157.04 144.43 18.85 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.64 0.776 . . . . 73.24 109.315 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -142.57 157.92 26.83 Favored Glycine 0 C--N 1.341 0.858 0 N-CA-C 111.561 -0.615 . . . . 73.45 111.561 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.87 62.21 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.115 0.966 . . . . 75.41 108.414 170.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 30.9 t70 . . . . . 0 CA--C 1.561 1.402 0 C-N-CA 125.034 1.334 . . . . 64.2 110.985 -175.333 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.461 0 N-CA-C 111.221 -0.752 . . . . 72.11 111.221 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.78 -116.57 6.97 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-O 119.639 -0.534 . . . . 74.42 113.04 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 52.0 41.64 29.85 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.815 1.246 . . . . 73.03 111.176 -172.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -72.5 148.78 44.73 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-N 114.567 -1.197 . . . . 74.52 109.533 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -146.59 164.14 33.56 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.277 0.631 . . . . 51.24 111.079 -166.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.57 46.5 0.03 OUTLIER Glycine 0 C--N 1.345 1.063 0 N-CA-C 110.946 -0.862 . . . . 61.22 110.946 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 97' ' ' ILE . . . . . 0.766 HD11 ' HB2' ' B' ' 94' ' ' MET . 9.1 tt -141.85 -16.78 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.467 1.107 . . . . 71.13 110.074 -176.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 16.8 t70 70.87 112.49 0.06 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.035 1.334 . . . . 74.23 111.804 177.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . 70.28 -68.02 0.22 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.516 1.526 . . . . 74.01 113.46 166.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 100' ' ' LEU . . . . . 0.492 HD21 HD11 ' B' ' 98' ' ' LEU . 54.0 tp 73.39 70.05 0.26 Allowed Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 125.431 1.493 . . . . 73.25 111.803 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -93.17 135.12 1.15 Allowed 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 123.13 2.553 . . . . 71.0 112.609 173.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 102' ' ' LEU . . . . . 0.44 HD13 ' HB1' ' B' ' 95' ' ' ALA . 0.7 OUTLIER -166.27 -159.46 0.38 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.567 0.747 . . . . 72.51 110.709 177.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 103' ' ' THR . . . . . 0.41 HG21 HG23 ' F' ' 107' ' ' THR . 72.4 p -62.48 81.06 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 125.806 1.642 . . . . 64.42 112.974 -174.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.96 168.61 41.35 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 115.205 -0.907 . . . . 73.11 111.595 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 61.42 -77.33 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.669 1.188 . . . . 74.11 110.287 -172.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -150.08 136.82 19.23 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.914 0.886 . . . . 64.41 109.511 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 107' ' ' THR . . . . . 0.41 HG23 HG21 ' F' ' 103' ' ' THR . 22.6 m -77.27 130.53 37.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.487 0.715 . . . . 75.14 110.082 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -81.12 -22.29 39.19 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.425 0.69 . . . . 71.52 111.125 177.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 109' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' F' ' 115' ' ' THR . 12.6 m-30 -92.54 50.99 1.67 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.881 -1.155 . . . . 72.15 107.881 167.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.92 140.17 58.32 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 115.617 -0.72 . . . . 73.33 111.214 -175.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 111' ' ' LEU . . . . . 0.701 HD11 HD22 ' B' ' 136' ' ' LEU . 16.1 tp -66.08 -10.49 40.82 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-N 115.721 -0.672 . . . . 74.52 111.029 177.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -54.83 171.82 0.12 Allowed 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 125.867 1.667 . . . . 73.44 110.681 167.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -71.41 71.05 0.64 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.505 0.669 . . . . 61.11 110.785 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -145.5 -164.34 1.92 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.74 1.216 . . . . 71.41 109.617 -169.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 115' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' F' ' 109' ' ' TYR . 52.1 p -77.21 60.02 1.86 Allowed 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 124.142 0.977 . . . . 74.03 110.586 173.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . -137.79 -77.3 0.07 OUTLIER Glycine 0 C--N 1.349 1.29 0 N-CA-C 110.391 -1.084 . . . . 63.43 110.391 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -86.28 132.65 42.57 Favored Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 108.676 -0.861 . . . . 75.34 108.676 169.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 118' ' ' PRO . . . . . 0.469 ' HG3' ' OD1' ' B' ' 139' ' ' ASN . 58.7 Cg_endo -70.23 -49.41 0.5 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 121.982 1.788 . . . . 74.21 110.936 172.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -153.68 -95.99 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 107.675 -1.232 . . . . 74.21 107.675 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 50.13 -82.88 0.01 OUTLIER 'General case' 0 C--N 1.37 1.475 0 C-N-CA 125.159 1.383 . . . . 74.34 112.038 -173.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 46.6 t -72.73 90.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.691 0 N-CA-C 108.643 -0.873 . . . . 60.01 108.643 177.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 45.5 p -59.19 153.05 19.14 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.837 -1.074 . . . . 75.4 110.059 173.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -69.32 75.03 0.36 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.855 0.862 . . . . 62.14 111.229 -174.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 8.3 t -179.35 -178.49 0.49 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.447 1.899 . . . . 71.41 107.431 -176.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -137.04 -71.24 0.44 Allowed 'General case' 0 N--CA 1.481 1.109 0 O-C-N 122.106 -0.371 . . . . 55.24 110.27 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -166.65 164.11 16.79 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.394 -0.821 . . . . 71.25 109.783 -175.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 50.5 m -79.42 87.84 5.04 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.931 -0.577 . . . . 63.25 109.508 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.67 104.34 2.37 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.329 -0.851 . . . . 64.12 109.452 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 32.4 m -85.25 125.56 32.98 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.144 0.578 . . . . 74.53 110.38 -175.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 130' ' ' ALA . . . . . 0.532 ' HB2' ' HG3' ' B' ' 124' ' ' PRO . . . -74.48 149.37 40.35 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.449 0.7 . . . . 43.22 110.915 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 42.0 p-90 -106.71 150.36 26.34 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 109.273 -0.64 . . . . 74.04 109.273 175.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 22.7 t -154.92 43.83 0.49 Allowed 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.366 -0.976 . . . . 74.52 108.366 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 40.0 p -65.09 106.65 1.33 Allowed 'General case' 0 C--N 1.354 0.762 0 CA-C-N 115.179 -0.918 . . . . 70.11 109.222 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -63.38 90.62 0.08 OUTLIER Glycine 0 C--N 1.35 1.315 0 O-C-N 123.972 0.795 . . . . 51.04 112.938 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 3.8 p -63.11 97.54 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-O 121.826 0.822 . . . . 74.11 109.336 175.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -80.74 69.43 7.28 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.894 -1.048 . . . . 75.53 110.318 -170.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 33.3 m 61.17 -77.94 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.381 1.472 . . . . 55.02 111.472 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -167.58 -39.99 0.02 OUTLIER 'General case' 0 C--O 1.242 0.699 0 C-N-CA 125.186 1.395 . . . . 73.12 107.565 174.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 9.5 t30 71.56 -72.96 0.1 Allowed 'General case' 0 C--N 1.361 1.096 0 C-N-CA 125.76 1.624 . . . . 72.33 110.579 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . 172.7 174.84 40.21 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 111.678 -0.569 . . . . 71.53 111.678 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -92.18 94.65 9.3 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.488 0.715 . . . . 54.1 109.592 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -142.15 140.73 32.51 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.628 0.771 . . . . 74.44 109.422 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -108.58 119.01 5.51 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.755 -0.938 . . . . 73.42 110.755 175.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 28.9 m -90.28 142.67 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 123.057 0.543 . . . . 71.22 110.381 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 108.552 -0.907 . . . . 55.31 108.552 175.748 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.434 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.298 0.094 . . . . 42.43 110.968 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.2 t -134.15 81.1 1.89 Allowed 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.94 -1.133 . . . . 73.53 107.94 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -100.57 108.71 20.69 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.317 1.047 . . . . 72.22 109.122 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -85.58 115.35 23.22 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.794 0.838 . . . . 73.52 110.07 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -128.3 174.65 9.12 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.178 -1.045 . . . . 74.03 108.178 175.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -61.48 -27.93 68.94 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.914 0.486 . . . . 63.32 111.578 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 t -145.16 155.4 43.26 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.703 0.801 . . . . 75.31 109.77 169.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -166.22 -69.32 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 106.733 -1.58 . . . . 74.1 106.733 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.44 ' HG2' HG23 ' A' ' 89' ' ' ILE . 67.0 mtt -136.22 162.84 31.85 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.369 1.068 . . . . 73.35 108.691 169.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 25.8 m -141.52 130.06 22.64 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.159 -1.052 . . . . 74.22 108.159 177.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -137.24 119.04 15.13 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.09 -1.078 . . . . 64.41 108.09 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -134.78 132.21 38.44 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.646 -0.872 . . . . 61.03 108.646 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.517 ' CD1' HG21 ' A' ' 105' ' ' ILE . 4.9 mt -94.33 113.36 28.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.645 -0.872 . . . . 73.21 108.645 175.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -78.43 -40.26 36.34 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 123.375 0.422 . . . . 75.1 110.006 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -170.68 124.7 0.68 Allowed 'General case' 0 C--N 1.354 0.799 0 CA-C-N 115.946 -0.57 . . . . 74.12 111.042 -173.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.412 HD12 ' HG3' ' C' ' 130' ' ' PRO . 81.2 mt -106.97 140.28 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 107.944 -1.132 . . . . 64.11 107.944 167.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.521 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 31.7 p90 -164.92 166.25 19.66 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.306 0.574 . . . . 64.53 111.366 -174.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -94.27 122.06 36.42 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 109.484 -0.562 . . . . 54.54 109.484 172.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.455 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 43.0 mtpt -80.11 -35.08 37.33 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.211 -0.662 . . . . 72.14 109.211 174.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -149.93 137.95 20.3 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.277 -1.329 . . . . 65.13 109.826 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.547 HG21 ' SD ' ' B' ' 117' ' ' MET . 73.1 mt -134.99 143.82 36.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 125.317 1.447 . . . . 74.35 108.008 178.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.9 t -156.71 119.93 4.16 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 123.524 0.515 . . . . 61.33 110.593 170.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.628 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.8 t80 -111.5 143.41 42.38 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.019 -1.475 . . . . 74.15 107.019 165.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -139.66 141.31 37.03 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.703 0.401 . . . . 72.12 110.669 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.19 69.92 13.01 Favored Pre-proline 0 C--O 1.242 0.692 0 N-CA-C 107.181 -1.415 . . . . 64.3 107.181 170.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.35 -8.21 19.48 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.448 2.099 . . . . 61.23 112.303 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -114.72 17.52 17.08 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 124.311 1.044 . . . . 62.44 109.246 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.517 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -46.24 -54.31 18.4 Favored Pre-proline 0 CA--C 1.567 1.607 0 CA-C-O 118.006 -0.997 . . . . 75.2 113.667 -169.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -61.81 -24.02 76.8 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 122.016 1.81 . . . . 73.01 113.542 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -84.84 -44.86 12.86 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.757 0.823 . . . . 72.41 111.017 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.927 HG21 ' HA ' ' A' ' 73' ' ' ALA . 8.6 p -77.03 -21.71 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 115.346 -0.843 . . . . 74.25 112.815 -161.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -66.96 -17.24 64.82 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 116.151 -0.477 . . . . 73.21 111.471 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 60.8 mt-30 -91.87 -14.46 29.65 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.551 1.14 . . . . 52.51 110.87 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.496 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 19.0 mmtp -79.54 160.31 26.53 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.21 0.604 . . . . 70.33 111.549 -176.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -69.59 131.24 44.35 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.896 0.879 . . . . 72.43 109.152 173.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.496 ' CE3' HD21 ' A' ' 68' ' ' LEU . 68.6 t-105 -81.6 81.07 7.8 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.494 0.664 . . . . 72.54 110.042 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -129.08 77.76 77.31 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.552 1.141 . . . . 72.03 108.035 172.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -85.96 145.22 8.71 Favored 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.669 2.246 . . . . 62.15 113.192 -173.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -101.31 84.97 2.71 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.826 -1.176 . . . . 71.41 107.826 164.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.679 HG11 HD11 ' A' ' 126' ' ' LEU . 77.7 t -81.65 96.96 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 108.419 -0.956 . . . . 61.44 108.419 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -95.96 123.3 39.5 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.347 -0.612 . . . . 74.43 109.347 177.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mp -97.91 107.05 19.45 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.504 -1.295 . . . . 65.44 107.504 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -111.58 119.16 37.79 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.469 -0.937 . . . . 54.31 108.469 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.498 HD22 HD21 ' A' ' 60' ' ' LEU . 89.0 mt -112.17 139.4 47.74 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.441 0.696 . . . . 73.1 111.805 -169.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.482 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 19.4 t70 -132.29 144.09 50.35 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.78 1.232 . . . . 41.54 108.536 176.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.4 m -141.35 135.19 30.23 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.495 0.718 . . . . 72.55 109.434 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.6 123.78 10.83 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.633 0.773 . . . . 63.42 109.483 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.419 ' HB3' ' HB3' ' A' ' 98' ' ' LEU . 78.9 p -97.54 162.39 13.33 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.445 0.698 . . . . 50.14 110.27 175.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.0 t -158.56 155.59 28.62 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.299 1.04 . . . . 72.25 108.53 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -102.53 115.96 31.63 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.296 -0.631 . . . . 70.24 109.296 175.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.634 HD11 ' HB2' ' A' ' 57' ' ' GLU . 56.6 mt -82.52 -40.83 20.48 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.494 0.718 . . . . 64.14 110.257 176.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.41 -174.57 5.0 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.251 -0.886 . . . . 65.11 110.713 -176.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -59.65 115.84 3.61 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.796 0.838 . . . . 72.15 110.135 176.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 71.74 -6.16 1.5 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.907 1.283 . . . . 74.44 112.843 -177.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.6 t -98.76 115.65 39.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.718 -0.845 . . . . 63.43 108.718 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -126.01 125.08 42.08 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.161 0.984 . . . . 61.52 109.061 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.634 ' HB2' HD11 ' A' ' 51' ' ' LEU . 33.2 tt0 -92.05 123.33 35.33 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.483 -0.562 . . . . 63.11 109.483 171.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.8 t -107.28 136.03 43.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.405 -0.961 . . . . 64.22 108.405 168.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.7 t -120.18 130.33 74.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.191 -1.04 . . . . 71.42 108.191 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.498 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -107.07 105.03 14.85 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.411 -1.7 . . . . 71.44 106.411 175.188 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.482 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 31.6 ttp180 -92.51 100.49 13.03 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.216 -1.402 . . . . 74.4 107.216 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.2 t -96.15 127.05 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 108.182 -1.044 . . . . 62.54 108.182 176.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.1 m -123.86 118.56 27.39 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.598 -0.89 . . . . 74.51 108.598 174.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.597 HG11 HD21 ' A' ' 126' ' ' LEU . 71.9 t -120.52 132.4 70.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 107.914 -1.143 . . . . 64.3 107.914 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 m -137.2 132.43 33.87 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.583 -0.895 . . . . 71.32 108.583 174.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.561 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -114.31 114.95 26.62 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.541 1.137 . . . . 62.42 108.142 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 71.2 m -120.81 134.98 55.27 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.401 0.619 . . . . 74.42 111.146 178.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.496 HD21 ' CE3' ' A' ' 36' ' ' TRP . 42.0 mt -94.91 42.27 1.09 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.402 1.481 . . . . 74.41 111.111 -176.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.61 -84.87 1.51 Allowed Glycine 0 C--N 1.339 0.698 0 CA-C-O 119.749 -0.473 . . . . 33.1 112.164 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -86.56 -30.66 21.71 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.211 0.529 . . . . 73.11 111.353 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.449 ' HB2' ' NZ ' ' A' ' 34' ' ' LYS . 4.6 tp10 -119.96 133.64 55.49 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.62 -0.881 . . . . 42.44 108.62 -174.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 73.7 m -77.71 134.37 38.13 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.111 -0.7 . . . . 64.31 109.111 170.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.927 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -71.83 -64.59 0.9 Allowed 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.507 0.723 . . . . 74.21 109.45 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -159.57 166.72 30.18 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.253 -0.885 . . . . 75.0 112.039 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.7 tp -117.92 143.11 46.62 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.571 -1.195 . . . . 64.43 108.693 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.446 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 79.1 m -143.07 104.53 4.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.131 0.973 . . . . 75.4 109.622 175.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -123.1 127.69 49.07 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.539 0.736 . . . . 74.21 109.017 177.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.3 t -137.55 112.75 10.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 124.352 1.061 . . . . 62.21 109.094 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -86.21 85.65 7.34 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.781 -0.822 . . . . 65.22 108.781 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -78.37 96.26 5.29 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.948 -1.024 . . . . 64.42 110.31 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.14 155.74 30.23 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 111.724 -0.551 . . . . 73.11 111.724 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.508 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -151.51 122.3 1.33 Allowed Glycine 0 C--N 1.329 0.164 0 N-CA-C 111.703 -0.559 . . . . 62.41 111.703 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.9 mt -81.17 117.63 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.941 0.896 . . . . 71.23 108.665 171.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.695 ' HB3' HD11 ' A' ' 86' ' ' ILE . 90.8 m-85 -124.27 122.26 37.26 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.489 1.116 . . . . 62.34 109.491 -177.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.1 t -91.77 105.39 17.68 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.239 -0.652 . . . . 75.11 109.239 173.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.695 HD11 ' HB3' ' A' ' 84' ' ' PHE . 1.9 mm -112.38 153.78 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.489 0.715 . . . . 72.5 109.43 -177.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.426 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -158.23 160.61 37.31 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.557 0.743 . . . . 73.24 111.235 177.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.1 -7.62 64.58 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 119.184 -0.787 . . . . 73.44 113.928 174.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.485 ' HA ' ' HG2' ' A' ' 151' ' ' GLU . 0.1 OUTLIER -144.06 153.37 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 124.056 0.942 . . . . 73.55 111.695 -178.529 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -141.84 178.25 7.63 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.01 1.724 . . . . 63.55 108.625 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.47 -139.78 29.62 Favored Glycine 0 C--N 1.349 1.26 0 N-CA-C 114.063 0.385 . . . . 73.43 114.063 173.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.2 t -72.4 -19.38 61.61 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.258 0.623 . . . . 64.44 111.439 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -70.78 -43.82 67.94 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.992 0.917 . . . . 72.21 109.576 173.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.8 tpt -63.82 -42.31 97.69 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.085 -0.961 . . . . 72.12 109.849 174.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.3 -33.75 76.2 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.449 -0.796 . . . . 62.41 111.344 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.463 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 53.0 t-80 -71.1 -27.02 63.3 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.169 0.588 . . . . 61.21 111.193 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -78.6 -52.79 7.95 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.823 -0.436 . . . . 72.3 109.823 175.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 48' ' ' SER . 89.6 mt -72.98 -35.24 66.84 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.789 0.835 . . . . 55.31 112.773 -171.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.08 4.0 60.55 Favored Glycine 0 N--CA 1.469 0.842 0 CA-C-N 115.97 -0.559 . . . . 64.31 113.674 -172.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.561 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -146.51 -58.45 0.29 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 117.31 0.555 . . . . 53.42 112.19 -173.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.409 ' O ' HG12 ' A' ' 105' ' ' ILE . 41.6 t80 -71.83 -42.28 67.15 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.046 0.451 . . . . 74.04 110.742 -176.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 63.7 m -67.63 -49.43 40.03 Favored Pre-proline 0 CA--C 1.565 1.552 0 C-N-CA 124.733 1.213 . . . . 74.01 112.852 -175.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.407 ' HA ' HD12 ' A' ' 106' ' ' LEU . 47.5 Cg_endo -65.79 -24.85 53.86 Favored 'Trans proline' 0 C--N 1.395 2.982 0 C-N-CA 122.035 1.823 . . . . 74.01 112.437 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -64.91 -37.14 86.64 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.457 0.703 . . . . 74.52 110.476 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.517 HG21 ' CD1' ' A' ' 13' ' ' ILE . 49.5 mm -69.02 -40.73 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.544 0.737 . . . . 72.23 110.407 174.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.508 HD21 ' HA3' ' A' ' 82' ' ' GLY . 48.3 mt -72.74 -25.18 61.11 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.475 -0.784 . . . . 62.1 112.123 -175.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -61.68 -45.09 93.15 Favored Pre-proline 0 N--CA 1.487 1.394 0 N-CA-C 113.768 1.025 . . . . 65.33 113.768 -172.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -52.05 -37.34 68.16 Favored 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 122.51 2.14 . . . . 75.53 113.876 170.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -84.09 -29.11 27.06 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.51 0.724 . . . . 74.32 112.001 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.76 -45.19 75.61 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.554 -0.906 . . . . 75.4 108.554 172.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.558 ' NH1' HD12 ' C' ' 105' ' ' ILE . 36.5 ttm180 -59.9 -40.81 90.06 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.071 -1.422 . . . . 74.31 110.515 174.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' C' ' 108' ' ' PRO . 25.7 tt0 -51.21 -54.53 24.77 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.623 1.169 . . . . 74.43 110.813 177.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 117' ' ' MET . 48.9 t -66.17 -47.21 74.72 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.435 -1.257 . . . . 64.12 111.437 -176.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 118' ' ' VAL . 92.1 mt -58.69 -59.14 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 124.173 0.989 . . . . 73.22 110.953 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.1 m -56.82 -38.55 72.77 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.359 1.064 . . . . 74.1 111.575 -177.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.1 t -63.35 -48.82 76.39 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.892 -1.049 . . . . 61.22 110.817 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.628 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 41.2 mtm -61.46 -40.25 93.83 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.816 0.697 . . . . 71.23 111.253 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 126' ' ' LEU . 82.5 t -56.77 -49.97 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 O-C-N 124.252 0.97 . . . . 54.51 110.813 175.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.6 t -68.17 -33.51 74.59 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.234 -0.893 . . . . 65.24 111.165 -177.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.55 HH12 ' HG3' ' B' ' 112' ' ' GLU . 81.8 mtt-85 -72.61 -29.43 63.48 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.537 0.735 . . . . 73.34 110.172 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.452 ' O ' HG22 ' A' ' 122' ' ' THR . . . -86.17 16.41 43.54 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-O 118.812 -0.993 . . . . 73.02 113.375 175.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.475 HG21 ' HE ' ' B' ' 15' ' ' ARG . 3.0 t 60.47 11.65 3.09 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 126.781 2.033 . . . . 74.41 113.66 176.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -81.88 156.66 69.86 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.708 0.803 . . . . 75.44 109.911 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.545 ' HB3' ' HA ' ' E' ' 131' ' ' TRP . 18.6 Cg_endo -60.21 129.29 29.41 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.503 2.136 . . . . 71.31 111.33 175.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -49.05 121.68 5.06 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 125.116 1.51 . . . . 73.43 112.213 -173.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.679 HD11 HG11 ' A' ' 40' ' ' VAL . 56.5 tp -108.78 102.11 11.18 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.922 -0.581 . . . . 72.41 109.662 -174.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.413 HD22 HG21 ' E' ' 135' ' ' VAL . 42.3 m-80 -98.85 121.87 41.35 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.594 -1.262 . . . . 64.03 107.594 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 11.2 mt -72.02 129.88 39.61 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 110.082 -0.34 . . . . 74.35 110.082 -177.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -64.91 141.36 98.35 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 116.046 -0.524 . . . . 74.22 110.771 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.613 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 49.2 Cg_exo -57.7 128.74 30.37 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.284 2.656 . . . . 75.34 113.558 -176.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 85.8 t -120.58 132.3 70.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 C-N-CA 123.942 0.897 . . . . 64.45 109.824 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -96.43 95.48 8.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.752 0.821 . . . . 63.13 108.871 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -62.57 -21.09 65.33 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.941 0.897 . . . . 65.43 112.576 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.561 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 11.7 t70 -56.96 -51.03 70.81 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.55 0.74 . . . . 65.13 110.045 170.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.7 -40.49 95.22 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 124.106 0.879 . . . . 74.32 111.326 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.92 -32.07 73.47 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.463 -0.79 . . . . 73.24 111.248 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -77.3 -33.94 55.56 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.737 -0.665 . . . . 74.33 110.413 176.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.624 ' SD ' HD23 ' A' ' 141' ' ' LEU . 26.3 mmt -61.25 -28.35 69.1 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.386 0.674 . . . . 54.22 111.517 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -61.63 -29.26 69.94 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.294 1.037 . . . . 74.0 111.5 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -92.76 -41.17 10.27 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.519 0.728 . . . . 72.43 110.324 174.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.624 HD23 ' SD ' ' A' ' 138' ' ' MET . 61.4 tp -66.73 -48.66 68.48 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.272 1.029 . . . . 75.41 111.897 -166.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.438 ' NE2' ' SD ' ' A' ' 138' ' ' MET . 28.5 pt20 -143.46 24.34 1.75 Allowed 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 112.02 0.378 . . . . 73.34 112.02 -165.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -69.71 -39.95 76.58 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.044 -0.724 . . . . 63.4 109.044 168.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -155.09 -27.72 0.11 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 114.669 -1.15 . . . . 74.4 110.029 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.3 -44.9 96.44 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.469 0.708 . . . . 71.01 111.807 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 106.79 -111.59 3.57 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-O 119.694 -0.503 . . . . 71.2 112.841 174.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -176.99 162.45 2.05 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.956 0.903 . . . . 71.11 109.196 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -151.91 53.55 0.47 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.684 -0.566 . . . . 63.21 111.684 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 26.4 p -76.76 88.41 3.39 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.683 0.754 . . . . 75.22 110.434 177.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -141.46 97.06 3.09 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 107.417 -1.327 . . . . 73.03 107.417 172.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.485 ' HG2' ' HA ' ' A' ' 89' ' ' ILE . 11.5 tp10 -130.41 120.41 24.19 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 120.939 0.4 . . . . 65.21 110.332 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -80.2 88.96 5.45 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.149 -1.056 . . . . 71.32 108.149 173.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -70.27 74.12 0.5 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.084 0.954 . . . . 74.43 111.056 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -133.57 158.75 42.37 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.125 0.57 . . . . 64.3 110.368 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.831 0 C-N-CA 124.507 1.123 . . . . 54.45 109.359 -179.023 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptp . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 120.303 0.097 . . . . 53.51 110.802 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -75.67 101.5 5.02 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 109.02 -0.733 . . . . 73.32 109.02 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -63.49 -24.09 67.67 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.055 0.942 . . . . 61.04 112.145 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -116.8 84.95 2.23 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.918 0.887 . . . . 74.21 108.697 175.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -172.77 89.58 0.09 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.204 1.002 . . . . 73.21 108.722 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -147.49 -44.14 0.17 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.296 1.038 . . . . 54.31 108.913 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 32.9 m 69.26 103.19 0.06 Allowed 'General case' 0 C--N 1.358 0.936 0 C-N-CA 125.091 1.356 . . . . 72.45 110.867 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 72.06 137.11 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.788 1.235 . . . . 63.02 111.704 175.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.578 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 0.5 OUTLIER 66.05 165.58 0.19 Allowed 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 125.662 1.585 . . . . 74.22 112.026 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.494 ' N ' ' SD ' ' B' ' 9' ' ' MET . 78.8 m -153.22 105.93 2.93 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.181 0.992 . . . . 74.42 108.746 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -109.72 139.46 44.73 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.413 -0.958 . . . . 73.52 108.413 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -149.89 141.24 23.26 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.699 0.8 . . . . 73.12 109.272 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 19.0 mt -94.6 124.98 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 107.545 -1.28 . . . . 60.43 107.545 171.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -87.53 -48.95 7.52 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.827 -0.434 . . . . 73.03 109.827 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.475 ' HE ' HG21 ' A' ' 122' ' ' THR . 48.2 ttt180 -166.45 136.35 3.2 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.609 0.568 . . . . 62.52 109.991 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.408 HD12 HD22 ' D' ' 127' ' ' ASN . 97.7 mt -115.25 135.64 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 107.602 -1.259 . . . . 63.13 107.602 174.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -163.18 143.88 9.31 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 112.767 0.654 . . . . 60.35 112.767 -174.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 56.0 m -73.79 120.8 19.88 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.617 -1.174 . . . . 65.11 108.918 170.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.552 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.2 mtpt -98.53 -18.9 17.93 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.113 0.965 . . . . 73.31 111.897 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -166.02 144.31 5.74 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.608 0.567 . . . . 64.23 110.824 -174.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.453 ' HB ' ' H ' ' A' ' 23' ' ' PHE . 45.6 mm -139.19 140.9 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.277 1.431 . . . . 70.12 108.745 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.5 t -142.71 125.8 16.34 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.649 1.18 . . . . 62.23 108.303 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.518 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 78.1 t80 -140.35 121.27 14.54 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.573 -1.269 . . . . 74.32 107.573 169.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -130.25 121.13 25.58 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.522 -0.918 . . . . 54.32 108.522 175.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.683 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -105.46 89.31 3.2 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 106.259 -1.756 . . . . 61.14 106.259 168.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -59.43 -36.72 93.06 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.86 2.374 . . . . 62.01 111.975 -171.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -106.47 16.54 24.54 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 118.06 -0.972 . . . . 74.3 111.611 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.683 ' HB2' ' HB3' ' B' ' 25' ' ' ALA . . . -30.73 -62.12 0.24 Allowed Pre-proline 0 N--CA 1.502 2.128 0 N-CA-C 115.117 1.525 . . . . 53.31 115.117 -171.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 17.4 Cg_exo -59.5 -41.39 57.73 Favored 'Trans proline' 0 C--N 1.399 3.19 0 C-N-CA 121.951 1.767 . . . . 63.15 112.686 -173.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -96.78 -19.35 18.98 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.079 -0.964 . . . . 72.11 113.296 -169.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.543 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.6 p -74.96 -12.93 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-O 121.155 0.502 . . . . 75.03 110.735 -176.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -77.44 -5.93 51.64 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.296 0.85 . . . . 74.23 113.296 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -68.31 -21.52 64.76 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.867 0.467 . . . . 75.45 110.433 169.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -94.33 87.1 5.09 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.254 1.021 . . . . 74.04 110.533 -175.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -86.54 90.97 8.41 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.522 -0.763 . . . . 75.31 110.346 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 34.8 p90 -173.98 -172.05 0.69 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.474 1.11 . . . . 72.44 109.3 171.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -80.15 117.61 68.38 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.101 0.561 . . . . 75.32 111.099 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.525 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 19.3 Cg_endo -64.73 147.4 89.77 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 121.74 1.627 . . . . 74.11 110.496 173.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.18 102.68 0.86 Allowed 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.728 -0.841 . . . . 73.11 108.728 174.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.68 HG11 HD11 ' B' ' 126' ' ' LEU . 41.8 t -99.86 145.86 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.213 -0.903 . . . . 54.21 109.875 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -140.06 127.35 21.23 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.69 1.196 . . . . 73.33 107.853 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.541 HD13 HD22 ' B' ' 128' ' ' LEU . 25.6 tp -86.4 145.29 26.92 Favored 'General case' 0 C--O 1.244 0.811 0 O-C-N 123.81 0.694 . . . . 73.0 109.211 173.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.558 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 11.4 t70 -143.95 150.07 37.76 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.992 -1.114 . . . . 61.0 107.992 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.4 HD11 HG11 ' B' ' 131' ' ' VAL . 72.5 mt -126.9 139.89 52.74 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.635 0.774 . . . . 61.21 109.458 -175.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 29.5 t70 -132.11 151.15 51.93 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.07 0.948 . . . . 60.12 109.072 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.7 m -124.61 111.97 16.26 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.151 0.58 . . . . 71.24 110.574 -166.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.477 ' HA ' ' CE1' ' F' ' 106' ' ' TYR . . . -146.63 117.48 7.66 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 109.379 -0.6 . . . . 72.12 109.379 174.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 48.1 p -143.89 170.87 15.08 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.063 0.545 . . . . 60.4 110.08 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 64.8 p -152.04 142.55 22.66 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.422 0.289 . . . . 54.12 111.62 -173.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -96.86 94.33 7.18 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.984 -0.747 . . . . 71.3 108.984 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 pp -110.13 24.43 13.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.008 0.523 . . . . 64.44 110.611 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.469 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -164.87 172.04 13.38 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 123.717 0.807 . . . . 41.21 111.153 172.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -97.15 124.73 41.28 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 107.922 -1.14 . . . . 40.23 107.922 172.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 66.02 4.72 3.16 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 124.362 1.065 . . . . 75.4 112.917 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 44.9 t -133.73 126.47 51.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.447 0 N-CA-C 107.041 -1.466 . . . . 55.51 107.041 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -132.7 141.19 48.46 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.794 -0.447 . . . . 74.31 109.794 -168.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -106.03 105.84 16.07 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.75 -1.204 . . . . 73.02 107.75 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 38.1 t -100.54 129.53 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.431 1.093 . . . . 53.54 109.54 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 t -118.26 114.59 45.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.629 -0.878 . . . . 70.15 108.629 173.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -100.71 108.58 20.48 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.72 -1.215 . . . . 71.34 107.72 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.417 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 31.5 ttm180 -85.98 119.7 26.57 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.288 -1.004 . . . . 70.11 108.288 173.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 31.4 t -105.18 123.94 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.92 -1.141 . . . . 75.32 107.92 175.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.558 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 45.2 m -111.02 136.78 49.51 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.89 -0.781 . . . . 73.43 108.89 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.677 HG11 HD21 ' B' ' 126' ' ' LEU . 59.4 t -129.44 114.87 32.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 124.054 0.942 . . . . 75.45 108.58 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 32.7 m -100.89 135.36 42.47 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.521 -0.918 . . . . 74.53 108.521 170.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.36 141.93 30.04 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.21 -0.663 . . . . 55.13 109.21 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.536 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 55.2 p -142.52 127.8 18.75 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 123.921 0.763 . . . . 63.23 111.324 -175.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 17.5 mt -92.93 111.79 23.52 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.056 0.943 . . . . 74.52 108.61 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.75 -123.51 19.22 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 124.054 0.846 . . . . 63.0 112.214 -175.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -97.41 3.23 51.0 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.311 0.644 . . . . 74.32 112.241 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -128.72 158.36 38.82 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.519 0.728 . . . . 72.21 110.063 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 41.8 m -70.02 135.33 49.21 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.03 0.532 . . . . 63.01 111.041 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.543 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -87.03 -62.26 1.54 Allowed 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.78 -1.192 . . . . 73.41 107.78 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -152.23 157.04 40.88 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.161 -1.382 . . . . 73.22 110.166 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 85.5 mt -127.73 110.48 12.68 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.216 -1.772 . . . . 61.21 106.216 173.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.469 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 36.7 t -119.98 137.41 54.09 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.686 -0.857 . . . . 61.22 108.686 -177.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -153.96 136.58 15.17 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.819 -0.808 . . . . 74.12 108.819 -173.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.421 HG21 ' HB3' ' B' ' 113' ' ' CYS . 91.1 t -133.6 148.31 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.291 -1.003 . . . . 72.51 108.291 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -121.42 100.52 7.07 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 108.186 -1.042 . . . . 73.42 108.186 172.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.432 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 8.0 tp-100 -93.29 104.18 16.37 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.53 -0.915 . . . . 72.42 108.53 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.552 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -93.43 163.56 26.36 Favored Glycine 0 C--O 1.24 0.49 0 CA-C-N 115.496 -0.775 . . . . 52.32 111.681 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.13 132.67 2.67 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.617 -0.325 . . . . 74.1 112.555 -176.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 45.0 mt -91.82 123.01 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 N-CA-C 107.745 -1.205 . . . . 64.34 107.745 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -129.82 135.56 48.55 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.736 0.814 . . . . 75.34 109.935 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 58.7 m -100.42 128.25 46.53 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.76 0.824 . . . . 35.12 109.71 174.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.447 ' HB ' HD11 ' B' ' 89' ' ' ILE . 1.4 pp -140.77 135.31 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 124.582 1.153 . . . . 73.34 111.029 -173.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.13 168.0 26.7 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.203 1.001 . . . . 70.24 109.557 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 91.36 -36.05 3.75 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 116.242 -0.435 . . . . 74.34 112.874 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.599 ' HB ' ' HA ' ' B' ' 94' ' ' MET . 9.0 pt -66.67 149.46 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.275 1.43 . . . . 74.24 111.81 175.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -147.45 162.02 39.88 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 124.351 1.06 . . . . 71.53 110.114 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.49 -136.04 27.66 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-N 114.432 -1.258 . . . . 72.41 113.985 175.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.9 m -66.04 -48.54 70.74 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.78 0.832 . . . . 61.3 109.759 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.469 ' HG3' ' NE2' ' B' ' 143' ' ' GLN . 10.2 tt0 -60.25 -25.6 65.81 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 113.882 -1.508 . . . . 73.3 112.059 -171.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.599 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 2.0 tmt? -59.78 -69.97 0.19 Allowed 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.349 1.06 . . . . 65.42 112.163 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.442 ' HB2' ' SD ' ' B' ' 94' ' ' MET . . . -80.38 -13.57 59.04 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 122.374 0.27 . . . . 61.14 111.584 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.89 -44.74 78.49 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.21 0.604 . . . . 70.03 109.591 167.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 44.4 t -57.46 -29.09 63.93 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.814 0.845 . . . . 53.55 111.965 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 71.6 mt -72.1 -40.06 68.45 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.991 0.916 . . . . 73.2 111.494 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 99' ' ' GLY . . . . . 0.555 ' HA3' ' NE2' ' F' ' 108' ' ' HIS . . . -101.39 4.08 54.48 Favored Glycine 0 C--N 1.341 0.812 0 CA-C-N 116.068 -0.515 . . . . 74.33 113.768 -176.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.551 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -126.3 -65.4 0.98 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.385 0.674 . . . . 40.44 111.218 -176.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -74.52 -45.13 47.78 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.955 -0.566 . . . . 74.33 111.354 -172.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.448 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 79.2 m -62.66 -47.46 87.94 Favored Pre-proline 0 CA--C 1.57 1.729 0 CA-C-O 118.519 -0.753 . . . . 74.43 112.228 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.448 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 76.1 Cg_exo -57.21 -33.37 95.84 Favored 'Trans proline' 0 C--N 1.398 3.172 0 C-N-CA 122.935 2.423 . . . . 72.32 113.705 171.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -67.47 -31.01 70.87 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.225 0.61 . . . . 72.13 111.243 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.0 mt -71.62 -40.18 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.596 0.758 . . . . 71.32 110.036 173.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 83.9 mt -77.46 -30.46 53.25 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.318 -0.855 . . . . 63.11 112.023 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -58.11 -44.67 99.48 Favored Pre-proline 0 CA--C 1.561 1.374 0 C-N-CA 124.394 1.078 . . . . 74.35 113.333 -172.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -50.21 -46.73 27.2 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 122.863 2.375 . . . . 52.24 114.491 173.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -65.78 -40.73 92.28 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.202 0.601 . . . . 52.32 110.796 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.432 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -66.07 -40.65 91.06 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.159 -0.928 . . . . 70.12 111.139 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -61.22 -51.54 68.54 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.117 1.367 . . . . 73.34 110.231 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.55 ' HG3' HH12 ' A' ' 120' ' ' ARG . 9.2 tp10 -61.8 -39.0 90.18 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.249 1.02 . . . . 72.11 110.396 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.521 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.1 t -68.72 -32.87 72.97 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.067 0.147 . . . . 55.41 110.764 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.469 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 50.9 mt -66.81 -53.02 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.832 0.853 . . . . 74.44 110.025 173.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.483 HG21 ' OG ' ' C' ' 119' ' ' SER . 15.3 m -59.31 -30.91 68.69 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.794 0.684 . . . . 41.33 111.027 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.497 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.1 t -64.31 -50.19 68.8 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.068 0.947 . . . . 74.2 110.174 175.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.547 ' SD ' HG21 ' A' ' 21' ' ' ILE . 33.5 mmt -62.9 -40.34 97.26 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.933 0.493 . . . . 72.24 110.889 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.41 HG23 ' O ' ' B' ' 114' ' ' ILE . 88.0 t -65.17 -39.67 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.728 1.211 . . . . 62.12 110.786 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 36.1 t -65.89 -36.19 82.73 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.156 -0.929 . . . . 70.22 111.032 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.497 ' HG3' ' O ' ' B' ' 116' ' ' SER . 71.3 mtt-85 -70.46 -37.86 74.37 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 115.646 -0.706 . . . . 72.51 109.945 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.77 -13.65 69.22 Favored Glycine 0 C--N 1.357 1.737 0 O-C-N 123.651 0.594 . . . . 73.44 112.765 171.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 13.4 m 67.35 32.26 5.98 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.644 1.578 . . . . 72.21 110.218 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -81.06 167.95 28.48 Favored Pre-proline 0 CA--C 1.558 1.252 0 CA-C-N 114.631 -1.168 . . . . 72.13 110.0 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -60.18 168.78 5.7 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 122.792 2.328 . . . . 70.51 113.519 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.605 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 59.9 tp60 -64.8 112.63 3.33 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 114.895 -1.048 . . . . 72.14 110.666 -174.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.68 HD11 HG11 ' B' ' 40' ' ' VAL . 23.5 tp -111.23 111.33 22.32 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 123.689 0.618 . . . . 74.42 109.353 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -123.47 134.08 53.96 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 107.895 -1.15 . . . . 72.11 107.895 170.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.541 HD22 HD13 ' B' ' 42' ' ' LEU . 74.7 mt -85.86 149.26 25.36 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 122.656 0.383 . . . . 74.51 111.251 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -67.02 138.38 94.98 Favored Pre-proline 0 CA--C 1.55 0.954 0 O-C-N 124.447 1.092 . . . . 54.01 110.343 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' B' ' 129' ' ' ALA . 11.5 Cg_exo -68.19 99.37 0.58 Allowed 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.774 2.316 . . . . 72.3 111.122 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.4 HG11 HD11 ' B' ' 44' ' ' LEU . 60.8 t -89.2 110.54 21.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.188 -1.042 . . . . 65.03 108.188 176.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -89.27 94.22 9.83 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 108.389 -0.967 . . . . 75.25 108.389 174.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -60.34 -22.73 63.59 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.292 -1.322 . . . . 73.02 111.661 -175.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.551 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 13.5 m-20 -58.22 -62.61 1.71 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.073 0.549 . . . . 71.2 110.733 172.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.28 -31.31 65.48 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 123.992 0.808 . . . . 55.44 111.661 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.626 ' HG ' ' HB3' ' F' ' 120' ' ' TYR . 7.3 tt -58.33 -55.61 32.71 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.349 1.06 . . . . 72.3 110.317 178.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -83.03 -15.33 51.51 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.328 0.651 . . . . 73.31 111.961 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 62.7 mtt -78.3 -31.56 48.93 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.327 0.651 . . . . 60.14 110.872 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -78.42 -34.1 48.21 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 110.034 -0.358 . . . . 71.23 110.034 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -74.05 -40.93 62.5 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.452 -0.794 . . . . 70.52 110.448 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.428 HD11 ' HE2' ' F' ' 109' ' ' TYR . 4.2 mm? -100.46 7.24 44.3 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.884 0.874 . . . . 72.24 112.222 -178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 59.04 27.09 15.91 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.737 0.815 . . . . 74.23 112.163 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 143' ' ' GLN . . . . . 0.469 ' NE2' ' HG3' ' B' ' 93' ' ' GLN . 30.5 tt0 -87.49 57.75 4.58 Favored 'General case' 0 CA--C 1.554 1.129 0 CA-C-O 122.162 0.982 . . . . 62.31 108.754 176.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -84.86 151.77 24.06 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.575 -0.703 . . . . 71.44 110.521 -174.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.82 165.87 16.61 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 124.04 0.936 . . . . 62.44 111.582 175.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -126.91 -79.26 0.29 Allowed Glycine 0 C--N 1.342 0.862 0 N-CA-C 111.646 -0.581 . . . . 73.15 111.646 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 62.88 -79.87 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.61 1.164 . . . . 73.13 110.962 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 98.69 -141.11 15.39 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 111.573 -0.611 . . . . 74.03 111.573 -176.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' THR . . . . . 0.52 HG21 ' HG3' ' D' ' 90' ' ' GLU . 75.6 m -153.45 135.71 14.91 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.55 0.74 . . . . 73.22 109.273 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.67 115.36 20.89 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.944 -0.762 . . . . 74.31 108.944 169.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.35 83.19 8.04 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 106.642 -1.614 . . . . 72.22 106.642 173.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -148.93 -40.0 0.15 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.382 -0.826 . . . . 74.21 110.061 -171.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' GLN . . . . . 0.423 ' HB3' ' HA2' ' D' ' 91' ' ' GLY . 23.6 tm0? -63.98 119.07 9.39 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 109.574 -0.528 . . . . 74.22 109.574 174.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -113.26 -57.62 2.26 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.534 -0.913 . . . . 70.32 108.534 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 C-N-CA 123.787 0.835 . . . . 54.53 109.015 175.416 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 90.0 mmm . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.213 -0.662 . . . . 71.05 109.213 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 78.5 p -152.39 149.76 28.95 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.197 0.522 . . . . 63.51 110.949 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -136.11 111.39 9.07 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.723 1.209 . . . . 74.55 107.919 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -73.55 100.75 3.38 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.661 0.384 . . . . 62.33 110.189 -174.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -162.04 92.57 0.85 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.217 0.607 . . . . 72.21 110.078 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -179.64 150.92 0.43 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.635 0.774 . . . . 71.14 111.087 173.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 30.8 p -87.07 -53.32 4.94 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.293 1.037 . . . . 75.43 111.439 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -145.39 134.21 22.38 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.833 0.453 . . . . 61.24 110.946 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 21.1 ttt 45.21 109.46 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 126.678 1.991 . . . . 70.22 114.519 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.641 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 53.1 m -93.11 120.48 33.45 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.643 -0.873 . . . . 73.31 108.643 169.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.613 ' HD2' ' HG2' ' A' ' 130' ' ' PRO . 37.1 t80 -127.71 124.25 37.39 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.212 -1.033 . . . . 71.13 108.212 161.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -150.73 121.05 7.31 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.431 -0.951 . . . . 75.3 108.431 177.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.422 ' CD1' HG21 ' C' ' 105' ' ' ILE . 30.2 mt -67.79 127.6 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 123.963 0.789 . . . . 72.13 108.905 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.426 HE22 ' HD2' ' E' ' 136' ' ' LYS . 11.9 mm100 -93.69 -37.75 11.67 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 123.506 0.504 . . . . 74.43 109.902 177.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 178.45 155.54 0.41 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.038 1.335 . . . . 72.33 109.134 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.434 ' HA ' ' HA2' ' C' ' 82' ' ' GLY . 2.8 pp -127.5 152.97 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 107.656 -1.239 . . . . 73.3 107.656 171.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.536 ' HE1' HG12 ' C' ' 83' ' ' ILE . 31.4 p90 -170.36 144.74 2.56 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 110.135 -0.32 . . . . 62.24 110.135 -174.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 66.2 p -73.08 111.77 8.5 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.976 0.51 . . . . 73.45 109.899 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.716 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 11.2 mmmm -66.91 -37.06 83.65 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.899 -0.778 . . . . 65.15 108.899 170.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.6 t70 -148.33 145.42 28.12 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.4 -1.273 . . . . 73.24 110.192 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.533 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.1 mt -136.89 144.15 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.722 1.609 . . . . 75.5 106.785 172.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.4 t -155.6 148.66 24.53 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.994 0.426 . . . . 55.51 110.337 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -151.4 127.72 10.61 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 107.255 -1.387 . . . . 63.01 107.255 173.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -135.49 112.24 10.12 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.065 0.546 . . . . 71.03 110.08 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.61 82.69 20.26 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 106.753 -1.573 . . . . 72.21 106.753 161.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.87 -25.94 32.43 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 122.626 2.217 . . . . 53.41 111.601 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -96.03 23.99 5.97 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.657 1.183 . . . . 72.22 109.618 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.2 -58.4 4.99 Favored Pre-proline 0 C--N 1.374 1.634 0 C-N-CA 124.999 1.32 . . . . 65.55 114.539 -163.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -61.57 -42.64 31.74 Favored 'Trans proline' 0 C--N 1.386 2.532 0 CA-C-N 121.362 1.522 . . . . 71.2 111.856 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -69.92 -34.39 73.41 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 114.89 -1.05 . . . . 75.25 112.541 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.553 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.9 p -79.98 -27.67 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.189 0.441 . . . . 74.15 112.189 -175.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -67.88 -34.06 75.93 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.011 0.434 . . . . 72.52 111.197 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -87.31 6.71 32.12 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.852 0.861 . . . . 73.02 111.743 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -85.99 154.93 21.1 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.579 0.752 . . . . 74.54 111.199 -175.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -60.8 115.85 3.99 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.286 1.034 . . . . 61.12 109.929 172.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -84.36 82.79 8.23 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.984 0.914 . . . . 73.43 110.787 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -133.82 78.91 59.52 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 107.398 -1.334 . . . . 44.42 107.398 168.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -92.7 135.24 1.3 Allowed 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 123.243 2.629 . . . . 70.21 113.351 -175.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 39' ' ' GLU . . . . . 0.405 ' HB3' ' HE3' ' C' ' 41' ' ' LYS . 4.4 mp0 -85.64 96.89 9.82 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.981 -1.489 . . . . 72.32 106.981 169.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' C' ' 65' ' ' THR . 94.3 t -90.48 106.38 17.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 115.71 -0.677 . . . . 74.12 110.316 -175.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' C' ' 39' ' ' GLU . 0.2 OUTLIER -95.08 105.04 16.93 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.172 -1.047 . . . . 62.42 108.172 173.039 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.501 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.5 pt? -86.47 124.11 32.43 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 107.344 -1.354 . . . . 72.12 107.344 171.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.426 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 21.5 t70 -118.01 140.84 49.16 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.846 -0.798 . . . . 73.2 108.846 -176.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.643 HD11 HG11 ' C' ' 131' ' ' VAL . 51.2 mt -127.38 113.32 16.08 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.02 0.928 . . . . 74.01 109.489 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -122.48 121.3 36.24 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.266 -1.383 . . . . 64.21 107.266 174.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 6.5 t -117.17 137.03 52.6 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.058 0.456 . . . . 72.2 111.013 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.99 157.87 25.06 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.146 0.978 . . . . 71.22 108.769 175.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 60.2 p -158.58 146.35 18.07 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.14 0.576 . . . . 54.01 109.978 177.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.1 p -156.07 160.29 39.85 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.012 0.925 . . . . 72.33 109.214 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -99.59 120.08 39.1 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.569 -0.901 . . . . 65.44 108.569 172.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' C' ' 57' ' ' GLU . 33.6 mt -84.42 -50.8 7.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.645 0.778 . . . . 70.41 109.809 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.58 -168.25 2.86 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.845 -1.071 . . . . 71.22 109.73 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.66 118.56 9.73 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.886 -0.597 . . . . 60.32 109.904 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 68.06 -4.91 0.94 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.995 1.318 . . . . 65.21 112.109 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.0 t -99.58 116.82 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 123.741 0.816 . . . . 73.43 109.199 -174.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -124.36 129.49 50.81 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.836 1.254 . . . . 72.22 108.7 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.577 ' HB2' HD11 ' C' ' 51' ' ' LEU . 42.0 tt0 -89.72 137.1 32.62 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 108.522 -0.918 . . . . 61.4 108.522 167.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 82.2 t -123.85 140.85 46.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 108.08 -1.082 . . . . 64.41 108.08 167.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.467 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 85.3 t -122.03 146.41 27.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 108.759 -0.83 . . . . 63.55 108.759 172.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.58 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -128.76 99.8 5.47 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.91 -1.515 . . . . 73.11 106.91 177.078 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 33.3 ttm-85 -80.85 105.54 12.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.799 -1.091 . . . . 71.43 108.322 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 26.1 t -106.08 121.16 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 108.432 -0.951 . . . . 71.55 108.432 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 14.2 m -120.15 110.46 16.65 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.678 -0.86 . . . . 61.02 108.678 -174.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.549 HG21 HG21 ' C' ' 114' ' ' ILE . 47.6 t -98.16 109.5 23.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.95 -0.759 . . . . 54.23 108.95 177.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' C' ' 40' ' ' VAL . 32.1 m -96.5 131.73 42.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.596 -1.261 . . . . 73.15 107.596 171.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.54 118.23 19.85 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.344 -1.724 . . . . 71.23 106.344 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 29.9 m -133.25 125.74 29.99 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.089 0.243 . . . . 44.45 110.838 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 16.5 mt -87.45 49.3 1.79 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.395 1.478 . . . . 64.24 109.723 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.82 -115.35 5.16 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 110.533 -1.027 . . . . 42.53 110.533 -170.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -90.22 -28.37 18.9 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.796 0.838 . . . . 71.14 110.124 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -63.68 122.09 15.52 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.804 1.242 . . . . 63.52 109.491 171.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.2 m -77.78 122.87 25.99 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.726 -0.842 . . . . 73.32 108.726 168.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.553 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -65.72 -59.39 3.96 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.307 -0.997 . . . . 62.33 108.307 171.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -165.39 164.37 19.69 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.908 -1.042 . . . . 63.32 110.658 174.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.424 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.7 tm? -120.51 141.01 50.62 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 106.354 -1.721 . . . . 61.22 106.354 166.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.436 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.6 t -146.95 110.06 4.76 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.79 -0.819 . . . . 74.13 108.79 177.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -117.44 119.74 36.01 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.08 -0.711 . . . . 75.43 109.08 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 55.1 t -117.08 114.17 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.78 -0.822 . . . . 73.41 108.78 173.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.409 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 78.2 mt-30 -90.06 87.22 6.81 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.185 -1.043 . . . . 74.3 108.185 173.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -78.42 104.48 9.05 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 115.693 -0.685 . . . . 44.2 109.325 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -83.48 179.3 52.53 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-N 116.613 -0.267 . . . . 43.25 112.717 172.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' C' ' 16' ' ' ILE . . . -178.73 136.81 3.01 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-O 119.945 -0.364 . . . . 61.44 112.719 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.536 HG12 ' HE1' ' C' ' 17' ' ' TYR . 36.6 mm -96.34 133.46 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 108.829 -0.804 . . . . 64.1 108.829 174.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -135.33 131.99 37.12 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.854 0.861 . . . . 62.42 110.308 -176.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 24.6 p -85.27 99.59 11.22 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.094 -1.076 . . . . 74.53 108.094 166.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.668 HG21 ' HE1' ' C' ' 94' ' ' MET . 11.7 mt -114.57 140.41 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.138 -1.06 . . . . 74.34 108.138 177.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.641 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -157.42 162.62 38.99 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 122.415 0.286 . . . . 74.05 111.245 -174.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.26 -35.88 3.5 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 115.917 -0.583 . . . . 31.44 113.279 172.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' C' ' 94' ' ' MET . 36.1 pt -88.04 165.23 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.713 0.805 . . . . 73.3 112.059 -175.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -162.24 151.73 15.94 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.941 0.896 . . . . 63.24 109.874 -177.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.98 -119.39 9.64 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 115.344 -0.844 . . . . 61.51 112.794 172.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 68.9 p -62.15 -38.16 87.95 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.004 0.922 . . . . 74.51 111.307 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.41 ' HG2' ' HB1' ' C' ' 145' ' ' ALA . 77.3 mt-30 -65.22 -52.75 52.7 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.829 0.852 . . . . 63.32 111.22 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.668 ' HE1' HG21 ' C' ' 86' ' ' ILE . 6.1 tpt -53.03 -52.9 56.95 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 124.074 0.859 . . . . 73.02 111.722 176.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.55 -35.4 80.73 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.186 0.595 . . . . 71.43 112.15 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -68.13 -35.48 78.17 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.437 0.695 . . . . 73.05 110.708 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -71.82 -37.17 70.38 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.495 -0.775 . . . . 53.35 110.433 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 83.8 mt -83.59 -33.7 25.31 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.999 0.92 . . . . 44.02 112.431 -175.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -113.14 11.09 24.54 Favored Glycine 0 N--CA 1.472 1.082 0 O-C-N 123.333 0.396 . . . . 40.43 113.803 -169.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.65 -54.29 0.19 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.77 0.428 . . . . 70.44 111.257 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -75.2 -47.73 26.87 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 112.479 0.548 . . . . 71.44 112.479 -172.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.491 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 91.5 m -64.43 -49.32 72.26 Favored Pre-proline 0 CA--C 1.561 1.367 0 C-N-CA 123.499 0.72 . . . . 72.52 110.886 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.58 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 51.2 Cg_exo -57.83 -28.21 81.44 Favored 'Trans proline' 0 C--N 1.396 3.074 0 C-N-CA 122.639 2.226 . . . . 72.11 113.633 174.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -66.06 -34.88 79.08 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.189 0.596 . . . . 71.34 110.916 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.558 HD12 ' NH1' ' A' ' 111' ' ' ARG . 35.7 mm -80.75 -29.98 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 122.556 0.343 . . . . 72.11 110.089 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 mp -75.34 -25.89 58.14 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.715 0.806 . . . . 63.4 111.496 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -58.97 -51.23 83.36 Favored Pre-proline 0 C--O 1.206 -1.225 0 CA-C-O 117.476 -1.25 . . . . 75.32 112.492 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 108' ' ' PRO . . . . . 0.571 ' HB3' ' HB2' ' A' ' 112' ' ' GLU . 65.3 Cg_exo -47.71 -44.47 26.29 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.774 2.316 . . . . 71.1 114.817 176.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -74.2 -40.49 62.44 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.095 0.558 . . . . 74.11 111.606 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.28 -42.35 93.28 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.268 0.627 . . . . 61.45 110.153 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 111' ' ' ARG . . . . . 0.616 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 31.6 ttt-85 -59.89 -52.16 66.6 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.029 1.732 . . . . 72.41 110.447 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.06 -37.7 88.4 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.234 0.959 . . . . 65.22 109.967 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 38.4 t -68.78 -35.66 77.33 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.476 0.485 . . . . 60.31 111.444 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.549 HG21 HG21 ' C' ' 64' ' ' VAL . 90.9 mt -68.65 -49.58 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.283 0.633 . . . . 73.13 110.203 174.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.6 m -66.36 -28.14 68.42 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.21 0.604 . . . . 75.33 110.991 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.426 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 46.2 t -66.45 -43.05 86.64 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.071 0.949 . . . . 54.12 109.041 172.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.564 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -67.76 -34.39 76.71 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.134 0.974 . . . . 72.24 112.089 177.527 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.48 HG23 ' O ' ' C' ' 114' ' ' ILE . 88.2 t -62.6 -43.96 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.619 0.767 . . . . 72.12 108.997 172.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.483 ' OG ' HG21 ' B' ' 115' ' ' THR . 29.4 t -63.88 -39.55 94.45 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.606 -1.179 . . . . 55.33 111.786 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.519 HH12 ' HG2' ' D' ' 112' ' ' GLU . 67.0 mtt-85 -69.95 -38.31 76.09 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.578 0.751 . . . . 72.34 109.942 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.6 -1.04 88.69 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 115.426 -0.806 . . . . 63.25 112.788 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.498 HG21 ' O ' ' D' ' 16' ' ' ILE . 31.5 p 61.72 30.49 18.46 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.43 1.892 . . . . 74.14 113.587 171.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.47 ' HB2' HG13 ' C' ' 118' ' ' VAL . 93.7 m-85 -85.66 151.31 55.35 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 107.871 -1.159 . . . . 64.1 107.871 166.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.605 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 24.5 Cg_endo -63.06 157.94 46.38 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 122.354 2.036 . . . . 64.04 112.721 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 -53.06 112.71 0.91 Allowed 'General case' 0 N--CA 1.477 0.908 0 O-C-N 124.585 1.178 . . . . 75.15 112.891 -172.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.59 HD12 ' HA ' ' F' ' 133' ' ' THR . 61.0 tp -109.61 87.8 2.59 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 113.924 -1.489 . . . . 74.53 107.512 174.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -92.93 99.91 12.46 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.899 -0.778 . . . . 74.24 108.899 -174.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.616 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 4.0 mm? -56.47 125.05 20.33 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.943 0.897 . . . . 75.33 111.274 -175.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.72 152.4 95.2 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 124.212 1.005 . . . . 74.31 111.4 -175.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.452 ' HG2' HG21 ' A' ' 13' ' ' ILE . 51.2 Cg_exo -54.72 108.26 0.28 Allowed 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.979 2.453 . . . . 74.41 112.926 175.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.643 HG11 HD11 ' C' ' 44' ' ' LEU . 6.8 p -101.0 135.55 36.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.599 0.76 . . . . 75.02 109.446 175.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -97.36 101.25 12.76 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.632 0.773 . . . . 72.22 109.359 -174.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.451 ' CE1' HD13 ' C' ' 44' ' ' LEU . 66.4 m-85 -68.98 -33.79 74.25 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.63 0.772 . . . . 73.51 111.462 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -59.15 -43.41 92.05 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.92 0.888 . . . . 62.21 109.435 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.88 -41.34 95.81 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 114.691 -1.141 . . . . 54.44 111.805 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 76.4 mt -65.91 -36.05 82.32 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.308 0.643 . . . . 64.32 110.831 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -74.1 -26.57 60.43 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 115.124 -0.944 . . . . 73.5 109.955 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 28.1 ttt -75.9 -37.05 59.22 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.1 0.96 . . . . 74.23 110.705 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -66.01 -36.61 83.74 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.197 0.599 . . . . 72.41 109.934 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -52.72 -85.92 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.038 0 O-C-N 124.758 1.286 . . . . 55.12 111.234 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 39.5 tp 174.72 -37.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.402 0.681 . . . . 60.3 111.02 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -83.4 -6.27 59.41 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 115.556 -0.747 . . . . 74.14 112.837 -162.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.69 101.83 5.16 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 108.891 -0.781 . . . . 62.51 108.891 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -147.81 34.15 0.84 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.049 0.94 . . . . 72.23 108.744 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 145' ' ' ALA . . . . . 0.41 ' HB1' ' HG2' ' C' ' 93' ' ' GLN . . . -152.22 117.61 5.29 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.137 0.575 . . . . 53.14 110.815 -172.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 165.98 52.77 0.02 OUTLIER Glycine 0 C--N 1.346 1.087 0 N-CA-C 111.642 -0.583 . . . . 22.12 111.642 176.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -111.09 171.01 7.72 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.827 0.851 . . . . 74.23 110.834 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 78.08 -146.93 31.24 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.701 -0.681 . . . . 64.22 112.104 -176.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 15.3 t -168.39 172.84 8.06 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.509 0.724 . . . . 70.45 110.097 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -64.44 142.03 58.57 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.195 0.998 . . . . 63.15 110.324 172.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.59 134.67 49.37 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 108.875 -0.787 . . . . 53.03 108.875 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -165.3 170.58 14.54 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.26 1.024 . . . . 71.21 109.861 -172.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -149.73 -36.43 0.16 Allowed 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 111.848 0.314 . . . . 75.22 111.848 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -70.74 -60.82 2.03 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.099 0.56 . . . . 75.53 109.776 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.91 0 N-CA-C 108.092 -1.077 . . . . 55.34 108.092 177.481 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 60.0 mtm . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 121.497 0.665 . . . . 75.22 109.217 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 33.9 t -88.92 141.78 28.21 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.365 0.666 . . . . 54.22 109.95 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -64.67 -57.35 9.28 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 124.022 0.826 . . . . 54.42 110.961 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -100.29 73.4 1.68 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.159 0.584 . . . . 65.53 109.924 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -156.98 150.91 24.74 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.162 -1.051 . . . . 70.24 108.162 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -73.42 83.56 1.46 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.105 -0.702 . . . . 73.44 109.105 177.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 14.9 t -162.63 173.86 13.35 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 124.522 1.129 . . . . 63.52 108.888 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' D' ' 9' ' ' MET . 5.6 tp10 66.57 -153.51 0.23 Allowed 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.261 1.024 . . . . 73.42 109.613 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.491 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 24.0 ttt -31.76 127.75 0.21 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.55 1.54 . . . . 75.4 115.043 176.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 4.6 t -112.04 138.54 48.55 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.946 0.898 . . . . 55.24 108.721 169.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.429 ' HD2' HG22 ' D' ' 86' ' ' ILE . 70.8 t80 -133.75 106.06 7.14 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.085 -1.45 . . . . 71.02 107.085 174.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -124.81 127.15 46.74 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.241 -1.022 . . . . 73.12 108.241 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.6 HG21 HD11 ' D' ' 16' ' ' ILE . 26.9 mt -77.09 116.51 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 109.296 -0.631 . . . . 65.03 109.296 178.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -84.07 -43.92 14.59 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.281 0.632 . . . . 75.0 110.385 -173.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -170.71 142.71 2.03 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.947 0.499 . . . . 72.42 110.362 -176.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.6 HD11 HG21 ' D' ' 13' ' ' ILE . 3.0 mp -115.07 148.48 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 106.872 -1.529 . . . . 72.14 106.872 172.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -169.59 168.33 9.26 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-O 121.54 0.686 . . . . 74.25 111.643 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.6 p -105.09 121.16 43.21 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 114.929 -1.032 . . . . 71.44 109.078 171.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -86.25 -25.28 25.64 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.42 0.688 . . . . 74.23 109.238 176.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.4 t70 -156.74 137.38 13.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.63 -1.168 . . . . 62.42 109.973 -175.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.564 HG21 ' HE2' ' C' ' 117' ' ' MET . 74.1 mt -140.14 141.4 33.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.218 1.407 . . . . 64.44 107.471 173.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.9 t -146.71 143.63 28.86 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.91 0.884 . . . . 54.11 109.116 173.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.533 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 84.5 t80 -146.99 133.64 19.91 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 106.581 -1.637 . . . . 70.04 106.581 172.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 48.0 mt-10 -135.27 141.77 45.79 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.96 0.904 . . . . 65.15 109.382 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.49 77.97 16.77 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 107.796 -1.187 . . . . 63.32 107.796 176.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.69 -19.42 21.31 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.666 2.244 . . . . 63.52 113.195 -173.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -108.45 -0.65 20.4 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.865 0.866 . . . . 71.5 110.707 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.716 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -19.51 -71.7 0.03 OUTLIER Pre-proline 0 CA--C 1.571 1.757 0 N-CA-C 116.908 2.188 . . . . 55.24 116.908 -165.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.431 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 81.4 Cg_endo -74.76 -25.1 12.71 Favored 'Trans proline' 0 C--N 1.385 2.458 0 CA-C-N 124.454 2.626 . . . . 74.44 113.84 -176.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -69.67 -39.68 76.89 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 124.419 1.087 . . . . 75.55 110.07 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.8 p -82.71 -22.53 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 CA-C-N 115.666 -0.697 . . . . 62.24 111.426 -175.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.431 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 22.1 m-85 -64.25 -26.39 68.48 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 122.265 0.226 . . . . 72.5 111.221 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -65.45 -7.08 12.39 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.834 1.253 . . . . 72.43 111.844 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.506 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 91.6 mttt -95.71 103.86 15.76 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.152 1.381 . . . . 63.31 110.095 175.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -95.36 76.32 3.38 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.581 0.752 . . . . 55.21 110.312 -175.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 44.2 p90 -156.75 -177.78 6.86 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.8 -0.815 . . . . 75.15 108.8 168.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.407 ' OE1' ' HB3' ' E' ' 127' ' ' SER . 29.6 tp60 -65.08 117.65 41.64 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.532 1.133 . . . . 73.32 110.91 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.438 ' O ' HG23 ' D' ' 40' ' ' VAL . 74.9 Cg_exo -55.49 112.88 1.18 Allowed 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 121.807 1.672 . . . . 75.02 109.457 165.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -70.95 107.41 4.05 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.055 -1.091 . . . . 73.02 108.055 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.656 HG13 HG13 ' D' ' 64' ' ' VAL . 96.0 t -102.45 131.4 50.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 115.122 -0.945 . . . . 43.35 109.913 -170.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -119.45 125.13 48.18 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.715 -1.217 . . . . 74.12 107.715 170.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.555 HD11 HG13 ' D' ' 62' ' ' VAL . 51.9 tp -96.18 141.48 29.5 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.852 -0.795 . . . . 62.45 108.852 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.58 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 35.1 t70 -134.71 113.28 11.51 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.026 -1.101 . . . . 71.31 108.026 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.59 HD12 HG23 ' E' ' 121' ' ' VAL . 93.7 mt -114.49 151.7 32.85 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.295 0.638 . . . . 62.53 110.696 -177.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.542 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 13.5 t0 -152.07 143.44 23.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.19 -0.914 . . . . 72.51 108.656 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 46' ' ' THR . . . . . 0.4 ' OG1' ' HB2' ' E' ' 111' ' ' LEU . 23.9 m -105.34 141.33 37.04 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.073 -0.714 . . . . 64.12 109.073 -176.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.54 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.86 162.5 41.21 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.214 1.006 . . . . 75.13 108.864 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 36.3 p -171.2 159.72 5.99 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.601 0.76 . . . . 34.51 110.011 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 84.6 p -154.43 169.03 24.72 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.336 1.054 . . . . 64.4 109.672 -175.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 99.38 149.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 127.847 2.459 . . . . 71.4 110.211 -175.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.545 HD23 ' N ' ' D' ' 52' ' ' ALA . 5.1 tt -65.6 158.05 28.23 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 107.804 -1.184 . . . . 53.05 107.804 173.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.545 ' N ' HD23 ' D' ' 51' ' ' LEU . . . -59.78 -123.68 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 124.608 1.163 . . . . 50.14 113.508 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 57.52 27.84 14.65 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.506 0.722 . . . . 64.23 111.59 -176.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 73.8 8.58 4.89 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.664 1.585 . . . . 64.43 112.505 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 t -108.82 99.37 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 108.773 -0.825 . . . . 73.4 108.773 -176.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.443 ' CE2' ' HA ' ' D' ' 52' ' ' ALA . 39.1 m-85 -133.88 129.57 36.6 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.53 -0.915 . . . . 62.11 108.53 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.604 ' HB3' HG13 ' D' ' 83' ' ' ILE . 0.0 OUTLIER -101.66 120.14 39.87 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.835 -1.172 . . . . 71.32 107.835 168.298 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.485 ' O ' ' HA2' ' D' ' 81' ' ' GLY . 79.7 t -101.02 132.9 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-N 114.472 -1.24 . . . . 55.45 109.451 -176.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 36.6 t -106.63 138.81 30.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 124.383 1.073 . . . . 73.31 108.722 178.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.561 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -120.73 118.31 29.72 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.016 -1.475 . . . . 55.11 107.016 173.842 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.542 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 55.3 ttm-85 -88.57 109.35 20.01 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.848 -1.168 . . . . 71.34 107.848 175.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.555 HG13 HD11 ' D' ' 42' ' ' LEU . 38.5 t -114.69 113.23 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.345 -0.613 . . . . 74.13 109.345 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.58 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 24.4 m -119.75 131.96 55.5 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 123.954 0.902 . . . . 71.51 108.978 -172.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.656 HG13 HG13 ' D' ' 40' ' ' VAL . 85.1 t -118.71 104.69 16.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 C-N-CA 123.294 0.638 . . . . 74.42 109.384 177.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 10.1 m -97.98 94.03 6.64 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.26 -1.385 . . . . 75.24 107.26 170.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.02 138.71 48.29 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.015 0.926 . . . . 74.23 108.679 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.546 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 61.1 m -144.55 136.03 25.53 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.346 0.658 . . . . 63.54 111.61 -172.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.509 HD12 HG22 ' D' ' 31' ' ' VAL . 32.1 mt -100.5 106.93 18.51 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.473 1.109 . . . . 71.12 109.061 174.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.17 -126.32 8.65 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-O 119.869 -0.406 . . . . 62.11 112.807 175.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.23 5.3 52.19 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.328 0.651 . . . . 65.12 112.081 -177.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 71' ' ' GLU . . . . . 0.506 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 9.3 pt-20 -133.69 164.55 26.97 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.991 0.516 . . . . 73.34 109.965 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 21.4 m -68.02 143.69 55.44 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.994 0.917 . . . . 74.13 111.766 178.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.551 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -91.75 -69.66 0.73 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.616 -1.624 . . . . 65.23 106.616 173.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -149.22 146.89 27.83 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 114.812 -1.086 . . . . 71.43 110.059 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 82.7 mt -110.36 145.97 36.59 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.015 -1.105 . . . . 75.33 108.015 174.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.454 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 46.6 t -156.49 147.03 21.6 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.469 0.308 . . . . 71.03 110.207 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -156.63 130.52 8.39 Favored 'General case' 0 C--N 1.345 0.373 0 C-N-CA 123.274 0.63 . . . . 52.31 109.724 168.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 78' ' ' VAL . . . . . 0.409 HG22 HG23 ' D' ' 21' ' ' ILE . 92.0 t -129.76 114.45 30.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 C-N-CA 124.512 1.125 . . . . 55.42 108.52 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.486 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.5 mt-30 -90.13 88.24 7.19 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.837 0.827 . . . . 72.15 109.074 173.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.7 107.2 13.31 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 113.688 -1.596 . . . . 63.43 109.912 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' D' ' 58' ' ' VAL . . . -110.85 162.22 12.58 Favored Glycine 0 N--CA 1.465 0.625 0 O-C-N 123.032 0.208 . . . . 63.34 113.397 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.09 148.9 9.15 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-O 119.366 -0.686 . . . . 52.11 112.935 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.604 HG13 ' HB3' ' D' ' 57' ' ' GLU . 3.7 mp -89.1 136.74 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.197 -1.038 . . . . 73.24 108.197 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -132.43 129.42 39.26 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.477 1.111 . . . . 73.13 108.303 176.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 30.2 p -81.53 101.89 10.24 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.043 -0.725 . . . . 74.21 109.043 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.429 HG22 ' HD2' ' D' ' 11' ' ' PHE . 2.3 pp -119.24 121.0 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 120.749 0.309 . . . . 71.21 110.757 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.16 167.93 8.49 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.481 1.112 . . . . 42.45 111.313 174.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 99.0 19.02 23.0 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 124.046 0.841 . . . . 71.34 112.626 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.609 HD13 ' HB2' ' D' ' 94' ' ' MET . 0.7 OUTLIER -140.18 162.16 24.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 C-N-CA 125.157 1.383 . . . . 72.43 109.461 177.617 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.52 ' HG3' HG21 ' B' ' 149' ' ' THR . 9.4 pt-20 -147.8 -174.05 4.45 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.404 0.682 . . . . 73.11 111.386 -173.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 91' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' B' ' 153' ' ' GLN . . . 78.7 -146.05 29.47 Favored Glycine 0 C--N 1.349 1.255 0 C-N-CA 124.047 0.832 . . . . 61.13 112.242 -172.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 68.0 p -94.32 -39.62 10.39 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.611 0.706 . . . . 42.12 111.027 174.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -65.61 -17.82 64.87 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.363 1.065 . . . . 75.34 113.591 -171.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.609 ' HB2' HD13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -57.04 -30.24 64.08 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.047 0.758 . . . . 54.44 113.047 176.517 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 95' ' ' ALA . . . . . 0.437 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -80.54 -13.97 58.63 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.486 0.714 . . . . 72.32 112.351 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -63.05 -29.83 71.12 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.072 0.549 . . . . 74.54 111.084 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 55.5 m -62.69 -28.3 69.84 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.387 0.675 . . . . 43.3 111.488 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.48 HD13 HD11 ' E' ' 102' ' ' LEU . 7.1 tt -92.41 -46.93 7.43 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.601 1.16 . . . . 51.15 110.063 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.22 -15.09 65.22 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 116.2 -0.455 . . . . 71.41 114.167 -169.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.91 -52.0 1.22 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.91 0.484 . . . . 51.14 110.685 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 101' ' ' TYR . . . . . 0.415 ' O ' HG12 ' D' ' 105' ' ' ILE . 61.8 t80 -73.74 -39.73 64.04 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 112.272 0.471 . . . . 64.53 112.272 -174.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 92.7 m -65.15 -46.97 73.13 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-O 118.542 -0.742 . . . . 72.41 111.638 177.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.561 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 84.2 Cg_exo -54.61 -33.77 80.42 Favored 'Trans proline' 0 C--N 1.393 2.907 0 C-N-CA 122.763 2.309 . . . . 75.43 113.661 167.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.27 -32.66 74.43 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.439 0.696 . . . . 72.31 110.978 177.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.415 HG12 ' O ' ' D' ' 101' ' ' TYR . 51.1 mm -74.33 -38.37 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.284 0.633 . . . . 75.31 110.244 173.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 70.6 mt -73.65 -22.9 59.83 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.521 -0.763 . . . . 63.55 111.709 -175.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -67.55 -42.01 34.18 Favored Pre-proline 0 N--CA 1.484 1.268 0 N-CA-C 113.635 0.976 . . . . 75.23 113.635 -172.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -47.15 -44.11 24.29 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.446 2.097 . . . . 73.33 113.855 167.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -79.36 -28.28 41.97 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.921 0.888 . . . . 74.41 112.252 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 110' ' ' ALA . . . . . 0.505 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -64.48 -47.4 79.11 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.733 0.777 . . . . 74.24 109.451 173.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -69.04 -34.29 74.96 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 113.723 -1.58 . . . . 72.45 110.385 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 112' ' ' GLU . . . . . 0.519 ' HG2' HH12 ' C' ' 120' ' ' ARG . 20.5 tt0 -53.42 -49.73 66.71 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.118 0.967 . . . . 64.32 110.452 175.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.428 ' O ' ' HG3' ' D' ' 117' ' ' MET . 46.1 t -67.69 -54.4 19.8 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.701 -1.136 . . . . 73.41 110.794 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.493 HG21 HG21 ' D' ' 64' ' ' VAL . 52.9 mt -60.28 -58.07 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.365 0.666 . . . . 54.42 111.855 -174.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 91.5 m -51.3 -41.15 60.3 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.102 0.876 . . . . 75.32 111.769 -175.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 47.2 t -66.09 -42.12 89.75 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 114.681 -1.145 . . . . 72.14 110.078 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 66.6 mtm -69.03 -30.53 68.91 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.057 0.543 . . . . 61.43 111.981 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.437 HG23 ' O ' ' D' ' 114' ' ' ILE . 95.7 t -62.97 -47.21 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.682 0.793 . . . . 72.34 109.198 174.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.3 p -74.25 -26.14 60.05 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.405 -0.816 . . . . 73.13 111.206 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' D' ' 116' ' ' SER . 88.6 mtt-85 -69.77 -32.85 71.58 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.464 0.705 . . . . 74.45 109.775 174.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.84 10.95 63.48 Favored Glycine 0 C--N 1.35 1.358 0 O-C-N 123.939 0.774 . . . . 40.31 112.501 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 70.3 p 54.79 27.04 8.32 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 126.095 1.758 . . . . 71.13 113.464 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -88.85 150.93 46.65 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 109.064 -0.717 . . . . 71.34 109.064 170.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.467 ' HA ' ' OG1' ' E' ' 129' ' ' THR . 97.2 Cg_exo -46.99 122.31 6.07 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.081 2.521 . . . . 54.42 113.53 171.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -45.62 123.19 4.1 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.682 1.593 . . . . 75.13 112.174 -175.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.432 ' HB3' HG21 ' D' ' 118' ' ' VAL . 20.6 tp -103.08 109.79 21.48 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.629 -0.878 . . . . 61.03 108.629 -175.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 127' ' ' ASN . . . . . 0.408 HD22 HD12 ' B' ' 16' ' ' ILE . 10.0 m120 -98.93 86.54 3.5 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 107.679 -1.23 . . . . 63.14 107.679 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 96.5 mt -54.38 115.04 1.88 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.026 0.53 . . . . 63.31 110.351 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.8 135.04 95.73 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 123.693 0.62 . . . . 73.5 110.557 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.62 121.81 10.45 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.545 2.163 . . . . 72.11 111.183 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 p -108.04 137.84 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.205 1.002 . . . . 74.12 108.903 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -78.27 98.4 5.89 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.176 -0.675 . . . . 74.14 109.176 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -61.43 -47.79 84.16 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.102 0.961 . . . . 75.31 111.05 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -63.06 -30.08 71.32 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.241 -0.89 . . . . 75.43 111.07 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.478 ' HA ' ' SD ' ' D' ' 138' ' ' MET . . . -58.78 -30.43 67.57 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.885 0.874 . . . . 74.21 112.714 -177.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 7.3 mp -78.71 -37.66 40.96 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.864 0.466 . . . . 75.32 111.032 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -66.27 -31.19 71.84 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 116.31 -0.405 . . . . 64.42 110.451 175.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.478 ' SD ' ' HA ' ' D' ' 135' ' ' ALA . 45.5 mtt -67.66 -46.96 70.9 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.007 0.923 . . . . 72.11 109.593 170.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -56.17 -38.42 70.9 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 125.594 1.558 . . . . 74.41 111.507 -173.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -51.23 -40.66 59.29 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.075 1.35 . . . . 74.31 111.549 176.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 mp -82.08 -49.55 10.07 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.814 0.846 . . . . 60.14 110.781 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -91.05 40.41 1.03 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 113.365 0.876 . . . . 70.01 113.365 -168.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -119.13 85.98 2.47 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 108.935 -0.765 . . . . 65.21 108.935 171.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -165.57 111.36 0.9 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.741 -1.118 . . . . 71.2 108.996 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . 65.38 24.58 12.03 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.548 1.139 . . . . 74.35 112.664 173.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -139.38 59.9 0.58 Allowed Glycine 0 N--CA 1.476 1.319 0 N-CA-C 111.558 -0.617 . . . . 73.02 111.558 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -129.08 117.06 20.23 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.999 0.92 . . . . 64.22 110.665 -175.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 141.21 101.31 0.44 Allowed Glycine 0 C--N 1.346 1.13 0 N-CA-C 111.602 -0.599 . . . . 65.3 111.602 177.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 32.3 p -129.99 151.55 50.42 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.533 1.133 . . . . 40.23 109.282 174.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -128.21 143.29 51.03 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.995 0.518 . . . . 71.41 111.343 -176.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.83 153.0 14.13 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 106.883 -1.525 . . . . 65.21 106.883 176.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -50.43 -53.85 26.39 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.887 0.875 . . . . 61.0 111.178 176.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? 59.33 88.52 0.07 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.732 1.213 . . . . 55.34 109.769 -173.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -120.01 -51.33 2.23 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.123 -0.944 . . . . 74.42 109.406 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 C-N-CA 123.971 0.908 . . . . 74.2 109.378 -178.297 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.472 0 N-CA-C 111.648 -0.581 . . . . 62.24 111.648 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 168.55 -116.01 0.64 Allowed Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.058 -0.817 . . . . 73.33 111.058 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -96.08 179.62 5.0 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.802 0.841 . . . . 73.43 109.872 175.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -89.89 -74.15 0.49 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 122.642 0.377 . . . . 71.31 111.065 -167.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -141.47 -56.62 0.48 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.691 0.796 . . . . 72.21 111.237 -173.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 127.91 75.15 0.19 Allowed Glycine 0 C--N 1.349 1.25 0 N-CA-C 111.184 -0.766 . . . . 73.25 111.184 -170.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 97' ' ' ILE . . . . . 0.441 HD11 ' SD ' ' D' ' 94' ' ' MET . 4.3 tt -55.48 -28.31 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 125.449 1.5 . . . . 72.14 112.113 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 32.4 t70 78.58 -88.11 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 114.292 1.219 . . . . 73.32 114.292 160.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -100.75 102.41 13.5 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 118.241 0.473 . . . . 62.4 111.083 -168.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 100' ' ' LEU . . . . . 0.575 ' HB2' HG23 ' E' ' 103' ' ' THR . 4.2 mp -111.38 142.15 25.87 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.776 0.83 . . . . 73.14 109.144 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.46 -15.29 29.4 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 123.436 2.757 . . . . 63.02 114.929 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 102' ' ' LEU . . . . . 0.48 HD11 HD13 ' D' ' 98' ' ' LEU . 1.4 pp -108.96 -13.21 14.77 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.63 0.772 . . . . 75.22 112.906 -173.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 103' ' ' THR . . . . . 0.575 HG23 ' HB2' ' E' ' 100' ' ' LEU . 58.0 p -76.21 -36.2 58.71 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.061 0.458 . . . . 45.51 109.781 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.59 151.81 16.95 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.242 -1.143 . . . . 74.24 110.242 167.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 67.17 11.52 8.43 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.138 0.975 . . . . 75.05 111.781 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 31.1 t80 65.91 -177.16 0.19 Allowed 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 123.97 0.908 . . . . 73.15 109.84 -175.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 17.5 p -58.74 -19.45 40.39 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.455 0.702 . . . . 73.13 112.679 176.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 68.86 -76.49 0.06 Allowed 'General case' 0 C--N 1.358 0.955 0 C-N-CA 125.287 1.435 . . . . 55.05 111.556 172.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -98.16 63.2 1.57 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.652 -1.24 . . . . 74.0 107.652 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.54 156.89 15.36 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 114.968 -1.015 . . . . 71.34 110.888 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 111' ' ' LEU . . . . . 0.413 HD23 ' CB ' ' D' ' 44' ' ' LEU . 19.1 tp -38.71 -64.2 0.46 Allowed 'General case' 0 N--CA 1.476 0.873 0 O-C-N 125.519 1.762 . . . . 44.22 113.4 -165.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -114.41 76.24 0.98 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.463 -0.94 . . . . 54.41 108.463 174.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -140.44 -68.02 0.42 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.344 0.658 . . . . 54.32 109.556 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -147.9 43.72 1.07 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.677 -0.692 . . . . 75.42 109.924 -172.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 20.3 p -90.45 52.37 2.21 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.652 0.781 . . . . 74.45 109.984 174.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.34 -91.12 0.38 Allowed Glycine 0 C--N 1.353 1.507 0 N-CA-C 110.691 -0.964 . . . . 44.44 110.691 -172.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -127.59 96.76 32.12 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 124.256 1.022 . . . . 50.24 108.255 171.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -75.18 72.84 4.62 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 123.128 2.552 . . . . 60.53 113.055 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -95.06 177.0 6.02 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 107.989 -1.115 . . . . 50.43 107.989 173.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 60.1 t80 80.07 -46.04 0.3 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 125.461 1.504 . . . . 64.04 110.979 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 121' ' ' VAL . . . . . 0.59 HG23 HD12 ' D' ' 44' ' ' LEU . 14.6 p -63.25 -26.61 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 C-N-CA 125.234 1.414 . . . . 53.4 111.768 170.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 62.6 p -70.37 -15.42 62.85 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.418 1.087 . . . . 74.24 111.625 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -108.66 158.39 17.64 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.128 0.971 . . . . 65.4 110.548 -173.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 70.4 m -149.96 -61.14 0.21 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.994 0.917 . . . . 64.31 108.673 171.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . 60.57 -154.65 0.36 Allowed 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.088 0.868 . . . . 71.02 109.602 -172.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . 68.24 103.62 0.05 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.878 0.871 . . . . 63.12 111.867 171.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 127' ' ' SER . . . . . 0.407 ' HB3' ' OE1' ' D' ' 37' ' ' GLN . 33.3 t -162.02 132.49 4.9 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.036 0.535 . . . . 53.41 110.204 -174.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -160.38 125.23 3.81 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.184 0.516 . . . . 64.42 111.529 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 129' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' D' ' 124' ' ' PRO . 0.6 OUTLIER -148.76 170.78 17.45 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.707 1.603 . . . . 74.4 108.832 174.906 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 130' ' ' ALA . . . . . 0.5 ' HB3' ' HD3' ' A' ' 124' ' ' PRO . . . -119.19 21.78 12.12 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.651 -0.704 . . . . 70.21 110.266 176.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 131' ' ' TRP . . . . . 0.545 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 47.8 t90 -62.26 113.59 2.98 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 123.394 0.678 . . . . 75.35 111.306 -176.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 47.7 p -161.82 16.82 0.1 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.77 0.828 . . . . 73.1 111.631 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 2.4 p -88.5 126.85 35.45 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.831 0.452 . . . . 74.22 111.785 -176.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -92.1 -13.37 57.67 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 115.335 -0.848 . . . . 73.4 111.78 169.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 135' ' ' VAL . . . . . 0.413 HG21 HD22 ' A' ' 127' ' ' ASN . 47.3 t 53.33 81.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.232 0 C-N-CA 125.804 1.642 . . . . 71.11 112.426 174.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 136' ' ' LYS . . . . . 0.426 ' HD2' HE22 ' C' ' 14' ' ' GLN . 21.2 mtpp -140.47 101.1 4.03 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 107.921 -1.14 . . . . 54.02 107.921 176.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 14.3 t -144.66 13.31 1.52 Allowed 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.819 0.674 . . . . 70.04 112.819 -168.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -147.82 -49.38 0.17 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.639 -0.504 . . . . 73.33 109.639 -177.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 139' ' ' ASN . . . . . 0.431 ' ND2' ' HA ' ' C' ' 10' ' ' THR . 35.0 t-20 -134.98 146.18 48.82 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.319 -0.993 . . . . 71.24 108.319 178.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.41 -92.05 1.97 Allowed Glycine 0 C--N 1.342 0.868 0 CA-C-N 116.739 -0.21 . . . . 43.12 113.379 -173.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 141' ' ' ALA . . . . . 0.573 ' HA ' HG21 ' C' ' 10' ' ' THR . . . -171.28 -174.88 1.54 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.194 1.398 . . . . 73.34 109.071 -177.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 37.8 tp -130.64 -65.9 0.78 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.72 0.408 . . . . 72.12 110.761 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . 130.02 50.56 0.11 Allowed Glycine 0 N--CA 1.472 1.067 0 N-CA-C 111.213 -0.755 . . . . 54.11 111.213 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 6.1 m -83.09 158.43 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.854 0.862 . . . . 75.04 111.291 -174.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 CA--C 1.548 0.867 0 C-N-CA 123.372 0.669 . . . . 74.14 109.453 178.362 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 CA-C-O 119.805 -0.442 . . . . 54.55 112.128 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 103.96 50.6 1.0 Allowed Glycine 0 C--N 1.35 1.325 0 N-CA-C 111.866 -0.494 . . . . 65.32 111.866 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -84.64 144.76 28.39 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.042 0.937 . . . . 75.11 109.73 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -148.46 175.89 10.76 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.115 0.966 . . . . 74.02 110.664 -176.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -127.54 145.14 50.96 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.394 1.077 . . . . 63.24 109.147 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -175.89 -66.56 0.06 OUTLIER Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.163 -0.775 . . . . 62.34 111.163 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 97' ' ' ILE . . . . . 0.433 HD12 ' HE2' ' B' ' 94' ' ' MET . 25.0 pt -95.67 116.61 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.934 0.893 . . . . 75.52 111.468 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -86.26 151.26 23.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.783 0.833 . . . . 51.4 110.157 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 99' ' ' ALA . . . . . 0.489 ' O ' ' HD3' ' F' ' 101' ' ' PRO . . . 56.6 100.7 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.773 1.229 . . . . 44.22 112.508 174.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 100' ' ' LEU . . . . . . . . . . . . . 5.4 mp -107.36 78.05 0.62 Allowed Pre-proline 0 CA--C 1.566 1.582 0 C-N-CA 124.465 1.106 . . . . 74.42 109.579 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 101' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' F' ' 99' ' ' ALA . 33.8 Cg_endo -101.21 29.5 0.1 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.707 2.938 . . . . 63.31 113.909 -167.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 71.69 -60.53 0.52 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.238 1.415 . . . . 75.32 110.61 -174.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -163.18 -42.43 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.469 1.508 . . . . 73.51 106.94 168.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . -167.41 -43.76 0.03 OUTLIER Glycine 0 C--N 1.343 0.938 0 CA-C-N 114.778 -1.101 . . . . 73.41 110.475 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -102.17 169.16 8.9 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.646 0.778 . . . . 60.1 110.306 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 106' ' ' TYR . . . . . 0.477 ' CE1' ' HA ' ' B' ' 47' ' ' ALA . 21.9 t80 -70.74 -37.07 73.42 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.876 1.27 . . . . 74.52 110.834 -175.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 14.2 m -100.77 16.25 25.64 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.254 1.022 . . . . 73.22 109.786 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 108' ' ' HIS . . . . . 0.555 ' NE2' ' HA3' ' B' ' 99' ' ' GLY . 43.7 m-70 67.0 -73.81 0.07 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.907 1.283 . . . . 74.14 109.346 -171.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 109' ' ' TYR . . . . . 0.428 ' HE2' HD11 ' B' ' 141' ' ' LEU . 93.6 m-85 -144.77 -57.73 0.35 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 107.607 -1.257 . . . . 60.31 107.607 171.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -148.39 142.14 25.63 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.977 -1.01 . . . . 75.24 110.01 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 48.1 tp -167.52 -48.49 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 106.215 -1.772 . . . . 61.32 106.215 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -91.58 164.36 13.8 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 113.659 -1.61 . . . . 64.4 107.282 158.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -60.65 133.91 56.56 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.568 0.747 . . . . 74.11 110.151 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -126.4 165.8 18.38 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 124.689 1.196 . . . . 74.44 109.437 175.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 7.8 t -73.19 91.64 1.67 Allowed 'General case' 0 CA--C 1.555 1.136 0 CA-C-O 121.75 0.786 . . . . 64.43 111.107 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.23 60.99 4.47 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.067 -0.969 . . . . 73.4 112.96 174.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -133.07 102.37 13.27 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 122.901 0.48 . . . . 73.3 109.88 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.42 102.46 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 123.07 2.514 . . . . 75.03 111.652 170.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -104.29 164.99 11.34 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.768 0.827 . . . . 71.25 110.302 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 120' ' ' TYR . . . . . 0.626 ' HB3' ' HG ' ' B' ' 136' ' ' LEU . 43.8 t80 -53.28 -44.53 68.32 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.305 1.442 . . . . 62.14 111.576 176.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 58.8 t -74.42 96.17 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 122.929 0.492 . . . . 62.24 110.149 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 5.9 t -81.26 -56.48 4.04 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 108.411 -0.959 . . . . 61.4 108.411 167.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -179.83 136.7 0.12 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.021 1.329 . . . . 75.4 108.538 172.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 55.5 m -153.33 125.93 8.2 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.562 0.745 . . . . 74.35 109.856 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -161.73 149.89 15.13 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.894 0.878 . . . . 71.4 109.461 175.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.06 141.7 28.42 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.181 0.593 . . . . 74.05 110.029 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 31.1 p -74.12 116.57 14.91 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.65 0.78 . . . . 63.33 109.647 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.51 127.88 33.6 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.628 0.771 . . . . 65.22 111.042 -177.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 39.6 p -81.62 139.53 34.95 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 122.536 0.334 . . . . 60.24 110.341 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.35 131.58 51.22 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 123.964 0.905 . . . . 54.03 110.498 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 131' ' ' TRP . . . . . 0.491 ' H ' ' HE3' ' F' ' 131' ' ' TRP . 1.0 OUTLIER -120.3 151.49 39.13 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.942 0.897 . . . . 75.05 110.222 -164.581 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 29.3 t -167.93 135.02 2.17 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.152 -0.685 . . . . 63.13 109.152 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 133' ' ' THR . . . . . 0.59 ' HA ' HD12 ' C' ' 126' ' ' LEU . 20.7 m -78.64 102.55 8.05 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.575 -0.898 . . . . 73.11 108.575 173.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -82.89 32.69 2.93 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 116.15 -0.477 . . . . 71.1 113.993 -173.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 28.0 m -70.79 126.79 31.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 108.854 -0.795 . . . . 61.54 108.854 174.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -73.65 -27.97 61.54 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 111.962 0.356 . . . . 62.24 111.962 -169.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 43.0 m -142.42 101.41 3.89 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.789 0.435 . . . . 64.42 111.028 -174.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -176.53 -54.15 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.36 1.038 . . . . 63.11 110.274 163.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -116.36 158.4 23.53 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.195 0.598 . . . . 55.51 110.758 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -73.64 136.55 22.18 Favored Glycine 0 C--N 1.346 1.11 0 N-CA-C 111.507 -0.637 . . . . 23.31 111.507 174.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -139.55 132.66 29.63 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.902 0.881 . . . . 74.21 109.55 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.93 106.68 5.12 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.48 0.712 . . . . 60.31 110.195 -176.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -83.93 62.45 4.59 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-N 115.975 -0.557 . . . . 61.32 111.837 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 16.3 m -68.39 120.26 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 C-N-CA 123.833 0.853 . . . . 63.21 110.696 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 34.1 t70 . . . . . 0 C--O 1.249 1.059 0 C-N-CA 123.385 0.674 . . . . 71.4 109.939 -176.157 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.828 -0.434 . . . . 73.32 109.828 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.7 p -131.05 115.6 16.67 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.957 -0.757 . . . . 73.02 108.957 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -131.98 42.96 3.09 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.64 0.733 . . . . 72.01 109.96 -177.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -86.66 19.42 2.91 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 115.177 -0.92 . . . . 75.44 111.731 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.501 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 4.8 t30 -61.16 100.03 0.11 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.827 0.851 . . . . 72.41 110.048 174.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.485 ' O ' ' HA2' ' A' ' 88' ' ' GLY . 26.7 t-20 -137.86 150.73 47.39 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 108.329 -0.989 . . . . 74.2 108.329 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.4 p -54.19 80.56 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 124.686 1.194 . . . . 63.0 113.695 -173.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 172.68 115.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 128.855 2.862 . . . . 74.11 105.459 177.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.534 ' HG2' HD12 ' A' ' 89' ' ' ILE . 13.8 tmm? -71.52 145.38 49.18 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.93 0.395 . . . . 74.12 111.004 -173.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.2 m -139.39 124.95 19.32 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 124.002 0.921 . . . . 72.1 108.929 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -120.38 120.68 36.68 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.295 1.038 . . . . 73.2 108.761 -177.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -140.45 135.33 31.9 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.993 0.517 . . . . 73.41 109.756 173.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.441 ' CD1' HG21 ' A' ' 105' ' ' ILE . 3.6 mt -92.77 115.26 31.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 108.349 -0.982 . . . . 74.13 108.349 173.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.67 -40.25 29.52 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.235 -0.654 . . . . 74.12 109.235 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -176.21 122.93 0.17 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 123.146 0.279 . . . . 62.32 110.706 -171.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 79.4 mt -105.61 136.76 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.833 -0.802 . . . . 51.41 108.833 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.467 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 33.2 p90 -169.76 155.43 5.85 Favored 'General case' 0 C--N 1.346 0.42 0 O-C-N 124.197 0.936 . . . . 71.54 110.704 -173.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -83.28 121.94 27.78 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.513 -0.767 . . . . 74.54 109.475 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.467 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.5 mtpt -84.71 -26.7 27.51 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.71 -0.478 . . . . 73.01 109.71 175.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.598 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 11.0 t70 -153.49 143.44 22.07 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 114.63 -1.168 . . . . 42.32 109.837 -178.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.485 HD13 ' SD ' ' B' ' 117' ' ' MET . 91.5 mt -143.63 142.2 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.498 1.519 . . . . 63.41 107.857 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.9 t -149.97 133.22 16.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.289 0.635 . . . . 74.13 109.839 172.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -125.58 140.44 52.74 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 107.014 -1.476 . . . . 70.43 107.014 169.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -142.01 108.5 5.32 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.586 0.755 . . . . 75.34 109.042 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -106.96 85.65 2.03 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 106.639 -1.615 . . . . 64.33 106.639 165.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.55 -38.79 5.65 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.392 2.061 . . . . 53.12 112.177 -169.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -111.22 31.41 6.1 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.871 0.869 . . . . 63.23 108.867 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.521 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -47.13 -54.72 18.98 Favored Pre-proline 0 N--CA 1.493 1.678 0 CA-C-O 117.693 -1.146 . . . . 61.5 113.72 -173.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -61.25 -28.2 84.5 Favored 'Trans proline' 0 C--N 1.401 3.334 0 C-N-CA 121.888 1.725 . . . . 54.42 112.667 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -90.64 -31.8 16.49 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.741 1.216 . . . . 52.34 112.055 -173.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.647 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.9 p -79.22 -21.4 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 120.875 0.369 . . . . 74.2 111.142 -171.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -73.58 -6.2 45.12 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 115.991 -0.55 . . . . 73.41 111.025 172.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -88.8 -28.98 20.07 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.925 0.89 . . . . 63.33 110.202 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.429 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 14.5 mmmm -77.0 157.58 31.1 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.636 0.774 . . . . 72.14 110.929 -176.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.78 119.37 9.2 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.438 0.695 . . . . 71.31 110.464 174.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.452 ' CE3' HD21 ' A' ' 68' ' ' LEU . 67.2 t-105 -81.6 87.69 6.25 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.49 0.662 . . . . 73.51 111.393 -175.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.533 ' H ' HD22 ' A' ' 68' ' ' LEU . 35.7 tt0 -124.1 82.93 56.25 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 124.652 1.181 . . . . 70.25 107.869 171.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.34 121.17 7.52 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.762 2.308 . . . . 63.24 113.257 -170.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -97.19 89.36 4.75 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.829 -0.804 . . . . 74.21 108.829 172.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.571 HG21 HD13 ' A' ' 126' ' ' LEU . 48.8 t -79.66 111.76 16.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-N 114.846 -1.07 . . . . 73.22 110.109 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -99.03 123.49 43.36 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.076 -0.713 . . . . 74.45 109.076 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 84.6 mt -99.31 108.48 21.02 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.515 0.726 . . . . 62.1 109.665 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.632 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 11.2 m-20 -104.72 106.07 16.41 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.418 -1.327 . . . . 44.43 107.418 170.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.41 HD13 ' CZ ' ' A' ' 133' ' ' PHE . 79.4 mt -106.95 117.31 33.71 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.04 -0.726 . . . . 72.43 109.04 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -122.62 130.77 53.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.882 -1.525 . . . . 60.15 106.882 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.4 HG21 ' HA2' ' A' ' 99' ' ' GLY . 99.9 m -108.35 136.0 48.73 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.69 -0.485 . . . . 70.45 109.69 177.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.38 109.93 6.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.127 0.971 . . . . 50.33 108.966 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 79.2 p -94.96 158.79 15.32 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.97 0.508 . . . . 74.5 109.955 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.0 t -148.74 119.96 7.8 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.519 -0.919 . . . . 51.41 108.519 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -81.88 115.87 21.27 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.365 -0.606 . . . . 72.31 109.365 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.0 mt -80.56 -42.42 22.39 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.532 0.733 . . . . 75.24 110.516 -176.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.67 -179.61 7.57 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.023 0.929 . . . . 74.32 110.139 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -60.73 121.48 12.37 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.673 0.789 . . . . 73.55 109.903 170.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 65.84 -2.56 0.88 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.381 1.472 . . . . 54.22 112.974 -176.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.0 t -104.68 105.1 17.94 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 N-CA-C 108.158 -1.053 . . . . 70.12 108.158 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -107.64 162.66 13.77 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.562 -0.903 . . . . 53.1 108.562 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -131.77 153.3 50.24 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 107.444 -1.317 . . . . 72.13 107.444 168.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.452 HG11 ' HD3' ' A' ' 103' ' ' PRO . 68.0 t -133.48 136.41 54.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 107.513 -1.291 . . . . 64.4 107.513 173.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.452 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 47.9 t -119.82 133.58 66.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.831 -0.803 . . . . 75.41 108.831 174.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.417 HD22 HG22 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -104.01 100.07 9.84 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 106.564 -1.643 . . . . 63.21 106.564 177.012 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -82.97 99.21 9.66 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.867 -1.16 . . . . 72.14 107.867 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.461 HG21 ' HB1' ' A' ' 110' ' ' ALA . 47.2 t -98.96 130.57 47.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 N-CA-C 108.353 -0.98 . . . . 73.24 108.353 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.632 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 9.3 m -127.36 107.76 10.25 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.731 -0.84 . . . . 75.14 108.731 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.57 HG11 HD21 ' A' ' 126' ' ' LEU . 54.1 t -101.24 128.23 53.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 124.547 1.139 . . . . 74.24 108.275 174.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.8 m -131.44 116.89 18.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.816 -0.809 . . . . 55.51 108.816 172.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.53 119.43 39.15 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.61 -1.256 . . . . 52.41 107.61 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -127.7 142.31 51.36 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.515 0.674 . . . . 74.42 110.597 -177.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.533 HD22 ' H ' ' A' ' 37' ' ' GLN . 50.4 mt -91.18 61.19 4.45 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.262 1.425 . . . . 72.14 107.927 170.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.2 -98.28 1.47 Allowed Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.198 -0.91 . . . . 60.03 112.684 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -88.35 -29.6 20.18 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.128 0.971 . . . . 73.11 110.287 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.429 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 5.1 tp10 -85.88 101.17 12.62 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.149 -0.932 . . . . 72.14 108.954 -174.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.4 m -68.16 124.27 22.98 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 119.291 0.951 . . . . 75.13 108.559 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.647 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -79.81 -54.52 5.76 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.17 -0.923 . . . . 74.3 108.853 -177.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.437 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 54.5 p90 -155.34 162.23 40.88 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.276 -0.874 . . . . 71.4 111.527 176.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 64' ' ' VAL . 45.0 tp -131.14 118.44 20.49 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 113.765 -1.561 . . . . 63.43 107.498 175.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.437 ' HG ' ' HD1' ' A' ' 74' ' ' PHE . 85.3 m -115.3 126.89 55.02 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.595 -0.891 . . . . 74.31 108.595 175.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -139.18 115.77 10.65 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.32 -0.622 . . . . 72.21 109.32 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.4 t -125.64 112.35 30.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.42 1.088 . . . . 71.14 109.047 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.598 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 19.2 mt-30 -84.62 84.89 7.52 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.505 -0.924 . . . . 74.21 108.505 169.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -76.7 96.85 4.3 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 114.681 -1.145 . . . . 72.51 108.941 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -84.91 160.8 35.69 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.88 -0.488 . . . . 45.04 111.88 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.506 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -156.49 125.05 1.54 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.186 -1.166 . . . . 72.22 110.186 174.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.409 HG13 ' HE1' ' A' ' 17' ' ' TYR . 65.1 mt -79.79 124.66 38.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.893 -1.151 . . . . 73.32 107.893 171.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.625 ' HB3' HD11 ' A' ' 86' ' ' ILE . 96.3 m-85 -125.03 119.42 28.63 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.889 -0.782 . . . . 72.01 108.889 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.7 t -89.14 90.99 8.62 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.249 -1.019 . . . . 63.45 108.249 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.625 HD11 ' HB3' ' A' ' 84' ' ' PHE . 13.1 mm -116.87 148.69 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 121.205 0.526 . . . . 74.24 110.816 -169.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.501 ' HB1' ' HA ' ' A' ' 5' ' ' ASN . . . -163.56 171.06 16.34 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.735 -1.12 . . . . 73.51 110.114 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 6' ' ' ASN . . . 106.24 -32.89 6.89 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.239 -0.437 . . . . 70.44 112.92 177.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.593 ' H ' HD13 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -121.39 169.0 13.25 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 124.278 1.031 . . . . 74.3 110.1 -175.227 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.406 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 12.6 tt0 -156.85 174.9 14.81 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 124.133 0.895 . . . . 74.54 109.07 176.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.73 -114.03 5.89 Favored Glycine 0 C--N 1.343 0.957 0 CA-C-N 115.69 -0.686 . . . . 41.04 114.293 176.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.4 p -71.36 -41.54 69.59 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.62 1.168 . . . . 73.34 112.217 -174.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -71.2 -34.77 71.18 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.067 0.547 . . . . 61.42 110.279 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.406 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 5.8 tpt -66.67 -42.52 86.43 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 123.469 0.481 . . . . 64.52 110.098 174.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.98 -35.08 79.51 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.373 0.669 . . . . 72.4 111.005 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.426 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 75.2 t60 -71.71 -28.28 63.58 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.663 0.785 . . . . 71.22 110.777 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.7 t -76.19 -50.49 14.38 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.461 -0.57 . . . . 63.25 109.461 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 87.1 mt -75.98 -23.96 55.34 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.532 0.733 . . . . 63.54 112.515 -173.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.4 ' HA2' HG21 ' A' ' 46' ' ' THR . . . -115.09 3.52 22.46 Favored Glycine 0 N--CA 1.473 1.139 0 CA-C-O 119.553 -0.582 . . . . 73.41 113.952 -171.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -143.41 -63.24 0.4 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 117.541 0.67 . . . . 72.43 111.276 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -68.62 -46.19 69.9 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.175 0.59 . . . . 73.4 111.777 -170.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 80.3 m -70.49 -47.41 18.53 Favored Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 124.235 1.014 . . . . 53.51 112.928 -176.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.452 ' HD3' HG11 ' A' ' 58' ' ' VAL . 51.5 Cg_endo -67.08 -18.66 51.59 Favored 'Trans proline' 0 C--N 1.394 2.967 0 CA-C-N 121.462 1.558 . . . . 53.45 112.461 174.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -72.77 -35.23 67.39 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.055 0.542 . . . . 73.44 109.74 174.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.441 HG21 ' CD1' ' A' ' 13' ' ' ILE . 39.1 mm -65.42 -44.38 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.849 0.859 . . . . 55.51 110.113 170.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.506 HD21 ' HA3' ' A' ' 82' ' ' GLY . 75.7 mt -71.49 -15.8 62.33 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.445 -0.798 . . . . 75.24 111.904 -175.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -70.03 -44.98 22.28 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 114.748 1.388 . . . . 72.31 114.748 -170.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.97 -32.14 84.66 Favored 'Trans proline' 0 C--N 1.384 2.437 0 CA-C-N 122.285 1.852 . . . . 63.32 112.314 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -76.84 -41.28 44.74 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.69 0.796 . . . . 65.13 111.65 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.461 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -66.44 -49.44 66.71 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.033 0.533 . . . . 74.34 109.749 178.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.487 ' NH1' HD12 ' C' ' 105' ' ' ILE . 30.5 ttm180 -46.8 -51.67 15.9 Favored 'General case' 0 C--N 1.353 0.761 0 O-C-N 125.258 1.599 . . . . 73.44 110.716 173.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -67.39 -43.78 80.5 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.316 1.01 . . . . 73.45 111.982 -175.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.554 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.7 t -57.68 -42.6 83.94 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.932 0.77 . . . . 74.03 110.122 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.487 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.5 mt -64.33 -54.84 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 114.451 -1.25 . . . . 53.01 110.253 175.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.5 m -56.59 -37.29 70.43 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.258 0.974 . . . . 65.3 111.567 -173.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.0 t -68.81 -47.9 64.92 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.664 -1.153 . . . . 71.11 110.096 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 8.6 mtp -57.12 -37.71 72.38 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.615 0.766 . . . . 55.24 111.664 175.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 114' ' ' ILE . 70.3 t -67.48 -49.16 73.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.378 1.071 . . . . 71.24 110.461 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.8 p -70.44 -33.19 71.03 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.018 0.527 . . . . 75.12 111.076 -175.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.541 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.9 mtt-85 -69.48 -31.97 70.57 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.959 0.904 . . . . 74.2 109.67 172.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.84 6.08 49.74 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-O 119.304 -0.72 . . . . 73.05 113.688 174.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.53 HG21 ' HE ' ' B' ' 15' ' ' ARG . 18.1 m 73.15 7.29 5.32 Favored 'General case' 0 C--N 1.367 1.345 0 C-N-CA 125.147 1.379 . . . . 71.03 112.152 176.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -86.51 137.53 34.24 Favored Pre-proline 0 C--O 1.24 0.568 0 N-CA-C 107.197 -1.409 . . . . 71.33 107.197 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.4 ' HB3' ' H ' ' E' ' 132' ' ' SER . 56.7 Cg_exo -54.67 165.87 2.25 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 123.416 2.744 . . . . 63.21 113.855 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.573 ' HG2' ' HB2' ' C' ' 15' ' ' ARG . 4.5 tp-100 -52.88 117.8 3.22 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 114.534 -1.212 . . . . 75.53 111.877 -172.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.571 HD13 HG21 ' A' ' 40' ' ' VAL . 25.5 tp -113.6 114.39 26.39 Favored 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 109.175 -0.676 . . . . 62.42 109.175 173.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.404 HD22 ' H ' ' C' ' 16' ' ' ILE . 5.2 m120 -110.03 125.69 53.18 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 106.152 -1.795 . . . . 63.52 106.152 176.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.473 HD11 HD12 ' A' ' 114' ' ' ILE . 10.9 mt -72.09 144.18 48.78 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 109.173 -0.677 . . . . 65.31 109.173 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.51 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -60.18 138.64 91.51 Favored Pre-proline 0 N--CA 1.48 1.059 0 CA-C-O 118.864 -0.588 . . . . 73.44 111.011 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -55.09 108.17 0.29 Allowed 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.519 2.146 . . . . 63.34 111.849 168.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 129' ' ' ALA . 75.4 t -104.18 137.17 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.078 0.951 . . . . 71.54 111.634 -173.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.441 ' ND2' ' HG2' ' C' ' 3' ' ' GLU . 50.9 t-20 -89.53 97.29 11.11 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.791 -1.095 . . . . 64.4 108.656 170.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.41 ' CZ ' HD13 ' A' ' 44' ' ' LEU . 57.2 m-85 -70.49 -18.58 62.96 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 112.827 0.677 . . . . 74.42 112.827 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -69.6 -40.02 76.9 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.45 -0.945 . . . . 52.11 108.45 174.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.07 -46.22 85.28 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.5 0.72 . . . . 63.31 110.942 174.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 56.9 mt -62.87 -33.58 75.58 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 123.748 0.655 . . . . 73.01 111.044 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.426 ' CE2' HD13 ' A' ' 141' ' ' LEU . 74.6 t80 -68.18 -45.02 74.6 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.507 -0.77 . . . . 72.43 109.808 176.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.402 ' HA ' ' HB3' ' A' ' 141' ' ' LEU . 74.9 mtp -64.03 -25.37 68.09 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 123.783 0.677 . . . . 75.43 112.011 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -64.38 -53.91 41.09 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.971 -0.751 . . . . 73.51 108.971 171.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -65.6 -31.3 72.27 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 115.648 -0.706 . . . . 74.0 111.759 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.426 HD13 ' CE2' ' A' ' 137' ' ' PHE . 49.7 tp -68.37 -40.95 81.24 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.183 1.393 . . . . 74.04 111.98 -171.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -167.39 -13.42 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.141 0 O-C-N 123.682 0.614 . . . . 73.24 112.231 -173.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 59.36 80.08 0.21 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.069 0.948 . . . . 62.4 110.494 -169.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -149.96 1.8 0.5 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.258 0.623 . . . . 74.45 111.366 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.02 164.22 17.5 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.052 0.541 . . . . 43.03 110.439 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -154.94 164.97 32.01 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.553 -0.749 . . . . 71.0 111.694 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -72.18 153.4 41.64 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.206 0.602 . . . . 54.52 109.49 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -128.75 84.76 0.32 Allowed Glycine 0 C--N 1.34 0.752 0 N-CA-C 111.429 -0.668 . . . . 44.53 111.429 -177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.1 m -73.97 148.9 41.69 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.674 0.79 . . . . 63.33 109.08 170.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.3 153.02 4.13 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.431 1.092 . . . . 63.35 113.517 -175.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -63.53 -63.45 1.17 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.33 1.052 . . . . 74.32 109.838 176.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -167.28 86.56 0.26 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.855 -1.165 . . . . 75.23 107.855 171.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -61.61 88.62 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.353 1.061 . . . . 72.35 109.591 175.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -68.59 -39.32 80.97 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.942 0.897 . . . . 74.4 111.276 -171.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.244 0 N-CA-C 108.313 -0.995 . . . . 72.13 108.313 174.518 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 109.599 -0.519 . . . . 64.41 109.599 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 14.4 t -167.7 32.15 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.407 0.683 . . . . 52.13 110.996 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -75.41 79.33 2.46 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.627 0.771 . . . . 74.12 110.368 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 64.06 -0.97 0.74 Allowed 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 124.745 1.218 . . . . 44.55 113.152 173.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -65.95 124.17 21.8 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.086 0.954 . . . . 71.22 110.273 -173.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . 0.285 30.1 p30 45.33 -68.7 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 126.026 2.079 . . . . 75.24 114.514 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 44.3 m 66.67 104.93 0.04 OUTLIER 'General case' 0 C--N 1.353 0.732 0 C-N-CA 125.29 1.436 . . . . 72.3 111.241 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -58.47 -21.91 53.0 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.468 -0.787 . . . . 73.35 111.851 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 1.4 tmt? 67.83 168.72 0.26 Allowed 'General case' 0 C--N 1.364 1.202 0 C-N-CA 125.138 1.375 . . . . 74.0 110.772 172.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.1 t -143.38 99.14 3.38 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.135 0.969 . . . . 62.33 109.373 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.474 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 54.1 t80 -112.63 141.0 46.92 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.334 -1.303 . . . . 75.23 107.684 173.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -147.55 134.14 19.85 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.764 -0.458 . . . . 64.55 109.764 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.473 HD11 HD13 ' B' ' 105' ' ' ILE . 41.4 mt -80.66 116.47 24.95 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 N-CA-C 107.011 -1.477 . . . . 55.13 107.011 170.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -90.06 -37.55 14.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.973 -0.751 . . . . 73.43 108.973 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.53 ' HE ' HG21 ' A' ' 122' ' ' THR . 11.7 ttt85 -168.92 151.88 5.07 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 123.611 0.569 . . . . 71.12 110.812 -177.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 53.8 mt -135.16 135.87 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 106.668 -1.604 . . . . 71.55 106.668 171.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.471 ' HE1' HG13 ' B' ' 83' ' ' ILE . 10.9 p90 -166.34 143.03 4.98 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.281 0.563 . . . . 73.01 111.79 -173.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 41.2 m -74.24 121.39 21.19 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.81 -1.086 . . . . 74.12 108.971 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.466 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.5 mtpt -98.51 -17.09 18.91 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.363 0.665 . . . . 72.11 110.979 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 3.2 t70 -163.67 145.36 9.3 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.83 0.852 . . . . 74.03 110.418 -177.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.404 HD13 HG13 ' B' ' 78' ' ' VAL . 39.4 mm -133.13 144.93 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 107.618 -1.253 . . . . 73.51 107.618 170.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 39.2 t -143.94 135.82 26.32 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.792 -0.818 . . . . 74.11 108.792 174.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.478 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.6 t80 -149.53 114.55 5.42 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 107.402 -1.333 . . . . 44.2 107.402 170.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -126.17 114.3 18.17 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.102 -1.073 . . . . 75.24 108.102 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.602 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -106.85 88.82 3.83 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 107.912 -1.144 . . . . 61.34 107.912 175.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.55 -33.33 46.33 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.723 2.282 . . . . 71.54 112.295 -172.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -106.32 7.96 31.53 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.075 0.95 . . . . 74.24 111.613 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.602 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -33.26 -64.03 0.27 Allowed Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 115.662 1.727 . . . . 74.11 115.662 -167.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.435 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 19.9 Cg_exo -60.72 -32.58 93.23 Favored 'Trans proline' 0 C--N 1.4 3.272 0 C-N-CA 122.438 2.092 . . . . 54.31 112.914 -170.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -94.77 -39.58 10.21 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 114.664 -1.153 . . . . 75.32 111.583 -170.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.706 HG22 HD12 ' B' ' 68' ' ' LEU . 7.4 p -66.32 -19.41 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.052 0.541 . . . . 62.14 111.925 -172.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -60.47 -21.63 62.57 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.015 0.926 . . . . 64.35 113.312 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -63.9 -18.27 64.03 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.346 0.658 . . . . 75.52 111.766 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.446 ' HB2' HD13 ' B' ' 68' ' ' LEU . 95.6 mttt -94.06 105.29 17.29 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.256 1.022 . . . . 75.25 109.142 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -100.52 79.58 2.12 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.477 0.711 . . . . 64.43 110.441 -172.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 46.5 p90 -154.41 167.84 28.67 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.824 -1.176 . . . . 74.14 107.824 165.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 22.9 tm0? -76.51 115.44 47.64 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 107.7 -1.222 . . . . 74.3 107.7 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.27 154.38 52.84 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.982 2.455 . . . . 71.14 114.285 -170.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -66.41 115.94 6.87 Favored 'General case' 0 C--N 1.347 0.486 0 N-CA-C 108.521 -0.918 . . . . 74.21 108.521 172.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.431 HG13 HG13 ' B' ' 64' ' ' VAL . 57.6 t -104.27 134.86 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.36 0.6 . . . . 74.52 111.015 -172.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -106.39 103.25 12.67 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.056 -1.461 . . . . 65.4 107.056 169.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.646 HD13 HD22 ' B' ' 128' ' ' LEU . 23.8 tp -85.48 147.05 26.65 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 107.855 -1.165 . . . . 73.25 107.855 171.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.517 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 12.0 t0 -155.27 154.09 31.61 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.337 -0.616 . . . . 61.05 109.337 -176.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.566 HD11 HG11 ' B' ' 131' ' ' VAL . 97.8 mt -124.92 130.54 52.56 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.341 0.657 . . . . 42.0 110.406 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -127.93 146.94 50.48 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.259 1.424 . . . . 72.54 108.048 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 7.8 t -145.32 127.42 15.63 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.004 0.431 . . . . 72.53 110.604 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.72 116.4 10.24 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.992 -1.114 . . . . 53.33 107.992 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.515 ' HB3' ' HA ' ' B' ' 58' ' ' VAL . 56.1 p -144.69 165.07 29.1 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.094 0.405 . . . . 45.12 112.094 -173.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 67.1 p -160.96 153.05 20.01 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.337 -0.847 . . . . 61.04 110.21 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -82.57 115.03 21.36 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.875 -0.787 . . . . 72.53 108.875 166.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 pp -122.26 24.26 9.47 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.283 0.633 . . . . 62.13 110.746 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.611 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -169.17 169.0 9.59 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.585 0.754 . . . . 72.44 111.548 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ASP . . . . . 0.427 ' O ' HG23 ' B' ' 55' ' ' VAL . 2.8 m-20 -60.59 95.43 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.392 1.077 . . . . 64.45 112.572 -175.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 56.56 25.24 9.62 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.417 1.087 . . . . 75.54 111.866 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 89.0 t -116.93 111.79 36.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-N 114.322 -1.308 . . . . 71.12 108.117 177.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.654 ' HB2' HD13 ' F' ' 100' ' ' LEU . 8.2 t80 -101.41 138.64 38.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.099 1.36 . . . . 74.52 109.275 -174.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -116.41 114.22 23.95 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.467 -1.308 . . . . 63.22 107.467 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.515 ' HA ' ' HB3' ' B' ' 48' ' ' SER . 2.7 p -108.72 129.18 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 122.766 0.427 . . . . 75.34 110.993 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.482 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.3 t -102.33 108.48 24.07 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 N-CA-C 107.777 -1.194 . . . . 73.25 107.777 171.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 56.8 tp -95.11 102.58 14.4 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 108.516 -0.92 . . . . 53.13 108.516 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -94.05 117.88 30.73 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.588 -0.733 . . . . 74.4 109.241 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 54.1 t -105.02 128.3 58.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 108.706 -0.85 . . . . 74.23 108.706 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 14.9 m -104.88 138.4 41.19 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.998 0.519 . . . . 53.14 110.026 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.821 HG11 HD21 ' B' ' 126' ' ' LEU . 58.2 t -133.38 112.31 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.191 -1.04 . . . . 52.25 108.191 173.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.425 HG23 ' CD2' ' B' ' 75' ' ' LEU . 87.0 m -111.48 105.64 14.29 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.25 -1.019 . . . . 74.32 108.25 174.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.89 150.54 29.05 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.871 0.367 . . . . 63.53 110.145 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.522 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 30.7 p -144.69 130.7 19.36 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.424 -0.807 . . . . 74.42 111.015 -171.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.706 HD12 HG22 ' B' ' 31' ' ' VAL . 85.8 mt -94.35 98.45 10.91 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.053 -1.092 . . . . 71.34 108.053 173.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.1 -122.55 11.48 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 115.2 -0.909 . . . . 74.44 113.992 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -82.1 2.66 30.25 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.523 0.729 . . . . 71.11 112.764 -172.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -143.57 159.52 42.29 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.843 0.457 . . . . 73.31 110.89 -171.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 40.0 m -69.62 133.54 47.7 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.256 -0.884 . . . . 71.41 110.325 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.548 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -84.75 -60.94 1.91 Allowed 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.03 -1.47 . . . . 61.14 107.03 172.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -154.06 162.74 40.99 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.749 -1.114 . . . . 73.21 111.541 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.425 ' CD2' HG23 ' B' ' 65' ' ' THR . 35.3 mt -123.47 112.25 17.28 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 106.129 -1.804 . . . . 74.54 106.129 169.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' B' ' 117' ' ' MET . 40.5 t -124.54 118.34 26.36 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.364 -0.606 . . . . 74.01 109.364 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -140.2 128.66 22.75 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.564 0.745 . . . . 72.51 109.208 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.404 HG13 HD13 ' B' ' 21' ' ' ILE . 42.4 t -125.5 150.7 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.801 0.84 . . . . 73.24 110.125 -175.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.415 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 22.4 mt-30 -114.94 110.48 19.69 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.56 -0.533 . . . . 73.23 109.56 171.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.448 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.1 tp-100 -99.77 102.84 14.4 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.397 -0.594 . . . . 72.21 109.397 170.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.46 160.46 29.19 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 111.011 -0.836 . . . . 60.24 111.011 174.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.66 126.54 1.62 Allowed Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.916 -0.474 . . . . 61.41 111.916 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.471 HG13 ' HE1' ' B' ' 17' ' ' TYR . 57.9 mt -88.05 122.56 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 108.224 -1.028 . . . . 62.22 108.224 175.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -135.63 140.62 44.7 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.554 0.741 . . . . 72.54 110.067 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 21.2 m -88.72 118.69 28.58 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.458 0.703 . . . . 51.12 109.104 170.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.588 HD13 ' HB3' ' B' ' 56' ' ' TYR . 4.0 mp -116.94 110.59 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.048 -1.464 . . . . 52.54 107.048 175.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.729 ' HA ' ' HB ' ' F' ' 97' ' ' ILE . . . -155.88 172.06 19.0 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.959 0.504 . . . . 73.42 111.14 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.02 -60.46 0.82 Allowed Glycine 0 C--N 1.344 1.012 0 N-CA-C 111.072 -0.811 . . . . 63.21 111.072 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.421 HD13 ' HB2' ' B' ' 94' ' ' MET . 0.9 OUTLIER -68.53 169.84 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 123.446 0.698 . . . . 63.34 111.876 173.232 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -154.52 177.9 10.67 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.319 0.648 . . . . 74.11 110.838 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.34 -126.68 8.32 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-N 115.703 -0.68 . . . . 62.13 114.145 172.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.6 m -89.73 -47.59 7.82 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.788 0.835 . . . . 72.1 109.946 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -64.33 -19.02 65.17 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.379 -1.282 . . . . 71.34 112.152 -169.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.421 ' HB2' HD13 ' B' ' 89' ' ' ILE . 23.9 ptt? -62.53 -37.13 84.89 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.735 0.814 . . . . 74.41 112.015 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.97 -13.27 59.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.414 0.686 . . . . 53.22 112.466 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.583 ' HB2' HD22 ' B' ' 141' ' ' LEU . 58.0 t-80 -63.72 -32.16 73.57 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.843 0.457 . . . . 71.23 109.929 170.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -64.45 -49.47 71.34 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.51 0.724 . . . . 65.01 111.428 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.47 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.4 pp -76.95 -32.02 57.01 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.066 -0.516 . . . . 74.33 111.827 -174.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.89 -22.08 37.26 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 123.26 0.35 . . . . 64.31 113.859 -173.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.01 -59.35 1.74 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.091 0.556 . . . . 72.53 111.516 -173.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -67.23 -42.77 83.49 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.224 0.61 . . . . 74.13 111.662 -172.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.474 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 63.3 m -68.43 -49.07 32.93 Favored Pre-proline 0 CA--C 1.566 1.575 0 N-CA-C 113.413 0.894 . . . . 70.31 113.413 -175.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.429 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 35.6 Cg_exo -64.72 -28.07 60.15 Favored 'Trans proline' 0 C--N 1.39 2.757 0 C-N-CA 121.851 1.701 . . . . 72.43 113.245 177.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -58.36 -34.43 70.66 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 123.216 0.606 . . . . 73.24 111.94 174.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.473 HD13 HD11 ' B' ' 13' ' ' ILE . 58.2 mt -68.49 -35.97 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 115.387 -0.824 . . . . 73.33 110.469 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 93.8 mt -88.5 -31.65 18.61 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.312 0.856 . . . . 51.33 113.312 -170.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -53.26 -43.7 95.69 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 113.855 1.057 . . . . 73.33 113.855 -173.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -52.18 -42.41 59.75 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.893 2.395 . . . . 72.31 114.84 174.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.448 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 86.0 m-85 -68.62 -43.59 76.04 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.731 0.412 . . . . 72.52 110.749 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.14 -43.04 99.51 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.407 -0.815 . . . . 61.24 110.661 175.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 28.8 ttt-85 -57.74 -53.9 53.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.14 1.376 . . . . 64.43 110.902 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -66.03 -39.17 89.98 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.247 0.967 . . . . 72.53 110.669 -175.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.541 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 7.4 t -70.25 -34.26 72.62 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.869 -0.605 . . . . 51.4 110.989 -176.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.498 HD13 HG23 ' B' ' 64' ' ' VAL . 67.7 mt -60.47 -53.46 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.626 0.771 . . . . 72.23 109.652 169.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.461 HG21 ' OG ' ' C' ' 119' ' ' SER . 17.0 m -60.14 -28.56 67.99 Favored 'General case' 0 CA--C 1.551 1.011 0 O-C-N 123.807 0.692 . . . . 73.13 111.332 -177.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 29.7 m -64.47 -52.04 59.97 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 123.543 0.737 . . . . 53.53 110.656 171.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.545 ' HB2' ' SG ' ' B' ' 76' ' ' CYS . 25.2 mmt -63.21 -33.13 74.81 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.049 0.54 . . . . 75.54 111.345 -177.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 92.1 t -72.07 -38.38 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.84 1.256 . . . . 75.51 110.902 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 47.2 t -66.54 -34.7 78.5 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.314 -0.857 . . . . 65.13 110.53 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.554 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 74.6 mtt-85 -71.37 -37.52 71.61 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 114.788 -1.097 . . . . 74.44 109.408 177.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.49 -9.73 78.33 Favored Glycine 0 C--N 1.355 1.587 0 O-C-N 123.522 0.514 . . . . 74.5 112.69 172.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 3.2 m 69.93 20.81 6.49 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 125.487 1.515 . . . . 72.23 111.721 171.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -78.24 159.67 74.81 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.524 0.73 . . . . 75.32 111.169 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.91 172.07 0.88 Allowed 'Trans proline' 0 C--N 1.387 2.569 0 C-N-CA 123.271 2.647 . . . . 71.33 114.558 174.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.759 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 10.6 tp-100 -62.75 132.51 52.47 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.482 0.919 . . . . 73.43 113.482 -166.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.821 HD21 HG11 ' B' ' 64' ' ' VAL . 59.6 tp -126.71 106.43 9.37 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.681 0.792 . . . . 72.11 109.031 176.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -112.59 119.37 37.9 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 107.639 -1.245 . . . . 64.13 107.639 170.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.646 HD22 HD13 ' B' ' 42' ' ' LEU . 31.0 mt -77.67 145.95 36.34 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 122.99 0.182 . . . . 71.22 111.39 -176.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.96 128.33 91.8 Favored Pre-proline 0 CA--C 1.546 0.812 0 O-C-N 124.366 1.041 . . . . 72.52 111.845 -175.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.485 ' HG3' HD11 ' D' ' 16' ' ' ILE . 51.3 Cg_endo -68.54 87.31 0.42 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.897 2.398 . . . . 52.15 112.033 176.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.566 HG11 HD11 ' B' ' 44' ' ' LEU . 2.5 p -90.49 109.8 21.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 108.291 -1.003 . . . . 75.15 108.291 172.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -74.78 110.12 8.82 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.726 -1.124 . . . . 64.51 108.216 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -61.69 -31.02 71.13 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.042 0.537 . . . . 72.12 111.206 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -55.73 -42.14 74.92 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.545 0.738 . . . . 62.22 111.322 171.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.2 -30.08 70.21 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 123.713 0.633 . . . . 74.2 112.03 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.3 mp -74.65 -54.44 7.43 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.284 0.564 . . . . 74.31 109.732 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -74.27 -12.78 60.65 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.075 0.95 . . . . 73.4 113.288 -173.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -21.04 61.12 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 120.871 0.367 . . . . 72.42 110.595 177.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -75.48 -33.32 60.8 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.076 0.55 . . . . 74.01 110.448 177.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 140' ' ' TYR . . . . . 0.442 ' HB2' HD12 ' B' ' 141' ' ' LEU . 89.3 m-85 -87.54 -49.12 7.39 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.843 -0.617 . . . . 73.24 110.769 -177.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.583 HD22 ' HB2' ' B' ' 96' ' ' HIS . 6.3 mp -100.55 10.63 40.93 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.745 0.818 . . . . 73.13 111.675 -172.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 66.89 176.27 0.24 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.717 1.207 . . . . 62.33 112.983 173.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -75.72 124.18 26.83 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.451 -0.795 . . . . 72.45 108.867 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -67.45 -52.76 35.65 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.498 0.719 . . . . 73.21 109.876 176.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -164.21 166.73 20.79 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.73 0.812 . . . . 54.12 110.809 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -173.77 40.44 0.14 Allowed Glycine 0 C--N 1.342 0.889 0 CA-C-N 116.271 -0.422 . . . . 65.0 112.279 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -94.4 149.4 21.28 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.027 0.931 . . . . 74.14 110.105 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 148' ' ' GLY . . . . . 0.557 ' HA3' ' HB2' ' D' ' 93' ' ' GLN . . . -137.68 -154.71 6.66 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 111.722 -0.551 . . . . 72.02 111.722 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 3.8 m 73.59 4.44 4.75 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 125.069 1.348 . . . . 74.12 111.814 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.73 -5.92 28.43 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.507 1.123 . . . . 74.44 112.566 -176.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 151' ' ' GLU . . . . . 0.484 ' HA ' ' HG ' ' D' ' 141' ' ' LEU . 0.3 OUTLIER -68.72 139.26 55.37 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 124.248 1.019 . . . . 71.11 110.475 178.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -127.75 -30.67 2.51 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.036 0.934 . . . . 45.11 111.487 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 68.07 97.92 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.113 1.365 . . . . 63.41 111.391 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -93.4 -62.95 1.27 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.876 -0.787 . . . . 74.55 108.876 176.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.869 0 N-CA-C 108.981 -0.748 . . . . 54.35 108.981 175.122 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 112.346 0.499 . . . . 63.33 112.346 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 63.5 m -148.79 43.33 0.98 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.462 0.648 . . . . 72.23 110.239 -169.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 3' ' ' GLU . . . . . 0.441 ' HG2' ' ND2' ' A' ' 132' ' ' ASN . 0.0 OUTLIER -138.5 112.9 8.78 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.485 0.714 . . . . 61.22 109.634 -179.248 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 51.37 45.25 28.24 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 125.404 1.482 . . . . 53.21 112.138 177.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -151.37 145.21 25.12 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.48 -0.782 . . . . 62.23 109.947 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.48 -44.69 50.38 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.945 -0.57 . . . . 71.12 110.399 173.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 12.8 p -144.82 -63.95 0.35 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.997 0.919 . . . . 54.33 109.087 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -153.44 -62.36 0.14 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.723 1.209 . . . . 55.12 108.606 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 25.9 ttt 65.74 114.38 0.03 OUTLIER 'General case' 0 C--N 1.361 1.088 0 C-N-CA 125.578 1.551 . . . . 63.11 111.693 -171.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 13.2 m -87.04 87.27 7.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.864 0.866 . . . . 55.31 109.751 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.51 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 64.0 t80 -113.57 118.61 34.9 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.539 -0.912 . . . . 73.42 108.539 177.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -135.79 125.21 24.93 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.275 -0.639 . . . . 64.33 109.275 -177.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 45.4 mt -77.16 128.16 38.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 109.466 -0.568 . . . . 70.32 109.466 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -88.69 -49.74 6.67 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.826 -0.805 . . . . 72.41 108.826 174.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.573 ' HB2' ' HG2' ' A' ' 125' ' ' GLN . 0.0 OUTLIER -174.58 149.48 1.27 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.221 1.008 . . . . 74.35 110.245 176.27 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.497 HG23 HD23 ' C' ' 106' ' ' LEU . 78.0 mt -120.57 131.59 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.503 1.121 . . . . 74.24 108.299 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.609 ' HB3' HG23 ' D' ' 122' ' ' THR . 20.8 p90 -164.44 172.19 13.7 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 121.422 0.63 . . . . 64.34 112.17 -167.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.1 p -100.38 120.3 39.76 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.268 -0.878 . . . . 72.35 109.248 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -69.29 -48.75 60.72 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 106.979 -1.489 . . . . 63.12 106.979 165.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.629 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.3 t70 -134.56 145.59 48.85 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 113.655 -1.611 . . . . 61.05 110.663 -173.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.406 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.5 mt -137.64 149.17 25.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 126.717 2.007 . . . . 72.35 105.714 172.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.1 t -156.95 149.58 23.45 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.829 -0.434 . . . . 74.53 109.829 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -155.98 129.59 8.39 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 107.265 -1.383 . . . . 74.31 107.265 174.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -132.15 132.91 43.66 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.681 -0.859 . . . . 74.25 108.681 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.33 80.55 22.6 Favored Pre-proline 0 CA--C 1.549 0.93 0 N-CA-C 106.625 -1.62 . . . . 73.13 106.625 170.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -65.25 -41.19 16.88 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.82 2.347 . . . . 63.04 111.702 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -94.82 18.37 11.92 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 114.398 -1.274 . . . . 63.11 110.779 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.98 -61.02 1.67 Allowed Pre-proline 0 C--N 1.369 1.427 0 C-N-CA 124.974 1.31 . . . . 61.42 114.097 -171.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -61.52 -39.48 54.89 Favored 'Trans proline' 0 C--N 1.39 2.715 0 C-N-CA 121.66 1.573 . . . . 75.31 112.15 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.48 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 85.2 t60 -71.4 -30.63 66.32 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 115.44 -0.8 . . . . 73.24 112.385 -178.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.728 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.0 p -82.96 -15.88 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 O-C-N 121.794 -0.566 . . . . 65.21 111.836 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -75.45 -20.76 58.64 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.112 0.565 . . . . 73.33 112.227 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 20.8 pt20 -94.07 8.69 40.61 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.493 0.717 . . . . 64.43 110.944 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -99.12 161.76 13.44 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.881 0.872 . . . . 71.01 110.988 -171.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -71.49 121.79 19.29 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.403 0.681 . . . . 75.04 109.638 172.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -83.74 93.39 7.93 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.22 0.608 . . . . 74.45 111.016 -174.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 37' ' ' GLN . . . . . 0.414 ' H ' HD22 ' C' ' 68' ' ' LEU . 52.9 tt0 -145.43 78.98 11.77 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.06 0.944 . . . . 71.22 108.494 173.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -82.45 141.33 11.2 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.695 2.263 . . . . 74.51 113.179 -173.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -87.38 88.43 7.68 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.012 -1.477 . . . . 64.21 107.012 163.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 40.3 t -83.87 111.96 20.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-N 115.117 -0.947 . . . . 74.53 110.078 -175.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.492 ' HA ' ' HB3' ' F' ' 136' ' ' LYS . 13.7 tmtt? -91.1 101.08 13.83 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 107.85 -1.167 . . . . 72.13 107.85 172.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.485 ' HB3' HG13 ' F' ' 135' ' ' VAL . 3.9 tt -87.61 121.69 30.36 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.069 -1.826 . . . . 70.44 106.069 173.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -118.31 138.35 52.45 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.428 -0.953 . . . . 60.0 108.428 -175.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.537 HD22 HD21 ' C' ' 60' ' ' LEU . 25.7 mt -132.02 111.84 11.86 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.852 0.834 . . . . 74.22 110.298 178.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -127.5 122.43 33.34 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.904 1.682 . . . . 72.55 107.268 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -123.16 125.86 45.93 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 120.99 0.424 . . . . 52.12 110.057 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.16 160.51 16.86 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.218 1.007 . . . . 62.23 109.384 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 31.1 p -151.94 146.06 25.33 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.308 0.643 . . . . 54.44 110.27 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 54.1 p -146.99 135.9 22.31 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.694 0.798 . . . . 72.14 109.351 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -78.32 117.08 19.22 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 108.856 -0.794 . . . . 71.15 108.856 175.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.707 HD11 ' HB2' ' C' ' 57' ' ' GLU . 30.8 mt -85.54 -33.28 21.79 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.899 0.88 . . . . 74.25 110.478 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.96 -174.48 3.34 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.408 1.083 . . . . 73.11 109.6 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.23 117.21 6.25 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.464 -0.789 . . . . 73.12 109.288 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 70.35 11.92 7.48 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.884 1.274 . . . . 72.3 112.044 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 30.4 t -118.32 116.27 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.196 -0.668 . . . . 60.35 109.196 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -127.46 125.12 39.95 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.017 0.927 . . . . 64.24 108.672 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.707 ' HB2' HD11 ' C' ' 51' ' ' LEU . 34.8 tt0 -85.8 142.14 29.15 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.964 -0.754 . . . . 71.1 108.964 169.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 60.1 t -128.8 122.84 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 107.817 -1.179 . . . . 64.5 107.817 167.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 68.2 t -109.64 127.56 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 109.283 -0.636 . . . . 70.44 109.283 173.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.537 HD21 HD22 ' C' ' 44' ' ' LEU . 0.1 OUTLIER -107.38 100.99 10.38 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 107.738 -1.208 . . . . 61.12 107.738 -176.544 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -82.22 106.12 13.85 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.455 0.702 . . . . 75.13 109.16 172.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.443 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.6 t -102.88 124.7 57.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.417 -1.327 . . . . 64.54 107.417 169.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 12.5 m -125.34 113.24 17.31 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.526 0.679 . . . . 62.2 109.486 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.428 HG21 HG21 ' C' ' 114' ' ' ILE . 99.5 t -102.49 111.07 30.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 124.482 1.113 . . . . 64.14 109.132 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.517 HG23 HD23 ' C' ' 75' ' ' LEU . 6.8 m -104.35 108.62 20.12 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 109.121 -0.696 . . . . 71.21 109.121 176.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.9 100.63 10.18 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.642 -0.873 . . . . 65.32 108.642 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 40.5 m -129.03 131.76 47.4 Favored 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 109.038 -0.727 . . . . 75.32 109.038 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.414 HD22 ' H ' ' C' ' 37' ' ' GLN . 12.2 mt -84.91 26.51 0.83 Allowed 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 125.137 1.375 . . . . 62.02 111.3 -175.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.62 -109.49 1.06 Allowed Glycine 0 C--N 1.348 1.229 0 N-CA-C 109.486 -1.446 . . . . 60.31 109.486 -170.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.59 -31.56 16.64 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.215 -0.661 . . . . 74.21 109.215 169.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -69.37 104.25 2.22 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 124.065 0.946 . . . . 72.11 109.964 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.1 m -78.55 123.95 27.63 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 109.384 -0.598 . . . . 72.43 109.384 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.728 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -77.42 -57.61 3.73 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.091 -1.077 . . . . 71.13 108.091 176.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 74' ' ' PHE . . . . . 0.435 ' HZ ' HD22 ' C' ' 126' ' ' LEU . 49.5 p90 -156.52 154.97 31.16 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.846 -1.07 . . . . 74.22 111.268 175.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.517 HD23 HG23 ' C' ' 65' ' ' THR . 2.5 tm? -113.09 145.47 40.85 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 106.094 -1.817 . . . . 74.43 106.094 163.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.449 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.6 t -151.68 125.16 8.88 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.989 -0.745 . . . . 74.31 108.989 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -131.76 136.71 47.79 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.331 -0.618 . . . . 74.15 109.331 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.466 HG11 ' HA ' ' C' ' 110' ' ' ALA . 22.7 t -132.13 113.92 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.658 -0.867 . . . . 74.3 108.658 174.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.629 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.3 mt-30 -91.73 87.96 6.5 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.017 0.927 . . . . 62.41 109.115 172.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -79.45 96.9 6.19 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.402 1.081 . . . . 53.11 110.337 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.77 144.54 22.15 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.396 -0.366 . . . . 72.22 112.694 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.425 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.24 128.11 2.86 Favored Glycine 0 CA--C 1.503 -0.713 0 N-CA-C 111.096 -0.802 . . . . 72.42 111.096 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.42 HD11 ' HB3' ' D' ' 29' ' ' PRO . 27.3 mm -95.09 123.54 47.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.248 -1.019 . . . . 75.14 108.248 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -132.23 118.68 19.83 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.517 0.727 . . . . 62.04 109.986 -173.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 56.9 m -76.41 100.8 5.32 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.464 -0.569 . . . . 71.12 109.464 170.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.576 HD13 ' SG ' ' C' ' 97' ' ' CYS . 18.4 mt -114.13 131.6 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.239 0.615 . . . . 70.44 110.042 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.479 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -153.4 169.4 23.23 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.163 0.985 . . . . 54.53 109.956 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.53 -19.2 41.78 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.936 -0.574 . . . . 63.54 113.452 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 22.3 pt -111.03 170.5 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.051 0.54 . . . . 63.51 111.135 -175.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -166.21 149.51 7.36 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.905 0.482 . . . . 74.3 110.7 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.81 -113.15 5.06 Favored Glycine 0 C--N 1.354 1.547 0 CA-C-N 115.872 -0.604 . . . . 63.11 113.43 170.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 92' ' ' THR . . . . . 0.453 ' HA ' HD11 ' C' ' 141' ' ' LEU . 34.6 p -61.19 -43.43 98.89 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.858 0.863 . . . . 75.11 111.281 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -59.24 -42.7 91.72 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 114.965 -1.016 . . . . 74.54 110.739 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.502 ' HE1' HG21 ' C' ' 86' ' ' ILE . 6.7 tpt -68.48 -43.63 76.52 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.845 -1.07 . . . . 64.25 110.573 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.75 -36.49 79.04 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.472 0.709 . . . . 71.31 111.318 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 96' ' ' HIS . . . . . 0.408 ' CD2' ' HB3' ' C' ' 100' ' ' ALA . 12.9 t-80 -77.32 -31.7 54.78 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.102 0.408 . . . . 74.03 112.102 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.576 ' SG ' HD13 ' C' ' 86' ' ' ILE . 24.7 t -66.36 -43.83 84.92 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.688 -0.856 . . . . 63.42 108.688 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 43.3 mt -78.69 -28.3 45.21 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.374 -1.285 . . . . 73.33 111.104 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.61 -27.97 52.92 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 115.701 -0.681 . . . . 65.15 114.14 -172.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.408 ' HB3' ' CD2' ' C' ' 96' ' ' HIS . . . -154.83 -48.75 0.09 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.172 1.175 . . . . 72.44 114.172 -163.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -62.73 -51.86 65.52 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.686 0.616 . . . . 61.12 111.465 -173.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.51 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 57.6 m -66.52 -50.05 48.86 Favored Pre-proline 0 CA--C 1.56 1.351 0 CA-C-O 118.271 -0.871 . . . . 52.44 111.502 177.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.504 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 85.4 Cg_exo -51.56 -30.99 38.0 Favored 'Trans proline' 0 C--N 1.399 3.227 0 C-N-CA 123.029 2.486 . . . . 61.12 114.898 172.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -65.35 -43.51 90.63 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.06 0.544 . . . . 60.34 109.717 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.487 HD12 ' NH1' ' A' ' 111' ' ' ARG . 35.1 mm -72.74 -29.12 28.99 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 CA-C-N 115.663 -0.699 . . . . 73.35 110.462 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.497 HD23 HG23 ' C' ' 16' ' ' ILE . 89.0 mt -77.62 -29.68 51.96 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.815 0.846 . . . . 71.45 111.883 178.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -58.78 -50.19 89.37 Favored Pre-proline 0 N--CA 1.482 1.173 0 CA-C-O 117.448 -1.263 . . . . 74.12 114.279 -168.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.93 -32.54 92.63 Favored 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 121.832 1.688 . . . . 62.22 112.75 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -68.42 -48.26 65.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.414 0.685 . . . . 75.41 110.425 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.466 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -62.57 -35.49 79.65 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 115.952 -0.567 . . . . 25.45 111.149 176.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -63.07 -54.85 31.51 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.313 1.445 . . . . 63.15 111.374 -177.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -66.98 -30.13 70.17 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.305 0.642 . . . . 71.1 110.153 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 14.0 t -68.43 -34.5 76.09 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.456 0.702 . . . . 70.31 111.394 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.449 HG23 ' SG ' ' C' ' 76' ' ' CYS . 96.3 mt -74.46 -50.56 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.478 0.711 . . . . 75.4 110.298 174.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 9.1 m -66.34 -28.39 68.63 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.26 0.624 . . . . 62.44 111.602 -173.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 79.5 p -66.59 -45.36 79.48 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 109.13 -0.693 . . . . 54.41 109.13 172.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.576 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.42 -40.65 78.79 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.421 1.088 . . . . 65.55 112.478 176.384 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.411 HG23 ' O ' ' C' ' 114' ' ' ILE . 62.8 t -64.73 -40.83 90.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.29 0.636 . . . . 61.15 110.609 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.461 ' OG ' HG21 ' B' ' 115' ' ' THR . 28.2 t -67.02 -34.63 78.15 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.05 0.94 . . . . 70.2 112.016 175.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' C' ' 116' ' ' SER . 66.0 mtt-85 -65.73 -36.3 83.19 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.237 0.615 . . . . 73.33 109.502 177.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.61 11.21 62.2 Favored Glycine 0 C--N 1.356 1.668 0 CA-C-O 119.284 -0.731 . . . . 65.13 113.322 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.425 HG23 ' HB3' ' D' ' 17' ' ' TYR . 67.6 p 59.09 21.76 9.77 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 126.139 1.776 . . . . 43.53 114.648 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -85.37 157.21 59.11 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 108.385 -0.969 . . . . 73.31 108.385 170.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.759 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 30.1 Cg_endo -61.6 168.46 8.28 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.831 2.354 . . . . 74.41 113.966 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -62.01 110.73 1.66 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.749 -1.114 . . . . 74.14 111.532 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.435 HD22 ' HZ ' ' C' ' 74' ' ' PHE . 9.5 mp -106.3 87.03 2.46 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.343 -1.354 . . . . 74.25 107.343 169.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -90.03 109.17 20.23 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.205 -1.035 . . . . 74.14 108.205 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 64.1 mt -61.04 131.29 50.13 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.529 0.732 . . . . 74.35 110.758 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.1 146.92 98.85 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 118.786 -0.626 . . . . 61.34 110.454 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -48.85 99.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.776 2.317 . . . . 75.32 112.7 172.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 58.0 t -97.4 109.03 22.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 107.494 -1.299 . . . . 64.41 107.494 172.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -86.11 101.3 12.85 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.669 -0.863 . . . . 75.22 108.669 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -57.18 -35.62 69.81 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.011 0.925 . . . . 74.21 111.347 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -68.46 -25.91 65.23 Favored 'General case' 0 C--O 1.219 -0.533 0 C-N-CA 123.949 0.9 . . . . 65.52 111.942 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.55 -40.54 56.68 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.031 0.532 . . . . 73.42 110.243 171.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 79.0 mt -65.65 -36.0 82.41 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.407 -0.815 . . . . 74.02 111.096 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -83.21 -32.43 26.53 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-N 115.878 -0.601 . . . . 74.23 110.265 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 40.2 ttm -56.89 -48.64 77.71 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.683 0.793 . . . . 63.42 111.684 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -62.17 -36.53 82.14 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.274 -0.875 . . . . 74.35 111.123 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -72.14 -85.79 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 123.772 0.829 . . . . 74.12 109.902 172.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.453 HD11 ' HA ' ' C' ' 92' ' ' THR . 8.7 tt -102.83 131.74 49.5 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.866 1.267 . . . . 65.32 109.275 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -121.66 163.07 19.59 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.298 1.039 . . . . 70.33 110.833 -177.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -115.05 -132.56 0.33 Allowed 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 108.487 -0.931 . . . . 71.34 108.487 172.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -172.75 114.76 0.28 Allowed 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.37 0.986 . . . . 64.13 111.128 -170.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 145' ' ' ALA . . . . . 0.407 ' HB3' ' HA2' ' E' ' 143' ' ' GLY . . . 174.78 170.76 0.25 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 125.031 1.332 . . . . 62.3 110.278 172.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.92 172.36 21.61 Favored Glycine 0 C--N 1.351 1.394 0 N-CA-C 112.031 -0.428 . . . . 54.4 112.031 175.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -110.61 -59.17 1.99 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.424 0.689 . . . . 75.55 109.92 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.4 96.08 0.16 Allowed Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.461 -0.79 . . . . 42.12 113.078 -176.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 32.0 p -73.65 -51.14 17.75 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.898 0.879 . . . . 74.23 111.992 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -151.75 149.64 29.28 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.308 0.643 . . . . 51.31 110.59 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -121.25 92.22 3.7 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.154 0.982 . . . . 53.31 109.871 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -140.22 178.99 6.9 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.032 0.933 . . . . 70.15 108.76 170.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -141.02 110.37 6.29 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.548 -0.908 . . . . 55.42 108.548 -177.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -84.78 158.15 20.79 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.043 0.537 . . . . 64.33 109.648 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.288 0 C-N-CA 124.298 1.039 . . . . 71.11 112.186 -174.784 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mpp? . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.733 -0.469 . . . . 74.21 109.733 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 54.2 m -138.36 107.16 5.94 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.228 0.611 . . . . 63.32 110.005 -177.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -71.49 91.07 1.02 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.269 0.628 . . . . 74.43 109.814 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -92.38 -41.18 10.48 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.994 0.918 . . . . 70.34 109.253 -175.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 52.6 t30 73.75 153.79 0.14 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 125.094 1.357 . . . . 72.0 110.377 -173.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -88.64 155.21 19.74 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.149 0.579 . . . . 72.31 110.598 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 15.2 p -140.94 -62.02 0.48 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.986 0.914 . . . . 71.44 108.922 173.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -132.55 91.61 2.95 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.569 0.748 . . . . 74.31 109.012 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -35.2 133.16 0.34 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.823 1.249 . . . . 75.11 112.796 169.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 6.2 t -133.23 135.63 45.12 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.117 0.567 . . . . 73.34 110.133 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.451 ' HD2' HG22 ' D' ' 86' ' ' ILE . 80.3 t80 -132.83 107.91 8.63 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.178 -1.416 . . . . 73.11 107.178 176.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -128.91 116.06 18.81 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.994 0.918 . . . . 74.41 108.658 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 10.7 mt -82.75 130.45 35.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 108.303 -0.999 . . . . 70.12 108.303 174.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -94.82 -34.65 12.39 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 123.621 0.575 . . . . 71.14 110.429 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -167.76 141.43 3.43 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.323 0.389 . . . . 75.1 111.015 -173.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.485 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.7 mp -122.98 134.92 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 107.292 -1.373 . . . . 72.02 107.292 171.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.448 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 36.4 p90 -161.54 176.42 11.07 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.535 0.683 . . . . 64.53 112.372 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 53.6 p -103.47 127.22 50.9 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.422 -0.808 . . . . 72.52 109.357 173.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.448 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 32.5 mtpt -97.39 -19.22 18.62 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.027 0.531 . . . . 75.32 109.823 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.599 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 31.7 t70 -158.52 144.29 16.78 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.836 0.855 . . . . 73.24 109.876 177.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.576 HD13 ' HE3' ' C' ' 117' ' ' MET . 81.2 mt -148.59 142.91 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.624 1.569 . . . . 75.04 107.528 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.9 t -154.78 134.43 12.77 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.45 0.7 . . . . 63.35 109.419 164.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 88.8 t80 -119.75 133.92 55.43 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 105.827 -1.916 . . . . 62.35 105.827 166.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -138.69 120.59 15.46 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.349 0.659 . . . . 75.1 109.518 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.551 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -119.03 85.04 28.28 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 107.527 -1.286 . . . . 72.25 107.527 175.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -71.9 -29.55 15.11 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.873 2.382 . . . . 72.32 112.801 -168.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -115.27 16.58 16.83 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.077 0.951 . . . . 75.12 110.74 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.551 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -42.96 -58.03 4.4 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 114.887 1.44 . . . . 74.0 114.887 -161.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.42 ' HB3' HD11 ' C' ' 83' ' ' ILE . 89.6 Cg_endo -72.31 -26.18 17.73 Favored 'Trans proline' 0 C--N 1.378 2.124 0 CA-C-N 122.356 1.877 . . . . 74.51 113.992 -175.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -74.95 -36.68 62.08 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.848 0.859 . . . . 72.32 109.887 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.432 HG12 ' O ' ' D' ' 28' ' ' ALA . 9.8 p -83.91 -16.89 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-N 115.94 -0.573 . . . . 73.11 111.683 -172.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -68.15 -13.06 61.94 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 111.741 0.275 . . . . 74.03 111.741 175.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -69.48 -3.74 15.81 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.293 0.637 . . . . 74.52 111.3 174.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -110.69 102.88 11.4 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.276 1.43 . . . . 75.21 109.505 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -99.98 84.56 2.89 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.387 0.675 . . . . 54.11 111.125 -174.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -156.82 172.81 17.97 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 114.68 -1.145 . . . . 65.5 108.507 166.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -68.15 120.18 72.67 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-O 118.251 -0.88 . . . . 74.41 108.744 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -51.02 134.76 43.42 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 122.892 2.395 . . . . 61.12 112.124 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -69.34 110.52 4.7 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.879 -1.526 . . . . 73.43 106.879 170.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.722 HG13 HG13 ' D' ' 64' ' ' VAL . 38.4 t -107.05 108.86 26.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.84 0 CA-C-N 115.759 -0.655 . . . . 52.2 109.907 -173.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -87.95 109.27 19.68 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.603 -0.888 . . . . 73.31 108.603 168.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.447 HD12 ' O ' ' D' ' 63' ' ' THR . 58.9 tp -97.18 141.05 30.77 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.273 1.029 . . . . 62.22 109.228 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.614 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 21.5 t70 -123.94 131.9 53.64 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.385 -1.339 . . . . 73.34 107.385 173.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.612 ' HB3' HD23 ' E' ' 111' ' ' LEU . 31.9 mt -119.65 129.9 54.8 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.095 -0.706 . . . . 74.13 109.095 174.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.6 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 30.7 t70 -138.07 140.53 40.06 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 107.7 -1.222 . . . . 72.32 107.7 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 3.8 t -104.2 148.17 26.62 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.242 -0.651 . . . . 63.12 109.242 -176.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.421 ' HA ' ' OG1' ' E' ' 107' ' ' THR . . . -149.96 151.22 33.0 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.812 0.845 . . . . 52.54 109.423 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.443 ' HB3' HG22 ' D' ' 58' ' ' VAL . 10.1 p -171.02 152.18 3.45 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.904 0.882 . . . . 75.11 109.235 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 51.6 p -155.1 118.8 4.54 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.613 0.365 . . . . 61.53 110.796 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 50' ' ' GLN . . . . . 0.508 ' HB2' ' HA ' ' D' ' 56' ' ' TYR . 4.5 mm-40 174.93 150.96 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 126.554 1.942 . . . . 74.04 108.449 170.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 8.1 mp -99.77 98.11 8.97 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.374 0.67 . . . . 53.23 109.217 176.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . 61.2 -145.73 0.45 Allowed 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.617 0.767 . . . . 54.43 111.12 174.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 19.8 t0 74.16 6.0 4.7 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.909 1.283 . . . . 71.2 112.534 170.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.619 ' HB2' ' HB3' ' E' ' 94' ' ' PHE . 41.4 m-20 62.47 8.02 2.65 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.193 1.397 . . . . 63.43 113.639 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 50.9 t -134.39 117.63 24.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 108.767 -0.827 . . . . 74.2 108.767 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.508 ' HA ' ' HB2' ' D' ' 50' ' ' GLN . 33.4 m-85 -131.98 132.74 43.74 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 107.016 -1.476 . . . . 75.41 107.016 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -85.83 115.35 23.42 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 107.357 -1.349 . . . . 75.14 107.357 171.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.443 HG22 ' HB3' ' D' ' 48' ' ' SER . 70.3 t -99.97 130.55 48.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.643 -1.162 . . . . 74.33 108.687 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.547 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 16.5 t -111.85 146.78 16.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.879 -0.786 . . . . 62.41 108.879 176.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.41 119.87 37.01 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.581 -1.266 . . . . 73.34 107.581 176.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.6 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 2.9 tmm_? -95.4 96.21 8.96 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 108.042 -1.095 . . . . 74.53 108.042 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.443 HG13 HD11 ' D' ' 42' ' ' LEU . 54.0 t -101.67 125.12 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.574 -0.899 . . . . 71.42 108.574 176.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.614 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 50.0 m -121.66 131.07 53.9 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 123.285 0.634 . . . . 52.54 109.526 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.722 HG13 HG13 ' D' ' 40' ' ' VAL . 83.7 t -113.86 127.06 71.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.778 -0.823 . . . . 73.43 108.778 172.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 22.4 m -119.61 92.92 3.91 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.336 -1.727 . . . . 72.43 106.336 168.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.54 143.59 30.53 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 109.652 -0.499 . . . . 71.21 109.652 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 77.9 p -147.7 137.3 22.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.238 0.542 . . . . 63.22 111.158 -173.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 26.8 mt -108.73 110.5 21.91 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.404 -1.332 . . . . 74.5 107.404 171.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.98 -134.98 20.85 Favored Glycine 0 C--N 1.342 0.909 0 O-C-N 123.589 0.556 . . . . 61.44 113.302 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.24 6.05 46.71 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.554 0.741 . . . . 73.33 112.179 -176.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -130.07 167.86 17.65 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.074 0.55 . . . . 74.31 110.602 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 66.0 m -71.46 138.67 49.2 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.454 -0.794 . . . . 72.11 111.217 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.427 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -89.77 -63.11 1.33 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.239 -1.393 . . . . 65.4 107.239 169.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -158.56 161.08 37.26 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.652 -1.158 . . . . 74.11 110.951 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 68.8 mt -131.8 112.64 12.67 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.458 1.503 . . . . 63.14 107.151 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.623 ' SG ' HG23 ' D' ' 114' ' ' ILE . 49.2 t -131.94 106.23 7.92 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 122.583 0.353 . . . . 54.35 110.378 -168.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -129.0 125.89 38.35 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.428 0.691 . . . . 42.33 109.657 -173.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 88.2 t -132.6 115.39 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.114 0.965 . . . . 73.24 109.822 -174.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.599 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 2.3 mp0 -90.03 87.31 6.85 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.892 0.877 . . . . 53.23 109.051 175.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -81.81 102.9 11.11 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.691 -1.14 . . . . 70.04 109.346 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -111.64 147.24 17.98 Favored Glycine 0 N--CA 1.475 1.236 0 CA-C-O 120.157 -0.246 . . . . 44.33 112.517 -178.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.91 151.91 23.1 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 117.133 0.467 . . . . 51.41 112.252 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 3.0 mp -89.74 118.22 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 108.707 -0.849 . . . . 71.43 108.707 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -115.29 150.08 36.81 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.943 0.897 . . . . 65.44 110.165 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 33.1 t -115.76 104.73 11.95 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.992 0.917 . . . . 60.42 109.152 175.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.495 HD11 HD23 ' D' ' 98' ' ' LEU . 47.2 pt -115.03 130.28 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.153 0.581 . . . . 62.21 109.838 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.87 165.29 34.98 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.587 0.755 . . . . 64.34 109.767 175.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.69 23.39 75.24 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-O 119.692 -0.504 . . . . 74.43 114.315 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.453 HG22 ' H ' ' D' ' 90' ' ' GLU . 0.1 OUTLIER -103.1 168.81 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 108.733 -0.84 . . . . 73.22 108.733 172.728 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.453 ' H ' HG22 ' D' ' 89' ' ' ILE . 8.8 pt-20 -135.1 178.17 7.24 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.02 0.928 . . . . 75.23 111.08 -178.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.79 -138.77 42.47 Favored Glycine 0 C--N 1.358 1.797 0 CA-C-N 115.676 -0.693 . . . . 64.22 113.068 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 65.5 p -88.31 -20.37 25.48 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.167 0.587 . . . . 64.13 110.284 170.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.751 ' HA ' ' HB3' ' D' ' 96' ' ' HIS . 25.7 tp60 -59.69 -21.42 60.56 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.186 1.395 . . . . 54.32 112.295 -175.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.425 ' HA ' ' HB ' ' D' ' 89' ' ' ILE . 16.8 ptp -57.51 -51.04 71.07 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.435 0.694 . . . . 71.12 111.856 172.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 95' ' ' ALA . . . . . 0.716 ' HB2' ' HB2' ' E' ' 100' ' ' LEU . . . -86.23 -22.77 26.72 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.943 0.497 . . . . 72.42 111.771 176.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.751 ' HB3' ' HA ' ' D' ' 93' ' ' GLN . 19.6 t-80 -75.02 -11.27 60.06 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.184 0.593 . . . . 54.22 110.094 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 43.7 t -72.99 -51.2 19.17 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.966 0.506 . . . . 73.41 110.447 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.517 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 3.2 pp -77.64 -19.03 56.14 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.037 0.384 . . . . 55.54 112.037 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.35 -0.82 64.91 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-O 119.817 -0.435 . . . . 73.35 113.345 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.14 -66.78 0.39 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.903 0.481 . . . . 64.02 111.212 -176.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -66.84 -43.33 83.97 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.436 0.294 . . . . 72.43 111.78 -173.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.517 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 75.6 m -63.74 -47.44 81.71 Favored Pre-proline 0 CA--C 1.567 1.629 0 CA-C-O 118.289 -0.862 . . . . 75.12 112.591 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.598 ' HA ' HD12 ' D' ' 106' ' ' LEU . 27.9 Cg_exo -62.51 -28.53 77.75 Favored 'Trans proline' 0 C--N 1.399 3.233 0 C-N-CA 122.153 1.902 . . . . 53.33 112.964 170.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -67.91 -32.86 73.63 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.616 0.367 . . . . 75.44 111.068 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 48.0 mm -65.58 -34.38 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.149 0.58 . . . . 74.2 110.241 173.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.598 HD12 ' HA ' ' D' ' 103' ' ' PRO . 29.5 mt -77.81 -18.27 56.55 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.381 -0.827 . . . . 72.31 111.933 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.04 -41.3 10.74 Favored Pre-proline 0 N--CA 1.486 1.358 0 N-CA-C 113.91 1.078 . . . . 71.2 113.91 -173.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -50.65 -42.91 48.34 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.208 1.939 . . . . 64.22 112.721 169.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 109' ' ' TYR . . . . . 0.455 ' OH ' ' HB3' ' B' ' 130' ' ' PRO . 93.2 m-85 -79.49 -27.29 41.47 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.634 0.774 . . . . 74.3 111.732 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.06 -49.5 67.41 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.049 -0.722 . . . . 75.24 109.049 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -67.13 -33.37 75.29 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 113.868 -1.515 . . . . 51.44 110.864 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -53.92 -55.79 23.73 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 124.007 0.923 . . . . 70.24 110.268 174.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.408 ' O ' ' HG3' ' D' ' 117' ' ' MET . 47.2 t -62.99 -47.52 82.79 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 114.225 -1.352 . . . . 74.32 111.182 -177.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.623 HG23 ' SG ' ' D' ' 76' ' ' CYS . 68.5 mt -60.95 -61.74 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.324 0.65 . . . . 73.02 111.576 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 22.3 m -51.97 -40.42 60.86 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 124.198 0.937 . . . . 73.42 111.455 -175.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 37.5 t -60.41 -50.77 72.27 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 114.343 -1.299 . . . . 74.42 110.751 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.408 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 72.4 mtm -66.54 -30.85 71.25 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.122 0.569 . . . . 75.41 112.16 -178.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.8 t -66.56 -44.34 90.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.722 0.809 . . . . 73.14 110.042 176.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 83.7 p -74.83 -28.67 60.79 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.746 -0.661 . . . . 73.3 110.56 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' D' ' 116' ' ' SER . 88.3 mtt-85 -69.84 -29.73 67.05 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.648 0.779 . . . . 61.45 109.809 173.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.46 6.98 80.88 Favored Glycine 0 C--N 1.356 1.672 0 O-C-N 123.656 0.598 . . . . 60.3 113.157 177.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.609 HG23 ' HB3' ' C' ' 17' ' ' TYR . 81.2 p 55.69 28.25 11.84 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 126.277 1.831 . . . . 61.44 113.442 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -90.9 151.34 43.34 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 123.641 0.776 . . . . 75.35 109.289 169.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -51.58 125.15 15.99 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.64 2.227 . . . . 65.42 112.211 172.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -42.89 135.64 2.95 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 126.191 1.796 . . . . 75.22 113.277 -175.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.655 HD13 HG21 ' D' ' 40' ' ' VAL . 28.7 tp -116.55 96.99 5.76 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.774 0.83 . . . . 55.4 109.78 -176.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -97.11 96.48 8.49 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 106.931 -1.507 . . . . 53.33 106.931 175.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.496 HD11 HD12 ' D' ' 114' ' ' ILE . 92.9 mt -54.13 127.25 25.95 Favored 'General case' 0 C--O 1.246 0.884 0 O-C-N 123.649 0.593 . . . . 73.15 110.397 -177.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.18 140.81 82.81 Favored Pre-proline 0 CA--C 1.551 0.982 0 O-C-N 124.185 0.928 . . . . 74.23 110.734 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.404 ' HD3' HG13 ' B' ' 13' ' ' ILE . 98.0 Cg_endo -74.22 108.4 2.66 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.566 2.177 . . . . 74.22 111.739 -170.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 59.1 t -106.48 117.25 51.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 108.186 -1.042 . . . . 71.43 108.186 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -74.28 113.14 11.14 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.698 -0.853 . . . . 54.5 108.698 169.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.439 ' CD2' ' HB2' ' D' ' 103' ' ' PRO . 2.0 m-85 -69.52 -29.03 66.55 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.239 -0.891 . . . . 72.55 110.826 -176.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -60.85 -51.12 70.65 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 108.75 -0.833 . . . . 32.2 108.75 173.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.53 -50.55 69.11 Favored 'General case' 0 C--N 1.352 0.691 0 O-C-N 124.423 1.077 . . . . 62.23 110.714 -174.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.585 HD23 ' HG ' ' E' ' 111' ' ' LEU . 33.8 tp -66.93 -39.87 87.46 Favored 'General case' 0 CA--C 1.55 0.98 0 O-C-N 123.926 0.766 . . . . 54.1 111.563 -174.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.493 ' O ' HD13 ' D' ' 141' ' ' LEU . 9.1 t80 -67.57 -41.59 83.92 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.425 -0.583 . . . . 72.25 109.425 176.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.488 ' O ' ' HG2' ' D' ' 142' ' ' GLN . 66.0 mtm -65.02 -29.29 70.19 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 116.022 -0.535 . . . . 65.34 111.315 174.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -66.57 -8.08 24.5 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 118.071 0.396 . . . . 75.13 111.732 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 140' ' ' TYR . . . . . 0.474 ' HD2' HD12 ' D' ' 141' ' ' LEU . 80.5 t80 -89.54 -41.97 11.71 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 121.109 0.481 . . . . 74.13 109.992 165.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.493 HD13 ' O ' ' D' ' 137' ' ' PHE . 6.4 mp -76.93 -64.25 1.17 Allowed 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 124.78 1.232 . . . . 72.22 112.39 -170.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 142' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' D' ' 138' ' ' MET . 29.2 pt20 -81.18 25.32 0.49 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.729 1.212 . . . . 75.12 113.291 -176.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -114.41 84.3 2.03 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 120.944 -1.097 . . . . 71.03 108.995 -168.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -177.65 -33.52 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 113.024 -1.898 . . . . 74.41 108.302 -175.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -145.14 128.62 16.99 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.857 1.263 . . . . 73.21 108.594 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.43 -177.06 43.83 Favored Glycine 0 C--N 1.347 1.163 0 O-C-N 123.36 0.412 . . . . 51.55 113.074 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -142.68 150.44 40.18 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.433 1.093 . . . . 73.34 109.349 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -149.54 97.62 0.18 Allowed Glycine 0 C--N 1.347 1.188 0 N-CA-C 111.051 -0.82 . . . . 61.31 111.051 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 47.3 p -119.14 116.42 26.31 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.249 1.02 . . . . 64.43 109.53 -177.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.6 12.04 2.3 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 113.586 0.958 . . . . 72.53 113.586 -166.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -70.32 105.14 2.9 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.436 0.694 . . . . 73.04 110.64 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -138.14 124.09 20.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.001 0.92 . . . . 73.33 109.104 176.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -126.72 154.51 44.06 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.518 1.127 . . . . 71.23 108.691 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -62.94 144.45 56.76 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.277 0.631 . . . . 63.34 110.233 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.005 0 C-N-CA 123.361 0.664 . . . . 71.33 110.878 -177.598 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.44 0 CA-C-O 120.168 -0.24 . . . . 52.01 112.948 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 178.93 -41.79 0.08 OUTLIER Glycine 0 C--N 1.347 1.16 0 N-CA-C 112.455 -0.258 . . . . 61.34 112.455 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -108.67 -61.6 1.58 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.812 0.845 . . . . 70.54 110.543 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 94' ' ' PHE . . . . . 0.619 ' HB3' ' HB2' ' D' ' 54' ' ' ASP . 0.3 OUTLIER -148.37 -139.46 0.1 Allowed 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 109.369 -0.604 . . . . 74.43 109.369 -172.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -103.37 -73.98 0.65 Allowed 'General case' 0 N--CA 1.505 2.31 0 CA-C-N 119.388 0.995 . . . . 70.13 111.978 -169.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 146.14 33.91 0.07 OUTLIER Glycine 0 C--N 1.357 1.709 0 CA-C-O 119.757 -0.468 . . . . 72.43 113.345 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 97' ' ' ILE . . . . . 0.476 ' HB ' HD22 ' E' ' 100' ' ' LEU . 30.3 mt 57.3 -84.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.064 1.746 . . . . 74.23 111.074 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -153.51 -74.68 0.13 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.679 0.792 . . . . 73.31 109.374 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -161.35 32.75 0.14 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.011 -0.995 . . . . 73.15 110.485 -168.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 100' ' ' LEU . . . . . 0.716 ' HB2' ' HB2' ' D' ' 95' ' ' ALA . 1.4 pt? -57.24 130.85 80.62 Favored Pre-proline 0 CA--C 1.559 1.302 0 C-N-CA 122.876 0.47 . . . . 75.35 111.397 -176.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -61.77 -20.71 70.11 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 123.22 2.613 . . . . 72.42 113.676 -172.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 102' ' ' LEU . . . . . 0.505 HD21 ' HA ' ' E' ' 107' ' ' THR . 0.7 OUTLIER -96.77 79.96 3.01 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.433 -0.951 . . . . 74.32 108.433 174.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 103' ' ' THR . . . . . 0.561 HG23 ' HG ' ' E' ' 100' ' ' LEU . 10.9 p -137.67 15.57 2.92 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.377 1.471 . . . . 70.43 108.474 169.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 179.06 162.68 28.81 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 114.363 -1.29 . . . . 51.2 110.238 -176.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 67.11 135.48 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.909 1.284 . . . . 63.3 109.923 -166.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -70.66 89.06 0.72 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.117 -0.697 . . . . 73.24 109.117 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 107' ' ' THR . . . . . 0.505 ' HA ' HD21 ' E' ' 102' ' ' LEU . 10.0 m 67.45 150.51 0.06 Allowed 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 125.59 1.556 . . . . 75.31 113.297 176.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -129.79 116.22 18.42 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 108.19 -1.041 . . . . 64.24 108.19 171.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 80.3 119.25 0.05 Allowed 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 126.903 2.081 . . . . 74.45 111.963 -175.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.49 146.29 32.78 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 109.201 -0.666 . . . . 72.33 109.201 169.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 111' ' ' LEU . . . . . 0.612 HD23 ' HB3' ' D' ' 44' ' ' LEU . 32.7 tp -78.81 -48.04 15.54 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.143 0.577 . . . . 75.31 111.643 -169.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 112' ' ' ASN . . . . . 0.504 ' HB2' ' H ' ' D' ' 44' ' ' LEU . 64.5 t30 -83.57 -44.58 14.46 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.265 0.626 . . . . 74.54 109.984 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -72.48 90.25 1.31 Allowed 'General case' 0 C--N 1.358 0.939 0 N-CA-C 108.865 -0.791 . . . . 75.34 108.865 176.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -145.94 158.27 43.87 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.622 -0.717 . . . . 62.44 110.455 -165.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 40.8 p -77.32 101.11 6.15 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.517 0.727 . . . . 65.22 110.752 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.92 93.63 0.91 Allowed Glycine 0 C--N 1.346 1.102 0 CA-C-N 115.657 -0.701 . . . . 54.4 113.192 172.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -132.63 98.14 16.73 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 123.619 0.767 . . . . 73.35 109.41 176.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -67.54 -77.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.108 1.872 . . . . 72.14 110.861 172.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -146.96 131.58 17.82 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.254 1.021 . . . . 75.3 109.109 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -173.94 -54.4 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.901 0.88 . . . . 70.42 109.018 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 121' ' ' VAL . . . . . . . . . . . . . 35.8 t -70.51 -43.34 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 115.225 -0.898 . . . . 54.42 110.069 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 59.4 p -117.03 134.1 55.17 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.357 1.063 . . . . 70.33 108.969 173.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -162.07 163.86 28.45 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.546 0.738 . . . . 74.11 109.671 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 41.5 m -74.88 74.23 2.13 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.784 0.834 . . . . 61.4 110.58 176.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -134.36 169.13 17.69 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.274 1.03 . . . . 63.53 110.253 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . 68.46 74.45 0.27 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.89 1.276 . . . . 53.24 112.006 174.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 27.1 m -76.67 99.89 5.2 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.021 -0.991 . . . . 53.5 109.644 176.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.98 173.62 6.97 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.604 -0.726 . . . . 20.55 111.142 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 1.9 m -92.69 139.12 30.88 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.308 -0.627 . . . . 75.23 109.308 174.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -71.59 152.35 43.0 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.091 0.556 . . . . 55.32 110.062 173.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 131' ' ' TRP . . . . . . . . . . . . . 91.6 t90 -60.29 138.14 58.0 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.63 0.581 . . . . 73.22 110.688 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 132' ' ' SER . . . . . 0.4 ' H ' ' HB3' ' A' ' 124' ' ' PRO . 70.3 m -161.06 137.8 8.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.281 1.032 . . . . 74.23 108.786 176.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 133' ' ' THR . . . . . 0.435 HG22 HG12 ' E' ' 135' ' ' VAL . 18.8 m -143.03 135.11 27.07 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.589 -0.523 . . . . 64.1 109.589 176.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -132.33 89.52 0.27 Allowed Glycine 0 C--N 1.347 1.193 0 N-CA-C 110.629 -0.989 . . . . 75.23 110.629 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 135' ' ' VAL . . . . . 0.435 HG12 HG22 ' E' ' 133' ' ' THR . 11.3 p -162.67 149.17 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.476 0.71 . . . . 74.22 109.96 -175.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -119.75 -111.02 0.34 Allowed 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 119.159 -0.448 . . . . 71.14 111.115 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 137' ' ' THR . . . . . 0.41 ' HA ' ' HB1' ' A' ' 129' ' ' ALA . 12.9 t -173.17 172.05 3.96 Favored 'General case' 0 C--N 1.361 1.104 0 C-N-CA 122.848 0.459 . . . . 60.43 111.928 -168.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -135.7 140.24 44.28 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.942 1.297 . . . . 74.11 108.538 172.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -63.15 122.86 17.15 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.522 0.729 . . . . 61.2 110.745 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . 168.15 63.86 0.03 OUTLIER Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.276 -0.73 . . . . 55.42 111.276 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -148.88 152.21 36.05 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.853 0.861 . . . . 62.44 109.549 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 76.6 mt 66.98 94.44 0.07 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.908 1.283 . . . . 72.32 111.326 -174.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 143' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' C' ' 145' ' ' ALA . . . -108.08 -119.22 4.33 Favored Glycine 0 C--N 1.34 0.776 0 N-CA-C 110.23 -1.148 . . . . 62.13 110.23 171.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 27.8 t -66.13 -24.56 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.386 0.674 . . . . 71.55 109.557 172.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 . . . . . 0 CA--C 1.551 1.014 0 C-N-CA 125.25 1.42 . . . . 63.44 109.861 178.029 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.485 0 N-CA-C 111.509 -0.636 . . . . 43.21 111.509 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.08 -56.8 4.86 Favored Glycine 0 C--N 1.35 1.316 0 C-N-CA 123.025 0.345 . . . . 52.13 112.483 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -79.5 71.44 6.08 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.547 1.139 . . . . 75.45 109.555 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -114.3 129.44 56.64 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.2 1.0 . . . . 73.42 109.181 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 95' ' ' LYS . . . . . 0.528 ' HD3' ' H ' ' F' ' 95' ' ' LYS . 0.0 OUTLIER -80.74 119.93 23.96 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 123.742 0.652 . . . . 74.44 110.07 175.491 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -170.19 5.33 0.04 OUTLIER Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.326 -0.708 . . . . 64.12 114.516 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 97' ' ' ILE . . . . . 0.729 ' HB ' ' HA ' ' B' ' 87' ' ' ALA . 7.2 tt -99.42 -75.15 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 118.018 0.909 . . . . 73.12 110.372 173.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 98' ' ' ASP . . . . . 0.599 ' H ' HG23 ' F' ' 97' ' ' ILE . 25.3 t70 173.24 -85.11 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.621 1.169 . . . . 72.2 108.577 -173.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.6 136.6 0.76 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.975 1.31 . . . . 74.33 108.754 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 100' ' ' LEU . . . . . 0.654 HD13 ' HB2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -147.49 75.55 11.25 Favored Pre-proline 0 CA--C 1.557 1.229 0 N-CA-C 113.183 0.809 . . . . 72.53 113.183 -176.326 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.89 27.83 0.59 Allowed 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 123.223 2.615 . . . . 73.14 112.006 170.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 102' ' ' LEU . . . . . 0.413 HD22 ' OG ' ' B' ' 48' ' ' SER . 42.2 tp 69.73 153.33 0.11 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 126.09 1.756 . . . . 75.24 111.583 -172.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 40.9 p -60.53 136.69 58.13 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.667 0.787 . . . . 70.1 110.254 170.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . -55.72 135.76 48.27 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 124.306 1.004 . . . . 73.21 115.571 -167.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 58.99 79.8 0.21 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.308 1.443 . . . . 53.51 112.625 172.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 16.8 t80 59.86 30.35 19.9 Favored 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.734 0.814 . . . . 74.11 112.386 168.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 11.3 m 56.39 57.72 4.73 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 122.09 0.948 . . . . 65.03 110.195 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -74.93 88.82 2.35 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.238 -0.892 . . . . 75.35 111.422 -174.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -127.76 -57.29 1.27 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.138 -1.06 . . . . 71.04 108.138 170.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -167.64 -28.76 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.113 -1.403 . . . . 45.24 110.203 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 tt -75.03 83.41 2.26 Favored 'General case' 0 C--N 1.359 0.989 0 C-N-CA 123.688 0.795 . . . . 71.41 109.064 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -136.31 133.48 36.93 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 106.875 -1.528 . . . . 73.34 106.875 176.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -64.32 125.88 26.0 Favored 'General case' 0 CA--C 1.551 0.986 0 O-C-N 123.246 0.341 . . . . 75.52 110.923 -172.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -178.0 -47.18 0.01 OUTLIER 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.313 1.045 . . . . 63.24 109.576 -170.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 5.4 m 66.41 149.67 0.05 Allowed 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 125.229 1.412 . . . . 72.45 111.401 -172.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.15 -60.3 2.28 Favored Glycine 0 C--N 1.346 1.087 0 N-CA-C 111.673 -0.571 . . . . 70.02 111.673 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 117' ' ' LYS . . . . . 0.431 ' HB2' ' HD3' ' F' ' 118' ' ' PRO . 12.1 mptt -70.55 -44.93 18.15 Favored Pre-proline 0 CA--C 1.556 1.181 0 CA-C-O 118.802 -0.618 . . . . 75.11 110.017 175.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 118' ' ' PRO . . . . . 0.431 ' HD3' ' HB2' ' F' ' 117' ' ' LYS . 2.8 Cg_exo -79.17 124.57 6.06 Favored 'Trans proline' 0 C--N 1.391 2.795 0 C-N-CA 121.973 1.782 . . . . 73.14 110.316 160.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -83.62 -164.91 0.98 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.467 0.707 . . . . 74.23 110.071 176.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 73.83 -64.75 0.38 Allowed 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 125.307 1.443 . . . . 61.33 110.833 -173.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 28.9 t -71.39 89.06 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 124.471 1.108 . . . . 73.23 109.995 -175.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 16.2 p -142.87 -66.96 0.37 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.51 1.124 . . . . 63.22 108.905 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -172.89 123.37 0.42 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.249 1.019 . . . . 70.33 109.63 -177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 20.0 m -156.26 116.23 3.61 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.403 -0.962 . . . . 73.5 108.403 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . 65.33 13.33 8.73 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.783 0.833 . . . . 31.32 112.955 173.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.37 97.38 4.24 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 123.425 0.69 . . . . 65.43 109.279 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 14.6 m -65.1 94.64 0.15 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.124 0.97 . . . . 74.33 112.088 -170.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.29 92.93 7.04 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.038 0.935 . . . . 53.51 109.865 176.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 13.3 p -129.6 161.02 31.5 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.933 0.893 . . . . 70.12 111.034 -174.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -74.71 137.8 42.35 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.017 0.927 . . . . 71.13 112.177 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -86.77 119.16 26.7 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.505 0.722 . . . . 72.55 109.979 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 22.9 t -171.58 165.73 6.79 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.616 0.766 . . . . 51.51 110.65 174.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 16.9 p -140.25 -178.49 5.5 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.52 1.128 . . . . 74.33 110.803 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -166.05 159.05 32.22 Favored Glycine 0 C--N 1.353 1.509 0 N-CA-C 111.146 -0.782 . . . . 73.43 111.146 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 135' ' ' VAL . . . . . 0.485 HG13 ' HB3' ' C' ' 42' ' ' LEU . 60.6 t -140.07 119.06 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 123.413 0.685 . . . . 74.44 109.551 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 136' ' ' LYS . . . . . 0.492 ' HB3' ' HA ' ' C' ' 41' ' ' LYS . 54.2 tttp -79.92 -79.17 0.15 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 122.549 0.339 . . . . 73.11 110.65 172.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 91.0 m -157.17 128.95 7.08 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.51 0.724 . . . . 45.53 109.517 -168.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -79.24 76.63 5.78 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.817 -0.809 . . . . 75.21 108.817 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -162.96 130.9 3.74 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.454 -0.943 . . . . 73.12 108.454 -173.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -82.15 60.53 4.79 Favored Glycine 0 C--N 1.342 0.907 0 O-C-N 123.575 0.547 . . . . 75.2 112.499 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.0 137.18 57.88 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.244 0.617 . . . . 72.42 110.995 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -138.35 -173.03 3.42 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.051 0.94 . . . . 73.13 109.684 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.87 8.03 65.6 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 112.242 -0.343 . . . . 44.43 112.242 -176.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 96.5 t -81.25 125.4 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 124.067 0.947 . . . . 71.1 110.842 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 30.1 t70 . . . . . 0 C--O 1.245 0.868 0 C-N-CA 123.794 0.837 . . . . 73.44 108.87 173.079 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ppp? . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 110.265 -0.272 . . . . 64.05 110.265 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.3 t -165.04 126.26 2.03 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 108.494 -0.928 . . . . 63.51 108.494 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -75.16 79.26 2.3 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-O 122.163 0.982 . . . . 71.52 110.183 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -154.07 -58.0 0.12 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.069 -0.969 . . . . 53.51 109.065 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -130.4 163.87 25.95 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.805 0.842 . . . . 74.55 109.355 -175.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -55.82 109.11 0.52 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.595 0.758 . . . . 61.23 110.07 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.2 m -61.65 150.84 35.23 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 124.159 0.984 . . . . 74.31 111.09 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -49.22 128.55 16.84 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 124.273 0.983 . . . . 74.0 111.113 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 56.9 mtt -80.41 161.97 24.68 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.366 -0.834 . . . . 74.51 110.175 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 75.9 m -139.06 113.8 9.18 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 107.672 -1.233 . . . . 74.21 107.672 173.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -114.91 120.5 40.16 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.725 -1.213 . . . . 73.25 107.725 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -139.11 123.77 18.51 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.55 -0.907 . . . . 71.43 108.55 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.453 HG21 ' HG3' ' C' ' 130' ' ' PRO . 3.0 mt -88.43 119.59 35.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.624 -0.88 . . . . 73.12 108.624 177.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -91.39 -37.27 13.31 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 123.785 0.678 . . . . 74.1 110.516 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -171.17 121.49 0.54 Allowed 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.353 0.408 . . . . 74.1 109.948 -176.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 76.2 mt -106.72 137.18 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.201 -1.037 . . . . 53.5 108.201 171.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.511 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 37.3 p90 -164.44 175.89 9.53 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-O 122.042 0.925 . . . . 73.11 111.92 -174.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 56.2 p -102.78 111.56 23.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.677 -1.147 . . . . 75.5 108.724 176.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.511 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 34.2 mtpt -72.92 -34.32 66.54 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.283 -0.636 . . . . 75.02 109.283 175.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.1 t70 -150.35 145.79 26.33 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.965 -1.016 . . . . 64.41 110.142 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.56 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 75.5 mt -142.78 143.3 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.663 1.585 . . . . 61.15 107.43 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.4 t -154.72 131.24 10.56 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.899 0.48 . . . . 63.2 110.165 173.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.513 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 87.6 t80 -126.99 141.9 51.68 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.332 -1.358 . . . . 65.03 107.332 172.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HB3' ' HD3' ' A' ' 26' ' ' PRO . 30.2 mt-10 -135.04 142.52 46.39 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.785 -0.45 . . . . 73.31 109.785 175.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.83 71.08 13.74 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 106.991 -1.485 . . . . 33.34 106.991 166.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.404 ' HD3' ' HB3' ' A' ' 24' ' ' GLU . 65.1 Cg_endo -71.78 -17.84 28.93 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 122.434 2.089 . . . . 75.13 112.2 -175.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -104.71 17.38 24.24 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-O 118.007 -0.996 . . . . 62.4 109.698 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.449 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -46.34 -55.72 13.03 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 113.674 0.99 . . . . 50.42 113.674 -169.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 32.2 Cg_exo -60.83 -26.85 83.83 Favored 'Trans proline' 0 C--N 1.388 2.616 0 C-N-CA 121.73 1.62 . . . . 63.12 113.612 178.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -81.86 -41.23 21.28 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.876 0.871 . . . . 71.24 110.522 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.574 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.8 p -74.95 -20.66 16.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 124.576 1.15 . . . . 73.43 111.787 -161.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -76.91 -21.27 55.13 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.584 0.754 . . . . 74.24 110.852 176.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -90.51 -11.94 38.71 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.697 1.199 . . . . 71.44 110.879 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -83.07 164.06 20.53 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.165 0.986 . . . . 72.41 111.44 -178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.96 118.86 17.41 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.538 0.735 . . . . 55.55 109.367 173.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.543 ' HD1' ' HB3' ' E' ' 132' ' ' SER . 71.2 t-105 -81.06 93.14 6.34 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 121.05 0.453 . . . . 75.24 110.737 -176.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -128.04 84.1 64.22 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 107.342 -1.355 . . . . 72.32 107.342 168.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -76.31 110.48 3.07 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.534 2.156 . . . . 54.11 112.443 -171.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -92.85 84.78 5.01 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 106.68 -1.6 . . . . 70.13 106.68 175.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.568 HG22 ' HB2' ' A' ' 66' ' ' ALA . 48.8 t -86.81 106.51 15.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 114.789 -1.096 . . . . 75.3 110.431 -173.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -79.01 123.47 27.33 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.19 -0.914 . . . . 71.51 109.454 171.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.8 mt -97.57 106.21 18.49 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.203 -1.036 . . . . 74.31 108.203 173.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.472 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 29.3 t70 -108.52 140.69 41.51 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.803 -1.184 . . . . 74.21 107.803 176.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.521 HD11 HG21 ' A' ' 131' ' ' VAL . 85.5 mt -136.56 150.95 48.87 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.173 0.589 . . . . 61.35 110.925 -172.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 21.8 t0 -154.77 148.98 25.98 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.931 -1.032 . . . . 71.01 109.417 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.455 HG21 ' HA2' ' A' ' 99' ' ' GLY . 89.3 m -130.86 147.44 52.51 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.614 0.766 . . . . 43.52 109.582 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -157.33 109.73 2.44 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.625 0.77 . . . . 73.34 109.661 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.3 p -93.15 154.38 18.1 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.111 0.564 . . . . 43.31 110.229 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.8 t -151.62 121.51 7.07 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.047 0.939 . . . . 64.14 109.023 -176.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -73.03 105.57 4.55 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.034 0.533 . . . . 60.44 109.679 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' ' 57' ' ' GLU . 60.6 mt -79.09 -38.65 35.73 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.195 0.598 . . . . 73.52 110.275 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.27 -179.88 7.93 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.925 -1.034 . . . . 65.2 109.485 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -68.46 124.93 24.9 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.012 0.525 . . . . 72.34 109.944 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 63.72 16.6 9.86 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.008 1.323 . . . . 74.42 111.717 -173.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.0 t -124.93 109.22 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.083 0.953 . . . . 64.5 108.526 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -121.9 125.62 46.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.332 -0.988 . . . . 72.4 108.332 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.442 ' HB2' HD11 ' A' ' 51' ' ' LEU . 21.7 tt0 -83.44 150.33 26.11 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.984 -1.117 . . . . 74.13 107.984 166.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.0 t -131.16 136.27 58.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 107.642 -1.244 . . . . 72.43 107.642 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.441 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 48.7 t -109.56 135.97 46.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.367 -0.975 . . . . 50.23 108.367 175.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.491 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -112.95 104.09 12.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.643 -1.614 . . . . 74.44 106.643 170.606 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.425 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 16.6 ttp180 -92.79 100.15 12.69 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.363 -1.347 . . . . 63.35 107.363 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.8 t -98.44 128.97 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 N-CA-C 108.235 -1.024 . . . . 74.43 108.235 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 16.8 m -120.95 112.04 18.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.524 0.678 . . . . 73.53 109.322 175.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 80.4 t -106.14 125.94 61.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 124.731 1.212 . . . . 65.13 107.883 -178.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.1 m -134.08 115.05 13.83 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 118.379 0.536 . . . . 71.25 109.848 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.568 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -100.79 121.85 42.4 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.059 -1.46 . . . . 44.52 107.059 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.1 m -121.84 135.71 54.91 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.435 0.694 . . . . 55.14 109.876 176.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.45 HD21 ' CE3' ' A' ' 36' ' ' TRP . 17.6 mt -88.13 72.1 9.18 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 107.65 -1.241 . . . . 54.24 107.65 174.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.77 -90.85 1.07 Allowed Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.218 -0.901 . . . . 52.41 111.515 -171.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -113.27 -27.03 8.12 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.165 0.586 . . . . 74.4 111.933 -174.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -85.65 129.83 34.72 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.504 -0.924 . . . . 71.42 108.504 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.3 m -72.85 125.87 28.57 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.876 -0.416 . . . . 64.12 109.876 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.574 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -71.26 -57.68 4.25 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.844 0.858 . . . . 54.01 110.319 175.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -155.06 164.5 38.8 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.261 -0.881 . . . . 74.31 111.497 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 64' ' ' VAL . 65.6 tp -118.82 140.95 49.11 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.8 -1.091 . . . . 75.01 108.202 170.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.487 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 83.2 m -140.07 96.84 3.12 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.711 0.805 . . . . 65.32 109.66 173.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -111.49 117.44 33.03 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.575 -0.528 . . . . 64.41 109.575 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.1 t -126.58 113.96 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.003 0.921 . . . . 72.4 109.845 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 53.0 mt-30 -86.3 85.58 7.34 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.774 0.83 . . . . 63.13 109.21 171.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.437 ' HG3' HD22 ' A' ' 106' ' ' LEU . 61.2 tp60 -78.62 96.34 5.47 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.079 -0.964 . . . . 75.13 109.978 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -100.72 145.43 17.11 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.552 -0.619 . . . . 72.11 111.552 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.47 130.42 3.94 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.65 -0.98 . . . . 74.11 110.65 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 48.8 mt -79.55 126.56 39.22 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 108.501 -0.925 . . . . 71.02 108.501 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.504 ' HB3' HD11 ' A' ' 86' ' ' ILE . 74.0 m-85 -131.6 123.29 27.59 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.426 0.69 . . . . 43.34 109.894 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.9 t -83.44 106.23 15.02 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.237 -0.653 . . . . 65.32 109.237 171.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.504 HD11 ' HB3' ' A' ' 84' ' ' PHE . 7.7 mm -117.05 150.52 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.418 0.687 . . . . 71.35 110.157 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.96 163.38 16.04 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.571 0.544 . . . . 64.24 112.079 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.22 -19.41 46.03 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-N 115.543 -0.753 . . . . 72.2 113.124 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.424 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -134.11 148.95 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.741 0.816 . . . . 72.15 111.216 -171.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -138.05 175.24 9.75 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.942 1.297 . . . . 71.3 109.183 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.5 -123.99 33.52 Favored Glycine 0 CA--C 1.533 1.195 0 O-C-N 123.623 0.577 . . . . 32.22 114.185 175.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 38.1 p -73.2 -30.34 63.45 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.037 0.935 . . . . 65.35 110.825 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -67.66 -37.83 82.93 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.306 1.042 . . . . 60.53 110.359 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 5.3 tpt -68.38 -45.55 72.44 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.939 -0.573 . . . . 74.24 109.648 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.69 -38.1 77.5 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.187 0.929 . . . . 75.4 111.75 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.467 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 58.9 t-80 -67.94 -33.91 75.58 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.31 0.644 . . . . 65.2 111.269 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.4 t -69.99 -45.11 68.0 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.019 0.437 . . . . 75.45 110.065 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.7 mt -80.79 -31.03 35.89 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.103 -0.953 . . . . 73.11 112.677 -170.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.455 ' HA2' HG21 ' A' ' 46' ' ' THR . . . -106.6 4.59 37.12 Favored Glycine 0 N--CA 1.472 1.059 0 CA-C-O 119.953 -0.36 . . . . 65.51 113.783 -173.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.571 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -136.13 -68.43 0.5 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 117.191 0.495 . . . . 61.24 111.186 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -68.22 -43.7 77.39 Favored 'General case' 0 CA--C 1.555 1.135 0 CA-C-N 116.316 -0.402 . . . . 73.41 111.914 -172.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.2 m -63.71 -51.47 65.38 Favored Pre-proline 0 CA--C 1.57 1.73 0 C-N-CA 124.247 1.019 . . . . 71.54 113.084 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.47 -19.97 48.39 Favored 'Trans proline' 0 C--N 1.397 3.084 0 C-N-CA 121.842 1.695 . . . . 62.22 113.008 173.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -67.99 -37.52 81.58 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.187 0.595 . . . . 63.33 110.519 174.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.439 HG21 HD13 ' A' ' 13' ' ' ILE . 48.7 mm -67.29 -41.45 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.529 0.732 . . . . 65.24 110.084 173.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.437 HD22 ' HG3' ' A' ' 80' ' ' GLN . 61.5 mt -73.5 -25.59 60.51 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.018 -0.992 . . . . 63.11 112.422 -174.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -61.12 -45.57 95.97 Favored Pre-proline 0 N--CA 1.486 1.354 0 N-CA-C 114.127 1.158 . . . . 75.55 114.127 -173.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -53.46 -36.46 79.77 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.265 1.977 . . . . 74.52 113.611 171.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.426 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 88.0 m-85 -83.36 -28.96 28.6 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.635 0.774 . . . . 64.13 112.252 -177.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.93 -46.77 70.57 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.414 -0.958 . . . . 41.43 108.414 172.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.476 ' HG2' ' OH ' ' C' ' 109' ' ' TYR . 32.0 ttm180 -58.25 -43.17 87.71 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 114.04 -1.436 . . . . 75.14 109.739 175.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 109' ' ' TYR . 11.6 tt0 -48.83 -57.94 5.6 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 125.055 1.342 . . . . 73.2 111.462 175.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 117' ' ' MET . 53.6 t -64.92 -45.19 86.91 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.428 -1.26 . . . . 65.52 111.693 -174.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.632 HD13 HD11 ' A' ' 128' ' ' LEU . 8.5 mt -58.6 -60.27 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.818 0.847 . . . . 63.53 110.554 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.9 m -50.1 -41.87 49.16 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 125.058 1.343 . . . . 65.51 112.513 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -67.97 -43.03 79.91 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.714 -1.13 . . . . 75.31 110.635 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.513 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 52.6 mtm -62.28 -39.32 92.55 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 122.807 0.443 . . . . 65.43 110.875 177.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 114' ' ' ILE . 94.9 t -57.58 -49.56 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 124.341 1.056 . . . . 75.13 110.232 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 81.6 p -71.61 -29.36 64.58 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.89 -0.595 . . . . 64.51 111.61 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -72.33 -29.19 63.59 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.673 0.789 . . . . 74.12 110.17 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.76 18.3 31.16 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-O 119.459 -0.634 . . . . 72.54 112.762 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.47 HG21 ' HE ' ' B' ' 15' ' ' ARG . 5.6 t 58.03 13.08 2.04 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 127.445 2.298 . . . . 61.31 114.014 178.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -78.98 150.25 74.72 Favored Pre-proline 0 C--O 1.245 0.85 0 N-CA-C 108.156 -1.053 . . . . 63.23 108.156 171.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.685 ' HB3' ' HA ' ' E' ' 131' ' ' TRP . 24.4 Cg_endo -58.61 144.25 97.64 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.278 1.985 . . . . 55.25 110.852 174.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -55.07 129.34 37.64 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 124.562 1.164 . . . . 72.42 111.698 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.9 tp -107.37 138.1 44.2 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 108.416 -0.957 . . . . 71.43 108.416 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -122.74 125.85 46.35 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.1 -1.074 . . . . 73.35 108.1 175.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.632 HD11 HD13 ' A' ' 114' ' ' ILE . 10.2 mt -73.1 126.54 30.24 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.492 -0.929 . . . . 74.14 108.492 177.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.551 ' HB2' ' HB ' ' E' ' 135' ' ' VAL . . . -57.71 134.99 82.79 Favored Pre-proline 0 CA--C 1.554 1.108 0 CA-C-O 118.974 -0.536 . . . . 50.14 110.883 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.59 116.56 2.8 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.653 2.902 . . . . 73.21 113.843 -175.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.521 HG21 HD11 ' A' ' 44' ' ' LEU . 61.4 t -105.87 131.94 54.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-O 121.058 0.456 . . . . 71.23 110.456 177.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.453 ' OD1' ' HB3' ' A' ' 134' ' ' ASP . 52.0 t-20 -99.66 91.79 5.04 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.581 -1.191 . . . . 53.25 107.82 175.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.402 ' CZ ' HD13 ' A' ' 44' ' ' LEU . 92.2 m-85 -63.16 -25.83 68.53 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.715 0.806 . . . . 72.44 112.637 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.571 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 28.9 t70 -59.37 -49.56 77.34 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.286 -0.635 . . . . 74.25 109.286 171.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.37 96.54 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.326 1.017 . . . . 73.23 111.286 177.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 72.6 mt -60.7 -43.4 97.83 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.084 0.554 . . . . 72.1 111.14 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -71.23 -33.52 69.95 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.863 -0.608 . . . . 73.22 110.153 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.515 ' HB3' ' HB3' ' A' ' 143' ' ' GLN . 0.3 OUTLIER -60.1 -42.68 95.19 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.229 0.612 . . . . 63.41 110.335 177.343 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -59.83 -39.06 83.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 123.581 0.551 . . . . 72.13 111.044 177.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -72.94 -38.65 66.73 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.671 -0.695 . . . . 74.41 110.886 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 37.3 tp -69.71 -52.96 20.92 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.696 0.798 . . . . 64.23 111.483 -168.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 172.5 -16.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 123.951 0.9 . . . . 65.33 111.665 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.515 ' HB3' ' HB3' ' A' ' 138' ' ' MET . 7.5 tp60 -82.8 128.12 34.1 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.178 0.591 . . . . 75.33 111.804 -171.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -106.14 99.15 8.75 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.499 -1.297 . . . . 55.44 107.499 174.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -145.49 128.9 16.9 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.279 0.632 . . . . 50.43 109.994 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.41 159.16 44.43 Favored Glycine 0 C--N 1.343 0.928 0 O-C-N 123.672 0.608 . . . . 51.3 112.843 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.88 148.23 34.7 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.627 0.771 . . . . 75.22 111.429 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -79.34 77.49 1.84 Allowed Glycine 0 C--N 1.348 1.206 0 N-CA-C 111.298 -0.721 . . . . 41.34 111.298 176.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.7 t -116.44 134.48 54.81 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.394 0.677 . . . . 61.12 109.328 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -161.66 160.61 28.9 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.217 -0.66 . . . . 71.23 109.217 -173.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.47 173.91 10.93 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 124.012 0.925 . . . . 74.43 111.223 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.58 ' HB3' HG21 ' C' ' 10' ' ' THR . 7.2 p80 -159.88 -45.57 0.05 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.847 0.859 . . . . 62.24 111.568 -176.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 61.3 -169.26 0.17 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.325 0.65 . . . . 63.5 110.077 -164.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -99.12 -160.74 0.82 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.087 0.555 . . . . 60.25 109.521 173.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.331 0 C-N-CA 122.828 0.451 . . . . 70.14 110.457 -179.401 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' F' ' 95' ' ' LYS . 52.5 ttm . . . . . 0 CA--C 1.545 0.781 0 N-CA-C 111.929 0.344 . . . . 72.4 111.929 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m -141.88 36.29 1.59 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.991 0.516 . . . . 72.21 111.388 -170.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -81.56 157.51 24.74 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.398 0.679 . . . . 52.14 111.049 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -146.59 29.4 1.03 Allowed 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.53 0.732 . . . . 75.15 109.535 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -161.36 169.28 22.32 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.019 -0.734 . . . . 70.34 109.019 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -68.72 87.17 0.34 Allowed 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.15 -0.685 . . . . 73.22 109.15 170.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.0 p -93.91 -154.54 0.41 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.053 0.941 . . . . 60.04 109.866 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -51.19 -31.77 21.31 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.465 1.106 . . . . 74.15 112.01 170.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.49 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 1.0 OUTLIER 65.45 168.51 0.2 Allowed 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 125.259 1.423 . . . . 72.53 110.97 177.376 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.467 ' N ' ' SD ' ' B' ' 9' ' ' MET . 79.3 m -149.45 108.48 3.9 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 123.987 0.915 . . . . 65.13 108.71 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.477 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 65.9 t80 -116.55 145.63 43.21 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.433 0.693 . . . . 53.35 109.363 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -158.91 141.7 14.36 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.194 -1.039 . . . . 72.4 108.194 170.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.461 HD13 HD11 ' B' ' 16' ' ' ILE . 31.6 mt -76.86 145.67 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 N-CA-C 108.267 -1.012 . . . . 64.45 108.267 170.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -109.25 -40.51 4.92 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.901 0.481 . . . . 70.52 110.183 174.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.47 ' HE ' HG21 ' A' ' 122' ' ' THR . 48.0 ttt180 -173.68 137.13 0.6 Allowed 'General case' 0 N--CA 1.476 0.871 0 O-C-N 123.73 0.644 . . . . 74.42 109.881 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.461 HD11 HD13 ' B' ' 13' ' ' ILE . 93.4 mt -114.92 138.55 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.848 1.259 . . . . 64.33 107.678 176.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -164.43 140.68 6.16 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.919 0.711 . . . . 70.4 112.919 -173.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 69.9 m -73.7 121.48 20.83 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.057 -0.974 . . . . 74.44 109.121 170.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.523 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 46.9 mtpt -98.77 -16.96 18.74 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.636 0.774 . . . . 65.02 111.764 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.572 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 34.5 t70 -169.81 144.66 2.86 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.724 0.64 . . . . 63.33 111.186 -172.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.525 HD11 ' SG ' ' B' ' 113' ' ' CYS . 30.6 mm -143.53 146.36 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.677 1.191 . . . . 75.4 110.173 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.501 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 72.4 m -144.02 139.28 28.92 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.528 1.531 . . . . 63.41 108.558 171.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.56 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 89.4 t80 -148.36 108.73 4.13 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.297 -1.742 . . . . 72.41 106.297 164.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -118.8 114.64 22.96 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.079 -1.082 . . . . 64.21 108.079 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.465 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -106.68 86.9 2.47 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.164 -1.421 . . . . 64.03 107.164 173.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.9 -35.52 20.65 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.883 2.389 . . . . 54.22 112.171 -171.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -103.1 16.38 26.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.977 0.911 . . . . 75.54 110.962 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.465 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -43.77 -58.52 4.49 Favored Pre-proline 0 N--CA 1.491 1.591 0 C-N-CA 124.985 1.314 . . . . 70.1 114.479 -168.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 33.9 Cg_exo -57.99 -45.42 32.35 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 122.367 2.044 . . . . 72.31 113.328 -171.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -96.55 -17.24 20.6 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.172 -0.922 . . . . 73.43 112.802 -170.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.584 HG21 ' HA ' ' B' ' 73' ' ' ALA . 5.2 p -73.07 -20.32 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 118.169 0.44 . . . . 73.41 110.345 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -72.61 -1.06 14.67 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.493 0.923 . . . . 74.21 113.493 -177.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -71.56 -16.88 62.33 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 120.911 0.386 . . . . 74.42 110.097 167.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -105.9 69.38 0.81 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.525 1.53 . . . . 74.41 110.0 -176.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -84.85 76.59 10.22 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.773 0.797 . . . . 72.04 110.492 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.444 ' O ' ' HG2' ' B' ' 124' ' ' PRO . 3.8 p90 -152.92 173.15 15.73 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.037 -1.097 . . . . 72.32 108.037 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -66.52 115.33 23.1 Favored Pre-proline 0 CA--C 1.563 1.445 0 N-CA-C 112.353 0.501 . . . . 72.12 112.353 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.413 ' HD3' ' HG2' ' B' ' 124' ' ' PRO . 60.2 Cg_endo -71.85 157.06 55.86 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.512 2.141 . . . . 64.12 111.593 176.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.68 103.96 5.16 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.252 -1.018 . . . . 75.43 108.252 169.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.671 HG11 HD11 ' B' ' 126' ' ' LEU . 21.5 t -96.18 157.08 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.204 1.002 . . . . 74.03 110.031 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -142.97 124.65 14.95 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.625 1.17 . . . . 75.43 107.94 172.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.59 HD13 HD22 ' B' ' 128' ' ' LEU . 21.5 tp -87.56 136.85 32.78 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 108.32 -0.992 . . . . 74.23 108.32 170.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -137.04 149.89 47.73 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.711 -0.848 . . . . 64.11 108.711 -173.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mp -128.6 150.5 50.19 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.92 0.888 . . . . 71.43 109.578 -174.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 27.2 t70 -154.55 152.15 29.72 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.57 1.148 . . . . 63.41 108.673 173.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' THR . . . . . 0.42 HG22 HD22 ' B' ' 60' ' ' LEU . 75.9 p -126.76 134.5 50.6 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 121.176 0.513 . . . . 73.12 111.474 -177.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.05 116.17 6.06 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.04 -1.467 . . . . 74.33 107.04 169.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.506 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 41.0 m -143.0 161.15 38.9 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.572 0.349 . . . . 61.34 110.741 -171.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.8 p -152.1 139.91 19.93 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.904 0.482 . . . . 33.13 111.288 -172.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -83.47 129.25 34.97 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.465 -0.939 . . . . 74.41 108.465 169.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 pp -141.84 25.05 1.99 Allowed 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.774 0.829 . . . . 74.33 109.823 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' B' ' 55' ' ' VAL . . . -161.43 148.01 14.44 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.154 -0.93 . . . . 62.14 109.789 -173.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.41 121.71 24.18 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.1 -0.704 . . . . 72.23 109.1 171.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 68.53 12.12 8.59 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 124.675 1.235 . . . . 50.12 113.03 174.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.407 ' O ' ' HB3' ' B' ' 52' ' ' ALA . 89.6 t -140.01 129.87 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 N-CA-C 107.068 -1.456 . . . . 74.34 107.068 -175.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.506 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 11.8 t80 -118.0 153.37 33.78 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.902 -0.499 . . . . 54.11 110.104 -175.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -116.3 105.77 12.92 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.63 -1.248 . . . . 61.22 107.63 176.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.43 143.41 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.859 0.864 . . . . 63.54 109.787 -176.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 22.7 t -129.83 127.06 63.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 C-N-CA 123.982 0.913 . . . . 63.53 108.756 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.42 HD22 HG22 ' B' ' 46' ' ' THR . 0.3 OUTLIER -110.53 120.41 42.32 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 107.628 -1.249 . . . . 54.05 107.628 172.766 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.428 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 16.7 ttm-85 -86.82 113.28 22.5 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.86 -0.793 . . . . 64.11 108.86 174.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.17 105.19 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.095 0.958 . . . . 73.21 108.652 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 23.9 m -107.08 148.01 29.29 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.209 1.004 . . . . 51.32 109.991 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.551 HG11 HD21 ' B' ' 126' ' ' LEU . 24.4 t -136.47 117.78 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.107 1.363 . . . . 74.24 108.797 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 85.8 m -104.96 136.53 44.27 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 108.119 -1.067 . . . . 63.14 108.119 169.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.2 144.65 36.69 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.801 -0.814 . . . . 64.42 108.801 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.489 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 61.2 p -144.54 133.35 22.44 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.745 0.646 . . . . 22.11 112.745 -173.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 53.0 mt -107.61 128.44 54.54 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.672 1.189 . . . . 61.32 110.506 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.76 -110.57 3.41 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 111.751 -0.539 . . . . 51.54 111.751 -173.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -116.9 1.73 12.7 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 123.536 0.734 . . . . 73.25 110.432 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -115.03 158.37 22.19 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.749 -0.595 . . . . 75.11 110.218 -174.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.8 m -68.77 130.87 44.07 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 110.062 -0.348 . . . . 65.02 110.062 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.584 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -81.0 -64.82 1.11 Allowed 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.634 -1.247 . . . . 73.11 107.634 173.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -151.29 164.77 35.88 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.058 -0.974 . . . . 64.24 111.492 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 74.5 mt -127.01 131.61 50.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 105.992 -1.855 . . . . 70.1 105.992 170.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 34.2 t -131.51 149.79 52.39 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.036 -1.098 . . . . 64.14 108.036 172.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.501 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 49.7 tt0 -158.41 131.89 7.56 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.072 -0.714 . . . . 70.02 109.072 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.411 HG11 ' HA ' ' B' ' 110' ' ' ALA . 87.4 t -129.44 148.38 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.443 -0.947 . . . . 74.15 108.443 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.572 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 27.2 mt-30 -124.91 93.56 3.93 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.958 -1.127 . . . . 73.11 107.958 171.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.412 ' HG3' HD22 ' B' ' 106' ' ' LEU . 61.5 tp60 -89.76 108.93 19.98 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.229 -0.896 . . . . 64.33 108.878 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.523 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -104.4 171.78 19.77 Favored Glycine 0 C--N 1.337 0.62 0 O-C-N 123.791 0.682 . . . . 63.42 111.867 177.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.46 137.48 4.26 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.468 -0.396 . . . . 74.42 112.47 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 51.4 mt -88.79 121.26 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 107.42 -1.326 . . . . 73.43 107.42 170.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -131.54 145.14 51.59 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.27 1.028 . . . . 61.04 108.974 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 56.4 m -89.53 121.88 32.16 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.548 0.739 . . . . 72.32 110.058 170.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.691 HG22 HD11 ' B' ' 89' ' ' ILE . 5.3 mp -125.29 108.79 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 107.472 -1.307 . . . . 74.02 107.472 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.574 ' HA ' ' HB ' ' F' ' 97' ' ' ILE . . . -144.86 166.12 26.17 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.609 0.763 . . . . 74.24 111.069 -177.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 94.37 -29.81 8.49 Favored Glycine 0 N--CA 1.482 1.739 0 CA-C-O 121.098 0.277 . . . . 45.2 113.419 176.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.691 HD11 HG22 ' B' ' 86' ' ' ILE . 0.7 OUTLIER -90.83 168.26 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 124.598 1.159 . . . . 71.11 110.999 176.801 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -157.16 163.47 38.85 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.649 0.78 . . . . 35.42 110.299 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.51 -113.4 4.33 Favored Glycine 0 C--N 1.356 1.641 0 C-N-CA 123.473 0.558 . . . . 63.41 112.521 171.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 31.4 m -104.22 -35.42 8.01 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.71 0.804 . . . . 55.5 109.604 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -66.3 -17.31 64.68 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.104 0.962 . . . . 74.21 111.98 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.478 ' HA ' HD13 ' B' ' 89' ' ' ILE . 21.5 ptm -61.21 -56.57 19.16 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 122.865 0.466 . . . . 74.13 111.514 173.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.403 ' HA ' ' HG ' ' B' ' 98' ' ' LEU . . . -81.0 -11.47 59.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.793 0.837 . . . . 63.14 111.939 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -64.75 -36.04 83.03 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.68 0.392 . . . . 64.2 110.778 169.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.1 t -66.76 -41.13 88.27 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.748 0.419 . . . . 74.45 111.516 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.603 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.6 pp -84.19 -29.82 26.29 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.892 0.477 . . . . 73.24 111.402 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.86 -24.65 31.88 Favored Glycine 0 C--N 1.345 1.081 0 O-C-N 123.535 0.522 . . . . 62.03 113.913 -172.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.4 -48.48 2.19 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.291 0.637 . . . . 72.33 111.513 -174.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -75.94 -47.07 26.62 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.689 0.396 . . . . 72.14 111.692 -173.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.603 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 73.6 m -64.03 -42.42 69.26 Favored Pre-proline 0 CA--C 1.566 1.559 0 N-CA-C 113.6 0.963 . . . . 70.51 113.6 -177.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.55 -21.22 53.01 Favored 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 121.878 1.719 . . . . 65.3 113.806 173.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -70.13 -30.55 67.75 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 122.539 0.335 . . . . 63.5 110.772 173.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.473 HG23 ' NH2' ' D' ' 111' ' ' ARG . 84.0 mt -67.34 -40.77 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.789 0.836 . . . . 75.44 109.689 170.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.412 HD22 ' HG3' ' B' ' 80' ' ' GLN . 96.8 mt -76.47 -27.36 56.1 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.831 -1.077 . . . . 63.23 112.51 -174.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -55.23 -47.47 98.47 Favored Pre-proline 0 CA--C 1.567 1.597 0 CA-C-O 118.042 -0.98 . . . . 72.13 113.494 -175.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -52.45 -41.3 68.23 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 122.838 2.359 . . . . 74.22 114.711 174.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -68.83 -36.62 78.41 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.057 0.543 . . . . 62.51 110.656 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.411 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -70.5 -36.08 73.59 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.765 0.826 . . . . 75.35 111.062 174.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.553 ' HA ' HD12 ' B' ' 128' ' ' LEU . 35.4 ttt-85 -63.3 -56.05 19.68 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.167 1.387 . . . . 70.45 110.661 -178.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.465 ' HG3' ' NH2' ' C' ' 120' ' ' ARG . 1.4 tm-20 -69.48 -22.53 63.61 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.762 -0.654 . . . . 75.42 109.832 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.525 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.3 t -75.97 -28.37 57.85 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 122.64 0.376 . . . . 73.21 111.138 176.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.481 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 52.3 mt -74.97 -56.22 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.515 0.726 . . . . 74.14 109.234 173.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 52.6 m -58.56 -27.95 65.07 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.185 0.994 . . . . 70.22 111.556 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.485 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 29.8 t -58.59 -53.76 54.75 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.921 0.888 . . . . 52.3 110.365 173.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.4 mmt -71.6 -32.8 68.41 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.905 0.882 . . . . 74.0 111.074 -172.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.426 HG21 ' CD2' ' B' ' 126' ' ' LEU . 98.7 t -64.67 -42.87 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.658 1.183 . . . . 65.13 110.459 173.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.7 t -65.93 -39.09 90.21 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.033 -0.985 . . . . 70.11 110.408 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' B' ' 116' ' ' SER . 66.4 mtt-85 -64.91 -45.44 85.89 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.518 -0.765 . . . . 74.44 109.214 174.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.506 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -64.22 -11.16 44.98 Favored Glycine 0 C--N 1.361 1.917 0 O-C-N 124.58 1.175 . . . . 74.45 113.494 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 15.8 m 66.01 29.16 10.25 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.792 1.237 . . . . 52.31 110.329 174.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -83.33 162.63 53.29 Favored Pre-proline 0 CA--C 1.552 1.036 0 CA-C-N 114.841 -1.072 . . . . 74.12 110.652 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.444 ' HG2' ' O ' ' B' ' 36' ' ' TRP . 92.0 Cg_exo -48.36 159.61 0.73 Allowed 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.786 2.991 . . . . 70.02 114.787 173.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.423 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 6.7 tp-100 -60.55 113.19 2.3 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.36 -0.837 . . . . 73.11 111.484 -173.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.671 HD11 HG11 ' B' ' 40' ' ' VAL . 15.9 tp -112.23 120.08 40.54 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.843 -0.799 . . . . 75.03 108.843 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -133.0 126.53 32.15 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 107.801 -1.185 . . . . 55.31 107.801 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.59 HD22 HD13 ' B' ' 42' ' ' LEU . 76.1 mt -83.27 134.2 34.95 Favored 'General case' 0 C--O 1.242 0.7 0 O-C-N 123.409 0.443 . . . . 72.23 110.96 -176.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.61 143.88 90.55 Favored Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 124.58 1.175 . . . . 24.23 110.144 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -65.79 92.74 0.26 Allowed 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.68 2.253 . . . . 72.24 111.429 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.554 HG13 ' HE2' ' F' ' 120' ' ' TYR . 98.6 t -90.66 109.49 20.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.682 -1.229 . . . . 73.44 107.682 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -85.83 115.88 23.74 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 107.539 -1.282 . . . . 74.53 107.539 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -53.48 -42.83 67.66 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 124.355 1.034 . . . . 74.24 111.137 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -63.16 -42.5 99.43 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.0 0.813 . . . . 70.14 110.813 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.27 -22.78 67.07 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 112.772 0.656 . . . . 73.45 112.772 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.564 ' HG ' ' HB3' ' F' ' 120' ' ' TYR . 7.7 tt -77.32 -54.74 6.09 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.112 -0.699 . . . . 72.21 109.112 175.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -71.09 -12.64 61.62 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 114.932 -1.031 . . . . 72.51 112.18 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -65.06 -35.56 81.56 Favored 'General case' 0 C--O 1.216 -0.665 0 C-N-CA 124.015 0.926 . . . . 73.25 109.604 175.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -75.32 -31.25 60.57 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.942 0.497 . . . . 63.01 110.71 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -74.41 -48.98 24.43 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.09 0.471 . . . . 72.23 110.696 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 18.0 tp -103.79 34.57 2.95 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.126 0.97 . . . . 72.54 108.991 -173.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -68.36 152.63 45.15 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.909 -1.042 . . . . 74.12 112.332 -173.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -120.51 -5.27 9.8 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.907 0.883 . . . . 70.01 109.74 174.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 76.6 139.36 0.07 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.734 1.614 . . . . 72.52 111.82 177.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -137.42 170.04 16.76 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.542 1.137 . . . . 74.3 109.632 173.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.67 86.99 0.06 OUTLIER Glycine 0 C--N 1.341 0.85 0 N-CA-C 111.441 -0.664 . . . . 72.52 111.441 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -89.9 141.22 28.85 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.331 0.652 . . . . 63.34 109.802 175.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 148' ' ' GLY . . . . . 0.517 ' HA2' ' HB ' ' D' ' 7' ' ' THR . . . -77.01 66.58 2.82 Favored Glycine 0 C--N 1.351 1.395 0 O-C-N 123.937 0.773 . . . . 71.12 112.68 178.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 36.9 p -112.39 74.13 0.85 Allowed 'General case' 0 C--O 1.244 0.783 0 C-N-CA 124.628 1.171 . . . . 74.53 109.526 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 71.3 tt0 -154.46 111.32 3.33 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.306 -0.861 . . . . 72.14 110.321 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -161.83 163.6 29.26 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.635 0.774 . . . . 74.23 110.6 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 25.7 m170 -86.19 87.58 7.45 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.911 0.885 . . . . 71.31 109.509 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -124.86 27.72 6.69 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.911 0.885 . . . . 74.42 109.741 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -59.06 -27.49 65.56 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.636 1.174 . . . . 65.24 112.178 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.283 0 C-N-CA 124.987 1.315 . . . . 64.31 112.0 172.551 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 1' ' ' MET . . . . . 0.497 ' N ' ' SD ' ' C' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.547 -0.538 . . . . 75.31 109.547 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 19.4 t 56.82 54.67 6.93 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.63 1.172 . . . . 51.34 111.755 169.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.98 118.23 7.52 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 109.313 -0.625 . . . . 73.4 109.313 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -77.69 -11.75 59.9 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.345 -0.388 . . . . 61.11 111.416 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 10.1 t30 61.38 28.27 17.72 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.478 1.111 . . . . 53.34 111.287 170.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -154.11 156.46 37.29 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.297 -0.865 . . . . 61.3 108.668 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 18.1 m -160.9 87.7 0.74 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.31 -0.996 . . . . 71.4 108.31 170.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -80.92 59.7 3.86 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.982 0.513 . . . . 75.24 109.9 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.46 ' CE ' HD13 ' C' ' 89' ' ' ILE . 20.6 ttt 58.39 111.02 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.334 1.453 . . . . 74.13 111.383 -173.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.58 HG21 ' HB3' ' A' ' 152' ' ' HIS . 76.6 m -102.14 85.16 2.61 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.175 -0.676 . . . . 72.12 109.175 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -97.95 140.12 32.78 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.189 -0.914 . . . . 73.24 108.594 174.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -159.22 123.9 4.04 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 108.898 -0.779 . . . . 63.52 108.898 175.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 62.2 mt -68.56 127.16 29.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 N-CA-C 108.741 -0.837 . . . . 74.12 108.741 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -89.38 -48.35 7.4 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 109.308 -0.627 . . . . 72.42 109.308 174.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.88 148.98 0.43 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.219 1.408 . . . . 71.2 108.731 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 2.7 pp -116.59 155.2 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 106.978 -1.49 . . . . 73.33 106.978 173.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.441 ' HB3' HG23 ' D' ' 122' ' ' THR . 29.5 p90 -175.28 151.36 1.25 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.68 0.752 . . . . 74.42 111.3 -174.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 64.7 p -78.79 102.62 8.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.818 -1.083 . . . . 73.45 108.84 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 8.8 mtmt -72.8 -30.4 64.04 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.061 -0.718 . . . . 72.23 109.061 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.762 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 20.8 t70 -143.91 138.8 28.81 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.104 -0.953 . . . . 63.11 109.732 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.52 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.6 mt -137.43 143.66 33.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 106.818 -1.549 . . . . 71.32 106.818 174.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 26.1 t -155.04 141.04 18.33 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 123.76 0.663 . . . . 71.04 110.084 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -145.32 113.0 6.32 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 106.974 -1.491 . . . . 74.03 106.974 171.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -117.71 122.92 44.77 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.167 0.587 . . . . 72.55 109.99 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.35 75.79 73.56 Favored Pre-proline 0 CA--C 1.552 1.026 0 N-CA-C 107.388 -1.338 . . . . 73.23 107.388 171.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -69.82 -22.75 31.36 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 122.77 2.314 . . . . 65.0 111.511 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -101.36 12.45 37.38 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.541 1.136 . . . . 73.43 110.191 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.446 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -49.1 -58.14 9.55 Favored Pre-proline 0 C--N 1.375 1.715 0 C-N-CA 124.388 1.075 . . . . 50.32 113.554 -169.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.446 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 18.4 Cg_exo -64.29 -35.95 48.45 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 121.704 1.603 . . . . 60.31 112.132 -176.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -69.82 -37.75 76.32 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.293 1.037 . . . . 74.35 112.297 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.614 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.1 p -81.29 -21.71 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 C-N-CA 122.819 0.448 . . . . 72.32 111.889 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -65.48 -26.84 68.11 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 120.681 0.277 . . . . 72.34 111.263 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -100.41 34.58 2.35 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.652 0.781 . . . . 73.45 110.279 174.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -125.05 163.08 23.15 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.523 0.729 . . . . 71.35 110.23 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -66.58 112.99 4.42 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.532 0.733 . . . . 70.3 110.656 173.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 69.5 t-105 -76.8 81.97 3.39 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.363 0.665 . . . . 72.33 110.529 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 37' ' ' GLN . . . . . 0.451 ' H ' HD22 ' C' ' 68' ' ' LEU . 96.8 mt-30 -136.17 73.72 57.31 Favored Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 124.522 1.129 . . . . 62.13 108.465 174.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.31 155.48 25.25 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.702 2.268 . . . . 53.23 113.837 -171.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 39' ' ' GLU . . . . . 0.409 ' HB2' HD21 ' F' ' 142' ' ' LEU . 9.9 tp10 -87.4 87.71 7.49 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 105.146 -2.168 . . . . 71.41 105.146 161.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.619 ' HB ' ' HA ' ' F' ' 135' ' ' VAL . 68.7 t -76.66 98.34 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.578 0 N-CA-C 107.527 -1.286 . . . . 73.14 107.527 177.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -114.59 103.8 11.37 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.953 -1.021 . . . . 71.34 108.329 -175.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.27 160.63 18.36 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.214 0.531 . . . . 62.24 110.287 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.611 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 18.1 t70 -145.69 121.15 10.34 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.614 1.166 . . . . 73.53 108.287 -177.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.522 HD21 HG13 ' C' ' 62' ' ' VAL . 81.8 mt -125.44 111.95 15.7 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.526 0.73 . . . . 72.45 109.99 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -136.52 127.06 26.9 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.439 -0.949 . . . . 70.13 108.439 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 12.4 t -115.05 146.27 41.45 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.272 0.629 . . . . 74.41 109.47 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.36 163.96 27.53 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.067 0.947 . . . . 55.34 109.304 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.465 ' OG ' ' HB3' ' C' ' 98' ' ' LEU . 3.2 m -142.89 143.71 32.16 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.805 -0.442 . . . . 73.3 109.805 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.9 t -145.2 127.81 16.12 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.0 0.92 . . . . 42.21 108.548 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -79.55 117.4 20.45 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.077 -0.712 . . . . 73.04 109.077 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.632 HD11 ' HB2' ' C' ' 57' ' ' GLU . 61.0 mt -86.39 -35.08 19.98 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.266 0.626 . . . . 74.23 111.027 -176.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.19 179.64 8.96 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.961 -1.018 . . . . 22.41 109.088 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.5 116.46 7.5 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.148 -0.686 . . . . 75.24 109.148 -178.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 68.33 18.9 9.08 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.447 1.099 . . . . 74.24 112.068 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 90.5 t -123.81 115.23 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 108.639 -0.874 . . . . 73.31 108.639 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -121.71 128.96 52.38 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.337 1.055 . . . . 71.52 109.577 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.632 ' HB2' HD11 ' C' ' 51' ' ' LEU . 44.2 tt0 -93.16 138.62 31.41 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.088 -0.708 . . . . 71.22 109.088 167.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 83.5 t -122.83 139.68 48.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.911 -1.144 . . . . 74.31 107.911 171.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 54.3 t -127.85 130.26 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 109.516 -0.55 . . . . 71.54 109.516 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.79 111.2 23.61 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.702 -1.221 . . . . 60.54 107.702 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -83.1 111.85 19.28 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 108.556 -0.905 . . . . 75.23 108.556 170.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.522 HG13 HD21 ' C' ' 44' ' ' LEU . 21.9 t -114.38 115.5 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 108.02 -1.104 . . . . 61.43 108.02 175.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 10.9 m -125.39 125.54 43.58 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.598 0.759 . . . . 64.23 108.956 -171.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.638 HG23 HD13 ' C' ' 114' ' ' ILE . 84.2 t -112.92 125.16 70.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 123.964 0.906 . . . . 72.52 108.89 177.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 12.5 m -104.12 138.81 40.08 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.77 -0.826 . . . . 53.44 108.77 170.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.97 101.56 5.48 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.636 -1.616 . . . . 64.42 106.636 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 41.1 m -134.02 126.46 30.26 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.537 -0.542 . . . . 74.43 109.537 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.451 HD22 ' H ' ' C' ' 37' ' ' GLN . 9.7 mt -84.47 52.85 2.47 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.618 1.167 . . . . 64.3 109.213 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.1 -99.83 1.93 Allowed Glycine 0 C--N 1.349 1.259 0 N-CA-C 110.515 -1.034 . . . . 70.4 110.515 -172.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 70' ' ' GLU . . . . . 0.52 ' HG2' HG21 ' F' ' 144' ' ' VAL . 13.9 pt-20 -101.11 -30.44 11.58 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.943 0.897 . . . . 64.44 110.439 175.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -70.33 109.98 5.02 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.424 1.089 . . . . 62.35 109.451 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 38.9 m -83.41 124.46 30.7 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.897 0.772 . . . . 73.34 110.025 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.614 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -76.6 -57.93 3.57 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 114.398 -1.274 . . . . 72.43 109.618 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -154.65 166.26 33.96 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.025 -0.989 . . . . 73.33 110.706 174.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.432 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.4 tm? -129.23 142.56 50.82 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 105.894 -1.891 . . . . 71.05 105.894 166.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.432 ' N ' HD13 ' C' ' 75' ' ' LEU . 49.1 t -143.59 143.31 31.44 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.075 -1.083 . . . . 43.42 108.075 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -157.18 132.11 8.85 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 122.796 0.439 . . . . 74.21 109.973 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.434 HG11 ' HA ' ' C' ' 110' ' ' ALA . 55.2 t -133.85 115.41 21.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 124.748 1.219 . . . . 73.23 108.804 -176.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.762 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.2 mt-30 -96.19 90.56 5.54 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.677 0.791 . . . . 74.3 109.116 173.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.484 ' HG3' HD22 ' C' ' 106' ' ' LEU . 60.0 tp60 -80.67 99.74 8.33 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.698 -1.137 . . . . 65.31 109.515 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.56 153.78 27.74 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.862 -0.495 . . . . 62.13 111.862 174.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.5 126.44 2.08 Favored Glycine 0 CA--C 1.501 -0.785 0 N-CA-C 110.966 -0.854 . . . . 74.24 110.966 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.482 HD12 HD11 ' C' ' 51' ' ' LEU . 13.3 mm -88.96 128.71 40.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 N-CA-C 108.891 -0.781 . . . . 73.44 108.891 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -135.87 118.39 15.88 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.379 0.671 . . . . 73.24 109.369 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.5 p -79.6 101.32 8.24 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.262 -1.014 . . . . 32.2 108.262 172.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.651 HG21 ' HE1' ' C' ' 94' ' ' MET . 21.3 mt -117.53 129.94 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.582 0.753 . . . . 73.1 110.52 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.427 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -139.28 164.62 29.33 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.297 0.639 . . . . 73.55 110.671 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.39 -19.24 44.86 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 114.896 0.718 . . . . 72.32 114.896 170.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' C' ' 94' ' ' MET . 47.4 pt -108.53 167.97 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 117.593 0.697 . . . . 74.24 111.457 -176.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -159.35 177.9 10.51 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.364 -1.289 . . . . 74.5 109.263 175.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.63 -120.53 12.07 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 115.815 1.086 . . . . 62.21 115.815 173.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 46.4 p -64.91 -36.87 85.77 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.408 1.083 . . . . 71.32 111.173 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -62.23 -58.31 8.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.496 1.118 . . . . 74.31 110.538 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.651 ' HE1' HG21 ' C' ' 86' ' ' ILE . 4.6 tpt -54.15 -52.51 60.88 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 124.066 0.946 . . . . 73.54 112.243 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.96 -40.9 77.33 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 123.87 0.731 . . . . 74.32 111.235 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -68.7 -37.31 79.42 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.2 0.6 . . . . 65.35 111.222 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.477 ' SG ' HD13 ' C' ' 86' ' ' ILE . 35.4 t -67.6 -34.56 77.25 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.659 -0.497 . . . . 70.23 109.659 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.465 ' HB3' ' OG ' ' C' ' 48' ' ' SER . 79.9 mt -88.16 -33.03 18.33 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.527 1.131 . . . . 74.2 112.173 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.5 10.91 26.02 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 114.63 0.612 . . . . 73.02 114.63 -167.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.11 -48.66 0.07 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 117.401 0.6 . . . . 55.51 111.613 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -72.74 -55.03 7.37 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.302 0.641 . . . . 74.34 111.306 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 94.4 m -63.74 -44.99 81.7 Favored Pre-proline 0 CA--C 1.562 1.419 0 CA-C-O 118.213 -0.898 . . . . 63.25 112.031 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -53.02 -31.55 54.07 Favored 'Trans proline' 0 C--N 1.394 2.962 0 C-N-CA 122.88 2.387 . . . . 72.32 114.204 170.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -67.52 -35.54 79.29 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.537 0.735 . . . . 75.13 110.373 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.468 HD12 ' NH1' ' A' ' 111' ' ' ARG . 46.0 mm -77.06 -33.26 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.375 0.67 . . . . 75.24 110.449 177.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.484 HD22 ' HG3' ' C' ' 80' ' ' GLN . 94.3 mt -82.23 -30.02 31.01 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.865 0.866 . . . . 72.44 112.034 -175.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -57.18 -49.45 93.86 Favored Pre-proline 0 N--CA 1.484 1.23 0 CA-C-O 117.891 -1.052 . . . . 73.34 113.457 -173.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.61 -40.91 81.86 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 122.561 2.174 . . . . 71.1 114.31 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.476 ' OH ' ' HG2' ' A' ' 111' ' ' ARG . 89.6 m-85 -74.98 -37.56 61.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.155 0.582 . . . . 72.35 111.425 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.434 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -68.34 -34.89 76.92 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.353 -0.84 . . . . 54.03 110.498 176.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 24.2 ttt-85 -66.12 -51.24 59.8 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.604 1.561 . . . . 74.32 109.757 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -60.0 -39.53 86.1 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 124.093 0.871 . . . . 74.34 110.154 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 35.1 t -66.41 -39.86 89.23 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.461 -0.79 . . . . 74.32 110.933 -177.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.638 HD13 HG23 ' C' ' 64' ' ' VAL . 84.2 mt -69.19 -56.16 12.84 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 O-C-N 123.376 0.423 . . . . 71.05 110.565 177.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.1 m -63.21 -27.73 69.55 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 122.928 0.491 . . . . 74.1 111.066 -173.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 38.4 t -65.68 -49.34 68.91 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.383 0.673 . . . . 71.42 109.486 169.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.509 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.63 -36.63 79.1 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 124.607 1.163 . . . . 72.4 112.719 179.319 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.435 HG23 ' O ' ' C' ' 114' ' ' ILE . 76.6 t -64.23 -46.41 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.636 0.774 . . . . 65.23 108.962 175.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 39.5 t -67.3 -31.18 71.31 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.004 -0.998 . . . . 61.45 111.47 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.465 ' NH2' ' HG3' ' B' ' 112' ' ' GLU . 72.7 mtt-85 -71.17 -37.24 72.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.891 0.876 . . . . 75.54 109.566 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.46 4.3 84.45 Favored Glycine 0 C--N 1.353 1.474 0 O-C-N 123.848 0.717 . . . . 62.14 112.496 172.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 71.9 p 59.02 29.31 18.83 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.385 1.874 . . . . 75.24 113.696 172.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -85.38 143.2 38.64 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 107.018 -1.475 . . . . 73.2 107.018 166.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -48.69 143.3 16.82 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 123.088 2.525 . . . . 73.12 112.979 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.423 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 12.6 mm100 -46.9 142.67 3.31 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 124.565 1.165 . . . . 74.42 112.786 -174.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.505 HD11 HG11 ' C' ' 40' ' ' VAL . 23.6 tp -144.88 88.49 1.9 Allowed 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.188 -1.041 . . . . 74.43 108.188 -177.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -91.85 117.2 29.56 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.502 -1.226 . . . . 63.24 109.063 -174.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.402 HD21 HG21 ' C' ' 64' ' ' VAL . 4.1 mm? -70.91 124.53 24.55 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 123.893 0.745 . . . . 73.11 109.864 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.13 145.17 85.65 Favored Pre-proline 0 CA--C 1.548 0.874 0 O-C-N 124.219 0.949 . . . . 74.11 111.333 -175.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.453 ' HG3' HG21 ' A' ' 13' ' ' ILE . 16.1 Cg_endo -55.86 108.77 0.35 Allowed 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.555 2.837 . . . . 73.22 112.081 173.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 14.0 p -98.67 152.48 4.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 109.203 -0.666 . . . . 70.52 109.203 174.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -82.97 99.17 9.64 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.163 0.985 . . . . 73.2 108.832 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -68.66 -20.44 64.45 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.091 0.556 . . . . 74.23 112.121 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.78 -32.5 67.71 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.295 0.638 . . . . 72.21 110.792 172.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.14 -31.65 64.41 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.329 0.652 . . . . 74.01 110.588 174.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 56.3 mt -78.8 -20.91 48.64 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.423 -0.808 . . . . 72.15 110.438 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 137' ' ' PHE . . . . . 0.605 ' HE2' HG12 ' E' ' 144' ' ' VAL . 69.0 t80 -82.25 -28.7 31.69 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.596 0.758 . . . . 73.5 110.582 172.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 38.0 ttm -58.87 -41.17 86.44 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.747 1.219 . . . . 74.11 112.337 -175.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -66.6 -32.68 74.17 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.162 0.585 . . . . 60.41 111.692 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -67.04 -159.99 0.02 OUTLIER 'General case' 0 CA--C 1.581 2.151 0 C-N-CA 124.013 0.925 . . . . 73.22 110.358 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 59.5 tp -169.95 145.87 3.01 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 120.874 -1.141 . . . . 72.12 108.88 -174.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -146.22 110.06 4.9 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.004 -1.11 . . . . 63.23 108.004 172.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -85.22 55.96 3.73 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.823 0.849 . . . . 65.34 111.276 -175.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -137.65 164.88 27.72 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.055 0.942 . . . . 74.41 109.141 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.16 169.82 15.4 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.166 0.986 . . . . 51.22 111.837 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -153.03 176.36 31.17 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 114.454 -1.248 . . . . 74.13 110.989 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 69.35 124.46 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.588 1.555 . . . . 74.43 111.296 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 174.08 29.82 0.03 OUTLIER Glycine 0 N--CA 1.467 0.722 0 CA-C-N 115.564 -0.744 . . . . 71.43 111.33 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 36.3 p -91.48 127.97 37.13 Favored 'General case' 0 C--N 1.348 0.505 0 C-N-CA 123.68 0.792 . . . . 63.53 111.049 -174.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -84.41 -146.07 0.09 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.439 1.095 . . . . 52.43 109.536 171.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -158.49 110.01 2.19 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 108.991 -0.744 . . . . 52.41 108.991 173.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -146.16 71.82 1.27 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 122.724 1.249 . . . . 70.04 108.02 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -62.86 116.89 5.67 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 112.97 -1.923 . . . . 53.22 109.804 172.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -104.71 -76.52 0.6 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.084 0.553 . . . . 63.02 110.405 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 N-CA-C 108.425 -0.954 . . . . 61.44 108.425 -175.406 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 53.8 ttm . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 110.236 -0.283 . . . . 74.22 110.236 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 26.4 m -110.9 105.58 14.43 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 122.159 -0.338 . . . . 64.22 111.038 -176.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.19 160.36 19.07 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.179 0.992 . . . . 75.52 109.21 173.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -121.58 78.7 1.47 Allowed 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.403 0.62 . . . . 75.45 109.649 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -64.42 -47.65 78.35 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.694 1.198 . . . . 72.12 109.683 173.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -174.83 118.84 0.2 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.396 1.078 . . . . 73.12 108.868 168.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.517 ' HB ' ' HA2' ' B' ' 148' ' ' GLY . 74.8 p -88.16 75.26 8.66 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 108.806 -0.813 . . . . 74.31 108.806 173.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -162.33 129.88 3.87 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.604 -1.18 . . . . 72.13 108.25 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 16.4 tpt -32.65 125.4 0.33 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.226 1.41 . . . . 75.12 112.975 168.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 28.9 p -108.48 118.52 36.98 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.537 0.735 . . . . 70.41 109.301 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -143.04 116.41 9.06 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.444 -1.317 . . . . 75.21 107.444 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -141.0 153.49 45.58 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.635 0.774 . . . . 63.21 109.415 172.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.523 HG21 HD11 ' D' ' 16' ' ' ILE . 73.8 mt -102.74 120.48 52.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.087 -1.079 . . . . 74.55 108.087 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -89.05 -42.57 11.66 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.17 0.588 . . . . 74.21 110.66 -175.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -163.37 142.36 8.27 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.285 0.366 . . . . 63.11 110.496 -172.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.523 HD11 HG21 ' D' ' 13' ' ' ILE . 2.7 mp -124.8 135.07 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 105.579 -2.008 . . . . 41.51 105.579 174.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.437 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 34.8 p90 -162.31 172.72 15.21 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 122.12 0.962 . . . . 72.35 112.079 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 18' ' ' THR . . . . . 0.49 HG21 HD11 ' D' ' 21' ' ' ILE . 75.7 p -107.34 120.48 42.26 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.181 -1.372 . . . . 63.11 109.028 178.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.437 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 29.6 mtpt -92.02 -19.7 22.1 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.742 -0.663 . . . . 74.32 109.493 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.456 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 32.6 t70 -162.14 138.77 8.0 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.94 0.896 . . . . 73.33 109.743 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.509 HG21 ' HE2' ' C' ' 117' ' ' MET . 63.9 mt -141.81 139.64 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.809 1.244 . . . . 71.33 107.773 175.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.7 t -141.9 145.44 34.59 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.37 1.068 . . . . 75.12 108.608 170.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.52 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.0 t80 -144.95 117.66 8.67 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.143 -1.799 . . . . 74.13 106.143 167.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -125.55 118.91 26.76 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.159 0.584 . . . . 64.21 109.787 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.496 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -113.89 80.32 5.19 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 107.695 -1.224 . . . . 61.53 107.695 174.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.6 -19.07 16.97 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.681 2.254 . . . . 54.1 113.014 -169.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -113.49 1.42 15.02 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.599 0.76 . . . . 75.34 111.178 -177.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.496 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -27.44 -70.01 0.07 OUTLIER Pre-proline 0 CA--C 1.567 1.61 0 N-CA-C 117.481 2.4 . . . . 61.32 117.481 -167.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.56 -18.01 15.8 Favored 'Trans proline' 0 C--N 1.387 2.564 0 CA-C-N 124.19 2.532 . . . . 65.11 113.971 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -78.31 -38.8 41.52 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.702 1.201 . . . . 72.11 109.699 175.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.428 HG21 ' HA ' ' D' ' 73' ' ' ALA . 5.1 p -83.83 -19.31 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-N 115.874 -0.603 . . . . 71.43 111.096 -175.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -64.07 -24.83 67.85 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 122.544 0.338 . . . . 75.23 111.159 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -65.97 -9.05 26.47 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.263 1.025 . . . . 74.42 111.711 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -100.52 99.33 9.91 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.225 1.41 . . . . 70.33 109.602 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -97.33 83.2 3.25 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.254 -0.885 . . . . 74.54 110.876 -171.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -158.82 176.97 11.68 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.822 0.849 . . . . 64.23 109.402 169.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -69.94 110.96 7.6 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.353 1.061 . . . . 73.14 109.829 174.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.454 ' HB3' ' HG ' ' D' ' 68' ' ' LEU . 38.9 Cg_endo -68.81 129.63 18.98 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.014 1.809 . . . . 74.33 110.588 175.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -67.4 116.55 8.29 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 107.514 -1.291 . . . . 73.54 107.514 168.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.562 ' CG1' HG13 ' D' ' 64' ' ' VAL . 16.1 t -98.23 114.41 35.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 108.9 -0.778 . . . . 74.21 108.9 176.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -89.54 116.93 28.06 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.81 -0.811 . . . . 73.04 108.81 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.497 HD22 HD11 ' D' ' 128' ' ' LEU . 49.2 tp -97.27 144.43 27.07 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.065 0.459 . . . . 74.12 110.23 -176.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -135.17 139.5 44.62 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.681 -1.6 . . . . 74.34 106.681 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.443 HD11 HG11 ' D' ' 131' ' ' VAL . 45.4 mt -130.0 132.07 46.12 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.226 0.61 . . . . 63.53 110.666 -174.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -140.35 154.11 46.63 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.598 1.159 . . . . 71.44 108.317 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 46' ' ' THR . . . . . 0.58 HG23 HD22 ' E' ' 111' ' ' LEU . 2.1 p -128.61 159.69 34.76 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.597 0.713 . . . . 75.55 110.778 176.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.544 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.75 177.8 9.46 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.218 -1.356 . . . . 61.1 108.528 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 61.9 p -174.29 -162.13 0.13 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.883 0.873 . . . . 64.22 108.977 -175.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 17.3 p -147.87 129.65 15.18 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.683 -1.229 . . . . 72.32 107.683 168.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -76.68 111.59 12.34 Favored 'General case' 0 C--N 1.345 0.405 0 C-N-CA 123.3 0.64 . . . . 75.35 110.423 -172.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 tt -161.34 91.89 0.87 Allowed 'General case' 0 C--O 1.242 0.668 0 N-CA-C 106.579 -1.637 . . . . 73.11 106.579 171.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.28 83.84 7.3 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.742 -1.117 . . . . 65.22 110.789 -174.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -159.09 41.67 0.23 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.818 0.818 . . . . 55.54 108.944 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 68.82 -4.69 1.14 Allowed 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 125.928 1.691 . . . . 74.51 113.951 175.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.06 106.06 20.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.166 -1.42 . . . . 60.22 107.166 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -129.6 147.81 51.44 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.385 -0.598 . . . . 73.31 109.385 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -111.98 148.85 32.9 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.065 -1.087 . . . . 63.42 108.065 161.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 71.2 t -123.27 140.78 45.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 124.811 1.244 . . . . 70.22 107.692 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 30.3 t -125.89 137.31 58.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.727 -1.212 . . . . 55.54 107.727 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.434 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -125.74 105.4 8.95 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.511 -1.292 . . . . 73.12 107.511 -176.764 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 41.4 ttm-85 -85.14 102.49 13.32 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.748 0.819 . . . . 74.42 109.214 174.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.491 HG13 HD11 ' D' ' 42' ' ' LEU . 57.9 t -100.86 116.4 44.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.603 -0.888 . . . . 74.14 108.603 173.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.8 m -119.0 122.96 43.38 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.944 0.878 . . . . 72.52 110.233 -171.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.562 HG13 ' CG1' ' D' ' 40' ' ' VAL . 51.9 t -108.39 130.64 60.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 125.746 1.618 . . . . 61.22 109.635 -176.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 80.9 m -134.81 92.1 2.85 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.841 -1.17 . . . . 74.51 107.841 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -96.48 154.82 17.05 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.65 0.78 . . . . 44.32 109.123 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.481 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 25.2 p -149.58 135.02 18.37 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 123.648 0.592 . . . . 72.14 112.178 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.454 ' HG ' ' HB3' ' D' ' 38' ' ' PRO . 20.9 mt -105.46 102.43 11.9 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 124.81 1.244 . . . . 72.44 108.302 171.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.32 -125.4 10.6 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.572 -0.74 . . . . 72.41 113.438 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -84.97 4.96 31.22 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.554 1.142 . . . . 74.41 112.893 -174.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -146.32 165.75 28.35 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 120.9 0.381 . . . . 75.13 111.13 -172.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 55.7 m -64.03 135.26 56.27 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.529 -1.214 . . . . 65.34 111.435 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.481 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.46 -71.33 0.57 Allowed 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.236 -1.394 . . . . 63.32 107.236 170.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -145.11 151.95 39.29 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-O 121.179 0.514 . . . . 74.22 111.002 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 66.3 mt -117.08 152.54 34.47 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.095 1.358 . . . . 72.43 107.872 175.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.546 ' SG ' HG12 ' D' ' 114' ' ' ILE . 40.6 t -159.29 149.64 19.28 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.692 0.797 . . . . 63.13 108.883 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -154.91 121.71 5.45 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.48 -0.563 . . . . 75.41 109.48 170.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.58 115.82 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.64 0.776 . . . . 75.01 109.543 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.456 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.7 mt-30 -90.68 90.19 7.85 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.47 0.708 . . . . 74.0 109.415 170.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 80' ' ' GLN . . . . . 0.427 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.8 tp-100 -80.98 101.57 9.6 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.877 -1.056 . . . . 74.04 108.897 178.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.92 143.88 15.9 Favored Glycine 0 C--N 1.338 0.693 0 N-CA-C 111.397 -0.681 . . . . 60.21 111.397 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.8 140.72 7.84 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 111.758 -0.537 . . . . 74.32 111.758 -174.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 50.8 mt -90.48 120.57 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.724 -0.843 . . . . 60.51 108.724 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -121.01 126.48 50.02 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.099 0.96 . . . . 73.12 109.521 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 44.5 p -88.86 96.6 10.76 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.913 -0.773 . . . . 74.14 108.913 173.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.56 HD11 HD23 ' D' ' 98' ' ' LEU . 37.7 pt -119.83 129.16 75.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 115.465 -0.789 . . . . 53.25 109.615 -172.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.75 167.79 7.56 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.357 0.663 . . . . 75.23 110.926 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.25 12.3 61.74 Favored Glycine 0 N--CA 1.476 1.364 0 CA-C-N 116.629 -0.26 . . . . 72.43 112.993 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.511 HG12 ' SG ' ' D' ' 97' ' ' CYS . 1.0 OUTLIER -125.34 159.93 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.892 1.277 . . . . 63.33 109.074 176.171 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -149.4 156.38 41.95 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 122.989 0.516 . . . . 64.15 110.472 -168.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.37 -131.55 10.71 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 116.003 -0.544 . . . . 75.22 114.374 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 40.0 p -84.55 -41.0 16.9 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.183 0.993 . . . . 62.43 111.067 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -66.69 -19.05 65.68 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.279 -0.873 . . . . 73.54 111.408 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.45 ' HA ' HD13 ' D' ' 89' ' ' ILE . 59.4 ttp -54.33 -57.76 10.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.954 1.301 . . . . 70.4 111.392 174.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.21 -15.18 51.46 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.308 -0.86 . . . . 71.02 111.854 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -64.01 -22.93 67.14 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.938 0.495 . . . . 75.21 111.43 172.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 97' ' ' CYS . . . . . 0.511 ' SG ' HG12 ' D' ' 89' ' ' ILE . 81.8 m -59.89 -46.52 89.07 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.236 0.614 . . . . 74.04 111.187 175.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.56 HD23 HD11 ' D' ' 86' ' ' ILE . 3.1 pp -94.59 -20.71 19.37 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.352 0.501 . . . . 71.22 112.352 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.98 -29.38 23.29 Favored Glycine 0 C--N 1.346 1.134 0 O-C-N 123.353 0.408 . . . . 62.01 113.396 -173.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.36 -49.18 1.08 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.809 0.444 . . . . 75.4 111.289 -174.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -74.91 -41.94 58.74 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 112.697 0.629 . . . . 65.31 112.697 -172.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 71.7 m -66.26 -44.79 59.69 Favored Pre-proline 0 CA--C 1.558 1.262 0 CA-C-O 118.558 -0.734 . . . . 55.42 111.704 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.434 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 68.6 Cg_exo -56.59 -33.73 93.76 Favored 'Trans proline' 0 C--N 1.391 2.814 0 C-N-CA 122.021 1.814 . . . . 65.13 112.909 167.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -68.32 -29.57 68.35 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.523 0.729 . . . . 73.21 111.172 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.2 mm -74.93 -37.28 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.355 0.662 . . . . 61.44 109.945 172.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.427 HD13 ' O ' ' D' ' 80' ' ' GLN . 93.3 mt -79.95 -17.76 52.16 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.472 0.709 . . . . 72.14 112.443 -177.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -68.03 -44.08 38.16 Favored Pre-proline 0 N--CA 1.486 1.348 0 CA-C-O 118.472 -0.775 . . . . 75.04 112.725 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.47 -37.11 72.38 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.368 2.046 . . . . 73.22 113.687 170.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -81.02 -32.9 33.97 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.971 0.909 . . . . 73.1 112.428 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.96 -45.21 71.27 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.177 -0.675 . . . . 62.44 109.177 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.473 ' NH2' HG23 ' B' ' 105' ' ' ILE . 43.2 ttp180 -65.51 -39.13 91.48 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 114.371 -1.286 . . . . 71.35 110.139 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -52.59 -46.32 66.9 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 123.986 0.914 . . . . 64.11 110.523 175.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.2 t -67.71 -50.28 58.32 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.903 -1.044 . . . . 74.23 110.86 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.546 HG12 ' SG ' ' D' ' 76' ' ' CYS . 79.3 mt -59.58 -62.14 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 123.951 0.782 . . . . 73.44 110.883 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 17.3 m -50.48 -39.65 48.75 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.949 1.299 . . . . 65.53 111.954 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 24.6 t -64.0 -48.08 77.79 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.046 -0.979 . . . . 62.51 109.977 177.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 68.6 mtm -69.35 -27.21 65.15 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.282 0.633 . . . . 72.24 112.093 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.467 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.6 t -66.33 -46.07 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.407 0.683 . . . . 75.42 109.196 175.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.5 p -73.19 -28.98 62.51 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.576 -0.738 . . . . 73.34 110.698 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' D' ' 116' ' ' SER . 87.9 mtt-85 -70.86 -28.58 64.68 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.816 0.846 . . . . 74.44 110.416 173.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 121' ' ' GLY . . . . . 0.421 ' HA2' ' HB2' ' C' ' 17' ' ' TYR . . . -89.11 8.08 80.67 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 123.824 0.703 . . . . 70.33 112.763 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.441 HG23 ' HB3' ' C' ' 17' ' ' TYR . 47.7 p 59.09 20.47 8.38 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 126.35 1.86 . . . . 64.13 113.507 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -87.04 154.44 55.01 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 123.614 0.766 . . . . 74.41 110.106 174.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -50.3 127.44 20.1 Favored 'Trans proline' 0 C--N 1.386 2.532 0 C-N-CA 123.576 2.851 . . . . 65.02 113.013 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' E' ' 127' ' ' SER . 56.5 tt0 -52.24 128.93 26.63 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 124.522 1.139 . . . . 74.42 111.596 -173.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 33.8 tp -107.13 97.23 7.02 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.726 -0.472 . . . . 65.34 109.726 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -98.45 89.87 4.58 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 107.272 -1.381 . . . . 75.4 107.272 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.497 HD11 HD22 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -67.98 122.29 17.9 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 108.872 -0.788 . . . . 72.41 108.872 -175.597 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.57 142.65 87.24 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 123.798 0.839 . . . . 53.13 111.05 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.07 121.68 10.34 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.889 2.393 . . . . 75.32 112.098 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 131' ' ' VAL . . . . . 0.443 HG11 HD11 ' D' ' 44' ' ' LEU . 8.3 p -107.39 133.4 52.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 123.623 0.769 . . . . 73.32 109.551 -173.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 132' ' ' ASN . . . . . 0.419 ' O ' HD13 ' D' ' 136' ' ' LEU . 82.3 m-20 -87.01 92.4 9.03 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.592 0.757 . . . . 62.21 108.96 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -53.62 -34.97 60.36 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.392 1.077 . . . . 74.45 112.81 -175.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -65.85 -37.78 87.1 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.219 0.607 . . . . 73.13 110.728 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.5 -31.45 72.66 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.547 0.739 . . . . 74.12 111.091 177.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.419 HD13 ' O ' ' D' ' 132' ' ' ASN . 9.0 mp -69.09 -39.3 79.09 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.959 0.904 . . . . 73.32 111.267 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -69.73 -35.3 74.89 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.007 0.523 . . . . 64.54 110.489 172.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 69.8 mtm -72.75 -23.25 60.8 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.452 0.701 . . . . 74.01 111.385 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.443 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 10.7 m120 -64.38 -29.82 70.87 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.31 0.644 . . . . 64.44 111.019 176.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -58.92 -37.09 75.85 Favored 'General case' 0 CA--C 1.555 1.141 0 O-C-N 123.267 0.355 . . . . 75.44 110.283 175.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 5.7 mp -83.77 -52.51 6.34 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.436 0.694 . . . . 51.2 111.646 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 142' ' ' GLN . . . . . 0.443 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 15.7 pt20 -78.91 8.27 5.84 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 114.092 1.145 . . . . 72.12 114.092 -164.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 143' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' D' ' 139' ' ' ASN . 14.5 mm100 -116.04 83.11 1.89 Allowed 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 122.126 0.965 . . . . 60.22 108.793 -176.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -143.54 -55.1 0.38 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 113.665 -1.607 . . . . 54.55 106.846 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.5 92.04 0.87 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.365 -0.976 . . . . 72.21 108.365 173.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -173.23 38.42 0.14 Allowed Glycine 0 C--N 1.341 0.829 0 CA-C-N 115.945 -0.57 . . . . 63.14 111.931 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.33 169.27 17.99 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.274 1.03 . . . . 60.42 109.676 -175.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 176.81 -179.26 47.87 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 116.064 -0.516 . . . . 72.2 112.587 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 8.9 t -101.03 145.83 28.2 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.024 0.93 . . . . 61.0 110.642 -174.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -126.85 137.58 53.2 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.814 0.846 . . . . 64.43 108.898 176.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.34 104.34 2.03 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.298 -1.001 . . . . 73.02 108.298 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -101.94 86.42 2.89 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.163 0.585 . . . . 72.01 109.587 172.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -69.72 102.71 1.96 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 109.355 -0.609 . . . . 62.53 109.355 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -157.88 141.75 15.73 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.438 0.695 . . . . 62.22 109.937 -173.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.872 0 C-N-CA 123.482 0.713 . . . . 65.32 109.25 -176.005 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.534 0 N-CA-C 110.965 -0.854 . . . . 24.33 110.965 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.14 -61.81 3.81 Favored Glycine 0 C--N 1.348 1.212 0 N-CA-C 111.567 -0.613 . . . . 73.25 111.567 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -86.62 147.92 25.7 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.884 0.874 . . . . 73.24 109.42 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -112.72 -100.67 0.42 Allowed 'General case' 0 CA--C 1.549 0.929 0 CA-C-O 118.279 -0.867 . . . . 64.14 109.53 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 58.6 pttt 172.09 19.0 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 124.629 1.172 . . . . 73.12 110.902 -176.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . -148.89 76.92 0.24 Allowed Glycine 0 C--N 1.354 1.535 0 CA-C-O 119.968 -0.351 . . . . 64.31 113.554 -172.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 97' ' ' ILE . . . . . 0.461 HG12 ' O ' ' E' ' 97' ' ' ILE . 7.0 tt -167.33 18.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.708 0 C-N-CA 123.995 0.918 . . . . 71.22 110.333 169.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -70.32 178.74 2.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.911 -1.118 . . . . 75.03 110.541 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . 68.73 15.91 8.98 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.372 1.069 . . . . 54.31 111.648 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.84 113.67 22.13 Favored Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 124.292 1.037 . . . . 73.05 108.676 178.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -85.82 -9.51 7.65 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.912 2.408 . . . . 62.12 114.217 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 102' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 53.74 29.15 9.08 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 124.58 1.152 . . . . 64.02 111.758 -176.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 103' ' ' THR . . . . . 0.446 ' HB ' ' HB2' ' E' ' 108' ' ' HIS . 72.9 p 47.99 74.36 0.17 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.735 1.614 . . . . 74.54 112.371 -173.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.57 -93.5 1.89 Allowed Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.438 -0.801 . . . . 70.25 112.263 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -140.68 -60.13 0.51 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.81 0.844 . . . . 73.2 109.199 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -95.38 -77.2 0.48 Allowed 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 107.992 -1.114 . . . . 64.42 107.992 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 9.0 p -155.41 134.42 12.16 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.135 1.374 . . . . 75.31 109.172 174.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 108' ' ' HIS . . . . . 0.446 ' HB2' ' HB ' ' E' ' 103' ' ' THR . 31.2 m170 -89.57 -33.36 16.74 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.082 0.553 . . . . 74.24 110.957 171.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -102.34 119.85 39.5 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.234 0.614 . . . . 74.13 109.443 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.15 119.07 12.13 Favored 'General case' 0 C--O 1.244 0.776 0 O-C-N 124.044 0.84 . . . . 73.45 110.368 177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 111' ' ' LEU . . . . . 0.58 HD22 HG23 ' D' ' 46' ' ' THR . 48.4 tp -66.07 -38.49 88.42 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 123.921 0.763 . . . . 74.24 109.852 173.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -84.49 -165.83 1.28 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.829 0.852 . . . . 61.33 109.832 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 113' ' ' LYS . . . . . 0.574 ' HA ' ' HE2' ' E' ' 113' ' ' LYS . 1.0 OUTLIER 68.35 90.83 0.09 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.053 0.941 . . . . 63.43 112.616 175.564 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -128.72 163.74 24.48 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.328 1.051 . . . . 61.12 108.507 170.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 37.4 p -76.25 173.96 10.74 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.64 0.776 . . . . 64.41 110.701 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . -87.43 61.21 4.22 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 112.189 -0.365 . . . . 61.51 112.189 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 13.2 mmtm -154.3 -49.42 0.01 OUTLIER Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 124.654 1.182 . . . . 61.13 110.79 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.12 78.72 3.35 Favored 'Trans proline' 0 C--N 1.394 2.944 0 C-N-CA 122.161 1.908 . . . . 74.24 111.097 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -79.46 88.83 5.03 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.715 -0.846 . . . . 52.14 108.715 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -132.19 -45.1 0.93 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.739 -1.119 . . . . 75.31 109.577 -173.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 121' ' ' VAL . . . . . . . . . . . . . 16.9 t -92.3 50.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-O 122.467 1.127 . . . . 62.41 108.723 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 6.8 t -173.19 -42.17 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.284 -1.325 . . . . 74.04 108.857 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -82.52 91.94 6.99 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 108.96 -0.756 . . . . 72.42 108.96 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 29.5 t -107.2 -45.89 4.02 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.747 -1.115 . . . . 44.22 110.566 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . 59.19 -150.51 0.43 Allowed 'General case' 0 C--N 1.36 1.024 0 O-C-N 124.383 1.052 . . . . 74.3 108.981 -167.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . 69.82 -0.89 2.52 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 113.89 1.07 . . . . 75.43 113.89 172.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 127' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' D' ' 125' ' ' GLN . 30.8 t -89.37 133.76 34.36 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.904 0.882 . . . . 73.4 108.816 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -151.12 156.05 40.19 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 123.05 0.54 . . . . 74.21 110.474 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 14.3 t -153.08 170.85 19.46 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.751 0.821 . . . . 73.45 109.958 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 130' ' ' ALA . . . . . 0.452 ' HB3' ' HD3' ' A' ' 124' ' ' PRO . . . -155.87 31.11 0.36 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.352 1.061 . . . . 64.24 108.421 172.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 131' ' ' TRP . . . . . 0.685 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 33.1 t90 -50.67 104.0 0.07 Allowed 'General case' 0 C--N 1.371 1.533 0 C-N-CA 124.507 1.123 . . . . 74.12 111.416 -171.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 132' ' ' SER . . . . . 0.543 ' HB3' ' HD1' ' A' ' 36' ' ' TRP . 15.0 t -170.25 107.6 0.34 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.29 1.036 . . . . 74.2 108.212 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 30.9 m -145.17 137.12 25.65 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.361 0.664 . . . . 74.51 109.521 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -148.09 134.34 5.04 Favored Glycine 0 C--N 1.342 0.874 0 N-CA-C 111.827 -0.509 . . . . 51.14 111.827 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 135' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 129' ' ' ALA . 19.5 m -122.42 178.63 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.038 0.935 . . . . 74.52 109.357 174.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -101.09 156.2 17.55 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 110.049 -0.352 . . . . 72.31 110.049 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 95.3 m -59.28 119.28 7.1 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.834 0.854 . . . . 63.22 111.547 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 138' ' ' TYR . . . . . 0.512 ' HD2' ' HB1' ' A' ' 129' ' ' ALA . 36.5 m-85 -145.14 138.75 26.81 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.026 1.33 . . . . 74.32 108.238 171.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -130.14 -177.18 4.2 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.225 0.61 . . . . 73.21 109.975 176.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . 161.51 174.69 31.69 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 115.813 -0.631 . . . . 62.32 112.156 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.87 93.87 0.07 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.865 1.266 . . . . 73.4 111.732 178.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 36.8 tp -122.24 128.49 51.21 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.999 0.919 . . . . 74.45 108.845 172.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.51 176.36 28.52 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 115.947 -0.57 . . . . 65.33 111.757 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 144' ' ' VAL . . . . . 0.605 HG12 ' HE2' ' C' ' 137' ' ' PHE . 18.1 m -140.38 -37.62 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.944 0.898 . . . . 63.31 110.175 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 . . . . . 0 C--O 1.25 1.101 0 C-N-CA 123.65 0.78 . . . . 72.23 110.142 -177.0 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.442 0 N-CA-C 112.566 -0.213 . . . . 54.32 112.566 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.32 1.05 89.53 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-O 119.79 -0.45 . . . . 73.43 113.995 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -63.82 114.95 4.37 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.252 0.621 . . . . 75.33 109.436 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -79.18 178.58 7.95 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.586 0.754 . . . . 73.32 111.153 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 95' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' B' ' 1' ' ' MET . 32.5 tptt -142.2 131.15 23.06 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 107.391 -1.336 . . . . 72.52 107.391 171.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.47 -49.86 0.18 Allowed Glycine 0 C--N 1.347 1.178 0 O-C-N 123.484 0.49 . . . . 51.03 112.986 -172.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 97' ' ' ILE . . . . . 0.574 ' HB ' ' HA ' ' B' ' 87' ' ' ALA . 8.1 tt -83.77 -45.17 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.046 0.538 . . . . 52.22 110.342 -177.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 28.8 t70 51.56 107.0 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 126.531 1.932 . . . . 71.03 113.189 176.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . 70.51 118.2 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.566 1.147 . . . . 55.13 110.453 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 100' ' ' LEU . . . . . 0.441 HD22 ' HB2' ' B' ' 56' ' ' TYR . 3.5 mp -116.72 86.01 18.16 Favored Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 123.71 0.804 . . . . 70.31 109.571 -172.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.8 105.55 2.1 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.543 2.162 . . . . 53.31 112.019 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 102' ' ' LEU . . . . . . . . . . . . . 30.5 tp -74.5 157.96 34.62 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 109.483 -0.562 . . . . 71.4 109.483 173.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 42.4 p -73.49 81.92 1.46 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.807 0.843 . . . . 34.54 109.597 173.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.25 -157.04 44.17 Favored Glycine 0 C--N 1.343 0.965 0 CA-C-N 115.547 -0.751 . . . . 32.11 111.807 -171.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -118.96 -61.14 1.68 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.612 0.765 . . . . 75.54 109.273 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -98.91 89.88 4.45 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.307 -1.368 . . . . 73.02 107.307 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 107' ' ' THR . . . . . 0.47 HG21 ' O ' ' F' ' 111' ' ' LEU . 11.6 m 61.65 -73.0 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 126.263 1.825 . . . . 64.45 114.808 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 80.82 -44.19 0.22 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 126.74 2.016 . . . . 74.05 111.578 -172.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -68.26 171.05 7.65 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.267 0.627 . . . . 72.43 110.549 173.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.87 68.63 9.43 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.115 0.566 . . . . 74.41 110.6 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 111' ' ' LEU . . . . . 0.47 ' O ' HG21 ' F' ' 107' ' ' THR . 10.0 tt -150.3 108.32 3.73 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.412 -0.958 . . . . 73.22 108.412 177.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -145.44 155.56 43.2 Favored 'General case' 0 C--O 1.247 0.934 0 N-CA-C 108.431 -0.951 . . . . 74.14 108.431 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -54.01 95.11 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.991 0 O-C-N 124.681 1.238 . . . . 72.45 111.263 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -166.94 -60.32 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.176 0.99 . . . . 64.41 108.439 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 91.2 m -158.36 148.39 19.89 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.762 1.225 . . . . 73.04 108.269 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.3 148.68 50.99 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-O 119.77 -0.461 . . . . 65.22 111.983 171.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 117' ' ' LYS . . . . . 0.497 ' HA ' ' HE3' ' F' ' 117' ' ' LYS . 1.5 tpmt? -71.56 119.93 76.87 Favored Pre-proline 0 CA--C 1.55 0.961 0 CA-C-O 118.218 -0.896 . . . . 65.2 110.065 -173.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.87 82.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.394 2.93 0 C-N-CA 123.916 3.078 . . . . 74.45 114.329 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -178.61 -35.88 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 126.655 1.982 . . . . 74.11 107.696 176.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 120' ' ' TYR . . . . . 0.564 ' HB3' ' HG ' ' B' ' 136' ' ' LEU . 40.6 t80 -139.89 163.35 32.88 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.992 1.317 . . . . 72.54 108.038 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 92.3 t 68.82 105.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 124.639 1.175 . . . . 75.23 109.845 -173.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 9.8 t -153.46 -35.64 0.11 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.926 0.89 . . . . 62.31 109.266 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 19.2 t70 62.52 114.77 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.53 1.532 . . . . 72.42 112.822 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 37.5 p -132.92 21.05 4.14 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.612 1.165 . . . . 73.51 108.735 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -107.52 -37.91 6.06 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.741 0.816 . . . . 64.12 111.475 -173.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.02 85.08 0.99 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.442 0.639 . . . . 73.12 110.36 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 50.1 m -143.47 163.49 32.97 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.039 0.936 . . . . 71.11 110.028 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . 66.81 18.72 10.69 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.762 1.225 . . . . 71.34 112.388 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 4.9 t -103.11 158.89 15.99 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.488 0.715 . . . . 71.14 111.027 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -177.1 -175.39 0.58 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.336 1.454 . . . . 50.45 109.056 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 48.0 t-105 -125.02 123.75 40.51 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.654 -0.869 . . . . 73.54 108.654 171.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 51.1 m -149.83 161.91 41.33 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.663 1.185 . . . . 70.33 108.738 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 26.6 m -137.24 137.64 39.28 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.252 0.621 . . . . 63.3 109.64 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -149.27 48.72 0.59 Allowed Glycine 0 C--N 1.343 0.953 0 N-CA-C 111.422 -0.671 . . . . 72.34 111.422 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 135' ' ' VAL . . . . . 0.619 ' HA ' ' HB ' ' C' ' 40' ' ' VAL . 44.4 t -76.21 -41.97 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 109.494 -0.558 . . . . 65.12 109.494 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 136' ' ' LYS . . . . . 0.434 ' HE3' ' H ' ' F' ' 141' ' ' ALA . 36.2 ttpt 62.01 83.46 0.15 Allowed 'General case' 0 C--N 1.365 1.25 0 O-C-N 124.532 1.145 . . . . 53.12 110.693 168.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 12.3 m 67.76 172.57 0.27 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.953 0.901 . . . . 73.44 110.116 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -65.32 -36.97 85.67 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.518 -0.739 . . . . 72.14 109.663 172.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -115.31 98.63 6.87 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.796 -0.816 . . . . 62.25 108.796 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -73.19 160.85 54.12 Favored Glycine 0 C--N 1.342 0.909 0 N-CA-C 111.465 -0.654 . . . . 61.14 111.465 171.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 141' ' ' ALA . . . . . 0.434 ' H ' ' HE3' ' F' ' 136' ' ' LYS . . . -161.17 139.06 9.36 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.039 0.536 . . . . 74.04 110.07 -178.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 142' ' ' LEU . . . . . 0.409 HD21 ' HB2' ' C' ' 39' ' ' GLU . 3.0 pp -163.5 168.46 20.13 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.98 0.912 . . . . 52.34 110.543 173.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -123.87 125.56 5.89 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 109.96 -1.256 . . . . 71.11 109.96 173.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 144' ' ' VAL . . . . . 0.52 HG21 ' HG2' ' C' ' 70' ' ' GLU . 14.7 p -64.34 -30.31 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.233 0.613 . . . . 74.11 111.558 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 34.5 t70 . . . . . 0 C--O 1.246 0.92 0 N-CA-C 107.863 -1.162 . . . . 73.33 107.863 170.966 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtm . . . . . 0 N--CA 1.481 1.125 0 N-CA-C 109.644 -0.502 . . . . 53.34 109.644 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.8 m 74.84 146.63 0.09 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.284 1.433 . . . . 73.42 111.882 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -152.37 160.19 43.34 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.057 0.943 . . . . 73.21 109.694 -172.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -156.42 138.36 14.42 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 122.809 0.444 . . . . 74.23 110.485 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -68.79 89.67 0.4 Allowed 'General case' 0 C--N 1.353 0.755 0 N-CA-C 108.091 -1.077 . . . . 63.54 108.091 168.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -68.75 -177.97 1.09 Allowed 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 113.827 -1.533 . . . . 75.45 111.875 -176.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.0 m -81.0 148.66 29.64 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.806 -0.813 . . . . 71.31 108.806 172.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.49 136.33 57.94 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.39 -0.596 . . . . 74.2 109.39 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 57.9 mtm -132.4 155.94 47.57 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.759 0.824 . . . . 75.51 109.447 -177.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.0 m -140.53 122.66 15.73 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.774 -0.824 . . . . 75.23 108.774 174.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -135.33 114.36 12.14 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.529 -1.286 . . . . 72.34 107.529 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -134.05 135.26 43.21 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.826 -1.176 . . . . 72.14 107.826 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.441 HD13 HG21 ' A' ' 105' ' ' ILE . 8.7 mt -93.95 114.44 30.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.381 -0.97 . . . . 63.04 108.381 174.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -81.54 -30.36 33.16 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 123.731 0.644 . . . . 71.53 110.47 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.475 HH22 ' HZ2' ' F' ' 131' ' ' TRP . 29.5 ttt180 -175.87 134.27 0.28 Allowed 'General case' 0 C--N 1.361 1.089 0 C-N-CA 123.13 0.572 . . . . 55.53 110.372 -175.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.546 HD12 ' HG3' ' C' ' 130' ' ' PRO . 66.2 mt -118.13 133.77 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.998 -1.112 . . . . 74.51 107.998 169.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.456 ' HE1' HG13 ' A' ' 83' ' ' ILE . 24.9 p90 -164.23 149.39 10.31 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 124.098 0.874 . . . . 74.23 110.838 -174.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.0 p -75.27 130.18 38.67 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.862 -0.792 . . . . 73.23 108.862 172.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.446 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.9 mtpt -97.55 -30.05 13.1 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.778 -0.452 . . . . 74.53 109.778 175.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.434 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 7.7 t70 -143.37 141.58 30.97 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.351 -0.611 . . . . 74.24 109.351 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.442 HG23 ' SD ' ' A' ' 117' ' ' MET . 62.6 mt -142.24 146.29 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.164 1.386 . . . . 64.4 107.917 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.8 t -155.8 132.48 10.42 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.482 0.713 . . . . 65.11 109.737 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.605 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 80.5 t80 -139.08 114.65 9.85 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 107.199 -1.408 . . . . 75.24 107.199 172.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -118.24 114.36 22.89 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.996 -0.742 . . . . 74.43 108.996 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.47 79.57 1.75 Allowed Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 107.892 -1.151 . . . . 74.02 107.892 164.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.07 -26.13 21.87 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.547 2.164 . . . . 61.52 112.04 -172.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -104.49 17.9 23.24 Favored 'General case' 0 C--O 1.21 -1.02 0 CA-C-O 117.942 -1.027 . . . . 71.53 110.056 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.415 ' HA ' HG12 ' A' ' 31' ' ' VAL . . . -45.0 -51.96 21.19 Favored Pre-proline 0 N--CA 1.503 2.197 0 N-CA-C 114.291 1.219 . . . . 34.11 114.291 -169.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.09 -26.07 43.26 Favored 'Trans proline' 0 C--N 1.386 2.529 0 C-N-CA 121.764 1.643 . . . . 73.14 112.808 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -81.43 -43.22 19.21 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.251 1.02 . . . . 71.13 110.245 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.714 HG21 ' HA ' ' A' ' 73' ' ' ALA . 8.2 p -78.96 -21.87 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 114.762 -1.108 . . . . 71.13 112.142 -163.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -70.79 -18.17 62.76 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.579 0.351 . . . . 73.14 111.785 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -76.02 -21.32 56.99 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.682 0.793 . . . . 70.35 110.581 173.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.406 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 35.1 mmtp -83.11 154.67 24.23 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.792 0.837 . . . . 72.03 111.625 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -68.36 136.61 53.65 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.12 -0.946 . . . . 70.34 109.995 172.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.535 ' CE3' HD21 ' A' ' 68' ' ' LEU . 67.9 t-105 -82.45 86.16 6.8 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.512 0.673 . . . . 75.41 110.634 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.41 ' H ' HD22 ' A' ' 68' ' ' LEU . 29.1 tt0 -124.55 80.47 60.95 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 107.757 -1.201 . . . . 55.32 107.757 167.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.18 122.88 9.43 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.535 2.157 . . . . 64.12 112.647 -174.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -95.81 85.67 4.17 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 105.847 -1.909 . . . . 64.14 105.847 172.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.8 t -90.31 134.91 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 114.972 -1.013 . . . . 73.51 110.085 -171.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -121.5 114.78 21.73 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.168 0.987 . . . . 75.52 108.395 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 128' ' ' LEU . 2.6 tt -101.59 119.03 38.13 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.35 -0.981 . . . . 72.5 108.35 -175.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -121.43 133.49 55.07 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.162 0.985 . . . . 64.04 109.174 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.565 HD22 HD21 ' A' ' 60' ' ' LEU . 72.6 mt -121.65 131.06 53.89 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.745 0.818 . . . . 61.04 110.693 -178.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -135.66 149.21 49.22 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.071 0.948 . . . . 64.12 108.816 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.5 m -135.87 129.13 31.86 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.424 0.69 . . . . 54.54 110.099 -177.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.43 111.15 11.06 Favored 'General case' 0 C--N 1.345 0.385 0 C-N-CA 124.179 0.992 . . . . 65.22 109.512 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.0 m -90.35 159.24 16.72 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.215 -0.661 . . . . 52.21 109.215 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.9 t -158.35 117.37 3.11 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.245 -0.65 . . . . 74.23 109.245 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -76.06 106.96 7.95 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.72 -0.474 . . . . 70.13 109.72 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.4 mt -79.8 -33.55 40.36 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.402 0.681 . . . . 73.44 111.02 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.92 -174.77 4.56 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.084 0.554 . . . . 50.2 111.086 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.46 114.93 4.66 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.761 0.825 . . . . 75.45 109.362 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 64.89 18.63 11.56 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.064 1.346 . . . . 72.24 112.335 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.7 t -118.29 105.37 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.452 -0.944 . . . . 74.11 108.452 174.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -115.96 122.81 46.38 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.809 0.844 . . . . 74.42 108.724 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -86.6 148.58 25.42 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.778 -0.823 . . . . 74.2 108.778 170.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.6 t -130.33 139.37 51.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 N-CA-C 107.821 -1.178 . . . . 74.02 107.821 168.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.421 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 26.4 t -121.13 127.46 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.84 -0.8 . . . . 62.5 108.84 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.565 HD21 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -102.23 106.75 17.62 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 106.817 -1.549 . . . . 71.33 106.817 176.925 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -92.76 101.82 14.22 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.865 -1.161 . . . . 53.4 107.865 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.23 126.91 48.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 N-CA-C 108.482 -0.933 . . . . 61.23 108.482 174.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.8 m -116.25 142.7 46.49 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.978 -0.749 . . . . 70.55 108.978 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.573 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 92.6 t -139.3 109.3 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 125.169 1.388 . . . . 75.41 107.749 -176.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.4 m -107.4 123.02 47.77 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.993 -0.743 . . . . 71.32 108.993 169.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.94 120.57 36.77 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.354 -0.98 . . . . 53.25 108.354 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.5 m -124.14 136.07 53.95 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.211 0.604 . . . . 52.33 110.755 -176.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.662 HD12 HG22 ' A' ' 31' ' ' VAL . 91.6 mt -87.75 74.99 9.02 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.354 -0.98 . . . . 75.3 108.354 174.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.47 -116.38 4.68 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 114.33 -1.305 . . . . 35.32 110.956 -169.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -91.94 -13.85 30.49 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.875 0.87 . . . . 63.42 110.743 176.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.406 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 5.9 tp10 -77.26 133.28 38.89 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.39 1.076 . . . . 75.43 108.267 173.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.6 m -87.7 127.5 35.3 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.729 0.695 . . . . 74.31 109.521 174.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.714 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -79.83 -58.85 2.98 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.53 -0.915 . . . . 73.43 108.53 173.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -162.39 165.24 26.67 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 115.458 -0.792 . . . . 63.54 111.652 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.3 tp -127.17 118.98 25.38 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.393 -1.276 . . . . 65.01 107.988 166.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.573 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.0 m -105.56 138.11 42.3 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.054 0.942 . . . . 71.24 109.257 171.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -147.92 132.75 18.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.694 -0.854 . . . . 73.32 108.694 168.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.2 t -138.7 110.85 5.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 C-N-CA 124.194 0.998 . . . . 65.15 108.461 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -84.89 85.46 7.47 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.282 -1.007 . . . . 74.02 108.282 169.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -75.92 96.99 3.85 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.096 -0.956 . . . . 64.2 109.011 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.06 160.14 34.78 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 111.513 -0.635 . . . . 75.01 111.513 178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.9 127.68 2.01 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.773 -0.931 . . . . 62.23 110.773 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.456 HG13 ' HE1' ' A' ' 17' ' ' TYR . 63.6 mt -80.97 124.0 38.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 107.948 -1.13 . . . . 74.33 107.948 171.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.81 ' HB3' HD11 ' A' ' 86' ' ' ILE . 87.7 m-85 -125.65 127.42 46.27 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 109.003 -0.74 . . . . 72.41 109.003 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.3 t -89.3 97.57 11.27 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.955 -0.757 . . . . 64.24 108.955 173.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.81 HD11 ' HB3' ' A' ' 84' ' ' PHE . 4.7 mm -112.76 150.92 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 122.74 0.416 . . . . 75.44 110.502 -175.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.54 170.85 12.36 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.003 0.814 . . . . 65.33 110.869 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.11 -31.39 7.05 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 115.987 -0.551 . . . . 74.54 113.924 172.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.602 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.2 161.03 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.812 0.845 . . . . 73.13 108.993 176.884 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.554 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 17.0 tt0 -153.5 176.65 11.8 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 109.457 -0.572 . . . . 75.21 109.457 -175.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.554 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 57.5 -123.37 32.5 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 124.144 0.902 . . . . 72.23 113.921 177.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.2 t -75.23 -24.72 57.75 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.262 0.625 . . . . 61.33 111.91 -176.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -76.27 -34.79 59.12 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.42 0.688 . . . . 74.3 110.368 176.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.435 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 6.4 tpt -62.86 -48.68 78.0 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.383 -0.599 . . . . 75.23 109.383 171.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.71 -36.62 72.24 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.645 0.778 . . . . 41.54 110.751 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -67.96 -38.0 82.24 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.422 0.689 . . . . 74.33 111.182 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.5 t -66.38 -40.43 89.68 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.849 -0.426 . . . . 70.42 109.849 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 94' ' ' MET . 53.9 mt -83.66 -25.61 30.59 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.741 0.816 . . . . 60.35 112.322 -174.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.53 3.38 34.53 Favored Glycine 0 N--CA 1.475 1.268 0 O-C-N 123.417 0.448 . . . . 73.12 113.726 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.546 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -136.8 -68.69 0.48 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.029 0.532 . . . . 60.05 110.059 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -65.82 -46.97 76.64 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.436 0.694 . . . . 74.02 111.721 -171.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 59.4 m -66.29 -50.75 47.75 Favored Pre-proline 0 CA--C 1.567 1.619 0 C-N-CA 124.464 1.105 . . . . 72.24 112.659 -175.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.96 -20.05 45.28 Favored 'Trans proline' 0 C--N 1.39 2.749 0 C-N-CA 121.841 1.694 . . . . 71.24 112.948 174.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -69.7 -35.71 75.3 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.847 0.459 . . . . 74.55 110.188 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.441 HG21 HD13 ' A' ' 13' ' ' ILE . 46.7 mm -64.25 -47.87 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.27 0.628 . . . . 73.12 109.828 171.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.5 mt -72.22 -21.7 61.36 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.116 -0.947 . . . . 74.21 112.552 -171.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -65.03 -45.46 73.44 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 114.26 1.207 . . . . 61.22 114.26 -172.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.425 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 82.8 Cg_exo -50.54 -40.95 54.29 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.055 1.837 . . . . 53.24 113.626 171.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -76.13 -38.58 56.64 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.371 0.668 . . . . 74.32 111.084 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.21 -48.12 74.46 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.347 0.659 . . . . 60.12 109.915 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.438 ' NH1' HG23 ' C' ' 105' ' ' ILE . 29.3 ttm105 -47.99 -55.91 8.92 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 125.023 1.452 . . . . 74.22 110.079 174.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -61.81 -48.34 81.02 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 124.478 1.111 . . . . 74.4 111.879 -175.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.531 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.0 t -57.05 -42.39 80.44 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 123.786 0.679 . . . . 73.23 110.57 -177.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 118' ' ' VAL . 82.9 mt -62.95 -52.15 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 115.097 -0.956 . . . . 74.35 110.319 173.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.426 HG21 ' HE2' ' C' ' 109' ' ' TYR . 61.7 m -55.28 -41.08 71.79 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.047 0.939 . . . . 70.32 111.319 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.8 t -68.99 -42.57 76.32 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 114.626 -1.17 . . . . 51.45 109.706 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.513 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 7.9 mtp -60.02 -42.49 94.45 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.871 0.868 . . . . 72.41 111.063 175.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 114' ' ' ILE . 70.1 t -61.66 -45.84 97.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 124.278 1.031 . . . . 54.12 110.1 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.5 p -73.95 -30.51 62.58 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.271 0.628 . . . . 75.34 111.647 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 78.6 mtt-85 -72.59 -29.21 63.32 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.509 0.724 . . . . 70.44 109.594 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.07 5.42 62.77 Favored Glycine 0 C--N 1.354 1.56 0 CA-C-O 119.213 -0.771 . . . . 65.33 112.962 175.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.593 HG21 ' HE ' ' B' ' 15' ' ' ARG . 44.6 m 72.61 10.35 5.63 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 122.587 1.184 . . . . 73.42 111.703 173.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -86.35 144.42 38.14 Favored Pre-proline 0 C--O 1.244 0.765 0 O-C-N 121.064 -1.023 . . . . 64.25 109.151 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -51.69 142.52 40.52 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.06 2.507 . . . . 74.35 112.159 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -57.06 136.34 56.33 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 123.999 0.812 . . . . 72.34 112.667 -170.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.445 HD21 HG11 ' A' ' 64' ' ' VAL . 35.8 tp -121.58 123.37 41.8 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.626 1.17 . . . . 74.02 108.486 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.499 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 92.2 m-20 -122.44 109.46 14.41 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.543 0.737 . . . . 71.12 109.124 -176.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.511 ' HB3' HD11 ' A' ' 42' ' ' LEU . 7.9 mt -70.01 116.46 10.4 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 109.217 -0.66 . . . . 63.23 109.217 -173.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.68 143.4 93.9 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 122.873 0.469 . . . . 53.14 111.57 -172.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -56.24 125.14 18.09 Favored 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.488 2.792 . . . . 63.44 114.141 -172.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.493 HG21 HD11 ' A' ' 44' ' ' LEU . 90.3 t -102.46 134.26 43.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 CA-C-N 115.335 -0.848 . . . . 71.24 110.382 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -90.54 86.54 6.44 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.709 -0.848 . . . . 71.34 108.709 176.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -63.11 -27.65 69.53 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.579 0.751 . . . . 75.42 112.029 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.546 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 18.7 t70 -66.91 -43.37 83.51 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 123.45 0.469 . . . . 62.4 109.745 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.65 -40.51 95.58 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 124.228 0.955 . . . . 71.23 111.105 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 89.3 mt -60.01 -51.94 67.5 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.275 0.63 . . . . 65.42 111.033 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -66.82 -36.43 82.35 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.686 -0.487 . . . . 71.04 109.686 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.15 -47.56 80.85 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 124.011 0.819 . . . . 74.1 110.226 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -56.83 -42.04 78.92 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.046 0.938 . . . . 73.22 111.522 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -76.24 -30.75 58.02 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.566 -0.743 . . . . 73.41 111.17 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 44.4 tp -67.21 -52.09 45.36 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.381 1.073 . . . . 75.44 110.998 -174.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 175.23 -13.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.14 0.976 . . . . 72.52 110.294 -175.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 75.06 -63.13 0.43 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.389 1.875 . . . . 63.44 109.795 -173.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -73.21 83.45 1.35 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.042 0.937 . . . . 72.32 109.607 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -162.99 165.17 25.22 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.452 1.101 . . . . 44.22 110.035 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -173.06 126.24 1.23 Allowed Glycine 0 C--N 1.34 0.76 0 N-CA-C 111.597 -0.601 . . . . 51.24 111.597 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -147.32 122.41 10.13 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.917 0.887 . . . . 65.43 109.078 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 179.95 53.85 0.08 OUTLIER Glycine 0 C--N 1.349 1.255 0 CA-C-N 116.308 -0.405 . . . . 61.1 112.218 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.0 p -129.93 142.83 50.6 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.35 -0.981 . . . . 74.02 108.35 175.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -145.94 104.47 3.85 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 108.642 -0.873 . . . . 41.12 108.642 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -166.66 38.12 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.473 0.709 . . . . 71.14 110.919 -174.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -131.32 141.44 49.93 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.722 0.409 . . . . 62.31 110.661 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -125.14 137.61 54.16 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.681 -0.859 . . . . 71.22 108.681 167.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -153.09 98.44 2.29 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.329 -0.989 . . . . 65.31 108.329 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.215 0 N-CA-C 108.447 -0.945 . . . . 71.5 108.447 -179.796 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.487 1.383 0 N-CA-C 109.699 -0.482 . . . . 73.41 109.699 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 48.5 t -154.7 112.32 3.42 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.319 1.048 . . . . 33.5 108.651 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -82.34 84.8 7.01 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.326 0.65 . . . . 42.43 110.084 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -137.26 111.26 8.3 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.878 0.871 . . . . 64.31 108.946 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -74.98 137.99 41.94 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 109.87 -0.419 . . . . 73.21 109.87 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 58.24 78.19 0.26 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.485 1.114 . . . . 73.3 110.19 -172.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.565 HG21 ' HA ' ' B' ' 89' ' ' ILE . 17.2 m -80.43 106.34 12.37 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 109.096 -0.705 . . . . 73.11 109.096 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -60.27 -29.04 68.54 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.562 1.145 . . . . 71.31 112.54 -177.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.644 ' HB3' HG23 ' B' ' 89' ' ' ILE . 25.5 ptm 51.49 -170.5 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 126.509 1.924 . . . . 70.31 113.437 -177.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.3 t -143.54 127.37 17.24 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 124.437 1.095 . . . . 70.51 108.096 171.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.402 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 75.2 t80 -123.51 146.19 48.27 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.613 0.765 . . . . 73.52 109.521 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.658 ' HG3' ' HB1' ' E' ' 125' ' ' ALA . 8.5 tt0 -149.99 131.26 14.57 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.248 0.619 . . . . 62.31 109.739 176.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 54.9 mt -80.3 122.82 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.538 -1.282 . . . . 71.41 107.538 168.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -93.58 -49.77 5.73 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.692 -0.855 . . . . 64.34 108.692 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.593 ' HE ' HG21 ' A' ' 122' ' ' THR . 26.1 ttt180 -164.14 143.57 7.75 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.767 -0.651 . . . . 54.14 110.841 -174.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 94.6 mt -124.02 141.45 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 107.039 -1.467 . . . . 74.33 107.039 173.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -165.43 138.98 4.56 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 112.886 0.699 . . . . 71.42 112.886 -174.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.6 m -73.91 119.38 18.05 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.668 0.787 . . . . 74.34 109.373 172.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.522 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.9 mtpt -96.89 -20.44 18.14 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.707 0.803 . . . . 74.11 111.678 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.578 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 34.0 t70 -160.18 149.64 17.72 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.097 0.559 . . . . 74.12 111.022 -177.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.605 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 26.9 mm -145.86 146.16 19.58 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 125.485 1.514 . . . . 73.45 108.374 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 36.3 t -155.6 145.6 21.51 Favored 'General case' 0 C--O 1.242 0.693 0 O-C-N 124.351 1.032 . . . . 70.14 110.087 169.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.44 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.1 t80 -151.56 108.54 3.54 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 107.457 -1.312 . . . . 73.12 107.457 169.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.18 113.53 21.69 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.243 -1.021 . . . . 74.2 108.243 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.64 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -107.78 86.42 2.97 Favored Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 107.888 -1.153 . . . . 74.54 107.888 174.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.2 -33.69 7.0 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.734 2.29 . . . . 72.11 112.933 -170.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -100.95 6.15 43.48 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.815 0.846 . . . . 72.11 111.389 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.64 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -41.39 -62.59 1.02 Allowed Pre-proline 0 N--CA 1.491 1.606 0 C-N-CA 125.436 1.494 . . . . 45.11 113.924 -168.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 52.8 Cg_exo -52.37 -38.29 73.21 Favored 'Trans proline' 0 C--N 1.391 2.792 0 C-N-CA 122.89 2.393 . . . . 63.14 113.756 -172.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -93.54 -35.03 13.12 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.193 -0.912 . . . . 74.02 111.636 -171.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.508 HG22 HD12 ' B' ' 68' ' ' LEU . 4.3 p -73.14 -14.74 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.239 0.616 . . . . 65.45 111.574 -171.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -64.31 -20.46 66.1 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.445 0.698 . . . . 70.41 112.771 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -65.17 -18.18 65.09 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.146 0.578 . . . . 52.25 110.942 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.452 ' HB2' HD13 ' B' ' 68' ' ' LEU . 93.0 mttt -91.2 79.61 5.69 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.787 1.235 . . . . 75.44 110.048 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -85.31 78.01 9.86 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.321 -0.854 . . . . 74.44 110.098 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 14.9 p90 -154.3 -174.68 5.06 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.952 0.901 . . . . 72.14 108.875 172.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.417 ' HB3' ' OG1' ' F' ' 129' ' ' THR . 4.8 pp0? -71.0 120.19 77.95 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 123.157 0.583 . . . . 70.1 111.079 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' F' ' 128' ' ' ALA . 58.1 Cg_endo -70.33 139.32 38.0 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 121.244 1.296 . . . . 41.44 109.513 172.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.61 101.02 1.2 Allowed 'General case' 0 C--O 1.242 0.691 0 N-CA-C 107.27 -1.381 . . . . 62.45 107.27 170.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.689 HG11 HD11 ' B' ' 126' ' ' LEU . 35.4 t -102.94 145.66 11.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 115.066 -0.97 . . . . 63.53 109.184 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -135.07 130.41 35.52 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.344 -0.844 . . . . 72.1 108.91 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.527 HD11 HG13 ' B' ' 62' ' ' VAL . 21.8 tp -94.09 126.97 39.63 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 124.212 0.945 . . . . 60.54 109.245 170.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -142.87 126.38 16.8 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.289 1.036 . . . . 71.12 108.466 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.546 HD23 HG22 ' B' ' 62' ' ' VAL . 4.0 mp -119.9 148.72 43.16 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.985 0.514 . . . . 72.43 110.537 -172.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.409 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 18.1 t70 -124.4 141.61 51.95 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.172 1.389 . . . . 73.04 108.097 176.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 27.4 m -113.34 104.16 12.04 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.561 -0.533 . . . . 52.13 109.561 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.59 134.43 55.05 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.088 -1.449 . . . . 74.25 107.088 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.45 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 51.9 m -142.99 162.8 34.51 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 122.493 0.317 . . . . 72.11 110.745 -175.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.9 p -152.09 135.6 16.08 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.431 0.692 . . . . 65.43 109.693 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -90.49 122.66 33.52 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 109.013 -0.736 . . . . 75.22 109.013 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 pp -143.96 25.11 1.62 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.286 -0.87 . . . . 63.54 109.589 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.97 156.76 20.19 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 123.632 0.773 . . . . 73.23 110.312 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.7 131.83 36.05 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 108.521 -0.918 . . . . 73.21 108.521 167.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 64.49 7.31 3.59 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.929 1.292 . . . . 72.42 112.215 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.7 HG22 ' HA ' ' B' ' 85' ' ' SER . 54.2 t -138.68 123.33 21.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 107.239 -1.393 . . . . 64.3 107.239 -174.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.45 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 1.5 t80 -117.26 145.45 43.93 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 108.364 -0.976 . . . . 55.12 108.364 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -100.51 103.13 14.45 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 106.547 -1.649 . . . . 44.01 106.547 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 6.8 p -102.52 132.44 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.345 -0.613 . . . . 71.32 109.345 -176.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.419 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 19.0 t -115.12 122.41 69.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 108.688 -0.856 . . . . 33.35 108.688 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 38.9 tp -103.54 105.89 16.25 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.754 -0.832 . . . . 71.22 108.754 173.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.432 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 14.4 ttm180 -84.9 110.09 18.61 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 108.588 -0.893 . . . . 74.3 108.588 174.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.546 HG22 HD23 ' B' ' 44' ' ' LEU . 61.4 t -105.03 104.7 17.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 123.572 0.749 . . . . 60.51 109.011 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 6.7 m -98.83 137.15 37.82 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.134 -0.939 . . . . 73.13 109.684 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.651 HG11 HD21 ' B' ' 126' ' ' LEU . 30.6 t -128.42 116.29 41.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 124.225 1.01 . . . . 62.11 108.524 174.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 97.0 m -101.95 136.56 41.58 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.985 -1.117 . . . . 73.51 107.985 168.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.87 141.22 36.61 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 109.443 -0.577 . . . . 73.33 109.443 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.521 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 40.9 p -148.15 130.98 16.08 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.542 0.526 . . . . 73.02 111.585 -173.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.508 HD12 HG22 ' B' ' 31' ' ' VAL . 75.8 mt -97.04 107.11 19.57 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.181 0.992 . . . . 71.45 108.664 176.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.58 -111.98 3.37 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 111.195 -0.762 . . . . 41.22 111.195 -172.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -117.54 1.65 12.31 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.674 0.79 . . . . 72.13 110.297 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -114.43 142.15 46.73 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.768 -0.583 . . . . 62.35 110.37 -174.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 25.4 m -66.39 115.25 6.11 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.719 0.808 . . . . 54.41 111.394 -175.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.521 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -70.02 -56.34 7.2 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.992 -1.114 . . . . 74.41 107.992 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -158.37 164.47 36.29 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 114.398 -1.274 . . . . 64.3 111.151 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 67.8 mt -129.9 112.23 13.33 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 106.683 -1.599 . . . . 70.02 106.683 172.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.519 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 34.2 t -119.94 115.12 23.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.772 -0.825 . . . . 72.41 108.772 177.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -128.0 124.81 38.11 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.885 0.874 . . . . 70.04 109.044 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 73.1 t -124.49 153.17 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.227 1.011 . . . . 73.02 109.276 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.578 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.5 mt-30 -122.9 111.78 17.05 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.349 -0.982 . . . . 72.33 108.349 167.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.461 ' HG3' HD22 ' B' ' 106' ' ' LEU . 8.0 tp-100 -101.54 106.83 17.97 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.526 -0.916 . . . . 74.23 108.526 171.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.522 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -100.91 167.28 19.59 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 111.525 -0.63 . . . . 55.44 111.525 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.26 143.82 8.67 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.127 -0.559 . . . . 70.24 112.98 -174.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 79.3 mt -101.76 113.65 38.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 107.651 -1.24 . . . . 72.44 107.651 174.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' PHE . . . . . 0.428 ' O ' HG13 ' B' ' 55' ' ' VAL . 38.9 m-85 -127.49 147.46 50.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.311 0.644 . . . . 73.22 109.593 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.7 ' HA ' HG22 ' B' ' 55' ' ' VAL . 49.3 m -94.25 115.71 28.01 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.542 1.137 . . . . 61.51 110.456 177.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.602 HG22 HD11 ' B' ' 89' ' ' ILE . 3.8 mp -120.67 104.89 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 106.929 -1.508 . . . . 73.4 106.929 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.34 167.79 21.32 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.107 0.563 . . . . 74.3 110.559 -175.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.46 -45.82 3.29 Favored Glycine 0 N--CA 1.476 1.321 0 O-C-N 123.138 0.274 . . . . 70.13 113.096 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.644 HG23 ' HB3' ' B' ' 9' ' ' MET . 0.8 OUTLIER -58.03 167.74 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 124.839 1.255 . . . . 71.01 113.415 175.326 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -152.55 149.85 28.93 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.467 -1.242 . . . . 75.23 110.696 -174.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.19 -126.67 7.61 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.519 0.512 . . . . 21.11 112.236 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 20.3 m -90.1 -19.58 24.15 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.028 0.531 . . . . 64.12 110.202 175.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -53.44 -33.7 55.08 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.055 0.942 . . . . 75.11 111.368 176.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.782 ' SD ' HG23 ' F' ' 97' ' ' ILE . 11.2 ptt? -62.22 -59.42 5.06 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.259 1.024 . . . . 74.44 111.707 -174.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.85 -14.15 58.29 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.348 0.659 . . . . 70.45 111.428 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -61.87 -38.61 88.91 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.846 0.858 . . . . 61.24 110.688 170.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.7 t -68.89 -55.36 11.29 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.81 0.444 . . . . 61.13 110.615 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.616 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 1.9 pp -74.17 -18.4 60.78 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.717 0.636 . . . . 73.01 112.717 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.41 0.93 55.78 Favored Glycine 0 N--CA 1.472 1.072 0 CA-C-O 119.413 -0.659 . . . . 65.31 114.199 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.556 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -149.04 -50.86 0.15 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 117.888 0.844 . . . . 71.45 112.006 -176.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.405 ' O ' ' HB3' ' B' ' 104' ' ' ASN . 39.7 t80 -73.01 -39.58 65.9 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.333 0.653 . . . . 75.43 111.046 -177.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.616 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 82.0 m -75.13 -43.7 4.56 Favored Pre-proline 0 CA--C 1.563 1.446 0 CA-C-O 118.476 -0.773 . . . . 63.24 113.027 -175.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.7 -22.39 64.27 Favored 'Trans proline' 0 C--N 1.389 2.669 0 CA-C-N 121.185 1.459 . . . . 71.41 112.692 170.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' B' ' 101' ' ' TYR . 22.8 t-20 -64.15 -37.44 87.46 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.886 0.474 . . . . 75.2 110.861 172.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.9 mt -66.37 -40.85 87.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.536 0.735 . . . . 71.13 110.09 173.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.461 HD22 ' HG3' ' B' ' 80' ' ' GLN . 88.1 mt -75.0 -28.17 60.43 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.822 0.849 . . . . 64.35 112.775 -174.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -56.16 -47.35 99.01 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 118.068 -0.968 . . . . 71.33 113.464 -173.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.538 ' HG2' ' HB2' ' D' ' 108' ' ' PRO . 85.0 Cg_exo -53.53 -42.99 61.45 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.813 2.342 . . . . 71.21 114.604 174.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.412 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 40.4 m-85 -67.62 -36.05 80.09 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.187 0.595 . . . . 73.23 110.476 -177.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.21 -39.75 74.95 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.573 0.749 . . . . 72.45 110.778 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.419 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 51.3 ttt-85 -60.79 -55.16 36.37 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.282 1.433 . . . . 74.0 111.175 -177.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -69.15 -26.15 64.73 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.618 0.574 . . . . 74.11 110.427 -177.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.528 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.8 t -70.44 -39.4 74.37 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 110.265 -0.272 . . . . 72.34 110.265 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.519 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 72.3 mt -61.44 -54.81 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 123.987 0.915 . . . . 70.42 109.762 170.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 36.7 m -59.1 -28.3 66.39 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.921 0.888 . . . . 73.52 111.263 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.8 t -68.28 -50.97 50.06 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 123.475 0.71 . . . . 73.22 109.943 175.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.501 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.4 mmt -68.22 -36.34 79.36 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.204 0.601 . . . . 73.43 111.206 -175.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.2 -43.55 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.606 1.162 . . . . 62.42 110.198 173.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 30.9 t -63.65 -34.44 77.84 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.014 -0.994 . . . . 72.45 110.581 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.531 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 81.2 mtt-85 -69.23 -34.76 75.34 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.89 -0.596 . . . . 63.34 110.297 178.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -75.28 -11.96 83.84 Favored Glycine 0 C--N 1.357 1.705 0 O-C-N 123.736 0.647 . . . . 41.34 112.456 170.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 16.9 m 66.92 33.63 5.79 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.769 1.628 . . . . 43.22 110.186 176.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -79.52 163.54 58.45 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 115.259 -0.882 . . . . 61.31 110.434 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -58.76 165.65 7.8 Favored 'Trans proline' 0 C--N 1.388 2.624 0 C-N-CA 122.655 2.237 . . . . 63.25 112.894 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.422 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 23.9 tp60 -63.88 112.47 2.93 Favored 'General case' 0 C--N 1.345 0.405 0 C-N-CA 123.86 0.864 . . . . 52.21 111.378 -167.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.689 HD11 HG11 ' B' ' 40' ' ' VAL . 23.3 tp -110.52 112.53 24.51 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.168 -0.924 . . . . 62.23 109.018 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.17 124.3 41.5 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 108.288 -1.005 . . . . 74.41 108.288 176.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.419 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 77.3 mt -83.59 136.62 34.17 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.691 0.396 . . . . 62.52 110.514 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.32 140.99 52.87 Favored Pre-proline 0 CA--C 1.55 0.952 0 O-C-N 123.972 0.795 . . . . 60.01 111.284 -174.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -60.02 93.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.541 2.828 . . . . 71.33 111.99 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 4.0 p -90.55 118.34 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 108.496 -0.927 . . . . 72.53 108.496 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -81.02 99.34 8.39 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.617 -0.72 . . . . 73.21 109.182 -175.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -64.41 -38.08 89.79 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.294 -0.867 . . . . 61.35 110.242 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.556 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 9.6 t70 -59.84 -50.47 73.68 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.053 -0.976 . . . . 61.25 110.331 -176.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.64 -36.77 85.34 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 124.15 0.906 . . . . 65.41 111.564 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.435 HD13 ' HB3' ' F' ' 120' ' ' TYR . 53.4 tp -59.54 -49.07 79.19 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.583 0.753 . . . . 52.24 110.602 177.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -72.04 -20.22 61.71 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.252 0.621 . . . . 72.41 111.787 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 8.2 mmt -73.15 -29.26 62.74 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.931 0.492 . . . . 64.13 110.891 174.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -78.72 -36.33 43.5 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.531 0.332 . . . . 71.34 110.215 172.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -60.44 -40.07 89.77 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.109 0.563 . . . . 74.4 111.268 174.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 37.1 tp -95.52 -7.93 36.61 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.4 0.68 . . . . 63.53 111.826 -176.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 67.0 120.68 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.707 1.203 . . . . 73.43 110.722 -171.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -150.91 153.5 35.39 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.471 -0.936 . . . . 72.14 108.471 177.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.24 115.59 5.08 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.862 -0.792 . . . . 51.13 108.862 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -148.96 145.58 27.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.014 0.926 . . . . 73.54 109.065 174.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -176.55 97.02 0.11 Allowed Glycine 0 C--N 1.338 0.685 0 N-CA-C 111.078 -0.809 . . . . 43.13 111.078 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -84.44 -172.69 4.31 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.936 0.495 . . . . 74.04 111.182 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -160.19 -42.56 0.02 OUTLIER Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.497 -0.641 . . . . 61.34 111.497 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 9.1 m 49.59 59.59 4.39 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.058 1.343 . . . . 55.44 110.931 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 150' ' ' GLU . . . . . 0.482 ' HA ' ' HA3' ' D' ' 91' ' ' GLY . 3.4 tm-20 -80.95 113.39 19.13 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.571 -1.195 . . . . 54.41 109.694 -172.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -163.54 130.54 3.38 Favored 'General case' 0 C--O 1.239 0.524 0 O-C-N 124.038 0.836 . . . . 71.15 109.372 168.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -168.99 100.93 0.37 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 107.395 -1.335 . . . . 72.34 107.395 172.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -74.53 -33.12 62.68 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.486 0.714 . . . . 72.14 112.677 -171.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 62.26 18.89 10.56 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.286 1.035 . . . . 71.11 111.781 -173.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.247 0 C-N-CA 124.186 0.994 . . . . 54.04 108.984 -179.217 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 109.339 -0.615 . . . . 73.4 109.339 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 2' ' ' SER . . . . . 0.433 ' H ' ' HA ' ' E' ' 142' ' ' LEU . 23.3 p -77.73 78.38 4.23 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.468 0.651 . . . . 65.33 109.399 174.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -70.78 86.65 0.68 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.587 -1.188 . . . . 74.34 110.499 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -124.02 134.26 53.48 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.398 1.079 . . . . 72.45 108.172 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 5' ' ' ASN . . . . . 0.673 ' HA ' ' HA2' ' C' ' 88' ' ' GLY . 62.6 t30 -154.77 42.35 0.47 Allowed 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 121.357 0.599 . . . . 73.44 110.376 -176.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -106.18 -79.8 0.56 Allowed 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.58 -0.526 . . . . 74.25 109.58 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 44.6 p -142.99 4.98 1.49 Allowed 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 123.769 0.827 . . . . 71.4 111.743 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -76.15 -54.87 6.18 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.796 0.838 . . . . 52.54 110.79 -167.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 47.6 ttm 63.03 110.59 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.335 1.454 . . . . 72.33 109.936 -165.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.411 HG21 ' OG ' ' C' ' 2' ' ' SER . 24.1 m -97.06 86.68 4.02 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.957 -0.757 . . . . 74.4 108.957 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.465 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 59.8 t80 -104.27 116.09 31.55 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.428 -0.953 . . . . 73.5 108.428 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -138.45 132.32 31.14 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 109.556 -0.535 . . . . 74.33 109.556 178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 21.6 mt -77.71 128.89 38.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 O-C-N 123.957 0.786 . . . . 52.52 109.395 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.431 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.8 mm-40 -89.05 -46.57 8.75 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.471 0.709 . . . . 64.32 109.153 174.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.499 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 13.6 ptp180 -176.26 150.17 0.91 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.61 1.164 . . . . 72.44 109.63 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 76.9 mt -128.22 129.9 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.409 1.083 . . . . 73.25 108.3 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.539 ' HB3' HG23 ' D' ' 122' ' ' THR . 35.7 p90 -158.07 175.1 14.23 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.804 0.841 . . . . 73.31 110.421 -166.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.6 p -98.07 114.23 26.34 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 122.932 0.493 . . . . 43.13 109.982 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.538 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 27.9 mmtp -65.39 -30.37 71.18 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.449 -0.574 . . . . 70.44 109.449 165.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.605 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.1 t70 -162.35 146.65 12.1 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.142 -0.935 . . . . 72.15 110.651 -172.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.598 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.7 mt -138.32 147.11 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.785 1.634 . . . . 74.43 107.25 173.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 43.8 t -152.45 148.04 26.96 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 122.935 0.494 . . . . 74.44 110.535 175.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.416 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 79.8 t80 -155.82 119.4 4.4 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 114.652 -1.158 . . . . 73.13 108.119 172.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -126.87 118.0 23.71 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.15 -0.685 . . . . 62.04 109.15 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.4 81.53 46.18 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 107.574 -1.269 . . . . 63.11 107.574 167.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.73 -36.05 43.01 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 122.739 2.292 . . . . 74.23 111.408 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -101.4 30.48 4.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.56 1.144 . . . . 73.25 109.535 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.24 -54.04 28.72 Favored Pre-proline 0 N--CA 1.495 1.789 0 C-N-CA 124.259 1.024 . . . . 73.51 113.297 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.46 -42.02 29.67 Favored 'Trans proline' 0 C--N 1.381 2.24 0 CA-C-N 121.17 1.454 . . . . 61.41 111.421 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -71.0 -27.75 63.92 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 114.277 -1.329 . . . . 64.22 113.042 -174.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.569 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.8 p -80.8 -28.93 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 O-C-N 122.059 -0.401 . . . . 41.12 111.664 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -65.15 -15.6 62.6 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 112.762 0.653 . . . . 75.01 112.762 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -105.32 22.46 15.37 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.947 0.899 . . . . 73.4 111.113 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.692 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -110.23 160.63 16.34 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.591 0.756 . . . . 64.22 110.562 -178.019 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -66.34 126.85 30.07 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.335 -0.617 . . . . 75.14 109.335 166.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -80.21 77.78 6.92 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.611 0.719 . . . . 63.31 109.683 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -129.02 66.44 76.31 Favored Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 123.963 0.905 . . . . 75.11 109.43 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -90.8 153.01 4.09 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.421 2.08 . . . . 51.44 112.578 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 39' ' ' GLU . . . . . 0.612 ' HB2' ' HE3' ' C' ' 41' ' ' LYS . 8.7 pt-20 -88.33 104.04 16.38 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.55 -1.278 . . . . 72.11 107.55 165.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.461 HG11 HD21 ' C' ' 126' ' ' LEU . 59.4 t -77.17 100.03 2.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.361 -0.977 . . . . 61.22 108.361 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.612 ' HE3' ' HB2' ' C' ' 39' ' ' GLU . 34.1 mmtp -103.59 105.57 15.84 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.421 -0.809 . . . . 75.23 109.96 -177.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mp -87.31 122.36 30.97 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 107.106 -1.442 . . . . 72.53 107.106 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.436 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 28.4 t70 -124.54 105.2 9.19 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.131 -0.692 . . . . 73.14 109.131 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.515 HD11 HG11 ' C' ' 131' ' ' VAL . 98.7 mt -94.2 141.96 27.95 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.871 0.868 . . . . 71.21 110.526 -177.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -148.46 143.64 26.87 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.255 -1.387 . . . . 73.51 107.255 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 46' ' ' THR . . . . . 0.436 HG21 ' HA2' ' C' ' 99' ' ' GLY . 10.0 t -133.93 149.55 51.29 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.883 -0.784 . . . . 63.02 108.883 175.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.77 143.55 27.6 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.443 -0.947 . . . . 72.13 108.443 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 7.0 m -132.3 150.71 52.1 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 109.908 -0.405 . . . . 61.21 109.908 -175.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.3 t -145.71 125.46 13.42 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.574 -0.898 . . . . 60.14 108.574 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -79.86 116.67 20.15 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.977 -0.749 . . . . 73.52 108.977 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.561 HD11 HD12 ' C' ' 83' ' ' ILE . 48.3 mt -86.04 -36.4 19.74 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.852 0.861 . . . . 74.03 110.614 -175.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.55 -172.04 3.81 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.015 0.926 . . . . 45.03 109.851 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -63.89 112.95 3.14 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.744 0.818 . . . . 64.43 109.958 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 63.99 20.8 12.36 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.641 1.176 . . . . 74.22 112.27 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 66.2 t -114.9 113.58 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.066 -1.087 . . . . 74.23 108.066 173.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -122.79 124.6 43.69 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.121 0.968 . . . . 73.2 109.673 -176.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.45 ' HB2' HD11 ' C' ' 51' ' ' LEU . 29.3 tt0 -84.46 137.74 33.19 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.501 -0.925 . . . . 65.31 108.501 168.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 92.4 t -127.21 136.37 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.544 -0.91 . . . . 54.5 108.544 172.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.472 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 58.4 t -130.08 126.06 61.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 108.931 -0.766 . . . . 73.42 108.931 177.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.518 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -102.61 98.16 8.25 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 107.162 -1.421 . . . . 75.33 107.162 -178.498 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.415 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 6.2 tmm_? -82.72 105.72 13.98 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.551 -0.907 . . . . 73.21 108.551 174.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 20.2 t -107.14 135.37 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.352 -0.981 . . . . 75.44 108.352 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 62.3 m -125.7 139.83 53.21 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.619 -0.882 . . . . 71.23 108.619 177.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.472 HG21 HG21 ' C' ' 114' ' ' ILE . 98.1 t -127.37 117.69 47.7 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 N-CA-C 108.744 -0.836 . . . . 74.11 108.744 173.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 19.3 m -103.81 140.16 38.03 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.114 -0.699 . . . . 73.12 109.114 171.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.39 112.35 17.45 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.61 -1.256 . . . . 74.33 107.61 174.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 30.4 m -126.67 127.67 45.52 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.008 0.432 . . . . 72.42 110.074 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.692 HD13 ' HG2' ' C' ' 34' ' ' LYS . 12.7 mt -96.96 23.37 7.27 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.96 1.304 . . . . 74.44 110.618 -174.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.74 -77.73 0.3 Allowed Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.196 -0.762 . . . . 50.33 111.196 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -117.48 -30.6 5.48 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.037 0.935 . . . . 74.01 109.418 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -79.68 122.54 26.68 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.551 1.14 . . . . 75.11 110.225 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 27.4 m -76.73 119.53 20.65 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 107.937 -1.134 . . . . 63.14 107.937 164.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.569 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -73.08 -48.51 35.27 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.385 0.612 . . . . 61.4 109.601 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -166.59 166.84 15.89 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 113.878 -1.51 . . . . 64.55 110.42 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -128.98 141.45 51.25 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.646 -1.612 . . . . 74.32 106.646 167.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 41.9 t -144.52 146.24 32.28 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.185 -1.043 . . . . 74.43 108.185 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -157.61 138.47 13.22 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.66 -0.496 . . . . 64.52 109.66 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 43.9 t -136.44 115.37 15.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 124.62 1.168 . . . . 62.13 108.375 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.605 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 45.9 mt-30 -90.59 86.85 6.51 Favored 'General case' 0 CA--C 1.523 -0.067 0 N-CA-C 107.922 -1.14 . . . . 62.32 107.922 168.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -80.11 99.38 7.71 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 108.573 -0.899 . . . . 73.54 108.573 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -102.34 146.09 16.75 Favored Glycine 0 C--O 1.217 -0.931 0 O-C-N 123.179 0.299 . . . . 61.24 113.193 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.13 146.18 14.37 Favored Glycine 0 C--N 1.331 0.264 0 N-CA-C 111.54 -0.624 . . . . 74.45 111.54 -176.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.561 HD12 HD11 ' C' ' 51' ' ' LEU . 30.7 mm -96.04 138.49 21.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.84 0 N-CA-C 109.389 -0.597 . . . . 74.25 109.389 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.553 ' CZ ' HD11 ' C' ' 106' ' ' LEU . 85.4 m-85 -136.36 123.08 21.11 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 123.36 0.664 . . . . 73.1 110.363 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 85' ' ' SER . . . . . 0.446 ' HB2' HD23 ' E' ' 142' ' ' LEU . 28.2 p -79.36 102.78 8.86 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 107.971 -1.122 . . . . 71.11 107.971 167.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.407 HG21 ' HE1' ' C' ' 94' ' ' MET . 19.2 mt -117.21 114.94 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.949 0.899 . . . . 62.2 110.412 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -122.01 170.88 9.39 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.885 0.874 . . . . 65.25 109.131 172.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 88' ' ' GLY . . . . . 0.673 ' HA2' ' HA ' ' C' ' 5' ' ' ASN . . . 98.73 -22.72 39.54 Favored Glycine 0 C--N 1.341 0.809 0 N-CA-C 114.308 0.483 . . . . 63.43 114.308 170.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' C' ' 94' ' ' MET . 44.8 pt -122.66 162.35 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 112.613 0.597 . . . . 74.14 112.613 -172.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -159.09 156.64 29.53 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 115.011 -0.995 . . . . 72.3 109.909 175.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.13 -122.36 6.15 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 123.802 0.689 . . . . 63.13 113.008 171.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 42.3 p -67.56 -29.89 69.37 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.504 0.722 . . . . 73.12 110.958 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.641 ' HG2' HE21 ' C' ' 144' ' ' GLN . 97.8 mt-30 -64.69 -59.94 3.68 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.753 0.821 . . . . 73.54 110.489 175.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.493 ' HE3' ' HA ' ' C' ' 94' ' ' MET . 5.2 tpt -46.64 -53.93 10.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.951 1.3 . . . . 72.04 112.2 173.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.09 -44.61 91.92 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.447 0.699 . . . . 73.33 111.41 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -64.12 -33.44 75.77 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.027 0.931 . . . . 75.21 111.73 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.478 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 19.4 t -68.85 -55.85 9.81 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.551 -0.907 . . . . 75.44 108.551 177.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 72.7 mt -65.43 -25.61 67.6 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.611 1.164 . . . . 73.22 112.964 -175.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 99' ' ' GLY . . . . . 0.436 ' HA2' HG21 ' C' ' 46' ' ' THR . . . -109.16 -8.77 26.92 Favored Glycine 0 C--N 1.347 1.174 0 N-CA-C 115.035 0.774 . . . . 41.13 115.035 -171.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.09 -52.88 0.38 Allowed 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 118.213 1.007 . . . . 74.11 111.766 -175.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.478 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 73.7 t80 -70.75 -58.49 3.58 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.272 0.629 . . . . 74.11 111.498 -173.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.569 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 83.0 m -53.52 -59.07 10.35 Favored Pre-proline 0 CA--C 1.559 1.321 0 CA-C-O 117.663 -1.161 . . . . 72.44 110.968 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.569 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 82.4 Cg_exo -50.51 -34.22 41.43 Favored 'Trans proline' 0 C--N 1.395 3.012 0 C-N-CA 122.822 2.348 . . . . 64.02 114.85 -177.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -65.03 -32.32 73.99 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.442 0.697 . . . . 70.52 111.24 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.438 HG23 ' NH1' ' A' ' 111' ' ' ARG . 35.3 mm -72.63 -31.77 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 123.922 0.889 . . . . 72.14 110.414 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.553 HD11 ' CZ ' ' C' ' 84' ' ' PHE . 5.5 mp -90.03 -17.12 28.4 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.474 0.71 . . . . 73.31 111.734 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -55.93 -49.6 92.05 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-O 117.829 -1.081 . . . . 61.13 113.778 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -61.16 -34.68 88.67 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 121.935 1.757 . . . . 74.21 113.07 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.426 ' HE2' HG21 ' A' ' 115' ' ' THR . 59.9 m-85 -64.24 -46.8 82.18 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.555 0.742 . . . . 75.43 110.217 175.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.07 -36.29 83.87 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.122 -0.945 . . . . 62.55 110.723 177.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -64.96 -49.45 70.28 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.058 1.343 . . . . 61.43 110.238 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.89 -32.52 73.06 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.484 0.714 . . . . 63.44 109.625 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 9.0 t -70.24 -39.7 74.9 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 122.985 0.514 . . . . 71.31 110.964 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.472 HG21 HG21 ' C' ' 64' ' ' VAL . 96.6 mt -67.68 -48.79 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.346 0.658 . . . . 73.1 109.828 177.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 15.7 m -66.03 -29.34 69.68 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.915 -0.584 . . . . 55.33 110.755 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 30.2 t -64.77 -50.29 67.38 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.363 -0.606 . . . . 73.03 109.363 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.465 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -55.8 -46.9 77.91 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.432 1.093 . . . . 65.24 111.59 177.536 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 69.2 t -65.69 -40.48 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.874 0.87 . . . . 73.42 110.87 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 33.8 t -72.18 -29.52 64.08 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.607 0.763 . . . . 73.55 111.481 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.584 HH22 ' HG2' ' D' ' 112' ' ' GLU . 64.6 mtt-85 -74.1 -29.62 61.94 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.447 -0.797 . . . . 71.51 109.782 176.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.23 12.43 58.35 Favored Glycine 0 C--N 1.353 1.479 0 O-C-N 124.015 0.822 . . . . 24.34 112.886 172.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.43 HG23 ' HB3' ' D' ' 17' ' ' TYR . 69.4 p 54.16 28.34 8.9 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 126.519 1.928 . . . . 70.33 114.214 176.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -84.24 151.93 60.58 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 109.365 -0.605 . . . . 74.44 109.365 172.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -47.39 136.23 19.93 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.35 2.7 . . . . 71.41 113.11 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.422 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 41.9 mm-40 -53.69 110.98 0.64 Allowed 'General case' 0 N--CA 1.478 0.965 0 O-C-N 124.317 1.01 . . . . 74.04 111.839 -175.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.461 HD21 HG11 ' C' ' 40' ' ' VAL . 3.9 tt -113.95 90.46 3.35 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.983 -1.117 . . . . 65.42 107.983 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -94.41 122.31 36.84 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.463 -0.94 . . . . 73.41 108.463 173.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 6.4 mp -66.73 145.18 55.81 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.174 0.921 . . . . 75.04 111.288 -171.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.8 151.9 77.06 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-N 115.602 -0.726 . . . . 64.32 110.791 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.546 ' HG3' HD12 ' A' ' 16' ' ' ILE . 21.6 Cg_exo -63.82 107.32 0.74 Allowed 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 123.062 2.508 . . . . 60.43 112.385 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.515 HG11 HD11 ' C' ' 44' ' ' LEU . 7.4 p -103.84 139.84 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 123.926 0.89 . . . . 73.33 109.096 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -94.43 104.35 16.32 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.709 0.804 . . . . 63.24 110.325 -171.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -63.4 -34.58 78.03 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.909 0.884 . . . . 74.23 112.425 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -64.99 -40.15 94.53 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.218 0.607 . . . . 61.21 110.414 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.43 -30.42 67.26 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.573 0.749 . . . . 65.51 111.177 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 91.6 mt -72.39 -40.23 67.4 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.011 0.524 . . . . 75.42 110.139 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -75.4 -18.04 60.03 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.198 -0.91 . . . . 73.4 110.226 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.725 ' HA ' ' HB2' ' C' ' 142' ' ' GLN . 47.8 ttm -65.86 -34.27 77.76 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.491 0.716 . . . . 74.3 110.363 176.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -65.8 -38.16 88.23 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.515 -0.766 . . . . 73.42 110.14 172.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -70.88 -90.15 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.054 0.942 . . . . 62.5 110.337 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mp -138.0 104.09 5.15 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.984 0.913 . . . . 75.32 109.345 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.725 ' HB2' ' HA ' ' C' ' 138' ' ' MET . 5.9 tp-100 -118.87 106.46 12.52 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.062 -0.718 . . . . 71.1 109.062 173.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -149.52 3.12 0.56 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.55 0.74 . . . . 62.11 109.715 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 144' ' ' GLN . . . . . 0.641 HE21 ' HG2' ' C' ' 93' ' ' GLN . 1.5 tm0? -100.87 126.76 47.49 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.592 -0.892 . . . . 63.12 108.592 -178.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -131.48 13.78 5.0 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.868 0.867 . . . . 62.34 110.295 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.98 115.09 4.21 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 111.324 -0.711 . . . . 54.23 111.324 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -91.94 106.06 18.17 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 107.798 -1.186 . . . . 63.31 107.798 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -90.13 74.96 1.78 Allowed Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.818 -0.628 . . . . 54.45 112.198 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 9.1 t -73.21 119.73 17.85 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 123.454 0.702 . . . . 73.01 110.678 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -132.84 144.33 50.14 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.259 0.624 . . . . 63.15 110.168 172.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -154.4 138.06 16.07 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.925 -1.139 . . . . 40.22 107.925 166.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -155.07 93.4 1.53 Allowed 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 108.362 -0.977 . . . . 72.04 108.362 175.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -88.82 86.79 7.04 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.723 0.809 . . . . 63.53 110.165 -176.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -173.78 -178.14 1.52 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.902 1.281 . . . . 65.3 108.686 173.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.216 0 C-N-CA 124.637 1.175 . . . . 73.12 110.953 177.657 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 109.331 -0.618 . . . . 72.2 109.331 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 7.8 m -133.83 105.68 6.91 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.745 0.818 . . . . 72.34 109.109 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -148.86 100.45 3.08 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.651 0.781 . . . . 72.12 109.135 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.84 80.94 8.01 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 106.126 -1.805 . . . . 71.11 106.126 164.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -165.71 159.83 16.68 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.363 -1.289 . . . . 71.43 108.139 -169.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -72.46 80.09 1.05 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.11 -0.7 . . . . 61.03 109.11 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 14.0 t 176.37 -170.91 0.07 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 126.164 1.786 . . . . 65.32 108.243 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' D' ' 9' ' ' MET . 8.2 tp10 69.53 -169.28 0.17 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.064 0.946 . . . . 71.1 110.881 168.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.475 ' HG2' HG13 ' D' ' 89' ' ' ILE . 0.4 OUTLIER -28.96 125.44 0.11 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.836 1.654 . . . . 73.12 112.455 164.811 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 11.1 t -115.0 139.99 49.4 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.334 0.654 . . . . 74.05 109.899 -176.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -133.23 92.4 3.0 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 106.875 -1.528 . . . . 75.33 106.875 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -114.19 117.35 30.92 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.629 0.772 . . . . 74.45 109.163 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 9.0 mt -82.25 132.59 31.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.009 -1.108 . . . . 55.03 108.009 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -101.35 -28.59 12.52 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.624 0.77 . . . . 74.1 110.556 -174.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -173.44 133.12 0.48 Allowed 'General case' 0 C--N 1.361 1.09 0 O-C-N 123.618 0.574 . . . . 75.03 110.41 -176.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.413 HD12 ' N ' ' D' ' 16' ' ' ILE . 3.3 mp -114.04 130.47 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 107.212 -1.403 . . . . 63.15 107.212 173.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.458 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 37.4 p90 -163.65 175.79 10.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.987 0.899 . . . . 72.12 112.45 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.8 p -108.18 118.76 37.61 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 114.218 -1.356 . . . . 72.32 108.871 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.458 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 29.9 mtpt -90.52 -11.27 40.68 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.991 -0.744 . . . . 55.23 108.991 177.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.751 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 18.7 t70 -166.23 135.67 3.18 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 124.766 1.226 . . . . 75.24 109.376 -175.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.465 HD13 ' HE3' ' C' ' 117' ' ' MET . 52.8 mt -144.36 138.22 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.185 1.394 . . . . 63.43 107.937 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -145.45 138.64 26.32 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.838 0.855 . . . . 74.22 109.21 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.598 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.4 t80 -142.07 135.69 29.41 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.113 -1.44 . . . . 75.32 107.113 170.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -135.74 148.45 48.82 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 108.837 -0.801 . . . . 72.22 108.837 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -142.87 75.72 17.63 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 107.104 -1.443 . . . . 65.15 107.104 175.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.92 -27.81 30.17 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.777 2.318 . . . . 70.14 112.938 -169.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -108.2 1.01 21.82 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 115.415 -0.811 . . . . 64.3 110.696 -175.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.476 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -20.87 -73.09 0.03 OUTLIER Pre-proline 0 CA--C 1.567 1.61 0 N-CA-C 116.612 2.078 . . . . 73.54 116.612 -166.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.538 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 93.1 Cg_endo -75.15 -20.55 16.47 Favored 'Trans proline' 0 C--N 1.379 2.182 0 CA-C-N 123.962 2.451 . . . . 73.34 114.135 -173.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -72.7 -40.63 66.06 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.877 0.871 . . . . 62.43 109.495 174.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.476 HG12 ' O ' ' D' ' 28' ' ' ALA . 5.5 p -83.52 -20.66 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 CA-C-N 115.612 -0.722 . . . . 72.45 111.566 -173.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.4 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 22.5 m-85 -66.99 -20.65 65.92 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 111.982 0.364 . . . . 73.35 111.982 178.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -64.03 -15.05 58.58 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.374 1.069 . . . . 73.34 110.926 176.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -92.7 96.62 10.28 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.117 1.367 . . . . 75.32 109.718 175.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -92.07 79.67 5.16 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.808 -1.087 . . . . 51.14 110.808 -172.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -158.89 171.33 20.26 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.447 -0.797 . . . . 73.54 109.727 168.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.481 HE21 ' HD2' ' D' ' 38' ' ' PRO . 31.1 tp60 -67.65 115.3 25.9 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 123.836 0.855 . . . . 75.23 109.274 177.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.481 ' HD2' HE21 ' D' ' 37' ' ' GLN . 81.3 Cg_exo -49.05 131.12 25.3 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 123.079 2.519 . . . . 52.21 112.475 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -65.04 110.37 2.46 Favored 'General case' 0 C--N 1.346 0.428 0 N-CA-C 107.008 -1.478 . . . . 73.21 107.008 171.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.709 HG13 HG13 ' D' ' 64' ' ' VAL . 96.9 t -113.05 127.19 70.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 108.517 -0.92 . . . . 73.14 108.517 -175.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.466 ' HE3' ' HB3' ' D' ' 41' ' ' LYS . 0.5 OUTLIER -120.76 129.42 53.6 Favored 'General case' 0 C--O 1.248 0.991 0 N-CA-C 106.493 -1.669 . . . . 63.23 106.493 172.414 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.631 HD11 HG13 ' D' ' 62' ' ' VAL . 33.1 tp -97.1 129.29 44.53 Favored 'General case' 0 C--O 1.238 0.477 0 O-C-N 123.931 0.77 . . . . 73.45 110.111 -172.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.601 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.2 m-20 -108.98 112.38 24.55 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.535 -1.654 . . . . 64.12 106.535 177.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.411 ' CD2' HG22 ' D' ' 62' ' ' VAL . 25.8 mt -107.23 131.95 53.62 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.374 0.606 . . . . 65.4 109.903 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.3 t70 -133.85 153.65 51.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.21 -1.359 . . . . 53.43 108.063 176.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 5.1 t -126.61 149.85 49.23 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.006 0.922 . . . . 64.13 109.047 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.478 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -148.78 141.11 24.14 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.216 -1.031 . . . . 63.03 108.216 178.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 91.3 p -155.73 -172.15 4.03 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.438 -0.949 . . . . 72.31 108.438 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 21.3 p -150.27 139.01 20.77 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 122.829 0.452 . . . . 60.42 109.847 -175.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -67.22 91.44 0.24 Allowed 'General case' 0 C--N 1.352 0.678 0 N-CA-C 108.215 -1.032 . . . . 74.55 108.215 169.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 42.7 tp -141.55 99.26 3.52 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 107.547 -1.279 . . . . 74.52 107.547 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.92 -142.13 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.614 0.766 . . . . 64.55 110.972 -175.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 70.99 12.24 7.02 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.852 1.261 . . . . 72.23 111.285 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.62 26.8 16.41 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.593 1.157 . . . . 75.02 111.024 -175.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 p -133.57 101.06 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.398 1.079 . . . . 64.25 108.217 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -118.24 144.27 45.9 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 114.634 -1.166 . . . . 75.24 108.84 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -105.43 136.26 45.31 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.428 0.632 . . . . 64.3 110.81 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 90.3 t -114.54 144.8 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-N 114.098 -1.41 . . . . 71.42 108.03 174.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 52.2 t -135.99 127.76 44.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.668 -1.234 . . . . 71.52 107.668 176.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.535 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -109.67 102.14 10.99 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 106.844 -1.539 . . . . 63.25 106.844 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.507 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.6 ttt180 -83.8 95.2 8.37 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.46 -0.941 . . . . 75.24 108.46 176.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.631 HG13 HD11 ' D' ' 42' ' ' LEU . 66.5 t -96.33 117.18 40.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.661 -1.154 . . . . 73.42 108.97 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.601 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 23.8 m -123.06 130.25 52.54 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 114.9 -1.045 . . . . 75.11 108.725 -174.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.709 HG13 HG13 ' D' ' 40' ' ' VAL . 47.2 t -111.25 121.37 63.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 C-N-CA 124.821 1.248 . . . . 73.4 108.967 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 18.4 m -100.26 110.92 23.18 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.463 -1.31 . . . . 52.53 107.463 164.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.07 138.62 54.1 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.986 -0.746 . . . . 63.41 108.986 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.482 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 80.9 p -142.07 140.67 32.62 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.347 0.594 . . . . 73.53 111.241 -175.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.427 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 35.3 mt -112.92 114.5 27.02 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 106.889 -1.522 . . . . 64.5 106.889 169.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.19 -129.2 9.23 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 123.166 0.291 . . . . 73.43 112.423 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.76 5.34 36.03 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.492 0.717 . . . . 72.04 110.901 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -121.97 165.15 16.43 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.469 0.708 . . . . 61.44 109.586 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 94.1 m -69.26 135.26 50.26 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.803 -0.635 . . . . 75.1 111.484 177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.482 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -82.32 -68.69 0.68 Allowed 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.595 -1.261 . . . . 75.04 107.595 170.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -149.3 161.88 41.17 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 114.974 -1.012 . . . . 71.41 110.363 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 78.7 mt -120.9 120.35 35.26 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.482 1.113 . . . . 73.14 108.22 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.658 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 1.7 m -116.78 139.15 50.91 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.214 -1.032 . . . . 70.13 108.214 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -157.12 121.85 4.46 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.931 0.493 . . . . 70.11 109.676 173.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -136.13 119.12 22.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 123.705 0.802 . . . . 52.1 109.041 -175.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.751 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.2 mt-30 -89.04 88.59 7.63 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 108.647 -0.871 . . . . 73.43 108.647 170.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -80.27 99.19 7.73 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.371 -1.286 . . . . 70.32 108.739 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.35 142.33 15.56 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 116.316 -0.402 . . . . 71.42 112.141 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.68 140.88 11.64 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 111.117 -0.793 . . . . 61.52 111.117 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 61.3 mt -90.78 119.14 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.933 -1.136 . . . . 72.23 107.933 175.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -119.85 131.31 55.24 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.692 0.797 . . . . 71.11 110.192 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 35.4 t -107.9 100.47 9.83 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.363 -0.977 . . . . 62.23 108.363 172.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 39.9 pt -110.54 147.67 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.674 1.19 . . . . 73.41 108.807 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.7 168.56 12.45 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.792 0.682 . . . . 64.12 111.033 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.6 21.92 49.09 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.596 0.56 . . . . 54.34 114.166 174.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.475 HG13 ' HG2' ' D' ' 9' ' ' MET . 0.7 OUTLIER -138.84 161.14 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.8 0.84 . . . . 72.34 111.475 -177.645 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -149.22 -171.89 3.99 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.215 -1.357 . . . . 74.33 109.192 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 91' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' B' ' 150' ' ' GLU . . . 77.31 -140.19 24.22 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-O 119.709 -0.495 . . . . 50.51 111.934 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 81.1 p -91.87 -35.82 13.84 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 117.529 0.664 . . . . 73.21 111.268 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.568 ' HA ' ' HB3' ' D' ' 96' ' ' HIS . 27.8 tp60 -65.63 -22.03 66.62 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.203 1.001 . . . . 71.24 112.023 -172.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.475 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 0.0 OUTLIER -60.85 -43.59 98.12 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.802 0.441 . . . . 71.12 111.433 177.257 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 95' ' ' ALA . . . . . 0.475 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -79.59 -31.01 41.72 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.775 0.83 . . . . 62.4 110.543 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.568 ' HB3' ' HA ' ' D' ' 93' ' ' GLN . 18.8 t-80 -75.06 -25.3 58.53 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 123.935 0.894 . . . . 75.12 112.153 -175.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 85.2 m -65.87 -38.27 88.35 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.56 0.695 . . . . 74.11 109.795 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.614 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 12.9 tp -77.97 -35.96 49.63 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.831 -1.077 . . . . 72.34 110.421 177.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.74 -28.45 42.63 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.434 -0.803 . . . . 62.23 115.03 -171.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.24 -47.2 2.27 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 118.295 1.047 . . . . 74.12 111.396 -175.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -74.7 -34.59 62.65 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 112.031 0.382 . . . . 72.42 112.031 -174.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.614 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 90.3 m -67.01 -47.55 52.35 Favored Pre-proline 0 CA--C 1.565 1.553 0 CA-C-O 118.46 -0.781 . . . . 75.32 112.174 177.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.535 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.5 Cg_exo -55.84 -34.27 90.92 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 122.158 1.905 . . . . 63.44 113.136 169.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -61.96 -37.34 84.38 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.482 0.713 . . . . 65.04 111.123 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 44.9 mm -68.25 -41.53 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.528 0.731 . . . . 74.15 110.601 174.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 96.6 mt -78.17 -15.13 59.11 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.742 -0.663 . . . . 70.14 112.331 -172.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -70.03 -44.09 20.63 Favored Pre-proline 0 N--CA 1.485 1.294 0 N-CA-C 113.858 1.059 . . . . 61.21 113.858 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 108' ' ' PRO . . . . . 0.538 ' HB2' ' HG2' ' B' ' 108' ' ' PRO . 18.8 Cg_endo -58.03 -29.24 86.2 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 121.624 1.55 . . . . 65.31 112.771 172.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -81.18 -31.23 34.1 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.782 0.833 . . . . 71.54 111.493 175.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.91 -50.28 71.48 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.792 0.837 . . . . 34.44 109.934 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -73.51 -29.47 62.5 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.198 -0.91 . . . . 74.12 110.593 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 112' ' ' GLU . . . . . 0.584 ' HG2' HH22 ' C' ' 120' ' ' ARG . 23.5 tt0 -53.19 -46.18 68.88 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.458 0.703 . . . . 65.34 110.479 173.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.1 t -70.38 -47.37 61.23 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.426 -0.806 . . . . 43.44 111.226 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.449 ' O ' HG23 ' D' ' 118' ' ' VAL . 76.8 mt -60.12 -61.27 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.887 0.875 . . . . 74.2 111.643 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 10.3 m -50.94 -38.94 53.54 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.448 1.099 . . . . 75.24 111.638 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -64.27 -48.29 76.32 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.347 -0.842 . . . . 64.03 110.012 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 73.7 mtm -67.24 -29.85 69.6 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.148 0.579 . . . . 74.42 111.767 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.449 HG23 ' O ' ' D' ' 114' ' ' ILE . 76.0 t -64.84 -46.69 91.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.62 0.768 . . . . 73.34 109.39 176.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.5 p -72.87 -31.42 64.72 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.875 -0.602 . . . . 62.21 110.588 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 77.6 mtt-85 -69.46 -28.87 66.47 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.775 0.83 . . . . 72.31 110.405 174.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.8 10.01 74.1 Favored Glycine 0 C--N 1.351 1.378 0 CA-C-O 119.317 -0.713 . . . . 71.24 112.647 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.539 HG23 ' HB3' ' C' ' 17' ' ' TYR . 74.5 p 52.68 37.45 23.6 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 126.12 1.768 . . . . 65.32 113.499 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -99.81 151.86 37.62 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 115.01 -0.995 . . . . 75.3 109.645 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.535 ' HB3' ' HA ' ' E' ' 129' ' ' THR . 80.3 Cg_exo -51.84 145.38 32.05 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.478 2.786 . . . . 73.11 113.194 171.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.511 ' HB3' ' HB3' ' E' ' 128' ' ' ALA . 65.1 tt0 -61.16 136.86 58.2 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.836 0.854 . . . . 73.54 112.631 -169.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.442 HD13 HG21 ' D' ' 40' ' ' VAL . 16.4 tp -124.81 99.42 6.14 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.434 1.094 . . . . 65.53 109.267 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -100.11 108.28 20.38 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 107.702 -1.222 . . . . 64.4 107.702 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 6.7 mp -70.81 116.28 10.94 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.333 -0.618 . . . . 73.34 109.333 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.495 ' HB2' ' HB3' ' E' ' 125' ' ' ALA . . . -61.11 141.38 93.84 Favored Pre-proline 0 CA--C 1.55 0.972 0 O-C-N 124.078 0.861 . . . . 62.44 111.772 -177.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.67 116.05 3.03 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.537 2.158 . . . . 60.12 110.868 175.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 13.1 p -108.62 146.53 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.811 0.845 . . . . 65.31 109.315 -172.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -73.6 104.45 4.55 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.834 -0.802 . . . . 72.41 108.834 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.697 ' HA ' HD23 ' D' ' 136' ' ' LEU . 75.3 m-85 -62.82 -36.89 84.66 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.571 0.748 . . . . 74.12 111.516 -178.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' E' ' 112' ' ' ASN . 24.8 m-20 -55.0 -38.23 67.62 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.242 0.617 . . . . 71.11 110.89 173.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.65 -18.62 59.6 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.073 0.949 . . . . 73.52 112.46 -176.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.697 HD23 ' HA ' ' D' ' 133' ' ' PHE . 3.6 mm? -59.81 -51.25 70.56 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 112.783 0.661 . . . . 71.5 112.783 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.45 ' HB2' ' HB3' ' E' ' 112' ' ' ASN . 13.5 m-85 -75.62 -30.45 59.54 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 119.708 -0.187 . . . . 74.02 111.025 176.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.419 ' HB3' ' N ' ' E' ' 117' ' ' LYS . 55.6 mtt -60.56 -34.82 74.71 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 120.879 0.371 . . . . 74.4 110.851 173.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.486 ' O ' ' HG3' ' D' ' 142' ' ' GLN . 7.1 t30 -76.59 -38.75 54.31 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.082 0.953 . . . . 74.12 109.396 176.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 140' ' ' TYR . . . . . 0.438 ' HB3' ' HA ' ' D' ' 137' ' ' PHE . 61.5 t80 -58.33 -38.08 76.42 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.204 1.001 . . . . 75.14 111.212 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.408 HD13 ' O ' ' D' ' 137' ' ' PHE . 8.3 mp -61.65 -43.07 99.55 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.13 0.572 . . . . 71.14 111.1 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 142' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' D' ' 139' ' ' ASN . 4.1 pp0? -86.9 7.99 24.95 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.106 0.562 . . . . 74.41 111.173 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 143' ' ' GLN . . . . . 0.514 ' HG3' ' HB3' ' D' ' 147' ' ' GLU . 33.7 tt0 -120.19 92.81 3.86 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.875 0.87 . . . . 63.54 109.371 -171.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -145.33 84.68 1.7 Allowed 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.221 -1.029 . . . . 70.43 108.221 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . 58.75 20.9 8.34 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.584 1.154 . . . . 75.42 112.55 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -140.51 23.44 2.67 Favored Glycine 0 C--N 1.348 1.221 0 C-N-CA 123.154 0.407 . . . . 72.14 112.409 -173.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 147' ' ' GLU . . . . . 0.514 ' HB3' ' HG3' ' D' ' 143' ' ' GLN . 0.1 OUTLIER -90.81 -27.9 18.56 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.437 0.695 . . . . 73.23 109.643 174.145 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.57 172.84 12.17 Favored Glycine 0 C--N 1.356 1.643 0 CA-C-O 121.253 0.363 . . . . 33.05 113.059 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 47.0 p -139.08 140.87 38.15 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.515 -0.92 . . . . 61.21 108.515 174.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -130.3 119.59 23.06 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.257 -0.645 . . . . 73.33 109.257 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -95.71 38.29 1.17 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.964 0.906 . . . . 64.35 110.749 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 152' ' ' HIS . . . . . 0.407 ' NE2' ' HB3' ' D' ' 154' ' ' ASP . 37.3 t60 -69.7 91.82 0.63 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.491 -0.559 . . . . 75.15 109.491 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -77.41 -9.95 59.17 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.731 0.812 . . . . 74.32 112.709 -174.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 154' ' ' ASP . . . . . 0.407 ' HB3' ' NE2' ' D' ' 152' ' ' HIS . 34.6 t70 -70.15 81.1 0.51 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.389 0.676 . . . . 75.31 109.516 176.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.277 0 CA-C-N 114.897 -1.047 . . . . 73.33 109.423 -177.624 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.878 0 N-CA-C 112.028 -0.429 . . . . 72.14 112.028 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . -90.29 -134.89 5.85 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 111.738 -0.545 . . . . 50.32 111.738 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 59.11 80.25 0.2 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.803 1.241 . . . . 75.45 111.759 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -104.81 -160.22 0.75 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.491 0.717 . . . . 73.43 109.671 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -133.32 135.96 45.13 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 108.323 -0.991 . . . . 72.21 108.323 169.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.99 -43.06 0.18 Allowed Glycine 0 C--N 1.339 0.721 0 N-CA-C 112.18 -0.368 . . . . 44.35 112.18 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 97' ' ' ILE . . . . . 0.452 HG12 ' CD2' ' E' ' 100' ' ' LEU . 4.7 tt -103.64 80.55 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 CA-C-O 123.252 1.501 . . . . 73.13 109.502 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -108.44 -40.93 4.98 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 114.897 -1.047 . . . . 72.12 110.586 -174.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.08 75.57 9.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.571 0.748 . . . . 52.43 111.588 -173.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 100' ' ' LEU . . . . . 0.478 HD12 HD23 ' E' ' 102' ' ' LEU . 2.3 pt? -164.5 136.21 3.53 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 123.927 0.891 . . . . 73.04 109.656 170.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.77 -14.34 11.32 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.527 2.151 . . . . 55.25 112.07 168.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 102' ' ' LEU . . . . . 0.478 HD23 HD12 ' E' ' 100' ' ' LEU . 1.0 OUTLIER 53.35 51.17 15.94 Favored 'General case' 0 C--N 1.367 1.332 0 C-N-CA 125.029 1.332 . . . . 73.21 108.903 -172.518 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 65.4 p 47.61 75.64 0.13 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.813 1.245 . . . . 55.12 111.072 -173.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.91 152.64 35.55 Favored Glycine 0 C--N 1.353 1.487 0 CA-C-N 115.755 -0.657 . . . . 54.35 113.32 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 66.98 68.42 0.41 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.923 1.289 . . . . 74.52 109.86 -170.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 54.3 t80 68.85 157.19 0.14 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.788 1.235 . . . . 70.21 111.336 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 4.2 m -67.08 108.27 2.58 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 122.985 0.514 . . . . 54.44 110.817 -177.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -80.26 -65.79 0.96 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.88 0.472 . . . . 73.42 109.854 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -139.18 138.09 36.62 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.306 -0.998 . . . . 72.14 108.306 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -164.84 -46.76 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.034 0.445 . . . . 54.44 111.384 -171.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 111' ' ' LEU . . . . . 0.505 ' HB3' ' O ' ' D' ' 133' ' ' PHE . 5.3 mp -87.15 65.15 8.73 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.954 0.902 . . . . 74.24 108.875 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 112' ' ' ASN . . . . . 0.45 ' HB3' ' HB2' ' D' ' 137' ' ' PHE . 22.5 p-10 -157.82 177.61 11.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.148 0.979 . . . . 52.4 109.837 -177.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -157.11 -62.17 0.09 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 122.222 0.209 . . . . 75.43 111.085 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.74 156.22 29.44 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.955 0.502 . . . . 74.13 111.483 -172.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 29.2 m 61.14 -91.83 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 125.142 1.377 . . . . 42.35 112.942 171.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 147.12 155.66 6.64 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 110.85 -0.9 . . . . 53.12 110.85 -168.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 117' ' ' LYS . . . . . 0.419 ' N ' ' HB3' ' D' ' 138' ' ' MET . 74.7 mmtt -118.97 154.24 53.06 Favored Pre-proline 0 N--CA 1.476 0.858 0 C-N-CA 123.703 0.801 . . . . 72.32 109.505 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -72.94 -156.73 0.05 OUTLIER 'Trans proline' 0 CA--C 1.555 1.534 0 C-N-CA 122.995 2.463 . . . . 51.21 111.566 166.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -61.39 85.71 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.374 1.07 . . . . 75.44 110.613 176.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -89.84 -66.67 0.9 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.168 -0.924 . . . . 73.24 111.136 -175.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 121' ' ' VAL . . . . . 0.502 HG21 HD13 ' D' ' 136' ' ' LEU . 39.5 t -76.76 83.57 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 109.627 -0.508 . . . . 72.43 109.627 -172.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 4.2 m -147.5 7.74 0.88 Allowed 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 123.89 0.876 . . . . 72.14 109.784 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -131.05 -179.5 5.37 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.551 0.741 . . . . 74.34 111.192 -173.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 23.1 t -163.23 176.23 10.17 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.294 1.037 . . . . 45.32 109.064 175.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 125' ' ' ALA . . . . . 0.658 ' HB1' ' HG3' ' B' ' 12' ' ' GLN . . . -146.08 99.15 3.21 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.328 0.651 . . . . 75.23 109.785 177.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -172.67 130.52 0.54 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.163 0.985 . . . . 74.41 108.98 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 35.3 p -149.26 100.36 3.02 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.721 0.408 . . . . 73.22 109.973 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 128' ' ' ALA . . . . . 0.511 ' HB3' ' HB3' ' D' ' 125' ' ' GLN . . . -161.11 82.53 0.64 Allowed 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.124 0.97 . . . . 73.44 108.686 174.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 129' ' ' THR . . . . . 0.535 ' HA ' ' HB3' ' D' ' 124' ' ' PRO . 7.5 t -116.09 114.03 23.97 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.912 -0.585 . . . . 75.13 110.319 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -178.69 111.17 0.06 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.797 1.639 . . . . 70.31 106.576 176.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 131' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -162.31 56.46 0.23 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.413 0.625 . . . . 72.43 110.126 -175.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 36.2 t -137.87 95.09 2.98 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.503 -0.925 . . . . 74.22 108.503 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 23.8 m -145.79 91.35 2.08 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 122.959 0.503 . . . . 72.24 110.388 -176.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.94 87.92 0.66 Allowed Glycine 0 C--N 1.343 0.921 0 N-CA-C 111.046 -0.821 . . . . 64.33 111.046 169.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 3.4 p -55.58 132.64 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 C-N-CA 124.63 1.172 . . . . 65.42 112.598 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -126.33 120.64 30.41 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 108.168 -1.049 . . . . 70.12 108.168 174.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 1.2 p -147.95 -59.07 0.25 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.389 0.676 . . . . 73.43 110.769 -176.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -104.98 -79.07 0.56 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.436 -0.347 . . . . 65.41 110.386 -169.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 23.1 m-80 -75.02 166.1 24.21 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.856 0.862 . . . . 71.24 111.308 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.34 142.0 36.54 Favored Glycine 0 C--N 1.349 1.254 0 O-C-N 123.624 0.578 . . . . 43.55 112.216 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.83 94.38 3.31 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.988 0.423 . . . . 63.13 109.868 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 142' ' ' LEU . . . . . 0.446 HD23 ' HB2' ' C' ' 85' ' ' SER . 48.2 tp -67.63 -42.72 81.89 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.288 -0.869 . . . . 74.1 109.791 172.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -156.51 143.15 9.38 Favored Glycine 0 C--N 1.33 0.23 0 N-CA-C 109.244 -1.542 . . . . 71.14 109.244 171.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 11.4 m -145.9 151.56 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 124.151 0.98 . . . . 72.54 109.355 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 36.2 t70 . . . . . 0 C--O 1.246 0.908 0 CA-C-O 118.621 -0.704 . . . . 64.44 109.717 179.173 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.772 0 N-CA-C 111.356 -0.698 . . . . 64.21 111.356 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.0 -55.46 3.67 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-O 119.979 -0.345 . . . . 34.44 113.089 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -77.38 71.91 3.89 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.747 0.819 . . . . 64.51 109.706 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -104.42 136.36 44.14 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 107.696 -1.224 . . . . 74.24 107.696 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -68.07 110.51 3.98 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.637 0.732 . . . . 75.41 112.111 -176.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -143.59 -166.0 11.06 Favored Glycine 0 C--O 1.245 0.824 0 N-CA-C 108.964 -1.655 . . . . 64.41 108.964 167.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 97' ' ' ILE . . . . . 0.782 HG23 ' SD ' ' B' ' 94' ' ' MET . 9.3 mt 71.45 -28.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.573 1.844 0 N-CA-C 114.786 1.402 . . . . 72.45 114.786 168.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 35.4 t70 81.45 -86.96 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.809 2.044 . . . . 61.14 111.434 -166.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -112.54 -46.23 3.17 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.35 0.66 . . . . 61.41 111.794 -169.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 100' ' ' LEU . . . . . 0.455 ' HB2' HG21 ' F' ' 97' ' ' ILE . 8.2 tp 75.42 74.04 0.2 Allowed Pre-proline 0 N--CA 1.479 0.996 0 C-N-CA 126.152 1.781 . . . . 74.3 112.473 -176.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -97.68 114.28 0.11 Allowed 'Trans proline' 0 CA--C 1.558 1.683 0 C-N-CA 123.13 2.553 . . . . 72.3 111.552 162.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 102' ' ' LEU . . . . . . . . . . . . . 1.7 tt -86.91 67.04 9.69 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 107.873 -1.158 . . . . 74.11 107.873 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 51.9 p 51.33 25.29 2.47 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.013 1.325 . . . . 70.42 113.284 174.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.66 49.62 4.78 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 111.955 -0.458 . . . . 62.12 111.955 -173.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 67.96 -75.51 0.06 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.494 1.517 . . . . 75.21 112.617 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -69.69 134.91 49.21 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.542 0.737 . . . . 72.3 110.052 -176.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 26.6 m -70.93 128.8 37.22 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.636 0.774 . . . . 72.53 110.581 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -76.23 -32.82 59.11 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.847 0.859 . . . . 74.12 110.377 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -65.61 119.01 10.35 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.032 -1.099 . . . . 74.52 108.032 170.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 110' ' ' ALA . . . . . 0.717 ' HB1' ' HB2' ' F' ' 113' ' ' LYS . . . -68.11 -5.89 20.11 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.342 0.867 . . . . 74.4 113.342 -170.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 22.7 tp 73.15 -74.07 0.09 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.986 1.314 . . . . 73.44 109.7 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -141.84 12.05 2.05 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.819 0.848 . . . . 70.24 110.358 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 113' ' ' LYS . . . . . 0.717 ' HB2' ' HB1' ' F' ' 110' ' ' ALA . 52.6 mtpt -86.1 25.69 1.12 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.468 -0.77 . . . . 74.43 112.767 -174.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 114' ' ' LYS . . . . . 0.413 ' HA ' ' HG3' ' F' ' 118' ' ' PRO . 93.8 mttt 77.76 -52.34 0.52 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.28 1.432 . . . . 73.21 113.911 165.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 8.0 t -64.56 154.48 36.03 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 122.687 0.395 . . . . 63.43 110.172 171.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.95 -117.0 4.4 Favored Glycine 0 C--N 1.342 0.862 0 N-CA-C 110.32 -1.112 . . . . 70.41 110.32 -171.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 5.2 ttmp? -159.48 81.07 2.55 Favored Pre-proline 0 N--CA 1.482 1.129 0 C-N-CA 123.25 0.62 . . . . 74.53 109.931 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 118' ' ' PRO . . . . . 0.413 ' HG3' ' HA ' ' F' ' 114' ' ' LYS . 29.8 Cg_endo -88.43 23.14 0.79 Allowed 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 123.138 2.558 . . . . 63.12 112.627 -178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.82 84.91 0.66 Allowed 'General case' 0 C--N 1.35 0.613 0 C-N-CA 124.463 1.105 . . . . 74.45 110.804 -174.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 120' ' ' TYR . . . . . 0.435 ' HB3' HD13 ' B' ' 136' ' ' LEU . 81.9 t80 -174.27 -50.35 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.633 1.573 . . . . 74.31 106.912 -174.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 42.2 t -87.11 113.26 24.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 114.724 -1.125 . . . . 65.34 108.193 175.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 23.1 m -70.45 -14.0 62.36 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.134 0.573 . . . . 65.4 111.504 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 25.5 t70 72.03 5.91 5.45 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.548 1.139 . . . . 54.01 112.557 169.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 26.7 m -137.41 105.17 5.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.267 1.027 . . . . 43.53 109.114 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -166.51 170.33 12.92 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.686 0.794 . . . . 62.54 110.534 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . 73.74 109.37 0.07 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.601 1.56 . . . . 51.23 111.869 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 45.3 t -127.38 102.17 6.78 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.477 1.111 . . . . 71.01 108.172 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 128' ' ' ALA . . . . . 0.492 ' HB3' ' HD2' ' B' ' 38' ' ' PRO . . . -85.9 77.99 9.59 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.483 0.713 . . . . 75.44 111.895 -170.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 129' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' B' ' 37' ' ' GLN . 4.4 m -101.4 65.2 1.04 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 108.703 -0.851 . . . . 74.3 108.703 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -160.13 107.52 1.63 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.038 -0.528 . . . . 75.11 110.373 -174.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 131' ' ' TRP . . . . . 0.475 ' HZ2' HH22 ' A' ' 15' ' ' ARG . 1.3 t90 -138.59 158.29 44.53 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.866 -0.79 . . . . 65.21 108.866 -176.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 132' ' ' SER . . . . . 0.454 ' HB3' ' HA ' ' C' ' 126' ' ' LEU . 43.6 p -65.8 157.61 29.92 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.152 0.581 . . . . 62.44 111.901 177.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 14.8 t -76.64 -173.16 2.47 Favored 'General case' 0 CA--C 1.556 1.193 0 CA-C-N 115.186 -0.916 . . . . 62.32 109.664 171.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.84 77.04 0.68 Allowed Glycine 0 CA--C 1.536 1.346 0 CA-C-N 117.459 0.118 . . . . 70.54 113.166 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.79 126.83 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 108.591 -0.892 . . . . 53.41 108.591 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -140.81 -146.76 0.2 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.224 1.01 . . . . 75.41 108.675 -176.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 36.1 p -51.96 -75.12 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.648 0.779 . . . . 75.32 110.85 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -147.33 -83.92 0.11 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.574 -0.898 . . . . 74.13 108.574 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 54.2 t30 57.63 107.32 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.077 1.351 . . . . 75.54 112.4 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.21 78.27 0.97 Allowed Glycine 0 C--N 1.351 1.386 0 N-CA-C 112.265 -0.334 . . . . 63.5 112.265 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.33 152.62 41.85 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.774 0.83 . . . . 51.5 110.634 -175.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 142' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' C' ' 39' ' ' GLU . 3.3 mp -125.0 -60.61 1.35 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.407 1.083 . . . . 75.33 108.526 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . 128.22 119.3 2.19 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-N 114.738 -1.119 . . . . 45.31 110.508 -173.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.67 -37.42 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-O 121.895 0.855 . . . . 71.21 109.763 172.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 18.3 t70 . . . . . 0 C--O 1.246 0.879 0 N-CA-C 107.381 -1.34 . . . . 71.51 107.381 175.206 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.46 ' SD ' ' HB2' ' C' ' 141' ' ' LEU . 94.6 mmm . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 108.864 -0.791 . . . . 75.35 108.864 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 m -64.38 89.27 0.06 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.319 0.58 . . . . 72.31 110.69 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -91.21 -46.06 8.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.545 1.138 . . . . 54.51 108.93 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -141.32 144.15 34.44 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 113.997 -1.456 . . . . 75.12 108.781 -176.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -73.52 102.56 3.87 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 109.846 -0.427 . . . . 73.23 109.846 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -71.51 154.69 41.3 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.954 0.902 . . . . 63.11 109.954 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.1 t -61.28 157.52 16.24 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.241 1.017 . . . . 74.44 113.193 -174.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -76.37 118.8 19.44 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.254 -0.885 . . . . 73.41 110.415 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.535 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -156.31 179.86 8.83 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.136 0.975 . . . . 75.43 110.058 -178.279 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.2 m -135.35 129.11 32.91 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.489 0.716 . . . . 62.33 109.177 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -131.42 112.48 12.73 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.823 -1.547 . . . . 64.25 106.823 167.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -137.72 114.15 10.27 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 107.809 -1.182 . . . . 72.14 107.809 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.618 HG21 ' HG2' ' C' ' 130' ' ' PRO . 51.0 mt -69.41 114.42 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 109.034 -0.728 . . . . 74.3 109.034 177.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -78.79 -34.74 45.21 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.285 -0.635 . . . . 73.23 109.285 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.43 ' HE ' ' HB ' ' B' ' 122' ' ' THR . 14.0 ttt85 -172.63 132.52 0.58 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.973 0.509 . . . . 72.05 110.227 -174.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.455 HD11 HD13 ' A' ' 13' ' ' ILE . 80.6 mt -117.44 127.35 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.021 -1.103 . . . . 75.14 108.021 166.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 25.0 p90 -163.78 154.02 15.28 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.787 0.679 . . . . 62.33 110.827 -171.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.7 p -80.03 116.78 20.35 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 109.712 -0.477 . . . . 73.41 109.712 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.45 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 42.9 mtpt -79.11 -25.52 43.0 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.601 -0.518 . . . . 72.1 109.601 172.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.495 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.1 t70 -155.06 146.8 23.31 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 114.882 -1.054 . . . . 55.22 110.526 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.485 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 81.2 mt -141.28 141.7 30.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 C-N-CA 126.114 1.766 . . . . 72.41 107.012 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.4 t -143.72 132.76 22.88 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.218 -1.03 . . . . 64.15 108.218 170.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.539 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 85.2 t80 -139.87 141.8 36.59 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.539 -1.282 . . . . 73.12 107.539 172.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -144.37 149.41 36.09 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.773 0.829 . . . . 72.25 108.889 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.28 74.83 11.67 Favored Pre-proline 0 C--O 1.241 0.639 0 N-CA-C 106.173 -1.788 . . . . 43.23 106.173 170.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.72 -29.93 28.53 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.233 1.955 . . . . 71.14 111.88 -171.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -96.82 9.43 41.81 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.798 0.839 . . . . 73.32 111.899 -175.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.464 ' HA ' HG12 ' A' ' 31' ' ' VAL . . . -47.36 -58.56 7.11 Favored Pre-proline 0 CA--C 1.563 1.471 0 N-CA-C 114.4 1.259 . . . . 41.32 114.4 -166.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 71.8 Cg_exo -49.84 -40.3 48.41 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.884 2.389 . . . . 71.44 114.455 -177.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -100.16 -13.97 18.73 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.214 0.82 . . . . 72.45 113.214 -175.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.597 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.7 p -77.27 -18.75 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-O 120.892 0.377 . . . . 74.34 110.912 -175.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -74.11 -19.96 60.41 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.393 0.677 . . . . 75.3 111.127 175.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -73.87 -28.92 61.82 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.631 0.773 . . . . 74.13 109.779 174.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -69.8 159.5 33.48 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.956 0.902 . . . . 65.32 112.119 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -68.94 123.35 20.76 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.538 -0.756 . . . . 45.41 109.234 171.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.494 ' CE3' HD21 ' A' ' 68' ' ' LEU . 71.9 t-105 -75.04 84.88 2.29 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.894 0.854 . . . . 74.43 109.841 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.433 ' H ' HD22 ' A' ' 68' ' ' LEU . 23.7 tt0 -120.48 79.63 29.44 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 125.48 1.512 . . . . 74.41 107.53 173.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.31 112.66 3.52 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.04 1.826 . . . . 64.04 112.446 -174.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.56 97.32 9.67 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 105.38 -2.082 . . . . 75.33 105.38 168.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.435 HG11 HD21 ' A' ' 126' ' ' LEU . 17.6 t -95.45 100.87 11.73 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-N 115.406 -0.815 . . . . 74.35 110.826 -170.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -77.84 114.03 16.31 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.774 -1.103 . . . . 71.24 110.027 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.3 mt -103.36 111.16 23.45 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.591 0.756 . . . . 53.31 109.671 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.598 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.8 m-20 -102.23 147.28 26.84 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.592 -0.892 . . . . 74.3 108.592 172.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.612 HD11 HG21 ' A' ' 131' ' ' VAL . 77.0 mt -131.23 141.34 50.0 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.413 0.685 . . . . 75.13 110.293 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 25.6 t70 -144.51 122.11 11.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.412 -1.267 . . . . 74.13 108.056 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.4 m -113.37 129.09 56.62 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.926 -0.768 . . . . 73.24 108.926 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.74 117.46 15.03 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.583 0.753 . . . . 33.33 109.567 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.43 ' HB3' ' HB3' ' A' ' 98' ' ' LEU . 19.4 p -88.86 173.32 8.59 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 122.968 0.507 . . . . 75.12 110.552 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.6 t -163.82 145.57 9.17 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.377 1.071 . . . . 74.55 108.771 -170.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -114.9 122.7 47.12 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.272 0.629 . . . . 64.34 109.31 170.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.6 mt -97.65 -37.61 9.84 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.387 0.675 . . . . 73.13 109.824 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.474 ' HB3' ' CG2' ' A' ' 55' ' ' VAL . . . -153.1 177.45 10.79 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.874 0.87 . . . . 60.11 109.481 177.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -64.59 125.36 24.45 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.853 0.461 . . . . 64.11 109.986 170.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 68.22 8.75 6.77 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.139 1.376 . . . . 71.34 112.163 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.474 ' CG2' ' HB3' ' A' ' 52' ' ' ALA . 51.5 t -115.62 92.74 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 108.31 -0.996 . . . . 65.44 108.31 176.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -110.59 122.3 47.42 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.077 0.465 . . . . 75.12 109.751 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -93.86 147.49 23.03 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.818 0.847 . . . . 65.5 109.101 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.8 t -131.79 143.32 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 107.986 -1.116 . . . . 75.12 107.986 173.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.526 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 60.6 t -121.42 137.96 53.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 108.487 -0.931 . . . . 71.22 108.487 176.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.89 98.76 6.51 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.243 -1.392 . . . . 72.24 107.243 175.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.486 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 43.3 ttp180 -84.98 101.23 12.21 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.48 -0.933 . . . . 74.44 108.48 173.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.6 t -95.69 132.71 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 108.003 -1.11 . . . . 70.33 108.003 175.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.598 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 12.0 m -112.93 142.15 45.93 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.927 -0.768 . . . . 64.22 108.927 171.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.604 HG21 HG21 ' A' ' 114' ' ' ILE . 77.1 t -135.84 114.85 16.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 107.502 -1.296 . . . . 71.4 107.502 -176.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.4 m -121.92 107.63 12.49 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.928 -0.767 . . . . 72.01 108.928 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.74 111.59 23.98 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 106.703 -1.592 . . . . 72.41 106.703 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 54.7 m -120.73 135.91 55.01 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.716 0.77 . . . . 70.41 111.289 -173.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.509 HD12 HG22 ' A' ' 31' ' ' VAL . 35.1 mt -88.86 81.66 6.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.482 1.513 . . . . 62.31 107.779 175.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.12 -99.06 1.03 Allowed Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.471 -0.786 . . . . 54.42 111.894 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -94.84 -29.58 14.65 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.274 0.63 . . . . 74.42 111.175 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -98.18 127.82 44.33 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.269 0.628 . . . . 65.14 109.892 -170.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.3 m -69.25 132.81 47.07 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 120.993 0.425 . . . . 45.35 110.406 173.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.597 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -76.93 -52.21 9.82 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.188 -0.914 . . . . 71.13 108.728 174.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -160.26 164.17 32.88 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.814 -1.085 . . . . 75.31 110.916 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.9 tp -124.31 132.07 53.55 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.414 1.086 . . . . 54.22 108.438 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.462 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 37.0 m -130.48 116.63 18.47 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.78 0.832 . . . . 64.42 109.147 175.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -131.04 116.25 17.54 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.494 -0.558 . . . . 74.02 109.494 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.0 t -124.25 114.3 40.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 124.14 0.976 . . . . 63.2 109.374 -173.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.495 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 35.4 mt-30 -85.36 83.59 7.91 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.5 -0.926 . . . . 73.32 108.5 172.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -75.77 94.55 3.3 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 114.773 -1.103 . . . . 73.55 108.564 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.24 169.49 47.88 Favored Glycine 0 C--O 1.241 0.557 0 N-CA-C 111.013 -0.835 . . . . 73.41 111.013 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.23 120.74 0.91 Allowed Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 110.87 -0.892 . . . . 74.44 110.87 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.425 HG13 ' HE1' ' A' ' 17' ' ' TYR . 51.6 mt -82.61 127.07 40.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 107.805 -1.183 . . . . 64.45 107.805 174.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.692 ' HB3' HD11 ' A' ' 86' ' ' ILE . 66.7 m-85 -128.06 123.51 34.77 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.528 -0.916 . . . . 60.45 108.528 -174.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.7 t -87.32 93.55 9.43 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.361 -0.977 . . . . 73.42 108.361 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.692 HD11 ' HB3' ' A' ' 84' ' ' PHE . 18.9 mm -117.23 147.95 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.451 0.7 . . . . 71.23 111.146 -169.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.61 173.73 11.62 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.666 0.786 . . . . 75.11 110.307 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 96.22 -33.2 5.77 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.973 -0.558 . . . . 71.21 113.022 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.56 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -124.42 140.12 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.602 0.761 . . . . 71.53 110.515 -173.286 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.452 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 11.6 mp0 -131.52 174.78 9.74 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.709 0.804 . . . . 72.33 110.02 178.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.88 -123.21 27.98 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 124.0 0.813 . . . . 71.31 114.205 173.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.9 t -71.93 -25.25 61.82 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.289 0.635 . . . . 65.12 111.354 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -75.37 -38.0 60.28 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.599 0.76 . . . . 54.42 109.527 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.452 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 6.1 tpt -66.5 -45.55 79.17 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.511 -0.768 . . . . 55.35 109.367 174.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.8 -37.01 77.93 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.358 -0.837 . . . . 53.22 110.883 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -68.54 -34.62 76.17 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.738 -0.664 . . . . 75.55 111.001 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.2 t -69.3 -45.61 69.16 Favored 'General case' 0 C--N 1.348 0.5 0 N-CA-C 109.445 -0.576 . . . . 72.43 109.445 178.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 94' ' ' MET . 49.2 mt -80.85 -22.3 40.01 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.47 -0.787 . . . . 33.41 112.273 -172.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.13 4.14 30.08 Favored Glycine 0 N--CA 1.475 1.239 0 CA-C-O 119.677 -0.513 . . . . 64.15 114.055 -174.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.484 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -142.71 -65.91 0.39 Allowed 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 117.406 0.603 . . . . 74.54 111.192 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -69.94 -43.34 71.81 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 111.988 0.366 . . . . 74.45 111.988 -173.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 65.6 m -66.65 -47.22 56.9 Favored Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 124.044 0.937 . . . . 71.0 112.806 -176.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.458 ' HA ' ' HB2' ' A' ' 106' ' ' LEU . 52.2 Cg_endo -67.41 -23.61 43.88 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 121.77 1.646 . . . . 64.42 113.168 170.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -66.39 -38.21 87.0 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 122.604 0.362 . . . . 64.21 110.033 173.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.9 mm -65.12 -45.71 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.742 0.817 . . . . 63.01 110.276 171.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 103' ' ' PRO . 61.4 mt -72.02 -21.77 61.5 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.763 0.825 . . . . 74.01 113.074 -172.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -66.85 -44.28 51.67 Favored Pre-proline 0 N--CA 1.484 1.264 0 N-CA-C 114.057 1.132 . . . . 73.45 114.057 -169.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -54.89 -31.54 73.78 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.812 1.675 . . . . 51.11 113.714 172.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.443 ' OH ' ' HB3' ' C' ' 130' ' ' PRO . 67.8 m-85 -84.49 -37.13 21.69 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.497 0.719 . . . . 71.11 111.305 -175.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.5 -46.87 78.03 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.286 -0.635 . . . . 54.34 109.286 172.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.545 ' NH1' HD12 ' C' ' 105' ' ' ILE . 32.9 ttm180 -49.57 -52.66 28.52 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 124.884 1.365 . . . . 74.4 110.463 174.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -63.27 -45.89 89.37 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.223 0.952 . . . . 73.13 112.05 -175.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.428 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 45.1 t -58.14 -46.25 85.98 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 124.045 0.84 . . . . 73.12 110.364 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.604 HG21 HG21 ' A' ' 64' ' ' VAL . 32.5 mt -60.93 -52.5 60.93 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 115.2 -0.909 . . . . 64.44 110.632 175.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.4 m -56.21 -40.16 73.6 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.127 0.892 . . . . 71.22 111.28 -174.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.516 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 41.9 t -67.62 -42.97 81.5 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 114.772 -1.104 . . . . 54.31 110.356 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.9 mtp -62.5 -37.38 85.79 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.552 0.741 . . . . 73.1 111.661 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 114' ' ' ILE . 86.1 t -62.2 -53.7 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.254 1.022 . . . . 41.42 109.917 177.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.5 p -69.92 -26.71 64.28 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.95 -1.023 . . . . 54.55 111.587 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.516 ' HB2' ' O ' ' A' ' 116' ' ' SER . 18.0 ttm-85 -75.49 -31.61 60.27 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.182 0.993 . . . . 71.44 109.083 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.437 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.88 19.82 18.96 Favored Glycine 0 C--N 1.354 1.576 0 CA-C-N 114.948 -1.024 . . . . 34.13 112.916 171.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.5 t 61.44 9.12 2.48 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 127.497 2.319 . . . . 75.11 114.03 175.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -78.93 140.05 57.8 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 108.409 -0.96 . . . . 74.34 108.409 175.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.08 136.06 44.94 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.857 2.372 . . . . 54.41 111.854 175.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -52.07 133.54 33.09 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.308 1.005 . . . . 73.42 113.269 -170.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.435 HD21 HG11 ' A' ' 40' ' ' VAL . 58.7 tp -112.42 137.3 50.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.406 -1.27 . . . . 65.03 108.986 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -122.93 123.75 41.64 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 107.806 -1.183 . . . . 74.43 107.806 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.453 HD11 HD13 ' A' ' 114' ' ' ILE . 7.5 mt -74.78 125.6 29.13 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.122 -0.696 . . . . 60.12 109.122 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.31 135.99 96.49 Favored Pre-proline 0 CA--C 1.555 1.17 0 CA-C-O 119.186 -0.435 . . . . 75.02 111.028 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.85 131.59 46.96 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 123.284 2.656 . . . . 75.12 113.705 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.612 HG21 HD11 ' A' ' 44' ' ' LEU . 67.2 t -115.07 133.56 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.87 0.868 . . . . 74.32 110.513 -177.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -88.49 87.87 7.42 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 108.663 -0.866 . . . . 63.54 108.663 173.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -60.87 -26.9 67.74 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.001 0.92 . . . . 72.32 111.965 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.484 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 4.1 t70 -71.02 -40.77 71.59 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 123.592 0.557 . . . . 51.25 109.648 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.52 94.17 Favored 'General case' 0 C--N 1.351 0.635 0 O-C-N 123.897 0.748 . . . . 60.02 110.772 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.7 mt -58.71 -50.95 71.99 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.694 0.621 . . . . 63.54 110.59 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -63.71 -35.96 82.29 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.855 -0.611 . . . . 64.45 110.363 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.539 ' HA ' ' HB3' ' A' ' 141' ' ' LEU . 26.4 ttm -67.02 -30.69 70.86 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.253 0.621 . . . . 73.23 111.199 -176.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -59.26 -32.02 69.63 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.683 0.793 . . . . 73.11 110.927 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -83.65 -43.3 15.74 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.821 0.849 . . . . 52.31 111.075 171.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.539 ' HB3' ' HA ' ' A' ' 138' ' ' MET . 57.2 tp -59.97 -52.39 65.58 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.209 1.004 . . . . 73.13 112.202 -165.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -178.83 -15.16 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.463 0.705 . . . . 73.25 111.087 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 74.73 -34.68 0.27 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.875 1.67 . . . . 72.21 112.701 -177.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -54.33 107.75 0.31 Allowed 'General case' 0 C--N 1.354 0.762 0 C-N-CA 124.304 1.042 . . . . 71.31 108.961 172.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.443 ' HA ' ' SD ' ' A' ' 138' ' ' MET . . . -87.9 146.25 25.65 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.57 0.748 . . . . 60.21 111.158 -175.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -132.69 158.13 22.91 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 110.375 -1.09 . . . . 73.35 110.375 173.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.84 157.05 43.93 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.452 0.644 . . . . 72.12 111.486 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 175.01 168.34 35.48 Favored Glycine 0 C--O 1.24 0.517 0 CA-C-N 114.633 -1.167 . . . . 64.03 111.078 -176.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 1' ' ' MET . 4.7 t -144.42 154.87 43.41 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 122.735 0.414 . . . . 72.12 110.225 176.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -143.16 168.54 19.52 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.367 1.067 . . . . 74.22 109.467 -173.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 76.74 114.62 0.06 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.87 1.668 . . . . 62.1 111.286 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -172.73 114.51 0.28 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.529 1.131 . . . . 62.52 108.879 174.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.15 28.86 0.17 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.152 0.581 . . . . 71.12 111.463 -173.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -57.19 152.48 13.63 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.891 1.276 . . . . 63.12 112.549 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 C-N-CA 123.6 0.76 . . . . 54.45 109.074 179.332 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.1 tpt . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 110.139 -0.319 . . . . 75.24 110.139 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 69.6 m -74.89 -179.42 4.23 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.782 0.833 . . . . 73.45 111.176 174.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -82.28 85.64 6.81 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.522 0.729 . . . . 72.23 109.376 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -59.49 123.4 16.71 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.271 -1.011 . . . . 74.22 108.271 171.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -58.44 113.69 2.1 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.011 0.819 . . . . 73.44 111.839 -166.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -54.3 92.43 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.324 1.85 . . . . 75.14 113.814 -170.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 33.5 p -80.7 79.57 7.32 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.51 -0.768 . . . . 71.42 110.032 173.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 64.85 53.37 1.47 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.514 1.125 . . . . 75.24 111.141 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 14.6 ptm 54.16 -172.42 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 126.714 2.005 . . . . 63.31 114.053 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 91.5 m -151.72 111.04 3.93 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.513 1.125 . . . . 71.43 108.424 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -109.56 144.48 37.81 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.853 0.461 . . . . 71.24 109.918 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -156.69 139.97 15.63 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.888 0.875 . . . . 44.51 109.505 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.8 mt -94.08 131.47 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.258 -1.386 . . . . 73.42 107.258 169.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -93.73 -46.69 7.12 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 120.968 0.414 . . . . 73.11 109.986 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -176.74 130.9 0.19 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.22 -0.9 . . . . 70.52 109.067 -172.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.513 HG21 ' CD1' ' B' ' 109' ' ' TYR . 81.6 mt -116.2 148.37 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 108.45 -0.945 . . . . 64.23 108.45 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -165.17 147.01 7.74 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 113.059 0.763 . . . . 73.35 113.059 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.2 m -73.53 121.42 20.57 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.457 -1.247 . . . . 74.43 108.991 168.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.414 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.9 mtpt -99.4 -20.79 16.3 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.499 0.719 . . . . 75.45 111.929 -177.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -164.67 135.54 4.14 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.326 0.25 . . . . 63.44 110.742 -171.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 48.4 mm -132.57 139.11 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.871 1.268 . . . . 63.42 109.601 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 37.2 t -136.28 126.73 26.78 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.38 -1.341 . . . . 70.54 107.38 174.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.485 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.8 t80 -145.01 111.6 5.75 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 107.589 -1.263 . . . . 73.53 107.589 170.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -128.32 112.73 14.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.311 -0.996 . . . . 61.51 108.311 -173.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.62 85.06 8.73 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 107.792 -1.188 . . . . 63.11 107.792 174.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.5 -30.07 12.73 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.579 2.186 . . . . 72.22 112.256 -175.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.451 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 2.1 m-20 -98.46 10.06 41.72 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.193 0.997 . . . . 71.13 110.571 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.469 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -41.92 -61.89 1.35 Allowed Pre-proline 0 CA--C 1.56 1.357 0 N-CA-C 115.293 1.59 . . . . 53.42 115.293 -164.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.409 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 15.5 Cg_exo -62.76 -27.65 75.69 Favored 'Trans proline' 0 C--N 1.391 2.765 0 C-N-CA 122.347 2.031 . . . . 71.51 112.721 -169.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -94.24 -37.89 11.31 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.704 -1.134 . . . . 71.53 111.804 -172.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.589 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.1 p -69.6 -12.22 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 122.753 0.421 . . . . 74.32 112.109 -173.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -70.38 -9.72 57.07 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 112.868 0.692 . . . . 73.24 112.868 177.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -61.92 -26.2 68.03 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.623 0.769 . . . . 62.33 110.915 171.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.614 ' HB2' HD13 ' B' ' 68' ' ' LEU . 30.4 mmtp -89.24 84.73 6.51 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.482 1.113 . . . . 54.24 110.171 -174.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -88.3 82.53 7.04 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.125 0.488 . . . . 70.22 110.834 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 26.8 p90 -160.92 -172.05 3.32 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.513 1.125 . . . . 72.12 108.966 169.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -79.59 119.29 76.4 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.152 0.581 . . . . 74.54 110.722 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.473 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 20.6 Cg_endo -68.59 152.02 74.89 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 121.843 1.695 . . . . 74.02 111.343 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -71.35 102.68 2.67 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.596 -0.89 . . . . 72.35 108.596 173.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.425 HG11 HD11 ' B' ' 126' ' ' LEU . 50.6 t -94.84 142.77 13.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 114.667 -1.151 . . . . 74.31 110.24 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -140.0 109.74 6.35 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 106.933 -1.506 . . . . 75.35 106.933 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.484 HD13 HD22 ' B' ' 128' ' ' LEU . 35.6 tp -92.61 146.08 23.94 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.949 0.9 . . . . 74.54 109.845 -173.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.598 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 16.2 m-20 -131.34 143.16 50.29 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.758 1.223 . . . . 65.44 108.62 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.501 HD12 HG21 ' F' ' 121' ' ' VAL . 98.0 mt -129.99 128.63 42.44 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.922 -1.14 . . . . 73.34 107.922 174.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -140.84 143.96 35.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.091 0.956 . . . . 71.0 108.595 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 25.8 m -118.91 102.35 8.72 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.644 -0.502 . . . . 74.04 109.644 -175.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' B' ' 59' ' ' VAL . . . -125.3 115.62 20.64 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 106.672 -1.603 . . . . 42.53 106.672 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 24.2 m -142.42 -178.27 5.67 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.75 0.42 . . . . 63.3 111.401 -164.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 69.4 p -150.67 137.01 18.65 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 123.396 0.678 . . . . 44.34 109.91 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -95.17 128.47 42.03 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.7 0.4 . . . . 60.44 110.097 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 19.0 mt -92.6 -30.99 15.34 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.491 0.494 . . . . 64.22 110.234 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.495 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -171.41 175.15 4.23 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.842 0.857 . . . . 72.24 111.418 -176.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.72 137.33 57.74 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 107.019 -1.475 . . . . 74.44 107.019 159.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 70.81 -4.1 1.8 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.421 1.088 . . . . 74.33 113.234 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 41.2 t -135.15 96.71 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 108.334 -0.987 . . . . 74.22 108.334 -178.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -115.9 140.71 48.98 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.73 -0.841 . . . . 73.43 108.73 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -110.44 96.84 6.45 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.149 -1.426 . . . . 71.24 107.149 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -99.85 146.77 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 115.893 -0.594 . . . . 72.34 109.999 -174.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' B' ' 47' ' ' ALA . 26.9 t -127.86 143.54 40.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 123.942 0.897 . . . . 60.44 108.802 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.466 HD13 ' HE2' ' B' ' 133' ' ' PHE . 46.4 tp -119.46 114.34 22.15 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.547 -0.909 . . . . 74.44 108.547 170.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -84.39 111.92 19.88 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.377 -0.972 . . . . 75.43 108.377 171.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.414 ' CG1' HD11 ' B' ' 42' ' ' LEU . 20.8 t -105.78 103.37 15.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.458 -1.312 . . . . 75.03 107.458 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.598 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 16.8 m -103.29 131.09 50.63 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.699 -0.482 . . . . 73.42 109.699 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.592 HG11 HD21 ' B' ' 126' ' ' LEU . 88.0 t -116.84 128.12 74.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 123.377 0.671 . . . . 54.2 109.903 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 90.0 m -106.67 141.19 38.33 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.637 -1.246 . . . . 74.42 107.637 163.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -147.47 140.58 25.12 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.537 -0.912 . . . . 53.33 108.537 174.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.49 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 29.2 p -142.91 128.28 18.87 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.748 -0.66 . . . . 73.25 110.589 -171.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.614 HD13 ' HB2' ' B' ' 34' ' ' LYS . 39.0 mt -99.52 108.81 21.33 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.133 0.973 . . . . 65.4 109.668 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.66 -125.86 9.49 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 116.018 -0.537 . . . . 74.32 111.872 -175.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -96.72 2.95 52.58 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.425 0.69 . . . . 64.34 112.105 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.451 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 17.3 pt-20 -125.01 159.43 31.32 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.901 0.48 . . . . 60.35 111.3 -174.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 85.0 m -67.77 130.58 43.43 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.582 0.753 . . . . 64.34 110.329 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.589 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -84.86 -67.51 0.79 Allowed 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.598 -1.26 . . . . 64.41 107.598 170.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -147.71 156.87 43.21 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.157 -0.929 . . . . 64.43 110.988 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 89.0 mt -124.24 109.89 13.97 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 107.008 -1.479 . . . . 70.05 107.008 172.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.5 t -117.87 156.72 27.93 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.653 -0.499 . . . . 32.11 109.653 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 38.1 tt0 -165.11 139.32 4.92 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.615 -0.883 . . . . 75.31 108.615 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.42 HG22 HD12 ' B' ' 21' ' ' ILE . 84.5 t -133.79 145.5 33.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.879 -1.156 . . . . 63.44 107.879 173.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -125.77 93.63 3.89 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.48 -0.933 . . . . 70.32 108.48 175.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.418 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.2 tp-100 -87.77 104.91 17.01 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.395 -0.821 . . . . 73.44 109.24 -177.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.414 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -97.06 173.37 29.02 Favored Glycine 0 C--N 1.336 0.553 0 O-C-N 123.664 0.603 . . . . 65.04 112.168 175.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.39 139.65 4.64 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 121.784 -0.246 . . . . 35.23 112.785 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 52.1 mt -85.69 113.45 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 108.37 -0.974 . . . . 71.33 108.37 173.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -117.4 135.45 53.87 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.643 0.777 . . . . 73.31 109.943 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 72.4 m -94.9 105.45 17.37 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.744 0.818 . . . . 65.23 109.633 172.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.637 ' HB ' HD11 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -114.3 105.15 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 124.236 1.015 . . . . 74.14 108.685 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.0 163.02 24.64 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.335 0.654 . . . . 71.42 111.523 -174.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.72 -30.76 3.43 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 114.402 0.521 . . . . 53.22 114.402 172.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.637 HD11 ' HB ' ' B' ' 86' ' ' ILE . 2.0 pt -67.83 161.29 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 124.495 1.118 . . . . 64.51 111.443 172.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -148.6 171.96 15.3 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 123.863 0.865 . . . . 75.21 111.062 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.52 -130.85 11.5 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 114.557 -1.201 . . . . 62.52 113.875 173.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 24.5 m -86.59 -35.7 19.3 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.853 0.861 . . . . 63.5 109.636 174.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -65.17 -23.33 67.08 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.103 -1.408 . . . . 71.24 111.666 -170.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.598 ' HA ' HD12 ' B' ' 89' ' ' ILE . 19.0 ptt? -66.23 -51.23 59.64 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.526 -0.761 . . . . 73.2 111.761 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.74 -13.46 59.43 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.483 0.713 . . . . 55.35 111.128 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -68.91 -32.57 72.29 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.308 0.643 . . . . 64.24 110.516 169.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -65.32 -52.09 56.27 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 120.899 0.381 . . . . 61.25 110.729 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.432 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.4 pp -71.13 -22.09 62.11 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 116.049 -0.523 . . . . 44.53 111.135 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.15 4.38 44.82 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 118.764 -1.02 . . . . 53.12 115.029 -172.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.27 -45.95 0.11 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 118.557 1.178 . . . . 72.03 111.294 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -74.82 -40.77 60.87 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.093 0.557 . . . . 73.45 110.686 -176.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.432 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 74.3 m -73.46 -46.19 7.55 Favored Pre-proline 0 CA--C 1.561 1.38 0 CA-C-O 118.492 -0.766 . . . . 65.2 112.94 -177.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.64 -16.48 54.95 Favored 'Trans proline' 0 C--N 1.396 3.064 0 C-N-CA 121.9 1.734 . . . . 73.52 113.246 171.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -73.33 -32.19 64.42 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.123 0.569 . . . . 74.04 110.644 172.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.475 HG23 ' NH2' ' D' ' 111' ' ' ARG . 91.3 mt -70.35 -39.73 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.04 0.936 . . . . 73.42 109.758 172.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 76.1 mt -75.57 -32.22 60.29 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.88 -1.054 . . . . 72.0 111.912 -174.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -57.24 -50.11 90.04 Favored Pre-proline 0 N--CA 1.488 1.471 0 CA-C-O 117.78 -1.105 . . . . 75.31 113.451 -173.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.35 -37.44 97.57 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 121.84 1.693 . . . . 63.41 112.593 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.513 ' CD1' HG21 ' B' ' 16' ' ' ILE . 3.6 m-30 -66.37 -39.37 89.08 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.727 0.811 . . . . 72.42 110.078 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.12 -31.56 67.91 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.15 0.98 . . . . 65.13 111.331 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -69.12 -52.96 22.93 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.529 1.132 . . . . 71.24 111.068 -173.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.0 -27.33 66.47 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.52 -0.548 . . . . 74.1 109.52 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.485 ' O ' ' HG2' ' B' ' 117' ' ' MET . 31.0 t -65.29 -42.6 92.95 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 122.945 0.498 . . . . 54.21 111.256 178.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.562 HD13 HG23 ' B' ' 64' ' ' VAL . 65.0 mt -62.74 -54.16 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.209 0.604 . . . . 62.34 109.573 173.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 4.3 m -62.32 -23.22 66.64 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 124.053 0.846 . . . . 73.13 111.334 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.447 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.3 t -69.19 -50.93 43.01 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 109.072 -0.714 . . . . 44.4 109.072 174.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.0 mmt -67.86 -34.96 77.7 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.074 0.55 . . . . 61.0 111.241 -176.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 70.4 t -64.75 -43.93 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.775 1.23 . . . . 72.53 110.216 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 31.4 t -64.74 -34.72 78.99 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.007 -0.997 . . . . 62.12 111.291 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' B' ' 116' ' ' SER . 82.1 mtt-85 -67.84 -35.88 79.36 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-N 115.718 -0.674 . . . . 62.25 109.802 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.31 -7.04 81.92 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.595 0.559 . . . . 64.15 113.324 172.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.43 ' HB ' ' HE ' ' A' ' 15' ' ' ARG . 8.5 m 64.94 33.4 9.89 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 125.144 1.377 . . . . 74.52 110.447 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -86.21 162.8 45.06 Favored Pre-proline 0 CA--C 1.555 1.173 0 CA-C-N 114.407 -1.269 . . . . 74.15 110.395 174.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.536 ' HA ' ' HB3' ' F' ' 131' ' ' TRP . 60.1 Cg_endo -68.21 169.97 15.61 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.528 2.152 . . . . 71.01 113.415 -176.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.488 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 62.4 tp60 -64.44 115.93 5.6 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 115.224 -0.898 . . . . 75.31 111.759 -169.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.592 HD21 HG11 ' B' ' 64' ' ' VAL . 55.8 tp -109.82 98.04 7.44 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.334 -0.848 . . . . 70.12 109.357 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 127' ' ' ASN . . . . . 0.415 ' ND2' ' HG3' ' B' ' 125' ' ' GLN . 40.7 m-80 -103.5 103.05 12.97 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.611 -1.255 . . . . 73.11 107.611 173.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.484 HD22 HD13 ' B' ' 42' ' ' LEU . 91.0 mt -62.54 141.54 58.39 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.566 0.346 . . . . 74.1 111.14 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.3 140.28 88.07 Favored Pre-proline 0 CA--C 1.55 0.96 0 O-C-N 124.016 0.822 . . . . 53.41 111.128 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -65.92 97.35 0.34 Allowed 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.513 2.142 . . . . 74.33 111.072 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.455 ' HA ' ' HE2' ' F' ' 120' ' ' TYR . 27.4 m -90.86 112.37 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.728 0.775 . . . . 55.41 110.501 -177.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -87.44 104.9 16.89 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.936 -1.135 . . . . 73.32 107.936 171.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.466 ' HE2' HD13 ' B' ' 60' ' ' LEU . 3.4 t80 -59.15 -34.52 72.19 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.798 1.239 . . . . 74.44 110.138 -177.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.39 -47.09 83.47 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.399 -1.273 . . . . 72.15 111.474 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.06 -32.02 73.29 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.442 0.697 . . . . 72.13 112.171 -176.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.415 HD12 HG23 ' F' ' 121' ' ' VAL . 6.4 tt -63.25 -45.83 89.72 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.97 0.908 . . . . 75.23 109.863 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.554 ' HA ' ' HD2' ' B' ' 140' ' ' TYR . 2.9 m-85 -77.43 -22.69 51.1 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.787 0.835 . . . . 74.45 111.96 177.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 13.1 tmm? -69.13 -35.96 76.94 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.024 0.93 . . . . 72.32 110.651 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -74.61 -29.55 61.34 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.497 -0.774 . . . . 62.4 110.965 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 140' ' ' TYR . . . . . 0.554 ' HD2' ' HA ' ' B' ' 137' ' ' PHE . 37.6 m-85 -63.34 -19.83 64.97 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.562 0.345 . . . . 75.55 111.345 171.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 6.8 tp -106.43 35.25 3.02 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 108.821 -0.807 . . . . 73.42 108.821 174.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 64.23 -87.49 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.814 1.645 . . . . 64.54 111.823 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -154.61 121.69 5.6 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.499 -0.926 . . . . 71.24 108.499 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -110.04 9.95 24.16 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.852 0.861 . . . . 74.03 110.562 176.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.45 175.26 10.7 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.788 0.835 . . . . 35.01 109.797 170.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 124.05 4.91 7.66 Favored Glycine 0 N--CA 1.473 1.142 0 N-CA-C 111.779 -0.529 . . . . 73.15 111.779 -174.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.44 -37.56 70.41 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.796 1.238 . . . . 74.35 110.236 169.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -110.36 -166.04 19.35 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 115.701 -0.682 . . . . 43.13 111.51 171.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 57.6 m -137.81 -79.62 0.36 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.95 -1.13 . . . . 70.04 107.95 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 150' ' ' GLU . . . . . 0.544 ' HA ' ' HA2' ' D' ' 88' ' ' GLY . 39.0 tt0 165.88 102.14 0.0 OUTLIER 'General case' 0 C--O 1.24 0.588 0 C-N-CA 125.485 1.514 . . . . 73.33 107.048 -171.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -67.51 -66.61 0.54 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 109.892 -0.41 . . . . 73.55 109.892 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 54.43 60.76 3.35 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.104 0.962 . . . . 72.12 111.638 170.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -113.37 137.33 51.68 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 115.335 -0.848 . . . . 70.01 109.377 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -158.35 -177.12 6.31 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.393 0.677 . . . . 74.42 110.073 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.184 0 C-N-CA 123.644 0.778 . . . . 71.33 109.219 -179.101 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 1' ' ' MET . . . . . 0.463 ' SD ' ' N ' ' C' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.484 1.226 0 N-CA-C 109.606 -0.516 . . . . 74.23 109.606 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 80.8 p 63.92 129.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 127.064 2.146 . . . . 45.31 114.211 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -57.58 -57.19 13.8 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 124.426 1.09 . . . . 74.54 110.935 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -171.62 173.26 4.72 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 123.915 0.76 . . . . 74.23 111.538 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -136.5 97.2 3.51 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.149 1.38 . . . . 75.42 107.412 171.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -144.61 155.98 43.89 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.251 0.62 . . . . 74.25 111.192 -166.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 6.5 t -76.9 75.5 3.5 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-O 122.342 1.067 . . . . 74.03 110.367 174.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -167.98 -46.85 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.588 -1.187 . . . . 74.31 108.92 -169.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 23.5 ttt 63.69 110.8 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.367 1.467 . . . . 75.0 110.965 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.634 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 7.4 m -88.36 77.73 8.09 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.695 0.798 . . . . 73.02 109.586 -176.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -106.14 137.22 44.45 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.605 0.762 . . . . 75.5 109.354 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 12' ' ' GLN . . . . . 0.673 ' HB2' ' HA3' ' E' ' 140' ' ' GLY . 6.5 tp-100 -154.13 141.58 19.72 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.679 0.392 . . . . 75.42 110.11 171.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 17.1 mt -91.31 123.56 43.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 109.452 -0.573 . . . . 65.53 109.452 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -88.22 -42.89 11.99 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.127 0.571 . . . . 44.34 109.542 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -172.56 147.35 1.83 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.154 0.982 . . . . 70.24 110.307 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 70.6 mt -125.03 130.79 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.104 1.362 . . . . 73.1 107.535 174.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.529 ' HB3' HG23 ' D' ' 122' ' ' THR . 31.1 p90 -162.96 173.26 13.87 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.682 0.753 . . . . 73.52 111.523 -167.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -98.36 117.28 32.42 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.982 -1.008 . . . . 60.31 109.586 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.491 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 21.4 mmtp -67.61 -48.08 67.83 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 107.904 -1.147 . . . . 63.45 107.904 168.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -139.32 144.01 38.08 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 113.85 -1.523 . . . . 73.04 109.921 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.425 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.9 mt -133.88 142.99 39.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 125.393 1.477 . . . . 74.24 107.078 173.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.0 t -152.5 146.0 24.91 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.325 0.583 . . . . 72.21 110.342 174.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -150.18 128.26 11.93 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 107.066 -1.457 . . . . 74.23 107.066 172.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -133.92 112.16 11.04 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.195 -0.668 . . . . 64.41 109.195 -177.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.56 80.81 69.32 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 107.695 -1.224 . . . . 61.13 107.695 166.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.29 -21.69 30.66 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.453 2.102 . . . . 70.23 111.609 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -100.49 15.0 29.38 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.985 1.314 . . . . 75.41 110.946 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.436 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -42.21 -56.51 5.32 Favored Pre-proline 0 N--CA 1.487 1.423 0 N-CA-C 114.385 1.254 . . . . 43.54 114.385 -169.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.436 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 36.1 Cg_exo -60.68 -41.6 45.78 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.286 1.991 . . . . 52.11 112.666 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -68.36 -39.09 81.94 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.025 -0.989 . . . . 62.32 112.059 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.758 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.1 p -79.2 -17.13 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.507 0 N-CA-C 112.841 0.682 . . . . 63.44 112.841 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -69.41 -26.85 64.83 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 112.745 0.646 . . . . 71.44 112.745 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -87.14 13.63 9.11 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.174 0.59 . . . . 65.31 111.591 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.79 160.34 15.31 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.796 0.838 . . . . 74.33 110.756 -173.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -71.59 129.83 39.7 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.603 0.761 . . . . 71.44 109.877 173.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -82.9 90.19 6.93 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.574 0.75 . . . . 72.24 110.724 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 37' ' ' GLN . . . . . 0.443 ' H ' HD22 ' C' ' 68' ' ' LEU . 52.6 tt0 -146.55 79.46 10.4 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 124.095 0.958 . . . . 74.41 108.845 173.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -86.24 158.36 9.75 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.547 2.165 . . . . 70.42 112.852 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.47 79.3 9.02 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 106.703 -1.592 . . . . 70.44 106.703 167.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 25.7 t -71.73 96.75 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.112 -0.949 . . . . 73.15 108.845 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.93 104.0 12.55 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.767 -1.568 . . . . 73.25 106.767 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 pp -85.48 145.59 27.35 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.967 -0.753 . . . . 72.52 108.967 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.406 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 22.5 t70 -128.12 115.44 18.43 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.746 -0.835 . . . . 70.15 108.746 178.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.524 HD11 HG11 ' C' ' 131' ' ' VAL . 93.0 mt -97.35 110.97 23.42 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.598 -0.519 . . . . 73.13 109.598 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -113.52 145.96 40.39 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.374 -1.343 . . . . 71.41 107.374 169.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.0 t -137.42 146.76 44.78 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.232 -0.655 . . . . 71.11 109.232 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.84 171.82 13.55 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.116 0.967 . . . . 61.05 108.8 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 32.8 p -156.15 156.03 33.53 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.284 0.633 . . . . 42.11 109.621 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -145.41 127.62 15.73 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.49 -0.93 . . . . 74.41 108.49 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -78.9 113.46 17.02 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 107.452 -1.314 . . . . 73.32 107.452 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.63 HD11 HD12 ' C' ' 83' ' ' ILE . 67.0 mt -84.61 -27.35 27.26 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.008 0.523 . . . . 72.04 110.444 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.3 -175.06 2.78 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.737 -1.12 . . . . 71.22 110.182 -176.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -64.37 104.11 0.73 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.101 -0.954 . . . . 64.35 110.343 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 65.56 21.33 11.73 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.453 1.101 . . . . 71.35 112.302 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.5 t -108.55 114.96 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 107.613 -1.254 . . . . 74.32 107.613 166.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -121.63 124.39 44.21 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.343 0.657 . . . . 54.11 109.542 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.433 ' HB2' HD11 ' C' ' 51' ' ' LEU . 26.3 tt0 -82.95 143.22 30.83 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 124.542 1.137 . . . . 74.41 108.563 165.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.445 HG11 ' HD3' ' C' ' 103' ' ' PRO . 96.0 t -132.95 133.55 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.787 -0.82 . . . . 73.44 108.787 171.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.45 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 58.7 t -113.4 139.71 37.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 123.661 0.785 . . . . 74.52 109.112 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.465 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -122.63 100.73 7.07 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.045 -1.465 . . . . 65.2 107.045 173.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -82.48 107.42 15.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.193 -0.912 . . . . 72.33 109.244 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 24.4 t -107.76 114.75 47.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.885 -1.154 . . . . 65.52 107.885 173.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.406 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 21.4 m -105.1 145.51 30.43 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.195 0.998 . . . . 74.02 108.783 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.54 HG21 HG21 ' C' ' 114' ' ' ILE . 87.4 t -126.49 119.49 53.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 109.103 -0.703 . . . . 71.41 109.103 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 38.6 m -99.14 134.72 41.59 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.559 -1.274 . . . . 72.53 107.559 166.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.27 103.83 4.5 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.115 -1.068 . . . . 71.33 108.115 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 42.4 m -130.31 132.25 45.79 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 121.156 0.503 . . . . 73.25 109.862 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.443 HD22 ' H ' ' C' ' 37' ' ' GLN . 12.7 mt -85.54 38.21 0.73 Allowed 'General case' 0 CA--C 1.556 1.212 0 C-N-CA 124.793 1.237 . . . . 62.42 109.87 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.49 -111.8 2.64 Favored Glycine 0 C--N 1.354 1.533 0 N-CA-C 110.217 -1.153 . . . . 64.25 110.217 -168.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -90.47 -31.22 16.88 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.151 0.981 . . . . 72.5 109.879 174.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -67.16 101.03 0.84 Allowed 'General case' 0 C--N 1.346 0.423 0 C-N-CA 124.032 0.933 . . . . 75.11 109.793 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 46.4 m -72.43 116.31 12.73 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.978 -0.749 . . . . 45.23 108.978 173.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.758 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -64.44 -49.17 72.53 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.072 0.858 . . . . 73.5 109.506 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -167.54 164.73 14.79 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.133 -1.394 . . . . 65.34 110.459 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.49 138.2 53.3 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 106.38 -1.711 . . . . 35.55 106.38 164.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 51.3 t -144.89 145.71 31.7 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.777 -0.823 . . . . 73.43 108.777 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -159.94 136.89 9.31 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.796 -0.446 . . . . 64.54 109.796 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 69.1 t -131.24 124.39 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.174 0.99 . . . . 63.31 108.668 175.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -99.85 84.12 2.85 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.789 -1.189 . . . . 73.41 107.789 177.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -78.63 95.74 5.32 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.33 -0.85 . . . . 63.03 109.502 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -94.56 146.52 18.2 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 115.697 -0.683 . . . . 72.41 111.905 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.08 140.74 9.64 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.346 -0.702 . . . . 72.43 111.346 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.63 HD12 HD11 ' C' ' 51' ' ' LEU . 15.4 mm -97.12 133.1 40.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 109.52 -0.548 . . . . 71.15 109.52 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.435 ' HZ ' HD11 ' C' ' 106' ' ' LEU . 25.7 m-85 -135.84 147.09 48.12 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.854 0.721 . . . . 74.42 110.029 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 85' ' ' SER . . . . . 0.48 ' HB2' ' HB3' ' E' ' 141' ' ' ALA . 12.9 p -101.2 101.16 11.8 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.806 -1.183 . . . . 65.34 107.806 168.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.629 HD13 ' SG ' ' C' ' 97' ' ' CYS . 22.5 mt -116.25 129.94 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.39 0.676 . . . . 72.5 110.303 -172.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.634 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -153.05 172.82 16.27 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.21 1.004 . . . . 74.23 109.516 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.32 -34.04 5.08 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-N 116.547 -0.297 . . . . 62.32 112.654 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.457 ' HB ' ' HB3' ' C' ' 93' ' ' GLN . 33.8 pt -96.69 162.28 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.54 0.736 . . . . 74.01 111.517 -176.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -158.52 152.47 23.69 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.674 0.79 . . . . 54.24 110.417 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.58 -127.94 8.38 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-O 119.717 -0.491 . . . . 31.44 112.879 174.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -59.46 -32.91 70.67 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 123.258 0.623 . . . . 71.05 110.817 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.457 ' HB3' ' HB ' ' C' ' 89' ' ' ILE . 92.9 mt-30 -62.74 -48.95 76.99 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.357 1.063 . . . . 64.31 111.695 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.547 ' HE3' ' HA ' ' C' ' 94' ' ' MET . 4.2 tpt -55.09 -52.67 62.49 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 123.784 0.677 . . . . 72.54 110.453 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.06 -32.49 73.87 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.146 0.578 . . . . 33.42 111.955 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -70.4 -32.64 70.35 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.87 0.868 . . . . 74.21 111.153 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.629 ' SG ' HD13 ' C' ' 86' ' ' ILE . 18.7 t -72.11 -43.96 63.93 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.295 0.569 . . . . 71.33 109.622 177.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 67.6 mt -81.02 -25.3 37.29 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 114.625 -1.17 . . . . 44.33 112.121 -174.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.4 3.29 20.23 Favored Glycine 0 N--CA 1.476 1.337 0 CA-C-O 119.201 -0.777 . . . . 41.14 114.719 -172.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.99 -53.15 0.15 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 118.151 0.976 . . . . 73.11 112.559 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -70.58 -58.6 3.51 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.884 0.474 . . . . 64.11 110.404 -171.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 58.9 m -64.64 -44.18 72.98 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-O 118.494 -0.765 . . . . 72.4 112.191 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.465 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 82.7 Cg_exo -53.7 -32.87 67.26 Favored 'Trans proline' 0 C--N 1.389 2.692 0 C-N-CA 122.366 2.044 . . . . 71.45 114.021 169.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -67.55 -40.72 84.95 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 122.974 0.51 . . . . 65.41 111.028 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.545 HD12 ' NH1' ' A' ' 111' ' ' ARG . 35.8 mm -70.66 -32.57 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 C-N-CA 122.812 0.445 . . . . 63.24 110.204 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.435 HD11 ' HZ ' ' C' ' 84' ' ' PHE . 2.5 mp -83.89 -20.83 32.38 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.455 1.102 . . . . 74.44 112.105 -176.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -58.44 -47.91 97.92 Favored Pre-proline 0 CA--C 1.554 1.108 0 CA-C-O 117.811 -1.09 . . . . 72.31 113.9 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -60.14 -37.37 84.24 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 121.91 1.74 . . . . 73.21 113.044 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -68.87 -43.74 74.75 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.602 0.761 . . . . 73.44 110.309 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.11 -40.17 94.96 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.035 -0.984 . . . . 51.1 110.35 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -63.98 -48.89 74.66 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.7 1.2 . . . . 73.54 110.496 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.74 -38.91 84.16 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.136 0.575 . . . . 70.4 109.805 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.44 ' O ' ' SD ' ' C' ' 117' ' ' MET . 6.8 t -63.88 -42.78 97.42 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.685 0.394 . . . . 71.12 111.136 -178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.54 HG21 HG21 ' C' ' 64' ' ' VAL . 75.8 mt -63.27 -52.01 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 122.911 0.484 . . . . 71.42 110.244 175.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 22.0 m -63.32 -27.92 69.65 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.849 -0.614 . . . . 74.14 110.877 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 26.6 t -66.86 -52.18 46.58 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.491 0.717 . . . . 72.13 109.274 173.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.635 ' HE2' HD13 ' D' ' 21' ' ' ILE . 0.1 OUTLIER -48.76 -46.56 41.42 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.706 1.202 . . . . 75.54 112.354 175.044 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 93.4 t -67.35 -43.03 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.557 1.143 . . . . 75.1 111.004 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 15.0 t -65.72 -30.99 71.74 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.226 1.011 . . . . 75.14 111.619 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.42 HH12 ' CD ' ' D' ' 112' ' ' GLU . 70.9 mtt-85 -75.0 -39.5 61.19 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.805 0.842 . . . . 71.41 109.676 178.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.68 -2.54 64.64 Favored Glycine 0 C--N 1.356 1.645 0 CA-C-N 115.436 -0.802 . . . . 64.51 112.876 170.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.1 p 65.38 30.01 11.18 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.316 1.846 . . . . 75.15 113.533 169.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -83.81 144.28 44.89 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 108.348 -0.982 . . . . 75.11 108.348 169.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.488 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 77.8 Cg_exo -50.42 143.26 27.74 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 123.318 2.679 . . . . 72.4 113.728 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.441 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 55.5 mm-40 -51.76 119.71 4.5 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.639 1.212 . . . . 52.53 112.337 -174.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 36.6 tp -124.15 84.22 2.25 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 107.587 -1.264 . . . . 75.21 107.587 -177.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 127' ' ' ASN . . . . . 0.401 ' HB2' HG23 ' B' ' 122' ' ' THR . 20.0 m120 -92.68 97.68 10.94 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.377 -0.829 . . . . 73.32 108.864 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -60.36 143.82 52.17 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.47 0.708 . . . . 75.42 112.019 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.2 142.54 97.92 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-N 115.171 -0.922 . . . . 74.11 110.617 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.618 ' HG2' HG21 ' A' ' 13' ' ' ILE . 4.9 Cg_exo -67.13 152.73 79.36 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.027 1.818 . . . . 71.42 112.762 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.524 HG11 HD11 ' C' ' 44' ' ' LEU . 7.2 p -136.5 134.92 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.442 -0.799 . . . . 55.32 108.855 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -87.57 103.4 15.52 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.975 0.51 . . . . 74.42 110.254 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -61.87 -29.53 70.25 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.897 0.879 . . . . 73.23 111.82 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -56.58 -55.19 37.02 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.559 0.744 . . . . 73.42 110.061 173.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.23 -47.95 77.45 Favored 'General case' 0 C--N 1.349 0.55 0 O-C-N 124.227 0.954 . . . . 61.01 111.594 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 73.2 mt -59.02 -38.3 78.96 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.559 0.744 . . . . 54.44 111.559 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -77.56 -30.45 52.64 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.138 -0.937 . . . . 65.02 110.806 -177.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.403 ' SD ' ' N ' ' A' ' 1' ' ' MET . 25.2 mmt -70.0 -38.92 76.11 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.129 0.572 . . . . 72.14 109.882 175.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -60.56 -39.0 86.37 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.748 0.655 . . . . 64.03 110.219 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -72.7 -155.69 0.03 OUTLIER 'General case' 0 CA--C 1.579 2.062 0 C-N-CA 124.004 0.921 . . . . 70.42 110.217 171.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.46 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 94.4 mt 62.12 179.25 0.13 Allowed 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 124.719 1.208 . . . . 63.1 112.23 -175.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -140.72 -56.29 0.51 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.921 0.888 . . . . 71.14 109.465 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -69.32 122.09 18.2 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.107 0.963 . . . . 63.33 110.758 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -66.81 105.32 1.55 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.106 0.562 . . . . 74.25 110.163 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -152.69 112.3 3.91 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.297 0.639 . . . . 74.02 109.715 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -177.42 124.5 0.95 Allowed Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.081 -1.208 . . . . 43.42 110.081 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.78 166.44 32.23 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 117.383 0.591 . . . . 71.32 111.005 -176.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -130.59 35.91 2.39 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 116.301 -0.408 . . . . 73.1 113.214 -172.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 63.5 m -70.59 119.48 14.81 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 122.942 0.497 . . . . 74.01 109.771 171.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -150.24 141.95 23.65 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.082 0.553 . . . . 74.31 110.727 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -145.95 124.54 12.49 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 107.507 -1.294 . . . . 65.53 107.507 163.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -79.07 77.07 5.56 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.881 0.848 . . . . 63.11 110.644 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -145.81 128.78 16.47 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.122 -0.944 . . . . 51.13 108.494 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -76.25 91.67 3.23 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.3 0.64 . . . . 74.51 110.173 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.138 0 C-N-CA 124.355 1.062 . . . . 71.42 108.55 178.633 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 109.621 -0.511 . . . . 74.45 109.621 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 25.5 m -73.55 85.53 1.56 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.611 0.764 . . . . 72.34 109.384 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -82.92 143.82 30.45 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.191 -0.913 . . . . 73.43 110.965 -170.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 4' ' ' GLN . . . . . 0.447 ' HB3' ' HG2' ' E' ' 95' ' ' LYS . 95.7 mt-30 -84.87 109.08 17.86 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.578 0.751 . . . . 73.04 109.772 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 5' ' ' ASN . . . . . 0.409 ' O ' ' HD3' ' E' ' 95' ' ' LYS . 6.4 p30 -94.98 131.7 40.64 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.755 0.822 . . . . 71.33 110.898 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.76 112.53 2.06 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.24 1.016 . . . . 71.15 111.066 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -141.03 149.83 42.21 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.514 1.126 . . . . 61.01 109.46 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -74.51 169.14 18.35 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.523 -0.547 . . . . 65.1 109.523 173.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.678 ' SD ' HG13 ' D' ' 89' ' ' ILE . 10.2 tpt -31.69 123.18 0.27 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.622 1.169 . . . . 73.54 114.119 177.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -119.23 131.97 55.88 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.167 0.987 . . . . 61.15 108.938 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.478 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 60.4 t80 -133.62 99.87 4.62 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.565 -1.272 . . . . 75.34 107.565 177.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -124.63 126.72 46.21 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.713 0.805 . . . . 73.53 108.868 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.421 HG21 HD11 ' D' ' 16' ' ' ILE . 11.0 mt -89.84 122.56 41.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.339 -0.985 . . . . 61.15 108.339 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -95.34 -18.94 20.36 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.37 0.668 . . . . 75.0 111.639 -171.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 179.05 124.28 0.05 Allowed 'General case' 0 C--N 1.359 0.989 0 C-N-CA 122.958 0.503 . . . . 72.34 109.818 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.421 HD11 HG21 ' D' ' 13' ' ' ILE . 3.7 mp -103.54 136.34 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 106.854 -1.536 . . . . 71.4 106.854 167.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -160.6 145.08 14.14 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 123.389 0.43 . . . . 74.34 111.363 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.2 p -84.48 112.3 20.26 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.681 -0.69 . . . . 64.44 109.677 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -79.81 -18.07 51.78 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.664 -0.698 . . . . 64.02 109.377 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.523 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 4.3 t70 -157.51 147.5 20.55 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 124.803 1.241 . . . . 65.44 110.005 175.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.635 HD13 ' HE2' ' C' ' 117' ' ' MET . 69.6 mt -141.99 147.28 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.661 1.584 . . . . 62.22 107.423 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 22' ' ' SER . . . . . 0.646 ' HB3' ' HB2' ' D' ' 77' ' ' GLU . 32.8 t -155.35 144.48 20.88 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.327 1.051 . . . . 64.53 109.266 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.425 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 91.6 t80 -151.96 129.43 11.4 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.37 -1.715 . . . . 75.1 106.37 170.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -134.14 126.98 31.14 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.527 0.731 . . . . 62.32 109.248 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.43 86.41 48.38 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 107.621 -1.251 . . . . 74.24 107.621 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.48 -36.24 15.75 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.721 2.281 . . . . 70.03 112.815 -170.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -110.53 12.32 22.86 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.856 0.862 . . . . 74.45 110.359 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.461 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -20.98 -70.23 0.04 OUTLIER Pre-proline 0 CA--C 1.57 1.714 0 N-CA-C 116.776 2.139 . . . . 65.31 116.776 -169.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.499 ' HB3' HD11 ' C' ' 83' ' ' ILE . 83.0 Cg_endo -76.26 -23.11 12.09 Favored 'Trans proline' 0 C--N 1.38 2.187 0 CA-C-N 123.741 2.372 . . . . 61.51 114.309 -174.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -71.24 -39.34 71.71 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.183 0.993 . . . . 74.35 109.3 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.576 HG21 ' HA ' ' D' ' 73' ' ' ALA . 9.8 p -84.0 -20.6 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.232 0 CA-C-N 114.798 -1.092 . . . . 61.13 111.825 -173.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.406 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 22.8 m-85 -67.22 -19.8 65.59 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 112.198 0.444 . . . . 72.43 112.198 177.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -63.09 -13.45 36.37 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.786 0.834 . . . . 62.44 110.958 176.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -99.18 91.14 4.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.24 1.416 . . . . 73.12 109.804 176.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -88.25 85.45 6.91 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.271 0.558 . . . . 72.23 110.691 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 38.9 p90 -156.91 172.22 19.04 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.001 -1.111 . . . . 75.44 108.001 165.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -68.13 116.75 42.31 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 109.351 -0.611 . . . . 63.52 109.351 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -57.38 131.14 42.92 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.648 2.232 . . . . 74.54 111.752 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 22.5 tt0 -60.02 109.98 1.09 Allowed 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.837 0.711 . . . . 72.21 109.366 175.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.845 HG13 HG13 ' D' ' 64' ' ' VAL . 45.8 t -105.43 115.25 46.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 114.622 -1.172 . . . . 62.55 109.377 -177.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.31 126.36 52.14 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 106.71 -1.589 . . . . 70.34 106.71 170.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.508 HD11 HG13 ' D' ' 62' ' ' VAL . 50.1 tp -97.57 141.92 30.02 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.605 0.762 . . . . 51.34 110.046 -168.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.764 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.5 m-20 -125.05 123.92 40.83 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 107.244 -1.391 . . . . 74.54 107.244 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 88.7 mt -124.37 138.48 54.37 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.173 0.511 . . . . 72.22 111.078 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 9.5 t70 -143.18 155.35 44.52 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.434 1.494 . . . . 64.22 107.685 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 46' ' ' THR . . . . . 0.4 HG23 HG21 ' E' ' 107' ' ' THR . 9.7 t -139.71 153.48 47.24 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-O 121.386 0.612 . . . . 72.32 110.074 174.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.9 170.46 18.76 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 114.588 -1.187 . . . . 63.4 109.005 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.3 p -161.55 -169.47 2.28 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.406 0.682 . . . . 74.05 109.574 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 25.0 p -149.79 126.72 11.16 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.838 -0.801 . . . . 73.03 108.838 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 50' ' ' GLN . . . . . 0.53 ' HB3' ' HB2' ' E' ' 102' ' ' LEU . 11.5 pm0 -72.14 96.12 1.74 Allowed 'General case' 0 C--N 1.348 0.506 0 CA-C-O 121.599 0.714 . . . . 63.33 110.066 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.448 HD12 HG13 ' D' ' 55' ' ' VAL . 1.2 tm? -142.46 104.8 4.46 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 106.025 -1.843 . . . . 71.0 106.025 177.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.452 ' HA ' ' CZ ' ' D' ' 56' ' ' TYR . . . -80.67 -154.96 0.11 Allowed 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 119.075 -0.488 . . . . 72.11 110.775 -175.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 39.0 t70 67.78 28.3 7.2 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.523 1.154 . . . . 73.03 109.226 -171.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.603 ' HB2' ' HA ' ' E' ' 93' ' ' PHE . 12.8 m-20 64.59 17.25 10.79 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 113.466 -1.697 . . . . 73.25 112.914 172.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.448 HG13 HD12 ' D' ' 51' ' ' LEU . 4.1 p -118.0 95.54 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 122.265 1.031 . . . . 73.1 108.95 175.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.452 ' CZ ' ' HA ' ' D' ' 52' ' ' ALA . 96.7 m-85 -117.46 146.56 43.41 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.12 -0.945 . . . . 65.32 109.924 -174.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -102.82 145.41 29.8 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.876 -0.602 . . . . 65.1 110.462 173.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 70.3 t -131.45 141.82 44.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 114.06 -1.427 . . . . 70.53 107.523 172.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.441 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 46.3 t -131.23 132.07 63.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 108.294 -1.002 . . . . 75.33 108.294 176.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.484 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -107.96 117.45 34.16 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 106.632 -1.618 . . . . 71.31 106.632 172.308 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.662 ' HG2' ' HG2' ' D' ' 79' ' ' GLN . 0.0 OUTLIER -101.32 97.23 7.75 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.208 -1.405 . . . . 65.31 107.208 178.312 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.508 HG13 HD11 ' D' ' 42' ' ' LEU . 54.2 t -91.08 144.25 9.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.43 -0.952 . . . . 71.22 108.43 172.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.764 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 52.2 m -138.77 135.89 35.14 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.571 -1.27 . . . . 73.33 107.571 174.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.845 HG13 HG13 ' D' ' 40' ' ' VAL . 94.9 t -117.52 127.11 75.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.976 -0.75 . . . . 73.31 108.976 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 6.0 m -111.49 93.95 4.72 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.16 -1.052 . . . . 72.23 108.16 173.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.567 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -105.29 142.29 35.31 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.002 0.521 . . . . 52.31 111.295 -177.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.505 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 42.0 m -145.52 142.27 29.05 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.153 0.581 . . . . 61.22 110.81 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.512 HD12 HG22 ' D' ' 31' ' ' VAL . 19.4 mt -108.57 109.49 20.73 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.7 -1.222 . . . . 72.02 107.7 170.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.61 -124.39 7.51 Favored Glycine 0 C--N 1.345 1.056 0 O-C-N 123.212 0.32 . . . . 61.32 112.953 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.4 5.61 37.23 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.171 0.588 . . . . 73.52 111.842 -177.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -124.3 155.39 38.75 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.093 0.557 . . . . 74.41 109.986 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 75.7 m -66.32 136.53 55.94 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 122.767 0.427 . . . . 64.4 110.726 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.576 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.51 -64.66 1.11 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.348 -1.352 . . . . 52.23 107.348 174.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -154.96 164.13 39.33 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 114.409 -1.269 . . . . 73.3 110.68 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 62.6 mt -130.12 144.49 51.38 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 105.821 -1.918 . . . . 75.55 105.821 174.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.59 ' SG ' HG23 ' D' ' 114' ' ' ILE . 9.1 t -152.72 106.81 3.11 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 118.812 0.733 . . . . 63.15 110.777 -173.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 77' ' ' GLU . . . . . 0.646 ' HB2' ' HB3' ' D' ' 22' ' ' SER . 10.9 mp0 -122.69 127.82 49.78 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.193 0.997 . . . . 71.53 109.793 -169.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 64.3 t -138.53 121.81 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 122.876 0.47 . . . . 61.02 109.741 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.662 ' HG2' ' HG2' ' D' ' 61' ' ' ARG . 43.2 mt-30 -89.99 88.58 7.36 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 108.965 -0.754 . . . . 71.31 108.965 167.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 80' ' ' GLN . . . . . 0.414 ' O ' HD13 ' D' ' 106' ' ' LEU . 6.9 tp-100 -82.58 94.58 7.54 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.236 -0.893 . . . . 64.13 108.925 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.78 173.06 37.88 Favored Glycine 0 C--O 1.242 0.623 0 CA-C-N 116.141 -0.481 . . . . 63.34 112.432 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.44 148.27 10.95 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.519 -0.34 . . . . 42.14 112.459 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.4 mt -100.44 113.67 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 108.211 -1.033 . . . . 73.22 108.211 175.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -114.24 133.51 55.58 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.969 0.908 . . . . 72.23 109.891 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 35.6 p -96.68 105.44 17.55 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.977 -0.749 . . . . 43.3 108.977 172.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.504 HD11 ' SG ' ' D' ' 102' ' ' CYS . 61.7 mt -117.12 119.23 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.252 1.021 . . . . 54.24 109.25 -173.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.49 ' HA ' ' HB ' ' E' ' 97' ' ' ILE . . . -158.19 125.66 5.1 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.539 0.735 . . . . 53.42 110.569 -176.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' B' ' 150' ' ' GLU . . . 111.93 19.47 7.27 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-O 119.583 -0.565 . . . . 55.4 114.497 170.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.678 HG13 ' SD ' ' D' ' 9' ' ' MET . 0.8 OUTLIER -118.15 149.25 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 108.86 -0.793 . . . . 72.03 108.86 167.413 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -129.33 -179.96 5.44 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.183 0.993 . . . . 73.15 108.664 -171.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.07 -140.44 34.22 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 116.152 -0.477 . . . . 73.51 113.685 173.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 61.4 p -82.0 -33.79 29.93 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.313 0.645 . . . . 72.04 111.038 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -64.65 -26.25 68.31 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.516 0.726 . . . . 71.53 111.891 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.615 ' HA ' HD13 ' D' ' 89' ' ' ILE . 48.2 ttp -46.37 -60.46 2.32 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.913 1.285 . . . . 74.34 112.805 -176.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.68 -14.41 48.58 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.38 0.672 . . . . 62.13 112.248 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 45.2 m170 -72.05 -28.79 63.58 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.926 0.49 . . . . 73.45 110.579 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 70.9 m -62.02 -30.15 70.76 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.158 0.583 . . . . 73.44 111.078 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.2 tt -89.49 -44.98 9.75 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.827 0.851 . . . . 72.01 110.197 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.3 -13.3 74.1 Favored Glycine 0 N--CA 1.472 1.095 0 CA-C-N 115.983 -0.553 . . . . 53.05 114.331 -170.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.7 -53.16 0.81 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 117.314 0.557 . . . . 72.41 111.544 -173.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -68.37 -40.95 81.27 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 112.043 0.386 . . . . 74.33 112.043 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.504 ' SG ' HD11 ' D' ' 86' ' ' ILE . 78.2 m -66.33 -46.13 60.37 Favored Pre-proline 0 CA--C 1.562 1.415 0 CA-C-O 118.447 -0.787 . . . . 65.43 112.655 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.484 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 73.4 Cg_exo -55.08 -37.4 94.02 Favored 'Trans proline' 0 C--N 1.396 3.039 0 C-N-CA 122.152 1.901 . . . . 72.31 112.812 168.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -62.47 -36.86 83.82 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.256 0.622 . . . . 63.44 111.018 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 38.2 mm -69.98 -40.6 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.923 0.889 . . . . 73.33 110.865 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.414 HD13 ' O ' ' D' ' 80' ' ' GLN . 89.4 mt -73.26 -16.89 61.38 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.877 -0.602 . . . . 72.3 111.937 -176.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -68.53 -43.39 30.62 Favored Pre-proline 0 CA--C 1.555 1.168 0 CA-C-O 118.095 -0.955 . . . . 70.43 113.235 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -46.09 -43.42 20.49 Favored 'Trans proline' 0 C--N 1.382 2.322 0 C-N-CA 122.151 1.901 . . . . 55.01 113.897 167.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -77.78 -36.66 50.26 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.64 0.776 . . . . 71.13 111.769 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.84 -50.68 47.95 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.405 0.682 . . . . 64.32 110.127 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.619 HH12 ' HB3' ' D' ' 130' ' ' PRO . 36.5 ttp180 -54.92 -41.81 71.47 Favored 'General case' 0 C--O 1.211 -0.969 0 O-C-N 124.727 1.267 . . . . 75.04 111.02 172.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 112' ' ' GLU . . . . . 0.42 ' CD ' HH12 ' C' ' 120' ' ' ARG . 1.6 tm-20 -56.97 -53.84 53.52 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.161 0.913 . . . . 71.23 111.293 -175.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.0 t -55.02 -41.56 71.5 Favored 'General case' 0 C--N 1.348 0.523 0 O-C-N 124.469 1.106 . . . . 71.3 110.955 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.59 HG23 ' SG ' ' D' ' 76' ' ' CYS . 90.5 mt -64.22 -53.56 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.949 0.9 . . . . 74.03 110.834 177.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 93.2 m -55.45 -39.63 70.58 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.202 1.401 . . . . 71.42 110.375 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.0 t -66.97 -47.52 71.32 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.824 -1.535 . . . . 74.34 110.596 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.422 ' HE2' ' HA ' ' D' ' 114' ' ' ILE . 78.8 mtm -68.4 -25.56 65.11 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.557 0.577 . . . . 74.34 112.557 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' D' ' 126' ' ' LEU . 76.0 t -68.65 -45.8 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.656 0.782 . . . . 74.51 109.294 175.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 72.5 p -73.95 -27.21 60.89 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 115.536 -0.757 . . . . 75.52 110.48 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 78.0 mtt-85 -74.4 -27.3 60.57 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.694 0.798 . . . . 75.21 110.123 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.7 10.22 73.03 Favored Glycine 0 C--N 1.351 1.372 0 O-C-N 123.653 0.595 . . . . 51.12 112.704 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.529 HG23 ' HB3' ' C' ' 17' ' ' TYR . 82.5 p 51.38 37.18 18.38 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.195 1.798 . . . . 71.32 114.203 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -95.99 154.04 39.04 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.148 -0.933 . . . . 72.22 109.345 168.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -49.62 132.53 30.78 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 123.173 2.582 . . . . 74.23 112.517 168.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -50.1 128.45 19.04 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.155 0.982 . . . . 65.13 112.508 -174.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.569 HD13 HG21 ' D' ' 40' ' ' VAL . 21.4 tp -107.68 128.74 54.82 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.938 0.895 . . . . 62.33 109.066 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -129.16 99.78 5.37 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.164 -1.05 . . . . 64.35 108.164 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.492 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 2.8 mm? -64.26 121.18 13.65 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.513 0.725 . . . . 73.34 110.032 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.35 123.0 74.28 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 123.123 0.569 . . . . 64.4 111.179 -176.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.619 ' HB3' HH12 ' D' ' 111' ' ' ARG . 72.2 Cg_endo -76.41 114.77 3.95 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.542 2.161 . . . . 63.5 112.431 -176.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.25 145.22 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.806 0.842 . . . . 63.42 109.355 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -70.38 115.06 9.12 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.341 -0.615 . . . . 73.24 109.341 173.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -64.08 -22.99 67.16 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.801 0.84 . . . . 62.11 111.367 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -54.86 -40.39 69.62 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.861 1.264 . . . . 75.03 111.496 172.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.55 -58.16 9.53 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 123.922 0.764 . . . . 62.41 110.405 177.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 56.6 tp -61.62 -32.87 73.03 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.558 0.743 . . . . 64.24 111.833 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -69.4 -46.23 67.36 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.016 0.927 . . . . 74.32 110.655 -174.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 22.8 ptp -74.69 -33.96 62.55 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.866 -0.606 . . . . 74.14 110.817 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -61.29 -35.94 78.71 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.896 0.479 . . . . 62.01 110.915 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -52.59 -46.62 67.0 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 124.473 1.108 . . . . 62.05 111.381 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.27 -28.22 69.56 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.011 0.524 . . . . 64.15 111.359 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -91.74 -1.18 57.5 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.889 0.876 . . . . 65.45 113.245 -174.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.23 45.63 2.61 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.925 0.869 . . . . 64.02 111.405 -174.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 144' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' D' ' 150' ' ' GLU . 9.9 pt20 -150.75 -177.96 6.29 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.306 -0.861 . . . . 72.3 109.91 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 145' ' ' ALA . . . . . 0.514 ' HA ' ' H ' ' D' ' 150' ' ' GLU . . . -72.14 -29.06 63.67 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.748 0.819 . . . . 74.03 111.395 176.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.8 -77.04 0.97 Allowed Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.544 -0.753 . . . . 72.1 112.275 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -130.58 -21.89 2.76 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.435 1.094 . . . . 64.42 110.573 -177.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -141.4 -80.12 0.06 OUTLIER Glycine 0 C--N 1.351 1.389 0 N-CA-C 112.271 -0.331 . . . . 64.34 112.271 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 10.2 t -161.21 120.63 2.57 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.007 0.923 . . . . 75.3 109.783 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 150' ' ' GLU . . . . . 0.514 ' H ' ' HA ' ' D' ' 145' ' ' ALA . 37.6 mt-10 -140.86 44.71 1.81 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.098 0.959 . . . . 72.11 109.219 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 151' ' ' GLU . . . . . 0.628 ' HG2' ' H ' ' D' ' 152' ' ' HIS . 20.5 tt0 -73.98 -171.53 1.13 Allowed 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 123.369 0.668 . . . . 75.25 110.398 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 152' ' ' HIS . . . . . 0.628 ' H ' ' HG2' ' D' ' 151' ' ' GLU . 73.3 m-70 74.75 85.54 0.1 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.027 1.331 . . . . 72.14 110.258 -171.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -71.29 -57.04 4.85 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 107.409 -1.33 . . . . 72.33 107.409 166.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 61.09 -77.97 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.852 1.661 . . . . 73.13 112.335 173.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.288 0 C-N-CA 124.767 1.227 . . . . 54.34 110.344 -178.525 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 CA-C-O 119.76 -0.467 . . . . 72.33 111.994 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.81 -52.06 4.64 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-N 117.102 0.451 . . . . 31.44 112.495 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 93' ' ' PHE . . . . . 0.603 ' HA ' ' HB2' ' D' ' 54' ' ' ASP . 3.7 m-85 -70.16 94.32 0.89 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.241 0.616 . . . . 55.24 109.46 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 94' ' ' PHE . . . . . 0.403 ' CD1' ' HE2' ' E' ' 95' ' ' LYS . 0.6 OUTLIER -168.8 154.35 6.38 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.845 0.458 . . . . 75.33 112.047 176.116 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 95' ' ' LYS . . . . . 0.447 ' HG2' ' HB3' ' D' ' 4' ' ' GLN . 40.2 mtmt 79.82 -47.56 0.35 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.196 1.798 . . . . 71.42 112.745 171.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.14 101.47 2.18 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.243 -0.743 . . . . 75.33 111.243 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 97' ' ' ILE . . . . . 0.49 ' HB ' ' HA ' ' D' ' 87' ' ' ALA . 4.1 tt -56.35 -44.41 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.392 1.077 . . . . 72.05 111.063 175.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 24.7 t70 65.42 166.14 0.18 Allowed 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 124.488 1.115 . . . . 64.41 112.957 175.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . 65.77 8.91 5.58 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.436 1.494 . . . . 63.02 113.072 177.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 100' ' ' LEU . . . . . . . . . . . . . 37.2 tp -114.77 92.03 28.15 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 124.773 1.229 . . . . 73.34 109.574 -174.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -96.23 3.76 1.99 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.527 2.818 . . . . 71.41 113.36 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 102' ' ' LEU . . . . . 0.53 ' HB2' ' HB3' ' D' ' 50' ' ' GLN . 4.1 mm? 59.96 24.73 13.87 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.476 1.11 . . . . 61.02 111.453 -172.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 43.3 p 58.6 -68.29 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.506 1.922 . . . . 61.01 111.725 -170.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.21 153.35 8.35 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 112.188 -0.365 . . . . 74.1 112.188 173.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.09 47.54 3.29 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.576 1.15 . . . . 74.14 109.586 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 40.6 t80 73.01 165.85 0.3 Allowed 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 124.975 1.31 . . . . 74.53 111.055 173.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 107' ' ' THR . . . . . 0.4 HG21 HG23 ' D' ' 46' ' ' THR . 27.9 m -62.8 127.09 29.63 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.932 0.893 . . . . 71.21 111.566 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -116.54 13.84 15.41 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.041 0.936 . . . . 61.42 110.946 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -101.42 -156.69 0.57 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.171 0.988 . . . . 62.13 110.801 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.54 177.73 0.13 Allowed 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.011 0.924 . . . . 64.51 113.13 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 111' ' ' LEU . . . . . . . . . . . . . 7.6 mp 69.32 -78.79 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.976 1.31 . . . . 60.24 109.49 -169.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -82.11 97.83 8.37 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 109.417 -0.586 . . . . 64.43 109.417 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 113' ' ' LYS . . . . . 0.602 ' HA ' ' HE2' ' E' ' 113' ' ' LYS . 7.5 mmpt? -132.33 50.51 2.23 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.974 0.892 . . . . 71.34 109.686 175.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -64.48 -45.18 88.49 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 113.788 -1.551 . . . . 44.4 109.153 172.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 43.2 p -95.01 93.27 7.29 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.314 -0.995 . . . . 50.45 108.314 167.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 137.8 -179.65 17.99 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 114.84 -1.073 . . . . 75.0 110.793 -174.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -126.15 104.61 25.7 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 123.353 0.661 . . . . 75.05 109.478 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -88.5 172.57 4.82 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.545 2.163 . . . . 72.02 112.763 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -149.57 -176.0 5.23 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.409 1.084 . . . . 75.33 108.451 168.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 36.5 t80 68.22 126.9 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.889 1.276 . . . . 62.22 111.705 175.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 121' ' ' VAL . . . . . . . . . . . . . 79.8 t 62.78 83.08 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.299 1.04 . . . . 62.14 110.21 -173.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 67.7 p -67.66 -39.94 84.53 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.224 -0.898 . . . . 71.11 108.719 169.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 123' ' ' ASP . . . . . 0.412 ' HA ' ' HB3' ' D' ' 42' ' ' LEU . 3.8 p30 -157.67 164.1 37.53 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.126 -1.397 . . . . 71.12 109.882 174.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 74.3 m -138.35 106.63 5.78 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.904 0.882 . . . . 62.1 108.909 173.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -160.1 141.56 12.58 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.836 0.855 . . . . 64.55 109.48 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -158.7 103.66 1.74 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.648 0.779 . . . . 73.25 109.377 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 33.0 p -173.06 162.66 4.61 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.065 0.946 . . . . 63.41 110.437 -178.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -159.43 123.82 3.93 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.439 0.696 . . . . 74.12 110.182 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 50.3 m -151.33 144.0 24.35 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.808 0.843 . . . . 74.42 109.865 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -93.74 155.49 17.21 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.169 -0.678 . . . . 61.44 109.169 167.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 131' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -140.11 79.76 1.73 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.305 0.574 . . . . 73.25 111.04 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 35.9 t -156.22 147.21 22.15 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.615 1.166 . . . . 73.02 108.764 173.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 5.7 p -132.53 -44.13 0.91 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.401 0.68 . . . . 65.43 110.434 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.69 61.58 2.89 Favored Glycine 0 C--N 1.346 1.11 0 N-CA-C 110.902 -0.879 . . . . 55.41 110.902 -171.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 78.7 t -63.07 117.31 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.942 0.897 . . . . 74.4 110.456 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -166.94 79.04 0.21 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.713 0.805 . . . . 74.23 109.385 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 18.2 m -93.38 -38.66 11.35 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.7 -0.482 . . . . 74.33 109.7 174.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -132.01 107.62 8.79 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.494 0.717 . . . . 65.4 110.096 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 57.32 -165.09 0.16 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 124.885 1.274 . . . . 71.23 112.979 172.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 140' ' ' GLY . . . . . 0.673 ' HA3' ' HB2' ' C' ' 12' ' ' GLN . . . 100.9 150.38 24.19 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 116.368 -0.378 . . . . 72.22 113.432 171.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 141' ' ' ALA . . . . . 0.48 ' HB3' ' HB2' ' C' ' 85' ' ' SER . . . -84.78 154.47 22.36 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.837 0.855 . . . . 71.42 110.576 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 1.5 tt -70.27 130.61 42.46 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 106.964 -1.495 . . . . 71.03 106.964 172.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -73.88 73.26 1.25 Allowed Glycine 0 C--N 1.35 1.358 0 O-C-N 123.298 0.374 . . . . 72.05 112.684 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 18.2 m -100.8 128.01 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.323 1.049 . . . . 74.41 109.821 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 119.222 -0.418 . . . . 75.21 110.849 175.756 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.68 0 N-CA-C 112.69 -0.164 . . . . 30.31 112.69 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.07 -83.4 1.18 Allowed Glycine 0 C--N 1.348 1.231 0 N-CA-C 111.758 -0.537 . . . . 65.52 111.758 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -74.02 124.0 25.42 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.564 -0.532 . . . . 63.43 109.564 173.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -107.46 140.1 40.95 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.549 0.74 . . . . 74.43 109.309 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.41 157.3 16.51 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.01 0.524 . . . . 71.42 111.099 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.63 -59.3 0.03 OUTLIER Glycine 0 C--O 1.245 0.814 0 N-CA-C 110.739 -0.944 . . . . 74.34 110.739 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 97' ' ' ILE . . . . . 0.491 HG12 ' O ' ' B' ' 89' ' ' ILE . 19.6 mt -62.7 103.19 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 108.893 -0.78 . . . . 72.41 108.893 172.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -57.57 -48.68 78.69 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.613 0.765 . . . . 34.42 111.57 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -132.67 95.54 3.62 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.504 -0.771 . . . . 74.41 109.73 -175.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 100' ' ' LEU . . . . . . . . . . . . . 46.1 tp -103.06 104.79 42.3 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 123.727 0.811 . . . . 72.45 110.571 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 101' ' ' PRO . . . . . 0.461 ' HB2' ' H ' ' F' ' 103' ' ' THR . 43.1 Cg_endo -100.88 -177.29 0.15 Allowed 'Trans proline' 0 C--N 1.366 1.466 0 C-N-CA 123.011 2.474 . . . . 74.04 112.291 161.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 102' ' ' LEU . . . . . . . . . . . . . 28.1 tp -102.66 7.44 39.85 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.785 0.834 . . . . 75.02 108.827 165.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 103' ' ' THR . . . . . 0.461 ' H ' ' HB2' ' F' ' 101' ' ' PRO . 62.5 p 55.64 36.23 26.79 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 126.335 1.854 . . . . 73.11 111.772 -175.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 124.71 168.58 12.85 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 114.808 -1.087 . . . . 61.04 111.836 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -81.96 129.28 34.73 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.274 0.63 . . . . 73.14 109.351 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 41.4 t80 71.46 157.85 0.18 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.294 1.437 . . . . 72.2 111.343 -175.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 7.3 t -71.05 142.0 50.89 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.473 0.709 . . . . 72.32 110.969 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -70.55 -49.48 47.64 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.696 -0.483 . . . . 71.03 109.696 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -77.3 90.11 3.75 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.449 -0.796 . . . . 75.34 109.009 172.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.68 134.0 50.32 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.256 0.623 . . . . 55.14 110.343 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 mp -80.16 -153.47 0.09 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.814 0.845 . . . . 75.0 110.709 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -67.34 87.28 0.18 Allowed 'General case' 0 C--N 1.356 0.882 0 N-CA-C 109.355 -0.609 . . . . 63.21 109.355 174.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -158.96 87.01 0.84 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.127 0.971 . . . . 74.25 109.127 -176.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 63.8 mttm 57.45 -89.47 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.425 1.49 . . . . 74.42 112.772 172.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 23.5 m -93.92 134.91 35.81 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.131 0.972 . . . . 60.04 110.104 -173.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 136.99 -177.58 19.62 Favored Glycine 0 C--N 1.34 0.79 0 N-CA-C 111.289 -0.724 . . . . 73.0 111.289 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.06 82.81 9.05 Favored Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 109.163 -0.68 . . . . 64.43 109.163 171.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.78 88.21 0.79 Allowed 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.774 2.316 . . . . 74.22 110.144 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -62.0 -47.64 83.88 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.601 1.16 . . . . 64.42 112.57 -175.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 120' ' ' TYR . . . . . 0.455 ' HE2' ' HA ' ' B' ' 131' ' ' VAL . 76.8 t80 -87.39 -56.88 3.17 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.234 1.013 . . . . 74.45 110.842 -171.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 121' ' ' VAL . . . . . 0.501 HG21 HD12 ' B' ' 44' ' ' LEU . 40.6 t -94.43 91.17 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 109.013 -0.736 . . . . 73.31 109.013 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 15.3 t -154.67 -6.26 0.14 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.854 0.862 . . . . 64.12 110.602 175.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -111.64 141.3 45.42 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.751 0.82 . . . . 70.15 110.682 -171.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 26.0 p -82.86 105.23 13.69 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.838 0.855 . . . . 72.02 109.908 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.18 157.57 44.71 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.791 0.836 . . . . 55.33 110.624 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . 62.37 84.27 0.14 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.625 1.17 . . . . 70.2 111.975 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 46.8 m -138.21 128.56 26.11 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.807 0.843 . . . . 73.04 109.186 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.43 167.24 12.11 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.216 0.606 . . . . 62.12 110.29 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 41.2 p -75.21 -172.67 1.78 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.725 0.81 . . . . 73.33 112.097 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.07 162.03 12.27 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 123.943 0.897 . . . . 74.23 112.734 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 131' ' ' TRP . . . . . 0.536 ' HB3' ' HA ' ' B' ' 124' ' ' PRO . 8.2 p90 -94.28 8.87 40.28 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.654 -1.157 . . . . 75.32 111.018 -178.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 15.3 m -50.1 95.35 0.01 OUTLIER 'General case' 0 C--N 1.357 0.898 0 C-N-CA 124.99 1.316 . . . . 72.31 112.433 -169.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 43.2 m -76.59 119.81 20.93 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.557 -1.202 . . . . 73.23 110.493 -176.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.39 -21.99 70.86 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.913 -0.585 . . . . 53.35 113.472 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 55.6 t -66.2 97.38 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 N-CA-C 109.225 -0.657 . . . . 73.1 109.225 173.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -63.94 -53.55 48.48 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.961 0.904 . . . . 74.43 109.755 175.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 137' ' ' THR . . . . . 0.422 HG21 ' HB3' ' F' ' 141' ' ' ALA . 8.9 t -157.69 -171.7 3.66 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 114.656 -1.156 . . . . 65.52 109.035 -177.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -76.19 -167.1 0.7 Allowed 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 124.493 1.117 . . . . 75.33 110.258 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -61.13 110.02 1.26 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.67 0.788 . . . . 72.22 110.47 175.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . 119.33 157.77 10.45 Favored Glycine 0 N--CA 1.472 1.064 0 N-CA-C 111.152 -0.779 . . . . 75.22 111.152 -173.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 141' ' ' ALA . . . . . 0.422 ' HB3' HG21 ' F' ' 137' ' ' THR . . . 62.79 35.48 13.78 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.869 0.868 . . . . 63.31 111.754 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 64.7 tp -61.78 123.58 18.36 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.871 1.268 . . . . 75.52 111.289 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.7 153.92 22.35 Favored Glycine 0 N--CA 1.476 1.324 0 O-C-N 123.231 0.332 . . . . 61.44 113.015 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 6.9 p -164.05 -34.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 124.393 1.077 . . . . 72.15 110.232 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 C--O 1.253 1.261 0 C-N-CA 124.025 0.93 . . . . 71.44 108.71 177.615 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.5 ptm . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 110.026 -0.361 . . . . 72.44 110.026 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -65.34 149.48 49.91 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.063 0.545 . . . . 71.32 110.293 176.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -70.47 -34.83 72.85 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.003 0.921 . . . . 63.05 110.841 -171.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 59.34 35.69 23.25 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 124.43 1.081 . . . . 73.41 110.186 -177.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -68.49 107.54 2.95 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 114.626 -1.17 . . . . 63.02 111.197 -170.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -71.89 127.9 34.04 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.646 -0.706 . . . . 71.25 109.988 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.8 m -101.41 127.01 48.25 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.426 0.69 . . . . 74.51 109.425 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -66.7 -75.22 0.1 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.367 0.667 . . . . 74.22 110.058 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.609 ' HG2' HD12 ' A' ' 89' ' ' ILE . 1.3 tmt? 62.77 142.57 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 125.229 1.412 . . . . 71.11 113.182 177.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.3 m -146.1 134.02 21.35 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.855 0.862 . . . . 72.11 109.261 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -129.01 120.75 26.57 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.006 -1.109 . . . . 74.25 108.006 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -147.65 108.92 4.28 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.472 -0.566 . . . . 74.51 109.472 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.485 ' CD1' HG21 ' A' ' 105' ' ' ILE . 12.6 mt -72.84 123.55 27.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 109.117 -0.698 . . . . 61.33 109.117 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -88.25 -37.55 15.96 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.167 0.587 . . . . 72.53 110.73 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -167.41 141.46 3.66 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 116.269 -0.423 . . . . 74.41 109.903 -173.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.0 mt -130.16 134.85 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 108.277 -1.008 . . . . 74.32 108.277 173.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -163.09 178.17 8.51 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 124.296 0.998 . . . . 74.34 111.434 -170.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -108.55 122.03 46.22 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.949 -0.76 . . . . 71.23 108.949 175.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.481 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 37.2 mtpt -81.38 -25.93 35.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.176 0.59 . . . . 61.31 110.338 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -160.13 152.63 20.96 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.331 -0.849 . . . . 74.12 109.186 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 73.9 mt -144.14 150.82 16.49 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 C-N-CA 125.346 1.458 . . . . 63.34 107.725 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.0 t -155.35 137.5 14.71 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.467 0.707 . . . . 75.12 109.842 173.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.494 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 86.5 t80 -143.67 122.07 12.38 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.402 -1.333 . . . . 74.24 107.402 174.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -124.76 114.72 19.64 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 109.227 -0.657 . . . . 73.44 109.227 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.05 80.75 0.44 Allowed Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 105.919 -1.882 . . . . 64.54 105.919 165.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.99 -29.02 28.28 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.784 2.322 . . . . 53.31 112.59 -162.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -115.86 30.13 7.54 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.864 0.865 . . . . 72.32 108.822 -175.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.457 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -44.8 -58.91 4.7 Favored Pre-proline 0 CA--C 1.569 1.673 0 N-CA-C 114.703 1.371 . . . . 73.4 114.703 -165.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 38.7 Cg_exo -60.34 -31.97 93.46 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 122.06 1.84 . . . . 63.12 113.087 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -81.74 -35.2 29.97 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.308 1.043 . . . . 74.55 112.385 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.837 HG21 ' HA ' ' A' ' 73' ' ' ALA . 6.0 p -79.87 -15.1 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 121.395 0.617 . . . . 64.41 111.718 -171.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -74.9 -12.19 60.3 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 116.089 -0.505 . . . . 73.22 111.482 168.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -83.37 -18.0 40.36 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 124.009 0.923 . . . . 65.03 110.584 171.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.538 ' HE2' ' HB3' ' A' ' 71' ' ' GLU . 26.3 mmmt -79.33 146.19 33.05 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.361 1.065 . . . . 65.14 111.451 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -61.67 128.14 34.84 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.134 0.974 . . . . 65.33 109.74 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.493 ' CE3' HD21 ' A' ' 68' ' ' LEU . 73.5 t-105 -82.21 88.83 6.48 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 121.121 0.486 . . . . 52.32 110.617 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 17.5 tm0? -129.33 84.96 60.62 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 106.205 -1.776 . . . . 74.14 106.205 167.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.07 125.23 10.72 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.475 2.117 . . . . 53.31 112.694 -173.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -97.0 92.95 6.32 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.757 -1.201 . . . . 62.31 107.757 169.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.666 HG11 HD11 ' A' ' 126' ' ' LEU . 88.2 t -94.82 107.63 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.345 0.658 . . . . 62.14 110.98 -175.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -88.13 129.52 35.29 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.361 -0.836 . . . . 73.45 109.415 175.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -95.88 119.33 34.18 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.897 -1.149 . . . . 64.31 107.897 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -130.18 141.6 50.64 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 108.795 -0.817 . . . . 52.34 108.795 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.664 HD11 HG21 ' A' ' 131' ' ' VAL . 56.6 mt -140.36 146.66 38.71 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.663 0.785 . . . . 74.42 110.0 -175.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -154.88 118.32 4.51 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.591 -0.892 . . . . 52.21 108.591 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.0 m -108.59 151.59 25.91 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.696 0.798 . . . . 74.34 110.453 -173.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.686 ' HB2' HH22 ' A' ' 61' ' ' ARG . . . -145.33 154.23 42.1 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.139 0.976 . . . . 72.13 109.886 172.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.419 ' HB3' HD13 ' A' ' 98' ' ' LEU . 4.1 m -112.87 154.68 25.95 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.991 -0.744 . . . . 71.23 108.991 172.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.0 t -149.61 117.57 6.31 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.125 -1.065 . . . . 74.03 108.125 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -79.96 105.14 11.02 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.154 -0.684 . . . . 75.23 109.154 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.608 HD11 ' HB2' ' A' ' 57' ' ' GLU . 45.9 mt -78.96 -35.68 42.73 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.094 0.558 . . . . 73.54 109.616 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.46 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -155.57 175.28 14.1 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.104 0.962 . . . . 60.3 109.848 176.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -65.25 124.98 23.62 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.583 -0.895 . . . . 75.23 108.583 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 66.67 11.32 8.1 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.251 1.42 . . . . 54.12 112.728 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 41.8 t -124.03 107.06 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.401 -0.962 . . . . 73.24 108.401 173.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -119.69 126.11 50.32 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.864 0.866 . . . . 73.35 109.018 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.608 ' HB2' HD11 ' A' ' 51' ' ' LEU . 32.2 tt0 -86.32 146.15 26.61 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.162 -0.681 . . . . 74.4 109.162 167.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.8 t -128.19 133.89 66.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.045 -1.095 . . . . 71.2 108.045 171.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.401 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 46.4 t -115.28 132.53 64.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.256 -0.646 . . . . 74.35 109.256 176.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.04 108.67 18.97 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.639 -0.874 . . . . 75.54 108.639 172.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.686 HH22 ' HB2' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -80.53 99.92 8.31 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 106.489 -1.671 . . . . 74.23 106.489 164.768 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.2 t -96.46 122.01 47.55 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 107.583 -1.266 . . . . 74.22 107.583 172.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.4 m -118.47 137.87 52.88 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 123.91 0.756 . . . . 73.11 109.034 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 77.0 t -140.98 139.05 34.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 125.055 1.342 . . . . 73.32 107.435 -172.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 37.1 m -137.53 130.77 30.77 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 109.411 -0.588 . . . . 72.44 109.411 171.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.489 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -114.68 120.37 39.88 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.298 -1.371 . . . . 72.31 107.298 174.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -125.93 135.45 51.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.392 0.677 . . . . 64.21 110.607 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.535 HD12 HG22 ' A' ' 31' ' ' VAL . 27.4 mt -92.92 84.69 4.96 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.944 1.298 . . . . 64.24 108.8 177.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.41 -100.95 1.45 Allowed Glycine 0 C--N 1.342 0.877 0 CA-C-N 115.267 -0.878 . . . . 64.52 111.782 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.33 -19.62 13.41 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.871 0.868 . . . . 73.45 109.85 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.538 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 10.0 tp10 -94.02 124.69 38.19 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.637 1.175 . . . . 71.15 109.317 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -74.41 134.51 42.4 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.207 0.458 . . . . 73.14 110.963 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.837 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -78.3 -59.31 2.83 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.721 -0.844 . . . . 74.4 108.721 174.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -159.12 161.52 36.35 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.303 -0.862 . . . . 64.52 112.139 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.431 HD12 ' O ' ' A' ' 64' ' ' VAL . 38.7 tp -111.71 148.35 33.64 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.992 1.717 . . . . 54.44 107.645 168.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.55 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 94.6 m -140.97 136.8 32.54 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.273 1.029 . . . . 75.24 109.154 177.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -149.29 137.96 21.05 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.076 -0.713 . . . . 73.15 109.076 172.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.6 t -141.73 115.69 4.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 123.967 0.907 . . . . 71.51 108.91 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.525 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 79.1 mt-30 -83.63 84.43 7.54 Favored 'General case' 0 C--N 1.343 0.31 0 N-CA-C 108.705 -0.85 . . . . 63.02 108.705 170.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.42 ' HG3' HD22 ' A' ' 106' ' ' LEU . 8.5 tp-100 -77.88 92.0 4.22 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.514 -0.921 . . . . 75.44 108.514 177.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -95.03 144.94 17.49 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 110.746 -0.942 . . . . 71.35 110.746 178.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.17 134.35 5.33 Favored Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 111.081 -0.808 . . . . 74.52 111.081 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.9 mt -82.07 124.77 39.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 108.416 -0.957 . . . . 75.33 108.416 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.801 ' HB3' HD11 ' A' ' 86' ' ' ILE . 92.4 m-85 -129.79 121.57 27.09 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.736 0.814 . . . . 65.35 109.029 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.4 t -86.36 103.44 14.93 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.436 -0.95 . . . . 61.11 108.436 174.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.801 HD11 ' HB3' ' A' ' 84' ' ' PHE . 3.5 mm -118.56 149.67 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 109.689 -0.486 . . . . 63.51 109.689 -177.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.53 168.14 25.67 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.061 0.544 . . . . 74.14 110.735 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 95.23 -32.35 6.27 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 116.044 -0.526 . . . . 72.15 113.061 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.609 HD12 ' HG2' ' A' ' 9' ' ' MET . 0.2 OUTLIER -122.21 141.12 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.622 0.769 . . . . 70.3 111.343 -173.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.628 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 21.7 mt-10 -142.37 173.54 11.44 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.54 1.136 . . . . 74.43 110.135 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.5 -125.33 28.68 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-O 119.771 -0.461 . . . . 64.24 112.614 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 77.3 p -76.83 -27.93 55.33 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.342 0.571 . . . . 70.12 110.616 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.562 ' HA ' ' HB ' ' C' ' 149' ' ' THR . 0.8 OUTLIER -58.98 -41.98 88.86 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.588 0.755 . . . . 74.3 109.25 175.379 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.628 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 3.0 tpt -69.98 -42.27 73.33 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 114.662 -1.153 . . . . 75.33 110.986 175.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.42 -25.21 67.06 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.09 0.956 . . . . 74.52 111.901 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -70.67 -49.36 48.11 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.806 0.442 . . . . 63.41 110.364 172.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.44 -37.46 85.93 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 123.177 0.298 . . . . 65.4 110.755 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.419 HD13 ' HB3' ' A' ' 48' ' ' SER . 52.7 mt -91.26 -30.89 16.36 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.032 0.533 . . . . 73.44 112.438 -175.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.95 4.08 33.91 Favored Glycine 0 N--CA 1.476 1.333 0 CA-C-O 119.94 -0.366 . . . . 71.14 113.752 -172.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.468 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -142.85 -61.92 0.43 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 117.006 0.403 . . . . 74.3 111.192 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.41 ' O ' HG12 ' A' ' 105' ' ' ILE . 45.6 t80 -73.63 -46.28 47.79 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 112.17 0.433 . . . . 72.51 112.17 -172.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 47.5 m -64.8 -47.91 73.88 Favored Pre-proline 0 N--CA 1.49 1.539 0 CA-C-O 118.303 -0.856 . . . . 75.21 112.465 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.17 -21.11 67.74 Favored 'Trans proline' 0 C--N 1.39 2.72 0 C-N-CA 121.805 1.67 . . . . 54.1 112.786 173.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -75.41 -33.0 60.93 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.866 0.466 . . . . 74.12 109.856 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.485 HG21 ' CD1' ' A' ' 13' ' ' ILE . 48.4 mm -69.93 -41.49 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.381 0.672 . . . . 61.43 109.753 171.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.42 HD22 ' HG3' ' A' ' 80' ' ' GLN . 66.1 mt -72.04 -30.51 65.24 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.654 0.781 . . . . 73.04 111.807 -175.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -61.01 -40.51 74.77 Favored Pre-proline 0 N--CA 1.488 1.431 0 N-CA-C 114.401 1.259 . . . . 74.52 114.401 -171.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -51.57 -42.99 53.26 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.071 1.847 . . . . 75.13 113.462 168.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -75.83 -35.7 59.89 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.269 0.628 . . . . 65.45 111.045 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.81 -48.38 71.9 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.734 0.813 . . . . 73.33 109.52 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.539 ' NH1' HD12 ' C' ' 105' ' ' ILE . 27.8 ttm105 -51.46 -52.15 48.86 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 125.05 1.469 . . . . 75.41 110.289 174.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -62.6 -45.98 90.41 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.61 1.194 . . . . 64.24 111.78 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.533 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.3 t -60.88 -36.98 80.61 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 123.872 0.733 . . . . 34.42 110.759 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.493 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.6 mt -67.94 -47.2 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.127 0.971 . . . . 72.52 110.439 174.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.434 HG21 ' HE2' ' C' ' 109' ' ' TYR . 35.7 m -59.37 -39.29 82.81 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.621 1.168 . . . . 75.45 111.27 -177.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -68.68 -44.12 74.7 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.364 -1.289 . . . . 64.2 110.224 -176.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.483 ' HG3' ' O ' ' A' ' 113' ' ' CYS . 25.6 mtm -60.48 -39.43 87.61 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.987 0.515 . . . . 45.2 110.831 177.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 114' ' ' ILE . 71.6 t -63.19 -47.85 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.296 1.038 . . . . 74.32 111.424 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.8 p -71.52 -33.36 69.13 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 116.147 -0.478 . . . . 73.0 111.178 -176.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.47 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 90.0 mtt-85 -67.96 -33.28 74.35 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.739 0.816 . . . . 65.52 109.742 173.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.446 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.14 15.12 40.67 Favored Glycine 0 C--N 1.352 1.417 0 CA-C-N 115.437 -0.801 . . . . 32.1 113.37 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.6 t 62.0 9.47 3.07 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 127.281 2.232 . . . . 71.15 114.016 173.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -81.33 138.79 48.32 Favored Pre-proline 0 C--O 1.244 0.793 0 N-CA-C 107.672 -1.232 . . . . 73.51 107.672 172.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.509 ' HB3' ' H ' ' E' ' 132' ' ' SER . 54.1 Cg_exo -53.98 142.53 64.57 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.75 2.3 . . . . 75.31 112.154 176.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -49.41 130.72 20.25 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.539 1.136 . . . . 71.34 113.779 -164.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.666 HD11 HG11 ' A' ' 40' ' ' VAL . 36.6 tp -109.27 108.62 19.28 Favored 'General case' 0 C--N 1.345 0.384 0 C-N-CA 123.169 0.588 . . . . 70.14 110.441 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.576 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 88.8 m-20 -103.26 125.76 50.08 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 107.699 -1.223 . . . . 74.03 107.699 175.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.47 ' H ' ' HG3' ' A' ' 111' ' ' ARG . 17.8 mt -72.85 144.59 47.4 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 117.735 0.243 . . . . 65.21 110.809 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.532 ' HB1' ' HB2' ' E' ' 138' ' ' TYR . . . -70.74 133.49 86.48 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.105 0.562 . . . . 64.14 110.089 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.53 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 32.3 Cg_exo -59.97 114.4 2.07 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.576 2.85 . . . . 62.31 113.604 -173.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.664 HG21 HD11 ' A' ' 44' ' ' LEU . 45.6 t -100.23 135.64 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.372 0.669 . . . . 71.03 110.017 -177.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -101.84 89.93 3.83 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.207 -1.034 . . . . 75.44 108.207 175.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.496 ' CE1' HD13 ' A' ' 44' ' ' LEU . 44.5 m-85 -63.82 -30.79 71.84 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.814 0.846 . . . . 64.22 111.568 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.523 ' O ' ' HB2' ' A' ' 138' ' ' MET . 6.4 m-20 -66.08 -33.35 75.58 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.347 -0.842 . . . . 43.31 110.476 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.76 -42.25 64.23 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.155 0.582 . . . . 70.11 110.491 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.12 -49.07 79.26 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.521 0.677 . . . . 63.04 110.59 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -64.93 -36.62 84.97 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.142 -1.39 . . . . 71.15 110.071 177.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.523 ' HB2' ' O ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -69.02 -34.81 75.84 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 119.011 -0.518 . . . . 71.1 110.39 -176.887 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -54.74 -40.17 69.02 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.095 0.474 . . . . 72.5 110.791 176.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -68.12 -48.77 64.53 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.955 -1.02 . . . . 64.42 110.496 172.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.464 ' HB3' ' HA ' ' A' ' 138' ' ' MET . 51.8 tp -61.94 -56.07 22.97 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.894 0.878 . . . . 73.52 112.675 -168.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 87.0 mt-30 -168.78 -17.25 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.614 0 C-N-CA 124.875 1.27 . . . . 74.13 110.748 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.459 ' N ' ' SD ' ' A' ' 138' ' ' MET . 19.7 tt0 72.06 -5.86 1.64 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 126.761 2.024 . . . . 75.42 112.795 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -149.98 110.56 4.25 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.052 0.541 . . . . 71.34 110.699 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -179.64 150.82 0.42 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.75 1.62 . . . . 71.24 108.181 171.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.547 ' HA2' ' H ' ' C' ' 3' ' ' GLU . . . 162.58 52.24 0.02 OUTLIER Glycine 0 C--N 1.347 1.156 0 C-N-CA 120.783 -0.722 . . . . 74.51 114.119 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.12 133.22 29.55 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.002 0.521 . . . . 61.41 109.847 176.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 135.3 30.14 0.36 Allowed Glycine 0 C--N 1.345 1.039 0 CA-C-N 115.479 -0.782 . . . . 72.5 111.427 -173.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.61 ' HA ' ' HB3' ' C' ' 145' ' ' ALA . 59.4 p -80.95 105.88 12.52 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.248 0.619 . . . . 72.24 109.906 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -153.61 135.76 14.8 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.64 0.776 . . . . 61.14 109.709 176.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -103.4 152.85 21.13 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.888 -0.782 . . . . 74.51 108.888 167.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.83 7.99 1.1 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.478 1.111 . . . . 74.54 110.301 176.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.452 ' HG2' ' H ' ' A' ' 155' ' ' ALA . 28.3 tt0 -175.29 129.08 0.28 Allowed 'General case' 0 C--N 1.356 0.876 0 C-N-CA 124.397 1.079 . . . . 73.02 108.528 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -84.73 7.08 21.76 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.127 0.571 . . . . 51.1 111.9 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.452 ' H ' ' HG2' ' A' ' 153' ' ' GLN . . . . . . . . 0 C--O 1.251 1.154 0 C-N-CA 125.592 1.557 . . . . 74.32 110.662 -175.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 110.184 -0.302 . . . . 73.24 110.184 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 33.6 m -64.33 -25.35 68.0 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.027 0.931 . . . . 72.11 112.379 -174.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.48 ' HG2' ' HB2' ' B' ' 5' ' ' ASN . 38.9 tt0 -76.51 111.5 12.05 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.939 -0.763 . . . . 72.51 108.939 174.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -70.69 -56.08 7.25 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.448 0.699 . . . . 63.0 109.257 176.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ASN . . . . . 0.48 ' HB2' ' HG2' ' B' ' 3' ' ' GLU . 37.4 t30 60.29 20.2 9.68 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 125.518 1.527 . . . . 53.13 112.537 176.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -72.71 104.49 3.96 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.652 0.781 . . . . 74.23 110.417 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 32.1 p -75.84 136.16 40.2 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.591 -0.731 . . . . 73.11 111.146 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -115.15 107.59 15.51 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.777 -1.194 . . . . 74.13 107.777 173.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.554 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 19.6 ptm 50.47 -167.45 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.949 1.699 . . . . 54.34 111.976 -172.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 5.5 t -153.09 138.99 18.06 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 109.147 -0.686 . . . . 71.44 109.147 166.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.539 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 68.9 t80 -134.28 137.74 44.5 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.13 0.972 . . . . 75.32 108.418 176.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -144.51 141.28 29.41 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.991 0.516 . . . . 55.32 109.938 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 66.9 mt -88.86 110.01 20.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 107.699 -1.223 . . . . 74.5 107.699 171.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -81.8 -39.1 24.57 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 123.282 0.364 . . . . 72.41 110.322 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -169.3 134.71 1.55 Allowed 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.304 0.377 . . . . 74.41 110.384 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.0 mt -114.97 142.58 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 107.247 -1.39 . . . . 70.41 107.247 171.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.434 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 40.1 p90 -169.81 162.67 9.59 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-O 122.045 0.926 . . . . 74.24 113.127 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 56.7 m -90.04 121.18 31.88 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 113.414 -1.721 . . . . 74.11 108.585 171.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.434 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 22.7 mtpp -87.29 -32.43 19.69 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.724 0.81 . . . . 73.42 110.52 178.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -158.52 143.49 16.25 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.022 -0.536 . . . . 74.44 110.89 -170.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 45.9 mm -136.3 142.88 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.466 1.506 . . . . 72.15 109.093 176.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 24.1 t -145.56 134.66 22.73 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.521 -1.218 . . . . 74.31 107.907 168.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.484 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 91.2 t80 -138.71 128.08 24.41 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.421 -1.696 . . . . 74.31 106.421 169.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -135.47 112.02 9.96 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.913 -1.143 . . . . 74.13 107.913 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.576 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -108.83 87.34 4.42 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 107.144 -1.428 . . . . 71.41 107.144 171.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.86 -42.01 21.48 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.654 2.236 . . . . 70.33 111.298 -174.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -97.39 5.77 49.28 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.726 -1.125 . . . . 71.2 111.65 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.576 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -29.81 -67.78 0.13 Allowed Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 115.428 1.64 . . . . 72.04 115.428 -166.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.481 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 21.3 Cg_endo -60.43 -28.49 86.84 Favored 'Trans proline' 0 C--N 1.397 3.106 0 C-N-CA 122.605 2.203 . . . . 53.13 113.03 -171.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -95.86 -39.76 9.66 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.981 -1.009 . . . . 63.41 111.996 -171.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.445 HG22 HD12 ' B' ' 68' ' ' LEU . 10.5 p -69.47 -11.76 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.22 0.608 . . . . 70.12 111.419 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -63.39 -13.18 36.95 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.269 0.628 . . . . 75.43 112.65 172.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -68.84 -13.07 62.18 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 123.874 0.87 . . . . 73.42 112.077 175.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.581 ' HB2' HD13 ' B' ' 68' ' ' LEU . 32.8 mmtp -97.41 92.71 6.09 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.494 1.118 . . . . 74.13 109.813 -174.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -92.81 80.44 4.68 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.364 0.665 . . . . 74.53 110.914 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 37.3 p90 -165.07 177.53 7.68 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.056 0.942 . . . . 64.1 110.123 170.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.581 ' HG3' ' HB3' ' F' ' 128' ' ' ALA . 42.7 tt0 -69.12 116.65 44.17 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 123.677 0.791 . . . . 61.23 109.667 173.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.431 ' HD3' ' HG2' ' B' ' 124' ' ' PRO . 34.2 Cg_endo -68.28 148.77 74.91 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 121.704 1.602 . . . . 72.31 110.727 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -71.19 104.07 2.98 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.776 -1.194 . . . . 74.35 107.776 172.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.524 HG11 HD11 ' B' ' 126' ' ' LEU . 32.9 t -98.09 141.51 16.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 114.705 -1.134 . . . . 71.22 109.568 -177.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -118.75 114.53 22.84 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.405 -1.702 . . . . 72.22 106.405 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.587 HD13 HD22 ' B' ' 128' ' ' LEU . 17.8 tp -89.15 132.21 34.93 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.238 -0.652 . . . . 73.32 109.238 174.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -129.41 148.2 51.3 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.871 1.268 . . . . 70.32 108.398 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.528 HD13 HD23 ' F' ' 111' ' ' LEU . 0.6 OUTLIER -142.77 151.53 41.32 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.643 0.777 . . . . 75.42 110.469 -178.43 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 19.8 t70 -148.11 139.37 23.45 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.654 1.182 . . . . 64.14 108.252 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.5 m -113.5 115.37 27.89 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.732 -0.84 . . . . 61.22 108.732 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.62 134.31 55.16 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.632 -0.877 . . . . 62.33 108.632 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.673 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 16.4 m -142.76 160.24 40.71 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.849 -0.426 . . . . 65.42 109.849 -175.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 29.5 p -166.63 136.9 3.21 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.678 0.791 . . . . 75.14 110.379 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -85.96 79.64 9.14 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 108.242 -1.021 . . . . 72.33 108.242 172.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.426 HD21 ' HB3' ' B' ' 57' ' ' GLU . 2.7 pp -93.1 6.57 47.49 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.506 -0.77 . . . . 73.31 111.02 -177.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.405 ' HB3' HG23 ' B' ' 55' ' ' VAL . . . -162.65 154.61 18.48 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.77 1.228 . . . . 74.3 108.773 173.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -75.75 129.19 36.68 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.646 0.378 . . . . 74.02 110.726 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 70.62 -3.12 2.01 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.957 1.303 . . . . 73.34 113.55 173.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.405 HG23 ' HB3' ' B' ' 52' ' ' ALA . 30.7 m -134.65 122.9 40.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.013 -1.106 . . . . 61.22 108.013 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.673 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 0.1 OUTLIER -99.34 156.76 16.83 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.654 0.782 . . . . 63.33 109.424 -177.087 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.426 ' HB3' HD21 ' B' ' 51' ' ' LEU . 4.5 tm-20 -121.41 97.43 5.51 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 105.728 -1.953 . . . . 72.22 105.728 166.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 12.5 p -100.56 141.76 16.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.768 -0.827 . . . . 75.1 108.768 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.436 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 18.4 t -115.57 148.25 18.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 124.944 1.298 . . . . 73.15 108.645 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 60.1 tp -128.36 107.06 9.44 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.477 -0.935 . . . . 75.53 108.477 171.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.468 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 31.3 ttm180 -86.64 132.72 33.81 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.151 -1.055 . . . . 73.53 108.151 172.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 38.9 t -129.46 124.65 60.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 107.243 -1.391 . . . . 75.43 107.243 175.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 6.3 m -120.78 131.06 54.28 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.378 -0.601 . . . . 72.41 109.378 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.663 HG11 HD21 ' B' ' 126' ' ' LEU . 89.6 t -119.41 108.41 23.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 123.905 0.882 . . . . 65.32 109.335 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 93.9 m -90.21 138.4 31.56 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.346 -0.983 . . . . 71.53 108.346 167.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.25 142.47 26.13 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.234 -0.654 . . . . 74.1 109.234 175.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.429 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 17.0 p -144.28 134.69 24.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.367 -0.833 . . . . 55.33 109.973 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.581 HD13 ' HB2' ' B' ' 34' ' ' LYS . 62.9 mt -101.19 113.89 27.35 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.577 1.151 . . . . 73.15 110.072 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.18 -112.02 3.62 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-N 115.686 -0.688 . . . . 65.45 111.548 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.58 27.62 6.85 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.396 0.679 . . . . 63.3 109.795 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -141.23 153.27 45.17 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.192 -0.67 . . . . 73.52 109.192 176.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 56.8 m -68.17 135.2 51.71 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.225 0.536 . . . . 51.33 110.855 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.429 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -88.26 -66.01 0.96 Allowed 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.41 -1.33 . . . . 75.14 107.41 174.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -150.27 159.29 44.55 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 114.881 -1.054 . . . . 73.41 110.267 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 78.4 mt -134.07 108.53 8.39 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.396 -1.705 . . . . 74.01 106.396 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.1 t -119.82 151.53 38.7 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.104 -0.702 . . . . 71.04 109.104 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -159.23 134.39 8.29 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.511 -0.922 . . . . 71.24 108.511 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' B' ' 113' ' ' CYS . 85.4 t -128.99 143.92 39.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.997 -1.112 . . . . 74.13 107.997 175.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -122.94 96.18 4.91 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.382 -0.97 . . . . 62.02 108.382 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -91.12 102.38 15.13 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.284 -0.636 . . . . 75.23 109.284 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -94.9 165.84 25.81 Favored Glycine 0 C--N 1.339 0.749 0 O-C-N 123.58 0.55 . . . . 41.44 112.138 177.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.9 134.6 3.27 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-O 119.772 -0.46 . . . . 71.41 113.314 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.413 HD12 ' HE1' ' B' ' 17' ' ' TYR . 3.9 mp -86.12 117.82 31.47 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 107.226 -1.398 . . . . 70.21 107.226 170.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -121.84 135.94 54.92 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.592 0.757 . . . . 73.53 109.112 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 56.1 m -89.34 126.26 35.46 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.785 0.834 . . . . 72.22 109.254 173.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.569 ' HB ' HD11 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -133.65 130.3 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.079 0.951 . . . . 72.41 108.468 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.67 ' HA ' ' HB ' ' F' ' 97' ' ' ILE . . . -157.67 171.98 19.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.505 0.722 . . . . 50.22 110.645 177.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.554 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 87.18 -50.13 4.07 Favored Glycine 0 C--N 1.352 1.437 0 C-N-CA 123.608 0.623 . . . . 52.42 111.949 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.569 HD11 ' HB ' ' B' ' 86' ' ' ILE . 11.3 pt -59.08 148.08 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.981 1.313 . . . . 45.31 111.81 171.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -153.19 163.31 40.11 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.837 0.855 . . . . 71.33 109.595 -176.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.35 -121.73 6.22 Favored Glycine 0 C--N 1.351 1.371 0 C-N-CA 123.358 0.504 . . . . 53.43 112.847 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 18.8 m -73.58 -39.71 64.44 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.883 0.849 . . . . 74.2 109.909 174.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -66.68 -27.11 67.39 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 113.623 -1.626 . . . . 71.41 111.96 -167.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.677 ' HB2' HD11 ' F' ' 97' ' ' ILE . 9.6 ptm -65.95 -57.71 7.22 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.675 -0.693 . . . . 74.04 111.661 -175.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.23 -14.51 57.42 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.352 0.661 . . . . 44.23 111.89 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -61.12 -40.28 93.18 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.735 0.814 . . . . 71.31 110.906 169.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.1 t -66.36 -54.27 26.47 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.705 0.402 . . . . 72.41 111.29 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.472 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.2 pp -68.34 -25.38 65.07 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.855 0.462 . . . . 72.44 112.167 -176.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.89 2.88 58.5 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-O 119.649 -0.528 . . . . 65.34 114.2 -175.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.564 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -148.73 -55.06 0.19 Allowed 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 117.56 0.68 . . . . 65.45 112.136 -174.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -70.56 -43.34 69.7 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.426 0.69 . . . . 74.34 111.146 -176.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.539 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 56.5 m -72.86 -43.27 8.12 Favored Pre-proline 0 CA--C 1.566 1.586 0 CA-C-O 118.621 -0.704 . . . . 55.41 112.784 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.0 -30.52 93.62 Favored 'Trans proline' 0 C--N 1.396 3.058 0 C-N-CA 122.229 1.953 . . . . 73.02 113.906 170.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.15 -37.66 77.85 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.567 0.747 . . . . 72.23 111.503 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 54.9 mt -65.11 -39.08 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.882 0.873 . . . . 73.12 110.782 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.19 -23.06 54.64 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.152 -0.931 . . . . 64.24 112.215 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -60.66 -47.17 96.73 Favored Pre-proline 0 CA--C 1.567 1.606 0 N-CA-C 114.281 1.215 . . . . 75.54 114.281 -174.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -53.86 -41.74 72.25 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 122.517 2.145 . . . . 65.35 114.106 175.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -68.98 -42.17 76.91 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.4 0.68 . . . . 74.12 110.754 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.05 98.92 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.321 -0.854 . . . . 31.43 110.774 177.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -61.35 -49.69 75.95 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.469 1.108 . . . . 70.32 110.763 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -67.3 -32.67 73.81 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.149 0.58 . . . . 72.12 110.19 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.509 ' O ' ' HG2' ' B' ' 117' ' ' MET . 9.1 t -71.11 -38.49 72.34 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 122.879 0.472 . . . . 73.43 111.082 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.415 HD13 HG23 ' B' ' 64' ' ' VAL . 81.8 mt -62.25 -56.77 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 123.684 0.794 . . . . 65.14 109.712 173.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 19.7 m -63.08 -24.74 68.04 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.763 0.825 . . . . 72.12 111.371 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.455 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.9 t -63.62 -52.45 60.79 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 109.265 -0.642 . . . . 74.33 109.265 171.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.9 mmt -66.67 -32.49 73.84 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.42 0.688 . . . . 61.15 111.357 -176.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.463 HG21 HD22 ' B' ' 126' ' ' LEU . 93.3 t -69.78 -40.28 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.073 0.949 . . . . 71.35 110.672 175.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 40.4 t -67.26 -32.07 72.84 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.304 -0.862 . . . . 72.14 110.367 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.533 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 77.8 mtt-85 -68.66 -34.6 75.99 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 115.478 -0.783 . . . . 65.42 109.851 176.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.01 -17.95 80.23 Favored Glycine 0 C--N 1.351 1.39 0 O-C-N 123.544 0.528 . . . . 52.23 112.483 170.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 18.0 m 66.93 31.23 7.23 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 123.153 1.454 . . . . 74.11 110.193 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.432 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 41.5 m-85 -78.02 167.26 37.25 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-N 114.099 -1.41 . . . . 75.42 111.168 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.646 ' HB3' ' HA ' ' F' ' 130' ' ' ALA . 50.4 Cg_exo -45.23 145.12 3.74 Favored 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 123.366 2.711 . . . . 72.12 114.566 170.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.406 ' HB2' ' H ' ' C' ' 125' ' ' GLN . 9.3 tp-100 -60.09 118.38 6.24 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.083 0.953 . . . . 72.11 111.301 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.663 HD21 HG11 ' B' ' 64' ' ' VAL . 12.0 tp -110.03 119.46 39.38 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.358 1.063 . . . . 62.51 108.727 -175.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -125.0 127.85 47.64 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.265 -1.013 . . . . 61.52 108.265 174.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.587 HD22 HD13 ' B' ' 42' ' ' LEU . 43.6 mt -86.55 143.29 27.76 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.022 0.529 . . . . 73.54 110.639 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.67 132.51 94.09 Favored Pre-proline 0 CA--C 1.548 0.889 0 O-C-N 124.085 0.866 . . . . 54.1 111.014 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.26 89.34 0.32 Allowed 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.085 2.524 . . . . 65.4 111.595 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.55 113.55 26.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 CA-C-O 121.535 0.683 . . . . 61.34 109.501 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -82.44 107.85 15.41 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.665 -1.235 . . . . 72.42 107.665 171.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -67.74 -24.89 65.41 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.508 0.723 . . . . 63.11 110.294 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.564 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 25.6 t70 -62.28 -41.95 98.93 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.999 -1.001 . . . . 74.12 110.737 171.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.43 -25.68 68.12 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.911 0.757 . . . . 65.05 111.803 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.417 ' HG ' HD12 ' F' ' 111' ' ' LEU . 1.0 OUTLIER -61.84 -55.43 29.95 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.761 -0.829 . . . . 75.3 108.761 176.854 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -74.82 -26.27 59.59 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.715 0.806 . . . . 63.5 111.493 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 15.7 tpt -75.55 -36.34 60.47 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.188 0.595 . . . . 74.42 110.247 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.496 ' HA ' ' HB2' ' B' ' 142' ' ' GLN . 14.6 m120 -80.77 -29.59 36.16 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.943 0.497 . . . . 73.0 110.234 175.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -73.15 -25.98 61.02 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.857 0.463 . . . . 72.11 110.914 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 18.2 tp -118.61 28.91 8.04 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-O 121.576 0.703 . . . . 60.33 109.771 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 142' ' ' GLN . . . . . 0.496 ' HB2' ' HA ' ' B' ' 139' ' ' ASN . 47.0 tt0 -72.18 -12.94 61.4 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.719 0.807 . . . . 33.35 111.789 -177.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -54.71 -29.2 52.55 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.919 0.887 . . . . 74.41 110.835 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -95.02 106.26 18.24 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.78 -0.822 . . . . 70.23 108.78 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -152.07 159.01 43.78 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.493 1.117 . . . . 64.24 108.756 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -162.33 6.44 0.08 OUTLIER Glycine 0 N--CA 1.471 1.029 0 CA-C-O 119.851 -0.416 . . . . 75.02 114.099 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -112.86 91.4 3.64 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.386 0.675 . . . . 73.01 109.66 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -90.47 179.77 43.48 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 115.292 -0.867 . . . . 33.43 111.054 173.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 22.1 p -136.55 126.14 25.32 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.29 0.636 . . . . 73.43 110.505 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -92.64 156.4 17.11 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.316 1.046 . . . . 72.01 109.378 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 151' ' ' GLU . . . . . 0.673 ' HB2' ' HB2' ' D' ' 6' ' ' ASN . 40.8 tt0 -115.7 126.65 54.37 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.059 -0.719 . . . . 63.42 109.059 172.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -147.08 54.57 1.09 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 105.803 -1.925 . . . . 61.32 105.803 172.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -70.55 115.5 9.79 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-N 115.325 -0.852 . . . . 64.12 110.516 -172.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -67.21 -32.92 74.31 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.631 -1.168 . . . . 71.52 109.968 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.225 0 C-N-CA 124.692 1.197 . . . . 62.43 107.88 171.797 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.9 ttm . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 109.277 -0.638 . . . . 44.33 109.277 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 16.5 p -91.95 88.61 6.66 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 108.906 -0.776 . . . . 73.45 108.906 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 3' ' ' GLU . . . . . 0.547 ' H ' ' HA2' ' A' ' 146' ' ' GLY . 32.6 mm-40 -103.62 163.25 12.43 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.866 0.466 . . . . 75.21 111.162 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -108.18 126.72 53.12 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.563 -0.903 . . . . 64.52 108.563 167.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -144.59 143.32 30.74 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.563 0.745 . . . . 74.21 109.696 -172.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -98.8 132.92 43.79 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 109.007 -0.738 . . . . 74.11 109.007 174.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 20.3 p -77.45 -54.19 6.73 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.486 1.114 . . . . 73.21 110.78 -176.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' C' ' 9' ' ' MET . 0.0 OUTLIER -149.53 -74.69 0.17 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.533 0.733 . . . . 71.13 109.985 171.046 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.566 ' HE2' HG21 ' C' ' 89' ' ' ILE . 56.8 ttm 50.43 113.6 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.255 1.822 . . . . 74.12 112.917 -174.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 86.3 m -83.94 76.4 10.04 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.009 -1.108 . . . . 53.54 108.009 173.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.53 ' HD2' ' HG2' ' A' ' 130' ' ' PRO . 28.9 t80 -102.85 119.63 39.18 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.335 -1.357 . . . . 73.31 107.335 176.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -137.97 133.35 33.58 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.206 -1.035 . . . . 54.24 108.206 172.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.485 HD13 HD11 ' C' ' 16' ' ' ILE . 17.3 mt -77.82 126.86 38.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 108.739 -0.838 . . . . 63.43 108.739 174.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.412 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 13.4 mm100 -82.05 -53.36 6.17 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.259 -1.015 . . . . 73.34 108.259 173.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.576 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -172.96 146.84 1.57 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.648 0.779 . . . . 74.12 110.471 178.323 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.485 HD11 HD13 ' C' ' 13' ' ' ILE . 72.5 mt -116.68 132.84 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.202 1.401 . . . . 74.41 107.586 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.442 ' HB3' HG23 ' D' ' 122' ' ' THR . 39.5 p90 -161.62 156.52 23.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.372 0.606 . . . . 63.34 112.105 -164.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 42.4 p -88.18 107.65 18.89 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.511 -0.768 . . . . 54.34 109.572 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.41 ' HG2' ' CE1' ' C' ' 17' ' ' TYR . 20.6 mtmt -74.32 -29.26 61.53 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.495 -0.557 . . . . 74.42 109.495 172.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.603 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 30.7 t70 -150.21 140.91 22.65 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.309 -0.86 . . . . 55.51 110.16 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 93.7 mt -137.37 144.81 30.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 125.562 1.545 . . . . 62.42 106.943 173.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -150.26 145.51 26.24 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 123.595 0.559 . . . . 75.03 109.624 173.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -151.52 116.77 5.3 Favored 'General case' 0 C--O 1.225 -0.21 0 N-CA-C 107.987 -1.116 . . . . 75.54 107.987 171.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -121.64 121.47 37.45 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.077 0.951 . . . . 72.11 108.547 176.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.17 87.6 6.22 Favored Pre-proline 0 C--O 1.239 0.525 0 N-CA-C 106.275 -1.75 . . . . 75.04 106.275 169.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.06 -21.65 36.46 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.631 2.221 . . . . 72.23 111.828 -168.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -125.65 31.18 5.57 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.201 1.0 . . . . 74.2 109.742 -177.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.24 -61.0 2.02 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 114.644 1.35 . . . . 53.13 114.644 -169.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.11 -34.73 45.29 Favored 'Trans proline' 0 C--N 1.382 2.337 0 CA-C-N 121.848 1.696 . . . . 73.14 112.268 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -69.0 -36.7 78.12 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.773 -1.103 . . . . 75.11 111.837 -176.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.593 ' HA ' ' HZ2' ' C' ' 34' ' ' LYS . 14.5 p -80.71 -28.67 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 112.863 0.69 . . . . 75.15 112.863 -176.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -63.71 -31.42 72.59 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.718 0.407 . . . . 71.14 111.984 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -88.12 12.48 13.52 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.419 1.088 . . . . 54.15 111.803 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.63 ' HZ3' ' HG2' ' C' ' 71' ' ' GLU . 10.2 ttpp -126.73 160.39 30.96 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.046 0.938 . . . . 75.01 111.434 -174.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -51.25 122.66 8.09 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.539 1.536 . . . . 74.2 112.435 178.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -86.13 82.56 8.02 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.622 0.725 . . . . 72.31 109.523 170.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -135.79 76.6 53.15 Favored Pre-proline 0 N--CA 1.472 0.662 0 N-CA-C 107.528 -1.286 . . . . 45.31 107.528 169.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -83.88 152.43 12.92 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.641 2.227 . . . . 61.25 111.703 -175.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -86.41 113.32 22.27 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.419 -1.326 . . . . 64.04 107.419 171.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.539 HG11 HG13 ' F' ' 135' ' ' VAL . 39.4 t -74.36 96.69 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.615 -0.883 . . . . 51.33 108.615 -177.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.476 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 14.2 mptt -101.04 101.47 12.24 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 106.33 -1.73 . . . . 74.52 106.33 168.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pp -105.64 162.88 13.13 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.823 0.449 . . . . 75.01 110.065 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.634 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 4.7 t70 -148.08 135.32 20.43 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.103 0.961 . . . . 63.34 108.878 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 45.5 mt -131.86 110.98 11.2 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.123 -1.066 . . . . 63.32 108.123 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -131.77 128.31 38.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.961 -1.125 . . . . 74.21 107.961 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -126.68 140.9 52.06 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 109.444 -0.576 . . . . 74.34 109.444 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.54 142.63 33.53 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.38 0.672 . . . . 70.14 109.81 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 20.4 m -124.34 148.5 47.44 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.331 0.653 . . . . 43.45 110.776 -175.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 21.4 p -147.38 127.11 13.41 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.134 0.974 . . . . 63.54 108.881 176.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -78.84 120.44 23.47 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.108 -0.701 . . . . 74.24 109.108 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' C' ' 57' ' ' GLU . 33.7 mt -84.07 -44.56 13.95 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.766 0.826 . . . . 73.2 109.89 -176.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.93 -174.52 4.82 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.255 -0.884 . . . . 41.22 109.789 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.44 111.52 1.42 Allowed 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.84 0.712 . . . . 71.44 110.417 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 64.91 17.09 10.89 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.763 1.225 . . . . 55.33 112.471 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.77 113.65 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.151 -1.055 . . . . 71.02 108.151 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -122.54 126.36 47.62 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.153 0.981 . . . . 64.0 109.706 -173.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.499 ' HB2' HD11 ' C' ' 51' ' ' LEU . 43.4 tt0 -89.36 132.82 34.78 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.792 -0.818 . . . . 64.05 108.792 167.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 90.5 t -122.68 137.28 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.582 -1.266 . . . . 62.4 107.582 168.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.14 133.07 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.17 -0.678 . . . . 72.12 109.17 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.15 98.98 8.12 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.403 -1.332 . . . . 75.24 107.403 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -83.2 106.53 15.07 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.932 -0.766 . . . . 64.43 108.932 171.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 16.4 t -103.32 129.42 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 108.175 -1.046 . . . . 62.52 108.175 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.634 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 22.6 m -119.0 139.97 50.8 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.674 -0.862 . . . . 64.1 108.674 176.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.633 HG21 HG21 ' C' ' 114' ' ' ILE . 91.6 t -129.58 120.44 50.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 124.097 0.959 . . . . 65.52 108.792 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.494 HG23 HD23 ' C' ' 75' ' ' LEU . 2.0 m -115.4 109.21 17.54 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.182 -1.044 . . . . 71.02 108.182 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.44 105.52 15.67 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.945 -1.131 . . . . 30.32 107.945 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 43.0 m -131.16 128.82 40.84 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.797 -0.446 . . . . 51.12 109.797 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.413 HD12 ' HG2' ' C' ' 71' ' ' GLU . 16.0 mt -86.96 35.79 0.7 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.617 1.167 . . . . 72.15 110.379 -177.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.27 -112.36 2.79 Favored Glycine 0 C--N 1.346 1.084 0 N-CA-C 110.523 -1.031 . . . . 55.35 110.523 -169.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -90.97 -26.26 19.33 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.44 0.696 . . . . 74.04 110.78 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 71' ' ' GLU . . . . . 0.63 ' HG2' ' HZ3' ' C' ' 34' ' ' LYS . 14.4 tp10 -68.87 118.49 11.88 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.334 -0.848 . . . . 74.24 109.095 170.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 94.9 m -87.49 120.5 28.86 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.82 -0.808 . . . . 74.33 108.82 165.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.97 -50.92 44.83 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.823 -1.08 . . . . 71.32 108.545 177.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -165.11 168.35 17.35 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 114.043 -1.435 . . . . 53.01 111.048 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.494 HD23 HG23 ' C' ' 65' ' ' THR . 2.6 tm? -127.46 140.9 51.85 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 106.269 -1.752 . . . . 74.41 106.269 166.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 51.2 t -142.83 148.39 37.0 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.656 -0.868 . . . . 74.32 108.656 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -157.81 140.13 14.45 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.708 -0.478 . . . . 71.14 109.708 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.408 HG11 ' HA ' ' C' ' 110' ' ' ALA . 68.9 t -136.13 115.04 15.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 124.462 1.105 . . . . 44.21 108.518 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.603 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.7 mt-30 -91.75 88.6 6.74 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.74 -0.837 . . . . 73.11 108.74 169.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -80.12 96.69 6.59 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.031 -0.986 . . . . 63.11 109.083 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.51 153.3 30.04 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 111.185 -0.766 . . . . 54.53 111.185 175.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.83 123.78 1.38 Allowed Glycine 0 CA--C 1.498 -1.011 0 N-CA-C 110.722 -0.951 . . . . 50.43 110.722 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.502 HD11 ' HB3' ' D' ' 29' ' ' PRO . 32.1 mm -89.96 130.48 39.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 108.758 -0.83 . . . . 63.25 108.758 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -132.03 119.35 20.91 Favored 'General case' 0 C--O 1.241 0.651 0 O-C-N 124.191 0.932 . . . . 75.54 108.49 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 21.1 p -79.36 100.48 7.62 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.656 -1.238 . . . . 71.02 107.656 171.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.431 HD13 ' SG ' ' C' ' 97' ' ' CYS . 25.2 mt -115.2 129.58 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.226 0.61 . . . . 73.21 109.612 -175.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.521 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -146.42 168.04 22.14 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.443 0.697 . . . . 72.53 110.315 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.76 -32.15 6.3 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 115.324 -0.853 . . . . 35.01 112.634 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.566 HG21 ' HE2' ' C' ' 9' ' ' MET . 37.9 pt -106.97 164.06 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.16 0.584 . . . . 70.22 111.791 -173.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -154.17 163.5 40.01 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.112 0.965 . . . . 64.23 109.189 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.97 -126.54 9.66 Favored Glycine 0 C--N 1.351 1.374 0 O-C-N 123.364 0.415 . . . . 63.3 113.923 168.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 67.2 p -69.58 -29.74 67.36 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.504 0.721 . . . . 74.04 111.223 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -63.82 -52.21 61.22 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.655 0.782 . . . . 73.4 110.157 175.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.509 ' HE3' ' HA ' ' C' ' 94' ' ' MET . 4.6 tpt -53.53 -50.88 64.5 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 124.318 1.011 . . . . 72.4 111.904 173.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.35 -40.02 92.73 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.162 0.585 . . . . 74.24 111.829 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -70.6 -34.09 71.76 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.197 0.999 . . . . 73.33 111.087 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.431 ' SG ' HD13 ' C' ' 86' ' ' ILE . 38.5 t -69.86 -37.12 76.01 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.764 -0.653 . . . . 60.14 109.896 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 90.8 mt -84.69 -32.32 23.63 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.299 1.04 . . . . 75.24 112.297 -176.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.52 11.38 28.19 Favored Glycine 0 N--CA 1.475 1.234 0 CA-C-O 119.785 -0.453 . . . . 73.04 114.102 -170.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.28 -51.58 0.11 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 117.372 0.586 . . . . 73.11 111.662 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -72.99 -49.88 26.43 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.32 0.248 . . . . 63.02 111.006 -175.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.432 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 86.0 m -64.68 -49.33 70.49 Favored Pre-proline 0 CA--C 1.561 1.39 0 CA-C-O 118.244 -0.884 . . . . 73.21 112.251 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.432 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 49.1 Cg_exo -58.75 -27.71 84.45 Favored 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 122.655 2.237 . . . . 65.02 113.547 174.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -64.51 -39.7 94.26 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.462 0.705 . . . . 55.03 110.415 174.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.539 HD12 ' NH1' ' A' ' 111' ' ' ARG . 29.2 mm -75.46 -35.73 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 O-C-N 123.267 0.355 . . . . 73.4 110.177 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 87.8 mt -74.41 -31.67 62.4 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.563 0.745 . . . . 71.23 112.223 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -55.83 -49.96 89.88 Favored Pre-proline 0 N--CA 1.484 1.26 0 CA-C-O 117.465 -1.255 . . . . 73.55 114.346 -173.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.63 -37.79 95.67 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.425 2.083 . . . . 72.1 113.445 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.434 ' HE2' HG21 ' A' ' 115' ' ' THR . 52.4 m-85 -67.6 -44.27 78.49 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.624 0.77 . . . . 74.54 110.247 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.408 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -64.9 -38.69 91.81 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.963 -1.017 . . . . 70.24 110.66 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -65.04 -46.06 82.83 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.385 1.474 . . . . 63.44 110.449 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.94 -38.45 79.47 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.586 -0.734 . . . . 52.13 109.402 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 32.1 t -65.35 -36.2 83.29 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.955 0.502 . . . . 60.44 111.663 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.633 HG21 HG21 ' C' ' 64' ' ' VAL . 96.3 mt -68.85 -57.95 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.218 0.607 . . . . 74.23 110.054 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 10.8 m -65.26 -27.69 68.83 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 122.792 0.437 . . . . 71.11 111.277 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.419 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 40.8 t -64.12 -48.87 74.41 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.359 0.664 . . . . 44.42 109.242 170.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.548 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.03 -38.44 76.22 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.428 1.091 . . . . 73.22 112.351 177.876 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.462 HG23 ' O ' ' C' ' 114' ' ' ILE . 91.8 t -69.75 -38.44 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.019 0.928 . . . . 73.33 110.105 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 28.5 t -71.56 -27.66 63.32 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.37 1.068 . . . . 61.44 111.729 174.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' C' ' 116' ' ' SER . 76.4 mtt-85 -73.63 -40.96 63.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.582 0.753 . . . . 43.44 109.09 178.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.27 1.0 66.27 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.365 -0.834 . . . . 72.14 112.505 170.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.439 HG21 ' O ' ' D' ' 16' ' ' ILE . 30.8 p 62.25 29.25 17.36 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.505 1.922 . . . . 64.23 113.588 170.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -80.29 151.18 72.12 Favored Pre-proline 0 C--O 1.246 0.882 0 N-CA-C 107.704 -1.221 . . . . 74.11 107.704 168.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.485 ' HG3' ' HB ' ' F' ' 129' ' ' THR . 31.4 Cg_exo -57.04 150.76 54.22 Favored 'Trans proline' 0 C--N 1.366 1.457 0 C-N-CA 122.015 1.81 . . . . 53.15 111.393 172.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' B' ' 123' ' ' PHE . 8.5 mm100 -45.8 129.8 9.29 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.551 1.157 . . . . 62.15 112.274 -175.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 38.3 tp -136.09 86.78 2.25 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.026 -1.472 . . . . 74.42 107.026 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -92.6 122.36 34.95 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.934 -1.03 . . . . 72.21 109.267 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.57 121.88 17.32 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 108.749 -0.834 . . . . 74.44 108.749 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.14 140.66 97.95 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 123.717 0.807 . . . . 73.33 110.917 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.8 108.64 0.43 Allowed 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.603 2.202 . . . . 73.41 112.759 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 26.3 t -99.9 122.0 51.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.386 -0.968 . . . . 52.11 108.386 173.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 132' ' ' ASN . . . . . 0.425 ' O ' ' HG ' ' C' ' 136' ' ' LEU . 56.7 t-20 -75.0 104.53 5.62 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.377 1.071 . . . . 74.33 110.297 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -66.65 -27.05 67.37 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.835 0.854 . . . . 72.21 112.687 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -66.87 -39.44 87.54 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.565 0.746 . . . . 72.25 110.201 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.04 92.66 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.7 -0.682 . . . . 73.44 110.708 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' C' ' 132' ' ' ASN . 71.5 mt -68.17 -32.79 73.29 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.368 0.667 . . . . 62.01 111.051 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -76.87 -22.49 53.39 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.03 -0.532 . . . . 73.33 109.917 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.401 ' SD ' ' HG3' ' C' ' 142' ' ' GLN . 13.7 tpt -76.35 -35.45 58.72 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 109.858 -0.423 . . . . 74.24 109.858 173.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -64.33 -35.52 81.13 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.249 0.62 . . . . 72.43 110.536 168.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -69.85 -86.86 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.273 0.629 . . . . 71.34 110.355 174.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 4.5 tt -166.65 99.55 0.58 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.888 0.475 . . . . 64.11 110.191 -175.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.401 ' HG3' ' SD ' ' C' ' 138' ' ' MET . 24.3 pt20 -165.46 -166.81 1.03 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.61 1.164 . . . . 75.32 108.864 166.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -139.15 95.28 2.92 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.725 -0.842 . . . . 63.35 108.725 170.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -112.84 125.94 54.9 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.811 0.845 . . . . 62.13 111.02 -175.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 145' ' ' ALA . . . . . 0.61 ' HB3' ' HA ' ' A' ' 149' ' ' THR . . . -175.61 105.36 0.08 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.31 1.444 . . . . 72.32 108.042 171.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -141.7 55.93 0.59 Allowed Glycine 0 C--N 1.348 1.217 0 N-CA-C 113.579 0.192 . . . . 42.14 113.579 -170.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -150.17 103.16 3.15 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.03 0.532 . . . . 65.51 110.121 172.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -150.16 41.38 0.81 Allowed Glycine 0 C--N 1.343 0.959 0 N-CA-C 109.97 -1.252 . . . . 73.52 109.97 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 149' ' ' THR . . . . . 0.562 ' HB ' ' HA ' ' A' ' 93' ' ' GLN . 97.9 m -62.62 114.39 3.55 Favored 'General case' 0 C--O 1.216 -0.68 0 C-N-CA 125.62 1.568 . . . . 75.22 113.678 -169.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.29 157.59 36.0 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 120.946 0.403 . . . . 75.3 111.036 175.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.92 -18.67 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.92 1.288 . . . . 74.42 109.848 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 43.2 m80 73.35 67.85 0.11 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.083 1.753 . . . . 72.45 112.047 173.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -86.25 175.58 8.39 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.245 -0.889 . . . . 74.23 110.829 170.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -83.7 146.39 28.24 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 115.132 -0.94 . . . . 71.14 108.622 172.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.984 0 C-N-CA 123.644 0.777 . . . . 74.14 111.111 -175.353 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 51.6 mtp . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 107.603 -1.258 . . . . 70.32 107.603 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 17.5 m -59.41 -54.12 50.38 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.941 0.896 . . . . 71.21 111.464 -175.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.96 75.59 6.33 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.335 -0.848 . . . . 73.41 110.359 -171.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.27 152.96 19.28 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 108.284 -1.006 . . . . 64.14 108.284 171.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -77.72 165.31 24.38 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.321 0.582 . . . . 73.22 111.827 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 6' ' ' ASN . . . . . 0.673 ' HB2' ' HB2' ' B' ' 151' ' ' GLU . 65.5 t30 -72.64 158.17 36.15 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.893 -1.049 . . . . 61.54 110.029 174.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 12.4 t -136.07 -179.84 5.91 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 123.441 0.696 . . . . 61.21 109.933 -175.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.29 112.83 4.75 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 107.953 -1.129 . . . . 63.12 107.953 175.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.561 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 0.0 OUTLIER -33.59 124.06 0.43 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.73 1.612 . . . . 61.31 113.416 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 8.2 t -132.24 158.09 42.68 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.994 0.918 . . . . 70.03 109.965 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.57 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 62.6 t80 -152.14 103.99 2.93 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.209 -1.404 . . . . 73.21 107.209 -177.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 12' ' ' GLN . . . . . 0.521 ' HB2' ' HB3' ' D' ' 85' ' ' SER . 38.2 mt-30 -112.77 114.0 26.35 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.345 -0.983 . . . . 74.41 108.345 -175.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.496 HG21 HD11 ' D' ' 16' ' ' ILE . 53.9 mt -77.91 125.13 37.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.489 -0.93 . . . . 64.43 108.489 175.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -88.77 -41.66 12.39 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 123.844 0.715 . . . . 74.35 109.861 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -177.43 136.91 0.2 Allowed 'General case' 0 N--CA 1.481 1.1 0 O-C-N 123.436 0.46 . . . . 74.11 110.864 -169.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.496 HD11 HG21 ' D' ' 13' ' ' ILE . 4.1 mp -110.98 142.72 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 107.193 -1.41 . . . . 74.53 107.193 169.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -166.35 163.42 17.51 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.868 0.842 . . . . 72.52 111.768 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 59.3 p -97.65 116.14 29.29 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.797 -1.092 . . . . 74.34 108.929 176.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.455 ' HD2' ' HA3' ' D' ' 81' ' ' GLY . 41.1 mtpt -85.39 -26.98 26.11 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.822 -0.807 . . . . 71.45 108.822 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.666 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 26.7 t70 -152.75 142.71 22.2 Favored 'General case' 0 C--N 1.35 0.597 0 C-N-CA 124.397 1.079 . . . . 71.52 109.749 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.548 HG21 ' HE2' ' C' ' 117' ' ' MET . 55.9 mt -141.96 145.65 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.865 1.266 . . . . 71.54 108.45 175.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -148.15 141.0 24.71 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.765 1.226 . . . . 44.51 109.384 174.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 23' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -144.81 129.45 18.1 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.319 -1.363 . . . . 63.03 107.319 167.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -137.44 111.56 8.42 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 123.98 0.912 . . . . 73.21 108.895 -171.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.19 86.08 1.91 Allowed Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 108.055 -1.091 . . . . 63.5 108.055 174.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -68.19 -35.67 18.67 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.808 2.338 . . . . 72.41 113.333 -165.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.486 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 50.1 m-20 -107.26 15.62 24.86 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.896 0.878 . . . . 54.2 110.813 -174.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.469 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -27.0 -71.19 0.05 OUTLIER Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 116.459 2.022 . . . . 54.34 116.459 -160.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.502 ' HB3' HD11 ' C' ' 83' ' ' ILE . 93.9 Cg_endo -74.12 -24.18 15.08 Favored 'Trans proline' 0 C--N 1.378 2.086 0 CA-C-N 123.491 2.283 . . . . 65.1 113.936 -172.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -73.1 -40.96 64.56 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.649 0.78 . . . . 70.13 109.776 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.608 HG22 HD12 ' D' ' 68' ' ' LEU . 7.6 p -79.37 -26.58 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.506 -0.77 . . . . 72.12 111.609 -170.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -61.45 -23.69 66.03 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 122.797 0.439 . . . . 65.41 112.16 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -67.21 -9.07 36.51 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.698 1.199 . . . . 71.03 112.009 -177.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -97.73 98.47 9.89 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.996 1.319 . . . . 73.12 110.182 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -88.78 88.44 7.6 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.792 0.837 . . . . 70.41 110.826 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 22.0 p90 -167.08 -177.99 3.98 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.103 0.961 . . . . 74.52 109.715 170.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -80.58 115.31 54.36 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 123.551 0.74 . . . . 70.51 109.471 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.38 142.68 97.92 Favored 'Trans proline' 0 C--N 1.386 2.501 0 C-N-CA 123.028 2.486 . . . . 72.44 112.379 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 14.0 mm-40 -67.18 106.46 2.02 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 107.531 -1.285 . . . . 72.11 107.531 171.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.625 HG13 HG13 ' D' ' 64' ' ' VAL . 62.4 t -106.17 116.09 49.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 O-C-N 123.729 0.643 . . . . 72.34 109.797 -178.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -98.98 152.64 19.58 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.642 -0.708 . . . . 45.34 109.569 169.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.444 HD11 HG13 ' D' ' 62' ' ' VAL . 31.9 tp -126.63 134.52 50.74 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.967 -1.015 . . . . 73.14 109.759 -173.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.551 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 13.2 t70 -130.35 113.77 14.77 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.415 -1.328 . . . . 74.22 107.415 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.709 HD12 HG23 ' E' ' 121' ' ' VAL . 94.3 mt -118.56 129.14 55.17 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.22 0.608 . . . . 70.33 109.438 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.436 ' HA ' ' HB2' ' E' ' 111' ' ' LEU . 8.5 t70 -160.03 155.76 25.86 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.633 -0.877 . . . . 73.32 108.633 172.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 46' ' ' THR . . . . . 0.499 HG22 ' HA ' ' D' ' 60' ' ' LEU . 30.4 p -123.61 168.64 12.37 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 122.167 0.984 . . . . 74.24 113.035 -170.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.13 143.97 26.33 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 113.465 -1.698 . . . . 60.22 107.208 173.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 37.2 p -144.65 152.88 41.11 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 120.58 0.229 . . . . 72.33 111.322 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 58.1 p -179.32 142.2 0.18 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.746 1.218 . . . . 74.03 109.603 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 50' ' ' GLN . . . . . 0.456 ' HB3' ' H ' ' D' ' 51' ' ' LEU . 0.7 OUTLIER -174.87 -98.02 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.27 1.028 . . . . 71.13 108.292 166.17 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.456 ' H ' ' HB3' ' D' ' 50' ' ' GLN . 84.6 mt -143.05 128.03 18.44 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.306 1.043 . . . . 73.1 109.291 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.33 78.03 0.74 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.764 0.825 . . . . 62.52 110.752 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 53' ' ' ASP . . . . . 0.515 ' HB3' ' H ' ' E' ' 92' ' ' GLY . 22.8 t70 -174.73 49.27 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.072 -1.455 . . . . 61.44 107.072 -176.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' D' ' 85' ' ' SER . 6.0 m-20 63.08 24.23 14.37 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.162 -1.381 . . . . 75.03 112.932 172.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.414 ' O ' ' HB3' ' D' ' 50' ' ' GLN . 58.8 t -134.87 102.16 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 107.635 -1.246 . . . . 74.45 107.635 177.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -135.33 135.06 40.47 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.039 0.535 . . . . 75.31 109.856 -174.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.514 ' HG2' HG12 ' D' ' 83' ' ' ILE . 42.3 mt-10 -87.14 115.02 24.25 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.882 -1.155 . . . . 64.04 107.882 167.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 70.6 t -97.58 136.22 29.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 106.797 -1.557 . . . . 70.12 106.797 171.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.426 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.1 t -128.41 123.76 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 108.239 -1.023 . . . . 73.33 108.239 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.499 ' HA ' HG22 ' D' ' 46' ' ' THR . 0.2 OUTLIER -103.31 121.21 42.27 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.824 -1.176 . . . . 60.51 107.824 176.189 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -100.53 105.99 17.47 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.237 -1.394 . . . . 61.5 107.237 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.444 HG13 HD11 ' D' ' 42' ' ' LEU . 59.1 t -99.99 120.43 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 N-CA-C 108.234 -1.025 . . . . 73.35 108.234 176.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 28.2 m -120.84 140.13 52.2 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.872 -0.788 . . . . 72.43 108.872 -177.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.625 HG13 HG13 ' D' ' 40' ' ' VAL . 77.3 t -131.37 130.36 62.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 115.398 -0.819 . . . . 74.15 109.914 -173.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 10.2 m -119.84 93.03 3.93 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.409 -0.96 . . . . 70.03 108.409 172.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.509 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -100.53 146.34 27.21 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.191 0.596 . . . . 63.13 110.037 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.521 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 23.5 p -153.89 127.93 8.97 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 112.815 0.672 . . . . 64.2 112.815 -169.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.608 HD12 HG22 ' D' ' 31' ' ' VAL . 80.0 mt -96.31 102.24 14.0 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.667 0.787 . . . . 70.24 109.121 174.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.84 -132.66 11.74 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 116.286 -0.415 . . . . 72.04 112.389 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.51 2.85 56.45 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.752 0.421 . . . . 71.33 111.038 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -114.94 158.31 22.19 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.362 -0.607 . . . . 71.2 109.362 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 91.6 m -75.33 139.14 42.25 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.083 0.553 . . . . 72.13 110.722 178.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.607 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.04 -62.32 1.51 Allowed 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.548 -1.279 . . . . 74.44 107.548 175.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -158.41 149.53 20.75 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.784 -1.098 . . . . 75.41 110.864 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 74.9 mt -116.75 120.8 39.7 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.689 1.596 . . . . 72.01 107.412 174.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.532 ' SG ' HG23 ' D' ' 114' ' ' ILE . 38.9 t -131.97 137.34 47.87 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.855 -0.424 . . . . 70.44 109.855 -174.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 77' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' D' ' 62' ' ' VAL . 38.5 tt0 -154.24 130.84 10.67 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.702 0.401 . . . . 72.42 110.984 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 78' ' ' VAL . . . . . 0.413 HG22 HG23 ' D' ' 21' ' ' ILE . 96.2 t -134.31 121.59 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.048 0.939 . . . . 71.52 109.487 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.666 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.7 mt-30 -90.2 86.35 6.5 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.677 -0.86 . . . . 71.44 108.677 169.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -80.36 101.29 8.89 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.217 -1.356 . . . . 65.13 109.073 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.455 ' HA3' ' HD2' ' D' ' 19' ' ' LYS . . . -96.85 161.07 21.78 Favored Glycine 0 N--CA 1.464 0.544 0 N-CA-C 112.479 -0.249 . . . . 70.53 112.479 178.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.03 140.72 6.63 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.729 -0.549 . . . . 74.14 111.729 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.514 HG12 ' HG2' ' D' ' 57' ' ' GLU . 50.1 mt -89.2 123.23 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.547 -1.279 . . . . 54.02 107.547 175.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -125.24 151.06 46.41 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.929 0.891 . . . . 71.45 109.768 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.521 ' HB3' ' HB2' ' D' ' 12' ' ' GLN . 33.7 t -113.19 103.76 11.66 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.324 -0.991 . . . . 71.31 108.324 173.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.63 HG22 HD11 ' D' ' 89' ' ' ILE . 3.1 mp -108.4 119.33 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 107.607 -1.257 . . . . 72.23 107.607 -176.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.33 168.69 24.59 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 123.645 0.591 . . . . 71.21 112.276 -172.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 77.83 22.59 68.82 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 115.307 -0.86 . . . . 53.21 112.957 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.63 HD11 HG22 ' D' ' 86' ' ' ILE . 0.5 OUTLIER -135.62 156.67 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.04 1.336 . . . . 55.01 108.401 176.218 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -152.08 163.85 38.47 Favored 'General case' 0 CA--C 1.561 1.379 0 N-CA-C 107.96 -1.126 . . . . 43.23 107.96 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.19 -134.31 13.65 Favored Glycine 0 C--N 1.349 1.279 0 C-N-CA 123.545 0.593 . . . . 51.51 111.971 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 13.1 m -81.89 -25.13 35.26 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 117.964 0.882 . . . . 75.32 110.625 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -66.99 -19.04 65.65 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.634 1.174 . . . . 74.44 112.898 -174.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.512 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 0.0 OUTLIER -81.06 -43.41 19.55 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.618 0.599 . . . . 75.12 112.618 -176.348 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 95' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -78.73 -15.31 58.61 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.046 0.539 . . . . 54.22 110.614 177.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -58.9 -46.89 86.81 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.63 1.172 . . . . 71.42 110.734 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 97' ' ' CYS . . . . . 0.406 ' HB2' HG21 ' D' ' 86' ' ' ILE . 51.3 m -72.23 -31.12 65.55 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.577 0.751 . . . . 73.5 111.538 -177.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.417 HD12 HG23 ' E' ' 103' ' ' THR . 2.3 tm? -64.51 -52.5 57.49 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.678 1.191 . . . . 70.32 109.457 177.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.78 -25.43 62.6 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 115.364 -0.835 . . . . 72.32 114.054 -173.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.9 -55.4 2.42 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 117.621 0.71 . . . . 65.13 112.25 -170.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -74.54 -39.76 62.14 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 111.799 0.296 . . . . 73.22 111.799 -171.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.57 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 73.8 m -63.47 -47.4 83.53 Favored Pre-proline 0 CA--C 1.569 1.708 0 CA-C-O 118.762 -0.637 . . . . 63.25 112.273 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.489 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 50.3 Cg_exo -59.72 -31.86 94.8 Favored 'Trans proline' 0 C--N 1.396 3.048 0 C-N-CA 122.656 2.237 . . . . 72.53 113.546 169.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -67.23 -28.84 68.4 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.279 0.631 . . . . 73.34 110.746 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.9 mm -74.12 -40.94 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.482 0.713 . . . . 73.32 110.227 172.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 88.3 mt -73.72 -24.92 59.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.367 0.667 . . . . 75.52 112.548 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -64.56 -44.69 75.33 Favored Pre-proline 0 N--CA 1.485 1.284 0 N-CA-C 113.766 1.024 . . . . 72.3 113.766 -171.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -55.1 -38.85 93.27 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 121.946 1.764 . . . . 74.15 113.17 173.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -73.77 -37.38 65.03 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.528 0.731 . . . . 51.12 111.074 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.62 -46.01 73.76 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.912 0.885 . . . . 73.13 110.759 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -73.8 -30.84 62.97 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-N 115.08 -0.963 . . . . 61.31 110.781 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -64.45 -46.52 82.74 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 124.105 0.878 . . . . 71.14 109.809 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.1 t -55.68 -44.84 77.7 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 124.14 0.9 . . . . 64.01 110.405 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.532 HG23 ' SG ' ' D' ' 76' ' ' CYS . 72.1 mt -62.99 -50.22 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.859 0.864 . . . . 64.44 111.064 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 63.0 m -55.27 -47.08 76.0 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.08 0.952 . . . . 64.33 110.781 -175.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.4 t -62.57 -42.18 99.39 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 113.778 -1.555 . . . . 62.44 109.967 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.2 mtm -70.18 -31.89 69.57 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.194 0.597 . . . . 71.43 112.047 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.505 HG23 ' O ' ' D' ' 114' ' ' ILE . 76.4 t -67.74 -42.67 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.659 0.784 . . . . 73.04 110.058 176.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.5 p -73.15 -28.05 62.02 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-N 115.628 -0.715 . . . . 65.53 110.449 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' C' ' 17' ' ' TYR . 68.8 mtt-85 -70.65 -30.41 67.02 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.426 0.69 . . . . 61.34 109.601 172.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.93 11.61 66.41 Favored Glycine 0 C--N 1.353 1.477 0 CA-C-O 119.54 -0.589 . . . . 61.12 113.587 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.442 HG23 ' HB3' ' C' ' 17' ' ' TYR . 74.2 p 58.07 21.77 8.25 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 126.122 1.769 . . . . 74.02 114.365 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -90.55 155.92 45.67 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 109.409 -0.589 . . . . 72.22 109.409 171.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.3 137.86 71.86 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 122.902 2.402 . . . . 71.1 112.076 173.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -49.35 122.17 5.82 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.05 1.34 . . . . 74.15 112.215 -175.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.436 ' HB3' HG21 ' D' ' 118' ' ' VAL . 37.7 tp -107.64 99.54 9.02 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.423 0.689 . . . . 74.11 110.431 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -99.33 104.59 16.49 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 106.956 -1.498 . . . . 75.11 106.956 172.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.428 HD21 HG21 ' D' ' 114' ' ' ILE . 3.0 mm? -62.9 129.25 39.61 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.038 -0.727 . . . . 73.53 109.038 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.27 134.11 90.78 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 123.854 0.862 . . . . 60.41 111.533 -170.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -68.47 111.11 2.44 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.758 2.306 . . . . 60.15 111.85 -174.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.8 m -107.99 142.25 21.14 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 CA-C-O 121.218 0.532 . . . . 62.12 109.603 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -86.42 111.66 20.73 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 107.916 -1.142 . . . . 54.3 107.916 174.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.436 ' HA ' HD13 ' D' ' 136' ' ' LEU . 60.1 m-85 -68.14 -18.19 64.56 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.269 0.628 . . . . 70.11 112.532 -174.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -63.71 -39.75 95.08 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.705 0.402 . . . . 72.31 110.127 171.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.3 -21.51 66.73 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.004 0.921 . . . . 64.35 111.79 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.574 HD23 ' HB3' ' E' ' 111' ' ' LEU . 7.3 mp -74.85 -28.24 60.59 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.801 0.84 . . . . 71.34 110.883 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -90.97 -32.12 16.08 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.734 0.413 . . . . 75.41 110.689 176.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 73.1 mtm -70.51 -22.62 62.61 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.201 0.6 . . . . 63.22 109.933 170.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.492 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 2.8 t-20 -58.62 -41.64 86.4 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 123.789 0.836 . . . . 74.32 110.137 173.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -59.31 -39.44 83.05 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 124.146 0.904 . . . . 74.33 110.709 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.1 mp -73.81 -35.35 64.86 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.596 0.758 . . . . 53.14 111.531 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 142' ' ' GLN . . . . . 0.492 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 21.1 pt20 -89.23 26.69 1.57 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.315 0.578 . . . . 72.2 111.231 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -117.1 51.7 1.0 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 107.469 -1.308 . . . . 43.44 107.469 172.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.72 113.81 7.68 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 104.946 -2.242 . . . . 74.33 104.946 176.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.44 90.56 0.38 Allowed 'General case' 0 CA--C 1.542 0.635 0 O-C-N 123.771 0.67 . . . . 73.44 110.719 -171.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.59 -124.85 5.48 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 115.432 -0.804 . . . . 73.33 111.381 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -151.77 156.69 40.76 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.402 0.681 . . . . 74.12 110.797 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -173.78 -179.0 44.14 Favored Glycine 0 C--O 1.24 0.523 0 CA-C-N 114.442 -1.253 . . . . 52.33 111.244 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 26.8 m -120.57 131.48 54.68 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.754 0.822 . . . . 60.45 108.91 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -67.73 134.71 51.51 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 123.19 0.596 . . . . 64.43 109.459 174.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -72.05 142.79 49.25 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 109.453 -0.573 . . . . 74.11 109.453 174.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -66.63 94.69 0.3 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.607 -0.516 . . . . 61.44 109.607 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -67.32 95.75 0.45 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.883 0.873 . . . . 65.14 111.204 -174.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -74.86 107.77 7.16 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 114.955 -1.021 . . . . 41.32 110.194 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.142 0 C-N-CA 123.773 0.829 . . . . 72.32 109.625 -179.319 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.691 0 N-CA-C 111.767 -0.533 . . . . 74.44 111.767 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 92' ' ' GLY . . . . . 0.515 ' H ' ' HB3' ' D' ' 53' ' ' ASP . . . -93.34 -107.39 1.84 Allowed Glycine 0 C--N 1.339 0.733 0 CA-C-O 119.553 -0.582 . . . . 53.44 111.757 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -159.79 16.64 0.15 Allowed 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.459 0.911 . . . . 75.22 113.459 -173.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -152.08 172.57 16.12 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 119.152 0.887 . . . . 74.12 111.711 -177.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -130.35 131.08 45.17 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 123.235 0.614 . . . . 64.02 111.159 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.99 -57.03 0.05 OUTLIER Glycine 0 C--N 1.343 0.947 0 N-CA-C 109.06 -1.616 . . . . 74.31 109.06 168.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 97' ' ' ILE . . . . . 0.431 HG21 HD23 ' E' ' 100' ' ' LEU . 2.0 mt -114.15 109.4 28.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 C-N-CA 124.526 1.13 . . . . 63.02 108.163 175.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -92.09 -35.83 13.68 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 120.937 0.398 . . . . 64.05 109.968 174.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -125.79 132.11 52.34 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.647 0.779 . . . . 73.22 109.989 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 100' ' ' LEU . . . . . 0.47 ' HB3' ' SD ' ' D' ' 94' ' ' MET . 0.3 OUTLIER -151.33 149.29 24.19 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.081 0.952 . . . . 61.23 111.221 173.03 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -67.19 -15.25 45.76 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.574 2.183 . . . . 65.13 111.567 163.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 102' ' ' LEU . . . . . . . . . . . . . 29.5 tp 79.0 -86.34 0.02 OUTLIER 'General case' 0 C--N 1.369 1.432 0 C-N-CA 125.742 1.617 . . . . 74.31 110.066 173.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 103' ' ' THR . . . . . 0.417 HG23 HD12 ' D' ' 98' ' ' LEU . 15.0 p -138.25 7.16 2.62 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.702 1.201 . . . . 72.11 109.297 171.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.64 -164.96 45.59 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 110.823 -0.911 . . . . 74.44 110.823 -166.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -70.36 107.35 3.74 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.347 -0.983 . . . . 71.41 108.347 171.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 58.5 t80 66.49 -80.51 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.621 1.168 . . . . 73.0 109.378 -175.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 3.2 p -151.02 125.97 9.79 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.249 1.42 . . . . 51.21 107.821 167.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -88.79 -25.74 22.08 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.083 0.553 . . . . 73.44 110.838 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -87.32 -33.49 19.18 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.449 0.7 . . . . 75.13 111.44 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . 67.22 131.39 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.018 1.327 . . . . 73.11 110.799 -166.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 111' ' ' LEU . . . . . 0.574 ' HB3' HD23 ' D' ' 136' ' ' LEU . 11.1 mp -77.56 -76.94 0.16 Allowed 'General case' 0 N--CA 1.477 0.904 0 O-C-N 122.052 -0.405 . . . . 73.25 111.783 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -68.32 -48.81 63.92 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 123.053 0.221 . . . . 74.13 111.259 -171.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 47.0 mttp 70.58 -42.26 0.52 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 126.166 1.787 . . . . 74.42 113.419 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 114' ' ' LYS . . . . . 0.448 ' HD2' HG22 ' E' ' 122' ' ' THR . 22.1 tptp 77.87 -8.44 1.67 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.118 1.767 . . . . 52.4 111.822 177.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 61.7 p -77.04 -21.94 53.74 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.077 0.951 . . . . 72.45 110.632 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.96 169.65 48.41 Favored Glycine 0 C--N 1.354 1.574 0 CA-C-N 116.087 -0.506 . . . . 55.33 112.349 173.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.35 164.29 62.13 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 124.544 1.138 . . . . 61.33 111.346 -177.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 118' ' ' PRO . . . . . 0.414 ' HA ' ' OG1' ' E' ' 122' ' ' THR . 25.9 Cg_exo -63.09 -167.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.393 2.872 0 C-N-CA 123.115 2.543 . . . . 71.04 113.368 175.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 23.2 t70 78.24 -51.2 0.49 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.669 1.587 . . . . 74.1 112.325 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -88.56 -113.55 0.06 Allowed 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 123.422 0.689 . . . . 75.21 111.386 -168.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 121' ' ' VAL . . . . . 0.709 HG23 HD12 ' D' ' 44' ' ' LEU . 13.4 p -94.45 43.87 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 123.57 1.653 . . . . 40.53 110.519 -172.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 122' ' ' THR . . . . . 0.448 HG22 ' HD2' ' E' ' 114' ' ' LYS . 19.5 p -144.82 -28.43 0.47 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 113.929 -1.487 . . . . 60.14 109.213 -176.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 123' ' ' ASP . . . . . 0.408 ' H ' ' H ' ' E' ' 122' ' ' THR . 17.8 t70 -132.62 153.49 51.0 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.642 1.177 . . . . 73.5 109.961 -172.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 65.4 m -142.61 83.75 1.83 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.159 0.984 . . . . 52.12 108.399 168.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.6 -52.49 64.94 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 115.452 -0.795 . . . . 72.33 111.143 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . 56.18 -158.84 0.23 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 124.378 1.049 . . . . 53.1 110.854 -176.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 6.6 p -171.75 118.01 0.42 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.889 0.876 . . . . 61.41 109.681 172.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -158.08 156.37 30.9 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.682 0.793 . . . . 73.45 110.613 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 8.8 t -78.42 141.31 38.41 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 115.743 -0.662 . . . . 64.15 109.629 175.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.46 174.53 10.54 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 123.239 0.615 . . . . 72.23 110.66 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 131' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -61.4 111.35 1.74 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.085 0.554 . . . . 70.14 109.901 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 132' ' ' SER . . . . . 0.509 ' H ' ' HB3' ' A' ' 124' ' ' PRO . 15.5 p -140.63 28.02 2.01 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.785 0.834 . . . . 70.22 111.34 -175.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 133' ' ' THR . . . . . 0.406 ' OG1' ' HB2' ' A' ' 124' ' ' PRO . 32.7 m -124.1 97.41 5.33 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.804 -0.443 . . . . 61.35 109.804 173.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -101.02 116.67 5.64 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 109.659 -1.376 . . . . 73.05 109.659 169.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.59 158.59 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 117.092 0.446 . . . . 60.43 110.603 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 136' ' ' LYS . . . . . 0.71 ' H ' ' HD3' ' E' ' 136' ' ' LYS . 0.4 OUTLIER -88.56 170.59 10.73 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.43 1.092 . . . . 61.53 109.745 173.614 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 15.3 t -81.65 176.46 9.62 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.12 0.568 . . . . 63.34 110.965 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 138' ' ' TYR . . . . . 0.532 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 6.2 t80 -137.69 3.27 2.49 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.332 0.653 . . . . 72.14 110.569 -177.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -69.46 166.7 18.22 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 112.313 0.486 . . . . 74.44 112.313 -174.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -89.03 150.79 21.68 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.907 -0.588 . . . . 71.22 112.785 -178.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -78.73 100.27 7.01 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.505 0.722 . . . . 54.42 110.5 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -73.1 -54.75 7.73 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.721 0.808 . . . . 70.42 109.367 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . 112.7 -164.7 12.03 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-N 115.199 -0.91 . . . . 61.2 110.89 -172.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 17.3 m -114.89 55.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-O 122.391 1.091 . . . . 71.11 110.775 -176.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 C--O 1.251 1.14 0 CA-C-N 114.615 -1.175 . . . . 75.54 109.031 175.38 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.765 0 CA-C-O 120.344 -0.142 . . . . 61.24 112.887 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . -87.0 120.04 5.37 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 111.0 -0.84 . . . . 74.55 111.0 173.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -110.63 -80.95 0.58 Allowed 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 117.324 0.562 . . . . 75.34 110.484 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -171.4 -173.83 1.31 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.067 0.947 . . . . 75.01 109.657 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -141.03 140.51 34.29 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.526 0.73 . . . . 65.01 110.716 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . 179.3 8.86 0.02 OUTLIER Glycine 0 C--N 1.356 1.682 0 CA-C-O 119.396 -0.669 . . . . 44.43 114.674 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 97' ' ' ILE . . . . . 0.677 HD11 ' HB2' ' B' ' 94' ' ' MET . 17.3 tt -132.91 114.59 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-N 118.335 1.068 . . . . 72.53 108.952 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -74.76 87.44 2.22 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.188 0.595 . . . . 73.02 111.114 -169.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . 66.2 163.54 0.17 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.464 1.506 . . . . 71.42 111.712 -174.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 100' ' ' LEU . . . . . . . . . . . . . 3.6 mp -138.05 72.04 47.41 Favored Pre-proline 0 CA--C 1.553 1.06 0 N-CA-C 108.833 -0.803 . . . . 61.24 108.833 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -68.1 -3.13 10.1 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.776 2.984 . . . . 73.21 115.62 -170.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 102' ' ' LEU . . . . . . . . . . . . . 30.4 tp 58.9 44.71 16.24 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.908 0.883 . . . . 72.23 110.802 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 42.7 p 55.06 25.68 7.29 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.699 1.6 . . . . 75.21 112.844 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.03 -82.48 0.99 Allowed Glycine 0 C--N 1.351 1.386 0 CA-C-N 115.859 -0.61 . . . . 51.12 111.822 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -96.41 164.13 12.76 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.599 0.76 . . . . 75.43 110.852 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -55.5 97.38 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.183 1.393 . . . . 74.43 109.793 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 9.9 m 52.38 67.61 0.95 Allowed 'General case' 0 CA--C 1.558 1.281 0 O-C-N 124.568 1.167 . . . . 53.12 109.963 -174.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -65.81 -39.0 90.46 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.913 -0.585 . . . . 74.33 112.14 -172.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -61.95 -29.84 70.51 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.291 0.37 . . . . 71.31 110.73 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 69.86 120.88 0.03 OUTLIER 'General case' 0 C--N 1.357 0.929 0 C-N-CA 125.258 1.423 . . . . 74.13 111.571 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 111' ' ' LEU . . . . . 0.528 HD23 HD13 ' B' ' 44' ' ' LEU . 15.3 tp -74.04 -65.4 0.84 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.668 0.787 . . . . 71.53 110.768 -173.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -89.64 36.16 0.84 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.801 1.24 . . . . 63.2 111.51 -174.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -76.72 174.05 10.91 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.715 0.806 . . . . 75.12 112.882 -170.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -71.43 93.68 1.19 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.71 -1.132 . . . . 64.11 108.807 169.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 12.8 m -90.08 -17.65 27.33 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.452 0.701 . . . . 64.02 110.407 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 127.86 -52.26 0.83 Allowed Glycine 0 C--N 1.348 1.214 0 CA-C-O 121.212 0.34 . . . . 64.55 112.549 170.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -107.55 -175.47 0.36 Allowed Pre-proline 0 N--CA 1.478 0.961 0 N-CA-C 107.816 -1.179 . . . . 73.34 107.816 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -57.94 -37.33 96.51 Favored 'Trans proline' 0 C--N 1.375 1.945 0 CA-C-N 120.79 1.318 . . . . 71.52 110.745 158.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 61.95 -88.1 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.685 1.194 . . . . 72.04 111.178 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -157.37 149.47 22.58 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.117 0.967 . . . . 74.44 109.099 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 19.1 t 54.99 59.06 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 C-N-CA 125.195 1.398 . . . . 72.22 111.118 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 16.4 p -145.31 -59.82 0.34 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.676 -1.147 . . . . 62.35 108.594 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -138.56 140.38 39.03 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 124.932 1.293 . . . . 75.32 108.79 -176.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 20.4 m 66.25 105.16 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.068 1.347 . . . . 24.4 111.783 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -154.56 -61.27 0.12 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.387 0.675 . . . . 63.44 109.758 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -159.37 166.81 30.32 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.703 0.801 . . . . 61.14 110.267 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 27.0 p -119.26 152.29 36.94 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.681 0.792 . . . . 71.5 110.549 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 128' ' ' ALA . . . . . 0.581 ' HB3' ' HG3' ' B' ' 37' ' ' GLN . . . -88.81 149.23 23.5 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.487 0.715 . . . . 70.35 109.371 175.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 129' ' ' THR . . . . . 0.485 ' HB ' ' HG3' ' C' ' 124' ' ' PRO . 12.9 p -102.39 130.96 49.29 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.907 0.483 . . . . 72.25 109.76 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 130' ' ' ALA . . . . . 0.646 ' HA ' ' HB3' ' B' ' 124' ' ' PRO . . . -71.08 157.97 37.28 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.043 1.127 . . . . 62.35 114.043 -169.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 58.7 t-105 -92.32 102.45 14.95 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 107.476 -1.305 . . . . 64.4 107.476 168.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 68.9 m -145.59 73.72 1.36 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.43 0.692 . . . . 65.23 109.505 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 15.3 t -157.88 165.18 35.89 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.35 -0.841 . . . . 74.35 109.87 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -142.77 133.48 5.57 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 110.349 -1.101 . . . . 74.22 110.349 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 135' ' ' VAL . . . . . 0.539 HG13 HG11 ' C' ' 40' ' ' VAL . 85.3 t -74.85 -78.69 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 109.58 -0.526 . . . . 53.03 109.58 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm 57.06 165.14 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.61 1.164 . . . . 75.32 111.687 -173.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 5.6 m 68.48 159.21 0.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.141 0.976 . . . . 71.42 111.361 174.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -134.38 90.8 2.71 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.516 -0.74 . . . . 72.15 109.351 172.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -170.36 153.67 4.47 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.347 -0.842 . . . . 72.31 110.221 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -114.99 -176.4 18.71 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 111.541 -0.624 . . . . 63.31 111.541 172.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -163.57 -174.2 3.62 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.257 0.623 . . . . 71.33 110.936 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -65.76 153.63 41.26 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.198 0.999 . . . . 64.14 111.566 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -125.16 132.53 8.1 Favored Glycine 0 C--N 1.346 1.099 0 N-CA-C 110.726 -0.95 . . . . 70.21 110.726 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 18.7 t -95.66 76.02 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.08 -0.711 . . . . 73.34 109.08 -176.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--O 1.249 1.032 0 C-N-CA 123.472 0.709 . . . . 73.31 109.417 -178.179 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.496 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 109.861 -0.422 . . . . 65.2 109.861 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.2 m -124.88 122.43 37.36 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.166 0.586 . . . . 75.13 109.686 -174.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -139.77 169.86 16.94 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.025 0.93 . . . . 71.14 109.37 172.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -87.57 27.45 1.11 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.898 0.879 . . . . 63.45 112.291 -174.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -155.97 174.95 14.59 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.023 0.929 . . . . 75.54 109.733 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -65.97 97.11 0.34 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.185 0.516 . . . . 63.33 110.467 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.609 HG22 ' H ' ' A' ' 8' ' ' GLU . 2.2 m -110.46 -152.58 0.5 Allowed 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 107.666 -1.235 . . . . 71.44 107.666 176.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.609 ' H ' HG22 ' A' ' 7' ' ' THR . 10.8 pt-20 -55.66 162.36 1.72 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.998 0.919 . . . . 71.42 111.641 166.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.623 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 5.1 ppp? -84.69 177.46 8.03 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.677 -0.692 . . . . 73.02 110.989 178.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 99.4 m -145.06 114.49 7.14 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.175 0.99 . . . . 51.44 109.022 -174.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.536 ' CD1' HD12 ' A' ' 86' ' ' ILE . 15.0 t80 -125.31 133.44 52.62 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.534 -0.913 . . . . 53.54 108.534 177.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -147.91 135.51 20.81 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.472 0.709 . . . . 70.32 109.452 171.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.611 HG21 ' HG2' ' C' ' 130' ' ' PRO . 3.9 mt -82.47 115.74 25.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.433 -0.951 . . . . 64.13 108.433 169.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.76 -41.12 19.59 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 109.451 -0.574 . . . . 53.3 109.451 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.426 ' NH2' ' HB ' ' B' ' 122' ' ' THR . 23.1 ttt180 -169.51 126.74 0.91 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.629 0.372 . . . . 74.25 110.962 -175.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.407 HD12 ' HG3' ' C' ' 130' ' ' PRO . 86.6 mt -111.76 137.21 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.902 -0.777 . . . . 74.11 108.902 170.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HB2' ' HA2' ' B' ' 121' ' ' GLY . 31.6 p90 -164.29 176.33 9.24 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 124.136 0.898 . . . . 53.2 111.178 -172.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.6 p -103.57 123.36 46.8 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.36 0.664 . . . . 64.53 109.289 174.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.482 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 39.5 mtpt -87.74 -27.23 22.49 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.506 -0.553 . . . . 73.43 109.506 174.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.449 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 22.3 t70 -152.25 142.05 21.98 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 114.931 -1.031 . . . . 71.45 109.418 -177.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 85.3 mt -139.63 142.24 33.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 C-N-CA 125.24 1.416 . . . . 70.05 107.409 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.8 t -149.64 123.22 9.15 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.934 0.494 . . . . 74.03 110.189 175.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.424 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 89.7 t80 -127.88 124.52 37.66 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 106.986 -1.487 . . . . 73.51 106.986 172.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 80.1 mt-10 -126.77 121.18 31.23 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.054 0.388 . . . . 75.13 110.105 -177.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.45 76.38 61.92 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 108.249 -1.019 . . . . 74.12 108.249 169.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -74.48 -23.59 14.84 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.676 2.25 . . . . 65.44 112.357 -177.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -97.43 15.57 22.73 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-O 118.198 -0.906 . . . . 64.22 109.954 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.593 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -39.94 -59.24 1.84 Allowed Pre-proline 0 CA--C 1.572 1.79 0 C-N-CA 124.703 1.201 . . . . 63.44 113.705 -168.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 32.5 Cg_exo -60.11 -35.11 93.66 Favored 'Trans proline' 0 C--N 1.387 2.601 0 C-N-CA 122.075 1.85 . . . . 75.01 113.199 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -76.38 -35.55 58.58 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.117 -0.947 . . . . 72.13 110.92 -174.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.752 HG21 ' HA ' ' A' ' 73' ' ' ALA . 5.5 p -80.61 -15.51 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.707 -0.679 . . . . 63.24 112.236 -168.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -77.11 -35.49 56.29 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.513 0.325 . . . . 71.44 110.51 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -78.19 -16.19 58.11 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.161 0.584 . . . . 75.5 111.139 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -73.33 154.6 40.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.51 0.724 . . . . 63.43 111.368 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.52 119.25 7.69 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.753 1.221 . . . . 65.24 110.331 177.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -79.67 80.76 6.02 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.709 0.766 . . . . 74.45 109.842 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -123.62 81.15 54.61 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 106.094 -1.817 . . . . 73.5 106.094 169.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -86.91 122.0 1.84 Allowed 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.695 2.264 . . . . 60.31 112.324 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -95.91 115.54 27.58 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 105.917 -1.883 . . . . 73.31 105.917 168.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.0 t -94.55 94.3 4.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 O-C-N 123.783 0.677 . . . . 65.0 109.711 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -80.19 113.55 18.45 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.922 -1.035 . . . . 64.14 109.282 175.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.594 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.6 pt? -109.81 111.64 23.21 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.549 0.69 . . . . 73.33 109.809 -177.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -101.6 137.72 39.54 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.576 1.15 . . . . 75.51 108.295 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.494 HD11 HG21 ' A' ' 131' ' ' VAL . 67.9 mt -126.56 120.45 29.63 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.412 0.625 . . . . 62.04 111.015 -173.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -125.17 122.12 36.16 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 114.028 -1.442 . . . . 74.4 108.047 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 83.8 m -122.9 135.81 54.64 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.312 0.645 . . . . 72.45 109.961 177.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.94 126.31 11.54 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.494 0.717 . . . . 61.31 109.734 176.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 64.7 p -96.94 172.78 7.64 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.457 0.703 . . . . 64.13 110.743 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.1 t -162.7 163.32 26.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.842 1.257 . . . . 53.24 108.871 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -110.92 116.91 32.04 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.277 0.631 . . . . 75.44 109.446 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.9 mt -85.91 -33.59 21.16 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.092 0.557 . . . . 75.22 110.376 175.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.9 -176.49 4.95 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.767 0.827 . . . . 72.34 110.348 -178.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -62.37 118.99 8.23 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.131 0.572 . . . . 63.1 109.61 176.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 65.35 10.43 6.51 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.767 1.227 . . . . 74.33 112.438 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.38 106.65 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.772 -0.825 . . . . 73.32 108.772 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -113.99 126.42 55.11 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.991 0.916 . . . . 75.25 109.876 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -93.62 136.69 33.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.942 -0.762 . . . . 71.21 108.942 171.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.4 t -120.85 138.16 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 108.31 -0.996 . . . . 61.03 108.31 170.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.4 t -120.52 131.25 73.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.015 -0.735 . . . . 72.52 109.015 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.485 HD21 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -109.18 105.02 14.29 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.18 -1.415 . . . . 73.45 107.18 174.784 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -88.91 100.78 13.45 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.322 -1.362 . . . . 60.13 107.322 172.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.0 t -94.06 126.65 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.5 -1.296 . . . . 53.44 107.5 172.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.3 m -117.61 126.59 52.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.022 -0.733 . . . . 61.52 109.022 177.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.52 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 64.0 t -115.31 126.15 72.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.087 -1.079 . . . . 65.21 108.087 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.9 m -120.68 130.5 54.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.54 -0.911 . . . . 73.5 108.54 172.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.7 123.57 29.6 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.947 -1.501 . . . . 71.11 106.947 175.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -137.27 128.92 28.62 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.23 0.538 . . . . 72.02 110.691 -174.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.699 HD12 HG22 ' A' ' 31' ' ' VAL . 33.5 mt -92.29 81.36 4.95 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.145 1.378 . . . . 64.25 107.913 175.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.71 -119.51 6.08 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 110.852 -0.899 . . . . 73.24 110.852 -174.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.4 -19.36 25.28 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.926 0.49 . . . . 53.3 110.201 175.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -80.92 106.69 13.13 Favored 'General case' 0 C--N 1.347 0.469 0 C-N-CA 124.035 0.934 . . . . 72.05 109.038 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.8 m -68.76 131.07 44.56 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 118.16 0.436 . . . . 62.54 109.939 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.752 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -77.66 -61.26 2.05 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.286 -1.005 . . . . 71.53 108.286 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 46.6 p90 -158.9 157.78 32.1 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.525 -0.761 . . . . 75.54 111.801 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 64' ' ' VAL . 57.1 tp -123.44 109.29 13.67 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.46 -1.245 . . . . 73.34 107.734 171.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.52 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 86.0 m -108.17 96.27 6.25 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.111 0.565 . . . . 52.32 110.301 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -111.42 115.67 29.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.9 -0.778 . . . . 70.43 108.9 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.65 133.06 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.603 0.761 . . . . 53.05 109.887 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 61.9 mt-30 -105.12 88.22 2.82 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 107.956 -1.127 . . . . 74.15 107.956 175.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -76.8 96.43 4.27 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.166 -0.924 . . . . 70.14 109.208 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.54 145.09 20.1 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 111.349 -0.701 . . . . 73.33 111.349 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.5 122.95 1.79 Allowed Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.696 -0.962 . . . . 62.23 110.696 -176.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.441 HG13 ' HE1' ' A' ' 17' ' ' TYR . 53.7 mt -80.77 127.29 39.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 108.151 -1.055 . . . . 63.42 108.151 170.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.802 ' HB3' HD11 ' A' ' 86' ' ' ILE . 92.8 m-85 -131.74 123.91 28.65 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.371 0.668 . . . . 74.33 109.4 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 t -86.43 98.0 10.77 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 108.903 -0.777 . . . . 72.21 108.903 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.802 HD11 ' HB3' ' A' ' 84' ' ' PHE . 4.1 mm -112.5 149.24 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 122.857 0.463 . . . . 74.45 110.886 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.26 167.28 16.2 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.748 0.819 . . . . 52.05 110.827 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.623 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 97.44 -32.92 6.24 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 114.304 0.482 . . . . 74.21 114.304 172.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.671 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -113.01 150.33 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.411 0.684 . . . . 61.51 110.639 -174.513 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -138.8 174.58 10.37 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.379 1.072 . . . . 64.44 109.527 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.86 -133.28 40.56 Favored Glycine 0 C--N 1.345 1.07 0 O-C-N 123.792 0.683 . . . . 64.01 113.732 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 47.5 p -67.77 -25.51 65.65 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.876 0.87 . . . . 64.54 111.631 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -69.37 -42.74 74.79 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.387 0.675 . . . . 74.11 110.827 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 5.8 tpt -66.34 -46.72 75.85 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 116.004 -0.544 . . . . 60.51 109.897 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.36 -34.77 72.8 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.563 -0.744 . . . . 64.4 110.894 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -68.84 -34.29 75.24 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.651 -0.704 . . . . 72.44 111.431 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.9 t -65.76 -44.27 86.4 Favored 'General case' 0 C--N 1.348 0.516 0 N-CA-C 109.815 -0.439 . . . . 60.53 109.815 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.6 mt -84.22 -35.31 23.56 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.235 -0.893 . . . . 73.42 112.036 -170.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.86 3.93 49.25 Favored Glycine 0 N--CA 1.473 1.11 0 CA-C-O 119.713 -0.493 . . . . 73.53 114.2 -172.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.52 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -141.67 -66.57 0.41 Allowed 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 117.587 0.694 . . . . 73.43 111.537 -177.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -65.48 -44.59 86.61 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 115.968 -0.56 . . . . 71.31 111.581 -173.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.6 m -63.44 -51.08 70.22 Favored Pre-proline 0 CA--C 1.564 1.494 0 C-N-CA 124.03 0.932 . . . . 65.25 112.354 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.45 -27.13 62.48 Favored 'Trans proline' 0 C--N 1.395 2.985 0 C-N-CA 121.717 1.611 . . . . 73.34 113.491 173.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.511 HD21 ' HA ' ' A' ' 132' ' ' ASN . 3.0 m120 -60.88 -38.29 85.1 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 118.09 0.405 . . . . 71.35 110.613 172.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.506 HG21 ' CD1' ' A' ' 13' ' ' ILE . 47.3 mm -72.12 -44.21 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.467 0.707 . . . . 63.01 110.065 176.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 70.2 mt -71.75 -23.61 61.63 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.551 -0.749 . . . . 64.24 112.29 -173.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -63.98 -47.27 80.53 Favored Pre-proline 0 N--CA 1.483 1.207 0 CA-C-O 117.932 -1.033 . . . . 75.02 113.391 -172.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.412 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 83.0 Cg_exo -51.29 -36.15 56.01 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.138 1.892 . . . . 65.23 113.943 172.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -80.55 -39.37 27.87 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.396 0.678 . . . . 65.03 111.716 -177.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.78 -47.49 74.96 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 109.457 -0.572 . . . . 40.32 109.457 176.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.614 HH12 HD12 ' C' ' 105' ' ' ILE . 27.9 ttm180 -51.6 -47.07 63.72 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.85 1.26 . . . . 72.12 110.568 172.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.43 -49.12 78.14 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.033 0.833 . . . . 55.25 111.433 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.4 t -57.17 -47.19 81.84 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.084 0.865 . . . . 50.42 110.193 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.527 HD13 HD11 ' A' ' 128' ' ' LEU . 23.5 mt -56.75 -51.76 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.743 1.217 . . . . 72.51 111.124 174.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.9 m -56.23 -45.09 80.09 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.535 1.134 . . . . 73.14 111.108 -176.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.2 t -67.66 -41.05 84.4 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.41 -1.268 . . . . 72.22 110.006 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 11.6 mtp -59.66 -44.61 93.5 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.59 0.756 . . . . 71.53 111.054 176.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 114' ' ' ILE . 82.1 t -59.33 -48.41 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 124.225 1.01 . . . . 62.23 110.543 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.9 p -71.19 -30.6 66.6 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.603 -0.726 . . . . 63.22 111.617 -176.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.468 HH12 ' HG3' ' B' ' 112' ' ' GLU . 80.3 mtt-85 -72.66 -28.31 62.64 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.98 0.512 . . . . 73.24 109.974 176.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.436 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.34 17.17 35.16 Favored Glycine 0 C--N 1.354 1.559 0 CA-C-O 119.291 -0.727 . . . . 64.24 113.432 174.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.4 t 59.73 9.96 1.84 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 127.202 2.201 . . . . 74.42 113.404 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -79.26 140.04 56.5 Favored Pre-proline 0 C--O 1.242 0.671 0 N-CA-C 108.311 -0.996 . . . . 73.33 108.311 175.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.453 ' HB2' HG23 ' E' ' 133' ' ' THR . 89.6 Cg_exo -46.49 126.7 10.64 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 123.065 2.51 . . . . 60.4 112.268 172.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -50.67 131.6 25.66 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.599 1.187 . . . . 72.32 112.84 -168.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.4 tp -109.24 138.09 46.12 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.642 0.777 . . . . 70.05 109.858 -176.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -132.97 117.67 17.92 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.531 -0.914 . . . . 64.01 108.531 174.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.527 HD11 HD13 ' A' ' 114' ' ' ILE . 16.1 mt -72.72 135.29 45.33 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.152 -0.684 . . . . 63.24 109.152 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.453 ' HB2' HG23 ' E' ' 137' ' ' THR . . . -65.13 142.78 98.69 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 122.651 0.38 . . . . 73.25 111.254 -177.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.464 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 63.3 Cg_exo -54.17 118.39 4.95 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.421 2.748 . . . . 73.24 114.074 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.494 HG21 HD11 ' A' ' 44' ' ' LEU . 88.5 t -102.86 129.03 55.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 123.518 0.727 . . . . 64.43 110.272 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.511 ' HA ' HD21 ' A' ' 104' ' ' ASN . 56.6 t30 -96.37 92.89 6.54 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.678 0.791 . . . . 63.14 109.12 176.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -67.98 -22.84 64.99 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.55 -0.75 . . . . 71.14 111.368 177.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.52 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 13.5 t70 -54.91 -50.96 67.52 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.574 0.75 . . . . 75.13 110.105 172.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.91 -55.65 30.47 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 114.78 -1.1 . . . . 71.43 110.086 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 91.8 mt -56.82 -36.91 70.5 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 124.217 0.948 . . . . 71.33 112.479 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -68.14 -38.99 82.79 Favored 'General case' 0 C--O 1.219 -0.542 0 O-C-N 123.777 0.673 . . . . 63.34 110.257 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.443 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . 9.9 mmt -77.99 -48.94 15.07 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.364 0.505 . . . . 52.54 112.364 -175.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.69 -17.06 45.62 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 118.108 0.413 . . . . 73.33 111.445 173.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -84.51 -50.66 7.53 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.881 0.872 . . . . 75.0 111.22 168.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 48.9 tp -67.55 -55.22 14.31 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.46 0.704 . . . . 72.33 111.948 -167.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 170.54 -15.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 126.488 1.915 . . . . 70.32 109.68 -175.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.443 ' HA ' ' HB3' ' A' ' 138' ' ' MET . 0.0 OUTLIER 64.33 83.85 0.16 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.234 1.414 . . . . 61.52 108.917 -177.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -147.26 -178.75 6.39 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.688 0.795 . . . . 61.23 110.795 -169.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.78 96.47 2.56 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.526 0.73 . . . . 74.12 111.027 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -136.66 25.33 3.11 Favored Glycine 0 N--CA 1.473 1.138 0 N-CA-C 111.924 -0.47 . . . . 61.02 111.924 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -99.86 94.62 6.4 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.663 0.785 . . . . 74.44 109.461 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.449 ' O ' ' HG2' ' A' ' 9' ' ' MET . . . -163.71 41.98 0.32 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 110.519 -1.032 . . . . 43.42 110.519 177.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 32.6 p -135.55 95.34 3.24 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.412 1.085 . . . . 74.1 109.037 -177.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -139.16 153.4 47.93 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.576 0.751 . . . . 62.0 110.433 -175.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.422 ' HG2' ' CD2' ' A' ' 11' ' ' PHE . 37.1 mt-10 -74.43 113.21 11.4 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.949 0.9 . . . . 70.1 110.592 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -157.63 94.81 1.39 Allowed 'General case' 0 CA--C 1.554 1.098 0 CA-C-O 120.984 0.421 . . . . 73.12 111.327 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -178.11 -170.61 0.24 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.095 1.358 . . . . 74.22 108.939 170.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -115.64 133.25 56.21 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.545 0.738 . . . . 74.21 109.078 169.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.266 0 C-N-CA 124.108 0.963 . . . . 75.04 109.309 175.379 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 49.0 mtm . . . . . 0 N--CA 1.485 1.288 0 N-CA-C 109.763 -0.458 . . . . 74.21 109.763 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 59.1 m -145.81 34.26 1.03 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.706 0.803 . . . . 72.52 109.336 177.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -78.04 -170.57 1.99 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.462 1.105 . . . . 72.23 110.7 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 66.09 50.51 1.42 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.32 1.048 . . . . 65.3 110.403 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -56.55 134.25 54.13 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.687 1.195 . . . . 74.44 112.222 -176.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -77.21 146.53 36.93 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.35 0.66 . . . . 54.22 109.853 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 17.6 m -79.32 149.16 31.83 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.657 0.783 . . . . 73.13 110.281 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -70.24 80.0 0.52 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.731 -0.84 . . . . 65.12 108.731 173.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.57 ' HG3' HG13 ' B' ' 89' ' ' ILE . 27.0 ttt 64.78 166.8 0.17 Allowed 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 125.668 1.587 . . . . 74.01 111.59 -171.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.415 ' N ' ' HG2' ' B' ' 9' ' ' MET . 85.3 m -138.01 123.08 19.12 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.875 1.27 . . . . 61.33 108.13 169.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.636 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 62.1 t80 -137.29 133.79 35.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.248 0.619 . . . . 71.34 109.608 177.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -150.57 140.13 21.57 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.568 0.747 . . . . 74.04 109.223 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.505 HD11 HD13 ' B' ' 105' ' ' ILE . 53.4 mt -83.16 130.27 36.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.23 -1.026 . . . . 53.14 108.23 171.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -98.78 -41.57 7.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.975 0.51 . . . . 75.11 110.4 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.401 ' NH2' HG23 ' E' ' 129' ' ' THR . 55.3 ttt180 -173.03 129.29 0.48 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.617 -0.72 . . . . 74.22 109.177 -175.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.557 HG21 ' CD1' ' B' ' 109' ' ' TYR . 75.1 mt -116.32 148.89 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.448 -0.945 . . . . 61.45 108.448 173.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -167.09 161.95 15.06 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-O 121.671 0.748 . . . . 71.24 112.016 -175.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.4 m -88.26 123.03 32.46 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.191 -1.368 . . . . 64.02 108.408 168.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.543 ' HZ2' ' HA3' ' B' ' 81' ' ' GLY . 43.0 mttp -80.05 -51.76 8.64 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.233 0.613 . . . . 75.11 110.593 170.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -144.85 141.77 29.39 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.283 -0.417 . . . . 61.43 110.725 -164.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.507 HD11 ' SG ' ' B' ' 113' ' ' CYS . 46.3 mm -134.95 138.66 48.73 Favored 'Isoleucine or valine' 0 C--N 1.354 0.791 0 C-N-CA 124.572 1.149 . . . . 70.43 109.726 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.42 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 40.2 t -138.32 128.47 25.76 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.923 1.289 . . . . 62.14 107.65 176.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.416 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 77.5 t80 -144.29 114.32 7.36 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 107.974 -1.121 . . . . 53.52 107.974 171.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -122.43 116.98 24.91 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.076 0.95 . . . . 65.44 108.941 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.18 86.57 3.35 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 107.595 -1.261 . . . . 72.12 107.595 169.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.86 -30.64 40.08 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.956 2.437 . . . . 71.21 112.715 -170.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -107.87 12.27 27.35 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 118.407 -0.806 . . . . 74.23 110.899 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.421 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -31.24 -73.22 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.918 0 C-N-CA 126.026 1.73 . . . . 74.24 114.604 -164.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.482 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 27.6 Cg_endo -64.06 -26.19 65.88 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 122.084 1.856 . . . . 74.14 112.954 -170.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -87.11 -41.74 13.56 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.14 -0.936 . . . . 62.24 111.383 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.498 HG22 HD12 ' B' ' 68' ' ' LEU . 8.8 p -69.18 -17.75 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.218 0.607 . . . . 55.43 111.175 -175.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -65.54 -11.09 40.6 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.128 0.788 . . . . 74.1 113.128 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.501 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.2 pt20 -63.13 -13.72 40.02 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.455 0.702 . . . . 71.32 111.446 172.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.501 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 97.9 mttt -109.06 110.3 21.53 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.779 1.632 . . . . 74.12 110.629 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -111.27 88.95 2.92 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.641 0.776 . . . . 64.22 109.822 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.607 ' HA ' ' HB2' ' F' ' 130' ' ' ALA . 33.7 p90 -167.66 172.49 9.28 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.879 0.872 . . . . 74.12 109.098 170.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -65.18 110.17 3.91 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 123.424 0.69 . . . . 54.33 110.704 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.414 ' O ' HG23 ' B' ' 40' ' ' VAL . 18.0 Cg_endo -64.83 166.3 18.63 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.051 1.834 . . . . 73.15 112.384 -177.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 33.8 tt0 -64.35 100.84 0.38 Allowed 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.509 -1.293 . . . . 54.31 107.509 168.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.689 HG11 HD11 ' B' ' 126' ' ' LEU . 54.6 t -104.32 149.31 8.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.213 -0.903 . . . . 70.01 109.125 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.504 ' HE3' ' HB2' ' B' ' 43' ' ' ASP . 12.6 ttpt -141.3 120.67 13.13 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.393 -1.336 . . . . 52.31 107.393 173.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.524 HD13 HD22 ' B' ' 128' ' ' LEU . 20.4 tp -88.53 134.62 33.81 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.614 -0.884 . . . . 73.24 108.614 174.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.504 ' HB2' ' HE3' ' B' ' 41' ' ' LYS . 2.5 t0 -142.41 146.66 35.11 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.879 -1.156 . . . . 62.42 107.879 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 mp -131.25 146.2 52.21 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.476 -0.565 . . . . 65.11 109.476 -175.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.519 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 35.0 m-20 -130.47 153.86 48.36 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.953 1.301 . . . . 73.52 108.087 170.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' THR . . . . . 0.476 HG22 HD22 ' F' ' 111' ' ' LEU . 5.9 t -139.11 130.86 27.49 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.344 0.593 . . . . 64.03 110.251 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.05 136.46 18.97 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.918 1.287 . . . . 75.53 107.662 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 19.0 m -140.8 175.22 9.79 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.923 0.489 . . . . 71.41 110.948 -170.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 58.9 p -151.66 136.94 17.55 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.725 0.41 . . . . 75.24 111.146 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -87.79 107.16 18.53 Favored 'General case' 0 C--N 1.349 0.545 0 N-CA-C 108.978 -0.749 . . . . 72.0 108.978 173.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.0 pp -125.34 15.43 8.32 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.273 -0.876 . . . . 62.13 109.717 177.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.76 151.1 14.25 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 124.439 1.096 . . . . 64.3 109.373 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -83.36 134.72 34.89 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.619 -0.882 . . . . 70.54 108.619 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' HB3' ' HB2' ' B' ' 87' ' ' ALA . 1.7 m-20 64.3 7.88 3.83 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.065 0.946 . . . . 74.52 112.275 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 86.8 t -142.03 112.17 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 107.556 -1.276 . . . . 71.53 107.556 -174.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.479 ' OH ' ' HB2' ' F' ' 102' ' ' LEU . 4.5 t80 -115.3 139.68 49.77 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 109.012 -0.736 . . . . 72.43 109.012 -171.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -101.33 104.37 15.36 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.79 -1.189 . . . . 72.52 107.79 -177.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.58 135.87 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.775 0.83 . . . . 72.42 110.072 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 15.4 t -122.81 111.28 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.6 0.76 . . . . 72.14 108.956 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 56.5 tp -98.27 115.0 27.47 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.261 -0.644 . . . . 72.03 109.261 175.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.519 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 37.9 ttm180 -85.39 130.74 34.52 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.893 -0.78 . . . . 75.45 108.893 170.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 64.6 t -123.45 104.72 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 108.228 -1.027 . . . . 74.35 108.228 173.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 11.9 m -100.66 136.7 40.12 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.737 0.815 . . . . 75.24 109.906 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.742 HG11 HD21 ' B' ' 126' ' ' LEU . 76.8 t -121.1 125.83 74.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 123.957 0.903 . . . . 74.01 109.227 173.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.4 m -100.49 138.67 37.25 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 107.806 -1.183 . . . . 74.43 107.806 169.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.03 144.49 27.96 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.887 0.375 . . . . 72.01 111.08 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.482 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 34.9 p -151.96 128.52 10.74 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.271 -0.877 . . . . 73.24 110.568 -178.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.498 HD12 HG22 ' B' ' 31' ' ' VAL . 66.9 mt -91.76 98.3 11.53 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.654 -1.239 . . . . 65.03 107.654 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.07 -119.49 5.93 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 114.397 -1.274 . . . . 65.13 112.287 -174.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -100.91 1.39 39.82 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.622 0.769 . . . . 62.33 111.552 -174.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -122.02 148.55 44.69 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.705 -0.48 . . . . 74.42 109.705 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.5 m -68.46 133.72 49.06 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.119 0.485 . . . . 71.44 111.019 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.482 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -87.95 -64.4 1.15 Allowed 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.914 -1.143 . . . . 73.43 107.914 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 74' ' ' PHE . . . . . 0.438 ' CZ ' HD22 ' B' ' 126' ' ' LEU . 43.0 p90 -154.06 155.09 34.82 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.262 -1.335 . . . . 63.31 109.364 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 72.4 mt -131.68 111.68 11.89 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.815 -1.55 . . . . 75.13 106.815 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 37.5 t -117.78 151.51 37.17 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.912 -0.773 . . . . 72.41 108.912 -176.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.42 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 34.9 tt0 -162.1 129.26 3.84 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.768 -0.826 . . . . 64.32 108.768 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 85.6 t -124.44 149.68 28.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 124.013 0.925 . . . . 73.22 108.535 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -126.51 95.83 4.48 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.181 -1.044 . . . . 71.03 108.181 171.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -90.75 107.39 19.15 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.671 -0.863 . . . . 75.04 108.671 -176.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.543 ' HA3' ' HZ2' ' B' ' 19' ' ' LYS . . . -97.94 154.82 20.3 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 112.075 -0.41 . . . . 74.54 112.075 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.5 132.83 3.13 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 117.089 0.444 . . . . 70.13 112.938 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 3.7 mp -86.02 113.66 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 N-CA-C 107.941 -1.133 . . . . 64.34 107.941 170.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -121.48 153.83 37.41 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.786 0.834 . . . . 74.4 109.266 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 49.1 m -100.71 107.41 19.01 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.245 0.618 . . . . 62.54 109.868 176.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.28 102.0 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 106.676 -1.601 . . . . 71.14 106.676 175.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.679 ' HB2' ' HB3' ' B' ' 54' ' ' ASP . . . -147.77 170.84 16.73 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.24 0.616 . . . . 53.53 111.368 -169.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.39 -54.62 4.86 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-O 121.253 0.363 . . . . 63.14 112.414 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.57 HG13 ' HG3' ' B' ' 9' ' ' MET . 1.1 pp -68.4 168.57 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.242 1.017 . . . . 65.23 111.826 171.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.59 -171.3 3.63 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.168 -0.924 . . . . 73.13 110.092 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.64 -132.57 22.53 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 115.081 -0.963 . . . . 64.31 114.166 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 15.8 m -83.55 -40.97 18.44 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.953 0.901 . . . . 63.25 109.86 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.518 ' HB2' ' HG3' ' B' ' 144' ' ' GLN . 38.9 tt0 -65.49 -25.99 67.72 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 113.609 -1.632 . . . . 74.52 112.131 -165.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.467 ' HB2' HD13 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -65.05 -40.82 95.31 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.054 0.942 . . . . 71.42 112.642 -177.728 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.23 -14.05 59.83 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.048 0.539 . . . . 75.14 112.276 -177.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -64.84 -32.44 74.15 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.833 0.453 . . . . 73.34 110.537 170.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.2 t -66.12 -56.29 12.2 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.592 0.357 . . . . 70.45 110.889 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.415 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.5 pp -67.2 -21.71 65.76 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.711 0.404 . . . . 75.02 111.378 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.84 0.37 57.73 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-O 119.093 -0.837 . . . . 65.04 114.506 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.611 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -148.4 -56.07 0.21 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 118.39 1.095 . . . . 53.34 111.937 -177.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -68.4 -43.79 76.51 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.436 0.695 . . . . 70.44 111.393 -173.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.636 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 58.9 m -70.89 -47.42 15.41 Favored Pre-proline 0 CA--C 1.562 1.441 0 C-N-CA 123.477 0.711 . . . . 71.23 112.21 -176.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 31.9 Cg_exo -60.85 -28.32 86.22 Favored 'Trans proline' 0 C--N 1.394 2.931 0 C-N-CA 121.953 1.769 . . . . 72.35 113.346 173.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.25 -32.9 72.71 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.577 0.751 . . . . 70.22 111.849 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.505 HD13 HD11 ' B' ' 13' ' ' ILE . 70.0 mt -75.6 -34.94 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.639 0.776 . . . . 63.44 110.155 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 85.4 mt -75.44 -31.8 60.45 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.207 -0.906 . . . . 45.14 111.372 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -57.67 -48.63 96.87 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 113.885 1.068 . . . . 52.01 113.885 -173.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.8 -32.48 91.81 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 122.293 1.996 . . . . 74.2 113.211 177.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.557 ' CD1' HG21 ' B' ' 16' ' ' ILE . 5.0 m-30 -79.53 -37.69 35.96 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.315 0.646 . . . . 75.53 110.514 -176.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.46 -37.95 88.39 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.35 -0.841 . . . . 71.34 110.077 173.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.486 ' HA ' HD12 ' B' ' 128' ' ' LEU . 46.2 ttt-85 -61.02 -55.24 35.11 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.888 1.275 . . . . 74.25 110.181 177.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.468 ' HG3' HH12 ' A' ' 120' ' ' ARG . 13.3 tp10 -61.24 -35.23 76.67 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.903 0.881 . . . . 73.35 110.747 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.592 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.0 t -69.13 -32.59 72.06 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 110.267 -0.271 . . . . 73.0 110.267 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.548 HD13 HG23 ' B' ' 64' ' ' VAL . 69.0 mt -71.19 -56.42 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.443 0.697 . . . . 72.3 110.411 174.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 22.7 m -58.24 -28.56 64.99 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.39 1.076 . . . . 74.4 111.416 -174.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.5 t -63.05 -57.14 11.67 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-N 115.782 -0.645 . . . . 74.12 109.574 171.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.592 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.2 mmt -64.02 -36.75 85.0 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.562 0.745 . . . . 64.24 111.254 -173.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.479 HG21 HD23 ' B' ' 126' ' ' LEU . 82.3 t -57.97 -50.08 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 124.545 1.138 . . . . 61.32 110.075 175.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 47.2 t -73.48 -20.25 60.73 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.785 -1.098 . . . . 74.33 111.496 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.456 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 90.9 mtt-85 -68.77 -31.19 70.04 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 110.149 -0.315 . . . . 71.22 110.149 173.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.45 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -78.65 -4.72 87.99 Favored Glycine 0 C--N 1.355 1.607 0 O-C-N 123.62 0.575 . . . . 52.0 112.485 168.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.426 ' HB ' ' NH2' ' A' ' 15' ' ' ARG . 8.6 m 62.93 33.36 15.04 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 125.684 1.594 . . . . 63.22 110.19 -177.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -76.92 163.75 63.47 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 114.353 -1.294 . . . . 72.0 110.534 176.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.448 ' HG3' ' O ' ' B' ' 36' ' ' TRP . 36.3 Cg_endo -61.34 157.34 41.11 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 122.557 2.171 . . . . 75.34 111.63 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -63.01 130.11 43.29 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.374 0.606 . . . . 60.23 111.924 -171.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.742 HD21 HG11 ' B' ' 64' ' ' VAL . 59.9 tp -120.74 99.86 6.77 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.485 -1.234 . . . . 54.52 109.004 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -95.66 121.99 37.95 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.75 -1.204 . . . . 70.01 107.75 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.524 HD22 HD13 ' B' ' 42' ' ' LEU . 38.6 mt -79.79 132.88 36.25 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 117.831 0.287 . . . . 52.2 110.522 176.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.45 131.82 82.21 Favored Pre-proline 0 C--O 1.243 0.717 0 O-C-N 123.993 0.808 . . . . 62.25 110.91 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.582 ' HG3' HD11 ' D' ' 16' ' ' ILE . 54.0 Cg_endo -67.85 110.04 2.05 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.456 2.104 . . . . 75.33 110.698 172.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 7.7 p -88.18 141.95 13.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 N-CA-C 108.134 -1.062 . . . . 75.2 108.134 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -78.61 72.72 5.15 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 122.537 1.161 . . . . 62.54 108.645 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -65.24 -35.13 80.1 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 112.701 -2.045 . . . . 72.43 110.596 -170.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.611 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 20.6 t70 -58.44 -55.29 36.93 Favored 'General case' 0 C--N 1.349 0.554 0 CA-C-N 114.497 -1.229 . . . . 64.31 110.684 177.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' B' ' 138' ' ' MET . . . -63.49 -33.22 75.1 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 124.257 0.973 . . . . 53.2 112.057 -175.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.528 HD13 ' HB3' ' F' ' 120' ' ' TYR . 37.1 tp -55.15 -46.62 75.7 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.219 1.008 . . . . 72.43 110.918 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -92.19 -15.7 27.24 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.304 0.483 . . . . 74.11 112.304 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 138' ' ' MET . . . . . 0.522 ' HB3' ' HA ' ' B' ' 135' ' ' ALA . 59.0 ttp -64.84 -37.24 86.97 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.766 0.426 . . . . 72.01 110.594 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -76.24 -24.21 54.56 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 123.208 0.317 . . . . 73.34 111.125 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -78.09 -38.43 44.14 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 109.9 -0.407 . . . . 55.42 109.9 177.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 6.1 mp -108.85 31.85 5.35 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.966 0.906 . . . . 63.13 110.308 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -67.4 -39.43 85.57 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.374 0.669 . . . . 73.03 110.111 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -67.0 109.13 2.85 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.608 0.763 . . . . 71.12 111.187 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 144' ' ' GLN . . . . . 0.518 ' HG3' ' HB2' ' B' ' 93' ' ' GLN . 21.6 tm0? -164.15 -77.47 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 109.07 -0.715 . . . . 64.34 109.07 176.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -179.13 -173.79 0.3 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.802 1.241 . . . . 34.32 109.869 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -158.88 -156.18 7.93 Favored Glycine 0 C--N 1.345 1.035 0 N-CA-C 111.405 -0.678 . . . . 74.32 111.405 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -161.35 163.52 30.67 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.574 0.75 . . . . 74.42 110.803 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -103.28 -152.39 23.4 Favored Glycine 0 C--N 1.347 1.161 0 N-CA-C 111.401 -0.68 . . . . 41.24 111.401 174.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 149' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' D' ' 150' ' ' GLU . 17.9 p -124.74 -77.36 0.59 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.573 0.749 . . . . 75.22 109.769 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 178.99 117.38 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.158 0.983 . . . . 71.41 109.116 172.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.58 108.66 8.55 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.792 0.837 . . . . 73.21 110.761 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -165.27 178.97 6.54 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.133 0.973 . . . . 73.13 109.786 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -110.02 -67.3 1.0 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.022 -0.732 . . . . 71.44 109.022 172.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -174.71 -48.42 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.376 1.071 . . . . 73.34 108.472 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.132 0 CA-C-N 115.335 -0.848 . . . . 62.24 109.213 178.061 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 84.8 mtp . . . . . 0 N--CA 1.484 1.275 0 CA-C-O 121.152 0.501 . . . . 74.11 110.119 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 52.4 p -136.58 36.21 2.68 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.998 0.919 . . . . 61.51 109.399 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.61 140.83 57.26 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 114.598 -1.183 . . . . 74.21 111.636 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -151.64 139.85 20.29 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.768 0.827 . . . . 71.02 109.653 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -86.0 -12.25 50.83 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.552 0.741 . . . . 74.4 111.068 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -62.86 130.76 46.25 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.32 0.648 . . . . 75.51 110.153 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -83.89 57.98 4.43 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 122.289 1.042 . . . . 71.45 109.975 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -61.68 -43.71 98.33 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-N 114.797 -1.092 . . . . 70.44 109.882 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.402 ' CE ' HD13 ' C' ' 89' ' ' ILE . 18.9 ttt 61.06 113.48 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.817 1.247 . . . . 63.13 110.962 -176.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.603 HG21 ' H ' ' E' ' 140' ' ' GLY . 19.5 m -128.42 108.41 10.54 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.039 0.447 . . . . 74.33 110.672 -174.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.479 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 75.6 t80 -97.58 145.64 26.06 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.229 1.012 . . . . 74.4 109.265 175.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 45.8 tp60 -151.81 142.87 23.16 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.268 0.627 . . . . 72.11 109.383 170.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 23.0 mt -88.18 131.9 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 108.107 -1.071 . . . . 74.43 108.107 173.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -90.26 -47.05 8.02 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.065 -0.717 . . . . 75.01 109.065 172.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -179.25 143.54 0.21 Allowed 'General case' 0 C--O 1.239 0.517 0 CA-C-N 113.914 -1.494 . . . . 75.31 108.424 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 pp -107.72 152.31 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.751 -1.203 . . . . 73.51 107.751 175.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.6 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 23.6 p90 -173.77 142.41 0.9 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.317 0.58 . . . . 74.43 111.368 -175.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -76.27 127.11 32.23 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.294 1.038 . . . . 63.42 110.669 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -86.31 -22.23 26.87 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.58 -0.896 . . . . 60.44 108.58 168.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.627 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.2 t70 -148.53 133.42 18.05 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.759 -0.655 . . . . 61.02 109.419 -175.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 63.6 mt -136.57 137.33 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 106.035 -1.839 . . . . 71.44 106.035 170.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.3 t -155.16 151.8 28.65 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.516 0.674 . . . . 61.25 112.174 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -153.31 143.73 22.48 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 113.747 -1.57 . . . . 73.23 107.843 174.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -145.57 113.52 6.48 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.174 0.589 . . . . 43.12 110.161 -177.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.23 77.21 48.83 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 108.059 -1.089 . . . . 44.21 108.059 164.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.46 -25.31 63.26 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.708 2.272 . . . . 73.3 111.938 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -94.39 18.65 10.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.111 1.364 . . . . 52.15 111.451 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.59 -57.24 5.9 Favored Pre-proline 0 CA--C 1.559 1.294 0 N-CA-C 113.837 1.051 . . . . 41.4 113.837 -170.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -61.72 -36.74 72.89 Favored 'Trans proline' 0 C--N 1.386 2.507 0 CA-C-N 121.575 1.598 . . . . 45.54 112.468 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -70.06 -40.25 75.18 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.967 0.907 . . . . 75.44 112.39 -178.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.777 HG21 ' HA ' ' C' ' 73' ' ' ALA . 11.3 p -76.78 -26.11 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 N-CA-C 112.649 0.611 . . . . 74.12 112.649 -176.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -61.73 -29.24 69.98 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 112.933 0.716 . . . . 71.12 112.933 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -91.72 13.09 19.16 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.921 0.488 . . . . 72.1 112.073 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.4 163.24 12.96 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.727 0.811 . . . . 74.11 109.662 177.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.62 127.96 34.91 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.425 0.69 . . . . 63.1 109.573 170.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -84.27 83.43 7.98 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.535 0.734 . . . . 74.12 110.808 -176.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -134.9 78.93 53.09 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.77 0.828 . . . . 74.14 108.799 171.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -86.76 154.39 8.77 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.755 2.303 . . . . 54.52 112.405 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -88.68 82.06 6.92 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.126 -1.435 . . . . 64.21 107.126 166.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 44.4 t -68.82 95.97 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.663 0 N-CA-C 107.856 -1.164 . . . . 64.0 107.856 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.414 ' NZ ' ' HB2' ' C' ' 43' ' ' ASP . 0.4 OUTLIER -104.18 104.87 14.86 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.124 -1.435 . . . . 60.44 107.124 -178.765 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.477 HD23 HD23 ' C' ' 128' ' ' LEU . 2.2 mp -86.74 144.97 26.84 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.689 -1.226 . . . . 73.51 107.689 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.534 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 32.6 t70 -138.26 140.97 39.87 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.176 -0.676 . . . . 64.55 109.176 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 92.8 mt -126.59 111.61 14.55 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.718 -0.845 . . . . 75.42 108.718 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -113.94 143.82 44.08 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.018 -1.475 . . . . 72.44 107.018 169.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.3 t -139.05 154.22 48.18 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 120.939 0.399 . . . . 63.44 110.034 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.82 156.26 42.98 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.172 -0.922 . . . . 74.23 108.99 175.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 30.5 p -152.66 150.45 29.48 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.27 0.628 . . . . 74.32 109.976 -175.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 49.9 p -160.56 144.85 14.05 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.201 0.6 . . . . 73.53 110.388 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -77.83 130.52 36.77 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.396 0.678 . . . . 53.43 110.176 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.703 HD11 ' HB2' ' C' ' 57' ' ' GLU . 54.0 mt -95.94 -39.75 9.63 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.521 0.729 . . . . 73.23 109.981 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.24 -171.41 2.6 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.847 0.859 . . . . 50.23 110.363 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -60.26 115.48 3.54 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.182 -0.917 . . . . 74.24 110.403 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 63.16 18.04 10.65 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.051 1.34 . . . . 65.54 111.733 177.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.8 t -121.76 117.56 52.89 Favored 'Isoleucine or valine' 0 C--N 1.354 0.763 0 C-N-CA 124.64 1.176 . . . . 43.33 108.578 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -131.14 130.35 42.96 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.313 1.045 . . . . 63.23 109.114 -176.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.703 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.0 tt0 -95.85 139.6 31.82 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.186 0.595 . . . . 73.51 109.841 173.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.01 135.01 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 108.648 -0.871 . . . . 45.45 108.648 170.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.535 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 84.3 t -113.75 144.08 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.111 0.964 . . . . 73.13 108.619 171.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.77 107.22 10.32 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.342 -0.984 . . . . 60.22 108.342 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 35.4 ttm-85 -82.08 107.63 14.93 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.517 0.727 . . . . 75.03 109.047 171.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 26.2 t -106.87 112.45 39.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.342 -0.984 . . . . 72.23 108.342 170.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 31.7 m -104.49 144.34 31.8 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.382 -0.827 . . . . 54.41 109.181 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.641 HG21 HG21 ' C' ' 114' ' ' ILE . 88.6 t -132.42 111.53 17.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 N-CA-C 107.301 -1.37 . . . . 74.41 107.301 175.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.0 m -99.11 137.27 37.87 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.908 -1.145 . . . . 71.41 107.908 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.38 104.88 5.29 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.441 -0.948 . . . . 52.44 108.441 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.9 m -129.56 132.2 46.76 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.99 0.424 . . . . 71.31 110.255 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 14.9 mt -85.36 36.94 0.66 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.623 1.169 . . . . 75.11 110.307 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.1 -108.05 2.64 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 110.954 -0.858 . . . . 50.22 110.954 -172.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -90.21 -31.98 16.79 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.113 0.565 . . . . 75.3 110.42 176.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -70.58 119.99 15.54 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.521 -0.918 . . . . 71.11 108.521 171.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 31.3 m -82.72 125.12 30.89 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.333 -0.988 . . . . 72.01 108.333 170.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.777 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.17 -52.6 18.29 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 109.226 -0.657 . . . . 71.41 109.226 176.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 74' ' ' PHE . . . . . 0.564 ' HZ ' HD21 ' C' ' 126' ' ' LEU . 33.9 p90 -165.7 169.6 14.99 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.653 -1.158 . . . . 72.1 110.913 176.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.413 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -128.48 143.25 50.95 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.422 -1.695 . . . . 53.21 106.422 167.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.546 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.6 t -150.03 122.97 8.75 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.17 -0.678 . . . . 62.12 109.17 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -137.98 134.22 34.61 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.547 -0.538 . . . . 74.24 109.547 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.512 HG21 ' HB3' ' C' ' 113' ' ' CYS . 71.7 t -128.75 136.76 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.093 0.957 . . . . 75.33 108.895 175.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.627 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.1 mt-30 -116.37 87.73 2.75 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.048 -1.093 . . . . 72.12 108.048 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -78.8 102.53 8.2 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.517 -1.22 . . . . 65.32 110.139 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -84.32 -179.64 51.62 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 116.511 -0.313 . . . . 63.24 112.646 173.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.46 134.42 2.27 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-O 119.96 -0.356 . . . . 74.52 112.511 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.517 HG12 ' HE1' ' C' ' 17' ' ' TYR . 33.5 mm -88.66 127.53 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.336 -0.987 . . . . 75.41 108.336 173.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -129.35 140.01 51.52 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.371 0.668 . . . . 73.01 110.595 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 57.8 m -97.42 103.51 15.45 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.551 0.74 . . . . 54.02 109.492 170.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.66 HG21 ' HE1' ' C' ' 94' ' ' MET . 51.0 mt -116.71 135.15 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.639 0.776 . . . . 74.31 109.358 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.92 164.38 30.24 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.157 0.583 . . . . 72.05 110.783 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.46 -18.2 57.9 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.711 -0.677 . . . . 63.13 114.487 172.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' C' ' 94' ' ' MET . 40.3 pt -119.91 173.55 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-N 118.019 0.91 . . . . 73.51 112.948 -171.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.531 ' HA ' ' HB2' ' E' ' 145' ' ' ASP . 12.1 pt-20 -161.74 178.99 8.47 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 114.028 -1.442 . . . . 54.43 109.769 174.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.96 -124.27 31.96 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 115.072 0.789 . . . . 74.2 115.072 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 4.6 m -72.28 -27.6 62.58 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.004 0.922 . . . . 70.34 111.21 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -67.15 -47.77 70.04 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.493 0.717 . . . . 73.03 109.558 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.66 ' HE1' HG21 ' C' ' 86' ' ' ILE . 4.6 tpt -55.03 -49.26 72.01 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 114.936 -1.029 . . . . 72.24 111.43 169.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.71 -33.37 68.35 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.785 0.678 . . . . 72.11 111.439 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -77.35 -36.16 53.96 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.016 0.526 . . . . 73.13 111.795 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.4 ' SG ' HD13 ' C' ' 86' ' ' ILE . 30.2 t -67.06 -36.58 82.34 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.999 -0.741 . . . . 64.43 108.999 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 55.6 mt -86.96 -22.51 25.54 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.522 1.129 . . . . 73.32 111.439 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.91 -29.19 23.97 Favored Glycine 0 C--N 1.346 1.093 0 O-C-N 123.489 0.493 . . . . 71.32 113.962 -172.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.35 -56.0 0.85 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.854 0.462 . . . . 34.14 111.351 -171.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -63.87 -59.0 5.07 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 123.543 0.527 . . . . 70.03 111.74 -169.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.479 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 72.9 m -58.83 -49.93 90.72 Favored Pre-proline 0 CA--C 1.559 1.309 0 CA-C-O 118.241 -0.885 . . . . 54.1 111.9 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 52.7 Cg_exo -57.94 -33.56 97.28 Favored 'Trans proline' 0 C--N 1.393 2.903 0 C-N-CA 122.122 1.882 . . . . 32.13 113.54 174.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -70.74 -28.45 64.72 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.832 0.453 . . . . 71.04 110.833 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.614 HD12 HH12 ' A' ' 111' ' ' ARG . 33.0 mm -74.75 -37.39 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.004 0.522 . . . . 74.31 109.833 173.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 82.4 mt -73.01 -25.18 60.88 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.894 0.877 . . . . 54.13 112.038 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 107' ' ' PHE . . . . . 0.411 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 71.7 t80 -58.23 -52.6 73.38 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 117.717 -1.135 . . . . 74.2 113.813 -174.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 108' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 52.9 Cg_exo -55.3 -34.4 88.39 Favored 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 121.917 1.745 . . . . 74.14 113.258 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -74.82 -45.55 42.56 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.492 0.717 . . . . 63.11 111.264 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.77 -35.05 75.45 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.872 0.869 . . . . 71.13 110.325 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -64.23 -49.72 70.85 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.408 1.483 . . . . 75.14 110.481 178.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -68.48 -34.21 75.53 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.127 0.571 . . . . 75.0 110.571 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.634 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 18.1 m -60.18 -53.61 55.67 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.973 0.509 . . . . 72.23 111.124 174.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.641 HG21 HG21 ' C' ' 64' ' ' VAL . 98.6 mt -58.98 -50.43 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 123.494 0.496 . . . . 74.02 110.02 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.3 m -50.17 -44.91 52.94 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 124.36 1.037 . . . . 71.4 111.415 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.3 t -66.32 -43.15 87.01 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.232 -0.895 . . . . 53.32 109.786 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.8 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.1 OUTLIER -60.28 -46.19 90.71 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.226 1.01 . . . . 53.11 111.664 178.018 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.517 HG23 ' O ' ' C' ' 114' ' ' ILE . 61.4 t -60.88 -43.31 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.723 0.809 . . . . 61.3 109.482 177.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 13.5 t -63.26 -39.12 93.7 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.038 -1.437 . . . . 62.43 111.993 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -71.61 -37.15 70.98 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.342 0.657 . . . . 54.22 109.883 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.2 -4.08 67.25 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.982 0.801 . . . . 60.05 112.608 172.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.407 HG21 ' O ' ' D' ' 16' ' ' ILE . 24.9 p 65.61 26.19 11.6 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.527 1.931 . . . . 74.1 113.288 170.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -83.04 150.05 60.53 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 108.539 -0.912 . . . . 75.35 108.539 171.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -47.33 138.75 17.42 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 123.342 2.695 . . . . 54.33 113.02 174.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -57.26 145.78 30.73 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.196 0.935 . . . . 73.02 113.514 -171.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.564 HD21 ' HZ ' ' C' ' 74' ' ' PHE . 3.4 pp -147.47 119.12 7.99 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.182 -0.917 . . . . 62.31 109.133 173.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -113.72 115.11 27.31 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.352 -1.351 . . . . 73.24 107.352 176.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.477 HD23 HD23 ' C' ' 42' ' ' LEU . 6.0 mp -61.22 134.15 56.69 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 124.156 0.91 . . . . 70.44 111.321 -170.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.39 146.77 96.05 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 123.513 0.725 . . . . 73.33 110.59 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.611 ' HG2' HG21 ' A' ' 13' ' ' ILE . 46.0 Cg_exo -55.93 104.1 0.13 Allowed 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.584 2.189 . . . . 62.21 112.295 174.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 52.7 t -99.08 113.65 34.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.157 -1.053 . . . . 55.24 108.157 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -75.66 103.32 5.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.954 0.501 . . . . 53.13 110.124 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -62.8 -28.13 69.78 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.441 0.696 . . . . 71.51 111.185 177.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.38 -43.13 86.74 Favored 'General case' 0 C--N 1.349 0.572 0 O-C-N 123.726 0.641 . . . . 54.04 109.769 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.53 -40.31 71.67 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.186 0.994 . . . . 63.42 111.051 175.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 49.8 mt -76.46 -35.0 58.7 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.116 -0.947 . . . . 74.15 111.158 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -81.29 -21.48 39.3 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.922 0.489 . . . . 72.52 111.428 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 65.3 mtt -68.47 -33.52 74.32 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.709 0.403 . . . . 42.13 109.927 172.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -61.88 -36.63 81.82 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.848 0.859 . . . . 51.34 110.118 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -69.39 -87.97 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.486 -0.779 . . . . 72.13 110.021 172.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 43.3 tp 59.32 166.25 0.06 Allowed 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 124.367 1.067 . . . . 73.54 110.994 -169.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -148.7 -80.8 0.13 Allowed 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.094 -1.003 . . . . 63.32 109.38 174.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.29 108.09 18.54 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.607 -0.886 . . . . 51.44 108.607 -172.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -73.5 93.77 2.03 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.236 1.014 . . . . 74.15 111.648 -174.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 53.18 32.48 13.35 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.957 1.303 . . . . 74.34 114.411 163.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.44 70.38 3.11 Favored Glycine 0 C--N 1.347 1.19 0 N-CA-C 110.662 -0.975 . . . . 64.0 110.662 175.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -116.34 124.86 51.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.063 0.945 . . . . 64.24 108.611 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -155.55 24.72 0.58 Allowed Glycine 0 C--N 1.34 0.797 0 N-CA-C 111.362 -0.695 . . . . 42.5 111.362 175.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 46.2 m -73.89 106.74 5.74 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.042 0.937 . . . . 62.21 110.614 -174.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -113.89 104.61 12.35 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.258 -1.015 . . . . 53.3 108.258 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -106.23 127.01 52.92 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.206 0.602 . . . . 72.41 109.511 176.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -137.37 109.78 7.41 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.371 0.605 . . . . 63.22 111.229 -168.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -103.18 138.36 40.09 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.916 -1.142 . . . . 62.22 107.916 168.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -70.54 120.61 16.43 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.084 -0.71 . . . . 55.22 109.084 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 N-CA-C 108.395 -0.965 . . . . 54.11 108.395 178.923 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 1' ' ' MET . . . . . 0.563 ' HA ' ' HA ' ' F' ' 123' ' ' ASP . 11.8 tpt . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.884 0.373 . . . . 74.44 110.074 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m -82.92 83.95 7.6 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.104 0.562 . . . . 61.43 110.66 -178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -175.3 143.07 0.64 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.679 0.792 . . . . 74.42 109.984 172.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -156.49 116.06 3.52 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.226 -1.398 . . . . 62.03 107.226 171.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -162.92 147.51 11.54 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.318 0.647 . . . . 71.03 109.451 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -75.28 124.17 26.61 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.334 -0.617 . . . . 54.54 109.334 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 45.3 p -110.65 -168.58 1.33 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.883 0.873 . . . . 60.52 109.559 176.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -72.03 -149.43 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.204 0.602 . . . . 52.45 110.508 170.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.516 ' HG2' HG13 ' D' ' 89' ' ' ILE . 0.3 OUTLIER -30.53 123.28 0.19 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 125.27 1.428 . . . . 73.55 112.761 177.467 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 27.2 p -105.38 126.96 52.7 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.303 0.641 . . . . 73.44 109.501 -177.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -142.78 104.44 4.35 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.434 -1.321 . . . . 71.5 107.434 174.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.96 147.23 34.87 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.256 -0.646 . . . . 74.12 109.256 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mt -93.15 127.79 45.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.628 -1.249 . . . . 71.22 107.628 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 14' ' ' GLN . . . . . 0.628 ' HB2' HG23 ' D' ' 83' ' ' ILE . 37.2 mt-30 -90.51 -31.02 16.93 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 123.588 0.555 . . . . 73.35 110.041 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -167.57 131.05 1.72 Allowed 'General case' 0 C--N 1.347 0.487 0 CA-C-N 115.984 -0.553 . . . . 73.34 110.259 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.582 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.8 mp -103.57 140.69 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 106.662 -1.607 . . . . 71.45 106.662 171.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -165.01 141.08 5.58 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.46 0.573 . . . . 74.13 111.981 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.7 p -84.08 114.33 21.67 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.651 -0.704 . . . . 73.31 109.772 175.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.0 mtpt -83.81 -10.25 58.19 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.309 -0.859 . . . . 74.11 110.309 175.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.638 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 14.2 t70 -166.01 144.86 5.94 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.609 1.164 . . . . 43.14 108.907 176.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.8 HD13 ' HE3' ' C' ' 117' ' ' MET . 82.6 mt -139.81 145.56 26.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 125.267 1.427 . . . . 71.11 107.428 174.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -153.41 144.36 22.84 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 123.634 0.584 . . . . 73.23 110.522 176.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.402 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 73.7 t80 -153.4 129.43 10.32 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.063 -1.458 . . . . 71.51 107.063 171.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -140.61 119.16 12.3 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.325 0.65 . . . . 71.43 110.407 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.02 90.04 3.37 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 108.132 -1.062 . . . . 63.41 108.132 170.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.97 -42.71 2.96 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 123.582 2.855 . . . . 53.21 113.072 -171.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.417 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 13.3 m120 -96.81 20.9 10.26 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.491 0.716 . . . . 65.33 110.708 -176.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.6 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -40.13 -66.66 0.34 Allowed Pre-proline 0 CA--C 1.576 1.964 0 N-CA-C 116.109 1.892 . . . . 55.23 116.109 -155.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.516 ' HB3' HD11 ' C' ' 83' ' ' ILE . 66.9 Cg_endo -74.35 -22.49 16.3 Favored 'Trans proline' 0 C--N 1.393 2.881 0 CA-C-N 123.686 2.352 . . . . 55.33 113.712 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -70.97 -37.95 72.76 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.836 0.854 . . . . 73.53 110.079 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.524 HG23 ' HG3' ' D' ' 71' ' ' GLU . 5.1 p -83.85 -19.78 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 122.615 0.366 . . . . 60.54 111.392 -173.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.41 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 23.3 m-30 -64.12 -18.58 64.55 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 112.411 0.523 . . . . 73.22 112.411 173.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -57.6 -26.26 61.26 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.713 0.805 . . . . 64.2 110.696 172.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.456 ' CB ' ' HB3' ' D' ' 68' ' ' LEU . 28.8 mmtp -85.74 99.43 11.33 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.728 1.211 . . . . 74.33 109.233 174.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -94.58 85.11 4.42 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 122.726 0.411 . . . . 71.43 110.336 -178.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 39.6 p90 -167.68 179.73 4.69 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.216 1.006 . . . . 73.23 109.824 169.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -68.79 118.34 59.82 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.248 0.619 . . . . 74.32 110.045 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.61 124.94 16.91 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.863 2.375 . . . . 74.43 111.89 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -63.31 108.72 1.37 Allowed 'General case' 0 C--N 1.353 0.759 0 N-CA-C 109.285 -0.635 . . . . 75.03 109.285 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.703 HG13 HG13 ' D' ' 64' ' ' VAL . 73.4 t -100.07 131.56 47.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.258 -0.883 . . . . 61.12 108.878 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.07 149.13 31.23 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 107.815 -1.18 . . . . 43.13 107.815 169.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.453 HD11 HG13 ' D' ' 62' ' ' VAL . 37.1 tp -116.19 136.23 53.2 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 116.037 -0.529 . . . . 74.34 110.212 -177.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.56 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 0.6 OUTLIER -126.92 132.23 50.93 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 107.382 -1.34 . . . . 74.43 107.382 172.721 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.627 HD12 HG21 ' E' ' 121' ' ' VAL . 89.5 mt -125.18 130.81 52.89 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.093 0.473 . . . . 72.42 110.084 178.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -134.53 120.15 19.33 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.209 -1.404 . . . . 73.22 107.209 177.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 46' ' ' THR . . . . . 0.406 HG21 ' HG3' ' D' ' 103' ' ' PRO . 56.7 m -105.56 148.51 27.2 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.365 0.602 . . . . 63.13 110.266 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.27 -179.11 6.93 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.668 1.187 . . . . 73.53 108.721 173.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 25.8 p -159.94 -164.13 1.25 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.112 -1.44 . . . . 71.14 107.112 174.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 79.1 p -150.91 145.13 25.43 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 109.694 -0.484 . . . . 74.44 109.694 174.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 50' ' ' GLN . . . . . 0.444 ' HG2' ' HB2' ' D' ' 52' ' ' ALA . 49.9 tt0 72.43 123.37 0.04 OUTLIER 'General case' 0 C--N 1.362 1.127 0 O-C-N 124.793 1.308 . . . . 74.34 111.0 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.613 HD11 ' HG3' ' E' ' 105' ' ' GLN . 3.7 mm? -58.58 -52.31 66.19 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.408 0.683 . . . . 65.25 109.48 177.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.444 ' HB2' ' HG2' ' D' ' 50' ' ' GLN . . . 67.89 -177.43 0.21 Allowed 'General case' 0 C--N 1.348 0.534 0 N-CA-C 114.775 1.398 . . . . 74.5 114.775 163.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -147.56 110.3 4.71 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 113.815 -1.539 . . . . 65.32 107.471 171.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 58.21 12.66 2.0 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.907 1.683 . . . . 72.34 114.372 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 72.8 t -135.13 98.12 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 108.306 -0.998 . . . . 62.12 108.306 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.466 ' OH ' HD21 ' E' ' 100' ' ' LEU . 4.4 m-85 -138.08 131.2 30.2 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.221 -0.659 . . . . 63.14 109.221 -174.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.48 118.51 36.91 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.026 -1.101 . . . . 65.33 108.026 170.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.405 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 85.7 t -101.9 141.29 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.771 0.828 . . . . 52.45 109.33 -177.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 15.3 t -121.63 131.45 73.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 124.2 1.0 . . . . 71.35 108.747 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.403 HD21 HD22 ' D' ' 44' ' ' LEU . 0.2 OUTLIER -106.19 122.94 47.22 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 107.244 -1.391 . . . . 74.52 107.244 176.186 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.499 ' HG2' ' HG2' ' D' ' 79' ' ' GLN . 0.0 OUTLIER -101.69 95.6 6.54 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 106.732 -1.581 . . . . 64.52 106.732 177.854 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.458 HG22 ' CD2' ' D' ' 44' ' ' LEU . 84.0 t -90.73 134.52 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 108.764 -0.828 . . . . 64.15 108.764 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.56 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 89.9 m -124.19 132.91 53.65 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 124.393 1.058 . . . . 73.42 109.246 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.703 HG13 HG13 ' D' ' 40' ' ' VAL . 73.5 t -127.31 130.3 70.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 124.671 1.188 . . . . 71.3 108.09 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 30.7 m -130.0 103.52 6.82 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.099 -1.074 . . . . 70.23 108.099 171.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.679 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -97.29 141.73 30.03 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.353 -0.84 . . . . 64.14 109.088 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.441 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 40.6 p -145.6 139.84 26.95 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.847 -0.615 . . . . 64.04 110.707 -172.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.456 ' HB3' ' CB ' ' D' ' 34' ' ' LYS . 31.7 mt -116.69 106.1 13.14 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.537 1.135 . . . . 61.21 108.832 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.4 -113.89 3.97 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 111.429 -0.668 . . . . 40.4 111.429 -173.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -121.06 23.2 10.73 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.531 0.732 . . . . 60.42 110.169 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 71' ' ' GLU . . . . . 0.524 ' HG3' HG23 ' D' ' 31' ' ' VAL . 12.9 pt-20 -134.74 158.1 45.01 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 121.698 -0.626 . . . . 61.32 110.416 175.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 40.5 m -75.41 124.29 26.88 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.236 -0.893 . . . . 75.02 111.89 -175.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.491 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -75.32 -69.96 0.45 Allowed 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.117 -1.068 . . . . 63.02 108.117 171.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -148.08 169.22 20.45 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.222 -0.899 . . . . 73.1 110.528 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 58.3 mt -130.38 151.18 51.15 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.103 -1.814 . . . . 52.41 106.103 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.661 ' SG ' HG12 ' D' ' 114' ' ' ILE . 12.0 t -159.17 128.22 5.35 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.561 -0.533 . . . . 71.33 109.561 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -150.7 121.44 7.53 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.611 0.244 . . . . 70.31 110.545 -171.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 93.7 t -131.6 126.87 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.696 0.798 . . . . 74.31 109.918 -171.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.638 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 44.3 mt-30 -91.6 89.02 6.98 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.679 -0.86 . . . . 72.41 108.679 166.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -87.34 98.14 11.19 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.357 -0.838 . . . . 64.23 109.359 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.07 165.0 23.92 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.797 -0.638 . . . . 74.13 112.69 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.67 137.57 4.72 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 111.642 -0.583 . . . . 42.31 111.642 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.628 HG23 ' HB2' ' D' ' 14' ' ' GLN . 8.4 tp -90.66 118.32 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 CA-C-O 121.568 0.699 . . . . 74.33 109.969 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.405 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 64.7 m-85 -112.99 138.91 49.15 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.624 1.17 . . . . 64.31 109.893 -178.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 23.7 t -115.49 104.36 11.67 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.639 -1.245 . . . . 42.43 107.639 169.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 50.2 pt -119.2 138.62 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.406 0.283 . . . . 62.41 110.466 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.89 169.01 22.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.432 1.093 . . . . 72.43 110.243 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.63 -13.68 66.76 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 114.519 0.568 . . . . 65.04 114.519 171.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.516 HG13 ' HG2' ' D' ' 9' ' ' MET . 0.8 OUTLIER -107.74 153.79 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.424 0.69 . . . . 73.0 110.781 -179.347 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -134.52 170.34 15.91 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.682 1.193 . . . . 65.14 109.818 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.34 -141.49 28.93 Favored Glycine 0 N--CA 1.472 1.074 0 O-C-N 123.271 0.357 . . . . 63.52 113.901 174.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 36.4 p -80.77 -43.81 19.57 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.355 0.662 . . . . 71.03 110.779 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -56.93 -26.95 60.44 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.196 0.998 . . . . 65.4 112.3 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.736 ' SD ' HD23 ' E' ' 100' ' ' LEU . 10.6 tmm? -59.15 -60.93 3.08 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 124.79 1.236 . . . . 74.42 112.103 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.91 -15.7 55.57 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.911 0.484 . . . . 64.33 111.345 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -66.35 -41.58 89.33 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.78 0.832 . . . . 74.25 109.851 175.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 73.0 m -60.65 -29.58 69.36 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.165 0.586 . . . . 43.55 111.406 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.594 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 18.5 tp -82.7 -43.26 17.07 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.06 0.544 . . . . 72.12 110.948 178.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 99' ' ' GLY . . . . . 0.432 ' HA3' HG21 ' E' ' 103' ' ' THR . . . -76.88 -21.83 73.29 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-N 115.682 -0.69 . . . . 74.2 113.661 -174.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -122.44 -56.55 1.79 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.241 0.616 . . . . 62.43 111.531 -174.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 101' ' ' TYR . . . . . 0.42 ' O ' HG12 ' D' ' 105' ' ' ILE . 31.6 t80 -73.28 -31.9 64.33 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 112.001 0.371 . . . . 74.3 112.001 -172.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.594 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 84.4 m -65.82 -49.89 56.79 Favored Pre-proline 0 CA--C 1.566 1.588 0 CA-C-O 118.309 -0.853 . . . . 74.22 112.334 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.406 ' HG3' HG21 ' D' ' 46' ' ' THR . 33.4 Cg_endo -65.13 -23.83 59.98 Favored 'Trans proline' 0 C--N 1.389 2.683 0 C-N-CA 121.753 1.635 . . . . 65.55 113.259 171.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.34 -36.28 83.62 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.694 -0.484 . . . . 72.33 109.694 174.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.42 HG12 ' O ' ' D' ' 101' ' ' TYR . 28.8 mm -70.13 -40.47 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.743 1.217 . . . . 74.24 111.012 175.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 55.4 mt -70.17 -20.36 63.14 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 116.017 -0.538 . . . . 63.33 111.617 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -68.84 -43.95 29.04 Favored Pre-proline 0 CA--C 1.56 1.334 0 N-CA-C 113.997 1.11 . . . . 75.34 113.997 -173.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 108' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' D' ' 105' ' ' ILE . 71.4 Cg_exo -45.93 -43.0 20.21 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 122.53 2.153 . . . . 62.34 113.732 168.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -80.53 -29.85 37.17 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.683 0.793 . . . . 74.51 112.206 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.93 -49.87 64.14 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.586 0.708 . . . . 74.45 109.397 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.541 HH12 ' HB3' ' D' ' 130' ' ' PRO . 34.4 ttp180 -63.0 -34.73 78.19 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 113.843 -1.526 . . . . 74.4 110.756 174.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 112' ' ' GLU . . . . . 0.482 ' HA ' ' CE2' ' B' ' 109' ' ' TYR . 9.5 tt0 -55.14 -54.2 46.25 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.625 0.77 . . . . 55.3 111.351 177.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.0 t -59.28 -46.24 89.06 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.726 -1.125 . . . . 75.03 110.508 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.661 HG12 ' SG ' ' D' ' 76' ' ' CYS . 74.9 mt -60.95 -56.5 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.411 1.084 . . . . 75.54 111.785 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 95.5 m -55.02 -40.95 70.75 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.823 1.249 . . . . 54.4 111.693 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 42.7 t -69.53 -27.95 65.61 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.435 -0.802 . . . . 33.34 111.327 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.602 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 76.8 mtm -84.33 -30.12 25.77 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.174 0.59 . . . . 73.22 111.873 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.421 HG23 ' O ' ' D' ' 114' ' ' ILE . 61.0 t -66.33 -39.38 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.725 0.81 . . . . 72.44 110.656 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.7 p -66.62 -27.29 67.58 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 115.652 -0.704 . . . . 72.43 110.678 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.634 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 64.3 mtt-85 -80.61 -16.25 54.56 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.775 0.83 . . . . 74.54 111.582 177.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.3 4.71 74.15 Favored Glycine 0 C--N 1.352 1.468 0 CA-C-O 119.621 -0.544 . . . . 54.21 113.156 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.555 HG23 ' HB3' ' C' ' 17' ' ' TYR . 81.0 p 56.17 27.67 11.95 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.874 1.669 . . . . 71.14 113.003 -174.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -95.08 149.62 36.5 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 123.121 0.568 . . . . 64.35 109.533 172.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -50.4 146.96 17.69 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 123.174 2.583 . . . . 70.43 113.966 171.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 41.2 tp60 -47.64 124.18 6.8 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.28 1.832 . . . . 73.43 112.911 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.561 HD13 HG21 ' D' ' 40' ' ' VAL . 13.0 tp -107.24 117.72 34.81 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.535 -0.913 . . . . 74.31 108.535 175.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -121.12 100.09 6.86 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.62 -1.252 . . . . 70.21 107.62 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.405 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 90.1 mt -65.21 120.09 12.08 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 109.411 -0.588 . . . . 72.43 109.411 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.87 122.96 69.49 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 122.839 0.455 . . . . 72.3 110.599 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.541 ' HB3' HH12 ' D' ' 111' ' ' ARG . 60.1 Cg_endo -71.42 114.31 3.89 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.395 2.063 . . . . 70.44 111.44 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 12.3 p -108.43 150.08 11.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 123.461 0.704 . . . . 73.0 109.276 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -79.03 109.53 13.43 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.116 -0.698 . . . . 73.03 109.116 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.576 ' HA ' HD13 ' D' ' 136' ' ' LEU . 1.3 m-85 -67.13 -21.43 65.84 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.725 0.81 . . . . 75.41 110.904 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -62.92 -37.69 88.01 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.844 0.857 . . . . 64.22 110.08 171.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.79 -33.62 74.17 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.682 0.793 . . . . 45.23 110.945 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.576 HD13 ' HA ' ' D' ' 133' ' ' PHE . 10.3 mp -59.34 -33.95 71.77 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.185 0.594 . . . . 74.03 110.495 175.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -77.6 -33.41 53.83 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.218 0.607 . . . . 71.32 111.763 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 45.5 mtt -58.21 -34.71 70.68 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 122.642 0.377 . . . . 61.4 110.423 176.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -51.07 -44.87 61.26 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.897 1.279 . . . . 54.33 111.796 175.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 140' ' ' TYR . . . . . 0.463 ' HB2' ' HB2' ' E' ' 110' ' ' ALA . 81.2 t80 -80.62 -38.74 28.71 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.634 -0.712 . . . . 74.05 110.837 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.26 -27.69 66.55 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.012 0.925 . . . . 73.11 112.153 -174.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -85.68 2.96 43.16 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.991 0.516 . . . . 74.22 111.301 177.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -118.17 44.5 2.2 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 122.968 1.366 . . . . 75.13 108.209 -173.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -173.24 -177.91 1.63 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 113.792 -1.549 . . . . 72.42 108.009 -175.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.81 82.95 1.18 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.021 -0.733 . . . . 71.41 109.021 172.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -139.88 36.55 1.81 Allowed Glycine 0 C--N 1.345 1.072 0 CA-C-N 114.569 -1.196 . . . . 33.02 110.772 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -59.11 133.71 56.34 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.251 1.02 . . . . 52.42 110.876 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 154.52 37.06 0.02 OUTLIER Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.612 -0.722 . . . . 11.4 111.406 -176.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 42.8 p -98.96 129.11 45.25 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.449 0.7 . . . . 54.53 109.805 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 150' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' B' ' 149' ' ' THR . 37.5 tt0 -122.62 117.12 25.08 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.913 0.885 . . . . 74.34 109.044 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -74.74 105.22 5.71 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.466 -0.939 . . . . 73.34 108.466 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -101.61 149.71 23.84 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.256 0.622 . . . . 64.35 111.026 -173.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -158.66 124.06 4.36 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.497 -1.297 . . . . 61.54 107.497 168.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -65.91 -39.66 90.77 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.795 0.438 . . . . 33.3 110.387 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.175 0 N-CA-C 108.48 -0.933 . . . . 73.54 108.48 170.837 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.495 0 N-CA-C 110.826 -0.91 . . . . 62.14 110.826 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.12 76.91 2.09 Favored Glycine 0 C--N 1.342 0.87 0 N-CA-C 111.408 -0.677 . . . . 75.24 111.408 173.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 66.01 -169.14 0.2 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.29 1.036 . . . . 74.34 111.509 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -103.69 175.5 5.46 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.628 0.771 . . . . 63.31 109.815 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -144.61 143.35 30.73 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.843 0.857 . . . . 62.3 109.999 166.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.34 -18.05 0.04 OUTLIER Glycine 0 C--N 1.347 1.156 0 CA-C-O 119.672 -0.516 . . . . 44.25 113.525 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 97' ' ' ILE . . . . . . . . . . . . . 41.5 mt -79.22 117.04 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 117.374 0.587 . . . . 74.44 110.264 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -81.61 78.87 8.31 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.103 0.961 . . . . 52.4 109.864 176.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . 64.89 149.57 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.132 1.373 . . . . 61.21 113.983 175.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 100' ' ' LEU . . . . . 0.736 HD23 ' SD ' ' D' ' 94' ' ' MET . 0.3 OUTLIER -161.32 147.69 11.31 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 123.684 0.793 . . . . 72.03 111.138 171.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -94.58 11.22 1.71 Allowed 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 123.137 2.558 . . . . 74.12 111.98 164.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 102' ' ' LEU . . . . . 0.452 HD23 HD22 ' E' ' 100' ' ' LEU . 28.0 mt 58.58 -164.38 0.2 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.37 1.068 . . . . 61.22 110.931 -171.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 103' ' ' THR . . . . . 0.432 HG21 ' HA3' ' D' ' 99' ' ' GLY . 23.5 p -80.76 73.88 7.72 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.022 0.529 . . . . 73.01 109.961 173.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 58.02 34.94 74.15 Favored Glycine 0 C--N 1.356 1.655 0 CA-C-N 115.888 -0.596 . . . . 43.43 114.334 176.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 105' ' ' GLN . . . . . 0.613 ' HG3' HD11 ' D' ' 51' ' ' LEU . 1.9 mp0 65.2 4.29 2.55 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.647 1.179 . . . . 61.31 113.079 -178.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -159.67 -85.4 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.162 0.585 . . . . 74.54 109.607 -177.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 2.7 p -137.75 -72.6 0.42 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.007 0.923 . . . . 75.54 108.696 170.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 11.4 m170 71.29 -54.77 0.67 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.43 1.492 . . . . 70.13 112.846 177.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -59.52 -75.24 0.06 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.122 0.969 . . . . 74.43 110.941 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 110' ' ' ALA . . . . . 0.463 ' HB2' ' HB2' ' D' ' 140' ' ' TYR . . . -160.55 -158.68 0.63 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.311 0.645 . . . . 63.51 109.605 -172.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 111' ' ' LEU . . . . . 0.493 ' HA ' HD23 ' D' ' 136' ' ' LEU . 3.2 tt 80.64 -59.58 0.28 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 125.696 1.598 . . . . 71.11 109.651 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -54.41 107.92 0.33 Allowed 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.99 0.916 . . . . 30.35 109.528 172.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -69.4 92.33 0.6 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.194 -0.912 . . . . 62.11 109.904 -175.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -84.61 78.83 9.77 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.906 -1.043 . . . . 71.32 109.1 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 24.6 m 62.78 -77.28 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 124.921 1.288 . . . . 70.03 111.794 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . -148.86 28.14 1.29 Allowed Glycine 0 C--N 1.35 1.309 0 CA-C-O 119.748 -0.473 . . . . 72.34 112.678 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -67.06 -48.82 48.57 Favored Pre-proline 0 CA--C 1.558 1.269 0 CA-C-O 118.636 -0.697 . . . . 71.41 111.034 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -86.53 131.43 3.43 Favored 'Trans proline' 0 C--N 1.393 2.883 0 C-N-CA 121.403 1.402 . . . . 71.41 111.636 171.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -66.46 -26.7 67.32 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.452 0.701 . . . . 61.41 110.024 173.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -76.76 149.02 36.33 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.048 -0.978 . . . . 74.32 109.878 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 121' ' ' VAL . . . . . 0.627 HG21 HD12 ' D' ' 44' ' ' LEU . 45.3 t 60.27 79.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.177 0.991 . . . . 64.43 110.574 176.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 13.7 t -173.34 -27.0 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.131 0.972 . . . . 53.01 109.782 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -74.9 154.58 38.13 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.546 0.738 . . . . 72.5 110.078 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 11.9 m -70.46 133.15 46.56 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.69 0.796 . . . . 64.51 111.005 -174.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.09 98.27 0.57 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.273 0.629 . . . . 53.13 109.873 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.48 111.51 9.74 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.791 0.837 . . . . 71.34 111.744 -173.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 64.1 m -139.62 166.06 25.61 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.356 1.062 . . . . 62.43 109.031 174.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.48 108.34 3.15 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.731 0.412 . . . . 75.13 110.53 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 129' ' ' THR . . . . . 0.401 HG23 ' NH2' ' B' ' 15' ' ' ARG . 42.5 m -150.67 141.34 22.67 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.181 0.993 . . . . 71.24 109.388 177.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -97.2 141.12 30.71 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 108.886 -0.783 . . . . 62.22 108.886 174.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 131' ' ' TRP . . . . . 0.452 ' HA ' ' HG3' ' A' ' 124' ' ' PRO . 7.0 t-105 -145.37 95.09 2.61 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.603 -0.517 . . . . 71.44 109.603 -174.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 41.7 t -159.05 138.78 11.78 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.446 0.699 . . . . 70.14 110.303 175.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 133' ' ' THR . . . . . 0.453 HG23 ' HB2' ' A' ' 124' ' ' PRO . 6.5 p -139.83 -69.01 0.41 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.545 1.138 . . . . 73.24 108.898 173.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . 64.3 55.15 25.23 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 111.572 -0.611 . . . . 73.12 111.572 -176.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 4.2 p -59.31 110.56 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.316 0 C-N-CA 123.69 0.796 . . . . 64.41 111.979 -173.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -119.01 89.79 3.2 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.335 1.054 . . . . 74.32 108.344 174.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 137' ' ' THR . . . . . 0.453 HG23 ' HB2' ' A' ' 129' ' ' ALA . 10.1 t -138.46 147.33 43.14 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.752 -0.462 . . . . 51.31 109.752 177.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 138' ' ' TYR . . . . . 0.419 ' HD2' ' HB3' ' A' ' 129' ' ' ALA . 34.3 m-85 60.31 33.34 20.87 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.096 0.959 . . . . 74.13 110.668 -172.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -131.68 142.09 49.74 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.924 0.89 . . . . 55.12 110.287 -176.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 140' ' ' GLY . . . . . 0.603 ' H ' HG21 ' C' ' 10' ' ' THR . . . 161.86 90.88 0.08 OUTLIER Glycine 0 C--N 1.354 1.572 0 N-CA-C 112.3 -0.32 . . . . 65.32 112.3 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -160.93 -171.44 3.08 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.209 1.004 . . . . 74.33 110.2 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 16.0 tp -150.09 145.8 26.56 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.117 -0.697 . . . . 73.11 109.117 176.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . 143.2 77.0 0.04 OUTLIER Glycine 0 C--N 1.346 1.129 0 N-CA-C 111.405 -0.678 . . . . 61.33 111.405 176.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 11.5 p -83.54 138.69 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.344 0.658 . . . . 64.3 110.469 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 145' ' ' ASP . . . . . 0.531 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 30.9 t70 . . . . . 0 C--O 1.248 1.021 0 N-CA-C 108.29 -1.004 . . . . 74.12 108.29 167.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.783 0 N-CA-C 112.203 -0.359 . . . . 65.52 112.203 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . -159.4 -152.59 6.53 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 110.786 -0.926 . . . . 72.41 110.786 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 56.32 69.08 0.77 Allowed 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.029 0.932 . . . . 74.41 111.425 176.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -156.29 29.36 0.34 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 113.381 0.882 . . . . 53.23 113.381 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 36.65 77.27 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 126.368 1.867 . . . . 62.33 114.133 175.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -131.12 -36.9 0.32 Allowed Glycine 0 N--CA 1.473 1.128 0 CA-C-N 115.893 -0.594 . . . . 61.14 112.457 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 97' ' ' ILE . . . . . 0.411 HD11 ' HB2' ' B' ' 94' ' ' MET . 14.6 tt -78.74 167.5 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.225 0 C-N-CA 123.05 0.54 . . . . 73.3 109.846 176.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.87 -84.43 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.798 0.839 . . . . 73.21 112.12 -175.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -153.6 5.74 0.33 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.133 0.573 . . . . 61.22 111.526 -172.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 100' ' ' LEU . . . . . 0.41 ' N ' ' HD3' ' F' ' 101' ' ' PRO . 86.8 mt 50.0 47.25 4.53 Favored Pre-proline 0 CA--C 1.571 1.767 0 C-N-CA 124.252 1.021 . . . . 75.03 113.038 -175.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 101' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' F' ' 100' ' ' LEU . 90.5 Cg_endo -86.68 112.31 1.01 Allowed 'Trans proline' 0 C--N 1.387 2.598 0 C-N-CA 122.242 1.961 . . . . 74.02 111.745 -176.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 102' ' ' LEU . . . . . 0.479 ' HB2' ' OH ' ' B' ' 56' ' ' TYR . 22.2 tp -74.94 153.48 38.57 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 109.354 -0.61 . . . . 64.23 109.354 177.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 27.9 p -71.03 90.58 0.84 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 121.624 0.726 . . . . 70.52 110.327 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.31 -93.0 0.78 Allowed Glycine 0 C--N 1.348 1.244 0 CA-C-N 114.866 -1.061 . . . . 73.5 110.535 -171.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -172.82 -69.75 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.497 1.119 . . . . 62.23 108.403 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -85.35 104.12 14.89 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 106.877 -1.527 . . . . 74.44 106.877 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 59.5 m -62.85 101.7 0.29 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.039 0.536 . . . . 65.03 110.7 -176.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 108' ' ' HIS . . . . . 0.533 ' HA ' ' HB3' ' F' ' 112' ' ' ASN . 81.2 m-70 -92.21 19.85 6.56 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.981 0.912 . . . . 74.42 112.101 -178.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -130.82 158.91 38.87 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 109.375 -0.602 . . . . 72.11 109.375 170.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 73.08 -67.49 0.26 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.068 1.347 . . . . 73.31 112.086 174.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 111' ' ' LEU . . . . . 0.476 HD22 HG22 ' B' ' 46' ' ' THR . 9.3 mp -78.61 -36.88 43.55 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.83 0.852 . . . . 70.31 110.408 175.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 112' ' ' ASN . . . . . 0.533 ' HB3' ' HA ' ' F' ' 108' ' ' HIS . 23.9 t-20 -117.79 153.05 34.11 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.443 1.097 . . . . 71.44 108.299 -177.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm 57.71 31.57 20.61 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.627 0.771 . . . . 74.14 111.664 -174.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 114' ' ' LYS . . . . . 0.418 ' H ' ' HD3' ' F' ' 114' ' ' LYS . 0.1 OUTLIER -84.19 59.45 5.34 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 123.142 1.448 . . . . 62.3 109.807 179.605 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 19.4 p -126.46 170.05 12.38 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 114.059 -1.428 . . . . 72.24 110.807 -172.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.21 -99.34 1.69 Allowed Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.511 -0.768 . . . . 71.44 111.826 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -77.32 163.82 62.19 Favored Pre-proline 0 CA--C 1.56 1.341 0 C-N-CA 123.742 0.817 . . . . 75.21 110.902 -177.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -40.83 117.2 0.48 Allowed 'Trans proline' 0 C--N 1.388 2.646 0 C-N-CA 124.257 3.305 . . . . 65.4 114.64 173.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -91.85 -173.6 3.55 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.584 0.754 . . . . 62.14 109.399 173.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 120' ' ' TYR . . . . . 0.528 ' HB3' HD13 ' B' ' 136' ' ' LEU . 52.4 t80 -146.53 41.78 1.15 Allowed 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.894 0.855 . . . . 75.15 109.139 -172.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 8.6 p -147.29 146.76 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 115.685 -0.689 . . . . 63.54 110.104 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 5.9 m 71.01 14.02 6.87 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.634 1.174 . . . . 72.32 112.136 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 123' ' ' ASP . . . . . 0.563 ' HA ' ' HA ' ' D' ' 1' ' ' MET . 3.9 m-20 -54.54 101.67 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.152 0.981 . . . . 73.3 111.711 -177.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 38.9 t 79.41 -44.4 0.32 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.097 1.759 . . . . 71.35 112.842 177.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . 71.14 168.9 0.32 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.086 1.354 . . . . 72.13 111.472 -171.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.62 -62.76 1.35 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.911 0.484 . . . . 75.2 110.967 -173.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 42.0 m 53.76 -148.17 0.46 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.1 0.96 . . . . 55.32 110.755 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -159.57 -91.45 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.333 0.515 . . . . 73.1 110.798 168.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 15.1 t -178.85 -177.35 0.49 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.47 0.708 . . . . 72.31 110.105 -171.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 130' ' ' ALA . . . . . 0.607 ' HB2' ' HA ' ' B' ' 36' ' ' TRP . . . -70.16 -173.2 0.65 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.151 0.98 . . . . 64.24 111.474 174.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -142.76 129.98 20.94 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 122.729 0.411 . . . . 70.44 110.08 -174.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 30.9 p -107.76 77.37 1.12 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.523 0.729 . . . . 71.01 109.726 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 15.8 p -83.89 93.84 8.11 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.525 -0.762 . . . . 61.43 110.49 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.94 7.23 29.37 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 115.817 -0.629 . . . . 72.11 114.05 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 p -69.54 92.33 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 CA-C-O 122.161 0.981 . . . . 65.42 110.086 173.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -122.85 107.53 11.97 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.151 -1.055 . . . . 75.32 108.151 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 10.4 m 64.11 -80.39 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.528 1.131 . . . . 53.34 109.806 -167.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -149.02 -170.76 3.71 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.389 1.476 . . . . 72.34 108.556 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -78.21 145.6 35.44 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.876 -0.416 . . . . 73.32 109.876 173.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -153.62 -107.0 0.29 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 110.859 -0.897 . . . . 71.24 110.859 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -138.29 84.14 2.01 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 108.973 -0.751 . . . . 61.14 108.973 175.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.0 176.25 7.76 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.759 0.824 . . . . 63.25 111.654 -176.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . 97.5 137.04 9.41 Favored Glycine 0 C--N 1.353 1.476 0 CA-C-N 115.567 -0.742 . . . . 72.13 111.838 -177.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 20.8 m -85.14 141.67 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.001 0.52 . . . . 75.01 111.129 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 C--O 1.254 1.305 0 C-N-CA 124.02 0.928 . . . . 73.34 109.297 176.762 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 109.487 -0.56 . . . . 63.44 109.487 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.9 t -129.61 98.38 4.81 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.604 0.362 . . . . 71.34 110.093 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -92.09 -173.9 3.6 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 108.611 -0.885 . . . . 72.12 108.611 170.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -93.19 53.13 1.89 Allowed 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.06 0.944 . . . . 74.11 110.586 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -74.7 88.81 2.24 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 108.668 -0.864 . . . . 44.24 108.668 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -63.39 -42.47 98.8 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 114.989 -1.005 . . . . 62.12 110.954 -176.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.9 p -77.82 73.13 4.39 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.674 0.79 . . . . 74.52 111.3 -178.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 179.58 -32.32 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.691 1.597 . . . . 72.44 110.085 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.636 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 22.7 ptp -147.24 178.49 8.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.608 0.718 . . . . 73.04 111.962 -167.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 76.2 m -137.59 102.41 4.75 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.328 -1.306 . . . . 71.43 107.611 174.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -100.27 116.29 31.91 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.881 -1.155 . . . . 64.01 107.881 174.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.5 tp60 -133.99 132.91 40.68 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.541 -0.911 . . . . 74.22 108.541 174.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.2 mt -91.17 119.84 39.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.233 -1.025 . . . . 75.3 108.233 175.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.54 -41.73 21.2 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.044 -0.725 . . . . 74.22 109.044 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -170.38 131.43 0.95 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.885 0.474 . . . . 72.03 110.049 -169.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.4 mt -117.46 131.22 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 108.492 -0.929 . . . . 64.2 108.492 173.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.452 ' HE1' HG13 ' A' ' 83' ' ' ILE . 27.2 p90 -161.78 177.85 9.51 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 123.952 0.783 . . . . 72.15 111.52 -173.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.6 p -107.09 126.29 52.17 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.438 -0.579 . . . . 63.44 109.438 173.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.448 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 44.4 mtpt -86.14 -33.44 20.87 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.623 -0.51 . . . . 74.03 109.623 175.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -148.15 142.95 26.75 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.632 -1.167 . . . . 61.02 109.874 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.458 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 81.7 mt -142.02 142.3 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.821 1.249 . . . . 53.4 108.23 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -149.42 121.5 8.29 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.03 0.532 . . . . 64.25 109.797 173.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.594 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 86.0 t80 -116.37 141.94 47.5 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.315 -1.365 . . . . 72.01 107.315 168.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 26.9 mt-10 -136.39 143.14 43.84 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.998 0.519 . . . . 74.25 109.834 175.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.17 75.74 10.53 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 107.427 -1.323 . . . . 73.45 107.427 170.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.83 -33.01 44.86 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.767 2.311 . . . . 71.05 112.267 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -100.86 15.5 28.26 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 114.682 -1.145 . . . . 71.32 110.171 -176.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.59 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -41.18 -56.19 4.45 Favored Pre-proline 0 N--CA 1.496 1.859 0 CA-C-O 117.698 -1.144 . . . . 53.03 113.477 -170.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -61.78 -32.43 85.99 Favored 'Trans proline' 0 C--N 1.391 2.783 0 CA-C-N 121.524 1.58 . . . . 74.03 112.788 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -75.96 -46.02 31.88 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.126 -0.943 . . . . 71.15 111.096 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.836 HG21 ' HA ' ' A' ' 73' ' ' ALA . 10.0 p -76.77 -14.8 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 124.111 0.964 . . . . 74.54 112.771 -160.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -69.02 -20.09 64.13 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.842 0.457 . . . . 55.4 111.439 171.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -82.81 -22.43 34.18 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.494 1.117 . . . . 75.52 111.016 174.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 71' ' ' GLU . 24.8 mmmt -67.1 154.61 40.81 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.235 1.014 . . . . 71.1 112.172 -178.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -74.92 125.55 29.1 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.286 -0.87 . . . . 72.04 109.259 173.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -77.71 88.33 3.97 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.605 0.717 . . . . 71.11 110.604 -174.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -117.14 83.51 15.51 Favored Pre-proline 0 N--CA 1.472 0.672 0 N-CA-C 106.313 -1.736 . . . . 64.12 106.313 170.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.8 93.85 0.87 Allowed 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 121.678 1.586 . . . . 71.52 111.151 -175.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -93.68 83.87 4.53 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 105.751 -1.944 . . . . 72.21 105.751 175.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 66' ' ' ALA . 42.7 t -91.68 117.84 35.82 Favored 'Isoleucine or valine' 0 C--N 1.342 0.279 0 CA-C-N 113.573 -1.649 . . . . 61.33 110.456 -168.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.601 ' HE2' ' HB2' ' A' ' 43' ' ' ASP . 85.6 tttt -79.28 121.59 25.28 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.932 -0.766 . . . . 43.21 108.932 169.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.0 mt -101.38 106.54 17.71 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.267 -1.012 . . . . 74.33 108.267 169.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.601 ' HB2' ' HE2' ' A' ' 41' ' ' LYS . 16.5 t70 -106.1 136.8 45.15 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.167 -1.42 . . . . 74.44 107.167 175.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.587 HD22 HD21 ' A' ' 60' ' ' LEU . 87.1 mt -130.56 134.3 46.91 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.22 0.533 . . . . 64.45 110.784 -174.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 21.3 t70 -134.48 146.78 50.08 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.63 1.172 . . . . 74.44 108.331 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.8 m -136.47 127.29 27.42 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.991 0.516 . . . . 53.11 109.633 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.62 110.53 9.95 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.555 0.742 . . . . 54.44 109.987 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 61.4 p -102.17 153.98 19.44 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.773 0.429 . . . . 74.43 110.747 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.3 t -150.78 125.13 9.47 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.65 0.78 . . . . 51.02 109.044 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -72.24 105.96 4.24 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.712 -0.477 . . . . 64.22 109.712 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.632 HD11 ' HB2' ' A' ' 57' ' ' GLU . 76.3 mt -78.83 -38.49 37.9 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.051 0.54 . . . . 65.33 109.902 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.65 176.21 11.99 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.455 1.102 . . . . 54.34 109.253 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -68.13 123.19 19.99 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 108.667 -0.864 . . . . 75.14 108.667 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 66.54 20.09 10.84 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.466 1.106 . . . . 71.44 111.793 -174.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.2 t -132.17 105.19 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 107.734 -1.21 . . . . 72.35 107.734 172.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -123.15 126.4 46.94 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.716 -0.846 . . . . 71.11 108.716 -177.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.632 ' HB2' HD11 ' A' ' 51' ' ' LEU . 33.9 tt0 -84.7 149.34 25.86 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.014 -0.736 . . . . 71.25 109.014 171.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.516 HG11 ' HD3' ' A' ' 103' ' ' PRO . 73.8 t -131.48 138.68 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 C-N-CA 124.364 1.066 . . . . 74.1 108.19 169.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.41 135.74 57.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.806 -0.812 . . . . 54.25 108.806 174.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.587 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -110.19 99.35 8.43 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 106.796 -1.557 . . . . 74.34 106.796 172.037 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.473 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 30.4 ttp180 -87.11 100.56 12.74 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.086 -1.079 . . . . 62.52 108.086 173.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 32.0 t -95.29 134.56 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 108.222 -1.029 . . . . 61.14 108.222 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.548 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 9.4 m -121.89 125.14 45.75 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.078 -0.712 . . . . 65.25 109.078 174.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.477 ' O ' HD12 ' A' ' 75' ' ' LEU . 70.4 t -121.81 120.02 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 124.456 1.103 . . . . 50.44 109.156 -174.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.6 m -128.54 116.6 19.91 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.406 0.548 . . . . 71.22 109.867 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.444 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -102.94 113.07 26.22 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 107.838 -1.171 . . . . 65.1 107.838 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 46.3 m -108.89 128.52 54.99 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.21 0.604 . . . . 72.32 110.012 177.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.432 HD11 ' HB2' ' A' ' 73' ' ' ALA . 19.6 mt -95.84 77.76 3.22 Favored 'General case' 0 C--O 1.247 0.961 0 C-N-CA 124.365 1.066 . . . . 22.5 108.566 -178.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.99 -85.69 0.89 Allowed Glycine 0 C--N 1.344 0.998 0 CA-C-N 115.376 -0.829 . . . . 62.21 111.764 -174.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -112.62 -30.92 6.93 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.844 0.857 . . . . 70.53 110.354 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.474 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 7.6 tp10 -101.98 119.07 38.19 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.858 0.463 . . . . 62.21 110.26 -170.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 88.2 m -70.99 135.59 47.93 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 122.809 0.443 . . . . 43.33 111.176 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.836 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -77.06 -64.42 1.14 Allowed 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.333 1.053 . . . . 50.31 110.135 175.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -151.08 170.39 19.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.751 0.786 . . . . 63.44 112.786 -177.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 64' ' ' VAL . 62.5 tp -123.92 144.94 49.48 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 113.809 -1.541 . . . . 71.13 107.911 169.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.44 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.1 m -146.44 102.5 3.59 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.722 0.809 . . . . 72.34 109.268 176.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 37.4 tt0 -119.5 116.31 25.83 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.311 0.644 . . . . 72.52 109.276 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 113' ' ' CYS . 39.4 t -127.31 113.68 33.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.221 1.008 . . . . 41.14 109.629 -174.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -85.27 87.24 7.36 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.539 -0.912 . . . . 74.22 108.539 171.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -76.44 92.8 3.43 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.453 -0.794 . . . . 74.35 109.173 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.74 146.13 19.79 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-N 115.703 -0.681 . . . . 74.23 111.467 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.27 122.67 1.68 Allowed Glycine 0 CA--C 1.503 -0.708 0 N-CA-C 110.258 -1.137 . . . . 61.45 110.258 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.492 HG23 HD12 ' A' ' 51' ' ' LEU . 49.0 mt -81.81 129.23 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.578 -1.267 . . . . 70.22 107.578 172.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.638 ' HB3' HD11 ' A' ' 86' ' ' ILE . 92.9 m-85 -130.46 134.5 47.14 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.326 -0.99 . . . . 71.1 108.326 -176.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.3 t -98.31 99.9 11.14 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.928 -1.138 . . . . 52.15 107.928 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.638 HD11 ' HB3' ' A' ' 84' ' ' PHE . 20.0 mm -120.35 129.86 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.235 0.614 . . . . 75.23 110.632 -169.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.41 173.26 12.44 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.964 0.905 . . . . 64.31 110.567 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.636 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 97.56 -32.1 7.12 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 116.309 -0.405 . . . . 63.12 112.925 175.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -122.39 159.98 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.942 0.897 . . . . 71.54 110.447 -176.056 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.464 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 19.7 tt0 -150.24 -179.29 7.07 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 108.886 -0.783 . . . . 63.21 108.886 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.464 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 59.3 -125.77 40.47 Favored Glycine 0 C--N 1.348 1.2 0 N-CA-C 114.547 0.579 . . . . 74.32 114.547 176.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.2 t -70.58 -27.14 63.89 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.116 0.566 . . . . 54.21 111.503 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -73.05 -36.14 66.84 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.96 0.904 . . . . 75.35 110.002 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.4 tpt -65.43 -46.42 80.0 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-N 115.381 -0.827 . . . . 73.05 109.628 175.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.4 -34.71 75.81 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.447 -0.797 . . . . 75.34 111.357 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.441 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 85.8 t60 -71.92 -32.97 67.89 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.462 0.705 . . . . 61.12 111.426 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -71.64 -44.8 63.7 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.019 0.438 . . . . 73.25 109.854 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 76.2 mt -80.73 -32.37 35.73 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.496 -0.775 . . . . 73.3 112.193 -173.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.42 3.49 59.65 Favored Glycine 0 N--CA 1.469 0.856 0 CA-C-O 119.591 -0.56 . . . . 44.12 113.736 -174.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.676 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.16 -62.61 0.26 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.664 0.616 . . . . 64.22 112.664 -174.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -68.05 -44.59 76.04 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 120.827 0.346 . . . . 65.55 111.572 -172.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 99.3 m -69.13 -47.38 29.15 Favored Pre-proline 0 CA--C 1.563 1.457 0 C-N-CA 124.086 0.954 . . . . 55.15 112.936 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.516 ' HD3' HG11 ' A' ' 58' ' ' VAL . 44.8 Cg_endo -66.89 -19.24 52.66 Favored 'Trans proline' 0 C--N 1.395 3.025 0 CA-C-N 121.694 1.641 . . . . 34.13 112.755 173.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -70.86 -38.18 73.13 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.021 0.528 . . . . 73.41 109.951 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 38.7 mm -64.22 -42.91 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.896 0.879 . . . . 72.23 110.155 171.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.408 ' HB2' ' HA ' ' A' ' 103' ' ' PRO . 49.5 mt -73.92 -22.73 59.57 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.325 -0.852 . . . . 74.34 112.289 -174.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -61.57 -46.64 93.97 Favored Pre-proline 0 N--CA 1.486 1.33 0 N-CA-C 114.416 1.265 . . . . 74.13 114.416 -172.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -52.89 -35.84 72.18 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 121.784 1.656 . . . . 74.31 113.045 172.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -79.88 -36.94 35.84 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.946 0.898 . . . . 60.11 111.877 -177.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.76 -49.6 65.42 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 109.161 -0.681 . . . . 53.34 109.161 176.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.4 HH12 HD12 ' C' ' 105' ' ' ILE . 32.5 ttm180 -50.17 -45.92 53.75 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.905 1.378 . . . . 72.32 110.218 173.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -62.94 -52.21 63.91 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.836 0.71 . . . . 54.0 111.504 -177.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.498 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 52.6 t -59.43 -34.78 72.91 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.827 0.704 . . . . 73.32 111.588 -178.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.572 HD13 HD11 ' A' ' 128' ' ' LEU . 24.4 mt -66.7 -59.27 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.691 0.796 . . . . 72.22 109.952 173.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 94.6 m -53.51 -37.65 62.98 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.829 1.252 . . . . 74.13 111.696 -174.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.2 t -69.62 -42.63 74.09 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 114.232 -1.349 . . . . 60.21 109.889 -178.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.594 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 35.3 mtm -65.69 -35.57 81.14 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.492 0.317 . . . . 63.05 110.998 176.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 114' ' ' ILE . 85.5 t -58.82 -49.42 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.892 0.877 . . . . 72.31 109.536 175.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.5 p -76.93 -27.97 55.07 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.644 -0.707 . . . . 71.23 111.725 -175.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -73.77 -28.96 61.93 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.48 0.712 . . . . 45.43 109.46 174.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.461 ' O ' HG22 ' A' ' 122' ' ' THR . . . -86.29 12.25 61.07 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.956 0.785 . . . . 73.41 112.557 171.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.3 t 63.2 11.5 5.37 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 127.127 2.171 . . . . 72.23 114.23 173.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -77.35 148.25 77.14 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 109.492 -0.559 . . . . 64.32 109.492 176.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.4 ' HG3' ' HB1' ' E' ' 130' ' ' ALA . 53.9 Cg_exo -52.9 128.1 27.42 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.788 2.326 . . . . 74.14 111.93 175.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -46.85 125.43 7.36 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.804 1.315 . . . . 63.33 112.404 -171.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 61.0 tp -106.77 137.33 45.0 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.625 -0.88 . . . . 70.45 108.625 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -129.7 113.95 15.39 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.802 -1.185 . . . . 72.13 107.802 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.572 HD11 HD13 ' A' ' 114' ' ' ILE . 7.4 mt -70.57 133.08 46.41 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.951 -0.759 . . . . 74.35 108.951 -176.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.55 136.66 94.59 Favored Pre-proline 0 CA--C 1.552 1.049 0 CA-C-O 118.997 -0.525 . . . . 43.31 111.047 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -55.72 109.88 0.48 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.272 2.648 . . . . 72.31 113.558 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.488 HG21 HD11 ' A' ' 44' ' ' LEU . 58.9 t -98.43 133.05 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.07 0.462 . . . . 74.55 110.215 -175.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -92.15 80.04 5.09 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.597 -1.183 . . . . 75.34 109.049 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -57.35 -35.52 70.02 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.179 0.992 . . . . 74.25 111.615 175.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.676 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 24.1 t70 -54.29 -47.78 72.01 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 124.373 1.046 . . . . 74.54 111.095 175.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.41 -42.02 83.94 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.953 0.783 . . . . 72.03 111.083 176.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 92.5 mt -54.48 -41.28 69.34 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.067 0.547 . . . . 74.13 111.224 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.44 ' HE2' HD13 ' A' ' 141' ' ' LEU . 33.6 t80 -78.16 -39.99 39.21 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.591 -0.731 . . . . 74.41 110.253 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.62 ' SD ' HD23 ' A' ' 141' ' ' LEU . 12.6 tpt -60.81 -32.12 71.5 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.001 0.92 . . . . 73.4 111.364 -173.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -63.96 -43.35 96.08 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.209 1.003 . . . . 75.44 110.14 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.415 ' HA ' ' HB2' ' A' ' 143' ' ' GLN . 53.9 t80 -74.81 -32.76 62.07 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.885 0.874 . . . . 63.34 111.143 175.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.62 HD23 ' SD ' ' A' ' 138' ' ' MET . 41.7 tp -64.56 -23.35 67.24 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.462 1.105 . . . . 70.24 111.697 -171.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -141.3 28.99 1.82 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.144 0.977 . . . . 63.44 108.607 -173.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.415 ' HB2' ' HA ' ' A' ' 140' ' ' TYR . 16.8 tt0 -71.81 -26.83 62.56 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 114.853 -1.067 . . . . 74.44 111.151 -176.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -137.84 -76.63 0.39 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 108.611 -0.885 . . . . 63.34 108.611 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -103.55 140.11 37.97 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.701 0.8 . . . . 74.41 109.672 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 107.78 135.17 7.61 Favored Glycine 0 C--N 1.341 0.831 0 N-CA-C 111.47 -0.652 . . . . 54.23 111.47 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -168.8 -177.93 3.2 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.461 1.104 . . . . 74.43 109.045 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 158.52 -126.95 1.77 Allowed Glycine 0 C--N 1.341 0.845 0 N-CA-C 111.892 -0.483 . . . . 62.54 111.892 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.9 t -171.78 167.12 6.44 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 123.8 0.84 . . . . 74.2 109.28 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -76.87 87.47 3.45 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.46 -0.941 . . . . 64.21 108.46 171.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.64 109.8 8.41 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.523 -0.762 . . . . 70.53 110.82 -175.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 33.1 p-80 -84.82 169.64 13.97 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.248 -0.887 . . . . 72.5 110.054 173.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -151.0 125.21 9.35 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.591 -0.892 . . . . 72.13 108.591 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -62.95 129.0 38.46 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.976 0.51 . . . . 74.44 110.857 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.936 0 O-C-N 124.048 0.843 . . . . 63.13 110.113 -177.967 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 108.638 -0.875 . . . . 74.33 108.638 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 72.9 m -147.85 -47.18 0.16 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.6 0.76 . . . . 75.21 109.844 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 66.87 146.66 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.112 1.365 . . . . 74.23 113.447 174.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.458 ' HG3' ' HA3' ' B' ' 91' ' ' GLY . 27.9 tt0 -169.73 99.63 0.31 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.513 1.125 . . . . 53.33 108.11 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -164.93 178.82 6.85 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.728 -0.471 . . . . 75.44 109.728 -175.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -64.28 105.87 0.99 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.413 0.685 . . . . 50.5 109.767 174.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 31.7 p -91.53 136.14 33.34 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.451 1.1 . . . . 54.1 111.353 -175.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -76.27 -29.92 57.63 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.89 0.876 . . . . 72.14 110.174 177.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 18.7 ptm 58.12 -179.41 0.07 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 127.325 2.25 . . . . 75.13 114.776 174.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 5.2 t -135.08 130.09 35.01 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 106.627 -1.62 . . . . 63.1 106.627 167.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.47 ' HD1' HG22 ' B' ' 86' ' ' ILE . 87.9 t80 -135.02 145.44 48.05 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.141 0.576 . . . . 71.34 110.016 -171.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -151.13 140.04 20.95 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.021 0.929 . . . . 74.41 109.121 171.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 49.8 mt -87.78 127.21 41.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.077 -1.083 . . . . 65.43 108.077 170.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -84.03 -49.21 9.14 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 109.187 -0.672 . . . . 65.23 109.187 176.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.401 ' HE ' ' CG2' ' A' ' 122' ' ' THR . 48.4 ttt180 -170.31 134.54 1.19 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.314 -0.857 . . . . 72.13 110.231 -172.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 91.4 mt -114.82 137.62 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 107.673 -1.232 . . . . 73.55 107.673 175.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -161.96 142.09 10.21 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.097 0.475 . . . . 65.2 111.537 -172.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.605 HG21 HD11 ' B' ' 21' ' ' ILE . 18.9 m -77.65 126.62 31.16 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 108.57 -0.9 . . . . 55.31 108.57 171.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.59 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 42.3 mtpt -99.57 -18.35 17.41 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.969 0.907 . . . . 73.33 111.798 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -161.31 138.73 8.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.9 0.48 . . . . 73.11 110.82 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.605 HD11 HG21 ' B' ' 18' ' ' THR . 47.0 mm -126.97 143.23 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.399 1.08 . . . . 43.23 108.331 168.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 27.9 t -144.79 119.81 10.03 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.227 -1.027 . . . . 63.24 108.227 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.458 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 82.9 t80 -132.1 116.46 17.06 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.808 -1.182 . . . . 72.23 107.808 173.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -123.01 113.89 19.67 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.87 0.868 . . . . 73.32 109.124 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -107.55 87.21 3.27 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 106.82 -1.548 . . . . 64.43 106.82 166.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.73 -26.41 45.56 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 122.559 2.173 . . . . 64.33 111.778 -173.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.446 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 72.2 m-20 -110.13 10.57 23.91 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 118.048 -0.977 . . . . 72.34 110.901 -177.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.473 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -33.71 -64.28 0.28 Allowed Pre-proline 0 N--CA 1.502 2.13 0 C-N-CA 124.955 1.302 . . . . 74.3 114.07 -171.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 11.9 Cg_exo -64.5 -29.75 61.8 Favored 'Trans proline' 0 C--N 1.396 3.041 0 C-N-CA 122.27 1.98 . . . . 74.34 112.889 -171.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -95.14 -26.49 15.99 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.848 0.859 . . . . 73.03 111.993 -171.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.487 HG21 ' HA ' ' B' ' 73' ' ' ALA . 4.8 p -82.43 -14.57 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 C-N-CA 122.678 0.391 . . . . 71.13 110.756 -176.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -68.39 -9.88 51.28 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 113.378 0.881 . . . . 65.52 113.378 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -71.37 -13.0 61.72 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 122.907 0.483 . . . . 75.3 110.8 173.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.427 ' HB2' HD13 ' B' ' 68' ' ' LEU . 89.3 mttt -103.21 81.57 1.97 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.597 1.159 . . . . 74.42 109.582 -175.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -88.48 74.86 8.48 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.453 -0.794 . . . . 62.35 110.077 -176.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -153.17 179.1 9.03 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.819 -0.628 . . . . 73.34 109.66 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.06 110.15 6.69 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.057 0.943 . . . . 74.11 109.283 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -71.54 145.97 48.5 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 121.956 1.771 . . . . 75.32 111.274 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 9.8 tp10 -64.56 102.09 0.52 Allowed 'General case' 0 C--N 1.343 0.321 0 N-CA-C 108.068 -1.086 . . . . 60.33 108.068 173.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.678 HG11 HD11 ' B' ' 126' ' ' LEU . 23.4 t -98.6 154.49 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 108.771 -0.826 . . . . 73.14 108.771 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -145.11 130.07 18.33 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.447 -0.946 . . . . 71.11 108.447 170.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.534 HD11 ' CG1' ' B' ' 62' ' ' VAL . 14.8 tp -86.21 138.21 32.05 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.491 -0.929 . . . . 63.34 108.491 170.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -137.0 117.02 13.29 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.933 -1.136 . . . . 64.35 107.933 -177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.407 HD23 ' CE2' ' B' ' 133' ' ' PHE . 4.4 mp -99.91 128.06 46.03 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.464 -0.939 . . . . 75.12 108.464 -171.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -132.17 143.87 50.27 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.325 -0.62 . . . . 73.31 109.325 175.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 18.5 p -128.91 125.86 38.46 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.472 0.709 . . . . 71.13 109.979 -174.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.415 ' O ' ' HB ' ' B' ' 59' ' ' VAL . . . -147.41 125.99 12.5 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 107.72 -1.215 . . . . 73.34 107.72 175.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.55 ' HB2' HD11 ' F' ' 102' ' ' LEU . 35.8 m -130.18 -179.01 4.99 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.085 0.554 . . . . 75.53 110.498 -176.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.8 p -152.17 135.64 16.05 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.916 -0.772 . . . . 72.2 108.916 172.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -91.83 119.14 31.36 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.286 -1.005 . . . . 71.5 108.286 170.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 pp -130.56 16.61 5.37 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.094 0.958 . . . . 53.44 110.077 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.19 157.8 36.51 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 123.583 0.753 . . . . 72.42 110.388 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -89.24 136.35 33.07 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 107.755 -1.202 . . . . 71.53 107.755 163.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.534 ' H ' HD11 ' F' ' 100' ' ' LEU . 5.0 m-20 71.97 4.35 4.99 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.793 1.237 . . . . 73.14 111.852 -176.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.625 HG22 ' HA ' ' B' ' 85' ' ' SER . 25.6 t -146.53 129.05 8.24 Favored 'Isoleucine or valine' 0 C--N 1.355 0.838 0 C-N-CA 124.08 0.952 . . . . 74.44 109.691 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.468 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 0.4 OUTLIER -113.53 163.53 14.8 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 108.713 -0.847 . . . . 74.41 108.713 166.38 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -119.92 107.23 12.87 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.287 -1.375 . . . . 61.3 107.287 177.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 65.8 t -100.42 125.21 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.714 0.805 . . . . 24.31 110.145 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.494 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.2 t -107.52 112.16 38.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 108.723 -0.843 . . . . 71.24 108.723 174.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 62.0 tp -93.92 112.58 24.45 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.633 -0.506 . . . . 71.5 109.633 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -95.76 106.06 18.14 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.482 0.713 . . . . 74.24 109.275 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.534 ' CG1' HD11 ' B' ' 42' ' ' LEU . 45.0 t -105.81 111.16 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 108.399 -0.963 . . . . 60.34 108.399 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 21.0 m -108.45 135.68 49.33 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.879 0.871 . . . . 71.51 109.965 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.739 HG11 HD21 ' B' ' 126' ' ' LEU . 44.4 t -129.36 115.69 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.945 1.298 . . . . 75.05 109.592 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 64.2 m -103.3 138.94 39.4 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.805 -0.813 . . . . 72.12 108.805 171.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -145.61 143.19 29.72 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.995 0.518 . . . . 64.32 109.776 176.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.549 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 67.4 p -141.5 131.81 25.07 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.546 -0.752 . . . . 71.33 110.913 -175.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.427 HD13 ' HB2' ' B' ' 34' ' ' LYS . 61.7 mt -100.49 111.55 23.82 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.556 1.142 . . . . 72.43 108.522 174.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.01 -128.63 11.06 Favored Glycine 0 C--N 1.342 0.887 0 O-C-N 123.436 0.46 . . . . 44.51 112.634 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -90.5 2.51 55.66 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.95 0.9 . . . . 73.25 112.207 -176.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.446 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 12.6 pt-20 -137.84 157.25 46.81 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.768 0.427 . . . . 74.2 111.565 -169.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.5 m -69.1 128.43 36.63 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.435 -0.802 . . . . 61.43 110.938 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.549 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -79.96 -64.02 1.28 Allowed 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.565 -1.272 . . . . 74.41 107.565 174.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -150.52 158.48 44.2 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 114.83 -1.077 . . . . 74.32 111.687 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 95.8 mt -125.27 113.34 17.48 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 106.333 -1.729 . . . . 61.41 106.333 172.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 27.0 t -118.28 146.35 44.37 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.915 -1.143 . . . . 40.23 107.915 175.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -161.62 126.76 3.53 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.254 -1.017 . . . . 62.45 108.254 -176.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.2 t -124.54 148.29 28.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.007 0.923 . . . . 54.43 108.729 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -121.95 96.82 5.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.226 -1.027 . . . . 74.23 108.226 169.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.429 ' HG3' HD22 ' B' ' 106' ' ' LEU . 53.8 tp60 -89.19 101.34 14.0 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.992 -0.744 . . . . 74.25 108.992 177.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.29 170.75 37.68 Favored Glycine 0 C--N 1.339 0.698 0 O-C-N 123.523 0.514 . . . . 72.42 112.017 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.99 132.76 2.5 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.512 -0.375 . . . . 64.53 112.659 -176.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 79.4 mt -91.26 111.11 23.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 108.001 -1.111 . . . . 62.32 108.001 173.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -113.34 133.8 54.95 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.104 0.562 . . . . 72.51 109.933 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.625 ' HA ' HG22 ' B' ' 55' ' ' VAL . 66.9 m -95.56 122.06 37.92 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.015 0.926 . . . . 70.25 109.319 175.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.474 HG12 HD12 ' F' ' 97' ' ' ILE . 0.2 OUTLIER -138.36 134.32 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.991 0.917 . . . . 74.54 110.599 -173.377 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.93 171.08 20.69 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.534 1.134 . . . . 64.32 108.191 169.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.9 -43.14 3.06 Favored Glycine 0 N--CA 1.469 0.878 0 N-CA-C 111.991 -0.444 . . . . 42.1 111.991 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.628 ' HB ' ' HA ' ' B' ' 94' ' ' MET . 9.4 pt -58.34 143.46 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.42 0.688 . . . . 73.32 110.802 171.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -161.26 152.68 18.97 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 123.858 0.724 . . . . 73.14 110.813 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.458 ' HA3' ' HG3' ' B' ' 4' ' ' GLN . . . 78.65 -133.88 13.3 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.625 -0.716 . . . . 75.5 111.854 -178.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 2.8 m -67.15 -44.03 80.82 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.666 0.787 . . . . 65.41 110.326 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -67.3 -18.93 65.38 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.048 -1.433 . . . . 74.15 111.757 -168.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.628 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 17.7 tmm? -68.14 -66.36 0.58 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.155 0.982 . . . . 72.41 111.56 -174.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.412 ' HB2' ' HD2' ' F' ' 101' ' ' PRO . . . -80.76 -9.36 59.81 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 120.857 0.36 . . . . 71.41 111.909 177.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -60.99 -31.74 71.34 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 122.866 0.467 . . . . 53.23 110.807 164.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.6 t -61.39 -40.45 94.39 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.831 0.852 . . . . 75.32 112.411 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' B' ' 95' ' ' ALA . 4.1 pp -69.69 -22.92 63.38 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.895 0.478 . . . . 65.33 112.001 177.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.05 -12.75 51.62 Favored Glycine 0 C--N 1.348 1.209 0 O-C-N 123.309 0.381 . . . . 75.44 113.797 -177.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.86 -57.67 1.04 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 117.364 0.582 . . . . 44.23 112.047 -173.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -75.16 -46.58 33.32 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.144 0.578 . . . . 73.31 111.615 -169.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.468 ' SG ' ' HE1' ' B' ' 56' ' ' TYR . 78.4 m -65.99 -47.18 63.93 Favored Pre-proline 0 CA--C 1.561 1.394 0 CA-C-O 118.459 -0.781 . . . . 61.01 112.595 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.96 -26.87 66.45 Favored 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 121.735 1.623 . . . . 71.3 112.746 172.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.42 -37.11 82.31 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.127 0.571 . . . . 73.33 110.868 175.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 66.7 mt -71.85 -44.49 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.758 0.823 . . . . 72.34 110.322 176.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.429 HD22 ' HG3' ' B' ' 80' ' ' GLN . 86.9 mt -78.47 -17.31 56.48 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.166 -0.924 . . . . 73.44 112.509 -171.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.422 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 55.4 t80 -63.33 -50.82 72.45 Favored Pre-proline 0 CA--C 1.55 0.957 0 CA-C-O 117.953 -1.022 . . . . 75.31 112.728 -176.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.597 ' HG2' ' HB2' ' D' ' 108' ' ' PRO . 93.6 Cg_exo -50.84 -42.58 50.87 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.261 1.974 . . . . 64.03 114.185 174.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -66.74 -44.44 81.5 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.361 0.665 . . . . 74.23 111.364 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.17 -37.2 83.34 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.676 -0.693 . . . . 73.23 110.995 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 60.7 ttt-85 -62.18 -51.54 67.43 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.341 1.456 . . . . 63.2 110.203 177.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -62.41 -36.8 83.48 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.238 0.961 . . . . 73.22 110.448 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.537 ' SG ' HD11 ' B' ' 21' ' ' ILE . 1.9 t -73.84 -30.2 62.55 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.018 0.127 . . . . 71.13 111.085 -177.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.569 HD13 HG23 ' B' ' 64' ' ' VAL . 41.8 mt -66.29 -55.82 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.679 0.791 . . . . 73.24 109.008 172.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.531 HG21 ' OG ' ' C' ' 119' ' ' SER . 31.9 m -62.08 -26.51 68.32 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 114.928 -1.033 . . . . 71.02 111.577 -177.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.3 t -61.65 -53.75 51.94 Favored 'General case' 0 C--N 1.347 0.458 0 N-CA-C 109.295 -0.631 . . . . 74.24 109.295 174.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.8 mmt -70.22 -30.81 67.98 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.599 0.76 . . . . 74.52 111.331 -174.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 68.8 t -66.41 -44.34 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.339 1.056 . . . . 52.2 110.271 172.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.1 t -67.28 -31.36 71.63 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.226 -0.897 . . . . 62.14 110.045 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.498 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 75.6 mtt-85 -68.44 -41.06 80.86 Favored 'General case' 0 C--O 1.211 -0.948 0 CA-C-N 115.818 -0.628 . . . . 73.23 109.561 176.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.97 -11.86 70.52 Favored Glycine 0 C--N 1.357 1.729 0 O-C-N 123.647 0.592 . . . . 71.43 112.628 171.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 11.3 m 67.11 30.74 7.2 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 125.51 1.524 . . . . 54.13 110.407 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -77.49 165.69 49.67 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-N 115.189 -0.914 . . . . 73.0 111.085 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.532 ' HG3' ' HB2' ' F' ' 131' ' ' TRP . 80.9 Cg_exo -48.23 151.07 4.65 Favored 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 123.257 2.638 . . . . 41.42 113.52 173.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.563 ' HB2' ' H ' ' C' ' 125' ' ' GLN . 29.2 tp60 -61.71 114.89 3.56 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.055 0.542 . . . . 71.41 111.572 -172.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.739 HD21 HG11 ' B' ' 64' ' ' VAL . 34.7 tp -108.79 110.35 21.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.888 -1.051 . . . . 73.14 108.656 -177.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -121.77 116.89 25.31 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.049 -1.093 . . . . 73.34 108.049 176.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 73.3 mt -75.37 144.75 42.13 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 120.909 0.385 . . . . 73.1 111.541 -175.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.5 ' H ' ' HB2' ' F' ' 126' ' ' ALA . . . -76.85 151.62 82.31 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 124.481 1.112 . . . . 72.25 110.708 -177.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.439 ' HG3' HD13 ' D' ' 16' ' ' ILE . 3.8 Cg_endo -80.23 84.53 2.0 Allowed 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.843 2.362 . . . . 74.13 110.666 -177.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 p -89.07 111.32 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 N-CA-C 108.714 -0.847 . . . . 74.52 108.714 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -80.8 107.56 13.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.521 -0.763 . . . . 61.02 109.539 -176.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.407 ' CE2' HD23 ' B' ' 44' ' ' LEU . 56.2 m-85 -54.83 -38.28 67.19 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.764 1.226 . . . . 60.01 111.137 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -58.42 -49.76 76.15 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 114.466 -1.243 . . . . 72.43 110.479 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.26 -35.25 71.47 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 123.955 0.784 . . . . 64.12 112.364 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.4 ' CD2' ' HB3' ' F' ' 111' ' ' LEU . 10.1 mp -69.28 -50.06 50.3 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.881 0.472 . . . . 65.51 110.993 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -68.66 -30.76 69.52 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.7 0.4 . . . . 71.15 111.423 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 10.6 tmm? -68.5 -40.33 80.91 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.517 0.727 . . . . 63.13 109.187 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.514 ' HA ' ' HB2' ' B' ' 142' ' ' GLN . 5.8 t-20 -82.51 -26.39 32.56 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.313 -0.858 . . . . 52.32 110.741 -173.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 140' ' ' TYR . . . . . 0.512 ' OH ' ' HG2' ' F' ' 114' ' ' LYS . 3.1 t80 -75.75 -34.5 60.29 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.44 -0.8 . . . . 60.21 110.594 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mp -104.75 18.74 21.73 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.516 0.726 . . . . 70.15 110.49 177.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 142' ' ' GLN . . . . . 0.514 ' HB2' ' HA ' ' B' ' 139' ' ' ASN . 15.5 tm0? -77.51 143.85 38.12 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.488 0.715 . . . . 74.13 110.314 -174.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -135.31 140.57 45.23 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.927 -1.138 . . . . 54.11 107.927 173.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 76.79 74.13 0.08 Allowed 'General case' 0 N--CA 1.481 1.093 0 O-C-N 124.837 1.335 . . . . 63.01 110.433 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -164.22 100.1 0.84 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.909 0.883 . . . . 44.35 109.489 172.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.82 23.23 2.31 Favored Glycine 0 N--CA 1.466 0.635 0 N-CA-C 110.712 -0.955 . . . . 50.11 110.712 173.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -85.65 79.8 9.22 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.106 0.962 . . . . 63.12 108.936 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -105.69 72.1 0.23 Allowed Glycine 0 C--N 1.339 0.727 0 CA-C-N 114.987 -1.006 . . . . 75.22 110.835 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 27.4 p -68.88 145.34 53.77 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.242 0.617 . . . . 63.2 110.563 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -115.95 170.42 8.5 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.726 0.811 . . . . 74.01 110.581 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -158.97 159.63 35.07 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.562 0.745 . . . . 74.03 109.115 173.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -55.06 108.64 0.43 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.221 1.009 . . . . 73.04 112.475 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -75.61 125.9 29.94 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.456 -0.942 . . . . 63.52 108.456 167.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -101.55 158.18 16.27 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.289 0.636 . . . . 72.22 111.49 -172.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 C-N-CA 124.404 1.082 . . . . 72.41 109.855 -177.224 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 1' ' ' MET . . . . . 0.477 ' SD ' ' N ' ' C' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 107.892 -1.151 . . . . 72.01 107.892 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 69.5 m -151.35 173.86 14.0 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.542 0.737 . . . . 72.33 110.72 -176.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -141.26 156.88 45.83 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.137 0.975 . . . . 74.43 110.026 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -69.26 101.59 1.53 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.498 -0.556 . . . . 73.53 109.498 176.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -77.99 144.62 36.57 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.994 0.918 . . . . 71.51 111.947 -174.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -101.97 158.54 16.07 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.576 0.75 . . . . 75.32 109.229 172.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 21.9 p -76.51 -32.86 58.55 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.819 0.847 . . . . 62.01 112.907 -171.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -85.39 73.99 10.44 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 107.966 -1.124 . . . . 71.32 107.966 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.475 ' HB3' HD21 ' E' ' 139' ' ' ASN . 17.7 ttt 41.67 113.76 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 127.127 2.171 . . . . 62.43 115.573 175.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.576 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 21.0 m -105.74 108.42 19.92 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 108.388 -0.968 . . . . 63.22 108.388 173.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -125.98 136.85 53.47 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.358 -0.608 . . . . 75.43 109.358 174.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -150.53 135.24 17.4 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.821 0.848 . . . . 53.23 108.884 169.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 53.4 mt -77.22 119.11 25.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 107.655 -1.239 . . . . 70.23 107.655 166.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -84.56 -43.08 14.84 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.7 -0.852 . . . . 75.33 108.7 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.97 158.31 0.55 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.195 1.398 . . . . 71.04 109.44 176.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.427 ' O ' HD12 ' C' ' 16' ' ' ILE . 2.0 pp -128.68 141.52 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.382 -1.34 . . . . 74.04 107.382 175.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.443 ' HB3' HG23 ' D' ' 122' ' ' THR . 17.7 p90 -170.52 157.57 5.96 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.284 0.564 . . . . 73.04 111.694 -168.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 66.5 p -80.33 113.31 18.42 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.982 -0.554 . . . . 75.0 109.639 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -34.6 71.58 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 108.04 -1.096 . . . . 75.04 108.04 171.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.5 t70 -151.24 145.55 25.45 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.372 -1.285 . . . . 53.22 110.385 -175.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.577 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.4 mt -139.82 147.42 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.9 1.68 . . . . 73.24 106.778 175.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -159.42 150.03 19.39 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.046 0.45 . . . . 73.02 110.217 171.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -151.12 135.89 17.24 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 107.454 -1.313 . . . . 61.3 107.454 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -136.0 124.73 23.86 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.888 0.475 . . . . 75.43 109.878 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.16 75.55 77.85 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 107.76 -1.2 . . . . 54.41 107.76 162.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -74.92 -10.01 21.14 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.291 1.994 . . . . 64.22 111.677 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -106.17 13.15 29.35 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.803 1.241 . . . . 71.12 109.798 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.98 -57.0 7.78 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 115.078 1.51 . . . . 73.0 115.078 -165.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -64.34 -41.14 22.01 Favored 'Trans proline' 0 C--N 1.378 2.116 0 CA-C-N 121.813 1.683 . . . . 60.43 112.177 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -68.67 -34.31 75.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.36 1.064 . . . . 52.3 111.702 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.93 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.1 p -79.67 -27.43 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 CA-C-N 116.147 -0.479 . . . . 60.32 111.877 -178.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -69.79 -31.51 69.47 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 111.598 0.221 . . . . 63.32 111.598 174.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -96.49 30.78 2.45 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.203 0.601 . . . . 72.11 110.552 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.75 167.44 10.48 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.315 1.046 . . . . 71.1 109.334 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -75.99 120.64 21.59 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.538 -0.541 . . . . 70.34 109.538 171.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -85.23 89.28 7.61 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.73 0.812 . . . . 74.35 110.857 -174.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -131.09 80.61 68.59 Favored Pre-proline 0 N--CA 1.481 1.109 0 C-N-CA 123.999 0.92 . . . . 71.45 108.839 167.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -71.8 111.41 3.14 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.292 1.994 . . . . 62.42 110.814 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -83.02 91.72 7.23 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 104.522 -2.399 . . . . 73.24 104.522 170.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.643 HG21 ' H ' ' F' ' 135' ' ' VAL . 62.0 t -75.28 140.59 17.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 113.623 -1.626 . . . . 74.43 110.729 -167.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -128.36 103.16 7.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.352 1.061 . . . . 71.3 108.766 171.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.549 HD11 HG13 ' F' ' 135' ' ' VAL . 87.0 mt -85.3 150.06 25.03 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.929 0.892 . . . . 74.43 108.74 174.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.426 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 31.6 t70 -143.64 141.93 30.8 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.296 0.638 . . . . 63.21 109.613 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 47.9 mt -132.42 133.18 43.58 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.192 0.997 . . . . 62.23 109.116 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -143.23 123.44 13.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.801 -1.555 . . . . 74.43 106.801 175.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 46' ' ' THR . . . . . 0.429 ' OG1' ' HG3' ' C' ' 103' ' ' PRO . 15.0 t -118.42 130.47 55.99 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.471 0.653 . . . . 72.13 109.418 176.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.35 153.41 29.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.177 -0.92 . . . . 53.4 109.095 176.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 37.2 p -146.64 143.0 28.48 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.862 -0.792 . . . . 75.51 108.862 175.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 45.9 t -156.89 135.82 11.78 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.163 0.585 . . . . 70.1 109.487 -177.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -79.48 116.82 19.93 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.764 -0.828 . . . . 72.22 108.764 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.602 HD11 ' HB2' ' C' ' 57' ' ' GLU . 63.4 mt -84.75 -34.94 22.75 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.613 0.765 . . . . 73.22 110.616 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.67 -176.02 5.63 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.143 -0.935 . . . . 44.3 109.868 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -58.44 108.61 0.65 Allowed 'General case' 0 C--O 1.242 0.674 0 O-C-N 124.122 0.889 . . . . 73.22 109.695 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 54' ' ' ASP . . . . . 0.585 ' HB3' ' HB2' ' C' ' 87' ' ' ALA . 16.9 m-20 66.2 24.63 10.74 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 124.311 1.007 . . . . 74.45 111.853 175.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.7 t -122.24 118.97 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 108.835 -0.802 . . . . 43.1 108.835 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -120.6 125.44 47.76 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.082 0.953 . . . . 73.34 109.997 -176.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.602 ' HB2' HD11 ' C' ' 51' ' ' LEU . 36.2 tt0 -84.71 131.99 34.51 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.531 -0.915 . . . . 73.51 108.531 166.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.484 HG11 ' HD3' ' C' ' 103' ' ' PRO . 61.3 t -122.45 123.05 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.08 -1.081 . . . . 73.14 108.08 168.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.574 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 73.5 t -108.84 145.44 15.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.19 -0.67 . . . . 65.01 109.19 174.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.06 101.27 7.44 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.651 -1.241 . . . . 75.13 107.651 174.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 35.9 ttm-85 -79.98 106.29 11.89 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.068 -1.086 . . . . 72.41 108.068 169.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.446 ' HB ' HD11 ' C' ' 114' ' ' ILE . 16.0 t -107.17 123.9 62.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.731 -1.211 . . . . 54.45 107.731 172.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 12.5 m -122.83 116.19 23.27 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.721 -0.844 . . . . 55.45 108.721 -176.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.415 HG21 HG21 ' C' ' 114' ' ' ILE . 73.8 t -111.35 110.69 33.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 124.463 1.105 . . . . 41.53 108.767 -174.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.4 m -99.67 139.28 35.56 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 115.356 -0.838 . . . . 71.21 108.88 175.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.45 105.23 6.81 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.093 -1.447 . . . . 74.42 107.093 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.0 m -123.33 135.28 54.12 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 108.179 -1.045 . . . . 45.02 108.179 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 36.2 mt -84.13 25.98 0.79 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.474 1.11 . . . . 63.25 110.714 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.76 -91.75 0.8 Allowed Glycine 0 C--N 1.357 1.722 0 N-CA-C 111.041 -0.823 . . . . 72.43 111.041 -177.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -89.11 -31.33 18.05 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.587 0.755 . . . . 73.34 110.261 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -89.34 124.06 34.08 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.819 1.248 . . . . 74.5 109.466 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.0 m -80.93 126.45 31.39 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.603 -0.888 . . . . 73.41 108.603 166.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.93 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -78.47 -55.81 4.93 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.42 -0.585 . . . . 72.14 109.42 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -159.01 166.05 32.64 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.665 0.745 . . . . 62.41 112.16 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.413 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.1 tm? -130.05 143.14 50.63 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 106.683 -1.599 . . . . 75.24 106.683 167.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.413 ' N ' HD13 ' C' ' 75' ' ' LEU . 48.5 t -149.87 112.08 4.65 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.661 -0.496 . . . . 52.03 109.661 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -116.68 124.61 50.14 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.219 -0.66 . . . . 54.41 109.219 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 49.4 t -122.97 115.07 44.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.77 -0.826 . . . . 72.2 108.77 172.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.468 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.1 mt-30 -93.86 87.69 5.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.046 0.938 . . . . 74.41 109.209 175.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -80.2 101.56 8.91 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.855 -1.066 . . . . 63.31 109.976 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -100.66 150.2 18.73 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-O 121.143 0.302 . . . . 35.01 112.746 177.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.7 132.51 4.78 Favored Glycine 0 CA--C 1.501 -0.798 0 N-CA-C 110.756 -0.937 . . . . 45.55 110.756 -175.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 34.7 mm -90.87 128.14 42.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 108.531 -0.915 . . . . 73.13 108.531 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -136.15 119.39 16.68 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.609 -0.885 . . . . 71.03 108.609 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 33.3 p -78.49 102.26 7.76 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.472 -0.936 . . . . 75.13 108.472 173.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.549 HD13 ' SG ' ' C' ' 97' ' ' CYS . 5.7 mt -116.07 140.32 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 122.832 0.453 . . . . 63.1 110.073 -176.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' C' ' 54' ' ' ASP . . . -160.35 172.07 17.97 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.777 0.831 . . . . 60.04 110.732 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.99 -47.19 3.5 Favored Glycine 0 C--N 1.345 1.062 0 O-C-N 123.896 0.747 . . . . 73.54 111.61 175.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.429 HD13 ' CE ' ' C' ' 9' ' ' MET . 41.7 pt -83.1 146.77 6.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 123.64 0.776 . . . . 63.1 111.154 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -149.38 -179.13 6.83 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.907 0.883 . . . . 75.32 109.595 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.57 -126.94 30.89 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-O 119.603 -0.554 . . . . 63.03 112.107 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.6 -26.0 62.41 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.269 0.627 . . . . 50.53 111.611 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.419 ' HB3' ' HB ' ' C' ' 89' ' ' ILE . 97.8 mt-30 -65.42 -60.77 2.6 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.527 0.331 . . . . 74.21 110.266 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.423 ' HE3' HD11 ' C' ' 89' ' ' ILE . 1.8 tpt -54.93 -48.36 73.24 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 123.796 0.685 . . . . 65.1 112.152 173.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.2 -40.2 76.92 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.728 0.642 . . . . 75.24 111.608 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -83.46 -23.34 32.28 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.403 0.681 . . . . 71.1 111.638 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.549 ' SG ' HD13 ' C' ' 86' ' ' ILE . 34.3 t -69.56 -37.89 77.19 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 108.354 -0.98 . . . . 73.1 108.354 175.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.421 ' HG ' ' HE2' ' C' ' 94' ' ' MET . 76.9 mt -81.1 -31.81 34.13 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.972 -1.013 . . . . 74.13 110.801 174.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 99' ' ' GLY . . . . . 0.418 ' HA3' ' CE2' ' C' ' 137' ' ' PHE . . . -78.05 -28.88 55.52 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.163 -0.926 . . . . 74.34 114.755 -168.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.99 -47.57 0.09 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.469 0.544 . . . . 73.52 112.469 -167.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.47 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 70.3 t80 -56.05 -59.3 5.11 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.345 0.658 . . . . 73.32 111.772 -176.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 88.6 m -63.66 -46.01 82.7 Favored Pre-proline 0 CA--C 1.566 1.582 0 C-N-CA 124.173 0.989 . . . . 73.32 111.691 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.484 ' HD3' HG11 ' C' ' 58' ' ' VAL . 96.0 Cg_exo -49.67 -36.11 40.24 Favored 'Trans proline' 0 C--N 1.395 2.997 0 C-N-CA 123.088 2.525 . . . . 35.33 114.832 168.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -67.97 -31.98 72.08 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.477 0.711 . . . . 62.02 111.249 177.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.4 HD12 HH12 ' A' ' 111' ' ' ARG . 32.2 mm -69.66 -38.78 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 109.185 -0.672 . . . . 64.14 109.185 175.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 53.5 mt -78.82 -34.4 45.27 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.262 1.025 . . . . 71.21 112.516 -174.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -54.46 -47.11 98.64 Favored Pre-proline 0 N--CA 1.484 1.24 0 N-CA-C 114.238 1.199 . . . . 74.32 114.238 -170.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.48 -39.06 58.54 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.167 1.912 . . . . 72.53 113.345 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -68.5 -40.42 80.9 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.278 0.631 . . . . 64.41 110.793 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.28 -41.86 99.04 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.16 -0.927 . . . . 73.33 109.866 174.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 111' ' ' ARG . . . . . 0.407 ' HA ' HD21 ' C' ' 128' ' ' LEU . 56.2 ttt180 -60.71 -49.35 77.86 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.936 1.294 . . . . 73.34 110.61 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.27 -40.88 90.42 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.724 0.64 . . . . 74.22 109.943 -176.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 49.4 t -68.83 -34.88 76.22 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.504 0.503 . . . . 74.44 111.986 -176.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.446 HD11 ' HB ' ' C' ' 62' ' ' VAL . 97.0 mt -69.43 -52.33 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.443 0.697 . . . . 72.12 110.363 175.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.4 m -67.95 -27.23 66.43 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 122.974 0.509 . . . . 53.14 111.254 -175.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 40.4 t -62.97 -47.06 84.81 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.971 0.908 . . . . 63.44 109.367 170.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.601 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.86 -38.68 91.79 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.433 1.093 . . . . 74.23 112.125 178.227 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 98.9 t -58.39 -45.79 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.462 0.705 . . . . 60.43 109.685 173.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.531 ' OG ' HG21 ' B' ' 115' ' ' THR . 28.9 t -68.76 -31.65 70.84 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.836 -1.074 . . . . 71.44 112.268 -178.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.446 HH12 ' HG2' ' D' ' 112' ' ' GLU . 73.0 mtt-85 -69.47 -40.4 77.11 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.162 -0.681 . . . . 65.02 109.162 177.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.56 -1.07 86.01 Favored Glycine 0 C--N 1.356 1.683 0 O-C-N 123.983 0.802 . . . . 62.42 112.66 172.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.3 p 65.46 25.61 11.89 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 126.819 2.048 . . . . 50.24 114.075 169.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -83.67 143.83 44.53 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 109.313 -0.625 . . . . 75.12 109.313 174.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.448 ' HG3' HG21 ' F' ' 129' ' ' THR . 78.0 Cg_exo -45.61 135.9 12.63 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 123.459 2.773 . . . . 75.04 113.055 171.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.563 ' H ' ' HB2' ' B' ' 125' ' ' GLN . 36.8 mm-40 -44.07 112.82 0.44 Allowed 'General case' 0 N--CA 1.483 1.211 0 O-C-N 124.882 1.364 . . . . 72.4 111.934 -174.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.497 HD11 ' H ' ' F' ' 135' ' ' VAL . 20.2 tp -108.18 83.94 1.86 Allowed 'General case' 0 C--O 1.239 0.525 0 N-CA-C 106.565 -1.643 . . . . 63.4 106.565 170.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -97.54 94.52 7.05 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 114.357 -1.292 . . . . 73.32 108.378 -170.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.577 HD23 ' H ' ' C' ' 128' ' ' LEU . 1.5 pt? -56.3 139.09 49.41 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.089 0.956 . . . . 65.02 111.967 -175.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.51 150.83 64.19 Favored Pre-proline 0 CA--C 1.548 0.891 0 CA-C-N 114.759 -1.109 . . . . 64.14 110.945 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.41 113.7 1.8 Allowed 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.852 2.368 . . . . 75.42 112.674 175.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 49.0 t -99.31 118.39 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 107.676 -1.231 . . . . 64.24 107.676 171.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -71.84 103.44 3.15 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.265 0.626 . . . . 61.24 110.42 -175.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -62.64 -31.46 72.32 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.253 1.021 . . . . 73.31 111.944 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -66.36 -37.66 85.81 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.278 0.631 . . . . 74.53 110.685 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.92 86.56 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.516 0.726 . . . . 64.0 110.373 175.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 98.4 mt -64.94 -35.34 80.83 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.925 -1.034 . . . . 72.22 110.889 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 137' ' ' PHE . . . . . 0.418 ' CE2' ' HA3' ' C' ' 99' ' ' GLY . 3.4 t80 -81.48 -26.12 35.46 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.95 -0.568 . . . . 74.32 111.307 -179.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 37.9 ttp -67.56 -46.74 71.83 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 123.827 0.704 . . . . 65.23 109.867 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -71.5 -34.88 70.51 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 115.739 -0.664 . . . . 74.02 110.564 177.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -55.42 -84.26 0.01 OUTLIER 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.112 0.965 . . . . 70.43 110.362 174.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 38.7 tp 61.67 160.59 0.06 Allowed 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 124.623 1.169 . . . . 64.21 111.569 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.29 -73.55 0.28 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 106.671 -1.603 . . . . 75.23 106.671 173.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -148.09 119.59 7.94 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.859 -0.793 . . . . 71.21 108.859 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -77.44 118.21 19.66 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-O 121.327 0.584 . . . . 62.51 110.03 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -151.83 56.05 0.85 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.286 -1.005 . . . . 73.41 108.286 177.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.78 59.06 4.99 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 114.129 -1.396 . . . . 42.22 112.197 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -105.01 112.59 25.79 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.376 1.07 . . . . 74.25 110.045 -174.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -151.25 36.48 0.87 Allowed Glycine 0 C--N 1.341 0.837 0 O-C-N 123.617 0.573 . . . . 72.22 111.834 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 15.3 t -101.2 142.33 32.79 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.552 0.741 . . . . 72.42 110.732 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -176.86 -27.07 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.626 1.17 . . . . 74.5 109.623 176.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.58 111.15 0.74 Allowed 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 124.262 1.025 . . . . 74.24 112.03 177.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -122.06 164.25 18.02 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.725 1.21 . . . . 73.51 108.507 174.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -62.95 98.7 0.13 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 109.348 -0.612 . . . . 74.34 109.348 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.3 -52.62 61.22 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.609 0.764 . . . . 54.31 110.267 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.303 0 CA-C-N 114.852 -1.067 . . . . 71.14 109.597 177.762 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 1' ' ' MET . . . . . 0.41 ' SD ' ' N ' ' D' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.479 0.977 0 CA-C-O 119.444 -0.312 . . . . 63.35 110.963 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 37.4 p -167.36 144.54 4.52 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.872 0.469 . . . . 74.44 111.262 -173.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -91.62 161.17 15.03 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.773 1.229 . . . . 73.45 109.743 174.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -68.94 140.68 55.09 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.443 0.697 . . . . 74.32 110.228 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.87 -73.13 0.15 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.298 1.039 . . . . 63.44 110.228 -171.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -170.75 150.78 3.32 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.749 1.219 . . . . 64.43 107.748 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 14.7 t -160.34 -154.56 0.39 Allowed 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 124.095 0.958 . . . . 63.3 108.787 -174.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.509 ' HG2' ' H ' ' D' ' 9' ' ' MET . 19.3 tt0 -73.24 -169.97 0.71 Allowed 'General case' 0 CA--C 1.572 1.798 0 C-N-CA 123.807 0.843 . . . . 74.4 109.95 173.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.509 ' H ' ' HG2' ' D' ' 8' ' ' GLU . 0.1 OUTLIER -29.54 125.07 0.14 Allowed 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 125.95 1.7 . . . . 65.11 113.113 178.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 8.2 t -112.59 134.55 54.06 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.797 0.839 . . . . 60.34 109.942 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.531 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 49.9 t80 -135.3 91.01 2.68 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 106.781 -1.563 . . . . 65.34 106.781 176.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -121.2 126.8 50.54 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.474 0.71 . . . . 63.42 109.252 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mt -96.21 132.77 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 107.84 -1.17 . . . . 73.22 107.84 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -104.09 -19.58 14.12 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 119.116 -0.468 . . . . 70.2 111.417 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.416 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 41.1 ttt180 -172.29 131.92 0.62 Allowed 'General case' 0 C--N 1.36 1.042 0 N-CA-C 112.065 0.395 . . . . 73.33 112.065 -176.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.439 HD13 ' HG3' ' B' ' 130' ' ' PRO . 2.6 mp -110.41 134.95 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 106.842 -1.54 . . . . 64.51 106.842 170.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.416 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 22.2 p90 -158.16 140.28 14.14 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 123.521 0.513 . . . . 64.31 111.685 -177.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -78.6 113.17 16.4 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.498 -0.774 . . . . 75.35 109.668 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -85.76 -11.24 54.06 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.602 -0.726 . . . . 75.11 109.9 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.651 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.4 t70 -165.54 145.25 6.59 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.594 1.158 . . . . 53.41 109.846 177.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.601 HD13 ' HE3' ' C' ' 117' ' ' MET . 66.4 mt -148.41 148.23 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 125.622 1.569 . . . . 74.43 107.695 175.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.1 t -154.98 146.24 22.89 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.356 1.062 . . . . 53.3 109.092 171.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.577 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 92.0 t80 -143.61 126.32 16.07 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 106.669 -1.604 . . . . 71.51 106.669 169.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 47.9 mt-10 -121.16 142.73 49.61 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.549 0.74 . . . . 73.53 109.227 175.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.433 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -138.69 75.51 37.1 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 107.018 -1.475 . . . . 60.01 107.018 169.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -71.99 -19.93 26.09 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.453 2.102 . . . . 72.54 112.772 -171.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -110.7 3.98 19.69 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.655 0.782 . . . . 74.24 111.153 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.452 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -27.33 -70.63 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 116.805 2.15 . . . . 64.24 116.805 -167.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.32 -19.46 15.17 Favored 'Trans proline' 0 C--N 1.388 2.618 0 CA-C-N 124.036 2.477 . . . . 52.44 114.011 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -74.5 -39.6 62.32 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.045 0.938 . . . . 53.52 109.816 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' D' ' 73' ' ' ALA . 9.3 p -82.98 -16.25 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 CA-C-N 116.065 -0.516 . . . . 75.1 111.101 -171.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -68.42 -13.42 62.28 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.07 0.767 . . . . 75.55 113.07 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -60.34 -27.29 67.24 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.788 0.835 . . . . 72.4 110.713 173.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -91.78 88.13 6.55 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.494 1.518 . . . . 71.14 110.179 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -83.11 90.92 7.12 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.221 -0.9 . . . . 72.22 110.682 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 40.7 p90 -165.4 172.01 12.72 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.138 0.975 . . . . 75.43 109.29 166.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -70.58 111.27 9.02 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.644 0.778 . . . . 62.01 109.321 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.44 128.47 30.23 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 122.937 2.424 . . . . 63.51 112.058 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.74 113.1 5.23 Favored 'General case' 0 C--O 1.24 0.566 0 O-C-N 123.773 0.671 . . . . 74.25 109.462 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.925 HG13 HG13 ' D' ' 64' ' ' VAL . 78.7 t -98.53 107.13 19.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-N 115.343 -0.844 . . . . 72.54 110.102 -174.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -87.65 111.04 20.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 105.693 -1.965 . . . . 64.11 105.693 165.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.441 HD11 HG13 ' D' ' 62' ' ' VAL . 49.7 tp -95.52 143.44 26.84 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.498 -0.927 . . . . 64.51 108.498 -172.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.613 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 15.8 m-20 -120.02 117.01 26.88 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.688 -1.226 . . . . 74.42 107.688 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.717 ' HB3' HD23 ' E' ' 111' ' ' LEU . 23.4 mt -116.31 131.0 57.06 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.048 0.452 . . . . 65.12 110.014 177.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.617 ' HA ' ' HB3' ' E' ' 111' ' ' LEU . 38.4 t70 -143.99 145.2 32.06 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.246 -1.02 . . . . 71.34 108.246 171.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 46' ' ' THR . . . . . 0.76 HG23 HD22 ' E' ' 111' ' ' LEU . 22.8 p -104.6 170.57 7.81 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.105 0.562 . . . . 64.43 110.493 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -166.35 163.08 17.49 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.463 1.105 . . . . 62.55 108.621 172.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 53.7 p -155.52 153.3 30.01 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 108.147 -1.057 . . . . 61.42 108.147 169.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 68.6 p -165.78 159.33 16.02 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.631 0.772 . . . . 65.31 109.481 -174.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 50' ' ' GLN . . . . . 0.452 ' HB2' ' HG3' ' D' ' 57' ' ' GLU . 25.1 tp60 152.09 -91.63 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 126.781 2.033 . . . . 71.32 107.855 164.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.461 ' HB2' HG13 ' D' ' 55' ' ' VAL . 80.7 mt -151.74 133.01 14.5 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.317 1.447 . . . . 63.23 107.482 -175.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.39 78.1 3.91 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 109.111 -0.7 . . . . 63.53 109.111 173.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -166.1 42.37 0.06 Allowed 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.095 -0.957 . . . . 74.51 108.762 -171.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 66.11 -1.79 1.09 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 124.622 1.169 . . . . 73.34 113.586 178.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.461 HG13 ' HB2' ' D' ' 51' ' ' LEU . 2.3 p -109.24 94.54 3.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 107.305 -1.368 . . . . 51.21 107.305 177.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -122.18 128.3 51.05 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.676 -0.861 . . . . 73.12 108.676 -171.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.452 ' HG3' ' HB2' ' D' ' 50' ' ' GLN . 31.4 mt-10 -85.89 152.99 22.53 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 107.318 -1.364 . . . . 73.14 107.318 162.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 53.3 t -130.16 138.57 53.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.302 -1.37 . . . . 64.1 107.302 165.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.471 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 32.3 t -126.11 130.12 72.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 108.249 -1.019 . . . . 71.23 108.249 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.595 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -109.02 119.96 41.1 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 106.824 -1.547 . . . . 72.44 106.824 178.722 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -99.36 97.99 8.97 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.384 -0.969 . . . . 72.01 108.384 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.441 HG13 HD11 ' D' ' 42' ' ' LEU . 31.9 t -101.82 117.14 46.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.291 -0.868 . . . . 74.14 108.713 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.613 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 22.6 m -126.7 119.14 26.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.382 0.673 . . . . 73.33 109.25 -173.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.925 HG13 HG13 ' D' ' 40' ' ' VAL . 55.1 t -100.89 124.16 54.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 123.715 0.806 . . . . 63.43 110.022 -177.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 28.4 m -114.69 96.19 5.61 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.239 -1.022 . . . . 71.23 108.239 170.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.604 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -106.69 142.56 36.13 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.482 -0.781 . . . . 71.51 110.076 -175.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.52 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 48.9 m -139.75 141.64 36.83 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.441 0.638 . . . . 73.44 112.258 -173.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.442 HD12 HG22 ' D' ' 31' ' ' VAL . 46.7 mt -111.57 114.71 27.96 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.32 -1.309 . . . . 73.41 107.642 170.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.52 -131.73 22.09 Favored Glycine 0 C--N 1.341 0.835 0 O-C-N 123.155 0.284 . . . . 60.42 112.768 -176.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.84 1.61 55.38 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.942 0.497 . . . . 75.41 111.41 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -119.15 164.66 15.24 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.751 0.42 . . . . 71.31 110.366 -175.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 98.8 m -67.82 131.59 45.82 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.06 -0.973 . . . . 73.13 110.998 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.581 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -84.9 -63.49 1.32 Allowed 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.698 -1.223 . . . . 51.41 107.698 170.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -152.05 148.82 28.14 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 114.587 -1.188 . . . . 62.13 110.607 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.446 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 82.6 mt -109.65 154.12 23.27 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.454 1.102 . . . . 74.3 108.27 170.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.542 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 43.0 t -157.9 148.62 20.86 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.316 -0.624 . . . . 52.41 109.316 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -155.6 131.45 9.91 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.313 0.645 . . . . 41.44 109.796 174.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -135.13 113.82 16.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 108.267 -1.012 . . . . 74.54 108.267 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.651 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.8 mt-30 -89.54 83.88 6.35 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.239 -1.023 . . . . 74.41 108.239 169.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -80.31 96.87 6.77 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 113.734 -1.575 . . . . 64.32 109.377 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.25 168.51 35.23 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.689 -0.687 . . . . 73.14 112.468 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.02 138.09 4.75 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 110.707 -0.957 . . . . 53.11 110.707 173.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.99 123.97 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 N-CA-C 108.549 -0.908 . . . . 60.41 108.549 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -115.13 125.73 53.81 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.681 1.192 . . . . 72.31 110.002 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 35.0 m -87.87 95.08 9.97 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 108.513 -0.921 . . . . 41.45 108.513 168.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 37.0 pt -109.78 142.7 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.415 -0.587 . . . . 75.43 109.415 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.63 166.94 9.82 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.933 0.893 . . . . 64.24 110.378 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.23 22.75 56.46 Favored Glycine 0 C--N 1.352 1.448 0 O-C-N 123.517 0.51 . . . . 52.35 113.796 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.581 ' HB ' ' HB3' ' D' ' 94' ' ' MET . 0.2 OUTLIER -120.33 148.97 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 124.187 0.995 . . . . 75.43 109.668 -179.068 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -129.06 -178.3 4.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.79 0.836 . . . . 64.52 109.904 -175.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.58 -142.58 47.05 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.363 -0.835 . . . . 53.14 112.63 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.2 p -90.81 -14.72 31.38 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.649 0.779 . . . . 74.41 111.267 173.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -56.38 -34.1 66.37 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.356 1.062 . . . . 72.34 112.247 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.581 ' HB3' ' HB ' ' D' ' 89' ' ' ILE . 0.0 OUTLIER -62.57 -43.5 98.65 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.306 0.642 . . . . 64.13 112.049 -179.426 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 95' ' ' ALA . . . . . 0.453 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.05 -22.92 28.8 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.384 0.674 . . . . 54.0 111.862 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -74.93 -38.4 61.78 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.734 -0.469 . . . . 73.43 109.734 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 73.7 m -73.05 -26.7 61.38 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.493 0.717 . . . . 70.41 110.888 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 53.2 tp -63.89 -43.63 95.44 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.711 0.804 . . . . 65.32 110.319 175.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 99' ' ' GLY . . . . . 0.409 ' O ' HG21 ' D' ' 46' ' ' THR . . . -94.56 -12.05 56.28 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 119.298 -0.723 . . . . 62.32 114.381 -175.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.04 -58.34 1.88 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 118.439 1.12 . . . . 70.23 112.341 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -74.57 -41.73 60.01 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.224 0.453 . . . . 75.41 112.224 -172.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.531 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 75.5 m -61.46 -47.52 93.17 Favored Pre-proline 0 CA--C 1.568 1.636 0 C-N-CA 123.383 0.673 . . . . 70.22 111.69 178.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.595 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 53.2 Cg_exo -61.63 -31.24 86.63 Favored 'Trans proline' 0 C--N 1.39 2.718 0 C-N-CA 122.344 2.029 . . . . 65.12 113.795 170.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -63.0 -33.33 75.19 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.022 0.529 . . . . 64.2 110.843 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.4 mm -67.22 -42.08 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.776 0.83 . . . . 73.31 110.49 173.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 54.0 mt -76.18 -11.35 59.91 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.357 -0.838 . . . . 73.23 111.638 -175.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -70.63 -44.81 17.42 Favored Pre-proline 0 CA--C 1.558 1.282 0 N-CA-C 114.086 1.143 . . . . 72.43 114.086 -172.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 108' ' ' PRO . . . . . 0.597 ' HB2' ' HG2' ' B' ' 108' ' ' PRO . 29.1 Cg_endo -61.97 -32.07 84.42 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 121.649 1.566 . . . . 75.35 112.469 172.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 109' ' ' TYR . . . . . 0.415 ' O ' ' HB3' ' D' ' 112' ' ' GLU . 62.5 m-85 -72.82 -31.69 64.99 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.752 0.821 . . . . 73.22 111.634 175.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.98 -48.08 72.43 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.437 0.637 . . . . 75.4 109.334 175.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 33.2 ttp180 -65.66 -31.92 73.21 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.174 -1.375 . . . . 54.21 110.858 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 112' ' ' GLU . . . . . 0.446 ' HG2' HH12 ' C' ' 120' ' ' ARG . 16.0 tt0 -53.17 -52.63 58.17 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.343 1.057 . . . . 72.4 110.317 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.9 t -69.51 -47.59 63.31 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.511 -1.222 . . . . 74.31 111.061 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.52 HG21 HG21 ' D' ' 64' ' ' VAL . 63.4 mt -62.37 -58.23 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.346 0.658 . . . . 75.22 111.062 -176.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 86.0 m -52.84 -39.57 62.64 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.107 0.879 . . . . 74.23 111.564 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 43.4 t -65.19 -45.11 86.14 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.128 -0.942 . . . . 52.0 110.121 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.452 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 79.0 mtm -66.31 -32.87 74.54 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.198 0.599 . . . . 75.43 111.959 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.428 HG23 ' O ' ' D' ' 114' ' ' ILE . 92.5 t -62.79 -48.47 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.616 0.767 . . . . 75.15 109.794 175.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 96.4 p -71.24 -27.67 63.63 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.593 -0.731 . . . . 74.45 110.787 -178.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' D' ' 116' ' ' SER . 90.4 mtt-85 -69.64 -33.76 73.08 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.541 0.736 . . . . 72.24 109.936 174.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.46 9.16 71.71 Favored Glycine 0 C--N 1.355 1.624 0 O-C-N 123.578 0.548 . . . . 62.33 112.933 176.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.443 HG23 ' HB3' ' C' ' 17' ' ' TYR . 82.1 p 56.51 36.56 27.76 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.93 1.692 . . . . 74.11 113.631 177.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -98.62 149.63 35.93 Favored Pre-proline 0 C--O 1.243 0.754 0 N-CA-C 108.557 -0.905 . . . . 73.34 108.557 171.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.46 ' HB3' ' HA ' ' E' ' 129' ' ' THR . 66.7 Cg_exo -45.58 131.1 12.44 Favored 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 123.308 2.672 . . . . 63.22 112.616 172.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -52.95 130.88 34.92 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 124.344 1.027 . . . . 75.5 111.479 -172.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.516 HD13 HG21 ' D' ' 40' ' ' VAL . 10.1 tp -105.71 98.61 8.28 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.182 -0.917 . . . . 72.42 108.603 -173.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -100.51 78.61 2.02 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.94 -1.133 . . . . 63.33 107.94 177.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.06 132.33 48.29 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 109.791 -0.448 . . . . 52.3 109.791 -175.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.77 144.03 97.99 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 123.815 0.846 . . . . 75.41 111.425 -174.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.65 132.63 46.67 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.635 2.223 . . . . 65.45 111.945 176.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 73.6 t -107.48 128.63 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.729 -0.841 . . . . 73.34 108.729 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -85.59 97.84 10.31 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.657 0.783 . . . . 70.21 108.997 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -62.49 -26.88 68.77 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.658 1.183 . . . . 51.35 112.229 -173.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -58.69 -41.71 86.89 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.915 0.886 . . . . 71.11 110.608 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.71 -30.95 71.09 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.81 -1.087 . . . . 64.32 111.937 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.4 mp -74.43 -40.74 61.78 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.282 0.633 . . . . 74.21 111.287 -175.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -67.38 -35.49 79.44 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.805 0.442 . . . . 75.15 111.485 175.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 75.8 mtm -72.59 -38.15 67.94 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.103 0.561 . . . . 72.34 110.919 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.446 ' O ' ' HG3' ' D' ' 143' ' ' GLN . 66.3 t30 -71.08 -35.05 71.72 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.332 0.653 . . . . 71.31 110.262 -175.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 140' ' ' TYR . . . . . 0.424 ' HD2' HD12 ' D' ' 141' ' ' LEU . 87.7 t80 -49.21 -41.0 35.73 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.874 1.27 . . . . 75.4 111.688 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.424 HD12 ' HD2' ' D' ' 140' ' ' TYR . 9.2 mp -73.92 -43.13 59.37 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.694 0.798 . . . . 73.3 111.768 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -91.22 27.99 1.76 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 113.194 0.813 . . . . 75.45 113.194 -169.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 143' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' D' ' 139' ' ' ASN . 46.8 mt-30 -121.44 87.25 2.72 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.276 0.56 . . . . 75.14 109.82 177.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -162.31 94.83 0.91 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.28 1.032 . . . . 62.12 109.336 -177.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.67 148.64 29.52 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.542 0.737 . . . . 74.43 110.519 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.29 102.86 1.87 Allowed Glycine 0 C--N 1.344 1.014 0 CA-C-N 115.909 -0.587 . . . . 75.42 111.768 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -68.43 137.5 54.54 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.887 0.875 . . . . 71.02 111.861 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -160.16 150.24 20.24 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 115.674 -0.693 . . . . 44.3 112.166 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 41.4 m -113.37 132.75 55.48 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.744 0.817 . . . . 74.53 109.576 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -75.63 173.56 10.89 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.193 0.597 . . . . 52.53 111.163 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -153.14 147.46 25.82 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.158 0.583 . . . . 75.14 110.391 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -136.72 121.41 18.5 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.796 0.839 . . . . 71.52 108.985 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -94.26 155.45 17.02 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.094 0.558 . . . . 63.2 109.574 171.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -162.77 147.81 11.93 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.384 -0.599 . . . . 72.22 109.384 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.285 0 C-N-CA 123.6 0.76 . . . . 64.21 109.138 -177.715 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.519 0 N-CA-C 111.823 -0.511 . . . . 73.24 111.823 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.52 -155.95 42.23 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 113.887 0.315 . . . . 73.2 113.887 175.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -121.09 169.05 10.89 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.422 1.089 . . . . 75.33 111.019 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -93.81 -169.57 2.13 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.952 0.901 . . . . 75.44 111.304 -174.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -158.16 101.02 1.73 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.686 -1.228 . . . . 61.45 107.686 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . -177.48 -52.85 0.07 OUTLIER Glycine 0 C--N 1.346 1.114 0 O-C-N 123.106 0.254 . . . . 54.44 112.809 -176.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 97' ' ' ILE . . . . . 0.481 HD12 HD13 ' D' ' 89' ' ' ILE . 4.0 tt -83.12 101.73 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 CA-C-O 122.177 0.989 . . . . 42.13 110.689 -177.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -155.66 89.17 1.16 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 114.763 -1.108 . . . . 74.41 108.063 171.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 99' ' ' ALA . . . . . 0.575 ' H ' HD23 ' E' ' 100' ' ' LEU . . . -166.41 25.73 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.308 1.043 . . . . 71.52 109.673 -177.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 100' ' ' LEU . . . . . 0.575 HD23 ' H ' ' E' ' 99' ' ' ALA . 2.1 pt? -151.93 152.32 29.72 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 123.645 0.778 . . . . 64.24 110.289 -173.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -84.9 152.5 11.27 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 122.454 2.103 . . . . 54.22 110.496 161.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 102' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -72.72 83.59 1.17 Allowed 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 109.323 -0.621 . . . . 62.13 109.323 178.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 48.4 p 54.41 15.75 1.08 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 126.356 1.862 . . . . 62.45 113.452 -174.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.65 -168.43 29.19 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.778 -0.529 . . . . 75.23 111.778 -173.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -66.5 -43.45 85.32 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.59 0.756 . . . . 53.12 111.433 -176.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -153.91 59.57 0.73 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 108.289 -1.004 . . . . 71.31 108.289 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 18.2 m 54.14 79.14 0.14 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.843 1.257 . . . . 54.35 111.4 176.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -61.4 -33.11 73.13 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.985 -1.007 . . . . 72.11 112.562 -169.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -70.12 -46.3 65.09 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.458 0.474 . . . . 74.15 110.255 174.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 110' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' E' ' 113' ' ' LYS . . . 62.03 115.82 0.02 OUTLIER 'General case' 0 C--N 1.357 0.896 0 O-C-N 124.614 1.197 . . . . 72.42 110.03 -165.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 111' ' ' LEU . . . . . 0.76 HD22 HG23 ' D' ' 46' ' ' THR . 52.5 tp -51.74 -57.32 9.6 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.041 0.936 . . . . 60.4 112.714 -168.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -107.9 72.16 0.84 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 107.588 -1.264 . . . . 74.52 107.588 171.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 113' ' ' LYS . . . . . 0.425 ' HB2' ' HB3' ' E' ' 110' ' ' ALA . 21.6 tptm -79.44 86.76 5.11 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.807 -0.442 . . . . 60.21 109.807 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 114' ' ' LYS . . . . . 0.59 ' HD3' ' HB2' ' E' ' 117' ' ' LYS . 36.4 ttmt -168.3 109.22 0.54 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.252 -0.886 . . . . 73.33 108.743 175.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 77.5 p -100.17 -16.0 17.94 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.422 0.689 . . . . 73.11 111.984 -175.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . -95.24 -30.21 8.39 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 116.338 -0.392 . . . . 72.1 113.301 -175.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 117' ' ' LYS . . . . . 0.59 ' HB2' ' HD3' ' E' ' 114' ' ' LYS . 63.1 mttp -131.96 164.48 42.72 Favored Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 123.469 0.707 . . . . 62.31 110.328 -178.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.98 179.28 6.23 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.475 2.116 . . . . 62.31 111.888 165.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -150.67 -162.82 1.63 Allowed 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 108.411 -0.959 . . . . 74.01 108.411 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -50.15 -32.56 16.44 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 125.159 1.384 . . . . 62.45 111.568 173.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 121' ' ' VAL . . . . . . . . . . . . . 48.0 t -77.15 83.35 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 C-N-CA 123.932 0.893 . . . . 74.14 110.464 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 1.8 p -157.37 147.66 20.92 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.559 1.544 . . . . 55.33 108.286 175.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -139.17 128.57 24.25 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.399 -0.593 . . . . 71.32 109.399 174.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 54.3 m -145.72 19.59 1.48 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.764 1.225 . . . . 55.31 108.921 170.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -108.2 -17.56 13.99 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.915 0.886 . . . . 75.14 111.087 -173.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.25 139.62 41.22 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.422 -0.584 . . . . 60.11 109.422 171.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 38.5 p -155.8 87.3 1.07 Allowed 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.348 0.594 . . . . 74.43 110.109 -175.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -128.73 66.14 1.42 Allowed 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.73 0.776 . . . . 65.15 108.99 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 129' ' ' THR . . . . . 0.46 ' HA ' ' HB3' ' D' ' 124' ' ' PRO . 8.1 t -88.26 119.35 28.58 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.98 -1.009 . . . . 63.15 110.449 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 130' ' ' ALA . . . . . 0.4 ' HB1' ' HG3' ' A' ' 124' ' ' PRO . . . -167.03 98.54 0.53 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.9 0.88 . . . . 73.11 109.731 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 131' ' ' TRP . . . . . . . . . . . . . 68.2 t90 -164.52 109.32 0.96 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.881 0.872 . . . . 75.11 109.274 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 19.3 p 179.13 87.07 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.546 1.138 . . . . 72.44 109.813 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 16.9 m -149.98 142.15 24.08 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.271 -0.64 . . . . 54.45 109.271 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -171.2 122.95 1.0 Allowed Glycine 0 C--N 1.343 0.963 0 N-CA-C 110.473 -1.051 . . . . 64.21 110.473 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 31.1 m -120.5 144.73 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.713 0.805 . . . . 62.34 110.699 -175.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -138.08 45.5 2.11 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.797 0.808 . . . . 75.25 108.883 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 24.4 p -72.58 -28.79 63.02 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.815 -0.63 . . . . 51.41 109.97 173.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -119.18 170.93 8.66 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.665 1.186 . . . . 64.23 109.61 173.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 139' ' ' ASN . . . . . 0.475 HD21 ' HB3' ' C' ' 9' ' ' MET . 51.8 t30 -120.04 -92.26 0.54 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.476 0.71 . . . . 74.51 110.006 -176.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . 172.13 179.35 42.98 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 112.295 -0.322 . . . . 74.3 112.295 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -163.19 -160.32 0.6 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.577 1.151 . . . . 53.41 109.585 -174.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 142' ' ' LEU . . . . . 0.454 HD12 ' HD1' ' C' ' 101' ' ' TYR . 92.3 mt 74.14 22.37 2.33 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 125.419 1.488 . . . . 70.41 111.84 174.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -86.77 108.05 3.28 Favored Glycine 0 C--N 1.344 0.996 0 N-CA-C 111.173 -0.771 . . . . 72.35 111.173 174.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 27.3 m -81.46 146.25 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 123.16 0.584 . . . . 62.41 110.919 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 29.1 t70 . . . . . 0 C--O 1.252 1.191 0 C-N-CA 124.218 1.007 . . . . 70.34 110.591 179.946 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.415 0 N-CA-C 112.301 -0.32 . . . . 64.51 112.301 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . -143.61 152.07 23.84 Favored Glycine 0 C--N 1.343 0.939 0 N-CA-C 110.319 -1.112 . . . . 71.34 110.319 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -107.22 -66.2 1.04 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.079 0.552 . . . . 73.45 110.64 -174.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -109.22 -102.93 0.38 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.468 0.307 . . . . 72.33 111.502 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -148.06 -63.56 0.26 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.149 0.58 . . . . 70.21 111.146 -162.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . 170.52 72.08 0.04 OUTLIER Glycine 0 C--N 1.34 0.799 0 CA-C-N 115.11 -0.95 . . . . 71.22 110.793 -170.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 97' ' ' ILE . . . . . 0.474 HD12 HG12 ' B' ' 86' ' ' ILE . 5.2 tt -48.65 -46.15 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 124.998 1.319 . . . . 44.33 111.445 177.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 t0 174.18 -72.02 0.01 OUTLIER 'General case' 0 C--N 1.355 0.812 0 C-N-CA 125.612 1.565 . . . . 64.34 107.843 175.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -175.69 -20.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.166 0.986 . . . . 71.14 111.089 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 100' ' ' LEU . . . . . 0.534 HD11 ' H ' ' B' ' 54' ' ' ASP . 2.7 mp 61.36 92.54 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.445 0 C-N-CA 125.743 1.617 . . . . 54.35 110.881 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 101' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' B' ' 95' ' ' ALA . 95.5 Cg_endo -93.64 89.54 0.15 Allowed 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.257 2.638 . . . . 62.14 110.289 175.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 102' ' ' LEU . . . . . 0.55 HD11 ' HB2' ' B' ' 48' ' ' SER . 32.6 tp -66.02 161.73 20.92 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 114.727 -1.124 . . . . 63.32 109.963 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 39.2 p -79.08 52.72 1.32 Allowed 'General case' 0 CA--C 1.564 1.484 0 C-N-CA 124.548 1.139 . . . . 74.51 111.673 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.71 -72.16 2.82 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 111.237 -0.745 . . . . 70.51 111.237 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -174.0 -67.07 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 106.689 -1.597 . . . . 74.54 106.689 177.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -81.26 120.28 24.71 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 106.561 -1.644 . . . . 74.34 106.561 168.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 35.6 m -61.64 110.15 1.41 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.576 0.35 . . . . 62.12 110.725 -173.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -86.65 48.2 1.6 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.354 1.062 . . . . 73.04 109.928 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -169.94 90.27 0.18 Allowed 'General case' 0 C--O 1.239 0.547 0 N-CA-C 106.474 -1.676 . . . . 61.31 106.474 -178.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.02 171.13 8.62 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.232 0.613 . . . . 70.03 111.789 -172.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 111' ' ' LEU . . . . . 0.4 ' HB3' ' CD2' ' B' ' 136' ' ' LEU . 4.0 mm? -61.79 90.67 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 114.556 -1.202 . . . . 63.01 110.223 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 71.85 7.39 5.86 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.183 1.393 . . . . 70.44 111.549 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -130.25 149.41 51.95 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.164 -0.96 . . . . 51.52 112.82 -168.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 114' ' ' LYS . . . . . 0.512 ' HG2' ' OH ' ' B' ' 140' ' ' TYR . 0.0 OUTLIER -141.36 39.16 1.73 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.642 1.577 . . . . 73.45 107.544 167.181 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 12.0 m 75.3 83.04 0.1 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.369 1.468 . . . . 65.1 109.274 -165.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . -115.26 -159.13 12.07 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 115.742 -0.663 . . . . 55.31 112.286 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 117' ' ' LYS . . . . . 0.447 ' HB2' ' HD3' ' F' ' 118' ' ' PRO . 10.1 mtpm? -142.46 -57.67 0.02 OUTLIER Pre-proline 0 CA--C 1.564 1.484 0 C-N-CA 124.048 0.939 . . . . 75.5 110.472 177.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 118' ' ' PRO . . . . . 0.447 ' HD3' ' HB2' ' F' ' 117' ' ' LYS . 18.8 Cg_endo -92.97 45.5 0.34 Allowed 'Trans proline' 0 C--N 1.393 2.879 0 C-N-CA 122.364 2.042 . . . . 64.32 112.458 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -69.59 171.12 9.43 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.639 0.776 . . . . 72.15 111.895 -174.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -50.44 -53.55 28.69 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.437 1.095 . . . . 74.54 110.971 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 48.2 t -82.99 83.99 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 108.589 -0.893 . . . . 61.52 108.589 175.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 10.1 t -90.26 -14.0 34.21 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 114.679 -1.146 . . . . 71.41 111.265 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -124.68 172.77 9.01 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.753 0.821 . . . . 73.11 109.953 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 22.6 m -63.98 -34.91 79.05 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.842 -0.617 . . . . 64.54 110.683 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . 72.19 -63.47 0.43 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.219 1.808 . . . . 25.21 111.412 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 126' ' ' ALA . . . . . 0.5 ' HB2' ' H ' ' B' ' 129' ' ' ALA . . . -77.18 95.32 4.26 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.944 0.898 . . . . 61.14 110.339 176.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 58.9 p -98.81 125.49 44.19 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.472 -0.936 . . . . 64.31 108.472 172.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.81 -164.73 0.31 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.706 0.802 . . . . 72.55 110.588 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 129' ' ' THR . . . . . 0.524 HG22 ' HB3' ' B' ' 125' ' ' GLN . 13.2 t -123.15 -179.13 4.18 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.791 -0.818 . . . . 72.24 108.791 170.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.66 164.87 25.49 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 123.033 0.533 . . . . 61.23 111.084 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 131' ' ' TRP . . . . . 0.532 ' HB2' ' HG3' ' B' ' 124' ' ' PRO . 27.3 t90 -79.92 83.22 5.87 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.31 -0.996 . . . . 71.15 108.31 174.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 14.8 p -109.03 48.6 0.86 Allowed 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.069 0.947 . . . . 71.34 109.422 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 24.4 m -78.62 122.05 25.45 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.761 -1.109 . . . . 74.34 110.296 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -78.85 -85.51 0.54 Allowed Glycine 0 C--N 1.348 1.226 0 O-C-N 123.654 0.596 . . . . 63.23 112.039 176.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 135' ' ' VAL . . . . . 0.643 ' H ' HG21 ' C' ' 40' ' ' VAL . 48.0 t 59.33 19.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 C-N-CA 124.897 1.279 . . . . 43.25 110.971 -177.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -85.71 73.22 10.45 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 122.095 0.95 . . . . 74.23 110.62 -176.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 2.0 m -132.61 29.74 4.17 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 114.137 -1.392 . . . . 75.24 107.308 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -152.49 148.54 27.53 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-N 114.516 -1.22 . . . . 71.23 108.456 -170.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -59.68 111.56 1.48 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.5 0.72 . . . . 72.31 110.268 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . 133.6 20.48 0.88 Allowed Glycine 0 CA--C 1.532 1.147 0 CA-C-N 115.36 -0.836 . . . . 54.1 111.772 -172.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.66 134.42 40.59 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.686 0.794 . . . . 75.21 110.521 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -146.89 158.31 43.88 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.306 0.642 . . . . 71.11 110.44 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -131.65 116.24 1.86 Allowed Glycine 0 C--N 1.345 1.065 0 N-CA-C 110.403 -1.079 . . . . 30.15 110.403 174.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 48.5 t -105.4 133.53 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 117.536 0.668 . . . . 72.11 109.746 -177.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 . . . . . 0 C--O 1.254 1.318 0 N-CA-C 108.587 -0.894 . . . . 75.31 108.587 174.075 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.404 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.492 -0.558 . . . . 70.21 109.492 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.6 m -72.39 93.29 1.51 Allowed 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.536 0.734 . . . . 70.32 109.801 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -144.91 156.89 44.24 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 122.905 0.482 . . . . 74.01 110.292 -176.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -67.94 160.61 28.22 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.543 1.137 . . . . 74.35 112.122 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -152.77 155.18 36.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.699 0.799 . . . . 75.51 109.173 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -57.33 134.72 56.24 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.13 0.972 . . . . 74.24 110.886 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -109.11 79.95 1.27 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 122.746 1.26 . . . . 74.53 109.405 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -128.07 28.78 5.49 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 114.466 -1.243 . . . . 71.44 109.971 -175.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.451 ' N ' ' SD ' ' A' ' 9' ' ' MET . 1.0 OUTLIER -71.02 160.31 33.16 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.973 0.909 . . . . 74.23 110.995 -179.411 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.7 m -140.25 111.89 7.39 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.352 -1.351 . . . . 72.34 107.352 172.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -129.49 113.91 15.46 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.068 -1.086 . . . . 64.42 108.068 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -134.08 118.44 17.74 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.016 -0.735 . . . . 65.35 109.016 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.471 HG21 ' HG2' ' C' ' 130' ' ' PRO . 43.4 mt -80.69 119.82 31.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 109.362 -0.607 . . . . 64.11 109.362 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -85.83 -38.78 17.76 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 123.607 0.567 . . . . 60.32 110.163 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -173.52 129.26 0.43 Allowed 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.599 -0.273 . . . . 65.21 110.365 -170.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.497 HD12 ' HG3' ' C' ' 130' ' ' PRO . 87.0 mt -119.79 134.02 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 108.235 -1.024 . . . . 53.2 108.235 173.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.435 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 36.8 p90 -162.27 168.1 22.87 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 124.036 0.835 . . . . 73.43 110.87 -170.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -89.78 119.49 30.21 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.665 -0.865 . . . . 62.31 108.665 172.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 32.8 mtpt -78.97 -26.33 43.44 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.736 -0.468 . . . . 74.24 109.736 172.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -159.08 146.31 17.31 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.292 1.037 . . . . 62.12 109.614 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.8 mt -135.85 146.36 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.092 1.357 . . . . 72.04 107.836 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.0 t -148.01 131.95 17.15 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 109.059 -0.719 . . . . 64.33 109.059 171.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 89.3 t80 -137.09 127.75 27.02 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 106.988 -1.486 . . . . 72.32 106.988 171.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -134.5 129.18 34.76 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.009 0.523 . . . . 74.41 109.856 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.93 75.21 79.84 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.479 -1.304 . . . . 73.43 107.479 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.49 -28.0 32.67 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.713 2.275 . . . . 54.34 112.377 -172.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -104.8 15.38 27.96 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.203 -0.908 . . . . 75.41 110.154 -177.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.563 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -43.85 -56.41 7.48 Favored Pre-proline 0 N--CA 1.494 1.763 0 N-CA-C 113.996 1.11 . . . . 71.21 113.996 -169.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 70.8 Cg_exo -54.98 -35.22 89.38 Favored 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 122.515 2.143 . . . . 71.04 113.607 176.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -78.36 -42.47 30.36 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.508 0.723 . . . . 73.22 110.042 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.1 p -67.05 -27.57 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 114.593 -1.185 . . . . 74.42 111.951 -159.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -72.99 -29.33 62.96 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.952 -0.567 . . . . 74.11 110.767 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -75.1 -24.29 58.08 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.239 1.016 . . . . 71.14 110.888 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -77.24 152.28 34.76 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.853 0.861 . . . . 35.34 110.707 -175.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.83 118.29 7.0 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.752 0.657 . . . . 54.33 109.623 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -83.82 85.06 7.35 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.679 0.752 . . . . 72.35 110.991 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -121.01 84.05 38.69 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 107.001 -1.481 . . . . 74.52 107.001 170.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.45 116.89 4.63 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.361 2.041 . . . . 62.45 111.982 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -96.38 101.79 13.48 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.319 -0.993 . . . . 75.31 108.319 174.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 t -97.39 108.1 21.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 114.818 -1.083 . . . . 70.14 110.796 -169.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -83.65 119.94 25.37 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.747 0.819 . . . . 72.5 109.035 170.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.6 tp -97.25 106.53 18.88 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.371 -0.974 . . . . 54.41 108.371 175.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.472 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.4 m-20 -107.92 148.52 29.53 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.373 1.069 . . . . 72.22 108.77 176.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.728 HD11 HG21 ' A' ' 131' ' ' VAL . 92.6 mt -137.68 154.91 49.62 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.306 0.642 . . . . 42.03 111.246 -175.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.606 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 6.8 m-20 -137.72 141.29 41.02 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.166 -1.379 . . . . 61.53 108.113 175.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.3 m -141.0 123.16 15.64 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.249 -0.649 . . . . 64.1 109.249 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.75 138.16 23.06 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.505 0.722 . . . . 64.33 109.511 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.8 m -90.57 165.77 13.57 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.078 0.551 . . . . 75.25 109.56 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.2 t -154.69 119.48 4.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.398 -0.964 . . . . 54.21 108.398 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -85.15 103.33 14.04 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.953 -1.129 . . . . 72.11 107.953 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 57' ' ' GLU . 83.4 mt -77.9 -40.1 40.97 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.12 0.568 . . . . 62.43 109.474 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.35 -178.41 6.96 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.0 -1.0 . . . . 71.01 109.731 178.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -61.7 115.85 4.31 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.475 -0.784 . . . . 73.12 109.358 172.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 72.05 -4.19 2.04 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 125.178 1.391 . . . . 74.44 113.427 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.1 t -100.94 104.59 16.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.477 -0.935 . . . . 75.33 108.477 175.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -115.18 123.31 48.56 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.622 -0.881 . . . . 72.14 108.622 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.466 ' HB2' HD11 ' A' ' 51' ' ' LEU . 32.4 tt0 -89.58 151.59 21.85 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 123.396 0.679 . . . . 54.3 109.313 166.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.457 HG11 ' HD3' ' A' ' 103' ' ' PRO . 83.2 t -130.03 138.03 55.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.983 -1.117 . . . . 64.32 107.983 168.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.1 t -114.3 132.51 63.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 CA-C-O 121.232 0.539 . . . . 60.11 109.749 174.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.546 HD21 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -113.68 110.3 19.98 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 106.313 -1.736 . . . . 72.01 106.313 174.326 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.606 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 16.8 ttp180 -101.31 107.07 18.33 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.878 -1.156 . . . . 73.22 107.878 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 36.1 t -93.67 123.61 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 108.585 -0.894 . . . . 64.22 108.585 176.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.472 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 22.1 m -114.7 111.88 21.97 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.212 -0.662 . . . . 72.32 109.212 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.528 HG21 HG21 ' A' ' 114' ' ' ILE . 81.7 t -103.02 120.9 53.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 124.539 1.135 . . . . 53.44 109.004 177.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.5 m -115.39 129.48 56.59 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.859 -0.793 . . . . 72.24 108.859 166.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.6 129.2 56.65 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.266 -1.383 . . . . 73.11 107.266 171.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.1 m -125.04 171.14 10.49 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.504 0.668 . . . . 73.13 109.936 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.7 mt -130.09 62.4 1.56 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 105.781 -1.933 . . . . 65.21 105.781 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.96 -103.52 2.01 Favored Glycine 0 C--N 1.338 0.648 0 CA-C-N 115.559 -0.746 . . . . 63.43 111.257 -173.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -91.16 -27.18 18.69 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.846 0.459 . . . . 71.52 111.708 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -97.44 123.84 41.42 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.802 0.441 . . . . 75.24 109.937 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 57.6 m -70.61 134.55 47.7 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.975 0.417 . . . . 71.55 110.391 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.581 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -79.26 -59.12 2.89 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.252 -0.885 . . . . 71.34 109.66 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -156.47 166.11 34.36 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.93 -1.032 . . . . 74.15 110.93 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.7 tp -135.46 114.11 11.81 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.366 1.066 . . . . 74.33 108.848 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.508 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 57.4 m -107.02 139.91 40.67 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.09 0.956 . . . . 70.11 108.917 174.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -149.95 117.81 6.26 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.592 -0.521 . . . . 72.11 109.592 175.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.5 t -127.59 114.5 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.835 0.854 . . . . 73.42 109.859 -175.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.604 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 10.4 mt-30 -86.77 81.18 8.27 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.548 -0.908 . . . . 64.4 108.548 174.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -76.57 95.94 4.02 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.59 -0.732 . . . . 74.12 109.407 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.85 146.48 16.38 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 111.351 -0.7 . . . . 64.1 111.351 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.29 134.05 6.49 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.104 -0.798 . . . . 51.13 111.104 -176.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.9 mt -81.24 125.57 39.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 108.777 -0.823 . . . . 71.43 108.777 173.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.812 ' HB3' HD11 ' A' ' 86' ' ' ILE . 82.0 m-85 -127.68 128.03 44.75 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.981 0.912 . . . . 74.15 109.202 -174.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.1 t -94.89 101.04 12.81 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.194 -1.039 . . . . 54.54 108.194 175.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.812 HD11 ' HB3' ' A' ' 84' ' ' PHE . 5.8 mm -113.5 153.52 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 122.4 0.28 . . . . 74.53 111.11 -171.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.06 167.5 12.51 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.546 1.139 . . . . 61.41 110.248 175.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.87 2.16 64.97 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-O 119.372 -0.682 . . . . 74.21 114.724 169.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.07 161.49 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 123.965 0.906 . . . . 74.01 110.554 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.475 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 18.1 tt0 -153.61 175.56 13.08 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 109.574 -0.528 . . . . 63.3 109.574 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.475 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 53.74 -121.23 17.22 Favored Glycine 0 C--N 1.349 1.299 0 O-C-N 124.099 0.874 . . . . 63.32 114.34 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.9 t -69.25 -30.35 68.45 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.028 0.931 . . . . 71.14 111.941 -176.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -74.42 -36.64 63.44 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.146 0.579 . . . . 62.42 110.459 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.411 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 4.9 tpt -65.26 -44.56 87.69 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.442 0.464 . . . . 74.52 110.405 175.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.62 -41.66 86.45 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.318 -0.855 . . . . 60.52 111.208 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.517 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 54.8 t-80 -78.58 -25.55 45.33 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.419 -0.809 . . . . 73.11 111.508 -177.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 44.0 t -69.95 -42.91 72.59 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.265 0.555 . . . . 75.44 109.962 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 88.0 mt -81.85 -40.97 21.68 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.846 -1.07 . . . . 74.51 111.732 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.32 3.16 81.91 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 116.035 -0.529 . . . . 71.11 114.284 -170.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.669 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -146.93 -58.76 0.28 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.54 0.67 . . . . 64.24 112.007 -171.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -67.65 -45.29 75.73 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-N 116.006 -0.543 . . . . 73.44 111.049 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.406 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 88.3 m -63.45 -52.34 60.83 Favored Pre-proline 0 CA--C 1.566 1.573 0 N-CA-C 113.435 0.902 . . . . 63.13 113.435 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.457 ' HD3' HG11 ' A' ' 58' ' ' VAL . 44.3 Cg_endo -65.7 -20.6 59.35 Favored 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 122.051 1.834 . . . . 55.5 113.052 177.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -63.83 -43.69 95.45 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 120.99 0.424 . . . . 72.21 110.043 172.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' A' ' 102' ' ' CYS . 31.2 mm -61.74 -38.15 79.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 124.405 1.082 . . . . 75.41 110.673 174.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 103' ' ' PRO . 78.0 mt -77.64 -22.46 50.66 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.079 0.952 . . . . 74.03 112.96 -173.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -70.3 -41.94 14.84 Favored Pre-proline 0 CA--C 1.557 1.245 0 N-CA-C 114.434 1.272 . . . . 74.24 114.434 -170.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -54.12 -39.39 86.07 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 121.902 1.734 . . . . 75.12 112.742 173.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -74.55 -40.81 61.45 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.748 0.819 . . . . 72.22 111.484 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.66 -49.01 74.91 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.974 0.509 . . . . 70.35 110.241 177.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.654 HH12 HD12 ' C' ' 105' ' ' ILE . 29.7 ttm180 -52.04 -48.88 64.36 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.719 1.262 . . . . 74.05 110.491 176.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -61.95 -50.51 71.82 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 124.204 0.94 . . . . 75.4 111.63 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.451 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 44.9 t -54.3 -44.75 72.24 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.361 1.038 . . . . 53.55 110.691 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.528 HG21 HG21 ' A' ' 64' ' ' VAL . 96.9 mt -63.05 -55.06 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 114.968 -1.014 . . . . 75.22 111.14 176.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 91.4 m -52.83 -43.44 66.0 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.12 0.968 . . . . 63.02 111.53 -175.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -68.0 -44.21 77.09 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.382 -1.281 . . . . 74.52 109.782 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 11.1 mtp -57.45 -42.45 82.51 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.887 0.875 . . . . 73.1 111.596 175.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 114' ' ' ILE . 72.3 t -59.72 -49.27 84.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.4 1.08 . . . . 73.53 110.274 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -72.42 -27.66 62.48 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.855 -0.612 . . . . 71.24 111.775 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 50.3 mtt-85 -70.77 -31.43 68.21 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.363 0.665 . . . . 72.34 109.932 175.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.422 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.48 18.2 25.57 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.572 -0.74 . . . . 63.21 113.073 175.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 121' ' ' GLY . 2.5 t 59.61 11.57 2.44 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 126.952 2.101 . . . . 71.21 113.225 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -79.07 139.31 56.78 Favored Pre-proline 0 C--O 1.245 0.858 0 N-CA-C 108.271 -1.011 . . . . 55.3 108.271 174.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.555 ' HB3' ' H ' ' E' ' 132' ' ' SER . 91.6 Cg_exo -48.58 135.79 27.0 Favored 'Trans proline' 0 C--N 1.365 1.438 0 C-N-CA 123.249 2.633 . . . . 74.3 112.519 173.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -58.8 127.5 32.5 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 124.292 0.995 . . . . 70.44 111.988 -166.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.0 tp -110.22 134.61 52.06 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 123.974 0.91 . . . . 72.14 108.859 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -129.02 122.22 29.58 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.823 -0.806 . . . . 44.2 108.823 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.2 mt -74.15 148.04 42.1 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.481 -0.562 . . . . 71.31 109.481 -176.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.686 ' HB2' ' HA ' ' E' ' 137' ' ' THR . . . -79.38 142.73 58.79 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 119.34 -0.362 . . . . 44.23 111.042 -179.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.507 ' HB3' ' OH ' ' C' ' 101' ' ' TYR . 53.3 Cg_exo -56.22 121.66 10.39 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 123.446 2.764 . . . . 73.45 113.774 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.728 HG21 HD11 ' A' ' 44' ' ' LEU . 57.7 t -102.35 121.03 52.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-N 115.485 -0.779 . . . . 74.14 109.265 176.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' C' ' 152' ' ' HIS . 46.5 t30 -91.15 81.31 5.57 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.618 -0.882 . . . . 74.11 108.618 176.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -59.29 -31.58 69.26 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 114.893 -1.049 . . . . 73.42 111.578 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.669 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 13.9 t70 -55.22 -47.84 74.75 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.966 0.906 . . . . 74.43 109.937 178.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.445 ' HB1' ' HB3' ' C' ' 153' ' ' GLN . . . -72.75 -42.43 64.05 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.384 -0.825 . . . . 73.4 111.694 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 76.1 mt -65.22 -42.15 93.75 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.034 0.534 . . . . 70.51 112.323 -174.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.579 ' HE2' HD13 ' A' ' 141' ' ' LEU . 25.3 t80 -71.05 -33.49 70.33 Favored 'General case' 0 C--O 1.212 -0.915 0 N-CA-C 109.349 -0.611 . . . . 62.33 109.349 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.632 ' HG3' ' HB3' ' A' ' 144' ' ' GLN . 7.2 tpt -72.85 -36.68 67.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.552 0.341 . . . . 52.2 110.894 -173.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.574 HD21 ' HA ' ' C' ' 2' ' ' SER . 0.7 OUTLIER -75.29 -25.81 58.24 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 110.224 -0.287 . . . . 63.23 110.224 174.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -76.92 -32.87 57.69 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.18 0.592 . . . . 71.32 111.112 172.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.579 HD13 ' HE2' ' A' ' 137' ' ' PHE . 50.2 tp -62.33 -48.79 78.29 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.712 1.205 . . . . 70.11 111.168 -171.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -165.92 18.04 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.126 -0.943 . . . . 72.53 109.95 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 0.6 OUTLIER 54.49 83.8 0.07 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.017 0.927 . . . . 61.11 109.012 -167.065 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.632 ' HB3' ' HG3' ' A' ' 138' ' ' MET . 30.3 tp60 -128.16 124.61 37.26 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.726 -0.67 . . . . 71.5 109.257 -178.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -151.54 -178.1 6.49 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.338 1.055 . . . . 62.34 109.191 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 78.16 69.52 1.39 Allowed Glycine 0 C--N 1.341 0.837 0 N-CA-C 111.749 -0.54 . . . . 44.34 111.749 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.22 147.05 48.64 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.029 0.531 . . . . 70.13 111.065 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.01 89.88 1.53 Allowed Glycine 0 C--N 1.336 0.583 0 N-CA-C 109.721 -1.352 . . . . 54.33 109.721 170.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.5 m -72.81 76.95 1.14 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.703 0.763 . . . . 74.43 110.415 -176.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -165.27 40.27 0.07 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 106.983 -1.488 . . . . 65.4 106.983 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -76.7 131.02 38.55 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 115.032 -0.985 . . . . 70.53 109.863 -176.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -126.27 37.05 4.4 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 123.969 0.793 . . . . 74.23 109.317 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -65.8 103.27 0.87 Allowed 'General case' 0 C--N 1.351 0.653 0 N-CA-C 109.06 -0.719 . . . . 65.12 109.06 170.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -73.26 114.52 11.54 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 114.766 -1.106 . . . . 74.31 109.508 -178.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.324 0 CA-C-O 118.126 -0.94 . . . . 63.41 108.673 178.33 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 58.0 ttp . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 109.855 -0.424 . . . . 74.42 109.855 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 43.0 t -157.21 -84.19 0.05 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.812 0.845 . . . . 73.55 109.582 176.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -159.31 106.39 1.74 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.365 0.666 . . . . 64.51 109.545 177.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -144.99 152.54 40.32 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.55 0.74 . . . . 71.41 109.954 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ASN . . . . . 0.7 ' H ' ' HB3' ' D' ' 147' ' ' GLU . 39.9 t30 -154.2 141.12 19.22 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.658 1.183 . . . . 64.43 109.244 -174.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -151.44 100.3 2.71 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.875 -1.158 . . . . 72.3 107.875 169.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 40.6 p -83.56 70.0 10.19 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 123.523 0.729 . . . . 74.01 110.408 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -75.59 104.14 6.01 Favored 'General case' 0 C--N 1.348 0.525 0 N-CA-C 107.226 -1.398 . . . . 73.14 107.226 169.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.606 ' HB3' HG23 ' B' ' 89' ' ' ILE . 21.4 ptm 54.71 -176.29 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.766 1.626 . . . . 70.41 113.225 -174.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 90.7 m -148.29 124.76 10.99 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.536 -1.283 . . . . 74.25 107.536 169.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -113.54 145.03 41.87 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.997 -0.742 . . . . 75.31 108.997 173.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -155.66 139.76 16.46 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.314 -0.624 . . . . 74.21 109.314 172.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.443 HD13 HD11 ' B' ' 16' ' ' ILE . 50.4 mt -82.07 132.25 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 108.022 -1.103 . . . . 65.24 108.022 168.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -100.61 -43.73 6.07 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.528 -0.545 . . . . 64.32 109.528 178.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.401 ' HE ' HG21 ' A' ' 122' ' ' THR . 55.0 ttt180 -173.27 134.22 0.53 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.473 -0.785 . . . . 75.32 108.907 -174.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.521 HG21 ' CD1' ' B' ' 109' ' ' TYR . 88.8 mt -121.1 148.37 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 108.596 -0.89 . . . . 74.33 108.596 177.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -162.39 142.87 9.99 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 112.857 0.688 . . . . 74.41 112.857 -175.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.3 m -73.15 117.14 14.52 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.686 -1.143 . . . . 64.45 108.445 167.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.466 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 42.3 mtpt -91.43 -33.76 15.11 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.076 0.551 . . . . 71.52 110.294 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.594 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 19.3 t70 -149.79 136.21 19.09 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.093 -0.503 . . . . 61.52 110.811 -167.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 43.9 mm -134.92 139.55 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.793 1.237 . . . . 74.31 108.033 174.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 47.0 t -144.21 115.1 7.81 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.256 -1.016 . . . . 74.22 108.256 177.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' B' ' 75' ' ' LEU . 77.9 t80 -126.4 130.47 50.79 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 107.715 -1.217 . . . . 64.12 107.715 171.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -140.24 120.69 14.08 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.863 0.865 . . . . 52.21 108.744 175.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.496 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -111.98 85.58 6.66 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 107.257 -1.386 . . . . 54.33 107.257 170.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.7 -26.57 53.16 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.799 2.333 . . . . 61.05 112.313 -173.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -108.5 5.24 25.02 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.469 -0.787 . . . . 64.23 111.078 -177.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.52 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -30.23 -67.18 0.15 Allowed Pre-proline 0 N--CA 1.498 1.959 0 C-N-CA 125.447 1.499 . . . . 51.03 114.868 -167.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 21.1 Cg_exo -61.95 -28.37 80.76 Favored 'Trans proline' 0 C--N 1.392 2.838 0 C-N-CA 122.043 1.828 . . . . 62.42 113.0 -170.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -94.03 -34.72 12.91 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.092 -0.958 . . . . 72.41 111.871 -172.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.682 HG22 HD12 ' B' ' 68' ' ' LEU . 9.9 p -72.19 -15.23 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 122.659 0.383 . . . . 72.34 111.202 -176.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -68.36 -9.81 50.67 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.557 0.743 . . . . 61.13 112.573 177.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.503 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.2 pt20 -67.0 -20.47 65.88 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.036 0.534 . . . . 32.01 110.808 174.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.503 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 99.5 mttt -103.03 110.78 22.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.991 1.316 . . . . 72.34 110.116 -175.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -112.92 97.31 6.46 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.692 0.397 . . . . 74.12 110.529 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 35.1 p90 -167.49 -171.31 1.64 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.439 1.096 . . . . 54.44 108.943 170.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 13.0 pm0 -71.36 111.39 10.01 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.482 0.713 . . . . 75.31 110.416 176.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.521 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 15.2 Cg_endo -65.61 152.14 82.62 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 121.204 1.27 . . . . 75.5 110.452 177.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 32.0 tt0 -69.72 99.85 1.4 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.787 -1.19 . . . . 71.23 107.787 173.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.472 HG23 ' O ' ' B' ' 38' ' ' PRO . 31.7 t -101.73 142.04 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 O-C-N 123.655 0.597 . . . . 73.34 110.134 -171.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -126.91 107.67 10.3 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.519 1.128 . . . . 62.41 108.51 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 17.9 tp -87.25 125.57 34.28 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.39 -0.966 . . . . 65.23 108.39 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -137.45 111.39 8.3 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.842 -1.17 . . . . 74.41 107.842 -170.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mp -100.99 140.65 34.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.039 0.536 . . . . 70.33 109.737 -175.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -142.96 145.33 32.89 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.107 0.963 . . . . 74.1 109.846 -177.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 4.0 t -126.37 104.62 8.27 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.701 0.8 . . . . 63.54 109.177 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.76 113.91 23.23 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.341 -1.355 . . . . 62.22 107.341 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 30.9 p -146.51 164.7 31.69 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.583 0.353 . . . . 73.01 111.819 -167.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 55.0 p -151.39 142.94 23.59 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.201 0.601 . . . . 52.41 110.83 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' F' ' 100' ' ' LEU . 62.1 tt0 -82.6 111.83 18.93 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 109.315 -0.624 . . . . 73.4 109.315 172.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 pp -121.64 21.81 10.75 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.336 -0.847 . . . . 72.13 109.851 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -168.04 148.37 4.95 Favored 'General case' 0 C--N 1.361 1.079 0 C-N-CA 123.401 0.68 . . . . 64.43 111.743 176.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.62 141.26 46.56 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 107.609 -1.256 . . . . 64.2 107.609 158.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.633 ' HB2' ' HB3' ' F' ' 93' ' ' PHE . 24.2 m-20 70.05 -2.49 2.05 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.692 1.197 . . . . 75.4 112.472 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.443 HG11 HG23 ' B' ' 83' ' ' ILE . 24.8 t -141.08 127.47 20.29 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 CA-C-N 118.755 0.707 . . . . 70.54 109.821 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.475 ' HD2' HG22 ' B' ' 58' ' ' VAL . 14.9 t80 -115.67 138.48 51.05 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 106.976 -1.49 . . . . 73.12 106.976 171.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -100.88 99.89 10.44 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 106.958 -1.497 . . . . 71.33 106.958 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.475 HG22 ' HD2' ' B' ' 56' ' ' TYR . 32.3 t -96.11 127.35 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.152 -0.931 . . . . 62.43 109.589 -173.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.414 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 17.5 t -114.9 112.44 40.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 109.149 -0.686 . . . . 74.15 109.149 175.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 63.4 tp -94.2 107.25 19.2 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 116.018 -0.537 . . . . 73.41 109.586 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -85.68 108.58 18.09 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.954 -0.758 . . . . 62.53 108.954 171.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 39.8 t -104.38 103.17 14.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 106.842 -1.54 . . . . 73.01 106.842 175.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 25.6 m -99.46 141.57 32.07 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.176 -0.92 . . . . 74.34 109.506 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.642 HG11 HD21 ' B' ' 126' ' ' LEU . 41.5 t -133.77 118.29 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.128 0.971 . . . . 75.11 109.425 175.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 40.5 m -105.3 139.65 39.62 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.162 -1.421 . . . . 72.41 107.162 172.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -146.06 141.02 27.19 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.537 0.608 . . . . 54.23 110.536 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.559 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 19.8 m -143.12 128.37 18.75 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.452 0.47 . . . . 73.24 112.018 -172.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.682 HD12 HG22 ' B' ' 31' ' ' VAL . 90.4 mt -95.1 117.74 30.72 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.673 0.789 . . . . 73.23 109.007 176.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.51 -110.59 3.09 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.948 -0.861 . . . . 44.14 110.948 -172.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.22 6.38 8.47 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.771 0.829 . . . . 74.55 109.698 177.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -113.75 148.34 36.66 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.039 0.536 . . . . 75.51 109.627 -175.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 27.7 m -66.1 120.75 13.73 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.787 0.435 . . . . 73.41 110.966 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.631 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -73.53 -63.8 1.12 Allowed 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.612 -1.255 . . . . 70.34 107.612 172.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 74' ' ' PHE . . . . . 0.402 ' HZ ' HD22 ' B' ' 126' ' ' LEU . 39.4 p90 -152.59 161.82 42.06 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 114.405 -1.271 . . . . 62.23 111.087 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 58.1 mt -123.26 112.34 17.52 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 105.328 -2.101 . . . . 50.42 105.328 171.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.525 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 47.5 t -120.43 139.94 52.11 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.612 -0.884 . . . . 71.43 108.612 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -157.09 135.47 11.31 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.273 -0.64 . . . . 55.25 109.273 -174.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 62.6 t -132.88 147.54 31.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.097 -0.956 . . . . 74.21 108.798 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.594 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 17.9 mt-30 -123.68 106.95 10.95 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.073 -1.084 . . . . 65.33 108.073 168.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.446 ' O ' HD13 ' B' ' 106' ' ' LEU . 8.2 tp-100 -97.03 104.39 16.4 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.356 -0.979 . . . . 73.13 108.356 176.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.466 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -94.77 167.57 27.05 Favored Glycine 0 C--N 1.338 0.649 0 O-C-N 123.543 0.527 . . . . 65.43 111.969 175.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.15 138.52 5.26 Favored Glycine 0 C--N 1.341 0.826 0 C-N-CA 121.156 -0.545 . . . . 70.42 114.053 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.443 HG23 HG11 ' B' ' 55' ' ' VAL . 70.3 mt -86.37 114.36 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 124.862 1.265 . . . . 62.42 108.184 169.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -126.31 133.4 51.4 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.278 0.631 . . . . 74.54 110.514 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 58.3 m -89.39 106.06 18.2 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.573 0.749 . . . . 71.14 110.767 175.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.59 HG22 HD11 ' B' ' 89' ' ' ILE . 54.9 mt -116.95 104.74 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 125.274 1.43 . . . . 72.31 108.395 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.12 166.7 23.47 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.938 0.895 . . . . 54.4 110.648 -174.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.6 -53.17 2.7 Favored Glycine 0 N--CA 1.476 1.36 0 O-C-N 123.111 0.257 . . . . 53.13 112.635 177.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.606 HG23 ' HB3' ' B' ' 9' ' ' MET . 0.5 OUTLIER -62.5 166.38 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 124.283 1.033 . . . . 74.5 112.271 171.978 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -159.79 151.9 20.68 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.108 -0.951 . . . . 73.15 110.41 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.67 -127.7 9.02 Favored Glycine 0 C--N 1.354 1.562 0 CA-C-N 116.365 -0.379 . . . . 30.22 113.179 174.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.6 m -79.8 -39.31 31.12 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.995 0.903 . . . . 71.14 110.292 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -60.77 -34.38 74.39 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 113.217 -1.81 . . . . 74.53 111.731 -168.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.533 ' SD ' ' N ' ' B' ' 95' ' ' ALA . 2.1 ppp? -65.72 -46.09 80.22 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.091 -0.959 . . . . 72.2 111.822 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.533 ' N ' ' SD ' ' B' ' 94' ' ' MET . . . -79.44 -12.45 59.89 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.472 0.709 . . . . 63.11 112.724 -175.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -62.4 -34.74 77.33 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 110.18 -0.304 . . . . 64.24 110.18 167.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -68.67 -51.18 44.67 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.944 0.498 . . . . 34.03 111.049 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.511 ' HG ' ' HA ' ' B' ' 95' ' ' ALA . 4.2 pp -70.82 -27.81 64.15 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.636 0.375 . . . . 75.44 111.687 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.1 3.82 67.15 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-O 119.142 -0.81 . . . . 72.42 114.185 -174.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.95 -51.88 0.1 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 117.948 0.874 . . . . 74.51 112.257 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -71.52 -40.36 70.18 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.051 0.54 . . . . 72.13 111.263 -175.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.475 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 72.3 m -68.87 -48.51 29.42 Favored Pre-proline 0 CA--C 1.56 1.337 0 CA-C-O 118.544 -0.741 . . . . 74.22 111.493 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 89.1 Cg_exo -53.5 -32.72 64.47 Favored 'Trans proline' 0 C--N 1.399 3.189 0 C-N-CA 122.636 2.224 . . . . 74.11 113.627 169.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -61.94 -34.84 76.82 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.366 0.666 . . . . 74.35 111.47 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.439 HD13 HD11 ' B' ' 13' ' ' ILE . 72.4 mt -75.99 -41.45 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.765 0.826 . . . . 73.14 110.195 176.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.446 HD13 ' O ' ' B' ' 80' ' ' GLN . 78.2 mt -71.29 -25.0 62.25 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 114.718 -1.128 . . . . 75.2 111.207 -176.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -62.63 -52.14 67.2 Favored Pre-proline 0 CA--C 1.552 1.024 0 CA-C-O 117.363 -1.304 . . . . 73.2 113.2 -172.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -54.06 -40.26 82.18 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.266 1.977 . . . . 72.33 113.023 177.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.521 ' CD1' HG21 ' B' ' 16' ' ' ILE . 5.2 m-30 -65.92 -44.13 86.05 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.981 -1.009 . . . . 73.02 110.495 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.81 -37.16 73.22 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.889 0.876 . . . . 73.34 111.456 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.659 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 52.4 ttt-85 -65.73 -54.88 21.28 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.243 1.417 . . . . 71.24 110.815 -176.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -73.23 -18.06 61.28 Favored 'General case' 0 CA--C 1.551 0.982 0 O-C-N 123.898 0.749 . . . . 61.32 110.06 -177.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.47 ' O ' ' HG2' ' B' ' 117' ' ' MET . 15.6 t -72.8 -42.1 64.24 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 122.739 0.416 . . . . 73.44 109.93 172.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.525 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 75.3 mt -57.52 -54.32 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 123.637 0.775 . . . . 73.31 109.704 171.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.41 HG21 ' OG ' ' C' ' 119' ' ' SER . 21.3 m -59.43 -29.91 68.11 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 124.34 1.025 . . . . 72.23 111.517 -177.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.6 t -68.39 -47.83 66.32 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.004 0.522 . . . . 71.21 110.357 174.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.6 mmt -69.66 -30.14 67.76 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.83 0.452 . . . . 71.45 111.115 -176.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.406 HG23 ' O ' ' B' ' 114' ' ' ILE . 91.0 t -67.68 -41.87 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.194 0.998 . . . . 74.44 109.861 172.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.8 t -66.86 -29.72 69.7 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.206 -0.906 . . . . 73.42 111.058 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' B' ' 116' ' ' SER . 84.5 mtt-85 -72.11 -35.2 69.11 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 123.116 0.566 . . . . 64.34 109.66 176.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.3 -9.85 81.41 Favored Glycine 0 C--N 1.354 1.562 0 O-C-N 123.531 0.519 . . . . 73.43 112.42 170.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.2 m 69.95 25.52 4.87 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 125.444 1.497 . . . . 71.55 110.643 174.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -78.38 165.26 51.33 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 124.043 0.937 . . . . 75.13 111.764 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.04 163.77 4.04 Favored 'Trans proline' 0 C--N 1.392 2.851 0 C-N-CA 123.313 2.675 . . . . 75.14 113.673 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -64.83 113.59 3.91 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.128 -0.942 . . . . 71.04 112.175 -171.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.642 HD21 HG11 ' B' ' 64' ' ' VAL . 48.6 tp -112.57 88.63 2.87 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 115.829 -0.623 . . . . 74.44 109.774 177.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -93.92 110.13 21.82 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.763 -1.199 . . . . 70.35 107.763 169.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.659 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 74.1 mt -65.46 146.32 55.02 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.331 0.253 . . . . 71.33 111.047 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.74 144.94 98.9 Favored Pre-proline 0 CA--C 1.55 0.964 0 O-C-N 124.406 1.066 . . . . 65.05 112.387 -173.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -68.11 84.47 0.44 Allowed 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.919 2.413 . . . . 62.31 111.61 173.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 19.8 m -101.28 126.92 55.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-O 121.2 0.524 . . . . 73.54 109.976 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -87.0 104.99 16.84 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 108.04 -1.096 . . . . 73.53 108.04 172.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -53.61 -38.61 64.18 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.455 1.102 . . . . 74.51 110.225 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -61.83 -44.43 96.86 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.33 -1.305 . . . . 73.52 111.046 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.53 -39.57 88.33 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.645 0.778 . . . . 75.33 112.561 -173.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.63 -45.81 81.62 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.906 0.483 . . . . 74.13 110.392 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -79.6 -17.09 54.65 Favored 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 115.423 -0.808 . . . . 75.44 111.377 -176.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 57.7 ttm -63.91 -27.19 68.98 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.387 1.075 . . . . 73.23 111.7 -175.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -73.16 -22.52 60.49 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.24 0.616 . . . . 74.04 111.052 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 140' ' ' TYR . . . . . 0.458 ' HB2' ' CE2' ' F' ' 109' ' ' TYR . 46.6 t80 -67.21 -40.32 86.4 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.852 0.861 . . . . 72.51 109.827 175.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.423 HD12 ' HB3' ' B' ' 140' ' ' TYR . 4.6 mp -91.15 -5.67 54.68 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.113 -0.949 . . . . 63.33 110.855 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 70.66 169.3 0.31 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.189 1.395 . . . . 55.03 111.364 -177.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -70.2 115.86 9.89 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.832 -0.622 . . . . 74.45 109.51 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.28 -57.3 6.92 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.263 -0.643 . . . . 72.13 109.263 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . 63.08 -175.1 0.15 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.476 1.111 . . . . 64.02 112.04 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 155.69 -177.38 32.85 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 116.647 -0.251 . . . . 43.21 113.028 175.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -138.12 132.46 32.03 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.446 0.698 . . . . 71.22 110.338 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -138.81 49.54 0.83 Allowed Glycine 0 C--N 1.343 0.926 0 N-CA-C 110.646 -0.982 . . . . 63.24 110.646 176.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 22.0 p -76.23 170.26 16.65 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.764 0.826 . . . . 74.21 112.463 -175.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 63.31 -93.24 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.0 1.32 . . . . 61.4 111.324 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 40.21 83.47 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.797 1.239 . . . . 34.21 112.626 -167.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -76.66 127.34 32.59 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.026 -0.534 . . . . 73.25 110.606 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -165.83 126.63 1.83 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.78 1.232 . . . . 73.31 107.786 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -67.33 138.56 56.89 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.669 -0.493 . . . . 73.34 109.669 176.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 C-N-CA 123.833 0.853 . . . . 54.12 108.803 -176.404 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mpp? . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 108.758 -0.83 . . . . 74.51 108.758 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 2' ' ' SER . . . . . 0.574 ' HA ' HD21 ' A' ' 139' ' ' ASN . 37.1 p -170.26 35.8 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.986 0.914 . . . . 74.03 109.557 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -68.11 101.99 1.25 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.02 -0.991 . . . . 73.03 109.828 -174.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -75.93 114.79 14.96 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.101 -0.954 . . . . 60.14 109.607 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -148.41 1.64 0.62 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.419 0.526 . . . . 62.2 112.419 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -135.34 96.38 3.46 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.952 0.501 . . . . 74.54 110.221 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 39.7 p -120.39 101.13 7.58 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.979 -0.748 . . . . 35.42 108.979 170.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -126.92 156.16 41.92 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.992 -0.744 . . . . 73.31 108.992 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.544 ' HE2' HD13 ' C' ' 89' ' ' ILE . 53.2 ttm 64.43 112.23 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.522 1.529 . . . . 75.04 110.781 -172.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.564 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 28.4 m -89.88 76.09 7.16 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 107.441 -1.318 . . . . 73.12 107.441 166.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -88.52 117.55 27.54 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.1 -1.444 . . . . 73.43 107.1 174.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -140.49 114.8 9.26 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.891 -1.151 . . . . 73.31 107.891 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 37.6 mt -72.31 131.75 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.639 -0.875 . . . . 74.44 108.639 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -86.59 -49.47 7.52 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.352 -0.61 . . . . 71.15 109.352 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.577 HH21 ' HD2' ' D' ' 32' ' ' PHE . 0.0 OUTLIER -178.36 151.83 0.64 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.48 1.112 . . . . 71.34 109.104 173.213 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 pp -109.43 151.7 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 107.653 -1.24 . . . . 64.21 107.653 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.561 ' HE1' HG12 ' C' ' 83' ' ' ILE . 49.2 p90 -172.28 153.35 2.98 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.145 0.43 . . . . 64.53 111.245 -176.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.2 p -85.31 111.59 20.02 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.704 -0.68 . . . . 72.33 111.533 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.463 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 31.2 mmtp -65.52 -33.07 75.06 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.382 0.673 . . . . 74.55 110.733 170.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -151.79 146.28 25.6 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.7 -1.136 . . . . 71.21 109.756 -177.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.467 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 80.8 mt -142.84 139.81 27.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 106.37 -1.715 . . . . 73.14 106.37 171.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.4 t -154.27 147.53 24.85 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.452 0.644 . . . . 73.14 109.901 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -146.94 136.33 22.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 106.811 -1.551 . . . . 71.12 106.811 172.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -137.94 133.44 33.75 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.502 -0.925 . . . . 62.41 108.502 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.11 77.65 6.11 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 108.197 -1.038 . . . . 62.24 108.197 172.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.34 -27.8 28.05 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.761 2.308 . . . . 63.32 111.144 177.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -99.08 14.33 29.66 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.773 -1.103 . . . . 73.54 111.052 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.463 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -45.59 -55.39 12.41 Favored Pre-proline 0 N--CA 1.49 1.525 0 C-N-CA 124.429 1.092 . . . . 75.35 113.11 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 32.4 Cg_exo -59.55 -46.47 20.62 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.062 1.842 . . . . 73.43 112.316 -177.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -69.71 -32.51 71.13 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.567 -1.197 . . . . 73.24 112.534 -174.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.642 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.1 p -79.5 -29.27 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 111.991 0.367 . . . . 75.24 111.991 -176.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -63.75 -32.28 73.73 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.704 0.401 . . . . 74.3 111.838 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -88.62 17.3 5.58 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.211 0.604 . . . . 72.44 111.621 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.408 ' HG2' HD13 ' C' ' 68' ' ' LEU . 2.4 ttpm? -120.33 152.06 38.37 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.076 0.951 . . . . 74.34 110.552 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -59.27 129.46 42.16 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.368 1.067 . . . . 65.31 111.361 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.4 ' HD1' ' HB2' ' F' ' 132' ' ' SER . 76.4 t-105 -85.49 85.7 7.41 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.973 0.909 . . . . 72.33 110.749 -177.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 16.6 tm0? -131.53 78.36 71.47 Favored Pre-proline 0 N--CA 1.479 1.008 0 N-CA-C 107.118 -1.438 . . . . 63.5 107.118 171.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -93.44 143.4 2.0 Allowed 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.538 2.158 . . . . 75.4 113.312 -175.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -85.5 98.21 10.48 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 106.686 -1.598 . . . . 74.45 106.686 159.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 94.7 t -76.48 99.52 2.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.14 -1.059 . . . . 75.32 108.14 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -90.8 100.72 13.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.148 -1.797 . . . . 71.32 106.148 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.585 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.5 pt? -97.44 162.0 13.52 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 115.626 -0.716 . . . . 74.52 109.587 -174.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.82 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 25.6 m-20 -142.32 146.26 34.83 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.744 0.818 . . . . 74.5 110.055 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.527 HD11 HG11 ' C' ' 131' ' ' VAL . 95.1 mt -134.53 111.12 9.83 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.771 0.828 . . . . 74.04 108.949 174.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.401 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 5.7 t70 -116.43 142.87 46.29 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.27 1.428 . . . . 73.24 107.277 173.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.6 t -152.69 152.67 31.99 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.752 -0.462 . . . . 74.13 109.752 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.82 157.63 38.19 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.466 0.706 . . . . 63.52 109.988 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 6.2 m -130.01 144.59 51.41 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.134 0.574 . . . . 61.14 109.629 176.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 37.8 p -145.29 127.48 15.71 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.672 0.789 . . . . 53.53 109.438 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -75.99 120.65 21.61 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.475 0.71 . . . . 74.03 110.51 -177.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' C' ' 57' ' ' GLU . 40.6 mt -91.42 -31.06 16.16 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.427 0.691 . . . . 44.33 110.661 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.55 -177.41 5.92 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.778 0.831 . . . . 72.22 110.375 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -65.24 119.71 11.41 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.769 -0.65 . . . . 73.23 110.116 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 65.94 11.56 7.79 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.902 1.281 . . . . 73.13 112.126 -175.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.3 t -116.23 111.59 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.051 -0.722 . . . . 61.14 109.051 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -123.0 124.2 42.6 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.965 -1.124 . . . . 74.42 107.965 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.577 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.1 tt0 -85.78 137.96 32.42 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.773 -0.825 . . . . 74.31 108.773 170.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.66 138.43 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 108.27 -1.011 . . . . 54.21 108.27 170.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 44.9 t -127.07 133.74 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 109.283 -0.636 . . . . 74.43 109.283 174.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.486 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -117.56 105.24 11.86 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.669 -1.234 . . . . 70.43 107.669 -177.886 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.401 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 16.9 ttm-85 -81.62 108.36 15.12 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.599 0.76 . . . . 75.11 109.505 171.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 44.0 t -104.78 119.06 53.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 108.015 -1.106 . . . . 74.13 108.015 171.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.82 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 79.2 m -114.66 145.41 42.05 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.056 0.942 . . . . 71.41 108.95 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 35.7 t -135.45 112.43 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.69 1.196 . . . . 73.14 108.314 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.7 m -101.77 122.66 44.37 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.309 -0.997 . . . . 72.15 108.309 168.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.6 119.24 38.93 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.148 -1.427 . . . . 74.01 107.148 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 32.2 m -141.25 129.01 21.64 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.109 0.255 . . . . 74.13 110.343 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.408 HD13 ' HG2' ' C' ' 34' ' ' LYS . 23.0 mt -86.56 44.08 1.12 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.506 1.122 . . . . 73.42 109.914 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.95 -104.96 2.54 Favored Glycine 0 C--N 1.344 1.019 0 N-CA-C 110.275 -1.13 . . . . 74.12 110.275 -172.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -90.85 -31.52 16.42 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.57 0.748 . . . . 72.22 109.438 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -65.91 121.56 15.35 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.71 1.204 . . . . 54.43 110.478 174.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 52.2 m -83.87 120.27 25.87 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.973 -0.751 . . . . 45.44 108.973 167.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.642 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.94 -55.07 8.12 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 123.945 0.778 . . . . 54.04 108.944 174.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -162.03 162.5 28.86 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 115.446 -0.797 . . . . 74.13 110.316 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.434 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.9 tm? -114.33 142.65 46.04 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 106.491 -1.67 . . . . 65.04 106.491 163.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.434 ' N ' HD13 ' C' ' 75' ' ' LEU . 46.1 t -145.06 143.49 30.46 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.29 -1.004 . . . . 34.53 108.29 175.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -156.98 130.01 7.8 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.465 -0.569 . . . . 74.13 109.465 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 86.0 t -130.96 122.19 51.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.504 -0.924 . . . . 61.55 108.504 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -99.05 88.46 3.97 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.839 -1.171 . . . . 75.25 107.839 177.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 65.3 tp60 -79.36 100.17 7.48 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.972 -1.013 . . . . 74.15 109.633 -175.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -82.09 174.55 53.7 Favored Glycine 0 C--O 1.237 0.316 0 CA-C-N 115.923 -0.58 . . . . 52.22 112.301 174.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.79 126.67 1.17 Allowed Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 111.786 -0.526 . . . . 72.24 111.786 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.561 HG12 ' HE1' ' C' ' 17' ' ' TYR . 31.7 mm -87.13 126.45 40.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.241 -1.022 . . . . 75.24 108.241 174.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -127.93 118.56 23.83 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.534 0.734 . . . . 63.24 109.431 -177.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 28.5 p -84.67 102.11 12.69 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.588 -0.893 . . . . 74.21 108.588 169.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 29.6 mt -115.43 118.59 59.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.692 1.197 . . . . 54.14 109.702 -175.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.564 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -124.96 170.1 11.44 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.712 0.805 . . . . 74.35 109.898 174.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.98 -39.64 2.68 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 116.432 -0.349 . . . . 65.53 113.616 171.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.544 HD13 ' HE2' ' C' ' 9' ' ' MET . 39.8 pt -103.93 165.33 3.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 123.283 0.633 . . . . 70.2 111.574 -171.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -159.92 154.35 23.84 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.254 -0.884 . . . . 74.22 109.195 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.2 -120.41 17.94 Favored Glycine 0 C--N 1.346 1.084 0 O-C-N 123.534 0.521 . . . . 63.25 113.579 174.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 35.1 p -61.6 -40.63 95.49 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.574 0.75 . . . . 72.2 111.831 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -63.49 -49.58 73.04 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.837 0.455 . . . . 75.41 110.908 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 6.2 tpt -52.36 -54.06 36.66 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 124.239 0.962 . . . . 65.43 111.909 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.63 -42.33 96.68 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.292 0.567 . . . . 73.13 111.639 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -65.4 -31.77 73.05 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.729 1.211 . . . . 61.44 111.037 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 48.7 t -76.63 -27.67 55.78 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.286 -0.87 . . . . 61.31 110.864 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 94.3 mt -94.53 -32.14 13.6 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.672 0.789 . . . . 72.13 112.975 -172.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.03 -8.0 37.19 Favored Glycine 0 N--CA 1.473 1.123 0 CA-C-O 119.963 -0.354 . . . . 41.32 113.7 -173.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.23 -54.42 1.11 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.853 0.461 . . . . 70.34 110.874 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.507 ' OH ' ' HB3' ' A' ' 130' ' ' PRO . 52.2 t80 -73.4 -49.84 24.98 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.898 -0.592 . . . . 64.22 112.0 -170.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.401 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 68.0 m -63.23 -47.74 84.44 Favored Pre-proline 0 CA--C 1.557 1.228 0 CA-C-O 118.64 -0.695 . . . . 74.43 111.55 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.486 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 78.1 Cg_exo -56.43 -31.8 86.89 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.453 2.102 . . . . 72.05 113.594 170.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -68.02 -32.48 72.89 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.971 0.508 . . . . 74.21 110.726 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.654 HD12 HH12 ' A' ' 111' ' ' ARG . 10.0 mm -72.62 -41.68 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 109.509 -0.552 . . . . 65.44 109.509 174.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 85.0 mt -74.48 -23.62 58.9 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.899 0.88 . . . . 73.23 112.238 -175.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 107' ' ' PHE . . . . . 0.401 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 53.7 t80 -59.77 -53.43 65.62 Favored Pre-proline 0 N--CA 1.48 1.027 0 CA-C-O 117.431 -1.271 . . . . 62.14 113.445 -174.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 108' ' ' PRO . . . . . 0.401 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 51.1 Cg_exo -56.29 -36.59 97.13 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 121.84 1.693 . . . . 74.2 113.155 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -67.4 -47.53 70.03 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.27 0.628 . . . . 74.34 111.271 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.2 -38.93 88.33 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.176 0.99 . . . . 71.41 110.601 177.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -64.72 -47.26 78.93 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.165 1.386 . . . . 73.04 110.178 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -67.48 -34.03 76.32 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 123.861 0.726 . . . . 54.51 110.062 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.6 t -72.11 -34.58 68.72 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.933 0.493 . . . . 71.31 111.052 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.413 HG23 ' SG ' ' C' ' 76' ' ' CYS . 65.2 mt -73.91 -50.36 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 122.856 0.462 . . . . 62.25 110.34 176.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.1 m -65.71 -28.43 69.06 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.101 0.56 . . . . 64.54 110.872 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 29.3 t -62.85 -49.18 75.89 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 108.951 -0.759 . . . . 72.3 108.951 169.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.528 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.64 -36.47 78.72 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.322 1.049 . . . . 74.14 112.629 179.04 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.4 HG23 ' O ' ' C' ' 114' ' ' ILE . 92.3 t -62.65 -49.25 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.544 0.737 . . . . 63.11 109.603 175.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.41 ' OG ' HG21 ' B' ' 115' ' ' THR . 29.2 t -65.44 -32.91 74.78 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.978 -1.01 . . . . 72.13 111.552 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.492 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 76.5 mtt-85 -67.18 -37.6 83.97 Favored 'General case' 0 C--O 1.214 -0.8 0 C-N-CA 123.448 0.699 . . . . 71.33 109.465 176.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.84 8.15 70.98 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.31 -0.717 . . . . 72.32 113.249 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.409 HG23 ' HB3' ' D' ' 17' ' ' TYR . 81.0 p 55.6 33.66 21.62 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.05 1.74 . . . . 73.51 113.124 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -93.28 145.7 30.52 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 108.431 -0.951 . . . . 74.5 108.431 171.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -51.32 148.58 18.77 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 123.72 2.946 . . . . 62.24 114.249 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -55.43 112.47 1.12 Allowed 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.274 0.984 . . . . 60.11 112.261 -176.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.535 HD12 HG23 ' F' ' 133' ' ' THR . 53.8 tp -110.49 86.87 2.39 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.481 -1.236 . . . . 73.02 107.805 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -91.6 101.62 14.25 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.555 -0.906 . . . . 74.33 108.555 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.9 127.84 33.35 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.898 0.879 . . . . 75.21 110.393 -174.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.72 151.48 94.71 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 123.916 0.886 . . . . 34.33 111.811 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.497 ' HG3' HD12 ' A' ' 16' ' ' ILE . 51.6 Cg_exo -52.95 107.93 0.23 Allowed 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.017 2.478 . . . . 63.24 112.995 175.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.527 HG11 HD11 ' C' ' 44' ' ' LEU . 6.3 p -101.56 124.25 55.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 109.254 -0.647 . . . . 65.43 109.254 175.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -85.54 104.65 15.5 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.176 0.59 . . . . 63.35 109.686 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -66.05 -22.41 66.43 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.948 -0.569 . . . . 71.14 111.493 176.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -71.18 -36.57 72.02 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.566 0.541 . . . . 71.42 109.802 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.71 -43.35 99.02 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.441 -0.8 . . . . 71.33 110.22 172.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.439 ' HA ' ' HB3' ' C' ' 139' ' ' ASN . 73.5 mt -71.3 -25.74 62.56 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.855 0.862 . . . . 63.32 111.537 178.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -75.09 -41.88 57.82 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.313 0.645 . . . . 73.43 110.01 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 73.5 mtm -69.1 -32.7 72.3 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.599 -0.728 . . . . 72.43 109.888 172.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 139' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' C' ' 136' ' ' LEU . 8.0 t30 -64.02 -34.47 78.09 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.035 1.334 . . . . 70.2 113.511 -175.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 140' ' ' TYR . . . . . 0.53 ' HD1' ' N ' ' C' ' 141' ' ' LEU . 0.8 OUTLIER -67.15 -151.22 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 118.661 0.664 . . . . 73.54 111.463 -176.082 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.53 ' N ' ' HD1' ' C' ' 140' ' ' TYR . 3.8 pp -67.04 13.8 0.06 Allowed 'General case' 0 CA--C 1.573 1.847 0 O-C-N 120.186 -1.571 . . . . 75.4 113.829 175.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -78.47 125.8 29.87 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.318 1.047 . . . . 71.33 109.693 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -114.89 71.42 0.76 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.797 0.839 . . . . 71.24 111.244 -175.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 144' ' ' GLN . . . . . 0.429 ' HB3' ' H ' ' C' ' 145' ' ' ALA . 0.9 OUTLIER -172.3 -101.56 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 107.972 -1.121 . . . . 70.42 107.972 170.031 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 145' ' ' ALA . . . . . 0.429 ' H ' ' HB3' ' C' ' 144' ' ' GLN . . . 173.57 -178.76 0.09 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.739 1.615 . . . . 62.42 108.608 -176.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -164.24 -82.86 0.05 OUTLIER Glycine 0 C--N 1.338 0.652 0 N-CA-C 109.916 -1.274 . . . . 63.34 109.916 177.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 61.29 -81.5 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 125.286 1.434 . . . . 73.12 111.824 174.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -115.49 109.11 2.0 Allowed Glycine 0 C--N 1.351 1.408 0 N-CA-C 111.667 -0.573 . . . . 74.15 111.667 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 3.3 t -159.38 100.4 1.5 Allowed 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.778 0.831 . . . . 71.43 109.412 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -176.27 135.84 0.27 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.304 1.041 . . . . 74.45 109.52 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -133.93 22.57 3.86 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.66 0.784 . . . . 73.24 112.184 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 152' ' ' HIS . . . . . 0.419 ' O ' ' HB3' ' A' ' 132' ' ' ASN . 20.9 t60 -66.1 98.85 0.47 Allowed 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 122.935 0.494 . . . . 73.14 110.015 175.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 153' ' ' GLN . . . . . 0.445 ' HB3' ' HB1' ' A' ' 135' ' ' ALA . 4.8 pt20 -132.3 73.69 1.54 Allowed 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.596 0.713 . . . . 74.33 112.643 -174.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.39 120.33 42.09 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.46 0.704 . . . . 55.05 109.247 169.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.327 0 C-N-CA 124.568 1.147 . . . . 61.01 109.588 -177.466 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.949 0.404 . . . . 62.44 110.136 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 29.7 t -146.13 -160.64 1.18 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 107.685 -1.228 . . . . 63.11 107.685 177.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 3' ' ' GLU . . . . . 0.662 ' HG2' ' HA3' ' D' ' 91' ' ' GLY . 34.4 mt-10 66.14 25.62 10.71 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.941 0.896 . . . . 73.34 111.712 170.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -139.81 151.23 45.57 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.764 1.226 . . . . 53.45 108.81 -174.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 59.72 93.15 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.465 1.106 . . . . 70.54 111.375 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -115.69 108.25 16.14 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.008 -0.738 . . . . 75.11 109.008 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 29.8 m -58.47 159.18 6.61 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.455 1.102 . . . . 71.32 110.238 172.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -49.85 92.67 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.651 0.781 . . . . 72.35 110.454 175.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.447 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 0.0 OUTLIER -34.18 121.11 0.46 Allowed 'General case' 0 C--N 1.359 0.982 0 C-N-CA 125.852 1.661 . . . . 71.43 112.101 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 5.6 t -108.14 145.01 34.76 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 123.342 0.657 . . . . 71.32 109.5 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.415 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 54.8 t80 -152.88 103.25 2.74 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.734 -1.21 . . . . 73.02 107.734 -175.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -112.68 128.67 56.46 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.252 -1.018 . . . . 75.53 108.252 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 12.8 mt -94.24 134.97 29.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.173 -1.047 . . . . 64.11 108.173 175.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -106.34 -33.45 7.76 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 122.779 0.431 . . . . 75.31 111.629 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -169.32 127.0 0.95 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 120.592 0.234 . . . . 61.02 111.594 -166.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.22 134.46 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 107.67 -1.233 . . . . 72.11 107.67 168.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' C' ' 120' ' ' ARG . 39.4 p90 -163.73 150.39 11.88 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-O 121.821 0.82 . . . . 72.53 111.873 175.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 18' ' ' THR . . . . . 0.4 HG21 HD11 ' D' ' 21' ' ' ILE . 81.4 p -85.89 126.3 33.96 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.684 -1.144 . . . . 63.41 109.199 176.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -99.37 -14.22 19.27 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.349 -0.611 . . . . 73.5 109.349 175.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.675 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.2 t70 -160.02 136.87 9.2 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.309 1.044 . . . . 63.34 109.032 176.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.528 HG21 ' HE2' ' C' ' 117' ' ' MET . 65.7 mt -137.67 144.66 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.626 1.17 . . . . 73.33 108.121 174.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.1 t -146.62 139.28 25.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.185 0.994 . . . . 72.44 108.955 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.467 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 77.5 t80 -150.31 123.24 8.73 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.753 -1.573 . . . . 60.25 106.753 167.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -127.38 129.67 48.0 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.15 -0.685 . . . . 75.11 109.15 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.441 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -118.1 79.49 14.32 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 107.57 -1.27 . . . . 44.23 107.57 169.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.75 -35.06 13.38 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.375 2.05 . . . . 74.44 112.151 -171.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -104.99 6.51 33.52 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.101 0.96 . . . . 64.02 110.515 -174.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.496 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -23.65 -77.75 0.02 OUTLIER Pre-proline 0 CA--C 1.567 1.613 0 N-CA-C 117.428 2.381 . . . . 51.45 117.428 -169.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.463 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 87.1 Cg_endo -75.29 -17.48 18.9 Favored 'Trans proline' 0 C--N 1.388 2.652 0 CA-C-N 124.643 2.694 . . . . 73.41 113.224 -170.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -70.88 -43.71 67.84 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.949 -0.76 . . . . 63.23 108.949 172.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.496 HG12 ' O ' ' D' ' 28' ' ' ALA . 4.8 p -83.88 -19.62 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 CA-C-N 115.748 -0.66 . . . . 73.44 111.517 -170.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.577 ' HD2' HH21 ' C' ' 15' ' ' ARG . 22.7 m-85 -67.4 -20.72 65.57 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 120.914 0.388 . . . . 62.41 111.416 177.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -64.31 -18.33 64.51 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.103 0.961 . . . . 64.23 111.083 174.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -92.19 81.54 5.01 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.747 1.219 . . . . 72.25 108.784 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -83.43 79.7 9.33 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 122.074 0.94 . . . . 75.1 111.062 -174.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -152.93 -174.91 5.1 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.092 -0.958 . . . . 65.14 109.041 169.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -77.21 114.59 41.52 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 123.516 0.726 . . . . 63.34 110.43 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -53.94 119.98 7.17 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 122.53 2.154 . . . . 61.31 110.764 172.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -67.2 108.83 2.84 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.76 -1.2 . . . . 74.0 107.76 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.749 HG13 HG13 ' D' ' 64' ' ' VAL . 93.9 t -100.88 132.51 46.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 CA-C-N 115.419 -0.809 . . . . 73.5 109.823 -171.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -115.24 118.94 34.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.569 -1.271 . . . . 73.21 107.569 173.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.621 HD11 HG13 ' D' ' 62' ' ' VAL . 37.9 tp -97.39 137.58 36.16 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.27 0.557 . . . . 64.34 110.131 -178.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.42 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 6.5 m-20 -133.66 122.19 23.08 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.028 1.331 . . . . 60.03 108.083 -175.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.416 ' CD2' HG22 ' D' ' 62' ' ' VAL . 89.1 mt -119.8 144.58 47.24 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.814 0.445 . . . . 74.42 110.759 -176.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.48 ' HB2' ' HB3' ' D' ' 61' ' ' ARG . 11.7 m-20 -142.13 134.61 28.05 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.218 1.007 . . . . 72.21 109.061 176.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 46' ' ' THR . . . . . 0.451 HG21 ' HA2' ' D' ' 99' ' ' GLY . 59.1 m -104.15 139.05 39.76 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.154 -1.054 . . . . 64.1 108.154 168.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.42 141.05 21.72 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.585 -1.265 . . . . 50.21 107.585 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 30.8 p -158.98 151.48 21.6 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 109.806 -0.442 . . . . 75.53 109.806 -175.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.403 ' O ' ' HG2' ' D' ' 50' ' ' GLN . 65.4 p -160.51 116.47 2.32 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 123.63 0.581 . . . . 55.45 110.791 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 50' ' ' GLN . . . . . 0.412 ' HB2' ' HA ' ' D' ' 56' ' ' TYR . 50.9 mm-40 -166.6 129.29 1.86 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 126.289 1.836 . . . . 72.34 106.809 175.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 40.9 tp -79.3 97.17 6.18 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 117.92 0.327 . . . . 71.1 110.583 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . 54.58 -151.36 0.37 Allowed 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 124.735 1.214 . . . . 72.41 112.609 171.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 19.9 t70 73.62 -0.64 3.3 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 124.919 1.288 . . . . 63.52 112.345 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' D' ' 85' ' ' SER . 80.9 m-20 64.66 26.32 13.15 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.681 1.192 . . . . 71.54 113.396 176.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 9.0 m -129.64 110.2 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.402 -0.962 . . . . 74.23 108.402 169.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.412 ' HA ' ' HB2' ' D' ' 50' ' ' GLN . 46.5 m-85 -126.88 132.58 50.89 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 109.31 -0.626 . . . . 73.2 109.31 -175.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -87.28 112.43 22.04 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.594 -0.891 . . . . 61.15 108.594 175.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.581 HG11 ' HD3' ' D' ' 103' ' ' PRO . 84.8 t -101.13 116.9 45.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.322 -0.992 . . . . 70.0 108.322 176.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.479 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 26.3 t -102.71 129.36 54.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 108.777 -0.823 . . . . 61.35 108.777 176.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' D' ' 79' ' ' GLN . 0.1 OUTLIER -110.31 122.78 48.48 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.41 -0.959 . . . . 74.43 108.41 -178.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.48 ' HB3' ' HB2' ' D' ' 45' ' ' ASP . 49.3 ttp180 -98.53 101.47 12.91 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.996 -0.742 . . . . 75.35 108.996 173.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.621 HG13 HD11 ' D' ' 42' ' ' LEU . 61.9 t -98.24 113.64 33.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 114.898 -1.046 . . . . 62.23 108.678 173.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.42 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 11.0 m -122.44 124.22 43.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.356 -0.838 . . . . 73.21 109.706 -172.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.749 HG13 HG13 ' D' ' 40' ' ' VAL . 39.9 t -109.15 123.24 64.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 C-N-CA 125.409 1.484 . . . . 62.03 108.774 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 20.4 m -113.52 101.27 9.19 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.902 -1.147 . . . . 62.31 107.902 169.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.47 142.95 41.53 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.636 -0.711 . . . . 75.22 109.105 -173.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.473 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 17.1 p -149.72 134.0 17.32 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.746 0.647 . . . . 73.1 112.746 -171.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.449 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 34.3 mt -109.06 112.01 23.96 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.797 1.239 . . . . 50.45 107.733 173.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.5 -140.41 22.7 Favored Glycine 0 C--N 1.344 1.004 0 O-C-N 123.286 0.367 . . . . 43.33 112.545 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.29 6.64 42.11 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.348 0.659 . . . . 63.01 111.799 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -132.35 173.99 10.71 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.885 0.474 . . . . 72.5 110.611 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 31.2 m -73.6 140.03 45.94 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.452 -0.794 . . . . 71.41 111.775 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.473 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.25 -67.19 0.84 Allowed 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.404 -1.332 . . . . 75.51 107.404 169.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -148.41 148.75 30.68 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.52 -1.218 . . . . 72.53 110.26 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 78.6 mt -103.41 150.38 23.89 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.73 1.212 . . . . 70.31 108.197 169.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.539 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.9 t -158.12 140.58 14.45 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.359 -0.608 . . . . 73.33 109.359 176.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -155.54 127.62 7.61 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.106 0.562 . . . . 61.42 109.698 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.93 114.97 34.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 123.126 0.57 . . . . 62.04 109.553 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.675 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.0 mt-30 -90.71 85.67 6.13 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.872 0.844 . . . . 72.34 109.394 171.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -81.18 101.44 9.67 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 113.818 -1.537 . . . . 74.4 109.726 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.42 143.89 17.56 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 112.273 -0.331 . . . . 72.31 112.273 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.65 134.0 6.57 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 111.855 -0.498 . . . . 74.04 111.855 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 61.6 mt -89.23 103.17 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 107.925 -1.139 . . . . 72.24 107.925 175.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -108.78 144.11 37.05 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.807 0.843 . . . . 73.22 110.641 -177.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' D' ' 54' ' ' ASP . 16.4 p -116.46 137.34 52.24 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.679 0.792 . . . . 55.44 110.097 171.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.449 HG12 HD11 ' D' ' 89' ' ' ILE . 6.3 tt -145.24 138.68 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.394 0.678 . . . . 60.15 110.81 -163.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.441 ' HA ' ' CG2' ' E' ' 97' ' ' ILE . . . -168.26 170.76 9.83 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.425 0.69 . . . . 61.43 111.645 175.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 93.61 7.58 61.56 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 115.748 -0.66 . . . . 45.51 112.793 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.449 HD11 HG12 ' D' ' 86' ' ' ILE . 1.4 pp -140.1 149.96 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.542 1.137 . . . . 45.43 110.225 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.9 173.26 17.26 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.746 0.819 . . . . 72.32 110.456 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 91' ' ' GLY . . . . . 0.662 ' HA3' ' HG2' ' D' ' 3' ' ' GLU . . . 79.86 -118.26 4.68 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 114.781 0.673 . . . . 64.41 114.781 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 54.2 p -90.08 -44.67 9.66 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.384 0.674 . . . . 63.13 111.388 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -66.86 -23.61 66.04 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 113.177 0.806 . . . . 71.44 113.177 -172.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.409 ' HE3' HG13 ' E' ' 97' ' ' ILE . 21.7 ptm -56.72 -51.31 69.33 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 113.851 1.056 . . . . 73.41 113.851 -174.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.9 -12.85 59.71 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.577 0.751 . . . . 65.34 112.411 -168.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -61.8 -37.62 85.05 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.942 0.497 . . . . 74.25 110.53 171.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 61.8 m -66.72 -25.48 66.54 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.876 -0.602 . . . . 72.03 111.943 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.444 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 89.6 mt -92.84 -39.34 11.25 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.815 0.846 . . . . 73.05 111.281 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 99' ' ' GLY . . . . . 0.451 ' HA2' HG21 ' D' ' 46' ' ' THR . . . -90.53 -1.85 73.9 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.622 -0.717 . . . . 44.3 113.54 -171.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.23 -49.64 0.13 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.157 0.429 . . . . 72.34 112.157 -173.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -73.63 -42.99 60.73 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 118.168 0.44 . . . . 72.55 111.958 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 89.8 m -60.27 -48.83 93.07 Favored Pre-proline 0 CA--C 1.562 1.425 0 CA-C-O 118.964 -0.541 . . . . 75.44 112.091 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.581 ' HD3' HG11 ' D' ' 58' ' ' VAL . 37.6 Cg_endo -65.54 -24.88 55.7 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 121.924 1.749 . . . . 63.33 112.835 173.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -67.98 -31.13 70.63 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.561 0.344 . . . . 65.21 110.262 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 37.5 mm -73.02 -38.92 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.025 0.93 . . . . 73.03 110.829 173.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' D' ' 103' ' ' PRO . 71.6 mt -69.76 -26.92 64.53 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.333 0.653 . . . . 70.05 111.899 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -62.82 -41.61 72.85 Favored Pre-proline 0 CA--C 1.554 1.132 0 N-CA-C 113.93 1.085 . . . . 74.41 113.93 -170.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -47.12 -45.43 21.54 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.205 1.937 . . . . 73.3 114.087 167.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -79.9 -32.69 40.22 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.678 0.791 . . . . 72.42 111.961 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.39 -36.14 66.0 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.236 0.614 . . . . 75.21 110.153 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.505 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.8 ttp180 -66.18 -45.1 82.02 Favored 'General case' 0 C--O 1.208 -1.116 0 CA-C-N 114.839 -1.073 . . . . 73.25 109.305 171.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -55.05 -48.56 73.29 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.958 0.903 . . . . 72.3 111.302 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.417 ' O ' ' HG3' ' D' ' 117' ' ' MET . 46.0 t -58.35 -45.8 87.49 Favored 'General case' 0 C--N 1.347 0.487 0 O-C-N 124.22 0.95 . . . . 74.23 111.032 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.539 HG12 ' SG ' ' D' ' 76' ' ' CYS . 45.1 mt -64.06 -55.04 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.111 0.565 . . . . 72.23 110.915 177.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.2 m -50.71 -40.66 54.8 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.354 1.462 . . . . 71.5 111.455 -176.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 34.4 t -66.66 -47.85 71.22 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.912 -1.04 . . . . 55.33 110.434 177.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.417 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 64.2 mtm -69.57 -29.5 67.06 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.495 0.554 . . . . 74.14 112.495 -175.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.419 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.4 t -67.82 -44.44 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.503 0.721 . . . . 62.31 109.471 176.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 65.9 p -71.66 -28.44 63.75 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 115.626 -0.716 . . . . 74.42 110.048 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' D' ' 116' ' ' SER . 92.7 mtt-85 -71.79 -30.05 65.12 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.82 0.848 . . . . 73.14 110.191 173.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.85 8.64 77.18 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 123.642 0.588 . . . . 71.32 112.748 176.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.411 HG23 ' HB3' ' C' ' 17' ' ' TYR . 82.0 p 54.91 31.12 15.2 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 126.165 1.786 . . . . 44.44 113.99 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -95.27 153.19 39.72 Favored Pre-proline 0 C--O 1.245 0.819 0 N-CA-C 107.702 -1.222 . . . . 61.2 107.702 168.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.49 150.33 60.75 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.657 2.238 . . . . 54.25 112.314 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -59.15 122.02 12.76 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.768 0.827 . . . . 72.44 111.829 -169.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.444 HD13 HG21 ' D' ' 40' ' ' VAL . 19.8 tp -107.42 100.68 10.09 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.066 0.947 . . . . 44.52 109.087 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -100.04 104.97 16.59 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.214 -1.032 . . . . 71.32 108.214 172.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.505 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 2.9 mm? -66.57 115.73 6.76 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 109.183 -0.673 . . . . 64.4 109.183 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.475 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -57.24 129.48 79.61 Favored Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 123.294 0.638 . . . . 34.5 112.087 -172.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 1.2 Cg_endo -79.05 117.09 3.8 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.068 2.512 . . . . 74.24 111.243 -175.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 14.8 p -127.03 149.21 31.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 123.697 0.799 . . . . 73.11 109.126 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -69.75 113.73 7.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.908 -0.775 . . . . 70.21 108.908 172.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -60.59 -34.03 73.61 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.898 0.879 . . . . 73.1 111.213 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -63.63 -33.64 76.07 Favored 'General case' 0 C--O 1.213 -0.844 0 O-C-N 124.051 0.845 . . . . 71.44 110.861 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.98 -28.7 69.99 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.616 0.766 . . . . 73.23 112.134 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.473 HD23 ' HB2' ' E' ' 112' ' ' ASN . 9.4 mp -71.21 -40.53 71.09 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.311 0.644 . . . . 72.21 110.712 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -76.6 -37.49 56.36 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.079 0.952 . . . . 71.54 109.107 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.49 ' HG2' ' HG2' ' D' ' 142' ' ' GLN . 24.3 ttm -68.78 -32.64 72.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.878 1.271 . . . . 54.42 110.034 -176.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -66.93 -8.29 28.38 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.186 0.994 . . . . 73.52 111.507 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -85.51 -38.96 17.97 Favored 'General case' 0 CA--C 1.552 1.029 0 O-C-N 121.34 -0.85 . . . . 74.24 109.997 170.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.5 mp -83.22 -67.43 0.79 Allowed 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 123.756 0.822 . . . . 71.11 112.456 -175.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 142' ' ' GLN . . . . . 0.49 ' HG2' ' HG2' ' D' ' 138' ' ' MET . 7.4 pt20 -79.98 38.61 0.41 Allowed 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 123.708 0.803 . . . . 70.21 112.922 -172.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -130.13 93.04 3.4 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.586 -0.696 . . . . 71.32 109.837 -165.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -147.62 171.41 15.65 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.484 1.114 . . . . 61.55 108.122 177.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.99 92.67 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.283 0.633 . . . . 74.52 111.241 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -168.04 44.78 0.24 Allowed Glycine 0 C--N 1.34 0.791 0 N-CA-C 110.771 -0.932 . . . . 71.14 110.771 -177.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 147' ' ' GLU . . . . . 0.7 ' HB3' ' H ' ' B' ' 5' ' ' ASN . 0.0 OUTLIER -113.72 -25.69 8.56 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.841 1.256 . . . . 74.22 111.218 -177.887 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 73.97 -114.39 4.54 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 111.173 -0.771 . . . . 71.52 111.173 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 12.8 t -171.05 18.03 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.039 0.935 . . . . 63.52 109.86 177.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -121.91 149.0 44.04 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.178 0.513 . . . . 75.14 111.783 -169.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -100.07 143.05 30.72 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.16 -1.422 . . . . 71.14 107.16 159.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -67.15 125.09 24.94 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.401 0.62 . . . . 73.14 112.465 -170.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -133.89 166.23 23.17 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.436 1.494 . . . . 60.02 108.241 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -61.09 90.61 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 CA-C-O 121.899 0.857 . . . . 73.43 111.725 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.211 0 C-N-CA 124.066 0.946 . . . . 50.04 108.859 -176.262 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.055 0 N-CA-C 110.779 -0.928 . . . . 64.14 110.779 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . -143.95 36.67 1.49 Allowed Glycine 0 C--N 1.343 0.94 0 CA-C-N 117.108 0.454 . . . . 74.53 113.49 -175.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -78.38 74.96 4.91 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 106.948 -1.501 . . . . 72.33 106.948 167.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -81.78 -101.96 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.62 -0.718 . . . . 72.22 110.193 -171.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -146.7 -60.16 0.29 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.498 0.666 . . . . 61.25 110.492 -166.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 152.4 122.29 0.95 Allowed Glycine 0 CA--C 1.519 0.301 0 N-CA-C 109.198 -1.561 . . . . 74.31 109.198 -171.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 97' ' ' ILE . . . . . 0.441 ' CG2' ' HA ' ' D' ' 87' ' ' ALA . 3.9 pt -81.11 48.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 124.111 0.964 . . . . 64.35 112.505 -177.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 t70 56.78 92.45 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.109 1.364 . . . . 73.32 110.836 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . 61.89 -168.56 0.18 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.874 0.87 . . . . 71.22 110.448 -172.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.83 72.21 3.64 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 109.033 -0.728 . . . . 75.51 109.033 175.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -80.04 71.06 7.25 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 122.877 2.385 . . . . 71.13 112.14 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 102' ' ' LEU . . . . . . . . . . . . . 1.8 tt -88.58 67.76 8.55 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 108.837 -0.801 . . . . 72.21 108.837 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 47.3 p 51.18 30.35 5.63 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.278 1.431 . . . . 62.45 113.07 176.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.38 -138.06 13.65 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 110.675 -0.97 . . . . 40.13 110.675 -171.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -94.9 -4.61 46.59 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.385 0.674 . . . . 64.35 111.032 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -164.09 148.9 10.23 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.753 1.221 . . . . 64.4 108.72 -174.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 8.3 m -77.41 88.75 3.79 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.436 -0.579 . . . . 73.15 109.436 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -66.19 -27.67 68.17 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.227 -0.897 . . . . 62.33 110.91 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -68.54 99.28 0.96 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 107.385 -1.339 . . . . 74.23 107.385 166.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.46 145.6 45.61 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 122.758 0.423 . . . . 62.13 110.991 -177.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 mp -78.38 87.39 4.41 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.75 0.82 . . . . 74.42 109.9 -171.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 112' ' ' ASN . . . . . 0.473 ' HB2' HD23 ' D' ' 136' ' ' LEU . 66.8 t30 63.77 84.95 0.14 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.087 1.355 . . . . 53.5 111.672 176.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -124.61 -51.06 1.73 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.211 1.005 . . . . 73.2 108.483 175.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -71.89 114.17 9.7 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.638 -0.875 . . . . 44.42 108.638 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 39.4 m -79.1 129.68 34.7 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.923 0.889 . . . . 71.42 110.263 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 140.98 39.76 0.08 OUTLIER Glycine 0 N--CA 1.469 0.891 0 N-CA-C 110.912 -0.875 . . . . 64.22 110.912 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -137.3 141.11 32.86 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.047 0.939 . . . . 73.5 109.558 -172.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -37.56 134.74 0.52 Allowed 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 124.022 3.148 . . . . 63.32 113.697 167.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -59.86 114.79 2.98 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.486 1.114 . . . . 75.44 113.0 -165.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -120.76 -75.47 0.59 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.965 0.906 . . . . 62.13 108.907 172.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 121' ' ' VAL . . . . . 0.538 HG11 HD23 ' D' ' 42' ' ' LEU . 37.2 t -130.3 70.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 108.562 -0.903 . . . . 70.25 108.562 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 6.8 p -128.92 153.44 47.51 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.26 -0.882 . . . . 72.2 109.937 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 29.0 t70 62.78 -86.12 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 124.808 1.243 . . . . 74.41 111.879 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 79.5 p -157.65 176.69 12.29 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.056 0.942 . . . . 23.21 108.891 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -132.62 -78.7 0.5 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.692 0.397 . . . . 64.43 110.009 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -117.66 173.18 6.88 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.331 0.653 . . . . 55.35 110.896 -175.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 127' ' ' SER . . . . . 0.62 ' HB2' HG22 ' E' ' 129' ' ' THR . 24.6 p -103.75 -76.48 0.59 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.648 0.779 . . . . 73.25 110.183 176.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . 58.9 27.26 15.96 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.967 0.907 . . . . 72.01 111.358 -173.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 129' ' ' THR . . . . . 0.62 HG22 ' HB2' ' E' ' 127' ' ' SER . 5.4 t -89.36 117.48 28.32 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.773 0.829 . . . . 74.33 111.393 -175.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -167.82 94.63 0.41 Allowed 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.091 0.956 . . . . 71.15 108.985 174.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 131' ' ' TRP . . . . . . . . . . . . . 19.5 t90 -143.99 112.34 6.42 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.679 -0.86 . . . . 74.42 108.679 176.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 132' ' ' SER . . . . . 0.555 ' H ' ' HB3' ' A' ' 124' ' ' PRO . 44.9 p -167.77 114.75 0.73 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.877 1.271 . . . . 72.55 108.844 178.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 133' ' ' THR . . . . . 0.473 HG23 ' HB2' ' A' ' 124' ' ' PRO . 0.2 OUTLIER -149.99 161.62 41.97 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.847 0.459 . . . . 53.32 111.027 -179.465 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -148.45 111.57 0.54 Allowed Glycine 0 C--N 1.345 1.063 0 N-CA-C 110.586 -1.006 . . . . 54.15 110.586 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.9 115.17 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.394 0.678 . . . . 75.32 109.467 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -95.33 25.46 4.37 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.687 0.795 . . . . 64.54 111.185 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 137' ' ' THR . . . . . 0.686 ' HA ' ' HB2' ' A' ' 129' ' ' ALA . 45.8 p 48.3 -97.88 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.118 1.367 . . . . 44.13 112.05 -168.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -172.15 -38.4 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.482 1.113 . . . . 71.01 109.385 176.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -136.83 -170.27 2.66 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.647 1.179 . . . . 65.53 108.866 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -70.08 81.27 0.35 Allowed Glycine 0 C--N 1.348 1.213 0 O-C-N 123.621 0.575 . . . . 23.21 111.986 174.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.54 76.13 3.25 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.641 0.776 . . . . 72.13 109.913 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 92.7 mt -80.1 156.32 27.1 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.824 -0.626 . . . . 71.45 111.74 -173.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.98 49.95 0.78 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 109.392 -1.483 . . . . 61.11 109.392 174.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 14.5 p -112.31 147.56 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.411 0.684 . . . . 75.42 109.608 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 CA--C 1.55 0.952 0 C-N-CA 123.458 0.703 . . . . 72.31 110.447 175.422 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.639 0 CA-C-O 119.567 -0.574 . . . . 43.3 112.061 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.44 62.38 3.28 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 116.843 0.321 . . . . 52.42 112.744 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 93' ' ' PHE . . . . . 0.633 ' HB3' ' HB2' ' B' ' 54' ' ' ASP . 17.9 t80 -83.03 -37.03 24.47 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.149 0.58 . . . . 73.23 109.617 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.25 -57.5 1.39 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.949 0.5 . . . . 74.01 110.251 -173.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -164.74 -68.44 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.347 0.259 . . . . 73.13 110.994 177.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.53 138.18 4.46 Favored Glycine 0 C--N 1.348 1.234 0 C-N-CA 121.818 -0.229 . . . . 41.12 113.179 -172.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 97' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' B' ' 94' ' ' MET . 9.8 tt -166.4 138.97 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.457 1.503 . . . . 60.01 107.308 176.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -56.81 -51.89 67.19 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 112.922 0.712 . . . . 72.51 112.922 -167.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -177.04 148.17 0.61 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.652 1.181 . . . . 73.33 107.841 -177.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 100' ' ' LEU . . . . . 0.476 ' HA ' ' HE1' ' B' ' 94' ' ' MET . 5.1 mp -112.37 96.38 35.43 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-N 117.931 0.332 . . . . 70.31 110.751 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -93.14 -172.53 0.35 Allowed 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 123.101 2.534 . . . . 73.03 110.221 163.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 102' ' ' LEU . . . . . . . . . . . . . 44.9 tp -95.63 -59.63 1.83 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 107.922 -1.14 . . . . 74.52 107.922 168.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.94 -55.7 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.113 1.365 . . . . 72.12 108.619 170.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . -147.82 -162.38 10.05 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.77 -0.65 . . . . 63.23 112.255 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -71.6 84.33 0.86 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.508 0.723 . . . . 72.44 110.186 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 53.3 t80 48.27 82.19 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.764 1.626 . . . . 73.14 112.528 177.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 7.8 t -116.36 144.13 44.66 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.576 0.75 . . . . 72.41 109.992 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -98.92 -59.0 1.81 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.17 -0.678 . . . . 72.45 109.17 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 109' ' ' TYR . . . . . 0.458 ' CE2' ' HB2' ' B' ' 140' ' ' TYR . 70.5 t80 63.95 102.75 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.524 1.129 . . . . 72.31 109.828 -172.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 62.72 -137.91 0.42 Allowed 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 124.101 0.96 . . . . 73.5 109.448 -168.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 85.8 mt 72.75 -69.98 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 125.118 1.367 . . . . 74.12 112.734 174.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -87.41 34.45 0.7 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.424 1.09 . . . . 73.31 112.723 -171.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? 67.34 -71.5 0.1 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.064 1.346 . . . . 60.54 111.624 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt 50.54 -66.16 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 127.798 2.439 . . . . 74.25 115.7 175.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 21.5 m -61.97 -32.09 72.51 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.039 0.936 . . . . 71.41 111.979 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 131.78 -56.25 0.74 Allowed Glycine 0 C--N 1.345 1.042 0 N-CA-C 112.064 -0.414 . . . . 63.34 112.064 175.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -122.68 96.93 44.94 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 123.284 0.634 . . . . 73.21 109.996 -176.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.45 104.59 1.93 Allowed 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.17 1.914 . . . . 72.14 111.097 173.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -75.62 69.71 2.37 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.954 0.883 . . . . 73.45 110.153 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 28.7 t80 173.25 -179.24 0.08 Allowed 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 126.99 2.116 . . . . 74.23 107.071 -174.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 98.3 t 75.05 -79.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 124.619 1.168 . . . . 74.25 111.515 172.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 31.4 p -88.43 96.59 10.66 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.317 0.647 . . . . 62.44 110.606 -174.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -159.84 102.69 1.49 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.342 -0.614 . . . . 63.04 109.342 177.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 23.1 t 63.15 7.8 2.97 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.496 1.118 . . . . 61.44 112.206 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -89.33 104.9 17.42 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.075 0.95 . . . . 55.11 110.421 -167.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . 62.27 18.59 10.31 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.644 1.178 . . . . 72.13 112.48 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 16.1 m -76.95 89.35 3.51 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.644 0.778 . . . . 74.21 110.547 -176.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -159.53 -63.91 0.07 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.715 0.806 . . . . 74.41 109.277 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 92.0 m 65.07 124.44 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.187 1.395 . . . . 71.23 113.432 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -161.61 154.41 20.49 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 114.717 -1.129 . . . . 62.14 109.037 169.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 51.8 t90 -143.48 22.1 1.84 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.284 1.033 . . . . 72.53 108.325 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 132' ' ' SER . . . . . 0.4 ' HB2' ' HD1' ' C' ' 36' ' ' TRP . 14.1 m -67.15 88.08 0.17 Allowed 'General case' 0 C--N 1.352 0.701 0 CA-C-O 121.438 0.637 . . . . 74.15 110.003 -178.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 133' ' ' THR . . . . . 0.535 HG23 HD12 ' C' ' 126' ' ' LEU . 21.4 m -73.87 92.39 2.06 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.658 -1.155 . . . . 53.32 108.453 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -82.7 36.58 2.65 Favored Glycine 0 C--N 1.355 1.612 0 CA-C-N 116.089 -0.505 . . . . 71.4 113.089 -175.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 15.0 p -75.22 136.45 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.519 0.727 . . . . 53.32 109.649 -177.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -118.39 179.85 3.99 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.607 -0.516 . . . . 73.1 109.607 175.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 10.2 t -66.69 168.14 9.94 Favored 'General case' 0 C--O 1.25 1.079 0 CA-C-N 115.675 -0.693 . . . . 74.33 109.517 169.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -64.36 118.51 8.8 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.175 -1.046 . . . . 72.32 108.175 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -63.75 119.25 9.58 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.998 0.919 . . . . 74.15 112.016 -167.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.88 11.21 29.7 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 115.796 -0.638 . . . . 74.41 112.778 178.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.35 -41.69 47.39 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.477 -0.564 . . . . 50.34 109.477 174.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 2.1 tm? 68.12 -71.75 0.11 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.556 1.542 . . . . 62.5 109.608 -176.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.84 -168.1 11.74 Favored Glycine 0 C--N 1.342 0.881 0 N-CA-C 111.228 -0.749 . . . . 50.5 111.228 173.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 99.1 t -120.47 -55.64 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.681 0.793 . . . . 54.4 109.031 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 . . . . . 0 N--CA 1.48 1.051 0 C-N-CA 123.675 0.79 . . . . 75.04 110.237 179.028 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtp . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 109.066 -0.716 . . . . 73.21 109.066 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.1 p -164.68 16.78 0.05 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.863 1.265 . . . . 74.41 109.377 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -124.63 -165.75 1.42 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.787 0.835 . . . . 72.3 110.311 -166.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -151.3 73.16 1.08 Allowed 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 122.1 0.952 . . . . 70.42 109.94 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -83.01 97.93 9.0 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.244 -0.889 . . . . 74.13 109.7 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.61 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 7.1 p30 -87.98 108.92 19.44 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.279 0.562 . . . . 61.42 109.86 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.5 m -143.62 -135.77 0.09 Allowed 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 107.908 -1.145 . . . . 73.15 107.908 -176.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -88.79 55.58 3.42 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.394 0.997 . . . . 74.21 109.426 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.2 mpt? 63.17 170.07 0.15 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.758 1.223 . . . . 73.33 112.038 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 58.5 m -140.56 114.7 9.15 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.08 -1.452 . . . . 62.52 107.08 167.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -131.66 118.82 20.55 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.047 -0.724 . . . . 74.43 109.047 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.486 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 0.0 OUTLIER -136.98 131.7 33.3 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 106.603 -1.628 . . . . 75.24 106.603 175.171 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.462 ' CD1' HG21 ' A' ' 105' ' ' ILE . 6.4 mt -94.38 107.54 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.496 -0.928 . . . . 73.04 108.496 173.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.96 -40.31 68.75 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.519 -0.919 . . . . 74.43 108.519 -176.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 -173.89 122.85 0.33 Allowed 'General case' 0 C--N 1.351 0.655 0 CA-C-N 115.949 -0.569 . . . . 54.51 110.527 -169.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.572 HD12 ' HG3' ' C' ' 130' ' ' PRO . 65.0 mt -106.49 134.72 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 107.979 -1.119 . . . . 72.33 107.979 169.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.5 ' HE1' HG13 ' A' ' 83' ' ' ILE . 30.9 p90 -164.5 178.79 7.14 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 124.165 0.916 . . . . 74.24 110.807 -172.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.1 p -109.47 124.15 50.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.624 -0.716 . . . . 60.22 109.316 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.414 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 42.7 mtpt -86.46 -30.73 21.81 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.66 -0.496 . . . . 75.54 109.66 175.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.46 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 31.9 t70 -149.6 145.59 26.86 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.065 -0.97 . . . . 52.44 109.739 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.3 mt -141.02 146.02 24.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 C-N-CA 125.086 1.354 . . . . 74.41 107.835 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.2 t -152.15 137.7 17.76 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.55 0.74 . . . . 41.15 109.791 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.502 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 92.2 t80 -144.42 132.49 21.6 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.993 -1.484 . . . . 71.4 106.993 173.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -133.05 111.75 11.23 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.869 -0.789 . . . . 74.24 108.869 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -104.36 81.92 0.57 Allowed Pre-proline 0 C--O 1.245 0.817 0 N-CA-C 106.415 -1.698 . . . . 65.3 106.415 161.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.56 -29.05 25.46 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.282 1.988 . . . . 72.24 111.281 -172.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -111.45 19.1 18.53 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-N 114.451 -1.25 . . . . 52.23 109.297 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.49 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -44.83 -49.35 28.17 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 113.633 0.975 . . . . 55.34 113.633 -171.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -59.82 -39.62 70.71 Favored 'Trans proline' 0 C--N 1.392 2.858 0 C-N-CA 121.686 1.591 . . . . 75.12 112.744 176.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.432 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 3.2 m80 -76.72 -38.04 55.0 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.223 -1.353 . . . . 62.32 110.588 -173.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.473 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.6 p -72.6 -25.68 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 124.563 1.145 . . . . 63.21 111.281 -163.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -76.21 -18.82 58.88 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.557 0.743 . . . . 74.41 110.98 176.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -85.11 -28.21 25.74 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.171 0.989 . . . . 71.41 110.258 173.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 1.3 mmmp? -79.35 159.69 27.04 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.291 1.036 . . . . 55.45 111.735 -173.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.85 119.74 9.96 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.853 0.861 . . . . 65.31 110.353 176.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -82.47 85.18 6.98 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.543 0.687 . . . . 64.5 110.16 -178.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.504 ' H ' HD22 ' A' ' 68' ' ' LEU . 8.3 tp-100 -121.07 76.05 30.32 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.673 1.189 . . . . 75.34 108.263 172.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.53 113.11 2.81 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.599 2.199 . . . . 71.21 112.622 -171.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -94.69 92.17 6.88 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.585 -1.265 . . . . 73.3 107.585 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.496 HG22 ' HB2' ' A' ' 66' ' ' ALA . 61.5 t -89.44 106.38 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.718 -1.128 . . . . 63.2 111.037 -173.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -86.45 140.43 29.98 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.372 0.669 . . . . 62.41 110.561 171.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.9 mt -106.67 106.21 16.61 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.038 -1.097 . . . . 74.12 108.038 171.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -107.4 108.59 20.02 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.691 1.196 . . . . 70.2 108.157 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.55 HD11 HG21 ' A' ' 131' ' ' VAL . 83.7 mt -104.25 155.07 19.04 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.692 0.758 . . . . 64.23 112.249 -170.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 17.3 t70 -158.2 139.45 13.36 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 113.705 -1.589 . . . . 64.52 108.357 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.8 m -138.87 122.25 17.16 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.163 -0.681 . . . . 75.53 109.163 175.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.86 111.8 11.91 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.56 0.744 . . . . 62.42 109.213 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 p -91.66 153.1 19.91 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.384 0.674 . . . . 71.32 110.342 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.2 t -149.64 121.21 8.0 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.711 0.804 . . . . 63.24 109.454 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -71.35 112.48 7.52 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.56 -0.533 . . . . 74.11 109.56 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' A' ' 57' ' ' GLU . 46.8 mt -81.28 -43.76 18.69 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.128 0.571 . . . . 63.51 109.76 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.77 178.76 8.58 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.282 -0.872 . . . . 74.53 110.074 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.32 129.43 39.89 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 109.311 -0.626 . . . . 74.12 109.311 175.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 63.18 18.75 11.21 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.368 1.067 . . . . 72.03 111.262 -175.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.2 t -130.85 102.53 6.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.821 0 C-N-CA 124.374 1.069 . . . . 74.14 108.576 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -113.74 123.19 49.28 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.524 -1.287 . . . . 74.34 107.524 175.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.554 ' HB2' HD11 ' A' ' 51' ' ' LEU . 32.8 tt0 -85.46 151.38 24.02 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.686 -0.857 . . . . 73.12 108.686 173.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.423 HG11 ' HD3' ' A' ' 103' ' ' PRO . 70.2 t -130.3 135.57 60.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.137 -1.06 . . . . 73.11 108.137 169.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.2 t -117.49 128.35 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.748 -0.834 . . . . 75.21 108.748 173.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.95 100.03 9.55 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 106.769 -1.567 . . . . 53.15 106.769 176.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.495 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 21.0 ttp180 -86.83 101.61 13.51 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.617 -0.883 . . . . 72.41 108.617 173.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 37.3 t -97.85 126.95 50.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 107.442 -1.318 . . . . 71.0 107.442 173.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.6 m -124.05 123.48 40.45 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.499 -0.926 . . . . 51.31 108.499 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.591 HG11 HD21 ' A' ' 126' ' ' LEU . 69.3 t -117.09 135.42 57.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 124.843 1.257 . . . . 63.52 108.472 -174.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 30.6 m -136.47 127.93 28.54 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 109.657 -0.498 . . . . 64.13 109.657 169.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.496 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -106.05 128.3 53.76 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 107.025 -1.472 . . . . 75.23 107.025 172.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.1 m -132.21 129.82 40.2 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.05 0.54 . . . . 61.04 110.884 -175.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.504 HD22 ' H ' ' A' ' 37' ' ' GLN . 17.2 mt -89.92 51.48 2.08 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.355 1.462 . . . . 64.24 109.917 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.3 -86.37 1.12 Allowed Glycine 0 C--N 1.349 1.271 0 CA-C-N 116.228 -0.442 . . . . 55.15 113.097 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.42 -28.94 20.58 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.504 0.722 . . . . 73.33 111.044 -177.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -111.69 135.79 51.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.067 0.947 . . . . 64.11 109.181 -174.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.6 m -76.64 134.03 39.42 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.392 -0.596 . . . . 64.41 109.392 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.473 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -77.55 -60.2 2.46 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.436 0.694 . . . . 43.11 109.69 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -153.38 163.22 40.3 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.092 -0.958 . . . . 61.41 111.027 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.401 HD12 ' H ' ' A' ' 76' ' ' CYS . 28.1 tp -126.1 142.63 51.44 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.057 1.343 . . . . 74.03 108.277 173.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.571 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.2 m -137.77 139.49 40.1 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.784 1.234 . . . . 73.25 108.318 176.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -148.7 124.34 10.44 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.955 -0.757 . . . . 72.3 108.955 169.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.5 t -128.66 119.87 51.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 109.041 -0.725 . . . . 71.13 109.041 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.495 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 51.9 mt-30 -92.97 85.5 5.15 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.286 -1.005 . . . . 75.21 108.286 172.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -76.2 94.78 3.58 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 114.363 -1.29 . . . . 61.2 109.183 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.0 145.47 19.27 Favored Glycine 0 C--N 1.341 0.828 0 N-CA-C 111.399 -0.681 . . . . 72.4 111.399 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.12 122.93 1.9 Allowed Glycine 0 CA--C 1.507 -0.415 0 N-CA-C 110.455 -1.058 . . . . 51.11 110.455 -176.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.5 HG13 ' HE1' ' A' ' 17' ' ' TYR . 53.0 mt -80.36 115.83 23.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 107.93 -1.137 . . . . 74.13 107.93 173.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.807 ' HB3' HD11 ' A' ' 86' ' ' ILE . 98.3 m-85 -120.3 123.78 43.98 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.92 -0.77 . . . . 74.35 108.92 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.486 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 17.8 m -86.33 94.28 9.31 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.631 -0.878 . . . . 33.43 108.631 176.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.807 HD11 ' HB3' ' A' ' 84' ' ' PHE . 6.3 mm -109.48 147.98 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 122.151 0.181 . . . . 63.42 110.598 -175.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.432 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -172.33 177.84 2.98 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.386 1.075 . . . . 71.11 109.566 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 6' ' ' ASN . . . 93.88 -24.09 27.97 Favored Glycine 0 N--CA 1.467 0.75 0 CA-C-O 120.246 -0.197 . . . . 51.1 113.192 176.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.485 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -129.54 170.16 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.816 0.846 . . . . 71.12 110.87 -176.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -155.55 179.15 9.45 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.337 -0.847 . . . . 72.05 109.478 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.53 -122.0 28.61 Favored Glycine 0 C--N 1.347 1.165 0 C-N-CA 123.531 0.586 . . . . 52.31 114.033 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.8 p -73.04 -30.81 64.0 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.032 0.933 . . . . 65.54 111.887 -176.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -71.19 -37.21 72.13 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.136 0.574 . . . . 74.05 110.189 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.403 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 4.9 tpt -66.47 -46.44 76.37 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.726 -0.67 . . . . 72.34 109.997 175.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.1 -35.6 75.58 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.654 -0.703 . . . . 53.1 110.798 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -71.12 -35.11 71.64 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.232 0.613 . . . . 73.03 111.327 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -65.12 -44.01 90.11 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 109.437 -0.579 . . . . 62.25 109.437 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.403 ' HG ' ' HE2' ' A' ' 94' ' ' MET . 33.0 mt -82.75 -27.53 31.02 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.213 -0.903 . . . . 73.35 112.534 -175.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.07 4.29 38.52 Favored Glycine 0 N--CA 1.473 1.16 0 CA-C-O 119.689 -0.506 . . . . 73.15 114.124 -171.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.93 -67.67 0.29 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 117.388 0.594 . . . . 54.01 111.503 -176.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -66.97 -47.76 70.58 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 112.506 0.558 . . . . 64.3 112.506 -172.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 86.6 m -64.55 -48.44 74.35 Favored Pre-proline 0 CA--C 1.561 1.397 0 CA-C-O 118.364 -0.827 . . . . 72.51 112.635 -177.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.423 ' HD3' HG11 ' A' ' 58' ' ' VAL . 32.5 Cg_endo -64.42 -24.08 64.45 Favored 'Trans proline' 0 C--N 1.395 2.999 0 C-N-CA 121.671 1.58 . . . . 71.51 112.797 172.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -67.7 -36.67 81.07 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.179 0.592 . . . . 71.04 110.38 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.462 HG21 ' CD1' ' A' ' 13' ' ' ILE . 44.2 mm -69.37 -42.5 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.635 0.774 . . . . 71.4 110.133 173.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.2 mt -72.41 -23.88 61.16 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.153 -0.931 . . . . 72.42 112.068 -174.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -66.41 -41.33 40.64 Favored Pre-proline 0 N--CA 1.484 1.262 0 N-CA-C 114.306 1.225 . . . . 74.21 114.306 -171.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -50.0 -44.39 37.57 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 121.92 1.746 . . . . 65.33 113.214 168.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -74.67 -36.37 62.8 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.627 0.771 . . . . 74.21 111.709 -177.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.19 -46.65 64.17 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.345 0.658 . . . . 44.41 109.846 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.535 ' NH1' HD12 ' C' ' 105' ' ' ILE . 33.2 ttm105 -49.72 -54.8 16.69 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.812 1.32 . . . . 71.23 109.994 173.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -63.06 -44.26 96.31 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.156 0.91 . . . . 71.54 111.798 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.453 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.6 t -61.79 -31.89 72.14 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.919 0.487 . . . . 73.54 111.432 -179.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.498 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 71.1 mt -71.49 -54.95 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.602 0.761 . . . . 75.15 109.657 172.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 46.2 m -56.32 -35.12 67.21 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.039 1.336 . . . . 72.11 111.605 -173.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.5 t -69.81 -44.24 70.41 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 114.956 -1.02 . . . . 74.25 109.734 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.502 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 51.7 mtm -63.42 -38.83 92.67 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.886 0.474 . . . . 74.14 110.715 177.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 114' ' ' ILE . 84.9 t -61.51 -47.85 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 124.399 1.08 . . . . 62.21 110.475 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.8 p -74.24 -34.38 63.62 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.124 0.569 . . . . 54.13 111.393 -175.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.524 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.1 mtt-85 -70.7 -27.22 63.83 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.744 0.818 . . . . 75.44 109.696 174.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.52 7.24 62.06 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.361 -0.836 . . . . 75.24 112.714 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.461 HG21 ' HE ' ' B' ' 15' ' ' ARG . 36.0 m 72.88 9.21 5.49 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 124.625 1.17 . . . . 70.13 112.083 173.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -83.91 139.91 40.21 Favored Pre-proline 0 C--O 1.244 0.794 0 O-C-N 121.225 -0.922 . . . . 71.35 108.785 173.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.682 ' HB3' ' HA ' ' E' ' 131' ' ' TRP . 9.2 Cg_endo -56.31 141.5 88.79 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.282 1.988 . . . . 75.13 110.85 174.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.7 ' HB3' ' HE1' ' E' ' 131' ' ' TRP . 26.2 tt0 -56.57 140.43 46.57 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 124.324 1.015 . . . . 72.55 113.08 -165.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.591 HD21 HG11 ' A' ' 64' ' ' VAL . 31.6 tp -119.56 105.29 11.08 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 113.665 -1.607 . . . . 71.32 109.424 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -99.28 118.85 36.87 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 107.941 -1.133 . . . . 75.54 107.941 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 11.9 mt -70.75 147.14 49.31 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.616 0.573 . . . . 72.04 110.012 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -64.55 132.52 95.42 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 123.043 0.537 . . . . 41.13 110.329 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 25.8 Cg_exo -62.87 116.85 3.81 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.794 2.329 . . . . 45.23 112.221 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.55 HG21 HD11 ' A' ' 44' ' ' LEU . 87.3 t -99.04 130.46 47.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 C-N-CA 123.131 0.572 . . . . 73.42 110.549 -172.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -90.76 89.06 7.33 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 108.324 -0.991 . . . . 54.04 108.324 174.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -65.03 -23.17 67.12 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.512 0.725 . . . . 74.33 112.373 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.31 -39.37 82.03 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.484 0.714 . . . . 64.34 110.29 174.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.88 83.94 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.237 0.615 . . . . 60.51 110.309 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 60.3 mt -65.54 -41.32 93.19 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.033 0.533 . . . . 65.34 111.052 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -63.34 -45.17 92.49 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.432 -0.803 . . . . 71.04 109.808 178.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 17.3 mmt -61.71 -43.88 98.0 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 123.819 0.699 . . . . 61.02 111.025 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -53.98 -43.36 69.92 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.37 0.668 . . . . 74.3 111.141 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -69.06 -43.36 74.78 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.675 0.79 . . . . 75.13 111.237 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 60.6 tp -65.96 -50.94 62.58 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.248 1.019 . . . . 65.12 112.238 -168.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -175.9 -19.03 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.55 0.74 . . . . 73.25 111.034 -174.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.46 90.59 0.06 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.703 1.601 . . . . 71.14 109.493 -176.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -149.17 143.11 25.74 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.111 0.564 . . . . 71.11 109.544 -176.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.92 103.5 2.67 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.89 0.744 . . . . 74.52 109.833 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -169.18 -156.36 10.61 Favored Glycine 0 C--N 1.338 0.667 0 O-C-N 123.598 0.561 . . . . 75.44 112.582 -177.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.613 ' HG3' HG23 ' A' ' 149' ' ' THR . 10.3 tp10 70.87 -70.91 0.14 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.542 1.537 . . . . 71.24 110.388 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.405 ' HA3' ' H ' ' C' ' 148' ' ' GLY . . . 59.75 40.84 97.15 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 114.375 0.51 . . . . 72.32 114.375 169.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.613 HG23 ' HG3' ' A' ' 147' ' ' GLU . 22.6 p -61.69 -19.03 61.91 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.892 0.877 . . . . 65.51 113.25 -177.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.94 118.54 12.29 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.566 -0.901 . . . . 72.51 108.566 172.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -167.22 146.83 5.26 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.668 1.187 . . . . 73.35 108.325 175.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -116.01 38.82 3.23 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.573 1.149 . . . . 73.43 109.794 -176.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -49.56 -82.76 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.673 1.189 . . . . 70.43 112.617 -172.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.6 t70 177.7 70.04 0.01 OUTLIER 'General case' 0 C--O 1.245 0.829 0 N-CA-C 107.586 -1.265 . . . . 73.34 107.586 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.192 0 CA-C-N 115.051 -0.977 . . . . 75.24 108.714 178.676 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 49.0 ttp . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 108.732 -0.84 . . . . 70.23 108.732 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 20.4 t 70.35 155.51 0.14 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 125.111 1.364 . . . . 72.15 111.092 -177.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.605 ' HG3' ' H ' ' B' ' 5' ' ' ASN . 12.1 tp10 67.8 139.92 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 124.744 1.218 . . . . 73.05 111.662 -177.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.83 12.81 4.39 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.093 0.957 . . . . 71.02 112.662 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ASN . . . . . 0.605 ' H ' ' HG3' ' B' ' 3' ' ' GLU . 1.6 m-20 61.63 63.69 1.13 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.393 1.077 . . . . 75.05 110.647 174.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -66.5 135.34 54.08 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 115.717 -0.674 . . . . 65.11 111.935 -172.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.475 ' HB ' ' HE1' ' E' ' 120' ' ' TYR . 9.1 t -172.01 158.55 4.74 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 124.702 1.201 . . . . 73.21 108.91 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -65.14 144.35 57.28 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 108.827 -0.805 . . . . 54.21 108.827 167.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.533 ' HG3' HG13 ' B' ' 89' ' ' ILE . 26.3 ttt 66.3 166.83 0.21 Allowed 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 124.785 1.234 . . . . 60.1 112.109 -176.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 41.7 m -142.39 101.98 4.0 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 107.262 -1.384 . . . . 60.3 107.262 172.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -123.54 132.96 54.04 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.547 -0.909 . . . . 74.54 108.547 175.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -157.8 140.34 14.64 Favored 'General case' 0 C--O 1.244 0.768 0 O-C-N 123.768 0.667 . . . . 73.22 109.621 171.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.591 HD13 HD11 ' B' ' 16' ' ' ILE . 41.2 mt -67.81 131.52 33.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 114.774 -1.103 . . . . 64.1 109.624 177.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' GLN . . . . . 0.438 ' OE1' ' HA3' ' F' ' 92' ' ' GLY . 30.6 mm-40 -94.9 -45.41 7.3 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.984 -0.747 . . . . 41.41 108.984 173.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.461 ' HE ' HG21 ' A' ' 122' ' ' THR . 16.4 ttt180 -169.96 131.68 1.06 Allowed 'General case' 0 C--N 1.353 0.725 0 CA-C-N 115.494 -0.775 . . . . 72.15 110.301 -174.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.591 HD11 HD13 ' B' ' 13' ' ' ILE . 93.9 mt -115.11 146.0 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 108.057 -1.09 . . . . 64.0 108.057 174.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -168.31 149.65 5.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 112.813 0.672 . . . . 71.33 112.813 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 46.4 m -76.84 123.82 26.8 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 114.834 -1.075 . . . . 74.11 109.61 170.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.589 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.4 mtpt -96.6 -17.65 20.27 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.602 0.761 . . . . 62.01 111.326 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -164.31 141.84 6.78 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 123.649 0.593 . . . . 35.25 110.406 -174.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.456 HD12 ' SG ' ' B' ' 113' ' ' CYS . 30.5 mm -130.9 144.35 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.062 0.945 . . . . 74.21 108.957 170.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 34.7 t -149.59 140.96 23.24 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.961 -1.018 . . . . 75.03 109.032 174.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.416 ' HB2' ' HB3' ' B' ' 117' ' ' MET . 91.5 t80 -148.2 124.83 11.09 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.07 -1.456 . . . . 71.51 107.07 169.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -132.18 112.92 12.7 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.527 0.731 . . . . 70.34 109.233 -177.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.568 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -107.8 87.69 3.84 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.469 -1.308 . . . . 71.15 107.469 171.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.3 -27.28 34.63 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.532 2.155 . . . . 72.22 112.081 -172.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -110.4 9.71 23.42 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.069 0.948 . . . . 70.2 110.911 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.568 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -30.64 -66.35 0.17 Allowed Pre-proline 0 N--CA 1.493 1.68 0 C-N-CA 125.668 1.587 . . . . 42.55 115.23 -167.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.507 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 28.8 Cg_exo -58.51 -36.27 97.61 Favored 'Trans proline' 0 C--N 1.398 3.173 0 C-N-CA 122.13 1.887 . . . . 72.2 113.266 -174.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -86.63 -37.66 17.83 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.168 -0.924 . . . . 71.14 111.79 -171.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.493 HG21 ' HA ' ' B' ' 73' ' ' ALA . 8.7 p -71.06 -9.21 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.371 0.668 . . . . 71.12 111.64 -174.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -72.87 -9.52 58.78 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.112 0.565 . . . . 71.41 112.301 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -67.97 -28.89 67.84 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.232 0.613 . . . . 61.11 110.221 171.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.44 ' HB2' HD13 ' B' ' 68' ' ' LEU . 30.5 mmtp -81.55 102.19 10.45 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.573 1.149 . . . . 52.34 108.941 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -107.38 87.95 2.62 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 120.956 0.408 . . . . 70.21 110.857 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -169.61 172.08 7.13 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.772 1.229 . . . . 71.01 108.64 169.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.7 117.74 53.71 Favored Pre-proline 0 N--CA 1.479 1.0 0 N-CA-C 109.021 -0.733 . . . . 73.04 109.021 175.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.432 ' O ' HG23 ' B' ' 40' ' ' VAL . 16.8 Cg_endo -60.52 150.21 82.65 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.245 1.963 . . . . 73.53 112.546 -176.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -70.64 112.31 6.78 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.087 -1.079 . . . . 72.23 108.087 172.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 38' ' ' PRO . 59.9 t -105.53 146.79 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 115.361 -0.836 . . . . 72.02 110.818 -172.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -129.78 106.44 8.7 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 106.933 -1.506 . . . . 74.44 106.933 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.44 HD13 HG22 ' B' ' 64' ' ' VAL . 23.6 tp -90.38 125.48 35.56 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.621 -0.511 . . . . 73.53 109.621 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -130.92 155.71 46.31 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.521 1.128 . . . . 71.42 108.112 -178.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.2 162.91 34.28 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.439 0.695 . . . . 62.53 111.547 -173.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.661 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 8.7 m-20 -138.5 126.11 22.08 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.753 1.221 . . . . 74.15 109.394 175.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' THR . . . . . 0.418 HG21 ' HZ ' ' B' ' 137' ' ' PHE . 7.8 t -114.98 111.14 20.68 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.544 0.687 . . . . 64.13 109.902 174.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.41 141.85 21.64 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.812 0.845 . . . . 75.34 109.013 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.497 ' OG ' HD11 ' F' ' 102' ' ' LEU . 79.0 p -142.07 172.22 12.99 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.571 0.348 . . . . 72.03 111.183 -176.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 54.4 p -151.27 141.37 22.17 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.387 0.675 . . . . 75.35 110.407 -174.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.466 ' HB2' ' CE1' ' B' ' 56' ' ' TYR . 43.5 tt0 -85.98 103.71 14.94 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 109.218 -0.66 . . . . 72.53 109.218 173.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 pp -126.07 24.94 6.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.352 -0.84 . . . . 72.23 109.027 174.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.85 157.67 24.36 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.535 -1.211 . . . . 53.55 109.7 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -83.18 104.47 13.39 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.524 0.73 . . . . 75.35 111.575 -167.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 58.16 23.97 10.81 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 124.696 1.198 . . . . 71.43 111.534 -172.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 85.9 t -131.13 115.85 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 113.788 -1.551 . . . . 60.41 107.288 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.466 ' CE1' ' HB2' ' B' ' 50' ' ' GLN . 0.2 OUTLIER -104.78 140.92 37.38 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.107 0.563 . . . . 61.51 109.769 -174.167 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -100.18 97.64 8.42 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.481 -1.303 . . . . 64.15 107.481 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.434 ' HA ' ' HB3' ' B' ' 48' ' ' SER . 55.3 t -93.06 126.97 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 123.642 0.777 . . . . 70.44 110.078 -177.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.429 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 20.3 t -107.22 142.77 19.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 123.453 0.701 . . . . 74.33 109.426 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.471 HD13 ' HB3' ' B' ' 103' ' ' PRO . 52.7 tp -129.73 108.8 10.46 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.253 -1.017 . . . . 74.54 108.253 171.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.661 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 37.9 ttm180 -87.06 115.34 24.38 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.063 -1.088 . . . . 72.05 108.063 171.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 25.1 t -103.89 119.4 52.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.548 -1.279 . . . . 71.11 107.548 173.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 24.4 m -119.83 128.81 54.04 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.207 -0.664 . . . . 73.34 109.207 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.587 HG11 HD21 ' B' ' 126' ' ' LEU . 84.9 t -117.96 109.55 27.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 123.975 0.91 . . . . 62.44 109.102 -175.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 99.5 m -89.13 138.04 31.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.676 -1.231 . . . . 71.45 107.676 168.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.41 141.09 25.61 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.191 -0.67 . . . . 71.05 109.191 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.46 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 31.9 p -145.28 138.07 26.15 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.522 0.514 . . . . 71.31 111.221 -173.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' B' ' 34' ' ' LYS . 77.7 mt -110.97 102.21 10.71 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.487 1.115 . . . . 71.32 109.159 176.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.77 -137.45 19.47 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.129 -0.788 . . . . 52.03 111.129 -172.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -92.54 3.14 56.11 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 117.405 0.602 . . . . 70.4 110.613 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -113.68 151.87 31.23 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.013 0.525 . . . . 74.44 109.654 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 60.7 m -72.88 133.23 44.32 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.119 -0.491 . . . . 54.51 110.216 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.493 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -84.23 -64.57 1.14 Allowed 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.883 -1.155 . . . . 54.34 107.883 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -155.36 158.88 39.4 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.45 -1.25 . . . . 71.52 110.581 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 53.4 mt -132.35 108.89 9.49 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 106.432 -1.692 . . . . 74.12 106.432 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 48.5 t -119.5 116.34 25.89 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.076 -0.713 . . . . 74.34 109.076 -177.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.411 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 43.9 tt0 -124.67 121.76 35.61 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.761 -0.829 . . . . 74.03 108.761 -175.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 79.4 t -126.41 135.37 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.89 0.876 . . . . 74.23 109.014 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -107.7 119.77 40.36 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.073 -1.084 . . . . 74.31 108.073 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.432 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 8.0 tp-100 -110.03 106.01 15.35 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.659 -0.867 . . . . 73.32 108.659 174.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.589 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -98.94 160.81 20.13 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.189 -0.764 . . . . 45.43 111.189 174.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.32 126.2 1.7 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 112.18 -0.368 . . . . 53.02 112.18 -174.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -85.39 114.17 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 N-CA-C 107.718 -1.215 . . . . 74.1 107.718 173.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -129.75 143.66 50.92 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.043 0.937 . . . . 73.03 109.774 -175.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.3 m -88.98 123.3 33.18 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.47 -0.567 . . . . 55.22 109.47 172.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.567 HG22 HD11 ' B' ' 89' ' ' ILE . 4.2 mp -122.98 115.64 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 N-CA-C 108.159 -1.052 . . . . 75.11 108.159 177.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.599 ' HA ' ' HB ' ' F' ' 97' ' ' ILE . . . -154.91 172.64 17.71 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.786 0.835 . . . . 73.0 110.389 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.402 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 88.73 -37.93 3.25 Favored Glycine 0 N--CA 1.481 1.669 0 C-N-CA 123.042 0.353 . . . . 62.11 113.942 172.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.567 HD11 HG22 ' B' ' 86' ' ' ILE . 0.8 OUTLIER -81.15 169.14 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 124.433 1.093 . . . . 73.41 111.87 176.304 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.407 ' HB3' ' HG2' ' D' ' 153' ' ' GLN . 11.5 pt-20 -154.06 175.18 13.73 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.282 -0.872 . . . . 65.53 110.349 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.1 -136.87 27.41 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.802 -0.635 . . . . 4.04 113.221 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.4 m -93.82 -29.16 15.48 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.01 0.524 . . . . 64.12 110.907 -177.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -56.19 -29.55 61.05 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.916 0.887 . . . . 72.13 111.224 175.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.555 ' HG2' HD11 ' F' ' 97' ' ' ILE . 0.7 OUTLIER -66.8 -57.2 7.53 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.612 1.565 . . . . 75.31 112.592 -179.237 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.413 ' N ' ' SD ' ' B' ' 94' ' ' MET . . . -78.41 -15.12 59.01 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 111.958 0.355 . . . . 51.05 111.958 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -59.51 -30.03 68.28 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.834 0.854 . . . . 64.35 110.499 169.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -63.48 -55.38 24.59 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.072 0.549 . . . . 65.42 111.774 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.487 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.6 pp -69.45 -31.96 70.6 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.631 0.372 . . . . 73.53 111.961 -174.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.02 -23.77 51.0 Favored Glycine 0 C--N 1.348 1.207 0 O-C-N 123.379 0.424 . . . . 35.14 113.567 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.595 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -125.43 -59.28 1.39 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.054 0.542 . . . . 71.1 112.002 -169.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -64.48 -43.74 93.19 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.266 0.626 . . . . 74.15 111.798 -174.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 79.8 m -65.59 -48.13 65.88 Favored Pre-proline 0 CA--C 1.566 1.58 0 CA-C-O 118.309 -0.853 . . . . 63.22 112.201 -176.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.471 ' HB3' HD13 ' B' ' 60' ' ' LEU . 85.8 Cg_exo -53.47 -34.55 72.4 Favored 'Trans proline' 0 C--N 1.397 3.122 0 C-N-CA 122.557 2.171 . . . . 70.23 113.829 170.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.533 HD21 ' HB2' ' B' ' 134' ' ' ASP . 90.9 m-20 -65.4 -29.47 70.18 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.14 0.576 . . . . 70.55 111.941 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.418 HG23 ' NH2' ' D' ' 111' ' ' ARG . 62.6 mt -71.56 -41.54 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.085 0.554 . . . . 65.43 109.858 174.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.4 mt -78.3 -29.87 48.06 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 114.79 -1.096 . . . . 53.24 112.453 -169.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.526 ' HB2' ' HE1' ' B' ' 133' ' ' PHE . 47.9 t80 -55.67 -49.6 91.82 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-O 117.739 -1.124 . . . . 73.2 113.304 -174.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -48.12 -47.51 19.23 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 122.907 2.405 . . . . 53.23 114.695 176.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -65.01 -46.27 82.1 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.137 0.575 . . . . 75.43 110.931 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.432 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -62.41 -39.54 93.61 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.204 -0.907 . . . . 63.42 110.698 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.51 HH22 HD21 ' B' ' 127' ' ' ASN . 52.3 ttt-85 -62.92 -47.06 84.9 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.552 1.541 . . . . 74.41 111.213 -176.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.23 -34.95 73.49 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.598 0.561 . . . . 72.53 110.09 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.524 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 8.8 t -68.58 -36.61 78.96 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.612 -0.267 . . . . 71.14 111.082 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.522 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 85.0 mt -59.49 -53.65 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.745 0.818 . . . . 73.44 109.897 169.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 54.5 m -57.13 -32.54 66.46 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.654 0.781 . . . . 70.31 111.546 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.475 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 42.8 t -63.79 -49.8 71.5 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.666 0.786 . . . . 64.42 109.891 174.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.524 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.5 mmt -70.67 -30.76 67.45 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.096 0.558 . . . . 73.24 111.54 -175.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.483 HG23 ' O ' ' B' ' 114' ' ' ILE . 95.3 t -66.35 -41.74 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.667 0.787 . . . . 72.52 109.704 173.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.2 t -65.83 -32.22 73.62 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.879 -1.055 . . . . 53.11 110.804 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' B' ' 116' ' ' SER . 88.1 mtt-85 -70.02 -34.71 73.64 Favored 'General case' 0 C--O 1.206 -1.23 0 CA-C-N 115.782 -0.644 . . . . 74.15 110.179 176.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.05 -13.89 82.77 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.428 0.455 . . . . 71.52 112.364 170.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.6 m 69.55 24.1 5.73 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 125.125 1.37 . . . . 21.33 110.519 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.487 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 71.5 m-85 -77.57 159.05 77.87 Favored Pre-proline 0 N--CA 1.477 0.91 0 CA-C-N 114.875 -1.057 . . . . 73.13 110.366 175.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.14 158.56 4.99 Favored 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 123.204 2.603 . . . . 53.32 113.794 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -62.14 126.35 27.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.71 0.804 . . . . 73.34 112.459 -170.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.587 HD21 HG11 ' B' ' 64' ' ' VAL . 39.6 tp -109.81 101.13 10.02 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-N 115.225 -0.898 . . . . 61.23 109.131 178.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 127' ' ' ASN . . . . . 0.51 HD21 HH22 ' B' ' 111' ' ' ARG . 6.9 m120 -99.25 105.69 17.74 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 107.187 -1.412 . . . . 61.53 107.187 167.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.467 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 46.8 mt -63.64 127.88 33.34 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.332 -0.618 . . . . 71.54 109.332 175.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.01 148.47 92.47 Favored Pre-proline 0 CA--C 1.553 1.078 0 O-C-N 123.775 0.672 . . . . 60.34 111.225 -175.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -69.57 90.3 0.5 Allowed 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.872 2.381 . . . . 65.04 111.863 -174.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 81.9 t -95.45 109.75 23.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.611 -0.885 . . . . 73.22 108.611 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -83.75 109.05 17.19 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.549 -1.278 . . . . 62.25 107.549 171.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.526 ' HE1' ' HB2' ' B' ' 107' ' ' PHE . 47.9 m-85 -67.61 -24.34 65.47 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.442 0.697 . . . . 53.14 110.521 -176.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.595 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 7.9 t70 -62.81 -37.79 88.13 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.34 -1.3 . . . . 73.42 110.989 177.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.11 -30.06 71.15 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.057 0.943 . . . . 73.42 112.52 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.62 -49.24 41.94 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 109.848 -0.427 . . . . 72.4 109.848 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.458 ' HA ' ' HD2' ' B' ' 140' ' ' TYR . 60.6 m-85 -67.41 -26.68 66.55 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 115.631 -0.713 . . . . 75.12 111.489 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 54.3 ttm -61.35 -27.29 68.4 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.508 1.123 . . . . 55.12 112.008 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -74.05 -40.96 62.47 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.49 0.316 . . . . 72.42 110.359 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 140' ' ' TYR . . . . . 0.458 ' HD2' ' HA ' ' B' ' 137' ' ' PHE . 53.2 m-85 -72.11 -32.91 67.41 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.711 -0.677 . . . . 73.23 110.649 -176.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 76.4 mt -103.93 36.36 2.36 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.109 -0.951 . . . . 73.43 111.267 -172.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -65.72 155.72 35.2 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.644 0.378 . . . . 71.25 110.699 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 65.72 65.53 0.54 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.362 1.065 . . . . 74.21 108.708 -172.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -153.36 106.22 2.93 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.141 -1.39 . . . . 51.44 107.552 -175.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -139.92 164.49 29.86 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.133 0.573 . . . . 40.45 111.447 -172.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -177.78 159.78 25.83 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 114.939 -1.028 . . . . 72.51 110.658 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -153.63 152.69 31.14 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.519 0.728 . . . . 73.5 109.703 -173.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.61 173.54 46.86 Favored Glycine 0 C--N 1.351 1.377 0 O-C-N 123.749 0.656 . . . . 73.43 113.211 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 9.5 t -145.61 -35.84 0.29 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.203 0.601 . . . . 53.24 110.807 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -68.15 100.74 1.05 Allowed 'General case' 0 C--O 1.244 0.791 0 CA-C-O 121.765 0.793 . . . . 73.31 110.977 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.09 153.17 22.4 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.965 -1.016 . . . . 64.11 110.256 171.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 152' ' ' HIS . . . . . 0.433 ' HB3' ' HA3' ' E' ' 116' ' ' GLY . 59.3 m80 -138.13 87.02 2.21 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.104 -0.702 . . . . 73.45 109.104 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -114.98 134.13 55.45 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.359 0.664 . . . . 75.25 110.382 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 154' ' ' ASP . . . . . 0.416 ' HB3' ' HB ' ' E' ' 115' ' ' THR . 38.2 t70 -131.7 97.16 4.13 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.415 -0.958 . . . . 54.42 108.415 170.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 C-N-CA 123.946 0.898 . . . . 71.43 108.897 -176.324 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 121.285 0.564 . . . . 71.55 110.112 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 18.0 t -84.85 102.65 13.25 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 108.597 -0.89 . . . . 24.21 108.597 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -69.0 -59.39 3.08 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.057 0.943 . . . . 65.21 113.517 -165.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 55.58 45.98 23.79 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.983 0.913 . . . . 73.42 110.907 -172.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -76.61 69.09 2.98 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 122.732 1.253 . . . . 55.11 110.828 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 6' ' ' ASN . . . . . 0.43 ' HA ' ' HA2' ' C' ' 88' ' ' GLY . 5.2 p-10 -75.64 -44.5 42.31 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.448 -1.251 . . . . 65.43 110.366 -174.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 7.5 p -88.66 75.01 8.31 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 121.781 0.8 . . . . 74.53 109.542 172.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -170.46 -45.38 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.132 -1.394 . . . . 73.24 108.553 175.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.43 ' HA ' ' HA3' ' C' ' 88' ' ' GLY . 21.4 ttt 62.6 115.39 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.353 1.461 . . . . 72.53 111.159 -171.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 49.6 m -111.83 114.17 26.96 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 108.411 -0.959 . . . . 65.23 108.411 173.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -123.42 117.82 26.04 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 107.317 -1.364 . . . . 72.35 107.317 167.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 12' ' ' GLN . . . . . 0.597 HE22 HG23 ' E' ' 135' ' ' VAL . 5.9 tp60 -141.27 136.03 31.23 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 120.919 0.39 . . . . 71.03 110.177 175.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.44 HG12 ' HE2' ' C' ' 84' ' ' PHE . 16.2 mt -75.92 120.11 25.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 115.083 -0.962 . . . . 72.44 108.407 174.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.523 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.0 mm-40 -87.88 -39.08 15.1 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 123.639 0.587 . . . . 75.44 109.486 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.3 ptt-85 177.96 153.86 0.31 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.513 1.125 . . . . 63.0 110.392 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 70.7 mt -135.05 125.69 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.179 1.391 . . . . 74.3 107.262 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.408 ' HB3' HG23 ' D' ' 122' ' ' THR . 29.8 p90 -164.42 158.68 18.73 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.229 0.538 . . . . 62.01 111.408 -166.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.7 p -87.8 109.63 19.88 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.455 -0.793 . . . . 54.51 110.164 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.534 ' HD2' ' HB3' ' D' ' 28' ' ' ALA . 13.8 mtmt -82.39 -16.68 48.2 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 110.069 -0.345 . . . . 74.42 110.069 172.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.684 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.4 t70 -153.7 139.01 17.53 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.862 -0.608 . . . . 71.44 109.911 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.6 mt -141.57 145.75 24.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 106.57 -1.641 . . . . 73.24 106.57 173.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.4 t -157.23 144.99 18.98 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.262 0.553 . . . . 74.12 110.2 173.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -142.93 129.68 20.4 Favored 'General case' 0 C--O 1.225 -0.208 0 N-CA-C 107.054 -1.462 . . . . 74.11 107.054 170.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -135.73 112.56 10.2 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.24 -0.652 . . . . 73.25 109.24 -175.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.25 85.73 5.77 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 106.981 -1.488 . . . . 24.55 106.981 168.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.26 -19.96 37.81 Favored 'Trans proline' 0 C--N 1.383 2.38 0 C-N-CA 122.69 2.26 . . . . 63.55 111.874 -174.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -120.02 31.01 6.71 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.332 1.053 . . . . 74.43 109.022 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.56 -60.63 2.77 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 114.24 1.2 . . . . 53.3 114.24 -170.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.21 -32.71 41.84 Favored 'Trans proline' 0 C--N 1.379 2.152 0 CA-C-N 121.34 1.514 . . . . 75.15 111.926 -177.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -69.32 -38.34 78.18 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.662 -1.153 . . . . 60.11 111.986 -177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' C' ' 73' ' ' ALA . 13.9 p -79.08 -29.55 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 112.075 0.398 . . . . 73.13 112.075 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -62.61 -30.01 71.03 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.013 0.525 . . . . 62.13 112.383 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -88.59 7.13 34.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.201 0.6 . . . . 71.01 111.949 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.403 ' HG2' HD13 ' C' ' 68' ' ' LEU . 2.8 ttpm? -114.71 143.2 45.43 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.659 0.783 . . . . 61.03 110.076 175.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.66 131.79 49.06 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.559 1.144 . . . . 72.11 111.985 -175.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.42 ' HZ2' HD21 ' C' ' 126' ' ' LEU . 75.3 t-105 -74.41 87.58 2.05 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.653 1.181 . . . . 64.51 111.683 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 37' ' ' GLN . . . . . 0.424 ' H ' HD22 ' C' ' 68' ' ' LEU . 47.2 mt-30 -132.91 73.05 76.27 Favored Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 124.253 1.021 . . . . 75.32 108.732 169.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -91.39 148.92 3.57 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.816 2.344 . . . . 61.32 112.598 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -88.25 81.12 7.38 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 107.268 -1.382 . . . . 72.11 107.268 164.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.54 113.3 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 CA-C-N 114.911 -1.041 . . . . 73.34 109.964 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -94.02 101.31 13.35 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.561 -0.903 . . . . 72.11 108.561 175.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' F' ' 138' ' ' TYR . 4.7 tt -87.81 129.82 35.07 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 106.97 -1.493 . . . . 74.55 106.97 176.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 14.2 t70 -128.93 140.56 51.61 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.08 0.952 . . . . 64.41 109.477 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.447 HD23 HG22 ' C' ' 62' ' ' VAL . 45.5 mt -125.95 111.12 14.4 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.616 -0.883 . . . . 70.51 108.616 172.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -122.46 121.32 36.33 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 107.74 -1.207 . . . . 54.34 107.74 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.3 t -121.32 144.18 48.78 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.324 -0.621 . . . . 61.14 109.324 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.99 151.56 42.62 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.907 0.883 . . . . 74.45 108.729 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 56.7 p -138.06 143.4 40.47 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 122.863 0.465 . . . . 71.25 110.304 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 78.9 p -145.41 153.52 41.29 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.545 0.738 . . . . 74.23 110.006 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -81.94 118.02 22.63 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 109.035 -0.728 . . . . 75.14 109.035 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.651 HD11 ' HB2' ' C' ' 57' ' ' GLU . 87.5 mt -82.89 -53.14 6.08 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.32 0.648 . . . . 42.21 109.288 174.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.15 -172.59 3.52 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 114.206 -1.361 . . . . 24.44 109.14 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.44 107.73 1.44 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.702 0.801 . . . . 74.03 110.068 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 70.69 12.62 7.27 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.367 1.467 . . . . 63.52 112.683 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 90.4 t -110.55 118.92 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.064 -0.717 . . . . 72.42 109.064 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -121.5 129.98 53.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.621 1.169 . . . . 72.54 109.343 -174.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.651 ' HB2' HD11 ' C' ' 51' ' ' LEU . 44.8 tt0 -96.77 115.09 26.84 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.208 -0.664 . . . . 74.31 109.208 170.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 89.1 t -96.76 116.01 37.76 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 N-CA-C 107.894 -1.151 . . . . 62.2 107.894 169.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.46 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 61.0 t -103.76 131.53 52.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.882 -0.785 . . . . 74.42 108.882 173.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.47 98.51 8.27 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 107.709 -1.219 . . . . 64.04 107.709 172.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -82.44 106.78 14.59 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.525 -0.917 . . . . 75.41 108.525 172.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.448 ' HB ' HD11 ' C' ' 114' ' ' ILE . 12.8 t -104.61 125.19 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.906 -0.775 . . . . 64.1 108.906 177.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 89.9 m -110.23 130.7 55.5 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.94 -0.763 . . . . 54.32 108.94 178.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.668 HG21 HG21 ' C' ' 114' ' ' ILE . 97.4 t -124.37 109.05 21.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.506 -0.924 . . . . 52.34 108.506 174.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.8 m -101.56 141.89 33.75 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.824 -0.806 . . . . 72.41 108.824 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.21 117.96 18.92 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.266 -1.012 . . . . 73.51 108.266 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 37.3 m -140.03 125.99 19.64 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.201 0.313 . . . . 62.31 111.297 -177.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.424 HD22 ' H ' ' C' ' 37' ' ' GLN . 21.2 mt -87.9 46.63 1.4 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.728 1.211 . . . . 70.34 110.138 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.94 -114.45 4.65 Favored Glycine 0 C--N 1.344 1.011 0 N-CA-C 110.519 -1.033 . . . . 64.55 110.519 -170.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.18 -12.53 37.88 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.25 0.62 . . . . 73.4 110.395 174.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -75.27 121.33 22.02 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 124.359 1.064 . . . . 71.22 109.678 174.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.1 m -82.58 115.9 21.75 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 108.685 -0.858 . . . . 62.01 108.685 165.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.618 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -69.96 -48.57 57.83 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.148 -1.056 . . . . 64.33 108.148 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -168.22 172.11 8.85 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 114.316 -1.311 . . . . 73.14 111.27 175.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.438 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.9 tm? -127.56 144.51 51.06 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 106.667 -1.605 . . . . 72.31 106.667 166.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.438 ' N ' HD13 ' C' ' 75' ' ' LEU . 54.1 t -145.86 145.86 30.9 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.71 -0.848 . . . . 71.45 108.71 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -158.81 140.28 13.31 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.762 -0.459 . . . . 63.02 109.762 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 27.0 t -135.81 114.39 15.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 124.65 1.18 . . . . 73.32 107.875 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.684 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.4 mt-30 -94.27 89.07 5.79 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.951 -0.759 . . . . 75.22 108.951 171.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -79.96 96.47 6.42 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.576 -1.193 . . . . 74.45 109.108 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -82.78 145.09 23.42 Favored Glycine 0 C--N 1.343 0.945 0 N-CA-C 111.425 -0.67 . . . . 70.53 111.425 177.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.05 117.68 1.09 Allowed Glycine 0 CA--C 1.507 -0.42 0 N-CA-C 111.028 -0.829 . . . . 73.44 111.028 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.523 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 15.5 mm -86.01 131.44 34.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.859 -0.793 . . . . 74.14 108.859 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.44 ' HE2' HG12 ' C' ' 13' ' ' ILE . 94.6 m-85 -137.8 120.54 16.31 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.667 0.787 . . . . 75.42 109.913 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 17.1 p -79.9 100.51 8.09 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 108.282 -1.007 . . . . 64.42 108.282 170.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.545 HD13 ' SG ' ' C' ' 97' ' ' CYS . 15.6 mt -114.3 140.28 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 123.168 0.587 . . . . 71.5 109.698 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.96 158.27 36.28 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.512 1.125 . . . . 74.32 109.315 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 88' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' C' ' 6' ' ' ASN . . . 96.01 -18.54 57.25 Favored Glycine 0 C--O 1.246 0.903 0 N-CA-C 115.761 1.064 . . . . 62.02 115.761 166.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 13.5 pt -106.98 170.53 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 117.315 0.558 . . . . 63.34 111.225 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.454 ' H ' HE21 ' C' ' 93' ' ' GLN . 12.4 tp10 -157.68 151.19 23.74 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.328 0.651 . . . . 74.02 110.65 -175.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.73 -121.99 10.02 Favored Glycine 0 C--N 1.348 1.213 0 O-C-N 123.929 0.768 . . . . 25.12 113.647 171.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.1 p -62.16 -30.56 71.14 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.836 0.855 . . . . 71.14 111.617 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.454 HE21 ' H ' ' C' ' 90' ' ' GLU . 17.4 mt-30 -69.98 -49.94 46.65 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.315 1.046 . . . . 72.3 111.137 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.04 -46.28 90.04 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 124.105 0.878 . . . . 73.14 110.429 176.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.39 90.92 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.477 0.711 . . . . 64.34 111.226 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -69.44 -35.88 76.11 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.221 0.609 . . . . 75.02 110.697 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.545 ' SG ' HD13 ' C' ' 86' ' ' ILE . 33.8 t -66.83 -51.28 57.51 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.871 0.732 . . . . 74.04 109.291 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 68.7 mt -74.85 -35.52 62.37 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.354 1.062 . . . . 64.33 113.063 -177.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.37 -14.05 33.97 Favored Glycine 0 N--CA 1.473 1.135 0 N-CA-C 115.032 0.773 . . . . 63.41 115.032 -165.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.507 ' HB2' ' HB2' ' C' ' 137' ' ' PHE . . . -138.01 -49.05 0.56 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 117.854 0.827 . . . . 60.41 111.944 -173.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -73.12 -49.95 25.51 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.951 0.901 . . . . 73.3 111.633 -172.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.402 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 84.5 m -67.25 -47.49 49.71 Favored Pre-proline 0 CA--C 1.564 1.516 0 C-N-CA 123.478 0.711 . . . . 72.03 112.233 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 52.9 Cg_exo -58.19 -27.8 81.74 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 122.464 2.109 . . . . 74.4 113.552 175.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -65.68 -38.27 88.79 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.188 0.595 . . . . 61.2 110.543 176.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.535 HD12 ' NH1' ' A' ' 111' ' ' ARG . 30.1 mm -71.01 -36.94 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 116.029 -0.532 . . . . 75.02 109.732 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 6.1 mp -79.19 -25.5 42.75 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.431 1.092 . . . . 75.41 112.768 -176.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 107' ' ' PHE . . . . . 0.403 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 56.6 t80 -57.23 -50.71 86.62 Favored Pre-proline 0 N--CA 1.479 0.997 0 CA-C-O 117.849 -1.072 . . . . 72.25 113.394 -172.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 108' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 38.7 Cg_exo -60.71 -34.21 92.19 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.016 1.81 . . . . 72.52 113.158 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -64.7 -47.87 76.75 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.226 0.61 . . . . 43.31 110.633 177.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.73 -35.51 80.29 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.775 -0.648 . . . . 54.54 110.788 177.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -61.31 -53.13 60.64 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.246 1.418 . . . . 74.42 110.593 -178.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 112' ' ' GLU . . . . . 0.405 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.7 tm-20 -66.07 -34.31 77.78 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.403 -0.817 . . . . 70.23 110.28 -178.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.0 t -67.06 -39.17 86.82 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.06 0.544 . . . . 65.32 111.099 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.668 HG21 HG21 ' C' ' 64' ' ' VAL . 87.1 mt -69.17 -50.78 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.371 0.669 . . . . 74.15 110.579 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.2 m -64.14 -28.69 69.94 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 123.486 0.491 . . . . 70.44 110.476 -176.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.4 t -64.44 -51.82 61.21 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 123.57 0.748 . . . . 62.51 109.704 171.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.43 ' CE ' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -50.33 -47.92 55.63 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 124.361 1.064 . . . . 73.03 112.013 177.101 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 91.8 t -67.95 -38.83 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 124.228 1.011 . . . . 53.43 111.12 -177.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 77.6 p -72.7 -30.44 64.21 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.188 0.595 . . . . 73.53 111.44 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' C' ' 116' ' ' SER . 86.8 mtt-85 -67.82 -39.83 83.86 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.239 1.016 . . . . 72.12 110.252 175.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.84 7.23 59.66 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-N 115.295 -0.866 . . . . 44.15 112.659 174.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 29.9 p 62.59 26.87 15.93 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.567 1.947 . . . . 75.11 113.46 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -87.3 152.29 52.41 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 107.821 -1.177 . . . . 71.14 107.821 166.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.17 169.11 6.61 Favored 'Trans proline' 0 C--N 1.369 1.653 0 C-N-CA 122.783 2.322 . . . . 65.13 113.383 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' B' ' 123' ' ' PHE . 57.4 mm-40 -59.86 113.46 2.29 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.405 -1.27 . . . . 70.31 112.485 -177.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.42 HD21 ' HZ2' ' C' ' 36' ' ' TRP . 63.6 mt -107.33 87.92 2.61 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.965 -1.124 . . . . 65.25 107.965 168.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -89.94 112.65 24.1 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.925 -1.139 . . . . 75.44 107.925 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 40.2 mt -64.73 129.64 40.56 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 123.434 0.459 . . . . 70.25 110.686 -175.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.53 150.65 93.75 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.571 0.748 . . . . 64.42 110.468 178.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.572 ' HG3' HD12 ' A' ' 16' ' ' ILE . 26.8 Cg_exo -59.81 105.39 0.27 Allowed 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.34 2.027 . . . . 72.3 112.268 174.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 35.7 t -99.52 117.36 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 108.12 -1.067 . . . . 52.24 108.12 176.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -77.08 103.37 6.97 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.826 0.85 . . . . 71.33 110.515 -172.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -65.78 -24.98 67.05 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.63 -0.714 . . . . 72.43 111.654 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -67.1 -40.07 86.83 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.327 0.651 . . . . 74.43 109.973 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.8 -45.79 91.01 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.362 0.665 . . . . 64.34 110.509 174.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 81.2 mt -69.34 -23.46 63.77 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.043 -0.98 . . . . 74.11 111.388 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 137' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' C' ' 100' ' ' ALA . 79.1 t80 -75.64 -58.03 3.53 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 116.313 -0.403 . . . . 72.21 110.104 176.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 52.5 mtm -61.29 -27.07 68.21 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.554 0.742 . . . . 65.23 111.256 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -49.94 -35.51 24.31 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.674 1.59 . . . . 71.11 113.074 174.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 140' ' ' TYR . . . . . 0.436 ' HE1' ' HG2' ' C' ' 142' ' ' GLN . 0.0 OUTLIER -70.38 -153.67 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.684 0 C-N-CA 122.587 0.355 . . . . 71.1 111.321 -177.286 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 59.8 tp -78.45 83.69 4.65 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.497 -0.752 . . . . 63.52 108.985 171.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.436 ' HG2' ' HE1' ' C' ' 140' ' ' TYR . 0.5 OUTLIER -109.32 103.45 12.4 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 107.152 -1.425 . . . . 73.32 107.152 176.11 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -85.93 -46.96 10.07 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.453 -0.339 . . . . 73.22 110.781 -175.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -105.82 105.29 15.26 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.188 0.518 . . . . 43.24 112.049 -170.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -107.85 -157.23 0.61 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.324 1.05 . . . . 75.51 108.364 167.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 118.17 118.72 2.87 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-O 119.597 -0.557 . . . . 63.13 111.988 174.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.24 178.33 6.54 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.942 0.897 . . . . 73.22 112.404 -177.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 148' ' ' GLY . . . . . 0.405 ' H ' ' HA3' ' A' ' 148' ' ' GLY . . . 89.08 120.52 1.83 Allowed Glycine 0 C--N 1.352 1.466 0 N-CA-C 111.287 -0.725 . . . . 72.04 111.287 -175.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 14.6 t -152.56 162.31 41.39 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 117.501 0.65 . . . . 72.33 111.317 -174.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -70.98 139.07 50.45 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.745 0.818 . . . . 61.43 110.445 174.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.34 156.02 25.69 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.4 -0.963 . . . . 74.32 108.4 175.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -69.85 134.34 48.38 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 109.658 -0.497 . . . . 74.24 109.658 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -81.52 -57.21 3.57 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.483 0.313 . . . . 71.32 111.018 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -156.69 163.19 39.57 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.479 0.712 . . . . 63.24 109.159 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.403 0 C-N-CA 123.487 0.715 . . . . 64.24 109.29 176.246 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 80.4 mtp . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 109.707 -0.479 . . . . 74.23 109.707 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 2' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' E' ' 98' ' ' ASP . 19.5 m -127.01 117.45 22.5 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.504 0.722 . . . . 73.14 109.284 178.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.19 103.88 5.53 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.82 -0.807 . . . . 75.25 108.82 174.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.83 113.5 7.13 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.103 0.561 . . . . 74.12 109.74 -173.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 5' ' ' ASN . . . . . 0.444 ' HB3' ' HG2' ' E' ' 95' ' ' LYS . 34.4 t30 -134.69 132.49 38.94 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.448 0.699 . . . . 74.11 109.417 176.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -84.96 130.94 34.55 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.592 0.757 . . . . 72.33 109.555 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 9.3 t -150.58 179.64 8.0 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 124.071 0.948 . . . . 74.1 108.535 176.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -54.66 103.57 0.09 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.356 0.662 . . . . 75.14 110.812 175.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -32.52 122.51 0.34 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 125.289 1.436 . . . . 75.51 111.751 175.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 24.3 m -114.57 129.1 56.63 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.168 -0.679 . . . . 74.22 109.168 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.496 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 50.6 t80 -133.98 98.61 4.2 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.457 -1.312 . . . . 64.0 107.457 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -132.51 127.97 36.33 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.257 -0.646 . . . . 71.2 109.257 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 6.1 mt -83.88 127.22 39.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 108.572 -0.899 . . . . 64.34 108.572 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 14' ' ' GLN . . . . . 0.505 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 16.0 mm100 -81.96 -35.21 29.25 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.478 0.711 . . . . 73.32 110.302 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -171.25 133.8 0.87 Allowed 'General case' 0 C--N 1.357 0.914 0 O-C-N 123.737 0.648 . . . . 74.2 110.7 -175.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.434 HD12 ' N ' ' D' ' 16' ' ' ILE . 3.4 mp -105.57 141.85 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 107.144 -1.428 . . . . 72.34 107.144 171.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -166.72 152.92 8.45 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.438 0.637 . . . . 74.11 111.7 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 71.3 p -89.14 117.29 28.03 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 114.882 -1.054 . . . . 72.11 109.702 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -86.56 -29.74 22.42 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.652 -0.704 . . . . 60.41 109.371 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.6 t70 -150.87 142.15 23.28 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.815 -1.084 . . . . 65.31 109.589 176.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.43 HG21 ' CE ' ' C' ' 117' ' ' MET . 76.7 mt -140.73 141.07 32.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 C-N-CA 125.367 1.467 . . . . 72.02 107.402 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.7 t -147.21 144.29 28.81 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.681 0.793 . . . . 53.41 109.54 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.494 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.6 t80 -147.51 134.42 20.2 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 107.301 -1.37 . . . . 72.43 107.301 168.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.636 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 43.6 mt-10 -133.33 148.69 51.89 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.13 0.972 . . . . 74.1 108.954 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.418 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -150.73 80.07 6.92 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 107.44 -1.319 . . . . 55.23 107.44 171.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -67.46 -52.38 0.59 Allowed 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.545 2.163 . . . . 72.52 112.385 -174.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -87.61 19.63 3.31 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.457 0.703 . . . . 72.43 111.05 -176.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.534 ' HB3' ' HD2' ' C' ' 19' ' ' LYS . . . -48.26 -61.09 3.45 Favored Pre-proline 0 CA--C 1.556 1.201 0 N-CA-C 114.826 1.417 . . . . 25.21 114.826 -164.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.464 ' HB3' HD11 ' C' ' 83' ' ' ILE . 60.2 Cg_endo -68.13 -20.5 43.7 Favored 'Trans proline' 0 C--N 1.388 2.617 0 CA-C-N 121.704 1.644 . . . . 73.41 113.288 -173.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -81.83 -40.72 22.09 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.987 -1.006 . . . . 61.53 110.795 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.434 HG22 HD12 ' D' ' 68' ' ' LEU . 9.8 p -83.12 -16.06 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 O-C-N 122.246 -0.284 . . . . 73.43 111.424 -169.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -62.58 -16.85 58.45 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 112.529 0.566 . . . . 75.45 112.529 170.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -69.12 -7.68 38.36 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.717 0.807 . . . . 73.14 111.424 174.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -106.27 100.57 10.1 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.797 1.239 . . . . 72.02 109.638 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -97.86 92.77 5.99 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.775 0.83 . . . . 72.03 110.327 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -167.09 -178.34 4.12 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.033 0.933 . . . . 74.31 109.918 171.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -69.64 113.14 14.99 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.132 0.973 . . . . 74.03 109.841 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -58.84 125.89 19.56 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.46 2.106 . . . . 53.42 111.239 176.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -76.75 114.09 15.12 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.085 -1.08 . . . . 62.41 108.085 173.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.549 ' CG1' HG13 ' D' ' 64' ' ' VAL . 9.0 t -112.69 129.79 67.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.886 -0.597 . . . . 74.33 110.341 -171.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.591 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 72.0 mmtt -88.6 108.51 19.48 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.979 -1.119 . . . . 74.3 107.979 168.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.484 HD11 HG13 ' D' ' 62' ' ' VAL . 42.5 tp -98.52 121.08 40.02 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.785 -0.82 . . . . 64.21 108.785 173.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.503 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 8.8 t0 -120.38 143.99 48.14 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.009 -1.478 . . . . 70.21 107.009 177.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.418 ' H ' ' HB2' ' E' ' 112' ' ' ASN . 58.1 mt -133.84 129.67 36.8 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.495 0.718 . . . . 74.52 109.577 -175.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.424 ' HB2' ' HB3' ' D' ' 61' ' ' ARG . 54.0 m-20 -134.56 145.67 48.93 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.708 -1.219 . . . . 72.22 107.708 173.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 7.1 t -105.03 161.15 14.46 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.788 -0.819 . . . . 72.21 108.788 169.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.64 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.83 152.68 35.53 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.945 0.898 . . . . 74.32 108.649 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' E' ' 105' ' ' GLN . 5.2 p -161.31 177.82 9.8 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.35 0.66 . . . . 65.44 110.037 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 49.3 p -164.06 160.21 21.4 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 111.963 0.357 . . . . 61.21 111.963 -176.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 50' ' ' GLN . . . . . 0.679 ' HG2' HD23 ' D' ' 51' ' ' LEU . 40.8 tt0 69.84 152.07 0.1 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 126.181 1.792 . . . . 74.34 111.483 -176.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.679 HD23 ' HG2' ' D' ' 50' ' ' GLN . 2.6 pt? -59.45 -34.44 72.53 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.749 -0.463 . . . . 74.43 109.749 174.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . 68.36 93.79 0.07 Allowed 'General case' 0 C--N 1.361 1.103 0 C-N-CA 125.38 1.472 . . . . 73.12 113.302 164.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.38 78.24 9.78 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 124.274 1.03 . . . . 73.33 108.712 174.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.417 ' HA ' ' HE1' ' D' ' 56' ' ' TYR . 61.8 m-20 66.67 7.2 4.99 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 125.035 1.334 . . . . 64.25 113.36 -177.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 15.7 t -124.26 98.65 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 107.89 -1.152 . . . . 74.25 107.89 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.417 ' HE1' ' HA ' ' D' ' 54' ' ' ASP . 30.2 m-85 -115.63 135.01 54.48 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.075 0.55 . . . . 74.4 109.742 -174.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.45 ' HG2' HD13 ' D' ' 83' ' ' ILE . 39.4 mt-10 -90.62 114.06 26.24 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.068 -1.086 . . . . 73.24 108.068 162.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 88.7 t -103.19 140.08 22.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.849 -1.167 . . . . 73.41 107.849 168.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.64 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 41.7 t -133.56 146.97 31.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 107.625 -1.25 . . . . 62.35 107.625 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.63 115.91 20.19 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.63 -1.248 . . . . 55.21 107.63 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.424 ' HB3' ' HB2' ' D' ' 45' ' ' ASP . 24.8 ttm-85 -93.07 98.56 11.41 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.046 -1.094 . . . . 71.34 108.046 175.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.484 HG13 HD11 ' D' ' 42' ' ' LEU . 49.4 t -99.12 112.72 32.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.785 -0.82 . . . . 70.03 108.785 176.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 63.9 m -105.72 134.21 49.2 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.75 -1.114 . . . . 74.54 109.206 -175.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.549 HG13 ' CG1' ' D' ' 40' ' ' VAL . 71.5 t -131.63 119.75 43.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 124.287 1.035 . . . . 73.24 108.556 -177.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.591 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 24.1 m -126.49 90.76 3.23 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.757 -1.201 . . . . 75.0 107.757 177.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -97.37 146.43 25.18 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.831 -0.622 . . . . 73.41 110.136 -174.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.519 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 31.4 p -147.31 139.93 24.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 123.871 0.732 . . . . 75.14 110.97 -173.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.434 HD12 HG22 ' D' ' 31' ' ' VAL . 24.0 mt -112.08 112.89 24.84 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 107.755 -1.202 . . . . 75.22 107.755 171.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.73 -114.29 3.8 Favored Glycine 0 C--N 1.347 1.14 0 N-CA-C 113.692 0.237 . . . . 62.43 113.692 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.06 12.53 11.95 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.345 0.658 . . . . 63.15 110.487 -178.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -130.52 162.37 29.41 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.024 0.53 . . . . 73.14 109.63 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -71.89 130.41 40.95 Favored 'General case' 0 C--O 1.243 0.721 0 O-C-N 123.809 0.693 . . . . 45.32 110.71 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.519 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -81.68 -65.24 1.04 Allowed 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.648 -1.241 . . . . 65.25 107.648 172.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -151.61 150.22 30.04 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.132 -0.94 . . . . 73.53 111.125 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.636 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 63.4 mt -108.55 153.94 22.65 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.516 1.126 . . . . 75.12 108.765 171.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.504 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.2 t -160.33 142.53 12.94 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.086 0.555 . . . . 63.22 109.796 174.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -154.9 126.15 7.27 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.943 -0.392 . . . . 72.43 109.943 171.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.0 t -125.76 117.03 48.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 123.771 0.828 . . . . 53.11 109.187 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.597 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.6 mt-30 -90.23 86.94 6.65 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.816 -0.809 . . . . 75.52 108.816 172.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.14 110.5 15.61 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.181 -1.372 . . . . 71.35 109.342 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -108.39 173.03 17.5 Favored Glycine 0 C--N 1.338 0.659 0 O-C-N 123.067 0.23 . . . . 45.24 113.468 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.74 152.83 14.6 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 115.735 -0.233 . . . . 73.44 112.937 177.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 19.3 mm -90.19 115.72 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 107.997 -1.112 . . . . 74.22 107.997 173.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -112.65 135.08 53.8 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.759 0.823 . . . . 61.24 110.326 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 39.3 t -102.11 106.96 17.91 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.817 -0.808 . . . . 74.54 108.817 172.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 42.9 pt -121.34 132.84 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.104 -0.702 . . . . 64.34 109.104 173.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.87 165.61 22.66 Favored 'General case' 0 C--O 1.243 0.744 0 O-C-N 123.448 0.468 . . . . 53.31 111.796 -173.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.27 -4.63 83.19 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.15 -0.932 . . . . 64.02 114.015 177.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.459 HD12 ' H ' ' D' ' 89' ' ' ILE . 0.5 OUTLIER -104.57 163.34 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 121.365 0.602 . . . . 64.31 110.665 -177.56 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' D' ' 91' ' ' GLY . 29.6 tt0 -148.05 174.34 12.02 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 114.453 -1.249 . . . . 74.33 108.639 -173.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 91' ' ' GLY . . . . . 0.449 ' H ' ' HG2' ' D' ' 90' ' ' GLU . . . 77.6 -140.9 24.91 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 123.218 0.437 . . . . 74.03 112.628 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 60.8 p -90.48 -29.64 17.8 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.212 0.605 . . . . 74.01 110.838 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.51 ' HA ' ' HB3' ' D' ' 96' ' ' HIS . 20.7 pt20 -64.63 -23.66 67.33 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.744 0.818 . . . . 74.24 112.401 -173.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.597 ' SD ' HD23 ' E' ' 100' ' ' LEU . 0.0 OUTLIER -64.78 -43.37 93.47 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.101 0.56 . . . . 32.43 111.327 178.054 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 95' ' ' ALA . . . . . 0.482 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.15 -17.33 37.55 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.477 0.711 . . . . 74.25 111.406 177.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.51 ' HB3' ' HA ' ' D' ' 93' ' ' GLN . 78.1 t60 -73.89 -37.58 64.64 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.67 0.788 . . . . 74.53 110.608 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 71.1 m -60.71 -34.91 75.09 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.947 0.499 . . . . 62.4 110.74 174.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.432 ' HA ' HD22 ' D' ' 98' ' ' LEU . 1.1 tm? -75.42 -43.45 49.82 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.264 1.026 . . . . 71.31 110.508 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.4 -26.68 60.93 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 115.565 -0.743 . . . . 74.3 114.06 -173.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.521 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -122.37 -59.02 1.67 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.026 0.53 . . . . 71.42 112.028 -169.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -71.04 -37.81 72.55 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 112.13 0.418 . . . . 70.31 112.13 -170.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.496 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 73.9 m -66.58 -47.76 56.28 Favored Pre-proline 0 CA--C 1.568 1.657 0 CA-C-O 118.723 -0.656 . . . . 71.13 111.943 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 51.8 Cg_exo -58.9 -33.3 98.57 Favored 'Trans proline' 0 C--N 1.394 2.948 0 C-N-CA 122.052 1.834 . . . . 75.23 113.372 170.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -64.22 -35.13 79.79 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.802 0.441 . . . . 75.42 110.849 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 24.1 mm -63.91 -39.52 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.08 0.952 . . . . 72.14 110.71 173.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 85.7 mt -78.13 -14.59 59.41 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.474 -0.784 . . . . 74.34 112.222 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -72.16 -40.68 7.76 Favored Pre-proline 0 N--CA 1.486 1.334 0 N-CA-C 113.497 0.925 . . . . 71.55 113.497 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -47.68 -49.06 14.22 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.351 2.034 . . . . 65.45 113.298 166.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -71.6 -35.15 70.41 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.43 0.692 . . . . 74.05 111.535 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.81 -57.46 8.83 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.713 0.805 . . . . 73.44 110.185 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.418 ' NH2' HG23 ' B' ' 105' ' ' ILE . 39.5 ttp180 -56.72 -42.2 78.77 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 114.332 -1.304 . . . . 71.44 110.761 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -56.78 -54.62 44.26 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.891 0.744 . . . . 74.25 110.727 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.4 t -54.87 -45.32 74.58 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.291 0.995 . . . . 62.14 110.867 -177.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.504 HG12 ' SG ' ' D' ' 76' ' ' CYS . 85.1 mt -61.16 -58.54 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.67 0.788 . . . . 54.51 110.923 176.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.7 m -51.87 -43.87 63.46 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.932 1.293 . . . . 75.03 111.598 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.411 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 33.3 t -63.79 -44.72 92.53 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 114.505 -1.225 . . . . 73.35 109.826 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 68.1 mtm -69.82 -30.88 68.5 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.034 0.534 . . . . 62.05 111.613 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.478 HG23 ' O ' ' D' ' 114' ' ' ILE . 80.3 t -64.4 -45.96 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.582 0.753 . . . . 75.44 109.573 175.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 95.2 p -74.4 -28.32 61.04 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.451 -0.795 . . . . 75.13 110.722 -178.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' D' ' 116' ' ' SER . 69.4 mtt-85 -70.26 -27.12 64.19 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.53 0.732 . . . . 71.31 109.932 173.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.75 10.5 67.44 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 123.804 0.69 . . . . 72.33 112.887 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.408 HG23 ' HB3' ' C' ' 17' ' ' TYR . 68.8 p 53.79 29.41 9.63 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 126.113 1.765 . . . . 64.51 113.561 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -92.47 158.49 38.53 Favored Pre-proline 0 C--O 1.242 0.688 0 CA-C-N 115.449 -0.796 . . . . 71.14 109.737 171.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -48.16 119.96 4.48 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.768 2.312 . . . . 74.41 112.113 169.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -46.54 124.51 5.99 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 124.72 1.262 . . . . 74.32 111.757 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.413 HD21 HG11 ' D' ' 40' ' ' VAL . 33.7 tp -107.5 98.69 8.27 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.962 0.41 . . . . 52.4 111.042 -173.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 127' ' ' ASN . . . . . 0.422 ' HB2' ' HB3' ' E' ' 126' ' ' ALA . 22.5 m120 -97.98 96.85 8.44 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 107.11 -1.441 . . . . 72.44 107.11 173.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.05 132.56 54.33 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.519 -0.764 . . . . 44.14 109.481 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.16 136.72 96.82 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 122.714 0.405 . . . . 61.15 110.45 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.542 ' HD3' HG13 ' B' ' 13' ' ' ILE . 93.8 Cg_endo -79.55 145.79 18.72 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.577 2.184 . . . . 75.14 111.864 -174.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 9.0 p -141.24 141.1 31.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 109.003 -0.74 . . . . 73.43 109.003 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -78.95 108.61 12.55 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.676 -0.861 . . . . 62.51 108.676 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.407 ' HA ' HD23 ' D' ' 136' ' ' LEU . 1.7 m-85 -62.69 -28.3 69.84 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.391 0.676 . . . . 65.32 110.346 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.521 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 5.6 t70 -60.53 -38.01 83.04 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.715 -1.129 . . . . 73.42 110.403 175.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.92 -32.46 74.19 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.807 0.843 . . . . 73.44 111.911 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' D' ' 133' ' ' PHE . 2.7 mm? -74.62 -46.97 34.91 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.75 0.42 . . . . 73.01 111.347 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.525 ' HE1' ' HB2' ' E' ' 108' ' ' HIS . 69.1 m-85 -70.0 -27.94 65.1 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 116.721 -0.218 . . . . 73.22 111.555 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 69.6 mtm -72.04 -37.2 69.75 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.456 0.303 . . . . 75.32 110.58 167.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.48 ' O ' ' HG3' ' D' ' 143' ' ' GLN . 36.1 t-20 -54.81 -40.52 69.6 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.075 0.95 . . . . 73.22 110.337 -178.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -57.3 -34.42 68.69 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.096 0.872 . . . . 75.21 111.849 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.2 mp -80.96 -29.48 35.35 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.892 0.877 . . . . 73.15 110.685 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -83.7 33.14 0.47 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.234 1.014 . . . . 72.24 111.778 -177.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 143' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' D' ' 139' ' ' ASN . 23.7 mt-30 -119.16 55.78 0.93 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 122.061 0.934 . . . . 73.52 109.141 -173.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -168.64 -60.02 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.028 -1.442 . . . . 74.3 108.573 -177.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.58 158.6 35.89 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.938 -1.028 . . . . 63.13 109.817 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.88 -27.92 0.02 OUTLIER Glycine 0 C--N 1.345 1.063 0 O-C-N 123.34 0.4 . . . . 73.35 112.572 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.35 89.79 0.08 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.535 1.534 . . . . 75.2 110.91 176.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -81.46 83.11 1.52 Allowed Glycine 0 C--N 1.346 1.097 0 CA-C-N 116.337 -0.392 . . . . 54.12 113.901 -174.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 7.6 t -119.04 120.95 38.73 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.896 -0.779 . . . . 75.44 108.896 172.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -117.59 147.42 42.86 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.838 0.455 . . . . 72.21 111.051 -176.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -132.8 79.04 1.83 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 106.999 -1.482 . . . . 74.21 106.999 170.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -152.07 -172.43 4.22 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.67 0.788 . . . . 71.42 109.746 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 153' ' ' GLN . . . . . 0.407 ' HG2' ' HB3' ' B' ' 90' ' ' GLU . 29.0 mm-40 -66.72 91.45 0.19 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.885 -0.413 . . . . 64.12 109.885 174.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -65.48 129.12 38.6 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.994 0.918 . . . . 71.12 110.327 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.217 0 C-N-CA 123.255 0.622 . . . . 72.11 109.98 -179.635 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.927 0 CA-C-O 119.922 -0.376 . . . . 75.52 112.597 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.67 44.44 89.6 Favored Glycine 0 C--N 1.357 1.698 0 CA-C-N 116.627 0.214 . . . . 74.41 112.888 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 56.66 -159.15 0.24 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.382 1.073 . . . . 73.04 110.442 -172.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -110.03 -161.55 0.76 Allowed 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.18 -0.95 . . . . 64.34 110.399 -172.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 95' ' ' LYS . . . . . 0.444 ' HG2' ' HB3' ' D' ' 5' ' ' ASN . 0.9 OUTLIER -71.25 109.55 5.35 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.828 -0.804 . . . . 75.4 108.828 171.063 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . -51.51 139.03 27.55 Favored Glycine 0 C--N 1.356 1.692 0 O-C-N 125.361 1.663 . . . . 72.14 113.499 -177.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 97' ' ' ILE . . . . . 0.448 HD13 ' HB2' ' D' ' 94' ' ' MET . 29.9 mt -51.2 -40.98 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.469 0.708 . . . . 73.13 111.57 -177.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 98' ' ' ASP . . . . . 0.4 ' HB2' ' HB2' ' D' ' 2' ' ' SER . 35.9 t70 76.0 -50.45 0.61 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.559 1.543 . . . . 54.53 113.268 169.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.34 -52.34 63.83 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.895 1.278 . . . . 74.35 112.512 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 100' ' ' LEU . . . . . 0.597 HD23 ' SD ' ' D' ' 94' ' ' MET . 3.6 pp -74.27 139.85 75.85 Favored Pre-proline 0 CA--C 1.549 0.916 0 O-C-N 123.099 0.25 . . . . 74.12 110.562 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 101' ' ' PRO . . . . . 0.504 ' HD2' HG23 ' E' ' 103' ' ' THR . 40.6 Cg_endo -94.9 24.27 0.37 Allowed 'Trans proline' 0 C--N 1.366 1.448 0 C-N-CA 123.127 2.551 . . . . 53.23 110.343 155.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 102' ' ' LEU . . . . . . . . . . . . . 1.4 tt 58.26 84.07 0.11 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.049 1.74 . . . . 74.43 109.689 -166.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 103' ' ' THR . . . . . 0.504 HG23 ' HD2' ' E' ' 101' ' ' PRO . 23.4 p -74.18 125.73 29.02 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.396 1.078 . . . . 65.42 111.663 -176.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.27 78.83 0.13 Allowed Glycine 0 C--N 1.355 1.594 0 O-C-N 123.974 0.796 . . . . 60.21 112.758 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 105' ' ' GLN . . . . . 0.418 ' HB3' ' O ' ' D' ' 48' ' ' SER . 22.6 mp0 -67.1 -60.84 2.28 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.933 0.493 . . . . 65.44 110.792 -172.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 106' ' ' TYR . . . . . 0.446 ' HA ' ' HA ' ' D' ' 47' ' ' ALA . 58.1 t80 -83.07 94.43 7.8 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.613 -0.884 . . . . 73.55 108.613 174.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 46.5 m 63.78 105.5 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.699 1.2 . . . . 63.33 110.963 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 108' ' ' HIS . . . . . 0.525 ' HB2' ' HE1' ' D' ' 137' ' ' PHE . 18.3 m-70 -66.09 -39.27 89.87 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 115.324 -0.853 . . . . 73.43 111.031 -170.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -138.97 -76.28 0.36 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.813 0.845 . . . . 63.14 109.001 173.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 110' ' ' ALA . . . . . 0.571 ' HB3' ' HE2' ' E' ' 114' ' ' LYS . . . -163.38 151.39 13.39 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.451 1.1 . . . . 73.24 108.578 176.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 111' ' ' LEU . . . . . 0.514 HD13 ' HE2' ' D' ' 137' ' ' PHE . 55.5 tp -131.0 -75.53 0.53 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.964 0.505 . . . . 54.31 110.363 -172.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 112' ' ' ASN . . . . . 0.418 ' HB2' ' H ' ' D' ' 44' ' ' LEU . 28.0 t-20 -57.36 -50.57 72.52 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.378 0.671 . . . . 72.32 112.127 -168.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -113.61 84.23 1.98 Allowed 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.255 -0.646 . . . . 73.23 109.255 176.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 114' ' ' LYS . . . . . 0.571 ' HE2' ' HB3' ' E' ' 110' ' ' ALA . 0.0 OUTLIER -84.81 122.76 29.6 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.662 -0.699 . . . . 64.5 109.19 168.554 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 115' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' B' ' 154' ' ' ASP . 23.3 p -73.88 80.49 1.64 Allowed 'General case' 0 CA--C 1.543 0.706 0 O-C-N 124.114 0.884 . . . . 74.42 109.877 174.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 116' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' B' ' 152' ' ' HIS . . . -122.6 83.77 0.36 Allowed Glycine 0 C--N 1.341 0.848 0 CA-C-N 114.553 -1.203 . . . . 52.04 110.225 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 117' ' ' LYS . . . . . 0.586 ' HB3' ' HD2' ' E' ' 118' ' ' PRO . 46.6 mtmt 67.97 177.82 0.05 OUTLIER Pre-proline 0 CA--C 1.563 1.454 0 C-N-CA 124.766 1.227 . . . . 71.04 108.958 -159.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 118' ' ' PRO . . . . . 0.586 ' HD2' ' HB3' ' E' ' 117' ' ' LYS . 16.2 Cg_exo -27.4 -52.64 0.11 Allowed 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 123.891 3.061 . . . . 53.22 116.113 172.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -160.37 169.91 22.13 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 120.86 0.362 . . . . 75.24 110.937 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 120' ' ' TYR . . . . . 0.475 ' HE1' ' HB ' ' B' ' 7' ' ' THR . 55.8 t80 -150.36 -29.26 0.22 Allowed 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.355 1.062 . . . . 74.34 110.174 174.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 121' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.36 82.79 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 123.114 0.566 . . . . 63.11 110.278 -178.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 122' ' ' THR . . . . . 0.477 ' H ' HD21 ' B' ' 5' ' ' ASN . 44.8 m -159.52 126.19 4.52 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.682 1.193 . . . . 62.13 108.732 166.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -172.2 165.79 6.02 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.123 0.889 . . . . 74.42 109.315 170.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 23.2 m -68.69 132.97 47.75 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.53 0.732 . . . . 70.42 110.649 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -84.11 157.68 21.65 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.587 0.755 . . . . 75.34 110.991 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 126' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' D' ' 127' ' ' ASN . . . -81.33 120.34 24.81 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.642 -0.708 . . . . 73.34 112.493 -170.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 39.5 m -138.29 -69.07 0.44 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.89 -0.781 . . . . 73.41 108.89 167.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . 56.26 21.81 5.65 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.193 0.997 . . . . 34.35 112.749 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 12.9 t -127.92 165.55 19.99 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.109 0.564 . . . . 73.45 111.153 -172.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -136.83 169.82 17.12 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.034 0.934 . . . . 65.42 110.406 -176.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 131' ' ' TRP . . . . . 0.7 ' HE1' ' HB3' ' A' ' 125' ' ' GLN . 29.6 t90 -114.32 103.2 10.83 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.723 -0.843 . . . . 70.4 108.723 173.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 55.0 m -151.77 66.84 0.87 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.621 0.768 . . . . 72.01 110.384 177.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 91.4 m -139.92 133.15 29.78 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.061 0.545 . . . . 51.14 109.712 173.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -162.99 148.93 16.11 Favored Glycine 0 C--N 1.342 0.882 0 N-CA-C 111.276 -0.73 . . . . 65.33 111.276 175.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 135' ' ' VAL . . . . . 0.597 HG23 HE22 ' C' ' 12' ' ' GLN . 29.2 m -87.8 -174.71 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.547 0.739 . . . . 74.13 110.546 176.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -97.92 156.61 16.53 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.201 0.6 . . . . 73.5 110.215 171.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 7.2 t -70.14 131.21 43.92 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.24 0.543 . . . . 63.21 111.872 -177.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -110.12 112.38 24.32 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.529 -1.286 . . . . 72.42 107.529 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -151.34 -55.34 0.14 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.206 0.602 . . . . 71.52 109.915 175.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . 63.03 28.6 72.35 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 120.88 0.156 . . . . 74.12 112.902 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -91.36 152.86 20.26 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.682 0.793 . . . . 60.35 110.359 -176.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 47.9 tp -91.93 -5.2 53.59 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.732 0.813 . . . . 74.33 110.027 174.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.08 164.26 35.62 Favored Glycine 0 C--N 1.351 1.386 0 N-CA-C 111.818 -0.513 . . . . 53.22 111.818 -173.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 42.1 t -117.94 -65.11 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 109.741 -0.466 . . . . 65.15 109.741 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 31.3 t70 . . . . . 0 C--O 1.249 1.054 0 C-N-CA 123.753 0.821 . . . . 64.11 109.01 -176.413 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.869 0 N-CA-C 112.192 -0.363 . . . . 71.24 112.192 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' F' F ' 92' ' ' GLY . . . . . 0.438 ' HA3' ' OE1' ' B' ' 14' ' ' GLN . . . 160.1 172.27 27.1 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-O 119.588 -0.562 . . . . 51.25 112.444 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 57.22 83.83 0.1 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.367 1.067 . . . . 74.44 110.869 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -120.82 -172.52 2.4 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.609 -0.723 . . . . 70.32 110.357 -173.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -141.96 89.78 2.21 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.82 -1.178 . . . . 75.34 107.82 172.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -157.53 11.1 0.25 Allowed Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.488 -0.778 . . . . 24.43 114.231 -174.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 97' ' ' ILE . . . . . 0.599 ' HB ' ' HA ' ' B' ' 87' ' ' ALA . 15.5 tt -124.46 157.2 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 109.282 -0.636 . . . . 64.4 109.282 174.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -75.96 -91.15 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 123.825 0.85 . . . . 63.41 111.356 -175.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -153.28 124.98 7.74 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 107.923 -1.14 . . . . 73.33 107.923 -176.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 100' ' ' LEU . . . . . 0.437 ' HB2' ' CE1' ' B' ' 56' ' ' TYR . 2.9 mp -98.86 106.09 35.33 Favored Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 123.43 0.692 . . . . 65.13 111.421 -164.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -89.88 152.27 4.96 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.74 2.293 . . . . 54.21 113.455 178.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 102' ' ' LEU . . . . . 0.497 HD11 ' OG ' ' B' ' 48' ' ' SER . 4.3 mm? -101.93 22.66 12.65 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.048 0.939 . . . . 72.24 109.777 167.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 72.9 p 51.16 29.87 5.16 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.788 1.635 . . . . 73.2 112.61 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 141.21 -87.46 0.19 Allowed Glycine 0 C--N 1.345 1.041 0 N-CA-C 110.139 -1.184 . . . . 74.42 110.139 -175.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -152.24 -62.72 0.17 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.103 -1.073 . . . . 71.54 108.103 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -126.22 78.35 1.76 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.134 -1.062 . . . . 74.31 108.134 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 29.2 m 58.72 113.48 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 124.722 1.209 . . . . 72.24 113.525 169.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -66.91 -26.52 66.9 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.939 0.496 . . . . 70.02 110.87 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -95.38 -109.78 0.14 Allowed 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 123.534 0.734 . . . . 62.15 109.82 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -178.48 154.93 0.83 Allowed 'General case' 0 C--N 1.362 1.113 0 C-N-CA 125.117 1.367 . . . . 54.3 108.925 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 53.8 tp -124.21 -46.75 1.92 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.131 0.572 . . . . 74.15 109.544 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -74.28 98.6 3.25 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.142 0.577 . . . . 75.35 110.58 174.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -133.21 165.32 25.06 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.892 0.877 . . . . 54.44 109.559 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 114' ' ' LYS . . . . . 0.562 ' HG3' ' H ' ' F' ' 116' ' ' GLY . 18.9 ptpt -144.07 -28.84 0.5 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.979 0.511 . . . . 52.25 111.943 -174.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 2.0 m 63.56 18.73 11.28 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.251 1.02 . . . . 63.31 111.342 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 116' ' ' GLY . . . . . 0.562 ' H ' ' HG3' ' F' ' 114' ' ' LYS . . . 72.3 -76.64 0.76 Allowed Glycine 0 C--N 1.353 1.481 0 N-CA-C 110.624 -0.991 . . . . 34.5 110.624 -168.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -86.7 110.74 34.7 Favored Pre-proline 0 CA--C 1.546 0.817 0 N-CA-C 107.592 -1.262 . . . . 61.1 107.592 169.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 118' ' ' PRO . . . . . 0.432 ' HB2' ' HA ' ' F' ' 122' ' ' THR . 30.7 Cg_exo -62.24 107.37 0.56 Allowed 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 123.056 2.504 . . . . 72.34 112.943 -176.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -71.69 -66.96 0.57 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.256 -0.884 . . . . 61.22 108.68 170.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -97.13 161.95 13.59 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.141 -1.059 . . . . 72.44 108.141 165.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 13.3 t 61.08 34.86 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 122.701 1.239 . . . . 64.03 108.874 -171.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 122' ' ' THR . . . . . 0.432 ' HA ' ' HB2' ' F' ' 118' ' ' PRO . 11.1 t -83.37 173.84 11.2 Favored 'General case' 0 C--O 1.245 0.858 0 CA-C-N 114.79 -1.095 . . . . 63.14 110.825 -178.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.64 129.36 40.19 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.421 0.688 . . . . 61.24 110.221 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 18.8 p -155.27 124.04 6.1 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 124.114 0.966 . . . . 74.53 109.272 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . 64.46 -104.05 0.11 Allowed 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.364 1.066 . . . . 52.24 110.593 -177.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . 53.99 20.2 2.34 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.744 1.218 . . . . 73.42 114.213 176.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 21.0 m -110.77 114.42 27.76 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.245 0.618 . . . . 74.04 110.139 -176.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -164.79 140.63 5.7 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.243 0.617 . . . . 62.34 110.632 177.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 13.4 t -91.7 -164.94 1.25 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.889 0.876 . . . . 75.11 109.199 175.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -126.21 136.12 52.44 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.337 0.655 . . . . 71.24 110.327 176.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 21.3 m95 57.91 -102.73 0.16 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.09 1.356 . . . . 75.24 112.582 175.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 15.4 m 57.44 31.7 20.64 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.043 0.937 . . . . 54.45 110.517 -167.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 133' ' ' THR . . . . . 0.441 HG22 ' HB ' ' F' ' 135' ' ' VAL . 29.7 m -82.55 120.11 25.1 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 114.739 -1.119 . . . . 74.5 110.406 -174.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.29 -49.6 72.88 Favored Glycine 0 C--N 1.355 1.606 0 O-C-N 123.747 0.655 . . . . 54.14 112.487 177.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 135' ' ' VAL . . . . . 0.441 ' HB ' HG22 ' F' ' 133' ' ' THR . 6.3 p 45.01 32.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 C-N-CA 126.424 1.89 . . . . 65.03 113.162 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -75.56 -68.21 0.59 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.363 -0.835 . . . . 60.45 111.544 -171.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 16.8 p -104.46 134.77 47.09 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.464 0.705 . . . . 73.31 110.7 -174.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 138' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' C' ' 42' ' ' LEU . 59.7 m-85 -108.55 86.81 2.36 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.954 0.902 . . . . 73.34 109.029 -176.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -165.16 129.28 2.39 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.729 0.812 . . . . 62.11 109.295 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -120.61 50.37 0.83 Allowed Glycine 0 C--N 1.342 0.877 0 N-CA-C 111.065 -0.814 . . . . 60.23 111.065 176.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.06 151.31 44.68 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.987 0.515 . . . . 54.24 111.754 -177.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 2.3 pp -149.44 171.94 15.76 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.528 0.731 . . . . 50.12 110.768 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -171.06 66.42 0.15 Allowed Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.408 -0.814 . . . . 54.31 111.163 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 90.8 t -58.44 126.16 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 123.988 0.915 . . . . 53.44 110.185 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 19.2 t70 . . . . . 0 C--O 1.252 1.198 0 N-CA-C 108.541 -0.911 . . . . 62.41 108.541 -177.458 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 109.482 -0.562 . . . . 71.44 109.482 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.1 m -109.95 124.68 51.83 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.77 0.828 . . . . 73.33 109.711 177.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.93 147.21 34.87 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 106.894 -1.521 . . . . 72.2 106.894 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -70.86 90.18 0.79 Allowed 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.214 0.606 . . . . 72.54 109.822 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -75.33 84.83 2.48 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.461 -0.94 . . . . 74.13 108.461 174.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -65.4 157.89 28.11 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.522 1.129 . . . . 74.4 111.205 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.6 t -71.05 81.99 0.68 Allowed 'General case' 0 CA--C 1.557 1.224 0 CA-C-O 122.191 0.996 . . . . 74.4 112.305 -171.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -105.7 -20.62 13.4 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.523 1.129 . . . . 73.04 109.648 170.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -62.59 150.01 41.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.255 1.022 . . . . 74.41 111.545 -170.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 63.0 m -140.7 126.85 19.64 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 106.496 -1.668 . . . . 53.03 106.496 172.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -137.45 125.21 22.45 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.845 -0.798 . . . . 75.55 108.845 -173.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -145.73 129.69 17.37 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.259 -0.645 . . . . 71.41 109.259 173.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.4 HD13 HD11 ' A' ' 16' ' ' ILE . 7.0 mt -84.77 126.18 40.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.505 -0.924 . . . . 73.11 108.505 175.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -93.04 -41.23 10.09 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.172 0.589 . . . . 64.33 110.347 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -172.73 121.49 0.41 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.62 -0.718 . . . . 74.43 109.969 -173.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.4 HD11 HD13 ' A' ' 13' ' ' ILE . 80.1 mt -105.4 132.43 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 107.373 -1.343 . . . . 61.52 107.373 172.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.478 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 28.2 p90 -162.98 164.02 25.86 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 123.687 0.617 . . . . 74.25 111.445 -172.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.7 p -90.37 122.19 33.02 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.779 -0.452 . . . . 61.03 109.779 174.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.478 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.1 mtpt -83.24 -33.55 26.05 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.055 0.542 . . . . 71.12 109.922 175.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -148.49 142.06 25.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.112 -0.949 . . . . 65.02 109.06 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.7 mt -135.47 145.9 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.778 1.231 . . . . 74.42 107.845 175.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -151.19 131.16 13.35 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.215 0.606 . . . . 71.15 109.999 172.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.449 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 90.6 t80 -131.37 133.1 44.95 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 106.781 -1.563 . . . . 75.22 106.781 171.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -135.67 125.97 26.5 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.627 -0.509 . . . . 74.23 109.627 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.82 79.21 4.41 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 106.16 -1.793 . . . . 75.03 106.16 163.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -65.7 -35.53 36.61 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.455 2.103 . . . . 74.01 112.027 -167.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -107.81 27.07 9.57 Favored 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 124.461 1.104 . . . . 73.52 109.261 -172.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.47 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -46.09 -54.94 14.85 Favored Pre-proline 0 CA--C 1.568 1.652 0 N-CA-C 114.723 1.379 . . . . 55.0 114.723 -165.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.453 ' HG3' ' HG3' ' B' ' 57' ' ' GLU . 28.0 Cg_exo -62.5 -25.85 76.0 Favored 'Trans proline' 0 C--N 1.39 2.736 0 CA-C-N 121.904 1.716 . . . . 74.02 113.26 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.505 ' O ' ' HG2' ' A' ' 33' ' ' GLN . 2.5 m-70 -86.83 -34.32 19.54 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.614 0.765 . . . . 54.31 110.479 -178.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.532 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.7 p -74.75 -12.04 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 C-N-CA 123.204 0.602 . . . . 71.2 111.894 -164.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -91.78 -18.44 23.87 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.44 0.696 . . . . 65.24 111.291 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 3.6 pt20 -96.98 -11.55 24.43 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.251 0.62 . . . . 72.33 110.251 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 14.3 mmmm -76.93 156.36 32.08 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.407 0.683 . . . . 65.53 111.106 177.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.06 119.3 10.54 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.467 0.707 . . . . 53.14 110.005 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.9 t-105 -76.89 84.74 3.45 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-O 121.596 0.713 . . . . 64.34 109.798 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -116.17 79.2 8.41 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 106.246 -1.761 . . . . 71.43 106.246 172.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -81.12 106.62 1.78 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.436 2.091 . . . . 63.51 112.188 -172.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -95.87 88.64 4.99 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 122.6 1.19 . . . . 71.33 107.859 174.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.556 HG22 ' HB2' ' A' ' 66' ' ' ALA . 61.6 t -86.85 101.55 11.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 114.474 -1.239 . . . . 73.43 110.237 -174.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -82.32 118.66 23.32 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.994 -1.003 . . . . 62.02 109.121 171.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.3 mp -95.56 108.16 20.39 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.633 -1.247 . . . . 71.51 107.633 173.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -105.93 150.67 25.44 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.267 -1.012 . . . . 64.42 108.267 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.511 HD22 HD21 ' A' ' 60' ' ' LEU . 67.1 mt -133.29 158.77 42.11 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.406 0.682 . . . . 75.11 110.766 -177.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 25.5 t70 -160.14 121.7 3.17 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.579 -1.191 . . . . 72.33 108.037 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.437 HG21 ' HA2' ' A' ' 99' ' ' GLY . 41.6 m -112.27 126.51 55.32 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 122.838 0.455 . . . . 73.05 110.196 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.46 112.91 11.32 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.776 0.83 . . . . 74.1 109.493 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.1 p -89.41 177.19 6.64 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.94 0.496 . . . . 52.52 109.867 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.441 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 26.0 t -165.38 153.31 11.21 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.284 1.034 . . . . 73.23 109.112 -168.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -113.73 131.1 56.31 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 109.034 -0.728 . . . . 73.24 109.034 172.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.419 HD12 HG23 ' A' ' 83' ' ' ILE . 80.5 mt -110.48 -34.45 6.31 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.5 0.72 . . . . 74.24 111.4 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.539 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -157.82 -171.23 3.46 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 123.536 0.734 . . . . 70.41 110.537 -177.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -70.59 119.09 14.23 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.533 -0.914 . . . . 75.41 108.533 172.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 65.54 10.72 6.88 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.361 1.065 . . . . 54.24 112.107 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 57.2 t -116.21 112.6 40.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 107.835 -1.172 . . . . 62.32 107.835 175.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -126.7 126.33 43.32 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.892 0.877 . . . . 72.4 109.036 -176.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 37.8 tt0 -86.65 149.11 25.14 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.512 -0.551 . . . . 63.51 109.512 175.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.409 HG21 ' CB ' ' A' ' 102' ' ' CYS . 91.1 t -130.77 142.13 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 108.062 -1.088 . . . . 73.45 108.062 173.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.53 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 52.5 t -123.48 133.02 70.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.434 -0.95 . . . . 65.14 108.434 175.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.511 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -113.57 106.81 14.98 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.506 -1.294 . . . . 75.2 107.506 173.129 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.455 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 24.8 ttp180 -93.63 100.59 12.81 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.856 -1.164 . . . . 71.13 107.856 175.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.6 t -94.57 122.92 46.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 107.562 -1.273 . . . . 74.3 107.562 174.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.4 m -116.77 107.61 14.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.567 0.698 . . . . 63.35 109.426 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.536 HG11 HD21 ' A' ' 126' ' ' LEU . 58.0 t -104.38 133.91 47.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 C-N-CA 124.788 1.235 . . . . 54.33 107.871 -178.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.0 m -135.44 136.4 41.32 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.697 -0.853 . . . . 75.03 108.697 170.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.556 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -116.19 130.89 57.01 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.487 -1.301 . . . . 73.01 107.487 171.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.7 m -124.79 169.76 11.7 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.102 -0.703 . . . . 54.34 109.102 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.7 mt -124.09 42.95 3.12 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.754 1.222 . . . . 73.4 108.265 -176.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.22 -89.66 1.58 Allowed Glycine 0 C--N 1.34 0.756 0 CA-C-N 114.725 -1.125 . . . . 42.5 111.34 -172.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.43 -19.53 19.81 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.74 0.816 . . . . 72.3 112.539 -173.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -121.49 132.78 54.91 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 109.693 -0.484 . . . . 75.23 109.693 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.0 m -72.18 137.13 46.7 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 122.449 0.3 . . . . 63.05 110.469 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.532 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -79.17 -62.24 1.76 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.721 -0.672 . . . . 70.12 109.609 176.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -157.07 168.4 27.58 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.164 -0.925 . . . . 70.13 111.614 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 64' ' ' VAL . 61.4 tp -125.41 141.97 51.76 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.939 1.296 . . . . 73.23 108.434 171.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.459 ' SG ' HG22 ' A' ' 118' ' ' VAL . 77.7 m -143.15 99.15 3.39 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.487 1.115 . . . . 72.41 109.289 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -124.25 117.55 24.81 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.711 -0.848 . . . . 70.12 108.711 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.7 t -130.65 128.86 63.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 123.84 0.856 . . . . 74.52 109.613 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.455 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 77.3 mt-30 -96.95 90.9 5.37 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.557 0.743 . . . . 74.41 109.151 169.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -77.59 94.16 4.32 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.79 -0.819 . . . . 72.32 108.79 174.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.84 172.35 49.86 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.986 -0.846 . . . . 72.45 110.986 175.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.08 126.36 1.2 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.16 -0.776 . . . . 74.0 111.16 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.419 HG23 HD12 ' A' ' 51' ' ' LEU . 50.0 mt -81.59 126.48 39.85 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 108.66 -0.867 . . . . 72.42 108.66 174.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.721 ' HB3' HD11 ' A' ' 86' ' ' ILE . 91.8 m-85 -132.23 121.0 22.96 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.15 0.58 . . . . 73.4 109.961 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.3 m -84.97 97.44 9.8 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.903 -0.777 . . . . 75.3 108.903 174.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.721 HD11 ' HB3' ' A' ' 84' ' ' PHE . 3.5 mm -108.28 153.89 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 122.949 0.5 . . . . 62.31 109.994 -178.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -165.27 166.03 19.1 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.943 0.497 . . . . 74.23 111.261 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.45 -21.85 42.39 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 116.113 -0.494 . . . . 41.35 114.003 174.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.467 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -133.95 147.61 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.176 0.59 . . . . 64.45 111.535 -172.187 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -134.28 175.54 9.41 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.91 1.284 . . . . 71.32 109.439 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.62 -124.64 36.28 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.854 0.721 . . . . 54.11 113.828 175.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.0 t -71.19 -29.56 65.33 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.328 0.651 . . . . 62.41 111.741 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -69.33 -43.89 72.77 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.94 0.496 . . . . 52.1 110.324 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.5 tpt -66.79 -40.3 88.08 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.819 -0.628 . . . . 75.42 110.457 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.13 -32.59 74.36 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.236 0.614 . . . . 43.24 110.846 176.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -73.14 -30.94 63.96 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.343 0.657 . . . . 45.32 110.934 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.8 t -73.1 -51.6 17.4 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 109.27 -0.641 . . . . 64.24 109.27 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.2 mt -76.9 -26.9 54.68 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.427 0.691 . . . . 73.11 112.258 -174.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.437 ' HA2' HG21 ' A' ' 46' ' ' THR . . . -107.81 3.56 34.04 Favored Glycine 0 N--CA 1.468 0.815 0 CA-C-O 119.492 -0.616 . . . . 22.2 114.033 -171.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.477 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.72 -60.34 0.23 Allowed 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 117.671 0.736 . . . . 64.1 112.323 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.428 ' O ' HG12 ' A' ' 105' ' ' ILE . 73.5 t80 -66.44 -45.54 79.51 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.858 0.463 . . . . 75.54 111.509 -175.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.409 ' CB ' HG21 ' A' ' 58' ' ' VAL . 85.9 m -67.51 -46.79 47.85 Favored Pre-proline 0 CA--C 1.564 1.484 0 C-N-CA 124.381 1.072 . . . . 72.34 111.818 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -55.76 -34.17 90.13 Favored 'Trans proline' 0 C--N 1.397 3.126 0 C-N-CA 122.615 2.21 . . . . 61.1 113.523 168.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.403 ' HB3' ' O ' ' A' ' 101' ' ' TYR . 26.7 t-20 -63.42 -39.77 95.39 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.777 0.831 . . . . 61.01 110.499 176.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 101' ' ' TYR . 49.8 mm -66.41 -40.08 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.562 0.745 . . . . 74.44 110.212 174.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 68.9 mt -77.69 -22.38 50.58 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.244 -0.889 . . . . 62.21 112.5 -172.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -65.3 -42.33 58.13 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 114.291 1.219 . . . . 71.14 114.291 -172.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -53.2 -38.05 80.92 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 121.974 1.782 . . . . 72.1 113.12 171.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -82.03 -30.2 31.58 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.514 0.725 . . . . 70.32 111.651 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.85 -48.21 72.38 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.941 -0.763 . . . . 72.12 108.941 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.605 HH12 HD12 ' C' ' 105' ' ' ILE . 31.5 ttm180 -60.81 -39.86 90.54 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 113.741 -1.572 . . . . 71.52 110.088 176.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.4 ' HB2' ' HB3' ' C' ' 108' ' ' PRO . 14.5 tt0 -52.46 -56.37 15.54 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.376 1.07 . . . . 54.22 110.727 176.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 45.1 t -60.17 -47.82 84.31 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 113.945 -1.48 . . . . 45.05 111.206 -175.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.1 mt -63.22 -59.85 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.714 0.806 . . . . 73.34 110.926 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 92.4 m -49.1 -42.5 39.23 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 124.338 1.024 . . . . 74.23 112.226 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.3 t -68.9 -46.75 67.54 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.745 -1.116 . . . . 53.45 110.582 -178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.449 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 9.9 mtp -53.67 -44.34 69.61 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.917 0.887 . . . . 72.44 111.226 175.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 114' ' ' ILE . 97.0 t -59.63 -49.71 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-N 114.726 -1.125 . . . . 60.23 110.772 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.4 p -70.9 -28.55 64.62 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.98 -0.554 . . . . 71.42 111.62 -177.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.489 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.4 mtt-85 -71.03 -29.9 65.94 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.674 0.79 . . . . 75.52 110.123 176.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.409 ' O ' HG22 ' A' ' 122' ' ' THR . . . -86.07 23.05 10.0 Favored Glycine 0 C--N 1.352 1.46 0 CA-C-O 118.957 -0.913 . . . . 55.41 113.407 176.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.409 HG22 ' O ' ' A' ' 121' ' ' GLY . 4.1 t 57.36 10.71 0.97 Allowed 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 127.047 2.139 . . . . 54.32 113.853 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -81.17 144.02 53.61 Favored Pre-proline 0 C--O 1.242 0.709 0 N-CA-C 108.392 -0.966 . . . . 73.22 108.392 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.501 ' HB3' ' N ' ' E' ' 132' ' ' SER . 83.0 Cg_exo -49.15 146.57 12.59 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 123.138 2.559 . . . . 72.13 111.94 173.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -59.74 133.24 55.92 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.105 0.478 . . . . 64.21 111.595 -174.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.536 HD21 HG11 ' A' ' 64' ' ' VAL . 28.1 tp -118.03 110.1 17.26 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.658 1.183 . . . . 75.13 108.753 176.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.438 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 72.3 m-20 -100.44 126.39 46.83 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.525 -1.287 . . . . 75.21 107.525 172.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 13.5 mt -73.27 141.37 47.22 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 123.125 0.266 . . . . 74.33 110.303 -178.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -65.59 135.65 95.78 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.299 0.64 . . . . 63.44 110.822 177.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 36.3 Cg_exo -61.74 120.69 8.44 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 123.307 2.671 . . . . 65.32 112.833 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.499 HG21 HD11 ' A' ' 44' ' ' LEU . 84.4 t -103.4 136.77 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.538 0.735 . . . . 62.03 110.809 -178.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.479 ' ND2' ' HB2' ' A' ' 135' ' ' ALA . 37.2 t30 -94.61 90.38 6.12 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 108.327 -0.99 . . . . 75.13 108.327 172.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.438 ' CE1' HD13 ' A' ' 44' ' ' LEU . 93.5 m-85 -63.44 -28.67 70.13 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.091 0.957 . . . . 74.2 112.561 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.477 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 7.9 m-20 -63.41 -35.79 81.57 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.122 0.569 . . . . 72.53 110.626 176.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.479 ' HB2' ' ND2' ' A' ' 132' ' ' ASN . . . -65.19 -48.93 71.71 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 123.549 0.531 . . . . 74.34 110.053 171.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 62.3 mt -56.67 -39.29 73.49 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.808 0.843 . . . . 61.42 111.329 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.456 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 84.8 t80 -65.66 -48.35 72.42 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.301 -0.863 . . . . 73.22 110.252 176.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 90.7 mmm -63.17 -27.72 69.56 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.571 0.544 . . . . 71.24 111.434 -177.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -67.89 -54.56 17.85 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.161 -0.681 . . . . 74.42 109.161 171.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -56.53 -30.42 63.03 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-O 121.088 0.47 . . . . 75.33 111.968 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 28.8 tp -64.34 -48.35 75.88 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.597 1.159 . . . . 72.04 111.72 -176.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -154.97 29.88 0.41 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 114.554 1.316 . . . . 71.05 114.554 -171.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -73.56 -67.34 0.6 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.987 -0.746 . . . . 63.03 108.987 172.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -133.03 153.23 51.69 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.029 0.932 . . . . 53.01 109.126 173.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -78.06 79.55 4.52 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.441 0.696 . . . . 72.23 109.6 176.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.41 -61.69 0.65 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 111.041 -0.824 . . . . 75.31 111.041 -177.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -90.16 65.52 6.43 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.67 0.788 . . . . 74.33 110.235 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -88.77 66.47 3.13 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 110.35 -1.1 . . . . 71.44 110.35 175.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.6 m -73.24 140.92 47.21 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.252 0.621 . . . . 74.2 110.442 -175.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -78.62 73.6 5.17 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.349 1.06 . . . . 74.41 110.792 -177.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -162.97 153.6 16.63 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.762 1.225 . . . . 63.3 109.481 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 178.58 -174.02 0.16 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.042 0.937 . . . . 52.2 110.273 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -59.46 128.9 39.34 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.194 0.998 . . . . 72.52 108.637 168.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -50.12 99.87 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.175 1.39 . . . . 75.21 112.755 -175.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.257 0 CA-C-N 114.517 -1.22 . . . . 65.34 108.974 178.358 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mpp? . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 109.366 -0.605 . . . . 73.24 109.366 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 61.9 p -75.51 137.1 40.67 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.657 0.783 . . . . 62.13 109.343 176.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -98.16 138.01 36.09 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 109.452 -0.573 . . . . 73.02 109.452 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -93.82 44.94 1.13 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.797 0.839 . . . . 74.3 109.013 177.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -91.36 78.89 5.67 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.939 0.896 . . . . 42.35 108.956 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -84.25 139.84 32.07 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.201 -0.909 . . . . 54.1 111.068 -170.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.7 t -139.73 138.18 35.73 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.858 0.863 . . . . 72.15 108.68 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 63.74 35.23 11.46 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.459 1.104 . . . . 63.45 109.49 -174.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 25.6 ttt 65.65 165.98 0.18 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 125.343 1.457 . . . . 75.33 112.766 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 89.5 m -151.05 128.12 11.12 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.965 1.306 . . . . 74.01 107.694 171.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.46 ' CE1' ' HE2' ' B' ' 101' ' ' TYR . 0.1 OUTLIER -146.86 135.54 22.11 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.304 0.573 . . . . 71.4 110.252 179.115 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -131.09 130.05 42.67 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.819 1.248 . . . . 75.11 109.212 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 69.4 mt -73.24 127.49 35.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 108.357 -0.979 . . . . 71.51 108.357 170.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -92.42 -43.67 9.09 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 123.744 0.652 . . . . 75.34 109.595 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -174.27 135.84 0.46 Allowed 'General case' 0 C--N 1.352 0.71 0 CA-C-N 115.703 -0.68 . . . . 70.41 109.932 -173.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.486 HG21 ' CE1' ' B' ' 109' ' ' TYR . 80.7 mt -122.84 138.8 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.065 -1.087 . . . . 51.14 108.065 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -164.15 157.33 17.95 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.127 0.788 . . . . 72.44 113.127 -171.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 53.5 m -83.66 119.48 24.81 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.366 -1.288 . . . . 72.14 108.864 171.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.47 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 39.6 mtpt -91.81 -24.98 19.21 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.658 0.783 . . . . 71.23 111.522 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -159.57 142.76 14.25 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 123.387 0.429 . . . . 71.13 111.02 -175.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.422 HD11 ' SG ' ' B' ' 113' ' ' CYS . 48.6 mm -134.37 144.19 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.939 1.295 . . . . 63.43 108.321 171.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 29.5 t -147.68 134.45 20.04 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.221 1.009 . . . . 63.44 108.35 171.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -134.87 131.89 37.91 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.979 -1.489 . . . . 74.1 106.979 167.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -132.69 125.39 30.18 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.177 -1.046 . . . . 54.13 108.177 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.572 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -114.75 87.37 14.55 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 106.899 -1.519 . . . . 61.43 106.899 164.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.39 -35.04 74.89 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.554 2.17 . . . . 72.14 111.228 -173.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -110.29 14.93 22.59 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.47 -1.241 . . . . 53.13 110.742 -175.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.593 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -31.63 -66.3 0.19 Allowed Pre-proline 0 N--CA 1.493 1.715 0 C-N-CA 125.951 1.701 . . . . 62.41 115.278 -172.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 24.8 Cg_exo -60.83 -36.51 83.62 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 122.457 2.105 . . . . 71.31 113.269 -167.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -93.31 -32.22 14.39 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.403 0.52 . . . . 74.11 112.403 -174.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.673 HG22 HD12 ' B' ' 68' ' ' LEU . 7.2 p -67.6 -11.69 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-N 118.209 0.458 . . . . 74.24 111.534 -173.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -74.1 -15.09 61.06 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.868 0.867 . . . . 75.41 112.976 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -61.54 -28.91 69.66 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.476 0.655 . . . . 42.34 109.543 172.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -88.91 105.17 17.58 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.894 1.278 . . . . 70.45 109.451 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -113.43 99.18 7.57 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.625 -0.88 . . . . 65.13 108.625 172.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 11.2 p90 -160.71 -172.78 3.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.368 -0.975 . . . . 75.24 108.368 170.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -73.84 107.3 3.32 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.353 0.661 . . . . 74.34 111.014 175.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' F' ' 129' ' ' THR . 37.9 Cg_endo -68.11 143.65 60.36 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 121.533 1.488 . . . . 74.12 110.5 178.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.23 101.46 1.19 Allowed 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.543 -0.91 . . . . 74.44 108.543 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.423 HG11 HD11 ' B' ' 126' ' ' LEU . 33.9 t -91.78 144.71 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 114.245 -1.343 . . . . 74.43 109.695 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.15 119.65 10.35 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.067 -1.827 . . . . 43.15 106.067 -175.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 20.9 tp -95.06 147.23 23.64 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.625 0.77 . . . . 74.52 109.362 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.564 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 13.0 t70 -140.62 134.29 30.25 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.692 -1.225 . . . . 62.24 107.692 -175.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 64.3 mt -128.0 126.27 41.02 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.632 -0.877 . . . . 53.23 108.632 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 19.5 t70 -126.1 119.79 28.48 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.369 1.067 . . . . 74.32 108.612 -173.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.8 p -110.29 102.95 11.57 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.33 0.652 . . . . 74.14 111.516 -169.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.73 136.83 51.11 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.135 0.974 . . . . 44.54 108.554 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.1 p -139.86 175.86 9.23 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.418 0.687 . . . . 60.14 109.721 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 75.3 p -157.12 140.15 15.34 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.093 0.557 . . . . 75.15 110.337 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.547 ' HB2' HD23 ' F' ' 102' ' ' LEU . 63.2 tt0 -94.87 128.46 41.65 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.617 -0.883 . . . . 74.13 108.617 172.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.91 16.41 2.48 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.72 0.808 . . . . 55.42 110.923 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.74 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -173.67 165.12 4.49 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.819 1.248 . . . . 73.13 109.73 173.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.45 119.24 13.41 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.884 -0.784 . . . . 54.52 108.884 176.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 69.16 -5.63 1.05 Allowed 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 124.687 1.195 . . . . 63.13 113.145 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.74 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 44.4 t -119.57 97.49 5.26 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.226 -1.028 . . . . 75.13 108.226 -172.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.64 ' HE1' HD12 ' B' ' 86' ' ' ILE . 54.4 p90 -99.23 -176.86 3.43 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 114.556 -1.202 . . . . 73.45 109.207 177.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.453 ' HG3' ' HG3' ' A' ' 29' ' ' PRO . 5.5 tm-20 -138.69 107.2 5.85 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 106.383 -1.71 . . . . 70.45 106.383 173.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 14.8 p -101.0 135.03 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 109.863 -0.421 . . . . 74.24 109.863 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 29.9 t -109.38 115.23 49.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 123.754 0.821 . . . . 53.44 108.955 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 54.5 tp -93.89 101.13 13.2 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.378 -0.971 . . . . 52.51 108.378 170.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.586 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 14.1 ttm-85 -87.33 116.82 25.69 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.681 -0.859 . . . . 74.35 108.681 172.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.37 125.9 66.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.029 -1.1 . . . . 72.23 108.029 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.564 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 8.7 m -121.84 131.67 54.17 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.242 -0.651 . . . . 73.13 109.242 178.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.707 HG11 HD21 ' B' ' 126' ' ' LEU . 56.7 t -115.88 125.2 72.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 124.569 1.148 . . . . 75.11 109.131 176.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 88.9 m -105.06 138.72 40.82 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.463 -0.94 . . . . 71.25 108.463 164.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.19 144.27 33.32 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 107.96 -1.126 . . . . 71.12 107.96 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.51 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 49.6 p -144.7 134.26 23.34 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.388 0.43 . . . . 64.41 111.978 -171.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.673 HD12 HG22 ' B' ' 31' ' ' VAL . 70.6 mt -102.61 99.57 9.58 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.487 -0.931 . . . . 73.23 108.487 175.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.05 -134.3 14.18 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.991 -0.549 . . . . 73.22 112.364 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -82.32 3.55 27.29 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.26 0.624 . . . . 75.13 112.515 -177.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -128.76 150.68 50.19 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.789 0.435 . . . . 72.05 111.767 -174.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 68.3 m -68.7 128.43 36.62 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.418 -0.81 . . . . 71.24 110.36 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.51 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -80.14 -59.28 2.77 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.366 -0.976 . . . . 62.5 108.366 176.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -152.51 157.85 41.71 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 114.701 -1.136 . . . . 74.11 111.437 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 98.2 mt -125.15 113.58 17.88 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.682 1.593 . . . . 75.35 107.262 171.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.9 t -118.39 140.14 50.31 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.177 -1.045 . . . . 75.44 108.177 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -151.22 127.64 10.68 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.813 -0.81 . . . . 72.34 108.813 -174.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 90.4 t -124.44 147.71 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 123.942 0.897 . . . . 42.05 108.83 177.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -120.74 106.38 11.64 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.477 -1.305 . . . . 74.14 107.477 168.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 48.1 tp60 -98.41 101.3 12.7 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.504 -1.295 . . . . 45.22 107.504 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.4 159.57 22.56 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 111.062 -0.815 . . . . 71.25 111.062 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.9 132.61 3.12 Favored Glycine 0 C--O 1.239 0.446 0 C-N-CA 121.718 -0.277 . . . . 72.42 112.411 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 54.6 mt -91.66 108.13 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 108.497 -0.927 . . . . 72.22 108.497 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -119.47 143.89 47.28 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.159 -1.052 . . . . 75.35 108.159 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 15.8 m -115.17 114.23 25.0 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.476 -0.935 . . . . 75.13 108.476 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.64 HD12 ' HE1' ' B' ' 56' ' ' TYR . 0.2 OUTLIER -115.56 142.22 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.359 -0.978 . . . . 61.4 108.359 178.559 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.38 168.6 26.83 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.981 0.512 . . . . 65.1 110.622 -177.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.86 -44.92 2.69 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.966 -0.561 . . . . 72.03 111.895 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.455 HD13 ' HB2' ' B' ' 94' ' ' MET . 1.0 OUTLIER -81.74 157.25 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.5 1.12 . . . . 63.03 111.261 178.131 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.47 ' HA ' ' SD ' ' B' ' 94' ' ' MET . 9.7 mp0 -145.9 177.95 8.55 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.483 1.113 . . . . 73.01 109.605 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.62 -125.42 23.07 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.127 -0.942 . . . . 73.42 113.81 173.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 27.2 m -79.27 -45.39 19.83 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.703 0.801 . . . . 51.22 110.724 -178.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -67.47 -28.91 68.25 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 113.953 -1.476 . . . . 52.34 111.886 -166.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.47 ' SD ' ' HA ' ' B' ' 90' ' ' GLU . 26.9 ptt? -64.34 -47.49 79.15 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.227 0.611 . . . . 72.53 111.373 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.477 ' HA ' ' HG ' ' B' ' 98' ' ' LEU . . . -81.0 -13.34 58.96 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.996 0.919 . . . . 41.24 112.186 -175.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -64.74 -32.13 73.67 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.655 0.382 . . . . 72.0 110.277 170.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 97' ' ' CYS . . . . . 0.408 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 48.0 t -67.51 -30.92 70.72 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.584 0.754 . . . . 64.31 111.53 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.763 HD21 HD11 ' F' ' 100' ' ' LEU . 4.0 pp -101.38 -24.48 14.19 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 112.942 0.719 . . . . 73.5 112.942 -175.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.76 -26.24 61.09 Favored Glycine 0 C--N 1.338 0.671 0 O-C-N 123.584 0.553 . . . . 40.4 112.736 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.08 -49.75 0.33 Allowed 'General case' 0 C--O 1.242 0.671 0 N-CA-C 112.568 0.581 . . . . 53.33 112.568 -165.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.46 ' HE2' ' CE1' ' B' ' 11' ' ' PHE . 16.0 t80 -68.02 -48.75 64.83 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.69 0.796 . . . . 64.02 112.155 -174.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 98.1 m -73.69 -37.94 3.74 Favored Pre-proline 0 CA--C 1.557 1.238 0 N-CA-C 112.627 0.603 . . . . 41.43 112.627 -177.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -51.43 -31.49 38.87 Favored 'Trans proline' 0 C--N 1.387 2.553 0 C-N-CA 122.399 2.066 . . . . 72.45 114.181 162.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -68.89 -25.41 64.59 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 122.767 0.427 . . . . 74.44 111.504 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.497 HG23 ' NH2' ' D' ' 111' ' ' ARG . 71.5 mt -69.05 -39.8 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 121.336 0.589 . . . . 71.54 109.413 170.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.457 ' CD2' HG23 ' B' ' 16' ' ' ILE . 70.3 mt -77.09 -24.6 51.8 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.689 1.196 . . . . 72.43 111.893 -177.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -59.18 -53.71 63.58 Favored Pre-proline 0 N--CA 1.484 1.248 0 N-CA-C 113.822 1.045 . . . . 65.14 113.822 -171.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.16 -30.56 55.26 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 121.62 1.547 . . . . 75.21 111.98 -177.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.486 ' CE1' HG21 ' B' ' 16' ' ' ILE . 2.4 m-30 -64.54 -47.8 77.46 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.02 0.928 . . . . 72.53 110.058 176.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.18 -40.57 97.9 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.026 0.93 . . . . 71.55 110.747 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.4 ttt-85 -64.69 -46.34 82.79 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.225 1.41 . . . . 74.42 110.861 -175.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.38 -35.06 77.15 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 123.776 0.673 . . . . 64.22 109.454 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.496 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.4 t -68.99 -35.51 76.8 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.891 0.476 . . . . 44.31 111.157 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.446 HD13 HG23 ' B' ' 64' ' ' VAL . 49.2 mt -62.89 -56.88 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.649 0.78 . . . . 72.43 109.339 173.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 18.1 m -59.63 -28.21 67.02 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.941 0.896 . . . . 55.03 111.459 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.7 t -66.25 -51.45 57.42 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.981 0.912 . . . . 54.04 110.3 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.496 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.5 mmt -70.14 -29.98 67.03 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.183 0.593 . . . . 73.12 111.245 -176.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 77.6 t -67.95 -41.86 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.513 1.125 . . . . 72.21 110.389 172.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.7 t -67.69 -32.03 72.41 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.604 -0.726 . . . . 75.31 110.341 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' B' ' 116' ' ' SER . 70.3 mtt-85 -69.74 -42.59 73.74 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 115.688 -0.687 . . . . 73.41 109.162 175.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.12 -10.82 62.81 Favored Glycine 0 C--N 1.358 1.801 0 O-C-N 123.736 0.648 . . . . 75.53 112.639 172.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 8.9 m 68.75 23.1 7.11 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 125.762 1.625 . . . . 63.33 110.973 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -78.96 164.26 55.96 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 124.019 0.927 . . . . 73.24 111.341 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -45.28 147.56 2.35 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 123.839 3.026 . . . . 72.01 114.85 172.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' F' ' 129' ' ' THR . 54.4 tp60 -59.95 113.29 2.23 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.272 1.029 . . . . 72.01 112.512 -172.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.707 HD21 HG11 ' B' ' 64' ' ' VAL . 28.5 tp -107.71 104.72 14.3 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.151 0.58 . . . . 73.4 109.457 -172.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -111.49 120.9 43.7 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.442 -0.947 . . . . 74.22 108.442 175.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.437 HD21 ' CG2' ' B' ' 64' ' ' VAL . 57.9 mt -78.14 149.29 33.82 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 110.296 -0.261 . . . . 74.43 110.296 175.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.61 143.39 84.9 Favored Pre-proline 0 CA--C 1.55 0.961 0 O-C-N 123.503 0.502 . . . . 43.14 111.238 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.61 81.76 0.76 Allowed 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 123.345 2.697 . . . . 70.42 112.191 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.17 110.68 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 121.402 0.62 . . . . 61.32 109.423 177.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -86.17 111.61 20.54 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.692 -1.225 . . . . 65.14 107.692 171.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -64.26 -29.92 70.99 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.564 -0.744 . . . . 75.33 110.931 -171.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -61.71 -33.42 73.99 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.936 0.895 . . . . 74.42 111.546 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.82 -47.59 82.78 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 124.008 0.818 . . . . 72.1 111.018 175.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.615 HD22 HD23 ' F' ' 111' ' ' LEU . 7.1 mp -63.76 -39.73 94.97 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.029 0.532 . . . . 74.31 110.826 -177.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.468 ' HE1' HD11 ' F' ' 111' ' ' LEU . 5.7 m-85 -64.68 -44.2 91.12 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.268 0.627 . . . . 71.43 110.48 174.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 138' ' ' MET . . . . . 0.521 ' O ' ' HB3' ' B' ' 142' ' ' GLN . 48.3 tpp -74.72 -13.06 60.56 Favored 'General case' 0 C--O 1.208 -1.083 0 CA-C-N 115.555 -0.748 . . . . 44.31 110.977 -176.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -74.74 -34.01 62.45 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 118.399 0.545 . . . . 75.21 110.242 174.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -90.88 -26.43 19.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.397 0.679 . . . . 75.34 110.858 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 96.0 mt -108.37 22.85 15.37 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.012 0.925 . . . . 70.12 111.237 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 142' ' ' GLN . . . . . 0.521 ' HB3' ' O ' ' B' ' 138' ' ' MET . 13.6 pt20 -79.63 177.9 8.54 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.54 0.686 . . . . 71.34 111.791 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -152.17 -171.0 3.8 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.663 -1.153 . . . . 73.42 109.019 175.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -66.05 -16.01 63.55 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.424 0.69 . . . . 42.02 111.654 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.71 103.38 0.11 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.247 1.019 . . . . 45.2 111.373 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.07 34.95 0.03 OUTLIER Glycine 0 C--N 1.342 0.864 0 CA-C-N 115.336 -0.847 . . . . 75.43 111.083 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -147.26 142.37 27.13 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.358 1.063 . . . . 71.12 109.735 -174.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 116.02 76.97 0.65 Allowed Glycine 0 C--N 1.352 1.467 0 O-C-N 123.428 0.455 . . . . 75.02 112.731 177.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 8.8 t -148.07 127.7 13.31 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.662 -0.866 . . . . 72.12 108.662 172.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -161.33 122.61 2.85 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.492 -0.559 . . . . 61.44 109.492 -173.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -160.49 96.84 1.18 Allowed 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.443 0.697 . . . . 72.52 109.175 167.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -80.16 72.74 6.98 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.508 0.723 . . . . 74.42 111.706 -176.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -154.79 113.73 3.62 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.284 0.634 . . . . 72.13 109.482 176.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -81.29 -32.12 33.31 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.673 0.789 . . . . 74.21 111.07 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.406 0 C-N-CA 123.615 0.766 . . . . 63.2 109.157 179.062 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.954 0 CA-C-O 121.674 0.75 . . . . 71.44 110.755 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 30.8 t -161.28 109.8 1.54 Allowed 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.336 -0.987 . . . . 64.21 108.336 175.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -78.99 -174.67 4.15 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.426 0.69 . . . . 74.11 111.647 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -136.18 124.37 23.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.986 0.915 . . . . 70.24 109.691 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -149.8 153.39 36.72 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.869 0.868 . . . . 71.32 108.878 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -62.55 -40.86 98.19 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.659 0.784 . . . . 73.24 109.892 174.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 4.9 t -108.81 77.43 1.07 Allowed 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 122.573 1.177 . . . . 63.13 108.766 171.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -97.89 -60.7 1.51 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.751 -1.113 . . . . 64.31 109.911 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.607 ' HE3' HG21 ' C' ' 89' ' ' ILE . 54.5 ttm 63.26 114.97 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.547 1.539 . . . . 75.24 111.354 -171.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 20.2 m -103.78 95.44 6.03 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.585 -0.894 . . . . 61.11 108.585 171.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -110.74 139.96 45.56 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.799 0.839 . . . . 63.12 109.074 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -151.59 124.62 8.66 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.989 -0.745 . . . . 64.35 108.989 174.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.417 ' HA ' ' HD2' ' C' ' 84' ' ' PHE . 53.0 mt -70.11 135.0 29.1 Favored 'Isoleucine or valine' 0 C--N 1.349 0.586 0 N-CA-C 108.45 -0.945 . . . . 72.03 108.45 174.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -97.5 -47.71 5.56 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.273 -0.64 . . . . 73.31 109.273 176.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.438 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 11.8 ptm180 -179.01 143.02 0.2 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.288 1.035 . . . . 74.34 109.255 -176.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.406 ' O ' HD12 ' C' ' 16' ' ' ILE . 2.4 pp -120.31 146.8 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 107.363 -1.347 . . . . 73.02 107.363 171.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.457 ' HB3' HG23 ' D' ' 122' ' ' THR . 28.6 p90 -170.78 154.58 4.4 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.201 0.524 . . . . 64.51 111.943 -168.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.0 p -81.01 109.24 15.4 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.216 -0.902 . . . . 71.44 108.848 173.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -77.3 -29.78 53.84 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.186 -0.672 . . . . 74.5 109.186 173.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.665 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 22.5 t70 -146.07 143.77 29.6 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.905 -1.043 . . . . 73.45 109.663 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 99.3 mt -137.92 145.34 29.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 125.237 1.415 . . . . 73.25 107.389 173.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.3 t -152.91 146.05 24.67 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.129 0.571 . . . . 73.55 109.723 175.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -147.48 118.58 7.74 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 107.861 -1.162 . . . . 62.31 107.861 170.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -120.79 113.48 20.23 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.073 0.949 . . . . 75.12 108.981 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.63 87.81 7.02 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 106.446 -1.687 . . . . 73.14 106.446 169.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.89 -42.67 23.35 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.845 2.363 . . . . 72.12 112.042 -170.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -113.06 35.53 3.89 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.759 -1.109 . . . . 71.12 109.239 -177.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.463 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -43.92 -53.27 13.34 Favored Pre-proline 0 C--N 1.373 1.604 0 C-N-CA 124.915 1.286 . . . . 61.22 114.113 -176.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.96 -50.88 7.91 Favored 'Trans proline' 0 C--N 1.39 2.749 0 C-N-CA 121.521 1.481 . . . . 74.32 111.906 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -70.04 -28.07 65.17 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.309 -1.314 . . . . 74.1 113.016 -173.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.723 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.0 p -77.79 -23.88 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 112.235 0.458 . . . . 64.22 112.235 -175.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -71.9 -21.27 61.66 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 112.118 0.414 . . . . 71.32 112.118 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -93.54 16.35 13.89 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.027 0.531 . . . . 75.4 111.016 175.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.794 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -104.17 154.01 20.27 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.748 0.819 . . . . 55.22 109.974 176.111 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -72.4 130.78 41.5 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.31 0.644 . . . . 64.03 109.711 171.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -85.39 90.24 7.89 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.819 0.848 . . . . 74.1 112.2 -171.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -145.7 77.52 12.32 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 124.675 1.19 . . . . 74.54 108.907 170.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -91.53 165.77 3.47 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.758 2.305 . . . . 71.14 113.562 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 39' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' C' ' 67' ' ' SER . 7.4 pt-20 -87.97 100.56 13.0 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.969 -1.122 . . . . 72.52 107.969 166.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 42.0 t -79.89 98.59 3.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.549 -0.908 . . . . 61.52 108.549 177.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -93.06 102.52 14.85 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.068 -1.456 . . . . 71.12 107.068 175.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 tt -87.78 138.21 31.66 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 106.817 -1.549 . . . . 70.35 106.817 176.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.467 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 36.0 t70 -131.56 134.71 46.36 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.053 0.941 . . . . 65.13 108.85 -175.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 96.2 mt -128.54 114.48 16.79 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.602 0.761 . . . . 62.44 110.018 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -117.12 120.75 39.29 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.671 -1.233 . . . . 71.14 107.671 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 10.1 t -118.24 149.24 41.45 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 109.778 -0.453 . . . . 53.52 109.778 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.17 149.12 26.72 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.572 0.749 . . . . 75.03 109.359 174.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 14.3 m -123.77 152.53 42.09 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.122 -0.696 . . . . 53.44 109.122 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 72.9 p -154.61 127.37 8.11 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.506 -0.924 . . . . 70.51 108.506 177.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -79.62 117.7 20.78 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.994 -0.743 . . . . 63.44 108.994 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.675 HD11 ' HB2' ' C' ' 57' ' ' GLU . 41.5 mt -83.55 -44.76 14.3 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.492 0.717 . . . . 75.0 110.273 -176.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.99 -176.55 4.72 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.449 -0.796 . . . . 44.21 109.691 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.08 107.77 0.59 Allowed 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.786 -1.097 . . . . 72.12 110.505 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 54' ' ' ASP . . . . . 0.418 ' HB2' HG13 ' E' ' 144' ' ' VAL . 1.3 m-20 64.38 25.31 13.38 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.452 1.101 . . . . 75.21 112.113 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 87.9 t -119.05 114.77 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.328 -0.989 . . . . 73.14 108.328 174.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -117.81 125.55 50.78 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.354 1.062 . . . . 74.53 109.291 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.675 ' HB2' HD11 ' C' ' 51' ' ' LEU . 37.4 tt0 -91.17 117.71 29.84 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.246 -0.65 . . . . 64.22 109.246 168.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.8 t -99.61 142.02 15.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.083 -1.08 . . . . 65.35 108.083 169.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 90.5 t -127.4 144.08 38.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.786 -0.82 . . . . 72.21 108.786 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.42 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -130.37 99.02 4.87 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 107.848 -1.168 . . . . 73.02 107.848 177.61 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -82.52 110.78 17.93 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.369 0.668 . . . . 72.22 109.41 171.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 39.6 t -108.52 122.77 63.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.698 -0.853 . . . . 73.33 108.698 178.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 16.8 m -126.1 127.48 45.86 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.449 0.7 . . . . 65.11 109.521 -176.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 60.2 t -114.36 112.11 38.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 124.165 0.986 . . . . 72.01 108.893 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 11.2 m -98.12 135.86 39.18 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.457 -1.312 . . . . 75.33 107.457 171.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.71 118.22 17.86 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.225 -1.398 . . . . 62.02 107.225 -175.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 67' ' ' SER . . . . . 0.41 ' O ' ' HG2' ' C' ' 39' ' ' GLU . 50.5 m -133.9 130.89 38.43 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.194 0.521 . . . . 73.11 110.545 178.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.794 HD13 ' HG2' ' C' ' 34' ' ' LYS . 14.2 mt -88.48 39.48 0.91 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.624 1.169 . . . . 72.31 109.626 174.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.91 -106.22 2.66 Favored Glycine 0 C--N 1.353 1.474 0 CA-C-N 115.823 -0.626 . . . . 63.44 111.701 -173.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -90.24 -30.05 17.79 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.792 -0.818 . . . . 71.13 108.792 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -65.76 121.05 14.14 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 114.713 -1.131 . . . . 73.1 109.435 169.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 89.8 m -83.97 120.65 26.36 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.124 -1.065 . . . . 71.24 108.124 164.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.723 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -67.41 -58.57 4.52 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 123.945 0.778 . . . . 51.12 109.139 175.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -165.13 176.57 8.39 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 121.984 0.897 . . . . 72.41 111.078 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.452 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.1 tm? -134.84 145.35 48.23 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 105.766 -1.939 . . . . 74.42 105.766 170.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.473 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.2 t -147.82 141.88 25.99 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.878 -1.156 . . . . 73.15 107.878 174.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -150.88 131.54 13.97 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.473 -0.566 . . . . 42.13 109.473 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 75.8 t -131.76 114.05 24.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.345 -0.983 . . . . 75.24 108.345 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.665 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.7 mt-30 -90.49 86.14 6.34 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.417 -0.957 . . . . 71.14 108.417 173.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -79.01 102.15 8.19 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.225 -1.352 . . . . 75.24 108.88 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.9 159.44 32.9 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 111.475 -0.65 . . . . 62.51 111.475 172.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.69 116.73 0.73 Allowed Glycine 0 CA--C 1.507 -0.428 0 N-CA-C 111.317 -0.713 . . . . 75.21 111.317 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.503 HD12 HD11 ' C' ' 51' ' ' LEU . 17.2 mm -84.4 132.42 31.61 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 N-CA-C 108.778 -0.823 . . . . 63.32 108.778 178.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.417 ' HD2' ' HA ' ' C' ' 13' ' ' ILE . 66.0 m-85 -135.66 139.07 43.44 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.483 0.713 . . . . 75.44 109.837 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 21.7 p -99.01 104.0 16.0 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.809 -1.182 . . . . 72.34 107.809 169.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.418 HG21 HD11 ' C' ' 89' ' ' ILE . 46.1 mt -115.72 132.62 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.898 0.879 . . . . 73.31 109.128 -176.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.83 164.46 33.58 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 122.902 0.481 . . . . 61.0 111.187 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.83 -41.75 2.71 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 115.353 -0.84 . . . . 75.32 113.392 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.607 HG21 ' HE3' ' C' ' 9' ' ' MET . 39.7 pt -85.98 168.84 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.274 0.629 . . . . 75.44 111.787 -174.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -164.5 168.23 18.58 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.981 1.312 . . . . 71.42 108.339 176.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.22 -119.46 11.7 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.805 -0.441 . . . . 62.51 112.982 171.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 69.9 p -69.0 -41.78 77.36 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.134 0.574 . . . . 73.34 110.644 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -61.93 -46.51 89.01 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.519 0.728 . . . . 72.11 110.9 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.434 ' HE3' ' HA ' ' C' ' 94' ' ' MET . 5.4 tpt -59.74 -51.45 69.69 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 123.734 0.646 . . . . 63.12 111.579 177.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.26 -40.88 97.67 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.68 0.612 . . . . 55.53 111.319 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -72.36 -34.54 68.06 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.901 -1.045 . . . . 71.04 111.119 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -65.11 -42.5 93.89 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.317 0.58 . . . . 65.12 109.885 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.44 -37.24 37.49 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.798 -1.092 . . . . 64.45 112.78 -175.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.78 11.66 45.81 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-O 119.429 -0.65 . . . . 42.31 114.597 -167.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.548 ' HB2' ' HB2' ' C' ' 137' ' ' PHE . . . -155.95 -56.67 0.09 Allowed 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 117.827 0.814 . . . . 65.3 111.385 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -63.7 -56.17 17.72 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.617 0.767 . . . . 70.4 111.815 -175.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.467 ' O ' HD13 ' C' ' 106' ' ' LEU . 85.5 m -65.25 -47.3 71.38 Favored Pre-proline 0 CA--C 1.561 1.397 0 C-N-CA 123.925 0.89 . . . . 62.12 112.371 -177.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.42 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 53.7 Cg_exo -55.66 -30.53 75.71 Favored 'Trans proline' 0 C--N 1.397 3.092 0 C-N-CA 122.44 2.093 . . . . 52.24 113.628 173.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -70.18 -28.71 65.54 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.289 0.636 . . . . 64.22 111.116 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.605 HD12 HH12 ' A' ' 111' ' ' ARG . 33.8 mm -77.91 -32.27 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 123.163 0.585 . . . . 71.35 109.971 175.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.467 HD13 ' O ' ' C' ' 102' ' ' CYS . 7.3 mp -78.4 -27.55 46.75 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.05 0.94 . . . . 55.41 111.578 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -56.82 -49.81 91.7 Favored Pre-proline 0 N--CA 1.48 1.069 0 CA-C-O 117.556 -1.212 . . . . 74.02 113.672 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 108' ' ' PRO . . . . . 0.4 ' HB3' ' HB2' ' A' ' 112' ' ' GLU . 97.3 Cg_exo -50.91 -40.68 57.83 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.72 2.28 . . . . 64.44 114.674 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.494 ' OH ' ' HG2' ' A' ' 111' ' ' ARG . 89.2 m-85 -79.15 -37.44 38.47 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.263 0.625 . . . . 71.21 111.455 -175.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.64 96.26 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.436 -0.802 . . . . 75.45 109.956 173.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 34.6 ttt-85 -62.97 -50.9 68.98 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.579 1.551 . . . . 75.41 110.394 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -60.67 -40.8 93.44 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.094 0.871 . . . . 72.13 110.126 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 31.8 t -72.33 -32.18 66.29 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.709 -0.678 . . . . 62.44 111.212 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.473 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 44.2 mt -69.1 -53.35 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.905 -0.406 . . . . 73.31 109.905 174.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 22.5 m -62.62 -28.98 70.27 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.442 0.697 . . . . 73.44 111.196 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 37.6 t -67.51 -49.21 64.48 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.254 0.622 . . . . 62.12 109.348 173.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.525 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.39 -39.79 84.48 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 124.432 1.093 . . . . 64.34 112.402 179.838 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.417 HG23 ' O ' ' C' ' 114' ' ' ILE . 93.7 t -65.23 -43.99 95.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.73 0.812 . . . . 62.15 110.223 176.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 22.0 t -66.07 -29.87 70.28 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.067 -0.97 . . . . 43.31 111.577 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.41 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 88.1 mtt-85 -73.02 -39.82 65.68 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.603 0.761 . . . . 72.14 109.506 177.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.61 -0.79 68.99 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 123.895 0.747 . . . . 63.41 112.522 171.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.0 p 63.4 32.17 14.66 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.823 2.049 . . . . 75.0 113.384 170.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -83.98 149.83 57.16 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 108.027 -1.101 . . . . 64.23 108.027 166.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.06 161.06 5.37 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 123.3 2.667 . . . . 62.51 113.96 176.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -58.55 113.57 2.06 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.751 0.82 . . . . 72.21 112.222 -172.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 50.8 tp -109.35 87.83 2.59 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.924 -1.034 . . . . 61.4 108.254 173.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -90.2 106.7 18.66 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.175 -1.046 . . . . 73.21 108.175 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 86.5 mt -64.45 129.25 39.16 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.41 0.684 . . . . 61.44 110.618 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.07 151.2 96.11 Favored Pre-proline 0 CA--C 1.553 1.076 0 O-C-N 124.34 1.025 . . . . 73.55 111.089 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.87 116.71 3.4 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.15 2.566 . . . . 55.42 112.853 177.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 28.9 t -99.35 133.22 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.042 -0.725 . . . . 72.24 109.042 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -87.64 96.47 10.44 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.745 0.818 . . . . 63.45 109.169 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -68.92 -24.58 64.31 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.396 0.679 . . . . 75.44 112.085 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -66.13 -41.15 90.88 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 109.076 -0.713 . . . . 61.01 109.076 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.79 -39.98 95.91 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.303 -0.862 . . . . 72.11 110.819 175.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 77.2 mt -67.6 -26.23 66.16 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.551 -0.75 . . . . 64.13 111.012 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 137' ' ' PHE . . . . . 0.548 ' HB2' ' HB2' ' C' ' 100' ' ' ALA . 34.5 t80 -78.8 -27.01 44.39 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 120.613 0.244 . . . . 70.22 110.878 176.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 62.7 mtt -65.59 -36.88 85.05 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.352 -0.61 . . . . 71.32 109.352 170.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -71.79 -33.39 68.53 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.858 0.863 . . . . 75.34 111.743 173.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -51.23 -83.49 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.512 1.125 . . . . 73.0 110.701 176.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 33.9 tp -133.36 92.64 3.03 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.253 -0.647 . . . . 63.15 109.253 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -77.88 82.32 4.26 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.458 -0.941 . . . . 71.51 108.458 172.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -141.4 -14.03 0.88 Allowed 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.066 -1.424 . . . . 62.03 108.88 178.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -147.32 168.53 21.53 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 123.852 0.861 . . . . 64.14 110.957 -171.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.74 -179.06 6.94 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.714 1.205 . . . . 63.42 109.075 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 165.22 101.01 0.15 Allowed Glycine 0 C--N 1.342 0.867 0 N-CA-C 111.499 -0.64 . . . . 51.03 111.499 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.44 127.61 12.05 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.324 -0.991 . . . . 73.25 108.324 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -169.95 58.17 0.19 Allowed Glycine 0 C--N 1.344 0.974 0 N-CA-C 111.789 -0.524 . . . . 74.31 111.789 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 13.2 p -67.46 95.9 0.48 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.359 0.664 . . . . 51.42 110.66 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -90.87 -171.77 3.13 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.461 1.104 . . . . 70.23 110.006 176.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -141.71 141.39 33.3 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.141 -1.059 . . . . 71.54 108.141 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -156.09 77.01 0.94 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.967 0.907 . . . . 72.01 110.092 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -78.67 171.44 15.14 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 115.2 -0.909 . . . . 72.42 111.113 174.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -165.96 98.17 0.64 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.155 -0.684 . . . . 45.53 109.155 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.318 -0.849 . . . . 72.14 109.212 -175.771 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 109.868 -0.419 . . . . 74.23 109.868 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 38.0 m -149.87 106.89 3.57 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.081 0.952 . . . . 64.41 108.86 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.42 79.33 1.2 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 109.475 -0.565 . . . . 73.42 109.475 -176.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -136.75 46.84 2.19 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 107.428 -1.323 . . . . 71.12 107.428 167.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -127.37 127.41 44.16 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.306 -0.861 . . . . 65.13 109.455 -176.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -93.57 -31.8 14.38 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.022 0.929 . . . . 74.43 109.749 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 6.3 m -71.96 161.25 31.2 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 123.92 0.888 . . . . 73.22 110.13 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 73.15 122.71 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.185 1.394 . . . . 75.3 111.014 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -33.76 123.14 0.45 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.613 1.165 . . . . 72.23 111.736 172.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.421 HG22 ' HB3' ' D' ' 87' ' ' ALA . 10.2 t -119.18 140.74 49.69 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.941 0.4 . . . . 33.54 110.286 -176.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -133.37 111.2 10.58 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.642 -1.244 . . . . 74.11 107.642 173.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -136.4 139.64 42.61 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.086 0.954 . . . . 63.2 108.655 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.506 HG21 HD11 ' D' ' 16' ' ' ILE . 7.4 mt -100.2 142.02 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 108.717 -0.846 . . . . 61.1 108.717 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -103.45 -34.6 8.65 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.324 0.65 . . . . 75.53 111.483 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -169.42 137.13 1.8 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.015 0.376 . . . . 72.14 112.015 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.506 HD11 HG21 ' D' ' 13' ' ' ILE . 3.5 mp -115.66 140.09 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 107.216 -1.402 . . . . 65.55 107.216 170.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.43 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 38.3 p90 -168.72 171.08 8.92 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.977 0.911 . . . . 73.31 110.15 176.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -98.41 117.83 33.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.888 -1.051 . . . . 71.25 109.089 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.43 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 22.4 mtpt -85.79 -25.8 26.15 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.721 -0.844 . . . . 65.01 108.721 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.629 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 26.6 t70 -155.68 136.87 13.83 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.648 -1.16 . . . . 74.0 109.576 -178.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.525 HG21 ' HE2' ' C' ' 117' ' ' MET . 67.9 mt -136.59 146.84 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.326 1.05 . . . . 71.15 109.019 174.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -145.5 141.25 28.13 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.608 1.163 . . . . 72.21 109.515 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.492 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.1 t80 -145.67 134.52 22.44 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 106.415 -1.698 . . . . 72.03 106.415 165.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.45 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 50.0 mt-10 -135.03 144.99 47.6 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.94 0.896 . . . . 74.34 109.366 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.96 79.77 8.32 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 107.037 -1.468 . . . . 75.54 107.037 170.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.16 -15.49 28.73 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.821 2.347 . . . . 71.51 112.232 -175.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.415 ' ND2' ' HB ' ' D' ' 72' ' ' THR . 40.5 m-20 -114.78 16.38 17.38 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 124.383 1.073 . . . . 73.23 110.588 -174.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.55 -65.11 0.98 Allowed Pre-proline 0 CA--C 1.562 1.412 0 N-CA-C 115.067 1.506 . . . . 61.13 115.067 -159.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.501 ' HB3' HD11 ' C' ' 83' ' ' ILE . 57.4 Cg_endo -69.96 -22.98 30.42 Favored 'Trans proline' 0 C--N 1.392 2.833 0 CA-C-N 122.51 1.932 . . . . 62.12 113.484 -177.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -69.47 -44.63 70.79 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.275 1.03 . . . . 70.42 110.498 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.463 HG21 ' HA ' ' D' ' 73' ' ' ALA . 5.7 p -85.0 -18.52 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 123.192 0.597 . . . . 72.34 111.613 -170.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -60.9 -23.55 65.31 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 112.447 0.536 . . . . 54.54 112.447 172.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -63.8 -22.73 67.05 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.434 0.694 . . . . 55.42 110.919 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.594 ' HZ1' ' HB3' ' D' ' 71' ' ' GLU . 90.9 mttt -85.59 104.78 15.65 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.489 1.115 . . . . 72.12 109.599 176.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -102.09 90.56 3.99 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.379 -0.6 . . . . 63.34 109.379 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 35.4 p90 -165.42 -168.44 1.36 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.882 0.873 . . . . 75.11 109.624 171.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -72.7 117.17 57.05 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.8 0.84 . . . . 65.24 110.497 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.88 110.63 0.62 Allowed 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 121.788 1.659 . . . . 64.23 109.862 168.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -67.79 109.61 3.44 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.048 -1.093 . . . . 74.22 108.048 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.683 HG21 HD13 ' D' ' 126' ' ' LEU . 92.3 t -106.62 122.68 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.4 -0.364 . . . . 71.44 110.397 -170.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 119.29 38.97 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.726 -1.583 . . . . 71.31 106.726 172.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.499 HD11 HG13 ' D' ' 62' ' ' VAL . 45.3 tp -95.11 141.91 28.19 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.334 -0.987 . . . . 75.24 108.334 178.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -136.53 125.3 23.97 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.229 -1.397 . . . . 73.21 107.229 -177.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.426 ' CD2' HG22 ' D' ' 62' ' ' VAL . 83.6 mt -120.08 142.13 49.15 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.143 0.577 . . . . 74.11 110.491 -175.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -146.38 143.22 28.92 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.344 1.458 . . . . 74.02 107.612 174.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 46' ' ' THR . . . . . 0.5 ' HB ' HD21 ' E' ' 111' ' ' LEU . 15.2 t -103.95 165.37 11.09 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.983 -0.747 . . . . 63.22 108.983 176.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.596 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.37 147.44 26.92 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.258 -1.386 . . . . 65.51 107.258 175.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 6.4 p -167.69 -170.61 1.43 Allowed 'General case' 0 C--O 1.246 0.899 0 C-N-CA 123.753 0.821 . . . . 62.23 108.879 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 27.8 p -148.5 119.27 7.55 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.167 0.587 . . . . 63.2 109.432 -173.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 50' ' ' GLN . . . . . 0.525 ' HB3' ' HB2' ' E' ' 102' ' ' LEU . 29.2 pt20 -79.12 -28.04 42.91 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.279 0.632 . . . . 74.15 111.282 -177.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 57.0 tp -69.51 85.0 0.43 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.906 0.882 . . . . 74.3 109.528 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -177.84 161.73 1.63 Allowed 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.301 1.041 . . . . 64.21 110.578 -175.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -116.59 92.87 4.0 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.424 -0.954 . . . . 44.12 108.424 171.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' D' ' 85' ' ' SER . 3.5 m-20 68.82 5.46 4.99 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 114.05 1.13 . . . . 55.52 114.05 169.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 89.8 t -134.18 100.54 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.001 -1.111 . . . . 62.31 108.001 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -117.84 138.47 52.07 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.034 0.934 . . . . 51.5 109.891 -170.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.672 ' HG2' HG13 ' D' ' 83' ' ' ILE . 33.8 mt-10 -87.95 108.34 19.15 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 108.521 -0.918 . . . . 72.2 108.521 170.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 97.4 t -101.08 123.79 54.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.77 -0.826 . . . . 55.31 108.77 175.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 21.3 t -114.24 130.86 67.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.994 -1.113 . . . . 74.34 107.994 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.583 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -105.35 119.81 40.01 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.792 -1.188 . . . . 71.52 107.792 -178.563 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -98.6 99.79 10.96 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.237 -1.024 . . . . 64.53 108.237 177.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.499 HG13 HD11 ' D' ' 42' ' ' LEU . 58.3 t -105.86 118.46 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 108.66 -0.867 . . . . 74.35 108.66 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.0 m -125.45 130.59 52.13 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.593 -0.73 . . . . 63.44 109.751 -170.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.661 HG13 HG13 ' D' ' 40' ' ' VAL . 70.3 t -113.22 130.6 66.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 124.845 1.258 . . . . 73.22 109.445 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 37.3 m -119.55 93.49 4.09 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.218 -1.401 . . . . 62.41 107.218 167.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.71 138.13 36.32 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.787 -0.82 . . . . 54.51 108.787 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.546 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 66.9 m -143.43 132.29 22.73 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.193 0.521 . . . . 75.54 111.232 -175.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.436 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 35.6 mt -95.55 99.26 11.16 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.482 -1.303 . . . . 51.41 107.482 173.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.57 -137.36 17.37 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.578 -0.737 . . . . 74.12 112.619 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.44 5.26 31.84 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.611 0.764 . . . . 73.43 111.95 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 71' ' ' GLU . . . . . 0.594 ' HB3' ' HZ1' ' D' ' 34' ' ' LYS . 5.4 tp10 -136.6 145.67 45.17 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.194 0.998 . . . . 72.22 109.599 -169.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 72' ' ' THR . . . . . 0.415 ' HB ' ' ND2' ' D' ' 27' ' ' ASN . 91.8 m -59.83 135.95 57.85 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.741 1.217 . . . . 53.22 112.522 -175.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.546 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.6 -65.62 1.0 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.301 -1.37 . . . . 74.12 107.301 170.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -152.57 158.26 42.23 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 114.542 -1.208 . . . . 53.24 110.045 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 76.0 mt -116.84 155.02 29.73 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.867 1.267 . . . . 73.52 108.269 171.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.574 ' SG ' HG12 ' D' ' 114' ' ' ILE . 49.1 t -154.42 147.71 24.9 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.059 -0.719 . . . . 63.42 109.059 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -157.43 123.78 4.88 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.818 0.447 . . . . 64.11 110.129 174.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 50.2 t -124.3 116.93 49.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 123.523 0.729 . . . . 62.2 109.118 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.629 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.9 mt-30 -93.25 85.1 4.92 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.938 0.875 . . . . 62.3 109.08 171.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -80.4 102.64 9.74 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 113.713 -1.585 . . . . 71.33 109.465 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.84 150.83 21.31 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 116.742 -0.208 . . . . 73.5 113.219 -178.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.58 137.24 5.58 Favored Glycine 0 C--N 1.34 0.791 0 N-CA-C 112.092 -0.403 . . . . 52.24 112.092 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.672 HG13 ' HG2' ' D' ' 57' ' ' GLU . 2.6 mp -91.15 112.84 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 107.775 -1.194 . . . . 65.13 107.775 174.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -115.33 145.29 42.64 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.69 0.796 . . . . 62.32 109.669 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' D' ' 54' ' ' ASP . 39.8 m -116.29 107.78 15.27 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.836 0.854 . . . . 63.41 109.766 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.488 HD11 HD23 ' D' ' 98' ' ' LEU . 46.9 pt -116.8 129.35 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.387 0.675 . . . . 73.42 109.391 176.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.421 ' HB3' HG22 ' D' ' 10' ' ' THR . . . -143.49 158.18 43.85 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.675 0.79 . . . . 71.44 110.149 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.07 23.64 44.18 Favored Glycine 0 C--N 1.347 1.16 0 O-C-N 123.709 0.631 . . . . 73.4 114.247 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.432 HD13 ' HG3' ' D' ' 94' ' ' MET . 0.7 OUTLIER -134.85 160.94 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.476 0.71 . . . . 62.45 110.726 178.254 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.13 160.2 40.48 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.137 0.898 . . . . 75.14 111.019 -171.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.67 -141.35 36.52 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.194 -0.912 . . . . 71.54 113.945 175.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.5 p -78.41 -32.31 48.62 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.138 0.575 . . . . 74.23 110.739 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -56.46 -33.58 66.06 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.881 0.873 . . . . 74.23 111.266 177.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.514 ' SD ' HG23 ' E' ' 97' ' ' ILE . 40.0 ttp -62.44 -62.19 1.93 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.146 1.378 . . . . 71.22 112.165 177.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.28 -15.09 51.54 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.066 0.546 . . . . 51.11 112.176 -171.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -70.83 -26.59 63.35 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.109 0.564 . . . . 74.22 110.088 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.7 t -66.41 -45.65 79.21 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.273 0.629 . . . . 75.42 110.947 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.599 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 4.3 pp -74.35 -23.08 58.97 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 116.608 -0.269 . . . . 74.42 111.207 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.82 -28.59 34.44 Favored Glycine 0 C--N 1.348 1.23 0 O-C-N 123.458 0.474 . . . . 55.01 112.958 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.24 -57.37 2.01 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 117.332 0.566 . . . . 50.22 112.233 -170.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -72.48 -37.64 68.39 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.524 0.329 . . . . 74.24 111.833 -174.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.599 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 88.6 m -65.35 -46.62 70.81 Favored Pre-proline 0 CA--C 1.566 1.592 0 CA-C-O 118.775 -0.631 . . . . 73.41 112.198 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.583 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 76.2 Cg_exo -57.61 -31.3 91.4 Favored 'Trans proline' 0 C--N 1.394 2.923 0 C-N-CA 122.622 2.215 . . . . 73.44 113.902 168.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -65.57 -28.55 69.23 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.092 0.557 . . . . 61.43 111.186 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.4 mm -73.32 -35.29 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.316 0.646 . . . . 75.05 110.332 174.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 68.3 mt -77.1 -18.24 58.1 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.352 -0.84 . . . . 74.14 111.891 -177.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 107' ' ' PHE . . . . . 0.421 ' HE2' ' HA ' ' D' ' 130' ' ' PRO . 8.4 t80 -70.46 -39.91 10.5 Favored Pre-proline 0 CA--C 1.557 1.218 0 N-CA-C 114.353 1.242 . . . . 71.52 114.353 -171.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.79 -44.9 45.15 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.962 1.775 . . . . 60.33 112.68 169.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -71.83 -32.58 67.69 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.845 0.858 . . . . 71.12 111.554 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.99 -50.52 64.01 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.467 0.707 . . . . 32.33 110.237 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.497 ' NH2' HG23 ' B' ' 105' ' ' ILE . 31.3 ttp180 -60.22 -43.06 96.31 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 124.353 1.033 . . . . 63.24 110.031 176.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -57.0 -52.77 63.94 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.102 0.876 . . . . 55.22 111.455 -176.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.437 ' O ' ' HG3' ' D' ' 117' ' ' MET . 43.2 t -57.06 -44.17 82.76 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 124.177 0.923 . . . . 73.3 110.598 -177.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.574 HG12 ' SG ' ' D' ' 76' ' ' CYS . 83.7 mt -60.62 -54.95 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.743 0.817 . . . . 64.04 110.696 175.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 77.2 m -53.43 -43.74 68.23 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.382 1.473 . . . . 62.01 111.055 -175.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -65.36 -45.9 82.31 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.403 -1.272 . . . . 72.04 109.805 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.437 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 71.2 mtm -70.87 -26.97 63.48 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.0 0.52 . . . . 73.43 112.391 -177.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.467 HG21 ' HB3' ' D' ' 126' ' ' LEU . 71.0 t -68.64 -46.16 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.216 0.606 . . . . 70.51 109.419 175.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 81.5 p -70.75 -29.69 66.0 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.588 -0.733 . . . . 72.45 110.463 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -70.83 -34.15 71.41 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.815 0.846 . . . . 64.35 110.0 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.7 6.17 71.06 Favored Glycine 0 C--N 1.355 1.625 0 O-C-N 123.681 0.613 . . . . 51.13 113.203 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.457 HG23 ' HB3' ' C' ' 17' ' ' TYR . 65.3 p 56.18 28.94 13.87 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 126.39 1.876 . . . . 72.53 113.349 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -92.79 148.93 36.94 Favored Pre-proline 0 C--O 1.241 0.655 0 N-CA-C 108.598 -0.89 . . . . 75.54 108.598 167.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.35 125.96 13.04 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 123.318 2.679 . . . . 71.04 112.466 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -47.91 124.9 8.05 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 124.607 1.192 . . . . 74.54 112.149 -173.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.683 HD13 HG21 ' D' ' 40' ' ' VAL . 16.6 tp -106.49 106.1 16.46 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.165 0.986 . . . . 75.03 109.682 -176.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -109.47 83.01 1.68 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.322 1.049 . . . . 73.44 108.532 175.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.479 ' HA ' ' HB1' ' E' ' 125' ' ' ALA . 3.6 pp -62.98 141.91 58.57 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.958 0.503 . . . . 64.34 110.393 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.24 139.86 90.14 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 122.74 0.416 . . . . 75.42 111.609 -173.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.421 ' HA ' ' HE2' ' D' ' 107' ' ' PHE . 74.3 Cg_endo -73.51 144.73 36.54 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.682 2.255 . . . . 72.32 111.365 176.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.99 145.59 23.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.815 0 C-N-CA 122.977 0.511 . . . . 70.33 110.129 -177.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -78.71 112.28 15.67 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.508 0.723 . . . . 71.42 109.24 176.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.425 ' HD2' HD23 ' E' ' 111' ' ' LEU . 32.2 m-85 -65.57 -26.0 67.66 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.968 0.907 . . . . 74.23 112.146 -176.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -51.8 -47.02 64.43 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 124.384 1.052 . . . . 74.21 109.624 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.85 -43.5 98.25 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-N 113.846 -1.524 . . . . 73.31 111.705 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 7.0 mp -58.65 -35.83 73.16 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 124.51 1.124 . . . . 73.41 113.002 -171.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -69.76 -41.83 74.67 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.961 0.504 . . . . 74.1 110.896 178.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 70.9 mtm -74.65 -20.18 59.98 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.476 -0.783 . . . . 73.44 110.858 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' D' ' 143' ' ' GLN . 76.3 m-20 -78.23 -30.42 48.74 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.107 0.963 . . . . 73.44 111.385 178.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -55.62 -33.95 64.46 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.02 0.928 . . . . 73.44 112.596 -177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.1 mp -71.41 -29.42 64.9 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.46 0.704 . . . . 72.33 110.696 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -82.53 -4.44 57.58 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.369 0.668 . . . . 65.43 112.09 -173.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 143' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' D' ' 139' ' ' ASN . 0.8 OUTLIER -123.35 83.24 2.1 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.857 0.863 . . . . 74.11 109.062 -173.639 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -164.94 173.73 11.3 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.677 1.191 . . . . 72.23 108.579 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.75 -65.82 0.62 Allowed 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 109.284 -0.636 . . . . 73.12 109.284 175.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 51.9 -95.38 0.01 OUTLIER Glycine 0 C--N 1.363 2.081 0 O-C-N 124.404 1.065 . . . . 53.24 112.384 -177.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -136.73 104.67 5.59 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 107.476 -1.305 . . . . 55.02 107.476 163.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 154.4 85.53 0.05 OUTLIER Glycine 0 C--N 1.339 0.748 0 O-C-N 123.721 0.638 . . . . 72.43 111.732 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 31.7 m -81.68 85.34 6.59 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.182 -0.674 . . . . 72.03 109.182 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -91.36 71.9 6.1 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.901 -0.778 . . . . 70.13 108.901 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.38 91.55 0.56 Allowed 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 115.225 -0.898 . . . . 74.21 109.385 176.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -73.07 90.99 1.56 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.717 -0.846 . . . . 75.1 108.717 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -70.24 132.76 46.22 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.086 -0.961 . . . . 74.24 110.163 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -91.67 152.92 20.01 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.516 -0.92 . . . . 64.43 108.516 174.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.262 0 CA-C-O 118.505 -0.759 . . . . 73.51 110.982 -178.052 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.838 0 N-CA-C 112.729 -0.149 . . . . 53.13 112.729 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.02 104.94 0.89 Allowed Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.383 -0.676 . . . . 62.25 112.163 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 49.1 t80 67.6 55.55 0.62 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.416 1.086 . . . . 61.15 109.921 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 73.07 132.56 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 125.926 1.69 . . . . 64.23 113.164 174.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 95' ' ' LYS . . . . . 0.437 ' HE2' ' HB2' ' E' ' 95' ' ' LYS . 0.0 OUTLIER -156.17 156.22 33.83 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-O 121.153 0.502 . . . . 63.23 110.383 167.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.48 -36.76 0.16 Allowed Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.105 -1.198 . . . . 73.34 110.105 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 97' ' ' ILE . . . . . 0.514 HG23 ' SD ' ' D' ' 94' ' ' MET . 86.4 mt -86.18 114.89 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.282 1.433 . . . . 41.31 107.819 173.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -100.29 0.89 41.04 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.687 0.795 . . . . 72.11 111.414 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -162.02 116.18 1.87 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.227 1.011 . . . . 72.41 109.439 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 100' ' ' LEU . . . . . 0.492 HD23 HG21 ' E' ' 97' ' ' ILE . 0.7 OUTLIER -112.52 99.4 47.17 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 123.255 0.622 . . . . 72.53 109.337 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -94.89 100.82 0.11 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 123.532 2.821 . . . . 75.11 110.413 165.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 102' ' ' LEU . . . . . 0.525 ' HB2' ' HB3' ' D' ' 50' ' ' GLN . 4.0 tt -79.79 73.12 6.54 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.543 0.737 . . . . 74.21 110.679 -169.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 62.6 p 51.29 12.02 0.13 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 125.994 1.718 . . . . 74.45 114.091 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 140.11 -65.09 0.52 Allowed Glycine 0 C--N 1.342 0.878 0 N-CA-C 109.738 -1.345 . . . . 54.13 109.738 -168.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -173.31 -38.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.836 1.255 . . . . 61.1 110.059 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -148.27 -160.57 1.19 Allowed 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 106.983 -1.488 . . . . 64.21 106.983 -172.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 16.0 m -52.14 88.19 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.727 1.211 . . . . 73.23 111.634 169.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 -79.21 -33.87 43.4 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.113 -0.949 . . . . 54.12 109.259 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -116.73 117.98 31.29 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.897 -1.149 . . . . 74.23 107.897 -178.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.98 142.53 58.4 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.03 0.832 . . . . 53.11 111.224 -177.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 111' ' ' LEU . . . . . 0.5 HD21 ' HB ' ' D' ' 46' ' ' THR . 5.5 mp -93.64 17.16 12.22 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.115 -0.948 . . . . 61.53 110.115 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -130.7 -164.77 1.47 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.588 1.155 . . . . 75.42 108.854 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -105.95 116.01 31.22 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.161 -0.681 . . . . 72.55 109.161 169.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -75.77 -23.65 55.94 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.723 0.809 . . . . 62.14 111.045 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 8.4 t -144.02 -45.45 0.26 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.992 0.517 . . . . 73.22 110.517 173.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 122.47 131.52 3.89 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-O 119.464 -0.631 . . . . 43.21 111.954 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -176.2 -58.89 0.0 OUTLIER Pre-proline 0 CA--C 1.564 1.494 0 C-N-CA 125.533 1.533 . . . . 75.15 108.938 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -81.94 -38.81 0.19 Allowed 'Trans proline' 0 C--N 1.397 3.112 0 C-N-CA 121.765 1.643 . . . . 75.11 112.475 175.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 54.3 38.52 29.54 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.87 1.268 . . . . 75.41 113.397 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -61.26 -38.08 85.44 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.08 0.552 . . . . 73.44 110.211 170.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 121' ' ' VAL . . . . . 0.498 HG21 ' O ' ' E' ' 111' ' ' LEU . 41.9 t -93.51 85.06 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.621 -1.251 . . . . 65.23 107.621 171.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 26.3 m -75.89 150.64 37.54 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.399 -1.273 . . . . 73.04 110.332 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -87.48 45.86 1.32 Allowed 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.989 0.899 . . . . 62.52 110.437 174.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 35.0 t -159.84 139.05 11.0 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.719 1.207 . . . . 72.2 108.201 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 125' ' ' ALA . . . . . 0.479 ' HB1' ' HA ' ' D' ' 128' ' ' LEU . . . -146.06 159.86 42.69 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.351 0.66 . . . . 73.43 110.511 -175.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.36 125.34 26.72 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.242 0.617 . . . . 62.4 109.787 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 42.0 t -161.53 166.88 26.4 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.56 0.744 . . . . 55.32 109.787 -178.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.72 170.16 15.39 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.624 0.77 . . . . 44.3 110.924 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 2.1 p -125.56 10.66 7.88 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.039 0.935 . . . . 43.32 111.006 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -144.22 146.18 32.52 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.257 0.623 . . . . 53.44 110.728 -175.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 131' ' ' TRP . . . . . . . . . . . . . 39.5 t-105 -162.4 169.69 20.06 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 124.045 0.938 . . . . 73.03 109.68 177.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 132' ' ' SER . . . . . 0.501 ' N ' ' HB3' ' A' ' 124' ' ' PRO . 24.1 m 74.16 105.47 0.07 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.758 1.623 . . . . 74.54 111.171 178.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 87.9 m -65.65 -31.84 73.08 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.325 1.05 . . . . 71.55 111.822 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.9 78.93 1.26 Allowed Glycine 0 C--N 1.342 0.883 0 N-CA-C 110.507 -1.037 . . . . 73.32 110.507 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 135' ' ' VAL . . . . . 0.406 HG11 ' HB ' ' C' ' 13' ' ' ILE . 58.2 t -73.49 126.63 34.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 123.579 0.751 . . . . 63.55 110.672 -175.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -114.06 177.42 4.65 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.352 1.061 . . . . 52.24 109.77 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 3.7 m -93.26 18.62 9.25 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.352 0.661 . . . . 75.31 110.391 176.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 71.5 t80 65.48 -76.7 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.152 1.381 . . . . 74.3 111.457 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -90.13 -50.09 6.2 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.473 0.709 . . . . 70.43 109.231 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.03 164.96 54.81 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.793 -0.639 . . . . 71.45 113.015 -175.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -110.07 172.6 6.77 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.858 0.863 . . . . 73.34 109.985 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 46.2 tp -86.1 139.44 31.11 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.606 0.363 . . . . 73.44 110.196 175.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -97.1 -107.32 2.47 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-O 119.418 -0.657 . . . . 60.1 111.509 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 144' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' C' ' 54' ' ' ASP . 40.4 t 58.97 84.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.562 1.145 . . . . 75.31 109.565 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 32.8 t70 . . . . . 0 C--O 1.252 1.194 0 C-N-CA 123.388 0.675 . . . . 70.1 110.895 -174.16 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.43 0 N-CA-C 111.593 -0.603 . . . . 64.33 111.593 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.35 39.35 3.12 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 114.344 0.498 . . . . 43.02 114.344 -174.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -89.91 89.46 7.74 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.535 -0.913 . . . . 75.34 108.535 172.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -113.53 173.66 6.3 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.367 1.067 . . . . 61.01 111.173 -174.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -130.31 153.8 48.29 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.076 0.95 . . . . 71.33 110.744 -175.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -166.94 -59.18 0.03 OUTLIER Glycine 0 C--N 1.352 1.454 0 O-C-N 123.545 0.528 . . . . 52.15 112.017 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 97' ' ' ILE . . . . . 0.513 HG21 ' HB2' ' F' ' 100' ' ' LEU . 37.0 mt -67.61 131.97 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 124.298 1.039 . . . . 75.51 109.291 173.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -85.62 7.0 24.93 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.239 0.829 . . . . 61.31 113.239 -176.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 99' ' ' ALA . . . . . 0.457 ' H ' HG22 ' F' ' 97' ' ' ILE . . . -158.16 -84.87 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 118.408 0.549 . . . . 33.14 111.47 -175.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 100' ' ' LEU . . . . . 0.763 HD11 HD21 ' B' ' 98' ' ' LEU . 38.5 tp 56.77 84.27 0.21 Allowed Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 124.812 1.245 . . . . 64.12 111.497 -175.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -90.47 6.77 3.92 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.853 2.369 . . . . 73.44 113.127 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 102' ' ' LEU . . . . . 0.547 HD23 ' HB2' ' B' ' 50' ' ' GLN . 3.6 mm? 60.71 14.13 4.83 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.913 0.885 . . . . 75.14 111.089 -176.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 9.2 p 45.5 36.39 2.46 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.951 1.7 . . . . 74.12 113.307 -171.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.71 172.93 16.08 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 116.251 -0.431 . . . . 75.5 112.376 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -67.69 -51.92 43.9 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.234 1.014 . . . . 62.14 110.824 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -110.6 141.94 43.12 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.196 -1.039 . . . . 73.41 108.196 175.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 32.4 m -72.47 118.01 14.84 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.33 0.652 . . . . 64.43 110.552 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -81.86 50.29 1.51 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.199 0.999 . . . . 75.44 110.397 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -169.19 45.79 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 106.395 -1.706 . . . . 73.12 106.395 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.49 147.49 47.73 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.877 -1.056 . . . . 23.42 109.636 176.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 111' ' ' LEU . . . . . 0.615 HD23 HD22 ' B' ' 136' ' ' LEU . 5.7 mp -79.61 3.74 18.09 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.374 0.67 . . . . 74.33 112.32 -171.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -152.92 -65.91 0.16 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.392 0.677 . . . . 32.55 109.428 177.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt 58.18 -96.06 0.06 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.283 1.033 . . . . 73.43 109.433 -172.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -169.19 -33.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 126.261 1.825 . . . . 71.25 108.637 171.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 8.9 m -88.7 16.61 6.46 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 124.086 0.954 . . . . 63.03 110.115 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.39 119.9 18.66 Favored Glycine 0 C--N 1.356 1.692 0 CA-C-N 116.338 -0.392 . . . . 63.42 112.604 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.34 159.39 83.6 Favored Pre-proline 0 N--CA 1.476 0.838 0 CA-C-O 117.503 -1.237 . . . . 71.03 109.148 175.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -24.2 103.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.398 3.143 1 C-N-CA 125.574 4.183 . . . . 72.3 114.438 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -89.69 -177.95 5.4 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.592 1.157 . . . . 73.12 112.214 -168.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -121.38 -8.08 9.18 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 115.045 -0.979 . . . . 73.35 110.903 -178.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 13.6 p -77.94 -29.62 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 122.749 0.42 . . . . 61.43 110.953 -176.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 43.8 p 56.26 -170.37 0.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 125.964 1.706 . . . . 73.53 112.569 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -53.52 -67.72 0.23 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.593 0.757 . . . . 53.24 111.079 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 23.3 t -173.28 -22.3 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.208 0.603 . . . . 75.41 110.303 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . 56.55 29.63 15.84 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.526 1.131 . . . . 65.11 110.909 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.74 74.17 6.63 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.962 -1.017 . . . . 75.15 110.6 -170.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 21.8 m -86.09 59.52 5.68 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.223 -0.899 . . . . 73.31 110.157 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -155.73 4.36 0.19 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.196 0.999 . . . . 61.44 110.826 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 129' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' B' ' 38' ' ' PRO . 16.5 p -75.56 91.8 2.86 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.805 0.842 . . . . 62.31 111.26 -177.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -150.75 147.4 27.27 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.508 1.123 . . . . 71.52 109.313 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 35.3 t90 -124.33 -69.71 0.79 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.024 0.53 . . . . 75.33 111.15 -178.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 53.7 m -64.01 112.8 3.12 Favored 'General case' 0 C--N 1.363 1.192 0 CA-C-O 121.094 0.473 . . . . 74.21 111.512 -173.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 9.0 t -124.26 -174.27 2.96 Favored 'General case' 0 C--O 1.244 0.763 0 C-N-CA 124.476 1.11 . . . . 64.22 108.992 175.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.13 69.79 2.44 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 120.377 -0.124 . . . . 71.31 113.139 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 6.1 m -85.36 87.82 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-O 122.178 0.99 . . . . 54.12 109.549 173.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.52 -172.95 3.84 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.133 -0.939 . . . . 74.13 109.771 174.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 32.5 m -59.59 127.28 31.22 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.441 -0.948 . . . . 75.23 108.441 172.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -61.86 86.63 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 O-C-N 124.321 1.013 . . . . 73.41 112.184 -170.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -173.63 142.82 0.97 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.186 -1.37 . . . . 72.41 108.454 -173.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -82.77 143.96 22.71 Favored Glycine 0 C--N 1.342 0.878 0 N-CA-C 112.053 -0.419 . . . . 71.43 112.053 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -150.82 -92.63 0.06 Allowed 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.258 -1.015 . . . . 74.11 108.258 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 19.1 mt -155.26 88.66 1.17 Allowed 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 107.276 -1.379 . . . . 73.44 107.276 165.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.92 73.07 1.98 Allowed Glycine 0 C--N 1.348 1.236 0 N-CA-C 111.654 -0.579 . . . . 70.3 111.654 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 29.9 m -114.19 138.54 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.53 1.132 . . . . 45.1 110.998 -171.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 C--O 1.248 0.99 0 C-N-CA 124.048 0.939 . . . . 62.44 109.256 168.207 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.7 ttm . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 107.73 -1.211 . . . . 72.41 107.73 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.0 m -58.88 95.79 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.623 0.769 . . . . 62.11 112.45 -167.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -77.49 151.18 34.74 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.829 0.852 . . . . 70.0 110.833 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.1 134.34 43.17 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.012 0.925 . . . . 71.34 109.604 177.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -80.14 147.35 31.4 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.152 0.581 . . . . 64.13 109.964 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -88.44 147.73 24.55 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.993 0.517 . . . . 63.03 110.03 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -113.69 -8.1 13.27 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.72 0.808 . . . . 55.12 110.675 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -106.11 79.54 1.41 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.594 0.758 . . . . 72.31 110.434 -174.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -123.28 174.24 7.42 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.901 0.88 . . . . 53.14 109.987 175.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.3 m -141.21 116.07 9.76 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.404 1.082 . . . . 74.5 108.218 169.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -120.96 119.77 33.54 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.978 0.911 . . . . 65.43 109.211 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -135.25 132.47 37.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.006 0.923 . . . . 73.44 108.586 174.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.466 ' CD1' HG21 ' A' ' 105' ' ' ILE . 4.8 mt -96.17 114.47 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 108.617 -0.883 . . . . 62.32 108.617 173.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -78.32 -32.95 49.52 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.014 0.525 . . . . 70.2 110.249 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -171.85 148.69 2.37 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 123.378 0.424 . . . . 64.34 110.144 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.2 mt -133.12 135.26 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 124.632 1.173 . . . . 65.34 108.502 173.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -163.2 171.74 15.81 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 123.982 0.801 . . . . 75.32 112.104 -171.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -101.78 124.39 47.34 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.366 -0.976 . . . . 72.21 108.366 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.532 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 44.2 mtpt -85.91 -35.69 20.36 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.039 0.447 . . . . 74.25 109.889 175.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.528 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 19.7 t70 -146.66 138.96 24.9 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.15 -0.932 . . . . 74.11 109.401 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 81.0 mt -129.11 140.32 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.009 -1.108 . . . . 71.14 108.009 174.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.7 t -138.87 123.67 18.71 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.365 0.666 . . . . 72.11 109.279 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 86.9 t80 -133.59 129.38 36.89 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.265 -1.754 . . . . 74.33 106.265 170.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -139.17 124.45 19.11 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.955 -1.128 . . . . 74.13 107.955 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.7 89.26 7.42 Favored Pre-proline 0 C--O 1.241 0.658 0 N-CA-C 107.886 -1.153 . . . . 71.44 107.886 175.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -52.31 -53.39 7.0 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 123.684 2.923 . . . . 72.24 113.504 -169.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.26 41.27 2.83 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.779 -0.823 . . . . 74.53 108.779 -173.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -44.66 -59.13 4.34 Favored Pre-proline 0 N--CA 1.495 1.789 0 CA-C-O 117.584 -1.198 . . . . 71.21 113.968 -171.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 20.9 Cg_exo -62.37 -22.54 74.22 Favored 'Trans proline' 0 C--N 1.389 2.669 0 CA-C-N 121.952 1.733 . . . . 74.5 112.618 -177.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -94.47 -28.36 15.5 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.613 1.165 . . . . 72.21 111.244 -173.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 28' ' ' ALA . 5.9 p -80.05 -17.09 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 122.698 0.399 . . . . 34.3 111.877 -170.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -78.23 -24.12 47.11 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.393 0.677 . . . . 75.24 111.206 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -92.56 -16.08 26.15 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.782 0.833 . . . . 75.35 110.687 176.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -67.57 157.81 33.5 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.29 0.636 . . . . 63.02 111.156 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -67.54 116.63 8.48 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.401 -0.963 . . . . 72.42 108.401 171.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.421 ' CE3' HD21 ' A' ' 68' ' ' LEU . 73.7 t-105 -83.8 82.13 8.46 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.092 0.557 . . . . 72.25 110.372 -175.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -115.16 81.78 8.33 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 107.572 -1.27 . . . . 73.42 107.572 168.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -86.53 121.34 1.88 Allowed 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.424 2.083 . . . . 73.4 112.499 -173.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -94.95 95.45 8.64 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.069 -1.456 . . . . 64.43 107.069 168.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.559 HG11 HD11 ' A' ' 126' ' ' LEU . 48.0 t -85.71 104.38 13.41 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-N 115.727 -0.67 . . . . 74.23 109.554 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -79.18 121.44 25.03 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.025 -1.102 . . . . 40.03 108.025 173.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tt -96.19 105.12 17.13 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 105.841 -1.911 . . . . 63.03 105.841 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -112.39 145.25 40.44 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 107.907 -1.146 . . . . 73.41 107.907 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.552 HD11 HG21 ' A' ' 131' ' ' VAL . 90.1 mt -136.82 146.98 46.3 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.913 0.485 . . . . 72.22 112.094 -171.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -155.09 117.52 4.25 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.906 -1.043 . . . . 73.12 108.765 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.3 m -117.5 126.9 53.4 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.068 0.547 . . . . 64.2 109.997 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.52 127.15 23.42 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.179 0.591 . . . . 54.53 109.94 176.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 61.7 p -101.82 170.72 7.97 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.943 0.897 . . . . 64.33 111.391 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 94.5 p -150.17 124.4 9.48 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.94 0.896 . . . . 53.1 109.382 -173.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -78.88 103.7 9.0 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.187 -0.671 . . . . 63.1 109.187 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 57' ' ' GLU . 69.9 mt -79.39 -26.8 41.87 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.512 0.725 . . . . 71.01 110.848 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.14 -175.08 2.51 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.918 0.887 . . . . 72.04 110.049 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.92 112.33 2.27 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 109.152 -0.684 . . . . 70.22 109.152 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 68.21 6.33 5.21 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.745 1.218 . . . . 75.22 112.884 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.6 t -105.16 116.23 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.014 -1.106 . . . . 61.23 108.014 173.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -132.25 127.33 35.49 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.302 -0.999 . . . . 73.1 108.302 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.445 ' HB2' HD11 ' A' ' 51' ' ' LEU . 23.9 tt0 -88.55 143.37 27.0 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 108.036 -1.098 . . . . 74.22 108.036 167.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.6 t -118.51 134.67 61.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.049 -1.093 . . . . 74.14 108.049 170.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.411 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 42.8 t -117.72 124.46 73.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 108.607 -0.886 . . . . 73.55 108.607 174.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.23 119.68 39.49 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.535 -1.283 . . . . 63.21 107.535 175.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 46.3 ttp85 -109.48 100.98 9.98 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.559 -1.274 . . . . 63.41 107.559 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.7 t -96.23 103.0 14.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 114.204 -1.362 . . . . 71.21 107.909 -178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.8 m -96.27 107.45 19.8 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 122.066 0.936 . . . . 71.1 108.918 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.556 HG11 HD21 ' A' ' 126' ' ' LEU . 43.4 t -104.72 135.91 40.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 114.599 -1.182 . . . . 73.21 108.592 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 35.7 m -138.1 126.43 23.17 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.497 -0.557 . . . . 75.32 109.497 173.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.547 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -105.31 130.34 53.45 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.326 -1.361 . . . . 70.34 107.326 173.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 54.9 m -136.52 134.15 37.23 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.7 0.625 . . . . 74.41 110.507 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.421 HD21 ' CE3' ' A' ' 36' ' ' TRP . 23.7 mt -87.25 69.12 10.01 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 107.532 -1.284 . . . . 75.01 107.532 174.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.26 -100.83 1.3 Allowed Glycine 0 C--N 1.346 1.117 0 CA-C-N 114.307 -1.315 . . . . 74.22 111.939 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -91.14 -27.54 18.47 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.931 0.892 . . . . 75.42 111.604 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -91.33 123.02 34.45 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.485 -0.561 . . . . 74.35 109.485 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.9 m -71.49 129.96 40.07 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.029 0.443 . . . . 44.51 110.431 172.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.33 -52.2 8.41 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.389 1.075 . . . . 75.12 109.162 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -160.47 160.49 32.11 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.225 -0.898 . . . . 73.22 111.615 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 64' ' ' VAL . 63.9 tp -112.68 143.53 43.74 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.806 1.242 . . . . 62.5 108.132 166.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.425 ' HB3' HG23 ' A' ' 114' ' ' ILE . 88.5 m -143.75 98.81 3.3 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.86 0.864 . . . . 74.21 109.651 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -122.37 116.12 23.48 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.915 -0.772 . . . . 61.04 108.915 -176.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.6 t -124.38 122.28 63.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 121.441 0.638 . . . . 64.41 109.885 -177.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -99.75 82.07 2.55 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.298 -1.319 . . . . 71.12 108.019 -178.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -76.02 94.47 3.43 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.038 -0.983 . . . . 74.14 109.11 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.05 150.99 21.8 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.664 -0.698 . . . . 72.12 111.383 177.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.76 132.68 3.35 Favored Glycine 0 CA--C 1.507 -0.446 0 N-CA-C 111.017 -0.833 . . . . 31.02 111.017 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.7 mt -81.41 127.07 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.384 -0.969 . . . . 63.43 108.384 175.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.602 ' HB3' HD11 ' A' ' 86' ' ' ILE . 95.8 m-85 -124.81 120.02 30.52 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.311 1.044 . . . . 62.54 108.618 -177.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.9 m -92.67 99.2 11.94 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.346 -1.353 . . . . 64.14 107.346 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.602 HD11 ' HB3' ' A' ' 84' ' ' PHE . 10.9 mm -117.15 145.99 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 122.787 0.435 . . . . 55.12 110.118 -174.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.91 169.95 17.41 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.688 0.617 . . . . 60.41 110.859 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.45 -15.12 63.36 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.702 -0.681 . . . . 53.35 112.824 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.45 164.54 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 124.188 0.995 . . . . 64.23 110.412 -177.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.591 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 13.8 tt0 -154.8 -177.74 6.72 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 109.402 -0.592 . . . . 74.12 109.402 173.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.528 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 67.53 -122.14 16.84 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 123.208 0.433 . . . . 65.44 113.513 176.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.5 t -74.36 -28.94 61.36 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.711 0.804 . . . . 73.22 111.522 -176.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -73.64 -37.29 65.38 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.518 0.727 . . . . 73.45 109.582 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.591 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 3.2 tpt -66.24 -42.79 88.09 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.237 -0.892 . . . . 72.21 110.053 175.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.18 88.82 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.362 -0.835 . . . . 50.41 111.109 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.534 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 55.8 t-80 -74.9 -20.53 59.68 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.014 0.526 . . . . 73.43 111.163 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.5 t -78.21 -49.01 14.57 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.785 -0.572 . . . . 75.15 109.539 174.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 76.1 mt -78.81 -31.44 45.9 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.245 0.618 . . . . 74.03 112.575 -172.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.35 4.41 51.36 Favored Glycine 0 N--CA 1.47 0.953 0 CA-C-O 119.649 -0.528 . . . . 75.15 113.583 -174.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -144.47 -63.64 0.36 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.448 0.624 . . . . 63.22 112.009 -175.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -69.61 -47.1 64.63 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 112.083 0.401 . . . . 73.14 112.083 -172.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 88.8 m -65.78 -47.13 66.26 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.401 1.08 . . . . 60.33 112.966 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.0 -24.81 59.75 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 122.023 1.815 . . . . 44.24 112.955 173.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -68.83 -33.69 74.25 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.13 0.572 . . . . 73.31 110.505 174.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.466 HG21 ' CD1' ' A' ' 13' ' ' ILE . 43.8 mm -68.3 -42.44 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.77 0.828 . . . . 72.0 110.4 172.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.8 mt -74.25 -25.01 59.38 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.054 -0.976 . . . . 70.31 112.089 -174.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -64.69 -40.87 52.73 Favored Pre-proline 0 CA--C 1.558 1.282 0 N-CA-C 114.49 1.293 . . . . 72.33 114.49 -171.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -52.55 -42.05 64.33 Favored 'Trans proline' 0 C--N 1.385 2.452 0 CA-C-N 121.966 1.738 . . . . 62.22 113.23 170.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -73.43 -40.28 64.36 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.533 0.733 . . . . 75.2 111.318 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.52 -46.59 82.25 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.483 0.713 . . . . 65.32 110.106 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.535 ' NH1' HD12 ' C' ' 105' ' ' ILE . 29.8 ttm180 -52.06 -50.43 61.51 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.959 1.304 . . . . 74.54 110.869 174.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -62.6 -47.79 82.26 Favored 'General case' 0 C--N 1.346 0.429 0 O-C-N 124.431 1.082 . . . . 70.15 111.436 -175.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.416 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 49.7 t -57.51 -42.76 83.42 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 124.173 0.921 . . . . 64.13 110.455 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.461 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.6 mt -60.97 -50.13 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.488 1.115 . . . . 52.13 110.607 175.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.0 m -61.33 -39.31 90.08 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.015 0.926 . . . . 74.13 111.379 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -69.89 -43.11 72.45 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.98 -1.009 . . . . 71.21 109.813 -177.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 6.9 mtp -56.97 -43.95 82.14 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.774 0.83 . . . . 75.01 111.129 174.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 114' ' ' ILE . 68.8 t -62.07 -47.11 94.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.556 1.142 . . . . 70.01 111.101 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.7 p -73.95 -29.38 61.98 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 122.906 0.483 . . . . 31.03 111.654 -176.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.448 ' NH1' ' HA ' ' B' ' 113' ' ' CYS . 68.4 mtt-85 -71.62 -30.93 66.33 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.214 0.606 . . . . 53.32 109.627 174.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.92 14.24 44.34 Favored Glycine 0 C--N 1.35 1.33 0 CA-C-N 115.413 -0.812 . . . . 72.43 112.976 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.532 HG21 ' HE ' ' B' ' 15' ' ' ARG . 3.2 t 57.31 13.8 1.88 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 127.156 2.183 . . . . 60.11 113.605 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -77.47 142.14 66.52 Favored Pre-proline 0 C--O 1.244 0.774 0 N-CA-C 108.903 -0.777 . . . . 73.32 108.903 175.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.546 ' HB3' ' HA ' ' E' ' 131' ' ' TRP . 41.5 Cg_exo -43.84 128.25 6.88 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 123.612 2.875 . . . . 74.51 112.622 170.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -55.35 131.88 46.76 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.22 0.95 . . . . 65.41 112.375 -167.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.559 HD11 HG11 ' A' ' 40' ' ' VAL . 42.6 tp -112.62 117.16 31.51 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.751 1.22 . . . . 71.31 109.932 -174.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -121.14 104.61 9.9 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.028 -0.73 . . . . 72.23 109.028 -174.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 111' ' ' ARG . 79.2 mt -61.81 144.69 54.42 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.367 0.667 . . . . 53.35 112.336 -173.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.435 ' H ' HG21 ' E' ' 135' ' ' VAL . . . -70.98 144.84 90.82 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.299 0.64 . . . . 72.32 110.304 177.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.406 ' HA ' HH22 ' A' ' 111' ' ' ARG . 24.8 Cg_exo -64.05 117.51 4.52 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.834 2.356 . . . . 64.12 112.599 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.552 HG21 HD11 ' A' ' 44' ' ' LEU . 87.9 t -100.22 132.6 45.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-N 116.126 -0.488 . . . . 61.23 110.299 -179.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.437 ' OD1' ' HB3' ' A' ' 134' ' ' ASP . 63.7 t30 -97.59 92.94 6.15 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.725 -1.213 . . . . 70.25 107.725 172.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.41 ' CE1' HD13 ' A' ' 44' ' ' LEU . 86.0 m-85 -65.3 -25.18 67.52 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.577 0.751 . . . . 62.24 111.355 177.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.459 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 1.1 t70 -54.74 -48.27 72.79 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.958 0.903 . . . . 72.32 110.291 168.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.504 ' HB1' ' HB2' ' C' ' 2' ' ' SER . . . -62.81 -45.41 92.77 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.571 0.748 . . . . 44.12 111.711 177.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.74 -35.98 79.66 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.365 0.666 . . . . 74.24 111.396 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -75.04 -35.68 61.89 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.504 -0.771 . . . . 64.32 109.858 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.608 ' SD ' HD23 ' A' ' 141' ' ' LEU . 17.8 mmt -57.99 -40.62 81.16 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 123.575 0.547 . . . . 73.13 111.464 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -49.77 -38.54 34.46 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.793 0.837 . . . . 74.41 111.966 177.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -88.83 -37.56 15.28 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.193 0.997 . . . . 73.23 111.514 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.608 HD23 ' SD ' ' A' ' 138' ' ' MET . 41.2 tp -62.65 -54.19 43.19 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.734 0.814 . . . . 75.42 111.954 -169.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.443 ' H ' ' H ' ' A' ' 143' ' ' GLN . 37.5 mt-30 -169.82 -14.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 124.709 1.203 . . . . 73.53 110.746 -177.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.443 ' H ' ' H ' ' A' ' 142' ' ' GLN . 14.3 tm0? 65.73 62.8 0.62 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.037 1.335 . . . . 72.14 108.674 -175.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -148.65 169.48 20.28 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.422 -0.808 . . . . 70.02 111.887 -173.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.36 167.36 18.6 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.542 -1.208 . . . . 71.44 110.888 170.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 139.53 93.75 0.26 Allowed Glycine 0 C--N 1.347 1.171 0 N-CA-C 110.946 -0.861 . . . . 70.01 110.946 -178.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -137.41 -85.29 0.31 Allowed 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 108.347 -0.983 . . . . 65.13 108.347 -176.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 64.65 63.97 3.89 Favored Glycine 0 C--N 1.355 1.618 0 N-CA-C 114.703 0.641 . . . . 63.2 114.703 171.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.7 t -84.85 161.81 19.76 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.626 0.37 . . . . 61.34 111.141 175.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -151.48 126.93 10.03 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.558 0.743 . . . . 73.04 109.05 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.51 102.7 3.91 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.875 0.87 . . . . 74.5 111.112 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.541 ' HA ' ' SD ' ' C' ' 138' ' ' MET . 10.8 m170 -148.99 128.66 13.22 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.429 0.692 . . . . 55.21 111.131 175.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -113.47 21.36 15.22 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.656 1.183 . . . . 62.24 110.189 173.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -108.22 140.57 41.26 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.64 0.776 . . . . 70.11 109.225 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.291 0 C-N-CA 124.0 0.92 . . . . 71.41 109.291 179.621 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.439 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 109.538 -0.542 . . . . 70.25 109.538 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 25.9 p -168.19 99.66 0.44 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.879 0.872 . . . . 75.43 109.287 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.482 ' H ' ' HB2' ' F' ' 99' ' ' ALA . 7.8 tp10 -123.75 173.52 8.08 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.365 0.666 . . . . 63.5 109.588 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.405 ' H ' ' HG3' ' B' ' 3' ' ' GLU . 17.2 mm-40 -76.26 -90.09 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.693 0.797 . . . . 73.21 112.044 -164.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -169.0 153.54 5.66 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.145 0.978 . . . . 65.34 109.176 -175.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 57.5 t30 -162.95 129.95 3.53 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.044 -1.095 . . . . 71.41 108.044 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 19.0 p -105.77 177.72 4.77 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.368 0.667 . . . . 74.13 112.121 -173.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 80.08 -43.73 0.26 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 126.621 1.968 . . . . 73.01 112.463 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.548 ' HB3' HG23 ' B' ' 89' ' ' ILE . 11.8 ptm 65.12 171.41 0.21 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 126.605 1.962 . . . . 71.03 115.442 172.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 5.0 t -135.79 126.93 28.04 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.46 -1.245 . . . . 72.33 107.701 168.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -130.82 144.18 51.27 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.909 0.484 . . . . 71.25 110.132 -176.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.422 ' HB3' ' HE2' ' F' ' 94' ' ' PHE . 59.0 tt0 -150.28 141.92 23.58 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 108.693 -0.855 . . . . 64.2 108.693 169.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 63.1 mt -81.44 125.2 39.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.527 -1.286 . . . . 73.1 107.527 171.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' GLN . . . . . 0.562 ' HB2' HG23 ' B' ' 83' ' ' ILE . 9.3 mm100 -90.16 -39.06 13.07 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.785 -0.45 . . . . 65.43 109.785 -176.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.532 ' HE ' HG21 ' A' ' 122' ' ' THR . 43.2 ttt180 -176.97 134.48 0.2 Allowed 'General case' 0 N--CA 1.477 0.917 0 O-C-N 123.919 0.762 . . . . 73.51 109.81 176.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.543 ' HB ' ' ND2' ' D' ' 127' ' ' ASN . 96.7 mt -115.63 141.37 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 107.851 -1.166 . . . . 54.13 107.851 173.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -168.44 151.35 5.41 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-O 121.386 0.613 . . . . 73.45 111.568 -174.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 89.5 m -79.06 126.9 31.3 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.953 -1.021 . . . . 60.2 109.24 172.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -89.61 -42.74 11.22 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.73 0.412 . . . . 70.01 110.071 169.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.1 t70 -140.65 136.82 33.07 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.573 -0.285 . . . . 75.43 110.541 -169.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.45 HD11 ' SG ' ' B' ' 113' ' ' CYS . 46.6 mm -126.18 137.09 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.015 0.926 . . . . 70.11 108.772 169.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.488 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 47.7 t -140.52 131.62 26.34 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.686 1.194 . . . . 75.23 107.866 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 80.2 t80 -143.68 121.81 12.18 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.319 -1.734 . . . . 73.0 106.319 170.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -126.71 113.59 16.87 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.117 -1.068 . . . . 62.51 108.117 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -106.7 87.21 2.66 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 106.633 -1.617 . . . . 65.1 106.633 167.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.66 -27.85 52.69 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.327 2.018 . . . . 74.21 110.962 -172.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.417 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 67.5 m-20 -109.82 11.49 24.31 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.507 1.123 . . . . 63.25 110.939 -177.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' B' ' 25' ' ' ALA . . . -30.48 -64.34 0.21 Allowed Pre-proline 0 N--CA 1.5 2.049 0 C-N-CA 125.517 1.527 . . . . 64.51 114.699 -172.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 14.3 Cg_exo -60.48 -34.8 92.52 Favored 'Trans proline' 0 C--N 1.395 3.015 0 C-N-CA 122.729 2.286 . . . . 70.31 112.199 -170.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.41 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 80.5 m80 -92.52 -39.76 11.19 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 114.442 -1.253 . . . . 71.24 112.39 -170.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.549 HG22 HD12 ' B' ' 68' ' ' LEU . 8.7 p -69.76 -12.66 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.032 0.533 . . . . 74.33 111.808 -171.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -69.76 -6.7 33.82 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.651 0.78 . . . . 71.44 112.92 173.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.452 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 29.4 pt20 -67.9 -22.11 65.1 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.816 0.447 . . . . 73.54 110.168 169.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.452 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 92.6 mttt -101.43 92.79 5.08 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.672 1.189 . . . . 74.31 109.869 -176.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -99.17 82.5 2.72 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.623 0.769 . . . . 63.53 110.057 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -157.01 -177.97 7.02 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.733 0.813 . . . . 52.4 109.61 172.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.711 ' HG3' ' HB ' ' F' ' 129' ' ' THR . 26.9 tt0 -66.86 114.77 19.41 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.63 0.772 . . . . 50.11 110.588 175.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.419 ' O ' HG23 ' B' ' 40' ' ' VAL . 41.8 Cg_endo -66.3 144.36 74.02 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 121.597 1.531 . . . . 73.55 110.678 172.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -71.4 113.3 8.29 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.525 -0.917 . . . . 70.22 108.525 172.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.494 HG11 HD11 ' B' ' 126' ' ' LEU . 57.4 t -106.5 150.41 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.063 0.945 . . . . 71.5 111.378 -170.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -138.0 119.29 14.66 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.925 1.29 . . . . 72.3 107.854 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.479 HD13 HD22 ' B' ' 128' ' ' LEU . 23.3 tp -85.43 138.62 32.13 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.359 -0.978 . . . . 34.31 108.359 173.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -140.05 112.38 7.77 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.858 -1.164 . . . . 45.24 107.858 -171.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 88.4 mt -103.1 139.57 38.45 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.275 0.63 . . . . 74.12 110.778 -171.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -148.28 146.02 28.43 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.126 1.37 . . . . 65.25 107.638 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.4 t -151.24 110.91 4.02 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 121.432 0.634 . . . . 65.32 111.737 -177.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.63 148.53 40.88 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.346 1.058 . . . . 74.2 108.367 175.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 20.8 p -142.8 177.18 8.51 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.429 0.691 . . . . 72.14 111.109 -172.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 58.7 p -156.2 134.6 11.52 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.314 1.045 . . . . 72.3 108.675 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -92.17 111.05 22.46 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.158 -1.053 . . . . 73.45 108.158 172.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 pp -120.53 17.31 12.09 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.945 0.898 . . . . 64.24 110.955 -175.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -162.3 150.86 14.88 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.321 1.048 . . . . 70.13 109.3 175.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -67.15 116.58 8.11 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.578 0.351 . . . . 53.24 110.341 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 72.35 -3.61 2.25 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.422 1.489 . . . . 61.12 112.357 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.577 HG21 ' HB3' ' F' ' 93' ' ' PHE . 44.0 t -119.32 102.15 12.48 Favored 'Isoleucine or valine' 0 C--N 1.347 0.483 0 N-CA-C 107.45 -1.315 . . . . 44.21 107.45 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.503 ' CE2' ' HB ' ' B' ' 58' ' ' VAL . 0.1 OUTLIER -94.31 -177.96 4.44 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.736 -0.838 . . . . 75.34 108.736 -178.055 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.519 ' HG2' ' HB ' ' B' ' 83' ' ' ILE . 4.2 tm-20 -142.34 118.54 10.76 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 107.218 -1.401 . . . . 75.13 107.218 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.503 ' HB ' ' CE2' ' B' ' 56' ' ' TYR . 12.0 p -111.09 148.19 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-O 121.094 0.473 . . . . 72.23 110.938 -178.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.474 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 28.7 t -119.02 134.36 62.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.052 -1.092 . . . . 73.14 108.052 171.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 59.1 tp -114.21 103.39 11.06 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 108.291 -1.003 . . . . 51.12 108.291 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -84.81 109.48 18.12 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.593 0.711 . . . . 74.14 109.241 175.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.433 HG13 HD11 ' B' ' 42' ' ' LEU . 56.1 t -107.06 103.44 15.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 107.769 -1.197 . . . . 51.53 107.769 174.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.9 m -102.21 132.69 47.98 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.738 -0.664 . . . . 72.22 109.567 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.894 HG11 HD21 ' B' ' 126' ' ' LEU . 82.6 t -116.76 117.31 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.138 0.975 . . . . 73.13 109.362 174.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 10.6 m -87.23 140.42 29.56 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.126 -1.064 . . . . 71.23 108.126 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.9 140.39 23.38 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 118.045 0.384 . . . . 65.54 110.413 175.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.462 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 52.6 p -146.44 133.13 19.93 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.058 0.456 . . . . 43.45 111.598 -175.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.549 HD12 HG22 ' B' ' 31' ' ' VAL . 72.9 mt -100.11 100.96 11.89 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.341 1.056 . . . . 75.35 108.661 176.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.58 -134.73 24.46 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.992 -0.549 . . . . 72.13 112.248 -176.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -83.01 4.28 26.66 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.755 0.822 . . . . 64.53 113.033 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.417 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 12.0 pt-20 -127.1 150.91 49.26 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.851 0.296 . . . . 74.01 110.49 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 85.8 m -69.4 135.84 50.85 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 123.533 0.521 . . . . 72.12 110.464 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.494 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -85.88 -63.64 1.29 Allowed 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.414 -1.328 . . . . 72.0 107.414 175.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -151.92 162.87 40.37 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.326 -1.306 . . . . 70.14 110.58 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 52.0 mt -132.32 110.42 10.57 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 105.443 -2.058 . . . . 73.31 105.443 175.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 34.4 t -116.96 145.32 43.71 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.323 -0.991 . . . . 75.34 108.323 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.488 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.9 tt0 -155.1 132.03 10.79 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.306 -0.998 . . . . 73.43 108.306 -177.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.47 HG21 ' HB3' ' B' ' 113' ' ' CYS . 94.7 t -127.26 143.53 40.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.973 -1.121 . . . . 43.1 107.973 174.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.486 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 26.2 mt-30 -119.6 86.99 2.65 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.092 -1.077 . . . . 60.03 108.092 174.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.462 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.5 tp-100 -82.95 102.84 11.97 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 114.738 -1.119 . . . . 74.42 109.281 -177.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -87.74 162.71 33.1 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-N 115.893 -0.594 . . . . 62.21 111.634 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.9 125.76 1.34 Allowed Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.544 -1.022 . . . . 62.34 110.544 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.562 HG23 ' HB2' ' B' ' 14' ' ' GLN . 18.8 tt -95.68 131.01 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 108.57 -0.9 . . . . 74.22 108.57 175.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -137.0 141.25 42.54 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.604 0.762 . . . . 74.53 109.437 -175.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.2 m -88.77 106.93 18.68 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.658 -0.867 . . . . 72.51 108.658 172.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.504 HG22 HD12 ' F' ' 97' ' ' ILE . 23.8 mm -97.37 109.66 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 107.873 -1.158 . . . . 73.22 107.873 -173.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.31 172.14 18.69 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.025 0.441 . . . . 75.43 111.58 -172.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 83.28 -47.11 3.76 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.506 -0.77 . . . . 73.3 112.631 -178.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.548 HG23 ' HB3' ' B' ' 9' ' ' MET . 1.0 OUTLIER -78.52 159.43 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 109.743 -0.465 . . . . 74.21 109.743 168.647 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -165.75 145.16 6.33 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 123.556 0.535 . . . . 74.32 110.86 -171.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.97 -100.54 2.7 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-O 120.174 -0.237 . . . . 73.02 113.347 175.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.1 m -95.96 -54.9 3.16 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 122.08 0.943 . . . . 71.34 110.12 -175.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -67.58 -18.23 64.92 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 113.52 -1.673 . . . . 61.44 111.383 -171.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.672 ' HB2' HD11 ' F' ' 97' ' ' ILE . 22.6 ptt? -61.42 -44.25 97.45 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.836 0.854 . . . . 74.52 113.057 -176.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.02 -11.72 60.01 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.049 0.54 . . . . 71.21 112.142 -175.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -63.79 -38.56 91.57 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.129 0.572 . . . . 64.32 110.359 168.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.5 t -58.75 -52.67 64.7 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.258 0.551 . . . . 74.02 111.164 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.8 pp -83.44 -27.19 29.7 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.525 -0.761 . . . . 73.4 112.146 -174.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.21 -16.62 62.37 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-O 120.016 -0.324 . . . . 72.22 113.338 -176.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.415 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -136.82 -58.13 0.72 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.784 0.434 . . . . 70.14 112.093 -170.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -66.37 -43.53 85.69 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.125 0.57 . . . . 74.13 112.196 -173.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.4 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 59.7 m -71.38 -44.81 13.39 Favored Pre-proline 0 CA--C 1.562 1.437 0 CA-C-O 118.567 -0.73 . . . . 74.2 112.33 -175.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.4 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 50.1 Cg_exo -59.17 -31.83 96.06 Favored 'Trans proline' 0 C--N 1.394 2.934 0 C-N-CA 121.887 1.725 . . . . 65.3 113.247 168.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -62.11 -36.81 82.87 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.192 0.597 . . . . 72.4 110.303 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 59.1 mt -65.39 -40.86 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.489 0.716 . . . . 73.35 110.433 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 94.7 mt -76.26 -24.88 54.51 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.698 -0.683 . . . . 71.22 112.668 -173.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -62.32 -45.04 89.93 Favored Pre-proline 0 CA--C 1.566 1.587 0 CA-C-O 117.78 -1.105 . . . . 72.41 113.691 -173.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -52.3 -43.33 54.55 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.516 2.144 . . . . 73.22 113.371 173.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.462 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 95.3 m-85 -64.17 -45.24 89.29 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.285 0.634 . . . . 74.44 110.149 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.87 82.37 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.457 -0.792 . . . . 33.31 111.049 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.491 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 65.0 ttt-85 -64.56 -61.34 2.27 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.454 1.102 . . . . 72.1 110.989 -175.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -67.44 -25.85 66.11 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 123.505 0.503 . . . . 45.44 111.032 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.552 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.9 t -66.19 -40.75 90.63 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 109.681 -0.488 . . . . 63.5 109.681 176.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.549 HD13 HG23 ' B' ' 64' ' ' VAL . 70.3 mt -62.9 -54.47 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.784 0.834 . . . . 60.32 110.418 172.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 6.3 m -60.89 -30.68 70.3 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.886 0.875 . . . . 52.43 111.68 -173.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.454 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 44.4 t -65.41 -48.63 72.17 Favored 'General case' 0 C--N 1.347 0.5 0 C-N-CA 123.6 0.76 . . . . 73.35 110.191 174.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.552 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.4 mmt -68.35 -29.74 68.54 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.032 0.533 . . . . 60.32 111.194 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.428 HG23 ' O ' ' B' ' 114' ' ' ILE . 69.5 t -65.37 -44.36 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.442 1.097 . . . . 74.25 110.02 173.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 40.5 t -68.72 -29.92 68.44 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.241 -0.89 . . . . 64.44 111.174 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' B' ' 116' ' ' SER . 88.7 mtt-85 -65.14 -39.7 93.37 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 108.934 -0.765 . . . . 54.44 108.934 174.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.0 -5.28 75.09 Favored Glycine 0 C--N 1.356 1.675 0 O-C-N 123.651 0.595 . . . . 51.05 113.558 172.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 8.0 m 67.58 31.11 6.31 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.136 1.374 . . . . 73.1 111.006 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -91.68 160.45 36.38 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-N 114.821 -1.081 . . . . 73.41 111.143 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.445 ' HG3' ' HB2' ' F' ' 131' ' ' TRP . 82.3 Cg_exo -51.31 157.72 4.33 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.838 3.025 . . . . 75.34 115.598 177.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.588 ' O ' ' HA ' ' F' ' 129' ' ' THR . 55.1 tp60 -58.26 113.91 2.16 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.257 1.423 . . . . 74.51 111.529 -177.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.894 HD21 HG11 ' B' ' 64' ' ' VAL . 32.5 tp -106.96 102.37 11.73 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.075 0.464 . . . . 74.33 109.771 -172.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 127' ' ' ASN . . . . . 0.489 HD21 ' HG3' ' B' ' 125' ' ' GLN . 29.2 m-80 -101.07 117.88 35.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.271 0.629 . . . . 71.34 109.431 -177.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.491 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 69.4 mt -85.89 135.9 33.5 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 109.886 -0.413 . . . . 73.21 109.886 172.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.34 138.43 74.94 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 123.494 0.718 . . . . 41.05 110.807 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.492 ' HG3' HD11 ' D' ' 16' ' ' ILE . 21.3 Cg_endo -60.19 101.99 0.17 Allowed 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 123.207 2.605 . . . . 61.21 111.946 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 18.1 m -90.15 109.95 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 122.013 0.911 . . . . 65.12 109.38 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -88.2 85.95 7.01 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.068 -0.969 . . . . 75.24 109.402 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -53.53 -33.62 55.2 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 114.569 -1.196 . . . . 75.05 111.641 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.415 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 6.0 m-20 -52.76 -52.68 55.52 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.362 1.065 . . . . 65.41 111.87 177.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.487 ' HA ' ' HB3' ' B' ' 138' ' ' MET . . . -69.86 -32.33 70.64 Favored 'General case' 0 C--O 1.218 -0.559 0 O-C-N 124.025 0.828 . . . . 75.12 110.96 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 tt -57.41 -42.43 82.27 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.927 0.891 . . . . 74.21 110.248 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -81.67 -36.68 28.49 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.116 0.566 . . . . 75.52 111.525 174.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 138' ' ' MET . . . . . 0.487 ' HB3' ' HA ' ' B' ' 135' ' ' ALA . 26.7 ttt -68.18 -19.86 64.82 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.677 0.791 . . . . 53.14 111.771 -174.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -74.76 -22.3 58.86 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.93 0.492 . . . . 71.41 110.754 178.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -90.09 -34.36 15.94 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.147 0.579 . . . . 75.44 110.186 174.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 7.6 mp -100.16 32.69 2.88 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.971 0.908 . . . . 73.1 110.724 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.8 110.15 9.99 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.146 0.579 . . . . 65.03 110.332 -173.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -156.56 179.74 8.97 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.661 1.184 . . . . 73.35 110.09 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 68.12 107.24 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.698 1.599 . . . . 72.14 111.007 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.95 0.72 1.99 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.036 0.934 . . . . 63.42 111.203 174.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.22 78.79 1.08 Allowed Glycine 0 C--N 1.354 1.574 0 O-C-N 123.488 0.492 . . . . 45.2 112.209 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -111.29 162.54 14.9 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.348 1.059 . . . . 74.23 110.553 -175.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -78.37 141.37 24.77 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 115.301 -0.863 . . . . 60.52 112.096 176.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 41.5 m -143.54 143.36 31.5 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.937 0.895 . . . . 64.14 109.058 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 75.27 133.27 0.05 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.271 1.428 . . . . 73.51 112.575 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -158.38 130.0 6.65 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 124.469 1.107 . . . . 74.03 108.631 171.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -114.97 154.48 28.69 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.713 0.805 . . . . 62.34 110.368 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -153.88 93.55 1.66 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.342 1.057 . . . . 72.3 109.017 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -169.76 152.57 4.59 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.687 0.795 . . . . 74.43 109.719 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 C-N-CA 123.967 0.907 . . . . 71.24 108.571 176.665 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 40.3 mtp . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 121.728 0.775 . . . . 71.24 109.663 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 2' ' ' SER . . . . . 0.504 ' HB2' ' HB1' ' A' ' 135' ' ' ALA . 19.9 m -144.43 -131.61 0.08 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.604 -1.18 . . . . 60.04 108.376 -167.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 3' ' ' GLU . . . . . 0.442 ' HA ' ' HB2' ' C' ' 154' ' ' ASP . 10.2 pt-20 -119.09 140.93 49.27 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 106.749 -1.574 . . . . 65.15 106.749 153.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 4' ' ' GLN . . . . . 0.64 ' HG2' ' HA ' ' C' ' 154' ' ' ASP . 13.8 mm-40 -75.25 98.38 3.76 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.33 -0.619 . . . . 71.1 109.33 174.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -59.67 -60.12 4.35 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 124.226 0.954 . . . . 73.35 109.624 172.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -76.95 178.54 6.85 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.244 0.618 . . . . 72.1 109.599 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 5.1 t -51.02 142.72 11.57 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.396 1.078 . . . . 74.22 112.111 176.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -63.5 -76.4 0.07 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.911 0.884 . . . . 54.53 110.998 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.468 ' HE2' HD13 ' C' ' 89' ' ' ILE . 47.2 ttm 56.7 113.22 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.679 1.192 . . . . 74.34 111.31 -173.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 11.9 m -86.38 74.69 9.92 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.781 -0.822 . . . . 63.54 108.781 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.869 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 69.1 t80 -90.89 121.44 32.74 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.828 -1.078 . . . . 74.23 108.094 178.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -136.81 122.69 20.06 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.641 -0.874 . . . . 70.24 108.641 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.432 HD11 HG21 ' C' ' 105' ' ' ILE . 46.5 mt -83.05 126.78 40.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 109.279 -0.637 . . . . 45.11 109.279 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.409 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 13.7 mm100 -87.06 -44.27 11.69 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.852 -0.796 . . . . 72.31 108.852 174.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 179.96 151.06 0.4 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.032 1.333 . . . . 74.12 109.462 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 83.7 mt -123.44 128.44 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 107.877 -1.157 . . . . 70.21 107.877 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.608 ' HB3' HG23 ' D' ' 122' ' ' THR . 35.5 p90 -161.27 149.92 16.01 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.318 0.58 . . . . 75.01 111.56 -167.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.7 p -80.61 119.72 23.62 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.35 -0.841 . . . . 74.3 110.575 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp -71.88 -36.62 70.14 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.619 -0.882 . . . . 73.42 108.619 169.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -148.85 148.43 29.89 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-N 115.092 -0.958 . . . . 72.21 110.006 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.1 mt -140.64 140.47 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 106.347 -1.724 . . . . 54.11 106.347 175.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 28.3 t -154.12 146.64 24.07 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.204 0.526 . . . . 74.12 110.526 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -155.17 129.37 8.9 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 107.013 -1.477 . . . . 74.04 107.013 172.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -137.69 123.96 20.55 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.247 0.619 . . . . 73.35 109.544 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -121.38 84.13 41.04 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 107.145 -1.428 . . . . 71.11 107.145 166.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.47 -24.07 43.01 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 122.422 2.081 . . . . 74.1 111.578 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -104.0 17.27 24.45 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.36 1.064 . . . . 74.21 110.516 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.42 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -47.53 -57.1 10.54 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 113.526 0.936 . . . . 75.4 113.526 -171.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.42 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 21.7 Cg_exo -63.04 -39.16 41.51 Favored 'Trans proline' 0 C--N 1.393 2.884 0 C-N-CA 122.112 1.874 . . . . 64.02 111.962 -176.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -69.26 -37.06 77.75 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.367 -1.288 . . . . 73.24 111.996 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.766 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.8 p -82.55 -21.03 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 N-CA-C 112.907 0.706 . . . . 62.41 112.907 -176.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -66.28 -29.22 69.4 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 120.856 0.36 . . . . 71.44 111.652 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -94.96 14.18 22.55 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.848 0.859 . . . . 71.54 111.371 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -104.55 158.26 16.61 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.708 0.803 . . . . 62.25 109.668 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -70.25 115.38 9.37 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.672 0.789 . . . . 75.24 110.158 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -80.6 91.57 5.84 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.243 1.017 . . . . 72.22 111.333 -171.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 37' ' ' GLN . . . . . 0.477 ' H ' HD22 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -139.58 73.72 34.89 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.368 1.067 . . . . 74.03 109.206 169.967 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -79.85 149.13 20.3 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.282 1.988 . . . . 71.01 112.192 -174.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -86.91 93.19 9.25 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.637 -1.616 . . . . 64.13 106.637 165.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.447 HG11 HG12 ' F' ' 135' ' ' VAL . 56.2 t -68.3 102.84 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 108.429 -0.952 . . . . 71.3 108.429 177.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -109.81 102.5 11.28 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.149 -1.056 . . . . 64.42 108.149 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.496 HD23 ' HB ' ' F' ' 135' ' ' VAL . 4.2 pp -87.96 139.57 30.38 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.011 -1.107 . . . . 62.4 108.011 172.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -139.86 118.64 12.42 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.148 -0.686 . . . . 75.42 109.148 -175.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 92.7 mt -111.95 138.95 47.88 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.77 0.828 . . . . 53.51 111.369 -171.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -147.62 127.08 13.17 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.788 1.235 . . . . 74.04 107.96 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 8.7 t -120.64 145.02 47.84 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 109.447 -0.575 . . . . 61.22 109.447 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.39 150.55 40.81 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.473 0.709 . . . . 75.01 109.781 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 32.8 m -141.64 155.0 45.73 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.053 0.541 . . . . 74.35 110.74 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 61.7 p -151.85 129.86 11.81 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.082 0.953 . . . . 63.54 109.06 178.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -73.71 117.44 15.48 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.04 -0.726 . . . . 72.04 109.04 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' C' ' 57' ' ' GLU . 71.1 mt -86.89 -43.56 12.34 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.41 0.684 . . . . 73.23 109.976 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.26 -173.93 4.52 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.341 -0.845 . . . . 61.55 110.249 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.3 107.74 0.81 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.011 0.924 . . . . 72.05 110.217 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 66.37 22.05 10.84 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.221 1.008 . . . . 75.13 111.026 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 96.0 t -119.39 119.31 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.025 0.93 . . . . 65.31 108.732 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -127.15 126.82 43.56 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.289 1.036 . . . . 72.42 108.988 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.629 ' HB2' HD11 ' C' ' 51' ' ' LEU . 35.9 tt0 -83.9 126.19 32.74 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.402 -0.962 . . . . 73.23 108.402 168.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 88.6 t -118.05 137.09 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.25 -0.648 . . . . 62.13 109.25 173.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.459 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 44.8 t -128.67 145.26 35.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.096 0.958 . . . . 73.02 108.869 177.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.455 HD11 ' CZ ' ' C' ' 133' ' ' PHE . 0.0 OUTLIER -126.72 104.35 8.03 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.476 -1.305 . . . . 75.41 107.476 177.783 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -81.98 106.17 13.68 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.285 -1.006 . . . . 75.44 108.285 171.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 23.2 t -104.65 133.57 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.907 -1.145 . . . . 72.13 107.907 172.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 84.9 m -126.97 136.74 52.68 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.385 -0.969 . . . . 62.35 108.385 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.496 HG23 HD13 ' C' ' 114' ' ' ILE . 85.2 t -122.56 114.12 41.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 109.422 -0.584 . . . . 62.42 109.422 173.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 18.7 m -98.54 137.34 37.34 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.716 -0.846 . . . . 74.1 108.716 172.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.79 113.81 17.12 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.14 -1.43 . . . . 70.31 107.14 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 44.0 m -136.76 128.61 29.15 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.464 0.477 . . . . 75.25 110.17 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.477 HD22 ' H ' ' C' ' 37' ' ' GLN . 49.8 mt -84.41 29.05 0.61 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.151 1.38 . . . . 61.52 111.265 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.64 -91.04 0.75 Allowed Glycine 0 C--N 1.35 1.345 0 N-CA-C 111.169 -0.772 . . . . 71.13 111.169 -175.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -90.67 -33.7 15.71 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.55 0.74 . . . . 71.15 109.27 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -88.87 122.18 31.99 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.597 1.159 . . . . 74.22 110.463 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 89.1 m -81.73 129.09 34.6 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.482 -0.562 . . . . 63.43 109.482 169.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.766 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -80.72 -58.45 3.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.791 0.836 . . . . 74.14 110.059 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -157.12 167.98 28.8 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.85 0.833 . . . . 75.32 111.224 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -131.51 137.35 48.5 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 106.655 -1.609 . . . . 53.21 106.655 166.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.604 ' SG ' HG23 ' C' ' 114' ' ' ILE . 41.8 t -137.07 149.32 47.32 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.582 -0.896 . . . . 54.45 108.582 176.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -157.78 133.65 9.27 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.44 -0.578 . . . . 71.3 109.44 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 73.7 t -132.75 132.46 59.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 124.143 0.977 . . . . 75.04 108.889 174.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -104.39 87.13 2.65 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.295 -1.002 . . . . 74.0 108.295 173.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -79.39 97.92 6.54 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.349 -0.841 . . . . 70.33 109.145 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -83.72 177.86 52.39 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 115.781 -0.645 . . . . 41.43 112.293 175.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 178.18 134.27 2.04 Favored Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 111.356 -0.698 . . . . 74.41 111.356 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.409 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 35.4 mm -88.7 125.81 41.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.361 -0.977 . . . . 71.23 108.361 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -130.3 117.86 20.44 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.47 0.708 . . . . 74.1 109.37 -178.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 11.4 p -85.01 102.19 12.99 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 108.466 -0.939 . . . . 72.23 108.466 172.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.435 HG21 ' HE1' ' C' ' 94' ' ' MET . 24.4 mt -114.29 129.54 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.814 0.845 . . . . 62.41 109.949 -175.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.86 171.15 14.86 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.654 0.782 . . . . 54.12 110.385 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.81 -35.06 4.62 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 116.26 -0.427 . . . . 50.44 113.075 176.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.468 HD13 ' HE2' ' C' ' 9' ' ' MET . 27.7 pt -108.12 171.71 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.251 0.62 . . . . 65.41 111.709 -171.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -167.19 156.93 10.79 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.801 0.84 . . . . 71.34 109.923 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.07 -115.62 6.24 Favored Glycine 0 C--N 1.349 1.304 0 O-C-N 123.324 0.39 . . . . 61.1 113.535 171.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 58.3 p -64.22 -40.07 95.28 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 123.688 0.795 . . . . 72.22 110.953 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -68.37 -47.66 66.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.899 0.88 . . . . 74.32 111.097 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.529 ' HE3' ' HA ' ' C' ' 94' ' ' MET . 5.2 tpt -53.86 -49.86 67.55 Favored 'General case' 0 C--N 1.352 0.694 0 O-C-N 123.875 0.734 . . . . 54.14 111.705 173.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.69 -38.76 89.01 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 123.637 0.585 . . . . 72.11 111.032 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 96' ' ' HIS . . . . . 0.543 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 44.5 t-80 -71.59 -19.68 62.1 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.553 1.141 . . . . 75.13 111.483 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 9.3 t -82.2 -51.96 7.44 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.517 -0.92 . . . . 73.31 108.517 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.11 -30.11 69.19 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.841 -1.072 . . . . 64.1 112.978 -172.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.94 11.28 29.54 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-O 119.45 -0.639 . . . . 63.3 113.64 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -151.34 -61.14 0.18 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 117.535 0.667 . . . . 35.54 112.222 -176.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -74.04 -53.31 10.28 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.422 0.689 . . . . 74.41 112.14 -169.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.869 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 34.5 m -58.56 -49.18 94.88 Favored Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.15 0.98 . . . . 71.24 111.924 176.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.521 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 77.1 Cg_exo -53.83 -35.76 80.44 Favored 'Trans proline' 0 C--N 1.402 3.384 0 C-N-CA 122.686 2.257 . . . . 61.24 113.24 173.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -68.76 -33.15 73.4 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.418 0.687 . . . . 60.24 111.708 -176.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.535 HD12 ' NH1' ' A' ' 111' ' ' ARG . 31.4 mm -70.11 -43.03 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 122.332 0.253 . . . . 53.01 110.691 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.403 ' HA ' ' CD1' ' C' ' 109' ' ' TYR . 1.7 pp -95.93 -3.56 45.01 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.372 0.878 . . . . 74.43 113.372 -176.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 107' ' ' PHE . . . . . 0.504 ' HZ ' HD22 ' C' ' 128' ' ' LEU . 56.0 t80 -55.06 -48.15 96.76 Favored Pre-proline 0 N--CA 1.485 1.317 0 CA-C-O 117.742 -1.123 . . . . 74.22 113.578 172.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -60.94 -30.67 90.4 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 121.738 1.626 . . . . 73.25 112.979 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.403 ' CD1' ' HA ' ' C' ' 106' ' ' LEU . 19.3 m-85 -68.66 -43.05 77.01 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.371 0.669 . . . . 73.01 109.479 176.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.54 -39.34 94.16 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.041 -0.981 . . . . 74.31 110.625 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -61.87 -52.77 62.75 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.382 1.073 . . . . 70.45 110.191 176.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -67.22 -28.37 68.01 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.596 0.759 . . . . 72.11 110.383 -174.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.49 ' O ' ' SD ' ' C' ' 117' ' ' MET . 8.2 t -71.05 -49.2 47.32 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 122.997 0.519 . . . . 70.12 110.334 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.604 HG23 ' SG ' ' C' ' 76' ' ' CYS . 86.8 mt -59.77 -47.28 91.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 123.29 0.636 . . . . 74.15 110.167 174.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 99.4 m -63.53 -31.05 72.1 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.812 0.845 . . . . 61.42 111.109 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 25.2 t -65.51 -48.42 72.59 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 108.808 -0.812 . . . . 73.13 108.808 171.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.901 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.2 OUTLIER -56.29 -43.19 78.6 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.953 0.901 . . . . 75.24 112.485 178.441 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.426 HG23 ' O ' ' C' ' 114' ' ' ILE . 87.9 t -69.33 -41.89 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.869 0.868 . . . . 74.05 110.26 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 30.6 t -64.1 -37.8 88.75 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.111 -0.949 . . . . 73.43 111.454 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.535 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 60.3 mtt-85 -69.64 -40.14 76.69 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.149 -0.932 . . . . 61.44 110.222 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.64 2.26 64.03 Favored Glycine 0 C--N 1.355 1.631 0 O-C-N 123.796 0.685 . . . . 74.21 112.847 174.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 44.2 p 60.94 28.19 18.0 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.952 1.701 . . . . 70.04 113.098 168.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -83.23 144.08 46.27 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.12 -1.067 . . . . 62.21 108.12 169.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -44.75 141.93 5.4 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.791 2.994 . . . . 72.14 114.071 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.494 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 13.3 mm-40 -59.22 124.75 21.02 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.908 0.755 . . . . 75.21 112.802 -170.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.405 HD21 HG13 ' C' ' 40' ' ' VAL . 40.1 tp -121.38 103.26 8.82 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.268 -1.012 . . . . 72.41 108.268 -176.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -96.19 116.0 28.31 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.387 -0.824 . . . . 74.42 109.658 -176.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.504 HD22 ' HZ ' ' C' ' 107' ' ' PHE . 0.9 OUTLIER -71.59 117.4 13.1 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.588 0.755 . . . . 75.22 109.027 -178.838 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.74 159.15 70.98 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 123.95 0.9 . . . . 73.11 111.654 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -55.49 100.74 0.08 OUTLIER 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.726 2.284 . . . . 63.31 113.199 174.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.9 t -99.56 111.09 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 108.218 -1.03 . . . . 63.12 108.218 172.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -86.06 104.38 15.61 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.407 0.683 . . . . 73.43 110.722 -175.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.455 ' CZ ' HD11 ' C' ' 60' ' ' LEU . 82.9 m-85 -64.51 -23.76 67.38 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.164 0.986 . . . . 72.43 112.041 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.457 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 2.4 t70 -65.25 -36.67 84.84 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.766 0.826 . . . . 62.3 109.753 178.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.4 -19.32 33.73 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.382 -1.281 . . . . 55.34 111.614 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 36.0 mt -82.88 -22.35 34.0 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 120.895 0.378 . . . . 62.21 110.697 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -75.1 -15.58 60.6 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.473 0.709 . . . . 65.13 110.469 177.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.541 ' SD ' ' HA ' ' A' ' 152' ' ' HIS . 48.2 ttp -43.92 -60.71 1.71 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.796 1.639 . . . . 74.13 112.325 173.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -72.87 -33.21 65.93 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.909 -1.041 . . . . 71.13 111.191 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -71.05 -155.98 0.03 OUTLIER 'General case' 0 CA--C 1.574 1.881 0 C-N-CA 123.635 0.774 . . . . 74.35 111.206 -175.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.597 HD23 ' HG2' ' C' ' 143' ' ' GLN . 32.2 tp 58.87 -85.23 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.013 1.325 . . . . 70.4 111.352 -176.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 175.96 -44.91 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.215 1.406 . . . . 71.22 108.425 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 143' ' ' GLN . . . . . 0.597 ' HG2' HD23 ' C' ' 141' ' ' LEU . 11.0 pt20 -83.61 168.83 15.99 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.305 -0.861 . . . . 63.11 110.907 179.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.6 141.57 25.91 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 106.281 -1.748 . . . . 71.45 106.281 172.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 70.65 59.99 0.21 Allowed 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.527 1.131 . . . . 72.25 109.333 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.82 -140.85 1.17 Allowed Glycine 0 C--N 1.349 1.261 0 CA-C-N 114.155 -1.384 . . . . 62.23 112.033 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.22 -172.15 3.8 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.035 0.534 . . . . 72.33 110.992 -176.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -160.28 64.9 0.28 Allowed Glycine 0 C--N 1.342 0.895 0 N-CA-C 110.203 -1.159 . . . . 72.44 110.203 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 10.5 t -64.73 139.92 58.81 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-O 121.254 0.55 . . . . 73.34 111.525 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.95 131.01 54.08 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.917 0.887 . . . . 75.33 109.032 -178.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 151' ' ' GLU . . . . . 0.551 ' HG2' ' H ' ' C' ' 152' ' ' HIS . 30.7 tt0 -172.98 -173.34 0.94 Allowed 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 107.859 -1.163 . . . . 75.25 107.859 -174.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 152' ' ' HIS . . . . . 0.551 ' H ' ' HG2' ' C' ' 151' ' ' GLU . 86.5 m-70 80.27 -177.31 0.07 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.167 1.387 . . . . 71.21 111.526 170.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.12 159.87 37.66 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.2 -1.407 . . . . 73.43 107.2 -176.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 154' ' ' ASP . . . . . 0.64 ' HA ' ' HG2' ' C' ' 4' ' ' GLN . 12.2 t70 -52.85 102.44 0.05 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.513 1.125 . . . . 63.2 111.549 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.274 0 N-CA-C 107.843 -1.169 . . . . 61.25 107.843 177.636 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptt? . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 109.457 -0.571 . . . . 63.2 109.457 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 47.2 t 61.57 100.51 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.891 1.276 . . . . 63.42 110.652 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -78.65 77.47 5.13 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-O 121.723 0.773 . . . . 74.22 110.562 -176.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 4' ' ' GLN . . . . . 0.55 ' HB2' ' HD2' ' E' ' 95' ' ' LYS . 74.2 mm-40 -138.53 128.77 25.77 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 106.68 -1.6 . . . . 74.05 106.68 175.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -169.68 -44.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.88 0.472 . . . . 73.22 110.372 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -75.96 98.71 4.33 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.592 0.757 . . . . 62.33 109.882 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.425 HG21 ' HE1' ' E' ' 94' ' ' PHE . 6.6 t -166.36 165.0 17.48 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.128 0.971 . . . . 71.23 109.409 179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -71.25 113.11 7.95 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.686 0.795 . . . . 75.13 109.897 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -31.74 123.76 0.27 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 125.717 1.607 . . . . 75.25 113.253 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 15.1 t -113.46 130.92 56.21 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 122.959 0.504 . . . . 73.32 109.644 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.572 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 51.0 t80 -138.64 93.88 2.77 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.397 -1.335 . . . . 73.44 107.397 174.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -124.3 126.11 45.49 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.754 -0.832 . . . . 72.04 108.754 -177.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 mt -82.41 121.35 35.44 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 N-CA-C 108.773 -0.825 . . . . 73.31 108.773 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -85.26 -29.66 24.44 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.282 1.033 . . . . 74.31 110.303 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -170.14 142.11 2.22 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 123.625 0.578 . . . . 72.15 110.426 -177.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.492 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.9 mp -118.24 130.4 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 105.503 -2.036 . . . . 71.23 105.503 170.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.4 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 25.2 p90 -159.99 141.92 12.98 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 118.701 0.682 . . . . 74.24 111.359 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 71.3 p -78.36 110.8 13.73 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.882 -1.054 . . . . 61.12 109.176 174.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.4 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 31.7 mtpt -78.41 -24.76 46.06 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.562 -0.744 . . . . 75.01 109.253 176.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.707 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 2.8 t70 -149.97 147.96 28.5 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.665 1.186 . . . . 71.34 110.02 174.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.901 HG21 ' HE2' ' C' ' 117' ' ' MET . 83.1 mt -139.51 146.51 25.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 126.07 1.748 . . . . 73.11 107.598 174.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 39.9 t -155.86 145.38 21.0 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.167 0.587 . . . . 75.12 110.428 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.513 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 79.7 t80 -151.98 139.88 20.01 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.703 -1.591 . . . . 74.42 106.703 171.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.441 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 40.6 mt-10 -142.99 146.3 33.77 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.404 0.681 . . . . 72.13 109.604 -175.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.75 85.57 6.55 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.039 0.935 . . . . 53.52 108.573 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.87 -36.9 21.72 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.348 2.699 . . . . 61.23 112.935 -177.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -103.66 16.17 27.06 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.14 -0.936 . . . . 74.11 110.749 -173.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -34.06 -66.2 0.23 Allowed Pre-proline 0 CA--C 1.571 1.761 0 N-CA-C 116.292 1.96 . . . . 73.54 116.292 -162.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.406 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 95.7 Cg_endo -75.82 -21.96 13.88 Favored 'Trans proline' 0 C--N 1.386 2.529 0 CA-C-N 123.977 2.456 . . . . 75.11 114.165 -178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -70.51 -41.81 72.12 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.712 1.205 . . . . 73.31 110.306 178.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.63 HG21 ' HA ' ' D' ' 73' ' ' ALA . 13.4 p -82.53 -20.53 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-N 115.233 -0.894 . . . . 63.31 111.56 -173.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.406 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.5 m-30 -62.41 -29.04 70.21 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 112.299 0.481 . . . . 65.22 112.299 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -63.87 -14.66 55.14 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.42 1.088 . . . . 73.32 111.567 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -93.6 109.36 20.98 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.829 1.252 . . . . 74.11 110.1 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -102.94 92.89 4.76 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.175 0.59 . . . . 53.44 111.059 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 42.4 p90 -168.46 -177.28 3.12 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.838 1.255 . . . . 65.35 108.421 168.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.448 ' HB2' ' HB2' ' E' ' 128' ' ' ALA . 61.0 tp60 -74.02 118.32 68.54 Favored Pre-proline 0 N--CA 1.479 0.985 0 CA-C-O 119.09 -0.481 . . . . 65.52 109.834 177.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -58.95 137.39 79.54 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.332 2.021 . . . . 70.31 111.195 174.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 25.5 mt-10 -62.81 106.9 0.87 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.447 -0.946 . . . . 73.12 108.447 174.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.668 HG13 HG13 ' D' ' 64' ' ' VAL . 57.2 t -99.96 108.48 22.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.374 -0.602 . . . . 55.1 109.374 -175.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -86.76 109.69 19.41 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.387 -1.338 . . . . 73.44 107.387 169.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.592 HD11 HG13 ' D' ' 62' ' ' VAL . 40.4 tp -96.08 123.31 39.64 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.5 -0.926 . . . . 74.32 108.5 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -118.86 143.91 46.69 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 106.282 -1.747 . . . . 63.02 106.282 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.626 ' H ' ' HB3' ' E' ' 112' ' ' ASN . 94.9 mt -136.73 148.23 47.18 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.419 0.688 . . . . 65.15 109.159 -174.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.755 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.8 t70 -145.38 136.32 24.64 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.426 -0.953 . . . . 72.12 108.426 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.3 t -102.43 158.42 16.22 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.967 -1.123 . . . . 74.41 107.967 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -161.9 165.92 26.95 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.995 0.518 . . . . 72.53 109.731 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.4 p -170.7 -159.79 0.18 Allowed 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.681 1.192 . . . . 75.52 108.201 -175.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 50.4 m -143.46 150.16 38.61 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.119 0.485 . . . . 64.33 110.295 -175.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -78.73 168.88 19.09 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.706 -1.134 . . . . 74.24 110.192 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 tt 63.76 105.04 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.231 -1.026 . . . . 72.12 108.231 -174.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.39 -77.68 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.179 0.592 . . . . 74.03 112.064 -171.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 12.2 t70 60.87 7.93 1.66 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.783 1.233 . . . . 71.42 113.277 175.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 61.38 17.09 8.03 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.803 1.241 . . . . 75.24 112.445 -173.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 47.6 t -118.05 100.18 9.56 Favored 'Isoleucine or valine' 0 C--N 1.35 0.588 0 N-CA-C 107.452 -1.314 . . . . 65.54 107.452 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -119.82 129.93 54.67 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 107.908 -1.145 . . . . 75.25 107.908 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -111.02 118.33 35.76 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.059 -1.46 . . . . 75.52 107.059 165.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 72.1 t -100.29 134.98 38.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.382 -0.97 . . . . 75.14 108.382 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.58 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 24.8 t -114.97 137.97 46.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.341 -0.985 . . . . 65.42 108.341 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.524 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -115.08 118.61 33.86 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.382 -1.34 . . . . 62.25 107.382 174.339 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.755 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 45.3 ttm-85 -95.54 99.31 11.21 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.831 -1.174 . . . . 73.04 107.831 171.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.592 HG13 HD11 ' D' ' 42' ' ' LEU . 94.8 t -89.25 128.98 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 106.746 -1.576 . . . . 64.15 106.746 169.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 5.3 m -129.56 126.07 37.69 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.64 -0.874 . . . . 74.34 108.64 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.668 HG13 HG13 ' D' ' 40' ' ' VAL . 55.6 t -108.41 132.0 57.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 108.049 -1.093 . . . . 73.54 108.049 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 49.5 m -126.69 90.86 3.24 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.322 -1.362 . . . . 65.33 107.322 171.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -104.35 139.07 39.84 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.28 -0.873 . . . . 73.13 109.838 -176.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.551 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 77.4 p -144.17 128.95 18.31 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-O 121.07 0.462 . . . . 75.4 112.233 -172.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.602 HD12 HG22 ' D' ' 31' ' ' VAL . 43.9 mt -92.4 104.08 16.45 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.956 -1.498 . . . . 74.35 106.956 170.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.15 -145.85 38.52 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 123.674 0.608 . . . . 34.01 111.998 -172.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.69 2.93 31.23 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 112.503 0.556 . . . . 75.23 112.503 -177.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -117.21 146.55 43.17 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 117.924 0.329 . . . . 74.1 110.163 -176.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 98.8 m -63.99 121.07 13.24 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 124.002 0.814 . . . . 74.52 111.108 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.63 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -76.86 -71.89 0.37 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.157 -1.423 . . . . 33.51 107.157 170.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -147.43 141.11 25.6 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.672 -0.695 . . . . 75.51 111.201 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.441 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 56.1 mt -103.96 149.53 25.05 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.218 -1.401 . . . . 73.21 107.218 166.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.578 ' SG ' HG12 ' D' ' 114' ' ' ILE . 6.3 t -157.94 106.23 2.02 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.081 0.401 . . . . 74.14 110.087 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -120.37 122.22 40.3 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.011 0.524 . . . . 74.41 110.204 -176.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 98.2 t -123.84 117.68 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.607 0.763 . . . . 54.44 109.42 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.707 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.1 mt-30 -88.68 83.37 6.74 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.482 -0.933 . . . . 72.54 108.482 168.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 80' ' ' GLN . . . . . 0.415 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.2 tp-100 -80.53 96.54 6.83 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.172 -1.376 . . . . 64.13 109.316 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.61 161.87 28.78 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 111.765 -0.534 . . . . 74.43 111.765 177.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.21 134.55 3.36 Favored Glycine 0 C--N 1.332 0.315 0 N-CA-C 111.624 -0.59 . . . . 75.42 111.624 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 48.4 mt -90.03 117.45 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 108.687 -0.857 . . . . 73.42 108.687 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -115.64 125.94 53.53 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.473 1.109 . . . . 61.04 109.804 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 53.6 p -84.2 104.13 13.98 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.736 -0.839 . . . . 72.11 108.736 171.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 45.3 mt -115.61 122.6 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.403 0.681 . . . . 74.21 109.492 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.08 168.43 25.55 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.659 1.183 . . . . 73.12 109.595 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.28 22.66 43.55 Favored Glycine 0 N--CA 1.476 1.325 0 N-CA-C 114.364 0.505 . . . . 65.21 114.364 172.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' D' ' 94' ' ' MET . 1.0 OUTLIER -136.63 172.42 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 124.349 1.06 . . . . 64.41 109.569 -179.318 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -153.17 -170.76 3.71 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.854 0.462 . . . . 73.14 110.583 177.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.49 -141.66 30.11 Favored Glycine 0 C--N 1.349 1.281 0 CA-C-N 116.011 -0.54 . . . . 54.13 112.383 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 11.2 t -89.91 -20.91 22.81 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.364 0.666 . . . . 75.04 109.878 170.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -58.63 -30.93 67.66 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.692 1.197 . . . . 71.32 112.03 -176.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.693 ' HA ' HD12 ' D' ' 89' ' ' ILE . 12.5 ptp -53.48 -54.12 41.69 Favored 'General case' 0 CA--C 1.55 0.968 0 O-C-N 123.817 0.698 . . . . 65.41 111.905 177.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 95' ' ' ALA . . . . . 0.438 ' H ' ' HG3' ' D' ' 94' ' ' MET . . . -87.38 -15.48 37.71 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.051 0.94 . . . . 44.04 112.071 -176.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -66.1 -39.11 89.72 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.628 0.771 . . . . 73.5 110.319 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 75.0 m -63.97 -38.9 92.75 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.423 -0.808 . . . . 44.33 110.987 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.532 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 6.2 tt -71.96 -39.51 69.31 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 115.389 -0.823 . . . . 74.44 110.666 -176.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.21 -27.51 52.19 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-O 119.793 -0.449 . . . . 61.54 114.212 -173.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.7 -51.89 2.25 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 122.985 0.514 . . . . 61.54 112.019 -172.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 101' ' ' TYR . . . . . 0.4 ' O ' HG12 ' D' ' 105' ' ' ILE . 70.1 t80 -73.64 -39.97 64.1 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.057 0.543 . . . . 72.31 111.526 -171.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.572 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 85.7 m -63.04 -47.98 85.2 Favored Pre-proline 0 CA--C 1.563 1.466 0 CA-C-O 118.4 -0.809 . . . . 54.5 112.345 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.524 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 53.1 Cg_exo -58.19 -36.76 97.53 Favored 'Trans proline' 0 C--N 1.396 3.058 0 C-N-CA 122.231 1.954 . . . . 70.12 112.963 168.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -62.33 -33.82 75.44 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.424 0.69 . . . . 64.24 111.535 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.4 HG12 ' O ' ' D' ' 101' ' ' TYR . 46.0 mm -69.68 -39.27 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.665 0.786 . . . . 64.33 110.888 175.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.415 HD13 ' O ' ' D' ' 80' ' ' GLN . 77.3 mt -73.86 -21.48 60.09 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.645 -0.707 . . . . 64.25 112.091 -175.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -66.78 -41.18 36.24 Favored Pre-proline 0 CA--C 1.56 1.364 0 CA-C-O 117.718 -1.134 . . . . 73.33 113.909 -172.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -45.63 -48.19 12.43 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 122.516 2.144 . . . . 74.12 113.75 168.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -72.2 -40.78 67.61 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.864 0.865 . . . . 75.44 111.771 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.01 -44.04 90.5 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.622 0.769 . . . . 63.14 110.933 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -61.99 -46.96 86.94 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.685 -1.143 . . . . 75.41 110.364 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -61.49 -44.9 96.25 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.976 0.91 . . . . 63.33 111.327 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.535 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 51.9 t -56.01 -46.59 78.71 Favored 'General case' 0 C--N 1.349 0.565 0 O-C-N 124.086 0.866 . . . . 73.44 110.472 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.578 HG12 ' SG ' ' D' ' 76' ' ' CYS . 69.8 mt -63.29 -48.84 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 114.956 -1.02 . . . . 71.42 111.472 176.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 86.1 m -56.05 -44.11 78.54 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 124.029 0.932 . . . . 72.54 111.123 -172.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 40.6 t -65.16 -41.47 94.65 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.386 -1.279 . . . . 71.23 110.467 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.447 ' HE2' ' HA ' ' D' ' 114' ' ' ILE . 75.5 mtm -71.29 -29.64 65.3 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.961 0.504 . . . . 73.44 111.754 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.517 HG23 ' O ' ' D' ' 114' ' ' ILE . 75.1 t -65.47 -43.35 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.008 0.923 . . . . 73.0 109.606 175.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 96.3 p -74.74 -24.45 58.72 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.613 -0.721 . . . . 62.01 110.902 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' D' ' 116' ' ' SER . 92.5 mtt-85 -70.08 -31.37 68.92 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.876 0.47 . . . . 70.33 110.107 172.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.92 10.24 68.96 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 123.581 0.55 . . . . 63.45 112.901 174.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.608 HG23 ' HB3' ' C' ' 17' ' ' TYR . 50.3 p 60.51 12.16 3.4 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 126.844 2.057 . . . . 64.14 114.411 -178.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -79.46 155.31 76.48 Favored Pre-proline 0 N--CA 1.48 1.031 0 CA-C-O 118.966 -0.54 . . . . 74.32 110.629 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -47.53 122.89 7.35 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.307 2.672 . . . . 51.12 111.474 173.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -50.27 132.33 24.22 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 124.759 1.287 . . . . 73.33 111.592 -171.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.482 HD13 HG21 ' D' ' 40' ' ' VAL . 48.7 tp -106.39 98.53 8.2 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 121.635 0.731 . . . . 75.23 109.968 -173.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 127' ' ' ASN . . . . . 0.543 ' ND2' ' HB ' ' B' ' 16' ' ' ILE . 6.9 m120 -99.08 89.32 4.22 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 106.269 -1.752 . . . . 74.11 106.269 174.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 87.7 mt -55.79 113.47 1.49 Allowed 'General case' 0 C--N 1.357 0.903 0 O-C-N 123.739 0.649 . . . . 73.3 109.518 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.91 123.03 82.55 Favored Pre-proline 0 CA--C 1.547 0.862 0 O-C-N 123.829 0.705 . . . . 72.34 109.393 -175.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.21 136.04 33.39 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.641 2.228 . . . . 74.14 112.4 -168.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.43 143.37 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.201 1.0 . . . . 73.35 109.079 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -73.99 115.2 13.18 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.226 0.61 . . . . 74.13 109.395 177.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -60.36 -38.59 84.34 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.384 1.074 . . . . 75.41 111.845 -175.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.44 -26.51 63.69 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.651 -0.704 . . . . 61.14 111.055 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.83 -30.38 70.99 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.869 0.468 . . . . 72.02 111.287 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 45.9 tp -75.87 -37.75 58.6 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.741 0.816 . . . . 64.04 110.511 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -64.72 -51.3 63.11 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.907 0.483 . . . . 72.12 110.967 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 75.3 mtm -62.55 -39.32 93.24 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.32 0.648 . . . . 75.23 110.642 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.479 ' O ' ' HG3' ' D' ' 143' ' ' GLN . 3.2 t-20 -52.46 -49.76 64.0 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 124.087 0.867 . . . . 74.42 110.257 173.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 140' ' ' TYR . . . . . 0.454 ' HE1' ' HG2' ' E' ' 114' ' ' LYS . 59.5 t80 -60.12 -42.9 95.74 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.451 1.094 . . . . 52.12 112.621 -177.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.4 -29.93 70.23 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.898 0.479 . . . . 43.11 111.191 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -92.24 25.33 2.96 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.329 1.052 . . . . 64.03 111.833 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 143' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' D' ' 139' ' ' ASN . 97.1 mt-30 -120.06 94.35 4.36 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.82 0.848 . . . . 71.21 109.67 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -143.82 41.84 1.44 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.892 0.877 . . . . 63.34 109.132 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . 70.15 -0.08 2.93 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 125.235 1.414 . . . . 71.41 113.254 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.26 -34.06 42.31 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 111.712 -0.555 . . . . 61.43 111.712 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.71 -66.42 0.9 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.757 0.823 . . . . 71.02 110.683 178.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 58.34 29.15 62.82 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 123.341 0.401 . . . . 72.34 113.547 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 20.8 m -85.73 99.78 11.56 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.7 0.8 . . . . 71.23 110.792 -172.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -90.07 98.73 11.94 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.45 0.7 . . . . 71.45 109.443 176.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -135.49 132.62 37.56 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.505 0.722 . . . . 71.32 110.868 -177.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 26.5 p-80 -159.62 148.13 17.59 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.742 1.217 . . . . 75.31 108.399 170.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -90.81 148.31 22.62 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.854 -0.795 . . . . 51.31 108.854 172.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.86 115.75 5.14 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.506 0.722 . . . . 75.15 109.167 173.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.221 0 C-N-CA 123.749 0.819 . . . . 61.33 109.628 -173.019 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.569 0 N-CA-C 111.838 -0.505 . . . . 72.33 111.838 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.85 -37.63 60.85 Favored Glycine 0 C--N 1.355 1.623 0 C-N-CA 122.987 0.327 . . . . 72.43 112.803 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -81.76 98.4 8.42 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 109.482 -0.562 . . . . 62.24 109.482 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 94' ' ' PHE . . . . . 0.425 ' HE1' HG21 ' D' ' 7' ' ' THR . 54.8 p90 -97.81 167.11 11.14 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.622 -0.881 . . . . 73.5 108.622 166.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 95' ' ' LYS . . . . . 0.686 ' HE2' ' HB3' ' E' ' 98' ' ' ASP . 12.2 tmtt? -81.69 134.61 35.48 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.304 0.642 . . . . 65.1 110.202 -177.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . -148.0 -70.35 0.01 OUTLIER Glycine 0 C--N 1.343 0.947 0 N-CA-C 110.542 -1.023 . . . . 72.03 110.542 172.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 97' ' ' ILE . . . . . 0.563 HD12 HD21 ' E' ' 100' ' ' LEU . 36.9 pt -102.32 120.86 52.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 CA-C-O 121.71 0.767 . . . . 62.53 110.523 178.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 98' ' ' ASP . . . . . 0.686 ' HB3' ' HE2' ' E' ' 95' ' ' LYS . 7.0 p-10 -116.67 -11.01 11.05 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.1 0.96 . . . . 73.55 112.153 -173.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.82 102.94 4.4 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.228 -0.656 . . . . 74.14 109.228 -174.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 100' ' ' LEU . . . . . 0.563 HD21 HD12 ' E' ' 97' ' ' ILE . 5.7 mp -117.69 143.31 32.14 Favored Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 108.909 -0.774 . . . . 63.43 108.909 176.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.38 -47.94 23.24 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 123.034 2.489 . . . . 74.15 113.464 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 102' ' ' LEU . . . . . 0.458 HD11 HD13 ' D' ' 98' ' ' LEU . 3.8 pp -75.37 -21.5 58.27 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.811 0.671 . . . . 73.12 112.811 -174.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 60.9 p -76.25 1.09 16.96 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.558 0.343 . . . . 53.32 111.531 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.58 -40.08 78.13 Favored Glycine 0 C--N 1.35 1.336 0 N-CA-C 111.458 -0.657 . . . . 72.11 111.458 165.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -164.05 -82.07 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.466 0.706 . . . . 73.23 109.921 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -173.17 151.53 2.1 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.339 1.056 . . . . 70.41 108.637 -174.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 8.4 t -69.93 132.94 46.74 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.287 0.635 . . . . 75.44 110.757 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -60.66 -50.09 74.91 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.574 0.75 . . . . 75.14 110.964 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -81.95 108.4 15.42 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.727 -0.842 . . . . 73.43 108.727 169.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.29 168.91 14.89 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.811 0.445 . . . . 52.1 110.362 173.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 111' ' ' LEU . . . . . . . . . . . . . 26.3 tp -49.22 -65.08 0.63 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.027 1.331 . . . . 74.24 112.366 -174.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 112' ' ' ASN . . . . . 0.626 ' HB3' ' H ' ' D' ' 44' ' ' LEU . 6.5 t30 -115.65 95.54 5.19 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 107.734 -1.209 . . . . 72.31 107.734 170.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -152.82 177.53 10.63 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 107.508 -1.293 . . . . 71.53 107.508 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 114' ' ' LYS . . . . . 0.454 ' HG2' ' HE1' ' D' ' 140' ' ' TYR . 58.6 tptt 63.3 -179.93 0.15 Allowed 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.389 0.676 . . . . 75.42 109.905 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 21.2 m 73.39 157.05 0.18 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.034 0.934 . . . . 74.11 110.456 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.41 -60.52 8.79 Favored Glycine 0 C--N 1.353 1.476 0 N-CA-C 111.71 -0.556 . . . . 61.12 111.71 172.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -142.04 113.07 6.3 Favored Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 124.423 1.089 . . . . 75.24 108.263 171.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -82.05 74.28 5.3 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 123.04 2.493 . . . . 73.43 111.587 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -89.2 26.03 1.73 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.909 0.884 . . . . 73.01 111.362 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -65.06 -36.23 83.67 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.359 1.063 . . . . 74.41 110.242 173.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 121' ' ' VAL . . . . . . . . . . . . . 33.3 m -82.4 -26.52 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 115.176 -0.92 . . . . 71.23 111.151 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 14.9 m -85.54 73.4 10.48 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-O 121.75 0.786 . . . . 65.53 109.812 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -83.69 -60.97 1.95 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.972 -1.013 . . . . 74.5 109.6 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 19.2 t -159.04 -179.11 7.74 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.1 -0.955 . . . . 71.42 109.52 -177.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -144.48 -177.73 5.63 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.007 0.923 . . . . 70.54 109.592 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -153.19 172.0 17.62 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.766 0.426 . . . . 64.23 111.958 -171.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 19.6 m 61.94 30.22 18.02 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.368 1.467 . . . . 72.23 113.103 175.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 128' ' ' ALA . . . . . 0.448 ' HB2' ' HB2' ' D' ' 37' ' ' GLN . . . -68.68 102.12 1.44 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.596 -0.729 . . . . 65.25 109.173 171.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 51.3 m -148.17 145.78 28.45 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.427 0.691 . . . . 74.2 109.928 -176.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.36 154.05 42.32 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.865 0.866 . . . . 64.32 111.179 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 131' ' ' TRP . . . . . 0.546 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 13.8 p90 -130.18 109.76 11.06 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 121.472 0.653 . . . . 75.2 110.394 178.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 132' ' ' SER . . . . . 0.507 ' H ' ' HB3' ' A' ' 124' ' ' PRO . 32.4 t -165.3 114.47 1.04 Allowed 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.991 -1.115 . . . . 71.43 107.991 175.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 133' ' ' THR . . . . . 0.409 ' OG1' ' HB2' ' A' ' 124' ' ' PRO . 63.5 m -142.23 -51.0 0.39 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.509 0.724 . . . . 74.41 109.235 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 134' ' ' GLY . . . . . 0.478 ' O ' HD12 ' A' ' 126' ' ' LEU . . . 70.75 -98.83 0.71 Allowed Glycine 0 C--N 1.349 1.276 0 CA-C-N 115.269 -0.878 . . . . 54.11 112.28 178.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 135' ' ' VAL . . . . . 0.435 HG21 ' H ' ' A' ' 129' ' ' ALA . 2.7 p -174.76 -49.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.712 1.205 . . . . 63.44 109.243 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp 67.7 -69.71 0.13 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.898 1.679 . . . . 74.24 112.413 -178.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 18.5 m -68.99 92.03 0.5 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.572 0.749 . . . . 64.0 110.956 -174.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -104.19 -61.6 1.42 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.731 1.212 . . . . 71.22 109.582 176.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -65.81 -69.46 0.3 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.178 0.991 . . . . 73.04 110.995 -171.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . 77.28 -78.65 1.42 Allowed Glycine 0 CA--C 1.531 1.074 0 CA-C-N 116.583 -0.28 . . . . 52.24 112.751 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -124.48 179.1 5.08 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.768 0.827 . . . . 53.34 110.533 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 36.3 tp -130.14 141.81 50.65 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.516 0.726 . . . . 74.05 109.466 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.8 41.89 1.34 Allowed Glycine 0 C--N 1.351 1.382 0 O-C-N 123.26 0.35 . . . . 74.14 113.036 -176.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 12.3 p -105.94 113.64 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 CA-C-O 121.271 0.558 . . . . 75.21 110.056 174.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 37.5 t70 . . . . . 0 CA--C 1.554 1.107 0 C-N-CA 125.55 1.54 . . . . 74.33 111.362 174.54 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.306 0 N-CA-C 112.301 -0.32 . . . . 54.34 112.301 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.28 -58.01 4.51 Favored Glycine 0 C--N 1.351 1.372 0 N-CA-C 111.529 -0.629 . . . . 73.24 111.529 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 93' ' ' PHE . . . . . 0.577 ' HB3' HG21 ' B' ' 55' ' ' VAL . 49.6 m-85 -71.12 109.34 5.13 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.211 1.004 . . . . 65.05 110.536 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 94' ' ' PHE . . . . . 0.422 ' HE2' ' HB3' ' B' ' 12' ' ' GLN . 52.0 p90 -108.74 159.39 16.79 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.303 0.641 . . . . 71.43 110.373 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -130.15 154.41 47.55 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.616 0.366 . . . . 71.34 110.853 -173.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . 160.65 48.27 0.02 OUTLIER Glycine 0 C--N 1.351 1.396 0 CA-C-O 120.948 0.193 . . . . 72.3 113.447 177.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 97' ' ' ILE . . . . . 0.672 HD11 ' HB2' ' B' ' 94' ' ' MET . 18.8 tt -133.15 -30.99 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.806 0.842 . . . . 64.11 108.79 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 30.0 t70 70.38 -71.39 0.13 Allowed 'General case' 0 C--N 1.359 1.004 0 C-N-CA 126.357 1.863 . . . . 64.03 113.444 171.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 99' ' ' ALA . . . . . 0.482 ' HB2' ' H ' ' B' ' 3' ' ' GLU . . . -82.32 26.04 0.57 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.356 1.062 . . . . 44.02 113.607 -167.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 100' ' ' LEU . . . . . 0.536 HD12 ' H ' ' F' ' 102' ' ' LEU . 36.6 tp -100.89 100.74 13.52 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 123.677 0.791 . . . . 63.35 110.647 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 101' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' F' ' 99' ' ' ALA . 42.9 Cg_endo -97.42 13.7 0.84 Allowed 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.589 2.859 . . . . 73.42 112.224 166.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 102' ' ' LEU . . . . . 0.536 ' H ' HD12 ' F' ' 100' ' ' LEU . 29.7 tp 71.0 142.72 0.05 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.775 1.63 . . . . 62.13 111.601 -177.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 103' ' ' THR . . . . . 0.438 ' H ' HD12 ' F' ' 102' ' ' LEU . 17.5 m -73.4 73.63 1.37 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.539 1.136 . . . . 75.03 110.977 -177.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 57.69 20.85 41.04 Favored Glycine 0 C--N 1.352 1.448 0 N-CA-C 115.555 0.982 . . . . 52.41 115.555 176.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 61.41 19.42 10.24 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.757 0.823 . . . . 75.2 112.222 -176.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -168.65 118.87 0.74 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.488 -1.301 . . . . 73.4 107.488 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 16.5 m -75.51 84.92 2.59 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 121.189 0.519 . . . . 60.33 110.631 -177.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -100.75 105.02 16.31 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.796 0.839 . . . . 75.21 109.905 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -167.06 -59.71 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 107.476 -1.305 . . . . 72.33 107.476 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -125.85 -166.12 1.52 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 114.388 -1.278 . . . . 65.23 109.199 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 8.2 mp 71.01 -67.46 0.25 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 125.237 1.415 . . . . 61.13 109.195 -171.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -61.86 126.95 29.14 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.612 -0.884 . . . . 74.55 108.612 165.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -66.42 98.35 0.48 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 122.231 1.015 . . . . 72.54 110.784 -174.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -82.38 -78.75 0.2 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.241 -1.345 . . . . 72.01 110.151 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 31.9 m -156.75 -44.72 0.07 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.85 0.86 . . . . 71.42 109.047 -172.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.37 158.06 31.89 Favored Glycine 0 C--N 1.355 1.628 0 CA-C-N 115.371 -0.831 . . . . 64.15 113.394 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -74.83 126.41 88.41 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 123.127 0.571 . . . . 72.02 110.999 -173.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 118' ' ' PRO . . . . . 0.447 ' HB2' ' HB ' ' F' ' 121' ' ' VAL . 95.8 Cg_endo -81.39 92.68 1.02 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 123.112 2.541 . . . . 61.43 111.623 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.68 -76.46 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.525 1.13 . . . . 54.23 113.086 -174.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -88.89 -14.72 36.12 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.298 0.239 . . . . 73.14 110.542 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 121' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' F' ' 118' ' ' PRO . 25.7 t -76.45 84.86 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 109.017 -0.735 . . . . 73.13 109.017 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 5.6 t -99.06 -49.1 4.62 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.21 -0.905 . . . . 71.52 110.361 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -178.82 -54.85 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.349 1.06 . . . . 61.41 109.877 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 32.1 t 179.25 -48.52 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.022 1.329 . . . . 60.3 107.981 -174.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . 64.92 -79.59 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.481 1.512 . . . . 52.12 111.659 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -81.34 97.22 7.6 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.882 0.473 . . . . 50.14 110.314 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 35.4 p -87.05 -49.57 7.24 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.498 0.719 . . . . 72.55 110.251 176.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . 55.74 32.56 19.69 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.733 1.213 . . . . 63.15 111.303 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 129' ' ' THR . . . . . 0.711 ' HB ' ' HG3' ' B' ' 37' ' ' GLN . 20.4 m -91.04 100.68 13.5 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.481 -0.781 . . . . 54.51 111.429 -170.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -142.93 147.45 35.27 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.013 0.925 . . . . 44.53 109.752 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 131' ' ' TRP . . . . . 0.445 ' HB2' ' HG3' ' B' ' 124' ' ' PRO . 8.5 t90 -106.89 140.32 39.89 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 109.13 -0.693 . . . . 74.24 109.13 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 33.7 t -83.79 157.66 21.99 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.887 -0.412 . . . . 72.21 109.887 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 14.2 t -65.76 163.93 15.66 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.146 0.578 . . . . 74.32 110.961 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.2 160.67 26.79 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 123.649 0.593 . . . . 54.23 112.929 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 135' ' ' VAL . . . . . 0.496 ' HB ' HD23 ' C' ' 42' ' ' LEU . 21.7 m -77.73 75.27 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-O 122.628 1.204 . . . . 62.32 110.892 -175.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 136' ' ' LYS . . . . . 0.437 ' NZ ' ' HB3' ' F' ' 136' ' ' LYS . 0.0 OUTLIER -77.68 88.69 3.95 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.521 -1.218 . . . . 63.44 108.823 -175.094 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 10.8 m -139.91 -38.85 0.46 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.53 1.132 . . . . 71.24 109.028 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -81.55 -171.24 3.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.86 0.864 . . . . 74.2 111.354 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -66.19 88.64 0.12 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.717 0.807 . . . . 60.52 109.843 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.91 54.93 0.08 OUTLIER Glycine 0 C--O 1.239 0.438 0 N-CA-C 109.535 -1.426 . . . . 64.53 109.535 -176.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.03 144.59 45.35 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.957 0.903 . . . . 72.42 110.62 -169.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 pp -141.29 167.05 23.11 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 123.971 0.908 . . . . 75.32 109.836 172.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.02 105.81 2.19 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.014 -0.834 . . . . 74.02 111.014 173.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.63 -50.73 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.725 0.81 . . . . 65.54 110.076 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 C--O 1.248 1.004 0 N-CA-C 108.296 -1.001 . . . . 61.2 108.296 176.926 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 mmt . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.363 -0.606 . . . . 65.03 109.363 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -131.21 123.25 28.06 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.779 0.832 . . . . 74.23 109.423 -174.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -147.1 92.98 2.19 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.532 0.682 . . . . 53.23 110.866 -171.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.8 tm0? -171.92 127.9 0.6 Allowed 'General case' 0 C--O 1.239 0.516 0 N-CA-C 106.861 -1.533 . . . . 64.21 106.861 176.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -70.09 91.12 0.68 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.131 0.491 . . . . 74.54 109.915 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -58.62 -56.04 27.3 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.831 1.252 . . . . 71.33 110.506 -177.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.497 HG23 HG22 ' A' ' 89' ' ' ILE . 6.0 t -153.58 152.03 30.44 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.328 -0.851 . . . . 42.1 110.345 -174.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -84.58 179.34 7.41 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.648 -0.706 . . . . 73.54 109.424 175.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.546 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 2.8 ppp? -145.28 175.18 10.48 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.122 0.569 . . . . 71.21 111.515 -172.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.4 m -140.88 129.7 23.02 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.388 1.075 . . . . 62.5 108.19 173.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -119.99 117.5 28.19 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.95 1.3 . . . . 72.13 108.337 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -133.89 109.8 9.29 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.619 -0.882 . . . . 71.4 108.619 -178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.8 mt -74.17 122.17 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.749 -0.834 . . . . 73.11 108.749 174.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -92.91 -42.17 9.64 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.088 0.555 . . . . 72.42 110.818 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -170.68 121.8 0.59 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 110.05 -0.352 . . . . 71.03 110.05 -175.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.401 HD12 ' HG3' ' C' ' 130' ' ' PRO . 98.1 mt -105.71 126.14 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 107.57 -1.27 . . . . 74.3 107.57 172.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.502 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 28.3 p90 -162.11 157.11 22.85 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 123.736 0.647 . . . . 75.11 110.896 -171.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.1 p -85.01 117.09 23.77 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 109.408 -0.59 . . . . 44.15 109.408 174.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.0 mtpt -78.19 -31.31 49.47 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.407 -0.59 . . . . 71.33 109.407 174.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 30.4 t70 -150.25 145.82 26.43 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.759 -1.109 . . . . 61.24 110.68 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 75.0 mt -138.92 145.41 27.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 C-N-CA 125.395 1.478 . . . . 61.42 107.951 176.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.3 t -149.26 133.05 16.95 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.833 0.853 . . . . 73.54 109.538 173.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -130.54 139.39 50.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.087 -1.449 . . . . 74.14 107.087 169.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -135.12 134.11 39.9 Favored 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 123.068 0.547 . . . . 55.2 109.621 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.8 71.57 11.45 Favored Pre-proline 0 C--O 1.243 0.738 0 N-CA-C 105.829 -1.915 . . . . 73.43 105.829 169.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.78 -30.99 10.9 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.142 1.895 . . . . 74.44 111.389 -177.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -94.03 12.97 24.41 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 118.35 -0.833 . . . . 70.52 109.91 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.559 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -42.91 -59.08 3.28 Favored Pre-proline 0 CA--C 1.573 1.844 0 CA-C-O 118.146 -0.931 . . . . 72.11 112.919 -173.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 20.5 Cg_exo -63.46 -15.02 45.91 Favored 'Trans proline' 0 C--N 1.395 2.995 0 C-N-CA 122.541 2.16 . . . . 52.51 113.956 -178.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -92.29 -42.65 9.71 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.868 0.867 . . . . 71.14 110.154 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.72 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.3 p -79.32 -13.48 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-N 114.02 -1.446 . . . . 54.43 112.617 -161.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -72.42 -15.38 61.83 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.186 0.594 . . . . 52.15 110.968 173.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -87.46 -12.56 45.71 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.352 1.061 . . . . 74.25 111.15 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -82.46 155.71 24.47 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.646 0.778 . . . . 63.12 111.394 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.98 128.53 36.31 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.49 0.716 . . . . 72.33 109.457 170.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.444 ' CE3' HD21 ' A' ' 68' ' ' LEU . 49.9 t-105 -81.04 76.34 7.99 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.848 0.832 . . . . 74.42 110.266 -177.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.3 tm0? -126.8 81.88 68.39 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 105.025 -2.213 . . . . 64.14 105.025 168.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -83.68 144.98 11.42 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.347 2.031 . . . . 73.43 112.141 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -96.46 84.11 3.64 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.457 -1.312 . . . . 64.33 107.457 173.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.423 HG13 HG13 ' A' ' 64' ' ' VAL . 43.3 t -88.13 94.44 4.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 CA-C-N 115.537 -0.756 . . . . 71.34 109.819 -175.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -92.93 134.12 35.43 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.056 -0.974 . . . . 62.04 109.978 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.1 mt -103.66 108.95 20.46 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.477 -0.935 . . . . 71.03 108.477 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.605 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 10.2 m-20 -101.63 107.92 19.31 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.367 -1.346 . . . . 60.41 107.367 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.594 HD11 HG21 ' A' ' 131' ' ' VAL . 86.8 mt -103.52 135.53 44.94 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.448 0.642 . . . . 70.5 111.279 -174.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 24.8 t70 -132.55 143.45 49.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.334 -1.303 . . . . 61.31 108.254 178.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.6 m -127.25 133.4 50.21 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.663 0.785 . . . . 55.43 108.963 175.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.77 147.71 52.32 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 124.547 1.139 . . . . 71.12 108.502 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.1 m -131.68 156.51 45.76 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 122.747 0.419 . . . . 73.21 109.883 174.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.9 t -154.31 118.89 4.87 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.257 -1.016 . . . . 73.21 108.257 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -72.87 107.48 5.3 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 108.544 -0.91 . . . . 74.33 108.544 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.5 mt -79.95 -36.62 35.96 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.987 -0.552 . . . . 64.24 110.454 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.55 -174.02 4.81 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.272 0.629 . . . . 44.04 110.869 -177.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -65.29 119.84 11.67 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.203 0.601 . . . . 54.11 109.634 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 65.73 5.61 3.45 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.988 1.315 . . . . 55.33 112.532 -175.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.5 t -107.12 111.12 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 109.108 -0.701 . . . . 73.23 109.108 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -121.23 124.58 45.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.108 -1.071 . . . . 72.05 108.108 176.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -87.78 143.63 27.05 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.677 -0.86 . . . . 72.02 108.677 170.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.458 HG11 ' HD3' ' A' ' 103' ' ' PRO . 96.9 t -126.4 137.58 57.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 107.873 -1.158 . . . . 71.15 107.873 170.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.458 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 44.7 t -119.27 130.75 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.473 -0.936 . . . . 74.25 108.473 174.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.548 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -104.74 105.91 16.19 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 105.957 -1.868 . . . . 65.45 105.957 173.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.568 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 28.6 ttp180 -92.88 99.98 12.53 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.345 -1.354 . . . . 72.41 107.345 176.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.5 t -94.93 129.24 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 107.705 -1.22 . . . . 70.1 107.705 176.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.605 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.3 m -121.71 114.58 21.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.887 -0.783 . . . . 72.12 108.887 176.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 90.6 t -102.06 106.89 20.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.32 -0.993 . . . . 73.13 108.32 177.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.9 m -103.3 132.68 49.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.43 -0.952 . . . . 64.14 108.43 172.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.98 118.26 13.65 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.527 -0.545 . . . . 74.31 109.527 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.0 m -123.24 138.2 54.69 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.368 0.667 . . . . 63.35 110.521 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.698 HD12 HG22 ' A' ' 31' ' ' VAL . 22.0 mt -92.32 86.31 5.67 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.973 1.309 . . . . 70.42 108.396 172.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.5 -95.75 0.89 Allowed Glycine 0 C--N 1.339 0.705 0 O-C-N 123.393 0.433 . . . . 74.01 112.34 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.85 -26.17 13.23 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.634 0.773 . . . . 70.15 110.752 -177.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -104.07 126.19 50.99 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.398 0.679 . . . . 55.02 110.4 -174.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.1 m -63.62 125.94 25.92 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 123.561 0.538 . . . . 51.54 110.75 173.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.72 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -72.63 -60.26 2.32 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.818 -0.808 . . . . 71.55 108.818 174.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -160.31 168.17 25.88 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.652 0.739 . . . . 55.44 111.757 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 64' ' ' VAL . 65.1 tp -127.2 143.11 51.32 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.003 1.321 . . . . 63.22 107.739 169.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.563 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 70.9 m -144.76 98.28 3.16 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.386 0.674 . . . . 63.02 109.777 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -118.64 116.93 27.61 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.673 -0.491 . . . . 74.34 109.673 -176.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.0 t -125.33 110.87 25.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 123.836 0.855 . . . . 75.13 109.022 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 51.9 mt-30 -84.9 82.51 8.41 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.231 -1.026 . . . . 55.03 108.231 172.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -76.07 94.43 3.45 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 114.474 -1.239 . . . . 71.35 108.574 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.46 163.34 40.73 Favored Glycine 0 C--O 1.24 0.474 0 N-CA-C 111.011 -0.836 . . . . 61.44 111.011 177.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.83 121.71 1.05 Allowed Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 110.371 -1.092 . . . . 32.31 110.371 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.8 mt -81.49 122.65 36.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.499 -1.297 . . . . 70.25 107.499 173.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.703 ' HB3' HD11 ' A' ' 86' ' ' ILE . 93.3 m-85 -128.19 121.17 28.8 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.359 0.664 . . . . 73.13 109.513 -178.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.1 t -85.25 98.1 10.31 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.418 -0.956 . . . . 74.35 108.418 173.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.703 HD11 ' HB3' ' A' ' 84' ' ' PHE . 4.2 mm -107.87 147.95 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.418 -0.586 . . . . 75.33 109.418 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.53 170.1 23.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.647 -0.706 . . . . 74.43 110.121 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 100.15 -34.17 5.73 Favored Glycine 0 C--N 1.341 0.818 0 O-C-N 123.613 0.571 . . . . 73.34 113.574 176.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.57 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -127.5 146.34 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 122.928 0.491 . . . . 71.01 111.739 -169.259 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.24 175.17 9.49 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.658 1.183 . . . . 65.43 109.335 175.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.26 -131.29 27.32 Favored Glycine 0 C--N 1.352 1.443 0 O-C-N 123.46 0.475 . . . . 51.41 113.611 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.9 t -72.8 -21.53 60.97 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.23 0.612 . . . . 54.2 111.212 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -73.64 -42.39 61.47 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.606 0.762 . . . . 70.23 109.387 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.3 tpt -66.55 -42.52 87.02 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 115.596 -0.729 . . . . 72.4 110.262 173.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.54 -29.2 70.4 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.385 -0.825 . . . . 72.43 111.13 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.488 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 60.4 t-80 -71.53 -35.27 70.61 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.98 -0.555 . . . . 74.44 110.926 176.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.9 t -71.89 -44.16 64.2 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 110.005 -0.368 . . . . 52.3 110.005 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.6 mt -82.38 -32.07 29.38 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.66 0.615 . . . . 73.04 112.66 -173.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.89 4.36 42.07 Favored Glycine 0 N--CA 1.472 1.034 0 CA-C-O 119.89 -0.395 . . . . 71.42 113.639 -172.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.538 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -140.49 -68.6 0.41 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 117.014 0.407 . . . . 55.23 110.759 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -67.97 -45.33 74.46 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 116.01 -0.541 . . . . 73.31 112.266 -168.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 82.4 m -67.19 -48.42 48.16 Favored Pre-proline 0 CA--C 1.559 1.296 0 CA-C-O 118.065 -0.969 . . . . 62.42 112.783 -176.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.458 ' HD3' HG11 ' A' ' 58' ' ' VAL . 41.0 Cg_endo -66.51 -18.72 54.72 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 121.576 1.517 . . . . 74.22 112.682 173.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -76.12 -34.62 59.47 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.923 0.489 . . . . 74.11 110.529 173.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.2 mm -64.35 -43.84 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.448 0.699 . . . . 71.51 109.447 170.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.2 mt -73.36 -23.48 60.21 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.045 -0.98 . . . . 73.24 112.522 -174.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -63.61 -45.64 82.88 Favored Pre-proline 0 N--CA 1.485 1.279 0 N-CA-C 114.331 1.234 . . . . 75.25 114.331 -172.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -52.95 -36.53 75.58 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 121.985 1.79 . . . . 73.14 113.47 172.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -79.08 -39.36 33.98 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.559 0.744 . . . . 71.12 111.352 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.45 -49.53 73.33 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.252 0.621 . . . . 63.22 109.369 175.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.47 ' NH1' HD12 ' C' ' 105' ' ' ILE . 27.4 ttm180 -49.96 -50.5 46.56 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 125.137 1.523 . . . . 71.32 111.084 175.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -65.24 -47.85 75.37 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 124.374 1.046 . . . . 75.24 111.747 -176.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.525 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 53.7 t -56.0 -42.01 75.75 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.135 0.897 . . . . 54.11 110.468 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.556 HG21 HG21 ' A' ' 64' ' ' VAL . 68.8 mt -62.66 -53.69 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 114.736 -1.12 . . . . 72.1 110.616 174.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.404 HG21 ' HE2' ' C' ' 109' ' ' TYR . 33.1 m -55.87 -36.86 68.04 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.679 0.791 . . . . 72.33 111.027 -175.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.7 t -68.68 -46.9 67.86 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.582 -1.19 . . . . 72.21 110.186 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.6 mtp -59.94 -42.29 93.7 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.605 0.762 . . . . 73.34 111.897 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 114' ' ' ILE . 84.5 t -63.76 -44.16 98.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 124.254 1.022 . . . . 64.45 110.252 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 99.4 p -73.23 -32.3 64.67 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.803 -0.635 . . . . 65.13 111.108 -176.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -67.78 -33.38 74.72 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.469 0.708 . . . . 70.33 109.738 173.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.54 15.05 37.67 Favored Glycine 0 C--N 1.354 1.562 0 CA-C-N 115.585 -0.734 . . . . 41.41 113.578 175.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.4 t 59.9 11.54 2.63 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 127.26 2.224 . . . . 62.34 114.488 174.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -79.76 140.01 54.56 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 107.96 -1.126 . . . . 72.3 107.96 175.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -43.15 133.56 6.21 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 123.529 2.819 . . . . 72.33 112.647 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -52.36 131.0 32.71 Favored 'General case' 0 C--N 1.363 1.164 0 O-C-N 123.93 0.769 . . . . 71.35 112.474 -169.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.419 HD21 HG11 ' A' ' 64' ' ' VAL . 22.3 tp -120.22 115.73 24.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.688 1.195 . . . . 63.51 109.303 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.551 ' HB2' HG22 ' E' ' 135' ' ' VAL . 19.7 m120 -109.17 128.04 54.7 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 105.715 -1.957 . . . . 63.44 105.715 173.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.454 ' H ' ' HG3' ' A' ' 111' ' ' ARG . 15.4 mt -71.7 147.44 47.41 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 118.29 0.496 . . . . 64.12 110.926 -175.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.33 137.6 86.53 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 122.98 0.512 . . . . 50.23 110.677 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.2 124.21 15.65 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 123.132 2.555 . . . . 62.5 113.329 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.594 HG21 HD11 ' A' ' 44' ' ' LEU . 68.6 t -109.43 128.6 65.3 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 C-N-CA 123.78 0.832 . . . . 53.22 110.388 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -92.18 84.3 5.22 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.466 -0.939 . . . . 73.24 108.466 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -60.83 -29.67 69.64 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.884 0.874 . . . . 74.43 111.587 177.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.538 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 5.5 t70 -64.24 -42.24 96.62 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 124.007 0.817 . . . . 70.41 109.559 178.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.92 -40.18 87.56 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.125 0.891 . . . . 50.53 111.275 176.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.64 -42.86 99.48 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 123.779 0.674 . . . . 75.33 111.016 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -71.32 -36.56 71.63 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 116.014 -0.539 . . . . 61.15 109.834 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.527 ' HG2' ' HA ' ' A' ' 143' ' ' GLN . 33.4 ttm -64.7 -27.97 69.28 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.51 0.506 . . . . 75.03 111.374 -174.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -58.33 -42.94 87.9 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.432 0.693 . . . . 74.15 110.668 172.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -78.05 -30.28 49.72 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 125.012 1.325 . . . . 65.04 111.403 176.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.483 ' HB3' ' HA ' ' A' ' 138' ' ' MET . 51.9 tp -68.28 -51.2 47.58 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.215 1.006 . . . . 63.14 111.508 -175.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 169.99 -18.81 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 125.002 1.321 . . . . 75.14 111.238 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.527 ' HA ' ' HG2' ' A' ' 138' ' ' MET . 0.0 OUTLIER 49.39 72.82 0.28 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.695 1.598 . . . . 73.4 111.273 -173.191 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -160.63 -54.06 0.05 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.632 -0.713 . . . . 64.34 109.261 177.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.59 155.39 48.38 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-N 115.463 -0.789 . . . . 55.24 110.614 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 174.59 124.36 0.79 Allowed Glycine 0 C--N 1.346 1.095 0 O-C-N 123.73 0.644 . . . . 44.55 112.713 176.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -145.3 -171.07 3.58 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.786 1.234 . . . . 62.12 108.33 170.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 120.95 65.57 0.25 Allowed Glycine 0 C--N 1.349 1.302 0 N-CA-C 112.47 -0.252 . . . . 63.42 112.47 177.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.8 t -153.26 152.81 31.58 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.319 0.647 . . . . 53.51 110.722 175.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -175.79 150.24 1.01 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.545 1.138 . . . . 74.02 109.156 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.64 124.65 52.31 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.81 -0.811 . . . . 64.54 108.81 172.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -158.32 117.73 3.18 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.162 1.385 . . . . 74.1 107.726 177.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -146.16 161.54 39.99 Favored 'General case' 0 C--O 1.24 0.572 0 O-C-N 123.79 0.681 . . . . 73.05 110.763 -175.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -116.67 -62.31 1.6 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.32 1.048 . . . . 42.12 108.553 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.918 0 C-N-CA 124.244 1.018 . . . . 44.43 108.686 179.39 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.708 ' SD ' ' HD2' ' F' ' 95' ' ' LYS . 57.2 mtm . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 109.12 -0.696 . . . . 72.0 109.12 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.2 t -103.47 93.48 4.97 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 109.053 -0.721 . . . . 72.3 109.053 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 68.8 80.26 0.2 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.754 1.222 . . . . 75.23 111.531 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -136.73 78.5 1.7 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.522 1.129 . . . . 44.43 108.553 170.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -152.78 123.49 7.34 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.423 -0.954 . . . . 75.12 108.423 -178.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -126.36 121.27 32.06 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.466 0.707 . . . . 72.13 109.239 -176.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 13.3 t -75.9 160.86 29.48 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.218 0.607 . . . . 74.33 110.705 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 61.94 27.83 16.92 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.376 1.071 . . . . 71.32 110.576 -173.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.529 ' HB3' HG23 ' B' ' 89' ' ' ILE . 20.7 ptm 49.43 -174.44 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 127.037 2.135 . . . . 65.22 112.71 -170.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -147.68 140.03 24.47 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 108.425 -0.954 . . . . 71.02 108.425 169.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -138.35 140.46 39.47 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.741 -0.837 . . . . 74.45 108.741 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -151.5 140.02 20.59 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 109.087 -0.708 . . . . 72.32 109.087 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.459 HD13 HD11 ' B' ' 16' ' ' ILE . 33.8 mt -75.1 133.0 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 107.535 -1.283 . . . . 51.33 107.535 167.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -98.43 -43.76 6.78 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.054 -0.721 . . . . 74.43 109.054 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -172.88 131.72 0.52 Allowed 'General case' 0 C--N 1.348 0.536 0 CA-C-N 115.723 -0.671 . . . . 62.41 109.69 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.507 HG21 ' CD1' ' B' ' 109' ' ' TYR . 58.6 mt -115.63 144.13 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.108 -1.071 . . . . 72.14 108.108 173.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -164.69 145.58 7.82 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.489 0.661 . . . . 75.22 111.931 -175.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.1 m -72.91 118.17 15.53 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.405 -1.27 . . . . 71.33 108.086 169.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -94.59 -23.29 17.7 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.509 0.724 . . . . 65.11 111.02 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -161.48 143.47 11.76 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.986 0.179 . . . . 60.21 110.9 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.448 HD11 ' SG ' ' B' ' 113' ' ' CYS . 47.1 mm -136.1 143.92 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.536 1.135 . . . . 61.43 109.536 176.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 68.9 m -141.27 132.58 26.63 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.962 1.705 . . . . 63.11 107.208 169.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 88.0 t80 -142.87 109.26 5.33 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.483 -1.673 . . . . 72.2 106.483 166.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 38.8 mt-10 -119.53 111.54 18.22 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.501 -0.925 . . . . 75.42 108.501 -176.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.56 86.47 1.78 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 106.566 -1.642 . . . . 71.2 106.566 173.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.28 -35.7 8.13 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.464 2.11 . . . . 73.15 112.199 -165.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -106.93 21.02 18.2 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.1 -0.954 . . . . 64.32 109.663 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.436 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -42.66 -62.33 1.31 Allowed Pre-proline 0 N--CA 1.487 1.424 0 C-N-CA 125.221 1.408 . . . . 64.43 114.722 -165.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.436 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 16.6 Cg_exo -61.81 -30.18 84.05 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 122.08 1.854 . . . . 74.33 112.375 -171.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -96.04 -27.99 14.84 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.564 -1.198 . . . . 74.31 111.983 -169.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' B' ' 73' ' ' ALA . 6.4 p -81.81 -10.02 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 120.775 0.322 . . . . 72.12 111.043 -176.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -70.57 -19.96 62.83 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.383 0.673 . . . . 65.22 112.678 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -65.92 -12.78 57.3 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.144 0.497 . . . . 72.24 111.229 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -97.36 92.26 5.89 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.053 1.341 . . . . 65.21 109.744 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -97.38 78.92 2.73 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.755 -0.657 . . . . 73.15 109.622 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 15.1 p90 -153.8 -173.24 4.5 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.092 0.557 . . . . 62.14 110.017 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -73.03 109.47 6.33 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 124.143 0.977 . . . . 72.14 110.088 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.476 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 55.6 Cg_endo -72.91 132.24 18.1 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 121.199 1.266 . . . . 70.02 111.317 175.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -65.6 104.86 1.09 Allowed 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.184 0.594 . . . . 64.01 109.809 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.525 ' HB ' ' O ' ' F' ' 126' ' ' ALA . 74.8 t -99.5 143.38 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 114.355 -1.293 . . . . 71.32 111.221 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -124.09 132.05 53.61 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 106.949 -1.5 . . . . 73.43 106.949 173.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.453 HD13 HD22 ' B' ' 128' ' ' LEU . 17.1 tp -102.06 124.98 48.6 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.073 -1.084 . . . . 52.11 108.073 172.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -124.85 139.59 53.7 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.615 -1.254 . . . . 72.24 107.615 -175.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mp -122.3 138.25 54.57 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.837 0.855 . . . . 65.42 109.453 -171.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.553 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 9.8 t70 -135.22 146.85 49.05 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.715 1.206 . . . . 74.4 108.442 173.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.1 m -126.74 103.42 7.53 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.919 -0.771 . . . . 74.14 108.919 -176.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.75 117.89 31.52 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 108.625 -0.879 . . . . 61.25 108.625 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 51.7 p -144.6 161.04 40.14 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 122.429 0.291 . . . . 75.42 110.752 -176.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.7 p -159.45 138.88 11.35 Favored 'General case' 0 C--O 1.244 0.799 0 O-C-N 123.444 0.465 . . . . 74.0 111.211 -174.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.453 ' HG3' HD12 ' F' ' 100' ' ' LEU . 61.0 tt0 -78.37 104.57 9.04 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 108.845 -0.798 . . . . 70.35 108.845 171.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 3.0 pp -122.53 11.31 9.88 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.647 -0.706 . . . . 44.41 109.928 175.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.07 158.49 43.09 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 115.702 -0.681 . . . . 61.23 110.49 -174.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.93 107.74 17.86 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.418 1.087 . . . . 72.23 110.883 -172.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 62.53 18.63 10.6 Favored 'General case' 0 N--CA 1.501 2.122 0 C-N-CA 124.275 1.03 . . . . 71.12 111.589 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 90.3 t -135.6 121.63 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.372 1.469 . . . . 61.3 107.248 -174.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -113.43 139.25 49.07 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.69 -0.856 . . . . 75.32 108.69 -172.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -104.51 101.29 10.96 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 106.578 -1.638 . . . . 42.43 106.578 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -104.04 133.66 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.201 0.601 . . . . 73.43 109.491 -177.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.505 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 25.8 t -118.4 122.11 68.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 C-N-CA 124.183 0.993 . . . . 73.15 108.437 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.45 109.94 21.78 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 107.796 -1.187 . . . . 72.11 107.796 174.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.553 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 39.2 ttm180 -85.85 112.23 20.94 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.889 -0.782 . . . . 53.13 108.889 175.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.447 HG13 HD11 ' B' ' 42' ' ' LEU . 61.7 t -105.37 103.59 15.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.42 -0.956 . . . . 73.4 108.42 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 7.5 m -99.44 131.39 45.48 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.427 -0.806 . . . . 73.53 109.648 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.664 HG11 HD21 ' B' ' 126' ' ' LEU . 72.4 t -120.05 133.14 67.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 123.758 0.823 . . . . 65.34 110.042 176.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 72.6 m -110.76 147.35 34.63 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 108.355 -0.98 . . . . 65.31 108.355 167.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.442 ' HB2' HG22 ' B' ' 40' ' ' VAL . . . -144.5 133.19 22.28 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.446 0.698 . . . . 62.23 109.359 173.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.463 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 16.6 m -133.98 126.38 30.15 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 123.418 0.449 . . . . 55.32 110.675 -174.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.476 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 60.4 mt -99.08 101.29 12.61 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.841 -1.17 . . . . 73.25 107.841 174.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.82 -144.82 24.33 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 115.747 -0.661 . . . . 74.43 111.54 -173.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -82.41 2.36 32.91 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.017 0.927 . . . . 71.43 112.652 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -123.34 158.83 30.18 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.638 0.775 . . . . 70.34 110.354 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 92.4 m -81.35 126.16 31.26 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.683 0.793 . . . . 63.43 110.689 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.468 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -77.67 -57.85 3.59 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.321 1.049 . . . . 71.43 108.96 174.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -143.99 162.41 36.26 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 122.249 1.023 . . . . 73.34 111.937 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.4 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 84.4 mt -126.76 147.5 49.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 112.886 -1.961 . . . . 65.03 106.554 171.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 32.5 t -149.45 150.85 33.01 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.006 -1.109 . . . . 53.5 108.006 174.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 35.7 tt0 -161.84 125.15 3.1 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.207 -1.034 . . . . 74.41 108.207 178.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 84.6 t -122.94 146.6 27.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.542 -0.911 . . . . 63.01 108.542 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -117.72 107.53 14.29 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.012 -1.107 . . . . 73.33 108.012 169.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -99.43 100.62 11.69 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.224 -1.028 . . . . 72.12 108.224 175.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -96.22 162.2 22.67 Favored Glycine 0 C--N 1.336 0.55 0 O-C-N 123.785 0.678 . . . . 53.34 111.599 177.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.9 131.98 2.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.695 -0.288 . . . . 64.32 112.642 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 47.0 mt -85.54 115.03 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 N-CA-C 107.612 -1.255 . . . . 65.24 107.612 171.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -127.32 140.95 51.85 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.832 0.853 . . . . 60.2 109.621 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 56.1 m -95.19 123.26 38.59 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.381 0.672 . . . . 75.34 110.191 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.727 HG22 HD11 ' B' ' 89' ' ' ILE . 2.4 mp -127.63 113.07 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 108.018 -1.104 . . . . 44.44 108.018 -178.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.82 155.46 35.84 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.176 0.59 . . . . 52.44 110.812 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 102.02 -34.15 5.93 Favored Glycine 0 N--CA 1.48 1.571 0 C-N-CA 123.786 0.707 . . . . 73.0 112.496 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.727 HD11 HG22 ' B' ' 86' ' ' ILE . 0.9 OUTLIER -80.74 167.63 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 124.509 1.124 . . . . 63.13 112.345 178.804 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.468 ' HA ' ' HB2' ' F' ' 98' ' ' ASP . 44.3 tt0 -156.59 148.98 23.37 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.819 0.848 . . . . 71.13 110.655 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.15 -134.16 12.34 Favored Glycine 0 C--N 1.356 1.673 0 C-N-CA 123.013 0.34 . . . . 70.5 113.655 172.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.5 m -64.64 -48.47 74.71 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.42 1.088 . . . . 44.11 110.255 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -66.28 -24.7 66.61 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 113.437 -1.711 . . . . 74.21 111.466 -170.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.8 -65.7 0.65 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.637 1.175 . . . . 73.44 112.215 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.52 -13.24 59.93 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.686 0.395 . . . . 42.41 111.983 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -59.82 -36.07 76.03 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.286 0.634 . . . . 75.32 110.402 168.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.4 t -65.16 -55.43 18.68 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.215 0.606 . . . . 74.12 111.524 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.619 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.6 pp -76.49 -18.25 58.86 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 112.646 0.61 . . . . 75.3 112.646 -177.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.93 -19.6 30.8 Favored Glycine 0 C--N 1.348 1.239 0 CA-C-O 119.766 -0.463 . . . . 52.03 113.861 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.72 -51.94 1.06 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 117.324 0.562 . . . . 52.22 111.49 -173.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -70.17 -40.15 74.87 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.414 0.686 . . . . 71.51 111.244 -175.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.619 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 81.8 m -70.99 -48.83 13.64 Favored Pre-proline 0 CA--C 1.56 1.36 0 CA-C-O 118.443 -0.789 . . . . 72.23 112.086 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 84.2 Cg_exo -54.14 -29.12 54.53 Favored 'Trans proline' 0 C--N 1.393 2.906 0 C-N-CA 122.49 2.127 . . . . 62.54 114.029 169.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -64.75 -33.31 75.68 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.4 0.68 . . . . 71.21 111.488 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.425 HG23 ' NH2' ' D' ' 111' ' ' ARG . 65.0 mt -72.89 -39.12 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.772 0.829 . . . . 75.04 110.122 175.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 71.2 mt -75.33 -34.18 61.19 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.737 -1.119 . . . . 64.33 111.722 -174.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -57.73 -47.34 99.11 Favored Pre-proline 0 N--CA 1.487 1.377 0 CA-C-O 117.559 -1.21 . . . . 62.11 113.776 -171.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -54.94 -35.93 90.78 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.21 1.94 . . . . 43.54 113.299 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.507 ' CD1' HG21 ' B' ' 16' ' ' ILE . 5.0 m-30 -76.03 -40.43 53.47 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.827 -0.624 . . . . 75.04 110.364 -176.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.04 -42.76 99.83 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.486 -0.779 . . . . 54.2 110.257 174.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 28.4 ttt-85 -60.47 -49.61 76.89 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.075 1.35 . . . . 74.1 110.819 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -69.32 -31.5 70.0 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.885 0.741 . . . . 74.52 109.998 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.533 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.9 t -68.51 -40.54 80.78 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 122.915 0.486 . . . . 54.41 110.316 177.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.501 HD13 HG23 ' B' ' 64' ' ' VAL . 81.8 mt -62.37 -54.82 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.63 0.772 . . . . 74.31 110.128 174.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.9 m -61.18 -27.95 68.78 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 123.916 0.76 . . . . 73.02 111.068 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.3 t -64.92 -53.27 49.12 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 123.208 0.603 . . . . 50.1 109.555 173.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.533 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.1 mmt -65.92 -33.8 76.66 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.27 0.628 . . . . 73.14 111.573 -175.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 78.2 t -68.3 -41.72 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.732 1.213 . . . . 61.12 110.604 176.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 39.0 t -67.11 -31.15 71.43 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.227 -0.897 . . . . 72.51 110.785 175.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.525 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 82.0 mtt-85 -69.55 -37.78 77.17 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 123.237 0.615 . . . . 75.41 110.001 176.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.31 -11.42 71.38 Favored Glycine 0 C--N 1.353 1.515 0 O-C-N 123.429 0.456 . . . . 64.13 112.749 170.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 10.1 m 67.93 26.93 7.36 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 125.804 1.641 . . . . 55.4 110.204 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -78.07 164.99 53.76 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-N 114.964 -1.016 . . . . 75.3 111.448 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -47.54 154.48 1.7 Allowed 'Trans proline' 0 C--N 1.393 2.911 0 C-N-CA 123.429 2.753 . . . . 72.42 114.351 171.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.652 ' HB3' ' HB3' ' F' ' 130' ' ' ALA . 0.0 OUTLIER -62.37 115.95 4.64 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.003 0.921 . . . . 53.31 111.595 -175.508 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.664 HD21 HG11 ' B' ' 64' ' ' VAL . 37.8 tp -109.57 108.13 18.46 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.546 -0.752 . . . . 72.14 109.392 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -114.35 120.51 40.63 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 107.73 -1.211 . . . . 61.13 107.73 169.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.456 HD21 HG21 ' B' ' 64' ' ' VAL . 87.9 mt -74.98 130.13 38.83 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 122.873 0.469 . . . . 64.24 110.32 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.11 136.24 90.94 Favored Pre-proline 0 CA--C 1.55 0.971 0 O-C-N 124.393 1.058 . . . . 64.45 110.77 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.03 94.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.711 2.274 . . . . 61.33 111.907 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 19.5 m -90.61 110.44 22.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.847 0.832 . . . . 75.14 109.201 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 132' ' ' ASN . . . . . 0.443 ' ND2' ' HB2' ' B' ' 135' ' ' ALA . 13.2 p-10 -85.77 106.02 16.71 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.542 -0.91 . . . . 74.11 108.542 174.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.459 ' HD1' HD21 ' F' ' 111' ' ' LEU . 15.0 m-85 -58.51 -33.28 69.66 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.116 -1.402 . . . . 72.2 109.843 176.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -56.36 -36.39 68.76 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 113.419 -1.719 . . . . 64.5 111.791 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.443 ' HB2' ' ND2' ' B' ' 132' ' ' ASN . . . -57.88 -35.31 70.81 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.951 0.9 . . . . 45.42 112.183 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.401 HD11 ' HB2' ' F' ' 120' ' ' TYR . 3.5 mm? -64.26 -49.16 72.99 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 123.761 0.663 . . . . 61.12 109.612 175.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -71.1 -23.39 62.1 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.368 0.667 . . . . 73.21 112.611 -177.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 60.7 mtt -65.34 -37.39 86.92 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.638 0.775 . . . . 73.04 111.298 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -106.53 -31.93 8.3 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.504 -0.771 . . . . 52.54 111.314 -167.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -76.46 -48.6 19.07 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.287 0.635 . . . . 52.41 109.794 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 6.4 mp -89.91 -7.68 53.6 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.783 0.433 . . . . 61.22 111.051 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 60.11 123.74 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.202 1.401 . . . . 52.44 112.876 -177.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -113.53 -65.4 1.19 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.661 -0.866 . . . . 71.32 108.661 170.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 55.7 86.27 0.06 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.65 1.18 . . . . 72.44 109.602 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.0 -23.47 64.11 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.567 0.747 . . . . 73.45 112.953 -171.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.23 24.49 54.43 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-O 119.735 -0.481 . . . . 62.23 112.746 -174.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 64.48 -78.46 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.972 1.309 . . . . 63.35 110.642 -175.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.17 7.53 2.24 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-O 119.437 -0.646 . . . . 73.34 112.906 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 7.7 m 59.79 81.94 0.16 Allowed 'General case' 0 C--N 1.357 0.922 0 C-N-CA 124.536 1.135 . . . . 61.04 110.757 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -79.47 156.82 27.67 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.329 0.652 . . . . 75.43 110.824 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -145.57 -176.79 5.26 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.059 0.944 . . . . 74.11 109.37 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 152' ' ' HIS . . . . . 0.73 ' HB3' ' HB3' ' D' ' 90' ' ' GLU . 5.0 p80 -155.85 86.15 1.04 Allowed 'General case' 0 C--N 1.355 0.806 0 CA-C-O 121.536 0.684 . . . . 72.14 111.546 174.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -75.29 -45.46 39.72 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.955 -0.757 . . . . 74.22 108.955 165.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -105.99 172.71 6.66 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.641 1.176 . . . . 73.51 110.885 -173.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 155' ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' E' ' 99' ' ' ALA . . . . . . . . 0 C--O 1.248 1.014 0 C-N-CA 124.171 0.988 . . . . 75.15 109.45 -177.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.82 0.343 . . . . 74.3 110.144 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 2' ' ' SER . . . . . 0.473 ' HB3' ' HG3' ' E' ' 136' ' ' LYS . 73.5 m -147.12 170.87 16.27 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.445 1.098 . . . . 71.53 109.24 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -66.19 88.42 0.12 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 108.739 -0.837 . . . . 75.11 108.739 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -136.08 88.88 2.43 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.825 -1.079 . . . . 65.15 108.894 -170.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -166.66 137.5 3.32 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.658 0.783 . . . . 74.11 109.094 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -141.64 169.51 17.46 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.223 1.009 . . . . 70.43 108.519 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 46.1 m -46.26 -44.04 16.07 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.541 1.137 . . . . 74.44 111.435 174.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -161.85 158.48 25.57 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.415 -1.266 . . . . 73.44 108.245 173.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 20.7 ttt 64.94 111.87 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.01 1.324 . . . . 61.34 110.894 -173.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 23.3 m -101.26 79.05 1.95 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.262 1.025 . . . . 54.42 108.461 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -99.07 130.45 45.4 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.325 -0.991 . . . . 61.53 108.325 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -150.3 126.05 10.37 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 109.045 -0.724 . . . . 75.2 109.045 174.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.628 ' HB ' HG21 ' E' ' 135' ' ' VAL . 59.5 mt -64.79 134.69 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 107.88 -1.156 . . . . 75.23 107.88 168.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.423 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 31.5 mm-40 -102.73 -39.22 7.12 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.847 0.459 . . . . 74.33 109.822 176.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -178.6 142.31 0.23 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.506 1.123 . . . . 74.32 109.448 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 35.1 mm -119.84 117.8 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 108.128 -1.064 . . . . 72.33 108.128 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.559 ' HB3' HG23 ' D' ' 122' ' ' THR . 41.2 p90 -145.4 162.03 38.26 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.489 0.661 . . . . 74.02 112.031 -167.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.4 p -93.72 115.36 27.79 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.112 -0.949 . . . . 61.32 109.086 175.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.416 ' HG2' ' HE2' ' C' ' 17' ' ' TYR . 77.6 mttt -77.59 -45.31 25.62 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.477 -0.935 . . . . 75.25 108.477 170.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.675 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 26.4 t70 -131.08 135.65 47.72 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 113.662 -1.608 . . . . 64.32 109.435 -171.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 77.5 mt -138.09 142.02 36.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 106.423 -1.695 . . . . 73.14 106.423 174.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.0 t -154.32 145.62 22.96 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.401 0.619 . . . . 71.13 110.326 177.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -149.68 126.03 10.81 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 106.745 -1.576 . . . . 64.13 106.745 170.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -131.63 116.54 17.5 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.478 0.711 . . . . 73.33 109.521 -175.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.54 78.34 62.59 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 124.021 0.928 . . . . 62.14 108.502 172.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.73 -25.99 39.4 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 122.431 2.087 . . . . 62.24 111.037 174.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -97.67 14.04 28.17 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.127 0.971 . . . . 72.42 110.937 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.413 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -49.65 -55.15 24.74 Favored Pre-proline 0 N--CA 1.491 1.602 0 CA-C-O 117.96 -1.019 . . . . 43.43 113.502 -172.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.413 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 37.5 Cg_exo -59.13 -43.79 39.35 Favored 'Trans proline' 0 C--N 1.391 2.815 0 C-N-CA 121.836 1.691 . . . . 62.14 112.077 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -68.78 -32.94 73.05 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.271 -1.331 . . . . 73.03 112.649 -174.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.607 HG21 ' HA ' ' C' ' 73' ' ' ALA . 12.9 p -80.81 -27.19 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 N-CA-C 112.146 0.425 . . . . 41.22 112.146 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -64.86 -27.73 69.07 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 122.893 0.477 . . . . 64.52 111.834 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -88.86 8.37 29.54 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.619 0.767 . . . . 74.14 111.504 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.464 ' HG2' HD13 ' C' ' 68' ' ' LEU . 1.0 OUTLIER -114.69 152.16 32.44 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.014 0.926 . . . . 75.3 110.258 -179.467 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -62.77 128.65 36.91 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.238 0.615 . . . . 64.53 111.12 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 65.8 t-105 -85.05 95.86 9.23 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.298 -0.865 . . . . 74.35 111.121 -174.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 37' ' ' GLN . . . . . 0.456 ' H ' HD22 ' C' ' 68' ' ' LEU . 34.5 tt0 -144.43 75.44 15.05 Favored Pre-proline 0 CA--C 1.549 0.918 0 N-CA-C 108.132 -1.062 . . . . 53.43 108.132 172.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -87.52 162.35 8.06 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.602 2.201 . . . . 74.43 112.686 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -90.08 108.1 19.53 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.407 -1.27 . . . . 72.22 107.692 171.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.45 96.99 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 109.078 -0.712 . . . . 63.23 109.078 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.684 ' HE3' ' HA3' ' F' ' 140' ' ' GLY . 0.8 OUTLIER -101.48 101.98 12.66 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.021 -1.103 . . . . 53.12 108.021 176.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.554 HD21 HG13 ' C' ' 62' ' ' VAL . 1.9 tt -103.65 127.44 51.1 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 107.3 -1.37 . . . . 74.23 107.3 177.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -119.56 117.85 29.46 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.575 0.75 . . . . 53.45 109.008 174.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -99.97 109.27 21.62 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.725 -0.843 . . . . 72.21 108.725 173.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -121.65 121.04 36.46 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.869 -1.16 . . . . 75.45 107.869 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.1 t -124.91 148.01 48.54 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.146 0.498 . . . . 73.43 110.309 -176.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.65 151.07 35.56 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.144 0.977 . . . . 72.14 108.733 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 14.4 m -123.1 150.41 43.22 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 123.715 0.806 . . . . 64.0 109.386 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 25.8 t -147.64 126.4 12.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.481 0.712 . . . . 70.34 109.319 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -76.86 117.56 18.59 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.206 -0.664 . . . . 74.34 109.206 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.532 HD11 ' HB2' ' C' ' 57' ' ' GLU . 50.3 mt -84.1 -43.64 14.84 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.618 0.767 . . . . 71.04 110.413 -175.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.47 -176.14 4.92 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.985 -1.007 . . . . 74.24 109.815 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.71 109.86 2.17 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.967 0.907 . . . . 71.41 110.4 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 65.27 19.98 11.79 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.923 1.289 . . . . 73.54 112.385 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 57.7 t -113.25 110.01 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 108.362 -0.977 . . . . 71.14 108.362 172.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -112.4 124.89 53.5 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.438 1.095 . . . . 70.14 109.794 -177.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.532 ' HB2' HD11 ' C' ' 51' ' ' LEU . 43.1 tt0 -91.24 142.66 27.48 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.759 -0.83 . . . . 75.24 108.759 170.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 82.8 t -124.81 139.4 51.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.995 -1.113 . . . . 53.22 107.995 167.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.06 130.07 72.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.975 -0.75 . . . . 74.34 108.975 173.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.541 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -110.48 111.73 23.17 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.218 -1.401 . . . . 72.12 107.218 178.545 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -90.67 107.24 19.04 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.303 -0.999 . . . . 52.33 108.303 173.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.554 HG13 HD21 ' C' ' 42' ' ' LEU . 38.9 t -101.32 118.89 48.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.949 -1.13 . . . . 74.34 107.949 173.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 26.0 m -118.7 137.48 53.29 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.984 -0.747 . . . . 61.14 108.984 -175.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.458 HG23 HD13 ' C' ' 114' ' ' ILE . 84.8 t -132.02 120.39 43.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 124.02 0.928 . . . . 75.14 109.046 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 10.0 m -113.17 130.31 56.25 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.349 -0.982 . . . . 60.02 108.349 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.88 115.71 24.36 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.16 -1.052 . . . . 73.21 108.16 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 54.5 m -134.02 130.21 37.22 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.431 0.457 . . . . 54.42 110.342 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.464 HD13 ' HG2' ' C' ' 34' ' ' LYS . 39.2 mt -85.84 39.34 0.8 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.699 1.2 . . . . 75.55 109.687 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.43 -102.48 2.2 Favored Glycine 0 C--N 1.348 1.24 0 N-CA-C 110.19 -1.164 . . . . 64.21 110.19 -170.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -89.79 -30.72 17.78 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.753 0.821 . . . . 72.43 110.397 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 71' ' ' GLU . . . . . 0.441 ' HG2' HD12 ' C' ' 68' ' ' LEU . 4.3 tp10 -69.7 121.36 17.03 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 123.95 0.9 . . . . 74.33 109.788 176.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -81.19 117.28 21.59 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.262 -1.014 . . . . 61.54 108.262 165.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.607 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.91 -50.8 21.48 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.654 -0.869 . . . . 73.51 108.654 176.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 74' ' ' PHE . . . . . 0.488 ' HZ ' HD21 ' C' ' 126' ' ' LEU . 31.3 p90 -164.86 164.49 20.91 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.284 -1.326 . . . . 62.52 110.723 177.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.42 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.0 tm? -121.62 144.57 48.67 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 105.965 -1.865 . . . . 61.15 105.965 164.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.527 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.9 t -149.13 137.73 21.07 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.085 -1.08 . . . . 63.34 108.085 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -155.69 132.74 10.7 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.892 -0.41 . . . . 62.34 109.892 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 92.8 t -126.02 135.93 62.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.122 0.969 . . . . 64.51 109.037 174.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.675 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.7 mt-30 -109.99 96.2 6.08 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.069 0.948 . . . . 73.34 108.925 171.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -80.66 102.31 9.78 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.501 -1.227 . . . . 51.35 109.189 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.41 148.85 25.51 Favored Glycine 0 C--N 1.342 0.898 0 N-CA-C 111.181 -0.767 . . . . 43.24 111.181 174.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.74 119.23 1.04 Allowed Glycine 0 N--CA 1.465 0.591 0 CA-C-N 117.419 0.609 . . . . 42.14 111.98 -176.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.446 HG12 ' HE1' ' C' ' 17' ' ' TYR . 22.8 mm -86.75 129.12 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.024 -0.732 . . . . 72.43 109.024 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -133.41 126.64 31.69 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.912 0.885 . . . . 74.04 109.227 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 10.2 p -87.49 101.67 13.82 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.881 -1.155 . . . . 52.21 107.881 168.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 7.7 mt -117.27 124.87 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.648 0.779 . . . . 75.5 110.317 -174.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.442 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -142.5 171.31 14.23 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.098 0.959 . . . . 64.23 109.2 177.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.21 -25.36 12.63 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-O 119.701 -0.499 . . . . 62.14 114.091 174.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.569 HD11 ' HE3' ' C' ' 94' ' ' MET . 37.7 pt -106.63 164.09 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 123.366 0.667 . . . . 72.33 111.393 -178.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -156.04 154.84 31.65 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.639 0.776 . . . . 73.24 110.127 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.41 -117.85 8.72 Favored Glycine 0 C--N 1.351 1.383 0 O-C-N 123.724 0.64 . . . . 61.11 113.411 169.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 17.7 m -62.19 -38.36 88.83 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.006 0.922 . . . . 73.42 111.134 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -67.43 -51.25 53.95 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.947 0.899 . . . . 74.33 111.239 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.569 ' HE3' HD11 ' C' ' 89' ' ' ILE . 5.3 tpt -55.55 -50.72 69.29 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 124.176 0.923 . . . . 62.12 111.431 174.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.32 -43.36 92.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.377 0.671 . . . . 74.51 111.801 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -70.93 -36.49 72.65 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.684 0.794 . . . . 75.31 111.288 -175.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -64.23 -36.79 85.23 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.601 -0.727 . . . . 61.33 110.394 177.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.505 ' HG ' ' HE2' ' C' ' 94' ' ' MET . 91.7 mt -83.65 -37.56 22.66 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.295 1.038 . . . . 63.35 112.752 -176.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.87 -13.62 36.66 Favored Glycine 0 N--CA 1.475 1.279 0 N-CA-C 113.996 0.359 . . . . 72.41 113.996 -168.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.17 -54.32 1.19 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 117.014 0.407 . . . . 50.14 111.488 -175.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -70.72 -52.05 23.42 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 116.251 -0.431 . . . . 75.42 111.781 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.436 ' O ' HD13 ' C' ' 106' ' ' LEU . 96.9 m -64.18 -48.67 76.33 Favored Pre-proline 0 CA--C 1.559 1.309 0 CA-C-O 118.101 -0.952 . . . . 42.4 112.487 -177.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.541 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 50.4 Cg_exo -57.46 -27.3 75.59 Favored 'Trans proline' 0 C--N 1.393 2.891 0 C-N-CA 122.228 1.952 . . . . 61.14 113.373 175.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.43 -38.02 80.81 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.413 0.685 . . . . 73.12 109.878 177.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.47 HD12 ' NH1' ' A' ' 111' ' ' ARG . 47.3 mm -72.47 -34.28 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.684 0.794 . . . . 74.14 110.338 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.436 HD13 ' O ' ' C' ' 102' ' ' CYS . 7.3 mp -80.52 -24.19 39.53 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.906 0.883 . . . . 53.32 112.259 -177.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -58.86 -50.73 86.4 Favored Pre-proline 0 N--CA 1.481 1.081 0 CA-C-O 117.335 -1.317 . . . . 75.0 113.968 -172.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -59.53 -37.34 89.49 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 121.968 1.779 . . . . 74.11 113.206 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.404 ' HE2' HG21 ' A' ' 115' ' ' THR . 58.6 m-85 -65.2 -47.27 77.49 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.643 0.777 . . . . 64.35 110.392 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.96 -34.25 77.97 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 114.48 -1.236 . . . . 60.14 111.329 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -67.3 -50.19 61.24 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.205 1.402 . . . . 73.41 110.701 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -65.76 -35.26 80.21 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 123.805 0.69 . . . . 74.31 109.696 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 18.9 t -67.83 -29.49 68.65 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.305 0.642 . . . . 41.41 111.964 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.527 HG23 ' SG ' ' C' ' 76' ' ' CYS . 65.4 mt -79.07 -53.51 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 123.15 0.58 . . . . 74.13 110.678 174.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 17.8 m -61.91 -28.36 69.47 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.283 0.633 . . . . 71.31 111.162 -175.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.6 t -65.52 -50.07 66.59 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.676 0.791 . . . . 74.1 109.568 171.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.495 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.69 -40.35 87.57 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.464 1.105 . . . . 65.43 112.519 -179.669 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.42 -42.61 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.752 0.821 . . . . 71.1 109.995 175.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 39.7 t -71.45 -27.6 63.38 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.082 -0.963 . . . . 71.13 111.776 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' C' ' 116' ' ' SER . 79.9 mtt-85 -72.88 -41.83 64.26 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.002 -0.74 . . . . 73.13 109.002 176.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.88 -3.33 63.68 Favored Glycine 0 C--N 1.357 1.733 0 CA-C-N 115.419 -0.81 . . . . 65.32 112.901 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 26.1 p 62.32 30.49 17.47 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.632 1.973 . . . . 63.43 112.823 172.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -83.75 145.84 48.19 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 108.504 -0.924 . . . . 53.42 108.504 169.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -46.01 140.51 10.26 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 124.013 3.142 . . . . 64.34 114.898 176.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.474 ' HB2' ' HD1' ' F' ' 131' ' ' TRP . 24.0 mm-40 -60.24 134.6 57.21 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.659 1.184 . . . . 72.0 113.116 -174.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.488 HD21 ' HZ ' ' C' ' 74' ' ' PHE . 0.8 OUTLIER -141.53 98.7 3.4 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 114.791 -1.095 . . . . 74.53 108.567 174.429 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -91.5 102.82 15.48 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.412 -0.959 . . . . 74.25 108.412 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.467 ' H ' HD22 ' C' ' 128' ' ' LEU . 2.7 mm? -57.58 129.93 44.08 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.62 1.168 . . . . 75.12 112.498 -167.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.68 144.53 98.92 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.096 0.958 . . . . 74.14 111.6 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.401 ' HG3' HD12 ' A' ' 16' ' ' ILE . 24.1 Cg_exo -62.19 123.62 12.85 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.948 2.432 . . . . 62.22 112.918 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 24.2 t -115.5 121.4 67.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 108.49 -0.929 . . . . 75.31 108.49 175.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 132' ' ' ASN . . . . . 0.481 HD21 ' HB3' ' C' ' 134' ' ' ASP . 57.3 t30 -75.13 107.47 7.24 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.587 0.755 . . . . 64.1 111.276 -175.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -65.37 -18.35 65.25 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.77 0.828 . . . . 52.11 112.994 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.481 ' HB3' HD21 ' C' ' 132' ' ' ASN . 9.9 t70 -65.52 -43.09 91.13 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.143 0.577 . . . . 71.52 109.846 172.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.09 -42.43 96.93 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.52 -0.764 . . . . 65.24 110.656 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 76.3 mt -70.64 -24.54 62.73 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.164 -0.925 . . . . 73.01 111.844 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -66.13 -35.8 81.45 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.26 0.624 . . . . 74.21 110.868 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 59.8 mtt -57.21 -28.25 62.7 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.211 1.004 . . . . 65.34 112.211 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -68.46 -28.31 66.92 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.893 1.277 . . . . 75.24 114.245 -176.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -158.01 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.486 0 N-CA-C 115.529 1.678 . . . . 64.05 115.529 -168.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 5.1 mp -126.97 133.7 50.54 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.386 -0.968 . . . . 71.15 108.386 175.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.657 ' HG3' ' H ' ' C' ' 144' ' ' GLN . 55.5 tp60 -170.61 136.53 1.26 Allowed 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.094 0.871 . . . . 73.41 109.25 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -79.81 -7.39 58.65 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.732 0.813 . . . . 75.21 111.135 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 144' ' ' GLN . . . . . 0.657 ' H ' ' HG3' ' C' ' 142' ' ' GLN . 65.6 tp60 -106.08 122.79 46.88 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.295 1.038 . . . . 65.23 108.56 170.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.52 -35.82 81.19 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.333 0.587 . . . . 71.24 109.958 174.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 128.06 -152.66 19.12 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 114.857 -1.065 . . . . 74.42 110.72 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -161.38 -55.99 0.05 OUTLIER 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.103 -0.702 . . . . 71.54 109.103 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 76.61 160.79 10.94 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 114.952 -1.022 . . . . 54.5 111.812 -171.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 7.8 t -162.08 142.77 10.41 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.308 0.643 . . . . 74.54 109.702 177.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -90.83 67.17 6.15 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 107.472 -1.307 . . . . 73.13 107.472 169.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -92.81 115.61 28.27 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.394 -0.821 . . . . 74.02 109.073 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 152' ' ' HIS . . . . . 0.468 ' CE1' ' SD ' ' A' ' 138' ' ' MET . 11.1 p80 -171.9 139.65 1.17 Allowed 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.44 -0.948 . . . . 74.43 108.44 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 153' ' ' GLN . . . . . 0.436 ' HB3' ' O ' ' E' ' 144' ' ' VAL . 3.7 tp-100 -161.95 143.53 11.06 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.693 -0.484 . . . . 64.52 109.693 177.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -108.02 163.92 12.73 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.101 0.56 . . . . 73.43 110.383 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.844 0 N-CA-C 108.0 -1.111 . . . . 72.35 108.0 171.48 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.6 ttm . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 110.209 -0.293 . . . . 63.24 110.209 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 34.3 t -159.04 -37.56 0.06 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.405 0.682 . . . . 34.43 110.575 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 65.44 160.08 0.12 Allowed 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 124.819 1.248 . . . . 61.41 112.855 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -169.54 166.3 10.12 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.405 0.682 . . . . 72.11 111.22 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -96.06 12.11 31.77 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.662 0.785 . . . . 73.33 111.57 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -64.26 122.1 15.84 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.119 0.568 . . . . 70.14 111.475 -176.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 13.3 t -76.74 -21.69 54.91 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.082 0.953 . . . . 72.15 111.361 -177.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -68.73 144.36 54.41 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 107.636 -1.246 . . . . 74.23 107.636 172.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.641 ' HG2' HG13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -27.3 122.6 0.09 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 126.147 1.779 . . . . 73.24 114.28 -167.842 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 13.0 t -120.81 138.58 53.97 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.15 0.58 . . . . 74.41 109.836 -176.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.431 ' HD2' HG22 ' D' ' 86' ' ' ILE . 84.9 t80 -134.84 101.93 5.08 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 107.861 -1.163 . . . . 52.41 107.861 176.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -127.5 120.07 27.46 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.421 -0.955 . . . . 55.43 108.421 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 10.5 mt -80.25 133.01 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 109.341 -0.614 . . . . 63.5 109.341 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -89.82 -40.58 12.36 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.829 0.852 . . . . 54.45 110.805 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -167.69 137.77 2.76 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.351 -0.386 . . . . 73.24 110.385 -175.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.9 mp -110.17 137.26 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 107.048 -1.464 . . . . 61.14 107.048 169.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -164.31 142.49 7.04 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.372 0.533 . . . . 71.41 111.457 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 67.9 p -77.95 121.0 23.6 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.866 -0.606 . . . . 73.5 109.749 176.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.518 ' HD2' ' HA3' ' D' ' 81' ' ' GLY . 34.9 mtpt -96.08 -13.89 23.31 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.297 0.639 . . . . 71.21 109.909 -178.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.4 t70 -163.79 139.7 6.51 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.352 1.061 . . . . 71.41 108.915 177.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.495 HG21 ' HE2' ' C' ' 117' ' ' MET . 76.8 mt -141.9 147.41 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.614 1.166 . . . . 55.14 108.488 177.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 74.3 m -148.85 142.01 24.99 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.0 1.72 . . . . 72.41 108.155 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 83.0 t80 -145.86 113.53 6.38 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 105.012 -2.218 . . . . 73.03 105.012 166.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -131.07 110.04 10.92 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.79 0.436 . . . . 63.41 110.254 -168.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.35 82.06 11.5 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 107.92 -1.141 . . . . 63.24 107.92 176.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.74 -17.6 17.85 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.57 2.18 . . . . 71.23 112.361 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.422 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 76.8 m-20 -107.48 9.08 29.69 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.84 0.856 . . . . 72.53 110.735 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.412 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -33.31 -67.82 0.18 Allowed Pre-proline 0 CA--C 1.572 1.808 0 N-CA-C 115.976 1.843 . . . . 51.43 115.976 -165.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.79 -15.19 15.26 Favored 'Trans proline' 0 C--N 1.385 2.495 0 CA-C-N 124.077 2.492 . . . . 65.24 114.014 -176.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 30' ' ' HIS . . . . . 0.422 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 7.2 t-160 -72.99 -40.99 64.79 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.652 1.181 . . . . 71.23 109.399 173.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.568 HG22 HD12 ' D' ' 68' ' ' LEU . 8.7 p -86.08 -19.69 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 CA-C-N 115.018 -0.992 . . . . 63.43 111.473 -175.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -67.66 -19.66 65.22 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 117.837 0.29 . . . . 75.21 111.658 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -67.28 -14.14 62.64 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.711 0.804 . . . . 70.3 110.832 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -103.22 69.1 1.0 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.958 1.303 . . . . 72.22 109.255 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -84.07 74.6 10.25 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-O 122.314 1.054 . . . . 72.25 110.489 -176.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 4.7 p90 -142.8 -165.05 1.97 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.587 -0.733 . . . . 73.41 109.311 175.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -64.5 108.51 1.99 Allowed Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 124.163 0.985 . . . . 72.44 111.027 177.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -72.24 126.89 12.12 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.168 1.912 . . . . 51.53 110.747 176.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.91 111.83 11.69 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.915 -1.142 . . . . 74.22 107.915 176.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.676 HG13 HG13 ' D' ' 64' ' ' VAL . 65.9 t -108.61 137.01 42.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 C-N-CA 123.846 0.858 . . . . 65.44 108.911 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 29.7 mmtm -126.85 134.47 50.51 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.456 0.702 . . . . 74.4 109.796 170.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.733 HD11 HG13 ' D' ' 62' ' ' VAL . 20.7 tp -96.68 147.68 23.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.255 -0.884 . . . . 63.04 109.971 -175.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.549 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 19.9 t70 -139.98 112.48 7.86 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.83 -1.174 . . . . 73.24 107.83 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.597 ' HB2' ' HB2' ' E' ' 111' ' ' LEU . 96.0 mt -115.08 132.73 56.51 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.391 0.677 . . . . 73.12 109.817 -172.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.577 ' HB2' ' HB3' ' D' ' 61' ' ' ARG . 3.5 m-20 -132.49 151.28 51.96 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.816 1.246 . . . . 75.43 108.658 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 46' ' ' THR . . . . . 0.414 HG21 ' O ' ' D' ' 99' ' ' GLY . 20.5 p -107.88 146.48 32.26 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.368 0.667 . . . . 71.43 110.47 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.639 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.37 163.39 37.88 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.126 0.97 . . . . 61.21 109.217 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 61.6 p -167.41 -171.8 1.79 Allowed 'General case' 0 CA--C 1.542 0.642 0 O-C-N 123.798 0.686 . . . . 73.44 110.917 -173.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' D' ' 57' ' ' GLU . 49.0 m -147.14 144.06 28.72 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.814 1.245 . . . . 52.44 108.331 174.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 50' ' ' GLN . . . . . 0.483 ' HA ' HD23 ' E' ' 102' ' ' LEU . 23.8 pt20 -79.19 -164.97 0.69 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.446 1.098 . . . . 71.11 111.722 -174.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 tm? 83.72 112.02 0.06 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 125.798 1.639 . . . . 72.41 109.308 -176.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' E' ' 100' ' ' LEU . . . -95.41 110.22 22.28 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.734 0.813 . . . . 53.31 112.415 -171.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -161.63 23.75 0.12 Allowed 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 120.731 0.3 . . . . 61.14 110.889 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 65.68 7.68 4.66 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 124.376 1.07 . . . . 73.25 112.015 -171.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.495 HG21 ' HA3' ' E' ' 92' ' ' GLY . 11.7 t -113.13 99.2 8.17 Favored 'Isoleucine or valine' 0 C--N 1.349 0.571 0 N-CA-C 107.422 -1.325 . . . . 63.31 107.422 177.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -127.84 131.79 49.46 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 120.596 0.236 . . . . 73.53 110.443 -173.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.461 ' HB3' ' HB2' ' D' ' 49' ' ' SER . 35.6 tp10 -87.6 138.49 31.42 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.651 -0.87 . . . . 74.11 108.651 174.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 78.7 t -136.25 138.33 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 C-N-CA 124.846 1.258 . . . . 63.1 107.909 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.639 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 21.5 t -132.94 120.24 40.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.424 -0.954 . . . . 53.12 108.424 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.539 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -93.2 124.84 37.46 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.112 -1.07 . . . . 73.02 108.112 174.149 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.591 ' HG2' ' HG2' ' D' ' 79' ' ' GLN . 1.5 tmm_? -100.27 104.65 16.14 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.095 -1.076 . . . . 62.02 108.095 174.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.733 HG13 HD11 ' D' ' 42' ' ' LEU . 82.8 t -103.1 121.5 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 123.923 0.889 . . . . 71.14 108.734 175.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.549 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 60.3 m -120.82 133.69 55.31 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.617 0.722 . . . . 73.31 109.47 175.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.676 HG13 HG13 ' D' ' 40' ' ' VAL . 34.5 t -110.26 119.69 59.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 114.457 -1.247 . . . . 74.42 108.662 174.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 15.6 m -109.04 91.86 3.81 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.21 -1.404 . . . . 63.24 107.21 171.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.63 147.19 25.07 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.513 -0.767 . . . . 71.41 109.372 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.423 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 53.8 p -156.28 132.86 10.2 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 123.513 0.508 . . . . 63.41 111.092 -173.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.568 HD12 HG22 ' D' ' 31' ' ' VAL . 21.5 mt -104.62 112.22 25.22 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.077 -1.083 . . . . 52.32 108.077 170.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.34 -115.94 4.41 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.926 -0.579 . . . . 72.42 111.737 -172.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -115.91 4.53 13.86 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 117.381 0.591 . . . . 65.34 111.388 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -114.25 154.86 27.2 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.49 0.316 . . . . 70.34 110.656 -175.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 95.3 m -63.12 120.06 10.74 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 123.975 0.797 . . . . 73.24 111.144 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.548 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -76.18 -67.37 0.69 Allowed 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.02 -1.474 . . . . 52.12 107.02 167.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 74' ' ' PHE . . . . . 0.402 ' HD1' ' HB2' ' D' ' 76' ' ' CYS . 53.2 p90 -154.23 142.95 20.9 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.997 -0.547 . . . . 71.41 110.997 176.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 57.8 mt -106.12 107.95 19.21 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 107.249 -1.389 . . . . 71.1 107.249 170.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.612 ' SG ' HG23 ' D' ' 114' ' ' ILE . 17.5 t -118.45 107.78 14.22 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.023 -0.732 . . . . 41.04 109.023 -172.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -128.9 131.37 47.58 Favored 'General case' 0 C--O 1.22 -0.487 0 C-N-CA 123.265 0.626 . . . . 74.52 110.088 -171.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 78' ' ' VAL . . . . . 0.446 HG21 ' HB3' ' D' ' 113' ' ' CYS . 86.3 t -134.43 116.18 21.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 123.734 0.814 . . . . 74.13 108.928 178.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.604 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 78.6 mt-30 -88.88 84.43 6.65 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.177 -1.045 . . . . 71.45 108.177 171.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -82.32 108.05 15.46 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 113.998 -1.456 . . . . 64.0 109.52 -176.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.518 ' HA3' ' HD2' ' D' ' 19' ' ' LYS . . . -99.61 172.95 25.45 Favored Glycine 0 C--O 1.241 0.558 0 O-C-N 123.374 0.421 . . . . 34.22 112.893 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.63 144.26 6.53 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.513 -0.344 . . . . 51.43 112.865 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 54.7 mt -90.11 128.08 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.019 -1.104 . . . . 74.42 108.019 172.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -124.57 140.27 53.1 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.914 0.886 . . . . 75.55 110.771 -175.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 7.1 m -98.83 98.73 9.79 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.387 1.075 . . . . 62.55 108.92 172.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.664 HG12 HD21 ' D' ' 98' ' ' LEU . 2.6 pp -115.96 132.87 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 109.26 -0.645 . . . . 75.2 109.26 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.92 168.19 19.71 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.234 1.014 . . . . 51.11 109.404 -177.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 90.74 -21.55 32.62 Favored Glycine 0 N--CA 1.477 1.381 0 C-N-CA 123.221 0.439 . . . . 42.32 113.91 175.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.641 HG13 ' HG2' ' D' ' 9' ' ' MET . 1.0 OUTLIER -101.03 155.85 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.864 0.865 . . . . 65.41 109.374 172.517 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.73 ' HB3' ' HB3' ' B' ' 152' ' ' HIS . 30.7 mt-10 -144.4 175.11 10.35 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.286 1.034 . . . . 63.42 110.457 -176.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.26 -140.56 23.05 Favored Glycine 0 C--N 1.357 1.732 0 N-CA-C 114.68 0.632 . . . . 72.11 114.68 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 86.2 m -79.79 -38.35 33.27 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.974 0.91 . . . . 73.33 111.046 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -60.72 -36.37 78.68 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.365 1.066 . . . . 53.54 111.198 -174.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.627 ' HB2' HD11 ' E' ' 97' ' ' ILE . 0.0 OUTLIER -68.07 -37.53 81.37 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.973 0.731 . . . . 73.2 112.973 -172.219 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.58 -25.35 33.36 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.383 0.673 . . . . 71.23 109.927 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -66.89 -27.39 67.47 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.099 0.96 . . . . 73.33 110.302 174.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 94.8 m -62.21 -42.83 99.65 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.383 0.673 . . . . 73.42 111.387 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.664 HD21 HG12 ' D' ' 86' ' ' ILE . 86.9 mt -70.71 -22.24 62.47 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.586 0.355 . . . . 73.0 111.361 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 99' ' ' GLY . . . . . 0.414 ' O ' HG21 ' D' ' 46' ' ' THR . . . -102.63 14.02 56.44 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-O 119.499 -0.612 . . . . 64.41 113.28 176.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.489 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -155.98 -66.11 0.11 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 118.277 1.039 . . . . 62.03 112.355 -177.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -65.43 -51.63 58.87 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.12 0.568 . . . . 75.02 111.632 -172.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.429 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 78.8 m -60.89 -47.01 96.87 Favored Pre-proline 0 CA--C 1.565 1.554 0 C-N-CA 123.772 0.829 . . . . 71.11 112.359 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.539 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.7 Cg_exo -54.32 -40.01 84.54 Favored 'Trans proline' 0 C--N 1.394 2.955 0 C-N-CA 122.388 2.059 . . . . 60.12 113.678 168.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 104' ' ' ASN . . . . . 0.418 ' HB2' ' HB2' ' D' ' 133' ' ' PHE . 56.1 t30 -61.98 -33.5 74.43 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.458 0.703 . . . . 64.12 111.325 -178.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.404 HG13 ' CZ ' ' D' ' 11' ' ' PHE . 43.6 mm -72.85 -36.12 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.361 1.064 . . . . 72.13 110.76 175.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 91.1 mt -71.93 -19.06 61.97 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.907 -0.588 . . . . 74.42 111.629 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -65.96 -44.42 61.37 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-O 117.782 -1.104 . . . . 72.12 113.335 -173.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.89 -42.12 31.57 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 122.343 2.028 . . . . 75.04 113.964 168.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -79.52 -32.35 42.32 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.687 0.795 . . . . 64.33 111.921 -177.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.94 -44.69 65.58 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.415 0.626 . . . . 73.53 109.996 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.577 HH12 ' HB3' ' D' ' 130' ' ' PRO . 37.4 ttp180 -65.67 -35.65 81.39 Favored 'General case' 0 C--O 1.206 -1.216 0 CA-C-N 114.012 -1.449 . . . . 74.03 110.365 174.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 112' ' ' GLU . . . . . 0.473 ' HA ' ' CE2' ' B' ' 109' ' ' TYR . 6.1 tt0 -52.86 -51.21 61.91 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.845 0.858 . . . . 73.44 111.151 176.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.456 ' O ' ' HG3' ' D' ' 117' ' ' MET . 43.8 t -63.7 -45.04 91.82 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.527 -1.215 . . . . 75.32 110.717 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.612 HG23 ' SG ' ' D' ' 76' ' ' CYS . 31.5 mt -60.55 -64.42 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.392 0.677 . . . . 65.51 111.269 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.4 m -40.54 -46.89 2.59 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.027 1.731 . . . . 71.14 112.63 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -62.95 -48.14 80.19 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 114.867 -1.061 . . . . 72.44 110.657 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.456 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 71.6 mtm -67.24 -31.46 71.83 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.42 0.688 . . . . 64.31 112.296 -178.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.485 HG21 ' HB3' ' D' ' 126' ' ' LEU . 87.2 t -65.53 -45.06 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.765 0.826 . . . . 52.33 109.946 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 56.0 p -70.38 -33.05 70.96 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 115.289 -0.869 . . . . 44.21 110.363 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 51.8 mtt-85 -67.36 -35.07 78.63 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.872 0.869 . . . . 75.14 110.576 175.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.21 11.19 61.31 Favored Glycine 0 C--N 1.355 1.6 0 CA-C-O 119.581 -0.566 . . . . 51.22 114.082 -178.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.559 HG23 ' HB3' ' C' ' 17' ' ' TYR . 66.9 p 57.2 30.25 18.06 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 126.2 1.8 . . . . 65.13 114.073 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -97.87 149.36 35.64 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.147 0.579 . . . . 75.21 109.781 170.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -45.17 120.99 3.36 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 123.75 2.967 . . . . 74.24 112.832 169.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' E' ' 127' ' ' SER . 46.3 tt0 -48.54 122.75 5.81 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 124.539 1.149 . . . . 74.1 111.876 -174.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.485 ' HB3' HG21 ' D' ' 118' ' ' VAL . 22.5 tp -105.44 106.59 17.16 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.45 0.7 . . . . 70.11 109.598 -174.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -106.53 89.87 3.16 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.288 1.035 . . . . 73.45 108.936 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.42 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 37.6 mt -57.39 117.88 4.57 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.048 0.939 . . . . 75.54 110.498 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.43 123.81 78.07 Favored Pre-proline 0 CA--C 1.56 1.338 0 C-N-CA 122.679 0.391 . . . . 55.11 111.176 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.577 ' HB3' HH12 ' D' ' 111' ' ' ARG . 76.6 Cg_endo -75.54 141.31 24.97 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 122.603 2.202 . . . . 71.1 111.876 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.87 152.22 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.574 0.75 . . . . 63.52 109.748 -175.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -68.58 103.9 1.82 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.382 0.673 . . . . 70.31 110.391 176.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.418 ' HB2' ' HB2' ' D' ' 104' ' ' ASN . 3.7 m-30 -62.36 -24.48 67.38 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.097 0.959 . . . . 70.45 112.639 -177.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.489 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 4.5 t70 -62.28 -40.11 95.18 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.797 0.685 . . . . 73.31 109.858 -178.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.52 -34.56 70.18 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.179 -0.919 . . . . 60.23 111.539 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.405 HD22 HD23 ' E' ' 111' ' ' LEU . 10.2 mp -65.76 -47.56 74.82 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 122.925 0.49 . . . . 65.24 110.621 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -68.69 -31.19 70.12 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 124.064 0.946 . . . . 61.44 109.893 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 32.8 ttm -66.3 -41.64 89.45 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.306 1.042 . . . . 74.11 110.668 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -80.08 -16.58 54.71 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.547 -0.752 . . . . 72.42 111.988 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -54.93 -39.9 69.35 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.648 0.779 . . . . 74.45 110.559 173.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.8 mp -68.12 -33.58 74.76 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 114.763 -1.108 . . . . 74.04 110.96 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -87.28 4.59 42.15 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.239 1.016 . . . . 34.04 112.159 -174.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -120.06 95.25 4.68 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.965 0.906 . . . . 73.11 109.262 -176.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -142.69 -168.18 2.7 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.661 0.784 . . . . 74.52 110.484 -175.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.03 -18.31 63.19 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.523 1.129 . . . . 72.41 113.144 -176.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.64 9.47 43.22 Favored Glycine 0 C--N 1.352 1.465 0 O-C-N 123.396 0.435 . . . . 61.05 113.306 175.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.25 139.42 39.2 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 106.952 -1.499 . . . . 74.01 106.952 174.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 148' ' ' GLY . . . . . 0.414 ' HA2' ' HE2' ' E' ' 117' ' ' LYS . . . -156.67 42.01 0.55 Allowed Glycine 0 C--N 1.351 1.392 0 N-CA-C 114.339 0.496 . . . . 73.1 114.339 -174.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 13.1 t -93.71 173.37 7.72 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 117.582 0.691 . . . . 35.34 110.161 173.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -156.25 150.05 25.0 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.833 0.853 . . . . 64.13 109.575 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -169.04 175.42 5.78 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.406 0.622 . . . . 65.31 111.481 171.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -126.12 137.43 53.6 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.496 1.118 . . . . 73.51 108.039 167.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -148.82 146.27 27.91 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.645 0.378 . . . . 75.22 111.17 -170.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 65.45 150.46 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.114 1.366 . . . . 74.23 113.502 171.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.057 0 C-N-CA 124.434 1.094 . . . . 61.12 108.85 176.482 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 CA-C-O 120.037 -0.313 . . . . 73.41 113.461 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' E' E ' 92' ' ' GLY . . . . . 0.495 ' HA3' HG21 ' D' ' 55' ' ' VAL . . . -158.42 -73.98 0.02 OUTLIER Glycine 0 C--N 1.342 0.9 0 N-CA-C 111.435 -0.666 . . . . 74.21 111.435 -177.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -166.01 172.32 11.57 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 112.854 0.687 . . . . 61.14 112.854 -172.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 5.1 t80 61.08 -94.39 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 126.216 1.806 . . . . 73.14 111.421 177.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 95' ' ' LYS . . . . . 0.43 ' HE3' ' HB2' ' E' ' 95' ' ' LYS . 39.0 mtmt -149.53 -80.92 0.12 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.409 0.623 . . . . 74.32 110.862 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 141.3 75.67 0.04 OUTLIER Glycine 0 C--N 1.345 1.042 0 N-CA-C 109.586 -1.406 . . . . 65.14 109.586 -166.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 97' ' ' ILE . . . . . 0.627 HD11 ' HB2' ' D' ' 94' ' ' MET . 1.5 tt -37.01 105.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 126.659 1.983 . . . . 71.44 113.908 -176.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 25.4 t70 52.41 -92.09 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.909 1.684 . . . . 63.03 112.284 172.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 99' ' ' ALA . . . . . 0.485 ' HB3' ' HB1' ' B' ' 155' ' ' ALA . . . -161.38 40.22 0.14 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.678 0.791 . . . . 63.53 109.885 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 100' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' D' ' 52' ' ' ALA . 12.8 tp -69.57 101.72 0.35 Allowed Pre-proline 0 N--CA 1.484 1.27 0 C-N-CA 124.913 1.285 . . . . 64.44 111.684 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -100.23 -2.78 0.63 Allowed 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 123.236 2.624 . . . . 70.31 113.595 -175.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 102' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' D' ' 50' ' ' GLN . 4.0 mm? 62.22 167.14 0.11 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 125.227 1.411 . . . . 72.21 112.313 -168.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 74.0 p -83.23 -43.62 15.89 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.545 -0.752 . . . . 73.14 109.508 175.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 168.71 -177.67 42.49 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-N 115.094 -0.957 . . . . 63.41 112.019 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -76.06 105.29 7.02 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.593 -0.892 . . . . 64.04 108.593 175.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 106' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' D' ' 47' ' ' ALA . 59.3 t80 72.01 132.59 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.903 1.281 . . . . 71.13 110.972 -176.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 8.3 t -124.62 157.26 35.92 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.453 0.701 . . . . 74.53 110.089 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -97.73 18.27 16.05 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.007 0.923 . . . . 72.32 110.634 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -80.58 71.27 7.44 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 108.785 -0.82 . . . . 72.41 108.785 166.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.09 138.62 38.85 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.408 -1.269 . . . . 75.23 110.207 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 111' ' ' LEU . . . . . 0.597 ' HB2' ' HB2' ' D' ' 44' ' ' LEU . 5.8 mp -65.09 -33.21 75.47 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.211 0.605 . . . . 61.42 110.096 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -98.38 95.48 7.38 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.552 -0.907 . . . . 70.43 108.552 171.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -103.59 77.89 1.53 Allowed 'General case' 0 C--O 1.242 0.69 0 N-CA-C 106.596 -1.631 . . . . 72.01 106.596 175.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -63.95 116.75 6.14 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 114.795 -1.093 . . . . 70.52 111.399 -175.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 5.5 m -140.51 5.67 2.04 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.909 0.884 . . . . 71.12 109.642 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.04 -29.24 12.56 Favored Glycine 0 C--N 1.35 1.341 0 N-CA-C 111.958 -0.457 . . . . 54.14 111.958 -175.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 117' ' ' LYS . . . . . 0.414 ' HE2' ' HA2' ' D' ' 148' ' ' GLY . 0.7 OUTLIER -68.93 131.2 91.07 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 108.573 -0.899 . . . . 75.33 108.573 174.886 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.18 112.4 0.92 Allowed 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.838 2.359 . . . . 74.12 111.474 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -60.89 154.71 21.5 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.734 0.814 . . . . 72.04 111.089 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -82.76 -2.23 53.79 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.925 -0.58 . . . . 75.01 111.055 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 121' ' ' VAL . . . . . 0.4 HG22 HD23 ' D' ' 136' ' ' LEU . 35.0 t -68.3 132.72 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 123.638 0.775 . . . . 63.24 109.553 172.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 29.6 m -62.56 138.23 58.44 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 122.811 0.444 . . . . 71.14 109.824 173.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -58.2 147.74 29.33 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.311 0.577 . . . . 63.44 111.126 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 4.6 m -88.57 42.83 1.09 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.017 -0.992 . . . . 65.25 111.117 -171.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -73.85 -159.62 0.08 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.728 1.211 . . . . 70.43 110.568 173.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . 65.56 54.28 1.13 Allowed 'General case' 0 C--N 1.356 0.891 0 CA-C-O 121.863 0.839 . . . . 45.03 110.31 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 127' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' D' ' 125' ' ' GLN . 4.7 p -122.72 113.82 19.72 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.93 -1.032 . . . . 72.33 109.779 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.81 99.68 1.07 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.426 1.09 . . . . 74.11 111.267 -174.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 32.7 p -87.94 74.53 8.95 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.923 0.889 . . . . 64.03 112.854 -171.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -166.68 109.31 0.71 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 107.667 -1.235 . . . . 54.01 107.667 170.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 131' ' ' TRP . . . . . . . . . . . . . 8.0 t-105 -148.64 158.33 44.06 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.419 0.525 . . . . 63.23 112.419 -175.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 14.4 t 70.36 104.09 0.06 Allowed 'General case' 0 C--N 1.357 0.922 0 C-N-CA 126.384 1.873 . . . . 64.04 110.998 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 29.1 m -79.52 -20.39 47.31 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.623 0.769 . . . . 50.41 109.959 169.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.2 -135.33 13.77 Favored Glycine 0 C--N 1.342 0.904 0 N-CA-C 109.46 -1.456 . . . . 75.44 109.46 -164.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 135' ' ' VAL . . . . . 0.628 HG21 ' HB ' ' C' ' 13' ' ' ILE . 77.0 t -141.07 -63.13 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.231 0.612 . . . . 64.14 110.232 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 136' ' ' LYS . . . . . 0.473 ' HG3' ' HB3' ' C' ' 2' ' ' SER . 4.2 mtmt 62.95 -160.21 0.31 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 124.068 0.855 . . . . 74.45 110.514 -171.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 7.6 t -134.63 150.64 50.69 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.851 -0.531 . . . . 74.53 110.542 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -64.15 -36.28 83.51 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.204 1.002 . . . . 64.34 110.677 172.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -160.57 126.65 4.04 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.014 0.926 . . . . 73.1 108.583 173.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -115.07 123.19 5.87 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.979 -0.448 . . . . 52.32 111.979 -177.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -159.5 145.94 16.4 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.412 0.685 . . . . 55.33 109.921 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 6.2 mp -86.02 123.45 31.35 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.688 -0.856 . . . . 43.32 108.688 175.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -81.69 -107.47 0.37 Allowed Glycine 0 CA--C 1.532 1.135 0 N-CA-C 112.158 -0.377 . . . . 74.54 112.158 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 144' ' ' VAL . . . . . 0.436 ' O ' ' HB3' ' C' ' 153' ' ' GLN . 10.5 p -171.63 172.7 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 124.799 1.24 . . . . 62.21 108.049 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 N--CA 1.49 1.563 0 CA-C-N 118.656 0.662 . . . . 64.4 110.441 174.808 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.914 0 CA-C-O 119.874 -0.403 . . . . 65.2 112.847 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . -132.92 59.72 0.68 Allowed Glycine 0 C--N 1.352 1.463 0 N-CA-C 111.366 -0.693 . . . . 60.12 111.366 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -93.81 90.31 6.49 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.734 0.814 . . . . 64.14 109.373 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -159.79 148.65 17.62 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.35 0.66 . . . . 74.24 110.346 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 95' ' ' LYS . . . . . 0.708 ' HD2' ' SD ' ' B' ' 1' ' ' MET . 0.7 OUTLIER -63.73 97.7 0.16 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.403 1.081 . . . . 74.23 111.772 -173.156 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -149.81 -6.02 0.2 Allowed Glycine 0 CA--C 1.535 1.317 0 CA-C-N 115.327 -0.851 . . . . 65.41 113.424 174.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 97' ' ' ILE . . . . . 0.516 HG21 ' HB2' ' F' ' 100' ' ' LEU . 8.8 tp -81.63 165.89 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 123.489 0.716 . . . . 51.45 110.863 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 98' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 22.2 t70 -93.53 -79.0 0.42 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.707 0.803 . . . . 71.25 110.17 173.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.31 78.7 1.86 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 108.85 -0.796 . . . . 64.25 108.85 -178.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 100' ' ' LEU . . . . . 0.516 ' HB2' HG21 ' F' ' 97' ' ' ILE . 1.7 tm? -55.63 -43.2 99.04 Favored Pre-proline 0 N--CA 1.491 1.616 0 C-N-CA 124.768 1.227 . . . . 72.01 113.444 -171.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.65 133.52 20.55 Favored 'Trans proline' 0 C--N 1.381 2.249 0 CA-C-N 121.071 1.418 . . . . 73.35 110.032 167.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 102' ' ' LEU . . . . . . . . . . . . . 61.1 mt -58.19 102.0 0.09 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.886 0.474 . . . . 70.0 110.648 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 6.3 t -54.56 137.52 43.04 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 125.261 1.424 . . . . 72.02 112.529 -174.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.92 -78.68 0.61 Allowed Glycine 0 C--N 1.341 0.86 0 N-CA-C 111.377 -0.689 . . . . 71.22 111.377 -176.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 105' ' ' GLN . . . . . 0.408 ' H ' ' HB2' ' F' ' 108' ' ' HIS . 50.9 tp60 -159.67 167.85 27.4 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.885 0.474 . . . . 62.25 110.023 -171.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -38.06 94.31 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.569 1.948 . . . . 64.31 111.641 168.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 19.3 m 50.05 73.27 0.27 Allowed 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 124.688 1.195 . . . . 62.54 110.669 -173.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 108' ' ' HIS . . . . . 0.408 ' HB2' ' H ' ' F' ' 105' ' ' GLN . 21.2 t-160 -65.3 -33.82 76.88 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 114.754 -1.112 . . . . 73.01 112.138 -173.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -71.0 -24.45 62.39 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.029 0.532 . . . . 74.21 111.137 176.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 62.94 94.38 0.05 OUTLIER 'General case' 0 C--N 1.356 0.86 0 C-N-CA 125.052 1.341 . . . . 73.24 112.196 174.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 111' ' ' LEU . . . . . 0.459 HD21 ' HD1' ' B' ' 133' ' ' PHE . 21.5 tp -65.3 -58.77 5.1 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.62 0.724 . . . . 61.21 109.182 173.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -153.88 75.89 1.04 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 106.167 -1.79 . . . . 75.33 106.167 170.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -86.26 -17.93 33.4 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.898 -1.046 . . . . 74.11 110.652 -176.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -125.87 156.85 38.99 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.07 0.948 . . . . 74.42 110.223 177.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 41.0 p -69.32 -20.79 63.87 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.642 0.777 . . . . 75.53 111.257 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.54 76.71 1.57 Allowed Glycine 0 C--N 1.346 1.104 0 N-CA-C 111.117 -0.793 . . . . 61.13 111.117 172.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 117' ' ' LYS . . . . . 0.481 ' HG3' ' HB ' ' F' ' 121' ' ' VAL . 0.0 OUTLIER -58.84 124.11 71.67 Favored Pre-proline 0 CA--C 1.562 1.434 0 C-N-CA 123.376 0.67 . . . . 72.32 111.243 174.204 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -64.23 -26.09 64.61 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.64 2.894 . . . . 63.51 115.684 -169.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -158.42 -54.87 0.07 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 120.916 0.389 . . . . 75.4 111.377 -169.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 120' ' ' TYR . . . . . 0.401 ' HB2' HD11 ' B' ' 136' ' ' LEU . 8.2 t80 -70.11 171.93 8.83 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.009 0.923 . . . . 65.32 110.913 -176.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 121' ' ' VAL . . . . . 0.481 ' HB ' ' HG3' ' F' ' 117' ' ' LYS . 62.1 t 62.31 87.36 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.393 1.077 . . . . 74.34 109.55 -178.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 122' ' ' THR . . . . . 0.467 HG23 ' H ' ' F' ' 124' ' ' SER . 13.0 t -113.52 -166.84 1.13 Allowed 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.954 -1.021 . . . . 71.11 109.88 -172.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -58.14 -30.42 66.33 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.268 1.027 . . . . 64.44 111.576 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 124' ' ' SER . . . . . 0.467 ' H ' HG23 ' F' ' 122' ' ' THR . 55.3 m -65.66 93.1 0.16 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.739 0.815 . . . . 42.41 110.41 175.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -144.17 -177.67 5.57 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.659 1.184 . . . . 25.13 109.279 -178.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 126' ' ' ALA . . . . . 0.525 ' O ' ' HB ' ' B' ' 40' ' ' VAL . . . -75.0 106.3 6.43 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.004 0.522 . . . . 72.43 110.338 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 66.5 m -139.43 93.38 2.67 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.426 -0.953 . . . . 71.32 108.426 174.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -158.74 149.24 19.9 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.477 0.711 . . . . 62.24 109.915 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 15.6 p -77.66 -78.18 0.14 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.864 -0.791 . . . . 62.44 108.864 170.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 130' ' ' ALA . . . . . 0.652 ' HB3' ' HB3' ' B' ' 125' ' ' GLN . . . 45.09 61.0 2.71 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.145 0.978 . . . . 74.32 110.968 -171.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 131' ' ' TRP . . . . . 0.474 ' HD1' ' HB2' ' C' ' 125' ' ' GLN . 9.7 t90 -154.61 18.06 0.46 Allowed 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.621 -1.172 . . . . 73.24 109.166 -176.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 57.2 p -64.34 -21.06 66.49 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.356 0.663 . . . . 65.1 111.843 -176.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 34.0 m -73.91 83.43 1.7 Allowed 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 121.256 0.55 . . . . 74.13 109.691 170.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.89 94.89 0.89 Allowed Glycine 0 C--N 1.351 1.39 0 N-CA-C 109.872 -1.291 . . . . 73.3 109.872 173.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 59.2 t -59.3 113.94 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 123.813 0.845 . . . . 74.33 111.228 -172.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 136' ' ' LYS . . . . . 0.479 ' HD3' ' H ' ' F' ' 136' ' ' LYS . 0.2 OUTLIER -128.45 -164.63 1.4 Allowed 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.558 1.143 . . . . 61.22 108.967 -175.645 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 5.4 t -57.96 132.58 53.85 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.219 0.607 . . . . 60.52 110.196 170.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -70.6 125.67 27.46 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.577 0.751 . . . . 72.22 111.627 -170.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -163.79 152.7 13.9 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.185 -1.042 . . . . 74.41 108.185 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 140' ' ' GLY . . . . . 0.684 ' HA3' ' HE3' ' C' ' 41' ' ' LYS . . . -132.08 -112.87 1.44 Allowed Glycine 0 C--N 1.337 0.634 0 CA-C-O 119.025 -0.875 . . . . 64.0 111.343 173.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . 70.12 -65.58 0.31 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.181 1.392 . . . . 72.34 110.561 -174.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 38.7 tp 64.47 -82.28 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.484 1.513 . . . . 63.41 111.399 174.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.99 59.52 6.91 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 111.377 -0.689 . . . . 63.13 111.377 -174.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 3.4 p -60.44 106.17 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 C-N-CA 123.777 0.831 . . . . 71.34 111.032 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 35.6 t70 . . . . . 0 C--O 1.244 0.797 0 C-N-CA 124.224 1.009 . . . . 74.33 108.521 -178.612 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 ttp . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 109.387 -0.597 . . . . 74.32 109.387 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.8 m -55.02 120.07 6.37 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.181 0.992 . . . . 74.44 111.004 174.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -151.4 119.41 6.24 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.421 0.688 . . . . 65.33 110.584 -177.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -122.59 -34.72 3.2 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.788 0.835 . . . . 73.21 109.596 166.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 61.3 t30 55.57 61.04 3.01 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 124.31 1.044 . . . . 74.55 110.13 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -159.39 154.61 25.29 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.817 -0.628 . . . . 73.41 110.518 -172.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.4 t -70.14 -9.24 54.99 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.408 1.083 . . . . 72.04 112.509 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.13 158.6 10.99 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.567 0.747 . . . . 74.3 111.704 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 41.1 mtt -46.72 144.33 2.38 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.538 1.935 . . . . 72.43 112.55 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.0 m -141.27 126.67 18.72 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.889 0.875 . . . . 61.01 109.586 -178.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -125.32 113.09 17.13 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.554 -0.906 . . . . 63.42 108.554 170.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -135.72 136.66 41.01 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.508 -0.923 . . . . 54.45 108.508 170.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.471 ' CD1' HG21 ' A' ' 105' ' ' ILE . 5.2 mt -93.35 117.15 36.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 108.762 -0.829 . . . . 74.21 108.762 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.03 -42.36 32.7 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.948 0.78 . . . . 72.35 109.32 -177.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -173.69 121.41 0.32 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 110.276 -0.268 . . . . 73.25 110.276 -171.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 65.8 mt -106.26 133.92 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.767 -0.827 . . . . 74.13 108.767 173.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.513 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 31.4 p90 -164.12 158.09 18.87 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 124.011 0.819 . . . . 74.32 111.33 -174.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.6 p -86.78 117.0 25.24 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.291 -0.633 . . . . 61.3 109.291 172.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.445 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 38.5 mtpt -75.82 -34.13 60.13 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.415 -0.587 . . . . 73.43 109.415 175.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 23.4 t70 -149.59 142.85 25.13 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.607 -1.179 . . . . 72.33 110.064 -178.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 76.1 mt -137.34 144.88 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.762 1.225 . . . . 60.14 108.119 175.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.5 t -148.92 138.3 21.71 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.667 0.787 . . . . 72.55 109.034 171.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.505 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 91.5 t80 -135.22 134.61 40.22 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.572 -1.64 . . . . 75.13 106.572 169.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -133.3 137.54 46.03 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.347 0.659 . . . . 71.13 109.542 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.94 76.64 11.38 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 106.582 -1.636 . . . . 63.32 106.582 171.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.75 -28.59 36.74 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.316 2.011 . . . . 63.25 111.199 -178.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -97.99 11.23 38.19 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.067 -0.969 . . . . 64.22 111.189 -175.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.439 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -44.87 -59.61 3.96 Favored Pre-proline 0 CA--C 1.564 1.51 0 N-CA-C 114.2 1.185 . . . . 70.31 114.2 -165.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.78 -36.85 96.41 Favored 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 122.015 1.81 . . . . 63.22 113.675 -171.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -99.39 -12.47 20.24 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.491 0.716 . . . . 60.25 112.863 -175.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.775 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.6 p -77.07 -23.49 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-N 118.073 0.397 . . . . 74.43 110.396 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -71.46 -18.47 62.31 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.514 0.726 . . . . 62.45 111.328 173.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -80.03 -27.58 39.45 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.496 0.719 . . . . 74.11 110.543 175.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.494 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 12.7 mmmm -72.87 152.64 41.39 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.942 0.897 . . . . 73.23 111.371 -175.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.25 123.45 18.69 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.547 0.739 . . . . 74.33 109.322 174.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -76.97 81.35 3.51 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.75 0.786 . . . . 74.42 110.116 -175.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.442 ' H ' HD22 ' A' ' 68' ' ' LEU . 19.5 tm0? -115.64 78.77 6.99 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 106.478 -1.675 . . . . 54.12 106.478 172.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -84.63 112.5 1.57 Allowed 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.224 1.95 . . . . 44.41 111.62 -172.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -92.88 88.09 6.06 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.445 -1.687 . . . . 61.45 106.445 171.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.7 t -88.15 102.92 13.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 114.332 -1.304 . . . . 63.14 110.392 -173.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -78.12 115.66 18.01 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.682 -1.145 . . . . 63.5 109.181 172.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 128' ' ' LEU . 3.6 tt -96.89 107.49 20.0 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 106.504 -1.665 . . . . 73.02 106.504 176.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -104.94 147.19 28.05 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.407 1.083 . . . . 72.13 108.739 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.761 HD11 HG21 ' A' ' 131' ' ' VAL . 87.5 mt -133.58 138.9 46.25 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.198 0.599 . . . . 51.23 110.891 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.561 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 24.2 t70 -136.62 144.82 44.27 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.105 1.362 . . . . 53.41 107.847 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.9 m -139.11 126.83 21.97 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.808 0.443 . . . . 72.13 110.354 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.2 127.01 32.85 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.867 0.867 . . . . 73.4 109.931 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.7 m -112.73 161.42 16.89 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.486 0.66 . . . . 62.32 111.185 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 90.0 p -149.12 162.12 40.6 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.344 1.458 . . . . 73.23 107.654 175.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -113.46 107.45 15.85 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.806 -0.812 . . . . 71.11 108.806 169.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.3 mt -79.4 -29.3 41.94 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.7 -0.682 . . . . 65.25 111.523 -175.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.67 -172.47 3.12 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.128 0.571 . . . . 74.04 111.352 -177.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -61.47 112.5 2.22 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.992 0.917 . . . . 45.23 109.751 174.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 69.89 2.0 3.69 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.955 1.702 . . . . 75.31 112.703 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.68 108.11 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.661 -0.65 . . . . 72.34 109.645 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -114.49 126.24 54.72 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.609 1.164 . . . . 75.22 108.31 177.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -91.71 139.9 30.23 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 108.46 -0.941 . . . . 72.45 108.46 171.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.446 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 98.1 t -123.5 139.64 49.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.196 -1.039 . . . . 71.45 108.196 170.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.449 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 50.3 t -120.04 132.64 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.424 -0.954 . . . . 43.23 108.424 174.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.667 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -111.94 104.5 12.78 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.751 -1.574 . . . . 72.01 106.751 170.947 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.561 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 13.3 ttp180 -94.28 100.49 12.53 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.443 -1.317 . . . . 63.23 107.443 176.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 36.0 t -93.72 123.99 46.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.663 -1.236 . . . . 63.41 107.663 177.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 m -118.68 115.72 25.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.829 0.823 . . . . 71.31 109.448 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.604 HG11 HD21 ' A' ' 126' ' ' LEU . 91.8 t -104.2 128.92 57.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 C-N-CA 124.866 1.266 . . . . 73.15 108.98 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.1 m -125.4 128.56 48.3 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 108.586 -0.894 . . . . 73.11 108.586 171.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.12 129.28 55.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.818 -1.178 . . . . 70.25 107.818 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.7 m -135.57 139.08 43.61 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.595 0.712 . . . . 74.22 110.655 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.442 HD22 ' H ' ' A' ' 37' ' ' GLN . 59.4 mt -95.86 62.63 2.28 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.373 1.869 . . . . 64.21 108.701 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.11 -84.63 0.92 Allowed Glycine 0 CA--C 1.529 0.955 0 CA-C-N 115.806 -0.634 . . . . 21.52 112.275 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.35 -26.79 11.84 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.542 0.737 . . . . 60.12 111.737 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.494 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 2.9 tp10 -95.66 112.86 24.49 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.702 0.801 . . . . 72.41 109.641 -174.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.9 m -67.96 129.97 41.53 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.933 0.788 . . . . 72.35 110.124 176.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.775 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -76.78 -60.64 2.27 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.34 -0.846 . . . . 72.43 109.173 177.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.415 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 51.9 p90 -159.09 170.45 21.99 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.48 -0.782 . . . . 72.31 111.489 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.4 tp -140.75 113.32 8.1 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.885 1.274 . . . . 74.05 108.457 176.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.541 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 58.9 m -105.63 141.66 36.7 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.181 0.993 . . . . 70.31 108.85 176.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -148.3 116.75 6.56 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.449 -0.575 . . . . 70.33 109.449 173.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.5 t -127.05 112.82 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.713 0.805 . . . . 43.53 109.38 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -84.82 83.36 8.07 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.181 -1.044 . . . . 73.43 108.181 170.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -76.17 92.17 3.22 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.191 -1.04 . . . . 74.44 108.191 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.93 164.91 41.27 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.777 -0.929 . . . . 70.31 110.777 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.25 122.01 1.06 Allowed Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.132 -1.187 . . . . 54.31 110.132 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.443 HG13 ' HE1' ' A' ' 17' ' ' TYR . 57.0 mt -81.13 125.92 39.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 107.654 -1.239 . . . . 54.31 107.654 171.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.573 ' HB3' HD11 ' A' ' 86' ' ' ILE . 87.7 m-85 -127.25 136.92 52.65 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.518 0.727 . . . . 72.34 109.285 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.5 p -100.38 90.98 4.5 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.695 0.798 . . . . 61.51 109.023 174.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.573 HD11 ' HB3' ' A' ' 84' ' ' PHE . 14.7 mm -111.12 147.45 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 114.859 -1.064 . . . . 75.21 110.638 -173.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.85 167.38 18.82 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.581 0.352 . . . . 61.21 111.754 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.96 1.67 88.72 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 115.145 0.818 . . . . 75.21 115.145 172.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.2 172.13 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.642 0.777 . . . . 73.54 110.179 177.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.483 ' HG3' ' HB2' ' A' ' 153' ' ' GLN . 0.6 OUTLIER -160.64 177.78 10.15 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.25 -0.886 . . . . 74.53 109.607 176.231 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.9 -116.36 8.61 Favored Glycine 0 C--N 1.351 1.391 0 O-C-N 123.793 0.683 . . . . 75.11 113.786 172.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.4 p -64.2 -41.15 97.19 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.762 1.225 . . . . 72.24 111.528 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -74.38 -36.87 63.56 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.045 0.538 . . . . 65.53 111.323 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.478 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 4.8 tpt -68.16 -45.92 72.2 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.55 -0.537 . . . . 71.52 109.55 177.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.88 -32.18 73.38 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.181 -0.918 . . . . 74.34 110.781 176.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -73.69 -38.04 65.02 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.105 0.562 . . . . 63.31 110.342 176.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.412 ' SG ' HG21 ' A' ' 86' ' ' ILE . 50.8 t -67.92 -39.31 83.56 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.619 -0.511 . . . . 63.34 109.619 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 78.8 mt -85.68 -28.1 24.92 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.679 0.792 . . . . 73.0 111.975 -177.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -114.7 4.48 22.88 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 114.508 0.563 . . . . 72.31 114.508 -170.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -143.31 -62.19 0.41 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 117.72 0.76 . . . . 65.11 110.958 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -62.84 -57.78 9.68 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.961 0.904 . . . . 71.44 111.593 -173.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 82.6 m -64.43 -46.78 78.12 Favored Pre-proline 0 CA--C 1.558 1.269 0 CA-C-O 117.895 -1.05 . . . . 73.35 113.102 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.7 -20.25 59.43 Favored 'Trans proline' 0 C--N 1.396 3.059 0 CA-C-N 121.446 1.552 . . . . 61.35 112.896 174.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -76.58 -32.32 58.05 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.952 0.501 . . . . 53.25 109.883 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.471 HG21 ' CD1' ' A' ' 13' ' ' ILE . 46.2 mm -67.0 -45.19 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.445 0.698 . . . . 74.34 109.7 169.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 59.1 mt -73.14 -22.97 60.41 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.788 -1.096 . . . . 60.52 111.946 -174.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -65.3 -44.49 68.55 Favored Pre-proline 0 N--CA 1.481 1.076 0 CA-C-O 117.296 -1.335 . . . . 75.3 113.78 -172.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 77.8 Cg_exo -54.33 -36.69 87.75 Favored 'Trans proline' 0 C--N 1.387 2.553 0 CA-C-N 121.96 1.736 . . . . 71.1 113.383 171.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -76.49 -39.2 53.83 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.187 0.595 . . . . 73.41 111.5 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.97 -47.07 75.79 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.519 0.728 . . . . 73.4 109.346 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -51.44 -52.66 44.4 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 125.546 1.538 . . . . 74.55 110.016 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -61.93 -47.74 83.57 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.554 1.159 . . . . 72.42 111.853 -175.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.516 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 49.9 t -55.91 -45.16 78.77 Favored 'General case' 0 C--N 1.351 0.631 0 O-C-N 124.498 1.124 . . . . 54.32 110.242 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.508 HG21 HG21 ' A' ' 64' ' ' VAL . 84.2 mt -62.35 -53.14 51.39 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 CA-C-N 114.844 -1.071 . . . . 74.31 110.804 175.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 38.5 m -57.73 -37.35 73.43 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.263 1.025 . . . . 62.42 110.964 -173.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.6 t -69.26 -46.24 67.76 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.766 -1.106 . . . . 72.31 109.818 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.505 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 9.0 mtp -58.84 -37.31 76.17 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.796 0.839 . . . . 64.44 111.837 176.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 114' ' ' ILE . 74.2 t -67.27 -45.61 85.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 124.183 0.993 . . . . 62.31 110.284 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 94.2 p -73.63 -28.04 61.58 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 116.248 -0.433 . . . . 72.14 110.772 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -70.38 -33.97 72.03 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.698 0.799 . . . . 74.14 109.376 172.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 122' ' ' THR . . . -81.99 8.13 61.17 Favored Glycine 0 C--N 1.353 1.502 0 CA-C-N 115.095 -0.957 . . . . 71.04 112.767 172.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.4 t 65.14 11.47 7.2 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 127.42 2.288 . . . . 54.41 113.888 171.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -79.38 143.81 60.68 Favored Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 108.962 -0.755 . . . . 65.5 108.962 177.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -48.05 143.54 13.8 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.372 2.715 . . . . 55.24 113.285 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -53.13 116.09 2.21 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.835 1.254 . . . . 73.32 113.283 -165.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.604 HD21 HG11 ' A' ' 64' ' ' VAL . 55.6 tp -110.71 96.06 5.94 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.159 0.584 . . . . 75.02 109.625 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.646 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 1.0 OUTLIER -100.31 113.51 26.28 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 106.287 -1.745 . . . . 73.32 106.287 175.566 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.442 ' HB3' HD11 ' A' ' 42' ' ' LEU . 16.2 mt -65.65 130.57 43.74 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 123.553 0.533 . . . . 61.3 109.751 -174.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.73 139.11 97.56 Favored Pre-proline 0 CA--C 1.554 1.128 0 CA-C-O 118.767 -0.635 . . . . 60.1 110.755 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.593 ' HD2' HE21 ' C' ' 12' ' ' GLN . 75.6 Cg_exo -50.31 140.51 34.06 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 123.617 2.878 . . . . 63.45 113.686 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.761 HG21 HD11 ' A' ' 44' ' ' LEU . 70.9 t -115.6 132.34 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 122.95 0.5 . . . . 75.11 110.082 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -93.06 79.77 4.56 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.201 -1.037 . . . . 70.22 108.201 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.454 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 84.8 m-85 -58.42 -25.0 61.66 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.977 0.911 . . . . 75.14 111.791 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -67.97 -49.67 60.3 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.223 1.009 . . . . 65.31 110.594 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.57 92.66 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.076 0.86 . . . . 71.44 110.194 177.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.7 mt -62.46 -36.62 83.02 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 114.727 -1.124 . . . . 64.0 111.312 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -67.32 -42.72 83.16 Favored 'General case' 0 C--O 1.216 -0.67 0 O-C-N 123.789 0.681 . . . . 71.12 110.109 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 22.5 mmt -59.99 -51.78 68.21 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 123.656 0.597 . . . . 52.34 111.208 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -70.55 -30.24 66.91 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.245 0.218 . . . . 62.03 111.436 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -74.73 -32.36 62.1 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.354 0.662 . . . . 73.34 111.126 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 59.8 tp -65.14 -50.39 66.22 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.998 0.919 . . . . 74.22 109.608 -175.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 174.86 -13.36 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.224 0 O-C-N 124.698 1.249 . . . . 72.4 110.909 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 68.73 154.33 0.11 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.048 1.339 . . . . 75.21 110.46 -172.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 67.37 -79.79 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.701 1.2 . . . . 74.43 110.869 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.84 143.76 47.71 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.619 0.767 . . . . 73.15 110.694 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -176.18 44.86 0.11 Allowed Glycine 0 C--N 1.336 0.534 0 N-CA-C 110.857 -0.897 . . . . 45.34 110.857 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -69.16 144.25 53.86 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.245 1.018 . . . . 71.32 111.018 -174.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -79.48 96.42 1.51 Allowed Glycine 0 C--N 1.345 1.035 0 CA-C-N 116.058 -0.519 . . . . 50.35 113.128 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.1 t -70.04 131.66 44.68 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-O 121.233 0.539 . . . . 62.45 111.139 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -136.54 171.9 13.81 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.916 1.287 . . . . 51.4 108.988 -178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 69.32 0.52 2.91 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 124.501 1.121 . . . . 71.1 111.928 175.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -103.75 97.45 7.46 Favored 'General case' 0 C--O 1.216 -0.681 0 N-CA-C 107.309 -1.367 . . . . 75.33 107.309 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.483 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 22.9 mt-30 64.08 168.39 0.16 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.399 1.08 . . . . 73.43 112.988 175.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.4 t70 179.81 96.25 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.46 -1.311 . . . . 63.24 107.46 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.479 0 C-N-CA 124.109 0.964 . . . . 74.4 108.999 -175.899 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.416 ' HB3' ' O ' ' B' ' 143' ' ' GLN . 1.2 tmt? . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 109.403 -0.591 . . . . 71.45 109.403 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 36.0 t -162.08 122.11 2.49 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.3 1.04 . . . . 72.52 108.275 174.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 59.86 73.31 0.49 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.775 1.23 . . . . 75.14 111.102 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -80.58 -55.87 4.55 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.285 -0.87 . . . . 73.11 108.962 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -85.74 116.67 24.14 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.265 1.026 . . . . 53.43 108.775 167.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -162.02 -58.74 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 108.399 -0.963 . . . . 70.34 108.399 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 40.3 p -88.96 144.15 26.37 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.433 -0.803 . . . . 75.54 109.721 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -68.96 -32.85 72.74 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.985 0.514 . . . . 72.41 110.901 176.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.531 ' HG3' HG13 ' B' ' 89' ' ' ILE . 26.9 ttt 63.44 165.16 0.12 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.88 1.672 . . . . 60.42 112.148 -177.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.8 m -140.84 125.69 18.14 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.936 -1.135 . . . . 62.14 107.936 167.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -136.18 142.07 44.1 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.705 0.802 . . . . 70.31 108.975 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -156.11 141.44 17.56 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 109.124 -0.695 . . . . 73.24 109.124 170.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.571 ' HB ' ' HB1' ' E' ' 126' ' ' ALA . 61.6 mt -80.77 134.23 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.033 -1.099 . . . . 55.12 108.033 175.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -99.98 -50.61 3.94 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.591 0.357 . . . . 70.32 110.224 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.434 ' HE ' HG21 ' A' ' 122' ' ' THR . 46.2 ttt180 -167.47 129.72 1.62 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.255 -0.646 . . . . 72.25 109.255 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.488 HG21 ' CD1' ' B' ' 109' ' ' TYR . 86.8 mt -115.32 149.6 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 108.539 -0.912 . . . . 74.3 108.539 175.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -167.41 162.85 14.88 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.63 0.728 . . . . 71.1 111.492 -173.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.443 ' H ' ' HA2' ' A' ' 121' ' ' GLY . 55.4 m -90.19 124.29 34.72 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 114.342 -1.299 . . . . 75.35 108.307 170.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -85.96 -45.56 11.37 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.944 0.898 . . . . 72.5 110.343 172.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.437 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 24.4 t70 -144.64 142.76 30.36 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.519 -0.309 . . . . 61.04 110.91 -167.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 46.4 mm -136.25 142.76 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.628 1.171 . . . . 72.1 109.116 177.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 29.4 m -138.17 135.37 35.6 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.102 1.361 . . . . 75.22 108.029 168.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 80.9 t80 -142.12 108.42 5.27 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 105.659 -1.978 . . . . 63.35 105.659 164.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -118.95 112.18 19.28 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.315 -0.994 . . . . 73.5 108.315 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.446 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -109.01 87.08 4.34 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 107.029 -1.471 . . . . 72.24 107.029 171.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.91 -26.63 21.93 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 122.24 1.96 . . . . 72.25 111.911 -172.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.409 ' OD1' ' HB2' ' B' ' 71' ' ' GLU . 15.4 m120 -107.99 14.62 25.09 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.537 1.135 . . . . 64.52 110.453 -176.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.513 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -43.98 -55.27 9.58 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 125.339 1.456 . . . . 61.25 114.832 -167.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -55.46 -44.68 46.21 Favored 'Trans proline' 0 C--N 1.4 3.239 0 C-N-CA 122.054 1.836 . . . . 61.44 113.348 -175.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -98.03 -16.79 19.48 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.899 1.074 . . . . 75.12 113.899 -171.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.404 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.5 p -76.1 -8.72 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-N 118.811 0.732 . . . . 75.4 112.05 -172.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -80.45 -1.62 42.37 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.897 0.479 . . . . 74.13 112.187 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -64.01 -25.19 68.01 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.086 0.554 . . . . 55.32 110.304 166.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.605 ' HB2' HD13 ' B' ' 68' ' ' LEU . 31.1 mmtp -90.96 107.94 19.53 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.988 1.315 . . . . 52.4 108.979 -178.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -115.89 86.09 2.41 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.384 0.611 . . . . 72.23 110.806 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 37.4 p90 -163.97 160.51 21.99 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.325 1.45 . . . . 72.2 107.78 171.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -62.75 116.18 22.1 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 108.376 -0.972 . . . . 73.42 108.376 172.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.01 157.54 58.91 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.042 1.828 . . . . 72.3 111.665 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -69.13 115.32 8.28 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 108.233 -1.025 . . . . 62.32 108.233 172.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.57 HG13 HG13 ' B' ' 64' ' ' VAL . 60.8 t -106.21 129.45 59.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 O-C-N 124.146 0.904 . . . . 62.12 110.602 -173.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.487 ' HE3' ' HB2' ' B' ' 43' ' ' ASP . 18.7 ttpt -106.48 120.5 42.08 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.509 -0.923 . . . . 70.54 108.509 168.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 16.1 tp -88.03 134.16 33.8 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.585 -0.894 . . . . 71.42 108.585 173.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 9.4 t0 -134.66 112.11 10.54 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.094 -1.076 . . . . 72.04 108.094 -172.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.433 HD11 HG11 ' B' ' 131' ' ' VAL . 78.4 mt -107.35 150.88 26.23 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.094 0.558 . . . . 71.2 110.306 -173.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.2 t70 -151.66 139.27 19.67 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.607 0.763 . . . . 63.14 109.686 -173.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 4.7 t -114.55 103.66 11.24 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-O 121.694 0.759 . . . . 73.13 109.68 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.28 118.67 30.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.555 -0.906 . . . . 73.43 108.555 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 54.0 p -145.77 172.35 13.43 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 122.086 -0.383 . . . . 61.13 111.563 -175.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 24.4 p -159.62 137.39 10.03 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.684 0.793 . . . . 74.23 110.702 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.48 ' HB2' ' CE2' ' B' ' 56' ' ' TYR . 58.8 tt0 -84.98 105.71 15.95 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 108.566 -0.901 . . . . 61.42 108.566 170.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 pp -123.72 14.12 9.35 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.1 -0.954 . . . . 74.04 110.161 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.67 142.98 12.73 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.6 -1.182 . . . . 71.32 108.571 -176.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -75.99 117.25 17.51 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.642 0.777 . . . . 73.44 109.982 -172.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 66.12 5.21 3.45 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 125.566 1.547 . . . . 75.12 112.758 -176.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.9 t -125.07 96.64 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.422 -1.325 . . . . 65.13 107.422 -175.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.48 ' CE2' ' HB2' ' B' ' 50' ' ' GLN . 1.8 t80 -94.27 140.24 30.03 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.97 -0.752 . . . . 75.54 108.97 -172.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -106.47 105.09 14.96 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.524 -1.287 . . . . 70.41 107.524 -177.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -103.11 129.08 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.331 1.052 . . . . 73.1 109.718 -174.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.405 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 16.3 t -115.84 112.44 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.762 -0.829 . . . . 75.33 108.762 176.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -94.18 110.31 22.04 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.751 -1.203 . . . . 74.04 107.751 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.535 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 7.1 tmm_? -91.19 124.67 35.58 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.758 -0.83 . . . . 72.54 108.758 176.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 19.3 t -111.63 135.35 51.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.66 -1.237 . . . . 72.53 107.66 173.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 22.9 m -128.64 128.52 44.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.81 0.814 . . . . 72.13 109.274 171.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.57 HG13 HG13 ' B' ' 40' ' ' VAL . 79.6 t -107.09 114.84 47.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 114.09 -1.414 . . . . 44.33 108.584 172.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 88.6 m -96.03 135.93 37.16 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.017 -1.105 . . . . 73.41 108.017 165.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.35 141.82 25.35 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.207 -0.664 . . . . 63.14 109.207 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.572 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 18.5 p -143.61 134.87 25.85 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.646 -0.707 . . . . 65.04 111.207 -172.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.605 HD13 ' HB2' ' B' ' 34' ' ' LYS . 85.2 mt -106.88 104.01 13.59 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.925 1.29 . . . . 72.11 110.733 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.44 -125.08 7.15 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-O 120.118 -0.268 . . . . 73.4 112.781 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -91.01 3.54 54.44 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.456 0.703 . . . . 64.43 111.77 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.409 ' HB2' ' OD1' ' B' ' 27' ' ' ASN . 13.1 pt-20 -135.2 146.68 48.92 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.066 0.546 . . . . 74.33 110.945 -170.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 49.1 m -71.91 130.54 41.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.843 -0.617 . . . . 73.33 110.842 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.572 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -79.33 -65.48 0.99 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.881 -1.054 . . . . 70.01 108.306 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -151.18 152.02 32.73 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.221 -0.899 . . . . 75.52 111.459 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 78.4 mt -118.99 109.39 15.89 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 105.928 -1.878 . . . . 52.23 105.928 168.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.6 t -117.29 135.43 53.83 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.877 -1.156 . . . . 62.23 107.877 -178.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.416 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 38.1 tt0 -149.5 135.96 19.23 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.725 -0.843 . . . . 73.22 108.725 -172.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.416 HG21 ' HB3' ' B' ' 113' ' ' CYS . 58.0 t -131.16 143.2 41.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.845 -0.798 . . . . 63.22 108.845 175.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -116.56 96.69 5.62 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.811 -1.181 . . . . 74.31 107.811 171.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 7.6 tp-100 -90.89 100.02 12.95 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.95 -0.759 . . . . 60.13 108.95 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.74 142.26 16.15 Favored Glycine 0 C--N 1.344 1.027 0 O-C-N 123.624 0.578 . . . . 74.23 111.705 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.45 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -142.67 125.93 2.75 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.643 -0.583 . . . . 71.44 111.643 -176.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 40.8 mt -84.93 115.73 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 107.517 -1.29 . . . . 63.13 107.517 171.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -128.93 146.26 51.0 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.583 0.753 . . . . 65.43 109.913 -177.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 44.4 m -94.0 110.09 21.8 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.374 0.67 . . . . 64.22 109.36 172.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 4.7 mp -112.91 111.42 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 108.154 -1.054 . . . . 75.52 108.154 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.679 ' HA ' ' HB ' ' F' ' 97' ' ' ILE . . . -155.51 169.24 24.73 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.11 0.564 . . . . 72.31 111.325 178.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.12 -67.63 0.85 Allowed Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.525 -0.63 . . . . 65.04 111.525 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.531 HG13 ' HG3' ' B' ' 9' ' ' MET . 0.9 OUTLIER -52.69 159.05 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 124.338 1.055 . . . . 65.35 111.759 168.333 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -151.46 145.77 25.45 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 112.624 0.602 . . . . 75.35 112.624 -171.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.442 ' O ' ' HG2' ' B' ' 94' ' ' MET . . . 70.09 -111.88 4.06 Favored Glycine 0 C--N 1.358 1.781 0 CA-C-N 115.453 -0.794 . . . . 70.31 113.985 173.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 8.9 m -73.44 -38.03 65.64 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 122.081 0.943 . . . . 70.44 109.625 177.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -69.63 -27.73 65.31 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 113.404 -1.725 . . . . 74.23 110.903 -170.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.525 ' HB2' HD11 ' F' ' 97' ' ' ILE . 25.1 ptt? -81.45 -43.91 18.2 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.345 0.658 . . . . 63.34 112.687 -173.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.3 -11.29 59.94 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.598 0.759 . . . . 62.21 112.19 -173.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -61.25 -35.31 76.91 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.505 0.322 . . . . 74.43 110.259 165.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.3 t -61.34 -61.09 2.79 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.812 0.445 . . . . 62.55 111.282 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.567 HD13 HD12 ' F' ' 102' ' ' LEU . 0.4 OUTLIER -71.56 -15.82 62.29 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 113.004 0.742 . . . . 74.21 113.004 -178.529 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.31 -2.45 59.02 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.689 -0.506 . . . . 71.14 113.532 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.83 -59.87 0.18 Allowed 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.405 0.603 . . . . 54.4 111.881 -174.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -67.61 -48.25 67.34 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.077 0.951 . . . . 63.34 111.784 -173.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.523 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 63.6 m -65.0 -48.69 70.78 Favored Pre-proline 0 CA--C 1.563 1.47 0 C-N-CA 123.802 0.841 . . . . 73.32 111.509 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.523 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 74.6 Cg_exo -57.33 -29.49 84.32 Favored 'Trans proline' 0 C--N 1.4 3.26 0 C-N-CA 122.731 2.287 . . . . 75.24 113.991 170.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -67.7 -30.35 69.84 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.032 0.933 . . . . 65.1 110.682 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.475 HD13 HD11 ' B' ' 13' ' ' ILE . 62.2 mt -76.04 -41.29 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.466 0.706 . . . . 72.42 110.135 175.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.45 HD21 ' HA3' ' B' ' 82' ' ' GLY . 80.9 mt -71.86 -34.22 69.04 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.801 -1.091 . . . . 75.14 111.912 -175.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -59.49 -47.62 97.47 Favored Pre-proline 0 CA--C 1.56 1.327 0 CA-C-O 117.513 -1.232 . . . . 73.25 113.167 -170.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -56.2 -36.72 96.99 Favored 'Trans proline' 0 C--N 1.392 2.849 0 C-N-CA 122.363 2.042 . . . . 75.3 113.229 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.488 ' CD1' HG21 ' B' ' 16' ' ' ILE . 4.0 m-30 -70.68 -42.62 70.48 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.526 0.731 . . . . 61.54 109.978 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -66.76 -36.53 82.64 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.009 -0.996 . . . . 71.14 110.91 176.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.473 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 50.4 ttt-85 -64.36 -48.91 73.69 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.231 1.413 . . . . 75.31 110.749 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -70.07 -31.62 69.32 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.549 0.739 . . . . 44.11 109.768 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.511 ' O ' ' HG2' ' B' ' 117' ' ' MET . 11.5 t -67.29 -38.64 85.34 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 123.017 0.527 . . . . 75.02 110.515 177.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.454 HD13 HG23 ' B' ' 64' ' ' VAL . 63.5 mt -63.36 -55.71 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.971 0.908 . . . . 70.04 110.141 174.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.425 HG21 ' OG ' ' C' ' 119' ' ' SER . 24.2 m -60.97 -30.41 70.23 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 124.136 0.898 . . . . 64.02 111.268 -175.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 29.8 t -60.49 -52.29 65.83 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.469 0.708 . . . . 74.15 109.235 173.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.511 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.6 mmt -65.85 -35.82 81.72 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.28 0.632 . . . . 73.42 111.414 -175.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.6 t -63.75 -44.59 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 124.144 0.978 . . . . 52.24 110.655 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.3 t -67.55 -32.59 73.46 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.713 -1.13 . . . . 75.15 111.294 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.516 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 77.3 mtt-85 -66.55 -43.46 85.01 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.572 -0.74 . . . . 71.43 109.507 175.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.68 -7.79 66.05 Favored Glycine 0 C--N 1.352 1.444 0 O-C-N 123.801 0.688 . . . . 74.44 113.259 175.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 7.4 m 63.94 29.98 14.33 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.897 1.279 . . . . 71.51 110.662 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.408 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 37.0 m-85 -83.14 159.47 62.33 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.138 0.975 . . . . 74.15 111.062 176.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.422 ' HA ' ' HB2' ' F' ' 131' ' ' TRP . 87.2 Cg_exo -48.76 149.12 7.87 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.489 2.793 . . . . 34.04 114.65 177.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 65.9 tp60 -59.49 114.34 2.65 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 124.382 1.051 . . . . 73.33 111.613 -171.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.465 HD21 HG11 ' B' ' 64' ' ' VAL . 21.2 tp -111.66 102.07 10.41 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.891 0.876 . . . . 75.01 109.88 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -107.58 119.01 38.24 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 107.793 -1.188 . . . . 72.41 107.793 167.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.473 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 42.1 mt -69.01 148.54 49.95 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 123.159 0.287 . . . . 75.31 110.711 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.36 147.5 97.08 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.429 0.692 . . . . 64.12 110.589 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.12 92.49 0.1 Allowed 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.505 2.137 . . . . 74.42 112.111 173.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.433 HG11 HD11 ' B' ' 44' ' ' LEU . 69.7 t -90.17 110.83 22.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 109.321 -0.622 . . . . 72.14 109.321 177.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -96.75 105.19 17.27 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.34 -0.985 . . . . 65.01 108.34 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -65.46 -27.94 68.86 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.145 0.978 . . . . 63.15 111.302 -176.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -54.17 -43.59 70.77 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.504 1.122 . . . . 73.35 110.909 176.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.84 -42.28 98.84 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.812 0.845 . . . . 52.53 111.846 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 9.2 mp -61.22 -47.07 87.79 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.315 0.646 . . . . 74.0 110.926 -176.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -78.64 -47.04 17.84 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.957 -0.565 . . . . 71.24 111.915 -177.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 88.5 mtp -67.78 -36.32 80.25 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 122.856 0.462 . . . . 73.21 112.022 -173.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -76.81 -21.2 55.44 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.521 0.329 . . . . 75.2 111.029 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -76.62 -39.23 53.11 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.855 -0.424 . . . . 71.12 109.855 171.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 11.1 mp -81.01 11.09 4.3 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.085 0.954 . . . . 73.43 111.727 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 72.55 150.75 0.1 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.56 1.544 . . . . 73.11 111.766 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 143' ' ' GLN . . . . . 0.416 ' O ' ' HB3' ' B' ' 1' ' ' MET . 49.6 mt-30 -84.01 -53.86 5.26 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.502 0.721 . . . . 70.21 109.886 177.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 54.47 86.42 0.05 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.832 1.253 . . . . 72.45 109.64 -178.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -141.76 135.77 30.07 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.161 0.584 . . . . 41.33 109.636 -175.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.18 -161.55 27.4 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 123.482 0.489 . . . . 53.03 111.972 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 70.38 100.62 0.06 Allowed 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.503 1.121 . . . . 75.42 111.476 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 148' ' ' GLY . . . . . 0.452 ' HA2' ' OD1' ' D' ' 5' ' ' ASN . . . -109.73 74.85 0.21 Allowed Glycine 0 C--N 1.347 1.182 0 CA-C-N 115.445 -0.798 . . . . 73.23 111.933 177.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 36.9 p -67.11 154.68 40.64 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.243 0.544 . . . . 64.01 112.011 -176.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -119.63 177.56 4.9 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.828 1.251 . . . . 61.03 109.384 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.28 -121.38 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 107.529 -1.285 . . . . 72.24 107.529 -177.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -144.82 133.88 22.69 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.524 1.129 . . . . 72.3 108.001 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -76.63 80.86 3.28 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.996 0.518 . . . . 73.01 109.622 174.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -56.24 120.26 7.28 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.05 0.94 . . . . 72.4 111.305 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 C-N-CA 123.618 0.767 . . . . 64.14 110.289 -176.212 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 109.171 -0.677 . . . . 75.31 109.171 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -50.58 -56.61 10.94 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.324 1.449 . . . . 63.31 111.049 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -175.35 -83.78 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 104.199 -2.519 . . . . 70.11 104.199 172.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -147.01 124.64 11.78 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 107.283 -1.377 . . . . 73.24 107.283 168.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -75.63 122.14 23.5 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.748 0.419 . . . . 53.51 110.657 -174.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -80.88 97.82 7.58 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.842 0.857 . . . . 62.43 110.632 -174.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 8.5 t -171.34 149.85 2.82 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.069 0.947 . . . . 73.1 110.016 174.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -101.45 72.0 1.38 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.676 0.79 . . . . 63.31 108.954 -177.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.4 ' CE ' HD13 ' C' ' 89' ' ' ILE . 9.3 ttt 65.69 122.57 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.662 1.585 . . . . 72.33 113.113 -176.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 32.0 m -133.38 119.03 19.15 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 124.103 0.961 . . . . 72.42 108.828 170.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.412 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 55.7 t80 -109.18 136.24 48.98 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.713 -0.847 . . . . 75.14 108.713 169.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 12' ' ' GLN . . . . . 0.813 ' HG2' ' HA ' ' E' ' 136' ' ' LYS . 1.3 tp60 -157.91 144.23 17.55 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.3 0.375 . . . . 75.24 110.54 168.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 57.2 mt -82.65 135.07 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 115.467 -0.788 . . . . 64.2 109.384 175.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -98.92 -46.47 5.61 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.475 0.71 . . . . 65.13 109.706 172.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.646 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -170.69 146.16 2.61 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.603 0.761 . . . . 74.31 110.746 174.037 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 36.3 mm -115.64 139.23 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 106.467 -1.679 . . . . 70.41 106.467 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.532 ' HB3' HG23 ' D' ' 122' ' ' THR . 19.3 p90 -169.45 157.78 7.53 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.896 0.855 . . . . 72.2 111.987 -171.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.6 p -82.9 102.87 11.96 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.222 -1.354 . . . . 74.43 109.422 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.642 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 11.2 mmmm -65.14 -34.36 78.21 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.381 0.61 . . . . 74.01 109.392 171.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.593 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.5 t70 -153.4 145.7 23.93 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.63 -1.168 . . . . 74.42 109.24 -175.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.525 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.5 mt -140.85 145.77 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.615 1.566 . . . . 52.54 107.098 176.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.6 t -156.27 150.57 25.5 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.179 0.514 . . . . 61.13 110.266 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -149.37 131.74 15.62 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.168 -1.419 . . . . 74.1 107.168 174.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -133.92 111.8 10.74 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.108 -0.701 . . . . 72.33 109.108 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.66 82.14 67.45 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 107.657 -1.238 . . . . 70.32 107.657 170.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.84 -44.97 18.37 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.552 2.168 . . . . 71.54 111.276 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -92.89 21.06 5.96 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.472 -1.24 . . . . 75.4 111.082 -176.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.423 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -46.62 -58.3 7.07 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 124.226 1.01 . . . . 62.31 113.471 -172.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -60.94 -38.95 65.11 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 121.679 1.586 . . . . 63.31 112.44 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -69.24 -39.38 78.55 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.348 -0.842 . . . . 73.54 111.419 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.71 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.5 p -78.46 -17.29 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 C-N-CA 123.009 0.524 . . . . 62.21 112.308 -171.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -70.81 -15.54 62.66 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 112.194 0.442 . . . . 74.53 112.194 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -109.17 19.68 19.19 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.13 0.572 . . . . 72.55 111.09 174.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.85 158.7 15.72 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.385 0.674 . . . . 71.14 109.757 173.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.56 125.33 23.91 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.34 0.656 . . . . 52.3 109.377 167.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 62.3 t-105 -85.37 80.25 9.2 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.164 0.586 . . . . 73.53 110.364 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -121.79 76.92 38.56 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 124.368 1.067 . . . . 73.33 108.316 170.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.612 ' HG2' HG23 ' F' ' 133' ' ' THR . 1.9 Cg_endo -85.35 119.45 2.03 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 123.553 2.835 . . . . 55.23 112.608 -170.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -87.35 94.62 9.73 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.468 -1.242 . . . . 70.34 108.487 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.02 110.12 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 113.869 -1.514 . . . . 61.11 110.526 -172.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.516 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 18.2 tptm -92.2 105.47 17.68 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.45 -0.945 . . . . 55.51 108.45 169.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 pp -86.9 128.89 35.06 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 106.64 -1.615 . . . . 74.3 106.64 169.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.532 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 16.3 t70 -125.78 105.31 8.87 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 108.897 -0.779 . . . . 75.43 108.897 -172.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 96.1 mt -96.27 130.85 43.26 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.356 0.662 . . . . 64.11 110.521 -174.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -144.58 125.71 14.6 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.731 1.212 . . . . 73.12 107.938 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.1 t -121.86 151.74 40.34 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 109.621 -0.511 . . . . 73.4 109.621 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.93 148.24 31.58 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 124.355 1.062 . . . . 74.23 108.354 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 13.6 m -143.43 143.77 31.75 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.332 -0.618 . . . . 74.52 109.332 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 65.0 p -145.22 136.36 24.88 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.931 0.892 . . . . 73.54 109.34 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -79.07 117.69 20.34 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 109.016 -0.735 . . . . 75.23 109.016 176.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.631 HD11 ' HB2' ' C' ' 57' ' ' GLU . 68.4 mt -84.25 -38.91 19.92 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.483 0.713 . . . . 61.2 110.19 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.22 -169.48 3.06 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.349 -0.841 . . . . 74.03 110.273 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.02 104.27 0.1 Allowed 'General case' 0 N--CA 1.481 1.088 0 O-C-N 124.185 0.928 . . . . 51.5 110.985 176.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 60.25 35.74 20.85 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 124.603 1.19 . . . . 73.15 111.338 174.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.4 t -127.7 119.24 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.867 -1.16 . . . . 72.11 107.867 174.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -123.63 124.13 42.1 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.961 0.905 . . . . 73.43 109.602 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.631 ' HB2' HD11 ' C' ' 51' ' ' LEU . 39.0 tt0 -85.51 132.11 34.25 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.471 -0.937 . . . . 74.35 108.471 167.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 51.5 t -118.82 143.71 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.32 -0.622 . . . . 52.02 109.32 171.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 90.3 t -124.33 140.54 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 C-N-CA 125.226 1.41 . . . . 53.41 108.433 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.403 HD11 ' CZ ' ' C' ' 133' ' ' PHE . 0.0 OUTLIER -121.14 96.96 5.3 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.184 -1.413 . . . . 75.1 107.184 173.833 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -82.2 105.91 13.67 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.465 -0.939 . . . . 74.25 108.465 173.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.415 ' HB ' HD11 ' C' ' 114' ' ' ILE . 28.6 t -105.38 129.01 58.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.769 -1.197 . . . . 75.42 107.769 173.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 69.5 m -116.42 125.06 51.49 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.499 -0.926 . . . . 62.01 108.499 175.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.45 HG21 HG21 ' C' ' 114' ' ' ILE . 68.0 t -103.83 110.25 29.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.2 -0.667 . . . . 70.22 109.2 170.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 7.4 m -96.48 131.97 42.52 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.83 -1.544 . . . . 73.31 106.83 170.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.75 113.39 14.66 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 106.682 -1.599 . . . . 72.23 106.682 -176.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 36.8 m -134.04 126.97 31.28 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-O 121.0 0.429 . . . . 75.24 110.144 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 16.2 mt -85.09 36.9 0.64 Allowed 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 125.829 1.652 . . . . 43.22 110.482 177.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.5 -92.62 1.04 Allowed Glycine 0 C--N 1.358 1.8 0 N-CA-C 111.085 -0.806 . . . . 74.2 111.085 176.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -90.33 -19.61 23.84 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.424 1.09 . . . . 73.14 110.697 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -103.54 124.13 48.21 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 125.335 1.454 . . . . 73.51 109.293 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 83.5 m -78.78 123.94 27.7 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.042 0.837 . . . . 72.4 109.222 167.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.71 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -70.55 -59.03 3.08 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.957 0.786 . . . . 74.51 109.335 174.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -162.54 173.77 13.54 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-O 121.468 0.651 . . . . 64.2 110.953 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.434 HD23 HG23 ' C' ' 65' ' ' THR . 2.7 tm? -138.0 104.16 5.17 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 106.435 -1.691 . . . . 64.34 106.435 175.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 49.3 t -108.21 145.42 34.28 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.26 -1.015 . . . . 71.31 108.26 176.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -154.25 128.79 9.23 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.304 -0.628 . . . . 75.25 109.304 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 69.1 t -126.91 136.2 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.011 0.924 . . . . 74.32 109.025 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.593 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 47.9 mt-30 -105.03 90.2 3.37 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.165 -1.05 . . . . 62.44 108.165 170.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -80.33 98.85 7.62 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.475 -0.784 . . . . 71.11 109.862 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.47 170.28 48.39 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 116.255 -0.429 . . . . 44.45 112.274 176.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.94 119.75 0.78 Allowed Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.82 -0.912 . . . . 54.51 110.82 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.448 HD12 HD11 ' C' ' 51' ' ' LEU . 36.0 mm -82.02 124.96 39.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.741 -0.837 . . . . 64.01 108.741 176.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -126.7 119.06 26.03 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 124.059 0.849 . . . . 64.24 108.779 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 12.4 p -80.65 99.21 8.04 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.895 -1.15 . . . . 74.55 107.895 172.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.562 HG21 ' HE3' ' C' ' 94' ' ' MET . 20.9 mt -118.14 123.87 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 109.403 -0.591 . . . . 74.55 109.403 -177.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.59 155.22 44.2 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.903 0.705 . . . . 54.32 112.903 -171.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.88 -28.13 6.79 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.13 -0.941 . . . . 50.52 115.14 168.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.643 HD11 ' HE3' ' C' ' 94' ' ' MET . 37.5 pt -96.16 159.04 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-O 121.726 0.774 . . . . 75.14 112.232 -175.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -149.41 -173.08 4.29 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 113.781 -1.554 . . . . 74.45 108.069 171.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.74 -128.22 46.15 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.494 0.496 . . . . 55.43 113.973 171.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 10.2 t -74.08 -32.13 63.12 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.142 0.977 . . . . 61.24 112.571 -174.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -65.88 -52.72 47.77 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.186 0.595 . . . . 75.44 109.987 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.643 ' HE3' HD11 ' C' ' 89' ' ' ILE . 4.6 tpt -54.72 -48.75 72.13 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 124.149 0.905 . . . . 75.31 111.632 173.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.43 -38.14 76.82 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.988 0.805 . . . . 71.12 111.388 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -80.42 -29.58 37.65 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.31 0.644 . . . . 74.41 111.805 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.413 ' SG ' HD13 ' C' ' 86' ' ' ILE . 35.0 t -70.35 -34.79 73.05 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.999 -0.741 . . . . 73.44 108.999 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 69.3 mt -87.36 -28.8 21.99 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.035 1.334 . . . . 62.41 111.123 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.42 -28.07 41.24 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 115.804 -0.635 . . . . 52.22 114.397 -170.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -139.21 -52.33 0.55 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 111.934 0.346 . . . . 63.1 111.934 -169.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -64.73 -53.65 43.81 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 123.293 0.371 . . . . 73.42 110.988 -173.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.412 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 94.9 m -59.23 -49.93 90.24 Favored Pre-proline 0 CA--C 1.564 1.5 0 CA-C-O 118.173 -0.918 . . . . 72.55 111.976 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -53.79 -33.25 69.93 Favored 'Trans proline' 0 C--N 1.397 3.125 0 C-N-CA 122.666 2.244 . . . . 72.35 114.628 171.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -67.1 -32.3 73.37 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 122.86 0.464 . . . . 71.12 110.958 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 44.0 mm -72.87 -40.71 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.041 0.536 . . . . 72.23 109.637 176.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 76.0 mt -78.9 -27.01 43.85 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.144 0.978 . . . . 71.11 112.272 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -56.43 -49.41 93.63 Favored Pre-proline 0 CA--C 1.56 1.328 0 N-CA-C 114.547 1.314 . . . . 71.23 114.547 -173.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -60.84 -38.65 68.54 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 122.022 1.815 . . . . 63.45 112.67 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -67.93 -41.06 83.13 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.451 -0.795 . . . . 72.14 110.119 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.9 -42.69 99.87 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.784 0.834 . . . . 75.11 109.929 175.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -57.76 -55.65 32.16 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.329 1.052 . . . . 72.34 110.377 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -66.07 -30.59 71.13 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.16 0.584 . . . . 75.31 110.426 -174.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.401 ' SG ' HG12 ' C' ' 21' ' ' ILE . 21.4 t -72.54 -33.89 67.15 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 122.94 0.496 . . . . 74.01 111.453 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.45 HG21 HG21 ' C' ' 64' ' ' VAL . 96.3 mt -75.15 -49.58 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 123.554 0.742 . . . . 74.34 110.144 175.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 13.5 m -67.14 -28.95 68.56 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.249 1.02 . . . . 71.14 110.819 -175.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 27.2 t -63.07 -50.07 72.05 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 108.612 -0.884 . . . . 71.53 108.612 170.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.534 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.52 -35.44 77.72 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.585 1.154 . . . . 73.33 112.602 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 93.3 t -63.36 -47.01 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.61 0.764 . . . . 63.3 109.706 173.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.425 ' OG ' HG21 ' B' ' 115' ' ' THR . 46.5 t -68.53 -28.94 67.43 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.813 -1.085 . . . . 63.42 111.506 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' C' ' 116' ' ' SER . 86.5 mtt-85 -72.06 -42.45 66.22 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.031 -0.729 . . . . 72.33 109.031 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.65 -0.82 60.04 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 115.588 -0.733 . . . . 70.03 112.686 170.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.8 p 61.59 32.68 18.57 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.493 1.917 . . . . 73.52 113.375 171.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -83.34 155.19 66.53 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 108.638 -0.875 . . . . 73.14 108.638 170.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -50.63 159.42 2.23 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.994 2.462 . . . . 71.34 113.947 171.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' B' ' 123' ' ' PHE . 2.9 mm-40 -51.01 138.79 18.82 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.815 1.246 . . . . 74.41 112.292 -176.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.454 HD13 HG21 ' F' ' 133' ' ' THR . 50.7 tp -149.1 86.2 1.49 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.123 -0.695 . . . . 42.34 109.123 178.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -91.64 123.29 34.93 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.219 -0.9 . . . . 74.11 108.707 175.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.08 119.81 15.74 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.403 -0.962 . . . . 75.43 108.403 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.29 143.57 95.45 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 123.768 0.827 . . . . 75.14 110.923 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -51.71 98.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.128 2.552 . . . . 62.42 113.014 174.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 60.2 t -98.29 111.7 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.489 -1.301 . . . . 74.12 107.489 173.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -74.03 102.82 4.3 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.048 0.539 . . . . 52.24 110.566 -174.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.403 ' CZ ' HD11 ' C' ' 60' ' ' LEU . 81.0 m-85 -62.18 -25.26 67.68 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.841 0.856 . . . . 74.12 111.454 176.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' C' ' 138' ' ' MET . 23.9 t70 -62.17 -49.96 73.71 Favored 'General case' 0 C--N 1.347 0.485 0 O-C-N 123.881 0.738 . . . . 62.15 109.713 177.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.16 -43.05 92.09 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 124.176 0.922 . . . . 43.54 111.654 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 79.7 mt -64.28 -39.89 94.85 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.953 -1.021 . . . . 73.54 111.428 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -82.45 -23.6 34.7 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.256 -0.429 . . . . 74.54 111.468 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.491 ' HG2' ' O ' ' C' ' 134' ' ' ASP . 22.2 mmt -63.81 -30.19 71.31 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 110.024 -0.362 . . . . 72.02 110.024 174.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -61.47 -41.88 97.92 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.035 0.934 . . . . 74.32 110.699 173.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -69.75 -83.35 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 115.315 -0.857 . . . . 64.12 109.745 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 15.0 tp -140.03 132.7 28.89 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.292 -1.003 . . . . 54.32 108.292 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -121.57 13.77 10.94 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.611 0.967 . . . . 74.14 113.611 -163.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 -88.37 139.79 30.13 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 109.69 -0.485 . . . . 74.3 109.69 177.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -170.84 174.46 4.84 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.631 0.772 . . . . 74.45 111.642 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -136.68 93.26 2.84 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 106.929 -1.508 . . . . 70.41 106.929 162.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -82.94 47.34 3.8 Favored Glycine 0 N--CA 1.476 1.357 0 C-N-CA 123.298 0.475 . . . . 31.2 113.953 -173.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -164.24 112.8 1.15 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.172 1.389 . . . . 74.41 107.885 177.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -110.82 178.84 19.91 Favored Glycine 0 C--N 1.339 0.705 0 CA-C-N 116.253 -0.43 . . . . 53.33 113.649 -175.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 1.4 p -156.14 111.04 2.88 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.131 1.373 . . . . 74.54 109.617 -176.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.58 158.94 16.71 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 107.906 -1.146 . . . . 60.12 107.906 171.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -120.62 -68.45 0.91 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.72 -0.845 . . . . 72.52 108.72 172.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -156.52 138.93 14.84 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.388 1.075 . . . . 75.41 110.008 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -144.37 161.66 38.43 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.582 1.153 . . . . 54.42 109.584 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -76.13 170.67 15.85 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.308 0.643 . . . . 64.41 111.472 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.188 0 C-N-CA 124.024 0.93 . . . . 75.32 109.814 178.4 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.483 1.197 0 CA-C-O 120.856 0.36 . . . . 72.54 110.198 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 39.5 t -148.49 118.14 7.04 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.622 -0.881 . . . . 71.43 108.622 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -70.82 176.74 4.03 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.438 0.695 . . . . 73.11 111.354 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 4' ' ' GLN . . . . . 0.45 ' NE2' ' HA ' ' E' ' 97' ' ' ILE . 20.8 mm-40 -99.27 105.59 17.62 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.305 0.642 . . . . 74.23 109.829 -175.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 5' ' ' ASN . . . . . 0.452 ' OD1' ' HA2' ' B' ' 148' ' ' GLY . 16.1 t30 -111.23 133.99 53.16 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.1 0.96 . . . . 72.51 109.884 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -60.25 -41.66 93.67 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.388 1.075 . . . . 74.01 111.713 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.81 -16.16 60.13 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.496 0.554 . . . . 72.25 112.496 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' D' ' 5' ' ' ASN . 30.8 tt0 -72.87 -30.32 63.88 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 118.679 -0.677 . . . . 75.12 110.889 174.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.413 ' HG2' HG13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -29.15 123.68 0.13 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 125.483 1.74 . . . . 74.22 113.746 -169.95 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 7.4 p -118.83 142.36 47.8 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.361 1.064 . . . . 64.42 109.806 -173.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.404 ' HD2' HG22 ' D' ' 86' ' ' ILE . 82.0 t80 -142.67 102.34 4.03 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.078 -1.082 . . . . 73.41 108.078 176.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -119.55 126.29 50.87 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.46 0.704 . . . . 74.14 109.465 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mt -91.79 137.89 21.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 123.657 0.783 . . . . 54.11 109.203 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -110.92 -44.41 3.62 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.191 0.596 . . . . 55.51 111.678 -176.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -169.03 122.98 0.82 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.822 -0.172 . . . . 64.11 110.566 -168.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.1 mp -103.82 137.17 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 107.287 -1.375 . . . . 73.14 107.287 166.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -158.33 146.62 18.62 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.228 0.611 . . . . 73.44 110.804 174.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -76.88 114.53 15.75 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.398 -0.819 . . . . 61.02 109.034 173.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -81.12 -21.13 40.09 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.586 -0.733 . . . . 53.12 109.896 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 7.3 t70 -162.12 142.67 10.29 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.941 1.297 . . . . 71.31 109.225 -176.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.534 HG21 ' HE2' ' C' ' 117' ' ' MET . 79.5 mt -142.94 148.73 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 124.889 1.276 . . . . 73.12 108.549 176.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.3 t -150.28 145.3 26.1 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.052 1.341 . . . . 51.13 108.352 172.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.525 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.5 t80 -151.69 136.18 16.92 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.497 -1.668 . . . . 75.33 106.497 171.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.508 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 48.0 mt-10 -138.97 148.55 43.64 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.335 0.654 . . . . 74.33 109.819 -176.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.68 78.43 9.1 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 107.718 -1.216 . . . . 74.22 107.718 175.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.6 -31.31 8.86 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.514 2.142 . . . . 74.52 112.827 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -94.46 -1.48 53.48 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.368 0.667 . . . . 71.31 111.096 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.642 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -24.55 -66.96 0.07 OUTLIER Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 126.841 2.057 . . . . 71.24 116.356 -164.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.71 -20.7 11.83 Favored 'Trans proline' 0 C--N 1.385 2.472 0 CA-C-N 123.046 2.124 . . . . 55.32 113.92 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -73.25 -39.24 65.61 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.055 0.942 . . . . 75.43 109.365 174.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.517 HG22 HD12 ' D' ' 68' ' ' LEU . 5.6 p -83.57 -24.12 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 CA-C-N 115.627 -0.715 . . . . 60.41 111.14 -172.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -63.83 -29.31 70.52 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.085 0.469 . . . . 75.14 111.207 176.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -56.87 -29.3 62.81 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.547 -1.206 . . . . 71.22 110.493 176.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -84.42 71.48 10.7 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.731 1.212 . . . . 74.31 109.498 169.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -76.85 92.92 3.66 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.185 -0.916 . . . . 71.22 109.676 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -164.91 -165.82 0.96 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.128 0.971 . . . . 73.31 109.964 173.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -77.68 115.02 46.43 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.471 1.108 . . . . 73.12 110.965 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.73 130.45 26.3 Favored 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 122.649 2.233 . . . . 71.31 111.203 173.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 30.0 mm-40 -67.52 109.6 3.3 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 108.122 -1.066 . . . . 63.44 108.122 171.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.66 HG13 HG13 ' D' ' 64' ' ' VAL . 45.7 t -99.16 128.07 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.774 -0.824 . . . . 75.33 108.774 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.02 127.87 48.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.605 -1.628 . . . . 63.32 106.605 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.613 HD11 HG13 ' D' ' 62' ' ' VAL . 55.4 tp -95.82 145.64 25.19 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.533 0.733 . . . . 72.41 110.522 -173.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.512 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 10.1 t70 -142.47 111.9 6.65 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 106.486 -1.672 . . . . 71.25 106.486 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.44 ' HB3' HD23 ' E' ' 111' ' ' LEU . 79.1 mt -109.71 145.27 36.86 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.256 0.55 . . . . 55.45 110.87 -174.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.701 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.0 t70 -137.33 149.88 47.35 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.71 1.204 . . . . 71.32 108.378 177.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 46' ' ' THR . . . . . 0.47 ' HB ' HG21 ' E' ' 107' ' ' THR . 30.2 m -120.92 144.16 48.59 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.82 -0.807 . . . . 60.43 108.82 173.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.546 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -147.23 170.31 17.51 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.931 1.292 . . . . 24.33 107.653 -177.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 10.0 p -168.38 165.32 12.79 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.692 0.397 . . . . 60.14 110.7 -172.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 12.0 p -169.68 165.95 9.94 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.646 0.778 . . . . 74.4 110.152 -173.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 50' ' ' GLN . . . . . 0.438 ' HB2' ' HA ' ' D' ' 56' ' ' TYR . 69.1 mm-40 79.93 157.55 0.16 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.193 1.797 . . . . 74.13 111.255 -176.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.697 ' H ' HD23 ' D' ' 51' ' ' LEU . 1.1 pt? -63.5 133.15 53.37 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.391 -1.277 . . . . 63.01 111.444 -177.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.66 82.4 7.89 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.387 1.075 . . . . 73.04 111.951 -167.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -150.72 74.37 1.17 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.864 0.84 . . . . 63.31 109.202 175.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' D' ' 85' ' ' SER . 68.0 m-20 62.84 -9.15 0.11 Allowed 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 125.856 1.663 . . . . 62.24 114.74 -176.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 40.4 t -135.62 96.04 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 119.316 0.962 . . . . 62.52 108.557 -173.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.438 ' HA ' ' HB2' ' D' ' 50' ' ' GLN . 1.3 p90 -152.51 161.27 42.81 Favored 'General case' 0 C--O 1.247 0.921 0 CA-C-N 114.299 -1.319 . . . . 61.52 108.649 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.545 ' HG2' HG12 ' D' ' 83' ' ' ILE . 36.1 mt-10 -89.77 143.74 26.55 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 114.934 -1.03 . . . . 74.2 110.323 177.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.431 HG11 ' HD3' ' D' ' 103' ' ' PRO . 91.6 t -116.75 139.67 42.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 113.251 -1.795 . . . . 52.33 106.902 167.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 41.5 t -129.22 129.87 67.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.426 -0.953 . . . . 74.15 108.426 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.537 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -110.95 120.64 43.07 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.251 -1.389 . . . . 73.22 107.251 173.849 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.701 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 7.3 ttm180 -102.03 100.88 11.19 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.091 -1.077 . . . . 75.52 108.091 175.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.613 HG13 HD11 ' D' ' 42' ' ' LEU . 49.0 t -92.12 122.84 43.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.299 -1.0 . . . . 64.54 108.299 173.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 17.5 m -122.05 129.13 52.14 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.745 -0.835 . . . . 73.41 108.745 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.66 HG13 HG13 ' D' ' 40' ' ' VAL . 67.5 t -118.8 121.02 65.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 124.281 1.032 . . . . 73.11 109.186 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 49.8 m -106.84 114.61 28.8 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.155 -1.424 . . . . 75.44 107.155 164.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.55 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -119.86 142.84 48.29 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.553 0.741 . . . . 64.25 109.25 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.561 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 68.6 p -147.32 130.92 16.83 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.141 0.422 . . . . 71.12 112.141 -170.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.517 HD12 HG22 ' D' ' 31' ' ' VAL . 18.7 mt -93.84 105.95 17.95 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.15 0.98 . . . . 61.51 108.38 175.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.08 -116.28 4.29 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 110.94 -0.864 . . . . 70.43 110.94 -174.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.51 4.95 16.44 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.312 0.645 . . . . 54.42 111.955 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -115.9 155.43 27.97 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.604 0.361 . . . . 70.55 110.842 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 61.7 m -64.91 119.85 11.46 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.924 0.889 . . . . 75.41 112.209 -177.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.561 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -79.24 -69.8 0.55 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.623 -1.251 . . . . 72.44 107.623 171.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -145.6 149.52 34.7 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 114.988 -1.005 . . . . 73.34 110.704 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 65.6 mt -112.54 152.97 28.21 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.906 1.282 . . . . 74.41 107.957 172.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.745 ' SG ' HG12 ' D' ' 114' ' ' ILE . 53.3 t -158.35 144.91 17.43 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.784 0.434 . . . . 53.01 110.058 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -155.65 125.89 6.68 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.042 0.537 . . . . 73.43 109.757 173.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 87.7 t -131.26 115.42 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.759 0.824 . . . . 73.41 109.231 -177.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.518 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.7 mt-30 -88.63 85.16 6.75 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.636 -0.876 . . . . 70.2 108.636 170.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -81.05 98.86 8.17 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 113.998 -1.456 . . . . 64.54 109.377 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.51 162.16 24.37 Favored Glycine 0 N--CA 1.465 0.596 0 N-CA-C 112.295 -0.322 . . . . 63.12 112.295 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.87 136.94 4.49 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.676 -0.569 . . . . 74.24 111.676 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.545 HG12 ' HG2' ' D' ' 57' ' ' GLU . 44.2 mt -90.76 105.59 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.779 -0.823 . . . . 73.22 108.779 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -107.93 141.75 39.09 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.727 0.811 . . . . 73.13 109.821 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' D' ' 54' ' ' ASP . 3.9 t -115.73 110.36 19.01 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 109.078 -0.712 . . . . 52.31 109.078 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.404 HG22 ' HD2' ' D' ' 11' ' ' PHE . 44.2 pt -126.67 134.33 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 123.531 0.732 . . . . 74.54 110.942 -174.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.95 170.36 17.87 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.888 0.875 . . . . 65.13 110.813 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.3 23.81 53.3 Favored Glycine 0 C--N 1.355 1.602 0 O-C-N 123.424 0.452 . . . . 71.34 113.171 173.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.413 HG13 ' HG2' ' D' ' 9' ' ' MET . 0.7 OUTLIER -140.82 144.86 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.449 0.7 . . . . 75.0 110.327 179.016 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -131.65 175.92 8.76 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.406 1.082 . . . . 73.44 110.492 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.82 -128.22 10.94 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 115.628 -0.715 . . . . 73.13 113.518 173.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 9.7 t -87.0 -38.39 16.63 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.233 0.613 . . . . 70.22 110.903 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -69.05 -22.07 64.05 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.261 0.625 . . . . 75.34 112.666 -171.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -64.49 -49.63 70.6 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.078 0.466 . . . . 74.12 111.081 177.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.09 -13.82 49.13 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.868 0.867 . . . . 70.23 110.965 -177.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -75.49 -22.83 56.85 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.061 0.545 . . . . 74.43 109.677 175.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 75.3 m -71.33 -50.98 26.9 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.077 0.551 . . . . 72.35 110.749 176.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 pp -67.03 -28.1 67.95 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.854 0.461 . . . . 64.25 111.772 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.15 -20.64 48.65 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.609 -0.551 . . . . 53.43 113.584 -178.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.52 -57.31 1.21 Allowed 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 117.794 0.797 . . . . 64.05 112.689 -170.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -68.94 -39.04 79.8 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 122.907 0.483 . . . . 74.51 111.281 -173.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 91.9 m -68.29 -47.09 38.82 Favored Pre-proline 0 CA--C 1.57 1.723 0 CA-C-O 118.401 -0.809 . . . . 73.42 111.767 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.537 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 86.4 Cg_exo -54.98 -33.31 82.46 Favored 'Trans proline' 0 C--N 1.402 3.355 0 C-N-CA 122.605 2.204 . . . . 72.04 113.685 166.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -65.86 -29.06 69.45 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.967 0.507 . . . . 54.44 111.139 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.1 mm -79.33 -33.66 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.901 0.88 . . . . 52.43 110.689 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 89.7 mt -75.1 -24.13 58.05 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.057 0.543 . . . . 72.32 112.147 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -67.37 -39.29 19.45 Favored Pre-proline 0 CA--C 1.562 1.437 0 CA-C-O 117.742 -1.123 . . . . 70.41 113.751 -172.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -50.48 -44.19 40.9 Favored 'Trans proline' 0 C--N 1.389 2.661 0 C-N-CA 122.182 1.921 . . . . 73.53 113.419 168.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -77.37 -35.49 54.47 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.778 0.831 . . . . 75.12 111.566 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.26 -47.51 67.53 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.546 0.738 . . . . 74.33 109.757 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.489 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 34.8 ttp180 -59.27 -43.67 92.49 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-N 114.643 -1.162 . . . . 71.25 110.254 172.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.13 -50.35 69.48 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 124.022 0.826 . . . . 52.35 111.365 -176.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.461 ' O ' ' HG3' ' D' ' 117' ' ' MET . 42.5 t -56.77 -44.58 81.97 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 124.453 1.096 . . . . 71.15 110.549 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.745 HG12 ' SG ' ' D' ' 76' ' ' CYS . 76.7 mt -62.71 -52.6 57.6 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 C-N-CA 124.159 0.984 . . . . 72.05 110.941 176.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 91.9 m -53.39 -45.58 69.33 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.502 1.521 . . . . 74.51 110.337 -175.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -64.94 -45.82 84.16 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.514 -1.676 . . . . 75.12 110.072 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.461 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 71.8 mtm -68.99 -30.13 68.48 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.824 0.449 . . . . 73.53 111.964 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.437 HG23 ' O ' ' D' ' 114' ' ' ILE . 78.6 t -67.07 -46.03 85.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.793 0.837 . . . . 74.41 109.218 176.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 83.4 p -72.61 -28.42 62.76 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 115.737 -0.665 . . . . 75.34 110.682 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 55.0 mtt-85 -74.61 -31.04 61.89 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.68 0.792 . . . . 75.3 110.165 175.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.94 4.41 85.37 Favored Glycine 0 C--N 1.354 1.574 0 O-C-N 123.466 0.479 . . . . 41.44 112.629 177.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.532 HG23 ' HB3' ' C' ' 17' ' ' TYR . 43.5 p 58.9 32.1 21.93 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 126.152 1.781 . . . . 64.52 112.67 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -96.83 150.11 36.52 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 115.392 -0.822 . . . . 73.33 109.786 170.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.499 ' HB3' ' HA ' ' E' ' 129' ' ' THR . 22.5 Cg_exo -43.29 122.82 3.15 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 124.042 3.161 . . . . 65.21 114.121 172.021 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -52.44 123.18 10.31 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.858 1.263 . . . . 72.54 112.049 -173.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.515 HD13 HG21 ' D' ' 40' ' ' VAL . 28.1 tp -107.63 112.46 25.19 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.299 1.04 . . . . 75.15 109.655 -176.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -116.07 79.63 1.33 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.505 -0.924 . . . . 62.23 108.505 176.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.516 HD11 HD22 ' D' ' 42' ' ' LEU . 0.3 OUTLIER -58.42 119.7 7.44 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 123.153 0.581 . . . . 53.54 109.918 -174.159 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -54.32 130.04 60.93 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 124.233 1.013 . . . . 54.31 112.317 -175.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.467 ' HG3' HH12 ' D' ' 111' ' ' ARG . 1.6 Cg_endo -76.59 118.19 4.79 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.481 2.121 . . . . 74.53 111.134 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 12.8 p -108.47 152.07 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.531 0.733 . . . . 74.05 109.51 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -72.99 102.21 3.42 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.414 -0.587 . . . . 73.3 109.414 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -60.81 -32.55 71.9 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.766 0.826 . . . . 64.44 111.205 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -56.83 -39.48 74.28 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.535 1.134 . . . . 73.43 110.263 176.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.401 ' HA ' ' HG2' ' D' ' 138' ' ' MET . . . -66.35 -42.65 87.79 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 114.872 -1.058 . . . . 74.43 111.145 176.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 10.6 mp -53.71 -41.54 67.08 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 123.165 0.586 . . . . 63.22 111.979 -177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -69.75 -49.99 47.73 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.929 0.491 . . . . 73.12 111.522 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.401 ' HG2' ' HA ' ' D' ' 135' ' ' ALA . 16.8 ptp -66.4 -32.1 73.27 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 119.695 -0.193 . . . . 72.44 111.128 -175.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -66.71 -33.58 75.96 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.237 1.015 . . . . 74.22 111.023 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -68.52 -46.16 70.32 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.124 0.57 . . . . 62.41 110.35 175.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.6 mp -73.41 -30.34 63.18 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.173 0.589 . . . . 73.42 112.25 -175.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -89.74 4.5 49.46 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 122.991 0.516 . . . . 63.52 111.849 -175.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -118.61 95.89 5.05 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.772 0.796 . . . . 73.34 110.85 -176.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -138.36 20.18 2.75 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 114.014 -1.448 . . . . 72.13 107.169 172.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.03 -44.47 18.01 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-N 114.623 -1.172 . . . . 43.23 110.619 -176.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 67.72 31.3 75.7 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.938 -0.574 . . . . 74.34 112.389 -177.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -84.91 88.52 7.43 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.791 0.836 . . . . 52.43 109.279 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -160.28 109.78 0.41 Allowed Glycine 0 C--N 1.345 1.042 0 CA-C-N 115.974 -0.557 . . . . 65.21 111.921 -177.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 14.9 t -154.07 135.76 14.41 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.41 0.684 . . . . 75.55 109.642 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -147.04 132.21 18.35 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.993 0.917 . . . . 74.31 109.735 174.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -135.76 143.51 45.3 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.267 1.027 . . . . 71.41 109.015 173.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -162.35 53.46 0.22 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.165 -1.42 . . . . 73.53 107.165 175.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -65.29 128.18 34.77 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 114.913 -1.039 . . . . 71.31 111.772 -173.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -143.8 116.34 8.63 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.567 1.147 . . . . 51.24 108.295 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.013 0 N-CA-C 109.373 -0.603 . . . . 55.4 109.373 177.405 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.673 0 N-CA-C 111.973 -0.451 . . . . 63.05 111.973 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.93 60.24 6.69 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.672 0.278 . . . . 74.23 112.441 -177.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -81.26 74.94 8.24 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.575 0.75 . . . . 70.14 109.74 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 67.06 173.47 0.26 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.937 1.295 . . . . 75.01 112.305 173.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -108.1 -52.41 2.77 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 112.812 0.671 . . . . 75.45 112.812 -166.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 118.14 94.14 1.66 Allowed Glycine 0 C--N 1.342 0.891 0 N-CA-C 111.099 -0.8 . . . . 63.22 111.099 -171.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 97' ' ' ILE . . . . . 0.517 HG13 HD11 ' E' ' 100' ' ' LEU . 26.2 pt -72.88 131.62 34.59 Favored 'Isoleucine or valine' 0 C--N 1.357 0.932 0 N-CA-C 107.8 -1.185 . . . . 62.31 107.8 172.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -105.06 167.92 9.39 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.18 -0.464 . . . . 61.14 110.585 -167.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . 71.07 23.99 4.04 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.3 1.44 . . . . 50.25 111.188 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 100' ' ' LEU . . . . . 0.517 HD11 HG13 ' E' ' 97' ' ' ILE . 69.5 mt -76.11 118.33 70.47 Favored Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 123.291 0.636 . . . . 71.31 110.916 176.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -92.33 0.07 4.05 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.557 2.171 . . . . 73.41 111.36 163.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.23 71.66 0.56 Allowed 'General case' 0 C--N 1.363 1.156 0 C-N-CA 125.381 1.472 . . . . 71.34 108.513 -168.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 103' ' ' THR . . . . . 0.619 ' HB ' ' HA ' ' E' ' 107' ' ' THR . 28.5 m 61.65 -73.18 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.522 1.529 . . . . 55.31 111.211 -170.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 104' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' E' ' 108' ' ' HIS . . . -157.89 51.19 0.41 Allowed Glycine 0 C--N 1.35 1.308 0 N-CA-C 111.984 -0.446 . . . . 74.21 111.984 175.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 69.75 97.13 0.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 125.126 1.37 . . . . 44.14 110.037 -175.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 53.2 t80 61.81 37.94 15.14 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.212 1.005 . . . . 74.31 110.206 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 107' ' ' THR . . . . . 0.619 ' HA ' ' HB ' ' E' ' 103' ' ' THR . 28.3 m 77.73 -55.8 0.51 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.922 1.689 . . . . 70.13 111.773 -177.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 108' ' ' HIS . . . . . 0.409 ' HB2' ' O ' ' E' ' 104' ' ' GLY . 54.4 t-80 78.68 -59.56 0.41 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 125.814 1.646 . . . . 71.41 112.191 176.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -68.29 127.07 31.62 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.726 0.411 . . . . 72.34 110.269 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.35 137.91 58.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.422 0.689 . . . . 61.04 109.773 173.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 111' ' ' LEU . . . . . 0.44 HD23 ' HB3' ' D' ' 44' ' ' LEU . 47.1 tp -79.57 67.93 5.46 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 121.967 0.889 . . . . 72.34 109.783 -178.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 172.79 -59.68 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 106.018 -1.845 . . . . 75.32 106.018 -174.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 18.1 tptp 65.44 128.72 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 126.294 1.837 . . . . 74.1 111.488 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -72.33 82.63 1.04 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.06 0.544 . . . . 63.43 110.225 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 13.3 t -122.79 -16.87 7.01 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.61 0.764 . . . . 62.52 110.799 -175.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 161.3 -88.32 0.11 Allowed Glycine 0 C--N 1.351 1.373 0 N-CA-C 112.491 -0.244 . . . . 73.13 112.491 175.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 32.9 pttt -156.21 141.81 12.67 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 123.788 0.835 . . . . 71.23 109.634 -175.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -96.75 68.09 0.13 Allowed 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.49 2.793 . . . . 70.25 113.656 -174.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -61.47 -45.45 94.22 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 123.826 0.85 . . . . 71.55 111.229 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -67.33 -26.92 66.74 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 114.89 -1.05 . . . . 74.33 112.017 -176.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 121' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.89 -12.24 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 C-N-CA 123.653 0.781 . . . . 61.22 110.452 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 28.2 p 74.05 -49.0 0.67 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 127.395 2.278 . . . . 50.32 112.691 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 15.9 t70 71.57 -80.41 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.732 1.213 . . . . 74.04 111.064 171.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 15.8 m -92.74 81.48 4.72 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.59 0.756 . . . . 70.42 109.253 177.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -155.0 155.94 35.08 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.896 -0.593 . . . . 74.55 110.516 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 126' ' ' ALA . . . . . 0.571 ' HB1' ' HB ' ' B' ' 13' ' ' ILE . . . 64.38 86.07 0.13 Allowed 'General case' 0 CA--C 1.551 1.014 0 O-C-N 124.809 1.318 . . . . 62.3 112.607 173.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 30.8 t -156.92 162.67 39.64 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.692 0.797 . . . . 43.03 109.881 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -141.58 110.74 6.29 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.898 0.879 . . . . 70.34 109.684 -173.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 129' ' ' THR . . . . . 0.499 ' HA ' ' HB3' ' D' ' 124' ' ' PRO . 3.6 t -96.73 124.89 40.85 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.526 0.731 . . . . 74.1 111.634 -176.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -166.34 117.35 0.99 Allowed 'General case' 0 C--N 1.357 0.928 0 C-N-CA 124.423 1.089 . . . . 74.32 109.454 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 131' ' ' TRP . . . . . . . . . . . . . 8.8 t90 -152.01 -174.39 4.85 Favored 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 124.075 0.95 . . . . 74.52 109.173 -178.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 23.7 t 83.35 95.0 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.464 1.906 . . . . 61.4 109.743 176.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.48 37.69 0.2 Allowed 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 125.007 1.323 . . . . 64.33 109.636 -176.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.12 90.02 0.5 Allowed Glycine 0 C--N 1.352 1.466 0 CA-C-N 115.56 -0.746 . . . . 72.32 112.195 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 29.9 m -71.1 122.15 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 C-N-CA 123.555 0.742 . . . . 71.21 111.127 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 136' ' ' LYS . . . . . 0.813 ' HA ' ' HG2' ' C' ' 12' ' ' GLN . 35.3 ttpt -145.39 16.8 1.5 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.405 0.621 . . . . 74.04 110.588 177.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 137' ' ' THR . . . . . 0.639 ' HA ' HG11 ' E' ' 144' ' ' VAL . 1.1 p -151.92 107.59 3.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.255 1.022 . . . . 75.24 109.059 174.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -138.24 5.99 2.55 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.918 0.887 . . . . 62.5 110.131 176.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -134.36 126.1 28.94 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.332 -0.988 . . . . 65.33 108.332 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -103.31 28.35 16.05 Favored Glycine 0 C--N 1.345 1.07 0 O-C-N 123.705 0.628 . . . . 73.44 112.904 -176.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.49 -55.74 9.38 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.404 0.682 . . . . 73.04 110.245 176.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 67.7 tp -174.97 -48.86 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.565 1.546 . . . . 74.13 106.91 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -131.92 -171.18 12.76 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 114.441 -1.254 . . . . 44.13 111.329 173.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 144' ' ' VAL . . . . . 0.639 HG11 ' HA ' ' E' ' 137' ' ' THR . 22.3 m -132.2 162.91 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.656 1.183 . . . . 75.05 110.995 -175.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 28.1 t70 . . . . . 0 C--O 1.254 1.34 0 C-N-CA 125.14 1.376 . . . . 75.04 107.527 174.486 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.671 0 N-CA-C 111.899 -0.481 . . . . 52.12 111.899 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . -121.23 114.66 2.64 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 111.851 -0.5 . . . . 65.22 111.851 -173.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -150.21 18.26 0.85 Allowed 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 112.886 0.699 . . . . 74.15 112.886 -174.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -166.45 146.39 5.97 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.517 0.327 . . . . 54.0 110.944 173.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -122.44 145.14 48.57 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.805 0.842 . . . . 74.41 109.094 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . 163.45 -24.33 0.19 Allowed Glycine 0 C--N 1.347 1.193 0 CA-C-O 119.442 -0.643 . . . . 63.24 114.472 173.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 97' ' ' ILE . . . . . 0.706 HD13 HD22 ' F' ' 100' ' ' LEU . 13.2 tt -109.75 140.96 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-N 117.883 0.841 . . . . 64.23 109.75 -177.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -87.92 118.38 27.42 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.918 -0.401 . . . . 53.42 109.918 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . 58.94 -75.86 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.601 1.56 . . . . 64.5 113.617 172.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 100' ' ' LEU . . . . . 0.706 HD22 HD13 ' F' ' 97' ' ' ILE . 29.6 tp 68.17 83.07 0.18 Allowed Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.49 1.516 . . . . 75.23 110.797 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -88.32 40.2 0.55 Allowed 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 123.619 2.879 . . . . 72.0 112.369 177.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 102' ' ' LEU . . . . . 0.567 HD12 HD13 ' B' ' 98' ' ' LEU . 68.4 tp 65.92 -80.61 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.516 1.127 . . . . 60.23 108.494 -165.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 4.7 p -163.59 -50.56 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.424 2.29 . . . . 73.53 105.0 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 177.24 -157.19 21.82 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 113.629 -1.623 . . . . 22.22 110.134 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -70.96 103.82 2.78 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.2 0.6 . . . . 74.04 110.426 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 42.8 t80 63.28 14.76 8.08 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 125.49 1.516 . . . . 74.2 112.137 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 29.8 m 68.35 119.26 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.42 1.088 . . . . 75.24 110.168 -169.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -70.71 83.76 0.63 Allowed 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.715 0.769 . . . . 74.44 109.1 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 78.9 t80 180.0 -50.32 0.01 OUTLIER 'General case' 0 C--O 1.241 0.61 0 N-CA-C 106.032 -1.84 . . . . 73.13 106.032 -170.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 67.36 120.84 0.03 OUTLIER 'General case' 0 C--N 1.36 1.045 0 O-C-N 125.463 1.727 . . . . 71.12 111.268 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 16.4 tp -85.87 20.72 2.12 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-O 121.664 0.745 . . . . 55.22 110.942 -175.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -92.38 19.85 6.74 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.883 1.273 . . . . 73.01 111.002 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -67.73 102.24 1.18 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.65 0.78 . . . . 53.11 109.42 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 114' ' ' LYS . . . . . 0.652 ' HA ' HG21 ' F' ' 122' ' ' THR . 37.0 mtmt -141.95 166.85 23.57 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.882 0.873 . . . . 63.32 110.905 -177.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 20.2 m 58.39 72.67 0.51 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.376 1.47 . . . . 72.14 112.684 170.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.93 -25.1 2.24 Favored Glycine 0 C--N 1.354 1.532 0 N-CA-C 115.1 0.8 . . . . 63.55 115.1 170.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -68.07 -46.72 41.47 Favored Pre-proline 0 CA--C 1.562 1.409 0 C-N-CA 123.691 0.796 . . . . 74.01 111.442 -176.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -89.62 -156.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.39 2.724 0 C-N-CA 122.2 1.934 . . . . 74.22 111.372 170.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -151.61 167.63 27.51 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.385 0.674 . . . . 74.02 109.614 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 74.5 t80 74.23 -67.93 0.24 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.5 1.52 . . . . 72.55 112.088 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.8 -40.5 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.727 0.811 . . . . 62.42 111.402 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 122' ' ' THR . . . . . 0.652 HG21 ' HA ' ' F' ' 114' ' ' LYS . 73.2 p -105.75 11.92 31.51 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.558 0.743 . . . . 73.12 111.378 -178.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -116.2 -65.5 1.18 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.426 0.69 . . . . 75.53 109.978 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 30.0 p -92.05 137.96 31.93 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.556 0.743 . . . . 64.32 109.535 178.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -121.48 -85.31 0.66 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.547 0.739 . . . . 63.15 109.935 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -177.23 -172.04 0.37 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.344 1.058 . . . . 73.45 110.006 -174.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 48.8 p -75.14 144.96 42.55 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 109.086 -0.709 . . . . 72.14 109.086 169.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.41 -33.04 73.03 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.851 0.86 . . . . 55.24 112.858 -173.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 129' ' ' THR . . . . . 0.523 HG22 ' H ' ' F' ' 130' ' ' ALA . 1.7 m 59.1 -154.94 0.36 Allowed 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 108.881 -0.785 . . . . 61.13 108.881 -176.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 130' ' ' ALA . . . . . 0.523 ' H ' HG22 ' F' ' 129' ' ' THR . . . -166.35 176.14 7.69 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 119.437 1.017 . . . . 62.13 111.486 176.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 131' ' ' TRP . . . . . 0.422 ' HB2' ' HA ' ' B' ' 124' ' ' PRO . 0.6 OUTLIER -142.26 95.51 2.81 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.155 0.982 . . . . 72.44 109.638 170.986 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 65.0 m -145.65 -66.25 0.31 Allowed 'General case' 0 C--O 1.239 0.527 0 N-CA-C 106.541 -1.651 . . . . 74.41 106.541 165.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 133' ' ' THR . . . . . 0.612 HG23 ' HG2' ' C' ' 38' ' ' PRO . 62.8 m 62.97 -79.55 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.941 0 O-C-N 124.634 1.209 . . . . 74.13 110.778 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.42 158.09 33.78 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 112.641 -0.184 . . . . 72.05 112.641 177.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 7.5 p -147.24 130.2 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 C-N-CA 123.723 0.809 . . . . 50.53 108.999 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -72.66 -55.85 6.21 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.323 0.649 . . . . 75.11 109.766 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 10.4 t -171.47 -147.87 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 106.7 -1.593 . . . . 72.53 106.7 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -56.96 -42.09 79.52 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 118.979 0.809 . . . . 75.15 110.45 173.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -107.81 148.82 29.01 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.907 0.883 . . . . 75.3 109.9 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -87.7 128.54 9.07 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.227 -0.749 . . . . 74.35 111.227 171.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -91.6 102.81 15.46 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.439 -0.578 . . . . 63.12 109.439 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 71.6 mt -65.82 81.28 0.07 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.967 0.907 . . . . 41.04 110.999 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -132.21 47.05 1.03 Allowed Glycine 0 C--N 1.341 0.828 0 N-CA-C 110.976 -0.85 . . . . 74.24 110.976 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 53.6 t -67.3 93.66 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 124.269 1.028 . . . . 71.14 109.96 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 34.0 t70 . . . . . 0 C--O 1.249 1.057 0 CA-C-N 114.607 -1.179 . . . . 73.14 110.205 -177.233 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptm . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 110.257 -0.275 . . . . 52.35 110.257 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.3 t -170.07 110.33 0.41 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.875 0.87 . . . . 62.13 108.963 177.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -82.26 88.66 6.51 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.597 0.713 . . . . 63.33 110.187 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -75.19 118.46 18.14 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.201 -1.363 . . . . 75.11 109.313 177.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -76.59 74.38 3.29 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.86 0.864 . . . . 74.31 110.241 -176.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -175.58 -160.53 0.08 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.85 1.66 . . . . 71.0 107.95 -174.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.8 p -91.5 2.21 56.59 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 112.707 0.632 . . . . 65.53 112.707 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -76.05 112.61 12.67 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.211 -1.033 . . . . 75.15 108.211 174.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.67 ' HB3' HG23 ' A' ' 89' ' ' ILE . 4.8 ppp? -139.88 179.2 6.74 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.09 -0.959 . . . . 73.14 110.418 -170.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.2 m -136.26 115.26 12.3 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.475 0.71 . . . . 65.33 109.375 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.455 ' HE1' ' SG ' ' A' ' 102' ' ' CYS . 62.0 t80 -110.24 121.39 45.16 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.737 -1.209 . . . . 74.01 107.737 173.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -133.92 134.62 42.84 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.148 -0.686 . . . . 71.41 109.148 176.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.426 HG21 ' HG2' ' C' ' 130' ' ' PRO . 47.8 mt -92.55 114.09 28.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 108.252 -1.018 . . . . 63.32 108.252 175.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -83.95 -35.46 23.98 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 123.399 0.437 . . . . 74.22 110.533 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -175.93 121.73 0.18 Allowed 'General case' 0 C--N 1.351 0.652 0 N-CA-C 109.553 -0.536 . . . . 73.5 109.553 -168.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.555 HD12 ' HG3' ' C' ' 130' ' ' PRO . 78.7 mt -109.42 135.75 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 107.832 -1.173 . . . . 63.14 107.832 171.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.434 ' CE2' ' HB1' ' B' ' 28' ' ' ALA . 31.3 p90 -161.83 177.1 10.17 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 124.021 0.826 . . . . 73.2 111.66 -174.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.5 p -102.49 118.64 37.29 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.942 -0.762 . . . . 61.34 108.942 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.1 mtpt -75.95 -35.87 59.52 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.229 -0.441 . . . . 72.25 110.002 172.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 18.2 t70 -145.51 144.46 30.56 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.654 -0.703 . . . . 55.01 109.787 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 57.4 mt -140.5 141.66 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 107.563 -1.273 . . . . 74.2 107.563 175.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.5 t -154.54 139.85 17.64 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.714 -0.476 . . . . 64.54 109.714 170.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.516 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 80.6 t80 -142.33 116.15 9.26 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.221 -1.4 . . . . 71.13 107.221 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -118.32 134.28 55.18 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.809 0.443 . . . . 71.44 109.991 -176.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.8 74.34 58.3 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 107.651 -1.24 . . . . 55.15 107.651 172.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.07 -27.23 20.59 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.528 2.152 . . . . 43.21 111.964 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -99.2 9.82 42.67 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.067 -0.97 . . . . 73.33 110.587 -177.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.483 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -45.82 -60.32 3.59 Favored Pre-proline 0 C--N 1.371 1.529 0 C-N-CA 124.295 1.038 . . . . 35.24 113.724 -166.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 23.4 Cg_exo -60.07 -31.31 93.21 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 121.755 1.636 . . . . 72.14 113.027 -171.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.52 -15.73 18.55 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.515 -0.766 . . . . 75.2 112.25 -175.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.78 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.8 p -77.04 -24.71 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-N 117.945 0.339 . . . . 73.21 110.391 -176.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -69.02 -22.34 64.06 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.92 -0.582 . . . . 75.24 110.583 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -74.68 -21.57 59.33 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.042 0.937 . . . . 74.43 111.437 176.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -81.93 161.42 23.09 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.208 0.603 . . . . 73.11 110.521 -177.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -63.11 117.52 6.62 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.244 0.618 . . . . 73.14 109.389 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.423 ' CE3' HD21 ' A' ' 68' ' ' LEU . 71.7 t-105 -81.32 89.05 6.06 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.629 0.728 . . . . 75.45 110.684 -178.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.465 ' H ' HD22 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -145.85 74.54 13.39 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 125.061 1.344 . . . . 74.3 108.569 172.728 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.0 149.79 17.76 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.924 2.416 . . . . 72.22 113.618 -171.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -97.92 97.79 9.24 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 107.108 -1.441 . . . . 55.44 107.108 167.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' A' ' 66' ' ' ALA . 59.4 t -83.03 94.71 3.25 Favored 'Isoleucine or valine' 0 C--N 1.345 0.382 0 CA-C-O 121.699 0.762 . . . . 74.11 109.303 176.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -78.02 117.12 19.03 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.299 -1.773 . . . . 73.41 109.456 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.5 tp -97.79 106.68 19.03 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.842 -0.617 . . . . 63.43 109.542 -175.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.673 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 2.0 m-20 -104.86 145.26 30.64 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.498 1.119 . . . . 72.44 108.51 172.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.463 HD11 HG21 ' A' ' 131' ' ' VAL . 95.7 mt -137.84 148.1 45.12 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.677 0.791 . . . . 73.54 109.626 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -148.55 142.22 25.54 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.507 1.123 . . . . 42.22 108.269 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.7 m -140.81 136.42 32.42 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.198 0.599 . . . . 75.42 110.129 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.99 130.22 9.62 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.687 0.795 . . . . 42.05 109.508 174.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 68.4 p -90.45 -179.52 5.61 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.71 0.804 . . . . 41.03 110.6 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.513 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 39.1 t -159.63 141.04 12.84 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.855 0.862 . . . . 54.01 109.149 -177.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -93.44 107.84 19.62 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.434 -0.95 . . . . 72.45 108.434 171.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 57' ' ' GLU . 53.6 mt -84.79 -43.57 14.1 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.004 0.522 . . . . 65.12 109.731 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.07 -173.34 4.53 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.26 -0.882 . . . . 52.41 110.041 -177.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -70.05 118.33 12.75 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.641 0.776 . . . . 72.01 109.295 176.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 64.18 14.26 8.48 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.152 1.381 . . . . 72.23 112.237 -174.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.0 t -117.41 110.26 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 108.664 -0.865 . . . . 71.24 108.664 176.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -121.99 124.66 44.52 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.198 0.999 . . . . 72.42 109.066 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 30.6 tt0 -86.12 152.85 22.52 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.763 -0.828 . . . . 55.15 108.763 169.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 77.2 t -132.03 138.79 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 N-CA-C 108.232 -1.025 . . . . 65.13 108.232 167.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.43 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 51.1 t -113.93 134.81 55.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.262 -0.644 . . . . 73.4 109.262 174.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.62 105.32 12.93 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.408 -1.331 . . . . 73.53 107.408 168.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 42.0 ttp180 -93.67 101.99 14.15 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.95 -1.13 . . . . 65.02 107.95 177.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.5 t -93.72 132.27 38.34 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 108.174 -1.047 . . . . 64.44 108.174 176.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.673 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 24.2 m -120.27 139.39 52.78 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.563 -0.902 . . . . 75.22 108.563 172.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.67 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.2 t -142.51 109.11 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 124.878 1.271 . . . . 72.42 107.692 -169.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.3 m -115.17 124.18 50.8 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 109.351 -0.611 . . . . 74.55 109.351 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.514 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -103.38 120.65 41.21 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.478 -1.675 . . . . 64.22 106.478 172.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 59.5 m -129.16 134.74 48.16 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.024 0.44 . . . . 72.24 110.496 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.465 HD22 ' H ' ' A' ' 37' ' ' GLN . 32.9 mt -88.46 64.39 7.47 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.338 -1.356 . . . . 75.34 107.338 174.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.26 -109.11 2.72 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 114.74 -1.118 . . . . 62.12 111.954 -174.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -86.93 -21.45 26.25 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.793 0.837 . . . . 73.42 109.133 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 9.5 tp10 -77.9 133.0 38.18 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.001 0.92 . . . . 70.34 108.857 172.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.4 m -89.03 129.07 35.73 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.799 0.727 . . . . 71.31 109.469 167.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.78 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -78.4 -59.58 2.72 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.019 -0.734 . . . . 72.31 109.019 173.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -159.47 169.63 23.48 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.443 -0.799 . . . . 65.22 110.892 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.426 HD12 ' H ' ' A' ' 76' ' ' CYS . 20.0 tp -132.44 142.17 49.14 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.484 -1.234 . . . . 72.24 107.939 174.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.67 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 64.6 m -137.32 132.96 34.38 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.773 1.229 . . . . 65.22 108.155 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -145.94 119.51 9.12 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.258 -0.645 . . . . 44.54 109.258 173.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.3 t -127.91 110.51 22.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.51 1.124 . . . . 62.05 108.7 -176.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 68.3 mt-30 -85.33 82.58 8.28 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.105 -1.072 . . . . 71.35 108.105 172.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -75.23 92.94 2.77 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.308 -0.86 . . . . 74.51 108.924 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -97.47 146.16 18.14 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 115.407 -0.815 . . . . 42.32 111.19 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.88 133.31 5.64 Favored Glycine 0 CA--C 1.505 -0.584 0 N-CA-C 110.64 -0.984 . . . . 40.34 110.64 -176.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.424 HG23 HD12 ' A' ' 51' ' ' LEU . 43.6 mt -81.59 126.41 39.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 108.43 -0.952 . . . . 64.03 108.43 173.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.743 ' HB3' HD11 ' A' ' 86' ' ' ILE . 84.7 m-85 -130.1 120.87 25.31 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.207 1.003 . . . . 61.01 109.036 -176.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.9 t -89.39 101.54 14.22 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.987 -0.746 . . . . 74.33 108.987 176.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.743 HD11 ' HB3' ' A' ' 84' ' ' PHE . 2.2 mm -113.45 137.81 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 122.789 0.436 . . . . 73.53 110.068 -175.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.9 167.24 25.32 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.755 0.822 . . . . 71.43 110.243 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.29 -31.8 8.14 Favored Glycine 0 C--N 1.352 1.426 0 N-CA-C 114.176 0.43 . . . . 74.01 114.176 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.67 HG23 ' HB3' ' A' ' 9' ' ' MET . 0.2 OUTLIER -131.51 163.08 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 123.331 0.652 . . . . 73.41 112.486 -166.477 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.76 175.11 13.67 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 114.454 -1.248 . . . . 61.23 109.105 175.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.02 -132.45 19.29 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 116.168 -0.469 . . . . 65.43 112.781 176.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.0 p -68.59 -30.63 69.42 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.503 0.721 . . . . 43.11 112.526 -177.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -66.38 -42.41 87.99 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 120.861 0.362 . . . . 73.14 110.12 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.431 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 6.1 tpt -68.87 -47.8 65.0 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.428 -0.806 . . . . 45.25 110.078 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.47 -41.34 72.82 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.623 0.769 . . . . 70.13 111.048 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -65.93 -37.38 85.89 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.473 -0.785 . . . . 72.42 111.422 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.7 t -66.52 -44.66 81.89 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.744 -0.465 . . . . 43.2 109.744 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 48' ' ' SER . 70.8 mt -78.04 -29.71 49.51 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.342 -0.844 . . . . 75.53 112.37 -171.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.34 0.22 43.63 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-O 119.592 -0.56 . . . . 62.23 114.488 -172.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.455 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -139.83 -63.41 0.5 Allowed 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 117.726 0.763 . . . . 32.03 111.406 -175.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -68.67 -43.92 75.17 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 116.067 -0.515 . . . . 74.42 111.851 -174.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.455 ' SG ' ' HE1' ' A' ' 11' ' ' PHE . 77.6 m -66.19 -49.6 54.46 Favored Pre-proline 0 CA--C 1.564 1.495 0 C-N-CA 124.218 1.007 . . . . 71.53 112.452 -176.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.39 -22.91 59.16 Favored 'Trans proline' 0 C--N 1.394 2.929 0 C-N-CA 121.751 1.634 . . . . 72.51 112.684 174.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -68.43 -37.17 80.03 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.248 0.619 . . . . 71.12 110.245 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.3 mm -65.46 -40.07 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.649 0.78 . . . . 72.45 110.233 172.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.7 mt -78.3 -19.12 54.25 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.032 0.933 . . . . 64.21 112.526 -174.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -70.63 -41.91 13.31 Favored Pre-proline 0 CA--C 1.559 1.29 0 N-CA-C 114.351 1.241 . . . . 74.24 114.351 -171.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.0 -37.23 78.45 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 121.901 1.734 . . . . 73.04 112.657 172.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -80.44 -36.01 34.18 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.857 0.863 . . . . 70.41 111.611 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.45 -51.2 64.29 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.073 0.549 . . . . 54.12 109.701 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.423 ' NH1' HD12 ' C' ' 105' ' ' ILE . 30.3 ttm180 -47.57 -53.28 14.99 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 124.862 1.351 . . . . 72.2 110.277 173.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -62.01 -45.98 91.23 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 124.433 1.083 . . . . 71.51 111.859 -174.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.614 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.3 t -57.2 -45.91 83.36 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.84 0.713 . . . . 73.12 110.352 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 118' ' ' VAL . 56.0 mt -61.8 -52.71 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 115.113 -0.948 . . . . 75.3 110.739 176.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 47.9 m -54.17 -42.33 69.51 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.219 1.008 . . . . 74.35 111.401 -174.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.3 t -69.05 -44.79 71.93 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.736 -1.12 . . . . 63.34 110.355 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.516 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 8.9 mtp -56.04 -43.58 77.97 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.762 0.825 . . . . 64.33 111.082 176.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 114' ' ' ILE . 73.4 t -59.71 -48.96 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.711 1.204 . . . . 71.45 110.465 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.0 p -72.47 -27.41 62.27 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.137 0.575 . . . . 71.33 111.632 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.475 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.3 mtt-85 -72.37 -29.05 63.42 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.46 0.704 . . . . 72.54 109.942 175.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.436 ' O ' HG22 ' A' ' 122' ' ' THR . . . -86.56 18.05 36.12 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-O 119.165 -0.797 . . . . 74.32 113.32 172.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.5 t 60.41 9.82 2.18 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 127.227 2.211 . . . . 73.21 113.76 177.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -80.79 142.66 52.92 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 108.161 -1.051 . . . . 71.54 108.161 172.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.616 ' HB3' ' HA ' ' E' ' 131' ' ' TRP . 11.7 Cg_endo -55.49 147.16 59.54 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.74 2.293 . . . . 70.33 112.768 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -54.28 129.0 33.69 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 124.65 1.219 . . . . 65.41 112.63 -172.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 31.3 tp -117.42 105.94 12.67 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.032 0.933 . . . . 61.41 109.901 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -99.93 113.02 25.29 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.306 -0.998 . . . . 63.01 108.306 176.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.434 HD11 HD13 ' A' ' 114' ' ' ILE . 18.4 mt -67.64 154.48 41.38 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 120.714 0.292 . . . . 74.43 110.984 -175.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.22 136.37 93.77 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 123.535 0.734 . . . . 74.54 111.377 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -62.45 112.1 1.49 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.547 2.165 . . . . 75.14 111.528 173.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.463 HG21 HD11 ' A' ' 44' ' ' LEU . 90.7 t -101.88 139.98 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 121.126 0.489 . . . . 70.14 111.17 -173.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.411 ' OD1' ' HB3' ' A' ' 134' ' ' ASP . 46.4 t-20 -90.63 86.68 6.45 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.285 -1.325 . . . . 72.53 109.024 176.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -62.87 -23.99 67.59 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 112.804 0.668 . . . . 75.24 112.804 172.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.455 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 21.8 t70 -65.61 -37.89 87.9 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.028 0.531 . . . . 74.21 109.639 175.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.15 -50.04 51.4 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.822 0.849 . . . . 53.3 110.294 174.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.04 -41.98 75.87 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.416 0.687 . . . . 65.14 111.435 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -71.07 -41.68 70.37 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.767 -0.651 . . . . 74.33 110.094 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -36.25 80.36 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 123.712 0.632 . . . . 73.21 109.856 -175.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 143' ' ' GLN . 81.8 m-20 -56.27 -31.36 63.53 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.397 1.079 . . . . 65.25 111.925 176.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -87.92 -44.5 11.0 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.589 0.755 . . . . 73.43 110.463 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.0 tp -48.83 -40.85 30.92 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.12 1.768 . . . . 52.52 113.271 -168.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -147.49 30.27 0.92 Allowed 'General case' 0 CA--C 1.549 0.907 0 CA-C-O 120.973 0.416 . . . . 43.43 111.219 -169.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 139' ' ' ASN . 20.5 tt0 -61.9 -62.04 2.07 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.357 0.598 . . . . 70.15 110.398 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -134.77 15.02 3.64 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.304 1.042 . . . . 72.02 109.504 176.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.59 -167.8 2.43 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.282 1.033 . . . . 61.45 109.5 -171.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 136.82 84.38 0.15 Allowed Glycine 0 C--N 1.343 0.919 0 N-CA-C 110.294 -1.122 . . . . 72.21 110.294 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -74.11 74.99 1.76 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.986 0.915 . . . . 62.34 110.859 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -81.26 57.65 4.87 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.825 -0.625 . . . . 74.11 112.07 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.6 t -120.55 137.92 54.13 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 124.519 1.127 . . . . 72.22 109.669 -174.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -131.61 159.09 39.28 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.586 -0.894 . . . . 64.24 108.586 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -138.55 134.19 33.54 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.259 0.624 . . . . 73.11 109.794 174.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -98.34 -28.1 13.81 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.754 0.821 . . . . 74.15 110.116 177.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -63.92 93.85 0.09 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.34 0.656 . . . . 73.41 110.538 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -76.16 87.92 3.04 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.14 0.976 . . . . 64.42 109.544 178.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 CA-C-N 114.933 -1.031 . . . . 72.11 109.387 -175.735 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 40.0 mtm . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 108.673 -0.862 . . . . 50.43 108.673 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 46.1 p -99.87 -45.8 5.59 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.528 0.731 . . . . 63.43 111.119 -176.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 54.32 48.85 19.81 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.252 1.021 . . . . 74.53 109.982 -176.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.557 ' HG2' ' H ' ' B' ' 5' ' ' ASN . 42.3 tt0 -159.72 -171.12 3.15 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 114.203 -1.362 . . . . 63.33 108.298 -167.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ASN . . . . . 0.557 ' H ' ' HG2' ' B' ' 4' ' ' GLN . 1.3 m-20 -61.82 96.52 0.07 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.046 0.938 . . . . 75.12 109.236 174.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -136.87 178.78 6.81 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 108.489 -0.93 . . . . 70.1 108.489 -174.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.434 ' OG1' ' HA ' ' B' ' 89' ' ' ILE . 7.5 t -71.68 92.65 1.19 Allowed 'General case' 0 CA--C 1.553 1.094 0 CA-C-O 122.701 1.239 . . . . 73.01 111.201 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -90.2 -11.1 42.03 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 114.34 -1.3 . . . . 65.22 110.061 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.454 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 18.2 ptm 59.35 171.64 0.07 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 127.315 2.246 . . . . 64.23 114.197 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 54.9 m -135.41 122.71 21.74 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.71 -1.218 . . . . 72.32 107.71 172.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -111.69 142.27 44.23 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.811 -0.811 . . . . 74.22 108.811 -177.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -150.08 120.52 7.4 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.72 0.408 . . . . 72.14 110.092 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.1 mt -77.96 126.83 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.368 -0.975 . . . . 72.53 108.368 171.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -98.27 -40.07 8.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.066 0.546 . . . . 73.13 109.838 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -173.09 134.96 0.57 Allowed 'General case' 0 C--N 1.353 0.745 0 O-C-N 123.554 0.534 . . . . 70.12 109.686 -173.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.2 mt -122.06 143.79 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 107.119 -1.437 . . . . 73.3 107.119 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -169.25 153.48 5.41 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.599 0.592 . . . . 75.54 112.599 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.665 HG21 HD11 ' B' ' 21' ' ' ILE . 30.6 m -82.05 118.58 23.13 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.03 -0.986 . . . . 54.41 109.778 176.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.437 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 44.4 mtpt -95.81 -18.01 20.72 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.437 0.695 . . . . 72.05 111.521 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 28.8 t70 -155.09 140.04 17.31 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.47 0.481 . . . . 72.2 110.916 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.665 HD11 HG21 ' B' ' 18' ' ' THR . 32.3 mm -129.25 144.38 38.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 N-CA-C 107.763 -1.199 . . . . 75.4 107.763 172.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.47 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 46.6 t -147.82 132.76 18.12 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.381 -1.282 . . . . 74.52 108.296 169.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.3 t80 -145.29 118.02 8.67 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 107.189 -1.411 . . . . 73.54 107.189 168.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -119.84 133.68 55.5 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.664 -0.865 . . . . 63.11 108.664 173.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.672 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -117.32 82.15 14.42 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 106.51 -1.663 . . . . 70.45 106.51 166.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.2 -24.96 27.06 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.885 2.39 . . . . 75.34 111.96 -171.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -114.41 9.67 16.87 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.908 0.883 . . . . 63.43 110.751 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.672 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -30.8 -64.99 0.2 Allowed Pre-proline 0 N--CA 1.494 1.736 0 C-N-CA 125.992 1.717 . . . . 70.24 114.812 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 14.6 Cg_exo -64.09 -36.72 46.46 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 122.398 2.065 . . . . 64.22 112.338 -166.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.454 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 77.5 m80 -95.98 -18.63 20.11 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.006 -0.997 . . . . 65.54 112.321 -173.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 3.6 p -83.17 -10.33 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 117.991 0.36 . . . . 50.34 110.654 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -76.06 -3.49 36.19 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 112.843 0.683 . . . . 75.33 112.843 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.8 pt20 -78.98 -5.01 52.79 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.8 0.44 . . . . 75.32 110.223 169.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -107.22 87.57 2.54 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.832 1.253 . . . . 64.23 110.395 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -93.37 87.57 5.66 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.135 -0.939 . . . . 71.23 110.318 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 18.6 p90 -162.97 -171.24 2.6 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.416 0.686 . . . . 72.54 110.04 172.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -79.1 111.82 23.09 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 124.367 1.067 . . . . 71.23 110.295 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.84 141.03 36.36 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 121.879 1.719 . . . . 75.21 111.522 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.64 108.07 2.76 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 109.626 -0.509 . . . . 64.43 109.626 176.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 88.0 t -99.21 149.29 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 115.045 -0.979 . . . . 72.02 110.554 -175.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -135.46 129.67 33.54 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.354 1.462 . . . . 71.45 107.541 172.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.44 HD13 HD22 ' B' ' 128' ' ' LEU . 20.5 tp -97.04 140.82 30.99 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.449 -0.945 . . . . 74.04 108.449 170.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.639 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 7.2 t70 -137.93 141.0 40.6 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.222 -1.399 . . . . 73.12 107.222 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 49.3 mt -137.61 126.71 24.39 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.42 -0.585 . . . . 73.43 109.42 -170.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -124.57 139.95 53.4 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.023 1.329 . . . . 72.11 108.753 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.12 105.61 11.17 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 109.084 -0.71 . . . . 63.13 109.084 -172.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.76 152.01 50.7 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.034 0.933 . . . . 40.11 109.208 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 29.5 p -149.72 -169.54 3.4 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.932 -0.48 . . . . 73.42 110.94 -175.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 50.9 p -155.23 136.16 13.7 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.884 0.874 . . . . 63.21 109.183 170.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -91.26 112.24 24.07 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.566 -1.272 . . . . 72.52 107.566 168.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 pp -131.17 17.23 5.02 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.119 0.567 . . . . 62.01 110.474 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.26 152.15 21.93 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.691 -0.686 . . . . 71.54 110.568 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -72.38 117.35 13.93 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.242 -0.89 . . . . 73.32 109.168 172.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 65.65 13.79 9.13 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.075 0.95 . . . . 64.53 112.979 172.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.5 t -137.3 123.52 27.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.794 -1.558 . . . . 73.43 106.794 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.583 ' HB2' HD11 ' B' ' 86' ' ' ILE . 16.2 t80 -124.4 140.34 53.04 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.473 -0.566 . . . . 74.52 109.473 -167.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -108.96 106.13 15.96 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 107.843 -1.169 . . . . 63.32 107.843 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 94.5 t -100.78 138.28 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.652 0.781 . . . . 73.23 109.703 -176.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 24.1 t -122.79 110.77 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.029 0.932 . . . . 73.32 109.255 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -95.19 112.29 24.02 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.997 -1.112 . . . . 74.13 107.997 174.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -85.18 118.79 24.95 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 108.487 -0.931 . . . . 74.53 108.487 174.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 23.0 t -105.63 131.87 53.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 107.848 -1.167 . . . . 65.51 107.848 171.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.639 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 19.9 m -121.18 139.13 53.78 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.924 -1.139 . . . . 74.21 107.924 173.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.821 HG11 HD21 ' B' ' 126' ' ' LEU . 80.8 t -130.12 130.91 66.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.242 0.544 . . . . 63.21 109.707 175.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.4 m -106.57 144.57 33.05 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.727 -1.124 . . . . 70.11 108.871 168.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.97 136.47 20.31 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.895 -1.15 . . . . 72.35 107.895 171.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 15.6 m -137.65 128.07 26.46 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.585 0.553 . . . . 71.23 111.436 -173.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.465 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 44.8 mt -94.56 105.2 17.15 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.569 -0.9 . . . . 62.51 108.569 176.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.62 -120.42 5.13 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.881 -0.599 . . . . 50.54 111.873 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.42 10.75 25.32 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.506 0.722 . . . . 74.0 110.972 -178.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -129.25 156.01 44.66 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.382 0.673 . . . . 73.44 109.734 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 32.3 m -65.18 136.25 56.44 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 123.544 0.528 . . . . 63.24 110.433 176.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.465 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -89.27 -60.72 1.87 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 107.397 -1.335 . . . . 71.32 107.397 172.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -155.39 163.51 39.98 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 114.169 -1.378 . . . . 73.1 110.891 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 93.1 mt -136.42 113.54 10.57 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.156 1.383 . . . . 71.3 107.696 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.541 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 39.2 t -121.73 117.26 26.18 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.758 -0.46 . . . . 73.31 109.758 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.47 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 37.9 tt0 -124.54 123.21 39.6 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.6 1.16 . . . . 52.13 108.993 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 96.8 t -128.84 130.42 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.583 0.753 . . . . 64.12 110.272 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.518 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 26.3 mt-30 -100.01 119.84 38.89 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.135 -1.061 . . . . 64.11 108.135 171.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.561 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 7.9 tp-100 -108.9 109.05 20.05 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.224 -1.028 . . . . 73.23 108.224 176.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.437 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -104.84 170.24 17.77 Favored Glycine 0 C--N 1.335 0.5 0 O-C-N 123.883 0.739 . . . . 53.44 112.115 177.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.22 144.63 7.64 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.201 -0.523 . . . . 63.21 113.321 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 3.2 mp -85.64 117.41 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 107.607 -1.257 . . . . 73.13 107.607 172.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -121.93 134.59 54.84 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.836 0.854 . . . . 73.12 109.152 176.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 49.1 m -88.87 113.51 24.49 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.473 -0.936 . . . . 74.23 108.473 174.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.583 HD11 ' HB2' ' B' ' 56' ' ' TYR . 1.0 OUTLIER -121.99 105.1 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.096 0.958 . . . . 65.5 108.536 -174.676 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.541 ' HA ' ' HB ' ' F' ' 97' ' ' ILE . . . -151.22 170.42 19.52 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.041 0.448 . . . . 63.44 110.338 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 97.83 -57.5 1.1 Allowed Glycine 0 C--N 1.339 0.725 0 N-CA-C 110.069 -1.212 . . . . 75.22 110.069 -170.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' B' ' 94' ' ' MET . 1.0 OUTLIER -67.18 156.53 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 124.019 0.928 . . . . 73.41 111.845 175.425 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -155.5 147.14 23.05 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.765 0.826 . . . . 74.14 109.368 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.95 -123.91 7.94 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 123.328 0.392 . . . . 72.24 113.323 174.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.0 m -84.08 -44.71 13.79 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.801 0.81 . . . . 63.11 110.217 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -64.96 -19.92 66.21 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 113.877 -1.511 . . . . 74.45 111.8 -169.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.527 ' HB2' HD13 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -74.73 -41.9 59.28 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.557 0.743 . . . . 74.54 111.422 -178.559 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.81 -15.19 59.26 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.448 0.699 . . . . 64.21 111.4 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -66.02 -37.81 86.82 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.725 0.81 . . . . 63.01 110.149 170.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 37.2 t -64.75 -62.87 1.31 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.435 0.636 . . . . 65.43 110.81 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.595 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.4 pp -70.09 -20.74 63.19 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 116.065 -0.516 . . . . 73.23 112.298 -176.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.15 -2.08 64.45 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-O 119.435 -0.647 . . . . 51.01 114.43 -177.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.526 ' HB1' ' HB2' ' B' ' 134' ' ' ASP . . . -148.88 -49.57 0.15 Allowed 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 117.714 0.757 . . . . 75.54 111.611 -175.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -71.81 -44.97 63.03 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.666 0.786 . . . . 63.43 111.087 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 80.7 m -66.01 -47.81 62.16 Favored Pre-proline 0 CA--C 1.562 1.404 0 CA-C-O 118.734 -0.65 . . . . 75.21 111.818 178.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 76.2 Cg_exo -51.01 -37.63 57.32 Favored 'Trans proline' 0 C--N 1.388 2.652 0 C-N-CA 122.796 2.33 . . . . 65.35 113.866 169.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.55 -32.28 73.69 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.58 0.752 . . . . 65.12 111.406 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.0 mt -74.53 -37.69 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.631 0.772 . . . . 64.23 110.403 176.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 80.4 mt -75.45 -29.65 59.73 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.808 0.843 . . . . 71.01 111.961 -176.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -57.64 -47.99 98.0 Favored Pre-proline 0 CA--C 1.561 1.385 0 CA-C-O 117.777 -1.106 . . . . 74.35 113.201 -174.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.429 ' HB3' ' HB2' ' D' ' 112' ' ' GLU . 68.4 Cg_exo -47.13 -45.87 20.56 Favored 'Trans proline' 0 C--N 1.387 2.599 0 C-N-CA 122.976 2.451 . . . . 74.21 114.664 174.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -72.36 -41.91 65.88 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.079 0.552 . . . . 73.42 111.032 -175.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.561 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -64.61 -40.68 95.93 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 122.599 0.36 . . . . 73.13 110.503 176.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 53.2 ttt-85 -60.16 -50.54 73.26 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.351 1.461 . . . . 72.33 110.734 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -68.38 -32.53 72.68 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.629 0.772 . . . . 73.41 109.98 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.572 ' SG ' HD11 ' B' ' 21' ' ' ILE . 5.6 t -69.96 -41.15 74.89 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.961 0.504 . . . . 53.12 110.577 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.541 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 73.6 mt -57.77 -53.77 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.391 1.077 . . . . 53.13 110.132 172.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.441 HG21 ' OG ' ' C' ' 119' ' ' SER . 17.7 m -60.78 -30.42 70.03 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.166 0.586 . . . . 63.3 111.138 -177.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.0 t -63.37 -50.48 69.74 Favored 'General case' 0 C--N 1.348 0.537 0 C-N-CA 123.041 0.536 . . . . 74.14 109.559 173.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.508 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.7 mmt -65.51 -32.66 74.38 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.439 0.696 . . . . 73.41 111.459 -176.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.411 HG23 ' O ' ' B' ' 114' ' ' ILE . 97.5 t -68.8 -42.69 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.733 0.813 . . . . 72.24 110.345 174.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.3 t -62.91 -35.1 78.95 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.326 -0.852 . . . . 44.24 110.838 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.614 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 77.0 mtt-85 -70.18 -38.53 75.4 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 114.679 -1.146 . . . . 74.2 110.096 177.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.39 -7.73 68.98 Favored Glycine 0 C--N 1.352 1.429 0 O-C-N 123.845 0.715 . . . . 71.24 112.839 173.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 16.8 m 66.94 24.92 9.51 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 125.118 1.367 . . . . 63.13 110.329 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -85.07 163.23 46.62 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 123.861 0.864 . . . . 71.42 111.145 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.21 166.76 1.5 Allowed 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 123.339 2.693 . . . . 73.32 114.524 175.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -65.05 114.64 4.74 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.329 1.051 . . . . 64.24 111.353 -172.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.821 HD21 HG11 ' B' ' 64' ' ' VAL . 26.4 tp -112.4 107.1 15.78 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.032 -0.729 . . . . 54.51 109.032 174.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -121.55 127.11 50.62 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.133 -1.062 . . . . 63.53 108.133 171.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.49 HD21 HG21 ' B' ' 64' ' ' VAL . 84.0 mt -77.56 138.58 39.25 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 123.427 0.454 . . . . 70.35 110.267 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.05 147.26 98.91 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.714 0.805 . . . . 50.12 111.066 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.27 81.01 0.29 Allowed 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.261 2.64 . . . . 61.03 111.678 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 4.1 p -96.51 112.24 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 115.259 -0.882 . . . . 54.15 109.545 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -78.85 114.65 17.96 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.302 -0.999 . . . . 73.3 108.302 172.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -56.88 -38.27 72.53 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.121 0.968 . . . . 63.33 110.775 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.526 ' HB2' ' HB1' ' B' ' 100' ' ' ALA . 27.7 t70 -65.92 -36.2 82.71 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 114.481 -1.236 . . . . 71.45 111.187 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.23 -37.76 86.64 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.986 0.514 . . . . 75.44 111.038 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.6 mp -69.58 -35.31 75.24 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.615 0.766 . . . . 61.52 110.047 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -69.03 -34.08 74.65 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.962 -0.563 . . . . 75.11 110.643 173.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 138' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' B' ' 134' ' ' ASP . 91.5 mtp -72.92 -20.32 61.09 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.265 1.026 . . . . 72.13 111.472 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.4 ' HB3' HG21 ' B' ' 149' ' ' THR . 4.3 m-20 -72.47 -39.82 67.42 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.592 -0.522 . . . . 72.31 109.592 176.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -77.8 -35.49 51.35 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 120.949 0.404 . . . . 74.32 110.07 175.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 28.9 tp -76.75 -7.31 55.15 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.547 0.739 . . . . 55.22 110.88 -175.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 69.22 -71.19 0.12 Allowed 'General case' 0 C--N 1.363 1.167 0 C-N-CA 125.743 1.617 . . . . 71.14 110.039 -176.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 70.54 -66.19 0.3 Allowed 'General case' 0 C--N 1.361 1.067 0 C-N-CA 125.907 1.683 . . . . 65.11 111.178 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -68.69 150.71 47.61 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.489 0.715 . . . . 74.23 110.238 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.62 98.6 0.05 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.05 0.94 . . . . 72.12 109.606 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 140.43 -134.93 6.74 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 110.286 -1.126 . . . . 31.53 110.286 -173.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -171.3 -63.41 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.681 0.792 . . . . 63.02 109.3 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 82.49 -62.44 4.59 Favored Glycine 0 C--N 1.35 1.33 0 CA-C-N 115.698 -0.683 . . . . 42.11 112.964 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 149' ' ' THR . . . . . 0.4 HG21 ' HB3' ' B' ' 139' ' ' ASN . 65.8 p -74.05 134.94 43.01 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.893 0.877 . . . . 55.33 110.871 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.2 146.27 28.62 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.053 -1.091 . . . . 71.33 108.053 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 60.79 20.67 10.78 Favored 'General case' 0 CA--C 1.575 1.905 0 C-N-CA 124.203 1.001 . . . . 73.54 111.85 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -148.34 53.95 1.02 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.246 1.418 . . . . 73.52 107.356 174.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -73.3 -76.51 0.12 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.184 -1.371 . . . . 74.23 110.352 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 154' ' ' ASP . . . . . 0.472 ' HA ' ' HB2' ' F' ' 110' ' ' ALA . 4.4 p30 -148.29 170.48 17.81 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.424 0.69 . . . . 75.01 110.303 -173.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.3 0 C-N-CA 124.038 0.935 . . . . 65.24 109.522 -179.445 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 87.7 mmm . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 110.07 -0.345 . . . . 61.32 110.07 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 73.0 p -76.87 90.48 3.5 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.556 0.693 . . . . 63.45 109.677 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -89.96 113.0 24.58 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.868 -1.06 . . . . 51.12 111.775 -172.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -136.09 155.61 49.94 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.715 1.206 . . . . 74.51 108.267 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 5' ' ' ASN . . . . . 0.569 ' HB3' ' HG2' ' C' ' 8' ' ' GLU . 33.8 t-20 -89.19 -81.23 0.28 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.594 -0.891 . . . . 72.04 108.594 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 154.32 -52.03 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 127.328 2.251 . . . . 65.14 106.864 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 80.9 p -124.54 56.34 1.29 Allowed 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.292 -0.867 . . . . 71.32 110.767 -175.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.634 ' HG3' ' H ' ' C' ' 155' ' ' ALA . 7.7 mm-40 -64.48 -33.67 76.43 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.109 0.481 . . . . 72.1 110.978 173.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.435 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 16.6 ttt 65.34 113.7 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.165 1.786 . . . . 71.12 111.601 -174.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 99.3 m -123.43 106.75 10.9 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 124.158 0.983 . . . . 74.32 108.594 176.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -105.48 128.59 53.64 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.396 -0.964 . . . . 70.23 108.396 174.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -141.71 122.51 14.39 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.015 0.526 . . . . 73.41 109.675 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.411 ' HA ' ' HD2' ' C' ' 84' ' ' PHE . 55.5 mt -71.88 120.49 20.28 Favored 'Isoleucine or valine' 0 C--N 1.35 0.624 0 N-CA-C 108.586 -0.894 . . . . 64.44 108.586 171.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -84.72 -45.28 12.58 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.545 -0.909 . . . . 73.22 108.545 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 178.15 165.71 0.74 Allowed 'General case' 0 C--N 1.353 0.724 0 CA-C-N 114.34 -1.3 . . . . 75.35 109.848 -176.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.496 ' HA ' ' HA2' ' C' ' 82' ' ' GLY . 2.8 pp -130.53 150.13 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 106.476 -1.676 . . . . 74.23 106.476 168.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.452 ' HB3' HG23 ' D' ' 122' ' ' THR . 19.2 p90 -178.35 141.38 0.23 Allowed 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 118.852 0.751 . . . . 72.24 110.777 -176.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 18' ' ' THR . . . . . 0.406 HG21 ' SG ' ' C' ' 113' ' ' CYS . 69.6 p -72.44 119.83 17.2 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.976 0.91 . . . . 64.12 110.116 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -73.16 -44.07 60.56 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.211 -1.033 . . . . 73.44 108.211 169.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 26.9 t70 -134.49 141.89 46.88 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 113.577 -1.647 . . . . 62.55 109.772 -169.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.567 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.6 mt -144.77 143.8 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 106.92 -1.511 . . . . 73.25 106.92 176.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.3 t -156.38 150.92 25.69 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.161 0.505 . . . . 64.11 110.306 176.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -152.83 123.43 7.28 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 107.065 -1.458 . . . . 72.31 107.065 172.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.0 113.46 14.0 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.245 0.618 . . . . 72.14 109.765 -174.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.11 82.7 67.95 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 107.666 -1.235 . . . . 40.21 107.666 167.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.2 -24.82 31.81 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.783 2.322 . . . . 54.52 112.04 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -106.9 26.03 10.58 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.132 1.373 . . . . 54.54 110.315 178.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.66 -52.25 18.71 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 113.915 1.08 . . . . 60.14 113.915 -174.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.97 -42.64 29.25 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 121.75 1.633 . . . . 74.05 112.251 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -68.32 -33.89 75.13 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.611 -1.177 . . . . 75.23 111.897 -175.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.716 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.1 p -80.23 -25.27 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 N-CA-C 112.757 0.651 . . . . 73.11 112.757 177.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -69.48 -28.98 66.54 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.55 -0.719 . . . . 70.22 112.184 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -89.4 35.04 0.81 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.378 0.671 . . . . 65.4 110.346 176.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.69 165.34 18.76 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.77 0.828 . . . . 70.12 110.856 -174.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -78.39 124.19 27.84 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 115.459 -0.791 . . . . 74.1 109.709 169.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -85.38 96.06 9.44 Favored 'General case' 0 C--O 1.242 0.674 0 O-C-N 123.514 0.509 . . . . 72.2 110.18 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -150.38 76.77 8.34 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 107.106 -1.442 . . . . 74.22 107.106 169.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -90.95 164.95 3.89 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.733 2.289 . . . . 65.11 113.025 -175.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -88.6 82.51 6.88 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.147 -1.427 . . . . 72.54 107.147 170.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 56.5 t -73.93 114.96 14.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 114.809 -1.087 . . . . 53.54 109.344 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -135.53 125.24 25.37 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.274 -0.875 . . . . 75.43 109.427 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.424 HD23 HD22 ' C' ' 128' ' ' LEU . 3.8 pp -89.3 159.59 17.31 Favored 'General case' 0 C--O 1.246 0.913 0 N-CA-C 108.71 -0.848 . . . . 73.45 108.71 165.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.525 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 17.5 t70 -134.33 134.21 41.55 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.636 -1.246 . . . . 75.22 107.636 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.439 HD11 HG21 ' C' ' 131' ' ' VAL . 78.6 mt -123.54 110.98 15.72 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.602 0.715 . . . . 74.33 110.341 -176.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -120.76 129.73 53.73 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 106.543 -1.651 . . . . 71.32 106.543 173.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.8 t -129.95 150.67 51.13 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.624 -0.509 . . . . 72.21 109.624 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.24 149.78 29.81 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.342 0.657 . . . . 54.14 110.274 -177.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 32.9 p -125.59 150.3 47.63 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.697 0.799 . . . . 72.33 109.744 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 36.1 t -145.44 126.6 14.72 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.84 -1.17 . . . . 72.34 107.84 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -81.89 117.32 22.05 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.94 -0.763 . . . . 65.34 108.94 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.497 HD11 ' HB2' ' C' ' 57' ' ' GLU . 51.0 mt -86.23 -43.15 13.2 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.862 0.865 . . . . 73.01 110.081 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.47 -177.31 5.7 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 114.501 -1.227 . . . . 74.54 108.777 176.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -66.76 116.94 8.2 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.242 -0.651 . . . . 62.23 109.242 -177.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 68.62 21.84 7.8 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.824 1.25 . . . . 74.2 112.887 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.3 t -126.81 110.76 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 108.873 -0.788 . . . . 75.23 108.873 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -117.99 125.37 50.26 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.853 0.861 . . . . 73.01 110.583 -174.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.497 ' HB2' HD11 ' C' ' 51' ' ' LEU . 28.4 tt0 -83.11 109.99 17.63 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.238 1.015 . . . . 74.04 108.543 168.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 77.5 t -99.18 139.04 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.341 -0.985 . . . . 61.54 108.341 169.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.0 t -134.1 132.83 56.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 108.779 -0.822 . . . . 74.32 108.779 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -112.63 105.06 13.15 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.628 -1.249 . . . . 73.42 107.628 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 30.4 ttm-85 -81.13 111.23 17.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.766 0.826 . . . . 62.12 109.216 171.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 24.6 t -111.28 113.54 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 108.12 -1.067 . . . . 72.11 108.12 173.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 22.0 m -116.21 123.25 47.3 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.925 0.89 . . . . 73.53 109.603 -174.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.529 HG23 HD13 ' C' ' 114' ' ' ILE . 71.6 t -100.99 120.12 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 122.965 0.506 . . . . 61.53 109.786 177.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 3.8 m -107.29 110.03 21.95 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.174 -1.047 . . . . 72.41 108.174 172.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.37 115.86 28.76 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.337 -0.986 . . . . 70.12 108.337 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -138.38 127.51 24.22 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.008 0.523 . . . . 72.42 110.097 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 16.9 mt -83.07 32.52 0.44 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.586 1.554 . . . . 64.01 111.276 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.68 -109.22 2.79 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 110.454 -1.058 . . . . 61.1 110.454 -171.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -89.94 -19.74 24.16 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.611 0.764 . . . . 73.2 110.366 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -87.43 121.12 29.45 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.51 1.124 . . . . 53.4 108.765 174.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 88.7 m -75.48 131.3 40.03 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.856 -0.794 . . . . 74.23 108.856 168.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.716 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.43 -61.1 2.02 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.05 -0.722 . . . . 74.41 109.05 171.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -162.57 155.14 19.27 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.365 -0.834 . . . . 74.54 109.918 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -114.38 135.81 53.68 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.979 -1.489 . . . . 62.04 106.979 167.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 49.8 t -142.13 148.03 37.65 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.321 -0.992 . . . . 62.41 108.321 -175.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -154.99 131.11 10.24 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.166 0.586 . . . . 74.2 109.703 177.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 68.8 t -125.23 132.03 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 108.273 -1.01 . . . . 73.53 108.273 167.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -107.83 90.81 3.41 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.96 -1.126 . . . . 53.23 107.96 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -78.4 108.6 11.87 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 114.876 -1.056 . . . . 74.44 109.072 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.71 171.87 54.14 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 111.778 -0.529 . . . . 70.01 111.778 173.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' C' ' 16' ' ' ILE . . . 179.18 116.28 0.5 Allowed Glycine 0 CA--C 1.508 -0.403 0 N-CA-C 110.055 -1.218 . . . . 72.23 110.055 -178.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.423 HG12 ' HA ' ' C' ' 57' ' ' GLU . 66.9 mt -105.93 136.29 40.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 123.607 0.763 . . . . 62.24 109.234 -173.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.411 ' HD2' ' HA ' ' C' ' 13' ' ' ILE . 64.3 m-85 -137.34 126.58 24.66 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.426 1.09 . . . . 63.22 109.274 -171.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 70.8 m -78.52 101.25 7.27 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.362 -0.977 . . . . 72.21 108.362 168.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.474 HD13 ' SG ' ' C' ' 97' ' ' CYS . 21.2 mt -116.21 126.84 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.183 -0.673 . . . . 73.4 109.183 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -135.92 168.33 19.54 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 122.937 0.495 . . . . 75.01 110.649 -177.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.84 -49.96 3.67 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.868 0.73 . . . . 71.33 112.479 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.44 HD11 HG21 ' C' ' 86' ' ' ILE . 26.5 pt -82.19 161.19 3.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 123.296 0.639 . . . . 54.24 111.671 -175.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -156.63 156.13 32.98 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.477 -0.783 . . . . 74.12 110.113 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.5 -113.6 5.99 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 124.069 0.856 . . . . 50.11 113.744 171.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 9.6 t -64.85 -36.18 83.51 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.828 0.851 . . . . 65.01 111.65 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -68.3 -44.06 76.28 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.585 0.754 . . . . 72.31 109.722 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.465 ' HE1' HG21 ' C' ' 86' ' ' ILE . 5.9 tpt -64.42 -47.26 79.82 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.777 -1.101 . . . . 62.2 110.372 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.84 -39.51 81.48 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.029 0.932 . . . . 71.32 111.034 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -65.35 -32.39 74.01 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.244 -0.889 . . . . 63.35 111.602 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.474 ' SG ' HD13 ' C' ' 86' ' ' ILE . 22.1 t -75.49 -45.32 39.08 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 109.644 -0.502 . . . . 52.02 109.644 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 61.4 mt -74.21 -32.7 63.14 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.21 1.004 . . . . 63.24 112.786 -172.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.71 11.77 30.06 Favored Glycine 0 N--CA 1.473 1.104 0 CA-C-O 119.646 -0.53 . . . . 62.54 114.361 -170.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.26 -56.91 0.12 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 117.677 0.739 . . . . 73.41 111.967 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -70.61 -48.33 55.64 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.037 0.535 . . . . 72.3 111.426 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.415 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 70.7 m -69.77 -47.4 24.15 Favored Pre-proline 0 CA--C 1.563 1.472 0 C-N-CA 123.958 0.903 . . . . 63.51 111.92 -176.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.464 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 77.8 Cg_exo -56.67 -26.29 64.54 Favored 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.407 2.072 . . . . 74.25 113.924 172.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -66.99 -37.96 85.15 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.981 0.513 . . . . 74.44 110.606 175.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.423 HD12 ' NH1' ' A' ' 111' ' ' ARG . 44.5 mm -73.85 -35.81 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.189 0.596 . . . . 71.15 109.928 177.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.23 -28.6 47.93 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.132 0.973 . . . . 74.45 112.744 -176.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -57.29 -51.39 82.07 Favored Pre-proline 0 N--CA 1.486 1.331 0 N-CA-C 113.951 1.093 . . . . 73.33 113.951 -172.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -58.51 -36.75 97.01 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 121.722 1.614 . . . . 74.33 113.239 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -67.97 -46.58 70.98 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.265 0.626 . . . . 73.33 110.918 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.66 -36.86 79.75 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.233 1.013 . . . . 61.45 110.78 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 111' ' ' ARG . . . . . 0.502 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 38.9 ttt-85 -62.61 -55.52 26.34 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.294 1.438 . . . . 62.54 110.408 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -64.69 -35.77 82.12 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 123.853 0.72 . . . . 71.42 110.203 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.406 ' SG ' HG21 ' C' ' 18' ' ' THR . 14.0 t -66.22 -33.79 76.54 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.055 0.542 . . . . 73.5 111.313 -177.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.529 HD13 HG23 ' C' ' 64' ' ' VAL . 96.0 mt -72.07 -52.21 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 122.833 0.453 . . . . 63.43 109.806 172.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -61.65 -28.97 69.76 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.141 0.576 . . . . 72.15 111.634 -173.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 25.9 t -66.13 -47.08 75.28 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.782 0.833 . . . . 54.13 108.967 173.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.623 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.3 -40.99 92.51 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.473 1.109 . . . . 74.43 111.757 176.779 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.436 HG23 ' O ' ' C' ' 114' ' ' ILE . 64.1 t -61.18 -44.6 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.655 0.782 . . . . 64.33 109.33 176.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.441 ' OG ' HG21 ' B' ' 115' ' ' THR . 30.1 t -66.69 -34.59 78.19 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 114.989 -1.005 . . . . 73.54 112.037 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.423 ' NH1' ' HA ' ' D' ' 113' ' ' CYS . 68.3 mtt-85 -69.81 -39.4 76.54 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.329 0.652 . . . . 70.05 109.585 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.28 6.48 71.89 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 123.853 0.721 . . . . 75.22 112.696 173.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.9 p 58.42 31.79 21.35 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.394 1.878 . . . . 63.03 113.204 171.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -87.2 150.64 49.93 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 108.678 -0.86 . . . . 73.51 108.678 168.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -44.41 147.05 1.73 Allowed 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 124.575 3.517 . . . . 73.24 115.73 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -51.83 117.18 2.54 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.356 1.062 . . . . 74.1 112.008 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 52.6 tp -107.71 90.57 3.34 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.607 0.718 . . . . 74.21 109.401 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -96.91 95.35 7.78 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.403 -0.817 . . . . 62.53 109.254 -175.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.502 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 90.6 mt -62.32 146.91 49.83 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.524 0.73 . . . . 64.4 112.096 -174.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.56 147.93 64.65 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 123.819 0.848 . . . . 63.35 110.791 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.555 ' HG3' HD12 ' A' ' 16' ' ' ILE . 43.9 Cg_exo -57.63 116.1 2.99 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 123.218 2.612 . . . . 63.34 112.279 175.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.439 HG21 HD11 ' C' ' 44' ' ' LEU . 60.5 t -100.02 132.93 44.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 110.243 -0.28 . . . . 73.42 110.243 176.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -94.99 92.32 6.81 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.888 0.875 . . . . 62.43 108.953 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -66.65 -26.99 67.32 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.503 0.721 . . . . 74.01 111.851 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -66.03 -41.21 91.21 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.552 0.741 . . . . 74.34 110.18 178.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.37 -42.3 96.27 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.774 0.829 . . . . 71.32 110.746 176.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 79.5 mt -66.1 -36.02 82.07 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.443 -0.799 . . . . 53.54 111.08 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -70.98 -33.7 70.68 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.754 0.822 . . . . 73.52 110.135 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 35.5 ttm -66.5 -39.56 88.75 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.445 1.098 . . . . 63.12 110.077 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -71.56 -36.98 71.11 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.358 -0.837 . . . . 72.21 110.827 171.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -72.17 -153.02 0.02 OUTLIER 'General case' 0 CA--C 1.57 1.716 0 C-N-CA 123.637 0.775 . . . . 71.43 109.767 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.428 HD22 ' H ' ' C' ' 142' ' ' GLN . 0.5 OUTLIER 57.25 -144.22 0.65 Allowed 'General case' 0 CA--C 1.566 1.593 0 C-N-CA 124.221 1.008 . . . . 61.23 109.137 -175.748 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.428 ' H ' HD22 ' C' ' 141' ' ' LEU . 63.6 tt0 -168.15 -64.37 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 107.196 -1.409 . . . . 64.41 107.196 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -88.31 111.04 21.25 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 115.845 -0.616 . . . . 72.2 109.739 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -71.81 97.27 1.77 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.418 -0.81 . . . . 74.04 108.962 172.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -132.79 128.06 35.95 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.747 -1.205 . . . . 73.41 107.747 176.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -150.29 120.14 1.1 Allowed Glycine 0 C--N 1.334 0.433 0 N-CA-C 110.918 -0.873 . . . . 73.44 110.918 -175.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -157.48 -171.01 3.42 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.98 0.912 . . . . 61.44 109.07 -175.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 91.6 155.54 31.85 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 112.063 -0.415 . . . . 63.15 112.063 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 9.9 t -113.21 163.6 14.58 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.97 0.508 . . . . 64.22 111.242 -175.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -153.87 79.87 1.14 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.375 -1.343 . . . . 74.23 107.375 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -134.87 -9.31 2.37 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.639 -0.71 . . . . 74.42 112.226 -172.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -161.72 156.77 23.39 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.168 -0.678 . . . . 53.34 109.168 -172.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 153' ' ' GLN . . . . . 0.492 ' HB3' HD21 ' E' ' 142' ' ' LEU . 78.3 mt-30 -112.81 110.45 20.57 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.67 0.788 . . . . 62.54 110.15 -178.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -155.6 -84.36 0.06 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.964 0.505 . . . . 73.31 109.874 174.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 155' ' ' ALA . . . . . 0.634 ' H ' ' HG3' ' C' ' 8' ' ' GLU . . . . . . . . 0 C--O 1.252 1.232 0 C-N-CA 124.447 1.099 . . . . 55.0 108.546 -177.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 109.993 -0.373 . . . . 72.51 109.993 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 40.8 t 70.82 154.22 0.13 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.842 1.257 . . . . 63.54 109.976 -168.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 67.5 128.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.728 1.211 . . . . 73.34 112.402 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -90.6 151.25 21.39 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.391 1.077 . . . . 63.23 108.316 175.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -63.64 -28.65 70.06 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 122.84 0.456 . . . . 71.52 110.88 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 55.2 28.57 11.3 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 124.357 1.063 . . . . 74.41 112.179 174.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.0 t -63.96 164.97 9.51 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.852 0.861 . . . . 72.34 110.931 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.44 154.14 39.33 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 109.472 -0.566 . . . . 71.05 109.472 169.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.623 ' HG2' HG13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -32.87 124.5 0.36 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.973 1.309 . . . . 60.31 112.38 179.457 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 10.2 t -148.25 158.23 43.96 Favored 'General case' 0 C--O 1.247 0.951 0 C-N-CA 123.681 0.792 . . . . 64.43 109.223 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -156.35 120.11 4.36 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.097 -1.075 . . . . 62.42 108.097 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -132.81 116.59 16.72 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.486 0.714 . . . . 72.4 109.376 -177.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 63.8 mt -78.92 129.06 38.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 115.288 -0.869 . . . . 74.42 108.932 176.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -99.2 -44.57 6.21 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.716 0.406 . . . . 73.32 110.98 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -167.84 147.41 4.89 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.265 0.226 . . . . 64.44 111.181 -174.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.0 mp -125.56 140.48 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 106.031 -1.84 . . . . 74.11 106.031 172.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -164.28 146.97 9.09 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 124.038 0.836 . . . . 75.42 110.614 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.1 p -85.01 112.87 20.99 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.396 -0.82 . . . . 63.11 109.622 176.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -83.76 -18.92 36.16 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.394 0.678 . . . . 73.33 109.661 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.674 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 30.6 t70 -159.8 131.73 6.27 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.976 0.91 . . . . 73.12 109.694 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.623 HG21 ' HE2' ' C' ' 117' ' ' MET . 77.3 mt -134.94 142.43 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 107.375 -1.342 . . . . 70.42 107.375 171.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 22' ' ' SER . . . . . 0.427 ' HB3' ' HB2' ' D' ' 77' ' ' GLU . 33.8 t -142.67 143.88 32.51 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.794 1.237 . . . . 62.03 107.961 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.567 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.9 t80 -152.69 117.91 5.22 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.279 -1.378 . . . . 71.04 107.279 172.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -130.28 113.1 13.98 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.717 0.807 . . . . 74.31 109.112 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.611 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -105.3 90.55 3.96 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 107.912 -1.144 . . . . 45.51 107.912 172.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.8 -30.47 9.36 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.977 2.452 . . . . 70.12 112.733 -172.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -109.57 7.64 24.7 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.593 0.757 . . . . 44.23 111.439 -171.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.611 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -44.45 -60.58 2.78 Favored Pre-proline 0 CA--C 1.558 1.25 0 N-CA-C 115.298 1.592 . . . . 64.22 115.298 -158.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.82 -34.54 23.88 Favored 'Trans proline' 0 C--N 1.377 2.035 0 CA-C-N 122.474 1.919 . . . . 64.01 113.873 -172.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -86.19 -21.34 27.55 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 116.637 -0.256 . . . . 74.51 110.497 -175.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.443 HG12 ' O ' ' D' ' 28' ' ' ALA . 1.8 p -83.1 -21.1 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.068 0.547 . . . . 53.11 110.307 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -57.88 -23.6 53.85 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.601 0.76 . . . . 72.1 112.864 174.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -59.31 -27.38 65.82 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.839 0.856 . . . . 70.54 111.167 176.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -83.92 90.79 7.45 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.697 1.199 . . . . 62.14 109.749 177.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -83.45 92.7 7.63 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.935 -1.03 . . . . 64.34 111.46 -175.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 44.6 p90 -167.8 172.68 8.93 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.247 1.019 . . . . 72.41 109.234 166.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -64.19 114.83 15.37 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 108.518 -0.919 . . . . 71.12 108.518 173.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.415 ' O ' HG23 ' D' ' 40' ' ' VAL . 53.3 Cg_exo -54.25 119.35 6.2 Favored 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 122.762 2.308 . . . . 74.52 110.457 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.47 111.05 3.38 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.991 -0.744 . . . . 64.25 108.991 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.655 HG13 HG13 ' D' ' 64' ' ' VAL . 88.3 t -99.07 140.86 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 113.983 -1.462 . . . . 73.31 108.6 -175.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -124.6 122.95 38.99 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.012 -1.477 . . . . 73.22 107.012 171.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 64.3 tp -97.17 138.54 34.52 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.757 0.823 . . . . 75.53 109.863 -170.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.762 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 9.0 m-20 -125.64 114.01 18.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.728 -1.124 . . . . 53.41 108.033 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 90.5 mt -109.23 135.27 50.6 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.091 -0.707 . . . . 54.42 109.091 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -146.04 154.03 41.41 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.388 1.075 . . . . 73.02 108.477 -177.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 8.8 t -117.96 150.84 38.57 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.294 0.569 . . . . 74.15 110.274 -177.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.07 170.35 19.61 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.415 1.486 . . . . 74.13 107.777 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 72.1 p -171.13 -171.33 0.95 Allowed 'General case' 0 C--O 1.243 0.724 0 CA-C-O 121.174 0.512 . . . . 65.3 110.925 -177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 36.4 m -147.42 119.62 8.32 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 106.239 -1.763 . . . . 50.53 106.239 172.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -83.62 130.47 34.98 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.108 0.563 . . . . 72.12 111.479 -169.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -159.1 99.25 1.5 Allowed 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.257 -1.757 . . . . 64.35 106.257 170.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.458 ' HB1' ' HB2' ' E' ' 98' ' ' ASP . . . -73.61 83.05 1.54 Allowed 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 121.751 0.786 . . . . 61.4 112.128 -171.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -145.49 19.32 1.52 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.936 1.294 . . . . 73.44 108.2 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' D' ' 85' ' ' SER . 1.0 OUTLIER 71.17 5.63 5.53 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 125.24 1.416 . . . . 71.34 113.112 -176.737 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 16.4 m -122.44 112.22 33.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 107.933 -1.136 . . . . 72.35 107.933 175.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.578 ' HB2' HD11 ' D' ' 98' ' ' LEU . 9.8 m-85 -134.88 133.12 39.33 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 106.746 -1.575 . . . . 71.1 106.746 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.471 ' HB3' HG13 ' D' ' 83' ' ' ILE . 7.4 pt-20 -86.92 122.67 31.1 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.708 -0.849 . . . . 71.43 108.708 173.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 78.3 t -101.06 141.44 17.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.421 -1.263 . . . . 54.54 108.272 177.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.574 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 36.3 t -128.18 123.97 61.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 108.181 -1.044 . . . . 54.21 108.181 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.514 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -95.09 109.11 21.21 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 106.828 -1.545 . . . . 75.34 106.828 177.763 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.49 95.3 10.21 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.388 -1.708 . . . . 73.13 106.388 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.48 HG21 ' CB ' ' D' ' 110' ' ' ALA . 44.9 t -97.69 145.13 9.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 115.406 -0.816 . . . . 74.01 109.057 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.762 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 52.7 m -141.21 143.12 34.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.939 -1.028 . . . . 74.12 108.683 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.655 HG13 HG13 ' D' ' 40' ' ' VAL . 12.3 t -133.6 115.69 22.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 123.796 0.838 . . . . 70.45 108.784 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 17.2 m -106.68 94.77 5.3 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.796 -0.816 . . . . 63.34 108.796 171.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.625 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -99.07 145.85 26.69 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 109.595 -0.52 . . . . 54.3 109.595 176.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 22.7 p -153.4 137.63 16.54 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.737 -0.665 . . . . 63.52 111.257 -171.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.428 ' HB2' HG22 ' D' ' 31' ' ' VAL . 22.1 mt -107.54 116.4 31.87 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.898 1.279 . . . . 71.45 108.225 173.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.26 -133.54 18.33 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-N 116.161 -0.472 . . . . 42.01 112.081 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -94.57 3.57 54.94 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.148 0.579 . . . . 64.22 111.551 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -124.39 167.43 14.39 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.729 0.412 . . . . 64.43 110.249 -176.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 12.0 m -68.1 144.91 54.85 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 124.137 0.898 . . . . 74.45 111.731 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.54 -59.91 1.63 Allowed 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.308 -1.367 . . . . 60.22 107.308 168.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 74' ' ' PHE . . . . . 0.426 ' CE1' HG22 ' D' ' 118' ' ' VAL . 54.1 p90 -157.97 158.95 35.91 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.476 -1.238 . . . . 74.23 110.306 178.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 51.2 mt -124.73 145.39 49.72 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 107.137 -1.431 . . . . 74.53 107.137 176.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.447 ' SG ' HG12 ' D' ' 114' ' ' ILE . 45.6 t -156.49 109.45 2.61 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 117.884 0.311 . . . . 55.21 110.738 -171.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 77' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' D' ' 22' ' ' SER . 12.1 mp0 -124.5 127.69 47.84 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.079 0.952 . . . . 74.35 109.384 -173.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 87.1 t -135.47 115.17 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.125 0.57 . . . . 73.45 109.887 -178.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.674 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.9 mt-30 -88.68 84.75 6.72 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.428 -0.953 . . . . 70.33 108.428 170.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 80' ' ' GLN . . . . . 0.403 ' O ' HD13 ' D' ' 106' ' ' LEU . 6.7 tp-100 -83.1 96.92 8.53 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 113.736 -1.574 . . . . 71.41 109.604 -176.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -100.02 170.53 22.8 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.538 -0.301 . . . . 74.52 113.678 -175.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.78 148.5 8.36 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-O 119.243 -0.754 . . . . 71.14 112.675 177.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.471 HG13 ' HB3' ' D' ' 57' ' ' GLU . 3.4 mp -89.32 126.3 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.099 -1.075 . . . . 71.03 108.099 176.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -123.37 149.77 44.54 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.97 0.908 . . . . 73.11 110.239 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' D' ' 54' ' ' ASP . 31.2 t -115.44 111.71 21.19 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.884 0.874 . . . . 64.43 109.073 176.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.407 HD13 ' HB2' ' D' ' 98' ' ' LEU . 46.0 pt -114.88 140.07 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.966 0.906 . . . . 72.25 108.985 177.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.588 ' HA ' HG12 ' E' ' 97' ' ' ILE . . . -162.16 161.92 28.21 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.062 0.458 . . . . 51.4 111.917 177.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.93 8.89 81.78 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.065 -0.971 . . . . 73.44 115.099 167.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.623 HG13 ' HG2' ' D' ' 9' ' ' MET . 0.5 OUTLIER -98.77 171.69 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 N-CA-C 107.986 -1.116 . . . . 73.33 107.986 174.773 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.428 ' H ' HG22 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -138.96 175.3 9.67 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.87 -0.519 . . . . 64.42 110.85 -177.57 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.8 -133.12 29.41 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 114.876 -1.057 . . . . 34.0 112.805 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -92.08 -29.99 16.25 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.639 0.776 . . . . 44.21 111.057 175.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -68.8 -15.5 63.52 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.234 0.613 . . . . 73.33 112.359 -173.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.506 ' HA ' ' HB ' ' D' ' 89' ' ' ILE . 0.0 OUTLIER -59.21 -37.74 78.2 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.708 0.633 . . . . 70.42 112.708 173.538 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 95' ' ' ALA . . . . . 0.516 ' HB1' HD23 ' E' ' 102' ' ' LEU . . . -83.73 -16.97 42.88 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.399 0.68 . . . . 62.23 111.481 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -66.62 -38.2 86.44 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.935 0.894 . . . . 74.33 111.154 -178.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 63.8 m -59.91 -30.47 69.06 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.623 0.769 . . . . 74.12 111.96 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.615 HD23 HD21 ' E' ' 102' ' ' LEU . 14.5 tp -79.53 -42.58 24.82 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.047 -0.979 . . . . 61.15 110.45 -177.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.08 -18.52 69.36 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 115.739 -0.664 . . . . 72.52 113.794 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.16 -63.08 1.37 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.06 0.544 . . . . 63.54 112.289 -170.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -70.59 -31.88 69.04 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 112.236 0.458 . . . . 75.33 112.236 -174.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.454 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 87.4 m -68.32 -49.5 32.4 Favored Pre-proline 0 CA--C 1.568 1.669 0 CA-C-O 118.531 -0.747 . . . . 53.0 112.114 177.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.514 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 51.7 Cg_exo -60.46 -27.36 84.71 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 122.273 1.982 . . . . 63.35 113.373 169.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -64.76 -36.07 83.13 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.325 0.65 . . . . 41.33 110.532 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 31.1 mm -66.5 -43.14 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.724 0.81 . . . . 61.21 110.371 172.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.403 HD13 ' O ' ' D' ' 80' ' ' GLN . 75.0 mt -75.52 -12.37 60.21 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.8 0.84 . . . . 75.34 112.979 -173.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -75.47 -45.9 4.36 Favored Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 113.559 0.948 . . . . 75.15 113.559 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.53 -33.57 78.83 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 121.871 1.714 . . . . 71.34 112.578 169.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -76.65 -32.06 57.74 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.468 0.707 . . . . 75.53 111.793 176.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 110' ' ' ALA . . . . . 0.48 ' CB ' HG21 ' D' ' 62' ' ' VAL . . . -64.2 -45.96 85.98 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.836 -0.431 . . . . 70.2 109.836 177.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' D' ' 111' ' ' ARG . 9.6 ptt-85 -76.61 -29.11 56.39 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 123.313 0.383 . . . . 73.32 110.697 178.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 112' ' ' GLU . . . . . 0.429 ' HB2' ' HB3' ' B' ' 108' ' ' PRO . 23.0 tt0 -51.13 -43.34 61.16 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.851 0.834 . . . . 74.33 109.878 172.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.423 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 18.8 t -72.8 -60.93 1.99 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.071 -1.422 . . . . 63.11 109.927 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.688 ' HA ' ' HE1' ' D' ' 117' ' ' MET . 80.4 mt -53.5 -56.7 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 124.77 1.228 . . . . 74.44 112.873 -174.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 28.7 m -48.72 -38.35 21.26 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.873 0.869 . . . . 74.43 111.545 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 12.7 t -69.02 -47.59 65.06 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.741 -1.118 . . . . 70.44 110.25 -178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.688 ' HE1' ' HA ' ' D' ' 114' ' ' ILE . 4.0 mpp? -63.14 -32.59 74.01 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 117.973 0.351 . . . . 63.53 111.65 178.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.484 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.2 t -62.24 -49.47 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 123.397 0.679 . . . . 73.45 109.927 176.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.7 p -71.92 -29.07 63.92 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.776 -0.647 . . . . 73.12 110.768 -177.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.4 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 86.4 mtt-85 -71.36 -30.41 66.13 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.746 0.818 . . . . 73.42 110.367 175.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.61 8.41 75.31 Favored Glycine 0 C--N 1.355 1.591 0 CA-C-O 119.367 -0.685 . . . . 52.23 112.82 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.452 HG23 ' HB3' ' C' ' 17' ' ' TYR . 74.7 p 51.75 56.8 7.3 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.497 1.519 . . . . 71.52 112.274 -175.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -120.74 148.28 47.9 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 108.518 -0.919 . . . . 71.02 108.518 169.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -50.28 141.13 32.53 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 123.167 2.578 . . . . 63.45 112.668 174.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -55.4 140.54 39.58 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.383 1.073 . . . . 74.52 113.2 -167.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.465 HD22 HG21 ' D' ' 40' ' ' VAL . 13.4 tp -126.8 98.55 5.41 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.008 0.923 . . . . 73.3 109.328 -178.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -102.1 103.0 13.54 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.163 -1.051 . . . . 54.03 108.163 175.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.08 121.92 14.25 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 123.59 0.556 . . . . 62.24 110.412 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.89 128.95 91.31 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.811 0.844 . . . . 72.11 110.977 -175.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -79.99 105.61 1.82 Allowed 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.905 2.403 . . . . 44.24 111.938 -170.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -107.79 124.62 64.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.015 -1.105 . . . . 75.21 108.015 172.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -68.2 117.06 9.53 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.932 -0.766 . . . . 75.54 108.932 175.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.593 ' HA ' HD23 ' D' ' 136' ' ' LEU . 1.5 m-85 -61.94 -21.4 64.75 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.025 1.33 . . . . 62.45 112.048 -171.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -53.07 -35.21 59.3 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.195 1.398 . . . . 65.44 111.481 173.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.31 -31.0 69.18 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.265 1.026 . . . . 74.51 112.404 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.593 HD23 ' HA ' ' D' ' 133' ' ' PHE . 3.5 mm? -72.83 -35.8 67.35 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.09 0.556 . . . . 72.24 110.586 177.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -78.39 -31.18 48.2 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.738 -0.665 . . . . 70.44 110.782 177.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 70.8 mtm -73.94 -26.15 60.35 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.883 0.473 . . . . 62.14 110.798 172.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.52 ' O ' ' HG2' ' D' ' 143' ' ' GLN . 6.7 t30 -51.35 -43.61 61.84 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.348 0.659 . . . . 73.23 109.759 173.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -52.81 -41.67 64.39 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.906 1.282 . . . . 64.12 112.222 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.4 mp -72.87 -38.86 66.87 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.19 0.596 . . . . 73.24 111.509 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -89.43 40.61 1.0 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.409 0.683 . . . . 62.14 112.191 -174.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 143' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' D' ' 139' ' ' ASN . 24.1 mm-40 -117.92 76.62 1.08 Allowed 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.557 -0.905 . . . . 64.54 108.557 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 144' ' ' GLN . . . . . 0.562 ' HG2' ' H ' ' D' ' 145' ' ' ALA . 44.2 tt0 -169.83 -150.67 0.08 Allowed 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 106.72 -1.585 . . . . 74.54 106.72 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 145' ' ' ALA . . . . . 0.562 ' H ' ' HG2' ' D' ' 144' ' ' GLN . . . -78.05 10.54 2.82 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 119.112 0.869 . . . . 61.22 112.13 175.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.5 60.65 4.0 Favored Glycine 0 C--N 1.355 1.607 0 C-N-CA 123.507 0.575 . . . . 73.22 112.269 172.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -79.08 173.85 12.16 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.343 1.057 . . . . 72.3 109.533 173.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -161.87 104.33 0.24 Allowed Glycine 0 C--N 1.335 0.499 0 N-CA-C 111.757 -0.537 . . . . 64.02 111.757 -175.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 3.8 t -77.37 71.18 3.84 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.997 0.919 . . . . 73.44 110.226 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -74.38 100.31 3.75 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.842 -0.799 . . . . 71.22 108.842 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -104.77 103.49 13.12 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.67 0.788 . . . . 55.34 109.699 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -151.44 82.13 1.3 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.276 -1.009 . . . . 73.44 108.276 171.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -140.44 121.98 15.16 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.949 -1.023 . . . . 73.34 109.212 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -94.83 122.35 37.36 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.938 -1.134 . . . . 75.11 107.938 170.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.942 0 C-N-CA 123.392 0.677 . . . . 38.07 110.286 -177.084 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.677 0 CA-C-O 120.124 -0.265 . . . . 74.05 112.488 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . -136.36 151.45 20.82 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 111.124 -0.791 . . . . 61.44 111.124 177.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -96.51 98.6 10.35 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.34 -1.356 . . . . 75.21 107.34 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -104.38 -22.31 13.35 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.898 0.879 . . . . 74.01 113.083 -165.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm 72.28 158.84 0.2 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.93 1.292 . . . . 73.52 112.854 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 177.54 -48.94 0.1 Allowed Glycine 0 C--N 1.343 0.944 0 N-CA-C 111.464 -0.654 . . . . 13.53 111.464 -177.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 97' ' ' ILE . . . . . 0.588 HG12 ' HA ' ' D' ' 87' ' ' ALA . 29.4 pt -132.81 96.27 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-O 122.884 1.326 . . . . 61.4 110.141 177.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 98' ' ' ASP . . . . . 0.458 ' HB2' ' HB1' ' D' ' 52' ' ' ALA . 4.9 p-10 -107.14 -170.91 1.78 Allowed 'General case' 0 C--O 1.244 0.81 0 CA-C-N 114.95 -1.023 . . . . 75.02 108.67 170.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . 63.65 15.14 8.7 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.943 0.897 . . . . 71.03 112.254 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 100' ' ' LEU . . . . . . . . . . . . . 4.0 pp -85.16 114.97 59.14 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 108.596 -0.89 . . . . 74.22 108.596 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -87.85 0.89 6.96 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.784 2.323 . . . . 62.23 112.454 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 102' ' ' LEU . . . . . 0.615 HD21 HD23 ' D' ' 98' ' ' LEU . 97.0 mt 59.04 29.78 19.43 Favored 'General case' 0 C--N 1.368 1.389 0 C-N-CA 124.248 1.019 . . . . 52.33 110.918 -173.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 70.2 p 53.27 22.27 2.64 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.931 1.692 . . . . 74.44 112.539 -175.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 150.31 145.42 4.12 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 109.181 -1.567 . . . . 64.44 109.181 -172.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -77.38 33.11 0.16 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.391 1.076 . . . . 74.41 112.859 -169.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -165.06 -64.99 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 106.41 -1.7 . . . . 73.34 106.41 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -177.11 142.07 0.35 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.732 2.013 . . . . 70.23 107.512 169.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -74.14 -38.0 63.89 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.662 -0.496 . . . . 72.42 109.662 172.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -134.76 126.61 29.3 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.595 1.158 . . . . 72.43 108.36 177.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.23 -174.54 3.11 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 123.568 0.747 . . . . 72.35 111.526 -172.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 111' ' ' LEU . . . . . . . . . . . . . 4.7 mp -83.89 177.86 8.14 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.741 1.216 . . . . 75.11 110.352 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 112' ' ' ASN . . . . . 0.6 ' HA ' HG21 ' E' ' 121' ' ' VAL . 0.9 OUTLIER 58.88 95.78 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.209 1.004 . . . . 73.14 111.462 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -70.07 127.69 33.72 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 108.217 -1.031 . . . . 74.1 108.217 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 114' ' ' LYS . . . . . 0.445 ' HD2' ' N ' ' E' ' 114' ' ' LYS . 10.6 mptt -80.03 -39.59 29.56 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.837 -0.801 . . . . 74.45 108.837 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 12.4 t -158.94 153.28 24.02 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 114.494 -1.23 . . . . 74.12 109.006 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 144.06 -98.4 0.21 Allowed Glycine 0 C--N 1.338 0.653 0 N-CA-C 111.893 -0.483 . . . . 72.24 111.893 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 117' ' ' LYS . . . . . 0.554 ' HD2' ' HD2' ' E' ' 118' ' ' PRO . 24.1 tptm -104.88 119.65 52.67 Favored Pre-proline 0 CA--C 1.548 0.873 0 N-CA-C 108.966 -0.753 . . . . 75.44 108.966 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 118' ' ' PRO . . . . . 0.554 ' HD2' ' HD2' ' E' ' 117' ' ' LYS . 52.8 Cg_endo -65.62 -177.9 0.82 Allowed 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.181 2.587 . . . . 65.24 113.551 -177.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 78.2 -36.15 0.2 Allowed 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 126.027 1.731 . . . . 71.11 112.701 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -64.23 124.02 20.62 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.794 0.838 . . . . 72.34 111.931 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 121' ' ' VAL . . . . . 0.6 HG21 ' HA ' ' E' ' 112' ' ' ASN . 61.7 t 68.81 100.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.55 1.54 . . . . 42.11 111.233 -177.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 35.4 p -105.54 171.13 7.49 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 124.428 1.091 . . . . 74.15 109.223 170.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.92 -87.69 0.09 Allowed 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 112.243 0.46 . . . . 51.2 112.243 -174.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 22.0 t -85.57 84.38 7.62 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.504 0.722 . . . . 64.23 109.766 -174.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -153.12 26.18 0.54 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.946 0.898 . . . . 73.43 110.401 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -135.67 130.16 33.87 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.115 0.566 . . . . 24.01 109.9 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 47.9 t 69.24 156.92 0.14 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.259 1.424 . . . . 74.32 112.298 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -157.12 15.03 0.27 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.806 0.842 . . . . 72.23 110.376 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 44.6 m -111.24 134.58 52.73 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.408 0.683 . . . . 71.43 110.45 -173.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.08 -169.63 2.12 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.339 1.055 . . . . 50.54 111.856 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 131' ' ' TRP . . . . . 0.616 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 0.9 OUTLIER -135.29 97.28 3.67 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 124.13 0.972 . . . . 72.34 108.554 -178.702 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 20.7 m -128.15 100.72 5.97 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.788 -0.57 . . . . 64.3 110.639 -173.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 22.8 m -142.28 106.11 4.71 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 107.664 -1.235 . . . . 53.11 107.664 171.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.61 -36.07 58.79 Favored Glycine 0 C--N 1.35 1.355 0 O-C-N 123.514 0.509 . . . . 71.42 112.931 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 63.8 t 65.21 -70.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 125.589 1.555 . . . . 75.41 111.694 -176.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 59.06 41.27 20.98 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.93 1.292 . . . . 75.12 110.706 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 40.2 p 52.44 28.61 6.05 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.563 1.545 . . . . 73.22 112.986 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 30.0 t80 57.89 29.26 17.3 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-O 122.363 1.078 . . . . 72.2 110.673 174.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -152.17 166.29 32.17 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 115.302 -0.863 . . . . 74.01 109.34 -173.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.07 81.17 0.25 Allowed Glycine 0 C--N 1.343 0.921 0 CA-C-N 116.503 -0.317 . . . . 54.32 112.323 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -79.28 168.0 20.15 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 124.046 0.938 . . . . 73.41 111.003 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 142' ' ' LEU . . . . . 0.492 HD21 ' HB3' ' C' ' 153' ' ' GLN . 3.8 mm? -72.01 160.56 32.3 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.76 -0.654 . . . . 74.12 110.421 177.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.34 73.19 1.83 Allowed Glycine 0 C--N 1.346 1.131 0 O-C-N 123.534 0.522 . . . . 43.14 112.009 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 6.7 m -109.79 100.81 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 124.031 0.932 . . . . 74.2 109.438 -177.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 33.1 t70 . . . . . 0 C--O 1.25 1.124 0 N-CA-C 108.754 -0.832 . . . . 45.51 108.754 -176.575 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.463 0 N-CA-C 111.841 -0.504 . . . . 74.33 111.841 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . -90.41 54.78 3.52 Favored Glycine 0 C--N 1.351 1.363 0 C-N-CA 122.867 0.27 . . . . 52.12 113.246 -175.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -137.74 112.71 9.06 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.996 0.919 . . . . 74.43 109.368 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -89.58 154.53 19.91 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.344 1.058 . . . . 75.43 109.657 175.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.06 168.24 14.86 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.941 0.496 . . . . 64.44 110.117 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . 140.77 31.57 0.16 Allowed Glycine 0 C--N 1.344 1.02 0 CA-C-N 116.302 -0.408 . . . . 74.33 113.298 177.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 97' ' ' ILE . . . . . 0.541 ' HB ' ' HA ' ' B' ' 87' ' ' ALA . 15.0 tt -104.24 -40.77 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 109.022 -0.732 . . . . 54.44 109.022 170.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 30.5 t70 58.19 109.03 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.615 1.566 . . . . 73.11 112.848 174.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . 68.79 110.69 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.44 1.096 . . . . 73.02 111.828 174.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 100' ' ' LEU . . . . . . . . . . . . . 5.4 mp -114.18 86.98 12.5 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 123.016 0.526 . . . . 72.52 109.665 174.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -86.49 -3.84 8.43 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.917 2.412 . . . . 74.02 112.031 168.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 102' ' ' LEU . . . . . 0.455 HD12 HD11 ' B' ' 98' ' ' LEU . 2.2 mm? 57.17 -95.78 0.06 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.526 1.53 . . . . 73.21 110.623 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 3.3 t -167.82 94.37 0.41 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.391 1.077 . . . . 61.43 108.67 174.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.47 -74.17 1.95 Allowed Glycine 0 C--N 1.344 1.014 0 CA-C-N 115.255 -0.884 . . . . 54.51 111.663 -174.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.21 -56.7 1.9 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.605 1.162 . . . . 74.1 107.985 176.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -166.66 165.11 16.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.758 1.223 . . . . 45.53 108.793 -177.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 28.8 m -45.47 102.26 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.104 1.362 . . . . 72.12 111.936 177.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -136.15 131.39 34.64 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 124.107 0.963 . . . . 71.23 108.494 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -142.97 -77.64 0.24 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 107.685 -1.228 . . . . 73.41 107.685 173.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 110' ' ' ALA . . . . . 0.472 ' HB2' ' HA ' ' B' ' 154' ' ' ASP . . . -153.64 -52.24 0.1 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.159 -1.052 . . . . 65.41 108.159 176.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 43.2 tp 58.74 -88.57 0.02 OUTLIER 'General case' 0 C--N 1.359 0.982 0 C-N-CA 125.33 1.452 . . . . 74.34 110.884 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 112' ' ' ASN . . . . . 0.505 HD22 ' HA ' ' B' ' 43' ' ' ASP . 2.9 t30 -169.35 15.14 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.981 0.912 . . . . 71.31 108.976 -172.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -79.94 127.3 32.1 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 123.277 0.631 . . . . 71.43 110.666 -171.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 50.9 tptt 58.92 40.72 22.24 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.477 1.111 . . . . 73.42 109.043 -175.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 3.2 m 63.53 33.0 13.81 Favored 'General case' 0 CA--C 1.557 1.231 0 CA-C-N 114.361 -1.29 . . . . 70.33 109.821 -176.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.66 74.14 1.58 Allowed Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.178 -0.919 . . . . 40.42 112.352 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -76.28 134.25 70.72 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 123.602 0.761 . . . . 63.24 111.091 -174.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 118' ' ' PRO . . . . . 0.483 ' HG2' ' HB3' ' F' ' 120' ' ' TYR . 66.9 Cg_endo -84.94 31.51 0.49 Allowed 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 123.368 2.712 . . . . 75.3 111.167 166.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 9.4 t70 56.57 40.84 29.24 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 125.895 1.678 . . . . 75.32 110.598 -171.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 120' ' ' TYR . . . . . 0.483 ' HB3' ' HG2' ' F' ' 118' ' ' PRO . 38.5 t80 -148.97 147.48 28.65 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 114.887 -1.051 . . . . 73.01 109.401 -173.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 99.1 t 65.27 104.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 125.184 1.394 . . . . 51.31 111.431 -175.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 32.2 m -95.92 136.72 35.98 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.145 -0.687 . . . . 63.42 109.145 173.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -83.45 -11.65 57.27 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.968 0.907 . . . . 63.41 112.544 -170.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 15.1 m -68.96 -9.98 55.01 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.851 0.86 . . . . 72.31 112.445 -177.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.87 -24.62 67.81 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.761 0.825 . . . . 74.55 111.85 174.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -83.06 -21.5 33.75 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.799 0.84 . . . . 44.13 111.937 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 41.3 m -81.64 98.02 8.17 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.388 0.675 . . . . 71.34 110.609 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -142.97 143.52 31.98 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.785 0.834 . . . . 64.15 109.949 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 26.0 m -73.76 98.73 2.99 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.832 0.853 . . . . 74.31 108.902 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -151.06 90.32 1.6 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.946 -0.57 . . . . 72.34 110.487 -174.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 64.2 t90 -151.29 153.31 34.58 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.337 0.655 . . . . 75.53 109.577 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 70.7 m -153.21 151.28 29.91 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.756 1.223 . . . . 52.24 109.799 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 14.4 t -87.82 -174.95 4.96 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.867 0.867 . . . . 73.33 109.925 174.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.28 -94.24 0.15 Allowed Glycine 0 C--N 1.348 1.199 0 CA-C-O 120.064 -0.298 . . . . 53.12 112.471 175.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 12.3 p -163.55 151.26 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.096 0.558 . . . . 72.22 109.644 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -123.09 130.49 52.85 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 107.758 -1.201 . . . . 73.51 107.758 168.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 88.0 m 68.26 120.26 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.557 1.143 . . . . 45.15 109.832 -167.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -60.4 -30.91 69.9 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.354 0.662 . . . . 72.04 111.323 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 66.08 96.08 0.05 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.274 1.43 . . . . 73.42 111.373 174.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -123.17 10.17 8.81 Favored Glycine 0 N--CA 1.472 1.063 0 N-CA-C 111.936 -0.466 . . . . 50.45 111.936 174.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.24 -63.98 1.21 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.718 0.807 . . . . 72.2 110.104 -177.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 45.2 tp 49.85 80.27 0.07 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.314 1.446 . . . . 61.31 111.939 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -104.09 121.89 7.18 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 111.233 -0.747 . . . . 42.23 111.233 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.84 -26.43 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.006 0.523 . . . . 65.32 111.211 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 27.5 t70 . . . . . 0 C--O 1.251 1.132 0 C-N-CA 124.402 1.081 . . . . 73.42 108.928 177.713 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 120.738 0.304 . . . . 74.43 110.548 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.5 t -159.77 173.62 15.73 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.221 1.008 . . . . 62.12 109.121 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -88.84 122.55 32.35 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 108.434 -0.95 . . . . 63.03 108.434 169.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -99.34 112.06 24.31 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.638 -0.875 . . . . 75.34 108.638 175.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -72.32 139.74 48.13 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.117 0.967 . . . . 74.32 110.522 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -81.36 138.46 35.63 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.091 0.556 . . . . 74.35 111.329 -176.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.9 p -121.86 -34.44 3.37 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.421 1.088 . . . . 53.25 109.517 176.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -105.5 -78.61 0.57 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.838 0.855 . . . . 70.12 109.802 175.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 68.9 mtm -148.13 159.56 43.81 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.177 1.391 . . . . 72.23 108.105 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 79.2 m -153.93 118.79 5.0 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.994 0.518 . . . . 74.35 110.845 176.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.402 ' HZ ' HG13 ' A' ' 105' ' ' ILE . 93.9 t80 -99.36 114.58 27.54 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 106.359 -1.719 . . . . 74.22 106.359 161.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -133.32 112.5 11.69 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.189 -0.671 . . . . 73.43 109.189 -177.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.658 HG21 ' HG2' ' C' ' 130' ' ' PRO . 41.3 mt -83.65 113.96 23.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 107.745 -1.206 . . . . 74.41 107.745 169.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -94.77 -28.72 15.13 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 109.705 -0.48 . . . . 65.45 109.705 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.416 ' NH2' ' HB ' ' B' ' 122' ' ' THR . 20.2 ttt180 -166.37 139.96 4.09 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 122.741 0.416 . . . . 43.11 111.101 -177.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.571 HD12 ' HG3' ' C' ' 130' ' ' PRO . 95.5 mt -128.45 138.45 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.687 1.195 . . . . 64.13 107.828 169.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.468 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 32.5 p90 -163.74 174.88 11.09 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.735 0.647 . . . . 71.43 111.395 -175.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.0 p -101.17 121.89 42.65 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.196 -0.668 . . . . 63.22 109.196 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.468 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 35.5 mtpt -81.5 -38.2 26.68 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.129 0.49 . . . . 63.33 109.908 175.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.494 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 21.0 t70 -142.59 144.24 32.77 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.825 -1.079 . . . . 74.31 110.17 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.574 HD13 ' SD ' ' B' ' 117' ' ' MET . 97.4 mt -144.03 144.75 22.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 125.581 1.552 . . . . 63.32 107.43 176.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.4 t -159.13 142.85 14.99 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 122.917 0.487 . . . . 64.14 110.22 168.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -136.84 143.74 43.26 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 107.427 -1.323 . . . . 72.41 107.427 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -137.84 127.0 24.42 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.841 0.456 . . . . 74.32 110.387 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.21 66.31 9.28 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 125.382 1.473 . . . . 72.44 108.236 167.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.89 -34.25 30.69 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.25 1.967 . . . . 73.33 110.804 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.418 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 20.0 p-10 -89.96 24.68 2.35 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 114.175 -1.375 . . . . 55.55 111.292 174.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.87 -49.8 71.89 Favored Pre-proline 0 CA--C 1.571 1.773 0 CA-C-O 118.44 -0.79 . . . . 55.32 112.659 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.48 -26.79 70.21 Favored 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 121.718 1.612 . . . . 53.41 113.765 175.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.418 ' HB2' ' HB2' ' A' ' 27' ' ' ASN . 16.9 m-70 -77.33 -49.04 15.83 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.664 0.745 . . . . 71.53 110.564 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.804 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.9 p -72.4 -25.61 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 CA-C-N 114.302 -1.317 . . . . 62.52 112.741 -167.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -64.72 -19.75 65.95 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 122.875 0.47 . . . . 70.03 111.882 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -86.47 -31.39 21.37 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.426 1.091 . . . . 64.22 110.129 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.52 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 4.0 tmtp? -68.97 142.9 54.54 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.138 0.975 . . . . 71.2 109.642 -174.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.52 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 10.2 m-20 -53.23 124.03 13.45 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.566 1.146 . . . . 73.33 110.922 176.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -85.13 85.07 7.5 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 121.629 0.728 . . . . 74.2 110.722 -175.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -130.96 76.97 76.14 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 107.137 -1.431 . . . . 71.5 107.137 167.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -85.55 133.43 4.49 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.281 1.988 . . . . 75.2 112.432 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -97.06 90.7 5.26 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.061 -1.459 . . . . 72.11 107.061 166.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.678 HG22 ' HB2' ' A' ' 66' ' ' ALA . 62.1 t -77.69 93.12 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 108.581 -0.896 . . . . 63.22 108.581 175.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.489 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -90.35 127.12 36.09 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.903 -1.044 . . . . 74.35 109.168 177.933 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.679 HD21 HG13 ' A' ' 62' ' ' VAL . 3.7 tt -108.48 123.05 48.29 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.205 -1.035 . . . . 74.34 108.205 -171.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.51 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 10.8 m-20 -113.24 114.69 27.08 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.471 1.108 . . . . 74.22 109.514 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.459 HD22 HD21 ' A' ' 60' ' ' LEU . 45.7 mt -99.38 146.96 25.74 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.068 0.547 . . . . 53.13 112.033 -178.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -148.02 146.9 29.09 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.079 1.351 . . . . 64.43 108.46 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 84.4 m -134.61 140.82 46.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.276 0.63 . . . . 63.32 110.169 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.07 154.04 49.29 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.662 1.185 . . . . 73.12 109.339 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.5 p -130.43 155.46 46.39 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.21 0.604 . . . . 62.43 109.63 173.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.7 t -149.09 120.21 7.75 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.217 1.007 . . . . 74.34 108.371 -176.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -73.27 111.11 8.09 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.382 -0.599 . . . . 61.55 109.382 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.612 HD11 ' HB2' ' A' ' 57' ' ' GLU . 52.6 mt -84.81 -30.45 24.56 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.215 0.606 . . . . 73.33 110.072 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.42 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -161.74 177.02 10.3 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.667 1.187 . . . . 74.04 109.596 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -63.67 125.06 23.07 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.581 -0.896 . . . . 72.33 108.581 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 60.0 18.92 8.04 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.129 0.972 . . . . 71.14 112.72 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 49.5 t -126.05 110.43 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 107.824 -1.176 . . . . 75.21 107.824 173.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -123.52 127.86 48.94 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.849 0.86 . . . . 74.11 109.008 -175.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.612 ' HB2' HD11 ' A' ' 51' ' ' LEU . 31.5 tt0 -84.55 139.32 32.21 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.487 -0.931 . . . . 74.53 108.487 165.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.48 HG11 ' HD3' ' A' ' 103' ' ' PRO . 72.0 t -120.71 136.41 57.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.936 -1.135 . . . . 62.11 107.936 169.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.11 131.97 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.687 -0.857 . . . . 72.21 108.687 174.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.459 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -107.59 107.22 17.95 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.8 -1.556 . . . . 63.12 106.8 173.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -92.97 99.84 12.4 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.192 -1.04 . . . . 55.21 108.192 176.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.679 HG13 HD21 ' A' ' 42' ' ' LEU . 40.4 t -95.91 124.75 48.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 114.256 -1.338 . . . . 62.2 107.648 176.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 5.0 m -115.61 136.88 52.63 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.91 -1.144 . . . . 74.42 107.91 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 71.8 t -137.91 126.2 31.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 107.487 -1.301 . . . . 63.23 107.487 -172.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.489 ' HB ' ' HD2' ' A' ' 41' ' ' LYS . 27.5 m -137.72 131.69 31.71 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.984 -0.747 . . . . 73.34 108.984 169.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.678 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -105.56 120.76 42.45 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 107.618 -1.253 . . . . 72.02 107.618 174.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.3 m -118.02 126.47 52.36 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.744 0.418 . . . . 71.21 110.006 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.2 mt -90.54 66.51 6.3 Favored 'General case' 0 C--O 1.248 1.011 0 C-N-CA 125.046 1.339 . . . . 74.12 108.68 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.05 -86.74 0.78 Allowed Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.796 -0.638 . . . . 70.2 111.842 -176.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -108.95 -29.19 8.72 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.004 0.922 . . . . 64.33 110.902 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -89.3 113.57 24.85 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.663 -0.865 . . . . 72.31 108.663 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.2 m -69.0 130.37 42.58 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.81 0.732 . . . . 44.41 109.203 174.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.804 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -75.99 -58.65 3.16 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.387 -0.824 . . . . 53.34 109.884 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -159.33 163.68 35.44 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.723 -1.126 . . . . 72.11 110.691 177.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.2 tp -124.27 135.57 53.49 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.483 1.113 . . . . 72.44 108.705 172.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.551 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 68.6 m -133.5 133.11 41.81 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.54 1.136 . . . . 63.14 109.133 175.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -145.36 123.05 11.83 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.872 -0.788 . . . . 72.05 108.872 172.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.7 t -131.09 125.12 57.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 123.947 0.899 . . . . 75.14 108.948 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.494 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 53.8 mt-30 -99.67 91.63 4.96 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.919 0.887 . . . . 71.53 108.879 173.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -78.66 97.98 6.03 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.969 -1.014 . . . . 73.53 109.625 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.54 150.65 23.57 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 111.54 -0.624 . . . . 74.04 111.54 177.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.48 125.82 2.08 Favored Glycine 0 CA--C 1.508 -0.384 0 N-CA-C 110.665 -0.974 . . . . 74.02 110.665 -177.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.2 mt -84.59 112.87 22.36 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 N-CA-C 109.052 -0.721 . . . . 63.35 109.052 176.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.659 ' HB3' HD11 ' A' ' 86' ' ' ILE . 81.7 m-85 -121.77 118.69 29.65 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.093 0.957 . . . . 70.25 108.752 -177.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.5 t -92.75 95.87 9.82 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.771 -1.196 . . . . 61.24 107.771 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.659 HD11 ' HB3' ' A' ' 84' ' ' PHE . 11.9 mm -112.72 142.73 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.902 -0.59 . . . . 72.43 110.109 -172.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.9 164.87 30.9 Favored 'General case' 0 C--O 1.241 0.615 0 O-C-N 123.584 0.553 . . . . 64.23 112.25 -172.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.77 6.65 85.15 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 114.852 -1.067 . . . . 63.0 114.191 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.436 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -134.11 165.23 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.159 0.984 . . . . 74.41 108.89 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -159.27 175.95 12.77 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 109.451 -0.574 . . . . 65.23 109.451 175.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.01 -117.19 8.42 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.007 0.813 . . . . 62.02 114.323 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 t -70.12 -31.08 68.44 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.279 1.032 . . . . 72.1 111.755 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -74.61 -39.72 61.99 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 123.181 0.592 . . . . 71.3 110.713 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.9 tpt -68.13 -40.8 82.4 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.311 0.382 . . . . 72.32 110.111 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.88 98.13 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.329 -0.85 . . . . 55.45 110.745 175.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.435 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 54.5 t-80 -68.4 -31.93 71.62 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.076 -0.511 . . . . 73.52 111.632 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.496 ' SG ' HG21 ' A' ' 86' ' ' ILE . 48.5 t -69.46 -44.97 70.14 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 110.062 -0.347 . . . . 34.23 110.062 -178.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 65.0 mt -83.12 -26.68 30.77 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.38 0.672 . . . . 55.44 111.961 -174.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.23 3.35 37.71 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-O 119.525 -0.597 . . . . 61.5 114.15 -173.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.493 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -142.38 -68.44 0.37 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 117.684 0.742 . . . . 73.32 111.646 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -69.38 -41.93 75.83 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 112.465 0.543 . . . . 63.41 112.465 -170.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 70.1 m -66.46 -50.08 49.29 Favored Pre-proline 0 CA--C 1.568 1.659 0 CA-C-O 118.53 -0.747 . . . . 64.01 111.93 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.48 ' HD3' HG11 ' A' ' 58' ' ' VAL . 37.8 Cg_endo -65.86 -21.02 58.12 Favored 'Trans proline' 0 C--N 1.395 3.019 0 C-N-CA 121.781 1.654 . . . . 54.54 113.288 172.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -66.25 -42.91 87.89 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.161 0.584 . . . . 72.5 109.812 172.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.419 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 39.7 mm -62.01 -43.39 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.899 0.879 . . . . 64.03 110.318 174.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.7 mt -72.04 -24.13 61.49 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.398 -0.819 . . . . 61.13 112.627 -173.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -62.93 -44.89 86.6 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 114.339 1.237 . . . . 73.4 114.339 -172.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.419 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 92.5 Cg_exo -50.06 -40.98 50.13 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.203 1.935 . . . . 70.14 114.083 171.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -76.92 -39.56 50.39 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.619 0.768 . . . . 75.5 111.049 -177.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.37 -47.24 82.89 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.648 0.779 . . . . 74.22 110.016 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.463 ' NH1' HD12 ' C' ' 105' ' ' ILE . 29.7 ttm180 -49.4 -55.93 11.36 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 125.023 1.452 . . . . 64.43 110.142 172.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -60.89 -45.48 94.4 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.496 1.122 . . . . 74.14 111.664 -174.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.402 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 45.1 t -56.91 -45.32 82.72 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.026 0.829 . . . . 73.14 110.434 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 118' ' ' VAL . 66.2 mt -63.27 -51.62 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 115.077 -0.965 . . . . 73.21 110.535 175.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 50.6 m -55.54 -41.48 73.26 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.113 0.965 . . . . 71.12 111.246 -174.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -69.78 -42.85 73.26 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.498 -1.228 . . . . 63.21 109.913 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.498 ' SD ' HG23 ' A' ' 21' ' ' ILE . 10.2 mtp -58.79 -41.73 87.39 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.642 0.777 . . . . 75.54 111.19 175.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 114' ' ' ILE . 83.1 t -65.08 -48.13 85.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.384 1.074 . . . . 74.3 110.329 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.3 p -71.62 -30.94 66.34 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.911 -0.586 . . . . 53.22 111.298 -176.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.478 HH12 ' HG3' ' B' ' 112' ' ' GLU . 64.8 mtt-85 -72.4 -30.25 64.48 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.554 0.742 . . . . 63.42 109.197 173.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.43 -2.6 74.91 Favored Glycine 0 C--N 1.356 1.643 0 O-C-N 123.88 0.737 . . . . 73.15 112.921 174.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.514 HG21 ' HE ' ' B' ' 15' ' ' ARG . 92.2 m 71.68 26.59 3.07 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 122.912 1.339 . . . . 75.11 111.288 174.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -98.26 145.08 29.23 Favored Pre-proline 0 C--O 1.244 0.801 0 N-CA-C 108.51 -0.922 . . . . 72.3 108.51 170.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.651 ' HB3' ' H ' ' E' ' 132' ' ' SER . 61.2 Cg_exo -43.98 132.68 8.44 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.389 2.726 . . . . 75.21 112.891 174.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -52.93 123.2 10.9 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 124.162 0.914 . . . . 74.35 112.399 -170.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 45.5 tp -109.24 100.68 9.78 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.908 0.883 . . . . 62.51 110.207 -174.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.434 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 88.9 m-20 -97.78 113.06 24.76 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.63 -1.248 . . . . 74.15 107.63 174.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 19.1 mt -65.21 147.68 53.02 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 123.58 0.55 . . . . 74.12 110.46 -175.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.76 134.74 88.05 Favored Pre-proline 0 CA--C 1.549 0.933 0 CA-C-O 118.914 -0.565 . . . . 52.51 111.158 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.49 120.93 9.17 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.256 2.637 . . . . 74.21 113.337 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.434 HG21 HD11 ' A' ' 44' ' ' LEU . 64.7 t -107.31 130.44 59.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 123.644 0.778 . . . . 74.34 110.37 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -92.51 92.22 7.97 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.051 -1.092 . . . . 75.24 108.051 173.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -62.64 -29.4 70.6 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.88 0.872 . . . . 73.31 112.22 176.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.493 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 6.7 m-20 -70.86 -25.48 62.84 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.291 0.636 . . . . 73.15 111.131 177.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.01 -40.96 37.32 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.239 0.616 . . . . 43.34 110.233 172.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.61 -44.69 96.53 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.207 0.603 . . . . 74.41 110.938 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -73.83 -29.29 62.06 Favored 'General case' 0 C--O 1.216 -0.708 0 CA-C-N 115.073 -0.967 . . . . 73.12 109.74 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.857 ' HE3' HD23 ' A' ' 141' ' ' LEU . 3.2 tpt -55.94 -41.44 74.65 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.623 0.769 . . . . 64.31 111.02 178.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -58.04 -34.43 70.06 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 124.167 0.917 . . . . 62.41 111.289 178.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -90.19 -30.28 17.69 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.804 1.242 . . . . 72.12 111.507 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.857 HD23 ' HE3' ' A' ' 138' ' ' MET . 51.4 tp -68.26 -50.53 53.2 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.91 0.884 . . . . 72.24 111.18 -168.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 174.1 -15.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 124.381 1.05 . . . . 65.42 110.653 177.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 70.02 -50.12 0.64 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.565 1.146 . . . . 72.51 111.225 -166.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -71.15 95.09 1.2 Allowed 'General case' 0 C--N 1.358 0.937 0 C-N-CA 123.068 0.547 . . . . 53.04 110.366 170.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -177.56 171.88 1.86 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.698 1.599 . . . . 65.41 108.344 170.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -127.26 -115.02 1.9 Allowed Glycine 0 C--N 1.339 0.719 0 N-CA-C 112.29 -0.324 . . . . 74.32 112.29 -177.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -146.3 160.75 41.6 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.079 0.952 . . . . 73.42 110.263 -173.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -165.44 135.47 3.73 Favored Glycine 0 C--N 1.339 0.695 0 CA-C-N 115.802 -0.635 . . . . 65.14 111.559 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.8 t -133.63 156.09 48.5 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.686 0.794 . . . . 55.41 109.572 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -88.69 151.58 22.35 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.121 0.568 . . . . 71.44 110.956 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -108.99 90.34 3.26 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 107.733 -1.21 . . . . 63.44 107.733 163.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -72.39 98.37 2.23 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.999 -1.111 . . . . 70.21 107.999 173.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 19.1 tm0? -59.86 104.37 0.29 Allowed 'General case' 0 C--N 1.352 0.698 0 N-CA-C 108.192 -1.04 . . . . 61.34 108.192 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -76.5 143.82 40.2 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 123.774 0.671 . . . . 72.11 109.549 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 C-N-CA 123.3 0.64 . . . . 60.51 110.166 -178.596 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptp . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 109.911 -0.403 . . . . 63.11 109.911 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.9 t 70.0 173.33 0.3 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.751 1.22 . . . . 70.32 110.705 -172.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -82.59 72.98 9.66 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.645 0.736 . . . . 75.42 110.441 -176.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -97.96 -3.97 37.27 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.808 -1.087 . . . . 71.04 111.267 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 65.44 63.79 0.62 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.535 1.134 . . . . 75.23 110.009 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -112.79 142.81 44.99 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.57 -1.195 . . . . 72.01 108.215 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 13.4 t -65.04 -16.86 63.92 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.419 0.687 . . . . 64.04 111.264 175.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 68.02 -105.85 0.08 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.279 1.432 . . . . 74.52 109.45 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.659 ' HG2' HG23 ' B' ' 89' ' ' ILE . 0.1 OUTLIER 55.17 170.0 0.02 OUTLIER 'General case' 0 CA--C 1.57 1.713 0 C-N-CA 124.753 1.221 . . . . 53.13 111.701 -174.623 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 85.2 m -154.41 102.26 2.41 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.11 -1.07 . . . . 74.34 108.11 168.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.428 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 50.9 t80 -119.9 134.35 55.27 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.068 -1.086 . . . . 72.11 108.068 173.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -164.01 142.12 7.3 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 123.702 0.626 . . . . 60.52 110.791 169.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.52 HD13 HD11 ' B' ' 16' ' ' ILE . 37.8 mt -80.07 132.4 31.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.021 -0.991 . . . . 74.45 109.43 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -99.12 -38.72 8.82 Favored 'General case' 0 C--O 1.242 0.662 0 O-C-N 123.816 0.697 . . . . 70.43 110.299 178.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.514 ' HE ' HG21 ' A' ' 122' ' ' THR . 40.3 ttt180 -173.46 137.18 0.63 Allowed 'General case' 0 C--N 1.349 0.583 0 O-C-N 123.747 0.654 . . . . 72.24 109.8 -175.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.52 HD11 HD13 ' B' ' 13' ' ' ILE . 96.6 mt -120.31 143.43 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 107.577 -1.268 . . . . 64.22 107.577 174.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -162.9 139.48 7.44 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.696 0.628 . . . . 75.43 112.696 -173.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.9 m -73.96 118.01 16.43 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.042 0.937 . . . . 53.43 109.499 172.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.474 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.6 mtpt -98.15 -9.98 24.89 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.932 0.893 . . . . 71.13 112.045 -176.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 16.1 t70 -174.27 144.6 0.95 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.168 0.587 . . . . 52.43 110.745 -176.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.507 HD11 ' SG ' ' B' ' 113' ' ' CYS . 43.8 mm -138.28 148.67 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 125.047 1.339 . . . . 64.4 108.792 175.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.51 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 38.9 t -148.68 139.99 23.3 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 125.159 1.384 . . . . 52.33 108.214 172.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.498 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 81.2 t80 -152.85 113.7 4.13 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.375 -1.343 . . . . 75.44 107.375 171.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -121.18 119.09 31.32 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.953 0.901 . . . . 72.52 108.712 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.637 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -107.45 87.12 3.11 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 107.194 -1.41 . . . . 72.14 107.194 167.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.68 -34.44 31.97 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.987 2.458 . . . . 71.13 111.662 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -101.84 3.39 39.25 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.44 1.096 . . . . 70.15 110.375 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.637 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -30.0 -65.06 0.19 Allowed Pre-proline 0 N--CA 1.499 1.997 0 C-N-CA 126.331 1.853 . . . . 44.11 114.886 -172.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 28.8 Cg_exo -57.69 -48.07 18.53 Favored 'Trans proline' 0 C--N 1.391 2.802 0 C-N-CA 122.934 2.423 . . . . 50.42 113.462 -166.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -96.36 -15.37 21.89 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.297 -0.865 . . . . 73.21 112.648 -172.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.421 HG22 HD12 ' B' ' 68' ' ' LEU . 3.4 p -73.76 -17.7 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-N 118.657 0.662 . . . . 64.13 110.647 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -68.62 -6.32 25.08 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 113.764 1.024 . . . . 70.12 113.764 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -71.24 -13.53 61.94 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 120.991 0.424 . . . . 71.03 110.747 172.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.59 ' HB2' HD13 ' B' ' 68' ' ' LEU . 91.1 mttt -98.62 88.0 3.96 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.729 1.212 . . . . 54.42 110.049 -177.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.45 77.92 9.92 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.989 -1.005 . . . . 70.22 110.99 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.405 ' O ' ' HG2' ' B' ' 124' ' ' PRO . 38.5 p90 -158.37 164.58 36.18 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.881 0.873 . . . . 65.54 108.721 169.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.54 117.4 60.34 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 108.181 -1.044 . . . . 73.13 108.181 177.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.442 ' O ' HG23 ' B' ' 40' ' ' VAL . 31.8 Cg_endo -65.98 147.56 84.8 Favored 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 122.207 1.938 . . . . 75.31 112.231 -177.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -69.93 114.17 7.86 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 109.004 -0.739 . . . . 75.2 109.004 178.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' F' ' 126' ' ' ALA . 77.7 t -111.04 138.06 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 114.998 -1.001 . . . . 74.22 111.939 -172.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.578 ' HE2' ' HD3' ' F' ' 114' ' ' LYS . 44.4 tttp -107.27 126.97 53.12 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 126.017 1.727 . . . . 71.53 107.503 174.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.747 HD13 HD22 ' B' ' 128' ' ' LEU . 15.6 tp -103.01 127.3 50.3 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.729 -0.841 . . . . 74.02 108.729 174.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -143.8 136.13 26.85 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 106.999 -1.482 . . . . 44.11 106.999 -177.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.7 mp -127.05 149.24 50.0 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.952 -0.758 . . . . 74.34 108.952 -171.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.577 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 7.6 t70 -125.77 146.29 49.84 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.772 1.229 . . . . 54.34 109.255 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 26.9 m -124.84 105.64 9.41 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.495 0.718 . . . . 72.21 109.643 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.7 120.45 39.39 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.366 -1.346 . . . . 71.51 107.366 176.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.721 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 25.1 m -135.41 161.57 35.06 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.495 0.318 . . . . 75.53 111.506 -168.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 42.0 p -165.15 139.29 4.88 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.322 0.649 . . . . 74.45 111.06 -177.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -87.57 96.65 10.48 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 108.782 -0.822 . . . . 74.41 108.782 171.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 pp -107.53 14.78 25.46 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.801 0.44 . . . . 65.14 110.688 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.98 143.75 22.83 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.775 0.83 . . . . 63.54 109.56 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -74.06 132.13 42.02 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.646 -0.872 . . . . 74.41 108.646 170.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 67.76 1.9 2.83 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.946 1.298 . . . . 51.23 113.442 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.489 HG21 ' HD2' ' F' ' 93' ' ' PHE . 58.2 t -140.08 128.28 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 107.851 -1.166 . . . . 72.24 107.851 -172.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.721 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 6.7 t80 -115.38 154.26 29.52 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.797 -0.565 . . . . 71.21 109.566 -176.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -124.24 117.67 25.08 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 107.739 -1.208 . . . . 61.0 107.739 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 p -118.71 127.8 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.881 0.873 . . . . 70.42 109.363 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.41 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.9 t -103.77 112.33 36.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 108.072 -1.085 . . . . 62.25 108.072 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -103.18 108.68 19.98 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.473 -0.936 . . . . 71.41 108.473 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.577 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 6.2 ttm180 -85.12 135.4 33.99 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.131 -0.941 . . . . 73.32 109.238 174.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.466 ' CG1' HD11 ' B' ' 42' ' ' LEU . 17.5 t -122.57 117.13 51.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.14 -1.059 . . . . 52.13 108.14 169.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 17.3 m -109.78 133.36 53.23 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.874 0.87 . . . . 63.23 109.786 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.557 HG21 HG21 ' B' ' 114' ' ' ILE . 55.4 t -115.78 114.5 46.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 125.308 1.443 . . . . 65.14 109.139 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 41.4 m -91.79 138.09 31.84 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.698 -1.223 . . . . 72.12 107.698 166.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.538 ' HB2' HG22 ' B' ' 40' ' ' VAL . . . -148.78 143.01 26.08 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 117.943 0.338 . . . . 64.2 110.467 178.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 73.7 p -147.96 133.42 18.64 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 123.768 0.667 . . . . 74.24 111.032 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.59 HD13 ' HB2' ' B' ' 34' ' ' LYS . 54.0 mt -93.89 108.73 20.49 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.171 0.988 . . . . 74.43 108.508 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.87 -116.64 4.39 Favored Glycine 0 C--N 1.342 0.861 0 N-CA-C 111.469 -0.652 . . . . 42.41 111.469 -175.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -111.62 -0.08 16.21 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.054 0.942 . . . . 72.44 110.645 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.426 ' HG2' ' NZ ' ' B' ' 34' ' ' LYS . 9.8 pt-20 -116.77 154.37 30.79 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.328 -0.619 . . . . 72.01 109.328 -178.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 39.4 m -62.81 141.4 58.64 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.972 0.509 . . . . 63.51 111.285 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.435 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -97.78 -64.06 1.07 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.658 -1.238 . . . . 74.32 107.658 172.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -151.88 154.4 36.07 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.639 -1.164 . . . . 73.23 109.949 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 88.5 mt -130.44 112.87 13.64 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 106.916 -1.513 . . . . 55.25 106.916 175.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.1 t -117.63 156.19 28.59 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.134 -0.691 . . . . 62.2 109.134 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.51 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.0 tt0 -161.93 129.63 4.03 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.649 0.78 . . . . 75.23 108.997 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 94.2 t -126.41 150.13 31.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.125 -1.065 . . . . 75.15 108.125 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.444 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.6 mt-30 -124.86 97.95 5.49 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.181 -1.044 . . . . 74.24 108.181 170.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -93.26 103.14 15.42 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.676 -0.693 . . . . 73.11 109.255 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.474 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -94.19 172.32 31.91 Favored Glycine 0 C--O 1.243 0.675 0 CA-C-N 115.824 -0.626 . . . . 62.0 111.862 176.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.91 142.71 6.88 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.808 -0.517 . . . . 71.1 111.808 -178.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 16.3 tt -107.54 116.86 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 C-N-CA 123.997 0.919 . . . . 74.21 108.661 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -123.3 134.7 54.04 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.089 0.955 . . . . 62.41 109.578 -172.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.0 m -89.12 130.83 35.49 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.024 0.53 . . . . 64.21 109.592 174.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.551 ' HB ' HD11 ' B' ' 89' ' ' ILE . 0.1 OUTLIER -135.75 139.55 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.14 0.976 . . . . 72.44 109.114 -178.472 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.534 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -157.9 169.39 24.69 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.98 0.912 . . . . 73.35 110.426 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.31 -41.47 3.0 Favored Glycine 0 C--N 1.352 1.449 0 C-N-CA 123.718 0.675 . . . . 65.24 113.35 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.659 HG23 ' HG2' ' B' ' 9' ' ' MET . 9.5 pt -65.5 153.29 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.388 1.475 . . . . 72.12 113.052 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -151.36 172.37 16.03 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.515 1.126 . . . . 64.35 110.049 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.73 -133.72 32.28 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-N 116.231 -0.44 . . . . 30.11 114.0 177.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.0 m -80.73 -47.27 14.2 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.972 0.909 . . . . 74.44 110.888 -175.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -65.51 -20.73 66.46 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.818 -1.083 . . . . 74.13 111.259 -172.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.576 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 11.0 ttt -52.47 -70.22 0.09 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.29 1.436 . . . . 70.52 112.428 174.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.414 ' HB1' HD23 ' F' ' 102' ' ' LEU . . . -78.9 -12.74 60.04 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.427 -0.351 . . . . 51.45 111.489 -175.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -61.87 -41.58 98.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.215 0.606 . . . . 60.12 110.713 167.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 t -64.06 -28.08 69.55 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.291 0.636 . . . . 43.41 112.346 -176.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.714 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.5 pp -103.23 -17.72 15.21 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.352 0.661 . . . . 73.32 111.501 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.11 -4.09 41.58 Favored Glycine 0 N--CA 1.478 1.48 0 N-CA-C 114.201 0.44 . . . . 51.22 114.201 -173.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.87 -49.71 0.52 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.459 0.704 . . . . 63.43 110.362 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -71.15 -39.02 72.19 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 122.7 0.4 . . . . 71.43 111.648 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.714 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 84.5 m -67.72 -47.45 44.48 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-O 118.493 -0.765 . . . . 71.21 111.717 177.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.44 -34.4 41.49 Favored 'Trans proline' 0 C--N 1.394 2.928 0 C-N-CA 122.66 2.24 . . . . 75.32 114.244 167.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -67.41 -35.6 79.59 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.043 0.937 . . . . 73.43 110.563 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.467 HD13 HD11 ' B' ' 13' ' ' ILE . 79.6 mt -68.58 -40.45 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.759 0.824 . . . . 63.5 110.164 173.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 95.5 mt -75.72 -20.97 57.97 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.971 -1.013 . . . . 73.12 112.191 -174.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -61.68 -50.29 82.7 Favored Pre-proline 0 CA--C 1.561 1.376 0 CA-C-O 118.012 -0.994 . . . . 51.33 112.8 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -50.9 -40.38 57.92 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 122.633 2.222 . . . . 63.01 114.145 173.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -67.97 -44.57 76.39 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.518 0.727 . . . . 72.21 110.879 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.67 -34.86 79.29 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.248 0.619 . . . . 63.42 110.829 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.495 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 31.5 ttt180 -66.35 -52.63 45.04 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.219 1.407 . . . . 71.34 110.094 -175.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.478 ' HG3' HH12 ' A' ' 120' ' ' ARG . 12.3 tp10 -65.0 -33.43 76.03 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.033 0.933 . . . . 74.31 110.647 176.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.507 ' SG ' HD11 ' B' ' 21' ' ' ILE . 1.9 t -70.57 -32.57 70.01 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 122.439 -0.163 . . . . 63.44 110.967 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.557 HG21 HG21 ' B' ' 64' ' ' VAL . 66.3 mt -70.56 -57.9 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.277 0.631 . . . . 63.51 109.445 173.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 13.3 m -61.54 -22.96 65.61 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 124.205 0.94 . . . . 64.31 111.346 -173.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.3 t -62.04 -52.7 62.9 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 123.444 0.698 . . . . 73.14 109.851 170.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.574 ' SD ' HD13 ' A' ' 21' ' ' ILE . 12.7 mmt -68.44 -33.39 74.12 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.862 0.865 . . . . 63.33 111.113 -175.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.413 HG21 HD23 ' B' ' 126' ' ' LEU . 86.4 t -65.45 -43.96 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.806 1.242 . . . . 71.04 110.135 173.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.5 t -63.83 -34.87 78.9 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.73 -1.123 . . . . 73.53 110.564 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' B' ' 116' ' ' SER . 77.4 mtt-85 -69.24 -33.31 73.09 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.05 -0.977 . . . . 72.43 110.373 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.37 -15.75 81.25 Favored Glycine 0 C--N 1.356 1.686 0 O-C-N 123.57 0.544 . . . . 73.43 112.389 170.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.416 ' HB ' ' NH2' ' A' ' 15' ' ' ARG . 15.7 m 65.33 37.91 6.08 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.715 1.606 . . . . 71.42 110.261 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -81.5 156.92 70.66 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 114.61 -1.177 . . . . 71.15 109.53 172.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.405 ' HG2' ' O ' ' B' ' 36' ' ' TRP . 88.1 Cg_exo -50.91 163.83 0.71 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.38 2.72 . . . . 74.33 114.48 175.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -59.4 118.25 5.78 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 115.481 -0.782 . . . . 60.45 111.342 -171.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.547 HD13 HG21 ' B' ' 40' ' ' VAL . 54.8 tp -107.62 95.21 5.54 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.614 -0.884 . . . . 70.02 108.614 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -96.55 106.4 18.66 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.998 -1.112 . . . . 73.23 107.998 172.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.747 HD22 HD13 ' B' ' 42' ' ' LEU . 30.4 mt -67.05 134.84 52.68 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 110.135 -0.32 . . . . 61.3 110.135 175.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.71 131.46 94.9 Favored Pre-proline 0 CA--C 1.549 0.914 0 O-C-N 124.106 0.879 . . . . 74.32 110.713 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -61.75 90.79 0.11 Allowed 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.087 2.525 . . . . 64.14 111.618 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 p -90.35 111.69 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.591 -0.731 . . . . 73.14 109.493 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -79.47 113.69 17.81 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.671 -1.233 . . . . 55.24 107.671 171.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -65.4 -40.0 92.89 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.706 0.802 . . . . 74.44 110.182 -177.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -57.23 -28.18 62.67 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 114.03 -1.441 . . . . 73.34 111.129 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.453 ' O ' ' HG2' ' B' ' 138' ' ' MET . . . -71.1 -39.26 72.22 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 124.023 0.929 . . . . 43.34 111.715 177.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.402 ' HG ' ' HB3' ' F' ' 120' ' ' TYR . 7.8 mp -64.19 -38.35 90.75 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 122.179 -0.326 . . . . 73.51 110.391 178.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -74.71 -35.98 62.7 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.289 0.636 . . . . 75.12 111.766 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 138' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' B' ' 135' ' ' ALA . 18.3 ptm -68.89 -36.09 77.64 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 110.02 -0.363 . . . . 52.42 110.02 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -80.78 -23.77 39.07 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.652 0.781 . . . . 64.14 111.12 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -71.85 -42.31 67.06 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.927 0.491 . . . . 73.24 109.911 175.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 10.3 mp -85.33 1.32 48.94 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.48 0.712 . . . . 63.21 111.185 175.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 64.37 85.49 0.14 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.446 1.498 . . . . 74.22 111.593 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -155.85 91.99 1.33 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 105.5 -2.037 . . . . 75.13 105.5 172.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -127.25 86.11 2.45 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.779 0.832 . . . . 54.45 109.859 -169.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . 61.56 -152.69 0.37 Allowed 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 124.254 1.022 . . . . 71.33 112.104 172.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 101.54 165.82 27.38 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-O 119.598 -0.557 . . . . 64.12 112.154 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 68.6 104.47 0.05 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.78 1.232 . . . . 72.14 111.759 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 156.93 49.99 0.01 OUTLIER Glycine 0 C--N 1.343 0.941 0 N-CA-C 111.247 -0.741 . . . . 41.05 111.247 177.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 70.8 p -87.43 179.28 6.6 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.706 0.802 . . . . 71.23 111.194 -172.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 74.49 126.98 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.907 1.683 . . . . 75.14 109.852 -171.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -165.19 132.89 3.08 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.466 1.107 . . . . 51.13 108.108 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 29.5 t60 -113.1 -72.39 0.71 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 107.747 -1.205 . . . . 73.24 107.747 172.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -176.21 -79.53 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.442 1.097 . . . . 71.1 109.414 172.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -142.32 101.95 4.0 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.75 1.22 . . . . 73.24 107.827 -178.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.561 1.378 0 O-C-N 124.508 1.13 . . . . 70.31 110.732 -175.133 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 43.8 ttm . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 109.742 -0.466 . . . . 74.14 109.742 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 72.0 m -159.03 92.9 1.12 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.691 0.796 . . . . 71.44 110.036 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.73 152.52 42.7 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.586 -0.733 . . . . 61.34 109.23 170.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -147.09 152.53 38.66 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.216 0.532 . . . . 73.11 110.844 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -121.64 30.88 6.5 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 106.958 -1.497 . . . . 75.34 106.958 168.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -70.78 149.8 46.5 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-N 114.818 -1.083 . . . . 72.1 110.299 -172.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 39.6 p -126.46 109.36 12.1 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.01 0.924 . . . . 74.2 110.019 -172.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -173.84 -44.47 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.635 0.774 . . . . 63.15 111.138 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.543 ' H ' ' HA3' ' C' ' 88' ' ' GLY . 12.2 ttt 57.05 110.41 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.046 1.738 . . . . 73.45 111.871 -164.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 88.5 m -126.95 114.47 17.88 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.368 1.067 . . . . 61.41 108.252 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.525 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 78.8 t80 -107.98 129.42 55.12 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.959 -0.756 . . . . 73.34 108.959 177.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -140.42 128.45 22.13 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.136 -0.69 . . . . 72.04 109.136 174.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 50.2 mt -76.77 128.85 37.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 108.809 -0.811 . . . . 70.53 108.809 172.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -90.15 -49.59 6.48 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.934 -0.765 . . . . 55.32 108.934 172.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.434 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -176.46 153.52 1.18 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.431 1.092 . . . . 62.21 110.049 179.213 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 84.3 mt -127.7 134.92 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.087 1.355 . . . . 71.41 107.71 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.516 ' HE2' ' HD3' ' C' ' 19' ' ' LYS . 42.4 p90 -163.72 174.2 11.94 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.439 0.695 . . . . 64.52 110.288 -164.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.7 p -105.92 116.16 31.46 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 122.988 0.515 . . . . 71.15 109.838 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.516 ' HD3' ' HE2' ' C' ' 17' ' ' TYR . 30.8 mmtp -65.78 -37.97 87.74 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.947 -0.76 . . . . 75.53 108.947 167.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.434 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 13.1 t70 -149.56 147.19 27.87 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 114.482 -1.235 . . . . 73.33 110.4 -174.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.507 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 91.5 mt -139.36 146.11 26.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 106.505 -1.665 . . . . 75.23 106.505 173.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 18.2 t -157.35 148.13 21.37 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 121.064 0.459 . . . . 54.24 110.32 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -156.2 108.56 2.58 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.635 -1.246 . . . . 74.45 107.635 174.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -117.29 112.02 20.18 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 122.92 0.488 . . . . 73.41 110.065 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -121.47 83.05 40.33 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.63 1.172 . . . . 75.21 107.951 169.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.66 -17.82 25.87 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.684 2.256 . . . . 64.53 111.385 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -102.8 12.26 36.45 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.543 1.137 . . . . 74.04 110.543 -178.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.99 -57.9 5.47 Favored Pre-proline 0 C--N 1.374 1.646 0 C-N-CA 124.761 1.224 . . . . 53.41 113.687 -169.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -60.25 -46.62 17.61 Favored 'Trans proline' 0 C--N 1.385 2.484 0 CA-C-N 121.427 1.545 . . . . 73.14 113.143 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -69.41 -29.41 67.14 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.155 -0.929 . . . . 70.02 111.899 -174.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.851 HG21 ' HA ' ' C' ' 73' ' ' ALA . 6.7 p -83.14 -21.14 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 N-CA-C 113.286 0.847 . . . . 63.41 113.286 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -67.9 -18.02 64.66 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 112.517 0.562 . . . . 75.04 112.517 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -100.12 16.25 24.72 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.875 0.87 . . . . 75.14 111.253 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.59 155.54 17.81 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.474 0.71 . . . . 73.32 110.339 -174.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.32 125.07 25.56 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.089 0.556 . . . . 75.33 110.303 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.1 t-105 -83.03 87.97 6.88 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.731 0.812 . . . . 72.42 110.627 -173.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -139.54 75.95 31.31 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 123.932 0.893 . . . . 64.1 108.891 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -82.83 145.03 12.54 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.224 1.949 . . . . 73.32 112.056 -175.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -86.15 89.1 7.73 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 104.849 -2.278 . . . . 74.01 104.849 168.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 58.1 t -78.64 98.33 2.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 114.996 -1.002 . . . . 61.13 109.175 -175.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -97.5 102.31 14.05 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.548 -0.908 . . . . 73.4 108.548 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.411 HD12 ' O ' ' C' ' 42' ' ' LEU . 3.1 pp -87.31 123.5 32.36 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.446 -1.316 . . . . 70.33 107.446 171.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -130.46 143.42 50.75 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.393 -0.966 . . . . 74.4 108.393 -172.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.459 HD13 ' CE1' ' C' ' 133' ' ' PHE . 91.9 mt -131.6 112.64 12.78 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.959 0.504 . . . . 61.14 110.959 -171.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -115.03 126.72 55.05 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 107.46 -1.311 . . . . 74.41 107.46 169.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -116.2 153.93 30.97 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 109.091 -0.707 . . . . 65.43 109.091 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.72 133.4 23.7 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.763 -0.828 . . . . 63.33 108.763 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 32.9 p -144.87 144.79 31.3 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.834 0.453 . . . . 73.54 110.154 -174.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 62.9 p -149.07 152.65 36.56 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.658 0.783 . . . . 72.11 109.872 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -85.43 117.99 24.68 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.043 -1.095 . . . . 71.34 108.043 173.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.698 HD11 ' HB2' ' C' ' 57' ' ' GLU . 31.9 mt -84.64 -40.2 17.73 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.595 0.758 . . . . 73.31 109.689 -176.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.31 -173.73 4.56 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.707 -1.133 . . . . 60.12 109.119 175.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -62.43 126.65 28.07 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.445 -0.798 . . . . 75.44 109.565 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 66.13 -0.72 1.33 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.847 1.259 . . . . 55.14 112.965 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 45.7 t -118.29 111.39 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 109.367 -0.605 . . . . 74.53 109.367 -176.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -113.32 166.62 11.3 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.973 0.909 . . . . 74.31 109.751 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.698 ' HB2' HD11 ' C' ' 51' ' ' LEU . 41.4 tt0 -127.86 144.55 51.09 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.174 0.99 . . . . 72.11 108.734 171.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 82.6 t -131.23 133.73 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 108.182 -1.044 . . . . 70.33 108.182 167.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.488 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 60.2 t -120.25 130.1 74.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 107.66 -1.237 . . . . 71.45 107.66 176.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.454 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -113.18 97.36 6.45 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.742 -1.207 . . . . 51.41 107.742 -176.678 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 7.9 ttm-85 -81.84 110.45 17.15 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.961 -0.755 . . . . 75.32 108.961 173.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.509 ' HB ' HD11 ' C' ' 114' ' ' ILE . 19.4 t -106.68 123.86 61.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.074 -1.084 . . . . 63.41 108.074 173.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 59.6 m -115.03 132.11 56.71 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.026 -1.102 . . . . 72.4 108.026 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.491 HG21 HG21 ' C' ' 114' ' ' ILE . 89.0 t -121.28 116.95 51.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 109.141 -0.689 . . . . 75.24 109.141 176.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 12.5 m -101.76 139.04 37.95 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.635 -0.876 . . . . 73.11 108.635 173.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.57 105.72 4.58 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.607 -0.886 . . . . 62.12 108.607 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 36.9 m -127.04 133.54 50.47 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.356 0.662 . . . . 71.35 109.705 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 11.3 mt -91.04 15.0 12.43 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.988 1.315 . . . . 64.41 111.474 -176.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 145.25 -110.46 0.55 Allowed Glycine 0 C--N 1.351 1.377 0 N-CA-C 110.026 -1.229 . . . . 44.23 110.026 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -88.74 -27.25 21.3 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.523 0.729 . . . . 72.34 109.088 169.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -74.55 119.47 18.79 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 124.438 1.095 . . . . 74.21 109.492 175.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 53.4 m -84.29 124.41 31.22 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.994 -0.743 . . . . 75.31 108.994 169.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.851 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -70.07 -54.86 11.24 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.462 0.705 . . . . 52.03 109.457 176.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -163.85 163.24 23.86 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.101 -0.954 . . . . 73.04 110.906 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.41 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.5 tm? -126.94 141.25 51.85 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 106.635 -1.617 . . . . 64.11 106.635 167.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.45 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.9 t -141.17 150.72 43.12 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.976 -0.749 . . . . 52.03 108.976 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -158.18 136.45 10.89 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.321 0.648 . . . . 65.33 109.853 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -135.82 114.21 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 124.496 1.118 . . . . 64.1 108.201 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.415 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 68.7 mt-30 -94.19 88.25 5.54 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.562 -0.903 . . . . 74.5 108.562 173.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -81.01 95.51 6.83 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.243 -0.89 . . . . 75.22 109.743 -176.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -83.58 149.1 25.53 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 116.016 -0.538 . . . . 31.25 112.23 178.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.08 125.49 1.79 Allowed Glycine 0 CA--C 1.505 -0.586 0 N-CA-C 111.143 -0.783 . . . . 71.44 111.143 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.581 HD11 ' HB3' ' D' ' 29' ' ' PRO . 26.4 mm -85.29 130.8 35.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 N-CA-C 108.475 -0.935 . . . . 64.15 108.475 175.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -135.75 118.76 16.38 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.474 0.71 . . . . 74.23 109.977 -178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 64.7 m -76.87 102.44 6.34 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.898 -0.778 . . . . 64.53 108.898 171.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.632 HG21 ' HE1' ' C' ' 94' ' ' MET . 22.3 mt -116.95 137.87 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 108.69 -0.855 . . . . 74.12 108.69 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -145.44 169.82 17.59 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.355 0.662 . . . . 64.52 109.309 176.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 88' ' ' GLY . . . . . 0.543 ' HA3' ' H ' ' C' ' 9' ' ' MET . . . 91.62 -15.5 61.37 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 114.881 0.713 . . . . 75.11 114.881 169.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.449 HD11 ' HE1' ' C' ' 94' ' ' MET . 27.6 pt -117.14 169.66 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-N 117.762 0.781 . . . . 74.02 111.561 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -159.97 152.03 20.51 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.289 -0.869 . . . . 73.11 109.995 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.67 -126.86 9.28 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 123.524 0.515 . . . . 70.44 113.345 172.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 35.5 p -67.37 -26.01 66.25 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.129 0.971 . . . . 61.54 111.828 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -65.57 -52.92 48.7 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.692 0.797 . . . . 70.31 109.711 174.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.632 ' HE1' HG21 ' C' ' 86' ' ' ILE . 5.5 tpt -54.14 -48.7 70.55 Favored 'General case' 0 C--N 1.353 0.72 0 CA-C-N 114.916 -1.038 . . . . 73.2 112.096 172.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.84 83.07 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.313 0.645 . . . . 61.22 111.181 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -68.05 -34.23 76.06 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.257 -0.883 . . . . 74.32 111.342 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.448 ' SG ' HD13 ' C' ' 86' ' ' ILE . 33.7 t -72.86 -42.08 64.08 Favored 'General case' 0 C--N 1.347 0.488 0 N-CA-C 109.392 -0.595 . . . . 74.22 109.392 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 92.3 mt -77.46 -28.79 52.47 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.959 0.904 . . . . 63.25 112.518 -175.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -114.44 11.1 21.73 Favored Glycine 0 N--CA 1.477 1.423 0 CA-C-O 119.597 -0.557 . . . . 55.25 114.27 -170.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.22 -55.05 0.12 Allowed 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 117.52 0.66 . . . . 55.44 111.846 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -70.4 -55.25 9.53 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.061 0.544 . . . . 73.32 111.705 -173.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.525 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 50.3 m -68.31 -43.92 34.63 Favored Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 123.764 0.826 . . . . 70.25 112.454 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.454 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 72.6 Cg_exo -55.62 -27.58 61.15 Favored 'Trans proline' 0 C--N 1.399 3.188 0 C-N-CA 122.402 2.068 . . . . 71.13 114.182 172.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -67.67 -35.42 78.82 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.328 0.651 . . . . 72.1 110.75 176.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.463 HD12 ' NH1' ' A' ' 111' ' ' ARG . 49.7 mm -75.71 -32.42 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.358 0.663 . . . . 74.43 110.212 177.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.75 -28.79 55.86 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.867 0.867 . . . . 54.24 111.79 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -56.78 -48.78 96.69 Favored Pre-proline 0 N--CA 1.482 1.175 0 N-CA-C 114.458 1.281 . . . . 71.13 114.458 -173.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.63 -38.69 92.64 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 121.895 1.73 . . . . 73.0 113.119 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -67.54 -43.56 80.41 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.832 0.853 . . . . 74.14 110.671 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.402 ' O ' HG13 ' C' ' 114' ' ' ILE . . . -65.22 -39.6 92.98 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.548 -0.751 . . . . 75.24 110.338 176.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -59.65 -49.89 75.97 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.205 1.402 . . . . 73.43 110.527 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.74 -37.8 88.83 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 123.944 0.778 . . . . 75.42 109.727 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.7 t -69.54 -33.13 72.35 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.176 0.59 . . . . 72.43 111.593 -176.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.509 HD11 ' HB ' ' C' ' 62' ' ' VAL . 88.2 mt -71.98 -51.91 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.236 0.614 . . . . 53.03 109.54 176.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.2 m -67.24 -29.23 68.81 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 123.695 0.622 . . . . 75.42 111.193 -175.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 48.3 t -63.47 -46.53 85.8 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.523 0.729 . . . . 74.34 109.077 172.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.532 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.53 -35.46 81.03 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.018 0.927 . . . . 62.53 112.32 178.105 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' C' ' 123' ' ' PHE . 95.4 t -68.85 -36.63 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.346 0.658 . . . . 53.21 109.71 174.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.0 t -71.13 -32.31 68.83 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.18 0.992 . . . . 64.43 111.447 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' C' ' 116' ' ' SER . 81.2 mtt-85 -73.3 -39.19 65.52 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.17 -0.678 . . . . 53.04 109.17 177.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.49 -3.72 78.59 Favored Glycine 0 C--N 1.353 1.488 0 O-C-N 123.928 0.767 . . . . 51.33 112.663 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 25.7 p 63.11 28.66 16.11 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 126.797 2.039 . . . . 64.55 113.627 170.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.427 ' HB2' HG13 ' C' ' 118' ' ' VAL . 94.8 m-85 -82.62 161.22 59.58 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.663 0.785 . . . . 72.33 109.077 169.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.402 ' HG3' HG21 ' F' ' 129' ' ' THR . 78.4 Cg_exo -51.91 140.94 47.51 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.815 2.343 . . . . 74.51 112.817 172.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -55.35 109.17 0.5 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.312 1.045 . . . . 71.11 112.323 -175.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 56.4 tp -112.02 88.43 2.81 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.318 -0.623 . . . . 71.0 109.318 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -90.54 123.04 33.89 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.783 -0.821 . . . . 73.24 108.783 177.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.67 140.55 51.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.659 0.784 . . . . 73.51 110.781 -176.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.528 ' HB2' HG12 ' F' ' 135' ' ' VAL . . . -76.95 155.17 82.91 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 115.33 -0.85 . . . . 71.24 111.058 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.658 ' HG2' HG21 ' A' ' 13' ' ' ILE . 39.6 Cg_exo -55.55 106.99 0.21 Allowed 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.995 2.463 . . . . 61.43 112.132 173.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 18.3 t -99.6 120.59 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 108.361 -0.977 . . . . 74.33 108.361 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 132' ' ' ASN . . . . . 0.406 ' O ' ' HG ' ' C' ' 136' ' ' LEU . 56.5 t-20 -79.53 100.9 7.96 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.82 0.848 . . . . 75.55 109.751 -176.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.459 ' CE1' HD13 ' C' ' 44' ' ' LEU . 93.6 m-85 -66.47 -29.13 69.19 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.826 0.85 . . . . 63.24 112.48 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -64.28 -42.79 96.25 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.341 0.657 . . . . 65.22 109.605 176.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.42 -36.38 81.15 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.229 -0.896 . . . . 75.4 110.858 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' C' ' 132' ' ' ASN . 54.0 mt -66.63 -38.9 87.88 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.902 0.481 . . . . 73.45 110.779 177.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -73.69 -26.99 60.99 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.367 -0.833 . . . . 65.14 110.41 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 47.2 ttm -66.07 -48.78 69.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.039 0.936 . . . . 61.22 110.651 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -71.36 -34.37 70.41 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 116.287 -0.415 . . . . 64.21 110.907 176.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -71.7 -155.72 0.03 OUTLIER 'General case' 0 CA--C 1.579 2.083 0 C-N-CA 123.316 0.646 . . . . 74.23 109.679 169.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.521 ' HG ' ' H ' ' C' ' 143' ' ' GLN . 22.0 tp 65.26 161.3 0.13 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.791 1.237 . . . . 71.24 111.034 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -131.48 16.18 4.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.049 -1.032 . . . . 41.45 111.078 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 143' ' ' GLN . . . . . 0.521 ' H ' ' HG ' ' C' ' 141' ' ' LEU . 4.6 tp60 -155.21 -157.74 0.77 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 108.908 -0.775 . . . . 72.5 108.908 -172.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -149.12 171.37 16.53 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.457 0.703 . . . . 53.02 110.023 175.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -127.23 145.18 50.86 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.291 1.036 . . . . 61.42 109.368 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -167.24 74.17 0.14 Allowed Glycine 0 C--N 1.342 0.887 0 N-CA-C 111.118 -0.793 . . . . 55.43 111.118 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -152.73 91.69 1.58 Allowed 'General case' 0 C--O 1.24 0.59 0 N-CA-C 109.11 -0.7 . . . . 63.5 109.11 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -91.66 130.89 10.51 Favored Glycine 0 C--N 1.344 1.024 0 N-CA-C 111.077 -0.809 . . . . 61.32 111.077 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 2.3 t -151.48 128.84 11.29 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.568 0.747 . . . . 75.32 110.03 -174.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -138.46 70.45 1.38 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.337 0.655 . . . . 74.02 110.678 -171.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -159.73 148.29 17.5 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.583 0.353 . . . . 74.04 111.438 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -170.86 31.02 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.03 1.332 . . . . 74.24 109.982 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -67.19 97.98 0.57 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.553 0.741 . . . . 72.45 110.829 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -94.11 124.73 38.31 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.473 -0.936 . . . . 70.01 108.473 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.185 0 C-N-CA 123.562 0.745 . . . . 54.3 109.458 -175.124 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mmt . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 110.152 -0.314 . . . . 74.45 110.152 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 68.4 p -78.54 73.57 5.09 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.483 0.713 . . . . 73.3 109.397 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.55 147.69 41.54 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.989 0.915 . . . . 63.45 111.703 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -158.2 129.9 6.74 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.721 0.808 . . . . 70.24 109.921 -176.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -143.49 144.39 31.96 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.272 1.029 . . . . 73.22 109.465 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -76.37 111.89 12.3 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.376 0.67 . . . . 53.42 110.303 -177.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 13.3 p -137.29 156.07 48.7 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.406 1.082 . . . . 62.11 109.326 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -74.31 176.64 6.51 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 109.454 -0.573 . . . . 74.2 109.454 175.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 18.3 121.13 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 127.179 2.192 . . . . 70.32 115.853 -165.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -139.09 150.76 46.08 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.731 -0.668 . . . . 63.34 110.855 -175.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.438 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 69.8 t80 -138.91 106.3 5.54 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 106.418 -1.697 . . . . 74.45 106.418 175.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 12' ' ' GLN . . . . . 0.483 ' HB2' ' OG ' ' D' ' 85' ' ' SER . 41.9 mt-30 -119.6 116.89 26.94 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.409 -0.589 . . . . 65.33 109.409 -175.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.556 HG21 HD11 ' D' ' 16' ' ' ILE . 63.1 mt -78.94 118.77 26.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.29 -1.004 . . . . 53.43 108.29 174.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 14' ' ' GLN . . . . . 0.486 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 8.5 mm-40 -95.84 -39.71 9.69 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.433 0.293 . . . . 62.11 110.474 -174.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -173.36 137.87 0.68 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.699 0.4 . . . . 74.33 110.166 -176.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.556 HD11 HG21 ' D' ' 13' ' ' ILE . 3.5 mp -115.09 142.4 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 107.195 -1.409 . . . . 65.11 107.195 172.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -163.12 147.27 11.08 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.305 0.642 . . . . 61.23 110.866 175.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.6 p -82.59 114.39 20.95 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.059 -0.973 . . . . 74.33 109.39 175.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -87.24 -15.76 37.23 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.919 0.888 . . . . 64.34 109.634 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.675 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.9 t70 -163.34 130.85 3.54 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.81 1.244 . . . . 63.23 109.081 -177.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.532 HG21 ' HE2' ' C' ' 117' ' ' MET . 76.2 mt -134.56 142.86 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.225 -1.028 . . . . 72.51 108.225 173.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.9 t -143.17 137.25 28.91 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.502 1.121 . . . . 54.33 108.556 172.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.507 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.1 t80 -135.44 121.44 19.96 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.134 -1.802 . . . . 75.23 106.134 166.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 40.5 mt-10 -127.08 110.49 12.98 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.662 0.785 . . . . 73.35 109.054 -177.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.99 89.14 3.45 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 107.761 -1.199 . . . . 40.42 107.761 171.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -71.46 -37.74 5.28 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.596 2.197 . . . . 71.0 112.314 -174.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -99.44 4.55 46.19 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.085 0.954 . . . . 74.42 110.367 -174.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.404 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -25.14 -70.22 0.05 OUTLIER Pre-proline 0 CA--C 1.564 1.514 0 C-N-CA 127.471 2.309 . . . . 74.24 116.62 -166.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.581 ' HB3' HD11 ' C' ' 83' ' ' ILE . 76.7 Cg_endo -76.99 -19.76 13.58 Favored 'Trans proline' 0 C--N 1.382 2.291 0 CA-C-N 123.293 2.212 . . . . 72.43 113.95 -171.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -78.56 -38.55 40.05 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.274 1.03 . . . . 72.24 109.922 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.746 HG21 ' HA ' ' D' ' 73' ' ' ALA . 11.1 p -82.8 -19.53 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 CA-C-N 115.61 -0.723 . . . . 65.24 111.574 -171.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -62.9 -23.39 67.33 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 112.558 0.577 . . . . 74.44 112.558 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -57.1 -31.1 64.92 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.346 1.058 . . . . 74.54 110.668 177.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -84.92 78.93 9.8 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.905 1.282 . . . . 71.21 110.047 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -79.87 83.79 5.75 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 121.684 0.754 . . . . 70.44 110.698 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -157.77 -179.08 7.81 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.508 -0.923 . . . . 73.41 108.508 167.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -64.02 114.48 13.89 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 123.771 0.828 . . . . 71.34 110.693 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.434 ' O ' HG23 ' D' ' 40' ' ' VAL . 60.5 Cg_exo -56.46 122.69 12.24 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 121.897 1.732 . . . . 72.34 110.677 171.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -66.43 110.58 3.17 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 107.391 -1.337 . . . . 74.34 107.391 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.728 HG21 HD13 ' D' ' 126' ' ' LEU . 85.2 t -100.82 136.71 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.987 0.915 . . . . 74.54 110.845 -170.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -111.0 119.34 38.73 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.507 -0.923 . . . . 60.31 108.507 167.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 63.2 tp -96.94 143.23 28.01 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.194 -0.669 . . . . 73.2 109.194 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.669 ' HA ' HD22 ' E' ' 112' ' ' ASN . 31.5 t70 -142.15 144.14 33.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.041 -0.981 . . . . 61.12 108.575 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.71 ' HB2' ' HB3' ' E' ' 111' ' ' LEU . 72.8 mt -134.65 133.89 40.58 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.393 -0.965 . . . . 65.43 108.393 -177.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 16.4 t70 -134.04 151.18 51.32 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.847 1.259 . . . . 70.13 107.764 177.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.22 163.58 14.19 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.506 0.67 . . . . 72.43 111.396 -175.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -167.25 147.7 5.48 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 113.84 -1.527 . . . . 75.43 107.382 169.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 29.0 p -161.36 147.47 14.26 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.835 -0.431 . . . . 54.45 109.835 171.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.567 ' HA ' HD21 ' E' ' 102' ' ' LEU . 35.4 p -177.88 128.99 0.14 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.441 0.696 . . . . 74.4 110.233 -176.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 50' ' ' GLN . . . . . 0.524 ' HB2' ' H ' ' D' ' 57' ' ' GLU . 10.7 tm0? -160.76 -85.46 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 106.736 -1.579 . . . . 62.34 106.736 171.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.411 ' H ' ' HB3' ' D' ' 50' ' ' GLN . 80.0 mt -138.15 -160.36 1.05 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.962 1.305 . . . . 71.15 107.545 170.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.536 ' HA ' ' HE2' ' D' ' 56' ' ' TYR . . . -133.38 78.45 1.78 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.566 -0.902 . . . . 55.12 108.566 170.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -163.97 50.58 0.14 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.646 -0.706 . . . . 73.33 109.496 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' D' ' 85' ' ' SER . 0.0 OUTLIER 72.88 -6.05 1.76 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 126.2 1.8 . . . . 61.2 113.419 177.126 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.96 105.52 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 108.869 -0.789 . . . . 64.43 108.869 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.536 ' HE2' ' HA ' ' D' ' 52' ' ' ALA . 47.0 m-85 -132.19 131.62 42.37 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.228 0.611 . . . . 74.44 110.478 -174.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.699 ' HG2' HG13 ' D' ' 83' ' ' ILE . 53.4 mt-10 -90.11 111.68 22.89 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.897 -0.779 . . . . 73.34 108.897 168.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 84.1 t -100.85 135.91 34.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 O-C-N 124.112 0.882 . . . . 73.3 109.379 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.527 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 47.2 t -122.78 133.96 67.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.033 1.333 . . . . 54.24 108.199 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.475 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -113.82 117.44 31.45 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.506 -1.294 . . . . 70.41 107.506 174.908 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.416 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 50.0 ttm-85 -93.87 95.02 8.83 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.419 -1.326 . . . . 70.11 107.419 174.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 49.0 t -91.11 144.13 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.44 -0.948 . . . . 72.33 108.44 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 36.0 m -139.87 141.25 36.61 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.036 -0.727 . . . . 62.13 109.036 -176.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.644 HG13 HG13 ' D' ' 40' ' ' VAL . 50.5 t -132.97 128.66 56.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 124.465 1.106 . . . . 75.14 108.49 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 56.6 m -125.01 93.37 3.87 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.371 -1.344 . . . . 65.4 107.371 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -95.71 154.59 17.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.941 -0.763 . . . . 74.42 108.941 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 28.7 p -153.37 132.56 12.67 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 123.331 0.394 . . . . 75.1 110.878 -173.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.496 HD12 HG22 ' D' ' 31' ' ' VAL . 52.1 mt -105.42 112.42 25.52 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.167 -1.049 . . . . 73.21 108.167 174.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.88 -133.42 15.3 Favored Glycine 0 C--N 1.345 1.057 0 O-C-N 123.38 0.425 . . . . 74.34 112.563 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.77 2.5 56.72 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.969 0.507 . . . . 75.4 111.758 -178.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -123.3 160.89 25.73 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.207 0.603 . . . . 74.54 110.528 -176.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 94.6 m -64.59 140.51 58.87 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.108 0.963 . . . . 72.34 110.992 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.746 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -92.33 -62.49 1.39 Allowed 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.855 -1.165 . . . . 74.14 107.855 172.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.84 165.78 35.55 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 114.347 -1.297 . . . . 64.14 109.937 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 87.5 mt -132.32 153.02 51.14 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.616 1.566 . . . . 54.35 107.257 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.652 ' SG ' HG12 ' D' ' 114' ' ' ILE . 53.0 t -158.61 145.1 17.2 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.747 0.419 . . . . 52.13 110.168 -177.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -154.54 126.8 7.84 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 123.103 0.561 . . . . 73.11 110.168 172.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 95.3 t -128.76 116.69 42.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 124.033 0.933 . . . . 75.1 109.059 -178.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.675 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.5 mt-30 -87.98 86.32 7.11 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.899 0.857 . . . . 64.53 108.863 168.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -82.46 97.9 8.63 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 113.831 -1.531 . . . . 73.11 109.394 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -96.2 166.62 24.58 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-N 116.48 -0.327 . . . . 60.11 112.706 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.7 153.26 12.97 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-O 119.837 -0.424 . . . . 63.22 112.783 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.699 HG13 ' HG2' ' D' ' 57' ' ' GLU . 3.0 mp -94.24 128.6 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 108.083 -1.08 . . . . 71.13 108.083 176.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -131.35 124.59 30.7 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.165 -1.05 . . . . 73.42 108.165 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' D' ' 54' ' ' ASP . 51.4 p -95.92 126.43 41.17 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 109.06 -0.719 . . . . 75.12 109.06 174.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.415 HG13 HD11 ' E' ' 97' ' ' ILE . 31.2 pt -133.61 129.39 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.452 -0.944 . . . . 74.43 108.452 -170.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.07 167.93 28.98 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.263 0.225 . . . . 63.1 111.18 -171.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.03 23.43 71.77 Favored Glycine 0 C--N 1.353 1.485 0 O-C-N 124.122 0.888 . . . . 74.02 114.484 171.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.673 HD13 ' HA ' ' D' ' 94' ' ' MET . 0.7 OUTLIER -133.54 155.45 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.158 0.583 . . . . 70.54 110.593 177.637 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.33 177.19 8.1 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.824 -1.08 . . . . 73.22 109.506 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.79 -140.78 25.49 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 123.29 0.368 . . . . 42.12 113.108 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 81.8 p -77.32 -43.09 34.3 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.772 0.829 . . . . 50.34 111.107 -175.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -57.96 -33.36 68.76 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.34 1.056 . . . . 74.21 111.771 -177.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.673 ' HA ' HD13 ' D' ' 89' ' ' ILE . 1.6 tmt? -47.56 -60.66 2.38 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.522 1.529 . . . . 74.44 112.729 -176.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.15 -15.7 46.19 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.204 0.601 . . . . 60.11 112.034 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -76.95 -17.52 58.85 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 122.859 0.464 . . . . 71.24 111.895 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 71.5 m -60.7 -44.26 96.77 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.586 0.354 . . . . 75.44 111.135 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.504 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 4.3 pp -79.27 -30.35 43.0 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.1 0.56 . . . . 75.25 111.816 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.55 -29.09 25.24 Favored Glycine 0 C--N 1.35 1.335 0 O-C-N 123.247 0.342 . . . . 55.44 113.669 -172.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.42 -57.12 2.02 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.447 0.699 . . . . 61.11 111.336 -171.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -72.87 -38.96 66.83 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 112.225 0.454 . . . . 61.4 112.225 -171.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.504 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 72.1 m -66.97 -46.1 53.58 Favored Pre-proline 0 CA--C 1.567 1.609 0 CA-C-O 118.679 -0.677 . . . . 71.44 111.937 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.475 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.4 Cg_exo -59.54 -32.0 95.46 Favored 'Trans proline' 0 C--N 1.393 2.913 0 C-N-CA 122.016 1.81 . . . . 73.51 112.911 169.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -64.63 -29.02 70.02 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.076 0.55 . . . . 71.22 111.125 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.407 ' O ' ' HD2' ' D' ' 108' ' ' PRO . 46.2 mm -78.23 -33.86 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.812 0.845 . . . . 73.1 110.786 174.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 65.3 mt -74.63 -18.79 60.49 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.24 0.616 . . . . 74.13 111.752 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -66.28 -45.81 60.63 Favored Pre-proline 0 CA--C 1.559 1.315 0 CA-C-O 118.195 -0.907 . . . . 75.31 113.306 -176.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 108' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' D' ' 105' ' ' ILE . 81.7 Cg_exo -52.37 -42.57 59.95 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.371 2.047 . . . . 72.32 114.323 171.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -71.99 -40.44 68.55 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.554 0.742 . . . . 70.35 111.49 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.03 -44.72 91.71 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.623 -0.717 . . . . 73.55 109.912 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.522 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 27.3 ttp180 -57.72 -49.1 77.66 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.74 1.275 . . . . 70.41 110.311 178.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -58.71 -49.02 79.12 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.373 1.045 . . . . 74.34 110.45 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 43.1 t -57.26 -45.64 83.8 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 124.031 0.832 . . . . 54.01 111.186 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.652 HG12 ' SG ' ' D' ' 76' ' ' CYS . 89.0 mt -61.17 -55.94 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.772 0.829 . . . . 74.32 110.673 175.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 90.7 m -52.86 -42.3 65.1 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 124.764 1.226 . . . . 72.25 111.088 -174.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 29.9 t -66.69 -43.14 85.18 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.492 -1.231 . . . . 44.44 109.863 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.6 mtm -70.69 -26.93 63.65 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.056 0.543 . . . . 32.03 111.941 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.472 HG21 ' HB3' ' D' ' 126' ' ' LEU . 79.8 t -64.73 -47.75 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.384 0.674 . . . . 71.42 109.38 173.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.9 p -72.82 -28.94 62.86 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.569 -0.741 . . . . 75.01 110.559 -178.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' D' ' 116' ' ' SER . 76.4 mtt-85 -71.16 -27.17 63.34 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.757 0.823 . . . . 73.14 110.097 173.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.46 8.87 79.11 Favored Glycine 0 C--N 1.351 1.398 0 CA-C-O 119.354 -0.692 . . . . 34.24 112.615 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.404 HG23 ' HB3' ' C' ' 17' ' ' TYR . 69.7 p 55.88 40.81 30.54 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.781 1.632 . . . . 64.54 113.761 177.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -105.93 152.95 40.4 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 109.001 -0.74 . . . . 75.33 109.001 170.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -48.91 133.46 28.08 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.024 2.483 . . . . 73.4 112.141 171.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -55.78 128.6 35.7 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 124.308 1.005 . . . . 75.04 112.389 -170.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.728 HD13 HG21 ' D' ' 40' ' ' VAL . 14.2 tp -111.23 102.57 10.98 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.139 0.976 . . . . 70.41 108.973 -176.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -100.9 104.39 15.59 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.647 -1.242 . . . . 53.1 107.647 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.522 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.2 mm? -64.32 114.75 4.47 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.189 0.595 . . . . 75.4 109.806 -177.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.14 132.76 93.94 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 123.105 0.562 . . . . 75.34 111.023 -174.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -61.43 116.66 3.55 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.06 2.507 . . . . 73.32 112.357 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 131' ' ' VAL . . . . . 0.426 HG11 HG23 ' E' ' 121' ' ' VAL . 7.2 p -110.54 136.1 47.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 N-CA-C 108.901 -0.777 . . . . 73.41 108.901 176.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -80.65 113.13 18.63 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.798 -0.816 . . . . 55.21 108.798 176.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -62.17 -40.02 94.63 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.027 0.931 . . . . 71.22 110.952 -177.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -51.59 -33.2 31.69 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.856 1.262 . . . . 73.21 112.481 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.26 -35.63 81.45 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.461 0.704 . . . . 32.43 111.572 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.534 ' HB3' ' HB1' ' E' ' 110' ' ' ALA . 2.5 mm? -75.33 -28.89 59.81 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.224 0.61 . . . . 74.25 111.389 178.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -75.54 -37.4 60.04 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.831 0.453 . . . . 73.31 110.649 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 73.7 mtm -71.43 -25.8 62.47 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.033 0.533 . . . . 73.35 110.297 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.518 ' O ' ' HG2' ' D' ' 143' ' ' GLN . 24.5 t-20 -67.29 -43.93 80.5 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.267 0.627 . . . . 43.35 109.6 169.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 140' ' ' TYR . . . . . 0.458 ' HD1' ' HG2' ' E' ' 114' ' ' LYS . 90.2 t80 -57.94 -43.32 86.29 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.841 0.857 . . . . 74.31 111.938 -176.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.59 -35.46 81.07 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.927 -0.578 . . . . 61.22 111.355 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -91.36 30.72 1.24 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 122.978 0.511 . . . . 62.42 111.273 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 143' ' ' GLN . . . . . 0.518 ' HG2' ' O ' ' D' ' 139' ' ' ASN . 31.2 mm-40 -118.22 52.29 1.03 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.266 1.026 . . . . 55.12 108.338 174.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -167.77 154.08 7.71 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-N 114.292 -1.322 . . . . 54.3 108.693 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.1 86.6 0.06 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.435 0.694 . . . . 61.44 110.218 174.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -164.63 40.86 0.3 Allowed Glycine 0 C--N 1.338 0.688 0 CA-C-N 114.987 -1.006 . . . . 73.33 111.075 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -89.18 161.37 16.49 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.907 0.883 . . . . 61.41 109.991 -178.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.49 75.72 0.66 Allowed Glycine 0 C--N 1.343 0.932 0 N-CA-C 110.76 -0.936 . . . . 54.3 110.76 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 3.3 t -141.33 100.58 3.82 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.999 0.92 . . . . 61.31 109.628 -176.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -170.33 149.42 3.39 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.332 1.053 . . . . 63.43 110.033 -176.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -143.89 89.46 2.05 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.084 0.953 . . . . 65.11 108.72 172.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -84.61 86.62 7.29 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.771 0.796 . . . . 73.35 109.133 170.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -136.99 111.96 8.94 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.557 0.743 . . . . 64.45 109.829 -176.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -132.57 158.81 41.23 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.316 1.046 . . . . 55.22 109.449 176.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.14 0 N-CA-C 108.671 -0.863 . . . . 74.1 108.671 177.486 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.948 0 N-CA-C 112.273 -0.331 . . . . 22.33 112.273 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.3 -87.84 0.5 Allowed Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.131 -0.788 . . . . 44.01 111.131 -172.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -172.76 173.89 3.77 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.959 1.304 . . . . 64.23 109.835 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 51.3 t80 67.92 -72.04 0.1 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.903 1.681 . . . . 73.44 112.897 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm 77.21 106.28 0.08 Allowed 'General case' 0 C--N 1.363 1.181 0 C-N-CA 125.774 1.629 . . . . 70.54 109.452 -173.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 96' ' ' GLY . . . . . 0.489 ' H ' ' HB3' ' D' ' 54' ' ' ASP . . . -131.87 -69.28 0.09 OUTLIER Glycine 0 C--N 1.337 0.602 0 N-CA-C 111.566 -0.614 . . . . 60.13 111.566 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 97' ' ' ILE . . . . . 0.476 ' HB ' ' HE2' ' D' ' 94' ' ' MET . 34.9 pt -123.66 131.65 72.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.516 0.727 . . . . 75.45 109.333 177.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -122.32 -47.1 2.14 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.228 0.611 . . . . 75.35 111.391 -172.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.14 79.77 6.65 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.331 0.586 . . . . 70.2 111.247 -173.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 100' ' ' LEU . . . . . . . . . . . . . 2.0 pp -140.83 150.31 59.31 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 124.343 1.057 . . . . 74.44 109.123 172.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.03 -3.33 13.11 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 122.487 2.125 . . . . 71.43 113.059 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 102' ' ' LEU . . . . . 0.567 HD21 ' HA ' ' D' ' 49' ' ' SER . 25.0 tp 61.48 27.24 16.83 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.342 1.057 . . . . 74.53 109.872 -178.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 17.3 p 49.17 36.9 9.84 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.385 1.474 . . . . 72.34 112.452 -175.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.7 24.33 67.65 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.626 -0.716 . . . . 74.14 113.494 176.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 105' ' ' GLN . . . . . 0.541 ' HG3' HD23 ' E' ' 102' ' ' LEU . 1.4 mp0 59.99 10.69 2.3 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 125.112 1.365 . . . . 64.01 113.378 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -150.29 -40.19 0.13 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 122.104 -0.373 . . . . 72.12 110.294 -170.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 7.3 m 66.94 -78.42 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.272 1.029 . . . . 62.33 109.648 -176.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 76.1 -52.76 0.61 Allowed 'General case' 0 C--N 1.36 1.052 0 C-N-CA 126.016 1.726 . . . . 73.23 112.946 173.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -59.23 149.98 26.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.664 0.786 . . . . 73.05 112.602 -171.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 110' ' ' ALA . . . . . 0.534 ' HB1' ' HB3' ' D' ' 136' ' ' LEU . . . 70.07 -151.67 0.11 Allowed 'General case' 0 CA--C 1.554 1.108 0 O-C-N 124.429 1.08 . . . . 75.31 111.321 174.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 111' ' ' LEU . . . . . 0.71 ' HB3' ' HB2' ' D' ' 44' ' ' LEU . 7.1 mp 73.78 -1.51 3.04 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.652 1.581 . . . . 61.45 113.424 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 112' ' ' ASN . . . . . 0.669 HD22 ' HA ' ' D' ' 43' ' ' ASP . 20.6 t-20 -176.88 -58.0 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.644 1.178 . . . . 73.02 107.909 -177.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -103.97 -159.0 0.69 Allowed 'General case' 0 C--O 1.243 0.723 0 CA-C-N 114.062 -1.427 . . . . 71.5 109.599 -176.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 114' ' ' LYS . . . . . 0.458 ' HG2' ' HD1' ' D' ' 140' ' ' TYR . 49.1 tptt 65.45 38.61 5.56 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 122.435 1.112 . . . . 71.41 109.213 -175.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 9.0 t -164.42 -43.44 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.412 -1.267 . . . . 72.15 109.671 -177.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 149.01 -96.06 0.17 Allowed Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.518 -1.033 . . . . 51.43 110.518 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -92.83 157.22 39.87 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 123.774 0.829 . . . . 74.11 110.632 -172.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -83.6 17.27 1.71 Allowed 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.66 2.906 . . . . 73.53 113.045 172.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -60.31 -30.19 69.34 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.983 0.913 . . . . 75.14 112.573 -174.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -75.83 -54.83 6.3 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.013 0.525 . . . . 61.4 110.956 -177.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 121' ' ' VAL . . . . . 0.426 HG23 HG11 ' D' ' 131' ' ' VAL . 8.5 p -71.19 -39.79 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.356 0.662 . . . . 72.05 110.803 -177.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 33.7 m -99.63 78.98 2.2 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.377 1.071 . . . . 72.33 108.15 176.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -96.19 107.88 20.27 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.666 -1.235 . . . . 55.2 107.666 171.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 21.6 p -77.85 116.92 18.73 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.961 -0.563 . . . . 73.12 110.628 -174.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -151.91 -161.09 1.25 Allowed 'General case' 0 C--O 1.246 0.918 0 C-N-CA 125.028 1.331 . . . . 71.41 107.891 172.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . 66.1 -178.24 0.19 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.845 0.858 . . . . 70.12 110.999 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 33.0 p -157.49 -74.75 0.09 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 110.023 -0.362 . . . . 72.32 110.023 175.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . 56.03 27.37 11.22 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.969 0.907 . . . . 75.23 111.756 -175.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 24.1 p -79.84 89.93 5.27 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 124.294 1.038 . . . . 52.42 110.932 -173.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -149.8 96.75 2.51 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.832 0.853 . . . . 62.22 108.918 176.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 131' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -149.36 98.3 2.77 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.902 0.881 . . . . 72.51 108.879 177.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 132' ' ' SER . . . . . 0.651 ' H ' ' HB3' ' A' ' 124' ' ' PRO . 32.5 t -174.88 103.08 0.09 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.108 1.363 . . . . 65.02 108.026 176.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 30.6 m -119.8 105.5 11.18 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.653 0.381 . . . . 50.4 110.739 -178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.23 87.21 1.0 Allowed Glycine 0 C--N 1.34 0.8 0 N-CA-C 109.653 -1.379 . . . . 71.01 109.653 167.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 82.6 t -59.68 -56.99 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.553 0.741 . . . . 64.25 109.978 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 65.9 -7.28 0.38 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.088 1.355 . . . . 64.5 113.96 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 137' ' ' THR . . . . . 0.665 HG22 ' H ' ' E' ' 139' ' ' ASN . 30.0 m 69.86 148.61 0.07 Allowed 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 124.956 1.303 . . . . 63.11 111.039 -168.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -55.08 -34.99 64.09 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.55 0.69 . . . . 71.12 110.181 171.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 139' ' ' ASN . . . . . 0.665 ' H ' HG22 ' E' ' 137' ' ' THR . 24.7 t-20 -91.31 85.29 5.78 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 107.808 -1.182 . . . . 63.31 107.808 167.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.57 138.36 35.77 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 115.323 -0.853 . . . . 41.21 112.934 -174.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.89 141.32 58.81 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.237 0.615 . . . . 63.12 111.094 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 89.9 mt -59.89 137.43 58.07 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.365 0.666 . . . . 64.41 110.778 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -72.65 74.2 0.93 Allowed Glycine 0 C--N 1.348 1.235 0 O-C-N 123.946 0.779 . . . . 53.21 112.001 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 13.0 m -88.83 84.69 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.191 0.996 . . . . 70.23 110.003 -174.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 16.1 t70 . . . . . 0 C--O 1.252 1.199 0 N-CA-C 108.25 -1.019 . . . . 64.22 108.25 -175.263 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.796 0 N-CA-C 112.079 -0.408 . . . . 62.3 112.079 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.26 -53.92 40.62 Favored Glycine 0 C--N 1.355 1.603 0 N-CA-C 114.146 0.418 . . . . 53.34 114.146 -172.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 93' ' ' PHE . . . . . 0.489 ' HD2' HG21 ' B' ' 55' ' ' VAL . 86.6 m-85 -70.73 97.52 1.38 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.799 0.84 . . . . 64.41 110.671 -178.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 94' ' ' PHE . . . . . 0.42 ' CD2' HG21 ' B' ' 10' ' ' THR . 70.4 t80 -95.18 160.42 14.56 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.453 0.701 . . . . 71.01 109.381 175.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -136.3 149.84 48.62 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.179 0.592 . . . . 54.32 112.451 -173.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.72 51.35 0.01 OUTLIER Glycine 0 C--N 1.351 1.413 0 CA-C-N 115.443 -0.799 . . . . 73.15 112.309 174.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 97' ' ' ILE . . . . . 0.505 ' HB ' ' HA ' ' B' ' 87' ' ' ALA . 7.2 tt -152.48 -20.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 124.502 1.121 . . . . 64.54 109.828 -177.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 98' ' ' ASP . . . . . 0.428 ' H ' ' H ' ' F' ' 97' ' ' ILE . 33.6 t70 65.93 -96.33 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.891 1.676 . . . . 53.03 112.009 177.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -98.78 144.13 28.35 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.635 0.774 . . . . 72.4 109.951 -172.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 100' ' ' LEU . . . . . . . . . . . . . 3.0 mp -128.19 86.17 58.65 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 123.198 0.599 . . . . 73.25 109.726 -177.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.92 -61.36 0.25 Allowed 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.632 2.221 . . . . 72.21 112.141 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 102' ' ' LEU . . . . . 0.414 HD23 ' HB1' ' B' ' 95' ' ' ALA . 2.2 tm? 56.55 94.53 0.02 OUTLIER 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.908 1.283 . . . . 72.34 109.824 -173.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 32.0 p 66.14 -63.69 0.23 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.384 1.874 . . . . 60.45 111.752 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 178.17 -38.46 0.08 OUTLIER Glycine 0 C--N 1.339 0.731 0 N-CA-C 110.959 -0.856 . . . . 63.12 110.959 173.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -170.97 -51.68 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.222 1.009 . . . . 72.54 109.493 -175.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -131.21 118.57 20.61 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.694 0.797 . . . . 74.11 109.384 -174.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 27.9 m -64.81 121.28 14.22 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.734 0.814 . . . . 74.33 110.656 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -128.31 7.46 5.92 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.533 0.733 . . . . 72.3 110.795 -177.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -82.15 73.11 9.2 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.723 0.809 . . . . 75.33 109.53 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 60.31 -167.92 0.17 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.179 0.992 . . . . 75.31 110.031 -170.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 86.2 mt 53.6 74.2 0.33 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.666 0.787 . . . . 72.41 111.204 176.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -160.07 -64.0 0.07 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.477 -0.783 . . . . 64.15 109.961 -171.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 113' ' ' LYS . . . . . 0.564 ' HE3' ' HB ' ' F' ' 115' ' ' THR . 54.3 pttt -175.3 -165.76 0.19 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.065 0.946 . . . . 73.34 110.187 -172.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 114' ' ' LYS . . . . . 0.578 ' HD3' ' HE2' ' B' ' 41' ' ' LYS . 53.7 mtmt -93.12 31.23 1.48 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.795 0.838 . . . . 64.02 111.322 178.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 115' ' ' THR . . . . . 0.564 ' HB ' ' HE3' ' F' ' 113' ' ' LYS . 57.4 m -130.43 148.62 52.26 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.464 1.106 . . . . 62.21 108.881 175.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.46 -136.07 13.12 Favored Glycine 0 C--N 1.341 0.859 0 N-CA-C 110.61 -0.996 . . . . 24.21 110.61 -175.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -128.24 84.14 64.1 Favored Pre-proline 0 CA--C 1.551 1.004 0 CA-C-N 117.392 0.596 . . . . 73.01 110.123 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -90.75 112.54 0.4 Allowed 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 123.914 3.076 . . . . 72.4 110.378 172.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -125.19 171.57 10.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.408 0.683 . . . . 62.33 110.658 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 120' ' ' TYR . . . . . 0.402 ' HB3' ' HG ' ' B' ' 136' ' ' LEU . 28.6 t80 74.58 -70.59 0.15 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.541 1.536 . . . . 74.22 110.966 175.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 99.7 t -129.45 114.21 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 123.466 0.706 . . . . 73.42 109.325 175.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 14.8 t -169.61 20.53 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.564 0.746 . . . . 72.54 110.361 176.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -123.16 -173.0 2.62 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.382 0.673 . . . . 62.03 111.353 -165.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 124' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' B' ' 41' ' ' LYS . 28.1 t -83.37 140.72 32.24 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 115.172 -0.922 . . . . 71.23 109.531 170.031 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -163.74 -34.52 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.604 0.762 . . . . 64.03 110.212 -176.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 126' ' ' ALA . . . . . 0.589 ' HB3' ' HB ' ' B' ' 40' ' ' VAL . . . -62.9 108.97 1.31 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.519 0.728 . . . . 52.04 111.626 -175.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 15.5 p -147.63 62.98 1.14 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.703 1.201 . . . . 61.14 108.381 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.84 -84.06 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.86 -1.064 . . . . 64.14 110.823 -173.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 129' ' ' THR . . . . . 0.402 HG21 ' HG3' ' C' ' 124' ' ' PRO . 14.8 m -154.71 140.36 17.98 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.803 0.441 . . . . 71.24 110.166 -178.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.99 167.29 19.5 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.384 1.074 . . . . 62.34 112.144 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -137.11 132.72 34.46 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.826 0.85 . . . . 64.13 108.85 176.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 21.3 t -162.16 76.8 0.48 Allowed 'General case' 0 C--O 1.238 0.49 0 O-C-N 123.957 0.786 . . . . 75.15 109.122 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 53.8 m -146.98 120.05 8.81 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.883 -0.784 . . . . 75.42 108.883 177.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.49 83.7 1.11 Allowed Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.694 -0.563 . . . . 52.51 111.694 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 135' ' ' VAL . . . . . 0.528 HG12 ' HB2' ' C' ' 129' ' ' ALA . 21.7 t -73.85 86.44 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 N-CA-C 108.31 -0.996 . . . . 74.32 108.31 176.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -107.88 106.08 16.19 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.593 1.157 . . . . 62.04 109.728 -173.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 82.2 p 51.82 -80.61 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 126.602 1.961 . . . . 72.25 112.937 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -156.66 133.86 10.54 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.346 1.058 . . . . 54.22 109.326 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -178.36 -62.43 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.083 0.953 . . . . 72.44 109.309 174.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . 74.7 -91.4 0.77 Allowed Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.136 -0.938 . . . . 44.21 112.197 -175.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -171.82 167.1 6.41 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.64 1.176 . . . . 42.34 109.363 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 4.7 pp -79.22 138.2 37.73 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 107.908 -1.145 . . . . 63.22 107.908 169.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.93 170.19 54.57 Favored Glycine 0 C--N 1.342 0.885 0 O-C-N 123.229 0.33 . . . . 63.25 112.92 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 40.9 t -69.11 -52.73 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 108.33 -0.989 . . . . 65.35 108.33 175.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 31.2 t70 . . . . . 0 C--O 1.247 0.937 0 CA-C-N 114.401 -1.272 . . . . 71.43 108.841 173.047 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.8 m . . . . . 0 CA--C 1.534 0.357 0 N-CA-C 106.942 -1.503 . . . . 75.44 106.942 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -137.32 121.11 17.48 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.752 -1.203 . . . . 72.45 107.752 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -143.02 110.82 5.91 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.157 -0.683 . . . . 62.25 109.157 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.9 mt -70.39 114.39 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.317 -0.623 . . . . 72.13 109.317 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -82.18 -39.93 22.47 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.653 0.595 . . . . 70.1 110.206 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -175.06 122.42 0.23 Allowed 'General case' 0 N--CA 1.481 1.098 0 O-C-N 123.608 0.568 . . . . 72.42 110.862 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 97.0 mt -106.21 136.0 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.378 -0.971 . . . . 73.15 108.378 171.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.532 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 30.7 p90 -166.78 164.93 16.54 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 123.843 0.714 . . . . 72.05 111.196 -174.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.3 p -88.33 124.0 33.47 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.77 -0.456 . . . . 55.15 109.77 175.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -90.85 -36.94 13.91 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.891 -0.781 . . . . 73.24 108.891 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.713 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 24.7 t70 -138.8 136.84 36.09 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.982 -1.008 . . . . 63.4 109.125 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 76.4 mt -130.88 142.62 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.804 1.242 . . . . 71.32 107.818 173.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.2 t -149.44 116.6 6.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.394 0.678 . . . . 65.13 109.983 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.707 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.1 t80 -122.79 136.69 54.95 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.472 -1.307 . . . . 63.23 107.472 168.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -133.47 129.55 37.37 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.196 0.598 . . . . 73.22 110.088 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.47 69.87 12.65 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 105.852 -1.907 . . . . 14.42 105.852 167.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.07 -16.58 17.83 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.325 2.017 . . . . 52.53 111.124 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -94.71 9.43 38.94 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.651 1.18 . . . . 74.5 110.369 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -47.66 -58.53 7.4 Favored Pre-proline 0 CA--C 1.569 1.698 0 C-N-CA 124.785 1.234 . . . . 73.25 113.853 -165.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.478 ' HB3' HD11 ' B' ' 51' ' ' LEU . 69.4 Cg_exo -51.85 -44.56 44.17 Favored 'Trans proline' 0 C--N 1.398 3.152 0 C-N-CA 122.715 2.277 . . . . 73.21 113.856 -173.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -96.18 -13.03 23.81 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.485 -0.78 . . . . 72.11 112.205 -174.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.472 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.4 p -77.45 -15.86 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 120.869 0.366 . . . . 74.51 110.708 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -77.41 -22.39 51.63 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.299 0.64 . . . . 74.12 110.904 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -77.62 -23.79 49.73 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.921 0.889 . . . . 75.2 110.283 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 71' ' ' GLU . 30.3 mmmt -65.64 144.93 56.63 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.22 1.008 . . . . 72.32 111.94 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -60.47 117.72 5.61 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.661 -0.866 . . . . 70.25 108.661 168.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.415 ' CE3' HD21 ' A' ' 68' ' ' LEU . 70.6 t-105 -75.6 84.68 2.65 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.676 0.75 . . . . 74.51 110.022 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.74 78.32 74.0 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 105.882 -1.896 . . . . 63.45 105.882 169.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -81.93 140.67 11.52 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.665 2.243 . . . . 73.44 111.908 -173.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -97.66 83.78 3.27 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.072 -1.455 . . . . 63.33 107.072 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 66' ' ' ALA . 58.0 t -81.96 119.16 30.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 CA-C-N 114.745 -1.116 . . . . 63.25 109.549 -174.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.437 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 74.0 mttt -113.86 113.57 25.06 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.237 1.015 . . . . 74.31 108.467 -170.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -98.43 121.16 40.02 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 108.294 -1.002 . . . . 71.33 108.294 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -130.43 138.57 50.39 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.39 1.076 . . . . 70.22 108.265 -176.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.525 HD22 HD21 ' A' ' 60' ' ' LEU . 88.3 mt -128.89 140.14 51.82 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.939 0.496 . . . . 53.02 110.95 -173.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.52 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 27.7 t70 -142.9 146.19 33.8 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.465 1.106 . . . . 74.02 108.742 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.2 m -131.8 128.85 39.63 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.117 0.567 . . . . 74.45 110.076 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.71 110.04 10.11 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.66 0.784 . . . . 62.13 109.151 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.4 p -90.68 161.23 15.47 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 109.512 -0.551 . . . . 51.01 109.512 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.4 t -152.97 121.17 6.21 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.966 0.906 . . . . 54.21 108.702 -172.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -79.72 104.23 10.17 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.589 -0.893 . . . . 73.43 108.589 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.6 mt -81.83 -35.58 29.25 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.893 0.477 . . . . 53.31 109.96 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.45 -176.47 5.08 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.628 0.771 . . . . 32.31 110.391 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.68 113.95 4.1 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.501 0.72 . . . . 74.2 110.181 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 66.27 17.89 10.8 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.629 1.172 . . . . 52.13 111.609 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.5 t -119.69 106.85 19.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 107.73 -1.211 . . . . 63.31 107.73 173.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -123.12 125.49 45.25 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.29 -1.004 . . . . 64.42 108.29 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -86.35 139.48 30.93 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.46 -0.941 . . . . 74.32 108.46 168.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.1 t -120.17 140.93 42.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.02 -1.104 . . . . 71.31 108.02 171.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.8 t -121.07 130.26 74.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.515 -0.92 . . . . 73.31 108.515 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.525 HD21 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -105.13 107.88 19.1 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.875 -1.528 . . . . 71.33 106.875 177.386 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.52 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 32.1 ttp180 -92.35 99.66 12.38 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.224 -1.399 . . . . 75.25 107.224 174.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.27 127.98 47.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 107.689 -1.226 . . . . 74.11 107.689 174.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.411 HG23 ' HB2' ' A' ' 77' ' ' GLU . 7.5 m -121.05 125.08 46.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.402 0.62 . . . . 53.43 109.672 175.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.663 HG11 HD21 ' A' ' 126' ' ' LEU . 58.9 t -116.23 125.12 73.15 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 C-N-CA 124.962 1.305 . . . . 73.11 107.567 177.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.437 ' HB ' ' HD2' ' A' ' 41' ' ' LYS . 13.8 m -127.75 127.07 42.98 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.155 0.889 . . . . 61.13 109.629 172.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.485 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -118.07 126.46 52.32 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.346 -0.983 . . . . 71.25 108.346 178.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 35.2 m -130.24 132.82 46.13 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.461 0.704 . . . . 61.23 110.352 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.415 HD21 ' CE3' ' A' ' 36' ' ' TRP . 12.6 mt -93.08 70.35 4.52 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 125.26 1.424 . . . . 73.01 109.058 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.8 -107.03 2.36 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-N 115.595 -0.73 . . . . 51.45 111.404 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.1 -26.77 17.31 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.551 0.74 . . . . 54.14 111.216 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.42 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 6.3 tp10 -93.81 123.9 37.46 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.587 0.755 . . . . 71.31 109.001 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 89.8 m -75.82 136.79 40.21 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 117.744 0.247 . . . . 65.43 110.57 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.472 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -74.34 -64.83 0.94 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.763 -0.828 . . . . 41.03 108.763 174.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.452 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 31.6 p90 -158.94 170.31 22.38 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.325 -0.852 . . . . 61.42 112.002 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 64' ' ' VAL . 57.2 tp -125.28 135.83 52.9 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.91 1.284 . . . . 64.14 107.831 167.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.45 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 73.7 m -135.4 97.75 3.78 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.692 0.797 . . . . 64.41 110.249 174.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.411 ' HB2' HG23 ' A' ' 63' ' ' THR . 34.9 tt0 -117.66 118.26 31.61 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.112 0.965 . . . . 72.15 108.543 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.9 t -127.68 121.82 57.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 109.134 -0.691 . . . . 62.4 109.134 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.713 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.2 mt-30 -92.79 86.37 5.49 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.275 -0.875 . . . . 72.14 108.865 173.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -76.71 99.37 5.06 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 113.786 -1.552 . . . . 73.24 109.469 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.14 159.73 32.85 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 111.419 -0.672 . . . . 34.22 111.419 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.437 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -161.02 122.45 1.12 Allowed Glycine 0 CA--C 1.498 -0.987 0 N-CA-C 110.336 -1.106 . . . . 55.31 110.336 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.6 mt -78.72 124.65 37.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 N-CA-C 107.337 -1.357 . . . . 74.41 107.337 173.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -123.79 160.04 28.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.884 -0.784 . . . . 72.12 108.884 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.6 t -117.75 101.57 8.43 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.349 -1.352 . . . . 54.4 107.349 173.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.0 mm -107.72 145.4 15.03 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 O-C-N 123.736 0.647 . . . . 75.44 110.249 -176.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.51 177.25 8.28 Favored 'General case' 0 C--O 1.231 0.116 0 O-C-N 123.761 0.663 . . . . 73.43 110.971 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.93 -27.18 11.61 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-N 116.061 -0.518 . . . . 53.1 113.047 176.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.45 148.19 24.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 C-N-CA 123.772 0.829 . . . . 70.24 110.808 -171.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.599 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 2.3 mp0 -135.9 175.42 9.61 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.915 0.886 . . . . 73.53 109.952 176.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.12 -119.77 9.88 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-N 115.341 -0.845 . . . . 74.52 113.497 174.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.5 p -73.2 -30.21 63.37 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.114 0.966 . . . . 54.12 110.448 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -74.66 -36.52 62.83 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.14 -0.937 . . . . 62.23 109.852 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.599 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 2.6 tpt -61.22 -44.78 96.72 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.295 0.638 . . . . 73.41 109.75 172.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.4 -29.48 69.0 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.269 -0.878 . . . . 55.51 111.271 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.506 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 54.0 t-80 -71.88 -27.66 63.01 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.288 0.635 . . . . 73.12 111.068 176.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 37.1 t -79.55 -60.73 2.24 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.147 -0.686 . . . . 73.15 109.147 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 78.5 mt -67.92 -34.15 76.06 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.03 0.932 . . . . 71.51 113.196 -172.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.87 3.46 52.5 Favored Glycine 0 N--CA 1.47 0.963 0 CA-C-O 119.688 -0.506 . . . . 73.4 113.775 -173.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.563 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -140.14 -70.47 0.39 Allowed 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 117.348 0.574 . . . . 62.15 111.332 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -67.69 -39.19 84.46 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 111.879 0.325 . . . . 64.22 111.879 -171.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 63.5 m -66.68 -53.35 28.87 Favored Pre-proline 0 CA--C 1.564 1.492 0 C-N-CA 124.566 1.146 . . . . 65.05 112.164 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.431 ' HA ' HD12 ' A' ' 106' ' ' LEU . 58.2 Cg_endo -68.35 -18.89 44.2 Favored 'Trans proline' 0 C--N 1.399 3.219 0 C-N-CA 121.965 1.777 . . . . 73.11 112.616 175.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 0.1 OUTLIER -67.4 -47.24 70.87 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.934 -0.765 . . . . 72.05 108.934 174.74 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.3 mm -59.56 -33.45 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.758 1.223 . . . . 71.04 111.299 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.437 HD21 ' HA3' ' A' ' 82' ' ' GLY . 49.3 mt -79.86 -18.8 49.85 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.315 0.646 . . . . 71.04 112.153 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -66.51 -40.55 34.14 Favored Pre-proline 0 CA--C 1.558 1.251 0 N-CA-C 114.737 1.384 . . . . 75.03 114.737 -172.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.5 -37.71 94.72 Favored 'Trans proline' 0 C--N 1.389 2.69 0 C-N-CA 121.998 1.798 . . . . 74.43 112.757 173.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -82.32 -35.2 28.16 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.098 -0.955 . . . . 75.43 111.022 -175.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.73 -49.39 73.24 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.157 -0.683 . . . . 64.04 109.157 174.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.518 ' NH1' HD12 ' C' ' 105' ' ' ILE . 32.3 ttm180 -49.86 -55.14 15.43 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 125.19 1.556 . . . . 64.13 110.511 174.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.85 -42.57 94.79 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.25 0.969 . . . . 64.32 111.686 -173.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 117' ' ' MET . 48.7 t -60.45 -40.79 92.44 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 123.5 0.5 . . . . 53.54 110.795 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.464 HG21 HG21 ' A' ' 64' ' ' VAL . 63.2 mt -64.58 -50.34 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.224 1.01 . . . . 75.4 110.597 174.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.446 HG21 ' HE2' ' C' ' 109' ' ' TYR . 82.9 m -58.03 -44.62 87.44 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.367 1.067 . . . . 74.4 111.245 -174.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 24.0 t -65.69 -40.74 92.64 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.329 -1.305 . . . . 74.22 110.21 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.707 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 38.0 mtm -64.07 -41.28 97.39 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.61 0.364 . . . . 73.13 111.034 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.409 HG13 ' HB2' ' A' ' 123' ' ' PHE . 79.3 t -61.58 -45.37 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 O-C-N 124.051 0.844 . . . . 65.0 110.587 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.3 p -71.91 -32.76 67.69 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.014 0.525 . . . . 73.21 111.273 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.463 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.5 mtt-85 -69.96 -30.88 68.35 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.271 0.629 . . . . 73.21 109.704 174.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.99 12.72 57.16 Favored Glycine 0 C--N 1.355 1.604 0 O-C-N 123.905 0.753 . . . . 51.25 112.861 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.402 HG21 ' HE ' ' B' ' 15' ' ' ARG . 1.5 t 62.19 14.19 6.46 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.153 2.181 . . . . 74.15 113.615 172.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.409 ' HB2' HG13 ' A' ' 118' ' ' VAL . 98.1 m-85 -80.49 149.35 68.26 Favored Pre-proline 0 C--O 1.244 0.813 0 N-CA-C 107.068 -1.456 . . . . 71.22 107.068 169.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.63 142.88 81.3 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.163 1.909 . . . . 50.41 111.396 176.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -55.53 122.63 11.71 Favored 'General case' 0 C--N 1.352 0.705 0 O-C-N 124.246 0.966 . . . . 63.02 111.481 -169.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.663 HD21 HG11 ' A' ' 64' ' ' VAL . 22.6 tp -106.15 121.15 43.59 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 108.35 -0.982 . . . . 73.31 108.35 -176.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.588 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 88.6 m-20 -117.74 124.28 48.08 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.657 -1.238 . . . . 71.33 107.657 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 9.6 mt -74.24 140.3 44.92 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.966 -0.753 . . . . 74.3 108.966 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.62 140.16 89.36 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-O 119.251 -0.404 . . . . 61.2 111.025 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -56.09 115.68 2.64 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 123.392 2.728 . . . . 72.31 113.343 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.414 HG21 HD11 ' A' ' 44' ' ' LEU . 92.0 t -102.72 123.38 56.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-N 115.421 -0.809 . . . . 73.44 109.517 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -87.24 90.72 8.46 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 107.778 -1.193 . . . . 71.45 107.778 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.412 ' CZ ' HD13 ' A' ' 44' ' ' LEU . 29.3 m-85 -63.58 -28.6 70.04 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.396 0.678 . . . . 60.4 111.465 177.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.563 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 14.8 t70 -61.7 -39.39 91.33 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.486 0.715 . . . . 75.43 110.11 175.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.5 -40.17 89.09 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.728 0.811 . . . . 62.33 110.651 173.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.97 -38.74 89.67 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.259 0.623 . . . . 73.53 111.352 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.502 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 60.1 t80 . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 109.79 -0.448 . . . . 74.31 109.79 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.449 ' HG3' HG13 ' B' ' 89' ' ' ILE . 24.6 ttt . . . . . 0 CA--C 1.562 1.413 0 CA-C-O 121.628 0.728 . . . . 73.22 111.564 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.406 ' N ' ' HG2' ' B' ' 9' ' ' MET . 2.6 t -138.75 126.58 22.26 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.691 1.196 . . . . 54.22 108.46 169.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -127.9 137.41 52.3 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.286 -1.005 . . . . 74.12 108.286 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -151.86 109.71 3.67 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.624 0.369 . . . . 71.43 110.359 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.431 HD13 HD11 ' B' ' 16' ' ' ILE . 47.4 mt -60.84 144.65 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 108.853 -0.795 . . . . 73.3 108.853 172.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -110.04 -45.21 3.64 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.684 -0.487 . . . . 75.52 109.684 176.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.402 ' HE ' HG21 ' A' ' 122' ' ' THR . 50.0 ttt180 -167.45 132.66 1.98 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.386 -0.598 . . . . 61.4 109.386 -173.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.431 HD11 HD13 ' B' ' 13' ' ' ILE . 96.4 mt -118.88 147.93 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 107.494 -1.299 . . . . 74.4 107.494 177.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -169.91 163.89 9.6 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.836 0.827 . . . . 73.2 112.139 -174.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 82.7 m -92.49 122.74 35.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.627 -1.624 . . . . 63.35 108.237 171.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -80.05 -49.94 11.07 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.571 0.748 . . . . 64.34 110.732 170.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -144.99 139.46 27.5 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 122.113 -0.367 . . . . 73.2 111.185 -168.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.462 HD11 ' SG ' ' B' ' 113' ' ' CYS . 49.5 mm -128.86 141.77 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.247 1.019 . . . . 74.0 109.911 173.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -144.82 133.35 22.02 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.69 1.196 . . . . 71.12 108.002 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -143.6 109.9 5.41 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.016 -1.105 . . . . 73.02 108.016 173.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -117.97 114.86 23.8 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.562 0.745 . . . . 72.03 109.039 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.25 88.31 2.47 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 106.431 -1.692 . . . . 75.11 106.431 170.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -72.02 -31.8 11.87 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.092 2.528 . . . . 72.11 113.256 -168.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -109.42 25.72 11.47 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.307 0.643 . . . . 74.53 109.268 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.532 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -44.36 -58.41 5.1 Favored Pre-proline 0 CA--C 1.564 1.487 0 N-CA-C 114.633 1.346 . . . . 74.13 114.633 -163.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 24.6 Cg_exo -61.3 -35.94 81.83 Favored 'Trans proline' 0 C--N 1.393 2.889 0 C-N-CA 122.078 1.852 . . . . 75.34 112.962 -174.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -95.08 -25.18 16.56 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.478 -0.783 . . . . 72.54 112.47 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.536 HG22 HD12 ' B' ' 68' ' ' LEU . 4.5 p -71.15 -14.25 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-O 121.332 0.587 . . . . 65.13 110.14 -175.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -73.31 -2.66 22.95 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.265 1.026 . . . . 74.34 112.459 174.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -68.63 -19.64 64.43 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.435 0.694 . . . . 73.24 110.116 169.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.573 ' HB2' HD13 ' B' ' 68' ' ' LEU . 29.4 mmtp -98.31 102.62 14.42 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 125.497 1.519 . . . . 74.4 108.884 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -99.8 77.35 2.04 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.807 0.443 . . . . 74.03 110.639 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 43.6 p90 -160.99 167.97 25.45 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.976 0.91 . . . . 74.52 109.581 169.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.46 113.97 22.45 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 107.328 -1.36 . . . . 73.04 107.328 176.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.92 163.92 15.22 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.809 2.339 . . . . 64.21 113.709 -173.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -71.21 103.95 2.95 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.388 -0.967 . . . . 44.43 108.388 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.555 HG11 HD11 ' B' ' 126' ' ' LEU . 49.0 t -94.33 146.5 6.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 114.996 -1.002 . . . . 64.35 110.253 -176.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -149.14 125.96 11.17 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.24 1.016 . . . . 74.3 108.282 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.441 HD11 ' CG1' ' B' ' 62' ' ' VAL . 16.3 tp -89.65 137.95 31.89 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.061 0.545 . . . . 75.33 109.768 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -139.56 113.29 8.57 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.441 1.096 . . . . 64.31 108.309 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 91.3 mt -99.69 152.46 20.05 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.751 0.82 . . . . 71.34 109.636 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.789 ' HB3' ' HD2' ' B' ' 61' ' ' ARG . 31.7 t70 -156.03 151.59 27.04 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 107.324 -1.362 . . . . 72.02 107.324 173.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . 0.45 HG22 ' HA ' ' B' ' 60' ' ' LEU . 0.9 OUTLIER -143.83 146.45 33.07 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.664 0.745 . . . . 74.31 112.315 -170.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.11 153.2 41.91 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.931 1.292 . . . . 63.32 108.359 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.487 ' HB2' ' CE2' ' B' ' 56' ' ' TYR . 74.4 p -145.7 176.05 9.93 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.565 0.579 . . . . 73.43 112.565 -174.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 65.5 p -162.01 139.29 8.46 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.688 1.195 . . . . 75.13 109.869 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -90.79 109.93 21.13 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.284 -0.635 . . . . 71.22 109.284 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' A' ' 29' ' ' PRO . 39.3 mt -86.56 -23.34 25.85 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.763 0.425 . . . . 71.41 110.531 175.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.543 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -163.1 167.42 22.28 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.452 0.701 . . . . 71.51 111.08 -176.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -82.17 138.49 34.69 Favored 'General case' 0 C--O 1.248 0.99 0 N-CA-C 107.291 -1.374 . . . . 71.14 107.291 161.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 78.17 -5.35 2.09 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 125.758 1.623 . . . . 73.5 112.258 -175.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 50.1 t -144.34 117.97 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.539 0.735 . . . . 71.21 109.044 -175.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.487 ' CE2' ' HB2' ' B' ' 48' ' ' SER . 26.9 t80 -126.61 151.58 47.8 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.195 0.598 . . . . 75.41 110.002 -173.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -116.26 121.0 40.73 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 107.755 -1.202 . . . . 74.31 107.755 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 12.9 p -127.48 147.93 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.128 0.571 . . . . 72.43 109.984 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 17.4 t -125.37 116.26 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.73 0.812 . . . . 64.2 109.808 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.45 ' HA ' HG22 ' B' ' 46' ' ' THR . 58.0 tp -94.72 105.27 17.21 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.051 -0.722 . . . . 74.32 109.051 170.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.789 ' HD2' ' HB3' ' B' ' 45' ' ' ASP . 1.7 tmt_? -86.54 120.46 27.89 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.709 -1.219 . . . . 72.43 107.709 172.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.441 ' CG1' HD11 ' B' ' 42' ' ' LEU . 32.3 t -114.81 133.04 62.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.284 -1.006 . . . . 52.15 108.284 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 24.7 m -131.03 131.81 44.54 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.325 0.583 . . . . 75.23 109.628 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.7 HG11 HD21 ' B' ' 126' ' ' LEU . 97.2 t -111.54 118.74 58.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 C-N-CA 124.419 1.087 . . . . 74.03 108.338 176.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 68.5 m -92.51 130.94 38.03 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.114 -1.069 . . . . 70.24 108.114 168.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.39 134.34 27.19 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.863 -0.792 . . . . 72.33 108.863 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.492 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 18.8 p -144.63 133.26 22.2 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 123.736 0.648 . . . . 63.22 110.803 -175.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.573 HD13 ' HB2' ' B' ' 34' ' ' LYS . 78.4 mt -99.45 103.05 14.79 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.47 1.108 . . . . 75.5 110.056 176.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.7 -111.7 3.41 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.797 -0.521 . . . . 63.31 111.797 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -115.19 1.32 13.81 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.256 0.622 . . . . 74.32 110.706 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.53 ' HG3' HG23 ' B' ' 31' ' ' VAL . 18.2 pt-20 -115.47 143.1 45.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.415 0.686 . . . . 75.12 109.396 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 63.4 m -69.11 132.13 46.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 121.235 0.54 . . . . 73.22 110.999 -178.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.492 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -83.31 -63.03 1.44 Allowed 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.819 -1.178 . . . . 72.22 107.819 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -153.87 152.36 30.55 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.523 -1.217 . . . . 74.54 110.358 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -125.79 111.85 15.36 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.427 -1.694 . . . . 75.15 106.427 170.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.49 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 49.5 t -117.42 134.63 54.62 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.909 -1.145 . . . . 73.34 107.909 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -146.09 126.36 13.92 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.427 -0.953 . . . . 73.24 108.427 -173.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 66.1 t -123.08 148.02 27.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.259 -1.015 . . . . 62.54 108.259 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -120.46 106.96 12.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.083 -1.451 . . . . 54.24 107.083 168.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -100.82 103.07 14.27 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.609 -0.885 . . . . 75.53 108.609 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.59 158.8 18.59 Favored Glycine 0 C--N 1.342 0.885 0 O-C-N 123.762 0.664 . . . . 74.34 111.548 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.44 142.45 7.86 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 117.314 0.557 . . . . 72.15 113.414 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 3.8 mp -90.34 124.68 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 107.941 -1.133 . . . . 75.42 107.941 170.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -129.59 153.35 48.15 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.315 1.046 . . . . 75.44 109.28 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 30.3 m -107.76 109.1 20.58 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.742 0.817 . . . . 73.12 109.191 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.598 HG22 HD11 ' B' ' 89' ' ' ILE . 4.0 mp -111.74 108.52 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.756 1.223 . . . . 63.04 107.93 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.98 158.43 43.92 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.048 0.539 . . . . 64.44 111.22 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.73 -56.14 0.88 Allowed Glycine 0 C--N 1.349 1.261 0 C-N-CA 123.292 0.472 . . . . 73.42 112.668 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.598 HD11 HG22 ' B' ' 86' ' ' ILE . 0.6 OUTLIER -56.22 166.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 124.528 1.131 . . . . 64.43 113.035 173.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -158.42 160.03 36.39 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.078 -0.964 . . . . 64.23 110.057 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.08 -109.92 3.81 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 112.166 -0.373 . . . . 54.11 112.166 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 80.0 m -99.94 -42.42 6.78 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.482 0.713 . . . . 73.24 110.677 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.405 ' HA ' ' HB3' ' B' ' 96' ' ' HIS . 2.8 mp0 -65.66 -19.14 65.79 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.207 1.003 . . . . 71.04 112.448 -173.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.456 ' HA ' HD13 ' B' ' 89' ' ' ILE . 20.3 ptm -61.69 -66.07 0.59 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.102 0.561 . . . . 64.03 111.613 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . 0.435 ' H ' ' HG3' ' B' ' 94' ' ' MET . . . -79.69 -14.26 58.89 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.801 0.44 . . . . 53.5 111.621 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . 0.405 ' HB3' ' HA ' ' B' ' 93' ' ' GLN . 35.7 t-80 -63.32 -34.9 78.7 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.278 0.631 . . . . 61.24 110.888 171.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 48.7 t -66.72 -44.21 82.2 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.819 0.447 . . . . 63.21 111.594 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.55 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 1.5 pp -80.23 -30.18 38.54 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.098 0.559 . . . . 74.13 111.464 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.51 -30.57 44.34 Favored Glycine 0 C--N 1.342 0.866 0 O-C-N 123.601 0.563 . . . . 72.41 113.601 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.41 -53.95 1.47 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.324 0.65 . . . . 62.25 111.967 -169.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -67.79 -37.46 82.08 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.333 0.653 . . . . 72.32 112.197 -174.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.55 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 79.9 m -71.14 -43.56 13.13 Favored Pre-proline 0 CA--C 1.563 1.456 0 CA-C-O 118.383 -0.818 . . . . 64.1 112.367 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -50.89 -36.88 54.38 Favored 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 122.366 2.044 . . . . 74.21 113.402 166.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -67.42 -29.75 69.32 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.2 0.6 . . . . 45.24 111.865 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.406 ' O ' ' HD2' ' B' ' 108' ' ' PRO . 74.9 mt -69.49 -41.57 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.314 0.646 . . . . 74.14 109.691 171.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.6 mt -76.85 -21.57 54.82 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.962 -1.017 . . . . 64.12 112.028 -174.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -59.15 -49.76 91.3 Favored Pre-proline 0 N--CA 1.485 1.314 0 CA-C-O 118.165 -0.921 . . . . 72.22 113.021 -176.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.406 ' HD2' ' O ' ' B' ' 105' ' ' ILE . 86.9 Cg_exo -53.17 -43.04 60.48 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 122.715 2.277 . . . . 75.15 114.224 175.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -67.29 -41.27 85.7 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.396 0.678 . . . . 51.23 110.565 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.32 -38.45 91.1 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.601 -0.727 . . . . 61.34 110.689 175.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.0 ttt-85 -64.93 -47.12 78.84 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.529 1.532 . . . . 61.42 110.831 -176.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -70.87 -34.0 71.17 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.988 0.515 . . . . 65.03 109.855 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.528 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.9 t -66.23 -34.66 78.52 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 123.352 0.408 . . . . 75.22 110.741 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.49 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 51.8 mt -65.46 -55.71 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.924 0.889 . . . . 64.42 109.858 173.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 10.2 m -63.35 -24.83 68.02 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.479 0.712 . . . . 74.34 111.496 -175.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.437 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 36.4 t -64.24 -50.15 69.11 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 123.385 0.674 . . . . 72.35 109.251 173.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.528 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.2 mmt -69.5 -34.35 74.18 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.305 0.642 . . . . 74.35 110.826 -176.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 114' ' ' ILE . 85.5 t -62.26 -43.73 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.88 0.872 . . . . 74.21 110.082 173.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 48.3 t -66.25 -31.89 72.98 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.027 -0.988 . . . . 71.23 111.041 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' B' ' 116' ' ' SER . 86.4 mtt-85 -68.95 -39.77 79.33 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.488 -0.778 . . . . 73.03 110.5 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.08 -14.26 81.98 Favored Glycine 0 C--N 1.354 1.531 0 O-C-N 123.698 0.624 . . . . 62.24 112.222 172.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 7.5 m 65.58 37.15 6.11 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.595 1.558 . . . . 63.33 110.058 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.432 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 57.5 m-85 -85.22 159.54 56.37 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 114.576 -1.193 . . . . 74.53 110.051 173.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -47.89 159.79 0.56 Allowed 'Trans proline' 0 C--N 1.385 2.458 0 C-N-CA 123.851 3.034 . . . . 74.34 115.249 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.527 HE21 ' ND2' ' B' ' 127' ' ' ASN . 60.0 tp60 -61.3 118.19 6.58 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 115.112 -0.949 . . . . 63.22 111.762 -173.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.7 HD21 HG11 ' B' ' 64' ' ' VAL . 32.8 tp -110.85 103.33 11.83 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.556 -0.747 . . . . 61.4 110.052 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.527 ' ND2' HE21 ' B' ' 125' ' ' GLN . 34.4 m-80 -108.1 114.9 29.15 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 107.908 -1.145 . . . . 72.43 107.908 169.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.44 HD21 ' CG2' ' B' ' 64' ' ' VAL . 41.9 mt -70.42 140.94 52.15 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.272 0.358 . . . . 64.44 110.352 176.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.47 145.79 98.99 Favored Pre-proline 0 CA--C 1.551 1.01 0 O-C-N 123.7 0.625 . . . . 73.5 110.529 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -60.88 92.05 0.1 OUTLIER 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.827 2.352 . . . . 72.33 111.74 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 94.7 t -99.23 112.51 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 123.24 0.616 . . . . 61.01 109.778 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 46.6 t30 . . . . . 0 CA--C 1.541 0.618 0 C-N-CA 123.943 0.897 . . . . 70.53 109.141 173.254 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 58.5 t80 . . . . . 0 C--O 1.238 0.497 0 N-CA-C 109.118 -0.697 . . . . 65.45 109.118 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -141.33 118.09 11.05 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.206 0.603 . . . . 74.51 109.698 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 60.4 mt -73.52 134.13 30.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 109.018 -0.734 . . . . 72.4 109.018 173.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.433 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.3 mm-40 -96.79 -49.97 4.86 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 108.998 -0.742 . . . . 52.22 108.998 171.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.588 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -178.2 146.0 0.38 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.32 1.048 . . . . 74.03 110.477 179.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 4.9 mp -109.7 124.84 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 107.549 -1.278 . . . . 72.42 107.549 172.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.477 ' HB3' HG23 ' D' ' 122' ' ' THR . 44.1 p90 -147.74 170.52 17.39 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.584 0.707 . . . . 74.25 111.712 -171.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . 0.411 HG21 HD11 ' C' ' 21' ' ' ILE . 75.5 p -102.7 108.17 19.32 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.493 -0.776 . . . . 73.23 109.936 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.562 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 26.7 mtpt -78.66 -23.15 45.89 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 109.468 -0.567 . . . . 74.42 109.468 174.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.485 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 10.5 t70 -148.51 138.88 22.59 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.699 0.8 . . . . 55.21 109.774 176.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.476 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 82.7 mt -136.89 140.17 43.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 106.314 -1.736 . . . . 54.33 106.314 169.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.9 t -153.18 143.92 22.75 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.457 0.703 . . . . 63.43 109.949 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -156.22 109.25 2.65 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 107.657 -1.238 . . . . 74.12 107.657 172.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -116.34 111.49 20.17 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.477 -0.564 . . . . 75.21 109.477 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.79 79.64 31.95 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 108.006 -1.109 . . . . 53.2 108.006 170.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.05 -17.04 25.26 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.614 2.209 . . . . 64.11 111.399 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -105.01 11.99 32.78 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.762 1.225 . . . . 70.22 110.274 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.475 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -50.96 -54.05 41.44 Favored Pre-proline 0 C--N 1.371 1.501 0 C-N-CA 124.351 1.06 . . . . 64.02 113.742 -169.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.6 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 12.4 Cg_endo -56.92 -52.7 6.22 Favored 'Trans proline' 0 C--N 1.391 2.789 0 C-N-CA 121.658 1.572 . . . . 74.14 111.67 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.453 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 85.4 t60 -67.77 -28.64 67.78 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.659 0.784 . . . . 62.31 112.654 -172.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.735 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.6 p -77.43 -19.68 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 N-CA-C 112.43 0.53 . . . . 73.52 112.43 -174.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -71.66 -13.52 61.77 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.856 0.687 . . . . 72.03 112.856 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 28.1 pt20 -99.18 6.34 46.43 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.188 0.595 . . . . 52.1 111.68 175.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.82 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -94.48 150.91 19.79 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.778 0.831 . . . . 55.43 110.442 -178.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.16 119.78 11.49 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.343 0.657 . . . . 64.33 109.277 169.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -82.89 92.37 7.28 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.557 0.743 . . . . 64.3 112.053 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -142.9 79.99 14.2 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 124.606 1.162 . . . . 74.3 107.895 169.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -87.29 163.06 8.41 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.732 2.288 . . . . 73.15 111.235 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -85.57 76.06 10.06 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.306 -1.368 . . . . 62.44 107.306 173.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 p -62.75 97.34 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 114.603 -1.18 . . . . 62.05 108.735 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -107.56 102.96 12.18 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 113.627 -1.624 . . . . 73.44 107.442 -171.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -88.3 129.36 35.4 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.017 -1.105 . . . . 70.52 108.017 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.437 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 15.4 t70 -124.62 139.04 54.24 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.95 -0.759 . . . . 75.21 108.95 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.449 HD22 HD21 ' C' ' 60' ' ' LEU . 79.0 mt -130.43 110.65 11.63 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.083 0.953 . . . . 51.2 108.568 175.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -124.22 119.77 30.31 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.175 -1.417 . . . . 75.13 107.175 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.1 t -119.91 145.32 46.82 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 109.621 -0.511 . . . . 70.54 109.621 -176.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.54 162.13 36.65 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.912 0.885 . . . . 54.42 108.931 176.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.409 ' OG ' ' HB3' ' C' ' 98' ' ' LEU . 5.4 m -129.12 164.08 24.11 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 109.468 -0.568 . . . . 61.22 109.468 174.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -148.65 125.61 11.3 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.675 -1.231 . . . . 72.31 107.675 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -84.21 114.83 22.09 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.897 -1.149 . . . . 65.52 107.897 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.597 HD11 ' HB2' ' C' ' 57' ' ' GLU . 50.1 mt -88.71 -42.67 11.82 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.4 0.68 . . . . 73.41 109.782 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.04 -171.22 3.85 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 115.081 -0.963 . . . . 63.52 109.967 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.37 113.32 2.85 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 114.92 -1.036 . . . . 55.42 109.307 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 63.86 15.29 8.99 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.037 0.935 . . . . 75.51 112.387 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 85.1 t -111.71 115.88 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.136 -1.061 . . . . 62.33 108.136 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -125.14 124.73 42.44 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.804 0.841 . . . . 63.11 109.185 -177.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.597 ' HB2' HD11 ' C' ' 51' ' ' LEU . 38.7 tt0 -83.74 133.63 34.78 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.238 -1.023 . . . . 74.21 108.238 164.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -118.94 135.61 58.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 108.247 -1.02 . . . . 73.42 108.247 168.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.413 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 57.3 t -119.75 141.93 37.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 123.644 0.778 . . . . 72.12 109.128 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.449 HD21 HD22 ' C' ' 44' ' ' LEU . 0.0 OUTLIER -123.11 102.01 7.73 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.713 -1.217 . . . . 75.44 107.713 177.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -81.87 106.97 14.21 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.687 -0.857 . . . . 73.51 108.687 172.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 11.0 t -109.86 113.91 45.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.24 -1.022 . . . . 70.53 108.24 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 26.8 m -111.98 132.13 54.97 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.197 -0.668 . . . . 73.42 109.197 -177.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.561 HG23 HD13 ' C' ' 114' ' ' ILE . 50.6 t -118.32 114.71 45.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.774 -0.824 . . . . 73.14 108.774 171.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.432 HG23 HD23 ' C' ' 75' ' ' LEU . 7.4 m -99.19 139.17 35.25 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.285 -1.006 . . . . 53.22 108.285 172.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.6 109.82 8.35 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.638 -0.875 . . . . 64.32 108.638 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 36.5 m -136.94 131.75 33.45 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.874 0.47 . . . . 54.24 110.293 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.82 HD13 ' HG2' ' C' ' 34' ' ' LYS . 1.6 mt -93.16 50.34 1.51 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.214 1.006 . . . . 64.35 108.572 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.32 -119.95 6.46 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 110.3 -1.12 . . . . 75.45 110.3 -171.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -90.48 -11.94 38.77 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.239 0.616 . . . . 63.15 109.836 172.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -71.58 119.53 15.87 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.753 0.821 . . . . 75.21 109.239 172.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 30.9 m -79.27 125.1 29.05 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.071 -0.714 . . . . 64.12 109.071 170.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.735 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -82.43 -53.92 5.61 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.39 -1.337 . . . . 75.33 107.39 168.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . 0.429 ' HZ ' HD13 ' C' ' 126' ' ' LEU . 32.7 p90 -169.77 168.56 8.88 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 114.73 -1.123 . . . . 74.11 110.41 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.432 HD23 HG23 ' C' ' 65' ' ' THR . 3.1 tm? -130.44 144.93 51.71 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 106.14 -1.8 . . . . 75.54 106.14 169.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.417 ' N ' HD13 ' C' ' 75' ' ' LEU . 49.2 t -150.17 146.21 26.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.739 0.416 . . . . 72.12 109.991 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -157.68 137.47 12.26 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.701 0.8 . . . . 75.21 109.673 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.562 HG21 ' HB3' ' C' ' 113' ' ' CYS . 24.2 t -134.34 113.51 17.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 124.562 1.145 . . . . 72.21 107.923 174.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.485 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 69.3 mt-30 -91.55 88.42 6.76 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.966 -1.124 . . . . 61.52 107.966 174.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -79.27 96.86 6.06 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.821 -1.081 . . . . 75.2 109.195 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -92.56 145.79 17.82 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 111.27 -0.732 . . . . 61.43 111.27 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.85 132.75 4.01 Favored Glycine 0 CA--C 1.501 -0.787 0 N-CA-C 110.898 -0.881 . . . . 74.21 110.898 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.433 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 26.5 mm -89.48 132.0 35.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 N-CA-C 109.174 -0.676 . . . . 73.14 109.174 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -134.51 119.27 18.27 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.727 0.811 . . . . 74.0 109.376 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 27.8 m -81.8 102.07 10.57 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.202 -1.036 . . . . 73.14 108.202 171.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.608 HG21 ' HE1' ' C' ' 94' ' ' MET . 27.5 mt -116.22 131.6 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.732 0.813 . . . . 53.13 109.481 -176.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.03 169.45 17.57 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.756 0.423 . . . . 74.31 110.956 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.21 -29.48 5.59 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 115.817 -0.629 . . . . 43.01 113.971 171.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.431 HD11 HG21 ' C' ' 86' ' ' ILE . 39.5 pt -96.95 171.79 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.338 0.655 . . . . 65.31 110.933 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -166.23 -179.15 4.91 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.198 0.999 . . . . 75.12 109.256 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.29 -119.9 13.71 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 123.925 0.766 . . . . 64.54 114.116 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 26.1 p -73.93 -30.83 62.77 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.696 0.798 . . . . 62.24 112.105 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -63.47 -48.24 78.48 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.944 0.498 . . . . 74.24 109.709 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.608 ' HE1' HG21 ' C' ' 86' ' ' ILE . 5.4 tpt -63.99 -48.08 77.83 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-N 115.547 -0.751 . . . . 75.44 110.501 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.4 -35.23 73.58 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.287 0.635 . . . . 34.25 111.486 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -83.74 -28.84 27.94 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.956 0.502 . . . . 70.24 110.954 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.559 ' SG ' HD13 ' C' ' 86' ' ' ILE . 18.8 t -68.34 -38.58 81.61 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.688 -0.856 . . . . 75.13 108.688 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.409 ' HB3' ' OG ' ' C' ' 48' ' ' SER . 53.9 mt -83.63 -33.34 25.31 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.523 -1.217 . . . . 54.33 110.857 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.27 -24.38 63.67 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.297 -0.865 . . . . 54.21 114.28 -169.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.36 -52.54 0.11 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.802 0.667 . . . . 72.42 112.802 -164.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -57.02 -57.54 12.11 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 123.999 0.812 . . . . 70.02 111.177 -176.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.403 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 95.3 m -64.28 -49.11 74.38 Favored Pre-proline 0 CA--C 1.564 1.486 0 C-N-CA 124.151 0.981 . . . . 71.22 112.422 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 74.8 Cg_exo -53.43 -32.89 64.6 Favored 'Trans proline' 0 C--N 1.402 3.359 0 C-N-CA 122.701 2.267 . . . . 74.13 113.889 173.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -67.97 -31.47 71.21 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.608 0.763 . . . . 70.43 110.694 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.518 HD12 ' NH1' ' A' ' 111' ' ' ARG . 25.7 mm -74.74 -35.62 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 122.899 0.48 . . . . 71.22 109.85 175.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.95 -27.74 57.66 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.781 0.832 . . . . 75.45 111.443 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -58.77 -50.93 85.37 Favored Pre-proline 0 N--CA 1.483 1.18 0 N-CA-C 114.552 1.316 . . . . 74.34 114.552 -171.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -58.69 -38.05 91.11 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 121.967 1.778 . . . . 72.33 112.873 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.446 ' HE2' HG21 ' A' ' 115' ' ' THR . 52.4 m-85 -67.25 -45.22 77.34 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.844 0.858 . . . . 73.55 110.3 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.08 86.3 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.162 -0.927 . . . . 72.32 110.907 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 41.8 ttt-85 -67.84 -43.87 78.52 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.883 1.273 . . . . 74.03 110.259 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . 0.403 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.1 tm-20 -66.29 -39.95 89.7 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.293 0.637 . . . . 45.11 109.591 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.562 ' HB3' HG21 ' C' ' 78' ' ' VAL . 28.6 m -59.91 -48.93 79.67 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.584 0.753 . . . . 73.3 111.996 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.561 HD13 HG23 ' C' ' 64' ' ' VAL . 71.0 mt -64.09 -52.32 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 123.439 0.462 . . . . 64.24 110.85 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 14.2 m -66.7 -29.07 68.97 Favored 'General case' 0 CA--C 1.556 1.181 0 O-C-N 123.462 0.476 . . . . 73.13 110.746 -175.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 39.2 t -63.91 -46.38 85.07 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.3 -0.63 . . . . 72.22 109.3 170.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.591 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.17 -41.01 96.03 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.469 1.107 . . . . 73.1 112.215 179.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.476 HG23 ' O ' ' C' ' 114' ' ' ILE . 92.6 t -64.81 -41.23 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.938 0.895 . . . . 71.33 109.572 176.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 11.6 t -67.12 -29.95 69.83 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.813 1.245 . . . . 75.23 112.129 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.439 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 75.3 mtt-85 -74.16 -41.3 61.71 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.575 0.75 . . . . 70.44 109.668 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.06 -0.42 60.67 Favored Glycine 0 C--N 1.354 1.572 0 O-C-N 123.719 0.637 . . . . 60.42 112.608 169.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 31.0 p 63.84 30.67 14.4 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.989 2.115 . . . . 64.34 113.025 169.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -82.33 156.44 68.82 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 107.916 -1.142 . . . . 64.53 107.916 167.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.446 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 12.8 Cg_endo -57.19 157.05 22.51 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.479 2.119 . . . . 53.32 112.845 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' B' ' 123' ' ' PHE . 53.8 mm-40 -56.02 112.78 1.29 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.21 0.944 . . . . 63.55 111.601 -176.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.429 HD13 ' HZ ' ' C' ' 74' ' ' PHE . 5.2 tt -116.75 85.15 2.26 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.476 -1.305 . . . . 71.22 107.476 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -95.28 122.17 37.7 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.691 -0.855 . . . . 74.13 108.691 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.79 144.38 37.18 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.589 0.556 . . . . 75.43 109.872 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.89 148.42 98.84 Favored Pre-proline 0 CA--C 1.55 0.958 0 O-C-N 124.076 0.86 . . . . 74.13 111.125 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.84 108.53 0.39 Allowed 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.798 2.332 . . . . 55.3 112.22 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 43.3 t -99.6 112.68 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.46 -0.941 . . . . 73.02 108.46 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -77.74 104.95 8.59 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.141 -0.689 . . . . 70.2 109.141 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -63.39 -35.52 80.68 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.664 0.785 . . . . 74.21 111.575 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.08 -21.51 65.88 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.931 0.892 . . . . 44.13 111.839 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.52 -47.31 33.75 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.96 0.904 . . . . 75.11 109.296 172.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 35.0 mt -65.79 -43.52 88.48 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.824 -0.625 . . . . 72.31 111.087 -176.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 24.5 t80 . . . . . 0 CA--C 1.542 0.664 0 CA-C-N 115.039 -0.982 . . . . 74.15 110.495 -177.139 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 59.2 m . . . . . 0 C--O 1.241 0.645 0 N-CA-C 109.939 -0.393 . . . . 74.41 109.939 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.59 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 47.3 t80 -142.94 91.65 2.32 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.023 -1.102 . . . . 75.33 108.023 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -113.24 123.74 50.87 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.517 -0.92 . . . . 70.42 108.517 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 12.4 mt -79.28 128.34 38.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.347 -0.982 . . . . 72.12 108.347 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . 0.447 HE21 ' HB2' ' D' ' 85' ' ' SER . 73.1 mm-40 -85.57 -43.19 13.72 Favored 'General case' 0 C--O 1.239 0.538 0 O-C-N 123.638 0.587 . . . . 73.43 109.817 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -171.09 131.62 0.8 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.799 -0.637 . . . . 71.51 110.575 -171.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 4.0 mp -106.46 141.48 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 107.348 -1.353 . . . . 72.04 107.348 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -167.01 145.51 5.06 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.648 0.592 . . . . 71.31 111.819 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -76.86 116.34 17.44 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.492 -0.776 . . . . 74.55 109.573 175.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.6 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 43.0 mtpt -88.92 -13.02 40.04 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.45 0.7 . . . . 70.22 110.439 178.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.645 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 25.3 t70 -162.55 141.63 9.07 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.099 0.96 . . . . 64.44 109.699 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.591 HG21 ' HE2' ' C' ' 117' ' ' MET . 98.4 mt -141.28 141.35 30.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 125.278 1.431 . . . . 72.35 107.884 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 41.1 t -149.3 141.38 23.91 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.667 1.187 . . . . 62.24 108.109 173.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.476 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 81.2 t80 -152.54 125.72 8.62 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 106.562 -1.644 . . . . 75.3 106.562 171.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -129.42 145.64 51.39 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.286 -0.635 . . . . 74.12 109.286 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.76 80.46 65.85 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 107.263 -1.384 . . . . 64.1 107.263 174.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.61 -38.54 31.64 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 123.513 2.809 . . . . 63.15 113.419 -169.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 42.2 m-20 -106.94 12.38 28.83 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 118.762 -0.637 . . . . 54.22 110.959 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.562 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -27.63 -69.42 0.08 OUTLIER Pre-proline 0 CA--C 1.571 1.772 0 N-CA-C 116.742 2.127 . . . . 72.01 116.742 -164.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.45 -18.69 13.69 Favored 'Trans proline' 0 C--N 1.385 2.483 0 CA-C-N 123.661 2.343 . . . . 74.44 114.212 -174.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.43 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 6.1 t-160 -74.49 -38.66 62.82 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.295 1.038 . . . . 72.01 109.103 174.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.487 HG12 ' O ' ' D' ' 28' ' ' ALA . 4.3 p -84.76 -20.66 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 CA-C-N 115.328 -0.851 . . . . 71.43 111.676 -174.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.505 ' HD2' HH21 ' C' ' 15' ' ' ARG . 20.6 m-85 -67.6 -18.54 65.02 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 122.586 0.354 . . . . 75.34 111.945 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.43 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 60.7 mt-30 -65.29 -16.84 63.99 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.203 1.001 . . . . 64.01 111.06 175.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.404 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 96.4 mttt -97.42 90.26 5.0 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 125.086 1.354 . . . . 74.54 110.463 -178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -90.67 93.22 9.16 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.954 0.502 . . . . 63.54 109.772 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 20.5 p90 -162.47 -170.39 2.42 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.874 0.87 . . . . 70.14 109.466 168.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -67.98 109.78 4.47 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.707 1.203 . . . . 61.12 110.898 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -58.54 122.27 11.38 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.27 1.98 . . . . 74.14 110.565 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 0.2 OUTLIER -66.68 107.21 2.06 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 106.983 -1.488 . . . . 75.31 106.983 175.289 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.601 HG22 ' HB2' ' D' ' 66' ' ' ALA . 93.8 t -111.67 142.93 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.876 -0.787 . . . . 51.02 108.876 -174.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -129.76 123.87 32.07 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.369 -0.974 . . . . 61.53 108.369 168.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.587 HD11 HG13 ' D' ' 62' ' ' VAL . 51.5 tp -95.73 125.98 40.68 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.001 -0.74 . . . . 75.24 109.001 174.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -124.9 111.11 15.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.787 -1.56 . . . . 72.23 106.787 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.538 HD22 HG22 ' D' ' 62' ' ' VAL . 62.0 mt -97.58 164.53 12.39 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.932 -1.031 . . . . 72.43 108.958 177.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -164.4 144.93 7.98 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.979 -1.119 . . . . 72.51 107.979 167.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 70.4 p -102.62 151.14 22.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.735 0.779 . . . . 74.13 109.769 -176.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.54 161.72 41.1 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 106.686 -1.598 . . . . 42.55 106.686 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 12.8 p . . . . . 0 C--O 1.238 0.464 0 C-N-CA 122.786 0.434 . . . . 53.41 110.255 -176.866 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' D' ' 85' ' ' SER . 6.5 m-20 . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 112.836 0.68 . . . . 70.14 112.836 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.87 117.81 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 108.239 -1.023 . . . . 74.22 108.239 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -135.13 125.55 26.59 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.626 -0.879 . . . . 72.14 108.626 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -90.0 129.97 36.26 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 106.857 -1.534 . . . . 73.34 106.857 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 83.3 t -132.96 131.26 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 124.097 0.959 . . . . 65.35 108.631 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.485 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 32.3 t -119.94 144.51 28.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 C-N-CA 124.642 1.177 . . . . 74.43 108.853 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.6 108.94 12.06 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.389 -1.337 . . . . 55.1 107.389 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 ttt85 -85.41 106.01 16.47 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.144 -0.687 . . . . 71.42 109.144 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.587 HG13 HD11 ' D' ' 42' ' ' LEU . 59.7 t -108.1 118.29 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 123.95 0.9 . . . . 61.42 109.07 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 17.0 m -128.71 131.14 47.91 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.613 0.57 . . . . 41.11 109.948 -171.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.57 HG13 HG13 ' D' ' 40' ' ' VAL . 90.9 t -113.78 135.3 53.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 124.536 1.134 . . . . 72.54 109.545 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 7.1 m -121.01 94.72 4.43 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.921 -1.14 . . . . 64.2 107.921 171.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.601 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -109.42 142.08 40.91 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.614 0.366 . . . . 74.33 110.711 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.525 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 49.6 m -148.61 132.72 17.29 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.069 0.947 . . . . 75.12 110.561 -171.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.2 mt -98.34 105.71 17.9 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.967 -1.123 . . . . 75.3 107.967 173.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.07 -120.39 5.19 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 115.506 -0.77 . . . . 54.4 112.391 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.12 6.7 27.12 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.592 0.757 . . . . 54.04 111.383 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 10.9 pt-20 -127.6 159.59 34.19 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.258 0.623 . . . . 72.43 109.321 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 93.9 m -70.34 136.92 50.16 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.335 0.654 . . . . 65.44 111.961 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.525 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -91.75 -70.52 0.68 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.19 -1.411 . . . . 53.2 107.19 174.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -146.35 148.09 32.0 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.092 -0.958 . . . . 74.13 110.414 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 73.6 mt -116.17 153.52 31.68 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.757 1.223 . . . . 75.52 107.741 171.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.615 ' SG ' HG12 ' D' ' 114' ' ' ILE . 34.6 t -154.35 146.66 23.87 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.584 -0.524 . . . . 53.31 109.584 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -157.4 122.21 4.43 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.728 0.411 . . . . 74.12 110.625 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 94.8 t -132.79 115.46 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.106 0.962 . . . . 53.33 109.277 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.645 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.0 mt-30 -89.3 88.51 7.53 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.693 -0.854 . . . . 71.24 108.693 172.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -83.01 103.59 12.57 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.338 -1.301 . . . . 65.31 109.528 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -102.83 167.84 17.69 Favored Glycine 0 N--CA 1.468 0.825 0 O-C-N 123.219 0.324 . . . . 64.41 113.055 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.16 143.07 6.07 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 112.447 -0.261 . . . . 63.15 112.447 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 2.5 mp -91.29 127.34 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.218 -1.03 . . . . 74.33 108.218 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -122.41 134.86 54.6 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.538 1.135 . . . . 55.33 109.532 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 34.1 t -84.96 103.53 14.09 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 108.287 -1.005 . . . . 74.14 108.287 171.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.572 HG22 HD11 ' D' ' 89' ' ' ILE . 15.1 mt -109.54 131.9 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.569 -0.9 . . . . 62.25 108.569 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.65 164.02 14.49 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.706 0.629 . . . . 54.43 111.281 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.71 21.59 74.27 Favored Glycine 0 C--N 1.353 1.473 0 O-C-N 123.918 0.761 . . . . 73.34 114.619 170.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.572 HD11 HG22 ' D' ' 86' ' ' ILE . 1.0 OUTLIER -133.27 140.91 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.306 1.042 . . . . 63.22 109.457 177.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 32.0 mp0 -129.56 175.79 8.5 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 123.962 0.905 . . . . 73.11 109.601 -175.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.64 -137.8 23.04 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.219 -0.901 . . . . 64.54 112.458 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 45.5 p -66.46 -45.6 79.22 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.692 0.797 . . . . 71.21 111.035 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -58.84 -28.5 66.11 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.009 1.324 . . . . 75.23 112.331 -175.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.523 ' HA ' HD13 ' D' ' 89' ' ' ILE . 26.4 ttt -49.17 -63.54 1.07 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.98 1.312 . . . . 63.12 112.508 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.91 -16.43 35.97 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.333 0.653 . . . . 65.12 111.81 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -72.78 -21.8 60.94 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.715 0.406 . . . . 65.21 111.625 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 75.3 m -56.99 -50.98 71.06 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 123.467 0.479 . . . . 72.21 111.654 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 pp -68.42 -18.23 64.39 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.266 0.627 . . . . 74.54 112.586 -176.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.83 -2.22 42.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 114.775 0.67 . . . . 71.33 114.775 -174.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.42 -54.29 0.29 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 118.011 0.905 . . . . 71.2 111.459 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -73.49 -51.1 18.28 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.039 0.535 . . . . 75.21 111.287 -172.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.59 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 35.1 m -61.18 -44.83 95.0 Favored Pre-proline 0 CA--C 1.566 1.573 0 C-N-CA 123.914 0.886 . . . . 61.25 112.44 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.429 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 50.0 Cg_exo -58.35 -36.45 97.6 Favored 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 122.331 2.021 . . . . 75.14 113.468 169.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -64.19 -31.11 72.19 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.279 0.632 . . . . 73.23 110.997 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 33.1 mm -67.54 -38.55 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.046 0.938 . . . . 64.24 110.623 174.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' D' ' 103' ' ' PRO . 60.5 mt -73.31 -20.47 60.79 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.261 -0.881 . . . . 75.34 111.895 -175.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -67.44 -41.74 33.74 Favored Pre-proline 0 CA--C 1.556 1.195 0 N-CA-C 114.274 1.212 . . . . 72.32 114.274 -172.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -45.42 -44.97 16.18 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.508 2.139 . . . . 54.35 113.584 169.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -78.18 -35.03 49.24 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.829 0.852 . . . . 64.52 111.496 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . 0.475 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -62.25 -56.15 21.42 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.652 0.781 . . . . 74.12 110.339 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.432 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 40.3 ttp180 -58.19 -42.88 87.06 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 114.038 -1.437 . . . . 75.11 110.574 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -55.29 -52.64 62.77 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.084 0.865 . . . . 72.33 110.481 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.4 t -56.27 -45.63 80.03 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.306 1.004 . . . . 54.23 111.13 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.615 HG12 ' SG ' ' D' ' 76' ' ' CYS . 42.3 mt -62.02 -57.36 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.379 -0.828 . . . . 75.31 111.1 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 30.2 m -55.35 -38.58 68.97 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.537 1.135 . . . . 62.03 111.124 -174.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 22.6 t -60.4 -50.96 71.52 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.62 -1.173 . . . . 63.24 109.662 176.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.72 -32.4 72.15 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.628 0.771 . . . . 63.42 112.178 -176.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.481 HG23 ' O ' ' D' ' 114' ' ' ILE . 84.0 t -60.44 -46.41 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.746 0.819 . . . . 73.11 109.519 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 32.4 t -72.49 -29.16 63.39 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 115.004 -0.998 . . . . 72.44 110.881 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.462 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 74.9 mtt-85 -71.49 -24.42 61.98 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.441 0.696 . . . . 72.13 110.674 176.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.21 11.71 71.33 Favored Glycine 0 C--N 1.353 1.476 0 CA-C-O 119.448 -0.64 . . . . 75.55 112.791 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.477 HG23 ' HB3' ' C' ' 17' ' ' TYR . 72.2 p 56.71 25.67 10.41 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 125.988 1.715 . . . . 64.34 113.242 -177.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -92.02 150.9 41.33 Favored Pre-proline 0 C--O 1.241 0.635 0 C-N-CA 123.38 0.672 . . . . 64.1 109.893 173.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -46.12 121.33 4.33 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 123.556 2.837 . . . . 64.14 112.883 170.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -45.86 131.08 9.58 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 124.48 1.113 . . . . 61.14 111.655 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 23.7 tp -117.55 107.17 13.94 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.208 1.003 . . . . 74.23 109.209 -175.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -101.02 96.08 7.01 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 108.041 -1.096 . . . . 74.23 108.041 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.432 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 47.1 mt -61.73 116.72 5.03 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 122.787 0.435 . . . . 71.05 110.134 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.484 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -54.47 130.78 62.84 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 123.352 0.661 . . . . 74.32 112.487 -174.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 6.1 Cg_exo -73.29 109.64 2.88 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 123.286 2.657 . . . . 74.21 110.985 -178.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.07 152.9 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.877 0.871 . . . . 75.34 110.897 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -75.02 108.54 7.81 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.647 0.779 . . . . 62.44 109.021 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 N--CA 1.488 1.437 0 C-N-CA 124.219 1.007 . . . . 73.12 111.803 179.979 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.8 m . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 108.459 -0.941 . . . . 65.35 108.459 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -121.13 112.46 18.71 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.228 -1.397 . . . . 74.34 107.228 167.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -135.68 135.64 40.27 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.804 -1.184 . . . . 62.21 107.804 171.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.9 mt -91.57 115.83 31.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.281 -1.007 . . . . 74.13 108.281 176.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -73.88 -40.24 63.35 Favored 'General case' 0 C--O 1.242 0.708 0 O-C-N 123.388 0.43 . . . . 70.32 110.51 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.506 ' HE ' ' HB ' ' B' ' 122' ' ' THR . 26.0 ttt180 -174.86 122.65 0.24 Allowed 'General case' 0 N--CA 1.479 1.0 0 O-C-N 123.227 0.33 . . . . 72.51 110.432 -169.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 73.7 mt -106.47 136.52 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 108.723 -0.843 . . . . 72.45 108.723 172.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.473 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 26.4 p90 -166.65 177.95 6.27 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 124.206 0.941 . . . . 75.02 111.802 -172.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.6 p -110.35 118.8 37.27 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.064 -0.971 . . . . 64.4 109.386 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.473 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 35.8 mtpt -82.97 -29.33 29.12 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.066 0.46 . . . . 61.21 109.79 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 30.6 t70 -150.52 136.8 18.67 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.765 -1.107 . . . . 71.14 109.28 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.406 HG23 HG22 ' A' ' 78' ' ' VAL . 59.8 mt -135.06 138.78 48.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.904 -1.147 . . . . 64.31 107.904 174.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.4 t -150.02 124.32 9.54 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.641 0.588 . . . . 71.2 110.04 173.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.7 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.6 t80 -120.95 132.97 55.25 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 106.87 -1.529 . . . . 74.14 106.87 168.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -128.5 139.93 52.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.301 -0.629 . . . . 63.13 109.301 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.13 78.07 65.68 Favored Pre-proline 0 C--O 1.24 0.581 0 N-CA-C 106.908 -1.516 . . . . 75.31 106.908 171.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -64.18 -34.51 56.61 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.671 2.247 . . . . 73.2 112.303 -171.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -106.11 22.34 15.85 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 118.146 -0.931 . . . . 73.44 110.488 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.428 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -43.04 -56.08 6.81 Favored Pre-proline 0 N--CA 1.493 1.721 0 CA-C-O 117.923 -1.037 . . . . 51.42 113.752 -171.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.428 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 22.8 Cg_exo -65.03 -27.87 57.6 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 121.906 1.738 . . . . 64.4 113.29 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -80.65 -40.43 25.57 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.847 0.859 . . . . 71.13 110.922 -175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.809 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.3 p -78.1 -21.33 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 CA-C-N 114.935 -1.029 . . . . 72.53 112.837 -158.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -71.05 -12.14 61.35 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.168 0.587 . . . . 74.32 111.438 176.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -90.22 -18.31 25.92 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.537 1.135 . . . . 62.12 111.011 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -81.55 161.01 23.73 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.494 0.717 . . . . 72.41 112.126 -172.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.13 116.14 6.9 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 114.75 -1.113 . . . . 74.33 108.765 173.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.43 ' CE3' HD21 ' A' ' 68' ' ' LEU . 63.6 t-105 -80.79 80.18 7.31 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.875 0.845 . . . . 73.41 109.678 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.427 ' H ' HD22 ' A' ' 68' ' ' LEU . 9.2 tt0 -123.97 69.71 48.39 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 124.898 1.279 . . . . 73.32 108.24 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -86.4 118.25 1.59 Allowed 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.602 2.201 . . . . 73.43 112.816 -170.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -94.45 103.46 15.43 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 105.023 -2.214 . . . . 74.45 105.023 168.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.458 ' CG1' HG13 ' A' ' 64' ' ' VAL . 57.5 t -90.74 101.8 12.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 123.39 0.676 . . . . 74.22 110.334 -177.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -79.6 117.97 21.01 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.662 -0.699 . . . . 74.51 109.855 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.3 mt -97.02 107.04 19.49 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.281 -1.007 . . . . 74.34 108.281 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.532 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.7 m-20 -106.85 106.77 17.45 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.174 0.99 . . . . 74.13 108.679 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.446 HD11 HG21 ' A' ' 131' ' ' VAL . 85.3 mt -98.91 149.64 22.74 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.858 0.463 . . . . 62.31 110.631 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -154.92 148.68 25.52 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.856 -1.065 . . . . 75.05 108.696 177.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.3 m -131.51 130.89 42.94 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.583 0.753 . . . . 74.33 109.878 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.87 109.12 9.87 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.806 0.842 . . . . 55.04 109.121 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.2 p -98.7 156.95 16.58 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.214 0.606 . . . . 64.31 110.327 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.2 t -150.2 151.63 33.37 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.629 1.172 . . . . 75.04 108.609 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -100.16 111.56 23.85 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.091 -1.077 . . . . 72.12 108.091 172.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 74.1 mt -79.22 -43.03 24.64 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.136 0.574 . . . . 53.33 110.234 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.98 -177.28 5.65 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.962 -0.563 . . . . 54.24 110.708 -176.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.02 110.76 0.87 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.088 0.955 . . . . 73.03 109.883 174.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 65.1 9.59 5.65 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.529 1.132 . . . . 72.55 112.655 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.2 t -104.27 107.24 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.299 -1.0 . . . . 63.52 108.299 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -114.77 126.55 54.97 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.495 -0.928 . . . . 75.45 108.495 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -90.51 151.63 21.28 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.163 -0.681 . . . . 64.35 109.163 168.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.409 HG11 ' HD3' ' A' ' 103' ' ' PRO . 55.1 t -132.57 136.34 56.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 124.882 1.273 . . . . 42.42 107.568 170.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 52.5 t -118.01 130.12 73.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.765 -0.828 . . . . 45.4 108.765 175.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.442 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -102.32 103.47 13.92 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.643 -1.614 . . . . 73.24 106.643 176.258 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -90.21 98.77 11.97 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.16 -1.422 . . . . 72.42 107.16 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.61 132.24 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 114.757 -1.111 . . . . 71.13 108.177 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 6.8 m -125.51 146.65 49.56 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.395 -0.965 . . . . 61.22 108.395 175.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 23.2 t -145.61 117.37 2.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 124.867 1.267 . . . . 64.4 107.933 -168.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.7 m -126.2 120.55 30.36 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.129 0.422 . . . . 74.32 110.004 177.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.42 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -101.24 105.59 16.72 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.264 -1.384 . . . . 54.21 107.264 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.2 m -109.07 126.13 52.84 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.044 0.537 . . . . 73.2 110.007 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.43 HD21 ' CE3' ' A' ' 36' ' ' TRP . 35.0 mt -89.79 74.76 7.42 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 125.021 1.328 . . . . 74.11 108.671 175.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.99 -84.39 0.92 Allowed Glycine 0 C--N 1.341 0.856 0 CA-C-N 115.713 -0.676 . . . . 72.02 111.921 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -114.28 -29.0 7.06 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.787 0.835 . . . . 53.44 111.007 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -88.89 134.41 33.96 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.837 0.455 . . . . 65.44 110.211 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -80.2 136.45 36.48 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 118.019 0.372 . . . . 65.21 110.126 175.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.809 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -87.12 -58.25 2.66 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.166 0.986 . . . . 63.03 109.264 176.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -154.54 168.28 27.26 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.579 -1.191 . . . . 64.13 110.695 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 64' ' ' VAL . 67.1 tp -124.56 147.37 48.48 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.213 1.405 . . . . 64.3 108.042 172.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.56 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 79.8 m -142.86 128.1 18.73 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.2 -1.037 . . . . 73.41 108.2 175.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -146.27 118.45 8.33 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.775 -0.454 . . . . 74.3 109.775 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.406 HG22 HG23 ' A' ' 21' ' ' ILE . 39.4 t -127.41 112.81 29.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.49 1.116 . . . . 64.51 108.97 -176.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 51.7 mt-30 -86.28 84.18 7.53 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.652 -0.87 . . . . 74.12 108.652 171.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -76.78 94.92 3.93 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.506 -1.224 . . . . 73.23 109.578 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.82 144.26 18.06 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 111.87 -0.492 . . . . 64.33 111.87 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.494 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.03 124.18 2.75 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.265 -1.134 . . . . 71.22 110.265 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.422 HG13 ' HE1' ' A' ' 17' ' ' TYR . 48.9 mt -81.74 129.15 37.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.923 -1.14 . . . . 73.01 107.923 172.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.653 ' HB3' HD11 ' A' ' 86' ' ' ILE . 88.9 m-85 -128.5 122.99 32.43 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.189 0.996 . . . . 74.44 109.298 -174.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.0 t -89.75 93.27 9.39 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.36 1.064 . . . . 73.05 108.841 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.653 HD11 ' HB3' ' A' ' 84' ' ' PHE . 15.9 mm -120.73 132.89 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.895 0.878 . . . . 74.13 111.379 -168.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.75 167.43 28.23 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.617 0.767 . . . . 62.21 110.708 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.86 8.67 72.5 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 119.325 -0.709 . . . . 63.24 114.73 173.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.47 HD11 HG22 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -143.41 164.07 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 124.112 0.965 . . . . 60.42 109.922 174.704 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.473 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 19.8 tt0 -154.94 179.05 9.49 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.501 -0.772 . . . . 62.22 109.089 174.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.473 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 61.99 -130.03 44.44 Favored Glycine 0 C--N 1.347 1.149 0 C-N-CA 123.283 0.468 . . . . 63.22 113.792 175.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.5 p -67.92 -28.58 67.62 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.995 0.918 . . . . 55.04 111.259 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -66.59 -43.22 85.46 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.71 0.804 . . . . 62.1 110.25 177.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.3 tpt -70.84 -41.3 71.68 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.571 -0.74 . . . . 75.41 110.594 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.71 84.87 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.359 0.663 . . . . 64.43 111.136 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.415 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 61.0 t-80 -71.7 -29.77 64.93 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.324 0.65 . . . . 73.51 110.75 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.8 t -71.41 -48.31 50.52 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.603 -0.517 . . . . 61.34 109.603 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 79.0 mt -80.37 -25.49 39.13 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.141 0.576 . . . . 74.15 112.494 -174.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.79 4.3 32.3 Favored Glycine 0 N--CA 1.474 1.175 0 CA-C-O 119.669 -0.517 . . . . 44.03 113.954 -173.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -144.2 -65.48 0.36 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 117.469 0.634 . . . . 74.31 111.33 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -67.6 -45.93 74.03 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 116.193 -0.458 . . . . 74.02 112.209 -171.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 68.6 m -66.98 -48.34 50.65 Favored Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 124.073 0.949 . . . . 73.41 112.863 -176.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HD3' HG11 ' A' ' 58' ' ' VAL . 46.0 Cg_endo -66.92 -21.02 50.73 Favored 'Trans proline' 0 C--N 1.393 2.893 0 C-N-CA 121.596 1.531 . . . . 72.52 112.562 173.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -71.84 -35.23 69.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.122 0.569 . . . . 54.21 110.364 174.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 38.6 mm -64.08 -42.72 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.65 0.78 . . . . 74.35 109.968 171.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.494 HD21 ' HA3' ' A' ' 82' ' ' GLY . 65.3 mt -76.17 -21.15 56.86 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.253 -0.885 . . . . 64.24 111.997 -174.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -64.31 -43.85 74.12 Favored Pre-proline 0 N--CA 1.484 1.261 0 CA-C-O 117.296 -1.335 . . . . 73.42 114.47 -172.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.78 -37.21 75.99 Favored 'Trans proline' 0 C--N 1.384 2.402 0 CA-C-N 122.04 1.764 . . . . 51.11 113.039 171.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -77.82 -39.39 43.84 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.581 0.753 . . . . 54.31 111.777 -177.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.56 -47.07 77.09 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.592 -0.521 . . . . 75.22 109.592 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.486 ' NH1' HD12 ' C' ' 105' ' ' ILE . 29.5 ttm180 -48.19 -56.06 8.87 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 125.157 1.535 . . . . 72.04 110.32 173.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.07 -44.96 94.32 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 124.432 1.082 . . . . 65.01 112.186 -174.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 117' ' ' MET . 42.1 t -59.27 -41.42 88.84 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.893 0.745 . . . . 72.02 110.82 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 118' ' ' VAL . 74.4 mt -64.32 -50.77 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.443 1.097 . . . . 75.3 110.561 174.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.0 m -59.56 -36.36 76.05 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.376 1.071 . . . . 75.12 111.386 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -71.38 -41.59 69.5 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 114.712 -1.131 . . . . 73.43 109.859 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.7 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 44.4 mtm -62.1 -38.37 88.62 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.731 0.413 . . . . 63.34 111.101 175.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 114' ' ' ILE . 65.6 t -63.52 -47.38 91.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 124.325 1.05 . . . . 72.51 111.157 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.8 p -71.79 -35.27 69.95 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.007 0.523 . . . . 72.2 111.327 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.467 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 87.5 mtt-85 -68.18 -30.75 69.93 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.561 0.744 . . . . 74.25 109.886 173.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.447 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.06 14.51 48.93 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-O 118.953 -0.915 . . . . 52.14 113.218 175.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.6 t 61.54 10.21 3.13 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 127.233 2.213 . . . . 74.43 114.214 176.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -82.18 145.08 51.75 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-O 119.176 -0.44 . . . . 74.23 109.82 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.427 ' HG2' ' NE1' ' A' ' 36' ' ' TRP . 92.7 Cg_exo -48.55 149.75 6.66 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 124.039 3.16 . . . . 75.43 113.83 174.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -55.68 128.4 34.55 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 124.246 0.966 . . . . 64.14 112.021 -171.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.457 HD11 HG11 ' A' ' 40' ' ' VAL . 41.4 tp -118.99 102.54 8.84 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.432 0.693 . . . . 74.42 110.172 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.517 HD21 ' HA ' ' C' ' 15' ' ' ARG . 82.2 m-20 -102.77 115.38 30.47 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 107.798 -1.186 . . . . 71.12 107.798 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.3 mt -67.17 134.09 51.06 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.339 -0.615 . . . . 73.2 109.339 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.424 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -61.15 137.8 94.27 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 123.532 0.733 . . . . 52.03 111.379 -175.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 32.4 Cg_exo -59.81 107.11 0.36 Allowed 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.337 2.691 . . . . 70.53 113.47 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.446 HG21 HD11 ' A' ' 44' ' ' LEU . 58.3 t -100.95 134.46 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.119 0.568 . . . . 52.02 111.518 -174.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.448 ' ND2' ' HB2' ' A' ' 135' ' ' ALA . 52.7 t30 -96.26 87.54 4.52 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.347 -1.297 . . . . 73.42 109.134 175.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -59.74 -25.07 64.56 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.979 0.911 . . . . 74.33 112.531 175.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.436 ' HB3' ' OD1' ' A' ' 132' ' ' ASN . 19.8 t70 -58.68 -49.94 75.69 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.651 0.78 . . . . 65.52 109.812 172.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.448 ' HB2' ' ND2' ' A' ' 132' ' ' ASN . . . -59.51 -49.6 77.16 Favored 'General case' 0 C--N 1.358 0.956 0 O-C-N 123.731 0.645 . . . . 54.12 110.727 175.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 85.7 mt -53.13 -44.65 67.89 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 124.144 0.903 . . . . 71.04 111.925 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 82.7 t80 . . . . . 0 N--CA 1.47 0.536 0 CA-C-N 115.533 -0.758 . . . . 72.25 110.467 179.643 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.523 ' SD ' HG23 ' B' ' 89' ' ' ILE . 11.8 tpt . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 121.459 0.647 . . . . 53.51 111.425 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 9.4 t -153.92 132.26 11.98 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 107.483 -1.303 . . . . 63.35 107.483 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -137.69 136.97 37.89 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.146 -0.687 . . . . 74.14 109.146 -175.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -155.72 141.5 18.02 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.373 0.669 . . . . 74.42 109.523 173.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 55.6 mt -87.72 125.16 41.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.199 -1.037 . . . . 62.4 108.199 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -89.94 -39.63 12.88 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.672 -0.695 . . . . 72.44 109.802 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.44 ' HE ' HG21 ' A' ' 122' ' ' THR . 38.6 ttt180 -171.49 143.79 1.83 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.687 -0.688 . . . . 62.32 109.725 -174.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 71.4 mt -130.25 138.14 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 107.519 -1.289 . . . . 73.14 107.519 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.421 ' HE1' HG13 ' B' ' 83' ' ' ILE . 26.7 p90 -161.66 143.37 11.42 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.248 0.547 . . . . 75.52 111.479 -172.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.697 HG21 HD11 ' B' ' 21' ' ' ILE . 21.1 m -76.44 123.26 25.73 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.946 -1.025 . . . . 73.1 108.522 171.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.43 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.8 mtpt -93.84 -26.54 16.88 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.265 0.626 . . . . 71.13 110.337 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 34.0 t70 -152.53 141.75 21.44 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.91 0.484 . . . . 75.11 110.814 -175.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.697 HD11 HG21 ' B' ' 18' ' ' THR . 32.8 mm -129.5 142.47 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.022 1.329 . . . . 72.51 108.449 174.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 46.5 m -147.58 134.27 19.97 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.846 -1.07 . . . . 71.22 109.668 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -147.16 109.05 4.4 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.752 -1.573 . . . . 70.52 106.752 167.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -120.98 114.84 22.1 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.487 -0.931 . . . . 65.34 108.487 -177.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.58 87.02 2.48 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 107.327 -1.36 . . . . 63.21 107.327 175.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.65 -37.28 22.12 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.502 2.134 . . . . 74.23 112.552 -169.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.528 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 82.4 m-20 -102.13 17.46 23.25 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.05 0.94 . . . . 73.13 110.621 -176.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.422 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -39.88 -60.74 1.28 Allowed Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 115.465 1.654 . . . . 75.53 115.465 -163.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 12.6 Cg_exo -67.57 -28.48 38.02 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 121.844 1.696 . . . . 72.34 112.349 -173.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.458 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 79.1 m80 -92.83 -25.43 18.12 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.137 -0.938 . . . . 74.03 112.145 -173.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.585 HG21 ' HA ' ' B' ' 73' ' ' ALA . 6.0 p -83.02 -7.55 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 121.259 0.552 . . . . 75.43 110.725 -176.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -77.76 -9.23 58.91 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.207 0.603 . . . . 72.13 112.626 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 10.5 pt20 -67.23 -17.25 64.73 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.809 0.444 . . . . 71.11 110.582 170.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.538 ' HB2' HD13 ' B' ' 68' ' ' LEU . 30.5 mmtp -92.92 98.43 11.36 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.841 1.257 . . . . 74.24 109.23 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -100.1 78.25 2.06 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.322 0.649 . . . . 75.14 110.233 -176.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 25.2 p90 -166.06 172.46 11.35 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.575 0.75 . . . . 65.14 110.244 174.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -71.73 117.59 59.02 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 123.201 0.6 . . . . 73.32 110.104 175.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.42 ' HD3' ' HG2' ' B' ' 124' ' ' PRO . 55.8 Cg_endo -70.53 147.35 57.74 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 121.754 1.636 . . . . 72.33 110.474 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -72.47 110.0 6.56 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.22 -1.03 . . . . 65.24 108.22 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.479 HG21 HD13 ' B' ' 126' ' ' LEU . 59.9 t -99.32 146.05 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 114.955 -1.02 . . . . 73.24 110.44 -174.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -119.23 117.86 29.77 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.981 1.312 . . . . 70.04 108.578 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.629 HD13 HD22 ' B' ' 128' ' ' LEU . 24.2 tp -89.26 144.77 25.85 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.922 -0.399 . . . . 61.14 109.922 172.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.412 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 12.3 t70 -150.82 119.25 6.42 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.752 -0.832 . . . . 74.04 108.752 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 90.5 mt -99.47 126.24 45.36 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.475 -0.565 . . . . 71.42 109.475 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -124.79 127.45 47.2 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.765 -1.198 . . . . 74.15 107.765 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.8 t -109.46 141.37 41.97 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 122.746 0.418 . . . . 74.2 110.178 -172.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.69 140.73 27.47 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.477 1.111 . . . . 74.35 108.104 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 14.9 m -137.92 163.8 30.57 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.764 0.426 . . . . 72.4 110.021 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 72.1 p -156.41 136.31 12.64 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.246 0.618 . . . . 73.3 109.705 174.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -91.43 134.6 34.49 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.248 -1.019 . . . . 73.04 108.248 170.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 pp -150.67 14.22 0.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.432 -0.804 . . . . 74.34 109.717 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.98 158.82 35.64 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.439 -0.801 . . . . 45.02 110.953 -174.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -83.66 127.03 33.46 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.778 -1.101 . . . . 70.31 108.897 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 64.03 4.0 1.88 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 124.472 1.109 . . . . 63.23 113.065 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 53.6 t -132.32 122.73 48.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.63 -0.878 . . . . 74.31 108.63 -173.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.43 140.62 44.49 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 108.214 -1.032 . . . . 73.13 108.214 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -99.48 101.37 12.59 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 105.442 -2.058 . . . . 63.54 105.442 172.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.512 HG21 ' HG3' ' B' ' 103' ' ' PRO . 14.6 p -109.29 140.14 29.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 121.407 0.622 . . . . 72.12 109.329 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.418 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 17.0 t -114.2 144.56 21.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 124.614 1.166 . . . . 61.03 108.683 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 48.1 tp -121.12 110.36 16.12 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 107.751 -1.203 . . . . 73.34 107.751 167.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -84.25 118.36 24.12 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.673 -1.232 . . . . 73.3 107.673 171.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.4 121.24 57.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.44 -0.948 . . . . 71.5 108.44 173.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 17.8 m -108.75 135.29 50.22 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.74 0.816 . . . . 64.42 109.384 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.537 HG11 HD21 ' B' ' 126' ' ' LEU . 82.0 t -134.11 119.88 32.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.903 0.881 . . . . 73.12 109.171 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 66.6 m -109.5 138.98 45.06 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 123.659 0.783 . . . . 75.14 109.072 173.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.469 ' HB2' HG22 ' B' ' 40' ' ' VAL . . . -148.73 141.86 24.96 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.728 0.411 . . . . 73.43 109.909 178.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.554 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 35.4 p -141.68 132.68 26.07 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.607 0.763 . . . . 71.43 110.904 -176.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.538 HD13 ' HB2' ' B' ' 34' ' ' LYS . 68.8 mt -102.04 103.41 14.0 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 124.664 1.186 . . . . 61.22 109.196 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.96 -124.59 7.88 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.794 -0.639 . . . . 62.14 111.986 -175.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -96.08 2.24 53.1 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.937 0.895 . . . . 74.12 111.037 -173.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.528 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 19.9 pt-20 -130.16 149.38 51.89 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.988 0.515 . . . . 73.3 110.901 -173.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 85.9 m -73.73 123.68 24.57 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.014 -0.539 . . . . 75.32 110.673 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.585 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -76.35 -60.94 2.12 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.651 -1.159 . . . . 74.51 108.704 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -153.13 152.71 31.58 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.058 -0.974 . . . . 75.11 111.85 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 75.2 mt -121.05 110.62 16.46 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.53 -1.656 . . . . 55.22 106.53 169.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 28.9 t -119.28 121.25 39.21 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.028 -0.73 . . . . 62.4 109.028 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -138.22 128.49 26.0 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.244 0.618 . . . . 64.54 109.409 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 73.3 t -126.44 134.94 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.596 0.758 . . . . 62.23 109.172 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.502 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.3 mt-30 -108.67 107.72 18.3 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.305 -0.998 . . . . 73.44 108.305 175.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.425 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 7.8 tp-100 -100.8 107.81 19.46 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.753 -0.832 . . . . 74.0 108.753 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.43 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -91.73 170.01 33.16 Favored Glycine 0 C--O 1.245 0.784 0 N-CA-C 111.865 -0.494 . . . . 54.22 111.865 175.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.53 139.66 5.78 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 121.727 -0.273 . . . . 71.22 113.069 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.421 HG13 ' HE1' ' B' ' 17' ' ' TYR . 66.5 mt -98.23 110.75 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 125.019 1.327 . . . . 71.23 108.182 176.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -122.79 143.95 49.5 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.713 0.805 . . . . 74.43 110.839 -175.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 37.1 m -102.2 122.94 45.16 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.73 0.812 . . . . 70.3 109.894 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.566 ' HB ' HD11 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -131.89 122.74 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 124.911 1.284 . . . . 75.3 109.302 179.266 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.94 150.51 24.4 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.885 0.474 . . . . 61.54 111.579 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.36 -35.67 4.73 Favored Glycine 0 N--CA 1.479 1.503 0 C-N-CA 123.263 0.458 . . . . 75.22 112.394 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.566 HD11 ' HB ' ' B' ' 86' ' ' ILE . 7.1 pt -63.75 160.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 124.891 1.276 . . . . 65.21 112.655 173.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -153.78 176.07 12.57 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.023 0.929 . . . . 64.22 110.317 -173.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.4 -130.86 41.2 Favored Glycine 0 C--N 1.354 1.533 0 O-C-N 123.73 0.643 . . . . 63.13 112.859 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 18.0 m -67.5 -45.29 76.26 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.678 0.791 . . . . 63.44 109.75 172.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -59.12 -23.66 62.31 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 113.556 -1.656 . . . . 74.3 112.238 -167.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 20.6 ttt -58.6 -70.23 0.15 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.014 1.326 . . . . 74.13 111.931 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.39 -12.8 56.08 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.803 0.441 . . . . 70.25 112.137 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -63.24 -41.78 99.11 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.355 0.662 . . . . 72.21 110.267 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -60.69 -43.64 97.5 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.855 -0.611 . . . . 72.31 111.6 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.562 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.2 pp -81.28 -23.83 37.67 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.726 0.41 . . . . 52.42 111.776 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.51 -1.61 60.46 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-O 119.784 -0.453 . . . . 62.01 113.877 -174.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.47 -55.99 0.39 Allowed 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.303 0.551 . . . . 64.21 111.891 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -69.11 -46.23 68.23 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.745 0.418 . . . . 54.33 110.33 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.562 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 79.3 m -66.19 -47.98 59.85 Favored Pre-proline 0 CA--C 1.569 1.687 0 N-CA-C 113.711 1.004 . . . . 60.03 113.711 -177.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.512 ' HG3' HG21 ' B' ' 58' ' ' VAL . 15.2 Cg_exo -65.12 -28.82 56.52 Favored 'Trans proline' 0 C--N 1.402 3.359 0 C-N-CA 122.033 1.822 . . . . 72.24 112.87 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -69.62 -29.03 66.44 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.092 0.557 . . . . 71.23 110.325 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.23 -35.69 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.339 0.656 . . . . 64.14 110.334 170.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 76.5 mt -80.26 -17.98 50.68 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.821 0.848 . . . . 73.21 112.33 -177.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -59.42 -50.71 85.89 Favored Pre-proline 0 CA--C 1.561 1.375 0 CA-C-O 117.515 -1.231 . . . . 73.02 112.898 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -54.73 -37.11 91.84 Favored 'Trans proline' 0 C--N 1.39 2.727 0 C-N-CA 122.429 2.086 . . . . 70.2 114.028 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -68.73 -46.69 68.24 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.376 0.671 . . . . 72.51 110.583 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.425 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -64.55 -34.72 78.91 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.592 -0.731 . . . . 62.3 110.924 176.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 31.2 ttt180 -64.99 -50.13 67.54 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.226 1.41 . . . . 73.45 110.813 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.38 -32.52 70.21 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.403 0.681 . . . . 55.01 109.933 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.56 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.9 t -67.31 -41.37 85.46 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 122.923 0.489 . . . . 65.54 110.728 177.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 49.8 mt -59.83 -54.42 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.837 0.855 . . . . 71.43 110.445 172.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 25.1 m -61.79 -29.22 70.0 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 123.757 0.661 . . . . 75.24 111.371 -177.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 44.6 t -64.5 -52.44 57.83 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 123.543 0.737 . . . . 74.5 109.839 173.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 15.6 mmt -66.02 -33.62 76.22 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.27 0.628 . . . . 64.22 111.612 -175.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.504 HG21 HD23 ' B' ' 126' ' ' LEU . 74.3 t -66.76 -44.48 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.639 1.176 . . . . 75.45 110.602 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.5 t -64.66 -32.83 74.67 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.099 -0.955 . . . . 65.45 110.567 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' B' ' 116' ' ' SER . 78.5 mtt-85 -64.67 -47.78 77.16 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 115.709 -0.678 . . . . 72.13 109.339 175.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . 0.468 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -67.95 -5.99 42.71 Favored Glycine 0 C--N 1.358 1.772 0 O-C-N 123.735 0.647 . . . . 22.41 113.615 174.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.506 ' HB ' ' HE ' ' A' ' 15' ' ' ARG . 2.2 m 66.77 27.62 9.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.539 1.536 . . . . 74.51 110.563 175.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -84.87 156.06 61.18 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.214 0.605 . . . . 74.32 110.971 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.42 ' HG2' ' HD3' ' B' ' 38' ' ' PRO . 71.6 Cg_exo -51.89 167.86 0.41 Allowed 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 123.991 3.127 . . . . 71.22 115.219 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -63.52 112.56 2.83 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.832 -1.076 . . . . 74.15 111.605 -167.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.537 HD21 HG11 ' B' ' 64' ' ' VAL . 43.6 tp -116.56 105.82 12.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.282 0.633 . . . . 74.23 109.56 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -121.49 120.96 36.41 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.034 -1.098 . . . . 72.21 108.034 170.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.629 HD22 HD13 ' B' ' 42' ' ' LEU . 59.2 mt -74.21 143.92 44.96 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.58 0.55 . . . . 63.03 110.988 -174.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.91 141.14 63.19 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 122.961 0.504 . . . . 73.11 110.843 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.655 ' HG3' HD11 ' D' ' 16' ' ' ILE . 61.7 Cg_endo -70.14 79.98 1.02 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.334 2.689 . . . . 73.33 111.216 174.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 p -100.01 125.42 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 115.498 -0.774 . . . . 74.44 110.053 -177.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 60.3 t30 . . . . . 0 CA--C 1.539 0.556 0 CA-C-N 115.677 -0.692 . . . . 72.12 110.108 -177.403 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 68.3 t80 . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 109.264 -0.643 . . . . 72.0 109.264 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -161.97 126.54 3.32 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.559 0.744 . . . . 74.03 109.591 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 48.5 mt -78.84 123.59 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 108.438 -0.949 . . . . 74.24 108.438 169.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.445 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 81.6 mm-40 -90.44 -42.12 11.07 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.644 0.777 . . . . 65.11 109.688 176.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.517 ' HA ' HD21 ' A' ' 127' ' ' ASN . 9.0 ptp85 -173.42 150.9 1.89 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.312 -0.858 . . . . 73.43 110.212 -178.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 74.3 mt -128.17 135.15 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 106.731 -1.581 . . . . 72.41 106.731 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -173.06 158.64 3.77 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.379 0.609 . . . . 61.11 111.724 -170.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 70.2 p -82.46 113.24 20.08 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.341 -0.845 . . . . 71.04 109.123 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.603 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 10.4 mmmm -68.61 -49.13 61.64 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.046 -1.094 . . . . 73.11 108.046 169.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.704 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 20.8 t70 -136.19 143.68 44.54 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 113.852 -1.522 . . . . 73.44 109.681 -172.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.552 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.5 mt -138.47 145.66 27.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 125.435 1.494 . . . . 75.23 107.25 175.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 41.3 t -153.17 147.75 26.12 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.463 0.649 . . . . 62.03 110.048 175.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -151.83 125.61 9.04 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.04 -1.467 . . . . 74.44 107.04 170.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -129.35 117.81 21.23 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.682 0.793 . . . . 71.05 108.867 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.22 85.62 5.62 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 107.304 -1.369 . . . . 75.41 107.304 167.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.91 -33.61 63.11 Favored 'Trans proline' 0 C--N 1.387 2.605 0 C-N-CA 123.097 2.531 . . . . 64.23 112.209 -172.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -113.6 31.51 6.45 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.861 -1.063 . . . . 70.44 109.605 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.414 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -43.91 -54.68 10.54 Favored Pre-proline 0 C--N 1.377 1.764 0 CA-C-O 117.837 -1.078 . . . . 54.12 113.383 -174.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 50.1 Cg_exo -53.28 -52.16 9.33 Favored 'Trans proline' 0 C--N 1.395 3.003 0 C-N-CA 122.001 1.801 . . . . 63.01 113.128 175.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -69.52 -32.57 71.49 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.608 -1.178 . . . . 74.4 113.2 -171.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.622 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.9 p -79.05 -24.44 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 N-CA-C 112.48 0.548 . . . . 73.51 112.48 -173.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -71.42 -17.86 62.36 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 112.349 0.5 . . . . 71.51 112.349 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -93.75 7.39 45.01 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.918 0.487 . . . . 71.12 111.759 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.696 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -94.62 158.74 15.39 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.232 0.613 . . . . 71.42 110.788 -177.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -68.22 129.65 40.55 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.057 0.943 . . . . 65.43 109.539 164.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . 0.567 ' HZ2' HD21 ' C' ' 126' ' ' LEU . 64.0 t-105 -82.24 90.49 6.62 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.211 0.604 . . . . 74.41 110.5 -178.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -143.14 78.38 15.16 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 107.709 -1.219 . . . . 74.35 107.709 171.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -93.79 169.85 1.99 Allowed 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 122.527 2.151 . . . . 64.35 112.835 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -92.78 89.76 6.76 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 106.181 -1.785 . . . . 63.43 106.181 171.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 61.2 t -68.16 96.97 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 109.037 -0.727 . . . . 74.14 109.037 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -96.75 104.68 16.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.884 -1.053 . . . . 74.42 108.641 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.682 ' H ' HD23 ' C' ' 42' ' ' LEU . 1.8 pt? -97.07 121.14 38.62 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.788 -1.56 . . . . 62.24 106.788 168.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -119.39 141.12 49.36 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.571 -0.9 . . . . 72.1 108.571 -174.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 50.0 mt -130.97 110.74 11.47 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.32 0.648 . . . . 65.54 110.165 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -114.54 122.86 47.85 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.967 1.707 . . . . 73.13 107.469 173.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.1 t -121.8 149.28 43.55 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.029 -0.73 . . . . 71.13 109.029 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.45 153.57 32.74 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.543 0.737 . . . . 51.32 109.281 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.456 ' OG ' ' HB3' ' C' ' 98' ' ' LEU . 12.8 m -131.71 145.36 51.59 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.304 0.642 . . . . 74.13 109.414 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.3 p -144.91 127.37 15.96 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.566 -0.901 . . . . 74.32 108.566 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -80.28 117.91 21.47 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 108.717 -0.846 . . . . 72.13 108.717 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.616 HD11 HD12 ' C' ' 83' ' ' ILE . 25.6 mt -83.82 -47.18 11.39 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.585 0.707 . . . . 71.34 109.656 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.57 -166.96 2.69 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 114.486 -1.233 . . . . 44.31 110.029 -171.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -57.77 105.0 0.22 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.399 1.079 . . . . 71.33 110.535 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 60.1 22.17 11.41 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.329 1.018 . . . . 71.52 112.978 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 85.6 t -104.3 119.64 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.661 0.785 . . . . 74.41 108.989 173.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -121.28 121.31 37.42 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.821 -1.177 . . . . 74.35 107.821 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -89.93 114.43 26.23 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.033 -1.099 . . . . 62.11 108.033 168.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 97.9 t -95.14 134.94 30.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.278 -1.379 . . . . 61.34 107.278 168.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 93.8 t -121.11 138.0 52.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 108.356 -0.979 . . . . 54.1 108.356 174.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.27 101.08 8.84 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.994 -1.113 . . . . 71.11 107.994 175.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 21.0 ttm-85 -81.07 107.13 13.62 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 108.434 -0.95 . . . . 74.44 108.434 170.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.49 ' HB ' HD11 ' C' ' 114' ' ' ILE . 7.8 t -106.58 120.11 57.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 108.09 -1.078 . . . . 70.32 108.09 173.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 17.5 m -119.21 116.16 25.72 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.251 0.621 . . . . 64.02 109.572 -174.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.475 HG21 HG21 ' C' ' 114' ' ' ILE . 63.3 t -104.06 109.04 26.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 123.452 0.701 . . . . 61.53 109.114 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 3.8 m -99.4 140.1 34.08 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.668 -1.234 . . . . 64.23 107.668 170.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.41 119.42 19.62 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 106.661 -1.607 . . . . 74.25 106.661 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 44.9 m -133.29 126.02 30.54 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.579 0.549 . . . . 61.43 110.452 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.696 HD13 ' HG2' ' C' ' 34' ' ' LYS . 11.0 mt -86.78 47.08 1.44 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.766 1.226 . . . . 62.11 109.317 176.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.65 -110.8 3.84 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 111.001 -0.84 . . . . 71.03 111.001 -174.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.16 -28.87 19.73 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.093 -0.706 . . . . 75.14 109.093 173.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -62.86 120.67 11.76 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.584 1.153 . . . . 72.14 109.194 172.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 20.9 m -84.24 125.06 31.87 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 108.443 -0.947 . . . . 75.13 108.443 169.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.622 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -73.45 -62.97 1.29 Allowed 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.328 -0.99 . . . . 64.4 108.328 174.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -157.33 169.89 23.7 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-O 121.917 0.865 . . . . 73.31 110.782 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.442 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.7 tm? -123.43 147.01 47.56 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 106.388 -1.708 . . . . 73.33 106.388 166.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.442 ' N ' HD13 ' C' ' 75' ' ' LEU . 48.4 t -149.22 145.62 27.2 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.846 -1.168 . . . . 54.53 107.846 177.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -157.07 136.56 12.17 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.301 -0.629 . . . . 74.15 109.301 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.474 HG11 ' HA ' ' C' ' 110' ' ' ALA . 54.7 t -134.22 113.52 17.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.136 -1.061 . . . . 63.3 108.136 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.704 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.4 mt-30 -94.44 89.21 5.77 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.828 -0.805 . . . . 71.03 108.828 173.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -79.68 102.4 8.94 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.509 -1.223 . . . . 74.55 110.09 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.58 150.47 26.93 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 112.007 -0.437 . . . . 61.41 112.007 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.404 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -152.22 117.69 0.84 Allowed Glycine 0 CA--C 1.502 -0.771 0 N-CA-C 110.233 -1.147 . . . . 63.3 110.233 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.616 HD12 HD11 ' C' ' 51' ' ' LEU . 25.5 mm -85.23 121.15 36.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.53 -0.915 . . . . 53.13 108.53 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -129.9 117.18 19.74 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.16 -1.052 . . . . 53.43 108.16 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 53.9 p -90.45 103.5 16.18 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.954 -0.758 . . . . 63.35 108.954 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.541 HD13 ' SG ' ' C' ' 97' ' ' CYS . 25.4 mt -116.86 138.74 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.146 0.978 . . . . 74.1 110.746 -171.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.06 170.4 19.48 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.657 0.783 . . . . 62.54 110.869 175.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.83 -18.67 38.01 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-N 115.534 -0.757 . . . . 42.14 113.756 172.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.401 HG22 HE21 ' C' ' 93' ' ' GLN . 34.8 pt -106.33 170.59 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.232 0.613 . . . . 64.13 111.261 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -160.81 158.84 29.13 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.645 0.778 . . . . 74.14 109.854 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.55 -114.76 7.1 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 123.615 0.572 . . . . 61.23 113.846 168.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 13.4 t -66.25 -35.5 80.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.635 0.774 . . . . 74.53 111.082 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.401 HE21 HG22 ' C' ' 89' ' ' ILE . 29.5 mt-30 -71.81 -42.66 66.78 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.646 0.778 . . . . 73.44 110.622 -178.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 6.2 tpt -62.5 -52.36 63.78 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 123.923 0.765 . . . . 54.25 110.024 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.87 -31.42 72.59 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.753 -0.658 . . . . 60.43 111.817 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -72.17 -34.18 68.26 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.142 0.577 . . . . 70.1 110.553 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.541 ' SG ' HD13 ' C' ' 86' ' ' ILE . 18.2 t -71.2 -41.37 70.35 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.699 -0.482 . . . . 61.54 109.699 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.456 ' HB3' ' OG ' ' C' ' 48' ' ' SER . 89.9 mt -85.05 -44.51 12.96 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.959 0.904 . . . . 72.01 112.815 -170.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.52 3.17 57.68 Favored Glycine 0 N--CA 1.472 1.072 0 CA-C-N 116.067 -0.515 . . . . 43.31 113.481 -170.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.31 -68.98 0.45 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.999 0.4 . . . . 64.2 111.096 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -60.21 -55.1 37.93 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.765 0.826 . . . . 72.14 112.475 -171.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 98.2 m -59.75 -46.74 98.45 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.794 0.838 . . . . 72.13 112.523 -177.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -50.85 -35.21 48.09 Favored 'Trans proline' 0 C--N 1.395 3.018 0 C-N-CA 123.071 2.514 . . . . 63.04 115.119 169.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -66.8 -33.9 76.63 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 118.719 0.69 . . . . 74.32 111.075 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.486 HD12 ' NH1' ' A' ' 111' ' ' ARG . 42.0 mm -72.53 -34.83 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 123.004 0.521 . . . . 75.34 109.907 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.404 HD21 ' HA3' ' C' ' 82' ' ' GLY . 89.4 mt -84.49 -24.56 29.37 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.855 0.862 . . . . 70.5 112.326 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -57.05 -52.11 76.6 Favored Pre-proline 0 N--CA 1.482 1.137 0 CA-C-O 117.334 -1.317 . . . . 71.15 113.867 -172.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.01 -34.41 80.65 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.168 1.912 . . . . 64.31 112.915 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -66.35 -47.62 72.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.483 0.713 . . . . 72.24 110.236 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.474 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -63.39 -36.88 85.2 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.855 -1.066 . . . . 73.15 110.943 177.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.2 ttt-85 -68.99 -46.57 67.71 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.409 1.484 . . . . 75.34 111.176 -175.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -67.97 -34.33 76.36 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.528 0.731 . . . . 65.11 109.486 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 12.8 t -65.86 -35.67 81.32 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.462 0.705 . . . . 65.02 111.249 177.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.49 HD11 ' HB ' ' C' ' 62' ' ' VAL . 85.7 mt -69.23 -58.04 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.345 0.658 . . . . 72.11 110.485 176.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 4.7 m -64.43 -28.38 69.64 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 122.707 0.403 . . . . 70.03 111.249 -173.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 42.0 t -61.6 -52.78 62.99 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 123.279 0.632 . . . . 51.21 109.37 169.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.549 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.08 -42.59 80.96 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.011 1.324 . . . . 74.43 113.002 -179.568 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.468 HG11 HD23 ' C' ' 126' ' ' LEU . 87.3 t -63.62 -45.67 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.381 1.072 . . . . 64.51 110.253 177.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.4 t -67.52 -29.67 69.13 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.281 -1.327 . . . . 71.31 111.429 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.48 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 87.3 mtt-85 -68.59 -39.53 80.89 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.072 -0.714 . . . . 64.45 109.072 176.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.79 12.03 58.04 Favored Glycine 0 C--N 1.354 1.535 0 CA-C-N 115.698 -0.683 . . . . 70.21 113.0 175.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 69.0 p 53.8 37.53 26.56 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 126.212 1.805 . . . . 75.33 114.146 175.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -93.99 148.03 34.52 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 107.583 -1.266 . . . . 74.11 107.583 165.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.01 169.45 0.64 Allowed 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.224 2.616 . . . . 73.0 114.168 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -59.32 123.3 16.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.159 0.984 . . . . 74.04 111.975 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.567 HD21 ' HZ2' ' C' ' 36' ' ' TRP . 3.5 mm? -116.27 86.14 2.43 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.674 -1.232 . . . . 71.44 107.674 166.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -91.46 95.17 9.82 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.727 -0.842 . . . . 53.13 108.727 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 8.5 mp -55.84 131.01 45.85 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.102 0.961 . . . . 73.11 111.583 -175.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.44 137.08 96.48 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-O 118.694 -0.669 . . . . 62.11 110.453 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -49.52 110.91 0.41 Allowed 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.673 2.915 . . . . 73.35 113.442 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.9 t -100.93 114.55 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 123.142 0.577 . . . . 75.32 109.455 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -80.88 105.7 12.32 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.421 0.689 . . . . 72.54 109.418 176.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -68.8 -20.78 64.34 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.372 0.669 . . . . 51.3 112.329 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.55 -29.85 65.22 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.116 0.566 . . . . 65.51 110.554 173.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.01 -35.0 64.36 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.064 0.546 . . . . 70.2 110.004 173.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 83.1 mt -67.68 -40.28 84.42 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.82 -0.627 . . . . 71.3 110.418 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 55.9 t80 . . . . . 0 N--CA 1.473 0.717 0 C-N-CA 123.741 0.816 . . . . 75.32 110.488 179.793 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 C--O 1.242 0.687 0 N-CA-C 109.525 -0.546 . . . . 64.14 109.525 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.483 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 58.5 t80 -134.5 105.41 6.53 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.648 -1.242 . . . . 62.22 107.648 175.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -129.83 115.82 17.8 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.724 -0.843 . . . . 61.43 108.724 -174.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 8.1 mt -76.04 122.53 30.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 108.314 -0.995 . . . . 72.23 108.314 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -89.16 -29.05 19.6 Favored 'General case' 0 C--O 1.242 0.675 0 O-C-N 123.822 0.701 . . . . 62.14 110.982 -176.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -172.77 138.2 0.81 Allowed 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.464 0.477 . . . . 51.31 110.146 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.655 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.5 mp -120.88 135.97 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.681 -1.229 . . . . 73.44 107.681 173.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -162.4 170.14 19.3 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.207 1.003 . . . . 71.13 112.85 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.5 p -105.05 119.24 38.54 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.224 -1.353 . . . . 63.51 108.509 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -88.0 -21.29 24.9 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.035 -0.53 . . . . 73.2 109.925 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.412 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 31.8 t70 -159.9 138.61 10.6 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.182 0.993 . . . . 63.14 109.219 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.549 HG21 ' HE2' ' C' ' 117' ' ' MET . 72.5 mt -139.77 138.29 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.971 1.308 . . . . 73.35 107.802 176.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.5 t -139.69 143.35 37.05 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.104 0.962 . . . . 74.21 109.008 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.552 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 91.7 t80 -150.0 122.99 8.78 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 106.612 -1.625 . . . . 62.12 106.612 170.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.63 111.65 11.9 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.715 0.806 . . . . 62.41 109.584 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.93 84.66 4.47 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 107.665 -1.235 . . . . 70.33 107.665 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.16 -43.64 0.53 Allowed 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.415 2.077 . . . . 61.14 112.336 -171.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -93.81 10.52 32.77 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.256 1.022 . . . . 71.42 110.414 -176.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.603 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -31.69 -64.79 0.22 Allowed Pre-proline 0 N--CA 1.488 1.441 0 C-N-CA 127.259 2.224 . . . . 61.11 116.334 -166.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.84 -21.65 14.13 Favored 'Trans proline' 0 C--N 1.38 2.222 0 CA-C-N 122.735 2.013 . . . . 74.53 114.073 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -77.33 -37.29 52.79 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.377 1.071 . . . . 73.44 109.909 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.438 HG12 ' O ' ' D' ' 28' ' ' ALA . 7.7 p -82.98 -25.57 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-N 115.452 -0.795 . . . . 63.21 111.308 -172.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -60.65 -25.78 66.58 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 122.883 0.473 . . . . 74.43 112.099 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -64.9 -8.66 16.43 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.776 1.23 . . . . 63.01 112.231 -175.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -96.41 95.01 7.75 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.2 1.4 . . . . 71.21 109.041 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -81.91 81.71 7.8 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.356 0.662 . . . . 74.11 111.093 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -160.78 -179.88 7.95 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.18 0.992 . . . . 72.12 109.1 166.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . 0.426 ' NE2' ' HD2' ' D' ' 38' ' ' PRO . 35.3 tp60 -75.78 114.12 33.61 Favored Pre-proline 0 N--CA 1.477 0.9 0 CA-C-O 118.294 -0.86 . . . . 64.13 109.167 178.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.426 ' HD2' ' NE2' ' D' ' 37' ' ' GLN . 51.1 Cg_exo -53.35 134.79 58.54 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.045 2.497 . . . . 74.33 111.856 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -63.81 107.82 1.3 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 107.623 -1.251 . . . . 74.22 107.623 175.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.664 HG13 HG13 ' D' ' 64' ' ' VAL . 86.5 t -104.4 129.55 56.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 109.416 -0.587 . . . . 73.31 109.416 -176.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -105.35 112.28 25.33 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 106.348 -1.723 . . . . 62.23 106.348 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.489 HD22 ' HB2' ' D' ' 128' ' ' LEU . 64.8 tp -94.33 150.02 20.68 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.678 -1.23 . . . . 54.23 107.678 174.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -148.27 140.07 23.83 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.255 -1.017 . . . . 75.23 108.255 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.506 HD22 HG22 ' D' ' 62' ' ' VAL . 91.4 mt -130.7 145.09 51.85 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.584 0.754 . . . . 73.02 109.452 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -155.62 141.35 18.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.766 -1.198 . . . . 73.41 107.766 169.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 25.9 m -102.84 156.18 17.83 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.214 1.005 . . . . 64.24 109.292 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.09 167.13 26.7 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 126.039 1.736 . . . . 74.32 106.8 172.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 13.5 p . . . . . 0 C--O 1.244 0.783 0 N-CA-C 109.306 -0.627 . . . . 62.32 109.306 -179.79 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' D' ' 85' ' ' SER . 1.9 m-20 . . . . . 0 N--CA 1.486 1.368 0 N-CA-C 112.011 0.374 . . . . 63.13 112.011 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.26 94.88 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 109.054 -0.721 . . . . 73.2 109.054 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -122.95 127.99 49.64 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.787 -0.82 . . . . 70.03 108.787 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -94.64 119.42 33.27 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.468 -0.938 . . . . 60.33 108.468 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 73.8 t -101.33 134.45 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.853 0.861 . . . . 71.13 108.851 173.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.515 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 33.4 t -116.02 128.44 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.185 0.994 . . . . 63.21 108.745 173.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.39 111.69 24.14 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.86 -1.163 . . . . 72.44 107.86 175.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 ttt85 -85.82 106.48 17.08 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.233 -0.655 . . . . 42.53 109.233 174.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.506 HG22 HD22 ' D' ' 44' ' ' LEU . 61.1 t -105.75 130.65 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.268 1.027 . . . . 44.33 108.624 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 7.3 m -134.75 144.46 47.72 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.014 0.435 . . . . 71.53 110.964 -173.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.664 HG13 HG13 ' D' ' 40' ' ' VAL . 55.0 t -133.85 114.28 19.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 C-N-CA 125.447 1.499 . . . . 60.12 108.902 -173.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 19.2 m -106.12 93.46 4.63 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.074 -1.084 . . . . 74.43 108.074 169.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.08 144.94 27.04 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.363 0.665 . . . . 72.25 109.937 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.496 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 48.2 m -151.89 127.85 10.35 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 123.424 0.69 . . . . 75.13 110.879 -177.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.437 ' HB2' HG22 ' D' ' 31' ' ' VAL . 16.6 mt -93.45 109.31 20.9 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 107.764 -1.199 . . . . 61.22 107.764 168.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.19 -124.32 8.27 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 116.064 -0.516 . . . . 54.55 112.496 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.15 3.99 28.55 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.329 0.652 . . . . 72.45 111.775 -176.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -118.42 158.88 24.46 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 109.574 -0.528 . . . . 60.43 109.574 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 52.0 m -72.43 129.56 38.63 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.615 -0.72 . . . . 73.13 111.685 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.496 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -81.54 -69.19 0.63 Allowed 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.829 -1.174 . . . . 72.31 107.829 173.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -153.54 153.77 33.03 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 115.841 -0.618 . . . . 74.43 111.105 176.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 50.0 mt -119.32 109.93 16.38 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.396 -1.335 . . . . 74.33 107.396 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.543 ' SG ' HG12 ' D' ' 114' ' ' ILE . 42.0 t -120.61 136.98 54.66 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 123.544 0.737 . . . . 70.14 109.586 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -152.06 123.88 7.98 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.9 0.48 . . . . 70.23 109.794 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 88.3 t -127.58 118.52 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.926 0.89 . . . . 71.22 109.836 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.412 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.2 mt-30 -90.72 90.13 7.82 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.517 0.727 . . . . 71.24 109.251 171.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -82.77 98.74 9.26 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.723 -1.126 . . . . 52.24 109.422 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -102.19 156.4 18.55 Favored Glycine 0 N--CA 1.471 1.012 0 N-CA-C 112.077 -0.409 . . . . 44.25 112.077 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.4 150.05 13.78 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 117.2 0.5 . . . . 64.12 112.619 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 57.5 mt -90.0 132.71 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 109.082 -0.71 . . . . 64.21 109.082 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -128.98 140.46 51.64 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.305 1.042 . . . . 64.42 109.575 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 39.8 t -93.59 108.27 20.01 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 107.682 -1.229 . . . . 71.32 107.682 168.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 33.9 pt -109.13 123.9 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 N-CA-C 108.654 -0.869 . . . . 74.04 108.654 172.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.45 168.29 6.52 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.173 0.589 . . . . 62.34 111.458 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.3 19.18 72.44 Favored Glycine 0 C--N 1.347 1.165 0 O-C-N 123.683 0.614 . . . . 61.4 112.941 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.43 164.25 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.266 1.027 . . . . 74.54 109.799 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -146.68 -179.35 6.72 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.749 0.82 . . . . 73.21 110.57 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.82 -140.29 27.64 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 115.984 -0.553 . . . . 71.3 112.472 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 60.8 p -89.62 -29.83 18.57 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.366 0.666 . . . . 74.04 110.752 172.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -53.4 -33.22 53.03 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.578 1.151 . . . . 74.12 112.474 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.492 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 2.9 ppp? -60.71 -50.63 72.72 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.876 0.87 . . . . 72.24 113.197 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . 0.492 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.25 -19.4 31.66 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.061 0.544 . . . . 65.24 110.978 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -67.88 -38.37 82.94 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.674 0.79 . . . . 74.11 110.49 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 86.9 m -61.15 -33.59 73.66 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.585 0.754 . . . . 72.21 111.587 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 27.0 tp -69.54 -37.57 77.13 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.916 0.486 . . . . 75.5 111.119 -176.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.2 0.11 68.47 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-O 119.388 -0.673 . . . . 74.44 113.6 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.75 -58.32 0.77 Allowed 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 117.74 0.77 . . . . 62.33 112.932 -171.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -72.35 -43.84 63.48 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.064 0.545 . . . . 63.12 110.925 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.483 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 75.2 m -60.45 -45.48 97.38 Favored Pre-proline 0 CA--C 1.571 1.752 0 C-N-CA 124.132 0.973 . . . . 70.41 112.166 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.401 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 73.5 Cg_exo -55.28 -42.05 72.33 Favored 'Trans proline' 0 C--N 1.395 3.014 0 C-N-CA 123.188 2.592 . . . . 70.04 113.836 165.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -63.38 -24.88 68.03 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.537 0.735 . . . . 55.24 110.972 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 44.8 mm -75.84 -45.5 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.798 0.839 . . . . 73.14 110.545 172.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.04 -25.79 65.54 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.477 -0.783 . . . . 75.24 111.672 -176.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -68.57 -40.01 17.26 Favored Pre-proline 0 CA--C 1.563 1.467 0 N-CA-C 114.507 1.299 . . . . 72.42 114.507 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -47.83 -46.64 20.9 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.447 2.098 . . . . 71.31 113.69 167.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . 0.428 ' OH ' ' HB3' ' B' ' 130' ' ' PRO . 99.0 m-85 -72.26 -38.46 68.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.631 0.773 . . . . 74.14 111.096 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . 0.417 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -65.93 -38.73 89.43 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.842 0.857 . . . . 72.21 110.776 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.485 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 24.3 ttp-105 -66.02 -48.93 69.49 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 115.104 -0.953 . . . . 73.25 110.032 175.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -56.16 -47.63 77.85 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.64 1.213 . . . . 54.44 110.977 -175.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.5 t -56.74 -46.26 81.48 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 124.032 0.832 . . . . 74.14 111.331 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.543 HG12 ' SG ' ' D' ' 76' ' ' CYS . 62.6 mt -63.33 -57.08 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.962 0.905 . . . . 60.22 111.096 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 38.8 m -52.89 -43.13 65.94 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.527 1.131 . . . . 54.1 111.273 -175.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 29.7 t -63.49 -43.42 97.31 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 114.251 -1.341 . . . . 64.14 109.925 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.8 mtm -69.87 -30.33 67.77 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.12 0.568 . . . . 74.2 111.763 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.4 t -64.56 -45.97 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.508 0.723 . . . . 62.34 109.916 175.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.2 p -74.53 -29.72 61.5 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.636 -0.711 . . . . 60.15 110.74 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 66.5 mtt-85 -70.65 -30.2 66.75 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.639 0.775 . . . . 73.21 109.868 173.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.62 8.97 75.59 Favored Glycine 0 C--N 1.354 1.539 0 O-C-N 123.62 0.575 . . . . 71.02 112.898 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 78.0 p 54.95 27.56 9.35 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 126.167 1.787 . . . . 73.04 113.974 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -88.67 151.04 47.29 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 109.211 -0.663 . . . . 72.52 109.211 168.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -48.3 133.85 25.11 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.642 2.895 . . . . 72.34 113.002 171.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -56.5 128.63 37.09 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.754 0.822 . . . . 55.42 112.006 -170.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.594 HD13 HG21 ' D' ' 40' ' ' VAL . 28.9 tp -108.93 98.23 7.74 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.612 1.165 . . . . 74.34 109.419 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -99.58 80.88 2.42 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.884 -1.154 . . . . 72.12 107.884 174.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.665 ' H ' HD23 ' D' ' 128' ' ' LEU . 0.3 OUTLIER -58.44 112.3 1.53 Allowed 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.64 -1.164 . . . . 74.12 109.686 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.6 139.48 75.6 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 125.102 1.361 . . . . 65.33 113.064 -169.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.48 ' HB3' HH12 ' D' ' 111' ' ' ARG . 96.2 Cg_endo -76.75 155.89 35.11 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.95 2.433 . . . . 73.21 112.633 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 9.6 p -148.79 143.47 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.551 -0.75 . . . . 63.44 109.568 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -81.49 105.98 13.09 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.161 -1.052 . . . . 60.31 108.161 172.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 . . . . . 0 N--CA 1.483 1.18 0 C-N-CA 124.154 0.982 . . . . 64.01 110.601 -177.801 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.0 m . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 109.361 -0.607 . . . . 74.32 109.361 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.431 ' CD1' HD12 ' A' ' 86' ' ' ILE . 46.7 t80 -125.32 114.43 18.89 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.847 -1.168 . . . . 64.24 107.847 175.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -134.38 133.4 40.55 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.254 -0.647 . . . . 75.44 109.254 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.498 ' CD1' HG21 ' A' ' 105' ' ' ILE . 4.7 mt -95.32 120.68 45.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 109.26 -0.644 . . . . 63.04 109.26 177.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -83.76 -39.6 19.86 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 123.554 0.534 . . . . 70.41 111.052 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -173.47 120.14 0.32 Allowed 'General case' 0 N--CA 1.472 0.675 0 O-C-N 123.393 0.433 . . . . 74.5 110.0 -170.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.518 HD12 ' HG3' ' C' ' 130' ' ' PRO . 64.7 mt -107.5 137.63 37.71 Favored 'Isoleucine or valine' 0 C--O 1.247 0.921 0 N-CA-C 108.17 -1.048 . . . . 75.12 108.17 171.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.458 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 35.9 p90 -166.4 179.27 5.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 124.304 1.003 . . . . 75.3 110.936 -170.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -111.39 120.21 41.43 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.422 0.689 . . . . 65.3 110.095 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.1 mtpt -86.08 -28.8 23.85 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.807 -0.442 . . . . 64.15 109.807 177.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 18.0 t70 -144.54 139.3 28.1 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.511 -0.768 . . . . 73.54 109.408 177.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.4 mt -139.42 140.47 37.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.405 -1.331 . . . . 40.34 107.405 172.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.5 t -153.6 125.29 7.69 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.58 0.752 . . . . 72.15 109.479 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.557 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 70.3 t80 -128.59 130.86 47.94 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 106.594 -1.632 . . . . 71.0 106.594 173.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -130.58 135.43 47.89 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.049 0.386 . . . . 71.32 110.002 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.2 76.29 12.34 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.234 1.014 . . . . 73.33 108.358 172.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.31 -34.87 9.22 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.509 2.139 . . . . 73.32 112.264 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.403 ' ND2' ' HG2' ' A' ' 71' ' ' GLU . 6.7 m-20 -91.34 11.77 22.61 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.537 -0.756 . . . . 63.1 110.74 -176.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.449 ' HA ' HG12 ' A' ' 31' ' ' VAL . . . -47.27 -54.12 23.66 Favored Pre-proline 0 CA--C 1.57 1.722 0 CA-C-O 118.03 -0.986 . . . . 74.44 113.035 -171.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 51.9 Cg_exo -55.86 -30.41 76.86 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 122.343 2.028 . . . . 75.22 113.451 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -81.05 -43.19 19.9 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.271 0.628 . . . . 73.32 110.165 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.566 HG21 ' HA ' ' A' ' 73' ' ' ALA . 2.0 p -77.58 -22.26 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 114.782 -1.099 . . . . 75.01 112.685 -159.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -73.28 -21.7 60.54 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.069 0.548 . . . . 54.22 111.629 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -77.96 -22.98 48.66 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.267 -0.879 . . . . 64.43 110.43 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -82.78 165.95 19.45 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.283 1.033 . . . . 71.33 111.323 -174.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -76.77 123.11 25.71 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.601 -0.727 . . . . 53.33 109.48 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -76.23 87.39 3.06 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.666 0.746 . . . . 74.44 110.329 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.94 75.96 47.21 Favored Pre-proline 0 C--O 1.242 0.663 0 N-CA-C 105.898 -1.89 . . . . 41.12 105.898 170.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.63 149.1 14.36 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.819 2.346 . . . . 53.45 112.923 -173.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -96.0 100.89 12.52 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 106.625 -1.62 . . . . 70.14 106.625 167.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 65' ' ' THR . 39.0 t -91.52 108.2 19.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 109.804 -0.443 . . . . 65.32 109.804 -176.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -102.54 114.09 28.01 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.963 -1.017 . . . . 73.12 109.178 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.617 HD11 HD13 ' A' ' 128' ' ' LEU . 6.7 tt -108.91 138.1 45.77 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.416 -0.957 . . . . 65.51 108.416 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -137.8 141.43 40.85 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.75 0.82 . . . . 63.35 109.396 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.604 HD22 HD21 ' A' ' 60' ' ' LEU . 97.3 mt -120.79 142.23 49.78 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.598 0.759 . . . . 53.34 111.337 -172.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.577 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 7.8 m-20 -134.54 137.72 44.05 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.49 -0.93 . . . . 72.4 108.49 176.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.5 HG21 ' HA2' ' A' ' 99' ' ' GLY . 74.6 m -123.48 126.81 47.42 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.36 0.664 . . . . 61.21 109.441 175.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.44 153.56 50.73 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 124.393 1.077 . . . . 74.41 108.915 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.8 m -126.8 159.55 33.49 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 122.962 0.505 . . . . 74.33 110.315 175.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.7 t -148.93 117.97 6.75 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.252 -1.018 . . . . 73.42 108.252 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -77.92 104.01 8.21 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.958 -0.756 . . . . 75.15 108.958 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 71.4 mt -78.63 -27.66 45.43 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.626 -0.716 . . . . 72.43 109.953 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.473 ' HB3' ' CG2' ' A' ' 55' ' ' VAL . . . -163.37 172.75 14.14 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.357 1.063 . . . . 62.25 109.093 175.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -66.44 127.98 34.39 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.582 -0.895 . . . . 44.5 108.582 169.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 69.0 12.83 8.72 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.482 1.113 . . . . 74.31 112.328 -174.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.473 ' CG2' ' HB3' ' A' ' 52' ' ' ALA . 26.6 t -127.79 112.02 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.01 0.924 . . . . 73.42 108.651 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -128.7 124.38 35.49 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.344 -0.614 . . . . 63.03 109.344 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -91.41 145.32 24.73 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.861 -0.792 . . . . 75.12 108.861 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.9 t -128.7 141.39 46.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.496 -0.928 . . . . 71.04 108.496 172.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 73.5 t -123.32 132.43 71.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 123.634 0.774 . . . . 73.25 109.225 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.604 HD21 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -110.07 110.14 20.94 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.22 -1.4 . . . . 65.43 107.22 175.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.577 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 22.0 ttp180 -93.88 100.55 12.7 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.189 -1.411 . . . . 74.42 107.189 175.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.1 t -95.13 124.6 47.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.228 -1.027 . . . . 61.35 108.228 174.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.9 m -121.04 122.0 39.14 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.346 -0.612 . . . . 74.11 109.346 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.512 HG21 HG21 ' A' ' 114' ' ' ILE . 86.9 t -109.58 132.43 57.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 124.49 1.116 . . . . 62.11 108.28 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 10.1 m -123.49 141.04 52.39 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.058 -1.46 . . . . 75.14 107.058 168.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.5 125.12 33.53 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 106.278 -1.749 . . . . 74.35 106.278 170.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.9 m -134.39 131.6 38.41 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 123.6 0.562 . . . . 61.24 111.205 -176.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.0 mt -89.82 84.79 6.27 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 108.134 -1.061 . . . . 71.33 108.134 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.65 -117.94 4.73 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 111.256 -0.738 . . . . 72.42 111.256 -173.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -88.18 -30.05 20.05 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 117.403 0.601 . . . . 73.12 109.588 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.403 ' HG2' ' ND2' ' A' ' 27' ' ' ASN . 22.4 tt0 -80.18 125.67 30.13 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.711 -0.477 . . . . 72.22 109.711 -175.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.2 m -80.27 134.75 36.12 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.271 0.558 . . . . 64.32 111.283 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.566 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -77.27 -60.7 2.25 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.148 -0.933 . . . . 54.21 108.96 174.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -152.14 163.61 39.01 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.786 -0.643 . . . . 72.42 111.033 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 32.0 tp -134.86 113.29 11.43 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.435 1.094 . . . . 74.05 108.611 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.476 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 70.5 m -104.88 140.26 38.4 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.92 0.888 . . . . 61.44 109.453 175.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -148.22 124.56 10.91 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.627 0.771 . . . . 53.43 109.466 172.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.0 t -133.75 112.77 17.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 124.274 1.029 . . . . 71.32 109.429 -174.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 65.4 mt-30 -84.68 89.45 7.49 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.39 -0.967 . . . . 73.04 108.39 167.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -76.4 93.83 3.55 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.896 -0.779 . . . . 70.13 108.896 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.11 148.36 21.43 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 111.551 -0.619 . . . . 65.32 111.551 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.04 122.33 1.45 Allowed Glycine 0 CA--C 1.506 -0.531 0 N-CA-C 110.801 -0.919 . . . . 60.43 110.801 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.8 mt -80.33 125.84 39.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 N-CA-C 108.305 -0.998 . . . . 74.31 108.305 171.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.815 ' HB3' HD11 ' A' ' 86' ' ' ILE . 86.3 m-85 -129.76 124.11 32.63 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.196 0.598 . . . . 65.44 109.687 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.4 m -85.5 93.65 8.82 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.777 -0.823 . . . . 71.53 108.777 172.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.815 HD11 ' HB3' ' A' ' 84' ' ' PHE . 7.9 mm -109.74 148.13 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 116.14 -0.482 . . . . 74.51 109.847 -176.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.79 171.12 19.37 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.057 0.543 . . . . 73.21 110.67 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.49 -34.21 5.61 Favored Glycine 0 C--N 1.344 0.973 0 O-C-N 123.853 0.721 . . . . 65.35 112.915 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.565 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -122.8 153.5 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.968 0.507 . . . . 71.22 111.364 -169.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.438 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 21.5 tt0 -143.89 -179.11 6.27 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.961 -1.018 . . . . 64.24 108.254 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.438 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 61.5 -133.19 47.77 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 113.784 0.274 . . . . 10.14 113.784 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.7 t -72.51 -23.22 60.99 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 122.951 0.5 . . . . 53.14 111.612 -177.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -71.73 -36.83 70.6 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.454 0.701 . . . . 75.11 110.183 177.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.415 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 4.6 tpt -66.07 -49.91 65.96 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.903 -0.59 . . . . 73.23 109.881 174.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.11 -33.27 70.65 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.146 -0.934 . . . . 73.23 111.192 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -72.26 -41.51 66.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.461 0.704 . . . . 72.13 110.898 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 46.5 t -64.25 -35.79 81.98 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 121.226 0.536 . . . . 72.22 110.189 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.9 mt -89.54 -26.81 20.67 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.146 -0.934 . . . . 63.44 112.214 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.5 ' HA2' HG21 ' A' ' 46' ' ' THR . . . -104.06 4.47 45.24 Favored Glycine 0 N--CA 1.473 1.118 0 O-C-N 123.102 0.251 . . . . 62.5 113.363 -173.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.595 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -141.87 -68.46 0.38 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 122.75 0.42 . . . . 63.35 110.805 -177.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -66.88 -46.63 74.35 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 116.246 -0.434 . . . . 75.11 111.864 -171.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 92.6 m -62.3 -52.91 62.95 Favored Pre-proline 0 CA--C 1.565 1.529 0 CA-C-O 118.489 -0.767 . . . . 72.34 112.672 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.431 ' HA ' ' HB2' ' A' ' 106' ' ' LEU . 44.5 Cg_endo -66.97 -20.27 51.18 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 121.647 1.565 . . . . 75.01 113.054 176.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -66.9 -38.87 87.04 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.187 0.595 . . . . 75.52 110.343 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.498 HG21 ' CD1' ' A' ' 13' ' ' ILE . 43.6 mm -68.18 -42.91 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.634 0.773 . . . . 73.24 109.63 174.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 103' ' ' PRO . 54.6 mt -69.95 -28.18 65.35 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.14 -0.936 . . . . 62.01 112.297 -174.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -62.61 -44.85 88.07 Favored Pre-proline 0 N--CA 1.487 1.382 0 N-CA-C 114.033 1.123 . . . . 71.13 114.033 -171.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.401 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 85.4 Cg_exo -50.78 -39.27 57.76 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.135 1.89 . . . . 64.31 113.585 171.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -77.68 -38.95 46.4 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.343 0.657 . . . . 74.4 111.706 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.1 -49.77 70.92 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.248 0.619 . . . . 63.22 109.444 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.407 HH12 HD12 ' C' ' 105' ' ' ILE . 31.7 ttm180 -49.13 -49.91 39.9 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.925 1.29 . . . . 73.52 110.741 173.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.76 -46.8 83.68 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 124.004 0.815 . . . . 73.35 111.558 -176.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.442 ' O ' ' HG3' ' A' ' 117' ' ' MET . 41.9 t -59.3 -35.56 74.02 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.446 0.698 . . . . 63.32 111.066 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.512 HG21 HG21 ' A' ' 64' ' ' VAL . 83.5 mt -70.51 -57.25 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 115.571 -0.74 . . . . 62.51 110.593 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.7 m -51.98 -39.23 59.03 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 124.586 1.154 . . . . 72.03 111.676 -174.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.3 t -66.37 -44.33 83.44 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.441 -1.254 . . . . 73.44 110.102 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.557 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 40.9 mtm -62.95 -39.76 95.61 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.561 0.344 . . . . 74.44 110.828 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.4 t -57.43 -48.38 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 O-C-N 124.018 0.824 . . . . 65.51 110.183 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 95.3 p -73.79 -33.2 64.13 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.887 -0.597 . . . . 74.41 111.711 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.411 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.2 mtt-85 -68.15 -32.46 72.75 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.293 0.637 . . . . 64.42 109.86 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.33 15.84 42.84 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 115.498 -0.774 . . . . 72.25 113.216 174.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 121' ' ' GLY . 0.8 OUTLIER 65.14 10.89 6.73 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.388 1.875 . . . . 42.5 113.234 172.578 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -83.42 144.09 45.73 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 109.506 -0.553 . . . . 75.32 109.506 175.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -50.81 137.53 42.68 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.288 2.658 . . . . 63.05 112.955 175.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -55.31 128.39 33.91 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.27 0.981 . . . . 63.21 111.986 -172.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.5 tp -113.43 129.1 56.62 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.568 0.747 . . . . 65.11 109.121 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.559 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 87.1 m-20 -119.77 114.44 22.14 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.188 -1.041 . . . . 75.34 108.188 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.617 HD13 HD11 ' A' ' 42' ' ' LEU . 14.7 mt -72.86 127.41 32.47 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 109.558 -0.534 . . . . 52.22 109.558 -176.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.85 134.49 92.45 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-O 119.157 -0.449 . . . . 65.32 110.415 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.89 124.7 16.61 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.822 2.348 . . . . 71.43 112.689 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.567 HG21 HD11 ' A' ' 44' ' ' LEU . 98.8 t -101.1 128.28 53.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-N 115.745 -0.661 . . . . 73.42 109.787 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -86.87 85.88 7.29 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.75 -0.833 . . . . 73.22 108.75 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -61.23 -27.43 68.43 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.425 -0.807 . . . . 72.14 111.947 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.595 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 17.2 t70 -61.71 -51.63 67.59 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.204 0.602 . . . . 74.55 109.72 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.14 86.97 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.237 0.961 . . . . 64.2 110.83 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.8 mt -61.73 -48.3 81.35 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.244 0.618 . . . . 71.22 111.457 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 31.6 t80 . . . . . 0 N--CA 1.473 0.698 0 N-CA-C 109.938 -0.393 . . . . 74.32 109.938 178.601 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.738 ' HB3' HG23 ' B' ' 89' ' ' ILE . 22.0 ptm . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 115.632 1.715 . . . . 71.34 115.632 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.3 p -133.47 104.08 6.24 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 106.949 -1.5 . . . . 71.32 106.949 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.473 ' CD2' ' HG3' ' D' ' 130' ' ' PRO . 24.0 t80 -107.91 137.03 46.62 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.149 -1.056 . . . . 65.12 108.149 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.618 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 0.1 OUTLIER -141.15 118.37 11.34 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.257 -0.646 . . . . 74.44 109.257 -178.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 57.1 mt -77.89 124.35 36.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.738 -1.208 . . . . 73.1 107.738 166.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . 0.412 ' NE2' HG22 ' B' ' 83' ' ' ILE . 40.1 mt-30 -100.29 -35.57 9.57 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.527 -0.546 . . . . 74.04 109.527 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -176.89 134.5 0.2 Allowed 'General case' 0 C--N 1.352 0.69 0 O-C-N 123.917 0.761 . . . . 74.32 109.846 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.535 HG21 ' CD1' ' B' ' 109' ' ' TYR . 78.6 mt -119.65 145.05 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.117 -1.068 . . . . 75.42 108.117 175.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -165.11 145.09 7.01 Favored 'General case' 0 C--N 1.346 0.414 0 N-CA-C 112.974 0.731 . . . . 73.43 112.974 -173.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 38.7 m -76.3 122.79 24.93 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.477 -0.783 . . . . 72.11 108.903 170.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.433 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.4 mtpt -100.12 -14.75 18.44 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.423 0.689 . . . . 75.45 111.392 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.6 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.1 t70 -158.48 141.81 15.01 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.644 0.378 . . . . 71.35 111.433 -174.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.722 HD11 ' SG ' ' B' ' 113' ' ' CYS . 29.0 mm -136.68 143.12 36.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 124.915 1.286 . . . . 64.33 108.408 174.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 68.8 m -148.4 131.84 16.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.544 -1.207 . . . . 45.34 108.484 167.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -143.71 108.79 4.98 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.719 -1.586 . . . . 63.01 106.719 168.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -124.88 112.84 17.11 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.527 -0.916 . . . . 71.35 108.527 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.6 88.29 4.12 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.749 -1.204 . . . . 61.43 107.749 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.04 -40.91 8.23 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.75 2.3 . . . . 72.1 112.772 -168.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -101.02 19.96 16.44 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.777 0.831 . . . . 54.11 110.672 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.483 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -39.38 -62.13 0.87 Allowed Pre-proline 0 CA--C 1.566 1.588 0 N-CA-C 114.737 1.384 . . . . 40.22 114.737 -163.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 22.9 Cg_exo -62.95 -29.41 75.86 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 122.21 1.94 . . . . 74.32 112.983 -174.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -87.97 -38.18 15.76 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.228 -0.896 . . . . 73.51 111.659 -174.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.668 HG22 HD12 ' B' ' 68' ' ' LEU . 5.7 p -72.7 -15.78 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.156 0.583 . . . . 52.33 110.927 -173.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -70.58 -10.02 58.26 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 113.693 0.997 . . . . 74.42 113.693 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -72.79 -17.16 61.6 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 120.832 0.348 . . . . 65.51 110.465 174.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -98.68 97.61 8.85 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 124.92 1.288 . . . . 64.41 110.109 -175.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -102.22 85.77 2.71 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.222 -0.659 . . . . 74.24 109.222 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 7.6 p90 -156.83 -176.47 5.99 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.958 0.903 . . . . 75.2 109.797 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -68.63 114.41 22.12 Favored Pre-proline 0 N--CA 1.472 0.658 0 C-N-CA 123.559 0.744 . . . . 64.42 110.542 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.421 ' O ' HG23 ' B' ' 40' ' ' VAL . 27.9 Cg_endo -68.34 145.15 64.62 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 121.22 1.28 . . . . 65.4 110.693 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 9.7 tp10 -64.62 99.71 0.33 Allowed 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.235 -1.024 . . . . 61.33 108.235 170.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.508 HG11 HD11 ' B' ' 126' ' ' LEU . 53.5 t -106.79 141.71 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 123.778 0.674 . . . . 64.25 110.324 -174.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.402 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 54.3 tttm -142.27 109.37 5.53 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.374 1.069 . . . . 73.14 108.753 -172.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.418 HD13 HD22 ' B' ' 128' ' ' LEU . 38.2 tp -90.55 127.3 36.21 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.389 -0.597 . . . . 74.42 109.389 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.682 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 9.5 m-20 -122.29 116.8 24.71 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.241 1.016 . . . . 73.1 108.678 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.515 HD11 HG11 ' B' ' 131' ' ' VAL . 69.3 mt -99.39 126.74 45.34 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.42 -0.956 . . . . 75.41 108.42 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -140.68 155.52 46.47 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.293 1.037 . . . . 74.41 108.52 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.4 t -148.18 117.83 7.05 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 121.328 0.585 . . . . 52.04 110.336 -177.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.64 125.34 53.64 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 106.726 -1.583 . . . . 64.35 106.726 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.546 ' HB2' ' HE2' ' B' ' 56' ' ' TYR . 62.0 p -139.41 177.15 8.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 119.652 -0.214 . . . . 74.41 110.886 -166.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 36.0 p -170.52 137.94 1.44 Allowed 'General case' 0 C--O 1.245 0.861 0 O-C-N 123.382 0.426 . . . . 75.4 111.16 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -76.0 126.36 30.86 Favored 'General case' 0 C--N 1.348 0.507 0 N-CA-C 108.573 -0.899 . . . . 71.01 108.573 165.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 pp -143.64 23.51 1.76 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.969 0.907 . . . . 64.21 109.092 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' B' ' 55' ' ' VAL . . . -166.25 170.89 12.74 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 123.457 0.703 . . . . 73.32 111.221 -175.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -100.76 118.02 36.02 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.666 0.787 . . . . 75.45 109.564 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 62.13 9.67 3.28 Favored 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 124.799 1.24 . . . . 50.34 112.584 -173.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.45 ' O ' ' HB3' ' B' ' 52' ' ' ALA . 74.8 t -128.75 129.96 68.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 107.631 -1.248 . . . . 74.12 107.631 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.546 ' HE2' ' HB2' ' B' ' 48' ' ' SER . 28.0 t80 -132.01 140.98 49.11 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.633 -0.877 . . . . 72.12 108.633 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -109.69 110.76 21.89 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 107.143 -1.428 . . . . 73.12 107.143 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.79 132.06 61.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 C-N-CA 123.333 0.653 . . . . 71.52 109.25 -177.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 32.7 t -111.53 113.85 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.022 -0.733 . . . . 61.43 109.022 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 60.9 tp -93.49 106.71 18.65 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.606 0.362 . . . . 62.23 110.103 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.445 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 20.9 ttm180 -86.06 108.23 18.17 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.356 0.662 . . . . 54.43 109.784 172.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.414 HG13 HD11 ' B' ' 42' ' ' LEU . 59.5 t -103.99 106.23 19.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.223 -1.029 . . . . 54.31 108.223 175.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.682 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 15.8 m -97.18 142.83 28.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.002 -0.999 . . . . 74.13 108.995 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.891 HG11 HD21 ' B' ' 126' ' ' LEU . 73.4 t -134.73 122.58 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.718 -0.845 . . . . 61.33 108.718 173.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 87.6 m -98.97 141.55 31.59 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.757 -1.201 . . . . 61.53 107.757 169.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.18 137.48 23.36 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.76 -0.459 . . . . 53.21 109.76 174.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.461 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 19.1 m -148.25 128.52 13.82 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.542 0.337 . . . . 70.32 111.489 -174.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.668 HD12 HG22 ' B' ' 31' ' ' VAL . 85.3 mt -93.95 99.92 12.16 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.174 -0.676 . . . . 61.53 109.174 178.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.69 -130.32 9.62 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 115.219 -0.901 . . . . 64.35 111.01 -171.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -97.18 2.0 50.49 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.087 0.955 . . . . 63.22 111.726 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -115.09 147.11 40.61 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.024 0.53 . . . . 65.14 110.569 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 49.7 m -68.92 133.06 47.7 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 123.5 0.5 . . . . 75.12 111.283 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.512 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -86.83 -60.74 1.9 Allowed 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.926 -1.138 . . . . 72.32 107.926 175.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -154.14 161.94 41.53 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 114.45 -1.25 . . . . 74.0 110.019 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -129.96 112.67 13.73 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.645 -1.613 . . . . 74.43 106.645 172.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.469 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 23.0 t -118.88 114.1 22.07 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.07 -0.715 . . . . 63.34 109.07 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -128.49 122.9 32.26 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.359 -0.978 . . . . 73.13 108.359 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 88.2 t -124.73 150.26 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.512 1.125 . . . . 53.24 108.552 -178.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.6 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 27.1 mt-30 -121.15 115.02 22.27 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.769 -0.826 . . . . 64.11 108.769 167.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -100.82 107.26 18.76 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.632 -0.877 . . . . 73.15 108.632 172.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.433 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -99.89 170.56 22.96 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 111.861 -0.496 . . . . 71.43 111.861 176.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.01 141.34 6.67 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 121.643 -0.313 . . . . 73.23 112.554 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.412 HG22 ' NE2' ' B' ' 14' ' ' GLN . 41.1 mt -97.77 106.61 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 108.517 -0.92 . . . . 70.11 108.517 176.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -116.08 135.24 54.12 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.103 0.561 . . . . 74.41 110.952 -175.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.618 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 57.7 m -95.24 129.6 42.31 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.889 0.876 . . . . 54.01 110.12 172.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.568 ' HB ' HD11 ' B' ' 89' ' ' ILE . 35.2 pt -138.39 136.61 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 124.048 0.939 . . . . 75.11 110.437 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.64 173.79 16.33 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.032 0.933 . . . . 74.03 109.787 174.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.86 -40.86 3.08 Favored Glycine 0 N--CA 1.479 1.557 0 CA-C-O 121.133 0.296 . . . . 65.41 112.823 177.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.738 HG23 ' HB3' ' B' ' 9' ' ' MET . 3.5 pt -58.8 154.76 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.474 1.11 . . . . 74.24 111.146 165.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -164.72 146.05 7.98 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.956 -1.02 . . . . 61.31 108.697 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.52 -134.8 12.28 Favored Glycine 0 C--N 1.348 1.218 0 O-C-N 123.442 0.464 . . . . 63.11 112.117 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 52.6 m -73.64 -54.22 8.65 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.757 0.823 . . . . 72.22 110.618 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.437 ' HA ' ' HB3' ' B' ' 96' ' ' HIS . 16.0 mm100 -56.52 -19.72 16.97 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.905 1.282 . . . . 74.14 113.197 -176.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.527 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 41.8 ttp -61.04 -70.29 0.19 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.325 1.05 . . . . 62.14 111.597 -177.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.51 -15.11 53.63 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 111.845 0.313 . . . . 74.44 111.845 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . 0.437 ' HB3' ' HA ' ' B' ' 93' ' ' GLN . 1.4 t-80 -58.78 -34.66 71.7 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.433 0.693 . . . . 71.51 110.313 168.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.6 t -58.71 -26.0 63.47 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.554 0.742 . . . . 72.41 111.694 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.401 HD22 ' HB3' ' B' ' 56' ' ' TYR . 52.0 mt -84.41 -29.04 26.49 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.96 0.904 . . . . 70.45 112.129 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.79 -10.53 57.64 Favored Glycine 0 C--N 1.342 0.873 0 O-C-N 123.56 0.538 . . . . 43.23 113.021 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.38 -59.19 1.48 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.088 0.555 . . . . 44.41 112.167 -174.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -78.01 -48.82 15.31 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.112 0.565 . . . . 74.2 110.937 -168.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 73.5 m -61.52 -50.17 83.88 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 123.865 0.866 . . . . 74.15 112.073 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.09 -17.98 35.76 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 121.73 1.62 . . . . 63.0 112.917 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -70.86 -30.47 66.87 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.598 0.359 . . . . 72.21 110.42 173.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.437 HG23 ' NH2' ' D' ' 111' ' ' ARG . 69.5 mt -71.82 -42.42 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.18 0.592 . . . . 72.12 109.831 171.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 77.8 mt -73.89 -28.49 61.58 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.047 -0.979 . . . . 64.43 111.825 -175.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -60.12 -49.41 91.02 Favored Pre-proline 0 N--CA 1.484 1.248 0 CA-C-O 118.024 -0.988 . . . . 74.43 113.28 -172.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -54.83 -33.78 82.72 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.545 2.163 . . . . 74.12 113.598 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.535 ' CD1' HG21 ' B' ' 16' ' ' ILE . 7.7 m-30 -78.82 -40.46 32.83 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.047 0.539 . . . . 71.32 110.504 -176.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.25 -39.9 95.9 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.489 0.716 . . . . 61.13 110.136 172.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.463 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 47.1 ttt-85 -62.6 -53.3 56.64 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.429 1.491 . . . . 71.41 110.724 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -66.49 -30.54 70.9 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.461 0.705 . . . . 75.3 109.848 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.722 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.1 t -70.16 -42.36 72.59 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 122.946 0.498 . . . . 75.13 110.273 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.479 ' O ' HG23 ' B' ' 118' ' ' VAL . 45.4 mt -58.79 -55.79 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.853 0.861 . . . . 61.51 110.408 173.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 9.6 m -63.7 -29.89 71.06 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.632 0.773 . . . . 74.41 111.382 -173.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.3 t -58.31 -54.94 41.28 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 108.831 -0.803 . . . . 73.05 108.831 171.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.529 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.8 mmt -64.98 -37.3 87.21 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.602 0.761 . . . . 75.43 111.4 -175.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.479 HG23 ' O ' ' B' ' 114' ' ' ILE . 81.4 t -59.89 -48.82 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 124.019 0.928 . . . . 73.23 110.544 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 32.8 t -75.27 -19.85 59.48 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.899 -1.046 . . . . 73.43 111.075 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' B' ' 116' ' ' SER . 90.3 mtt-85 -68.21 -32.47 72.7 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 110.027 -0.36 . . . . 75.52 110.027 170.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . 0.433 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -79.49 -5.58 89.22 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 123.655 0.597 . . . . 60.33 112.397 169.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 6.6 m 66.39 25.57 10.31 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.624 1.57 . . . . 60.11 110.652 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -77.33 163.21 65.8 Favored Pre-proline 0 CA--C 1.555 1.148 0 CA-C-N 114.884 -1.053 . . . . 74.23 110.836 175.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -48.51 144.49 13.8 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 123.312 2.675 . . . . 63.31 114.764 174.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.471 ' HB2' ' HG2' ' C' ' 125' ' ' GLN . 41.0 tp60 -54.59 118.05 3.86 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.055 0.942 . . . . 31.21 110.758 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.891 HD21 HG11 ' B' ' 64' ' ' VAL . 20.5 tp -110.04 99.36 8.47 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.14 -0.936 . . . . 74.23 109.602 -171.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.413 HD21 ' HG3' ' B' ' 125' ' ' GLN . 43.8 m-80 -96.03 110.68 22.88 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.453 -0.573 . . . . 75.14 109.453 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.463 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 55.0 mt -77.21 126.21 30.57 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.871 -0.789 . . . . 75.31 108.871 171.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.58 154.6 83.66 Favored Pre-proline 0 CA--C 1.552 1.051 0 O-C-N 124.268 0.98 . . . . 34.04 111.706 -169.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.492 ' HG3' HD13 ' D' ' 16' ' ' ILE . 3.8 Cg_exo -77.33 87.68 1.48 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.401 2.734 . . . . 72.41 112.686 -167.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.515 HG11 HD11 ' B' ' 44' ' ' LEU . 4.6 p -92.8 122.35 44.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 115.333 -0.849 . . . . 65.12 110.517 177.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 9.0 p30 . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 107.464 -1.31 . . . . 74.41 107.464 169.03 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 59.7 t80 . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 109.353 -0.61 . . . . 65.33 109.353 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -152.96 131.55 12.25 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 109.617 -0.512 . . . . 72.52 109.617 171.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 57.2 mt -69.88 125.96 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 108.65 -0.87 . . . . 74.43 108.65 170.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -89.93 -49.78 6.41 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.961 -0.755 . . . . 64.23 108.961 175.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.559 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -173.53 150.92 1.85 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.111 0.964 . . . . 75.22 109.973 174.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 pp -114.54 152.28 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 107.878 -1.156 . . . . 60.3 107.878 173.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.638 ' HB3' HG23 ' D' ' 122' ' ' THR . 28.2 p90 -179.56 162.46 1.11 Allowed 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.456 0.646 . . . . 73.34 110.882 -174.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.2 p -92.35 115.33 27.99 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 123.43 0.692 . . . . 74.43 109.882 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.401 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 19.6 mmtp -64.43 -40.47 95.8 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.233 -1.025 . . . . 75.22 108.233 170.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -150.07 147.87 28.32 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.407 -1.269 . . . . 73.52 110.787 -174.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.54 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.6 mt -138.39 144.51 30.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 C-N-CA 125.896 1.679 . . . . 74.24 106.584 174.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 31.2 t -153.46 150.01 28.34 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 122.568 0.347 . . . . 54.23 110.481 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -155.28 137.08 14.41 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.451 1.1 . . . . 73.32 108.166 175.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -140.23 133.73 30.08 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.281 0.633 . . . . 71.2 109.433 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.79 81.41 22.87 Favored Pre-proline 0 C--O 1.241 0.621 0 N-CA-C 108.001 -1.111 . . . . 64.22 108.001 169.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.2 -30.41 74.48 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 123.017 2.478 . . . . 54.02 112.622 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . 0.479 ' OD1' ' HB ' ' C' ' 31' ' ' VAL . 5.9 p30 -117.07 34.54 5.06 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.222 0.609 . . . . 54.33 109.575 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -40.08 -57.85 2.56 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 114.148 1.166 . . . . 74.22 114.148 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -64.61 -35.39 47.82 Favored 'Trans proline' 0 C--N 1.382 2.292 0 CA-C-N 121.569 1.596 . . . . 43.2 112.64 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.656 ' HA ' HE21 ' C' ' 33' ' ' GLN . 80.5 t60 -68.71 -38.09 79.97 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.813 0.845 . . . . 73.13 112.24 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.623 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.5 p -76.34 -30.27 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 N-CA-C 112.573 0.583 . . . . 74.13 112.573 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -59.79 -34.02 72.48 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 112.447 0.536 . . . . 73.22 112.447 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.656 HE21 ' HA ' ' C' ' 30' ' ' HIS . 24.7 pt20 -86.15 11.89 10.89 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.398 0.679 . . . . 71.3 112.408 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.429 ' HG2' HD13 ' C' ' 68' ' ' LEU . 1.8 ttpm? -113.95 147.85 37.86 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.877 0.871 . . . . 74.53 110.124 177.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.16 125.26 23.11 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 123.381 0.673 . . . . 71.41 110.93 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -81.55 105.81 13.01 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.927 -1.033 . . . . 63.04 110.993 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -162.78 79.44 1.77 Allowed Pre-proline 0 C--O 1.241 0.607 0 N-CA-C 107.469 -1.308 . . . . 75.21 107.469 164.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -87.04 164.52 8.67 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 122.913 2.409 . . . . 43.24 113.02 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -86.75 85.32 7.28 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 106.725 -1.583 . . . . 73.21 106.725 168.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 99.2 t -68.58 109.7 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 115.008 -0.996 . . . . 64.34 109.767 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.582 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 65.7 mttm -92.08 103.96 16.4 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.354 -0.98 . . . . 73.02 108.354 178.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 tt -89.08 123.91 33.81 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 107.057 -1.46 . . . . 51.52 107.057 174.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.609 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 17.0 t70 -128.39 139.53 52.32 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.153 0.981 . . . . 74.54 108.409 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.522 HD22 HD21 ' C' ' 60' ' ' LEU . 24.6 mt -135.3 126.41 27.96 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.438 0.695 . . . . 72.33 110.218 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -130.53 139.29 50.48 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.63 1.172 . . . . 61.11 108.193 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.0 t -144.07 139.47 28.94 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.019 0.438 . . . . 75.33 110.283 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.95 156.05 45.48 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.937 0.895 . . . . 54.13 109.608 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 2.3 m -132.43 144.18 50.31 Favored 'General case' 0 C--O 1.24 0.564 0 O-C-N 123.299 0.374 . . . . 54.14 110.034 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 22.4 p -145.12 126.07 14.48 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.916 0.886 . . . . 72.32 109.473 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -78.76 118.67 21.04 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.317 -0.623 . . . . 73.04 109.317 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' C' ' 57' ' ' GLU . 34.5 mt -88.45 -41.47 12.76 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.83 0.852 . . . . 73.42 110.638 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.19 -172.66 4.22 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.061 -0.972 . . . . 62.54 110.181 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.42 112.62 1.83 Allowed 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.036 0.835 . . . . 44.45 110.591 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 66.31 9.33 6.31 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.661 1.185 . . . . 62.23 112.425 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 87.0 t -106.81 107.62 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.23 0.612 . . . . 61.33 109.857 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -106.72 124.63 49.89 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.768 0.827 . . . . 74.53 109.073 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.56 ' HB2' HD11 ' C' ' 51' ' ' LEU . 30.2 tt0 -82.72 126.65 32.61 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.296 -1.002 . . . . 75.21 108.296 169.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.8 t -112.4 138.2 42.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.486 -0.931 . . . . 72.4 108.486 167.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 86.6 t -120.9 131.37 73.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 108.529 -0.915 . . . . 53.42 108.529 170.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.522 HD21 HD22 ' C' ' 44' ' ' LEU . 0.9 OUTLIER -114.22 107.23 15.33 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.676 -1.231 . . . . 74.04 107.676 172.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.414 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 0.0 OUTLIER -95.9 117.74 31.18 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 114.671 -1.149 . . . . 74.42 109.153 178.083 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 10.8 t -102.07 132.37 48.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 107.838 -1.171 . . . . 65.44 107.838 172.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.609 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 29.9 m -123.31 128.02 49.35 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.099 -1.074 . . . . 71.05 108.099 175.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.409 HG23 HD13 ' C' ' 114' ' ' ILE . 85.7 t -122.95 128.75 75.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.576 -0.738 . . . . 71.33 109.34 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 25.4 m -118.32 139.24 51.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.621 -1.251 . . . . 71.44 107.621 176.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.24 113.01 15.76 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.669 -1.604 . . . . 65.45 106.669 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 65.4 m -135.62 126.21 27.05 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.672 0.607 . . . . 60.14 109.9 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.429 HD13 ' HG2' ' C' ' 34' ' ' LYS . 12.0 mt -85.98 56.06 3.81 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.224 1.41 . . . . 72.34 107.908 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.58 -107.73 3.08 Favored Glycine 0 C--N 1.341 0.851 0 N-CA-C 110.026 -1.23 . . . . 64.11 110.026 -169.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -103.59 -17.14 15.29 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.64 0.776 . . . . 72.22 110.044 173.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -68.55 99.89 1.04 Allowed 'General case' 0 C--N 1.348 0.542 0 C-N-CA 123.341 0.656 . . . . 64.22 109.44 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 50.4 m -73.36 114.83 12.01 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.169 -0.678 . . . . 71.31 109.169 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.623 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -67.84 -57.52 6.13 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.248 -1.342 . . . . 42.22 108.613 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -155.13 159.64 40.34 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.745 -1.116 . . . . 71.42 110.732 172.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.417 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -118.68 143.06 47.09 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.799 -1.556 . . . . 73.24 106.799 167.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.417 ' N ' HD13 ' C' ' 75' ' ' LEU . 46.6 t -149.7 141.9 24.08 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.598 -0.89 . . . . 72.33 108.598 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -154.65 134.9 13.21 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.472 -0.566 . . . . 71.4 109.472 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.48 HG11 ' HA ' ' C' ' 110' ' ' ALA . 40.9 t -133.71 114.65 20.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 124.263 1.025 . . . . 73.53 108.836 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.414 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 53.4 mt-30 -91.27 87.64 6.57 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.654 -0.869 . . . . 65.14 108.654 174.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.439 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.4 tp-100 -79.86 99.11 7.38 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.408 0.683 . . . . 72.24 110.121 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.67 149.11 25.43 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 116.329 -0.396 . . . . 55.35 112.36 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.538 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.27 125.73 2.01 Favored Glycine 0 CA--C 1.503 -0.678 0 N-CA-C 110.508 -1.037 . . . . 43.42 110.508 -178.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.538 HD12 HD11 ' C' ' 51' ' ' LEU . 31.8 mm -93.7 125.24 46.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 108.278 -1.008 . . . . 63.11 108.278 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -133.64 121.84 22.6 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.457 0.703 . . . . 74.43 109.721 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 20.6 p -82.28 103.99 12.27 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 108.745 -0.835 . . . . 71.12 108.745 171.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.612 HG21 ' HE3' ' C' ' 94' ' ' MET . 17.8 mt -116.19 137.57 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.585 0.754 . . . . 74.14 109.74 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.28 170.51 19.33 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.199 0.6 . . . . 74.2 110.639 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.34 -49.12 1.51 Allowed Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.98 -0.555 . . . . 73.02 113.371 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.599 HD11 ' HE3' ' C' ' 94' ' ' MET . 42.7 pt -91.06 171.28 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 123.445 0.698 . . . . 74.34 112.635 -167.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -157.97 157.47 33.1 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.751 -1.113 . . . . 41.13 109.508 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.66 -131.16 21.25 Favored Glycine 0 C--N 1.348 1.241 0 O-C-N 123.412 0.445 . . . . 73.32 113.805 172.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.8 p -60.46 -35.21 75.33 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.27 1.028 . . . . 61.13 111.789 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -57.72 -57.47 12.61 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.857 0.863 . . . . 64.1 110.607 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.612 ' HE3' HG21 ' C' ' 86' ' ' ILE . 4.1 tpt -55.23 -50.17 70.13 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.067 0.947 . . . . 75.11 112.505 175.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.68 -33.88 74.76 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.114 0.566 . . . . 74.11 111.253 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -73.99 -36.55 64.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.974 0.51 . . . . 72.23 110.55 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.466 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 33.7 t -69.45 -33.56 73.12 Favored 'General case' 0 C--N 1.35 0.614 0 N-CA-C 109.734 -0.469 . . . . 75.12 109.734 -177.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 96.9 mt -85.78 -37.48 19.23 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.982 0.913 . . . . 65.2 111.896 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.87 3.92 45.56 Favored Glycine 0 N--CA 1.473 1.15 0 CA-C-O 119.525 -0.597 . . . . 53.2 114.58 -168.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.543 ' HA ' ' HB3' ' C' ' 133' ' ' PHE . . . -149.35 -54.46 0.17 Allowed 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.808 0.804 . . . . 63.42 112.045 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.466 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 51.3 t80 -66.6 -56.68 9.61 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.286 0.634 . . . . 75.43 112.111 -174.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 97.2 m -60.89 -47.26 96.14 Favored Pre-proline 0 CA--C 1.562 1.41 0 CA-C-O 118.787 -0.625 . . . . 74.13 112.42 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -54.54 -30.88 67.07 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 122.409 2.072 . . . . 74.22 114.318 172.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -70.72 -30.9 67.57 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.026 0.53 . . . . 54.52 111.114 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.407 HD12 HH12 ' A' ' 111' ' ' ARG . 44.5 mm -73.01 -35.3 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 109.62 -0.511 . . . . 71.5 109.62 175.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.538 HD21 ' HA3' ' C' ' 82' ' ' GLY . 94.7 mt -81.22 -30.97 34.06 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.971 0.908 . . . . 74.35 112.733 -175.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -55.92 -50.11 89.13 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 113.884 1.068 . . . . 74.41 113.884 -172.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.85 -36.25 95.14 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.251 1.968 . . . . 71.34 113.396 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -70.05 -44.37 69.31 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.05 0.54 . . . . 64.23 111.356 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.48 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -66.7 -33.6 76.0 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.876 -0.602 . . . . 45.14 110.713 175.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -62.63 -51.49 67.09 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.925 1.29 . . . . 75.43 110.446 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -69.37 -29.36 67.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.95 0.5 . . . . 71.52 110.377 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.9 t -69.18 -37.68 78.29 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 122.75 0.42 . . . . 63.43 110.709 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.447 ' O ' HG23 ' C' ' 118' ' ' VAL . 98.6 mt -71.65 -47.39 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 122.931 0.492 . . . . 73.53 110.054 174.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.7 m -53.23 -42.44 66.39 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.532 1.133 . . . . 71.02 111.664 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.428 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.1 t -66.68 -38.94 87.82 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.425 -0.807 . . . . 74.12 109.538 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.541 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -66.2 -39.83 89.93 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.187 0.995 . . . . 73.33 111.778 178.404 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.447 HG23 ' O ' ' C' ' 114' ' ' ILE . 61.8 t -59.04 -42.79 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 109.258 -0.645 . . . . 62.23 109.258 172.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.2 t -66.13 -38.67 88.72 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.816 -1.083 . . . . 74.03 112.248 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' C' ' 116' ' ' SER . 64.7 mtt-85 -69.58 -39.21 77.45 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.264 0.625 . . . . 71.42 110.19 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.45 3.71 84.0 Favored Glycine 0 C--N 1.351 1.361 0 CA-C-N 115.669 -0.696 . . . . 74.33 112.544 173.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 33.6 p 58.38 30.74 20.04 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.058 1.743 . . . . 72.43 113.068 171.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -81.94 154.58 70.27 Favored Pre-proline 0 C--O 1.242 0.684 0 CA-C-N 115.703 -0.681 . . . . 73.01 109.57 175.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.48 127.76 27.32 Favored 'Trans proline' 0 C--N 1.363 1.333 0 C-N-CA 122.093 1.862 . . . . 73.12 112.022 168.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.471 ' HG2' ' HB2' ' B' ' 125' ' ' GLN . 23.6 mm-40 -53.72 154.6 3.69 Favored 'General case' 0 C--O 1.248 0.981 0 O-C-N 124.623 1.202 . . . . 73.22 113.604 -170.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 21.1 tp -147.76 86.38 1.59 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-N 113.847 -1.524 . . . . 75.54 108.168 -172.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -91.97 108.63 20.07 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.787 -1.097 . . . . 70.14 108.692 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -67.81 137.99 55.79 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.513 0.725 . . . . 74.43 110.118 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.78 152.53 95.12 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 123.665 0.786 . . . . 51.25 111.106 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.518 ' HG3' HD12 ' A' ' 16' ' ' ILE . 52.1 Cg_exo -54.98 114.93 2.09 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.662 2.241 . . . . 74.54 112.272 172.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . 0.477 HG11 HD11 ' C' ' 44' ' ' LEU . 5.0 p -98.14 125.95 51.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 123.103 0.561 . . . . 45.13 110.19 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -81.53 101.7 10.11 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.653 -0.869 . . . . 75.32 108.653 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . 0.543 ' HB3' ' HA ' ' C' ' 100' ' ' ALA . 82.9 m-85 -67.3 -25.34 65.99 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.356 -0.838 . . . . 55.3 111.31 177.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -63.86 -36.5 84.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.324 0.649 . . . . 64.31 110.323 175.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.64 -42.1 95.69 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.647 0.779 . . . . 63.44 110.414 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 71.0 mt -72.72 -27.09 61.84 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.839 -1.073 . . . . 72.24 110.873 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 70.9 t80 . . . . . 0 C--O 1.213 -0.864 0 C-N-CA 123.029 0.531 . . . . 65.44 110.699 177.853 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 C--O 1.244 0.808 0 N-CA-C 109.03 -0.73 . . . . 74.33 109.03 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.419 ' HZ ' ' HG ' ' D' ' 102' ' ' CYS . 59.7 t80 -137.4 101.16 4.43 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.371 -1.344 . . . . 71.42 107.371 175.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -125.92 124.47 40.89 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.692 0.797 . . . . 72.21 109.104 -175.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.602 HD13 HG21 ' D' ' 105' ' ' ILE . 5.4 mt -84.18 137.42 20.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.786 -0.82 . . . . 60.21 108.786 177.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -97.02 -42.5 7.87 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 122.975 0.51 . . . . 72.03 110.461 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.42 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 40.8 ttt180 -174.23 142.77 0.83 Allowed 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.313 0.383 . . . . 71.33 111.383 -170.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.492 HD13 ' HG3' ' B' ' 130' ' ' PRO . 2.1 mp -115.55 137.75 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 105.882 -1.895 . . . . 72.43 105.882 174.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.42 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 19.0 p90 -161.54 137.0 7.64 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 123.609 0.568 . . . . 73.11 110.967 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.4 p -76.65 110.63 11.39 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.321 -0.854 . . . . 64.3 109.487 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -85.53 -9.81 56.86 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.496 -0.775 . . . . 71.32 109.712 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.636 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 17.4 t70 -169.11 143.43 3.01 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 124.896 1.278 . . . . 61.34 109.733 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.541 HG21 ' HE2' ' C' ' 117' ' ' MET . 80.4 mt -147.4 144.71 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 125.266 1.427 . . . . 70.44 107.9 177.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.8 t -147.04 145.92 29.85 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.967 0.907 . . . . 73.1 109.249 170.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.54 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 81.1 t80 -149.87 118.55 6.57 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 106.963 -1.495 . . . . 71.52 106.963 169.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -123.54 140.27 53.17 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.479 -0.563 . . . . 74.23 109.479 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.68 82.39 60.97 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 107.813 -1.18 . . . . 75.54 107.813 174.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.8 -29.24 42.51 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.924 2.416 . . . . 73.54 113.008 -170.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.41 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 38.0 m-80 -108.66 8.86 27.17 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-O 118.479 -0.772 . . . . 70.43 110.852 -177.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.426 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -20.05 -73.17 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 116.63 2.085 . . . . 60.1 116.63 -166.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.437 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 92.2 Cg_endo -75.5 -21.66 14.72 Favored 'Trans proline' 0 C--N 1.386 2.552 0 CA-C-N 124.056 2.484 . . . . 60.15 114.117 -176.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.435 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 5.6 t-160 -74.46 -37.93 63.08 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.257 1.023 . . . . 72.31 110.25 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.651 HG22 HD12 ' D' ' 68' ' ' LEU . 11.0 p -82.04 -20.51 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 115.953 -0.567 . . . . 62.42 111.506 -174.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.437 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 23.0 m-85 -63.75 -28.67 70.04 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 120.801 0.334 . . . . 72.44 111.819 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.435 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 60.8 mt-30 -58.41 -22.27 53.48 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.71 1.204 . . . . 73.5 111.241 177.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -90.22 69.42 7.14 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.994 1.318 . . . . 73.52 110.2 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.73 85.45 4.74 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.411 -0.813 . . . . 61.22 110.67 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 10.2 p90 -154.07 -173.21 4.49 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.453 0.701 . . . . 63.21 109.902 172.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -63.27 112.4 6.91 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.377 1.071 . . . . 64.51 110.772 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -60.76 120.25 7.87 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.066 1.844 . . . . 75.1 110.805 172.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -67.63 104.32 1.58 Allowed 'General case' 0 C--N 1.35 0.592 0 N-CA-C 106.417 -1.697 . . . . 74.01 106.417 169.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.586 HG13 HG13 ' D' ' 64' ' ' VAL . 71.3 t -103.05 115.31 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 N-CA-C 108.792 -0.818 . . . . 74.13 108.792 -174.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -96.98 110.25 22.83 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 105.783 -1.932 . . . . 75.52 105.783 176.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.475 HD11 HG13 ' D' ' 62' ' ' VAL . 63.4 tp -94.37 138.5 32.26 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.418 -1.327 . . . . 74.3 107.418 175.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -141.75 147.92 38.15 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.528 -1.286 . . . . 71.44 107.528 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.42 ' CD2' HG22 ' D' ' 62' ' ' VAL . 73.7 mt -131.0 136.06 48.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.548 0.689 . . . . 74.53 110.874 -173.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 11.6 t70 -133.03 129.17 37.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 113.977 -1.465 . . . . 53.31 107.692 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 2.6 p -106.94 150.78 26.1 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.546 0.689 . . . . 65.01 110.094 174.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.87 166.57 29.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.233 -1.349 . . . . 51.13 107.86 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.8 p . . . . . 0 C--O 1.241 0.614 0 N-CA-C 109.633 -0.506 . . . . 62.41 109.633 -179.962 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 113.811 1.041 . . . . 70.13 113.811 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 45.8 t -128.57 100.94 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 107.484 -1.302 . . . . 71.31 107.484 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -122.18 127.81 50.47 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.946 -0.761 . . . . 61.14 108.946 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -87.91 114.88 24.95 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 108.158 -1.053 . . . . 71.02 108.158 169.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 95.4 t -100.35 134.91 38.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 107.286 -1.376 . . . . 72.54 107.286 171.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 49.1 t -128.9 126.79 65.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.687 -1.227 . . . . 74.41 107.687 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.522 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -114.52 103.93 11.51 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.505 -1.294 . . . . 74.4 107.505 -176.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.446 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 41.1 ttm-85 -83.35 103.14 12.5 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.579 -0.897 . . . . 65.41 108.579 173.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.475 HG13 HD11 ' D' ' 42' ' ' LEU . 66.4 t -97.32 121.83 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.027 -0.731 . . . . 74.14 109.027 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 56.8 m -119.4 133.44 55.71 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.005 0.922 . . . . 70.43 109.106 -172.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.586 HG13 HG13 ' D' ' 40' ' ' VAL . 75.4 t -125.81 132.44 70.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 124.226 1.01 . . . . 54.33 108.788 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 26.7 m -127.93 93.14 3.61 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.676 -1.602 . . . . 72.0 106.676 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.83 147.24 24.62 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.704 -0.85 . . . . 71.0 108.704 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.551 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 32.5 p -149.56 133.94 17.44 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.208 0.528 . . . . 74.24 111.505 -173.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.651 HD12 HG22 ' D' ' 31' ' ' VAL . 79.4 mt -104.17 102.62 12.35 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.923 -1.035 . . . . 65.52 108.283 170.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.03 -128.96 17.49 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 115.764 -0.653 . . . . 63.31 113.154 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -84.56 3.08 38.32 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.931 0.892 . . . . 61.42 113.022 -174.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -137.0 154.92 50.28 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-O 121.115 0.483 . . . . 74.23 110.871 -173.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.0 m -69.18 126.56 30.17 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.583 -1.189 . . . . 73.43 111.072 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.577 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -75.65 -64.78 1.0 Allowed 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.624 -1.25 . . . . 71.51 107.624 173.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -153.24 141.84 20.88 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.266 -0.879 . . . . 75.12 111.152 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 65.9 mt -101.11 153.58 19.46 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.284 1.034 . . . . 60.43 108.771 167.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.716 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.8 t -156.82 142.19 17.42 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.123 0.569 . . . . 54.14 109.496 176.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -155.37 122.22 5.39 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.213 -0.292 . . . . 65.34 110.213 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.6 t -126.0 115.11 41.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 124.066 0.947 . . . . 72.41 109.338 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.636 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.6 mt-30 -88.72 87.64 7.32 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.6 -0.889 . . . . 75.33 108.6 171.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -83.39 100.84 10.94 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.483 -1.235 . . . . 74.44 109.083 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.37 149.01 17.74 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 112.327 -0.309 . . . . 70.3 112.327 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.37 142.97 10.49 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.77 -0.532 . . . . 52.3 111.77 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.0 mt -89.29 117.01 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 108.099 -1.074 . . . . 65.42 108.099 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.24 127.78 55.71 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.701 0.8 . . . . 74.24 110.548 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 33.6 t -84.87 122.79 29.67 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.275 -1.009 . . . . 61.12 108.275 166.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.474 HD12 ' HB2' ' D' ' 97' ' ' CYS . 3.0 tt -143.67 125.78 11.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 108.565 -0.902 . . . . 44.32 108.565 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.06 167.99 14.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.784 0.834 . . . . 51.43 110.458 -174.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.56 21.13 52.43 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.447 0.467 . . . . 74.35 114.01 173.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.64 171.54 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.045 0.938 . . . . 70.42 108.975 177.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -147.62 179.92 7.34 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.645 -0.872 . . . . 62.01 108.645 -175.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.85 -136.66 22.11 Favored Glycine 0 C--N 1.347 1.16 0 C-N-CA 122.992 0.329 . . . . 74.03 112.875 172.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.6 m -91.91 -36.76 13.28 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.126 0.571 . . . . 63.21 111.242 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -65.65 -19.63 65.98 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.185 0.594 . . . . 65.15 112.46 -171.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.422 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 0.0 OUTLIER -64.51 -36.99 86.0 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.951 0.5 . . . . 74.11 112.247 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . 0.422 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.11 -14.88 45.74 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.267 0.627 . . . . 64.23 111.851 178.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -63.96 -38.84 92.57 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.52 0.728 . . . . 64.34 112.282 -176.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . 0.474 ' HB2' HD12 ' D' ' 86' ' ' ILE . 69.1 m -65.43 -49.58 68.65 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.476 0.31 . . . . 74.35 111.629 -177.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.684 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 3.6 pp -67.47 -22.16 65.49 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.05 0.389 . . . . 70.22 112.05 -176.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.93 -29.33 11.84 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-O 119.881 -0.399 . . . . 72.43 113.593 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.0 -52.89 2.3 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 117.309 0.555 . . . . 32.24 111.838 -173.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -73.71 -39.57 64.23 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 112.103 0.408 . . . . 74.41 112.103 -173.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.684 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 89.1 m -65.31 -46.76 71.31 Favored Pre-proline 0 CA--C 1.556 1.189 0 CA-C-O 118.728 -0.653 . . . . 54.21 111.692 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.522 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 50.1 Cg_exo -58.71 -35.12 99.1 Favored 'Trans proline' 0 C--N 1.389 2.692 0 C-N-CA 121.653 1.569 . . . . 52.31 112.777 168.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.47 -31.73 73.06 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.346 0.658 . . . . 71.34 111.394 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.602 HG21 HD13 ' D' ' 13' ' ' ILE . 36.5 mm -69.78 -43.67 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.533 0.733 . . . . 74.12 110.223 172.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 74.6 mt -72.81 -19.74 61.28 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.26 -0.882 . . . . 72.24 111.699 -175.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -66.32 -45.42 60.08 Favored Pre-proline 0 CA--C 1.556 1.175 0 N-CA-C 113.498 0.925 . . . . 72.12 113.498 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -49.27 -41.02 43.17 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.443 2.095 . . . . 70.11 113.86 170.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -78.97 -33.23 45.37 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.458 0.703 . . . . 70.01 112.102 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.91 -44.27 73.51 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.523 0.677 . . . . 70.45 109.506 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.437 ' NH2' HG23 ' B' ' 105' ' ' ILE . 46.5 ttp180 -66.42 -37.29 84.87 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 114.005 -1.452 . . . . 70.5 110.172 175.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . 0.428 ' HA ' ' CE2' ' B' ' 109' ' ' TYR . 8.7 tt0 -52.29 -46.86 66.08 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.732 0.813 . . . . 73.41 111.148 176.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.8 t -66.72 -47.77 71.27 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.775 -1.102 . . . . 64.25 110.71 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.716 HG12 ' SG ' ' D' ' 76' ' ' CYS . 42.6 mt -60.29 -62.77 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.978 0.511 . . . . 53.42 110.363 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 98.3 m -41.68 -46.32 3.71 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 125.709 1.603 . . . . 63.23 112.799 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 22.9 t -68.48 -45.17 73.08 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.192 -0.913 . . . . 74.13 110.67 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.1 mtm -67.44 -34.3 76.93 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.802 0.441 . . . . 71.33 111.589 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.484 HG23 ' O ' ' D' ' 114' ' ' ILE . 84.9 t -60.54 -46.81 94.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 123.797 0.839 . . . . 71.33 110.082 176.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.0 p -70.45 -28.5 65.07 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 115.785 -0.643 . . . . 71.13 110.705 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' D' ' 116' ' ' SER . 72.6 mtt-85 -71.89 -22.92 61.43 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.531 0.733 . . . . 75.22 111.251 176.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.52 12.71 68.56 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-O 119.564 -0.576 . . . . 45.23 112.709 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.638 HG23 ' HB3' ' C' ' 17' ' ' TYR . 72.6 p 60.03 11.87 2.89 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 126.735 2.014 . . . . 61.11 113.391 -174.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -81.51 149.38 64.7 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.776 -0.453 . . . . 75.33 109.776 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -48.22 120.06 4.61 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 123.095 2.53 . . . . 54.11 113.03 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -42.23 119.73 1.44 Allowed 'General case' 0 C--N 1.364 1.237 0 O-C-N 124.875 1.359 . . . . 72.13 111.402 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.484 HD13 HG21 ' D' ' 40' ' ' VAL . 29.8 tp -106.48 99.61 9.18 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.309 0.644 . . . . 60.42 109.51 -171.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -97.82 97.9 9.37 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 107.449 -1.315 . . . . 65.14 107.449 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.4 HD11 HD12 ' D' ' 114' ' ' ILE . 38.8 mt -59.59 137.14 58.12 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-N 115.133 -0.939 . . . . 73.42 109.995 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.49 148.49 73.66 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 123.541 0.736 . . . . 72.3 111.184 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.473 ' HG3' ' CD2' ' B' ' 11' ' ' PHE . 32.0 Cg_endo -60.47 122.95 12.09 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.647 2.231 . . . . 74.42 111.298 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 99.9 t -108.08 115.26 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.395 -0.366 . . . . 75.32 110.631 -175.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -83.64 96.55 8.71 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 107.745 -1.206 . . . . 55.01 107.745 167.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 . . . . . 0 N--CA 1.489 1.501 0 C-N-CA 124.047 0.939 . . . . 45.22 112.109 -174.635 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 84.6 m . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 120.934 0.397 . . . . 74.14 110.486 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.807 ' HE1' ' HG ' ' A' ' 102' ' ' CYS . 72.6 t80 -120.62 124.87 46.3 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.767 -1.197 . . . . 62.04 107.767 172.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -132.23 132.72 43.36 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.284 -0.635 . . . . 75.2 109.284 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.471 HG21 ' HG2' ' C' ' 130' ' ' PRO . 69.4 mt -89.69 109.63 20.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.158 -1.053 . . . . 64.02 108.158 171.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.63 -40.66 17.19 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 109.048 -0.723 . . . . 72.23 109.048 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 -168.88 122.28 0.82 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.64 0.376 . . . . 63.41 110.283 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 83.7 mt -107.07 136.71 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.776 -0.824 . . . . 74.4 108.776 170.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.454 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 22.1 p90 -164.92 169.51 16.4 Favored 'General case' 0 C--N 1.347 0.47 0 O-C-N 123.822 0.701 . . . . 52.33 111.699 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -94.47 120.6 34.96 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.116 -0.698 . . . . 70.41 109.116 172.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.454 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 34.8 mtpt -78.9 -34.88 44.35 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.164 0.507 . . . . 70.2 109.673 175.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 17.8 t70 -150.01 140.47 22.41 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.646 -1.161 . . . . 64.22 109.865 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.4 mt -130.92 139.69 50.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 124.873 1.269 . . . . 65.45 107.835 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -145.54 127.97 15.95 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.297 -1.001 . . . . 61.34 108.297 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.464 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 86.9 t80 -135.63 129.49 32.91 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.112 -1.44 . . . . 74.01 107.112 171.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -129.59 135.95 49.2 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.165 -0.679 . . . . 72.44 109.165 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.31 76.93 71.66 Favored Pre-proline 0 C--O 1.24 0.553 0 N-CA-C 105.817 -1.919 . . . . 72.15 105.817 167.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.67 -22.92 36.91 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.591 2.194 . . . . 53.45 112.027 -171.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -110.12 22.3 15.74 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.233 1.013 . . . . 65.51 109.447 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.478 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -46.88 -52.79 30.47 Favored Pre-proline 0 CA--C 1.568 1.654 0 CA-C-O 117.846 -1.073 . . . . 75.02 113.658 -171.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.57 -23.22 64.31 Favored 'Trans proline' 0 C--N 1.391 2.778 0 CA-C-N 121.536 1.584 . . . . 64.03 113.374 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -84.12 -39.69 19.17 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.675 0.79 . . . . 74.51 111.017 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.893 HG21 ' HA ' ' A' ' 73' ' ' ALA . 5.5 p -78.23 -23.56 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 CA-C-N 115.306 -0.861 . . . . 72.35 113.159 -157.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -70.06 -19.35 63.29 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 122.739 0.416 . . . . 74.43 110.874 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -86.81 -16.5 36.03 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.568 1.147 . . . . 74.31 110.772 177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -81.5 158.06 24.63 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.873 0.869 . . . . 72.31 111.884 -174.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.48 118.27 8.53 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 123.992 0.917 . . . . 72.13 109.413 173.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -78.55 84.92 4.65 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.661 0.743 . . . . 75.14 109.91 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -122.85 76.09 48.44 Favored Pre-proline 0 C--O 1.243 0.745 0 N-CA-C 106.799 -1.556 . . . . 53.31 106.799 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.44 ' HB2' HG23 ' A' ' 40' ' ' VAL . 83.7 Cg_endo -78.47 115.1 3.61 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 121.817 1.678 . . . . 72.32 111.363 -171.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -93.31 81.59 4.45 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 105.554 -2.017 . . . . 70.23 105.554 172.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.44 HG23 ' HB2' ' A' ' 38' ' ' PRO . 46.0 t -86.05 93.74 3.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 CA-C-N 114.532 -1.213 . . . . 61.55 109.555 -174.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.72 118.82 21.88 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.953 -1.476 . . . . 53.51 108.384 174.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.7 mt -95.39 108.55 20.75 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.435 -1.32 . . . . 75.45 107.435 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -102.61 141.18 35.85 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.387 -0.968 . . . . 75.32 108.387 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.55 HD11 HG21 ' A' ' 131' ' ' VAL . 75.5 mt -135.39 131.41 36.28 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 109.498 -0.556 . . . . 72.41 109.498 -174.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -134.03 129.56 36.27 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.448 -1.316 . . . . 61.31 107.448 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.485 HG21 ' HA2' ' A' ' 99' ' ' GLY . 85.3 m -108.54 130.97 55.28 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.876 -0.787 . . . . 51.42 108.876 172.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.72 109.37 9.11 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.819 -0.808 . . . . 51.22 108.819 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.6 p -91.28 163.42 14.24 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.318 0.647 . . . . 74.31 110.098 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.9 t -160.39 154.14 22.6 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.28 1.432 . . . . 75.41 107.328 -166.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -116.29 125.41 52.12 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.681 -0.489 . . . . 70.12 109.681 171.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.7 mt -95.02 -32.99 12.89 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.21 0.604 . . . . 54.41 110.583 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.95 -179.5 7.2 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.192 0.597 . . . . 64.14 111.39 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -63.51 123.7 19.47 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 109.346 -0.613 . . . . 64.03 109.346 174.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 70.2 -8.53 0.84 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 125.835 1.654 . . . . 64.4 112.886 -173.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.7 t -100.64 106.61 19.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 121.496 0.665 . . . . 73.43 109.301 -177.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -114.27 125.61 54.1 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.735 -1.209 . . . . 71.43 107.735 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -94.32 128.77 41.02 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.919 -0.771 . . . . 72.42 108.919 172.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.1 t -113.2 137.71 45.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.369 -0.974 . . . . 71.01 108.369 171.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.7 t -119.32 130.58 73.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.905 -0.776 . . . . 75.44 108.905 173.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.31 97.8 7.56 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 105.675 -1.972 . . . . 73.12 105.675 172.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -84.94 97.58 9.87 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.928 -1.138 . . . . 73.13 107.928 174.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 50.0 t -94.97 131.25 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 107.49 -1.3 . . . . 74.33 107.49 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.8 m -127.12 118.4 24.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.817 0.817 . . . . 74.24 110.203 175.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.597 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 91.5 t -104.33 125.49 59.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 124.56 1.144 . . . . 43.0 108.905 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.1 m -122.43 126.49 48.05 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.648 -0.871 . . . . 42.04 108.648 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.404 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -113.21 108.3 17.08 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 107.847 -1.168 . . . . 63.42 107.847 175.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.0 m -109.03 134.29 51.85 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.179 0.591 . . . . 72.21 110.037 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.4 mt -100.7 57.74 0.91 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.247 1.019 . . . . 62.41 108.341 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.46 -103.15 3.0 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 110.82 -0.912 . . . . 45.41 110.82 -169.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -96.59 -28.56 14.31 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.352 0.661 . . . . 73.45 111.428 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -102.74 123.07 45.74 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.471 0.308 . . . . 71.33 110.639 -173.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.6 m -71.5 138.42 48.92 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.514 0.726 . . . . 63.21 110.871 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.893 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -79.78 -60.06 2.49 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.317 1.047 . . . . 74.2 109.817 173.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -151.02 156.64 41.55 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 114.629 -1.169 . . . . 73.45 111.071 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 39.9 tp -126.82 115.05 18.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.633 1.173 . . . . 61.23 108.58 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.597 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 66.3 m -105.9 142.3 35.85 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.044 0.937 . . . . 72.32 109.339 175.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -146.44 121.35 9.98 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.644 -0.873 . . . . 53.32 108.644 166.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.4 t -126.09 109.81 22.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.703 -0.851 . . . . 73.52 108.703 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -85.78 82.01 8.36 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 114.379 -1.282 . . . . 72.33 108.443 174.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -76.23 95.55 3.74 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.828 -1.078 . . . . 61.14 109.164 -177.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.32 154.88 29.15 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 111.361 -0.696 . . . . 41.02 111.361 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.29 121.51 1.23 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.682 -0.967 . . . . 30.3 110.682 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.4 mt -81.68 127.1 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 107.823 -1.177 . . . . 74.12 107.823 171.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.844 ' HB3' HD11 ' A' ' 86' ' ' ILE . 71.0 m-85 -135.71 125.15 24.95 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.095 0.958 . . . . 72.24 109.561 -171.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.1 m -94.65 97.95 10.46 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 109.216 -0.661 . . . . 73.42 109.216 175.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.844 HD11 ' HB3' ' A' ' 84' ' ' PHE . 6.0 mm -108.04 156.69 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.385 0.674 . . . . 62.11 110.679 -172.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.41 162.84 8.47 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.523 1.129 . . . . 74.23 110.909 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.21 -13.94 62.81 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-N 115.951 -0.568 . . . . 25.4 114.422 174.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.482 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -133.46 146.6 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.824 0.85 . . . . 41.53 110.736 -177.108 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -144.16 174.76 10.6 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.296 1.038 . . . . 64.41 109.735 174.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.99 -139.01 26.42 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 116.012 -0.54 . . . . 60.21 112.618 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.7 p -69.79 -16.61 63.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 117.105 0.453 . . . . 73.12 111.501 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.57 -45.71 85.88 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.254 0.621 . . . . 74.12 109.959 170.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.403 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 6.1 tpt -66.75 -43.79 83.2 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.103 -0.953 . . . . 63.35 109.662 -178.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.95 -31.16 72.25 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.601 -0.727 . . . . 63.3 111.125 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.441 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 57.8 t-80 -74.3 -30.3 62.01 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.667 0.787 . . . . 63.44 110.696 176.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.4 t -72.8 -44.54 61.38 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 109.115 -0.698 . . . . 60.01 109.115 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 94' ' ' MET . 35.9 mt -84.99 -24.72 28.14 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.389 -0.823 . . . . 72.13 112.019 -174.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.485 ' HA2' HG21 ' A' ' 46' ' ' THR . . . -108.01 4.45 33.89 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 119.597 -0.557 . . . . 45.13 113.947 -174.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.562 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -147.52 -64.22 0.27 Allowed 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 117.667 0.734 . . . . 62.4 112.372 -177.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -68.16 -47.27 68.48 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 123.352 0.408 . . . . 74.35 111.697 -171.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.807 ' HG ' ' HE1' ' A' ' 11' ' ' PHE . 98.4 m -65.2 -45.83 71.87 Favored Pre-proline 0 CA--C 1.56 1.333 0 CA-C-O 117.987 -1.006 . . . . 70.0 112.316 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -54.26 -35.26 82.78 Favored 'Trans proline' 0 C--N 1.398 3.178 0 C-N-CA 122.188 1.925 . . . . 72.13 112.889 169.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -68.53 -34.25 75.54 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.531 0.732 . . . . 64.43 111.093 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.5 mm -67.88 -43.23 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.49 0.716 . . . . 53.42 110.054 172.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 55.9 mt -75.19 -20.24 59.4 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.053 -0.976 . . . . 61.33 111.877 -174.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -65.63 -45.24 67.1 Favored Pre-proline 0 N--CA 1.478 0.93 0 CA-C-O 117.05 -1.452 . . . . 72.11 113.537 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -50.72 -34.11 42.8 Favored 'Trans proline' 0 C--N 1.39 2.715 0 CA-C-N 122.182 1.815 . . . . 44.51 113.592 171.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -85.69 -36.47 20.22 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.711 0.804 . . . . 72.21 112.054 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.42 -48.25 67.84 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.968 -0.752 . . . . 64.02 108.968 175.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.453 ' NH1' HD12 ' C' ' 105' ' ' ILE . 27.9 ttm180 -47.87 -58.48 4.32 Favored 'General case' 0 C--O 1.213 -0.82 0 O-C-N 125.203 1.565 . . . . 61.31 110.677 171.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -60.79 -45.35 94.74 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 124.321 1.013 . . . . 74.44 111.792 -173.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.416 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 47.4 t -58.74 -45.9 88.62 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.045 0.841 . . . . 71.34 110.498 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.505 HG21 HG21 ' A' ' 64' ' ' VAL . 83.3 mt -61.16 -51.44 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 124.27 0.982 . . . . 64.33 110.603 175.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.2 m -58.75 -37.11 75.5 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.36 1.064 . . . . 73.21 110.687 -173.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.1 t -70.59 -44.56 67.06 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.444 -1.253 . . . . 54.44 109.866 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.4 mtp -59.39 -38.62 81.0 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.658 0.783 . . . . 63.41 111.774 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 114' ' ' ILE . 79.3 t -67.27 -46.08 84.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.211 1.004 . . . . 70.02 110.073 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.9 p -71.88 -30.63 65.61 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.828 -0.624 . . . . 55.14 111.106 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.413 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 81.7 mtt-85 -72.22 -33.69 67.78 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.675 0.79 . . . . 75.31 109.432 172.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.61 -2.17 74.32 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 115.019 -0.991 . . . . 73.21 112.962 175.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.529 HG22 HH21 ' B' ' 15' ' ' ARG . 52.1 m 76.92 19.99 1.34 Allowed 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 122.593 1.187 . . . . 74.33 111.882 168.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -93.31 148.75 36.17 Favored Pre-proline 0 C--O 1.248 1.022 0 N-CA-C 108.296 -1.002 . . . . 71.42 108.296 170.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -54.47 138.96 74.9 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.494 2.129 . . . . 72.04 111.156 175.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -56.21 127.48 30.96 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.332 1.02 . . . . 75.34 112.274 -167.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.542 HD21 HG11 ' A' ' 64' ' ' VAL . 36.0 tp -113.04 97.14 6.33 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 114.454 -1.248 . . . . 74.44 109.406 -175.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -96.04 103.23 15.11 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.038 -1.467 . . . . 74.34 107.038 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 17.3 mt -55.24 136.12 49.08 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.778 0.673 . . . . 74.51 111.134 -169.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.84 137.86 97.28 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 122.755 0.422 . . . . 42.03 111.274 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.537 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 53.2 Cg_exo -55.47 114.84 2.07 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.593 2.862 . . . . 64.43 113.689 -178.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.55 HG21 HD11 ' A' ' 44' ' ' LEU . 45.1 t -104.2 133.24 48.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 CA-C-N 115.455 -0.793 . . . . 70.45 109.842 177.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 63.4 t-20 -96.97 87.12 4.16 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.515 -0.921 . . . . 55.13 108.515 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -59.68 -26.6 65.7 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.708 0.803 . . . . 73.24 113.056 175.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.562 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 8.6 t0 -63.67 -43.97 95.15 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.931 -0.766 . . . . 74.34 108.931 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.05 -35.22 80.46 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.893 -1.048 . . . . 61.34 111.476 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 77.9 mt -71.83 -40.66 68.93 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.022 0.826 . . . . 74.45 111.879 -177.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 59.8 t80 . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 108.796 -0.816 . . . . 74.12 108.796 175.688 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.582 ' HG3' HG23 ' B' ' 89' ' ' ILE . 1.2 tmt? . . . . . 0 N--CA 1.486 1.354 0 N-CA-C 111.804 0.298 . . . . 72.42 111.804 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.484 ' N ' ' SD ' ' B' ' 9' ' ' MET . 9.5 t -159.89 133.59 7.16 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.844 0.857 . . . . 61.25 109.405 176.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -117.36 141.85 47.81 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 107.842 -1.17 . . . . 72.15 107.842 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -149.46 137.54 20.54 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 122.76 0.424 . . . . 74.41 110.701 176.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 44.6 mt -96.23 128.16 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.049 -1.093 . . . . 73.43 108.049 173.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -95.35 -42.03 8.72 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.524 0.515 . . . . 64.34 110.525 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.529 HH21 HG22 ' A' ' 122' ' ' THR . 22.8 ttt180 -172.93 138.69 0.8 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.737 -0.665 . . . . 70.45 109.303 -172.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.8 mt -123.31 139.88 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 106.661 -1.607 . . . . 52.33 106.661 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -164.01 145.21 8.7 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.22 0.822 . . . . 73.44 113.22 -174.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 64.0 m -76.28 120.43 21.54 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.737 -1.119 . . . . 61.12 109.094 172.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.637 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 37.0 mtpt -97.82 -22.82 16.17 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.049 0.94 . . . . 55.21 111.006 -178.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 17.8 t70 -158.53 143.25 16.07 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.185 0.594 . . . . 74.12 110.358 -175.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.464 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 38.9 mm -138.9 141.47 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.252 1.421 . . . . 63.13 107.849 174.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 67.8 m -145.83 138.45 25.69 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.529 0.732 . . . . 71.04 109.13 170.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.3 t80 -143.41 116.76 9.05 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.792 -1.929 . . . . 74.1 105.792 169.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -127.89 111.14 13.26 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.323 -0.992 . . . . 62.03 108.323 -176.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.607 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -110.2 87.91 6.6 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 108.211 -1.033 . . . . 73.32 108.211 175.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.07 -34.06 14.28 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.232 1.955 . . . . 74.25 111.547 -175.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -99.97 3.81 44.54 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.325 1.05 . . . . 72.35 110.902 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.607 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -24.89 -64.68 0.1 OUTLIER Pre-proline 0 N--CA 1.504 2.266 0 C-N-CA 126.606 1.962 . . . . 72.44 115.332 -172.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 7.9 Cg_exo -66.57 -42.34 9.66 Favored 'Trans proline' 0 C--N 1.388 2.63 0 C-N-CA 122.154 1.903 . . . . 70.52 112.386 -170.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -86.03 -28.19 24.31 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.651 0.78 . . . . 75.22 111.89 -171.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.523 HG22 HD12 ' B' ' 68' ' ' LEU . 4.8 p -77.59 -11.66 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 122.889 0.476 . . . . 53.41 110.696 -175.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -65.89 -20.52 66.25 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 113.101 0.778 . . . . 65.15 113.101 173.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -63.21 -25.16 68.21 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.313 0.578 . . . . 62.54 110.111 173.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -90.83 66.98 6.12 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.307 1.043 . . . . 72.54 109.713 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -80.6 82.08 6.7 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 122.291 1.043 . . . . 75.15 109.114 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -152.83 -173.3 4.52 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.102 -0.954 . . . . 75.32 109.122 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -72.51 110.35 7.97 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 123.992 0.917 . . . . 75.42 109.631 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.409 ' O ' HG23 ' B' ' 40' ' ' VAL . 49.2 Cg_endo -70.38 141.1 41.88 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 121.653 1.569 . . . . 71.01 109.747 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -68.12 99.97 0.95 Allowed 'General case' 0 C--O 1.242 0.687 0 N-CA-C 106.906 -1.516 . . . . 63.42 106.906 171.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.667 HG11 HD11 ' B' ' 126' ' ' LEU . 39.1 t -95.72 154.2 3.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 114.593 -1.185 . . . . 73.44 108.734 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -143.81 117.5 9.25 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.93 -0.766 . . . . 73.13 108.93 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.495 HD13 HD22 ' B' ' 128' ' ' LEU . 31.1 tp -93.27 137.31 32.71 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 108.832 -0.803 . . . . 65.01 108.832 172.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -159.55 128.22 5.11 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 107.702 -1.221 . . . . 73.05 107.702 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.461 HD23 HG22 ' B' ' 62' ' ' VAL . 4.0 mp -108.59 151.25 26.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.879 -0.785 . . . . 72.45 108.879 -174.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.55 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.4 t70 -127.54 144.14 51.1 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.027 0.931 . . . . 73.31 109.111 -177.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 26.1 p -113.07 106.51 14.76 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.534 0.734 . . . . 64.44 110.653 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.99 136.25 52.77 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.971 -1.122 . . . . 51.43 107.971 171.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.571 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 58.0 m -142.85 177.55 8.26 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.567 0.347 . . . . 62.14 110.774 -173.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 79.4 p -159.21 139.18 11.89 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.785 0.434 . . . . 61.41 111.136 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -90.24 125.16 35.39 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 108.696 -0.853 . . . . 52.53 108.696 169.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.6 pp -140.32 17.71 2.41 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.978 0.911 . . . . 74.22 109.845 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.77 152.65 17.93 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.454 1.102 . . . . 75.33 109.078 174.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -76.98 135.43 38.7 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.279 -1.008 . . . . 74.22 108.279 164.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 70.59 -4.25 1.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.139 0.976 . . . . 71.11 113.113 172.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 63.6 t -136.27 128.46 45.0 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 106.725 -1.583 . . . . 62.04 106.725 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.571 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 4.9 t80 -122.16 169.64 10.67 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.836 0.351 . . . . 64.3 110.564 -172.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -134.72 111.45 9.98 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 107.664 -1.235 . . . . 72.45 107.664 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 61.5 t -106.75 130.67 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.056 0.942 . . . . 75.52 109.198 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.2 t -111.28 113.31 43.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 N-CA-C 109.277 -0.638 . . . . 73.45 109.277 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' B' ' 103' ' ' PRO . 63.1 tp -93.79 110.77 22.4 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 109.076 -0.713 . . . . 62.23 109.076 171.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.55 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 14.0 ttm180 -84.66 132.89 34.43 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.855 -1.165 . . . . 74.51 107.855 169.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.461 HG22 HD23 ' B' ' 44' ' ' LEU . 43.8 t -123.49 104.15 13.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.571 -1.27 . . . . 71.43 107.571 174.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 15.2 m -100.63 131.71 46.4 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.068 0.461 . . . . 52.43 110.112 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.616 HG11 HD21 ' B' ' 126' ' ' LEU . 70.3 t -122.92 126.54 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.222 1.009 . . . . 63.14 108.5 175.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.8 m -111.3 138.9 47.18 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 107.54 -1.281 . . . . 71.22 107.54 168.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.12 137.09 28.88 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.034 -0.728 . . . . 74.53 109.034 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.569 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 25.1 p -147.05 128.28 14.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.085 0.469 . . . . 64.41 111.584 -172.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.523 HD12 HG22 ' B' ' 31' ' ' VAL . 56.4 mt -99.03 103.79 15.76 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 124.919 1.288 . . . . 72.24 108.507 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.3 -119.04 4.82 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 115.657 -0.701 . . . . 62.54 111.824 -174.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -112.22 3.93 17.47 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.94 0.896 . . . . 73.33 111.368 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -118.0 148.62 42.05 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.119 0.567 . . . . 75.11 109.672 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 99.2 m -72.63 125.66 28.02 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.8 -0.636 . . . . 62.45 111.232 -177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.569 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -71.66 -62.43 1.42 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.81 -1.181 . . . . 61.42 107.81 173.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -152.89 157.89 41.35 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.586 -1.188 . . . . 70.13 111.186 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 70.8 mt -126.08 108.5 11.42 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 106.255 -1.758 . . . . 72.25 106.255 172.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 39.3 t -119.17 113.76 21.4 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.507 -0.923 . . . . 74.12 108.507 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -128.57 124.62 36.38 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.973 -1.121 . . . . 75.33 107.973 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 67.3 t -123.63 155.84 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.855 0.862 . . . . 64.13 109.24 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.53 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.7 mt-30 -131.25 108.03 9.4 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.19 -0.67 . . . . 55.13 109.19 171.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 8.5 tp-100 -96.89 109.38 22.11 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.568 0.747 . . . . 61.53 109.518 173.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.637 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -99.64 170.61 23.25 Favored Glycine 0 N--CA 1.464 0.535 0 N-CA-C 112.021 -0.432 . . . . 73.42 112.021 174.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.97 138.78 5.12 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 112.573 -0.211 . . . . 51.42 112.573 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 49.5 mt -92.17 122.08 43.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.267 1.027 . . . . 71.25 108.764 174.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -127.45 135.21 50.1 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.002 0.921 . . . . 70.1 109.727 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 24.1 m -106.32 128.65 54.15 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.691 0.796 . . . . 73.11 109.5 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.626 ' HB ' HD11 ' B' ' 89' ' ' ILE . 1.9 pp -139.77 147.06 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.374 0.669 . . . . 72.52 111.089 -177.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.68 165.92 35.03 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.4 0.68 . . . . 62.04 111.104 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 90.8 -45.83 2.91 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 116.087 -0.506 . . . . 31.2 112.741 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.626 HD11 ' HB ' ' B' ' 86' ' ' ILE . 4.0 pt -56.38 152.33 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.559 1.143 . . . . 72.34 111.426 169.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -157.94 164.09 37.2 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.536 0.734 . . . . 74.22 109.536 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.36 -111.07 3.49 Favored Glycine 0 C--N 1.355 1.631 0 O-C-N 123.197 0.31 . . . . 53.34 112.699 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 25.0 m -84.34 -43.22 14.97 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 123.695 0.798 . . . . 73.43 109.696 175.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -62.53 -24.66 67.62 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 113.758 -1.565 . . . . 75.43 111.694 -168.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.566 ' HA ' HD12 ' B' ' 89' ' ' ILE . 23.9 ptm -66.1 -65.67 0.65 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.084 0.772 . . . . 75.54 113.084 -177.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.19 -14.4 58.48 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.21 0.448 . . . . 61.1 112.21 -175.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -61.33 -37.03 81.82 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.365 0.666 . . . . 74.15 110.554 171.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . 0.456 ' SG ' HG21 ' B' ' 86' ' ' ILE . 43.8 t -60.13 -24.56 64.78 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.114 0.966 . . . . 52.24 112.024 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.501 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 26.7 mt -97.76 -39.13 9.19 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.124 0.969 . . . . 72.42 111.497 -177.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.26 -19.27 69.69 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 116.43 -0.35 . . . . 73.52 113.572 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.87 -48.48 1.89 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.003 0.521 . . . . 73.24 111.767 -172.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -83.05 -41.96 18.03 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 111.877 0.325 . . . . 72.43 111.877 -171.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.501 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 94.8 m -63.05 -43.23 81.15 Favored Pre-proline 0 CA--C 1.57 1.733 0 N-CA-C 113.569 0.952 . . . . 45.23 113.569 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.424 ' HB3' HD13 ' B' ' 60' ' ' LEU . 51.5 Cg_exo -58.27 -27.62 81.52 Favored 'Trans proline' 0 C--N 1.399 3.196 0 C-N-CA 122.239 1.96 . . . . 73.24 113.674 173.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -65.01 -33.55 76.31 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.663 0.785 . . . . 72.23 110.591 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 57.4 mt -73.89 -41.7 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.883 0.873 . . . . 75.01 110.088 176.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 92.5 mt -75.94 -30.01 58.53 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.23 -0.896 . . . . 60.12 112.424 -172.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -56.98 -49.7 92.44 Favored Pre-proline 0 N--CA 1.484 1.239 0 CA-C-O 117.342 -1.313 . . . . 64.13 113.477 -172.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -50.31 -39.64 53.01 Favored 'Trans proline' 0 C--N 1.391 2.788 0 C-N-CA 122.512 2.141 . . . . 74.11 114.161 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -70.15 -47.15 62.89 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.334 0.654 . . . . 72.23 110.509 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -62.35 -35.53 79.41 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.37 -0.832 . . . . 65.44 111.337 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.533 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 50.2 ttt-85 -67.53 -49.73 61.97 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.134 1.374 . . . . 72.41 110.349 -177.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.6 -32.34 73.61 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.021 0.826 . . . . 60.33 109.687 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.51 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.3 t -69.56 -42.84 74.02 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.257 0.623 . . . . 65.24 110.829 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.424 HD13 HG23 ' B' ' 64' ' ' VAL . 74.9 mt -60.23 -54.52 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.392 0.677 . . . . 72.25 110.603 172.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 25.5 m -58.9 -28.69 66.43 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.503 0.721 . . . . 70.44 111.276 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 22.9 t -67.69 -53.2 29.58 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 123.203 0.601 . . . . 71.43 109.59 173.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.51 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.2 mmt -64.52 -31.89 73.3 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 122.758 0.423 . . . . 75.15 111.774 -175.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.8 t -69.7 -42.1 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.268 1.027 . . . . 73.04 110.562 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 81.5 p -72.43 -28.89 63.24 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.001 0.429 . . . . 52.42 111.087 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' B' ' 116' ' ' SER . 88.5 mtt-85 -67.93 -40.72 83.31 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.12 -0.945 . . . . 71.54 109.505 175.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.45 -6.18 61.43 Favored Glycine 0 C--N 1.352 1.467 0 O-C-N 123.764 0.665 . . . . 64.13 113.071 173.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 9.7 m 64.98 31.45 11.25 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.282 1.433 . . . . 73.12 110.298 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -89.53 164.03 31.08 Favored Pre-proline 0 CA--C 1.556 1.193 0 CA-C-N 114.22 -1.354 . . . . 63.11 111.129 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -39.74 146.55 0.22 Allowed 'Trans proline' 0 C--N 1.393 2.885 0 C-N-CA 124.647 3.565 . . . . 50.32 115.86 174.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -61.05 112.84 2.25 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.301 0.641 . . . . 74.41 109.768 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.667 HD11 HG11 ' B' ' 40' ' ' VAL . 43.4 tp -109.93 110.72 21.76 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.424 0.69 . . . . 70.34 109.463 -174.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -107.29 117.53 34.32 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.201 -1.037 . . . . 73.02 108.201 175.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.533 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 51.4 mt -78.56 147.46 33.74 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 120.535 0.207 . . . . 54.52 110.53 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . 0.441 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -73.13 142.11 81.97 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 123.641 0.776 . . . . 71.54 112.375 -170.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' B' ' 129' ' ' ALA . 11.2 Cg_endo -85.04 104.04 0.86 Allowed 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.312 2.675 . . . . 41.11 111.192 176.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.95 134.93 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 122.83 0.452 . . . . 74.51 110.327 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 41.0 t30 . . . . . 0 N--CA 1.474 0.756 0 C-N-CA 123.259 0.624 . . . . 73.4 109.432 177.926 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.537 ' HD2' ' HG2' ' A' ' 130' ' ' PRO . 35.0 t80 . . . . . 0 C--O 1.239 0.53 0 N-CA-C 108.0 -1.111 . . . . 75.21 108.0 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -142.03 131.25 23.44 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.711 -0.848 . . . . 71.4 108.711 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 19.9 mt -84.22 134.77 26.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.723 -0.843 . . . . 73.14 108.723 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.499 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 20.9 mm-40 -91.35 -45.67 8.45 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.592 -0.892 . . . . 74.22 108.592 175.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -177.58 153.35 0.88 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.048 1.339 . . . . 73.24 109.455 175.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.491 HG23 HD23 ' C' ' 106' ' ' LEU . 75.0 mt -128.75 118.55 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.731 1.212 . . . . 62.34 108.379 177.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.511 ' HB3' HG23 ' D' ' 122' ' ' THR . 6.1 p90 -151.37 154.45 36.7 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.008 0.908 . . . . 72.45 112.249 -164.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.2 p -79.22 108.85 13.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.562 -1.199 . . . . 71.15 109.406 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -72.83 -45.01 60.69 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 107.557 -1.275 . . . . 53.41 107.557 172.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.71 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 10.4 t70 -134.52 137.54 43.94 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 113.186 -1.825 . . . . 64.11 109.19 -174.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.4 mt -134.78 143.44 37.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 125.455 1.502 . . . . 70.22 106.969 172.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.7 t -150.01 138.0 20.24 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 109.154 -0.684 . . . . 75.31 109.154 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -139.01 128.61 24.57 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.48 -1.304 . . . . 71.33 107.48 171.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -130.18 120.19 24.14 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.534 1.134 . . . . 70.53 108.784 -174.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.14 84.0 58.66 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 106.969 -1.493 . . . . 74.5 106.969 169.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.5 -26.9 28.36 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 122.397 2.064 . . . . 64.13 111.227 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -107.39 21.83 16.89 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.486 1.114 . . . . 65.44 109.836 -176.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.82 -64.94 0.71 Allowed Pre-proline 0 CA--C 1.571 1.777 0 N-CA-C 114.466 1.284 . . . . 32.11 114.466 -165.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -67.54 -27.87 38.83 Favored 'Trans proline' 0 C--N 1.385 2.453 0 CA-C-N 122.326 1.867 . . . . 74.34 112.615 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -68.13 -37.86 81.57 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.893 0.877 . . . . 73.13 111.366 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.632 HG21 ' HA ' ' C' ' 73' ' ' ALA . 14.8 p -82.01 -24.87 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 116.184 -0.462 . . . . 71.15 111.941 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -65.72 -30.66 71.36 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 121.787 -0.57 . . . . 71.35 111.015 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -90.82 29.93 1.27 Allowed 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.109 0.964 . . . . 64.0 111.228 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -124.74 153.38 42.49 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.457 1.103 . . . . 71.3 109.711 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -67.76 129.76 40.9 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 122.994 0.518 . . . . 75.34 109.89 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 66.5 t-105 -85.0 83.44 8.06 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.8 0.84 . . . . 74.13 111.346 -173.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -131.21 78.87 71.74 Favored Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 123.739 0.816 . . . . 71.41 109.071 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -83.23 155.61 14.6 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.553 2.169 . . . . 71.11 112.428 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -88.52 100.48 13.11 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 106.749 -1.574 . . . . 72.51 106.749 168.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 57.4 t -74.64 99.42 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 109.024 -0.732 . . . . 53.51 109.024 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 32.5 mmtm -131.65 106.79 8.39 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.086 0.954 . . . . 61.02 109.472 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 pp -95.74 165.35 12.35 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.69 0.796 . . . . 72.11 109.933 175.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 19.9 t70 -139.86 143.98 37.01 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.414 1.086 . . . . 73.21 108.235 175.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 97.4 mt -128.58 112.57 14.43 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.382 0.611 . . . . 61.2 109.613 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -112.87 121.18 43.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.635 -1.617 . . . . 64.4 106.635 172.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.2 t -118.68 142.92 47.2 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.36 0.6 . . . . 75.12 109.382 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.45 151.86 49.62 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.561 1.144 . . . . 70.41 108.274 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 53.1 p -147.32 142.21 26.89 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 109.348 -0.612 . . . . 64.42 109.348 174.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 72.6 p -150.35 151.85 33.5 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.291 1.036 . . . . 64.14 108.585 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -98.87 117.22 32.87 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.925 -0.769 . . . . 71.04 108.925 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.654 HD11 ' HB2' ' C' ' 57' ' ' GLU . 61.4 mt -84.42 -37.01 21.98 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.497 0.719 . . . . 75.43 110.233 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.38 -175.76 5.6 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.169 0.988 . . . . 63.31 109.759 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -59.16 110.23 1.02 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 123.641 0.588 . . . . 72.52 110.363 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 62.85 22.72 13.58 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.287 1.035 . . . . 71.22 112.066 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 95.6 t -117.63 117.49 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.874 1.27 . . . . 51.04 107.58 173.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -127.28 125.36 40.74 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.068 0.947 . . . . 72.14 109.554 -174.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.654 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.0 tt0 -88.33 122.12 31.48 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.832 -0.803 . . . . 61.04 108.832 169.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 65.8 t -112.49 124.13 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 108.713 -0.847 . . . . 75.44 108.713 172.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.538 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 61.6 t -109.75 134.75 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.019 0.528 . . . . 53.13 109.938 176.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.47 99.56 8.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.848 -1.168 . . . . 75.4 107.848 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -80.31 106.8 12.6 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.121 -1.066 . . . . 75.14 108.121 170.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.15 122.5 58.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 107.866 -1.161 . . . . 74.42 107.866 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 25.1 m -113.3 138.61 49.77 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 107.415 -1.328 . . . . 61.33 107.415 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.426 HG21 HG21 ' C' ' 114' ' ' ILE . 69.1 t -134.34 111.64 14.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 108.021 -1.103 . . . . 62.51 108.021 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.457 HG23 HD23 ' C' ' 75' ' ' LEU . 4.3 m -108.22 117.4 34.05 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.707 -0.679 . . . . 73.41 109.17 -177.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.42 104.04 10.71 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.565 -0.902 . . . . 62.42 108.565 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 63.4 m -128.77 132.91 47.94 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.186 -0.672 . . . . 65.44 109.186 176.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 9.6 mt -84.68 42.32 0.9 Allowed 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 125.428 1.491 . . . . 70.22 109.889 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.22 -104.61 2.46 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 110.97 -0.852 . . . . 53.12 110.97 -172.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -89.7 -32.19 17.13 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.514 0.726 . . . . 75.3 109.945 174.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -75.95 105.84 7.21 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 114.877 -1.056 . . . . 71.54 109.808 -178.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 61.4 m -74.21 124.52 26.55 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 118.479 0.582 . . . . 53.42 109.597 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.632 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -77.79 -53.89 6.98 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.582 -0.736 . . . . 53.54 109.111 176.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -162.03 164.13 28.42 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.827 -1.079 . . . . 75.55 110.729 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.457 HD23 HG23 ' C' ' 65' ' ' THR . 2.7 tm? -128.41 142.17 51.19 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.211 -1.774 . . . . 61.12 106.211 167.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 42.5 t -149.44 129.8 13.8 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.94 -0.763 . . . . 72.15 108.94 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -140.66 128.62 21.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.714 0.406 . . . . 72.31 110.027 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 37.3 t -125.24 115.69 44.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 124.468 1.107 . . . . 73.04 108.891 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.71 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.5 mt-30 -90.41 91.09 8.32 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.57 -0.9 . . . . 72.44 108.57 172.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -83.78 96.07 8.63 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.342 -1.299 . . . . 75.21 109.183 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -93.2 145.73 17.75 Favored Glycine 0 C--O 1.222 -0.638 0 N-CA-C 111.616 -0.594 . . . . 70.02 111.616 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.94 132.13 4.91 Favored Glycine 0 CA--C 1.503 -0.703 0 N-CA-C 110.991 -0.844 . . . . 74.43 110.991 -176.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.499 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 22.8 mm -85.66 124.46 40.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 107.467 -1.308 . . . . 74.02 107.467 174.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -129.94 118.2 21.29 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.638 0.775 . . . . 73.01 109.703 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.6 p -86.92 104.62 16.43 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.035 -0.728 . . . . 64.22 109.035 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.53 HD13 ' SG ' ' C' ' 97' ' ' CYS . 19.5 mt -116.73 126.98 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.532 0.733 . . . . 63.34 110.314 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.25 169.01 18.54 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.125 0.97 . . . . 63.23 109.887 177.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.66 -17.65 57.2 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 119.365 -0.686 . . . . 53.11 114.47 174.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' C' ' 94' ' ' MET . 38.0 pt -119.01 166.76 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 CA-C-N 118.079 0.94 . . . . 74.12 112.493 -175.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -159.39 156.44 28.47 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.685 1.194 . . . . 72.12 109.078 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.08 -138.14 14.88 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-O 120.073 -0.293 . . . . 74.41 112.926 171.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 47.1 p -65.08 -25.18 67.68 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.796 0.838 . . . . 63.25 111.457 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -61.15 -54.24 46.87 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.166 0.986 . . . . 74.43 110.635 171.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.587 ' HE3' ' HA ' ' C' ' 94' ' ' MET . 4.5 tpt -56.67 -48.61 77.23 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 124.058 0.849 . . . . 62.44 111.803 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.17 -40.96 91.76 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 123.59 0.556 . . . . 43.12 111.514 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -69.56 -30.95 68.86 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.055 0.942 . . . . 75.14 111.239 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.53 ' SG ' HD13 ' C' ' 86' ' ' ILE . 12.2 t -75.41 -35.39 61.02 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.652 -0.499 . . . . 70.11 109.652 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 96.2 mt -84.14 -32.82 24.46 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.002 0.921 . . . . 71.33 112.521 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.88 8.77 27.6 Favored Glycine 0 N--CA 1.473 1.166 0 CA-C-O 119.656 -0.525 . . . . 71.43 114.135 -170.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.75 -55.32 0.22 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 117.411 0.606 . . . . 53.25 111.644 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -71.36 -54.34 11.08 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 117.566 0.166 . . . . 74.13 111.264 -174.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.45 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 84.8 m -57.58 -50.48 87.92 Favored Pre-proline 0 CA--C 1.565 1.524 0 CA-C-O 118.182 -0.913 . . . . 55.4 111.974 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.464 ' HA ' HD12 ' C' ' 106' ' ' LEU . 38.9 Cg_exo -60.11 -28.21 86.5 Favored 'Trans proline' 0 C--N 1.4 3.256 0 C-N-CA 122.601 2.201 . . . . 75.11 113.567 174.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -68.09 -35.61 78.45 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.201 0.6 . . . . 55.21 110.778 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.453 HD12 ' NH1' ' A' ' 111' ' ' ARG . 19.9 mm -79.86 -29.62 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 109.972 -0.381 . . . . 70.35 109.972 177.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.491 HD23 HG23 ' C' ' 16' ' ' ILE . 73.9 mt -70.09 -32.08 69.96 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.406 0.683 . . . . 73.21 111.254 176.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -53.29 -53.26 58.08 Favored Pre-proline 0 N--CA 1.485 1.322 0 CA-C-O 117.228 -1.368 . . . . 71.41 114.459 -173.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.82 -36.46 96.98 Favored 'Trans proline' 0 C--N 1.391 2.783 0 C-N-CA 122.074 1.849 . . . . 54.44 113.219 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -70.17 -46.55 64.42 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.706 0.802 . . . . 71.33 110.307 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.94 81.86 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 115.027 -0.988 . . . . 60.25 110.369 175.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.9 ttt-85 -65.74 -47.16 76.2 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.199 1.399 . . . . 64.32 110.757 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -69.63 -33.78 73.13 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.362 0.665 . . . . 74.34 110.055 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 40.2 t -68.68 -39.53 80.53 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.336 0.655 . . . . 61.44 111.258 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.441 ' O ' HG23 ' C' ' 118' ' ' VAL . 96.7 mt -69.35 -48.19 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.572 0.749 . . . . 73.15 110.406 174.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 28.5 m -54.52 -40.16 68.35 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.561 1.144 . . . . 62.42 110.876 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.4 t -64.55 -48.05 76.48 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.002 -0.999 . . . . 52.13 109.0 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.52 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.8 -40.24 79.44 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.839 1.256 . . . . 74.24 112.672 178.433 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.441 HG23 ' O ' ' C' ' 114' ' ' ILE . 86.8 t -66.72 -41.0 87.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.531 0.732 . . . . 54.31 110.287 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 46.7 t -71.94 -27.82 63.05 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.782 0.833 . . . . 62.4 111.501 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 82.5 mtt-85 -72.52 -34.17 67.42 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.494 0.718 . . . . 74.55 109.495 175.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.24 10.39 63.81 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.388 -0.823 . . . . 74.42 112.636 173.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 72.5 p 58.7 22.9 10.47 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 126.153 1.781 . . . . 62.1 114.286 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -83.66 149.16 56.59 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 108.689 -0.856 . . . . 72.21 108.689 171.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -55.53 157.67 14.66 Favored 'Trans proline' 0 C--N 1.382 2.322 0 C-N-CA 123.073 2.516 . . . . 61.32 113.702 176.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -58.49 114.16 2.33 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.882 0.873 . . . . 72.14 112.223 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.9 tt -110.56 86.04 2.23 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 106.601 -1.629 . . . . 62.33 106.601 172.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -91.19 105.02 17.5 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.046 -0.724 . . . . 74.24 109.046 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.5 145.59 55.88 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.484 0.714 . . . . 72.51 111.983 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.22 153.15 84.24 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.575 0.75 . . . . 62.31 110.347 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.471 ' HG2' HG21 ' A' ' 13' ' ' ILE . 51.9 Cg_exo -54.71 115.68 2.58 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.892 2.395 . . . . 74.13 112.548 173.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.3 t -98.05 116.91 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.656 -0.868 . . . . 70.51 108.656 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -76.02 103.25 5.98 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.368 0.667 . . . . 75.01 110.531 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -67.18 -22.41 65.74 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.489 0.716 . . . . 74.24 112.065 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -65.46 -42.91 91.81 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.498 0.719 . . . . 72.12 110.476 175.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.08 -46.74 87.78 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 123.675 0.61 . . . . 64.03 110.354 176.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.03 -27.75 67.67 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.267 -0.878 . . . . 74.44 111.435 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 88.2 t80 . . . . . 0 N--CA 1.472 0.647 0 C-N-CA 123.262 0.625 . . . . 53.11 110.494 -179.821 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 8.2 t . . . . . 0 C--O 1.24 0.563 0 N-CA-C 109.149 -0.685 . . . . 54.01 109.149 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.465 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 54.9 t80 -143.41 89.76 2.11 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.183 -1.414 . . . . 71.34 107.183 174.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -116.85 119.85 36.67 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.24 -1.022 . . . . 64.32 108.24 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 5.5 mt -75.79 121.17 27.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.061 -1.088 . . . . 75.11 108.061 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . 0.684 ' HB2' HG23 ' D' ' 83' ' ' ILE . 10.8 mm-40 -84.9 -30.04 24.7 Favored 'General case' 0 C--O 1.242 0.674 0 O-C-N 123.802 0.688 . . . . 71.3 110.462 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -174.63 131.42 0.35 Allowed 'General case' 0 C--N 1.364 1.222 0 O-C-N 123.415 0.447 . . . . 72.2 111.149 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.412 ' N ' HD12 ' D' ' 16' ' ' ILE . 3.5 mp -108.18 135.24 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.423 -1.325 . . . . 73.04 107.423 172.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -165.84 170.57 13.71 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.744 0.783 . . . . 71.04 111.89 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -101.46 124.31 46.93 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.406 -1.27 . . . . 63.43 109.357 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.461 ' HD2' ' HA3' ' D' ' 81' ' ' GLY . 28.3 mtpt -95.28 -28.92 14.76 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.735 -0.839 . . . . 71.33 108.735 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.607 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 7.9 t70 -146.1 135.09 22.59 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 113.997 -1.456 . . . . 63.13 108.915 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.52 HG21 ' HE2' ' C' ' 117' ' ' MET . 61.9 mt -136.5 138.99 45.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.937 -1.134 . . . . 72.43 107.937 170.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.9 t -141.44 140.81 33.68 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.233 1.013 . . . . 73.34 108.52 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.49 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.2 t80 -144.71 130.44 19.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 106.059 -1.83 . . . . 73.31 106.059 168.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -134.28 138.03 44.71 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.51 -0.922 . . . . 63.24 108.51 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.421 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -144.14 78.12 13.94 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 107.718 -1.216 . . . . 74.24 107.718 174.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.37 -28.98 9.88 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.803 2.335 . . . . 72.42 112.688 -173.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -101.18 3.64 41.25 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.857 0.863 . . . . 74.51 110.692 -176.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.481 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -33.06 -64.07 0.26 Allowed Pre-proline 0 CA--C 1.566 1.56 0 N-CA-C 116.46 2.022 . . . . 74.32 116.46 -164.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.451 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 73.3 Cg_endo -74.39 -29.12 9.69 Favored 'Trans proline' 0 C--N 1.389 2.68 0 CA-C-N 123.503 2.287 . . . . 71.51 113.311 -178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -65.53 -39.73 92.1 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.649 1.18 . . . . 74.35 109.68 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.519 HG22 HD12 ' D' ' 68' ' ' LEU . 9.8 p -85.53 -16.39 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 CA-C-N 115.423 -0.808 . . . . 70.04 111.532 -176.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.451 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 17.7 m-85 -65.66 -20.92 66.48 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 118.05 0.386 . . . . 73.34 111.585 176.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -61.86 -23.22 66.14 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.7 0.8 . . . . 74.24 110.865 174.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -92.77 95.57 9.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.723 1.209 . . . . 62.44 110.219 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -94.3 94.86 8.54 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.551 0.74 . . . . 74.34 110.153 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -161.84 179.32 8.16 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.686 0.794 . . . . 72.34 110.164 166.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -58.07 111.48 3.59 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.563 1.145 . . . . 72.4 110.031 173.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.419 ' O ' HG23 ' D' ' 40' ' ' VAL . 51.3 Cg_exo -55.6 125.4 18.99 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.205 1.936 . . . . 72.55 110.288 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -72.29 107.33 4.84 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.32 -1.363 . . . . 74.3 107.32 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.879 HG13 HG13 ' D' ' 64' ' ' VAL . 87.5 t -113.1 103.14 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 123.308 0.38 . . . . 73.14 110.08 -168.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -87.16 119.25 27.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.796 -1.187 . . . . 71.23 107.796 172.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.794 HD22 HD11 ' D' ' 128' ' ' LEU . 57.0 tp -92.82 148.01 22.38 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.333 -0.988 . . . . 75.23 108.333 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.5 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 27.6 t70 -144.76 111.96 6.0 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.388 -1.338 . . . . 70.44 107.388 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' D' ' 62' ' ' VAL . 85.2 mt -108.11 131.83 54.21 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.062 0.545 . . . . 74.31 110.073 -173.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -132.15 133.92 44.82 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.89 -1.522 . . . . 75.02 106.89 173.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.8 t -139.24 141.79 37.85 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.833 0.825 . . . . 72.31 110.009 176.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.8 161.82 41.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.391 -1.277 . . . . 64.54 107.738 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 34.0 p . . . . . 0 C--N 1.322 -0.617 0 N-CA-C 109.287 -0.634 . . . . 73.04 109.287 177.755 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.506 2.333 0 N-CA-C 114.232 1.197 . . . . 42.04 114.232 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.539 ' HB ' HD11 ' D' ' 83' ' ' ILE . 23.3 m -130.97 129.09 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 107.262 -1.384 . . . . 61.32 107.262 173.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -141.81 130.09 22.29 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.822 -0.807 . . . . 72.33 108.822 -171.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -87.77 109.98 20.13 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.409 -0.96 . . . . 75.33 108.409 173.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.507 HG11 ' HD3' ' D' ' 103' ' ' PRO . 67.3 t -99.08 120.16 48.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 107.443 -1.317 . . . . 73.15 107.443 175.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.457 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.5 t -107.41 134.76 48.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.606 -0.887 . . . . 75.15 108.606 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.54 116.09 26.98 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.997 -0.742 . . . . 72.14 108.997 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -97.76 96.97 8.6 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.252 1.021 . . . . 70.23 109.051 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.603 HG13 HD11 ' D' ' 42' ' ' LEU . 57.7 t -94.73 109.14 21.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 108.523 -0.918 . . . . 60.01 108.523 175.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 40.6 m -106.11 132.18 52.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.957 -1.019 . . . . 63.52 109.065 -176.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.879 HG13 HG13 ' D' ' 40' ' ' VAL . 86.6 t -120.39 127.61 75.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.032 -0.729 . . . . 45.54 109.032 177.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 14.7 m -117.61 93.37 4.13 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.306 -1.368 . . . . 73.13 107.306 169.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.566 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -102.06 134.94 44.48 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.438 -0.579 . . . . 72.2 109.438 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.534 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 50.2 m -144.5 139.28 28.15 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 115.749 -0.66 . . . . 71.22 110.532 -171.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.519 HD12 HG22 ' D' ' 31' ' ' VAL . 21.1 mt -109.88 110.51 21.49 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.081 -1.451 . . . . 71.22 107.081 172.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.88 -147.34 38.08 Favored Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.956 -0.458 . . . . 73.34 111.956 -175.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.75 4.22 22.79 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.088 0.555 . . . . 42.41 112.357 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -119.63 161.95 19.79 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.399 0.68 . . . . 72.4 109.995 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.8 m -71.97 137.8 47.57 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.245 -0.889 . . . . 72.21 111.106 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.534 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -89.14 -65.8 0.98 Allowed 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.114 -1.439 . . . . 73.22 107.114 170.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -153.8 143.37 21.68 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.646 -1.161 . . . . 71.42 109.967 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 63.2 mt -101.53 149.24 24.3 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.047 -1.094 . . . . 75.43 108.047 167.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.574 ' SG ' HG23 ' D' ' 114' ' ' ILE . 35.3 t -158.92 118.91 3.14 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 117.724 0.238 . . . . 74.3 110.373 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -140.77 122.03 14.85 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.776 0.43 . . . . 63.14 110.035 -174.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 92.7 t -127.71 117.17 45.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 123.951 0.9 . . . . 74.12 109.488 -175.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.607 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.8 mt-30 -90.09 90.48 8.14 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.133 -0.691 . . . . 74.51 109.133 171.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -80.72 99.53 8.26 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.669 -1.151 . . . . 64.34 108.709 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.461 ' HA3' ' HD2' ' D' ' 19' ' ' LYS . . . -92.44 143.3 16.44 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 112.193 -0.363 . . . . 42.31 112.193 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.58 130.83 4.08 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 111.822 -0.511 . . . . 53.12 111.822 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.684 HG23 ' HB2' ' D' ' 14' ' ' GLN . 5.2 tp -91.22 114.43 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.554 -0.906 . . . . 71.25 108.554 174.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -111.0 130.22 55.65 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.143 0.977 . . . . 73.34 110.291 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 10.8 t -94.6 100.79 12.68 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 109.02 -0.733 . . . . 74.32 109.02 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.513 HG21 HD21 ' D' ' 98' ' ' LEU . 3.6 tt -117.73 133.61 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.611 1.165 . . . . 70.11 109.552 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.93 169.6 11.25 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.921 0.888 . . . . 64.32 110.502 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.91 21.54 55.35 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 115.88 -0.6 . . . . 61.3 113.974 174.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.34 168.51 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.809 0.843 . . . . 72.24 110.978 175.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.21 -168.43 3.1 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.68 1.192 . . . . 75.53 109.744 177.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.7 -139.4 22.89 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-N 116.156 -0.474 . . . . 73.11 112.794 174.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 11.7 m -80.23 -39.35 29.22 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.248 0.619 . . . . 75.41 109.756 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -58.16 -36.28 72.78 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.384 1.074 . . . . 70.24 112.68 -173.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.406 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 0.0 OUTLIER -60.03 -48.56 81.22 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 112.807 0.669 . . . . 74.23 112.807 -172.243 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . 0.406 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.91 -26.05 25.79 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.833 0.453 . . . . 64.54 111.754 177.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -63.01 -34.25 77.15 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.587 0.755 . . . . 74.12 110.061 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 82.4 m -59.43 -50.41 74.03 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.055 0.542 . . . . 63.14 111.071 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.645 HD23 ' SG ' ' D' ' 102' ' ' CYS . 93.2 mt -69.5 -27.53 65.28 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.961 0.504 . . . . 74.14 111.95 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.82 3.71 71.16 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.488 -0.618 . . . . 54.2 113.829 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.83 -63.36 0.17 Allowed 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 117.695 0.748 . . . . 72.01 112.403 -175.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . 0.442 ' O ' HG12 ' D' ' 105' ' ' ILE . 71.1 t80 -69.01 -39.4 79.31 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.177 0.436 . . . . 75.12 112.177 -172.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.645 ' SG ' HD23 ' D' ' 98' ' ' LEU . 50.5 m -69.61 -47.07 25.85 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 123.712 0.805 . . . . 74.15 111.477 -176.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.507 ' HD3' HG11 ' D' ' 58' ' ' VAL . 28.1 Cg_endo -64.1 -26.78 65.31 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 121.421 1.414 . . . . 54.34 112.638 170.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -66.92 -31.2 71.64 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.741 0.416 . . . . 72.42 110.94 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.442 HG12 ' O ' ' D' ' 101' ' ' TYR . 41.9 mm -68.74 -39.76 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.006 0.923 . . . . 75.55 110.51 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' D' ' 103' ' ' PRO . 42.5 mt -74.31 -22.6 59.18 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.534 -0.757 . . . . 71.11 111.573 -175.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -65.28 -41.45 52.04 Favored Pre-proline 0 CA--C 1.562 1.431 0 N-CA-C 114.095 1.146 . . . . 74.42 114.095 -172.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -47.26 -48.31 15.29 Favored 'Trans proline' 0 C--N 1.389 2.669 0 C-N-CA 122.466 2.111 . . . . 73.3 113.649 169.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -73.53 -38.15 65.37 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.93 0.892 . . . . 70.51 111.26 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.39 -44.04 79.86 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.577 -0.738 . . . . 74.31 110.794 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 28.3 ttp180 -59.91 -49.01 79.39 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.21 0.944 . . . . 73.23 110.33 174.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -59.83 -46.0 90.62 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.142 0.901 . . . . 75.02 110.697 -175.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.4 ' O ' ' HG3' ' D' ' 117' ' ' MET . 42.5 t -55.04 -45.67 75.24 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 124.343 1.027 . . . . 45.1 110.309 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.574 HG23 ' SG ' ' D' ' 76' ' ' CYS . 72.4 mt -61.25 -60.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 124.067 0.854 . . . . 74.35 110.851 175.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 37.7 m -52.5 -42.77 64.57 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.032 1.333 . . . . 62.45 111.786 -172.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 33.1 t -65.72 -43.6 88.61 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.465 -1.243 . . . . 60.12 109.823 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 72.2 mtm -68.77 -28.07 66.46 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.059 0.544 . . . . 73.13 111.964 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.465 HG23 ' O ' ' D' ' 114' ' ' ILE . 92.6 t -67.23 -46.34 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.597 0.759 . . . . 73.42 109.566 176.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.7 p -73.13 -29.71 63.08 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.618 -0.719 . . . . 63.42 110.448 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 66.7 mtt-85 -69.54 -30.75 68.65 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 123.595 0.758 . . . . 71.53 109.557 172.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.65 7.23 81.75 Favored Glycine 0 C--N 1.357 1.71 0 C-N-CA 123.536 0.588 . . . . 61.11 113.0 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.511 HG23 ' HB3' ' C' ' 17' ' ' TYR . 66.4 p 55.37 38.92 31.01 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 126.402 1.881 . . . . 64.35 114.268 176.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -99.88 158.46 32.03 Favored Pre-proline 0 C--O 1.243 0.747 0 C-N-CA 123.427 0.691 . . . . 71.15 109.249 170.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_exo -48.72 125.19 12.28 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.7 2.267 . . . . 73.25 112.156 168.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -47.28 126.69 9.79 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.826 1.329 . . . . 63.32 112.495 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.679 HD13 HG21 ' D' ' 40' ' ' VAL . 17.5 tp -107.21 97.75 7.48 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.9 0.88 . . . . 74.21 109.058 -176.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -99.35 99.0 9.87 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.608 -1.256 . . . . 72.13 107.608 173.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.794 HD11 HD22 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -68.47 120.24 14.22 Favored 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 108.259 -1.015 . . . . 60.02 108.259 -179.445 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.49 141.7 94.45 Favored Pre-proline 0 CA--C 1.562 1.413 0 C-N-CA 123.535 0.734 . . . . 72.52 110.914 -177.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -57.74 132.61 51.07 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 123.091 2.527 . . . . 72.44 113.388 -174.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 96.1 t -107.44 123.43 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 108.415 -0.957 . . . . 73.1 108.415 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -86.9 91.93 8.84 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.044 -1.095 . . . . 41.02 108.044 173.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 . . . . . 0 N--CA 1.484 1.275 0 C-N-CA 124.397 1.079 . . . . 75.5 111.796 -174.349 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 25.8 m . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 108.159 -1.052 . . . . 74.22 108.159 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -137.24 119.04 15.13 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.09 -1.078 . . . . 64.41 108.09 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -134.78 132.21 38.44 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.646 -0.872 . . . . 61.03 108.646 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.517 ' CD1' HG21 ' A' ' 105' ' ' ILE . 4.9 mt -94.33 113.36 28.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.645 -0.872 . . . . 73.21 108.645 175.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -78.43 -40.26 36.34 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 123.375 0.422 . . . . 75.1 110.006 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -170.68 124.7 0.68 Allowed 'General case' 0 C--N 1.354 0.799 0 CA-C-N 115.946 -0.57 . . . . 74.12 111.042 -173.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.412 HD12 ' HG3' ' C' ' 130' ' ' PRO . 81.2 mt -106.97 140.28 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 107.944 -1.132 . . . . 64.11 107.944 167.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.521 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 31.7 p90 -164.92 166.25 19.66 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.306 0.574 . . . . 64.53 111.366 -174.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -94.27 122.06 36.42 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 109.484 -0.562 . . . . 54.54 109.484 172.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.455 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 43.0 mtpt -80.11 -35.08 37.33 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.211 -0.662 . . . . 72.14 109.211 174.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -149.93 137.95 20.3 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.277 -1.329 . . . . 65.13 109.826 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.547 HG21 ' SD ' ' B' ' 117' ' ' MET . 73.1 mt -134.99 143.82 36.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 125.317 1.447 . . . . 74.35 108.008 178.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.9 t -156.71 119.93 4.16 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 123.524 0.515 . . . . 61.33 110.593 170.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.628 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.8 t80 -111.5 143.41 42.38 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.019 -1.475 . . . . 74.15 107.019 165.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -139.66 141.31 37.03 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.703 0.401 . . . . 72.12 110.669 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.19 69.92 13.01 Favored Pre-proline 0 C--O 1.242 0.692 0 N-CA-C 107.181 -1.415 . . . . 64.3 107.181 170.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.35 -8.21 19.48 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.448 2.099 . . . . 61.23 112.303 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -114.72 17.52 17.08 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 124.311 1.044 . . . . 62.44 109.246 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.517 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -46.24 -54.31 18.4 Favored Pre-proline 0 CA--C 1.567 1.607 0 CA-C-O 118.006 -0.997 . . . . 75.2 113.667 -169.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -61.81 -24.02 76.8 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 122.016 1.81 . . . . 73.01 113.542 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -84.84 -44.86 12.86 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.757 0.823 . . . . 72.41 111.017 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.927 HG21 ' HA ' ' A' ' 73' ' ' ALA . 8.6 p -77.03 -21.71 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 115.346 -0.843 . . . . 74.25 112.815 -161.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -66.96 -17.24 64.82 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 116.151 -0.477 . . . . 73.21 111.471 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -91.87 -14.46 29.65 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.551 1.14 . . . . 52.51 110.87 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.496 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 19.0 mmtp -79.54 160.31 26.53 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.21 0.604 . . . . 70.33 111.549 -176.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -69.59 131.24 44.35 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.896 0.879 . . . . 72.43 109.152 173.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.496 ' CE3' HD21 ' A' ' 68' ' ' LEU . 68.6 t-105 -81.6 81.07 7.8 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.494 0.664 . . . . 72.54 110.042 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -129.08 77.76 77.31 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.552 1.141 . . . . 72.03 108.035 172.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -85.96 145.22 8.71 Favored 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.669 2.246 . . . . 62.15 113.192 -173.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -101.31 84.97 2.71 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.826 -1.176 . . . . 71.41 107.826 164.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.679 HG11 HD11 ' A' ' 126' ' ' LEU . 77.7 t -81.65 96.96 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 108.419 -0.956 . . . . 61.44 108.419 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -95.96 123.3 39.5 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.347 -0.612 . . . . 74.43 109.347 177.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mp -97.91 107.05 19.45 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.504 -1.295 . . . . 65.44 107.504 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -111.58 119.16 37.79 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.469 -0.937 . . . . 54.31 108.469 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.498 HD22 HD21 ' A' ' 60' ' ' LEU . 89.0 mt -112.17 139.4 47.74 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.441 0.696 . . . . 73.1 111.805 -169.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.482 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 19.4 t70 -132.29 144.09 50.35 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.78 1.232 . . . . 41.54 108.536 176.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.4 m -141.35 135.19 30.23 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.495 0.718 . . . . 72.55 109.434 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.6 123.78 10.83 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.633 0.773 . . . . 63.42 109.483 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.419 ' HB3' ' HB3' ' A' ' 98' ' ' LEU . 78.9 p -97.54 162.39 13.33 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.445 0.698 . . . . 50.14 110.27 175.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.0 t -158.56 155.59 28.62 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.299 1.04 . . . . 72.25 108.53 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -102.53 115.96 31.63 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.296 -0.631 . . . . 70.24 109.296 175.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.634 HD11 ' HB2' ' A' ' 57' ' ' GLU . 56.6 mt -82.52 -40.83 20.48 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.494 0.718 . . . . 64.14 110.257 176.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.41 -174.57 5.0 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.251 -0.886 . . . . 65.11 110.713 -176.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -59.65 115.84 3.61 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.796 0.838 . . . . 72.15 110.135 176.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 71.74 -6.16 1.5 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.907 1.283 . . . . 74.44 112.843 -177.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.6 t -98.76 115.65 39.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.718 -0.845 . . . . 63.43 108.718 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -126.01 125.08 42.08 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.161 0.984 . . . . 61.52 109.061 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.634 ' HB2' HD11 ' A' ' 51' ' ' LEU . 33.2 tt0 -92.05 123.33 35.33 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.483 -0.562 . . . . 63.11 109.483 171.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.8 t -107.28 136.03 43.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.405 -0.961 . . . . 64.22 108.405 168.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.7 t -120.18 130.33 74.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.191 -1.04 . . . . 71.42 108.191 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.498 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -107.07 105.03 14.85 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.411 -1.7 . . . . 71.44 106.411 175.188 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.482 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 31.6 ttp180 -92.51 100.49 13.03 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.216 -1.402 . . . . 74.4 107.216 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.2 t -96.15 127.05 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 108.182 -1.044 . . . . 62.54 108.182 176.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.1 m -123.86 118.56 27.39 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.598 -0.89 . . . . 74.51 108.598 174.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.597 HG11 HD21 ' A' ' 126' ' ' LEU . 71.9 t -120.52 132.4 70.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 107.914 -1.143 . . . . 64.3 107.914 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 m -137.2 132.43 33.87 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.583 -0.895 . . . . 71.32 108.583 174.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.561 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -114.31 114.95 26.62 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.541 1.137 . . . . 62.42 108.142 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 71.2 m -120.81 134.98 55.27 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.401 0.619 . . . . 74.42 111.146 178.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.496 HD21 ' CE3' ' A' ' 36' ' ' TRP . 42.0 mt -94.91 42.27 1.09 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.402 1.481 . . . . 74.41 111.111 -176.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.61 -84.87 1.51 Allowed Glycine 0 C--N 1.339 0.698 0 CA-C-O 119.749 -0.473 . . . . 33.1 112.164 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -86.56 -30.66 21.71 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.211 0.529 . . . . 73.11 111.353 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.449 ' HB2' ' NZ ' ' A' ' 34' ' ' LYS . 4.6 tp10 -119.96 133.64 55.49 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.62 -0.881 . . . . 42.44 108.62 -174.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 73.7 m -77.71 134.37 38.13 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.111 -0.7 . . . . 64.31 109.111 170.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.927 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -71.83 -64.59 0.9 Allowed 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.507 0.723 . . . . 74.21 109.45 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -159.57 166.72 30.18 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.253 -0.885 . . . . 75.0 112.039 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.7 tp -117.92 143.11 46.62 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.571 -1.195 . . . . 64.43 108.693 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.446 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 79.1 m -143.07 104.53 4.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.131 0.973 . . . . 75.4 109.622 175.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -123.1 127.69 49.07 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.539 0.736 . . . . 74.21 109.017 177.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.3 t -137.55 112.75 10.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 124.352 1.061 . . . . 62.21 109.094 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -86.21 85.65 7.34 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.781 -0.822 . . . . 65.22 108.781 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -78.37 96.26 5.29 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.948 -1.024 . . . . 64.42 110.31 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.14 155.74 30.23 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 111.724 -0.551 . . . . 73.11 111.724 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.508 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -151.51 122.3 1.33 Allowed Glycine 0 C--N 1.329 0.164 0 N-CA-C 111.703 -0.559 . . . . 62.41 111.703 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.9 mt -81.17 117.63 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.941 0.896 . . . . 71.23 108.665 171.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.695 ' HB3' HD11 ' A' ' 86' ' ' ILE . 90.8 m-85 -124.27 122.26 37.26 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.489 1.116 . . . . 62.34 109.491 -177.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.1 t -91.77 105.39 17.68 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.239 -0.652 . . . . 75.11 109.239 173.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.695 HD11 ' HB3' ' A' ' 84' ' ' PHE . 1.9 mm -112.38 153.78 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.489 0.715 . . . . 72.5 109.43 -177.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.426 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -158.23 160.61 37.31 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.557 0.743 . . . . 73.24 111.235 177.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.1 -7.62 64.58 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 119.184 -0.787 . . . . 73.44 113.928 174.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.06 153.37 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 124.056 0.942 . . . . 73.55 111.695 -178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -141.84 178.25 7.63 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.01 1.724 . . . . 63.55 108.625 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.47 -139.78 29.62 Favored Glycine 0 C--N 1.349 1.26 0 N-CA-C 114.063 0.385 . . . . 73.43 114.063 173.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.2 t -72.4 -19.38 61.61 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.258 0.623 . . . . 64.44 111.439 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -70.78 -43.82 67.94 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.992 0.917 . . . . 72.21 109.576 173.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.8 tpt -63.82 -42.31 97.69 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.085 -0.961 . . . . 72.12 109.849 174.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.3 -33.75 76.2 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.449 -0.796 . . . . 62.41 111.344 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.463 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 53.0 t-80 -71.1 -27.02 63.3 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.169 0.588 . . . . 61.21 111.193 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -78.6 -52.79 7.95 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.823 -0.436 . . . . 72.3 109.823 175.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 48' ' ' SER . 89.6 mt -72.98 -35.24 66.84 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.789 0.835 . . . . 55.31 112.773 -171.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.08 4.0 60.55 Favored Glycine 0 N--CA 1.469 0.842 0 CA-C-N 115.97 -0.559 . . . . 64.31 113.674 -172.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.561 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -146.51 -58.45 0.29 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 117.31 0.555 . . . . 53.42 112.19 -173.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.409 ' O ' HG12 ' A' ' 105' ' ' ILE . 41.6 t80 -71.83 -42.28 67.15 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.046 0.451 . . . . 74.04 110.742 -176.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 63.7 m -67.63 -49.43 40.03 Favored Pre-proline 0 CA--C 1.565 1.552 0 C-N-CA 124.733 1.213 . . . . 74.01 112.852 -175.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.407 ' HA ' HD12 ' A' ' 106' ' ' LEU . 47.5 Cg_endo -65.79 -24.85 53.86 Favored 'Trans proline' 0 C--N 1.395 2.982 0 C-N-CA 122.035 1.823 . . . . 74.01 112.437 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -64.91 -37.14 86.64 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.457 0.703 . . . . 74.52 110.476 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.517 HG21 ' CD1' ' A' ' 13' ' ' ILE . 49.5 mm -69.02 -40.73 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.544 0.737 . . . . 72.23 110.407 174.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.508 HD21 ' HA3' ' A' ' 82' ' ' GLY . 48.3 mt -72.74 -25.18 61.11 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.475 -0.784 . . . . 62.1 112.123 -175.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -61.68 -45.09 93.15 Favored Pre-proline 0 N--CA 1.487 1.394 0 N-CA-C 113.768 1.025 . . . . 65.33 113.768 -172.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -52.05 -37.34 68.16 Favored 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 122.51 2.14 . . . . 75.53 113.876 170.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -84.09 -29.11 27.06 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.51 0.724 . . . . 74.32 112.001 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.76 -45.19 75.61 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.554 -0.906 . . . . 75.4 108.554 172.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.558 ' NH1' HD12 ' C' ' 105' ' ' ILE . 36.5 ttm180 -59.9 -40.81 90.06 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.071 -1.422 . . . . 74.31 110.515 174.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' C' ' 108' ' ' PRO . 25.7 tt0 -51.21 -54.53 24.77 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.623 1.169 . . . . 74.43 110.813 177.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 117' ' ' MET . 48.9 t -66.17 -47.21 74.72 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.435 -1.257 . . . . 64.12 111.437 -176.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 118' ' ' VAL . 92.1 mt -58.69 -59.14 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 124.173 0.989 . . . . 73.22 110.953 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.1 m -56.82 -38.55 72.77 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.359 1.064 . . . . 74.1 111.575 -177.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.1 t -63.35 -48.82 76.39 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.892 -1.049 . . . . 61.22 110.817 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.628 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 41.2 mtm -61.46 -40.25 93.83 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.816 0.697 . . . . 71.23 111.253 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 126' ' ' LEU . 82.5 t -56.77 -49.97 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 O-C-N 124.252 0.97 . . . . 54.51 110.813 175.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.6 t -68.17 -33.51 74.59 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.234 -0.893 . . . . 65.24 111.165 -177.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.55 HH12 ' HG3' ' B' ' 112' ' ' GLU . 81.8 mtt-85 -72.61 -29.43 63.48 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.537 0.735 . . . . 73.34 110.172 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.452 ' O ' HG22 ' A' ' 122' ' ' THR . . . -86.17 16.41 43.54 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-O 118.812 -0.993 . . . . 73.02 113.375 175.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.475 HG21 ' HE ' ' B' ' 15' ' ' ARG . 3.0 t 60.47 11.65 3.09 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 126.781 2.033 . . . . 74.41 113.66 176.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -81.88 156.66 69.86 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.708 0.803 . . . . 75.44 109.911 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.21 129.29 29.41 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.503 2.136 . . . . 71.31 111.33 175.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -49.05 121.68 5.06 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 125.116 1.51 . . . . 73.43 112.213 -173.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.679 HD11 HG11 ' A' ' 40' ' ' VAL . 56.5 tp -108.78 102.11 11.18 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.922 -0.581 . . . . 72.41 109.662 -174.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -98.85 121.87 41.35 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.594 -1.262 . . . . 64.03 107.594 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 11.2 mt -72.02 129.88 39.61 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 110.082 -0.34 . . . . 74.35 110.082 -177.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -64.91 141.36 98.35 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 116.046 -0.524 . . . . 74.22 110.771 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.613 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 49.2 Cg_exo -57.7 128.74 30.37 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.284 2.656 . . . . 75.34 113.558 -176.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 85.8 t -120.58 132.3 70.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 C-N-CA 123.942 0.897 . . . . 64.45 109.824 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -96.43 95.48 8.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.752 0.821 . . . . 63.13 108.871 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -62.57 -21.09 65.33 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.941 0.897 . . . . 65.43 112.576 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.561 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 11.7 t70 -56.96 -51.03 70.81 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.55 0.74 . . . . 65.13 110.045 170.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.7 -40.49 95.22 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 124.106 0.879 . . . . 74.32 111.326 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.92 -32.07 73.47 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.463 -0.79 . . . . 73.24 111.248 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 62.6 t80 . . . . . 0 N--CA 1.469 0.522 0 CA-C-N 115.737 -0.665 . . . . 74.33 110.413 176.409 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.578 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 0.5 OUTLIER . . . . . 0 CA--C 1.563 1.461 0 CA-C-O 121.232 0.539 . . . . 74.22 112.026 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.494 ' N ' ' SD ' ' B' ' 9' ' ' MET . 78.8 m -153.22 105.93 2.93 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.181 0.992 . . . . 74.42 108.746 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -109.72 139.46 44.73 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.413 -0.958 . . . . 73.52 108.413 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -149.89 141.24 23.26 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.699 0.8 . . . . 73.12 109.272 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 19.0 mt -94.6 124.98 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 107.545 -1.28 . . . . 60.43 107.545 171.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -87.53 -48.95 7.52 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.827 -0.434 . . . . 73.03 109.827 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.475 ' HE ' HG21 ' A' ' 122' ' ' THR . 48.2 ttt180 -166.45 136.35 3.2 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.609 0.568 . . . . 62.52 109.991 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.408 HD12 HD22 ' D' ' 127' ' ' ASN . 97.7 mt -115.25 135.64 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 107.602 -1.259 . . . . 63.13 107.602 174.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -163.18 143.88 9.31 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 112.767 0.654 . . . . 60.35 112.767 -174.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 56.0 m -73.79 120.8 19.88 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.617 -1.174 . . . . 65.11 108.918 170.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.552 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.2 mtpt -98.53 -18.9 17.93 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.113 0.965 . . . . 73.31 111.897 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -166.02 144.31 5.74 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.608 0.567 . . . . 64.23 110.824 -174.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.453 ' HB ' ' H ' ' A' ' 23' ' ' PHE . 45.6 mm -139.19 140.9 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.277 1.431 . . . . 70.12 108.745 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.5 t -142.71 125.8 16.34 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.649 1.18 . . . . 62.23 108.303 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.518 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 78.1 t80 -140.35 121.27 14.54 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.573 -1.269 . . . . 74.32 107.573 169.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -130.25 121.13 25.58 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.522 -0.918 . . . . 54.32 108.522 175.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.683 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -105.46 89.31 3.2 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 106.259 -1.756 . . . . 61.14 106.259 168.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -59.43 -36.72 93.06 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.86 2.374 . . . . 62.01 111.975 -171.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -106.47 16.54 24.54 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 118.06 -0.972 . . . . 74.3 111.611 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.683 ' HB2' ' HB3' ' B' ' 25' ' ' ALA . . . -30.73 -62.12 0.24 Allowed Pre-proline 0 N--CA 1.502 2.128 0 N-CA-C 115.117 1.525 . . . . 53.31 115.117 -171.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 17.4 Cg_exo -59.5 -41.39 57.73 Favored 'Trans proline' 0 C--N 1.399 3.19 0 C-N-CA 121.951 1.767 . . . . 63.15 112.686 -173.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -96.78 -19.35 18.98 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.079 -0.964 . . . . 72.11 113.296 -169.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.543 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.6 p -74.96 -12.93 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-O 121.155 0.502 . . . . 75.03 110.735 -176.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -77.44 -5.93 51.64 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.296 0.85 . . . . 74.23 113.296 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -68.31 -21.52 64.76 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.867 0.467 . . . . 75.45 110.433 169.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -94.33 87.1 5.09 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.254 1.021 . . . . 74.04 110.533 -175.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -86.54 90.97 8.41 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.522 -0.763 . . . . 75.31 110.346 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 34.8 p90 -173.98 -172.05 0.69 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.474 1.11 . . . . 72.44 109.3 171.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -80.15 117.61 68.38 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.101 0.561 . . . . 75.32 111.099 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.525 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 19.3 Cg_endo -64.73 147.4 89.77 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 121.74 1.627 . . . . 74.11 110.496 173.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.18 102.68 0.86 Allowed 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.728 -0.841 . . . . 73.11 108.728 174.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.68 HG11 HD11 ' B' ' 126' ' ' LEU . 41.8 t -99.86 145.86 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.213 -0.903 . . . . 54.21 109.875 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -140.06 127.35 21.23 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.69 1.196 . . . . 73.33 107.853 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.541 HD13 HD22 ' B' ' 128' ' ' LEU . 25.6 tp -86.4 145.29 26.92 Favored 'General case' 0 C--O 1.244 0.811 0 O-C-N 123.81 0.694 . . . . 73.0 109.211 173.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.558 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 11.4 t70 -143.95 150.07 37.76 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.992 -1.114 . . . . 61.0 107.992 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.4 HD11 HG11 ' B' ' 131' ' ' VAL . 72.5 mt -126.9 139.89 52.74 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.635 0.774 . . . . 61.21 109.458 -175.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 29.5 t70 -132.11 151.15 51.93 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.07 0.948 . . . . 60.12 109.072 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.7 m -124.61 111.97 16.26 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.151 0.58 . . . . 71.24 110.574 -166.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.63 117.48 7.66 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 109.379 -0.6 . . . . 72.12 109.379 174.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 48.1 p -143.89 170.87 15.08 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.063 0.545 . . . . 60.4 110.08 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 64.8 p -152.04 142.55 22.66 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.422 0.289 . . . . 54.12 111.62 -173.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -96.86 94.33 7.18 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.984 -0.747 . . . . 71.3 108.984 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 pp -110.13 24.43 13.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.008 0.523 . . . . 64.44 110.611 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.469 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -164.87 172.04 13.38 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 123.717 0.807 . . . . 41.21 111.153 172.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -97.15 124.73 41.28 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 107.922 -1.14 . . . . 40.23 107.922 172.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 66.02 4.72 3.16 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 124.362 1.065 . . . . 75.4 112.917 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 44.9 t -133.73 126.47 51.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.447 0 N-CA-C 107.041 -1.466 . . . . 55.51 107.041 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -132.7 141.19 48.46 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.794 -0.447 . . . . 74.31 109.794 -168.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -106.03 105.84 16.07 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.75 -1.204 . . . . 73.02 107.75 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 38.1 t -100.54 129.53 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.431 1.093 . . . . 53.54 109.54 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 t -118.26 114.59 45.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.629 -0.878 . . . . 70.15 108.629 173.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -100.71 108.58 20.48 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.72 -1.215 . . . . 71.34 107.72 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.417 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 31.5 ttm180 -85.98 119.7 26.57 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.288 -1.004 . . . . 70.11 108.288 173.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 31.4 t -105.18 123.94 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.92 -1.141 . . . . 75.32 107.92 175.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.558 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 45.2 m -111.02 136.78 49.51 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.89 -0.781 . . . . 73.43 108.89 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.677 HG11 HD21 ' B' ' 126' ' ' LEU . 59.4 t -129.44 114.87 32.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 124.054 0.942 . . . . 75.45 108.58 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 32.7 m -100.89 135.36 42.47 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.521 -0.918 . . . . 74.53 108.521 170.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.36 141.93 30.04 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.21 -0.663 . . . . 55.13 109.21 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.536 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 55.2 p -142.52 127.8 18.75 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 123.921 0.763 . . . . 63.23 111.324 -175.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 17.5 mt -92.93 111.79 23.52 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.056 0.943 . . . . 74.52 108.61 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.75 -123.51 19.22 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 124.054 0.846 . . . . 63.0 112.214 -175.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -97.41 3.23 51.0 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.311 0.644 . . . . 74.32 112.241 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -128.72 158.36 38.82 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.519 0.728 . . . . 72.21 110.063 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 41.8 m -70.02 135.33 49.21 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.03 0.532 . . . . 63.01 111.041 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.543 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -87.03 -62.26 1.54 Allowed 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.78 -1.192 . . . . 73.41 107.78 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -152.23 157.04 40.88 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.161 -1.382 . . . . 73.22 110.166 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 85.5 mt -127.73 110.48 12.68 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.216 -1.772 . . . . 61.21 106.216 173.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.469 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 36.7 t -119.98 137.41 54.09 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.686 -0.857 . . . . 61.22 108.686 -177.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -153.96 136.58 15.17 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.819 -0.808 . . . . 74.12 108.819 -173.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.421 HG21 ' HB3' ' B' ' 113' ' ' CYS . 91.1 t -133.6 148.31 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.291 -1.003 . . . . 72.51 108.291 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -121.42 100.52 7.07 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 108.186 -1.042 . . . . 73.42 108.186 172.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.432 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 8.0 tp-100 -93.29 104.18 16.37 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.53 -0.915 . . . . 72.42 108.53 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.552 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -93.43 163.56 26.36 Favored Glycine 0 C--O 1.24 0.49 0 CA-C-N 115.496 -0.775 . . . . 52.32 111.681 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.13 132.67 2.67 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.617 -0.325 . . . . 74.1 112.555 -176.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 45.0 mt -91.82 123.01 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 N-CA-C 107.745 -1.205 . . . . 64.34 107.745 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -129.82 135.56 48.55 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.736 0.814 . . . . 75.34 109.935 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 58.7 m -100.42 128.25 46.53 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.76 0.824 . . . . 35.12 109.71 174.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.447 ' HB ' HD11 ' B' ' 89' ' ' ILE . 1.4 pp -140.77 135.31 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 124.582 1.153 . . . . 73.34 111.029 -173.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.13 168.0 26.7 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.203 1.001 . . . . 70.24 109.557 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 91.36 -36.05 3.75 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 116.242 -0.435 . . . . 74.34 112.874 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.599 ' HB ' ' HA ' ' B' ' 94' ' ' MET . 9.0 pt -66.67 149.46 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.275 1.43 . . . . 74.24 111.81 175.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -147.45 162.02 39.88 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 124.351 1.06 . . . . 71.53 110.114 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.49 -136.04 27.66 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-N 114.432 -1.258 . . . . 72.41 113.985 175.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.9 m -66.04 -48.54 70.74 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.78 0.832 . . . . 61.3 109.759 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -60.25 -25.6 65.81 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 113.882 -1.508 . . . . 73.3 112.059 -171.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.599 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 2.0 tmt? -59.78 -69.97 0.19 Allowed 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.349 1.06 . . . . 65.42 112.163 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . 0.442 ' HB2' ' SD ' ' B' ' 94' ' ' MET . . . -80.38 -13.57 59.04 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 122.374 0.27 . . . . 61.14 111.584 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.89 -44.74 78.49 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.21 0.604 . . . . 70.03 109.591 167.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 44.4 t -57.46 -29.09 63.93 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.814 0.845 . . . . 53.55 111.965 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 71.6 mt -72.1 -40.06 68.45 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.991 0.916 . . . . 73.2 111.494 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.39 4.08 54.48 Favored Glycine 0 C--N 1.341 0.812 0 CA-C-N 116.068 -0.515 . . . . 74.33 113.768 -176.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.3 -65.4 0.98 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.385 0.674 . . . . 40.44 111.218 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -74.52 -45.13 47.78 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.955 -0.566 . . . . 74.33 111.354 -172.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.448 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 79.2 m -62.66 -47.46 87.94 Favored Pre-proline 0 CA--C 1.57 1.729 0 CA-C-O 118.519 -0.753 . . . . 74.43 112.228 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.448 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 76.1 Cg_exo -57.21 -33.37 95.84 Favored 'Trans proline' 0 C--N 1.398 3.172 0 C-N-CA 122.935 2.423 . . . . 72.32 113.705 171.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -67.47 -31.01 70.87 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.225 0.61 . . . . 72.13 111.243 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.0 mt -71.62 -40.18 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.596 0.758 . . . . 71.32 110.036 173.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 83.9 mt -77.46 -30.46 53.25 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.318 -0.855 . . . . 63.11 112.023 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -58.11 -44.67 99.48 Favored Pre-proline 0 CA--C 1.561 1.374 0 C-N-CA 124.394 1.078 . . . . 74.35 113.333 -172.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -50.21 -46.73 27.2 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 122.863 2.375 . . . . 52.24 114.491 173.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -65.78 -40.73 92.28 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.202 0.601 . . . . 52.32 110.796 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.432 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -66.07 -40.65 91.06 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.159 -0.928 . . . . 70.12 111.139 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -61.22 -51.54 68.54 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.117 1.367 . . . . 73.34 110.231 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.55 ' HG3' HH12 ' A' ' 120' ' ' ARG . 9.2 tp10 -61.8 -39.0 90.18 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.249 1.02 . . . . 72.11 110.396 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.521 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.1 t -68.72 -32.87 72.97 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.067 0.147 . . . . 55.41 110.764 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.469 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 50.9 mt -66.81 -53.02 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.832 0.853 . . . . 74.44 110.025 173.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.483 HG21 ' OG ' ' C' ' 119' ' ' SER . 15.3 m -59.31 -30.91 68.69 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.794 0.684 . . . . 41.33 111.027 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.497 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.1 t -64.31 -50.19 68.8 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.068 0.947 . . . . 74.2 110.174 175.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.547 ' SD ' HG21 ' A' ' 21' ' ' ILE . 33.5 mmt -62.9 -40.34 97.26 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.933 0.493 . . . . 72.24 110.889 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.41 HG23 ' O ' ' B' ' 114' ' ' ILE . 88.0 t -65.17 -39.67 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.728 1.211 . . . . 62.12 110.786 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 36.1 t -65.89 -36.19 82.73 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.156 -0.929 . . . . 70.22 111.032 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.497 ' HG3' ' O ' ' B' ' 116' ' ' SER . 71.3 mtt-85 -70.46 -37.86 74.37 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 115.646 -0.706 . . . . 72.51 109.945 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.77 -13.65 69.22 Favored Glycine 0 C--N 1.357 1.737 0 O-C-N 123.651 0.594 . . . . 73.44 112.765 171.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 13.4 m 67.35 32.26 5.98 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.644 1.578 . . . . 72.21 110.218 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -81.06 167.95 28.48 Favored Pre-proline 0 CA--C 1.558 1.252 0 CA-C-N 114.631 -1.168 . . . . 72.13 110.0 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -60.18 168.78 5.7 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 122.792 2.328 . . . . 70.51 113.519 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.605 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 59.9 tp60 -64.8 112.63 3.33 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 114.895 -1.048 . . . . 72.14 110.666 -174.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.68 HD11 HG11 ' B' ' 40' ' ' VAL . 23.5 tp -111.23 111.33 22.32 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 123.689 0.618 . . . . 74.42 109.353 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -123.47 134.08 53.96 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 107.895 -1.15 . . . . 72.11 107.895 170.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.541 HD22 HD13 ' B' ' 42' ' ' LEU . 74.7 mt -85.86 149.26 25.36 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 122.656 0.383 . . . . 74.51 111.251 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -67.02 138.38 94.98 Favored Pre-proline 0 CA--C 1.55 0.954 0 O-C-N 124.447 1.092 . . . . 54.01 110.343 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' B' ' 129' ' ' ALA . 11.5 Cg_exo -68.19 99.37 0.58 Allowed 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.774 2.316 . . . . 72.3 111.122 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.4 HG11 HD11 ' B' ' 44' ' ' LEU . 60.8 t -89.2 110.54 21.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.188 -1.042 . . . . 65.03 108.188 176.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 . . . . . 0 C--O 1.243 0.721 0 N-CA-C 108.389 -0.967 . . . . 75.25 108.389 174.914 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.613 ' HD2' ' HG2' ' A' ' 130' ' ' PRO . 37.1 t80 . . . . . 0 C--O 1.239 0.505 0 N-CA-C 108.212 -1.033 . . . . 71.13 108.212 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -150.73 121.05 7.31 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.431 -0.951 . . . . 75.3 108.431 177.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.422 ' CD1' HG21 ' C' ' 105' ' ' ILE . 30.2 mt -67.79 127.6 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 123.963 0.789 . . . . 72.13 108.905 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -93.69 -37.75 11.67 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 123.506 0.504 . . . . 74.43 109.902 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 178.45 155.54 0.41 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.038 1.335 . . . . 72.33 109.134 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.434 ' HA ' ' HA2' ' C' ' 82' ' ' GLY . 2.8 pp -127.5 152.97 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 107.656 -1.239 . . . . 73.3 107.656 171.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.536 ' HE1' HG12 ' C' ' 83' ' ' ILE . 31.4 p90 -170.36 144.74 2.56 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 110.135 -0.32 . . . . 62.24 110.135 -174.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 66.2 p -73.08 111.77 8.5 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.976 0.51 . . . . 73.45 109.899 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.716 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 11.2 mmmm -66.91 -37.06 83.65 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.899 -0.778 . . . . 65.15 108.899 170.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.6 t70 -148.33 145.42 28.12 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.4 -1.273 . . . . 73.24 110.192 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.533 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.1 mt -136.89 144.15 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.722 1.609 . . . . 75.5 106.785 172.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.4 t -155.6 148.66 24.53 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.994 0.426 . . . . 55.51 110.337 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -151.4 127.72 10.61 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 107.255 -1.387 . . . . 63.01 107.255 173.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -135.49 112.24 10.12 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.065 0.546 . . . . 71.03 110.08 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.61 82.69 20.26 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 106.753 -1.573 . . . . 72.21 106.753 161.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.87 -25.94 32.43 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 122.626 2.217 . . . . 53.41 111.601 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -96.03 23.99 5.97 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.657 1.183 . . . . 72.22 109.618 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.2 -58.4 4.99 Favored Pre-proline 0 C--N 1.374 1.634 0 C-N-CA 124.999 1.32 . . . . 65.55 114.539 -163.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -61.57 -42.64 31.74 Favored 'Trans proline' 0 C--N 1.386 2.532 0 CA-C-N 121.362 1.522 . . . . 71.2 111.856 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -69.92 -34.39 73.41 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 114.89 -1.05 . . . . 75.25 112.541 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.553 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.9 p -79.98 -27.67 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.189 0.441 . . . . 74.15 112.189 -175.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -67.88 -34.06 75.93 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.011 0.434 . . . . 72.52 111.197 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -87.31 6.71 32.12 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.852 0.861 . . . . 73.02 111.743 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -85.99 154.93 21.1 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.579 0.752 . . . . 74.54 111.199 -175.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -60.8 115.85 3.99 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.286 1.034 . . . . 61.12 109.929 172.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -84.36 82.79 8.23 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.984 0.914 . . . . 73.43 110.787 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -133.82 78.91 59.52 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 107.398 -1.334 . . . . 44.42 107.398 168.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -92.7 135.24 1.3 Allowed 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 123.243 2.629 . . . . 70.21 113.351 -175.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . 0.405 ' HB3' ' HE3' ' C' ' 41' ' ' LYS . 4.4 mp0 -85.64 96.89 9.82 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.981 -1.489 . . . . 72.32 106.981 169.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' C' ' 65' ' ' THR . 94.3 t -90.48 106.38 17.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 115.71 -0.677 . . . . 74.12 110.316 -175.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' C' ' 39' ' ' GLU . 0.2 OUTLIER -95.08 105.04 16.93 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.172 -1.047 . . . . 62.42 108.172 173.039 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.501 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.5 pt? -86.47 124.11 32.43 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 107.344 -1.354 . . . . 72.12 107.344 171.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.426 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 21.5 t70 -118.01 140.84 49.16 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.846 -0.798 . . . . 73.2 108.846 -176.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.643 HD11 HG11 ' C' ' 131' ' ' VAL . 51.2 mt -127.38 113.32 16.08 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.02 0.928 . . . . 74.01 109.489 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -122.48 121.3 36.24 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.266 -1.383 . . . . 64.21 107.266 174.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 6.5 t -117.17 137.03 52.6 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.058 0.456 . . . . 72.2 111.013 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.99 157.87 25.06 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.146 0.978 . . . . 71.22 108.769 175.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 60.2 p -158.58 146.35 18.07 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.14 0.576 . . . . 54.01 109.978 177.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.1 p -156.07 160.29 39.85 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.012 0.925 . . . . 72.33 109.214 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -99.59 120.08 39.1 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.569 -0.901 . . . . 65.44 108.569 172.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' C' ' 57' ' ' GLU . 33.6 mt -84.42 -50.8 7.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.645 0.778 . . . . 70.41 109.809 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.58 -168.25 2.86 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.845 -1.071 . . . . 71.22 109.73 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.66 118.56 9.73 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.886 -0.597 . . . . 60.32 109.904 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 68.06 -4.91 0.94 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.995 1.318 . . . . 65.21 112.109 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.0 t -99.58 116.82 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 123.741 0.816 . . . . 73.43 109.199 -174.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -124.36 129.49 50.81 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.836 1.254 . . . . 72.22 108.7 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.577 ' HB2' HD11 ' C' ' 51' ' ' LEU . 42.0 tt0 -89.72 137.1 32.62 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 108.522 -0.918 . . . . 61.4 108.522 167.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 82.2 t -123.85 140.85 46.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 108.08 -1.082 . . . . 64.41 108.08 167.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.467 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 85.3 t -122.03 146.41 27.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 108.759 -0.83 . . . . 63.55 108.759 172.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.58 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -128.76 99.8 5.47 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.91 -1.515 . . . . 73.11 106.91 177.078 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 33.3 ttm-85 -80.85 105.54 12.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.799 -1.091 . . . . 71.43 108.322 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 26.1 t -106.08 121.16 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 108.432 -0.951 . . . . 71.55 108.432 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 14.2 m -120.15 110.46 16.65 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.678 -0.86 . . . . 61.02 108.678 -174.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.549 HG21 HG21 ' C' ' 114' ' ' ILE . 47.6 t -98.16 109.5 23.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.95 -0.759 . . . . 54.23 108.95 177.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' C' ' 40' ' ' VAL . 32.1 m -96.5 131.73 42.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.596 -1.261 . . . . 73.15 107.596 171.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.54 118.23 19.85 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.344 -1.724 . . . . 71.23 106.344 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 29.9 m -133.25 125.74 29.99 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.089 0.243 . . . . 44.45 110.838 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 16.5 mt -87.45 49.3 1.79 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.395 1.478 . . . . 64.24 109.723 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.82 -115.35 5.16 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 110.533 -1.027 . . . . 42.53 110.533 -170.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -90.22 -28.37 18.9 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.796 0.838 . . . . 71.14 110.124 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -63.68 122.09 15.52 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.804 1.242 . . . . 63.52 109.491 171.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.2 m -77.78 122.87 25.99 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.726 -0.842 . . . . 73.32 108.726 168.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.553 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -65.72 -59.39 3.96 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.307 -0.997 . . . . 62.33 108.307 171.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -165.39 164.37 19.69 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.908 -1.042 . . . . 63.32 110.658 174.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.424 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.7 tm? -120.51 141.01 50.62 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 106.354 -1.721 . . . . 61.22 106.354 166.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.436 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.6 t -146.95 110.06 4.76 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.79 -0.819 . . . . 74.13 108.79 177.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -117.44 119.74 36.01 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.08 -0.711 . . . . 75.43 109.08 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 55.1 t -117.08 114.17 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.78 -0.822 . . . . 73.41 108.78 173.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.409 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 78.2 mt-30 -90.06 87.22 6.81 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.185 -1.043 . . . . 74.3 108.185 173.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -78.42 104.48 9.05 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 115.693 -0.685 . . . . 44.2 109.325 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -83.48 179.3 52.53 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-N 116.613 -0.267 . . . . 43.25 112.717 172.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' C' ' 16' ' ' ILE . . . -178.73 136.81 3.01 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-O 119.945 -0.364 . . . . 61.44 112.719 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.536 HG12 ' HE1' ' C' ' 17' ' ' TYR . 36.6 mm -96.34 133.46 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 108.829 -0.804 . . . . 64.1 108.829 174.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -135.33 131.99 37.12 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.854 0.861 . . . . 62.42 110.308 -176.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 24.6 p -85.27 99.59 11.22 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.094 -1.076 . . . . 74.53 108.094 166.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.668 HG21 ' HE1' ' C' ' 94' ' ' MET . 11.7 mt -114.57 140.41 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.138 -1.06 . . . . 74.34 108.138 177.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.42 162.62 38.99 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 122.415 0.286 . . . . 74.05 111.245 -174.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.26 -35.88 3.5 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 115.917 -0.583 . . . . 31.44 113.279 172.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.518 HG22 HE21 ' C' ' 93' ' ' GLN . 36.1 pt -88.04 165.23 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.713 0.805 . . . . 73.3 112.059 -175.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -162.24 151.73 15.94 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.941 0.896 . . . . 63.24 109.874 -177.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.98 -119.39 9.64 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 115.344 -0.844 . . . . 61.51 112.794 172.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 68.9 p -62.15 -38.16 87.95 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.004 0.922 . . . . 74.51 111.307 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.518 HE21 HG22 ' C' ' 89' ' ' ILE . 27.0 mt-30 -65.22 -52.75 52.7 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.829 0.852 . . . . 63.32 111.22 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.668 ' HE1' HG21 ' C' ' 86' ' ' ILE . 6.1 tpt -53.03 -52.9 56.95 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 124.074 0.859 . . . . 73.02 111.722 176.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.55 -35.4 80.73 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.186 0.595 . . . . 71.43 112.15 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -68.13 -35.48 78.17 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.437 0.695 . . . . 73.05 110.708 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -71.82 -37.17 70.38 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.495 -0.775 . . . . 53.35 110.433 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 83.8 mt -83.59 -33.7 25.31 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.999 0.92 . . . . 44.02 112.431 -175.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -113.14 11.09 24.54 Favored Glycine 0 N--CA 1.472 1.082 0 O-C-N 123.333 0.396 . . . . 40.43 113.803 -169.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.65 -54.29 0.19 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.77 0.428 . . . . 70.44 111.257 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -75.2 -47.73 26.87 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 112.479 0.548 . . . . 71.44 112.479 -172.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.491 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 91.5 m -64.43 -49.32 72.26 Favored Pre-proline 0 CA--C 1.561 1.367 0 C-N-CA 123.499 0.72 . . . . 72.52 110.886 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.58 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 51.2 Cg_exo -57.83 -28.21 81.44 Favored 'Trans proline' 0 C--N 1.396 3.074 0 C-N-CA 122.639 2.226 . . . . 72.11 113.633 174.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -66.06 -34.88 79.08 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.189 0.596 . . . . 71.34 110.916 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.558 HD12 ' NH1' ' A' ' 111' ' ' ARG . 35.7 mm -80.75 -29.98 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 122.556 0.343 . . . . 72.11 110.089 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 mp -75.34 -25.89 58.14 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.715 0.806 . . . . 63.4 111.496 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -58.97 -51.23 83.36 Favored Pre-proline 0 C--O 1.206 -1.225 0 CA-C-O 117.476 -1.25 . . . . 75.32 112.492 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . 0.571 ' HB3' ' HB2' ' A' ' 112' ' ' GLU . 65.3 Cg_exo -47.71 -44.47 26.29 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.774 2.316 . . . . 71.1 114.817 176.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -74.2 -40.49 62.44 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.095 0.558 . . . . 74.11 111.606 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.28 -42.35 93.28 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.268 0.627 . . . . 61.45 110.153 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . 0.616 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 31.6 ttt-85 -59.89 -52.16 66.6 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.029 1.732 . . . . 72.41 110.447 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.06 -37.7 88.4 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.234 0.959 . . . . 65.22 109.967 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 38.4 t -68.78 -35.66 77.33 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.476 0.485 . . . . 60.31 111.444 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.549 HG21 HG21 ' C' ' 64' ' ' VAL . 90.9 mt -68.65 -49.58 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.283 0.633 . . . . 73.13 110.203 174.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.6 m -66.36 -28.14 68.42 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.21 0.604 . . . . 75.33 110.991 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.426 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 46.2 t -66.45 -43.05 86.64 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.071 0.949 . . . . 54.12 109.041 172.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.564 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -67.76 -34.39 76.71 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.134 0.974 . . . . 72.24 112.089 177.527 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.48 HG23 ' O ' ' C' ' 114' ' ' ILE . 88.2 t -62.6 -43.96 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.619 0.767 . . . . 72.12 108.997 172.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.483 ' OG ' HG21 ' B' ' 115' ' ' THR . 29.4 t -63.88 -39.55 94.45 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.606 -1.179 . . . . 55.33 111.786 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.519 HH12 ' HG2' ' D' ' 112' ' ' GLU . 67.0 mtt-85 -69.95 -38.31 76.09 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.578 0.751 . . . . 72.34 109.942 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.6 -1.04 88.69 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 115.426 -0.806 . . . . 63.25 112.788 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.498 HG21 ' O ' ' D' ' 16' ' ' ILE . 31.5 p 61.72 30.49 18.46 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.43 1.892 . . . . 74.14 113.587 171.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.47 ' HB2' HG13 ' C' ' 118' ' ' VAL . 93.7 m-85 -85.66 151.31 55.35 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 107.871 -1.159 . . . . 64.1 107.871 166.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.605 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 24.5 Cg_endo -63.06 157.94 46.38 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 122.354 2.036 . . . . 64.04 112.721 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 -53.06 112.71 0.91 Allowed 'General case' 0 N--CA 1.477 0.908 0 O-C-N 124.585 1.178 . . . . 75.15 112.891 -172.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 61.0 tp -109.61 87.8 2.59 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 113.924 -1.489 . . . . 74.53 107.512 174.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -92.93 99.91 12.46 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.899 -0.778 . . . . 74.24 108.899 -174.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.616 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 4.0 mm? -56.47 125.05 20.33 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.943 0.897 . . . . 75.33 111.274 -175.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.72 152.4 95.2 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 124.212 1.005 . . . . 74.31 111.4 -175.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.452 ' HG2' HG21 ' A' ' 13' ' ' ILE . 51.2 Cg_exo -54.72 108.26 0.28 Allowed 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.979 2.453 . . . . 74.41 112.926 175.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . 0.643 HG11 HD11 ' C' ' 44' ' ' LEU . 6.8 p -101.0 135.55 36.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.599 0.76 . . . . 75.02 109.446 175.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -97.36 101.25 12.76 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.632 0.773 . . . . 72.22 109.359 -174.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . 0.451 ' CE1' HD13 ' C' ' 44' ' ' LEU . 66.4 m-85 -68.98 -33.79 74.25 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.63 0.772 . . . . 73.51 111.462 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -59.15 -43.41 92.05 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.92 0.888 . . . . 62.21 109.435 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.88 -41.34 95.81 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 114.691 -1.141 . . . . 54.44 111.805 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 76.4 mt -65.91 -36.05 82.32 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.308 0.643 . . . . 64.32 110.831 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 18.0 t80 . . . . . 0 CA--C 1.554 1.108 0 CA-C-N 115.124 -0.944 . . . . 73.5 109.955 177.051 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 4.6 t . . . . . 0 C--O 1.243 0.724 0 N-CA-C 108.721 -0.844 . . . . 55.24 108.721 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.429 ' HD2' HG22 ' D' ' 86' ' ' ILE . 70.8 t80 -133.75 106.06 7.14 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.085 -1.45 . . . . 71.02 107.085 174.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -124.81 127.15 46.74 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.241 -1.022 . . . . 73.12 108.241 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.6 HG21 HD11 ' D' ' 16' ' ' ILE . 26.9 mt -77.09 116.51 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 109.296 -0.631 . . . . 65.03 109.296 178.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -84.07 -43.92 14.59 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.281 0.632 . . . . 75.0 110.385 -173.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -170.71 142.71 2.03 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.947 0.499 . . . . 72.42 110.362 -176.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.6 HD11 HG21 ' D' ' 13' ' ' ILE . 3.0 mp -115.07 148.48 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 106.872 -1.529 . . . . 72.14 106.872 172.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -169.59 168.33 9.26 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-O 121.54 0.686 . . . . 74.25 111.643 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.6 p -105.09 121.16 43.21 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 114.929 -1.032 . . . . 71.44 109.078 171.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -86.25 -25.28 25.64 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.42 0.688 . . . . 74.23 109.238 176.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.4 t70 -156.74 137.38 13.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.63 -1.168 . . . . 62.42 109.973 -175.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.564 HG21 ' HE2' ' C' ' 117' ' ' MET . 74.1 mt -140.14 141.4 33.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.218 1.407 . . . . 64.44 107.471 173.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.9 t -146.71 143.63 28.86 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.91 0.884 . . . . 54.11 109.116 173.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.533 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 84.5 t80 -146.99 133.64 19.91 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 106.581 -1.637 . . . . 70.04 106.581 172.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 48.0 mt-10 -135.27 141.77 45.79 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.96 0.904 . . . . 65.15 109.382 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.49 77.97 16.77 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 107.796 -1.187 . . . . 63.32 107.796 176.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.69 -19.42 21.31 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.666 2.244 . . . . 63.52 113.195 -173.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -108.45 -0.65 20.4 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.865 0.866 . . . . 71.5 110.707 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.716 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -19.51 -71.7 0.03 OUTLIER Pre-proline 0 CA--C 1.571 1.757 0 N-CA-C 116.908 2.188 . . . . 55.24 116.908 -165.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.431 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 81.4 Cg_endo -74.76 -25.1 12.71 Favored 'Trans proline' 0 C--N 1.385 2.458 0 CA-C-N 124.454 2.626 . . . . 74.44 113.84 -176.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.498 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 4.6 t-160 -69.67 -39.68 76.89 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 124.419 1.087 . . . . 75.55 110.07 178.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.8 p -82.71 -22.53 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 CA-C-N 115.666 -0.697 . . . . 62.24 111.426 -175.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.431 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 22.1 m-85 -64.25 -26.39 68.48 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 122.265 0.226 . . . . 72.5 111.221 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.498 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 61.7 mt-30 -65.45 -7.08 12.39 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.834 1.253 . . . . 72.43 111.844 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.506 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 91.6 mttt -95.71 103.86 15.76 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.152 1.381 . . . . 63.31 110.095 175.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -95.36 76.32 3.38 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.581 0.752 . . . . 55.21 110.312 -175.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 44.2 p90 -156.75 -177.78 6.86 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.8 -0.815 . . . . 75.15 108.8 168.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.6 tp60 -65.08 117.65 41.64 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.532 1.133 . . . . 73.32 110.91 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.438 ' O ' HG23 ' D' ' 40' ' ' VAL . 74.9 Cg_exo -55.49 112.88 1.18 Allowed 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 121.807 1.672 . . . . 75.02 109.457 165.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -70.95 107.41 4.05 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.055 -1.091 . . . . 73.02 108.055 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.656 HG13 HG13 ' D' ' 64' ' ' VAL . 96.0 t -102.45 131.4 50.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 115.122 -0.945 . . . . 43.35 109.913 -170.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -119.45 125.13 48.18 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.715 -1.217 . . . . 74.12 107.715 170.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.555 HD11 HG13 ' D' ' 62' ' ' VAL . 51.9 tp -96.18 141.48 29.5 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.852 -0.795 . . . . 62.45 108.852 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.58 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 35.1 t70 -134.71 113.28 11.51 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.026 -1.101 . . . . 71.31 108.026 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' D' ' 62' ' ' VAL . 93.7 mt -114.49 151.7 32.85 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.295 0.638 . . . . 62.53 110.696 -177.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.542 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 13.5 t0 -152.07 143.44 23.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.19 -0.914 . . . . 72.51 108.656 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 23.9 m -105.34 141.33 37.04 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.073 -0.714 . . . . 64.12 109.073 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.54 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.86 162.5 41.21 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.214 1.006 . . . . 75.13 108.864 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 36.3 p . . . . . 0 C--O 1.243 0.722 0 C-N-CA 123.601 0.76 . . . . 34.51 110.011 175.507 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 112.505 0.557 . . . . 64.43 112.505 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 t -108.82 99.37 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 108.773 -0.825 . . . . 73.4 108.773 -176.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -133.88 129.57 36.6 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.53 -0.915 . . . . 62.11 108.53 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.604 ' HB3' HG13 ' D' ' 83' ' ' ILE . 0.0 OUTLIER -101.66 120.14 39.87 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.835 -1.172 . . . . 71.32 107.835 168.298 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.485 ' O ' ' HA2' ' D' ' 81' ' ' GLY . 79.7 t -101.02 132.9 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-N 114.472 -1.24 . . . . 55.45 109.451 -176.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 36.6 t -106.63 138.81 30.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 124.383 1.073 . . . . 73.31 108.722 178.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.561 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -120.73 118.31 29.72 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.016 -1.475 . . . . 55.11 107.016 173.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.542 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 55.3 ttm-85 -88.57 109.35 20.01 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.848 -1.168 . . . . 71.34 107.848 175.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.555 HG13 HD11 ' D' ' 42' ' ' LEU . 38.5 t -114.69 113.23 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.345 -0.613 . . . . 74.13 109.345 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.58 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 24.4 m -119.75 131.96 55.5 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 123.954 0.902 . . . . 71.51 108.978 -172.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.656 HG13 HG13 ' D' ' 40' ' ' VAL . 85.1 t -118.71 104.69 16.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 C-N-CA 123.294 0.638 . . . . 74.42 109.384 177.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 10.1 m -97.98 94.03 6.64 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.26 -1.385 . . . . 75.24 107.26 170.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.02 138.71 48.29 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.015 0.926 . . . . 74.23 108.679 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.546 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 61.1 m -144.55 136.03 25.53 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.346 0.658 . . . . 63.54 111.61 -172.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.509 HD12 HG22 ' D' ' 31' ' ' VAL . 32.1 mt -100.5 106.93 18.51 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.473 1.109 . . . . 71.12 109.061 174.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.17 -126.32 8.65 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-O 119.869 -0.406 . . . . 62.11 112.807 175.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.23 5.3 52.19 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.328 0.651 . . . . 65.12 112.081 -177.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . 0.506 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 9.3 pt-20 -133.69 164.55 26.97 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.991 0.516 . . . . 73.34 109.965 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 21.4 m -68.02 143.69 55.44 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.994 0.917 . . . . 74.13 111.766 178.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.551 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -91.75 -69.66 0.73 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.616 -1.624 . . . . 65.23 106.616 173.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -149.22 146.89 27.83 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 114.812 -1.086 . . . . 71.43 110.059 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 82.7 mt -110.36 145.97 36.59 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.015 -1.105 . . . . 75.33 108.015 174.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.454 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 46.6 t -156.49 147.03 21.6 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.469 0.308 . . . . 71.03 110.207 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -156.63 130.52 8.39 Favored 'General case' 0 C--N 1.345 0.373 0 C-N-CA 123.274 0.63 . . . . 52.31 109.724 168.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . 0.409 HG22 HG23 ' D' ' 21' ' ' ILE . 92.0 t -129.76 114.45 30.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 C-N-CA 124.512 1.125 . . . . 55.42 108.52 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.486 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.5 mt-30 -90.13 88.24 7.19 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.837 0.827 . . . . 72.15 109.074 173.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.7 107.2 13.31 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 113.688 -1.596 . . . . 63.43 109.912 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' D' ' 58' ' ' VAL . . . -110.85 162.22 12.58 Favored Glycine 0 N--CA 1.465 0.625 0 O-C-N 123.032 0.208 . . . . 63.34 113.397 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.09 148.9 9.15 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-O 119.366 -0.686 . . . . 52.11 112.935 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.604 HG13 ' HB3' ' D' ' 57' ' ' GLU . 3.7 mp -89.1 136.74 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.197 -1.038 . . . . 73.24 108.197 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -132.43 129.42 39.26 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.477 1.111 . . . . 73.13 108.303 176.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 30.2 p -81.53 101.89 10.24 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.043 -0.725 . . . . 74.21 109.043 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.429 HG22 ' HD2' ' D' ' 11' ' ' PHE . 2.3 pp -119.24 121.0 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 120.749 0.309 . . . . 71.21 110.757 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.16 167.93 8.49 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.481 1.112 . . . . 42.45 111.313 174.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.0 19.02 23.0 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 124.046 0.841 . . . . 71.34 112.626 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.609 HD13 ' HB2' ' D' ' 94' ' ' MET . 0.7 OUTLIER -140.18 162.16 24.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 C-N-CA 125.157 1.383 . . . . 72.43 109.461 177.617 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -147.8 -174.05 4.45 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.404 0.682 . . . . 73.11 111.386 -173.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.7 -146.05 29.47 Favored Glycine 0 C--N 1.349 1.255 0 C-N-CA 124.047 0.832 . . . . 61.13 112.242 -172.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 68.0 p -94.32 -39.62 10.39 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.611 0.706 . . . . 42.12 111.027 174.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -65.61 -17.82 64.87 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.363 1.065 . . . . 75.34 113.591 -171.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.609 ' HB2' HD13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -57.04 -30.24 64.08 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.047 0.758 . . . . 54.44 113.047 176.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . 0.437 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -80.54 -13.97 58.63 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.486 0.714 . . . . 72.32 112.351 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -63.05 -29.83 71.12 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.072 0.549 . . . . 74.54 111.084 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 55.5 m -62.69 -28.3 69.84 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.387 0.675 . . . . 43.3 111.488 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.1 tt -92.41 -46.93 7.43 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.601 1.16 . . . . 51.15 110.063 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.22 -15.09 65.22 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 116.2 -0.455 . . . . 71.41 114.167 -169.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.91 -52.0 1.22 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.91 0.484 . . . . 51.14 110.685 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . 0.415 ' O ' HG12 ' D' ' 105' ' ' ILE . 61.8 t80 -73.74 -39.73 64.04 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 112.272 0.471 . . . . 64.53 112.272 -174.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 92.7 m -65.15 -46.97 73.13 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-O 118.542 -0.742 . . . . 72.41 111.638 177.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.561 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 84.2 Cg_exo -54.61 -33.77 80.42 Favored 'Trans proline' 0 C--N 1.393 2.907 0 C-N-CA 122.763 2.309 . . . . 75.43 113.661 167.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.27 -32.66 74.43 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.439 0.696 . . . . 72.31 110.978 177.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.415 HG12 ' O ' ' D' ' 101' ' ' TYR . 51.1 mm -74.33 -38.37 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.284 0.633 . . . . 75.31 110.244 173.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 70.6 mt -73.65 -22.9 59.83 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.521 -0.763 . . . . 63.55 111.709 -175.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -67.55 -42.01 34.18 Favored Pre-proline 0 N--CA 1.484 1.268 0 N-CA-C 113.635 0.976 . . . . 75.23 113.635 -172.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -47.15 -44.11 24.29 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.446 2.097 . . . . 73.33 113.855 167.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -79.36 -28.28 41.97 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.921 0.888 . . . . 74.41 112.252 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . 0.505 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -64.48 -47.4 79.11 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.733 0.777 . . . . 74.24 109.451 173.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -69.04 -34.29 74.96 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 113.723 -1.58 . . . . 72.45 110.385 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . 0.519 ' HG2' HH12 ' C' ' 120' ' ' ARG . 20.5 tt0 -53.42 -49.73 66.71 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.118 0.967 . . . . 64.32 110.452 175.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.428 ' O ' ' HG3' ' D' ' 117' ' ' MET . 46.1 t -67.69 -54.4 19.8 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.701 -1.136 . . . . 73.41 110.794 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.493 HG21 HG21 ' D' ' 64' ' ' VAL . 52.9 mt -60.28 -58.07 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.365 0.666 . . . . 54.42 111.855 -174.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 91.5 m -51.3 -41.15 60.3 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.102 0.876 . . . . 75.32 111.769 -175.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 47.2 t -66.09 -42.12 89.75 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 114.681 -1.145 . . . . 72.14 110.078 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 66.6 mtm -69.03 -30.53 68.91 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.057 0.543 . . . . 61.43 111.981 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.437 HG23 ' O ' ' D' ' 114' ' ' ILE . 95.7 t -62.97 -47.21 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.682 0.793 . . . . 72.34 109.198 174.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.3 p -74.25 -26.14 60.05 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.405 -0.816 . . . . 73.13 111.206 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' D' ' 116' ' ' SER . 88.6 mtt-85 -69.77 -32.85 71.58 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.464 0.705 . . . . 74.45 109.775 174.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.84 10.95 63.48 Favored Glycine 0 C--N 1.35 1.358 0 O-C-N 123.939 0.774 . . . . 40.31 112.501 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 70.3 p 54.79 27.04 8.32 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 126.095 1.758 . . . . 71.13 113.464 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -88.85 150.93 46.65 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 109.064 -0.717 . . . . 71.34 109.064 170.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -46.99 122.31 6.07 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.081 2.521 . . . . 54.42 113.53 171.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -45.62 123.19 4.1 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.682 1.593 . . . . 75.13 112.174 -175.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.432 ' HB3' HG21 ' D' ' 118' ' ' VAL . 20.6 tp -103.08 109.79 21.48 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.629 -0.878 . . . . 61.03 108.629 -175.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . 0.408 HD22 HD12 ' B' ' 16' ' ' ILE . 10.0 m120 -98.93 86.54 3.5 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 107.679 -1.23 . . . . 63.14 107.679 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 96.5 mt -54.38 115.04 1.88 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.026 0.53 . . . . 63.31 110.351 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.8 135.04 95.73 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 123.693 0.62 . . . . 73.5 110.557 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.62 121.81 10.45 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.545 2.163 . . . . 72.11 111.183 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 p -108.04 137.84 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.205 1.002 . . . . 74.12 108.903 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -78.27 98.4 5.89 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.176 -0.675 . . . . 74.14 109.176 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 . . . . . 0 N--CA 1.475 0.804 0 C-N-CA 124.102 0.961 . . . . 75.31 111.05 -178.432 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.2 m . . . . . 0 CA--C 1.536 0.432 0 N-CA-C 108.929 -0.767 . . . . 72.1 108.929 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -120.38 120.68 36.68 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.295 1.038 . . . . 73.2 108.761 -177.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -140.45 135.33 31.9 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.993 0.517 . . . . 73.41 109.756 173.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.441 ' CD1' HG21 ' A' ' 105' ' ' ILE . 3.6 mt -92.77 115.26 31.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 108.349 -0.982 . . . . 74.13 108.349 173.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.67 -40.25 29.52 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.235 -0.654 . . . . 74.12 109.235 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -176.21 122.93 0.17 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 123.146 0.279 . . . . 62.32 110.706 -171.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 79.4 mt -105.61 136.76 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.833 -0.802 . . . . 51.41 108.833 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.467 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 33.2 p90 -169.76 155.43 5.85 Favored 'General case' 0 C--N 1.346 0.42 0 O-C-N 124.197 0.936 . . . . 71.54 110.704 -173.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -83.28 121.94 27.78 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.513 -0.767 . . . . 74.54 109.475 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.467 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.5 mtpt -84.71 -26.7 27.51 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.71 -0.478 . . . . 73.01 109.71 175.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.598 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 11.0 t70 -153.49 143.44 22.07 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 114.63 -1.168 . . . . 42.32 109.837 -178.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.485 HD13 ' SD ' ' B' ' 117' ' ' MET . 91.5 mt -143.63 142.2 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.498 1.519 . . . . 63.41 107.857 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.9 t -149.97 133.22 16.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.289 0.635 . . . . 74.13 109.839 172.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -125.58 140.44 52.74 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 107.014 -1.476 . . . . 70.43 107.014 169.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -142.01 108.5 5.32 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.586 0.755 . . . . 75.34 109.042 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -106.96 85.65 2.03 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 106.639 -1.615 . . . . 64.33 106.639 165.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.55 -38.79 5.65 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.392 2.061 . . . . 53.12 112.177 -169.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -111.22 31.41 6.1 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.871 0.869 . . . . 63.23 108.867 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.521 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -47.13 -54.72 18.98 Favored Pre-proline 0 N--CA 1.493 1.678 0 CA-C-O 117.693 -1.146 . . . . 61.5 113.72 -173.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -61.25 -28.2 84.5 Favored 'Trans proline' 0 C--N 1.401 3.334 0 C-N-CA 121.888 1.725 . . . . 54.42 112.667 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.533 ' HA ' ' NE2' ' A' ' 33' ' ' GLN . 9.0 t60 -90.64 -31.8 16.49 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.741 1.216 . . . . 52.34 112.055 -173.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.647 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.9 p -79.22 -21.4 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 120.875 0.369 . . . . 74.2 111.142 -171.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -73.58 -6.2 45.12 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 115.991 -0.55 . . . . 73.41 111.025 172.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.533 ' NE2' ' HA ' ' A' ' 30' ' ' HIS . 9.9 mt-30 -88.8 -28.98 20.07 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.925 0.89 . . . . 63.33 110.202 172.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.429 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 14.5 mmmm -77.0 157.58 31.1 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.636 0.774 . . . . 72.14 110.929 -176.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.78 119.37 9.2 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.438 0.695 . . . . 71.31 110.464 174.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.452 ' CE3' HD21 ' A' ' 68' ' ' LEU . 67.2 t-105 -81.6 87.69 6.25 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.49 0.662 . . . . 73.51 111.393 -175.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.533 ' H ' HD22 ' A' ' 68' ' ' LEU . 35.7 tt0 -124.1 82.93 56.25 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 124.652 1.181 . . . . 70.25 107.869 171.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.34 121.17 7.52 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.762 2.308 . . . . 63.24 113.257 -170.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -97.19 89.36 4.75 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.829 -0.804 . . . . 74.21 108.829 172.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.571 HG21 HD13 ' A' ' 126' ' ' LEU . 48.8 t -79.66 111.76 16.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-N 114.846 -1.07 . . . . 73.22 110.109 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -99.03 123.49 43.36 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.076 -0.713 . . . . 74.45 109.076 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 84.6 mt -99.31 108.48 21.02 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.515 0.726 . . . . 62.1 109.665 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.632 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 11.2 m-20 -104.72 106.07 16.41 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.418 -1.327 . . . . 44.43 107.418 170.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.41 HD13 ' CZ ' ' A' ' 133' ' ' PHE . 79.4 mt -106.95 117.31 33.71 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.04 -0.726 . . . . 72.43 109.04 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -122.62 130.77 53.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.882 -1.525 . . . . 60.15 106.882 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.4 HG21 ' HA2' ' A' ' 99' ' ' GLY . 99.9 m -108.35 136.0 48.73 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.69 -0.485 . . . . 70.45 109.69 177.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.38 109.93 6.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.127 0.971 . . . . 50.33 108.966 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 79.2 p -94.96 158.79 15.32 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.97 0.508 . . . . 74.5 109.955 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.0 t -148.74 119.96 7.8 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.519 -0.919 . . . . 51.41 108.519 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -81.88 115.87 21.27 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.365 -0.606 . . . . 72.31 109.365 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.0 mt -80.56 -42.42 22.39 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.532 0.733 . . . . 75.24 110.516 -176.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.67 -179.61 7.57 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.023 0.929 . . . . 74.32 110.139 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -60.73 121.48 12.37 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.673 0.789 . . . . 73.55 109.903 170.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 65.84 -2.56 0.88 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.381 1.472 . . . . 54.22 112.974 -176.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.0 t -104.68 105.1 17.94 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 N-CA-C 108.158 -1.053 . . . . 70.12 108.158 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -107.64 162.66 13.77 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.562 -0.903 . . . . 53.1 108.562 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -131.77 153.3 50.24 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 107.444 -1.317 . . . . 72.13 107.444 168.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.452 HG11 ' HD3' ' A' ' 103' ' ' PRO . 68.0 t -133.48 136.41 54.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 107.513 -1.291 . . . . 64.4 107.513 173.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.452 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 47.9 t -119.82 133.58 66.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.831 -0.803 . . . . 75.41 108.831 174.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.417 HD22 HG22 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -104.01 100.07 9.84 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 106.564 -1.643 . . . . 63.21 106.564 177.012 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -82.97 99.21 9.66 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.867 -1.16 . . . . 72.14 107.867 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.461 HG21 ' HB1' ' A' ' 110' ' ' ALA . 47.2 t -98.96 130.57 47.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 N-CA-C 108.353 -0.98 . . . . 73.24 108.353 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.632 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 9.3 m -127.36 107.76 10.25 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.731 -0.84 . . . . 75.14 108.731 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.57 HG11 HD21 ' A' ' 126' ' ' LEU . 54.1 t -101.24 128.23 53.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 124.547 1.139 . . . . 74.24 108.275 174.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.8 m -131.44 116.89 18.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.816 -0.809 . . . . 55.51 108.816 172.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.53 119.43 39.15 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.61 -1.256 . . . . 52.41 107.61 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -127.7 142.31 51.36 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.515 0.674 . . . . 74.42 110.597 -177.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.533 HD22 ' H ' ' A' ' 37' ' ' GLN . 50.4 mt -91.18 61.19 4.45 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.262 1.425 . . . . 72.14 107.927 170.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.2 -98.28 1.47 Allowed Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.198 -0.91 . . . . 60.03 112.684 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -88.35 -29.6 20.18 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.128 0.971 . . . . 73.11 110.287 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.429 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 5.1 tp10 -85.88 101.17 12.62 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.149 -0.932 . . . . 72.14 108.954 -174.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.4 m -68.16 124.27 22.98 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 119.291 0.951 . . . . 75.13 108.559 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.647 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -79.81 -54.52 5.76 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.17 -0.923 . . . . 74.3 108.853 -177.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.437 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 54.5 p90 -155.34 162.23 40.88 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.276 -0.874 . . . . 71.4 111.527 176.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 64' ' ' VAL . 45.0 tp -131.14 118.44 20.49 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 113.765 -1.561 . . . . 63.43 107.498 175.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.437 ' HG ' ' HD1' ' A' ' 74' ' ' PHE . 85.3 m -115.3 126.89 55.02 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.595 -0.891 . . . . 74.31 108.595 175.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -139.18 115.77 10.65 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.32 -0.622 . . . . 72.21 109.32 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.4 t -125.64 112.35 30.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.42 1.088 . . . . 71.14 109.047 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.598 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 4.2 mt-30 -84.62 84.89 7.52 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.505 -0.924 . . . . 74.21 108.505 169.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -76.7 96.85 4.3 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 114.681 -1.145 . . . . 72.51 108.941 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -84.91 160.8 35.69 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.88 -0.488 . . . . 45.04 111.88 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.506 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -156.49 125.05 1.54 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.186 -1.166 . . . . 72.22 110.186 174.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.409 HG13 ' HE1' ' A' ' 17' ' ' TYR . 65.1 mt -79.79 124.66 38.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.893 -1.151 . . . . 73.32 107.893 171.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.625 ' HB3' HD11 ' A' ' 86' ' ' ILE . 96.3 m-85 -125.03 119.42 28.63 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.889 -0.782 . . . . 72.01 108.889 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.7 t -89.14 90.99 8.62 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.249 -1.019 . . . . 63.45 108.249 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.625 HD11 ' HB3' ' A' ' 84' ' ' PHE . 13.1 mm -116.87 148.69 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 121.205 0.526 . . . . 74.24 110.816 -169.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.56 171.06 16.34 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.735 -1.12 . . . . 73.51 110.114 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 106.24 -32.89 6.89 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.239 -0.437 . . . . 70.44 112.92 177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.593 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -121.39 169.0 13.25 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 124.278 1.031 . . . . 74.3 110.1 -175.227 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.406 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 12.6 tt0 -156.85 174.9 14.81 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 124.133 0.895 . . . . 74.54 109.07 176.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.73 -114.03 5.89 Favored Glycine 0 C--N 1.343 0.957 0 CA-C-N 115.69 -0.686 . . . . 41.04 114.293 176.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.4 p -71.36 -41.54 69.59 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.62 1.168 . . . . 73.34 112.217 -174.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -71.2 -34.77 71.18 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.067 0.547 . . . . 61.42 110.279 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.406 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 5.8 tpt -66.67 -42.52 86.43 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 123.469 0.481 . . . . 64.52 110.098 174.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.98 -35.08 79.51 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.373 0.669 . . . . 72.4 111.005 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.426 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 52.9 t-80 -71.71 -28.28 63.58 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.663 0.785 . . . . 71.22 110.777 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.7 t -76.19 -50.49 14.38 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.461 -0.57 . . . . 63.25 109.461 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 87.1 mt -75.98 -23.96 55.34 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.532 0.733 . . . . 63.54 112.515 -173.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.4 ' HA2' HG21 ' A' ' 46' ' ' THR . . . -115.09 3.52 22.46 Favored Glycine 0 N--CA 1.473 1.139 0 CA-C-O 119.553 -0.582 . . . . 73.41 113.952 -171.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -143.41 -63.24 0.4 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 117.541 0.67 . . . . 72.43 111.276 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -68.62 -46.19 69.9 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.175 0.59 . . . . 73.4 111.777 -170.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 80.3 m -70.49 -47.41 18.53 Favored Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 124.235 1.014 . . . . 53.51 112.928 -176.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.452 ' HD3' HG11 ' A' ' 58' ' ' VAL . 51.5 Cg_endo -67.08 -18.66 51.59 Favored 'Trans proline' 0 C--N 1.394 2.967 0 CA-C-N 121.462 1.558 . . . . 53.45 112.461 174.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -72.77 -35.23 67.39 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.055 0.542 . . . . 73.44 109.74 174.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.441 HG21 ' CD1' ' A' ' 13' ' ' ILE . 39.1 mm -65.42 -44.38 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.849 0.859 . . . . 55.51 110.113 170.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.506 HD21 ' HA3' ' A' ' 82' ' ' GLY . 75.7 mt -71.49 -15.8 62.33 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.445 -0.798 . . . . 75.24 111.904 -175.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -70.03 -44.98 22.28 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 114.748 1.388 . . . . 72.31 114.748 -170.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.97 -32.14 84.66 Favored 'Trans proline' 0 C--N 1.384 2.437 0 CA-C-N 122.285 1.852 . . . . 63.32 112.314 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -76.84 -41.28 44.74 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.69 0.796 . . . . 65.13 111.65 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.461 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -66.44 -49.44 66.71 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.033 0.533 . . . . 74.34 109.749 178.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.487 ' NH1' HD12 ' C' ' 105' ' ' ILE . 30.5 ttm180 -46.8 -51.67 15.9 Favored 'General case' 0 C--N 1.353 0.761 0 O-C-N 125.258 1.599 . . . . 73.44 110.716 173.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -67.39 -43.78 80.5 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.316 1.01 . . . . 73.45 111.982 -175.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.554 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.7 t -57.68 -42.6 83.94 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.932 0.77 . . . . 74.03 110.122 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.487 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.5 mt -64.33 -54.84 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 114.451 -1.25 . . . . 53.01 110.253 175.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.5 m -56.59 -37.29 70.43 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.258 0.974 . . . . 65.3 111.567 -173.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.0 t -68.81 -47.9 64.92 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.664 -1.153 . . . . 71.11 110.096 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 8.6 mtp -57.12 -37.71 72.38 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.615 0.766 . . . . 55.24 111.664 175.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 114' ' ' ILE . 70.3 t -67.48 -49.16 73.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.378 1.071 . . . . 71.24 110.461 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.8 p -70.44 -33.19 71.03 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.018 0.527 . . . . 75.12 111.076 -175.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.541 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.9 mtt-85 -69.48 -31.97 70.57 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.959 0.904 . . . . 74.2 109.67 172.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.84 6.08 49.74 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-O 119.304 -0.72 . . . . 73.05 113.688 174.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.53 HG21 ' HE ' ' B' ' 15' ' ' ARG . 18.1 m 73.15 7.29 5.32 Favored 'General case' 0 C--N 1.367 1.345 0 C-N-CA 125.147 1.379 . . . . 71.03 112.152 176.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -86.51 137.53 34.24 Favored Pre-proline 0 C--O 1.24 0.568 0 N-CA-C 107.197 -1.409 . . . . 71.33 107.197 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -54.67 165.87 2.25 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 123.416 2.744 . . . . 63.21 113.855 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.573 ' HG2' ' HB2' ' C' ' 15' ' ' ARG . 40.6 tp60 -52.88 117.8 3.22 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 114.534 -1.212 . . . . 75.53 111.877 -172.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.571 HD13 HG21 ' A' ' 40' ' ' VAL . 25.5 tp -113.6 114.39 26.39 Favored 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 109.175 -0.676 . . . . 62.42 109.175 173.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.486 HD21 ' HA ' ' C' ' 15' ' ' ARG . 5.7 m-80 -110.03 125.69 53.18 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 106.152 -1.795 . . . . 63.52 106.152 176.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.473 HD11 HD12 ' A' ' 114' ' ' ILE . 10.9 mt -72.09 144.18 48.78 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 109.173 -0.677 . . . . 65.31 109.173 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.51 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -60.18 138.64 91.51 Favored Pre-proline 0 N--CA 1.48 1.059 0 CA-C-O 118.864 -0.588 . . . . 73.44 111.011 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -55.09 108.17 0.29 Allowed 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.519 2.146 . . . . 63.34 111.849 168.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 129' ' ' ALA . 75.4 t -104.18 137.17 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.078 0.951 . . . . 71.54 111.634 -173.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -89.53 97.29 11.11 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.791 -1.095 . . . . 64.4 108.656 170.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.41 ' CZ ' HD13 ' A' ' 44' ' ' LEU . 57.2 m-85 -70.49 -18.58 62.96 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 112.827 0.677 . . . . 74.42 112.827 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -69.6 -40.02 76.9 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.45 -0.945 . . . . 52.11 108.45 174.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.07 -46.22 85.28 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.5 0.72 . . . . 63.31 110.942 174.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 56.9 mt -62.87 -33.58 75.58 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 123.748 0.655 . . . . 73.01 111.044 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.421 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 74.6 t80 . . . . . 0 C--O 1.218 -0.588 0 CA-C-N 115.507 -0.77 . . . . 72.43 109.808 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 1.4 tmt? . . . . . 0 CA--C 1.552 1.055 0 CA-C-O 120.801 0.334 . . . . 74.0 110.772 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.1 t -143.38 99.14 3.38 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.135 0.969 . . . . 62.33 109.373 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.474 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 54.1 t80 -112.63 141.0 46.92 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.334 -1.303 . . . . 75.23 107.684 173.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -147.55 134.14 19.85 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.764 -0.458 . . . . 64.55 109.764 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.473 HD11 HD13 ' B' ' 105' ' ' ILE . 41.4 mt -80.66 116.47 24.95 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 N-CA-C 107.011 -1.477 . . . . 55.13 107.011 170.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -90.06 -37.55 14.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.973 -0.751 . . . . 73.43 108.973 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.53 ' HE ' HG21 ' A' ' 122' ' ' THR . 11.7 ttt85 -168.92 151.88 5.07 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 123.611 0.569 . . . . 71.12 110.812 -177.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 53.8 mt -135.16 135.87 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 106.668 -1.604 . . . . 71.55 106.668 171.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.471 ' HE1' HG13 ' B' ' 83' ' ' ILE . 10.9 p90 -166.34 143.03 4.98 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.281 0.563 . . . . 73.01 111.79 -173.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 41.2 m -74.24 121.39 21.19 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.81 -1.086 . . . . 74.12 108.971 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.466 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.5 mtpt -98.51 -17.09 18.91 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.363 0.665 . . . . 72.11 110.979 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 3.2 t70 -163.67 145.36 9.3 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.83 0.852 . . . . 74.03 110.418 -177.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.404 HD13 HG13 ' B' ' 78' ' ' VAL . 39.4 mm -133.13 144.93 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 107.618 -1.253 . . . . 73.51 107.618 170.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 39.2 t -143.94 135.82 26.32 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.792 -0.818 . . . . 74.11 108.792 174.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.478 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.6 t80 -149.53 114.55 5.42 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 107.402 -1.333 . . . . 44.2 107.402 170.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -126.17 114.3 18.17 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.102 -1.073 . . . . 75.24 108.102 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.602 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -106.85 88.82 3.83 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 107.912 -1.144 . . . . 61.34 107.912 175.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.55 -33.33 46.33 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.723 2.282 . . . . 71.54 112.295 -172.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -106.32 7.96 31.53 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.075 0.95 . . . . 74.24 111.613 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.602 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -33.26 -64.03 0.27 Allowed Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 115.662 1.727 . . . . 74.11 115.662 -167.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.435 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 19.9 Cg_exo -60.72 -32.58 93.23 Favored 'Trans proline' 0 C--N 1.4 3.272 0 C-N-CA 122.438 2.092 . . . . 54.31 112.914 -170.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -94.77 -39.58 10.21 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 114.664 -1.153 . . . . 75.32 111.583 -170.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.706 HG22 HD12 ' B' ' 68' ' ' LEU . 7.4 p -66.32 -19.41 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.052 0.541 . . . . 62.14 111.925 -172.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -60.47 -21.63 62.57 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.015 0.926 . . . . 64.35 113.312 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -63.9 -18.27 64.03 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.346 0.658 . . . . 75.52 111.766 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.446 ' HB2' HD13 ' B' ' 68' ' ' LEU . 95.6 mttt -94.06 105.29 17.29 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.256 1.022 . . . . 75.25 109.142 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -100.52 79.58 2.12 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.477 0.711 . . . . 64.43 110.441 -172.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 46.5 p90 -154.41 167.84 28.67 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.824 -1.176 . . . . 74.14 107.824 165.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 22.9 tm0? -76.51 115.44 47.64 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 107.7 -1.222 . . . . 74.3 107.7 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.27 154.38 52.84 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.982 2.455 . . . . 71.14 114.285 -170.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -66.41 115.94 6.87 Favored 'General case' 0 C--N 1.347 0.486 0 N-CA-C 108.521 -0.918 . . . . 74.21 108.521 172.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.431 HG13 HG13 ' B' ' 64' ' ' VAL . 57.6 t -104.27 134.86 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.36 0.6 . . . . 74.52 111.015 -172.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -106.39 103.25 12.67 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.056 -1.461 . . . . 65.4 107.056 169.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.646 HD13 HD22 ' B' ' 128' ' ' LEU . 23.8 tp -85.48 147.05 26.65 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 107.855 -1.165 . . . . 73.25 107.855 171.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.517 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 12.0 t0 -155.27 154.09 31.61 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.337 -0.616 . . . . 61.05 109.337 -176.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.566 HD11 HG11 ' B' ' 131' ' ' VAL . 97.8 mt -124.92 130.54 52.56 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.341 0.657 . . . . 42.0 110.406 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -127.93 146.94 50.48 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.259 1.424 . . . . 72.54 108.048 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 7.8 t -145.32 127.42 15.63 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.004 0.431 . . . . 72.53 110.604 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.72 116.4 10.24 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.992 -1.114 . . . . 53.33 107.992 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.515 ' HB3' ' HA ' ' B' ' 58' ' ' VAL . 56.1 p -144.69 165.07 29.1 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.094 0.405 . . . . 45.12 112.094 -173.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 67.1 p -160.96 153.05 20.01 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.337 -0.847 . . . . 61.04 110.21 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . 0.418 HE21 ' H ' ' B' ' 54' ' ' ASP . 56.0 tt0 -82.57 115.03 21.36 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.875 -0.787 . . . . 72.53 108.875 166.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 pp -122.26 24.26 9.47 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.283 0.633 . . . . 62.13 110.746 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.611 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -169.17 169.0 9.59 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.585 0.754 . . . . 72.44 111.548 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . 0.427 ' O ' HG23 ' B' ' 55' ' ' VAL . 2.8 m-20 -60.59 95.43 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.392 1.077 . . . . 64.45 112.572 -175.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.418 ' H ' HE21 ' B' ' 50' ' ' GLN . 1.0 OUTLIER 56.56 25.24 9.62 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.417 1.087 . . . . 75.54 111.866 -178.672 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 89.0 t -116.93 111.79 36.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-N 114.322 -1.308 . . . . 71.12 108.117 177.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.588 ' HB3' HD13 ' B' ' 86' ' ' ILE . 8.2 t80 -101.41 138.64 38.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.099 1.36 . . . . 74.52 109.275 -174.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -116.41 114.22 23.95 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.467 -1.308 . . . . 63.22 107.467 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.515 ' HA ' ' HB3' ' B' ' 48' ' ' SER . 2.7 p -108.72 129.18 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 122.766 0.427 . . . . 75.34 110.993 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.482 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.3 t -102.33 108.48 24.07 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 N-CA-C 107.777 -1.194 . . . . 73.25 107.777 171.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 56.8 tp -95.11 102.58 14.4 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 108.516 -0.92 . . . . 53.13 108.516 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -94.05 117.88 30.73 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.588 -0.733 . . . . 74.4 109.241 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 54.1 t -105.02 128.3 58.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 108.706 -0.85 . . . . 74.23 108.706 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 14.9 m -104.88 138.4 41.19 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.998 0.519 . . . . 53.14 110.026 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.821 HG11 HD21 ' B' ' 126' ' ' LEU . 58.2 t -133.38 112.31 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.191 -1.04 . . . . 52.25 108.191 173.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.425 HG23 ' CD2' ' B' ' 75' ' ' LEU . 87.0 m -111.48 105.64 14.29 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.25 -1.019 . . . . 74.32 108.25 174.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.89 150.54 29.05 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.871 0.367 . . . . 63.53 110.145 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.522 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 30.7 p -144.69 130.7 19.36 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.424 -0.807 . . . . 74.42 111.015 -171.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.706 HD12 HG22 ' B' ' 31' ' ' VAL . 85.8 mt -94.35 98.45 10.91 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.053 -1.092 . . . . 71.34 108.053 173.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.1 -122.55 11.48 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 115.2 -0.909 . . . . 74.44 113.992 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -82.1 2.66 30.25 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.523 0.729 . . . . 71.11 112.764 -172.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -143.57 159.52 42.29 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.843 0.457 . . . . 73.31 110.89 -171.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 40.0 m -69.62 133.54 47.7 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.256 -0.884 . . . . 71.41 110.325 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.548 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -84.75 -60.94 1.91 Allowed 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.03 -1.47 . . . . 61.14 107.03 172.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -154.06 162.74 40.99 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.749 -1.114 . . . . 73.21 111.541 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.425 ' CD2' HG23 ' B' ' 65' ' ' THR . 35.3 mt -123.47 112.25 17.28 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 106.129 -1.804 . . . . 74.54 106.129 169.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' B' ' 117' ' ' MET . 40.5 t -124.54 118.34 26.36 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.364 -0.606 . . . . 74.01 109.364 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -140.2 128.66 22.75 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.564 0.745 . . . . 72.51 109.208 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.404 HG13 HD13 ' B' ' 21' ' ' ILE . 42.4 t -125.5 150.7 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.801 0.84 . . . . 73.24 110.125 -175.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.415 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 22.4 mt-30 -114.94 110.48 19.69 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.56 -0.533 . . . . 73.23 109.56 171.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.448 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.1 tp-100 -99.77 102.84 14.4 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.397 -0.594 . . . . 72.21 109.397 170.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.46 160.46 29.19 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 111.011 -0.836 . . . . 60.24 111.011 174.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.66 126.54 1.62 Allowed Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.916 -0.474 . . . . 61.41 111.916 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.471 HG13 ' HE1' ' B' ' 17' ' ' TYR . 57.9 mt -88.05 122.56 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 108.224 -1.028 . . . . 62.22 108.224 175.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -135.63 140.62 44.7 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.554 0.741 . . . . 72.54 110.067 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 21.2 m -88.72 118.69 28.58 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.458 0.703 . . . . 51.12 109.104 170.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.588 HD13 ' HB3' ' B' ' 56' ' ' TYR . 4.0 mp -116.94 110.59 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.048 -1.464 . . . . 52.54 107.048 175.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.88 172.06 19.0 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.959 0.504 . . . . 73.42 111.14 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.02 -60.46 0.82 Allowed Glycine 0 C--N 1.344 1.012 0 N-CA-C 111.072 -0.811 . . . . 63.21 111.072 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.421 HD13 ' HB2' ' B' ' 94' ' ' MET . 0.9 OUTLIER -68.53 169.84 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 123.446 0.698 . . . . 63.34 111.876 173.232 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -154.52 177.9 10.67 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.319 0.648 . . . . 74.11 110.838 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.34 -126.68 8.32 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-N 115.703 -0.68 . . . . 62.13 114.145 172.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.6 m -89.73 -47.59 7.82 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.788 0.835 . . . . 72.1 109.946 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -64.33 -19.02 65.17 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.379 -1.282 . . . . 71.34 112.152 -169.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.421 ' HB2' HD13 ' B' ' 89' ' ' ILE . 23.9 ptt? -62.53 -37.13 84.89 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.735 0.814 . . . . 74.41 112.015 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.97 -13.27 59.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.414 0.686 . . . . 53.22 112.466 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -63.72 -32.16 73.57 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.843 0.457 . . . . 71.23 109.929 170.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -64.45 -49.47 71.34 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.51 0.724 . . . . 65.01 111.428 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.47 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.4 pp -76.95 -32.02 57.01 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.066 -0.516 . . . . 74.33 111.827 -174.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.89 -22.08 37.26 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 123.26 0.35 . . . . 64.31 113.859 -173.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.01 -59.35 1.74 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.091 0.556 . . . . 72.53 111.516 -173.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -67.23 -42.77 83.49 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.224 0.61 . . . . 74.13 111.662 -172.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.474 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 63.3 m -68.43 -49.07 32.93 Favored Pre-proline 0 CA--C 1.566 1.575 0 N-CA-C 113.413 0.894 . . . . 70.31 113.413 -175.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.429 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 35.6 Cg_exo -64.72 -28.07 60.15 Favored 'Trans proline' 0 C--N 1.39 2.757 0 C-N-CA 121.851 1.701 . . . . 72.43 113.245 177.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -58.36 -34.43 70.66 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 123.216 0.606 . . . . 73.24 111.94 174.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.473 HD13 HD11 ' B' ' 13' ' ' ILE . 58.2 mt -68.49 -35.97 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 115.387 -0.824 . . . . 73.33 110.469 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 93.8 mt -88.5 -31.65 18.61 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.312 0.856 . . . . 51.33 113.312 -170.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -53.26 -43.7 95.69 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 113.855 1.057 . . . . 73.33 113.855 -173.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -52.18 -42.41 59.75 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.893 2.395 . . . . 72.31 114.84 174.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.448 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 86.0 m-85 -68.62 -43.59 76.04 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.731 0.412 . . . . 72.52 110.749 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.14 -43.04 99.51 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.407 -0.815 . . . . 61.24 110.661 175.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 28.8 ttt-85 -57.74 -53.9 53.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.14 1.376 . . . . 64.43 110.902 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -66.03 -39.17 89.98 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.247 0.967 . . . . 72.53 110.669 -175.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.541 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 7.4 t -70.25 -34.26 72.62 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.869 -0.605 . . . . 51.4 110.989 -176.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.498 HD13 HG23 ' B' ' 64' ' ' VAL . 67.7 mt -60.47 -53.46 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.626 0.771 . . . . 72.23 109.652 169.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.461 HG21 ' OG ' ' C' ' 119' ' ' SER . 17.0 m -60.14 -28.56 67.99 Favored 'General case' 0 CA--C 1.551 1.011 0 O-C-N 123.807 0.692 . . . . 73.13 111.332 -177.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 29.7 m -64.47 -52.04 59.97 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 123.543 0.737 . . . . 53.53 110.656 171.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.545 ' HB2' ' SG ' ' B' ' 76' ' ' CYS . 25.2 mmt -63.21 -33.13 74.81 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.049 0.54 . . . . 75.54 111.345 -177.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 92.1 t -72.07 -38.38 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.84 1.256 . . . . 75.51 110.902 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 47.2 t -66.54 -34.7 78.5 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.314 -0.857 . . . . 65.13 110.53 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.554 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 74.6 mtt-85 -71.37 -37.52 71.61 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 114.788 -1.097 . . . . 74.44 109.408 177.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.49 -9.73 78.33 Favored Glycine 0 C--N 1.355 1.587 0 O-C-N 123.522 0.514 . . . . 74.5 112.69 172.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 3.2 m 69.93 20.81 6.49 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 125.487 1.515 . . . . 72.23 111.721 171.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -78.24 159.67 74.81 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.524 0.73 . . . . 75.32 111.169 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.91 172.07 0.88 Allowed 'Trans proline' 0 C--N 1.387 2.569 0 C-N-CA 123.271 2.647 . . . . 71.33 114.558 174.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.759 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 56.3 tp60 -62.75 132.51 52.47 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.482 0.919 . . . . 73.43 113.482 -166.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.821 HD21 HG11 ' B' ' 64' ' ' VAL . 59.6 tp -126.71 106.43 9.37 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.681 0.792 . . . . 72.11 109.031 176.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.412 HD21 ' HA ' ' C' ' 122' ' ' THR . 88.3 m-20 -112.59 119.37 37.9 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 107.639 -1.245 . . . . 64.13 107.639 170.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.646 HD22 HD13 ' B' ' 42' ' ' LEU . 31.0 mt -77.67 145.95 36.34 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 122.99 0.182 . . . . 71.22 111.39 -176.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.96 128.33 91.8 Favored Pre-proline 0 CA--C 1.546 0.812 0 O-C-N 124.366 1.041 . . . . 72.52 111.845 -175.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.485 ' HG3' HD11 ' D' ' 16' ' ' ILE . 51.3 Cg_endo -68.54 87.31 0.42 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.897 2.398 . . . . 52.15 112.033 176.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.566 HG11 HD11 ' B' ' 44' ' ' LEU . 2.5 p -90.49 109.8 21.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 108.291 -1.003 . . . . 75.15 108.291 172.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 37.0 t30 . . . . . 0 CA--C 1.533 0.289 0 CA-C-N 114.726 -1.124 . . . . 64.51 108.216 178.066 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.51 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 64.0 t80 . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 108.539 -0.912 . . . . 73.42 108.539 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -135.79 125.21 24.93 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.275 -0.639 . . . . 64.33 109.275 -177.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 45.4 mt -77.16 128.16 38.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 109.466 -0.568 . . . . 70.32 109.466 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -88.69 -49.74 6.67 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.826 -0.805 . . . . 72.41 108.826 174.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.573 ' HB2' ' HG2' ' A' ' 125' ' ' GLN . 0.0 OUTLIER -174.58 149.48 1.27 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.221 1.008 . . . . 74.35 110.245 176.27 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.497 HG23 HD23 ' C' ' 106' ' ' LEU . 78.0 mt -120.57 131.59 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.503 1.121 . . . . 74.24 108.299 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.609 ' HB3' HG23 ' D' ' 122' ' ' THR . 20.8 p90 -164.44 172.19 13.7 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 121.422 0.63 . . . . 64.34 112.17 -167.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.1 p -100.38 120.3 39.76 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.268 -0.878 . . . . 72.35 109.248 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -69.29 -48.75 60.72 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 106.979 -1.489 . . . . 63.12 106.979 165.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.629 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.3 t70 -134.56 145.59 48.85 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 113.655 -1.611 . . . . 61.05 110.663 -173.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.406 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.5 mt -137.64 149.17 25.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 126.717 2.007 . . . . 72.35 105.714 172.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.1 t -156.95 149.58 23.45 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.829 -0.434 . . . . 74.53 109.829 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -155.98 129.59 8.39 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 107.265 -1.383 . . . . 74.31 107.265 174.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -132.15 132.91 43.66 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.681 -0.859 . . . . 74.25 108.681 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.33 80.55 22.6 Favored Pre-proline 0 CA--C 1.549 0.93 0 N-CA-C 106.625 -1.62 . . . . 73.13 106.625 170.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -65.25 -41.19 16.88 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.82 2.347 . . . . 63.04 111.702 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -94.82 18.37 11.92 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 114.398 -1.274 . . . . 63.11 110.779 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.98 -61.02 1.67 Allowed Pre-proline 0 C--N 1.369 1.427 0 C-N-CA 124.974 1.31 . . . . 61.42 114.097 -171.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -61.52 -39.48 54.89 Favored 'Trans proline' 0 C--N 1.39 2.715 0 C-N-CA 121.66 1.573 . . . . 75.31 112.15 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.48 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 85.2 t60 -71.4 -30.63 66.32 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 115.44 -0.8 . . . . 73.24 112.385 -178.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.728 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.0 p -82.96 -15.88 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 O-C-N 121.794 -0.566 . . . . 65.21 111.836 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -75.45 -20.76 58.64 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.112 0.565 . . . . 73.33 112.227 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 20.8 pt20 -94.07 8.69 40.61 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.493 0.717 . . . . 64.43 110.944 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -99.12 161.76 13.44 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.881 0.872 . . . . 71.01 110.988 -171.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -71.49 121.79 19.29 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.403 0.681 . . . . 75.04 109.638 172.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -83.74 93.39 7.93 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.22 0.608 . . . . 74.45 111.016 -174.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . 0.414 ' H ' HD22 ' C' ' 68' ' ' LEU . 52.9 tt0 -145.43 78.98 11.77 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.06 0.944 . . . . 71.22 108.494 173.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -82.45 141.33 11.2 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.695 2.263 . . . . 74.51 113.179 -173.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -87.38 88.43 7.68 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.012 -1.477 . . . . 64.21 107.012 163.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 40.3 t -83.87 111.96 20.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-N 115.117 -0.947 . . . . 74.53 110.078 -175.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.489 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 13.7 tmtt? -91.1 101.08 13.83 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 107.85 -1.167 . . . . 72.13 107.85 172.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.9 tt -87.61 121.69 30.36 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.069 -1.826 . . . . 70.44 106.069 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -118.31 138.35 52.45 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.428 -0.953 . . . . 60.0 108.428 -175.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.537 HD22 HD21 ' C' ' 60' ' ' LEU . 25.7 mt -132.02 111.84 11.86 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.852 0.834 . . . . 74.22 110.298 178.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -127.5 122.43 33.34 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.904 1.682 . . . . 72.55 107.268 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -123.16 125.86 45.93 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 120.99 0.424 . . . . 52.12 110.057 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.16 160.51 16.86 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.218 1.007 . . . . 62.23 109.384 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 31.1 p -151.94 146.06 25.33 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.308 0.643 . . . . 54.44 110.27 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 54.1 p -146.99 135.9 22.31 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.694 0.798 . . . . 72.14 109.351 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -78.32 117.08 19.22 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 108.856 -0.794 . . . . 71.15 108.856 175.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.707 HD11 ' HB2' ' C' ' 57' ' ' GLU . 30.8 mt -85.54 -33.28 21.79 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.899 0.88 . . . . 74.25 110.478 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.96 -174.48 3.34 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.408 1.083 . . . . 73.11 109.6 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.23 117.21 6.25 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.464 -0.789 . . . . 73.12 109.288 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 70.35 11.92 7.48 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.884 1.274 . . . . 72.3 112.044 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 30.4 t -118.32 116.27 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.196 -0.668 . . . . 60.35 109.196 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -127.46 125.12 39.95 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.017 0.927 . . . . 64.24 108.672 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.707 ' HB2' HD11 ' C' ' 51' ' ' LEU . 34.8 tt0 -85.8 142.14 29.15 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.964 -0.754 . . . . 71.1 108.964 169.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 60.1 t -128.8 122.84 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 107.817 -1.179 . . . . 64.5 107.817 167.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 68.2 t -109.64 127.56 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 109.283 -0.636 . . . . 70.44 109.283 173.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.537 HD21 HD22 ' C' ' 44' ' ' LEU . 0.1 OUTLIER -107.38 100.99 10.38 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 107.738 -1.208 . . . . 61.12 107.738 -176.544 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -82.22 106.12 13.85 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.455 0.702 . . . . 75.13 109.16 172.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.443 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.6 t -102.88 124.7 57.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.417 -1.327 . . . . 64.54 107.417 169.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 12.5 m -125.34 113.24 17.31 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.526 0.679 . . . . 62.2 109.486 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.428 HG21 HG21 ' C' ' 114' ' ' ILE . 99.5 t -102.49 111.07 30.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 124.482 1.113 . . . . 64.14 109.132 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.517 HG23 HD23 ' C' ' 75' ' ' LEU . 6.8 m -104.35 108.62 20.12 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 109.121 -0.696 . . . . 71.21 109.121 176.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.9 100.63 10.18 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.642 -0.873 . . . . 65.32 108.642 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 40.5 m -129.03 131.76 47.4 Favored 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 109.038 -0.727 . . . . 75.32 109.038 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.414 HD22 ' H ' ' C' ' 37' ' ' GLN . 12.2 mt -84.91 26.51 0.83 Allowed 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 125.137 1.375 . . . . 62.02 111.3 -175.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.62 -109.49 1.06 Allowed Glycine 0 C--N 1.348 1.229 0 N-CA-C 109.486 -1.446 . . . . 60.31 109.486 -170.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.59 -31.56 16.64 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.215 -0.661 . . . . 74.21 109.215 169.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -69.37 104.25 2.22 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 124.065 0.946 . . . . 72.11 109.964 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.1 m -78.55 123.95 27.63 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 109.384 -0.598 . . . . 72.43 109.384 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.728 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -77.42 -57.61 3.73 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.091 -1.077 . . . . 71.13 108.091 176.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . 0.435 ' HZ ' HD22 ' C' ' 126' ' ' LEU . 49.5 p90 -156.52 154.97 31.16 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.846 -1.07 . . . . 74.22 111.268 175.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.517 HD23 HG23 ' C' ' 65' ' ' THR . 2.5 tm? -113.09 145.47 40.85 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 106.094 -1.817 . . . . 74.43 106.094 163.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.449 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.6 t -151.68 125.16 8.88 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.989 -0.745 . . . . 74.31 108.989 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -131.76 136.71 47.79 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.331 -0.618 . . . . 74.15 109.331 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.466 HG11 ' HA ' ' C' ' 110' ' ' ALA . 22.7 t -132.13 113.92 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.658 -0.867 . . . . 74.3 108.658 174.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.629 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.3 mt-30 -91.73 87.96 6.5 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.017 0.927 . . . . 62.41 109.115 172.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -79.45 96.9 6.19 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.402 1.081 . . . . 53.11 110.337 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.77 144.54 22.15 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.396 -0.366 . . . . 72.22 112.694 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.425 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.24 128.11 2.86 Favored Glycine 0 CA--C 1.503 -0.713 0 N-CA-C 111.096 -0.802 . . . . 72.42 111.096 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.42 HD11 ' HB3' ' D' ' 29' ' ' PRO . 27.3 mm -95.09 123.54 47.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.248 -1.019 . . . . 75.14 108.248 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -132.23 118.68 19.83 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.517 0.727 . . . . 62.04 109.986 -173.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 56.9 m -76.41 100.8 5.32 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.464 -0.569 . . . . 71.12 109.464 170.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.576 HD13 ' SG ' ' C' ' 97' ' ' CYS . 18.4 mt -114.13 131.6 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.239 0.615 . . . . 70.44 110.042 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.4 169.4 23.23 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.163 0.985 . . . . 54.53 109.956 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.53 -19.2 41.78 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.936 -0.574 . . . . 63.54 113.452 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 22.3 pt -111.03 170.5 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.051 0.54 . . . . 63.51 111.135 -175.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -166.21 149.51 7.36 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.905 0.482 . . . . 74.3 110.7 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.81 -113.15 5.06 Favored Glycine 0 C--N 1.354 1.547 0 CA-C-N 115.872 -0.604 . . . . 63.11 113.43 170.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 34.6 p -61.19 -43.43 98.89 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.858 0.863 . . . . 75.11 111.281 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -59.24 -42.7 91.72 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 114.965 -1.016 . . . . 74.54 110.739 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.502 ' HE1' HG21 ' C' ' 86' ' ' ILE . 6.7 tpt -68.48 -43.63 76.52 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.845 -1.07 . . . . 64.25 110.573 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.75 -36.49 79.04 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.472 0.709 . . . . 71.31 111.318 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . 0.408 ' CD2' ' HB3' ' C' ' 100' ' ' ALA . 12.9 t-80 -77.32 -31.7 54.78 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.102 0.408 . . . . 74.03 112.102 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.576 ' SG ' HD13 ' C' ' 86' ' ' ILE . 24.7 t -66.36 -43.83 84.92 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.688 -0.856 . . . . 63.42 108.688 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 43.3 mt -78.69 -28.3 45.21 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.374 -1.285 . . . . 73.33 111.104 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.61 -27.97 52.92 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 115.701 -0.681 . . . . 65.15 114.14 -172.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.408 ' HB3' ' CD2' ' C' ' 96' ' ' HIS . . . -154.83 -48.75 0.09 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.172 1.175 . . . . 72.44 114.172 -163.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -62.73 -51.86 65.52 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.686 0.616 . . . . 61.12 111.465 -173.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.51 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 57.6 m -66.52 -50.05 48.86 Favored Pre-proline 0 CA--C 1.56 1.351 0 CA-C-O 118.271 -0.871 . . . . 52.44 111.502 177.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.504 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 85.4 Cg_exo -51.56 -30.99 38.0 Favored 'Trans proline' 0 C--N 1.399 3.227 0 C-N-CA 123.029 2.486 . . . . 61.12 114.898 172.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -65.35 -43.51 90.63 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.06 0.544 . . . . 60.34 109.717 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.487 HD12 ' NH1' ' A' ' 111' ' ' ARG . 35.1 mm -72.74 -29.12 28.99 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 CA-C-N 115.663 -0.699 . . . . 73.35 110.462 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.497 HD23 HG23 ' C' ' 16' ' ' ILE . 89.0 mt -77.62 -29.68 51.96 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.815 0.846 . . . . 71.45 111.883 178.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -58.78 -50.19 89.37 Favored Pre-proline 0 N--CA 1.482 1.173 0 CA-C-O 117.448 -1.263 . . . . 74.12 114.279 -168.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.93 -32.54 92.63 Favored 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 121.832 1.688 . . . . 62.22 112.75 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -68.42 -48.26 65.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.414 0.685 . . . . 75.41 110.425 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.466 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -62.57 -35.49 79.65 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 115.952 -0.567 . . . . 25.45 111.149 176.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -63.07 -54.85 31.51 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.313 1.445 . . . . 63.15 111.374 -177.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -66.98 -30.13 70.17 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.305 0.642 . . . . 71.1 110.153 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 14.0 t -68.43 -34.5 76.09 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.456 0.702 . . . . 70.31 111.394 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.449 HG23 ' SG ' ' C' ' 76' ' ' CYS . 96.3 mt -74.46 -50.56 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.478 0.711 . . . . 75.4 110.298 174.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 9.1 m -66.34 -28.39 68.63 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.26 0.624 . . . . 62.44 111.602 -173.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 79.5 p -66.59 -45.36 79.48 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 109.13 -0.693 . . . . 54.41 109.13 172.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.576 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.42 -40.65 78.79 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.421 1.088 . . . . 65.55 112.478 176.384 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.411 HG23 ' O ' ' C' ' 114' ' ' ILE . 62.8 t -64.73 -40.83 90.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.29 0.636 . . . . 61.15 110.609 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.461 ' OG ' HG21 ' B' ' 115' ' ' THR . 28.2 t -67.02 -34.63 78.15 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.05 0.94 . . . . 70.2 112.016 175.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' C' ' 116' ' ' SER . 66.0 mtt-85 -65.73 -36.3 83.19 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.237 0.615 . . . . 73.33 109.502 177.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.61 11.21 62.2 Favored Glycine 0 C--N 1.356 1.668 0 CA-C-O 119.284 -0.731 . . . . 65.13 113.322 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.425 HG23 ' HB3' ' D' ' 17' ' ' TYR . 67.6 p 59.09 21.76 9.77 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 126.139 1.776 . . . . 43.53 114.648 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -85.37 157.21 59.11 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 108.385 -0.969 . . . . 73.31 108.385 170.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.759 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 30.1 Cg_endo -61.6 168.46 8.28 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.831 2.354 . . . . 74.41 113.966 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -62.01 110.73 1.66 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.749 -1.114 . . . . 74.14 111.532 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.435 HD22 ' HZ ' ' C' ' 74' ' ' PHE . 9.5 mp -106.3 87.03 2.46 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.343 -1.354 . . . . 74.25 107.343 169.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -90.03 109.17 20.23 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.205 -1.035 . . . . 74.14 108.205 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 64.1 mt -61.04 131.29 50.13 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.529 0.732 . . . . 74.35 110.758 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.1 146.92 98.85 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 118.786 -0.626 . . . . 61.34 110.454 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -48.85 99.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.776 2.317 . . . . 75.32 112.7 172.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 58.0 t -97.4 109.03 22.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 107.494 -1.299 . . . . 64.41 107.494 172.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -86.11 101.3 12.85 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.669 -0.863 . . . . 75.22 108.669 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -57.18 -35.62 69.81 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.011 0.925 . . . . 74.21 111.347 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -68.46 -25.91 65.23 Favored 'General case' 0 C--O 1.219 -0.533 0 C-N-CA 123.949 0.9 . . . . 65.52 111.942 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.55 -40.54 56.68 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.031 0.532 . . . . 73.42 110.243 171.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 79.0 mt -65.65 -36.0 82.41 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.407 -0.815 . . . . 74.02 111.096 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 2.1 t80 . . . . . 0 C--O 1.211 -0.939 0 CA-C-N 115.878 -0.601 . . . . 74.23 110.265 179.376 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 C--O 1.242 0.666 0 CA-C-O 120.983 0.421 . . . . 73.34 110.133 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.451 ' HD2' HG22 ' D' ' 86' ' ' ILE . 80.3 t80 -132.83 107.91 8.63 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.178 -1.416 . . . . 73.11 107.178 176.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -128.91 116.06 18.81 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.994 0.918 . . . . 74.41 108.658 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 10.7 mt -82.75 130.45 35.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 108.303 -0.999 . . . . 70.12 108.303 174.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -94.82 -34.65 12.39 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 123.621 0.575 . . . . 71.14 110.429 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -167.76 141.43 3.43 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.323 0.389 . . . . 75.1 111.015 -173.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.485 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.7 mp -122.98 134.92 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 107.292 -1.373 . . . . 72.02 107.292 171.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.448 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 36.4 p90 -161.54 176.42 11.07 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.535 0.683 . . . . 64.53 112.372 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 53.6 p -103.47 127.22 50.9 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.422 -0.808 . . . . 72.52 109.357 173.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.448 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 32.5 mtpt -97.39 -19.22 18.62 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.027 0.531 . . . . 75.32 109.823 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.599 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 31.7 t70 -158.52 144.29 16.78 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.836 0.855 . . . . 73.24 109.876 177.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.576 HD13 ' HE3' ' C' ' 117' ' ' MET . 81.2 mt -148.59 142.91 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.624 1.569 . . . . 75.04 107.528 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.9 t -154.78 134.43 12.77 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.45 0.7 . . . . 63.35 109.419 164.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 88.8 t80 -119.75 133.92 55.43 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 105.827 -1.916 . . . . 62.35 105.827 166.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -138.69 120.59 15.46 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.349 0.659 . . . . 75.1 109.518 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.551 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -119.03 85.04 28.28 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 107.527 -1.286 . . . . 72.25 107.527 175.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -71.9 -29.55 15.11 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.873 2.382 . . . . 72.32 112.801 -168.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -115.27 16.58 16.83 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.077 0.951 . . . . 75.12 110.74 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.551 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -42.96 -58.03 4.4 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 114.887 1.44 . . . . 74.0 114.887 -161.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.42 ' HB3' HD11 ' C' ' 83' ' ' ILE . 89.6 Cg_endo -72.31 -26.18 17.73 Favored 'Trans proline' 0 C--N 1.378 2.124 0 CA-C-N 122.356 1.877 . . . . 74.51 113.992 -175.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -74.95 -36.68 62.08 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.848 0.859 . . . . 72.32 109.887 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.432 HG12 ' O ' ' D' ' 28' ' ' ALA . 9.8 p -83.91 -16.89 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-N 115.94 -0.573 . . . . 73.11 111.683 -172.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -68.15 -13.06 61.94 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 111.741 0.275 . . . . 74.03 111.741 175.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -69.48 -3.74 15.81 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.293 0.637 . . . . 74.52 111.3 174.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -110.69 102.88 11.4 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.276 1.43 . . . . 75.21 109.505 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -99.98 84.56 2.89 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.387 0.675 . . . . 54.11 111.125 -174.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -156.82 172.81 17.97 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 114.68 -1.145 . . . . 65.5 108.507 166.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -68.15 120.18 72.67 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-O 118.251 -0.88 . . . . 74.41 108.744 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -51.02 134.76 43.42 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 122.892 2.395 . . . . 61.12 112.124 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -69.34 110.52 4.7 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.879 -1.526 . . . . 73.43 106.879 170.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.722 HG13 HG13 ' D' ' 64' ' ' VAL . 38.4 t -107.05 108.86 26.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.84 0 CA-C-N 115.759 -0.655 . . . . 52.2 109.907 -173.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -87.95 109.27 19.68 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.603 -0.888 . . . . 73.31 108.603 168.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.447 HD12 ' O ' ' D' ' 63' ' ' THR . 58.9 tp -97.18 141.05 30.77 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.273 1.029 . . . . 62.22 109.228 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.614 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 21.5 t70 -123.94 131.9 53.64 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.385 -1.339 . . . . 73.34 107.385 173.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.433 ' CD2' HG22 ' D' ' 62' ' ' VAL . 31.9 mt -119.65 129.9 54.8 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.095 -0.706 . . . . 74.13 109.095 174.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.6 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 30.7 t70 -138.07 140.53 40.06 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 107.7 -1.222 . . . . 72.32 107.7 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 3.8 t -104.2 148.17 26.62 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.242 -0.651 . . . . 63.12 109.242 -176.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.96 151.22 33.0 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.812 0.845 . . . . 52.54 109.423 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.443 ' HB3' HG22 ' D' ' 58' ' ' VAL . 10.1 p . . . . . 0 C--O 1.243 0.759 0 C-N-CA 123.904 0.882 . . . . 75.11 109.235 177.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 . . . . . 0 N--CA 1.486 1.353 0 N-CA-C 113.639 0.978 . . . . 63.43 113.639 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 50.9 t -134.39 117.63 24.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 108.767 -0.827 . . . . 74.2 108.767 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -131.98 132.74 43.74 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 107.016 -1.476 . . . . 75.41 107.016 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -85.83 115.35 23.42 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 107.357 -1.349 . . . . 75.14 107.357 171.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.443 HG22 ' HB3' ' D' ' 48' ' ' SER . 70.3 t -99.97 130.55 48.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.643 -1.162 . . . . 74.33 108.687 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.547 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 16.5 t -111.85 146.78 16.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.879 -0.786 . . . . 62.41 108.879 176.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.41 119.87 37.01 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.581 -1.266 . . . . 73.34 107.581 176.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.6 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 2.9 tmm_? -95.4 96.21 8.96 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 108.042 -1.095 . . . . 74.53 108.042 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.443 HG13 HD11 ' D' ' 42' ' ' LEU . 54.0 t -101.67 125.12 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.574 -0.899 . . . . 71.42 108.574 176.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.614 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 50.0 m -121.66 131.07 53.9 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 123.285 0.634 . . . . 52.54 109.526 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.722 HG13 HG13 ' D' ' 40' ' ' VAL . 83.7 t -113.86 127.06 71.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.778 -0.823 . . . . 73.43 108.778 172.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 22.4 m -119.61 92.92 3.91 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.336 -1.727 . . . . 72.43 106.336 168.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.54 143.59 30.53 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 109.652 -0.499 . . . . 71.21 109.652 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 77.9 p -147.7 137.3 22.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.238 0.542 . . . . 63.22 111.158 -173.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 26.8 mt -108.73 110.5 21.91 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.404 -1.332 . . . . 74.5 107.404 171.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.98 -134.98 20.85 Favored Glycine 0 C--N 1.342 0.909 0 O-C-N 123.589 0.556 . . . . 61.44 113.302 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.24 6.05 46.71 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.554 0.741 . . . . 73.33 112.179 -176.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -130.07 167.86 17.65 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.074 0.55 . . . . 74.31 110.602 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 66.0 m -71.46 138.67 49.2 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.454 -0.794 . . . . 72.11 111.217 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.427 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -89.77 -63.11 1.33 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.239 -1.393 . . . . 65.4 107.239 169.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -158.56 161.08 37.26 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.652 -1.158 . . . . 74.11 110.951 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 68.8 mt -131.8 112.64 12.67 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.458 1.503 . . . . 63.14 107.151 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.623 ' SG ' HG23 ' D' ' 114' ' ' ILE . 49.2 t -131.94 106.23 7.92 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 122.583 0.353 . . . . 54.35 110.378 -168.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -129.0 125.89 38.35 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.428 0.691 . . . . 42.33 109.657 -173.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 88.2 t -132.6 115.39 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.114 0.965 . . . . 73.24 109.822 -174.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.599 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 2.3 mp0 -90.03 87.31 6.85 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.892 0.877 . . . . 53.23 109.051 175.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -81.81 102.9 11.11 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.691 -1.14 . . . . 70.04 109.346 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -111.64 147.24 17.98 Favored Glycine 0 N--CA 1.475 1.236 0 CA-C-O 120.157 -0.246 . . . . 44.33 112.517 -178.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.91 151.91 23.1 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 117.133 0.467 . . . . 51.41 112.252 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 3.0 mp -89.74 118.22 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 108.707 -0.849 . . . . 71.43 108.707 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -115.29 150.08 36.81 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.943 0.897 . . . . 65.44 110.165 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 33.1 t -115.76 104.73 11.95 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.992 0.917 . . . . 60.42 109.152 175.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.495 HD11 HD23 ' D' ' 98' ' ' LEU . 47.2 pt -115.03 130.28 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.153 0.581 . . . . 62.21 109.838 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.87 165.29 34.98 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.587 0.755 . . . . 64.34 109.767 175.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.69 23.39 75.24 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-O 119.692 -0.504 . . . . 74.43 114.315 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.453 HG22 ' H ' ' D' ' 90' ' ' GLU . 0.1 OUTLIER -103.1 168.81 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 108.733 -0.84 . . . . 73.22 108.733 172.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.453 ' H ' HG22 ' D' ' 89' ' ' ILE . 8.8 pt-20 -135.1 178.17 7.24 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.02 0.928 . . . . 75.23 111.08 -178.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.79 -138.77 42.47 Favored Glycine 0 C--N 1.358 1.797 0 CA-C-N 115.676 -0.693 . . . . 64.22 113.068 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 65.5 p -88.31 -20.37 25.48 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.167 0.587 . . . . 64.13 110.284 170.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.751 ' HA ' ' HB3' ' D' ' 96' ' ' HIS . 25.7 tp60 -59.69 -21.42 60.56 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.186 1.395 . . . . 54.32 112.295 -175.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.425 ' HA ' ' HB ' ' D' ' 89' ' ' ILE . 16.8 ptp -57.51 -51.04 71.07 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.435 0.694 . . . . 71.12 111.856 172.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.23 -22.77 26.72 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.943 0.497 . . . . 72.42 111.771 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . 0.751 ' HB3' ' HA ' ' D' ' 93' ' ' GLN . 19.6 t-80 -75.02 -11.27 60.06 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.184 0.593 . . . . 54.22 110.094 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 43.7 t -72.99 -51.2 19.17 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.966 0.506 . . . . 73.41 110.447 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.517 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 3.2 pp -77.64 -19.03 56.14 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.037 0.384 . . . . 55.54 112.037 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.35 -0.82 64.91 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-O 119.817 -0.435 . . . . 73.35 113.345 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.14 -66.78 0.39 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.903 0.481 . . . . 64.02 111.212 -176.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -66.84 -43.33 83.97 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.436 0.294 . . . . 72.43 111.78 -173.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.517 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 75.6 m -63.74 -47.44 81.71 Favored Pre-proline 0 CA--C 1.567 1.629 0 CA-C-O 118.289 -0.862 . . . . 75.12 112.591 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.598 ' HA ' HD12 ' D' ' 106' ' ' LEU . 27.9 Cg_exo -62.51 -28.53 77.75 Favored 'Trans proline' 0 C--N 1.399 3.233 0 C-N-CA 122.153 1.902 . . . . 53.33 112.964 170.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -67.91 -32.86 73.63 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.616 0.367 . . . . 75.44 111.068 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 48.0 mm -65.58 -34.38 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.149 0.58 . . . . 74.2 110.241 173.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.598 HD12 ' HA ' ' D' ' 103' ' ' PRO . 29.5 mt -77.81 -18.27 56.55 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.381 -0.827 . . . . 72.31 111.933 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.04 -41.3 10.74 Favored Pre-proline 0 N--CA 1.486 1.358 0 N-CA-C 113.91 1.078 . . . . 71.2 113.91 -173.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -50.65 -42.91 48.34 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.208 1.939 . . . . 64.22 112.721 169.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . 0.455 ' OH ' ' HB3' ' B' ' 130' ' ' PRO . 93.2 m-85 -79.49 -27.29 41.47 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.634 0.774 . . . . 74.3 111.732 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.06 -49.5 67.41 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.049 -0.722 . . . . 75.24 109.049 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -67.13 -33.37 75.29 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 113.868 -1.515 . . . . 51.44 110.864 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -53.92 -55.79 23.73 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 124.007 0.923 . . . . 70.24 110.268 174.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.408 ' O ' ' HG3' ' D' ' 117' ' ' MET . 47.2 t -62.99 -47.52 82.79 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 114.225 -1.352 . . . . 74.32 111.182 -177.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.623 HG23 ' SG ' ' D' ' 76' ' ' CYS . 68.5 mt -60.95 -61.74 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.324 0.65 . . . . 73.02 111.576 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 22.3 m -51.97 -40.42 60.86 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 124.198 0.937 . . . . 73.42 111.455 -175.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 37.5 t -60.41 -50.77 72.27 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 114.343 -1.299 . . . . 74.42 110.751 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.408 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 72.4 mtm -66.54 -30.85 71.25 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.122 0.569 . . . . 75.41 112.16 -178.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.8 t -66.56 -44.34 90.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.722 0.809 . . . . 73.14 110.042 176.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 83.7 p -74.83 -28.67 60.79 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.746 -0.661 . . . . 73.3 110.56 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' D' ' 116' ' ' SER . 88.3 mtt-85 -69.84 -29.73 67.05 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.648 0.779 . . . . 61.45 109.809 173.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.46 6.98 80.88 Favored Glycine 0 C--N 1.356 1.672 0 O-C-N 123.656 0.598 . . . . 60.3 113.157 177.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.609 HG23 ' HB3' ' C' ' 17' ' ' TYR . 81.2 p 55.69 28.25 11.84 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 126.277 1.831 . . . . 61.44 113.442 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -90.9 151.34 43.34 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 123.641 0.776 . . . . 75.35 109.289 169.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -51.58 125.15 15.99 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.64 2.227 . . . . 65.42 112.211 172.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -42.89 135.64 2.95 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 126.191 1.796 . . . . 75.22 113.277 -175.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.655 HD13 HG21 ' D' ' 40' ' ' VAL . 28.7 tp -116.55 96.99 5.76 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.774 0.83 . . . . 55.4 109.78 -176.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -97.11 96.48 8.49 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 106.931 -1.507 . . . . 53.33 106.931 175.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.496 HD11 HD12 ' D' ' 114' ' ' ILE . 92.9 mt -54.13 127.25 25.95 Favored 'General case' 0 C--O 1.246 0.884 0 O-C-N 123.649 0.593 . . . . 73.15 110.397 -177.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.18 140.81 82.81 Favored Pre-proline 0 CA--C 1.551 0.982 0 O-C-N 124.185 0.928 . . . . 74.23 110.734 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.404 ' HD3' HG13 ' B' ' 13' ' ' ILE . 98.0 Cg_endo -74.22 108.4 2.66 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.566 2.177 . . . . 74.22 111.739 -170.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 59.1 t -106.48 117.25 51.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 108.186 -1.042 . . . . 71.43 108.186 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -74.28 113.14 11.14 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.698 -0.853 . . . . 54.5 108.698 169.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . 0.439 ' CD2' ' HB2' ' D' ' 103' ' ' PRO . 2.0 m-85 . . . . . 0 N--CA 1.471 0.594 0 CA-C-N 115.239 -0.891 . . . . 72.55 110.826 -176.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 75.9 m . . . . . 0 N--CA 1.457 -0.118 0 N-CA-C 107.672 -1.233 . . . . 74.21 107.672 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -114.91 120.5 40.16 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.725 -1.213 . . . . 73.25 107.725 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -139.11 123.77 18.51 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.55 -0.907 . . . . 71.43 108.55 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.453 HG21 ' HG3' ' C' ' 130' ' ' PRO . 3.0 mt -88.43 119.59 35.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.624 -0.88 . . . . 73.12 108.624 177.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -91.39 -37.27 13.31 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 123.785 0.678 . . . . 74.1 110.516 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -171.17 121.49 0.54 Allowed 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.353 0.408 . . . . 74.1 109.948 -176.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 76.2 mt -106.72 137.18 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.201 -1.037 . . . . 53.5 108.201 171.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.511 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 37.3 p90 -164.44 175.89 9.53 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-O 122.042 0.925 . . . . 73.11 111.92 -174.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 56.2 p -102.78 111.56 23.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.677 -1.147 . . . . 75.5 108.724 176.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.511 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 34.2 mtpt -72.92 -34.32 66.54 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.283 -0.636 . . . . 75.02 109.283 175.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.1 t70 -150.35 145.79 26.33 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.965 -1.016 . . . . 64.41 110.142 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.56 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 75.5 mt -142.78 143.3 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.663 1.585 . . . . 61.15 107.43 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.4 t -154.72 131.24 10.56 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.899 0.48 . . . . 63.2 110.165 173.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.513 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 87.6 t80 -126.99 141.9 51.68 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.332 -1.358 . . . . 65.03 107.332 172.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HB3' ' HD3' ' A' ' 26' ' ' PRO . 30.2 mt-10 -135.04 142.52 46.39 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.785 -0.45 . . . . 73.31 109.785 175.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.83 71.08 13.74 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 106.991 -1.485 . . . . 33.34 106.991 166.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.404 ' HD3' ' HB3' ' A' ' 24' ' ' GLU . 65.1 Cg_endo -71.78 -17.84 28.93 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 122.434 2.089 . . . . 75.13 112.2 -175.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -104.71 17.38 24.24 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-O 118.007 -0.996 . . . . 62.4 109.698 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.449 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -46.34 -55.72 13.03 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 113.674 0.99 . . . . 50.42 113.674 -169.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 32.2 Cg_exo -60.83 -26.85 83.83 Favored 'Trans proline' 0 C--N 1.388 2.616 0 C-N-CA 121.73 1.62 . . . . 63.12 113.612 178.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -81.86 -41.23 21.28 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.876 0.871 . . . . 71.24 110.522 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.574 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.8 p -74.95 -20.66 16.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 124.576 1.15 . . . . 73.43 111.787 -161.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -76.91 -21.27 55.13 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.584 0.754 . . . . 74.24 110.852 176.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -90.51 -11.94 38.71 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.697 1.199 . . . . 71.44 110.879 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -83.07 164.06 20.53 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.165 0.986 . . . . 72.41 111.44 -178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.96 118.86 17.41 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.538 0.735 . . . . 55.55 109.367 173.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.45 ' CE3' HD21 ' A' ' 68' ' ' LEU . 71.2 t-105 -81.06 93.14 6.34 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 121.05 0.453 . . . . 75.24 110.737 -176.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -128.04 84.1 64.22 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 107.342 -1.355 . . . . 72.32 107.342 168.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -76.31 110.48 3.07 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.534 2.156 . . . . 54.11 112.443 -171.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -92.85 84.78 5.01 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 106.68 -1.6 . . . . 70.13 106.68 175.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.568 HG22 ' HB2' ' A' ' 66' ' ' ALA . 48.8 t -86.81 106.51 15.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 114.789 -1.096 . . . . 75.3 110.431 -173.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -79.01 123.47 27.33 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.19 -0.914 . . . . 71.51 109.454 171.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.8 mt -97.57 106.21 18.49 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.203 -1.036 . . . . 74.31 108.203 173.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.472 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 29.3 t70 -108.52 140.69 41.51 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.803 -1.184 . . . . 74.21 107.803 176.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.521 HD11 HG21 ' A' ' 131' ' ' VAL . 85.5 mt -136.56 150.95 48.87 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.173 0.589 . . . . 61.35 110.925 -172.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 21.8 t0 -154.77 148.98 25.98 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.931 -1.032 . . . . 71.01 109.417 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.455 HG21 ' HA2' ' A' ' 99' ' ' GLY . 89.3 m -130.86 147.44 52.51 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.614 0.766 . . . . 43.52 109.582 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -157.33 109.73 2.44 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.625 0.77 . . . . 73.34 109.661 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.3 p -93.15 154.38 18.1 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.111 0.564 . . . . 43.31 110.229 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.8 t -151.62 121.51 7.07 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.047 0.939 . . . . 64.14 109.023 -176.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -73.03 105.57 4.55 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.034 0.533 . . . . 60.44 109.679 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' ' 57' ' ' GLU . 60.6 mt -79.09 -38.65 35.73 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.195 0.598 . . . . 73.52 110.275 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.27 -179.88 7.93 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.925 -1.034 . . . . 65.2 109.485 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -68.46 124.93 24.9 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.012 0.525 . . . . 72.34 109.944 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 63.72 16.6 9.86 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.008 1.323 . . . . 74.42 111.717 -173.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.0 t -124.93 109.22 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.083 0.953 . . . . 64.5 108.526 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -121.9 125.62 46.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.332 -0.988 . . . . 72.4 108.332 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.442 ' HB2' HD11 ' A' ' 51' ' ' LEU . 21.7 tt0 -83.44 150.33 26.11 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.984 -1.117 . . . . 74.13 107.984 166.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.0 t -131.16 136.27 58.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 107.642 -1.244 . . . . 72.43 107.642 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.441 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 48.7 t -109.56 135.97 46.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.367 -0.975 . . . . 50.23 108.367 175.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.491 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -112.95 104.09 12.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.643 -1.614 . . . . 74.44 106.643 170.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.425 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 16.6 ttp180 -92.79 100.15 12.69 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.363 -1.347 . . . . 63.35 107.363 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.8 t -98.44 128.97 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 N-CA-C 108.235 -1.024 . . . . 74.43 108.235 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 16.8 m -120.95 112.04 18.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.524 0.678 . . . . 73.53 109.322 175.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 80.4 t -106.14 125.94 61.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 124.731 1.212 . . . . 65.13 107.883 -178.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.1 m -134.08 115.05 13.83 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 118.379 0.536 . . . . 71.25 109.848 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.568 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -100.79 121.85 42.4 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.059 -1.46 . . . . 44.52 107.059 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.1 m -121.84 135.71 54.91 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.435 0.694 . . . . 55.14 109.876 176.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.45 HD21 ' CE3' ' A' ' 36' ' ' TRP . 17.6 mt -88.13 72.1 9.18 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 107.65 -1.241 . . . . 54.24 107.65 174.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.77 -90.85 1.07 Allowed Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.218 -0.901 . . . . 52.41 111.515 -171.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -113.27 -27.03 8.12 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.165 0.586 . . . . 74.4 111.933 -174.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -85.65 129.83 34.72 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.504 -0.924 . . . . 71.42 108.504 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.3 m -72.85 125.87 28.57 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.876 -0.416 . . . . 64.12 109.876 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.574 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -71.26 -57.68 4.25 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.844 0.858 . . . . 54.01 110.319 175.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -155.06 164.5 38.8 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.261 -0.881 . . . . 74.31 111.497 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 64' ' ' VAL . 65.6 tp -118.82 140.95 49.11 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.8 -1.091 . . . . 75.01 108.202 170.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.487 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 83.2 m -140.07 96.84 3.12 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.711 0.805 . . . . 65.32 109.66 173.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -111.49 117.44 33.03 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.575 -0.528 . . . . 64.41 109.575 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.1 t -126.58 113.96 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.003 0.921 . . . . 72.4 109.845 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 53.0 mt-30 -86.3 85.58 7.34 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.774 0.83 . . . . 63.13 109.21 171.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.437 ' HG3' HD22 ' A' ' 106' ' ' LEU . 7.9 tp-100 -78.62 96.34 5.47 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.079 -0.964 . . . . 75.13 109.978 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -100.72 145.43 17.11 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.552 -0.619 . . . . 72.11 111.552 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.47 130.42 3.94 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.65 -0.98 . . . . 74.11 110.65 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 48.8 mt -79.55 126.56 39.22 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 108.501 -0.925 . . . . 71.02 108.501 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.504 ' HB3' HD11 ' A' ' 86' ' ' ILE . 74.0 m-85 -131.6 123.29 27.59 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.426 0.69 . . . . 43.34 109.894 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.9 t -83.44 106.23 15.02 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.237 -0.653 . . . . 65.32 109.237 171.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.504 HD11 ' HB3' ' A' ' 84' ' ' PHE . 7.7 mm -117.05 150.52 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.418 0.687 . . . . 71.35 110.157 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.96 163.38 16.04 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.571 0.544 . . . . 64.24 112.079 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.22 -19.41 46.03 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-N 115.543 -0.753 . . . . 72.2 113.124 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.424 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -134.11 148.95 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.741 0.816 . . . . 72.15 111.216 -171.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -138.05 175.24 9.75 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.942 1.297 . . . . 71.3 109.183 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.5 -123.99 33.52 Favored Glycine 0 CA--C 1.533 1.195 0 O-C-N 123.623 0.577 . . . . 32.22 114.185 175.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 38.1 p -73.2 -30.34 63.45 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.037 0.935 . . . . 65.35 110.825 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -67.66 -37.83 82.93 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.306 1.042 . . . . 60.53 110.359 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 5.3 tpt -68.38 -45.55 72.44 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.939 -0.573 . . . . 74.24 109.648 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.69 -38.1 77.5 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.187 0.929 . . . . 75.4 111.75 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.467 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 58.9 t-80 -67.94 -33.91 75.58 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.31 0.644 . . . . 65.2 111.269 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.4 t -69.99 -45.11 68.0 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.019 0.437 . . . . 75.45 110.065 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.7 mt -80.79 -31.03 35.89 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.103 -0.953 . . . . 73.11 112.677 -170.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.455 ' HA2' HG21 ' A' ' 46' ' ' THR . . . -106.6 4.59 37.12 Favored Glycine 0 N--CA 1.472 1.059 0 CA-C-O 119.953 -0.36 . . . . 65.51 113.783 -173.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.571 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -136.13 -68.43 0.5 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 117.191 0.495 . . . . 61.24 111.186 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -68.22 -43.7 77.39 Favored 'General case' 0 CA--C 1.555 1.135 0 CA-C-N 116.316 -0.402 . . . . 73.41 111.914 -172.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.2 m -63.71 -51.47 65.38 Favored Pre-proline 0 CA--C 1.57 1.73 0 C-N-CA 124.247 1.019 . . . . 71.54 113.084 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.47 -19.97 48.39 Favored 'Trans proline' 0 C--N 1.397 3.084 0 C-N-CA 121.842 1.695 . . . . 62.22 113.008 173.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -67.99 -37.52 81.58 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.187 0.595 . . . . 63.33 110.519 174.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.439 HG21 HD13 ' A' ' 13' ' ' ILE . 48.7 mm -67.29 -41.45 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.529 0.732 . . . . 65.24 110.084 173.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.437 HD22 ' HG3' ' A' ' 80' ' ' GLN . 61.5 mt -73.5 -25.59 60.51 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.018 -0.992 . . . . 63.11 112.422 -174.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -61.12 -45.57 95.97 Favored Pre-proline 0 N--CA 1.486 1.354 0 N-CA-C 114.127 1.158 . . . . 75.55 114.127 -173.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -53.46 -36.46 79.77 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.265 1.977 . . . . 74.52 113.611 171.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.426 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 88.0 m-85 -83.36 -28.96 28.6 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.635 0.774 . . . . 64.13 112.252 -177.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.93 -46.77 70.57 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.414 -0.958 . . . . 41.43 108.414 172.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.476 ' HG2' ' OH ' ' C' ' 109' ' ' TYR . 32.0 ttm180 -58.25 -43.17 87.71 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 114.04 -1.436 . . . . 75.14 109.739 175.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 109' ' ' TYR . 11.6 tt0 -48.83 -57.94 5.6 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 125.055 1.342 . . . . 73.2 111.462 175.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 117' ' ' MET . 53.6 t -64.92 -45.19 86.91 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.428 -1.26 . . . . 65.52 111.693 -174.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.632 HD13 HD11 ' A' ' 128' ' ' LEU . 8.5 mt -58.6 -60.27 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.818 0.847 . . . . 63.53 110.554 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.9 m -50.1 -41.87 49.16 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 125.058 1.343 . . . . 65.51 112.513 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -67.97 -43.03 79.91 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.714 -1.13 . . . . 75.31 110.635 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.513 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 52.6 mtm -62.28 -39.32 92.55 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 122.807 0.443 . . . . 65.43 110.875 177.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 114' ' ' ILE . 94.9 t -57.58 -49.56 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 124.341 1.056 . . . . 75.13 110.232 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 81.6 p -71.61 -29.36 64.58 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.89 -0.595 . . . . 64.51 111.61 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -72.33 -29.19 63.59 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.673 0.789 . . . . 74.12 110.17 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.76 18.3 31.16 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-O 119.459 -0.634 . . . . 72.54 112.762 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.47 HG21 ' HE ' ' B' ' 15' ' ' ARG . 5.6 t 58.03 13.08 2.04 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 127.445 2.298 . . . . 61.31 114.014 178.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -78.98 150.25 74.72 Favored Pre-proline 0 C--O 1.245 0.85 0 N-CA-C 108.156 -1.053 . . . . 63.23 108.156 171.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -58.61 144.25 97.64 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.278 1.985 . . . . 55.25 110.852 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -55.07 129.34 37.64 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 124.562 1.164 . . . . 72.42 111.698 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.9 tp -107.37 138.1 44.2 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 108.416 -0.957 . . . . 71.43 108.416 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -122.74 125.85 46.35 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.1 -1.074 . . . . 73.35 108.1 175.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.632 HD11 HD13 ' A' ' 114' ' ' ILE . 10.2 mt -73.1 126.54 30.24 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.492 -0.929 . . . . 74.14 108.492 177.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.71 134.99 82.79 Favored Pre-proline 0 CA--C 1.554 1.108 0 CA-C-O 118.974 -0.536 . . . . 50.14 110.883 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.59 116.56 2.8 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.653 2.902 . . . . 73.21 113.843 -175.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.521 HG21 HD11 ' A' ' 44' ' ' LEU . 61.4 t -105.87 131.94 54.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-O 121.058 0.456 . . . . 71.23 110.456 177.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.453 ' OD1' ' HB3' ' A' ' 134' ' ' ASP . 52.0 t-20 -99.66 91.79 5.04 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.581 -1.191 . . . . 53.25 107.82 175.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.402 ' CZ ' HD13 ' A' ' 44' ' ' LEU . 92.2 m-85 -63.16 -25.83 68.53 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.715 0.806 . . . . 72.44 112.637 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.571 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 28.9 t70 -59.37 -49.56 77.34 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.286 -0.635 . . . . 74.25 109.286 171.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.37 96.54 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.326 1.017 . . . . 73.23 111.286 177.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 72.6 mt -60.7 -43.4 97.83 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.084 0.554 . . . . 72.1 111.14 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 39.3 t80 . . . . . 0 CA--C 1.539 0.548 0 CA-C-N 115.863 -0.608 . . . . 73.22 110.153 178.878 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.49 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 1.0 OUTLIER . . . . . 0 CA--C 1.565 1.539 0 CA-C-O 120.905 0.383 . . . . 72.53 110.97 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.467 ' N ' ' SD ' ' B' ' 9' ' ' MET . 79.3 m -149.45 108.48 3.9 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 123.987 0.915 . . . . 65.13 108.71 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.477 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 65.9 t80 -116.55 145.63 43.21 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.433 0.693 . . . . 53.35 109.363 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -158.91 141.7 14.36 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.194 -1.039 . . . . 72.4 108.194 170.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.461 HD13 HD11 ' B' ' 16' ' ' ILE . 31.6 mt -76.86 145.67 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 N-CA-C 108.267 -1.012 . . . . 64.45 108.267 170.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -109.25 -40.51 4.92 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.901 0.481 . . . . 70.52 110.183 174.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.47 ' HE ' HG21 ' A' ' 122' ' ' THR . 48.0 ttt180 -173.68 137.13 0.6 Allowed 'General case' 0 N--CA 1.476 0.871 0 O-C-N 123.73 0.644 . . . . 74.42 109.881 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.461 HD11 HD13 ' B' ' 13' ' ' ILE . 93.4 mt -114.92 138.55 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.848 1.259 . . . . 64.33 107.678 176.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -164.43 140.68 6.16 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.919 0.711 . . . . 70.4 112.919 -173.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 69.9 m -73.7 121.48 20.83 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.057 -0.974 . . . . 74.44 109.121 170.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.523 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 46.9 mtpt -98.77 -16.96 18.74 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.636 0.774 . . . . 65.02 111.764 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.572 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 34.5 t70 -169.81 144.66 2.86 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.724 0.64 . . . . 63.33 111.186 -172.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.525 HD11 ' SG ' ' B' ' 113' ' ' CYS . 30.6 mm -143.53 146.36 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.677 1.191 . . . . 75.4 110.173 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.501 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 72.4 m -144.02 139.28 28.92 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.528 1.531 . . . . 63.41 108.558 171.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.56 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 89.4 t80 -148.36 108.73 4.13 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.297 -1.742 . . . . 72.41 106.297 164.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -118.8 114.64 22.96 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.079 -1.082 . . . . 64.21 108.079 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.465 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -106.68 86.9 2.47 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.164 -1.421 . . . . 64.03 107.164 173.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.9 -35.52 20.65 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.883 2.389 . . . . 54.22 112.171 -171.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -103.1 16.38 26.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.977 0.911 . . . . 75.54 110.962 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.465 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -43.77 -58.52 4.49 Favored Pre-proline 0 N--CA 1.491 1.591 0 C-N-CA 124.985 1.314 . . . . 70.1 114.479 -168.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 33.9 Cg_exo -57.99 -45.42 32.35 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 122.367 2.044 . . . . 72.31 113.328 -171.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -96.55 -17.24 20.6 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.172 -0.922 . . . . 73.43 112.802 -170.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.584 HG21 ' HA ' ' B' ' 73' ' ' ALA . 5.2 p -73.07 -20.32 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 118.169 0.44 . . . . 73.41 110.345 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -72.61 -1.06 14.67 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.493 0.923 . . . . 74.21 113.493 -177.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -71.56 -16.88 62.33 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 120.911 0.386 . . . . 74.42 110.097 167.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -105.9 69.38 0.81 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.525 1.53 . . . . 74.41 110.0 -176.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -84.85 76.59 10.22 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.773 0.797 . . . . 72.04 110.492 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.444 ' O ' ' HG2' ' B' ' 124' ' ' PRO . 3.8 p90 -152.92 173.15 15.73 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.037 -1.097 . . . . 72.32 108.037 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -66.52 115.33 23.1 Favored Pre-proline 0 CA--C 1.563 1.445 0 N-CA-C 112.353 0.501 . . . . 72.12 112.353 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.413 ' HD3' ' HG2' ' B' ' 124' ' ' PRO . 60.2 Cg_endo -71.85 157.06 55.86 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.512 2.141 . . . . 64.12 111.593 176.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.68 103.96 5.16 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.252 -1.018 . . . . 75.43 108.252 169.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.671 HG11 HD11 ' B' ' 126' ' ' LEU . 21.5 t -96.18 157.08 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.204 1.002 . . . . 74.03 110.031 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -142.97 124.65 14.95 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.625 1.17 . . . . 75.43 107.94 172.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.59 HD13 HD22 ' B' ' 128' ' ' LEU . 21.5 tp -87.56 136.85 32.78 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 108.32 -0.992 . . . . 74.23 108.32 170.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -137.04 149.89 47.73 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.711 -0.848 . . . . 64.11 108.711 -173.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mp -128.6 150.5 50.19 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.92 0.888 . . . . 71.43 109.578 -174.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 27.2 t70 -154.55 152.15 29.72 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.57 1.148 . . . . 63.41 108.673 173.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . 0.42 HG22 HD22 ' B' ' 60' ' ' LEU . 75.9 p -126.76 134.5 50.6 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 121.176 0.513 . . . . 73.12 111.474 -177.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.05 116.17 6.06 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.04 -1.467 . . . . 74.33 107.04 169.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.506 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 41.0 m -143.0 161.15 38.9 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.572 0.349 . . . . 61.34 110.741 -171.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.8 p -152.1 139.91 19.93 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.904 0.482 . . . . 33.13 111.288 -172.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -83.47 129.25 34.97 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.465 -0.939 . . . . 74.41 108.465 169.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 pp -141.84 25.05 1.99 Allowed 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.774 0.829 . . . . 74.33 109.823 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' B' ' 55' ' ' VAL . . . -161.43 148.01 14.44 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.154 -0.93 . . . . 62.14 109.789 -173.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.41 121.71 24.18 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.1 -0.704 . . . . 72.23 109.1 171.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 68.53 12.12 8.59 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 124.675 1.235 . . . . 50.12 113.03 174.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.407 ' O ' ' HB3' ' B' ' 52' ' ' ALA . 89.6 t -140.01 129.87 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 N-CA-C 107.068 -1.456 . . . . 74.34 107.068 -175.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.506 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 11.8 t80 -118.0 153.37 33.78 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.902 -0.499 . . . . 54.11 110.104 -175.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -116.3 105.77 12.92 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.63 -1.248 . . . . 61.22 107.63 176.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.43 143.41 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.859 0.864 . . . . 63.54 109.787 -176.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 22.7 t -129.83 127.06 63.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 C-N-CA 123.982 0.913 . . . . 63.53 108.756 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.42 HD22 HG22 ' B' ' 46' ' ' THR . 0.3 OUTLIER -110.53 120.41 42.32 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 107.628 -1.249 . . . . 54.05 107.628 172.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.428 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 16.7 ttm-85 -86.82 113.28 22.5 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.86 -0.793 . . . . 64.11 108.86 174.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.17 105.19 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.095 0.958 . . . . 73.21 108.652 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 23.9 m -107.08 148.01 29.29 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.209 1.004 . . . . 51.32 109.991 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.551 HG11 HD21 ' B' ' 126' ' ' LEU . 24.4 t -136.47 117.78 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.107 1.363 . . . . 74.24 108.797 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 85.8 m -104.96 136.53 44.27 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 108.119 -1.067 . . . . 63.14 108.119 169.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.2 144.65 36.69 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.801 -0.814 . . . . 64.42 108.801 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.489 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 61.2 p -144.54 133.35 22.44 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.745 0.646 . . . . 22.11 112.745 -173.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 53.0 mt -107.61 128.44 54.54 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.672 1.189 . . . . 61.32 110.506 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.76 -110.57 3.41 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 111.751 -0.539 . . . . 51.54 111.751 -173.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -116.9 1.73 12.7 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 123.536 0.734 . . . . 73.25 110.432 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -115.03 158.37 22.19 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.749 -0.595 . . . . 75.11 110.218 -174.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.8 m -68.77 130.87 44.07 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 110.062 -0.348 . . . . 65.02 110.062 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.584 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -81.0 -64.82 1.11 Allowed 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.634 -1.247 . . . . 73.11 107.634 173.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -151.29 164.77 35.88 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.058 -0.974 . . . . 64.24 111.492 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 74.5 mt -127.01 131.61 50.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 105.992 -1.855 . . . . 70.1 105.992 170.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 34.2 t -131.51 149.79 52.39 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.036 -1.098 . . . . 64.14 108.036 172.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.501 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 49.7 tt0 -158.41 131.89 7.56 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.072 -0.714 . . . . 70.02 109.072 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.411 HG11 ' HA ' ' B' ' 110' ' ' ALA . 87.4 t -129.44 148.38 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.443 -0.947 . . . . 74.15 108.443 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.572 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 27.2 mt-30 -124.91 93.56 3.93 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.958 -1.127 . . . . 73.11 107.958 171.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.412 ' HG3' HD22 ' B' ' 106' ' ' LEU . 8.7 tp-100 -89.76 108.93 19.98 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.229 -0.896 . . . . 64.33 108.878 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.523 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -104.4 171.78 19.77 Favored Glycine 0 C--N 1.337 0.62 0 O-C-N 123.791 0.682 . . . . 63.42 111.867 177.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.46 137.48 4.26 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.468 -0.396 . . . . 74.42 112.47 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 51.4 mt -88.79 121.26 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 107.42 -1.326 . . . . 73.43 107.42 170.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -131.54 145.14 51.59 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.27 1.028 . . . . 61.04 108.974 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 56.4 m -89.53 121.88 32.16 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.548 0.739 . . . . 72.32 110.058 170.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.691 HG22 HD11 ' B' ' 89' ' ' ILE . 5.3 mp -125.29 108.79 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 107.472 -1.307 . . . . 74.02 107.472 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.86 166.12 26.17 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.609 0.763 . . . . 74.24 111.069 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 94.37 -29.81 8.49 Favored Glycine 0 N--CA 1.482 1.739 0 CA-C-O 121.098 0.277 . . . . 45.2 113.419 176.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.691 HD11 HG22 ' B' ' 86' ' ' ILE . 0.7 OUTLIER -90.83 168.26 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 124.598 1.159 . . . . 71.11 110.999 176.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -157.16 163.47 38.85 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.649 0.78 . . . . 35.42 110.299 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.51 -113.4 4.33 Favored Glycine 0 C--N 1.356 1.641 0 C-N-CA 123.473 0.558 . . . . 63.41 112.521 171.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 31.4 m -104.22 -35.42 8.01 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.71 0.804 . . . . 55.5 109.604 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -66.3 -17.31 64.68 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.104 0.962 . . . . 74.21 111.98 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.478 ' HA ' HD13 ' B' ' 89' ' ' ILE . 21.5 ptm -61.21 -56.57 19.16 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 122.865 0.466 . . . . 74.13 111.514 173.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . 0.403 ' HA ' ' HG ' ' B' ' 98' ' ' LEU . . . -81.0 -11.47 59.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.793 0.837 . . . . 63.14 111.939 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -64.75 -36.04 83.03 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.68 0.392 . . . . 64.2 110.778 169.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.1 t -66.76 -41.13 88.27 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.748 0.419 . . . . 74.45 111.516 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.603 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.6 pp -84.19 -29.82 26.29 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.892 0.477 . . . . 73.24 111.402 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.86 -24.65 31.88 Favored Glycine 0 C--N 1.345 1.081 0 O-C-N 123.535 0.522 . . . . 62.03 113.913 -172.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.4 -48.48 2.19 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.291 0.637 . . . . 72.33 111.513 -174.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -75.94 -47.07 26.62 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.689 0.396 . . . . 72.14 111.692 -173.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.603 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 73.6 m -64.03 -42.42 69.26 Favored Pre-proline 0 CA--C 1.566 1.559 0 N-CA-C 113.6 0.963 . . . . 70.51 113.6 -177.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.55 -21.22 53.01 Favored 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 121.878 1.719 . . . . 65.3 113.806 173.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -70.13 -30.55 67.75 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 122.539 0.335 . . . . 63.5 110.772 173.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.473 HG23 ' NH2' ' D' ' 111' ' ' ARG . 84.0 mt -67.34 -40.77 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.789 0.836 . . . . 75.44 109.689 170.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.412 HD22 ' HG3' ' B' ' 80' ' ' GLN . 96.8 mt -76.47 -27.36 56.1 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.831 -1.077 . . . . 63.23 112.51 -174.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -55.23 -47.47 98.47 Favored Pre-proline 0 CA--C 1.567 1.597 0 CA-C-O 118.042 -0.98 . . . . 72.13 113.494 -175.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -52.45 -41.3 68.23 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 122.838 2.359 . . . . 74.22 114.711 174.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -68.83 -36.62 78.41 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.057 0.543 . . . . 62.51 110.656 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.411 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -70.5 -36.08 73.59 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.765 0.826 . . . . 75.35 111.062 174.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.553 ' HA ' HD12 ' B' ' 128' ' ' LEU . 35.4 ttt-85 -63.3 -56.05 19.68 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.167 1.387 . . . . 70.45 110.661 -178.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.465 ' HG3' ' NH2' ' C' ' 120' ' ' ARG . 1.4 tm-20 -69.48 -22.53 63.61 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.762 -0.654 . . . . 75.42 109.832 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.525 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.3 t -75.97 -28.37 57.85 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 122.64 0.376 . . . . 73.21 111.138 176.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.481 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 52.3 mt -74.97 -56.22 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.515 0.726 . . . . 74.14 109.234 173.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 52.6 m -58.56 -27.95 65.07 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.185 0.994 . . . . 70.22 111.556 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.485 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 29.8 t -58.59 -53.76 54.75 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.921 0.888 . . . . 52.3 110.365 173.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.4 mmt -71.6 -32.8 68.41 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.905 0.882 . . . . 74.0 111.074 -172.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.426 HG21 ' CD2' ' B' ' 126' ' ' LEU . 98.7 t -64.67 -42.87 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.658 1.183 . . . . 65.13 110.459 173.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.7 t -65.93 -39.09 90.21 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.033 -0.985 . . . . 70.11 110.408 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' B' ' 116' ' ' SER . 66.4 mtt-85 -64.91 -45.44 85.89 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.518 -0.765 . . . . 74.44 109.214 174.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . 0.506 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -64.22 -11.16 44.98 Favored Glycine 0 C--N 1.361 1.917 0 O-C-N 124.58 1.175 . . . . 74.45 113.494 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 15.8 m 66.01 29.16 10.25 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.792 1.237 . . . . 52.31 110.329 174.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -83.33 162.63 53.29 Favored Pre-proline 0 CA--C 1.552 1.036 0 CA-C-N 114.841 -1.072 . . . . 74.12 110.652 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.444 ' HG2' ' O ' ' B' ' 36' ' ' TRP . 92.0 Cg_exo -48.36 159.61 0.73 Allowed 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.786 2.991 . . . . 70.02 114.787 173.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.423 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 22.8 tp60 -60.55 113.19 2.3 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.36 -0.837 . . . . 73.11 111.484 -173.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.671 HD11 HG11 ' B' ' 40' ' ' VAL . 15.9 tp -112.23 120.08 40.54 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.843 -0.799 . . . . 75.03 108.843 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -133.0 126.53 32.15 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 107.801 -1.185 . . . . 55.31 107.801 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.59 HD22 HD13 ' B' ' 42' ' ' LEU . 76.1 mt -83.27 134.2 34.95 Favored 'General case' 0 C--O 1.242 0.7 0 O-C-N 123.409 0.443 . . . . 72.23 110.96 -176.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.61 143.88 90.55 Favored Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 124.58 1.175 . . . . 24.23 110.144 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -65.79 92.74 0.26 Allowed 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.68 2.253 . . . . 72.24 111.429 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 98.6 t -90.66 109.49 20.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.682 -1.229 . . . . 73.44 107.682 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 . . . . . 0 C--O 1.245 0.821 0 N-CA-C 107.539 -1.282 . . . . 74.53 107.539 177.15 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 65.0 t80 . . . . . 0 C--O 1.237 0.425 0 N-CA-C 108.594 -0.891 . . . . 73.24 108.594 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -159.22 123.9 4.04 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 108.898 -0.779 . . . . 63.52 108.898 175.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 62.2 mt -68.56 127.16 29.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 N-CA-C 108.741 -0.837 . . . . 74.12 108.741 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -89.38 -48.35 7.4 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 109.308 -0.627 . . . . 72.42 109.308 174.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.88 148.98 0.43 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.219 1.408 . . . . 71.2 108.731 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 2.7 pp -116.59 155.2 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 106.978 -1.49 . . . . 73.33 106.978 173.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.441 ' HB3' HG23 ' D' ' 122' ' ' THR . 29.5 p90 -175.28 151.36 1.25 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.68 0.752 . . . . 74.42 111.3 -174.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 64.7 p -78.79 102.62 8.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.818 -1.083 . . . . 73.45 108.84 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 8.8 mtmt -72.8 -30.4 64.04 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.061 -0.718 . . . . 72.23 109.061 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.762 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 20.8 t70 -143.91 138.8 28.81 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.104 -0.953 . . . . 63.11 109.732 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.52 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.6 mt -137.43 143.66 33.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 106.818 -1.549 . . . . 71.32 106.818 174.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 26.1 t -155.04 141.04 18.33 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 123.76 0.663 . . . . 71.04 110.084 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -145.32 113.0 6.32 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 106.974 -1.491 . . . . 74.03 106.974 171.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -117.71 122.92 44.77 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.167 0.587 . . . . 72.55 109.99 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.35 75.79 73.56 Favored Pre-proline 0 CA--C 1.552 1.026 0 N-CA-C 107.388 -1.338 . . . . 73.23 107.388 171.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -69.82 -22.75 31.36 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 122.77 2.314 . . . . 65.0 111.511 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -101.36 12.45 37.38 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.541 1.136 . . . . 73.43 110.191 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.446 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -49.1 -58.14 9.55 Favored Pre-proline 0 C--N 1.375 1.715 0 C-N-CA 124.388 1.075 . . . . 50.32 113.554 -169.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.446 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 18.4 Cg_exo -64.29 -35.95 48.45 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 121.704 1.603 . . . . 60.31 112.132 -176.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -69.82 -37.75 76.32 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.293 1.037 . . . . 74.35 112.297 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.614 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.1 p -81.29 -21.71 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 C-N-CA 122.819 0.448 . . . . 72.32 111.889 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -65.48 -26.84 68.11 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 120.681 0.277 . . . . 72.34 111.263 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -100.41 34.58 2.35 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.652 0.781 . . . . 73.45 110.279 174.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -125.05 163.08 23.15 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.523 0.729 . . . . 71.35 110.23 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -66.58 112.99 4.42 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.532 0.733 . . . . 70.3 110.656 173.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 69.5 t-105 -76.8 81.97 3.39 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.363 0.665 . . . . 72.33 110.529 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . 0.451 ' H ' HD22 ' C' ' 68' ' ' LEU . 96.8 mt-30 -136.17 73.72 57.31 Favored Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 124.522 1.129 . . . . 62.13 108.465 174.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.31 155.48 25.25 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.702 2.268 . . . . 53.23 113.837 -171.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -87.4 87.71 7.49 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 105.146 -2.168 . . . . 71.41 105.146 161.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.505 HG11 HD11 ' C' ' 126' ' ' LEU . 68.7 t -76.66 98.34 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.578 0 N-CA-C 107.527 -1.286 . . . . 73.14 107.527 177.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -114.59 103.8 11.37 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.953 -1.021 . . . . 71.34 108.329 -175.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.27 160.63 18.36 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.214 0.531 . . . . 62.24 110.287 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.611 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 18.1 t70 -145.69 121.15 10.34 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.614 1.166 . . . . 73.53 108.287 -177.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.522 HD21 HG13 ' C' ' 62' ' ' VAL . 81.8 mt -125.44 111.95 15.7 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.526 0.73 . . . . 72.45 109.99 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -136.52 127.06 26.9 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.439 -0.949 . . . . 70.13 108.439 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 12.4 t -115.05 146.27 41.45 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.272 0.629 . . . . 74.41 109.47 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.36 163.96 27.53 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.067 0.947 . . . . 55.34 109.304 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.465 ' OG ' ' HB3' ' C' ' 98' ' ' LEU . 3.2 m -142.89 143.71 32.16 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.805 -0.442 . . . . 73.3 109.805 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.9 t -145.2 127.81 16.12 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.0 0.92 . . . . 42.21 108.548 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -79.55 117.4 20.45 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.077 -0.712 . . . . 73.04 109.077 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.632 HD11 ' HB2' ' C' ' 57' ' ' GLU . 61.0 mt -86.39 -35.08 19.98 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.266 0.626 . . . . 74.23 111.027 -176.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.19 179.64 8.96 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.961 -1.018 . . . . 22.41 109.088 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.5 116.46 7.5 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.148 -0.686 . . . . 75.24 109.148 -178.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 68.33 18.9 9.08 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.447 1.099 . . . . 74.24 112.068 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 90.5 t -123.81 115.23 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 108.639 -0.874 . . . . 73.31 108.639 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -121.71 128.96 52.38 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.337 1.055 . . . . 71.52 109.577 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.632 ' HB2' HD11 ' C' ' 51' ' ' LEU . 44.2 tt0 -93.16 138.62 31.41 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.088 -0.708 . . . . 71.22 109.088 167.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 83.5 t -122.83 139.68 48.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.911 -1.144 . . . . 74.31 107.911 171.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 54.3 t -127.85 130.26 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 109.516 -0.55 . . . . 71.54 109.516 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.79 111.2 23.61 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.702 -1.221 . . . . 60.54 107.702 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -83.1 111.85 19.28 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 108.556 -0.905 . . . . 75.23 108.556 170.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.522 HG13 HD21 ' C' ' 44' ' ' LEU . 21.9 t -114.38 115.5 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 108.02 -1.104 . . . . 61.43 108.02 175.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 10.9 m -125.39 125.54 43.58 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.598 0.759 . . . . 64.23 108.956 -171.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.638 HG23 HD13 ' C' ' 114' ' ' ILE . 84.2 t -112.92 125.16 70.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 123.964 0.906 . . . . 72.52 108.89 177.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 12.5 m -104.12 138.81 40.08 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.77 -0.826 . . . . 53.44 108.77 170.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.97 101.56 5.48 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.636 -1.616 . . . . 64.42 106.636 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 41.1 m -134.02 126.46 30.26 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.537 -0.542 . . . . 74.43 109.537 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.451 HD22 ' H ' ' C' ' 37' ' ' GLN . 9.7 mt -84.47 52.85 2.47 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.618 1.167 . . . . 64.3 109.213 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.1 -99.83 1.93 Allowed Glycine 0 C--N 1.349 1.259 0 N-CA-C 110.515 -1.034 . . . . 70.4 110.515 -172.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -101.11 -30.44 11.58 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.943 0.897 . . . . 64.44 110.439 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -70.33 109.98 5.02 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.424 1.089 . . . . 62.35 109.451 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 38.9 m -83.41 124.46 30.7 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.897 0.772 . . . . 73.34 110.025 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.614 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -76.6 -57.93 3.57 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 114.398 -1.274 . . . . 72.43 109.618 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -154.65 166.26 33.96 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.025 -0.989 . . . . 73.33 110.706 174.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.432 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.4 tm? -129.23 142.56 50.82 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 105.894 -1.891 . . . . 71.05 105.894 166.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.432 ' N ' HD13 ' C' ' 75' ' ' LEU . 49.1 t -143.59 143.31 31.44 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.075 -1.083 . . . . 43.42 108.075 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -157.18 132.11 8.85 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 122.796 0.439 . . . . 74.21 109.973 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.434 HG11 ' HA ' ' C' ' 110' ' ' ALA . 55.2 t -133.85 115.41 21.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 124.748 1.219 . . . . 73.23 108.804 -176.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.762 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.2 mt-30 -96.19 90.56 5.54 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.677 0.791 . . . . 74.3 109.116 173.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.484 ' HG3' HD22 ' C' ' 106' ' ' LEU . 7.1 tp-100 -80.67 99.74 8.33 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.698 -1.137 . . . . 65.31 109.515 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.56 153.78 27.74 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.862 -0.495 . . . . 62.13 111.862 174.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.5 126.44 2.08 Favored Glycine 0 CA--C 1.501 -0.785 0 N-CA-C 110.966 -0.854 . . . . 74.24 110.966 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.482 HD12 HD11 ' C' ' 51' ' ' LEU . 13.3 mm -88.96 128.71 40.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 N-CA-C 108.891 -0.781 . . . . 73.44 108.891 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -135.87 118.39 15.88 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.379 0.671 . . . . 73.24 109.369 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.5 p -79.6 101.32 8.24 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.262 -1.014 . . . . 32.2 108.262 172.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.651 HG21 ' HE1' ' C' ' 94' ' ' MET . 21.3 mt -117.53 129.94 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.582 0.753 . . . . 73.1 110.52 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -139.28 164.62 29.33 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.297 0.639 . . . . 73.55 110.671 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.39 -19.24 44.86 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 114.896 0.718 . . . . 72.32 114.896 170.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' C' ' 94' ' ' MET . 47.4 pt -108.53 167.97 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 117.593 0.697 . . . . 74.24 111.457 -176.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -159.35 177.9 10.51 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.364 -1.289 . . . . 74.5 109.263 175.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.63 -120.53 12.07 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 115.815 1.086 . . . . 62.21 115.815 173.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 46.4 p -64.91 -36.87 85.77 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.408 1.083 . . . . 71.32 111.173 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -62.23 -58.31 8.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.496 1.118 . . . . 74.31 110.538 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.651 ' HE1' HG21 ' C' ' 86' ' ' ILE . 4.6 tpt -54.15 -52.51 60.88 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 124.066 0.946 . . . . 73.54 112.243 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.96 -40.9 77.33 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 123.87 0.731 . . . . 74.32 111.235 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -68.7 -37.31 79.42 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.2 0.6 . . . . 65.35 111.222 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.477 ' SG ' HD13 ' C' ' 86' ' ' ILE . 35.4 t -67.6 -34.56 77.25 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.659 -0.497 . . . . 70.23 109.659 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.465 ' HB3' ' OG ' ' C' ' 48' ' ' SER . 79.9 mt -88.16 -33.03 18.33 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.527 1.131 . . . . 74.2 112.173 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.5 10.91 26.02 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 114.63 0.612 . . . . 73.02 114.63 -167.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.11 -48.66 0.07 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 117.401 0.6 . . . . 55.51 111.613 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -72.74 -55.03 7.37 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.302 0.641 . . . . 74.34 111.306 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 94.4 m -63.74 -44.99 81.7 Favored Pre-proline 0 CA--C 1.562 1.419 0 CA-C-O 118.213 -0.898 . . . . 63.25 112.031 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -53.02 -31.55 54.07 Favored 'Trans proline' 0 C--N 1.394 2.962 0 C-N-CA 122.88 2.387 . . . . 72.32 114.204 170.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -67.52 -35.54 79.29 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.537 0.735 . . . . 75.13 110.373 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.468 HD12 ' NH1' ' A' ' 111' ' ' ARG . 46.0 mm -77.06 -33.26 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.375 0.67 . . . . 75.24 110.449 177.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.484 HD22 ' HG3' ' C' ' 80' ' ' GLN . 94.3 mt -82.23 -30.02 31.01 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.865 0.866 . . . . 72.44 112.034 -175.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -57.18 -49.45 93.86 Favored Pre-proline 0 N--CA 1.484 1.23 0 CA-C-O 117.891 -1.052 . . . . 73.34 113.457 -173.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.61 -40.91 81.86 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 122.561 2.174 . . . . 71.1 114.31 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.476 ' OH ' ' HG2' ' A' ' 111' ' ' ARG . 89.6 m-85 -74.98 -37.56 61.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.155 0.582 . . . . 72.35 111.425 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.434 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -68.34 -34.89 76.92 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.353 -0.84 . . . . 54.03 110.498 176.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 24.2 ttt-85 -66.12 -51.24 59.8 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.604 1.561 . . . . 74.32 109.757 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -60.0 -39.53 86.1 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 124.093 0.871 . . . . 74.34 110.154 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 35.1 t -66.41 -39.86 89.23 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.461 -0.79 . . . . 74.32 110.933 -177.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.638 HD13 HG23 ' C' ' 64' ' ' VAL . 84.2 mt -69.19 -56.16 12.84 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 O-C-N 123.376 0.423 . . . . 71.05 110.565 177.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.1 m -63.21 -27.73 69.55 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 122.928 0.491 . . . . 74.1 111.066 -173.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 38.4 t -65.68 -49.34 68.91 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.383 0.673 . . . . 71.42 109.486 169.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.509 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.63 -36.63 79.1 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 124.607 1.163 . . . . 72.4 112.719 179.319 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.435 HG23 ' O ' ' C' ' 114' ' ' ILE . 76.6 t -64.23 -46.41 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.636 0.774 . . . . 65.23 108.962 175.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 39.5 t -67.3 -31.18 71.31 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.004 -0.998 . . . . 61.45 111.47 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.465 ' NH2' ' HG3' ' B' ' 112' ' ' GLU . 72.7 mtt-85 -71.17 -37.24 72.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.891 0.876 . . . . 75.54 109.566 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.46 4.3 84.45 Favored Glycine 0 C--N 1.353 1.474 0 O-C-N 123.848 0.717 . . . . 62.14 112.496 172.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 71.9 p 59.02 29.31 18.83 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.385 1.874 . . . . 75.24 113.696 172.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -85.38 143.2 38.64 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 107.018 -1.475 . . . . 73.2 107.018 166.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -48.69 143.3 16.82 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 123.088 2.525 . . . . 73.12 112.979 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.423 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 20.7 mm-40 -46.9 142.67 3.31 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 124.565 1.165 . . . . 74.42 112.786 -174.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.505 HD11 HG11 ' C' ' 40' ' ' VAL . 23.6 tp -144.88 88.49 1.9 Allowed 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.188 -1.041 . . . . 74.43 108.188 -177.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -91.85 117.2 29.56 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.502 -1.226 . . . . 63.24 109.063 -174.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.402 HD21 HG21 ' C' ' 64' ' ' VAL . 4.1 mm? -70.91 124.53 24.55 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 123.893 0.745 . . . . 73.11 109.864 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.13 145.17 85.65 Favored Pre-proline 0 CA--C 1.548 0.874 0 O-C-N 124.219 0.949 . . . . 74.11 111.333 -175.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.453 ' HG3' HG21 ' A' ' 13' ' ' ILE . 16.1 Cg_endo -55.86 108.77 0.35 Allowed 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.555 2.837 . . . . 73.22 112.081 173.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 14.0 p -98.67 152.48 4.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 109.203 -0.666 . . . . 70.52 109.203 174.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -82.97 99.17 9.64 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.163 0.985 . . . . 73.2 108.832 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -68.66 -20.44 64.45 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.091 0.556 . . . . 74.23 112.121 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.78 -32.5 67.71 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.295 0.638 . . . . 72.21 110.792 172.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.14 -31.65 64.41 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.329 0.652 . . . . 74.01 110.588 174.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 56.3 mt -78.8 -20.91 48.64 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.423 -0.808 . . . . 72.15 110.438 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 69.0 t80 . . . . . 0 CA--C 1.548 0.88 0 C-N-CA 123.596 0.758 . . . . 73.5 110.582 172.976 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 28.9 p . . . . . 0 CA--C 1.545 0.776 0 N-CA-C 109.301 -0.629 . . . . 70.41 109.301 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -143.04 116.41 9.06 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.444 -1.317 . . . . 75.21 107.444 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -141.0 153.49 45.58 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.635 0.774 . . . . 63.21 109.415 172.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.523 HG21 HD11 ' D' ' 16' ' ' ILE . 73.8 mt -102.74 120.48 52.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.087 -1.079 . . . . 74.55 108.087 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -89.05 -42.57 11.66 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.17 0.588 . . . . 74.21 110.66 -175.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -163.37 142.36 8.27 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.285 0.366 . . . . 63.11 110.496 -172.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.523 HD11 HG21 ' D' ' 13' ' ' ILE . 2.7 mp -124.8 135.07 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 105.579 -2.008 . . . . 41.51 105.579 174.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.437 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 34.8 p90 -162.31 172.72 15.21 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 122.12 0.962 . . . . 72.35 112.079 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . 0.49 HG21 HD11 ' D' ' 21' ' ' ILE . 75.7 p -107.34 120.48 42.26 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.181 -1.372 . . . . 63.11 109.028 178.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.437 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 29.6 mtpt -92.02 -19.7 22.1 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.742 -0.663 . . . . 74.32 109.493 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.456 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 32.6 t70 -162.14 138.77 8.0 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.94 0.896 . . . . 73.33 109.743 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.509 HG21 ' HE2' ' C' ' 117' ' ' MET . 63.9 mt -141.81 139.64 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.809 1.244 . . . . 71.33 107.773 175.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.7 t -141.9 145.44 34.59 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.37 1.068 . . . . 75.12 108.608 170.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.52 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.0 t80 -144.95 117.66 8.67 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.143 -1.799 . . . . 74.13 106.143 167.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -125.55 118.91 26.76 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.159 0.584 . . . . 64.21 109.787 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.496 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -113.89 80.32 5.19 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 107.695 -1.224 . . . . 61.53 107.695 174.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.6 -19.07 16.97 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.681 2.254 . . . . 54.1 113.014 -169.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -113.49 1.42 15.02 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.599 0.76 . . . . 75.34 111.178 -177.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.496 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -27.44 -70.01 0.07 OUTLIER Pre-proline 0 CA--C 1.567 1.61 0 N-CA-C 117.481 2.4 . . . . 61.32 117.481 -167.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.56 -18.01 15.8 Favored 'Trans proline' 0 C--N 1.387 2.564 0 CA-C-N 124.19 2.532 . . . . 65.11 113.971 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.451 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 3.4 t-160 -78.31 -38.8 41.52 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.702 1.201 . . . . 72.11 109.699 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.428 HG21 ' HA ' ' D' ' 73' ' ' ALA . 5.1 p -83.83 -19.31 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-N 115.874 -0.603 . . . . 71.43 111.096 -175.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -64.07 -24.83 67.85 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 122.544 0.338 . . . . 75.23 111.159 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.451 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 62.1 mt-30 -65.97 -9.05 26.47 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.263 1.025 . . . . 74.42 111.711 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -100.52 99.33 9.91 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.225 1.41 . . . . 70.33 109.602 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -97.33 83.2 3.25 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.254 -0.885 . . . . 74.54 110.876 -171.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -158.82 176.97 11.68 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.822 0.849 . . . . 64.23 109.402 169.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -69.94 110.96 7.6 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.353 1.061 . . . . 73.14 109.829 174.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.454 ' HB3' ' HG ' ' D' ' 68' ' ' LEU . 38.9 Cg_endo -68.81 129.63 18.98 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.014 1.809 . . . . 74.33 110.588 175.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -67.4 116.55 8.29 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 107.514 -1.291 . . . . 73.54 107.514 168.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.562 ' CG1' HG13 ' D' ' 64' ' ' VAL . 16.1 t -98.23 114.41 35.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 108.9 -0.778 . . . . 74.21 108.9 176.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -89.54 116.93 28.06 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.81 -0.811 . . . . 73.04 108.81 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.497 HD22 HD11 ' D' ' 128' ' ' LEU . 49.2 tp -97.27 144.43 27.07 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.065 0.459 . . . . 74.12 110.23 -176.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -135.17 139.5 44.62 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.681 -1.6 . . . . 74.34 106.681 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.443 HD11 HG11 ' D' ' 131' ' ' VAL . 45.4 mt -130.0 132.07 46.12 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.226 0.61 . . . . 63.53 110.666 -174.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -140.35 154.11 46.63 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.598 1.159 . . . . 71.44 108.317 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 2.1 p -128.61 159.69 34.76 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.597 0.713 . . . . 75.55 110.778 176.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.544 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.75 177.8 9.46 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.218 -1.356 . . . . 61.1 108.528 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 61.9 p . . . . . 0 N--CA 1.476 0.866 0 C-N-CA 123.883 0.873 . . . . 64.22 108.977 -175.187 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.497 1.899 0 N-CA-C 113.951 1.093 . . . . 74.51 113.951 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.06 106.06 20.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.166 -1.42 . . . . 60.22 107.166 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -129.6 147.81 51.44 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.385 -0.598 . . . . 73.31 109.385 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -111.98 148.85 32.9 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.065 -1.087 . . . . 63.42 108.065 161.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 71.2 t -123.27 140.78 45.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 124.811 1.244 . . . . 70.22 107.692 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 30.3 t -125.89 137.31 58.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.727 -1.212 . . . . 55.54 107.727 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.434 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -125.74 105.4 8.95 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.511 -1.292 . . . . 73.12 107.511 -176.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 41.4 ttm-85 -85.14 102.49 13.32 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.748 0.819 . . . . 74.42 109.214 174.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.491 HG13 HD11 ' D' ' 42' ' ' LEU . 57.9 t -100.86 116.4 44.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.603 -0.888 . . . . 74.14 108.603 173.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.8 m -119.0 122.96 43.38 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.944 0.878 . . . . 72.52 110.233 -171.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.562 HG13 ' CG1' ' D' ' 40' ' ' VAL . 51.9 t -108.39 130.64 60.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 125.746 1.618 . . . . 61.22 109.635 -176.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 80.9 m -134.81 92.1 2.85 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.841 -1.17 . . . . 74.51 107.841 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -96.48 154.82 17.05 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.65 0.78 . . . . 44.32 109.123 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.481 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 25.2 p -149.58 135.02 18.37 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 123.648 0.592 . . . . 72.14 112.178 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.454 ' HG ' ' HB3' ' D' ' 38' ' ' PRO . 20.9 mt -105.46 102.43 11.9 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 124.81 1.244 . . . . 72.44 108.302 171.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.32 -125.4 10.6 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.572 -0.74 . . . . 72.41 113.438 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -84.97 4.96 31.22 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.554 1.142 . . . . 74.41 112.893 -174.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -146.32 165.75 28.35 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 120.9 0.381 . . . . 75.13 111.13 -172.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 55.7 m -64.03 135.26 56.27 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.529 -1.214 . . . . 65.34 111.435 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.481 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.46 -71.33 0.57 Allowed 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.236 -1.394 . . . . 63.32 107.236 170.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -145.11 151.95 39.29 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-O 121.179 0.514 . . . . 74.22 111.002 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 66.3 mt -117.08 152.54 34.47 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.095 1.358 . . . . 72.43 107.872 175.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.546 ' SG ' HG12 ' D' ' 114' ' ' ILE . 40.6 t -159.29 149.64 19.28 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.692 0.797 . . . . 63.13 108.883 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -154.91 121.71 5.45 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.48 -0.563 . . . . 75.41 109.48 170.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.58 115.82 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.64 0.776 . . . . 75.01 109.543 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.456 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.7 mt-30 -90.68 90.19 7.85 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.47 0.708 . . . . 74.0 109.415 170.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . 0.427 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.8 tp-100 -80.98 101.57 9.6 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.877 -1.056 . . . . 74.04 108.897 178.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.92 143.88 15.9 Favored Glycine 0 C--N 1.338 0.693 0 N-CA-C 111.397 -0.681 . . . . 60.21 111.397 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.8 140.72 7.84 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 111.758 -0.537 . . . . 74.32 111.758 -174.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 50.8 mt -90.48 120.57 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.724 -0.843 . . . . 60.51 108.724 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -121.01 126.48 50.02 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.099 0.96 . . . . 73.12 109.521 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 44.5 p -88.86 96.6 10.76 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.913 -0.773 . . . . 74.14 108.913 173.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.56 HD11 HD23 ' D' ' 98' ' ' LEU . 37.7 pt -119.83 129.16 75.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 115.465 -0.789 . . . . 53.25 109.615 -172.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.75 167.79 7.56 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.357 0.663 . . . . 75.23 110.926 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.25 12.3 61.74 Favored Glycine 0 N--CA 1.476 1.364 0 CA-C-N 116.629 -0.26 . . . . 72.43 112.993 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.511 HG12 ' SG ' ' D' ' 97' ' ' CYS . 1.0 OUTLIER -125.34 159.93 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.892 1.277 . . . . 63.33 109.074 176.171 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -149.4 156.38 41.95 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 122.989 0.516 . . . . 64.15 110.472 -168.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.37 -131.55 10.71 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 116.003 -0.544 . . . . 75.22 114.374 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 40.0 p -84.55 -41.0 16.9 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.183 0.993 . . . . 62.43 111.067 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -66.69 -19.05 65.68 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.279 -0.873 . . . . 73.54 111.408 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.45 ' HA ' HD13 ' D' ' 89' ' ' ILE . 59.4 ttp -54.33 -57.76 10.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.954 1.301 . . . . 70.4 111.392 174.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.21 -15.18 51.46 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.308 -0.86 . . . . 71.02 111.854 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -64.01 -22.93 67.14 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.938 0.495 . . . . 75.21 111.43 172.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . 0.511 ' SG ' HG12 ' D' ' 89' ' ' ILE . 81.8 m -59.89 -46.52 89.07 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.236 0.614 . . . . 74.04 111.187 175.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.56 HD23 HD11 ' D' ' 86' ' ' ILE . 3.1 pp -94.59 -20.71 19.37 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.352 0.501 . . . . 71.22 112.352 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.98 -29.38 23.29 Favored Glycine 0 C--N 1.346 1.134 0 O-C-N 123.353 0.408 . . . . 62.01 113.396 -173.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.36 -49.18 1.08 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.809 0.444 . . . . 75.4 111.289 -174.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -74.91 -41.94 58.74 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 112.697 0.629 . . . . 65.31 112.697 -172.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 71.7 m -66.26 -44.79 59.69 Favored Pre-proline 0 CA--C 1.558 1.262 0 CA-C-O 118.558 -0.734 . . . . 55.42 111.704 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.434 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 68.6 Cg_exo -56.59 -33.73 93.76 Favored 'Trans proline' 0 C--N 1.391 2.814 0 C-N-CA 122.021 1.814 . . . . 65.13 112.909 167.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -68.32 -29.57 68.35 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.523 0.729 . . . . 73.21 111.172 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.2 mm -74.93 -37.28 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.355 0.662 . . . . 61.44 109.945 172.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.427 HD13 ' O ' ' D' ' 80' ' ' GLN . 93.3 mt -79.95 -17.76 52.16 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.472 0.709 . . . . 72.14 112.443 -177.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -68.03 -44.08 38.16 Favored Pre-proline 0 N--CA 1.486 1.348 0 CA-C-O 118.472 -0.775 . . . . 75.04 112.725 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.47 -37.11 72.38 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.368 2.046 . . . . 73.22 113.687 170.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -81.02 -32.9 33.97 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.971 0.909 . . . . 73.1 112.428 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.96 -45.21 71.27 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.177 -0.675 . . . . 62.44 109.177 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.473 ' NH2' HG23 ' B' ' 105' ' ' ILE . 43.2 ttp180 -65.51 -39.13 91.48 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 114.371 -1.286 . . . . 71.35 110.139 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -52.59 -46.32 66.9 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 123.986 0.914 . . . . 64.11 110.523 175.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.2 t -67.71 -50.28 58.32 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.903 -1.044 . . . . 74.23 110.86 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.546 HG12 ' SG ' ' D' ' 76' ' ' CYS . 79.3 mt -59.58 -62.14 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 123.951 0.782 . . . . 73.44 110.883 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 17.3 m -50.48 -39.65 48.75 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.949 1.299 . . . . 65.53 111.954 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 24.6 t -64.0 -48.08 77.79 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.046 -0.979 . . . . 62.51 109.977 177.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 68.6 mtm -69.35 -27.21 65.15 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.282 0.633 . . . . 72.24 112.093 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.467 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.6 t -66.33 -46.07 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.407 0.683 . . . . 75.42 109.196 175.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.5 p -73.19 -28.98 62.51 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.576 -0.738 . . . . 73.34 110.698 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' D' ' 116' ' ' SER . 87.9 mtt-85 -70.86 -28.58 64.68 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.816 0.846 . . . . 74.44 110.416 173.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . 0.421 ' HA2' ' HB2' ' C' ' 17' ' ' TYR . . . -89.11 8.08 80.67 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 123.824 0.703 . . . . 70.33 112.763 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.441 HG23 ' HB3' ' C' ' 17' ' ' TYR . 47.7 p 59.09 20.47 8.38 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 126.35 1.86 . . . . 64.13 113.507 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -87.04 154.44 55.01 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 123.614 0.766 . . . . 74.41 110.106 174.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -50.3 127.44 20.1 Favored 'Trans proline' 0 C--N 1.386 2.532 0 C-N-CA 123.576 2.851 . . . . 65.02 113.013 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -52.24 128.93 26.63 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 124.522 1.139 . . . . 74.42 111.596 -173.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 33.8 tp -107.13 97.23 7.02 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.726 -0.472 . . . . 65.34 109.726 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -98.45 89.87 4.58 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 107.272 -1.381 . . . . 75.4 107.272 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.497 HD11 HD22 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -67.98 122.29 17.9 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 108.872 -0.788 . . . . 72.41 108.872 -175.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.57 142.65 87.24 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 123.798 0.839 . . . . 53.13 111.05 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.07 121.68 10.34 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.889 2.393 . . . . 75.32 112.098 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . 0.443 HG11 HD11 ' D' ' 44' ' ' LEU . 8.3 p -107.39 133.4 52.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 123.623 0.769 . . . . 73.32 109.551 -173.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -87.01 92.4 9.03 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.592 0.757 . . . . 62.21 108.96 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 N--CA 1.486 1.368 0 C-N-CA 124.392 1.077 . . . . 74.45 112.81 -175.683 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.0 m . . . . . 0 N--CA 1.467 0.4 0 N-CA-C 108.774 -0.824 . . . . 75.23 108.774 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -135.33 114.36 12.14 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.529 -1.286 . . . . 72.34 107.529 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -134.05 135.26 43.21 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.826 -1.176 . . . . 72.14 107.826 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.441 HD13 HG21 ' A' ' 105' ' ' ILE . 8.7 mt -93.95 114.44 30.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.381 -0.97 . . . . 63.04 108.381 174.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -81.54 -30.36 33.16 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 123.731 0.644 . . . . 71.53 110.47 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -175.87 134.27 0.28 Allowed 'General case' 0 C--N 1.361 1.089 0 C-N-CA 123.13 0.572 . . . . 55.53 110.372 -175.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.546 HD12 ' HG3' ' C' ' 130' ' ' PRO . 66.2 mt -118.13 133.77 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.998 -1.112 . . . . 74.51 107.998 169.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.456 ' HE1' HG13 ' A' ' 83' ' ' ILE . 24.9 p90 -164.23 149.39 10.31 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 124.098 0.874 . . . . 74.23 110.838 -174.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.0 p -75.27 130.18 38.67 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.862 -0.792 . . . . 73.23 108.862 172.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.446 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.9 mtpt -97.55 -30.05 13.1 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.778 -0.452 . . . . 74.53 109.778 175.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.434 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 7.7 t70 -143.37 141.58 30.97 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.351 -0.611 . . . . 74.24 109.351 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.442 HG23 ' SD ' ' A' ' 117' ' ' MET . 62.6 mt -142.24 146.29 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.164 1.386 . . . . 64.4 107.917 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.8 t -155.8 132.48 10.42 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.482 0.713 . . . . 65.11 109.737 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.605 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 80.5 t80 -139.08 114.65 9.85 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 107.199 -1.408 . . . . 75.24 107.199 172.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -118.24 114.36 22.89 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.996 -0.742 . . . . 74.43 108.996 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.47 79.57 1.75 Allowed Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 107.892 -1.151 . . . . 74.02 107.892 164.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.07 -26.13 21.87 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.547 2.164 . . . . 61.52 112.04 -172.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -104.49 17.9 23.24 Favored 'General case' 0 C--O 1.21 -1.02 0 CA-C-O 117.942 -1.027 . . . . 71.53 110.056 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.415 ' HA ' HG12 ' A' ' 31' ' ' VAL . . . -45.0 -51.96 21.19 Favored Pre-proline 0 N--CA 1.503 2.197 0 N-CA-C 114.291 1.219 . . . . 34.11 114.291 -169.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.09 -26.07 43.26 Favored 'Trans proline' 0 C--N 1.386 2.529 0 C-N-CA 121.764 1.643 . . . . 73.14 112.808 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -81.43 -43.22 19.21 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.251 1.02 . . . . 71.13 110.245 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.714 HG21 ' HA ' ' A' ' 73' ' ' ALA . 8.2 p -78.96 -21.87 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 114.762 -1.108 . . . . 71.13 112.142 -163.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -70.79 -18.17 62.76 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.579 0.351 . . . . 73.14 111.785 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -76.02 -21.32 56.99 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.682 0.793 . . . . 70.35 110.581 173.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.406 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 35.1 mmtp -83.11 154.67 24.23 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.792 0.837 . . . . 72.03 111.625 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -68.36 136.61 53.65 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.12 -0.946 . . . . 70.34 109.995 172.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.535 ' CE3' HD21 ' A' ' 68' ' ' LEU . 67.9 t-105 -82.45 86.16 6.8 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.512 0.673 . . . . 75.41 110.634 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.41 ' H ' HD22 ' A' ' 68' ' ' LEU . 29.1 tt0 -124.55 80.47 60.95 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 107.757 -1.201 . . . . 55.32 107.757 167.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.18 122.88 9.43 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.535 2.157 . . . . 64.12 112.647 -174.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -95.81 85.67 4.17 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 105.847 -1.909 . . . . 64.14 105.847 172.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.8 t -90.31 134.91 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 114.972 -1.013 . . . . 73.51 110.085 -171.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -121.5 114.78 21.73 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.168 0.987 . . . . 75.52 108.395 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 128' ' ' LEU . 2.6 tt -101.59 119.03 38.13 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.35 -0.981 . . . . 72.5 108.35 -175.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -121.43 133.49 55.07 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.162 0.985 . . . . 64.04 109.174 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.565 HD22 HD21 ' A' ' 60' ' ' LEU . 72.6 mt -121.65 131.06 53.89 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.745 0.818 . . . . 61.04 110.693 -178.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -135.66 149.21 49.22 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.071 0.948 . . . . 64.12 108.816 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.5 m -135.87 129.13 31.86 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.424 0.69 . . . . 54.54 110.099 -177.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.43 111.15 11.06 Favored 'General case' 0 C--N 1.345 0.385 0 C-N-CA 124.179 0.992 . . . . 65.22 109.512 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.0 m -90.35 159.24 16.72 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.215 -0.661 . . . . 52.21 109.215 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.9 t -158.35 117.37 3.11 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.245 -0.65 . . . . 74.23 109.245 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -76.06 106.96 7.95 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.72 -0.474 . . . . 70.13 109.72 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.4 mt -79.8 -33.55 40.36 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.402 0.681 . . . . 73.44 111.02 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.92 -174.77 4.56 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.084 0.554 . . . . 50.2 111.086 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.46 114.93 4.66 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.761 0.825 . . . . 75.45 109.362 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 64.89 18.63 11.56 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.064 1.346 . . . . 72.24 112.335 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.7 t -118.29 105.37 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.452 -0.944 . . . . 74.11 108.452 174.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -115.96 122.81 46.38 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.809 0.844 . . . . 74.42 108.724 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -86.6 148.58 25.42 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.778 -0.823 . . . . 74.2 108.778 170.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.6 t -130.33 139.37 51.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 N-CA-C 107.821 -1.178 . . . . 74.02 107.821 168.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.421 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 26.4 t -121.13 127.46 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.84 -0.8 . . . . 62.5 108.84 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.565 HD21 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -102.23 106.75 17.62 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 106.817 -1.549 . . . . 71.33 106.817 176.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -92.76 101.82 14.22 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.865 -1.161 . . . . 53.4 107.865 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.23 126.91 48.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 N-CA-C 108.482 -0.933 . . . . 61.23 108.482 174.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.8 m -116.25 142.7 46.49 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.978 -0.749 . . . . 70.55 108.978 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.573 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 92.6 t -139.3 109.3 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 125.169 1.388 . . . . 75.41 107.749 -176.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.4 m -107.4 123.02 47.77 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.993 -0.743 . . . . 71.32 108.993 169.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.94 120.57 36.77 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.354 -0.98 . . . . 53.25 108.354 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.5 m -124.14 136.07 53.95 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.211 0.604 . . . . 52.33 110.755 -176.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.662 HD12 HG22 ' A' ' 31' ' ' VAL . 91.6 mt -87.75 74.99 9.02 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.354 -0.98 . . . . 75.3 108.354 174.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.47 -116.38 4.68 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 114.33 -1.305 . . . . 35.32 110.956 -169.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -91.94 -13.85 30.49 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.875 0.87 . . . . 63.42 110.743 176.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.406 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 5.9 tp10 -77.26 133.28 38.89 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.39 1.076 . . . . 75.43 108.267 173.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.6 m -87.7 127.5 35.3 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.729 0.695 . . . . 74.31 109.521 174.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.714 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -79.83 -58.85 2.98 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.53 -0.915 . . . . 73.43 108.53 173.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -162.39 165.24 26.67 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 115.458 -0.792 . . . . 63.54 111.652 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.3 tp -127.17 118.98 25.38 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.393 -1.276 . . . . 65.01 107.988 166.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.573 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.0 m -105.56 138.11 42.3 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.054 0.942 . . . . 71.24 109.257 171.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -147.92 132.75 18.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.694 -0.854 . . . . 73.32 108.694 168.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.2 t -138.7 110.85 5.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 C-N-CA 124.194 0.998 . . . . 65.15 108.461 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -84.89 85.46 7.47 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.282 -1.007 . . . . 74.02 108.282 169.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -75.92 96.99 3.85 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.096 -0.956 . . . . 64.2 109.011 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.06 160.14 34.78 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 111.513 -0.635 . . . . 75.01 111.513 178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.9 127.68 2.01 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.773 -0.931 . . . . 62.23 110.773 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.456 HG13 ' HE1' ' A' ' 17' ' ' TYR . 63.6 mt -80.97 124.0 38.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 107.948 -1.13 . . . . 74.33 107.948 171.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.81 ' HB3' HD11 ' A' ' 86' ' ' ILE . 87.7 m-85 -125.65 127.42 46.27 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 109.003 -0.74 . . . . 72.41 109.003 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.3 t -89.3 97.57 11.27 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.955 -0.757 . . . . 64.24 108.955 173.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.81 HD11 ' HB3' ' A' ' 84' ' ' PHE . 4.7 mm -112.76 150.92 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 122.74 0.416 . . . . 75.44 110.502 -175.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.54 170.85 12.36 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.003 0.814 . . . . 65.33 110.869 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.11 -31.39 7.05 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 115.987 -0.551 . . . . 74.54 113.924 172.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.602 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.2 161.03 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.812 0.845 . . . . 73.13 108.993 176.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.554 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 17.0 tt0 -153.5 176.65 11.8 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 109.457 -0.572 . . . . 75.21 109.457 -175.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.554 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 57.5 -123.37 32.5 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 124.144 0.902 . . . . 72.23 113.921 177.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.2 t -75.23 -24.72 57.75 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.262 0.625 . . . . 61.33 111.91 -176.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -76.27 -34.79 59.12 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.42 0.688 . . . . 74.3 110.368 176.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.435 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 6.4 tpt -62.86 -48.68 78.0 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.383 -0.599 . . . . 75.23 109.383 171.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.71 -36.62 72.24 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.645 0.778 . . . . 41.54 110.751 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -67.96 -38.0 82.24 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.422 0.689 . . . . 74.33 111.182 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.5 t -66.38 -40.43 89.68 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.849 -0.426 . . . . 70.42 109.849 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 94' ' ' MET . 53.9 mt -83.66 -25.61 30.59 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.741 0.816 . . . . 60.35 112.322 -174.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.53 3.38 34.53 Favored Glycine 0 N--CA 1.475 1.268 0 O-C-N 123.417 0.448 . . . . 73.12 113.726 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.546 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -136.8 -68.69 0.48 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.029 0.532 . . . . 60.05 110.059 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -65.82 -46.97 76.64 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.436 0.694 . . . . 74.02 111.721 -171.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 59.4 m -66.29 -50.75 47.75 Favored Pre-proline 0 CA--C 1.567 1.619 0 C-N-CA 124.464 1.105 . . . . 72.24 112.659 -175.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.96 -20.05 45.28 Favored 'Trans proline' 0 C--N 1.39 2.749 0 C-N-CA 121.841 1.694 . . . . 71.24 112.948 174.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -69.7 -35.71 75.3 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.847 0.459 . . . . 74.55 110.188 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.441 HG21 HD13 ' A' ' 13' ' ' ILE . 46.7 mm -64.25 -47.87 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.27 0.628 . . . . 73.12 109.828 171.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.5 mt -72.22 -21.7 61.36 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.116 -0.947 . . . . 74.21 112.552 -171.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -65.03 -45.46 73.44 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 114.26 1.207 . . . . 61.22 114.26 -172.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.425 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 82.8 Cg_exo -50.54 -40.95 54.29 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.055 1.837 . . . . 53.24 113.626 171.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -76.13 -38.58 56.64 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.371 0.668 . . . . 74.32 111.084 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.21 -48.12 74.46 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.347 0.659 . . . . 60.12 109.915 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.438 ' NH1' HG23 ' C' ' 105' ' ' ILE . 29.3 ttm105 -47.99 -55.91 8.92 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 125.023 1.452 . . . . 74.22 110.079 174.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -61.81 -48.34 81.02 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 124.478 1.111 . . . . 74.4 111.879 -175.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.531 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.0 t -57.05 -42.39 80.44 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 123.786 0.679 . . . . 73.23 110.57 -177.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 118' ' ' VAL . 82.9 mt -62.95 -52.15 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 115.097 -0.956 . . . . 74.35 110.319 173.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.426 HG21 ' HE2' ' C' ' 109' ' ' TYR . 61.7 m -55.28 -41.08 71.79 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.047 0.939 . . . . 70.32 111.319 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.8 t -68.99 -42.57 76.32 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 114.626 -1.17 . . . . 51.45 109.706 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.513 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 7.9 mtp -60.02 -42.49 94.45 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.871 0.868 . . . . 72.41 111.063 175.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 114' ' ' ILE . 70.1 t -61.66 -45.84 97.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 124.278 1.031 . . . . 54.12 110.1 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.5 p -73.95 -30.51 62.58 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.271 0.628 . . . . 75.34 111.647 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 78.6 mtt-85 -72.59 -29.21 63.32 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.509 0.724 . . . . 70.44 109.594 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.07 5.42 62.77 Favored Glycine 0 C--N 1.354 1.56 0 CA-C-O 119.213 -0.771 . . . . 65.33 112.962 175.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.593 HG21 ' HE ' ' B' ' 15' ' ' ARG . 44.6 m 72.61 10.35 5.63 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 122.587 1.184 . . . . 73.42 111.703 173.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -86.35 144.42 38.14 Favored Pre-proline 0 C--O 1.244 0.765 0 O-C-N 121.064 -1.023 . . . . 64.25 109.151 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -51.69 142.52 40.52 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.06 2.507 . . . . 74.35 112.159 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -57.06 136.34 56.33 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 123.999 0.812 . . . . 72.34 112.667 -170.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.445 HD21 HG11 ' A' ' 64' ' ' VAL . 35.8 tp -121.58 123.37 41.8 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.626 1.17 . . . . 74.02 108.486 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.499 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 92.2 m-20 -122.44 109.46 14.41 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.543 0.737 . . . . 71.12 109.124 -176.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.511 ' HB3' HD11 ' A' ' 42' ' ' LEU . 7.9 mt -70.01 116.46 10.4 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 109.217 -0.66 . . . . 63.23 109.217 -173.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.445 ' HB2' HE22 ' C' ' 12' ' ' GLN . . . -61.68 143.4 93.9 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 122.873 0.469 . . . . 53.14 111.57 -172.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -56.24 125.14 18.09 Favored 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.488 2.792 . . . . 63.44 114.141 -172.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.493 HG21 HD11 ' A' ' 44' ' ' LEU . 90.3 t -102.46 134.26 43.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 CA-C-N 115.335 -0.848 . . . . 71.24 110.382 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -90.54 86.54 6.44 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.709 -0.848 . . . . 71.34 108.709 176.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -63.11 -27.65 69.53 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.579 0.751 . . . . 75.42 112.029 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.546 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 18.7 t70 -66.91 -43.37 83.51 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 123.45 0.469 . . . . 62.4 109.745 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.65 -40.51 95.58 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 124.228 0.955 . . . . 71.23 111.105 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 89.3 mt -60.01 -51.94 67.5 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.275 0.63 . . . . 65.42 111.033 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 25.1 t80 . . . . . 0 N--CA 1.47 0.538 0 N-CA-C 109.686 -0.487 . . . . 71.04 109.686 -179.823 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.644 ' HB3' HG23 ' B' ' 89' ' ' ILE . 25.5 ptm . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 113.437 0.903 . . . . 70.31 113.437 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.3 t -143.54 127.37 17.24 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 124.437 1.095 . . . . 70.51 108.096 171.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.402 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 75.2 t80 -123.51 146.19 48.27 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.613 0.765 . . . . 73.52 109.521 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.432 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 8.5 tt0 -149.99 131.26 14.57 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.248 0.619 . . . . 62.31 109.739 176.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 54.9 mt -80.3 122.82 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.538 -1.282 . . . . 71.41 107.538 168.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -93.58 -49.77 5.73 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.692 -0.855 . . . . 64.34 108.692 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.593 ' HE ' HG21 ' A' ' 122' ' ' THR . 26.1 ttt180 -164.14 143.57 7.75 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.767 -0.651 . . . . 54.14 110.841 -174.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 94.6 mt -124.02 141.45 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 107.039 -1.467 . . . . 74.33 107.039 173.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -165.43 138.98 4.56 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 112.886 0.699 . . . . 71.42 112.886 -174.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.6 m -73.91 119.38 18.05 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.668 0.787 . . . . 74.34 109.373 172.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.522 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.9 mtpt -96.89 -20.44 18.14 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.707 0.803 . . . . 74.11 111.678 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.578 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 34.0 t70 -160.18 149.64 17.72 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.097 0.559 . . . . 74.12 111.022 -177.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.605 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 26.9 mm -145.86 146.16 19.58 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 125.485 1.514 . . . . 73.45 108.374 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 36.3 t -155.6 145.6 21.51 Favored 'General case' 0 C--O 1.242 0.693 0 O-C-N 124.351 1.032 . . . . 70.14 110.087 169.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.44 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.1 t80 -151.56 108.54 3.54 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 107.457 -1.312 . . . . 73.12 107.457 169.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.18 113.53 21.69 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.243 -1.021 . . . . 74.2 108.243 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.64 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -107.78 86.42 2.97 Favored Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 107.888 -1.153 . . . . 74.54 107.888 174.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.2 -33.69 7.0 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.734 2.29 . . . . 72.11 112.933 -170.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -100.95 6.15 43.48 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.815 0.846 . . . . 72.11 111.389 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.64 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -41.39 -62.59 1.02 Allowed Pre-proline 0 N--CA 1.491 1.606 0 C-N-CA 125.436 1.494 . . . . 45.11 113.924 -168.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 52.8 Cg_exo -52.37 -38.29 73.21 Favored 'Trans proline' 0 C--N 1.391 2.792 0 C-N-CA 122.89 2.393 . . . . 63.14 113.756 -172.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -93.54 -35.03 13.12 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.193 -0.912 . . . . 74.02 111.636 -171.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.508 HG22 HD12 ' B' ' 68' ' ' LEU . 4.3 p -73.14 -14.74 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.239 0.616 . . . . 65.45 111.574 -171.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -64.31 -20.46 66.1 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.445 0.698 . . . . 70.41 112.771 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -65.17 -18.18 65.09 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.146 0.578 . . . . 52.25 110.942 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.452 ' HB2' HD13 ' B' ' 68' ' ' LEU . 93.0 mttt -91.2 79.61 5.69 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.787 1.235 . . . . 75.44 110.048 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -85.31 78.01 9.86 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.321 -0.854 . . . . 74.44 110.098 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 14.9 p90 -154.3 -174.68 5.06 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.952 0.901 . . . . 72.14 108.875 172.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.0 120.19 77.95 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 123.157 0.583 . . . . 70.1 111.079 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.33 139.32 38.0 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 121.244 1.296 . . . . 41.44 109.513 172.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.61 101.02 1.2 Allowed 'General case' 0 C--O 1.242 0.691 0 N-CA-C 107.27 -1.381 . . . . 62.45 107.27 170.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.689 HG11 HD11 ' B' ' 126' ' ' LEU . 35.4 t -102.94 145.66 11.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 115.066 -0.97 . . . . 63.53 109.184 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -135.07 130.41 35.52 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.344 -0.844 . . . . 72.1 108.91 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.527 HD11 HG13 ' B' ' 62' ' ' VAL . 21.8 tp -94.09 126.97 39.63 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 124.212 0.945 . . . . 60.54 109.245 170.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -142.87 126.38 16.8 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.289 1.036 . . . . 71.12 108.466 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.546 HD23 HG22 ' B' ' 62' ' ' VAL . 4.0 mp -119.9 148.72 43.16 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.985 0.514 . . . . 72.43 110.537 -172.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.409 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 18.1 t70 -124.4 141.61 51.95 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.172 1.389 . . . . 73.04 108.097 176.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 27.4 m -113.34 104.16 12.04 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.561 -0.533 . . . . 52.13 109.561 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.59 134.43 55.05 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.088 -1.449 . . . . 74.25 107.088 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.45 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 51.9 m -142.99 162.8 34.51 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 122.493 0.317 . . . . 72.11 110.745 -175.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.9 p -152.09 135.6 16.08 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.431 0.692 . . . . 65.43 109.693 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -90.49 122.66 33.52 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 109.013 -0.736 . . . . 75.22 109.013 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 pp -143.96 25.11 1.62 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.286 -0.87 . . . . 63.54 109.589 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.97 156.76 20.19 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 123.632 0.773 . . . . 73.23 110.312 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.7 131.83 36.05 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 108.521 -0.918 . . . . 73.21 108.521 167.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 64.49 7.31 3.59 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.929 1.292 . . . . 72.42 112.215 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.7 HG22 ' HA ' ' B' ' 85' ' ' SER . 54.2 t -138.68 123.33 21.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 107.239 -1.393 . . . . 64.3 107.239 -174.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.45 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 1.5 t80 -117.26 145.45 43.93 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 108.364 -0.976 . . . . 55.12 108.364 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -100.51 103.13 14.45 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 106.547 -1.649 . . . . 44.01 106.547 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 6.8 p -102.52 132.44 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.345 -0.613 . . . . 71.32 109.345 -176.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.419 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 19.0 t -115.12 122.41 69.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 108.688 -0.856 . . . . 33.35 108.688 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 38.9 tp -103.54 105.89 16.25 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.754 -0.832 . . . . 71.22 108.754 173.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.432 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 14.4 ttm180 -84.9 110.09 18.61 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 108.588 -0.893 . . . . 74.3 108.588 174.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.546 HG22 HD23 ' B' ' 44' ' ' LEU . 61.4 t -105.03 104.7 17.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 123.572 0.749 . . . . 60.51 109.011 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 6.7 m -98.83 137.15 37.82 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.134 -0.939 . . . . 73.13 109.684 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.651 HG11 HD21 ' B' ' 126' ' ' LEU . 30.6 t -128.42 116.29 41.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 124.225 1.01 . . . . 62.11 108.524 174.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 97.0 m -101.95 136.56 41.58 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.985 -1.117 . . . . 73.51 107.985 168.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.87 141.22 36.61 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 109.443 -0.577 . . . . 73.33 109.443 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.521 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 40.9 p -148.15 130.98 16.08 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.542 0.526 . . . . 73.02 111.585 -173.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.508 HD12 HG22 ' B' ' 31' ' ' VAL . 75.8 mt -97.04 107.11 19.57 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.181 0.992 . . . . 71.45 108.664 176.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.58 -111.98 3.37 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 111.195 -0.762 . . . . 41.22 111.195 -172.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -117.54 1.65 12.31 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.674 0.79 . . . . 72.13 110.297 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -114.43 142.15 46.73 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.768 -0.583 . . . . 62.35 110.37 -174.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 25.4 m -66.39 115.25 6.11 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.719 0.808 . . . . 54.41 111.394 -175.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.521 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -70.02 -56.34 7.2 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.992 -1.114 . . . . 74.41 107.992 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -158.37 164.47 36.29 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 114.398 -1.274 . . . . 64.3 111.151 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 67.8 mt -129.9 112.23 13.33 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 106.683 -1.599 . . . . 70.02 106.683 172.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.519 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 34.2 t -119.94 115.12 23.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.772 -0.825 . . . . 72.41 108.772 177.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -128.0 124.81 38.11 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.885 0.874 . . . . 70.04 109.044 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 73.1 t -124.49 153.17 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.227 1.011 . . . . 73.02 109.276 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.578 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.5 mt-30 -122.9 111.78 17.05 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.349 -0.982 . . . . 72.33 108.349 167.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.461 ' HG3' HD22 ' B' ' 106' ' ' LEU . 8.0 tp-100 -101.54 106.83 17.97 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.526 -0.916 . . . . 74.23 108.526 171.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.522 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -100.91 167.28 19.59 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 111.525 -0.63 . . . . 55.44 111.525 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.26 143.82 8.67 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.127 -0.559 . . . . 70.24 112.98 -174.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 79.3 mt -101.76 113.65 38.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 107.651 -1.24 . . . . 72.44 107.651 174.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . 0.428 ' O ' HG13 ' B' ' 55' ' ' VAL . 38.9 m-85 -127.49 147.46 50.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.311 0.644 . . . . 73.22 109.593 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.7 ' HA ' HG22 ' B' ' 55' ' ' VAL . 49.3 m -94.25 115.71 28.01 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.542 1.137 . . . . 61.51 110.456 177.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.602 HG22 HD11 ' B' ' 89' ' ' ILE . 3.8 mp -120.67 104.89 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 106.929 -1.508 . . . . 73.4 106.929 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.34 167.79 21.32 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.107 0.563 . . . . 74.3 110.559 -175.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.46 -45.82 3.29 Favored Glycine 0 N--CA 1.476 1.321 0 O-C-N 123.138 0.274 . . . . 70.13 113.096 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.644 HG23 ' HB3' ' B' ' 9' ' ' MET . 0.8 OUTLIER -58.03 167.74 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 124.839 1.255 . . . . 71.01 113.415 175.326 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -152.55 149.85 28.93 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.467 -1.242 . . . . 75.23 110.696 -174.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.19 -126.67 7.61 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.519 0.512 . . . . 21.11 112.236 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 20.3 m -90.1 -19.58 24.15 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.028 0.531 . . . . 64.12 110.202 175.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -53.44 -33.7 55.08 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.055 0.942 . . . . 75.11 111.368 176.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 11.2 ptt? -62.22 -59.42 5.06 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.259 1.024 . . . . 74.44 111.707 -174.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.85 -14.15 58.29 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.348 0.659 . . . . 70.45 111.428 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -61.87 -38.61 88.91 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.846 0.858 . . . . 61.24 110.688 170.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.7 t -68.89 -55.36 11.29 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.81 0.444 . . . . 61.13 110.615 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.616 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 1.9 pp -74.17 -18.4 60.78 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.717 0.636 . . . . 73.01 112.717 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.41 0.93 55.78 Favored Glycine 0 N--CA 1.472 1.072 0 CA-C-O 119.413 -0.659 . . . . 65.31 114.199 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.04 -50.86 0.15 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 117.888 0.844 . . . . 71.45 112.006 -176.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.405 ' O ' ' HB3' ' B' ' 104' ' ' ASN . 39.7 t80 -73.01 -39.58 65.9 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.333 0.653 . . . . 75.43 111.046 -177.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.616 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 82.0 m -75.13 -43.7 4.56 Favored Pre-proline 0 CA--C 1.563 1.446 0 CA-C-O 118.476 -0.773 . . . . 63.24 113.027 -175.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.7 -22.39 64.27 Favored 'Trans proline' 0 C--N 1.389 2.669 0 CA-C-N 121.185 1.459 . . . . 71.41 112.692 170.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' B' ' 101' ' ' TYR . 22.8 t-20 -64.15 -37.44 87.46 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.886 0.474 . . . . 75.2 110.861 172.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.9 mt -66.37 -40.85 87.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.536 0.735 . . . . 71.13 110.09 173.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.461 HD22 ' HG3' ' B' ' 80' ' ' GLN . 88.1 mt -75.0 -28.17 60.43 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.822 0.849 . . . . 64.35 112.775 -174.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -56.16 -47.35 99.01 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 118.068 -0.968 . . . . 71.33 113.464 -173.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.538 ' HG2' ' HB2' ' D' ' 108' ' ' PRO . 85.0 Cg_exo -53.53 -42.99 61.45 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.813 2.342 . . . . 71.21 114.604 174.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.412 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 40.4 m-85 -67.62 -36.05 80.09 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.187 0.595 . . . . 73.23 110.476 -177.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.21 -39.75 74.95 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.573 0.749 . . . . 72.45 110.778 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.419 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 51.3 ttt-85 -60.79 -55.16 36.37 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.282 1.433 . . . . 74.0 111.175 -177.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -69.15 -26.15 64.73 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.618 0.574 . . . . 74.11 110.427 -177.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.528 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.8 t -70.44 -39.4 74.37 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 110.265 -0.272 . . . . 72.34 110.265 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.519 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 72.3 mt -61.44 -54.81 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 123.987 0.915 . . . . 70.42 109.762 170.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 36.7 m -59.1 -28.3 66.39 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.921 0.888 . . . . 73.52 111.263 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.8 t -68.28 -50.97 50.06 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 123.475 0.71 . . . . 73.22 109.943 175.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.501 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.4 mmt -68.22 -36.34 79.36 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.204 0.601 . . . . 73.43 111.206 -175.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.2 -43.55 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.606 1.162 . . . . 62.42 110.198 173.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 30.9 t -63.65 -34.44 77.84 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.014 -0.994 . . . . 72.45 110.581 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.531 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 81.2 mtt-85 -69.23 -34.76 75.34 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.89 -0.596 . . . . 63.34 110.297 178.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -75.28 -11.96 83.84 Favored Glycine 0 C--N 1.357 1.705 0 O-C-N 123.736 0.647 . . . . 41.34 112.456 170.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 16.9 m 66.92 33.63 5.79 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.769 1.628 . . . . 43.22 110.186 176.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -79.52 163.54 58.45 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 115.259 -0.882 . . . . 61.31 110.434 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -58.76 165.65 7.8 Favored 'Trans proline' 0 C--N 1.388 2.624 0 C-N-CA 122.655 2.237 . . . . 63.25 112.894 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.422 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 23.9 tp60 -63.88 112.47 2.93 Favored 'General case' 0 C--N 1.345 0.405 0 C-N-CA 123.86 0.864 . . . . 52.21 111.378 -167.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.689 HD11 HG11 ' B' ' 40' ' ' VAL . 23.3 tp -110.52 112.53 24.51 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.168 -0.924 . . . . 62.23 109.018 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.17 124.3 41.5 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 108.288 -1.005 . . . . 74.41 108.288 176.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.419 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 77.3 mt -83.59 136.62 34.17 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.691 0.396 . . . . 62.52 110.514 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.32 140.99 52.87 Favored Pre-proline 0 CA--C 1.55 0.952 0 O-C-N 123.972 0.795 . . . . 60.01 111.284 -174.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -60.02 93.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.541 2.828 . . . . 71.33 111.99 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 4.0 p -90.55 118.34 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 108.496 -0.927 . . . . 72.53 108.496 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 . . . . . 0 C--O 1.242 0.662 0 CA-C-N 115.617 -0.72 . . . . 73.21 109.182 -175.975 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.465 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 59.8 t80 . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 108.428 -0.953 . . . . 73.5 108.428 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . 0.445 HE22 ' HB2' ' A' ' 129' ' ' ALA . 60.8 tp60 -138.45 132.32 31.14 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 109.556 -0.535 . . . . 74.33 109.556 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 21.6 mt -77.71 128.89 38.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 O-C-N 123.957 0.786 . . . . 52.52 109.395 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.431 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.8 mm-40 -89.05 -46.57 8.75 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.471 0.709 . . . . 64.32 109.153 174.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.499 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 13.6 ptp180 -176.26 150.17 0.91 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.61 1.164 . . . . 72.44 109.63 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 76.9 mt -128.22 129.9 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.409 1.083 . . . . 73.25 108.3 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.539 ' HB3' HG23 ' D' ' 122' ' ' THR . 35.7 p90 -158.07 175.1 14.23 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.804 0.841 . . . . 73.31 110.421 -166.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.6 p -98.07 114.23 26.34 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 122.932 0.493 . . . . 43.13 109.982 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.538 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 27.9 mmtp -65.39 -30.37 71.18 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.449 -0.574 . . . . 70.44 109.449 165.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.605 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.1 t70 -162.35 146.65 12.1 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.142 -0.935 . . . . 72.15 110.651 -172.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.598 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.7 mt -138.32 147.11 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.785 1.634 . . . . 74.43 107.25 173.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 43.8 t -152.45 148.04 26.96 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 122.935 0.494 . . . . 74.44 110.535 175.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.416 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 79.8 t80 -155.82 119.4 4.4 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 114.652 -1.158 . . . . 73.13 108.119 172.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -126.87 118.0 23.71 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.15 -0.685 . . . . 62.04 109.15 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.4 81.53 46.18 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 107.574 -1.269 . . . . 63.11 107.574 167.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.73 -36.05 43.01 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 122.739 2.292 . . . . 74.23 111.408 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -101.4 30.48 4.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.56 1.144 . . . . 73.25 109.535 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.24 -54.04 28.72 Favored Pre-proline 0 N--CA 1.495 1.789 0 C-N-CA 124.259 1.024 . . . . 73.51 113.297 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.46 -42.02 29.67 Favored 'Trans proline' 0 C--N 1.381 2.24 0 CA-C-N 121.17 1.454 . . . . 61.41 111.421 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -71.0 -27.75 63.92 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 114.277 -1.329 . . . . 64.22 113.042 -174.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.569 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.8 p -80.8 -28.93 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 O-C-N 122.059 -0.401 . . . . 41.12 111.664 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -65.15 -15.6 62.6 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 112.762 0.653 . . . . 75.01 112.762 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -105.32 22.46 15.37 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.947 0.899 . . . . 73.4 111.113 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.692 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -110.23 160.63 16.34 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.591 0.756 . . . . 64.22 110.562 -178.019 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -66.34 126.85 30.07 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.335 -0.617 . . . . 75.14 109.335 166.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -80.21 77.78 6.92 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.611 0.719 . . . . 63.31 109.683 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -129.02 66.44 76.31 Favored Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 123.963 0.905 . . . . 75.11 109.43 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -90.8 153.01 4.09 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.421 2.08 . . . . 51.44 112.578 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . 0.612 ' HB2' ' HE3' ' C' ' 41' ' ' LYS . 8.7 pt-20 -88.33 104.04 16.38 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.55 -1.278 . . . . 72.11 107.55 165.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.461 HG11 HD21 ' C' ' 126' ' ' LEU . 59.4 t -77.17 100.03 2.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.361 -0.977 . . . . 61.22 108.361 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.612 ' HE3' ' HB2' ' C' ' 39' ' ' GLU . 34.1 mmtp -103.59 105.57 15.84 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.421 -0.809 . . . . 75.23 109.96 -177.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mp -87.31 122.36 30.97 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 107.106 -1.442 . . . . 72.53 107.106 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.436 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 28.4 t70 -124.54 105.2 9.19 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.131 -0.692 . . . . 73.14 109.131 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.515 HD11 HG11 ' C' ' 131' ' ' VAL . 98.7 mt -94.2 141.96 27.95 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.871 0.868 . . . . 71.21 110.526 -177.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -148.46 143.64 26.87 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.255 -1.387 . . . . 73.51 107.255 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . 0.436 HG21 ' HA2' ' C' ' 99' ' ' GLY . 10.0 t -133.93 149.55 51.29 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.883 -0.784 . . . . 63.02 108.883 175.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.77 143.55 27.6 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.443 -0.947 . . . . 72.13 108.443 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 7.0 m -132.3 150.71 52.1 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 109.908 -0.405 . . . . 61.21 109.908 -175.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.3 t -145.71 125.46 13.42 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.574 -0.898 . . . . 60.14 108.574 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -79.86 116.67 20.15 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.977 -0.749 . . . . 73.52 108.977 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.561 HD11 HD12 ' C' ' 83' ' ' ILE . 48.3 mt -86.04 -36.4 19.74 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.852 0.861 . . . . 74.03 110.614 -175.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.55 -172.04 3.81 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.015 0.926 . . . . 45.03 109.851 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -63.89 112.95 3.14 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.744 0.818 . . . . 64.43 109.958 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 63.99 20.8 12.36 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.641 1.176 . . . . 74.22 112.27 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 66.2 t -114.9 113.58 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.066 -1.087 . . . . 74.23 108.066 173.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -122.79 124.6 43.69 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.121 0.968 . . . . 73.2 109.673 -176.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.45 ' HB2' HD11 ' C' ' 51' ' ' LEU . 29.3 tt0 -84.46 137.74 33.19 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.501 -0.925 . . . . 65.31 108.501 168.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 92.4 t -127.21 136.37 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.544 -0.91 . . . . 54.5 108.544 172.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.472 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 58.4 t -130.08 126.06 61.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 108.931 -0.766 . . . . 73.42 108.931 177.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.518 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -102.61 98.16 8.25 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 107.162 -1.421 . . . . 75.33 107.162 -178.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.415 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 6.2 tmm_? -82.72 105.72 13.98 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.551 -0.907 . . . . 73.21 108.551 174.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 20.2 t -107.14 135.37 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.352 -0.981 . . . . 75.44 108.352 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 62.3 m -125.7 139.83 53.21 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.619 -0.882 . . . . 71.23 108.619 177.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.472 HG21 HG21 ' C' ' 114' ' ' ILE . 98.1 t -127.37 117.69 47.7 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 N-CA-C 108.744 -0.836 . . . . 74.11 108.744 173.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 19.3 m -103.81 140.16 38.03 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.114 -0.699 . . . . 73.12 109.114 171.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.39 112.35 17.45 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.61 -1.256 . . . . 74.33 107.61 174.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 30.4 m -126.67 127.67 45.52 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.008 0.432 . . . . 72.42 110.074 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.692 HD13 ' HG2' ' C' ' 34' ' ' LYS . 12.7 mt -96.96 23.37 7.27 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.96 1.304 . . . . 74.44 110.618 -174.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.74 -77.73 0.3 Allowed Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.196 -0.762 . . . . 50.33 111.196 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -117.48 -30.6 5.48 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.037 0.935 . . . . 74.01 109.418 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -79.68 122.54 26.68 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.551 1.14 . . . . 75.11 110.225 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 27.4 m -76.73 119.53 20.65 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 107.937 -1.134 . . . . 63.14 107.937 164.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.569 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -73.08 -48.51 35.27 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.385 0.612 . . . . 61.4 109.601 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -166.59 166.84 15.89 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 113.878 -1.51 . . . . 64.55 110.42 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -128.98 141.45 51.25 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.646 -1.612 . . . . 74.32 106.646 167.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 41.9 t -144.52 146.24 32.28 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.185 -1.043 . . . . 74.43 108.185 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -157.61 138.47 13.22 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.66 -0.496 . . . . 64.52 109.66 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 43.9 t -136.44 115.37 15.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 124.62 1.168 . . . . 62.13 108.375 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.605 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 50.9 mt-30 -90.59 86.85 6.51 Favored 'General case' 0 CA--C 1.523 -0.067 0 N-CA-C 107.922 -1.14 . . . . 62.32 107.922 168.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -80.11 99.38 7.71 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 108.573 -0.899 . . . . 73.54 108.573 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -102.34 146.09 16.75 Favored Glycine 0 C--O 1.217 -0.931 0 O-C-N 123.179 0.299 . . . . 61.24 113.193 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.13 146.18 14.37 Favored Glycine 0 C--N 1.331 0.264 0 N-CA-C 111.54 -0.624 . . . . 74.45 111.54 -176.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.561 HD12 HD11 ' C' ' 51' ' ' LEU . 30.7 mm -96.04 138.49 21.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.84 0 N-CA-C 109.389 -0.597 . . . . 74.25 109.389 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.553 ' CZ ' HD11 ' C' ' 106' ' ' LEU . 85.4 m-85 -136.36 123.08 21.11 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 123.36 0.664 . . . . 73.1 110.363 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 28.2 p -79.36 102.78 8.86 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 107.971 -1.122 . . . . 71.11 107.971 167.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.407 HG21 ' HE1' ' C' ' 94' ' ' MET . 19.2 mt -117.21 114.94 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.949 0.899 . . . . 62.2 110.412 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -122.01 170.88 9.39 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.885 0.874 . . . . 65.25 109.131 172.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.73 -22.72 39.54 Favored Glycine 0 C--N 1.341 0.809 0 N-CA-C 114.308 0.483 . . . . 63.43 114.308 170.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' C' ' 94' ' ' MET . 44.8 pt -122.66 162.35 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 112.613 0.597 . . . . 74.14 112.613 -172.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -159.09 156.64 29.53 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 115.011 -0.995 . . . . 72.3 109.909 175.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.13 -122.36 6.15 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 123.802 0.689 . . . . 63.13 113.008 171.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 42.3 p -67.56 -29.89 69.37 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.504 0.722 . . . . 73.12 110.958 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -64.69 -59.94 3.68 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.753 0.821 . . . . 73.54 110.489 175.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.493 ' HE3' ' HA ' ' C' ' 94' ' ' MET . 5.2 tpt -46.64 -53.93 10.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.951 1.3 . . . . 72.04 112.2 173.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.09 -44.61 91.92 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.447 0.699 . . . . 73.33 111.41 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -64.12 -33.44 75.77 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.027 0.931 . . . . 75.21 111.73 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.478 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 19.4 t -68.85 -55.85 9.81 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.551 -0.907 . . . . 75.44 108.551 177.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 72.7 mt -65.43 -25.61 67.6 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.611 1.164 . . . . 73.22 112.964 -175.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . 0.436 ' HA2' HG21 ' C' ' 46' ' ' THR . . . -109.16 -8.77 26.92 Favored Glycine 0 C--N 1.347 1.174 0 N-CA-C 115.035 0.774 . . . . 41.13 115.035 -171.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.09 -52.88 0.38 Allowed 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 118.213 1.007 . . . . 74.11 111.766 -175.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.478 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 73.7 t80 -70.75 -58.49 3.58 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.272 0.629 . . . . 74.11 111.498 -173.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.569 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 83.0 m -53.52 -59.07 10.35 Favored Pre-proline 0 CA--C 1.559 1.321 0 CA-C-O 117.663 -1.161 . . . . 72.44 110.968 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.569 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 82.4 Cg_exo -50.51 -34.22 41.43 Favored 'Trans proline' 0 C--N 1.395 3.012 0 C-N-CA 122.822 2.348 . . . . 64.02 114.85 -177.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -65.03 -32.32 73.99 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.442 0.697 . . . . 70.52 111.24 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.438 HG23 ' NH1' ' A' ' 111' ' ' ARG . 35.3 mm -72.63 -31.77 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 123.922 0.889 . . . . 72.14 110.414 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.553 HD11 ' CZ ' ' C' ' 84' ' ' PHE . 5.5 mp -90.03 -17.12 28.4 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.474 0.71 . . . . 73.31 111.734 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -55.93 -49.6 92.05 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-O 117.829 -1.081 . . . . 61.13 113.778 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -61.16 -34.68 88.67 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 121.935 1.757 . . . . 74.21 113.07 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.426 ' HE2' HG21 ' A' ' 115' ' ' THR . 59.9 m-85 -64.24 -46.8 82.18 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.555 0.742 . . . . 75.43 110.217 175.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.07 -36.29 83.87 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.122 -0.945 . . . . 62.55 110.723 177.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -64.96 -49.45 70.28 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.058 1.343 . . . . 61.43 110.238 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.89 -32.52 73.06 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.484 0.714 . . . . 63.44 109.625 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 9.0 t -70.24 -39.7 74.9 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 122.985 0.514 . . . . 71.31 110.964 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.472 HG21 HG21 ' C' ' 64' ' ' VAL . 96.6 mt -67.68 -48.79 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.346 0.658 . . . . 73.1 109.828 177.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 15.7 m -66.03 -29.34 69.68 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.915 -0.584 . . . . 55.33 110.755 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 30.2 t -64.77 -50.29 67.38 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.363 -0.606 . . . . 73.03 109.363 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.465 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -55.8 -46.9 77.91 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.432 1.093 . . . . 65.24 111.59 177.536 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 69.2 t -65.69 -40.48 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.874 0.87 . . . . 73.42 110.87 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 33.8 t -72.18 -29.52 64.08 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.607 0.763 . . . . 73.55 111.481 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.584 HH22 ' HG2' ' D' ' 112' ' ' GLU . 64.6 mtt-85 -74.1 -29.62 61.94 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.447 -0.797 . . . . 71.51 109.782 176.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.23 12.43 58.35 Favored Glycine 0 C--N 1.353 1.479 0 O-C-N 124.015 0.822 . . . . 24.34 112.886 172.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.43 HG23 ' HB3' ' D' ' 17' ' ' TYR . 69.4 p 54.16 28.34 8.9 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 126.519 1.928 . . . . 70.33 114.214 176.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -84.24 151.93 60.58 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 109.365 -0.605 . . . . 74.44 109.365 172.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -47.39 136.23 19.93 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.35 2.7 . . . . 71.41 113.11 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.422 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 41.9 mm-40 -53.69 110.98 0.64 Allowed 'General case' 0 N--CA 1.478 0.965 0 O-C-N 124.317 1.01 . . . . 74.04 111.839 -175.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.461 HD21 HG11 ' C' ' 40' ' ' VAL . 3.9 tt -113.95 90.46 3.35 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.983 -1.117 . . . . 65.42 107.983 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -94.41 122.31 36.84 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.463 -0.94 . . . . 73.41 108.463 173.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 6.4 mp -66.73 145.18 55.81 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.174 0.921 . . . . 75.04 111.288 -171.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.8 151.9 77.06 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-N 115.602 -0.726 . . . . 64.32 110.791 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.546 ' HG3' HD12 ' A' ' 16' ' ' ILE . 21.6 Cg_exo -63.82 107.32 0.74 Allowed 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 123.062 2.508 . . . . 60.43 112.385 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . 0.515 HG11 HD11 ' C' ' 44' ' ' LEU . 7.4 p -103.84 139.84 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 123.926 0.89 . . . . 73.33 109.096 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -94.43 104.35 16.32 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.709 0.804 . . . . 63.24 110.325 -171.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -63.4 -34.58 78.03 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.909 0.884 . . . . 74.23 112.425 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -64.99 -40.15 94.53 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.218 0.607 . . . . 61.21 110.414 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.43 -30.42 67.26 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.573 0.749 . . . . 65.51 111.177 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 91.6 mt -72.39 -40.23 67.4 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.011 0.524 . . . . 75.42 110.139 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 25.8 t80 . . . . . 0 CA--C 1.546 0.825 0 CA-C-N 115.198 -0.91 . . . . 73.4 110.226 178.615 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 C--O 1.242 0.67 0 CA-C-O 120.98 0.419 . . . . 74.05 109.899 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -133.23 92.4 3.0 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 106.875 -1.528 . . . . 75.33 106.875 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -114.19 117.35 30.92 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.629 0.772 . . . . 74.45 109.163 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 9.0 mt -82.25 132.59 31.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.009 -1.108 . . . . 55.03 108.009 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -101.35 -28.59 12.52 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.624 0.77 . . . . 74.1 110.556 -174.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -173.44 133.12 0.48 Allowed 'General case' 0 C--N 1.361 1.09 0 O-C-N 123.618 0.574 . . . . 75.03 110.41 -176.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.413 HD12 ' N ' ' D' ' 16' ' ' ILE . 3.3 mp -114.04 130.47 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 107.212 -1.403 . . . . 63.15 107.212 173.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.458 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 37.4 p90 -163.65 175.79 10.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.987 0.899 . . . . 72.12 112.45 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.8 p -108.18 118.76 37.61 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 114.218 -1.356 . . . . 72.32 108.871 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.458 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 29.9 mtpt -90.52 -11.27 40.68 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.991 -0.744 . . . . 55.23 108.991 177.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.751 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 18.7 t70 -166.23 135.67 3.18 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 124.766 1.226 . . . . 75.24 109.376 -175.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.465 HD13 ' HE3' ' C' ' 117' ' ' MET . 52.8 mt -144.36 138.22 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.185 1.394 . . . . 63.43 107.937 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -145.45 138.64 26.32 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.838 0.855 . . . . 74.22 109.21 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.598 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.4 t80 -142.07 135.69 29.41 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.113 -1.44 . . . . 75.32 107.113 170.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -135.74 148.45 48.82 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 108.837 -0.801 . . . . 72.22 108.837 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -142.87 75.72 17.63 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 107.104 -1.443 . . . . 65.15 107.104 175.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.92 -27.81 30.17 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.777 2.318 . . . . 70.14 112.938 -169.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -108.2 1.01 21.82 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 115.415 -0.811 . . . . 64.3 110.696 -175.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.476 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -20.87 -73.09 0.03 OUTLIER Pre-proline 0 CA--C 1.567 1.61 0 N-CA-C 116.612 2.078 . . . . 73.54 116.612 -166.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.538 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 93.1 Cg_endo -75.15 -20.55 16.47 Favored 'Trans proline' 0 C--N 1.379 2.182 0 CA-C-N 123.962 2.451 . . . . 73.34 114.135 -173.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.464 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 5.1 t-160 -72.7 -40.63 66.06 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.877 0.871 . . . . 62.43 109.495 174.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.476 HG12 ' O ' ' D' ' 28' ' ' ALA . 5.5 p -83.52 -20.66 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 CA-C-N 115.612 -0.722 . . . . 72.45 111.566 -173.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.4 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 22.5 m-85 -66.99 -20.65 65.92 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 111.982 0.364 . . . . 73.35 111.982 178.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 62.0 mt-30 -64.03 -15.05 58.58 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.374 1.069 . . . . 73.34 110.926 176.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -92.7 96.62 10.28 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.117 1.367 . . . . 75.32 109.718 175.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -92.07 79.67 5.16 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.808 -1.087 . . . . 51.14 110.808 -172.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -158.89 171.33 20.26 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.447 -0.797 . . . . 73.54 109.727 168.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . 0.481 HE21 ' HD2' ' D' ' 38' ' ' PRO . 31.1 tp60 -67.65 115.3 25.9 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 123.836 0.855 . . . . 75.23 109.274 177.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.481 ' HD2' HE21 ' D' ' 37' ' ' GLN . 81.3 Cg_exo -49.05 131.12 25.3 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 123.079 2.519 . . . . 52.21 112.475 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -65.04 110.37 2.46 Favored 'General case' 0 C--N 1.346 0.428 0 N-CA-C 107.008 -1.478 . . . . 73.21 107.008 171.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.709 HG13 HG13 ' D' ' 64' ' ' VAL . 96.9 t -113.05 127.19 70.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 108.517 -0.92 . . . . 73.14 108.517 -175.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.466 ' HE3' ' HB3' ' D' ' 41' ' ' LYS . 0.5 OUTLIER -120.76 129.42 53.6 Favored 'General case' 0 C--O 1.248 0.991 0 N-CA-C 106.493 -1.669 . . . . 63.23 106.493 172.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.631 HD11 HG13 ' D' ' 62' ' ' VAL . 33.1 tp -97.1 129.29 44.53 Favored 'General case' 0 C--O 1.238 0.477 0 O-C-N 123.931 0.77 . . . . 73.45 110.111 -172.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.601 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.2 m-20 -108.98 112.38 24.55 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.535 -1.654 . . . . 64.12 106.535 177.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.411 ' CD2' HG22 ' D' ' 62' ' ' VAL . 25.8 mt -107.23 131.95 53.62 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.374 0.606 . . . . 65.4 109.903 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.3 t70 -133.85 153.65 51.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.21 -1.359 . . . . 53.43 108.063 176.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 5.1 t -126.61 149.85 49.23 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.006 0.922 . . . . 64.13 109.047 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.478 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -148.78 141.11 24.14 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.216 -1.031 . . . . 63.03 108.216 178.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 91.3 p . . . . . 0 C--O 1.243 0.723 0 N-CA-C 108.438 -0.949 . . . . 72.31 108.438 178.775 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 121.213 0.53 . . . . 75.02 111.024 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 p -133.57 101.06 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.398 1.079 . . . . 64.25 108.217 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -118.24 144.27 45.9 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 114.634 -1.166 . . . . 75.24 108.84 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -105.43 136.26 45.31 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.428 0.632 . . . . 64.3 110.81 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 90.3 t -114.54 144.8 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-N 114.098 -1.41 . . . . 71.42 108.03 174.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 52.2 t -135.99 127.76 44.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.668 -1.234 . . . . 71.52 107.668 176.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.535 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -109.67 102.14 10.99 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 106.844 -1.539 . . . . 63.25 106.844 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.507 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.6 ttt180 -83.8 95.2 8.37 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.46 -0.941 . . . . 75.24 108.46 176.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.631 HG13 HD11 ' D' ' 42' ' ' LEU . 66.5 t -96.33 117.18 40.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.661 -1.154 . . . . 73.42 108.97 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.601 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 23.8 m -123.06 130.25 52.54 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 114.9 -1.045 . . . . 75.11 108.725 -174.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.709 HG13 HG13 ' D' ' 40' ' ' VAL . 47.2 t -111.25 121.37 63.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 C-N-CA 124.821 1.248 . . . . 73.4 108.967 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 18.4 m -100.26 110.92 23.18 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.463 -1.31 . . . . 52.53 107.463 164.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.07 138.62 54.1 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.986 -0.746 . . . . 63.41 108.986 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.482 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 80.9 p -142.07 140.67 32.62 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.347 0.594 . . . . 73.53 111.241 -175.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.427 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 35.3 mt -112.92 114.5 27.02 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 106.889 -1.522 . . . . 64.5 106.889 169.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.19 -129.2 9.23 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 123.166 0.291 . . . . 73.43 112.423 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.76 5.34 36.03 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.492 0.717 . . . . 72.04 110.901 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -121.97 165.15 16.43 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.469 0.708 . . . . 61.44 109.586 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 94.1 m -69.26 135.26 50.26 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.803 -0.635 . . . . 75.1 111.484 177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.482 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -82.32 -68.69 0.68 Allowed 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.595 -1.261 . . . . 75.04 107.595 170.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -149.3 161.88 41.17 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 114.974 -1.012 . . . . 71.41 110.363 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 78.7 mt -120.9 120.35 35.26 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.482 1.113 . . . . 73.14 108.22 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.658 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 1.7 m -116.78 139.15 50.91 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.214 -1.032 . . . . 70.13 108.214 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -157.12 121.85 4.46 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.931 0.493 . . . . 70.11 109.676 173.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -136.13 119.12 22.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 123.705 0.802 . . . . 52.1 109.041 -175.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.751 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.2 mt-30 -89.04 88.59 7.63 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 108.647 -0.871 . . . . 73.43 108.647 170.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -80.27 99.19 7.73 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.371 -1.286 . . . . 70.32 108.739 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.35 142.33 15.56 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 116.316 -0.402 . . . . 71.42 112.141 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.68 140.88 11.64 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 111.117 -0.793 . . . . 61.52 111.117 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 61.3 mt -90.78 119.14 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.933 -1.136 . . . . 72.23 107.933 175.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -119.85 131.31 55.24 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.692 0.797 . . . . 71.11 110.192 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 35.4 t -107.9 100.47 9.83 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.363 -0.977 . . . . 62.23 108.363 172.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 39.9 pt -110.54 147.67 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.674 1.19 . . . . 73.41 108.807 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.7 168.56 12.45 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.792 0.682 . . . . 64.12 111.033 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.6 21.92 49.09 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.596 0.56 . . . . 54.34 114.166 174.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -138.84 161.14 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.8 0.84 . . . . 72.34 111.475 -177.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -149.22 -171.89 3.99 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.215 -1.357 . . . . 74.33 109.192 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.31 -140.19 24.22 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-O 119.709 -0.495 . . . . 50.51 111.934 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 81.1 p -91.87 -35.82 13.84 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 117.529 0.664 . . . . 73.21 111.268 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.568 ' HA ' ' HB3' ' D' ' 96' ' ' HIS . 27.8 tp60 -65.63 -22.03 66.62 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.203 1.001 . . . . 71.24 112.023 -172.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.475 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 0.0 OUTLIER -60.85 -43.59 98.12 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.802 0.441 . . . . 71.12 111.433 177.257 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . 0.475 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -79.59 -31.01 41.72 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.775 0.83 . . . . 62.4 110.543 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . 0.568 ' HB3' ' HA ' ' D' ' 93' ' ' GLN . 18.8 t-80 -75.06 -25.3 58.53 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 123.935 0.894 . . . . 75.12 112.153 -175.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 85.2 m -65.87 -38.27 88.35 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.56 0.695 . . . . 74.11 109.795 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.614 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 12.9 tp -77.97 -35.96 49.63 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.831 -1.077 . . . . 72.34 110.421 177.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.74 -28.45 42.63 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.434 -0.803 . . . . 62.23 115.03 -171.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.24 -47.2 2.27 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 118.295 1.047 . . . . 74.12 111.396 -175.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -74.7 -34.59 62.65 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 112.031 0.382 . . . . 72.42 112.031 -174.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.614 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 90.3 m -67.01 -47.55 52.35 Favored Pre-proline 0 CA--C 1.565 1.553 0 CA-C-O 118.46 -0.781 . . . . 75.32 112.174 177.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.535 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.5 Cg_exo -55.84 -34.27 90.92 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 122.158 1.905 . . . . 63.44 113.136 169.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -61.96 -37.34 84.38 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.482 0.713 . . . . 65.04 111.123 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 44.9 mm -68.25 -41.53 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.528 0.731 . . . . 74.15 110.601 174.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 96.6 mt -78.17 -15.13 59.11 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.742 -0.663 . . . . 70.14 112.331 -172.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -70.03 -44.09 20.63 Favored Pre-proline 0 N--CA 1.485 1.294 0 N-CA-C 113.858 1.059 . . . . 61.21 113.858 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . 0.538 ' HB2' ' HG2' ' B' ' 108' ' ' PRO . 18.8 Cg_endo -58.03 -29.24 86.2 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 121.624 1.55 . . . . 65.31 112.771 172.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -81.18 -31.23 34.1 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.782 0.833 . . . . 71.54 111.493 175.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.91 -50.28 71.48 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.792 0.837 . . . . 34.44 109.934 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -73.51 -29.47 62.5 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.198 -0.91 . . . . 74.12 110.593 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . 0.584 ' HG2' HH22 ' C' ' 120' ' ' ARG . 23.5 tt0 -53.19 -46.18 68.88 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.458 0.703 . . . . 65.34 110.479 173.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.1 t -70.38 -47.37 61.23 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.426 -0.806 . . . . 43.44 111.226 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.449 ' O ' HG23 ' D' ' 118' ' ' VAL . 76.8 mt -60.12 -61.27 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.887 0.875 . . . . 74.2 111.643 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 10.3 m -50.94 -38.94 53.54 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.448 1.099 . . . . 75.24 111.638 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -64.27 -48.29 76.32 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.347 -0.842 . . . . 64.03 110.012 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 73.7 mtm -67.24 -29.85 69.6 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.148 0.579 . . . . 74.42 111.767 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.449 HG23 ' O ' ' D' ' 114' ' ' ILE . 76.0 t -64.84 -46.69 91.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.62 0.768 . . . . 73.34 109.39 176.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.5 p -72.87 -31.42 64.72 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.875 -0.602 . . . . 62.21 110.588 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 77.6 mtt-85 -69.46 -28.87 66.47 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.775 0.83 . . . . 72.31 110.405 174.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.8 10.01 74.1 Favored Glycine 0 C--N 1.351 1.378 0 CA-C-O 119.317 -0.713 . . . . 71.24 112.647 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.539 HG23 ' HB3' ' C' ' 17' ' ' TYR . 74.5 p 52.68 37.45 23.6 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 126.12 1.768 . . . . 65.32 113.499 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -99.81 151.86 37.62 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 115.01 -0.995 . . . . 75.3 109.645 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -51.84 145.38 32.05 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.478 2.786 . . . . 73.11 113.194 171.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -61.16 136.86 58.2 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.836 0.854 . . . . 73.54 112.631 -169.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.442 HD13 HG21 ' D' ' 40' ' ' VAL . 16.4 tp -124.81 99.42 6.14 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.434 1.094 . . . . 65.53 109.267 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -100.11 108.28 20.38 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 107.702 -1.222 . . . . 64.4 107.702 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 6.7 mp -70.81 116.28 10.94 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.333 -0.618 . . . . 73.34 109.333 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.11 141.38 93.84 Favored Pre-proline 0 CA--C 1.55 0.972 0 O-C-N 124.078 0.861 . . . . 62.44 111.772 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.67 116.05 3.03 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.537 2.158 . . . . 60.12 110.868 175.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 13.1 p -108.62 146.53 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.811 0.845 . . . . 65.31 109.315 -172.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -73.6 104.45 4.55 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.834 -0.802 . . . . 72.41 108.834 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 . . . . . 0 N--CA 1.471 0.601 0 C-N-CA 123.571 0.748 . . . . 74.12 111.516 -178.543 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.2 m . . . . . 0 CA--C 1.535 0.379 0 N-CA-C 109.177 -0.675 . . . . 62.33 109.177 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -131.42 112.48 12.73 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.823 -1.547 . . . . 64.25 106.823 167.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -137.72 114.15 10.27 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 107.809 -1.182 . . . . 72.14 107.809 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.618 HG21 ' HG2' ' C' ' 130' ' ' PRO . 51.0 mt -69.41 114.42 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 109.034 -0.728 . . . . 74.3 109.034 177.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -78.79 -34.74 45.21 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.285 -0.635 . . . . 73.23 109.285 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.43 ' HE ' ' HB ' ' B' ' 122' ' ' THR . 14.0 ttt85 -172.63 132.52 0.58 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.973 0.509 . . . . 72.05 110.227 -174.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.455 HD11 HD13 ' A' ' 13' ' ' ILE . 80.6 mt -117.44 127.35 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.021 -1.103 . . . . 75.14 108.021 166.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 25.0 p90 -163.78 154.02 15.28 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.787 0.679 . . . . 62.33 110.827 -171.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.7 p -80.03 116.78 20.35 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 109.712 -0.477 . . . . 73.41 109.712 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.45 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 42.9 mtpt -79.11 -25.52 43.0 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.601 -0.518 . . . . 72.1 109.601 172.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.495 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.1 t70 -155.06 146.8 23.31 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 114.882 -1.054 . . . . 55.22 110.526 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.485 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 81.2 mt -141.28 141.7 30.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 C-N-CA 126.114 1.766 . . . . 72.41 107.012 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.4 t -143.72 132.76 22.88 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.218 -1.03 . . . . 64.15 108.218 170.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.539 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 85.2 t80 -139.87 141.8 36.59 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.539 -1.282 . . . . 73.12 107.539 172.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -144.37 149.41 36.09 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.773 0.829 . . . . 72.25 108.889 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.28 74.83 11.67 Favored Pre-proline 0 C--O 1.241 0.639 0 N-CA-C 106.173 -1.788 . . . . 43.23 106.173 170.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.72 -29.93 28.53 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.233 1.955 . . . . 71.14 111.88 -171.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -96.82 9.43 41.81 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.798 0.839 . . . . 73.32 111.899 -175.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.464 ' HA ' HG12 ' A' ' 31' ' ' VAL . . . -47.36 -58.56 7.11 Favored Pre-proline 0 CA--C 1.563 1.471 0 N-CA-C 114.4 1.259 . . . . 41.32 114.4 -166.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 71.8 Cg_exo -49.84 -40.3 48.41 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.884 2.389 . . . . 71.44 114.455 -177.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -100.16 -13.97 18.73 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.214 0.82 . . . . 72.45 113.214 -175.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.597 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.7 p -77.27 -18.75 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-O 120.892 0.377 . . . . 74.34 110.912 -175.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -74.11 -19.96 60.41 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.393 0.677 . . . . 75.3 111.127 175.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -73.87 -28.92 61.82 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.631 0.773 . . . . 74.13 109.779 174.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -69.8 159.5 33.48 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.956 0.902 . . . . 65.32 112.119 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -68.94 123.35 20.76 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.538 -0.756 . . . . 45.41 109.234 171.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.494 ' CE3' HD21 ' A' ' 68' ' ' LEU . 71.9 t-105 -75.04 84.88 2.29 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.894 0.854 . . . . 74.43 109.841 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.433 ' H ' HD22 ' A' ' 68' ' ' LEU . 23.7 tt0 -120.48 79.63 29.44 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 125.48 1.512 . . . . 74.41 107.53 173.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.31 112.66 3.52 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.04 1.826 . . . . 64.04 112.446 -174.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.56 97.32 9.67 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 105.38 -2.082 . . . . 75.33 105.38 168.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.435 HG11 HD21 ' A' ' 126' ' ' LEU . 17.6 t -95.45 100.87 11.73 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-N 115.406 -0.815 . . . . 74.35 110.826 -170.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -77.84 114.03 16.31 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.774 -1.103 . . . . 71.24 110.027 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.3 mt -103.36 111.16 23.45 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.591 0.756 . . . . 53.31 109.671 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.598 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.8 m-20 -102.23 147.28 26.84 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.592 -0.892 . . . . 74.3 108.592 172.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.612 HD11 HG21 ' A' ' 131' ' ' VAL . 77.0 mt -131.23 141.34 50.0 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.413 0.685 . . . . 75.13 110.293 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 25.6 t70 -144.51 122.11 11.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.412 -1.267 . . . . 74.13 108.056 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.4 m -113.37 129.09 56.62 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.926 -0.768 . . . . 73.24 108.926 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.74 117.46 15.03 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.583 0.753 . . . . 33.33 109.567 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.43 ' HB3' ' HB3' ' A' ' 98' ' ' LEU . 19.4 p -88.86 173.32 8.59 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 122.968 0.507 . . . . 75.12 110.552 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.6 t -163.82 145.57 9.17 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.377 1.071 . . . . 74.55 108.771 -170.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -114.9 122.7 47.12 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.272 0.629 . . . . 64.34 109.31 170.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.6 mt -97.65 -37.61 9.84 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.387 0.675 . . . . 73.13 109.824 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.474 ' HB3' ' CG2' ' A' ' 55' ' ' VAL . . . -153.1 177.45 10.79 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.874 0.87 . . . . 60.11 109.481 177.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -64.59 125.36 24.45 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.853 0.461 . . . . 64.11 109.986 170.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 68.22 8.75 6.77 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.139 1.376 . . . . 71.34 112.163 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.474 ' CG2' ' HB3' ' A' ' 52' ' ' ALA . 51.5 t -115.62 92.74 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 108.31 -0.996 . . . . 65.44 108.31 176.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -110.59 122.3 47.42 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.077 0.465 . . . . 75.12 109.751 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -93.86 147.49 23.03 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.818 0.847 . . . . 65.5 109.101 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.8 t -131.79 143.32 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 107.986 -1.116 . . . . 75.12 107.986 173.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.526 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 60.6 t -121.42 137.96 53.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 108.487 -0.931 . . . . 71.22 108.487 176.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.89 98.76 6.51 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.243 -1.392 . . . . 72.24 107.243 175.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.486 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 43.3 ttp180 -84.98 101.23 12.21 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.48 -0.933 . . . . 74.44 108.48 173.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.6 t -95.69 132.71 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 108.003 -1.11 . . . . 70.33 108.003 175.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.598 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 12.0 m -112.93 142.15 45.93 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.927 -0.768 . . . . 64.22 108.927 171.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.604 HG21 HG21 ' A' ' 114' ' ' ILE . 77.1 t -135.84 114.85 16.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 107.502 -1.296 . . . . 71.4 107.502 -176.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.4 m -121.92 107.63 12.49 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.928 -0.767 . . . . 72.01 108.928 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.74 111.59 23.98 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 106.703 -1.592 . . . . 72.41 106.703 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 54.7 m -120.73 135.91 55.01 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.716 0.77 . . . . 70.41 111.289 -173.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.509 HD12 HG22 ' A' ' 31' ' ' VAL . 35.1 mt -88.86 81.66 6.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.482 1.513 . . . . 62.31 107.779 175.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.12 -99.06 1.03 Allowed Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.471 -0.786 . . . . 54.42 111.894 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -94.84 -29.58 14.65 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.274 0.63 . . . . 74.42 111.175 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -98.18 127.82 44.33 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.269 0.628 . . . . 65.14 109.892 -170.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.3 m -69.25 132.81 47.07 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 120.993 0.425 . . . . 45.35 110.406 173.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.597 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -76.93 -52.21 9.82 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.188 -0.914 . . . . 71.13 108.728 174.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -160.26 164.17 32.88 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.814 -1.085 . . . . 75.31 110.916 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.9 tp -124.31 132.07 53.55 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.414 1.086 . . . . 54.22 108.438 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.462 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 37.0 m -130.48 116.63 18.47 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.78 0.832 . . . . 64.42 109.147 175.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -131.04 116.25 17.54 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.494 -0.558 . . . . 74.02 109.494 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.0 t -124.25 114.3 40.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 124.14 0.976 . . . . 63.2 109.374 -173.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.495 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 35.4 mt-30 -85.36 83.59 7.91 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.5 -0.926 . . . . 73.32 108.5 172.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -75.77 94.55 3.3 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 114.773 -1.103 . . . . 73.55 108.564 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.24 169.49 47.88 Favored Glycine 0 C--O 1.241 0.557 0 N-CA-C 111.013 -0.835 . . . . 73.41 111.013 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.23 120.74 0.91 Allowed Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 110.87 -0.892 . . . . 74.44 110.87 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.425 HG13 ' HE1' ' A' ' 17' ' ' TYR . 51.6 mt -82.61 127.07 40.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 107.805 -1.183 . . . . 64.45 107.805 174.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.692 ' HB3' HD11 ' A' ' 86' ' ' ILE . 66.7 m-85 -128.06 123.51 34.77 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.528 -0.916 . . . . 60.45 108.528 -174.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.7 t -87.32 93.55 9.43 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.361 -0.977 . . . . 73.42 108.361 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.692 HD11 ' HB3' ' A' ' 84' ' ' PHE . 18.9 mm -117.23 147.95 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.451 0.7 . . . . 71.23 111.146 -169.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.61 173.73 11.62 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.666 0.786 . . . . 75.11 110.307 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.22 -33.2 5.77 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.973 -0.558 . . . . 71.21 113.022 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.56 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -124.42 140.12 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.602 0.761 . . . . 71.53 110.515 -173.286 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.452 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 11.6 mp0 -131.52 174.78 9.74 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.709 0.804 . . . . 72.33 110.02 178.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.88 -123.21 27.98 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 124.0 0.813 . . . . 71.31 114.205 173.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.9 t -71.93 -25.25 61.82 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.289 0.635 . . . . 65.12 111.354 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -75.37 -38.0 60.28 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.599 0.76 . . . . 54.42 109.527 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.452 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 6.1 tpt -66.5 -45.55 79.17 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.511 -0.768 . . . . 55.35 109.367 174.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.8 -37.01 77.93 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.358 -0.837 . . . . 53.22 110.883 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -68.54 -34.62 76.17 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.738 -0.664 . . . . 75.55 111.001 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.2 t -69.3 -45.61 69.16 Favored 'General case' 0 C--N 1.348 0.5 0 N-CA-C 109.445 -0.576 . . . . 72.43 109.445 178.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 94' ' ' MET . 49.2 mt -80.85 -22.3 40.01 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.47 -0.787 . . . . 33.41 112.273 -172.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.13 4.14 30.08 Favored Glycine 0 N--CA 1.475 1.239 0 CA-C-O 119.677 -0.513 . . . . 64.15 114.055 -174.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.484 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -142.71 -65.91 0.39 Allowed 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 117.406 0.603 . . . . 74.54 111.192 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -69.94 -43.34 71.81 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 111.988 0.366 . . . . 74.45 111.988 -173.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 65.6 m -66.65 -47.22 56.9 Favored Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 124.044 0.937 . . . . 71.0 112.806 -176.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.458 ' HA ' ' HB2' ' A' ' 106' ' ' LEU . 52.2 Cg_endo -67.41 -23.61 43.88 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 121.77 1.646 . . . . 64.42 113.168 170.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -66.39 -38.21 87.0 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 122.604 0.362 . . . . 64.21 110.033 173.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.9 mm -65.12 -45.71 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.742 0.817 . . . . 63.01 110.276 171.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 103' ' ' PRO . 61.4 mt -72.02 -21.77 61.5 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.763 0.825 . . . . 74.01 113.074 -172.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -66.85 -44.28 51.67 Favored Pre-proline 0 N--CA 1.484 1.264 0 N-CA-C 114.057 1.132 . . . . 73.45 114.057 -169.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -54.89 -31.54 73.78 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.812 1.675 . . . . 51.11 113.714 172.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.443 ' OH ' ' HB3' ' C' ' 130' ' ' PRO . 67.8 m-85 -84.49 -37.13 21.69 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.497 0.719 . . . . 71.11 111.305 -175.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.5 -46.87 78.03 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.286 -0.635 . . . . 54.34 109.286 172.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.545 ' NH1' HD12 ' C' ' 105' ' ' ILE . 32.9 ttm180 -49.57 -52.66 28.52 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 124.884 1.365 . . . . 74.4 110.463 174.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -63.27 -45.89 89.37 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.223 0.952 . . . . 73.13 112.05 -175.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.428 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 45.1 t -58.14 -46.25 85.98 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 124.045 0.84 . . . . 73.12 110.364 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.604 HG21 HG21 ' A' ' 64' ' ' VAL . 32.5 mt -60.93 -52.5 60.93 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 115.2 -0.909 . . . . 64.44 110.632 175.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.4 m -56.21 -40.16 73.6 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.127 0.892 . . . . 71.22 111.28 -174.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.516 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 41.9 t -67.62 -42.97 81.5 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 114.772 -1.104 . . . . 54.31 110.356 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.9 mtp -62.5 -37.38 85.79 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.552 0.741 . . . . 73.1 111.661 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 114' ' ' ILE . 86.1 t -62.2 -53.7 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.254 1.022 . . . . 41.42 109.917 177.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.5 p -69.92 -26.71 64.28 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.95 -1.023 . . . . 54.55 111.587 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.516 ' HB2' ' O ' ' A' ' 116' ' ' SER . 18.0 ttm-85 -75.49 -31.61 60.27 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.182 0.993 . . . . 71.44 109.083 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.437 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.88 19.82 18.96 Favored Glycine 0 C--N 1.354 1.576 0 CA-C-N 114.948 -1.024 . . . . 34.13 112.916 171.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.5 t 61.44 9.12 2.48 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 127.497 2.319 . . . . 75.11 114.03 175.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -78.93 140.05 57.8 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 108.409 -0.96 . . . . 74.34 108.409 175.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.08 136.06 44.94 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.857 2.372 . . . . 54.41 111.854 175.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -52.07 133.54 33.09 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.308 1.005 . . . . 73.42 113.269 -170.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.435 HD21 HG11 ' A' ' 40' ' ' VAL . 58.7 tp -112.42 137.3 50.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.406 -1.27 . . . . 65.03 108.986 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.563 HD21 ' HA ' ' C' ' 15' ' ' ARG . 83.7 m-20 -122.93 123.75 41.64 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 107.806 -1.183 . . . . 74.43 107.806 178.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.453 HD11 HD13 ' A' ' 114' ' ' ILE . 7.5 mt -74.78 125.6 29.13 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.122 -0.696 . . . . 60.12 109.122 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.31 135.99 96.49 Favored Pre-proline 0 CA--C 1.555 1.17 0 CA-C-O 119.186 -0.435 . . . . 75.02 111.028 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.85 131.59 46.96 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 123.284 2.656 . . . . 75.12 113.705 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.612 HG21 HD11 ' A' ' 44' ' ' LEU . 67.2 t -115.07 133.56 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.87 0.868 . . . . 74.32 110.513 -177.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -88.49 87.87 7.42 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 108.663 -0.866 . . . . 63.54 108.663 173.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -60.87 -26.9 67.74 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.001 0.92 . . . . 72.32 111.965 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.484 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 4.1 t70 -71.02 -40.77 71.59 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 123.592 0.557 . . . . 51.25 109.648 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.52 94.17 Favored 'General case' 0 C--N 1.351 0.635 0 O-C-N 123.897 0.748 . . . . 60.02 110.772 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.7 mt -58.71 -50.95 71.99 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.694 0.621 . . . . 63.54 110.59 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 53.9 t80 . . . . . 0 N--CA 1.474 0.74 0 CA-C-N 115.855 -0.611 . . . . 64.45 110.363 178.979 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 14.6 ptm . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 114.053 1.131 . . . . 63.31 114.053 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 91.5 m -151.72 111.04 3.93 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.513 1.125 . . . . 71.43 108.424 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -109.56 144.48 37.81 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.853 0.461 . . . . 71.24 109.918 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -156.69 139.97 15.63 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.888 0.875 . . . . 44.51 109.505 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.8 mt -94.08 131.47 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.258 -1.386 . . . . 73.42 107.258 169.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -93.73 -46.69 7.12 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 120.968 0.414 . . . . 73.11 109.986 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -176.74 130.9 0.19 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.22 -0.9 . . . . 70.52 109.067 -172.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.513 HG21 ' CD1' ' B' ' 109' ' ' TYR . 81.6 mt -116.2 148.37 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 108.45 -0.945 . . . . 64.23 108.45 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -165.17 147.01 7.74 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 113.059 0.763 . . . . 73.35 113.059 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.2 m -73.53 121.42 20.57 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.457 -1.247 . . . . 74.43 108.991 168.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.414 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.9 mtpt -99.4 -20.79 16.3 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.499 0.719 . . . . 75.45 111.929 -177.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -164.67 135.54 4.14 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.326 0.25 . . . . 63.44 110.742 -171.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 48.4 mm -132.57 139.11 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.871 1.268 . . . . 63.42 109.601 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 37.2 t -136.28 126.73 26.78 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.38 -1.341 . . . . 70.54 107.38 174.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.485 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.8 t80 -145.01 111.6 5.75 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 107.589 -1.263 . . . . 73.53 107.589 170.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -128.32 112.73 14.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.311 -0.996 . . . . 61.51 108.311 -173.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.62 85.06 8.73 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 107.792 -1.188 . . . . 63.11 107.792 174.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.5 -30.07 12.73 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.579 2.186 . . . . 72.22 112.256 -175.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.451 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 2.1 m-20 -98.46 10.06 41.72 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.193 0.997 . . . . 71.13 110.571 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.469 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -41.92 -61.89 1.35 Allowed Pre-proline 0 CA--C 1.56 1.357 0 N-CA-C 115.293 1.59 . . . . 53.42 115.293 -164.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.409 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 15.5 Cg_exo -62.76 -27.65 75.69 Favored 'Trans proline' 0 C--N 1.391 2.765 0 C-N-CA 122.347 2.031 . . . . 71.51 112.721 -169.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -94.24 -37.89 11.31 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.704 -1.134 . . . . 71.53 111.804 -172.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.589 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.1 p -69.6 -12.22 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 122.753 0.421 . . . . 74.32 112.109 -173.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -70.38 -9.72 57.07 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 112.868 0.692 . . . . 73.24 112.868 177.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -61.92 -26.2 68.03 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.623 0.769 . . . . 62.33 110.915 171.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.614 ' HB2' HD13 ' B' ' 68' ' ' LEU . 30.4 mmtp -89.24 84.73 6.51 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.482 1.113 . . . . 54.24 110.171 -174.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -88.3 82.53 7.04 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.125 0.488 . . . . 70.22 110.834 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 26.8 p90 -160.92 -172.05 3.32 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.513 1.125 . . . . 72.12 108.966 169.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -79.59 119.29 76.4 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.152 0.581 . . . . 74.54 110.722 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.473 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 20.6 Cg_endo -68.59 152.02 74.89 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 121.843 1.695 . . . . 74.02 111.343 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -71.35 102.68 2.67 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.596 -0.89 . . . . 72.35 108.596 173.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.425 HG11 HD11 ' B' ' 126' ' ' LEU . 50.6 t -94.84 142.77 13.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 114.667 -1.151 . . . . 74.31 110.24 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -140.0 109.74 6.35 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 106.933 -1.506 . . . . 75.35 106.933 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.484 HD13 HD22 ' B' ' 128' ' ' LEU . 35.6 tp -92.61 146.08 23.94 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.949 0.9 . . . . 74.54 109.845 -173.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.598 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 16.2 m-20 -131.34 143.16 50.29 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.758 1.223 . . . . 65.44 108.62 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 98.0 mt -129.99 128.63 42.44 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.922 -1.14 . . . . 73.34 107.922 174.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -140.84 143.96 35.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.091 0.956 . . . . 71.0 108.595 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 25.8 m -118.91 102.35 8.72 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.644 -0.502 . . . . 74.04 109.644 -175.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' B' ' 59' ' ' VAL . . . -125.3 115.62 20.64 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 106.672 -1.603 . . . . 42.53 106.672 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 24.2 m -142.42 -178.27 5.67 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.75 0.42 . . . . 63.3 111.401 -164.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 69.4 p -150.67 137.01 18.65 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 123.396 0.678 . . . . 44.34 109.91 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -95.17 128.47 42.03 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.7 0.4 . . . . 60.44 110.097 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 19.0 mt -92.6 -30.99 15.34 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.491 0.494 . . . . 64.22 110.234 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.495 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -171.41 175.15 4.23 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.842 0.857 . . . . 72.24 111.418 -176.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.72 137.33 57.74 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 107.019 -1.475 . . . . 74.44 107.019 159.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 70.81 -4.1 1.8 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.421 1.088 . . . . 74.33 113.234 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 41.2 t -135.15 96.71 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 108.334 -0.987 . . . . 74.22 108.334 -178.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -115.9 140.71 48.98 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.73 -0.841 . . . . 73.43 108.73 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -110.44 96.84 6.45 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.149 -1.426 . . . . 71.24 107.149 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -99.85 146.77 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 115.893 -0.594 . . . . 72.34 109.999 -174.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' B' ' 47' ' ' ALA . 26.9 t -127.86 143.54 40.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 123.942 0.897 . . . . 60.44 108.802 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 46.4 tp -119.46 114.34 22.15 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.547 -0.909 . . . . 74.44 108.547 170.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -84.39 111.92 19.88 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.377 -0.972 . . . . 75.43 108.377 171.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.414 ' CG1' HD11 ' B' ' 42' ' ' LEU . 20.8 t -105.78 103.37 15.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.458 -1.312 . . . . 75.03 107.458 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.598 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 16.8 m -103.29 131.09 50.63 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.699 -0.482 . . . . 73.42 109.699 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.592 HG11 HD21 ' B' ' 126' ' ' LEU . 88.0 t -116.84 128.12 74.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 123.377 0.671 . . . . 54.2 109.903 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 90.0 m -106.67 141.19 38.33 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.637 -1.246 . . . . 74.42 107.637 163.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -147.47 140.58 25.12 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.537 -0.912 . . . . 53.33 108.537 174.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.49 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 29.2 p -142.91 128.28 18.87 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.748 -0.66 . . . . 73.25 110.589 -171.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.614 HD13 ' HB2' ' B' ' 34' ' ' LYS . 39.0 mt -99.52 108.81 21.33 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.133 0.973 . . . . 65.4 109.668 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.66 -125.86 9.49 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 116.018 -0.537 . . . . 74.32 111.872 -175.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -96.72 2.95 52.58 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.425 0.69 . . . . 64.34 112.105 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.451 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 17.3 pt-20 -125.01 159.43 31.32 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.901 0.48 . . . . 60.35 111.3 -174.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 85.0 m -67.77 130.58 43.43 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.582 0.753 . . . . 64.34 110.329 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.589 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -84.86 -67.51 0.79 Allowed 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.598 -1.26 . . . . 64.41 107.598 170.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -147.71 156.87 43.21 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.157 -0.929 . . . . 64.43 110.988 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 89.0 mt -124.24 109.89 13.97 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 107.008 -1.479 . . . . 70.05 107.008 172.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.5 t -117.87 156.72 27.93 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.653 -0.499 . . . . 32.11 109.653 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 38.1 tt0 -165.11 139.32 4.92 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.615 -0.883 . . . . 75.31 108.615 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.42 HG22 HD12 ' B' ' 21' ' ' ILE . 84.5 t -133.79 145.5 33.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.879 -1.156 . . . . 63.44 107.879 173.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -125.77 93.63 3.89 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.48 -0.933 . . . . 70.32 108.48 175.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.418 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.2 tp-100 -87.77 104.91 17.01 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.395 -0.821 . . . . 73.44 109.24 -177.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.414 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -97.06 173.37 29.02 Favored Glycine 0 C--N 1.336 0.553 0 O-C-N 123.664 0.603 . . . . 65.04 112.168 175.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.39 139.65 4.64 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 121.784 -0.246 . . . . 35.23 112.785 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 52.1 mt -85.69 113.45 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 108.37 -0.974 . . . . 71.33 108.37 173.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -117.4 135.45 53.87 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.643 0.777 . . . . 73.31 109.943 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 72.4 m -94.9 105.45 17.37 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.744 0.818 . . . . 65.23 109.633 172.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.637 ' HB ' HD11 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -114.3 105.15 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 124.236 1.015 . . . . 74.14 108.685 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.0 163.02 24.64 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.335 0.654 . . . . 71.42 111.523 -174.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.72 -30.76 3.43 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 114.402 0.521 . . . . 53.22 114.402 172.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.637 HD11 ' HB ' ' B' ' 86' ' ' ILE . 2.0 pt -67.83 161.29 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 124.495 1.118 . . . . 64.51 111.443 172.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -148.6 171.96 15.3 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 123.863 0.865 . . . . 75.21 111.062 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.52 -130.85 11.5 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 114.557 -1.201 . . . . 62.52 113.875 173.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 24.5 m -86.59 -35.7 19.3 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.853 0.861 . . . . 63.5 109.636 174.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -65.17 -23.33 67.08 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.103 -1.408 . . . . 71.24 111.666 -170.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.598 ' HA ' HD12 ' B' ' 89' ' ' ILE . 19.0 ptt? -66.23 -51.23 59.64 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.526 -0.761 . . . . 73.2 111.761 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.74 -13.46 59.43 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.483 0.713 . . . . 55.35 111.128 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -68.91 -32.57 72.29 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.308 0.643 . . . . 64.24 110.516 169.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -65.32 -52.09 56.27 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 120.899 0.381 . . . . 61.25 110.729 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.432 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.4 pp -71.13 -22.09 62.11 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 116.049 -0.523 . . . . 44.53 111.135 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.15 4.38 44.82 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 118.764 -1.02 . . . . 53.12 115.029 -172.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.27 -45.95 0.11 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 118.557 1.178 . . . . 72.03 111.294 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -74.82 -40.77 60.87 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.093 0.557 . . . . 73.45 110.686 -176.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.432 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 74.3 m -73.46 -46.19 7.55 Favored Pre-proline 0 CA--C 1.561 1.38 0 CA-C-O 118.492 -0.766 . . . . 65.2 112.94 -177.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.64 -16.48 54.95 Favored 'Trans proline' 0 C--N 1.396 3.064 0 C-N-CA 121.9 1.734 . . . . 73.52 113.246 171.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -73.33 -32.19 64.42 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.123 0.569 . . . . 74.04 110.644 172.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.475 HG23 ' NH2' ' D' ' 111' ' ' ARG . 91.3 mt -70.35 -39.73 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.04 0.936 . . . . 73.42 109.758 172.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 76.1 mt -75.57 -32.22 60.29 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.88 -1.054 . . . . 72.0 111.912 -174.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -57.24 -50.11 90.04 Favored Pre-proline 0 N--CA 1.488 1.471 0 CA-C-O 117.78 -1.105 . . . . 75.31 113.451 -173.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.35 -37.44 97.57 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 121.84 1.693 . . . . 63.41 112.593 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.513 ' CD1' HG21 ' B' ' 16' ' ' ILE . 3.6 m-30 -66.37 -39.37 89.08 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.727 0.811 . . . . 72.42 110.078 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.12 -31.56 67.91 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.15 0.98 . . . . 65.13 111.331 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -69.12 -52.96 22.93 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.529 1.132 . . . . 71.24 111.068 -173.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.0 -27.33 66.47 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.52 -0.548 . . . . 74.1 109.52 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.485 ' O ' ' HG2' ' B' ' 117' ' ' MET . 31.0 t -65.29 -42.6 92.95 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 122.945 0.498 . . . . 54.21 111.256 178.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.562 HD13 HG23 ' B' ' 64' ' ' VAL . 65.0 mt -62.74 -54.16 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.209 0.604 . . . . 62.34 109.573 173.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 4.3 m -62.32 -23.22 66.64 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 124.053 0.846 . . . . 73.13 111.334 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.447 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.3 t -69.19 -50.93 43.01 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 109.072 -0.714 . . . . 44.4 109.072 174.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.0 mmt -67.86 -34.96 77.7 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.074 0.55 . . . . 61.0 111.241 -176.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 70.4 t -64.75 -43.93 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.775 1.23 . . . . 72.53 110.216 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 31.4 t -64.74 -34.72 78.99 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.007 -0.997 . . . . 62.12 111.291 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' B' ' 116' ' ' SER . 82.1 mtt-85 -67.84 -35.88 79.36 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-N 115.718 -0.674 . . . . 62.25 109.802 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.31 -7.04 81.92 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.595 0.559 . . . . 64.15 113.324 172.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.43 ' HB ' ' HE ' ' A' ' 15' ' ' ARG . 8.5 m 64.94 33.4 9.89 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 125.144 1.377 . . . . 74.52 110.447 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -86.21 162.8 45.06 Favored Pre-proline 0 CA--C 1.555 1.173 0 CA-C-N 114.407 -1.269 . . . . 74.15 110.395 174.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.21 169.97 15.61 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.528 2.152 . . . . 71.01 113.415 -176.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.488 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 62.4 tp60 -64.44 115.93 5.6 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 115.224 -0.898 . . . . 75.31 111.759 -169.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.592 HD21 HG11 ' B' ' 64' ' ' VAL . 55.8 tp -109.82 98.04 7.44 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.334 -0.848 . . . . 70.12 109.357 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.409 ' ND2' HE21 ' B' ' 125' ' ' GLN . 19.2 m120 -103.5 103.05 12.97 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.611 -1.255 . . . . 73.11 107.611 173.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.484 HD22 HD13 ' B' ' 42' ' ' LEU . 91.0 mt -62.54 141.54 58.39 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.566 0.346 . . . . 74.1 111.14 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.3 140.28 88.07 Favored Pre-proline 0 CA--C 1.55 0.96 0 O-C-N 124.016 0.822 . . . . 53.41 111.128 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -65.92 97.35 0.34 Allowed 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.513 2.142 . . . . 74.33 111.072 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 27.4 m -90.86 112.37 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.728 0.775 . . . . 55.41 110.501 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 55.7 t30 . . . . . 0 C--O 1.24 0.595 0 N-CA-C 107.936 -1.135 . . . . 73.32 107.936 171.44 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 71.0 t80 . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 109.354 -0.61 . . . . 75.5 109.354 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -154.13 141.58 19.72 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.679 0.392 . . . . 75.42 110.11 171.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 17.1 mt -91.31 123.56 43.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 109.452 -0.573 . . . . 65.53 109.452 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -88.22 -42.89 11.99 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.127 0.571 . . . . 44.34 109.542 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.563 ' HA ' HD21 ' A' ' 127' ' ' ASN . 14.2 ptp180 -172.56 147.35 1.83 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.154 0.982 . . . . 70.24 110.307 -178.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 70.6 mt -125.03 130.79 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.104 1.362 . . . . 73.1 107.535 174.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.529 ' HB3' HG23 ' D' ' 122' ' ' THR . 31.1 p90 -162.96 173.26 13.87 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.682 0.753 . . . . 73.52 111.523 -167.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -98.36 117.28 32.42 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.982 -1.008 . . . . 60.31 109.586 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.491 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 21.4 mmtp -67.61 -48.08 67.83 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 107.904 -1.147 . . . . 63.45 107.904 168.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -139.32 144.01 38.08 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 113.85 -1.523 . . . . 73.04 109.921 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.425 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.9 mt -133.88 142.99 39.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 125.393 1.477 . . . . 74.24 107.078 173.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.0 t -152.5 146.0 24.91 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.325 0.583 . . . . 72.21 110.342 174.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -150.18 128.26 11.93 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 107.066 -1.457 . . . . 74.23 107.066 172.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -133.92 112.16 11.04 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.195 -0.668 . . . . 64.41 109.195 -177.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.56 80.81 69.32 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 107.695 -1.224 . . . . 61.13 107.695 166.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.29 -21.69 30.66 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.453 2.102 . . . . 70.23 111.609 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -100.49 15.0 29.38 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.985 1.314 . . . . 75.41 110.946 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.436 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -42.21 -56.51 5.32 Favored Pre-proline 0 N--CA 1.487 1.423 0 N-CA-C 114.385 1.254 . . . . 43.54 114.385 -169.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.436 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 36.1 Cg_exo -60.68 -41.6 45.78 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.286 1.991 . . . . 52.11 112.666 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -68.36 -39.09 81.94 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.025 -0.989 . . . . 62.32 112.059 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.758 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.1 p -79.2 -17.13 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.507 0 N-CA-C 112.841 0.682 . . . . 63.44 112.841 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -69.41 -26.85 64.83 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 112.745 0.646 . . . . 71.44 112.745 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -87.14 13.63 9.11 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.174 0.59 . . . . 65.31 111.591 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.79 160.34 15.31 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.796 0.838 . . . . 74.33 110.756 -173.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -71.59 129.83 39.7 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.603 0.761 . . . . 71.44 109.877 173.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -82.9 90.19 6.93 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.574 0.75 . . . . 72.24 110.724 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . 0.443 ' H ' HD22 ' C' ' 68' ' ' LEU . 52.6 tt0 -146.55 79.46 10.4 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 124.095 0.958 . . . . 74.41 108.845 173.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -86.24 158.36 9.75 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.547 2.165 . . . . 70.42 112.852 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.47 79.3 9.02 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 106.703 -1.592 . . . . 70.44 106.703 167.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 25.7 t -71.73 96.75 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.112 -0.949 . . . . 73.15 108.845 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.93 104.0 12.55 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.767 -1.568 . . . . 73.25 106.767 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 pp -85.48 145.59 27.35 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.967 -0.753 . . . . 72.52 108.967 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.406 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 22.5 t70 -128.12 115.44 18.43 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.746 -0.835 . . . . 70.15 108.746 178.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.524 HD11 HG11 ' C' ' 131' ' ' VAL . 93.0 mt -97.35 110.97 23.42 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.598 -0.519 . . . . 73.13 109.598 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -113.52 145.96 40.39 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.374 -1.343 . . . . 71.41 107.374 169.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.0 t -137.42 146.76 44.78 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.232 -0.655 . . . . 71.11 109.232 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.84 171.82 13.55 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.116 0.967 . . . . 61.05 108.8 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 32.8 p -156.15 156.03 33.53 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.284 0.633 . . . . 42.11 109.621 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -145.41 127.62 15.73 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.49 -0.93 . . . . 74.41 108.49 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -78.9 113.46 17.02 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 107.452 -1.314 . . . . 73.32 107.452 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.63 HD11 HD12 ' C' ' 83' ' ' ILE . 67.0 mt -84.61 -27.35 27.26 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.008 0.523 . . . . 72.04 110.444 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.3 -175.06 2.78 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.737 -1.12 . . . . 71.22 110.182 -176.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -64.37 104.11 0.73 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.101 -0.954 . . . . 64.35 110.343 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 65.56 21.33 11.73 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.453 1.101 . . . . 71.35 112.302 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.5 t -108.55 114.96 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 107.613 -1.254 . . . . 74.32 107.613 166.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -121.63 124.39 44.21 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.343 0.657 . . . . 54.11 109.542 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.433 ' HB2' HD11 ' C' ' 51' ' ' LEU . 26.3 tt0 -82.95 143.22 30.83 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 124.542 1.137 . . . . 74.41 108.563 165.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.445 HG11 ' HD3' ' C' ' 103' ' ' PRO . 96.0 t -132.95 133.55 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.787 -0.82 . . . . 73.44 108.787 171.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.45 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 58.7 t -113.4 139.71 37.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 123.661 0.785 . . . . 74.52 109.112 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.465 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -122.63 100.73 7.07 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.045 -1.465 . . . . 65.2 107.045 173.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -82.48 107.42 15.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.193 -0.912 . . . . 72.33 109.244 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 24.4 t -107.76 114.75 47.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.885 -1.154 . . . . 65.52 107.885 173.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.406 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 21.4 m -105.1 145.51 30.43 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.195 0.998 . . . . 74.02 108.783 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.54 HG21 HG21 ' C' ' 114' ' ' ILE . 87.4 t -126.49 119.49 53.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 109.103 -0.703 . . . . 71.41 109.103 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 38.6 m -99.14 134.72 41.59 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.559 -1.274 . . . . 72.53 107.559 166.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.27 103.83 4.5 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.115 -1.068 . . . . 71.33 108.115 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 42.4 m -130.31 132.25 45.79 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 121.156 0.503 . . . . 73.25 109.862 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.443 HD22 ' H ' ' C' ' 37' ' ' GLN . 12.7 mt -85.54 38.21 0.73 Allowed 'General case' 0 CA--C 1.556 1.212 0 C-N-CA 124.793 1.237 . . . . 62.42 109.87 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.49 -111.8 2.64 Favored Glycine 0 C--N 1.354 1.533 0 N-CA-C 110.217 -1.153 . . . . 64.25 110.217 -168.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -90.47 -31.22 16.88 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.151 0.981 . . . . 72.5 109.879 174.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -67.16 101.03 0.84 Allowed 'General case' 0 C--N 1.346 0.423 0 C-N-CA 124.032 0.933 . . . . 75.11 109.793 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 46.4 m -72.43 116.31 12.73 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.978 -0.749 . . . . 45.23 108.978 173.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.758 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -64.44 -49.17 72.53 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.072 0.858 . . . . 73.5 109.506 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -167.54 164.73 14.79 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.133 -1.394 . . . . 65.34 110.459 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.49 138.2 53.3 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 106.38 -1.711 . . . . 35.55 106.38 164.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 51.3 t -144.89 145.71 31.7 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.777 -0.823 . . . . 73.43 108.777 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -159.94 136.89 9.31 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.796 -0.446 . . . . 64.54 109.796 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 69.1 t -131.24 124.39 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.174 0.99 . . . . 63.31 108.668 175.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -99.85 84.12 2.85 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.789 -1.189 . . . . 73.41 107.789 177.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -78.63 95.74 5.32 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.33 -0.85 . . . . 63.03 109.502 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -94.56 146.52 18.2 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 115.697 -0.683 . . . . 72.41 111.905 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.08 140.74 9.64 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.346 -0.702 . . . . 72.43 111.346 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.63 HD12 HD11 ' C' ' 51' ' ' LEU . 15.4 mm -97.12 133.1 40.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 109.52 -0.548 . . . . 71.15 109.52 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.435 ' HZ ' HD11 ' C' ' 106' ' ' LEU . 25.7 m-85 -135.84 147.09 48.12 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.854 0.721 . . . . 74.42 110.029 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 12.9 p -101.2 101.16 11.8 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.806 -1.183 . . . . 65.34 107.806 168.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.629 HD13 ' SG ' ' C' ' 97' ' ' CYS . 22.5 mt -116.25 129.94 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.39 0.676 . . . . 72.5 110.303 -172.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.05 172.82 16.27 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.21 1.004 . . . . 74.23 109.516 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.32 -34.04 5.08 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-N 116.547 -0.297 . . . . 62.32 112.654 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.457 ' HB ' ' HB3' ' C' ' 93' ' ' GLN . 33.8 pt -96.69 162.28 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.54 0.736 . . . . 74.01 111.517 -176.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -158.52 152.47 23.69 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.674 0.79 . . . . 54.24 110.417 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.58 -127.94 8.38 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-O 119.717 -0.491 . . . . 31.44 112.879 174.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -59.46 -32.91 70.67 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 123.258 0.623 . . . . 71.05 110.817 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.457 ' HB3' ' HB ' ' C' ' 89' ' ' ILE . 21.6 mt-30 -62.74 -48.95 76.99 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.357 1.063 . . . . 64.31 111.695 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.547 ' HE3' ' HA ' ' C' ' 94' ' ' MET . 4.2 tpt -55.09 -52.67 62.49 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 123.784 0.677 . . . . 72.54 110.453 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.06 -32.49 73.87 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.146 0.578 . . . . 33.42 111.955 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -70.4 -32.64 70.35 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.87 0.868 . . . . 74.21 111.153 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.629 ' SG ' HD13 ' C' ' 86' ' ' ILE . 18.7 t -72.11 -43.96 63.93 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.295 0.569 . . . . 71.33 109.622 177.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 67.6 mt -81.02 -25.3 37.29 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 114.625 -1.17 . . . . 44.33 112.121 -174.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.4 3.29 20.23 Favored Glycine 0 N--CA 1.476 1.337 0 CA-C-O 119.201 -0.777 . . . . 41.14 114.719 -172.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.99 -53.15 0.15 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 118.151 0.976 . . . . 73.11 112.559 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -70.58 -58.6 3.51 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.884 0.474 . . . . 64.11 110.404 -171.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 58.9 m -64.64 -44.18 72.98 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-O 118.494 -0.765 . . . . 72.4 112.191 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.465 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 82.7 Cg_exo -53.7 -32.87 67.26 Favored 'Trans proline' 0 C--N 1.389 2.692 0 C-N-CA 122.366 2.044 . . . . 71.45 114.021 169.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -67.55 -40.72 84.95 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 122.974 0.51 . . . . 65.41 111.028 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.545 HD12 ' NH1' ' A' ' 111' ' ' ARG . 35.8 mm -70.66 -32.57 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 C-N-CA 122.812 0.445 . . . . 63.24 110.204 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.435 HD11 ' HZ ' ' C' ' 84' ' ' PHE . 2.5 mp -83.89 -20.83 32.38 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.455 1.102 . . . . 74.44 112.105 -176.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -58.44 -47.91 97.92 Favored Pre-proline 0 CA--C 1.554 1.108 0 CA-C-O 117.811 -1.09 . . . . 72.31 113.9 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -60.14 -37.37 84.24 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 121.91 1.74 . . . . 73.21 113.044 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -68.87 -43.74 74.75 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.602 0.761 . . . . 73.44 110.309 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.11 -40.17 94.96 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.035 -0.984 . . . . 51.1 110.35 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -63.98 -48.89 74.66 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.7 1.2 . . . . 73.54 110.496 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.74 -38.91 84.16 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.136 0.575 . . . . 70.4 109.805 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.44 ' O ' ' SD ' ' C' ' 117' ' ' MET . 6.8 t -63.88 -42.78 97.42 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.685 0.394 . . . . 71.12 111.136 -178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.54 HG21 HG21 ' C' ' 64' ' ' VAL . 75.8 mt -63.27 -52.01 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 122.911 0.484 . . . . 71.42 110.244 175.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 22.0 m -63.32 -27.92 69.65 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.849 -0.614 . . . . 74.14 110.877 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 26.6 t -66.86 -52.18 46.58 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.491 0.717 . . . . 72.13 109.274 173.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.635 ' HE2' HD13 ' D' ' 21' ' ' ILE . 0.1 OUTLIER -48.76 -46.56 41.42 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.706 1.202 . . . . 75.54 112.354 175.044 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 93.4 t -67.35 -43.03 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.557 1.143 . . . . 75.1 111.004 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 15.0 t -65.72 -30.99 71.74 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.226 1.011 . . . . 75.14 111.619 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.42 HH12 ' CD ' ' D' ' 112' ' ' GLU . 70.9 mtt-85 -75.0 -39.5 61.19 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.805 0.842 . . . . 71.41 109.676 178.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.68 -2.54 64.64 Favored Glycine 0 C--N 1.356 1.645 0 CA-C-N 115.436 -0.802 . . . . 64.51 112.876 170.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.1 p 65.38 30.01 11.18 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.316 1.846 . . . . 75.15 113.533 169.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -83.81 144.28 44.89 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 108.348 -0.982 . . . . 75.11 108.348 169.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.488 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 77.8 Cg_exo -50.42 143.26 27.74 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 123.318 2.679 . . . . 72.4 113.728 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.441 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 55.5 mm-40 -51.76 119.71 4.5 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.639 1.212 . . . . 52.53 112.337 -174.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 36.6 tp -124.15 84.22 2.25 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 107.587 -1.264 . . . . 75.21 107.587 -177.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . 0.401 ' HB2' HG23 ' B' ' 122' ' ' THR . 20.0 m120 -92.68 97.68 10.94 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.377 -0.829 . . . . 73.32 108.864 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -60.36 143.82 52.17 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.47 0.708 . . . . 75.42 112.019 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.2 142.54 97.92 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-N 115.171 -0.922 . . . . 74.11 110.617 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.618 ' HG2' HG21 ' A' ' 13' ' ' ILE . 4.9 Cg_exo -67.13 152.73 79.36 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.027 1.818 . . . . 71.42 112.762 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . 0.524 HG11 HD11 ' C' ' 44' ' ' LEU . 7.2 p -136.5 134.92 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.442 -0.799 . . . . 55.32 108.855 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -87.57 103.4 15.52 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.975 0.51 . . . . 74.42 110.254 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -61.87 -29.53 70.25 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.897 0.879 . . . . 73.23 111.82 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -56.58 -55.19 37.02 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.559 0.744 . . . . 73.42 110.061 173.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.23 -47.95 77.45 Favored 'General case' 0 C--N 1.349 0.55 0 O-C-N 124.227 0.954 . . . . 61.01 111.594 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 73.2 mt -59.02 -38.3 78.96 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.559 0.744 . . . . 54.44 111.559 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 39.8 t80 . . . . . 0 N--CA 1.471 0.624 0 CA-C-N 115.138 -0.937 . . . . 65.02 110.806 -177.271 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 C--O 1.242 0.694 0 N-CA-C 108.938 -0.764 . . . . 61.15 108.938 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.478 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 60.4 t80 -133.62 99.87 4.62 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.565 -1.272 . . . . 75.34 107.565 177.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -124.63 126.72 46.21 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.713 0.805 . . . . 73.53 108.868 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.421 HG21 HD11 ' D' ' 16' ' ' ILE . 11.0 mt -89.84 122.56 41.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.339 -0.985 . . . . 61.15 108.339 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -95.34 -18.94 20.36 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.37 0.668 . . . . 75.0 111.639 -171.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 179.05 124.28 0.05 Allowed 'General case' 0 C--N 1.359 0.989 0 C-N-CA 122.958 0.503 . . . . 72.34 109.818 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.421 HD11 HG21 ' D' ' 13' ' ' ILE . 3.7 mp -103.54 136.34 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 106.854 -1.536 . . . . 71.4 106.854 167.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -160.6 145.08 14.14 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 123.389 0.43 . . . . 74.34 111.363 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.2 p -84.48 112.3 20.26 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.681 -0.69 . . . . 64.44 109.677 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -79.81 -18.07 51.78 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.664 -0.698 . . . . 64.02 109.377 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.523 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 4.3 t70 -157.51 147.5 20.55 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 124.803 1.241 . . . . 65.44 110.005 175.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.635 HD13 ' HE2' ' C' ' 117' ' ' MET . 69.6 mt -141.99 147.28 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.661 1.584 . . . . 62.22 107.423 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . 0.646 ' HB3' ' HB2' ' D' ' 77' ' ' GLU . 32.8 t -155.35 144.48 20.88 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.327 1.051 . . . . 64.53 109.266 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.425 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 91.6 t80 -151.96 129.43 11.4 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.37 -1.715 . . . . 75.1 106.37 170.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -134.14 126.98 31.14 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.527 0.731 . . . . 62.32 109.248 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.43 86.41 48.38 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 107.621 -1.251 . . . . 74.24 107.621 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.48 -36.24 15.75 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.721 2.281 . . . . 70.03 112.815 -170.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -110.53 12.32 22.86 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.856 0.862 . . . . 74.45 110.359 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.461 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -20.98 -70.23 0.04 OUTLIER Pre-proline 0 CA--C 1.57 1.714 0 N-CA-C 116.776 2.139 . . . . 65.31 116.776 -169.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.499 ' HB3' HD11 ' C' ' 83' ' ' ILE . 83.0 Cg_endo -76.26 -23.11 12.09 Favored 'Trans proline' 0 C--N 1.38 2.187 0 CA-C-N 123.741 2.372 . . . . 61.51 114.309 -174.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -71.24 -39.34 71.71 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.183 0.993 . . . . 74.35 109.3 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.576 HG21 ' HA ' ' D' ' 73' ' ' ALA . 9.8 p -84.0 -20.6 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.232 0 CA-C-N 114.798 -1.092 . . . . 61.13 111.825 -173.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.406 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 22.8 m-85 -67.22 -19.8 65.59 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 112.198 0.444 . . . . 72.43 112.198 177.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -63.09 -13.45 36.37 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.786 0.834 . . . . 62.44 110.958 176.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -99.18 91.14 4.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.24 1.416 . . . . 73.12 109.804 176.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -88.25 85.45 6.91 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.271 0.558 . . . . 72.23 110.691 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 38.9 p90 -156.91 172.22 19.04 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.001 -1.111 . . . . 75.44 108.001 165.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -68.13 116.75 42.31 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 109.351 -0.611 . . . . 63.52 109.351 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -57.38 131.14 42.92 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.648 2.232 . . . . 74.54 111.752 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 22.5 tt0 -60.02 109.98 1.09 Allowed 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.837 0.711 . . . . 72.21 109.366 175.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.845 HG13 HG13 ' D' ' 64' ' ' VAL . 45.8 t -105.43 115.25 46.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 114.622 -1.172 . . . . 62.55 109.377 -177.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.31 126.36 52.14 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 106.71 -1.589 . . . . 70.34 106.71 170.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.508 HD11 HG13 ' D' ' 62' ' ' VAL . 50.1 tp -97.57 141.92 30.02 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.605 0.762 . . . . 51.34 110.046 -168.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.764 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.5 m-20 -125.05 123.92 40.83 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 107.244 -1.391 . . . . 74.54 107.244 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 88.7 mt -124.37 138.48 54.37 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.173 0.511 . . . . 72.22 111.078 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 9.5 t70 -143.18 155.35 44.52 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.434 1.494 . . . . 64.22 107.685 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.7 t -139.71 153.48 47.24 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-O 121.386 0.612 . . . . 72.32 110.074 174.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.9 170.46 18.76 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 114.588 -1.187 . . . . 63.4 109.005 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.3 p . . . . . 0 C--O 1.24 0.597 0 C-N-CA 123.406 0.682 . . . . 74.05 109.574 -177.394 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 112.914 0.709 . . . . 73.25 112.914 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 4.1 p -118.0 95.54 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 122.265 1.031 . . . . 73.1 108.95 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -117.46 146.56 43.41 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.12 -0.945 . . . . 65.32 109.924 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -102.82 145.41 29.8 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.876 -0.602 . . . . 65.1 110.462 173.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 70.3 t -131.45 141.82 44.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 114.06 -1.427 . . . . 70.53 107.523 172.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.441 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 46.3 t -131.23 132.07 63.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 108.294 -1.002 . . . . 75.33 108.294 176.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.484 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -107.96 117.45 34.16 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 106.632 -1.618 . . . . 71.31 106.632 172.308 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.662 ' HG2' ' HG2' ' D' ' 79' ' ' GLN . 0.0 OUTLIER -101.32 97.23 7.75 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.208 -1.405 . . . . 65.31 107.208 178.312 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.508 HG13 HD11 ' D' ' 42' ' ' LEU . 54.2 t -91.08 144.25 9.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.43 -0.952 . . . . 71.22 108.43 172.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.764 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 52.2 m -138.77 135.89 35.14 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.571 -1.27 . . . . 73.33 107.571 174.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.845 HG13 HG13 ' D' ' 40' ' ' VAL . 94.9 t -117.52 127.11 75.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.976 -0.75 . . . . 73.31 108.976 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 6.0 m -111.49 93.95 4.72 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.16 -1.052 . . . . 72.23 108.16 173.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.567 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -105.29 142.29 35.31 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.002 0.521 . . . . 52.31 111.295 -177.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.505 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 42.0 m -145.52 142.27 29.05 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.153 0.581 . . . . 61.22 110.81 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.512 HD12 HG22 ' D' ' 31' ' ' VAL . 19.4 mt -108.57 109.49 20.73 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.7 -1.222 . . . . 72.02 107.7 170.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.61 -124.39 7.51 Favored Glycine 0 C--N 1.345 1.056 0 O-C-N 123.212 0.32 . . . . 61.32 112.953 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.4 5.61 37.23 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.171 0.588 . . . . 73.52 111.842 -177.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -124.3 155.39 38.75 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.093 0.557 . . . . 74.41 109.986 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 75.7 m -66.32 136.53 55.94 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 122.767 0.427 . . . . 64.4 110.726 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.576 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.51 -64.66 1.11 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.348 -1.352 . . . . 52.23 107.348 174.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -154.96 164.13 39.33 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 114.409 -1.269 . . . . 73.3 110.68 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 62.6 mt -130.12 144.49 51.38 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 105.821 -1.918 . . . . 75.55 105.821 174.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.59 ' SG ' HG23 ' D' ' 114' ' ' ILE . 9.1 t -152.72 106.81 3.11 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 118.812 0.733 . . . . 63.15 110.777 -173.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . 0.646 ' HB2' ' HB3' ' D' ' 22' ' ' SER . 10.9 mp0 -122.69 127.82 49.78 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.193 0.997 . . . . 71.53 109.793 -169.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 64.3 t -138.53 121.81 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 122.876 0.47 . . . . 61.02 109.741 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.662 ' HG2' ' HG2' ' D' ' 61' ' ' ARG . 43.2 mt-30 -89.99 88.58 7.36 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 108.965 -0.754 . . . . 71.31 108.965 167.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . 0.414 ' O ' HD13 ' D' ' 106' ' ' LEU . 6.9 tp-100 -82.58 94.58 7.54 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.236 -0.893 . . . . 64.13 108.925 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.78 173.06 37.88 Favored Glycine 0 C--O 1.242 0.623 0 CA-C-N 116.141 -0.481 . . . . 63.34 112.432 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.44 148.27 10.95 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.519 -0.34 . . . . 42.14 112.459 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.4 mt -100.44 113.67 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 108.211 -1.033 . . . . 73.22 108.211 175.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -114.24 133.51 55.58 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.969 0.908 . . . . 72.23 109.891 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 35.6 p -96.68 105.44 17.55 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.977 -0.749 . . . . 43.3 108.977 172.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.504 HD11 ' SG ' ' D' ' 102' ' ' CYS . 61.7 mt -117.12 119.23 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.252 1.021 . . . . 54.24 109.25 -173.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.19 125.66 5.1 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.539 0.735 . . . . 53.42 110.569 -176.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.93 19.47 7.27 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-O 119.583 -0.565 . . . . 55.4 114.497 170.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.615 HD13 ' HA ' ' D' ' 94' ' ' MET . 0.8 OUTLIER -118.15 149.25 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 108.86 -0.793 . . . . 72.03 108.86 167.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -129.33 -179.96 5.44 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.183 0.993 . . . . 73.15 108.664 -171.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.07 -140.44 34.22 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 116.152 -0.477 . . . . 73.51 113.685 173.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 61.4 p -82.0 -33.79 29.93 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.313 0.645 . . . . 72.04 111.038 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -64.65 -26.25 68.31 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.516 0.726 . . . . 71.53 111.891 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.615 ' HA ' HD13 ' D' ' 89' ' ' ILE . 48.2 ttp -46.37 -60.46 2.32 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.913 1.285 . . . . 74.34 112.805 -176.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.68 -14.41 48.58 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.38 0.672 . . . . 62.13 112.248 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 45.2 m170 -72.05 -28.79 63.58 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.926 0.49 . . . . 73.45 110.579 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 70.9 m -62.02 -30.15 70.76 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.158 0.583 . . . . 73.44 111.078 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.2 tt -89.49 -44.98 9.75 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.827 0.851 . . . . 72.01 110.197 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.3 -13.3 74.1 Favored Glycine 0 N--CA 1.472 1.095 0 CA-C-N 115.983 -0.553 . . . . 53.05 114.331 -170.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.7 -53.16 0.81 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 117.314 0.557 . . . . 72.41 111.544 -173.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -68.37 -40.95 81.27 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 112.043 0.386 . . . . 74.33 112.043 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.504 ' SG ' HD11 ' D' ' 86' ' ' ILE . 78.2 m -66.33 -46.13 60.37 Favored Pre-proline 0 CA--C 1.562 1.415 0 CA-C-O 118.447 -0.787 . . . . 65.43 112.655 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.484 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 73.4 Cg_exo -55.08 -37.4 94.02 Favored 'Trans proline' 0 C--N 1.396 3.039 0 C-N-CA 122.152 1.901 . . . . 72.31 112.812 168.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -62.47 -36.86 83.82 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.256 0.622 . . . . 63.44 111.018 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 38.2 mm -69.98 -40.6 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.923 0.889 . . . . 73.33 110.865 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.414 HD13 ' O ' ' D' ' 80' ' ' GLN . 89.4 mt -73.26 -16.89 61.38 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.877 -0.602 . . . . 72.3 111.937 -176.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -68.53 -43.39 30.62 Favored Pre-proline 0 CA--C 1.555 1.168 0 CA-C-O 118.095 -0.955 . . . . 70.43 113.235 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -46.09 -43.42 20.49 Favored 'Trans proline' 0 C--N 1.382 2.322 0 C-N-CA 122.151 1.901 . . . . 55.01 113.897 167.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -77.78 -36.66 50.26 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.64 0.776 . . . . 71.13 111.769 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.84 -50.68 47.95 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.405 0.682 . . . . 64.32 110.127 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.619 HH12 ' HB3' ' D' ' 130' ' ' PRO . 36.5 ttp180 -54.92 -41.81 71.47 Favored 'General case' 0 C--O 1.211 -0.969 0 O-C-N 124.727 1.267 . . . . 75.04 111.02 172.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . 0.42 ' CD ' HH12 ' C' ' 120' ' ' ARG . 1.6 tm-20 -56.97 -53.84 53.52 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.161 0.913 . . . . 71.23 111.293 -175.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.0 t -55.02 -41.56 71.5 Favored 'General case' 0 C--N 1.348 0.523 0 O-C-N 124.469 1.106 . . . . 71.3 110.955 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.59 HG23 ' SG ' ' D' ' 76' ' ' CYS . 90.5 mt -64.22 -53.56 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.949 0.9 . . . . 74.03 110.834 177.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 93.2 m -55.45 -39.63 70.58 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.202 1.401 . . . . 71.42 110.375 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.0 t -66.97 -47.52 71.32 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.824 -1.535 . . . . 74.34 110.596 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.422 ' HE2' ' HA ' ' D' ' 114' ' ' ILE . 78.8 mtm -68.4 -25.56 65.11 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.557 0.577 . . . . 74.34 112.557 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' D' ' 126' ' ' LEU . 76.0 t -68.65 -45.8 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.656 0.782 . . . . 74.51 109.294 175.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 72.5 p -73.95 -27.21 60.89 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 115.536 -0.757 . . . . 75.52 110.48 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 78.0 mtt-85 -74.4 -27.3 60.57 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.694 0.798 . . . . 75.21 110.123 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.7 10.22 73.03 Favored Glycine 0 C--N 1.351 1.372 0 O-C-N 123.653 0.595 . . . . 51.12 112.704 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.529 HG23 ' HB3' ' C' ' 17' ' ' TYR . 82.5 p 51.38 37.18 18.38 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.195 1.798 . . . . 71.32 114.203 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -95.99 154.04 39.04 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.148 -0.933 . . . . 72.22 109.345 168.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -49.62 132.53 30.78 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 123.173 2.582 . . . . 74.23 112.517 168.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -50.1 128.45 19.04 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.155 0.982 . . . . 65.13 112.508 -174.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.569 HD13 HG21 ' D' ' 40' ' ' VAL . 21.4 tp -107.68 128.74 54.82 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.938 0.895 . . . . 62.33 109.066 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -129.16 99.78 5.37 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.164 -1.05 . . . . 64.35 108.164 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.492 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 2.8 mm? -64.26 121.18 13.65 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.513 0.725 . . . . 73.34 110.032 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.35 123.0 74.28 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 123.123 0.569 . . . . 64.4 111.179 -176.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.619 ' HB3' HH12 ' D' ' 111' ' ' ARG . 72.2 Cg_endo -76.41 114.77 3.95 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.542 2.161 . . . . 63.5 112.431 -176.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.25 145.22 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.806 0.842 . . . . 63.42 109.355 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -70.38 115.06 9.12 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.341 -0.615 . . . . 73.24 109.341 173.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 . . . . . 0 N--CA 1.482 1.157 0 C-N-CA 123.801 0.84 . . . . 62.11 111.367 -179.69 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.3 m . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 109.261 -0.644 . . . . 72.11 109.261 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -129.01 120.75 26.57 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.006 -1.109 . . . . 74.25 108.006 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -147.65 108.92 4.28 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.472 -0.566 . . . . 74.51 109.472 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.485 ' CD1' HG21 ' A' ' 105' ' ' ILE . 12.6 mt -72.84 123.55 27.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 109.117 -0.698 . . . . 61.33 109.117 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -88.25 -37.55 15.96 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.167 0.587 . . . . 72.53 110.73 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -167.41 141.46 3.66 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 116.269 -0.423 . . . . 74.41 109.903 -173.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.0 mt -130.16 134.85 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 108.277 -1.008 . . . . 74.32 108.277 173.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -163.09 178.17 8.51 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 124.296 0.998 . . . . 74.34 111.434 -170.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -108.55 122.03 46.22 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.949 -0.76 . . . . 71.23 108.949 175.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.481 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 37.2 mtpt -81.38 -25.93 35.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.176 0.59 . . . . 61.31 110.338 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -160.13 152.63 20.96 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.331 -0.849 . . . . 74.12 109.186 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 73.9 mt -144.14 150.82 16.49 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 C-N-CA 125.346 1.458 . . . . 63.34 107.725 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.0 t -155.35 137.5 14.71 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.467 0.707 . . . . 75.12 109.842 173.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.494 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 86.5 t80 -143.67 122.07 12.38 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.402 -1.333 . . . . 74.24 107.402 174.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -124.76 114.72 19.64 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 109.227 -0.657 . . . . 73.44 109.227 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.05 80.75 0.44 Allowed Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 105.919 -1.882 . . . . 64.54 105.919 165.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.458 ' HG2' ' ND2' ' A' ' 27' ' ' ASN . 57.7 Cg_endo -68.99 -29.02 28.28 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.784 2.322 . . . . 53.31 112.59 -162.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.458 ' ND2' ' HG2' ' A' ' 26' ' ' PRO . 1.6 m-80 -115.86 30.13 7.54 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.864 0.865 . . . . 72.32 108.822 -175.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.457 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -44.8 -58.91 4.7 Favored Pre-proline 0 CA--C 1.569 1.673 0 N-CA-C 114.703 1.371 . . . . 73.4 114.703 -165.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 38.7 Cg_exo -60.34 -31.97 93.46 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 122.06 1.84 . . . . 63.12 113.087 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.518 ' HA ' ' NE2' ' A' ' 33' ' ' GLN . 6.8 t60 -81.74 -35.2 29.97 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.308 1.043 . . . . 74.55 112.385 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.837 HG21 ' HA ' ' A' ' 73' ' ' ALA . 6.0 p -79.87 -15.1 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 121.395 0.617 . . . . 64.41 111.718 -171.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -74.9 -12.19 60.3 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 116.089 -0.505 . . . . 73.22 111.482 168.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.518 ' NE2' ' HA ' ' A' ' 30' ' ' HIS . 9.3 mt-30 -83.37 -18.0 40.36 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 124.009 0.923 . . . . 65.03 110.584 171.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.538 ' HE2' ' HB3' ' A' ' 71' ' ' GLU . 26.3 mmmt -79.33 146.19 33.05 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.361 1.065 . . . . 65.14 111.451 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -61.67 128.14 34.84 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.134 0.974 . . . . 65.33 109.74 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.493 ' CE3' HD21 ' A' ' 68' ' ' LEU . 73.5 t-105 -82.21 88.83 6.48 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 121.121 0.486 . . . . 52.32 110.617 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 17.5 tm0? -129.33 84.96 60.62 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 106.205 -1.776 . . . . 74.14 106.205 167.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.07 125.23 10.72 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.475 2.117 . . . . 53.31 112.694 -173.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -97.0 92.95 6.32 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.757 -1.201 . . . . 62.31 107.757 169.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.666 HG11 HD11 ' A' ' 126' ' ' LEU . 88.2 t -94.82 107.63 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.345 0.658 . . . . 62.14 110.98 -175.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -88.13 129.52 35.29 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.361 -0.836 . . . . 73.45 109.415 175.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -95.88 119.33 34.18 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.897 -1.149 . . . . 64.31 107.897 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -130.18 141.6 50.64 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 108.795 -0.817 . . . . 52.34 108.795 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.664 HD11 HG21 ' A' ' 131' ' ' VAL . 56.6 mt -140.36 146.66 38.71 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.663 0.785 . . . . 74.42 110.0 -175.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -154.88 118.32 4.51 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.591 -0.892 . . . . 52.21 108.591 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.0 m -108.59 151.59 25.91 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.696 0.798 . . . . 74.34 110.453 -173.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.686 ' HB2' HH22 ' A' ' 61' ' ' ARG . . . -145.33 154.23 42.1 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.139 0.976 . . . . 72.13 109.886 172.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.419 ' HB3' HD13 ' A' ' 98' ' ' LEU . 4.1 m -112.87 154.68 25.95 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.991 -0.744 . . . . 71.23 108.991 172.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.0 t -149.61 117.57 6.31 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.125 -1.065 . . . . 74.03 108.125 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -79.96 105.14 11.02 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.154 -0.684 . . . . 75.23 109.154 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.608 HD11 ' HB2' ' A' ' 57' ' ' GLU . 45.9 mt -78.96 -35.68 42.73 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.094 0.558 . . . . 73.54 109.616 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.46 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -155.57 175.28 14.1 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.104 0.962 . . . . 60.3 109.848 176.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -65.25 124.98 23.62 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.583 -0.895 . . . . 75.23 108.583 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 66.67 11.32 8.1 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.251 1.42 . . . . 54.12 112.728 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 41.8 t -124.03 107.06 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.401 -0.962 . . . . 73.24 108.401 173.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -119.69 126.11 50.32 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.864 0.866 . . . . 73.35 109.018 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.608 ' HB2' HD11 ' A' ' 51' ' ' LEU . 32.2 tt0 -86.32 146.15 26.61 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.162 -0.681 . . . . 74.4 109.162 167.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.8 t -128.19 133.89 66.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.045 -1.095 . . . . 71.2 108.045 171.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.401 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 46.4 t -115.28 132.53 64.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.256 -0.646 . . . . 74.35 109.256 176.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.04 108.67 18.97 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.639 -0.874 . . . . 75.54 108.639 172.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.686 HH22 ' HB2' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -80.53 99.92 8.31 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 106.489 -1.671 . . . . 74.23 106.489 164.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.2 t -96.46 122.01 47.55 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 107.583 -1.266 . . . . 74.22 107.583 172.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.4 m -118.47 137.87 52.88 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 123.91 0.756 . . . . 73.11 109.034 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 77.0 t -140.98 139.05 34.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 125.055 1.342 . . . . 73.32 107.435 -172.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 37.1 m -137.53 130.77 30.77 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 109.411 -0.588 . . . . 72.44 109.411 171.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.489 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -114.68 120.37 39.88 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.298 -1.371 . . . . 72.31 107.298 174.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -125.93 135.45 51.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.392 0.677 . . . . 64.21 110.607 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.535 HD12 HG22 ' A' ' 31' ' ' VAL . 27.4 mt -92.92 84.69 4.96 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.944 1.298 . . . . 64.24 108.8 177.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.41 -100.95 1.45 Allowed Glycine 0 C--N 1.342 0.877 0 CA-C-N 115.267 -0.878 . . . . 64.52 111.782 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.33 -19.62 13.41 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.871 0.868 . . . . 73.45 109.85 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.538 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 10.0 tp10 -94.02 124.69 38.19 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.637 1.175 . . . . 71.15 109.317 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -74.41 134.51 42.4 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.207 0.458 . . . . 73.14 110.963 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.837 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -78.3 -59.31 2.83 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.721 -0.844 . . . . 74.4 108.721 174.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -159.12 161.52 36.35 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.303 -0.862 . . . . 64.52 112.139 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.431 HD12 ' O ' ' A' ' 64' ' ' VAL . 38.7 tp -111.71 148.35 33.64 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.992 1.717 . . . . 54.44 107.645 168.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.55 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 94.6 m -140.97 136.8 32.54 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.273 1.029 . . . . 75.24 109.154 177.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -149.29 137.96 21.05 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.076 -0.713 . . . . 73.15 109.076 172.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.6 t -141.73 115.69 4.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 123.967 0.907 . . . . 71.51 108.91 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.525 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 79.1 mt-30 -83.63 84.43 7.54 Favored 'General case' 0 C--N 1.343 0.31 0 N-CA-C 108.705 -0.85 . . . . 63.02 108.705 170.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.42 ' HG3' HD22 ' A' ' 106' ' ' LEU . 8.5 tp-100 -77.88 92.0 4.22 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.514 -0.921 . . . . 75.44 108.514 177.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -95.03 144.94 17.49 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 110.746 -0.942 . . . . 71.35 110.746 178.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.17 134.35 5.33 Favored Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 111.081 -0.808 . . . . 74.52 111.081 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.9 mt -82.07 124.77 39.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 108.416 -0.957 . . . . 75.33 108.416 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.801 ' HB3' HD11 ' A' ' 86' ' ' ILE . 92.4 m-85 -129.79 121.57 27.09 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.736 0.814 . . . . 65.35 109.029 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.4 t -86.36 103.44 14.93 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.436 -0.95 . . . . 61.11 108.436 174.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.801 HD11 ' HB3' ' A' ' 84' ' ' PHE . 3.5 mm -118.56 149.67 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 109.689 -0.486 . . . . 63.51 109.689 -177.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.53 168.14 25.67 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.061 0.544 . . . . 74.14 110.735 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.23 -32.35 6.27 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 116.044 -0.526 . . . . 72.15 113.061 178.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.587 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -122.21 141.12 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.622 0.769 . . . . 70.3 111.343 -173.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.628 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 21.7 mt-10 -142.37 173.54 11.44 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.54 1.136 . . . . 74.43 110.135 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.5 -125.33 28.68 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-O 119.771 -0.461 . . . . 64.24 112.614 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 77.3 p -76.83 -27.93 55.33 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.342 0.571 . . . . 70.12 110.616 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.506 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 0.8 OUTLIER -58.98 -41.98 88.86 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.588 0.755 . . . . 74.3 109.25 175.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.628 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 3.0 tpt -69.98 -42.27 73.33 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 114.662 -1.153 . . . . 75.33 110.986 175.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.42 -25.21 67.06 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.09 0.956 . . . . 74.52 111.901 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -70.67 -49.36 48.11 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.806 0.442 . . . . 63.41 110.364 172.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.44 -37.46 85.93 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 123.177 0.298 . . . . 65.4 110.755 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.419 HD13 ' HB3' ' A' ' 48' ' ' SER . 52.7 mt -91.26 -30.89 16.36 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.032 0.533 . . . . 73.44 112.438 -175.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.95 4.08 33.91 Favored Glycine 0 N--CA 1.476 1.333 0 CA-C-O 119.94 -0.366 . . . . 71.14 113.752 -172.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.468 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -142.85 -61.92 0.43 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 117.006 0.403 . . . . 74.3 111.192 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.41 ' O ' HG12 ' A' ' 105' ' ' ILE . 45.6 t80 -73.63 -46.28 47.79 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 112.17 0.433 . . . . 72.51 112.17 -172.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 47.5 m -64.8 -47.91 73.88 Favored Pre-proline 0 N--CA 1.49 1.539 0 CA-C-O 118.303 -0.856 . . . . 75.21 112.465 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.17 -21.11 67.74 Favored 'Trans proline' 0 C--N 1.39 2.72 0 C-N-CA 121.805 1.67 . . . . 54.1 112.786 173.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -75.41 -33.0 60.93 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.866 0.466 . . . . 74.12 109.856 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.485 HG21 ' CD1' ' A' ' 13' ' ' ILE . 48.4 mm -69.93 -41.49 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.381 0.672 . . . . 61.43 109.753 171.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.42 HD22 ' HG3' ' A' ' 80' ' ' GLN . 66.1 mt -72.04 -30.51 65.24 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.654 0.781 . . . . 73.04 111.807 -175.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -61.01 -40.51 74.77 Favored Pre-proline 0 N--CA 1.488 1.431 0 N-CA-C 114.401 1.259 . . . . 74.52 114.401 -171.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -51.57 -42.99 53.26 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.071 1.847 . . . . 75.13 113.462 168.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -75.83 -35.7 59.89 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.269 0.628 . . . . 65.45 111.045 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.81 -48.38 71.9 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.734 0.813 . . . . 73.33 109.52 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.539 ' NH1' HD12 ' C' ' 105' ' ' ILE . 27.8 ttm105 -51.46 -52.15 48.86 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 125.05 1.469 . . . . 75.41 110.289 174.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -62.6 -45.98 90.41 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.61 1.194 . . . . 64.24 111.78 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.533 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.3 t -60.88 -36.98 80.61 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 123.872 0.733 . . . . 34.42 110.759 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.493 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.6 mt -67.94 -47.2 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.127 0.971 . . . . 72.52 110.439 174.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.434 HG21 ' HE2' ' C' ' 109' ' ' TYR . 35.7 m -59.37 -39.29 82.81 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.621 1.168 . . . . 75.45 111.27 -177.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -68.68 -44.12 74.7 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.364 -1.289 . . . . 64.2 110.224 -176.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.483 ' HG3' ' O ' ' A' ' 113' ' ' CYS . 25.6 mtm -60.48 -39.43 87.61 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.987 0.515 . . . . 45.2 110.831 177.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 114' ' ' ILE . 71.6 t -63.19 -47.85 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.296 1.038 . . . . 74.32 111.424 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.8 p -71.52 -33.36 69.13 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 116.147 -0.478 . . . . 73.0 111.178 -176.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.47 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 90.0 mtt-85 -67.96 -33.28 74.35 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.739 0.816 . . . . 65.52 109.742 173.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.446 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.14 15.12 40.67 Favored Glycine 0 C--N 1.352 1.417 0 CA-C-N 115.437 -0.801 . . . . 32.1 113.37 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.6 t 62.0 9.47 3.07 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 127.281 2.232 . . . . 71.15 114.016 173.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -81.33 138.79 48.32 Favored Pre-proline 0 C--O 1.244 0.793 0 N-CA-C 107.672 -1.232 . . . . 73.51 107.672 172.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -53.98 142.53 64.57 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.75 2.3 . . . . 75.31 112.154 176.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -49.41 130.72 20.25 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.539 1.136 . . . . 71.34 113.779 -164.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.666 HD11 HG11 ' A' ' 40' ' ' VAL . 36.6 tp -109.27 108.62 19.28 Favored 'General case' 0 C--N 1.345 0.384 0 C-N-CA 123.169 0.588 . . . . 70.14 110.441 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.576 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 88.8 m-20 -103.26 125.76 50.08 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 107.699 -1.223 . . . . 74.03 107.699 175.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.47 ' H ' ' HG3' ' A' ' 111' ' ' ARG . 17.8 mt -72.85 144.59 47.4 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 117.735 0.243 . . . . 65.21 110.809 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -70.74 133.49 86.48 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.105 0.562 . . . . 64.14 110.089 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.53 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 32.3 Cg_exo -59.97 114.4 2.07 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.576 2.85 . . . . 62.31 113.604 -173.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.664 HG21 HD11 ' A' ' 44' ' ' LEU . 45.6 t -100.23 135.64 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.372 0.669 . . . . 71.03 110.017 -177.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -101.84 89.93 3.83 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.207 -1.034 . . . . 75.44 108.207 175.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.496 ' CE1' HD13 ' A' ' 44' ' ' LEU . 44.5 m-85 -63.82 -30.79 71.84 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.814 0.846 . . . . 64.22 111.568 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.468 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 6.4 m-20 -66.08 -33.35 75.58 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.347 -0.842 . . . . 43.31 110.476 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.76 -42.25 64.23 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.155 0.582 . . . . 70.11 110.491 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.12 -49.07 79.26 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.521 0.677 . . . . 63.04 110.59 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 59.8 t80 . . . . . 0 CA--C 1.536 0.405 0 CA-C-N 114.142 -1.39 . . . . 71.15 110.071 177.919 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.554 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 19.6 ptm . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 111.976 0.361 . . . . 54.34 111.976 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 5.5 t -153.09 138.99 18.06 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 109.147 -0.686 . . . . 71.44 109.147 166.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.539 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 68.9 t80 -134.28 137.74 44.5 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.13 0.972 . . . . 75.32 108.418 176.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -144.51 141.28 29.41 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.991 0.516 . . . . 55.32 109.938 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 66.9 mt -88.86 110.01 20.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 107.699 -1.223 . . . . 74.5 107.699 171.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -81.8 -39.1 24.57 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 123.282 0.364 . . . . 72.41 110.322 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -169.3 134.71 1.55 Allowed 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.304 0.377 . . . . 74.41 110.384 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.0 mt -114.97 142.58 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 107.247 -1.39 . . . . 70.41 107.247 171.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.434 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 40.1 p90 -169.81 162.67 9.59 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-O 122.045 0.926 . . . . 74.24 113.127 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 56.7 m -90.04 121.18 31.88 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 113.414 -1.721 . . . . 74.11 108.585 171.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.434 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 22.7 mtpp -87.29 -32.43 19.69 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.724 0.81 . . . . 73.42 110.52 178.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -158.52 143.49 16.25 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.022 -0.536 . . . . 74.44 110.89 -170.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 45.9 mm -136.3 142.88 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.466 1.506 . . . . 72.15 109.093 176.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 24.1 t -145.56 134.66 22.73 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.521 -1.218 . . . . 74.31 107.907 168.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.484 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 91.2 t80 -138.71 128.08 24.41 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.421 -1.696 . . . . 74.31 106.421 169.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -135.47 112.02 9.96 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.913 -1.143 . . . . 74.13 107.913 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.576 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -108.83 87.34 4.42 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 107.144 -1.428 . . . . 71.41 107.144 171.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.86 -42.01 21.48 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.654 2.236 . . . . 70.33 111.298 -174.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -97.39 5.77 49.28 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.726 -1.125 . . . . 71.2 111.65 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.576 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -29.81 -67.78 0.13 Allowed Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 115.428 1.64 . . . . 72.04 115.428 -166.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.481 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 21.3 Cg_endo -60.43 -28.49 86.84 Favored 'Trans proline' 0 C--N 1.397 3.106 0 C-N-CA 122.605 2.203 . . . . 53.13 113.03 -171.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -95.86 -39.76 9.66 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.981 -1.009 . . . . 63.41 111.996 -171.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.445 HG22 HD12 ' B' ' 68' ' ' LEU . 10.5 p -69.47 -11.76 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.22 0.608 . . . . 70.12 111.419 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -63.39 -13.18 36.95 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.269 0.628 . . . . 75.43 112.65 172.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -68.84 -13.07 62.18 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 123.874 0.87 . . . . 73.42 112.077 175.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.581 ' HB2' HD13 ' B' ' 68' ' ' LEU . 32.8 mmtp -97.41 92.71 6.09 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.494 1.118 . . . . 74.13 109.813 -174.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -92.81 80.44 4.68 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.364 0.665 . . . . 74.53 110.914 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 37.3 p90 -165.07 177.53 7.68 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.056 0.942 . . . . 64.1 110.123 170.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -69.12 116.65 44.17 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 123.677 0.791 . . . . 61.23 109.667 173.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.431 ' HD3' ' HG2' ' B' ' 124' ' ' PRO . 34.2 Cg_endo -68.28 148.77 74.91 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 121.704 1.602 . . . . 72.31 110.727 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -71.19 104.07 2.98 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.776 -1.194 . . . . 74.35 107.776 172.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.524 HG11 HD11 ' B' ' 126' ' ' LEU . 32.9 t -98.09 141.51 16.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 114.705 -1.134 . . . . 71.22 109.568 -177.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -118.75 114.53 22.84 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.405 -1.702 . . . . 72.22 106.405 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.587 HD13 HD22 ' B' ' 128' ' ' LEU . 17.8 tp -89.15 132.21 34.93 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.238 -0.652 . . . . 73.32 109.238 174.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -129.41 148.2 51.3 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.871 1.268 . . . . 70.32 108.398 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.77 151.53 41.32 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.643 0.777 . . . . 75.42 110.469 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 19.8 t70 -148.11 139.37 23.45 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.654 1.182 . . . . 64.14 108.252 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.5 m -113.5 115.37 27.89 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.732 -0.84 . . . . 61.22 108.732 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.62 134.31 55.16 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.632 -0.877 . . . . 62.33 108.632 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.673 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 16.4 m -142.76 160.24 40.71 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.849 -0.426 . . . . 65.42 109.849 -175.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 29.5 p -166.63 136.9 3.21 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.678 0.791 . . . . 75.14 110.379 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -85.96 79.64 9.14 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 108.242 -1.021 . . . . 72.33 108.242 172.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.426 HD21 ' HB3' ' B' ' 57' ' ' GLU . 2.7 pp -93.1 6.57 47.49 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.506 -0.77 . . . . 73.31 111.02 -177.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.405 ' HB3' HG23 ' B' ' 55' ' ' VAL . . . -162.65 154.61 18.48 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.77 1.228 . . . . 74.3 108.773 173.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -75.75 129.19 36.68 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.646 0.378 . . . . 74.02 110.726 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 70.62 -3.12 2.01 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.957 1.303 . . . . 73.34 113.55 173.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.405 HG23 ' HB3' ' B' ' 52' ' ' ALA . 30.7 m -134.65 122.9 40.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.013 -1.106 . . . . 61.22 108.013 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.673 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 0.1 OUTLIER -99.34 156.76 16.83 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.654 0.782 . . . . 63.33 109.424 -177.087 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.426 ' HB3' HD21 ' B' ' 51' ' ' LEU . 4.5 tm-20 -121.41 97.43 5.51 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 105.728 -1.953 . . . . 72.22 105.728 166.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 12.5 p -100.56 141.76 16.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.768 -0.827 . . . . 75.1 108.768 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.436 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 18.4 t -115.57 148.25 18.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 124.944 1.298 . . . . 73.15 108.645 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 60.1 tp -128.36 107.06 9.44 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.477 -0.935 . . . . 75.53 108.477 171.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.468 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 31.3 ttm180 -86.64 132.72 33.81 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.151 -1.055 . . . . 73.53 108.151 172.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 38.9 t -129.46 124.65 60.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 107.243 -1.391 . . . . 75.43 107.243 175.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 6.3 m -120.78 131.06 54.28 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.378 -0.601 . . . . 72.41 109.378 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.663 HG11 HD21 ' B' ' 126' ' ' LEU . 89.6 t -119.41 108.41 23.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 123.905 0.882 . . . . 65.32 109.335 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 93.9 m -90.21 138.4 31.56 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.346 -0.983 . . . . 71.53 108.346 167.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.25 142.47 26.13 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.234 -0.654 . . . . 74.1 109.234 175.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.429 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 17.0 p -144.28 134.69 24.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.367 -0.833 . . . . 55.33 109.973 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.581 HD13 ' HB2' ' B' ' 34' ' ' LYS . 62.9 mt -101.19 113.89 27.35 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.577 1.151 . . . . 73.15 110.072 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.18 -112.02 3.62 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-N 115.686 -0.688 . . . . 65.45 111.548 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.58 27.62 6.85 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.396 0.679 . . . . 63.3 109.795 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -141.23 153.27 45.17 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.192 -0.67 . . . . 73.52 109.192 176.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 56.8 m -68.17 135.2 51.71 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.225 0.536 . . . . 51.33 110.855 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.429 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -88.26 -66.01 0.96 Allowed 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.41 -1.33 . . . . 75.14 107.41 174.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -150.27 159.29 44.55 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 114.881 -1.054 . . . . 73.41 110.267 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 78.4 mt -134.07 108.53 8.39 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.396 -1.705 . . . . 74.01 106.396 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.1 t -119.82 151.53 38.7 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.104 -0.702 . . . . 71.04 109.104 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -159.23 134.39 8.29 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.511 -0.922 . . . . 71.24 108.511 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' B' ' 113' ' ' CYS . 85.4 t -128.99 143.92 39.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.997 -1.112 . . . . 74.13 107.997 175.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -122.94 96.18 4.91 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.382 -0.97 . . . . 62.02 108.382 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -91.12 102.38 15.13 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.284 -0.636 . . . . 75.23 109.284 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -94.9 165.84 25.81 Favored Glycine 0 C--N 1.339 0.749 0 O-C-N 123.58 0.55 . . . . 41.44 112.138 177.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.9 134.6 3.27 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-O 119.772 -0.46 . . . . 71.41 113.314 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.413 HD12 ' HE1' ' B' ' 17' ' ' TYR . 3.9 mp -86.12 117.82 31.47 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 107.226 -1.398 . . . . 70.21 107.226 170.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -121.84 135.94 54.92 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.592 0.757 . . . . 73.53 109.112 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 56.1 m -89.34 126.26 35.46 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.785 0.834 . . . . 72.22 109.254 173.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.569 ' HB ' HD11 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -133.65 130.3 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.079 0.951 . . . . 72.41 108.468 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' B' ' 9' ' ' MET . . . -157.67 171.98 19.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.505 0.722 . . . . 50.22 110.645 177.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.554 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 87.18 -50.13 4.07 Favored Glycine 0 C--N 1.352 1.437 0 C-N-CA 123.608 0.623 . . . . 52.42 111.949 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.569 HD11 ' HB ' ' B' ' 86' ' ' ILE . 11.3 pt -59.08 148.08 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.981 1.313 . . . . 45.31 111.81 171.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -153.19 163.31 40.11 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.837 0.855 . . . . 71.33 109.595 -176.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.35 -121.73 6.22 Favored Glycine 0 C--N 1.351 1.371 0 C-N-CA 123.358 0.504 . . . . 53.43 112.847 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 18.8 m -73.58 -39.71 64.44 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.883 0.849 . . . . 74.2 109.909 174.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -66.68 -27.11 67.39 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 113.623 -1.626 . . . . 71.41 111.96 -167.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.441 ' HA ' HD12 ' B' ' 89' ' ' ILE . 9.6 ptm -65.95 -57.71 7.22 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.675 -0.693 . . . . 74.04 111.661 -175.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.23 -14.51 57.42 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.352 0.661 . . . . 44.23 111.89 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -61.12 -40.28 93.18 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.735 0.814 . . . . 71.31 110.906 169.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.1 t -66.36 -54.27 26.47 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.705 0.402 . . . . 72.41 111.29 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.472 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.2 pp -68.34 -25.38 65.07 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.855 0.462 . . . . 72.44 112.167 -176.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.89 2.88 58.5 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-O 119.649 -0.528 . . . . 65.34 114.2 -175.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.73 -55.06 0.19 Allowed 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 117.56 0.68 . . . . 65.45 112.136 -174.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -70.56 -43.34 69.7 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.426 0.69 . . . . 74.34 111.146 -176.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.539 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 56.5 m -72.86 -43.27 8.12 Favored Pre-proline 0 CA--C 1.566 1.586 0 CA-C-O 118.621 -0.704 . . . . 55.41 112.784 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.0 -30.52 93.62 Favored 'Trans proline' 0 C--N 1.396 3.058 0 C-N-CA 122.229 1.953 . . . . 73.02 113.906 170.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.15 -37.66 77.85 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.567 0.747 . . . . 72.23 111.503 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 54.9 mt -65.11 -39.08 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.882 0.873 . . . . 73.12 110.782 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.19 -23.06 54.64 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.152 -0.931 . . . . 64.24 112.215 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -60.66 -47.17 96.73 Favored Pre-proline 0 CA--C 1.567 1.606 0 N-CA-C 114.281 1.215 . . . . 75.54 114.281 -174.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -53.86 -41.74 72.25 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 122.517 2.145 . . . . 65.35 114.106 175.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -68.98 -42.17 76.91 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.4 0.68 . . . . 74.12 110.754 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.05 98.92 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.321 -0.854 . . . . 31.43 110.774 177.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -61.35 -49.69 75.95 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.469 1.108 . . . . 70.32 110.763 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -67.3 -32.67 73.81 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.149 0.58 . . . . 72.12 110.19 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.509 ' O ' ' HG2' ' B' ' 117' ' ' MET . 9.1 t -71.11 -38.49 72.34 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 122.879 0.472 . . . . 73.43 111.082 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.415 HD13 HG23 ' B' ' 64' ' ' VAL . 81.8 mt -62.25 -56.77 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 123.684 0.794 . . . . 65.14 109.712 173.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 19.7 m -63.08 -24.74 68.04 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.763 0.825 . . . . 72.12 111.371 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.455 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.9 t -63.62 -52.45 60.79 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 109.265 -0.642 . . . . 74.33 109.265 171.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.9 mmt -66.67 -32.49 73.84 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.42 0.688 . . . . 61.15 111.357 -176.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.463 HG21 HD22 ' B' ' 126' ' ' LEU . 93.3 t -69.78 -40.28 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.073 0.949 . . . . 71.35 110.672 175.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 40.4 t -67.26 -32.07 72.84 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.304 -0.862 . . . . 72.14 110.367 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.533 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 77.8 mtt-85 -68.66 -34.6 75.99 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 115.478 -0.783 . . . . 65.42 109.851 176.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.01 -17.95 80.23 Favored Glycine 0 C--N 1.351 1.39 0 O-C-N 123.544 0.528 . . . . 52.23 112.483 170.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 18.0 m 66.93 31.23 7.23 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 123.153 1.454 . . . . 74.11 110.193 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.432 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 41.5 m-85 -78.02 167.26 37.25 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-N 114.099 -1.41 . . . . 75.42 111.168 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.431 ' HG2' ' HD3' ' B' ' 38' ' ' PRO . 50.4 Cg_exo -45.23 145.12 3.74 Favored 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 123.366 2.711 . . . . 72.12 114.566 170.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.422 HE21 ' ND2' ' B' ' 127' ' ' ASN . 58.9 tp60 -60.09 118.38 6.24 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.083 0.953 . . . . 72.11 111.301 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.663 HD21 HG11 ' B' ' 64' ' ' VAL . 12.0 tp -110.03 119.46 39.38 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.358 1.063 . . . . 62.51 108.727 -175.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.422 ' ND2' HE21 ' B' ' 125' ' ' GLN . 53.7 m-80 -125.0 127.85 47.64 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.265 -1.013 . . . . 61.52 108.265 174.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.587 HD22 HD13 ' B' ' 42' ' ' LEU . 43.6 mt -86.55 143.29 27.76 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.022 0.529 . . . . 73.54 110.639 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.67 132.51 94.09 Favored Pre-proline 0 CA--C 1.548 0.889 0 O-C-N 124.085 0.866 . . . . 54.1 111.014 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.26 89.34 0.32 Allowed 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.085 2.524 . . . . 65.4 111.595 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.55 113.55 26.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 CA-C-O 121.535 0.683 . . . . 61.34 109.501 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 58.9 t30 . . . . . 0 C--O 1.237 0.401 0 N-CA-C 107.665 -1.235 . . . . 72.42 107.665 171.562 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.53 ' HD2' ' HG2' ' A' ' 130' ' ' PRO . 28.9 t80 . . . . . 0 C--O 1.24 0.558 0 N-CA-C 107.335 -1.357 . . . . 73.31 107.335 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -137.97 133.35 33.58 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.206 -1.035 . . . . 54.24 108.206 172.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.485 HD13 HD11 ' C' ' 16' ' ' ILE . 17.3 mt -77.82 126.86 38.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 108.739 -0.838 . . . . 63.43 108.739 174.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.412 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 27.5 mm-40 -82.05 -53.36 6.17 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.259 -1.015 . . . . 73.34 108.259 173.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.576 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -172.96 146.84 1.57 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.648 0.779 . . . . 74.12 110.471 178.323 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.485 HD11 HD13 ' C' ' 13' ' ' ILE . 72.5 mt -116.68 132.84 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.202 1.401 . . . . 74.41 107.586 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.442 ' HB3' HG23 ' D' ' 122' ' ' THR . 39.5 p90 -161.62 156.52 23.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.372 0.606 . . . . 63.34 112.105 -164.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 42.4 p -88.18 107.65 18.89 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.511 -0.768 . . . . 54.34 109.572 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.41 ' HG2' ' CE1' ' C' ' 17' ' ' TYR . 20.6 mtmt -74.32 -29.26 61.53 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.495 -0.557 . . . . 74.42 109.495 172.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.603 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 30.7 t70 -150.21 140.91 22.65 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.309 -0.86 . . . . 55.51 110.16 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 93.7 mt -137.37 144.81 30.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 125.562 1.545 . . . . 62.42 106.943 173.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -150.26 145.51 26.24 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 123.595 0.559 . . . . 75.03 109.624 173.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -151.52 116.77 5.3 Favored 'General case' 0 C--O 1.225 -0.21 0 N-CA-C 107.987 -1.116 . . . . 75.54 107.987 171.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -121.64 121.47 37.45 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.077 0.951 . . . . 72.11 108.547 176.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.17 87.6 6.22 Favored Pre-proline 0 C--O 1.239 0.525 0 N-CA-C 106.275 -1.75 . . . . 75.04 106.275 169.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.06 -21.65 36.46 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.631 2.221 . . . . 72.23 111.828 -168.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -125.65 31.18 5.57 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.201 1.0 . . . . 74.2 109.742 -177.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.24 -61.0 2.02 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 114.644 1.35 . . . . 53.13 114.644 -169.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.11 -34.73 45.29 Favored 'Trans proline' 0 C--N 1.382 2.337 0 CA-C-N 121.848 1.696 . . . . 73.14 112.268 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -69.0 -36.7 78.12 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.773 -1.103 . . . . 75.11 111.837 -176.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.593 ' HA ' ' HZ2' ' C' ' 34' ' ' LYS . 14.5 p -80.71 -28.67 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 112.863 0.69 . . . . 75.15 112.863 -176.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -63.71 -31.42 72.59 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.718 0.407 . . . . 71.14 111.984 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -88.12 12.48 13.52 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.419 1.088 . . . . 54.15 111.803 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.63 ' HZ3' ' HG2' ' C' ' 71' ' ' GLU . 10.2 ttpp -126.73 160.39 30.96 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.046 0.938 . . . . 75.01 111.434 -174.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -51.25 122.66 8.09 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.539 1.536 . . . . 74.2 112.435 178.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -86.13 82.56 8.02 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.622 0.725 . . . . 72.31 109.523 170.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -135.79 76.6 53.15 Favored Pre-proline 0 N--CA 1.472 0.662 0 N-CA-C 107.528 -1.286 . . . . 45.31 107.528 169.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -83.88 152.43 12.92 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.641 2.227 . . . . 61.25 111.703 -175.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -86.41 113.32 22.27 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.419 -1.326 . . . . 64.04 107.419 171.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 39.4 t -74.36 96.69 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.615 -0.883 . . . . 51.33 108.615 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.476 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 14.2 mptt -101.04 101.47 12.24 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 106.33 -1.73 . . . . 74.52 106.33 168.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pp -105.64 162.88 13.13 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.823 0.449 . . . . 75.01 110.065 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.634 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 4.7 t70 -148.08 135.32 20.43 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.103 0.961 . . . . 63.34 108.878 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 45.5 mt -131.86 110.98 11.2 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.123 -1.066 . . . . 63.32 108.123 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -131.77 128.31 38.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.961 -1.125 . . . . 74.21 107.961 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -126.68 140.9 52.06 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 109.444 -0.576 . . . . 74.34 109.444 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.54 142.63 33.53 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.38 0.672 . . . . 70.14 109.81 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 20.4 m -124.34 148.5 47.44 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.331 0.653 . . . . 43.45 110.776 -175.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 21.4 p -147.38 127.11 13.41 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.134 0.974 . . . . 63.54 108.881 176.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -78.84 120.44 23.47 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.108 -0.701 . . . . 74.24 109.108 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' C' ' 57' ' ' GLU . 33.7 mt -84.07 -44.56 13.95 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.766 0.826 . . . . 73.2 109.89 -176.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.93 -174.52 4.82 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.255 -0.884 . . . . 41.22 109.789 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.44 111.52 1.42 Allowed 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.84 0.712 . . . . 71.44 110.417 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 64.91 17.09 10.89 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.763 1.225 . . . . 55.33 112.471 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.77 113.65 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.151 -1.055 . . . . 71.02 108.151 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -122.54 126.36 47.62 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.153 0.981 . . . . 64.0 109.706 -173.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.499 ' HB2' HD11 ' C' ' 51' ' ' LEU . 43.4 tt0 -89.36 132.82 34.78 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.792 -0.818 . . . . 64.05 108.792 167.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 90.5 t -122.68 137.28 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.582 -1.266 . . . . 62.4 107.582 168.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.14 133.07 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.17 -0.678 . . . . 72.12 109.17 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.15 98.98 8.12 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.403 -1.332 . . . . 75.24 107.403 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -83.2 106.53 15.07 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.932 -0.766 . . . . 64.43 108.932 171.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 16.4 t -103.32 129.42 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 108.175 -1.046 . . . . 62.52 108.175 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.634 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 22.6 m -119.0 139.97 50.8 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.674 -0.862 . . . . 64.1 108.674 176.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.633 HG21 HG21 ' C' ' 114' ' ' ILE . 91.6 t -129.58 120.44 50.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 124.097 0.959 . . . . 65.52 108.792 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.494 HG23 HD23 ' C' ' 75' ' ' LEU . 2.0 m -115.4 109.21 17.54 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.182 -1.044 . . . . 71.02 108.182 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.44 105.52 15.67 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.945 -1.131 . . . . 30.32 107.945 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 43.0 m -131.16 128.82 40.84 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.797 -0.446 . . . . 51.12 109.797 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.413 HD12 ' HG2' ' C' ' 71' ' ' GLU . 16.0 mt -86.96 35.79 0.7 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.617 1.167 . . . . 72.15 110.379 -177.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.27 -112.36 2.79 Favored Glycine 0 C--N 1.346 1.084 0 N-CA-C 110.523 -1.031 . . . . 55.35 110.523 -169.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -90.97 -26.26 19.33 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.44 0.696 . . . . 74.04 110.78 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . 0.63 ' HG2' ' HZ3' ' C' ' 34' ' ' LYS . 14.4 tp10 -68.87 118.49 11.88 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.334 -0.848 . . . . 74.24 109.095 170.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 94.9 m -87.49 120.5 28.86 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.82 -0.808 . . . . 74.33 108.82 165.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.97 -50.92 44.83 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.823 -1.08 . . . . 71.32 108.545 177.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -165.11 168.35 17.35 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 114.043 -1.435 . . . . 53.01 111.048 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.494 HD23 HG23 ' C' ' 65' ' ' THR . 2.6 tm? -127.46 140.9 51.85 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 106.269 -1.752 . . . . 74.41 106.269 166.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 51.2 t -142.83 148.39 37.0 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.656 -0.868 . . . . 74.32 108.656 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -157.81 140.13 14.45 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.708 -0.478 . . . . 71.14 109.708 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.408 HG11 ' HA ' ' C' ' 110' ' ' ALA . 68.9 t -136.13 115.04 15.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 124.462 1.105 . . . . 44.21 108.518 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.603 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.7 mt-30 -91.75 88.6 6.74 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.74 -0.837 . . . . 73.11 108.74 169.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -80.12 96.69 6.59 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.031 -0.986 . . . . 63.11 109.083 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.51 153.3 30.04 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 111.185 -0.766 . . . . 54.53 111.185 175.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.83 123.78 1.38 Allowed Glycine 0 CA--C 1.498 -1.011 0 N-CA-C 110.722 -0.951 . . . . 50.43 110.722 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.502 HD11 ' HB3' ' D' ' 29' ' ' PRO . 32.1 mm -89.96 130.48 39.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 108.758 -0.83 . . . . 63.25 108.758 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -132.03 119.35 20.91 Favored 'General case' 0 C--O 1.241 0.651 0 O-C-N 124.191 0.932 . . . . 75.54 108.49 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 21.1 p -79.36 100.48 7.62 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.656 -1.238 . . . . 71.02 107.656 171.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.431 HD13 ' SG ' ' C' ' 97' ' ' CYS . 25.2 mt -115.2 129.58 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.226 0.61 . . . . 73.21 109.612 -175.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.42 168.04 22.14 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.443 0.697 . . . . 72.53 110.315 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.76 -32.15 6.3 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 115.324 -0.853 . . . . 35.01 112.634 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.425 HD11 ' HE3' ' C' ' 94' ' ' MET . 37.9 pt -106.97 164.06 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.16 0.584 . . . . 70.22 111.791 -173.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -154.17 163.5 40.01 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.112 0.965 . . . . 64.23 109.189 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.97 -126.54 9.66 Favored Glycine 0 C--N 1.351 1.374 0 O-C-N 123.364 0.415 . . . . 63.3 113.923 168.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 67.2 p -69.58 -29.74 67.36 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.504 0.721 . . . . 74.04 111.223 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -63.82 -52.21 61.22 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.655 0.782 . . . . 73.4 110.157 175.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.509 ' HE3' ' HA ' ' C' ' 94' ' ' MET . 4.6 tpt -53.53 -50.88 64.5 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 124.318 1.011 . . . . 72.4 111.904 173.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.35 -40.02 92.73 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.162 0.585 . . . . 74.24 111.829 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -70.6 -34.09 71.76 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.197 0.999 . . . . 73.33 111.087 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.431 ' SG ' HD13 ' C' ' 86' ' ' ILE . 38.5 t -69.86 -37.12 76.01 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.764 -0.653 . . . . 60.14 109.896 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 90.8 mt -84.69 -32.32 23.63 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.299 1.04 . . . . 75.24 112.297 -176.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.52 11.38 28.19 Favored Glycine 0 N--CA 1.475 1.234 0 CA-C-O 119.785 -0.453 . . . . 73.04 114.102 -170.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.28 -51.58 0.11 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 117.372 0.586 . . . . 73.11 111.662 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -72.99 -49.88 26.43 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.32 0.248 . . . . 63.02 111.006 -175.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.432 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 86.0 m -64.68 -49.33 70.49 Favored Pre-proline 0 CA--C 1.561 1.39 0 CA-C-O 118.244 -0.884 . . . . 73.21 112.251 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.432 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 49.1 Cg_exo -58.75 -27.71 84.45 Favored 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 122.655 2.237 . . . . 65.02 113.547 174.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -64.51 -39.7 94.26 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.462 0.705 . . . . 55.03 110.415 174.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.539 HD12 ' NH1' ' A' ' 111' ' ' ARG . 29.2 mm -75.46 -35.73 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 O-C-N 123.267 0.355 . . . . 73.4 110.177 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 87.8 mt -74.41 -31.67 62.4 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.563 0.745 . . . . 71.23 112.223 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -55.83 -49.96 89.88 Favored Pre-proline 0 N--CA 1.484 1.26 0 CA-C-O 117.465 -1.255 . . . . 73.55 114.346 -173.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.63 -37.79 95.67 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.425 2.083 . . . . 72.1 113.445 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.434 ' HE2' HG21 ' A' ' 115' ' ' THR . 52.4 m-85 -67.6 -44.27 78.49 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.624 0.77 . . . . 74.54 110.247 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.408 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -64.9 -38.69 91.81 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.963 -1.017 . . . . 70.24 110.66 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -65.04 -46.06 82.83 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.385 1.474 . . . . 63.44 110.449 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.94 -38.45 79.47 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.586 -0.734 . . . . 52.13 109.402 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 32.1 t -65.35 -36.2 83.29 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.955 0.502 . . . . 60.44 111.663 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.633 HG21 HG21 ' C' ' 64' ' ' VAL . 96.3 mt -68.85 -57.95 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.218 0.607 . . . . 74.23 110.054 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 10.8 m -65.26 -27.69 68.83 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 122.792 0.437 . . . . 71.11 111.277 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.419 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 40.8 t -64.12 -48.87 74.41 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.359 0.664 . . . . 44.42 109.242 170.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.548 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.03 -38.44 76.22 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.428 1.091 . . . . 73.22 112.351 177.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.462 HG23 ' O ' ' C' ' 114' ' ' ILE . 91.8 t -69.75 -38.44 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.019 0.928 . . . . 73.33 110.105 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 28.5 t -71.56 -27.66 63.32 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.37 1.068 . . . . 61.44 111.729 174.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' C' ' 116' ' ' SER . 76.4 mtt-85 -73.63 -40.96 63.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.582 0.753 . . . . 43.44 109.09 178.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.27 1.0 66.27 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.365 -0.834 . . . . 72.14 112.505 170.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.439 HG21 ' O ' ' D' ' 16' ' ' ILE . 30.8 p 62.25 29.25 17.36 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.505 1.922 . . . . 64.23 113.588 170.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -80.29 151.18 72.12 Favored Pre-proline 0 C--O 1.246 0.882 0 N-CA-C 107.704 -1.221 . . . . 74.11 107.704 168.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.04 150.76 54.22 Favored 'Trans proline' 0 C--N 1.366 1.457 0 C-N-CA 122.015 1.81 . . . . 53.15 111.393 172.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' B' ' 123' ' ' PHE . 57.6 mm-40 -45.8 129.8 9.29 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.551 1.157 . . . . 62.15 112.274 -175.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 38.3 tp -136.09 86.78 2.25 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.026 -1.472 . . . . 74.42 107.026 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -92.6 122.36 34.95 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.934 -1.03 . . . . 72.21 109.267 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.57 121.88 17.32 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 108.749 -0.834 . . . . 74.44 108.749 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.14 140.66 97.95 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 123.717 0.807 . . . . 73.33 110.917 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.8 108.64 0.43 Allowed 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.603 2.202 . . . . 73.41 112.759 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 26.3 t -99.9 122.0 51.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.386 -0.968 . . . . 52.11 108.386 173.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . 0.425 ' O ' ' HG ' ' C' ' 136' ' ' LEU . 56.7 t-20 -75.0 104.53 5.62 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.377 1.071 . . . . 74.33 110.297 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -66.65 -27.05 67.37 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.835 0.854 . . . . 72.21 112.687 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -66.87 -39.44 87.54 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.565 0.746 . . . . 72.25 110.201 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.04 92.66 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.7 -0.682 . . . . 73.44 110.708 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' C' ' 132' ' ' ASN . 71.5 mt -68.17 -32.79 73.29 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.368 0.667 . . . . 62.01 111.051 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 25.2 t80 . . . . . 0 CA--C 1.542 0.667 0 CA-C-N 116.03 -0.532 . . . . 73.33 109.917 177.663 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 8.2 t . . . . . 0 C--O 1.243 0.733 0 CA-C-O 121.237 0.541 . . . . 70.03 109.965 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.57 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 62.6 t80 -152.14 103.99 2.93 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.209 -1.404 . . . . 73.21 107.209 -177.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . 0.521 ' HB2' ' HB3' ' D' ' 85' ' ' SER . 38.2 mt-30 -112.77 114.0 26.35 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.345 -0.983 . . . . 74.41 108.345 -175.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.496 HG21 HD11 ' D' ' 16' ' ' ILE . 53.9 mt -77.91 125.13 37.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.489 -0.93 . . . . 64.43 108.489 175.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -88.77 -41.66 12.39 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 123.844 0.715 . . . . 74.35 109.861 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -177.43 136.91 0.2 Allowed 'General case' 0 N--CA 1.481 1.1 0 O-C-N 123.436 0.46 . . . . 74.11 110.864 -169.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.496 HD11 HG21 ' D' ' 13' ' ' ILE . 4.1 mp -110.98 142.72 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 107.193 -1.41 . . . . 74.53 107.193 169.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -166.35 163.42 17.51 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.868 0.842 . . . . 72.52 111.768 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 59.3 p -97.65 116.14 29.29 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.797 -1.092 . . . . 74.34 108.929 176.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.455 ' HD2' ' HA3' ' D' ' 81' ' ' GLY . 41.1 mtpt -85.39 -26.98 26.11 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.822 -0.807 . . . . 71.45 108.822 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.666 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 26.7 t70 -152.75 142.71 22.2 Favored 'General case' 0 C--N 1.35 0.597 0 C-N-CA 124.397 1.079 . . . . 71.52 109.749 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.548 HG21 ' HE2' ' C' ' 117' ' ' MET . 55.9 mt -141.96 145.65 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.865 1.266 . . . . 71.54 108.45 175.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -148.15 141.0 24.71 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.765 1.226 . . . . 44.51 109.384 174.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -144.81 129.45 18.1 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.319 -1.363 . . . . 63.03 107.319 167.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -137.44 111.56 8.42 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 123.98 0.912 . . . . 73.21 108.895 -171.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.19 86.08 1.91 Allowed Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 108.055 -1.091 . . . . 63.5 108.055 174.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -68.19 -35.67 18.67 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.808 2.338 . . . . 72.41 113.333 -165.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.486 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 50.1 m-20 -107.26 15.62 24.86 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.896 0.878 . . . . 54.2 110.813 -174.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.469 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -27.0 -71.19 0.05 OUTLIER Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 116.459 2.022 . . . . 54.34 116.459 -160.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.502 ' HB3' HD11 ' C' ' 83' ' ' ILE . 93.9 Cg_endo -74.12 -24.18 15.08 Favored 'Trans proline' 0 C--N 1.378 2.086 0 CA-C-N 123.491 2.283 . . . . 65.1 113.936 -172.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.468 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 4.8 t-160 -73.1 -40.96 64.56 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.649 0.78 . . . . 70.13 109.776 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.608 HG22 HD12 ' D' ' 68' ' ' LEU . 7.6 p -79.37 -26.58 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.506 -0.77 . . . . 72.12 111.609 -170.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -61.45 -23.69 66.03 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 122.797 0.439 . . . . 65.41 112.16 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.468 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 64.6 mt-30 -67.21 -9.07 36.51 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.698 1.199 . . . . 71.03 112.009 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -97.73 98.47 9.89 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.996 1.319 . . . . 73.12 110.182 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -88.78 88.44 7.6 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.792 0.837 . . . . 70.41 110.826 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 22.0 p90 -167.08 -177.99 3.98 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.103 0.961 . . . . 74.52 109.715 170.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . 0.483 HE21 ' HD2' ' D' ' 38' ' ' PRO . 29.6 tp60 -80.58 115.31 54.36 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 123.551 0.74 . . . . 70.51 109.471 177.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.483 ' HD2' HE21 ' D' ' 37' ' ' GLN . 52.6 Cg_exo -58.38 142.68 97.92 Favored 'Trans proline' 0 C--N 1.386 2.501 0 C-N-CA 123.028 2.486 . . . . 72.44 112.379 177.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 14.0 mm-40 -67.18 106.46 2.02 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 107.531 -1.285 . . . . 72.11 107.531 171.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.625 HG13 HG13 ' D' ' 64' ' ' VAL . 62.4 t -106.17 116.09 49.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 O-C-N 123.729 0.643 . . . . 72.34 109.797 -178.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -98.98 152.64 19.58 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.642 -0.708 . . . . 45.34 109.569 169.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.444 HD11 HG13 ' D' ' 62' ' ' VAL . 31.9 tp -126.63 134.52 50.74 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.967 -1.015 . . . . 73.14 109.759 -173.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.551 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 13.2 t70 -130.35 113.77 14.77 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.415 -1.328 . . . . 74.22 107.415 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.437 ' CD2' HG22 ' D' ' 62' ' ' VAL . 94.3 mt -118.56 129.14 55.17 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.22 0.608 . . . . 70.33 109.438 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -160.03 155.76 25.86 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.633 -0.877 . . . . 73.32 108.633 172.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . 0.499 HG22 ' HA ' ' D' ' 60' ' ' LEU . 30.4 p -123.61 168.64 12.37 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 122.167 0.984 . . . . 74.24 113.035 -170.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.13 143.97 26.33 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 113.465 -1.698 . . . . 60.22 107.208 173.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 37.2 p . . . . . 0 C--O 1.242 0.678 0 CA-C-O 120.58 0.229 . . . . 72.33 111.322 -178.675 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' D' ' 85' ' ' SER . 6.0 m-20 . . . . . 0 N--CA 1.485 1.322 0 N-CA-C 112.932 0.715 . . . . 75.03 112.932 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 58.8 t -134.87 102.16 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 107.635 -1.246 . . . . 74.45 107.635 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -135.33 135.06 40.47 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.039 0.535 . . . . 75.31 109.856 -174.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.514 ' HG2' HG12 ' D' ' 83' ' ' ILE . 42.3 mt-10 -87.14 115.02 24.25 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.882 -1.155 . . . . 64.04 107.882 167.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 70.6 t -97.58 136.22 29.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 106.797 -1.557 . . . . 70.12 106.797 171.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.426 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.1 t -128.41 123.76 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 108.239 -1.023 . . . . 73.33 108.239 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.499 ' HA ' HG22 ' D' ' 46' ' ' THR . 0.2 OUTLIER -103.31 121.21 42.27 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.824 -1.176 . . . . 60.51 107.824 176.189 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -100.53 105.99 17.47 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.237 -1.394 . . . . 61.5 107.237 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.444 HG13 HD11 ' D' ' 42' ' ' LEU . 59.1 t -99.99 120.43 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 N-CA-C 108.234 -1.025 . . . . 73.35 108.234 176.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 28.2 m -120.84 140.13 52.2 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.872 -0.788 . . . . 72.43 108.872 -177.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.625 HG13 HG13 ' D' ' 40' ' ' VAL . 77.3 t -131.37 130.36 62.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 115.398 -0.819 . . . . 74.15 109.914 -173.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 10.2 m -119.84 93.03 3.93 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.409 -0.96 . . . . 70.03 108.409 172.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.509 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -100.53 146.34 27.21 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.191 0.596 . . . . 63.13 110.037 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.521 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 23.5 p -153.89 127.93 8.97 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 112.815 0.672 . . . . 64.2 112.815 -169.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.608 HD12 HG22 ' D' ' 31' ' ' VAL . 80.0 mt -96.31 102.24 14.0 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.667 0.787 . . . . 70.24 109.121 174.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.84 -132.66 11.74 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 116.286 -0.415 . . . . 72.04 112.389 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.51 2.85 56.45 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.752 0.421 . . . . 71.33 111.038 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -114.94 158.31 22.19 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.362 -0.607 . . . . 71.2 109.362 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 91.6 m -75.33 139.14 42.25 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.083 0.553 . . . . 72.13 110.722 178.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.607 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.04 -62.32 1.51 Allowed 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.548 -1.279 . . . . 74.44 107.548 175.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -158.41 149.53 20.75 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.784 -1.098 . . . . 75.41 110.864 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 74.9 mt -116.75 120.8 39.7 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.689 1.596 . . . . 72.01 107.412 174.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.532 ' SG ' HG23 ' D' ' 114' ' ' ILE . 38.9 t -131.97 137.34 47.87 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.855 -0.424 . . . . 70.44 109.855 -174.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' D' ' 62' ' ' VAL . 38.5 tt0 -154.24 130.84 10.67 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.702 0.401 . . . . 72.42 110.984 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . 0.413 HG22 HG23 ' D' ' 21' ' ' ILE . 96.2 t -134.31 121.59 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.048 0.939 . . . . 71.52 109.487 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.666 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.7 mt-30 -90.2 86.35 6.5 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.677 -0.86 . . . . 71.44 108.677 169.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -80.36 101.29 8.89 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.217 -1.356 . . . . 65.13 109.073 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.455 ' HA3' ' HD2' ' D' ' 19' ' ' LYS . . . -96.85 161.07 21.78 Favored Glycine 0 N--CA 1.464 0.544 0 N-CA-C 112.479 -0.249 . . . . 70.53 112.479 178.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.03 140.72 6.63 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.729 -0.549 . . . . 74.14 111.729 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.514 HG12 ' HG2' ' D' ' 57' ' ' GLU . 50.1 mt -89.2 123.23 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.547 -1.279 . . . . 54.02 107.547 175.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -125.24 151.06 46.41 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.929 0.891 . . . . 71.45 109.768 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.521 ' HB3' ' HB2' ' D' ' 12' ' ' GLN . 33.7 t -113.19 103.76 11.66 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.324 -0.991 . . . . 71.31 108.324 173.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.63 HG22 HD11 ' D' ' 89' ' ' ILE . 3.1 mp -108.4 119.33 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 107.607 -1.257 . . . . 72.23 107.607 -176.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.33 168.69 24.59 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 123.645 0.591 . . . . 71.21 112.276 -172.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.83 22.59 68.82 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 115.307 -0.86 . . . . 53.21 112.957 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.63 HD11 HG22 ' D' ' 86' ' ' ILE . 0.5 OUTLIER -135.62 156.67 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.04 1.336 . . . . 55.01 108.401 176.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -152.08 163.85 38.47 Favored 'General case' 0 CA--C 1.561 1.379 0 N-CA-C 107.96 -1.126 . . . . 43.23 107.96 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.19 -134.31 13.65 Favored Glycine 0 C--N 1.349 1.279 0 C-N-CA 123.545 0.593 . . . . 51.51 111.971 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 13.1 m -81.89 -25.13 35.26 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 117.964 0.882 . . . . 75.32 110.625 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -66.99 -19.04 65.65 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.634 1.174 . . . . 74.44 112.898 -174.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.512 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 0.0 OUTLIER -81.06 -43.41 19.55 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.618 0.599 . . . . 75.12 112.618 -176.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -78.73 -15.31 58.61 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.046 0.539 . . . . 54.22 110.614 177.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -58.9 -46.89 86.81 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.63 1.172 . . . . 71.42 110.734 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . 0.406 ' HB2' HG21 ' D' ' 86' ' ' ILE . 51.3 m -72.23 -31.12 65.55 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.577 0.751 . . . . 73.5 111.538 -177.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -64.51 -52.5 57.49 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.678 1.191 . . . . 70.32 109.457 177.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.78 -25.43 62.6 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 115.364 -0.835 . . . . 72.32 114.054 -173.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.9 -55.4 2.42 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 117.621 0.71 . . . . 65.13 112.25 -170.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -74.54 -39.76 62.14 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 111.799 0.296 . . . . 73.22 111.799 -171.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.57 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 73.8 m -63.47 -47.4 83.53 Favored Pre-proline 0 CA--C 1.569 1.708 0 CA-C-O 118.762 -0.637 . . . . 63.25 112.273 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.489 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 50.3 Cg_exo -59.72 -31.86 94.8 Favored 'Trans proline' 0 C--N 1.396 3.048 0 C-N-CA 122.656 2.237 . . . . 72.53 113.546 169.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -67.23 -28.84 68.4 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.279 0.631 . . . . 73.34 110.746 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.9 mm -74.12 -40.94 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.482 0.713 . . . . 73.32 110.227 172.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 88.3 mt -73.72 -24.92 59.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.367 0.667 . . . . 75.52 112.548 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -64.56 -44.69 75.33 Favored Pre-proline 0 N--CA 1.485 1.284 0 N-CA-C 113.766 1.024 . . . . 72.3 113.766 -171.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -55.1 -38.85 93.27 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 121.946 1.764 . . . . 74.15 113.17 173.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -73.77 -37.38 65.03 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.528 0.731 . . . . 51.12 111.074 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.62 -46.01 73.76 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.912 0.885 . . . . 73.13 110.759 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -73.8 -30.84 62.97 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-N 115.08 -0.963 . . . . 61.31 110.781 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -64.45 -46.52 82.74 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 124.105 0.878 . . . . 71.14 109.809 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.1 t -55.68 -44.84 77.7 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 124.14 0.9 . . . . 64.01 110.405 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.532 HG23 ' SG ' ' D' ' 76' ' ' CYS . 72.1 mt -62.99 -50.22 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.859 0.864 . . . . 64.44 111.064 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 63.0 m -55.27 -47.08 76.0 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.08 0.952 . . . . 64.33 110.781 -175.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.4 t -62.57 -42.18 99.39 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 113.778 -1.555 . . . . 62.44 109.967 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.2 mtm -70.18 -31.89 69.57 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.194 0.597 . . . . 71.43 112.047 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.505 HG23 ' O ' ' D' ' 114' ' ' ILE . 76.4 t -67.74 -42.67 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.659 0.784 . . . . 73.04 110.058 176.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.5 p -73.15 -28.05 62.02 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-N 115.628 -0.715 . . . . 65.53 110.449 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' C' ' 17' ' ' TYR . 68.8 mtt-85 -70.65 -30.41 67.02 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.426 0.69 . . . . 61.34 109.601 172.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.93 11.61 66.41 Favored Glycine 0 C--N 1.353 1.477 0 CA-C-O 119.54 -0.589 . . . . 61.12 113.587 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.442 HG23 ' HB3' ' C' ' 17' ' ' TYR . 74.2 p 58.07 21.77 8.25 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 126.122 1.769 . . . . 74.02 114.365 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -90.55 155.92 45.67 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 109.409 -0.589 . . . . 72.22 109.409 171.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.3 137.86 71.86 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 122.902 2.402 . . . . 71.1 112.076 173.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -49.35 122.17 5.82 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.05 1.34 . . . . 74.15 112.215 -175.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.436 ' HB3' HG21 ' D' ' 118' ' ' VAL . 37.7 tp -107.64 99.54 9.02 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.423 0.689 . . . . 74.11 110.431 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -99.33 104.59 16.49 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 106.956 -1.498 . . . . 75.11 106.956 172.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.428 HD21 HG21 ' D' ' 114' ' ' ILE . 3.0 mm? -62.9 129.25 39.61 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.038 -0.727 . . . . 73.53 109.038 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.27 134.11 90.78 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 123.854 0.862 . . . . 60.41 111.533 -170.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -68.47 111.11 2.44 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.758 2.306 . . . . 60.15 111.85 -174.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.8 m -107.99 142.25 21.14 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 CA-C-O 121.218 0.532 . . . . 62.12 109.603 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -86.42 111.66 20.73 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 107.916 -1.142 . . . . 54.3 107.916 174.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 . . . . . 0 N--CA 1.483 1.221 0 C-N-CA 123.269 0.628 . . . . 70.11 112.532 -174.518 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 99.4 m . . . . . 0 CA--C 1.544 0.724 0 N-CA-C 109.022 -0.733 . . . . 51.44 109.022 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.536 ' CD1' HD12 ' A' ' 86' ' ' ILE . 15.0 t80 -125.31 133.44 52.62 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.534 -0.913 . . . . 53.54 108.534 177.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -147.91 135.51 20.81 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.472 0.709 . . . . 70.32 109.452 171.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.611 HG21 ' HG2' ' C' ' 130' ' ' PRO . 3.9 mt -82.47 115.74 25.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.433 -0.951 . . . . 64.13 108.433 169.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.76 -41.12 19.59 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 109.451 -0.574 . . . . 53.3 109.451 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.426 ' NH2' ' HB ' ' B' ' 122' ' ' THR . 23.1 ttt180 -169.51 126.74 0.91 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.629 0.372 . . . . 74.25 110.962 -175.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.407 HD12 ' HG3' ' C' ' 130' ' ' PRO . 86.6 mt -111.76 137.21 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.902 -0.777 . . . . 74.11 108.902 170.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HB2' ' HA2' ' B' ' 121' ' ' GLY . 31.6 p90 -164.29 176.33 9.24 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 124.136 0.898 . . . . 53.2 111.178 -172.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.6 p -103.57 123.36 46.8 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.36 0.664 . . . . 64.53 109.289 174.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.482 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 39.5 mtpt -87.74 -27.23 22.49 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.506 -0.553 . . . . 73.43 109.506 174.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.449 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 22.3 t70 -152.25 142.05 21.98 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 114.931 -1.031 . . . . 71.45 109.418 -177.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 85.3 mt -139.63 142.24 33.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 C-N-CA 125.24 1.416 . . . . 70.05 107.409 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.8 t -149.64 123.22 9.15 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.934 0.494 . . . . 74.03 110.189 175.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.424 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 89.7 t80 -127.88 124.52 37.66 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 106.986 -1.487 . . . . 73.51 106.986 172.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 80.1 mt-10 -126.77 121.18 31.23 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.054 0.388 . . . . 75.13 110.105 -177.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.45 76.38 61.92 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 108.249 -1.019 . . . . 74.12 108.249 169.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -74.48 -23.59 14.84 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.676 2.25 . . . . 65.44 112.357 -177.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -97.43 15.57 22.73 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-O 118.198 -0.906 . . . . 64.22 109.954 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.593 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -39.94 -59.24 1.84 Allowed Pre-proline 0 CA--C 1.572 1.79 0 C-N-CA 124.703 1.201 . . . . 63.44 113.705 -168.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 32.5 Cg_exo -60.11 -35.11 93.66 Favored 'Trans proline' 0 C--N 1.387 2.601 0 C-N-CA 122.075 1.85 . . . . 75.01 113.199 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.425 ' HA ' HE21 ' A' ' 33' ' ' GLN . 3.0 m-70 -76.38 -35.55 58.58 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.117 -0.947 . . . . 72.13 110.92 -174.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.752 HG21 ' HA ' ' A' ' 73' ' ' ALA . 5.5 p -80.61 -15.51 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.707 -0.679 . . . . 63.24 112.236 -168.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -77.11 -35.49 56.29 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.513 0.325 . . . . 71.44 110.51 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.425 HE21 ' HA ' ' A' ' 30' ' ' HIS . 29.3 pt20 -78.19 -16.19 58.11 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.161 0.584 . . . . 75.5 111.139 177.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -73.33 154.6 40.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.51 0.724 . . . . 63.43 111.368 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.52 119.25 7.69 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.753 1.221 . . . . 65.24 110.331 177.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -79.67 80.76 6.02 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.709 0.766 . . . . 74.45 109.842 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -123.62 81.15 54.61 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 106.094 -1.817 . . . . 73.5 106.094 169.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -86.91 122.0 1.84 Allowed 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.695 2.264 . . . . 60.31 112.324 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -95.91 115.54 27.58 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 105.917 -1.883 . . . . 73.31 105.917 168.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.0 t -94.55 94.3 4.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 O-C-N 123.783 0.677 . . . . 65.0 109.711 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -80.19 113.55 18.45 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.922 -1.035 . . . . 64.14 109.282 175.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.594 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.6 pt? -109.81 111.64 23.21 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.549 0.69 . . . . 73.33 109.809 -177.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -101.6 137.72 39.54 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.576 1.15 . . . . 75.51 108.295 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.494 HD11 HG21 ' A' ' 131' ' ' VAL . 67.9 mt -126.56 120.45 29.63 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.412 0.625 . . . . 62.04 111.015 -173.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -125.17 122.12 36.16 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 114.028 -1.442 . . . . 74.4 108.047 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 83.8 m -122.9 135.81 54.64 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.312 0.645 . . . . 72.45 109.961 177.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.94 126.31 11.54 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.494 0.717 . . . . 61.31 109.734 176.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 64.7 p -96.94 172.78 7.64 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.457 0.703 . . . . 64.13 110.743 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.1 t -162.7 163.32 26.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.842 1.257 . . . . 53.24 108.871 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -110.92 116.91 32.04 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.277 0.631 . . . . 75.44 109.446 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.9 mt -85.91 -33.59 21.16 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.092 0.557 . . . . 75.22 110.376 175.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.9 -176.49 4.95 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.767 0.827 . . . . 72.34 110.348 -178.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -62.37 118.99 8.23 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.131 0.572 . . . . 63.1 109.61 176.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 65.35 10.43 6.51 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.767 1.227 . . . . 74.33 112.438 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.38 106.65 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.772 -0.825 . . . . 73.32 108.772 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -113.99 126.42 55.11 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.991 0.916 . . . . 75.25 109.876 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -93.62 136.69 33.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.942 -0.762 . . . . 71.21 108.942 171.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.4 t -120.85 138.16 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 108.31 -0.996 . . . . 61.03 108.31 170.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.4 t -120.52 131.25 73.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.015 -0.735 . . . . 72.52 109.015 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.485 HD21 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -109.18 105.02 14.29 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.18 -1.415 . . . . 73.45 107.18 174.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -88.91 100.78 13.45 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.322 -1.362 . . . . 60.13 107.322 172.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.0 t -94.06 126.65 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.5 -1.296 . . . . 53.44 107.5 172.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.3 m -117.61 126.59 52.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.022 -0.733 . . . . 61.52 109.022 177.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.52 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 64.0 t -115.31 126.15 72.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.087 -1.079 . . . . 65.21 108.087 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.9 m -120.68 130.5 54.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.54 -0.911 . . . . 73.5 108.54 172.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.7 123.57 29.6 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.947 -1.501 . . . . 71.11 106.947 175.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -137.27 128.92 28.62 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.23 0.538 . . . . 72.02 110.691 -174.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.699 HD12 HG22 ' A' ' 31' ' ' VAL . 33.5 mt -92.29 81.36 4.95 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.145 1.378 . . . . 64.25 107.913 175.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.71 -119.51 6.08 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 110.852 -0.899 . . . . 73.24 110.852 -174.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.4 -19.36 25.28 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.926 0.49 . . . . 53.3 110.201 175.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -80.92 106.69 13.13 Favored 'General case' 0 C--N 1.347 0.469 0 C-N-CA 124.035 0.934 . . . . 72.05 109.038 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.8 m -68.76 131.07 44.56 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 118.16 0.436 . . . . 62.54 109.939 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.752 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -77.66 -61.26 2.05 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.286 -1.005 . . . . 71.53 108.286 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 46.6 p90 -158.9 157.78 32.1 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.525 -0.761 . . . . 75.54 111.801 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 64' ' ' VAL . 57.1 tp -123.44 109.29 13.67 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.46 -1.245 . . . . 73.34 107.734 171.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.52 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 86.0 m -108.17 96.27 6.25 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.111 0.565 . . . . 52.32 110.301 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -111.42 115.67 29.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.9 -0.778 . . . . 70.43 108.9 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.65 133.06 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.603 0.761 . . . . 53.05 109.887 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 61.9 mt-30 -105.12 88.22 2.82 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 107.956 -1.127 . . . . 74.15 107.956 175.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -76.8 96.43 4.27 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.166 -0.924 . . . . 70.14 109.208 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.54 145.09 20.1 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 111.349 -0.701 . . . . 73.33 111.349 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.5 122.95 1.79 Allowed Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.696 -0.962 . . . . 62.23 110.696 -176.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.441 HG13 ' HE1' ' A' ' 17' ' ' TYR . 53.7 mt -80.77 127.29 39.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 108.151 -1.055 . . . . 63.42 108.151 170.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.802 ' HB3' HD11 ' A' ' 86' ' ' ILE . 92.8 m-85 -131.74 123.91 28.65 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.371 0.668 . . . . 74.33 109.4 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 t -86.43 98.0 10.77 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 108.903 -0.777 . . . . 72.21 108.903 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.802 HD11 ' HB3' ' A' ' 84' ' ' PHE . 4.1 mm -112.5 149.24 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 122.857 0.463 . . . . 74.45 110.886 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.26 167.28 16.2 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.748 0.819 . . . . 52.05 110.827 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.44 -32.92 6.24 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 114.304 0.482 . . . . 74.21 114.304 172.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.671 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -113.01 150.33 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.411 0.684 . . . . 61.51 110.639 -174.513 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -138.8 174.58 10.37 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.379 1.072 . . . . 64.44 109.527 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.86 -133.28 40.56 Favored Glycine 0 C--N 1.345 1.07 0 O-C-N 123.792 0.683 . . . . 64.01 113.732 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 47.5 p -67.77 -25.51 65.65 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.876 0.87 . . . . 64.54 111.631 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -69.37 -42.74 74.79 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.387 0.675 . . . . 74.11 110.827 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 5.8 tpt -66.34 -46.72 75.85 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 116.004 -0.544 . . . . 60.51 109.897 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.36 -34.77 72.8 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.563 -0.744 . . . . 64.4 110.894 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -68.84 -34.29 75.24 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.651 -0.704 . . . . 72.44 111.431 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.9 t -65.76 -44.27 86.4 Favored 'General case' 0 C--N 1.348 0.516 0 N-CA-C 109.815 -0.439 . . . . 60.53 109.815 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.6 mt -84.22 -35.31 23.56 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.235 -0.893 . . . . 73.42 112.036 -170.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.86 3.93 49.25 Favored Glycine 0 N--CA 1.473 1.11 0 CA-C-O 119.713 -0.493 . . . . 73.53 114.2 -172.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.52 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -141.67 -66.57 0.41 Allowed 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 117.587 0.694 . . . . 73.43 111.537 -177.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -65.48 -44.59 86.61 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 115.968 -0.56 . . . . 71.31 111.581 -173.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.6 m -63.44 -51.08 70.22 Favored Pre-proline 0 CA--C 1.564 1.494 0 C-N-CA 124.03 0.932 . . . . 65.25 112.354 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.45 -27.13 62.48 Favored 'Trans proline' 0 C--N 1.395 2.985 0 C-N-CA 121.717 1.611 . . . . 73.34 113.491 173.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.511 HD21 ' HA ' ' A' ' 132' ' ' ASN . 3.0 m120 -60.88 -38.29 85.1 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 118.09 0.405 . . . . 71.35 110.613 172.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.506 HG21 ' CD1' ' A' ' 13' ' ' ILE . 47.3 mm -72.12 -44.21 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.467 0.707 . . . . 63.01 110.065 176.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 70.2 mt -71.75 -23.61 61.63 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.551 -0.749 . . . . 64.24 112.29 -173.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -63.98 -47.27 80.53 Favored Pre-proline 0 N--CA 1.483 1.207 0 CA-C-O 117.932 -1.033 . . . . 75.02 113.391 -172.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.412 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 83.0 Cg_exo -51.29 -36.15 56.01 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.138 1.892 . . . . 65.23 113.943 172.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -80.55 -39.37 27.87 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.396 0.678 . . . . 65.03 111.716 -177.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.78 -47.49 74.96 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 109.457 -0.572 . . . . 40.32 109.457 176.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.614 HH12 HD12 ' C' ' 105' ' ' ILE . 27.9 ttm180 -51.6 -47.07 63.72 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.85 1.26 . . . . 72.12 110.568 172.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.43 -49.12 78.14 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.033 0.833 . . . . 55.25 111.433 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.4 t -57.17 -47.19 81.84 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.084 0.865 . . . . 50.42 110.193 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.527 HD13 HD11 ' A' ' 128' ' ' LEU . 23.5 mt -56.75 -51.76 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.743 1.217 . . . . 72.51 111.124 174.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.9 m -56.23 -45.09 80.09 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.535 1.134 . . . . 73.14 111.108 -176.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.2 t -67.66 -41.05 84.4 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.41 -1.268 . . . . 72.22 110.006 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 11.6 mtp -59.66 -44.61 93.5 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.59 0.756 . . . . 71.53 111.054 176.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 114' ' ' ILE . 82.1 t -59.33 -48.41 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 124.225 1.01 . . . . 62.23 110.543 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.9 p -71.19 -30.6 66.6 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.603 -0.726 . . . . 63.22 111.617 -176.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.468 HH12 ' HG3' ' B' ' 112' ' ' GLU . 80.3 mtt-85 -72.66 -28.31 62.64 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.98 0.512 . . . . 73.24 109.974 176.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.436 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.34 17.17 35.16 Favored Glycine 0 C--N 1.354 1.559 0 CA-C-O 119.291 -0.727 . . . . 64.24 113.432 174.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.4 t 59.73 9.96 1.84 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 127.202 2.201 . . . . 74.42 113.404 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -79.26 140.04 56.5 Favored Pre-proline 0 C--O 1.242 0.671 0 N-CA-C 108.311 -0.996 . . . . 73.33 108.311 175.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -46.49 126.7 10.64 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 123.065 2.51 . . . . 60.4 112.268 172.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -50.67 131.6 25.66 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.599 1.187 . . . . 72.32 112.84 -168.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.4 tp -109.24 138.09 46.12 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.642 0.777 . . . . 70.05 109.858 -176.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -132.97 117.67 17.92 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.531 -0.914 . . . . 64.01 108.531 174.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.527 HD11 HD13 ' A' ' 114' ' ' ILE . 16.1 mt -72.72 135.29 45.33 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.152 -0.684 . . . . 63.24 109.152 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.13 142.78 98.69 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 122.651 0.38 . . . . 73.25 111.254 -177.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.464 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 63.3 Cg_exo -54.17 118.39 4.95 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.421 2.748 . . . . 73.24 114.074 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.494 HG21 HD11 ' A' ' 44' ' ' LEU . 88.5 t -102.86 129.03 55.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 123.518 0.727 . . . . 64.43 110.272 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.511 ' HA ' HD21 ' A' ' 104' ' ' ASN . 56.6 t30 -96.37 92.89 6.54 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.678 0.791 . . . . 63.14 109.12 176.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -67.98 -22.84 64.99 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.55 -0.75 . . . . 71.14 111.368 177.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.52 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 13.5 t70 -54.91 -50.96 67.52 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.574 0.75 . . . . 75.13 110.105 172.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.91 -55.65 30.47 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 114.78 -1.1 . . . . 71.43 110.086 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 91.8 mt -56.82 -36.91 70.5 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 124.217 0.948 . . . . 71.33 112.479 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 81.8 t80 . . . . . 0 C--O 1.219 -0.542 0 O-C-N 123.777 0.673 . . . . 63.34 110.257 178.288 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.57 ' HG3' HG13 ' B' ' 89' ' ' ILE . 27.0 ttt . . . . . 0 CA--C 1.566 1.571 0 CA-C-O 121.454 0.645 . . . . 74.01 111.59 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.415 ' N ' ' HG2' ' B' ' 9' ' ' MET . 85.3 m -138.01 123.08 19.12 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.875 1.27 . . . . 61.33 108.13 169.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.636 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 62.1 t80 -137.29 133.79 35.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.248 0.619 . . . . 71.34 109.608 177.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -150.57 140.13 21.57 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.568 0.747 . . . . 74.04 109.223 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.505 HD11 HD13 ' B' ' 105' ' ' ILE . 53.4 mt -83.16 130.27 36.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.23 -1.026 . . . . 53.14 108.23 171.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -98.78 -41.57 7.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.975 0.51 . . . . 75.11 110.4 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -173.03 129.29 0.48 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.617 -0.72 . . . . 74.22 109.177 -175.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.557 HG21 ' CD1' ' B' ' 109' ' ' TYR . 75.1 mt -116.32 148.89 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.448 -0.945 . . . . 61.45 108.448 173.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -167.09 161.95 15.06 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-O 121.671 0.748 . . . . 71.24 112.016 -175.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.4 m -88.26 123.03 32.46 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.191 -1.368 . . . . 64.02 108.408 168.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.543 ' HZ2' ' HA3' ' B' ' 81' ' ' GLY . 43.0 mttp -80.05 -51.76 8.64 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.233 0.613 . . . . 75.11 110.593 170.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -144.85 141.77 29.39 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.283 -0.417 . . . . 61.43 110.725 -164.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.507 HD11 ' SG ' ' B' ' 113' ' ' CYS . 46.3 mm -134.95 138.66 48.73 Favored 'Isoleucine or valine' 0 C--N 1.354 0.791 0 C-N-CA 124.572 1.149 . . . . 70.43 109.726 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.42 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 40.2 t -138.32 128.47 25.76 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.923 1.289 . . . . 62.14 107.65 176.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.416 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 77.5 t80 -144.29 114.32 7.36 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 107.974 -1.121 . . . . 53.52 107.974 171.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -122.43 116.98 24.91 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.076 0.95 . . . . 65.44 108.941 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.18 86.57 3.35 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 107.595 -1.261 . . . . 72.12 107.595 169.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.86 -30.64 40.08 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.956 2.437 . . . . 71.21 112.715 -170.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -107.87 12.27 27.35 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 118.407 -0.806 . . . . 74.23 110.899 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.421 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -31.24 -73.22 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.918 0 C-N-CA 126.026 1.73 . . . . 74.24 114.604 -164.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.482 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 27.6 Cg_endo -64.06 -26.19 65.88 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 122.084 1.856 . . . . 74.14 112.954 -170.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -87.11 -41.74 13.56 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.14 -0.936 . . . . 62.24 111.383 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.498 HG22 HD12 ' B' ' 68' ' ' LEU . 8.8 p -69.18 -17.75 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.218 0.607 . . . . 55.43 111.175 -175.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -65.54 -11.09 40.6 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.128 0.788 . . . . 74.1 113.128 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.501 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.2 pt20 -63.13 -13.72 40.02 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.455 0.702 . . . . 71.32 111.446 172.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.501 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 97.9 mttt -109.06 110.3 21.53 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.779 1.632 . . . . 74.12 110.629 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -111.27 88.95 2.92 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.641 0.776 . . . . 64.22 109.822 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.448 ' O ' ' HG3' ' B' ' 124' ' ' PRO . 33.7 p90 -167.66 172.49 9.28 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.879 0.872 . . . . 74.12 109.098 170.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -65.18 110.17 3.91 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 123.424 0.69 . . . . 54.33 110.704 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.414 ' O ' HG23 ' B' ' 40' ' ' VAL . 18.0 Cg_endo -64.83 166.3 18.63 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.051 1.834 . . . . 73.15 112.384 -177.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 33.8 tt0 -64.35 100.84 0.38 Allowed 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.509 -1.293 . . . . 54.31 107.509 168.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.689 HG11 HD11 ' B' ' 126' ' ' LEU . 54.6 t -104.32 149.31 8.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.213 -0.903 . . . . 70.01 109.125 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.504 ' HE3' ' HB2' ' B' ' 43' ' ' ASP . 12.6 ttpt -141.3 120.67 13.13 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.393 -1.336 . . . . 52.31 107.393 173.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.524 HD13 HD22 ' B' ' 128' ' ' LEU . 20.4 tp -88.53 134.62 33.81 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.614 -0.884 . . . . 73.24 108.614 174.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.504 ' HB2' ' HE3' ' B' ' 41' ' ' LYS . 2.5 t0 -142.41 146.66 35.11 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.879 -1.156 . . . . 62.42 107.879 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 mp -131.25 146.2 52.21 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.476 -0.565 . . . . 65.11 109.476 -175.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.519 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 35.0 m-20 -130.47 153.86 48.36 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.953 1.301 . . . . 73.52 108.087 170.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 5.9 t -139.11 130.86 27.49 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.344 0.593 . . . . 64.03 110.251 176.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.05 136.46 18.97 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.918 1.287 . . . . 75.53 107.662 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 19.0 m -140.8 175.22 9.79 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.923 0.489 . . . . 71.41 110.948 -170.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 58.9 p -151.66 136.94 17.55 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.725 0.41 . . . . 75.24 111.146 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -87.79 107.16 18.53 Favored 'General case' 0 C--N 1.349 0.545 0 N-CA-C 108.978 -0.749 . . . . 72.0 108.978 173.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.0 pp -125.34 15.43 8.32 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.273 -0.876 . . . . 62.13 109.717 177.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.76 151.1 14.25 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 124.439 1.096 . . . . 64.3 109.373 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -83.36 134.72 34.89 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.619 -0.882 . . . . 70.54 108.619 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' HB3' ' HB2' ' B' ' 87' ' ' ALA . 1.7 m-20 64.3 7.88 3.83 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.065 0.946 . . . . 74.52 112.275 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 86.8 t -142.03 112.17 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 107.556 -1.276 . . . . 71.53 107.556 -174.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -115.3 139.68 49.77 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 109.012 -0.736 . . . . 72.43 109.012 -171.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -101.33 104.37 15.36 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.79 -1.189 . . . . 72.52 107.79 -177.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.58 135.87 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.775 0.83 . . . . 72.42 110.072 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 15.4 t -122.81 111.28 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.6 0.76 . . . . 72.14 108.956 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 56.5 tp -98.27 115.0 27.47 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.261 -0.644 . . . . 72.03 109.261 175.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.519 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 37.9 ttm180 -85.39 130.74 34.52 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.893 -0.78 . . . . 75.45 108.893 170.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 64.6 t -123.45 104.72 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 108.228 -1.027 . . . . 74.35 108.228 173.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 11.9 m -100.66 136.7 40.12 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.737 0.815 . . . . 75.24 109.906 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.742 HG11 HD21 ' B' ' 126' ' ' LEU . 76.8 t -121.1 125.83 74.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 123.957 0.903 . . . . 74.01 109.227 173.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.4 m -100.49 138.67 37.25 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 107.806 -1.183 . . . . 74.43 107.806 169.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.03 144.49 27.96 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.887 0.375 . . . . 72.01 111.08 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.482 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 34.9 p -151.96 128.52 10.74 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.271 -0.877 . . . . 73.24 110.568 -178.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.498 HD12 HG22 ' B' ' 31' ' ' VAL . 66.9 mt -91.76 98.3 11.53 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.654 -1.239 . . . . 65.03 107.654 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.07 -119.49 5.93 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 114.397 -1.274 . . . . 65.13 112.287 -174.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -100.91 1.39 39.82 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.622 0.769 . . . . 62.33 111.552 -174.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -122.02 148.55 44.69 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.705 -0.48 . . . . 74.42 109.705 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.5 m -68.46 133.72 49.06 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.119 0.485 . . . . 71.44 111.019 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.482 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -87.95 -64.4 1.15 Allowed 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.914 -1.143 . . . . 73.43 107.914 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . 0.438 ' CZ ' HD22 ' B' ' 126' ' ' LEU . 43.0 p90 -154.06 155.09 34.82 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.262 -1.335 . . . . 63.31 109.364 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 72.4 mt -131.68 111.68 11.89 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.815 -1.55 . . . . 75.13 106.815 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 37.5 t -117.78 151.51 37.17 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.912 -0.773 . . . . 72.41 108.912 -176.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.42 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 34.9 tt0 -162.1 129.26 3.84 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.768 -0.826 . . . . 64.32 108.768 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 85.6 t -124.44 149.68 28.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 124.013 0.925 . . . . 73.22 108.535 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -126.51 95.83 4.48 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.181 -1.044 . . . . 71.03 108.181 171.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -90.75 107.39 19.15 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.671 -0.863 . . . . 75.04 108.671 -176.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.543 ' HA3' ' HZ2' ' B' ' 19' ' ' LYS . . . -97.94 154.82 20.3 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 112.075 -0.41 . . . . 74.54 112.075 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.5 132.83 3.13 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 117.089 0.444 . . . . 70.13 112.938 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 3.7 mp -86.02 113.66 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 N-CA-C 107.941 -1.133 . . . . 64.34 107.941 170.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -121.48 153.83 37.41 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.786 0.834 . . . . 74.4 109.266 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 49.1 m -100.71 107.41 19.01 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.245 0.618 . . . . 62.54 109.868 176.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.28 102.0 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 106.676 -1.601 . . . . 71.14 106.676 175.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.679 ' HB2' ' HB3' ' B' ' 54' ' ' ASP . . . -147.77 170.84 16.73 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.24 0.616 . . . . 53.53 111.368 -169.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.39 -54.62 4.86 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-O 121.253 0.363 . . . . 63.14 112.414 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.57 HG13 ' HG3' ' B' ' 9' ' ' MET . 1.1 pp -68.4 168.57 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.242 1.017 . . . . 65.23 111.826 171.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.59 -171.3 3.63 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.168 -0.924 . . . . 73.13 110.092 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.64 -132.57 22.53 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 115.081 -0.963 . . . . 64.31 114.166 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 15.8 m -83.55 -40.97 18.44 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.953 0.901 . . . . 63.25 109.86 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -65.49 -25.99 67.72 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 113.609 -1.632 . . . . 74.52 112.131 -165.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.467 ' HB2' HD13 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -65.05 -40.82 95.31 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.054 0.942 . . . . 71.42 112.642 -177.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.23 -14.05 59.83 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.048 0.539 . . . . 75.14 112.276 -177.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -64.84 -32.44 74.15 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.833 0.453 . . . . 73.34 110.537 170.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.2 t -66.12 -56.29 12.2 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.592 0.357 . . . . 70.45 110.889 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.415 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.5 pp -67.2 -21.71 65.76 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.711 0.404 . . . . 75.02 111.378 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.84 0.37 57.73 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-O 119.093 -0.837 . . . . 65.04 114.506 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.4 -56.07 0.21 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 118.39 1.095 . . . . 53.34 111.937 -177.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -68.4 -43.79 76.51 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.436 0.695 . . . . 70.44 111.393 -173.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.636 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 58.9 m -70.89 -47.42 15.41 Favored Pre-proline 0 CA--C 1.562 1.441 0 C-N-CA 123.477 0.711 . . . . 71.23 112.21 -176.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 31.9 Cg_exo -60.85 -28.32 86.22 Favored 'Trans proline' 0 C--N 1.394 2.931 0 C-N-CA 121.953 1.769 . . . . 72.35 113.346 173.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.25 -32.9 72.71 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.577 0.751 . . . . 70.22 111.849 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.505 HD13 HD11 ' B' ' 13' ' ' ILE . 70.0 mt -75.6 -34.94 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.639 0.776 . . . . 63.44 110.155 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 85.4 mt -75.44 -31.8 60.45 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.207 -0.906 . . . . 45.14 111.372 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -57.67 -48.63 96.87 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 113.885 1.068 . . . . 52.01 113.885 -173.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.8 -32.48 91.81 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 122.293 1.996 . . . . 74.2 113.211 177.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.557 ' CD1' HG21 ' B' ' 16' ' ' ILE . 5.0 m-30 -79.53 -37.69 35.96 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.315 0.646 . . . . 75.53 110.514 -176.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.46 -37.95 88.39 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.35 -0.841 . . . . 71.34 110.077 173.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.486 ' HA ' HD12 ' B' ' 128' ' ' LEU . 46.2 ttt-85 -61.02 -55.24 35.11 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.888 1.275 . . . . 74.25 110.181 177.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.468 ' HG3' HH12 ' A' ' 120' ' ' ARG . 13.3 tp10 -61.24 -35.23 76.67 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.903 0.881 . . . . 73.35 110.747 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.592 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.0 t -69.13 -32.59 72.06 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 110.267 -0.271 . . . . 73.0 110.267 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.548 HD13 HG23 ' B' ' 64' ' ' VAL . 69.0 mt -71.19 -56.42 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.443 0.697 . . . . 72.3 110.411 174.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 22.7 m -58.24 -28.56 64.99 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.39 1.076 . . . . 74.4 111.416 -174.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.5 t -63.05 -57.14 11.67 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-N 115.782 -0.645 . . . . 74.12 109.574 171.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.592 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.2 mmt -64.02 -36.75 85.0 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.562 0.745 . . . . 64.24 111.254 -173.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.479 HG21 HD23 ' B' ' 126' ' ' LEU . 82.3 t -57.97 -50.08 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 124.545 1.138 . . . . 61.32 110.075 175.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 47.2 t -73.48 -20.25 60.73 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.785 -1.098 . . . . 74.33 111.496 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.456 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 90.9 mtt-85 -68.77 -31.19 70.04 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 110.149 -0.315 . . . . 71.22 110.149 173.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . 0.45 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -78.65 -4.72 87.99 Favored Glycine 0 C--N 1.355 1.607 0 O-C-N 123.62 0.575 . . . . 52.0 112.485 168.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.426 ' HB ' ' NH2' ' A' ' 15' ' ' ARG . 8.6 m 62.93 33.36 15.04 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 125.684 1.594 . . . . 63.22 110.19 -177.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -76.92 163.75 63.47 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 114.353 -1.294 . . . . 72.0 110.534 176.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.448 ' HG3' ' O ' ' B' ' 36' ' ' TRP . 36.3 Cg_endo -61.34 157.34 41.11 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 122.557 2.171 . . . . 75.34 111.63 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -63.01 130.11 43.29 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.374 0.606 . . . . 60.23 111.924 -171.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.742 HD21 HG11 ' B' ' 64' ' ' VAL . 59.9 tp -120.74 99.86 6.77 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.485 -1.234 . . . . 54.52 109.004 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -95.66 121.99 37.95 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.75 -1.204 . . . . 70.01 107.75 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.524 HD22 HD13 ' B' ' 42' ' ' LEU . 38.6 mt -79.79 132.88 36.25 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 117.831 0.287 . . . . 52.2 110.522 176.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.45 131.82 82.21 Favored Pre-proline 0 C--O 1.243 0.717 0 O-C-N 123.993 0.808 . . . . 62.25 110.91 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.582 ' HG3' HD11 ' D' ' 16' ' ' ILE . 54.0 Cg_endo -67.85 110.04 2.05 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.456 2.104 . . . . 75.33 110.698 172.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 7.7 p -88.18 141.95 13.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 N-CA-C 108.134 -1.062 . . . . 75.2 108.134 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 . . . . . 0 CA--C 1.547 0.83 0 CA-C-O 122.537 1.161 . . . . 62.54 108.645 -179.452 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.479 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 75.6 t80 . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 109.265 -0.643 . . . . 74.4 109.265 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 45.8 tp60 -151.81 142.87 23.16 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.268 0.627 . . . . 72.11 109.383 170.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 23.0 mt -88.18 131.9 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 108.107 -1.071 . . . . 74.43 108.107 173.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -90.26 -47.05 8.02 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.065 -0.717 . . . . 75.01 109.065 172.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -179.25 143.54 0.21 Allowed 'General case' 0 C--O 1.239 0.517 0 CA-C-N 113.914 -1.494 . . . . 75.31 108.424 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 pp -107.72 152.31 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.751 -1.203 . . . . 73.51 107.751 175.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.6 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 23.6 p90 -173.77 142.41 0.9 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.317 0.58 . . . . 74.43 111.368 -175.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -76.27 127.11 32.23 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.294 1.038 . . . . 63.42 110.669 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -86.31 -22.23 26.87 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.58 -0.896 . . . . 60.44 108.58 168.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.627 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.2 t70 -148.53 133.42 18.05 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.759 -0.655 . . . . 61.02 109.419 -175.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 63.6 mt -136.57 137.33 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 106.035 -1.839 . . . . 71.44 106.035 170.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.3 t -155.16 151.8 28.65 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.516 0.674 . . . . 61.25 112.174 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -153.31 143.73 22.48 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 113.747 -1.57 . . . . 73.23 107.843 174.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -145.57 113.52 6.48 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.174 0.589 . . . . 43.12 110.161 -177.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.23 77.21 48.83 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 108.059 -1.089 . . . . 44.21 108.059 164.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.46 -25.31 63.26 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.708 2.272 . . . . 73.3 111.938 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -94.39 18.65 10.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.111 1.364 . . . . 52.15 111.451 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.59 -57.24 5.9 Favored Pre-proline 0 CA--C 1.559 1.294 0 N-CA-C 113.837 1.051 . . . . 41.4 113.837 -170.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -61.72 -36.74 72.89 Favored 'Trans proline' 0 C--N 1.386 2.507 0 CA-C-N 121.575 1.598 . . . . 45.54 112.468 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -70.06 -40.25 75.18 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.967 0.907 . . . . 75.44 112.39 -178.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.777 HG21 ' HA ' ' C' ' 73' ' ' ALA . 11.3 p -76.78 -26.11 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 N-CA-C 112.649 0.611 . . . . 74.12 112.649 -176.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -61.73 -29.24 69.98 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 112.933 0.716 . . . . 71.12 112.933 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -91.72 13.09 19.16 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.921 0.488 . . . . 72.1 112.073 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.4 163.24 12.96 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.727 0.811 . . . . 74.11 109.662 177.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.62 127.96 34.91 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.425 0.69 . . . . 63.1 109.573 170.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -84.27 83.43 7.98 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.535 0.734 . . . . 74.12 110.808 -176.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -134.9 78.93 53.09 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.77 0.828 . . . . 74.14 108.799 171.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -86.76 154.39 8.77 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.755 2.303 . . . . 54.52 112.405 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -88.68 82.06 6.92 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.126 -1.435 . . . . 64.21 107.126 166.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 44.4 t -68.82 95.97 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.663 0 N-CA-C 107.856 -1.164 . . . . 64.0 107.856 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.414 ' NZ ' ' HB2' ' C' ' 43' ' ' ASP . 0.4 OUTLIER -104.18 104.87 14.86 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.124 -1.435 . . . . 60.44 107.124 -178.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.477 HD23 HD23 ' C' ' 128' ' ' LEU . 2.2 mp -86.74 144.97 26.84 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.689 -1.226 . . . . 73.51 107.689 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.534 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 32.6 t70 -138.26 140.97 39.87 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.176 -0.676 . . . . 64.55 109.176 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 92.8 mt -126.59 111.61 14.55 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.718 -0.845 . . . . 75.42 108.718 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -113.94 143.82 44.08 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.018 -1.475 . . . . 72.44 107.018 169.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.3 t -139.05 154.22 48.18 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 120.939 0.399 . . . . 63.44 110.034 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.82 156.26 42.98 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.172 -0.922 . . . . 74.23 108.99 175.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 30.5 p -152.66 150.45 29.48 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.27 0.628 . . . . 74.32 109.976 -175.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 49.9 p -160.56 144.85 14.05 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.201 0.6 . . . . 73.53 110.388 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -77.83 130.52 36.77 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.396 0.678 . . . . 53.43 110.176 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.703 HD11 ' HB2' ' C' ' 57' ' ' GLU . 54.0 mt -95.94 -39.75 9.63 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.521 0.729 . . . . 73.23 109.981 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.24 -171.41 2.6 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.847 0.859 . . . . 50.23 110.363 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -60.26 115.48 3.54 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.182 -0.917 . . . . 74.24 110.403 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 63.16 18.04 10.65 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.051 1.34 . . . . 65.54 111.733 177.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.8 t -121.76 117.56 52.89 Favored 'Isoleucine or valine' 0 C--N 1.354 0.763 0 C-N-CA 124.64 1.176 . . . . 43.33 108.578 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -131.14 130.35 42.96 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.313 1.045 . . . . 63.23 109.114 -176.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.703 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.0 tt0 -95.85 139.6 31.82 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.186 0.595 . . . . 73.51 109.841 173.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.01 135.01 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 108.648 -0.871 . . . . 45.45 108.648 170.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.535 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 84.3 t -113.75 144.08 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.111 0.964 . . . . 73.13 108.619 171.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.77 107.22 10.32 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.342 -0.984 . . . . 60.22 108.342 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 35.4 ttm-85 -82.08 107.63 14.93 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.517 0.727 . . . . 75.03 109.047 171.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 26.2 t -106.87 112.45 39.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.342 -0.984 . . . . 72.23 108.342 170.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 31.7 m -104.49 144.34 31.8 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.382 -0.827 . . . . 54.41 109.181 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.641 HG21 HG21 ' C' ' 114' ' ' ILE . 88.6 t -132.42 111.53 17.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 N-CA-C 107.301 -1.37 . . . . 74.41 107.301 175.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.0 m -99.11 137.27 37.87 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.908 -1.145 . . . . 71.41 107.908 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.38 104.88 5.29 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.441 -0.948 . . . . 52.44 108.441 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.9 m -129.56 132.2 46.76 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.99 0.424 . . . . 71.31 110.255 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 14.9 mt -85.36 36.94 0.66 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.623 1.169 . . . . 75.11 110.307 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.1 -108.05 2.64 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 110.954 -0.858 . . . . 50.22 110.954 -172.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -90.21 -31.98 16.79 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.113 0.565 . . . . 75.3 110.42 176.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -70.58 119.99 15.54 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.521 -0.918 . . . . 71.11 108.521 171.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 31.3 m -82.72 125.12 30.89 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.333 -0.988 . . . . 72.01 108.333 170.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.777 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.17 -52.6 18.29 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 109.226 -0.657 . . . . 71.41 109.226 176.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . 0.564 ' HZ ' HD21 ' C' ' 126' ' ' LEU . 33.9 p90 -165.7 169.6 14.99 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.653 -1.158 . . . . 72.1 110.913 176.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.413 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -128.48 143.25 50.95 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.422 -1.695 . . . . 53.21 106.422 167.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.546 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.6 t -150.03 122.97 8.75 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.17 -0.678 . . . . 62.12 109.17 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -137.98 134.22 34.61 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.547 -0.538 . . . . 74.24 109.547 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.512 HG21 ' HB3' ' C' ' 113' ' ' CYS . 71.7 t -128.75 136.76 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.093 0.957 . . . . 75.33 108.895 175.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.627 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.1 mt-30 -116.37 87.73 2.75 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.048 -1.093 . . . . 72.12 108.048 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -78.8 102.53 8.2 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.517 -1.22 . . . . 65.32 110.139 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -84.32 -179.64 51.62 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 116.511 -0.313 . . . . 63.24 112.646 173.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.46 134.42 2.27 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-O 119.96 -0.356 . . . . 74.52 112.511 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.517 HG12 ' HE1' ' C' ' 17' ' ' TYR . 33.5 mm -88.66 127.53 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.336 -0.987 . . . . 75.41 108.336 173.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -129.35 140.01 51.52 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.371 0.668 . . . . 73.01 110.595 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 57.8 m -97.42 103.51 15.45 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.551 0.74 . . . . 54.02 109.492 170.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.66 HG21 ' HE1' ' C' ' 94' ' ' MET . 51.0 mt -116.71 135.15 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.639 0.776 . . . . 74.31 109.358 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.92 164.38 30.24 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.157 0.583 . . . . 72.05 110.783 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.46 -18.2 57.9 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.711 -0.677 . . . . 63.13 114.487 172.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' C' ' 94' ' ' MET . 40.3 pt -119.91 173.55 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-N 118.019 0.91 . . . . 73.51 112.948 -171.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -161.74 178.99 8.47 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 114.028 -1.442 . . . . 54.43 109.769 174.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.96 -124.27 31.96 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 115.072 0.789 . . . . 74.2 115.072 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 4.6 m -72.28 -27.6 62.58 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.004 0.922 . . . . 70.34 111.21 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -67.15 -47.77 70.04 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.493 0.717 . . . . 73.03 109.558 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.66 ' HE1' HG21 ' C' ' 86' ' ' ILE . 4.6 tpt -55.03 -49.26 72.01 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 114.936 -1.029 . . . . 72.24 111.43 169.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.71 -33.37 68.35 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.785 0.678 . . . . 72.11 111.439 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -77.35 -36.16 53.96 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.016 0.526 . . . . 73.13 111.795 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.4 ' SG ' HD13 ' C' ' 86' ' ' ILE . 30.2 t -67.06 -36.58 82.34 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.999 -0.741 . . . . 64.43 108.999 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 55.6 mt -86.96 -22.51 25.54 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.522 1.129 . . . . 73.32 111.439 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.91 -29.19 23.97 Favored Glycine 0 C--N 1.346 1.093 0 O-C-N 123.489 0.493 . . . . 71.32 113.962 -172.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.35 -56.0 0.85 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.854 0.462 . . . . 34.14 111.351 -171.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -63.87 -59.0 5.07 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 123.543 0.527 . . . . 70.03 111.74 -169.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.479 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 72.9 m -58.83 -49.93 90.72 Favored Pre-proline 0 CA--C 1.559 1.309 0 CA-C-O 118.241 -0.885 . . . . 54.1 111.9 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 52.7 Cg_exo -57.94 -33.56 97.28 Favored 'Trans proline' 0 C--N 1.393 2.903 0 C-N-CA 122.122 1.882 . . . . 32.13 113.54 174.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -70.74 -28.45 64.72 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.832 0.453 . . . . 71.04 110.833 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.614 HD12 HH12 ' A' ' 111' ' ' ARG . 33.0 mm -74.75 -37.39 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.004 0.522 . . . . 74.31 109.833 173.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 82.4 mt -73.01 -25.18 60.88 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.894 0.877 . . . . 54.13 112.038 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . 0.411 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 71.7 t80 -58.23 -52.6 73.38 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 117.717 -1.135 . . . . 74.2 113.813 -174.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 52.9 Cg_exo -55.3 -34.4 88.39 Favored 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 121.917 1.745 . . . . 74.14 113.258 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -74.82 -45.55 42.56 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.492 0.717 . . . . 63.11 111.264 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.77 -35.05 75.45 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.872 0.869 . . . . 71.13 110.325 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -64.23 -49.72 70.85 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.408 1.483 . . . . 75.14 110.481 178.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -68.48 -34.21 75.53 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.127 0.571 . . . . 75.0 110.571 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.634 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 18.1 m -60.18 -53.61 55.67 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.973 0.509 . . . . 72.23 111.124 174.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.641 HG21 HG21 ' C' ' 64' ' ' VAL . 98.6 mt -58.98 -50.43 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 123.494 0.496 . . . . 74.02 110.02 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.3 m -50.17 -44.91 52.94 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 124.36 1.037 . . . . 71.4 111.415 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.3 t -66.32 -43.15 87.01 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.232 -0.895 . . . . 53.32 109.786 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.8 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.1 OUTLIER -60.28 -46.19 90.71 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.226 1.01 . . . . 53.11 111.664 178.018 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.517 HG23 ' O ' ' C' ' 114' ' ' ILE . 61.4 t -60.88 -43.31 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.723 0.809 . . . . 61.3 109.482 177.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 13.5 t -63.26 -39.12 93.7 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.038 -1.437 . . . . 62.43 111.993 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -71.61 -37.15 70.98 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.342 0.657 . . . . 54.22 109.883 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.2 -4.08 67.25 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.982 0.801 . . . . 60.05 112.608 172.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.407 HG21 ' O ' ' D' ' 16' ' ' ILE . 24.9 p 65.61 26.19 11.6 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.527 1.931 . . . . 74.1 113.288 170.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -83.04 150.05 60.53 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 108.539 -0.912 . . . . 75.35 108.539 171.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -47.33 138.75 17.42 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 123.342 2.695 . . . . 54.33 113.02 174.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -57.26 145.78 30.73 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.196 0.935 . . . . 73.02 113.514 -171.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.564 HD21 ' HZ ' ' C' ' 74' ' ' PHE . 3.4 pp -147.47 119.12 7.99 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.182 -0.917 . . . . 62.31 109.133 173.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -113.72 115.11 27.31 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.352 -1.351 . . . . 73.24 107.352 176.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.477 HD23 HD23 ' C' ' 42' ' ' LEU . 6.0 mp -61.22 134.15 56.69 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 124.156 0.91 . . . . 70.44 111.321 -170.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.39 146.77 96.05 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 123.513 0.725 . . . . 73.33 110.59 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.611 ' HG2' HG21 ' A' ' 13' ' ' ILE . 46.0 Cg_exo -55.93 104.1 0.13 Allowed 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.584 2.189 . . . . 62.21 112.295 174.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 52.7 t -99.08 113.65 34.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.157 -1.053 . . . . 55.24 108.157 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -75.66 103.32 5.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.954 0.501 . . . . 53.13 110.124 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -62.8 -28.13 69.78 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.441 0.696 . . . . 71.51 111.185 177.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.38 -43.13 86.74 Favored 'General case' 0 C--N 1.349 0.572 0 O-C-N 123.726 0.641 . . . . 54.04 109.769 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.53 -40.31 71.67 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.186 0.994 . . . . 63.42 111.051 175.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 49.8 mt -76.46 -35.0 58.7 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.116 -0.947 . . . . 74.15 111.158 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 42.2 t80 . . . . . 0 N--CA 1.478 0.941 0 C-N-CA 122.922 0.489 . . . . 72.52 111.428 -177.745 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 27.2 p . . . . . 0 N--CA 1.464 0.246 0 N-CA-C 109.501 -0.555 . . . . 73.44 109.501 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -142.78 104.44 4.35 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.434 -1.321 . . . . 71.5 107.434 174.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . 0.499 HE22 ' HB3' ' D' ' 85' ' ' SER . 0.4 OUTLIER -142.96 147.23 34.87 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.256 -0.646 . . . . 74.12 109.256 176.137 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mt -93.15 127.79 45.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.628 -1.249 . . . . 71.22 107.628 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . 0.628 ' HB2' HG23 ' D' ' 83' ' ' ILE . 34.5 mt-30 -90.51 -31.02 16.93 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 123.588 0.555 . . . . 73.35 110.041 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -167.57 131.05 1.72 Allowed 'General case' 0 C--N 1.347 0.487 0 CA-C-N 115.984 -0.553 . . . . 73.34 110.259 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.582 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.8 mp -103.57 140.69 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 106.662 -1.607 . . . . 71.45 106.662 171.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -165.01 141.08 5.58 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.46 0.573 . . . . 74.13 111.981 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.7 p -84.08 114.33 21.67 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.651 -0.704 . . . . 73.31 109.772 175.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.0 mtpt -83.81 -10.25 58.19 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.309 -0.859 . . . . 74.11 110.309 175.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.638 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 14.2 t70 -166.01 144.86 5.94 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.609 1.164 . . . . 43.14 108.907 176.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.8 HD13 ' HE3' ' C' ' 117' ' ' MET . 82.6 mt -139.81 145.56 26.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 125.267 1.427 . . . . 71.11 107.428 174.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -153.41 144.36 22.84 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 123.634 0.584 . . . . 73.23 110.522 176.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.402 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 73.7 t80 -153.4 129.43 10.32 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.063 -1.458 . . . . 71.51 107.063 171.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -140.61 119.16 12.3 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.325 0.65 . . . . 71.43 110.407 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.02 90.04 3.37 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 108.132 -1.062 . . . . 63.41 108.132 170.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.97 -42.71 2.96 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 123.582 2.855 . . . . 53.21 113.072 -171.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.417 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 67.6 m-20 -96.81 20.9 10.26 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.491 0.716 . . . . 65.33 110.708 -176.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.6 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -40.13 -66.66 0.34 Allowed Pre-proline 0 CA--C 1.576 1.964 0 N-CA-C 116.109 1.892 . . . . 55.23 116.109 -155.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.516 ' HB3' HD11 ' C' ' 83' ' ' ILE . 66.9 Cg_endo -74.35 -22.49 16.3 Favored 'Trans proline' 0 C--N 1.393 2.881 0 CA-C-N 123.686 2.352 . . . . 55.33 113.712 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -70.97 -37.95 72.76 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.836 0.854 . . . . 73.53 110.079 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.524 HG23 ' HG3' ' D' ' 71' ' ' GLU . 5.1 p -83.85 -19.78 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 122.615 0.366 . . . . 60.54 111.392 -173.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.41 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 23.3 m-30 -64.12 -18.58 64.55 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 112.411 0.523 . . . . 73.22 112.411 173.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -57.6 -26.26 61.26 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.713 0.805 . . . . 64.2 110.696 172.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.456 ' CB ' ' HB3' ' D' ' 68' ' ' LEU . 28.8 mmtp -85.74 99.43 11.33 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.728 1.211 . . . . 74.33 109.233 174.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -94.58 85.11 4.42 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 122.726 0.411 . . . . 71.43 110.336 -178.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 39.6 p90 -167.68 179.73 4.69 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.216 1.006 . . . . 73.23 109.824 169.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -68.79 118.34 59.82 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.248 0.619 . . . . 74.32 110.045 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.61 124.94 16.91 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.863 2.375 . . . . 74.43 111.89 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -63.31 108.72 1.37 Allowed 'General case' 0 C--N 1.353 0.759 0 N-CA-C 109.285 -0.635 . . . . 75.03 109.285 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.703 HG13 HG13 ' D' ' 64' ' ' VAL . 73.4 t -100.07 131.56 47.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.258 -0.883 . . . . 61.12 108.878 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.07 149.13 31.23 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 107.815 -1.18 . . . . 43.13 107.815 169.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.453 HD11 HG13 ' D' ' 62' ' ' VAL . 37.1 tp -116.19 136.23 53.2 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 116.037 -0.529 . . . . 74.34 110.212 -177.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.56 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 0.6 OUTLIER -126.92 132.23 50.93 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 107.382 -1.34 . . . . 74.43 107.382 172.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.458 ' CD2' HG22 ' D' ' 62' ' ' VAL . 89.5 mt -125.18 130.81 52.89 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.093 0.473 . . . . 72.42 110.084 178.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -134.53 120.15 19.33 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.209 -1.404 . . . . 73.22 107.209 177.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . 0.406 HG21 ' HG3' ' D' ' 103' ' ' PRO . 56.7 m -105.56 148.51 27.2 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.365 0.602 . . . . 63.13 110.266 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.27 -179.11 6.93 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.668 1.187 . . . . 73.53 108.721 173.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 25.8 p . . . . . 0 C--N 1.317 -0.824 0 N-CA-C 107.112 -1.44 . . . . 71.14 107.112 174.337 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . 0.598 ' N ' ' HH ' ' D' ' 56' ' ' TYR . 6.1 m-20 . . . . . 0 N--CA 1.486 1.358 0 N-CA-C 114.372 1.249 . . . . 72.34 114.372 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 72.8 t -135.13 98.12 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 108.306 -0.998 . . . . 62.12 108.306 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.598 ' HH ' ' N ' ' D' ' 54' ' ' ASP . 4.4 m-85 -138.08 131.2 30.2 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.221 -0.659 . . . . 63.14 109.221 -174.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.48 118.51 36.91 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.026 -1.101 . . . . 65.33 108.026 170.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.405 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 85.7 t -101.9 141.29 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.771 0.828 . . . . 52.45 109.33 -177.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 15.3 t -121.63 131.45 73.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 124.2 1.0 . . . . 71.35 108.747 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.403 HD21 HD22 ' D' ' 44' ' ' LEU . 0.2 OUTLIER -106.19 122.94 47.22 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 107.244 -1.391 . . . . 74.52 107.244 176.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.499 ' HG2' ' HG2' ' D' ' 79' ' ' GLN . 0.0 OUTLIER -101.69 95.6 6.54 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 106.732 -1.581 . . . . 64.52 106.732 177.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.458 HG22 ' CD2' ' D' ' 44' ' ' LEU . 84.0 t -90.73 134.52 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 108.764 -0.828 . . . . 64.15 108.764 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.56 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 89.9 m -124.19 132.91 53.65 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 124.393 1.058 . . . . 73.42 109.246 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.703 HG13 HG13 ' D' ' 40' ' ' VAL . 73.5 t -127.31 130.3 70.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 124.671 1.188 . . . . 71.3 108.09 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 30.7 m -130.0 103.52 6.82 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.099 -1.074 . . . . 70.23 108.099 171.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.679 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -97.29 141.73 30.03 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.353 -0.84 . . . . 64.14 109.088 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.441 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 40.6 p -145.6 139.84 26.95 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.847 -0.615 . . . . 64.04 110.707 -172.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.456 ' HB3' ' CB ' ' D' ' 34' ' ' LYS . 31.7 mt -116.69 106.1 13.14 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.537 1.135 . . . . 61.21 108.832 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.4 -113.89 3.97 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 111.429 -0.668 . . . . 40.4 111.429 -173.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -121.06 23.2 10.73 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.531 0.732 . . . . 60.42 110.169 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . 0.524 ' HG3' HG23 ' D' ' 31' ' ' VAL . 12.9 pt-20 -134.74 158.1 45.01 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 121.698 -0.626 . . . . 61.32 110.416 175.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 40.5 m -75.41 124.29 26.88 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.236 -0.893 . . . . 75.02 111.89 -175.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.491 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -75.32 -69.96 0.45 Allowed 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.117 -1.068 . . . . 63.02 108.117 171.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -148.08 169.22 20.45 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.222 -0.899 . . . . 73.1 110.528 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 58.3 mt -130.38 151.18 51.15 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.103 -1.814 . . . . 52.41 106.103 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.661 ' SG ' HG12 ' D' ' 114' ' ' ILE . 12.0 t -159.17 128.22 5.35 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.561 -0.533 . . . . 71.33 109.561 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -150.7 121.44 7.53 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.611 0.244 . . . . 70.31 110.545 -171.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 93.7 t -131.6 126.87 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.696 0.798 . . . . 74.31 109.918 -171.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.638 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 44.3 mt-30 -91.6 89.02 6.98 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.679 -0.86 . . . . 72.41 108.679 166.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -87.34 98.14 11.19 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.357 -0.838 . . . . 64.23 109.359 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.07 165.0 23.92 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.797 -0.638 . . . . 74.13 112.69 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.67 137.57 4.72 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 111.642 -0.583 . . . . 42.31 111.642 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.628 HG23 ' HB2' ' D' ' 14' ' ' GLN . 8.4 tp -90.66 118.32 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 CA-C-O 121.568 0.699 . . . . 74.33 109.969 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.405 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 64.7 m-85 -112.99 138.91 49.15 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.624 1.17 . . . . 64.31 109.893 -178.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.499 ' HB3' HE22 ' D' ' 12' ' ' GLN . 23.7 t -115.49 104.36 11.67 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.639 -1.245 . . . . 42.43 107.639 169.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 50.2 pt -119.2 138.62 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.406 0.283 . . . . 62.41 110.466 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.89 169.01 22.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.432 1.093 . . . . 72.43 110.243 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.63 -13.68 66.76 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 114.519 0.568 . . . . 65.04 114.519 171.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.458 HD13 ' HG2' ' D' ' 94' ' ' MET . 0.8 OUTLIER -107.74 153.79 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.424 0.69 . . . . 73.0 110.781 -179.347 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -134.52 170.34 15.91 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.682 1.193 . . . . 65.14 109.818 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.34 -141.49 28.93 Favored Glycine 0 N--CA 1.472 1.074 0 O-C-N 123.271 0.357 . . . . 63.52 113.901 174.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 36.4 p -80.77 -43.81 19.57 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.355 0.662 . . . . 71.03 110.779 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -56.93 -26.95 60.44 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.196 0.998 . . . . 65.4 112.3 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.458 ' HG2' HD13 ' D' ' 89' ' ' ILE . 10.6 tmm? -59.15 -60.93 3.08 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 124.79 1.236 . . . . 74.42 112.103 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.91 -15.7 55.57 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.911 0.484 . . . . 64.33 111.345 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -66.35 -41.58 89.33 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.78 0.832 . . . . 74.25 109.851 175.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 73.0 m -60.65 -29.58 69.36 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.165 0.586 . . . . 43.55 111.406 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.594 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 18.5 tp -82.7 -43.26 17.07 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.06 0.544 . . . . 72.12 110.948 178.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.88 -21.83 73.29 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-N 115.682 -0.69 . . . . 74.2 113.661 -174.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -122.44 -56.55 1.79 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.241 0.616 . . . . 62.43 111.531 -174.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . 0.42 ' O ' HG12 ' D' ' 105' ' ' ILE . 31.6 t80 -73.28 -31.9 64.33 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 112.001 0.371 . . . . 74.3 112.001 -172.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.594 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 84.4 m -65.82 -49.89 56.79 Favored Pre-proline 0 CA--C 1.566 1.588 0 CA-C-O 118.309 -0.853 . . . . 74.22 112.334 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.406 ' HG3' HG21 ' D' ' 46' ' ' THR . 33.4 Cg_endo -65.13 -23.83 59.98 Favored 'Trans proline' 0 C--N 1.389 2.683 0 C-N-CA 121.753 1.635 . . . . 65.55 113.259 171.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.34 -36.28 83.62 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.694 -0.484 . . . . 72.33 109.694 174.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.42 HG12 ' O ' ' D' ' 101' ' ' TYR . 28.8 mm -70.13 -40.47 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.743 1.217 . . . . 74.24 111.012 175.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 55.4 mt -70.17 -20.36 63.14 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 116.017 -0.538 . . . . 63.33 111.617 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -68.84 -43.95 29.04 Favored Pre-proline 0 CA--C 1.56 1.334 0 N-CA-C 113.997 1.11 . . . . 75.34 113.997 -173.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' D' ' 105' ' ' ILE . 71.4 Cg_exo -45.93 -43.0 20.21 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 122.53 2.153 . . . . 62.34 113.732 168.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -80.53 -29.85 37.17 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.683 0.793 . . . . 74.51 112.206 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.93 -49.87 64.14 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.586 0.708 . . . . 74.45 109.397 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.541 HH12 ' HB3' ' D' ' 130' ' ' PRO . 34.4 ttp180 -63.0 -34.73 78.19 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 113.843 -1.526 . . . . 74.4 110.756 174.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . 0.482 ' HA ' ' CE2' ' B' ' 109' ' ' TYR . 9.5 tt0 -55.14 -54.2 46.25 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.625 0.77 . . . . 55.3 111.351 177.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.0 t -59.28 -46.24 89.06 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.726 -1.125 . . . . 75.03 110.508 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.661 HG12 ' SG ' ' D' ' 76' ' ' CYS . 74.9 mt -60.95 -56.5 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.411 1.084 . . . . 75.54 111.785 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 95.5 m -55.02 -40.95 70.75 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.823 1.249 . . . . 54.4 111.693 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 42.7 t -69.53 -27.95 65.61 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.435 -0.802 . . . . 33.34 111.327 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.602 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 76.8 mtm -84.33 -30.12 25.77 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.174 0.59 . . . . 73.22 111.873 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.421 HG23 ' O ' ' D' ' 114' ' ' ILE . 61.0 t -66.33 -39.38 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.725 0.81 . . . . 72.44 110.656 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.7 p -66.62 -27.29 67.58 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 115.652 -0.704 . . . . 72.43 110.678 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.634 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 64.3 mtt-85 -80.61 -16.25 54.56 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.775 0.83 . . . . 74.54 111.582 177.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.3 4.71 74.15 Favored Glycine 0 C--N 1.352 1.468 0 CA-C-O 119.621 -0.544 . . . . 54.21 113.156 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.555 HG23 ' HB3' ' C' ' 17' ' ' TYR . 81.0 p 56.17 27.67 11.95 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.874 1.669 . . . . 71.14 113.003 -174.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -95.08 149.62 36.5 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 123.121 0.568 . . . . 64.35 109.533 172.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -50.4 146.96 17.69 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 123.174 2.583 . . . . 70.43 113.966 171.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 41.2 tp60 -47.64 124.18 6.8 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.28 1.832 . . . . 73.43 112.911 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.561 HD13 HG21 ' D' ' 40' ' ' VAL . 13.0 tp -107.24 117.72 34.81 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.535 -0.913 . . . . 74.31 108.535 175.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -121.12 100.09 6.86 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.62 -1.252 . . . . 70.21 107.62 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.405 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 90.1 mt -65.21 120.09 12.08 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 109.411 -0.588 . . . . 72.43 109.411 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.87 122.96 69.49 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 122.839 0.455 . . . . 72.3 110.599 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.541 ' HB3' HH12 ' D' ' 111' ' ' ARG . 60.1 Cg_endo -71.42 114.31 3.89 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.395 2.063 . . . . 70.44 111.44 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 12.3 p -108.43 150.08 11.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 123.461 0.704 . . . . 73.0 109.276 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -79.03 109.53 13.43 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.116 -0.698 . . . . 73.03 109.116 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 . . . . . 0 N--CA 1.483 1.208 0 C-N-CA 123.725 0.81 . . . . 75.41 110.904 179.111 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 76.2 m . . . . . 0 C--O 1.239 0.552 0 N-CA-C 107.611 -1.255 . . . . 71.43 107.611 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -100.27 116.29 31.91 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.881 -1.155 . . . . 64.01 107.881 174.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.5 tp60 -133.99 132.91 40.68 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.541 -0.911 . . . . 74.22 108.541 174.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.2 mt -91.17 119.84 39.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.233 -1.025 . . . . 75.3 108.233 175.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.54 -41.73 21.2 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.044 -0.725 . . . . 74.22 109.044 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -170.38 131.43 0.95 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.885 0.474 . . . . 72.03 110.049 -169.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.4 mt -117.46 131.22 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 108.492 -0.929 . . . . 64.2 108.492 173.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.452 ' HE1' HG13 ' A' ' 83' ' ' ILE . 27.2 p90 -161.78 177.85 9.51 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 123.952 0.783 . . . . 72.15 111.52 -173.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.6 p -107.09 126.29 52.17 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.438 -0.579 . . . . 63.44 109.438 173.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.448 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 44.4 mtpt -86.14 -33.44 20.87 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.623 -0.51 . . . . 74.03 109.623 175.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -148.15 142.95 26.75 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.632 -1.167 . . . . 61.02 109.874 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.458 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 81.7 mt -142.02 142.3 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.821 1.249 . . . . 53.4 108.23 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -149.42 121.5 8.29 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.03 0.532 . . . . 64.25 109.797 173.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.594 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 86.0 t80 -116.37 141.94 47.5 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.315 -1.365 . . . . 72.01 107.315 168.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 26.9 mt-10 -136.39 143.14 43.84 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.998 0.519 . . . . 74.25 109.834 175.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.17 75.74 10.53 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 107.427 -1.323 . . . . 73.45 107.427 170.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.83 -33.01 44.86 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.767 2.311 . . . . 71.05 112.267 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -100.86 15.5 28.26 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 114.682 -1.145 . . . . 71.32 110.171 -176.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.59 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -41.18 -56.19 4.45 Favored Pre-proline 0 N--CA 1.496 1.859 0 CA-C-O 117.698 -1.144 . . . . 53.03 113.477 -170.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -61.78 -32.43 85.99 Favored 'Trans proline' 0 C--N 1.391 2.783 0 CA-C-N 121.524 1.58 . . . . 74.03 112.788 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -75.96 -46.02 31.88 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.126 -0.943 . . . . 71.15 111.096 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.836 HG21 ' HA ' ' A' ' 73' ' ' ALA . 10.0 p -76.77 -14.8 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 124.111 0.964 . . . . 74.54 112.771 -160.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -69.02 -20.09 64.13 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.842 0.457 . . . . 55.4 111.439 171.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -82.81 -22.43 34.18 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.494 1.117 . . . . 75.52 111.016 174.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 71' ' ' GLU . 24.8 mmmt -67.1 154.61 40.81 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.235 1.014 . . . . 71.1 112.172 -178.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -74.92 125.55 29.1 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.286 -0.87 . . . . 72.04 109.259 173.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -77.71 88.33 3.97 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.605 0.717 . . . . 71.11 110.604 -174.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -117.14 83.51 15.51 Favored Pre-proline 0 N--CA 1.472 0.672 0 N-CA-C 106.313 -1.736 . . . . 64.12 106.313 170.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.8 93.85 0.87 Allowed 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 121.678 1.586 . . . . 71.52 111.151 -175.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -93.68 83.87 4.53 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 105.751 -1.944 . . . . 72.21 105.751 175.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 66' ' ' ALA . 42.7 t -91.68 117.84 35.82 Favored 'Isoleucine or valine' 0 C--N 1.342 0.279 0 CA-C-N 113.573 -1.649 . . . . 61.33 110.456 -168.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.601 ' HE2' ' HB2' ' A' ' 43' ' ' ASP . 85.6 tttt -79.28 121.59 25.28 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.932 -0.766 . . . . 43.21 108.932 169.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.0 mt -101.38 106.54 17.71 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.267 -1.012 . . . . 74.33 108.267 169.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.601 ' HB2' ' HE2' ' A' ' 41' ' ' LYS . 16.5 t70 -106.1 136.8 45.15 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.167 -1.42 . . . . 74.44 107.167 175.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.587 HD22 HD21 ' A' ' 60' ' ' LEU . 87.1 mt -130.56 134.3 46.91 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.22 0.533 . . . . 64.45 110.784 -174.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 21.3 t70 -134.48 146.78 50.08 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.63 1.172 . . . . 74.44 108.331 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.8 m -136.47 127.29 27.42 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.991 0.516 . . . . 53.11 109.633 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.62 110.53 9.95 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.555 0.742 . . . . 54.44 109.987 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 61.4 p -102.17 153.98 19.44 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.773 0.429 . . . . 74.43 110.747 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.3 t -150.78 125.13 9.47 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.65 0.78 . . . . 51.02 109.044 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -72.24 105.96 4.24 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.712 -0.477 . . . . 64.22 109.712 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.632 HD11 ' HB2' ' A' ' 57' ' ' GLU . 76.3 mt -78.83 -38.49 37.9 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.051 0.54 . . . . 65.33 109.902 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.65 176.21 11.99 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.455 1.102 . . . . 54.34 109.253 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -68.13 123.19 19.99 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 108.667 -0.864 . . . . 75.14 108.667 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 66.54 20.09 10.84 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.466 1.106 . . . . 71.44 111.793 -174.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.2 t -132.17 105.19 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 107.734 -1.21 . . . . 72.35 107.734 172.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -123.15 126.4 46.94 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.716 -0.846 . . . . 71.11 108.716 -177.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.632 ' HB2' HD11 ' A' ' 51' ' ' LEU . 33.9 tt0 -84.7 149.34 25.86 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.014 -0.736 . . . . 71.25 109.014 171.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.516 HG11 ' HD3' ' A' ' 103' ' ' PRO . 73.8 t -131.48 138.68 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 C-N-CA 124.364 1.066 . . . . 74.1 108.19 169.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.41 135.74 57.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.806 -0.812 . . . . 54.25 108.806 174.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.587 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -110.19 99.35 8.43 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 106.796 -1.557 . . . . 74.34 106.796 172.037 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.473 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 30.4 ttp180 -87.11 100.56 12.74 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.086 -1.079 . . . . 62.52 108.086 173.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 32.0 t -95.29 134.56 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 108.222 -1.029 . . . . 61.14 108.222 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.548 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 9.4 m -121.89 125.14 45.75 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.078 -0.712 . . . . 65.25 109.078 174.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.477 ' O ' HD12 ' A' ' 75' ' ' LEU . 70.4 t -121.81 120.02 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 124.456 1.103 . . . . 50.44 109.156 -174.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.6 m -128.54 116.6 19.91 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.406 0.548 . . . . 71.22 109.867 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.444 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -102.94 113.07 26.22 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 107.838 -1.171 . . . . 65.1 107.838 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 46.3 m -108.89 128.52 54.99 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.21 0.604 . . . . 72.32 110.012 177.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.432 HD11 ' HB2' ' A' ' 73' ' ' ALA . 19.6 mt -95.84 77.76 3.22 Favored 'General case' 0 C--O 1.247 0.961 0 C-N-CA 124.365 1.066 . . . . 22.5 108.566 -178.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.99 -85.69 0.89 Allowed Glycine 0 C--N 1.344 0.998 0 CA-C-N 115.376 -0.829 . . . . 62.21 111.764 -174.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -112.62 -30.92 6.93 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.844 0.857 . . . . 70.53 110.354 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.474 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 7.6 tp10 -101.98 119.07 38.19 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.858 0.463 . . . . 62.21 110.26 -170.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 88.2 m -70.99 135.59 47.93 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 122.809 0.443 . . . . 43.33 111.176 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.836 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -77.06 -64.42 1.14 Allowed 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.333 1.053 . . . . 50.31 110.135 175.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -151.08 170.39 19.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.751 0.786 . . . . 63.44 112.786 -177.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 64' ' ' VAL . 62.5 tp -123.92 144.94 49.48 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 113.809 -1.541 . . . . 71.13 107.911 169.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.44 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.1 m -146.44 102.5 3.59 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.722 0.809 . . . . 72.34 109.268 176.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 37.4 tt0 -119.5 116.31 25.83 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.311 0.644 . . . . 72.52 109.276 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 113' ' ' CYS . 39.4 t -127.31 113.68 33.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.221 1.008 . . . . 41.14 109.629 -174.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -85.27 87.24 7.36 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.539 -0.912 . . . . 74.22 108.539 171.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -76.44 92.8 3.43 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.453 -0.794 . . . . 74.35 109.173 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.74 146.13 19.79 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-N 115.703 -0.681 . . . . 74.23 111.467 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.27 122.67 1.68 Allowed Glycine 0 CA--C 1.503 -0.708 0 N-CA-C 110.258 -1.137 . . . . 61.45 110.258 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.492 HG23 HD12 ' A' ' 51' ' ' LEU . 49.0 mt -81.81 129.23 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.578 -1.267 . . . . 70.22 107.578 172.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.638 ' HB3' HD11 ' A' ' 86' ' ' ILE . 92.9 m-85 -130.46 134.5 47.14 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.326 -0.99 . . . . 71.1 108.326 -176.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.3 t -98.31 99.9 11.14 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.928 -1.138 . . . . 52.15 107.928 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.638 HD11 ' HB3' ' A' ' 84' ' ' PHE . 20.0 mm -120.35 129.86 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.235 0.614 . . . . 75.23 110.632 -169.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.41 173.26 12.44 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.964 0.905 . . . . 64.31 110.567 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.56 -32.1 7.12 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 116.309 -0.405 . . . . 63.12 112.925 175.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -122.39 159.98 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.942 0.897 . . . . 71.54 110.447 -176.056 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.464 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 19.7 tt0 -150.24 -179.29 7.07 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 108.886 -0.783 . . . . 63.21 108.886 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.464 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 59.3 -125.77 40.47 Favored Glycine 0 C--N 1.348 1.2 0 N-CA-C 114.547 0.579 . . . . 74.32 114.547 176.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.2 t -70.58 -27.14 63.89 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.116 0.566 . . . . 54.21 111.503 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -73.05 -36.14 66.84 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.96 0.904 . . . . 75.35 110.002 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.4 tpt -65.43 -46.42 80.0 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-N 115.381 -0.827 . . . . 73.05 109.628 175.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.4 -34.71 75.81 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.447 -0.797 . . . . 75.34 111.357 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.441 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 39.5 t-80 -71.92 -32.97 67.89 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.462 0.705 . . . . 61.12 111.426 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -71.64 -44.8 63.7 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.019 0.438 . . . . 73.25 109.854 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 76.2 mt -80.73 -32.37 35.73 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.496 -0.775 . . . . 73.3 112.193 -173.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.42 3.49 59.65 Favored Glycine 0 N--CA 1.469 0.856 0 CA-C-O 119.591 -0.56 . . . . 44.12 113.736 -174.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.676 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.16 -62.61 0.26 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.664 0.616 . . . . 64.22 112.664 -174.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -68.05 -44.59 76.04 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 120.827 0.346 . . . . 65.55 111.572 -172.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 99.3 m -69.13 -47.38 29.15 Favored Pre-proline 0 CA--C 1.563 1.457 0 C-N-CA 124.086 0.954 . . . . 55.15 112.936 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.516 ' HD3' HG11 ' A' ' 58' ' ' VAL . 44.8 Cg_endo -66.89 -19.24 52.66 Favored 'Trans proline' 0 C--N 1.395 3.025 0 CA-C-N 121.694 1.641 . . . . 34.13 112.755 173.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -70.86 -38.18 73.13 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.021 0.528 . . . . 73.41 109.951 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 38.7 mm -64.22 -42.91 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.896 0.879 . . . . 72.23 110.155 171.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.408 ' HB2' ' HA ' ' A' ' 103' ' ' PRO . 49.5 mt -73.92 -22.73 59.57 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.325 -0.852 . . . . 74.34 112.289 -174.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -61.57 -46.64 93.97 Favored Pre-proline 0 N--CA 1.486 1.33 0 N-CA-C 114.416 1.265 . . . . 74.13 114.416 -172.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -52.89 -35.84 72.18 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 121.784 1.656 . . . . 74.31 113.045 172.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -79.88 -36.94 35.84 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.946 0.898 . . . . 60.11 111.877 -177.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.76 -49.6 65.42 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 109.161 -0.681 . . . . 53.34 109.161 176.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.4 HH12 HD12 ' C' ' 105' ' ' ILE . 32.5 ttm180 -50.17 -45.92 53.75 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.905 1.378 . . . . 72.32 110.218 173.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -62.94 -52.21 63.91 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.836 0.71 . . . . 54.0 111.504 -177.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.498 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 52.6 t -59.43 -34.78 72.91 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.827 0.704 . . . . 73.32 111.588 -178.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.572 HD13 HD11 ' A' ' 128' ' ' LEU . 24.4 mt -66.7 -59.27 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.691 0.796 . . . . 72.22 109.952 173.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 94.6 m -53.51 -37.65 62.98 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.829 1.252 . . . . 74.13 111.696 -174.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.2 t -69.62 -42.63 74.09 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 114.232 -1.349 . . . . 60.21 109.889 -178.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.594 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 35.3 mtm -65.69 -35.57 81.14 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.492 0.317 . . . . 63.05 110.998 176.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 114' ' ' ILE . 85.5 t -58.82 -49.42 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.892 0.877 . . . . 72.31 109.536 175.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.5 p -76.93 -27.97 55.07 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.644 -0.707 . . . . 71.23 111.725 -175.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -73.77 -28.96 61.93 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.48 0.712 . . . . 45.43 109.46 174.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.461 ' O ' HG22 ' A' ' 122' ' ' THR . . . -86.29 12.25 61.07 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.956 0.785 . . . . 73.41 112.557 171.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.3 t 63.2 11.5 5.37 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 127.127 2.171 . . . . 72.23 114.23 173.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -77.35 148.25 77.14 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 109.492 -0.559 . . . . 64.32 109.492 176.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.9 128.1 27.42 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.788 2.326 . . . . 74.14 111.93 175.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -46.85 125.43 7.36 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.804 1.315 . . . . 63.33 112.404 -171.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 61.0 tp -106.77 137.33 45.0 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.625 -0.88 . . . . 70.45 108.625 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.41 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 90.9 m-20 -129.7 113.95 15.39 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.802 -1.185 . . . . 72.13 107.802 -178.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.572 HD11 HD13 ' A' ' 114' ' ' ILE . 7.4 mt -70.57 133.08 46.41 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.951 -0.759 . . . . 74.35 108.951 -176.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.55 136.66 94.59 Favored Pre-proline 0 CA--C 1.552 1.049 0 CA-C-O 118.997 -0.525 . . . . 43.31 111.047 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -55.72 109.88 0.48 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.272 2.648 . . . . 72.31 113.558 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.488 HG21 HD11 ' A' ' 44' ' ' LEU . 58.9 t -98.43 133.05 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.07 0.462 . . . . 74.55 110.215 -175.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -92.15 80.04 5.09 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.597 -1.183 . . . . 75.34 109.049 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -57.35 -35.52 70.02 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.179 0.992 . . . . 74.25 111.615 175.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.676 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 24.1 t70 -54.29 -47.78 72.01 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 124.373 1.046 . . . . 74.54 111.095 175.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.41 -42.02 83.94 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.953 0.783 . . . . 72.03 111.083 176.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 92.5 mt -54.48 -41.28 69.34 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.067 0.547 . . . . 74.13 111.224 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 33.6 t80 . . . . . 0 CA--C 1.541 0.624 0 CA-C-N 115.591 -0.731 . . . . 74.41 110.253 176.527 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 18.7 ptm . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 114.776 1.398 . . . . 75.13 114.776 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 5.2 t -135.08 130.09 35.01 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 106.627 -1.62 . . . . 63.1 106.627 167.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.47 ' HD1' HG22 ' B' ' 86' ' ' ILE . 87.9 t80 -135.02 145.44 48.05 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.141 0.576 . . . . 71.34 110.016 -171.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -151.13 140.04 20.95 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.021 0.929 . . . . 74.41 109.121 171.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 49.8 mt -87.78 127.21 41.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.077 -1.083 . . . . 65.43 108.077 170.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -84.03 -49.21 9.14 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 109.187 -0.672 . . . . 65.23 109.187 176.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.401 ' HE ' ' CG2' ' A' ' 122' ' ' THR . 48.4 ttt180 -170.31 134.54 1.19 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.314 -0.857 . . . . 72.13 110.231 -172.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.446 HD12 HD22 ' D' ' 127' ' ' ASN . 91.4 mt -114.82 137.62 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 107.673 -1.232 . . . . 73.55 107.673 175.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -161.96 142.09 10.21 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.097 0.475 . . . . 65.2 111.537 -172.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.605 HG21 HD11 ' B' ' 21' ' ' ILE . 18.9 m -77.65 126.62 31.16 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 108.57 -0.9 . . . . 55.31 108.57 171.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.59 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 42.3 mtpt -99.57 -18.35 17.41 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.969 0.907 . . . . 73.33 111.798 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -161.31 138.73 8.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.9 0.48 . . . . 73.11 110.82 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.605 HD11 HG21 ' B' ' 18' ' ' THR . 47.0 mm -126.97 143.23 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.399 1.08 . . . . 43.23 108.331 168.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 27.9 t -144.79 119.81 10.03 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.227 -1.027 . . . . 63.24 108.227 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.458 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 82.9 t80 -132.1 116.46 17.06 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.808 -1.182 . . . . 72.23 107.808 173.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -123.01 113.89 19.67 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.87 0.868 . . . . 73.32 109.124 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -107.55 87.21 3.27 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 106.82 -1.548 . . . . 64.43 106.82 166.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.73 -26.41 45.56 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 122.559 2.173 . . . . 64.33 111.778 -173.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.446 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 72.2 m-20 -110.13 10.57 23.91 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 118.048 -0.977 . . . . 72.34 110.901 -177.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.473 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -33.71 -64.28 0.28 Allowed Pre-proline 0 N--CA 1.502 2.13 0 C-N-CA 124.955 1.302 . . . . 74.3 114.07 -171.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 11.9 Cg_exo -64.5 -29.75 61.8 Favored 'Trans proline' 0 C--N 1.396 3.041 0 C-N-CA 122.27 1.98 . . . . 74.34 112.889 -171.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -95.14 -26.49 15.99 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.848 0.859 . . . . 73.03 111.993 -171.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.487 HG21 ' HA ' ' B' ' 73' ' ' ALA . 4.8 p -82.43 -14.57 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 C-N-CA 122.678 0.391 . . . . 71.13 110.756 -176.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -68.39 -9.88 51.28 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 113.378 0.881 . . . . 65.52 113.378 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -71.37 -13.0 61.72 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 122.907 0.483 . . . . 75.3 110.8 173.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.427 ' HB2' HD13 ' B' ' 68' ' ' LEU . 89.3 mttt -103.21 81.57 1.97 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.597 1.159 . . . . 74.42 109.582 -175.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -88.48 74.86 8.48 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.453 -0.794 . . . . 62.35 110.077 -176.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -153.17 179.1 9.03 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.819 -0.628 . . . . 73.34 109.66 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.06 110.15 6.69 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.057 0.943 . . . . 74.11 109.283 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -71.54 145.97 48.5 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 121.956 1.771 . . . . 75.32 111.274 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 9.8 tp10 -64.56 102.09 0.52 Allowed 'General case' 0 C--N 1.343 0.321 0 N-CA-C 108.068 -1.086 . . . . 60.33 108.068 173.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.678 HG11 HD11 ' B' ' 126' ' ' LEU . 23.4 t -98.6 154.49 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 108.771 -0.826 . . . . 73.14 108.771 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -145.11 130.07 18.33 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.447 -0.946 . . . . 71.11 108.447 170.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.534 HD11 ' CG1' ' B' ' 62' ' ' VAL . 14.8 tp -86.21 138.21 32.05 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.491 -0.929 . . . . 63.34 108.491 170.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -137.0 117.02 13.29 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.933 -1.136 . . . . 64.35 107.933 -177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 4.4 mp -99.91 128.06 46.03 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.464 -0.939 . . . . 75.12 108.464 -171.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -132.17 143.87 50.27 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.325 -0.62 . . . . 73.31 109.325 175.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 18.5 p -128.91 125.86 38.46 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.472 0.709 . . . . 71.13 109.979 -174.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.415 ' O ' ' HB ' ' B' ' 59' ' ' VAL . . . -147.41 125.99 12.5 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 107.72 -1.215 . . . . 73.34 107.72 175.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 35.8 m -130.18 -179.01 4.99 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.085 0.554 . . . . 75.53 110.498 -176.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.8 p -152.17 135.64 16.05 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.916 -0.772 . . . . 72.2 108.916 172.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -91.83 119.14 31.36 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.286 -1.005 . . . . 71.5 108.286 170.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 pp -130.56 16.61 5.37 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.094 0.958 . . . . 53.44 110.077 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.19 157.8 36.51 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 123.583 0.753 . . . . 72.42 110.388 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -89.24 136.35 33.07 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 107.755 -1.202 . . . . 71.53 107.755 163.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 71.97 4.35 4.99 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.793 1.237 . . . . 73.14 111.852 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.625 HG22 ' HA ' ' B' ' 85' ' ' SER . 25.6 t -146.53 129.05 8.24 Favored 'Isoleucine or valine' 0 C--N 1.355 0.838 0 C-N-CA 124.08 0.952 . . . . 74.44 109.691 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.468 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 0.4 OUTLIER -113.53 163.53 14.8 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 108.713 -0.847 . . . . 74.41 108.713 166.38 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -119.92 107.23 12.87 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.287 -1.375 . . . . 61.3 107.287 177.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 65.8 t -100.42 125.21 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.714 0.805 . . . . 24.31 110.145 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.494 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.2 t -107.52 112.16 38.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 108.723 -0.843 . . . . 71.24 108.723 174.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 62.0 tp -93.92 112.58 24.45 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.633 -0.506 . . . . 71.5 109.633 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -95.76 106.06 18.14 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.482 0.713 . . . . 74.24 109.275 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.534 ' CG1' HD11 ' B' ' 42' ' ' LEU . 45.0 t -105.81 111.16 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 108.399 -0.963 . . . . 60.34 108.399 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 21.0 m -108.45 135.68 49.33 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.879 0.871 . . . . 71.51 109.965 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.739 HG11 HD21 ' B' ' 126' ' ' LEU . 44.4 t -129.36 115.69 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.945 1.298 . . . . 75.05 109.592 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 64.2 m -103.3 138.94 39.4 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.805 -0.813 . . . . 72.12 108.805 171.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -145.61 143.19 29.72 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.995 0.518 . . . . 64.32 109.776 176.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.549 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 67.4 p -141.5 131.81 25.07 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.546 -0.752 . . . . 71.33 110.913 -175.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.427 HD13 ' HB2' ' B' ' 34' ' ' LYS . 61.7 mt -100.49 111.55 23.82 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.556 1.142 . . . . 72.43 108.522 174.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.01 -128.63 11.06 Favored Glycine 0 C--N 1.342 0.887 0 O-C-N 123.436 0.46 . . . . 44.51 112.634 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -90.5 2.51 55.66 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.95 0.9 . . . . 73.25 112.207 -176.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.446 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 12.6 pt-20 -137.84 157.25 46.81 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.768 0.427 . . . . 74.2 111.565 -169.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.5 m -69.1 128.43 36.63 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.435 -0.802 . . . . 61.43 110.938 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.549 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -79.96 -64.02 1.28 Allowed 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.565 -1.272 . . . . 74.41 107.565 174.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -150.52 158.48 44.2 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 114.83 -1.077 . . . . 74.32 111.687 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 95.8 mt -125.27 113.34 17.48 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 106.333 -1.729 . . . . 61.41 106.333 172.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 27.0 t -118.28 146.35 44.37 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.915 -1.143 . . . . 40.23 107.915 175.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -161.62 126.76 3.53 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.254 -1.017 . . . . 62.45 108.254 -176.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.2 t -124.54 148.29 28.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.007 0.923 . . . . 54.43 108.729 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -121.95 96.82 5.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.226 -1.027 . . . . 74.23 108.226 169.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.429 ' HG3' HD22 ' B' ' 106' ' ' LEU . 7.9 tp-100 -89.19 101.34 14.0 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.992 -0.744 . . . . 74.25 108.992 177.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.29 170.75 37.68 Favored Glycine 0 C--N 1.339 0.698 0 O-C-N 123.523 0.514 . . . . 72.42 112.017 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.99 132.76 2.5 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.512 -0.375 . . . . 64.53 112.659 -176.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 79.4 mt -91.26 111.11 23.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 108.001 -1.111 . . . . 62.32 108.001 173.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -113.34 133.8 54.95 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.104 0.562 . . . . 72.51 109.933 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.625 ' HA ' HG22 ' B' ' 55' ' ' VAL . 66.9 m -95.56 122.06 37.92 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.015 0.926 . . . . 70.25 109.319 175.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.47 HG22 ' HD1' ' B' ' 11' ' ' PHE . 0.2 OUTLIER -138.36 134.32 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.991 0.917 . . . . 74.54 110.599 -173.377 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.93 171.08 20.69 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.534 1.134 . . . . 64.32 108.191 169.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.9 -43.14 3.06 Favored Glycine 0 N--CA 1.469 0.878 0 N-CA-C 111.991 -0.444 . . . . 42.1 111.991 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.628 ' HB ' ' HA ' ' B' ' 94' ' ' MET . 9.4 pt -58.34 143.46 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.42 0.688 . . . . 73.32 110.802 171.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -161.26 152.68 18.97 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 123.858 0.724 . . . . 73.14 110.813 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.65 -133.88 13.3 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.625 -0.716 . . . . 75.5 111.854 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 2.8 m -67.15 -44.03 80.82 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.666 0.787 . . . . 65.41 110.326 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -67.3 -18.93 65.38 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.048 -1.433 . . . . 74.15 111.757 -168.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.628 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 17.7 tmm? -68.14 -66.36 0.58 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.155 0.982 . . . . 72.41 111.56 -174.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . 0.408 ' O ' ' HG ' ' B' ' 98' ' ' LEU . . . -80.76 -9.36 59.81 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 120.857 0.36 . . . . 71.41 111.909 177.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -60.99 -31.74 71.34 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 122.866 0.467 . . . . 53.23 110.807 164.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.6 t -61.39 -40.45 94.39 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.831 0.852 . . . . 75.32 112.411 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' B' ' 95' ' ' ALA . 4.1 pp -69.69 -22.92 63.38 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.895 0.478 . . . . 65.33 112.001 177.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.05 -12.75 51.62 Favored Glycine 0 C--N 1.348 1.209 0 O-C-N 123.309 0.381 . . . . 75.44 113.797 -177.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.86 -57.67 1.04 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 117.364 0.582 . . . . 44.23 112.047 -173.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -75.16 -46.58 33.32 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.144 0.578 . . . . 73.31 111.615 -169.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.468 ' SG ' ' HE1' ' B' ' 56' ' ' TYR . 78.4 m -65.99 -47.18 63.93 Favored Pre-proline 0 CA--C 1.561 1.394 0 CA-C-O 118.459 -0.781 . . . . 61.01 112.595 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.96 -26.87 66.45 Favored 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 121.735 1.623 . . . . 71.3 112.746 172.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.42 -37.11 82.31 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.127 0.571 . . . . 73.33 110.868 175.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 66.7 mt -71.85 -44.49 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.758 0.823 . . . . 72.34 110.322 176.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.429 HD22 ' HG3' ' B' ' 80' ' ' GLN . 86.9 mt -78.47 -17.31 56.48 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.166 -0.924 . . . . 73.44 112.509 -171.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.422 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 55.4 t80 -63.33 -50.82 72.45 Favored Pre-proline 0 CA--C 1.55 0.957 0 CA-C-O 117.953 -1.022 . . . . 75.31 112.728 -176.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.597 ' HG2' ' HB2' ' D' ' 108' ' ' PRO . 93.6 Cg_exo -50.84 -42.58 50.87 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.261 1.974 . . . . 64.03 114.185 174.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -66.74 -44.44 81.5 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.361 0.665 . . . . 74.23 111.364 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.17 -37.2 83.34 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.676 -0.693 . . . . 73.23 110.995 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 60.7 ttt-85 -62.18 -51.54 67.43 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.341 1.456 . . . . 63.2 110.203 177.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -62.41 -36.8 83.48 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.238 0.961 . . . . 73.22 110.448 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.537 ' SG ' HD11 ' B' ' 21' ' ' ILE . 1.9 t -73.84 -30.2 62.55 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.018 0.127 . . . . 71.13 111.085 -177.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.569 HD13 HG23 ' B' ' 64' ' ' VAL . 41.8 mt -66.29 -55.82 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.679 0.791 . . . . 73.24 109.008 172.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.531 HG21 ' OG ' ' C' ' 119' ' ' SER . 31.9 m -62.08 -26.51 68.32 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 114.928 -1.033 . . . . 71.02 111.577 -177.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.3 t -61.65 -53.75 51.94 Favored 'General case' 0 C--N 1.347 0.458 0 N-CA-C 109.295 -0.631 . . . . 74.24 109.295 174.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.8 mmt -70.22 -30.81 67.98 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.599 0.76 . . . . 74.52 111.331 -174.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 68.8 t -66.41 -44.34 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.339 1.056 . . . . 52.2 110.271 172.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.1 t -67.28 -31.36 71.63 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.226 -0.897 . . . . 62.14 110.045 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.498 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 75.6 mtt-85 -68.44 -41.06 80.86 Favored 'General case' 0 C--O 1.211 -0.948 0 CA-C-N 115.818 -0.628 . . . . 73.23 109.561 176.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.97 -11.86 70.52 Favored Glycine 0 C--N 1.357 1.729 0 O-C-N 123.647 0.592 . . . . 71.43 112.628 171.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 11.3 m 67.11 30.74 7.2 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 125.51 1.524 . . . . 54.13 110.407 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -77.49 165.69 49.67 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-N 115.189 -0.914 . . . . 73.0 111.085 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -48.23 151.07 4.65 Favored 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 123.257 2.638 . . . . 41.42 113.52 173.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.563 ' HB2' ' H ' ' C' ' 125' ' ' GLN . 29.2 tp60 -61.71 114.89 3.56 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.055 0.542 . . . . 71.41 111.572 -172.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.739 HD21 HG11 ' B' ' 64' ' ' VAL . 34.7 tp -108.79 110.35 21.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.888 -1.051 . . . . 73.14 108.656 -177.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -121.77 116.89 25.31 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.049 -1.093 . . . . 73.34 108.049 176.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 73.3 mt -75.37 144.75 42.13 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 120.909 0.385 . . . . 73.1 111.541 -175.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.85 151.62 82.31 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 124.481 1.112 . . . . 72.25 110.708 -177.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.439 ' HG3' HD13 ' D' ' 16' ' ' ILE . 3.8 Cg_endo -80.23 84.53 2.0 Allowed 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.843 2.362 . . . . 74.13 110.666 -177.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 p -89.07 111.32 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 N-CA-C 108.714 -0.847 . . . . 74.52 108.714 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 43.5 t30 . . . . . 0 N--CA 1.472 0.628 0 CA-C-N 115.521 -0.763 . . . . 61.02 109.539 -176.951 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 61.7 t80 . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.358 -0.608 . . . . 75.43 109.358 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -150.53 135.24 17.4 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.821 0.848 . . . . 53.23 108.884 169.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 53.4 mt -77.22 119.11 25.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 107.655 -1.239 . . . . 70.23 107.655 166.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -84.56 -43.08 14.84 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.7 -0.852 . . . . 75.33 108.7 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.41 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER 178.97 158.31 0.55 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.195 1.398 . . . . 71.04 109.44 176.761 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.427 ' O ' HD12 ' C' ' 16' ' ' ILE . 2.0 pp -128.68 141.52 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.382 -1.34 . . . . 74.04 107.382 175.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.443 ' HB3' HG23 ' D' ' 122' ' ' THR . 17.7 p90 -170.52 157.57 5.96 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.284 0.564 . . . . 73.04 111.694 -168.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 66.5 p -80.33 113.31 18.42 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.982 -0.554 . . . . 75.0 109.639 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -34.6 71.58 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 108.04 -1.096 . . . . 75.04 108.04 171.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.5 t70 -151.24 145.55 25.45 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.372 -1.285 . . . . 53.22 110.385 -175.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.577 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.4 mt -139.82 147.42 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.9 1.68 . . . . 73.24 106.778 175.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -159.42 150.03 19.39 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.046 0.45 . . . . 73.02 110.217 171.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -151.12 135.89 17.24 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 107.454 -1.313 . . . . 61.3 107.454 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -136.0 124.73 23.86 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.888 0.475 . . . . 75.43 109.878 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.16 75.55 77.85 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 107.76 -1.2 . . . . 54.41 107.76 162.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -74.92 -10.01 21.14 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.291 1.994 . . . . 64.22 111.677 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -106.17 13.15 29.35 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.803 1.241 . . . . 71.12 109.798 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.98 -57.0 7.78 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 115.078 1.51 . . . . 73.0 115.078 -165.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -64.34 -41.14 22.01 Favored 'Trans proline' 0 C--N 1.378 2.116 0 CA-C-N 121.813 1.683 . . . . 60.43 112.177 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -68.67 -34.31 75.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.36 1.064 . . . . 52.3 111.702 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.93 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.1 p -79.67 -27.43 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 CA-C-N 116.147 -0.479 . . . . 60.32 111.877 -178.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -69.79 -31.51 69.47 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 111.598 0.221 . . . . 63.32 111.598 174.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -96.49 30.78 2.45 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.203 0.601 . . . . 72.11 110.552 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.75 167.44 10.48 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.315 1.046 . . . . 71.1 109.334 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -75.99 120.64 21.59 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.538 -0.541 . . . . 70.34 109.538 171.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -85.23 89.28 7.61 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.73 0.812 . . . . 74.35 110.857 -174.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -131.09 80.61 68.59 Favored Pre-proline 0 N--CA 1.481 1.109 0 C-N-CA 123.999 0.92 . . . . 71.45 108.839 167.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -71.8 111.41 3.14 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.292 1.994 . . . . 62.42 110.814 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -83.02 91.72 7.23 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 104.522 -2.399 . . . . 73.24 104.522 170.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.487 HG21 HD11 ' C' ' 126' ' ' LEU . 62.0 t -75.28 140.59 17.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 113.623 -1.626 . . . . 74.43 110.729 -167.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -128.36 103.16 7.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.352 1.061 . . . . 71.3 108.766 171.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 87.0 mt -85.3 150.06 25.03 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.929 0.892 . . . . 74.43 108.74 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.426 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 31.6 t70 -143.64 141.93 30.8 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.296 0.638 . . . . 63.21 109.613 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 47.9 mt -132.42 133.18 43.58 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.192 0.997 . . . . 62.23 109.116 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -143.23 123.44 13.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.801 -1.555 . . . . 74.43 106.801 175.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . 0.429 ' OG1' ' HG3' ' C' ' 103' ' ' PRO . 15.0 t -118.42 130.47 55.99 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.471 0.653 . . . . 72.13 109.418 176.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.35 153.41 29.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.177 -0.92 . . . . 53.4 109.095 176.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 37.2 p -146.64 143.0 28.48 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.862 -0.792 . . . . 75.51 108.862 175.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 45.9 t -156.89 135.82 11.78 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.163 0.585 . . . . 70.1 109.487 -177.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -79.48 116.82 19.93 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.764 -0.828 . . . . 72.22 108.764 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.602 HD11 ' HB2' ' C' ' 57' ' ' GLU . 63.4 mt -84.75 -34.94 22.75 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.613 0.765 . . . . 73.22 110.616 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.67 -176.02 5.63 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.143 -0.935 . . . . 44.3 109.868 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -58.44 108.61 0.65 Allowed 'General case' 0 C--O 1.242 0.674 0 O-C-N 124.122 0.889 . . . . 73.22 109.695 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . 0.585 ' HB3' ' HB2' ' C' ' 87' ' ' ALA . 16.9 m-20 66.2 24.63 10.74 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 124.311 1.007 . . . . 74.45 111.853 175.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.7 t -122.24 118.97 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 108.835 -0.802 . . . . 43.1 108.835 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -120.6 125.44 47.76 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.082 0.953 . . . . 73.34 109.997 -176.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.602 ' HB2' HD11 ' C' ' 51' ' ' LEU . 36.2 tt0 -84.71 131.99 34.51 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.531 -0.915 . . . . 73.51 108.531 166.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.484 HG11 ' HD3' ' C' ' 103' ' ' PRO . 61.3 t -122.45 123.05 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.08 -1.081 . . . . 73.14 108.08 168.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.574 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 73.5 t -108.84 145.44 15.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.19 -0.67 . . . . 65.01 109.19 174.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.06 101.27 7.44 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.651 -1.241 . . . . 75.13 107.651 174.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 35.9 ttm-85 -79.98 106.29 11.89 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.068 -1.086 . . . . 72.41 108.068 169.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.446 ' HB ' HD11 ' C' ' 114' ' ' ILE . 16.0 t -107.17 123.9 62.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.731 -1.211 . . . . 54.45 107.731 172.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 12.5 m -122.83 116.19 23.27 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.721 -0.844 . . . . 55.45 108.721 -176.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.415 HG21 HG21 ' C' ' 114' ' ' ILE . 73.8 t -111.35 110.69 33.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 124.463 1.105 . . . . 41.53 108.767 -174.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.4 m -99.67 139.28 35.56 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 115.356 -0.838 . . . . 71.21 108.88 175.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.45 105.23 6.81 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.093 -1.447 . . . . 74.42 107.093 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.0 m -123.33 135.28 54.12 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 108.179 -1.045 . . . . 45.02 108.179 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 36.2 mt -84.13 25.98 0.79 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.474 1.11 . . . . 63.25 110.714 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.76 -91.75 0.8 Allowed Glycine 0 C--N 1.357 1.722 0 N-CA-C 111.041 -0.823 . . . . 72.43 111.041 -177.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -89.11 -31.33 18.05 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.587 0.755 . . . . 73.34 110.261 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -89.34 124.06 34.08 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.819 1.248 . . . . 74.5 109.466 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.0 m -80.93 126.45 31.39 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.603 -0.888 . . . . 73.41 108.603 166.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.93 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -78.47 -55.81 4.93 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.42 -0.585 . . . . 72.14 109.42 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -159.01 166.05 32.64 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.665 0.745 . . . . 62.41 112.16 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.413 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.1 tm? -130.05 143.14 50.63 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 106.683 -1.599 . . . . 75.24 106.683 167.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.413 ' N ' HD13 ' C' ' 75' ' ' LEU . 48.5 t -149.87 112.08 4.65 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.661 -0.496 . . . . 52.03 109.661 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -116.68 124.61 50.14 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.219 -0.66 . . . . 54.41 109.219 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 49.4 t -122.97 115.07 44.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.77 -0.826 . . . . 72.2 108.77 172.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.468 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.1 mt-30 -93.86 87.69 5.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.046 0.938 . . . . 74.41 109.209 175.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -80.2 101.56 8.91 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.855 -1.066 . . . . 63.31 109.976 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -100.66 150.2 18.73 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-O 121.143 0.302 . . . . 35.01 112.746 177.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.7 132.51 4.78 Favored Glycine 0 CA--C 1.501 -0.798 0 N-CA-C 110.756 -0.937 . . . . 45.55 110.756 -175.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 34.7 mm -90.87 128.14 42.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 108.531 -0.915 . . . . 73.13 108.531 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -136.15 119.39 16.68 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.609 -0.885 . . . . 71.03 108.609 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 33.3 p -78.49 102.26 7.76 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.472 -0.936 . . . . 75.13 108.472 173.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.549 HD13 ' SG ' ' C' ' 97' ' ' CYS . 5.7 mt -116.07 140.32 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 122.832 0.453 . . . . 63.1 110.073 -176.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' C' ' 54' ' ' ASP . . . -160.35 172.07 17.97 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.777 0.831 . . . . 60.04 110.732 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.99 -47.19 3.5 Favored Glycine 0 C--N 1.345 1.062 0 O-C-N 123.896 0.747 . . . . 73.54 111.61 175.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.423 HD11 ' HE3' ' C' ' 94' ' ' MET . 41.7 pt -83.1 146.77 6.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 123.64 0.776 . . . . 63.1 111.154 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -149.38 -179.13 6.83 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.907 0.883 . . . . 75.32 109.595 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.57 -126.94 30.89 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-O 119.603 -0.554 . . . . 63.03 112.107 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.6 -26.0 62.41 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.269 0.627 . . . . 50.53 111.611 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.419 ' HB3' ' HB ' ' C' ' 89' ' ' ILE . 26.5 mt-30 -65.42 -60.77 2.6 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.527 0.331 . . . . 74.21 110.266 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.423 ' HE3' HD11 ' C' ' 89' ' ' ILE . 1.8 tpt -54.93 -48.36 73.24 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 123.796 0.685 . . . . 65.1 112.152 173.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.2 -40.2 76.92 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.728 0.642 . . . . 75.24 111.608 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -83.46 -23.34 32.28 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.403 0.681 . . . . 71.1 111.638 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.549 ' SG ' HD13 ' C' ' 86' ' ' ILE . 34.3 t -69.56 -37.89 77.19 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 108.354 -0.98 . . . . 73.1 108.354 175.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.421 ' HG ' ' HE2' ' C' ' 94' ' ' MET . 76.9 mt -81.1 -31.81 34.13 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.972 -1.013 . . . . 74.13 110.801 174.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . 0.418 ' HA3' ' CE2' ' C' ' 137' ' ' PHE . . . -78.05 -28.88 55.52 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.163 -0.926 . . . . 74.34 114.755 -168.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.99 -47.57 0.09 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.469 0.544 . . . . 73.52 112.469 -167.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.47 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 70.3 t80 -56.05 -59.3 5.11 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.345 0.658 . . . . 73.32 111.772 -176.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 88.6 m -63.66 -46.01 82.7 Favored Pre-proline 0 CA--C 1.566 1.582 0 C-N-CA 124.173 0.989 . . . . 73.32 111.691 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.484 ' HD3' HG11 ' C' ' 58' ' ' VAL . 96.0 Cg_exo -49.67 -36.11 40.24 Favored 'Trans proline' 0 C--N 1.395 2.997 0 C-N-CA 123.088 2.525 . . . . 35.33 114.832 168.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -67.97 -31.98 72.08 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.477 0.711 . . . . 62.02 111.249 177.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.4 HD12 HH12 ' A' ' 111' ' ' ARG . 32.2 mm -69.66 -38.78 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 109.185 -0.672 . . . . 64.14 109.185 175.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 53.5 mt -78.82 -34.4 45.27 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.262 1.025 . . . . 71.21 112.516 -174.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -54.46 -47.11 98.64 Favored Pre-proline 0 N--CA 1.484 1.24 0 N-CA-C 114.238 1.199 . . . . 74.32 114.238 -170.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.48 -39.06 58.54 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.167 1.912 . . . . 72.53 113.345 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -68.5 -40.42 80.9 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.278 0.631 . . . . 64.41 110.793 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.28 -41.86 99.04 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.16 -0.927 . . . . 73.33 109.866 174.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . 0.407 ' HA ' HD21 ' C' ' 128' ' ' LEU . 56.2 ttt180 -60.71 -49.35 77.86 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.936 1.294 . . . . 73.34 110.61 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.27 -40.88 90.42 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.724 0.64 . . . . 74.22 109.943 -176.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 49.4 t -68.83 -34.88 76.22 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.504 0.503 . . . . 74.44 111.986 -176.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.446 HD11 ' HB ' ' C' ' 62' ' ' VAL . 97.0 mt -69.43 -52.33 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.443 0.697 . . . . 72.12 110.363 175.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.4 m -67.95 -27.23 66.43 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 122.974 0.509 . . . . 53.14 111.254 -175.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 40.4 t -62.97 -47.06 84.81 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.971 0.908 . . . . 63.44 109.367 170.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.553 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.86 -38.68 91.79 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.433 1.093 . . . . 74.23 112.125 178.227 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 98.9 t -58.39 -45.79 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.462 0.705 . . . . 60.43 109.685 173.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.531 ' OG ' HG21 ' B' ' 115' ' ' THR . 28.9 t -68.76 -31.65 70.84 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.836 -1.074 . . . . 71.44 112.268 -178.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.446 HH12 ' HG2' ' D' ' 112' ' ' GLU . 73.0 mtt-85 -69.47 -40.4 77.11 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.162 -0.681 . . . . 65.02 109.162 177.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.56 -1.07 86.01 Favored Glycine 0 C--N 1.356 1.683 0 O-C-N 123.983 0.802 . . . . 62.42 112.66 172.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.3 p 65.46 25.61 11.89 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 126.819 2.048 . . . . 50.24 114.075 169.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -83.67 143.83 44.53 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 109.313 -0.625 . . . . 75.12 109.313 174.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.408 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 78.0 Cg_exo -45.61 135.9 12.63 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 123.459 2.773 . . . . 75.04 113.055 171.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.563 ' H ' ' HB2' ' B' ' 125' ' ' GLN . 36.8 mm-40 -44.07 112.82 0.44 Allowed 'General case' 0 N--CA 1.483 1.211 0 O-C-N 124.882 1.364 . . . . 72.4 111.934 -174.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.487 HD11 HG21 ' C' ' 40' ' ' VAL . 20.2 tp -108.18 83.94 1.86 Allowed 'General case' 0 C--O 1.239 0.525 0 N-CA-C 106.565 -1.643 . . . . 63.4 106.565 170.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -97.54 94.52 7.05 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 114.357 -1.292 . . . . 73.32 108.378 -170.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.577 HD23 ' H ' ' C' ' 128' ' ' LEU . 1.5 pt? -56.3 139.09 49.41 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.089 0.956 . . . . 65.02 111.967 -175.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.51 150.83 64.19 Favored Pre-proline 0 CA--C 1.548 0.891 0 CA-C-N 114.759 -1.109 . . . . 64.14 110.945 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.41 113.7 1.8 Allowed 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.852 2.368 . . . . 75.42 112.674 175.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 49.0 t -99.31 118.39 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 107.676 -1.231 . . . . 64.24 107.676 171.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -71.84 103.44 3.15 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.265 0.626 . . . . 61.24 110.42 -175.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -62.64 -31.46 72.32 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.253 1.021 . . . . 73.31 111.944 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -66.36 -37.66 85.81 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.278 0.631 . . . . 74.53 110.685 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.92 86.56 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.516 0.726 . . . . 64.0 110.373 175.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 98.4 mt -64.94 -35.34 80.83 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.925 -1.034 . . . . 72.22 110.889 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . 0.418 ' CE2' ' HA3' ' C' ' 99' ' ' GLY . 3.4 t80 . . . . . 0 C--O 1.238 0.463 0 CA-C-N 115.95 -0.568 . . . . 74.32 111.307 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 8.2 t . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 120.975 0.417 . . . . 60.34 109.942 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.531 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 49.9 t80 -135.3 91.01 2.68 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 106.781 -1.563 . . . . 65.34 106.781 176.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -121.2 126.8 50.54 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.474 0.71 . . . . 63.42 109.252 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mt -96.21 132.77 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 107.84 -1.17 . . . . 73.22 107.84 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -104.09 -19.58 14.12 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 119.116 -0.468 . . . . 70.2 111.417 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.416 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 41.1 ttt180 -172.29 131.92 0.62 Allowed 'General case' 0 C--N 1.36 1.042 0 N-CA-C 112.065 0.395 . . . . 73.33 112.065 -176.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.439 HD13 ' HG3' ' B' ' 130' ' ' PRO . 2.6 mp -110.41 134.95 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 106.842 -1.54 . . . . 64.51 106.842 170.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.416 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 22.2 p90 -158.16 140.28 14.14 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 123.521 0.513 . . . . 64.31 111.685 -177.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -78.6 113.17 16.4 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.498 -0.774 . . . . 75.35 109.668 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -85.76 -11.24 54.06 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.602 -0.726 . . . . 75.11 109.9 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.651 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.4 t70 -165.54 145.25 6.59 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.594 1.158 . . . . 53.41 109.846 177.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.553 HD13 ' HE3' ' C' ' 117' ' ' MET . 66.4 mt -148.41 148.23 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 125.622 1.569 . . . . 74.43 107.695 175.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.1 t -154.98 146.24 22.89 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.356 1.062 . . . . 53.3 109.092 171.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.577 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 92.0 t80 -143.61 126.32 16.07 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 106.669 -1.604 . . . . 71.51 106.669 169.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 47.9 mt-10 -121.16 142.73 49.61 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.549 0.74 . . . . 73.53 109.227 175.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.433 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -138.69 75.51 37.1 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 107.018 -1.475 . . . . 60.01 107.018 169.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -71.99 -19.93 26.09 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.453 2.102 . . . . 72.54 112.772 -171.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -110.7 3.98 19.69 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.655 0.782 . . . . 74.24 111.153 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.452 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -27.33 -70.63 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 116.805 2.15 . . . . 64.24 116.805 -167.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.32 -19.46 15.17 Favored 'Trans proline' 0 C--N 1.388 2.618 0 CA-C-N 124.036 2.477 . . . . 52.44 114.011 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -74.5 -39.6 62.32 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.045 0.938 . . . . 53.52 109.816 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' D' ' 73' ' ' ALA . 9.3 p -82.98 -16.25 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 CA-C-N 116.065 -0.516 . . . . 75.1 111.101 -171.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -68.42 -13.42 62.28 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.07 0.767 . . . . 75.55 113.07 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -60.34 -27.29 67.24 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.788 0.835 . . . . 72.4 110.713 173.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -91.78 88.13 6.55 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.494 1.518 . . . . 71.14 110.179 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -83.11 90.92 7.12 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.221 -0.9 . . . . 72.22 110.682 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 40.7 p90 -165.4 172.01 12.72 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.138 0.975 . . . . 75.43 109.29 166.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -70.58 111.27 9.02 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.644 0.778 . . . . 62.01 109.321 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.44 128.47 30.23 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 122.937 2.424 . . . . 63.51 112.058 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.74 113.1 5.23 Favored 'General case' 0 C--O 1.24 0.566 0 O-C-N 123.773 0.671 . . . . 74.25 109.462 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.925 HG13 HG13 ' D' ' 64' ' ' VAL . 78.7 t -98.53 107.13 19.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-N 115.343 -0.844 . . . . 72.54 110.102 -174.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -87.65 111.04 20.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 105.693 -1.965 . . . . 64.11 105.693 165.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.441 HD11 HG13 ' D' ' 62' ' ' VAL . 49.7 tp -95.52 143.44 26.84 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.498 -0.927 . . . . 64.51 108.498 -172.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.613 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 15.8 m-20 -120.02 117.01 26.88 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.688 -1.226 . . . . 74.42 107.688 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.404 ' CD2' HG22 ' D' ' 62' ' ' VAL . 23.4 mt -116.31 131.0 57.06 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.048 0.452 . . . . 65.12 110.014 177.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -143.99 145.2 32.06 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.246 -1.02 . . . . 71.34 108.246 171.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . 0.409 HG21 ' O ' ' D' ' 99' ' ' GLY . 22.8 p -104.6 170.57 7.81 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.105 0.562 . . . . 64.43 110.493 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -166.35 163.08 17.49 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.463 1.105 . . . . 62.55 108.621 172.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 53.7 p . . . . . 0 C--O 1.245 0.861 0 N-CA-C 108.147 -1.057 . . . . 61.42 108.147 169.62 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.498 1.95 0 N-CA-C 113.586 0.958 . . . . 73.34 113.586 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 p -109.24 94.54 3.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 107.305 -1.368 . . . . 51.21 107.305 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -122.18 128.3 51.05 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.676 -0.861 . . . . 73.12 108.676 -171.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -85.89 152.99 22.53 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 107.318 -1.364 . . . . 73.14 107.318 162.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 53.3 t -130.16 138.57 53.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.302 -1.37 . . . . 64.1 107.302 165.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.471 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 32.3 t -126.11 130.12 72.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 108.249 -1.019 . . . . 71.23 108.249 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.595 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -109.02 119.96 41.1 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 106.824 -1.547 . . . . 72.44 106.824 178.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -99.36 97.99 8.97 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.384 -0.969 . . . . 72.01 108.384 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.441 HG13 HD11 ' D' ' 42' ' ' LEU . 31.9 t -101.82 117.14 46.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.291 -0.868 . . . . 74.14 108.713 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.613 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 22.6 m -126.7 119.14 26.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.382 0.673 . . . . 73.33 109.25 -173.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.925 HG13 HG13 ' D' ' 40' ' ' VAL . 55.1 t -100.89 124.16 54.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 123.715 0.806 . . . . 63.43 110.022 -177.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 28.4 m -114.69 96.19 5.61 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.239 -1.022 . . . . 71.23 108.239 170.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.604 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -106.69 142.56 36.13 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.482 -0.781 . . . . 71.51 110.076 -175.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.52 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 48.9 m -139.75 141.64 36.83 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.441 0.638 . . . . 73.44 112.258 -173.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.442 HD12 HG22 ' D' ' 31' ' ' VAL . 46.7 mt -111.57 114.71 27.96 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.32 -1.309 . . . . 73.41 107.642 170.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.52 -131.73 22.09 Favored Glycine 0 C--N 1.341 0.835 0 O-C-N 123.155 0.284 . . . . 60.42 112.768 -176.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.84 1.61 55.38 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.942 0.497 . . . . 75.41 111.41 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -119.15 164.66 15.24 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.751 0.42 . . . . 71.31 110.366 -175.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 98.8 m -67.82 131.59 45.82 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.06 -0.973 . . . . 73.13 110.998 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.581 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -84.9 -63.49 1.32 Allowed 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.698 -1.223 . . . . 51.41 107.698 170.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -152.05 148.82 28.14 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 114.587 -1.188 . . . . 62.13 110.607 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.446 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 82.6 mt -109.65 154.12 23.27 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.454 1.102 . . . . 74.3 108.27 170.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.542 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 43.0 t -157.9 148.62 20.86 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.316 -0.624 . . . . 52.41 109.316 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -155.6 131.45 9.91 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.313 0.645 . . . . 41.44 109.796 174.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -135.13 113.82 16.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 108.267 -1.012 . . . . 74.54 108.267 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.651 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.8 mt-30 -89.54 83.88 6.35 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.239 -1.023 . . . . 74.41 108.239 169.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -80.31 96.87 6.77 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 113.734 -1.575 . . . . 64.32 109.377 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.25 168.51 35.23 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.689 -0.687 . . . . 73.14 112.468 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.02 138.09 4.75 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 110.707 -0.957 . . . . 53.11 110.707 173.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.99 123.97 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 N-CA-C 108.549 -0.908 . . . . 60.41 108.549 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -115.13 125.73 53.81 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.681 1.192 . . . . 72.31 110.002 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 35.0 m -87.87 95.08 9.97 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 108.513 -0.921 . . . . 41.45 108.513 168.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 37.0 pt -109.78 142.7 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.415 -0.587 . . . . 75.43 109.415 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.63 166.94 9.82 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.933 0.893 . . . . 64.24 110.378 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.23 22.75 56.46 Favored Glycine 0 C--N 1.352 1.448 0 O-C-N 123.517 0.51 . . . . 52.35 113.796 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.581 ' HB ' ' HB3' ' D' ' 94' ' ' MET . 0.2 OUTLIER -120.33 148.97 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 124.187 0.995 . . . . 75.43 109.668 -179.068 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -129.06 -178.3 4.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.79 0.836 . . . . 64.52 109.904 -175.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.58 -142.58 47.05 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.363 -0.835 . . . . 53.14 112.63 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.2 p -90.81 -14.72 31.38 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.649 0.779 . . . . 74.41 111.267 173.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -56.38 -34.1 66.37 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.356 1.062 . . . . 72.34 112.247 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.581 ' HB3' ' HB ' ' D' ' 89' ' ' ILE . 0.0 OUTLIER -62.57 -43.5 98.65 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.306 0.642 . . . . 64.13 112.049 -179.426 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . 0.453 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.05 -22.92 28.8 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.384 0.674 . . . . 54.0 111.862 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -74.93 -38.4 61.78 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.734 -0.469 . . . . 73.43 109.734 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 73.7 m -73.05 -26.7 61.38 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.493 0.717 . . . . 70.41 110.888 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 53.2 tp -63.89 -43.63 95.44 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.711 0.804 . . . . 65.32 110.319 175.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . 0.409 ' O ' HG21 ' D' ' 46' ' ' THR . . . -94.56 -12.05 56.28 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 119.298 -0.723 . . . . 62.32 114.381 -175.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.04 -58.34 1.88 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 118.439 1.12 . . . . 70.23 112.341 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -74.57 -41.73 60.01 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.224 0.453 . . . . 75.41 112.224 -172.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.531 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 75.5 m -61.46 -47.52 93.17 Favored Pre-proline 0 CA--C 1.568 1.636 0 C-N-CA 123.383 0.673 . . . . 70.22 111.69 178.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.595 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 53.2 Cg_exo -61.63 -31.24 86.63 Favored 'Trans proline' 0 C--N 1.39 2.718 0 C-N-CA 122.344 2.029 . . . . 65.12 113.795 170.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -63.0 -33.33 75.19 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.022 0.529 . . . . 64.2 110.843 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.4 mm -67.22 -42.08 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.776 0.83 . . . . 73.31 110.49 173.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 54.0 mt -76.18 -11.35 59.91 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.357 -0.838 . . . . 73.23 111.638 -175.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -70.63 -44.81 17.42 Favored Pre-proline 0 CA--C 1.558 1.282 0 N-CA-C 114.086 1.143 . . . . 72.43 114.086 -172.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . 0.597 ' HB2' ' HG2' ' B' ' 108' ' ' PRO . 29.1 Cg_endo -61.97 -32.07 84.42 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 121.649 1.566 . . . . 75.35 112.469 172.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . 0.415 ' O ' ' HB3' ' D' ' 112' ' ' GLU . 62.5 m-85 -72.82 -31.69 64.99 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.752 0.821 . . . . 73.22 111.634 175.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.98 -48.08 72.43 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.437 0.637 . . . . 75.4 109.334 175.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 33.2 ttp180 -65.66 -31.92 73.21 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.174 -1.375 . . . . 54.21 110.858 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . 0.446 ' HG2' HH12 ' C' ' 120' ' ' ARG . 16.0 tt0 -53.17 -52.63 58.17 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.343 1.057 . . . . 72.4 110.317 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.9 t -69.51 -47.59 63.31 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.511 -1.222 . . . . 74.31 111.061 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.52 HG21 HG21 ' D' ' 64' ' ' VAL . 63.4 mt -62.37 -58.23 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.346 0.658 . . . . 75.22 111.062 -176.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 86.0 m -52.84 -39.57 62.64 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.107 0.879 . . . . 74.23 111.564 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 43.4 t -65.19 -45.11 86.14 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.128 -0.942 . . . . 52.0 110.121 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.452 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 79.0 mtm -66.31 -32.87 74.54 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.198 0.599 . . . . 75.43 111.959 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.428 HG23 ' O ' ' D' ' 114' ' ' ILE . 92.5 t -62.79 -48.47 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.616 0.767 . . . . 75.15 109.794 175.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 96.4 p -71.24 -27.67 63.63 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.593 -0.731 . . . . 74.45 110.787 -178.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' D' ' 116' ' ' SER . 90.4 mtt-85 -69.64 -33.76 73.08 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.541 0.736 . . . . 72.24 109.936 174.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.46 9.16 71.71 Favored Glycine 0 C--N 1.355 1.624 0 O-C-N 123.578 0.548 . . . . 62.33 112.933 176.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.443 HG23 ' HB3' ' C' ' 17' ' ' TYR . 82.1 p 56.51 36.56 27.76 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.93 1.692 . . . . 74.11 113.631 177.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -98.62 149.63 35.93 Favored Pre-proline 0 C--O 1.243 0.754 0 N-CA-C 108.557 -0.905 . . . . 73.34 108.557 171.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -45.58 131.1 12.44 Favored 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 123.308 2.672 . . . . 63.22 112.616 172.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -52.95 130.88 34.92 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 124.344 1.027 . . . . 75.5 111.479 -172.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.516 HD13 HG21 ' D' ' 40' ' ' VAL . 10.1 tp -105.71 98.61 8.28 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.182 -0.917 . . . . 72.42 108.603 -173.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . 0.446 HD22 HD12 ' B' ' 16' ' ' ILE . 10.2 m120 -100.51 78.61 2.02 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.94 -1.133 . . . . 63.33 107.94 177.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.06 132.33 48.29 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 109.791 -0.448 . . . . 52.3 109.791 -175.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.77 144.03 97.99 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 123.815 0.846 . . . . 75.41 111.425 -174.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.65 132.63 46.67 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.635 2.223 . . . . 65.45 111.945 176.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 73.6 t -107.48 128.63 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.729 -0.841 . . . . 73.34 108.729 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -85.59 97.84 10.31 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.657 0.783 . . . . 70.21 108.997 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 . . . . . 0 N--CA 1.487 1.424 0 C-N-CA 124.658 1.183 . . . . 51.35 112.229 -173.621 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.7 m . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 107.352 -1.351 . . . . 72.34 107.352 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -129.49 113.91 15.46 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.068 -1.086 . . . . 64.42 108.068 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -134.08 118.44 17.74 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.016 -0.735 . . . . 65.35 109.016 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.471 HG21 ' HG2' ' C' ' 130' ' ' PRO . 43.4 mt -80.69 119.82 31.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 109.362 -0.607 . . . . 64.11 109.362 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -85.83 -38.78 17.76 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 123.607 0.567 . . . . 60.32 110.163 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -173.52 129.26 0.43 Allowed 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.599 -0.273 . . . . 65.21 110.365 -170.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.497 HD12 ' HG3' ' C' ' 130' ' ' PRO . 87.0 mt -119.79 134.02 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 108.235 -1.024 . . . . 53.2 108.235 173.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.435 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 36.8 p90 -162.27 168.1 22.87 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 124.036 0.835 . . . . 73.43 110.87 -170.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -89.78 119.49 30.21 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.665 -0.865 . . . . 62.31 108.665 172.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 32.8 mtpt -78.97 -26.33 43.44 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.736 -0.468 . . . . 74.24 109.736 172.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -159.08 146.31 17.31 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.292 1.037 . . . . 62.12 109.614 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.8 mt -135.85 146.36 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.092 1.357 . . . . 72.04 107.836 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.0 t -148.01 131.95 17.15 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 109.059 -0.719 . . . . 64.33 109.059 171.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 89.3 t80 -137.09 127.75 27.02 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 106.988 -1.486 . . . . 72.32 106.988 171.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -134.5 129.18 34.76 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.009 0.523 . . . . 74.41 109.856 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.93 75.21 79.84 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.479 -1.304 . . . . 73.43 107.479 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.49 -28.0 32.67 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.713 2.275 . . . . 54.34 112.377 -172.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -104.8 15.38 27.96 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.203 -0.908 . . . . 75.41 110.154 -177.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.563 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -43.85 -56.41 7.48 Favored Pre-proline 0 N--CA 1.494 1.763 0 N-CA-C 113.996 1.11 . . . . 71.21 113.996 -169.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 70.8 Cg_exo -54.98 -35.22 89.38 Favored 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 122.515 2.143 . . . . 71.04 113.607 176.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.409 ' HA ' ' NE2' ' A' ' 33' ' ' GLN . 1.9 m-70 -78.36 -42.47 30.36 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.508 0.723 . . . . 73.22 110.042 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.1 p -67.05 -27.57 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 114.593 -1.185 . . . . 74.42 111.951 -159.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -72.99 -29.33 62.96 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.952 -0.567 . . . . 74.11 110.767 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.409 ' NE2' ' HA ' ' A' ' 30' ' ' HIS . 38.9 mt-30 -75.1 -24.29 58.08 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.239 1.016 . . . . 71.14 110.888 178.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -77.24 152.28 34.76 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.853 0.861 . . . . 35.34 110.707 -175.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.83 118.29 7.0 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.752 0.657 . . . . 54.33 109.623 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -83.82 85.06 7.35 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.679 0.752 . . . . 72.35 110.991 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -121.01 84.05 38.69 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 107.001 -1.481 . . . . 74.52 107.001 170.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.45 116.89 4.63 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.361 2.041 . . . . 62.45 111.982 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -96.38 101.79 13.48 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.319 -0.993 . . . . 75.31 108.319 174.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 t -97.39 108.1 21.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 114.818 -1.083 . . . . 70.14 110.796 -169.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -83.65 119.94 25.37 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.747 0.819 . . . . 72.5 109.035 170.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.6 tp -97.25 106.53 18.88 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.371 -0.974 . . . . 54.41 108.371 175.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.472 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.4 m-20 -107.92 148.52 29.53 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.373 1.069 . . . . 72.22 108.77 176.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.728 HD11 HG21 ' A' ' 131' ' ' VAL . 92.6 mt -137.68 154.91 49.62 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.306 0.642 . . . . 42.03 111.246 -175.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.606 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 6.8 m-20 -137.72 141.29 41.02 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.166 -1.379 . . . . 61.53 108.113 175.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.3 m -141.0 123.16 15.64 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.249 -0.649 . . . . 64.1 109.249 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.75 138.16 23.06 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.505 0.722 . . . . 64.33 109.511 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.8 m -90.57 165.77 13.57 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.078 0.551 . . . . 75.25 109.56 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.2 t -154.69 119.48 4.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.398 -0.964 . . . . 54.21 108.398 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -85.15 103.33 14.04 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.953 -1.129 . . . . 72.11 107.953 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 57' ' ' GLU . 83.4 mt -77.9 -40.1 40.97 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.12 0.568 . . . . 62.43 109.474 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.35 -178.41 6.96 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.0 -1.0 . . . . 71.01 109.731 178.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -61.7 115.85 4.31 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.475 -0.784 . . . . 73.12 109.358 172.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 72.05 -4.19 2.04 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 125.178 1.391 . . . . 74.44 113.427 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.1 t -100.94 104.59 16.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.477 -0.935 . . . . 75.33 108.477 175.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -115.18 123.31 48.56 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.622 -0.881 . . . . 72.14 108.622 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.466 ' HB2' HD11 ' A' ' 51' ' ' LEU . 32.4 tt0 -89.58 151.59 21.85 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 123.396 0.679 . . . . 54.3 109.313 166.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.457 HG11 ' HD3' ' A' ' 103' ' ' PRO . 83.2 t -130.03 138.03 55.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.983 -1.117 . . . . 64.32 107.983 168.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.1 t -114.3 132.51 63.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 CA-C-O 121.232 0.539 . . . . 60.11 109.749 174.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.546 HD21 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -113.68 110.3 19.98 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 106.313 -1.736 . . . . 72.01 106.313 174.326 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.606 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 16.8 ttp180 -101.31 107.07 18.33 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.878 -1.156 . . . . 73.22 107.878 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 36.1 t -93.67 123.61 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 108.585 -0.894 . . . . 64.22 108.585 176.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.472 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 22.1 m -114.7 111.88 21.97 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.212 -0.662 . . . . 72.32 109.212 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.528 HG21 HG21 ' A' ' 114' ' ' ILE . 81.7 t -103.02 120.9 53.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 124.539 1.135 . . . . 53.44 109.004 177.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.5 m -115.39 129.48 56.59 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.859 -0.793 . . . . 72.24 108.859 166.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.6 129.2 56.65 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.266 -1.383 . . . . 73.11 107.266 171.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.1 m -125.04 171.14 10.49 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.504 0.668 . . . . 73.13 109.936 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.7 mt -130.09 62.4 1.56 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 105.781 -1.933 . . . . 65.21 105.781 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.96 -103.52 2.01 Favored Glycine 0 C--N 1.338 0.648 0 CA-C-N 115.559 -0.746 . . . . 63.43 111.257 -173.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -91.16 -27.18 18.69 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.846 0.459 . . . . 71.52 111.708 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -97.44 123.84 41.42 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.802 0.441 . . . . 75.24 109.937 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 57.6 m -70.61 134.55 47.7 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.975 0.417 . . . . 71.55 110.391 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.581 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -79.26 -59.12 2.89 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.252 -0.885 . . . . 71.34 109.66 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -156.47 166.11 34.36 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.93 -1.032 . . . . 74.15 110.93 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.7 tp -135.46 114.11 11.81 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.366 1.066 . . . . 74.33 108.848 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.508 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 57.4 m -107.02 139.91 40.67 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.09 0.956 . . . . 70.11 108.917 174.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -149.95 117.81 6.26 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.592 -0.521 . . . . 72.11 109.592 175.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.5 t -127.59 114.5 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.835 0.854 . . . . 73.42 109.859 -175.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.604 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 10.4 mt-30 -86.77 81.18 8.27 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.548 -0.908 . . . . 64.4 108.548 174.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -76.57 95.94 4.02 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.59 -0.732 . . . . 74.12 109.407 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.85 146.48 16.38 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 111.351 -0.7 . . . . 64.1 111.351 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.29 134.05 6.49 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.104 -0.798 . . . . 51.13 111.104 -176.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.9 mt -81.24 125.57 39.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 108.777 -0.823 . . . . 71.43 108.777 173.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.812 ' HB3' HD11 ' A' ' 86' ' ' ILE . 82.0 m-85 -127.68 128.03 44.75 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.981 0.912 . . . . 74.15 109.202 -174.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.1 t -94.89 101.04 12.81 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.194 -1.039 . . . . 54.54 108.194 175.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.812 HD11 ' HB3' ' A' ' 84' ' ' PHE . 5.8 mm -113.5 153.52 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 122.4 0.28 . . . . 74.53 111.11 -171.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.06 167.5 12.51 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.546 1.139 . . . . 61.41 110.248 175.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.87 2.16 64.97 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-O 119.372 -0.682 . . . . 74.21 114.724 169.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.07 161.49 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 123.965 0.906 . . . . 74.01 110.554 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.475 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 18.1 tt0 -153.61 175.56 13.08 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 109.574 -0.528 . . . . 63.3 109.574 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.475 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 53.74 -121.23 17.22 Favored Glycine 0 C--N 1.349 1.299 0 O-C-N 124.099 0.874 . . . . 63.32 114.34 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.9 t -69.25 -30.35 68.45 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.028 0.931 . . . . 71.14 111.941 -176.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -74.42 -36.64 63.44 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.146 0.579 . . . . 62.42 110.459 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.411 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 4.9 tpt -65.26 -44.56 87.69 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.442 0.464 . . . . 74.52 110.405 175.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.62 -41.66 86.45 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.318 -0.855 . . . . 60.52 111.208 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.517 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 54.8 t-80 -78.58 -25.55 45.33 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.419 -0.809 . . . . 73.11 111.508 -177.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 44.0 t -69.95 -42.91 72.59 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.265 0.555 . . . . 75.44 109.962 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 88.0 mt -81.85 -40.97 21.68 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.846 -1.07 . . . . 74.51 111.732 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.32 3.16 81.91 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 116.035 -0.529 . . . . 71.11 114.284 -170.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.669 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -146.93 -58.76 0.28 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.54 0.67 . . . . 64.24 112.007 -171.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -67.65 -45.29 75.73 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-N 116.006 -0.543 . . . . 73.44 111.049 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.406 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 88.3 m -63.45 -52.34 60.83 Favored Pre-proline 0 CA--C 1.566 1.573 0 N-CA-C 113.435 0.902 . . . . 63.13 113.435 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.457 ' HD3' HG11 ' A' ' 58' ' ' VAL . 44.3 Cg_endo -65.7 -20.6 59.35 Favored 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 122.051 1.834 . . . . 55.5 113.052 177.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -63.83 -43.69 95.45 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 120.99 0.424 . . . . 72.21 110.043 172.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' A' ' 102' ' ' CYS . 31.2 mm -61.74 -38.15 79.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 124.405 1.082 . . . . 75.41 110.673 174.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 103' ' ' PRO . 78.0 mt -77.64 -22.46 50.66 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.079 0.952 . . . . 74.03 112.96 -173.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -70.3 -41.94 14.84 Favored Pre-proline 0 CA--C 1.557 1.245 0 N-CA-C 114.434 1.272 . . . . 74.24 114.434 -170.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -54.12 -39.39 86.07 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 121.902 1.734 . . . . 75.12 112.742 173.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -74.55 -40.81 61.45 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.748 0.819 . . . . 72.22 111.484 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.66 -49.01 74.91 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.974 0.509 . . . . 70.35 110.241 177.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.654 HH12 HD12 ' C' ' 105' ' ' ILE . 29.7 ttm180 -52.04 -48.88 64.36 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.719 1.262 . . . . 74.05 110.491 176.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -61.95 -50.51 71.82 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 124.204 0.94 . . . . 75.4 111.63 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.451 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 44.9 t -54.3 -44.75 72.24 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.361 1.038 . . . . 53.55 110.691 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.528 HG21 HG21 ' A' ' 64' ' ' VAL . 96.9 mt -63.05 -55.06 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 114.968 -1.014 . . . . 75.22 111.14 176.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 91.4 m -52.83 -43.44 66.0 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.12 0.968 . . . . 63.02 111.53 -175.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -68.0 -44.21 77.09 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.382 -1.281 . . . . 74.52 109.782 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 11.1 mtp -57.45 -42.45 82.51 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.887 0.875 . . . . 73.1 111.596 175.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 114' ' ' ILE . 72.3 t -59.72 -49.27 84.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.4 1.08 . . . . 73.53 110.274 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -72.42 -27.66 62.48 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.855 -0.612 . . . . 71.24 111.775 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 50.3 mtt-85 -70.77 -31.43 68.21 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.363 0.665 . . . . 72.34 109.932 175.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.422 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.48 18.2 25.57 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.572 -0.74 . . . . 63.21 113.073 175.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 121' ' ' GLY . 2.5 t 59.61 11.57 2.44 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 126.952 2.101 . . . . 71.21 113.225 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -79.07 139.31 56.78 Favored Pre-proline 0 C--O 1.245 0.858 0 N-CA-C 108.271 -1.011 . . . . 55.3 108.271 174.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -48.58 135.79 27.0 Favored 'Trans proline' 0 C--N 1.365 1.438 0 C-N-CA 123.249 2.633 . . . . 74.3 112.519 173.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -58.8 127.5 32.5 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 124.292 0.995 . . . . 70.44 111.988 -166.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.0 tp -110.22 134.61 52.06 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 123.974 0.91 . . . . 72.14 108.859 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.46 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 85.6 m-20 -129.02 122.22 29.58 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.823 -0.806 . . . . 44.2 108.823 178.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.2 mt -74.15 148.04 42.1 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.481 -0.562 . . . . 71.31 109.481 -176.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.38 142.73 58.79 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 119.34 -0.362 . . . . 44.23 111.042 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.507 ' HB3' ' OH ' ' C' ' 101' ' ' TYR . 53.3 Cg_exo -56.22 121.66 10.39 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 123.446 2.764 . . . . 73.45 113.774 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.728 HG21 HD11 ' A' ' 44' ' ' LEU . 57.7 t -102.35 121.03 52.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-N 115.485 -0.779 . . . . 74.14 109.265 176.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -91.15 81.31 5.57 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.618 -0.882 . . . . 74.11 108.618 176.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -59.29 -31.58 69.26 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 114.893 -1.049 . . . . 73.42 111.578 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.669 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 13.9 t70 -55.22 -47.84 74.75 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.966 0.906 . . . . 74.43 109.937 178.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.75 -42.43 64.05 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.384 -0.825 . . . . 73.4 111.694 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 76.1 mt -65.22 -42.15 93.75 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.034 0.534 . . . . 70.51 112.323 -174.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.418 ' HB3' ' HB2' ' A' ' 100' ' ' ALA . 25.3 t80 . . . . . 0 C--O 1.212 -0.915 0 N-CA-C 109.349 -0.611 . . . . 62.33 109.349 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.606 ' HB3' HG23 ' B' ' 89' ' ' ILE . 21.4 ptm . . . . . 0 N--CA 1.484 1.226 0 CA-C-O 122.035 0.922 . . . . 70.41 113.225 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 90.7 m -148.29 124.76 10.99 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.536 -1.283 . . . . 74.25 107.536 169.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -113.54 145.03 41.87 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.997 -0.742 . . . . 75.31 108.997 173.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.537 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -155.66 139.76 16.46 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.314 -0.624 . . . . 74.21 109.314 172.513 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.443 HD13 HD11 ' B' ' 16' ' ' ILE . 50.4 mt -82.07 132.25 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 108.022 -1.103 . . . . 65.24 108.022 168.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -100.61 -43.73 6.07 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.528 -0.545 . . . . 64.32 109.528 178.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.401 ' HE ' HG21 ' A' ' 122' ' ' THR . 55.0 ttt180 -173.27 134.22 0.53 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.473 -0.785 . . . . 75.32 108.907 -174.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.521 HG21 ' CD1' ' B' ' 109' ' ' TYR . 88.8 mt -121.1 148.37 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 108.596 -0.89 . . . . 74.33 108.596 177.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -162.39 142.87 9.99 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 112.857 0.688 . . . . 74.41 112.857 -175.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.3 m -73.15 117.14 14.52 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.686 -1.143 . . . . 64.45 108.445 167.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.466 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 42.3 mtpt -91.43 -33.76 15.11 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.076 0.551 . . . . 71.52 110.294 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.594 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 19.3 t70 -149.79 136.21 19.09 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.093 -0.503 . . . . 61.52 110.811 -167.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 43.9 mm -134.92 139.55 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.793 1.237 . . . . 74.31 108.033 174.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 47.0 t -144.21 115.1 7.81 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.256 -1.016 . . . . 74.22 108.256 177.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' B' ' 75' ' ' LEU . 77.9 t80 -126.4 130.47 50.79 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 107.715 -1.217 . . . . 64.12 107.715 171.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -140.24 120.69 14.08 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.863 0.865 . . . . 52.21 108.744 175.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.496 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -111.98 85.58 6.66 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 107.257 -1.386 . . . . 54.33 107.257 170.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.7 -26.57 53.16 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.799 2.333 . . . . 61.05 112.313 -173.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -108.5 5.24 25.02 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.469 -0.787 . . . . 64.23 111.078 -177.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.52 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -30.23 -67.18 0.15 Allowed Pre-proline 0 N--CA 1.498 1.959 0 C-N-CA 125.447 1.499 . . . . 51.03 114.868 -167.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 21.1 Cg_exo -61.95 -28.37 80.76 Favored 'Trans proline' 0 C--N 1.392 2.838 0 C-N-CA 122.043 1.828 . . . . 62.42 113.0 -170.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -94.03 -34.72 12.91 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.092 -0.958 . . . . 72.41 111.871 -172.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.682 HG22 HD12 ' B' ' 68' ' ' LEU . 9.9 p -72.19 -15.23 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 122.659 0.383 . . . . 72.34 111.202 -176.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -68.36 -9.81 50.67 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.557 0.743 . . . . 61.13 112.573 177.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.503 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.2 pt20 -67.0 -20.47 65.88 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.036 0.534 . . . . 32.01 110.808 174.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.503 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 99.5 mttt -103.03 110.78 22.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.991 1.316 . . . . 72.34 110.116 -175.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -112.92 97.31 6.46 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.692 0.397 . . . . 74.12 110.529 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 35.1 p90 -167.49 -171.31 1.64 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.439 1.096 . . . . 54.44 108.943 170.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 13.0 pm0 -71.36 111.39 10.01 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.482 0.713 . . . . 75.31 110.416 176.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.521 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 15.2 Cg_endo -65.61 152.14 82.62 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 121.204 1.27 . . . . 75.5 110.452 177.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 32.0 tt0 -69.72 99.85 1.4 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.787 -1.19 . . . . 71.23 107.787 173.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.472 HG23 ' O ' ' B' ' 38' ' ' PRO . 31.7 t -101.73 142.04 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 O-C-N 123.655 0.597 . . . . 73.34 110.134 -171.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -126.91 107.67 10.3 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.519 1.128 . . . . 62.41 108.51 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 17.9 tp -87.25 125.57 34.28 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.39 -0.966 . . . . 65.23 108.39 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -137.45 111.39 8.3 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.842 -1.17 . . . . 74.41 107.842 -170.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mp -100.99 140.65 34.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.039 0.536 . . . . 70.33 109.737 -175.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -142.96 145.33 32.89 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.107 0.963 . . . . 74.1 109.846 -177.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 4.0 t -126.37 104.62 8.27 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.701 0.8 . . . . 63.54 109.177 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.76 113.91 23.23 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.341 -1.355 . . . . 62.22 107.341 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 30.9 p -146.51 164.7 31.69 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.583 0.353 . . . . 73.01 111.819 -167.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 55.0 p -151.39 142.94 23.59 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.201 0.601 . . . . 52.41 110.83 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -82.6 111.83 18.93 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 109.315 -0.624 . . . . 73.4 109.315 172.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 pp -121.64 21.81 10.75 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.336 -0.847 . . . . 72.13 109.851 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -168.04 148.37 4.95 Favored 'General case' 0 C--N 1.361 1.079 0 C-N-CA 123.401 0.68 . . . . 64.43 111.743 176.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.62 141.26 46.56 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 107.609 -1.256 . . . . 64.2 107.609 158.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 70.05 -2.49 2.05 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.692 1.197 . . . . 75.4 112.472 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.443 HG11 HG23 ' B' ' 83' ' ' ILE . 24.8 t -141.08 127.47 20.29 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 CA-C-N 118.755 0.707 . . . . 70.54 109.821 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.475 ' HD2' HG22 ' B' ' 58' ' ' VAL . 14.9 t80 -115.67 138.48 51.05 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 106.976 -1.49 . . . . 73.12 106.976 171.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -100.88 99.89 10.44 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 106.958 -1.497 . . . . 71.33 106.958 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.475 HG22 ' HD2' ' B' ' 56' ' ' TYR . 32.3 t -96.11 127.35 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.152 -0.931 . . . . 62.43 109.589 -173.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.414 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 17.5 t -114.9 112.44 40.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 109.149 -0.686 . . . . 74.15 109.149 175.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 63.4 tp -94.2 107.25 19.2 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 116.018 -0.537 . . . . 73.41 109.586 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -85.68 108.58 18.09 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.954 -0.758 . . . . 62.53 108.954 171.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 39.8 t -104.38 103.17 14.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 106.842 -1.54 . . . . 73.01 106.842 175.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 25.6 m -99.46 141.57 32.07 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.176 -0.92 . . . . 74.34 109.506 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.642 HG11 HD21 ' B' ' 126' ' ' LEU . 41.5 t -133.77 118.29 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.128 0.971 . . . . 75.11 109.425 175.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 40.5 m -105.3 139.65 39.62 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.162 -1.421 . . . . 72.41 107.162 172.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -146.06 141.02 27.19 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.537 0.608 . . . . 54.23 110.536 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.559 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 19.8 m -143.12 128.37 18.75 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.452 0.47 . . . . 73.24 112.018 -172.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.682 HD12 HG22 ' B' ' 31' ' ' VAL . 90.4 mt -95.1 117.74 30.72 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.673 0.789 . . . . 73.23 109.007 176.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.51 -110.59 3.09 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.948 -0.861 . . . . 44.14 110.948 -172.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.22 6.38 8.47 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.771 0.829 . . . . 74.55 109.698 177.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -113.75 148.34 36.66 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.039 0.536 . . . . 75.51 109.627 -175.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 27.7 m -66.1 120.75 13.73 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.787 0.435 . . . . 73.41 110.966 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.631 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -73.53 -63.8 1.12 Allowed 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.612 -1.255 . . . . 70.34 107.612 172.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . 0.402 ' HZ ' HD22 ' B' ' 126' ' ' LEU . 39.4 p90 -152.59 161.82 42.06 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 114.405 -1.271 . . . . 62.23 111.087 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 58.1 mt -123.26 112.34 17.52 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 105.328 -2.101 . . . . 50.42 105.328 171.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.525 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 47.5 t -120.43 139.94 52.11 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.612 -0.884 . . . . 71.43 108.612 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -157.09 135.47 11.31 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.273 -0.64 . . . . 55.25 109.273 -174.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 62.6 t -132.88 147.54 31.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.097 -0.956 . . . . 74.21 108.798 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.594 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 17.9 mt-30 -123.68 106.95 10.95 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.073 -1.084 . . . . 65.33 108.073 168.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.446 ' O ' HD13 ' B' ' 106' ' ' LEU . 8.2 tp-100 -97.03 104.39 16.4 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.356 -0.979 . . . . 73.13 108.356 176.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.466 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -94.77 167.57 27.05 Favored Glycine 0 C--N 1.338 0.649 0 O-C-N 123.543 0.527 . . . . 65.43 111.969 175.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.15 138.52 5.26 Favored Glycine 0 C--N 1.341 0.826 0 C-N-CA 121.156 -0.545 . . . . 70.42 114.053 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.443 HG23 HG11 ' B' ' 55' ' ' VAL . 70.3 mt -86.37 114.36 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 124.862 1.265 . . . . 62.42 108.184 169.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -126.31 133.4 51.4 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.278 0.631 . . . . 74.54 110.514 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 58.3 m -89.39 106.06 18.2 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.573 0.749 . . . . 71.14 110.767 175.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.59 HG22 HD11 ' B' ' 89' ' ' ILE . 54.9 mt -116.95 104.74 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 125.274 1.43 . . . . 72.31 108.395 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.12 166.7 23.47 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.938 0.895 . . . . 54.4 110.648 -174.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.6 -53.17 2.7 Favored Glycine 0 N--CA 1.476 1.36 0 O-C-N 123.111 0.257 . . . . 53.13 112.635 177.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.606 HG23 ' HB3' ' B' ' 9' ' ' MET . 0.5 OUTLIER -62.5 166.38 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 124.283 1.033 . . . . 74.5 112.271 171.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -159.79 151.9 20.68 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.108 -0.951 . . . . 73.15 110.41 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.67 -127.7 9.02 Favored Glycine 0 C--N 1.354 1.562 0 CA-C-N 116.365 -0.379 . . . . 30.22 113.179 174.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.6 m -79.8 -39.31 31.12 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.995 0.903 . . . . 71.14 110.292 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -60.77 -34.38 74.39 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 113.217 -1.81 . . . . 74.53 111.731 -168.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.533 ' SD ' ' N ' ' B' ' 95' ' ' ALA . 2.1 ppp? -65.72 -46.09 80.22 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.091 -0.959 . . . . 72.2 111.822 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . 0.533 ' N ' ' SD ' ' B' ' 94' ' ' MET . . . -79.44 -12.45 59.89 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.472 0.709 . . . . 63.11 112.724 -175.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -62.4 -34.74 77.33 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 110.18 -0.304 . . . . 64.24 110.18 167.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -68.67 -51.18 44.67 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.944 0.498 . . . . 34.03 111.049 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.511 ' HG ' ' HA ' ' B' ' 95' ' ' ALA . 4.2 pp -70.82 -27.81 64.15 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.636 0.375 . . . . 75.44 111.687 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.1 3.82 67.15 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-O 119.142 -0.81 . . . . 72.42 114.185 -174.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.95 -51.88 0.1 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 117.948 0.874 . . . . 74.51 112.257 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -71.52 -40.36 70.18 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.051 0.54 . . . . 72.13 111.263 -175.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.475 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 72.3 m -68.87 -48.51 29.42 Favored Pre-proline 0 CA--C 1.56 1.337 0 CA-C-O 118.544 -0.741 . . . . 74.22 111.493 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 89.1 Cg_exo -53.5 -32.72 64.47 Favored 'Trans proline' 0 C--N 1.399 3.189 0 C-N-CA 122.636 2.224 . . . . 74.11 113.627 169.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -61.94 -34.84 76.82 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.366 0.666 . . . . 74.35 111.47 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.439 HD13 HD11 ' B' ' 13' ' ' ILE . 72.4 mt -75.99 -41.45 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.765 0.826 . . . . 73.14 110.195 176.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.446 HD13 ' O ' ' B' ' 80' ' ' GLN . 78.2 mt -71.29 -25.0 62.25 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 114.718 -1.128 . . . . 75.2 111.207 -176.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -62.63 -52.14 67.2 Favored Pre-proline 0 CA--C 1.552 1.024 0 CA-C-O 117.363 -1.304 . . . . 73.2 113.2 -172.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -54.06 -40.26 82.18 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.266 1.977 . . . . 72.33 113.023 177.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.521 ' CD1' HG21 ' B' ' 16' ' ' ILE . 5.2 m-30 -65.92 -44.13 86.05 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.981 -1.009 . . . . 73.02 110.495 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.81 -37.16 73.22 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.889 0.876 . . . . 73.34 111.456 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.659 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 52.4 ttt-85 -65.73 -54.88 21.28 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.243 1.417 . . . . 71.24 110.815 -176.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -73.23 -18.06 61.28 Favored 'General case' 0 CA--C 1.551 0.982 0 O-C-N 123.898 0.749 . . . . 61.32 110.06 -177.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.47 ' O ' ' HG2' ' B' ' 117' ' ' MET . 15.6 t -72.8 -42.1 64.24 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 122.739 0.416 . . . . 73.44 109.93 172.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.525 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 75.3 mt -57.52 -54.32 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 123.637 0.775 . . . . 73.31 109.704 171.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.41 HG21 ' OG ' ' C' ' 119' ' ' SER . 21.3 m -59.43 -29.91 68.11 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 124.34 1.025 . . . . 72.23 111.517 -177.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.6 t -68.39 -47.83 66.32 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.004 0.522 . . . . 71.21 110.357 174.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.6 mmt -69.66 -30.14 67.76 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.83 0.452 . . . . 71.45 111.115 -176.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.406 HG23 ' O ' ' B' ' 114' ' ' ILE . 91.0 t -67.68 -41.87 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.194 0.998 . . . . 74.44 109.861 172.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.8 t -66.86 -29.72 69.7 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.206 -0.906 . . . . 73.42 111.058 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' B' ' 116' ' ' SER . 84.5 mtt-85 -72.11 -35.2 69.11 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 123.116 0.566 . . . . 64.34 109.66 176.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.3 -9.85 81.41 Favored Glycine 0 C--N 1.354 1.562 0 O-C-N 123.531 0.519 . . . . 73.43 112.42 170.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.2 m 69.95 25.52 4.87 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 125.444 1.497 . . . . 71.55 110.643 174.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -78.38 165.26 51.33 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 124.043 0.937 . . . . 75.13 111.764 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.04 163.77 4.04 Favored 'Trans proline' 0 C--N 1.392 2.851 0 C-N-CA 123.313 2.675 . . . . 75.14 113.673 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -64.83 113.59 3.91 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.128 -0.942 . . . . 71.04 112.175 -171.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.642 HD21 HG11 ' B' ' 64' ' ' VAL . 48.6 tp -112.57 88.63 2.87 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 115.829 -0.623 . . . . 74.44 109.774 177.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -93.92 110.13 21.82 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.763 -1.199 . . . . 70.35 107.763 169.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.659 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 74.1 mt -65.46 146.32 55.02 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.331 0.253 . . . . 71.33 111.047 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.74 144.94 98.9 Favored Pre-proline 0 CA--C 1.55 0.964 0 O-C-N 124.406 1.066 . . . . 65.05 112.387 -173.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -68.11 84.47 0.44 Allowed 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.919 2.413 . . . . 62.31 111.61 173.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 19.8 m -101.28 126.92 55.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-O 121.2 0.524 . . . . 73.54 109.976 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 54.4 t30 . . . . . 0 C--O 1.244 0.785 0 N-CA-C 108.04 -1.096 . . . . 73.53 108.04 172.113 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 29.6 t80 . . . . . 0 C--O 1.24 0.561 0 N-CA-C 107.1 -1.444 . . . . 73.43 107.1 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -140.49 114.8 9.26 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.891 -1.151 . . . . 73.31 107.891 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 37.6 mt -72.31 131.75 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.639 -0.875 . . . . 74.44 108.639 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -86.59 -49.47 7.52 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.352 -0.61 . . . . 71.15 109.352 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.577 HH21 ' HD2' ' D' ' 32' ' ' PHE . 0.0 OUTLIER -178.36 151.83 0.64 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.48 1.112 . . . . 71.34 109.104 173.213 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 pp -109.43 151.7 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 107.653 -1.24 . . . . 64.21 107.653 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.561 ' HE1' HG12 ' C' ' 83' ' ' ILE . 49.2 p90 -172.28 153.35 2.98 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.145 0.43 . . . . 64.53 111.245 -176.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.2 p -85.31 111.59 20.02 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.704 -0.68 . . . . 72.33 111.533 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.463 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 31.2 mmtp -65.52 -33.07 75.06 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.382 0.673 . . . . 74.55 110.733 170.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -151.79 146.28 25.6 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.7 -1.136 . . . . 71.21 109.756 -177.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.467 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 80.8 mt -142.84 139.81 27.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 106.37 -1.715 . . . . 73.14 106.37 171.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.4 t -154.27 147.53 24.85 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.452 0.644 . . . . 73.14 109.901 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -146.94 136.33 22.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 106.811 -1.551 . . . . 71.12 106.811 172.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -137.94 133.44 33.75 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.502 -0.925 . . . . 62.41 108.502 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.11 77.65 6.11 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 108.197 -1.038 . . . . 62.24 108.197 172.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.34 -27.8 28.05 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.761 2.308 . . . . 63.32 111.144 177.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -99.08 14.33 29.66 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.773 -1.103 . . . . 73.54 111.052 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.463 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -45.59 -55.39 12.41 Favored Pre-proline 0 N--CA 1.49 1.525 0 C-N-CA 124.429 1.092 . . . . 75.35 113.11 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 32.4 Cg_exo -59.55 -46.47 20.62 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.062 1.842 . . . . 73.43 112.316 -177.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -69.71 -32.51 71.13 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.567 -1.197 . . . . 73.24 112.534 -174.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.642 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.1 p -79.5 -29.27 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 111.991 0.367 . . . . 75.24 111.991 -176.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -63.75 -32.28 73.73 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.704 0.401 . . . . 74.3 111.838 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -88.62 17.3 5.58 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.211 0.604 . . . . 72.44 111.621 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.408 ' HG2' HD13 ' C' ' 68' ' ' LEU . 2.4 ttpm? -120.33 152.06 38.37 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.076 0.951 . . . . 74.34 110.552 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -59.27 129.46 42.16 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.368 1.067 . . . . 65.31 111.361 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -85.49 85.7 7.41 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.973 0.909 . . . . 72.33 110.749 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -131.53 78.36 71.47 Favored Pre-proline 0 N--CA 1.479 1.008 0 N-CA-C 107.118 -1.438 . . . . 63.5 107.118 171.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -93.44 143.4 2.0 Allowed 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.538 2.158 . . . . 75.4 113.312 -175.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -85.5 98.21 10.48 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 106.686 -1.598 . . . . 74.45 106.686 159.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 94.7 t -76.48 99.52 2.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.14 -1.059 . . . . 75.32 108.14 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -90.8 100.72 13.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.148 -1.797 . . . . 71.32 106.148 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.585 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.5 pt? -97.44 162.0 13.52 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 115.626 -0.716 . . . . 74.52 109.587 -174.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.82 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 25.6 m-20 -142.32 146.26 34.83 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.744 0.818 . . . . 74.5 110.055 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.527 HD11 HG11 ' C' ' 131' ' ' VAL . 95.1 mt -134.53 111.12 9.83 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.771 0.828 . . . . 74.04 108.949 174.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.401 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 5.7 t70 -116.43 142.87 46.29 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.27 1.428 . . . . 73.24 107.277 173.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.6 t -152.69 152.67 31.99 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.752 -0.462 . . . . 74.13 109.752 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.82 157.63 38.19 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.466 0.706 . . . . 63.52 109.988 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 6.2 m -130.01 144.59 51.41 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.134 0.574 . . . . 61.14 109.629 176.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 37.8 p -145.29 127.48 15.71 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.672 0.789 . . . . 53.53 109.438 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -75.99 120.65 21.61 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.475 0.71 . . . . 74.03 110.51 -177.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' C' ' 57' ' ' GLU . 40.6 mt -91.42 -31.06 16.16 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.427 0.691 . . . . 44.33 110.661 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.55 -177.41 5.92 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.778 0.831 . . . . 72.22 110.375 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -65.24 119.71 11.41 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.769 -0.65 . . . . 73.23 110.116 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 65.94 11.56 7.79 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.902 1.281 . . . . 73.13 112.126 -175.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.3 t -116.23 111.59 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.051 -0.722 . . . . 61.14 109.051 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -123.0 124.2 42.6 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.965 -1.124 . . . . 74.42 107.965 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.577 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.1 tt0 -85.78 137.96 32.42 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.773 -0.825 . . . . 74.31 108.773 170.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.66 138.43 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 108.27 -1.011 . . . . 54.21 108.27 170.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 44.9 t -127.07 133.74 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 109.283 -0.636 . . . . 74.43 109.283 174.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.486 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -117.56 105.24 11.86 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.669 -1.234 . . . . 70.43 107.669 -177.886 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.401 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 16.9 ttm-85 -81.62 108.36 15.12 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.599 0.76 . . . . 75.11 109.505 171.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 44.0 t -104.78 119.06 53.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 108.015 -1.106 . . . . 74.13 108.015 171.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.82 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 79.2 m -114.66 145.41 42.05 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.056 0.942 . . . . 71.41 108.95 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 35.7 t -135.45 112.43 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.69 1.196 . . . . 73.14 108.314 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.7 m -101.77 122.66 44.37 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.309 -0.997 . . . . 72.15 108.309 168.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.6 119.24 38.93 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.148 -1.427 . . . . 74.01 107.148 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 32.2 m -141.25 129.01 21.64 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.109 0.255 . . . . 74.13 110.343 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.408 HD13 ' HG2' ' C' ' 34' ' ' LYS . 23.0 mt -86.56 44.08 1.12 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.506 1.122 . . . . 73.42 109.914 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.95 -104.96 2.54 Favored Glycine 0 C--N 1.344 1.019 0 N-CA-C 110.275 -1.13 . . . . 74.12 110.275 -172.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -90.85 -31.52 16.42 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.57 0.748 . . . . 72.22 109.438 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -65.91 121.56 15.35 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.71 1.204 . . . . 54.43 110.478 174.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 52.2 m -83.87 120.27 25.87 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.973 -0.751 . . . . 45.44 108.973 167.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.642 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.94 -55.07 8.12 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 123.945 0.778 . . . . 54.04 108.944 174.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -162.03 162.5 28.86 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 115.446 -0.797 . . . . 74.13 110.316 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.434 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.9 tm? -114.33 142.65 46.04 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 106.491 -1.67 . . . . 65.04 106.491 163.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.434 ' N ' HD13 ' C' ' 75' ' ' LEU . 46.1 t -145.06 143.49 30.46 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.29 -1.004 . . . . 34.53 108.29 175.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -156.98 130.01 7.8 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.465 -0.569 . . . . 74.13 109.465 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 86.0 t -130.96 122.19 51.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.504 -0.924 . . . . 61.55 108.504 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -99.05 88.46 3.97 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.839 -1.171 . . . . 75.25 107.839 177.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -79.36 100.17 7.48 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.972 -1.013 . . . . 74.15 109.633 -175.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -82.09 174.55 53.7 Favored Glycine 0 C--O 1.237 0.316 0 CA-C-N 115.923 -0.58 . . . . 52.22 112.301 174.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.79 126.67 1.17 Allowed Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 111.786 -0.526 . . . . 72.24 111.786 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.561 HG12 ' HE1' ' C' ' 17' ' ' TYR . 31.7 mm -87.13 126.45 40.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.241 -1.022 . . . . 75.24 108.241 174.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -127.93 118.56 23.83 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.534 0.734 . . . . 63.24 109.431 -177.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 28.5 p -84.67 102.11 12.69 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.588 -0.893 . . . . 74.21 108.588 169.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 29.6 mt -115.43 118.59 59.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.692 1.197 . . . . 54.14 109.702 -175.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -124.96 170.1 11.44 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.712 0.805 . . . . 74.35 109.898 174.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.98 -39.64 2.68 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 116.432 -0.349 . . . . 65.53 113.616 171.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 39.8 pt -103.93 165.33 3.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 123.283 0.633 . . . . 70.2 111.574 -171.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -159.92 154.35 23.84 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.254 -0.884 . . . . 74.22 109.195 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.2 -120.41 17.94 Favored Glycine 0 C--N 1.346 1.084 0 O-C-N 123.534 0.521 . . . . 63.25 113.579 174.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 35.1 p -61.6 -40.63 95.49 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.574 0.75 . . . . 72.2 111.831 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -63.49 -49.58 73.04 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.837 0.455 . . . . 75.41 110.908 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 6.2 tpt -52.36 -54.06 36.66 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 124.239 0.962 . . . . 65.43 111.909 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.63 -42.33 96.68 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.292 0.567 . . . . 73.13 111.639 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -65.4 -31.77 73.05 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.729 1.211 . . . . 61.44 111.037 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 48.7 t -76.63 -27.67 55.78 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.286 -0.87 . . . . 61.31 110.864 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 94.3 mt -94.53 -32.14 13.6 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.672 0.789 . . . . 72.13 112.975 -172.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.03 -8.0 37.19 Favored Glycine 0 N--CA 1.473 1.123 0 CA-C-O 119.963 -0.354 . . . . 41.32 113.7 -173.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.23 -54.42 1.11 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.853 0.461 . . . . 70.34 110.874 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.507 ' OH ' ' HB3' ' A' ' 130' ' ' PRO . 52.2 t80 -73.4 -49.84 24.98 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.898 -0.592 . . . . 64.22 112.0 -170.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.401 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 68.0 m -63.23 -47.74 84.44 Favored Pre-proline 0 CA--C 1.557 1.228 0 CA-C-O 118.64 -0.695 . . . . 74.43 111.55 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.486 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 78.1 Cg_exo -56.43 -31.8 86.89 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.453 2.102 . . . . 72.05 113.594 170.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -68.02 -32.48 72.89 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.971 0.508 . . . . 74.21 110.726 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.654 HD12 HH12 ' A' ' 111' ' ' ARG . 10.0 mm -72.62 -41.68 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 109.509 -0.552 . . . . 65.44 109.509 174.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 85.0 mt -74.48 -23.62 58.9 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.899 0.88 . . . . 73.23 112.238 -175.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . 0.401 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 53.7 t80 -59.77 -53.43 65.62 Favored Pre-proline 0 N--CA 1.48 1.027 0 CA-C-O 117.431 -1.271 . . . . 62.14 113.445 -174.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . 0.401 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 51.1 Cg_exo -56.29 -36.59 97.13 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 121.84 1.693 . . . . 74.2 113.155 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -67.4 -47.53 70.03 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.27 0.628 . . . . 74.34 111.271 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.2 -38.93 88.33 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.176 0.99 . . . . 71.41 110.601 177.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -64.72 -47.26 78.93 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.165 1.386 . . . . 73.04 110.178 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -67.48 -34.03 76.32 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 123.861 0.726 . . . . 54.51 110.062 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.6 t -72.11 -34.58 68.72 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.933 0.493 . . . . 71.31 111.052 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.413 HG23 ' SG ' ' C' ' 76' ' ' CYS . 65.2 mt -73.91 -50.36 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 122.856 0.462 . . . . 62.25 110.34 176.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.1 m -65.71 -28.43 69.06 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.101 0.56 . . . . 64.54 110.872 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 29.3 t -62.85 -49.18 75.89 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 108.951 -0.759 . . . . 72.3 108.951 169.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.528 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.64 -36.47 78.72 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.322 1.049 . . . . 74.14 112.629 179.04 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.4 HG23 ' O ' ' C' ' 114' ' ' ILE . 92.3 t -62.65 -49.25 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.544 0.737 . . . . 63.11 109.603 175.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.41 ' OG ' HG21 ' B' ' 115' ' ' THR . 29.2 t -65.44 -32.91 74.78 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.978 -1.01 . . . . 72.13 111.552 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.492 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 76.5 mtt-85 -67.18 -37.6 83.97 Favored 'General case' 0 C--O 1.214 -0.8 0 C-N-CA 123.448 0.699 . . . . 71.33 109.465 176.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.84 8.15 70.98 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.31 -0.717 . . . . 72.32 113.249 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.409 HG23 ' HB3' ' D' ' 17' ' ' TYR . 81.0 p 55.6 33.66 21.62 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.05 1.74 . . . . 73.51 113.124 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -93.28 145.7 30.52 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 108.431 -0.951 . . . . 74.5 108.431 171.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -51.32 148.58 18.77 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 123.72 2.946 . . . . 62.24 114.249 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -55.43 112.47 1.12 Allowed 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.274 0.984 . . . . 60.11 112.261 -176.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 53.8 tp -110.49 86.87 2.39 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.481 -1.236 . . . . 73.02 107.805 177.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -91.6 101.62 14.25 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.555 -0.906 . . . . 74.33 108.555 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.9 127.84 33.35 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.898 0.879 . . . . 75.21 110.393 -174.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.72 151.48 94.71 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 123.916 0.886 . . . . 34.33 111.811 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.497 ' HG3' HD12 ' A' ' 16' ' ' ILE . 51.6 Cg_exo -52.95 107.93 0.23 Allowed 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.017 2.478 . . . . 63.24 112.995 175.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . 0.527 HG11 HD11 ' C' ' 44' ' ' LEU . 6.3 p -101.56 124.25 55.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 109.254 -0.647 . . . . 65.43 109.254 175.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -85.54 104.65 15.5 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.176 0.59 . . . . 63.35 109.686 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -66.05 -22.41 66.43 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.948 -0.569 . . . . 71.14 111.493 176.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -71.18 -36.57 72.02 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.566 0.541 . . . . 71.42 109.802 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.71 -43.35 99.02 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.441 -0.8 . . . . 71.33 110.22 172.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 73.5 mt -71.3 -25.74 62.56 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.855 0.862 . . . . 63.32 111.537 178.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 40.2 t80 . . . . . 0 N--CA 1.472 0.667 0 C-N-CA 123.313 0.645 . . . . 73.43 110.01 -179.272 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 5.6 t . . . . . 0 C--O 1.243 0.76 0 N-CA-C 109.5 -0.555 . . . . 71.32 109.5 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.415 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 54.8 t80 -152.88 103.25 2.74 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.734 -1.21 . . . . 73.02 107.734 -175.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -112.68 128.67 56.46 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.252 -1.018 . . . . 75.53 108.252 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 12.8 mt -94.24 134.97 29.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.173 -1.047 . . . . 64.11 108.173 175.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -106.34 -33.45 7.76 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 122.779 0.431 . . . . 75.31 111.629 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -169.32 127.0 0.95 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 120.592 0.234 . . . . 61.02 111.594 -166.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.22 134.46 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 107.67 -1.233 . . . . 72.11 107.67 168.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' C' ' 120' ' ' ARG . 39.4 p90 -163.73 150.39 11.88 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-O 121.821 0.82 . . . . 72.53 111.873 175.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . 0.4 HG21 HD11 ' D' ' 21' ' ' ILE . 81.4 p -85.89 126.3 33.96 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.684 -1.144 . . . . 63.41 109.199 176.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -99.37 -14.22 19.27 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.349 -0.611 . . . . 73.5 109.349 175.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.675 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.2 t70 -160.02 136.87 9.2 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.309 1.044 . . . . 63.34 109.032 176.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.528 HG21 ' HE2' ' C' ' 117' ' ' MET . 65.7 mt -137.67 144.66 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.626 1.17 . . . . 73.33 108.121 174.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.1 t -146.62 139.28 25.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.185 0.994 . . . . 72.44 108.955 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.467 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 77.5 t80 -150.31 123.24 8.73 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.753 -1.573 . . . . 60.25 106.753 167.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -127.38 129.67 48.0 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.15 -0.685 . . . . 75.11 109.15 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.441 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -118.1 79.49 14.32 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 107.57 -1.27 . . . . 44.23 107.57 169.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.75 -35.06 13.38 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.375 2.05 . . . . 74.44 112.151 -171.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -104.99 6.51 33.52 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.101 0.96 . . . . 64.02 110.515 -174.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.496 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -23.65 -77.75 0.02 OUTLIER Pre-proline 0 CA--C 1.567 1.613 0 N-CA-C 117.428 2.381 . . . . 51.45 117.428 -169.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.463 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 87.1 Cg_endo -75.29 -17.48 18.9 Favored 'Trans proline' 0 C--N 1.388 2.652 0 CA-C-N 124.643 2.694 . . . . 73.41 113.224 -170.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.474 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 6.4 t-160 -70.88 -43.71 67.84 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.949 -0.76 . . . . 63.23 108.949 172.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.496 HG12 ' O ' ' D' ' 28' ' ' ALA . 4.8 p -83.88 -19.62 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 CA-C-N 115.748 -0.66 . . . . 73.44 111.517 -170.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.577 ' HD2' HH21 ' C' ' 15' ' ' ARG . 22.7 m-85 -67.4 -20.72 65.57 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 120.914 0.388 . . . . 62.41 111.416 177.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.474 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 58.8 mt-30 -64.31 -18.33 64.51 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.103 0.961 . . . . 64.23 111.083 174.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -92.19 81.54 5.01 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.747 1.219 . . . . 72.25 108.784 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -83.43 79.7 9.33 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 122.074 0.94 . . . . 75.1 111.062 -174.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -152.93 -174.91 5.1 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.092 -0.958 . . . . 65.14 109.041 169.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -77.21 114.59 41.52 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 123.516 0.726 . . . . 63.34 110.43 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -53.94 119.98 7.17 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 122.53 2.154 . . . . 61.31 110.764 172.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -67.2 108.83 2.84 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.76 -1.2 . . . . 74.0 107.76 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.749 HG13 HG13 ' D' ' 64' ' ' VAL . 93.9 t -100.88 132.51 46.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 CA-C-N 115.419 -0.809 . . . . 73.5 109.823 -171.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -115.24 118.94 34.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.569 -1.271 . . . . 73.21 107.569 173.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.621 HD11 HG13 ' D' ' 62' ' ' VAL . 37.9 tp -97.39 137.58 36.16 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.27 0.557 . . . . 64.34 110.131 -178.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.42 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 6.5 m-20 -133.66 122.19 23.08 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.028 1.331 . . . . 60.03 108.083 -175.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.416 ' CD2' HG22 ' D' ' 62' ' ' VAL . 89.1 mt -119.8 144.58 47.24 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.814 0.445 . . . . 74.42 110.759 -176.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.48 ' HB2' ' HB3' ' D' ' 61' ' ' ARG . 11.7 m-20 -142.13 134.61 28.05 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.218 1.007 . . . . 72.21 109.061 176.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . 0.451 HG21 ' HA2' ' D' ' 99' ' ' GLY . 59.1 m -104.15 139.05 39.76 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.154 -1.054 . . . . 64.1 108.154 168.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.42 141.05 21.72 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.585 -1.265 . . . . 50.21 107.585 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 30.8 p . . . . . 0 C--O 1.243 0.731 0 N-CA-C 109.806 -0.442 . . . . 75.53 109.806 -175.962 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' D' ' 85' ' ' SER . 80.9 m-20 . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 113.396 0.887 . . . . 71.54 113.396 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 9.0 m -129.64 110.2 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.402 -0.962 . . . . 74.23 108.402 169.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -126.88 132.58 50.89 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 109.31 -0.626 . . . . 73.2 109.31 -175.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -87.28 112.43 22.04 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.594 -0.891 . . . . 61.15 108.594 175.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.581 HG11 ' HD3' ' D' ' 103' ' ' PRO . 84.8 t -101.13 116.9 45.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.322 -0.992 . . . . 70.0 108.322 176.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.479 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 26.3 t -102.71 129.36 54.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 108.777 -0.823 . . . . 61.35 108.777 176.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' D' ' 79' ' ' GLN . 0.1 OUTLIER -110.31 122.78 48.48 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.41 -0.959 . . . . 74.43 108.41 -178.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.48 ' HB3' ' HB2' ' D' ' 45' ' ' ASP . 49.3 ttp180 -98.53 101.47 12.91 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.996 -0.742 . . . . 75.35 108.996 173.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.621 HG13 HD11 ' D' ' 42' ' ' LEU . 61.9 t -98.24 113.64 33.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 114.898 -1.046 . . . . 62.23 108.678 173.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.42 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 11.0 m -122.44 124.22 43.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.356 -0.838 . . . . 73.21 109.706 -172.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.749 HG13 HG13 ' D' ' 40' ' ' VAL . 39.9 t -109.15 123.24 64.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 C-N-CA 125.409 1.484 . . . . 62.03 108.774 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 20.4 m -113.52 101.27 9.19 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.902 -1.147 . . . . 62.31 107.902 169.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.47 142.95 41.53 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.636 -0.711 . . . . 75.22 109.105 -173.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.473 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 17.1 p -149.72 134.0 17.32 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.746 0.647 . . . . 73.1 112.746 -171.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.449 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 34.3 mt -109.06 112.01 23.96 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.797 1.239 . . . . 50.45 107.733 173.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.5 -140.41 22.7 Favored Glycine 0 C--N 1.344 1.004 0 O-C-N 123.286 0.367 . . . . 43.33 112.545 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.29 6.64 42.11 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.348 0.659 . . . . 63.01 111.799 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -132.35 173.99 10.71 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.885 0.474 . . . . 72.5 110.611 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 31.2 m -73.6 140.03 45.94 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.452 -0.794 . . . . 71.41 111.775 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.473 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.25 -67.19 0.84 Allowed 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.404 -1.332 . . . . 75.51 107.404 169.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -148.41 148.75 30.68 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.52 -1.218 . . . . 72.53 110.26 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 78.6 mt -103.41 150.38 23.89 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.73 1.212 . . . . 70.31 108.197 169.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.539 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.9 t -158.12 140.58 14.45 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.359 -0.608 . . . . 73.33 109.359 176.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -155.54 127.62 7.61 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.106 0.562 . . . . 61.42 109.698 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.93 114.97 34.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 123.126 0.57 . . . . 62.04 109.553 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.675 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.0 mt-30 -90.71 85.67 6.13 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.872 0.844 . . . . 72.34 109.394 171.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -81.18 101.44 9.67 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 113.818 -1.537 . . . . 74.4 109.726 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.42 143.89 17.56 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 112.273 -0.331 . . . . 72.31 112.273 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.65 134.0 6.57 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 111.855 -0.498 . . . . 74.04 111.855 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 61.6 mt -89.23 103.17 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 107.925 -1.139 . . . . 72.24 107.925 175.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -108.78 144.11 37.05 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.807 0.843 . . . . 73.22 110.641 -177.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' D' ' 54' ' ' ASP . 16.4 p -116.46 137.34 52.24 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.679 0.792 . . . . 55.44 110.097 171.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.449 HG12 HD11 ' D' ' 89' ' ' ILE . 6.3 tt -145.24 138.68 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.394 0.678 . . . . 60.15 110.81 -163.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.26 170.76 9.83 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.425 0.69 . . . . 61.43 111.645 175.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.61 7.58 61.56 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 115.748 -0.66 . . . . 45.51 112.793 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.462 HG22 ' NE2' ' D' ' 93' ' ' GLN . 1.4 pp -140.1 149.96 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.542 1.137 . . . . 45.43 110.225 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.9 173.26 17.26 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.746 0.819 . . . . 72.32 110.456 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.86 -118.26 4.68 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 114.781 0.673 . . . . 64.41 114.781 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 54.2 p -90.08 -44.67 9.66 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.384 0.674 . . . . 63.13 111.388 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.462 ' NE2' HG22 ' D' ' 89' ' ' ILE . 12.8 pt20 -66.86 -23.61 66.04 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 113.177 0.806 . . . . 71.44 113.177 -172.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 21.7 ptm -56.72 -51.31 69.33 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 113.851 1.056 . . . . 73.41 113.851 -174.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.9 -12.85 59.71 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.577 0.751 . . . . 65.34 112.411 -168.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -61.8 -37.62 85.05 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.942 0.497 . . . . 74.25 110.53 171.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 61.8 m -66.72 -25.48 66.54 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.876 -0.602 . . . . 72.03 111.943 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.444 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 89.6 mt -92.84 -39.34 11.25 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.815 0.846 . . . . 73.05 111.281 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . 0.451 ' HA2' HG21 ' D' ' 46' ' ' THR . . . -90.53 -1.85 73.9 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.622 -0.717 . . . . 44.3 113.54 -171.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.23 -49.64 0.13 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.157 0.429 . . . . 72.34 112.157 -173.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -73.63 -42.99 60.73 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 118.168 0.44 . . . . 72.55 111.958 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 89.8 m -60.27 -48.83 93.07 Favored Pre-proline 0 CA--C 1.562 1.425 0 CA-C-O 118.964 -0.541 . . . . 75.44 112.091 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.581 ' HD3' HG11 ' D' ' 58' ' ' VAL . 37.6 Cg_endo -65.54 -24.88 55.7 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 121.924 1.749 . . . . 63.33 112.835 173.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -67.98 -31.13 70.63 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.561 0.344 . . . . 65.21 110.262 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 37.5 mm -73.02 -38.92 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.025 0.93 . . . . 73.03 110.829 173.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' D' ' 103' ' ' PRO . 71.6 mt -69.76 -26.92 64.53 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.333 0.653 . . . . 70.05 111.899 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -62.82 -41.61 72.85 Favored Pre-proline 0 CA--C 1.554 1.132 0 N-CA-C 113.93 1.085 . . . . 74.41 113.93 -170.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -47.12 -45.43 21.54 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.205 1.937 . . . . 73.3 114.087 167.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -79.9 -32.69 40.22 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.678 0.791 . . . . 72.42 111.961 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.39 -36.14 66.0 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.236 0.614 . . . . 75.21 110.153 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.505 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.8 ttp180 -66.18 -45.1 82.02 Favored 'General case' 0 C--O 1.208 -1.116 0 CA-C-N 114.839 -1.073 . . . . 73.25 109.305 171.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -55.05 -48.56 73.29 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.958 0.903 . . . . 72.3 111.302 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.417 ' O ' ' HG3' ' D' ' 117' ' ' MET . 46.0 t -58.35 -45.8 87.49 Favored 'General case' 0 C--N 1.347 0.487 0 O-C-N 124.22 0.95 . . . . 74.23 111.032 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.539 HG12 ' SG ' ' D' ' 76' ' ' CYS . 45.1 mt -64.06 -55.04 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.111 0.565 . . . . 72.23 110.915 177.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.2 m -50.71 -40.66 54.8 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.354 1.462 . . . . 71.5 111.455 -176.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 34.4 t -66.66 -47.85 71.22 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.912 -1.04 . . . . 55.33 110.434 177.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.417 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 64.2 mtm -69.57 -29.5 67.06 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.495 0.554 . . . . 74.14 112.495 -175.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.419 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.4 t -67.82 -44.44 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.503 0.721 . . . . 62.31 109.471 176.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 65.9 p -71.66 -28.44 63.75 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 115.626 -0.716 . . . . 74.42 110.048 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' D' ' 116' ' ' SER . 92.7 mtt-85 -71.79 -30.05 65.12 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.82 0.848 . . . . 73.14 110.191 173.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.85 8.64 77.18 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 123.642 0.588 . . . . 71.32 112.748 176.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.411 HG23 ' HB3' ' C' ' 17' ' ' TYR . 82.0 p 54.91 31.12 15.2 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 126.165 1.786 . . . . 44.44 113.99 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -95.27 153.19 39.72 Favored Pre-proline 0 C--O 1.245 0.819 0 N-CA-C 107.702 -1.222 . . . . 61.2 107.702 168.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.49 150.33 60.75 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.657 2.238 . . . . 54.25 112.314 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -59.15 122.02 12.76 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.768 0.827 . . . . 72.44 111.829 -169.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.444 HD13 HG21 ' D' ' 40' ' ' VAL . 19.8 tp -107.42 100.68 10.09 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.066 0.947 . . . . 44.52 109.087 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -100.04 104.97 16.59 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.214 -1.032 . . . . 71.32 108.214 172.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.505 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 2.9 mm? -66.57 115.73 6.76 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 109.183 -0.673 . . . . 64.4 109.183 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.475 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -57.24 129.48 79.61 Favored Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 123.294 0.638 . . . . 34.5 112.087 -172.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 1.2 Cg_endo -79.05 117.09 3.8 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.068 2.512 . . . . 74.24 111.243 -175.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 14.8 p -127.03 149.21 31.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 123.697 0.799 . . . . 73.11 109.126 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -69.75 113.73 7.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.908 -0.775 . . . . 70.21 108.908 172.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 . . . . . 0 N--CA 1.481 1.121 0 C-N-CA 123.898 0.879 . . . . 73.1 111.213 -178.637 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 58.5 m . . . . . 0 C--O 1.235 0.295 0 N-CA-C 107.08 -1.452 . . . . 62.52 107.08 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -131.66 118.82 20.55 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.047 -0.724 . . . . 74.43 109.047 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.486 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 0.0 OUTLIER -136.98 131.7 33.3 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 106.603 -1.628 . . . . 75.24 106.603 175.171 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.462 ' CD1' HG21 ' A' ' 105' ' ' ILE . 6.4 mt -94.38 107.54 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.496 -0.928 . . . . 73.04 108.496 173.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.96 -40.31 68.75 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.519 -0.919 . . . . 74.43 108.519 -176.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 -173.89 122.85 0.33 Allowed 'General case' 0 C--N 1.351 0.655 0 CA-C-N 115.949 -0.569 . . . . 54.51 110.527 -169.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.572 HD12 ' HG3' ' C' ' 130' ' ' PRO . 65.0 mt -106.49 134.72 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 107.979 -1.119 . . . . 72.33 107.979 169.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.5 ' HE1' HG13 ' A' ' 83' ' ' ILE . 30.9 p90 -164.5 178.79 7.14 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 124.165 0.916 . . . . 74.24 110.807 -172.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.1 p -109.47 124.15 50.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.624 -0.716 . . . . 60.22 109.316 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.414 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 42.7 mtpt -86.46 -30.73 21.81 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.66 -0.496 . . . . 75.54 109.66 175.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.46 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 31.9 t70 -149.6 145.59 26.86 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.065 -0.97 . . . . 52.44 109.739 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.3 mt -141.02 146.02 24.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 C-N-CA 125.086 1.354 . . . . 74.41 107.835 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.2 t -152.15 137.7 17.76 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.55 0.74 . . . . 41.15 109.791 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.502 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 92.2 t80 -144.42 132.49 21.6 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.993 -1.484 . . . . 71.4 106.993 173.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -133.05 111.75 11.23 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.869 -0.789 . . . . 74.24 108.869 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -104.36 81.92 0.57 Allowed Pre-proline 0 C--O 1.245 0.817 0 N-CA-C 106.415 -1.698 . . . . 65.3 106.415 161.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.56 -29.05 25.46 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.282 1.988 . . . . 72.24 111.281 -172.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -111.45 19.1 18.53 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-N 114.451 -1.25 . . . . 52.23 109.297 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.49 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -44.83 -49.35 28.17 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 113.633 0.975 . . . . 55.34 113.633 -171.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -59.82 -39.62 70.71 Favored 'Trans proline' 0 C--N 1.392 2.858 0 C-N-CA 121.686 1.591 . . . . 75.12 112.744 176.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.432 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 3.7 m-70 -76.72 -38.04 55.0 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.223 -1.353 . . . . 62.32 110.588 -173.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.473 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.6 p -72.6 -25.68 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 124.563 1.145 . . . . 63.21 111.281 -163.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -76.21 -18.82 58.88 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.557 0.743 . . . . 74.41 110.98 176.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -85.11 -28.21 25.74 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.171 0.989 . . . . 71.41 110.258 173.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 1.3 mmmp? -79.35 159.69 27.04 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.291 1.036 . . . . 55.45 111.735 -173.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.85 119.74 9.96 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.853 0.861 . . . . 65.31 110.353 176.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -82.47 85.18 6.98 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.543 0.687 . . . . 64.5 110.16 -178.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.504 ' H ' HD22 ' A' ' 68' ' ' LEU . 8.3 tp-100 -121.07 76.05 30.32 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.673 1.189 . . . . 75.34 108.263 172.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.53 113.11 2.81 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.599 2.199 . . . . 71.21 112.622 -171.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -94.69 92.17 6.88 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.585 -1.265 . . . . 73.3 107.585 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.496 HG22 ' HB2' ' A' ' 66' ' ' ALA . 61.5 t -89.44 106.38 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.718 -1.128 . . . . 63.2 111.037 -173.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -86.45 140.43 29.98 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.372 0.669 . . . . 62.41 110.561 171.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.9 mt -106.67 106.21 16.61 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.038 -1.097 . . . . 74.12 108.038 171.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -107.4 108.59 20.02 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.691 1.196 . . . . 70.2 108.157 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.55 HD11 HG21 ' A' ' 131' ' ' VAL . 83.7 mt -104.25 155.07 19.04 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.692 0.758 . . . . 64.23 112.249 -170.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 17.3 t70 -158.2 139.45 13.36 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 113.705 -1.589 . . . . 64.52 108.357 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.8 m -138.87 122.25 17.16 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.163 -0.681 . . . . 75.53 109.163 175.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.86 111.8 11.91 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.56 0.744 . . . . 62.42 109.213 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 p -91.66 153.1 19.91 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.384 0.674 . . . . 71.32 110.342 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.2 t -149.64 121.21 8.0 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.711 0.804 . . . . 63.24 109.454 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -71.35 112.48 7.52 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.56 -0.533 . . . . 74.11 109.56 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' A' ' 57' ' ' GLU . 46.8 mt -81.28 -43.76 18.69 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.128 0.571 . . . . 63.51 109.76 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.77 178.76 8.58 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.282 -0.872 . . . . 74.53 110.074 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.32 129.43 39.89 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 109.311 -0.626 . . . . 74.12 109.311 175.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 63.18 18.75 11.21 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.368 1.067 . . . . 72.03 111.262 -175.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.2 t -130.85 102.53 6.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.821 0 C-N-CA 124.374 1.069 . . . . 74.14 108.576 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -113.74 123.19 49.28 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.524 -1.287 . . . . 74.34 107.524 175.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.554 ' HB2' HD11 ' A' ' 51' ' ' LEU . 32.8 tt0 -85.46 151.38 24.02 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.686 -0.857 . . . . 73.12 108.686 173.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.423 HG11 ' HD3' ' A' ' 103' ' ' PRO . 70.2 t -130.3 135.57 60.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.137 -1.06 . . . . 73.11 108.137 169.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.2 t -117.49 128.35 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.748 -0.834 . . . . 75.21 108.748 173.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.95 100.03 9.55 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 106.769 -1.567 . . . . 53.15 106.769 176.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.495 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 21.0 ttp180 -86.83 101.61 13.51 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.617 -0.883 . . . . 72.41 108.617 173.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 37.3 t -97.85 126.95 50.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 107.442 -1.318 . . . . 71.0 107.442 173.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.6 m -124.05 123.48 40.45 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.499 -0.926 . . . . 51.31 108.499 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.591 HG11 HD21 ' A' ' 126' ' ' LEU . 69.3 t -117.09 135.42 57.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 124.843 1.257 . . . . 63.52 108.472 -174.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 30.6 m -136.47 127.93 28.54 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 109.657 -0.498 . . . . 64.13 109.657 169.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.496 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -106.05 128.3 53.76 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 107.025 -1.472 . . . . 75.23 107.025 172.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.1 m -132.21 129.82 40.2 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.05 0.54 . . . . 61.04 110.884 -175.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.504 HD22 ' H ' ' A' ' 37' ' ' GLN . 17.2 mt -89.92 51.48 2.08 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.355 1.462 . . . . 64.24 109.917 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.3 -86.37 1.12 Allowed Glycine 0 C--N 1.349 1.271 0 CA-C-N 116.228 -0.442 . . . . 55.15 113.097 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.42 -28.94 20.58 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.504 0.722 . . . . 73.33 111.044 -177.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -111.69 135.79 51.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.067 0.947 . . . . 64.11 109.181 -174.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.6 m -76.64 134.03 39.42 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.392 -0.596 . . . . 64.41 109.392 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.473 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -77.55 -60.2 2.46 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.436 0.694 . . . . 43.11 109.69 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -153.38 163.22 40.3 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.092 -0.958 . . . . 61.41 111.027 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.401 HD12 ' H ' ' A' ' 76' ' ' CYS . 28.1 tp -126.1 142.63 51.44 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.057 1.343 . . . . 74.03 108.277 173.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.571 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.2 m -137.77 139.49 40.1 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.784 1.234 . . . . 73.25 108.318 176.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -148.7 124.34 10.44 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.955 -0.757 . . . . 72.3 108.955 169.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.5 t -128.66 119.87 51.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 109.041 -0.725 . . . . 71.13 109.041 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.495 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 51.9 mt-30 -92.97 85.5 5.15 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.286 -1.005 . . . . 75.21 108.286 172.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -76.2 94.78 3.58 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 114.363 -1.29 . . . . 61.2 109.183 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.0 145.47 19.27 Favored Glycine 0 C--N 1.341 0.828 0 N-CA-C 111.399 -0.681 . . . . 72.4 111.399 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.12 122.93 1.9 Allowed Glycine 0 CA--C 1.507 -0.415 0 N-CA-C 110.455 -1.058 . . . . 51.11 110.455 -176.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.5 HG13 ' HE1' ' A' ' 17' ' ' TYR . 53.0 mt -80.36 115.83 23.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 107.93 -1.137 . . . . 74.13 107.93 173.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.807 ' HB3' HD11 ' A' ' 86' ' ' ILE . 98.3 m-85 -120.3 123.78 43.98 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.92 -0.77 . . . . 74.35 108.92 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.486 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 17.8 m -86.33 94.28 9.31 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.631 -0.878 . . . . 33.43 108.631 176.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.807 HD11 ' HB3' ' A' ' 84' ' ' PHE . 6.3 mm -109.48 147.98 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 122.151 0.181 . . . . 63.42 110.598 -175.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.432 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -172.33 177.84 2.98 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.386 1.075 . . . . 71.11 109.566 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.88 -24.09 27.97 Favored Glycine 0 N--CA 1.467 0.75 0 CA-C-O 120.246 -0.197 . . . . 51.1 113.192 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.485 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -129.54 170.16 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.816 0.846 . . . . 71.12 110.87 -176.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -155.55 179.15 9.45 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.337 -0.847 . . . . 72.05 109.478 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.53 -122.0 28.61 Favored Glycine 0 C--N 1.347 1.165 0 C-N-CA 123.531 0.586 . . . . 52.31 114.033 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.8 p -73.04 -30.81 64.0 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.032 0.933 . . . . 65.54 111.887 -176.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -71.19 -37.21 72.13 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.136 0.574 . . . . 74.05 110.189 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.403 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 4.9 tpt -66.47 -46.44 76.37 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.726 -0.67 . . . . 72.34 109.997 175.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.1 -35.6 75.58 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.654 -0.703 . . . . 53.1 110.798 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -71.12 -35.11 71.64 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.232 0.613 . . . . 73.03 111.327 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -65.12 -44.01 90.11 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 109.437 -0.579 . . . . 62.25 109.437 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.403 ' HG ' ' HE2' ' A' ' 94' ' ' MET . 33.0 mt -82.75 -27.53 31.02 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.213 -0.903 . . . . 73.35 112.534 -175.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.07 4.29 38.52 Favored Glycine 0 N--CA 1.473 1.16 0 CA-C-O 119.689 -0.506 . . . . 73.15 114.124 -171.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.93 -67.67 0.29 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 117.388 0.594 . . . . 54.01 111.503 -176.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -66.97 -47.76 70.58 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 112.506 0.558 . . . . 64.3 112.506 -172.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 86.6 m -64.55 -48.44 74.35 Favored Pre-proline 0 CA--C 1.561 1.397 0 CA-C-O 118.364 -0.827 . . . . 72.51 112.635 -177.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.423 ' HD3' HG11 ' A' ' 58' ' ' VAL . 32.5 Cg_endo -64.42 -24.08 64.45 Favored 'Trans proline' 0 C--N 1.395 2.999 0 C-N-CA 121.671 1.58 . . . . 71.51 112.797 172.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -67.7 -36.67 81.07 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.179 0.592 . . . . 71.04 110.38 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.462 HG21 ' CD1' ' A' ' 13' ' ' ILE . 44.2 mm -69.37 -42.5 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.635 0.774 . . . . 71.4 110.133 173.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.2 mt -72.41 -23.88 61.16 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.153 -0.931 . . . . 72.42 112.068 -174.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -66.41 -41.33 40.64 Favored Pre-proline 0 N--CA 1.484 1.262 0 N-CA-C 114.306 1.225 . . . . 74.21 114.306 -171.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -50.0 -44.39 37.57 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 121.92 1.746 . . . . 65.33 113.214 168.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -74.67 -36.37 62.8 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.627 0.771 . . . . 74.21 111.709 -177.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.19 -46.65 64.17 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.345 0.658 . . . . 44.41 109.846 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.535 ' NH1' HD12 ' C' ' 105' ' ' ILE . 33.2 ttm105 -49.72 -54.8 16.69 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.812 1.32 . . . . 71.23 109.994 173.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -63.06 -44.26 96.31 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.156 0.91 . . . . 71.54 111.798 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.453 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.6 t -61.79 -31.89 72.14 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.919 0.487 . . . . 73.54 111.432 -179.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.498 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 71.1 mt -71.49 -54.95 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.602 0.761 . . . . 75.15 109.657 172.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 46.2 m -56.32 -35.12 67.21 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.039 1.336 . . . . 72.11 111.605 -173.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.5 t -69.81 -44.24 70.41 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 114.956 -1.02 . . . . 74.25 109.734 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.502 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 51.7 mtm -63.42 -38.83 92.67 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.886 0.474 . . . . 74.14 110.715 177.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 114' ' ' ILE . 84.9 t -61.51 -47.85 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 124.399 1.08 . . . . 62.21 110.475 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.8 p -74.24 -34.38 63.62 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.124 0.569 . . . . 54.13 111.393 -175.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.524 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.1 mtt-85 -70.7 -27.22 63.83 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.744 0.818 . . . . 75.44 109.696 174.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.52 7.24 62.06 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.361 -0.836 . . . . 75.24 112.714 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.461 HG21 ' HE ' ' B' ' 15' ' ' ARG . 36.0 m 72.88 9.21 5.49 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 124.625 1.17 . . . . 70.13 112.083 173.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -83.91 139.91 40.21 Favored Pre-proline 0 C--O 1.244 0.794 0 O-C-N 121.225 -0.922 . . . . 71.35 108.785 173.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -56.31 141.5 88.79 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.282 1.988 . . . . 75.13 110.85 174.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -56.57 140.43 46.57 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 124.324 1.015 . . . . 72.55 113.08 -165.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.591 HD21 HG11 ' A' ' 64' ' ' VAL . 31.6 tp -119.56 105.29 11.08 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 113.665 -1.607 . . . . 71.32 109.424 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -99.28 118.85 36.87 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 107.941 -1.133 . . . . 75.54 107.941 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 11.9 mt -70.75 147.14 49.31 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.616 0.573 . . . . 72.04 110.012 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -64.55 132.52 95.42 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 123.043 0.537 . . . . 41.13 110.329 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 25.8 Cg_exo -62.87 116.85 3.81 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.794 2.329 . . . . 45.23 112.221 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.55 HG21 HD11 ' A' ' 44' ' ' LEU . 87.3 t -99.04 130.46 47.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 C-N-CA 123.131 0.572 . . . . 73.42 110.549 -172.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -90.76 89.06 7.33 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 108.324 -0.991 . . . . 54.04 108.324 174.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -65.03 -23.17 67.12 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.512 0.725 . . . . 74.33 112.373 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.31 -39.37 82.03 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.484 0.714 . . . . 64.34 110.29 174.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.88 83.94 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.237 0.615 . . . . 60.51 110.309 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 60.3 mt -65.54 -41.32 93.19 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.033 0.533 . . . . 65.34 111.052 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.7 t80 . . . . . 0 N--CA 1.47 0.561 0 CA-C-N 115.432 -0.803 . . . . 71.04 109.808 178.414 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.533 ' HG3' HG13 ' B' ' 89' ' ' ILE . 26.3 ttt . . . . . 0 CA--C 1.562 1.435 0 CA-C-O 121.789 0.804 . . . . 60.1 112.109 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 41.7 m -142.39 101.98 4.0 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 107.262 -1.384 . . . . 60.3 107.262 172.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -123.54 132.96 54.04 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.547 -0.909 . . . . 74.54 108.547 175.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -157.8 140.34 14.64 Favored 'General case' 0 C--O 1.244 0.768 0 O-C-N 123.768 0.667 . . . . 73.22 109.621 171.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.591 HD13 HD11 ' B' ' 16' ' ' ILE . 41.2 mt -67.81 131.52 33.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 114.774 -1.103 . . . . 64.1 109.624 177.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -94.9 -45.41 7.3 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.984 -0.747 . . . . 41.41 108.984 173.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.461 ' HE ' HG21 ' A' ' 122' ' ' THR . 16.4 ttt180 -169.96 131.68 1.06 Allowed 'General case' 0 C--N 1.353 0.725 0 CA-C-N 115.494 -0.775 . . . . 72.15 110.301 -174.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.591 HD11 HD13 ' B' ' 13' ' ' ILE . 93.9 mt -115.11 146.0 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 108.057 -1.09 . . . . 64.0 108.057 174.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -168.31 149.65 5.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 112.813 0.672 . . . . 71.33 112.813 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 46.4 m -76.84 123.82 26.8 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 114.834 -1.075 . . . . 74.11 109.61 170.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.589 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.4 mtpt -96.6 -17.65 20.27 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.602 0.761 . . . . 62.01 111.326 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -164.31 141.84 6.78 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 123.649 0.593 . . . . 35.25 110.406 -174.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.456 HD12 ' SG ' ' B' ' 113' ' ' CYS . 30.5 mm -130.9 144.35 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.062 0.945 . . . . 74.21 108.957 170.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 34.7 t -149.59 140.96 23.24 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.961 -1.018 . . . . 75.03 109.032 174.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.416 ' HB2' ' HB3' ' B' ' 117' ' ' MET . 91.5 t80 -148.2 124.83 11.09 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.07 -1.456 . . . . 71.51 107.07 169.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -132.18 112.92 12.7 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.527 0.731 . . . . 70.34 109.233 -177.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.568 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -107.8 87.69 3.84 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.469 -1.308 . . . . 71.15 107.469 171.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.3 -27.28 34.63 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.532 2.155 . . . . 72.22 112.081 -172.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.506 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 78.6 m-20 -110.4 9.71 23.42 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.069 0.948 . . . . 70.2 110.911 -177.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.568 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -30.64 -66.35 0.17 Allowed Pre-proline 0 N--CA 1.493 1.68 0 C-N-CA 125.668 1.587 . . . . 42.55 115.23 -167.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.507 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 28.8 Cg_exo -58.51 -36.27 97.61 Favored 'Trans proline' 0 C--N 1.398 3.173 0 C-N-CA 122.13 1.887 . . . . 72.2 113.266 -174.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -86.63 -37.66 17.83 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.168 -0.924 . . . . 71.14 111.79 -171.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.493 HG21 ' HA ' ' B' ' 73' ' ' ALA . 8.7 p -71.06 -9.21 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.371 0.668 . . . . 71.12 111.64 -174.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -72.87 -9.52 58.78 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.112 0.565 . . . . 71.41 112.301 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -67.97 -28.89 67.84 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.232 0.613 . . . . 61.11 110.221 171.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.44 ' HB2' HD13 ' B' ' 68' ' ' LEU . 30.5 mmtp -81.55 102.19 10.45 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.573 1.149 . . . . 52.34 108.941 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -107.38 87.95 2.62 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 120.956 0.408 . . . . 70.21 110.857 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -169.61 172.08 7.13 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.772 1.229 . . . . 71.01 108.64 169.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.7 117.74 53.71 Favored Pre-proline 0 N--CA 1.479 1.0 0 N-CA-C 109.021 -0.733 . . . . 73.04 109.021 175.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.432 ' O ' HG23 ' B' ' 40' ' ' VAL . 16.8 Cg_endo -60.52 150.21 82.65 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.245 1.963 . . . . 73.53 112.546 -176.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -70.64 112.31 6.78 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.087 -1.079 . . . . 72.23 108.087 172.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 38' ' ' PRO . 59.9 t -105.53 146.79 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 115.361 -0.836 . . . . 72.02 110.818 -172.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -129.78 106.44 8.7 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 106.933 -1.506 . . . . 74.44 106.933 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.44 HD13 HG22 ' B' ' 64' ' ' VAL . 23.6 tp -90.38 125.48 35.56 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.621 -0.511 . . . . 73.53 109.621 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -130.92 155.71 46.31 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.521 1.128 . . . . 71.42 108.112 -178.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.2 162.91 34.28 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.439 0.695 . . . . 62.53 111.547 -173.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.661 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 8.7 m-20 -138.5 126.11 22.08 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.753 1.221 . . . . 74.15 109.394 175.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 7.8 t -114.98 111.14 20.68 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.544 0.687 . . . . 64.13 109.902 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.41 141.85 21.64 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.812 0.845 . . . . 75.34 109.013 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.434 ' HB3' ' HA ' ' B' ' 58' ' ' VAL . 79.0 p -142.07 172.22 12.99 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.571 0.348 . . . . 72.03 111.183 -176.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 54.4 p -151.27 141.37 22.17 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.387 0.675 . . . . 75.35 110.407 -174.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . 0.466 ' HB2' ' CE1' ' B' ' 56' ' ' TYR . 43.5 tt0 -85.98 103.71 14.94 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 109.218 -0.66 . . . . 72.53 109.218 173.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 pp -126.07 24.94 6.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.352 -0.84 . . . . 72.23 109.027 174.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.85 157.67 24.36 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.535 -1.211 . . . . 53.55 109.7 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -83.18 104.47 13.39 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.524 0.73 . . . . 75.35 111.575 -167.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 58.16 23.97 10.81 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 124.696 1.198 . . . . 71.43 111.534 -172.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 85.9 t -131.13 115.85 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 113.788 -1.551 . . . . 60.41 107.288 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.466 ' CE1' ' HB2' ' B' ' 50' ' ' GLN . 0.2 OUTLIER -104.78 140.92 37.38 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.107 0.563 . . . . 61.51 109.769 -174.167 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -100.18 97.64 8.42 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.481 -1.303 . . . . 64.15 107.481 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.434 ' HA ' ' HB3' ' B' ' 48' ' ' SER . 55.3 t -93.06 126.97 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 123.642 0.777 . . . . 70.44 110.078 -177.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.429 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 20.3 t -107.22 142.77 19.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 123.453 0.701 . . . . 74.33 109.426 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.471 HD13 ' HB3' ' B' ' 103' ' ' PRO . 52.7 tp -129.73 108.8 10.46 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.253 -1.017 . . . . 74.54 108.253 171.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.661 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 37.9 ttm180 -87.06 115.34 24.38 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.063 -1.088 . . . . 72.05 108.063 171.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 25.1 t -103.89 119.4 52.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.548 -1.279 . . . . 71.11 107.548 173.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 24.4 m -119.83 128.81 54.04 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.207 -0.664 . . . . 73.34 109.207 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.587 HG11 HD21 ' B' ' 126' ' ' LEU . 84.9 t -117.96 109.55 27.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 123.975 0.91 . . . . 62.44 109.102 -175.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 99.5 m -89.13 138.04 31.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.676 -1.231 . . . . 71.45 107.676 168.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.41 141.09 25.61 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.191 -0.67 . . . . 71.05 109.191 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.46 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 31.9 p -145.28 138.07 26.15 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.522 0.514 . . . . 71.31 111.221 -173.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' B' ' 34' ' ' LYS . 77.7 mt -110.97 102.21 10.71 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.487 1.115 . . . . 71.32 109.159 176.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.77 -137.45 19.47 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.129 -0.788 . . . . 52.03 111.129 -172.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -92.54 3.14 56.11 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 117.405 0.602 . . . . 70.4 110.613 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.506 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 16.7 pt-20 -113.68 151.87 31.23 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.013 0.525 . . . . 74.44 109.654 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 60.7 m -72.88 133.23 44.32 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.119 -0.491 . . . . 54.51 110.216 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.493 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -84.23 -64.57 1.14 Allowed 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.883 -1.155 . . . . 54.34 107.883 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -155.36 158.88 39.4 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.45 -1.25 . . . . 71.52 110.581 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 53.4 mt -132.35 108.89 9.49 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 106.432 -1.692 . . . . 74.12 106.432 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 48.5 t -119.5 116.34 25.89 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.076 -0.713 . . . . 74.34 109.076 -177.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.411 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 43.9 tt0 -124.67 121.76 35.61 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.761 -0.829 . . . . 74.03 108.761 -175.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 79.4 t -126.41 135.37 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.89 0.876 . . . . 74.23 109.014 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -107.7 119.77 40.36 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.073 -1.084 . . . . 74.31 108.073 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.432 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 8.0 tp-100 -110.03 106.01 15.35 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.659 -0.867 . . . . 73.32 108.659 174.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.589 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -98.94 160.81 20.13 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.189 -0.764 . . . . 45.43 111.189 174.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.32 126.2 1.7 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 112.18 -0.368 . . . . 53.02 112.18 -174.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -85.39 114.17 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 N-CA-C 107.718 -1.215 . . . . 74.1 107.718 173.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -129.75 143.66 50.92 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.043 0.937 . . . . 73.03 109.774 -175.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.3 m -88.98 123.3 33.18 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.47 -0.567 . . . . 55.22 109.47 172.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.567 HG22 HD11 ' B' ' 89' ' ' ILE . 4.2 mp -122.98 115.64 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 N-CA-C 108.159 -1.052 . . . . 75.11 108.159 177.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.91 172.64 17.71 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.786 0.835 . . . . 73.0 110.389 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.402 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 88.73 -37.93 3.25 Favored Glycine 0 N--CA 1.481 1.669 0 C-N-CA 123.042 0.353 . . . . 62.11 113.942 172.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.567 HD11 HG22 ' B' ' 86' ' ' ILE . 0.8 OUTLIER -81.15 169.14 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 124.433 1.093 . . . . 73.41 111.87 176.304 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -154.06 175.18 13.73 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.282 -0.872 . . . . 65.53 110.349 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.1 -136.87 27.41 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.802 -0.635 . . . . 4.04 113.221 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.4 m -93.82 -29.16 15.48 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.01 0.524 . . . . 64.12 110.907 -177.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -56.19 -29.55 61.05 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.916 0.887 . . . . 72.13 111.224 175.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.413 ' SD ' ' N ' ' B' ' 95' ' ' ALA . 0.7 OUTLIER -66.8 -57.2 7.53 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.612 1.565 . . . . 75.31 112.592 -179.237 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . 0.413 ' N ' ' SD ' ' B' ' 94' ' ' MET . . . -78.41 -15.12 59.01 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 111.958 0.355 . . . . 51.05 111.958 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -59.51 -30.03 68.28 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.834 0.854 . . . . 64.35 110.499 169.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -63.48 -55.38 24.59 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.072 0.549 . . . . 65.42 111.774 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.487 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.6 pp -69.45 -31.96 70.6 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.631 0.372 . . . . 73.53 111.961 -174.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.02 -23.77 51.0 Favored Glycine 0 C--N 1.348 1.207 0 O-C-N 123.379 0.424 . . . . 35.14 113.567 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.43 -59.28 1.39 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.054 0.542 . . . . 71.1 112.002 -169.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -64.48 -43.74 93.19 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.266 0.626 . . . . 74.15 111.798 -174.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 79.8 m -65.59 -48.13 65.88 Favored Pre-proline 0 CA--C 1.566 1.58 0 CA-C-O 118.309 -0.853 . . . . 63.22 112.201 -176.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.471 ' HB3' HD13 ' B' ' 60' ' ' LEU . 85.8 Cg_exo -53.47 -34.55 72.4 Favored 'Trans proline' 0 C--N 1.397 3.122 0 C-N-CA 122.557 2.171 . . . . 70.23 113.829 170.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -65.4 -29.47 70.18 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.14 0.576 . . . . 70.55 111.941 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.418 HG23 ' NH2' ' D' ' 111' ' ' ARG . 62.6 mt -71.56 -41.54 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.085 0.554 . . . . 65.43 109.858 174.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.4 mt -78.3 -29.87 48.06 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 114.79 -1.096 . . . . 53.24 112.453 -169.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -55.67 -49.6 91.82 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-O 117.739 -1.124 . . . . 73.2 113.304 -174.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -48.12 -47.51 19.23 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 122.907 2.405 . . . . 53.23 114.695 176.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -65.01 -46.27 82.1 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.137 0.575 . . . . 75.43 110.931 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.432 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -62.41 -39.54 93.61 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.204 -0.907 . . . . 63.42 110.698 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.467 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 52.3 ttt-85 -62.92 -47.06 84.9 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.552 1.541 . . . . 74.41 111.213 -176.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.23 -34.95 73.49 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.598 0.561 . . . . 72.53 110.09 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.524 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 8.8 t -68.58 -36.61 78.96 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.612 -0.267 . . . . 71.14 111.082 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.522 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 85.0 mt -59.49 -53.65 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.745 0.818 . . . . 73.44 109.897 169.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 54.5 m -57.13 -32.54 66.46 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.654 0.781 . . . . 70.31 111.546 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.475 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 42.8 t -63.79 -49.8 71.5 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.666 0.786 . . . . 64.42 109.891 174.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.524 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.5 mmt -70.67 -30.76 67.45 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.096 0.558 . . . . 73.24 111.54 -175.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.483 HG23 ' O ' ' B' ' 114' ' ' ILE . 95.3 t -66.35 -41.74 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.667 0.787 . . . . 72.52 109.704 173.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.2 t -65.83 -32.22 73.62 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.879 -1.055 . . . . 53.11 110.804 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' B' ' 116' ' ' SER . 88.1 mtt-85 -70.02 -34.71 73.64 Favored 'General case' 0 C--O 1.206 -1.23 0 CA-C-N 115.782 -0.644 . . . . 74.15 110.179 176.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.05 -13.89 82.77 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.428 0.455 . . . . 71.52 112.364 170.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.6 m 69.55 24.1 5.73 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 125.125 1.37 . . . . 21.33 110.519 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.487 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 71.5 m-85 -77.57 159.05 77.87 Favored Pre-proline 0 N--CA 1.477 0.91 0 CA-C-N 114.875 -1.057 . . . . 73.13 110.366 175.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.14 158.56 4.99 Favored 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 123.204 2.603 . . . . 53.32 113.794 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.466 HE21 ' ND2' ' B' ' 127' ' ' ASN . 42.6 tp60 -62.14 126.35 27.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.71 0.804 . . . . 73.34 112.459 -170.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.587 HD21 HG11 ' B' ' 64' ' ' VAL . 39.6 tp -109.81 101.13 10.02 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-N 115.225 -0.898 . . . . 61.23 109.131 178.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.466 ' ND2' HE21 ' B' ' 125' ' ' GLN . 21.6 m-80 -99.25 105.69 17.74 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 107.187 -1.412 . . . . 61.53 107.187 167.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.467 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 46.8 mt -63.64 127.88 33.34 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.332 -0.618 . . . . 71.54 109.332 175.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.01 148.47 92.47 Favored Pre-proline 0 CA--C 1.553 1.078 0 O-C-N 123.775 0.672 . . . . 60.34 111.225 -175.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -69.57 90.3 0.5 Allowed 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.872 2.381 . . . . 65.04 111.863 -174.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 81.9 t -95.45 109.75 23.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.611 -0.885 . . . . 73.22 108.611 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 41.7 t30 . . . . . 0 C--O 1.24 0.6 0 N-CA-C 107.549 -1.278 . . . . 62.25 107.549 171.691 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 66.6 t80 . . . . . 0 N--CA 1.471 0.586 0 N-CA-C 107.317 -1.364 . . . . 72.35 107.317 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -141.27 136.03 31.23 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 120.919 0.39 . . . . 71.03 110.177 175.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.44 HG12 ' HE2' ' C' ' 84' ' ' PHE . 16.2 mt -75.92 120.11 25.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 115.083 -0.962 . . . . 72.44 108.407 174.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.523 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.0 mm-40 -87.88 -39.08 15.1 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 123.639 0.587 . . . . 75.44 109.486 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.3 ptt-85 177.96 153.86 0.31 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.513 1.125 . . . . 63.0 110.392 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 70.7 mt -135.05 125.69 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.179 1.391 . . . . 74.3 107.262 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.408 ' HB3' HG23 ' D' ' 122' ' ' THR . 29.8 p90 -164.42 158.68 18.73 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.229 0.538 . . . . 62.01 111.408 -166.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.7 p -87.8 109.63 19.88 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.455 -0.793 . . . . 54.51 110.164 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.534 ' HD2' ' HB3' ' D' ' 28' ' ' ALA . 13.8 mtmt -82.39 -16.68 48.2 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 110.069 -0.345 . . . . 74.42 110.069 172.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.684 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.4 t70 -153.7 139.01 17.53 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.862 -0.608 . . . . 71.44 109.911 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.6 mt -141.57 145.75 24.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 106.57 -1.641 . . . . 73.24 106.57 173.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.4 t -157.23 144.99 18.98 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.262 0.553 . . . . 74.12 110.2 173.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -142.93 129.68 20.4 Favored 'General case' 0 C--O 1.225 -0.208 0 N-CA-C 107.054 -1.462 . . . . 74.11 107.054 170.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -135.73 112.56 10.2 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.24 -0.652 . . . . 73.25 109.24 -175.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.25 85.73 5.77 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 106.981 -1.488 . . . . 24.55 106.981 168.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.26 -19.96 37.81 Favored 'Trans proline' 0 C--N 1.383 2.38 0 C-N-CA 122.69 2.26 . . . . 63.55 111.874 -174.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -120.02 31.01 6.71 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.332 1.053 . . . . 74.43 109.022 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.56 -60.63 2.77 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 114.24 1.2 . . . . 53.3 114.24 -170.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.21 -32.71 41.84 Favored 'Trans proline' 0 C--N 1.379 2.152 0 CA-C-N 121.34 1.514 . . . . 75.15 111.926 -177.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.538 ' HA ' HE21 ' C' ' 33' ' ' GLN . 81.4 t60 -69.32 -38.34 78.18 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.662 -1.153 . . . . 60.11 111.986 -177.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' C' ' 73' ' ' ALA . 13.9 p -79.08 -29.55 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 112.075 0.398 . . . . 73.13 112.075 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -62.61 -30.01 71.03 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.013 0.525 . . . . 62.13 112.383 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.538 HE21 ' HA ' ' C' ' 30' ' ' HIS . 29.3 pt20 -88.59 7.13 34.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.201 0.6 . . . . 71.01 111.949 178.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.403 ' HG2' HD13 ' C' ' 68' ' ' LEU . 2.8 ttpm? -114.71 143.2 45.43 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.659 0.783 . . . . 61.03 110.076 175.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.66 131.79 49.06 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.559 1.144 . . . . 72.11 111.985 -175.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . 0.42 ' HZ2' HD21 ' C' ' 126' ' ' LEU . 75.3 t-105 -74.41 87.58 2.05 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.653 1.181 . . . . 64.51 111.683 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . 0.424 ' H ' HD22 ' C' ' 68' ' ' LEU . 47.2 mt-30 -132.91 73.05 76.27 Favored Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 124.253 1.021 . . . . 75.32 108.732 169.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -91.39 148.92 3.57 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.816 2.344 . . . . 61.32 112.598 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -88.25 81.12 7.38 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 107.268 -1.382 . . . . 72.11 107.268 164.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.54 113.3 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 CA-C-N 114.911 -1.041 . . . . 73.34 109.964 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -94.02 101.31 13.35 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.561 -0.903 . . . . 72.11 108.561 175.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 tt -87.81 129.82 35.07 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 106.97 -1.493 . . . . 74.55 106.97 176.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 14.2 t70 -128.93 140.56 51.61 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.08 0.952 . . . . 64.41 109.477 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.447 HD23 HG22 ' C' ' 62' ' ' VAL . 45.5 mt -125.95 111.12 14.4 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.616 -0.883 . . . . 70.51 108.616 172.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -122.46 121.32 36.33 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 107.74 -1.207 . . . . 54.34 107.74 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.3 t -121.32 144.18 48.78 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.324 -0.621 . . . . 61.14 109.324 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.99 151.56 42.62 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.907 0.883 . . . . 74.45 108.729 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 56.7 p -138.06 143.4 40.47 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 122.863 0.465 . . . . 71.25 110.304 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 78.9 p -145.41 153.52 41.29 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.545 0.738 . . . . 74.23 110.006 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -81.94 118.02 22.63 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 109.035 -0.728 . . . . 75.14 109.035 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.651 HD11 ' HB2' ' C' ' 57' ' ' GLU . 87.5 mt -82.89 -53.14 6.08 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.32 0.648 . . . . 42.21 109.288 174.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.15 -172.59 3.52 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 114.206 -1.361 . . . . 24.44 109.14 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.44 107.73 1.44 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.702 0.801 . . . . 74.03 110.068 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 70.69 12.62 7.27 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.367 1.467 . . . . 63.52 112.683 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 90.4 t -110.55 118.92 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.064 -0.717 . . . . 72.42 109.064 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -121.5 129.98 53.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.621 1.169 . . . . 72.54 109.343 -174.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.651 ' HB2' HD11 ' C' ' 51' ' ' LEU . 44.8 tt0 -96.77 115.09 26.84 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.208 -0.664 . . . . 74.31 109.208 170.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 89.1 t -96.76 116.01 37.76 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 N-CA-C 107.894 -1.151 . . . . 62.2 107.894 169.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.46 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 61.0 t -103.76 131.53 52.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.882 -0.785 . . . . 74.42 108.882 173.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.47 98.51 8.27 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 107.709 -1.219 . . . . 64.04 107.709 172.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -82.44 106.78 14.59 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.525 -0.917 . . . . 75.41 108.525 172.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.448 ' HB ' HD11 ' C' ' 114' ' ' ILE . 12.8 t -104.61 125.19 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.906 -0.775 . . . . 64.1 108.906 177.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 89.9 m -110.23 130.7 55.5 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.94 -0.763 . . . . 54.32 108.94 178.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.668 HG21 HG21 ' C' ' 114' ' ' ILE . 97.4 t -124.37 109.05 21.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.506 -0.924 . . . . 52.34 108.506 174.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.8 m -101.56 141.89 33.75 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.824 -0.806 . . . . 72.41 108.824 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.21 117.96 18.92 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.266 -1.012 . . . . 73.51 108.266 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 37.3 m -140.03 125.99 19.64 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.201 0.313 . . . . 62.31 111.297 -177.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.424 HD22 ' H ' ' C' ' 37' ' ' GLN . 21.2 mt -87.9 46.63 1.4 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.728 1.211 . . . . 70.34 110.138 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.94 -114.45 4.65 Favored Glycine 0 C--N 1.344 1.011 0 N-CA-C 110.519 -1.033 . . . . 64.55 110.519 -170.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.18 -12.53 37.88 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.25 0.62 . . . . 73.4 110.395 174.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -75.27 121.33 22.02 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 124.359 1.064 . . . . 71.22 109.678 174.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.1 m -82.58 115.9 21.75 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 108.685 -0.858 . . . . 62.01 108.685 165.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.618 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -69.96 -48.57 57.83 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.148 -1.056 . . . . 64.33 108.148 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -168.22 172.11 8.85 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 114.316 -1.311 . . . . 73.14 111.27 175.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.438 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.9 tm? -127.56 144.51 51.06 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 106.667 -1.605 . . . . 72.31 106.667 166.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.438 ' N ' HD13 ' C' ' 75' ' ' LEU . 54.1 t -145.86 145.86 30.9 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.71 -0.848 . . . . 71.45 108.71 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -158.81 140.28 13.31 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.762 -0.459 . . . . 63.02 109.762 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 27.0 t -135.81 114.39 15.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 124.65 1.18 . . . . 73.32 107.875 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.684 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.4 mt-30 -94.27 89.07 5.79 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.951 -0.759 . . . . 75.22 108.951 171.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -79.96 96.47 6.42 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.576 -1.193 . . . . 74.45 109.108 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -82.78 145.09 23.42 Favored Glycine 0 C--N 1.343 0.945 0 N-CA-C 111.425 -0.67 . . . . 70.53 111.425 177.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.05 117.68 1.09 Allowed Glycine 0 CA--C 1.507 -0.42 0 N-CA-C 111.028 -0.829 . . . . 73.44 111.028 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.523 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 15.5 mm -86.01 131.44 34.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.859 -0.793 . . . . 74.14 108.859 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.44 ' HE2' HG12 ' C' ' 13' ' ' ILE . 94.6 m-85 -137.8 120.54 16.31 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.667 0.787 . . . . 75.42 109.913 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 17.1 p -79.9 100.51 8.09 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 108.282 -1.007 . . . . 64.42 108.282 170.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.545 HD13 ' SG ' ' C' ' 97' ' ' CYS . 15.6 mt -114.3 140.28 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 123.168 0.587 . . . . 71.5 109.698 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.96 158.27 36.28 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.512 1.125 . . . . 74.32 109.315 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.01 -18.54 57.25 Favored Glycine 0 C--O 1.246 0.903 0 N-CA-C 115.761 1.064 . . . . 62.02 115.761 166.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 13.5 pt -106.98 170.53 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 117.315 0.558 . . . . 63.34 111.225 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . 0.454 ' H ' HE21 ' C' ' 93' ' ' GLN . 12.4 tp10 -157.68 151.19 23.74 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.328 0.651 . . . . 74.02 110.65 -175.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.73 -121.99 10.02 Favored Glycine 0 C--N 1.348 1.213 0 O-C-N 123.929 0.768 . . . . 25.12 113.647 171.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.1 p -62.16 -30.56 71.14 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.836 0.855 . . . . 71.14 111.617 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.454 HE21 ' H ' ' C' ' 90' ' ' GLU . 17.4 mt-30 -69.98 -49.94 46.65 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.315 1.046 . . . . 72.3 111.137 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.04 -46.28 90.04 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 124.105 0.878 . . . . 73.14 110.429 176.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.39 90.92 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.477 0.711 . . . . 64.34 111.226 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -69.44 -35.88 76.11 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.221 0.609 . . . . 75.02 110.697 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.545 ' SG ' HD13 ' C' ' 86' ' ' ILE . 33.8 t -66.83 -51.28 57.51 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.871 0.732 . . . . 74.04 109.291 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 68.7 mt -74.85 -35.52 62.37 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.354 1.062 . . . . 64.33 113.063 -177.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.37 -14.05 33.97 Favored Glycine 0 N--CA 1.473 1.135 0 N-CA-C 115.032 0.773 . . . . 63.41 115.032 -165.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.507 ' HB2' ' HB2' ' C' ' 137' ' ' PHE . . . -138.01 -49.05 0.56 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 117.854 0.827 . . . . 60.41 111.944 -173.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -73.12 -49.95 25.51 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.951 0.901 . . . . 73.3 111.633 -172.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.402 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 84.5 m -67.25 -47.49 49.71 Favored Pre-proline 0 CA--C 1.564 1.516 0 C-N-CA 123.478 0.711 . . . . 72.03 112.233 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 52.9 Cg_exo -58.19 -27.8 81.74 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 122.464 2.109 . . . . 74.4 113.552 175.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -65.68 -38.27 88.79 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.188 0.595 . . . . 61.2 110.543 176.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.535 HD12 ' NH1' ' A' ' 111' ' ' ARG . 30.1 mm -71.01 -36.94 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 116.029 -0.532 . . . . 75.02 109.732 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 6.1 mp -79.19 -25.5 42.75 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.431 1.092 . . . . 75.41 112.768 -176.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . 0.403 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 56.6 t80 -57.23 -50.71 86.62 Favored Pre-proline 0 N--CA 1.479 0.997 0 CA-C-O 117.849 -1.072 . . . . 72.25 113.394 -172.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 38.7 Cg_exo -60.71 -34.21 92.19 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.016 1.81 . . . . 72.52 113.158 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -64.7 -47.87 76.75 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.226 0.61 . . . . 43.31 110.633 177.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.73 -35.51 80.29 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.775 -0.648 . . . . 54.54 110.788 177.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -61.31 -53.13 60.64 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.246 1.418 . . . . 74.42 110.593 -178.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . 0.405 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.7 tm-20 -66.07 -34.31 77.78 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.403 -0.817 . . . . 70.23 110.28 -178.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.0 t -67.06 -39.17 86.82 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.06 0.544 . . . . 65.32 111.099 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.668 HG21 HG21 ' C' ' 64' ' ' VAL . 87.1 mt -69.17 -50.78 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.371 0.669 . . . . 74.15 110.579 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.2 m -64.14 -28.69 69.94 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 123.486 0.491 . . . . 70.44 110.476 -176.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.4 t -64.44 -51.82 61.21 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 123.57 0.748 . . . . 62.51 109.704 171.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.43 ' CE ' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -50.33 -47.92 55.63 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 124.361 1.064 . . . . 73.03 112.013 177.101 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 91.8 t -67.95 -38.83 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 124.228 1.011 . . . . 53.43 111.12 -177.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 77.6 p -72.7 -30.44 64.21 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.188 0.595 . . . . 73.53 111.44 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' C' ' 116' ' ' SER . 86.8 mtt-85 -67.82 -39.83 83.86 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.239 1.016 . . . . 72.12 110.252 175.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.84 7.23 59.66 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-N 115.295 -0.866 . . . . 44.15 112.659 174.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 29.9 p 62.59 26.87 15.93 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.567 1.947 . . . . 75.11 113.46 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -87.3 152.29 52.41 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 107.821 -1.177 . . . . 71.14 107.821 166.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.17 169.11 6.61 Favored 'Trans proline' 0 C--N 1.369 1.653 0 C-N-CA 122.783 2.322 . . . . 65.13 113.383 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' B' ' 123' ' ' PHE . 57.4 mm-40 -59.86 113.46 2.29 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.405 -1.27 . . . . 70.31 112.485 -177.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.42 HD21 ' HZ2' ' C' ' 36' ' ' TRP . 63.6 mt -107.33 87.92 2.61 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.965 -1.124 . . . . 65.25 107.965 168.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -89.94 112.65 24.1 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.925 -1.139 . . . . 75.44 107.925 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 40.2 mt -64.73 129.64 40.56 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 123.434 0.459 . . . . 70.25 110.686 -175.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.53 150.65 93.75 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.571 0.748 . . . . 64.42 110.468 178.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.572 ' HG3' HD12 ' A' ' 16' ' ' ILE . 26.8 Cg_exo -59.81 105.39 0.27 Allowed 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.34 2.027 . . . . 72.3 112.268 174.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 35.7 t -99.52 117.36 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 108.12 -1.067 . . . . 52.24 108.12 176.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -77.08 103.37 6.97 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.826 0.85 . . . . 71.33 110.515 -172.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -65.78 -24.98 67.05 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.63 -0.714 . . . . 72.43 111.654 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -67.1 -40.07 86.83 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.327 0.651 . . . . 74.43 109.973 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.8 -45.79 91.01 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.362 0.665 . . . . 64.34 110.509 174.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 81.2 mt -69.34 -23.46 63.77 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.043 -0.98 . . . . 74.11 111.388 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' C' ' 100' ' ' ALA . 79.1 t80 . . . . . 0 C--O 1.217 -0.61 0 CA-C-N 116.313 -0.403 . . . . 72.21 110.104 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 24.3 m . . . . . 0 C--O 1.235 0.3 0 N-CA-C 109.168 -0.679 . . . . 74.22 109.168 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.496 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 50.6 t80 -133.98 98.61 4.2 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.457 -1.312 . . . . 64.0 107.457 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -132.51 127.97 36.33 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.257 -0.646 . . . . 71.2 109.257 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 6.1 mt -83.88 127.22 39.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 108.572 -0.899 . . . . 64.34 108.572 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . 0.505 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 75.1 mm-40 -81.96 -35.21 29.25 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.478 0.711 . . . . 73.32 110.302 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -171.25 133.8 0.87 Allowed 'General case' 0 C--N 1.357 0.914 0 O-C-N 123.737 0.648 . . . . 74.2 110.7 -175.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.434 HD12 ' N ' ' D' ' 16' ' ' ILE . 3.4 mp -105.57 141.85 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 107.144 -1.428 . . . . 72.34 107.144 171.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -166.72 152.92 8.45 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.438 0.637 . . . . 74.11 111.7 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 71.3 p -89.14 117.29 28.03 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 114.882 -1.054 . . . . 72.11 109.702 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -86.56 -29.74 22.42 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.652 -0.704 . . . . 60.41 109.371 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.6 t70 -150.87 142.15 23.28 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.815 -1.084 . . . . 65.31 109.589 176.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.43 HG21 ' CE ' ' C' ' 117' ' ' MET . 76.7 mt -140.73 141.07 32.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 C-N-CA 125.367 1.467 . . . . 72.02 107.402 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.7 t -147.21 144.29 28.81 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.681 0.793 . . . . 53.41 109.54 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.494 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.6 t80 -147.51 134.42 20.2 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 107.301 -1.37 . . . . 72.43 107.301 168.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.636 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 43.6 mt-10 -133.33 148.69 51.89 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.13 0.972 . . . . 74.1 108.954 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.418 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -150.73 80.07 6.92 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 107.44 -1.319 . . . . 55.23 107.44 171.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -67.46 -52.38 0.59 Allowed 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.545 2.163 . . . . 72.52 112.385 -174.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -87.61 19.63 3.31 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.457 0.703 . . . . 72.43 111.05 -176.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.534 ' HB3' ' HD2' ' C' ' 19' ' ' LYS . . . -48.26 -61.09 3.45 Favored Pre-proline 0 CA--C 1.556 1.201 0 N-CA-C 114.826 1.417 . . . . 25.21 114.826 -164.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.464 ' HB3' HD11 ' C' ' 83' ' ' ILE . 60.2 Cg_endo -68.13 -20.5 43.7 Favored 'Trans proline' 0 C--N 1.388 2.617 0 CA-C-N 121.704 1.644 . . . . 73.41 113.288 -173.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.422 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 6.1 t-160 -81.83 -40.72 22.09 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.987 -1.006 . . . . 61.53 110.795 177.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.434 HG22 HD12 ' D' ' 68' ' ' LEU . 9.8 p -83.12 -16.06 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 O-C-N 122.246 -0.284 . . . . 73.43 111.424 -169.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -62.58 -16.85 58.45 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 112.529 0.566 . . . . 75.45 112.529 170.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.422 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 56.8 mt-30 -69.12 -7.68 38.36 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.717 0.807 . . . . 73.14 111.424 174.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -106.27 100.57 10.1 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.797 1.239 . . . . 72.02 109.638 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -97.86 92.77 5.99 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.775 0.83 . . . . 72.03 110.327 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -167.09 -178.34 4.12 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.033 0.933 . . . . 74.31 109.918 171.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -69.64 113.14 14.99 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.132 0.973 . . . . 74.03 109.841 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -58.84 125.89 19.56 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.46 2.106 . . . . 53.42 111.239 176.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -76.75 114.09 15.12 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.085 -1.08 . . . . 62.41 108.085 173.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.549 ' CG1' HG13 ' D' ' 64' ' ' VAL . 9.0 t -112.69 129.79 67.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.886 -0.597 . . . . 74.33 110.341 -171.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.591 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 72.0 mmtt -88.6 108.51 19.48 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.979 -1.119 . . . . 74.3 107.979 168.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.484 HD11 HG13 ' D' ' 62' ' ' VAL . 42.5 tp -98.52 121.08 40.02 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.785 -0.82 . . . . 64.21 108.785 173.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.503 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 8.8 t0 -120.38 143.99 48.14 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.009 -1.478 . . . . 70.21 107.009 177.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 58.1 mt -133.84 129.67 36.8 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.495 0.718 . . . . 74.52 109.577 -175.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.424 ' HB2' ' HB3' ' D' ' 61' ' ' ARG . 54.0 m-20 -134.56 145.67 48.93 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.708 -1.219 . . . . 72.22 107.708 173.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 7.1 t -105.03 161.15 14.46 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.788 -0.819 . . . . 72.21 108.788 169.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.64 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.83 152.68 35.53 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.945 0.898 . . . . 74.32 108.649 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 N--CA 1.471 0.579 0 C-N-CA 123.35 0.66 . . . . 65.44 110.037 -179.704 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . 0.417 ' HA ' ' HE1' ' D' ' 56' ' ' TYR . 61.8 m-20 . . . . . 0 N--CA 1.487 1.391 0 N-CA-C 113.36 0.874 . . . . 64.25 113.36 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 15.7 t -124.26 98.65 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 107.89 -1.152 . . . . 74.25 107.89 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.417 ' HE1' ' HA ' ' D' ' 54' ' ' ASP . 30.2 m-85 -115.63 135.01 54.48 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.075 0.55 . . . . 74.4 109.742 -174.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.45 ' HG2' HD13 ' D' ' 83' ' ' ILE . 39.4 mt-10 -90.62 114.06 26.24 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.068 -1.086 . . . . 73.24 108.068 162.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 88.7 t -103.19 140.08 22.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.849 -1.167 . . . . 73.41 107.849 168.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.64 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 41.7 t -133.56 146.97 31.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 107.625 -1.25 . . . . 62.35 107.625 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.63 115.91 20.19 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.63 -1.248 . . . . 55.21 107.63 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.424 ' HB3' ' HB2' ' D' ' 45' ' ' ASP . 24.8 ttm-85 -93.07 98.56 11.41 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.046 -1.094 . . . . 71.34 108.046 175.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.484 HG13 HD11 ' D' ' 42' ' ' LEU . 49.4 t -99.12 112.72 32.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.785 -0.82 . . . . 70.03 108.785 176.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 63.9 m -105.72 134.21 49.2 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.75 -1.114 . . . . 74.54 109.206 -175.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.549 HG13 ' CG1' ' D' ' 40' ' ' VAL . 71.5 t -131.63 119.75 43.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 124.287 1.035 . . . . 73.24 108.556 -177.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.591 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 24.1 m -126.49 90.76 3.23 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.757 -1.201 . . . . 75.0 107.757 177.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -97.37 146.43 25.18 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.831 -0.622 . . . . 73.41 110.136 -174.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.519 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 31.4 p -147.31 139.93 24.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 123.871 0.732 . . . . 75.14 110.97 -173.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.434 HD12 HG22 ' D' ' 31' ' ' VAL . 24.0 mt -112.08 112.89 24.84 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 107.755 -1.202 . . . . 75.22 107.755 171.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.73 -114.29 3.8 Favored Glycine 0 C--N 1.347 1.14 0 N-CA-C 113.692 0.237 . . . . 62.43 113.692 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.06 12.53 11.95 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.345 0.658 . . . . 63.15 110.487 -178.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -130.52 162.37 29.41 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.024 0.53 . . . . 73.14 109.63 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -71.89 130.41 40.95 Favored 'General case' 0 C--O 1.243 0.721 0 O-C-N 123.809 0.693 . . . . 45.32 110.71 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.519 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -81.68 -65.24 1.04 Allowed 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.648 -1.241 . . . . 65.25 107.648 172.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -151.61 150.22 30.04 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.132 -0.94 . . . . 73.53 111.125 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.636 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 63.4 mt -108.55 153.94 22.65 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.516 1.126 . . . . 75.12 108.765 171.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.504 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.2 t -160.33 142.53 12.94 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.086 0.555 . . . . 63.22 109.796 174.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -154.9 126.15 7.27 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.943 -0.392 . . . . 72.43 109.943 171.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.0 t -125.76 117.03 48.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 123.771 0.828 . . . . 53.11 109.187 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.597 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.6 mt-30 -90.23 86.94 6.65 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.816 -0.809 . . . . 75.52 108.816 172.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.14 110.5 15.61 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.181 -1.372 . . . . 71.35 109.342 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -108.39 173.03 17.5 Favored Glycine 0 C--N 1.338 0.659 0 O-C-N 123.067 0.23 . . . . 45.24 113.468 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.74 152.83 14.6 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 115.735 -0.233 . . . . 73.44 112.937 177.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 19.3 mm -90.19 115.72 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 107.997 -1.112 . . . . 74.22 107.997 173.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -112.65 135.08 53.8 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.759 0.823 . . . . 61.24 110.326 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 39.3 t -102.11 106.96 17.91 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.817 -0.808 . . . . 74.54 108.817 172.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 42.9 pt -121.34 132.84 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.104 -0.702 . . . . 64.34 109.104 173.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.87 165.61 22.66 Favored 'General case' 0 C--O 1.243 0.744 0 O-C-N 123.448 0.468 . . . . 53.31 111.796 -173.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.27 -4.63 83.19 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.15 -0.932 . . . . 64.02 114.015 177.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.459 HD12 ' H ' ' D' ' 89' ' ' ILE . 0.5 OUTLIER -104.57 163.34 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 121.365 0.602 . . . . 64.31 110.665 -177.56 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' D' ' 91' ' ' GLY . 29.6 tt0 -148.05 174.34 12.02 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 114.453 -1.249 . . . . 74.33 108.639 -173.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . 0.449 ' H ' ' HG2' ' D' ' 90' ' ' GLU . . . 77.6 -140.9 24.91 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 123.218 0.437 . . . . 74.03 112.628 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 60.8 p -90.48 -29.64 17.8 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.212 0.605 . . . . 74.01 110.838 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.51 ' HA ' ' HB3' ' D' ' 96' ' ' HIS . 20.7 pt20 -64.63 -23.66 67.33 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.744 0.818 . . . . 74.24 112.401 -173.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.482 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 0.0 OUTLIER -64.78 -43.37 93.47 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.101 0.56 . . . . 32.43 111.327 178.054 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . 0.482 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.15 -17.33 37.55 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.477 0.711 . . . . 74.25 111.406 177.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . 0.51 ' HB3' ' HA ' ' D' ' 93' ' ' GLN . 78.1 t60 -73.89 -37.58 64.64 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.67 0.788 . . . . 74.53 110.608 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 71.1 m -60.71 -34.91 75.09 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.947 0.499 . . . . 62.4 110.74 174.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.432 ' HA ' HD22 ' D' ' 98' ' ' LEU . 1.1 tm? -75.42 -43.45 49.82 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.264 1.026 . . . . 71.31 110.508 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.4 -26.68 60.93 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 115.565 -0.743 . . . . 74.3 114.06 -173.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -122.37 -59.02 1.67 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.026 0.53 . . . . 71.42 112.028 -169.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -71.04 -37.81 72.55 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 112.13 0.418 . . . . 70.31 112.13 -170.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.496 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 73.9 m -66.58 -47.76 56.28 Favored Pre-proline 0 CA--C 1.568 1.657 0 CA-C-O 118.723 -0.656 . . . . 71.13 111.943 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 51.8 Cg_exo -58.9 -33.3 98.57 Favored 'Trans proline' 0 C--N 1.394 2.948 0 C-N-CA 122.052 1.834 . . . . 75.23 113.372 170.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -64.22 -35.13 79.79 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.802 0.441 . . . . 75.42 110.849 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 24.1 mm -63.91 -39.52 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.08 0.952 . . . . 72.14 110.71 173.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 85.7 mt -78.13 -14.59 59.41 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.474 -0.784 . . . . 74.34 112.222 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -72.16 -40.68 7.76 Favored Pre-proline 0 N--CA 1.486 1.334 0 N-CA-C 113.497 0.925 . . . . 71.55 113.497 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -47.68 -49.06 14.22 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.351 2.034 . . . . 65.45 113.298 166.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -71.6 -35.15 70.41 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.43 0.692 . . . . 74.05 111.535 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.81 -57.46 8.83 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.713 0.805 . . . . 73.44 110.185 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.418 ' NH2' HG23 ' B' ' 105' ' ' ILE . 39.5 ttp180 -56.72 -42.2 78.77 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 114.332 -1.304 . . . . 71.44 110.761 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -56.78 -54.62 44.26 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.891 0.744 . . . . 74.25 110.727 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.4 t -54.87 -45.32 74.58 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.291 0.995 . . . . 62.14 110.867 -177.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.504 HG12 ' SG ' ' D' ' 76' ' ' CYS . 85.1 mt -61.16 -58.54 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.67 0.788 . . . . 54.51 110.923 176.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.7 m -51.87 -43.87 63.46 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.932 1.293 . . . . 75.03 111.598 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.411 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 33.3 t -63.79 -44.72 92.53 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 114.505 -1.225 . . . . 73.35 109.826 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 68.1 mtm -69.82 -30.88 68.5 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.034 0.534 . . . . 62.05 111.613 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.478 HG23 ' O ' ' D' ' 114' ' ' ILE . 80.3 t -64.4 -45.96 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.582 0.753 . . . . 75.44 109.573 175.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 95.2 p -74.4 -28.32 61.04 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.451 -0.795 . . . . 75.13 110.722 -178.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' D' ' 116' ' ' SER . 69.4 mtt-85 -70.26 -27.12 64.19 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.53 0.732 . . . . 71.31 109.932 173.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.75 10.5 67.44 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 123.804 0.69 . . . . 72.33 112.887 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.408 HG23 ' HB3' ' C' ' 17' ' ' TYR . 68.8 p 53.79 29.41 9.63 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 126.113 1.765 . . . . 64.51 113.561 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -92.47 158.49 38.53 Favored Pre-proline 0 C--O 1.242 0.688 0 CA-C-N 115.449 -0.796 . . . . 71.14 109.737 171.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -48.16 119.96 4.48 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.768 2.312 . . . . 74.41 112.113 169.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -46.54 124.51 5.99 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 124.72 1.262 . . . . 74.32 111.757 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.413 HD21 HG11 ' D' ' 40' ' ' VAL . 33.7 tp -107.5 98.69 8.27 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.962 0.41 . . . . 52.4 111.042 -173.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . 0.466 ' ND2' ' H ' ' B' ' 16' ' ' ILE . 83.4 m-20 -97.98 96.85 8.44 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 107.11 -1.441 . . . . 72.44 107.11 173.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.05 132.56 54.33 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.519 -0.764 . . . . 44.14 109.481 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.16 136.72 96.82 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 122.714 0.405 . . . . 61.15 110.45 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.542 ' HD3' HG13 ' B' ' 13' ' ' ILE . 93.8 Cg_endo -79.55 145.79 18.72 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.577 2.184 . . . . 75.14 111.864 -174.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 9.0 p -141.24 141.1 31.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 109.003 -0.74 . . . . 73.43 109.003 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -78.95 108.61 12.55 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.676 -0.861 . . . . 62.51 108.676 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 . . . . . 0 N--CA 1.484 1.232 0 C-N-CA 123.391 0.676 . . . . 65.32 110.346 178.261 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 63.0 m . . . . . 0 CA--C 1.532 0.273 0 N-CA-C 106.496 -1.668 . . . . 53.03 106.496 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -137.45 125.21 22.45 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.845 -0.798 . . . . 75.55 108.845 -173.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -145.73 129.69 17.37 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.259 -0.645 . . . . 71.41 109.259 173.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.4 HD13 HD11 ' A' ' 16' ' ' ILE . 7.0 mt -84.77 126.18 40.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.505 -0.924 . . . . 73.11 108.505 175.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -93.04 -41.23 10.09 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.172 0.589 . . . . 64.33 110.347 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -172.73 121.49 0.41 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.62 -0.718 . . . . 74.43 109.969 -173.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.4 HD11 HD13 ' A' ' 13' ' ' ILE . 80.1 mt -105.4 132.43 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 107.373 -1.343 . . . . 61.52 107.373 172.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.478 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 28.2 p90 -162.98 164.02 25.86 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 123.687 0.617 . . . . 74.25 111.445 -172.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.7 p -90.37 122.19 33.02 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.779 -0.452 . . . . 61.03 109.779 174.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.478 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.1 mtpt -83.24 -33.55 26.05 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.055 0.542 . . . . 71.12 109.922 175.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -148.49 142.06 25.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.112 -0.949 . . . . 65.02 109.06 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.7 mt -135.47 145.9 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.778 1.231 . . . . 74.42 107.845 175.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -151.19 131.16 13.35 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.215 0.606 . . . . 71.15 109.999 172.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.449 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 90.6 t80 -131.37 133.1 44.95 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 106.781 -1.563 . . . . 75.22 106.781 171.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -135.67 125.97 26.5 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.627 -0.509 . . . . 74.23 109.627 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.82 79.21 4.41 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 106.16 -1.793 . . . . 75.03 106.16 163.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -65.7 -35.53 36.61 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.455 2.103 . . . . 74.01 112.027 -167.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -107.81 27.07 9.57 Favored 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 124.461 1.104 . . . . 73.52 109.261 -172.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.47 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -46.09 -54.94 14.85 Favored Pre-proline 0 CA--C 1.568 1.652 0 N-CA-C 114.723 1.379 . . . . 55.0 114.723 -165.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.453 ' HG3' ' HG3' ' B' ' 57' ' ' GLU . 28.0 Cg_exo -62.5 -25.85 76.0 Favored 'Trans proline' 0 C--N 1.39 2.736 0 CA-C-N 121.904 1.716 . . . . 74.02 113.26 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.505 ' O ' ' HG2' ' A' ' 33' ' ' GLN . 2.5 m-70 -86.83 -34.32 19.54 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.614 0.765 . . . . 54.31 110.479 -178.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.532 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.7 p -74.75 -12.04 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 C-N-CA 123.204 0.602 . . . . 71.2 111.894 -164.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -91.78 -18.44 23.87 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.44 0.696 . . . . 65.24 111.291 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 29.9 pt20 -96.98 -11.55 24.43 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.251 0.62 . . . . 72.33 110.251 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 14.3 mmmm -76.93 156.36 32.08 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.407 0.683 . . . . 65.53 111.106 177.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.06 119.3 10.54 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.467 0.707 . . . . 53.14 110.005 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.9 t-105 -76.89 84.74 3.45 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-O 121.596 0.713 . . . . 64.34 109.798 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -116.17 79.2 8.41 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 106.246 -1.761 . . . . 71.43 106.246 172.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -81.12 106.62 1.78 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.436 2.091 . . . . 63.51 112.188 -172.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -95.87 88.64 4.99 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 122.6 1.19 . . . . 71.33 107.859 174.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.556 HG22 ' HB2' ' A' ' 66' ' ' ALA . 61.6 t -86.85 101.55 11.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 114.474 -1.239 . . . . 73.43 110.237 -174.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -82.32 118.66 23.32 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.994 -1.003 . . . . 62.02 109.121 171.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.3 mp -95.56 108.16 20.39 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.633 -1.247 . . . . 71.51 107.633 173.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -105.93 150.67 25.44 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.267 -1.012 . . . . 64.42 108.267 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.511 HD22 HD21 ' A' ' 60' ' ' LEU . 67.1 mt -133.29 158.77 42.11 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.406 0.682 . . . . 75.11 110.766 -177.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 25.5 t70 -160.14 121.7 3.17 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.579 -1.191 . . . . 72.33 108.037 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.437 HG21 ' HA2' ' A' ' 99' ' ' GLY . 41.6 m -112.27 126.51 55.32 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 122.838 0.455 . . . . 73.05 110.196 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.46 112.91 11.32 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.776 0.83 . . . . 74.1 109.493 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.1 p -89.41 177.19 6.64 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.94 0.496 . . . . 52.52 109.867 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.441 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 26.0 t -165.38 153.31 11.21 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.284 1.034 . . . . 73.23 109.112 -168.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -113.73 131.1 56.31 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 109.034 -0.728 . . . . 73.24 109.034 172.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.419 HD12 HG23 ' A' ' 83' ' ' ILE . 80.5 mt -110.48 -34.45 6.31 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.5 0.72 . . . . 74.24 111.4 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.539 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -157.82 -171.23 3.46 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 123.536 0.734 . . . . 70.41 110.537 -177.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -70.59 119.09 14.23 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.533 -0.914 . . . . 75.41 108.533 172.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 65.54 10.72 6.88 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.361 1.065 . . . . 54.24 112.107 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 57.2 t -116.21 112.6 40.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 107.835 -1.172 . . . . 62.32 107.835 175.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -126.7 126.33 43.32 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.892 0.877 . . . . 72.4 109.036 -176.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 37.8 tt0 -86.65 149.11 25.14 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.512 -0.551 . . . . 63.51 109.512 175.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.409 HG21 ' CB ' ' A' ' 102' ' ' CYS . 91.1 t -130.77 142.13 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 108.062 -1.088 . . . . 73.45 108.062 173.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.53 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 52.5 t -123.48 133.02 70.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.434 -0.95 . . . . 65.14 108.434 175.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.511 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -113.57 106.81 14.98 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.506 -1.294 . . . . 75.2 107.506 173.129 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.455 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 24.8 ttp180 -93.63 100.59 12.81 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.856 -1.164 . . . . 71.13 107.856 175.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.6 t -94.57 122.92 46.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 107.562 -1.273 . . . . 74.3 107.562 174.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.4 m -116.77 107.61 14.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.567 0.698 . . . . 63.35 109.426 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.536 HG11 HD21 ' A' ' 126' ' ' LEU . 58.0 t -104.38 133.91 47.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 C-N-CA 124.788 1.235 . . . . 54.33 107.871 -178.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.0 m -135.44 136.4 41.32 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.697 -0.853 . . . . 75.03 108.697 170.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.556 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -116.19 130.89 57.01 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.487 -1.301 . . . . 73.01 107.487 171.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.7 m -124.79 169.76 11.7 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.102 -0.703 . . . . 54.34 109.102 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.7 mt -124.09 42.95 3.12 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.754 1.222 . . . . 73.4 108.265 -176.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.22 -89.66 1.58 Allowed Glycine 0 C--N 1.34 0.756 0 CA-C-N 114.725 -1.125 . . . . 42.5 111.34 -172.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.43 -19.53 19.81 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.74 0.816 . . . . 72.3 112.539 -173.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -121.49 132.78 54.91 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 109.693 -0.484 . . . . 75.23 109.693 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.0 m -72.18 137.13 46.7 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 122.449 0.3 . . . . 63.05 110.469 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.532 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -79.17 -62.24 1.76 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.721 -0.672 . . . . 70.12 109.609 176.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -157.07 168.4 27.58 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.164 -0.925 . . . . 70.13 111.614 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 64' ' ' VAL . 61.4 tp -125.41 141.97 51.76 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.939 1.296 . . . . 73.23 108.434 171.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.459 ' SG ' HG22 ' A' ' 118' ' ' VAL . 77.7 m -143.15 99.15 3.39 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.487 1.115 . . . . 72.41 109.289 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -124.25 117.55 24.81 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.711 -0.848 . . . . 70.12 108.711 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.7 t -130.65 128.86 63.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 123.84 0.856 . . . . 74.52 109.613 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.455 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 77.3 mt-30 -96.95 90.9 5.37 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.557 0.743 . . . . 74.41 109.151 169.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -77.59 94.16 4.32 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.79 -0.819 . . . . 72.32 108.79 174.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.84 172.35 49.86 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.986 -0.846 . . . . 72.45 110.986 175.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.08 126.36 1.2 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.16 -0.776 . . . . 74.0 111.16 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.419 HG23 HD12 ' A' ' 51' ' ' LEU . 50.0 mt -81.59 126.48 39.85 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 108.66 -0.867 . . . . 72.42 108.66 174.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.721 ' HB3' HD11 ' A' ' 86' ' ' ILE . 91.8 m-85 -132.23 121.0 22.96 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.15 0.58 . . . . 73.4 109.961 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.3 m -84.97 97.44 9.8 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.903 -0.777 . . . . 75.3 108.903 174.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.721 HD11 ' HB3' ' A' ' 84' ' ' PHE . 3.5 mm -108.28 153.89 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 122.949 0.5 . . . . 62.31 109.994 -178.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -165.27 166.03 19.1 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.943 0.497 . . . . 74.23 111.261 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.45 -21.85 42.39 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 116.113 -0.494 . . . . 41.35 114.003 174.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.467 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -133.95 147.61 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.176 0.59 . . . . 64.45 111.535 -172.187 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -134.28 175.54 9.41 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.91 1.284 . . . . 71.32 109.439 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.62 -124.64 36.28 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.854 0.721 . . . . 54.11 113.828 175.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.0 t -71.19 -29.56 65.33 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.328 0.651 . . . . 62.41 111.741 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -69.33 -43.89 72.77 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.94 0.496 . . . . 52.1 110.324 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.5 tpt -66.79 -40.3 88.08 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.819 -0.628 . . . . 75.42 110.457 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.13 -32.59 74.36 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.236 0.614 . . . . 43.24 110.846 176.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -73.14 -30.94 63.96 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.343 0.657 . . . . 45.32 110.934 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.8 t -73.1 -51.6 17.4 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 109.27 -0.641 . . . . 64.24 109.27 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.2 mt -76.9 -26.9 54.68 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.427 0.691 . . . . 73.11 112.258 -174.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.437 ' HA2' HG21 ' A' ' 46' ' ' THR . . . -107.81 3.56 34.04 Favored Glycine 0 N--CA 1.468 0.815 0 CA-C-O 119.492 -0.616 . . . . 22.2 114.033 -171.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.477 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.72 -60.34 0.23 Allowed 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 117.671 0.736 . . . . 64.1 112.323 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.428 ' O ' HG12 ' A' ' 105' ' ' ILE . 73.5 t80 -66.44 -45.54 79.51 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.858 0.463 . . . . 75.54 111.509 -175.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.409 ' CB ' HG21 ' A' ' 58' ' ' VAL . 85.9 m -67.51 -46.79 47.85 Favored Pre-proline 0 CA--C 1.564 1.484 0 C-N-CA 124.381 1.072 . . . . 72.34 111.818 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -55.76 -34.17 90.13 Favored 'Trans proline' 0 C--N 1.397 3.126 0 C-N-CA 122.615 2.21 . . . . 61.1 113.523 168.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.403 ' HB3' ' O ' ' A' ' 101' ' ' TYR . 26.7 t-20 -63.42 -39.77 95.39 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.777 0.831 . . . . 61.01 110.499 176.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 101' ' ' TYR . 49.8 mm -66.41 -40.08 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.562 0.745 . . . . 74.44 110.212 174.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 68.9 mt -77.69 -22.38 50.58 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.244 -0.889 . . . . 62.21 112.5 -172.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -65.3 -42.33 58.13 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 114.291 1.219 . . . . 71.14 114.291 -172.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -53.2 -38.05 80.92 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 121.974 1.782 . . . . 72.1 113.12 171.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -82.03 -30.2 31.58 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.514 0.725 . . . . 70.32 111.651 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.85 -48.21 72.38 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.941 -0.763 . . . . 72.12 108.941 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.605 HH12 HD12 ' C' ' 105' ' ' ILE . 31.5 ttm180 -60.81 -39.86 90.54 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 113.741 -1.572 . . . . 71.52 110.088 176.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.4 ' HB2' ' HB3' ' C' ' 108' ' ' PRO . 14.5 tt0 -52.46 -56.37 15.54 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.376 1.07 . . . . 54.22 110.727 176.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 45.1 t -60.17 -47.82 84.31 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 113.945 -1.48 . . . . 45.05 111.206 -175.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.1 mt -63.22 -59.85 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.714 0.806 . . . . 73.34 110.926 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 92.4 m -49.1 -42.5 39.23 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 124.338 1.024 . . . . 74.23 112.226 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.3 t -68.9 -46.75 67.54 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.745 -1.116 . . . . 53.45 110.582 -178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.449 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 9.9 mtp -53.67 -44.34 69.61 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.917 0.887 . . . . 72.44 111.226 175.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 114' ' ' ILE . 97.0 t -59.63 -49.71 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-N 114.726 -1.125 . . . . 60.23 110.772 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.4 p -70.9 -28.55 64.62 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.98 -0.554 . . . . 71.42 111.62 -177.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.489 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.4 mtt-85 -71.03 -29.9 65.94 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.674 0.79 . . . . 75.52 110.123 176.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.409 ' O ' HG22 ' A' ' 122' ' ' THR . . . -86.07 23.05 10.0 Favored Glycine 0 C--N 1.352 1.46 0 CA-C-O 118.957 -0.913 . . . . 55.41 113.407 176.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.409 HG22 ' O ' ' A' ' 121' ' ' GLY . 4.1 t 57.36 10.71 0.97 Allowed 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 127.047 2.139 . . . . 54.32 113.853 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -81.17 144.02 53.61 Favored Pre-proline 0 C--O 1.242 0.709 0 N-CA-C 108.392 -0.966 . . . . 73.22 108.392 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -49.15 146.57 12.59 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 123.138 2.559 . . . . 72.13 111.94 173.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -59.74 133.24 55.92 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.105 0.478 . . . . 64.21 111.595 -174.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.536 HD21 HG11 ' A' ' 64' ' ' VAL . 28.1 tp -118.03 110.1 17.26 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.658 1.183 . . . . 75.13 108.753 176.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.438 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 72.3 m-20 -100.44 126.39 46.83 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.525 -1.287 . . . . 75.21 107.525 172.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 13.5 mt -73.27 141.37 47.22 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 123.125 0.266 . . . . 74.33 110.303 -178.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -65.59 135.65 95.78 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.299 0.64 . . . . 63.44 110.822 177.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 36.3 Cg_exo -61.74 120.69 8.44 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 123.307 2.671 . . . . 65.32 112.833 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.499 HG21 HD11 ' A' ' 44' ' ' LEU . 84.4 t -103.4 136.77 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.538 0.735 . . . . 62.03 110.809 -178.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.479 ' ND2' ' HB2' ' A' ' 135' ' ' ALA . 37.2 t30 -94.61 90.38 6.12 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 108.327 -0.99 . . . . 75.13 108.327 172.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.438 ' CE1' HD13 ' A' ' 44' ' ' LEU . 93.5 m-85 -63.44 -28.67 70.13 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.091 0.957 . . . . 74.2 112.561 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.477 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 7.9 m-20 -63.41 -35.79 81.57 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.122 0.569 . . . . 72.53 110.626 176.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.479 ' HB2' ' ND2' ' A' ' 132' ' ' ASN . . . -65.19 -48.93 71.71 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 123.549 0.531 . . . . 74.34 110.053 171.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 62.3 mt -56.67 -39.29 73.49 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.808 0.843 . . . . 61.42 111.329 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.456 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 84.8 t80 . . . . . 0 C--N 1.349 0.569 0 CA-C-N 115.301 -0.863 . . . . 73.22 110.252 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 25.6 ttt . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 112.766 0.654 . . . . 75.33 112.766 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 89.5 m -151.05 128.12 11.12 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.965 1.306 . . . . 74.01 107.694 171.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.46 ' CE1' ' HE2' ' B' ' 101' ' ' TYR . 0.1 OUTLIER -146.86 135.54 22.11 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.304 0.573 . . . . 71.4 110.252 179.115 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.529 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -131.09 130.05 42.67 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.819 1.248 . . . . 75.11 109.212 -179.575 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 69.4 mt -73.24 127.49 35.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 108.357 -0.979 . . . . 71.51 108.357 170.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -92.42 -43.67 9.09 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 123.744 0.652 . . . . 75.34 109.595 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -174.27 135.84 0.46 Allowed 'General case' 0 C--N 1.352 0.71 0 CA-C-N 115.703 -0.68 . . . . 70.41 109.932 -173.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.486 HG21 ' CE1' ' B' ' 109' ' ' TYR . 80.7 mt -122.84 138.8 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.065 -1.087 . . . . 51.14 108.065 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -164.15 157.33 17.95 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.127 0.788 . . . . 72.44 113.127 -171.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 53.5 m -83.66 119.48 24.81 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.366 -1.288 . . . . 72.14 108.864 171.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.47 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 39.6 mtpt -91.81 -24.98 19.21 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.658 0.783 . . . . 71.23 111.522 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -159.57 142.76 14.25 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 123.387 0.429 . . . . 71.13 111.02 -175.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.422 HD11 ' SG ' ' B' ' 113' ' ' CYS . 48.6 mm -134.37 144.19 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.939 1.295 . . . . 63.43 108.321 171.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 29.5 t -147.68 134.45 20.04 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.221 1.009 . . . . 63.44 108.35 171.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -134.87 131.89 37.91 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.979 -1.489 . . . . 74.1 106.979 167.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -132.69 125.39 30.18 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.177 -1.046 . . . . 54.13 108.177 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.572 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -114.75 87.37 14.55 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 106.899 -1.519 . . . . 61.43 106.899 164.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.39 -35.04 74.89 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.554 2.17 . . . . 72.14 111.228 -173.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -110.29 14.93 22.59 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.47 -1.241 . . . . 53.13 110.742 -175.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.593 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -31.63 -66.3 0.19 Allowed Pre-proline 0 N--CA 1.493 1.715 0 C-N-CA 125.951 1.701 . . . . 62.41 115.278 -172.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 24.8 Cg_exo -60.83 -36.51 83.62 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 122.457 2.105 . . . . 71.31 113.269 -167.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -93.31 -32.22 14.39 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.403 0.52 . . . . 74.11 112.403 -174.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.673 HG22 HD12 ' B' ' 68' ' ' LEU . 7.2 p -67.6 -11.69 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-N 118.209 0.458 . . . . 74.24 111.534 -173.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -74.1 -15.09 61.06 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.868 0.867 . . . . 75.41 112.976 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -61.54 -28.91 69.66 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.476 0.655 . . . . 42.34 109.543 172.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -88.91 105.17 17.58 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.894 1.278 . . . . 70.45 109.451 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -113.43 99.18 7.57 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.625 -0.88 . . . . 65.13 108.625 172.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 11.2 p90 -160.71 -172.78 3.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.368 -0.975 . . . . 75.24 108.368 170.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -73.84 107.3 3.32 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.353 0.661 . . . . 74.34 111.014 175.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.11 143.65 60.36 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 121.533 1.488 . . . . 74.12 110.5 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.23 101.46 1.19 Allowed 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.543 -0.91 . . . . 74.44 108.543 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.423 HG11 HD11 ' B' ' 126' ' ' LEU . 33.9 t -91.78 144.71 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 114.245 -1.343 . . . . 74.43 109.695 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.15 119.65 10.35 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.067 -1.827 . . . . 43.15 106.067 -175.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 20.9 tp -95.06 147.23 23.64 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.625 0.77 . . . . 74.52 109.362 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.564 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 13.0 t70 -140.62 134.29 30.25 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.692 -1.225 . . . . 62.24 107.692 -175.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 64.3 mt -128.0 126.27 41.02 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.632 -0.877 . . . . 53.23 108.632 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 19.5 t70 -126.1 119.79 28.48 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.369 1.067 . . . . 74.32 108.612 -173.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.8 p -110.29 102.95 11.57 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.33 0.652 . . . . 74.14 111.516 -169.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.73 136.83 51.11 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.135 0.974 . . . . 44.54 108.554 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.1 p -139.86 175.86 9.23 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.418 0.687 . . . . 60.14 109.721 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 75.3 p -157.12 140.15 15.34 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.093 0.557 . . . . 75.15 110.337 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -94.87 128.46 41.65 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.617 -0.883 . . . . 74.13 108.617 172.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.91 16.41 2.48 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.72 0.808 . . . . 55.42 110.923 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.74 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -173.67 165.12 4.49 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.819 1.248 . . . . 73.13 109.73 173.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.45 119.24 13.41 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.884 -0.784 . . . . 54.52 108.884 176.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 69.16 -5.63 1.05 Allowed 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 124.687 1.195 . . . . 63.13 113.145 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.74 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 44.4 t -119.57 97.49 5.26 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.226 -1.028 . . . . 75.13 108.226 -172.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.64 ' HE1' HD12 ' B' ' 86' ' ' ILE . 54.4 p90 -99.23 -176.86 3.43 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 114.556 -1.202 . . . . 73.45 109.207 177.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.453 ' HG3' ' HG3' ' A' ' 29' ' ' PRO . 5.5 tm-20 -138.69 107.2 5.85 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 106.383 -1.71 . . . . 70.45 106.383 173.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 14.8 p -101.0 135.03 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 109.863 -0.421 . . . . 74.24 109.863 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 29.9 t -109.38 115.23 49.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 123.754 0.821 . . . . 53.44 108.955 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 54.5 tp -93.89 101.13 13.2 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.378 -0.971 . . . . 52.51 108.378 170.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.586 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 14.1 ttm-85 -87.33 116.82 25.69 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.681 -0.859 . . . . 74.35 108.681 172.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.37 125.9 66.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.029 -1.1 . . . . 72.23 108.029 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.564 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 8.7 m -121.84 131.67 54.17 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.242 -0.651 . . . . 73.13 109.242 178.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.707 HG11 HD21 ' B' ' 126' ' ' LEU . 56.7 t -115.88 125.2 72.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 124.569 1.148 . . . . 75.11 109.131 176.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 88.9 m -105.06 138.72 40.82 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.463 -0.94 . . . . 71.25 108.463 164.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.19 144.27 33.32 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 107.96 -1.126 . . . . 71.12 107.96 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.51 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 49.6 p -144.7 134.26 23.34 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.388 0.43 . . . . 64.41 111.978 -171.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.673 HD12 HG22 ' B' ' 31' ' ' VAL . 70.6 mt -102.61 99.57 9.58 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.487 -0.931 . . . . 73.23 108.487 175.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.05 -134.3 14.18 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.991 -0.549 . . . . 73.22 112.364 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -82.32 3.55 27.29 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.26 0.624 . . . . 75.13 112.515 -177.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -128.76 150.68 50.19 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.789 0.435 . . . . 72.05 111.767 -174.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 68.3 m -68.7 128.43 36.62 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.418 -0.81 . . . . 71.24 110.36 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.51 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -80.14 -59.28 2.77 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.366 -0.976 . . . . 62.5 108.366 176.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -152.51 157.85 41.71 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 114.701 -1.136 . . . . 74.11 111.437 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 98.2 mt -125.15 113.58 17.88 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.682 1.593 . . . . 75.35 107.262 171.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.9 t -118.39 140.14 50.31 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.177 -1.045 . . . . 75.44 108.177 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -151.22 127.64 10.68 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.813 -0.81 . . . . 72.34 108.813 -174.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 90.4 t -124.44 147.71 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 123.942 0.897 . . . . 42.05 108.83 177.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -120.74 106.38 11.64 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.477 -1.305 . . . . 74.14 107.477 168.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -98.41 101.3 12.7 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.504 -1.295 . . . . 45.22 107.504 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.4 159.57 22.56 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 111.062 -0.815 . . . . 71.25 111.062 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.9 132.61 3.12 Favored Glycine 0 C--O 1.239 0.446 0 C-N-CA 121.718 -0.277 . . . . 72.42 112.411 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 54.6 mt -91.66 108.13 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 108.497 -0.927 . . . . 72.22 108.497 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -119.47 143.89 47.28 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.159 -1.052 . . . . 75.35 108.159 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 15.8 m -115.17 114.23 25.0 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.476 -0.935 . . . . 75.13 108.476 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.64 HD12 ' HE1' ' B' ' 56' ' ' TYR . 0.2 OUTLIER -115.56 142.22 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.359 -0.978 . . . . 61.4 108.359 178.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.38 168.6 26.83 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.981 0.512 . . . . 65.1 110.622 -177.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.86 -44.92 2.69 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.966 -0.561 . . . . 72.03 111.895 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.455 HD13 ' HB2' ' B' ' 94' ' ' MET . 1.0 OUTLIER -81.74 157.25 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.5 1.12 . . . . 63.03 111.261 178.131 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.47 ' HA ' ' SD ' ' B' ' 94' ' ' MET . 9.7 mp0 -145.9 177.95 8.55 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.483 1.113 . . . . 73.01 109.605 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.62 -125.42 23.07 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.127 -0.942 . . . . 73.42 113.81 173.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 27.2 m -79.27 -45.39 19.83 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.703 0.801 . . . . 51.22 110.724 -178.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -67.47 -28.91 68.25 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 113.953 -1.476 . . . . 52.34 111.886 -166.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.47 ' SD ' ' HA ' ' B' ' 90' ' ' GLU . 26.9 ptt? -64.34 -47.49 79.15 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.227 0.611 . . . . 72.53 111.373 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . 0.477 ' HA ' ' HG ' ' B' ' 98' ' ' LEU . . . -81.0 -13.34 58.96 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.996 0.919 . . . . 41.24 112.186 -175.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -64.74 -32.13 73.67 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.655 0.382 . . . . 72.0 110.277 170.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . 0.408 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 48.0 t -67.51 -30.92 70.72 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.584 0.754 . . . . 64.31 111.53 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.477 ' HG ' ' HA ' ' B' ' 95' ' ' ALA . 4.0 pp -101.38 -24.48 14.19 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 112.942 0.719 . . . . 73.5 112.942 -175.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.76 -26.24 61.09 Favored Glycine 0 C--N 1.338 0.671 0 O-C-N 123.584 0.553 . . . . 40.4 112.736 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.08 -49.75 0.33 Allowed 'General case' 0 C--O 1.242 0.671 0 N-CA-C 112.568 0.581 . . . . 53.33 112.568 -165.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.46 ' HE2' ' CE1' ' B' ' 11' ' ' PHE . 16.0 t80 -68.02 -48.75 64.83 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.69 0.796 . . . . 64.02 112.155 -174.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 98.1 m -73.69 -37.94 3.74 Favored Pre-proline 0 CA--C 1.557 1.238 0 N-CA-C 112.627 0.603 . . . . 41.43 112.627 -177.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -51.43 -31.49 38.87 Favored 'Trans proline' 0 C--N 1.387 2.553 0 C-N-CA 122.399 2.066 . . . . 72.45 114.181 162.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -68.89 -25.41 64.59 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 122.767 0.427 . . . . 74.44 111.504 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.497 HG23 ' NH2' ' D' ' 111' ' ' ARG . 71.5 mt -69.05 -39.8 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 121.336 0.589 . . . . 71.54 109.413 170.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.457 ' CD2' HG23 ' B' ' 16' ' ' ILE . 70.3 mt -77.09 -24.6 51.8 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.689 1.196 . . . . 72.43 111.893 -177.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -59.18 -53.71 63.58 Favored Pre-proline 0 N--CA 1.484 1.248 0 N-CA-C 113.822 1.045 . . . . 65.14 113.822 -171.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.16 -30.56 55.26 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 121.62 1.547 . . . . 75.21 111.98 -177.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.486 ' CE1' HG21 ' B' ' 16' ' ' ILE . 2.4 m-30 -64.54 -47.8 77.46 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.02 0.928 . . . . 72.53 110.058 176.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.18 -40.57 97.9 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.026 0.93 . . . . 71.55 110.747 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.4 ttt-85 -64.69 -46.34 82.79 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.225 1.41 . . . . 74.42 110.861 -175.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.38 -35.06 77.15 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 123.776 0.673 . . . . 64.22 109.454 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.496 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.4 t -68.99 -35.51 76.8 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.891 0.476 . . . . 44.31 111.157 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.446 HD13 HG23 ' B' ' 64' ' ' VAL . 49.2 mt -62.89 -56.88 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.649 0.78 . . . . 72.43 109.339 173.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 18.1 m -59.63 -28.21 67.02 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.941 0.896 . . . . 55.03 111.459 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.7 t -66.25 -51.45 57.42 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.981 0.912 . . . . 54.04 110.3 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.496 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.5 mmt -70.14 -29.98 67.03 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.183 0.593 . . . . 73.12 111.245 -176.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 77.6 t -67.95 -41.86 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.513 1.125 . . . . 72.21 110.389 172.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.7 t -67.69 -32.03 72.41 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.604 -0.726 . . . . 75.31 110.341 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' B' ' 116' ' ' SER . 70.3 mtt-85 -69.74 -42.59 73.74 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 115.688 -0.687 . . . . 73.41 109.162 175.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.12 -10.82 62.81 Favored Glycine 0 C--N 1.358 1.801 0 O-C-N 123.736 0.648 . . . . 75.53 112.639 172.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 8.9 m 68.75 23.1 7.11 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 125.762 1.625 . . . . 63.33 110.973 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -78.96 164.26 55.96 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 124.019 0.927 . . . . 73.24 111.341 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -45.28 147.56 2.35 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 123.839 3.026 . . . . 72.01 114.85 172.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.409 HE21 ' ND2' ' B' ' 127' ' ' ASN . 54.4 tp60 -59.95 113.29 2.23 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.272 1.029 . . . . 72.01 112.512 -172.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.707 HD21 HG11 ' B' ' 64' ' ' VAL . 28.5 tp -107.71 104.72 14.3 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.151 0.58 . . . . 73.4 109.457 -172.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.409 ' ND2' HE21 ' B' ' 125' ' ' GLN . 54.2 m-80 -111.49 120.9 43.7 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.442 -0.947 . . . . 74.22 108.442 175.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.437 HD21 ' CG2' ' B' ' 64' ' ' VAL . 57.9 mt -78.14 149.29 33.82 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 110.296 -0.261 . . . . 74.43 110.296 175.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.61 143.39 84.9 Favored Pre-proline 0 CA--C 1.55 0.961 0 O-C-N 123.503 0.502 . . . . 43.14 111.238 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.61 81.76 0.76 Allowed 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 123.345 2.697 . . . . 70.42 112.191 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.17 110.68 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 121.402 0.62 . . . . 61.32 109.423 177.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 107.692 -1.225 . . . . 65.14 107.692 171.279 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 88.2 t80 . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 109.074 -0.713 . . . . 63.12 109.074 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . 0.461 HE21 HE22 ' C' ' 14' ' ' GLN . 29.9 tt0 -151.59 124.62 8.66 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.989 -0.745 . . . . 64.35 108.989 174.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.417 ' HA ' ' HD2' ' C' ' 84' ' ' PHE . 53.0 mt -70.11 135.0 29.1 Favored 'Isoleucine or valine' 0 C--N 1.349 0.586 0 N-CA-C 108.45 -0.945 . . . . 72.03 108.45 174.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.461 HE22 HE21 ' C' ' 12' ' ' GLN . 23.3 mm-40 -97.5 -47.71 5.56 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.273 -0.64 . . . . 73.31 109.273 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.438 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 11.8 ptm180 -179.01 143.02 0.2 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.288 1.035 . . . . 74.34 109.255 -176.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.406 ' O ' HD12 ' C' ' 16' ' ' ILE . 2.4 pp -120.31 146.8 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 107.363 -1.347 . . . . 73.02 107.363 171.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.457 ' HB3' HG23 ' D' ' 122' ' ' THR . 28.6 p90 -170.78 154.58 4.4 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.201 0.524 . . . . 64.51 111.943 -168.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.0 p -81.01 109.24 15.4 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.216 -0.902 . . . . 71.44 108.848 173.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -77.3 -29.78 53.84 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.186 -0.672 . . . . 74.5 109.186 173.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.665 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 22.5 t70 -146.07 143.77 29.6 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.905 -1.043 . . . . 73.45 109.663 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 99.3 mt -137.92 145.34 29.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 125.237 1.415 . . . . 73.25 107.389 173.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.3 t -152.91 146.05 24.67 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.129 0.571 . . . . 73.55 109.723 175.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -147.48 118.58 7.74 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 107.861 -1.162 . . . . 62.31 107.861 170.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -120.79 113.48 20.23 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.073 0.949 . . . . 75.12 108.981 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.63 87.81 7.02 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 106.446 -1.687 . . . . 73.14 106.446 169.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.89 -42.67 23.35 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.845 2.363 . . . . 72.12 112.042 -170.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -113.06 35.53 3.89 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.759 -1.109 . . . . 71.12 109.239 -177.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.463 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -43.92 -53.27 13.34 Favored Pre-proline 0 C--N 1.373 1.604 0 C-N-CA 124.915 1.286 . . . . 61.22 114.113 -176.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.96 -50.88 7.91 Favored 'Trans proline' 0 C--N 1.39 2.749 0 C-N-CA 121.521 1.481 . . . . 74.32 111.906 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -70.04 -28.07 65.17 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.309 -1.314 . . . . 74.1 113.016 -173.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.723 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.0 p -77.79 -23.88 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 112.235 0.458 . . . . 64.22 112.235 -175.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -71.9 -21.27 61.66 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 112.118 0.414 . . . . 71.32 112.118 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -93.54 16.35 13.89 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.027 0.531 . . . . 75.4 111.016 175.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.794 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -104.17 154.01 20.27 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.748 0.819 . . . . 55.22 109.974 176.111 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -72.4 130.78 41.5 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.31 0.644 . . . . 64.03 109.711 171.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -85.39 90.24 7.89 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.819 0.848 . . . . 74.1 112.2 -171.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -145.7 77.52 12.32 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 124.675 1.19 . . . . 74.54 108.907 170.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -91.53 165.77 3.47 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.758 2.305 . . . . 71.14 113.562 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' C' ' 67' ' ' SER . 7.4 pt-20 -87.97 100.56 13.0 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.969 -1.122 . . . . 72.52 107.969 166.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 42.0 t -79.89 98.59 3.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.549 -0.908 . . . . 61.52 108.549 177.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -93.06 102.52 14.85 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.068 -1.456 . . . . 71.12 107.068 175.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 tt -87.78 138.21 31.66 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 106.817 -1.549 . . . . 70.35 106.817 176.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.467 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 36.0 t70 -131.56 134.71 46.36 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.053 0.941 . . . . 65.13 108.85 -175.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 96.2 mt -128.54 114.48 16.79 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.602 0.761 . . . . 62.44 110.018 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -117.12 120.75 39.29 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.671 -1.233 . . . . 71.14 107.671 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 10.1 t -118.24 149.24 41.45 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 109.778 -0.453 . . . . 53.52 109.778 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.17 149.12 26.72 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.572 0.749 . . . . 75.03 109.359 174.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 14.3 m -123.77 152.53 42.09 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.122 -0.696 . . . . 53.44 109.122 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 72.9 p -154.61 127.37 8.11 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.506 -0.924 . . . . 70.51 108.506 177.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -79.62 117.7 20.78 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.994 -0.743 . . . . 63.44 108.994 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.675 HD11 ' HB2' ' C' ' 57' ' ' GLU . 41.5 mt -83.55 -44.76 14.3 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.492 0.717 . . . . 75.0 110.273 -176.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.99 -176.55 4.72 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.449 -0.796 . . . . 44.21 109.691 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.08 107.77 0.59 Allowed 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.786 -1.097 . . . . 72.12 110.505 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 64.38 25.31 13.38 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.452 1.101 . . . . 75.21 112.113 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 87.9 t -119.05 114.77 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.328 -0.989 . . . . 73.14 108.328 174.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -117.81 125.55 50.78 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.354 1.062 . . . . 74.53 109.291 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.675 ' HB2' HD11 ' C' ' 51' ' ' LEU . 37.4 tt0 -91.17 117.71 29.84 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.246 -0.65 . . . . 64.22 109.246 168.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.8 t -99.61 142.02 15.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.083 -1.08 . . . . 65.35 108.083 169.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 90.5 t -127.4 144.08 38.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.786 -0.82 . . . . 72.21 108.786 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.42 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -130.37 99.02 4.87 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 107.848 -1.168 . . . . 73.02 107.848 177.61 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -82.52 110.78 17.93 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.369 0.668 . . . . 72.22 109.41 171.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 39.6 t -108.52 122.77 63.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.698 -0.853 . . . . 73.33 108.698 178.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 16.8 m -126.1 127.48 45.86 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.449 0.7 . . . . 65.11 109.521 -176.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 60.2 t -114.36 112.11 38.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 124.165 0.986 . . . . 72.01 108.893 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 11.2 m -98.12 135.86 39.18 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.457 -1.312 . . . . 75.33 107.457 171.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.71 118.22 17.86 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.225 -1.398 . . . . 62.02 107.225 -175.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . 0.41 ' O ' ' HG2' ' C' ' 39' ' ' GLU . 50.5 m -133.9 130.89 38.43 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.194 0.521 . . . . 73.11 110.545 178.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.794 HD13 ' HG2' ' C' ' 34' ' ' LYS . 14.2 mt -88.48 39.48 0.91 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.624 1.169 . . . . 72.31 109.626 174.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.91 -106.22 2.66 Favored Glycine 0 C--N 1.353 1.474 0 CA-C-N 115.823 -0.626 . . . . 63.44 111.701 -173.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -90.24 -30.05 17.79 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.792 -0.818 . . . . 71.13 108.792 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -65.76 121.05 14.14 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 114.713 -1.131 . . . . 73.1 109.435 169.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 89.8 m -83.97 120.65 26.36 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.124 -1.065 . . . . 71.24 108.124 164.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.723 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -67.41 -58.57 4.52 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 123.945 0.778 . . . . 51.12 109.139 175.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -165.13 176.57 8.39 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 121.984 0.897 . . . . 72.41 111.078 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.452 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.1 tm? -134.84 145.35 48.23 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 105.766 -1.939 . . . . 74.42 105.766 170.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.473 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.2 t -147.82 141.88 25.99 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.878 -1.156 . . . . 73.15 107.878 174.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -150.88 131.54 13.97 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.473 -0.566 . . . . 42.13 109.473 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 75.8 t -131.76 114.05 24.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.345 -0.983 . . . . 75.24 108.345 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.665 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.7 mt-30 -90.49 86.14 6.34 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.417 -0.957 . . . . 71.14 108.417 173.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -79.01 102.15 8.19 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.225 -1.352 . . . . 75.24 108.88 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.9 159.44 32.9 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 111.475 -0.65 . . . . 62.51 111.475 172.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.69 116.73 0.73 Allowed Glycine 0 CA--C 1.507 -0.428 0 N-CA-C 111.317 -0.713 . . . . 75.21 111.317 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.503 HD12 HD11 ' C' ' 51' ' ' LEU . 17.2 mm -84.4 132.42 31.61 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 N-CA-C 108.778 -0.823 . . . . 63.32 108.778 178.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.417 ' HD2' ' HA ' ' C' ' 13' ' ' ILE . 66.0 m-85 -135.66 139.07 43.44 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.483 0.713 . . . . 75.44 109.837 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 21.7 p -99.01 104.0 16.0 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.809 -1.182 . . . . 72.34 107.809 169.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.418 HG21 HD11 ' C' ' 89' ' ' ILE . 46.1 mt -115.72 132.62 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.898 0.879 . . . . 73.31 109.128 -176.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.83 164.46 33.58 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 122.902 0.481 . . . . 61.0 111.187 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.83 -41.75 2.71 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 115.353 -0.84 . . . . 75.32 113.392 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' C' ' 94' ' ' MET . 39.7 pt -85.98 168.84 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.274 0.629 . . . . 75.44 111.787 -174.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -164.5 168.23 18.58 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.981 1.312 . . . . 71.42 108.339 176.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.22 -119.46 11.7 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.805 -0.441 . . . . 62.51 112.982 171.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 69.9 p -69.0 -41.78 77.36 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.134 0.574 . . . . 73.34 110.644 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -61.93 -46.51 89.01 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.519 0.728 . . . . 72.11 110.9 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.434 ' HE3' ' HA ' ' C' ' 94' ' ' MET . 5.4 tpt -59.74 -51.45 69.69 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 123.734 0.646 . . . . 63.12 111.579 177.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.26 -40.88 97.67 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.68 0.612 . . . . 55.53 111.319 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -72.36 -34.54 68.06 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.901 -1.045 . . . . 71.04 111.119 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -65.11 -42.5 93.89 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.317 0.58 . . . . 65.12 109.885 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.44 -37.24 37.49 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.798 -1.092 . . . . 64.45 112.78 -175.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.78 11.66 45.81 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-O 119.429 -0.65 . . . . 42.31 114.597 -167.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.548 ' HB2' ' HB2' ' C' ' 137' ' ' PHE . . . -155.95 -56.67 0.09 Allowed 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 117.827 0.814 . . . . 65.3 111.385 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -63.7 -56.17 17.72 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.617 0.767 . . . . 70.4 111.815 -175.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.467 ' O ' HD13 ' C' ' 106' ' ' LEU . 85.5 m -65.25 -47.3 71.38 Favored Pre-proline 0 CA--C 1.561 1.397 0 C-N-CA 123.925 0.89 . . . . 62.12 112.371 -177.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.42 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 53.7 Cg_exo -55.66 -30.53 75.71 Favored 'Trans proline' 0 C--N 1.397 3.092 0 C-N-CA 122.44 2.093 . . . . 52.24 113.628 173.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -70.18 -28.71 65.54 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.289 0.636 . . . . 64.22 111.116 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.605 HD12 HH12 ' A' ' 111' ' ' ARG . 33.8 mm -77.91 -32.27 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 123.163 0.585 . . . . 71.35 109.971 175.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.467 HD13 ' O ' ' C' ' 102' ' ' CYS . 7.3 mp -78.4 -27.55 46.75 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.05 0.94 . . . . 55.41 111.578 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -56.82 -49.81 91.7 Favored Pre-proline 0 N--CA 1.48 1.069 0 CA-C-O 117.556 -1.212 . . . . 74.02 113.672 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . 0.4 ' HB3' ' HB2' ' A' ' 112' ' ' GLU . 97.3 Cg_exo -50.91 -40.68 57.83 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.72 2.28 . . . . 64.44 114.674 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.494 ' OH ' ' HG2' ' A' ' 111' ' ' ARG . 89.2 m-85 -79.15 -37.44 38.47 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.263 0.625 . . . . 71.21 111.455 -175.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.64 96.26 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.436 -0.802 . . . . 75.45 109.956 173.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 34.6 ttt-85 -62.97 -50.9 68.98 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.579 1.551 . . . . 75.41 110.394 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -60.67 -40.8 93.44 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.094 0.871 . . . . 72.13 110.126 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 31.8 t -72.33 -32.18 66.29 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.709 -0.678 . . . . 62.44 111.212 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.473 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 44.2 mt -69.1 -53.35 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.905 -0.406 . . . . 73.31 109.905 174.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 22.5 m -62.62 -28.98 70.27 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.442 0.697 . . . . 73.44 111.196 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 37.6 t -67.51 -49.21 64.48 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.254 0.622 . . . . 62.12 109.348 173.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.525 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.39 -39.79 84.48 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 124.432 1.093 . . . . 64.34 112.402 179.838 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.417 HG23 ' O ' ' C' ' 114' ' ' ILE . 93.7 t -65.23 -43.99 95.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.73 0.812 . . . . 62.15 110.223 176.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 22.0 t -66.07 -29.87 70.28 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.067 -0.97 . . . . 43.31 111.577 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.41 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 88.1 mtt-85 -73.02 -39.82 65.68 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.603 0.761 . . . . 72.14 109.506 177.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.61 -0.79 68.99 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 123.895 0.747 . . . . 63.41 112.522 171.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.0 p 63.4 32.17 14.66 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.823 2.049 . . . . 75.0 113.384 170.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -83.98 149.83 57.16 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 108.027 -1.101 . . . . 64.23 108.027 166.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.06 161.06 5.37 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 123.3 2.667 . . . . 62.51 113.96 176.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -58.55 113.57 2.06 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.751 0.82 . . . . 72.21 112.222 -172.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 50.8 tp -109.35 87.83 2.59 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.924 -1.034 . . . . 61.4 108.254 173.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -90.2 106.7 18.66 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.175 -1.046 . . . . 73.21 108.175 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 86.5 mt -64.45 129.25 39.16 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.41 0.684 . . . . 61.44 110.618 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.07 151.2 96.11 Favored Pre-proline 0 CA--C 1.553 1.076 0 O-C-N 124.34 1.025 . . . . 73.55 111.089 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.87 116.71 3.4 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.15 2.566 . . . . 55.42 112.853 177.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 28.9 t -99.35 133.22 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.042 -0.725 . . . . 72.24 109.042 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -87.64 96.47 10.44 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.745 0.818 . . . . 63.45 109.169 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -68.92 -24.58 64.31 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.396 0.679 . . . . 75.44 112.085 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -66.13 -41.15 90.88 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 109.076 -0.713 . . . . 61.01 109.076 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.79 -39.98 95.91 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.303 -0.862 . . . . 72.11 110.819 175.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 77.2 mt -67.6 -26.23 66.16 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.551 -0.75 . . . . 64.13 111.012 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . 0.548 ' HB2' ' HB2' ' C' ' 100' ' ' ALA . 34.5 t80 . . . . . 0 CA--C 1.546 0.804 0 CA-C-O 120.613 0.244 . . . . 70.22 110.878 176.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.421 HG22 ' HB3' ' D' ' 87' ' ' ALA . 10.2 t . . . . . 0 N--CA 1.47 0.565 0 CA-C-O 120.941 0.4 . . . . 33.54 110.286 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -133.37 111.2 10.58 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.642 -1.244 . . . . 74.11 107.642 173.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -136.4 139.64 42.61 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.086 0.954 . . . . 63.2 108.655 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.506 HG21 HD11 ' D' ' 16' ' ' ILE . 7.4 mt -100.2 142.02 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 108.717 -0.846 . . . . 61.1 108.717 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -103.45 -34.6 8.65 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.324 0.65 . . . . 75.53 111.483 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -169.42 137.13 1.8 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.015 0.376 . . . . 72.14 112.015 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.506 HD11 HG21 ' D' ' 13' ' ' ILE . 3.5 mp -115.66 140.09 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 107.216 -1.402 . . . . 65.55 107.216 170.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.43 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 38.3 p90 -168.72 171.08 8.92 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.977 0.911 . . . . 73.31 110.15 176.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -98.41 117.83 33.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.888 -1.051 . . . . 71.25 109.089 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.43 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 22.4 mtpt -85.79 -25.8 26.15 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.721 -0.844 . . . . 65.01 108.721 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.629 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 26.6 t70 -155.68 136.87 13.83 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.648 -1.16 . . . . 74.0 109.576 -178.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.525 HG21 ' HE2' ' C' ' 117' ' ' MET . 67.9 mt -136.59 146.84 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.326 1.05 . . . . 71.15 109.019 174.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -145.5 141.25 28.13 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.608 1.163 . . . . 72.21 109.515 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.492 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.1 t80 -145.67 134.52 22.44 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 106.415 -1.698 . . . . 72.03 106.415 165.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.45 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 50.0 mt-10 -135.03 144.99 47.6 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.94 0.896 . . . . 74.34 109.366 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.96 79.77 8.32 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 107.037 -1.468 . . . . 75.54 107.037 170.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.16 -15.49 28.73 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.821 2.347 . . . . 71.51 112.232 -175.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.415 ' ND2' ' HB ' ' D' ' 72' ' ' THR . 40.5 m-20 -114.78 16.38 17.38 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 124.383 1.073 . . . . 73.23 110.588 -174.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.55 -65.11 0.98 Allowed Pre-proline 0 CA--C 1.562 1.412 0 N-CA-C 115.067 1.506 . . . . 61.13 115.067 -159.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.501 ' HB3' HD11 ' C' ' 83' ' ' ILE . 57.4 Cg_endo -69.96 -22.98 30.42 Favored 'Trans proline' 0 C--N 1.392 2.833 0 CA-C-N 122.51 1.932 . . . . 62.12 113.484 -177.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -69.47 -44.63 70.79 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.275 1.03 . . . . 70.42 110.498 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.463 HG21 ' HA ' ' D' ' 73' ' ' ALA . 5.7 p -85.0 -18.52 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 123.192 0.597 . . . . 72.34 111.613 -170.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -60.9 -23.55 65.31 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 112.447 0.536 . . . . 54.54 112.447 172.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -63.8 -22.73 67.05 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.434 0.694 . . . . 55.42 110.919 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.594 ' HZ1' ' HB3' ' D' ' 71' ' ' GLU . 90.9 mttt -85.59 104.78 15.65 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.489 1.115 . . . . 72.12 109.599 176.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -102.09 90.56 3.99 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.379 -0.6 . . . . 63.34 109.379 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 35.4 p90 -165.42 -168.44 1.36 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.882 0.873 . . . . 75.11 109.624 171.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . 0.444 HE21 ' HD2' ' D' ' 38' ' ' PRO . 27.3 tp60 -72.7 117.17 57.05 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.8 0.84 . . . . 65.24 110.497 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.444 ' HD2' HE21 ' D' ' 37' ' ' GLN . 53.0 Cg_exo -56.88 110.63 0.62 Allowed 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 121.788 1.659 . . . . 64.23 109.862 168.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -67.79 109.61 3.44 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.048 -1.093 . . . . 74.22 108.048 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.683 HG21 HD13 ' D' ' 126' ' ' LEU . 92.3 t -106.62 122.68 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.4 -0.364 . . . . 71.44 110.397 -170.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 119.29 38.97 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.726 -1.583 . . . . 71.31 106.726 172.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.499 HD11 HG13 ' D' ' 62' ' ' VAL . 45.3 tp -95.11 141.91 28.19 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.334 -0.987 . . . . 75.24 108.334 178.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -136.53 125.3 23.97 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.229 -1.397 . . . . 73.21 107.229 -177.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.426 ' CD2' HG22 ' D' ' 62' ' ' VAL . 83.6 mt -120.08 142.13 49.15 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.143 0.577 . . . . 74.11 110.491 -175.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -146.38 143.22 28.92 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.344 1.458 . . . . 74.02 107.612 174.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 15.2 t -103.95 165.37 11.09 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.983 -0.747 . . . . 63.22 108.983 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.596 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.37 147.44 26.92 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.258 -1.386 . . . . 65.51 107.258 175.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 6.4 p . . . . . 0 C--O 1.246 0.899 0 C-N-CA 123.753 0.821 . . . . 62.23 108.879 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' D' ' 85' ' ' SER . 3.5 m-20 . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 114.05 1.13 . . . . 55.52 114.05 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 89.8 t -134.18 100.54 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.001 -1.111 . . . . 62.31 108.001 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -117.84 138.47 52.07 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.034 0.934 . . . . 51.5 109.891 -170.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.672 ' HG2' HG13 ' D' ' 83' ' ' ILE . 33.8 mt-10 -87.95 108.34 19.15 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 108.521 -0.918 . . . . 72.2 108.521 170.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 97.4 t -101.08 123.79 54.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.77 -0.826 . . . . 55.31 108.77 175.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 21.3 t -114.24 130.86 67.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.994 -1.113 . . . . 74.34 107.994 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.583 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -105.35 119.81 40.01 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.792 -1.188 . . . . 71.52 107.792 -178.563 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -98.6 99.79 10.96 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.237 -1.024 . . . . 64.53 108.237 177.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.499 HG13 HD11 ' D' ' 42' ' ' LEU . 58.3 t -105.86 118.46 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 108.66 -0.867 . . . . 74.35 108.66 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.0 m -125.45 130.59 52.13 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.593 -0.73 . . . . 63.44 109.751 -170.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.661 HG13 HG13 ' D' ' 40' ' ' VAL . 70.3 t -113.22 130.6 66.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 124.845 1.258 . . . . 73.22 109.445 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 37.3 m -119.55 93.49 4.09 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.218 -1.401 . . . . 62.41 107.218 167.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.71 138.13 36.32 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.787 -0.82 . . . . 54.51 108.787 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.546 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 66.9 m -143.43 132.29 22.73 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.193 0.521 . . . . 75.54 111.232 -175.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.436 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 35.6 mt -95.55 99.26 11.16 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.482 -1.303 . . . . 51.41 107.482 173.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.57 -137.36 17.37 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.578 -0.737 . . . . 74.12 112.619 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.44 5.26 31.84 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.611 0.764 . . . . 73.43 111.95 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . 0.594 ' HB3' ' HZ1' ' D' ' 34' ' ' LYS . 5.4 tp10 -136.6 145.67 45.17 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.194 0.998 . . . . 72.22 109.599 -169.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . 0.415 ' HB ' ' ND2' ' D' ' 27' ' ' ASN . 91.8 m -59.83 135.95 57.85 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.741 1.217 . . . . 53.22 112.522 -175.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.546 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.6 -65.62 1.0 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.301 -1.37 . . . . 74.12 107.301 170.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -152.57 158.26 42.23 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 114.542 -1.208 . . . . 53.24 110.045 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 76.0 mt -116.84 155.02 29.73 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.867 1.267 . . . . 73.52 108.269 171.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.574 ' SG ' HG12 ' D' ' 114' ' ' ILE . 49.1 t -154.42 147.71 24.9 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.059 -0.719 . . . . 63.42 109.059 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -157.43 123.78 4.88 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.818 0.447 . . . . 64.11 110.129 174.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 50.2 t -124.3 116.93 49.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 123.523 0.729 . . . . 62.2 109.118 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.629 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.9 mt-30 -93.25 85.1 4.92 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.938 0.875 . . . . 62.3 109.08 171.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -80.4 102.64 9.74 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 113.713 -1.585 . . . . 71.33 109.465 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.84 150.83 21.31 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 116.742 -0.208 . . . . 73.5 113.219 -178.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.58 137.24 5.58 Favored Glycine 0 C--N 1.34 0.791 0 N-CA-C 112.092 -0.403 . . . . 52.24 112.092 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.672 HG13 ' HG2' ' D' ' 57' ' ' GLU . 2.6 mp -91.15 112.84 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 107.775 -1.194 . . . . 65.13 107.775 174.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -115.33 145.29 42.64 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.69 0.796 . . . . 62.32 109.669 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' D' ' 54' ' ' ASP . 39.8 m -116.29 107.78 15.27 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.836 0.854 . . . . 63.41 109.766 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.488 HD11 HD23 ' D' ' 98' ' ' LEU . 46.9 pt -116.8 129.35 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.387 0.675 . . . . 73.42 109.391 176.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.421 ' HB3' HG22 ' D' ' 10' ' ' THR . . . -143.49 158.18 43.85 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.675 0.79 . . . . 71.44 110.149 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.07 23.64 44.18 Favored Glycine 0 C--N 1.347 1.16 0 O-C-N 123.709 0.631 . . . . 73.4 114.247 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.432 HD13 ' HG3' ' D' ' 94' ' ' MET . 0.7 OUTLIER -134.85 160.94 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.476 0.71 . . . . 62.45 110.726 178.254 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.13 160.2 40.48 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.137 0.898 . . . . 75.14 111.019 -171.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.67 -141.35 36.52 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.194 -0.912 . . . . 71.54 113.945 175.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.5 p -78.41 -32.31 48.62 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.138 0.575 . . . . 74.23 110.739 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -56.46 -33.58 66.06 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.881 0.873 . . . . 74.23 111.266 177.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.432 ' HG3' HD13 ' D' ' 89' ' ' ILE . 40.0 ttp -62.44 -62.19 1.93 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.146 1.378 . . . . 71.22 112.165 177.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.28 -15.09 51.54 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.066 0.546 . . . . 51.11 112.176 -171.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -70.83 -26.59 63.35 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.109 0.564 . . . . 74.22 110.088 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.7 t -66.41 -45.65 79.21 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.273 0.629 . . . . 75.42 110.947 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.599 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 4.3 pp -74.35 -23.08 58.97 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 116.608 -0.269 . . . . 74.42 111.207 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.82 -28.59 34.44 Favored Glycine 0 C--N 1.348 1.23 0 O-C-N 123.458 0.474 . . . . 55.01 112.958 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.24 -57.37 2.01 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 117.332 0.566 . . . . 50.22 112.233 -170.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -72.48 -37.64 68.39 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.524 0.329 . . . . 74.24 111.833 -174.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.599 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 88.6 m -65.35 -46.62 70.81 Favored Pre-proline 0 CA--C 1.566 1.592 0 CA-C-O 118.775 -0.631 . . . . 73.41 112.198 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.583 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 76.2 Cg_exo -57.61 -31.3 91.4 Favored 'Trans proline' 0 C--N 1.394 2.923 0 C-N-CA 122.622 2.215 . . . . 73.44 113.902 168.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -65.57 -28.55 69.23 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.092 0.557 . . . . 61.43 111.186 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.4 mm -73.32 -35.29 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.316 0.646 . . . . 75.05 110.332 174.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 68.3 mt -77.1 -18.24 58.1 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.352 -0.84 . . . . 74.14 111.891 -177.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . 0.421 ' HE2' ' HA ' ' D' ' 130' ' ' PRO . 8.4 t80 -70.46 -39.91 10.5 Favored Pre-proline 0 CA--C 1.557 1.218 0 N-CA-C 114.353 1.242 . . . . 71.52 114.353 -171.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.79 -44.9 45.15 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.962 1.775 . . . . 60.33 112.68 169.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -71.83 -32.58 67.69 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.845 0.858 . . . . 71.12 111.554 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.99 -50.52 64.01 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.467 0.707 . . . . 32.33 110.237 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.497 ' NH2' HG23 ' B' ' 105' ' ' ILE . 31.3 ttp180 -60.22 -43.06 96.31 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 124.353 1.033 . . . . 63.24 110.031 176.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -57.0 -52.77 63.94 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.102 0.876 . . . . 55.22 111.455 -176.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.437 ' O ' ' HG3' ' D' ' 117' ' ' MET . 43.2 t -57.06 -44.17 82.76 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 124.177 0.923 . . . . 73.3 110.598 -177.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.574 HG12 ' SG ' ' D' ' 76' ' ' CYS . 83.7 mt -60.62 -54.95 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.743 0.817 . . . . 64.04 110.696 175.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 77.2 m -53.43 -43.74 68.23 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.382 1.473 . . . . 62.01 111.055 -175.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -65.36 -45.9 82.31 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.403 -1.272 . . . . 72.04 109.805 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.437 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 71.2 mtm -70.87 -26.97 63.48 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.0 0.52 . . . . 73.43 112.391 -177.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.467 HG21 ' HB3' ' D' ' 126' ' ' LEU . 71.0 t -68.64 -46.16 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.216 0.606 . . . . 70.51 109.419 175.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 81.5 p -70.75 -29.69 66.0 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.588 -0.733 . . . . 72.45 110.463 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -70.83 -34.15 71.41 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.815 0.846 . . . . 64.35 110.0 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.7 6.17 71.06 Favored Glycine 0 C--N 1.355 1.625 0 O-C-N 123.681 0.613 . . . . 51.13 113.203 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.457 HG23 ' HB3' ' C' ' 17' ' ' TYR . 65.3 p 56.18 28.94 13.87 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 126.39 1.876 . . . . 72.53 113.349 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -92.79 148.93 36.94 Favored Pre-proline 0 C--O 1.241 0.655 0 N-CA-C 108.598 -0.89 . . . . 75.54 108.598 167.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.35 125.96 13.04 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 123.318 2.679 . . . . 71.04 112.466 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -47.91 124.9 8.05 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 124.607 1.192 . . . . 74.54 112.149 -173.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.683 HD13 HG21 ' D' ' 40' ' ' VAL . 16.6 tp -106.49 106.1 16.46 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.165 0.986 . . . . 75.03 109.682 -176.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -109.47 83.01 1.68 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.322 1.049 . . . . 73.44 108.532 175.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.452 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.6 pp -62.98 141.91 58.57 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.958 0.503 . . . . 64.34 110.393 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.24 139.86 90.14 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 122.74 0.416 . . . . 75.42 111.609 -173.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.421 ' HA ' ' HE2' ' D' ' 107' ' ' PHE . 74.3 Cg_endo -73.51 144.73 36.54 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.682 2.255 . . . . 72.32 111.365 176.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.99 145.59 23.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.815 0 C-N-CA 122.977 0.511 . . . . 70.33 110.129 -177.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -78.71 112.28 15.67 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.508 0.723 . . . . 71.42 109.24 176.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 . . . . . 0 N--CA 1.48 1.039 0 C-N-CA 123.968 0.907 . . . . 74.23 112.146 -176.489 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.3 m . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 108.218 -1.03 . . . . 74.5 108.218 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -120.96 119.77 33.54 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.978 0.911 . . . . 65.43 109.211 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -135.25 132.47 37.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.006 0.923 . . . . 73.44 108.586 174.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.466 ' CD1' HG21 ' A' ' 105' ' ' ILE . 4.8 mt -96.17 114.47 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 108.617 -0.883 . . . . 62.32 108.617 173.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -78.32 -32.95 49.52 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.014 0.525 . . . . 70.2 110.249 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -171.85 148.69 2.37 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 123.378 0.424 . . . . 64.34 110.144 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.2 mt -133.12 135.26 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 124.632 1.173 . . . . 65.34 108.502 173.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -163.2 171.74 15.81 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 123.982 0.801 . . . . 75.32 112.104 -171.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -101.78 124.39 47.34 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.366 -0.976 . . . . 72.21 108.366 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.532 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 44.2 mtpt -85.91 -35.69 20.36 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.039 0.447 . . . . 74.25 109.889 175.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.528 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 19.7 t70 -146.66 138.96 24.9 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.15 -0.932 . . . . 74.11 109.401 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 81.0 mt -129.11 140.32 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.009 -1.108 . . . . 71.14 108.009 174.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.7 t -138.87 123.67 18.71 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.365 0.666 . . . . 72.11 109.279 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 86.9 t80 -133.59 129.38 36.89 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.265 -1.754 . . . . 74.33 106.265 170.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -139.17 124.45 19.11 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.955 -1.128 . . . . 74.13 107.955 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.7 89.26 7.42 Favored Pre-proline 0 C--O 1.241 0.658 0 N-CA-C 107.886 -1.153 . . . . 71.44 107.886 175.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -52.31 -53.39 7.0 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 123.684 2.923 . . . . 72.24 113.504 -169.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.26 41.27 2.83 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.779 -0.823 . . . . 74.53 108.779 -173.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -44.66 -59.13 4.34 Favored Pre-proline 0 N--CA 1.495 1.789 0 CA-C-O 117.584 -1.198 . . . . 71.21 113.968 -171.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 20.9 Cg_exo -62.37 -22.54 74.22 Favored 'Trans proline' 0 C--N 1.389 2.669 0 CA-C-N 121.952 1.733 . . . . 74.5 112.618 -177.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.43 ' HA ' HE21 ' A' ' 33' ' ' GLN . 9.4 m-70 -94.47 -28.36 15.5 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.613 1.165 . . . . 72.21 111.244 -173.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 28' ' ' ALA . 5.9 p -80.05 -17.09 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 122.698 0.399 . . . . 34.3 111.877 -170.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -78.23 -24.12 47.11 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.393 0.677 . . . . 75.24 111.206 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.43 HE21 ' HA ' ' A' ' 30' ' ' HIS . 29.5 pt20 -92.56 -16.08 26.15 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.782 0.833 . . . . 75.35 110.687 176.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -67.57 157.81 33.5 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.29 0.636 . . . . 63.02 111.156 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -67.54 116.63 8.48 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.401 -0.963 . . . . 72.42 108.401 171.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.421 ' CE3' HD21 ' A' ' 68' ' ' LEU . 73.7 t-105 -83.8 82.13 8.46 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.092 0.557 . . . . 72.25 110.372 -175.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -115.16 81.78 8.33 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 107.572 -1.27 . . . . 73.42 107.572 168.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -86.53 121.34 1.88 Allowed 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.424 2.083 . . . . 73.4 112.499 -173.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -94.95 95.45 8.64 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.069 -1.456 . . . . 64.43 107.069 168.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.559 HG11 HD11 ' A' ' 126' ' ' LEU . 48.0 t -85.71 104.38 13.41 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-N 115.727 -0.67 . . . . 74.23 109.554 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -79.18 121.44 25.03 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.025 -1.102 . . . . 40.03 108.025 173.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tt -96.19 105.12 17.13 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 105.841 -1.911 . . . . 63.03 105.841 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -112.39 145.25 40.44 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 107.907 -1.146 . . . . 73.41 107.907 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.552 HD11 HG21 ' A' ' 131' ' ' VAL . 90.1 mt -136.82 146.98 46.3 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.913 0.485 . . . . 72.22 112.094 -171.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -155.09 117.52 4.25 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.906 -1.043 . . . . 73.12 108.765 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.3 m -117.5 126.9 53.4 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.068 0.547 . . . . 64.2 109.997 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.52 127.15 23.42 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.179 0.591 . . . . 54.53 109.94 176.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 61.7 p -101.82 170.72 7.97 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.943 0.897 . . . . 64.33 111.391 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 94.5 p -150.17 124.4 9.48 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.94 0.896 . . . . 53.1 109.382 -173.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -78.88 103.7 9.0 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.187 -0.671 . . . . 63.1 109.187 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 57' ' ' GLU . 69.9 mt -79.39 -26.8 41.87 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.512 0.725 . . . . 71.01 110.848 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.14 -175.08 2.51 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.918 0.887 . . . . 72.04 110.049 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.92 112.33 2.27 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 109.152 -0.684 . . . . 70.22 109.152 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 68.21 6.33 5.21 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.745 1.218 . . . . 75.22 112.884 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.6 t -105.16 116.23 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.014 -1.106 . . . . 61.23 108.014 173.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -132.25 127.33 35.49 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.302 -0.999 . . . . 73.1 108.302 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.445 ' HB2' HD11 ' A' ' 51' ' ' LEU . 23.9 tt0 -88.55 143.37 27.0 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 108.036 -1.098 . . . . 74.22 108.036 167.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.6 t -118.51 134.67 61.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.049 -1.093 . . . . 74.14 108.049 170.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.411 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 42.8 t -117.72 124.46 73.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 108.607 -0.886 . . . . 73.55 108.607 174.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.23 119.68 39.49 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.535 -1.283 . . . . 63.21 107.535 175.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 46.3 ttp85 -109.48 100.98 9.98 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.559 -1.274 . . . . 63.41 107.559 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.7 t -96.23 103.0 14.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 114.204 -1.362 . . . . 71.21 107.909 -178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.8 m -96.27 107.45 19.8 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 122.066 0.936 . . . . 71.1 108.918 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.556 HG11 HD21 ' A' ' 126' ' ' LEU . 43.4 t -104.72 135.91 40.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 114.599 -1.182 . . . . 73.21 108.592 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 35.7 m -138.1 126.43 23.17 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.497 -0.557 . . . . 75.32 109.497 173.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.547 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -105.31 130.34 53.45 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.326 -1.361 . . . . 70.34 107.326 173.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 54.9 m -136.52 134.15 37.23 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.7 0.625 . . . . 74.41 110.507 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.421 HD21 ' CE3' ' A' ' 36' ' ' TRP . 23.7 mt -87.25 69.12 10.01 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 107.532 -1.284 . . . . 75.01 107.532 174.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.26 -100.83 1.3 Allowed Glycine 0 C--N 1.346 1.117 0 CA-C-N 114.307 -1.315 . . . . 74.22 111.939 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -91.14 -27.54 18.47 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.931 0.892 . . . . 75.42 111.604 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -91.33 123.02 34.45 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.485 -0.561 . . . . 74.35 109.485 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.9 m -71.49 129.96 40.07 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.029 0.443 . . . . 44.51 110.431 172.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.33 -52.2 8.41 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.389 1.075 . . . . 75.12 109.162 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -160.47 160.49 32.11 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.225 -0.898 . . . . 73.22 111.615 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 64' ' ' VAL . 63.9 tp -112.68 143.53 43.74 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.806 1.242 . . . . 62.5 108.132 166.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.425 ' HB3' HG23 ' A' ' 114' ' ' ILE . 88.5 m -143.75 98.81 3.3 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.86 0.864 . . . . 74.21 109.651 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -122.37 116.12 23.48 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.915 -0.772 . . . . 61.04 108.915 -176.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.6 t -124.38 122.28 63.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 121.441 0.638 . . . . 64.41 109.885 -177.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -99.75 82.07 2.55 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.298 -1.319 . . . . 71.12 108.019 -178.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -76.02 94.47 3.43 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.038 -0.983 . . . . 74.14 109.11 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.05 150.99 21.8 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.664 -0.698 . . . . 72.12 111.383 177.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.76 132.68 3.35 Favored Glycine 0 CA--C 1.507 -0.446 0 N-CA-C 111.017 -0.833 . . . . 31.02 111.017 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.7 mt -81.41 127.07 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.384 -0.969 . . . . 63.43 108.384 175.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.602 ' HB3' HD11 ' A' ' 86' ' ' ILE . 95.8 m-85 -124.81 120.02 30.52 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.311 1.044 . . . . 62.54 108.618 -177.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.9 m -92.67 99.2 11.94 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.346 -1.353 . . . . 64.14 107.346 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.602 HD11 ' HB3' ' A' ' 84' ' ' PHE . 10.9 mm -117.15 145.99 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 122.787 0.435 . . . . 55.12 110.118 -174.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.91 169.95 17.41 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.688 0.617 . . . . 60.41 110.859 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.45 -15.12 63.36 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.702 -0.681 . . . . 53.35 112.824 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.45 164.54 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 124.188 0.995 . . . . 64.23 110.412 -177.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.591 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 13.8 tt0 -154.8 -177.74 6.72 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 109.402 -0.592 . . . . 74.12 109.402 173.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.528 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 67.53 -122.14 16.84 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 123.208 0.433 . . . . 65.44 113.513 176.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.5 t -74.36 -28.94 61.36 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.711 0.804 . . . . 73.22 111.522 -176.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -73.64 -37.29 65.38 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.518 0.727 . . . . 73.45 109.582 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.591 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 3.2 tpt -66.24 -42.79 88.09 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.237 -0.892 . . . . 72.21 110.053 175.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.18 88.82 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.362 -0.835 . . . . 50.41 111.109 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.534 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 55.8 t-80 -74.9 -20.53 59.68 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.014 0.526 . . . . 73.43 111.163 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.5 t -78.21 -49.01 14.57 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.785 -0.572 . . . . 75.15 109.539 174.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 76.1 mt -78.81 -31.44 45.9 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.245 0.618 . . . . 74.03 112.575 -172.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.35 4.41 51.36 Favored Glycine 0 N--CA 1.47 0.953 0 CA-C-O 119.649 -0.528 . . . . 75.15 113.583 -174.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -144.47 -63.64 0.36 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.448 0.624 . . . . 63.22 112.009 -175.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -69.61 -47.1 64.63 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 112.083 0.401 . . . . 73.14 112.083 -172.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 88.8 m -65.78 -47.13 66.26 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.401 1.08 . . . . 60.33 112.966 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.0 -24.81 59.75 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 122.023 1.815 . . . . 44.24 112.955 173.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -68.83 -33.69 74.25 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.13 0.572 . . . . 73.31 110.505 174.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.466 HG21 ' CD1' ' A' ' 13' ' ' ILE . 43.8 mm -68.3 -42.44 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.77 0.828 . . . . 72.0 110.4 172.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.8 mt -74.25 -25.01 59.38 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.054 -0.976 . . . . 70.31 112.089 -174.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -64.69 -40.87 52.73 Favored Pre-proline 0 CA--C 1.558 1.282 0 N-CA-C 114.49 1.293 . . . . 72.33 114.49 -171.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -52.55 -42.05 64.33 Favored 'Trans proline' 0 C--N 1.385 2.452 0 CA-C-N 121.966 1.738 . . . . 62.22 113.23 170.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -73.43 -40.28 64.36 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.533 0.733 . . . . 75.2 111.318 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.52 -46.59 82.25 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.483 0.713 . . . . 65.32 110.106 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.535 ' NH1' HD12 ' C' ' 105' ' ' ILE . 29.8 ttm180 -52.06 -50.43 61.51 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.959 1.304 . . . . 74.54 110.869 174.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -62.6 -47.79 82.26 Favored 'General case' 0 C--N 1.346 0.429 0 O-C-N 124.431 1.082 . . . . 70.15 111.436 -175.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.416 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 49.7 t -57.51 -42.76 83.42 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 124.173 0.921 . . . . 64.13 110.455 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.461 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.6 mt -60.97 -50.13 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.488 1.115 . . . . 52.13 110.607 175.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.0 m -61.33 -39.31 90.08 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.015 0.926 . . . . 74.13 111.379 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -69.89 -43.11 72.45 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.98 -1.009 . . . . 71.21 109.813 -177.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 6.9 mtp -56.97 -43.95 82.14 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.774 0.83 . . . . 75.01 111.129 174.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 114' ' ' ILE . 68.8 t -62.07 -47.11 94.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.556 1.142 . . . . 70.01 111.101 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.7 p -73.95 -29.38 61.98 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 122.906 0.483 . . . . 31.03 111.654 -176.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.448 ' NH1' ' HA ' ' B' ' 113' ' ' CYS . 68.4 mtt-85 -71.62 -30.93 66.33 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.214 0.606 . . . . 53.32 109.627 174.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.92 14.24 44.34 Favored Glycine 0 C--N 1.35 1.33 0 CA-C-N 115.413 -0.812 . . . . 72.43 112.976 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.532 HG21 ' HE ' ' B' ' 15' ' ' ARG . 3.2 t 57.31 13.8 1.88 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 127.156 2.183 . . . . 60.11 113.605 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -77.47 142.14 66.52 Favored Pre-proline 0 C--O 1.244 0.774 0 N-CA-C 108.903 -0.777 . . . . 73.32 108.903 175.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -43.84 128.25 6.88 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 123.612 2.875 . . . . 74.51 112.622 170.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -55.35 131.88 46.76 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.22 0.95 . . . . 65.41 112.375 -167.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.559 HD11 HG11 ' A' ' 40' ' ' VAL . 42.6 tp -112.62 117.16 31.51 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.751 1.22 . . . . 71.31 109.932 -174.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -121.14 104.61 9.9 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.028 -0.73 . . . . 72.23 109.028 -174.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 111' ' ' ARG . 79.2 mt -61.81 144.69 54.42 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.367 0.667 . . . . 53.35 112.336 -173.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.98 144.84 90.82 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.299 0.64 . . . . 72.32 110.304 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.406 ' HA ' HH22 ' A' ' 111' ' ' ARG . 24.8 Cg_exo -64.05 117.51 4.52 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.834 2.356 . . . . 64.12 112.599 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.552 HG21 HD11 ' A' ' 44' ' ' LEU . 87.9 t -100.22 132.6 45.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-N 116.126 -0.488 . . . . 61.23 110.299 -179.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.437 ' OD1' ' HB3' ' A' ' 134' ' ' ASP . 63.7 t30 -97.59 92.94 6.15 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.725 -1.213 . . . . 70.25 107.725 172.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.41 ' CE1' HD13 ' A' ' 44' ' ' LEU . 86.0 m-85 -65.3 -25.18 67.52 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.577 0.751 . . . . 62.24 111.355 177.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.459 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 1.1 t70 -54.74 -48.27 72.79 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.958 0.903 . . . . 72.32 110.291 168.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.409 ' HB2' HD22 ' A' ' 132' ' ' ASN . . . -62.81 -45.41 92.77 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.571 0.748 . . . . 44.12 111.711 177.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.74 -35.98 79.66 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.365 0.666 . . . . 74.24 111.396 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 42.4 t80 . . . . . 0 CA--C 1.538 0.517 0 CA-C-N 115.504 -0.771 . . . . 64.32 109.858 177.939 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.548 ' HB3' HG23 ' B' ' 89' ' ' ILE . 11.8 ptm . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 115.442 1.645 . . . . 71.03 115.442 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 5.0 t -135.79 126.93 28.04 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.46 -1.245 . . . . 72.33 107.701 168.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -130.82 144.18 51.27 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.909 0.484 . . . . 71.25 110.132 -176.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -150.28 141.92 23.58 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 108.693 -0.855 . . . . 64.2 108.693 169.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 63.1 mt -81.44 125.2 39.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.527 -1.286 . . . . 73.1 107.527 171.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . 0.562 ' HB2' HG23 ' B' ' 83' ' ' ILE . 9.3 mm100 -90.16 -39.06 13.07 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.785 -0.45 . . . . 65.43 109.785 -176.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.532 ' HE ' HG21 ' A' ' 122' ' ' THR . 43.2 ttt180 -176.97 134.48 0.2 Allowed 'General case' 0 N--CA 1.477 0.917 0 O-C-N 123.919 0.762 . . . . 73.51 109.81 176.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.543 ' HB ' ' ND2' ' D' ' 127' ' ' ASN . 96.7 mt -115.63 141.37 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 107.851 -1.166 . . . . 54.13 107.851 173.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -168.44 151.35 5.41 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-O 121.386 0.613 . . . . 73.45 111.568 -174.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 89.5 m -79.06 126.9 31.3 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.953 -1.021 . . . . 60.2 109.24 172.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -89.61 -42.74 11.22 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.73 0.412 . . . . 70.01 110.071 169.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.1 t70 -140.65 136.82 33.07 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.573 -0.285 . . . . 75.43 110.541 -169.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.45 HD11 ' SG ' ' B' ' 113' ' ' CYS . 46.6 mm -126.18 137.09 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.015 0.926 . . . . 70.11 108.772 169.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.488 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 47.7 t -140.52 131.62 26.34 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.686 1.194 . . . . 75.23 107.866 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 80.2 t80 -143.68 121.81 12.18 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.319 -1.734 . . . . 73.0 106.319 170.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -126.71 113.59 16.87 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.117 -1.068 . . . . 62.51 108.117 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -106.7 87.21 2.66 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 106.633 -1.617 . . . . 65.1 106.633 167.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.66 -27.85 52.69 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.327 2.018 . . . . 74.21 110.962 -172.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.417 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 67.5 m-20 -109.82 11.49 24.31 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.507 1.123 . . . . 63.25 110.939 -177.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' B' ' 25' ' ' ALA . . . -30.48 -64.34 0.21 Allowed Pre-proline 0 N--CA 1.5 2.049 0 C-N-CA 125.517 1.527 . . . . 64.51 114.699 -172.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 14.3 Cg_exo -60.48 -34.8 92.52 Favored 'Trans proline' 0 C--N 1.395 3.015 0 C-N-CA 122.729 2.286 . . . . 70.31 112.199 -170.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.41 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 80.5 m80 -92.52 -39.76 11.19 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 114.442 -1.253 . . . . 71.24 112.39 -170.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.549 HG22 HD12 ' B' ' 68' ' ' LEU . 8.7 p -69.76 -12.66 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.032 0.533 . . . . 74.33 111.808 -171.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -69.76 -6.7 33.82 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.651 0.78 . . . . 71.44 112.92 173.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.452 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 29.4 pt20 -67.9 -22.11 65.1 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.816 0.447 . . . . 73.54 110.168 169.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.452 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 92.6 mttt -101.43 92.79 5.08 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.672 1.189 . . . . 74.31 109.869 -176.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -99.17 82.5 2.72 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.623 0.769 . . . . 63.53 110.057 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -157.01 -177.97 7.02 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.733 0.813 . . . . 52.4 109.61 172.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -66.86 114.77 19.41 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.63 0.772 . . . . 50.11 110.588 175.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.419 ' O ' HG23 ' B' ' 40' ' ' VAL . 41.8 Cg_endo -66.3 144.36 74.02 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 121.597 1.531 . . . . 73.55 110.678 172.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -71.4 113.3 8.29 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.525 -0.917 . . . . 70.22 108.525 172.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.494 HG11 HD11 ' B' ' 126' ' ' LEU . 57.4 t -106.5 150.41 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.063 0.945 . . . . 71.5 111.378 -170.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -138.0 119.29 14.66 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.925 1.29 . . . . 72.3 107.854 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.479 HD13 HD22 ' B' ' 128' ' ' LEU . 23.3 tp -85.43 138.62 32.13 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.359 -0.978 . . . . 34.31 108.359 173.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -140.05 112.38 7.77 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.858 -1.164 . . . . 45.24 107.858 -171.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 88.4 mt -103.1 139.57 38.45 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.275 0.63 . . . . 74.12 110.778 -171.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -148.28 146.02 28.43 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.126 1.37 . . . . 65.25 107.638 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.4 t -151.24 110.91 4.02 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 121.432 0.634 . . . . 65.32 111.737 -177.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.63 148.53 40.88 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.346 1.058 . . . . 74.2 108.367 175.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 20.8 p -142.8 177.18 8.51 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.429 0.691 . . . . 72.14 111.109 -172.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 58.7 p -156.2 134.6 11.52 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.314 1.045 . . . . 72.3 108.675 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -92.17 111.05 22.46 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.158 -1.053 . . . . 73.45 108.158 172.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 pp -120.53 17.31 12.09 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.945 0.898 . . . . 64.24 110.955 -175.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -162.3 150.86 14.88 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.321 1.048 . . . . 70.13 109.3 175.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -67.15 116.58 8.11 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.578 0.351 . . . . 53.24 110.341 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 72.35 -3.61 2.25 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.422 1.489 . . . . 61.12 112.357 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 44.0 t -119.32 102.15 12.48 Favored 'Isoleucine or valine' 0 C--N 1.347 0.483 0 N-CA-C 107.45 -1.315 . . . . 44.21 107.45 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.503 ' CE2' ' HB ' ' B' ' 58' ' ' VAL . 0.1 OUTLIER -94.31 -177.96 4.44 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.736 -0.838 . . . . 75.34 108.736 -178.055 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.519 ' HG2' ' HB ' ' B' ' 83' ' ' ILE . 4.2 tm-20 -142.34 118.54 10.76 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 107.218 -1.401 . . . . 75.13 107.218 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.503 ' HB ' ' CE2' ' B' ' 56' ' ' TYR . 12.0 p -111.09 148.19 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-O 121.094 0.473 . . . . 72.23 110.938 -178.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.474 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 28.7 t -119.02 134.36 62.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.052 -1.092 . . . . 73.14 108.052 171.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 59.1 tp -114.21 103.39 11.06 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 108.291 -1.003 . . . . 51.12 108.291 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -84.81 109.48 18.12 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.593 0.711 . . . . 74.14 109.241 175.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.433 HG13 HD11 ' B' ' 42' ' ' LEU . 56.1 t -107.06 103.44 15.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 107.769 -1.197 . . . . 51.53 107.769 174.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.9 m -102.21 132.69 47.98 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.738 -0.664 . . . . 72.22 109.567 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.894 HG11 HD21 ' B' ' 126' ' ' LEU . 82.6 t -116.76 117.31 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.138 0.975 . . . . 73.13 109.362 174.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 10.6 m -87.23 140.42 29.56 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.126 -1.064 . . . . 71.23 108.126 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.9 140.39 23.38 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 118.045 0.384 . . . . 65.54 110.413 175.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.462 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 52.6 p -146.44 133.13 19.93 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.058 0.456 . . . . 43.45 111.598 -175.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.549 HD12 HG22 ' B' ' 31' ' ' VAL . 72.9 mt -100.11 100.96 11.89 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.341 1.056 . . . . 75.35 108.661 176.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.58 -134.73 24.46 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.992 -0.549 . . . . 72.13 112.248 -176.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -83.01 4.28 26.66 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.755 0.822 . . . . 64.53 113.033 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.417 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 12.0 pt-20 -127.1 150.91 49.26 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.851 0.296 . . . . 74.01 110.49 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 85.8 m -69.4 135.84 50.85 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 123.533 0.521 . . . . 72.12 110.464 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.494 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -85.88 -63.64 1.29 Allowed 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.414 -1.328 . . . . 72.0 107.414 175.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -151.92 162.87 40.37 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.326 -1.306 . . . . 70.14 110.58 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 52.0 mt -132.32 110.42 10.57 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 105.443 -2.058 . . . . 73.31 105.443 175.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 34.4 t -116.96 145.32 43.71 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.323 -0.991 . . . . 75.34 108.323 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.488 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.9 tt0 -155.1 132.03 10.79 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.306 -0.998 . . . . 73.43 108.306 -177.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.47 HG21 ' HB3' ' B' ' 113' ' ' CYS . 94.7 t -127.26 143.53 40.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.973 -1.121 . . . . 43.1 107.973 174.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.486 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 26.2 mt-30 -119.6 86.99 2.65 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.092 -1.077 . . . . 60.03 108.092 174.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.462 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.5 tp-100 -82.95 102.84 11.97 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 114.738 -1.119 . . . . 74.42 109.281 -177.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -87.74 162.71 33.1 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-N 115.893 -0.594 . . . . 62.21 111.634 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.9 125.76 1.34 Allowed Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.544 -1.022 . . . . 62.34 110.544 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.562 HG23 ' HB2' ' B' ' 14' ' ' GLN . 18.8 tt -95.68 131.01 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 108.57 -0.9 . . . . 74.22 108.57 175.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -137.0 141.25 42.54 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.604 0.762 . . . . 74.53 109.437 -175.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.2 m -88.77 106.93 18.68 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.658 -0.867 . . . . 72.51 108.658 172.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 23.8 mm -97.37 109.66 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 107.873 -1.158 . . . . 73.22 107.873 -173.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.31 172.14 18.69 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.025 0.441 . . . . 75.43 111.58 -172.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 83.28 -47.11 3.76 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.506 -0.77 . . . . 73.3 112.631 -178.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.548 HG23 ' HB3' ' B' ' 9' ' ' MET . 1.0 OUTLIER -78.52 159.43 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 109.743 -0.465 . . . . 74.21 109.743 168.647 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -165.75 145.16 6.33 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 123.556 0.535 . . . . 74.32 110.86 -171.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.97 -100.54 2.7 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-O 120.174 -0.237 . . . . 73.02 113.347 175.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.1 m -95.96 -54.9 3.16 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 122.08 0.943 . . . . 71.34 110.12 -175.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -67.58 -18.23 64.92 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 113.52 -1.673 . . . . 61.44 111.383 -171.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 22.6 ptt? -61.42 -44.25 97.45 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.836 0.854 . . . . 74.52 113.057 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.02 -11.72 60.01 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.049 0.54 . . . . 71.21 112.142 -175.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -63.79 -38.56 91.57 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.129 0.572 . . . . 64.32 110.359 168.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.5 t -58.75 -52.67 64.7 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.258 0.551 . . . . 74.02 111.164 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.8 pp -83.44 -27.19 29.7 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.525 -0.761 . . . . 73.4 112.146 -174.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.21 -16.62 62.37 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-O 120.016 -0.324 . . . . 72.22 113.338 -176.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.82 -58.13 0.72 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.784 0.434 . . . . 70.14 112.093 -170.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -66.37 -43.53 85.69 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.125 0.57 . . . . 74.13 112.196 -173.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.4 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 59.7 m -71.38 -44.81 13.39 Favored Pre-proline 0 CA--C 1.562 1.437 0 CA-C-O 118.567 -0.73 . . . . 74.2 112.33 -175.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.4 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 50.1 Cg_exo -59.17 -31.83 96.06 Favored 'Trans proline' 0 C--N 1.394 2.934 0 C-N-CA 121.887 1.725 . . . . 65.3 113.247 168.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -62.11 -36.81 82.87 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.192 0.597 . . . . 72.4 110.303 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 59.1 mt -65.39 -40.86 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.489 0.716 . . . . 73.35 110.433 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 94.7 mt -76.26 -24.88 54.51 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.698 -0.683 . . . . 71.22 112.668 -173.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -62.32 -45.04 89.93 Favored Pre-proline 0 CA--C 1.566 1.587 0 CA-C-O 117.78 -1.105 . . . . 72.41 113.691 -173.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -52.3 -43.33 54.55 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.516 2.144 . . . . 73.22 113.371 173.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.462 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 95.3 m-85 -64.17 -45.24 89.29 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.285 0.634 . . . . 74.44 110.149 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.87 82.37 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.457 -0.792 . . . . 33.31 111.049 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.491 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 65.0 ttt-85 -64.56 -61.34 2.27 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.454 1.102 . . . . 72.1 110.989 -175.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -67.44 -25.85 66.11 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 123.505 0.503 . . . . 45.44 111.032 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.552 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.9 t -66.19 -40.75 90.63 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 109.681 -0.488 . . . . 63.5 109.681 176.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.549 HD13 HG23 ' B' ' 64' ' ' VAL . 70.3 mt -62.9 -54.47 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.784 0.834 . . . . 60.32 110.418 172.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 6.3 m -60.89 -30.68 70.3 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.886 0.875 . . . . 52.43 111.68 -173.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.454 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 44.4 t -65.41 -48.63 72.17 Favored 'General case' 0 C--N 1.347 0.5 0 C-N-CA 123.6 0.76 . . . . 73.35 110.191 174.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.552 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.4 mmt -68.35 -29.74 68.54 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.032 0.533 . . . . 60.32 111.194 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.428 HG23 ' O ' ' B' ' 114' ' ' ILE . 69.5 t -65.37 -44.36 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.442 1.097 . . . . 74.25 110.02 173.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 40.5 t -68.72 -29.92 68.44 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.241 -0.89 . . . . 64.44 111.174 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' B' ' 116' ' ' SER . 88.7 mtt-85 -65.14 -39.7 93.37 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 108.934 -0.765 . . . . 54.44 108.934 174.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.0 -5.28 75.09 Favored Glycine 0 C--N 1.356 1.675 0 O-C-N 123.651 0.595 . . . . 51.05 113.558 172.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 8.0 m 67.58 31.11 6.31 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.136 1.374 . . . . 73.1 111.006 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -91.68 160.45 36.38 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-N 114.821 -1.081 . . . . 73.41 111.143 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -51.31 157.72 4.33 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.838 3.025 . . . . 75.34 115.598 177.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.494 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 55.1 tp60 -58.26 113.91 2.16 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.257 1.423 . . . . 74.51 111.529 -177.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.894 HD21 HG11 ' B' ' 64' ' ' VAL . 32.5 tp -106.96 102.37 11.73 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.075 0.464 . . . . 74.33 109.771 -172.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.489 HD21 ' HG3' ' B' ' 125' ' ' GLN . 29.2 m-80 -101.07 117.88 35.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.271 0.629 . . . . 71.34 109.431 -177.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.491 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 69.4 mt -85.89 135.9 33.5 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 109.886 -0.413 . . . . 73.21 109.886 172.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.34 138.43 74.94 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 123.494 0.718 . . . . 41.05 110.807 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.492 ' HG3' HD11 ' D' ' 16' ' ' ILE . 21.3 Cg_endo -60.19 101.99 0.17 Allowed 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 123.207 2.605 . . . . 61.21 111.946 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 18.1 m -90.15 109.95 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 122.013 0.911 . . . . 65.12 109.38 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 . . . . . 0 C--O 1.242 0.701 0 CA-C-N 115.068 -0.969 . . . . 75.24 109.402 -178.46 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.869 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 69.1 t80 . . . . . 0 C--O 1.237 0.422 0 N-CA-C 108.094 -1.076 . . . . 74.23 108.094 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -136.81 122.69 20.06 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.641 -0.874 . . . . 70.24 108.641 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.432 HD11 HG21 ' C' ' 105' ' ' ILE . 46.5 mt -83.05 126.78 40.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 109.279 -0.637 . . . . 45.11 109.279 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.409 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 27.7 mm-40 -87.06 -44.27 11.69 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.852 -0.796 . . . . 72.31 108.852 174.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 179.96 151.06 0.4 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.032 1.333 . . . . 74.12 109.462 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 83.7 mt -123.44 128.44 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 107.877 -1.157 . . . . 70.21 107.877 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.608 ' HB3' HG23 ' D' ' 122' ' ' THR . 35.5 p90 -161.27 149.92 16.01 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.318 0.58 . . . . 75.01 111.56 -167.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.7 p -80.61 119.72 23.62 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.35 -0.841 . . . . 74.3 110.575 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp -71.88 -36.62 70.14 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.619 -0.882 . . . . 73.42 108.619 169.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -148.85 148.43 29.89 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-N 115.092 -0.958 . . . . 72.21 110.006 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.1 mt -140.64 140.47 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 106.347 -1.724 . . . . 54.11 106.347 175.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 28.3 t -154.12 146.64 24.07 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.204 0.526 . . . . 74.12 110.526 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -155.17 129.37 8.9 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 107.013 -1.477 . . . . 74.04 107.013 172.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -137.69 123.96 20.55 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.247 0.619 . . . . 73.35 109.544 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -121.38 84.13 41.04 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 107.145 -1.428 . . . . 71.11 107.145 166.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.47 -24.07 43.01 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 122.422 2.081 . . . . 74.1 111.578 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -104.0 17.27 24.45 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.36 1.064 . . . . 74.21 110.516 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.42 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -47.53 -57.1 10.54 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 113.526 0.936 . . . . 75.4 113.526 -171.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.42 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 21.7 Cg_exo -63.04 -39.16 41.51 Favored 'Trans proline' 0 C--N 1.393 2.884 0 C-N-CA 122.112 1.874 . . . . 64.02 111.962 -176.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -69.26 -37.06 77.75 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.367 -1.288 . . . . 73.24 111.996 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.766 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.8 p -82.55 -21.03 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 N-CA-C 112.907 0.706 . . . . 62.41 112.907 -176.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -66.28 -29.22 69.4 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 120.856 0.36 . . . . 71.44 111.652 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -94.96 14.18 22.55 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.848 0.859 . . . . 71.54 111.371 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -104.55 158.26 16.61 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.708 0.803 . . . . 62.25 109.668 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -70.25 115.38 9.37 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.672 0.789 . . . . 75.24 110.158 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -80.6 91.57 5.84 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.243 1.017 . . . . 72.22 111.333 -171.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . 0.478 HE22 ' HB3' ' C' ' 68' ' ' LEU . 0.2 OUTLIER -139.58 73.72 34.89 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.368 1.067 . . . . 74.03 109.206 169.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -79.85 149.13 20.3 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.282 1.988 . . . . 71.01 112.192 -174.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -86.91 93.19 9.25 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.637 -1.616 . . . . 64.13 106.637 165.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.405 HG13 HD21 ' C' ' 126' ' ' LEU . 56.2 t -68.3 102.84 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 108.429 -0.952 . . . . 71.3 108.429 177.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -109.81 102.5 11.28 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.149 -1.056 . . . . 64.42 108.149 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 pp -87.96 139.57 30.38 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.011 -1.107 . . . . 62.4 108.011 172.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -139.86 118.64 12.42 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.148 -0.686 . . . . 75.42 109.148 -175.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 92.7 mt -111.95 138.95 47.88 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.77 0.828 . . . . 53.51 111.369 -171.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -147.62 127.08 13.17 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.788 1.235 . . . . 74.04 107.96 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 8.7 t -120.64 145.02 47.84 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 109.447 -0.575 . . . . 61.22 109.447 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.39 150.55 40.81 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.473 0.709 . . . . 75.01 109.781 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 32.8 m -141.64 155.0 45.73 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.053 0.541 . . . . 74.35 110.74 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 61.7 p -151.85 129.86 11.81 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.082 0.953 . . . . 63.54 109.06 178.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -73.71 117.44 15.48 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.04 -0.726 . . . . 72.04 109.04 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' C' ' 57' ' ' GLU . 71.1 mt -86.89 -43.56 12.34 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.41 0.684 . . . . 73.23 109.976 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.26 -173.93 4.52 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.341 -0.845 . . . . 61.55 110.249 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.3 107.74 0.81 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.011 0.924 . . . . 72.05 110.217 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 66.37 22.05 10.84 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.221 1.008 . . . . 75.13 111.026 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 96.0 t -119.39 119.31 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.025 0.93 . . . . 65.31 108.732 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -127.15 126.82 43.56 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.289 1.036 . . . . 72.42 108.988 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.629 ' HB2' HD11 ' C' ' 51' ' ' LEU . 35.9 tt0 -83.9 126.19 32.74 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.402 -0.962 . . . . 73.23 108.402 168.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 88.6 t -118.05 137.09 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.25 -0.648 . . . . 62.13 109.25 173.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.459 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 44.8 t -128.67 145.26 35.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.096 0.958 . . . . 73.02 108.869 177.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.455 HD11 ' CZ ' ' C' ' 133' ' ' PHE . 0.0 OUTLIER -126.72 104.35 8.03 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.476 -1.305 . . . . 75.41 107.476 177.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -81.98 106.17 13.68 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.285 -1.006 . . . . 75.44 108.285 171.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 23.2 t -104.65 133.57 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.907 -1.145 . . . . 72.13 107.907 172.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 84.9 m -126.97 136.74 52.68 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.385 -0.969 . . . . 62.35 108.385 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.496 HG23 HD13 ' C' ' 114' ' ' ILE . 85.2 t -122.56 114.12 41.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 109.422 -0.584 . . . . 62.42 109.422 173.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 18.7 m -98.54 137.34 37.34 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.716 -0.846 . . . . 74.1 108.716 172.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.79 113.81 17.12 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.14 -1.43 . . . . 70.31 107.14 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 44.0 m -136.76 128.61 29.15 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.464 0.477 . . . . 75.25 110.17 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.478 ' HB3' HE22 ' C' ' 37' ' ' GLN . 49.8 mt -84.41 29.05 0.61 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.151 1.38 . . . . 61.52 111.265 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.64 -91.04 0.75 Allowed Glycine 0 C--N 1.35 1.345 0 N-CA-C 111.169 -0.772 . . . . 71.13 111.169 -175.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -90.67 -33.7 15.71 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.55 0.74 . . . . 71.15 109.27 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -88.87 122.18 31.99 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.597 1.159 . . . . 74.22 110.463 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 89.1 m -81.73 129.09 34.6 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.482 -0.562 . . . . 63.43 109.482 169.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.766 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -80.72 -58.45 3.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.791 0.836 . . . . 74.14 110.059 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -157.12 167.98 28.8 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.85 0.833 . . . . 75.32 111.224 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -131.51 137.35 48.5 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 106.655 -1.609 . . . . 53.21 106.655 166.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.604 ' SG ' HG23 ' C' ' 114' ' ' ILE . 41.8 t -137.07 149.32 47.32 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.582 -0.896 . . . . 54.45 108.582 176.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -157.78 133.65 9.27 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.44 -0.578 . . . . 71.3 109.44 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 73.7 t -132.75 132.46 59.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 124.143 0.977 . . . . 75.04 108.889 174.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -104.39 87.13 2.65 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.295 -1.002 . . . . 74.0 108.295 173.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -79.39 97.92 6.54 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.349 -0.841 . . . . 70.33 109.145 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -83.72 177.86 52.39 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 115.781 -0.645 . . . . 41.43 112.293 175.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 178.18 134.27 2.04 Favored Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 111.356 -0.698 . . . . 74.41 111.356 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.409 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 35.4 mm -88.7 125.81 41.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.361 -0.977 . . . . 71.23 108.361 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -130.3 117.86 20.44 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.47 0.708 . . . . 74.1 109.37 -178.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 11.4 p -85.01 102.19 12.99 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 108.466 -0.939 . . . . 72.23 108.466 172.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.435 HG21 ' HE1' ' C' ' 94' ' ' MET . 24.4 mt -114.29 129.54 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.814 0.845 . . . . 62.41 109.949 -175.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.86 171.15 14.86 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.654 0.782 . . . . 54.12 110.385 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.81 -35.06 4.62 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 116.26 -0.427 . . . . 50.44 113.075 176.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 27.7 pt -108.12 171.71 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.251 0.62 . . . . 65.41 111.709 -171.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -167.19 156.93 10.79 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.801 0.84 . . . . 71.34 109.923 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.07 -115.62 6.24 Favored Glycine 0 C--N 1.349 1.304 0 O-C-N 123.324 0.39 . . . . 61.1 113.535 171.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 58.3 p -64.22 -40.07 95.28 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 123.688 0.795 . . . . 72.22 110.953 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -68.37 -47.66 66.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.899 0.88 . . . . 74.32 111.097 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.529 ' HE3' ' HA ' ' C' ' 94' ' ' MET . 5.2 tpt -53.86 -49.86 67.55 Favored 'General case' 0 C--N 1.352 0.694 0 O-C-N 123.875 0.734 . . . . 54.14 111.705 173.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.69 -38.76 89.01 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 123.637 0.585 . . . . 72.11 111.032 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . 0.543 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 44.5 t-80 -71.59 -19.68 62.1 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.553 1.141 . . . . 75.13 111.483 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 9.3 t -82.2 -51.96 7.44 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.517 -0.92 . . . . 73.31 108.517 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.11 -30.11 69.19 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.841 -1.072 . . . . 64.1 112.978 -172.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.94 11.28 29.54 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-O 119.45 -0.639 . . . . 63.3 113.64 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -151.34 -61.14 0.18 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 117.535 0.667 . . . . 35.54 112.222 -176.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -74.04 -53.31 10.28 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.422 0.689 . . . . 74.41 112.14 -169.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.869 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 34.5 m -58.56 -49.18 94.88 Favored Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.15 0.98 . . . . 71.24 111.924 176.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.521 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 77.1 Cg_exo -53.83 -35.76 80.44 Favored 'Trans proline' 0 C--N 1.402 3.384 0 C-N-CA 122.686 2.257 . . . . 61.24 113.24 173.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -68.76 -33.15 73.4 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.418 0.687 . . . . 60.24 111.708 -176.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.535 HD12 ' NH1' ' A' ' 111' ' ' ARG . 31.4 mm -70.11 -43.03 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 122.332 0.253 . . . . 53.01 110.691 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.403 ' HA ' ' CD1' ' C' ' 109' ' ' TYR . 1.7 pp -95.93 -3.56 45.01 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.372 0.878 . . . . 74.43 113.372 -176.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . 0.504 ' HZ ' HD22 ' C' ' 128' ' ' LEU . 56.0 t80 -55.06 -48.15 96.76 Favored Pre-proline 0 N--CA 1.485 1.317 0 CA-C-O 117.742 -1.123 . . . . 74.22 113.578 172.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -60.94 -30.67 90.4 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 121.738 1.626 . . . . 73.25 112.979 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.403 ' CD1' ' HA ' ' C' ' 106' ' ' LEU . 19.3 m-85 -68.66 -43.05 77.01 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.371 0.669 . . . . 73.01 109.479 176.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.54 -39.34 94.16 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.041 -0.981 . . . . 74.31 110.625 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -61.87 -52.77 62.75 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.382 1.073 . . . . 70.45 110.191 176.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -67.22 -28.37 68.01 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.596 0.759 . . . . 72.11 110.383 -174.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.49 ' O ' ' SD ' ' C' ' 117' ' ' MET . 8.2 t -71.05 -49.2 47.32 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 122.997 0.519 . . . . 70.12 110.334 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.604 HG23 ' SG ' ' C' ' 76' ' ' CYS . 86.8 mt -59.77 -47.28 91.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 123.29 0.636 . . . . 74.15 110.167 174.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 99.4 m -63.53 -31.05 72.1 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.812 0.845 . . . . 61.42 111.109 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 25.2 t -65.51 -48.42 72.59 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 108.808 -0.812 . . . . 73.13 108.808 171.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.901 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.2 OUTLIER -56.29 -43.19 78.6 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.953 0.901 . . . . 75.24 112.485 178.441 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.426 HG23 ' O ' ' C' ' 114' ' ' ILE . 87.9 t -69.33 -41.89 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.869 0.868 . . . . 74.05 110.26 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 30.6 t -64.1 -37.8 88.75 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.111 -0.949 . . . . 73.43 111.454 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.535 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 60.3 mtt-85 -69.64 -40.14 76.69 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.149 -0.932 . . . . 61.44 110.222 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.64 2.26 64.03 Favored Glycine 0 C--N 1.355 1.631 0 O-C-N 123.796 0.685 . . . . 74.21 112.847 174.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 44.2 p 60.94 28.19 18.0 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.952 1.701 . . . . 70.04 113.098 168.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -83.23 144.08 46.27 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.12 -1.067 . . . . 62.21 108.12 169.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -44.75 141.93 5.4 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.791 2.994 . . . . 72.14 114.071 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.494 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 13.3 mm-40 -59.22 124.75 21.02 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.908 0.755 . . . . 75.21 112.802 -170.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.405 HD21 HG13 ' C' ' 40' ' ' VAL . 40.1 tp -121.38 103.26 8.82 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.268 -1.012 . . . . 72.41 108.268 -176.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -96.19 116.0 28.31 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.387 -0.824 . . . . 74.42 109.658 -176.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.504 HD22 ' HZ ' ' C' ' 107' ' ' PHE . 0.9 OUTLIER -71.59 117.4 13.1 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.588 0.755 . . . . 75.22 109.027 -178.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.74 159.15 70.98 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 123.95 0.9 . . . . 73.11 111.654 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -55.49 100.74 0.08 OUTLIER 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.726 2.284 . . . . 63.31 113.199 174.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.9 t -99.56 111.09 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 108.218 -1.03 . . . . 63.12 108.218 172.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -86.06 104.38 15.61 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.407 0.683 . . . . 73.43 110.722 -175.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . 0.455 ' CZ ' HD11 ' C' ' 60' ' ' LEU . 82.9 m-85 -64.51 -23.76 67.38 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.164 0.986 . . . . 72.43 112.041 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . 0.457 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 2.4 t70 -65.25 -36.67 84.84 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.766 0.826 . . . . 62.3 109.753 178.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.4 -19.32 33.73 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.382 -1.281 . . . . 55.34 111.614 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 36.0 mt -82.88 -22.35 34.0 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 120.895 0.378 . . . . 62.21 110.697 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 38.0 t80 . . . . . 0 CA--C 1.554 1.119 0 C-N-CA 123.473 0.709 . . . . 65.13 110.469 177.371 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 C--O 1.244 0.765 0 N-CA-C 109.644 -0.502 . . . . 73.32 109.644 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.572 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 51.0 t80 -138.64 93.88 2.77 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.397 -1.335 . . . . 73.44 107.397 174.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -124.3 126.11 45.49 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.754 -0.832 . . . . 72.04 108.754 -177.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 mt -82.41 121.35 35.44 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 N-CA-C 108.773 -0.825 . . . . 73.31 108.773 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -85.26 -29.66 24.44 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.282 1.033 . . . . 74.31 110.303 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -170.14 142.11 2.22 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 123.625 0.578 . . . . 72.15 110.426 -177.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.492 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.9 mp -118.24 130.4 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 105.503 -2.036 . . . . 71.23 105.503 170.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.4 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 25.2 p90 -159.99 141.92 12.98 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 118.701 0.682 . . . . 74.24 111.359 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 71.3 p -78.36 110.8 13.73 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.882 -1.054 . . . . 61.12 109.176 174.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.4 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 31.7 mtpt -78.41 -24.76 46.06 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.562 -0.744 . . . . 75.01 109.253 176.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.707 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 2.8 t70 -149.97 147.96 28.5 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.665 1.186 . . . . 71.34 110.02 174.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.901 HG21 ' HE2' ' C' ' 117' ' ' MET . 83.1 mt -139.51 146.51 25.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 126.07 1.748 . . . . 73.11 107.598 174.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 39.9 t -155.86 145.38 21.0 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.167 0.587 . . . . 75.12 110.428 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.513 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 79.7 t80 -151.98 139.88 20.01 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.703 -1.591 . . . . 74.42 106.703 171.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.441 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 40.6 mt-10 -142.99 146.3 33.77 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.404 0.681 . . . . 72.13 109.604 -175.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.75 85.57 6.55 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.039 0.935 . . . . 53.52 108.573 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.87 -36.9 21.72 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.348 2.699 . . . . 61.23 112.935 -177.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.434 ' ND2' ' HB2' ' D' ' 71' ' ' GLU . 67.9 m-20 -103.66 16.17 27.06 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.14 -0.936 . . . . 74.11 110.749 -173.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -34.06 -66.2 0.23 Allowed Pre-proline 0 CA--C 1.571 1.761 0 N-CA-C 116.292 1.96 . . . . 73.54 116.292 -162.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.406 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 95.7 Cg_endo -75.82 -21.96 13.88 Favored 'Trans proline' 0 C--N 1.386 2.529 0 CA-C-N 123.977 2.456 . . . . 75.11 114.165 -178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -70.51 -41.81 72.12 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.712 1.205 . . . . 73.31 110.306 178.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.63 HG21 ' HA ' ' D' ' 73' ' ' ALA . 13.4 p -82.53 -20.53 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-N 115.233 -0.894 . . . . 63.31 111.56 -173.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.406 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.5 m-30 -62.41 -29.04 70.21 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 112.299 0.481 . . . . 65.22 112.299 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -63.87 -14.66 55.14 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.42 1.088 . . . . 73.32 111.567 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -93.6 109.36 20.98 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.829 1.252 . . . . 74.11 110.1 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -102.94 92.89 4.76 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.175 0.59 . . . . 53.44 111.059 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 42.4 p90 -168.46 -177.28 3.12 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.838 1.255 . . . . 65.35 108.421 168.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 61.0 tp60 -74.02 118.32 68.54 Favored Pre-proline 0 N--CA 1.479 0.985 0 CA-C-O 119.09 -0.481 . . . . 65.52 109.834 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -58.95 137.39 79.54 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.332 2.021 . . . . 70.31 111.195 174.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 25.5 mt-10 -62.81 106.9 0.87 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.447 -0.946 . . . . 73.12 108.447 174.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.668 HG13 HG13 ' D' ' 64' ' ' VAL . 57.2 t -99.96 108.48 22.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.374 -0.602 . . . . 55.1 109.374 -175.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -86.76 109.69 19.41 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.387 -1.338 . . . . 73.44 107.387 169.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.592 HD11 HG13 ' D' ' 62' ' ' VAL . 40.4 tp -96.08 123.31 39.64 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.5 -0.926 . . . . 74.32 108.5 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -118.86 143.91 46.69 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 106.282 -1.747 . . . . 63.02 106.282 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.404 ' CD2' HG22 ' D' ' 62' ' ' VAL . 94.9 mt -136.73 148.23 47.18 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.419 0.688 . . . . 65.15 109.159 -174.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.755 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.8 t70 -145.38 136.32 24.64 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.426 -0.953 . . . . 72.12 108.426 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.3 t -102.43 158.42 16.22 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.967 -1.123 . . . . 74.41 107.967 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -161.9 165.92 26.95 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.995 0.518 . . . . 72.53 109.731 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.4 p . . . . . 0 C--O 1.242 0.69 0 C-N-CA 124.681 1.192 . . . . 75.52 108.201 -175.762 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 112.445 0.535 . . . . 75.24 112.445 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 47.6 t -118.05 100.18 9.56 Favored 'Isoleucine or valine' 0 C--N 1.35 0.588 0 N-CA-C 107.452 -1.314 . . . . 65.54 107.452 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -119.82 129.93 54.67 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 107.908 -1.145 . . . . 75.25 107.908 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -111.02 118.33 35.76 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.059 -1.46 . . . . 75.52 107.059 165.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 72.1 t -100.29 134.98 38.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.382 -0.97 . . . . 75.14 108.382 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.58 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 24.8 t -114.97 137.97 46.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.341 -0.985 . . . . 65.42 108.341 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.524 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -115.08 118.61 33.86 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.382 -1.34 . . . . 62.25 107.382 174.339 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.755 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 45.3 ttm-85 -95.54 99.31 11.21 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.831 -1.174 . . . . 73.04 107.831 171.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.592 HG13 HD11 ' D' ' 42' ' ' LEU . 94.8 t -89.25 128.98 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 106.746 -1.576 . . . . 64.15 106.746 169.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 5.3 m -129.56 126.07 37.69 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.64 -0.874 . . . . 74.34 108.64 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.668 HG13 HG13 ' D' ' 40' ' ' VAL . 55.6 t -108.41 132.0 57.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 108.049 -1.093 . . . . 73.54 108.049 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 49.5 m -126.69 90.86 3.24 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.322 -1.362 . . . . 65.33 107.322 171.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -104.35 139.07 39.84 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.28 -0.873 . . . . 73.13 109.838 -176.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.551 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 77.4 p -144.17 128.95 18.31 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-O 121.07 0.462 . . . . 75.4 112.233 -172.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.602 HD12 HG22 ' D' ' 31' ' ' VAL . 43.9 mt -92.4 104.08 16.45 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.956 -1.498 . . . . 74.35 106.956 170.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.15 -145.85 38.52 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 123.674 0.608 . . . . 34.01 111.998 -172.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.69 2.93 31.23 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 112.503 0.556 . . . . 75.23 112.503 -177.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . 0.434 ' HB2' ' ND2' ' D' ' 27' ' ' ASN . 13.1 pt-20 -117.21 146.55 43.17 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 117.924 0.329 . . . . 74.1 110.163 -176.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 98.8 m -63.99 121.07 13.24 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 124.002 0.814 . . . . 74.52 111.108 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.63 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -76.86 -71.89 0.37 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.157 -1.423 . . . . 33.51 107.157 170.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -147.43 141.11 25.6 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.672 -0.695 . . . . 75.51 111.201 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.441 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 56.1 mt -103.96 149.53 25.05 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.218 -1.401 . . . . 73.21 107.218 166.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.578 ' SG ' HG12 ' D' ' 114' ' ' ILE . 6.3 t -157.94 106.23 2.02 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.081 0.401 . . . . 74.14 110.087 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -120.37 122.22 40.3 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.011 0.524 . . . . 74.41 110.204 -176.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 98.2 t -123.84 117.68 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.607 0.763 . . . . 54.44 109.42 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.707 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.1 mt-30 -88.68 83.37 6.74 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.482 -0.933 . . . . 72.54 108.482 168.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . 0.415 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.2 tp-100 -80.53 96.54 6.83 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.172 -1.376 . . . . 64.13 109.316 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.61 161.87 28.78 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 111.765 -0.534 . . . . 74.43 111.765 177.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.21 134.55 3.36 Favored Glycine 0 C--N 1.332 0.315 0 N-CA-C 111.624 -0.59 . . . . 75.42 111.624 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 48.4 mt -90.03 117.45 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 108.687 -0.857 . . . . 73.42 108.687 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -115.64 125.94 53.53 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.473 1.109 . . . . 61.04 109.804 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 53.6 p -84.2 104.13 13.98 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.736 -0.839 . . . . 72.11 108.736 171.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 45.3 mt -115.61 122.6 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.403 0.681 . . . . 74.21 109.492 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.08 168.43 25.55 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.659 1.183 . . . . 73.12 109.595 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.28 22.66 43.55 Favored Glycine 0 N--CA 1.476 1.325 0 N-CA-C 114.364 0.505 . . . . 65.21 114.364 172.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' D' ' 94' ' ' MET . 1.0 OUTLIER -136.63 172.42 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 124.349 1.06 . . . . 64.41 109.569 -179.318 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -153.17 -170.76 3.71 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.854 0.462 . . . . 73.14 110.583 177.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.49 -141.66 30.11 Favored Glycine 0 C--N 1.349 1.281 0 CA-C-N 116.011 -0.54 . . . . 54.13 112.383 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 11.2 t -89.91 -20.91 22.81 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.364 0.666 . . . . 75.04 109.878 170.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -58.63 -30.93 67.66 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.692 1.197 . . . . 71.32 112.03 -176.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.693 ' HA ' HD12 ' D' ' 89' ' ' ILE . 12.5 ptp -53.48 -54.12 41.69 Favored 'General case' 0 CA--C 1.55 0.968 0 O-C-N 123.817 0.698 . . . . 65.41 111.905 177.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . 0.438 ' H ' ' HG3' ' D' ' 94' ' ' MET . . . -87.38 -15.48 37.71 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.051 0.94 . . . . 44.04 112.071 -176.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -66.1 -39.11 89.72 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.628 0.771 . . . . 73.5 110.319 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 75.0 m -63.97 -38.9 92.75 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.423 -0.808 . . . . 44.33 110.987 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.532 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 6.2 tt -71.96 -39.51 69.31 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 115.389 -0.823 . . . . 74.44 110.666 -176.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.21 -27.51 52.19 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-O 119.793 -0.449 . . . . 61.54 114.212 -173.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.7 -51.89 2.25 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 122.985 0.514 . . . . 61.54 112.019 -172.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . 0.4 ' O ' HG12 ' D' ' 105' ' ' ILE . 70.1 t80 -73.64 -39.97 64.1 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.057 0.543 . . . . 72.31 111.526 -171.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.572 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 85.7 m -63.04 -47.98 85.2 Favored Pre-proline 0 CA--C 1.563 1.466 0 CA-C-O 118.4 -0.809 . . . . 54.5 112.345 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.524 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 53.1 Cg_exo -58.19 -36.76 97.53 Favored 'Trans proline' 0 C--N 1.396 3.058 0 C-N-CA 122.231 1.954 . . . . 70.12 112.963 168.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -62.33 -33.82 75.44 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.424 0.69 . . . . 64.24 111.535 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.4 HG12 ' O ' ' D' ' 101' ' ' TYR . 46.0 mm -69.68 -39.27 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.665 0.786 . . . . 64.33 110.888 175.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.415 HD13 ' O ' ' D' ' 80' ' ' GLN . 77.3 mt -73.86 -21.48 60.09 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.645 -0.707 . . . . 64.25 112.091 -175.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -66.78 -41.18 36.24 Favored Pre-proline 0 CA--C 1.56 1.364 0 CA-C-O 117.718 -1.134 . . . . 73.33 113.909 -172.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -45.63 -48.19 12.43 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 122.516 2.144 . . . . 74.12 113.75 168.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -72.2 -40.78 67.61 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.864 0.865 . . . . 75.44 111.771 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.01 -44.04 90.5 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.622 0.769 . . . . 63.14 110.933 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -61.99 -46.96 86.94 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.685 -1.143 . . . . 75.41 110.364 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -61.49 -44.9 96.25 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.976 0.91 . . . . 63.33 111.327 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.535 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 51.9 t -56.01 -46.59 78.71 Favored 'General case' 0 C--N 1.349 0.565 0 O-C-N 124.086 0.866 . . . . 73.44 110.472 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.578 HG12 ' SG ' ' D' ' 76' ' ' CYS . 69.8 mt -63.29 -48.84 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 114.956 -1.02 . . . . 71.42 111.472 176.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 86.1 m -56.05 -44.11 78.54 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 124.029 0.932 . . . . 72.54 111.123 -172.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 40.6 t -65.16 -41.47 94.65 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.386 -1.279 . . . . 71.23 110.467 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.447 ' HE2' ' HA ' ' D' ' 114' ' ' ILE . 75.5 mtm -71.29 -29.64 65.3 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.961 0.504 . . . . 73.44 111.754 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.517 HG23 ' O ' ' D' ' 114' ' ' ILE . 75.1 t -65.47 -43.35 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.008 0.923 . . . . 73.0 109.606 175.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 96.3 p -74.74 -24.45 58.72 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.613 -0.721 . . . . 62.01 110.902 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' D' ' 116' ' ' SER . 92.5 mtt-85 -70.08 -31.37 68.92 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.876 0.47 . . . . 70.33 110.107 172.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.92 10.24 68.96 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 123.581 0.55 . . . . 63.45 112.901 174.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.608 HG23 ' HB3' ' C' ' 17' ' ' TYR . 50.3 p 60.51 12.16 3.4 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 126.844 2.057 . . . . 64.14 114.411 -178.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -79.46 155.31 76.48 Favored Pre-proline 0 N--CA 1.48 1.031 0 CA-C-O 118.966 -0.54 . . . . 74.32 110.629 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -47.53 122.89 7.35 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.307 2.672 . . . . 51.12 111.474 173.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -50.27 132.33 24.22 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 124.759 1.287 . . . . 73.33 111.592 -171.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.482 HD13 HG21 ' D' ' 40' ' ' VAL . 48.7 tp -106.39 98.53 8.2 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 121.635 0.731 . . . . 75.23 109.968 -173.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . 0.543 ' ND2' ' HB ' ' B' ' 16' ' ' ILE . 6.9 m120 -99.08 89.32 4.22 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 106.269 -1.752 . . . . 74.11 106.269 174.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 87.7 mt -55.79 113.47 1.49 Allowed 'General case' 0 C--N 1.357 0.903 0 O-C-N 123.739 0.649 . . . . 73.3 109.518 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.91 123.03 82.55 Favored Pre-proline 0 CA--C 1.547 0.862 0 O-C-N 123.829 0.705 . . . . 72.34 109.393 -175.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.21 136.04 33.39 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.641 2.228 . . . . 74.14 112.4 -168.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.43 143.37 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.201 1.0 . . . . 73.35 109.079 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -73.99 115.2 13.18 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.226 0.61 . . . . 74.13 109.395 177.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 . . . . . 0 N--CA 1.483 1.181 0 C-N-CA 124.384 1.074 . . . . 75.41 111.845 -175.969 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.4 m . . . . . 0 CA--C 1.541 0.622 0 N-CA-C 108.19 -1.041 . . . . 62.5 108.19 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -119.99 117.5 28.19 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.95 1.3 . . . . 72.13 108.337 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.454 ' HG3' HE21 ' A' ' 14' ' ' GLN . 19.4 tp60 -133.89 109.8 9.29 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.619 -0.882 . . . . 71.4 108.619 -178.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.8 mt -74.17 122.17 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.749 -0.834 . . . . 73.11 108.749 174.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.454 HE21 ' HG3' ' A' ' 12' ' ' GLN . 25.7 mm-40 -92.91 -42.17 9.64 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.088 0.555 . . . . 72.42 110.818 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -170.68 121.8 0.59 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 110.05 -0.352 . . . . 71.03 110.05 -175.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.401 HD12 ' HG3' ' C' ' 130' ' ' PRO . 98.1 mt -105.71 126.14 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 107.57 -1.27 . . . . 74.3 107.57 172.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.502 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 28.3 p90 -162.11 157.11 22.85 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 123.736 0.647 . . . . 75.11 110.896 -171.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.1 p -85.01 117.09 23.77 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 109.408 -0.59 . . . . 44.15 109.408 174.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.0 mtpt -78.19 -31.31 49.47 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.407 -0.59 . . . . 71.33 109.407 174.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 30.4 t70 -150.25 145.82 26.43 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.759 -1.109 . . . . 61.24 110.68 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 75.0 mt -138.92 145.41 27.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 C-N-CA 125.395 1.478 . . . . 61.42 107.951 176.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.3 t -149.26 133.05 16.95 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.833 0.853 . . . . 73.54 109.538 173.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -130.54 139.39 50.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.087 -1.449 . . . . 74.14 107.087 169.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -135.12 134.11 39.9 Favored 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 123.068 0.547 . . . . 55.2 109.621 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.8 71.57 11.45 Favored Pre-proline 0 C--O 1.243 0.738 0 N-CA-C 105.829 -1.915 . . . . 73.43 105.829 169.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.78 -30.99 10.9 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.142 1.895 . . . . 74.44 111.389 -177.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -94.03 12.97 24.41 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 118.35 -0.833 . . . . 70.52 109.91 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.559 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -42.91 -59.08 3.28 Favored Pre-proline 0 CA--C 1.573 1.844 0 CA-C-O 118.146 -0.931 . . . . 72.11 112.919 -173.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 20.5 Cg_exo -63.46 -15.02 45.91 Favored 'Trans proline' 0 C--N 1.395 2.995 0 C-N-CA 122.541 2.16 . . . . 52.51 113.956 -178.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -92.29 -42.65 9.71 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.868 0.867 . . . . 71.14 110.154 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.72 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.3 p -79.32 -13.48 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-N 114.02 -1.446 . . . . 54.43 112.617 -161.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -72.42 -15.38 61.83 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.186 0.594 . . . . 52.15 110.968 173.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -87.46 -12.56 45.71 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.352 1.061 . . . . 74.25 111.15 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -82.46 155.71 24.47 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.646 0.778 . . . . 63.12 111.394 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.98 128.53 36.31 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.49 0.716 . . . . 72.33 109.457 170.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.444 ' CE3' HD21 ' A' ' 68' ' ' LEU . 49.9 t-105 -81.04 76.34 7.99 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.848 0.832 . . . . 74.42 110.266 -177.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.3 tm0? -126.8 81.88 68.39 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 105.025 -2.213 . . . . 64.14 105.025 168.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -83.68 144.98 11.42 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.347 2.031 . . . . 73.43 112.141 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -96.46 84.11 3.64 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.457 -1.312 . . . . 64.33 107.457 173.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.423 HG13 HG13 ' A' ' 64' ' ' VAL . 43.3 t -88.13 94.44 4.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 CA-C-N 115.537 -0.756 . . . . 71.34 109.819 -175.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -92.93 134.12 35.43 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.056 -0.974 . . . . 62.04 109.978 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.1 mt -103.66 108.95 20.46 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.477 -0.935 . . . . 71.03 108.477 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.605 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 10.2 m-20 -101.63 107.92 19.31 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.367 -1.346 . . . . 60.41 107.367 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.594 HD11 HG21 ' A' ' 131' ' ' VAL . 86.8 mt -103.52 135.53 44.94 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.448 0.642 . . . . 70.5 111.279 -174.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 24.8 t70 -132.55 143.45 49.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.334 -1.303 . . . . 61.31 108.254 178.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.6 m -127.25 133.4 50.21 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.663 0.785 . . . . 55.43 108.963 175.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.77 147.71 52.32 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 124.547 1.139 . . . . 71.12 108.502 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.1 m -131.68 156.51 45.76 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 122.747 0.419 . . . . 73.21 109.883 174.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.9 t -154.31 118.89 4.87 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.257 -1.016 . . . . 73.21 108.257 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -72.87 107.48 5.3 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 108.544 -0.91 . . . . 74.33 108.544 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.5 mt -79.95 -36.62 35.96 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.987 -0.552 . . . . 64.24 110.454 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.55 -174.02 4.81 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.272 0.629 . . . . 44.04 110.869 -177.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -65.29 119.84 11.67 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.203 0.601 . . . . 54.11 109.634 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 65.73 5.61 3.45 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.988 1.315 . . . . 55.33 112.532 -175.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.5 t -107.12 111.12 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 109.108 -0.701 . . . . 73.23 109.108 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -121.23 124.58 45.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.108 -1.071 . . . . 72.05 108.108 176.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -87.78 143.63 27.05 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.677 -0.86 . . . . 72.02 108.677 170.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.458 HG11 ' HD3' ' A' ' 103' ' ' PRO . 96.9 t -126.4 137.58 57.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 107.873 -1.158 . . . . 71.15 107.873 170.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.458 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 44.7 t -119.27 130.75 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.473 -0.936 . . . . 74.25 108.473 174.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.548 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -104.74 105.91 16.19 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 105.957 -1.868 . . . . 65.45 105.957 173.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.568 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 28.6 ttp180 -92.88 99.98 12.53 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.345 -1.354 . . . . 72.41 107.345 176.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.5 t -94.93 129.24 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 107.705 -1.22 . . . . 70.1 107.705 176.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.605 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.3 m -121.71 114.58 21.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.887 -0.783 . . . . 72.12 108.887 176.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 90.6 t -102.06 106.89 20.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.32 -0.993 . . . . 73.13 108.32 177.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.9 m -103.3 132.68 49.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.43 -0.952 . . . . 64.14 108.43 172.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.98 118.26 13.65 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.527 -0.545 . . . . 74.31 109.527 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.0 m -123.24 138.2 54.69 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.368 0.667 . . . . 63.35 110.521 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.698 HD12 HG22 ' A' ' 31' ' ' VAL . 22.0 mt -92.32 86.31 5.67 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.973 1.309 . . . . 70.42 108.396 172.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.5 -95.75 0.89 Allowed Glycine 0 C--N 1.339 0.705 0 O-C-N 123.393 0.433 . . . . 74.01 112.34 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.85 -26.17 13.23 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.634 0.773 . . . . 70.15 110.752 -177.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -104.07 126.19 50.99 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.398 0.679 . . . . 55.02 110.4 -174.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.1 m -63.62 125.94 25.92 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 123.561 0.538 . . . . 51.54 110.75 173.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.72 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -72.63 -60.26 2.32 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.818 -0.808 . . . . 71.55 108.818 174.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -160.31 168.17 25.88 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.652 0.739 . . . . 55.44 111.757 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 64' ' ' VAL . 65.1 tp -127.2 143.11 51.32 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.003 1.321 . . . . 63.22 107.739 169.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.563 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 70.9 m -144.76 98.28 3.16 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.386 0.674 . . . . 63.02 109.777 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -118.64 116.93 27.61 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.673 -0.491 . . . . 74.34 109.673 -176.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.0 t -125.33 110.87 25.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 123.836 0.855 . . . . 75.13 109.022 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 51.9 mt-30 -84.9 82.51 8.41 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.231 -1.026 . . . . 55.03 108.231 172.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -76.07 94.43 3.45 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 114.474 -1.239 . . . . 71.35 108.574 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.46 163.34 40.73 Favored Glycine 0 C--O 1.24 0.474 0 N-CA-C 111.011 -0.836 . . . . 61.44 111.011 177.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.83 121.71 1.05 Allowed Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 110.371 -1.092 . . . . 32.31 110.371 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.8 mt -81.49 122.65 36.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.499 -1.297 . . . . 70.25 107.499 173.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.703 ' HB3' HD11 ' A' ' 86' ' ' ILE . 93.3 m-85 -128.19 121.17 28.8 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.359 0.664 . . . . 73.13 109.513 -178.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.1 t -85.25 98.1 10.31 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.418 -0.956 . . . . 74.35 108.418 173.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.703 HD11 ' HB3' ' A' ' 84' ' ' PHE . 4.2 mm -107.87 147.95 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.418 -0.586 . . . . 75.33 109.418 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.53 170.1 23.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.647 -0.706 . . . . 74.43 110.121 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.15 -34.17 5.73 Favored Glycine 0 C--N 1.341 0.818 0 O-C-N 123.613 0.571 . . . . 73.34 113.574 176.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.57 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -127.5 146.34 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 122.928 0.491 . . . . 71.01 111.739 -169.259 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.24 175.17 9.49 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.658 1.183 . . . . 65.43 109.335 175.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.26 -131.29 27.32 Favored Glycine 0 C--N 1.352 1.443 0 O-C-N 123.46 0.475 . . . . 51.41 113.611 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.9 t -72.8 -21.53 60.97 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.23 0.612 . . . . 54.2 111.212 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -73.64 -42.39 61.47 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.606 0.762 . . . . 70.23 109.387 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.3 tpt -66.55 -42.52 87.02 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 115.596 -0.729 . . . . 72.4 110.262 173.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.54 -29.2 70.4 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.385 -0.825 . . . . 72.43 111.13 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.488 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 60.4 t-80 -71.53 -35.27 70.61 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.98 -0.555 . . . . 74.44 110.926 176.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.9 t -71.89 -44.16 64.2 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 110.005 -0.368 . . . . 52.3 110.005 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.6 mt -82.38 -32.07 29.38 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.66 0.615 . . . . 73.04 112.66 -173.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.89 4.36 42.07 Favored Glycine 0 N--CA 1.472 1.034 0 CA-C-O 119.89 -0.395 . . . . 71.42 113.639 -172.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.538 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -140.49 -68.6 0.41 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 117.014 0.407 . . . . 55.23 110.759 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -67.97 -45.33 74.46 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 116.01 -0.541 . . . . 73.31 112.266 -168.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 82.4 m -67.19 -48.42 48.16 Favored Pre-proline 0 CA--C 1.559 1.296 0 CA-C-O 118.065 -0.969 . . . . 62.42 112.783 -176.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.458 ' HD3' HG11 ' A' ' 58' ' ' VAL . 41.0 Cg_endo -66.51 -18.72 54.72 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 121.576 1.517 . . . . 74.22 112.682 173.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -76.12 -34.62 59.47 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.923 0.489 . . . . 74.11 110.529 173.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.2 mm -64.35 -43.84 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.448 0.699 . . . . 71.51 109.447 170.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.2 mt -73.36 -23.48 60.21 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.045 -0.98 . . . . 73.24 112.522 -174.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -63.61 -45.64 82.88 Favored Pre-proline 0 N--CA 1.485 1.279 0 N-CA-C 114.331 1.234 . . . . 75.25 114.331 -172.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -52.95 -36.53 75.58 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 121.985 1.79 . . . . 73.14 113.47 172.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -79.08 -39.36 33.98 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.559 0.744 . . . . 71.12 111.352 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.45 -49.53 73.33 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.252 0.621 . . . . 63.22 109.369 175.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.47 ' NH1' HD12 ' C' ' 105' ' ' ILE . 27.4 ttm180 -49.96 -50.5 46.56 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 125.137 1.523 . . . . 71.32 111.084 175.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -65.24 -47.85 75.37 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 124.374 1.046 . . . . 75.24 111.747 -176.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.525 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 53.7 t -56.0 -42.01 75.75 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.135 0.897 . . . . 54.11 110.468 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.556 HG21 HG21 ' A' ' 64' ' ' VAL . 68.8 mt -62.66 -53.69 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 114.736 -1.12 . . . . 72.1 110.616 174.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.404 HG21 ' HE2' ' C' ' 109' ' ' TYR . 33.1 m -55.87 -36.86 68.04 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.679 0.791 . . . . 72.33 111.027 -175.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.7 t -68.68 -46.9 67.86 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.582 -1.19 . . . . 72.21 110.186 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.6 mtp -59.94 -42.29 93.7 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.605 0.762 . . . . 73.34 111.897 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 114' ' ' ILE . 84.5 t -63.76 -44.16 98.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 124.254 1.022 . . . . 64.45 110.252 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 99.4 p -73.23 -32.3 64.67 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.803 -0.635 . . . . 65.13 111.108 -176.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -67.78 -33.38 74.72 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.469 0.708 . . . . 70.33 109.738 173.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.54 15.05 37.67 Favored Glycine 0 C--N 1.354 1.562 0 CA-C-N 115.585 -0.734 . . . . 41.41 113.578 175.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.4 t 59.9 11.54 2.63 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 127.26 2.224 . . . . 62.34 114.488 174.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -79.76 140.01 54.56 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 107.96 -1.126 . . . . 72.3 107.96 175.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -43.15 133.56 6.21 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 123.529 2.819 . . . . 72.33 112.647 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -52.36 131.0 32.71 Favored 'General case' 0 C--N 1.363 1.164 0 O-C-N 123.93 0.769 . . . . 71.35 112.474 -169.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.419 HD21 HG11 ' A' ' 64' ' ' VAL . 22.3 tp -120.22 115.73 24.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.688 1.195 . . . . 63.51 109.303 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -109.17 128.04 54.7 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 105.715 -1.957 . . . . 63.44 105.715 173.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.454 ' H ' ' HG3' ' A' ' 111' ' ' ARG . 15.4 mt -71.7 147.44 47.41 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 118.29 0.496 . . . . 64.12 110.926 -175.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.33 137.6 86.53 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 122.98 0.512 . . . . 50.23 110.677 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.2 124.21 15.65 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 123.132 2.555 . . . . 62.5 113.329 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.594 HG21 HD11 ' A' ' 44' ' ' LEU . 68.6 t -109.43 128.6 65.3 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 C-N-CA 123.78 0.832 . . . . 53.22 110.388 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -92.18 84.3 5.22 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.466 -0.939 . . . . 73.24 108.466 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -60.83 -29.67 69.64 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.884 0.874 . . . . 74.43 111.587 177.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.538 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 5.5 t70 -64.24 -42.24 96.62 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 124.007 0.817 . . . . 70.41 109.559 178.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.92 -40.18 87.56 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.125 0.891 . . . . 50.53 111.275 176.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.64 -42.86 99.48 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 123.779 0.674 . . . . 75.33 111.016 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 69.2 t80 . . . . . 0 C--N 1.346 0.445 0 CA-C-N 116.014 -0.539 . . . . 61.15 109.834 174.742 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.529 ' HB3' HG23 ' B' ' 89' ' ' ILE . 20.7 ptm . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 121.433 0.635 . . . . 65.22 112.71 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -147.68 140.03 24.47 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 108.425 -0.954 . . . . 71.02 108.425 169.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -138.35 140.46 39.47 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.741 -0.837 . . . . 74.45 108.741 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -151.5 140.02 20.59 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 109.087 -0.708 . . . . 72.32 109.087 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.459 HD13 HD11 ' B' ' 16' ' ' ILE . 33.8 mt -75.1 133.0 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 107.535 -1.283 . . . . 51.33 107.535 167.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -98.43 -43.76 6.78 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.054 -0.721 . . . . 74.43 109.054 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -172.88 131.72 0.52 Allowed 'General case' 0 C--N 1.348 0.536 0 CA-C-N 115.723 -0.671 . . . . 62.41 109.69 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.507 HG21 ' CD1' ' B' ' 109' ' ' TYR . 58.6 mt -115.63 144.13 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.108 -1.071 . . . . 72.14 108.108 173.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -164.69 145.58 7.82 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.489 0.661 . . . . 75.22 111.931 -175.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.1 m -72.91 118.17 15.53 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.405 -1.27 . . . . 71.33 108.086 169.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -94.59 -23.29 17.7 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.509 0.724 . . . . 65.11 111.02 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -161.48 143.47 11.76 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.986 0.179 . . . . 60.21 110.9 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.448 HD11 ' SG ' ' B' ' 113' ' ' CYS . 47.1 mm -136.1 143.92 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.536 1.135 . . . . 61.43 109.536 176.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 68.9 m -141.27 132.58 26.63 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.962 1.705 . . . . 63.11 107.208 169.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 88.0 t80 -142.87 109.26 5.33 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.483 -1.673 . . . . 72.2 106.483 166.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 38.8 mt-10 -119.53 111.54 18.22 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.501 -0.925 . . . . 75.42 108.501 -176.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.56 86.47 1.78 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 106.566 -1.642 . . . . 71.2 106.566 173.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.28 -35.7 8.13 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.464 2.11 . . . . 73.15 112.199 -165.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -106.93 21.02 18.2 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.1 -0.954 . . . . 64.32 109.663 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.436 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -42.66 -62.33 1.31 Allowed Pre-proline 0 N--CA 1.487 1.424 0 C-N-CA 125.221 1.408 . . . . 64.43 114.722 -165.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.436 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 16.6 Cg_exo -61.81 -30.18 84.05 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 122.08 1.854 . . . . 74.33 112.375 -171.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -96.04 -27.99 14.84 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.564 -1.198 . . . . 74.31 111.983 -169.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' B' ' 73' ' ' ALA . 6.4 p -81.81 -10.02 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 120.775 0.322 . . . . 72.12 111.043 -176.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -70.57 -19.96 62.83 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.383 0.673 . . . . 65.22 112.678 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -65.92 -12.78 57.3 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.144 0.497 . . . . 72.24 111.229 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -97.36 92.26 5.89 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.053 1.341 . . . . 65.21 109.744 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -97.38 78.92 2.73 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.755 -0.657 . . . . 73.15 109.622 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 15.1 p90 -153.8 -173.24 4.5 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.092 0.557 . . . . 62.14 110.017 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -73.03 109.47 6.33 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 124.143 0.977 . . . . 72.14 110.088 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.476 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 55.6 Cg_endo -72.91 132.24 18.1 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 121.199 1.266 . . . . 70.02 111.317 175.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -65.6 104.86 1.09 Allowed 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.184 0.594 . . . . 64.01 109.809 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.461 HG11 HD11 ' B' ' 126' ' ' LEU . 74.8 t -99.5 143.38 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 114.355 -1.293 . . . . 71.32 111.221 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -124.09 132.05 53.61 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 106.949 -1.5 . . . . 73.43 106.949 173.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.453 HD13 HD22 ' B' ' 128' ' ' LEU . 17.1 tp -102.06 124.98 48.6 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.073 -1.084 . . . . 52.11 108.073 172.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -124.85 139.59 53.7 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.615 -1.254 . . . . 72.24 107.615 -175.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mp -122.3 138.25 54.57 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.837 0.855 . . . . 65.42 109.453 -171.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.553 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 9.8 t70 -135.22 146.85 49.05 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.715 1.206 . . . . 74.4 108.442 173.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.1 m -126.74 103.42 7.53 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.919 -0.771 . . . . 74.14 108.919 -176.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.75 117.89 31.52 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 108.625 -0.879 . . . . 61.25 108.625 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 51.7 p -144.6 161.04 40.14 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 122.429 0.291 . . . . 75.42 110.752 -176.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.7 p -159.45 138.88 11.35 Favored 'General case' 0 C--O 1.244 0.799 0 O-C-N 123.444 0.465 . . . . 74.0 111.211 -174.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -78.37 104.57 9.04 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 108.845 -0.798 . . . . 70.35 108.845 171.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 3.0 pp -122.53 11.31 9.88 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.647 -0.706 . . . . 44.41 109.928 175.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.07 158.49 43.09 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 115.702 -0.681 . . . . 61.23 110.49 -174.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.93 107.74 17.86 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.418 1.087 . . . . 72.23 110.883 -172.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 62.53 18.63 10.6 Favored 'General case' 0 N--CA 1.501 2.122 0 C-N-CA 124.275 1.03 . . . . 71.12 111.589 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 90.3 t -135.6 121.63 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.372 1.469 . . . . 61.3 107.248 -174.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -113.43 139.25 49.07 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.69 -0.856 . . . . 75.32 108.69 -172.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -104.51 101.29 10.96 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 106.578 -1.638 . . . . 42.43 106.578 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -104.04 133.66 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.201 0.601 . . . . 73.43 109.491 -177.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.505 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 25.8 t -118.4 122.11 68.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 C-N-CA 124.183 0.993 . . . . 73.15 108.437 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.45 109.94 21.78 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 107.796 -1.187 . . . . 72.11 107.796 174.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.553 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 39.2 ttm180 -85.85 112.23 20.94 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.889 -0.782 . . . . 53.13 108.889 175.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.447 HG13 HD11 ' B' ' 42' ' ' LEU . 61.7 t -105.37 103.59 15.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.42 -0.956 . . . . 73.4 108.42 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 7.5 m -99.44 131.39 45.48 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.427 -0.806 . . . . 73.53 109.648 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.664 HG11 HD21 ' B' ' 126' ' ' LEU . 72.4 t -120.05 133.14 67.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 123.758 0.823 . . . . 65.34 110.042 176.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 72.6 m -110.76 147.35 34.63 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 108.355 -0.98 . . . . 65.31 108.355 167.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.442 ' HB2' HG22 ' B' ' 40' ' ' VAL . . . -144.5 133.19 22.28 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.446 0.698 . . . . 62.23 109.359 173.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.463 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 16.6 m -133.98 126.38 30.15 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 123.418 0.449 . . . . 55.32 110.675 -174.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.476 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 60.4 mt -99.08 101.29 12.61 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.841 -1.17 . . . . 73.25 107.841 174.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.82 -144.82 24.33 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 115.747 -0.661 . . . . 74.43 111.54 -173.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -82.41 2.36 32.91 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.017 0.927 . . . . 71.43 112.652 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -123.34 158.83 30.18 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.638 0.775 . . . . 70.34 110.354 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 92.4 m -81.35 126.16 31.26 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.683 0.793 . . . . 63.43 110.689 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.468 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -77.67 -57.85 3.59 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.321 1.049 . . . . 71.43 108.96 174.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -143.99 162.41 36.26 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 122.249 1.023 . . . . 73.34 111.937 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.4 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 84.4 mt -126.76 147.5 49.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 112.886 -1.961 . . . . 65.03 106.554 171.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 32.5 t -149.45 150.85 33.01 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.006 -1.109 . . . . 53.5 108.006 174.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 35.7 tt0 -161.84 125.15 3.1 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.207 -1.034 . . . . 74.41 108.207 178.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 84.6 t -122.94 146.6 27.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.542 -0.911 . . . . 63.01 108.542 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -117.72 107.53 14.29 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.012 -1.107 . . . . 73.33 108.012 169.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -99.43 100.62 11.69 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.224 -1.028 . . . . 72.12 108.224 175.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -96.22 162.2 22.67 Favored Glycine 0 C--N 1.336 0.55 0 O-C-N 123.785 0.678 . . . . 53.34 111.599 177.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.9 131.98 2.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.695 -0.288 . . . . 64.32 112.642 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 47.0 mt -85.54 115.03 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 N-CA-C 107.612 -1.255 . . . . 65.24 107.612 171.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -127.32 140.95 51.85 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.832 0.853 . . . . 60.2 109.621 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 56.1 m -95.19 123.26 38.59 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.381 0.672 . . . . 75.34 110.191 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.727 HG22 HD11 ' B' ' 89' ' ' ILE . 2.4 mp -127.63 113.07 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 108.018 -1.104 . . . . 44.44 108.018 -178.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.82 155.46 35.84 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.176 0.59 . . . . 52.44 110.812 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 102.02 -34.15 5.93 Favored Glycine 0 N--CA 1.48 1.571 0 C-N-CA 123.786 0.707 . . . . 73.0 112.496 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.727 HD11 HG22 ' B' ' 86' ' ' ILE . 0.9 OUTLIER -80.74 167.63 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 124.509 1.124 . . . . 63.13 112.345 178.804 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -156.59 148.98 23.37 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.819 0.848 . . . . 71.13 110.655 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.15 -134.16 12.34 Favored Glycine 0 C--N 1.356 1.673 0 C-N-CA 123.013 0.34 . . . . 70.5 113.655 172.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.5 m -64.64 -48.47 74.71 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.42 1.088 . . . . 44.11 110.255 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -66.28 -24.7 66.61 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 113.437 -1.711 . . . . 74.21 111.466 -170.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.8 -65.7 0.65 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.637 1.175 . . . . 73.44 112.215 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.52 -13.24 59.93 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.686 0.395 . . . . 42.41 111.983 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -59.82 -36.07 76.03 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.286 0.634 . . . . 75.32 110.402 168.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.4 t -65.16 -55.43 18.68 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.215 0.606 . . . . 74.12 111.524 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.619 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.6 pp -76.49 -18.25 58.86 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 112.646 0.61 . . . . 75.3 112.646 -177.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.93 -19.6 30.8 Favored Glycine 0 C--N 1.348 1.239 0 CA-C-O 119.766 -0.463 . . . . 52.03 113.861 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.72 -51.94 1.06 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 117.324 0.562 . . . . 52.22 111.49 -173.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -70.17 -40.15 74.87 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.414 0.686 . . . . 71.51 111.244 -175.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.619 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 81.8 m -70.99 -48.83 13.64 Favored Pre-proline 0 CA--C 1.56 1.36 0 CA-C-O 118.443 -0.789 . . . . 72.23 112.086 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 84.2 Cg_exo -54.14 -29.12 54.53 Favored 'Trans proline' 0 C--N 1.393 2.906 0 C-N-CA 122.49 2.127 . . . . 62.54 114.029 169.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -64.75 -33.31 75.68 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.4 0.68 . . . . 71.21 111.488 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.425 HG23 ' NH2' ' D' ' 111' ' ' ARG . 65.0 mt -72.89 -39.12 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.772 0.829 . . . . 75.04 110.122 175.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 71.2 mt -75.33 -34.18 61.19 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.737 -1.119 . . . . 64.33 111.722 -174.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -57.73 -47.34 99.11 Favored Pre-proline 0 N--CA 1.487 1.377 0 CA-C-O 117.559 -1.21 . . . . 62.11 113.776 -171.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -54.94 -35.93 90.78 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.21 1.94 . . . . 43.54 113.299 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.507 ' CD1' HG21 ' B' ' 16' ' ' ILE . 5.0 m-30 -76.03 -40.43 53.47 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.827 -0.624 . . . . 75.04 110.364 -176.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.04 -42.76 99.83 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.486 -0.779 . . . . 54.2 110.257 174.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 28.4 ttt-85 -60.47 -49.61 76.89 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.075 1.35 . . . . 74.1 110.819 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -69.32 -31.5 70.0 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.885 0.741 . . . . 74.52 109.998 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.533 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.9 t -68.51 -40.54 80.78 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 122.915 0.486 . . . . 54.41 110.316 177.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.501 HD13 HG23 ' B' ' 64' ' ' VAL . 81.8 mt -62.37 -54.82 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.63 0.772 . . . . 74.31 110.128 174.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.9 m -61.18 -27.95 68.78 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 123.916 0.76 . . . . 73.02 111.068 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.3 t -64.92 -53.27 49.12 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 123.208 0.603 . . . . 50.1 109.555 173.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.533 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.1 mmt -65.92 -33.8 76.66 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.27 0.628 . . . . 73.14 111.573 -175.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 78.2 t -68.3 -41.72 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.732 1.213 . . . . 61.12 110.604 176.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 39.0 t -67.11 -31.15 71.43 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.227 -0.897 . . . . 72.51 110.785 175.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.525 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 82.0 mtt-85 -69.55 -37.78 77.17 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 123.237 0.615 . . . . 75.41 110.001 176.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.31 -11.42 71.38 Favored Glycine 0 C--N 1.353 1.515 0 O-C-N 123.429 0.456 . . . . 64.13 112.749 170.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 10.1 m 67.93 26.93 7.36 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 125.804 1.641 . . . . 55.4 110.204 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -78.07 164.99 53.76 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-N 114.964 -1.016 . . . . 75.3 111.448 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -47.54 154.48 1.7 Allowed 'Trans proline' 0 C--N 1.393 2.911 0 C-N-CA 123.429 2.753 . . . . 72.42 114.351 171.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.528 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -62.37 115.95 4.64 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.003 0.921 . . . . 53.31 111.595 -175.508 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.664 HD21 HG11 ' B' ' 64' ' ' VAL . 37.8 tp -109.57 108.13 18.46 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.546 -0.752 . . . . 72.14 109.392 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -114.35 120.51 40.63 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 107.73 -1.211 . . . . 61.13 107.73 169.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.456 HD21 HG21 ' B' ' 64' ' ' VAL . 87.9 mt -74.98 130.13 38.83 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 122.873 0.469 . . . . 64.24 110.32 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.11 136.24 90.94 Favored Pre-proline 0 CA--C 1.55 0.971 0 O-C-N 124.393 1.058 . . . . 64.45 110.77 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.03 94.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.711 2.274 . . . . 61.33 111.907 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 19.5 m -90.61 110.44 22.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.847 0.832 . . . . 75.14 109.201 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 108.542 -0.91 . . . . 74.11 108.542 174.501 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 56.1 t80 . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 108.325 -0.991 . . . . 61.53 108.325 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -150.3 126.05 10.37 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 109.045 -0.724 . . . . 75.2 109.045 174.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 59.5 mt -64.79 134.69 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 107.88 -1.156 . . . . 75.23 107.88 168.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.423 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 31.5 mm-40 -102.73 -39.22 7.12 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.847 0.459 . . . . 74.33 109.822 176.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -178.6 142.31 0.23 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.506 1.123 . . . . 74.32 109.448 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 35.1 mm -119.84 117.8 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 108.128 -1.064 . . . . 72.33 108.128 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.559 ' HB3' HG23 ' D' ' 122' ' ' THR . 41.2 p90 -145.4 162.03 38.26 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.489 0.661 . . . . 74.02 112.031 -167.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.4 p -93.72 115.36 27.79 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.112 -0.949 . . . . 61.32 109.086 175.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.416 ' HG2' ' HE2' ' C' ' 17' ' ' TYR . 77.6 mttt -77.59 -45.31 25.62 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.477 -0.935 . . . . 75.25 108.477 170.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.675 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 26.4 t70 -131.08 135.65 47.72 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 113.662 -1.608 . . . . 64.32 109.435 -171.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 77.5 mt -138.09 142.02 36.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 106.423 -1.695 . . . . 73.14 106.423 174.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.0 t -154.32 145.62 22.96 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.401 0.619 . . . . 71.13 110.326 177.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -149.68 126.03 10.81 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 106.745 -1.576 . . . . 64.13 106.745 170.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -131.63 116.54 17.5 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.478 0.711 . . . . 73.33 109.521 -175.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.54 78.34 62.59 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 124.021 0.928 . . . . 62.14 108.502 172.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.73 -25.99 39.4 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 122.431 2.087 . . . . 62.24 111.037 174.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -97.67 14.04 28.17 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.127 0.971 . . . . 72.42 110.937 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.413 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -49.65 -55.15 24.74 Favored Pre-proline 0 N--CA 1.491 1.602 0 CA-C-O 117.96 -1.019 . . . . 43.43 113.502 -172.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.413 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 37.5 Cg_exo -59.13 -43.79 39.35 Favored 'Trans proline' 0 C--N 1.391 2.815 0 C-N-CA 121.836 1.691 . . . . 62.14 112.077 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -68.78 -32.94 73.05 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.271 -1.331 . . . . 73.03 112.649 -174.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.607 HG21 ' HA ' ' C' ' 73' ' ' ALA . 12.9 p -80.81 -27.19 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 N-CA-C 112.146 0.425 . . . . 41.22 112.146 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -64.86 -27.73 69.07 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 122.893 0.477 . . . . 64.52 111.834 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -88.86 8.37 29.54 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.619 0.767 . . . . 74.14 111.504 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.464 ' HG2' HD13 ' C' ' 68' ' ' LEU . 1.0 OUTLIER -114.69 152.16 32.44 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.014 0.926 . . . . 75.3 110.258 -179.467 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -62.77 128.65 36.91 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.238 0.615 . . . . 64.53 111.12 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 65.8 t-105 -85.05 95.86 9.23 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.298 -0.865 . . . . 74.35 111.121 -174.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . 0.456 ' H ' HD22 ' C' ' 68' ' ' LEU . 34.5 tt0 -144.43 75.44 15.05 Favored Pre-proline 0 CA--C 1.549 0.918 0 N-CA-C 108.132 -1.062 . . . . 53.43 108.132 172.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -87.52 162.35 8.06 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.602 2.201 . . . . 74.43 112.686 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -90.08 108.1 19.53 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.407 -1.27 . . . . 72.22 107.692 171.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.45 96.99 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 109.078 -0.712 . . . . 63.23 109.078 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.48 101.98 12.66 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.021 -1.103 . . . . 53.12 108.021 176.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.554 HD21 HG13 ' C' ' 62' ' ' VAL . 1.9 tt -103.65 127.44 51.1 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 107.3 -1.37 . . . . 74.23 107.3 177.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -119.56 117.85 29.46 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.575 0.75 . . . . 53.45 109.008 174.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -99.97 109.27 21.62 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.725 -0.843 . . . . 72.21 108.725 173.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -121.65 121.04 36.46 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.869 -1.16 . . . . 75.45 107.869 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.1 t -124.91 148.01 48.54 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.146 0.498 . . . . 73.43 110.309 -176.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.65 151.07 35.56 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.144 0.977 . . . . 72.14 108.733 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 14.4 m -123.1 150.41 43.22 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 123.715 0.806 . . . . 64.0 109.386 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 25.8 t -147.64 126.4 12.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.481 0.712 . . . . 70.34 109.319 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -76.86 117.56 18.59 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.206 -0.664 . . . . 74.34 109.206 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.532 HD11 ' HB2' ' C' ' 57' ' ' GLU . 50.3 mt -84.1 -43.64 14.84 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.618 0.767 . . . . 71.04 110.413 -175.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.47 -176.14 4.92 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.985 -1.007 . . . . 74.24 109.815 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.71 109.86 2.17 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.967 0.907 . . . . 71.41 110.4 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 65.27 19.98 11.79 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.923 1.289 . . . . 73.54 112.385 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 57.7 t -113.25 110.01 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 108.362 -0.977 . . . . 71.14 108.362 172.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -112.4 124.89 53.5 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.438 1.095 . . . . 70.14 109.794 -177.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.532 ' HB2' HD11 ' C' ' 51' ' ' LEU . 43.1 tt0 -91.24 142.66 27.48 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.759 -0.83 . . . . 75.24 108.759 170.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 82.8 t -124.81 139.4 51.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.995 -1.113 . . . . 53.22 107.995 167.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.06 130.07 72.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.975 -0.75 . . . . 74.34 108.975 173.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.541 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -110.48 111.73 23.17 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.218 -1.401 . . . . 72.12 107.218 178.545 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -90.67 107.24 19.04 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.303 -0.999 . . . . 52.33 108.303 173.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.554 HG13 HD21 ' C' ' 42' ' ' LEU . 38.9 t -101.32 118.89 48.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.949 -1.13 . . . . 74.34 107.949 173.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 26.0 m -118.7 137.48 53.29 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.984 -0.747 . . . . 61.14 108.984 -175.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.458 HG23 HD13 ' C' ' 114' ' ' ILE . 84.8 t -132.02 120.39 43.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 124.02 0.928 . . . . 75.14 109.046 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 10.0 m -113.17 130.31 56.25 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.349 -0.982 . . . . 60.02 108.349 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.88 115.71 24.36 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.16 -1.052 . . . . 73.21 108.16 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 54.5 m -134.02 130.21 37.22 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.431 0.457 . . . . 54.42 110.342 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.464 HD13 ' HG2' ' C' ' 34' ' ' LYS . 39.2 mt -85.84 39.34 0.8 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.699 1.2 . . . . 75.55 109.687 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.43 -102.48 2.2 Favored Glycine 0 C--N 1.348 1.24 0 N-CA-C 110.19 -1.164 . . . . 64.21 110.19 -170.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -89.79 -30.72 17.78 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.753 0.821 . . . . 72.43 110.397 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . 0.441 ' HG2' HD12 ' C' ' 68' ' ' LEU . 4.3 tp10 -69.7 121.36 17.03 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 123.95 0.9 . . . . 74.33 109.788 176.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -81.19 117.28 21.59 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.262 -1.014 . . . . 61.54 108.262 165.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.607 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.91 -50.8 21.48 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.654 -0.869 . . . . 73.51 108.654 176.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . 0.488 ' HZ ' HD21 ' C' ' 126' ' ' LEU . 31.3 p90 -164.86 164.49 20.91 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.284 -1.326 . . . . 62.52 110.723 177.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.42 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.0 tm? -121.62 144.57 48.67 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 105.965 -1.865 . . . . 61.15 105.965 164.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.527 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.9 t -149.13 137.73 21.07 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.085 -1.08 . . . . 63.34 108.085 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -155.69 132.74 10.7 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.892 -0.41 . . . . 62.34 109.892 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 92.8 t -126.02 135.93 62.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.122 0.969 . . . . 64.51 109.037 174.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.675 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.7 mt-30 -109.99 96.2 6.08 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.069 0.948 . . . . 73.34 108.925 171.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -80.66 102.31 9.78 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.501 -1.227 . . . . 51.35 109.189 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.41 148.85 25.51 Favored Glycine 0 C--N 1.342 0.898 0 N-CA-C 111.181 -0.767 . . . . 43.24 111.181 174.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.74 119.23 1.04 Allowed Glycine 0 N--CA 1.465 0.591 0 CA-C-N 117.419 0.609 . . . . 42.14 111.98 -176.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.446 HG12 ' HE1' ' C' ' 17' ' ' TYR . 22.8 mm -86.75 129.12 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.024 -0.732 . . . . 72.43 109.024 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -133.41 126.64 31.69 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.912 0.885 . . . . 74.04 109.227 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 10.2 p -87.49 101.67 13.82 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.881 -1.155 . . . . 52.21 107.881 168.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 7.7 mt -117.27 124.87 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.648 0.779 . . . . 75.5 110.317 -174.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.5 171.31 14.23 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.098 0.959 . . . . 64.23 109.2 177.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.21 -25.36 12.63 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-O 119.701 -0.499 . . . . 62.14 114.091 174.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.569 HD11 ' HE3' ' C' ' 94' ' ' MET . 37.7 pt -106.63 164.09 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 123.366 0.667 . . . . 72.33 111.393 -178.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -156.04 154.84 31.65 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.639 0.776 . . . . 73.24 110.127 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.41 -117.85 8.72 Favored Glycine 0 C--N 1.351 1.383 0 O-C-N 123.724 0.64 . . . . 61.11 113.411 169.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 17.7 m -62.19 -38.36 88.83 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.006 0.922 . . . . 73.42 111.134 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -67.43 -51.25 53.95 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.947 0.899 . . . . 74.33 111.239 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.569 ' HE3' HD11 ' C' ' 89' ' ' ILE . 5.3 tpt -55.55 -50.72 69.29 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 124.176 0.923 . . . . 62.12 111.431 174.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.32 -43.36 92.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.377 0.671 . . . . 74.51 111.801 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -70.93 -36.49 72.65 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.684 0.794 . . . . 75.31 111.288 -175.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -64.23 -36.79 85.23 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.601 -0.727 . . . . 61.33 110.394 177.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.505 ' HG ' ' HE2' ' C' ' 94' ' ' MET . 91.7 mt -83.65 -37.56 22.66 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.295 1.038 . . . . 63.35 112.752 -176.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.87 -13.62 36.66 Favored Glycine 0 N--CA 1.475 1.279 0 N-CA-C 113.996 0.359 . . . . 72.41 113.996 -168.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.17 -54.32 1.19 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 117.014 0.407 . . . . 50.14 111.488 -175.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -70.72 -52.05 23.42 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 116.251 -0.431 . . . . 75.42 111.781 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.436 ' O ' HD13 ' C' ' 106' ' ' LEU . 96.9 m -64.18 -48.67 76.33 Favored Pre-proline 0 CA--C 1.559 1.309 0 CA-C-O 118.101 -0.952 . . . . 42.4 112.487 -177.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.541 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 50.4 Cg_exo -57.46 -27.3 75.59 Favored 'Trans proline' 0 C--N 1.393 2.891 0 C-N-CA 122.228 1.952 . . . . 61.14 113.373 175.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.43 -38.02 80.81 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.413 0.685 . . . . 73.12 109.878 177.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.47 HD12 ' NH1' ' A' ' 111' ' ' ARG . 47.3 mm -72.47 -34.28 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.684 0.794 . . . . 74.14 110.338 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.436 HD13 ' O ' ' C' ' 102' ' ' CYS . 7.3 mp -80.52 -24.19 39.53 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.906 0.883 . . . . 53.32 112.259 -177.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -58.86 -50.73 86.4 Favored Pre-proline 0 N--CA 1.481 1.081 0 CA-C-O 117.335 -1.317 . . . . 75.0 113.968 -172.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -59.53 -37.34 89.49 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 121.968 1.779 . . . . 74.11 113.206 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.404 ' HE2' HG21 ' A' ' 115' ' ' THR . 58.6 m-85 -65.2 -47.27 77.49 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.643 0.777 . . . . 64.35 110.392 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.96 -34.25 77.97 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 114.48 -1.236 . . . . 60.14 111.329 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -67.3 -50.19 61.24 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.205 1.402 . . . . 73.41 110.701 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -65.76 -35.26 80.21 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 123.805 0.69 . . . . 74.31 109.696 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 18.9 t -67.83 -29.49 68.65 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.305 0.642 . . . . 41.41 111.964 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.527 HG23 ' SG ' ' C' ' 76' ' ' CYS . 65.4 mt -79.07 -53.51 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 123.15 0.58 . . . . 74.13 110.678 174.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 17.8 m -61.91 -28.36 69.47 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.283 0.633 . . . . 71.31 111.162 -175.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.6 t -65.52 -50.07 66.59 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.676 0.791 . . . . 74.1 109.568 171.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.495 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.69 -40.35 87.57 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.464 1.105 . . . . 65.43 112.519 -179.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.42 -42.61 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.752 0.821 . . . . 71.1 109.995 175.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 39.7 t -71.45 -27.6 63.38 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.082 -0.963 . . . . 71.13 111.776 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' C' ' 116' ' ' SER . 79.9 mtt-85 -72.88 -41.83 64.26 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.002 -0.74 . . . . 73.13 109.002 176.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.88 -3.33 63.68 Favored Glycine 0 C--N 1.357 1.733 0 CA-C-N 115.419 -0.81 . . . . 65.32 112.901 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 26.1 p 62.32 30.49 17.47 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.632 1.973 . . . . 63.43 112.823 172.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -83.75 145.84 48.19 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 108.504 -0.924 . . . . 53.42 108.504 169.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -46.01 140.51 10.26 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 124.013 3.142 . . . . 64.34 114.898 176.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -60.24 134.6 57.21 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.659 1.184 . . . . 72.0 113.116 -174.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.488 HD21 ' HZ ' ' C' ' 74' ' ' PHE . 0.8 OUTLIER -141.53 98.7 3.4 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 114.791 -1.095 . . . . 74.53 108.567 174.429 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -91.5 102.82 15.48 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.412 -0.959 . . . . 74.25 108.412 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.467 ' H ' HD22 ' C' ' 128' ' ' LEU . 2.7 mm? -57.58 129.93 44.08 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.62 1.168 . . . . 75.12 112.498 -167.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.68 144.53 98.92 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.096 0.958 . . . . 74.14 111.6 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.401 ' HG3' HD12 ' A' ' 16' ' ' ILE . 24.1 Cg_exo -62.19 123.62 12.85 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.948 2.432 . . . . 62.22 112.918 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 24.2 t -115.5 121.4 67.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 108.49 -0.929 . . . . 75.31 108.49 175.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . 0.481 HD21 ' HB3' ' C' ' 134' ' ' ASP . 57.3 t30 -75.13 107.47 7.24 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.587 0.755 . . . . 64.1 111.276 -175.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -65.37 -18.35 65.25 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.77 0.828 . . . . 52.11 112.994 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . 0.481 ' HB3' HD21 ' C' ' 132' ' ' ASN . 9.9 t70 -65.52 -43.09 91.13 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.143 0.577 . . . . 71.52 109.846 172.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.09 -42.43 96.93 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.52 -0.764 . . . . 65.24 110.656 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 76.3 mt -70.64 -24.54 62.73 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.164 -0.925 . . . . 73.01 111.844 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 83.4 t80 . . . . . 0 N--CA 1.47 0.568 0 C-N-CA 123.26 0.624 . . . . 74.21 110.868 -178.496 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 C--O 1.243 0.748 0 N-CA-C 109.836 -0.431 . . . . 74.41 109.836 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.431 ' HD2' HG22 ' D' ' 86' ' ' ILE . 84.9 t80 -134.84 101.93 5.08 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 107.861 -1.163 . . . . 52.41 107.861 176.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -127.5 120.07 27.46 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.421 -0.955 . . . . 55.43 108.421 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 10.5 mt -80.25 133.01 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 109.341 -0.614 . . . . 63.5 109.341 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -89.82 -40.58 12.36 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.829 0.852 . . . . 54.45 110.805 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -167.69 137.77 2.76 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.351 -0.386 . . . . 73.24 110.385 -175.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.9 mp -110.17 137.26 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 107.048 -1.464 . . . . 61.14 107.048 169.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -164.31 142.49 7.04 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.372 0.533 . . . . 71.41 111.457 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 67.9 p -77.95 121.0 23.6 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.866 -0.606 . . . . 73.5 109.749 176.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.518 ' HD2' ' HA3' ' D' ' 81' ' ' GLY . 34.9 mtpt -96.08 -13.89 23.31 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.297 0.639 . . . . 71.21 109.909 -178.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.4 t70 -163.79 139.7 6.51 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.352 1.061 . . . . 71.41 108.915 177.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.495 HG21 ' HE2' ' C' ' 117' ' ' MET . 76.8 mt -141.9 147.41 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.614 1.166 . . . . 55.14 108.488 177.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 74.3 m -148.85 142.01 24.99 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.0 1.72 . . . . 72.41 108.155 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 83.0 t80 -145.86 113.53 6.38 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 105.012 -2.218 . . . . 73.03 105.012 166.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -131.07 110.04 10.92 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.79 0.436 . . . . 63.41 110.254 -168.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.35 82.06 11.5 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 107.92 -1.141 . . . . 63.24 107.92 176.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.74 -17.6 17.85 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.57 2.18 . . . . 71.23 112.361 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.422 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 76.8 m-20 -107.48 9.08 29.69 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.84 0.856 . . . . 72.53 110.735 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.412 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -33.31 -67.82 0.18 Allowed Pre-proline 0 CA--C 1.572 1.808 0 N-CA-C 115.976 1.843 . . . . 51.43 115.976 -165.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.79 -15.19 15.26 Favored 'Trans proline' 0 C--N 1.385 2.495 0 CA-C-N 124.077 2.492 . . . . 65.24 114.014 -176.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.422 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 7.2 t-160 -72.99 -40.99 64.79 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.652 1.181 . . . . 71.23 109.399 173.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.568 HG22 HD12 ' D' ' 68' ' ' LEU . 8.7 p -86.08 -19.69 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 CA-C-N 115.018 -0.992 . . . . 63.43 111.473 -175.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -67.66 -19.66 65.22 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 117.837 0.29 . . . . 75.21 111.658 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -67.28 -14.14 62.64 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.711 0.804 . . . . 70.3 110.832 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -103.22 69.1 1.0 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.958 1.303 . . . . 72.22 109.255 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -84.07 74.6 10.25 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-O 122.314 1.054 . . . . 72.25 110.489 -176.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 4.7 p90 -142.8 -165.05 1.97 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.587 -0.733 . . . . 73.41 109.311 175.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -64.5 108.51 1.99 Allowed Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 124.163 0.985 . . . . 72.44 111.027 177.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -72.24 126.89 12.12 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.168 1.912 . . . . 51.53 110.747 176.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.91 111.83 11.69 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.915 -1.142 . . . . 74.22 107.915 176.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.676 HG13 HG13 ' D' ' 64' ' ' VAL . 65.9 t -108.61 137.01 42.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 C-N-CA 123.846 0.858 . . . . 65.44 108.911 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 29.7 mmtm -126.85 134.47 50.51 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.456 0.702 . . . . 74.4 109.796 170.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.733 HD11 HG13 ' D' ' 62' ' ' VAL . 20.7 tp -96.68 147.68 23.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.255 -0.884 . . . . 63.04 109.971 -175.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.549 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 19.9 t70 -139.98 112.48 7.86 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.83 -1.174 . . . . 73.24 107.83 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.0 mt -115.08 132.73 56.51 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.391 0.677 . . . . 73.12 109.817 -172.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.577 ' HB2' ' HB3' ' D' ' 61' ' ' ARG . 3.5 m-20 -132.49 151.28 51.96 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.816 1.246 . . . . 75.43 108.658 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . 0.414 HG21 ' O ' ' D' ' 99' ' ' GLY . 20.5 p -107.88 146.48 32.26 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.368 0.667 . . . . 71.43 110.47 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.639 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.37 163.39 37.88 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.126 0.97 . . . . 61.21 109.217 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 61.6 p . . . . . 0 CA--C 1.542 0.642 0 O-C-N 123.798 0.686 . . . . 73.44 110.917 -173.748 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 . . . . . 0 N--CA 1.499 2.019 0 N-CA-C 112.015 0.376 . . . . 73.25 112.015 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 11.7 t -113.13 99.2 8.17 Favored 'Isoleucine or valine' 0 C--N 1.349 0.571 0 N-CA-C 107.422 -1.325 . . . . 63.31 107.422 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -127.84 131.79 49.46 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 120.596 0.236 . . . . 73.53 110.443 -173.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -87.6 138.49 31.42 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.651 -0.87 . . . . 74.11 108.651 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 78.7 t -136.25 138.33 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 C-N-CA 124.846 1.258 . . . . 63.1 107.909 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.639 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 21.5 t -132.94 120.24 40.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.424 -0.954 . . . . 53.12 108.424 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.539 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -93.2 124.84 37.46 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.112 -1.07 . . . . 73.02 108.112 174.149 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.591 ' HG2' ' HG2' ' D' ' 79' ' ' GLN . 1.5 tmm_? -100.27 104.65 16.14 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.095 -1.076 . . . . 62.02 108.095 174.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.733 HG13 HD11 ' D' ' 42' ' ' LEU . 82.8 t -103.1 121.5 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 123.923 0.889 . . . . 71.14 108.734 175.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.549 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 60.3 m -120.82 133.69 55.31 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.617 0.722 . . . . 73.31 109.47 175.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.676 HG13 HG13 ' D' ' 40' ' ' VAL . 34.5 t -110.26 119.69 59.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 114.457 -1.247 . . . . 74.42 108.662 174.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 15.6 m -109.04 91.86 3.81 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.21 -1.404 . . . . 63.24 107.21 171.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.63 147.19 25.07 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.513 -0.767 . . . . 71.41 109.372 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.423 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 53.8 p -156.28 132.86 10.2 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 123.513 0.508 . . . . 63.41 111.092 -173.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.568 HD12 HG22 ' D' ' 31' ' ' VAL . 21.5 mt -104.62 112.22 25.22 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.077 -1.083 . . . . 52.32 108.077 170.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.34 -115.94 4.41 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.926 -0.579 . . . . 72.42 111.737 -172.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -115.91 4.53 13.86 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 117.381 0.591 . . . . 65.34 111.388 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -114.25 154.86 27.2 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.49 0.316 . . . . 70.34 110.656 -175.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 95.3 m -63.12 120.06 10.74 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 123.975 0.797 . . . . 73.24 111.144 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.548 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -76.18 -67.37 0.69 Allowed 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.02 -1.474 . . . . 52.12 107.02 167.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . 0.402 ' HD1' ' HB2' ' D' ' 76' ' ' CYS . 53.2 p90 -154.23 142.95 20.9 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.997 -0.547 . . . . 71.41 110.997 176.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 57.8 mt -106.12 107.95 19.21 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 107.249 -1.389 . . . . 71.1 107.249 170.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.612 ' SG ' HG23 ' D' ' 114' ' ' ILE . 17.5 t -118.45 107.78 14.22 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.023 -0.732 . . . . 41.04 109.023 -172.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -128.9 131.37 47.58 Favored 'General case' 0 C--O 1.22 -0.487 0 C-N-CA 123.265 0.626 . . . . 74.52 110.088 -171.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . 0.446 HG21 ' HB3' ' D' ' 113' ' ' CYS . 86.3 t -134.43 116.18 21.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 123.734 0.814 . . . . 74.13 108.928 178.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.604 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 78.6 mt-30 -88.88 84.43 6.65 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.177 -1.045 . . . . 71.45 108.177 171.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -82.32 108.05 15.46 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 113.998 -1.456 . . . . 64.0 109.52 -176.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.518 ' HA3' ' HD2' ' D' ' 19' ' ' LYS . . . -99.61 172.95 25.45 Favored Glycine 0 C--O 1.241 0.558 0 O-C-N 123.374 0.421 . . . . 34.22 112.893 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.63 144.26 6.53 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.513 -0.344 . . . . 51.43 112.865 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 54.7 mt -90.11 128.08 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.019 -1.104 . . . . 74.42 108.019 172.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -124.57 140.27 53.1 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.914 0.886 . . . . 75.55 110.771 -175.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 7.1 m -98.83 98.73 9.79 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.387 1.075 . . . . 62.55 108.92 172.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.664 HG12 HD21 ' D' ' 98' ' ' LEU . 2.6 pp -115.96 132.87 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 109.26 -0.645 . . . . 75.2 109.26 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.92 168.19 19.71 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.234 1.014 . . . . 51.11 109.404 -177.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.74 -21.55 32.62 Favored Glycine 0 N--CA 1.477 1.381 0 C-N-CA 123.221 0.439 . . . . 42.32 113.91 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.433 HD13 ' HB2' ' D' ' 94' ' ' MET . 1.0 OUTLIER -101.03 155.85 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.864 0.865 . . . . 65.41 109.374 172.517 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -144.4 175.11 10.35 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.286 1.034 . . . . 63.42 110.457 -176.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.26 -140.56 23.05 Favored Glycine 0 C--N 1.357 1.732 0 N-CA-C 114.68 0.632 . . . . 72.11 114.68 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 86.2 m -79.79 -38.35 33.27 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.974 0.91 . . . . 73.33 111.046 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -60.72 -36.37 78.68 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.365 1.066 . . . . 53.54 111.198 -174.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.433 ' HB2' HD13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -68.07 -37.53 81.37 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.973 0.731 . . . . 73.2 112.973 -172.219 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.58 -25.35 33.36 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.383 0.673 . . . . 71.23 109.927 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -66.89 -27.39 67.47 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.099 0.96 . . . . 73.33 110.302 174.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 94.8 m -62.21 -42.83 99.65 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.383 0.673 . . . . 73.42 111.387 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.664 HD21 HG12 ' D' ' 86' ' ' ILE . 86.9 mt -70.71 -22.24 62.47 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.586 0.355 . . . . 73.0 111.361 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . 0.414 ' O ' HG21 ' D' ' 46' ' ' THR . . . -102.63 14.02 56.44 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-O 119.499 -0.612 . . . . 64.41 113.28 176.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.98 -66.11 0.11 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 118.277 1.039 . . . . 62.03 112.355 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -65.43 -51.63 58.87 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.12 0.568 . . . . 75.02 111.632 -172.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.429 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 78.8 m -60.89 -47.01 96.87 Favored Pre-proline 0 CA--C 1.565 1.554 0 C-N-CA 123.772 0.829 . . . . 71.11 112.359 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.539 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.7 Cg_exo -54.32 -40.01 84.54 Favored 'Trans proline' 0 C--N 1.394 2.955 0 C-N-CA 122.388 2.059 . . . . 60.12 113.678 168.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . 0.418 ' HB2' ' HB2' ' D' ' 133' ' ' PHE . 2.6 t-20 -61.98 -33.5 74.43 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.458 0.703 . . . . 64.12 111.325 -178.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.404 HG13 ' CZ ' ' D' ' 11' ' ' PHE . 43.6 mm -72.85 -36.12 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.361 1.064 . . . . 72.13 110.76 175.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 91.1 mt -71.93 -19.06 61.97 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.907 -0.588 . . . . 74.42 111.629 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -65.96 -44.42 61.37 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-O 117.782 -1.104 . . . . 72.12 113.335 -173.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.89 -42.12 31.57 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 122.343 2.028 . . . . 75.04 113.964 168.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -79.52 -32.35 42.32 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.687 0.795 . . . . 64.33 111.921 -177.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.94 -44.69 65.58 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.415 0.626 . . . . 73.53 109.996 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.577 HH12 ' HB3' ' D' ' 130' ' ' PRO . 37.4 ttp180 -65.67 -35.65 81.39 Favored 'General case' 0 C--O 1.206 -1.216 0 CA-C-N 114.012 -1.449 . . . . 74.03 110.365 174.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . 0.473 ' HA ' ' CE2' ' B' ' 109' ' ' TYR . 6.1 tt0 -52.86 -51.21 61.91 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.845 0.858 . . . . 73.44 111.151 176.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.456 ' O ' ' HG3' ' D' ' 117' ' ' MET . 43.8 t -63.7 -45.04 91.82 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.527 -1.215 . . . . 75.32 110.717 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.612 HG23 ' SG ' ' D' ' 76' ' ' CYS . 31.5 mt -60.55 -64.42 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.392 0.677 . . . . 65.51 111.269 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.4 m -40.54 -46.89 2.59 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.027 1.731 . . . . 71.14 112.63 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -62.95 -48.14 80.19 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 114.867 -1.061 . . . . 72.44 110.657 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.456 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 71.6 mtm -67.24 -31.46 71.83 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.42 0.688 . . . . 64.31 112.296 -178.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.485 HG21 ' HB3' ' D' ' 126' ' ' LEU . 87.2 t -65.53 -45.06 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.765 0.826 . . . . 52.33 109.946 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 56.0 p -70.38 -33.05 70.96 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 115.289 -0.869 . . . . 44.21 110.363 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 51.8 mtt-85 -67.36 -35.07 78.63 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.872 0.869 . . . . 75.14 110.576 175.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.21 11.19 61.31 Favored Glycine 0 C--N 1.355 1.6 0 CA-C-O 119.581 -0.566 . . . . 51.22 114.082 -178.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.559 HG23 ' HB3' ' C' ' 17' ' ' TYR . 66.9 p 57.2 30.25 18.06 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 126.2 1.8 . . . . 65.13 114.073 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -97.87 149.36 35.64 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.147 0.579 . . . . 75.21 109.781 170.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -45.17 120.99 3.36 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 123.75 2.967 . . . . 74.24 112.832 169.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -48.54 122.75 5.81 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 124.539 1.149 . . . . 74.1 111.876 -174.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.485 ' HB3' HG21 ' D' ' 118' ' ' VAL . 22.5 tp -105.44 106.59 17.16 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.45 0.7 . . . . 70.11 109.598 -174.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -106.53 89.87 3.16 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.288 1.035 . . . . 73.45 108.936 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.42 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 37.6 mt -57.39 117.88 4.57 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.048 0.939 . . . . 75.54 110.498 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.43 123.81 78.07 Favored Pre-proline 0 CA--C 1.56 1.338 0 C-N-CA 122.679 0.391 . . . . 55.11 111.176 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.577 ' HB3' HH12 ' D' ' 111' ' ' ARG . 76.6 Cg_endo -75.54 141.31 24.97 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 122.603 2.202 . . . . 71.1 111.876 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.87 152.22 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.574 0.75 . . . . 63.52 109.748 -175.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -68.58 103.9 1.82 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.382 0.673 . . . . 70.31 110.391 176.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . 0.418 ' HB2' ' HB2' ' D' ' 104' ' ' ASN . 3.7 m-30 . . . . . 0 N--CA 1.486 1.349 0 C-N-CA 124.097 0.959 . . . . 70.45 112.639 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.0 m . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 109.586 -0.524 . . . . 61.01 109.586 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -125.32 113.09 17.13 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.554 -0.906 . . . . 63.42 108.554 170.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -135.72 136.66 41.01 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.508 -0.923 . . . . 54.45 108.508 170.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.471 ' CD1' HG21 ' A' ' 105' ' ' ILE . 5.2 mt -93.35 117.15 36.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 108.762 -0.829 . . . . 74.21 108.762 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.03 -42.36 32.7 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.948 0.78 . . . . 72.35 109.32 -177.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -173.69 121.41 0.32 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 110.276 -0.268 . . . . 73.25 110.276 -171.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 65.8 mt -106.26 133.92 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.767 -0.827 . . . . 74.13 108.767 173.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.513 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 31.4 p90 -164.12 158.09 18.87 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 124.011 0.819 . . . . 74.32 111.33 -174.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.6 p -86.78 117.0 25.24 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.291 -0.633 . . . . 61.3 109.291 172.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.445 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 38.5 mtpt -75.82 -34.13 60.13 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.415 -0.587 . . . . 73.43 109.415 175.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 23.4 t70 -149.59 142.85 25.13 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.607 -1.179 . . . . 72.33 110.064 -178.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 76.1 mt -137.34 144.88 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.762 1.225 . . . . 60.14 108.119 175.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.5 t -148.92 138.3 21.71 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.667 0.787 . . . . 72.55 109.034 171.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.505 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 91.5 t80 -135.22 134.61 40.22 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.572 -1.64 . . . . 75.13 106.572 169.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -133.3 137.54 46.03 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.347 0.659 . . . . 71.13 109.542 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.94 76.64 11.38 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 106.582 -1.636 . . . . 63.32 106.582 171.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.75 -28.59 36.74 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.316 2.011 . . . . 63.25 111.199 -178.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -97.99 11.23 38.19 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.067 -0.969 . . . . 64.22 111.189 -175.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.439 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -44.87 -59.61 3.96 Favored Pre-proline 0 CA--C 1.564 1.51 0 N-CA-C 114.2 1.185 . . . . 70.31 114.2 -165.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.78 -36.85 96.41 Favored 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 122.015 1.81 . . . . 63.22 113.675 -171.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -99.39 -12.47 20.24 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.491 0.716 . . . . 60.25 112.863 -175.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.775 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.6 p -77.07 -23.49 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-N 118.073 0.397 . . . . 74.43 110.396 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -71.46 -18.47 62.31 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.514 0.726 . . . . 62.45 111.328 173.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -80.03 -27.58 39.45 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.496 0.719 . . . . 74.11 110.543 175.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.494 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 12.7 mmmm -72.87 152.64 41.39 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.942 0.897 . . . . 73.23 111.371 -175.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.25 123.45 18.69 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.547 0.739 . . . . 74.33 109.322 174.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -76.97 81.35 3.51 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.75 0.786 . . . . 74.42 110.116 -175.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.442 ' H ' HD22 ' A' ' 68' ' ' LEU . 19.5 tm0? -115.64 78.77 6.99 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 106.478 -1.675 . . . . 54.12 106.478 172.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -84.63 112.5 1.57 Allowed 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.224 1.95 . . . . 44.41 111.62 -172.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -92.88 88.09 6.06 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.445 -1.687 . . . . 61.45 106.445 171.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.7 t -88.15 102.92 13.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 114.332 -1.304 . . . . 63.14 110.392 -173.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -78.12 115.66 18.01 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.682 -1.145 . . . . 63.5 109.181 172.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 128' ' ' LEU . 3.6 tt -96.89 107.49 20.0 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 106.504 -1.665 . . . . 73.02 106.504 176.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -104.94 147.19 28.05 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.407 1.083 . . . . 72.13 108.739 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.761 HD11 HG21 ' A' ' 131' ' ' VAL . 87.5 mt -133.58 138.9 46.25 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.198 0.599 . . . . 51.23 110.891 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.561 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 24.2 t70 -136.62 144.82 44.27 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.105 1.362 . . . . 53.41 107.847 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.9 m -139.11 126.83 21.97 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.808 0.443 . . . . 72.13 110.354 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.2 127.01 32.85 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.867 0.867 . . . . 73.4 109.931 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.7 m -112.73 161.42 16.89 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.486 0.66 . . . . 62.32 111.185 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 90.0 p -149.12 162.12 40.6 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.344 1.458 . . . . 73.23 107.654 175.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -113.46 107.45 15.85 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.806 -0.812 . . . . 71.11 108.806 169.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.3 mt -79.4 -29.3 41.94 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.7 -0.682 . . . . 65.25 111.523 -175.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.67 -172.47 3.12 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.128 0.571 . . . . 74.04 111.352 -177.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -61.47 112.5 2.22 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.992 0.917 . . . . 45.23 109.751 174.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 69.89 2.0 3.69 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.955 1.702 . . . . 75.31 112.703 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.68 108.11 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.661 -0.65 . . . . 72.34 109.645 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -114.49 126.24 54.72 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.609 1.164 . . . . 75.22 108.31 177.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -91.71 139.9 30.23 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 108.46 -0.941 . . . . 72.45 108.46 171.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.446 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 98.1 t -123.5 139.64 49.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.196 -1.039 . . . . 71.45 108.196 170.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.449 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 50.3 t -120.04 132.64 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.424 -0.954 . . . . 43.23 108.424 174.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.667 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -111.94 104.5 12.78 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.751 -1.574 . . . . 72.01 106.751 170.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.561 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 13.3 ttp180 -94.28 100.49 12.53 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.443 -1.317 . . . . 63.23 107.443 176.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 36.0 t -93.72 123.99 46.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.663 -1.236 . . . . 63.41 107.663 177.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 m -118.68 115.72 25.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.829 0.823 . . . . 71.31 109.448 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.604 HG11 HD21 ' A' ' 126' ' ' LEU . 91.8 t -104.2 128.92 57.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 C-N-CA 124.866 1.266 . . . . 73.15 108.98 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.1 m -125.4 128.56 48.3 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 108.586 -0.894 . . . . 73.11 108.586 171.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.12 129.28 55.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.818 -1.178 . . . . 70.25 107.818 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.7 m -135.57 139.08 43.61 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.595 0.712 . . . . 74.22 110.655 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.442 HD22 ' H ' ' A' ' 37' ' ' GLN . 59.4 mt -95.86 62.63 2.28 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.373 1.869 . . . . 64.21 108.701 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.11 -84.63 0.92 Allowed Glycine 0 CA--C 1.529 0.955 0 CA-C-N 115.806 -0.634 . . . . 21.52 112.275 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.35 -26.79 11.84 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.542 0.737 . . . . 60.12 111.737 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.494 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 2.9 tp10 -95.66 112.86 24.49 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.702 0.801 . . . . 72.41 109.641 -174.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.9 m -67.96 129.97 41.53 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.933 0.788 . . . . 72.35 110.124 176.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.775 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -76.78 -60.64 2.27 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.34 -0.846 . . . . 72.43 109.173 177.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.415 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 51.9 p90 -159.09 170.45 21.99 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.48 -0.782 . . . . 72.31 111.489 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.4 tp -140.75 113.32 8.1 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.885 1.274 . . . . 74.05 108.457 176.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.541 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 58.9 m -105.63 141.66 36.7 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.181 0.993 . . . . 70.31 108.85 176.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -148.3 116.75 6.56 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.449 -0.575 . . . . 70.33 109.449 173.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.5 t -127.05 112.82 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.713 0.805 . . . . 43.53 109.38 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -84.82 83.36 8.07 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.181 -1.044 . . . . 73.43 108.181 170.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -76.17 92.17 3.22 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.191 -1.04 . . . . 74.44 108.191 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.93 164.91 41.27 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.777 -0.929 . . . . 70.31 110.777 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.25 122.01 1.06 Allowed Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.132 -1.187 . . . . 54.31 110.132 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.443 HG13 ' HE1' ' A' ' 17' ' ' TYR . 57.0 mt -81.13 125.92 39.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 107.654 -1.239 . . . . 54.31 107.654 171.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.573 ' HB3' HD11 ' A' ' 86' ' ' ILE . 87.7 m-85 -127.25 136.92 52.65 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.518 0.727 . . . . 72.34 109.285 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.5 p -100.38 90.98 4.5 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.695 0.798 . . . . 61.51 109.023 174.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.573 HD11 ' HB3' ' A' ' 84' ' ' PHE . 14.7 mm -111.12 147.45 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 114.859 -1.064 . . . . 75.21 110.638 -173.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.85 167.38 18.82 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.581 0.352 . . . . 61.21 111.754 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.96 1.67 88.72 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 115.145 0.818 . . . . 75.21 115.145 172.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.2 172.13 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.642 0.777 . . . . 73.54 110.179 177.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 0.6 OUTLIER -160.64 177.78 10.15 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.25 -0.886 . . . . 74.53 109.607 176.231 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.9 -116.36 8.61 Favored Glycine 0 C--N 1.351 1.391 0 O-C-N 123.793 0.683 . . . . 75.11 113.786 172.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.4 p -64.2 -41.15 97.19 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.762 1.225 . . . . 72.24 111.528 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -74.38 -36.87 63.56 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.045 0.538 . . . . 65.53 111.323 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.478 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 4.8 tpt -68.16 -45.92 72.2 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.55 -0.537 . . . . 71.52 109.55 177.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.88 -32.18 73.38 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.181 -0.918 . . . . 74.34 110.781 176.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -73.69 -38.04 65.02 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.105 0.562 . . . . 63.31 110.342 176.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.412 ' SG ' HG21 ' A' ' 86' ' ' ILE . 50.8 t -67.92 -39.31 83.56 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.619 -0.511 . . . . 63.34 109.619 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 78.8 mt -85.68 -28.1 24.92 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.679 0.792 . . . . 73.0 111.975 -177.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -114.7 4.48 22.88 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 114.508 0.563 . . . . 72.31 114.508 -170.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -143.31 -62.19 0.41 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 117.72 0.76 . . . . 65.11 110.958 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -62.84 -57.78 9.68 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.961 0.904 . . . . 71.44 111.593 -173.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 82.6 m -64.43 -46.78 78.12 Favored Pre-proline 0 CA--C 1.558 1.269 0 CA-C-O 117.895 -1.05 . . . . 73.35 113.102 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.7 -20.25 59.43 Favored 'Trans proline' 0 C--N 1.396 3.059 0 CA-C-N 121.446 1.552 . . . . 61.35 112.896 174.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -76.58 -32.32 58.05 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.952 0.501 . . . . 53.25 109.883 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.471 HG21 ' CD1' ' A' ' 13' ' ' ILE . 46.2 mm -67.0 -45.19 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.445 0.698 . . . . 74.34 109.7 169.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 59.1 mt -73.14 -22.97 60.41 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.788 -1.096 . . . . 60.52 111.946 -174.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -65.3 -44.49 68.55 Favored Pre-proline 0 N--CA 1.481 1.076 0 CA-C-O 117.296 -1.335 . . . . 75.3 113.78 -172.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 77.8 Cg_exo -54.33 -36.69 87.75 Favored 'Trans proline' 0 C--N 1.387 2.553 0 CA-C-N 121.96 1.736 . . . . 71.1 113.383 171.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -76.49 -39.2 53.83 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.187 0.595 . . . . 73.41 111.5 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.97 -47.07 75.79 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.519 0.728 . . . . 73.4 109.346 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -51.44 -52.66 44.4 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 125.546 1.538 . . . . 74.55 110.016 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -61.93 -47.74 83.57 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.554 1.159 . . . . 72.42 111.853 -175.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.516 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 49.9 t -55.91 -45.16 78.77 Favored 'General case' 0 C--N 1.351 0.631 0 O-C-N 124.498 1.124 . . . . 54.32 110.242 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.508 HG21 HG21 ' A' ' 64' ' ' VAL . 84.2 mt -62.35 -53.14 51.39 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 CA-C-N 114.844 -1.071 . . . . 74.31 110.804 175.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 38.5 m -57.73 -37.35 73.43 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.263 1.025 . . . . 62.42 110.964 -173.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.6 t -69.26 -46.24 67.76 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.766 -1.106 . . . . 72.31 109.818 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.505 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 9.0 mtp -58.84 -37.31 76.17 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.796 0.839 . . . . 64.44 111.837 176.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 114' ' ' ILE . 74.2 t -67.27 -45.61 85.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 124.183 0.993 . . . . 62.31 110.284 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 94.2 p -73.63 -28.04 61.58 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 116.248 -0.433 . . . . 72.14 110.772 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -70.38 -33.97 72.03 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.698 0.799 . . . . 74.14 109.376 172.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 122' ' ' THR . . . -81.99 8.13 61.17 Favored Glycine 0 C--N 1.353 1.502 0 CA-C-N 115.095 -0.957 . . . . 71.04 112.767 172.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.4 t 65.14 11.47 7.2 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 127.42 2.288 . . . . 54.41 113.888 171.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -79.38 143.81 60.68 Favored Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 108.962 -0.755 . . . . 65.5 108.962 177.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -48.05 143.54 13.8 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.372 2.715 . . . . 55.24 113.285 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -53.13 116.09 2.21 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.835 1.254 . . . . 73.32 113.283 -165.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.604 HD21 HG11 ' A' ' 64' ' ' VAL . 55.6 tp -110.71 96.06 5.94 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.159 0.584 . . . . 75.02 109.625 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.646 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 1.0 OUTLIER -100.31 113.51 26.28 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 106.287 -1.745 . . . . 73.32 106.287 175.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.442 ' HB3' HD11 ' A' ' 42' ' ' LEU . 16.2 mt -65.65 130.57 43.74 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 123.553 0.533 . . . . 61.3 109.751 -174.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.73 139.11 97.56 Favored Pre-proline 0 CA--C 1.554 1.128 0 CA-C-O 118.767 -0.635 . . . . 60.1 110.755 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.593 ' HD2' HE21 ' C' ' 12' ' ' GLN . 75.6 Cg_exo -50.31 140.51 34.06 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 123.617 2.878 . . . . 63.45 113.686 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.761 HG21 HD11 ' A' ' 44' ' ' LEU . 70.9 t -115.6 132.34 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 122.95 0.5 . . . . 75.11 110.082 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -93.06 79.77 4.56 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.201 -1.037 . . . . 70.22 108.201 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.454 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 84.8 m-85 -58.42 -25.0 61.66 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.977 0.911 . . . . 75.14 111.791 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -67.97 -49.67 60.3 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.223 1.009 . . . . 65.31 110.594 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.57 92.66 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.076 0.86 . . . . 71.44 110.194 177.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 88.7 mt -62.46 -36.62 83.02 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 114.727 -1.124 . . . . 64.0 111.312 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.1 t80 . . . . . 0 C--O 1.216 -0.67 0 O-C-N 123.789 0.681 . . . . 71.12 110.109 177.042 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.531 ' HG3' HG13 ' B' ' 89' ' ' ILE . 26.9 ttt . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 121.698 0.761 . . . . 60.42 112.148 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.8 m -140.84 125.69 18.14 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.936 -1.135 . . . . 62.14 107.936 167.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -136.18 142.07 44.1 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.705 0.802 . . . . 70.31 108.975 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -156.11 141.44 17.56 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 109.124 -0.695 . . . . 73.24 109.124 170.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.475 HD11 HD13 ' B' ' 105' ' ' ILE . 61.6 mt -80.77 134.23 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.033 -1.099 . . . . 55.12 108.033 175.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -99.98 -50.61 3.94 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.591 0.357 . . . . 70.32 110.224 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.434 ' HE ' HG21 ' A' ' 122' ' ' THR . 46.2 ttt180 -167.47 129.72 1.62 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.255 -0.646 . . . . 72.25 109.255 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.488 HG21 ' CD1' ' B' ' 109' ' ' TYR . 86.8 mt -115.32 149.6 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 108.539 -0.912 . . . . 74.3 108.539 175.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -167.41 162.85 14.88 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.63 0.728 . . . . 71.1 111.492 -173.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.443 ' H ' ' HA2' ' A' ' 121' ' ' GLY . 55.4 m -90.19 124.29 34.72 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 114.342 -1.299 . . . . 75.35 108.307 170.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -85.96 -45.56 11.37 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.944 0.898 . . . . 72.5 110.343 172.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.437 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 24.4 t70 -144.64 142.76 30.36 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.519 -0.309 . . . . 61.04 110.91 -167.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 46.4 mm -136.25 142.76 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.628 1.171 . . . . 72.1 109.116 177.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 29.4 m -138.17 135.37 35.6 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.102 1.361 . . . . 75.22 108.029 168.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 80.9 t80 -142.12 108.42 5.27 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 105.659 -1.978 . . . . 63.35 105.659 164.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -118.95 112.18 19.28 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.315 -0.994 . . . . 73.5 108.315 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.446 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -109.01 87.08 4.34 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 107.029 -1.471 . . . . 72.24 107.029 171.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.91 -26.63 21.93 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 122.24 1.96 . . . . 72.25 111.911 -172.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.556 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 75.2 m-20 -107.99 14.62 25.09 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.537 1.135 . . . . 64.52 110.453 -176.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.513 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -43.98 -55.27 9.58 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 125.339 1.456 . . . . 61.25 114.832 -167.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -55.46 -44.68 46.21 Favored 'Trans proline' 0 C--N 1.4 3.239 0 C-N-CA 122.054 1.836 . . . . 61.44 113.348 -175.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -98.03 -16.79 19.48 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.899 1.074 . . . . 75.12 113.899 -171.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.404 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.5 p -76.1 -8.72 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-N 118.811 0.732 . . . . 75.4 112.05 -172.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -80.45 -1.62 42.37 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.897 0.479 . . . . 74.13 112.187 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -64.01 -25.19 68.01 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.086 0.554 . . . . 55.32 110.304 166.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.605 ' HB2' HD13 ' B' ' 68' ' ' LEU . 31.1 mmtp -90.96 107.94 19.53 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.988 1.315 . . . . 52.4 108.979 -178.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -115.89 86.09 2.41 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.384 0.611 . . . . 72.23 110.806 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 37.4 p90 -163.97 160.51 21.99 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.325 1.45 . . . . 72.2 107.78 171.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -62.75 116.18 22.1 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 108.376 -0.972 . . . . 73.42 108.376 172.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.01 157.54 58.91 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.042 1.828 . . . . 72.3 111.665 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -69.13 115.32 8.28 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 108.233 -1.025 . . . . 62.32 108.233 172.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.57 HG13 HG13 ' B' ' 64' ' ' VAL . 60.8 t -106.21 129.45 59.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 O-C-N 124.146 0.904 . . . . 62.12 110.602 -173.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.487 ' HE3' ' HB2' ' B' ' 43' ' ' ASP . 18.7 ttpt -106.48 120.5 42.08 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.509 -0.923 . . . . 70.54 108.509 168.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 16.1 tp -88.03 134.16 33.8 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.585 -0.894 . . . . 71.42 108.585 173.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 9.4 t0 -134.66 112.11 10.54 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.094 -1.076 . . . . 72.04 108.094 -172.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.433 HD11 HG11 ' B' ' 131' ' ' VAL . 78.4 mt -107.35 150.88 26.23 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.094 0.558 . . . . 71.2 110.306 -173.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.2 t70 -151.66 139.27 19.67 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.607 0.763 . . . . 63.14 109.686 -173.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 4.7 t -114.55 103.66 11.24 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-O 121.694 0.759 . . . . 73.13 109.68 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.28 118.67 30.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.555 -0.906 . . . . 73.43 108.555 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 54.0 p -145.77 172.35 13.43 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 122.086 -0.383 . . . . 61.13 111.563 -175.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 24.4 p -159.62 137.39 10.03 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.684 0.793 . . . . 74.23 110.702 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . 0.48 ' HB2' ' CE2' ' B' ' 56' ' ' TYR . 58.8 tt0 -84.98 105.71 15.95 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 108.566 -0.901 . . . . 61.42 108.566 170.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 pp -123.72 14.12 9.35 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.1 -0.954 . . . . 74.04 110.161 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.67 142.98 12.73 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.6 -1.182 . . . . 71.32 108.571 -176.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -75.99 117.25 17.51 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.642 0.777 . . . . 73.44 109.982 -172.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 66.12 5.21 3.45 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 125.566 1.547 . . . . 75.12 112.758 -176.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.9 t -125.07 96.64 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.422 -1.325 . . . . 65.13 107.422 -175.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.48 ' CE2' ' HB2' ' B' ' 50' ' ' GLN . 1.8 t80 -94.27 140.24 30.03 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.97 -0.752 . . . . 75.54 108.97 -172.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -106.47 105.09 14.96 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.524 -1.287 . . . . 70.41 107.524 -177.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -103.11 129.08 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.331 1.052 . . . . 73.1 109.718 -174.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.405 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 16.3 t -115.84 112.44 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.762 -0.829 . . . . 75.33 108.762 176.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -94.18 110.31 22.04 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.751 -1.203 . . . . 74.04 107.751 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.535 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 7.1 tmm_? -91.19 124.67 35.58 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.758 -0.83 . . . . 72.54 108.758 176.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 19.3 t -111.63 135.35 51.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.66 -1.237 . . . . 72.53 107.66 173.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 22.9 m -128.64 128.52 44.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.81 0.814 . . . . 72.13 109.274 171.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.57 HG13 HG13 ' B' ' 40' ' ' VAL . 79.6 t -107.09 114.84 47.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 114.09 -1.414 . . . . 44.33 108.584 172.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 88.6 m -96.03 135.93 37.16 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.017 -1.105 . . . . 73.41 108.017 165.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.35 141.82 25.35 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.207 -0.664 . . . . 63.14 109.207 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.572 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 18.5 p -143.61 134.87 25.85 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.646 -0.707 . . . . 65.04 111.207 -172.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.605 HD13 ' HB2' ' B' ' 34' ' ' LYS . 85.2 mt -106.88 104.01 13.59 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.925 1.29 . . . . 72.11 110.733 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.44 -125.08 7.15 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-O 120.118 -0.268 . . . . 73.4 112.781 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -91.01 3.54 54.44 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.456 0.703 . . . . 64.43 111.77 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.556 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 13.1 pt-20 -135.2 146.68 48.92 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.066 0.546 . . . . 74.33 110.945 -170.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 49.1 m -71.91 130.54 41.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.843 -0.617 . . . . 73.33 110.842 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.572 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -79.33 -65.48 0.99 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.881 -1.054 . . . . 70.01 108.306 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -151.18 152.02 32.73 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.221 -0.899 . . . . 75.52 111.459 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 78.4 mt -118.99 109.39 15.89 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 105.928 -1.878 . . . . 52.23 105.928 168.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.6 t -117.29 135.43 53.83 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.877 -1.156 . . . . 62.23 107.877 -178.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.416 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 38.1 tt0 -149.5 135.96 19.23 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.725 -0.843 . . . . 73.22 108.725 -172.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.416 HG21 ' HB3' ' B' ' 113' ' ' CYS . 58.0 t -131.16 143.2 41.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.845 -0.798 . . . . 63.22 108.845 175.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -116.56 96.69 5.62 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.811 -1.181 . . . . 74.31 107.811 171.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 7.6 tp-100 -90.89 100.02 12.95 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.95 -0.759 . . . . 60.13 108.95 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.74 142.26 16.15 Favored Glycine 0 C--N 1.344 1.027 0 O-C-N 123.624 0.578 . . . . 74.23 111.705 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.45 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -142.67 125.93 2.75 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.643 -0.583 . . . . 71.44 111.643 -176.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 40.8 mt -84.93 115.73 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 107.517 -1.29 . . . . 63.13 107.517 171.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -128.93 146.26 51.0 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.583 0.753 . . . . 65.43 109.913 -177.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 44.4 m -94.0 110.09 21.8 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.374 0.67 . . . . 64.22 109.36 172.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 4.7 mp -112.91 111.42 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 108.154 -1.054 . . . . 75.52 108.154 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.51 169.24 24.73 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.11 0.564 . . . . 72.31 111.325 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.12 -67.63 0.85 Allowed Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.525 -0.63 . . . . 65.04 111.525 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.531 HG13 ' HG3' ' B' ' 9' ' ' MET . 0.9 OUTLIER -52.69 159.05 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 124.338 1.055 . . . . 65.35 111.759 168.333 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -151.46 145.77 25.45 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 112.624 0.602 . . . . 75.35 112.624 -171.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . 0.442 ' O ' ' HG2' ' B' ' 94' ' ' MET . . . 70.09 -111.88 4.06 Favored Glycine 0 C--N 1.358 1.781 0 CA-C-N 115.453 -0.794 . . . . 70.31 113.985 173.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 8.9 m -73.44 -38.03 65.64 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 122.081 0.943 . . . . 70.44 109.625 177.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -69.63 -27.73 65.31 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 113.404 -1.725 . . . . 74.23 110.903 -170.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' B' ' 91' ' ' GLY . 25.1 ptt? -81.45 -43.91 18.2 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.345 0.658 . . . . 63.34 112.687 -173.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.3 -11.29 59.94 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.598 0.759 . . . . 62.21 112.19 -173.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -61.25 -35.31 76.91 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.505 0.322 . . . . 74.43 110.259 165.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.3 t -61.34 -61.09 2.79 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.812 0.445 . . . . 62.55 111.282 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.56 -15.82 62.29 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 113.004 0.742 . . . . 74.21 113.004 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.31 -2.45 59.02 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.689 -0.506 . . . . 71.14 113.532 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.83 -59.87 0.18 Allowed 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.405 0.603 . . . . 54.4 111.881 -174.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -67.61 -48.25 67.34 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.077 0.951 . . . . 63.34 111.784 -173.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.523 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 63.6 m -65.0 -48.69 70.78 Favored Pre-proline 0 CA--C 1.563 1.47 0 C-N-CA 123.802 0.841 . . . . 73.32 111.509 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.523 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 74.6 Cg_exo -57.33 -29.49 84.32 Favored 'Trans proline' 0 C--N 1.4 3.26 0 C-N-CA 122.731 2.287 . . . . 75.24 113.991 170.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -67.7 -30.35 69.84 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.032 0.933 . . . . 65.1 110.682 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.475 HD13 HD11 ' B' ' 13' ' ' ILE . 62.2 mt -76.04 -41.29 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.466 0.706 . . . . 72.42 110.135 175.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.45 HD21 ' HA3' ' B' ' 82' ' ' GLY . 80.9 mt -71.86 -34.22 69.04 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.801 -1.091 . . . . 75.14 111.912 -175.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -59.49 -47.62 97.47 Favored Pre-proline 0 CA--C 1.56 1.327 0 CA-C-O 117.513 -1.232 . . . . 73.25 113.167 -170.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -56.2 -36.72 96.99 Favored 'Trans proline' 0 C--N 1.392 2.849 0 C-N-CA 122.363 2.042 . . . . 75.3 113.229 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.488 ' CD1' HG21 ' B' ' 16' ' ' ILE . 4.0 m-30 -70.68 -42.62 70.48 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.526 0.731 . . . . 61.54 109.978 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -66.76 -36.53 82.64 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.009 -0.996 . . . . 71.14 110.91 176.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.473 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 50.4 ttt-85 -64.36 -48.91 73.69 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.231 1.413 . . . . 75.31 110.749 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -70.07 -31.62 69.32 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.549 0.739 . . . . 44.11 109.768 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.511 ' O ' ' HG2' ' B' ' 117' ' ' MET . 11.5 t -67.29 -38.64 85.34 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 123.017 0.527 . . . . 75.02 110.515 177.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.454 HD13 HG23 ' B' ' 64' ' ' VAL . 63.5 mt -63.36 -55.71 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.971 0.908 . . . . 70.04 110.141 174.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.425 HG21 ' OG ' ' C' ' 119' ' ' SER . 24.2 m -60.97 -30.41 70.23 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 124.136 0.898 . . . . 64.02 111.268 -175.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 29.8 t -60.49 -52.29 65.83 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.469 0.708 . . . . 74.15 109.235 173.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.511 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.6 mmt -65.85 -35.82 81.72 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.28 0.632 . . . . 73.42 111.414 -175.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.6 t -63.75 -44.59 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 124.144 0.978 . . . . 52.24 110.655 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.3 t -67.55 -32.59 73.46 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.713 -1.13 . . . . 75.15 111.294 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.516 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 77.3 mtt-85 -66.55 -43.46 85.01 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.572 -0.74 . . . . 71.43 109.507 175.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.68 -7.79 66.05 Favored Glycine 0 C--N 1.352 1.444 0 O-C-N 123.801 0.688 . . . . 74.44 113.259 175.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.637 HG23 HD22 ' C' ' 127' ' ' ASN . 7.4 m 63.94 29.98 14.33 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.897 1.279 . . . . 71.51 110.662 177.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.408 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 37.0 m-85 -83.14 159.47 62.33 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.138 0.975 . . . . 74.15 111.062 176.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -48.76 149.12 7.87 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.489 2.793 . . . . 34.04 114.65 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.478 HE21 ' ND2' ' B' ' 127' ' ' ASN . 65.9 tp60 -59.49 114.34 2.65 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 124.382 1.051 . . . . 73.33 111.613 -171.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.465 HD21 HG11 ' B' ' 64' ' ' VAL . 21.2 tp -111.66 102.07 10.41 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.891 0.876 . . . . 75.01 109.88 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.478 ' ND2' HE21 ' B' ' 125' ' ' GLN . 58.2 m-80 -107.58 119.01 38.24 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 107.793 -1.188 . . . . 72.41 107.793 167.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.473 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 42.1 mt -69.01 148.54 49.95 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 123.159 0.287 . . . . 75.31 110.711 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.36 147.5 97.08 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.429 0.692 . . . . 64.12 110.589 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.12 92.49 0.1 Allowed 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.505 2.137 . . . . 74.42 112.111 173.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.433 HG11 HD11 ' B' ' 44' ' ' LEU . 69.7 t -90.17 110.83 22.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 109.321 -0.622 . . . . 72.14 109.321 177.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 108.34 -0.985 . . . . 65.01 108.34 176.477 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.412 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 55.7 t80 . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 108.713 -0.847 . . . . 75.14 108.713 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . 0.593 HE21 ' HD2' ' A' ' 130' ' ' PRO . 1.3 tp60 -157.91 144.23 17.55 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.3 0.375 . . . . 75.24 110.54 168.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 57.2 mt -82.65 135.07 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 115.467 -0.788 . . . . 64.2 109.384 175.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -98.92 -46.47 5.61 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.475 0.71 . . . . 65.13 109.706 172.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.646 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -170.69 146.16 2.61 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.603 0.761 . . . . 74.31 110.746 174.037 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 36.3 mm -115.64 139.23 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 106.467 -1.679 . . . . 70.41 106.467 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.532 ' HB3' HG23 ' D' ' 122' ' ' THR . 19.3 p90 -169.45 157.78 7.53 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.896 0.855 . . . . 72.2 111.987 -171.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.6 p -82.9 102.87 11.96 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.222 -1.354 . . . . 74.43 109.422 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.642 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 11.2 mmmm -65.14 -34.36 78.21 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.381 0.61 . . . . 74.01 109.392 171.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.593 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.5 t70 -153.4 145.7 23.93 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.63 -1.168 . . . . 74.42 109.24 -175.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.525 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.5 mt -140.85 145.77 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.615 1.566 . . . . 52.54 107.098 176.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.6 t -156.27 150.57 25.5 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.179 0.514 . . . . 61.13 110.266 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -149.37 131.74 15.62 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.168 -1.419 . . . . 74.1 107.168 174.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -133.92 111.8 10.74 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.108 -0.701 . . . . 72.33 109.108 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.66 82.14 67.45 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 107.657 -1.238 . . . . 70.32 107.657 170.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.84 -44.97 18.37 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.552 2.168 . . . . 71.54 111.276 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -92.89 21.06 5.96 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.472 -1.24 . . . . 75.4 111.082 -176.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.423 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -46.62 -58.3 7.07 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 124.226 1.01 . . . . 62.31 113.471 -172.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -60.94 -38.95 65.11 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 121.679 1.586 . . . . 63.31 112.44 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -69.24 -39.38 78.55 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.348 -0.842 . . . . 73.54 111.419 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.71 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.5 p -78.46 -17.29 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 C-N-CA 123.009 0.524 . . . . 62.21 112.308 -171.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -70.81 -15.54 62.66 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 112.194 0.442 . . . . 74.53 112.194 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -109.17 19.68 19.19 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.13 0.572 . . . . 72.55 111.09 174.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.85 158.7 15.72 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.385 0.674 . . . . 71.14 109.757 173.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.56 125.33 23.91 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.34 0.656 . . . . 52.3 109.377 167.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 62.3 t-105 -85.37 80.25 9.2 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.164 0.586 . . . . 73.53 110.364 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -121.79 76.92 38.56 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 124.368 1.067 . . . . 73.33 108.316 170.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -85.35 119.45 2.03 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 123.553 2.835 . . . . 55.23 112.608 -170.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -87.35 94.62 9.73 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.468 -1.242 . . . . 70.34 108.487 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.02 110.12 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 113.869 -1.514 . . . . 61.11 110.526 -172.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.516 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 18.2 tptm -92.2 105.47 17.68 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.45 -0.945 . . . . 55.51 108.45 169.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 pp -86.9 128.89 35.06 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 106.64 -1.615 . . . . 74.3 106.64 169.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.532 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 16.3 t70 -125.78 105.31 8.87 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 108.897 -0.779 . . . . 75.43 108.897 -172.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 96.1 mt -96.27 130.85 43.26 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.356 0.662 . . . . 64.11 110.521 -174.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -144.58 125.71 14.6 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.731 1.212 . . . . 73.12 107.938 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.1 t -121.86 151.74 40.34 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 109.621 -0.511 . . . . 73.4 109.621 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.93 148.24 31.58 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 124.355 1.062 . . . . 74.23 108.354 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 13.6 m -143.43 143.77 31.75 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.332 -0.618 . . . . 74.52 109.332 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 65.0 p -145.22 136.36 24.88 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.931 0.892 . . . . 73.54 109.34 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -79.07 117.69 20.34 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 109.016 -0.735 . . . . 75.23 109.016 176.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.631 HD11 ' HB2' ' C' ' 57' ' ' GLU . 68.4 mt -84.25 -38.91 19.92 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.483 0.713 . . . . 61.2 110.19 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.22 -169.48 3.06 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.349 -0.841 . . . . 74.03 110.273 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.02 104.27 0.1 Allowed 'General case' 0 N--CA 1.481 1.088 0 O-C-N 124.185 0.928 . . . . 51.5 110.985 176.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 60.25 35.74 20.85 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 124.603 1.19 . . . . 73.15 111.338 174.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.4 t -127.7 119.24 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.867 -1.16 . . . . 72.11 107.867 174.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -123.63 124.13 42.1 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.961 0.905 . . . . 73.43 109.602 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.631 ' HB2' HD11 ' C' ' 51' ' ' LEU . 39.0 tt0 -85.51 132.11 34.25 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.471 -0.937 . . . . 74.35 108.471 167.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 51.5 t -118.82 143.71 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.32 -0.622 . . . . 52.02 109.32 171.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 90.3 t -124.33 140.54 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 C-N-CA 125.226 1.41 . . . . 53.41 108.433 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.403 HD11 ' CZ ' ' C' ' 133' ' ' PHE . 0.0 OUTLIER -121.14 96.96 5.3 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.184 -1.413 . . . . 75.1 107.184 173.833 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -82.2 105.91 13.67 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.465 -0.939 . . . . 74.25 108.465 173.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.415 ' HB ' HD11 ' C' ' 114' ' ' ILE . 28.6 t -105.38 129.01 58.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.769 -1.197 . . . . 75.42 107.769 173.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 69.5 m -116.42 125.06 51.49 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.499 -0.926 . . . . 62.01 108.499 175.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.45 HG21 HG21 ' C' ' 114' ' ' ILE . 68.0 t -103.83 110.25 29.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.2 -0.667 . . . . 70.22 109.2 170.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 7.4 m -96.48 131.97 42.52 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.83 -1.544 . . . . 73.31 106.83 170.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.75 113.39 14.66 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 106.682 -1.599 . . . . 72.23 106.682 -176.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 36.8 m -134.04 126.97 31.28 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-O 121.0 0.429 . . . . 75.24 110.144 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 16.2 mt -85.09 36.9 0.64 Allowed 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 125.829 1.652 . . . . 43.22 110.482 177.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.5 -92.62 1.04 Allowed Glycine 0 C--N 1.358 1.8 0 N-CA-C 111.085 -0.806 . . . . 74.2 111.085 176.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -90.33 -19.61 23.84 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.424 1.09 . . . . 73.14 110.697 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -103.54 124.13 48.21 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 125.335 1.454 . . . . 73.51 109.293 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 83.5 m -78.78 123.94 27.7 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.042 0.837 . . . . 72.4 109.222 167.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.71 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -70.55 -59.03 3.08 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.957 0.786 . . . . 74.51 109.335 174.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -162.54 173.77 13.54 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-O 121.468 0.651 . . . . 64.2 110.953 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.434 HD23 HG23 ' C' ' 65' ' ' THR . 2.7 tm? -138.0 104.16 5.17 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 106.435 -1.691 . . . . 64.34 106.435 175.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 49.3 t -108.21 145.42 34.28 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.26 -1.015 . . . . 71.31 108.26 176.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -154.25 128.79 9.23 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.304 -0.628 . . . . 75.25 109.304 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 69.1 t -126.91 136.2 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.011 0.924 . . . . 74.32 109.025 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.593 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.1 mt-30 -105.03 90.2 3.37 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.165 -1.05 . . . . 62.44 108.165 170.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -80.33 98.85 7.62 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.475 -0.784 . . . . 71.11 109.862 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.47 170.28 48.39 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 116.255 -0.429 . . . . 44.45 112.274 176.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.94 119.75 0.78 Allowed Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.82 -0.912 . . . . 54.51 110.82 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.448 HD12 HD11 ' C' ' 51' ' ' LEU . 36.0 mm -82.02 124.96 39.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.741 -0.837 . . . . 64.01 108.741 176.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -126.7 119.06 26.03 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 124.059 0.849 . . . . 64.24 108.779 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 12.4 p -80.65 99.21 8.04 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.895 -1.15 . . . . 74.55 107.895 172.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.562 HG21 ' HE3' ' C' ' 94' ' ' MET . 20.9 mt -118.14 123.87 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 109.403 -0.591 . . . . 74.55 109.403 -177.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.59 155.22 44.2 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.903 0.705 . . . . 54.32 112.903 -171.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.88 -28.13 6.79 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.13 -0.941 . . . . 50.52 115.14 168.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.643 HD11 ' HE3' ' C' ' 94' ' ' MET . 37.5 pt -96.16 159.04 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-O 121.726 0.774 . . . . 75.14 112.232 -175.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -149.41 -173.08 4.29 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 113.781 -1.554 . . . . 74.45 108.069 171.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.74 -128.22 46.15 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.494 0.496 . . . . 55.43 113.973 171.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 10.2 t -74.08 -32.13 63.12 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.142 0.977 . . . . 61.24 112.571 -174.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -65.88 -52.72 47.77 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.186 0.595 . . . . 75.44 109.987 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.643 ' HE3' HD11 ' C' ' 89' ' ' ILE . 4.6 tpt -54.72 -48.75 72.13 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 124.149 0.905 . . . . 75.31 111.632 173.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.43 -38.14 76.82 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.988 0.805 . . . . 71.12 111.388 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -80.42 -29.58 37.65 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.31 0.644 . . . . 74.41 111.805 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.413 ' SG ' HD13 ' C' ' 86' ' ' ILE . 35.0 t -70.35 -34.79 73.05 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.999 -0.741 . . . . 73.44 108.999 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 69.3 mt -87.36 -28.8 21.99 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.035 1.334 . . . . 62.41 111.123 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.42 -28.07 41.24 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 115.804 -0.635 . . . . 52.22 114.397 -170.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -139.21 -52.33 0.55 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 111.934 0.346 . . . . 63.1 111.934 -169.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -64.73 -53.65 43.81 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 123.293 0.371 . . . . 73.42 110.988 -173.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.412 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 94.9 m -59.23 -49.93 90.24 Favored Pre-proline 0 CA--C 1.564 1.5 0 CA-C-O 118.173 -0.918 . . . . 72.55 111.976 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -53.79 -33.25 69.93 Favored 'Trans proline' 0 C--N 1.397 3.125 0 C-N-CA 122.666 2.244 . . . . 72.35 114.628 171.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -67.1 -32.3 73.37 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 122.86 0.464 . . . . 71.12 110.958 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 44.0 mm -72.87 -40.71 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.041 0.536 . . . . 72.23 109.637 176.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 76.0 mt -78.9 -27.01 43.85 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.144 0.978 . . . . 71.11 112.272 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -56.43 -49.41 93.63 Favored Pre-proline 0 CA--C 1.56 1.328 0 N-CA-C 114.547 1.314 . . . . 71.23 114.547 -173.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -60.84 -38.65 68.54 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 122.022 1.815 . . . . 63.45 112.67 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -67.93 -41.06 83.13 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.451 -0.795 . . . . 72.14 110.119 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.9 -42.69 99.87 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.784 0.834 . . . . 75.11 109.929 175.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -57.76 -55.65 32.16 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.329 1.052 . . . . 72.34 110.377 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -66.07 -30.59 71.13 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.16 0.584 . . . . 75.31 110.426 -174.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.401 ' SG ' HG12 ' C' ' 21' ' ' ILE . 21.4 t -72.54 -33.89 67.15 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 122.94 0.496 . . . . 74.01 111.453 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.45 HG21 HG21 ' C' ' 64' ' ' VAL . 96.3 mt -75.15 -49.58 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 123.554 0.742 . . . . 74.34 110.144 175.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 13.5 m -67.14 -28.95 68.56 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.249 1.02 . . . . 71.14 110.819 -175.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 27.2 t -63.07 -50.07 72.05 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 108.612 -0.884 . . . . 71.53 108.612 170.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.534 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.52 -35.44 77.72 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.585 1.154 . . . . 73.33 112.602 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 93.3 t -63.36 -47.01 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.61 0.764 . . . . 63.3 109.706 173.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.425 ' OG ' HG21 ' B' ' 115' ' ' THR . 46.5 t -68.53 -28.94 67.43 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.813 -1.085 . . . . 63.42 111.506 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' C' ' 116' ' ' SER . 86.5 mtt-85 -72.06 -42.45 66.22 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.031 -0.729 . . . . 72.33 109.031 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.65 -0.82 60.04 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 115.588 -0.733 . . . . 70.03 112.686 170.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.8 p 61.59 32.68 18.57 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.493 1.917 . . . . 73.52 113.375 171.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -83.34 155.19 66.53 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 108.638 -0.875 . . . . 73.14 108.638 170.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -50.63 159.42 2.23 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.994 2.462 . . . . 71.34 113.947 171.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' B' ' 123' ' ' PHE . 2.9 mm-40 -51.01 138.79 18.82 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.815 1.246 . . . . 74.41 112.292 -176.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 50.7 tp -149.1 86.2 1.49 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.123 -0.695 . . . . 42.34 109.123 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . 0.637 HD22 HG23 ' B' ' 122' ' ' THR . 83.6 m-20 -91.64 123.29 34.93 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.219 -0.9 . . . . 74.11 108.707 175.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.08 119.81 15.74 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.403 -0.962 . . . . 75.43 108.403 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.29 143.57 95.45 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 123.768 0.827 . . . . 75.14 110.923 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -51.71 98.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.128 2.552 . . . . 62.42 113.014 174.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 60.2 t -98.29 111.7 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.489 -1.301 . . . . 74.12 107.489 173.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -74.03 102.82 4.3 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.048 0.539 . . . . 52.24 110.566 -174.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . 0.403 ' CZ ' HD11 ' C' ' 60' ' ' LEU . 81.0 m-85 -62.18 -25.26 67.68 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.841 0.856 . . . . 74.12 111.454 176.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . 0.454 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 23.9 t70 -62.17 -49.96 73.71 Favored 'General case' 0 C--N 1.347 0.485 0 O-C-N 123.881 0.738 . . . . 62.15 109.713 177.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.16 -43.05 92.09 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 124.176 0.922 . . . . 43.54 111.654 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 79.7 mt -64.28 -39.89 94.85 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.953 -1.021 . . . . 73.54 111.428 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 27.3 t80 . . . . . 0 CA--C 1.543 0.689 0 CA-C-N 116.256 -0.429 . . . . 74.54 111.468 -177.954 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 109.806 -0.442 . . . . 64.42 109.806 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.404 ' HD2' HG22 ' D' ' 86' ' ' ILE . 82.0 t80 -142.67 102.34 4.03 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.078 -1.082 . . . . 73.41 108.078 176.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -119.55 126.29 50.87 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.46 0.704 . . . . 74.14 109.465 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mt -91.79 137.89 21.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 123.657 0.783 . . . . 54.11 109.203 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . 0.406 ' NE2' HG22 ' D' ' 83' ' ' ILE . 51.2 mt-30 -110.92 -44.41 3.62 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.191 0.596 . . . . 55.51 111.678 -176.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -169.03 122.98 0.82 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.822 -0.172 . . . . 64.11 110.566 -168.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.1 mp -103.82 137.17 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 107.287 -1.375 . . . . 73.14 107.287 166.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -158.33 146.62 18.62 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.228 0.611 . . . . 73.44 110.804 174.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -76.88 114.53 15.75 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.398 -0.819 . . . . 61.02 109.034 173.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -81.12 -21.13 40.09 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.586 -0.733 . . . . 53.12 109.896 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 7.3 t70 -162.12 142.67 10.29 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.941 1.297 . . . . 71.31 109.225 -176.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.534 HG21 ' HE2' ' C' ' 117' ' ' MET . 79.5 mt -142.94 148.73 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 124.889 1.276 . . . . 73.12 108.549 176.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.3 t -150.28 145.3 26.1 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.052 1.341 . . . . 51.13 108.352 172.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.525 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.5 t80 -151.69 136.18 16.92 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.497 -1.668 . . . . 75.33 106.497 171.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.508 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 48.0 mt-10 -138.97 148.55 43.64 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.335 0.654 . . . . 74.33 109.819 -176.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.68 78.43 9.1 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 107.718 -1.216 . . . . 74.22 107.718 175.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.6 -31.31 8.86 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.514 2.142 . . . . 74.52 112.827 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -94.46 -1.48 53.48 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.368 0.667 . . . . 71.31 111.096 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.642 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -24.55 -66.96 0.07 OUTLIER Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 126.841 2.057 . . . . 71.24 116.356 -164.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.71 -20.7 11.83 Favored 'Trans proline' 0 C--N 1.385 2.472 0 CA-C-N 123.046 2.124 . . . . 55.32 113.92 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.505 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 3.9 t-160 -73.25 -39.24 65.61 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.055 0.942 . . . . 75.43 109.365 174.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.517 HG22 HD12 ' D' ' 68' ' ' LEU . 5.6 p -83.57 -24.12 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 CA-C-N 115.627 -0.715 . . . . 60.41 111.14 -172.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -63.83 -29.31 70.52 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.085 0.469 . . . . 75.14 111.207 176.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.505 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 69.5 mt-30 -56.87 -29.3 62.81 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.547 -1.206 . . . . 71.22 110.493 176.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -84.42 71.48 10.7 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.731 1.212 . . . . 74.31 109.498 169.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -76.85 92.92 3.66 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.185 -0.916 . . . . 71.22 109.676 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -164.91 -165.82 0.96 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.128 0.971 . . . . 73.31 109.964 173.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -77.68 115.02 46.43 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.471 1.108 . . . . 73.12 110.965 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.73 130.45 26.3 Favored 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 122.649 2.233 . . . . 71.31 111.203 173.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 30.0 mm-40 -67.52 109.6 3.3 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 108.122 -1.066 . . . . 63.44 108.122 171.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.66 HG13 HG13 ' D' ' 64' ' ' VAL . 45.7 t -99.16 128.07 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.774 -0.824 . . . . 75.33 108.774 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.02 127.87 48.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.605 -1.628 . . . . 63.32 106.605 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.613 HD11 HG13 ' D' ' 62' ' ' VAL . 55.4 tp -95.82 145.64 25.19 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.533 0.733 . . . . 72.41 110.522 -173.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.512 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 10.1 t70 -142.47 111.9 6.65 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 106.486 -1.672 . . . . 71.25 106.486 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 79.1 mt -109.71 145.27 36.86 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.256 0.55 . . . . 55.45 110.87 -174.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.701 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.0 t70 -137.33 149.88 47.35 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.71 1.204 . . . . 71.32 108.378 177.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 30.2 m -120.92 144.16 48.59 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.82 -0.807 . . . . 60.43 108.82 173.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.546 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -147.23 170.31 17.51 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.931 1.292 . . . . 24.33 107.653 -177.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.469 0.478 0 C-N-CA 122.692 0.397 . . . . 60.14 110.7 -172.139 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' D' ' 85' ' ' SER . 68.0 m-20 . . . . . 0 N--CA 1.498 1.952 0 N-CA-C 114.74 1.385 . . . . 62.24 114.74 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 40.4 t -135.62 96.04 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 119.316 0.962 . . . . 62.52 108.557 -173.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -152.51 161.27 42.81 Favored 'General case' 0 C--O 1.247 0.921 0 CA-C-N 114.299 -1.319 . . . . 61.52 108.649 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.545 ' HG2' HG12 ' D' ' 83' ' ' ILE . 36.1 mt-10 -89.77 143.74 26.55 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 114.934 -1.03 . . . . 74.2 110.323 177.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.431 HG11 ' HD3' ' D' ' 103' ' ' PRO . 91.6 t -116.75 139.67 42.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 113.251 -1.795 . . . . 52.33 106.902 167.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 41.5 t -129.22 129.87 67.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.426 -0.953 . . . . 74.15 108.426 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.537 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -110.95 120.64 43.07 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.251 -1.389 . . . . 73.22 107.251 173.849 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.701 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 7.3 ttm180 -102.03 100.88 11.19 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.091 -1.077 . . . . 75.52 108.091 175.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.613 HG13 HD11 ' D' ' 42' ' ' LEU . 49.0 t -92.12 122.84 43.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.299 -1.0 . . . . 64.54 108.299 173.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 17.5 m -122.05 129.13 52.14 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.745 -0.835 . . . . 73.41 108.745 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.66 HG13 HG13 ' D' ' 40' ' ' VAL . 67.5 t -118.8 121.02 65.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 124.281 1.032 . . . . 73.11 109.186 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 49.8 m -106.84 114.61 28.8 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.155 -1.424 . . . . 75.44 107.155 164.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.55 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -119.86 142.84 48.29 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.553 0.741 . . . . 64.25 109.25 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.561 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 68.6 p -147.32 130.92 16.83 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.141 0.422 . . . . 71.12 112.141 -170.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.517 HD12 HG22 ' D' ' 31' ' ' VAL . 18.7 mt -93.84 105.95 17.95 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.15 0.98 . . . . 61.51 108.38 175.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.08 -116.28 4.29 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 110.94 -0.864 . . . . 70.43 110.94 -174.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.51 4.95 16.44 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.312 0.645 . . . . 54.42 111.955 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -115.9 155.43 27.97 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.604 0.361 . . . . 70.55 110.842 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 61.7 m -64.91 119.85 11.46 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.924 0.889 . . . . 75.41 112.209 -177.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.561 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -79.24 -69.8 0.55 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.623 -1.251 . . . . 72.44 107.623 171.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -145.6 149.52 34.7 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 114.988 -1.005 . . . . 73.34 110.704 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 65.6 mt -112.54 152.97 28.21 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.906 1.282 . . . . 74.41 107.957 172.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.745 ' SG ' HG12 ' D' ' 114' ' ' ILE . 53.3 t -158.35 144.91 17.43 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.784 0.434 . . . . 53.01 110.058 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -155.65 125.89 6.68 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.042 0.537 . . . . 73.43 109.757 173.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 87.7 t -131.26 115.42 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.759 0.824 . . . . 73.41 109.231 -177.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.518 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.7 mt-30 -88.63 85.16 6.75 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.636 -0.876 . . . . 70.2 108.636 170.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -81.05 98.86 8.17 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 113.998 -1.456 . . . . 64.54 109.377 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.51 162.16 24.37 Favored Glycine 0 N--CA 1.465 0.596 0 N-CA-C 112.295 -0.322 . . . . 63.12 112.295 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.87 136.94 4.49 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.676 -0.569 . . . . 74.24 111.676 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.545 HG12 ' HG2' ' D' ' 57' ' ' GLU . 44.2 mt -90.76 105.59 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.779 -0.823 . . . . 73.22 108.779 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -107.93 141.75 39.09 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.727 0.811 . . . . 73.13 109.821 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' D' ' 54' ' ' ASP . 3.9 t -115.73 110.36 19.01 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 109.078 -0.712 . . . . 52.31 109.078 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.404 HG22 ' HD2' ' D' ' 11' ' ' PHE . 44.2 pt -126.67 134.33 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 123.531 0.732 . . . . 74.54 110.942 -174.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.95 170.36 17.87 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.888 0.875 . . . . 65.13 110.813 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.3 23.81 53.3 Favored Glycine 0 C--N 1.355 1.602 0 O-C-N 123.424 0.452 . . . . 71.34 113.171 173.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.611 HG22 HE21 ' D' ' 93' ' ' GLN . 0.7 OUTLIER -140.82 144.86 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.449 0.7 . . . . 75.0 110.327 179.016 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -131.65 175.92 8.76 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.406 1.082 . . . . 73.44 110.492 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.82 -128.22 10.94 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 115.628 -0.715 . . . . 73.13 113.518 173.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 9.7 t -87.0 -38.39 16.63 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.233 0.613 . . . . 70.22 110.903 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.611 HE21 HG22 ' D' ' 89' ' ' ILE . 13.8 pt20 -69.05 -22.07 64.05 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.261 0.625 . . . . 75.34 112.666 -171.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -64.49 -49.63 70.6 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.078 0.466 . . . . 74.12 111.081 177.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.09 -13.82 49.13 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.868 0.867 . . . . 70.23 110.965 -177.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -75.49 -22.83 56.85 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.061 0.545 . . . . 74.43 109.677 175.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 75.3 m -71.33 -50.98 26.9 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.077 0.551 . . . . 72.35 110.749 176.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 pp -67.03 -28.1 67.95 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.854 0.461 . . . . 64.25 111.772 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.15 -20.64 48.65 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.609 -0.551 . . . . 53.43 113.584 -178.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.52 -57.31 1.21 Allowed 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 117.794 0.797 . . . . 64.05 112.689 -170.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -68.94 -39.04 79.8 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 122.907 0.483 . . . . 74.51 111.281 -173.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 91.9 m -68.29 -47.09 38.82 Favored Pre-proline 0 CA--C 1.57 1.723 0 CA-C-O 118.401 -0.809 . . . . 73.42 111.767 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.537 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 86.4 Cg_exo -54.98 -33.31 82.46 Favored 'Trans proline' 0 C--N 1.402 3.355 0 C-N-CA 122.605 2.204 . . . . 72.04 113.685 166.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -65.86 -29.06 69.45 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.967 0.507 . . . . 54.44 111.139 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.1 mm -79.33 -33.66 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.901 0.88 . . . . 52.43 110.689 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 89.7 mt -75.1 -24.13 58.05 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.057 0.543 . . . . 72.32 112.147 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -67.37 -39.29 19.45 Favored Pre-proline 0 CA--C 1.562 1.437 0 CA-C-O 117.742 -1.123 . . . . 70.41 113.751 -172.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -50.48 -44.19 40.9 Favored 'Trans proline' 0 C--N 1.389 2.661 0 C-N-CA 122.182 1.921 . . . . 73.53 113.419 168.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -77.37 -35.49 54.47 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.778 0.831 . . . . 75.12 111.566 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.26 -47.51 67.53 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.546 0.738 . . . . 74.33 109.757 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.489 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 34.8 ttp180 -59.27 -43.67 92.49 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-N 114.643 -1.162 . . . . 71.25 110.254 172.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.13 -50.35 69.48 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 124.022 0.826 . . . . 52.35 111.365 -176.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.461 ' O ' ' HG3' ' D' ' 117' ' ' MET . 42.5 t -56.77 -44.58 81.97 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 124.453 1.096 . . . . 71.15 110.549 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.745 HG12 ' SG ' ' D' ' 76' ' ' CYS . 76.7 mt -62.71 -52.6 57.6 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 C-N-CA 124.159 0.984 . . . . 72.05 110.941 176.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 91.9 m -53.39 -45.58 69.33 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.502 1.521 . . . . 74.51 110.337 -175.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -64.94 -45.82 84.16 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.514 -1.676 . . . . 75.12 110.072 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.461 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 71.8 mtm -68.99 -30.13 68.48 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.824 0.449 . . . . 73.53 111.964 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.437 HG23 ' O ' ' D' ' 114' ' ' ILE . 78.6 t -67.07 -46.03 85.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.793 0.837 . . . . 74.41 109.218 176.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 83.4 p -72.61 -28.42 62.76 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 115.737 -0.665 . . . . 75.34 110.682 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 55.0 mtt-85 -74.61 -31.04 61.89 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.68 0.792 . . . . 75.3 110.165 175.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.94 4.41 85.37 Favored Glycine 0 C--N 1.354 1.574 0 O-C-N 123.466 0.479 . . . . 41.44 112.629 177.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.532 HG23 ' HB3' ' C' ' 17' ' ' TYR . 43.5 p 58.9 32.1 21.93 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 126.152 1.781 . . . . 64.52 112.67 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -96.83 150.11 36.52 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 115.392 -0.822 . . . . 73.33 109.786 170.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -43.29 122.82 3.15 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 124.042 3.161 . . . . 65.21 114.121 172.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -52.44 123.18 10.31 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.858 1.263 . . . . 72.54 112.049 -173.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.515 HD13 HG21 ' D' ' 40' ' ' VAL . 28.1 tp -107.63 112.46 25.19 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.299 1.04 . . . . 75.15 109.655 -176.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -116.07 79.63 1.33 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.505 -0.924 . . . . 62.23 108.505 176.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.516 HD11 HD22 ' D' ' 42' ' ' LEU . 0.3 OUTLIER -58.42 119.7 7.44 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 123.153 0.581 . . . . 53.54 109.918 -174.159 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -54.32 130.04 60.93 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 124.233 1.013 . . . . 54.31 112.317 -175.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.467 ' HG3' HH12 ' D' ' 111' ' ' ARG . 1.6 Cg_endo -76.59 118.19 4.79 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.481 2.121 . . . . 74.53 111.134 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 12.8 p -108.47 152.07 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.531 0.733 . . . . 74.05 109.51 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -72.99 102.21 3.42 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.414 -0.587 . . . . 73.3 109.414 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 . . . . . 0 N--CA 1.487 1.39 0 C-N-CA 123.766 0.826 . . . . 64.44 111.205 -179.141 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.2 m . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 109.375 -0.602 . . . . 65.33 109.375 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.455 ' HE1' ' SG ' ' A' ' 102' ' ' CYS . 62.0 t80 -110.24 121.39 45.16 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.737 -1.209 . . . . 74.01 107.737 173.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -133.92 134.62 42.84 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.148 -0.686 . . . . 71.41 109.148 176.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.426 HG21 ' HG2' ' C' ' 130' ' ' PRO . 47.8 mt -92.55 114.09 28.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 108.252 -1.018 . . . . 63.32 108.252 175.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -83.95 -35.46 23.98 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 123.399 0.437 . . . . 74.22 110.533 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -175.93 121.73 0.18 Allowed 'General case' 0 C--N 1.351 0.652 0 N-CA-C 109.553 -0.536 . . . . 73.5 109.553 -168.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.555 HD12 ' HG3' ' C' ' 130' ' ' PRO . 78.7 mt -109.42 135.75 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 107.832 -1.173 . . . . 63.14 107.832 171.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.434 ' CE2' ' HB1' ' B' ' 28' ' ' ALA . 31.3 p90 -161.83 177.1 10.17 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 124.021 0.826 . . . . 73.2 111.66 -174.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.5 p -102.49 118.64 37.29 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.942 -0.762 . . . . 61.34 108.942 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.1 mtpt -75.95 -35.87 59.52 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.229 -0.441 . . . . 72.25 110.002 172.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 18.2 t70 -145.51 144.46 30.56 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.654 -0.703 . . . . 55.01 109.787 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 57.4 mt -140.5 141.66 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 107.563 -1.273 . . . . 74.2 107.563 175.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.5 t -154.54 139.85 17.64 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.714 -0.476 . . . . 64.54 109.714 170.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.516 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 80.6 t80 -142.33 116.15 9.26 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.221 -1.4 . . . . 71.13 107.221 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -118.32 134.28 55.18 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.809 0.443 . . . . 71.44 109.991 -176.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.8 74.34 58.3 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 107.651 -1.24 . . . . 55.15 107.651 172.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.07 -27.23 20.59 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.528 2.152 . . . . 43.21 111.964 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -99.2 9.82 42.67 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.067 -0.97 . . . . 73.33 110.587 -177.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.483 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -45.82 -60.32 3.59 Favored Pre-proline 0 C--N 1.371 1.529 0 C-N-CA 124.295 1.038 . . . . 35.24 113.724 -166.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 23.4 Cg_exo -60.07 -31.31 93.21 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 121.755 1.636 . . . . 72.14 113.027 -171.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.52 -15.73 18.55 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.515 -0.766 . . . . 75.2 112.25 -175.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.78 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.8 p -77.04 -24.71 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-N 117.945 0.339 . . . . 73.21 110.391 -176.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -69.02 -22.34 64.06 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.92 -0.582 . . . . 75.24 110.583 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -74.68 -21.57 59.33 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.042 0.937 . . . . 74.43 111.437 176.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -81.93 161.42 23.09 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.208 0.603 . . . . 73.11 110.521 -177.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -63.11 117.52 6.62 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.244 0.618 . . . . 73.14 109.389 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.423 ' CE3' HD21 ' A' ' 68' ' ' LEU . 71.7 t-105 -81.32 89.05 6.06 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.629 0.728 . . . . 75.45 110.684 -178.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.465 ' H ' HD22 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -145.85 74.54 13.39 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 125.061 1.344 . . . . 74.3 108.569 172.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.0 149.79 17.76 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.924 2.416 . . . . 72.22 113.618 -171.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -97.92 97.79 9.24 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 107.108 -1.441 . . . . 55.44 107.108 167.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' A' ' 66' ' ' ALA . 59.4 t -83.03 94.71 3.25 Favored 'Isoleucine or valine' 0 C--N 1.345 0.382 0 CA-C-O 121.699 0.762 . . . . 74.11 109.303 176.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -78.02 117.12 19.03 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.299 -1.773 . . . . 73.41 109.456 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.5 tp -97.79 106.68 19.03 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.842 -0.617 . . . . 63.43 109.542 -175.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.673 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 2.0 m-20 -104.86 145.26 30.64 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.498 1.119 . . . . 72.44 108.51 172.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.463 HD11 HG21 ' A' ' 131' ' ' VAL . 95.7 mt -137.84 148.1 45.12 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.677 0.791 . . . . 73.54 109.626 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -148.55 142.22 25.54 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.507 1.123 . . . . 42.22 108.269 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.7 m -140.81 136.42 32.42 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.198 0.599 . . . . 75.42 110.129 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.99 130.22 9.62 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.687 0.795 . . . . 42.05 109.508 174.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 68.4 p -90.45 -179.52 5.61 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.71 0.804 . . . . 41.03 110.6 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.513 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 39.1 t -159.63 141.04 12.84 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.855 0.862 . . . . 54.01 109.149 -177.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -93.44 107.84 19.62 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.434 -0.95 . . . . 72.45 108.434 171.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 57' ' ' GLU . 53.6 mt -84.79 -43.57 14.1 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.004 0.522 . . . . 65.12 109.731 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.07 -173.34 4.53 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.26 -0.882 . . . . 52.41 110.041 -177.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -70.05 118.33 12.75 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.641 0.776 . . . . 72.01 109.295 176.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 64.18 14.26 8.48 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.152 1.381 . . . . 72.23 112.237 -174.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.0 t -117.41 110.26 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 108.664 -0.865 . . . . 71.24 108.664 176.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -121.99 124.66 44.52 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.198 0.999 . . . . 72.42 109.066 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 30.6 tt0 -86.12 152.85 22.52 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.763 -0.828 . . . . 55.15 108.763 169.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 77.2 t -132.03 138.79 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 N-CA-C 108.232 -1.025 . . . . 65.13 108.232 167.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.43 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 51.1 t -113.93 134.81 55.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.262 -0.644 . . . . 73.4 109.262 174.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.62 105.32 12.93 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.408 -1.331 . . . . 73.53 107.408 168.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 42.0 ttp180 -93.67 101.99 14.15 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.95 -1.13 . . . . 65.02 107.95 177.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.5 t -93.72 132.27 38.34 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 108.174 -1.047 . . . . 64.44 108.174 176.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.673 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 24.2 m -120.27 139.39 52.78 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.563 -0.902 . . . . 75.22 108.563 172.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.67 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.2 t -142.51 109.11 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 124.878 1.271 . . . . 72.42 107.692 -169.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.3 m -115.17 124.18 50.8 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 109.351 -0.611 . . . . 74.55 109.351 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.514 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -103.38 120.65 41.21 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.478 -1.675 . . . . 64.22 106.478 172.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 59.5 m -129.16 134.74 48.16 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.024 0.44 . . . . 72.24 110.496 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.465 HD22 ' H ' ' A' ' 37' ' ' GLN . 32.9 mt -88.46 64.39 7.47 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.338 -1.356 . . . . 75.34 107.338 174.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.26 -109.11 2.72 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 114.74 -1.118 . . . . 62.12 111.954 -174.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -86.93 -21.45 26.25 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.793 0.837 . . . . 73.42 109.133 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 9.5 tp10 -77.9 133.0 38.18 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.001 0.92 . . . . 70.34 108.857 172.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.4 m -89.03 129.07 35.73 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.799 0.727 . . . . 71.31 109.469 167.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.78 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -78.4 -59.58 2.72 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.019 -0.734 . . . . 72.31 109.019 173.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -159.47 169.63 23.48 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.443 -0.799 . . . . 65.22 110.892 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.426 HD12 ' H ' ' A' ' 76' ' ' CYS . 20.0 tp -132.44 142.17 49.14 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.484 -1.234 . . . . 72.24 107.939 174.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.67 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 64.6 m -137.32 132.96 34.38 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.773 1.229 . . . . 65.22 108.155 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -145.94 119.51 9.12 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.258 -0.645 . . . . 44.54 109.258 173.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.3 t -127.91 110.51 22.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.51 1.124 . . . . 62.05 108.7 -176.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 18.3 mt-30 -85.33 82.58 8.28 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.105 -1.072 . . . . 71.35 108.105 172.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -75.23 92.94 2.77 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.308 -0.86 . . . . 74.51 108.924 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -97.47 146.16 18.14 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 115.407 -0.815 . . . . 42.32 111.19 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.88 133.31 5.64 Favored Glycine 0 CA--C 1.505 -0.584 0 N-CA-C 110.64 -0.984 . . . . 40.34 110.64 -176.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.424 HG23 HD12 ' A' ' 51' ' ' LEU . 43.6 mt -81.59 126.41 39.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 108.43 -0.952 . . . . 64.03 108.43 173.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.743 ' HB3' HD11 ' A' ' 86' ' ' ILE . 84.7 m-85 -130.1 120.87 25.31 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.207 1.003 . . . . 61.01 109.036 -176.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.9 t -89.39 101.54 14.22 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.987 -0.746 . . . . 74.33 108.987 176.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.743 HD11 ' HB3' ' A' ' 84' ' ' PHE . 2.2 mm -113.45 137.81 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 122.789 0.436 . . . . 73.53 110.068 -175.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.9 167.24 25.32 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.755 0.822 . . . . 71.43 110.243 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.29 -31.8 8.14 Favored Glycine 0 C--N 1.352 1.426 0 N-CA-C 114.176 0.43 . . . . 74.01 114.176 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.545 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -131.51 163.08 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 123.331 0.652 . . . . 73.41 112.486 -166.477 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.76 175.11 13.67 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 114.454 -1.248 . . . . 61.23 109.105 175.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.02 -132.45 19.29 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 116.168 -0.469 . . . . 65.43 112.781 176.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.0 p -68.59 -30.63 69.42 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.503 0.721 . . . . 43.11 112.526 -177.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -66.38 -42.41 87.99 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 120.861 0.362 . . . . 73.14 110.12 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.431 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 6.1 tpt -68.87 -47.8 65.0 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.428 -0.806 . . . . 45.25 110.078 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.47 -41.34 72.82 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.623 0.769 . . . . 70.13 111.048 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -65.93 -37.38 85.89 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.473 -0.785 . . . . 72.42 111.422 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.7 t -66.52 -44.66 81.89 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.744 -0.465 . . . . 43.2 109.744 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 48' ' ' SER . 70.8 mt -78.04 -29.71 49.51 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.342 -0.844 . . . . 75.53 112.37 -171.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.34 0.22 43.63 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-O 119.592 -0.56 . . . . 62.23 114.488 -172.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.455 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -139.83 -63.41 0.5 Allowed 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 117.726 0.763 . . . . 32.03 111.406 -175.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -68.67 -43.92 75.17 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 116.067 -0.515 . . . . 74.42 111.851 -174.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.455 ' SG ' ' HE1' ' A' ' 11' ' ' PHE . 77.6 m -66.19 -49.6 54.46 Favored Pre-proline 0 CA--C 1.564 1.495 0 C-N-CA 124.218 1.007 . . . . 71.53 112.452 -176.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.39 -22.91 59.16 Favored 'Trans proline' 0 C--N 1.394 2.929 0 C-N-CA 121.751 1.634 . . . . 72.51 112.684 174.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -68.43 -37.17 80.03 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.248 0.619 . . . . 71.12 110.245 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.3 mm -65.46 -40.07 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.649 0.78 . . . . 72.45 110.233 172.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.7 mt -78.3 -19.12 54.25 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.032 0.933 . . . . 64.21 112.526 -174.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -70.63 -41.91 13.31 Favored Pre-proline 0 CA--C 1.559 1.29 0 N-CA-C 114.351 1.241 . . . . 74.24 114.351 -171.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.0 -37.23 78.45 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 121.901 1.734 . . . . 73.04 112.657 172.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -80.44 -36.01 34.18 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.857 0.863 . . . . 70.41 111.611 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.45 -51.2 64.29 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.073 0.549 . . . . 54.12 109.701 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.423 ' NH1' HD12 ' C' ' 105' ' ' ILE . 30.3 ttm180 -47.57 -53.28 14.99 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 124.862 1.351 . . . . 72.2 110.277 173.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -62.01 -45.98 91.23 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 124.433 1.083 . . . . 71.51 111.859 -174.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.614 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.3 t -57.2 -45.91 83.36 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.84 0.713 . . . . 73.12 110.352 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 118' ' ' VAL . 56.0 mt -61.8 -52.71 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 115.113 -0.948 . . . . 75.3 110.739 176.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 47.9 m -54.17 -42.33 69.51 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.219 1.008 . . . . 74.35 111.401 -174.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.3 t -69.05 -44.79 71.93 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.736 -1.12 . . . . 63.34 110.355 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.516 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 8.9 mtp -56.04 -43.58 77.97 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.762 0.825 . . . . 64.33 111.082 176.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 114' ' ' ILE . 73.4 t -59.71 -48.96 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.711 1.204 . . . . 71.45 110.465 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.0 p -72.47 -27.41 62.27 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.137 0.575 . . . . 71.33 111.632 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.475 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.3 mtt-85 -72.37 -29.05 63.42 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.46 0.704 . . . . 72.54 109.942 175.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.436 ' O ' HG22 ' A' ' 122' ' ' THR . . . -86.56 18.05 36.12 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-O 119.165 -0.797 . . . . 74.32 113.32 172.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.5 t 60.41 9.82 2.18 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 127.227 2.211 . . . . 73.21 113.76 177.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -80.79 142.66 52.92 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 108.161 -1.051 . . . . 71.54 108.161 172.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.49 147.16 59.54 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.74 2.293 . . . . 70.33 112.768 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -54.28 129.0 33.69 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 124.65 1.219 . . . . 65.41 112.63 -172.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 31.3 tp -117.42 105.94 12.67 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.032 0.933 . . . . 61.41 109.901 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -99.93 113.02 25.29 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.306 -0.998 . . . . 63.01 108.306 176.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.434 HD11 HD13 ' A' ' 114' ' ' ILE . 18.4 mt -67.64 154.48 41.38 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 120.714 0.292 . . . . 74.43 110.984 -175.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.22 136.37 93.77 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 123.535 0.734 . . . . 74.54 111.377 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -62.45 112.1 1.49 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.547 2.165 . . . . 75.14 111.528 173.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.463 HG21 HD11 ' A' ' 44' ' ' LEU . 90.7 t -101.88 139.98 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 121.126 0.489 . . . . 70.14 111.17 -173.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.411 ' OD1' ' HB3' ' A' ' 134' ' ' ASP . 46.4 t-20 -90.63 86.68 6.45 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.285 -1.325 . . . . 72.53 109.024 176.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -62.87 -23.99 67.59 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 112.804 0.668 . . . . 75.24 112.804 172.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.455 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 21.8 t70 -65.61 -37.89 87.9 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.028 0.531 . . . . 74.21 109.639 175.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.15 -50.04 51.4 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.822 0.849 . . . . 53.3 110.294 174.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.04 -41.98 75.87 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.416 0.687 . . . . 65.14 111.435 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.5 t80 . . . . . 0 N--CA 1.467 0.399 0 CA-C-N 115.767 -0.651 . . . . 74.33 110.094 179.415 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.454 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 18.2 ptm . . . . . 0 N--CA 1.487 1.383 0 N-CA-C 114.197 1.184 . . . . 64.23 114.197 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 54.9 m -135.41 122.71 21.74 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.71 -1.218 . . . . 72.32 107.71 172.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -111.69 142.27 44.23 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.811 -0.811 . . . . 74.22 108.811 -177.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -150.08 120.52 7.4 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.72 0.408 . . . . 72.14 110.092 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.1 mt -77.96 126.83 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.368 -0.975 . . . . 72.53 108.368 171.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -98.27 -40.07 8.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.066 0.546 . . . . 73.13 109.838 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -173.09 134.96 0.57 Allowed 'General case' 0 C--N 1.353 0.745 0 O-C-N 123.554 0.534 . . . . 70.12 109.686 -173.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.2 mt -122.06 143.79 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 107.119 -1.437 . . . . 73.3 107.119 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -169.25 153.48 5.41 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.599 0.592 . . . . 75.54 112.599 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.665 HG21 HD11 ' B' ' 21' ' ' ILE . 30.6 m -82.05 118.58 23.13 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.03 -0.986 . . . . 54.41 109.778 176.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.437 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 44.4 mtpt -95.81 -18.01 20.72 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.437 0.695 . . . . 72.05 111.521 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 28.8 t70 -155.09 140.04 17.31 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.47 0.481 . . . . 72.2 110.916 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.665 HD11 HG21 ' B' ' 18' ' ' THR . 32.3 mm -129.25 144.38 38.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 N-CA-C 107.763 -1.199 . . . . 75.4 107.763 172.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.47 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 46.6 t -147.82 132.76 18.12 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.381 -1.282 . . . . 74.52 108.296 169.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.3 t80 -145.29 118.02 8.67 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 107.189 -1.411 . . . . 73.54 107.189 168.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -119.84 133.68 55.5 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.664 -0.865 . . . . 63.11 108.664 173.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.672 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -117.32 82.15 14.42 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 106.51 -1.663 . . . . 70.45 106.51 166.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.2 -24.96 27.06 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.885 2.39 . . . . 75.34 111.96 -171.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -114.41 9.67 16.87 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.908 0.883 . . . . 63.43 110.751 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.672 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -30.8 -64.99 0.2 Allowed Pre-proline 0 N--CA 1.494 1.736 0 C-N-CA 125.992 1.717 . . . . 70.24 114.812 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 14.6 Cg_exo -64.09 -36.72 46.46 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 122.398 2.065 . . . . 64.22 112.338 -166.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.454 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 77.5 m80 -95.98 -18.63 20.11 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.006 -0.997 . . . . 65.54 112.321 -173.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 3.6 p -83.17 -10.33 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 117.991 0.36 . . . . 50.34 110.654 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -76.06 -3.49 36.19 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 112.843 0.683 . . . . 75.33 112.843 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.8 pt20 -78.98 -5.01 52.79 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.8 0.44 . . . . 75.32 110.223 169.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -107.22 87.57 2.54 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.832 1.253 . . . . 64.23 110.395 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -93.37 87.57 5.66 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.135 -0.939 . . . . 71.23 110.318 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 18.6 p90 -162.97 -171.24 2.6 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.416 0.686 . . . . 72.54 110.04 172.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.543 ' H ' ' NE2' ' B' ' 37' ' ' GLN . 0.0 OUTLIER -79.1 111.82 23.09 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 124.367 1.067 . . . . 71.23 110.295 178.47 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.84 141.03 36.36 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 121.879 1.719 . . . . 75.21 111.522 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.64 108.07 2.76 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 109.626 -0.509 . . . . 64.43 109.626 176.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 88.0 t -99.21 149.29 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 115.045 -0.979 . . . . 72.02 110.554 -175.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -135.46 129.67 33.54 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.354 1.462 . . . . 71.45 107.541 172.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.44 HD13 HD22 ' B' ' 128' ' ' LEU . 20.5 tp -97.04 140.82 30.99 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.449 -0.945 . . . . 74.04 108.449 170.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.639 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 7.2 t70 -137.93 141.0 40.6 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.222 -1.399 . . . . 73.12 107.222 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 49.3 mt -137.61 126.71 24.39 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.42 -0.585 . . . . 73.43 109.42 -170.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -124.57 139.95 53.4 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.023 1.329 . . . . 72.11 108.753 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.12 105.61 11.17 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 109.084 -0.71 . . . . 63.13 109.084 -172.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.76 152.01 50.7 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.034 0.933 . . . . 40.11 109.208 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 29.5 p -149.72 -169.54 3.4 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.932 -0.48 . . . . 73.42 110.94 -175.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 50.9 p -155.23 136.16 13.7 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.884 0.874 . . . . 63.21 109.183 170.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -91.26 112.24 24.07 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.566 -1.272 . . . . 72.52 107.566 168.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 pp -131.17 17.23 5.02 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.119 0.567 . . . . 62.01 110.474 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.26 152.15 21.93 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.691 -0.686 . . . . 71.54 110.568 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -72.38 117.35 13.93 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.242 -0.89 . . . . 73.32 109.168 172.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 65.65 13.79 9.13 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.075 0.95 . . . . 64.53 112.979 172.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.5 t -137.3 123.52 27.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.794 -1.558 . . . . 73.43 106.794 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.583 ' HB2' HD11 ' B' ' 86' ' ' ILE . 16.2 t80 -124.4 140.34 53.04 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.473 -0.566 . . . . 74.52 109.473 -167.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -108.96 106.13 15.96 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 107.843 -1.169 . . . . 63.32 107.843 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 94.5 t -100.78 138.28 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.652 0.781 . . . . 73.23 109.703 -176.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 24.1 t -122.79 110.77 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.029 0.932 . . . . 73.32 109.255 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -95.19 112.29 24.02 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.997 -1.112 . . . . 74.13 107.997 174.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -85.18 118.79 24.95 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 108.487 -0.931 . . . . 74.53 108.487 174.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 23.0 t -105.63 131.87 53.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 107.848 -1.167 . . . . 65.51 107.848 171.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.639 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 19.9 m -121.18 139.13 53.78 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.924 -1.139 . . . . 74.21 107.924 173.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.821 HG11 HD21 ' B' ' 126' ' ' LEU . 80.8 t -130.12 130.91 66.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.242 0.544 . . . . 63.21 109.707 175.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.4 m -106.57 144.57 33.05 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.727 -1.124 . . . . 70.11 108.871 168.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.97 136.47 20.31 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.895 -1.15 . . . . 72.35 107.895 171.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 15.6 m -137.65 128.07 26.46 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.585 0.553 . . . . 71.23 111.436 -173.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.465 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 44.8 mt -94.56 105.2 17.15 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.569 -0.9 . . . . 62.51 108.569 176.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.62 -120.42 5.13 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.881 -0.599 . . . . 50.54 111.873 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.42 10.75 25.32 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.506 0.722 . . . . 74.0 110.972 -178.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -129.25 156.01 44.66 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.382 0.673 . . . . 73.44 109.734 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 32.3 m -65.18 136.25 56.44 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 123.544 0.528 . . . . 63.24 110.433 176.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.465 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -89.27 -60.72 1.87 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 107.397 -1.335 . . . . 71.32 107.397 172.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -155.39 163.51 39.98 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 114.169 -1.378 . . . . 73.1 110.891 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 93.1 mt -136.42 113.54 10.57 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.156 1.383 . . . . 71.3 107.696 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.541 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 39.2 t -121.73 117.26 26.18 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.758 -0.46 . . . . 73.31 109.758 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.47 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 37.9 tt0 -124.54 123.21 39.6 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.6 1.16 . . . . 52.13 108.993 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 96.8 t -128.84 130.42 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.583 0.753 . . . . 64.12 110.272 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.518 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 26.3 mt-30 -100.01 119.84 38.89 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.135 -1.061 . . . . 64.11 108.135 171.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.561 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 7.9 tp-100 -108.9 109.05 20.05 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.224 -1.028 . . . . 73.23 108.224 176.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.437 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -104.84 170.24 17.77 Favored Glycine 0 C--N 1.335 0.5 0 O-C-N 123.883 0.739 . . . . 53.44 112.115 177.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.22 144.63 7.64 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.201 -0.523 . . . . 63.21 113.321 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 3.2 mp -85.64 117.41 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 107.607 -1.257 . . . . 73.13 107.607 172.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -121.93 134.59 54.84 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.836 0.854 . . . . 73.12 109.152 176.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 49.1 m -88.87 113.51 24.49 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.473 -0.936 . . . . 74.23 108.473 174.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.583 HD11 ' HB2' ' B' ' 56' ' ' TYR . 1.0 OUTLIER -121.99 105.1 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.096 0.958 . . . . 65.5 108.536 -174.676 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.22 170.42 19.52 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.041 0.448 . . . . 63.44 110.338 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 97.83 -57.5 1.1 Allowed Glycine 0 C--N 1.339 0.725 0 N-CA-C 110.069 -1.212 . . . . 75.22 110.069 -170.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' B' ' 94' ' ' MET . 1.0 OUTLIER -67.18 156.53 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 124.019 0.928 . . . . 73.41 111.845 175.425 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -155.5 147.14 23.05 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.765 0.826 . . . . 74.14 109.368 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.95 -123.91 7.94 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 123.328 0.392 . . . . 72.24 113.323 174.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.0 m -84.08 -44.71 13.79 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.801 0.81 . . . . 63.11 110.217 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -64.96 -19.92 66.21 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 113.877 -1.511 . . . . 74.45 111.8 -169.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.527 ' HB2' HD13 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -74.73 -41.9 59.28 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.557 0.743 . . . . 74.54 111.422 -178.559 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.81 -15.19 59.26 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.448 0.699 . . . . 64.21 111.4 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -66.02 -37.81 86.82 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.725 0.81 . . . . 63.01 110.149 170.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 37.2 t -64.75 -62.87 1.31 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.435 0.636 . . . . 65.43 110.81 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.595 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.4 pp -70.09 -20.74 63.19 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 116.065 -0.516 . . . . 73.23 112.298 -176.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.15 -2.08 64.45 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-O 119.435 -0.647 . . . . 51.01 114.43 -177.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.88 -49.57 0.15 Allowed 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 117.714 0.757 . . . . 75.54 111.611 -175.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -71.81 -44.97 63.03 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.666 0.786 . . . . 63.43 111.087 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 80.7 m -66.01 -47.81 62.16 Favored Pre-proline 0 CA--C 1.562 1.404 0 CA-C-O 118.734 -0.65 . . . . 75.21 111.818 178.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 76.2 Cg_exo -51.01 -37.63 57.32 Favored 'Trans proline' 0 C--N 1.388 2.652 0 C-N-CA 122.796 2.33 . . . . 65.35 113.866 169.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.55 -32.28 73.69 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.58 0.752 . . . . 65.12 111.406 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.0 mt -74.53 -37.69 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.631 0.772 . . . . 64.23 110.403 176.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 80.4 mt -75.45 -29.65 59.73 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.808 0.843 . . . . 71.01 111.961 -176.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -57.64 -47.99 98.0 Favored Pre-proline 0 CA--C 1.561 1.385 0 CA-C-O 117.777 -1.106 . . . . 74.35 113.201 -174.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.429 ' HB3' ' HB2' ' D' ' 112' ' ' GLU . 68.4 Cg_exo -47.13 -45.87 20.56 Favored 'Trans proline' 0 C--N 1.387 2.599 0 C-N-CA 122.976 2.451 . . . . 74.21 114.664 174.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -72.36 -41.91 65.88 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.079 0.552 . . . . 73.42 111.032 -175.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.561 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -64.61 -40.68 95.93 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 122.599 0.36 . . . . 73.13 110.503 176.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 53.2 ttt-85 -60.16 -50.54 73.26 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.351 1.461 . . . . 72.33 110.734 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -68.38 -32.53 72.68 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.629 0.772 . . . . 73.41 109.98 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.572 ' SG ' HD11 ' B' ' 21' ' ' ILE . 5.6 t -69.96 -41.15 74.89 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.961 0.504 . . . . 53.12 110.577 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.541 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 73.6 mt -57.77 -53.77 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.391 1.077 . . . . 53.13 110.132 172.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.441 HG21 ' OG ' ' C' ' 119' ' ' SER . 17.7 m -60.78 -30.42 70.03 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.166 0.586 . . . . 63.3 111.138 -177.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.0 t -63.37 -50.48 69.74 Favored 'General case' 0 C--N 1.348 0.537 0 C-N-CA 123.041 0.536 . . . . 74.14 109.559 173.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.508 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.7 mmt -65.51 -32.66 74.38 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.439 0.696 . . . . 73.41 111.459 -176.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.411 HG23 ' O ' ' B' ' 114' ' ' ILE . 97.5 t -68.8 -42.69 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.733 0.813 . . . . 72.24 110.345 174.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.3 t -62.91 -35.1 78.95 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.326 -0.852 . . . . 44.24 110.838 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.614 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 77.0 mtt-85 -70.18 -38.53 75.4 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 114.679 -1.146 . . . . 74.2 110.096 177.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.39 -7.73 68.98 Favored Glycine 0 C--N 1.352 1.429 0 O-C-N 123.845 0.715 . . . . 71.24 112.839 173.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 16.8 m 66.94 24.92 9.51 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 125.118 1.367 . . . . 63.13 110.329 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -85.07 163.23 46.62 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 123.861 0.864 . . . . 71.42 111.145 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.21 166.76 1.5 Allowed 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 123.339 2.693 . . . . 73.32 114.524 175.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -65.05 114.64 4.74 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.329 1.051 . . . . 64.24 111.353 -172.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.821 HD21 HG11 ' B' ' 64' ' ' VAL . 26.4 tp -112.4 107.1 15.78 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.032 -0.729 . . . . 54.51 109.032 174.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -121.55 127.11 50.62 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.133 -1.062 . . . . 63.53 108.133 171.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.49 HD21 HG21 ' B' ' 64' ' ' VAL . 84.0 mt -77.56 138.58 39.25 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 123.427 0.454 . . . . 70.35 110.267 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.05 147.26 98.91 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.714 0.805 . . . . 50.12 111.066 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.27 81.01 0.29 Allowed 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.261 2.64 . . . . 61.03 111.678 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 4.1 p -96.51 112.24 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 115.259 -0.882 . . . . 54.15 109.545 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 37.6 t30 . . . . . 0 C--O 1.236 0.344 0 N-CA-C 108.302 -0.999 . . . . 73.3 108.302 172.436 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 75.2 t80 . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 108.396 -0.964 . . . . 70.23 108.396 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -141.71 122.51 14.39 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.015 0.526 . . . . 73.41 109.675 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.411 ' HA ' ' HD2' ' C' ' 84' ' ' PHE . 55.5 mt -71.88 120.49 20.28 Favored 'Isoleucine or valine' 0 C--N 1.35 0.624 0 N-CA-C 108.586 -0.894 . . . . 64.44 108.586 171.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -84.72 -45.28 12.58 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.545 -0.909 . . . . 73.22 108.545 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 178.15 165.71 0.74 Allowed 'General case' 0 C--N 1.353 0.724 0 CA-C-N 114.34 -1.3 . . . . 75.35 109.848 -176.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.496 ' HA ' ' HA2' ' C' ' 82' ' ' GLY . 2.8 pp -130.53 150.13 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 106.476 -1.676 . . . . 74.23 106.476 168.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.452 ' HB3' HG23 ' D' ' 122' ' ' THR . 19.2 p90 -178.35 141.38 0.23 Allowed 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 118.852 0.751 . . . . 72.24 110.777 -176.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . 0.406 HG21 ' SG ' ' C' ' 113' ' ' CYS . 69.6 p -72.44 119.83 17.2 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.976 0.91 . . . . 64.12 110.116 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -73.16 -44.07 60.56 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.211 -1.033 . . . . 73.44 108.211 169.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 26.9 t70 -134.49 141.89 46.88 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 113.577 -1.647 . . . . 62.55 109.772 -169.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.567 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.6 mt -144.77 143.8 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 106.92 -1.511 . . . . 73.25 106.92 176.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.3 t -156.38 150.92 25.69 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.161 0.505 . . . . 64.11 110.306 176.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -152.83 123.43 7.28 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 107.065 -1.458 . . . . 72.31 107.065 172.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.0 113.46 14.0 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.245 0.618 . . . . 72.14 109.765 -174.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.11 82.7 67.95 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 107.666 -1.235 . . . . 40.21 107.666 167.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.2 -24.82 31.81 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.783 2.322 . . . . 54.52 112.04 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -106.9 26.03 10.58 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.132 1.373 . . . . 54.54 110.315 178.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.66 -52.25 18.71 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 113.915 1.08 . . . . 60.14 113.915 -174.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.97 -42.64 29.25 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 121.75 1.633 . . . . 74.05 112.251 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -68.32 -33.89 75.13 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.611 -1.177 . . . . 75.23 111.897 -175.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.716 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.1 p -80.23 -25.27 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 N-CA-C 112.757 0.651 . . . . 73.11 112.757 177.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -69.48 -28.98 66.54 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.55 -0.719 . . . . 70.22 112.184 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -89.4 35.04 0.81 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.378 0.671 . . . . 65.4 110.346 176.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.69 165.34 18.76 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.77 0.828 . . . . 70.12 110.856 -174.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -78.39 124.19 27.84 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 115.459 -0.791 . . . . 74.1 109.709 169.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -85.38 96.06 9.44 Favored 'General case' 0 C--O 1.242 0.674 0 O-C-N 123.514 0.509 . . . . 72.2 110.18 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -150.38 76.77 8.34 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 107.106 -1.442 . . . . 74.22 107.106 169.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -90.95 164.95 3.89 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.733 2.289 . . . . 65.11 113.025 -175.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -88.6 82.51 6.88 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.147 -1.427 . . . . 72.54 107.147 170.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 56.5 t -73.93 114.96 14.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 114.809 -1.087 . . . . 53.54 109.344 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -135.53 125.24 25.37 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.274 -0.875 . . . . 75.43 109.427 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.424 HD23 HD22 ' C' ' 128' ' ' LEU . 3.8 pp -89.3 159.59 17.31 Favored 'General case' 0 C--O 1.246 0.913 0 N-CA-C 108.71 -0.848 . . . . 73.45 108.71 165.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.525 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 17.5 t70 -134.33 134.21 41.55 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.636 -1.246 . . . . 75.22 107.636 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.439 HD11 HG21 ' C' ' 131' ' ' VAL . 78.6 mt -123.54 110.98 15.72 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.602 0.715 . . . . 74.33 110.341 -176.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -120.76 129.73 53.73 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 106.543 -1.651 . . . . 71.32 106.543 173.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.8 t -129.95 150.67 51.13 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.624 -0.509 . . . . 72.21 109.624 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.24 149.78 29.81 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.342 0.657 . . . . 54.14 110.274 -177.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 32.9 p -125.59 150.3 47.63 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.697 0.799 . . . . 72.33 109.744 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 36.1 t -145.44 126.6 14.72 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.84 -1.17 . . . . 72.34 107.84 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -81.89 117.32 22.05 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.94 -0.763 . . . . 65.34 108.94 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.497 HD11 ' HB2' ' C' ' 57' ' ' GLU . 51.0 mt -86.23 -43.15 13.2 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.862 0.865 . . . . 73.01 110.081 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.47 -177.31 5.7 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 114.501 -1.227 . . . . 74.54 108.777 176.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -66.76 116.94 8.2 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.242 -0.651 . . . . 62.23 109.242 -177.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 68.62 21.84 7.8 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.824 1.25 . . . . 74.2 112.887 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.3 t -126.81 110.76 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 108.873 -0.788 . . . . 75.23 108.873 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -117.99 125.37 50.26 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.853 0.861 . . . . 73.01 110.583 -174.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.497 ' HB2' HD11 ' C' ' 51' ' ' LEU . 28.4 tt0 -83.11 109.99 17.63 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.238 1.015 . . . . 74.04 108.543 168.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 77.5 t -99.18 139.04 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.341 -0.985 . . . . 61.54 108.341 169.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.0 t -134.1 132.83 56.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 108.779 -0.822 . . . . 74.32 108.779 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -112.63 105.06 13.15 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.628 -1.249 . . . . 73.42 107.628 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 30.4 ttm-85 -81.13 111.23 17.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.766 0.826 . . . . 62.12 109.216 171.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 24.6 t -111.28 113.54 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 108.12 -1.067 . . . . 72.11 108.12 173.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 22.0 m -116.21 123.25 47.3 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.925 0.89 . . . . 73.53 109.603 -174.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.529 HG23 HD13 ' C' ' 114' ' ' ILE . 71.6 t -100.99 120.12 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 122.965 0.506 . . . . 61.53 109.786 177.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 3.8 m -107.29 110.03 21.95 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.174 -1.047 . . . . 72.41 108.174 172.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.37 115.86 28.76 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.337 -0.986 . . . . 70.12 108.337 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -138.38 127.51 24.22 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.008 0.523 . . . . 72.42 110.097 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 16.9 mt -83.07 32.52 0.44 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.586 1.554 . . . . 64.01 111.276 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.68 -109.22 2.79 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 110.454 -1.058 . . . . 61.1 110.454 -171.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -89.94 -19.74 24.16 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.611 0.764 . . . . 73.2 110.366 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -87.43 121.12 29.45 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.51 1.124 . . . . 53.4 108.765 174.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 88.7 m -75.48 131.3 40.03 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.856 -0.794 . . . . 74.23 108.856 168.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.716 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.43 -61.1 2.02 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.05 -0.722 . . . . 74.41 109.05 171.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -162.57 155.14 19.27 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.365 -0.834 . . . . 74.54 109.918 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -114.38 135.81 53.68 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.979 -1.489 . . . . 62.04 106.979 167.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 49.8 t -142.13 148.03 37.65 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.321 -0.992 . . . . 62.41 108.321 -175.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -154.99 131.11 10.24 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.166 0.586 . . . . 74.2 109.703 177.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 68.8 t -125.23 132.03 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 108.273 -1.01 . . . . 73.53 108.273 167.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -107.83 90.81 3.41 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.96 -1.126 . . . . 53.23 107.96 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -78.4 108.6 11.87 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 114.876 -1.056 . . . . 74.44 109.072 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.71 171.87 54.14 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 111.778 -0.529 . . . . 70.01 111.778 173.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' C' ' 16' ' ' ILE . . . 179.18 116.28 0.5 Allowed Glycine 0 CA--C 1.508 -0.403 0 N-CA-C 110.055 -1.218 . . . . 72.23 110.055 -178.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.423 HG12 ' HA ' ' C' ' 57' ' ' GLU . 66.9 mt -105.93 136.29 40.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 123.607 0.763 . . . . 62.24 109.234 -173.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.411 ' HD2' ' HA ' ' C' ' 13' ' ' ILE . 64.3 m-85 -137.34 126.58 24.66 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.426 1.09 . . . . 63.22 109.274 -171.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 70.8 m -78.52 101.25 7.27 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.362 -0.977 . . . . 72.21 108.362 168.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.474 HD13 ' SG ' ' C' ' 97' ' ' CYS . 21.2 mt -116.21 126.84 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.183 -0.673 . . . . 73.4 109.183 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.92 168.33 19.54 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 122.937 0.495 . . . . 75.01 110.649 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.84 -49.96 3.67 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.868 0.73 . . . . 71.33 112.479 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.44 HD11 HG21 ' C' ' 86' ' ' ILE . 26.5 pt -82.19 161.19 3.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 123.296 0.639 . . . . 54.24 111.671 -175.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -156.63 156.13 32.98 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.477 -0.783 . . . . 74.12 110.113 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.5 -113.6 5.99 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 124.069 0.856 . . . . 50.11 113.744 171.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 9.6 t -64.85 -36.18 83.51 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.828 0.851 . . . . 65.01 111.65 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -68.3 -44.06 76.28 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.585 0.754 . . . . 72.31 109.722 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.465 ' HE1' HG21 ' C' ' 86' ' ' ILE . 5.9 tpt -64.42 -47.26 79.82 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.777 -1.101 . . . . 62.2 110.372 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.84 -39.51 81.48 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.029 0.932 . . . . 71.32 111.034 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -65.35 -32.39 74.01 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.244 -0.889 . . . . 63.35 111.602 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.474 ' SG ' HD13 ' C' ' 86' ' ' ILE . 22.1 t -75.49 -45.32 39.08 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 109.644 -0.502 . . . . 52.02 109.644 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 61.4 mt -74.21 -32.7 63.14 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.21 1.004 . . . . 63.24 112.786 -172.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.71 11.77 30.06 Favored Glycine 0 N--CA 1.473 1.104 0 CA-C-O 119.646 -0.53 . . . . 62.54 114.361 -170.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.26 -56.91 0.12 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 117.677 0.739 . . . . 73.41 111.967 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -70.61 -48.33 55.64 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.037 0.535 . . . . 72.3 111.426 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.415 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 70.7 m -69.77 -47.4 24.15 Favored Pre-proline 0 CA--C 1.563 1.472 0 C-N-CA 123.958 0.903 . . . . 63.51 111.92 -176.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.464 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 77.8 Cg_exo -56.67 -26.29 64.54 Favored 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.407 2.072 . . . . 74.25 113.924 172.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -66.99 -37.96 85.15 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.981 0.513 . . . . 74.44 110.606 175.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.423 HD12 ' NH1' ' A' ' 111' ' ' ARG . 44.5 mm -73.85 -35.81 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.189 0.596 . . . . 71.15 109.928 177.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.23 -28.6 47.93 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.132 0.973 . . . . 74.45 112.744 -176.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -57.29 -51.39 82.07 Favored Pre-proline 0 N--CA 1.486 1.331 0 N-CA-C 113.951 1.093 . . . . 73.33 113.951 -172.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -58.51 -36.75 97.01 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 121.722 1.614 . . . . 74.33 113.239 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -67.97 -46.58 70.98 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.265 0.626 . . . . 73.33 110.918 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.66 -36.86 79.75 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.233 1.013 . . . . 61.45 110.78 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . 0.502 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 38.9 ttt-85 -62.61 -55.52 26.34 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.294 1.438 . . . . 62.54 110.408 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -64.69 -35.77 82.12 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 123.853 0.72 . . . . 71.42 110.203 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.406 ' SG ' HG21 ' C' ' 18' ' ' THR . 14.0 t -66.22 -33.79 76.54 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.055 0.542 . . . . 73.5 111.313 -177.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.529 HD13 HG23 ' C' ' 64' ' ' VAL . 96.0 mt -72.07 -52.21 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 122.833 0.453 . . . . 63.43 109.806 172.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -61.65 -28.97 69.76 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.141 0.576 . . . . 72.15 111.634 -173.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 25.9 t -66.13 -47.08 75.28 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.782 0.833 . . . . 54.13 108.967 173.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.623 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.3 -40.99 92.51 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.473 1.109 . . . . 74.43 111.757 176.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.436 HG23 ' O ' ' C' ' 114' ' ' ILE . 64.1 t -61.18 -44.6 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.655 0.782 . . . . 64.33 109.33 176.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.441 ' OG ' HG21 ' B' ' 115' ' ' THR . 30.1 t -66.69 -34.59 78.19 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 114.989 -1.005 . . . . 73.54 112.037 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.423 ' NH1' ' HA ' ' D' ' 113' ' ' CYS . 68.3 mtt-85 -69.81 -39.4 76.54 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.329 0.652 . . . . 70.05 109.585 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.28 6.48 71.89 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 123.853 0.721 . . . . 75.22 112.696 173.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.9 p 58.42 31.79 21.35 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.394 1.878 . . . . 63.03 113.204 171.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -87.2 150.64 49.93 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 108.678 -0.86 . . . . 73.51 108.678 168.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -44.41 147.05 1.73 Allowed 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 124.575 3.517 . . . . 73.24 115.73 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -51.83 117.18 2.54 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.356 1.062 . . . . 74.1 112.008 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 52.6 tp -107.71 90.57 3.34 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.607 0.718 . . . . 74.21 109.401 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -96.91 95.35 7.78 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.403 -0.817 . . . . 62.53 109.254 -175.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.502 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 90.6 mt -62.32 146.91 49.83 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.524 0.73 . . . . 64.4 112.096 -174.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.56 147.93 64.65 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 123.819 0.848 . . . . 63.35 110.791 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.555 ' HG3' HD12 ' A' ' 16' ' ' ILE . 43.9 Cg_exo -57.63 116.1 2.99 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 123.218 2.612 . . . . 63.34 112.279 175.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . 0.439 HG21 HD11 ' C' ' 44' ' ' LEU . 60.5 t -100.02 132.93 44.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 110.243 -0.28 . . . . 73.42 110.243 176.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -94.99 92.32 6.81 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.888 0.875 . . . . 62.43 108.953 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -66.65 -26.99 67.32 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.503 0.721 . . . . 74.01 111.851 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -66.03 -41.21 91.21 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.552 0.741 . . . . 74.34 110.18 178.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.37 -42.3 96.27 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.774 0.829 . . . . 71.32 110.746 176.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 79.5 mt -66.1 -36.02 82.07 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.443 -0.799 . . . . 53.54 111.08 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 63.2 t80 . . . . . 0 N--CA 1.476 0.851 0 C-N-CA 123.754 0.822 . . . . 73.52 110.135 177.598 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.247 0.951 0 N-CA-C 109.223 -0.658 . . . . 64.43 109.223 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -156.35 120.11 4.36 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.097 -1.075 . . . . 62.42 108.097 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -132.81 116.59 16.72 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.486 0.714 . . . . 72.4 109.376 -177.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 63.8 mt -78.92 129.06 38.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 115.288 -0.869 . . . . 74.42 108.932 176.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -99.2 -44.57 6.21 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.716 0.406 . . . . 73.32 110.98 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -167.84 147.41 4.89 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.265 0.226 . . . . 64.44 111.181 -174.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.0 mp -125.56 140.48 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 106.031 -1.84 . . . . 74.11 106.031 172.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -164.28 146.97 9.09 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 124.038 0.836 . . . . 75.42 110.614 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.1 p -85.01 112.87 20.99 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.396 -0.82 . . . . 63.11 109.622 176.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -83.76 -18.92 36.16 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.394 0.678 . . . . 73.33 109.661 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.674 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 30.6 t70 -159.8 131.73 6.27 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.976 0.91 . . . . 73.12 109.694 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.623 HG21 ' HE2' ' C' ' 117' ' ' MET . 77.3 mt -134.94 142.43 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 107.375 -1.342 . . . . 70.42 107.375 171.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . 0.427 ' HB3' ' HB2' ' D' ' 77' ' ' GLU . 33.8 t -142.67 143.88 32.51 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.794 1.237 . . . . 62.03 107.961 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.567 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.9 t80 -152.69 117.91 5.22 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.279 -1.378 . . . . 71.04 107.279 172.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -130.28 113.1 13.98 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.717 0.807 . . . . 74.31 109.112 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.611 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -105.3 90.55 3.96 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 107.912 -1.144 . . . . 45.51 107.912 172.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.8 -30.47 9.36 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.977 2.452 . . . . 70.12 112.733 -172.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -109.57 7.64 24.7 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.593 0.757 . . . . 44.23 111.439 -171.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.611 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -44.45 -60.58 2.78 Favored Pre-proline 0 CA--C 1.558 1.25 0 N-CA-C 115.298 1.592 . . . . 64.22 115.298 -158.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.82 -34.54 23.88 Favored 'Trans proline' 0 C--N 1.377 2.035 0 CA-C-N 122.474 1.919 . . . . 64.01 113.873 -172.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -86.19 -21.34 27.55 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 116.637 -0.256 . . . . 74.51 110.497 -175.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.443 HG12 ' O ' ' D' ' 28' ' ' ALA . 1.8 p -83.1 -21.1 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.068 0.547 . . . . 53.11 110.307 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -57.88 -23.6 53.85 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.601 0.76 . . . . 72.1 112.864 174.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -59.31 -27.38 65.82 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.839 0.856 . . . . 70.54 111.167 176.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -83.92 90.79 7.45 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.697 1.199 . . . . 62.14 109.749 177.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -83.45 92.7 7.63 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.935 -1.03 . . . . 64.34 111.46 -175.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 44.6 p90 -167.8 172.68 8.93 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.247 1.019 . . . . 72.41 109.234 166.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -64.19 114.83 15.37 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 108.518 -0.919 . . . . 71.12 108.518 173.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.415 ' O ' HG23 ' D' ' 40' ' ' VAL . 53.3 Cg_exo -54.25 119.35 6.2 Favored 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 122.762 2.308 . . . . 74.52 110.457 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.47 111.05 3.38 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.991 -0.744 . . . . 64.25 108.991 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.655 HG13 HG13 ' D' ' 64' ' ' VAL . 88.3 t -99.07 140.86 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 113.983 -1.462 . . . . 73.31 108.6 -175.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -124.6 122.95 38.99 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.012 -1.477 . . . . 73.22 107.012 171.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 64.3 tp -97.17 138.54 34.52 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.757 0.823 . . . . 75.53 109.863 -170.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.762 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 9.0 m-20 -125.64 114.01 18.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.728 -1.124 . . . . 53.41 108.033 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 90.5 mt -109.23 135.27 50.6 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.091 -0.707 . . . . 54.42 109.091 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -146.04 154.03 41.41 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.388 1.075 . . . . 73.02 108.477 -177.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 8.8 t -117.96 150.84 38.57 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.294 0.569 . . . . 74.15 110.274 -177.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.07 170.35 19.61 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.415 1.486 . . . . 74.13 107.777 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 72.1 p . . . . . 0 C--O 1.243 0.724 0 CA-C-O 121.174 0.512 . . . . 65.3 110.925 -177.311 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' D' ' 85' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 N-CA-C 113.112 0.782 . . . . 71.34 113.112 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 16.4 m -122.44 112.22 33.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 107.933 -1.136 . . . . 72.35 107.933 175.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.578 ' HB2' HD11 ' D' ' 98' ' ' LEU . 9.8 m-85 -134.88 133.12 39.33 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 106.746 -1.575 . . . . 71.1 106.746 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.471 ' HB3' HG13 ' D' ' 83' ' ' ILE . 7.4 pt-20 -86.92 122.67 31.1 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.708 -0.849 . . . . 71.43 108.708 173.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 78.3 t -101.06 141.44 17.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.421 -1.263 . . . . 54.54 108.272 177.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.574 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 36.3 t -128.18 123.97 61.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 108.181 -1.044 . . . . 54.21 108.181 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.514 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -95.09 109.11 21.21 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 106.828 -1.545 . . . . 75.34 106.828 177.763 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.49 95.3 10.21 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.388 -1.708 . . . . 73.13 106.388 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.48 HG21 ' CB ' ' D' ' 110' ' ' ALA . 44.9 t -97.69 145.13 9.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 115.406 -0.816 . . . . 74.01 109.057 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.762 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 52.7 m -141.21 143.12 34.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.939 -1.028 . . . . 74.12 108.683 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.655 HG13 HG13 ' D' ' 40' ' ' VAL . 12.3 t -133.6 115.69 22.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 123.796 0.838 . . . . 70.45 108.784 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 17.2 m -106.68 94.77 5.3 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.796 -0.816 . . . . 63.34 108.796 171.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.625 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -99.07 145.85 26.69 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 109.595 -0.52 . . . . 54.3 109.595 176.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 22.7 p -153.4 137.63 16.54 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.737 -0.665 . . . . 63.52 111.257 -171.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.428 ' HB2' HG22 ' D' ' 31' ' ' VAL . 22.1 mt -107.54 116.4 31.87 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.898 1.279 . . . . 71.45 108.225 173.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.26 -133.54 18.33 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-N 116.161 -0.472 . . . . 42.01 112.081 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -94.57 3.57 54.94 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.148 0.579 . . . . 64.22 111.551 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -124.39 167.43 14.39 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.729 0.412 . . . . 64.43 110.249 -176.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 12.0 m -68.1 144.91 54.85 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 124.137 0.898 . . . . 74.45 111.731 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.54 -59.91 1.63 Allowed 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.308 -1.367 . . . . 60.22 107.308 168.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . 0.426 ' CE1' HG22 ' D' ' 118' ' ' VAL . 54.1 p90 -157.97 158.95 35.91 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.476 -1.238 . . . . 74.23 110.306 178.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 51.2 mt -124.73 145.39 49.72 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 107.137 -1.431 . . . . 74.53 107.137 176.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.447 ' SG ' HG12 ' D' ' 114' ' ' ILE . 45.6 t -156.49 109.45 2.61 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 117.884 0.311 . . . . 55.21 110.738 -171.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' D' ' 22' ' ' SER . 12.1 mp0 -124.5 127.69 47.84 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.079 0.952 . . . . 74.35 109.384 -173.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 87.1 t -135.47 115.17 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.125 0.57 . . . . 73.45 109.887 -178.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.674 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.9 mt-30 -88.68 84.75 6.72 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.428 -0.953 . . . . 70.33 108.428 170.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . 0.403 ' O ' HD13 ' D' ' 106' ' ' LEU . 6.7 tp-100 -83.1 96.92 8.53 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 113.736 -1.574 . . . . 71.41 109.604 -176.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -100.02 170.53 22.8 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.538 -0.301 . . . . 74.52 113.678 -175.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.78 148.5 8.36 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-O 119.243 -0.754 . . . . 71.14 112.675 177.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.471 HG13 ' HB3' ' D' ' 57' ' ' GLU . 3.4 mp -89.32 126.3 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.099 -1.075 . . . . 71.03 108.099 176.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -123.37 149.77 44.54 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.97 0.908 . . . . 73.11 110.239 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' D' ' 54' ' ' ASP . 31.2 t -115.44 111.71 21.19 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.884 0.874 . . . . 64.43 109.073 176.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.407 HD13 ' HB2' ' D' ' 98' ' ' LEU . 46.0 pt -114.88 140.07 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.966 0.906 . . . . 72.25 108.985 177.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.16 161.92 28.21 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.062 0.458 . . . . 51.4 111.917 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.93 8.89 81.78 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.065 -0.971 . . . . 73.44 115.099 167.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.506 ' HB ' ' HA ' ' D' ' 94' ' ' MET . 0.5 OUTLIER -98.77 171.69 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 N-CA-C 107.986 -1.116 . . . . 73.33 107.986 174.773 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.428 ' H ' HG22 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -138.96 175.3 9.67 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.87 -0.519 . . . . 64.42 110.85 -177.57 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.8 -133.12 29.41 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 114.876 -1.057 . . . . 34.0 112.805 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -92.08 -29.99 16.25 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.639 0.776 . . . . 44.21 111.057 175.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -68.8 -15.5 63.52 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.234 0.613 . . . . 73.33 112.359 -173.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.506 ' HA ' ' HB ' ' D' ' 89' ' ' ILE . 0.0 OUTLIER -59.21 -37.74 78.2 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.708 0.633 . . . . 70.42 112.708 173.538 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.73 -16.97 42.88 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.399 0.68 . . . . 62.23 111.481 177.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -66.62 -38.2 86.44 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.935 0.894 . . . . 74.33 111.154 -178.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 63.8 m -59.91 -30.47 69.06 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.623 0.769 . . . . 74.12 111.96 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' D' ' 56' ' ' TYR . 14.5 tp -79.53 -42.58 24.82 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.047 -0.979 . . . . 61.15 110.45 -177.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.08 -18.52 69.36 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 115.739 -0.664 . . . . 72.52 113.794 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.16 -63.08 1.37 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.06 0.544 . . . . 63.54 112.289 -170.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -70.59 -31.88 69.04 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 112.236 0.458 . . . . 75.33 112.236 -174.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.454 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 87.4 m -68.32 -49.5 32.4 Favored Pre-proline 0 CA--C 1.568 1.669 0 CA-C-O 118.531 -0.747 . . . . 53.0 112.114 177.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.514 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 51.7 Cg_exo -60.46 -27.36 84.71 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 122.273 1.982 . . . . 63.35 113.373 169.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -64.76 -36.07 83.13 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.325 0.65 . . . . 41.33 110.532 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 31.1 mm -66.5 -43.14 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.724 0.81 . . . . 61.21 110.371 172.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.403 HD13 ' O ' ' D' ' 80' ' ' GLN . 75.0 mt -75.52 -12.37 60.21 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.8 0.84 . . . . 75.34 112.979 -173.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -75.47 -45.9 4.36 Favored Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 113.559 0.948 . . . . 75.15 113.559 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.53 -33.57 78.83 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 121.871 1.714 . . . . 71.34 112.578 169.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -76.65 -32.06 57.74 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.468 0.707 . . . . 75.53 111.793 176.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . 0.48 ' CB ' HG21 ' D' ' 62' ' ' VAL . . . -64.2 -45.96 85.98 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.836 -0.431 . . . . 70.2 109.836 177.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' D' ' 111' ' ' ARG . 9.6 ptt-85 -76.61 -29.11 56.39 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 123.313 0.383 . . . . 73.32 110.697 178.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . 0.429 ' HB2' ' HB3' ' B' ' 108' ' ' PRO . 23.0 tt0 -51.13 -43.34 61.16 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.851 0.834 . . . . 74.33 109.878 172.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.423 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 18.8 t -72.8 -60.93 1.99 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.071 -1.422 . . . . 63.11 109.927 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.688 ' HA ' ' HE1' ' D' ' 117' ' ' MET . 80.4 mt -53.5 -56.7 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 124.77 1.228 . . . . 74.44 112.873 -174.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 28.7 m -48.72 -38.35 21.26 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.873 0.869 . . . . 74.43 111.545 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 12.7 t -69.02 -47.59 65.06 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.741 -1.118 . . . . 70.44 110.25 -178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.688 ' HE1' ' HA ' ' D' ' 114' ' ' ILE . 4.0 mpp? -63.14 -32.59 74.01 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 117.973 0.351 . . . . 63.53 111.65 178.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.484 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.2 t -62.24 -49.47 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 123.397 0.679 . . . . 73.45 109.927 176.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.7 p -71.92 -29.07 63.92 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.776 -0.647 . . . . 73.12 110.768 -177.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.4 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 86.4 mtt-85 -71.36 -30.41 66.13 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.746 0.818 . . . . 73.42 110.367 175.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.61 8.41 75.31 Favored Glycine 0 C--N 1.355 1.591 0 CA-C-O 119.367 -0.685 . . . . 52.23 112.82 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.452 HG23 ' HB3' ' C' ' 17' ' ' TYR . 74.7 p 51.75 56.8 7.3 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.497 1.519 . . . . 71.52 112.274 -175.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -120.74 148.28 47.9 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 108.518 -0.919 . . . . 71.02 108.518 169.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -50.28 141.13 32.53 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 123.167 2.578 . . . . 63.45 112.668 174.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -55.4 140.54 39.58 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.383 1.073 . . . . 74.52 113.2 -167.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.465 HD22 HG21 ' D' ' 40' ' ' VAL . 13.4 tp -126.8 98.55 5.41 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.008 0.923 . . . . 73.3 109.328 -178.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -102.1 103.0 13.54 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.163 -1.051 . . . . 54.03 108.163 175.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.08 121.92 14.25 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 123.59 0.556 . . . . 62.24 110.412 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.89 128.95 91.31 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.811 0.844 . . . . 72.11 110.977 -175.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -79.99 105.61 1.82 Allowed 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.905 2.403 . . . . 44.24 111.938 -170.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -107.79 124.62 64.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.015 -1.105 . . . . 75.21 108.015 172.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -68.2 117.06 9.53 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.932 -0.766 . . . . 75.54 108.932 175.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . 0.418 ' HD1' ' H ' ' D' ' 133' ' ' PHE . 1.5 m-85 . . . . . 0 N--CA 1.486 1.354 0 C-N-CA 125.025 1.33 . . . . 62.45 112.048 -171.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 79.2 m . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 120.568 0.223 . . . . 74.35 110.845 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.402 ' HZ ' HG13 ' A' ' 105' ' ' ILE . 93.9 t80 -99.36 114.58 27.54 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 106.359 -1.719 . . . . 74.22 106.359 161.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -133.32 112.5 11.69 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.189 -0.671 . . . . 73.43 109.189 -177.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.658 HG21 ' HG2' ' C' ' 130' ' ' PRO . 41.3 mt -83.65 113.96 23.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 107.745 -1.206 . . . . 74.41 107.745 169.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -94.77 -28.72 15.13 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 109.705 -0.48 . . . . 65.45 109.705 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.416 ' NH2' ' HB ' ' B' ' 122' ' ' THR . 20.2 ttt180 -166.37 139.96 4.09 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 122.741 0.416 . . . . 43.11 111.101 -177.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.571 HD12 ' HG3' ' C' ' 130' ' ' PRO . 95.5 mt -128.45 138.45 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.687 1.195 . . . . 64.13 107.828 169.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.468 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 32.5 p90 -163.74 174.88 11.09 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.735 0.647 . . . . 71.43 111.395 -175.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.0 p -101.17 121.89 42.65 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.196 -0.668 . . . . 63.22 109.196 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.468 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 35.5 mtpt -81.5 -38.2 26.68 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.129 0.49 . . . . 63.33 109.908 175.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.494 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 21.0 t70 -142.59 144.24 32.77 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.825 -1.079 . . . . 74.31 110.17 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.574 HD13 ' SD ' ' B' ' 117' ' ' MET . 97.4 mt -144.03 144.75 22.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 125.581 1.552 . . . . 63.32 107.43 176.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.4 t -159.13 142.85 14.99 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 122.917 0.487 . . . . 64.14 110.22 168.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -136.84 143.74 43.26 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 107.427 -1.323 . . . . 72.41 107.427 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -137.84 127.0 24.42 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.841 0.456 . . . . 74.32 110.387 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.21 66.31 9.28 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 125.382 1.473 . . . . 72.44 108.236 167.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.89 -34.25 30.69 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.25 1.967 . . . . 73.33 110.804 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.418 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 20.0 p-10 -89.96 24.68 2.35 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 114.175 -1.375 . . . . 55.55 111.292 174.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.87 -49.8 71.89 Favored Pre-proline 0 CA--C 1.571 1.773 0 CA-C-O 118.44 -0.79 . . . . 55.32 112.659 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.48 -26.79 70.21 Favored 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 121.718 1.612 . . . . 53.41 113.765 175.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.418 ' HB2' ' HB2' ' A' ' 27' ' ' ASN . 16.9 m-70 -77.33 -49.04 15.83 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.664 0.745 . . . . 71.53 110.564 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.804 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.9 p -72.4 -25.61 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 CA-C-N 114.302 -1.317 . . . . 62.52 112.741 -167.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -64.72 -19.75 65.95 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 122.875 0.47 . . . . 70.03 111.882 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -86.47 -31.39 21.37 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.426 1.091 . . . . 64.22 110.129 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.52 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 4.0 tmtp? -68.97 142.9 54.54 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.138 0.975 . . . . 71.2 109.642 -174.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.52 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 10.2 m-20 -53.23 124.03 13.45 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.566 1.146 . . . . 73.33 110.922 176.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -85.13 85.07 7.5 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 121.629 0.728 . . . . 74.2 110.722 -175.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -130.96 76.97 76.14 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 107.137 -1.431 . . . . 71.5 107.137 167.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -85.55 133.43 4.49 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.281 1.988 . . . . 75.2 112.432 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -97.06 90.7 5.26 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.061 -1.459 . . . . 72.11 107.061 166.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.678 HG22 ' HB2' ' A' ' 66' ' ' ALA . 62.1 t -77.69 93.12 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 108.581 -0.896 . . . . 63.22 108.581 175.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.489 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -90.35 127.12 36.09 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.903 -1.044 . . . . 74.35 109.168 177.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.679 HD21 HG13 ' A' ' 62' ' ' VAL . 3.7 tt -108.48 123.05 48.29 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.205 -1.035 . . . . 74.34 108.205 -171.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.51 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 10.8 m-20 -113.24 114.69 27.08 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.471 1.108 . . . . 74.22 109.514 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.459 HD22 HD21 ' A' ' 60' ' ' LEU . 45.7 mt -99.38 146.96 25.74 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.068 0.547 . . . . 53.13 112.033 -178.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -148.02 146.9 29.09 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.079 1.351 . . . . 64.43 108.46 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 84.4 m -134.61 140.82 46.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.276 0.63 . . . . 63.32 110.169 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.07 154.04 49.29 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.662 1.185 . . . . 73.12 109.339 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.5 p -130.43 155.46 46.39 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.21 0.604 . . . . 62.43 109.63 173.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.7 t -149.09 120.21 7.75 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.217 1.007 . . . . 74.34 108.371 -176.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -73.27 111.11 8.09 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.382 -0.599 . . . . 61.55 109.382 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.612 HD11 ' HB2' ' A' ' 57' ' ' GLU . 52.6 mt -84.81 -30.45 24.56 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.215 0.606 . . . . 73.33 110.072 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.42 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -161.74 177.02 10.3 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.667 1.187 . . . . 74.04 109.596 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -63.67 125.06 23.07 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.581 -0.896 . . . . 72.33 108.581 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 60.0 18.92 8.04 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.129 0.972 . . . . 71.14 112.72 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 49.5 t -126.05 110.43 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 107.824 -1.176 . . . . 75.21 107.824 173.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -123.52 127.86 48.94 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.849 0.86 . . . . 74.11 109.008 -175.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.612 ' HB2' HD11 ' A' ' 51' ' ' LEU . 31.5 tt0 -84.55 139.32 32.21 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.487 -0.931 . . . . 74.53 108.487 165.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.48 HG11 ' HD3' ' A' ' 103' ' ' PRO . 72.0 t -120.71 136.41 57.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.936 -1.135 . . . . 62.11 107.936 169.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.11 131.97 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.687 -0.857 . . . . 72.21 108.687 174.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.459 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -107.59 107.22 17.95 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.8 -1.556 . . . . 63.12 106.8 173.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -92.97 99.84 12.4 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.192 -1.04 . . . . 55.21 108.192 176.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.679 HG13 HD21 ' A' ' 42' ' ' LEU . 40.4 t -95.91 124.75 48.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 114.256 -1.338 . . . . 62.2 107.648 176.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 5.0 m -115.61 136.88 52.63 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.91 -1.144 . . . . 74.42 107.91 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 71.8 t -137.91 126.2 31.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 107.487 -1.301 . . . . 63.23 107.487 -172.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.489 ' HB ' ' HD2' ' A' ' 41' ' ' LYS . 27.5 m -137.72 131.69 31.71 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.984 -0.747 . . . . 73.34 108.984 169.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.678 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -105.56 120.76 42.45 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 107.618 -1.253 . . . . 72.02 107.618 174.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.3 m -118.02 126.47 52.36 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.744 0.418 . . . . 71.21 110.006 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.2 mt -90.54 66.51 6.3 Favored 'General case' 0 C--O 1.248 1.011 0 C-N-CA 125.046 1.339 . . . . 74.12 108.68 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.05 -86.74 0.78 Allowed Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.796 -0.638 . . . . 70.2 111.842 -176.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -108.95 -29.19 8.72 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.004 0.922 . . . . 64.33 110.902 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -89.3 113.57 24.85 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.663 -0.865 . . . . 72.31 108.663 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.2 m -69.0 130.37 42.58 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.81 0.732 . . . . 44.41 109.203 174.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.804 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -75.99 -58.65 3.16 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.387 -0.824 . . . . 53.34 109.884 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -159.33 163.68 35.44 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.723 -1.126 . . . . 72.11 110.691 177.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.2 tp -124.27 135.57 53.49 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.483 1.113 . . . . 72.44 108.705 172.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.551 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 68.6 m -133.5 133.11 41.81 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.54 1.136 . . . . 63.14 109.133 175.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -145.36 123.05 11.83 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.872 -0.788 . . . . 72.05 108.872 172.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.7 t -131.09 125.12 57.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 123.947 0.899 . . . . 75.14 108.948 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.494 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 53.8 mt-30 -99.67 91.63 4.96 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.919 0.887 . . . . 71.53 108.879 173.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -78.66 97.98 6.03 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.969 -1.014 . . . . 73.53 109.625 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.54 150.65 23.57 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 111.54 -0.624 . . . . 74.04 111.54 177.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.48 125.82 2.08 Favored Glycine 0 CA--C 1.508 -0.384 0 N-CA-C 110.665 -0.974 . . . . 74.02 110.665 -177.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.2 mt -84.59 112.87 22.36 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 N-CA-C 109.052 -0.721 . . . . 63.35 109.052 176.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.659 ' HB3' HD11 ' A' ' 86' ' ' ILE . 81.7 m-85 -121.77 118.69 29.65 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.093 0.957 . . . . 70.25 108.752 -177.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.5 t -92.75 95.87 9.82 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.771 -1.196 . . . . 61.24 107.771 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.659 HD11 ' HB3' ' A' ' 84' ' ' PHE . 11.9 mm -112.72 142.73 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.902 -0.59 . . . . 72.43 110.109 -172.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.9 164.87 30.9 Favored 'General case' 0 C--O 1.241 0.615 0 O-C-N 123.584 0.553 . . . . 64.23 112.25 -172.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.77 6.65 85.15 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 114.852 -1.067 . . . . 63.0 114.191 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.436 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -134.11 165.23 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.159 0.984 . . . . 74.41 108.89 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -159.27 175.95 12.77 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 109.451 -0.574 . . . . 65.23 109.451 175.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.01 -117.19 8.42 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.007 0.813 . . . . 62.02 114.323 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 t -70.12 -31.08 68.44 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.279 1.032 . . . . 72.1 111.755 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -74.61 -39.72 61.99 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 123.181 0.592 . . . . 71.3 110.713 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.9 tpt -68.13 -40.8 82.4 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.311 0.382 . . . . 72.32 110.111 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.88 98.13 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.329 -0.85 . . . . 55.45 110.745 175.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.435 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 54.5 t-80 -68.4 -31.93 71.62 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.076 -0.511 . . . . 73.52 111.632 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.496 ' SG ' HG21 ' A' ' 86' ' ' ILE . 48.5 t -69.46 -44.97 70.14 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 110.062 -0.347 . . . . 34.23 110.062 -178.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 65.0 mt -83.12 -26.68 30.77 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.38 0.672 . . . . 55.44 111.961 -174.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.23 3.35 37.71 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-O 119.525 -0.597 . . . . 61.5 114.15 -173.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.493 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -142.38 -68.44 0.37 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 117.684 0.742 . . . . 73.32 111.646 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -69.38 -41.93 75.83 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 112.465 0.543 . . . . 63.41 112.465 -170.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 70.1 m -66.46 -50.08 49.29 Favored Pre-proline 0 CA--C 1.568 1.659 0 CA-C-O 118.53 -0.747 . . . . 64.01 111.93 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.48 ' HD3' HG11 ' A' ' 58' ' ' VAL . 37.8 Cg_endo -65.86 -21.02 58.12 Favored 'Trans proline' 0 C--N 1.395 3.019 0 C-N-CA 121.781 1.654 . . . . 54.54 113.288 172.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -66.25 -42.91 87.89 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.161 0.584 . . . . 72.5 109.812 172.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.419 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 39.7 mm -62.01 -43.39 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.899 0.879 . . . . 64.03 110.318 174.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.7 mt -72.04 -24.13 61.49 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.398 -0.819 . . . . 61.13 112.627 -173.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -62.93 -44.89 86.6 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 114.339 1.237 . . . . 73.4 114.339 -172.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.419 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 92.5 Cg_exo -50.06 -40.98 50.13 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.203 1.935 . . . . 70.14 114.083 171.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -76.92 -39.56 50.39 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.619 0.768 . . . . 75.5 111.049 -177.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.37 -47.24 82.89 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.648 0.779 . . . . 74.22 110.016 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.463 ' NH1' HD12 ' C' ' 105' ' ' ILE . 29.7 ttm180 -49.4 -55.93 11.36 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 125.023 1.452 . . . . 64.43 110.142 172.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -60.89 -45.48 94.4 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.496 1.122 . . . . 74.14 111.664 -174.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.402 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 45.1 t -56.91 -45.32 82.72 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.026 0.829 . . . . 73.14 110.434 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 118' ' ' VAL . 66.2 mt -63.27 -51.62 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 115.077 -0.965 . . . . 73.21 110.535 175.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 50.6 m -55.54 -41.48 73.26 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.113 0.965 . . . . 71.12 111.246 -174.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -69.78 -42.85 73.26 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.498 -1.228 . . . . 63.21 109.913 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.498 ' SD ' HG23 ' A' ' 21' ' ' ILE . 10.2 mtp -58.79 -41.73 87.39 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.642 0.777 . . . . 75.54 111.19 175.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 114' ' ' ILE . 83.1 t -65.08 -48.13 85.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.384 1.074 . . . . 74.3 110.329 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.3 p -71.62 -30.94 66.34 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.911 -0.586 . . . . 53.22 111.298 -176.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.478 HH12 ' HG3' ' B' ' 112' ' ' GLU . 64.8 mtt-85 -72.4 -30.25 64.48 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.554 0.742 . . . . 63.42 109.197 173.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.43 -2.6 74.91 Favored Glycine 0 C--N 1.356 1.643 0 O-C-N 123.88 0.737 . . . . 73.15 112.921 174.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.514 HG21 ' HE ' ' B' ' 15' ' ' ARG . 92.2 m 71.68 26.59 3.07 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 122.912 1.339 . . . . 75.11 111.288 174.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -98.26 145.08 29.23 Favored Pre-proline 0 C--O 1.244 0.801 0 N-CA-C 108.51 -0.922 . . . . 72.3 108.51 170.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -43.98 132.68 8.44 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.389 2.726 . . . . 75.21 112.891 174.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -52.93 123.2 10.9 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 124.162 0.914 . . . . 74.35 112.399 -170.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 45.5 tp -109.24 100.68 9.78 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.908 0.883 . . . . 62.51 110.207 -174.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.434 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 88.9 m-20 -97.78 113.06 24.76 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.63 -1.248 . . . . 74.15 107.63 174.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 19.1 mt -65.21 147.68 53.02 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 123.58 0.55 . . . . 74.12 110.46 -175.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.76 134.74 88.05 Favored Pre-proline 0 CA--C 1.549 0.933 0 CA-C-O 118.914 -0.565 . . . . 52.51 111.158 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.49 120.93 9.17 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.256 2.637 . . . . 74.21 113.337 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.434 HG21 HD11 ' A' ' 44' ' ' LEU . 64.7 t -107.31 130.44 59.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 123.644 0.778 . . . . 74.34 110.37 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -92.51 92.22 7.97 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.051 -1.092 . . . . 75.24 108.051 173.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -62.64 -29.4 70.6 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.88 0.872 . . . . 73.31 112.22 176.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.493 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 6.7 m-20 -70.86 -25.48 62.84 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.291 0.636 . . . . 73.15 111.131 177.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.01 -40.96 37.32 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.239 0.616 . . . . 43.34 110.233 172.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.61 -44.69 96.53 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.207 0.603 . . . . 74.41 110.938 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.3 t80 . . . . . 0 C--O 1.216 -0.708 0 CA-C-N 115.073 -0.967 . . . . 73.12 109.74 179.199 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.659 ' HG2' HG23 ' B' ' 89' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.57 1.713 0 CA-C-O 121.318 0.58 . . . . 53.13 111.701 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 85.2 m -154.41 102.26 2.41 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.11 -1.07 . . . . 74.34 108.11 168.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.428 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 50.9 t80 -119.9 134.35 55.27 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.068 -1.086 . . . . 72.11 108.068 173.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -164.01 142.12 7.3 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 123.702 0.626 . . . . 60.52 110.791 169.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.52 HD13 HD11 ' B' ' 16' ' ' ILE . 37.8 mt -80.07 132.4 31.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.021 -0.991 . . . . 74.45 109.43 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -99.12 -38.72 8.82 Favored 'General case' 0 C--O 1.242 0.662 0 O-C-N 123.816 0.697 . . . . 70.43 110.299 178.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.514 ' HE ' HG21 ' A' ' 122' ' ' THR . 40.3 ttt180 -173.46 137.18 0.63 Allowed 'General case' 0 C--N 1.349 0.583 0 O-C-N 123.747 0.654 . . . . 72.24 109.8 -175.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.52 HD11 HD13 ' B' ' 13' ' ' ILE . 96.6 mt -120.31 143.43 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 107.577 -1.268 . . . . 64.22 107.577 174.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -162.9 139.48 7.44 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.696 0.628 . . . . 75.43 112.696 -173.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.9 m -73.96 118.01 16.43 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.042 0.937 . . . . 53.43 109.499 172.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.474 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.6 mtpt -98.15 -9.98 24.89 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.932 0.893 . . . . 71.13 112.045 -176.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 16.1 t70 -174.27 144.6 0.95 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.168 0.587 . . . . 52.43 110.745 -176.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.507 HD11 ' SG ' ' B' ' 113' ' ' CYS . 43.8 mm -138.28 148.67 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 125.047 1.339 . . . . 64.4 108.792 175.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.51 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 38.9 t -148.68 139.99 23.3 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 125.159 1.384 . . . . 52.33 108.214 172.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.498 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 81.2 t80 -152.85 113.7 4.13 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.375 -1.343 . . . . 75.44 107.375 171.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -121.18 119.09 31.32 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.953 0.901 . . . . 72.52 108.712 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.637 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -107.45 87.12 3.11 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 107.194 -1.41 . . . . 72.14 107.194 167.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.68 -34.44 31.97 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.987 2.458 . . . . 71.13 111.662 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -101.84 3.39 39.25 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.44 1.096 . . . . 70.15 110.375 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.637 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -30.0 -65.06 0.19 Allowed Pre-proline 0 N--CA 1.499 1.997 0 C-N-CA 126.331 1.853 . . . . 44.11 114.886 -172.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 28.8 Cg_exo -57.69 -48.07 18.53 Favored 'Trans proline' 0 C--N 1.391 2.802 0 C-N-CA 122.934 2.423 . . . . 50.42 113.462 -166.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -96.36 -15.37 21.89 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.297 -0.865 . . . . 73.21 112.648 -172.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.421 HG22 HD12 ' B' ' 68' ' ' LEU . 3.4 p -73.76 -17.7 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-N 118.657 0.662 . . . . 64.13 110.647 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -68.62 -6.32 25.08 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 113.764 1.024 . . . . 70.12 113.764 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -71.24 -13.53 61.94 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 120.991 0.424 . . . . 71.03 110.747 172.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.59 ' HB2' HD13 ' B' ' 68' ' ' LEU . 91.1 mttt -98.62 88.0 3.96 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.729 1.212 . . . . 54.42 110.049 -177.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.45 77.92 9.92 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.989 -1.005 . . . . 70.22 110.99 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.405 ' O ' ' HG2' ' B' ' 124' ' ' PRO . 38.5 p90 -158.37 164.58 36.18 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.881 0.873 . . . . 65.54 108.721 169.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.54 117.4 60.34 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 108.181 -1.044 . . . . 73.13 108.181 177.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.442 ' O ' HG23 ' B' ' 40' ' ' VAL . 31.8 Cg_endo -65.98 147.56 84.8 Favored 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 122.207 1.938 . . . . 75.31 112.231 -177.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -69.93 114.17 7.86 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 109.004 -0.739 . . . . 75.2 109.004 178.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.547 HG21 HD13 ' B' ' 126' ' ' LEU . 77.7 t -111.04 138.06 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 114.998 -1.001 . . . . 74.22 111.939 -172.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.478 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 44.4 tttp -107.27 126.97 53.12 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 126.017 1.727 . . . . 71.53 107.503 174.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.747 HD13 HD22 ' B' ' 128' ' ' LEU . 15.6 tp -103.01 127.3 50.3 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.729 -0.841 . . . . 74.02 108.729 174.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -143.8 136.13 26.85 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 106.999 -1.482 . . . . 44.11 106.999 -177.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.7 mp -127.05 149.24 50.0 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.952 -0.758 . . . . 74.34 108.952 -171.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.577 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 7.6 t70 -125.77 146.29 49.84 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.772 1.229 . . . . 54.34 109.255 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 26.9 m -124.84 105.64 9.41 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.495 0.718 . . . . 72.21 109.643 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.7 120.45 39.39 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.366 -1.346 . . . . 71.51 107.366 176.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.721 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 25.1 m -135.41 161.57 35.06 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.495 0.318 . . . . 75.53 111.506 -168.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 42.0 p -165.15 139.29 4.88 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.322 0.649 . . . . 74.45 111.06 -177.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -87.57 96.65 10.48 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 108.782 -0.822 . . . . 74.41 108.782 171.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 pp -107.53 14.78 25.46 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.801 0.44 . . . . 65.14 110.688 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.98 143.75 22.83 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.775 0.83 . . . . 63.54 109.56 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -74.06 132.13 42.02 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.646 -0.872 . . . . 74.41 108.646 170.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 67.76 1.9 2.83 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.946 1.298 . . . . 51.23 113.442 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 58.2 t -140.08 128.28 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 107.851 -1.166 . . . . 72.24 107.851 -172.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.721 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 6.7 t80 -115.38 154.26 29.52 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.797 -0.565 . . . . 71.21 109.566 -176.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -124.24 117.67 25.08 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 107.739 -1.208 . . . . 61.0 107.739 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 p -118.71 127.8 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.881 0.873 . . . . 70.42 109.363 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.41 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.9 t -103.77 112.33 36.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 108.072 -1.085 . . . . 62.25 108.072 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -103.18 108.68 19.98 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.473 -0.936 . . . . 71.41 108.473 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.577 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 6.2 ttm180 -85.12 135.4 33.99 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.131 -0.941 . . . . 73.32 109.238 174.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.466 ' CG1' HD11 ' B' ' 42' ' ' LEU . 17.5 t -122.57 117.13 51.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.14 -1.059 . . . . 52.13 108.14 169.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 17.3 m -109.78 133.36 53.23 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.874 0.87 . . . . 63.23 109.786 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.557 HG21 HG21 ' B' ' 114' ' ' ILE . 55.4 t -115.78 114.5 46.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 125.308 1.443 . . . . 65.14 109.139 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 41.4 m -91.79 138.09 31.84 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.698 -1.223 . . . . 72.12 107.698 166.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.538 ' HB2' HG22 ' B' ' 40' ' ' VAL . . . -148.78 143.01 26.08 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 117.943 0.338 . . . . 64.2 110.467 178.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 73.7 p -147.96 133.42 18.64 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 123.768 0.667 . . . . 74.24 111.032 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.59 HD13 ' HB2' ' B' ' 34' ' ' LYS . 54.0 mt -93.89 108.73 20.49 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.171 0.988 . . . . 74.43 108.508 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.87 -116.64 4.39 Favored Glycine 0 C--N 1.342 0.861 0 N-CA-C 111.469 -0.652 . . . . 42.41 111.469 -175.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -111.62 -0.08 16.21 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.054 0.942 . . . . 72.44 110.645 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.426 ' HG2' ' NZ ' ' B' ' 34' ' ' LYS . 9.8 pt-20 -116.77 154.37 30.79 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.328 -0.619 . . . . 72.01 109.328 -178.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 39.4 m -62.81 141.4 58.64 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.972 0.509 . . . . 63.51 111.285 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.435 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -97.78 -64.06 1.07 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.658 -1.238 . . . . 74.32 107.658 172.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -151.88 154.4 36.07 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.639 -1.164 . . . . 73.23 109.949 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 88.5 mt -130.44 112.87 13.64 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 106.916 -1.513 . . . . 55.25 106.916 175.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.1 t -117.63 156.19 28.59 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.134 -0.691 . . . . 62.2 109.134 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.51 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.0 tt0 -161.93 129.63 4.03 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.649 0.78 . . . . 75.23 108.997 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 94.2 t -126.41 150.13 31.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.125 -1.065 . . . . 75.15 108.125 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.444 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.6 mt-30 -124.86 97.95 5.49 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.181 -1.044 . . . . 74.24 108.181 170.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -93.26 103.14 15.42 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.676 -0.693 . . . . 73.11 109.255 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.474 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -94.19 172.32 31.91 Favored Glycine 0 C--O 1.243 0.675 0 CA-C-N 115.824 -0.626 . . . . 62.0 111.862 176.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.91 142.71 6.88 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.808 -0.517 . . . . 71.1 111.808 -178.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 16.3 tt -107.54 116.86 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 C-N-CA 123.997 0.919 . . . . 74.21 108.661 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -123.3 134.7 54.04 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.089 0.955 . . . . 62.41 109.578 -172.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.0 m -89.12 130.83 35.49 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.024 0.53 . . . . 64.21 109.592 174.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.551 ' HB ' HD11 ' B' ' 89' ' ' ILE . 0.1 OUTLIER -135.75 139.55 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.14 0.976 . . . . 72.44 109.114 -178.472 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.534 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -157.9 169.39 24.69 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.98 0.912 . . . . 73.35 110.426 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.31 -41.47 3.0 Favored Glycine 0 C--N 1.352 1.449 0 C-N-CA 123.718 0.675 . . . . 65.24 113.35 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.659 HG23 ' HG2' ' B' ' 9' ' ' MET . 9.5 pt -65.5 153.29 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.388 1.475 . . . . 72.12 113.052 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -151.36 172.37 16.03 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.515 1.126 . . . . 64.35 110.049 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.73 -133.72 32.28 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-N 116.231 -0.44 . . . . 30.11 114.0 177.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.0 m -80.73 -47.27 14.2 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.972 0.909 . . . . 74.44 110.888 -175.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -65.51 -20.73 66.46 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.818 -1.083 . . . . 74.13 111.259 -172.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.576 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 11.0 ttt -52.47 -70.22 0.09 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.29 1.436 . . . . 70.52 112.428 174.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.9 -12.74 60.04 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.427 -0.351 . . . . 51.45 111.489 -175.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -61.87 -41.58 98.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.215 0.606 . . . . 60.12 110.713 167.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 t -64.06 -28.08 69.55 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.291 0.636 . . . . 43.41 112.346 -176.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.714 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.5 pp -103.23 -17.72 15.21 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.352 0.661 . . . . 73.32 111.501 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.11 -4.09 41.58 Favored Glycine 0 N--CA 1.478 1.48 0 N-CA-C 114.201 0.44 . . . . 51.22 114.201 -173.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.87 -49.71 0.52 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.459 0.704 . . . . 63.43 110.362 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -71.15 -39.02 72.19 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 122.7 0.4 . . . . 71.43 111.648 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.714 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 84.5 m -67.72 -47.45 44.48 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-O 118.493 -0.765 . . . . 71.21 111.717 177.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.44 -34.4 41.49 Favored 'Trans proline' 0 C--N 1.394 2.928 0 C-N-CA 122.66 2.24 . . . . 75.32 114.244 167.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -67.41 -35.6 79.59 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.043 0.937 . . . . 73.43 110.563 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.467 HD13 HD11 ' B' ' 13' ' ' ILE . 79.6 mt -68.58 -40.45 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.759 0.824 . . . . 63.5 110.164 173.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 95.5 mt -75.72 -20.97 57.97 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.971 -1.013 . . . . 73.12 112.191 -174.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -61.68 -50.29 82.7 Favored Pre-proline 0 CA--C 1.561 1.376 0 CA-C-O 118.012 -0.994 . . . . 51.33 112.8 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -50.9 -40.38 57.92 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 122.633 2.222 . . . . 63.01 114.145 173.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -67.97 -44.57 76.39 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.518 0.727 . . . . 72.21 110.879 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.67 -34.86 79.29 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.248 0.619 . . . . 63.42 110.829 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.495 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 31.5 ttt180 -66.35 -52.63 45.04 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.219 1.407 . . . . 71.34 110.094 -175.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.478 ' HG3' HH12 ' A' ' 120' ' ' ARG . 12.3 tp10 -65.0 -33.43 76.03 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.033 0.933 . . . . 74.31 110.647 176.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.507 ' SG ' HD11 ' B' ' 21' ' ' ILE . 1.9 t -70.57 -32.57 70.01 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 122.439 -0.163 . . . . 63.44 110.967 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.557 HG21 HG21 ' B' ' 64' ' ' VAL . 66.3 mt -70.56 -57.9 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.277 0.631 . . . . 63.51 109.445 173.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 13.3 m -61.54 -22.96 65.61 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 124.205 0.94 . . . . 64.31 111.346 -173.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.3 t -62.04 -52.7 62.9 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 123.444 0.698 . . . . 73.14 109.851 170.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.574 ' SD ' HD13 ' A' ' 21' ' ' ILE . 12.7 mmt -68.44 -33.39 74.12 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.862 0.865 . . . . 63.33 111.113 -175.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.413 HG21 HD23 ' B' ' 126' ' ' LEU . 86.4 t -65.45 -43.96 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.806 1.242 . . . . 71.04 110.135 173.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.5 t -63.83 -34.87 78.9 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.73 -1.123 . . . . 73.53 110.564 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' B' ' 116' ' ' SER . 77.4 mtt-85 -69.24 -33.31 73.09 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.05 -0.977 . . . . 72.43 110.373 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.37 -15.75 81.25 Favored Glycine 0 C--N 1.356 1.686 0 O-C-N 123.57 0.544 . . . . 73.43 112.389 170.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.416 ' HB ' ' NH2' ' A' ' 15' ' ' ARG . 15.7 m 65.33 37.91 6.08 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.715 1.606 . . . . 71.42 110.261 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -81.5 156.92 70.66 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 114.61 -1.177 . . . . 71.15 109.53 172.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.405 ' HG2' ' O ' ' B' ' 36' ' ' TRP . 88.1 Cg_exo -50.91 163.83 0.71 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.38 2.72 . . . . 74.33 114.48 175.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -59.4 118.25 5.78 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 115.481 -0.782 . . . . 60.45 111.342 -171.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.547 HD13 HG21 ' B' ' 40' ' ' VAL . 54.8 tp -107.62 95.21 5.54 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.614 -0.884 . . . . 70.02 108.614 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -96.55 106.4 18.66 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.998 -1.112 . . . . 73.23 107.998 172.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.747 HD22 HD13 ' B' ' 42' ' ' LEU . 30.4 mt -67.05 134.84 52.68 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 110.135 -0.32 . . . . 61.3 110.135 175.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.71 131.46 94.9 Favored Pre-proline 0 CA--C 1.549 0.914 0 O-C-N 124.106 0.879 . . . . 74.32 110.713 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -61.75 90.79 0.11 Allowed 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.087 2.525 . . . . 64.14 111.618 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 p -90.35 111.69 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.591 -0.731 . . . . 73.14 109.493 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 44.5 t30 . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 107.671 -1.233 . . . . 55.24 107.671 171.984 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.525 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 78.8 t80 . . . . . 0 C--O 1.237 0.438 0 N-CA-C 108.959 -0.756 . . . . 73.34 108.959 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -140.42 128.45 22.13 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.136 -0.69 . . . . 72.04 109.136 174.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 50.2 mt -76.77 128.85 37.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 108.809 -0.811 . . . . 70.53 108.809 172.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -90.15 -49.59 6.48 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.934 -0.765 . . . . 55.32 108.934 172.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.434 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -176.46 153.52 1.18 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.431 1.092 . . . . 62.21 110.049 179.213 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 84.3 mt -127.7 134.92 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.087 1.355 . . . . 71.41 107.71 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.516 ' HE2' ' HD3' ' C' ' 19' ' ' LYS . 42.4 p90 -163.72 174.2 11.94 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.439 0.695 . . . . 64.52 110.288 -164.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.7 p -105.92 116.16 31.46 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 122.988 0.515 . . . . 71.15 109.838 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.516 ' HD3' ' HE2' ' C' ' 17' ' ' TYR . 30.8 mmtp -65.78 -37.97 87.74 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.947 -0.76 . . . . 75.53 108.947 167.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.434 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 13.1 t70 -149.56 147.19 27.87 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 114.482 -1.235 . . . . 73.33 110.4 -174.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.507 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 91.5 mt -139.36 146.11 26.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 106.505 -1.665 . . . . 75.23 106.505 173.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 18.2 t -157.35 148.13 21.37 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 121.064 0.459 . . . . 54.24 110.32 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -156.2 108.56 2.58 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.635 -1.246 . . . . 74.45 107.635 174.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -117.29 112.02 20.18 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 122.92 0.488 . . . . 73.41 110.065 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -121.47 83.05 40.33 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.63 1.172 . . . . 75.21 107.951 169.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.66 -17.82 25.87 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.684 2.256 . . . . 64.53 111.385 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -102.8 12.26 36.45 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.543 1.137 . . . . 74.04 110.543 -178.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.99 -57.9 5.47 Favored Pre-proline 0 C--N 1.374 1.646 0 C-N-CA 124.761 1.224 . . . . 53.41 113.687 -169.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -60.25 -46.62 17.61 Favored 'Trans proline' 0 C--N 1.385 2.484 0 CA-C-N 121.427 1.545 . . . . 73.14 113.143 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -69.41 -29.41 67.14 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.155 -0.929 . . . . 70.02 111.899 -174.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.851 HG21 ' HA ' ' C' ' 73' ' ' ALA . 6.7 p -83.14 -21.14 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 N-CA-C 113.286 0.847 . . . . 63.41 113.286 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -67.9 -18.02 64.66 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 112.517 0.562 . . . . 75.04 112.517 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -100.12 16.25 24.72 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.875 0.87 . . . . 75.14 111.253 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.59 155.54 17.81 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.474 0.71 . . . . 73.32 110.339 -174.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.32 125.07 25.56 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.089 0.556 . . . . 75.33 110.303 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.1 t-105 -83.03 87.97 6.88 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.731 0.812 . . . . 72.42 110.627 -173.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -139.54 75.95 31.31 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 123.932 0.893 . . . . 64.1 108.891 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -82.83 145.03 12.54 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.224 1.949 . . . . 73.32 112.056 -175.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -86.15 89.1 7.73 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 104.849 -2.278 . . . . 74.01 104.849 168.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 58.1 t -78.64 98.33 2.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 114.996 -1.002 . . . . 61.13 109.175 -175.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -97.5 102.31 14.05 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.548 -0.908 . . . . 73.4 108.548 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.411 HD12 ' O ' ' C' ' 42' ' ' LEU . 3.1 pp -87.31 123.5 32.36 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.446 -1.316 . . . . 70.33 107.446 171.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -130.46 143.42 50.75 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.393 -0.966 . . . . 74.4 108.393 -172.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.459 HD13 ' CE1' ' C' ' 133' ' ' PHE . 91.9 mt -131.6 112.64 12.78 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.959 0.504 . . . . 61.14 110.959 -171.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -115.03 126.72 55.05 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 107.46 -1.311 . . . . 74.41 107.46 169.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -116.2 153.93 30.97 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 109.091 -0.707 . . . . 65.43 109.091 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.72 133.4 23.7 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.763 -0.828 . . . . 63.33 108.763 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 32.9 p -144.87 144.79 31.3 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.834 0.453 . . . . 73.54 110.154 -174.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 62.9 p -149.07 152.65 36.56 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.658 0.783 . . . . 72.11 109.872 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -85.43 117.99 24.68 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.043 -1.095 . . . . 71.34 108.043 173.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.698 HD11 ' HB2' ' C' ' 57' ' ' GLU . 31.9 mt -84.64 -40.2 17.73 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.595 0.758 . . . . 73.31 109.689 -176.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.31 -173.73 4.56 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.707 -1.133 . . . . 60.12 109.119 175.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -62.43 126.65 28.07 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.445 -0.798 . . . . 75.44 109.565 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 66.13 -0.72 1.33 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.847 1.259 . . . . 55.14 112.965 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 45.7 t -118.29 111.39 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 109.367 -0.605 . . . . 74.53 109.367 -176.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -113.32 166.62 11.3 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.973 0.909 . . . . 74.31 109.751 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.698 ' HB2' HD11 ' C' ' 51' ' ' LEU . 41.4 tt0 -127.86 144.55 51.09 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.174 0.99 . . . . 72.11 108.734 171.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 82.6 t -131.23 133.73 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 108.182 -1.044 . . . . 70.33 108.182 167.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.488 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 60.2 t -120.25 130.1 74.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 107.66 -1.237 . . . . 71.45 107.66 176.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.454 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -113.18 97.36 6.45 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.742 -1.207 . . . . 51.41 107.742 -176.678 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 7.9 ttm-85 -81.84 110.45 17.15 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.961 -0.755 . . . . 75.32 108.961 173.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.509 ' HB ' HD11 ' C' ' 114' ' ' ILE . 19.4 t -106.68 123.86 61.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.074 -1.084 . . . . 63.41 108.074 173.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 59.6 m -115.03 132.11 56.71 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.026 -1.102 . . . . 72.4 108.026 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.491 HG21 HG21 ' C' ' 114' ' ' ILE . 89.0 t -121.28 116.95 51.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 109.141 -0.689 . . . . 75.24 109.141 176.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 12.5 m -101.76 139.04 37.95 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.635 -0.876 . . . . 73.11 108.635 173.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.57 105.72 4.58 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.607 -0.886 . . . . 62.12 108.607 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 36.9 m -127.04 133.54 50.47 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.356 0.662 . . . . 71.35 109.705 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 11.3 mt -91.04 15.0 12.43 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.988 1.315 . . . . 64.41 111.474 -176.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 145.25 -110.46 0.55 Allowed Glycine 0 C--N 1.351 1.377 0 N-CA-C 110.026 -1.229 . . . . 44.23 110.026 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -88.74 -27.25 21.3 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.523 0.729 . . . . 72.34 109.088 169.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -74.55 119.47 18.79 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 124.438 1.095 . . . . 74.21 109.492 175.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 53.4 m -84.29 124.41 31.22 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.994 -0.743 . . . . 75.31 108.994 169.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.851 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -70.07 -54.86 11.24 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.462 0.705 . . . . 52.03 109.457 176.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -163.85 163.24 23.86 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.101 -0.954 . . . . 73.04 110.906 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.41 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.5 tm? -126.94 141.25 51.85 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 106.635 -1.617 . . . . 64.11 106.635 167.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.45 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.9 t -141.17 150.72 43.12 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.976 -0.749 . . . . 52.03 108.976 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -158.18 136.45 10.89 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.321 0.648 . . . . 65.33 109.853 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -135.82 114.21 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 124.496 1.118 . . . . 64.1 108.201 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.415 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 68.7 mt-30 -94.19 88.25 5.54 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.562 -0.903 . . . . 74.5 108.562 173.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -81.01 95.51 6.83 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.243 -0.89 . . . . 75.22 109.743 -176.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -83.58 149.1 25.53 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 116.016 -0.538 . . . . 31.25 112.23 178.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.08 125.49 1.79 Allowed Glycine 0 CA--C 1.505 -0.586 0 N-CA-C 111.143 -0.783 . . . . 71.44 111.143 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.581 HD11 ' HB3' ' D' ' 29' ' ' PRO . 26.4 mm -85.29 130.8 35.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 N-CA-C 108.475 -0.935 . . . . 64.15 108.475 175.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -135.75 118.76 16.38 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.474 0.71 . . . . 74.23 109.977 -178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 64.7 m -76.87 102.44 6.34 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.898 -0.778 . . . . 64.53 108.898 171.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.632 HG21 ' HE1' ' C' ' 94' ' ' MET . 22.3 mt -116.95 137.87 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 108.69 -0.855 . . . . 74.12 108.69 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.44 169.82 17.59 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.355 0.662 . . . . 64.52 109.309 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.62 -15.5 61.37 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 114.881 0.713 . . . . 75.11 114.881 169.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.449 HD11 ' HE1' ' C' ' 94' ' ' MET . 27.6 pt -117.14 169.66 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-N 117.762 0.781 . . . . 74.02 111.561 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -159.97 152.03 20.51 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.289 -0.869 . . . . 73.11 109.995 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.67 -126.86 9.28 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 123.524 0.515 . . . . 70.44 113.345 172.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 35.5 p -67.37 -26.01 66.25 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.129 0.971 . . . . 61.54 111.828 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -65.57 -52.92 48.7 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.692 0.797 . . . . 70.31 109.711 174.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.632 ' HE1' HG21 ' C' ' 86' ' ' ILE . 5.5 tpt -54.14 -48.7 70.55 Favored 'General case' 0 C--N 1.353 0.72 0 CA-C-N 114.916 -1.038 . . . . 73.2 112.096 172.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.84 83.07 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.313 0.645 . . . . 61.22 111.181 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -68.05 -34.23 76.06 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.257 -0.883 . . . . 74.32 111.342 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.448 ' SG ' HD13 ' C' ' 86' ' ' ILE . 33.7 t -72.86 -42.08 64.08 Favored 'General case' 0 C--N 1.347 0.488 0 N-CA-C 109.392 -0.595 . . . . 74.22 109.392 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 92.3 mt -77.46 -28.79 52.47 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.959 0.904 . . . . 63.25 112.518 -175.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -114.44 11.1 21.73 Favored Glycine 0 N--CA 1.477 1.423 0 CA-C-O 119.597 -0.557 . . . . 55.25 114.27 -170.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.22 -55.05 0.12 Allowed 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 117.52 0.66 . . . . 55.44 111.846 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -70.4 -55.25 9.53 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.061 0.544 . . . . 73.32 111.705 -173.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.525 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 50.3 m -68.31 -43.92 34.63 Favored Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 123.764 0.826 . . . . 70.25 112.454 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.454 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 72.6 Cg_exo -55.62 -27.58 61.15 Favored 'Trans proline' 0 C--N 1.399 3.188 0 C-N-CA 122.402 2.068 . . . . 71.13 114.182 172.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -67.67 -35.42 78.82 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.328 0.651 . . . . 72.1 110.75 176.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.463 HD12 ' NH1' ' A' ' 111' ' ' ARG . 49.7 mm -75.71 -32.42 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.358 0.663 . . . . 74.43 110.212 177.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.75 -28.79 55.86 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.867 0.867 . . . . 54.24 111.79 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -56.78 -48.78 96.69 Favored Pre-proline 0 N--CA 1.482 1.175 0 N-CA-C 114.458 1.281 . . . . 71.13 114.458 -173.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.63 -38.69 92.64 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 121.895 1.73 . . . . 73.0 113.119 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -67.54 -43.56 80.41 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.832 0.853 . . . . 74.14 110.671 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.402 ' O ' HG13 ' C' ' 114' ' ' ILE . . . -65.22 -39.6 92.98 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.548 -0.751 . . . . 75.24 110.338 176.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -59.65 -49.89 75.97 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.205 1.402 . . . . 73.43 110.527 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.74 -37.8 88.83 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 123.944 0.778 . . . . 75.42 109.727 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.7 t -69.54 -33.13 72.35 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.176 0.59 . . . . 72.43 111.593 -176.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.509 HD11 ' HB ' ' C' ' 62' ' ' VAL . 88.2 mt -71.98 -51.91 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.236 0.614 . . . . 53.03 109.54 176.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.2 m -67.24 -29.23 68.81 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 123.695 0.622 . . . . 75.42 111.193 -175.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 48.3 t -63.47 -46.53 85.8 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.523 0.729 . . . . 74.34 109.077 172.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.532 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.53 -35.46 81.03 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.018 0.927 . . . . 62.53 112.32 178.105 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' C' ' 123' ' ' PHE . 95.4 t -68.85 -36.63 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.346 0.658 . . . . 53.21 109.71 174.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.0 t -71.13 -32.31 68.83 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.18 0.992 . . . . 64.43 111.447 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' C' ' 116' ' ' SER . 81.2 mtt-85 -73.3 -39.19 65.52 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.17 -0.678 . . . . 53.04 109.17 177.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.49 -3.72 78.59 Favored Glycine 0 C--N 1.353 1.488 0 O-C-N 123.928 0.767 . . . . 51.33 112.663 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 25.7 p 63.11 28.66 16.11 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 126.797 2.039 . . . . 64.55 113.627 170.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.427 ' HB2' HG13 ' C' ' 118' ' ' VAL . 94.8 m-85 -82.62 161.22 59.58 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.663 0.785 . . . . 72.33 109.077 169.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -51.91 140.94 47.51 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.815 2.343 . . . . 74.51 112.817 172.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -55.35 109.17 0.5 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.312 1.045 . . . . 71.11 112.323 -175.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 56.4 tp -112.02 88.43 2.81 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.318 -0.623 . . . . 71.0 109.318 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -90.54 123.04 33.89 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.783 -0.821 . . . . 73.24 108.783 177.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.67 140.55 51.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.659 0.784 . . . . 73.51 110.781 -176.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.95 155.17 82.91 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 115.33 -0.85 . . . . 71.24 111.058 -178.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.658 ' HG2' HG21 ' A' ' 13' ' ' ILE . 39.6 Cg_exo -55.55 106.99 0.21 Allowed 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.995 2.463 . . . . 61.43 112.132 173.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 18.3 t -99.6 120.59 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 108.361 -0.977 . . . . 74.33 108.361 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . 0.406 ' O ' ' HG ' ' C' ' 136' ' ' LEU . 56.5 t-20 -79.53 100.9 7.96 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.82 0.848 . . . . 75.55 109.751 -176.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . 0.459 ' CE1' HD13 ' C' ' 44' ' ' LEU . 93.6 m-85 -66.47 -29.13 69.19 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.826 0.85 . . . . 63.24 112.48 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -64.28 -42.79 96.25 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.341 0.657 . . . . 65.22 109.605 176.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.42 -36.38 81.15 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.229 -0.896 . . . . 75.4 110.858 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 136' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' C' ' 132' ' ' ASN . 54.0 mt -66.63 -38.9 87.88 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.902 0.481 . . . . 73.45 110.779 177.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 38.1 t80 . . . . . 0 CA--C 1.546 0.817 0 CA-C-N 115.367 -0.833 . . . . 65.14 110.41 179.524 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 C--O 1.244 0.785 0 CA-C-O 121.296 0.57 . . . . 63.34 110.855 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.438 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 69.8 t80 -138.91 106.3 5.54 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 106.418 -1.697 . . . . 74.45 106.418 175.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . 0.483 ' HB2' ' OG ' ' D' ' 85' ' ' SER . 41.9 mt-30 -119.6 116.89 26.94 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.409 -0.589 . . . . 65.33 109.409 -175.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.556 HG21 HD11 ' D' ' 16' ' ' ILE . 63.1 mt -78.94 118.77 26.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.29 -1.004 . . . . 53.43 108.29 174.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . 0.486 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 8.5 mm-40 -95.84 -39.71 9.69 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.433 0.293 . . . . 62.11 110.474 -174.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -173.36 137.87 0.68 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.699 0.4 . . . . 74.33 110.166 -176.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.556 HD11 HG21 ' D' ' 13' ' ' ILE . 3.5 mp -115.09 142.4 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 107.195 -1.409 . . . . 65.11 107.195 172.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -163.12 147.27 11.08 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.305 0.642 . . . . 61.23 110.866 175.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.6 p -82.59 114.39 20.95 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.059 -0.973 . . . . 74.33 109.39 175.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -87.24 -15.76 37.23 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.919 0.888 . . . . 64.34 109.634 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.675 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.9 t70 -163.34 130.85 3.54 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.81 1.244 . . . . 63.23 109.081 -177.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.532 HG21 ' HE2' ' C' ' 117' ' ' MET . 76.2 mt -134.56 142.86 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.225 -1.028 . . . . 72.51 108.225 173.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.9 t -143.17 137.25 28.91 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.502 1.121 . . . . 54.33 108.556 172.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.507 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.1 t80 -135.44 121.44 19.96 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.134 -1.802 . . . . 75.23 106.134 166.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 40.5 mt-10 -127.08 110.49 12.98 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.662 0.785 . . . . 73.35 109.054 -177.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.99 89.14 3.45 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 107.761 -1.199 . . . . 40.42 107.761 171.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -71.46 -37.74 5.28 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.596 2.197 . . . . 71.0 112.314 -174.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -99.44 4.55 46.19 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.085 0.954 . . . . 74.42 110.367 -174.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.404 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -25.14 -70.22 0.05 OUTLIER Pre-proline 0 CA--C 1.564 1.514 0 C-N-CA 127.471 2.309 . . . . 74.24 116.62 -166.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.581 ' HB3' HD11 ' C' ' 83' ' ' ILE . 76.7 Cg_endo -76.99 -19.76 13.58 Favored 'Trans proline' 0 C--N 1.382 2.291 0 CA-C-N 123.293 2.212 . . . . 72.43 113.95 -171.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -78.56 -38.55 40.05 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.274 1.03 . . . . 72.24 109.922 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.746 HG21 ' HA ' ' D' ' 73' ' ' ALA . 11.1 p -82.8 -19.53 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 CA-C-N 115.61 -0.723 . . . . 65.24 111.574 -171.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -62.9 -23.39 67.33 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 112.558 0.577 . . . . 74.44 112.558 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -57.1 -31.1 64.92 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.346 1.058 . . . . 74.54 110.668 177.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -84.92 78.93 9.8 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.905 1.282 . . . . 71.21 110.047 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -79.87 83.79 5.75 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 121.684 0.754 . . . . 70.44 110.698 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -157.77 -179.08 7.81 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.508 -0.923 . . . . 73.41 108.508 167.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -64.02 114.48 13.89 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 123.771 0.828 . . . . 71.34 110.693 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.434 ' O ' HG23 ' D' ' 40' ' ' VAL . 60.5 Cg_exo -56.46 122.69 12.24 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 121.897 1.732 . . . . 72.34 110.677 171.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -66.43 110.58 3.17 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 107.391 -1.337 . . . . 74.34 107.391 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.728 HG21 HD13 ' D' ' 126' ' ' LEU . 85.2 t -100.82 136.71 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.987 0.915 . . . . 74.54 110.845 -170.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -111.0 119.34 38.73 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.507 -0.923 . . . . 60.31 108.507 167.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 63.2 tp -96.94 143.23 28.01 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.194 -0.669 . . . . 73.2 109.194 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.509 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 31.5 t70 -142.15 144.14 33.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.041 -0.981 . . . . 61.12 108.575 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 72.8 mt -134.65 133.89 40.58 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.393 -0.965 . . . . 65.43 108.393 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 16.4 t70 -134.04 151.18 51.32 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.847 1.259 . . . . 70.13 107.764 177.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.22 163.58 14.19 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.506 0.67 . . . . 72.43 111.396 -175.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -167.25 147.7 5.48 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 113.84 -1.527 . . . . 75.43 107.382 169.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 29.0 p . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.835 -0.431 . . . . 54.45 109.835 171.877 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' D' ' 85' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 113.419 0.896 . . . . 61.2 113.419 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.96 105.52 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 108.869 -0.789 . . . . 64.43 108.869 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -132.19 131.62 42.37 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.228 0.611 . . . . 74.44 110.478 -174.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.699 ' HG2' HG13 ' D' ' 83' ' ' ILE . 53.4 mt-10 -90.11 111.68 22.89 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.897 -0.779 . . . . 73.34 108.897 168.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 84.1 t -100.85 135.91 34.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 O-C-N 124.112 0.882 . . . . 73.3 109.379 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.527 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 47.2 t -122.78 133.96 67.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.033 1.333 . . . . 54.24 108.199 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.475 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -113.82 117.44 31.45 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.506 -1.294 . . . . 70.41 107.506 174.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.416 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 50.0 ttm-85 -93.87 95.02 8.83 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.419 -1.326 . . . . 70.11 107.419 174.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 49.0 t -91.11 144.13 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.44 -0.948 . . . . 72.33 108.44 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 36.0 m -139.87 141.25 36.61 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.036 -0.727 . . . . 62.13 109.036 -176.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.644 HG13 HG13 ' D' ' 40' ' ' VAL . 50.5 t -132.97 128.66 56.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 124.465 1.106 . . . . 75.14 108.49 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 56.6 m -125.01 93.37 3.87 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.371 -1.344 . . . . 65.4 107.371 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -95.71 154.59 17.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.941 -0.763 . . . . 74.42 108.941 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 28.7 p -153.37 132.56 12.67 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 123.331 0.394 . . . . 75.1 110.878 -173.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.496 HD12 HG22 ' D' ' 31' ' ' VAL . 52.1 mt -105.42 112.42 25.52 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.167 -1.049 . . . . 73.21 108.167 174.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.88 -133.42 15.3 Favored Glycine 0 C--N 1.345 1.057 0 O-C-N 123.38 0.425 . . . . 74.34 112.563 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.77 2.5 56.72 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.969 0.507 . . . . 75.4 111.758 -178.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -123.3 160.89 25.73 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.207 0.603 . . . . 74.54 110.528 -176.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 94.6 m -64.59 140.51 58.87 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.108 0.963 . . . . 72.34 110.992 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.746 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -92.33 -62.49 1.39 Allowed 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.855 -1.165 . . . . 74.14 107.855 172.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.84 165.78 35.55 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 114.347 -1.297 . . . . 64.14 109.937 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 87.5 mt -132.32 153.02 51.14 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.616 1.566 . . . . 54.35 107.257 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.652 ' SG ' HG12 ' D' ' 114' ' ' ILE . 53.0 t -158.61 145.1 17.2 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.747 0.419 . . . . 52.13 110.168 -177.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -154.54 126.8 7.84 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 123.103 0.561 . . . . 73.11 110.168 172.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 95.3 t -128.76 116.69 42.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 124.033 0.933 . . . . 75.1 109.059 -178.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.675 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.5 mt-30 -87.98 86.32 7.11 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.899 0.857 . . . . 64.53 108.863 168.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -82.46 97.9 8.63 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 113.831 -1.531 . . . . 73.11 109.394 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -96.2 166.62 24.58 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-N 116.48 -0.327 . . . . 60.11 112.706 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.7 153.26 12.97 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-O 119.837 -0.424 . . . . 63.22 112.783 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.699 HG13 ' HG2' ' D' ' 57' ' ' GLU . 3.0 mp -94.24 128.6 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 108.083 -1.08 . . . . 71.13 108.083 176.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -131.35 124.59 30.7 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.165 -1.05 . . . . 73.42 108.165 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' D' ' 54' ' ' ASP . 51.4 p -95.92 126.43 41.17 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 109.06 -0.719 . . . . 75.12 109.06 174.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 31.2 pt -133.61 129.39 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.452 -0.944 . . . . 74.43 108.452 -170.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.07 167.93 28.98 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.263 0.225 . . . . 63.1 111.18 -171.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.03 23.43 71.77 Favored Glycine 0 C--N 1.353 1.485 0 O-C-N 124.122 0.888 . . . . 74.02 114.484 171.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.673 HD13 ' HA ' ' D' ' 94' ' ' MET . 0.7 OUTLIER -133.54 155.45 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.158 0.583 . . . . 70.54 110.593 177.637 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.33 177.19 8.1 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.824 -1.08 . . . . 73.22 109.506 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.79 -140.78 25.49 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 123.29 0.368 . . . . 42.12 113.108 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 81.8 p -77.32 -43.09 34.3 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.772 0.829 . . . . 50.34 111.107 -175.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -57.96 -33.36 68.76 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.34 1.056 . . . . 74.21 111.771 -177.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.673 ' HA ' HD13 ' D' ' 89' ' ' ILE . 1.6 tmt? -47.56 -60.66 2.38 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.522 1.529 . . . . 74.44 112.729 -176.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.15 -15.7 46.19 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.204 0.601 . . . . 60.11 112.034 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -76.95 -17.52 58.85 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 122.859 0.464 . . . . 71.24 111.895 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 71.5 m -60.7 -44.26 96.77 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.586 0.354 . . . . 75.44 111.135 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.504 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 4.3 pp -79.27 -30.35 43.0 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.1 0.56 . . . . 75.25 111.816 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.55 -29.09 25.24 Favored Glycine 0 C--N 1.35 1.335 0 O-C-N 123.247 0.342 . . . . 55.44 113.669 -172.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.42 -57.12 2.02 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.447 0.699 . . . . 61.11 111.336 -171.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -72.87 -38.96 66.83 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 112.225 0.454 . . . . 61.4 112.225 -171.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.504 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 72.1 m -66.97 -46.1 53.58 Favored Pre-proline 0 CA--C 1.567 1.609 0 CA-C-O 118.679 -0.677 . . . . 71.44 111.937 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.475 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.4 Cg_exo -59.54 -32.0 95.46 Favored 'Trans proline' 0 C--N 1.393 2.913 0 C-N-CA 122.016 1.81 . . . . 73.51 112.911 169.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -64.63 -29.02 70.02 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.076 0.55 . . . . 71.22 111.125 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.407 ' O ' ' HD2' ' D' ' 108' ' ' PRO . 46.2 mm -78.23 -33.86 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.812 0.845 . . . . 73.1 110.786 174.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 65.3 mt -74.63 -18.79 60.49 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.24 0.616 . . . . 74.13 111.752 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -66.28 -45.81 60.63 Favored Pre-proline 0 CA--C 1.559 1.315 0 CA-C-O 118.195 -0.907 . . . . 75.31 113.306 -176.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' D' ' 105' ' ' ILE . 81.7 Cg_exo -52.37 -42.57 59.95 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.371 2.047 . . . . 72.32 114.323 171.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -71.99 -40.44 68.55 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.554 0.742 . . . . 70.35 111.49 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.03 -44.72 91.71 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.623 -0.717 . . . . 73.55 109.912 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.522 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 27.3 ttp180 -57.72 -49.1 77.66 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.74 1.275 . . . . 70.41 110.311 178.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -58.71 -49.02 79.12 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.373 1.045 . . . . 74.34 110.45 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 43.1 t -57.26 -45.64 83.8 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 124.031 0.832 . . . . 54.01 111.186 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.652 HG12 ' SG ' ' D' ' 76' ' ' CYS . 89.0 mt -61.17 -55.94 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.772 0.829 . . . . 74.32 110.673 175.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 90.7 m -52.86 -42.3 65.1 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 124.764 1.226 . . . . 72.25 111.088 -174.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 29.9 t -66.69 -43.14 85.18 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.492 -1.231 . . . . 44.44 109.863 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.6 mtm -70.69 -26.93 63.65 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.056 0.543 . . . . 32.03 111.941 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.472 HG21 ' HB3' ' D' ' 126' ' ' LEU . 79.8 t -64.73 -47.75 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.384 0.674 . . . . 71.42 109.38 173.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.9 p -72.82 -28.94 62.86 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.569 -0.741 . . . . 75.01 110.559 -178.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' D' ' 116' ' ' SER . 76.4 mtt-85 -71.16 -27.17 63.34 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.757 0.823 . . . . 73.14 110.097 173.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.46 8.87 79.11 Favored Glycine 0 C--N 1.351 1.398 0 CA-C-O 119.354 -0.692 . . . . 34.24 112.615 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.404 HG23 ' HB3' ' C' ' 17' ' ' TYR . 69.7 p 55.88 40.81 30.54 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.781 1.632 . . . . 64.54 113.761 177.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -105.93 152.95 40.4 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 109.001 -0.74 . . . . 75.33 109.001 170.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -48.91 133.46 28.08 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.024 2.483 . . . . 73.4 112.141 171.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -55.78 128.6 35.7 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 124.308 1.005 . . . . 75.04 112.389 -170.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.728 HD13 HG21 ' D' ' 40' ' ' VAL . 14.2 tp -111.23 102.57 10.98 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.139 0.976 . . . . 70.41 108.973 -176.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -100.9 104.39 15.59 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.647 -1.242 . . . . 53.1 107.647 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.522 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.2 mm? -64.32 114.75 4.47 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.189 0.595 . . . . 75.4 109.806 -177.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.14 132.76 93.94 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 123.105 0.562 . . . . 75.34 111.023 -174.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -61.43 116.66 3.55 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.06 2.507 . . . . 73.32 112.357 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p -110.54 136.1 47.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 N-CA-C 108.901 -0.777 . . . . 73.41 108.901 176.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -80.65 113.13 18.63 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.798 -0.816 . . . . 55.21 108.798 176.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 124.027 0.931 . . . . 71.22 110.952 -177.326 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 mmt . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 108.773 -0.825 . . . . 74.34 108.773 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.0 m -143.44 97.4 3.07 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.004 0.521 . . . . 72.34 109.828 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -67.63 118.09 10.45 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.108 0.563 . . . . 75.53 109.587 176.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -108.61 81.6 1.49 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.585 0.754 . . . . 74.13 109.669 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -76.86 142.29 40.27 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.512 -0.767 . . . . 75.12 109.986 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -87.89 116.02 25.76 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.751 0.82 . . . . 74.32 108.907 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.0 p -126.62 161.78 27.25 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.026 0.93 . . . . 74.43 110.797 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 66.2 45.19 2.36 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.073 1.349 . . . . 74.43 112.201 172.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -83.94 167.49 16.91 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.657 0.741 . . . . 62.3 111.542 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.8 m -140.12 126.03 19.55 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 106.942 -1.503 . . . . 75.44 106.942 164.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -137.32 121.11 17.48 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.752 -1.203 . . . . 72.45 107.752 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -143.02 110.82 5.91 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.157 -0.683 . . . . 62.25 109.157 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.9 mt -70.39 114.39 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.317 -0.623 . . . . 72.13 109.317 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -82.18 -39.93 22.47 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.653 0.595 . . . . 70.1 110.206 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -175.06 122.42 0.23 Allowed 'General case' 0 N--CA 1.481 1.098 0 O-C-N 123.608 0.568 . . . . 72.42 110.862 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 97.0 mt -106.21 136.0 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 108.378 -0.971 . . . . 73.15 108.378 171.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.532 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 30.7 p90 -166.78 164.93 16.54 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 123.843 0.714 . . . . 72.05 111.196 -174.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.3 p -88.33 124.0 33.47 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.77 -0.456 . . . . 55.15 109.77 175.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -90.85 -36.94 13.91 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.891 -0.781 . . . . 73.24 108.891 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.713 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 24.7 t70 -138.8 136.84 36.09 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.982 -1.008 . . . . 63.4 109.125 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 76.4 mt -130.88 142.62 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.804 1.242 . . . . 71.32 107.818 173.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.2 t -149.44 116.6 6.04 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.394 0.678 . . . . 65.13 109.983 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.707 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.1 t80 -122.79 136.69 54.95 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.472 -1.307 . . . . 63.23 107.472 168.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -133.47 129.55 37.37 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.196 0.598 . . . . 73.22 110.088 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.47 69.87 12.65 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 105.852 -1.907 . . . . 14.42 105.852 167.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.07 -16.58 17.83 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.325 2.017 . . . . 52.53 111.124 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -94.71 9.43 38.94 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.651 1.18 . . . . 74.5 110.369 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -47.66 -58.53 7.4 Favored Pre-proline 0 CA--C 1.569 1.698 0 C-N-CA 124.785 1.234 . . . . 73.25 113.853 -165.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.478 ' HB3' HD11 ' B' ' 51' ' ' LEU . 69.4 Cg_exo -51.85 -44.56 44.17 Favored 'Trans proline' 0 C--N 1.398 3.152 0 C-N-CA 122.715 2.277 . . . . 73.21 113.856 -173.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -96.18 -13.03 23.81 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.485 -0.78 . . . . 72.11 112.205 -174.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.472 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.4 p -77.45 -15.86 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 120.869 0.366 . . . . 74.51 110.708 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -77.41 -22.39 51.63 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.299 0.64 . . . . 74.12 110.904 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -77.62 -23.79 49.73 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.921 0.889 . . . . 75.2 110.283 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 71' ' ' GLU . 30.3 mmmt -65.64 144.93 56.63 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.22 1.008 . . . . 72.32 111.94 -177.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -60.47 117.72 5.61 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 108.661 -0.866 . . . . 70.25 108.661 168.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.415 ' CE3' HD21 ' A' ' 68' ' ' LEU . 70.6 t-105 -75.6 84.68 2.65 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.676 0.75 . . . . 74.51 110.022 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.74 78.32 74.0 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 105.882 -1.896 . . . . 63.45 105.882 169.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -81.93 140.67 11.52 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.665 2.243 . . . . 73.44 111.908 -173.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -97.66 83.78 3.27 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.072 -1.455 . . . . 63.33 107.072 173.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 66' ' ' ALA . 58.0 t -81.96 119.16 30.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 CA-C-N 114.745 -1.116 . . . . 63.25 109.549 -174.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.437 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 74.0 mttt -113.86 113.57 25.06 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.237 1.015 . . . . 74.31 108.467 -170.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -98.43 121.16 40.02 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 108.294 -1.002 . . . . 71.33 108.294 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -130.43 138.57 50.39 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.39 1.076 . . . . 70.22 108.265 -176.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.525 HD22 HD21 ' A' ' 60' ' ' LEU . 88.3 mt -128.89 140.14 51.82 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.939 0.496 . . . . 53.02 110.95 -173.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.52 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 27.7 t70 -142.9 146.19 33.8 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.465 1.106 . . . . 74.02 108.742 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.2 m -131.8 128.85 39.63 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.117 0.567 . . . . 74.45 110.076 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.71 110.04 10.11 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.66 0.784 . . . . 62.13 109.151 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.4 p -90.68 161.23 15.47 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 109.512 -0.551 . . . . 51.01 109.512 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.4 t -152.97 121.17 6.21 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.966 0.906 . . . . 54.21 108.702 -172.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -79.72 104.23 10.17 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.589 -0.893 . . . . 73.43 108.589 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.6 mt -81.83 -35.58 29.25 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.893 0.477 . . . . 53.31 109.96 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.45 -176.47 5.08 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.628 0.771 . . . . 32.31 110.391 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.68 113.95 4.1 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.501 0.72 . . . . 74.2 110.181 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 66.27 17.89 10.8 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.629 1.172 . . . . 52.13 111.609 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.5 t -119.69 106.85 19.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 107.73 -1.211 . . . . 63.31 107.73 173.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -123.12 125.49 45.25 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.29 -1.004 . . . . 64.42 108.29 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -86.35 139.48 30.93 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.46 -0.941 . . . . 74.32 108.46 168.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.1 t -120.17 140.93 42.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.02 -1.104 . . . . 71.31 108.02 171.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.8 t -121.07 130.26 74.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.515 -0.92 . . . . 73.31 108.515 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.525 HD21 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -105.13 107.88 19.1 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.875 -1.528 . . . . 71.33 106.875 177.386 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.52 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 32.1 ttp180 -92.35 99.66 12.38 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.224 -1.399 . . . . 75.25 107.224 174.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.27 127.98 47.88 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 N-CA-C 107.689 -1.226 . . . . 74.11 107.689 174.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.411 HG23 ' HB2' ' A' ' 77' ' ' GLU . 7.5 m -121.05 125.08 46.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.402 0.62 . . . . 53.43 109.672 175.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.663 HG11 HD21 ' A' ' 126' ' ' LEU . 58.9 t -116.23 125.12 73.15 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.707 0 C-N-CA 124.962 1.305 . . . . 73.11 107.567 177.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.437 ' HB ' ' HD2' ' A' ' 41' ' ' LYS . 13.8 m -127.75 127.07 42.98 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.155 0.889 . . . . 61.13 109.629 172.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.485 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -118.07 126.46 52.32 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.346 -0.983 . . . . 71.25 108.346 178.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 35.2 m -130.24 132.82 46.13 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.461 0.704 . . . . 61.23 110.352 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.415 HD21 ' CE3' ' A' ' 36' ' ' TRP . 12.6 mt -93.08 70.35 4.52 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 125.26 1.424 . . . . 73.01 109.058 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.8 -107.03 2.36 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-N 115.595 -0.73 . . . . 51.45 111.404 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.1 -26.77 17.31 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.551 0.74 . . . . 54.14 111.216 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.42 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 6.3 tp10 -93.81 123.9 37.46 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.587 0.755 . . . . 71.31 109.001 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 89.8 m -75.82 136.79 40.21 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 117.744 0.247 . . . . 65.43 110.57 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.472 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -74.34 -64.83 0.94 Allowed 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.763 -0.828 . . . . 41.03 108.763 174.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.452 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 31.6 p90 -158.94 170.31 22.38 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.325 -0.852 . . . . 61.42 112.002 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 64' ' ' VAL . 57.2 tp -125.28 135.83 52.9 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.91 1.284 . . . . 64.14 107.831 167.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.45 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 73.7 m -135.4 97.75 3.78 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.692 0.797 . . . . 64.41 110.249 174.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.411 ' HB2' HG23 ' A' ' 63' ' ' THR . 34.9 tt0 -117.66 118.26 31.61 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.112 0.965 . . . . 72.15 108.543 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.9 t -127.68 121.82 57.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 109.134 -0.691 . . . . 62.4 109.134 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.713 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.2 mt-30 -92.79 86.37 5.49 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.275 -0.875 . . . . 72.14 108.865 173.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -76.71 99.37 5.06 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 113.786 -1.552 . . . . 73.24 109.469 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.14 159.73 32.85 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 111.419 -0.672 . . . . 34.22 111.419 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.437 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -161.02 122.45 1.12 Allowed Glycine 0 CA--C 1.498 -0.987 0 N-CA-C 110.336 -1.106 . . . . 55.31 110.336 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.6 mt -78.72 124.65 37.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 N-CA-C 107.337 -1.357 . . . . 74.41 107.337 173.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -123.79 160.04 28.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.884 -0.784 . . . . 72.12 108.884 176.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.6 t -117.75 101.57 8.43 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.349 -1.352 . . . . 54.4 107.349 173.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.0 mm -107.72 145.4 15.03 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 O-C-N 123.736 0.647 . . . . 75.44 110.249 -176.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.51 177.25 8.28 Favored 'General case' 0 C--O 1.231 0.116 0 O-C-N 123.761 0.663 . . . . 73.43 110.971 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.93 -27.18 11.61 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-N 116.061 -0.518 . . . . 53.1 113.047 176.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.45 148.19 24.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 C-N-CA 123.772 0.829 . . . . 70.24 110.808 -171.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.599 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 2.3 mp0 -135.9 175.42 9.61 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.915 0.886 . . . . 73.53 109.952 176.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.12 -119.77 9.88 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-N 115.341 -0.845 . . . . 74.52 113.497 174.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.5 p -73.2 -30.21 63.37 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.114 0.966 . . . . 54.12 110.448 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -74.66 -36.52 62.83 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.14 -0.937 . . . . 62.23 109.852 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.599 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 2.6 tpt -61.22 -44.78 96.72 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.295 0.638 . . . . 73.41 109.75 172.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.4 -29.48 69.0 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.269 -0.878 . . . . 55.51 111.271 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.506 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 54.0 t-80 -71.88 -27.66 63.01 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.288 0.635 . . . . 73.12 111.068 176.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 37.1 t -79.55 -60.73 2.24 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.147 -0.686 . . . . 73.15 109.147 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 78.5 mt -67.92 -34.15 76.06 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.03 0.932 . . . . 71.51 113.196 -172.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.87 3.46 52.5 Favored Glycine 0 N--CA 1.47 0.963 0 CA-C-O 119.688 -0.506 . . . . 73.4 113.775 -173.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.563 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -140.14 -70.47 0.39 Allowed 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 117.348 0.574 . . . . 62.15 111.332 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -67.69 -39.19 84.46 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 111.879 0.325 . . . . 64.22 111.879 -171.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 63.5 m -66.68 -53.35 28.87 Favored Pre-proline 0 CA--C 1.564 1.492 0 C-N-CA 124.566 1.146 . . . . 65.05 112.164 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.431 ' HA ' HD12 ' A' ' 106' ' ' LEU . 58.2 Cg_endo -68.35 -18.89 44.2 Favored 'Trans proline' 0 C--N 1.399 3.219 0 C-N-CA 121.965 1.777 . . . . 73.11 112.616 175.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.449 ' ND2' ' HA ' ' E' ' 145' ' ' ASP . 0.1 OUTLIER -67.4 -47.24 70.87 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.934 -0.765 . . . . 72.05 108.934 174.74 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.3 mm -59.56 -33.45 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.758 1.223 . . . . 71.04 111.299 175.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.437 HD21 ' HA3' ' A' ' 82' ' ' GLY . 49.3 mt -79.86 -18.8 49.85 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.315 0.646 . . . . 71.04 112.153 -178.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -66.51 -40.55 34.14 Favored Pre-proline 0 CA--C 1.558 1.251 0 N-CA-C 114.737 1.384 . . . . 75.03 114.737 -172.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -55.5 -37.71 94.72 Favored 'Trans proline' 0 C--N 1.389 2.69 0 C-N-CA 121.998 1.798 . . . . 74.43 112.757 173.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -82.32 -35.2 28.16 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.098 -0.955 . . . . 75.43 111.022 -175.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.73 -49.39 73.24 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.157 -0.683 . . . . 64.04 109.157 174.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.518 ' NH1' HD12 ' C' ' 105' ' ' ILE . 32.3 ttm180 -49.86 -55.14 15.43 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 125.19 1.556 . . . . 64.13 110.511 174.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.85 -42.57 94.79 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.25 0.969 . . . . 64.32 111.686 -173.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.462 ' O ' ' HG3' ' A' ' 117' ' ' MET . 48.7 t -60.45 -40.79 92.44 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 123.5 0.5 . . . . 53.54 110.795 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.464 HG21 HG21 ' A' ' 64' ' ' VAL . 63.2 mt -64.58 -50.34 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.224 1.01 . . . . 75.4 110.597 174.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.446 HG21 ' HE2' ' C' ' 109' ' ' TYR . 82.9 m -58.03 -44.62 87.44 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.367 1.067 . . . . 74.4 111.245 -174.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 24.0 t -65.69 -40.74 92.64 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.329 -1.305 . . . . 74.22 110.21 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.707 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 38.0 mtm -64.07 -41.28 97.39 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.61 0.364 . . . . 73.13 111.034 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.409 HG13 ' HB2' ' A' ' 123' ' ' PHE . 79.3 t -61.58 -45.37 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 O-C-N 124.051 0.844 . . . . 65.0 110.587 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.3 p -71.91 -32.76 67.69 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.014 0.525 . . . . 73.21 111.273 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.463 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.5 mtt-85 -69.96 -30.88 68.35 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.271 0.629 . . . . 73.21 109.704 174.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.99 12.72 57.16 Favored Glycine 0 C--N 1.355 1.604 0 O-C-N 123.905 0.753 . . . . 51.25 112.861 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.402 HG21 ' HE ' ' B' ' 15' ' ' ARG . 1.5 t 62.19 14.19 6.46 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.153 2.181 . . . . 74.15 113.615 172.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.409 ' HB2' HG13 ' A' ' 118' ' ' VAL . 98.1 m-85 -80.49 149.35 68.26 Favored Pre-proline 0 C--O 1.244 0.813 0 N-CA-C 107.068 -1.456 . . . . 71.22 107.068 169.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.687 ' HB3' ' HA ' ' E' ' 131' ' ' TRP . 12.2 Cg_endo -55.63 142.88 81.3 Favored 'Trans proline' 0 C--N 1.366 1.467 0 C-N-CA 122.163 1.909 . . . . 50.41 111.396 176.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -55.53 122.63 11.71 Favored 'General case' 0 C--N 1.352 0.705 0 O-C-N 124.246 0.966 . . . . 63.02 111.481 -169.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.663 HD21 HG11 ' A' ' 64' ' ' VAL . 22.6 tp -106.15 121.15 43.59 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 108.35 -0.982 . . . . 73.31 108.35 -176.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.588 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 88.6 m-20 -117.74 124.28 48.08 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.657 -1.238 . . . . 71.33 107.657 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 9.6 mt -74.24 140.3 44.92 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.966 -0.753 . . . . 74.3 108.966 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.421 ' HB3' ' HD1' ' E' ' 138' ' ' TYR . . . -69.62 140.16 89.36 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-O 119.251 -0.404 . . . . 61.2 111.025 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -56.09 115.68 2.64 Favored 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 123.392 2.728 . . . . 72.31 113.343 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.414 HG21 HD11 ' A' ' 44' ' ' LEU . 92.0 t -102.72 123.38 56.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-N 115.421 -0.809 . . . . 73.44 109.517 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -87.24 90.72 8.46 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 107.778 -1.193 . . . . 71.45 107.778 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.412 ' CZ ' HD13 ' A' ' 44' ' ' LEU . 29.3 m-85 -63.58 -28.6 70.04 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.396 0.678 . . . . 60.4 111.465 177.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.563 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 14.8 t70 -61.7 -39.39 91.33 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.486 0.715 . . . . 75.43 110.11 175.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.5 -40.17 89.09 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.728 0.811 . . . . 62.33 110.651 173.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.97 -38.74 89.67 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.259 0.623 . . . . 73.53 111.352 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.502 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 60.1 t80 -74.51 -39.73 62.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.79 -0.448 . . . . 74.31 109.79 177.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.491 ' HE3' HD23 ' A' ' 141' ' ' LEU . 1.9 tpt -54.46 -35.86 63.48 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.273 1.029 . . . . 74.14 111.027 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -56.23 -55.33 34.58 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.915 0.886 . . . . 73.11 110.851 176.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -71.0 -31.5 68.05 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.625 0.77 . . . . 72.11 111.253 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.491 HD23 ' HE3' ' A' ' 138' ' ' MET . 32.0 tp -68.13 -52.77 31.05 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.09 0.556 . . . . 64.22 111.37 -170.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 179.18 -15.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 113.681 0.993 . . . . 63.52 113.681 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 58.99 56.0 4.21 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.556 0.742 . . . . 72.14 111.348 -173.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -164.18 100.89 0.85 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.381 0.672 . . . . 74.42 110.185 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -167.95 135.6 2.26 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.71 1.204 . . . . 64.44 108.525 175.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -168.14 125.92 1.35 Allowed Glycine 0 C--N 1.348 1.196 0 C-N-CA 121.631 -0.319 . . . . 71.33 113.006 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.629 ' HA ' ' HA3' ' C' ' 148' ' ' GLY . 42.5 mt-10 -132.75 147.81 52.32 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.544 1.137 . . . . 75.1 109.227 173.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 140.26 117.19 1.39 Allowed Glycine 0 C--N 1.341 0.851 0 N-CA-C 111.428 -0.669 . . . . 61.11 111.428 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.442 HG22 ' O ' ' C' ' 147' ' ' GLU . 5.1 t -149.88 65.74 0.98 Allowed 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.408 -0.96 . . . . 60.21 108.408 170.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -66.92 98.67 0.57 Allowed 'General case' 0 C--N 1.35 0.592 0 CA-C-N 114.59 -1.186 . . . . 73.35 110.466 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -104.64 127.91 52.53 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 108.469 -0.937 . . . . 64.05 108.469 171.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -83.19 100.74 10.76 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.338 -0.616 . . . . 71.24 109.338 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -118.63 102.53 8.94 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.773 0.829 . . . . 71.03 108.808 173.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -163.54 133.06 4.09 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.462 0.705 . . . . 71.31 109.859 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.941 0 C-N-CA 124.158 0.983 . . . . 53.12 108.732 178.867 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 110.06 -0.348 . . . . 75.12 110.06 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 74.9 m -93.32 78.18 4.48 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 123.433 0.693 . . . . 65.43 109.767 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -175.23 32.11 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.225 -0.898 . . . . 70.15 110.795 -177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -132.98 -179.72 5.66 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.795 0.438 . . . . 72.01 110.761 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -90.95 95.87 10.34 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.679 0.792 . . . . 55.53 109.274 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.59 ' HB3' ' HB2' ' B' ' 154' ' ' ASP . 63.4 t30 -151.61 170.29 20.05 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.718 0.807 . . . . 73.05 109.144 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 45.8 p -56.96 134.99 56.11 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.364 1.066 . . . . 64.11 111.087 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -70.94 127.3 32.13 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.204 1.001 . . . . 71.31 110.536 -171.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.449 ' HG3' HG13 ' B' ' 89' ' ' ILE . 24.6 ttt 65.97 166.94 0.2 Allowed 'General case' 0 CA--C 1.562 1.413 0 C-N-CA 124.725 1.21 . . . . 73.22 111.564 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.406 ' N ' ' HG2' ' B' ' 9' ' ' MET . 2.6 t -138.75 126.58 22.26 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.691 1.196 . . . . 54.22 108.46 169.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -127.9 137.41 52.3 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.286 -1.005 . . . . 74.12 108.286 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.556 HE21 ' HB2' ' E' ' 126' ' ' ALA . 26.2 tp60 -151.86 109.71 3.67 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.624 0.369 . . . . 71.43 110.359 -176.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.431 HD13 HD11 ' B' ' 16' ' ' ILE . 47.4 mt -60.84 144.65 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 108.853 -0.795 . . . . 73.3 108.853 172.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -110.04 -45.21 3.64 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.684 -0.487 . . . . 75.52 109.684 176.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.402 ' HE ' HG21 ' A' ' 122' ' ' THR . 50.0 ttt180 -167.45 132.66 1.98 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.386 -0.598 . . . . 61.4 109.386 -173.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.431 HD11 HD13 ' B' ' 13' ' ' ILE . 96.4 mt -118.88 147.93 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 107.494 -1.299 . . . . 74.4 107.494 177.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -169.91 163.89 9.6 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.836 0.827 . . . . 73.2 112.139 -174.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 82.7 m -92.49 122.74 35.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.627 -1.624 . . . . 63.35 108.237 171.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -80.05 -49.94 11.07 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.571 0.748 . . . . 64.34 110.732 170.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -144.99 139.46 27.5 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 122.113 -0.367 . . . . 73.2 111.185 -168.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.462 HD11 ' SG ' ' B' ' 113' ' ' CYS . 49.5 mm -128.86 141.77 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.247 1.019 . . . . 74.0 109.911 173.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -144.82 133.35 22.02 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.69 1.196 . . . . 71.12 108.002 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -143.6 109.9 5.41 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.016 -1.105 . . . . 73.02 108.016 173.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -117.97 114.86 23.8 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.562 0.745 . . . . 72.03 109.039 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.25 88.31 2.47 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 106.431 -1.692 . . . . 75.11 106.431 170.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -72.02 -31.8 11.87 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.092 2.528 . . . . 72.11 113.256 -168.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -109.42 25.72 11.47 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.307 0.643 . . . . 74.53 109.268 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.532 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -44.36 -58.41 5.1 Favored Pre-proline 0 CA--C 1.564 1.487 0 N-CA-C 114.633 1.346 . . . . 74.13 114.633 -163.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 24.6 Cg_exo -61.3 -35.94 81.83 Favored 'Trans proline' 0 C--N 1.393 2.889 0 C-N-CA 122.078 1.852 . . . . 75.34 112.962 -174.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -95.08 -25.18 16.56 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.478 -0.783 . . . . 72.54 112.47 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.536 HG22 HD12 ' B' ' 68' ' ' LEU . 4.5 p -71.15 -14.25 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-O 121.332 0.587 . . . . 65.13 110.14 -175.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -73.31 -2.66 22.95 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.265 1.026 . . . . 74.34 112.459 174.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -68.63 -19.64 64.43 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.435 0.694 . . . . 73.24 110.116 169.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.573 ' HB2' HD13 ' B' ' 68' ' ' LEU . 29.4 mmtp -98.31 102.62 14.42 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 125.497 1.519 . . . . 74.4 108.884 -177.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -99.8 77.35 2.04 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.807 0.443 . . . . 74.03 110.639 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 43.6 p90 -160.99 167.97 25.45 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.976 0.91 . . . . 74.52 109.581 169.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.46 113.97 22.45 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 107.328 -1.36 . . . . 73.04 107.328 176.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.92 163.92 15.22 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.809 2.339 . . . . 64.21 113.709 -173.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -71.21 103.95 2.95 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.388 -0.967 . . . . 44.43 108.388 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.555 HG11 HD11 ' B' ' 126' ' ' LEU . 49.0 t -94.33 146.5 6.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 114.996 -1.002 . . . . 64.35 110.253 -176.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -149.14 125.96 11.17 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.24 1.016 . . . . 74.3 108.282 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.441 HD11 ' CG1' ' B' ' 62' ' ' VAL . 16.3 tp -89.65 137.95 31.89 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.061 0.545 . . . . 75.33 109.768 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -139.56 113.29 8.57 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.441 1.096 . . . . 64.31 108.309 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 91.3 mt -99.69 152.46 20.05 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.751 0.82 . . . . 71.34 109.636 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.789 ' HB3' ' HD2' ' B' ' 61' ' ' ARG . 31.7 t70 -156.03 151.59 27.04 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 107.324 -1.362 . . . . 72.02 107.324 173.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . 0.485 ' HB ' ' CE2' ' F' ' 106' ' ' TYR . 0.9 OUTLIER -143.83 146.45 33.07 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.664 0.745 . . . . 74.31 112.315 -170.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.11 153.2 41.91 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.931 1.292 . . . . 63.32 108.359 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.487 ' HB2' ' CE2' ' B' ' 56' ' ' TYR . 74.4 p -145.7 176.05 9.93 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.565 0.579 . . . . 73.43 112.565 -174.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 65.5 p -162.01 139.29 8.46 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.688 1.195 . . . . 75.13 109.869 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -90.79 109.93 21.13 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.284 -0.635 . . . . 71.22 109.284 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' A' ' 29' ' ' PRO . 39.3 mt -86.56 -23.34 25.85 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.763 0.425 . . . . 71.41 110.531 175.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.543 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -163.1 167.42 22.28 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.452 0.701 . . . . 71.51 111.08 -176.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -82.17 138.49 34.69 Favored 'General case' 0 C--O 1.248 0.99 0 N-CA-C 107.291 -1.374 . . . . 71.14 107.291 161.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 78.17 -5.35 2.09 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 125.758 1.623 . . . . 73.5 112.258 -175.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 50.1 t -144.34 117.97 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.539 0.735 . . . . 71.21 109.044 -175.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.487 ' CE2' ' HB2' ' B' ' 48' ' ' SER . 26.9 t80 -126.61 151.58 47.8 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.195 0.598 . . . . 75.41 110.002 -173.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -116.26 121.0 40.73 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 107.755 -1.202 . . . . 74.31 107.755 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 12.9 p -127.48 147.93 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.128 0.571 . . . . 72.43 109.984 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 17.4 t -125.37 116.26 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 123.73 0.812 . . . . 64.2 109.808 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.45 ' HA ' HG22 ' B' ' 46' ' ' THR . 58.0 tp -94.72 105.27 17.21 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.051 -0.722 . . . . 74.32 109.051 170.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.789 ' HD2' ' HB3' ' B' ' 45' ' ' ASP . 1.7 tmt_? -86.54 120.46 27.89 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.709 -1.219 . . . . 72.43 107.709 172.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.441 ' CG1' HD11 ' B' ' 42' ' ' LEU . 32.3 t -114.81 133.04 62.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.284 -1.006 . . . . 52.15 108.284 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 24.7 m -131.03 131.81 44.54 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.325 0.583 . . . . 75.23 109.628 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.7 HG11 HD21 ' B' ' 126' ' ' LEU . 97.2 t -111.54 118.74 58.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 C-N-CA 124.419 1.087 . . . . 74.03 108.338 176.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 68.5 m -92.51 130.94 38.03 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.114 -1.069 . . . . 70.24 108.114 168.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.39 134.34 27.19 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.863 -0.792 . . . . 72.33 108.863 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.492 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 18.8 p -144.63 133.26 22.2 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 123.736 0.648 . . . . 63.22 110.803 -175.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.573 HD13 ' HB2' ' B' ' 34' ' ' LYS . 78.4 mt -99.45 103.05 14.79 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.47 1.108 . . . . 75.5 110.056 176.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.7 -111.7 3.41 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.797 -0.521 . . . . 63.31 111.797 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -115.19 1.32 13.81 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.256 0.622 . . . . 74.32 110.706 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.53 ' HG3' HG23 ' B' ' 31' ' ' VAL . 18.2 pt-20 -115.47 143.1 45.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.415 0.686 . . . . 75.12 109.396 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 63.4 m -69.11 132.13 46.09 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 121.235 0.54 . . . . 73.22 110.999 -178.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.492 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -83.31 -63.03 1.44 Allowed 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.819 -1.178 . . . . 72.22 107.819 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -153.87 152.36 30.55 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.523 -1.217 . . . . 74.54 110.358 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -125.79 111.85 15.36 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.427 -1.694 . . . . 75.15 106.427 170.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.49 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 49.5 t -117.42 134.63 54.62 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 107.909 -1.145 . . . . 73.34 107.909 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -146.09 126.36 13.92 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.427 -0.953 . . . . 73.24 108.427 -173.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 66.1 t -123.08 148.02 27.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.259 -1.015 . . . . 62.54 108.259 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -120.46 106.96 12.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.083 -1.451 . . . . 54.24 107.083 168.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -100.82 103.07 14.27 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.609 -0.885 . . . . 75.53 108.609 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.59 158.8 18.59 Favored Glycine 0 C--N 1.342 0.885 0 O-C-N 123.762 0.664 . . . . 74.34 111.548 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.44 142.45 7.86 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 117.314 0.557 . . . . 72.15 113.414 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 3.8 mp -90.34 124.68 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 107.941 -1.133 . . . . 75.42 107.941 170.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -129.59 153.35 48.15 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.315 1.046 . . . . 75.44 109.28 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 30.3 m -107.76 109.1 20.58 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.742 0.817 . . . . 73.12 109.191 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.598 HG22 HD11 ' B' ' 89' ' ' ILE . 4.0 mp -111.74 108.52 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 124.756 1.223 . . . . 63.04 107.93 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.98 158.43 43.92 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.048 0.539 . . . . 64.44 111.22 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.73 -56.14 0.88 Allowed Glycine 0 C--N 1.349 1.261 0 C-N-CA 123.292 0.472 . . . . 73.42 112.668 175.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.598 HD11 HG22 ' B' ' 86' ' ' ILE . 0.6 OUTLIER -56.22 166.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 124.528 1.131 . . . . 64.43 113.035 173.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -158.42 160.03 36.39 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.078 -0.964 . . . . 64.23 110.057 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.08 -109.92 3.81 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 112.166 -0.373 . . . . 54.11 112.166 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 80.0 m -99.94 -42.42 6.78 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.482 0.713 . . . . 73.24 110.677 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.405 ' HA ' ' HB3' ' B' ' 96' ' ' HIS . 2.8 mp0 -65.66 -19.14 65.79 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.207 1.003 . . . . 71.04 112.448 -173.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.456 ' HA ' HD13 ' B' ' 89' ' ' ILE . 20.3 ptm -61.69 -66.07 0.59 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.102 0.561 . . . . 64.03 111.613 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.435 ' H ' ' HG3' ' B' ' 94' ' ' MET . . . -79.69 -14.26 58.89 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.801 0.44 . . . . 53.5 111.621 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.405 ' HB3' ' HA ' ' B' ' 93' ' ' GLN . 35.7 t-80 -63.32 -34.9 78.7 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.278 0.631 . . . . 61.24 110.888 171.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 48.7 t -66.72 -44.21 82.2 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.819 0.447 . . . . 63.21 111.594 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.55 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 1.5 pp -80.23 -30.18 38.54 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.098 0.559 . . . . 74.13 111.464 177.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.51 -30.57 44.34 Favored Glycine 0 C--N 1.342 0.866 0 O-C-N 123.601 0.563 . . . . 72.41 113.601 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.41 -53.95 1.47 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.324 0.65 . . . . 62.25 111.967 -169.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -67.79 -37.46 82.08 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.333 0.653 . . . . 72.32 112.197 -174.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.55 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 79.9 m -71.14 -43.56 13.13 Favored Pre-proline 0 CA--C 1.563 1.456 0 CA-C-O 118.383 -0.818 . . . . 64.1 112.367 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -50.89 -36.88 54.38 Favored 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 122.366 2.044 . . . . 74.21 113.402 166.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -67.42 -29.75 69.32 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.2 0.6 . . . . 45.24 111.865 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.406 ' O ' ' HD2' ' B' ' 108' ' ' PRO . 74.9 mt -69.49 -41.57 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.314 0.646 . . . . 74.14 109.691 171.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.6 mt -76.85 -21.57 54.82 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.962 -1.017 . . . . 64.12 112.028 -174.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -59.15 -49.76 91.3 Favored Pre-proline 0 N--CA 1.485 1.314 0 CA-C-O 118.165 -0.921 . . . . 72.22 113.021 -176.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.406 ' HD2' ' O ' ' B' ' 105' ' ' ILE . 86.9 Cg_exo -53.17 -43.04 60.48 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 122.715 2.277 . . . . 75.15 114.224 175.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -67.29 -41.27 85.7 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.396 0.678 . . . . 51.23 110.565 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.32 -38.45 91.1 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.601 -0.727 . . . . 61.34 110.689 175.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.0 ttt-85 -64.93 -47.12 78.84 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.529 1.532 . . . . 61.42 110.831 -176.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -70.87 -34.0 71.17 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.988 0.515 . . . . 65.03 109.855 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.528 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.9 t -66.23 -34.66 78.52 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 123.352 0.408 . . . . 75.22 110.741 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.49 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 51.8 mt -65.46 -55.71 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.924 0.889 . . . . 64.42 109.858 173.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 10.2 m -63.35 -24.83 68.02 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.479 0.712 . . . . 74.34 111.496 -175.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.437 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 36.4 t -64.24 -50.15 69.11 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 123.385 0.674 . . . . 72.35 109.251 173.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.528 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.2 mmt -69.5 -34.35 74.18 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.305 0.642 . . . . 74.35 110.826 -176.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 114' ' ' ILE . 85.5 t -62.26 -43.73 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 123.88 0.872 . . . . 74.21 110.082 173.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 48.3 t -66.25 -31.89 72.98 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.027 -0.988 . . . . 71.23 111.041 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' B' ' 116' ' ' SER . 86.4 mtt-85 -68.95 -39.77 79.33 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.488 -0.778 . . . . 73.03 110.5 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.08 -14.26 81.98 Favored Glycine 0 C--N 1.354 1.531 0 O-C-N 123.698 0.624 . . . . 62.24 112.222 172.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 7.5 m 65.58 37.15 6.11 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.595 1.558 . . . . 63.33 110.058 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.432 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 57.5 m-85 -85.22 159.54 56.37 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 114.576 -1.193 . . . . 74.53 110.051 173.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.45 ' HG3' ' HB2' ' F' ' 131' ' ' TRP . 86.6 Cg_exo -47.89 159.79 0.56 Allowed 'Trans proline' 0 C--N 1.385 2.458 0 C-N-CA 123.851 3.034 . . . . 74.34 115.249 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.527 HE21 ' ND2' ' B' ' 127' ' ' ASN . 60.0 tp60 -61.3 118.19 6.58 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 115.112 -0.949 . . . . 63.22 111.762 -173.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.7 HD21 HG11 ' B' ' 64' ' ' VAL . 32.8 tp -110.85 103.33 11.83 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.556 -0.747 . . . . 61.4 110.052 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.527 ' ND2' HE21 ' B' ' 125' ' ' GLN . 34.4 m-80 -108.1 114.9 29.15 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 107.908 -1.145 . . . . 72.43 107.908 169.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.44 HD21 ' CG2' ' B' ' 64' ' ' VAL . 41.9 mt -70.42 140.94 52.15 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.272 0.358 . . . . 64.44 110.352 176.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.47 145.79 98.99 Favored Pre-proline 0 CA--C 1.551 1.01 0 O-C-N 123.7 0.625 . . . . 73.5 110.529 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.477 ' HD2' ' HB1' ' F' ' 125' ' ' ALA . 39.3 Cg_exo -60.88 92.05 0.1 OUTLIER 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.827 2.352 . . . . 72.33 111.74 174.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 94.7 t -99.23 112.51 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 123.24 0.616 . . . . 61.01 109.778 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -79.2 113.74 17.58 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.943 0.897 . . . . 70.53 109.141 173.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -62.56 -36.01 81.3 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.134 0.974 . . . . 70.3 110.76 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -55.31 -45.6 76.29 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.37 1.044 . . . . 73.33 110.912 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -50.74 -39.74 52.83 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.347 1.03 . . . . 71.51 113.594 -170.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 5.5 mp -72.0 -42.08 66.86 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.617 0.367 . . . . 45.24 111.053 -176.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -74.91 -25.88 59.24 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 116.381 -0.372 . . . . 73.42 111.666 175.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -73.21 -37.92 66.27 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.433 0.693 . . . . 61.41 109.81 -177.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -75.23 -22.83 57.62 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 116.253 -0.43 . . . . 45.13 110.491 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -82.76 -23.54 33.9 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.256 0.622 . . . . 75.11 111.037 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 24.4 tp -117.31 25.08 10.71 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.648 0.779 . . . . 72.12 109.398 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -71.65 -47.07 56.83 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.586 0.754 . . . . 73.13 110.093 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -70.97 90.77 0.84 Allowed 'General case' 0 C--N 1.354 0.769 0 N-CA-C 107.649 -1.241 . . . . 74.51 107.649 177.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -167.7 -51.57 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.243 -0.89 . . . . 52.23 109.375 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . 68.88 168.44 0.28 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.918 1.287 . . . . 72.32 111.551 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 162.31 68.27 0.02 OUTLIER Glycine 0 C--N 1.343 0.949 0 N-CA-C 111.961 -0.456 . . . . 64.45 111.961 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -83.18 97.32 8.77 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.187 -0.671 . . . . 53.42 109.187 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.76 179.05 38.55 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 115.895 -0.593 . . . . 40.11 113.559 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 27.7 m -98.2 144.5 27.59 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 109.078 -0.712 . . . . 21.32 109.078 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -66.35 92.38 0.19 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.709 0.804 . . . . 72.23 110.417 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -158.27 114.71 2.79 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.958 1.303 . . . . 75.14 107.52 176.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -84.75 140.98 30.86 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 122.292 0.237 . . . . 72.02 110.489 -175.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -85.55 -163.84 0.92 Allowed 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 109.296 -0.631 . . . . 75.44 109.296 171.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . 0.59 ' HB2' ' HB3' ' B' ' 6' ' ' ASN . 18.3 p-10 -135.99 179.05 6.58 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.067 0.547 . . . . 74.43 110.712 177.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-N 114.959 -1.019 . . . . 73.41 110.171 -179.95 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.473 0.707 0 CA-C-O 119.538 -0.267 . . . . 70.14 111.434 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 31.9 t -171.53 30.9 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.622 0.369 . . . . 73.1 111.617 -172.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -80.73 80.91 7.11 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.379 0.609 . . . . 73.22 110.066 -177.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -113.67 16.36 18.63 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.803 0.841 . . . . 62.21 110.637 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -81.9 102.44 10.89 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.94 0.896 . . . . 71.3 109.45 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -113.27 99.43 7.8 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.631 0.773 . . . . 73.52 110.062 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 31.4 p -127.65 -175.52 3.49 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.242 1.017 . . . . 72.31 109.854 174.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -69.35 137.26 52.75 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 107.86 -1.163 . . . . 71.41 107.86 165.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.492 ' HE3' HG21 ' C' ' 89' ' ' ILE . 55.6 ttm 61.5 111.58 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.046 1.338 . . . . 75.2 111.284 -172.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.461 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 58.0 m -103.15 80.37 1.84 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 106.942 -1.503 . . . . 54.33 106.942 172.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -92.26 126.86 37.52 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 114.96 -1.018 . . . . 65.45 109.118 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -141.33 118.09 11.05 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.206 0.603 . . . . 74.51 109.698 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 60.4 mt -73.52 134.13 30.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 109.018 -0.734 . . . . 72.4 109.018 173.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.433 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.3 mm-40 -96.79 -49.97 4.86 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 108.998 -0.742 . . . . 52.22 108.998 171.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.588 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -178.2 146.0 0.38 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.32 1.048 . . . . 74.03 110.477 179.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 4.9 mp -109.7 124.84 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 107.549 -1.278 . . . . 72.42 107.549 172.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.477 ' HB3' HG23 ' D' ' 122' ' ' THR . 44.1 p90 -147.74 170.52 17.39 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.584 0.707 . . . . 74.25 111.712 -171.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . 0.411 HG21 HD11 ' C' ' 21' ' ' ILE . 75.5 p -102.7 108.17 19.32 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.493 -0.776 . . . . 73.23 109.936 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.562 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 26.7 mtpt -78.66 -23.15 45.89 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 109.468 -0.567 . . . . 74.42 109.468 174.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.485 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 10.5 t70 -148.51 138.88 22.59 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.699 0.8 . . . . 55.21 109.774 176.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.476 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 82.7 mt -136.89 140.17 43.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 106.314 -1.736 . . . . 54.33 106.314 169.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.9 t -153.18 143.92 22.75 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.457 0.703 . . . . 63.43 109.949 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -156.22 109.25 2.65 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 107.657 -1.238 . . . . 74.12 107.657 172.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -116.34 111.49 20.17 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.477 -0.564 . . . . 75.21 109.477 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.79 79.64 31.95 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 108.006 -1.109 . . . . 53.2 108.006 170.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.05 -17.04 25.26 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.614 2.209 . . . . 64.11 111.399 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -105.01 11.99 32.78 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.762 1.225 . . . . 70.22 110.274 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.475 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -50.96 -54.05 41.44 Favored Pre-proline 0 C--N 1.371 1.501 0 C-N-CA 124.351 1.06 . . . . 64.02 113.742 -169.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.6 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 12.4 Cg_endo -56.92 -52.7 6.22 Favored 'Trans proline' 0 C--N 1.391 2.789 0 C-N-CA 121.658 1.572 . . . . 74.14 111.67 -178.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.453 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 85.4 t60 -67.77 -28.64 67.78 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.659 0.784 . . . . 62.31 112.654 -172.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.735 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.6 p -77.43 -19.68 14.15 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.171 0 N-CA-C 112.43 0.53 . . . . 73.52 112.43 -174.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -71.66 -13.52 61.77 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.856 0.687 . . . . 72.03 112.856 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 28.1 pt20 -99.18 6.34 46.43 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.188 0.595 . . . . 52.1 111.68 175.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.82 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -94.48 150.91 19.79 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.778 0.831 . . . . 55.43 110.442 -178.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.16 119.78 11.49 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.343 0.657 . . . . 64.33 109.277 169.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -82.89 92.37 7.28 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.557 0.743 . . . . 64.3 112.053 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -142.9 79.99 14.2 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 124.606 1.162 . . . . 74.3 107.895 169.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -87.29 163.06 8.41 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.732 2.288 . . . . 73.15 111.235 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -85.57 76.06 10.06 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.306 -1.368 . . . . 62.44 107.306 173.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 p -62.75 97.34 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 114.603 -1.18 . . . . 62.05 108.735 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -107.56 102.96 12.18 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 113.627 -1.624 . . . . 73.44 107.442 -171.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -88.3 129.36 35.4 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.017 -1.105 . . . . 70.52 108.017 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.437 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 15.4 t70 -124.62 139.04 54.24 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.95 -0.759 . . . . 75.21 108.95 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.449 HD22 HD21 ' C' ' 60' ' ' LEU . 79.0 mt -130.43 110.65 11.63 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.083 0.953 . . . . 51.2 108.568 175.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -124.22 119.77 30.31 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.175 -1.417 . . . . 75.13 107.175 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.1 t -119.91 145.32 46.82 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 109.621 -0.511 . . . . 70.54 109.621 -176.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.54 162.13 36.65 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.912 0.885 . . . . 54.42 108.931 176.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.409 ' OG ' ' HB3' ' C' ' 98' ' ' LEU . 5.4 m -129.12 164.08 24.11 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 109.468 -0.568 . . . . 61.22 109.468 174.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -148.65 125.61 11.3 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.675 -1.231 . . . . 72.31 107.675 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -84.21 114.83 22.09 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.897 -1.149 . . . . 65.52 107.897 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.597 HD11 ' HB2' ' C' ' 57' ' ' GLU . 50.1 mt -88.71 -42.67 11.82 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.4 0.68 . . . . 73.41 109.782 -175.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.04 -171.22 3.85 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 115.081 -0.963 . . . . 63.52 109.967 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.37 113.32 2.85 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 114.92 -1.036 . . . . 55.42 109.307 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 63.86 15.29 8.99 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.037 0.935 . . . . 75.51 112.387 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 85.1 t -111.71 115.88 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.136 -1.061 . . . . 62.33 108.136 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -125.14 124.73 42.44 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.804 0.841 . . . . 63.11 109.185 -177.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.597 ' HB2' HD11 ' C' ' 51' ' ' LEU . 38.7 tt0 -83.74 133.63 34.78 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.238 -1.023 . . . . 74.21 108.238 164.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -118.94 135.61 58.79 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 N-CA-C 108.247 -1.02 . . . . 73.42 108.247 168.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.413 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 57.3 t -119.75 141.93 37.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 123.644 0.778 . . . . 72.12 109.128 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.449 HD21 HD22 ' C' ' 44' ' ' LEU . 0.0 OUTLIER -123.11 102.01 7.73 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.713 -1.217 . . . . 75.44 107.713 177.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -81.87 106.97 14.21 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.687 -0.857 . . . . 73.51 108.687 172.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 11.0 t -109.86 113.91 45.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.24 -1.022 . . . . 70.53 108.24 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 26.8 m -111.98 132.13 54.97 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.197 -0.668 . . . . 73.42 109.197 -177.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.561 HG23 HD13 ' C' ' 114' ' ' ILE . 50.6 t -118.32 114.71 45.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.774 -0.824 . . . . 73.14 108.774 171.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.432 HG23 HD23 ' C' ' 75' ' ' LEU . 7.4 m -99.19 139.17 35.25 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.285 -1.006 . . . . 53.22 108.285 172.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.6 109.82 8.35 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.638 -0.875 . . . . 64.32 108.638 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 36.5 m -136.94 131.75 33.45 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.874 0.47 . . . . 54.24 110.293 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.82 HD13 ' HG2' ' C' ' 34' ' ' LYS . 1.6 mt -93.16 50.34 1.51 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.214 1.006 . . . . 64.35 108.572 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.32 -119.95 6.46 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 110.3 -1.12 . . . . 75.45 110.3 -171.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -90.48 -11.94 38.77 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.239 0.616 . . . . 63.15 109.836 172.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -71.58 119.53 15.87 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.753 0.821 . . . . 75.21 109.239 172.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 30.9 m -79.27 125.1 29.05 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.071 -0.714 . . . . 64.12 109.071 170.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.735 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -82.43 -53.92 5.61 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.39 -1.337 . . . . 75.33 107.39 168.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . 0.429 ' HZ ' HD13 ' C' ' 126' ' ' LEU . 32.7 p90 -169.77 168.56 8.88 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 114.73 -1.123 . . . . 74.11 110.41 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.432 HD23 HG23 ' C' ' 65' ' ' THR . 3.1 tm? -130.44 144.93 51.71 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 106.14 -1.8 . . . . 75.54 106.14 169.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.417 ' N ' HD13 ' C' ' 75' ' ' LEU . 49.2 t -150.17 146.21 26.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.739 0.416 . . . . 72.12 109.991 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -157.68 137.47 12.26 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.701 0.8 . . . . 75.21 109.673 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.562 HG21 ' HB3' ' C' ' 113' ' ' CYS . 24.2 t -134.34 113.51 17.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 124.562 1.145 . . . . 72.21 107.923 174.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.485 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 69.3 mt-30 -91.55 88.42 6.76 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.966 -1.124 . . . . 61.52 107.966 174.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -79.27 96.86 6.06 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.821 -1.081 . . . . 75.2 109.195 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -92.56 145.79 17.82 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 111.27 -0.732 . . . . 61.43 111.27 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.85 132.75 4.01 Favored Glycine 0 CA--C 1.501 -0.787 0 N-CA-C 110.898 -0.881 . . . . 74.21 110.898 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.433 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 26.5 mm -89.48 132.0 35.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.836 0 N-CA-C 109.174 -0.676 . . . . 73.14 109.174 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -134.51 119.27 18.27 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.727 0.811 . . . . 74.0 109.376 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 27.8 m -81.8 102.07 10.57 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.202 -1.036 . . . . 73.14 108.202 171.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.608 HG21 ' HE1' ' C' ' 94' ' ' MET . 27.5 mt -116.22 131.6 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.732 0.813 . . . . 53.13 109.481 -176.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.461 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -142.03 169.45 17.57 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.756 0.423 . . . . 74.31 110.956 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.21 -29.48 5.59 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 115.817 -0.629 . . . . 43.01 113.971 171.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.492 HG21 ' HE3' ' C' ' 9' ' ' MET . 39.5 pt -96.95 171.79 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.338 0.655 . . . . 65.31 110.933 -177.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -166.23 -179.15 4.91 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.198 0.999 . . . . 75.12 109.256 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.29 -119.9 13.71 Favored Glycine 0 CA--C 1.531 1.054 0 O-C-N 123.925 0.766 . . . . 64.54 114.116 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . 0.689 ' HB ' HD12 ' C' ' 141' ' ' LEU . 26.1 p -73.93 -30.83 62.77 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.696 0.798 . . . . 62.24 112.105 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -63.47 -48.24 78.48 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.944 0.498 . . . . 74.24 109.709 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.608 ' HE1' HG21 ' C' ' 86' ' ' ILE . 5.4 tpt -63.99 -48.08 77.83 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-N 115.547 -0.751 . . . . 75.44 110.501 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.4 -35.23 73.58 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.287 0.635 . . . . 34.25 111.486 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -83.74 -28.84 27.94 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.956 0.502 . . . . 70.24 110.954 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.559 ' SG ' HD13 ' C' ' 86' ' ' ILE . 18.8 t -68.34 -38.58 81.61 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.688 -0.856 . . . . 75.13 108.688 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.409 ' HB3' ' OG ' ' C' ' 48' ' ' SER . 53.9 mt -83.63 -33.34 25.31 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.523 -1.217 . . . . 54.33 110.857 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.27 -24.38 63.67 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.297 -0.865 . . . . 54.21 114.28 -169.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.36 -52.54 0.11 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.802 0.667 . . . . 72.42 112.802 -164.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -57.02 -57.54 12.11 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 123.999 0.812 . . . . 70.02 111.177 -176.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.403 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 95.3 m -64.28 -49.11 74.38 Favored Pre-proline 0 CA--C 1.564 1.486 0 C-N-CA 124.151 0.981 . . . . 71.22 112.422 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 74.8 Cg_exo -53.43 -32.89 64.6 Favored 'Trans proline' 0 C--N 1.402 3.359 0 C-N-CA 122.701 2.267 . . . . 74.13 113.889 173.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -67.97 -31.47 71.21 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.608 0.763 . . . . 70.43 110.694 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.518 HD12 ' NH1' ' A' ' 111' ' ' ARG . 25.7 mm -74.74 -35.62 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 122.899 0.48 . . . . 71.22 109.85 175.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.95 -27.74 57.66 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.781 0.832 . . . . 75.45 111.443 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -58.77 -50.93 85.37 Favored Pre-proline 0 N--CA 1.483 1.18 0 N-CA-C 114.552 1.316 . . . . 74.34 114.552 -171.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -58.69 -38.05 91.11 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 121.967 1.778 . . . . 72.33 112.873 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.446 ' HE2' HG21 ' A' ' 115' ' ' THR . 52.4 m-85 -67.25 -45.22 77.34 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.844 0.858 . . . . 73.55 110.3 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.08 86.3 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.162 -0.927 . . . . 72.32 110.907 178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 41.8 ttt-85 -67.84 -43.87 78.52 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.883 1.273 . . . . 74.03 110.259 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . 0.403 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.1 tm-20 -66.29 -39.95 89.7 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.293 0.637 . . . . 45.11 109.591 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.562 ' HB3' HG21 ' C' ' 78' ' ' VAL . 28.6 m -59.91 -48.93 79.67 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.584 0.753 . . . . 73.3 111.996 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.561 HD13 HG23 ' C' ' 64' ' ' VAL . 71.0 mt -64.09 -52.32 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 O-C-N 123.439 0.462 . . . . 64.24 110.85 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 14.2 m -66.7 -29.07 68.97 Favored 'General case' 0 CA--C 1.556 1.181 0 O-C-N 123.462 0.476 . . . . 73.13 110.746 -175.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 39.2 t -63.91 -46.38 85.07 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.3 -0.63 . . . . 72.22 109.3 170.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.591 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.17 -41.01 96.03 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.469 1.107 . . . . 73.1 112.215 179.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.476 HG23 ' O ' ' C' ' 114' ' ' ILE . 92.6 t -64.81 -41.23 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.938 0.895 . . . . 71.33 109.572 176.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 11.6 t -67.12 -29.95 69.83 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.813 1.245 . . . . 75.23 112.129 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.439 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 75.3 mtt-85 -74.16 -41.3 61.71 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.575 0.75 . . . . 70.44 109.668 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.06 -0.42 60.67 Favored Glycine 0 C--N 1.354 1.572 0 O-C-N 123.719 0.637 . . . . 60.42 112.608 169.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.412 ' O ' HG21 ' F' ' 129' ' ' THR . 31.0 p 63.84 30.67 14.4 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.989 2.115 . . . . 64.34 113.025 169.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -82.33 156.44 68.82 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 107.916 -1.142 . . . . 64.53 107.916 167.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.446 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 12.8 Cg_endo -57.19 157.05 22.51 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.479 2.119 . . . . 53.32 112.845 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' B' ' 123' ' ' PHE . 53.8 mm-40 -56.02 112.78 1.29 Allowed 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.21 0.944 . . . . 63.55 111.601 -176.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.507 ' HA ' HG23 ' F' ' 133' ' ' THR . 5.2 tt -116.75 85.15 2.26 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.476 -1.305 . . . . 71.22 107.476 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -95.28 122.17 37.7 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.691 -0.855 . . . . 74.13 108.691 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.79 144.38 37.18 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.589 0.556 . . . . 75.43 109.872 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.89 148.42 98.84 Favored Pre-proline 0 CA--C 1.55 0.958 0 O-C-N 124.076 0.86 . . . . 74.13 111.125 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.84 108.53 0.39 Allowed 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.798 2.332 . . . . 55.3 112.22 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 43.3 t -99.6 112.68 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 108.46 -0.941 . . . . 73.02 108.46 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -77.74 104.95 8.59 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.141 -0.689 . . . . 70.2 109.141 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -63.39 -35.52 80.68 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.664 0.785 . . . . 74.21 111.575 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.08 -21.51 65.88 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.931 0.892 . . . . 44.13 111.839 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.52 -47.31 33.75 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.96 0.904 . . . . 75.11 109.296 172.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 35.0 mt -65.79 -43.52 88.48 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.824 -0.625 . . . . 72.31 111.087 -176.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -77.67 -16.33 58.58 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.039 -0.982 . . . . 74.15 110.495 -177.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 50.4 ttm -59.75 -30.62 68.98 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.731 0.813 . . . . 73.13 110.967 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -68.65 -42.83 77.43 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.8 -1.091 . . . . 62.12 110.353 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -72.71 -87.03 0.03 OUTLIER 'General case' 0 CA--C 1.56 1.353 0 C-N-CA 123.856 0.862 . . . . 73.24 111.805 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.689 HD12 ' HB ' ' C' ' 92' ' ' THR . 4.2 mm? 52.15 -99.79 0.09 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.443 1.097 . . . . 64.1 111.174 -168.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 176.9 -67.06 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.72 1.208 . . . . 72.12 108.233 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -91.28 131.57 36.71 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.135 -0.691 . . . . 72.34 109.135 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -88.27 85.9 6.98 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 107.383 -1.34 . . . . 74.3 107.383 174.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -171.68 114.46 0.36 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.284 1.034 . . . . 53.03 108.834 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -165.96 13.98 0.08 OUTLIER Glycine 0 C--N 1.344 1.007 0 O-C-N 123.316 0.385 . . . . 40.31 113.197 -176.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . 0.442 ' O ' HG22 ' A' ' 149' ' ' THR . 1.0 OUTLIER -73.58 161.06 30.75 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.713 0.805 . . . . 75.14 110.667 176.109 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . 0.629 ' HA3' ' HA ' ' A' ' 147' ' ' GLU . . . -160.4 -108.04 0.23 Allowed Glycine 0 C--N 1.339 0.7 0 N-CA-C 110.945 -0.862 . . . . 61.34 110.945 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 56.3 p 48.89 80.78 0.06 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.621 1.168 . . . . 63.02 112.192 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -146.31 141.66 27.51 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.303 -1.369 . . . . 73.34 107.303 177.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.05 120.26 9.35 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.989 -0.745 . . . . 74.41 108.989 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -153.41 119.68 5.49 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.317 -0.623 . . . . 74.24 109.317 -172.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.19 73.89 5.77 Favored 'General case' 0 CA--C 1.554 1.116 0 N-CA-C 109.183 -0.673 . . . . 52.34 109.183 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -176.22 169.16 2.8 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.688 1.195 . . . . 71.01 109.293 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.366 0 N-CA-C 107.997 -1.112 . . . . 73.32 107.997 176.613 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 56.0 ttm . . . . . 0 N--CA 1.484 1.263 0 N-CA-C 109.437 -0.579 . . . . 74.21 109.437 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 16.1 m 64.03 20.67 12.3 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.868 1.267 . . . . 61.34 110.722 -171.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -177.07 165.98 2.38 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 125.47 1.508 . . . . 65.12 108.545 -173.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -81.19 -13.33 58.71 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.74 0.416 . . . . 70.51 111.155 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -68.77 103.12 1.68 Allowed 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.999 -0.741 . . . . 72.25 108.999 175.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . 0.502 ' HB3' ' HB2' ' D' ' 9' ' ' MET . 57.7 m-20 -67.29 -46.93 72.13 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.962 0.905 . . . . 74.1 110.033 -176.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 21.3 m 64.89 -73.61 0.06 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.612 1.565 . . . . 61.21 113.207 169.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -93.57 0.69 56.71 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.64 0.776 . . . . 65.23 112.308 -174.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.507 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 0.0 OUTLIER -32.14 126.51 0.26 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 125.193 1.397 . . . . 64.23 113.253 174.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 59.2 m -127.68 132.84 49.62 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.308 0.643 . . . . 74.41 109.939 -176.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.59 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 47.3 t80 -142.94 91.65 2.32 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.023 -1.102 . . . . 75.33 108.023 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -113.24 123.74 50.87 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.517 -0.92 . . . . 70.42 108.517 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 12.4 mt -79.28 128.34 38.58 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.347 -0.982 . . . . 72.12 108.347 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.447 HE21 ' HB2' ' D' ' 85' ' ' SER . 73.1 mm-40 -85.57 -43.19 13.72 Favored 'General case' 0 C--O 1.239 0.538 0 O-C-N 123.638 0.587 . . . . 73.43 109.817 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -171.09 131.62 0.8 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.799 -0.637 . . . . 71.51 110.575 -171.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 4.0 mp -106.46 141.48 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 107.348 -1.353 . . . . 72.04 107.348 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -167.01 145.51 5.06 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 123.648 0.592 . . . . 71.31 111.819 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -76.86 116.34 17.44 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.492 -0.776 . . . . 74.55 109.573 175.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.6 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 43.0 mtpt -88.92 -13.02 40.04 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.45 0.7 . . . . 70.22 110.439 178.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.645 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 25.3 t70 -162.55 141.63 9.07 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.099 0.96 . . . . 64.44 109.699 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.591 HG21 ' HE2' ' C' ' 117' ' ' MET . 98.4 mt -141.28 141.35 30.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 125.278 1.431 . . . . 72.35 107.884 177.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 41.1 t -149.3 141.38 23.91 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.667 1.187 . . . . 62.24 108.109 173.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.476 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 81.2 t80 -152.54 125.72 8.62 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 106.562 -1.644 . . . . 75.3 106.562 171.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -129.42 145.64 51.39 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.286 -0.635 . . . . 74.12 109.286 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.76 80.46 65.85 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 107.263 -1.384 . . . . 64.1 107.263 174.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.61 -38.54 31.64 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 123.513 2.809 . . . . 63.15 113.419 -169.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 42.2 m-20 -106.94 12.38 28.83 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 118.762 -0.637 . . . . 54.22 110.959 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.562 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -27.63 -69.42 0.08 OUTLIER Pre-proline 0 CA--C 1.571 1.772 0 N-CA-C 116.742 2.127 . . . . 72.01 116.742 -164.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.45 -18.69 13.69 Favored 'Trans proline' 0 C--N 1.385 2.483 0 CA-C-N 123.661 2.343 . . . . 74.44 114.212 -174.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.43 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 6.1 t-160 -74.49 -38.66 62.82 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.295 1.038 . . . . 72.01 109.103 174.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.487 HG12 ' O ' ' D' ' 28' ' ' ALA . 4.3 p -84.76 -20.66 8.37 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 CA-C-N 115.328 -0.851 . . . . 71.43 111.676 -174.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.505 ' HD2' HH21 ' C' ' 15' ' ' ARG . 20.6 m-85 -67.6 -18.54 65.02 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 122.586 0.354 . . . . 75.34 111.945 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.43 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 60.7 mt-30 -65.29 -16.84 63.99 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.203 1.001 . . . . 64.01 111.06 175.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.404 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 96.4 mttt -97.42 90.26 5.0 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 125.086 1.354 . . . . 74.54 110.463 -178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -90.67 93.22 9.16 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.954 0.502 . . . . 63.54 109.772 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 20.5 p90 -162.47 -170.39 2.42 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.874 0.87 . . . . 70.14 109.466 168.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -67.98 109.78 4.47 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.707 1.203 . . . . 61.12 110.898 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -58.54 122.27 11.38 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.27 1.98 . . . . 74.14 110.565 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 0.2 OUTLIER -66.68 107.21 2.06 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 106.983 -1.488 . . . . 75.31 106.983 175.289 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.601 HG22 ' HB2' ' D' ' 66' ' ' ALA . 93.8 t -111.67 142.93 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 108.876 -0.787 . . . . 51.02 108.876 -174.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -129.76 123.87 32.07 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.369 -0.974 . . . . 61.53 108.369 168.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.587 HD11 HG13 ' D' ' 62' ' ' VAL . 51.5 tp -95.73 125.98 40.68 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.001 -0.74 . . . . 75.24 109.001 174.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -124.9 111.11 15.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.787 -1.56 . . . . 72.23 106.787 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.538 HD22 HG22 ' D' ' 62' ' ' VAL . 62.0 mt -97.58 164.53 12.39 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.932 -1.031 . . . . 72.43 108.958 177.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -164.4 144.93 7.98 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.979 -1.119 . . . . 72.51 107.979 167.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . 0.493 HG23 HD22 ' E' ' 111' ' ' LEU . 70.4 p -102.62 151.14 22.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.735 0.779 . . . . 74.13 109.769 -176.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.54 161.72 41.1 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 106.686 -1.598 . . . . 42.55 106.686 177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 12.8 p -175.32 -176.95 0.97 Allowed 'General case' 0 C--O 1.238 0.464 0 C-N-CA 122.786 0.434 . . . . 53.41 110.255 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 57.9 p -148.47 119.01 7.41 Favored 'General case' 0 C--O 1.247 0.95 0 N-CA-C 107.667 -1.234 . . . . 70.32 107.667 174.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . 0.571 ' HB2' HD13 ' E' ' 102' ' ' LEU . 51.2 tt0 -72.11 86.02 1.04 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.323 -1.308 . . . . 73.0 108.896 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -80.85 -37.13 30.46 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.762 -1.199 . . . . 64.41 107.762 177.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . 68.38 -175.48 0.2 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.949 1.3 . . . . 60.34 112.175 175.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 25.0 t70 52.21 55.1 9.68 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.36 1.064 . . . . 71.42 109.677 -168.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.573 ' HB2' ' HB3' ' E' ' 93' ' ' PHE . 6.5 m-20 67.03 3.98 3.38 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 114.007 -1.451 . . . . 70.14 112.836 175.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 59.1 t -108.87 117.81 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 108.239 -1.023 . . . . 74.22 108.239 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -135.13 125.55 26.59 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 108.626 -0.879 . . . . 72.14 108.626 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -90.0 129.97 36.26 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 106.857 -1.534 . . . . 73.34 106.857 171.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 83.3 t -132.96 131.26 58.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 124.097 0.959 . . . . 65.35 108.631 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.485 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 32.3 t -119.94 144.51 28.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 C-N-CA 124.642 1.177 . . . . 74.43 108.853 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.6 108.94 12.06 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.389 -1.337 . . . . 55.1 107.389 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 ttt85 -85.41 106.01 16.47 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 109.144 -0.687 . . . . 71.42 109.144 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.587 HG13 HD11 ' D' ' 42' ' ' LEU . 59.7 t -108.1 118.29 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 123.95 0.9 . . . . 61.42 109.07 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 17.0 m -128.71 131.14 47.91 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.613 0.57 . . . . 41.11 109.948 -171.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.57 HG13 HG13 ' D' ' 40' ' ' VAL . 90.9 t -113.78 135.3 53.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 124.536 1.134 . . . . 72.54 109.545 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 7.1 m -121.01 94.72 4.43 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.921 -1.14 . . . . 64.2 107.921 171.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.601 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -109.42 142.08 40.91 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.614 0.366 . . . . 74.33 110.711 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.525 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 49.6 m -148.61 132.72 17.29 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 124.069 0.947 . . . . 75.12 110.561 -171.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 19.2 mt -98.34 105.71 17.9 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 107.967 -1.123 . . . . 75.3 107.967 173.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.07 -120.39 5.19 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 115.506 -0.77 . . . . 54.4 112.391 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.12 6.7 27.12 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.592 0.757 . . . . 54.04 111.383 -177.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 10.9 pt-20 -127.6 159.59 34.19 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.258 0.623 . . . . 72.43 109.321 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 93.9 m -70.34 136.92 50.16 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.335 0.654 . . . . 65.44 111.961 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.525 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -91.75 -70.52 0.68 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.19 -1.411 . . . . 53.2 107.19 174.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -146.35 148.09 32.0 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.092 -0.958 . . . . 74.13 110.414 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 73.6 mt -116.17 153.52 31.68 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.757 1.223 . . . . 75.52 107.741 171.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.615 ' SG ' HG12 ' D' ' 114' ' ' ILE . 34.6 t -154.35 146.66 23.87 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.584 -0.524 . . . . 53.31 109.584 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -157.4 122.21 4.43 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.728 0.411 . . . . 74.12 110.625 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 94.8 t -132.79 115.46 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.106 0.962 . . . . 53.33 109.277 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.645 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.0 mt-30 -89.3 88.51 7.53 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.693 -0.854 . . . . 71.24 108.693 172.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -83.01 103.59 12.57 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 114.338 -1.301 . . . . 65.31 109.528 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -102.83 167.84 17.69 Favored Glycine 0 N--CA 1.468 0.825 0 O-C-N 123.219 0.324 . . . . 64.41 113.055 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.16 143.07 6.07 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 112.447 -0.261 . . . . 63.15 112.447 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 2.5 mp -91.29 127.34 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.218 -1.03 . . . . 74.33 108.218 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -122.41 134.86 54.6 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.538 1.135 . . . . 55.33 109.532 -177.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 34.1 t -84.96 103.53 14.09 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 108.287 -1.005 . . . . 74.14 108.287 171.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.572 HG22 HD11 ' D' ' 89' ' ' ILE . 15.1 mt -109.54 131.9 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 108.569 -0.9 . . . . 62.25 108.569 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.65 164.02 14.49 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.706 0.629 . . . . 54.43 111.281 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 76.71 21.59 74.27 Favored Glycine 0 C--N 1.353 1.473 0 O-C-N 123.918 0.761 . . . . 73.34 114.619 170.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.572 HD11 HG22 ' D' ' 86' ' ' ILE . 1.0 OUTLIER -133.27 140.91 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.306 1.042 . . . . 63.22 109.457 177.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 32.0 mp0 -129.56 175.79 8.5 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 123.962 0.905 . . . . 73.11 109.601 -175.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.64 -137.8 23.04 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.219 -0.901 . . . . 64.54 112.458 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 45.5 p -66.46 -45.6 79.22 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.692 0.797 . . . . 71.21 111.035 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -58.84 -28.5 66.11 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.009 1.324 . . . . 75.23 112.331 -175.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.523 ' HA ' HD13 ' D' ' 89' ' ' ILE . 26.4 ttt -49.17 -63.54 1.07 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.98 1.312 . . . . 63.12 112.508 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.91 -16.43 35.97 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.333 0.653 . . . . 65.12 111.81 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -72.78 -21.8 60.94 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.715 0.406 . . . . 65.21 111.625 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 75.3 m -56.99 -50.98 71.06 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 123.467 0.479 . . . . 72.21 111.654 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 pp -68.42 -18.23 64.39 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.266 0.627 . . . . 74.54 112.586 -176.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . 0.486 ' HA3' HG21 ' E' ' 103' ' ' THR . . . -104.83 -2.22 42.72 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 114.775 0.67 . . . . 71.33 114.775 -174.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.42 -54.29 0.29 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 118.011 0.905 . . . . 71.2 111.459 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -73.49 -51.1 18.28 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.039 0.535 . . . . 75.21 111.287 -172.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.59 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 35.1 m -61.18 -44.83 95.0 Favored Pre-proline 0 CA--C 1.566 1.573 0 C-N-CA 123.914 0.886 . . . . 61.25 112.44 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.429 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 50.0 Cg_exo -58.35 -36.45 97.6 Favored 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 122.331 2.021 . . . . 75.14 113.468 169.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -64.19 -31.11 72.19 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.279 0.632 . . . . 73.23 110.997 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 33.1 mm -67.54 -38.55 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.046 0.938 . . . . 64.24 110.623 174.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' D' ' 103' ' ' PRO . 60.5 mt -73.31 -20.47 60.79 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.261 -0.881 . . . . 75.34 111.895 -175.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -67.44 -41.74 33.74 Favored Pre-proline 0 CA--C 1.556 1.195 0 N-CA-C 114.274 1.212 . . . . 72.32 114.274 -172.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -45.42 -44.97 16.18 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.508 2.139 . . . . 54.35 113.584 169.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -78.18 -35.03 49.24 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.829 0.852 . . . . 64.52 111.496 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . 0.475 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -62.25 -56.15 21.42 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.652 0.781 . . . . 74.12 110.339 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.432 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 40.3 ttp180 -58.19 -42.88 87.06 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 114.038 -1.437 . . . . 75.11 110.574 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -55.29 -52.64 62.77 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.084 0.865 . . . . 72.33 110.481 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.4 t -56.27 -45.63 80.03 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.306 1.004 . . . . 54.23 111.13 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.615 HG12 ' SG ' ' D' ' 76' ' ' CYS . 42.3 mt -62.02 -57.36 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.379 -0.828 . . . . 75.31 111.1 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 30.2 m -55.35 -38.58 68.97 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.537 1.135 . . . . 62.03 111.124 -174.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 22.6 t -60.4 -50.96 71.52 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.62 -1.173 . . . . 63.24 109.662 176.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.72 -32.4 72.15 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.628 0.771 . . . . 63.42 112.178 -176.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.481 HG23 ' O ' ' D' ' 114' ' ' ILE . 84.0 t -60.44 -46.41 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.746 0.819 . . . . 73.11 109.519 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 32.4 t -72.49 -29.16 63.39 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 115.004 -0.998 . . . . 72.44 110.881 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.462 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 74.9 mtt-85 -71.49 -24.42 61.98 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.441 0.696 . . . . 72.13 110.674 176.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.21 11.71 71.33 Favored Glycine 0 C--N 1.353 1.476 0 CA-C-O 119.448 -0.64 . . . . 75.55 112.791 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.477 HG23 ' HB3' ' C' ' 17' ' ' TYR . 72.2 p 56.71 25.67 10.41 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 125.988 1.715 . . . . 64.34 113.242 -177.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -92.02 150.9 41.33 Favored Pre-proline 0 C--O 1.241 0.635 0 C-N-CA 123.38 0.672 . . . . 64.1 109.893 173.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.773 ' HB3' ' HA ' ' E' ' 129' ' ' THR . 46.6 Cg_exo -46.12 121.33 4.33 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 123.556 2.837 . . . . 64.14 112.883 170.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -45.86 131.08 9.58 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 124.48 1.113 . . . . 61.14 111.655 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 23.7 tp -117.55 107.17 13.94 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.208 1.003 . . . . 74.23 109.209 -175.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' E' ' 126' ' ' ALA . 82.2 m-20 -101.02 96.08 7.01 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 108.041 -1.096 . . . . 74.23 108.041 178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.432 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 47.1 mt -61.73 116.72 5.03 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 122.787 0.435 . . . . 71.05 110.134 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.484 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -54.47 130.78 62.84 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 123.352 0.661 . . . . 74.32 112.487 -174.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 6.1 Cg_exo -73.29 109.64 2.88 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 123.286 2.657 . . . . 74.21 110.985 -178.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.07 152.9 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 123.877 0.871 . . . . 75.34 110.897 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -75.02 108.54 7.81 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.647 0.779 . . . . 62.44 109.021 175.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -58.47 -36.03 73.08 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.219 1.007 . . . . 73.12 111.803 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.28 -38.64 77.38 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.598 -1.183 . . . . 62.32 110.33 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.463 ' HA ' ' HB3' ' D' ' 138' ' ' MET . . . -70.58 -28.98 65.3 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 123.974 0.909 . . . . 63.32 112.631 -175.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 9.4 mp -66.65 -37.98 85.93 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 118.499 0.59 . . . . 61.03 111.05 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -78.24 -34.63 49.05 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.192 0.597 . . . . 65.24 110.242 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.463 ' HB3' ' HA ' ' D' ' 135' ' ' ALA . 40.8 ttm -71.69 -23.85 61.72 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.232 1.013 . . . . 71.32 111.43 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.411 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 83.9 m-20 -59.81 -41.42 91.19 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.501 0.72 . . . . 72.44 109.896 175.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -58.05 -39.07 77.52 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 124.429 1.081 . . . . 71.21 110.972 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.2 mp -77.43 -31.13 53.74 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.374 0.67 . . . . 64.31 111.492 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.411 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 11.0 pt20 -91.28 37.77 0.95 Allowed 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.342 0.592 . . . . 60.02 111.172 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.56 58.05 0.84 Allowed 'General case' 0 N--CA 1.481 1.125 0 CA-C-O 122.163 0.983 . . . . 74.31 109.335 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -145.76 -42.29 0.21 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.331 -1.304 . . . . 71.43 108.852 176.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -106.56 149.07 27.52 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.997 0.919 . . . . 71.52 109.76 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -160.84 29.25 0.32 Allowed Glycine 0 N--CA 1.467 0.747 0 CA-C-N 115.578 -0.737 . . . . 53.15 111.346 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.58 -163.93 1.01 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.343 1.057 . . . . 73.34 111.055 -176.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 100.17 -121.77 7.35 Favored Glycine 0 C--N 1.351 1.397 0 N-CA-C 110.689 -0.964 . . . . 51.12 110.689 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 6.1 m 57.22 81.52 0.14 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.079 1.352 . . . . 75.03 110.548 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -79.18 -178.03 5.96 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.461 -0.79 . . . . 73.32 110.857 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -76.23 174.49 10.07 Favored 'General case' 0 CA--C 1.553 1.092 0 N-CA-C 109.102 -0.703 . . . . 75.21 109.102 172.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -69.1 105.15 2.35 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.019 0.528 . . . . 62.11 110.401 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.31 106.09 1.04 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.695 1.598 . . . . 74.22 110.978 -173.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -102.91 140.76 36.77 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.159 0.584 . . . . 72.4 109.807 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 N-CA-C 109.137 -0.69 . . . . 73.0 109.137 -178.974 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.688 0 CA-C-O 120.072 -0.293 . . . . 50.43 113.388 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . -141.31 -57.85 0.03 OUTLIER Glycine 0 C--N 1.347 1.19 0 N-CA-C 111.255 -0.738 . . . . 71.33 111.255 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 93' ' ' PHE . . . . . 0.573 ' HB3' ' HB2' ' D' ' 54' ' ' ASP . 32.7 t80 -67.56 -36.66 81.37 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.603 0.761 . . . . 73.43 110.166 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -153.99 -156.83 0.72 Allowed 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 105.396 -2.076 . . . . 75.21 105.396 166.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.81 138.25 52.83 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 108.29 -1.004 . . . . 71.32 108.29 164.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.36 -103.91 0.24 Allowed Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.359 -0.448 . . . . 74.4 112.322 177.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 97' ' ' ILE . . . . . . . . . . . . . 37.2 pt -107.66 131.82 56.88 Favored 'Isoleucine or valine' 0 C--N 1.35 0.588 0 CA-C-O 121.672 0.749 . . . . 71.34 111.871 -166.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -147.29 -34.1 0.26 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.719 -1.128 . . . . 71.33 109.984 -177.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -105.06 90.49 3.46 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.398 0.679 . . . . 51.32 110.708 -177.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -151.77 169.34 9.59 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.317 1.047 . . . . 72.44 110.45 -177.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -89.88 173.03 3.64 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 122.459 2.106 . . . . 71.02 111.43 161.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 102' ' ' LEU . . . . . 0.571 HD13 ' HB2' ' D' ' 50' ' ' GLN . 23.2 tp -84.27 66.98 9.63 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 108.819 -0.808 . . . . 63.44 108.819 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 103' ' ' THR . . . . . 0.505 HG23 ' H ' ' E' ' 104' ' ' GLY 0.277 10.8 t 45.38 -74.02 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 126.6 1.96 . . . . 63.32 113.113 -166.174 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 104' ' ' GLY . . . . . 0.505 ' H ' HG23 ' E' ' 103' ' ' THR . . . -101.68 -134.97 8.66 Favored Glycine 0 C--N 1.347 1.184 0 N-CA-C 109.915 -1.274 . . . . 74.04 109.915 171.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -98.8 -17.21 18.58 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.967 0.507 . . . . 73.41 110.36 170.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -169.03 -71.59 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 106.695 -1.594 . . . . 75.44 106.695 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . 0.454 HG22 ' OG1' ' D' ' 46' ' ' THR . 80.4 p -131.96 -51.28 0.97 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 107.544 -1.28 . . . . 74.15 107.544 165.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 67.58 14.78 9.66 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 125.45 1.5 . . . . 63.34 111.271 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -144.2 -36.27 0.34 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.128 0.971 . . . . 64.3 110.336 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . 69.0 127.39 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.116 1.367 . . . . 72.14 110.512 -167.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . 0.494 HD23 ' HB3' ' D' ' 44' ' ' LEU . 33.6 tp -78.89 79.2 5.3 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.161 0.584 . . . . 71.21 110.607 -173.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 34.3 p-10 -161.36 178.99 8.65 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.483 -0.761 . . . . 63.44 110.719 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -76.33 119.69 20.57 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.994 0.918 . . . . 73.4 110.222 -177.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -91.23 141.51 28.72 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.18 -0.674 . . . . 54.21 109.18 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 35.2 p -77.87 86.75 4.09 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.249 0.62 . . . . 62.04 110.149 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . -136.2 -102.23 0.65 Allowed Glycine 0 C--N 1.343 0.919 0 CA-C-N 115.122 -0.945 . . . . 70.44 110.967 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 117' ' ' LYS . . . . . 0.471 ' HB3' ' HD3' ' E' ' 118' ' ' PRO . 12.7 tmtt? -119.86 -60.45 0.03 OUTLIER Pre-proline 0 CA--C 1.565 1.532 0 CA-C-O 118.142 -0.932 . . . . 74.0 110.485 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 118' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' E' ' 117' ' ' LYS . 1.6 Cg_endo -79.67 106.85 2.04 Favored 'Trans proline' 0 C--N 1.395 3.024 0 C-N-CA 121.833 1.689 . . . . 71.24 111.339 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -82.48 61.03 5.43 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.515 0.726 . . . . 73.3 110.096 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -78.36 153.95 31.19 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.297 -0.865 . . . . 73.24 109.443 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 121' ' ' VAL . . . . . . . . . . . . . 48.1 t 79.51 118.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 125.817 1.647 . . . . 74.12 110.395 -171.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 30.2 m -144.07 84.87 1.78 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.821 -0.807 . . . . 74.11 108.821 171.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -68.8 -38.56 80.02 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.042 1.337 . . . . 73.52 112.873 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 21.6 m -69.33 -12.64 61.83 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 113.507 0.929 . . . . 72.13 113.507 -173.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -83.3 10.16 9.18 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.087 0.555 . . . . 51.13 111.553 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 126' ' ' ALA . . . . . 0.556 ' HB2' HE21 ' B' ' 12' ' ' GLN . . . -136.56 101.54 4.67 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.073 0.949 . . . . 74.43 110.043 178.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 64.6 p -169.51 152.9 4.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.52 0.728 . . . . 74.01 110.328 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.5 -56.18 4.86 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.245 0.618 . . . . 71.32 110.513 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 129' ' ' THR . . . . . 0.773 ' HA ' ' HB3' ' D' ' 124' ' ' PRO . 24.4 m 58.6 79.25 0.22 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.766 1.226 . . . . 55.05 111.969 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -165.51 127.22 2.0 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.091 0.956 . . . . 73.11 110.197 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 131' ' ' TRP . . . . . 0.687 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 71.6 t90 -161.64 101.73 1.18 Allowed 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.604 0.762 . . . . 63.42 109.684 176.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 20.9 m -147.77 113.17 5.6 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.52 1.128 . . . . 74.33 108.895 173.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 40.8 m -139.32 137.08 35.5 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 118.414 0.552 . . . . 75.14 111.06 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -116.71 93.51 0.6 Allowed Glycine 0 C--N 1.347 1.19 0 N-CA-C 110.183 -1.167 . . . . 50.13 110.183 171.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 79.7 t -64.01 101.08 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 124.012 0.925 . . . . 75.2 109.462 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -67.43 108.97 2.99 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.092 0.557 . . . . 73.51 109.983 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 12.3 t -70.28 141.07 52.43 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 123.723 0.64 . . . . 74.5 110.814 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 138' ' ' TYR . . . . . 0.421 ' HD1' ' HB3' ' A' ' 129' ' ' ALA . 92.0 m-85 -117.76 116.46 27.05 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.849 -0.797 . . . . 74.23 108.849 177.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -75.57 147.26 39.79 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.578 -0.737 . . . . 62.12 110.622 -176.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.42 -84.63 0.05 OUTLIER Glycine 0 C--N 1.344 1.002 0 N-CA-C 111.033 -0.827 . . . . 53.23 111.033 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -167.6 172.89 9.01 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.861 0.865 . . . . 75.02 110.43 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 6.8 mp -80.89 141.67 34.34 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.749 0.82 . . . . 73.55 109.067 173.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . 178.03 -119.44 0.67 Allowed Glycine 0 C--N 1.336 0.528 0 N-CA-C 110.937 -0.865 . . . . 75.13 110.937 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 13.7 p -159.74 158.27 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 124.01 0.924 . . . . 72.2 109.189 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 145' ' ' ASP . . . . . 0.449 ' HA ' ' ND2' ' A' ' 104' ' ' ASN . 2.8 m-20 . . . . . 0 C--O 1.251 1.164 0 N-CA-C 107.533 -1.284 . . . . 72.55 107.533 164.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.863 0 N-CA-C 113.47 0.148 . . . . 42.32 113.47 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.01 -61.91 1.9 Allowed Glycine 0 C--N 1.346 1.095 0 N-CA-C 111.886 -0.486 . . . . 63.14 111.886 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 93' ' ' PHE . . . . . 0.414 ' CD1' HG21 ' B' ' 55' ' ' VAL . 0.8 OUTLIER -70.92 -59.35 2.84 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.333 -0.618 . . . . 75.2 109.333 -178.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -103.1 -77.94 0.56 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 117.763 0.256 . . . . 74.22 110.557 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -148.25 -83.57 0.11 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.159 0.436 . . . . 74.43 112.043 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.36 89.93 0.08 OUTLIER Glycine 0 C--N 1.347 1.159 0 N-CA-C 111.312 -0.715 . . . . 50.32 111.312 -170.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 97' ' ' ILE . . . . . 0.4 HD11 ' HB2' ' B' ' 94' ' ' MET . 9.4 tt -99.67 8.47 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.325 0 C-N-CA 124.696 1.198 . . . . 74.2 108.781 171.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 30.6 t70 69.66 -77.78 0.05 Allowed 'General case' 0 C--N 1.361 1.071 0 C-N-CA 125.798 1.639 . . . . 65.55 109.194 -165.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -163.42 147.99 10.92 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.528 1.131 . . . . 73.14 108.82 176.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 100' ' ' LEU . . . . . 0.422 HD13 ' HD1' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -118.06 93.3 44.3 Favored Pre-proline 0 CA--C 1.56 1.333 0 C-N-CA 123.276 0.63 . . . . 73.52 110.819 -177.096 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -83.9 -167.21 0.42 Allowed 'Trans proline' 0 C--N 1.379 2.163 0 C-N-CA 123.072 2.515 . . . . 54.14 111.089 173.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 102' ' ' LEU . . . . . 0.405 HD13 ' CD1' ' F' ' 106' ' ' TYR . 17.0 mt -150.07 80.78 1.37 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.339 0.655 . . . . 74.15 110.222 175.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 70.5 p 46.92 38.69 6.45 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.715 1.606 . . . . 74.54 113.909 169.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 84.31 -59.0 4.98 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 111.316 -0.714 . . . . 42.21 111.316 -174.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 105' ' ' GLN . . . . . 0.405 ' NE2' ' HB3' ' F' ' 108' ' ' HIS . 44.0 tt0 -140.08 137.24 34.39 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 124.382 1.073 . . . . 74.54 109.233 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 106' ' ' TYR . . . . . 0.485 ' CE2' ' HB ' ' B' ' 46' ' ' THR . 41.7 t80 -84.36 130.56 34.78 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 123.631 0.772 . . . . 74.01 109.253 174.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 3.8 m 68.96 159.44 0.17 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 124.596 1.185 . . . . 75.12 110.107 -177.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 108' ' ' HIS . . . . . 0.589 ' HA ' ' HB2' ' F' ' 112' ' ' ASN . 54.6 t-80 75.08 -9.75 1.33 Allowed 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 124.137 0.975 . . . . 65.44 112.107 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -79.8 -27.78 40.29 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.385 1.074 . . . . 75.31 110.331 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -157.25 -70.11 0.1 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.024 0.93 . . . . 41.11 109.302 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 10.3 tt -73.76 113.48 10.96 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.002 -1.11 . . . . 72.11 108.002 174.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 112' ' ' ASN . . . . . 0.589 ' HB2' ' HA ' ' F' ' 108' ' ' HIS . 7.2 t30 -162.83 146.05 10.97 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 123.917 0.761 . . . . 75.31 110.279 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -68.58 79.5 0.28 Allowed 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 124.568 1.147 . . . . 74.14 109.863 173.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . 0.563 ' HB2' HD22 ' F' ' 112' ' ' ASN . 22.0 tptm -162.14 164.62 27.85 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.311 0.644 . . . . 73.51 110.071 -174.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 26.9 m -71.04 76.57 0.66 Allowed 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 124.145 0.978 . . . . 52.2 109.757 171.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 171.19 40.97 0.03 OUTLIER Glycine 0 N--CA 1.464 0.561 0 CA-C-N 114.868 -1.06 . . . . 54.03 110.495 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -71.26 147.9 93.43 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.807 0.843 . . . . 75.3 110.734 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.88 -165.46 0.33 Allowed 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 122.981 2.454 . . . . 65.34 111.781 171.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -81.24 -176.72 6.13 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.626 0.77 . . . . 74.54 110.252 173.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 21.4 t80 74.62 179.03 0.2 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.336 1.054 . . . . 74.44 110.23 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 99.4 t 75.05 136.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 C-N-CA 125.018 1.327 . . . . 72.33 111.138 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 54.7 m 56.96 86.28 0.07 Allowed 'General case' 0 C--N 1.361 1.071 0 C-N-CA 124.684 1.193 . . . . 75.4 110.121 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -151.46 177.99 9.75 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.459 -0.791 . . . . 65.32 109.282 -169.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 15.4 m -68.84 86.61 0.34 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.056 0.943 . . . . 63.21 111.01 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . 0.477 ' HB1' ' HD2' ' B' ' 130' ' ' PRO . . . -164.29 135.7 4.5 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.418 1.087 . . . . 73.15 109.129 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . 69.76 -178.39 0.22 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.74 1.216 . . . . 65.14 111.578 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 45.3 p -155.03 147.31 23.87 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.325 0.65 . . . . 33.21 110.996 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.18 115.66 23.09 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.527 -0.916 . . . . 64.15 108.527 172.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 129' ' ' THR . . . . . 0.412 HG21 ' O ' ' C' ' 122' ' ' THR . 74.4 p -81.48 -78.13 0.2 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 122.925 0.49 . . . . 53.51 110.732 -176.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -177.24 -168.91 0.21 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.874 0.87 . . . . 73.23 110.305 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 131' ' ' TRP . . . . . 0.45 ' HB2' ' HG3' ' B' ' 124' ' ' PRO . 27.7 t90 -120.58 -11.05 9.13 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.015 0.926 . . . . 75.34 110.164 168.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 35.4 t -54.48 99.83 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.699 0.8 . . . . 43.53 112.031 -169.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 133' ' ' THR . . . . . 0.507 HG23 ' HA ' ' C' ' 126' ' ' LEU . 22.8 m -76.61 -42.08 43.71 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.927 -1.033 . . . . 71.44 109.365 174.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . 71.91 13.62 75.65 Favored Glycine 0 C--N 1.356 1.659 0 CA-C-N 114.937 -1.029 . . . . 73.45 114.096 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 10.0 p -74.45 90.54 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.128 0 CA-C-O 122.419 1.104 . . . . 53.24 110.872 -174.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -94.68 97.55 10.16 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.08 -0.964 . . . . 74.43 108.624 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 13.7 m 66.4 -87.23 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 125.116 1.366 . . . . 72.41 110.145 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -142.38 23.59 1.98 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.188 0.995 . . . . 75.43 110.007 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -144.21 170.79 15.3 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.086 0.954 . . . . 70.32 109.116 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -128.12 -113.09 1.72 Allowed Glycine 0 C--N 1.348 1.224 0 N-CA-C 111.457 -0.657 . . . . 53.31 111.457 174.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -160.27 -166.61 1.72 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.28 1.032 . . . . 63.11 109.906 -175.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.01 117.59 22.79 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.931 0.892 . . . . 61.31 109.12 171.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -89.59 61.57 3.49 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 115.756 -0.657 . . . . 55.13 112.972 -175.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 32.1 m -109.66 152.83 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.617 0.767 . . . . 75.25 110.521 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 . . . . . 0 CA--C 1.551 0.998 0 C-N-CA 124.895 1.278 . . . . 73.43 110.575 -177.157 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtm . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 109.683 -0.488 . . . . 73.22 109.683 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.1 p -164.19 -43.99 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.444 1.098 . . . . 74.45 108.425 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 63.99 16.63 10.05 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 125.22 1.408 . . . . 71.4 111.705 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -96.95 124.58 40.96 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 123.809 0.843 . . . . 71.13 108.9 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -85.27 -9.65 57.45 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.017 0.527 . . . . 71.43 110.038 175.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -88.76 14.07 11.04 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.311 1.044 . . . . 73.32 111.988 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.3 p -60.12 -71.39 0.13 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.174 0.589 . . . . 53.22 110.358 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.524 ' HG2' ' SD ' ' A' ' 9' ' ' MET . 43.2 tt0 178.56 -69.01 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 107.298 -1.371 . . . . 73.41 107.298 172.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.524 ' SD ' ' HG2' ' A' ' 8' ' ' GLU . 0.7 OUTLIER -99.85 170.66 8.38 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.767 0.827 . . . . 71.22 109.809 170.599 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.8 m -146.5 111.56 5.38 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.244 1.018 . . . . 65.35 108.459 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -121.13 112.46 18.71 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.228 -1.397 . . . . 74.34 107.228 167.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.55 HE22 ' HE2' ' F' ' 138' ' ' TYR . 50.4 tp60 -135.68 135.64 40.27 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.804 -1.184 . . . . 62.21 107.804 171.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.9 mt -91.57 115.83 31.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 108.281 -1.007 . . . . 74.13 108.281 176.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -73.88 -40.24 63.35 Favored 'General case' 0 C--O 1.242 0.708 0 O-C-N 123.388 0.43 . . . . 70.32 110.51 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.506 ' HE ' ' HB ' ' B' ' 122' ' ' THR . 26.0 ttt180 -174.86 122.65 0.24 Allowed 'General case' 0 N--CA 1.479 1.0 0 O-C-N 123.227 0.33 . . . . 72.51 110.432 -169.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 73.7 mt -106.47 136.52 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 108.723 -0.843 . . . . 72.45 108.723 172.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.473 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 26.4 p90 -166.65 177.95 6.27 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 124.206 0.941 . . . . 75.02 111.802 -172.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.6 p -110.35 118.8 37.27 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.064 -0.971 . . . . 64.4 109.386 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.473 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 35.8 mtpt -82.97 -29.33 29.12 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.066 0.46 . . . . 61.21 109.79 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 30.6 t70 -150.52 136.8 18.67 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.765 -1.107 . . . . 71.14 109.28 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.406 HG23 HG22 ' A' ' 78' ' ' VAL . 59.8 mt -135.06 138.78 48.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.904 -1.147 . . . . 64.31 107.904 174.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.4 t -150.02 124.32 9.54 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.641 0.588 . . . . 71.2 110.04 173.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.7 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.6 t80 -120.95 132.97 55.25 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 106.87 -1.529 . . . . 74.14 106.87 168.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -128.5 139.93 52.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.301 -0.629 . . . . 63.13 109.301 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.13 78.07 65.68 Favored Pre-proline 0 C--O 1.24 0.581 0 N-CA-C 106.908 -1.516 . . . . 75.31 106.908 171.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -64.18 -34.51 56.61 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.671 2.247 . . . . 73.2 112.303 -171.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -106.11 22.34 15.85 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 118.146 -0.931 . . . . 73.44 110.488 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.428 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -43.04 -56.08 6.81 Favored Pre-proline 0 N--CA 1.493 1.721 0 CA-C-O 117.923 -1.037 . . . . 51.42 113.752 -171.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.428 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 22.8 Cg_exo -65.03 -27.87 57.6 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 121.906 1.738 . . . . 64.4 113.29 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -80.65 -40.43 25.57 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.847 0.859 . . . . 71.13 110.922 -175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.809 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.3 p -78.1 -21.33 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 CA-C-N 114.935 -1.029 . . . . 72.53 112.837 -158.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -71.05 -12.14 61.35 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.168 0.587 . . . . 74.32 111.438 176.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -90.22 -18.31 25.92 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.537 1.135 . . . . 62.12 111.011 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -81.55 161.01 23.73 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.494 0.717 . . . . 72.41 112.126 -172.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.13 116.14 6.9 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 114.75 -1.113 . . . . 74.33 108.765 173.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.43 ' CE3' HD21 ' A' ' 68' ' ' LEU . 63.6 t-105 -80.79 80.18 7.31 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.875 0.845 . . . . 73.41 109.678 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.427 ' H ' HD22 ' A' ' 68' ' ' LEU . 9.2 tt0 -123.97 69.71 48.39 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 124.898 1.279 . . . . 73.32 108.24 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -86.4 118.25 1.59 Allowed 'Trans proline' 0 C--N 1.382 2.325 0 C-N-CA 122.602 2.201 . . . . 73.43 112.816 -170.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -94.45 103.46 15.43 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 105.023 -2.214 . . . . 74.45 105.023 168.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.458 ' CG1' HG13 ' A' ' 64' ' ' VAL . 57.5 t -90.74 101.8 12.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 123.39 0.676 . . . . 74.22 110.334 -177.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -79.6 117.97 21.01 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.662 -0.699 . . . . 74.51 109.855 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 49.3 mt -97.02 107.04 19.49 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.281 -1.007 . . . . 74.34 108.281 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.532 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.7 m-20 -106.85 106.77 17.45 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.174 0.99 . . . . 74.13 108.679 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.446 HD11 HG21 ' A' ' 131' ' ' VAL . 85.3 mt -98.91 149.64 22.74 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.858 0.463 . . . . 62.31 110.631 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -154.92 148.68 25.52 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.856 -1.065 . . . . 75.05 108.696 177.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.3 m -131.51 130.89 42.94 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.583 0.753 . . . . 74.33 109.878 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.87 109.12 9.87 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.806 0.842 . . . . 55.04 109.121 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 88.2 p -98.7 156.95 16.58 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.214 0.606 . . . . 64.31 110.327 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.2 t -150.2 151.63 33.37 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.629 1.172 . . . . 75.04 108.609 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -100.16 111.56 23.85 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.091 -1.077 . . . . 72.12 108.091 172.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 74.1 mt -79.22 -43.03 24.64 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.136 0.574 . . . . 53.33 110.234 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.98 -177.28 5.65 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.962 -0.563 . . . . 54.24 110.708 -176.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.02 110.76 0.87 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.088 0.955 . . . . 73.03 109.883 174.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 65.1 9.59 5.65 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.529 1.132 . . . . 72.55 112.655 -178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.2 t -104.27 107.24 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.299 -1.0 . . . . 63.52 108.299 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -114.77 126.55 54.97 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.495 -0.928 . . . . 75.45 108.495 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -90.51 151.63 21.28 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.163 -0.681 . . . . 64.35 109.163 168.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.409 HG11 ' HD3' ' A' ' 103' ' ' PRO . 55.1 t -132.57 136.34 56.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 124.882 1.273 . . . . 42.42 107.568 170.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 52.5 t -118.01 130.12 73.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.765 -0.828 . . . . 45.4 108.765 175.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.442 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -102.32 103.47 13.92 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.643 -1.614 . . . . 73.24 106.643 176.258 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -90.21 98.77 11.97 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.16 -1.422 . . . . 72.42 107.16 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.61 132.24 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 114.757 -1.111 . . . . 71.13 108.177 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 6.8 m -125.51 146.65 49.56 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.395 -0.965 . . . . 61.22 108.395 175.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 23.2 t -145.61 117.37 2.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 124.867 1.267 . . . . 64.4 107.933 -168.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.7 m -126.2 120.55 30.36 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.129 0.422 . . . . 74.32 110.004 177.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.42 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -101.24 105.59 16.72 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.264 -1.384 . . . . 54.21 107.264 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.2 m -109.07 126.13 52.84 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.044 0.537 . . . . 73.2 110.007 -176.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.43 HD21 ' CE3' ' A' ' 36' ' ' TRP . 35.0 mt -89.79 74.76 7.42 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 125.021 1.328 . . . . 74.11 108.671 175.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.99 -84.39 0.92 Allowed Glycine 0 C--N 1.341 0.856 0 CA-C-N 115.713 -0.676 . . . . 72.02 111.921 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -114.28 -29.0 7.06 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.787 0.835 . . . . 53.44 111.007 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -88.89 134.41 33.96 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.837 0.455 . . . . 65.44 110.211 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -80.2 136.45 36.48 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 118.019 0.372 . . . . 65.21 110.126 175.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.809 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -87.12 -58.25 2.66 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.166 0.986 . . . . 63.03 109.264 176.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -154.54 168.28 27.26 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.579 -1.191 . . . . 64.13 110.695 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 64' ' ' VAL . 67.1 tp -124.56 147.37 48.48 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.213 1.405 . . . . 64.3 108.042 172.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.56 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 79.8 m -142.86 128.1 18.73 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.2 -1.037 . . . . 73.41 108.2 175.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -146.27 118.45 8.33 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.775 -0.454 . . . . 74.3 109.775 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.406 HG22 HG23 ' A' ' 21' ' ' ILE . 39.4 t -127.41 112.81 29.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.49 1.116 . . . . 64.51 108.97 -176.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 51.7 mt-30 -86.28 84.18 7.53 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.652 -0.87 . . . . 74.12 108.652 171.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -76.78 94.92 3.93 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.506 -1.224 . . . . 73.23 109.578 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.82 144.26 18.06 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 111.87 -0.492 . . . . 64.33 111.87 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.494 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.03 124.18 2.75 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.265 -1.134 . . . . 71.22 110.265 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.422 HG13 ' HE1' ' A' ' 17' ' ' TYR . 48.9 mt -81.74 129.15 37.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.923 -1.14 . . . . 73.01 107.923 172.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.653 ' HB3' HD11 ' A' ' 86' ' ' ILE . 88.9 m-85 -128.5 122.99 32.43 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.189 0.996 . . . . 74.44 109.298 -174.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.0 t -89.75 93.27 9.39 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.36 1.064 . . . . 73.05 108.841 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.653 HD11 ' HB3' ' A' ' 84' ' ' PHE . 15.9 mm -120.73 132.89 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.895 0.878 . . . . 74.13 111.379 -168.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.75 167.43 28.23 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.617 0.767 . . . . 62.21 110.708 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.86 8.67 72.5 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 119.325 -0.709 . . . . 63.24 114.73 173.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.47 HD11 HG22 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -143.41 164.07 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 124.112 0.965 . . . . 60.42 109.922 174.704 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.473 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 19.8 tt0 -154.94 179.05 9.49 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.501 -0.772 . . . . 62.22 109.089 174.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.473 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 61.99 -130.03 44.44 Favored Glycine 0 C--N 1.347 1.149 0 C-N-CA 123.283 0.468 . . . . 63.22 113.792 175.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.5 p -67.92 -28.58 67.62 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.995 0.918 . . . . 55.04 111.259 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -66.59 -43.22 85.46 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.71 0.804 . . . . 62.1 110.25 177.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.3 tpt -70.84 -41.3 71.68 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.571 -0.74 . . . . 75.41 110.594 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.97 -36.71 84.87 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.359 0.663 . . . . 64.43 111.136 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.415 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 61.0 t-80 -71.7 -29.77 64.93 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.324 0.65 . . . . 73.51 110.75 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.8 t -71.41 -48.31 50.52 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.603 -0.517 . . . . 61.34 109.603 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 79.0 mt -80.37 -25.49 39.13 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.141 0.576 . . . . 74.15 112.494 -174.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.79 4.3 32.3 Favored Glycine 0 N--CA 1.474 1.175 0 CA-C-O 119.669 -0.517 . . . . 44.03 113.954 -173.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -144.2 -65.48 0.36 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 117.469 0.634 . . . . 74.31 111.33 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -67.6 -45.93 74.03 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 116.193 -0.458 . . . . 74.02 112.209 -171.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 68.6 m -66.98 -48.34 50.65 Favored Pre-proline 0 CA--C 1.559 1.311 0 C-N-CA 124.073 0.949 . . . . 73.41 112.863 -176.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HD3' HG11 ' A' ' 58' ' ' VAL . 46.0 Cg_endo -66.92 -21.02 50.73 Favored 'Trans proline' 0 C--N 1.393 2.893 0 C-N-CA 121.596 1.531 . . . . 72.52 112.562 173.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -71.84 -35.23 69.81 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.122 0.569 . . . . 54.21 110.364 174.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 38.6 mm -64.08 -42.72 96.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.65 0.78 . . . . 74.35 109.968 171.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.494 HD21 ' HA3' ' A' ' 82' ' ' GLY . 65.3 mt -76.17 -21.15 56.86 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.253 -0.885 . . . . 64.24 111.997 -174.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -64.31 -43.85 74.12 Favored Pre-proline 0 N--CA 1.484 1.261 0 CA-C-O 117.296 -1.335 . . . . 73.42 114.47 -172.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.78 -37.21 75.99 Favored 'Trans proline' 0 C--N 1.384 2.402 0 CA-C-N 122.04 1.764 . . . . 51.11 113.039 171.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -77.82 -39.39 43.84 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.581 0.753 . . . . 54.31 111.777 -177.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.56 -47.07 77.09 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 109.592 -0.521 . . . . 75.22 109.592 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.486 ' NH1' HD12 ' C' ' 105' ' ' ILE . 29.5 ttm180 -48.19 -56.06 8.87 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 125.157 1.535 . . . . 72.04 110.32 173.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.07 -44.96 94.32 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 124.432 1.082 . . . . 65.01 112.186 -174.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 117' ' ' MET . 42.1 t -59.27 -41.42 88.84 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.893 0.745 . . . . 72.02 110.82 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.45 ' O ' HG23 ' A' ' 118' ' ' VAL . 74.4 mt -64.32 -50.77 74.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.443 1.097 . . . . 75.3 110.561 174.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.0 m -59.56 -36.36 76.05 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.376 1.071 . . . . 75.12 111.386 -177.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -71.38 -41.59 69.5 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 114.712 -1.131 . . . . 73.43 109.859 -178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.7 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 44.4 mtm -62.1 -38.37 88.62 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.731 0.413 . . . . 63.34 111.101 175.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 114' ' ' ILE . 65.6 t -63.52 -47.38 91.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 124.325 1.05 . . . . 72.51 111.157 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.8 p -71.79 -35.27 69.95 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.007 0.523 . . . . 72.2 111.327 -177.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.467 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 87.5 mtt-85 -68.18 -30.75 69.93 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.561 0.744 . . . . 74.25 109.886 173.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.447 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.06 14.51 48.93 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-O 118.953 -0.915 . . . . 52.14 113.218 175.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.6 t 61.54 10.21 3.13 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 127.233 2.213 . . . . 74.43 114.214 176.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -82.18 145.08 51.75 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-O 119.176 -0.44 . . . . 74.23 109.82 177.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.427 ' HG2' ' NE1' ' A' ' 36' ' ' TRP . 92.7 Cg_exo -48.55 149.75 6.66 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 124.039 3.16 . . . . 75.43 113.83 174.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -55.68 128.4 34.55 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 124.246 0.966 . . . . 64.14 112.021 -171.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.457 HD11 HG11 ' A' ' 40' ' ' VAL . 41.4 tp -118.99 102.54 8.84 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.432 0.693 . . . . 74.42 110.172 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.517 HD21 ' HA ' ' C' ' 15' ' ' ARG . 82.2 m-20 -102.77 115.38 30.47 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 107.798 -1.186 . . . . 71.12 107.798 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.3 mt -67.17 134.09 51.06 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.339 -0.615 . . . . 73.2 109.339 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.424 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -61.15 137.8 94.27 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 123.532 0.733 . . . . 52.03 111.379 -175.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 32.4 Cg_exo -59.81 107.11 0.36 Allowed 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.337 2.691 . . . . 70.53 113.47 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.446 HG21 HD11 ' A' ' 44' ' ' LEU . 58.3 t -100.95 134.46 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.119 0.568 . . . . 52.02 111.518 -174.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.503 ' HB2' ' HA2' ' E' ' 140' ' ' GLY . 52.7 t30 -96.26 87.54 4.52 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 114.347 -1.297 . . . . 73.42 109.134 175.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -59.74 -25.07 64.56 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.979 0.911 . . . . 74.33 112.531 175.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.436 ' HB3' ' OD1' ' A' ' 132' ' ' ASN . 19.8 t70 -58.68 -49.94 75.69 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.651 0.78 . . . . 65.52 109.812 172.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.448 ' HB2' ' ND2' ' A' ' 132' ' ' ASN . . . -59.51 -49.6 77.16 Favored 'General case' 0 C--N 1.358 0.956 0 O-C-N 123.731 0.645 . . . . 54.12 110.727 175.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 85.7 mt -53.13 -44.65 67.89 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 124.144 0.903 . . . . 71.04 111.925 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -66.66 -45.2 79.73 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.533 -0.758 . . . . 72.25 110.467 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.478 ' HA ' ' HB3' ' A' ' 141' ' ' LEU . 17.4 mtp -74.0 -19.39 60.66 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.964 -0.562 . . . . 75.31 112.006 -174.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 85.8 m-20 -66.51 -37.5 85.19 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.453 0.701 . . . . 74.53 110.194 171.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -74.3 -42.72 59.05 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.766 0.826 . . . . 63.42 110.593 173.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.478 ' HB3' ' HA ' ' A' ' 138' ' ' MET . 40.9 tp -68.16 -49.1 63.19 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.308 1.043 . . . . 71.42 112.331 -170.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.407 ' HG3' ' HB2' ' A' ' 144' ' ' GLN . 19.8 pt20 -160.4 20.15 0.15 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.151 0.58 . . . . 74.13 111.553 -172.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 77.4 mt-30 62.23 16.11 8.12 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.89 1.276 . . . . 71.52 113.304 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.407 ' HB2' ' HG3' ' A' ' 142' ' ' GLN . 28.1 tt0 -74.53 109.01 7.66 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.553 0.341 . . . . 75.31 111.242 -172.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.52 178.38 9.94 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.121 0.968 . . . . 61.35 110.097 175.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 160.68 39.94 0.02 OUTLIER Glycine 0 C--N 1.342 0.895 0 N-CA-C 111.541 -0.624 . . . . 63.15 111.541 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -75.04 152.99 38.62 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.739 0.816 . . . . 74.51 110.562 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.422 ' HA3' HG23 ' C' ' 7' ' ' THR . . . -85.19 -177.56 50.78 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 116.03 -0.532 . . . . 74.23 114.052 -173.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 41.3 p -124.09 108.69 12.6 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.126 0.97 . . . . 75.43 108.434 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.444 ' HB3' HG23 ' C' ' 10' ' ' THR . 2.0 mp0 -78.76 85.89 4.74 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.459 -0.571 . . . . 71.33 109.459 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.0 86.52 1.31 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 106.53 -1.656 . . . . 72.12 106.53 171.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -85.34 143.93 28.37 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.38 -0.827 . . . . 70.55 110.333 -167.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.73 -163.17 1.0 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.372 0.669 . . . . 72.4 110.786 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -108.3 139.42 43.03 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.504 0.722 . . . . 64.43 109.444 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.934 0 C-N-CA 123.89 0.876 . . . . 73.03 109.828 176.861 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.438 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.847 0.355 . . . . 53.02 110.929 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 61.4 p -93.16 54.27 2.1 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.948 0.899 . . . . 54.33 109.836 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -122.79 -171.08 2.21 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.49 1.116 . . . . 74.54 111.252 -163.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 62.04 -81.0 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 125.708 1.603 . . . . 75.24 111.952 176.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 58.42 79.81 0.2 Allowed 'General case' 0 C--N 1.362 1.141 0 C-N-CA 124.307 1.043 . . . . 74.14 109.959 -175.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -61.52 100.34 0.14 Allowed 'General case' 0 C--N 1.353 0.754 0 CA-C-N 115.298 -0.865 . . . . 71.14 111.348 -171.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 37.4 m -66.76 151.63 47.08 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 113.866 -1.515 . . . . 61.12 111.25 -176.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.24 155.82 23.68 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.913 0.885 . . . . 74.4 110.769 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.523 ' SD ' HG23 ' B' ' 89' ' ' ILE . 11.8 tpt 66.84 163.4 0.18 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 125.634 1.574 . . . . 53.51 111.425 -169.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 9.4 t -153.92 132.26 11.98 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 107.483 -1.303 . . . . 63.35 107.483 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -137.69 136.97 37.89 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.146 -0.687 . . . . 74.14 109.146 -175.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -155.72 141.5 18.02 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.373 0.669 . . . . 74.42 109.523 173.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 55.6 mt -87.72 125.16 41.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.199 -1.037 . . . . 62.4 108.199 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -89.94 -39.63 12.88 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.672 -0.695 . . . . 72.44 109.802 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.44 ' HE ' HG21 ' A' ' 122' ' ' THR . 38.6 ttt180 -171.49 143.79 1.83 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.687 -0.688 . . . . 62.32 109.725 -174.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 71.4 mt -130.25 138.14 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 107.519 -1.289 . . . . 73.14 107.519 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.421 ' HE1' HG13 ' B' ' 83' ' ' ILE . 26.7 p90 -161.66 143.37 11.42 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.248 0.547 . . . . 75.52 111.479 -172.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.697 HG21 HD11 ' B' ' 21' ' ' ILE . 21.1 m -76.44 123.26 25.73 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.946 -1.025 . . . . 73.1 108.522 171.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.43 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.8 mtpt -93.84 -26.54 16.88 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.265 0.626 . . . . 71.13 110.337 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 34.0 t70 -152.53 141.75 21.44 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.91 0.484 . . . . 75.11 110.814 -175.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.697 HD11 HG21 ' B' ' 18' ' ' THR . 32.8 mm -129.5 142.47 43.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.022 1.329 . . . . 72.51 108.449 174.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 46.5 m -147.58 134.27 19.97 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.846 -1.07 . . . . 71.22 109.668 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -147.16 109.05 4.4 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.752 -1.573 . . . . 70.52 106.752 167.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -120.98 114.84 22.1 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.487 -0.931 . . . . 65.34 108.487 -177.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.58 87.02 2.48 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 107.327 -1.36 . . . . 63.21 107.327 175.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.65 -37.28 22.12 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.502 2.134 . . . . 74.23 112.552 -169.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.528 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 82.4 m-20 -102.13 17.46 23.25 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.05 0.94 . . . . 73.13 110.621 -176.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.422 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -39.88 -60.74 1.28 Allowed Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 115.465 1.654 . . . . 75.53 115.465 -163.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 12.6 Cg_exo -67.57 -28.48 38.02 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 121.844 1.696 . . . . 72.34 112.349 -173.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.458 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 79.1 m80 -92.83 -25.43 18.12 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.137 -0.938 . . . . 74.03 112.145 -173.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.585 HG21 ' HA ' ' B' ' 73' ' ' ALA . 6.0 p -83.02 -7.55 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-O 121.259 0.552 . . . . 75.43 110.725 -176.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -77.76 -9.23 58.91 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.207 0.603 . . . . 72.13 112.626 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 10.5 pt20 -67.23 -17.25 64.73 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.809 0.444 . . . . 71.11 110.582 170.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.538 ' HB2' HD13 ' B' ' 68' ' ' LEU . 30.5 mmtp -92.92 98.43 11.36 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.841 1.257 . . . . 74.24 109.23 -178.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' F' ' 132' ' ' SER . 3.9 m-20 -100.1 78.25 2.06 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.322 0.649 . . . . 75.14 110.233 -176.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 25.2 p90 -166.06 172.46 11.35 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.575 0.75 . . . . 65.14 110.244 174.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -71.73 117.59 59.02 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 123.201 0.6 . . . . 73.32 110.104 175.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.42 ' HD3' ' HG2' ' B' ' 124' ' ' PRO . 55.8 Cg_endo -70.53 147.35 57.74 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 121.754 1.636 . . . . 72.33 110.474 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -72.47 110.0 6.56 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.22 -1.03 . . . . 65.24 108.22 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.479 HG21 HD13 ' B' ' 126' ' ' LEU . 59.9 t -99.32 146.05 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 114.955 -1.02 . . . . 73.24 110.44 -174.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -119.23 117.86 29.77 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.981 1.312 . . . . 70.04 108.578 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.629 HD13 HD22 ' B' ' 128' ' ' LEU . 24.2 tp -89.26 144.77 25.85 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.922 -0.399 . . . . 61.14 109.922 172.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.412 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 12.3 t70 -150.82 119.25 6.42 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.752 -0.832 . . . . 74.04 108.752 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.51 ' H ' ' HE2' ' F' ' 113' ' ' LYS . 90.5 mt -99.47 126.24 45.36 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.475 -0.565 . . . . 71.42 109.475 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -124.79 127.45 47.2 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.765 -1.198 . . . . 74.15 107.765 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.8 t -109.46 141.37 41.97 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 122.746 0.418 . . . . 74.2 110.178 -172.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.69 140.73 27.47 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.477 1.111 . . . . 74.35 108.104 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 14.9 m -137.92 163.8 30.57 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.764 0.426 . . . . 72.4 110.021 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 72.1 p -156.41 136.31 12.64 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.246 0.618 . . . . 73.3 109.705 174.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -91.43 134.6 34.49 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.248 -1.019 . . . . 73.04 108.248 170.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 pp -150.67 14.22 0.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.432 -0.804 . . . . 74.34 109.717 177.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.98 158.82 35.64 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.439 -0.801 . . . . 45.02 110.953 -174.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -83.66 127.03 33.46 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.778 -1.101 . . . . 70.31 108.897 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 64.03 4.0 1.88 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 124.472 1.109 . . . . 63.23 113.065 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 53.6 t -132.32 122.73 48.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.63 -0.878 . . . . 74.31 108.63 -173.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.43 140.62 44.49 Favored 'General case' 0 C--O 1.243 0.753 0 N-CA-C 108.214 -1.032 . . . . 73.13 108.214 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -99.48 101.37 12.59 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 105.442 -2.058 . . . . 63.54 105.442 172.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.512 HG21 ' HG3' ' B' ' 103' ' ' PRO . 14.6 p -109.29 140.14 29.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 121.407 0.622 . . . . 72.12 109.329 -178.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.418 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 17.0 t -114.2 144.56 21.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 124.614 1.166 . . . . 61.03 108.683 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 48.1 tp -121.12 110.36 16.12 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 107.751 -1.203 . . . . 73.34 107.751 167.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -84.25 118.36 24.12 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.673 -1.232 . . . . 73.3 107.673 171.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.4 121.24 57.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.44 -0.948 . . . . 71.5 108.44 173.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 17.8 m -108.75 135.29 50.22 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.74 0.816 . . . . 64.42 109.384 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.537 HG11 HD21 ' B' ' 126' ' ' LEU . 82.0 t -134.11 119.88 32.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.903 0.881 . . . . 73.12 109.171 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 66.6 m -109.5 138.98 45.06 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 123.659 0.783 . . . . 75.14 109.072 173.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.469 ' HB2' HG22 ' B' ' 40' ' ' VAL . . . -148.73 141.86 24.96 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.728 0.411 . . . . 73.43 109.909 178.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.554 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 35.4 p -141.68 132.68 26.07 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.607 0.763 . . . . 71.43 110.904 -176.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.538 HD13 ' HB2' ' B' ' 34' ' ' LYS . 68.8 mt -102.04 103.41 14.0 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 124.664 1.186 . . . . 61.22 109.196 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.96 -124.59 7.88 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.794 -0.639 . . . . 62.14 111.986 -175.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -96.08 2.24 53.1 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.937 0.895 . . . . 74.12 111.037 -173.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.528 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 19.9 pt-20 -130.16 149.38 51.89 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.988 0.515 . . . . 73.3 110.901 -173.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 85.9 m -73.73 123.68 24.57 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 116.014 -0.539 . . . . 75.32 110.673 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.585 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -76.35 -60.94 2.12 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.651 -1.159 . . . . 74.51 108.704 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -153.13 152.71 31.58 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.058 -0.974 . . . . 75.11 111.85 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 75.2 mt -121.05 110.62 16.46 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.53 -1.656 . . . . 55.22 106.53 169.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 28.9 t -119.28 121.25 39.21 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.028 -0.73 . . . . 62.4 109.028 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -138.22 128.49 26.0 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.244 0.618 . . . . 64.54 109.409 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 73.3 t -126.44 134.94 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.596 0.758 . . . . 62.23 109.172 175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.502 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.3 mt-30 -108.67 107.72 18.3 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.305 -0.998 . . . . 73.44 108.305 175.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.425 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 7.8 tp-100 -100.8 107.81 19.46 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.753 -0.832 . . . . 74.0 108.753 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.43 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -91.73 170.01 33.16 Favored Glycine 0 C--O 1.245 0.784 0 N-CA-C 111.865 -0.494 . . . . 54.22 111.865 175.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.53 139.66 5.78 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 121.727 -0.273 . . . . 71.22 113.069 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.421 HG13 ' HE1' ' B' ' 17' ' ' TYR . 66.5 mt -98.23 110.75 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 C-N-CA 125.019 1.327 . . . . 71.23 108.182 176.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -122.79 143.95 49.5 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 123.713 0.805 . . . . 74.43 110.839 -175.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 37.1 m -102.2 122.94 45.16 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.73 0.812 . . . . 70.3 109.894 175.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.566 ' HB ' HD11 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -131.89 122.74 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 C-N-CA 124.911 1.284 . . . . 75.3 109.302 179.266 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.532 ' HA ' ' HB ' ' F' ' 97' ' ' ILE . . . -156.94 150.51 24.4 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.885 0.474 . . . . 61.54 111.579 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.36 -35.67 4.73 Favored Glycine 0 N--CA 1.479 1.503 0 C-N-CA 123.263 0.458 . . . . 75.22 112.394 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.566 HD11 ' HB ' ' B' ' 86' ' ' ILE . 7.1 pt -63.75 160.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 124.891 1.276 . . . . 65.21 112.655 173.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -153.78 176.07 12.57 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.023 0.929 . . . . 64.22 110.317 -173.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.4 -130.86 41.2 Favored Glycine 0 C--N 1.354 1.533 0 O-C-N 123.73 0.643 . . . . 63.13 112.859 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 18.0 m -67.5 -45.29 76.26 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.678 0.791 . . . . 63.44 109.75 172.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -59.12 -23.66 62.31 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 113.556 -1.656 . . . . 74.3 112.238 -167.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.446 ' HG3' HD11 ' F' ' 97' ' ' ILE . 20.6 ttt -58.6 -70.23 0.15 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.014 1.326 . . . . 74.13 111.931 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.39 -12.8 56.08 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.803 0.441 . . . . 70.25 112.137 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -63.24 -41.78 99.11 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.355 0.662 . . . . 72.21 110.267 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -60.69 -43.64 97.5 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.855 -0.611 . . . . 72.31 111.6 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.562 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.2 pp -81.28 -23.83 37.67 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.726 0.41 . . . . 52.42 111.776 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.51 -1.61 60.46 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-O 119.784 -0.453 . . . . 62.01 113.877 -174.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.47 -55.99 0.39 Allowed 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.303 0.551 . . . . 64.21 111.891 -174.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -69.11 -46.23 68.23 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 122.745 0.418 . . . . 54.33 110.33 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.562 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 79.3 m -66.19 -47.98 59.85 Favored Pre-proline 0 CA--C 1.569 1.687 0 N-CA-C 113.711 1.004 . . . . 60.03 113.711 -177.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.512 ' HG3' HG21 ' B' ' 58' ' ' VAL . 15.2 Cg_exo -65.12 -28.82 56.52 Favored 'Trans proline' 0 C--N 1.402 3.359 0 C-N-CA 122.033 1.822 . . . . 72.24 112.87 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -69.62 -29.03 66.44 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.092 0.557 . . . . 71.23 110.325 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.2 mt -65.23 -35.69 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.339 0.656 . . . . 64.14 110.334 170.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 76.5 mt -80.26 -17.98 50.68 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.821 0.848 . . . . 73.21 112.33 -177.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -59.42 -50.71 85.89 Favored Pre-proline 0 CA--C 1.561 1.375 0 CA-C-O 117.515 -1.231 . . . . 73.02 112.898 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -54.73 -37.11 91.84 Favored 'Trans proline' 0 C--N 1.39 2.727 0 C-N-CA 122.429 2.086 . . . . 70.2 114.028 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -68.73 -46.69 68.24 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.376 0.671 . . . . 72.51 110.583 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.425 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -64.55 -34.72 78.91 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.592 -0.731 . . . . 62.3 110.924 176.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 31.2 ttt180 -64.99 -50.13 67.54 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.226 1.41 . . . . 73.45 110.813 -178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.38 -32.52 70.21 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.403 0.681 . . . . 55.01 109.933 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.56 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.9 t -67.31 -41.37 85.46 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 122.923 0.489 . . . . 65.54 110.728 177.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 49.8 mt -59.83 -54.42 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.837 0.855 . . . . 71.43 110.445 172.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 25.1 m -61.79 -29.22 70.0 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 123.757 0.661 . . . . 75.24 111.371 -177.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 44.6 t -64.5 -52.44 57.83 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 123.543 0.737 . . . . 74.5 109.839 173.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 15.6 mmt -66.02 -33.62 76.22 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.27 0.628 . . . . 64.22 111.612 -175.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.504 HG21 HD23 ' B' ' 126' ' ' LEU . 74.3 t -66.76 -44.48 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.639 1.176 . . . . 75.45 110.602 174.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.5 t -64.66 -32.83 74.67 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.099 -0.955 . . . . 65.45 110.567 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' B' ' 116' ' ' SER . 78.5 mtt-85 -64.67 -47.78 77.16 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 115.709 -0.678 . . . . 72.13 109.339 175.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.468 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -67.95 -5.99 42.71 Favored Glycine 0 C--N 1.358 1.772 0 O-C-N 123.735 0.647 . . . . 22.41 113.615 174.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.506 ' HB ' ' HE ' ' A' ' 15' ' ' ARG . 2.2 m 66.77 27.62 9.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.539 1.536 . . . . 74.51 110.563 175.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -84.87 156.06 61.18 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 123.214 0.605 . . . . 74.32 110.971 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.581 ' HG3' ' HB3' ' F' ' 131' ' ' TRP . 71.6 Cg_exo -51.89 167.86 0.41 Allowed 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 123.991 3.127 . . . . 71.22 115.219 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -63.52 112.56 2.83 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.832 -1.076 . . . . 74.15 111.605 -167.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.537 HD21 HG11 ' B' ' 64' ' ' VAL . 43.6 tp -116.56 105.82 12.88 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.282 0.633 . . . . 74.23 109.56 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -121.49 120.96 36.41 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.034 -1.098 . . . . 72.21 108.034 170.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.629 HD22 HD13 ' B' ' 42' ' ' LEU . 59.2 mt -74.21 143.92 44.96 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.58 0.55 . . . . 63.03 110.988 -174.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.91 141.14 63.19 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 122.961 0.504 . . . . 73.11 110.843 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.655 ' HG3' HD11 ' D' ' 16' ' ' ILE . 61.7 Cg_endo -70.14 79.98 1.02 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.334 2.689 . . . . 73.33 111.216 174.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 p -100.01 125.42 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 115.498 -0.774 . . . . 74.44 110.053 -177.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -83.06 107.69 15.82 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.677 -0.692 . . . . 72.12 110.108 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -76.56 -27.91 56.06 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.428 0.691 . . . . 73.14 110.977 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -55.43 -40.37 71.41 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.144 0.978 . . . . 71.54 112.118 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.88 -34.07 62.61 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.658 0.783 . . . . 62.33 112.25 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.401 HD21 HG23 ' F' ' 121' ' ' VAL . 5.9 mp -72.53 -35.3 68.03 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.494 0.718 . . . . 72.22 110.202 -178.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -72.18 -36.13 69.18 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 116.409 -0.36 . . . . 64.24 111.092 170.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 2.4 mmt -75.06 -29.35 60.69 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 113.079 0.77 . . . . 73.52 113.079 -170.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -82.02 -39.19 23.9 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.35 0.26 . . . . 75.24 110.5 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -76.72 -47.56 21.51 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.642 0.377 . . . . 72.12 111.277 -175.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 69.9 mt -93.11 25.22 3.36 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.376 1.07 . . . . 72.54 110.715 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -72.44 171.23 12.68 Favored 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 123.397 0.679 . . . . 75.1 109.629 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 73.1 128.96 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.262 1.425 . . . . 75.4 111.318 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.18 159.25 42.61 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 107.131 -1.433 . . . . 73.22 107.131 -173.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.0 96.82 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.525 0.73 . . . . 62.55 110.249 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.41 -49.08 0.58 Allowed Glycine 0 C--N 1.34 0.785 0 N-CA-C 110.093 -1.203 . . . . 63.24 110.093 -174.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 68.81 130.92 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 126.215 1.806 . . . . 74.23 113.369 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -120.18 90.75 0.48 Allowed Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.013 -0.835 . . . . 71.44 111.013 173.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 8.2 p -79.6 71.45 6.22 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.454 0.702 . . . . 71.52 110.456 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -82.67 105.89 14.07 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 107.949 -1.13 . . . . 73.15 107.949 171.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -64.94 125.26 24.33 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.059 0.944 . . . . 75.44 110.892 -173.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -121.88 127.11 50.1 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.849 0.86 . . . . 71.24 109.432 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -74.61 140.9 44.65 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 109.76 -0.459 . . . . 75.31 109.76 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -72.91 -62.55 1.42 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.522 0.729 . . . . 72.33 109.061 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.132 0 C-N-CA 124.344 1.058 . . . . 74.21 108.402 177.347 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 109.445 -0.576 . . . . 75.34 109.445 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 53.7 m -163.44 96.99 0.88 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.923 1.289 . . . . 41.33 108.517 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -110.81 150.29 29.34 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 108.801 -0.815 . . . . 74.14 108.801 168.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . 0.731 HE22 ' HG3' ' C' ' 153' ' ' GLN . 12.0 pt20 -147.81 -167.02 2.68 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.016 0.526 . . . . 74.44 111.172 -161.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -61.87 115.13 3.77 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-N 114.954 -1.021 . . . . 74.41 109.419 167.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.77 -73.41 0.23 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.913 -1.143 . . . . 74.1 107.913 -175.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.437 HG21 ' HG3' ' A' ' 150' ' ' GLU . 22.0 m -110.1 161.44 15.54 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 124.132 0.973 . . . . 62.1 110.275 -169.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -64.14 81.83 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.379 1.072 . . . . 74.55 108.808 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.408 ' HG2' ' HB2' ' C' ' 11' ' ' PHE . 59.8 ttm 60.74 113.47 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.367 1.467 . . . . 72.3 110.282 -162.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.444 HG23 ' HB3' ' A' ' 150' ' ' GLU . 16.9 m -86.2 85.63 7.35 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.246 -1.02 . . . . 75.32 108.246 172.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.408 ' HB2' ' HG2' ' C' ' 9' ' ' MET . 68.3 t80 -109.48 145.25 36.54 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.71 0.804 . . . . 72.0 109.264 -174.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -161.97 126.54 3.32 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.559 0.744 . . . . 74.03 109.591 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 48.5 mt -78.84 123.59 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 108.438 -0.949 . . . . 74.24 108.438 169.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.445 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 81.6 mm-40 -90.44 -42.12 11.07 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.644 0.777 . . . . 65.11 109.688 176.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.517 ' HA ' HD21 ' A' ' 127' ' ' ASN . 9.0 ptp85 -173.42 150.9 1.89 Allowed 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.312 -0.858 . . . . 73.43 110.212 -178.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 74.3 mt -128.17 135.15 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 106.731 -1.581 . . . . 72.41 106.731 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -173.06 158.64 3.77 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.379 0.609 . . . . 61.11 111.724 -170.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 70.2 p -82.46 113.24 20.08 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.341 -0.845 . . . . 71.04 109.123 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.603 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 10.4 mmmm -68.61 -49.13 61.64 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.046 -1.094 . . . . 73.11 108.046 169.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.704 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 20.8 t70 -136.19 143.68 44.54 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 113.852 -1.522 . . . . 73.44 109.681 -172.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.552 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.5 mt -138.47 145.66 27.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 125.435 1.494 . . . . 75.23 107.25 175.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 41.3 t -153.17 147.75 26.12 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.463 0.649 . . . . 62.03 110.048 175.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -151.83 125.61 9.04 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.04 -1.467 . . . . 74.44 107.04 170.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -129.35 117.81 21.23 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.682 0.793 . . . . 71.05 108.867 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.22 85.62 5.62 Favored Pre-proline 0 CA--C 1.548 0.886 0 N-CA-C 107.304 -1.369 . . . . 75.41 107.304 167.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.91 -33.61 63.11 Favored 'Trans proline' 0 C--N 1.387 2.605 0 C-N-CA 123.097 2.531 . . . . 64.23 112.209 -172.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -113.6 31.51 6.45 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.861 -1.063 . . . . 70.44 109.605 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.414 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -43.91 -54.68 10.54 Favored Pre-proline 0 C--N 1.377 1.764 0 CA-C-O 117.837 -1.078 . . . . 54.12 113.383 -174.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 50.1 Cg_exo -53.28 -52.16 9.33 Favored 'Trans proline' 0 C--N 1.395 3.003 0 C-N-CA 122.001 1.801 . . . . 63.01 113.128 175.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -69.52 -32.57 71.49 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.608 -1.178 . . . . 74.4 113.2 -171.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.622 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.9 p -79.05 -24.44 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 N-CA-C 112.48 0.548 . . . . 73.51 112.48 -173.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -71.42 -17.86 62.36 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 112.349 0.5 . . . . 71.51 112.349 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -93.75 7.39 45.01 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.918 0.487 . . . . 71.12 111.759 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.696 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -94.62 158.74 15.39 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.232 0.613 . . . . 71.42 110.788 -177.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -68.22 129.65 40.55 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.057 0.943 . . . . 65.43 109.539 164.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.567 ' HZ2' HD21 ' C' ' 126' ' ' LEU . 64.0 t-105 -82.24 90.49 6.62 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.211 0.604 . . . . 74.41 110.5 -178.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -143.14 78.38 15.16 Favored Pre-proline 0 N--CA 1.474 0.731 0 N-CA-C 107.709 -1.219 . . . . 74.35 107.709 171.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -93.79 169.85 1.99 Allowed 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 122.527 2.151 . . . . 64.35 112.835 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -92.78 89.76 6.76 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 106.181 -1.785 . . . . 63.43 106.181 171.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 61.2 t -68.16 96.97 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 109.037 -0.727 . . . . 74.14 109.037 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -96.75 104.68 16.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.884 -1.053 . . . . 74.42 108.641 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.682 ' H ' HD23 ' C' ' 42' ' ' LEU . 1.8 pt? -97.07 121.14 38.62 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.788 -1.56 . . . . 62.24 106.788 168.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -119.39 141.12 49.36 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.571 -0.9 . . . . 72.1 108.571 -174.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 50.0 mt -130.97 110.74 11.47 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.32 0.648 . . . . 65.54 110.165 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -114.54 122.86 47.85 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 125.967 1.707 . . . . 73.13 107.469 173.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.1 t -121.8 149.28 43.55 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.029 -0.73 . . . . 71.13 109.029 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.45 153.57 32.74 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.543 0.737 . . . . 51.32 109.281 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.456 ' OG ' ' HB3' ' C' ' 98' ' ' LEU . 12.8 m -131.71 145.36 51.59 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.304 0.642 . . . . 74.13 109.414 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.3 p -144.91 127.37 15.96 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.566 -0.901 . . . . 74.32 108.566 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -80.28 117.91 21.47 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 108.717 -0.846 . . . . 72.13 108.717 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.616 HD11 HD12 ' C' ' 83' ' ' ILE . 25.6 mt -83.82 -47.18 11.39 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.585 0.707 . . . . 71.34 109.656 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.57 -166.96 2.69 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 114.486 -1.233 . . . . 44.31 110.029 -171.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -57.77 105.0 0.22 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.399 1.079 . . . . 71.33 110.535 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 60.1 22.17 11.41 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.329 1.018 . . . . 71.52 112.978 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 85.6 t -104.3 119.64 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.661 0.785 . . . . 74.41 108.989 173.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -121.28 121.31 37.42 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.821 -1.177 . . . . 74.35 107.821 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -89.93 114.43 26.23 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.033 -1.099 . . . . 62.11 108.033 168.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 97.9 t -95.14 134.94 30.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.278 -1.379 . . . . 61.34 107.278 168.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 93.8 t -121.11 138.0 52.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 108.356 -0.979 . . . . 54.1 108.356 174.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.27 101.08 8.84 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.994 -1.113 . . . . 71.11 107.994 175.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 21.0 ttm-85 -81.07 107.13 13.62 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 108.434 -0.95 . . . . 74.44 108.434 170.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.49 ' HB ' HD11 ' C' ' 114' ' ' ILE . 7.8 t -106.58 120.11 57.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 108.09 -1.078 . . . . 70.32 108.09 173.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 17.5 m -119.21 116.16 25.72 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.251 0.621 . . . . 64.02 109.572 -174.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.475 HG21 HG21 ' C' ' 114' ' ' ILE . 63.3 t -104.06 109.04 26.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 123.452 0.701 . . . . 61.53 109.114 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 3.8 m -99.4 140.1 34.08 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.668 -1.234 . . . . 64.23 107.668 170.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.41 119.42 19.62 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 106.661 -1.607 . . . . 74.25 106.661 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 44.9 m -133.29 126.02 30.54 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.579 0.549 . . . . 61.43 110.452 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.696 HD13 ' HG2' ' C' ' 34' ' ' LYS . 11.0 mt -86.78 47.08 1.44 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.766 1.226 . . . . 62.11 109.317 176.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.65 -110.8 3.84 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 111.001 -0.84 . . . . 71.03 111.001 -174.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.16 -28.87 19.73 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.093 -0.706 . . . . 75.14 109.093 173.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -62.86 120.67 11.76 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.584 1.153 . . . . 72.14 109.194 172.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 20.9 m -84.24 125.06 31.87 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 108.443 -0.947 . . . . 75.13 108.443 169.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.622 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -73.45 -62.97 1.29 Allowed 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.328 -0.99 . . . . 64.4 108.328 174.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -157.33 169.89 23.7 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-O 121.917 0.865 . . . . 73.31 110.782 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.442 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.7 tm? -123.43 147.01 47.56 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 106.388 -1.708 . . . . 73.33 106.388 166.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.442 ' N ' HD13 ' C' ' 75' ' ' LEU . 48.4 t -149.22 145.62 27.2 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 107.846 -1.168 . . . . 54.53 107.846 177.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -157.07 136.56 12.17 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.301 -0.629 . . . . 74.15 109.301 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.474 HG11 ' HA ' ' C' ' 110' ' ' ALA . 54.7 t -134.22 113.52 17.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.136 -1.061 . . . . 63.3 108.136 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.704 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.4 mt-30 -94.44 89.21 5.77 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.828 -0.805 . . . . 71.03 108.828 173.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -79.68 102.4 8.94 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.509 -1.223 . . . . 74.55 110.09 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.58 150.47 26.93 Favored Glycine 0 C--N 1.34 0.758 0 N-CA-C 112.007 -0.437 . . . . 61.41 112.007 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.404 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -152.22 117.69 0.84 Allowed Glycine 0 CA--C 1.502 -0.771 0 N-CA-C 110.233 -1.147 . . . . 63.3 110.233 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.616 HD12 HD11 ' C' ' 51' ' ' LEU . 25.5 mm -85.23 121.15 36.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.53 -0.915 . . . . 53.13 108.53 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -129.9 117.18 19.74 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.16 -1.052 . . . . 53.43 108.16 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 53.9 p -90.45 103.5 16.18 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.954 -0.758 . . . . 63.35 108.954 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.541 HD13 ' SG ' ' C' ' 97' ' ' CYS . 25.4 mt -116.86 138.74 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.146 0.978 . . . . 74.1 110.746 -171.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.06 170.4 19.48 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.657 0.783 . . . . 62.54 110.869 175.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.83 -18.67 38.01 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-N 115.534 -0.757 . . . . 42.14 113.756 172.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.401 HG22 HE21 ' C' ' 93' ' ' GLN . 34.8 pt -106.33 170.59 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.232 0.613 . . . . 64.13 111.261 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -160.81 158.84 29.13 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.645 0.778 . . . . 74.14 109.854 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.55 -114.76 7.1 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 123.615 0.572 . . . . 61.23 113.846 168.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 13.4 t -66.25 -35.5 80.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.635 0.774 . . . . 74.53 111.082 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.401 HE21 HG22 ' C' ' 89' ' ' ILE . 29.5 mt-30 -71.81 -42.66 66.78 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.646 0.778 . . . . 73.44 110.622 -178.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 6.2 tpt -62.5 -52.36 63.78 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 123.923 0.765 . . . . 54.25 110.024 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.87 -31.42 72.59 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.753 -0.658 . . . . 60.43 111.817 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -72.17 -34.18 68.26 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.142 0.577 . . . . 70.1 110.553 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.541 ' SG ' HD13 ' C' ' 86' ' ' ILE . 18.2 t -71.2 -41.37 70.35 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.699 -0.482 . . . . 61.54 109.699 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.456 ' HB3' ' OG ' ' C' ' 48' ' ' SER . 89.9 mt -85.05 -44.51 12.96 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.959 0.904 . . . . 72.01 112.815 -170.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.52 3.17 57.68 Favored Glycine 0 N--CA 1.472 1.072 0 CA-C-N 116.067 -0.515 . . . . 43.31 113.481 -170.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.31 -68.98 0.45 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.999 0.4 . . . . 64.2 111.096 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -60.21 -55.1 37.93 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.765 0.826 . . . . 72.14 112.475 -171.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 98.2 m -59.75 -46.74 98.45 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 123.794 0.838 . . . . 72.13 112.523 -177.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -50.85 -35.21 48.09 Favored 'Trans proline' 0 C--N 1.395 3.018 0 C-N-CA 123.071 2.514 . . . . 63.04 115.119 169.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -66.8 -33.9 76.63 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 118.719 0.69 . . . . 74.32 111.075 176.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.486 HD12 ' NH1' ' A' ' 111' ' ' ARG . 42.0 mm -72.53 -34.83 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 123.004 0.521 . . . . 75.34 109.907 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.404 HD21 ' HA3' ' C' ' 82' ' ' GLY . 89.4 mt -84.49 -24.56 29.37 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.855 0.862 . . . . 70.5 112.326 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -57.05 -52.11 76.6 Favored Pre-proline 0 N--CA 1.482 1.137 0 CA-C-O 117.334 -1.317 . . . . 71.15 113.867 -172.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -62.01 -34.41 80.65 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.168 1.912 . . . . 64.31 112.915 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -66.35 -47.62 72.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.483 0.713 . . . . 72.24 110.236 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.474 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -63.39 -36.88 85.2 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.855 -1.066 . . . . 73.15 110.943 177.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.2 ttt-85 -68.99 -46.57 67.71 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.409 1.484 . . . . 75.34 111.176 -175.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -67.97 -34.33 76.36 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.528 0.731 . . . . 65.11 109.486 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 12.8 t -65.86 -35.67 81.32 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.462 0.705 . . . . 65.02 111.249 177.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.49 HD11 ' HB ' ' C' ' 62' ' ' VAL . 85.7 mt -69.23 -58.04 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.345 0.658 . . . . 72.11 110.485 176.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 4.7 m -64.43 -28.38 69.64 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 122.707 0.403 . . . . 70.03 111.249 -173.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 42.0 t -61.6 -52.78 62.99 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 123.279 0.632 . . . . 51.21 109.37 169.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.549 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.08 -42.59 80.96 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 125.011 1.324 . . . . 74.43 113.002 -179.568 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.468 HG11 HD23 ' C' ' 126' ' ' LEU . 87.3 t -63.62 -45.67 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.381 1.072 . . . . 64.51 110.253 177.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.4 t -67.52 -29.67 69.13 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.281 -1.327 . . . . 71.31 111.429 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.48 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 87.3 mtt-85 -68.59 -39.53 80.89 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.072 -0.714 . . . . 64.45 109.072 176.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.79 12.03 58.04 Favored Glycine 0 C--N 1.354 1.535 0 CA-C-N 115.698 -0.683 . . . . 70.21 113.0 175.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 69.0 p 53.8 37.53 26.56 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 126.212 1.805 . . . . 75.33 114.146 175.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -93.99 148.03 34.52 Favored Pre-proline 0 C--O 1.245 0.84 0 N-CA-C 107.583 -1.266 . . . . 74.11 107.583 165.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.01 169.45 0.64 Allowed 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.224 2.616 . . . . 73.0 114.168 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -59.32 123.3 16.28 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.159 0.984 . . . . 74.04 111.975 -177.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.567 HD21 ' HZ2' ' C' ' 36' ' ' TRP . 3.5 mm? -116.27 86.14 2.43 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.674 -1.232 . . . . 71.44 107.674 166.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -91.46 95.17 9.82 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.727 -0.842 . . . . 53.13 108.727 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.466 ' HA ' HG21 ' F' ' 135' ' ' VAL . 8.5 mp -55.84 131.01 45.85 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.102 0.961 . . . . 73.11 111.583 -175.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.44 137.08 96.48 Favored Pre-proline 0 CA--C 1.553 1.07 0 CA-C-O 118.694 -0.669 . . . . 62.11 110.453 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -49.52 110.91 0.41 Allowed 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.673 2.915 . . . . 73.35 113.442 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.9 t -100.93 114.55 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 123.142 0.577 . . . . 75.32 109.455 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -80.88 105.7 12.32 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.421 0.689 . . . . 72.54 109.418 176.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -68.8 -20.78 64.34 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.372 0.669 . . . . 51.3 112.329 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.55 -29.85 65.22 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.116 0.566 . . . . 65.51 110.554 173.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.01 -35.0 64.36 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.064 0.546 . . . . 70.2 110.004 173.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.406 ' HA ' HD21 ' C' ' 139' ' ' ASN . 83.1 mt -67.68 -40.28 84.42 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.82 -0.627 . . . . 71.3 110.418 175.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -72.09 -31.47 66.1 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.741 0.816 . . . . 75.32 110.488 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 23.5 ttt -60.54 -52.13 66.49 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.898 0.879 . . . . 55.25 110.524 177.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . 0.406 HD21 ' HA ' ' C' ' 136' ' ' LEU . 11.4 p30 -71.45 -36.02 71.08 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 116.477 -0.329 . . . . 61.34 110.882 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -64.47 -86.43 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.964 0.906 . . . . 73.31 111.354 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 54.4 tp -152.31 117.87 5.34 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.456 0.702 . . . . 74.02 109.578 -172.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -155.36 154.13 31.53 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.372 1.069 . . . . 71.22 109.7 172.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -170.52 91.3 0.17 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 107.921 -1.14 . . . . 73.44 107.921 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -54.17 132.48 43.24 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.171 0.989 . . . . 70.45 111.658 -178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -87.72 175.41 7.88 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.629 0.772 . . . . 43.03 111.268 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -108.76 3.32 32.14 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 116.036 -0.529 . . . . 73.13 113.071 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -89.87 149.24 22.73 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.807 0.843 . . . . 64.3 110.597 -174.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -132.74 136.68 8.87 Favored Glycine 0 C--N 1.346 1.095 0 N-CA-C 111.064 -0.814 . . . . 51.21 111.064 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 10.0 t -67.38 150.55 48.8 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.144 0.978 . . . . 71.2 110.652 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -135.92 146.32 47.21 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.15 0.5 . . . . 72.3 110.822 -176.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -67.47 138.05 56.31 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.806 1.243 . . . . 74.21 109.834 170.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -144.74 -52.82 0.3 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.228 0.611 . . . . 72.43 109.809 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . 0.731 ' HG3' HE22 ' C' ' 4' ' ' GLN . 8.0 pt20 -148.49 78.17 1.41 Allowed 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.05 -1.093 . . . . 75.21 108.05 -178.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -162.05 131.48 4.51 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.184 -0.916 . . . . 73.42 110.008 -177.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 N-CA-C 108.667 -0.864 . . . . 62.52 108.667 -179.784 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.13 -0.693 . . . . 74.31 109.13 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 41.1 m -90.96 90.34 7.84 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.002 -0.74 . . . . 63.13 109.002 170.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -82.58 -28.95 30.56 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 109.588 -0.523 . . . . 65.42 109.588 171.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -69.41 129.94 41.15 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.673 0.789 . . . . 70.42 110.157 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -144.64 172.49 12.91 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.571 0.748 . . . . 53.4 110.497 -176.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -111.32 124.24 51.84 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 108.482 -0.933 . . . . 75.4 108.482 173.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 3.2 p -144.03 -57.64 0.38 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.391 1.077 . . . . 70.24 109.749 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.479 ' HG2' ' H ' ' D' ' 9' ' ' MET . 24.1 tt0 -143.38 -170.49 3.29 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.881 0.872 . . . . 72.54 109.169 -176.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.479 ' H ' ' HG2' ' D' ' 8' ' ' GLU . 0.6 OUTLIER -29.25 128.02 0.1 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 126.3 1.84 . . . . 71.22 113.14 174.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 39.9 p -104.17 116.99 33.18 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.408 0.683 . . . . 64.14 109.525 -175.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.483 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 58.5 t80 -134.5 105.41 6.53 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.648 -1.242 . . . . 62.22 107.648 175.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -129.83 115.82 17.8 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.724 -0.843 . . . . 61.43 108.724 -174.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 8.1 mt -76.04 122.53 30.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 108.314 -0.995 . . . . 72.23 108.314 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 77.7 mm-40 -89.16 -29.05 19.6 Favored 'General case' 0 C--O 1.242 0.675 0 O-C-N 123.822 0.701 . . . . 62.14 110.982 -176.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -172.77 138.2 0.81 Allowed 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.464 0.477 . . . . 51.31 110.146 -175.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.655 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.5 mp -120.88 135.97 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.681 -1.229 . . . . 73.44 107.681 173.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -162.4 170.14 19.3 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.207 1.003 . . . . 71.13 112.85 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.5 p -105.05 119.24 38.54 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.224 -1.353 . . . . 63.51 108.509 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -88.0 -21.29 24.9 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.035 -0.53 . . . . 73.2 109.925 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.412 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 31.8 t70 -159.9 138.61 10.6 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.182 0.993 . . . . 63.14 109.219 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.549 HG21 ' HE2' ' C' ' 117' ' ' MET . 72.5 mt -139.77 138.29 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.971 1.308 . . . . 73.35 107.802 176.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.5 t -139.69 143.35 37.05 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.104 0.962 . . . . 74.21 109.008 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.552 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 91.7 t80 -150.0 122.99 8.78 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 106.612 -1.625 . . . . 62.12 106.612 170.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.63 111.65 11.9 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.715 0.806 . . . . 62.41 109.584 -177.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.93 84.66 4.47 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 107.665 -1.235 . . . . 70.33 107.665 174.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.16 -43.64 0.53 Allowed 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.415 2.077 . . . . 61.14 112.336 -171.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -93.81 10.52 32.77 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.256 1.022 . . . . 71.42 110.414 -176.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.603 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -31.69 -64.79 0.22 Allowed Pre-proline 0 N--CA 1.488 1.441 0 C-N-CA 127.259 2.224 . . . . 61.11 116.334 -166.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.84 -21.65 14.13 Favored 'Trans proline' 0 C--N 1.38 2.222 0 CA-C-N 122.735 2.013 . . . . 74.53 114.073 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -77.33 -37.29 52.79 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.377 1.071 . . . . 73.44 109.909 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.438 HG12 ' O ' ' D' ' 28' ' ' ALA . 7.7 p -82.98 -25.57 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.124 0 CA-C-N 115.452 -0.795 . . . . 63.21 111.308 -172.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -60.65 -25.78 66.58 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 122.883 0.473 . . . . 74.43 112.099 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -64.9 -8.66 16.43 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.776 1.23 . . . . 63.01 112.231 -175.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -96.41 95.01 7.75 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.2 1.4 . . . . 71.21 109.041 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -81.91 81.71 7.8 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.356 0.662 . . . . 74.11 111.093 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -160.78 -179.88 7.95 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.18 0.992 . . . . 72.12 109.1 166.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.426 ' NE2' ' HD2' ' D' ' 38' ' ' PRO . 35.3 tp60 -75.78 114.12 33.61 Favored Pre-proline 0 N--CA 1.477 0.9 0 CA-C-O 118.294 -0.86 . . . . 64.13 109.167 178.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.426 ' HD2' ' NE2' ' D' ' 37' ' ' GLN . 51.1 Cg_exo -53.35 134.79 58.54 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.045 2.497 . . . . 74.33 111.856 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -63.81 107.82 1.3 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 107.623 -1.251 . . . . 74.22 107.623 175.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.664 HG13 HG13 ' D' ' 64' ' ' VAL . 86.5 t -104.4 129.55 56.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 109.416 -0.587 . . . . 73.31 109.416 -176.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -105.35 112.28 25.33 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 106.348 -1.723 . . . . 62.23 106.348 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.489 HD22 ' HB2' ' D' ' 128' ' ' LEU . 64.8 tp -94.33 150.02 20.68 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.678 -1.23 . . . . 54.23 107.678 174.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -148.27 140.07 23.83 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.255 -1.017 . . . . 75.23 108.255 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.582 HD12 HG22 ' E' ' 121' ' ' VAL . 91.4 mt -130.7 145.09 51.85 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.584 0.754 . . . . 73.02 109.452 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -155.62 141.35 18.0 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.766 -1.198 . . . . 73.41 107.766 169.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' E' ' 106' ' ' TYR . 25.9 m -102.84 156.18 17.83 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 124.214 1.005 . . . . 64.24 109.292 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.09 167.13 26.7 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 126.039 1.736 . . . . 74.32 106.8 172.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 13.5 p -165.84 -164.86 0.75 Allowed 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.306 -0.627 . . . . 62.32 109.306 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 33.3 p -149.31 133.8 17.58 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 122.994 0.518 . . . . 54.25 110.129 -176.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -82.97 97.84 8.93 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 116.004 -0.544 . . . . 62.41 109.798 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 47.2 tp -140.69 112.56 7.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 106.738 -1.578 . . . . 71.52 106.738 174.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.25 -161.17 0.14 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.455 0.302 . . . . 54.32 110.751 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 68.69 23.07 7.22 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.997 0.919 . . . . 71.23 109.76 -164.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.443 ' O ' ' HA ' ' D' ' 85' ' ' SER . 1.9 m-20 64.13 15.38 9.26 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.745 1.618 . . . . 63.13 112.011 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.26 94.88 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 109.054 -0.721 . . . . 73.2 109.054 -174.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -122.95 127.99 49.64 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.787 -0.82 . . . . 70.03 108.787 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -94.64 119.42 33.27 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.468 -0.938 . . . . 60.33 108.468 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 73.8 t -101.33 134.45 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.853 0.861 . . . . 71.13 108.851 173.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.515 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 33.4 t -116.02 128.44 73.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.185 0.994 . . . . 63.21 108.745 173.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.39 111.69 24.14 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.86 -1.163 . . . . 72.44 107.86 175.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 ttt85 -85.82 106.48 17.08 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.233 -0.655 . . . . 42.53 109.233 174.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.506 HG22 HD22 ' D' ' 44' ' ' LEU . 61.1 t -105.75 130.65 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.268 1.027 . . . . 44.33 108.624 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 7.3 m -134.75 144.46 47.72 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.014 0.435 . . . . 71.53 110.964 -173.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.664 HG13 HG13 ' D' ' 40' ' ' VAL . 55.0 t -133.85 114.28 19.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 C-N-CA 125.447 1.499 . . . . 60.12 108.902 -173.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 19.2 m -106.12 93.46 4.63 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.074 -1.084 . . . . 74.43 108.074 169.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.08 144.94 27.04 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.363 0.665 . . . . 72.25 109.937 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.496 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 48.2 m -151.89 127.85 10.35 Favored 'General case' 0 C--N 1.344 0.36 0 C-N-CA 123.424 0.69 . . . . 75.13 110.879 -177.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.437 ' HB2' HG22 ' D' ' 31' ' ' VAL . 16.6 mt -93.45 109.31 20.9 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 107.764 -1.199 . . . . 61.22 107.764 168.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.19 -124.32 8.27 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 116.064 -0.516 . . . . 54.55 112.496 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.15 3.99 28.55 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.329 0.652 . . . . 72.45 111.775 -176.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -118.42 158.88 24.46 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 109.574 -0.528 . . . . 60.43 109.574 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 52.0 m -72.43 129.56 38.63 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.615 -0.72 . . . . 73.13 111.685 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.496 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -81.54 -69.19 0.63 Allowed 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.829 -1.174 . . . . 72.31 107.829 173.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -153.54 153.77 33.03 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 115.841 -0.618 . . . . 74.43 111.105 176.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 50.0 mt -119.32 109.93 16.38 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.396 -1.335 . . . . 74.33 107.396 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.543 ' SG ' HG12 ' D' ' 114' ' ' ILE . 42.0 t -120.61 136.98 54.66 Favored 'General case' 0 C--O 1.219 -0.543 0 C-N-CA 123.544 0.737 . . . . 70.14 109.586 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -152.06 123.88 7.98 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.9 0.48 . . . . 70.23 109.794 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 88.3 t -127.58 118.52 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.926 0.89 . . . . 71.22 109.836 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.412 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.2 mt-30 -90.72 90.13 7.82 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.517 0.727 . . . . 71.24 109.251 171.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -82.77 98.74 9.26 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 114.723 -1.126 . . . . 52.24 109.422 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -102.19 156.4 18.55 Favored Glycine 0 N--CA 1.471 1.012 0 N-CA-C 112.077 -0.409 . . . . 44.25 112.077 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.4 150.05 13.78 Favored Glycine 0 C--N 1.336 0.544 0 CA-C-N 117.2 0.5 . . . . 64.12 112.619 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 57.5 mt -90.0 132.71 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 109.082 -0.71 . . . . 64.21 109.082 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -128.98 140.46 51.64 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.305 1.042 . . . . 64.42 109.575 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 39.8 t -93.59 108.27 20.01 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 107.682 -1.229 . . . . 71.32 107.682 168.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 33.9 pt -109.13 123.9 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 N-CA-C 108.654 -0.869 . . . . 74.04 108.654 172.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.45 168.29 6.52 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.173 0.589 . . . . 62.34 111.458 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.3 19.18 72.44 Favored Glycine 0 C--N 1.347 1.165 0 O-C-N 123.683 0.614 . . . . 61.4 112.941 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.43 164.25 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.266 1.027 . . . . 74.54 109.799 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -146.68 -179.35 6.72 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.749 0.82 . . . . 73.21 110.57 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.82 -140.29 27.64 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-N 115.984 -0.553 . . . . 71.3 112.472 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 60.8 p -89.62 -29.83 18.57 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.366 0.666 . . . . 74.04 110.752 172.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -53.4 -33.22 53.03 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.578 1.151 . . . . 74.12 112.474 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.633 ' HE1' ' HB3' ' E' ' 100' ' ' LEU . 2.9 ppp? -60.71 -50.63 72.72 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 123.876 0.87 . . . . 72.24 113.197 -175.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . 0.492 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.25 -19.4 31.66 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.061 0.544 . . . . 65.24 110.978 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -67.88 -38.37 82.94 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.674 0.79 . . . . 74.11 110.49 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 86.9 m -61.15 -33.59 73.66 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.585 0.754 . . . . 72.21 111.587 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 27.0 tp -69.54 -37.57 77.13 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.916 0.486 . . . . 75.5 111.119 -176.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.2 0.11 68.47 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-O 119.388 -0.673 . . . . 74.44 113.6 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.75 -58.32 0.77 Allowed 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 117.74 0.77 . . . . 62.33 112.932 -171.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -72.35 -43.84 63.48 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.064 0.545 . . . . 63.12 110.925 -176.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.483 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 75.2 m -60.45 -45.48 97.38 Favored Pre-proline 0 CA--C 1.571 1.752 0 C-N-CA 124.132 0.973 . . . . 70.41 112.166 178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.401 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 73.5 Cg_exo -55.28 -42.05 72.33 Favored 'Trans proline' 0 C--N 1.395 3.014 0 C-N-CA 123.188 2.592 . . . . 70.04 113.836 165.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -63.38 -24.88 68.03 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.537 0.735 . . . . 55.24 110.972 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 44.8 mm -75.84 -45.5 37.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.798 0.839 . . . . 73.14 110.545 172.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.04 -25.79 65.54 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.477 -0.783 . . . . 75.24 111.672 -176.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -68.57 -40.01 17.26 Favored Pre-proline 0 CA--C 1.563 1.467 0 N-CA-C 114.507 1.299 . . . . 72.42 114.507 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -47.83 -46.64 20.9 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.447 2.098 . . . . 71.31 113.69 167.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . 0.428 ' OH ' ' HB3' ' B' ' 130' ' ' PRO . 99.0 m-85 -72.26 -38.46 68.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.631 0.773 . . . . 74.14 111.096 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . 0.417 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -65.93 -38.73 89.43 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.842 0.857 . . . . 72.21 110.776 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.485 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 24.3 ttp-105 -66.02 -48.93 69.49 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 115.104 -0.953 . . . . 73.25 110.032 175.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -56.16 -47.63 77.85 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.64 1.213 . . . . 54.44 110.977 -175.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.5 t -56.74 -46.26 81.48 Favored 'General case' 0 C--N 1.353 0.732 0 O-C-N 124.032 0.832 . . . . 74.14 111.331 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.543 HG12 ' SG ' ' D' ' 76' ' ' CYS . 62.6 mt -63.33 -57.08 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.962 0.905 . . . . 60.22 111.096 177.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 38.8 m -52.89 -43.13 65.94 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.527 1.131 . . . . 54.1 111.273 -175.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 29.7 t -63.49 -43.42 97.31 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 114.251 -1.341 . . . . 64.14 109.925 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.8 mtm -69.87 -30.33 67.77 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.12 0.568 . . . . 74.2 111.763 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.4 t -64.56 -45.97 93.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.508 0.723 . . . . 62.34 109.916 175.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.2 p -74.53 -29.72 61.5 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.636 -0.711 . . . . 60.15 110.74 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 66.5 mtt-85 -70.65 -30.2 66.75 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.639 0.775 . . . . 73.21 109.868 173.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.62 8.97 75.59 Favored Glycine 0 C--N 1.354 1.539 0 O-C-N 123.62 0.575 . . . . 71.02 112.898 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 78.0 p 54.95 27.56 9.35 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 126.167 1.787 . . . . 73.04 113.974 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -88.67 151.04 47.29 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 109.211 -0.663 . . . . 72.52 109.211 168.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.495 ' HB3' ' HA ' ' E' ' 129' ' ' THR . 90.5 Cg_exo -48.3 133.85 25.11 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.642 2.895 . . . . 72.34 113.002 171.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -56.5 128.63 37.09 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.754 0.822 . . . . 55.42 112.006 -170.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.594 HD13 HG21 ' D' ' 40' ' ' VAL . 28.9 tp -108.93 98.23 7.74 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.612 1.165 . . . . 74.34 109.419 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -99.58 80.88 2.42 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.884 -1.154 . . . . 72.12 107.884 174.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.665 ' H ' HD23 ' D' ' 128' ' ' LEU . 0.3 OUTLIER -58.44 112.3 1.53 Allowed 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 114.64 -1.164 . . . . 74.12 109.686 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.6 139.48 75.6 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 125.102 1.361 . . . . 65.33 113.064 -169.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.48 ' HB3' HH12 ' D' ' 111' ' ' ARG . 96.2 Cg_endo -76.75 155.89 35.11 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.95 2.433 . . . . 73.21 112.633 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 9.6 p -148.79 143.47 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.551 -0.75 . . . . 63.44 109.568 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -81.49 105.98 13.09 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.161 -1.052 . . . . 60.31 108.161 172.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -62.43 -30.57 71.33 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.154 0.982 . . . . 64.01 110.601 -177.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -61.23 -42.5 98.72 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.641 1.176 . . . . 64.03 110.827 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.73 -34.76 76.39 Favored 'General case' 0 C--N 1.35 0.596 0 CA-C-N 114.315 -1.311 . . . . 71.34 111.11 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.725 HD13 ' HB2' ' E' ' 120' ' ' TYR . 27.6 tp -69.29 -43.79 73.13 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.978 0.911 . . . . 74.22 112.55 -176.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.487 ' O ' HD13 ' D' ' 141' ' ' LEU . 87.0 m-85 -59.11 -42.48 90.64 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 120.765 0.317 . . . . 71.32 110.617 178.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 75.8 mtm -73.69 -40.97 63.25 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.825 -0.625 . . . . 55.2 110.949 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.406 ' O ' ' HG3' ' D' ' 143' ' ' GLN . 64.2 t30 -61.69 -48.06 82.48 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.186 0.995 . . . . 72.43 110.594 -174.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -52.61 -38.67 60.58 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.648 1.179 . . . . 63.31 111.629 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.487 HD13 ' O ' ' D' ' 137' ' ' PHE . 8.9 mp -76.18 -46.81 26.66 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.667 0.787 . . . . 72.42 111.526 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -85.05 27.09 0.8 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.078 0.551 . . . . 75.54 112.424 -170.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' D' ' 139' ' ' ASN . 46.0 mt-30 -117.93 94.11 4.39 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.964 0.906 . . . . 55.42 109.548 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -140.22 21.13 2.42 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.666 -1.152 . . . . 73.1 108.862 171.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -165.22 -177.14 4.39 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.352 1.461 . . . . 61.5 109.029 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.62 163.66 39.45 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 123.3 0.375 . . . . 74.2 113.774 173.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -60.23 125.31 23.2 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.838 0.855 . . . . 72.54 111.109 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -165.17 109.63 0.37 Allowed Glycine 0 C--N 1.336 0.539 0 N-CA-C 111.102 -0.799 . . . . 42.33 111.102 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 14.8 t -74.72 -167.88 0.63 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.264 0.626 . . . . 74.01 109.654 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.62 128.79 31.79 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 109.376 -0.601 . . . . 72.51 109.376 170.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -174.16 101.52 0.1 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.92 1.688 . . . . 74.43 108.114 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . 0.402 ' CD2' ' HB3' ' D' ' 154' ' ' ASP . 2.2 t60 -173.23 121.99 0.37 Allowed 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 109.942 -0.392 . . . . 71.1 109.942 177.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -75.24 -42.83 54.35 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.283 0.633 . . . . 72.23 110.692 176.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . 0.402 ' HB3' ' CD2' ' D' ' 152' ' ' HIS . 1.9 t70 -59.89 132.53 54.25 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.848 0.859 . . . . 73.24 110.044 172.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.874 0 C-N-CA 123.784 0.834 . . . . 74.1 109.88 -175.035 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.348 0 N-CA-C 110.95 -0.86 . . . . 71.24 110.95 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.38 -36.43 63.11 Favored Glycine 0 C--N 1.35 1.309 0 C-N-CA 122.945 0.307 . . . . 70.43 112.556 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -75.45 170.13 16.71 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.648 0.779 . . . . 73.21 110.221 175.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -79.62 18.48 0.75 Allowed 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 124.736 1.214 . . . . 75.42 112.451 -169.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt 77.25 19.04 1.34 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.698 1.199 . . . . 74.24 112.263 167.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.02 103.89 2.9 Favored Glycine 0 C--N 1.342 0.906 0 O-C-N 121.845 -0.535 . . . . 71.24 114.162 163.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 97' ' ' ILE . . . . . . . . . . . . . 7.1 tt -82.25 72.81 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 CA-C-O 122.715 1.245 . . . . 71.54 108.469 166.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.6 -38.23 83.69 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 115.212 -0.904 . . . . 73.02 111.788 -176.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.27 81.45 1.84 Allowed 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.643 0.777 . . . . 72.44 112.198 -169.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 100' ' ' LEU . . . . . 0.633 ' HB3' ' HE1' ' D' ' 94' ' ' MET . 2.2 pp -161.21 149.69 12.96 Favored Pre-proline 0 N--CA 1.481 1.116 0 C-N-CA 123.79 0.836 . . . . 72.43 111.57 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -90.15 9.24 3.33 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 123.353 2.702 . . . . 64.33 111.778 166.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 102' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 76.43 -57.52 0.55 Allowed 'General case' 0 C--N 1.363 1.178 0 C-N-CA 126.563 1.945 . . . . 75.31 110.216 -174.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 33.6 m 79.31 -52.69 0.43 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.066 1.746 . . . . 73.33 112.225 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . -83.4 25.28 5.08 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-O 119.12 -0.822 . . . . 54.32 114.979 -174.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -70.62 79.7 0.59 Allowed 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 117.734 0.767 . . . . 74.31 109.935 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 106' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' D' ' 46' ' ' THR . 21.8 t80 62.29 102.3 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 125.575 1.55 . . . . 73.14 109.306 -175.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . 0.432 ' OG1' ' HB ' ' D' ' 46' ' ' THR . 70.1 p -89.6 42.34 1.09 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.845 0.858 . . . . 60.14 112.013 -167.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -74.01 75.65 1.7 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.453 1.101 . . . . 75.33 109.182 -176.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -166.76 -59.73 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.482 1.113 . . . . 64.23 109.328 -170.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . 0.497 ' O ' ' HD2' ' E' ' 114' ' ' LYS . . . -100.23 -24.86 14.44 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.362 -0.835 . . . . 72.15 112.668 -168.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . . . . . . . . . 10.0 mp -89.76 -50.52 6.01 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 118.128 0.422 . . . . 74.32 111.915 -175.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 112' ' ' ASN . . . . . 0.452 ' OD1' ' HG2' ' E' ' 113' ' ' LYS . 27.2 t-20 -79.33 -85.71 0.08 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.042 0.537 . . . . 75.35 110.782 -173.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 113' ' ' LYS . . . . . 0.452 ' HG2' ' OD1' ' E' ' 112' ' ' ASN . 26.3 mmmt -83.73 106.01 15.09 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.605 0.762 . . . . 62.15 111.087 -176.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . 0.497 ' HD2' ' O ' ' E' ' 110' ' ' ALA . 2.1 mppt? -118.11 -10.46 10.32 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 107.713 -1.217 . . . . 65.05 107.713 155.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 28.2 m 58.18 -97.46 0.07 Allowed 'General case' 0 C--N 1.363 1.182 0 C-N-CA 124.897 1.279 . . . . 73.33 109.267 -169.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 44.65 -141.99 3.37 Favored Glycine 0 C--N 1.361 1.966 0 N-CA-C 115.532 0.973 . . . . 64.14 115.532 172.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.82 178.52 1.13 Allowed Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 125.021 1.328 . . . . 75.04 107.549 169.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -55.1 89.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 121.772 1.648 . . . . 74.22 111.692 162.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.53 -103.7 0.05 Allowed 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.557 1.143 . . . . 74.21 108.775 -177.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 120' ' ' TYR . . . . . 0.725 ' HB2' HD13 ' D' ' 136' ' ' LEU . 47.8 m-85 -114.23 150.47 34.28 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.068 -1.456 . . . . 62.14 107.068 161.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 121' ' ' VAL . . . . . 0.582 HG22 HD12 ' D' ' 44' ' ' LEU . 92.3 t 56.63 -108.95 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.463 0 N-CA-C 108.362 -0.977 . . . . 53.02 108.362 -166.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . 0.409 ' N ' HG12 ' E' ' 121' ' ' VAL . 3.8 m 56.35 -75.07 0.01 OUTLIER 'General case' 0 C--N 1.363 1.166 0 C-N-CA 125.215 1.406 . . . . 53.01 111.896 -175.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -136.17 -154.51 0.57 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.059 1.343 . . . . 65.44 108.602 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 19.2 t -157.65 169.21 25.17 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.055 0.542 . . . . 65.25 110.12 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -140.13 129.35 23.79 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.811 0.845 . . . . 64.23 110.289 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -149.48 149.9 31.49 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.32 1.048 . . . . 63.11 109.316 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 37.1 p -146.35 83.93 1.62 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.152 0.501 . . . . 70.1 110.338 -177.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -138.83 62.71 1.54 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.684 0.793 . . . . 34.51 109.417 177.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 129' ' ' THR . . . . . 0.495 ' HA ' ' HB3' ' D' ' 124' ' ' PRO . 88.9 m -89.33 122.27 32.4 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.209 -0.905 . . . . 74.24 110.928 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -157.73 105.77 2.03 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.895 0.878 . . . . 73.31 109.03 171.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 131' ' ' TRP . . . . . 0.423 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 13.3 t90 -161.87 106.13 1.23 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 108.888 -0.782 . . . . 55.53 108.888 175.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 59.5 m -150.57 10.82 0.66 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.34 0.656 . . . . 72.41 111.543 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 53.0 m -96.79 135.52 38.62 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.231 0.613 . . . . 65.04 111.278 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -160.62 130.98 2.51 Favored Glycine 0 C--N 1.352 1.435 0 N-CA-C 110.729 -0.948 . . . . 72.44 110.729 177.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 27.3 m -90.69 162.4 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 123.42 0.688 . . . . 64.23 111.545 -175.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -157.43 159.16 37.05 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.945 0.898 . . . . 74.41 111.164 -178.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 6.0 m 57.1 77.99 0.24 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.179 1.391 . . . . 75.21 113.103 168.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -172.0 85.75 0.08 Allowed 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.989 0.916 . . . . 73.32 108.69 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -83.34 173.11 11.85 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.45 0.7 . . . . 73.01 111.032 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 140' ' ' GLY . . . . . 0.503 ' HA2' ' HB2' ' A' ' 132' ' ' ASN . . . -121.1 49.39 0.89 Allowed Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.812 -0.631 . . . . 31.14 111.602 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . 55.29 41.63 31.08 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.649 1.18 . . . . 62.4 111.191 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 142' ' ' LEU . . . . . 0.455 HD22 ' HB ' ' E' ' 144' ' ' VAL . 4.5 tt 72.73 -68.51 0.22 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.617 1.567 . . . . 72.21 109.848 -172.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.57 54.74 2.45 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 111.638 -0.585 . . . . 75.41 111.638 -175.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 144' ' ' VAL . . . . . 0.455 ' HB ' HD22 ' E' ' 142' ' ' LEU . 4.6 p -96.62 131.72 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.913 0.885 . . . . 63.52 110.01 176.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 21.0 t70 . . . . . 0 C--O 1.253 1.243 0 N-CA-C 108.335 -0.987 . . . . 72.35 108.335 174.879 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.925 0 CA-C-O 119.927 -0.374 . . . . 24.25 113.177 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.53 45.43 29.24 Favored Glycine 0 C--N 1.345 1.083 0 O-C-N 123.79 0.347 . . . . 14.14 112.349 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -78.29 -50.6 11.52 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.56 0.744 . . . . 55.21 111.351 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -159.18 -55.31 0.06 Allowed 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 112.244 0.461 . . . . 74.1 112.244 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt 58.9 79.9 0.21 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.986 0.914 . . . . 73.41 110.511 -171.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -149.19 -34.64 0.05 OUTLIER Glycine 0 N--CA 1.469 0.842 0 CA-C-N 116.025 -0.534 . . . . 63.43 112.639 -172.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 97' ' ' ILE . . . . . 0.532 ' HB ' ' HA ' ' B' ' 87' ' ' ALA . 10.3 tt -71.72 -40.6 70.22 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 N-CA-C 108.107 -1.072 . . . . 74.22 108.107 171.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 23.5 t70 60.07 137.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 126.497 1.919 . . . . 75.11 113.692 173.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . 53.58 57.83 5.75 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.804 0.841 . . . . 71.43 111.254 176.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 100' ' ' LEU . . . . . 0.407 HD22 HG21 ' F' ' 97' ' ' ILE . 50.3 tp -100.52 104.84 33.29 Favored Pre-proline 0 N--CA 1.474 0.738 0 CA-C-N 115.812 -0.631 . . . . 73.43 110.814 -174.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -98.77 -172.35 0.14 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 122.98 2.453 . . . . 71.41 111.93 169.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 102' ' ' LEU . . . . . . . . . . . . . 24.4 tp -94.0 163.57 13.43 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.043 -1.095 . . . . 74.35 108.043 166.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 70.2 p -62.46 -32.41 73.29 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.454 0.702 . . . . 63.35 110.714 173.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.63 -12.85 65.95 Favored Glycine 0 C--N 1.351 1.388 0 CA-C-N 115.453 -0.794 . . . . 72.1 111.919 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -85.28 141.1 30.32 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.772 0.829 . . . . 74.02 110.525 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -121.75 -87.59 0.64 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.046 0.938 . . . . 71.4 108.843 -175.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . 0.479 HG22 ' HB2' ' F' ' 111' ' ' LEU . 39.9 p -144.88 -158.78 0.92 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.727 1.211 . . . . 53.15 107.851 176.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 77.33 -18.53 0.49 Allowed 'General case' 0 N--CA 1.511 2.611 0 C-N-CA 124.484 1.114 . . . . 64.13 113.542 173.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -140.14 13.76 2.42 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.69 0.796 . . . . 64.43 110.553 -177.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -156.7 -74.73 0.1 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.955 -0.757 . . . . 72.24 108.955 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . 0.479 ' HB2' HG22 ' F' ' 107' ' ' THR . 8.9 mp -76.15 76.91 2.98 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.529 0.732 . . . . 62.21 109.712 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 112' ' ' ASN . . . . . 0.519 HD22 ' HB2' ' F' ' 117' ' ' LYS . 2.4 m-20 -121.53 102.14 8.06 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 114.969 -1.014 . . . . 63.14 109.02 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 113' ' ' LYS . . . . . 0.569 ' HB3' ' HB ' ' F' ' 121' ' ' VAL . 0.0 OUTLIER -129.27 74.06 1.56 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.524 1.13 . . . . 54.11 109.319 179.117 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -168.39 -177.02 3.05 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-N 114.575 -1.193 . . . . 72.4 108.359 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 37.2 p -51.41 -35.82 40.89 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.356 1.063 . . . . 70.12 111.8 169.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.84 86.61 0.76 Allowed Glycine 0 C--N 1.354 1.538 0 CA-C-N 115.714 -0.675 . . . . 52.32 111.761 175.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 117' ' ' LYS . . . . . 0.519 ' HB2' HD22 ' F' ' 112' ' ' ASN . 3.9 mptp? 65.0 82.39 0.21 Allowed Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 124.944 1.298 . . . . 72.4 111.212 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.74 89.6 0.63 Allowed 'Trans proline' 0 CA--C 1.558 1.716 0 C-N-CA 122.576 2.184 . . . . 72.54 111.16 174.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -78.63 -96.78 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.355 0.662 . . . . 74.11 111.501 -171.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -100.67 -55.29 2.62 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.048 -0.723 . . . . 72.41 109.048 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 121' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' F' ' 113' ' ' LYS . 11.7 t -80.15 126.32 39.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.454 -1.313 . . . . 74.22 107.454 174.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 89.1 m -160.33 155.9 25.43 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.365 1.066 . . . . 32.31 108.556 -175.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 8.9 t70 74.85 -178.87 0.17 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.948 1.299 . . . . 71.45 110.859 170.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 7.6 m -72.14 -23.15 61.26 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.606 1.162 . . . . 55.24 113.119 -173.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . 66.16 -165.74 0.22 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.977 0.911 . . . . 45.2 110.347 -169.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.82 115.57 9.2 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.259 0.623 . . . . 50.1 111.719 -177.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 50.3 m -127.09 120.07 28.05 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.829 -1.175 . . . . 71.25 107.829 170.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -144.61 176.8 9.14 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.884 0.474 . . . . 73.44 111.318 -172.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 71.4 p 59.69 -170.31 0.14 Allowed 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 125.856 1.663 . . . . 74.35 112.47 -175.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -148.46 -179.54 7.04 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.805 0.842 . . . . 74.41 110.018 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 131' ' ' TRP . . . . . 0.581 ' HB3' ' HG3' ' B' ' 124' ' ' PRO . 47.5 t-105 -151.93 133.55 14.72 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.371 0.668 . . . . 61.41 109.292 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 132' ' ' SER . . . . . 0.408 ' HB2' ' HB3' ' B' ' 35' ' ' ASP . 34.2 t -169.4 -42.35 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 O-C-N 124.455 1.097 . . . . 75.23 109.359 -175.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 23.1 m -70.91 83.03 0.66 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.344 1.058 . . . . 71.03 111.055 -176.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -83.75 57.48 5.05 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-O 119.596 -0.558 . . . . 65.14 112.92 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 135' ' ' VAL . . . . . 0.466 HG21 ' HA ' ' C' ' 128' ' ' LEU . 94.8 t 72.67 -17.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 125.28 1.432 . . . . 65.13 113.468 175.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt 71.9 164.09 0.28 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.014 1.326 . . . . 71.02 110.139 -175.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 11.4 m -76.27 70.84 2.93 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 123.562 0.745 . . . . 64.15 112.411 -171.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 138' ' ' TYR . . . . . 0.55 ' HE2' HE22 ' A' ' 12' ' ' GLN . 63.8 m-85 51.51 24.49 2.27 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 125.989 1.716 . . . . 64.43 113.609 171.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -163.07 143.92 9.49 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.718 0.807 . . . . 74.24 108.834 -174.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -83.06 67.54 3.73 Favored Glycine 0 C--N 1.342 0.911 0 O-C-N 123.544 0.528 . . . . 51.4 112.119 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.98 154.26 41.99 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.39 0.676 . . . . 63.52 109.917 173.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 62.0 tp -64.61 123.09 18.38 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.548 0.339 . . . . 74.3 111.096 -172.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -68.3 103.92 1.1 Allowed Glycine 0 C--N 1.345 1.062 0 N-CA-C 110.598 -1.001 . . . . 62.54 110.598 171.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.02 97.2 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.858 0.863 . . . . 74.52 109.259 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 26.8 t70 . . . . . 0 C--O 1.249 1.063 0 C-N-CA 123.441 0.696 . . . . 74.32 109.146 -174.352 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 109.215 -0.661 . . . . 71.42 109.215 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.1 m -127.16 113.44 16.37 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.388 -0.967 . . . . 64.3 108.388 -176.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -69.48 108.78 3.92 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.721 -0.844 . . . . 71.42 108.721 175.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 -70.42 107.92 4.03 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.116 0.566 . . . . 61.15 110.402 -173.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -130.92 77.11 1.77 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.747 0.819 . . . . 72.24 110.329 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -79.77 -68.57 0.66 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.746 -0.835 . . . . 72.21 108.746 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.9 t -178.74 99.48 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.019 1.328 . . . . 74.53 108.706 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.16 -171.4 3.61 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.16 0.584 . . . . 75.41 111.125 -172.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.654 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 23.3 ptt? -83.96 166.77 17.53 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.925 -0.58 . . . . 72.41 111.829 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.0 m -142.45 132.32 24.28 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.164 0.986 . . . . 74.32 109.361 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.431 ' CD1' HD12 ' A' ' 86' ' ' ILE . 46.7 t80 -125.32 114.43 18.89 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.847 -1.168 . . . . 64.24 107.847 175.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -134.38 133.4 40.55 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.254 -0.647 . . . . 75.44 109.254 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.498 ' CD1' HG21 ' A' ' 105' ' ' ILE . 4.7 mt -95.32 120.68 45.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 109.26 -0.644 . . . . 63.04 109.26 177.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -83.76 -39.6 19.86 Favored 'General case' 0 C--O 1.238 0.475 0 O-C-N 123.554 0.534 . . . . 70.41 111.052 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -173.47 120.14 0.32 Allowed 'General case' 0 N--CA 1.472 0.675 0 O-C-N 123.393 0.433 . . . . 74.5 110.0 -170.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.518 HD12 ' HG3' ' C' ' 130' ' ' PRO . 64.7 mt -107.5 137.63 37.71 Favored 'Isoleucine or valine' 0 C--O 1.247 0.921 0 N-CA-C 108.17 -1.048 . . . . 75.12 108.17 171.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.458 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 35.9 p90 -166.4 179.27 5.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 124.304 1.003 . . . . 75.3 110.936 -170.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -111.39 120.21 41.43 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.422 0.689 . . . . 65.3 110.095 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.1 mtpt -86.08 -28.8 23.85 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.807 -0.442 . . . . 64.15 109.807 177.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 18.0 t70 -144.54 139.3 28.1 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.511 -0.768 . . . . 73.54 109.408 177.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.4 mt -139.42 140.47 37.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.405 -1.331 . . . . 40.34 107.405 172.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.5 t -153.6 125.29 7.69 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.58 0.752 . . . . 72.15 109.479 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.557 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 70.3 t80 -128.59 130.86 47.94 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 106.594 -1.632 . . . . 71.0 106.594 173.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -130.58 135.43 47.89 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.049 0.386 . . . . 71.32 110.002 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.2 76.29 12.34 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 124.234 1.014 . . . . 73.33 108.358 172.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.31 -34.87 9.22 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.509 2.139 . . . . 73.32 112.264 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.403 ' ND2' ' HG2' ' A' ' 71' ' ' GLU . 6.7 m-20 -91.34 11.77 22.61 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.537 -0.756 . . . . 63.1 110.74 -176.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.449 ' HA ' HG12 ' A' ' 31' ' ' VAL . . . -47.27 -54.12 23.66 Favored Pre-proline 0 CA--C 1.57 1.722 0 CA-C-O 118.03 -0.986 . . . . 74.44 113.035 -171.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.421 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 51.9 Cg_exo -55.86 -30.41 76.86 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 122.343 2.028 . . . . 75.22 113.451 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -81.05 -43.19 19.9 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.271 0.628 . . . . 73.32 110.165 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.566 HG21 ' HA ' ' A' ' 73' ' ' ALA . 2.0 p -77.58 -22.26 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 114.782 -1.099 . . . . 75.01 112.685 -159.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -73.28 -21.7 60.54 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.069 0.548 . . . . 54.22 111.629 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -77.96 -22.98 48.66 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.267 -0.879 . . . . 64.43 110.43 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -82.78 165.95 19.45 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.283 1.033 . . . . 71.33 111.323 -174.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -76.77 123.11 25.71 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 115.601 -0.727 . . . . 53.33 109.48 177.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -76.23 87.39 3.06 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.666 0.746 . . . . 74.44 110.329 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.94 75.96 47.21 Favored Pre-proline 0 C--O 1.242 0.663 0 N-CA-C 105.898 -1.89 . . . . 41.12 105.898 170.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -82.63 149.1 14.36 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.819 2.346 . . . . 53.45 112.923 -173.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -96.0 100.89 12.52 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 106.625 -1.62 . . . . 70.14 106.625 167.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 65' ' ' THR . 39.0 t -91.52 108.2 19.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 109.804 -0.443 . . . . 65.32 109.804 -176.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -102.54 114.09 28.01 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.963 -1.017 . . . . 73.12 109.178 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.617 HD11 HD13 ' A' ' 128' ' ' LEU . 6.7 tt -108.91 138.1 45.77 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.416 -0.957 . . . . 65.51 108.416 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -137.8 141.43 40.85 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.75 0.82 . . . . 63.35 109.396 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.604 HD22 HD21 ' A' ' 60' ' ' LEU . 97.3 mt -120.79 142.23 49.78 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.598 0.759 . . . . 53.34 111.337 -172.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.577 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 7.8 m-20 -134.54 137.72 44.05 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.49 -0.93 . . . . 72.4 108.49 176.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.5 HG21 ' HA2' ' A' ' 99' ' ' GLY . 74.6 m -123.48 126.81 47.42 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.36 0.664 . . . . 61.21 109.441 175.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.44 153.56 50.73 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 124.393 1.077 . . . . 74.41 108.915 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.8 m -126.8 159.55 33.49 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 122.962 0.505 . . . . 74.33 110.315 175.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.7 t -148.93 117.97 6.75 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.252 -1.018 . . . . 73.42 108.252 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -77.92 104.01 8.21 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.958 -0.756 . . . . 75.15 108.958 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 71.4 mt -78.63 -27.66 45.43 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.626 -0.716 . . . . 72.43 109.953 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.473 ' HB3' ' CG2' ' A' ' 55' ' ' VAL . . . -163.37 172.75 14.14 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.357 1.063 . . . . 62.25 109.093 175.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -66.44 127.98 34.39 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.582 -0.895 . . . . 44.5 108.582 169.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 69.0 12.83 8.72 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.482 1.113 . . . . 74.31 112.328 -174.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.473 ' CG2' ' HB3' ' A' ' 52' ' ' ALA . 26.6 t -127.79 112.02 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.01 0.924 . . . . 73.42 108.651 173.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -128.7 124.38 35.49 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.344 -0.614 . . . . 63.03 109.344 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -91.41 145.32 24.73 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.861 -0.792 . . . . 75.12 108.861 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.9 t -128.7 141.39 46.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.496 -0.928 . . . . 71.04 108.496 172.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 73.5 t -123.32 132.43 71.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 123.634 0.774 . . . . 73.25 109.225 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.604 HD21 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -110.07 110.14 20.94 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.22 -1.4 . . . . 65.43 107.22 175.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.577 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 22.0 ttp180 -93.88 100.55 12.7 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.189 -1.411 . . . . 74.42 107.189 175.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.1 t -95.13 124.6 47.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.228 -1.027 . . . . 61.35 108.228 174.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.9 m -121.04 122.0 39.14 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.346 -0.612 . . . . 74.11 109.346 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.512 HG21 HG21 ' A' ' 114' ' ' ILE . 86.9 t -109.58 132.43 57.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 124.49 1.116 . . . . 62.11 108.28 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 10.1 m -123.49 141.04 52.39 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.058 -1.46 . . . . 75.14 107.058 168.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.5 125.12 33.53 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 106.278 -1.749 . . . . 74.35 106.278 170.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.9 m -134.39 131.6 38.41 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 123.6 0.562 . . . . 61.24 111.205 -176.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 27.0 mt -89.82 84.79 6.27 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 108.134 -1.061 . . . . 71.33 108.134 174.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.65 -117.94 4.73 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 111.256 -0.738 . . . . 72.42 111.256 -173.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -88.18 -30.05 20.05 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 117.403 0.601 . . . . 73.12 109.588 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.403 ' HG2' ' ND2' ' A' ' 27' ' ' ASN . 22.4 tt0 -80.18 125.67 30.13 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.711 -0.477 . . . . 72.22 109.711 -175.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.2 m -80.27 134.75 36.12 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.271 0.558 . . . . 64.32 111.283 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.566 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -77.27 -60.7 2.25 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.148 -0.933 . . . . 54.21 108.96 174.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -152.14 163.61 39.01 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.786 -0.643 . . . . 72.42 111.033 175.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 32.0 tp -134.86 113.29 11.43 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.435 1.094 . . . . 74.05 108.611 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.476 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 70.5 m -104.88 140.26 38.4 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.92 0.888 . . . . 61.44 109.453 175.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -148.22 124.56 10.91 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.627 0.771 . . . . 53.43 109.466 172.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.0 t -133.75 112.77 17.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 124.274 1.029 . . . . 71.32 109.429 -174.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 65.4 mt-30 -84.68 89.45 7.49 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.39 -0.967 . . . . 73.04 108.39 167.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -76.4 93.83 3.55 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.896 -0.779 . . . . 70.13 108.896 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.11 148.36 21.43 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 111.551 -0.619 . . . . 65.32 111.551 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.04 122.33 1.45 Allowed Glycine 0 CA--C 1.506 -0.531 0 N-CA-C 110.801 -0.919 . . . . 60.43 110.801 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.8 mt -80.33 125.84 39.26 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 N-CA-C 108.305 -0.998 . . . . 74.31 108.305 171.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.815 ' HB3' HD11 ' A' ' 86' ' ' ILE . 86.3 m-85 -129.76 124.11 32.63 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.196 0.598 . . . . 65.44 109.687 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.4 m -85.5 93.65 8.82 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.777 -0.823 . . . . 71.53 108.777 172.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.815 HD11 ' HB3' ' A' ' 84' ' ' PHE . 7.9 mm -109.74 148.13 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 116.14 -0.482 . . . . 74.51 109.847 -176.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.79 171.12 19.37 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.057 0.543 . . . . 73.21 110.67 -178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.654 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 99.49 -34.21 5.61 Favored Glycine 0 C--N 1.344 0.973 0 O-C-N 123.853 0.721 . . . . 65.35 112.915 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.565 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -122.8 153.5 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.968 0.507 . . . . 71.22 111.364 -169.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.438 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 21.5 tt0 -143.89 -179.11 6.27 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.961 -1.018 . . . . 64.24 108.254 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.438 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 61.5 -133.19 47.77 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 113.784 0.274 . . . . 10.14 113.784 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.7 t -72.51 -23.22 60.99 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 122.951 0.5 . . . . 53.14 111.612 -177.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -71.73 -36.83 70.6 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.454 0.701 . . . . 75.11 110.183 177.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.415 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 4.6 tpt -66.07 -49.91 65.96 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.903 -0.59 . . . . 73.23 109.881 174.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.11 -33.27 70.65 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.146 -0.934 . . . . 73.23 111.192 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -72.26 -41.51 66.66 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.461 0.704 . . . . 72.13 110.898 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 46.5 t -64.25 -35.79 81.98 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 121.226 0.536 . . . . 72.22 110.189 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 67.9 mt -89.54 -26.81 20.67 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.146 -0.934 . . . . 63.44 112.214 -177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.5 ' HA2' HG21 ' A' ' 46' ' ' THR . . . -104.06 4.47 45.24 Favored Glycine 0 N--CA 1.473 1.118 0 O-C-N 123.102 0.251 . . . . 62.5 113.363 -173.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.595 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -141.87 -68.46 0.38 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 122.75 0.42 . . . . 63.35 110.805 -177.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -66.88 -46.63 74.35 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 116.246 -0.434 . . . . 75.11 111.864 -171.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 92.6 m -62.3 -52.91 62.95 Favored Pre-proline 0 CA--C 1.565 1.529 0 CA-C-O 118.489 -0.767 . . . . 72.34 112.672 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.431 ' HA ' ' HB2' ' A' ' 106' ' ' LEU . 44.5 Cg_endo -66.97 -20.27 51.18 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 121.647 1.565 . . . . 75.01 113.054 176.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -66.9 -38.87 87.04 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.187 0.595 . . . . 75.52 110.343 173.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.498 HG21 ' CD1' ' A' ' 13' ' ' ILE . 43.6 mm -68.18 -42.91 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.634 0.773 . . . . 73.24 109.63 174.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 103' ' ' PRO . 54.6 mt -69.95 -28.18 65.35 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.14 -0.936 . . . . 62.01 112.297 -174.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -62.61 -44.85 88.07 Favored Pre-proline 0 N--CA 1.487 1.382 0 N-CA-C 114.033 1.123 . . . . 71.13 114.033 -171.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.401 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 85.4 Cg_exo -50.78 -39.27 57.76 Favored 'Trans proline' 0 C--N 1.377 2.064 0 C-N-CA 122.135 1.89 . . . . 64.31 113.585 171.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -77.68 -38.95 46.4 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.343 0.657 . . . . 74.4 111.706 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.1 -49.77 70.92 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.248 0.619 . . . . 63.22 109.444 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.407 HH12 HD12 ' C' ' 105' ' ' ILE . 31.7 ttm180 -49.13 -49.91 39.9 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.925 1.29 . . . . 73.52 110.741 173.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.76 -46.8 83.68 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 124.004 0.815 . . . . 73.35 111.558 -176.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.442 ' O ' ' HG3' ' A' ' 117' ' ' MET . 41.9 t -59.3 -35.56 74.02 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.446 0.698 . . . . 63.32 111.066 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.512 HG21 HG21 ' A' ' 64' ' ' VAL . 83.5 mt -70.51 -57.25 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 115.571 -0.74 . . . . 62.51 110.593 175.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.7 m -51.98 -39.23 59.03 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 124.586 1.154 . . . . 72.03 111.676 -174.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.3 t -66.37 -44.33 83.44 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.441 -1.254 . . . . 73.44 110.102 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.557 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 40.9 mtm -62.95 -39.76 95.61 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.561 0.344 . . . . 74.44 110.828 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.4 t -57.43 -48.38 82.91 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 O-C-N 124.018 0.824 . . . . 65.51 110.183 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 95.3 p -73.79 -33.2 64.13 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.887 -0.597 . . . . 74.41 111.711 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.411 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.2 mtt-85 -68.15 -32.46 72.75 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.293 0.637 . . . . 64.42 109.86 176.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.33 15.84 42.84 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 115.498 -0.774 . . . . 72.25 113.216 174.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 121' ' ' GLY . 0.8 OUTLIER 65.14 10.89 6.73 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.388 1.875 . . . . 42.5 113.234 172.578 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -83.42 144.09 45.73 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 109.506 -0.553 . . . . 75.32 109.506 175.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.567 ' HG3' ' HB3' ' E' ' 130' ' ' ALA . 82.3 Cg_exo -50.81 137.53 42.68 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 123.288 2.658 . . . . 63.05 112.955 175.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -55.31 128.39 33.91 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.27 0.981 . . . . 63.21 111.986 -172.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.5 tp -113.43 129.1 56.62 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.568 0.747 . . . . 65.11 109.121 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.559 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 87.1 m-20 -119.77 114.44 22.14 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.188 -1.041 . . . . 75.34 108.188 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.617 HD13 HD11 ' A' ' 42' ' ' LEU . 14.7 mt -72.86 127.41 32.47 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 109.558 -0.534 . . . . 52.22 109.558 -176.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.85 134.49 92.45 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-O 119.157 -0.449 . . . . 65.32 110.415 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.89 124.7 16.61 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.822 2.348 . . . . 71.43 112.689 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.567 HG21 HD11 ' A' ' 44' ' ' LEU . 98.8 t -101.1 128.28 53.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 CA-C-N 115.745 -0.661 . . . . 73.42 109.787 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -86.87 85.88 7.29 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.75 -0.833 . . . . 73.22 108.75 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -61.23 -27.43 68.43 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.425 -0.807 . . . . 72.14 111.947 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.595 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 17.2 t70 -61.71 -51.63 67.59 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.204 0.602 . . . . 74.55 109.72 174.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.0 -41.14 86.97 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.237 0.961 . . . . 64.2 110.83 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.8 mt -61.73 -48.3 81.35 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.244 0.618 . . . . 71.22 111.457 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -66.23 -34.19 77.47 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.938 -0.393 . . . . 74.32 109.938 178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.498 ' SD ' HD23 ' A' ' 141' ' ' LEU . 19.5 mmt -57.78 -45.04 86.54 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.986 0.514 . . . . 61.42 110.488 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -55.81 -33.92 64.86 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 122.738 0.415 . . . . 54.05 111.854 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -77.66 -40.89 40.12 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.64 0.776 . . . . 74.12 111.141 173.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.498 HD23 ' SD ' ' A' ' 138' ' ' MET . 46.2 tp -67.69 -55.52 12.87 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.935 0.894 . . . . 74.11 111.723 -170.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 60.8 mt-30 -169.96 -18.56 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 125.317 1.447 . . . . 64.41 110.383 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 77.56 -48.62 0.5 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.943 2.097 . . . . 72.34 111.41 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -66.96 125.0 24.57 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.397 0.679 . . . . 64.34 109.683 173.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.68 131.26 28.99 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.624 -0.88 . . . . 34.35 108.624 175.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -156.52 45.15 0.51 Allowed Glycine 0 C--N 1.339 0.75 0 N-CA-C 112.016 -0.434 . . . . 50.23 112.016 -177.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -153.16 140.96 20.09 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.3 0.64 . . . . 73.41 110.07 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 179.08 48.36 0.08 OUTLIER Glycine 0 C--N 1.341 0.845 0 CA-C-N 115.978 -0.555 . . . . 51.53 112.881 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.7 t -90.65 146.63 23.87 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 117.214 0.507 . . . . 72.21 110.063 176.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -157.56 41.57 0.3 Allowed 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 121.936 0.874 . . . . 62.54 109.459 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -93.58 118.62 31.6 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.596 -1.183 . . . . 51.03 109.869 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -174.05 97.56 0.1 Allowed 'General case' 0 C--O 1.241 0.625 0 C-N-CA 125.077 1.351 . . . . 73.43 107.919 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -86.04 134.93 33.81 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-O 121.059 0.457 . . . . 73.53 110.043 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -160.44 121.94 3.09 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.664 -1.236 . . . . 74.23 107.664 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.214 0 C-N-CA 122.946 0.498 . . . . 74.44 109.998 -175.171 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 56.0 ttm . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 109.625 -0.509 . . . . 62.13 109.625 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 14.5 t 59.14 -157.15 0.33 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.161 0.985 . . . . 55.23 110.235 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -121.19 159.22 26.34 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 108.482 -0.933 . . . . 74.51 108.482 172.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -51.37 -53.32 37.53 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.094 0.958 . . . . 71.02 112.927 -172.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 43.4 t30 57.39 92.87 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 O-C-N 124.269 0.981 . . . . 75.54 110.337 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -57.33 -68.32 0.24 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.213 1.005 . . . . 75.44 113.186 -164.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 60.7 p -106.73 20.27 19.27 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.744 0.646 . . . . 73.2 112.744 -172.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 58.79 25.28 13.31 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 122.359 1.076 . . . . 73.4 110.18 -175.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.738 ' HB3' HG23 ' B' ' 89' ' ' ILE . 22.0 ptm 52.1 176.24 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.287 2.235 . . . . 71.34 115.632 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.3 p -133.47 104.08 6.24 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 106.949 -1.5 . . . . 71.32 106.949 173.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.473 ' CD2' ' HG3' ' D' ' 130' ' ' PRO . 24.0 t80 -107.91 137.03 46.62 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.149 -1.056 . . . . 65.12 108.149 -177.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.618 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 0.1 OUTLIER -141.15 118.37 11.34 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.257 -0.646 . . . . 74.44 109.257 -178.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 57.1 mt -77.89 124.35 36.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 107.738 -1.208 . . . . 73.1 107.738 166.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . 0.412 ' NE2' HG22 ' B' ' 83' ' ' ILE . 40.1 mt-30 -100.29 -35.57 9.57 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.527 -0.546 . . . . 74.04 109.527 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -176.89 134.5 0.2 Allowed 'General case' 0 C--N 1.352 0.69 0 O-C-N 123.917 0.761 . . . . 74.32 109.846 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.535 HG21 ' CD1' ' B' ' 109' ' ' TYR . 78.6 mt -119.65 145.05 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.117 -1.068 . . . . 75.42 108.117 175.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 18.8 p90 -165.11 145.09 7.01 Favored 'General case' 0 C--N 1.346 0.414 0 N-CA-C 112.974 0.731 . . . . 73.43 112.974 -173.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 38.7 m -76.3 122.79 24.93 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.477 -0.783 . . . . 72.11 108.903 170.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.433 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.4 mtpt -100.12 -14.75 18.44 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.423 0.689 . . . . 75.45 111.392 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.6 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.1 t70 -158.48 141.81 15.01 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.644 0.378 . . . . 71.35 111.433 -174.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.722 HD11 ' SG ' ' B' ' 113' ' ' CYS . 29.0 mm -136.68 143.12 36.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 C-N-CA 124.915 1.286 . . . . 64.33 108.408 174.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 68.8 m -148.4 131.84 16.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.544 -1.207 . . . . 45.34 108.484 167.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -143.71 108.79 4.98 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 106.719 -1.586 . . . . 63.01 106.719 168.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -124.88 112.84 17.11 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.527 -0.916 . . . . 71.35 108.527 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.6 88.29 4.12 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.749 -1.204 . . . . 61.43 107.749 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.04 -40.91 8.23 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.75 2.3 . . . . 72.1 112.772 -168.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -101.02 19.96 16.44 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.777 0.831 . . . . 54.11 110.672 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.483 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -39.38 -62.13 0.87 Allowed Pre-proline 0 CA--C 1.566 1.588 0 N-CA-C 114.737 1.384 . . . . 40.22 114.737 -163.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 22.9 Cg_exo -62.95 -29.41 75.86 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 122.21 1.94 . . . . 74.32 112.983 -174.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -87.97 -38.18 15.76 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.228 -0.896 . . . . 73.51 111.659 -174.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.668 HG22 HD12 ' B' ' 68' ' ' LEU . 5.7 p -72.7 -15.78 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 123.156 0.583 . . . . 52.33 110.927 -173.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -70.58 -10.02 58.26 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 113.693 0.997 . . . . 74.42 113.693 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -72.79 -17.16 61.6 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 120.832 0.348 . . . . 65.51 110.465 174.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -98.68 97.61 8.85 Favored 'General case' 0 C--N 1.344 0.355 0 C-N-CA 124.92 1.288 . . . . 64.41 110.109 -175.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -102.22 85.77 2.71 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.222 -0.659 . . . . 74.24 109.222 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 7.6 p90 -156.83 -176.47 5.99 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.958 0.903 . . . . 75.2 109.797 173.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -68.63 114.41 22.12 Favored Pre-proline 0 N--CA 1.472 0.658 0 C-N-CA 123.559 0.744 . . . . 64.42 110.542 177.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.421 ' O ' HG23 ' B' ' 40' ' ' VAL . 27.9 Cg_endo -68.34 145.15 64.62 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 121.22 1.28 . . . . 65.4 110.693 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.41 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 9.7 tp10 -64.62 99.71 0.33 Allowed 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.235 -1.024 . . . . 61.33 108.235 170.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.508 HG11 HD11 ' B' ' 126' ' ' LEU . 53.5 t -106.79 141.71 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 O-C-N 123.778 0.674 . . . . 64.25 110.324 -174.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.402 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 54.3 tttm -142.27 109.37 5.53 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.374 1.069 . . . . 73.14 108.753 -172.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.418 HD13 HD22 ' B' ' 128' ' ' LEU . 38.2 tp -90.55 127.3 36.21 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.389 -0.597 . . . . 74.42 109.389 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.682 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 9.5 m-20 -122.29 116.8 24.71 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.241 1.016 . . . . 73.1 108.678 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.515 HD11 HG11 ' B' ' 131' ' ' VAL . 69.3 mt -99.39 126.74 45.34 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.42 -0.956 . . . . 75.41 108.42 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -140.68 155.52 46.47 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.293 1.037 . . . . 74.41 108.52 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . 0.486 HG23 ' HB ' ' F' ' 107' ' ' THR . 1.4 t -148.18 117.83 7.05 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 121.328 0.585 . . . . 52.04 110.336 -177.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.64 125.34 53.64 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 106.726 -1.583 . . . . 64.35 106.726 176.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.546 ' HB2' ' HE2' ' B' ' 56' ' ' TYR . 62.0 p -139.41 177.15 8.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 119.652 -0.214 . . . . 74.41 110.886 -166.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 36.0 p -170.52 137.94 1.44 Allowed 'General case' 0 C--O 1.245 0.861 0 O-C-N 123.382 0.426 . . . . 75.4 111.16 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -76.0 126.36 30.86 Favored 'General case' 0 C--N 1.348 0.507 0 N-CA-C 108.573 -0.899 . . . . 71.01 108.573 165.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 pp -143.64 23.51 1.76 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.969 0.907 . . . . 64.21 109.092 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' B' ' 55' ' ' VAL . . . -166.25 170.89 12.74 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 123.457 0.703 . . . . 73.32 111.221 -175.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -100.76 118.02 36.02 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.666 0.787 . . . . 75.45 109.564 177.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 62.13 9.67 3.28 Favored 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 124.799 1.24 . . . . 50.34 112.584 -173.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.45 ' O ' ' HB3' ' B' ' 52' ' ' ALA . 74.8 t -128.75 129.96 68.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 107.631 -1.248 . . . . 74.12 107.631 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.546 ' HE2' ' HB2' ' B' ' 48' ' ' SER . 28.0 t80 -132.01 140.98 49.11 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.633 -0.877 . . . . 72.12 108.633 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -109.69 110.76 21.89 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 107.143 -1.428 . . . . 73.12 107.143 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 7.5 p -111.79 132.06 61.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 C-N-CA 123.333 0.653 . . . . 71.52 109.25 -177.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 32.7 t -111.53 113.85 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 109.022 -0.733 . . . . 61.43 109.022 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 60.9 tp -93.49 106.71 18.65 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.606 0.362 . . . . 62.23 110.103 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.445 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 20.9 ttm180 -86.06 108.23 18.17 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.356 0.662 . . . . 54.43 109.784 172.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.414 HG13 HD11 ' B' ' 42' ' ' LEU . 59.5 t -103.99 106.23 19.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.223 -1.029 . . . . 54.31 108.223 175.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.682 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 15.8 m -97.18 142.83 28.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.002 -0.999 . . . . 74.13 108.995 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.891 HG11 HD21 ' B' ' 126' ' ' LEU . 73.4 t -134.73 122.58 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.718 -0.845 . . . . 61.33 108.718 173.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 87.6 m -98.97 141.55 31.59 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.757 -1.201 . . . . 61.53 107.757 169.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.18 137.48 23.36 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 109.76 -0.459 . . . . 53.21 109.76 174.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.461 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 19.1 m -148.25 128.52 13.82 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.542 0.337 . . . . 70.32 111.489 -174.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.668 HD12 HG22 ' B' ' 31' ' ' VAL . 85.3 mt -93.95 99.92 12.16 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.174 -0.676 . . . . 61.53 109.174 178.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.69 -130.32 9.62 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 115.219 -0.901 . . . . 64.35 111.01 -171.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -97.18 2.0 50.49 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.087 0.955 . . . . 63.22 111.726 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -115.09 147.11 40.61 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.024 0.53 . . . . 65.14 110.569 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 49.7 m -68.92 133.06 47.7 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 123.5 0.5 . . . . 75.12 111.283 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.512 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -86.83 -60.74 1.9 Allowed 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.926 -1.138 . . . . 72.32 107.926 175.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -154.14 161.94 41.53 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 114.45 -1.25 . . . . 74.0 110.019 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.9 mt -129.96 112.67 13.73 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.645 -1.613 . . . . 74.43 106.645 172.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.469 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 23.0 t -118.88 114.1 22.07 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 109.07 -0.715 . . . . 63.34 109.07 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -128.49 122.9 32.26 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.359 -0.978 . . . . 73.13 108.359 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 88.2 t -124.73 150.26 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.512 1.125 . . . . 53.24 108.552 -178.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.6 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 27.1 mt-30 -121.15 115.02 22.27 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.769 -0.826 . . . . 64.11 108.769 167.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -100.82 107.26 18.76 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.632 -0.877 . . . . 73.15 108.632 172.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.433 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -99.89 170.56 22.96 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 111.861 -0.496 . . . . 71.43 111.861 176.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.01 141.34 6.67 Favored Glycine 0 C--N 1.34 0.754 0 C-N-CA 121.643 -0.313 . . . . 73.23 112.554 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.412 HG22 ' NE2' ' B' ' 14' ' ' GLN . 41.1 mt -97.77 106.61 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 N-CA-C 108.517 -0.92 . . . . 70.11 108.517 176.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -116.08 135.24 54.12 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.103 0.561 . . . . 74.41 110.952 -175.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.618 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 57.7 m -95.24 129.6 42.31 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.889 0.876 . . . . 54.01 110.12 172.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.568 ' HB ' HD11 ' B' ' 89' ' ' ILE . 35.2 pt -138.39 136.61 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 124.048 0.939 . . . . 75.11 110.437 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.64 173.79 16.33 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.032 0.933 . . . . 74.03 109.787 174.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.86 -40.86 3.08 Favored Glycine 0 N--CA 1.479 1.557 0 CA-C-O 121.133 0.296 . . . . 65.41 112.823 177.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.738 HG23 ' HB3' ' B' ' 9' ' ' MET . 3.5 pt -58.8 154.76 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.474 1.11 . . . . 74.24 111.146 165.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -164.72 146.05 7.98 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.956 -1.02 . . . . 61.31 108.697 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.52 -134.8 12.28 Favored Glycine 0 C--N 1.348 1.218 0 O-C-N 123.442 0.464 . . . . 63.11 112.117 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 52.6 m -73.64 -54.22 8.65 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.757 0.823 . . . . 72.22 110.618 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.437 ' HA ' ' HB3' ' B' ' 96' ' ' HIS . 16.0 mm100 -56.52 -19.72 16.97 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.905 1.282 . . . . 74.14 113.197 -176.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.688 ' SD ' HG23 ' F' ' 97' ' ' ILE . 41.8 ttp -61.04 -70.29 0.19 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.325 1.05 . . . . 62.14 111.597 -177.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.591 ' HB1' HD23 ' F' ' 102' ' ' LEU . . . -82.51 -15.11 53.63 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 111.845 0.313 . . . . 74.44 111.845 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.437 ' HB3' ' HA ' ' B' ' 93' ' ' GLN . 1.4 t-80 -58.78 -34.66 71.7 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.433 0.693 . . . . 71.51 110.313 168.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.6 t -58.71 -26.0 63.47 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.554 0.742 . . . . 72.41 111.694 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.401 HD22 ' HB3' ' B' ' 56' ' ' TYR . 52.0 mt -84.41 -29.04 26.49 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.96 0.904 . . . . 70.45 112.129 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.79 -10.53 57.64 Favored Glycine 0 C--N 1.342 0.873 0 O-C-N 123.56 0.538 . . . . 43.23 113.021 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.675 ' HA ' ' HB2' ' B' ' 133' ' ' PHE . . . -124.38 -59.19 1.48 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.088 0.555 . . . . 44.41 112.167 -174.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -78.01 -48.82 15.31 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.112 0.565 . . . . 74.2 110.937 -168.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 73.5 m -61.52 -50.17 83.88 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 123.865 0.866 . . . . 74.15 112.073 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -70.09 -17.98 35.76 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 121.73 1.62 . . . . 63.0 112.917 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -70.86 -30.47 66.87 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 122.598 0.359 . . . . 72.21 110.42 173.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.437 HG23 ' NH2' ' D' ' 111' ' ' ARG . 69.5 mt -71.82 -42.42 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.18 0.592 . . . . 72.12 109.831 171.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 77.8 mt -73.89 -28.49 61.58 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.047 -0.979 . . . . 64.43 111.825 -175.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -60.12 -49.41 91.02 Favored Pre-proline 0 N--CA 1.484 1.248 0 CA-C-O 118.024 -0.988 . . . . 74.43 113.28 -172.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -54.83 -33.78 82.72 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.545 2.163 . . . . 74.12 113.598 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.535 ' CD1' HG21 ' B' ' 16' ' ' ILE . 7.7 m-30 -78.82 -40.46 32.83 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.047 0.539 . . . . 71.32 110.504 -176.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.25 -39.9 95.9 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.489 0.716 . . . . 61.13 110.136 172.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.463 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 47.1 ttt-85 -62.6 -53.3 56.64 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.429 1.491 . . . . 71.41 110.724 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -66.49 -30.54 70.9 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.461 0.705 . . . . 75.3 109.848 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.722 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.1 t -70.16 -42.36 72.59 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 122.946 0.498 . . . . 75.13 110.273 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.479 ' O ' HG23 ' B' ' 118' ' ' VAL . 45.4 mt -58.79 -55.79 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.853 0.861 . . . . 61.51 110.408 173.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 9.6 m -63.7 -29.89 71.06 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.632 0.773 . . . . 74.41 111.382 -173.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.3 t -58.31 -54.94 41.28 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 108.831 -0.803 . . . . 73.05 108.831 171.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.529 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.8 mmt -64.98 -37.3 87.21 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.602 0.761 . . . . 75.43 111.4 -175.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.479 HG23 ' O ' ' B' ' 114' ' ' ILE . 81.4 t -59.89 -48.82 86.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 124.019 0.928 . . . . 73.23 110.544 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 32.8 t -75.27 -19.85 59.48 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.899 -1.046 . . . . 73.43 111.075 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' B' ' 116' ' ' SER . 90.3 mtt-85 -68.21 -32.47 72.7 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 110.027 -0.36 . . . . 75.52 110.027 170.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.433 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -79.49 -5.58 89.22 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 123.655 0.597 . . . . 60.33 112.397 169.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 6.6 m 66.39 25.57 10.31 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 125.624 1.57 . . . . 60.11 110.652 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -77.33 163.21 65.8 Favored Pre-proline 0 CA--C 1.555 1.148 0 CA-C-N 114.884 -1.053 . . . . 74.23 110.836 175.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.552 ' HA ' ' HB3' ' F' ' 131' ' ' TRP . 91.6 Cg_exo -48.51 144.49 13.8 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 123.312 2.675 . . . . 63.31 114.764 174.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.533 ' HB3' ' HB3' ' F' ' 130' ' ' ALA . 41.0 tp60 -54.59 118.05 3.86 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.055 0.942 . . . . 31.21 110.758 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.891 HD21 HG11 ' B' ' 64' ' ' VAL . 20.5 tp -110.04 99.36 8.47 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.14 -0.936 . . . . 74.23 109.602 -171.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.413 HD21 ' HG3' ' B' ' 125' ' ' GLN . 43.8 m-80 -96.03 110.68 22.88 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.453 -0.573 . . . . 75.14 109.453 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.463 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 55.0 mt -77.21 126.21 30.57 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.871 -0.789 . . . . 75.31 108.871 171.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.558 ' HB3' ' HA ' ' F' ' 119' ' ' ASP . . . -76.58 154.6 83.66 Favored Pre-proline 0 CA--C 1.552 1.051 0 O-C-N 124.268 0.98 . . . . 34.04 111.706 -169.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.492 ' HG3' HD13 ' D' ' 16' ' ' ILE . 3.8 Cg_exo -77.33 87.68 1.48 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 123.401 2.734 . . . . 72.41 112.686 -167.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.515 HG11 HD11 ' B' ' 44' ' ' LEU . 4.6 p -92.8 122.35 44.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 115.333 -0.849 . . . . 65.12 110.517 177.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -94.67 117.25 29.83 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 107.464 -1.31 . . . . 74.41 107.464 169.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.675 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 77.1 m-85 -64.3 -15.19 59.77 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.562 0.745 . . . . 71.33 111.887 -177.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -55.46 -43.56 75.58 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.451 1.1 . . . . 64.35 110.858 169.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.02 -31.83 67.36 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.717 0.807 . . . . 71.33 112.055 177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.561 HD13 ' HA ' ' B' ' 133' ' ' PHE . 6.7 mp -76.12 -29.42 57.85 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.545 0.738 . . . . 74.23 110.407 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -73.79 -39.97 63.76 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 122.759 0.423 . . . . 53.03 110.507 169.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 20.9 mmt -62.64 -35.66 80.33 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.08 0.952 . . . . 73.54 111.425 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.76 -32.61 60.03 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.563 -0.744 . . . . 63.1 110.374 -175.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -79.91 -38.74 31.86 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.299 -0.864 . . . . 64.4 110.552 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 98.5 mt -99.64 29.78 3.93 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.989 0.916 . . . . 73.44 110.647 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.23 98.29 0.22 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.558 0.743 . . . . 75.24 109.255 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -178.79 -58.43 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.587 1.155 . . . . 75.34 108.106 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -82.58 94.25 7.47 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 114.532 -1.213 . . . . 71.22 108.182 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.03 -178.01 3.49 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.916 0.887 . . . . 71.45 110.634 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -146.83 96.72 0.18 Allowed Glycine 0 C--N 1.344 0.972 0 CA-C-N 115.962 -0.563 . . . . 72.45 111.976 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -81.43 84.24 6.73 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.73 0.776 . . . . 74.42 110.673 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.67 107.65 2.22 Favored Glycine 0 C--N 1.347 1.174 0 CA-C-N 115.107 -0.951 . . . . 71.54 110.731 174.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 6.2 t -119.46 129.71 54.88 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.345 0.658 . . . . 73.55 110.941 -172.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' D' ' 90' ' ' GLU . 13.8 mm-40 -91.36 134.58 34.48 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.587 -0.894 . . . . 75.43 108.587 169.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -94.84 43.89 1.1 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.666 0.786 . . . . 61.2 110.501 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 51.6 m80 69.64 121.36 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.174 1.39 . . . . 72.42 111.685 -176.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . 0.418 ' HB3' ' HA2' ' D' ' 91' ' ' GLY . 11.0 pt20 -68.5 146.11 53.43 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.483 0.713 . . . . 74.24 110.792 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -82.19 170.2 15.72 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.65 0.78 . . . . 74.31 112.015 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.156 0 CA-C-N 114.996 -1.002 . . . . 71.42 109.046 176.922 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 84.1 mtp . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 110.487 -0.19 . . . . 73.04 110.487 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 13.5 p -160.56 97.44 1.2 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.464 0.705 . . . . 73.12 109.742 174.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.82 90.68 2.92 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.582 0.706 . . . . 73.25 110.369 178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -78.94 67.3 4.61 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-O 122.642 1.21 . . . . 63.32 109.956 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -69.64 127.28 32.4 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.436 -1.257 . . . . 74.34 110.855 -172.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -163.84 149.31 10.91 Favored 'General case' 0 C--O 1.245 0.854 0 C-N-CA 123.842 0.857 . . . . 64.24 110.134 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 32.4 m -83.13 82.6 8.18 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.774 -1.195 . . . . 63.05 107.774 169.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -161.29 -47.1 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.647 -0.872 . . . . 55.24 108.647 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.637 ' HE3' HG21 ' C' ' 89' ' ' ILE . 51.2 ttm 65.11 115.66 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.844 1.258 . . . . 72.14 111.611 -176.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 51.6 m -98.78 95.9 7.53 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.079 -0.711 . . . . 51.3 109.079 172.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -109.83 135.94 49.93 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.353 -0.61 . . . . 65.33 109.353 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -152.96 131.55 12.25 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 109.617 -0.512 . . . . 72.52 109.617 171.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 57.2 mt -69.88 125.96 29.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 108.65 -0.87 . . . . 74.43 108.65 170.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -89.93 -49.78 6.41 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.961 -0.755 . . . . 64.23 108.961 175.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.559 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -173.53 150.92 1.85 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.111 0.964 . . . . 75.22 109.973 174.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 pp -114.54 152.28 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 107.878 -1.156 . . . . 60.3 107.878 173.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.638 ' HB3' HG23 ' D' ' 122' ' ' THR . 28.2 p90 -179.56 162.46 1.11 Allowed 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.456 0.646 . . . . 73.34 110.882 -174.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.2 p -92.35 115.33 27.99 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 123.43 0.692 . . . . 74.43 109.882 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.401 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 19.6 mmtp -64.43 -40.47 95.8 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.233 -1.025 . . . . 75.22 108.233 170.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -150.07 147.87 28.32 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.407 -1.269 . . . . 73.52 110.787 -174.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.54 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.6 mt -138.39 144.51 30.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 C-N-CA 125.896 1.679 . . . . 74.24 106.584 174.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 31.2 t -153.46 150.01 28.34 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 122.568 0.347 . . . . 54.23 110.481 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -155.28 137.08 14.41 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.451 1.1 . . . . 73.32 108.166 175.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -140.23 133.73 30.08 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.281 0.633 . . . . 71.2 109.433 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.79 81.41 22.87 Favored Pre-proline 0 C--O 1.241 0.621 0 N-CA-C 108.001 -1.111 . . . . 64.22 108.001 169.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.2 -30.41 74.48 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 123.017 2.478 . . . . 54.02 112.622 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . 0.479 ' OD1' ' HB ' ' C' ' 31' ' ' VAL . 5.9 p30 -117.07 34.54 5.06 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.222 0.609 . . . . 54.33 109.575 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -40.08 -57.85 2.56 Favored Pre-proline 0 N--CA 1.49 1.57 0 N-CA-C 114.148 1.166 . . . . 74.22 114.148 -174.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -64.61 -35.39 47.82 Favored 'Trans proline' 0 C--N 1.382 2.292 0 CA-C-N 121.569 1.596 . . . . 43.2 112.64 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.656 ' HA ' HE21 ' C' ' 33' ' ' GLN . 80.5 t60 -68.71 -38.09 79.97 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.813 0.845 . . . . 73.13 112.24 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.623 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.5 p -76.34 -30.27 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 N-CA-C 112.573 0.583 . . . . 74.13 112.573 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -59.79 -34.02 72.48 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 112.447 0.536 . . . . 73.22 112.447 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.656 HE21 ' HA ' ' C' ' 30' ' ' HIS . 24.7 pt20 -86.15 11.89 10.89 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.398 0.679 . . . . 71.3 112.408 -178.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.429 ' HG2' HD13 ' C' ' 68' ' ' LEU . 1.8 ttpm? -113.95 147.85 37.86 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.877 0.871 . . . . 74.53 110.124 177.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.16 125.26 23.11 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 123.381 0.673 . . . . 71.41 110.93 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -81.55 105.81 13.01 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.927 -1.033 . . . . 63.04 110.993 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -162.78 79.44 1.77 Allowed Pre-proline 0 C--O 1.241 0.607 0 N-CA-C 107.469 -1.308 . . . . 75.21 107.469 164.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -87.04 164.52 8.67 Favored 'Trans proline' 0 C--N 1.367 1.541 0 C-N-CA 122.913 2.409 . . . . 43.24 113.02 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -86.75 85.32 7.28 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 106.725 -1.583 . . . . 73.21 106.725 168.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 99.2 t -68.58 109.7 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 115.008 -0.996 . . . . 64.34 109.767 -177.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.582 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 65.7 mttm -92.08 103.96 16.4 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.354 -0.98 . . . . 73.02 108.354 178.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 tt -89.08 123.91 33.81 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 107.057 -1.46 . . . . 51.52 107.057 174.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.609 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 17.0 t70 -128.39 139.53 52.32 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.153 0.981 . . . . 74.54 108.409 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.522 HD22 HD21 ' C' ' 60' ' ' LEU . 24.6 mt -135.3 126.41 27.96 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.438 0.695 . . . . 72.33 110.218 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -130.53 139.29 50.48 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.63 1.172 . . . . 61.11 108.193 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.0 t -144.07 139.47 28.94 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.019 0.438 . . . . 75.33 110.283 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.95 156.05 45.48 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.937 0.895 . . . . 54.13 109.608 -178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 2.3 m -132.43 144.18 50.31 Favored 'General case' 0 C--O 1.24 0.564 0 O-C-N 123.299 0.374 . . . . 54.14 110.034 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 22.4 p -145.12 126.07 14.48 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.916 0.886 . . . . 72.32 109.473 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -78.76 118.67 21.04 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.317 -0.623 . . . . 73.04 109.317 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' C' ' 57' ' ' GLU . 34.5 mt -88.45 -41.47 12.76 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.83 0.852 . . . . 73.42 110.638 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.19 -172.66 4.22 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.061 -0.972 . . . . 62.54 110.181 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.42 112.62 1.83 Allowed 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.036 0.835 . . . . 44.45 110.591 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 66.31 9.33 6.31 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.661 1.185 . . . . 62.23 112.425 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 87.0 t -106.81 107.62 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.23 0.612 . . . . 61.33 109.857 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -106.72 124.63 49.89 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 123.768 0.827 . . . . 74.53 109.073 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.56 ' HB2' HD11 ' C' ' 51' ' ' LEU . 30.2 tt0 -82.72 126.65 32.61 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.296 -1.002 . . . . 75.21 108.296 169.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.8 t -112.4 138.2 42.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.486 -0.931 . . . . 72.4 108.486 167.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 86.6 t -120.9 131.37 73.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 108.529 -0.915 . . . . 53.42 108.529 170.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.522 HD21 HD22 ' C' ' 44' ' ' LEU . 0.9 OUTLIER -114.22 107.23 15.33 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.676 -1.231 . . . . 74.04 107.676 172.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.414 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 0.0 OUTLIER -95.9 117.74 31.18 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 114.671 -1.149 . . . . 74.42 109.153 178.083 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 10.8 t -102.07 132.37 48.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 107.838 -1.171 . . . . 65.44 107.838 172.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.609 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 29.9 m -123.31 128.02 49.35 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.099 -1.074 . . . . 71.05 108.099 175.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.409 HG23 HD13 ' C' ' 114' ' ' ILE . 85.7 t -122.95 128.75 75.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.576 -0.738 . . . . 71.33 109.34 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 25.4 m -118.32 139.24 51.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.621 -1.251 . . . . 71.44 107.621 176.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.24 113.01 15.76 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 106.669 -1.604 . . . . 65.45 106.669 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 65.4 m -135.62 126.21 27.05 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.672 0.607 . . . . 60.14 109.9 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.429 HD13 ' HG2' ' C' ' 34' ' ' LYS . 12.0 mt -85.98 56.06 3.81 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.224 1.41 . . . . 72.34 107.908 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.58 -107.73 3.08 Favored Glycine 0 C--N 1.341 0.851 0 N-CA-C 110.026 -1.23 . . . . 64.11 110.026 -169.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -103.59 -17.14 15.29 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.64 0.776 . . . . 72.22 110.044 173.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -68.55 99.89 1.04 Allowed 'General case' 0 C--N 1.348 0.542 0 C-N-CA 123.341 0.656 . . . . 64.22 109.44 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 50.4 m -73.36 114.83 12.01 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.169 -0.678 . . . . 71.31 109.169 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.623 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -67.84 -57.52 6.13 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.248 -1.342 . . . . 42.22 108.613 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -155.13 159.64 40.34 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.745 -1.116 . . . . 71.42 110.732 172.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.417 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -118.68 143.06 47.09 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.799 -1.556 . . . . 73.24 106.799 167.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.417 ' N ' HD13 ' C' ' 75' ' ' LEU . 46.6 t -149.7 141.9 24.08 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.598 -0.89 . . . . 72.33 108.598 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -154.65 134.9 13.21 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.472 -0.566 . . . . 71.4 109.472 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.48 HG11 ' HA ' ' C' ' 110' ' ' ALA . 40.9 t -133.71 114.65 20.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 124.263 1.025 . . . . 73.53 108.836 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.414 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 53.4 mt-30 -91.27 87.64 6.57 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.654 -0.869 . . . . 65.14 108.654 174.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.439 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.4 tp-100 -79.86 99.11 7.38 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.408 0.683 . . . . 72.24 110.121 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.67 149.11 25.43 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 116.329 -0.396 . . . . 55.35 112.36 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.538 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.27 125.73 2.01 Favored Glycine 0 CA--C 1.503 -0.678 0 N-CA-C 110.508 -1.037 . . . . 43.42 110.508 -178.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.538 HD12 HD11 ' C' ' 51' ' ' LEU . 31.8 mm -93.7 125.24 46.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 108.278 -1.008 . . . . 63.11 108.278 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -133.64 121.84 22.6 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.457 0.703 . . . . 74.43 109.721 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 20.6 p -82.28 103.99 12.27 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 108.745 -0.835 . . . . 71.12 108.745 171.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.612 HG21 ' HE3' ' C' ' 94' ' ' MET . 17.8 mt -116.19 137.57 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.585 0.754 . . . . 74.14 109.74 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.538 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -151.28 170.51 19.33 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.199 0.6 . . . . 74.2 110.639 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.34 -49.12 1.51 Allowed Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.98 -0.555 . . . . 73.02 113.371 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.637 HG21 ' HE3' ' C' ' 9' ' ' MET . 42.7 pt -91.06 171.28 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.621 0 C-N-CA 123.445 0.698 . . . . 74.34 112.635 -167.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -157.97 157.47 33.1 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.751 -1.113 . . . . 41.13 109.508 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.66 -131.16 21.25 Favored Glycine 0 C--N 1.348 1.241 0 O-C-N 123.412 0.445 . . . . 73.32 113.805 172.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.8 p -60.46 -35.21 75.33 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.27 1.028 . . . . 61.13 111.789 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 -57.72 -57.47 12.61 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.857 0.863 . . . . 64.1 110.607 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.612 ' HE3' HG21 ' C' ' 86' ' ' ILE . 4.1 tpt -55.23 -50.17 70.13 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.067 0.947 . . . . 75.11 112.505 175.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.68 -33.88 74.76 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.114 0.566 . . . . 74.11 111.253 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -73.99 -36.55 64.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.974 0.51 . . . . 72.23 110.55 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.466 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 33.7 t -69.45 -33.56 73.12 Favored 'General case' 0 C--N 1.35 0.614 0 N-CA-C 109.734 -0.469 . . . . 75.12 109.734 -177.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 96.9 mt -85.78 -37.48 19.23 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.982 0.913 . . . . 65.2 111.896 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.87 3.92 45.56 Favored Glycine 0 N--CA 1.473 1.15 0 CA-C-O 119.525 -0.597 . . . . 53.2 114.58 -168.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.543 ' HA ' ' HB3' ' C' ' 133' ' ' PHE . . . -149.35 -54.46 0.17 Allowed 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.808 0.804 . . . . 63.42 112.045 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.466 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 51.3 t80 -66.6 -56.68 9.61 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.286 0.634 . . . . 75.43 112.111 -174.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 97.2 m -60.89 -47.26 96.14 Favored Pre-proline 0 CA--C 1.562 1.41 0 CA-C-O 118.787 -0.625 . . . . 74.13 112.42 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -54.54 -30.88 67.07 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 122.409 2.072 . . . . 74.22 114.318 172.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -70.72 -30.9 67.57 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.026 0.53 . . . . 54.52 111.114 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.407 HD12 HH12 ' A' ' 111' ' ' ARG . 44.5 mm -73.01 -35.3 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 109.62 -0.511 . . . . 71.5 109.62 175.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.538 HD21 ' HA3' ' C' ' 82' ' ' GLY . 94.7 mt -81.22 -30.97 34.06 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.971 0.908 . . . . 74.35 112.733 -175.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -55.92 -50.11 89.13 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 113.884 1.068 . . . . 74.41 113.884 -172.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.85 -36.25 95.14 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.251 1.968 . . . . 71.34 113.396 179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -70.05 -44.37 69.31 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.05 0.54 . . . . 64.23 111.356 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.48 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -66.7 -33.6 76.0 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.876 -0.602 . . . . 45.14 110.713 175.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -62.63 -51.49 67.09 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.925 1.29 . . . . 75.43 110.446 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -69.37 -29.36 67.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.95 0.5 . . . . 71.52 110.377 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.9 t -69.18 -37.68 78.29 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 122.75 0.42 . . . . 63.43 110.709 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.447 ' O ' HG23 ' C' ' 118' ' ' VAL . 98.6 mt -71.65 -47.39 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 122.931 0.492 . . . . 73.53 110.054 174.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.7 m -53.23 -42.44 66.39 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.532 1.133 . . . . 71.02 111.664 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.428 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.1 t -66.68 -38.94 87.82 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.425 -0.807 . . . . 74.12 109.538 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.541 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -66.2 -39.83 89.93 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.187 0.995 . . . . 73.33 111.778 178.404 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.447 HG23 ' O ' ' C' ' 114' ' ' ILE . 61.8 t -59.04 -42.79 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 N-CA-C 109.258 -0.645 . . . . 62.23 109.258 172.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.2 t -66.13 -38.67 88.72 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.816 -1.083 . . . . 74.03 112.248 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' C' ' 116' ' ' SER . 64.7 mtt-85 -69.58 -39.21 77.45 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.264 0.625 . . . . 71.42 110.19 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.45 3.71 84.0 Favored Glycine 0 C--N 1.351 1.361 0 CA-C-N 115.669 -0.696 . . . . 74.33 112.544 173.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 33.6 p 58.38 30.74 20.04 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.058 1.743 . . . . 72.43 113.068 171.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -81.94 154.58 70.27 Favored Pre-proline 0 C--O 1.242 0.684 0 CA-C-N 115.703 -0.681 . . . . 73.01 109.57 175.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.48 127.76 27.32 Favored 'Trans proline' 0 C--N 1.363 1.333 0 C-N-CA 122.093 1.862 . . . . 73.12 112.022 168.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.471 ' HG2' ' HB2' ' B' ' 125' ' ' GLN . 23.6 mm-40 -53.72 154.6 3.69 Favored 'General case' 0 C--O 1.248 0.981 0 O-C-N 124.623 1.202 . . . . 73.22 113.604 -170.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.424 HD13 HG21 ' F' ' 133' ' ' THR . 21.1 tp -147.76 86.38 1.59 Allowed 'General case' 0 C--O 1.239 0.526 0 CA-C-N 113.847 -1.524 . . . . 75.54 108.168 -172.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -91.97 108.63 20.07 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.787 -1.097 . . . . 70.14 108.692 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -67.81 137.99 55.79 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.513 0.725 . . . . 74.43 110.118 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.78 152.53 95.12 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 123.665 0.786 . . . . 51.25 111.106 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.518 ' HG3' HD12 ' A' ' 16' ' ' ILE . 52.1 Cg_exo -54.98 114.93 2.09 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.662 2.241 . . . . 74.54 112.272 172.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.54 ' HA ' ' HE1' ' F' ' 138' ' ' TYR . 5.0 p -98.14 125.95 51.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 123.103 0.561 . . . . 45.13 110.19 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -81.53 101.7 10.11 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.653 -0.869 . . . . 75.32 108.653 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.543 ' HB3' ' HA ' ' C' ' 100' ' ' ALA . 82.9 m-85 -67.3 -25.34 65.99 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.356 -0.838 . . . . 55.3 111.31 177.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -63.86 -36.5 84.12 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.324 0.649 . . . . 64.31 110.323 175.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.64 -42.1 95.69 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.647 0.779 . . . . 63.44 110.414 177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 71.0 mt -72.72 -27.09 61.84 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.839 -1.073 . . . . 72.24 110.873 178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -80.96 -24.0 38.39 Favored 'General case' 0 C--O 1.213 -0.864 0 C-N-CA 123.029 0.531 . . . . 65.44 110.699 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 93.1 mtp -78.7 -28.57 45.14 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 122.037 -0.414 . . . . 75.24 110.367 169.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -62.3 -33.99 75.71 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.963 1.305 . . . . 73.41 112.122 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -156.86 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.659 0 C-N-CA 123.06 0.544 . . . . 73.1 112.236 -172.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.435 ' HG ' ' H ' ' C' ' 143' ' ' GLN . 14.4 tp 65.79 156.32 0.09 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 124.757 1.223 . . . . 73.03 111.794 172.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -115.66 7.67 14.81 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.513 -0.742 . . . . 75.02 110.931 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . 0.435 ' H ' ' HG ' ' C' ' 141' ' ' LEU . 54.6 mt-30 -135.13 157.29 47.3 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.747 0.819 . . . . 73.21 110.448 -178.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -119.19 82.13 1.82 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.513 -0.921 . . . . 75.05 108.513 175.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -130.85 146.0 52.16 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.306 1.042 . . . . 61.4 109.446 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -160.12 48.44 0.39 Allowed Glycine 0 C--N 1.346 1.092 0 O-C-N 123.237 0.336 . . . . 60.54 112.927 -174.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -72.06 93.39 1.39 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 109.044 -0.725 . . . . 75.14 109.044 173.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -147.11 82.36 0.19 Allowed Glycine 0 C--N 1.341 0.815 0 N-CA-C 111.457 -0.657 . . . . 53.14 111.457 -175.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 9.9 t -112.89 135.54 53.54 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.24 0.616 . . . . 75.42 110.414 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -121.66 161.16 23.0 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.927 0.891 . . . . 61.44 110.115 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -84.62 137.14 33.45 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.728 0.811 . . . . 65.3 109.03 174.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -101.21 116.49 32.94 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.959 0.409 . . . . 74.13 110.594 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -124.93 109.61 13.21 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 107.934 -1.135 . . . . 74.23 107.934 169.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -69.51 158.53 35.03 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.608 0.363 . . . . 73.33 111.185 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.988 0 C-N-CA 123.634 0.773 . . . . 70.21 109.593 -174.475 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 109.822 -0.436 . . . . 75.03 109.822 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 12.6 m -90.9 -72.41 0.58 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.539 -0.911 . . . . 74.53 108.539 169.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.13 138.37 4.61 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.372 1.469 . . . . 64.12 107.634 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -163.87 77.85 0.39 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.005 0.431 . . . . 74.35 110.493 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -172.64 -64.29 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.782 0.833 . . . . 72.51 109.432 173.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -159.41 160.12 34.51 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.665 0.786 . . . . 72.42 110.0 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 32.8 m -67.43 100.71 0.87 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.572 0.749 . . . . 60.01 109.966 176.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -76.54 -163.85 0.36 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.389 0.675 . . . . 74.42 111.069 174.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.591 ' HG2' HG13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -31.5 123.17 0.26 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.51 1.524 . . . . 63.23 112.497 177.573 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 9.7 t -129.57 135.88 49.12 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.59 0.756 . . . . 74.33 109.03 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.419 ' HZ ' ' HG ' ' D' ' 102' ' ' CYS . 59.7 t80 -137.4 101.16 4.43 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.371 -1.344 . . . . 71.42 107.371 175.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -125.92 124.47 40.89 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.692 0.797 . . . . 72.21 109.104 -175.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.602 HD13 HG21 ' D' ' 105' ' ' ILE . 5.4 mt -84.18 137.42 20.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.786 -0.82 . . . . 60.21 108.786 177.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -97.02 -42.5 7.87 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 122.975 0.51 . . . . 72.03 110.461 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.42 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 40.8 ttt180 -174.23 142.77 0.83 Allowed 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.313 0.383 . . . . 71.33 111.383 -170.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.492 HD13 ' HG3' ' B' ' 130' ' ' PRO . 2.1 mp -115.55 137.75 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 105.882 -1.895 . . . . 72.43 105.882 174.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.42 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 19.0 p90 -161.54 137.0 7.64 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 123.609 0.568 . . . . 73.11 110.967 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.4 p -76.65 110.63 11.39 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.321 -0.854 . . . . 64.3 109.487 176.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -85.53 -9.81 56.86 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.496 -0.775 . . . . 71.32 109.712 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.636 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 17.4 t70 -169.11 143.43 3.01 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 124.896 1.278 . . . . 61.34 109.733 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.541 HG21 ' HE2' ' C' ' 117' ' ' MET . 80.4 mt -147.4 144.71 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 125.266 1.427 . . . . 70.44 107.9 177.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.8 t -147.04 145.92 29.85 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.967 0.907 . . . . 73.1 109.249 170.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.54 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 81.1 t80 -149.87 118.55 6.57 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 106.963 -1.495 . . . . 71.52 106.963 169.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -123.54 140.27 53.17 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.479 -0.563 . . . . 74.23 109.479 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.68 82.39 60.97 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 107.813 -1.18 . . . . 75.54 107.813 174.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.8 -29.24 42.51 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.924 2.416 . . . . 73.54 113.008 -170.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.41 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 38.0 m-80 -108.66 8.86 27.17 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-O 118.479 -0.772 . . . . 70.43 110.852 -177.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.426 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -20.05 -73.17 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 116.63 2.085 . . . . 60.1 116.63 -166.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.437 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 92.2 Cg_endo -75.5 -21.66 14.72 Favored 'Trans proline' 0 C--N 1.386 2.552 0 CA-C-N 124.056 2.484 . . . . 60.15 114.117 -176.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.435 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 5.6 t-160 -74.46 -37.93 63.08 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.257 1.023 . . . . 72.31 110.25 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.651 HG22 HD12 ' D' ' 68' ' ' LEU . 11.0 p -82.04 -20.51 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 115.953 -0.567 . . . . 62.42 111.506 -174.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.437 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 23.0 m-85 -63.75 -28.67 70.04 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 120.801 0.334 . . . . 72.44 111.819 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.435 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 60.8 mt-30 -58.41 -22.27 53.48 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.71 1.204 . . . . 73.5 111.241 177.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -90.22 69.42 7.14 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.994 1.318 . . . . 73.52 110.2 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -78.73 85.45 4.74 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.411 -0.813 . . . . 61.22 110.67 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 10.2 p90 -154.07 -173.21 4.49 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.453 0.701 . . . . 63.21 109.902 172.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -63.27 112.4 6.91 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.377 1.071 . . . . 64.51 110.772 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -60.76 120.25 7.87 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.066 1.844 . . . . 75.1 110.805 172.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -67.63 104.32 1.58 Allowed 'General case' 0 C--N 1.35 0.592 0 N-CA-C 106.417 -1.697 . . . . 74.01 106.417 169.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.586 HG13 HG13 ' D' ' 64' ' ' VAL . 71.3 t -103.05 115.31 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 N-CA-C 108.792 -0.818 . . . . 74.13 108.792 -174.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -96.98 110.25 22.83 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 105.783 -1.932 . . . . 75.52 105.783 176.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.475 HD11 HG13 ' D' ' 62' ' ' VAL . 63.4 tp -94.37 138.5 32.26 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 107.418 -1.327 . . . . 74.3 107.418 175.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -141.75 147.92 38.15 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.528 -1.286 . . . . 71.44 107.528 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.42 ' CD2' HG22 ' D' ' 62' ' ' VAL . 73.7 mt -131.0 136.06 48.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.548 0.689 . . . . 74.53 110.874 -173.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 11.6 t70 -133.03 129.17 37.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 113.977 -1.465 . . . . 53.31 107.692 177.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . 0.52 HG23 HD22 ' E' ' 111' ' ' LEU . 2.6 p -106.94 150.78 26.1 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.546 0.689 . . . . 65.01 110.094 174.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.87 166.57 29.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.233 -1.349 . . . . 51.13 107.86 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.8 p -153.52 -165.61 2.19 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.633 -0.506 . . . . 62.41 109.633 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.8 m -144.74 149.68 35.96 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.98 -0.748 . . . . 50.51 108.98 -172.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -71.65 -170.23 0.52 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.654 -0.703 . . . . 74.34 110.631 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 tm? 69.52 83.43 0.15 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 107.735 -1.209 . . . . 74.54 107.735 -165.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -95.6 92.27 6.54 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 114.478 -1.237 . . . . 63.12 109.395 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -164.05 75.3 0.32 Allowed 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.799 -0.815 . . . . 74.53 108.799 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 64.88 -2.62 0.67 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 125.255 1.422 . . . . 70.13 113.811 173.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 45.8 t -128.57 100.94 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 107.484 -1.302 . . . . 71.31 107.484 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -122.18 127.81 50.47 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.946 -0.761 . . . . 61.14 108.946 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -87.91 114.88 24.95 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 108.158 -1.053 . . . . 71.02 108.158 169.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 95.4 t -100.35 134.91 38.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 107.286 -1.376 . . . . 72.54 107.286 171.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 49.1 t -128.9 126.79 65.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.687 -1.227 . . . . 74.41 107.687 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.522 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -114.52 103.93 11.51 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.505 -1.294 . . . . 74.4 107.505 -176.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.677 HH21 ' HE1' ' E' ' 106' ' ' TYR . 41.1 ttm-85 -83.35 103.14 12.5 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.579 -0.897 . . . . 65.41 108.579 173.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.475 HG13 HD11 ' D' ' 42' ' ' LEU . 66.4 t -97.32 121.83 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.027 -0.731 . . . . 74.14 109.027 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 56.8 m -119.4 133.44 55.71 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.005 0.922 . . . . 70.43 109.106 -172.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.586 HG13 HG13 ' D' ' 40' ' ' VAL . 75.4 t -125.81 132.44 70.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 124.226 1.01 . . . . 54.33 108.788 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 26.7 m -127.93 93.14 3.61 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.676 -1.602 . . . . 72.0 106.676 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.83 147.24 24.62 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.704 -0.85 . . . . 71.0 108.704 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.551 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 32.5 p -149.56 133.94 17.44 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.208 0.528 . . . . 74.24 111.505 -173.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.651 HD12 HG22 ' D' ' 31' ' ' VAL . 79.4 mt -104.17 102.62 12.35 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.923 -1.035 . . . . 65.52 108.283 170.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.03 -128.96 17.49 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 115.764 -0.653 . . . . 63.31 113.154 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -84.56 3.08 38.32 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.931 0.892 . . . . 61.42 113.022 -174.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -137.0 154.92 50.28 Favored 'General case' 0 C--O 1.246 0.884 0 CA-C-O 121.115 0.483 . . . . 74.23 110.871 -173.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.0 m -69.18 126.56 30.17 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.583 -1.189 . . . . 73.43 111.072 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.577 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -75.65 -64.78 1.0 Allowed 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.624 -1.25 . . . . 71.51 107.624 173.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -153.24 141.84 20.88 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.266 -0.879 . . . . 75.12 111.152 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 65.9 mt -101.11 153.58 19.46 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.284 1.034 . . . . 60.43 108.771 167.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.716 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.8 t -156.82 142.19 17.42 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.123 0.569 . . . . 54.14 109.496 176.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -155.37 122.22 5.39 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.213 -0.292 . . . . 65.34 110.213 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.6 t -126.0 115.11 41.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 124.066 0.947 . . . . 72.41 109.338 -176.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.636 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.6 mt-30 -88.72 87.64 7.32 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.6 -0.889 . . . . 75.33 108.6 171.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -83.39 100.84 10.94 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.483 -1.235 . . . . 74.44 109.083 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.37 149.01 17.74 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 112.327 -0.309 . . . . 70.3 112.327 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.37 142.97 10.49 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.77 -0.532 . . . . 52.3 111.77 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.0 mt -89.29 117.01 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 108.099 -1.074 . . . . 65.42 108.099 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.24 127.78 55.71 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.701 0.8 . . . . 74.24 110.548 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 33.6 t -84.87 122.79 29.67 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.275 -1.009 . . . . 61.12 108.275 166.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.474 HD12 ' HB2' ' D' ' 97' ' ' CYS . 3.0 tt -143.67 125.78 11.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 108.565 -0.902 . . . . 44.32 108.565 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.406 ' HB1' ' HA3' ' E' ' 96' ' ' GLY . . . -167.06 167.99 14.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.784 0.834 . . . . 51.43 110.458 -174.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.525 ' H ' ' HA3' ' E' ' 96' ' ' GLY . . . 86.56 21.13 52.43 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.447 0.467 . . . . 74.35 114.01 173.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.591 HG13 ' HG2' ' D' ' 9' ' ' MET . 0.4 OUTLIER -131.64 171.54 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.045 0.938 . . . . 70.42 108.975 177.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' B' ' 150' ' ' GLU . 7.2 tm-20 -147.62 179.92 7.34 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.645 -0.872 . . . . 62.01 108.645 -175.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' B' ' 153' ' ' GLN . . . 73.85 -136.66 22.11 Favored Glycine 0 C--N 1.347 1.16 0 C-N-CA 122.992 0.329 . . . . 74.03 112.875 172.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.6 m -91.91 -36.76 13.28 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.126 0.571 . . . . 63.21 111.242 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -65.65 -19.63 65.98 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.185 0.594 . . . . 65.15 112.46 -171.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.422 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 0.0 OUTLIER -64.51 -36.99 86.0 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.951 0.5 . . . . 74.11 112.247 179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . 0.422 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.11 -14.88 45.74 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.267 0.627 . . . . 64.23 111.851 178.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -63.96 -38.84 92.57 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.52 0.728 . . . . 64.34 112.282 -176.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . 0.474 ' HB2' HD12 ' D' ' 86' ' ' ILE . 69.1 m -65.43 -49.58 68.65 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.476 0.31 . . . . 74.35 111.629 -177.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.684 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 3.6 pp -67.47 -22.16 65.49 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.05 0.389 . . . . 70.22 112.05 -176.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.93 -29.33 11.84 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-O 119.881 -0.399 . . . . 72.43 113.593 -178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.0 -52.89 2.3 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 117.309 0.555 . . . . 32.24 111.838 -173.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -73.71 -39.57 64.23 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 112.103 0.408 . . . . 74.41 112.103 -173.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.684 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 89.1 m -65.31 -46.76 71.31 Favored Pre-proline 0 CA--C 1.556 1.189 0 CA-C-O 118.728 -0.653 . . . . 54.21 111.692 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.522 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 50.1 Cg_exo -58.71 -35.12 99.1 Favored 'Trans proline' 0 C--N 1.389 2.692 0 C-N-CA 121.653 1.569 . . . . 52.31 112.777 168.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.47 -31.73 73.06 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.346 0.658 . . . . 71.34 111.394 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.602 HG21 HD13 ' D' ' 13' ' ' ILE . 36.5 mm -69.78 -43.67 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.533 0.733 . . . . 74.12 110.223 172.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 74.6 mt -72.81 -19.74 61.28 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.26 -0.882 . . . . 72.24 111.699 -175.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -66.32 -45.42 60.08 Favored Pre-proline 0 CA--C 1.556 1.175 0 N-CA-C 113.498 0.925 . . . . 72.12 113.498 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -49.27 -41.02 43.17 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.443 2.095 . . . . 70.11 113.86 170.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -78.97 -33.23 45.37 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.458 0.703 . . . . 70.01 112.102 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.91 -44.27 73.51 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.523 0.677 . . . . 70.45 109.506 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.437 ' NH2' HG23 ' B' ' 105' ' ' ILE . 46.5 ttp180 -66.42 -37.29 84.87 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 114.005 -1.452 . . . . 70.5 110.172 175.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . 0.428 ' HA ' ' CE2' ' B' ' 109' ' ' TYR . 8.7 tt0 -52.29 -46.86 66.08 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.732 0.813 . . . . 73.41 111.148 176.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.8 t -66.72 -47.77 71.27 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.775 -1.102 . . . . 64.25 110.71 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.716 HG12 ' SG ' ' D' ' 76' ' ' CYS . 42.6 mt -60.29 -62.77 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.978 0.511 . . . . 53.42 110.363 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 98.3 m -41.68 -46.32 3.71 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 125.709 1.603 . . . . 63.23 112.799 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 22.9 t -68.48 -45.17 73.08 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.192 -0.913 . . . . 74.13 110.67 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.1 mtm -67.44 -34.3 76.93 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.802 0.441 . . . . 71.33 111.589 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.484 HG23 ' O ' ' D' ' 114' ' ' ILE . 84.9 t -60.54 -46.81 94.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 123.797 0.839 . . . . 71.33 110.082 176.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.0 p -70.45 -28.5 65.07 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 115.785 -0.643 . . . . 71.13 110.705 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' D' ' 116' ' ' SER . 72.6 mtt-85 -71.89 -22.92 61.43 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.531 0.733 . . . . 75.22 111.251 176.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.52 12.71 68.56 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-O 119.564 -0.576 . . . . 45.23 112.709 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.638 HG23 ' HB3' ' C' ' 17' ' ' TYR . 72.6 p 60.03 11.87 2.89 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 126.735 2.014 . . . . 61.11 113.391 -174.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -81.51 149.38 64.7 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.776 -0.453 . . . . 75.33 109.776 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -48.22 120.06 4.61 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 123.095 2.53 . . . . 54.11 113.03 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.479 ' O ' ' HA ' ' E' ' 127' ' ' SER . 25.2 tt0 -42.23 119.73 1.44 Allowed 'General case' 0 C--N 1.364 1.237 0 O-C-N 124.875 1.359 . . . . 72.13 111.402 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.484 HD13 HG21 ' D' ' 40' ' ' VAL . 29.8 tp -106.48 99.61 9.18 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.309 0.644 . . . . 60.42 109.51 -171.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -97.82 97.9 9.37 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 107.449 -1.315 . . . . 65.14 107.449 174.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.4 HD11 HD12 ' D' ' 114' ' ' ILE . 38.8 mt -59.59 137.14 58.12 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-N 115.133 -0.939 . . . . 73.42 109.995 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.49 148.49 73.66 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 123.541 0.736 . . . . 72.3 111.184 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.473 ' HG3' ' CD2' ' B' ' 11' ' ' PHE . 32.0 Cg_endo -60.47 122.95 12.09 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.647 2.231 . . . . 74.42 111.298 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . 0.424 ' HA ' ' HE1' ' E' ' 120' ' ' TYR . 99.9 t -108.08 115.26 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.395 -0.366 . . . . 75.32 110.631 -175.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -83.64 96.55 8.71 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 107.745 -1.206 . . . . 55.01 107.745 167.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.482 ' HA ' HD13 ' D' ' 136' ' ' LEU . 28.5 m-85 -59.39 -26.86 65.47 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.047 0.939 . . . . 45.22 112.109 -174.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -49.5 -49.14 47.05 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 125.015 1.326 . . . . 72.4 111.13 172.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.2 -32.3 73.82 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 114.92 -1.036 . . . . 75.45 112.009 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' D' ' 133' ' ' PHE . 6.7 mp -72.05 -31.09 65.8 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 117.986 0.357 . . . . 73.11 111.108 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -78.36 -45.97 21.17 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.769 0.428 . . . . 75.33 110.684 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 79.9 mtm -67.0 -39.18 87.06 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.312 0.645 . . . . 51.32 111.464 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.546 ' O ' ' HB2' ' D' ' 143' ' ' GLN . 6.2 m-20 -61.5 -39.26 90.33 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.888 0.475 . . . . 73.41 110.862 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -54.87 -29.53 55.68 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.309 0.644 . . . . 73.41 111.623 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.8 mp -83.0 -50.48 8.5 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.097 0.559 . . . . 73.42 111.067 173.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.537 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 10.7 pt20 -90.88 18.22 6.86 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 113.672 0.99 . . . . 62.52 113.672 -171.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . 0.546 ' HB2' ' O ' ' D' ' 139' ' ' ASN . 1.1 tm0? -121.31 91.19 3.47 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.955 -0.758 . . . . 71.03 108.955 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -145.32 -57.87 0.33 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.953 0.901 . . . . 61.43 109.296 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.53 125.88 18.8 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.449 0.7 . . . . 74.11 110.513 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.69 74.69 1.27 Allowed Glycine 0 C--N 1.345 1.048 0 N-CA-C 111.323 -0.711 . . . . 71.32 111.323 -175.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -73.51 88.21 1.63 Allowed 'General case' 0 CA--C 1.549 0.913 0 CA-C-O 121.744 0.783 . . . . 64.53 110.754 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 75.87 153.02 4.17 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.227 -0.897 . . . . 64.52 112.805 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 91.1 m -146.61 118.6 8.21 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.114 0.566 . . . . 71.12 109.705 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.27 100.75 3.81 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.758 0.789 . . . . 72.11 109.169 175.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.66 112.03 6.66 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.839 -1.171 . . . . 73.23 107.839 -176.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -158.0 33.32 0.25 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.53 0.732 . . . . 75.45 110.195 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -148.79 114.82 5.76 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.515 0.726 . . . . 73.34 109.412 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -86.22 169.41 13.06 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.105 0.562 . . . . 54.1 111.146 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.847 0 N-CA-C 108.299 -1.0 . . . . 37.81 108.299 179.146 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.869 0 CA-C-O 119.455 -0.636 . . . . 23.02 111.835 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.52 -65.04 2.48 Favored Glycine 0 C--N 1.356 1.684 0 N-CA-C 111.201 -0.759 . . . . 45.12 111.201 -173.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -73.02 175.15 6.92 Favored 'General case' 0 C--O 1.249 1.03 0 C-N-CA 124.778 1.231 . . . . 72.24 109.293 166.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -66.19 117.74 8.92 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.594 -0.521 . . . . 73.22 109.594 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.08 101.41 7.85 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.048 -0.723 . . . . 63.23 109.048 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 96' ' ' GLY . . . . . 0.525 ' HA3' ' H ' ' D' ' 88' ' ' GLY . . . -125.38 -46.04 0.24 Allowed Glycine 0 C--N 1.342 0.905 0 CA-C-N 115.38 -0.827 . . . . 31.24 112.389 177.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 97' ' ' ILE . . . . . . . . . . . . . 40.7 pt -133.99 154.12 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-O 121.885 0.85 . . . . 73.03 112.389 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -162.74 -41.43 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 113.939 -1.482 . . . . 72.12 109.008 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -81.26 91.38 6.19 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 123.48 0.712 . . . . 75.01 109.99 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pp -143.13 142.44 21.73 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 123.352 0.661 . . . . 72.14 110.539 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -64.35 -26.94 63.31 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 122.811 2.341 . . . . 74.2 112.932 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 102' ' ' LEU . . . . . 0.493 ' HG ' ' H ' ' E' ' 104' ' ' GLY . 34.5 tp 70.34 168.9 0.31 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.448 1.099 . . . . 71.44 110.019 -176.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 29.3 p -78.77 -25.55 44.4 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.714 -0.616 . . . . 75.41 110.678 174.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 104' ' ' GLY . . . . . 0.493 ' H ' ' HG ' ' E' ' 102' ' ' LEU . . . 138.91 161.96 8.95 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 110.618 -0.993 . . . . 74.22 110.618 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -61.14 -37.94 84.63 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-O 121.392 0.615 . . . . 74.42 110.312 176.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 106' ' ' TYR . . . . . 0.677 ' HE1' HH21 ' D' ' 61' ' ' ARG . 48.6 t80 -132.53 9.01 4.28 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-N 114.766 -1.107 . . . . 73.42 110.083 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 35.0 m 69.57 160.79 0.2 Allowed 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 125.039 1.336 . . . . 62.41 111.652 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -150.75 40.22 0.73 Allowed 'General case' 0 CA--C 1.559 1.306 0 CA-C-O 122.426 1.108 . . . . 53.45 109.306 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -125.26 -170.88 2.25 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.982 0.913 . . . . 73.4 110.274 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.39 56.47 3.27 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.691 0.757 . . . . 73.22 111.031 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . 0.52 HD22 HG23 ' D' ' 46' ' ' THR . 1.6 tt -172.37 53.77 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 105.167 -2.16 . . . . 63.51 105.167 -177.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -167.79 160.82 12.82 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 113.842 -1.526 . . . . 63.44 109.131 -164.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 53.7 tttm 75.49 141.78 0.07 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.674 1.19 . . . . 64.23 111.019 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -58.7 -23.43 59.58 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 113.469 0.915 . . . . 75.43 113.469 -173.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 3.3 t -144.34 78.36 1.57 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 122.095 0.95 . . . . 63.14 109.266 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . -79.07 169.49 54.09 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-N 114.728 -1.124 . . . . 62.34 112.499 173.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -76.0 127.49 85.16 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 123.681 0.793 . . . . 73.52 110.424 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.78 117.01 4.73 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.667 2.245 . . . . 74.14 111.064 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -133.78 -72.04 0.5 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.813 -0.63 . . . . 64.22 109.779 -172.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 120' ' ' TYR . . . . . 0.424 ' HE1' ' HA ' ' D' ' 131' ' ' VAL . 71.8 t80 -77.41 -57.52 3.78 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.867 -0.79 . . . . 72.23 108.867 172.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 121' ' ' VAL . . . . . . . . . . . . . 17.8 m -79.36 120.82 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-N 115.179 -0.919 . . . . 71.44 109.723 175.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 3.8 m -108.8 174.0 6.07 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 108.473 -0.936 . . . . 70.35 108.473 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 123' ' ' ASP . . . . . 0.472 ' HA ' ' O ' ' D' ' 40' ' ' VAL . 6.8 p-10 -76.86 -174.24 2.99 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.596 0.358 . . . . 74.24 110.875 175.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 32.7 t 62.17 35.76 15.42 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.632 0.773 . . . . 64.33 110.982 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.84 156.2 21.27 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.268 0.627 . . . . 65.45 110.95 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -60.5 88.73 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.035 0.934 . . . . 73.32 112.047 -169.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 127' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' D' ' 125' ' ' GLN . 7.4 p -113.22 88.8 2.92 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.47 0.708 . . . . 62.14 110.445 176.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.53 -173.76 3.88 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.539 1.136 . . . . 71.31 109.865 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 27.4 m 81.01 138.88 0.07 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 125.037 1.335 . . . . 72.33 111.32 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 130' ' ' ALA . . . . . 0.567 ' HB3' ' HG3' ' A' ' 124' ' ' PRO . . . -93.33 168.13 11.28 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.349 0.659 . . . . 62.15 110.296 177.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 131' ' ' TRP . . . . . 0.409 ' O ' ' HB3' ' A' ' 124' ' ' PRO . 18.7 t90 -73.68 170.43 15.25 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 124.248 1.019 . . . . 73.24 110.481 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 43.0 p -48.49 127.64 13.54 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.747 1.219 . . . . 74.44 112.942 -173.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 15.4 t -76.65 167.42 21.87 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.871 0.869 . . . . 74.12 111.178 -177.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.15 134.02 36.67 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-N 115.788 -0.642 . . . . 54.42 112.872 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 91.9 t -79.1 77.6 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 C-N-CA 124.053 0.941 . . . . 65.45 109.952 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -86.88 -32.96 19.94 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.099 -0.955 . . . . 74.03 109.841 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 25.9 m 69.28 -81.41 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.796 1.238 . . . . 63.42 111.68 170.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 138' ' ' TYR . . . . . 0.529 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 39.6 p90 -140.86 -17.93 0.84 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.969 0.507 . . . . 73.32 111.837 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -74.95 84.62 2.24 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.021 0.528 . . . . 72.51 109.912 -173.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.53 -160.11 11.8 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.087 -0.961 . . . . 72.22 112.355 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -88.28 173.73 8.6 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.052 0.941 . . . . 51.13 112.019 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 42.7 tp -92.53 160.53 15.0 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.567 -1.197 . . . . 72.44 109.339 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -74.08 73.64 1.27 Allowed Glycine 0 C--N 1.352 1.456 0 O-C-N 123.291 0.37 . . . . 74.3 112.326 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.46 136.85 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.655 1.182 . . . . 74.12 109.518 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 34.8 t70 . . . . . 0 C--O 1.248 0.974 0 C-N-CA 123.384 0.674 . . . . 64.41 109.293 178.308 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.426 0 N-CA-C 111.648 -0.581 . . . . 35.54 111.648 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.92 -178.26 17.38 Favored Glycine 0 C--N 1.346 1.132 0 O-C-N 123.802 0.354 . . . . 43.25 113.725 175.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 59.96 70.31 0.64 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.246 1.018 . . . . 75.55 110.551 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -87.37 -169.46 2.62 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.919 -1.037 . . . . 74.4 109.907 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.44 32.87 1.07 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.238 0.615 . . . . 74.21 110.813 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -87.19 -47.47 4.68 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 115.406 -0.816 . . . . 73.14 112.431 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 97' ' ' ILE . . . . . 0.688 HG23 ' SD ' ' B' ' 94' ' ' MET . 55.3 mt -70.37 -45.04 76.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 123.979 0.912 . . . . 64.21 110.297 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 23.1 t70 71.42 -72.91 0.1 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.507 1.523 . . . . 74.43 111.019 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -91.4 108.64 20.03 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.904 0.882 . . . . 65.13 109.917 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 100' ' ' LEU . . . . . 0.491 HD13 HG21 ' F' ' 97' ' ' ILE . 30.5 tp -138.73 66.37 41.25 Favored Pre-proline 0 N--CA 1.488 1.446 0 C-N-CA 122.779 0.431 . . . . 74.1 111.727 -177.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.49 -34.21 3.59 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.41 2.073 . . . . 64.44 112.091 173.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 102' ' ' LEU . . . . . 0.591 HD23 ' HB1' ' B' ' 95' ' ' ALA . 1.8 tm? 53.19 74.57 0.29 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.66 1.184 . . . . 70.24 108.996 -169.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 103' ' ' THR . . . . . 0.619 HG21 ' HB2' ' F' ' 109' ' ' TYR . 56.6 p 52.29 28.74 5.94 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 125.797 1.639 . . . . 64.32 113.05 176.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.7 -149.09 19.22 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-N 115.594 -0.73 . . . . 72.11 112.953 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -88.15 32.12 0.77 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.953 0.901 . . . . 74.15 110.284 -177.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -172.05 150.04 2.46 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.54 -0.911 . . . . 72.23 108.54 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . 0.486 ' HB ' HG23 ' B' ' 46' ' ' THR . 15.7 m -79.87 103.05 9.5 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 109.227 -0.657 . . . . 74.45 109.227 174.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -114.95 30.43 7.36 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.546 1.139 . . . . 74.04 109.343 -175.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 109' ' ' TYR . . . . . 0.619 ' HB2' HG21 ' F' ' 103' ' ' THR . 7.4 t80 -137.88 112.93 9.14 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.835 0.454 . . . . 74.11 109.883 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 62.15 -173.79 0.14 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.229 1.012 . . . . 65.45 111.612 -174.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 mp 66.29 134.94 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.111 0.965 . . . . 71.43 111.161 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 62.21 -147.85 0.38 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.081 -0.711 . . . . 71.22 109.081 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 69.62 -72.69 0.1 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.154 1.381 . . . . 64.41 110.214 177.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -71.62 133.12 45.5 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.614 -0.884 . . . . 73.41 108.614 169.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 9.7 t -60.76 120.71 10.63 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 121.193 0.521 . . . . 72.32 110.042 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . -138.6 115.15 1.12 Allowed Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.75 -0.94 . . . . 63.32 110.75 -175.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 117' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' F' ' 121' ' ' VAL . 0.5 OUTLIER -68.99 165.41 38.27 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 123.536 0.735 . . . . 63.1 109.936 -178.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -58.27 -168.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 122.098 1.865 . . . . 54.22 113.766 173.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 119' ' ' ASP . . . . . 0.571 ' HB2' ' HA ' ' F' ' 125' ' ' ALA . 8.8 t70 79.18 -78.25 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.812 1.645 . . . . 72.3 110.855 -177.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -139.85 24.51 2.39 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 122.868 0.467 . . . . 72.42 110.895 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 121' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' F' ' 117' ' ' LYS . 21.9 t 61.73 30.91 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 CA-C-O 122.832 1.301 . . . . 74.51 110.039 178.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 25.6 p -103.92 -88.15 0.42 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.816 -1.083 . . . . 73.44 110.428 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -163.39 -57.85 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.098 0.559 . . . . 73.31 109.94 -175.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 14.6 m -79.05 130.92 36.03 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.326 -0.852 . . . . 52.12 109.582 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . 0.571 ' HA ' ' HB2' ' F' ' 119' ' ' ASP . . . -135.01 135.93 41.75 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 122.847 0.459 . . . . 75.35 111.377 -177.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -86.8 140.86 29.29 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.596 0.758 . . . . 73.43 110.239 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 47.7 t -148.77 -73.9 0.18 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.146 0.579 . . . . 74.31 110.574 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . 63.05 -175.24 0.15 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.193 0.997 . . . . 60.15 111.737 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 3.4 t -126.78 84.61 2.28 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.229 1.014 . . . . 72.11 109.054 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 130' ' ' ALA . . . . . 0.533 ' HB3' ' HB3' ' B' ' 125' ' ' GLN . . . -84.97 73.87 10.61 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.112 -0.949 . . . . 62.11 110.006 -178.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 131' ' ' TRP . . . . . 0.552 ' HB3' ' HA ' ' B' ' 124' ' ' PRO . 82.5 t90 175.07 114.11 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.538 1.535 . . . . 74.42 107.965 173.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 7.6 t -166.97 32.97 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.406 -0.961 . . . . 70.33 108.406 172.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 133' ' ' THR . . . . . 0.424 HG21 HD13 ' C' ' 126' ' ' LEU . 1.5 m -72.98 125.0 26.58 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.954 -1.021 . . . . 65.22 110.505 -174.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -83.92 56.34 5.04 Favored Glycine 0 C--N 1.348 1.246 0 N-CA-C 112.128 -0.389 . . . . 70.24 112.128 175.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 3.9 p -91.43 91.3 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 124.061 0.944 . . . . 54.54 110.04 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -158.86 85.76 0.83 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.435 -0.802 . . . . 75.13 110.079 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 30.6 m -109.54 -71.6 0.76 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.566 -0.902 . . . . 75.33 108.566 172.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 138' ' ' TYR . . . . . 0.54 ' HE1' ' HA ' ' C' ' 131' ' ' VAL . 10.0 t80 60.83 -165.38 0.22 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.2 1.0 . . . . 72.22 111.114 175.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -68.42 -26.76 65.69 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.181 0.592 . . . . 71.41 110.496 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -172.31 -59.98 0.04 OUTLIER Glycine 0 C--N 1.346 1.095 0 CA-C-N 115.958 -0.565 . . . . 74.12 111.736 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.26 92.9 0.05 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.822 1.249 . . . . 73.54 112.502 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 60.9 tp -90.89 103.69 16.37 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.519 0.728 . . . . 73.31 110.146 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -179.87 141.98 4.93 Favored Glycine 0 C--N 1.343 0.937 0 C-N-CA 121.588 -0.339 . . . . 64.24 112.476 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 9.2 p -154.57 145.34 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.714 0.806 . . . . 61.42 109.647 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 29.8 t70 . . . . . 0 C--O 1.249 1.06 0 C-N-CA 123.324 0.65 . . . . 74.51 109.396 176.305 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 108.607 -0.886 . . . . 61.52 108.607 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -159.66 156.57 28.07 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 122.87 0.468 . . . . 74.43 110.396 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -83.95 139.31 32.66 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.012 0.925 . . . . 74.11 109.627 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -69.62 -95.62 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.31 1.044 . . . . 71.23 110.798 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.8 t30 170.94 53.92 0.0 OUTLIER 'General case' 0 C--N 1.366 1.3 0 C-N-CA 124.888 1.275 . . . . 54.31 108.205 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -148.12 -84.39 0.1 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 109.605 -0.517 . . . . 74.51 109.605 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.6 m -157.02 85.03 0.94 Allowed 'General case' 0 C--O 1.242 0.686 0 N-CA-C 107.36 -1.348 . . . . 74.32 107.36 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -93.36 144.22 25.54 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.131 -0.941 . . . . 60.13 109.512 -178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.434 ' N ' ' SD ' ' A' ' 9' ' ' MET . 1.3 mpt? -80.47 172.23 14.03 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.743 0.817 . . . . 74.4 110.661 -175.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 84.6 m -140.66 118.44 11.72 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.261 0.624 . . . . 74.14 110.486 -174.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.807 ' HE1' ' HG ' ' A' ' 102' ' ' CYS . 72.6 t80 -120.62 124.87 46.3 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.767 -1.197 . . . . 62.04 107.767 172.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -132.23 132.72 43.36 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.284 -0.635 . . . . 75.2 109.284 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.471 HG21 ' HG2' ' C' ' 130' ' ' PRO . 69.4 mt -89.69 109.63 20.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.158 -1.053 . . . . 64.02 108.158 171.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.63 -40.66 17.19 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 109.048 -0.723 . . . . 72.23 109.048 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 -168.88 122.28 0.82 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.64 0.376 . . . . 63.41 110.283 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 83.7 mt -107.07 136.71 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.776 -0.824 . . . . 74.4 108.776 170.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.454 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 22.1 p90 -164.92 169.51 16.4 Favored 'General case' 0 C--N 1.347 0.47 0 O-C-N 123.822 0.701 . . . . 52.33 111.699 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -94.47 120.6 34.96 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.116 -0.698 . . . . 70.41 109.116 172.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.454 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 34.8 mtpt -78.9 -34.88 44.35 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.164 0.507 . . . . 70.2 109.673 175.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 17.8 t70 -150.01 140.47 22.41 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.646 -1.161 . . . . 64.22 109.865 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.4 mt -130.92 139.69 50.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 124.873 1.269 . . . . 65.45 107.835 174.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -145.54 127.97 15.95 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.297 -1.001 . . . . 61.34 108.297 177.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.464 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 86.9 t80 -135.63 129.49 32.91 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.112 -1.44 . . . . 74.01 107.112 171.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -129.59 135.95 49.2 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.165 -0.679 . . . . 72.44 109.165 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.31 76.93 71.66 Favored Pre-proline 0 C--O 1.24 0.553 0 N-CA-C 105.817 -1.919 . . . . 72.15 105.817 167.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.67 -22.92 36.91 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.591 2.194 . . . . 53.45 112.027 -171.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -110.12 22.3 15.74 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.233 1.013 . . . . 65.51 109.447 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.478 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -46.88 -52.79 30.47 Favored Pre-proline 0 CA--C 1.568 1.654 0 CA-C-O 117.846 -1.073 . . . . 75.02 113.658 -171.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.57 -23.22 64.31 Favored 'Trans proline' 0 C--N 1.391 2.778 0 CA-C-N 121.536 1.584 . . . . 64.03 113.374 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -84.12 -39.69 19.17 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.675 0.79 . . . . 74.51 111.017 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.893 HG21 ' HA ' ' A' ' 73' ' ' ALA . 5.5 p -78.23 -23.56 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 CA-C-N 115.306 -0.861 . . . . 72.35 113.159 -157.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -70.06 -19.35 63.29 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 122.739 0.416 . . . . 74.43 110.874 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -86.81 -16.5 36.03 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.568 1.147 . . . . 74.31 110.772 177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -81.5 158.06 24.63 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.873 0.869 . . . . 72.31 111.884 -174.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -64.48 118.27 8.53 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 123.992 0.917 . . . . 72.13 109.413 173.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 49.9 t-105 -78.55 84.92 4.65 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.661 0.743 . . . . 75.14 109.91 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -122.85 76.09 48.44 Favored Pre-proline 0 C--O 1.243 0.745 0 N-CA-C 106.799 -1.556 . . . . 53.31 106.799 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.44 ' HB2' HG23 ' A' ' 40' ' ' VAL . 83.7 Cg_endo -78.47 115.1 3.61 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 121.817 1.678 . . . . 72.32 111.363 -171.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -93.31 81.59 4.45 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 105.554 -2.017 . . . . 70.23 105.554 172.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.44 HG23 ' HB2' ' A' ' 38' ' ' PRO . 46.0 t -86.05 93.74 3.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 CA-C-N 114.532 -1.213 . . . . 61.55 109.555 -174.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.72 118.82 21.88 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 113.953 -1.476 . . . . 53.51 108.384 174.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.7 mt -95.39 108.55 20.75 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.435 -1.32 . . . . 75.45 107.435 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -102.61 141.18 35.85 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.387 -0.968 . . . . 75.32 108.387 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.55 HD11 HG21 ' A' ' 131' ' ' VAL . 75.5 mt -135.39 131.41 36.28 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 109.498 -0.556 . . . . 72.41 109.498 -174.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -134.03 129.56 36.27 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.448 -1.316 . . . . 61.31 107.448 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.485 HG21 ' HA2' ' A' ' 99' ' ' GLY . 85.3 m -108.54 130.97 55.28 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.876 -0.787 . . . . 51.42 108.876 172.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.72 109.37 9.11 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.819 -0.808 . . . . 51.22 108.819 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.6 p -91.28 163.42 14.24 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.318 0.647 . . . . 74.31 110.098 176.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.9 t -160.39 154.14 22.6 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.28 1.432 . . . . 75.41 107.328 -166.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -116.29 125.41 52.12 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.681 -0.489 . . . . 70.12 109.681 171.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.7 mt -95.02 -32.99 12.89 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.21 0.604 . . . . 54.41 110.583 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.95 -179.5 7.2 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.192 0.597 . . . . 64.14 111.39 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -63.51 123.7 19.47 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 109.346 -0.613 . . . . 64.03 109.346 174.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 70.2 -8.53 0.84 Allowed 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 125.835 1.654 . . . . 64.4 112.886 -173.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.7 t -100.64 106.61 19.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-O 121.496 0.665 . . . . 73.43 109.301 -177.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -114.27 125.61 54.1 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.735 -1.209 . . . . 71.43 107.735 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -94.32 128.77 41.02 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.919 -0.771 . . . . 72.42 108.919 172.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.1 t -113.2 137.71 45.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.369 -0.974 . . . . 71.01 108.369 171.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.7 t -119.32 130.58 73.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.905 -0.776 . . . . 75.44 108.905 173.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.31 97.8 7.56 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 105.675 -1.972 . . . . 73.12 105.675 172.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -84.94 97.58 9.87 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.928 -1.138 . . . . 73.13 107.928 174.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 50.0 t -94.97 131.25 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 107.49 -1.3 . . . . 74.33 107.49 176.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.8 m -127.12 118.4 24.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.817 0.817 . . . . 74.24 110.203 175.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.597 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 91.5 t -104.33 125.49 59.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 124.56 1.144 . . . . 43.0 108.905 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.1 m -122.43 126.49 48.05 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.648 -0.871 . . . . 42.04 108.648 171.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.404 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -113.21 108.3 17.08 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 107.847 -1.168 . . . . 63.42 107.847 175.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.0 m -109.03 134.29 51.85 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.179 0.591 . . . . 72.21 110.037 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.4 mt -100.7 57.74 0.91 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.247 1.019 . . . . 62.41 108.341 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.46 -103.15 3.0 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 110.82 -0.912 . . . . 45.41 110.82 -169.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -96.59 -28.56 14.31 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.352 0.661 . . . . 73.45 111.428 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -102.74 123.07 45.74 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.471 0.308 . . . . 71.33 110.639 -173.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.6 m -71.5 138.42 48.92 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.514 0.726 . . . . 63.21 110.871 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.893 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -79.78 -60.06 2.49 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 124.317 1.047 . . . . 74.2 109.817 173.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -151.02 156.64 41.55 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 114.629 -1.169 . . . . 73.45 111.071 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 39.9 tp -126.82 115.05 18.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.633 1.173 . . . . 61.23 108.58 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.597 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 66.3 m -105.9 142.3 35.85 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.044 0.937 . . . . 72.32 109.339 175.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -146.44 121.35 9.98 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.644 -0.873 . . . . 53.32 108.644 166.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.4 t -126.09 109.81 22.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.703 -0.851 . . . . 73.52 108.703 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -85.78 82.01 8.36 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 114.379 -1.282 . . . . 72.33 108.443 174.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -76.23 95.55 3.74 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.828 -1.078 . . . . 61.14 109.164 -177.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.32 154.88 29.15 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 111.361 -0.696 . . . . 41.02 111.361 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.29 121.51 1.23 Allowed Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.682 -0.967 . . . . 30.3 110.682 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.4 mt -81.68 127.1 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 107.823 -1.177 . . . . 74.12 107.823 171.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.844 ' HB3' HD11 ' A' ' 86' ' ' ILE . 71.0 m-85 -135.71 125.15 24.95 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.095 0.958 . . . . 72.24 109.561 -171.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.1 m -94.65 97.95 10.46 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 109.216 -0.661 . . . . 73.42 109.216 175.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.844 HD11 ' HB3' ' A' ' 84' ' ' PHE . 6.0 mm -108.04 156.69 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.385 0.674 . . . . 62.11 110.679 -172.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.41 162.84 8.47 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.523 1.129 . . . . 74.23 110.909 176.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.21 -13.94 62.81 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-N 115.951 -0.568 . . . . 25.4 114.422 174.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.482 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -133.46 146.6 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.824 0.85 . . . . 41.53 110.736 -177.108 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -144.16 174.76 10.6 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.296 1.038 . . . . 64.41 109.735 174.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.99 -139.01 26.42 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 116.012 -0.54 . . . . 60.21 112.618 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.7 p -69.79 -16.61 63.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 117.105 0.453 . . . . 73.12 111.501 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' C' ' 154' ' ' ASP . 48.4 mt-30 -64.57 -45.71 85.88 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.254 0.621 . . . . 74.12 109.959 170.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.403 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 6.1 tpt -66.75 -43.79 83.2 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.103 -0.953 . . . . 63.35 109.662 -178.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.95 -31.16 72.25 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.601 -0.727 . . . . 63.3 111.125 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.441 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 57.8 t-80 -74.3 -30.3 62.01 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.667 0.787 . . . . 63.44 110.696 176.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 50.4 t -72.8 -44.54 61.38 Favored 'General case' 0 C--N 1.349 0.581 0 N-CA-C 109.115 -0.698 . . . . 60.01 109.115 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 94' ' ' MET . 35.9 mt -84.99 -24.72 28.14 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.389 -0.823 . . . . 72.13 112.019 -174.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.485 ' HA2' HG21 ' A' ' 46' ' ' THR . . . -108.01 4.45 33.89 Favored Glycine 0 C--N 1.344 0.989 0 CA-C-O 119.597 -0.557 . . . . 45.13 113.947 -174.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.562 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -147.52 -64.22 0.27 Allowed 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 117.667 0.734 . . . . 62.4 112.372 -177.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -68.16 -47.27 68.48 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 123.352 0.408 . . . . 74.35 111.697 -171.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.807 ' HG ' ' HE1' ' A' ' 11' ' ' PHE . 98.4 m -65.2 -45.83 71.87 Favored Pre-proline 0 CA--C 1.56 1.333 0 CA-C-O 117.987 -1.006 . . . . 70.0 112.316 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -54.26 -35.26 82.78 Favored 'Trans proline' 0 C--N 1.398 3.178 0 C-N-CA 122.188 1.925 . . . . 72.13 112.889 169.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -68.53 -34.25 75.54 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.531 0.732 . . . . 64.43 111.093 178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.5 mm -67.88 -43.23 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.49 0.716 . . . . 53.42 110.054 172.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 55.9 mt -75.19 -20.24 59.4 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.053 -0.976 . . . . 61.33 111.877 -174.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -65.63 -45.24 67.1 Favored Pre-proline 0 N--CA 1.478 0.93 0 CA-C-O 117.05 -1.452 . . . . 72.11 113.537 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -50.72 -34.11 42.8 Favored 'Trans proline' 0 C--N 1.39 2.715 0 CA-C-N 122.182 1.815 . . . . 44.51 113.592 171.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -85.69 -36.47 20.22 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.711 0.804 . . . . 72.21 112.054 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.42 -48.25 67.84 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.968 -0.752 . . . . 64.02 108.968 175.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.453 ' NH1' HD12 ' C' ' 105' ' ' ILE . 27.9 ttm180 -47.87 -58.48 4.32 Favored 'General case' 0 C--O 1.213 -0.82 0 O-C-N 125.203 1.565 . . . . 61.31 110.677 171.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -60.79 -45.35 94.74 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 124.321 1.013 . . . . 74.44 111.792 -173.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.416 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 47.4 t -58.74 -45.9 88.62 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.045 0.841 . . . . 71.34 110.498 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.505 HG21 HG21 ' A' ' 64' ' ' VAL . 83.3 mt -61.16 -51.44 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 124.27 0.982 . . . . 64.33 110.603 175.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 44.2 m -58.75 -37.11 75.5 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.36 1.064 . . . . 73.21 110.687 -173.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.1 t -70.59 -44.56 67.06 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.444 -1.253 . . . . 54.44 109.866 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.4 mtp -59.39 -38.62 81.0 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.658 0.783 . . . . 63.41 111.774 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 114' ' ' ILE . 79.3 t -67.27 -46.08 84.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.211 1.004 . . . . 70.02 110.073 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.9 p -71.88 -30.63 65.61 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 115.828 -0.624 . . . . 55.14 111.106 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.413 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 81.7 mtt-85 -72.22 -33.69 67.78 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.675 0.79 . . . . 75.31 109.432 172.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.61 -2.17 74.32 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 115.019 -0.991 . . . . 73.21 112.962 175.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.529 HG22 HH21 ' B' ' 15' ' ' ARG . 52.1 m 76.92 19.99 1.34 Allowed 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 122.593 1.187 . . . . 74.33 111.882 168.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -93.31 148.75 36.17 Favored Pre-proline 0 C--O 1.248 1.022 0 N-CA-C 108.296 -1.002 . . . . 71.42 108.296 170.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.659 ' HB3' ' HA ' ' E' ' 131' ' ' TRP . 11.9 Cg_endo -54.47 138.96 74.9 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.494 2.129 . . . . 72.04 111.156 175.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -56.21 127.48 30.96 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.332 1.02 . . . . 75.34 112.274 -167.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.542 HD21 HG11 ' A' ' 64' ' ' VAL . 36.0 tp -113.04 97.14 6.33 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 114.454 -1.248 . . . . 74.44 109.406 -175.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -96.04 103.23 15.11 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.038 -1.467 . . . . 74.34 107.038 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 17.3 mt -55.24 136.12 49.08 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.778 0.673 . . . . 74.51 111.134 -169.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.84 137.86 97.28 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 122.755 0.422 . . . . 42.03 111.274 -174.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.537 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 53.2 Cg_exo -55.47 114.84 2.07 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.593 2.862 . . . . 64.43 113.689 -178.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.55 HG21 HD11 ' A' ' 44' ' ' LEU . 45.1 t -104.2 133.24 48.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 CA-C-N 115.455 -0.793 . . . . 70.45 109.842 177.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 63.4 t-20 -96.97 87.12 4.16 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.515 -0.921 . . . . 55.13 108.515 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -59.68 -26.6 65.7 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.708 0.803 . . . . 73.24 113.056 175.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.562 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 8.6 t0 -63.67 -43.97 95.15 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.931 -0.766 . . . . 74.34 108.931 176.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.05 -35.22 80.46 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.893 -1.048 . . . . 61.34 111.476 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.418 ' HA ' ' ND2' ' A' ' 139' ' ' ASN . 77.9 mt -71.83 -40.66 68.93 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 124.022 0.826 . . . . 74.45 111.879 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -67.05 -42.3 85.05 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.796 -0.816 . . . . 74.12 108.796 175.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.569 ' HG3' ' HA ' ' A' ' 143' ' ' GLN . 5.4 tpt -64.09 -47.55 79.61 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 124.208 0.942 . . . . 70.1 111.336 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.69 ' HA ' ' HB2' ' A' ' 143' ' ' GLN . 23.8 p30 -66.79 -30.62 70.87 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 120.975 0.417 . . . . 74.53 110.77 -176.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -72.78 -41.52 64.93 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.296 1.038 . . . . 75.21 110.432 172.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 42.3 tp -66.52 -49.88 65.06 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.037 0.935 . . . . 75.24 110.889 -172.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 179.83 -19.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.974 0.909 . . . . 55.22 110.748 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.69 ' HB2' ' HA ' ' A' ' 139' ' ' ASN . 55.7 tt0 60.43 86.75 0.09 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.706 1.602 . . . . 75.34 111.857 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -151.52 -1.02 0.34 Allowed 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.732 -0.667 . . . . 73.42 110.561 -176.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.483 ' HB3' ' SD ' ' A' ' 138' ' ' MET . . . -144.1 -175.11 4.48 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.447 1.099 . . . . 73.1 108.99 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 168.79 -53.66 0.21 Allowed Glycine 0 C--N 1.341 0.825 0 N-CA-C 112.119 -0.393 . . . . 73.21 112.119 178.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.44 175.0 8.61 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.672 0.749 . . . . 75.42 112.016 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -161.15 -173.55 29.92 Favored Glycine 0 C--O 1.242 0.61 0 CA-C-N 114.813 -1.085 . . . . 63.35 111.429 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.6 m -148.37 159.9 43.55 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 108.121 -1.066 . . . . 74.01 108.121 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -147.64 178.2 8.66 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.027 0.931 . . . . 75.21 110.038 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.557 ' HA ' ' HA ' ' C' ' 147' ' ' GLU . 4.4 mp0 -76.73 94.95 3.9 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 109.32 -0.622 . . . . 65.42 109.32 172.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.459 ' HB3' ' HA3' ' C' ' 146' ' ' GLY . 46.6 t-80 -71.09 80.05 0.68 Allowed 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.212 -1.033 . . . . 71.31 108.212 170.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -170.01 108.6 0.38 Allowed 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.126 -1.064 . . . . 64.11 108.126 -172.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.432 ' HB2' ' HA ' ' C' ' 139' ' ' ASN . 2.6 m-20 -118.83 101.78 8.32 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 108.98 -0.748 . . . . 64.23 108.98 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.879 0 C-N-CA 123.74 0.816 . . . . 75.33 109.066 -178.231 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 109.452 -0.573 . . . . 75.44 109.452 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 66.2 m -149.38 163.35 37.98 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.698 1.199 . . . . 70.23 109.96 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.501 ' HB3' ' ND2' ' B' ' 6' ' ' ASN . 0.9 OUTLIER -69.05 137.21 53.38 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.141 0.976 . . . . 65.11 110.546 -172.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -75.9 -54.17 7.31 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.463 1.105 . . . . 71.45 112.652 -170.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -90.45 70.89 6.98 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.559 0.695 . . . . 72.03 110.592 -170.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.501 ' ND2' ' HB3' ' B' ' 3' ' ' GLU . 2.7 m-80 -112.06 139.02 47.92 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.102 0.961 . . . . 73.12 109.791 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 12.7 m -68.18 -14.25 62.84 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.429 1.091 . . . . 64.12 111.72 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -57.1 -21.72 34.19 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.588 1.155 . . . . 64.41 112.089 171.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.582 ' HG3' HG23 ' B' ' 89' ' ' ILE . 1.2 tmt? 68.23 167.66 0.26 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.573 1.549 . . . . 72.42 111.804 176.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.484 ' N ' ' SD ' ' B' ' 9' ' ' MET . 9.5 t -159.89 133.59 7.16 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.844 0.857 . . . . 61.25 109.405 176.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -117.36 141.85 47.81 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 107.842 -1.17 . . . . 72.15 107.842 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -149.46 137.54 20.54 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 122.76 0.424 . . . . 74.41 110.701 176.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 44.6 mt -96.23 128.16 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.049 -1.093 . . . . 73.43 108.049 173.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 -95.35 -42.03 8.72 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 123.524 0.515 . . . . 64.34 110.525 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.529 HH21 HG22 ' A' ' 122' ' ' THR . 22.8 ttt180 -172.93 138.69 0.8 Allowed 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.737 -0.665 . . . . 70.45 109.303 -172.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.8 mt -123.31 139.88 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 106.661 -1.607 . . . . 52.33 106.661 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -164.01 145.21 8.7 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.22 0.822 . . . . 73.44 113.22 -174.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 64.0 m -76.28 120.43 21.54 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.737 -1.119 . . . . 61.12 109.094 172.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.637 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 37.0 mtpt -97.82 -22.82 16.17 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.049 0.94 . . . . 55.21 111.006 -178.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 17.8 t70 -158.53 143.25 16.07 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.185 0.594 . . . . 74.12 110.358 -175.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.464 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 38.9 mm -138.9 141.47 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.252 1.421 . . . . 63.13 107.849 174.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 67.8 m -145.83 138.45 25.69 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.529 0.732 . . . . 71.04 109.13 170.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.3 t80 -143.41 116.76 9.05 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.792 -1.929 . . . . 74.1 105.792 169.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -127.89 111.14 13.26 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.323 -0.992 . . . . 62.03 108.323 -176.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.607 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -110.2 87.91 6.6 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 108.211 -1.033 . . . . 73.32 108.211 175.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.07 -34.06 14.28 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.232 1.955 . . . . 74.25 111.547 -175.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -99.97 3.81 44.54 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.325 1.05 . . . . 72.35 110.902 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.607 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -24.89 -64.68 0.1 OUTLIER Pre-proline 0 N--CA 1.504 2.266 0 C-N-CA 126.606 1.962 . . . . 72.44 115.332 -172.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 7.9 Cg_exo -66.57 -42.34 9.66 Favored 'Trans proline' 0 C--N 1.388 2.63 0 C-N-CA 122.154 1.903 . . . . 70.52 112.386 -170.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -86.03 -28.19 24.31 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.651 0.78 . . . . 75.22 111.89 -171.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.523 HG22 HD12 ' B' ' 68' ' ' LEU . 4.8 p -77.59 -11.66 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 122.889 0.476 . . . . 53.41 110.696 -175.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -65.89 -20.52 66.25 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 113.101 0.778 . . . . 65.15 113.101 173.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -63.21 -25.16 68.21 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 121.313 0.578 . . . . 62.54 110.111 173.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -90.83 66.98 6.12 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.307 1.043 . . . . 72.54 109.713 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -80.6 82.08 6.7 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 122.291 1.043 . . . . 75.15 109.114 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -152.83 -173.3 4.52 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.102 -0.954 . . . . 75.32 109.122 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -72.51 110.35 7.97 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 123.992 0.917 . . . . 75.42 109.631 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.409 ' O ' HG23 ' B' ' 40' ' ' VAL . 49.2 Cg_endo -70.38 141.1 41.88 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 121.653 1.569 . . . . 71.01 109.747 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -68.12 99.97 0.95 Allowed 'General case' 0 C--O 1.242 0.687 0 N-CA-C 106.906 -1.516 . . . . 63.42 106.906 171.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.667 HG11 HD11 ' B' ' 126' ' ' LEU . 39.1 t -95.72 154.2 3.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 114.593 -1.185 . . . . 73.44 108.734 -177.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -143.81 117.5 9.25 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 108.93 -0.766 . . . . 73.13 108.93 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.495 HD13 HD22 ' B' ' 128' ' ' LEU . 31.1 tp -93.27 137.31 32.71 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 108.832 -0.803 . . . . 65.01 108.832 172.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -159.55 128.22 5.11 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 107.702 -1.221 . . . . 73.05 107.702 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.651 ' HB2' HD23 ' F' ' 111' ' ' LEU . 4.0 mp -108.59 151.25 26.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.879 -0.785 . . . . 72.45 108.879 -174.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.55 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.4 t70 -127.54 144.14 51.1 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.027 0.931 . . . . 73.31 109.111 -177.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 26.1 p -113.07 106.51 14.76 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.534 0.734 . . . . 64.44 110.653 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.99 136.25 52.77 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.971 -1.122 . . . . 51.43 107.971 171.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.571 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 58.0 m -142.85 177.55 8.26 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.567 0.347 . . . . 62.14 110.774 -173.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 79.4 p -159.21 139.18 11.89 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.785 0.434 . . . . 61.41 111.136 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -90.24 125.16 35.39 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 108.696 -0.853 . . . . 52.53 108.696 169.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.6 pp -140.32 17.71 2.41 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.978 0.911 . . . . 74.22 109.845 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.77 152.65 17.93 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 124.454 1.102 . . . . 75.33 109.078 174.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -76.98 135.43 38.7 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.279 -1.008 . . . . 74.22 108.279 164.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 70.59 -4.25 1.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.139 0.976 . . . . 71.11 113.113 172.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 63.6 t -136.27 128.46 45.0 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 106.725 -1.583 . . . . 62.04 106.725 -175.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.571 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 4.9 t80 -122.16 169.64 10.67 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.836 0.351 . . . . 64.3 110.564 -172.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -134.72 111.45 9.98 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 107.664 -1.235 . . . . 72.45 107.664 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 61.5 t -106.75 130.67 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.056 0.942 . . . . 75.52 109.198 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.2 t -111.28 113.31 43.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 N-CA-C 109.277 -0.638 . . . . 73.45 109.277 176.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' B' ' 103' ' ' PRO . 63.1 tp -93.79 110.77 22.4 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 109.076 -0.713 . . . . 62.23 109.076 171.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.55 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 14.0 ttm180 -84.66 132.89 34.43 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.855 -1.165 . . . . 74.51 107.855 169.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.461 HG22 HD23 ' B' ' 44' ' ' LEU . 43.8 t -123.49 104.15 13.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.571 -1.27 . . . . 71.43 107.571 174.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 15.2 m -100.63 131.71 46.4 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.068 0.461 . . . . 52.43 110.112 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.616 HG11 HD21 ' B' ' 126' ' ' LEU . 70.3 t -122.92 126.54 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.222 1.009 . . . . 63.14 108.5 175.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.8 m -111.3 138.9 47.18 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 107.54 -1.281 . . . . 71.22 107.54 168.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.12 137.09 28.88 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.034 -0.728 . . . . 74.53 109.034 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.569 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 25.1 p -147.05 128.28 14.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.085 0.469 . . . . 64.41 111.584 -172.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.523 HD12 HG22 ' B' ' 31' ' ' VAL . 56.4 mt -99.03 103.79 15.76 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 124.919 1.288 . . . . 72.24 108.507 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.3 -119.04 4.82 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 115.657 -0.701 . . . . 62.54 111.824 -174.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -112.22 3.93 17.47 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.94 0.896 . . . . 73.33 111.368 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -118.0 148.62 42.05 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.119 0.567 . . . . 75.11 109.672 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 99.2 m -72.63 125.66 28.02 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.8 -0.636 . . . . 62.45 111.232 -177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.569 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -71.66 -62.43 1.42 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.81 -1.181 . . . . 61.42 107.81 173.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -152.89 157.89 41.35 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.586 -1.188 . . . . 70.13 111.186 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 70.8 mt -126.08 108.5 11.42 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 106.255 -1.758 . . . . 72.25 106.255 172.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 39.3 t -119.17 113.76 21.4 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.507 -0.923 . . . . 74.12 108.507 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -128.57 124.62 36.38 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.973 -1.121 . . . . 75.33 107.973 -175.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 67.3 t -123.63 155.84 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.855 0.862 . . . . 64.13 109.24 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.53 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.7 mt-30 -131.25 108.03 9.4 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.19 -0.67 . . . . 55.13 109.19 171.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 8.5 tp-100 -96.89 109.38 22.11 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.568 0.747 . . . . 61.53 109.518 173.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.637 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -99.64 170.61 23.25 Favored Glycine 0 N--CA 1.464 0.535 0 N-CA-C 112.021 -0.432 . . . . 73.42 112.021 174.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.97 138.78 5.12 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 112.573 -0.211 . . . . 51.42 112.573 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 49.5 mt -92.17 122.08 43.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 124.267 1.027 . . . . 71.25 108.764 174.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -127.45 135.21 50.1 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.002 0.921 . . . . 70.1 109.727 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 24.1 m -106.32 128.65 54.15 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.691 0.796 . . . . 73.11 109.5 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.626 ' HB ' HD11 ' B' ' 89' ' ' ILE . 1.9 pp -139.77 147.06 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.374 0.669 . . . . 72.52 111.089 -177.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.648 ' HA ' ' HB ' ' F' ' 97' ' ' ILE . . . -154.68 165.92 35.03 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.4 0.68 . . . . 62.04 111.104 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 90.8 -45.83 2.91 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 116.087 -0.506 . . . . 31.2 112.741 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.626 HD11 ' HB ' ' B' ' 86' ' ' ILE . 4.0 pt -56.38 152.33 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.559 1.143 . . . . 72.34 111.426 169.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -157.94 164.09 37.2 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.536 0.734 . . . . 74.22 109.536 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.36 -111.07 3.49 Favored Glycine 0 C--N 1.355 1.631 0 O-C-N 123.197 0.31 . . . . 53.34 112.699 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 25.0 m -84.34 -43.22 14.97 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 123.695 0.798 . . . . 73.43 109.696 175.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -62.53 -24.66 67.62 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 113.758 -1.565 . . . . 75.43 111.694 -168.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.766 ' HB2' HD11 ' F' ' 97' ' ' ILE . 23.9 ptm -66.1 -65.67 0.65 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.084 0.772 . . . . 75.54 113.084 -177.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.44 ' HB1' HD13 ' F' ' 102' ' ' LEU . . . -80.19 -14.4 58.48 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.21 0.448 . . . . 61.1 112.21 -175.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -61.33 -37.03 81.82 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.365 0.666 . . . . 74.15 110.554 171.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . 0.456 ' SG ' HG21 ' B' ' 86' ' ' ILE . 43.8 t -60.13 -24.56 64.78 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.114 0.966 . . . . 52.24 112.024 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.501 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 26.7 mt -97.76 -39.13 9.19 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.124 0.969 . . . . 72.42 111.497 -177.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.26 -19.27 69.69 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 116.43 -0.35 . . . . 73.52 113.572 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.87 -48.48 1.89 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.003 0.521 . . . . 73.24 111.767 -172.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -83.05 -41.96 18.03 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 111.877 0.325 . . . . 72.43 111.877 -171.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.501 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 94.8 m -63.05 -43.23 81.15 Favored Pre-proline 0 CA--C 1.57 1.733 0 N-CA-C 113.569 0.952 . . . . 45.23 113.569 -178.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.424 ' HB3' HD13 ' B' ' 60' ' ' LEU . 51.5 Cg_exo -58.27 -27.62 81.52 Favored 'Trans proline' 0 C--N 1.399 3.196 0 C-N-CA 122.239 1.96 . . . . 73.24 113.674 173.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -65.01 -33.55 76.31 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.663 0.785 . . . . 72.23 110.591 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 57.4 mt -73.89 -41.7 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.883 0.873 . . . . 75.01 110.088 176.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 92.5 mt -75.94 -30.01 58.53 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.23 -0.896 . . . . 60.12 112.424 -172.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -56.98 -49.7 92.44 Favored Pre-proline 0 N--CA 1.484 1.239 0 CA-C-O 117.342 -1.313 . . . . 64.13 113.477 -172.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -50.31 -39.64 53.01 Favored 'Trans proline' 0 C--N 1.391 2.788 0 C-N-CA 122.512 2.141 . . . . 74.11 114.161 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -70.15 -47.15 62.89 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.334 0.654 . . . . 72.23 110.509 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -62.35 -35.53 79.41 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.37 -0.832 . . . . 65.44 111.337 177.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.533 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 50.2 ttt-85 -67.53 -49.73 61.97 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.134 1.374 . . . . 72.41 110.349 -177.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.6 -32.34 73.61 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.021 0.826 . . . . 60.33 109.687 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.51 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.3 t -69.56 -42.84 74.02 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.257 0.623 . . . . 65.24 110.829 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.424 HD13 HG23 ' B' ' 64' ' ' VAL . 74.9 mt -60.23 -54.52 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.392 0.677 . . . . 72.25 110.603 172.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 25.5 m -58.9 -28.69 66.43 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.503 0.721 . . . . 70.44 111.276 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 22.9 t -67.69 -53.2 29.58 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 123.203 0.601 . . . . 71.43 109.59 173.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.51 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.2 mmt -64.52 -31.89 73.3 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 122.758 0.423 . . . . 75.15 111.774 -175.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.8 t -69.7 -42.1 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.268 1.027 . . . . 73.04 110.562 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 81.5 p -72.43 -28.89 63.24 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.001 0.429 . . . . 52.42 111.087 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' B' ' 116' ' ' SER . 88.5 mtt-85 -67.93 -40.72 83.31 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.12 -0.945 . . . . 71.54 109.505 175.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.45 -6.18 61.43 Favored Glycine 0 C--N 1.352 1.467 0 O-C-N 123.764 0.665 . . . . 64.13 113.071 173.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 9.7 m 64.98 31.45 11.25 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.282 1.433 . . . . 73.12 110.298 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -89.53 164.03 31.08 Favored Pre-proline 0 CA--C 1.556 1.193 0 CA-C-N 114.22 -1.354 . . . . 63.11 111.129 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.532 ' HG3' ' HB2' ' F' ' 130' ' ' ALA . 31.1 Cg_exo -39.74 146.55 0.22 Allowed 'Trans proline' 0 C--N 1.393 2.885 0 C-N-CA 124.647 3.565 . . . . 50.32 115.86 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -61.05 112.84 2.25 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.301 0.641 . . . . 74.41 109.768 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.667 HD11 HG11 ' B' ' 40' ' ' VAL . 43.4 tp -109.93 110.72 21.76 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.424 0.69 . . . . 70.34 109.463 -174.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -107.29 117.53 34.32 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.201 -1.037 . . . . 73.02 108.201 175.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.533 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 51.4 mt -78.56 147.46 33.74 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 120.535 0.207 . . . . 54.52 110.53 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.441 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -73.13 142.11 81.97 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 123.641 0.776 . . . . 71.54 112.375 -170.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' B' ' 129' ' ' ALA . 11.2 Cg_endo -85.04 104.04 0.86 Allowed 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.312 2.675 . . . . 41.11 111.192 176.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.95 134.93 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 122.83 0.452 . . . . 74.51 110.327 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -80.21 114.36 19.06 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.259 0.624 . . . . 73.4 109.432 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -54.22 -42.77 70.18 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.187 1.395 . . . . 63.52 111.453 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -52.96 -41.4 64.5 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.045 -1.434 . . . . 72.42 112.379 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.12 -32.61 73.21 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.703 0.627 . . . . 44.33 112.414 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.701 HD22 HD11 ' F' ' 111' ' ' LEU . 6.8 mp -74.16 -35.08 64.01 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.365 0.666 . . . . 73.42 110.929 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -87.4 -15.93 36.39 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.249 0.62 . . . . 74.24 111.581 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 48.1 ttm -68.11 -38.84 82.72 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.498 0.719 . . . . 74.41 110.906 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.499 ' HA ' ' HG3' ' B' ' 143' ' ' GLN . 9.8 p30 -82.71 -33.6 27.54 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.34 -0.846 . . . . 64.31 110.583 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -67.91 -31.24 70.89 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.31 0.644 . . . . 74.32 110.31 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 25.4 tp -97.74 14.61 26.3 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.82 0.848 . . . . 43.0 110.365 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 72.63 123.31 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.443 1.497 . . . . 74.2 111.915 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . 0.499 ' HG3' ' HA ' ' B' ' 139' ' ' ASN . 25.2 mt-30 -78.71 121.85 25.24 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.562 0.745 . . . . 74.04 109.717 175.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -90.86 88.04 6.89 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.102 0.561 . . . . 64.31 109.852 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . 59.25 -81.12 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.623 1.569 . . . . 73.45 113.342 171.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.99 -30.36 0.44 Allowed Glycine 0 C--N 1.342 0.864 0 N-CA-C 110.584 -1.006 . . . . 63.52 110.584 -173.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 71.93 -67.93 0.24 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.087 1.755 . . . . 74.54 111.633 175.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -129.99 147.44 18.07 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 110.949 -0.86 . . . . 54.43 110.949 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 10.8 t -157.86 22.69 0.27 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.744 0.818 . . . . 71.22 109.749 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . 0.413 ' HG2' ' NE2' ' D' ' 93' ' ' GLN . 6.6 mm-40 69.12 107.77 0.05 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.475 1.51 . . . . 61.21 109.502 -165.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -92.81 14.09 18.38 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.948 0.899 . . . . 71.54 110.01 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -148.13 130.87 16.0 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.052 0.941 . . . . 73.34 109.586 -169.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . 0.543 ' HG3' ' HG3' ' D' ' 90' ' ' GLU . 58.8 tt0 -93.9 99.61 11.93 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 109.802 -0.444 . . . . 71.31 109.802 178.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . 0.604 ' HB2' ' HA2' ' D' ' 91' ' ' GLY . 4.6 m-20 -116.11 158.51 23.1 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.771 0.828 . . . . 65.04 110.533 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.977 0 C-N-CA 124.489 1.116 . . . . 64.13 108.315 -179.53 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ttt . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.447 0.165 . . . . 73.34 110.799 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 43.2 m -149.54 126.35 11.12 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.613 0.765 . . . . 45.32 109.219 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . 0.505 ' HB2' ' NE2' ' A' ' 143' ' ' GLN . 14.7 mp0 -67.84 97.73 0.67 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 108.792 -0.818 . . . . 52.05 108.792 176.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . 0.429 HE21 ' HG3' ' C' ' 8' ' ' GLU . 50.5 mt-30 -71.67 116.16 11.71 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.765 0.826 . . . . 73.35 109.587 178.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -75.44 79.28 2.49 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 107.786 -1.19 . . . . 55.14 107.786 171.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 171.05 177.14 0.06 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.109 1.764 . . . . 75.21 106.758 -171.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 44.4 m -65.76 119.99 12.2 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 108.466 -0.939 . . . . 73.55 108.466 162.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.429 ' HG3' HE21 ' C' ' 4' ' ' GLN . 34.9 tt0 -59.58 -49.17 78.82 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 124.072 0.858 . . . . 62.12 111.855 -174.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.583 ' HE2' HG21 ' C' ' 89' ' ' ILE . 50.1 ttm 64.24 116.33 0.02 OUTLIER 'General case' 0 C--N 1.357 0.907 0 O-C-N 125.119 1.512 . . . . 64.43 111.324 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 96.7 m -84.46 97.02 9.29 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.047 -1.094 . . . . 74.35 108.047 173.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.537 ' HD2' ' HG2' ' A' ' 130' ' ' PRO . 35.0 t80 -115.5 127.38 55.26 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.0 -1.111 . . . . 75.21 108.0 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.418 HE22 ' HE3' ' E' ' 136' ' ' LYS . 29.1 tt0 -142.03 131.25 23.44 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.711 -0.848 . . . . 71.4 108.711 177.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 19.9 mt -84.22 134.77 26.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.723 -0.843 . . . . 73.14 108.723 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.499 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 20.9 mm-40 -91.35 -45.67 8.45 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.592 -0.892 . . . . 74.22 108.592 175.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -177.58 153.35 0.88 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.048 1.339 . . . . 73.24 109.455 175.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.491 HG23 HD23 ' C' ' 106' ' ' LEU . 75.0 mt -128.75 118.55 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.731 1.212 . . . . 62.34 108.379 177.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.511 ' HB3' HG23 ' D' ' 122' ' ' THR . 6.1 p90 -151.37 154.45 36.7 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.008 0.908 . . . . 72.45 112.249 -164.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.2 p -79.22 108.85 13.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.562 -1.199 . . . . 71.15 109.406 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -72.83 -45.01 60.69 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 107.557 -1.275 . . . . 53.41 107.557 172.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.71 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 10.4 t70 -134.52 137.54 43.94 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 113.186 -1.825 . . . . 64.11 109.19 -174.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.4 mt -134.78 143.44 37.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 125.455 1.502 . . . . 70.22 106.969 172.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.7 t -150.01 138.0 20.24 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 109.154 -0.684 . . . . 75.31 109.154 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -139.01 128.61 24.57 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.48 -1.304 . . . . 71.33 107.48 171.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -130.18 120.19 24.14 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.534 1.134 . . . . 70.53 108.784 -174.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.14 84.0 58.66 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 106.969 -1.493 . . . . 74.5 106.969 169.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.5 -26.9 28.36 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 122.397 2.064 . . . . 64.13 111.227 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 -107.39 21.83 16.89 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.486 1.114 . . . . 65.44 109.836 -176.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.82 -64.94 0.71 Allowed Pre-proline 0 CA--C 1.571 1.777 0 N-CA-C 114.466 1.284 . . . . 32.11 114.466 -165.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -67.54 -27.87 38.83 Favored 'Trans proline' 0 C--N 1.385 2.453 0 CA-C-N 122.326 1.867 . . . . 74.34 112.615 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -68.13 -37.86 81.57 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.893 0.877 . . . . 73.13 111.366 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.632 HG21 ' HA ' ' C' ' 73' ' ' ALA . 14.8 p -82.01 -24.87 9.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-N 116.184 -0.462 . . . . 71.15 111.941 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -65.72 -30.66 71.36 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 121.787 -0.57 . . . . 71.35 111.015 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -90.82 29.93 1.27 Allowed 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.109 0.964 . . . . 64.0 111.228 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -124.74 153.38 42.49 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.457 1.103 . . . . 71.3 109.711 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -67.76 129.76 40.9 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 122.994 0.518 . . . . 75.34 109.89 174.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 66.5 t-105 -85.0 83.44 8.06 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.8 0.84 . . . . 74.13 111.346 -173.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -131.21 78.87 71.74 Favored Pre-proline 0 N--CA 1.481 1.104 0 C-N-CA 123.739 0.816 . . . . 71.41 109.071 173.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -83.23 155.61 14.6 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.553 2.169 . . . . 71.11 112.428 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -88.52 100.48 13.11 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 106.749 -1.574 . . . . 72.51 106.749 168.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 57.4 t -74.64 99.42 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 109.024 -0.732 . . . . 53.51 109.024 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 32.5 mmtm -131.65 106.79 8.39 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.086 0.954 . . . . 61.02 109.472 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 pp -95.74 165.35 12.35 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.69 0.796 . . . . 72.11 109.933 175.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 19.9 t70 -139.86 143.98 37.01 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.414 1.086 . . . . 73.21 108.235 175.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 97.4 mt -128.58 112.57 14.43 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.382 0.611 . . . . 61.2 109.613 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -112.87 121.18 43.92 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.635 -1.617 . . . . 64.4 106.635 172.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.2 t -118.68 142.92 47.2 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.36 0.6 . . . . 75.12 109.382 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.45 151.86 49.62 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.561 1.144 . . . . 70.41 108.274 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 53.1 p -147.32 142.21 26.89 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 109.348 -0.612 . . . . 64.42 109.348 174.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 72.6 p -150.35 151.85 33.5 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.291 1.036 . . . . 64.14 108.585 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -98.87 117.22 32.87 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.925 -0.769 . . . . 71.04 108.925 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.654 HD11 ' HB2' ' C' ' 57' ' ' GLU . 61.4 mt -84.42 -37.01 21.98 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.497 0.719 . . . . 75.43 110.233 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.38 -175.76 5.6 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.169 0.988 . . . . 63.31 109.759 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -59.16 110.23 1.02 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 123.641 0.588 . . . . 72.52 110.363 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 62.85 22.72 13.58 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.287 1.035 . . . . 71.22 112.066 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 95.6 t -117.63 117.49 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.874 1.27 . . . . 51.04 107.58 173.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -127.28 125.36 40.74 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.068 0.947 . . . . 72.14 109.554 -174.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.654 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.0 tt0 -88.33 122.12 31.48 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.832 -0.803 . . . . 61.04 108.832 169.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 65.8 t -112.49 124.13 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 108.713 -0.847 . . . . 75.44 108.713 172.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.538 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 61.6 t -109.75 134.75 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.019 0.528 . . . . 53.13 109.938 176.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.47 99.56 8.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.848 -1.168 . . . . 75.4 107.848 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -80.31 106.8 12.6 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.121 -1.066 . . . . 75.14 108.121 170.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.15 122.5 58.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 107.866 -1.161 . . . . 74.42 107.866 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 25.1 m -113.3 138.61 49.77 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 107.415 -1.328 . . . . 61.33 107.415 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.426 HG21 HG21 ' C' ' 114' ' ' ILE . 69.1 t -134.34 111.64 14.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 108.021 -1.103 . . . . 62.51 108.021 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.457 HG23 HD23 ' C' ' 75' ' ' LEU . 4.3 m -108.22 117.4 34.05 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.707 -0.679 . . . . 73.41 109.17 -177.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.42 104.04 10.71 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.565 -0.902 . . . . 62.42 108.565 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 63.4 m -128.77 132.91 47.94 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.186 -0.672 . . . . 65.44 109.186 176.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 9.6 mt -84.68 42.32 0.9 Allowed 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 125.428 1.491 . . . . 70.22 109.889 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.22 -104.61 2.46 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 110.97 -0.852 . . . . 53.12 110.97 -172.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -89.7 -32.19 17.13 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.514 0.726 . . . . 75.3 109.945 174.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -75.95 105.84 7.21 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 114.877 -1.056 . . . . 71.54 109.808 -178.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 61.4 m -74.21 124.52 26.55 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 118.479 0.582 . . . . 53.42 109.597 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.632 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -77.79 -53.89 6.98 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.582 -0.736 . . . . 53.54 109.111 176.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -162.03 164.13 28.42 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.827 -1.079 . . . . 75.55 110.729 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.457 HD23 HG23 ' C' ' 65' ' ' THR . 2.7 tm? -128.41 142.17 51.19 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.211 -1.774 . . . . 61.12 106.211 167.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 42.5 t -149.44 129.8 13.8 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.94 -0.763 . . . . 72.15 108.94 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -140.66 128.62 21.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.714 0.406 . . . . 72.31 110.027 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 37.3 t -125.24 115.69 44.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 124.468 1.107 . . . . 73.04 108.891 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.71 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.5 mt-30 -90.41 91.09 8.32 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.57 -0.9 . . . . 72.44 108.57 172.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -83.78 96.07 8.63 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.342 -1.299 . . . . 75.21 109.183 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -93.2 145.73 17.75 Favored Glycine 0 C--O 1.222 -0.638 0 N-CA-C 111.616 -0.594 . . . . 70.02 111.616 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.94 132.13 4.91 Favored Glycine 0 CA--C 1.503 -0.703 0 N-CA-C 110.991 -0.844 . . . . 74.43 110.991 -176.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.499 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 22.8 mm -85.66 124.46 40.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 107.467 -1.308 . . . . 74.02 107.467 174.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -129.94 118.2 21.29 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.638 0.775 . . . . 73.01 109.703 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.6 p -86.92 104.62 16.43 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.035 -0.728 . . . . 64.22 109.035 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.53 HD13 ' SG ' ' C' ' 97' ' ' CYS . 19.5 mt -116.73 126.98 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.532 0.733 . . . . 63.34 110.314 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.25 169.01 18.54 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.125 0.97 . . . . 63.23 109.887 177.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.66 -17.65 57.2 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 119.365 -0.686 . . . . 53.11 114.47 174.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.583 HG21 ' HE2' ' C' ' 9' ' ' MET . 38.0 pt -119.01 166.76 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 CA-C-N 118.079 0.94 . . . . 74.12 112.493 -175.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -159.39 156.44 28.47 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.685 1.194 . . . . 72.12 109.078 176.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.08 -138.14 14.88 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-O 120.073 -0.293 . . . . 74.41 112.926 171.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 47.1 p -65.08 -25.18 67.68 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.796 0.838 . . . . 63.25 111.457 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -61.15 -54.24 46.87 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.166 0.986 . . . . 74.43 110.635 171.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.587 ' HE3' ' HA ' ' C' ' 94' ' ' MET . 4.5 tpt -56.67 -48.61 77.23 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 124.058 0.849 . . . . 62.44 111.803 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.17 -40.96 91.76 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 123.59 0.556 . . . . 43.12 111.514 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -69.56 -30.95 68.86 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.055 0.942 . . . . 75.14 111.239 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.53 ' SG ' HD13 ' C' ' 86' ' ' ILE . 12.2 t -75.41 -35.39 61.02 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.652 -0.499 . . . . 70.11 109.652 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 96.2 mt -84.14 -32.82 24.46 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.002 0.921 . . . . 71.33 112.521 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.88 8.77 27.6 Favored Glycine 0 N--CA 1.473 1.166 0 CA-C-O 119.656 -0.525 . . . . 71.43 114.135 -170.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.75 -55.32 0.22 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 117.411 0.606 . . . . 53.25 111.644 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -71.36 -54.34 11.08 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 117.566 0.166 . . . . 74.13 111.264 -174.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.45 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 84.8 m -57.58 -50.48 87.92 Favored Pre-proline 0 CA--C 1.565 1.524 0 CA-C-O 118.182 -0.913 . . . . 55.4 111.974 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.464 ' HA ' HD12 ' C' ' 106' ' ' LEU . 38.9 Cg_exo -60.11 -28.21 86.5 Favored 'Trans proline' 0 C--N 1.4 3.256 0 C-N-CA 122.601 2.201 . . . . 75.11 113.567 174.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -68.09 -35.61 78.45 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.201 0.6 . . . . 55.21 110.778 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.453 HD12 ' NH1' ' A' ' 111' ' ' ARG . 19.9 mm -79.86 -29.62 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 109.972 -0.381 . . . . 70.35 109.972 177.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.491 HD23 HG23 ' C' ' 16' ' ' ILE . 73.9 mt -70.09 -32.08 69.96 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.406 0.683 . . . . 73.21 111.254 176.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -53.29 -53.26 58.08 Favored Pre-proline 0 N--CA 1.485 1.322 0 CA-C-O 117.228 -1.368 . . . . 71.41 114.459 -173.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.82 -36.46 96.98 Favored 'Trans proline' 0 C--N 1.391 2.783 0 C-N-CA 122.074 1.849 . . . . 54.44 113.219 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -70.17 -46.55 64.42 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.706 0.802 . . . . 71.33 110.307 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.94 81.86 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 115.027 -0.988 . . . . 60.25 110.369 175.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.9 ttt-85 -65.74 -47.16 76.2 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.199 1.399 . . . . 64.32 110.757 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -69.63 -33.78 73.13 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.362 0.665 . . . . 74.34 110.055 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 40.2 t -68.68 -39.53 80.53 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.336 0.655 . . . . 61.44 111.258 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.441 ' O ' HG23 ' C' ' 118' ' ' VAL . 96.7 mt -69.35 -48.19 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.572 0.749 . . . . 73.15 110.406 174.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 28.5 m -54.52 -40.16 68.35 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.561 1.144 . . . . 62.42 110.876 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.4 t -64.55 -48.05 76.48 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.002 -0.999 . . . . 52.13 109.0 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.52 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.8 -40.24 79.44 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.839 1.256 . . . . 74.24 112.672 178.433 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.441 HG23 ' O ' ' C' ' 114' ' ' ILE . 86.8 t -66.72 -41.0 87.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.531 0.732 . . . . 54.31 110.287 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 46.7 t -71.94 -27.82 63.05 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 123.782 0.833 . . . . 62.4 111.501 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 82.5 mtt-85 -72.52 -34.17 67.42 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.494 0.718 . . . . 74.55 109.495 175.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.24 10.39 63.81 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.388 -0.823 . . . . 74.42 112.636 173.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 72.5 p 58.7 22.9 10.47 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 126.153 1.781 . . . . 62.1 114.286 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -83.66 149.16 56.59 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 108.689 -0.856 . . . . 72.21 108.689 171.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -55.53 157.67 14.66 Favored 'Trans proline' 0 C--N 1.382 2.322 0 C-N-CA 123.073 2.516 . . . . 61.32 113.702 176.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -58.49 114.16 2.33 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.882 0.873 . . . . 72.14 112.223 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.9 tt -110.56 86.04 2.23 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 106.601 -1.629 . . . . 62.33 106.601 172.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -91.19 105.02 17.5 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.046 -0.724 . . . . 74.24 109.046 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.5 145.59 55.88 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.484 0.714 . . . . 72.51 111.983 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.22 153.15 84.24 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 123.575 0.75 . . . . 62.31 110.347 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.471 ' HG2' HG21 ' A' ' 13' ' ' ILE . 51.9 Cg_exo -54.71 115.68 2.58 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.892 2.395 . . . . 74.13 112.548 173.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.3 t -98.05 116.91 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.656 -0.868 . . . . 70.51 108.656 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -76.02 103.25 5.98 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.368 0.667 . . . . 75.01 110.531 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -67.18 -22.41 65.74 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.489 0.716 . . . . 74.24 112.065 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -65.46 -42.91 91.81 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.498 0.719 . . . . 72.12 110.476 175.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.08 -46.74 87.78 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 123.675 0.61 . . . . 64.03 110.354 176.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 72.9 mt -67.03 -27.75 67.67 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.267 -0.878 . . . . 74.44 111.435 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -73.21 -47.94 39.26 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.262 0.625 . . . . 53.11 110.494 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 72.6 mtm -70.02 -29.36 66.39 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.267 0.556 . . . . 74.34 110.31 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . 0.432 ' HA ' ' HB2' ' A' ' 154' ' ' ASP . 6.3 t30 -57.92 -33.79 69.15 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.336 1.455 . . . . 72.42 113.718 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -159.98 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 113.283 0.846 . . . . 61.42 113.283 -168.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.435 ' HG ' ' HG2' ' C' ' 142' ' ' GLN . 40.0 tp 40.38 -85.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 125.831 1.652 . . . . 73.03 113.575 170.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.435 ' HG2' ' HG ' ' C' ' 141' ' ' LEU . 9.9 pt20 -162.43 161.15 27.08 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 125.682 1.593 . . . . 75.21 107.638 176.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -78.92 81.56 5.19 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.493 0.663 . . . . 62.22 109.234 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -76.55 144.65 39.55 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.645 -1.162 . . . . 63.31 110.01 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -52.65 123.21 10.62 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.795 1.238 . . . . 72.3 112.858 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . 0.459 ' HA3' ' HB3' ' A' ' 152' ' ' HIS . . . -176.11 122.3 0.85 Allowed Glycine 0 C--N 1.338 0.672 0 N-CA-C 110.104 -1.198 . . . . 51.33 110.104 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 151' ' ' GLU . 14.5 pt-20 -161.13 -174.92 4.59 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.214 0.606 . . . . 65.55 110.743 -172.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 89.59 71.51 1.25 Allowed Glycine 0 C--N 1.345 1.054 0 CA-C-N 115.467 -0.788 . . . . 71.02 111.68 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.25 125.17 19.56 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.057 0.543 . . . . 73.52 110.671 173.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -70.35 86.99 0.61 Allowed 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.836 -0.801 . . . . 72.11 108.836 178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -84.92 78.57 9.87 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.455 -1.248 . . . . 61.24 111.018 -172.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -96.4 102.24 14.0 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.327 -0.851 . . . . 75.13 109.136 176.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . 0.4 ' HA ' ' NE2' ' A' ' 93' ' ' GLN . 24.7 tt0 -95.41 76.64 3.37 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.71 0.767 . . . . 63.41 109.31 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 93' ' ' GLN . 4.5 p-10 -83.45 110.19 17.97 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.857 -1.065 . . . . 74.02 110.194 -178.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.97 0 CA-C-N 115.233 -0.894 . . . . 75.43 110.662 -177.376 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 N-CA-C 109.928 -0.397 . . . . 71.24 109.928 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 58.7 p -67.19 134.69 52.19 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.114 0.565 . . . . 53.13 110.579 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -74.7 100.07 3.87 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.605 -0.887 . . . . 62.31 108.605 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . 0.445 ' H ' ' NE2' ' D' ' 4' ' ' GLN . 0.0 OUTLIER -68.36 83.48 0.25 Allowed 'General case' 0 CA--C 1.558 1.257 0 CA-C-O 122.741 1.258 . . . . 71.23 107.798 168.153 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -96.13 144.84 26.01 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.269 -1.332 . . . . 45.42 110.366 -168.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -78.51 81.91 4.81 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 123.632 0.583 . . . . 62.22 110.084 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 75.3 p -85.65 -168.33 2.18 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.178 -1.045 . . . . 41.42 108.178 169.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -60.79 88.28 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 122.892 0.477 . . . . 73.02 109.808 168.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.48 ' HG2' HG13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -34.62 122.99 0.53 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.341 1.456 . . . . 74.21 112.337 176.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 8.2 t -111.25 133.34 53.66 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 109.149 -0.685 . . . . 54.01 109.149 176.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.465 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 54.9 t80 -143.41 89.76 2.11 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.183 -1.414 . . . . 71.34 107.183 174.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -116.85 119.85 36.67 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.24 -1.022 . . . . 64.32 108.24 -175.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 5.5 mt -75.79 121.17 27.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.061 -1.088 . . . . 75.11 108.061 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.684 ' HB2' HG23 ' D' ' 83' ' ' ILE . 10.8 mm-40 -84.9 -30.04 24.7 Favored 'General case' 0 C--O 1.242 0.674 0 O-C-N 123.802 0.688 . . . . 71.3 110.462 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ttt180 -174.63 131.42 0.35 Allowed 'General case' 0 C--N 1.364 1.222 0 O-C-N 123.415 0.447 . . . . 72.2 111.149 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.412 ' N ' HD12 ' D' ' 16' ' ' ILE . 3.5 mp -108.18 135.24 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.423 -1.325 . . . . 73.04 107.423 172.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -165.84 170.57 13.71 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.744 0.783 . . . . 71.04 111.89 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -101.46 124.31 46.93 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.406 -1.27 . . . . 63.43 109.357 177.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.461 ' HD2' ' HA3' ' D' ' 81' ' ' GLY . 28.3 mtpt -95.28 -28.92 14.76 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.735 -0.839 . . . . 71.33 108.735 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.607 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 7.9 t70 -146.1 135.09 22.59 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 113.997 -1.456 . . . . 63.13 108.915 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.52 HG21 ' HE2' ' C' ' 117' ' ' MET . 61.9 mt -136.5 138.99 45.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.937 -1.134 . . . . 72.43 107.937 170.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.9 t -141.44 140.81 33.68 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.233 1.013 . . . . 73.34 108.52 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.49 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.2 t80 -144.71 130.44 19.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 106.059 -1.83 . . . . 73.31 106.059 168.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -134.28 138.03 44.71 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.51 -0.922 . . . . 63.24 108.51 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.421 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -144.14 78.12 13.94 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 107.718 -1.216 . . . . 74.24 107.718 174.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.37 -28.98 9.88 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.803 2.335 . . . . 72.42 112.688 -173.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -101.18 3.64 41.25 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.857 0.863 . . . . 74.51 110.692 -176.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.481 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -33.06 -64.07 0.26 Allowed Pre-proline 0 CA--C 1.566 1.56 0 N-CA-C 116.46 2.022 . . . . 74.32 116.46 -164.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.451 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 73.3 Cg_endo -74.39 -29.12 9.69 Favored 'Trans proline' 0 C--N 1.389 2.68 0 CA-C-N 123.503 2.287 . . . . 71.51 113.311 -178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -65.53 -39.73 92.1 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.649 1.18 . . . . 74.35 109.68 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.519 HG22 HD12 ' D' ' 68' ' ' LEU . 9.8 p -85.53 -16.39 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 CA-C-N 115.423 -0.808 . . . . 70.04 111.532 -176.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.451 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 17.7 m-85 -65.66 -20.92 66.48 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 118.05 0.386 . . . . 73.34 111.585 176.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -61.86 -23.22 66.14 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.7 0.8 . . . . 74.24 110.865 174.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -92.77 95.57 9.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.723 1.209 . . . . 62.44 110.219 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -94.3 94.86 8.54 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.551 0.74 . . . . 74.34 110.153 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 34.5 p90 -161.84 179.32 8.16 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.686 0.794 . . . . 72.34 110.164 166.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -58.07 111.48 3.59 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.563 1.145 . . . . 72.4 110.031 173.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.419 ' O ' HG23 ' D' ' 40' ' ' VAL . 51.3 Cg_exo -55.6 125.4 18.99 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.205 1.936 . . . . 72.55 110.288 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -72.29 107.33 4.84 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.32 -1.363 . . . . 74.3 107.32 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.879 HG13 HG13 ' D' ' 64' ' ' VAL . 87.5 t -113.1 103.14 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 123.308 0.38 . . . . 73.14 110.08 -168.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -87.16 119.25 27.21 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.796 -1.187 . . . . 71.23 107.796 172.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.794 HD22 HD11 ' D' ' 128' ' ' LEU . 57.0 tp -92.82 148.01 22.38 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.333 -0.988 . . . . 75.23 108.333 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.5 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 27.6 t70 -144.76 111.96 6.0 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.388 -1.338 . . . . 70.44 107.388 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' D' ' 62' ' ' VAL . 85.2 mt -108.11 131.83 54.21 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.062 0.545 . . . . 74.31 110.073 -173.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -132.15 133.92 44.82 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.89 -1.522 . . . . 75.02 106.89 173.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.8 t -139.24 141.79 37.85 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.833 0.825 . . . . 72.31 110.009 176.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.8 161.82 41.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.391 -1.277 . . . . 64.54 107.738 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 34.0 p -133.76 158.93 42.08 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.287 -0.634 . . . . 73.04 109.287 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 78.1 p -148.72 120.21 7.95 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 109.452 -0.573 . . . . 72.3 109.452 -175.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -176.73 159.34 1.8 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.83 1.252 . . . . 74.4 108.452 172.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -55.32 -15.33 2.41 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 126.255 1.822 . . . . 71.12 113.729 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.562 ' HA ' ' CE2' ' D' ' 56' ' ' TYR . . . 78.63 89.29 0.06 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.886 1.674 . . . . 75.41 109.042 -172.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -161.66 40.39 0.14 Allowed 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.749 -1.114 . . . . 64.24 108.649 -167.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 68.8 -1.63 1.96 Allowed 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 114.232 1.197 . . . . 42.04 114.232 172.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.539 ' HB ' HD11 ' D' ' 83' ' ' ILE . 23.3 m -130.97 129.09 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 107.262 -1.384 . . . . 61.32 107.262 173.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.562 ' CE2' ' HA ' ' D' ' 52' ' ' ALA . 70.3 m-85 -141.81 130.09 22.29 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.822 -0.807 . . . . 72.33 108.822 -171.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -87.77 109.98 20.13 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.409 -0.96 . . . . 75.33 108.409 173.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.507 HG11 ' HD3' ' D' ' 103' ' ' PRO . 67.3 t -99.08 120.16 48.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 107.443 -1.317 . . . . 73.15 107.443 175.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.457 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.5 t -107.41 134.76 48.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.606 -0.887 . . . . 75.15 108.606 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.54 116.09 26.98 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.997 -0.742 . . . . 72.14 108.997 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -97.76 96.97 8.6 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.252 1.021 . . . . 70.23 109.051 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.603 HG13 HD11 ' D' ' 42' ' ' LEU . 57.7 t -94.73 109.14 21.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 108.523 -0.918 . . . . 60.01 108.523 175.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 40.6 m -106.11 132.18 52.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.957 -1.019 . . . . 63.52 109.065 -176.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.879 HG13 HG13 ' D' ' 40' ' ' VAL . 86.6 t -120.39 127.61 75.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.032 -0.729 . . . . 45.54 109.032 177.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 14.7 m -117.61 93.37 4.13 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.306 -1.368 . . . . 73.13 107.306 169.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.566 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -102.06 134.94 44.48 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.438 -0.579 . . . . 72.2 109.438 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.534 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 50.2 m -144.5 139.28 28.15 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 115.749 -0.66 . . . . 71.22 110.532 -171.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.519 HD12 HG22 ' D' ' 31' ' ' VAL . 21.1 mt -109.88 110.51 21.49 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 107.081 -1.451 . . . . 71.22 107.081 172.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.88 -147.34 38.08 Favored Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.956 -0.458 . . . . 73.34 111.956 -175.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.75 4.22 22.79 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.088 0.555 . . . . 42.41 112.357 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -119.63 161.95 19.79 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.399 0.68 . . . . 72.4 109.995 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.8 m -71.97 137.8 47.57 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.245 -0.889 . . . . 72.21 111.106 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.534 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -89.14 -65.8 0.98 Allowed 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.114 -1.439 . . . . 73.22 107.114 170.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -153.8 143.37 21.68 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.646 -1.161 . . . . 71.42 109.967 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 63.2 mt -101.53 149.24 24.3 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.047 -1.094 . . . . 75.43 108.047 167.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.574 ' SG ' HG23 ' D' ' 114' ' ' ILE . 35.3 t -158.92 118.91 3.14 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 117.724 0.238 . . . . 74.3 110.373 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -140.77 122.03 14.85 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.776 0.43 . . . . 63.14 110.035 -174.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 92.7 t -127.71 117.17 45.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 C-N-CA 123.951 0.9 . . . . 74.12 109.488 -175.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.607 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.8 mt-30 -90.09 90.48 8.14 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.133 -0.691 . . . . 74.51 109.133 171.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -80.72 99.53 8.26 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.669 -1.151 . . . . 64.34 108.709 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.461 ' HA3' ' HD2' ' D' ' 19' ' ' LYS . . . -92.44 143.3 16.44 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 112.193 -0.363 . . . . 42.31 112.193 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.58 130.83 4.08 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 111.822 -0.511 . . . . 53.12 111.822 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.684 HG23 ' HB2' ' D' ' 14' ' ' GLN . 5.2 tp -91.22 114.43 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.554 -0.906 . . . . 71.25 108.554 174.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -111.0 130.22 55.65 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.143 0.977 . . . . 73.34 110.291 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 10.8 t -94.6 100.79 12.68 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 109.02 -0.733 . . . . 74.32 109.02 172.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.513 HG21 HD21 ' D' ' 98' ' ' LEU . 3.6 tt -117.73 133.61 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.611 1.165 . . . . 70.11 109.552 -176.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.93 169.6 11.25 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.921 0.888 . . . . 64.32 110.502 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.91 21.54 55.35 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 115.88 -0.6 . . . . 61.3 113.974 174.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.48 HG13 ' HG2' ' D' ' 9' ' ' MET . 0.9 OUTLIER -142.34 168.51 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.809 0.843 . . . . 72.24 110.978 175.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.543 ' HG3' ' HG3' ' B' ' 153' ' ' GLN . 0.2 OUTLIER -149.21 -168.43 3.1 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.68 1.192 . . . . 75.53 109.744 177.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . 0.604 ' HA2' ' HB2' ' B' ' 154' ' ' ASP . . . 77.7 -139.4 22.89 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-N 116.156 -0.474 . . . . 73.11 112.794 174.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 11.7 m -80.23 -39.35 29.22 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.248 0.619 . . . . 75.41 109.756 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.413 ' NE2' ' HG2' ' B' ' 150' ' ' GLU . 9.7 tt0 -58.16 -36.28 72.78 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.384 1.074 . . . . 70.24 112.68 -173.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.644 ' HB2' HD11 ' E' ' 97' ' ' ILE . 0.0 OUTLIER -60.03 -48.56 81.22 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 112.807 0.669 . . . . 74.23 112.807 -172.243 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . 0.406 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.91 -26.05 25.79 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.833 0.453 . . . . 64.54 111.754 177.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -63.01 -34.25 77.15 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.587 0.755 . . . . 74.12 110.061 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 82.4 m -59.43 -50.41 74.03 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.055 0.542 . . . . 63.14 111.071 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.645 HD23 ' SG ' ' D' ' 102' ' ' CYS . 93.2 mt -69.5 -27.53 65.28 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.961 0.504 . . . . 74.14 111.95 -179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.82 3.71 71.16 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.488 -0.618 . . . . 54.2 113.829 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.83 -63.36 0.17 Allowed 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 117.695 0.748 . . . . 72.01 112.403 -175.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . 0.442 ' O ' HG12 ' D' ' 105' ' ' ILE . 71.1 t80 -69.01 -39.4 79.31 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.177 0.436 . . . . 75.12 112.177 -172.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.645 ' SG ' HD23 ' D' ' 98' ' ' LEU . 50.5 m -69.61 -47.07 25.85 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 123.712 0.805 . . . . 74.15 111.477 -176.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.507 ' HD3' HG11 ' D' ' 58' ' ' VAL . 28.1 Cg_endo -64.1 -26.78 65.31 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 121.421 1.414 . . . . 54.34 112.638 170.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -66.92 -31.2 71.64 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.741 0.416 . . . . 72.42 110.94 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.442 HG12 ' O ' ' D' ' 101' ' ' TYR . 41.9 mm -68.74 -39.76 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.006 0.923 . . . . 75.55 110.51 173.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' D' ' 103' ' ' PRO . 42.5 mt -74.31 -22.6 59.18 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.534 -0.757 . . . . 71.11 111.573 -175.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -65.28 -41.45 52.04 Favored Pre-proline 0 CA--C 1.562 1.431 0 N-CA-C 114.095 1.146 . . . . 74.42 114.095 -172.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -47.26 -48.31 15.29 Favored 'Trans proline' 0 C--N 1.389 2.669 0 C-N-CA 122.466 2.111 . . . . 73.3 113.649 169.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -73.53 -38.15 65.37 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.93 0.892 . . . . 70.51 111.26 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.39 -44.04 79.86 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.577 -0.738 . . . . 74.31 110.794 -178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 28.3 ttp180 -59.91 -49.01 79.39 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.21 0.944 . . . . 73.23 110.33 174.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -59.83 -46.0 90.62 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.142 0.901 . . . . 75.02 110.697 -175.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.4 ' O ' ' HG3' ' D' ' 117' ' ' MET . 42.5 t -55.04 -45.67 75.24 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 124.343 1.027 . . . . 45.1 110.309 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.574 HG23 ' SG ' ' D' ' 76' ' ' CYS . 72.4 mt -61.25 -60.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 124.067 0.854 . . . . 74.35 110.851 175.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 37.7 m -52.5 -42.77 64.57 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.032 1.333 . . . . 62.45 111.786 -172.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 33.1 t -65.72 -43.6 88.61 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 114.465 -1.243 . . . . 60.12 109.823 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 72.2 mtm -68.77 -28.07 66.46 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.059 0.544 . . . . 73.13 111.964 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.465 HG23 ' O ' ' D' ' 114' ' ' ILE . 92.6 t -67.23 -46.34 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.597 0.759 . . . . 73.42 109.566 176.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.7 p -73.13 -29.71 63.08 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.618 -0.719 . . . . 63.42 110.448 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 66.7 mtt-85 -69.54 -30.75 68.65 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 123.595 0.758 . . . . 71.53 109.557 172.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.65 7.23 81.75 Favored Glycine 0 C--N 1.357 1.71 0 C-N-CA 123.536 0.588 . . . . 61.11 113.0 176.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.511 HG23 ' HB3' ' C' ' 17' ' ' TYR . 66.4 p 55.37 38.92 31.01 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 126.402 1.881 . . . . 64.35 114.268 176.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -99.88 158.46 32.03 Favored Pre-proline 0 C--O 1.243 0.747 0 C-N-CA 123.427 0.691 . . . . 71.15 109.249 170.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.451 ' HA ' ' OG1' ' E' ' 129' ' ' THR . 97.7 Cg_exo -48.72 125.19 12.28 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.7 2.267 . . . . 73.25 112.156 168.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -47.28 126.69 9.79 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.826 1.329 . . . . 63.32 112.495 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.679 HD13 HG21 ' D' ' 40' ' ' VAL . 17.5 tp -107.21 97.75 7.48 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.9 0.88 . . . . 74.21 109.058 -176.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -99.35 99.0 9.87 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.608 -1.256 . . . . 72.13 107.608 173.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.794 HD11 HD22 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -68.47 120.24 14.22 Favored 'General case' 0 CA--C 1.552 1.048 0 N-CA-C 108.259 -1.015 . . . . 60.02 108.259 -179.445 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.49 141.7 94.45 Favored Pre-proline 0 CA--C 1.562 1.413 0 C-N-CA 123.535 0.734 . . . . 72.52 110.914 -177.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -57.74 132.61 51.07 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 123.091 2.527 . . . . 72.44 113.388 -174.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 96.1 t -107.44 123.43 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 108.415 -0.957 . . . . 73.1 108.415 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -86.9 91.93 8.84 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.044 -1.095 . . . . 41.02 108.044 173.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -58.7 -31.61 68.41 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.397 1.079 . . . . 75.5 111.796 -174.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -63.03 -36.64 84.25 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.142 -0.936 . . . . 72.42 110.461 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.79 -31.2 68.99 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.836 0.854 . . . . 72.23 111.932 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 6.2 mp -71.53 -45.43 62.39 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.734 -0.469 . . . . 72.4 109.734 175.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.579 ' HA ' ' HE1' ' E' ' 109' ' ' TYR . 3.8 t80 -61.73 -36.9 82.33 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.484 -0.78 . . . . 72.45 110.083 178.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 29.1 ttm -68.71 -37.88 79.82 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.062 1.345 . . . . 64.45 110.82 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -61.9 -36.13 80.41 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.748 1.219 . . . . 63.04 111.353 -178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -68.02 -44.17 77.14 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.682 0.793 . . . . 74.41 111.172 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.409 HD13 ' O ' ' D' ' 137' ' ' PHE . 10.6 mp -69.36 -32.27 71.22 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.392 0.677 . . . . 63.4 111.623 -177.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -90.8 17.72 7.39 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.95 0.5 . . . . 71.33 110.819 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -118.23 45.33 2.02 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.631 -1.248 . . . . 72.43 107.631 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -145.0 179.5 7.31 Favored 'General case' 0 C--O 1.248 1.024 0 CA-C-N 113.288 -1.778 . . . . 74.42 108.404 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.35 92.69 1.44 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.374 -0.602 . . . . 64.52 109.374 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 164.7 -13.26 0.08 OUTLIER Glycine 0 C--N 1.34 0.802 0 CA-C-N 114.936 -1.029 . . . . 73.44 112.594 -176.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -60.17 104.19 0.29 Allowed 'General case' 0 C--N 1.361 1.101 0 C-N-CA 123.338 0.655 . . . . 73.24 110.651 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 178.04 51.36 0.07 OUTLIER Glycine 0 CA--C 1.506 -0.515 0 N-CA-C 110.063 -1.215 . . . . 65.5 110.063 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 5.3 t -116.61 95.38 5.01 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.953 0.901 . . . . 60.13 109.867 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.94 91.8 1.66 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 106.832 -1.544 . . . . 73.03 106.832 172.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -149.92 30.79 0.71 Allowed 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.755 1.222 . . . . 70.02 108.773 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 -152.99 140.65 19.91 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.989 -1.005 . . . . 74.14 108.544 -177.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -60.55 -64.31 1.0 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.329 1.052 . . . . 73.21 111.517 -173.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -108.56 151.27 26.33 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.116 0.966 . . . . 65.23 109.484 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 C-N-CA 123.33 0.652 . . . . 70.24 109.256 -177.704 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 CA-C-O 119.939 -0.367 . . . . 43.21 112.431 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.27 96.58 0.05 OUTLIER Glycine 0 C--N 1.354 1.531 0 CA-C-O 119.198 -0.779 . . . . 74.42 111.955 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 93' ' ' PHE . . . . . 0.411 ' CD2' HG11 ' D' ' 55' ' ' VAL . 3.1 m-85 70.82 103.74 0.06 Allowed 'General case' 0 CA--C 1.56 1.344 0 C-N-CA 124.739 1.216 . . . . 75.33 110.094 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -78.5 178.97 7.34 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.349 1.059 . . . . 73.23 113.026 -166.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.24 133.97 21.13 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.262 1.025 . . . . 71.32 109.295 174.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 162.23 -60.73 0.28 Allowed Glycine 0 C--N 1.356 1.69 0 CA-C-O 119.962 -0.355 . . . . 73.2 113.343 -177.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 97' ' ' ILE . . . . . 0.644 HD11 ' HB2' ' D' ' 94' ' ' MET . 1.9 tt -73.33 127.63 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-O 121.437 0.637 . . . . 60.21 110.658 -175.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -140.25 -167.53 2.34 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.018 0.927 . . . . 74.03 109.74 -177.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . 66.85 30.3 7.91 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.768 1.227 . . . . 41.51 111.172 -175.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 100' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -88.22 103.67 5.57 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 124.022 0.929 . . . . 73.23 110.804 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -87.07 -26.88 0.75 Allowed 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.065 2.51 . . . . 73.45 113.816 -175.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 102' ' ' LEU . . . . . 0.573 HD12 HG23 ' E' ' 103' ' ' THR . 2.3 pp -85.64 3.4 41.08 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.033 0.933 . . . . 75.02 111.602 -173.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 103' ' ' THR . . . . . 0.573 HG23 HD12 ' E' ' 102' ' ' LEU . 44.6 p -110.08 -14.36 14.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.522 1.129 . . . . 74.33 110.937 -178.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . -73.18 -69.44 1.39 Allowed Glycine 0 C--N 1.352 1.425 0 O-C-N 123.074 0.234 . . . . 74.41 112.638 -177.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -110.56 -62.51 1.52 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.399 0.679 . . . . 73.44 109.678 -176.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -165.88 144.64 6.0 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 114.734 -1.121 . . . . 71.22 108.167 -173.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 10.0 m -67.26 116.64 8.26 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.223 -0.658 . . . . 74.13 109.223 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -73.89 -5.02 38.53 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.339 0.656 . . . . 44.35 112.023 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 109' ' ' TYR . . . . . 0.579 ' HE1' ' HA ' ' D' ' 137' ' ' PHE . 70.7 t80 -137.53 82.03 1.9 Allowed 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 107.193 -1.41 . . . . 73.42 107.193 164.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -85.74 58.17 4.89 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.476 0.71 . . . . 74.51 111.692 -174.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . . . . . . . . . 22.9 tp 69.56 -77.86 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.518 1.527 . . . . 72.43 111.926 174.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -75.2 95.59 3.15 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.942 0.497 . . . . 75.32 110.267 -178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -122.85 133.74 54.42 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.481 -0.563 . . . . 64.3 109.481 173.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . 0.405 ' H ' ' HG2' ' E' ' 114' ' ' LYS . 15.5 ptmt -80.87 68.81 7.26 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.46 1.104 . . . . 74.44 109.887 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 46.9 p -70.68 -52.8 18.71 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.692 -1.14 . . . . 54.33 110.965 -175.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . -164.26 -56.25 0.02 OUTLIER Glycine 0 C--N 1.34 0.765 0 CA-C-N 115.871 -0.604 . . . . 55.41 111.663 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -176.17 77.08 0.28 Allowed Pre-proline 0 CA--C 1.557 1.226 0 C-N-CA 124.032 0.933 . . . . 73.2 108.696 -177.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -71.05 -33.2 12.12 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 122.377 2.051 . . . . 72.5 113.292 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 61.14 23.34 13.54 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 125.275 1.43 . . . . 72.24 113.149 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -108.9 157.18 18.87 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.119 -1.067 . . . . 74.34 108.119 171.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 121' ' ' VAL . . . . . 0.465 HG13 HD23 ' D' ' 42' ' ' LEU . 57.0 t 74.98 101.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.49 1.116 . . . . 71.43 109.118 -175.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 15.1 t -76.9 166.14 23.74 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.446 -0.797 . . . . 61.34 112.792 -169.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -112.58 -4.86 14.06 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.974 1.31 . . . . 63.13 110.33 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 49.4 m -144.63 125.37 14.2 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.192 0.597 . . . . 74.32 110.206 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -84.89 166.43 16.85 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.098 0.559 . . . . 74.2 110.156 173.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -116.82 32.4 6.17 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.446 0.698 . . . . 71.14 111.172 -175.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 55.0 m -136.83 120.93 17.77 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.424 0.69 . . . . 55.34 109.424 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -145.38 136.35 24.66 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.236 0.614 . . . . 70.42 109.723 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 129' ' ' THR . . . . . 0.46 HG22 ' NH2' ' B' ' 15' ' ' ARG . 61.2 p -118.66 133.52 55.8 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.954 0.902 . . . . 74.54 109.729 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.43 84.48 0.59 Allowed 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.504 0.721 . . . . 72.34 109.141 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 131' ' ' TRP . . . . . 0.659 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 1.9 t-105 -96.13 66.42 2.52 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.256 -0.884 . . . . 73.42 109.316 -171.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 57.4 m -135.31 84.03 2.06 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.55 -0.75 . . . . 75.03 109.915 -179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 63.0 m -145.68 104.74 3.91 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.793 0.837 . . . . 73.42 108.952 176.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -99.81 43.66 1.77 Allowed Glycine 0 C--N 1.345 1.063 0 CA-C-O 119.592 -0.56 . . . . 74.14 112.12 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 135' ' ' VAL . . . . . 0.473 HG12 ' H ' ' E' ' 137' ' ' THR . 57.9 t 63.51 -79.99 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 125.077 1.351 . . . . 63.3 111.977 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 136' ' ' LYS . . . . . 0.418 ' HE3' HE22 ' C' ' 12' ' ' GLN . 8.0 mmpt? 56.09 31.37 18.02 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.532 1.133 . . . . 62.54 112.847 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 137' ' ' THR . . . . . 0.473 ' H ' HG12 ' E' ' 135' ' ' VAL . 18.5 m -98.99 -48.9 4.71 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.217 0.451 . . . . 54.11 112.217 -175.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -97.28 -12.69 22.6 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.395 0.678 . . . . 64.31 111.724 -170.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -72.97 89.14 1.4 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.721 0.808 . . . . 61.5 111.197 -171.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -90.69 -29.22 13.97 Favored Glycine 0 C--N 1.344 0.978 0 CA-C-N 115.892 -0.594 . . . . 61.03 112.547 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -113.72 164.71 13.35 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.842 0.857 . . . . 60.3 111.321 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 49.6 tp -157.04 144.43 18.85 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.64 0.776 . . . . 73.24 109.315 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -142.57 157.92 26.83 Favored Glycine 0 C--N 1.341 0.858 0 N-CA-C 111.561 -0.615 . . . . 73.45 111.561 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.87 62.21 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.115 0.966 . . . . 75.41 108.414 170.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 30.9 t70 . . . . . 0 CA--C 1.561 1.402 0 C-N-CA 125.034 1.334 . . . . 64.2 110.985 -175.333 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.461 0 N-CA-C 111.221 -0.752 . . . . 72.11 111.221 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.78 -116.57 6.97 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-O 119.639 -0.534 . . . . 74.42 113.04 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 52.0 41.64 29.85 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.815 1.246 . . . . 73.03 111.176 -172.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -72.5 148.78 44.73 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-N 114.567 -1.197 . . . . 74.52 109.533 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -146.59 164.14 33.56 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.277 0.631 . . . . 51.24 111.079 -166.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.57 46.5 0.03 OUTLIER Glycine 0 C--N 1.345 1.063 0 N-CA-C 110.946 -0.862 . . . . 61.22 110.946 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 97' ' ' ILE . . . . . 0.766 HD11 ' HB2' ' B' ' 94' ' ' MET . 9.1 tt -141.85 -16.78 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.467 1.107 . . . . 71.13 110.074 -176.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 16.8 t70 70.87 112.49 0.06 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.035 1.334 . . . . 74.23 111.804 177.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . 70.28 -68.02 0.22 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 125.516 1.526 . . . . 74.01 113.46 166.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 100' ' ' LEU . . . . . 0.492 HD21 HD11 ' B' ' 98' ' ' LEU . 54.0 tp 73.39 70.05 0.26 Allowed Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 125.431 1.493 . . . . 73.25 111.803 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -93.17 135.12 1.15 Allowed 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 123.13 2.553 . . . . 71.0 112.609 173.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 102' ' ' LEU . . . . . 0.44 HD13 ' HB1' ' B' ' 95' ' ' ALA . 0.7 OUTLIER -166.27 -159.46 0.38 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.567 0.747 . . . . 72.51 110.709 177.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 103' ' ' THR . . . . . 0.41 HG21 HG23 ' F' ' 107' ' ' THR . 72.4 p -62.48 81.06 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 125.806 1.642 . . . . 64.42 112.974 -174.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . -85.96 168.61 41.35 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 115.205 -0.907 . . . . 73.11 111.595 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 61.42 -77.33 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.669 1.188 . . . . 74.11 110.287 -172.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -150.08 136.82 19.23 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.914 0.886 . . . . 64.41 109.511 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . 0.41 HG23 HG21 ' F' ' 103' ' ' THR . 22.6 m -77.27 130.53 37.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.487 0.715 . . . . 75.14 110.082 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -81.12 -22.29 39.19 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.425 0.69 . . . . 71.52 111.125 177.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 109' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' F' ' 115' ' ' THR . 12.6 m-30 -92.54 50.99 1.67 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.881 -1.155 . . . . 72.15 107.881 167.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.92 140.17 58.32 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 115.617 -0.72 . . . . 73.33 111.214 -175.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . 0.701 HD11 HD22 ' B' ' 136' ' ' LEU . 16.1 tp -66.08 -10.49 40.82 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-N 115.721 -0.672 . . . . 74.52 111.029 177.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -54.83 171.82 0.12 Allowed 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 125.867 1.667 . . . . 73.44 110.681 167.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -71.41 71.05 0.64 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.505 0.669 . . . . 61.11 110.785 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -145.5 -164.34 1.92 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.74 1.216 . . . . 71.41 109.617 -169.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 115' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' F' ' 109' ' ' TYR . 52.1 p -77.21 60.02 1.86 Allowed 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 124.142 0.977 . . . . 74.03 110.586 173.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . -137.79 -77.3 0.07 OUTLIER Glycine 0 C--N 1.349 1.29 0 N-CA-C 110.391 -1.084 . . . . 63.43 110.391 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -86.28 132.65 42.57 Favored Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 108.676 -0.861 . . . . 75.34 108.676 169.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 118' ' ' PRO . . . . . 0.469 ' HG3' ' OD1' ' B' ' 139' ' ' ASN . 58.7 Cg_endo -70.23 -49.41 0.5 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 121.982 1.788 . . . . 74.21 110.936 172.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -153.68 -95.99 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 107.675 -1.232 . . . . 74.21 107.675 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 50.13 -82.88 0.01 OUTLIER 'General case' 0 C--N 1.37 1.475 0 C-N-CA 125.159 1.383 . . . . 74.34 112.038 -173.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 46.6 t -72.73 90.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.691 0 N-CA-C 108.643 -0.873 . . . . 60.01 108.643 177.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 45.5 p -59.19 153.05 19.14 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.837 -1.074 . . . . 75.4 110.059 173.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -69.32 75.03 0.36 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.855 0.862 . . . . 62.14 111.229 -174.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 8.3 t -179.35 -178.49 0.49 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.447 1.899 . . . . 71.41 107.431 -176.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -137.04 -71.24 0.44 Allowed 'General case' 0 N--CA 1.481 1.109 0 O-C-N 122.106 -0.371 . . . . 55.24 110.27 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -166.65 164.11 16.79 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.394 -0.821 . . . . 71.25 109.783 -175.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 50.5 m -79.42 87.84 5.04 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.931 -0.577 . . . . 63.25 109.508 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.67 104.34 2.37 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.329 -0.851 . . . . 64.12 109.452 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 32.4 m -85.25 125.56 32.98 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.144 0.578 . . . . 74.53 110.38 -175.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 130' ' ' ALA . . . . . 0.532 ' HB2' ' HG3' ' B' ' 124' ' ' PRO . . . -74.48 149.37 40.35 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.449 0.7 . . . . 43.22 110.915 178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 42.0 p-90 -106.71 150.36 26.34 Favored 'General case' 0 C--O 1.245 0.855 0 N-CA-C 109.273 -0.64 . . . . 74.04 109.273 175.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 22.7 t -154.92 43.83 0.49 Allowed 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.366 -0.976 . . . . 74.52 108.366 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 40.0 p -65.09 106.65 1.33 Allowed 'General case' 0 C--N 1.354 0.762 0 CA-C-N 115.179 -0.918 . . . . 70.11 109.222 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -63.38 90.62 0.08 OUTLIER Glycine 0 C--N 1.35 1.315 0 O-C-N 123.972 0.795 . . . . 51.04 112.938 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 3.8 p -63.11 97.54 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-O 121.826 0.822 . . . . 74.11 109.336 175.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -80.74 69.43 7.28 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.894 -1.048 . . . . 75.53 110.318 -170.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 33.3 m 61.17 -77.94 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.381 1.472 . . . . 55.02 111.472 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -167.58 -39.99 0.02 OUTLIER 'General case' 0 C--O 1.242 0.699 0 C-N-CA 125.186 1.395 . . . . 73.12 107.565 174.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 9.5 t30 71.56 -72.96 0.1 Allowed 'General case' 0 C--N 1.361 1.096 0 C-N-CA 125.76 1.624 . . . . 72.33 110.579 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . 172.7 174.84 40.21 Favored Glycine 0 C--N 1.341 0.824 0 N-CA-C 111.678 -0.569 . . . . 71.53 111.678 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -92.18 94.65 9.3 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.488 0.715 . . . . 54.1 109.592 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -142.15 140.73 32.51 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.628 0.771 . . . . 74.44 109.422 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -108.58 119.01 5.51 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 110.755 -0.938 . . . . 73.42 110.755 175.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 28.9 m -90.28 142.67 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 123.057 0.543 . . . . 71.22 110.381 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 108.552 -0.907 . . . . 55.31 108.552 175.748 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.434 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.298 0.094 . . . . 42.43 110.968 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.2 t -134.15 81.1 1.89 Allowed 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.94 -1.133 . . . . 73.53 107.94 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -100.57 108.71 20.69 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.317 1.047 . . . . 72.22 109.122 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -85.58 115.35 23.22 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.794 0.838 . . . . 73.52 110.07 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -128.3 174.65 9.12 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.178 -1.045 . . . . 74.03 108.178 175.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -61.48 -27.93 68.94 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.914 0.486 . . . . 63.32 111.578 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.8 t -145.16 155.4 43.26 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.703 0.801 . . . . 75.31 109.77 169.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -166.22 -69.32 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 106.733 -1.58 . . . . 74.1 106.733 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.44 ' HG2' HG23 ' A' ' 89' ' ' ILE . 67.0 mtt -136.22 162.84 31.85 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.369 1.068 . . . . 73.35 108.691 169.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 25.8 m -141.52 130.06 22.64 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.159 -1.052 . . . . 74.22 108.159 177.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -137.24 119.04 15.13 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.09 -1.078 . . . . 64.41 108.09 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -134.78 132.21 38.44 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.646 -0.872 . . . . 61.03 108.646 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.517 ' CD1' HG21 ' A' ' 105' ' ' ILE . 4.9 mt -94.33 113.36 28.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.645 -0.872 . . . . 73.21 108.645 175.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -78.43 -40.26 36.34 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 123.375 0.422 . . . . 75.1 110.006 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -170.68 124.7 0.68 Allowed 'General case' 0 C--N 1.354 0.799 0 CA-C-N 115.946 -0.57 . . . . 74.12 111.042 -173.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.412 HD12 ' HG3' ' C' ' 130' ' ' PRO . 81.2 mt -106.97 140.28 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 107.944 -1.132 . . . . 64.11 107.944 167.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.521 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 31.7 p90 -164.92 166.25 19.66 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.306 0.574 . . . . 64.53 111.366 -174.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -94.27 122.06 36.42 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 109.484 -0.562 . . . . 54.54 109.484 172.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.455 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 43.0 mtpt -80.11 -35.08 37.33 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.211 -0.662 . . . . 72.14 109.211 174.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -149.93 137.95 20.3 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.277 -1.329 . . . . 65.13 109.826 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.547 HG21 ' SD ' ' B' ' 117' ' ' MET . 73.1 mt -134.99 143.82 36.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 125.317 1.447 . . . . 74.35 108.008 178.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.9 t -156.71 119.93 4.16 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 123.524 0.515 . . . . 61.33 110.593 170.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.628 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.8 t80 -111.5 143.41 42.38 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.019 -1.475 . . . . 74.15 107.019 165.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -139.66 141.31 37.03 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.703 0.401 . . . . 72.12 110.669 177.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.19 69.92 13.01 Favored Pre-proline 0 C--O 1.242 0.692 0 N-CA-C 107.181 -1.415 . . . . 64.3 107.181 170.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.35 -8.21 19.48 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.448 2.099 . . . . 61.23 112.303 -174.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -114.72 17.52 17.08 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 124.311 1.044 . . . . 62.44 109.246 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.517 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -46.24 -54.31 18.4 Favored Pre-proline 0 CA--C 1.567 1.607 0 CA-C-O 118.006 -0.997 . . . . 75.2 113.667 -169.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -61.81 -24.02 76.8 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 122.016 1.81 . . . . 73.01 113.542 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -84.84 -44.86 12.86 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.757 0.823 . . . . 72.41 111.017 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.927 HG21 ' HA ' ' A' ' 73' ' ' ALA . 8.6 p -77.03 -21.71 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 115.346 -0.843 . . . . 74.25 112.815 -161.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -66.96 -17.24 64.82 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 116.151 -0.477 . . . . 73.21 111.471 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -91.87 -14.46 29.65 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.551 1.14 . . . . 52.51 110.87 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.496 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 19.0 mmtp -79.54 160.31 26.53 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.21 0.604 . . . . 70.33 111.549 -176.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -69.59 131.24 44.35 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.896 0.879 . . . . 72.43 109.152 173.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.496 ' CE3' HD21 ' A' ' 68' ' ' LEU . 68.6 t-105 -81.6 81.07 7.8 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.494 0.664 . . . . 72.54 110.042 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -129.08 77.76 77.31 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.552 1.141 . . . . 72.03 108.035 172.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -85.96 145.22 8.71 Favored 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.669 2.246 . . . . 62.15 113.192 -173.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -101.31 84.97 2.71 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.826 -1.176 . . . . 71.41 107.826 164.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.679 HG11 HD11 ' A' ' 126' ' ' LEU . 77.7 t -81.65 96.96 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 108.419 -0.956 . . . . 61.44 108.419 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -95.96 123.3 39.5 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.347 -0.612 . . . . 74.43 109.347 177.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mp -97.91 107.05 19.45 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.504 -1.295 . . . . 65.44 107.504 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -111.58 119.16 37.79 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.469 -0.937 . . . . 54.31 108.469 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.498 HD22 HD21 ' A' ' 60' ' ' LEU . 89.0 mt -112.17 139.4 47.74 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.441 0.696 . . . . 73.1 111.805 -169.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.482 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 19.4 t70 -132.29 144.09 50.35 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.78 1.232 . . . . 41.54 108.536 176.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.4 m -141.35 135.19 30.23 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 123.495 0.718 . . . . 72.55 109.434 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.6 123.78 10.83 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.633 0.773 . . . . 63.42 109.483 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.419 ' HB3' ' HB3' ' A' ' 98' ' ' LEU . 78.9 p -97.54 162.39 13.33 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.445 0.698 . . . . 50.14 110.27 175.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 42.0 t -158.56 155.59 28.62 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.299 1.04 . . . . 72.25 108.53 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -102.53 115.96 31.63 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.296 -0.631 . . . . 70.24 109.296 175.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.634 HD11 ' HB2' ' A' ' 57' ' ' GLU . 56.6 mt -82.52 -40.83 20.48 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.494 0.718 . . . . 64.14 110.257 176.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.41 -174.57 5.0 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.251 -0.886 . . . . 65.11 110.713 -176.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -59.65 115.84 3.61 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.796 0.838 . . . . 72.15 110.135 176.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 71.74 -6.16 1.5 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.907 1.283 . . . . 74.44 112.843 -177.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.6 t -98.76 115.65 39.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.718 -0.845 . . . . 63.43 108.718 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -126.01 125.08 42.08 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.161 0.984 . . . . 61.52 109.061 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.634 ' HB2' HD11 ' A' ' 51' ' ' LEU . 33.2 tt0 -92.05 123.33 35.33 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.483 -0.562 . . . . 63.11 109.483 171.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.8 t -107.28 136.03 43.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.405 -0.961 . . . . 64.22 108.405 168.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.7 t -120.18 130.33 74.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.191 -1.04 . . . . 71.42 108.191 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.498 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -107.07 105.03 14.85 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.411 -1.7 . . . . 71.44 106.411 175.188 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.482 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 31.6 ttp180 -92.51 100.49 13.03 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.216 -1.402 . . . . 74.4 107.216 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.2 t -96.15 127.05 48.59 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 108.182 -1.044 . . . . 62.54 108.182 176.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 25.1 m -123.86 118.56 27.39 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.598 -0.89 . . . . 74.51 108.598 174.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.597 HG11 HD21 ' A' ' 126' ' ' LEU . 71.9 t -120.52 132.4 70.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 107.914 -1.143 . . . . 64.3 107.914 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.1 m -137.2 132.43 33.87 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.583 -0.895 . . . . 71.32 108.583 174.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.561 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -114.31 114.95 26.62 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.541 1.137 . . . . 62.42 108.142 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 71.2 m -120.81 134.98 55.27 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.401 0.619 . . . . 74.42 111.146 178.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.496 HD21 ' CE3' ' A' ' 36' ' ' TRP . 42.0 mt -94.91 42.27 1.09 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.402 1.481 . . . . 74.41 111.111 -176.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.61 -84.87 1.51 Allowed Glycine 0 C--N 1.339 0.698 0 CA-C-O 119.749 -0.473 . . . . 33.1 112.164 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -86.56 -30.66 21.71 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.211 0.529 . . . . 73.11 111.353 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.449 ' HB2' ' NZ ' ' A' ' 34' ' ' LYS . 4.6 tp10 -119.96 133.64 55.49 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.62 -0.881 . . . . 42.44 108.62 -174.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 73.7 m -77.71 134.37 38.13 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.111 -0.7 . . . . 64.31 109.111 170.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.927 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -71.83 -64.59 0.9 Allowed 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.507 0.723 . . . . 74.21 109.45 177.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -159.57 166.72 30.18 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 115.253 -0.885 . . . . 75.0 112.039 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.7 tp -117.92 143.11 46.62 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.571 -1.195 . . . . 64.43 108.693 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.446 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 79.1 m -143.07 104.53 4.31 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.131 0.973 . . . . 75.4 109.622 175.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -123.1 127.69 49.07 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.539 0.736 . . . . 74.21 109.017 177.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.3 t -137.55 112.75 10.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 124.352 1.061 . . . . 62.21 109.094 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -86.21 85.65 7.34 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.781 -0.822 . . . . 65.22 108.781 171.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -78.37 96.26 5.29 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.948 -1.024 . . . . 64.42 110.31 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.14 155.74 30.23 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 111.724 -0.551 . . . . 73.11 111.724 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.508 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -151.51 122.3 1.33 Allowed Glycine 0 C--N 1.329 0.164 0 N-CA-C 111.703 -0.559 . . . . 62.41 111.703 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.9 mt -81.17 117.63 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.941 0.896 . . . . 71.23 108.665 171.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.695 ' HB3' HD11 ' A' ' 86' ' ' ILE . 90.8 m-85 -124.27 122.26 37.26 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.489 1.116 . . . . 62.34 109.491 -177.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.1 t -91.77 105.39 17.68 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.239 -0.652 . . . . 75.11 109.239 173.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.695 HD11 ' HB3' ' A' ' 84' ' ' PHE . 1.9 mm -112.38 153.78 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.489 0.715 . . . . 72.5 109.43 -177.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.426 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -158.23 160.61 37.31 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.557 0.743 . . . . 73.24 111.235 177.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.1 -7.62 64.58 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 119.184 -0.787 . . . . 73.44 113.928 174.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.485 ' HA ' ' HG2' ' A' ' 151' ' ' GLU . 0.1 OUTLIER -144.06 153.37 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 124.056 0.942 . . . . 73.55 111.695 -178.529 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -141.84 178.25 7.63 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.01 1.724 . . . . 63.55 108.625 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.47 -139.78 29.62 Favored Glycine 0 C--N 1.349 1.26 0 N-CA-C 114.063 0.385 . . . . 73.43 114.063 173.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.2 t -72.4 -19.38 61.61 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.258 0.623 . . . . 64.44 111.439 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.574 HE22 ' HB2' ' A' ' 151' ' ' GLU . 8.2 mt-30 -70.78 -43.82 67.94 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.992 0.917 . . . . 72.21 109.576 173.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.8 tpt -63.82 -42.31 97.69 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.085 -0.961 . . . . 72.12 109.849 174.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.3 -33.75 76.2 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.449 -0.796 . . . . 62.41 111.344 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.463 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 53.0 t-80 -71.1 -27.02 63.3 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.169 0.588 . . . . 61.21 111.193 178.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -78.6 -52.79 7.95 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 109.823 -0.436 . . . . 72.3 109.823 175.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 48' ' ' SER . 89.6 mt -72.98 -35.24 66.84 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.789 0.835 . . . . 55.31 112.773 -171.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.08 4.0 60.55 Favored Glycine 0 N--CA 1.469 0.842 0 CA-C-N 115.97 -0.559 . . . . 64.31 113.674 -172.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.561 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -146.51 -58.45 0.29 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 117.31 0.555 . . . . 53.42 112.19 -173.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.409 ' O ' HG12 ' A' ' 105' ' ' ILE . 41.6 t80 -71.83 -42.28 67.15 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.046 0.451 . . . . 74.04 110.742 -176.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 63.7 m -67.63 -49.43 40.03 Favored Pre-proline 0 CA--C 1.565 1.552 0 C-N-CA 124.733 1.213 . . . . 74.01 112.852 -175.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.407 ' HA ' HD12 ' A' ' 106' ' ' LEU . 47.5 Cg_endo -65.79 -24.85 53.86 Favored 'Trans proline' 0 C--N 1.395 2.982 0 C-N-CA 122.035 1.823 . . . . 74.01 112.437 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -64.91 -37.14 86.64 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.457 0.703 . . . . 74.52 110.476 175.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.517 HG21 ' CD1' ' A' ' 13' ' ' ILE . 49.5 mm -69.02 -40.73 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.544 0.737 . . . . 72.23 110.407 174.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.508 HD21 ' HA3' ' A' ' 82' ' ' GLY . 48.3 mt -72.74 -25.18 61.11 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.475 -0.784 . . . . 62.1 112.123 -175.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -61.68 -45.09 93.15 Favored Pre-proline 0 N--CA 1.487 1.394 0 N-CA-C 113.768 1.025 . . . . 65.33 113.768 -172.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -52.05 -37.34 68.16 Favored 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 122.51 2.14 . . . . 75.53 113.876 170.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -84.09 -29.11 27.06 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.51 0.724 . . . . 74.32 112.001 -176.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.76 -45.19 75.61 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.554 -0.906 . . . . 75.4 108.554 172.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.558 ' NH1' HD12 ' C' ' 105' ' ' ILE . 36.5 ttm180 -59.9 -40.81 90.06 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.071 -1.422 . . . . 74.31 110.515 174.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' C' ' 108' ' ' PRO . 25.7 tt0 -51.21 -54.53 24.77 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.623 1.169 . . . . 74.43 110.813 177.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 117' ' ' MET . 48.9 t -66.17 -47.21 74.72 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.435 -1.257 . . . . 64.12 111.437 -176.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 118' ' ' VAL . 92.1 mt -58.69 -59.14 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 124.173 0.989 . . . . 73.22 110.953 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 27.1 m -56.82 -38.55 72.77 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.359 1.064 . . . . 74.1 111.575 -177.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.1 t -63.35 -48.82 76.39 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.892 -1.049 . . . . 61.22 110.817 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.628 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 41.2 mtm -61.46 -40.25 93.83 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.816 0.697 . . . . 71.23 111.253 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 126' ' ' LEU . 82.5 t -56.77 -49.97 76.5 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 O-C-N 124.252 0.97 . . . . 54.51 110.813 175.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.6 t -68.17 -33.51 74.59 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.234 -0.893 . . . . 65.24 111.165 -177.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.55 HH12 ' HG3' ' B' ' 112' ' ' GLU . 81.8 mtt-85 -72.61 -29.43 63.48 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.537 0.735 . . . . 73.34 110.172 177.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.452 ' O ' HG22 ' A' ' 122' ' ' THR . . . -86.17 16.41 43.54 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-O 118.812 -0.993 . . . . 73.02 113.375 175.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.475 HG21 ' HE ' ' B' ' 15' ' ' ARG . 3.0 t 60.47 11.65 3.09 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 126.781 2.033 . . . . 74.41 113.66 176.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -81.88 156.66 69.86 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.708 0.803 . . . . 75.44 109.911 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.545 ' HB3' ' HA ' ' E' ' 131' ' ' TRP . 18.6 Cg_endo -60.21 129.29 29.41 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.503 2.136 . . . . 71.31 111.33 175.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -49.05 121.68 5.06 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 125.116 1.51 . . . . 73.43 112.213 -173.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.679 HD11 HG11 ' A' ' 40' ' ' VAL . 56.5 tp -108.78 102.11 11.18 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.922 -0.581 . . . . 72.41 109.662 -174.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.413 HD22 HG21 ' E' ' 135' ' ' VAL . 42.3 m-80 -98.85 121.87 41.35 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.594 -1.262 . . . . 64.03 107.594 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 11.2 mt -72.02 129.88 39.61 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 110.082 -0.34 . . . . 74.35 110.082 -177.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -64.91 141.36 98.35 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 116.046 -0.524 . . . . 74.22 110.771 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.613 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 49.2 Cg_exo -57.7 128.74 30.37 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 123.284 2.656 . . . . 75.34 113.558 -176.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 85.8 t -120.58 132.3 70.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 C-N-CA 123.942 0.897 . . . . 64.45 109.824 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -96.43 95.48 8.07 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.752 0.821 . . . . 63.13 108.871 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -62.57 -21.09 65.33 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.941 0.897 . . . . 65.43 112.576 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.561 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 11.7 t70 -56.96 -51.03 70.81 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.55 0.74 . . . . 65.13 110.045 170.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.7 -40.49 95.22 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 124.106 0.879 . . . . 74.32 111.326 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.92 -32.07 73.47 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.463 -0.79 . . . . 73.24 111.248 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -77.3 -33.94 55.56 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.737 -0.665 . . . . 74.33 110.413 176.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.624 ' SD ' HD23 ' A' ' 141' ' ' LEU . 26.3 mmt -61.25 -28.35 69.1 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.386 0.674 . . . . 54.22 111.517 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -61.63 -29.26 69.94 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.294 1.037 . . . . 74.0 111.5 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -92.76 -41.17 10.27 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.519 0.728 . . . . 72.43 110.324 174.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.624 HD23 ' SD ' ' A' ' 138' ' ' MET . 61.4 tp -66.73 -48.66 68.48 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.272 1.029 . . . . 75.41 111.897 -166.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.438 ' NE2' ' SD ' ' A' ' 138' ' ' MET . 28.5 pt20 -143.46 24.34 1.75 Allowed 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 112.02 0.378 . . . . 73.34 112.02 -165.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -69.71 -39.95 76.58 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 109.044 -0.724 . . . . 63.4 109.044 168.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -155.09 -27.72 0.11 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 114.669 -1.15 . . . . 74.4 110.029 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.3 -44.9 96.44 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.469 0.708 . . . . 71.01 111.807 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 106.79 -111.59 3.57 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-O 119.694 -0.503 . . . . 71.2 112.841 174.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -176.99 162.45 2.05 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.956 0.903 . . . . 71.11 109.196 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -151.91 53.55 0.47 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.684 -0.566 . . . . 63.21 111.684 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 26.4 p -76.76 88.41 3.39 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.683 0.754 . . . . 75.22 110.434 177.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -141.46 97.06 3.09 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 107.417 -1.327 . . . . 73.03 107.417 172.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.574 ' HB2' HE22 ' A' ' 93' ' ' GLN . 11.5 tp10 -130.41 120.41 24.19 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 120.939 0.4 . . . . 65.21 110.332 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -80.2 88.96 5.45 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.149 -1.056 . . . . 71.32 108.149 173.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -70.27 74.12 0.5 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.084 0.954 . . . . 74.43 111.056 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -133.57 158.75 42.37 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.125 0.57 . . . . 64.3 110.368 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.831 0 C-N-CA 124.507 1.123 . . . . 54.45 109.359 -179.023 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptp . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 120.303 0.097 . . . . 53.51 110.802 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -75.67 101.5 5.02 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 109.02 -0.733 . . . . 73.32 109.02 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -63.49 -24.09 67.67 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.055 0.942 . . . . 61.04 112.145 -178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -116.8 84.95 2.23 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.918 0.887 . . . . 74.21 108.697 175.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -172.77 89.58 0.09 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.204 1.002 . . . . 73.21 108.722 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -147.49 -44.14 0.17 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.296 1.038 . . . . 54.31 108.913 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 32.9 m 69.26 103.19 0.06 Allowed 'General case' 0 C--N 1.358 0.936 0 C-N-CA 125.091 1.356 . . . . 72.45 110.867 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 72.06 137.11 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.788 1.235 . . . . 63.02 111.704 175.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.578 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 0.5 OUTLIER 66.05 165.58 0.19 Allowed 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 125.662 1.585 . . . . 74.22 112.026 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.494 ' N ' ' SD ' ' B' ' 9' ' ' MET . 78.8 m -153.22 105.93 2.93 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.181 0.992 . . . . 74.42 108.746 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -109.72 139.46 44.73 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.413 -0.958 . . . . 73.52 108.413 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -149.89 141.24 23.26 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.699 0.8 . . . . 73.12 109.272 174.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 19.0 mt -94.6 124.98 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 107.545 -1.28 . . . . 60.43 107.545 171.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -87.53 -48.95 7.52 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.827 -0.434 . . . . 73.03 109.827 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.475 ' HE ' HG21 ' A' ' 122' ' ' THR . 48.2 ttt180 -166.45 136.35 3.2 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 123.609 0.568 . . . . 62.52 109.991 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.408 HD12 HD22 ' D' ' 127' ' ' ASN . 97.7 mt -115.25 135.64 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 107.602 -1.259 . . . . 63.13 107.602 174.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -163.18 143.88 9.31 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 112.767 0.654 . . . . 60.35 112.767 -174.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 56.0 m -73.79 120.8 19.88 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.617 -1.174 . . . . 65.11 108.918 170.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.552 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.2 mtpt -98.53 -18.9 17.93 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.113 0.965 . . . . 73.31 111.897 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -166.02 144.31 5.74 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.608 0.567 . . . . 64.23 110.824 -174.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.453 ' HB ' ' H ' ' A' ' 23' ' ' PHE . 45.6 mm -139.19 140.9 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.277 1.431 . . . . 70.12 108.745 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.5 t -142.71 125.8 16.34 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.649 1.18 . . . . 62.23 108.303 176.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.518 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 78.1 t80 -140.35 121.27 14.54 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 107.573 -1.269 . . . . 74.32 107.573 169.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -130.25 121.13 25.58 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.522 -0.918 . . . . 54.32 108.522 175.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.683 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -105.46 89.31 3.2 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 106.259 -1.756 . . . . 61.14 106.259 168.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -59.43 -36.72 93.06 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.86 2.374 . . . . 62.01 111.975 -171.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -106.47 16.54 24.54 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 118.06 -0.972 . . . . 74.3 111.611 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.683 ' HB2' ' HB3' ' B' ' 25' ' ' ALA . . . -30.73 -62.12 0.24 Allowed Pre-proline 0 N--CA 1.502 2.128 0 N-CA-C 115.117 1.525 . . . . 53.31 115.117 -171.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 17.4 Cg_exo -59.5 -41.39 57.73 Favored 'Trans proline' 0 C--N 1.399 3.19 0 C-N-CA 121.951 1.767 . . . . 63.15 112.686 -173.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -96.78 -19.35 18.98 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.079 -0.964 . . . . 72.11 113.296 -169.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.543 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.6 p -74.96 -12.93 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 CA-C-O 121.155 0.502 . . . . 75.03 110.735 -176.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -77.44 -5.93 51.64 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.296 0.85 . . . . 74.23 113.296 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -68.31 -21.52 64.76 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.867 0.467 . . . . 75.45 110.433 169.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -94.33 87.1 5.09 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.254 1.021 . . . . 74.04 110.533 -175.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -86.54 90.97 8.41 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.522 -0.763 . . . . 75.31 110.346 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 34.8 p90 -173.98 -172.05 0.69 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.474 1.11 . . . . 72.44 109.3 171.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -80.15 117.61 68.38 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.101 0.561 . . . . 75.32 111.099 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.525 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 19.3 Cg_endo -64.73 147.4 89.77 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 121.74 1.627 . . . . 74.11 110.496 173.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.18 102.68 0.86 Allowed 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.728 -0.841 . . . . 73.11 108.728 174.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.68 HG11 HD11 ' B' ' 126' ' ' LEU . 41.8 t -99.86 145.86 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.213 -0.903 . . . . 54.21 109.875 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 43.4 tttm -140.06 127.35 21.23 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.69 1.196 . . . . 73.33 107.853 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.541 HD13 HD22 ' B' ' 128' ' ' LEU . 25.6 tp -86.4 145.29 26.92 Favored 'General case' 0 C--O 1.244 0.811 0 O-C-N 123.81 0.694 . . . . 73.0 109.211 173.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.558 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 11.4 t70 -143.95 150.07 37.76 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.992 -1.114 . . . . 61.0 107.992 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.4 HD11 HG11 ' B' ' 131' ' ' VAL . 72.5 mt -126.9 139.89 52.74 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.635 0.774 . . . . 61.21 109.458 -175.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 29.5 t70 -132.11 151.15 51.93 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.07 0.948 . . . . 60.12 109.072 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.7 m -124.61 111.97 16.26 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.151 0.58 . . . . 71.24 110.574 -166.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.477 ' HA ' ' CE1' ' F' ' 106' ' ' TYR . . . -146.63 117.48 7.66 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 109.379 -0.6 . . . . 72.12 109.379 174.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 48.1 p -143.89 170.87 15.08 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.063 0.545 . . . . 60.4 110.08 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 64.8 p -152.04 142.55 22.66 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.422 0.289 . . . . 54.12 111.62 -173.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -96.86 94.33 7.18 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.984 -0.747 . . . . 71.3 108.984 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 pp -110.13 24.43 13.02 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.008 0.523 . . . . 64.44 110.611 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.469 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -164.87 172.04 13.38 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 123.717 0.807 . . . . 41.21 111.153 172.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -97.15 124.73 41.28 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 107.922 -1.14 . . . . 40.23 107.922 172.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 66.02 4.72 3.16 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 124.362 1.065 . . . . 75.4 112.917 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 44.9 t -133.73 126.47 51.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.447 0 N-CA-C 107.041 -1.466 . . . . 55.51 107.041 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -132.7 141.19 48.46 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 109.794 -0.447 . . . . 74.31 109.794 -168.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -106.03 105.84 16.07 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.75 -1.204 . . . . 73.02 107.75 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 38.1 t -100.54 129.53 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.431 1.093 . . . . 53.54 109.54 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 t -118.26 114.59 45.61 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.629 -0.878 . . . . 70.15 108.629 173.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -100.71 108.58 20.48 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.72 -1.215 . . . . 71.34 107.72 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.417 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 31.5 ttm180 -85.98 119.7 26.57 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.288 -1.004 . . . . 70.11 108.288 173.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 31.4 t -105.18 123.94 59.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.92 -1.141 . . . . 75.32 107.92 175.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.558 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 45.2 m -111.02 136.78 49.51 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.89 -0.781 . . . . 73.43 108.89 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.677 HG11 HD21 ' B' ' 126' ' ' LEU . 59.4 t -129.44 114.87 32.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 124.054 0.942 . . . . 75.45 108.58 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 32.7 m -100.89 135.36 42.47 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.521 -0.918 . . . . 74.53 108.521 170.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.36 141.93 30.04 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.21 -0.663 . . . . 55.13 109.21 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.536 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 55.2 p -142.52 127.8 18.75 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 123.921 0.763 . . . . 63.23 111.324 -175.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 17.5 mt -92.93 111.79 23.52 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.056 0.943 . . . . 74.52 108.61 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.75 -123.51 19.22 Favored Glycine 0 C--N 1.338 0.688 0 O-C-N 124.054 0.846 . . . . 63.0 112.214 -175.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -97.41 3.23 51.0 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.311 0.644 . . . . 74.32 112.241 -176.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -128.72 158.36 38.82 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.519 0.728 . . . . 72.21 110.063 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 41.8 m -70.02 135.33 49.21 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.03 0.532 . . . . 63.01 111.041 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.543 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -87.03 -62.26 1.54 Allowed 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.78 -1.192 . . . . 73.41 107.78 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -152.23 157.04 40.88 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.161 -1.382 . . . . 73.22 110.166 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 85.5 mt -127.73 110.48 12.68 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.216 -1.772 . . . . 61.21 106.216 173.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.469 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 36.7 t -119.98 137.41 54.09 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.686 -0.857 . . . . 61.22 108.686 -177.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -153.96 136.58 15.17 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.819 -0.808 . . . . 74.12 108.819 -173.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.421 HG21 ' HB3' ' B' ' 113' ' ' CYS . 91.1 t -133.6 148.31 30.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.291 -1.003 . . . . 72.51 108.291 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -121.42 100.52 7.07 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 108.186 -1.042 . . . . 73.42 108.186 172.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.432 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 8.0 tp-100 -93.29 104.18 16.37 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.53 -0.915 . . . . 72.42 108.53 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.552 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -93.43 163.56 26.36 Favored Glycine 0 C--O 1.24 0.49 0 CA-C-N 115.496 -0.775 . . . . 52.32 111.681 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.13 132.67 2.67 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.617 -0.325 . . . . 74.1 112.555 -176.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 45.0 mt -91.82 123.01 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 N-CA-C 107.745 -1.205 . . . . 64.34 107.745 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -129.82 135.56 48.55 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.736 0.814 . . . . 75.34 109.935 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 58.7 m -100.42 128.25 46.53 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.76 0.824 . . . . 35.12 109.71 174.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.447 ' HB ' HD11 ' B' ' 89' ' ' ILE . 1.4 pp -140.77 135.31 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 124.582 1.153 . . . . 73.34 111.029 -173.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.13 168.0 26.7 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.203 1.001 . . . . 70.24 109.557 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 91.36 -36.05 3.75 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 116.242 -0.435 . . . . 74.34 112.874 178.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.599 ' HB ' ' HA ' ' B' ' 94' ' ' MET . 9.0 pt -66.67 149.46 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.275 1.43 . . . . 74.24 111.81 175.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -147.45 162.02 39.88 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 124.351 1.06 . . . . 71.53 110.114 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.49 -136.04 27.66 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-N 114.432 -1.258 . . . . 72.41 113.985 175.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.9 m -66.04 -48.54 70.74 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.78 0.832 . . . . 61.3 109.759 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.469 ' HG3' ' NE2' ' B' ' 143' ' ' GLN . 10.2 tt0 -60.25 -25.6 65.81 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 113.882 -1.508 . . . . 73.3 112.059 -171.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.599 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 2.0 tmt? -59.78 -69.97 0.19 Allowed 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.349 1.06 . . . . 65.42 112.163 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.442 ' HB2' ' SD ' ' B' ' 94' ' ' MET . . . -80.38 -13.57 59.04 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 122.374 0.27 . . . . 61.14 111.584 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.89 -44.74 78.49 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.21 0.604 . . . . 70.03 109.591 167.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 44.4 t -57.46 -29.09 63.93 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.814 0.845 . . . . 53.55 111.965 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 71.6 mt -72.1 -40.06 68.45 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.991 0.916 . . . . 73.2 111.494 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . 0.555 ' HA3' ' NE2' ' F' ' 108' ' ' HIS . . . -101.39 4.08 54.48 Favored Glycine 0 C--N 1.341 0.812 0 CA-C-N 116.068 -0.515 . . . . 74.33 113.768 -176.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.551 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -126.3 -65.4 0.98 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.385 0.674 . . . . 40.44 111.218 -176.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -74.52 -45.13 47.78 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.955 -0.566 . . . . 74.33 111.354 -172.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.448 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 79.2 m -62.66 -47.46 87.94 Favored Pre-proline 0 CA--C 1.57 1.729 0 CA-C-O 118.519 -0.753 . . . . 74.43 112.228 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.448 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 76.1 Cg_exo -57.21 -33.37 95.84 Favored 'Trans proline' 0 C--N 1.398 3.172 0 C-N-CA 122.935 2.423 . . . . 72.32 113.705 171.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -67.47 -31.01 70.87 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.225 0.61 . . . . 72.13 111.243 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.0 mt -71.62 -40.18 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.596 0.758 . . . . 71.32 110.036 173.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 83.9 mt -77.46 -30.46 53.25 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.318 -0.855 . . . . 63.11 112.023 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -58.11 -44.67 99.48 Favored Pre-proline 0 CA--C 1.561 1.374 0 C-N-CA 124.394 1.078 . . . . 74.35 113.333 -172.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -50.21 -46.73 27.2 Favored 'Trans proline' 0 C--N 1.386 2.515 0 C-N-CA 122.863 2.375 . . . . 52.24 114.491 173.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -65.78 -40.73 92.28 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.202 0.601 . . . . 52.32 110.796 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.432 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -66.07 -40.65 91.06 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.159 -0.928 . . . . 70.12 111.139 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -61.22 -51.54 68.54 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.117 1.367 . . . . 73.34 110.231 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.55 ' HG3' HH12 ' A' ' 120' ' ' ARG . 9.2 tp10 -61.8 -39.0 90.18 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.249 1.02 . . . . 72.11 110.396 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.521 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.1 t -68.72 -32.87 72.97 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.067 0.147 . . . . 55.41 110.764 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.469 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 50.9 mt -66.81 -53.02 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.832 0.853 . . . . 74.44 110.025 173.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.483 HG21 ' OG ' ' C' ' 119' ' ' SER . 15.3 m -59.31 -30.91 68.69 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.794 0.684 . . . . 41.33 111.027 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.497 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.1 t -64.31 -50.19 68.8 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.068 0.947 . . . . 74.2 110.174 175.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.547 ' SD ' HG21 ' A' ' 21' ' ' ILE . 33.5 mmt -62.9 -40.34 97.26 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.933 0.493 . . . . 72.24 110.889 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.41 HG23 ' O ' ' B' ' 114' ' ' ILE . 88.0 t -65.17 -39.67 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.728 1.211 . . . . 62.12 110.786 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 36.1 t -65.89 -36.19 82.73 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.156 -0.929 . . . . 70.22 111.032 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.497 ' HG3' ' O ' ' B' ' 116' ' ' SER . 71.3 mtt-85 -70.46 -37.86 74.37 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 115.646 -0.706 . . . . 72.51 109.945 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.77 -13.65 69.22 Favored Glycine 0 C--N 1.357 1.737 0 O-C-N 123.651 0.594 . . . . 73.44 112.765 171.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 13.4 m 67.35 32.26 5.98 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.644 1.578 . . . . 72.21 110.218 176.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -81.06 167.95 28.48 Favored Pre-proline 0 CA--C 1.558 1.252 0 CA-C-N 114.631 -1.168 . . . . 72.13 110.0 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -60.18 168.78 5.7 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 122.792 2.328 . . . . 70.51 113.519 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.605 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 59.9 tp60 -64.8 112.63 3.33 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 114.895 -1.048 . . . . 72.14 110.666 -174.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.68 HD11 HG11 ' B' ' 40' ' ' VAL . 23.5 tp -111.23 111.33 22.32 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 123.689 0.618 . . . . 74.42 109.353 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -123.47 134.08 53.96 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 107.895 -1.15 . . . . 72.11 107.895 170.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.541 HD22 HD13 ' B' ' 42' ' ' LEU . 74.7 mt -85.86 149.26 25.36 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 122.656 0.383 . . . . 74.51 111.251 -175.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -67.02 138.38 94.98 Favored Pre-proline 0 CA--C 1.55 0.954 0 O-C-N 124.447 1.092 . . . . 54.01 110.343 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' B' ' 129' ' ' ALA . 11.5 Cg_exo -68.19 99.37 0.58 Allowed 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.774 2.316 . . . . 72.3 111.122 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.4 HG11 HD11 ' B' ' 44' ' ' LEU . 60.8 t -89.2 110.54 21.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.188 -1.042 . . . . 65.03 108.188 176.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -89.27 94.22 9.83 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 108.389 -0.967 . . . . 75.25 108.389 174.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -60.34 -22.73 63.59 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.292 -1.322 . . . . 73.02 111.661 -175.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.551 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 13.5 m-20 -58.22 -62.61 1.71 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.073 0.549 . . . . 71.2 110.733 172.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.28 -31.31 65.48 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 123.992 0.808 . . . . 55.44 111.661 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.626 ' HG ' ' HB3' ' F' ' 120' ' ' TYR . 7.3 tt -58.33 -55.61 32.71 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.349 1.06 . . . . 72.3 110.317 178.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -83.03 -15.33 51.51 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.328 0.651 . . . . 73.31 111.961 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 62.7 mtt -78.3 -31.56 48.93 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.327 0.651 . . . . 60.14 110.872 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -78.42 -34.1 48.21 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 110.034 -0.358 . . . . 71.23 110.034 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -74.05 -40.93 62.5 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.452 -0.794 . . . . 70.52 110.448 -177.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.428 HD11 ' HE2' ' F' ' 109' ' ' TYR . 4.2 mm? -100.46 7.24 44.3 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.884 0.874 . . . . 72.24 112.222 -178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 59.04 27.09 15.91 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.737 0.815 . . . . 74.23 112.163 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . 0.469 ' NE2' ' HG3' ' B' ' 93' ' ' GLN . 30.5 tt0 -87.49 57.75 4.58 Favored 'General case' 0 CA--C 1.554 1.129 0 CA-C-O 122.162 0.982 . . . . 62.31 108.754 176.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -84.86 151.77 24.06 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.575 -0.703 . . . . 71.44 110.521 -174.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.82 165.87 16.61 Favored 'General case' 0 C--O 1.244 0.804 0 C-N-CA 124.04 0.936 . . . . 62.44 111.582 175.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -126.91 -79.26 0.29 Allowed Glycine 0 C--N 1.342 0.862 0 N-CA-C 111.646 -0.581 . . . . 73.15 111.646 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 62.88 -79.87 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.61 1.164 . . . . 73.13 110.962 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 98.69 -141.11 15.39 Favored Glycine 0 C--N 1.339 0.731 0 N-CA-C 111.573 -0.611 . . . . 74.03 111.573 -176.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . 0.52 HG21 ' HG3' ' D' ' 90' ' ' GLU . 75.6 m -153.45 135.71 14.91 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.55 0.74 . . . . 73.22 109.273 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.67 115.36 20.89 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.944 -0.762 . . . . 74.31 108.944 169.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.35 83.19 8.04 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 106.642 -1.614 . . . . 72.22 106.642 173.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -148.93 -40.0 0.15 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.382 -0.826 . . . . 74.21 110.061 -171.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . 0.423 ' HB3' ' HA2' ' D' ' 91' ' ' GLY . 23.6 tm0? -63.98 119.07 9.39 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 109.574 -0.528 . . . . 74.22 109.574 174.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -113.26 -57.62 2.26 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.534 -0.913 . . . . 70.32 108.534 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 C-N-CA 123.787 0.835 . . . . 54.53 109.015 175.416 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 90.0 mmm . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.213 -0.662 . . . . 71.05 109.213 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 78.5 p -152.39 149.76 28.95 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-O 121.197 0.522 . . . . 63.51 110.949 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -136.11 111.39 9.07 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.723 1.209 . . . . 74.55 107.919 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -73.55 100.75 3.38 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.661 0.384 . . . . 62.33 110.189 -174.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -162.04 92.57 0.85 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.217 0.607 . . . . 72.21 110.078 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -179.64 150.92 0.43 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.635 0.774 . . . . 71.14 111.087 173.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 30.8 p -87.07 -53.32 4.94 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.293 1.037 . . . . 75.43 111.439 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -145.39 134.21 22.38 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.833 0.453 . . . . 61.24 110.946 -175.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 21.1 ttt 45.21 109.46 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 126.678 1.991 . . . . 70.22 114.519 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.641 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 53.1 m -93.11 120.48 33.45 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.643 -0.873 . . . . 73.31 108.643 169.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.613 ' HD2' ' HG2' ' A' ' 130' ' ' PRO . 37.1 t80 -127.71 124.25 37.39 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.212 -1.033 . . . . 71.13 108.212 161.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -150.73 121.05 7.31 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.431 -0.951 . . . . 75.3 108.431 177.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.422 ' CD1' HG21 ' C' ' 105' ' ' ILE . 30.2 mt -67.79 127.6 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 123.963 0.789 . . . . 72.13 108.905 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.477 HE22 ' HG2' ' E' ' 136' ' ' LYS . 19.5 mm-40 -93.69 -37.75 11.67 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 123.506 0.504 . . . . 74.43 109.902 177.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 178.45 155.54 0.41 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.038 1.335 . . . . 72.33 109.134 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.434 ' HA ' ' HA2' ' C' ' 82' ' ' GLY . 2.8 pp -127.5 152.97 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 107.656 -1.239 . . . . 73.3 107.656 171.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.536 ' HE1' HG12 ' C' ' 83' ' ' ILE . 31.4 p90 -170.36 144.74 2.56 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 110.135 -0.32 . . . . 62.24 110.135 -174.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 66.2 p -73.08 111.77 8.5 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.976 0.51 . . . . 73.45 109.899 177.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.716 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 11.2 mmmm -66.91 -37.06 83.65 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.899 -0.778 . . . . 65.15 108.899 170.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.6 t70 -148.33 145.42 28.12 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.4 -1.273 . . . . 73.24 110.192 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.533 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.1 mt -136.89 144.15 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.722 1.609 . . . . 75.5 106.785 172.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.4 t -155.6 148.66 24.53 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.994 0.426 . . . . 55.51 110.337 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -151.4 127.72 10.61 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 107.255 -1.387 . . . . 63.01 107.255 173.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -135.49 112.24 10.12 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.065 0.546 . . . . 71.03 110.08 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.61 82.69 20.26 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 106.753 -1.573 . . . . 72.21 106.753 161.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.87 -25.94 32.43 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 122.626 2.217 . . . . 53.41 111.601 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -96.03 23.99 5.97 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.657 1.183 . . . . 72.22 109.618 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.2 -58.4 4.99 Favored Pre-proline 0 C--N 1.374 1.634 0 C-N-CA 124.999 1.32 . . . . 65.55 114.539 -163.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -61.57 -42.64 31.74 Favored 'Trans proline' 0 C--N 1.386 2.532 0 CA-C-N 121.362 1.522 . . . . 71.2 111.856 -176.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -69.92 -34.39 73.41 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 114.89 -1.05 . . . . 75.25 112.541 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.553 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.9 p -79.98 -27.67 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.189 0.441 . . . . 74.15 112.189 -175.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -67.88 -34.06 75.93 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-O 121.011 0.434 . . . . 72.52 111.197 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -87.31 6.71 32.12 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.852 0.861 . . . . 73.02 111.743 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -85.99 154.93 21.1 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.579 0.752 . . . . 74.54 111.199 -175.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -60.8 115.85 3.99 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.286 1.034 . . . . 61.12 109.929 172.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -84.36 82.79 8.23 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.984 0.914 . . . . 73.43 110.787 -173.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -133.82 78.91 59.52 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 107.398 -1.334 . . . . 44.42 107.398 168.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -92.7 135.24 1.3 Allowed 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 123.243 2.629 . . . . 70.21 113.351 -175.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . 0.405 ' HB3' ' HE3' ' C' ' 41' ' ' LYS . 4.4 mp0 -85.64 96.89 9.82 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.981 -1.489 . . . . 72.32 106.981 169.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' C' ' 65' ' ' THR . 94.3 t -90.48 106.38 17.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 CA-C-N 115.71 -0.677 . . . . 74.12 110.316 -175.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' C' ' 39' ' ' GLU . 0.2 OUTLIER -95.08 105.04 16.93 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.172 -1.047 . . . . 62.42 108.172 173.039 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.501 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.5 pt? -86.47 124.11 32.43 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 107.344 -1.354 . . . . 72.12 107.344 171.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.426 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 21.5 t70 -118.01 140.84 49.16 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.846 -0.798 . . . . 73.2 108.846 -176.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.643 HD11 HG11 ' C' ' 131' ' ' VAL . 51.2 mt -127.38 113.32 16.08 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.02 0.928 . . . . 74.01 109.489 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -122.48 121.3 36.24 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.266 -1.383 . . . . 64.21 107.266 174.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 6.5 t -117.17 137.03 52.6 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.058 0.456 . . . . 72.2 111.013 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.99 157.87 25.06 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.146 0.978 . . . . 71.22 108.769 175.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 60.2 p -158.58 146.35 18.07 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.14 0.576 . . . . 54.01 109.978 177.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.1 p -156.07 160.29 39.85 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.012 0.925 . . . . 72.33 109.214 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -99.59 120.08 39.1 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.569 -0.901 . . . . 65.44 108.569 172.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' C' ' 57' ' ' GLU . 33.6 mt -84.42 -50.8 7.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.645 0.778 . . . . 70.41 109.809 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.58 -168.25 2.86 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.845 -1.071 . . . . 71.22 109.73 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.66 118.56 9.73 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.886 -0.597 . . . . 60.32 109.904 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 68.06 -4.91 0.94 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.995 1.318 . . . . 65.21 112.109 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.0 t -99.58 116.82 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 123.741 0.816 . . . . 73.43 109.199 -174.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -124.36 129.49 50.81 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.836 1.254 . . . . 72.22 108.7 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.577 ' HB2' HD11 ' C' ' 51' ' ' LEU . 42.0 tt0 -89.72 137.1 32.62 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 108.522 -0.918 . . . . 61.4 108.522 167.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 82.2 t -123.85 140.85 46.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 N-CA-C 108.08 -1.082 . . . . 64.41 108.08 167.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.467 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 85.3 t -122.03 146.41 27.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 108.759 -0.83 . . . . 63.55 108.759 172.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.58 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -128.76 99.8 5.47 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.91 -1.515 . . . . 73.11 106.91 177.078 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 33.3 ttm-85 -80.85 105.54 12.16 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.799 -1.091 . . . . 71.43 108.322 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 26.1 t -106.08 121.16 58.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 108.432 -0.951 . . . . 71.55 108.432 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 14.2 m -120.15 110.46 16.65 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.678 -0.86 . . . . 61.02 108.678 -174.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.549 HG21 HG21 ' C' ' 114' ' ' ILE . 47.6 t -98.16 109.5 23.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.95 -0.759 . . . . 54.23 108.95 177.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' C' ' 40' ' ' VAL . 32.1 m -96.5 131.73 42.8 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.596 -1.261 . . . . 73.15 107.596 171.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.54 118.23 19.85 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 106.344 -1.724 . . . . 71.23 106.344 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 29.9 m -133.25 125.74 29.99 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.089 0.243 . . . . 44.45 110.838 -177.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 16.5 mt -87.45 49.3 1.79 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.395 1.478 . . . . 64.24 109.723 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.82 -115.35 5.16 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 110.533 -1.027 . . . . 42.53 110.533 -170.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -90.22 -28.37 18.9 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.796 0.838 . . . . 71.14 110.124 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -63.68 122.09 15.52 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.804 1.242 . . . . 63.52 109.491 171.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.2 m -77.78 122.87 25.99 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 108.726 -0.842 . . . . 73.32 108.726 168.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.553 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -65.72 -59.39 3.96 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.307 -0.997 . . . . 62.33 108.307 171.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -165.39 164.37 19.69 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 114.908 -1.042 . . . . 63.32 110.658 174.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.424 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.7 tm? -120.51 141.01 50.62 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 106.354 -1.721 . . . . 61.22 106.354 166.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.436 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.6 t -146.95 110.06 4.76 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.79 -0.819 . . . . 74.13 108.79 177.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -117.44 119.74 36.01 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 109.08 -0.711 . . . . 75.43 109.08 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 55.1 t -117.08 114.17 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.78 -0.822 . . . . 73.41 108.78 173.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.409 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 78.2 mt-30 -90.06 87.22 6.81 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.185 -1.043 . . . . 74.3 108.185 173.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -78.42 104.48 9.05 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 115.693 -0.685 . . . . 44.2 109.325 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -83.48 179.3 52.53 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-N 116.613 -0.267 . . . . 43.25 112.717 172.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' C' ' 16' ' ' ILE . . . -178.73 136.81 3.01 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-O 119.945 -0.364 . . . . 61.44 112.719 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.536 HG12 ' HE1' ' C' ' 17' ' ' TYR . 36.6 mm -96.34 133.46 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 108.829 -0.804 . . . . 64.1 108.829 174.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -135.33 131.99 37.12 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.854 0.861 . . . . 62.42 110.308 -176.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 24.6 p -85.27 99.59 11.22 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.094 -1.076 . . . . 74.53 108.094 166.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.668 HG21 ' HE1' ' C' ' 94' ' ' MET . 11.7 mt -114.57 140.41 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 108.138 -1.06 . . . . 74.34 108.138 177.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.641 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -157.42 162.62 38.99 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 122.415 0.286 . . . . 74.05 111.245 -174.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.26 -35.88 3.5 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 115.917 -0.583 . . . . 31.44 113.279 172.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.518 HG22 HE21 ' C' ' 93' ' ' GLN . 36.1 pt -88.04 165.23 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.713 0.805 . . . . 73.3 112.059 -175.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -162.24 151.73 15.94 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.941 0.896 . . . . 63.24 109.874 -177.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.98 -119.39 9.64 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-N 115.344 -0.844 . . . . 61.51 112.794 172.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 68.9 p -62.15 -38.16 87.95 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.004 0.922 . . . . 74.51 111.307 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.518 HE21 HG22 ' C' ' 89' ' ' ILE . 27.0 mt-30 -65.22 -52.75 52.7 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.829 0.852 . . . . 63.32 111.22 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.668 ' HE1' HG21 ' C' ' 86' ' ' ILE . 6.1 tpt -53.03 -52.9 56.95 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 124.074 0.859 . . . . 73.02 111.722 176.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.55 -35.4 80.73 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.186 0.595 . . . . 71.43 112.15 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -68.13 -35.48 78.17 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.437 0.695 . . . . 73.05 110.708 177.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -71.82 -37.17 70.38 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.495 -0.775 . . . . 53.35 110.433 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 83.8 mt -83.59 -33.7 25.31 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.999 0.92 . . . . 44.02 112.431 -175.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -113.14 11.09 24.54 Favored Glycine 0 N--CA 1.472 1.082 0 O-C-N 123.333 0.396 . . . . 40.43 113.803 -169.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.65 -54.29 0.19 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.77 0.428 . . . . 70.44 111.257 178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -75.2 -47.73 26.87 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 112.479 0.548 . . . . 71.44 112.479 -172.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.491 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 91.5 m -64.43 -49.32 72.26 Favored Pre-proline 0 CA--C 1.561 1.367 0 C-N-CA 123.499 0.72 . . . . 72.52 110.886 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.58 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 51.2 Cg_exo -57.83 -28.21 81.44 Favored 'Trans proline' 0 C--N 1.396 3.074 0 C-N-CA 122.639 2.226 . . . . 72.11 113.633 174.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -66.06 -34.88 79.08 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.189 0.596 . . . . 71.34 110.916 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.558 HD12 ' NH1' ' A' ' 111' ' ' ARG . 35.7 mm -80.75 -29.98 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 122.556 0.343 . . . . 72.11 110.089 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 mp -75.34 -25.89 58.14 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.715 0.806 . . . . 63.4 111.496 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -58.97 -51.23 83.36 Favored Pre-proline 0 C--O 1.206 -1.225 0 CA-C-O 117.476 -1.25 . . . . 75.32 112.492 -176.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . 0.571 ' HB3' ' HB2' ' A' ' 112' ' ' GLU . 65.3 Cg_exo -47.71 -44.47 26.29 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.774 2.316 . . . . 71.1 114.817 176.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -74.2 -40.49 62.44 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.095 0.558 . . . . 74.11 111.606 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.28 -42.35 93.28 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.268 0.627 . . . . 61.45 110.153 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . 0.616 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 31.6 ttt-85 -59.89 -52.16 66.6 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.029 1.732 . . . . 72.41 110.447 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.06 -37.7 88.4 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.234 0.959 . . . . 65.22 109.967 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 38.4 t -68.78 -35.66 77.33 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 123.476 0.485 . . . . 60.31 111.444 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.549 HG21 HG21 ' C' ' 64' ' ' VAL . 90.9 mt -68.65 -49.58 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.283 0.633 . . . . 73.13 110.203 174.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.6 m -66.36 -28.14 68.42 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.21 0.604 . . . . 75.33 110.991 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.426 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 46.2 t -66.45 -43.05 86.64 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.071 0.949 . . . . 54.12 109.041 172.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.564 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -67.76 -34.39 76.71 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.134 0.974 . . . . 72.24 112.089 177.527 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.48 HG23 ' O ' ' C' ' 114' ' ' ILE . 88.2 t -62.6 -43.96 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.619 0.767 . . . . 72.12 108.997 172.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.483 ' OG ' HG21 ' B' ' 115' ' ' THR . 29.4 t -63.88 -39.55 94.45 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.606 -1.179 . . . . 55.33 111.786 178.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.519 HH12 ' HG2' ' D' ' 112' ' ' GLU . 67.0 mtt-85 -69.95 -38.31 76.09 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.578 0.751 . . . . 72.34 109.942 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.6 -1.04 88.69 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 115.426 -0.806 . . . . 63.25 112.788 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.498 HG21 ' O ' ' D' ' 16' ' ' ILE . 31.5 p 61.72 30.49 18.46 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.43 1.892 . . . . 74.14 113.587 171.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.47 ' HB2' HG13 ' C' ' 118' ' ' VAL . 93.7 m-85 -85.66 151.31 55.35 Favored Pre-proline 0 CA--C 1.548 0.899 0 N-CA-C 107.871 -1.159 . . . . 64.1 107.871 166.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.605 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 24.5 Cg_endo -63.06 157.94 46.38 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 122.354 2.036 . . . . 64.04 112.721 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 -53.06 112.71 0.91 Allowed 'General case' 0 N--CA 1.477 0.908 0 O-C-N 124.585 1.178 . . . . 75.15 112.891 -172.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.59 HD12 ' HA ' ' F' ' 133' ' ' THR . 61.0 tp -109.61 87.8 2.59 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 113.924 -1.489 . . . . 74.53 107.512 174.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -92.93 99.91 12.46 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.899 -0.778 . . . . 74.24 108.899 -174.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.616 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 4.0 mm? -56.47 125.05 20.33 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.943 0.897 . . . . 75.33 111.274 -175.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.72 152.4 95.2 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 124.212 1.005 . . . . 74.31 111.4 -175.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.452 ' HG2' HG21 ' A' ' 13' ' ' ILE . 51.2 Cg_exo -54.72 108.26 0.28 Allowed 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.979 2.453 . . . . 74.41 112.926 175.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.643 HG11 HD11 ' C' ' 44' ' ' LEU . 6.8 p -101.0 135.55 36.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 123.599 0.76 . . . . 75.02 109.446 175.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -97.36 101.25 12.76 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.632 0.773 . . . . 72.22 109.359 -174.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.451 ' CE1' HD13 ' C' ' 44' ' ' LEU . 66.4 m-85 -68.98 -33.79 74.25 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.63 0.772 . . . . 73.51 111.462 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -59.15 -43.41 92.05 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.92 0.888 . . . . 62.21 109.435 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.88 -41.34 95.81 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 114.691 -1.141 . . . . 54.44 111.805 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 76.4 mt -65.91 -36.05 82.32 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.308 0.643 . . . . 64.32 110.831 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -74.1 -26.57 60.43 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 115.124 -0.944 . . . . 73.5 109.955 177.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 28.1 ttt -75.9 -37.05 59.22 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.1 0.96 . . . . 74.23 110.705 176.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -66.01 -36.61 83.74 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.197 0.599 . . . . 72.41 109.934 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -52.72 -85.92 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.038 0 O-C-N 124.758 1.286 . . . . 55.12 111.234 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 39.5 tp 174.72 -37.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.402 0.681 . . . . 60.3 111.02 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -83.4 -6.27 59.41 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 115.556 -0.747 . . . . 74.14 112.837 -162.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.69 101.83 5.16 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 108.891 -0.781 . . . . 62.51 108.891 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -147.81 34.15 0.84 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.049 0.94 . . . . 72.23 108.744 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . 0.41 ' HB1' ' HG2' ' C' ' 93' ' ' GLN . . . -152.22 117.61 5.29 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.137 0.575 . . . . 53.14 110.815 -172.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 165.98 52.77 0.02 OUTLIER Glycine 0 C--N 1.346 1.087 0 N-CA-C 111.642 -0.583 . . . . 22.12 111.642 176.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -111.09 171.01 7.72 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.827 0.851 . . . . 74.23 110.834 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 78.08 -146.93 31.24 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.701 -0.681 . . . . 64.22 112.104 -176.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 15.3 t -168.39 172.84 8.06 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.509 0.724 . . . . 70.45 110.097 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -64.44 142.03 58.57 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.195 0.998 . . . . 63.15 110.324 172.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.59 134.67 49.37 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 108.875 -0.787 . . . . 53.03 108.875 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -165.3 170.58 14.54 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.26 1.024 . . . . 71.21 109.861 -172.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -149.73 -36.43 0.16 Allowed 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 111.848 0.314 . . . . 75.22 111.848 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -70.74 -60.82 2.03 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.099 0.56 . . . . 75.53 109.776 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.91 0 N-CA-C 108.092 -1.077 . . . . 55.34 108.092 177.481 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 60.0 mtm . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 121.497 0.665 . . . . 75.22 109.217 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 33.9 t -88.92 141.78 28.21 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.365 0.666 . . . . 54.22 109.95 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -64.67 -57.35 9.28 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 124.022 0.826 . . . . 54.42 110.961 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -100.29 73.4 1.68 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.159 0.584 . . . . 65.53 109.924 -176.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -156.98 150.91 24.74 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.162 -1.051 . . . . 70.24 108.162 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -73.42 83.56 1.46 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 109.105 -0.702 . . . . 73.44 109.105 177.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 14.9 t -162.63 173.86 13.35 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 124.522 1.129 . . . . 63.52 108.888 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' D' ' 9' ' ' MET . 5.6 tp10 66.57 -153.51 0.23 Allowed 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.261 1.024 . . . . 73.42 109.613 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.491 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 24.0 ttt -31.76 127.75 0.21 Allowed 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.55 1.54 . . . . 75.4 115.043 176.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 4.6 t -112.04 138.54 48.55 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.946 0.898 . . . . 55.24 108.721 169.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.429 ' HD2' HG22 ' D' ' 86' ' ' ILE . 70.8 t80 -133.75 106.06 7.14 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.085 -1.45 . . . . 71.02 107.085 174.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -124.81 127.15 46.74 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.241 -1.022 . . . . 73.12 108.241 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.6 HG21 HD11 ' D' ' 16' ' ' ILE . 26.9 mt -77.09 116.51 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 109.296 -0.631 . . . . 65.03 109.296 178.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -84.07 -43.92 14.59 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.281 0.632 . . . . 75.0 110.385 -173.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -170.71 142.71 2.03 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.947 0.499 . . . . 72.42 110.362 -176.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.6 HD11 HG21 ' D' ' 13' ' ' ILE . 3.0 mp -115.07 148.48 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 106.872 -1.529 . . . . 72.14 106.872 172.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -169.59 168.33 9.26 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-O 121.54 0.686 . . . . 74.25 111.643 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.6 p -105.09 121.16 43.21 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 114.929 -1.032 . . . . 71.44 109.078 171.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -86.25 -25.28 25.64 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.42 0.688 . . . . 74.23 109.238 176.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.4 t70 -156.74 137.38 13.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.63 -1.168 . . . . 62.42 109.973 -175.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.564 HG21 ' HE2' ' C' ' 117' ' ' MET . 74.1 mt -140.14 141.4 33.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 125.218 1.407 . . . . 64.44 107.471 173.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.9 t -146.71 143.63 28.86 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.91 0.884 . . . . 54.11 109.116 173.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.533 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 84.5 t80 -146.99 133.64 19.91 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 106.581 -1.637 . . . . 70.04 106.581 172.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 48.0 mt-10 -135.27 141.77 45.79 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.96 0.904 . . . . 65.15 109.382 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.49 77.97 16.77 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 107.796 -1.187 . . . . 63.32 107.796 176.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.69 -19.42 21.31 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.666 2.244 . . . . 63.52 113.195 -173.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -108.45 -0.65 20.4 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.865 0.866 . . . . 71.5 110.707 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.716 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -19.51 -71.7 0.03 OUTLIER Pre-proline 0 CA--C 1.571 1.757 0 N-CA-C 116.908 2.188 . . . . 55.24 116.908 -165.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.431 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 81.4 Cg_endo -74.76 -25.1 12.71 Favored 'Trans proline' 0 C--N 1.385 2.458 0 CA-C-N 124.454 2.626 . . . . 74.44 113.84 -176.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.498 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 4.6 t-160 -69.67 -39.68 76.89 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 124.419 1.087 . . . . 75.55 110.07 178.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' D' ' 73' ' ' ALA . 7.8 p -82.71 -22.53 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 CA-C-N 115.666 -0.697 . . . . 62.24 111.426 -175.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.431 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 22.1 m-85 -64.25 -26.39 68.48 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 122.265 0.226 . . . . 72.5 111.221 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.498 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 61.7 mt-30 -65.45 -7.08 12.39 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.834 1.253 . . . . 72.43 111.844 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.506 ' NZ ' ' HG2' ' D' ' 71' ' ' GLU . 91.6 mttt -95.71 103.86 15.76 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.152 1.381 . . . . 63.31 110.095 175.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -95.36 76.32 3.38 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.581 0.752 . . . . 55.21 110.312 -175.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 44.2 p90 -156.75 -177.78 6.86 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.8 -0.815 . . . . 75.15 108.8 168.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.407 ' OE1' ' HB3' ' E' ' 127' ' ' SER . 29.6 tp60 -65.08 117.65 41.64 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.532 1.133 . . . . 73.32 110.91 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.438 ' O ' HG23 ' D' ' 40' ' ' VAL . 74.9 Cg_exo -55.49 112.88 1.18 Allowed 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 121.807 1.672 . . . . 75.02 109.457 165.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -70.95 107.41 4.05 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.055 -1.091 . . . . 73.02 108.055 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.656 HG13 HG13 ' D' ' 64' ' ' VAL . 96.0 t -102.45 131.4 50.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 115.122 -0.945 . . . . 43.35 109.913 -170.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -119.45 125.13 48.18 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 107.715 -1.217 . . . . 74.12 107.715 170.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.555 HD11 HG13 ' D' ' 62' ' ' VAL . 51.9 tp -96.18 141.48 29.5 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.852 -0.795 . . . . 62.45 108.852 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.58 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 35.1 t70 -134.71 113.28 11.51 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.026 -1.101 . . . . 71.31 108.026 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.59 HD12 HG23 ' E' ' 121' ' ' VAL . 93.7 mt -114.49 151.7 32.85 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.295 0.638 . . . . 62.53 110.696 -177.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.542 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 13.5 t0 -152.07 143.44 23.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.19 -0.914 . . . . 72.51 108.656 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . 0.4 ' OG1' ' HB2' ' E' ' 111' ' ' LEU . 23.9 m -105.34 141.33 37.04 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.073 -0.714 . . . . 64.12 109.073 -176.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.54 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.86 162.5 41.21 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.214 1.006 . . . . 75.13 108.864 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 36.3 p -171.2 159.72 5.99 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.601 0.76 . . . . 34.51 110.011 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 84.6 p -154.43 169.03 24.72 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.336 1.054 . . . . 64.4 109.672 -175.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 99.38 149.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 127.847 2.459 . . . . 71.4 110.211 -175.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.545 HD23 ' N ' ' D' ' 52' ' ' ALA . 5.1 tt -65.6 158.05 28.23 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 107.804 -1.184 . . . . 53.05 107.804 173.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.545 ' N ' HD23 ' D' ' 51' ' ' LEU . . . -59.78 -123.68 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 124.608 1.163 . . . . 50.14 113.508 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 57.52 27.84 14.65 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.506 0.722 . . . . 64.23 111.59 -176.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 73.8 8.58 4.89 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.664 1.585 . . . . 64.43 112.505 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 t -108.82 99.37 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 108.773 -0.825 . . . . 73.4 108.773 -176.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.443 ' CE2' ' HA ' ' D' ' 52' ' ' ALA . 39.1 m-85 -133.88 129.57 36.6 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.53 -0.915 . . . . 62.11 108.53 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.604 ' HB3' HG13 ' D' ' 83' ' ' ILE . 0.0 OUTLIER -101.66 120.14 39.87 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.835 -1.172 . . . . 71.32 107.835 168.298 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.485 ' O ' ' HA2' ' D' ' 81' ' ' GLY . 79.7 t -101.02 132.9 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.414 0 CA-C-N 114.472 -1.24 . . . . 55.45 109.451 -176.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 36.6 t -106.63 138.81 30.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 124.383 1.073 . . . . 73.31 108.722 178.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.561 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -120.73 118.31 29.72 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.016 -1.475 . . . . 55.11 107.016 173.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.542 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 55.3 ttm-85 -88.57 109.35 20.01 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 107.848 -1.168 . . . . 71.34 107.848 175.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.555 HG13 HD11 ' D' ' 42' ' ' LEU . 38.5 t -114.69 113.23 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 N-CA-C 109.345 -0.613 . . . . 74.13 109.345 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.58 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 24.4 m -119.75 131.96 55.5 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 123.954 0.902 . . . . 71.51 108.978 -172.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.656 HG13 HG13 ' D' ' 40' ' ' VAL . 85.1 t -118.71 104.69 16.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 C-N-CA 123.294 0.638 . . . . 74.42 109.384 177.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 10.1 m -97.98 94.03 6.64 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.26 -1.385 . . . . 75.24 107.26 170.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.02 138.71 48.29 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.015 0.926 . . . . 74.23 108.679 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.546 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 61.1 m -144.55 136.03 25.53 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.346 0.658 . . . . 63.54 111.61 -172.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.509 HD12 HG22 ' D' ' 31' ' ' VAL . 32.1 mt -100.5 106.93 18.51 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.473 1.109 . . . . 71.12 109.061 174.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.17 -126.32 8.65 Favored Glycine 0 C--N 1.345 1.04 0 CA-C-O 119.869 -0.406 . . . . 62.11 112.807 175.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.23 5.3 52.19 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.328 0.651 . . . . 65.12 112.081 -177.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . 0.506 ' HG2' ' NZ ' ' D' ' 34' ' ' LYS . 9.3 pt-20 -133.69 164.55 26.97 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.991 0.516 . . . . 73.34 109.965 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 21.4 m -68.02 143.69 55.44 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.994 0.917 . . . . 74.13 111.766 178.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.551 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -91.75 -69.66 0.73 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.616 -1.624 . . . . 65.23 106.616 173.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -149.22 146.89 27.83 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 114.812 -1.086 . . . . 71.43 110.059 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 82.7 mt -110.36 145.97 36.59 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.015 -1.105 . . . . 75.33 108.015 174.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.454 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 46.6 t -156.49 147.03 21.6 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.469 0.308 . . . . 71.03 110.207 -177.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -156.63 130.52 8.39 Favored 'General case' 0 C--N 1.345 0.373 0 C-N-CA 123.274 0.63 . . . . 52.31 109.724 168.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . 0.409 HG22 HG23 ' D' ' 21' ' ' ILE . 92.0 t -129.76 114.45 30.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 C-N-CA 124.512 1.125 . . . . 55.42 108.52 178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.486 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.5 mt-30 -90.13 88.24 7.19 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.837 0.827 . . . . 72.15 109.074 173.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.7 107.2 13.31 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 113.688 -1.596 . . . . 63.43 109.912 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' D' ' 58' ' ' VAL . . . -110.85 162.22 12.58 Favored Glycine 0 N--CA 1.465 0.625 0 O-C-N 123.032 0.208 . . . . 63.34 113.397 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.09 148.9 9.15 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-O 119.366 -0.686 . . . . 52.11 112.935 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.604 HG13 ' HB3' ' D' ' 57' ' ' GLU . 3.7 mp -89.1 136.74 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.197 -1.038 . . . . 73.24 108.197 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -132.43 129.42 39.26 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.477 1.111 . . . . 73.13 108.303 176.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 30.2 p -81.53 101.89 10.24 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.043 -0.725 . . . . 74.21 109.043 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.429 HG22 ' HD2' ' D' ' 11' ' ' PHE . 2.3 pp -119.24 121.0 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 120.749 0.309 . . . . 71.21 110.757 -177.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.16 167.93 8.49 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.481 1.112 . . . . 42.45 111.313 174.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 99.0 19.02 23.0 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 124.046 0.841 . . . . 71.34 112.626 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.609 HD13 ' HB2' ' D' ' 94' ' ' MET . 0.7 OUTLIER -140.18 162.16 24.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 C-N-CA 125.157 1.383 . . . . 72.43 109.461 177.617 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.52 ' HG3' HG21 ' B' ' 149' ' ' THR . 9.4 pt-20 -147.8 -174.05 4.45 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.404 0.682 . . . . 73.11 111.386 -173.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' B' ' 153' ' ' GLN . . . 78.7 -146.05 29.47 Favored Glycine 0 C--N 1.349 1.255 0 C-N-CA 124.047 0.832 . . . . 61.13 112.242 -172.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 68.0 p -94.32 -39.62 10.39 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.611 0.706 . . . . 42.12 111.027 174.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -65.61 -17.82 64.87 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.363 1.065 . . . . 75.34 113.591 -171.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.609 ' HB2' HD13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -57.04 -30.24 64.08 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 113.047 0.758 . . . . 54.44 113.047 176.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . 0.437 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -80.54 -13.97 58.63 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.486 0.714 . . . . 72.32 112.351 -178.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -63.05 -29.83 71.12 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.072 0.549 . . . . 74.54 111.084 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 55.5 m -62.69 -28.3 69.84 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.387 0.675 . . . . 43.3 111.488 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.48 HD13 HD11 ' E' ' 102' ' ' LEU . 7.1 tt -92.41 -46.93 7.43 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.601 1.16 . . . . 51.15 110.063 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.22 -15.09 65.22 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 116.2 -0.455 . . . . 71.41 114.167 -169.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.91 -52.0 1.22 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.91 0.484 . . . . 51.14 110.685 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . 0.415 ' O ' HG12 ' D' ' 105' ' ' ILE . 61.8 t80 -73.74 -39.73 64.04 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 112.272 0.471 . . . . 64.53 112.272 -174.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 92.7 m -65.15 -46.97 73.13 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-O 118.542 -0.742 . . . . 72.41 111.638 177.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.561 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 84.2 Cg_exo -54.61 -33.77 80.42 Favored 'Trans proline' 0 C--N 1.393 2.907 0 C-N-CA 122.763 2.309 . . . . 75.43 113.661 167.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -65.27 -32.66 74.43 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.439 0.696 . . . . 72.31 110.978 177.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.415 HG12 ' O ' ' D' ' 101' ' ' TYR . 51.1 mm -74.33 -38.37 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.284 0.633 . . . . 75.31 110.244 173.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 70.6 mt -73.65 -22.9 59.83 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.521 -0.763 . . . . 63.55 111.709 -175.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -67.55 -42.01 34.18 Favored Pre-proline 0 N--CA 1.484 1.268 0 N-CA-C 113.635 0.976 . . . . 75.23 113.635 -172.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -47.15 -44.11 24.29 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.446 2.097 . . . . 73.33 113.855 167.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -79.36 -28.28 41.97 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.921 0.888 . . . . 74.41 112.252 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . 0.505 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -64.48 -47.4 79.11 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.733 0.777 . . . . 74.24 109.451 173.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -69.04 -34.29 74.96 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 113.723 -1.58 . . . . 72.45 110.385 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . 0.519 ' HG2' HH12 ' C' ' 120' ' ' ARG . 20.5 tt0 -53.42 -49.73 66.71 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.118 0.967 . . . . 64.32 110.452 175.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.428 ' O ' ' HG3' ' D' ' 117' ' ' MET . 46.1 t -67.69 -54.4 19.8 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.701 -1.136 . . . . 73.41 110.794 -178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.493 HG21 HG21 ' D' ' 64' ' ' VAL . 52.9 mt -60.28 -58.07 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.365 0.666 . . . . 54.42 111.855 -174.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 91.5 m -51.3 -41.15 60.3 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.102 0.876 . . . . 75.32 111.769 -175.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 47.2 t -66.09 -42.12 89.75 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 114.681 -1.145 . . . . 72.14 110.078 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 66.6 mtm -69.03 -30.53 68.91 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.057 0.543 . . . . 61.43 111.981 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.437 HG23 ' O ' ' D' ' 114' ' ' ILE . 95.7 t -62.97 -47.21 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.682 0.793 . . . . 72.34 109.198 174.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.3 p -74.25 -26.14 60.05 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.405 -0.816 . . . . 73.13 111.206 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' D' ' 116' ' ' SER . 88.6 mtt-85 -69.77 -32.85 71.58 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.464 0.705 . . . . 74.45 109.775 174.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.84 10.95 63.48 Favored Glycine 0 C--N 1.35 1.358 0 O-C-N 123.939 0.774 . . . . 40.31 112.501 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 70.3 p 54.79 27.04 8.32 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 126.095 1.758 . . . . 71.13 113.464 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -88.85 150.93 46.65 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 109.064 -0.717 . . . . 71.34 109.064 170.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.467 ' HA ' ' OG1' ' E' ' 129' ' ' THR . 97.2 Cg_exo -46.99 122.31 6.07 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.081 2.521 . . . . 54.42 113.53 171.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -45.62 123.19 4.1 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.682 1.593 . . . . 75.13 112.174 -175.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.432 ' HB3' HG21 ' D' ' 118' ' ' VAL . 20.6 tp -103.08 109.79 21.48 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.629 -0.878 . . . . 61.03 108.629 -175.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . 0.408 HD22 HD12 ' B' ' 16' ' ' ILE . 10.0 m120 -98.93 86.54 3.5 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 107.679 -1.23 . . . . 63.14 107.679 -178.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 96.5 mt -54.38 115.04 1.88 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.026 0.53 . . . . 63.31 110.351 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.8 135.04 95.73 Favored Pre-proline 0 CA--C 1.548 0.882 0 O-C-N 123.693 0.62 . . . . 73.5 110.557 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.62 121.81 10.45 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.545 2.163 . . . . 72.11 111.183 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.5 p -108.04 137.84 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.205 1.002 . . . . 74.12 108.903 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -78.27 98.4 5.89 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.176 -0.675 . . . . 74.14 109.176 175.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -61.43 -47.79 84.16 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.102 0.961 . . . . 75.31 111.05 -178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -63.06 -30.08 71.32 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.241 -0.89 . . . . 75.43 111.07 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.478 ' HA ' ' SD ' ' D' ' 138' ' ' MET . . . -58.78 -30.43 67.57 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.885 0.874 . . . . 74.21 112.714 -177.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 7.3 mp -78.71 -37.66 40.96 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.864 0.466 . . . . 75.32 111.032 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -66.27 -31.19 71.84 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 116.31 -0.405 . . . . 64.42 110.451 175.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.478 ' SD ' ' HA ' ' D' ' 135' ' ' ALA . 45.5 mtt -67.66 -46.96 70.9 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.007 0.923 . . . . 72.11 109.593 170.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -56.17 -38.42 70.9 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 125.594 1.558 . . . . 74.41 111.507 -173.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -51.23 -40.66 59.29 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 125.075 1.35 . . . . 74.31 111.549 176.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 mp -82.08 -49.55 10.07 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.814 0.846 . . . . 60.14 110.781 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -91.05 40.41 1.03 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 113.365 0.876 . . . . 70.01 113.365 -168.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -119.13 85.98 2.47 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 108.935 -0.765 . . . . 65.21 108.935 171.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -165.57 111.36 0.9 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.741 -1.118 . . . . 71.2 108.996 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . 65.38 24.58 12.03 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.548 1.139 . . . . 74.35 112.664 173.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -139.38 59.9 0.58 Allowed Glycine 0 N--CA 1.476 1.319 0 N-CA-C 111.558 -0.617 . . . . 73.02 111.558 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -129.08 117.06 20.23 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.999 0.92 . . . . 64.22 110.665 -175.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 141.21 101.31 0.44 Allowed Glycine 0 C--N 1.346 1.13 0 N-CA-C 111.602 -0.599 . . . . 65.3 111.602 177.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 32.3 p -129.99 151.55 50.42 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.533 1.133 . . . . 40.23 109.282 174.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -128.21 143.29 51.03 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.995 0.518 . . . . 71.41 111.343 -176.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.83 153.0 14.13 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 106.883 -1.525 . . . . 65.21 106.883 176.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -50.43 -53.85 26.39 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.887 0.875 . . . . 61.0 111.178 176.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? 59.33 88.52 0.07 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.732 1.213 . . . . 55.34 109.769 -173.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -120.01 -51.33 2.23 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 115.123 -0.944 . . . . 74.42 109.406 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 C-N-CA 123.971 0.908 . . . . 74.2 109.378 -178.297 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.472 0 N-CA-C 111.648 -0.581 . . . . 62.24 111.648 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 168.55 -116.01 0.64 Allowed Glycine 0 C--N 1.344 0.998 0 N-CA-C 111.058 -0.817 . . . . 73.33 111.058 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -96.08 179.62 5.0 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.802 0.841 . . . . 73.43 109.872 175.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -89.89 -74.15 0.49 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 122.642 0.377 . . . . 71.31 111.065 -167.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -141.47 -56.62 0.48 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.691 0.796 . . . . 72.21 111.237 -173.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 127.91 75.15 0.19 Allowed Glycine 0 C--N 1.349 1.25 0 N-CA-C 111.184 -0.766 . . . . 73.25 111.184 -170.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 97' ' ' ILE . . . . . 0.441 HD11 ' SD ' ' D' ' 94' ' ' MET . 4.3 tt -55.48 -28.31 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 C-N-CA 125.449 1.5 . . . . 72.14 112.113 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 32.4 t70 78.58 -88.11 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 114.292 1.219 . . . . 73.32 114.292 160.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -100.75 102.41 13.5 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 118.241 0.473 . . . . 62.4 111.083 -168.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 100' ' ' LEU . . . . . 0.575 ' HB2' HG23 ' E' ' 103' ' ' THR . 4.2 mp -111.38 142.15 25.87 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 123.776 0.83 . . . . 73.14 109.144 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.46 -15.29 29.4 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 123.436 2.757 . . . . 63.02 114.929 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 102' ' ' LEU . . . . . 0.48 HD11 HD13 ' D' ' 98' ' ' LEU . 1.4 pp -108.96 -13.21 14.77 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.63 0.772 . . . . 75.22 112.906 -173.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 103' ' ' THR . . . . . 0.575 HG23 ' HB2' ' E' ' 100' ' ' LEU . 58.0 p -76.21 -36.2 58.71 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.061 0.458 . . . . 45.51 109.781 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.59 151.81 16.95 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.242 -1.143 . . . . 74.24 110.242 167.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 67.17 11.52 8.43 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.138 0.975 . . . . 75.05 111.781 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 31.1 t80 65.91 -177.16 0.19 Allowed 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 123.97 0.908 . . . . 73.15 109.84 -175.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 17.5 p -58.74 -19.45 40.39 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.455 0.702 . . . . 73.13 112.679 176.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 68.86 -76.49 0.06 Allowed 'General case' 0 C--N 1.358 0.955 0 C-N-CA 125.287 1.435 . . . . 55.05 111.556 172.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -98.16 63.2 1.57 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.652 -1.24 . . . . 74.0 107.652 173.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.54 156.89 15.36 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 114.968 -1.015 . . . . 71.34 110.888 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . 0.413 HD23 ' CB ' ' D' ' 44' ' ' LEU . 19.1 tp -38.71 -64.2 0.46 Allowed 'General case' 0 N--CA 1.476 0.873 0 O-C-N 125.519 1.762 . . . . 44.22 113.4 -165.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -114.41 76.24 0.98 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.463 -0.94 . . . . 54.41 108.463 174.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -140.44 -68.02 0.42 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.344 0.658 . . . . 54.32 109.556 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -147.9 43.72 1.07 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.677 -0.692 . . . . 75.42 109.924 -172.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 20.3 p -90.45 52.37 2.21 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.652 0.781 . . . . 74.45 109.984 174.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.34 -91.12 0.38 Allowed Glycine 0 C--N 1.353 1.507 0 N-CA-C 110.691 -0.964 . . . . 44.44 110.691 -172.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -127.59 96.76 32.12 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 124.256 1.022 . . . . 50.24 108.255 171.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -75.18 72.84 4.62 Favored 'Trans proline' 0 C--N 1.371 1.716 0 C-N-CA 123.128 2.552 . . . . 60.53 113.055 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -95.06 177.0 6.02 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 107.989 -1.115 . . . . 50.43 107.989 173.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 60.1 t80 80.07 -46.04 0.3 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 125.461 1.504 . . . . 64.04 110.979 176.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 121' ' ' VAL . . . . . 0.59 HG23 HD12 ' D' ' 44' ' ' LEU . 14.6 p -63.25 -26.61 41.3 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 C-N-CA 125.234 1.414 . . . . 53.4 111.768 170.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 62.6 p -70.37 -15.42 62.85 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.418 1.087 . . . . 74.24 111.625 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -108.66 158.39 17.64 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.128 0.971 . . . . 65.4 110.548 -173.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 70.4 m -149.96 -61.14 0.21 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.994 0.917 . . . . 64.31 108.673 171.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . 60.57 -154.65 0.36 Allowed 'General case' 0 N--CA 1.481 1.089 0 O-C-N 124.088 0.868 . . . . 71.02 109.602 -172.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . 68.24 103.62 0.05 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.878 0.871 . . . . 63.12 111.867 171.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 127' ' ' SER . . . . . 0.407 ' HB3' ' OE1' ' D' ' 37' ' ' GLN . 33.3 t -162.02 132.49 4.9 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.036 0.535 . . . . 53.41 110.204 -174.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -160.38 125.23 3.81 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 121.184 0.516 . . . . 64.42 111.529 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 129' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' D' ' 124' ' ' PRO . 0.6 OUTLIER -148.76 170.78 17.45 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.707 1.603 . . . . 74.4 108.832 174.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 130' ' ' ALA . . . . . 0.5 ' HB3' ' HD3' ' A' ' 124' ' ' PRO . . . -119.19 21.78 12.12 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.651 -0.704 . . . . 70.21 110.266 176.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 131' ' ' TRP . . . . . 0.545 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 47.8 t90 -62.26 113.59 2.98 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 123.394 0.678 . . . . 75.35 111.306 -176.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 47.7 p -161.82 16.82 0.1 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.77 0.828 . . . . 73.1 111.631 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 2.4 p -88.5 126.85 35.45 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.831 0.452 . . . . 74.22 111.785 -176.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -92.1 -13.37 57.67 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 115.335 -0.848 . . . . 73.4 111.78 169.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 135' ' ' VAL . . . . . 0.413 HG21 HD22 ' A' ' 127' ' ' ASN . 47.3 t 53.33 81.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.232 0 C-N-CA 125.804 1.642 . . . . 71.11 112.426 174.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 136' ' ' LYS . . . . . 0.477 ' HG2' HE22 ' C' ' 14' ' ' GLN . 21.2 mtpp -140.47 101.1 4.03 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 107.921 -1.14 . . . . 54.02 107.921 176.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 14.3 t -144.66 13.31 1.52 Allowed 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.819 0.674 . . . . 70.04 112.819 -168.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -147.82 -49.38 0.17 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.639 -0.504 . . . . 73.33 109.639 -177.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 139' ' ' ASN . . . . . 0.431 ' ND2' ' HA ' ' C' ' 10' ' ' THR . 35.0 t-20 -134.98 146.18 48.82 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.319 -0.993 . . . . 71.24 108.319 178.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.41 -92.05 1.97 Allowed Glycine 0 C--N 1.342 0.868 0 CA-C-N 116.739 -0.21 . . . . 43.12 113.379 -173.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 141' ' ' ALA . . . . . 0.573 ' HA ' HG21 ' C' ' 10' ' ' THR . . . -171.28 -174.88 1.54 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.194 1.398 . . . . 73.34 109.071 -177.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 37.8 tp -130.64 -65.9 0.78 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.72 0.408 . . . . 72.12 110.761 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . 130.02 50.56 0.11 Allowed Glycine 0 N--CA 1.472 1.067 0 N-CA-C 111.213 -0.755 . . . . 54.11 111.213 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 6.1 m -83.09 158.43 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.854 0.862 . . . . 75.04 111.291 -174.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 CA--C 1.548 0.867 0 C-N-CA 123.372 0.669 . . . . 74.14 109.453 178.362 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 CA-C-O 119.805 -0.442 . . . . 54.55 112.128 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 103.96 50.6 1.0 Allowed Glycine 0 C--N 1.35 1.325 0 N-CA-C 111.866 -0.494 . . . . 65.32 111.866 -177.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -84.64 144.76 28.39 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.042 0.937 . . . . 75.11 109.73 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -148.46 175.89 10.76 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.115 0.966 . . . . 74.02 110.664 -176.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -127.54 145.14 50.96 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.394 1.077 . . . . 63.24 109.147 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -175.89 -66.56 0.06 OUTLIER Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.163 -0.775 . . . . 62.34 111.163 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 97' ' ' ILE . . . . . 0.433 HD12 ' HE2' ' B' ' 94' ' ' MET . 25.0 pt -95.67 116.61 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.934 0.893 . . . . 75.52 111.468 -177.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -86.26 151.26 23.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.783 0.833 . . . . 51.4 110.157 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 99' ' ' ALA . . . . . 0.489 ' O ' ' HD3' ' F' ' 101' ' ' PRO . . . 56.6 100.7 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.773 1.229 . . . . 44.22 112.508 174.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 100' ' ' LEU . . . . . . . . . . . . . 5.4 mp -107.36 78.05 0.62 Allowed Pre-proline 0 CA--C 1.566 1.582 0 C-N-CA 124.465 1.106 . . . . 74.42 109.579 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 101' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' F' ' 99' ' ' ALA . 33.8 Cg_endo -101.21 29.5 0.1 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.707 2.938 . . . . 63.31 113.909 -167.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 102' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 71.69 -60.53 0.52 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.238 1.415 . . . . 75.32 110.61 -174.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -163.18 -42.43 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.469 1.508 . . . . 73.51 106.94 168.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . -167.41 -43.76 0.03 OUTLIER Glycine 0 C--N 1.343 0.938 0 CA-C-N 114.778 -1.101 . . . . 73.41 110.475 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -102.17 169.16 8.9 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.646 0.778 . . . . 60.1 110.306 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 106' ' ' TYR . . . . . 0.477 ' CE1' ' HA ' ' B' ' 47' ' ' ALA . 21.9 t80 -70.74 -37.07 73.42 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.876 1.27 . . . . 74.52 110.834 -175.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 14.2 m -100.77 16.25 25.64 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 124.254 1.022 . . . . 73.22 109.786 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 108' ' ' HIS . . . . . 0.555 ' NE2' ' HA3' ' B' ' 99' ' ' GLY . 43.7 m-70 67.0 -73.81 0.07 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.907 1.283 . . . . 74.14 109.346 -171.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 109' ' ' TYR . . . . . 0.428 ' HE2' HD11 ' B' ' 141' ' ' LEU . 93.6 m-85 -144.77 -57.73 0.35 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 107.607 -1.257 . . . . 60.31 107.607 171.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -148.39 142.14 25.63 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.977 -1.01 . . . . 75.24 110.01 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 48.1 tp -167.52 -48.49 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 106.215 -1.772 . . . . 61.32 106.215 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -91.58 164.36 13.8 Favored 'General case' 0 CA--C 1.555 1.146 0 CA-C-N 113.659 -1.61 . . . . 64.4 107.282 158.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -60.65 133.91 56.56 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.568 0.747 . . . . 74.11 110.151 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -126.4 165.8 18.38 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 124.689 1.196 . . . . 74.44 109.437 175.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 7.8 t -73.19 91.64 1.67 Allowed 'General case' 0 CA--C 1.555 1.136 0 CA-C-O 121.75 0.786 . . . . 64.43 111.107 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.23 60.99 4.47 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.067 -0.969 . . . . 73.4 112.96 174.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -133.07 102.37 13.27 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 122.901 0.48 . . . . 73.3 109.88 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.42 102.46 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 123.07 2.514 . . . . 75.03 111.652 170.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -104.29 164.99 11.34 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.768 0.827 . . . . 71.25 110.302 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 120' ' ' TYR . . . . . 0.626 ' HB3' ' HG ' ' B' ' 136' ' ' LEU . 43.8 t80 -53.28 -44.53 68.32 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.305 1.442 . . . . 62.14 111.576 176.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 58.8 t -74.42 96.17 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 122.929 0.492 . . . . 62.24 110.149 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 5.9 t -81.26 -56.48 4.04 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 108.411 -0.959 . . . . 61.4 108.411 167.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -179.83 136.7 0.12 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.021 1.329 . . . . 75.4 108.538 172.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 55.5 m -153.33 125.93 8.2 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.562 0.745 . . . . 74.35 109.856 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -161.73 149.89 15.13 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.894 0.878 . . . . 71.4 109.461 175.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.06 141.7 28.42 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.181 0.593 . . . . 74.05 110.029 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 31.1 p -74.12 116.57 14.91 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.65 0.78 . . . . 63.33 109.647 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.51 127.88 33.6 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.628 0.771 . . . . 65.22 111.042 -177.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 39.6 p -81.62 139.53 34.95 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 122.536 0.334 . . . . 60.24 110.341 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.35 131.58 51.22 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 123.964 0.905 . . . . 54.03 110.498 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 131' ' ' TRP . . . . . 0.491 ' H ' ' HE3' ' F' ' 131' ' ' TRP . 1.0 OUTLIER -120.3 151.49 39.13 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.942 0.897 . . . . 75.05 110.222 -164.581 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 29.3 t -167.93 135.02 2.17 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.152 -0.685 . . . . 63.13 109.152 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 133' ' ' THR . . . . . 0.59 ' HA ' HD12 ' C' ' 126' ' ' LEU . 20.7 m -78.64 102.55 8.05 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.575 -0.898 . . . . 73.11 108.575 173.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -82.89 32.69 2.93 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 116.15 -0.477 . . . . 71.1 113.993 -173.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 28.0 m -70.79 126.79 31.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 108.854 -0.795 . . . . 61.54 108.854 174.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -73.65 -27.97 61.54 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 111.962 0.356 . . . . 62.24 111.962 -169.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 43.0 m -142.42 101.41 3.89 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.789 0.435 . . . . 64.42 111.028 -174.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -176.53 -54.15 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.36 1.038 . . . . 63.11 110.274 163.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -116.36 158.4 23.53 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.195 0.598 . . . . 55.51 110.758 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -73.64 136.55 22.18 Favored Glycine 0 C--N 1.346 1.11 0 N-CA-C 111.507 -0.637 . . . . 23.31 111.507 174.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -139.55 132.66 29.63 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.902 0.881 . . . . 74.21 109.55 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.93 106.68 5.12 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.48 0.712 . . . . 60.31 110.195 -176.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -83.93 62.45 4.59 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-N 115.975 -0.557 . . . . 61.32 111.837 174.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 16.3 m -68.39 120.26 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.122 0 C-N-CA 123.833 0.853 . . . . 63.21 110.696 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 34.1 t70 . . . . . 0 C--O 1.249 1.059 0 C-N-CA 123.385 0.674 . . . . 71.4 109.939 -176.157 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.828 -0.434 . . . . 73.32 109.828 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.7 p -131.05 115.6 16.67 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 108.957 -0.757 . . . . 73.02 108.957 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -131.98 42.96 3.09 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.64 0.733 . . . . 72.01 109.96 -177.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -86.66 19.42 2.91 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 115.177 -0.92 . . . . 75.44 111.731 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.501 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 26.9 t-20 -61.16 100.03 0.11 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.827 0.851 . . . . 72.41 110.048 174.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.485 ' O ' ' HA2' ' A' ' 88' ' ' GLY . 26.7 t-20 -137.86 150.73 47.39 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 108.329 -0.989 . . . . 74.2 108.329 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.4 p -54.19 80.56 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 124.686 1.194 . . . . 63.0 113.695 -173.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 172.68 115.59 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 128.855 2.862 . . . . 74.11 105.459 177.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.534 ' HG2' HD12 ' A' ' 89' ' ' ILE . 13.8 tmm? -71.52 145.38 49.18 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.93 0.395 . . . . 74.12 111.004 -173.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.2 m -139.39 124.95 19.32 Favored 'General case' 0 C--N 1.347 0.467 0 C-N-CA 124.002 0.921 . . . . 72.1 108.929 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -120.38 120.68 36.68 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.295 1.038 . . . . 73.2 108.761 -177.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -140.45 135.33 31.9 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.993 0.517 . . . . 73.41 109.756 173.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.441 ' CD1' HG21 ' A' ' 105' ' ' ILE . 3.6 mt -92.77 115.26 31.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 108.349 -0.982 . . . . 74.13 108.349 173.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.67 -40.25 29.52 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.235 -0.654 . . . . 74.12 109.235 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -176.21 122.93 0.17 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 123.146 0.279 . . . . 62.32 110.706 -171.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 79.4 mt -105.61 136.76 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.833 -0.802 . . . . 51.41 108.833 173.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.467 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 33.2 p90 -169.76 155.43 5.85 Favored 'General case' 0 C--N 1.346 0.42 0 O-C-N 124.197 0.936 . . . . 71.54 110.704 -173.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -83.28 121.94 27.78 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.513 -0.767 . . . . 74.54 109.475 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.467 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.5 mtpt -84.71 -26.7 27.51 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.71 -0.478 . . . . 73.01 109.71 175.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.598 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 11.0 t70 -153.49 143.44 22.07 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 114.63 -1.168 . . . . 42.32 109.837 -178.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.485 HD13 ' SD ' ' B' ' 117' ' ' MET . 91.5 mt -143.63 142.2 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.498 1.519 . . . . 63.41 107.857 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.9 t -149.97 133.22 16.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.289 0.635 . . . . 74.13 109.839 172.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -125.58 140.44 52.74 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 107.014 -1.476 . . . . 70.43 107.014 169.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -142.01 108.5 5.32 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.586 0.755 . . . . 75.34 109.042 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -106.96 85.65 2.03 Favored Pre-proline 0 CA--C 1.545 0.786 0 N-CA-C 106.639 -1.615 . . . . 64.33 106.639 165.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.55 -38.79 5.65 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.392 2.061 . . . . 53.12 112.177 -169.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -111.22 31.41 6.1 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.871 0.869 . . . . 63.23 108.867 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.521 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -47.13 -54.72 18.98 Favored Pre-proline 0 N--CA 1.493 1.678 0 CA-C-O 117.693 -1.146 . . . . 61.5 113.72 -173.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -61.25 -28.2 84.5 Favored 'Trans proline' 0 C--N 1.401 3.334 0 C-N-CA 121.888 1.725 . . . . 54.42 112.667 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.533 ' HA ' ' NE2' ' A' ' 33' ' ' GLN . 9.0 t60 -90.64 -31.8 16.49 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.741 1.216 . . . . 52.34 112.055 -173.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.647 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.9 p -79.22 -21.4 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 120.875 0.369 . . . . 74.2 111.142 -171.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -73.58 -6.2 45.12 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 115.991 -0.55 . . . . 73.41 111.025 172.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.533 ' NE2' ' HA ' ' A' ' 30' ' ' HIS . 9.9 mt-30 -88.8 -28.98 20.07 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.925 0.89 . . . . 63.33 110.202 172.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.429 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 14.5 mmmm -77.0 157.58 31.1 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.636 0.774 . . . . 72.14 110.929 -176.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.78 119.37 9.2 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.438 0.695 . . . . 71.31 110.464 174.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.452 ' CE3' HD21 ' A' ' 68' ' ' LEU . 67.2 t-105 -81.6 87.69 6.25 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.49 0.662 . . . . 73.51 111.393 -175.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.533 ' H ' HD22 ' A' ' 68' ' ' LEU . 35.7 tt0 -124.1 82.93 56.25 Favored Pre-proline 0 CA--C 1.557 1.222 0 C-N-CA 124.652 1.181 . . . . 70.25 107.869 171.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.34 121.17 7.52 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.762 2.308 . . . . 63.24 113.257 -170.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -97.19 89.36 4.75 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.829 -0.804 . . . . 74.21 108.829 172.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.571 HG21 HD13 ' A' ' 126' ' ' LEU . 48.8 t -79.66 111.76 16.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-N 114.846 -1.07 . . . . 73.22 110.109 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -99.03 123.49 43.36 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.076 -0.713 . . . . 74.45 109.076 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 84.6 mt -99.31 108.48 21.02 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.515 0.726 . . . . 62.1 109.665 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.632 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 11.2 m-20 -104.72 106.07 16.41 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.418 -1.327 . . . . 44.43 107.418 170.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.41 HD13 ' CZ ' ' A' ' 133' ' ' PHE . 79.4 mt -106.95 117.31 33.71 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 109.04 -0.726 . . . . 72.43 109.04 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -122.62 130.77 53.35 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.882 -1.525 . . . . 60.15 106.882 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.4 HG21 ' HA2' ' A' ' 99' ' ' GLY . 99.9 m -108.35 136.0 48.73 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.69 -0.485 . . . . 70.45 109.69 177.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.38 109.93 6.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.127 0.971 . . . . 50.33 108.966 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 79.2 p -94.96 158.79 15.32 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.97 0.508 . . . . 74.5 109.955 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.0 t -148.74 119.96 7.8 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.519 -0.919 . . . . 51.41 108.519 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -81.88 115.87 21.27 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.365 -0.606 . . . . 72.31 109.365 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.0 mt -80.56 -42.42 22.39 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.532 0.733 . . . . 75.24 110.516 -176.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.67 -179.61 7.57 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.023 0.929 . . . . 74.32 110.139 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -60.73 121.48 12.37 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.673 0.789 . . . . 73.55 109.903 170.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 65.84 -2.56 0.88 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.381 1.472 . . . . 54.22 112.974 -176.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.0 t -104.68 105.1 17.94 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 N-CA-C 108.158 -1.053 . . . . 70.12 108.158 174.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -107.64 162.66 13.77 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.562 -0.903 . . . . 53.1 108.562 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -131.77 153.3 50.24 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 107.444 -1.317 . . . . 72.13 107.444 168.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.452 HG11 ' HD3' ' A' ' 103' ' ' PRO . 68.0 t -133.48 136.41 54.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.56 0 N-CA-C 107.513 -1.291 . . . . 64.4 107.513 173.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.452 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 47.9 t -119.82 133.58 66.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.831 -0.803 . . . . 75.41 108.831 174.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.417 HD22 HG22 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -104.01 100.07 9.84 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 106.564 -1.643 . . . . 63.21 106.564 177.012 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -82.97 99.21 9.66 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 107.867 -1.16 . . . . 72.14 107.867 175.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.461 HG21 ' HB1' ' A' ' 110' ' ' ALA . 47.2 t -98.96 130.57 47.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 N-CA-C 108.353 -0.98 . . . . 73.24 108.353 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.632 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 9.3 m -127.36 107.76 10.25 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.731 -0.84 . . . . 75.14 108.731 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.57 HG11 HD21 ' A' ' 126' ' ' LEU . 54.1 t -101.24 128.23 53.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 C-N-CA 124.547 1.139 . . . . 74.24 108.275 174.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.8 m -131.44 116.89 18.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.816 -0.809 . . . . 55.51 108.816 172.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.53 119.43 39.15 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 107.61 -1.256 . . . . 52.41 107.61 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -127.7 142.31 51.36 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.515 0.674 . . . . 74.42 110.597 -177.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.533 HD22 ' H ' ' A' ' 37' ' ' GLN . 50.4 mt -91.18 61.19 4.45 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.262 1.425 . . . . 72.14 107.927 170.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.2 -98.28 1.47 Allowed Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.198 -0.91 . . . . 60.03 112.684 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -88.35 -29.6 20.18 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.128 0.971 . . . . 73.11 110.287 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.429 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 5.1 tp10 -85.88 101.17 12.62 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.149 -0.932 . . . . 72.14 108.954 -174.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.4 m -68.16 124.27 22.98 Favored 'General case' 0 C--O 1.245 0.836 0 CA-C-N 119.291 0.951 . . . . 75.13 108.559 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.647 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -79.81 -54.52 5.76 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.17 -0.923 . . . . 74.3 108.853 -177.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.437 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 54.5 p90 -155.34 162.23 40.88 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.276 -0.874 . . . . 71.4 111.527 176.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 64' ' ' VAL . 45.0 tp -131.14 118.44 20.49 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 113.765 -1.561 . . . . 63.43 107.498 175.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.437 ' HG ' ' HD1' ' A' ' 74' ' ' PHE . 85.3 m -115.3 126.89 55.02 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.595 -0.891 . . . . 74.31 108.595 175.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -139.18 115.77 10.65 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.32 -0.622 . . . . 72.21 109.32 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.4 t -125.64 112.35 30.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.42 1.088 . . . . 71.14 109.047 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.598 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 4.2 mt-30 -84.62 84.89 7.52 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.505 -0.924 . . . . 74.21 108.505 169.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -76.7 96.85 4.3 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 114.681 -1.145 . . . . 72.51 108.941 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -84.91 160.8 35.69 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.88 -0.488 . . . . 45.04 111.88 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.506 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -156.49 125.05 1.54 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.186 -1.166 . . . . 72.22 110.186 174.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.409 HG13 ' HE1' ' A' ' 17' ' ' TYR . 65.1 mt -79.79 124.66 38.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.893 -1.151 . . . . 73.32 107.893 171.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.625 ' HB3' HD11 ' A' ' 86' ' ' ILE . 96.3 m-85 -125.03 119.42 28.63 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.889 -0.782 . . . . 72.01 108.889 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.7 t -89.14 90.99 8.62 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.249 -1.019 . . . . 63.45 108.249 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.625 HD11 ' HB3' ' A' ' 84' ' ' PHE . 13.1 mm -116.87 148.69 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-O 121.205 0.526 . . . . 74.24 110.816 -169.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.501 ' HB1' ' HA ' ' A' ' 5' ' ' ASN . . . -163.56 171.06 16.34 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 114.735 -1.12 . . . . 73.51 110.114 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 6' ' ' ASN . . . 106.24 -32.89 6.89 Favored Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.239 -0.437 . . . . 70.44 112.92 177.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.593 ' H ' HD13 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -121.39 169.0 13.25 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 124.278 1.031 . . . . 74.3 110.1 -175.227 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.406 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 12.6 tt0 -156.85 174.9 14.81 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 124.133 0.895 . . . . 74.54 109.07 176.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.73 -114.03 5.89 Favored Glycine 0 C--N 1.343 0.957 0 CA-C-N 115.69 -0.686 . . . . 41.04 114.293 176.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.4 p -71.36 -41.54 69.59 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.62 1.168 . . . . 73.34 112.217 -174.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -71.2 -34.77 71.18 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.067 0.547 . . . . 61.42 110.279 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.406 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 5.8 tpt -66.67 -42.52 86.43 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 123.469 0.481 . . . . 64.52 110.098 174.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.98 -35.08 79.51 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.373 0.669 . . . . 72.4 111.005 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.556 ' HE1' ' HG2' ' C' ' 147' ' ' GLU . 52.9 t-80 -71.71 -28.28 63.58 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.663 0.785 . . . . 71.22 110.777 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.7 t -76.19 -50.49 14.38 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.461 -0.57 . . . . 63.25 109.461 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 87.1 mt -75.98 -23.96 55.34 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.532 0.733 . . . . 63.54 112.515 -173.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.4 ' HA2' HG21 ' A' ' 46' ' ' THR . . . -115.09 3.52 22.46 Favored Glycine 0 N--CA 1.473 1.139 0 CA-C-O 119.553 -0.582 . . . . 73.41 113.952 -171.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -143.41 -63.24 0.4 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 117.541 0.67 . . . . 72.43 111.276 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -68.62 -46.19 69.9 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.175 0.59 . . . . 73.4 111.777 -170.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 80.3 m -70.49 -47.41 18.53 Favored Pre-proline 0 CA--C 1.561 1.368 0 C-N-CA 124.235 1.014 . . . . 53.51 112.928 -176.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.452 ' HD3' HG11 ' A' ' 58' ' ' VAL . 51.5 Cg_endo -67.08 -18.66 51.59 Favored 'Trans proline' 0 C--N 1.394 2.967 0 CA-C-N 121.462 1.558 . . . . 53.45 112.461 174.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -72.77 -35.23 67.39 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.055 0.542 . . . . 73.44 109.74 174.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.441 HG21 ' CD1' ' A' ' 13' ' ' ILE . 39.1 mm -65.42 -44.38 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.849 0.859 . . . . 55.51 110.113 170.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.506 HD21 ' HA3' ' A' ' 82' ' ' GLY . 75.7 mt -71.49 -15.8 62.33 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.445 -0.798 . . . . 75.24 111.904 -175.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -70.03 -44.98 22.28 Favored Pre-proline 0 CA--C 1.552 1.049 0 N-CA-C 114.748 1.388 . . . . 72.31 114.748 -170.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.97 -32.14 84.66 Favored 'Trans proline' 0 C--N 1.384 2.437 0 CA-C-N 122.285 1.852 . . . . 63.32 112.314 172.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -76.84 -41.28 44.74 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.69 0.796 . . . . 65.13 111.65 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.461 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -66.44 -49.44 66.71 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.033 0.533 . . . . 74.34 109.749 178.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.487 ' NH1' HD12 ' C' ' 105' ' ' ILE . 30.5 ttm180 -46.8 -51.67 15.9 Favored 'General case' 0 C--N 1.353 0.761 0 O-C-N 125.258 1.599 . . . . 73.44 110.716 173.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -67.39 -43.78 80.5 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.316 1.01 . . . . 73.45 111.982 -175.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.554 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.7 t -57.68 -42.6 83.94 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.932 0.77 . . . . 74.03 110.122 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.487 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.5 mt -64.33 -54.84 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 114.451 -1.25 . . . . 53.01 110.253 175.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.5 m -56.59 -37.29 70.43 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.258 0.974 . . . . 65.3 111.567 -173.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.0 t -68.81 -47.9 64.92 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.664 -1.153 . . . . 71.11 110.096 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 8.6 mtp -57.12 -37.71 72.38 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.615 0.766 . . . . 55.24 111.664 175.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 114' ' ' ILE . 70.3 t -67.48 -49.16 73.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 124.378 1.071 . . . . 71.24 110.461 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 91.8 p -70.44 -33.19 71.03 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.018 0.527 . . . . 75.12 111.076 -175.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.541 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.9 mtt-85 -69.48 -31.97 70.57 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.959 0.904 . . . . 74.2 109.67 172.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.84 6.08 49.74 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-O 119.304 -0.72 . . . . 73.05 113.688 174.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.53 HG21 ' HE ' ' B' ' 15' ' ' ARG . 18.1 m 73.15 7.29 5.32 Favored 'General case' 0 C--N 1.367 1.345 0 C-N-CA 125.147 1.379 . . . . 71.03 112.152 176.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -86.51 137.53 34.24 Favored Pre-proline 0 C--O 1.24 0.568 0 N-CA-C 107.197 -1.409 . . . . 71.33 107.197 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.4 ' HB3' ' H ' ' E' ' 132' ' ' SER . 56.7 Cg_exo -54.67 165.87 2.25 Favored 'Trans proline' 0 C--N 1.365 1.424 0 C-N-CA 123.416 2.744 . . . . 63.21 113.855 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.573 ' HG2' ' HB2' ' C' ' 15' ' ' ARG . 40.6 tp60 -52.88 117.8 3.22 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 114.534 -1.212 . . . . 75.53 111.877 -172.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.571 HD13 HG21 ' A' ' 40' ' ' VAL . 25.5 tp -113.6 114.39 26.39 Favored 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 109.175 -0.676 . . . . 62.42 109.175 173.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.486 HD21 ' HA ' ' C' ' 15' ' ' ARG . 5.7 m-80 -110.03 125.69 53.18 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 106.152 -1.795 . . . . 63.52 106.152 176.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.473 HD11 HD12 ' A' ' 114' ' ' ILE . 10.9 mt -72.09 144.18 48.78 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 109.173 -0.677 . . . . 65.31 109.173 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.51 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -60.18 138.64 91.51 Favored Pre-proline 0 N--CA 1.48 1.059 0 CA-C-O 118.864 -0.588 . . . . 73.44 111.011 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -55.09 108.17 0.29 Allowed 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.519 2.146 . . . . 63.34 111.849 168.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 129' ' ' ALA . 75.4 t -104.18 137.17 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.078 0.951 . . . . 71.54 111.634 -173.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.441 ' ND2' ' HG2' ' C' ' 3' ' ' GLU . 50.9 t-20 -89.53 97.29 11.11 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.791 -1.095 . . . . 64.4 108.656 170.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.41 ' CZ ' HD13 ' A' ' 44' ' ' LEU . 57.2 m-85 -70.49 -18.58 62.96 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 112.827 0.677 . . . . 74.42 112.827 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -69.6 -40.02 76.9 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.45 -0.945 . . . . 52.11 108.45 174.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.07 -46.22 85.28 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.5 0.72 . . . . 63.31 110.942 174.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.428 ' HA ' ' ND2' ' A' ' 139' ' ' ASN . 56.9 mt -62.87 -33.58 75.58 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 123.748 0.655 . . . . 73.01 111.044 178.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.426 ' CE2' HD13 ' A' ' 141' ' ' LEU . 74.6 t80 -68.18 -45.02 74.6 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 115.507 -0.77 . . . . 72.43 109.808 176.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.402 ' HA ' ' HB3' ' A' ' 141' ' ' LEU . 74.9 mtp -64.03 -25.37 68.09 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 123.783 0.677 . . . . 75.43 112.011 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.428 ' ND2' ' HA ' ' A' ' 136' ' ' LEU . 69.6 m-20 -64.38 -53.91 41.09 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.971 -0.751 . . . . 73.51 108.971 171.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -65.6 -31.3 72.27 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 115.648 -0.706 . . . . 74.0 111.759 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.426 HD13 ' CE2' ' A' ' 137' ' ' PHE . 49.7 tp -68.37 -40.95 81.24 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.183 1.393 . . . . 74.04 111.98 -171.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -167.39 -13.42 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.141 0 O-C-N 123.682 0.614 . . . . 73.24 112.231 -173.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 59.36 80.08 0.21 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.069 0.948 . . . . 62.4 110.494 -169.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.493 ' NE2' ' HG2' ' C' ' 150' ' ' GLU . 26.0 pt20 -149.96 1.8 0.5 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.258 0.623 . . . . 74.45 111.366 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.02 164.22 17.5 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.052 0.541 . . . . 43.03 110.439 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -154.94 164.97 32.01 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.553 -0.749 . . . . 71.0 111.694 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -72.18 153.4 41.64 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.206 0.602 . . . . 54.52 109.49 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -128.75 84.76 0.32 Allowed Glycine 0 C--N 1.34 0.752 0 N-CA-C 111.429 -0.668 . . . . 44.53 111.429 -177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.1 m -73.97 148.9 41.69 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.674 0.79 . . . . 63.33 109.08 170.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.3 153.02 4.13 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.431 1.092 . . . . 63.35 113.517 -175.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -63.53 -63.45 1.17 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.33 1.052 . . . . 74.32 109.838 176.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -167.28 86.56 0.26 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.855 -1.165 . . . . 75.23 107.855 171.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -61.61 88.62 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.353 1.061 . . . . 72.35 109.591 175.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -68.59 -39.32 80.97 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.942 0.897 . . . . 74.4 111.276 -171.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.244 0 N-CA-C 108.313 -0.995 . . . . 72.13 108.313 174.518 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 109.599 -0.519 . . . . 64.41 109.599 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 14.4 t -167.7 32.15 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.407 0.683 . . . . 52.13 110.996 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -75.41 79.33 2.46 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.627 0.771 . . . . 74.12 110.368 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 64.06 -0.97 0.74 Allowed 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 124.745 1.218 . . . . 44.55 113.152 173.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -65.95 124.17 21.8 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.086 0.954 . . . . 71.22 110.273 -173.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . 0.285 30.1 p30 45.33 -68.7 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 126.026 2.079 . . . . 75.24 114.514 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 44.3 m 66.67 104.93 0.04 OUTLIER 'General case' 0 C--N 1.353 0.732 0 C-N-CA 125.29 1.436 . . . . 72.3 111.241 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -58.47 -21.91 53.0 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.468 -0.787 . . . . 73.35 111.851 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 1.4 tmt? 67.83 168.72 0.26 Allowed 'General case' 0 C--N 1.364 1.202 0 C-N-CA 125.138 1.375 . . . . 74.0 110.772 172.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.1 t -143.38 99.14 3.38 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 122.135 0.969 . . . . 62.33 109.373 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.474 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 54.1 t80 -112.63 141.0 46.92 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.334 -1.303 . . . . 75.23 107.684 173.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -147.55 134.14 19.85 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.764 -0.458 . . . . 64.55 109.764 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.473 HD11 HD13 ' B' ' 105' ' ' ILE . 41.4 mt -80.66 116.47 24.95 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 N-CA-C 107.011 -1.477 . . . . 55.13 107.011 170.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -90.06 -37.55 14.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.973 -0.751 . . . . 73.43 108.973 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.53 ' HE ' HG21 ' A' ' 122' ' ' THR . 11.7 ttt85 -168.92 151.88 5.07 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 123.611 0.569 . . . . 71.12 110.812 -177.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 53.8 mt -135.16 135.87 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 106.668 -1.604 . . . . 71.55 106.668 171.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.471 ' HE1' HG13 ' B' ' 83' ' ' ILE . 10.9 p90 -166.34 143.03 4.98 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.281 0.563 . . . . 73.01 111.79 -173.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 41.2 m -74.24 121.39 21.19 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.81 -1.086 . . . . 74.12 108.971 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.466 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.5 mtpt -98.51 -17.09 18.91 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.363 0.665 . . . . 72.11 110.979 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 3.2 t70 -163.67 145.36 9.3 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.83 0.852 . . . . 74.03 110.418 -177.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.404 HD13 HG13 ' B' ' 78' ' ' VAL . 39.4 mm -133.13 144.93 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 107.618 -1.253 . . . . 73.51 107.618 170.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 39.2 t -143.94 135.82 26.32 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.792 -0.818 . . . . 74.11 108.792 174.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.478 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.6 t80 -149.53 114.55 5.42 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 107.402 -1.333 . . . . 44.2 107.402 170.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -126.17 114.3 18.17 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.102 -1.073 . . . . 75.24 108.102 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.602 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -106.85 88.82 3.83 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 107.912 -1.144 . . . . 61.34 107.912 175.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.55 -33.33 46.33 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.723 2.282 . . . . 71.54 112.295 -172.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -106.32 7.96 31.53 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.075 0.95 . . . . 74.24 111.613 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.602 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -33.26 -64.03 0.27 Allowed Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 115.662 1.727 . . . . 74.11 115.662 -167.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.435 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 19.9 Cg_exo -60.72 -32.58 93.23 Favored 'Trans proline' 0 C--N 1.4 3.272 0 C-N-CA 122.438 2.092 . . . . 54.31 112.914 -170.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -94.77 -39.58 10.21 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 114.664 -1.153 . . . . 75.32 111.583 -170.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.706 HG22 HD12 ' B' ' 68' ' ' LEU . 7.4 p -66.32 -19.41 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.052 0.541 . . . . 62.14 111.925 -172.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -60.47 -21.63 62.57 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.015 0.926 . . . . 64.35 113.312 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -63.9 -18.27 64.03 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.346 0.658 . . . . 75.52 111.766 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.446 ' HB2' HD13 ' B' ' 68' ' ' LEU . 95.6 mttt -94.06 105.29 17.29 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.256 1.022 . . . . 75.25 109.142 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -100.52 79.58 2.12 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.477 0.711 . . . . 64.43 110.441 -172.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 46.5 p90 -154.41 167.84 28.67 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.824 -1.176 . . . . 74.14 107.824 165.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 22.9 tm0? -76.51 115.44 47.64 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 107.7 -1.222 . . . . 74.3 107.7 176.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.27 154.38 52.84 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.982 2.455 . . . . 71.14 114.285 -170.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -66.41 115.94 6.87 Favored 'General case' 0 C--N 1.347 0.486 0 N-CA-C 108.521 -0.918 . . . . 74.21 108.521 172.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.431 HG13 HG13 ' B' ' 64' ' ' VAL . 57.6 t -104.27 134.86 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 121.36 0.6 . . . . 74.52 111.015 -172.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -106.39 103.25 12.67 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 107.056 -1.461 . . . . 65.4 107.056 169.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.646 HD13 HD22 ' B' ' 128' ' ' LEU . 23.8 tp -85.48 147.05 26.65 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 107.855 -1.165 . . . . 73.25 107.855 171.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.517 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 12.0 t0 -155.27 154.09 31.61 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 109.337 -0.616 . . . . 61.05 109.337 -176.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.566 HD11 HG11 ' B' ' 131' ' ' VAL . 97.8 mt -124.92 130.54 52.56 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.341 0.657 . . . . 42.0 110.406 -174.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -127.93 146.94 50.48 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.259 1.424 . . . . 72.54 108.048 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 7.8 t -145.32 127.42 15.63 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.004 0.431 . . . . 72.53 110.604 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.72 116.4 10.24 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.992 -1.114 . . . . 53.33 107.992 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.515 ' HB3' ' HA ' ' B' ' 58' ' ' VAL . 56.1 p -144.69 165.07 29.1 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.094 0.405 . . . . 45.12 112.094 -173.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 67.1 p -160.96 153.05 20.01 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.337 -0.847 . . . . 61.04 110.21 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.418 HE21 ' H ' ' B' ' 54' ' ' ASP . 56.0 tt0 -82.57 115.03 21.36 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.875 -0.787 . . . . 72.53 108.875 166.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 pp -122.26 24.26 9.47 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.283 0.633 . . . . 62.13 110.746 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.611 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -169.17 169.0 9.59 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.585 0.754 . . . . 72.44 111.548 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . 0.427 ' O ' HG23 ' B' ' 55' ' ' VAL . 2.8 m-20 -60.59 95.43 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.392 1.077 . . . . 64.45 112.572 -175.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.418 ' H ' HE21 ' B' ' 50' ' ' GLN . 1.0 OUTLIER 56.56 25.24 9.62 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.417 1.087 . . . . 75.54 111.866 -178.672 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 89.0 t -116.93 111.79 36.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 CA-C-N 114.322 -1.308 . . . . 71.12 108.117 177.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.654 ' HB2' HD13 ' F' ' 100' ' ' LEU . 8.2 t80 -101.41 138.64 38.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.099 1.36 . . . . 74.52 109.275 -174.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -116.41 114.22 23.95 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.467 -1.308 . . . . 63.22 107.467 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.515 ' HA ' ' HB3' ' B' ' 48' ' ' SER . 2.7 p -108.72 129.18 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 122.766 0.427 . . . . 75.34 110.993 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.482 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.3 t -102.33 108.48 24.07 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 N-CA-C 107.777 -1.194 . . . . 73.25 107.777 171.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 56.8 tp -95.11 102.58 14.4 Favored 'General case' 0 C--O 1.244 0.798 0 N-CA-C 108.516 -0.92 . . . . 53.13 108.516 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -94.05 117.88 30.73 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.588 -0.733 . . . . 74.4 109.241 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 54.1 t -105.02 128.3 58.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 108.706 -0.85 . . . . 74.23 108.706 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 14.9 m -104.88 138.4 41.19 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.998 0.519 . . . . 53.14 110.026 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.821 HG11 HD21 ' B' ' 126' ' ' LEU . 58.2 t -133.38 112.31 17.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 108.191 -1.04 . . . . 52.25 108.191 173.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.425 HG23 ' CD2' ' B' ' 75' ' ' LEU . 87.0 m -111.48 105.64 14.29 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.25 -1.019 . . . . 74.32 108.25 174.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.89 150.54 29.05 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.871 0.367 . . . . 63.53 110.145 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.522 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 30.7 p -144.69 130.7 19.36 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.424 -0.807 . . . . 74.42 111.015 -171.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.706 HD12 HG22 ' B' ' 31' ' ' VAL . 85.8 mt -94.35 98.45 10.91 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.053 -1.092 . . . . 71.34 108.053 173.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.1 -122.55 11.48 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 115.2 -0.909 . . . . 74.44 113.992 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -82.1 2.66 30.25 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.523 0.729 . . . . 71.11 112.764 -172.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -143.57 159.52 42.29 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 122.843 0.457 . . . . 73.31 110.89 -171.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 40.0 m -69.62 133.54 47.7 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.256 -0.884 . . . . 71.41 110.325 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.548 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -84.75 -60.94 1.91 Allowed 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.03 -1.47 . . . . 61.14 107.03 172.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -154.06 162.74 40.99 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.749 -1.114 . . . . 73.21 111.541 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.425 ' CD2' HG23 ' B' ' 65' ' ' THR . 35.3 mt -123.47 112.25 17.28 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 106.129 -1.804 . . . . 74.54 106.129 169.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' B' ' 117' ' ' MET . 40.5 t -124.54 118.34 26.36 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 109.364 -0.606 . . . . 74.01 109.364 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -140.2 128.66 22.75 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.564 0.745 . . . . 72.51 109.208 -174.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.404 HG13 HD13 ' B' ' 21' ' ' ILE . 42.4 t -125.5 150.7 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.801 0.84 . . . . 73.24 110.125 -175.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.415 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 22.4 mt-30 -114.94 110.48 19.69 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.56 -0.533 . . . . 73.23 109.56 171.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.448 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.1 tp-100 -99.77 102.84 14.4 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.397 -0.594 . . . . 72.21 109.397 170.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.46 160.46 29.19 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 111.011 -0.836 . . . . 60.24 111.011 174.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.66 126.54 1.62 Allowed Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.916 -0.474 . . . . 61.41 111.916 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.471 HG13 ' HE1' ' B' ' 17' ' ' TYR . 57.9 mt -88.05 122.56 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 108.224 -1.028 . . . . 62.22 108.224 175.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -135.63 140.62 44.7 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.554 0.741 . . . . 72.54 110.067 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 21.2 m -88.72 118.69 28.58 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.458 0.703 . . . . 51.12 109.104 170.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.588 HD13 ' HB3' ' B' ' 56' ' ' TYR . 4.0 mp -116.94 110.59 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.048 -1.464 . . . . 52.54 107.048 175.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.729 ' HA ' ' HB ' ' F' ' 97' ' ' ILE . . . -155.88 172.06 19.0 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.959 0.504 . . . . 73.42 111.14 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.02 -60.46 0.82 Allowed Glycine 0 C--N 1.344 1.012 0 N-CA-C 111.072 -0.811 . . . . 63.21 111.072 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.421 HD13 ' HB2' ' B' ' 94' ' ' MET . 0.9 OUTLIER -68.53 169.84 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 123.446 0.698 . . . . 63.34 111.876 173.232 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -154.52 177.9 10.67 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.319 0.648 . . . . 74.11 110.838 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.34 -126.68 8.32 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-N 115.703 -0.68 . . . . 62.13 114.145 172.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.6 m -89.73 -47.59 7.82 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.788 0.835 . . . . 72.1 109.946 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -64.33 -19.02 65.17 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.379 -1.282 . . . . 71.34 112.152 -169.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.421 ' HB2' HD13 ' B' ' 89' ' ' ILE . 23.9 ptt? -62.53 -37.13 84.89 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.735 0.814 . . . . 74.41 112.015 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.97 -13.27 59.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.414 0.686 . . . . 53.22 112.466 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.583 ' HB2' HD22 ' B' ' 141' ' ' LEU . 58.0 t-80 -63.72 -32.16 73.57 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.843 0.457 . . . . 71.23 109.929 170.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -64.45 -49.47 71.34 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.51 0.724 . . . . 65.01 111.428 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.47 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.4 pp -76.95 -32.02 57.01 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 116.066 -0.516 . . . . 74.33 111.827 -174.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.89 -22.08 37.26 Favored Glycine 0 C--N 1.35 1.346 0 O-C-N 123.26 0.35 . . . . 64.31 113.859 -173.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.01 -59.35 1.74 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.091 0.556 . . . . 72.53 111.516 -173.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -67.23 -42.77 83.49 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.224 0.61 . . . . 74.13 111.662 -172.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.474 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 63.3 m -68.43 -49.07 32.93 Favored Pre-proline 0 CA--C 1.566 1.575 0 N-CA-C 113.413 0.894 . . . . 70.31 113.413 -175.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.429 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 35.6 Cg_exo -64.72 -28.07 60.15 Favored 'Trans proline' 0 C--N 1.39 2.757 0 C-N-CA 121.851 1.701 . . . . 72.43 113.245 177.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -58.36 -34.43 70.66 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 123.216 0.606 . . . . 73.24 111.94 174.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.473 HD13 HD11 ' B' ' 13' ' ' ILE . 58.2 mt -68.49 -35.97 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 115.387 -0.824 . . . . 73.33 110.469 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 93.8 mt -88.5 -31.65 18.61 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.312 0.856 . . . . 51.33 113.312 -170.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -53.26 -43.7 95.69 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 113.855 1.057 . . . . 73.33 113.855 -173.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -52.18 -42.41 59.75 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.893 2.395 . . . . 72.31 114.84 174.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.448 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 86.0 m-85 -68.62 -43.59 76.04 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.731 0.412 . . . . 72.52 110.749 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.14 -43.04 99.51 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.407 -0.815 . . . . 61.24 110.661 175.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 28.8 ttt-85 -57.74 -53.9 53.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.14 1.376 . . . . 64.43 110.902 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -66.03 -39.17 89.98 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.247 0.967 . . . . 72.53 110.669 -175.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.541 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 7.4 t -70.25 -34.26 72.62 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.869 -0.605 . . . . 51.4 110.989 -176.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.498 HD13 HG23 ' B' ' 64' ' ' VAL . 67.7 mt -60.47 -53.46 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.626 0.771 . . . . 72.23 109.652 169.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.461 HG21 ' OG ' ' C' ' 119' ' ' SER . 17.0 m -60.14 -28.56 67.99 Favored 'General case' 0 CA--C 1.551 1.011 0 O-C-N 123.807 0.692 . . . . 73.13 111.332 -177.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 29.7 m -64.47 -52.04 59.97 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 123.543 0.737 . . . . 53.53 110.656 171.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.545 ' HB2' ' SG ' ' B' ' 76' ' ' CYS . 25.2 mmt -63.21 -33.13 74.81 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.049 0.54 . . . . 75.54 111.345 -177.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 92.1 t -72.07 -38.38 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.84 1.256 . . . . 75.51 110.902 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 47.2 t -66.54 -34.7 78.5 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.314 -0.857 . . . . 65.13 110.53 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.554 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 74.6 mtt-85 -71.37 -37.52 71.61 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-N 114.788 -1.097 . . . . 74.44 109.408 177.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.49 -9.73 78.33 Favored Glycine 0 C--N 1.355 1.587 0 O-C-N 123.522 0.514 . . . . 74.5 112.69 172.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 3.2 m 69.93 20.81 6.49 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 125.487 1.515 . . . . 72.23 111.721 171.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -78.24 159.67 74.81 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 123.524 0.73 . . . . 75.32 111.169 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.91 172.07 0.88 Allowed 'Trans proline' 0 C--N 1.387 2.569 0 C-N-CA 123.271 2.647 . . . . 71.33 114.558 174.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.759 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 56.3 tp60 -62.75 132.51 52.47 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.482 0.919 . . . . 73.43 113.482 -166.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.821 HD21 HG11 ' B' ' 64' ' ' VAL . 59.6 tp -126.71 106.43 9.37 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.681 0.792 . . . . 72.11 109.031 176.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.412 HD21 ' HA ' ' C' ' 122' ' ' THR . 88.3 m-20 -112.59 119.37 37.9 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 107.639 -1.245 . . . . 64.13 107.639 170.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.646 HD22 HD13 ' B' ' 42' ' ' LEU . 31.0 mt -77.67 145.95 36.34 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 122.99 0.182 . . . . 71.22 111.39 -176.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.96 128.33 91.8 Favored Pre-proline 0 CA--C 1.546 0.812 0 O-C-N 124.366 1.041 . . . . 72.52 111.845 -175.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.485 ' HG3' HD11 ' D' ' 16' ' ' ILE . 51.3 Cg_endo -68.54 87.31 0.42 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.897 2.398 . . . . 52.15 112.033 176.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.566 HG11 HD11 ' B' ' 44' ' ' LEU . 2.5 p -90.49 109.8 21.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 108.291 -1.003 . . . . 75.15 108.291 172.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -74.78 110.12 8.82 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.726 -1.124 . . . . 64.51 108.216 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -61.69 -31.02 71.13 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.042 0.537 . . . . 72.12 111.206 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -55.73 -42.14 74.92 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.545 0.738 . . . . 62.22 111.322 171.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.2 -30.08 70.21 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 123.713 0.633 . . . . 74.2 112.03 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.3 mp -74.65 -54.44 7.43 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.284 0.564 . . . . 74.31 109.732 175.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -74.27 -12.78 60.65 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.075 0.95 . . . . 73.4 113.288 -173.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -21.04 61.12 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 120.871 0.367 . . . . 72.42 110.595 177.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -75.48 -33.32 60.8 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.076 0.55 . . . . 74.01 110.448 177.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . 0.442 ' HB2' HD12 ' B' ' 141' ' ' LEU . 89.3 m-85 -87.54 -49.12 7.39 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.843 -0.617 . . . . 73.24 110.769 -177.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.583 HD22 ' HB2' ' B' ' 96' ' ' HIS . 6.3 mp -100.55 10.63 40.93 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.745 0.818 . . . . 73.13 111.675 -172.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 66.89 176.27 0.24 Allowed 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.717 1.207 . . . . 62.33 112.983 173.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -75.72 124.18 26.83 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.451 -0.795 . . . . 72.45 108.867 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -67.45 -52.76 35.65 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.498 0.719 . . . . 73.21 109.876 176.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -164.21 166.73 20.79 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.73 0.812 . . . . 54.12 110.809 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -173.77 40.44 0.14 Allowed Glycine 0 C--N 1.342 0.889 0 CA-C-N 116.271 -0.422 . . . . 65.0 112.279 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -94.4 149.4 21.28 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.027 0.931 . . . . 74.14 110.105 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . 0.557 ' HA3' ' HB2' ' D' ' 93' ' ' GLN . . . -137.68 -154.71 6.66 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 111.722 -0.551 . . . . 72.02 111.722 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 3.8 m 73.59 4.44 4.75 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 125.069 1.348 . . . . 74.12 111.814 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.73 -5.92 28.43 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.507 1.123 . . . . 74.44 112.566 -176.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . 0.484 ' HA ' ' HG ' ' D' ' 141' ' ' LEU . 0.3 OUTLIER -68.72 139.26 55.37 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 124.248 1.019 . . . . 71.11 110.475 178.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -127.75 -30.67 2.51 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.036 0.934 . . . . 45.11 111.487 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 68.07 97.92 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.113 1.365 . . . . 63.41 111.391 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -93.4 -62.95 1.27 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.876 -0.787 . . . . 74.55 108.876 176.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.869 0 N-CA-C 108.981 -0.748 . . . . 54.35 108.981 175.122 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 112.346 0.499 . . . . 63.33 112.346 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 63.5 m -148.79 43.33 0.98 Allowed 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.462 0.648 . . . . 72.23 110.239 -169.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . 0.441 ' HG2' ' ND2' ' A' ' 132' ' ' ASN . 0.0 OUTLIER -138.5 112.9 8.78 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.485 0.714 . . . . 61.22 109.634 -179.248 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 51.37 45.25 28.24 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 125.404 1.482 . . . . 53.21 112.138 177.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -151.37 145.21 25.12 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.48 -0.782 . . . . 62.23 109.947 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.48 -44.69 50.38 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.945 -0.57 . . . . 71.12 110.399 173.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 12.8 p -144.82 -63.95 0.35 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.997 0.919 . . . . 54.33 109.087 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -153.44 -62.36 0.14 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.723 1.209 . . . . 55.12 108.606 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 25.9 ttt 65.74 114.38 0.03 OUTLIER 'General case' 0 C--N 1.361 1.088 0 C-N-CA 125.578 1.551 . . . . 63.11 111.693 -171.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 13.2 m -87.04 87.27 7.42 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.864 0.866 . . . . 55.31 109.751 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.51 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 64.0 t80 -113.57 118.61 34.9 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.539 -0.912 . . . . 73.42 108.539 177.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -135.79 125.21 24.93 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.275 -0.639 . . . . 64.33 109.275 -177.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 45.4 mt -77.16 128.16 38.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 109.466 -0.568 . . . . 70.32 109.466 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -88.69 -49.74 6.67 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.826 -0.805 . . . . 72.41 108.826 174.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.573 ' HB2' ' HG2' ' A' ' 125' ' ' GLN . 0.0 OUTLIER -174.58 149.48 1.27 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.221 1.008 . . . . 74.35 110.245 176.27 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.497 HG23 HD23 ' C' ' 106' ' ' LEU . 78.0 mt -120.57 131.59 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.503 1.121 . . . . 74.24 108.299 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.609 ' HB3' HG23 ' D' ' 122' ' ' THR . 20.8 p90 -164.44 172.19 13.7 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 121.422 0.63 . . . . 64.34 112.17 -167.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.1 p -100.38 120.3 39.76 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.268 -0.878 . . . . 72.35 109.248 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -69.29 -48.75 60.72 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 106.979 -1.489 . . . . 63.12 106.979 165.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.629 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.3 t70 -134.56 145.59 48.85 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 113.655 -1.611 . . . . 61.05 110.663 -173.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.406 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.5 mt -137.64 149.17 25.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 126.717 2.007 . . . . 72.35 105.714 172.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.1 t -156.95 149.58 23.45 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.829 -0.434 . . . . 74.53 109.829 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -155.98 129.59 8.39 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 107.265 -1.383 . . . . 74.31 107.265 174.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -132.15 132.91 43.66 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.681 -0.859 . . . . 74.25 108.681 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.33 80.55 22.6 Favored Pre-proline 0 CA--C 1.549 0.93 0 N-CA-C 106.625 -1.62 . . . . 73.13 106.625 170.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -65.25 -41.19 16.88 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.82 2.347 . . . . 63.04 111.702 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -94.82 18.37 11.92 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 114.398 -1.274 . . . . 63.11 110.779 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.98 -61.02 1.67 Allowed Pre-proline 0 C--N 1.369 1.427 0 C-N-CA 124.974 1.31 . . . . 61.42 114.097 -171.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -61.52 -39.48 54.89 Favored 'Trans proline' 0 C--N 1.39 2.715 0 C-N-CA 121.66 1.573 . . . . 75.31 112.15 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.48 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 85.2 t60 -71.4 -30.63 66.32 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 115.44 -0.8 . . . . 73.24 112.385 -178.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.728 HG21 ' HA ' ' C' ' 73' ' ' ALA . 4.0 p -82.96 -15.88 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.368 0 O-C-N 121.794 -0.566 . . . . 65.21 111.836 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -75.45 -20.76 58.64 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.112 0.565 . . . . 73.33 112.227 178.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 20.8 pt20 -94.07 8.69 40.61 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.493 0.717 . . . . 64.43 110.944 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -99.12 161.76 13.44 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.881 0.872 . . . . 71.01 110.988 -171.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -71.49 121.79 19.29 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.403 0.681 . . . . 75.04 109.638 172.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -83.74 93.39 7.93 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.22 0.608 . . . . 74.45 111.016 -174.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . 0.414 ' H ' HD22 ' C' ' 68' ' ' LEU . 52.9 tt0 -145.43 78.98 11.77 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 124.06 0.944 . . . . 71.22 108.494 173.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -82.45 141.33 11.2 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.695 2.263 . . . . 74.51 113.179 -173.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -87.38 88.43 7.68 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.012 -1.477 . . . . 64.21 107.012 163.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 40.3 t -83.87 111.96 20.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 CA-C-N 115.117 -0.947 . . . . 74.53 110.078 -175.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.492 ' HA ' ' HB3' ' F' ' 136' ' ' LYS . 13.7 tmtt? -91.1 101.08 13.83 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 107.85 -1.167 . . . . 72.13 107.85 172.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.485 ' HB3' HG13 ' F' ' 135' ' ' VAL . 3.9 tt -87.61 121.69 30.36 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.069 -1.826 . . . . 70.44 106.069 173.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -118.31 138.35 52.45 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.428 -0.953 . . . . 60.0 108.428 -175.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.537 HD22 HD21 ' C' ' 60' ' ' LEU . 25.7 mt -132.02 111.84 11.86 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.852 0.834 . . . . 74.22 110.298 178.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -127.5 122.43 33.34 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.904 1.682 . . . . 72.55 107.268 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -123.16 125.86 45.93 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 120.99 0.424 . . . . 52.12 110.057 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.16 160.51 16.86 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.218 1.007 . . . . 62.23 109.384 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 31.1 p -151.94 146.06 25.33 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.308 0.643 . . . . 54.44 110.27 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 54.1 p -146.99 135.9 22.31 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.694 0.798 . . . . 72.14 109.351 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -78.32 117.08 19.22 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 108.856 -0.794 . . . . 71.15 108.856 175.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.707 HD11 ' HB2' ' C' ' 57' ' ' GLU . 30.8 mt -85.54 -33.28 21.79 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.899 0.88 . . . . 74.25 110.478 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.96 -174.48 3.34 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.408 1.083 . . . . 73.11 109.6 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.23 117.21 6.25 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.464 -0.789 . . . . 73.12 109.288 176.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 70.35 11.92 7.48 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.884 1.274 . . . . 72.3 112.044 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 30.4 t -118.32 116.27 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.196 -0.668 . . . . 60.35 109.196 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -127.46 125.12 39.95 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.017 0.927 . . . . 64.24 108.672 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.707 ' HB2' HD11 ' C' ' 51' ' ' LEU . 34.8 tt0 -85.8 142.14 29.15 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.964 -0.754 . . . . 71.1 108.964 169.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 60.1 t -128.8 122.84 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 107.817 -1.179 . . . . 64.5 107.817 167.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 68.2 t -109.64 127.56 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 109.283 -0.636 . . . . 70.44 109.283 173.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.537 HD21 HD22 ' C' ' 44' ' ' LEU . 0.1 OUTLIER -107.38 100.99 10.38 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 107.738 -1.208 . . . . 61.12 107.738 -176.544 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -82.22 106.12 13.85 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.455 0.702 . . . . 75.13 109.16 172.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.443 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.6 t -102.88 124.7 57.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 N-CA-C 107.417 -1.327 . . . . 64.54 107.417 169.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 12.5 m -125.34 113.24 17.31 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.526 0.679 . . . . 62.2 109.486 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.428 HG21 HG21 ' C' ' 114' ' ' ILE . 99.5 t -102.49 111.07 30.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 124.482 1.113 . . . . 64.14 109.132 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.517 HG23 HD23 ' C' ' 75' ' ' LEU . 6.8 m -104.35 108.62 20.12 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 109.121 -0.696 . . . . 71.21 109.121 176.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.9 100.63 10.18 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.642 -0.873 . . . . 65.32 108.642 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 40.5 m -129.03 131.76 47.4 Favored 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 109.038 -0.727 . . . . 75.32 109.038 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.414 HD22 ' H ' ' C' ' 37' ' ' GLN . 12.2 mt -84.91 26.51 0.83 Allowed 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 125.137 1.375 . . . . 62.02 111.3 -175.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.62 -109.49 1.06 Allowed Glycine 0 C--N 1.348 1.229 0 N-CA-C 109.486 -1.446 . . . . 60.31 109.486 -170.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.59 -31.56 16.64 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.215 -0.661 . . . . 74.21 109.215 169.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -69.37 104.25 2.22 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 124.065 0.946 . . . . 72.11 109.964 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.1 m -78.55 123.95 27.63 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 109.384 -0.598 . . . . 72.43 109.384 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.728 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -77.42 -57.61 3.73 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.091 -1.077 . . . . 71.13 108.091 176.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . 0.435 ' HZ ' HD22 ' C' ' 126' ' ' LEU . 49.5 p90 -156.52 154.97 31.16 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.846 -1.07 . . . . 74.22 111.268 175.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.517 HD23 HG23 ' C' ' 65' ' ' THR . 2.5 tm? -113.09 145.47 40.85 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 106.094 -1.817 . . . . 74.43 106.094 163.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.449 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.6 t -151.68 125.16 8.88 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.989 -0.745 . . . . 74.31 108.989 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -131.76 136.71 47.79 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.331 -0.618 . . . . 74.15 109.331 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.466 HG11 ' HA ' ' C' ' 110' ' ' ALA . 22.7 t -132.13 113.92 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.658 -0.867 . . . . 74.3 108.658 174.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.629 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.3 mt-30 -91.73 87.96 6.5 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.017 0.927 . . . . 62.41 109.115 172.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -79.45 96.9 6.19 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.402 1.081 . . . . 53.11 110.337 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.77 144.54 22.15 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.396 -0.366 . . . . 72.22 112.694 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.425 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.24 128.11 2.86 Favored Glycine 0 CA--C 1.503 -0.713 0 N-CA-C 111.096 -0.802 . . . . 72.42 111.096 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.42 HD11 ' HB3' ' D' ' 29' ' ' PRO . 27.3 mm -95.09 123.54 47.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.248 -1.019 . . . . 75.14 108.248 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -132.23 118.68 19.83 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.517 0.727 . . . . 62.04 109.986 -173.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 56.9 m -76.41 100.8 5.32 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.464 -0.569 . . . . 71.12 109.464 170.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.576 HD13 ' SG ' ' C' ' 97' ' ' CYS . 18.4 mt -114.13 131.6 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.239 0.615 . . . . 70.44 110.042 -177.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.479 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -153.4 169.4 23.23 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.163 0.985 . . . . 54.53 109.956 178.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.53 -19.2 41.78 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.936 -0.574 . . . . 63.54 113.452 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 22.3 pt -111.03 170.5 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.051 0.54 . . . . 63.51 111.135 -175.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -166.21 149.51 7.36 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.905 0.482 . . . . 74.3 110.7 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.81 -113.15 5.06 Favored Glycine 0 C--N 1.354 1.547 0 CA-C-N 115.872 -0.604 . . . . 63.11 113.43 170.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . 0.453 ' HA ' HD11 ' C' ' 141' ' ' LEU . 34.6 p -61.19 -43.43 98.89 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.858 0.863 . . . . 75.11 111.281 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -59.24 -42.7 91.72 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 114.965 -1.016 . . . . 74.54 110.739 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.502 ' HE1' HG21 ' C' ' 86' ' ' ILE . 6.7 tpt -68.48 -43.63 76.52 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.845 -1.07 . . . . 64.25 110.573 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.75 -36.49 79.04 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.472 0.709 . . . . 71.31 111.318 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.408 ' CD2' ' HB3' ' C' ' 100' ' ' ALA . 12.9 t-80 -77.32 -31.7 54.78 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.102 0.408 . . . . 74.03 112.102 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.576 ' SG ' HD13 ' C' ' 86' ' ' ILE . 24.7 t -66.36 -43.83 84.92 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.688 -0.856 . . . . 63.42 108.688 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 43.3 mt -78.69 -28.3 45.21 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.374 -1.285 . . . . 73.33 111.104 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.61 -27.97 52.92 Favored Glycine 0 C--N 1.347 1.153 0 CA-C-N 115.701 -0.681 . . . . 65.15 114.14 -172.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.408 ' HB3' ' CD2' ' C' ' 96' ' ' HIS . . . -154.83 -48.75 0.09 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.172 1.175 . . . . 72.44 114.172 -163.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -62.73 -51.86 65.52 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.686 0.616 . . . . 61.12 111.465 -173.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.51 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 57.6 m -66.52 -50.05 48.86 Favored Pre-proline 0 CA--C 1.56 1.351 0 CA-C-O 118.271 -0.871 . . . . 52.44 111.502 177.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.504 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 85.4 Cg_exo -51.56 -30.99 38.0 Favored 'Trans proline' 0 C--N 1.399 3.227 0 C-N-CA 123.029 2.486 . . . . 61.12 114.898 172.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -65.35 -43.51 90.63 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.06 0.544 . . . . 60.34 109.717 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.487 HD12 ' NH1' ' A' ' 111' ' ' ARG . 35.1 mm -72.74 -29.12 28.99 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.235 0 CA-C-N 115.663 -0.699 . . . . 73.35 110.462 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.497 HD23 HG23 ' C' ' 16' ' ' ILE . 89.0 mt -77.62 -29.68 51.96 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.815 0.846 . . . . 71.45 111.883 178.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -58.78 -50.19 89.37 Favored Pre-proline 0 N--CA 1.482 1.173 0 CA-C-O 117.448 -1.263 . . . . 74.12 114.279 -168.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.93 -32.54 92.63 Favored 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 121.832 1.688 . . . . 62.22 112.75 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -68.42 -48.26 65.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.414 0.685 . . . . 75.41 110.425 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.466 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -62.57 -35.49 79.65 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 115.952 -0.567 . . . . 25.45 111.149 176.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -63.07 -54.85 31.51 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.313 1.445 . . . . 63.15 111.374 -177.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -66.98 -30.13 70.17 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.305 0.642 . . . . 71.1 110.153 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 14.0 t -68.43 -34.5 76.09 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.456 0.702 . . . . 70.31 111.394 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.449 HG23 ' SG ' ' C' ' 76' ' ' CYS . 96.3 mt -74.46 -50.56 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.478 0.711 . . . . 75.4 110.298 174.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 9.1 m -66.34 -28.39 68.63 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.26 0.624 . . . . 62.44 111.602 -173.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 79.5 p -66.59 -45.36 79.48 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 109.13 -0.693 . . . . 54.41 109.13 172.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.576 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.42 -40.65 78.79 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.421 1.088 . . . . 65.55 112.478 176.384 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.411 HG23 ' O ' ' C' ' 114' ' ' ILE . 62.8 t -64.73 -40.83 90.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.29 0.636 . . . . 61.15 110.609 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.461 ' OG ' HG21 ' B' ' 115' ' ' THR . 28.2 t -67.02 -34.63 78.15 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.05 0.94 . . . . 70.2 112.016 175.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' C' ' 116' ' ' SER . 66.0 mtt-85 -65.73 -36.3 83.19 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.237 0.615 . . . . 73.33 109.502 177.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.61 11.21 62.2 Favored Glycine 0 C--N 1.356 1.668 0 CA-C-O 119.284 -0.731 . . . . 65.13 113.322 175.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.425 HG23 ' HB3' ' D' ' 17' ' ' TYR . 67.6 p 59.09 21.76 9.77 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 126.139 1.776 . . . . 43.53 114.648 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -85.37 157.21 59.11 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 108.385 -0.969 . . . . 73.31 108.385 170.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.759 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 30.1 Cg_endo -61.6 168.46 8.28 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.831 2.354 . . . . 74.41 113.966 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -62.01 110.73 1.66 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.749 -1.114 . . . . 74.14 111.532 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.435 HD22 ' HZ ' ' C' ' 74' ' ' PHE . 9.5 mp -106.3 87.03 2.46 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.343 -1.354 . . . . 74.25 107.343 169.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -90.03 109.17 20.23 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.205 -1.035 . . . . 74.14 108.205 -178.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 64.1 mt -61.04 131.29 50.13 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.529 0.732 . . . . 74.35 110.758 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.1 146.92 98.85 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 118.786 -0.626 . . . . 61.34 110.454 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -48.85 99.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.776 2.317 . . . . 75.32 112.7 172.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 58.0 t -97.4 109.03 22.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 107.494 -1.299 . . . . 64.41 107.494 172.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -86.11 101.3 12.85 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.669 -0.863 . . . . 75.22 108.669 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -57.18 -35.62 69.81 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.011 0.925 . . . . 74.21 111.347 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -68.46 -25.91 65.23 Favored 'General case' 0 C--O 1.219 -0.533 0 C-N-CA 123.949 0.9 . . . . 65.52 111.942 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.55 -40.54 56.68 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.031 0.532 . . . . 73.42 110.243 171.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 79.0 mt -65.65 -36.0 82.41 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.407 -0.815 . . . . 74.02 111.096 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -83.21 -32.43 26.53 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-N 115.878 -0.601 . . . . 74.23 110.265 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 40.2 ttm -56.89 -48.64 77.71 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.683 0.793 . . . . 63.42 111.684 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -62.17 -36.53 82.14 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.274 -0.875 . . . . 74.35 111.123 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -72.14 -85.79 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 123.772 0.829 . . . . 74.12 109.902 172.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.453 HD11 ' HA ' ' C' ' 92' ' ' THR . 8.7 tt -102.83 131.74 49.5 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.866 1.267 . . . . 65.32 109.275 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -121.66 163.07 19.59 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.298 1.039 . . . . 70.33 110.833 -177.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -115.05 -132.56 0.33 Allowed 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 108.487 -0.931 . . . . 71.34 108.487 172.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -172.75 114.76 0.28 Allowed 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.37 0.986 . . . . 64.13 111.128 -170.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . 0.407 ' HB3' ' HA2' ' E' ' 143' ' ' GLY . . . 174.78 170.76 0.25 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 125.031 1.332 . . . . 62.3 110.278 172.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.92 172.36 21.61 Favored Glycine 0 C--N 1.351 1.394 0 N-CA-C 112.031 -0.428 . . . . 54.4 112.031 175.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . 0.556 ' HG2' ' HE1' ' A' ' 96' ' ' HIS . 20.7 tt0 -110.61 -59.17 1.99 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.424 0.689 . . . . 75.55 109.92 -178.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.4 96.08 0.16 Allowed Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.461 -0.79 . . . . 42.12 113.078 -176.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 32.0 p -73.65 -51.14 17.75 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.898 0.879 . . . . 74.23 111.992 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . 0.493 ' HG2' ' NE2' ' A' ' 144' ' ' GLN . 9.0 tp10 -151.75 149.64 29.28 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.308 0.643 . . . . 51.31 110.59 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -121.25 92.22 3.7 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.154 0.982 . . . . 53.31 109.871 174.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -140.22 178.99 6.9 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.032 0.933 . . . . 70.15 108.76 170.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -141.02 110.37 6.29 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.548 -0.908 . . . . 55.42 108.548 -177.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -84.78 158.15 20.79 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.043 0.537 . . . . 64.33 109.648 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.288 0 C-N-CA 124.298 1.039 . . . . 71.11 112.186 -174.784 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mpp? . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.733 -0.469 . . . . 74.21 109.733 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 54.2 m -138.36 107.16 5.94 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.228 0.611 . . . . 63.32 110.005 -177.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -71.49 91.07 1.02 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.269 0.628 . . . . 74.43 109.814 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -92.38 -41.18 10.48 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.994 0.918 . . . . 70.34 109.253 -175.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 52.6 t30 73.75 153.79 0.14 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 125.094 1.357 . . . . 72.0 110.377 -173.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . 0.425 ' ND2' ' HB3' ' D' ' 90' ' ' GLU . 9.1 p30 -88.64 155.21 19.74 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.149 0.579 . . . . 72.31 110.598 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 15.2 p -140.94 -62.02 0.48 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.986 0.914 . . . . 71.44 108.922 173.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -132.55 91.61 2.95 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.569 0.748 . . . . 74.31 109.012 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -35.2 133.16 0.34 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 124.823 1.249 . . . . 75.11 112.796 169.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 6.2 t -133.23 135.63 45.12 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.117 0.567 . . . . 73.34 110.133 176.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.451 ' HD2' HG22 ' D' ' 86' ' ' ILE . 80.3 t80 -132.83 107.91 8.63 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.178 -1.416 . . . . 73.11 107.178 176.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -128.91 116.06 18.81 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.994 0.918 . . . . 74.41 108.658 -176.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 10.7 mt -82.75 130.45 35.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 108.303 -0.999 . . . . 70.12 108.303 174.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -94.82 -34.65 12.39 Favored 'General case' 0 C--O 1.244 0.786 0 O-C-N 123.621 0.575 . . . . 71.14 110.429 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -167.76 141.43 3.43 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.323 0.389 . . . . 75.1 111.015 -173.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.485 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.7 mp -122.98 134.92 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 107.292 -1.373 . . . . 72.02 107.292 171.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.448 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 36.4 p90 -161.54 176.42 11.07 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.535 0.683 . . . . 64.53 112.372 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 53.6 p -103.47 127.22 50.9 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.422 -0.808 . . . . 72.52 109.357 173.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.448 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 32.5 mtpt -97.39 -19.22 18.62 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.027 0.531 . . . . 75.32 109.823 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.599 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 31.7 t70 -158.52 144.29 16.78 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.836 0.855 . . . . 73.24 109.876 177.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.576 HD13 ' HE3' ' C' ' 117' ' ' MET . 81.2 mt -148.59 142.91 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.624 1.569 . . . . 75.04 107.528 177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.9 t -154.78 134.43 12.77 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.45 0.7 . . . . 63.35 109.419 164.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 88.8 t80 -119.75 133.92 55.43 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 105.827 -1.916 . . . . 62.35 105.827 166.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -138.69 120.59 15.46 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.349 0.659 . . . . 75.1 109.518 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.551 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -119.03 85.04 28.28 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 107.527 -1.286 . . . . 72.25 107.527 175.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -71.9 -29.55 15.11 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.873 2.382 . . . . 72.32 112.801 -168.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -115.27 16.58 16.83 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.077 0.951 . . . . 75.12 110.74 -175.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.551 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -42.96 -58.03 4.4 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 114.887 1.44 . . . . 74.0 114.887 -161.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.42 ' HB3' HD11 ' C' ' 83' ' ' ILE . 89.6 Cg_endo -72.31 -26.18 17.73 Favored 'Trans proline' 0 C--N 1.378 2.124 0 CA-C-N 122.356 1.877 . . . . 74.51 113.992 -175.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -74.95 -36.68 62.08 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.848 0.859 . . . . 72.32 109.887 177.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.432 HG12 ' O ' ' D' ' 28' ' ' ALA . 9.8 p -83.91 -16.89 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-N 115.94 -0.573 . . . . 73.11 111.683 -172.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -68.15 -13.06 61.94 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 111.741 0.275 . . . . 74.03 111.741 175.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -69.48 -3.74 15.81 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.293 0.637 . . . . 74.52 111.3 174.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -110.69 102.88 11.4 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.276 1.43 . . . . 75.21 109.505 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -99.98 84.56 2.89 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.387 0.675 . . . . 54.11 111.125 -174.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -156.82 172.81 17.97 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 114.68 -1.145 . . . . 65.5 108.507 166.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -68.15 120.18 72.67 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-O 118.251 -0.88 . . . . 74.41 108.744 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -51.02 134.76 43.42 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 122.892 2.395 . . . . 61.12 112.124 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -69.34 110.52 4.7 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.879 -1.526 . . . . 73.43 106.879 170.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.722 HG13 HG13 ' D' ' 64' ' ' VAL . 38.4 t -107.05 108.86 26.24 Favored 'Isoleucine or valine' 0 C--O 1.245 0.84 0 CA-C-N 115.759 -0.655 . . . . 52.2 109.907 -173.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -87.95 109.27 19.68 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.603 -0.888 . . . . 73.31 108.603 168.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.447 HD12 ' O ' ' D' ' 63' ' ' THR . 58.9 tp -97.18 141.05 30.77 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.273 1.029 . . . . 62.22 109.228 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.614 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 21.5 t70 -123.94 131.9 53.64 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.385 -1.339 . . . . 73.34 107.385 173.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.612 ' HB3' HD23 ' E' ' 111' ' ' LEU . 31.9 mt -119.65 129.9 54.8 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.095 -0.706 . . . . 74.13 109.095 174.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.6 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 30.7 t70 -138.07 140.53 40.06 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 107.7 -1.222 . . . . 72.32 107.7 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 3.8 t -104.2 148.17 26.62 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.242 -0.651 . . . . 63.12 109.242 -176.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.421 ' HA ' ' OG1' ' E' ' 107' ' ' THR . . . -149.96 151.22 33.0 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.812 0.845 . . . . 52.54 109.423 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.443 ' HB3' HG22 ' D' ' 58' ' ' VAL . 10.1 p -171.02 152.18 3.45 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.904 0.882 . . . . 75.11 109.235 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 51.6 p -155.1 118.8 4.54 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.613 0.365 . . . . 61.53 110.796 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . 0.508 ' HB2' ' HA ' ' D' ' 56' ' ' TYR . 4.5 mm-40 174.93 150.96 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 126.554 1.942 . . . . 74.04 108.449 170.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 8.1 mp -99.77 98.11 8.97 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.374 0.67 . . . . 53.23 109.217 176.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . 61.2 -145.73 0.45 Allowed 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.617 0.767 . . . . 54.43 111.12 174.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 19.8 t0 74.16 6.0 4.7 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.909 1.283 . . . . 71.2 112.534 170.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.619 ' HB2' ' HB3' ' E' ' 94' ' ' PHE . 41.4 m-20 62.47 8.02 2.65 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.193 1.397 . . . . 63.43 113.639 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 50.9 t -134.39 117.63 24.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 108.767 -0.827 . . . . 74.2 108.767 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.508 ' HA ' ' HB2' ' D' ' 50' ' ' GLN . 33.4 m-85 -131.98 132.74 43.74 Favored 'General case' 0 C--O 1.248 1.003 0 N-CA-C 107.016 -1.476 . . . . 75.41 107.016 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -85.83 115.35 23.42 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 107.357 -1.349 . . . . 75.14 107.357 171.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.443 HG22 ' HB3' ' D' ' 48' ' ' SER . 70.3 t -99.97 130.55 48.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.643 -1.162 . . . . 74.33 108.687 -178.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.547 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 16.5 t -111.85 146.78 16.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.879 -0.786 . . . . 62.41 108.879 176.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.41 119.87 37.01 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.581 -1.266 . . . . 73.34 107.581 176.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.6 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 2.9 tmm_? -95.4 96.21 8.96 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 108.042 -1.095 . . . . 74.53 108.042 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.443 HG13 HD11 ' D' ' 42' ' ' LEU . 54.0 t -101.67 125.12 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.574 -0.899 . . . . 71.42 108.574 176.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.614 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 50.0 m -121.66 131.07 53.9 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 123.285 0.634 . . . . 52.54 109.526 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.722 HG13 HG13 ' D' ' 40' ' ' VAL . 83.7 t -113.86 127.06 71.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.778 -0.823 . . . . 73.43 108.778 172.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 22.4 m -119.61 92.92 3.91 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.336 -1.727 . . . . 72.43 106.336 168.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.54 143.59 30.53 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 109.652 -0.499 . . . . 71.21 109.652 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 77.9 p -147.7 137.3 22.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.238 0.542 . . . . 63.22 111.158 -173.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 26.8 mt -108.73 110.5 21.91 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.404 -1.332 . . . . 74.5 107.404 171.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.98 -134.98 20.85 Favored Glycine 0 C--N 1.342 0.909 0 O-C-N 123.589 0.556 . . . . 61.44 113.302 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.24 6.05 46.71 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.554 0.741 . . . . 73.33 112.179 -176.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -130.07 167.86 17.65 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.074 0.55 . . . . 74.31 110.602 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 66.0 m -71.46 138.67 49.2 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.454 -0.794 . . . . 72.11 111.217 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.427 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -89.77 -63.11 1.33 Allowed 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.239 -1.393 . . . . 65.4 107.239 169.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -158.56 161.08 37.26 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.652 -1.158 . . . . 74.11 110.951 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 68.8 mt -131.8 112.64 12.67 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.458 1.503 . . . . 63.14 107.151 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.623 ' SG ' HG23 ' D' ' 114' ' ' ILE . 49.2 t -131.94 106.23 7.92 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 122.583 0.353 . . . . 54.35 110.378 -168.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -129.0 125.89 38.35 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.428 0.691 . . . . 42.33 109.657 -173.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 88.2 t -132.6 115.39 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.114 0.965 . . . . 73.24 109.822 -174.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.599 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 2.3 mp0 -90.03 87.31 6.85 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.892 0.877 . . . . 53.23 109.051 175.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -81.81 102.9 11.11 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.691 -1.14 . . . . 70.04 109.346 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -111.64 147.24 17.98 Favored Glycine 0 N--CA 1.475 1.236 0 CA-C-O 120.157 -0.246 . . . . 44.33 112.517 -178.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.91 151.91 23.1 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 117.133 0.467 . . . . 51.41 112.252 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 3.0 mp -89.74 118.22 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 N-CA-C 108.707 -0.849 . . . . 71.43 108.707 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -115.29 150.08 36.81 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.943 0.897 . . . . 65.44 110.165 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 33.1 t -115.76 104.73 11.95 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.992 0.917 . . . . 60.42 109.152 175.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.495 HD11 HD23 ' D' ' 98' ' ' LEU . 47.2 pt -115.03 130.28 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.153 0.581 . . . . 62.21 109.838 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.87 165.29 34.98 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.587 0.755 . . . . 64.34 109.767 175.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.69 23.39 75.24 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-O 119.692 -0.504 . . . . 74.43 114.315 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.453 HG22 ' H ' ' D' ' 90' ' ' GLU . 0.1 OUTLIER -103.1 168.81 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 108.733 -0.84 . . . . 73.22 108.733 172.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.453 ' H ' HG22 ' D' ' 89' ' ' ILE . 8.8 pt-20 -135.1 178.17 7.24 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.02 0.928 . . . . 75.23 111.08 -178.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.79 -138.77 42.47 Favored Glycine 0 C--N 1.358 1.797 0 CA-C-N 115.676 -0.693 . . . . 64.22 113.068 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 65.5 p -88.31 -20.37 25.48 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.167 0.587 . . . . 64.13 110.284 170.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.751 ' HA ' ' HB3' ' D' ' 96' ' ' HIS . 25.7 tp60 -59.69 -21.42 60.56 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.186 1.395 . . . . 54.32 112.295 -175.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.425 ' HA ' ' HB ' ' D' ' 89' ' ' ILE . 16.8 ptp -57.51 -51.04 71.07 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.435 0.694 . . . . 71.12 111.856 172.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . 0.716 ' HB2' ' HB2' ' E' ' 100' ' ' LEU . . . -86.23 -22.77 26.72 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.943 0.497 . . . . 72.42 111.771 176.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.751 ' HB3' ' HA ' ' D' ' 93' ' ' GLN . 19.6 t-80 -75.02 -11.27 60.06 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.184 0.593 . . . . 54.22 110.094 176.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 43.7 t -72.99 -51.2 19.17 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.966 0.506 . . . . 73.41 110.447 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.517 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 3.2 pp -77.64 -19.03 56.14 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.037 0.384 . . . . 55.54 112.037 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.35 -0.82 64.91 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-O 119.817 -0.435 . . . . 73.35 113.345 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.14 -66.78 0.39 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.903 0.481 . . . . 64.02 111.212 -176.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -66.84 -43.33 83.97 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.436 0.294 . . . . 72.43 111.78 -173.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.517 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 75.6 m -63.74 -47.44 81.71 Favored Pre-proline 0 CA--C 1.567 1.629 0 CA-C-O 118.289 -0.862 . . . . 75.12 112.591 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.598 ' HA ' HD12 ' D' ' 106' ' ' LEU . 27.9 Cg_exo -62.51 -28.53 77.75 Favored 'Trans proline' 0 C--N 1.399 3.233 0 C-N-CA 122.153 1.902 . . . . 53.33 112.964 170.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -67.91 -32.86 73.63 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.616 0.367 . . . . 75.44 111.068 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 48.0 mm -65.58 -34.38 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.149 0.58 . . . . 74.2 110.241 173.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.598 HD12 ' HA ' ' D' ' 103' ' ' PRO . 29.5 mt -77.81 -18.27 56.55 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.381 -0.827 . . . . 72.31 111.933 -179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -71.04 -41.3 10.74 Favored Pre-proline 0 N--CA 1.486 1.358 0 N-CA-C 113.91 1.078 . . . . 71.2 113.91 -173.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -50.65 -42.91 48.34 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.208 1.939 . . . . 64.22 112.721 169.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . 0.455 ' OH ' ' HB3' ' B' ' 130' ' ' PRO . 93.2 m-85 -79.49 -27.29 41.47 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.634 0.774 . . . . 74.3 111.732 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.06 -49.5 67.41 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.049 -0.722 . . . . 75.24 109.049 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -67.13 -33.37 75.29 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 113.868 -1.515 . . . . 51.44 110.864 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -53.92 -55.79 23.73 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 124.007 0.923 . . . . 70.24 110.268 174.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.408 ' O ' ' HG3' ' D' ' 117' ' ' MET . 47.2 t -62.99 -47.52 82.79 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 114.225 -1.352 . . . . 74.32 111.182 -177.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.623 HG23 ' SG ' ' D' ' 76' ' ' CYS . 68.5 mt -60.95 -61.74 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.324 0.65 . . . . 73.02 111.576 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 22.3 m -51.97 -40.42 60.86 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 124.198 0.937 . . . . 73.42 111.455 -175.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 37.5 t -60.41 -50.77 72.27 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-N 114.343 -1.299 . . . . 74.42 110.751 177.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.408 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 72.4 mtm -66.54 -30.85 71.25 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.122 0.569 . . . . 75.41 112.16 -178.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.8 t -66.56 -44.34 90.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.722 0.809 . . . . 73.14 110.042 176.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 83.7 p -74.83 -28.67 60.79 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.746 -0.661 . . . . 73.3 110.56 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' D' ' 116' ' ' SER . 88.3 mtt-85 -69.84 -29.73 67.05 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.648 0.779 . . . . 61.45 109.809 173.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.46 6.98 80.88 Favored Glycine 0 C--N 1.356 1.672 0 O-C-N 123.656 0.598 . . . . 60.3 113.157 177.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.609 HG23 ' HB3' ' C' ' 17' ' ' TYR . 81.2 p 55.69 28.25 11.84 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 126.277 1.831 . . . . 61.44 113.442 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -90.9 151.34 43.34 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 123.641 0.776 . . . . 75.35 109.289 169.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -51.58 125.15 15.99 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.64 2.227 . . . . 65.42 112.211 172.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -42.89 135.64 2.95 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 126.191 1.796 . . . . 75.22 113.277 -175.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.655 HD13 HG21 ' D' ' 40' ' ' VAL . 28.7 tp -116.55 96.99 5.76 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.774 0.83 . . . . 55.4 109.78 -176.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -97.11 96.48 8.49 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 106.931 -1.507 . . . . 53.33 106.931 175.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.496 HD11 HD12 ' D' ' 114' ' ' ILE . 92.9 mt -54.13 127.25 25.95 Favored 'General case' 0 C--O 1.246 0.884 0 O-C-N 123.649 0.593 . . . . 73.15 110.397 -177.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.18 140.81 82.81 Favored Pre-proline 0 CA--C 1.551 0.982 0 O-C-N 124.185 0.928 . . . . 74.23 110.734 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.404 ' HD3' HG13 ' B' ' 13' ' ' ILE . 98.0 Cg_endo -74.22 108.4 2.66 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.566 2.177 . . . . 74.22 111.739 -170.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 59.1 t -106.48 117.25 51.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 108.186 -1.042 . . . . 71.43 108.186 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -74.28 113.14 11.14 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.698 -0.853 . . . . 54.5 108.698 169.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.439 ' CD2' ' HB2' ' D' ' 103' ' ' PRO . 2.0 m-85 -69.52 -29.03 66.55 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.239 -0.891 . . . . 72.55 110.826 -176.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -60.85 -51.12 70.65 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 108.75 -0.833 . . . . 32.2 108.75 173.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.53 -50.55 69.11 Favored 'General case' 0 C--N 1.352 0.691 0 O-C-N 124.423 1.077 . . . . 62.23 110.714 -174.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.585 HD23 ' HG ' ' E' ' 111' ' ' LEU . 33.8 tp -66.93 -39.87 87.46 Favored 'General case' 0 CA--C 1.55 0.98 0 O-C-N 123.926 0.766 . . . . 54.1 111.563 -174.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.493 ' O ' HD13 ' D' ' 141' ' ' LEU . 9.1 t80 -67.57 -41.59 83.92 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.425 -0.583 . . . . 72.25 109.425 176.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.488 ' O ' ' HG2' ' D' ' 142' ' ' GLN . 66.0 mtm -65.02 -29.29 70.19 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 116.022 -0.535 . . . . 65.34 111.315 174.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -66.57 -8.08 24.5 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 118.071 0.396 . . . . 75.13 111.732 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . 0.474 ' HD2' HD12 ' D' ' 141' ' ' LEU . 80.5 t80 -89.54 -41.97 11.71 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 121.109 0.481 . . . . 74.13 109.992 165.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.493 HD13 ' O ' ' D' ' 137' ' ' PHE . 6.4 mp -76.93 -64.25 1.17 Allowed 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 124.78 1.232 . . . . 72.22 112.39 -170.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' D' ' 138' ' ' MET . 29.2 pt20 -81.18 25.32 0.49 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 124.729 1.212 . . . . 75.12 113.291 -176.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -114.41 84.3 2.03 Favored 'General case' 0 N--CA 1.482 1.168 0 O-C-N 120.944 -1.097 . . . . 71.03 108.995 -168.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -177.65 -33.52 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 113.024 -1.898 . . . . 74.41 108.302 -175.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -145.14 128.62 16.99 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.857 1.263 . . . . 73.21 108.594 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.43 -177.06 43.83 Favored Glycine 0 C--N 1.347 1.163 0 O-C-N 123.36 0.412 . . . . 51.55 113.074 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -142.68 150.44 40.18 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.433 1.093 . . . . 73.34 109.349 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -149.54 97.62 0.18 Allowed Glycine 0 C--N 1.347 1.188 0 N-CA-C 111.051 -0.82 . . . . 61.31 111.051 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 47.3 p -119.14 116.42 26.31 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.249 1.02 . . . . 64.43 109.53 -177.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.6 12.04 2.3 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 113.586 0.958 . . . . 72.53 113.586 -166.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -70.32 105.14 2.9 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.436 0.694 . . . . 73.04 110.64 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -138.14 124.09 20.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.001 0.92 . . . . 73.33 109.104 176.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -126.72 154.51 44.06 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.518 1.127 . . . . 71.23 108.691 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -62.94 144.45 56.76 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.277 0.631 . . . . 63.34 110.233 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.005 0 C-N-CA 123.361 0.664 . . . . 71.33 110.878 -177.598 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.44 0 CA-C-O 120.168 -0.24 . . . . 52.01 112.948 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 178.93 -41.79 0.08 OUTLIER Glycine 0 C--N 1.347 1.16 0 N-CA-C 112.455 -0.258 . . . . 61.34 112.455 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -108.67 -61.6 1.58 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.812 0.845 . . . . 70.54 110.543 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 94' ' ' PHE . . . . . 0.619 ' HB3' ' HB2' ' D' ' 54' ' ' ASP . 0.3 OUTLIER -148.37 -139.46 0.1 Allowed 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 109.369 -0.604 . . . . 74.43 109.369 -172.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -103.37 -73.98 0.65 Allowed 'General case' 0 N--CA 1.505 2.31 0 CA-C-N 119.388 0.995 . . . . 70.13 111.978 -169.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 146.14 33.91 0.07 OUTLIER Glycine 0 C--N 1.357 1.709 0 CA-C-O 119.757 -0.468 . . . . 72.43 113.345 -178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 97' ' ' ILE . . . . . 0.476 ' HB ' HD22 ' E' ' 100' ' ' LEU . 30.3 mt 57.3 -84.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.064 1.746 . . . . 74.23 111.074 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -153.51 -74.68 0.13 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.679 0.792 . . . . 73.31 109.374 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -161.35 32.75 0.14 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.011 -0.995 . . . . 73.15 110.485 -168.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 100' ' ' LEU . . . . . 0.716 ' HB2' ' HB2' ' D' ' 95' ' ' ALA . 1.4 pt? -57.24 130.85 80.62 Favored Pre-proline 0 CA--C 1.559 1.302 0 C-N-CA 122.876 0.47 . . . . 75.35 111.397 -176.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -61.77 -20.71 70.11 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 123.22 2.613 . . . . 72.42 113.676 -172.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 102' ' ' LEU . . . . . 0.505 HD21 ' HA ' ' E' ' 107' ' ' THR . 0.7 OUTLIER -96.77 79.96 3.01 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.433 -0.951 . . . . 74.32 108.433 174.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 103' ' ' THR . . . . . 0.561 HG23 ' HG ' ' E' ' 100' ' ' LEU . 10.9 p -137.67 15.57 2.92 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.377 1.471 . . . . 70.43 108.474 169.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 179.06 162.68 28.81 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 114.363 -1.29 . . . . 51.2 110.238 -176.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 67.11 135.48 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.909 1.284 . . . . 63.3 109.923 -166.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -70.66 89.06 0.72 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.117 -0.697 . . . . 73.24 109.117 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . 0.505 ' HA ' HD21 ' E' ' 102' ' ' LEU . 10.0 m 67.45 150.51 0.06 Allowed 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 125.59 1.556 . . . . 75.31 113.297 176.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 57.4 t60 -129.79 116.22 18.42 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 108.19 -1.041 . . . . 64.24 108.19 171.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 80.3 119.25 0.05 Allowed 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 126.903 2.081 . . . . 74.45 111.963 -175.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.49 146.29 32.78 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 109.201 -0.666 . . . . 72.33 109.201 169.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . 0.612 HD23 ' HB3' ' D' ' 44' ' ' LEU . 32.7 tp -78.81 -48.04 15.54 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.143 0.577 . . . . 75.31 111.643 -169.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 112' ' ' ASN . . . . . 0.504 ' HB2' ' H ' ' D' ' 44' ' ' LEU . 64.5 t30 -83.57 -44.58 14.46 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.265 0.626 . . . . 74.54 109.984 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -72.48 90.25 1.31 Allowed 'General case' 0 C--N 1.358 0.939 0 N-CA-C 108.865 -0.791 . . . . 75.34 108.865 176.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -145.94 158.27 43.87 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.622 -0.717 . . . . 62.44 110.455 -165.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 40.8 p -77.32 101.11 6.15 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.517 0.727 . . . . 65.22 110.752 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.92 93.63 0.91 Allowed Glycine 0 C--N 1.346 1.102 0 CA-C-N 115.657 -0.701 . . . . 54.4 113.192 172.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -132.63 98.14 16.73 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 123.619 0.767 . . . . 73.35 109.41 176.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -67.54 -77.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.108 1.872 . . . . 72.14 110.861 172.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -146.96 131.58 17.82 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.254 1.021 . . . . 75.3 109.109 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -173.94 -54.4 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.901 0.88 . . . . 70.42 109.018 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 121' ' ' VAL . . . . . . . . . . . . . 35.8 t -70.51 -43.34 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-N 115.225 -0.898 . . . . 54.42 110.069 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 59.4 p -117.03 134.1 55.17 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.357 1.063 . . . . 70.33 108.969 173.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -162.07 163.86 28.45 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.546 0.738 . . . . 74.11 109.671 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 41.5 m -74.88 74.23 2.13 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.784 0.834 . . . . 61.4 110.58 176.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -134.36 169.13 17.69 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.274 1.03 . . . . 63.53 110.253 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . 68.46 74.45 0.27 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.89 1.276 . . . . 53.24 112.006 174.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 27.1 m -76.67 99.89 5.2 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.021 -0.991 . . . . 53.5 109.644 176.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.98 173.62 6.97 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.604 -0.726 . . . . 20.55 111.142 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 1.9 m -92.69 139.12 30.88 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.308 -0.627 . . . . 75.23 109.308 174.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -71.59 152.35 43.0 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.091 0.556 . . . . 55.32 110.062 173.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 131' ' ' TRP . . . . . . . . . . . . . 91.6 t90 -60.29 138.14 58.0 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.63 0.581 . . . . 73.22 110.688 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 132' ' ' SER . . . . . 0.4 ' H ' ' HB3' ' A' ' 124' ' ' PRO . 70.3 m -161.06 137.8 8.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.281 1.032 . . . . 74.23 108.786 176.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 133' ' ' THR . . . . . 0.435 HG22 HG12 ' E' ' 135' ' ' VAL . 18.8 m -143.03 135.11 27.07 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.589 -0.523 . . . . 64.1 109.589 176.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -132.33 89.52 0.27 Allowed Glycine 0 C--N 1.347 1.193 0 N-CA-C 110.629 -0.989 . . . . 75.23 110.629 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 135' ' ' VAL . . . . . 0.435 HG12 HG22 ' E' ' 133' ' ' THR . 11.3 p -162.67 149.17 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.476 0.71 . . . . 74.22 109.96 -175.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -119.75 -111.02 0.34 Allowed 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 119.159 -0.448 . . . . 71.14 111.115 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 137' ' ' THR . . . . . 0.41 ' HA ' ' HB1' ' A' ' 129' ' ' ALA . 12.9 t -173.17 172.05 3.96 Favored 'General case' 0 C--N 1.361 1.104 0 C-N-CA 122.848 0.459 . . . . 60.43 111.928 -168.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -135.7 140.24 44.28 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.942 1.297 . . . . 74.11 108.538 172.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -63.15 122.86 17.15 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.522 0.729 . . . . 61.2 110.745 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . 168.15 63.86 0.03 OUTLIER Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.276 -0.73 . . . . 55.42 111.276 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -148.88 152.21 36.05 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.853 0.861 . . . . 62.44 109.549 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 76.6 mt 66.98 94.44 0.07 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.908 1.283 . . . . 72.32 111.326 -174.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 143' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' C' ' 145' ' ' ALA . . . -108.08 -119.22 4.33 Favored Glycine 0 C--N 1.34 0.776 0 N-CA-C 110.23 -1.148 . . . . 62.13 110.23 171.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 27.8 t -66.13 -24.56 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.386 0.674 . . . . 71.55 109.557 172.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 . . . . . 0 CA--C 1.551 1.014 0 C-N-CA 125.25 1.42 . . . . 63.44 109.861 178.029 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.485 0 N-CA-C 111.509 -0.636 . . . . 43.21 111.509 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.08 -56.8 4.86 Favored Glycine 0 C--N 1.35 1.316 0 C-N-CA 123.025 0.345 . . . . 52.13 112.483 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -79.5 71.44 6.08 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.547 1.139 . . . . 75.45 109.555 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -114.3 129.44 56.64 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.2 1.0 . . . . 73.42 109.181 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 95' ' ' LYS . . . . . 0.528 ' HD3' ' H ' ' F' ' 95' ' ' LYS . 0.0 OUTLIER -80.74 119.93 23.96 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 123.742 0.652 . . . . 74.44 110.07 175.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -170.19 5.33 0.04 OUTLIER Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.326 -0.708 . . . . 64.12 114.516 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 97' ' ' ILE . . . . . 0.729 ' HB ' ' HA ' ' B' ' 87' ' ' ALA . 7.2 tt -99.42 -75.15 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-N 118.018 0.909 . . . . 73.12 110.372 173.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 98' ' ' ASP . . . . . 0.599 ' H ' HG23 ' F' ' 97' ' ' ILE . 25.3 t70 173.24 -85.11 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.621 1.169 . . . . 72.2 108.577 -173.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.6 136.6 0.76 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.975 1.31 . . . . 74.33 108.754 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 100' ' ' LEU . . . . . 0.654 HD13 ' HB2' ' B' ' 56' ' ' TYR . 0.4 OUTLIER -147.49 75.55 11.25 Favored Pre-proline 0 CA--C 1.557 1.229 0 N-CA-C 113.183 0.809 . . . . 72.53 113.183 -176.326 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -83.89 27.83 0.59 Allowed 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 123.223 2.615 . . . . 73.14 112.006 170.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 102' ' ' LEU . . . . . 0.413 HD22 ' OG ' ' B' ' 48' ' ' SER . 42.2 tp 69.73 153.33 0.11 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 126.09 1.756 . . . . 75.24 111.583 -172.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 40.9 p -60.53 136.69 58.13 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.667 0.787 . . . . 70.1 110.254 170.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . -55.72 135.76 48.27 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 124.306 1.004 . . . . 73.21 115.571 -167.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 58.99 79.8 0.21 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.308 1.443 . . . . 53.51 112.625 172.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 16.8 t80 59.86 30.35 19.9 Favored 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.734 0.814 . . . . 74.11 112.386 168.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 11.3 m 56.39 57.72 4.73 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 122.09 0.948 . . . . 65.03 110.195 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -74.93 88.82 2.35 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.238 -0.892 . . . . 75.35 111.422 -174.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -127.76 -57.29 1.27 Allowed 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.138 -1.06 . . . . 71.04 108.138 170.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -167.64 -28.76 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.113 -1.403 . . . . 45.24 110.203 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 tt -75.03 83.41 2.26 Favored 'General case' 0 C--N 1.359 0.989 0 C-N-CA 123.688 0.795 . . . . 71.41 109.064 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -136.31 133.48 36.93 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 106.875 -1.528 . . . . 73.34 106.875 176.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -64.32 125.88 26.0 Favored 'General case' 0 CA--C 1.551 0.986 0 O-C-N 123.246 0.341 . . . . 75.52 110.923 -172.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -178.0 -47.18 0.01 OUTLIER 'General case' 0 C--O 1.242 0.697 0 C-N-CA 124.313 1.045 . . . . 63.24 109.576 -170.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 5.4 m 66.41 149.67 0.05 Allowed 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 125.229 1.412 . . . . 72.45 111.401 -172.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.15 -60.3 2.28 Favored Glycine 0 C--N 1.346 1.087 0 N-CA-C 111.673 -0.571 . . . . 70.02 111.673 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 117' ' ' LYS . . . . . 0.431 ' HB2' ' HD3' ' F' ' 118' ' ' PRO . 12.1 mptt -70.55 -44.93 18.15 Favored Pre-proline 0 CA--C 1.556 1.181 0 CA-C-O 118.802 -0.618 . . . . 75.11 110.017 175.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 118' ' ' PRO . . . . . 0.431 ' HD3' ' HB2' ' F' ' 117' ' ' LYS . 2.8 Cg_exo -79.17 124.57 6.06 Favored 'Trans proline' 0 C--N 1.391 2.795 0 C-N-CA 121.973 1.782 . . . . 73.14 110.316 160.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -83.62 -164.91 0.98 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.467 0.707 . . . . 74.23 110.071 176.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 73.83 -64.75 0.38 Allowed 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 125.307 1.443 . . . . 61.33 110.833 -173.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 28.9 t -71.39 89.06 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 124.471 1.108 . . . . 73.23 109.995 -175.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 16.2 p -142.87 -66.96 0.37 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.51 1.124 . . . . 63.22 108.905 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -172.89 123.37 0.42 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.249 1.019 . . . . 70.33 109.63 -177.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 20.0 m -156.26 116.23 3.61 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.403 -0.962 . . . . 73.5 108.403 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . 65.33 13.33 8.73 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.783 0.833 . . . . 31.32 112.955 173.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.37 97.38 4.24 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 123.425 0.69 . . . . 65.43 109.279 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 14.6 m -65.1 94.64 0.15 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.124 0.97 . . . . 74.33 112.088 -170.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.29 92.93 7.04 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.038 0.935 . . . . 53.51 109.865 176.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 13.3 p -129.6 161.02 31.5 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.933 0.893 . . . . 70.12 111.034 -174.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -74.71 137.8 42.35 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.017 0.927 . . . . 71.13 112.177 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -86.77 119.16 26.7 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.505 0.722 . . . . 72.55 109.979 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 22.9 t -171.58 165.73 6.79 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.616 0.766 . . . . 51.51 110.65 174.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 16.9 p -140.25 -178.49 5.5 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.52 1.128 . . . . 74.33 110.803 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -166.05 159.05 32.22 Favored Glycine 0 C--N 1.353 1.509 0 N-CA-C 111.146 -0.782 . . . . 73.43 111.146 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 135' ' ' VAL . . . . . 0.485 HG13 ' HB3' ' C' ' 42' ' ' LEU . 60.6 t -140.07 119.06 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 C-N-CA 123.413 0.685 . . . . 74.44 109.551 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 136' ' ' LYS . . . . . 0.492 ' HB3' ' HA ' ' C' ' 41' ' ' LYS . 54.2 tttp -79.92 -79.17 0.15 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 122.549 0.339 . . . . 73.11 110.65 172.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 91.0 m -157.17 128.95 7.08 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.51 0.724 . . . . 45.53 109.517 -168.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -79.24 76.63 5.78 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.817 -0.809 . . . . 75.21 108.817 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -162.96 130.9 3.74 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.454 -0.943 . . . . 73.12 108.454 -173.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -82.15 60.53 4.79 Favored Glycine 0 C--N 1.342 0.907 0 O-C-N 123.575 0.547 . . . . 75.2 112.499 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.0 137.18 57.88 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.244 0.617 . . . . 72.42 110.995 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -138.35 -173.03 3.42 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.051 0.94 . . . . 73.13 109.684 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.87 8.03 65.6 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 112.242 -0.343 . . . . 44.43 112.242 -176.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 96.5 t -81.25 125.4 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 124.067 0.947 . . . . 71.1 110.842 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 30.1 t70 . . . . . 0 C--O 1.245 0.868 0 C-N-CA 123.794 0.837 . . . . 73.44 108.87 173.079 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ppp? . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 110.265 -0.272 . . . . 64.05 110.265 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.3 t -165.04 126.26 2.03 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 108.494 -0.928 . . . . 63.51 108.494 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -75.16 79.26 2.3 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-O 122.163 0.982 . . . . 71.52 110.183 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -154.07 -58.0 0.12 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.069 -0.969 . . . . 53.51 109.065 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -130.4 163.87 25.95 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.805 0.842 . . . . 74.55 109.355 -175.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -55.82 109.11 0.52 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.595 0.758 . . . . 61.23 110.07 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.2 m -61.65 150.84 35.23 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 124.159 0.984 . . . . 74.31 111.09 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -49.22 128.55 16.84 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 124.273 0.983 . . . . 74.0 111.113 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 56.9 mtt -80.41 161.97 24.68 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.366 -0.834 . . . . 74.51 110.175 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 75.9 m -139.06 113.8 9.18 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 107.672 -1.233 . . . . 74.21 107.672 173.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -114.91 120.5 40.16 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.725 -1.213 . . . . 73.25 107.725 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -139.11 123.77 18.51 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 108.55 -0.907 . . . . 71.43 108.55 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.453 HG21 ' HG3' ' C' ' 130' ' ' PRO . 3.0 mt -88.43 119.59 35.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.624 -0.88 . . . . 73.12 108.624 177.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -91.39 -37.27 13.31 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 123.785 0.678 . . . . 74.1 110.516 -177.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.5 ttt180 -171.17 121.49 0.54 Allowed 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.353 0.408 . . . . 74.1 109.948 -176.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 76.2 mt -106.72 137.18 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.201 -1.037 . . . . 53.5 108.201 171.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.511 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 37.3 p90 -164.44 175.89 9.53 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-O 122.042 0.925 . . . . 73.11 111.92 -174.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 56.2 p -102.78 111.56 23.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.677 -1.147 . . . . 75.5 108.724 176.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.511 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 34.2 mtpt -72.92 -34.32 66.54 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.283 -0.636 . . . . 75.02 109.283 175.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.1 t70 -150.35 145.79 26.33 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.965 -1.016 . . . . 64.41 110.142 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.56 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 75.5 mt -142.78 143.3 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.663 1.585 . . . . 61.15 107.43 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.4 t -154.72 131.24 10.56 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 122.899 0.48 . . . . 63.2 110.165 173.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.513 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 87.6 t80 -126.99 141.9 51.68 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.332 -1.358 . . . . 65.03 107.332 172.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HB3' ' HD3' ' A' ' 26' ' ' PRO . 30.2 mt-10 -135.04 142.52 46.39 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.785 -0.45 . . . . 73.31 109.785 175.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.83 71.08 13.74 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 106.991 -1.485 . . . . 33.34 106.991 166.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.404 ' HD3' ' HB3' ' A' ' 24' ' ' GLU . 65.1 Cg_endo -71.78 -17.84 28.93 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 122.434 2.089 . . . . 75.13 112.2 -175.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -104.71 17.38 24.24 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-O 118.007 -0.996 . . . . 62.4 109.698 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.449 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -46.34 -55.72 13.03 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 113.674 0.99 . . . . 50.42 113.674 -169.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.449 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 32.2 Cg_exo -60.83 -26.85 83.83 Favored 'Trans proline' 0 C--N 1.388 2.616 0 C-N-CA 121.73 1.62 . . . . 63.12 113.612 178.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -81.86 -41.23 21.28 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.876 0.871 . . . . 71.24 110.522 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.574 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.8 p -74.95 -20.66 16.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 124.576 1.15 . . . . 73.43 111.787 -161.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -76.91 -21.27 55.13 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.584 0.754 . . . . 74.24 110.852 176.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -90.51 -11.94 38.71 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.697 1.199 . . . . 71.44 110.879 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -83.07 164.06 20.53 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.165 0.986 . . . . 72.41 111.44 -178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.96 118.86 17.41 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.538 0.735 . . . . 55.55 109.367 173.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.543 ' HD1' ' HB3' ' E' ' 132' ' ' SER . 71.2 t-105 -81.06 93.14 6.34 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 121.05 0.453 . . . . 75.24 110.737 -176.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -128.04 84.1 64.22 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 107.342 -1.355 . . . . 72.32 107.342 168.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -76.31 110.48 3.07 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.534 2.156 . . . . 54.11 112.443 -171.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -92.85 84.78 5.01 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 106.68 -1.6 . . . . 70.13 106.68 175.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.568 HG22 ' HB2' ' A' ' 66' ' ' ALA . 48.8 t -86.81 106.51 15.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 114.789 -1.096 . . . . 75.3 110.431 -173.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -79.01 123.47 27.33 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.19 -0.914 . . . . 71.51 109.454 171.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.8 mt -97.57 106.21 18.49 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.203 -1.036 . . . . 74.31 108.203 173.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.472 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 29.3 t70 -108.52 140.69 41.51 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.803 -1.184 . . . . 74.21 107.803 176.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.521 HD11 HG21 ' A' ' 131' ' ' VAL . 85.5 mt -136.56 150.95 48.87 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.173 0.589 . . . . 61.35 110.925 -172.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 21.8 t0 -154.77 148.98 25.98 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.931 -1.032 . . . . 71.01 109.417 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.455 HG21 ' HA2' ' A' ' 99' ' ' GLY . 89.3 m -130.86 147.44 52.51 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.614 0.766 . . . . 43.52 109.582 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -157.33 109.73 2.44 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.625 0.77 . . . . 73.34 109.661 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.3 p -93.15 154.38 18.1 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.111 0.564 . . . . 43.31 110.229 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.8 t -151.62 121.51 7.07 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.047 0.939 . . . . 64.14 109.023 -176.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -73.03 105.57 4.55 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.034 0.533 . . . . 60.44 109.679 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' ' 57' ' ' GLU . 60.6 mt -79.09 -38.65 35.73 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.195 0.598 . . . . 73.52 110.275 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.27 -179.88 7.93 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.925 -1.034 . . . . 65.2 109.485 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -68.46 124.93 24.9 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.012 0.525 . . . . 72.34 109.944 176.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 63.72 16.6 9.86 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.008 1.323 . . . . 74.42 111.717 -173.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.0 t -124.93 109.22 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.083 0.953 . . . . 64.5 108.526 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -121.9 125.62 46.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.332 -0.988 . . . . 72.4 108.332 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.442 ' HB2' HD11 ' A' ' 51' ' ' LEU . 21.7 tt0 -83.44 150.33 26.11 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.984 -1.117 . . . . 74.13 107.984 166.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.0 t -131.16 136.27 58.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 107.642 -1.244 . . . . 72.43 107.642 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.441 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 48.7 t -109.56 135.97 46.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.367 -0.975 . . . . 50.23 108.367 175.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.491 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -112.95 104.09 12.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.643 -1.614 . . . . 74.44 106.643 170.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.425 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 16.6 ttp180 -92.79 100.15 12.69 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.363 -1.347 . . . . 63.35 107.363 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.8 t -98.44 128.97 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 N-CA-C 108.235 -1.024 . . . . 74.43 108.235 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 16.8 m -120.95 112.04 18.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.524 0.678 . . . . 73.53 109.322 175.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 80.4 t -106.14 125.94 61.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 124.731 1.212 . . . . 65.13 107.883 -178.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.1 m -134.08 115.05 13.83 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 118.379 0.536 . . . . 71.25 109.848 176.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.568 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -100.79 121.85 42.4 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.059 -1.46 . . . . 44.52 107.059 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 74.1 m -121.84 135.71 54.91 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.435 0.694 . . . . 55.14 109.876 176.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.45 HD21 ' CE3' ' A' ' 36' ' ' TRP . 17.6 mt -88.13 72.1 9.18 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 107.65 -1.241 . . . . 54.24 107.65 174.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.77 -90.85 1.07 Allowed Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.218 -0.901 . . . . 52.41 111.515 -171.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -113.27 -27.03 8.12 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.165 0.586 . . . . 74.4 111.933 -174.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -85.65 129.83 34.72 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.504 -0.924 . . . . 71.42 108.504 174.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 84.3 m -72.85 125.87 28.57 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.876 -0.416 . . . . 64.12 109.876 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.574 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -71.26 -57.68 4.25 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.844 0.858 . . . . 54.01 110.319 175.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -155.06 164.5 38.8 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.261 -0.881 . . . . 74.31 111.497 177.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 64' ' ' VAL . 65.6 tp -118.82 140.95 49.11 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.8 -1.091 . . . . 75.01 108.202 170.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.487 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 83.2 m -140.07 96.84 3.12 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.711 0.805 . . . . 65.32 109.66 173.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -111.49 117.44 33.03 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.575 -0.528 . . . . 64.41 109.575 177.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.1 t -126.58 113.96 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.003 0.921 . . . . 72.4 109.845 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 53.0 mt-30 -86.3 85.58 7.34 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.774 0.83 . . . . 63.13 109.21 171.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.437 ' HG3' HD22 ' A' ' 106' ' ' LEU . 7.9 tp-100 -78.62 96.34 5.47 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.079 -0.964 . . . . 75.13 109.978 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -100.72 145.43 17.11 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 111.552 -0.619 . . . . 72.11 111.552 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.47 130.42 3.94 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.65 -0.98 . . . . 74.11 110.65 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 48.8 mt -79.55 126.56 39.22 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 108.501 -0.925 . . . . 71.02 108.501 174.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.504 ' HB3' HD11 ' A' ' 86' ' ' ILE . 74.0 m-85 -131.6 123.29 27.59 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.426 0.69 . . . . 43.34 109.894 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.9 t -83.44 106.23 15.02 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.237 -0.653 . . . . 65.32 109.237 171.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.504 HD11 ' HB3' ' A' ' 84' ' ' PHE . 7.7 mm -117.05 150.52 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.418 0.687 . . . . 71.35 110.157 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.96 163.38 16.04 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.571 0.544 . . . . 64.24 112.079 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.22 -19.41 46.03 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-N 115.543 -0.753 . . . . 72.2 113.124 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.424 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -134.11 148.95 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.741 0.816 . . . . 72.15 111.216 -171.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -138.05 175.24 9.75 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.942 1.297 . . . . 71.3 109.183 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.5 -123.99 33.52 Favored Glycine 0 CA--C 1.533 1.195 0 O-C-N 123.623 0.577 . . . . 32.22 114.185 175.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 38.1 p -73.2 -30.34 63.45 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.037 0.935 . . . . 65.35 110.825 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -67.66 -37.83 82.93 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.306 1.042 . . . . 60.53 110.359 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 5.3 tpt -68.38 -45.55 72.44 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.939 -0.573 . . . . 74.24 109.648 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.69 -38.1 77.5 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.187 0.929 . . . . 75.4 111.75 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.467 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 58.9 t-80 -67.94 -33.91 75.58 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.31 0.644 . . . . 65.2 111.269 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.4 t -69.99 -45.11 68.0 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.019 0.437 . . . . 75.45 110.065 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.7 mt -80.79 -31.03 35.89 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.103 -0.953 . . . . 73.11 112.677 -170.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.455 ' HA2' HG21 ' A' ' 46' ' ' THR . . . -106.6 4.59 37.12 Favored Glycine 0 N--CA 1.472 1.059 0 CA-C-O 119.953 -0.36 . . . . 65.51 113.783 -173.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.571 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -136.13 -68.43 0.5 Allowed 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 117.191 0.495 . . . . 61.24 111.186 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -68.22 -43.7 77.39 Favored 'General case' 0 CA--C 1.555 1.135 0 CA-C-N 116.316 -0.402 . . . . 73.41 111.914 -172.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.2 m -63.71 -51.47 65.38 Favored Pre-proline 0 CA--C 1.57 1.73 0 C-N-CA 124.247 1.019 . . . . 71.54 113.084 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.47 -19.97 48.39 Favored 'Trans proline' 0 C--N 1.397 3.084 0 C-N-CA 121.842 1.695 . . . . 62.22 113.008 173.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -67.99 -37.52 81.58 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.187 0.595 . . . . 63.33 110.519 174.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.439 HG21 HD13 ' A' ' 13' ' ' ILE . 48.7 mm -67.29 -41.45 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.529 0.732 . . . . 65.24 110.084 173.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.437 HD22 ' HG3' ' A' ' 80' ' ' GLN . 61.5 mt -73.5 -25.59 60.51 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.018 -0.992 . . . . 63.11 112.422 -174.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -61.12 -45.57 95.97 Favored Pre-proline 0 N--CA 1.486 1.354 0 N-CA-C 114.127 1.158 . . . . 75.55 114.127 -173.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -53.46 -36.46 79.77 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.265 1.977 . . . . 74.52 113.611 171.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.426 ' O ' ' HB3' ' A' ' 112' ' ' GLU . 88.0 m-85 -83.36 -28.96 28.6 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.635 0.774 . . . . 64.13 112.252 -177.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.93 -46.77 70.57 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.414 -0.958 . . . . 41.43 108.414 172.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.476 ' HG2' ' OH ' ' C' ' 109' ' ' TYR . 32.0 ttm180 -58.25 -43.17 87.71 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 114.04 -1.436 . . . . 75.14 109.739 175.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.426 ' HB3' ' O ' ' A' ' 109' ' ' TYR . 11.6 tt0 -48.83 -57.94 5.6 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 125.055 1.342 . . . . 73.2 111.462 175.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 117' ' ' MET . 53.6 t -64.92 -45.19 86.91 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.428 -1.26 . . . . 65.52 111.693 -174.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.632 HD13 HD11 ' A' ' 128' ' ' LEU . 8.5 mt -58.6 -60.27 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.818 0.847 . . . . 63.53 110.554 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.9 m -50.1 -41.87 49.16 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 125.058 1.343 . . . . 65.51 112.513 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -67.97 -43.03 79.91 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.714 -1.13 . . . . 75.31 110.635 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.513 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 52.6 mtm -62.28 -39.32 92.55 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 122.807 0.443 . . . . 65.43 110.875 177.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 114' ' ' ILE . 94.9 t -57.58 -49.56 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 124.341 1.056 . . . . 75.13 110.232 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 81.6 p -71.61 -29.36 64.58 Favored 'General case' 0 CA--C 1.554 1.101 0 CA-C-N 115.89 -0.595 . . . . 64.51 111.61 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -72.33 -29.19 63.59 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.673 0.789 . . . . 74.12 110.17 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.76 18.3 31.16 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-O 119.459 -0.634 . . . . 72.54 112.762 173.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.47 HG21 ' HE ' ' B' ' 15' ' ' ARG . 5.6 t 58.03 13.08 2.04 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 127.445 2.298 . . . . 61.31 114.014 178.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -78.98 150.25 74.72 Favored Pre-proline 0 C--O 1.245 0.85 0 N-CA-C 108.156 -1.053 . . . . 63.23 108.156 171.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.685 ' HB3' ' HA ' ' E' ' 131' ' ' TRP . 24.4 Cg_endo -58.61 144.25 97.64 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.278 1.985 . . . . 55.25 110.852 174.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -55.07 129.34 37.64 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 124.562 1.164 . . . . 72.42 111.698 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.9 tp -107.37 138.1 44.2 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 108.416 -0.957 . . . . 71.43 108.416 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -122.74 125.85 46.35 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.1 -1.074 . . . . 73.35 108.1 175.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.632 HD11 HD13 ' A' ' 114' ' ' ILE . 10.2 mt -73.1 126.54 30.24 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.492 -0.929 . . . . 74.14 108.492 177.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.551 ' HB2' ' HB ' ' E' ' 135' ' ' VAL . . . -57.71 134.99 82.79 Favored Pre-proline 0 CA--C 1.554 1.108 0 CA-C-O 118.974 -0.536 . . . . 50.14 110.883 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.59 116.56 2.8 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.653 2.902 . . . . 73.21 113.843 -175.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.521 HG21 HD11 ' A' ' 44' ' ' LEU . 61.4 t -105.87 131.94 54.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-O 121.058 0.456 . . . . 71.23 110.456 177.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.453 ' OD1' ' HB3' ' A' ' 134' ' ' ASP . 52.0 t-20 -99.66 91.79 5.04 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.581 -1.191 . . . . 53.25 107.82 175.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.402 ' CZ ' HD13 ' A' ' 44' ' ' LEU . 92.2 m-85 -63.16 -25.83 68.53 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.715 0.806 . . . . 72.44 112.637 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.571 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 28.9 t70 -59.37 -49.56 77.34 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.286 -0.635 . . . . 74.25 109.286 171.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.09 -41.37 96.54 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.326 1.017 . . . . 73.23 111.286 177.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 72.6 mt -60.7 -43.4 97.83 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.084 0.554 . . . . 72.1 111.14 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -71.23 -33.52 69.95 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.863 -0.608 . . . . 73.22 110.153 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.515 ' HB3' ' HB3' ' A' ' 143' ' ' GLN . 0.3 OUTLIER -60.1 -42.68 95.19 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.229 0.612 . . . . 63.41 110.335 177.343 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -59.83 -39.06 83.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 123.581 0.551 . . . . 72.13 111.044 177.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -72.94 -38.65 66.73 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.671 -0.695 . . . . 74.41 110.886 177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 37.3 tp -69.71 -52.96 20.92 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.696 0.798 . . . . 64.23 111.483 -168.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 172.5 -16.94 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 123.951 0.9 . . . . 65.33 111.665 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.515 ' HB3' ' HB3' ' A' ' 138' ' ' MET . 7.5 tp60 -82.8 128.12 34.1 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.178 0.591 . . . . 75.33 111.804 -171.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -106.14 99.15 8.75 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.499 -1.297 . . . . 55.44 107.499 174.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -145.49 128.9 16.9 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.279 0.632 . . . . 50.43 109.994 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.41 159.16 44.43 Favored Glycine 0 C--N 1.343 0.928 0 O-C-N 123.672 0.608 . . . . 51.3 112.843 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -77.88 148.23 34.7 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.627 0.771 . . . . 75.22 111.429 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -79.34 77.49 1.84 Allowed Glycine 0 C--N 1.348 1.206 0 N-CA-C 111.298 -0.721 . . . . 41.34 111.298 176.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.7 t -116.44 134.48 54.81 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.394 0.677 . . . . 61.12 109.328 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -161.66 160.61 28.9 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.217 -0.66 . . . . 71.23 109.217 -173.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.47 173.91 10.93 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 124.012 0.925 . . . . 74.43 111.223 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.58 ' HB3' HG21 ' C' ' 10' ' ' THR . 7.2 p80 -159.88 -45.57 0.05 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.847 0.859 . . . . 62.24 111.568 -176.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 61.3 -169.26 0.17 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.325 0.65 . . . . 63.5 110.077 -164.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -99.12 -160.74 0.82 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.087 0.555 . . . . 60.25 109.521 173.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.331 0 C-N-CA 122.828 0.451 . . . . 70.14 110.457 -179.401 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' F' ' 95' ' ' LYS . 52.5 ttm . . . . . 0 CA--C 1.545 0.781 0 N-CA-C 111.929 0.344 . . . . 72.4 111.929 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m -141.88 36.29 1.59 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.991 0.516 . . . . 72.21 111.388 -170.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -81.56 157.51 24.74 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.398 0.679 . . . . 52.14 111.049 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -146.59 29.4 1.03 Allowed 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.53 0.732 . . . . 75.15 109.535 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -161.36 169.28 22.32 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.019 -0.734 . . . . 70.34 109.019 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -68.72 87.17 0.34 Allowed 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.15 -0.685 . . . . 73.22 109.15 170.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 73.0 p -93.91 -154.54 0.41 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.053 0.941 . . . . 60.04 109.866 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -51.19 -31.77 21.31 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.465 1.106 . . . . 74.15 112.01 170.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.49 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 1.0 OUTLIER 65.45 168.51 0.2 Allowed 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 125.259 1.423 . . . . 72.53 110.97 177.376 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.467 ' N ' ' SD ' ' B' ' 9' ' ' MET . 79.3 m -149.45 108.48 3.9 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 123.987 0.915 . . . . 65.13 108.71 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.477 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 65.9 t80 -116.55 145.63 43.21 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.433 0.693 . . . . 53.35 109.363 177.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -158.91 141.7 14.36 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.194 -1.039 . . . . 72.4 108.194 170.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.461 HD13 HD11 ' B' ' 16' ' ' ILE . 31.6 mt -76.86 145.67 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 N-CA-C 108.267 -1.012 . . . . 64.45 108.267 170.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -109.25 -40.51 4.92 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.901 0.481 . . . . 70.52 110.183 174.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.47 ' HE ' HG21 ' A' ' 122' ' ' THR . 48.0 ttt180 -173.68 137.13 0.6 Allowed 'General case' 0 N--CA 1.476 0.871 0 O-C-N 123.73 0.644 . . . . 74.42 109.881 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.461 HD11 HD13 ' B' ' 13' ' ' ILE . 93.4 mt -114.92 138.55 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.848 1.259 . . . . 64.33 107.678 176.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -164.43 140.68 6.16 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.919 0.711 . . . . 70.4 112.919 -173.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 69.9 m -73.7 121.48 20.83 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 115.057 -0.974 . . . . 74.44 109.121 170.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.523 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 46.9 mtpt -98.77 -16.96 18.74 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.636 0.774 . . . . 65.02 111.764 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.572 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 34.5 t70 -169.81 144.66 2.86 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.724 0.64 . . . . 63.33 111.186 -172.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.525 HD11 ' SG ' ' B' ' 113' ' ' CYS . 30.6 mm -143.53 146.36 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.677 1.191 . . . . 75.4 110.173 -177.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.501 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 72.4 m -144.02 139.28 28.92 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.528 1.531 . . . . 63.41 108.558 171.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.56 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 89.4 t80 -148.36 108.73 4.13 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 106.297 -1.742 . . . . 72.41 106.297 164.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -118.8 114.64 22.96 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.079 -1.082 . . . . 64.21 108.079 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.465 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -106.68 86.9 2.47 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.164 -1.421 . . . . 64.03 107.164 173.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.9 -35.52 20.65 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.883 2.389 . . . . 54.22 112.171 -171.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -103.1 16.38 26.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.977 0.911 . . . . 75.54 110.962 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.465 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -43.77 -58.52 4.49 Favored Pre-proline 0 N--CA 1.491 1.591 0 C-N-CA 124.985 1.314 . . . . 70.1 114.479 -168.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 33.9 Cg_exo -57.99 -45.42 32.35 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 122.367 2.044 . . . . 72.31 113.328 -171.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -96.55 -17.24 20.6 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.172 -0.922 . . . . 73.43 112.802 -170.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.584 HG21 ' HA ' ' B' ' 73' ' ' ALA . 5.2 p -73.07 -20.32 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-N 118.169 0.44 . . . . 73.41 110.345 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -72.61 -1.06 14.67 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.493 0.923 . . . . 74.21 113.493 -177.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -71.56 -16.88 62.33 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 120.911 0.386 . . . . 74.42 110.097 167.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -105.9 69.38 0.81 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.525 1.53 . . . . 74.41 110.0 -176.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -84.85 76.59 10.22 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.773 0.797 . . . . 72.04 110.492 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.444 ' O ' ' HG2' ' B' ' 124' ' ' PRO . 3.8 p90 -152.92 173.15 15.73 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 108.037 -1.097 . . . . 72.32 108.037 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -66.52 115.33 23.1 Favored Pre-proline 0 CA--C 1.563 1.445 0 N-CA-C 112.353 0.501 . . . . 72.12 112.353 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.413 ' HD3' ' HG2' ' B' ' 124' ' ' PRO . 60.2 Cg_endo -71.85 157.06 55.86 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.512 2.141 . . . . 64.12 111.593 176.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -74.68 103.96 5.16 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.252 -1.018 . . . . 75.43 108.252 169.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.671 HG11 HD11 ' B' ' 126' ' ' LEU . 21.5 t -96.18 157.08 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.204 1.002 . . . . 74.03 110.031 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -142.97 124.65 14.95 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.625 1.17 . . . . 75.43 107.94 172.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.59 HD13 HD22 ' B' ' 128' ' ' LEU . 21.5 tp -87.56 136.85 32.78 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 108.32 -0.992 . . . . 74.23 108.32 170.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -137.04 149.89 47.73 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.711 -0.848 . . . . 64.11 108.711 -173.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mp -128.6 150.5 50.19 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.92 0.888 . . . . 71.43 109.578 -174.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 27.2 t70 -154.55 152.15 29.72 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.57 1.148 . . . . 63.41 108.673 173.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . 0.42 HG22 HD22 ' B' ' 60' ' ' LEU . 75.9 p -126.76 134.5 50.6 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 121.176 0.513 . . . . 73.12 111.474 -177.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.05 116.17 6.06 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.04 -1.467 . . . . 74.33 107.04 169.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.506 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 41.0 m -143.0 161.15 38.9 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.572 0.349 . . . . 61.34 110.741 -171.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.8 p -152.1 139.91 19.93 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.904 0.482 . . . . 33.13 111.288 -172.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -83.47 129.25 34.97 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.465 -0.939 . . . . 74.41 108.465 169.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 pp -141.84 25.05 1.99 Allowed 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.774 0.829 . . . . 74.33 109.823 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' B' ' 55' ' ' VAL . . . -161.43 148.01 14.44 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.154 -0.93 . . . . 62.14 109.789 -173.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -77.41 121.71 24.18 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.1 -0.704 . . . . 72.23 109.1 171.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 68.53 12.12 8.59 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 124.675 1.235 . . . . 50.12 113.03 174.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.407 ' O ' ' HB3' ' B' ' 52' ' ' ALA . 89.6 t -140.01 129.87 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 N-CA-C 107.068 -1.456 . . . . 74.34 107.068 -175.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.506 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 11.8 t80 -118.0 153.37 33.78 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 121.902 -0.499 . . . . 54.11 110.104 -175.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -116.3 105.77 12.92 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.63 -1.248 . . . . 61.22 107.63 176.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.43 143.41 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.859 0.864 . . . . 63.54 109.787 -176.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 22.7 t -129.83 127.06 63.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 C-N-CA 123.982 0.913 . . . . 63.53 108.756 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.42 HD22 HG22 ' B' ' 46' ' ' THR . 0.3 OUTLIER -110.53 120.41 42.32 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 107.628 -1.249 . . . . 54.05 107.628 172.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.428 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 16.7 ttm-85 -86.82 113.28 22.5 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.86 -0.793 . . . . 64.11 108.86 174.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.17 105.19 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.095 0.958 . . . . 73.21 108.652 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 23.9 m -107.08 148.01 29.29 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.209 1.004 . . . . 51.32 109.991 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.551 HG11 HD21 ' B' ' 126' ' ' LEU . 24.4 t -136.47 117.78 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.107 1.363 . . . . 74.24 108.797 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 85.8 m -104.96 136.53 44.27 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 108.119 -1.067 . . . . 63.14 108.119 169.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.2 144.65 36.69 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.801 -0.814 . . . . 64.42 108.801 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.489 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 61.2 p -144.54 133.35 22.44 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.745 0.646 . . . . 22.11 112.745 -173.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 53.0 mt -107.61 128.44 54.54 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.672 1.189 . . . . 61.32 110.506 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.76 -110.57 3.41 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 111.751 -0.539 . . . . 51.54 111.751 -173.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -116.9 1.73 12.7 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 123.536 0.734 . . . . 73.25 110.432 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -115.03 158.37 22.19 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.749 -0.595 . . . . 75.11 110.218 -174.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.8 m -68.77 130.87 44.07 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 110.062 -0.348 . . . . 65.02 110.062 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.584 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -81.0 -64.82 1.11 Allowed 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.634 -1.247 . . . . 73.11 107.634 173.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -151.29 164.77 35.88 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.058 -0.974 . . . . 64.24 111.492 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 74.5 mt -127.01 131.61 50.95 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 105.992 -1.855 . . . . 70.1 105.992 170.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 34.2 t -131.51 149.79 52.39 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.036 -1.098 . . . . 64.14 108.036 172.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.501 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 49.7 tt0 -158.41 131.89 7.56 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.072 -0.714 . . . . 70.02 109.072 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.411 HG11 ' HA ' ' B' ' 110' ' ' ALA . 87.4 t -129.44 148.38 33.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.443 -0.947 . . . . 74.15 108.443 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.572 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 27.2 mt-30 -124.91 93.56 3.93 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.958 -1.127 . . . . 73.11 107.958 171.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.412 ' HG3' HD22 ' B' ' 106' ' ' LEU . 8.7 tp-100 -89.76 108.93 19.98 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.229 -0.896 . . . . 64.33 108.878 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.523 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -104.4 171.78 19.77 Favored Glycine 0 C--N 1.337 0.62 0 O-C-N 123.791 0.682 . . . . 63.42 111.867 177.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.46 137.48 4.26 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.468 -0.396 . . . . 74.42 112.47 -177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 51.4 mt -88.79 121.26 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 107.42 -1.326 . . . . 73.43 107.42 170.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -131.54 145.14 51.59 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.27 1.028 . . . . 61.04 108.974 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 56.4 m -89.53 121.88 32.16 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.548 0.739 . . . . 72.32 110.058 170.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.691 HG22 HD11 ' B' ' 89' ' ' ILE . 5.3 mp -125.29 108.79 20.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 107.472 -1.307 . . . . 74.02 107.472 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.574 ' HA ' ' HB ' ' F' ' 97' ' ' ILE . . . -144.86 166.12 26.17 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.609 0.763 . . . . 74.24 111.069 -177.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 94.37 -29.81 8.49 Favored Glycine 0 N--CA 1.482 1.739 0 CA-C-O 121.098 0.277 . . . . 45.2 113.419 176.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.691 HD11 HG22 ' B' ' 86' ' ' ILE . 0.7 OUTLIER -90.83 168.26 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 124.598 1.159 . . . . 71.11 110.999 176.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -157.16 163.47 38.85 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.649 0.78 . . . . 35.42 110.299 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.51 -113.4 4.33 Favored Glycine 0 C--N 1.356 1.641 0 C-N-CA 123.473 0.558 . . . . 63.41 112.521 171.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 31.4 m -104.22 -35.42 8.01 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.71 0.804 . . . . 55.5 109.604 174.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -66.3 -17.31 64.68 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.104 0.962 . . . . 74.21 111.98 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.478 ' HA ' HD13 ' B' ' 89' ' ' ILE . 21.5 ptm -61.21 -56.57 19.16 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 122.865 0.466 . . . . 74.13 111.514 173.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.403 ' HA ' ' HG ' ' B' ' 98' ' ' LEU . . . -81.0 -11.47 59.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.793 0.837 . . . . 63.14 111.939 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -64.75 -36.04 83.03 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.68 0.392 . . . . 64.2 110.778 169.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.1 t -66.76 -41.13 88.27 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.748 0.419 . . . . 74.45 111.516 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.603 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.6 pp -84.19 -29.82 26.29 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.892 0.477 . . . . 73.24 111.402 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.86 -24.65 31.88 Favored Glycine 0 C--N 1.345 1.081 0 O-C-N 123.535 0.522 . . . . 62.03 113.913 -172.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.4 -48.48 2.19 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.291 0.637 . . . . 72.33 111.513 -174.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -75.94 -47.07 26.62 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.689 0.396 . . . . 72.14 111.692 -173.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.603 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 73.6 m -64.03 -42.42 69.26 Favored Pre-proline 0 CA--C 1.566 1.559 0 N-CA-C 113.6 0.963 . . . . 70.51 113.6 -177.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.55 -21.22 53.01 Favored 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 121.878 1.719 . . . . 65.3 113.806 173.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -70.13 -30.55 67.75 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 122.539 0.335 . . . . 63.5 110.772 173.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.473 HG23 ' NH2' ' D' ' 111' ' ' ARG . 84.0 mt -67.34 -40.77 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.789 0.836 . . . . 75.44 109.689 170.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.412 HD22 ' HG3' ' B' ' 80' ' ' GLN . 96.8 mt -76.47 -27.36 56.1 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.831 -1.077 . . . . 63.23 112.51 -174.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -55.23 -47.47 98.47 Favored Pre-proline 0 CA--C 1.567 1.597 0 CA-C-O 118.042 -0.98 . . . . 72.13 113.494 -175.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -52.45 -41.3 68.23 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 122.838 2.359 . . . . 74.22 114.711 174.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -68.83 -36.62 78.41 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.057 0.543 . . . . 62.51 110.656 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.411 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -70.5 -36.08 73.59 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.765 0.826 . . . . 75.35 111.062 174.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.553 ' HA ' HD12 ' B' ' 128' ' ' LEU . 35.4 ttt-85 -63.3 -56.05 19.68 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.167 1.387 . . . . 70.45 110.661 -178.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.465 ' HG3' ' NH2' ' C' ' 120' ' ' ARG . 1.4 tm-20 -69.48 -22.53 63.61 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.762 -0.654 . . . . 75.42 109.832 -178.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.525 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.3 t -75.97 -28.37 57.85 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 122.64 0.376 . . . . 73.21 111.138 176.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.481 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 52.3 mt -74.97 -56.22 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.515 0.726 . . . . 74.14 109.234 173.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 52.6 m -58.56 -27.95 65.07 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.185 0.994 . . . . 70.22 111.556 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.485 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 29.8 t -58.59 -53.76 54.75 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.921 0.888 . . . . 52.3 110.365 173.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.4 mmt -71.6 -32.8 68.41 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.905 0.882 . . . . 74.0 111.074 -172.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.426 HG21 ' CD2' ' B' ' 126' ' ' LEU . 98.7 t -64.67 -42.87 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.658 1.183 . . . . 65.13 110.459 173.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 44.7 t -65.93 -39.09 90.21 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.033 -0.985 . . . . 70.11 110.408 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' B' ' 116' ' ' SER . 66.4 mtt-85 -64.91 -45.44 85.89 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.518 -0.765 . . . . 74.44 109.214 174.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.506 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -64.22 -11.16 44.98 Favored Glycine 0 C--N 1.361 1.917 0 O-C-N 124.58 1.175 . . . . 74.45 113.494 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 15.8 m 66.01 29.16 10.25 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.792 1.237 . . . . 52.31 110.329 174.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -83.33 162.63 53.29 Favored Pre-proline 0 CA--C 1.552 1.036 0 CA-C-N 114.841 -1.072 . . . . 74.12 110.652 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.444 ' HG2' ' O ' ' B' ' 36' ' ' TRP . 92.0 Cg_exo -48.36 159.61 0.73 Allowed 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.786 2.991 . . . . 70.02 114.787 173.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.423 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 22.8 tp60 -60.55 113.19 2.3 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.36 -0.837 . . . . 73.11 111.484 -173.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.671 HD11 HG11 ' B' ' 40' ' ' VAL . 15.9 tp -112.23 120.08 40.54 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.843 -0.799 . . . . 75.03 108.843 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -133.0 126.53 32.15 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 107.801 -1.185 . . . . 55.31 107.801 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.59 HD22 HD13 ' B' ' 42' ' ' LEU . 76.1 mt -83.27 134.2 34.95 Favored 'General case' 0 C--O 1.242 0.7 0 O-C-N 123.409 0.443 . . . . 72.23 110.96 -176.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.61 143.88 90.55 Favored Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 124.58 1.175 . . . . 24.23 110.144 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -65.79 92.74 0.26 Allowed 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.68 2.253 . . . . 72.24 111.429 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.554 HG13 ' HE2' ' F' ' 120' ' ' TYR . 98.6 t -90.66 109.49 20.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.682 -1.229 . . . . 73.44 107.682 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -85.83 115.88 23.74 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 107.539 -1.282 . . . . 74.53 107.539 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -53.48 -42.83 67.66 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 124.355 1.034 . . . . 74.24 111.137 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -63.16 -42.5 99.43 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.0 0.813 . . . . 70.14 110.813 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.27 -22.78 67.07 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 112.772 0.656 . . . . 73.45 112.772 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.564 ' HG ' ' HB3' ' F' ' 120' ' ' TYR . 7.7 tt -77.32 -54.74 6.09 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.112 -0.699 . . . . 72.21 109.112 175.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -71.09 -12.64 61.62 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 114.932 -1.031 . . . . 72.51 112.18 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -65.06 -35.56 81.56 Favored 'General case' 0 C--O 1.216 -0.665 0 C-N-CA 124.015 0.926 . . . . 73.25 109.604 175.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -75.32 -31.25 60.57 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.942 0.497 . . . . 63.01 110.71 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -74.41 -48.98 24.43 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.09 0.471 . . . . 72.23 110.696 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 18.0 tp -103.79 34.57 2.95 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.126 0.97 . . . . 72.54 108.991 -173.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -68.36 152.63 45.15 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.909 -1.042 . . . . 74.12 112.332 -173.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -120.51 -5.27 9.8 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.907 0.883 . . . . 70.01 109.74 174.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 76.6 139.36 0.07 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.734 1.614 . . . . 72.52 111.82 177.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -137.42 170.04 16.76 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.542 1.137 . . . . 74.3 109.632 173.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.67 86.99 0.06 OUTLIER Glycine 0 C--N 1.341 0.85 0 N-CA-C 111.441 -0.664 . . . . 72.52 111.441 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -89.9 141.22 28.85 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.331 0.652 . . . . 63.34 109.802 175.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . 0.517 ' HA2' ' HB ' ' D' ' 7' ' ' THR . . . -77.01 66.58 2.82 Favored Glycine 0 C--N 1.351 1.395 0 O-C-N 123.937 0.773 . . . . 71.12 112.68 178.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 36.9 p -112.39 74.13 0.85 Allowed 'General case' 0 C--O 1.244 0.783 0 C-N-CA 124.628 1.171 . . . . 74.53 109.526 -176.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 71.3 tt0 -154.46 111.32 3.33 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.306 -0.861 . . . . 72.14 110.321 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -161.83 163.6 29.26 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.635 0.774 . . . . 74.23 110.6 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 25.7 m170 -86.19 87.58 7.45 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.911 0.885 . . . . 71.31 109.509 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -124.86 27.72 6.69 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.911 0.885 . . . . 74.42 109.741 174.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -59.06 -27.49 65.56 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.636 1.174 . . . . 65.24 112.178 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.283 0 C-N-CA 124.987 1.315 . . . . 64.31 112.0 172.551 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . 0.497 ' N ' ' SD ' ' C' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.547 -0.538 . . . . 75.31 109.547 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 19.4 t 56.82 54.67 6.93 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.63 1.172 . . . . 51.34 111.755 169.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.98 118.23 7.52 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 109.313 -0.625 . . . . 73.4 109.313 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -77.69 -11.75 59.9 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.345 -0.388 . . . . 61.11 111.416 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 10.1 t30 61.38 28.27 17.72 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.478 1.111 . . . . 53.34 111.287 170.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -154.11 156.46 37.29 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.297 -0.865 . . . . 61.3 108.668 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 18.1 m -160.9 87.7 0.74 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.31 -0.996 . . . . 71.4 108.31 170.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -80.92 59.7 3.86 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.982 0.513 . . . . 75.24 109.9 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.46 ' CE ' HD13 ' C' ' 89' ' ' ILE . 20.6 ttt 58.39 111.02 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.334 1.453 . . . . 74.13 111.383 -173.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.58 HG21 ' HB3' ' A' ' 152' ' ' HIS . 76.6 m -102.14 85.16 2.61 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.175 -0.676 . . . . 72.12 109.175 177.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -97.95 140.12 32.78 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.189 -0.914 . . . . 73.24 108.594 174.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -159.22 123.9 4.04 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 108.898 -0.779 . . . . 63.52 108.898 175.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 62.2 mt -68.56 127.16 29.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 N-CA-C 108.741 -0.837 . . . . 74.12 108.741 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -89.38 -48.35 7.4 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 109.308 -0.627 . . . . 72.42 109.308 174.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.88 148.98 0.43 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.219 1.408 . . . . 71.2 108.731 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 2.7 pp -116.59 155.2 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 106.978 -1.49 . . . . 73.33 106.978 173.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.441 ' HB3' HG23 ' D' ' 122' ' ' THR . 29.5 p90 -175.28 151.36 1.25 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.68 0.752 . . . . 74.42 111.3 -174.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 64.7 p -78.79 102.62 8.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.818 -1.083 . . . . 73.45 108.84 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 8.8 mtmt -72.8 -30.4 64.04 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.061 -0.718 . . . . 72.23 109.061 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.762 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 20.8 t70 -143.91 138.8 28.81 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.104 -0.953 . . . . 63.11 109.732 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.52 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.6 mt -137.43 143.66 33.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 106.818 -1.549 . . . . 71.32 106.818 174.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 26.1 t -155.04 141.04 18.33 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 123.76 0.663 . . . . 71.04 110.084 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -145.32 113.0 6.32 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 106.974 -1.491 . . . . 74.03 106.974 171.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -117.71 122.92 44.77 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.167 0.587 . . . . 72.55 109.99 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.35 75.79 73.56 Favored Pre-proline 0 CA--C 1.552 1.026 0 N-CA-C 107.388 -1.338 . . . . 73.23 107.388 171.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -69.82 -22.75 31.36 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 122.77 2.314 . . . . 65.0 111.511 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -101.36 12.45 37.38 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.541 1.136 . . . . 73.43 110.191 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.446 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -49.1 -58.14 9.55 Favored Pre-proline 0 C--N 1.375 1.715 0 C-N-CA 124.388 1.075 . . . . 50.32 113.554 -169.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.446 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 18.4 Cg_exo -64.29 -35.95 48.45 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 121.704 1.603 . . . . 60.31 112.132 -176.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -69.82 -37.75 76.32 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.293 1.037 . . . . 74.35 112.297 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.614 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.1 p -81.29 -21.71 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 C-N-CA 122.819 0.448 . . . . 72.32 111.889 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -65.48 -26.84 68.11 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 120.681 0.277 . . . . 72.34 111.263 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -100.41 34.58 2.35 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.652 0.781 . . . . 73.45 110.279 174.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -125.05 163.08 23.15 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.523 0.729 . . . . 71.35 110.23 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -66.58 112.99 4.42 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.532 0.733 . . . . 70.3 110.656 173.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 69.5 t-105 -76.8 81.97 3.39 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.363 0.665 . . . . 72.33 110.529 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . 0.451 ' H ' HD22 ' C' ' 68' ' ' LEU . 96.8 mt-30 -136.17 73.72 57.31 Favored Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 124.522 1.129 . . . . 62.13 108.465 174.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.31 155.48 25.25 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.702 2.268 . . . . 53.23 113.837 -171.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . 0.409 ' HB2' HD21 ' F' ' 142' ' ' LEU . 9.9 tp10 -87.4 87.71 7.49 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 105.146 -2.168 . . . . 71.41 105.146 161.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.619 ' HB ' ' HA ' ' F' ' 135' ' ' VAL . 68.7 t -76.66 98.34 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.578 0 N-CA-C 107.527 -1.286 . . . . 73.14 107.527 177.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -114.59 103.8 11.37 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.953 -1.021 . . . . 71.34 108.329 -175.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.27 160.63 18.36 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.214 0.531 . . . . 62.24 110.287 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.611 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 18.1 t70 -145.69 121.15 10.34 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.614 1.166 . . . . 73.53 108.287 -177.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.522 HD21 HG13 ' C' ' 62' ' ' VAL . 81.8 mt -125.44 111.95 15.7 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.526 0.73 . . . . 72.45 109.99 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -136.52 127.06 26.9 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 108.439 -0.949 . . . . 70.13 108.439 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 12.4 t -115.05 146.27 41.45 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.272 0.629 . . . . 74.41 109.47 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.36 163.96 27.53 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.067 0.947 . . . . 55.34 109.304 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.465 ' OG ' ' HB3' ' C' ' 98' ' ' LEU . 3.2 m -142.89 143.71 32.16 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.805 -0.442 . . . . 73.3 109.805 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.9 t -145.2 127.81 16.12 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.0 0.92 . . . . 42.21 108.548 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -79.55 117.4 20.45 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 109.077 -0.712 . . . . 73.04 109.077 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.632 HD11 ' HB2' ' C' ' 57' ' ' GLU . 61.0 mt -86.39 -35.08 19.98 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.266 0.626 . . . . 74.23 111.027 -176.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.19 179.64 8.96 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.961 -1.018 . . . . 22.41 109.088 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -66.5 116.46 7.5 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.148 -0.686 . . . . 75.24 109.148 -178.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 68.33 18.9 9.08 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.447 1.099 . . . . 74.24 112.068 -177.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 90.5 t -123.81 115.23 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 108.639 -0.874 . . . . 73.31 108.639 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -121.71 128.96 52.38 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.337 1.055 . . . . 71.52 109.577 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.632 ' HB2' HD11 ' C' ' 51' ' ' LEU . 44.2 tt0 -93.16 138.62 31.41 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.088 -0.708 . . . . 71.22 109.088 167.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 83.5 t -122.83 139.68 48.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.911 -1.144 . . . . 74.31 107.911 171.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 54.3 t -127.85 130.26 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 109.516 -0.55 . . . . 71.54 109.516 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.79 111.2 23.61 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.702 -1.221 . . . . 60.54 107.702 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -83.1 111.85 19.28 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 108.556 -0.905 . . . . 75.23 108.556 170.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.522 HG13 HD21 ' C' ' 44' ' ' LEU . 21.9 t -114.38 115.5 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 108.02 -1.104 . . . . 61.43 108.02 175.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.611 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 10.9 m -125.39 125.54 43.58 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.598 0.759 . . . . 64.23 108.956 -171.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.638 HG23 HD13 ' C' ' 114' ' ' ILE . 84.2 t -112.92 125.16 70.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 123.964 0.906 . . . . 72.52 108.89 177.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 12.5 m -104.12 138.81 40.08 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.77 -0.826 . . . . 53.44 108.77 170.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.97 101.56 5.48 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.636 -1.616 . . . . 64.42 106.636 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 41.1 m -134.02 126.46 30.26 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.537 -0.542 . . . . 74.43 109.537 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.451 HD22 ' H ' ' C' ' 37' ' ' GLN . 9.7 mt -84.47 52.85 2.47 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 124.618 1.167 . . . . 64.3 109.213 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.1 -99.83 1.93 Allowed Glycine 0 C--N 1.349 1.259 0 N-CA-C 110.515 -1.034 . . . . 70.4 110.515 -172.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . 0.52 ' HG2' HG21 ' F' ' 144' ' ' VAL . 13.9 pt-20 -101.11 -30.44 11.58 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.943 0.897 . . . . 64.44 110.439 175.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -70.33 109.98 5.02 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.424 1.089 . . . . 62.35 109.451 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 38.9 m -83.41 124.46 30.7 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.897 0.772 . . . . 73.34 110.025 177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.614 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -76.6 -57.93 3.57 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 114.398 -1.274 . . . . 72.43 109.618 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -154.65 166.26 33.96 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.025 -0.989 . . . . 73.33 110.706 174.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.432 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.4 tm? -129.23 142.56 50.82 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 105.894 -1.891 . . . . 71.05 105.894 166.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.432 ' N ' HD13 ' C' ' 75' ' ' LEU . 49.1 t -143.59 143.31 31.44 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.075 -1.083 . . . . 43.42 108.075 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -157.18 132.11 8.85 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 122.796 0.439 . . . . 74.21 109.973 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.434 HG11 ' HA ' ' C' ' 110' ' ' ALA . 55.2 t -133.85 115.41 21.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 124.748 1.219 . . . . 73.23 108.804 -176.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.762 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.2 mt-30 -96.19 90.56 5.54 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.677 0.791 . . . . 74.3 109.116 173.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.484 ' HG3' HD22 ' C' ' 106' ' ' LEU . 7.1 tp-100 -80.67 99.74 8.33 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.698 -1.137 . . . . 65.31 109.515 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.56 153.78 27.74 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.862 -0.495 . . . . 62.13 111.862 174.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.5 126.44 2.08 Favored Glycine 0 CA--C 1.501 -0.785 0 N-CA-C 110.966 -0.854 . . . . 74.24 110.966 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.482 HD12 HD11 ' C' ' 51' ' ' LEU . 13.3 mm -88.96 128.71 40.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 N-CA-C 108.891 -0.781 . . . . 73.44 108.891 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -135.87 118.39 15.88 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.379 0.671 . . . . 73.24 109.369 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.5 p -79.6 101.32 8.24 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.262 -1.014 . . . . 32.2 108.262 172.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.651 HG21 ' HE1' ' C' ' 94' ' ' MET . 21.3 mt -117.53 129.94 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.582 0.753 . . . . 73.1 110.52 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.427 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -139.28 164.62 29.33 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.297 0.639 . . . . 73.55 110.671 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.39 -19.24 44.86 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 114.896 0.718 . . . . 72.32 114.896 170.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' C' ' 94' ' ' MET . 47.4 pt -108.53 167.97 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 117.593 0.697 . . . . 74.24 111.457 -176.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -159.35 177.9 10.51 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.364 -1.289 . . . . 74.5 109.263 175.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.63 -120.53 12.07 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 115.815 1.086 . . . . 62.21 115.815 173.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 46.4 p -64.91 -36.87 85.77 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.408 1.083 . . . . 71.32 111.173 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -62.23 -58.31 8.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.496 1.118 . . . . 74.31 110.538 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.651 ' HE1' HG21 ' C' ' 86' ' ' ILE . 4.6 tpt -54.15 -52.51 60.88 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 124.066 0.946 . . . . 73.54 112.243 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.96 -40.9 77.33 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 123.87 0.731 . . . . 74.32 111.235 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -68.7 -37.31 79.42 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.2 0.6 . . . . 65.35 111.222 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.477 ' SG ' HD13 ' C' ' 86' ' ' ILE . 35.4 t -67.6 -34.56 77.25 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.659 -0.497 . . . . 70.23 109.659 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.465 ' HB3' ' OG ' ' C' ' 48' ' ' SER . 79.9 mt -88.16 -33.03 18.33 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.527 1.131 . . . . 74.2 112.173 -176.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.5 10.91 26.02 Favored Glycine 0 N--CA 1.474 1.19 0 N-CA-C 114.63 0.612 . . . . 73.02 114.63 -167.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.11 -48.66 0.07 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 117.401 0.6 . . . . 55.51 111.613 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -72.74 -55.03 7.37 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.302 0.641 . . . . 74.34 111.306 -176.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 94.4 m -63.74 -44.99 81.7 Favored Pre-proline 0 CA--C 1.562 1.419 0 CA-C-O 118.213 -0.898 . . . . 63.25 112.031 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -53.02 -31.55 54.07 Favored 'Trans proline' 0 C--N 1.394 2.962 0 C-N-CA 122.88 2.387 . . . . 72.32 114.204 170.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -67.52 -35.54 79.29 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.537 0.735 . . . . 75.13 110.373 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.468 HD12 ' NH1' ' A' ' 111' ' ' ARG . 46.0 mm -77.06 -33.26 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.375 0.67 . . . . 75.24 110.449 177.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.484 HD22 ' HG3' ' C' ' 80' ' ' GLN . 94.3 mt -82.23 -30.02 31.01 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.865 0.866 . . . . 72.44 112.034 -175.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -57.18 -49.45 93.86 Favored Pre-proline 0 N--CA 1.484 1.23 0 CA-C-O 117.891 -1.052 . . . . 73.34 113.457 -173.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.61 -40.91 81.86 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 122.561 2.174 . . . . 71.1 114.31 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.476 ' OH ' ' HG2' ' A' ' 111' ' ' ARG . 89.6 m-85 -74.98 -37.56 61.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.155 0.582 . . . . 72.35 111.425 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.434 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -68.34 -34.89 76.92 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.353 -0.84 . . . . 54.03 110.498 176.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 24.2 ttt-85 -66.12 -51.24 59.8 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.604 1.561 . . . . 74.32 109.757 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -60.0 -39.53 86.1 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 124.093 0.871 . . . . 74.34 110.154 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 35.1 t -66.41 -39.86 89.23 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.461 -0.79 . . . . 74.32 110.933 -177.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.638 HD13 HG23 ' C' ' 64' ' ' VAL . 84.2 mt -69.19 -56.16 12.84 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 O-C-N 123.376 0.423 . . . . 71.05 110.565 177.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.1 m -63.21 -27.73 69.55 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 122.928 0.491 . . . . 74.1 111.066 -173.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 38.4 t -65.68 -49.34 68.91 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.383 0.673 . . . . 71.42 109.486 169.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.509 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.63 -36.63 79.1 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 124.607 1.163 . . . . 72.4 112.719 179.319 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.435 HG23 ' O ' ' C' ' 114' ' ' ILE . 76.6 t -64.23 -46.41 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.636 0.774 . . . . 65.23 108.962 175.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 39.5 t -67.3 -31.18 71.31 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.004 -0.998 . . . . 61.45 111.47 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.465 ' NH2' ' HG3' ' B' ' 112' ' ' GLU . 72.7 mtt-85 -71.17 -37.24 72.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.891 0.876 . . . . 75.54 109.566 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.46 4.3 84.45 Favored Glycine 0 C--N 1.353 1.474 0 O-C-N 123.848 0.717 . . . . 62.14 112.496 172.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 71.9 p 59.02 29.31 18.83 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.385 1.874 . . . . 75.24 113.696 172.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -85.38 143.2 38.64 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 107.018 -1.475 . . . . 73.2 107.018 166.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -48.69 143.3 16.82 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 123.088 2.525 . . . . 73.12 112.979 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.423 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 20.7 mm-40 -46.9 142.67 3.31 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 124.565 1.165 . . . . 74.42 112.786 -174.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.505 HD11 HG11 ' C' ' 40' ' ' VAL . 23.6 tp -144.88 88.49 1.9 Allowed 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.188 -1.041 . . . . 74.43 108.188 -177.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -91.85 117.2 29.56 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.502 -1.226 . . . . 63.24 109.063 -174.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.402 HD21 HG21 ' C' ' 64' ' ' VAL . 4.1 mm? -70.91 124.53 24.55 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 123.893 0.745 . . . . 73.11 109.864 -178.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.13 145.17 85.65 Favored Pre-proline 0 CA--C 1.548 0.874 0 O-C-N 124.219 0.949 . . . . 74.11 111.333 -175.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.453 ' HG3' HG21 ' A' ' 13' ' ' ILE . 16.1 Cg_endo -55.86 108.77 0.35 Allowed 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 123.555 2.837 . . . . 73.22 112.081 173.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 14.0 p -98.67 152.48 4.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 109.203 -0.666 . . . . 70.52 109.203 174.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -82.97 99.17 9.64 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.163 0.985 . . . . 73.2 108.832 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -68.66 -20.44 64.45 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.091 0.556 . . . . 74.23 112.121 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.78 -32.5 67.71 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.295 0.638 . . . . 72.21 110.792 172.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.14 -31.65 64.41 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.329 0.652 . . . . 74.01 110.588 174.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 56.3 mt -78.8 -20.91 48.64 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.423 -0.808 . . . . 72.15 110.438 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . 0.605 ' HE2' HG12 ' E' ' 144' ' ' VAL . 69.0 t80 -82.25 -28.7 31.69 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.596 0.758 . . . . 73.5 110.582 172.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 38.0 ttm -58.87 -41.17 86.44 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.747 1.219 . . . . 74.11 112.337 -175.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -66.6 -32.68 74.17 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.162 0.585 . . . . 60.41 111.692 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -67.04 -159.99 0.02 OUTLIER 'General case' 0 CA--C 1.581 2.151 0 C-N-CA 124.013 0.925 . . . . 73.22 110.358 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 59.5 tp -169.95 145.87 3.01 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 120.874 -1.141 . . . . 72.12 108.88 -174.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -146.22 110.06 4.9 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.004 -1.11 . . . . 63.23 108.004 172.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -85.22 55.96 3.73 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.823 0.849 . . . . 65.34 111.276 -175.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -137.65 164.88 27.72 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.055 0.942 . . . . 74.41 109.141 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.16 169.82 15.4 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 124.166 0.986 . . . . 51.22 111.837 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -153.03 176.36 31.17 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 114.454 -1.248 . . . . 74.13 110.989 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 69.35 124.46 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.588 1.555 . . . . 74.43 111.296 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 174.08 29.82 0.03 OUTLIER Glycine 0 N--CA 1.467 0.722 0 CA-C-N 115.564 -0.744 . . . . 71.43 111.33 173.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 36.3 p -91.48 127.97 37.13 Favored 'General case' 0 C--N 1.348 0.505 0 C-N-CA 123.68 0.792 . . . . 63.53 111.049 -174.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -84.41 -146.07 0.09 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.439 1.095 . . . . 52.43 109.536 171.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -158.49 110.01 2.19 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 108.991 -0.744 . . . . 52.41 108.991 173.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -146.16 71.82 1.27 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 122.724 1.249 . . . . 70.04 108.02 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -62.86 116.89 5.67 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 112.97 -1.923 . . . . 53.22 109.804 172.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -104.71 -76.52 0.6 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.084 0.553 . . . . 63.02 110.405 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 N-CA-C 108.425 -0.954 . . . . 61.44 108.425 -175.406 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 53.8 ttm . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 110.236 -0.283 . . . . 74.22 110.236 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 26.4 m -110.9 105.58 14.43 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 122.159 -0.338 . . . . 64.22 111.038 -176.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.19 160.36 19.07 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.179 0.992 . . . . 75.52 109.21 173.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -121.58 78.7 1.47 Allowed 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.403 0.62 . . . . 75.45 109.649 -177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -64.42 -47.65 78.35 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.694 1.198 . . . . 72.12 109.683 173.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -174.83 118.84 0.2 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.396 1.078 . . . . 73.12 108.868 168.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.517 ' HB ' ' HA2' ' B' ' 148' ' ' GLY . 74.8 p -88.16 75.26 8.66 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 108.806 -0.813 . . . . 74.31 108.806 173.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -162.33 129.88 3.87 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.604 -1.18 . . . . 72.13 108.25 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 16.4 tpt -32.65 125.4 0.33 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.226 1.41 . . . . 75.12 112.975 168.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 28.9 p -108.48 118.52 36.98 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.537 0.735 . . . . 70.41 109.301 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -143.04 116.41 9.06 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.444 -1.317 . . . . 75.21 107.444 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -141.0 153.49 45.58 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.635 0.774 . . . . 63.21 109.415 172.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.523 HG21 HD11 ' D' ' 16' ' ' ILE . 73.8 mt -102.74 120.48 52.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.087 -1.079 . . . . 74.55 108.087 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -89.05 -42.57 11.66 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.17 0.588 . . . . 74.21 110.66 -175.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -163.37 142.36 8.27 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.285 0.366 . . . . 63.11 110.496 -172.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.523 HD11 HG21 ' D' ' 13' ' ' ILE . 2.7 mp -124.8 135.07 65.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 105.579 -2.008 . . . . 41.51 105.579 174.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.437 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 34.8 p90 -162.31 172.72 15.21 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 122.12 0.962 . . . . 72.35 112.079 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . 0.49 HG21 HD11 ' D' ' 21' ' ' ILE . 75.7 p -107.34 120.48 42.26 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.181 -1.372 . . . . 63.11 109.028 178.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.437 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 29.6 mtpt -92.02 -19.7 22.1 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.742 -0.663 . . . . 74.32 109.493 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.456 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 32.6 t70 -162.14 138.77 8.0 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.94 0.896 . . . . 73.33 109.743 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.509 HG21 ' HE2' ' C' ' 117' ' ' MET . 63.9 mt -141.81 139.64 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.809 1.244 . . . . 71.33 107.773 175.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.7 t -141.9 145.44 34.59 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.37 1.068 . . . . 75.12 108.608 170.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.52 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.0 t80 -144.95 117.66 8.67 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 106.143 -1.799 . . . . 74.13 106.143 167.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -125.55 118.91 26.76 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.159 0.584 . . . . 64.21 109.787 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.496 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -113.89 80.32 5.19 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 107.695 -1.224 . . . . 61.53 107.695 174.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.6 -19.07 16.97 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.681 2.254 . . . . 54.1 113.014 -169.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -113.49 1.42 15.02 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.599 0.76 . . . . 75.34 111.178 -177.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.496 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -27.44 -70.01 0.07 OUTLIER Pre-proline 0 CA--C 1.567 1.61 0 N-CA-C 117.481 2.4 . . . . 61.32 117.481 -167.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.56 -18.01 15.8 Favored 'Trans proline' 0 C--N 1.387 2.564 0 CA-C-N 124.19 2.532 . . . . 65.11 113.971 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.451 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 3.4 t-160 -78.31 -38.8 41.52 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.702 1.201 . . . . 72.11 109.699 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.428 HG21 ' HA ' ' D' ' 73' ' ' ALA . 5.1 p -83.83 -19.31 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-N 115.874 -0.603 . . . . 71.43 111.096 -175.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -64.07 -24.83 67.85 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 122.544 0.338 . . . . 75.23 111.159 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.451 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 62.1 mt-30 -65.97 -9.05 26.47 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.263 1.025 . . . . 74.42 111.711 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -100.52 99.33 9.91 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 125.225 1.41 . . . . 70.33 109.602 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -97.33 83.2 3.25 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.254 -0.885 . . . . 74.54 110.876 -171.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 45.3 p90 -158.82 176.97 11.68 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.822 0.849 . . . . 64.23 109.402 169.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -69.94 110.96 7.6 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.353 1.061 . . . . 73.14 109.829 174.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.454 ' HB3' ' HG ' ' D' ' 68' ' ' LEU . 38.9 Cg_endo -68.81 129.63 18.98 Favored 'Trans proline' 0 C--N 1.379 2.178 0 C-N-CA 122.014 1.809 . . . . 74.33 110.588 175.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -67.4 116.55 8.29 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 107.514 -1.291 . . . . 73.54 107.514 168.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.562 ' CG1' HG13 ' D' ' 64' ' ' VAL . 16.1 t -98.23 114.41 35.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 108.9 -0.778 . . . . 74.21 108.9 176.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -89.54 116.93 28.06 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.81 -0.811 . . . . 73.04 108.81 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.497 HD22 HD11 ' D' ' 128' ' ' LEU . 49.2 tp -97.27 144.43 27.07 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.065 0.459 . . . . 74.12 110.23 -176.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -135.17 139.5 44.62 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.681 -1.6 . . . . 74.34 106.681 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.443 HD11 HG11 ' D' ' 131' ' ' VAL . 45.4 mt -130.0 132.07 46.12 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.226 0.61 . . . . 63.53 110.666 -174.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -140.35 154.11 46.63 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.598 1.159 . . . . 71.44 108.317 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . 0.58 HG23 HD22 ' E' ' 111' ' ' LEU . 2.1 p -128.61 159.69 34.76 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.597 0.713 . . . . 75.55 110.778 176.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.544 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.75 177.8 9.46 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.218 -1.356 . . . . 61.1 108.528 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 61.9 p -174.29 -162.13 0.13 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.883 0.873 . . . . 64.22 108.977 -175.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 17.3 p -147.87 129.65 15.18 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.683 -1.229 . . . . 72.32 107.683 168.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -76.68 111.59 12.34 Favored 'General case' 0 C--N 1.345 0.405 0 C-N-CA 123.3 0.64 . . . . 75.35 110.423 -172.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 tt -161.34 91.89 0.87 Allowed 'General case' 0 C--O 1.242 0.668 0 N-CA-C 106.579 -1.637 . . . . 73.11 106.579 171.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -82.28 83.84 7.3 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.742 -1.117 . . . . 65.22 110.789 -174.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -159.09 41.67 0.23 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.818 0.818 . . . . 55.54 108.944 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 68.82 -4.69 1.14 Allowed 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 125.928 1.691 . . . . 74.51 113.951 175.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.06 106.06 20.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 107.166 -1.42 . . . . 60.22 107.166 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -129.6 147.81 51.44 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.385 -0.598 . . . . 73.31 109.385 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -111.98 148.85 32.9 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.065 -1.087 . . . . 63.42 108.065 161.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 71.2 t -123.27 140.78 45.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 124.811 1.244 . . . . 70.22 107.692 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 30.3 t -125.89 137.31 58.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.727 -1.212 . . . . 55.54 107.727 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.434 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -125.74 105.4 8.95 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.511 -1.292 . . . . 73.12 107.511 -176.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 41.4 ttm-85 -85.14 102.49 13.32 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.748 0.819 . . . . 74.42 109.214 174.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.491 HG13 HD11 ' D' ' 42' ' ' LEU . 57.9 t -100.86 116.4 44.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.603 -0.888 . . . . 74.14 108.603 173.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.8 m -119.0 122.96 43.38 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.944 0.878 . . . . 72.52 110.233 -171.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.562 HG13 ' CG1' ' D' ' 40' ' ' VAL . 51.9 t -108.39 130.64 60.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 C-N-CA 125.746 1.618 . . . . 61.22 109.635 -176.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 80.9 m -134.81 92.1 2.85 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.841 -1.17 . . . . 74.51 107.841 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -96.48 154.82 17.05 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.65 0.78 . . . . 44.32 109.123 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.481 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 25.2 p -149.58 135.02 18.37 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 123.648 0.592 . . . . 72.14 112.178 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.454 ' HG ' ' HB3' ' D' ' 38' ' ' PRO . 20.9 mt -105.46 102.43 11.9 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 124.81 1.244 . . . . 72.44 108.302 171.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.32 -125.4 10.6 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-N 115.572 -0.74 . . . . 72.41 113.438 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -84.97 4.96 31.22 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.554 1.142 . . . . 74.41 112.893 -174.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -146.32 165.75 28.35 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 120.9 0.381 . . . . 75.13 111.13 -172.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 55.7 m -64.03 135.26 56.27 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.529 -1.214 . . . . 65.34 111.435 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.481 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.46 -71.33 0.57 Allowed 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.236 -1.394 . . . . 63.32 107.236 170.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -145.11 151.95 39.29 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-O 121.179 0.514 . . . . 74.22 111.002 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 66.3 mt -117.08 152.54 34.47 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.095 1.358 . . . . 72.43 107.872 175.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.546 ' SG ' HG12 ' D' ' 114' ' ' ILE . 40.6 t -159.29 149.64 19.28 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 123.692 0.797 . . . . 63.13 108.883 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -154.91 121.71 5.45 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.48 -0.563 . . . . 75.41 109.48 170.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.58 115.82 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 123.64 0.776 . . . . 75.01 109.543 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.456 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.7 mt-30 -90.68 90.19 7.85 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.47 0.708 . . . . 74.0 109.415 170.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . 0.427 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.8 tp-100 -80.98 101.57 9.6 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 114.877 -1.056 . . . . 74.04 108.897 178.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.92 143.88 15.9 Favored Glycine 0 C--N 1.338 0.693 0 N-CA-C 111.397 -0.681 . . . . 60.21 111.397 178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.8 140.72 7.84 Favored Glycine 0 C--N 1.334 0.42 0 N-CA-C 111.758 -0.537 . . . . 74.32 111.758 -174.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 50.8 mt -90.48 120.57 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.724 -0.843 . . . . 60.51 108.724 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -121.01 126.48 50.02 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.099 0.96 . . . . 73.12 109.521 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 44.5 p -88.86 96.6 10.76 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.913 -0.773 . . . . 74.14 108.913 173.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.56 HD11 HD23 ' D' ' 98' ' ' LEU . 37.7 pt -119.83 129.16 75.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 115.465 -0.789 . . . . 53.25 109.615 -172.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.75 167.79 7.56 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.357 0.663 . . . . 75.23 110.926 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.25 12.3 61.74 Favored Glycine 0 N--CA 1.476 1.364 0 CA-C-N 116.629 -0.26 . . . . 72.43 112.993 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.511 HG12 ' SG ' ' D' ' 97' ' ' CYS . 1.0 OUTLIER -125.34 159.93 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.892 1.277 . . . . 63.33 109.074 176.171 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -149.4 156.38 41.95 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 122.989 0.516 . . . . 64.15 110.472 -168.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.37 -131.55 10.71 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 116.003 -0.544 . . . . 75.22 114.374 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 40.0 p -84.55 -41.0 16.9 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.183 0.993 . . . . 62.43 111.067 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -66.69 -19.05 65.68 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.279 -0.873 . . . . 73.54 111.408 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.45 ' HA ' HD13 ' D' ' 89' ' ' ILE . 59.4 ttp -54.33 -57.76 10.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.954 1.301 . . . . 70.4 111.392 174.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.21 -15.18 51.46 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.308 -0.86 . . . . 71.02 111.854 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -64.01 -22.93 67.14 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.938 0.495 . . . . 75.21 111.43 172.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . 0.511 ' SG ' HG12 ' D' ' 89' ' ' ILE . 81.8 m -59.89 -46.52 89.07 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.236 0.614 . . . . 74.04 111.187 175.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.56 HD23 HD11 ' D' ' 86' ' ' ILE . 3.1 pp -94.59 -20.71 19.37 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 112.352 0.501 . . . . 71.22 112.352 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.98 -29.38 23.29 Favored Glycine 0 C--N 1.346 1.134 0 O-C-N 123.353 0.408 . . . . 62.01 113.396 -173.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.36 -49.18 1.08 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.809 0.444 . . . . 75.4 111.289 -174.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -74.91 -41.94 58.74 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 112.697 0.629 . . . . 65.31 112.697 -172.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 71.7 m -66.26 -44.79 59.69 Favored Pre-proline 0 CA--C 1.558 1.262 0 CA-C-O 118.558 -0.734 . . . . 55.42 111.704 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.434 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 68.6 Cg_exo -56.59 -33.73 93.76 Favored 'Trans proline' 0 C--N 1.391 2.814 0 C-N-CA 122.021 1.814 . . . . 65.13 112.909 167.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -68.32 -29.57 68.35 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.523 0.729 . . . . 73.21 111.172 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.2 mm -74.93 -37.28 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.355 0.662 . . . . 61.44 109.945 172.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.427 HD13 ' O ' ' D' ' 80' ' ' GLN . 93.3 mt -79.95 -17.76 52.16 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.472 0.709 . . . . 72.14 112.443 -177.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -68.03 -44.08 38.16 Favored Pre-proline 0 N--CA 1.486 1.348 0 CA-C-O 118.472 -0.775 . . . . 75.04 112.725 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.47 -37.11 72.38 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.368 2.046 . . . . 73.22 113.687 170.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -81.02 -32.9 33.97 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.971 0.909 . . . . 73.1 112.428 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.96 -45.21 71.27 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.177 -0.675 . . . . 62.44 109.177 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.473 ' NH2' HG23 ' B' ' 105' ' ' ILE . 43.2 ttp180 -65.51 -39.13 91.48 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 114.371 -1.286 . . . . 71.35 110.139 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -52.59 -46.32 66.9 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 123.986 0.914 . . . . 64.11 110.523 175.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.2 t -67.71 -50.28 58.32 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.903 -1.044 . . . . 74.23 110.86 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.546 HG12 ' SG ' ' D' ' 76' ' ' CYS . 79.3 mt -59.58 -62.14 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 123.951 0.782 . . . . 73.44 110.883 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 17.3 m -50.48 -39.65 48.75 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.949 1.299 . . . . 65.53 111.954 -175.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 24.6 t -64.0 -48.08 77.79 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.046 -0.979 . . . . 62.51 109.977 177.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 68.6 mtm -69.35 -27.21 65.15 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.282 0.633 . . . . 72.24 112.093 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.467 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.6 t -66.33 -46.07 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.407 0.683 . . . . 75.42 109.196 175.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.5 p -73.19 -28.98 62.51 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.576 -0.738 . . . . 73.34 110.698 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' D' ' 116' ' ' SER . 87.9 mtt-85 -70.86 -28.58 64.68 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.816 0.846 . . . . 74.44 110.416 173.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . 0.421 ' HA2' ' HB2' ' C' ' 17' ' ' TYR . . . -89.11 8.08 80.67 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 123.824 0.703 . . . . 70.33 112.763 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.441 HG23 ' HB3' ' C' ' 17' ' ' TYR . 47.7 p 59.09 20.47 8.38 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 126.35 1.86 . . . . 64.13 113.507 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -87.04 154.44 55.01 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 123.614 0.766 . . . . 74.41 110.106 174.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -50.3 127.44 20.1 Favored 'Trans proline' 0 C--N 1.386 2.532 0 C-N-CA 123.576 2.851 . . . . 65.02 113.013 175.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' E' ' 127' ' ' SER . 56.5 tt0 -52.24 128.93 26.63 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 124.522 1.139 . . . . 74.42 111.596 -173.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 33.8 tp -107.13 97.23 7.02 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.726 -0.472 . . . . 65.34 109.726 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -98.45 89.87 4.58 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 107.272 -1.381 . . . . 75.4 107.272 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.497 HD11 HD22 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -67.98 122.29 17.9 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 108.872 -0.788 . . . . 72.41 108.872 -175.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.57 142.65 87.24 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 123.798 0.839 . . . . 53.13 111.05 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.07 121.68 10.34 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.889 2.393 . . . . 75.32 112.098 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . 0.443 HG11 HD11 ' D' ' 44' ' ' LEU . 8.3 p -107.39 133.4 52.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 123.623 0.769 . . . . 73.32 109.551 -173.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . 0.419 ' O ' HD13 ' D' ' 136' ' ' LEU . 82.3 m-20 -87.01 92.4 9.03 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.592 0.757 . . . . 62.21 108.96 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -53.62 -34.97 60.36 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.392 1.077 . . . . 74.45 112.81 -175.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -65.85 -37.78 87.1 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.219 0.607 . . . . 73.13 110.728 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.5 -31.45 72.66 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.547 0.739 . . . . 74.12 111.091 177.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.419 HD13 ' O ' ' D' ' 132' ' ' ASN . 9.0 mp -69.09 -39.3 79.09 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.959 0.904 . . . . 73.32 111.267 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -69.73 -35.3 74.89 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.007 0.523 . . . . 64.54 110.489 172.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 69.8 mtm -72.75 -23.25 60.8 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.452 0.701 . . . . 74.01 111.385 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.443 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 10.7 m120 -64.38 -29.82 70.87 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.31 0.644 . . . . 64.44 111.019 176.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -58.92 -37.09 75.85 Favored 'General case' 0 CA--C 1.555 1.141 0 O-C-N 123.267 0.355 . . . . 75.44 110.283 175.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 5.7 mp -83.77 -52.51 6.34 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.436 0.694 . . . . 51.2 111.646 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.443 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 15.7 pt20 -78.91 8.27 5.84 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 114.092 1.145 . . . . 72.12 114.092 -164.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' D' ' 139' ' ' ASN . 14.5 mm100 -116.04 83.11 1.89 Allowed 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 122.126 0.965 . . . . 60.22 108.793 -176.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -143.54 -55.1 0.38 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 113.665 -1.607 . . . . 54.55 106.846 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.5 92.04 0.87 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.365 -0.976 . . . . 72.21 108.365 173.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -173.23 38.42 0.14 Allowed Glycine 0 C--N 1.341 0.829 0 CA-C-N 115.945 -0.57 . . . . 63.14 111.931 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.33 169.27 17.99 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.274 1.03 . . . . 60.42 109.676 -175.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 176.81 -179.26 47.87 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 116.064 -0.516 . . . . 72.2 112.587 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 8.9 t -101.03 145.83 28.2 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.024 0.93 . . . . 61.0 110.642 -174.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -126.85 137.58 53.2 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.814 0.846 . . . . 64.43 108.898 176.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.34 104.34 2.03 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.298 -1.001 . . . . 73.02 108.298 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -101.94 86.42 2.89 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.163 0.585 . . . . 72.01 109.587 172.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -69.72 102.71 1.96 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 109.355 -0.609 . . . . 62.53 109.355 173.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -157.88 141.75 15.73 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.438 0.695 . . . . 62.22 109.937 -173.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.872 0 C-N-CA 123.482 0.713 . . . . 65.32 109.25 -176.005 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.534 0 N-CA-C 110.965 -0.854 . . . . 24.33 110.965 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.14 -61.81 3.81 Favored Glycine 0 C--N 1.348 1.212 0 N-CA-C 111.567 -0.613 . . . . 73.25 111.567 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -86.62 147.92 25.7 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.884 0.874 . . . . 73.24 109.42 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -112.72 -100.67 0.42 Allowed 'General case' 0 CA--C 1.549 0.929 0 CA-C-O 118.279 -0.867 . . . . 64.14 109.53 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 58.6 pttt 172.09 19.0 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 124.629 1.172 . . . . 73.12 110.902 -176.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . -148.89 76.92 0.24 Allowed Glycine 0 C--N 1.354 1.535 0 CA-C-O 119.968 -0.351 . . . . 64.31 113.554 -172.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 97' ' ' ILE . . . . . 0.461 HG12 ' O ' ' E' ' 97' ' ' ILE . 7.0 tt -167.33 18.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.708 0 C-N-CA 123.995 0.918 . . . . 71.22 110.333 169.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -70.32 178.74 2.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.911 -1.118 . . . . 75.03 110.541 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . 68.73 15.91 8.98 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.372 1.069 . . . . 54.31 111.648 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.84 113.67 22.13 Favored Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 124.292 1.037 . . . . 73.05 108.676 178.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -85.82 -9.51 7.65 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.912 2.408 . . . . 62.12 114.217 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 102' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 53.74 29.15 9.08 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 124.58 1.152 . . . . 64.02 111.758 -176.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 103' ' ' THR . . . . . 0.446 ' HB ' ' HB2' ' E' ' 108' ' ' HIS . 72.9 p 47.99 74.36 0.17 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.735 1.614 . . . . 74.54 112.371 -173.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.57 -93.5 1.89 Allowed Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.438 -0.801 . . . . 70.25 112.263 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -140.68 -60.13 0.51 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.81 0.844 . . . . 73.2 109.199 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -95.38 -77.2 0.48 Allowed 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 107.992 -1.114 . . . . 64.42 107.992 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 9.0 p -155.41 134.42 12.16 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.135 1.374 . . . . 75.31 109.172 174.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 108' ' ' HIS . . . . . 0.446 ' HB2' ' HB ' ' E' ' 103' ' ' THR . 31.2 m170 -89.57 -33.36 16.74 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.082 0.553 . . . . 74.24 110.957 171.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -102.34 119.85 39.5 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.234 0.614 . . . . 74.13 109.443 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.15 119.07 12.13 Favored 'General case' 0 C--O 1.244 0.776 0 O-C-N 124.044 0.84 . . . . 73.45 110.368 177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . 0.58 HD22 HG23 ' D' ' 46' ' ' THR . 48.4 tp -66.07 -38.49 88.42 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 123.921 0.763 . . . . 74.24 109.852 173.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -84.49 -165.83 1.28 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.829 0.852 . . . . 61.33 109.832 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 113' ' ' LYS . . . . . 0.574 ' HA ' ' HE2' ' E' ' 113' ' ' LYS . 1.0 OUTLIER 68.35 90.83 0.09 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.053 0.941 . . . . 63.43 112.616 175.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -128.72 163.74 24.48 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.328 1.051 . . . . 61.12 108.507 170.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 37.4 p -76.25 173.96 10.74 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.64 0.776 . . . . 64.41 110.701 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . -87.43 61.21 4.22 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 112.189 -0.365 . . . . 61.51 112.189 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 13.2 mmtm -154.3 -49.42 0.01 OUTLIER Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 124.654 1.182 . . . . 61.13 110.79 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.12 78.72 3.35 Favored 'Trans proline' 0 C--N 1.394 2.944 0 C-N-CA 122.161 1.908 . . . . 74.24 111.097 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -79.46 88.83 5.03 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.715 -0.846 . . . . 52.14 108.715 177.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -132.19 -45.1 0.93 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.739 -1.119 . . . . 75.31 109.577 -173.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 121' ' ' VAL . . . . . . . . . . . . . 16.9 t -92.3 50.68 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-O 122.467 1.127 . . . . 62.41 108.723 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 6.8 t -173.19 -42.17 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.284 -1.325 . . . . 74.04 108.857 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -82.52 91.94 6.99 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 108.96 -0.756 . . . . 72.42 108.96 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 29.5 t -107.2 -45.89 4.02 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.747 -1.115 . . . . 44.22 110.566 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . 59.19 -150.51 0.43 Allowed 'General case' 0 C--N 1.36 1.024 0 O-C-N 124.383 1.052 . . . . 74.3 108.981 -167.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . 69.82 -0.89 2.52 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 113.89 1.07 . . . . 75.43 113.89 172.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 127' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' D' ' 125' ' ' GLN . 30.8 t -89.37 133.76 34.36 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.904 0.882 . . . . 73.4 108.816 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -151.12 156.05 40.19 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 123.05 0.54 . . . . 74.21 110.474 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 14.3 t -153.08 170.85 19.46 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.751 0.821 . . . . 73.45 109.958 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 130' ' ' ALA . . . . . 0.452 ' HB3' ' HD3' ' A' ' 124' ' ' PRO . . . -155.87 31.11 0.36 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.352 1.061 . . . . 64.24 108.421 172.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 131' ' ' TRP . . . . . 0.685 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 33.1 t90 -50.67 104.0 0.07 Allowed 'General case' 0 C--N 1.371 1.533 0 C-N-CA 124.507 1.123 . . . . 74.12 111.416 -171.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 132' ' ' SER . . . . . 0.543 ' HB3' ' HD1' ' A' ' 36' ' ' TRP . 15.0 t -170.25 107.6 0.34 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.29 1.036 . . . . 74.2 108.212 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 30.9 m -145.17 137.12 25.65 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.361 0.664 . . . . 74.51 109.521 -176.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -148.09 134.34 5.04 Favored Glycine 0 C--N 1.342 0.874 0 N-CA-C 111.827 -0.509 . . . . 51.14 111.827 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 135' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 129' ' ' ALA . 19.5 m -122.42 178.63 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.038 0.935 . . . . 74.52 109.357 174.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 23.1 ttpp -101.09 156.2 17.55 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 110.049 -0.352 . . . . 72.31 110.049 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 95.3 m -59.28 119.28 7.1 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.834 0.854 . . . . 63.22 111.547 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 138' ' ' TYR . . . . . 0.512 ' HD2' ' HB1' ' A' ' 129' ' ' ALA . 36.5 m-85 -145.14 138.75 26.81 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.026 1.33 . . . . 74.32 108.238 171.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -130.14 -177.18 4.2 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.225 0.61 . . . . 73.21 109.975 176.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . 161.51 174.69 31.69 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 115.813 -0.631 . . . . 62.32 112.156 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.87 93.87 0.07 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.865 1.266 . . . . 73.4 111.732 178.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 36.8 tp -122.24 128.49 51.21 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.999 0.919 . . . . 74.45 108.845 172.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.51 176.36 28.52 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 115.947 -0.57 . . . . 65.33 111.757 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 144' ' ' VAL . . . . . 0.605 HG12 ' HE2' ' C' ' 137' ' ' PHE . 18.1 m -140.38 -37.62 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.944 0.898 . . . . 63.31 110.175 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 . . . . . 0 C--O 1.25 1.101 0 C-N-CA 123.65 0.78 . . . . 72.23 110.142 -177.0 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.442 0 N-CA-C 112.566 -0.213 . . . . 54.32 112.566 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.32 1.05 89.53 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-O 119.79 -0.45 . . . . 73.43 113.995 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -63.82 114.95 4.37 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.252 0.621 . . . . 75.33 109.436 178.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -79.18 178.58 7.95 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.586 0.754 . . . . 73.32 111.153 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 95' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' B' ' 1' ' ' MET . 32.5 tptt -142.2 131.15 23.06 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 107.391 -1.336 . . . . 72.52 107.391 171.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.47 -49.86 0.18 Allowed Glycine 0 C--N 1.347 1.178 0 O-C-N 123.484 0.49 . . . . 51.03 112.986 -172.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 97' ' ' ILE . . . . . 0.574 ' HB ' ' HA ' ' B' ' 87' ' ' ALA . 8.1 tt -83.77 -45.17 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.046 0.538 . . . . 52.22 110.342 -177.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 28.8 t70 51.56 107.0 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 126.531 1.932 . . . . 71.03 113.189 176.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . 70.51 118.2 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.566 1.147 . . . . 55.13 110.453 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 100' ' ' LEU . . . . . 0.441 HD22 ' HB2' ' B' ' 56' ' ' TYR . 3.5 mp -116.72 86.01 18.16 Favored Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 123.71 0.804 . . . . 70.31 109.571 -172.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.8 105.55 2.1 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.543 2.162 . . . . 53.31 112.019 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 102' ' ' LEU . . . . . . . . . . . . . 30.5 tp -74.5 157.96 34.62 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 109.483 -0.562 . . . . 71.4 109.483 173.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 42.4 p -73.49 81.92 1.46 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.807 0.843 . . . . 34.54 109.597 173.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.25 -157.04 44.17 Favored Glycine 0 C--N 1.343 0.965 0 CA-C-N 115.547 -0.751 . . . . 32.11 111.807 -171.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -118.96 -61.14 1.68 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.612 0.765 . . . . 75.54 109.273 177.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -98.91 89.88 4.45 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.307 -1.368 . . . . 73.02 107.307 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . 0.47 HG21 ' O ' ' F' ' 111' ' ' LEU . 11.6 m 61.65 -73.0 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 126.263 1.825 . . . . 64.45 114.808 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 80.82 -44.19 0.22 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 126.74 2.016 . . . . 74.05 111.578 -172.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -68.26 171.05 7.65 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.267 0.627 . . . . 72.43 110.549 173.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.87 68.63 9.43 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.115 0.566 . . . . 74.41 110.6 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . 0.47 ' O ' HG21 ' F' ' 107' ' ' THR . 10.0 tt -150.3 108.32 3.73 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.412 -0.958 . . . . 73.22 108.412 177.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -145.44 155.56 43.2 Favored 'General case' 0 C--O 1.247 0.934 0 N-CA-C 108.431 -0.951 . . . . 74.14 108.431 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -54.01 95.11 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.991 0 O-C-N 124.681 1.238 . . . . 72.45 111.263 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -166.94 -60.32 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.176 0.99 . . . . 64.41 108.439 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 91.2 m -158.36 148.39 19.89 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.762 1.225 . . . . 73.04 108.269 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.3 148.68 50.99 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-O 119.77 -0.461 . . . . 65.22 111.983 171.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 117' ' ' LYS . . . . . 0.497 ' HA ' ' HE3' ' F' ' 117' ' ' LYS . 1.5 tpmt? -71.56 119.93 76.87 Favored Pre-proline 0 CA--C 1.55 0.961 0 CA-C-O 118.218 -0.896 . . . . 65.2 110.065 -173.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.87 82.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.394 2.93 0 C-N-CA 123.916 3.078 . . . . 74.45 114.329 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -178.61 -35.88 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 126.655 1.982 . . . . 74.11 107.696 176.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 120' ' ' TYR . . . . . 0.564 ' HB3' ' HG ' ' B' ' 136' ' ' LEU . 40.6 t80 -139.89 163.35 32.88 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.992 1.317 . . . . 72.54 108.038 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 92.3 t 68.82 105.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 124.639 1.175 . . . . 75.23 109.845 -173.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 9.8 t -153.46 -35.64 0.11 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.926 0.89 . . . . 62.31 109.266 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 19.2 t70 62.52 114.77 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.53 1.532 . . . . 72.42 112.822 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 37.5 p -132.92 21.05 4.14 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.612 1.165 . . . . 73.51 108.735 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -107.52 -37.91 6.06 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.741 0.816 . . . . 64.12 111.475 -173.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.02 85.08 0.99 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.442 0.639 . . . . 73.12 110.36 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 50.1 m -143.47 163.49 32.97 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.039 0.936 . . . . 71.11 110.028 -177.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . 66.81 18.72 10.69 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.762 1.225 . . . . 71.34 112.388 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 4.9 t -103.11 158.89 15.99 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.488 0.715 . . . . 71.14 111.027 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -177.1 -175.39 0.58 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.336 1.454 . . . . 50.45 109.056 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 48.0 t-105 -125.02 123.75 40.51 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 108.654 -0.869 . . . . 73.54 108.654 171.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 51.1 m -149.83 161.91 41.33 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.663 1.185 . . . . 70.33 108.738 177.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 26.6 m -137.24 137.64 39.28 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.252 0.621 . . . . 63.3 109.64 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -149.27 48.72 0.59 Allowed Glycine 0 C--N 1.343 0.953 0 N-CA-C 111.422 -0.671 . . . . 72.34 111.422 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 135' ' ' VAL . . . . . 0.619 ' HA ' ' HB ' ' C' ' 40' ' ' VAL . 44.4 t -76.21 -41.97 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 109.494 -0.558 . . . . 65.12 109.494 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 136' ' ' LYS . . . . . 0.434 ' HE3' ' H ' ' F' ' 141' ' ' ALA . 36.2 ttpt 62.01 83.46 0.15 Allowed 'General case' 0 C--N 1.365 1.25 0 O-C-N 124.532 1.145 . . . . 53.12 110.693 168.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 12.3 m 67.76 172.57 0.27 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.953 0.901 . . . . 73.44 110.116 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -65.32 -36.97 85.67 Favored 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.518 -0.739 . . . . 72.14 109.663 172.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -115.31 98.63 6.87 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.796 -0.816 . . . . 62.25 108.796 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -73.19 160.85 54.12 Favored Glycine 0 C--N 1.342 0.909 0 N-CA-C 111.465 -0.654 . . . . 61.14 111.465 171.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 141' ' ' ALA . . . . . 0.434 ' H ' ' HE3' ' F' ' 136' ' ' LYS . . . -161.17 139.06 9.36 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.039 0.536 . . . . 74.04 110.07 -178.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 142' ' ' LEU . . . . . 0.409 HD21 ' HB2' ' C' ' 39' ' ' GLU . 3.0 pp -163.5 168.46 20.13 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.98 0.912 . . . . 52.34 110.543 173.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -123.87 125.56 5.89 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 109.96 -1.256 . . . . 71.11 109.96 173.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 144' ' ' VAL . . . . . 0.52 HG21 ' HG2' ' C' ' 70' ' ' GLU . 14.7 p -64.34 -30.31 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.233 0.613 . . . . 74.11 111.558 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 34.5 t70 . . . . . 0 C--O 1.246 0.92 0 N-CA-C 107.863 -1.162 . . . . 73.33 107.863 170.966 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtm . . . . . 0 N--CA 1.481 1.125 0 N-CA-C 109.644 -0.502 . . . . 53.34 109.644 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.8 m 74.84 146.63 0.09 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.284 1.433 . . . . 73.42 111.882 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -152.37 160.19 43.34 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.057 0.943 . . . . 73.21 109.694 -172.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -156.42 138.36 14.42 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 122.809 0.444 . . . . 74.23 110.485 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -68.79 89.67 0.4 Allowed 'General case' 0 C--N 1.353 0.755 0 N-CA-C 108.091 -1.077 . . . . 63.54 108.091 168.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -68.75 -177.97 1.09 Allowed 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 113.827 -1.533 . . . . 75.45 111.875 -176.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.0 m -81.0 148.66 29.64 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.806 -0.813 . . . . 71.31 108.806 172.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.49 136.33 57.94 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.39 -0.596 . . . . 74.2 109.39 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 57.9 mtm -132.4 155.94 47.57 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.759 0.824 . . . . 75.51 109.447 -177.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.0 m -140.53 122.66 15.73 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.774 -0.824 . . . . 75.23 108.774 174.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -135.33 114.36 12.14 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.529 -1.286 . . . . 72.34 107.529 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -134.05 135.26 43.21 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 107.826 -1.176 . . . . 72.14 107.826 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.441 HD13 HG21 ' A' ' 105' ' ' ILE . 8.7 mt -93.95 114.44 30.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.381 -0.97 . . . . 63.04 108.381 174.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -81.54 -30.36 33.16 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 123.731 0.644 . . . . 71.53 110.47 -177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.475 HH22 ' HZ2' ' F' ' 131' ' ' TRP . 29.5 ttt180 -175.87 134.27 0.28 Allowed 'General case' 0 C--N 1.361 1.089 0 C-N-CA 123.13 0.572 . . . . 55.53 110.372 -175.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.546 HD12 ' HG3' ' C' ' 130' ' ' PRO . 66.2 mt -118.13 133.77 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 107.998 -1.112 . . . . 74.51 107.998 169.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.456 ' HE1' HG13 ' A' ' 83' ' ' ILE . 24.9 p90 -164.23 149.39 10.31 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 124.098 0.874 . . . . 74.23 110.838 -174.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.0 p -75.27 130.18 38.67 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 108.862 -0.792 . . . . 73.23 108.862 172.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.446 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.9 mtpt -97.55 -30.05 13.1 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.778 -0.452 . . . . 74.53 109.778 175.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.434 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 7.7 t70 -143.37 141.58 30.97 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.351 -0.611 . . . . 74.24 109.351 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.442 HG23 ' SD ' ' A' ' 117' ' ' MET . 62.6 mt -142.24 146.29 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.164 1.386 . . . . 64.4 107.917 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.8 t -155.8 132.48 10.42 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.482 0.713 . . . . 65.11 109.737 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.605 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 80.5 t80 -139.08 114.65 9.85 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 107.199 -1.408 . . . . 75.24 107.199 172.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -118.24 114.36 22.89 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 108.996 -0.742 . . . . 74.43 108.996 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.47 79.57 1.75 Allowed Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 107.892 -1.151 . . . . 74.02 107.892 164.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.07 -26.13 21.87 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.547 2.164 . . . . 61.52 112.04 -172.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -104.49 17.9 23.24 Favored 'General case' 0 C--O 1.21 -1.02 0 CA-C-O 117.942 -1.027 . . . . 71.53 110.056 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.415 ' HA ' HG12 ' A' ' 31' ' ' VAL . . . -45.0 -51.96 21.19 Favored Pre-proline 0 N--CA 1.503 2.197 0 N-CA-C 114.291 1.219 . . . . 34.11 114.291 -169.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.09 -26.07 43.26 Favored 'Trans proline' 0 C--N 1.386 2.529 0 C-N-CA 121.764 1.643 . . . . 73.14 112.808 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -81.43 -43.22 19.21 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.251 1.02 . . . . 71.13 110.245 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.714 HG21 ' HA ' ' A' ' 73' ' ' ALA . 8.2 p -78.96 -21.87 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 114.762 -1.108 . . . . 71.13 112.142 -163.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -70.79 -18.17 62.76 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.579 0.351 . . . . 73.14 111.785 173.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -76.02 -21.32 56.99 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.682 0.793 . . . . 70.35 110.581 173.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.406 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 35.1 mmtp -83.11 154.67 24.23 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.792 0.837 . . . . 72.03 111.625 -178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -68.36 136.61 53.65 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.12 -0.946 . . . . 70.34 109.995 172.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.535 ' CE3' HD21 ' A' ' 68' ' ' LEU . 67.9 t-105 -82.45 86.16 6.8 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.512 0.673 . . . . 75.41 110.634 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.41 ' H ' HD22 ' A' ' 68' ' ' LEU . 29.1 tt0 -124.55 80.47 60.95 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 107.757 -1.201 . . . . 55.32 107.757 167.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -70.18 122.88 9.43 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 122.535 2.157 . . . . 64.12 112.647 -174.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -95.81 85.67 4.17 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 105.847 -1.909 . . . . 64.14 105.847 172.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.8 t -90.31 134.91 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 114.972 -1.013 . . . . 73.51 110.085 -171.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -121.5 114.78 21.73 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.168 0.987 . . . . 75.52 108.395 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 128' ' ' LEU . 2.6 tt -101.59 119.03 38.13 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.35 -0.981 . . . . 72.5 108.35 -175.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -121.43 133.49 55.07 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.162 0.985 . . . . 64.04 109.174 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.565 HD22 HD21 ' A' ' 60' ' ' LEU . 72.6 mt -121.65 131.06 53.89 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.745 0.818 . . . . 61.04 110.693 -178.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -135.66 149.21 49.22 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.071 0.948 . . . . 64.12 108.816 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.5 m -135.87 129.13 31.86 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.424 0.69 . . . . 54.54 110.099 -177.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.43 111.15 11.06 Favored 'General case' 0 C--N 1.345 0.385 0 C-N-CA 124.179 0.992 . . . . 65.22 109.512 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.0 m -90.35 159.24 16.72 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.215 -0.661 . . . . 52.21 109.215 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.9 t -158.35 117.37 3.11 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.245 -0.65 . . . . 74.23 109.245 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -76.06 106.96 7.95 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.72 -0.474 . . . . 70.13 109.72 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.4 mt -79.8 -33.55 40.36 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.402 0.681 . . . . 73.44 111.02 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.92 -174.77 4.56 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.084 0.554 . . . . 50.2 111.086 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.46 114.93 4.66 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.761 0.825 . . . . 75.45 109.362 176.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 64.89 18.63 11.56 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.064 1.346 . . . . 72.24 112.335 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.7 t -118.29 105.37 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.452 -0.944 . . . . 74.11 108.452 174.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -115.96 122.81 46.38 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.809 0.844 . . . . 74.42 108.724 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -86.6 148.58 25.42 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.778 -0.823 . . . . 74.2 108.778 170.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.6 t -130.33 139.37 51.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 N-CA-C 107.821 -1.178 . . . . 74.02 107.821 168.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.421 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 26.4 t -121.13 127.46 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.84 -0.8 . . . . 62.5 108.84 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.565 HD21 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -102.23 106.75 17.62 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 106.817 -1.549 . . . . 71.33 106.817 176.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.2 ttp180 -92.76 101.82 14.22 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.865 -1.161 . . . . 53.4 107.865 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.23 126.91 48.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 N-CA-C 108.482 -0.933 . . . . 61.23 108.482 174.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.8 m -116.25 142.7 46.49 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.978 -0.749 . . . . 70.55 108.978 173.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.573 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 92.6 t -139.3 109.3 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 125.169 1.388 . . . . 75.41 107.749 -176.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.4 m -107.4 123.02 47.77 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.993 -0.743 . . . . 71.32 108.993 169.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.94 120.57 36.77 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 108.354 -0.98 . . . . 53.25 108.354 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.5 m -124.14 136.07 53.95 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.211 0.604 . . . . 52.33 110.755 -176.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.662 HD12 HG22 ' A' ' 31' ' ' VAL . 91.6 mt -87.75 74.99 9.02 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 108.354 -0.98 . . . . 75.3 108.354 174.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.47 -116.38 4.68 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 114.33 -1.305 . . . . 35.32 110.956 -169.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -91.94 -13.85 30.49 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.875 0.87 . . . . 63.42 110.743 176.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.406 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 5.9 tp10 -77.26 133.28 38.89 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.39 1.076 . . . . 75.43 108.267 173.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.6 m -87.7 127.5 35.3 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.729 0.695 . . . . 74.31 109.521 174.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.714 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -79.83 -58.85 2.98 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.53 -0.915 . . . . 73.43 108.53 173.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -162.39 165.24 26.67 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 115.458 -0.792 . . . . 63.54 111.652 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.3 tp -127.17 118.98 25.38 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 114.393 -1.276 . . . . 65.01 107.988 166.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.573 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.0 m -105.56 138.11 42.3 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.054 0.942 . . . . 71.24 109.257 171.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -147.92 132.75 18.01 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.694 -0.854 . . . . 73.32 108.694 168.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.2 t -138.7 110.85 5.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 C-N-CA 124.194 0.998 . . . . 65.15 108.461 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -84.89 85.46 7.47 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.282 -1.007 . . . . 74.02 108.282 169.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -75.92 96.99 3.85 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.096 -0.956 . . . . 64.2 109.011 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.06 160.14 34.78 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 111.513 -0.635 . . . . 75.01 111.513 178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.9 127.68 2.01 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.773 -0.931 . . . . 62.23 110.773 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.456 HG13 ' HE1' ' A' ' 17' ' ' TYR . 63.6 mt -80.97 124.0 38.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 107.948 -1.13 . . . . 74.33 107.948 171.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.81 ' HB3' HD11 ' A' ' 86' ' ' ILE . 87.7 m-85 -125.65 127.42 46.27 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 109.003 -0.74 . . . . 72.41 109.003 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.3 t -89.3 97.57 11.27 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.955 -0.757 . . . . 64.24 108.955 173.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.81 HD11 ' HB3' ' A' ' 84' ' ' PHE . 4.7 mm -112.76 150.92 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 122.74 0.416 . . . . 75.44 110.502 -175.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.54 170.85 12.36 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.003 0.814 . . . . 65.33 110.869 178.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.11 -31.39 7.05 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-N 115.987 -0.551 . . . . 74.54 113.924 172.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.602 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.2 161.03 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 123.812 0.845 . . . . 73.13 108.993 176.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.554 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 17.0 tt0 -153.5 176.65 11.8 Favored 'General case' 0 C--O 1.244 0.78 0 N-CA-C 109.457 -0.572 . . . . 75.21 109.457 -175.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.554 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 57.5 -123.37 32.5 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 124.144 0.902 . . . . 72.23 113.921 177.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.2 t -75.23 -24.72 57.75 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.262 0.625 . . . . 61.33 111.91 -176.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -76.27 -34.79 59.12 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.42 0.688 . . . . 74.3 110.368 176.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.435 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 6.4 tpt -62.86 -48.68 78.0 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.383 -0.599 . . . . 75.23 109.383 171.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.71 -36.62 72.24 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.645 0.778 . . . . 41.54 110.751 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -67.96 -38.0 82.24 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.422 0.689 . . . . 74.33 111.182 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.5 t -66.38 -40.43 89.68 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.849 -0.426 . . . . 70.42 109.849 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 94' ' ' MET . 53.9 mt -83.66 -25.61 30.59 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.741 0.816 . . . . 60.35 112.322 -174.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.53 3.38 34.53 Favored Glycine 0 N--CA 1.475 1.268 0 O-C-N 123.417 0.448 . . . . 73.12 113.726 -173.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.546 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -136.8 -68.69 0.48 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.029 0.532 . . . . 60.05 110.059 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -65.82 -46.97 76.64 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 123.436 0.694 . . . . 74.02 111.721 -171.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 59.4 m -66.29 -50.75 47.75 Favored Pre-proline 0 CA--C 1.567 1.619 0 C-N-CA 124.464 1.105 . . . . 72.24 112.659 -175.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.96 -20.05 45.28 Favored 'Trans proline' 0 C--N 1.39 2.749 0 C-N-CA 121.841 1.694 . . . . 71.24 112.948 174.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -69.7 -35.71 75.3 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.847 0.459 . . . . 74.55 110.188 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.441 HG21 HD13 ' A' ' 13' ' ' ILE . 46.7 mm -64.25 -47.87 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.27 0.628 . . . . 73.12 109.828 171.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.5 mt -72.22 -21.7 61.36 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.116 -0.947 . . . . 74.21 112.552 -171.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -65.03 -45.46 73.44 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 114.26 1.207 . . . . 61.22 114.26 -172.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.425 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 82.8 Cg_exo -50.54 -40.95 54.29 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.055 1.837 . . . . 53.24 113.626 171.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -76.13 -38.58 56.64 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.371 0.668 . . . . 74.32 111.084 -177.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.21 -48.12 74.46 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.347 0.659 . . . . 60.12 109.915 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.438 ' NH1' HG23 ' C' ' 105' ' ' ILE . 29.3 ttm105 -47.99 -55.91 8.92 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 125.023 1.452 . . . . 74.22 110.079 174.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -61.81 -48.34 81.02 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 124.478 1.111 . . . . 74.4 111.879 -175.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.531 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.0 t -57.05 -42.39 80.44 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 123.786 0.679 . . . . 73.23 110.57 -177.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 118' ' ' VAL . 82.9 mt -62.95 -52.15 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 115.097 -0.956 . . . . 74.35 110.319 173.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.426 HG21 ' HE2' ' C' ' 109' ' ' TYR . 61.7 m -55.28 -41.08 71.79 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.047 0.939 . . . . 70.32 111.319 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.8 t -68.99 -42.57 76.32 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 114.626 -1.17 . . . . 51.45 109.706 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.513 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 7.9 mtp -60.02 -42.49 94.45 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.871 0.868 . . . . 72.41 111.063 175.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 114' ' ' ILE . 70.1 t -61.66 -45.84 97.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 C-N-CA 124.278 1.031 . . . . 54.12 110.1 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.5 p -73.95 -30.51 62.58 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.271 0.628 . . . . 75.34 111.647 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 78.6 mtt-85 -72.59 -29.21 63.32 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.509 0.724 . . . . 70.44 109.594 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.07 5.42 62.77 Favored Glycine 0 C--N 1.354 1.56 0 CA-C-O 119.213 -0.771 . . . . 65.33 112.962 175.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.593 HG21 ' HE ' ' B' ' 15' ' ' ARG . 44.6 m 72.61 10.35 5.63 Favored 'General case' 0 CA--C 1.565 1.524 0 CA-C-O 122.587 1.184 . . . . 73.42 111.703 173.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -86.35 144.42 38.14 Favored Pre-proline 0 C--O 1.244 0.765 0 O-C-N 121.064 -1.023 . . . . 64.25 109.151 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -51.69 142.52 40.52 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.06 2.507 . . . . 74.35 112.159 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -57.06 136.34 56.33 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 123.999 0.812 . . . . 72.34 112.667 -170.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.445 HD21 HG11 ' A' ' 64' ' ' VAL . 35.8 tp -121.58 123.37 41.8 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.626 1.17 . . . . 74.02 108.486 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.499 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 92.2 m-20 -122.44 109.46 14.41 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.543 0.737 . . . . 71.12 109.124 -176.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.511 ' HB3' HD11 ' A' ' 42' ' ' LEU . 7.9 mt -70.01 116.46 10.4 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 109.217 -0.66 . . . . 63.23 109.217 -173.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.445 ' HB2' HE22 ' C' ' 12' ' ' GLN . . . -61.68 143.4 93.9 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 122.873 0.469 . . . . 53.14 111.57 -172.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -56.24 125.14 18.09 Favored 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.488 2.792 . . . . 63.44 114.141 -172.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.493 HG21 HD11 ' A' ' 44' ' ' LEU . 90.3 t -102.46 134.26 43.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 CA-C-N 115.335 -0.848 . . . . 71.24 110.382 -178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.5 t-20 -90.54 86.54 6.44 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.709 -0.848 . . . . 71.34 108.709 176.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -63.11 -27.65 69.53 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.579 0.751 . . . . 75.42 112.029 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.546 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 18.7 t70 -66.91 -43.37 83.51 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 123.45 0.469 . . . . 62.4 109.745 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.65 -40.51 95.58 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 124.228 0.955 . . . . 71.23 111.105 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 89.3 mt -60.01 -51.94 67.5 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.275 0.63 . . . . 65.42 111.033 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -66.82 -36.43 82.35 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.686 -0.487 . . . . 71.04 109.686 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.15 -47.56 80.85 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 124.011 0.819 . . . . 74.1 110.226 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -56.83 -42.04 78.92 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.046 0.938 . . . . 73.22 111.522 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -76.24 -30.75 58.02 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.566 -0.743 . . . . 73.41 111.17 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 44.4 tp -67.21 -52.09 45.36 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.381 1.073 . . . . 75.44 110.998 -174.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 175.23 -13.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.14 0.976 . . . . 72.52 110.294 -175.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 75.06 -63.13 0.43 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.389 1.875 . . . . 63.44 109.795 -173.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -73.21 83.45 1.35 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.042 0.937 . . . . 72.32 109.607 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -162.99 165.17 25.22 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.452 1.101 . . . . 44.22 110.035 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -173.06 126.24 1.23 Allowed Glycine 0 C--N 1.34 0.76 0 N-CA-C 111.597 -0.601 . . . . 51.24 111.597 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -147.32 122.41 10.13 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.917 0.887 . . . . 65.43 109.078 177.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 179.95 53.85 0.08 OUTLIER Glycine 0 C--N 1.349 1.255 0 CA-C-N 116.308 -0.405 . . . . 61.1 112.218 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.0 p -129.93 142.83 50.6 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.35 -0.981 . . . . 74.02 108.35 175.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -145.94 104.47 3.85 Favored 'General case' 0 C--O 1.244 0.788 0 N-CA-C 108.642 -0.873 . . . . 41.12 108.642 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -166.66 38.12 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.473 0.709 . . . . 71.14 110.919 -174.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -131.32 141.44 49.93 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 122.722 0.409 . . . . 62.31 110.661 -175.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -125.14 137.61 54.16 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.681 -0.859 . . . . 71.22 108.681 167.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -153.09 98.44 2.29 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.329 -0.989 . . . . 65.31 108.329 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.215 0 N-CA-C 108.447 -0.945 . . . . 71.5 108.447 -179.796 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.487 1.383 0 N-CA-C 109.699 -0.482 . . . . 73.41 109.699 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 48.5 t -154.7 112.32 3.42 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.319 1.048 . . . . 33.5 108.651 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -82.34 84.8 7.01 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.326 0.65 . . . . 42.43 110.084 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -137.26 111.26 8.3 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.878 0.871 . . . . 64.31 108.946 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -74.98 137.99 41.94 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 109.87 -0.419 . . . . 73.21 109.87 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 58.24 78.19 0.26 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.485 1.114 . . . . 73.3 110.19 -172.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.565 HG21 ' HA ' ' B' ' 89' ' ' ILE . 17.2 m -80.43 106.34 12.37 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 109.096 -0.705 . . . . 73.11 109.096 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -60.27 -29.04 68.54 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.562 1.145 . . . . 71.31 112.54 -177.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.644 ' HB3' HG23 ' B' ' 89' ' ' ILE . 25.5 ptm 51.49 -170.5 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 126.509 1.924 . . . . 70.31 113.437 -177.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.3 t -143.54 127.37 17.24 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 124.437 1.095 . . . . 70.51 108.096 171.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.402 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 75.2 t80 -123.51 146.19 48.27 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.613 0.765 . . . . 73.52 109.521 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.658 ' HG3' ' HB1' ' E' ' 125' ' ' ALA . 8.5 tt0 -149.99 131.26 14.57 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.248 0.619 . . . . 62.31 109.739 176.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 54.9 mt -80.3 122.82 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.538 -1.282 . . . . 71.41 107.538 168.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -93.58 -49.77 5.73 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.692 -0.855 . . . . 64.34 108.692 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.593 ' HE ' HG21 ' A' ' 122' ' ' THR . 26.1 ttt180 -164.14 143.57 7.75 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.767 -0.651 . . . . 54.14 110.841 -174.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 94.6 mt -124.02 141.45 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 107.039 -1.467 . . . . 74.33 107.039 173.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -165.43 138.98 4.56 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 112.886 0.699 . . . . 71.42 112.886 -174.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.6 m -73.91 119.38 18.05 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.668 0.787 . . . . 74.34 109.373 172.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.522 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.9 mtpt -96.89 -20.44 18.14 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.707 0.803 . . . . 74.11 111.678 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.578 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 34.0 t70 -160.18 149.64 17.72 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.097 0.559 . . . . 74.12 111.022 -177.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.605 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 26.9 mm -145.86 146.16 19.58 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 125.485 1.514 . . . . 73.45 108.374 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 36.3 t -155.6 145.6 21.51 Favored 'General case' 0 C--O 1.242 0.693 0 O-C-N 124.351 1.032 . . . . 70.14 110.087 169.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.44 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.1 t80 -151.56 108.54 3.54 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 107.457 -1.312 . . . . 73.12 107.457 169.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -118.18 113.53 21.69 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.243 -1.021 . . . . 74.2 108.243 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.64 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -107.78 86.42 2.97 Favored Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 107.888 -1.153 . . . . 74.54 107.888 174.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.2 -33.69 7.0 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.734 2.29 . . . . 72.11 112.933 -170.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -100.95 6.15 43.48 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.815 0.846 . . . . 72.11 111.389 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.64 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -41.39 -62.59 1.02 Allowed Pre-proline 0 N--CA 1.491 1.606 0 C-N-CA 125.436 1.494 . . . . 45.11 113.924 -168.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 52.8 Cg_exo -52.37 -38.29 73.21 Favored 'Trans proline' 0 C--N 1.391 2.792 0 C-N-CA 122.89 2.393 . . . . 63.14 113.756 -172.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -93.54 -35.03 13.12 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.193 -0.912 . . . . 74.02 111.636 -171.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.508 HG22 HD12 ' B' ' 68' ' ' LEU . 4.3 p -73.14 -14.74 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 123.239 0.616 . . . . 65.45 111.574 -171.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -64.31 -20.46 66.1 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.445 0.698 . . . . 70.41 112.771 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -65.17 -18.18 65.09 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.146 0.578 . . . . 52.25 110.942 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.452 ' HB2' HD13 ' B' ' 68' ' ' LEU . 93.0 mttt -91.2 79.61 5.69 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.787 1.235 . . . . 75.44 110.048 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -85.31 78.01 9.86 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.321 -0.854 . . . . 74.44 110.098 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 14.9 p90 -154.3 -174.68 5.06 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.952 0.901 . . . . 72.14 108.875 172.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.417 ' HB3' ' OG1' ' F' ' 129' ' ' THR . 0.0 OUTLIER -71.0 120.19 77.95 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 123.157 0.583 . . . . 70.1 111.079 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' F' ' 128' ' ' ALA . 58.1 Cg_endo -70.33 139.32 38.0 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 121.244 1.296 . . . . 41.44 109.513 172.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.61 101.02 1.2 Allowed 'General case' 0 C--O 1.242 0.691 0 N-CA-C 107.27 -1.381 . . . . 62.45 107.27 170.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.689 HG11 HD11 ' B' ' 126' ' ' LEU . 35.4 t -102.94 145.66 11.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 115.066 -0.97 . . . . 63.53 109.184 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -135.07 130.41 35.52 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.344 -0.844 . . . . 72.1 108.91 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.527 HD11 HG13 ' B' ' 62' ' ' VAL . 21.8 tp -94.09 126.97 39.63 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 124.212 0.945 . . . . 60.54 109.245 170.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -142.87 126.38 16.8 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.289 1.036 . . . . 71.12 108.466 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.546 HD23 HG22 ' B' ' 62' ' ' VAL . 4.0 mp -119.9 148.72 43.16 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.985 0.514 . . . . 72.43 110.537 -172.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.409 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 18.1 t70 -124.4 141.61 51.95 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.172 1.389 . . . . 73.04 108.097 176.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 27.4 m -113.34 104.16 12.04 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.561 -0.533 . . . . 52.13 109.561 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.59 134.43 55.05 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.088 -1.449 . . . . 74.25 107.088 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.45 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 51.9 m -142.99 162.8 34.51 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 122.493 0.317 . . . . 72.11 110.745 -175.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.9 p -152.09 135.6 16.08 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.431 0.692 . . . . 65.43 109.693 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -90.49 122.66 33.52 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 109.013 -0.736 . . . . 75.22 109.013 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 pp -143.96 25.11 1.62 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.286 -0.87 . . . . 63.54 109.589 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.97 156.76 20.19 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 123.632 0.773 . . . . 73.23 110.312 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -79.7 131.83 36.05 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 108.521 -0.918 . . . . 73.21 108.521 167.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 64.49 7.31 3.59 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.929 1.292 . . . . 72.42 112.215 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.7 HG22 ' HA ' ' B' ' 85' ' ' SER . 54.2 t -138.68 123.33 21.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 107.239 -1.393 . . . . 64.3 107.239 -174.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.45 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 1.5 t80 -117.26 145.45 43.93 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 108.364 -0.976 . . . . 55.12 108.364 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -100.51 103.13 14.45 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 106.547 -1.649 . . . . 44.01 106.547 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 6.8 p -102.52 132.44 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.345 -0.613 . . . . 71.32 109.345 -176.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.419 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 19.0 t -115.12 122.41 69.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 108.688 -0.856 . . . . 33.35 108.688 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 38.9 tp -103.54 105.89 16.25 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.754 -0.832 . . . . 71.22 108.754 173.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.432 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 14.4 ttm180 -84.9 110.09 18.61 Favored 'General case' 0 C--O 1.222 -0.38 0 N-CA-C 108.588 -0.893 . . . . 74.3 108.588 174.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.546 HG22 HD23 ' B' ' 44' ' ' LEU . 61.4 t -105.03 104.7 17.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 123.572 0.749 . . . . 60.51 109.011 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 6.7 m -98.83 137.15 37.82 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.134 -0.939 . . . . 73.13 109.684 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.651 HG11 HD21 ' B' ' 126' ' ' LEU . 30.6 t -128.42 116.29 41.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 124.225 1.01 . . . . 62.11 108.524 174.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 97.0 m -101.95 136.56 41.58 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.985 -1.117 . . . . 73.51 107.985 168.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.87 141.22 36.61 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 109.443 -0.577 . . . . 73.33 109.443 178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.521 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 40.9 p -148.15 130.98 16.08 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.542 0.526 . . . . 73.02 111.585 -173.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.508 HD12 HG22 ' B' ' 31' ' ' VAL . 75.8 mt -97.04 107.11 19.57 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.181 0.992 . . . . 71.45 108.664 176.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.58 -111.98 3.37 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 111.195 -0.762 . . . . 41.22 111.195 -172.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -117.54 1.65 12.31 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.674 0.79 . . . . 72.13 110.297 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -114.43 142.15 46.73 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.768 -0.583 . . . . 62.35 110.37 -174.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 25.4 m -66.39 115.25 6.11 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.719 0.808 . . . . 54.41 111.394 -175.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.521 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -70.02 -56.34 7.2 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.992 -1.114 . . . . 74.41 107.992 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -158.37 164.47 36.29 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 114.398 -1.274 . . . . 64.3 111.151 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 67.8 mt -129.9 112.23 13.33 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 106.683 -1.599 . . . . 70.02 106.683 172.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.519 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 34.2 t -119.94 115.12 23.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.772 -0.825 . . . . 72.41 108.772 177.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -128.0 124.81 38.11 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.885 0.874 . . . . 70.04 109.044 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 73.1 t -124.49 153.17 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.227 1.011 . . . . 73.02 109.276 -177.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.578 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.5 mt-30 -122.9 111.78 17.05 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.349 -0.982 . . . . 72.33 108.349 167.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.461 ' HG3' HD22 ' B' ' 106' ' ' LEU . 8.0 tp-100 -101.54 106.83 17.97 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.526 -0.916 . . . . 74.23 108.526 171.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.522 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -100.91 167.28 19.59 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 111.525 -0.63 . . . . 55.44 111.525 176.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.26 143.82 8.67 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 121.127 -0.559 . . . . 70.24 112.98 -174.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 79.3 mt -101.76 113.65 38.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 107.651 -1.24 . . . . 72.44 107.651 174.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . 0.428 ' O ' HG13 ' B' ' 55' ' ' VAL . 38.9 m-85 -127.49 147.46 50.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.311 0.644 . . . . 73.22 109.593 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.7 ' HA ' HG22 ' B' ' 55' ' ' VAL . 49.3 m -94.25 115.71 28.01 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.542 1.137 . . . . 61.51 110.456 177.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.602 HG22 HD11 ' B' ' 89' ' ' ILE . 3.8 mp -120.67 104.89 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 106.929 -1.508 . . . . 73.4 106.929 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.34 167.79 21.32 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.107 0.563 . . . . 74.3 110.559 -175.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.46 -45.82 3.29 Favored Glycine 0 N--CA 1.476 1.321 0 O-C-N 123.138 0.274 . . . . 70.13 113.096 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.644 HG23 ' HB3' ' B' ' 9' ' ' MET . 0.8 OUTLIER -58.03 167.74 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 124.839 1.255 . . . . 71.01 113.415 175.326 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -152.55 149.85 28.93 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.467 -1.242 . . . . 75.23 110.696 -174.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.19 -126.67 7.61 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.519 0.512 . . . . 21.11 112.236 173.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 20.3 m -90.1 -19.58 24.15 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.028 0.531 . . . . 64.12 110.202 175.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -53.44 -33.7 55.08 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.055 0.942 . . . . 75.11 111.368 176.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.782 ' SD ' HG23 ' F' ' 97' ' ' ILE . 11.2 ptt? -62.22 -59.42 5.06 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.259 1.024 . . . . 74.44 111.707 -174.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.85 -14.15 58.29 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.348 0.659 . . . . 70.45 111.428 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -61.87 -38.61 88.91 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.846 0.858 . . . . 61.24 110.688 170.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.7 t -68.89 -55.36 11.29 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.81 0.444 . . . . 61.13 110.615 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.616 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 1.9 pp -74.17 -18.4 60.78 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.717 0.636 . . . . 73.01 112.717 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.41 0.93 55.78 Favored Glycine 0 N--CA 1.472 1.072 0 CA-C-O 119.413 -0.659 . . . . 65.31 114.199 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.556 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -149.04 -50.86 0.15 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 117.888 0.844 . . . . 71.45 112.006 -176.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.405 ' O ' ' HB3' ' B' ' 104' ' ' ASN . 39.7 t80 -73.01 -39.58 65.9 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.333 0.653 . . . . 75.43 111.046 -177.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.616 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 82.0 m -75.13 -43.7 4.56 Favored Pre-proline 0 CA--C 1.563 1.446 0 CA-C-O 118.476 -0.773 . . . . 63.24 113.027 -175.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.7 -22.39 64.27 Favored 'Trans proline' 0 C--N 1.389 2.669 0 CA-C-N 121.185 1.459 . . . . 71.41 112.692 170.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' B' ' 101' ' ' TYR . 22.8 t-20 -64.15 -37.44 87.46 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.886 0.474 . . . . 75.2 110.861 172.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.9 mt -66.37 -40.85 87.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.536 0.735 . . . . 71.13 110.09 173.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.461 HD22 ' HG3' ' B' ' 80' ' ' GLN . 88.1 mt -75.0 -28.17 60.43 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.822 0.849 . . . . 64.35 112.775 -174.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -56.16 -47.35 99.01 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 118.068 -0.968 . . . . 71.33 113.464 -173.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.538 ' HG2' ' HB2' ' D' ' 108' ' ' PRO . 85.0 Cg_exo -53.53 -42.99 61.45 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.813 2.342 . . . . 71.21 114.604 174.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.412 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 40.4 m-85 -67.62 -36.05 80.09 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.187 0.595 . . . . 73.23 110.476 -177.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.21 -39.75 74.95 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.573 0.749 . . . . 72.45 110.778 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.419 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 51.3 ttt-85 -60.79 -55.16 36.37 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.282 1.433 . . . . 74.0 111.175 -177.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -69.15 -26.15 64.73 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.618 0.574 . . . . 74.11 110.427 -177.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.528 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.8 t -70.44 -39.4 74.37 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 110.265 -0.272 . . . . 72.34 110.265 177.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.519 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 72.3 mt -61.44 -54.81 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 C-N-CA 123.987 0.915 . . . . 70.42 109.762 170.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 36.7 m -59.1 -28.3 66.39 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.921 0.888 . . . . 73.52 111.263 -177.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.8 t -68.28 -50.97 50.06 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 123.475 0.71 . . . . 73.22 109.943 175.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.501 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.4 mmt -68.22 -36.34 79.36 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.204 0.601 . . . . 73.43 111.206 -175.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.2 -43.55 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.606 1.162 . . . . 62.42 110.198 173.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 30.9 t -63.65 -34.44 77.84 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.014 -0.994 . . . . 72.45 110.581 177.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.531 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 81.2 mtt-85 -69.23 -34.76 75.34 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-N 115.89 -0.596 . . . . 63.34 110.297 178.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -75.28 -11.96 83.84 Favored Glycine 0 C--N 1.357 1.705 0 O-C-N 123.736 0.647 . . . . 41.34 112.456 170.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 16.9 m 66.92 33.63 5.79 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.769 1.628 . . . . 43.22 110.186 176.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -79.52 163.54 58.45 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-N 115.259 -0.882 . . . . 61.31 110.434 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -58.76 165.65 7.8 Favored 'Trans proline' 0 C--N 1.388 2.624 0 C-N-CA 122.655 2.237 . . . . 63.25 112.894 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.422 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 23.9 tp60 -63.88 112.47 2.93 Favored 'General case' 0 C--N 1.345 0.405 0 C-N-CA 123.86 0.864 . . . . 52.21 111.378 -167.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.689 HD11 HG11 ' B' ' 40' ' ' VAL . 23.3 tp -110.52 112.53 24.51 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.168 -0.924 . . . . 62.23 109.018 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.17 124.3 41.5 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 108.288 -1.005 . . . . 74.41 108.288 176.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.419 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 77.3 mt -83.59 136.62 34.17 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.691 0.396 . . . . 62.52 110.514 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.32 140.99 52.87 Favored Pre-proline 0 CA--C 1.55 0.952 0 O-C-N 123.972 0.795 . . . . 60.01 111.284 -174.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -60.02 93.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.541 2.828 . . . . 71.33 111.99 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 4.0 p -90.55 118.34 35.6 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 108.496 -0.927 . . . . 72.53 108.496 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -81.02 99.34 8.39 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.617 -0.72 . . . . 73.21 109.182 -175.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -64.41 -38.08 89.79 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.294 -0.867 . . . . 61.35 110.242 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.556 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 9.6 t70 -59.84 -50.47 73.68 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.053 -0.976 . . . . 61.25 110.331 -176.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.64 -36.77 85.34 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 124.15 0.906 . . . . 65.41 111.564 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.435 HD13 ' HB3' ' F' ' 120' ' ' TYR . 53.4 tp -59.54 -49.07 79.19 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.583 0.753 . . . . 52.24 110.602 177.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -72.04 -20.22 61.71 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.252 0.621 . . . . 72.41 111.787 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 8.2 mmt -73.15 -29.26 62.74 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.931 0.492 . . . . 64.13 110.891 174.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -78.72 -36.33 43.5 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.531 0.332 . . . . 71.34 110.215 172.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -60.44 -40.07 89.77 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.109 0.563 . . . . 74.4 111.268 174.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 37.1 tp -95.52 -7.93 36.61 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.4 0.68 . . . . 63.53 111.826 -176.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 67.0 120.68 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.707 1.203 . . . . 73.43 110.722 -171.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -150.91 153.5 35.39 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.471 -0.936 . . . . 72.14 108.471 177.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -151.24 115.59 5.08 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.862 -0.792 . . . . 51.13 108.862 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -148.96 145.58 27.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.014 0.926 . . . . 73.54 109.065 174.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -176.55 97.02 0.11 Allowed Glycine 0 C--N 1.338 0.685 0 N-CA-C 111.078 -0.809 . . . . 43.13 111.078 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -84.44 -172.69 4.31 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.936 0.495 . . . . 74.04 111.182 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -160.19 -42.56 0.02 OUTLIER Glycine 0 C--N 1.343 0.926 0 N-CA-C 111.497 -0.641 . . . . 61.34 111.497 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 9.1 m 49.59 59.59 4.39 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.058 1.343 . . . . 55.44 110.931 175.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . 0.482 ' HA ' ' HA3' ' D' ' 91' ' ' GLY . 3.4 tm-20 -80.95 113.39 19.13 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.571 -1.195 . . . . 54.41 109.694 -172.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -163.54 130.54 3.38 Favored 'General case' 0 C--O 1.239 0.524 0 O-C-N 124.038 0.836 . . . . 71.15 109.372 168.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -168.99 100.93 0.37 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 107.395 -1.335 . . . . 72.34 107.395 172.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -74.53 -33.12 62.68 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.486 0.714 . . . . 72.14 112.677 -171.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 62.26 18.89 10.56 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.286 1.035 . . . . 71.11 111.781 -173.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.247 0 C-N-CA 124.186 0.994 . . . . 54.04 108.984 -179.217 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 109.339 -0.615 . . . . 73.4 109.339 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . 0.433 ' H ' ' HA ' ' E' ' 142' ' ' LEU . 23.3 p -77.73 78.38 4.23 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.468 0.651 . . . . 65.33 109.399 174.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -70.78 86.65 0.68 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.587 -1.188 . . . . 74.34 110.499 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -124.02 134.26 53.48 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.398 1.079 . . . . 72.45 108.172 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . 0.673 ' HA ' ' HA2' ' C' ' 88' ' ' GLY . 62.6 t30 -154.77 42.35 0.47 Allowed 'General case' 0 CA--C 1.549 0.927 0 CA-C-O 121.357 0.599 . . . . 73.44 110.376 -176.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -106.18 -79.8 0.56 Allowed 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.58 -0.526 . . . . 74.25 109.58 176.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 44.6 p -142.99 4.98 1.49 Allowed 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 123.769 0.827 . . . . 71.4 111.743 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -76.15 -54.87 6.18 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.796 0.838 . . . . 52.54 110.79 -167.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 47.6 ttm 63.03 110.59 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.335 1.454 . . . . 72.33 109.936 -165.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.411 HG21 ' OG ' ' C' ' 2' ' ' SER . 24.1 m -97.06 86.68 4.02 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.957 -0.757 . . . . 74.4 108.957 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.465 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 59.8 t80 -104.27 116.09 31.55 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.428 -0.953 . . . . 73.5 108.428 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.445 HE22 ' HB2' ' A' ' 129' ' ' ALA . 60.8 tp60 -138.45 132.32 31.14 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 109.556 -0.535 . . . . 74.33 109.556 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 21.6 mt -77.71 128.89 38.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 O-C-N 123.957 0.786 . . . . 52.52 109.395 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.431 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.8 mm-40 -89.05 -46.57 8.75 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.471 0.709 . . . . 64.32 109.153 174.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.499 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 13.6 ptp180 -176.26 150.17 0.91 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.61 1.164 . . . . 72.44 109.63 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 76.9 mt -128.22 129.9 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.409 1.083 . . . . 73.25 108.3 175.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.539 ' HB3' HG23 ' D' ' 122' ' ' THR . 35.7 p90 -158.07 175.1 14.23 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.804 0.841 . . . . 73.31 110.421 -166.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.6 p -98.07 114.23 26.34 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 122.932 0.493 . . . . 43.13 109.982 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.538 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 27.9 mmtp -65.39 -30.37 71.18 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 109.449 -0.574 . . . . 70.44 109.449 165.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.605 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.1 t70 -162.35 146.65 12.1 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.142 -0.935 . . . . 72.15 110.651 -172.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.598 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.7 mt -138.32 147.11 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.785 1.634 . . . . 74.43 107.25 173.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 43.8 t -152.45 148.04 26.96 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 122.935 0.494 . . . . 74.44 110.535 175.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.416 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 79.8 t80 -155.82 119.4 4.4 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 114.652 -1.158 . . . . 73.13 108.119 172.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -126.87 118.0 23.71 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.15 -0.685 . . . . 62.04 109.15 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.4 81.53 46.18 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 107.574 -1.269 . . . . 63.11 107.574 167.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.73 -36.05 43.01 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 122.739 2.292 . . . . 74.23 111.408 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -101.4 30.48 4.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.56 1.144 . . . . 73.25 109.535 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.24 -54.04 28.72 Favored Pre-proline 0 N--CA 1.495 1.789 0 C-N-CA 124.259 1.024 . . . . 73.51 113.297 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.46 -42.02 29.67 Favored 'Trans proline' 0 C--N 1.381 2.24 0 CA-C-N 121.17 1.454 . . . . 61.41 111.421 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -71.0 -27.75 63.92 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 114.277 -1.329 . . . . 64.22 113.042 -174.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.569 HG21 ' HA ' ' C' ' 73' ' ' ALA . 10.8 p -80.8 -28.93 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 O-C-N 122.059 -0.401 . . . . 41.12 111.664 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -65.15 -15.6 62.6 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 112.762 0.653 . . . . 75.01 112.762 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -105.32 22.46 15.37 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.947 0.899 . . . . 73.4 111.113 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.692 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -110.23 160.63 16.34 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.591 0.756 . . . . 64.22 110.562 -178.019 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -66.34 126.85 30.07 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.335 -0.617 . . . . 75.14 109.335 166.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -80.21 77.78 6.92 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.611 0.719 . . . . 63.31 109.683 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -129.02 66.44 76.31 Favored Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 123.963 0.905 . . . . 75.11 109.43 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -90.8 153.01 4.09 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.421 2.08 . . . . 51.44 112.578 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . 0.612 ' HB2' ' HE3' ' C' ' 41' ' ' LYS . 8.7 pt-20 -88.33 104.04 16.38 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.55 -1.278 . . . . 72.11 107.55 165.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.461 HG11 HD21 ' C' ' 126' ' ' LEU . 59.4 t -77.17 100.03 2.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 108.361 -0.977 . . . . 61.22 108.361 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.612 ' HE3' ' HB2' ' C' ' 39' ' ' GLU . 34.1 mmtp -103.59 105.57 15.84 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.421 -0.809 . . . . 75.23 109.96 -177.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mp -87.31 122.36 30.97 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 107.106 -1.442 . . . . 72.53 107.106 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.436 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 28.4 t70 -124.54 105.2 9.19 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.131 -0.692 . . . . 73.14 109.131 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.515 HD11 HG11 ' C' ' 131' ' ' VAL . 98.7 mt -94.2 141.96 27.95 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.871 0.868 . . . . 71.21 110.526 -177.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -148.46 143.64 26.87 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.255 -1.387 . . . . 73.51 107.255 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . 0.436 HG21 ' HA2' ' C' ' 99' ' ' GLY . 10.0 t -133.93 149.55 51.29 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.883 -0.784 . . . . 63.02 108.883 175.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.77 143.55 27.6 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.443 -0.947 . . . . 72.13 108.443 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 7.0 m -132.3 150.71 52.1 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 109.908 -0.405 . . . . 61.21 109.908 -175.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.3 t -145.71 125.46 13.42 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.574 -0.898 . . . . 60.14 108.574 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -79.86 116.67 20.15 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.977 -0.749 . . . . 73.52 108.977 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.561 HD11 HD12 ' C' ' 83' ' ' ILE . 48.3 mt -86.04 -36.4 19.74 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.852 0.861 . . . . 74.03 110.614 -175.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.55 -172.04 3.81 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.015 0.926 . . . . 45.03 109.851 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -63.89 112.95 3.14 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.744 0.818 . . . . 64.43 109.958 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 63.99 20.8 12.36 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.641 1.176 . . . . 74.22 112.27 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 66.2 t -114.9 113.58 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.066 -1.087 . . . . 74.23 108.066 173.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -122.79 124.6 43.69 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.121 0.968 . . . . 73.2 109.673 -176.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.45 ' HB2' HD11 ' C' ' 51' ' ' LEU . 29.3 tt0 -84.46 137.74 33.19 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.501 -0.925 . . . . 65.31 108.501 168.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 92.4 t -127.21 136.37 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.544 -0.91 . . . . 54.5 108.544 172.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.472 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 58.4 t -130.08 126.06 61.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 108.931 -0.766 . . . . 73.42 108.931 177.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.518 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -102.61 98.16 8.25 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 107.162 -1.421 . . . . 75.33 107.162 -178.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.415 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 6.2 tmm_? -82.72 105.72 13.98 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.551 -0.907 . . . . 73.21 108.551 174.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 20.2 t -107.14 135.37 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.352 -0.981 . . . . 75.44 108.352 176.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 62.3 m -125.7 139.83 53.21 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.619 -0.882 . . . . 71.23 108.619 177.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.472 HG21 HG21 ' C' ' 114' ' ' ILE . 98.1 t -127.37 117.69 47.7 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 N-CA-C 108.744 -0.836 . . . . 74.11 108.744 173.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 19.3 m -103.81 140.16 38.03 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.114 -0.699 . . . . 73.12 109.114 171.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.39 112.35 17.45 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.61 -1.256 . . . . 74.33 107.61 174.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 30.4 m -126.67 127.67 45.52 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.008 0.432 . . . . 72.42 110.074 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.692 HD13 ' HG2' ' C' ' 34' ' ' LYS . 12.7 mt -96.96 23.37 7.27 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.96 1.304 . . . . 74.44 110.618 -174.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.74 -77.73 0.3 Allowed Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.196 -0.762 . . . . 50.33 111.196 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -117.48 -30.6 5.48 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.037 0.935 . . . . 74.01 109.418 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -79.68 122.54 26.68 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 124.551 1.14 . . . . 75.11 110.225 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 27.4 m -76.73 119.53 20.65 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 107.937 -1.134 . . . . 63.14 107.937 164.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.569 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -73.08 -48.51 35.27 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.385 0.612 . . . . 61.4 109.601 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -166.59 166.84 15.89 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 113.878 -1.51 . . . . 64.55 110.42 174.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -128.98 141.45 51.25 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 106.646 -1.612 . . . . 74.32 106.646 167.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 41.9 t -144.52 146.24 32.28 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.185 -1.043 . . . . 74.43 108.185 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -157.61 138.47 13.22 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.66 -0.496 . . . . 64.52 109.66 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 43.9 t -136.44 115.37 15.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 124.62 1.168 . . . . 62.13 108.375 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.605 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 50.9 mt-30 -90.59 86.85 6.51 Favored 'General case' 0 CA--C 1.523 -0.067 0 N-CA-C 107.922 -1.14 . . . . 62.32 107.922 168.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -80.11 99.38 7.71 Favored 'General case' 0 C--O 1.221 -0.404 0 N-CA-C 108.573 -0.899 . . . . 73.54 108.573 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -102.34 146.09 16.75 Favored Glycine 0 C--O 1.217 -0.931 0 O-C-N 123.179 0.299 . . . . 61.24 113.193 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.13 146.18 14.37 Favored Glycine 0 C--N 1.331 0.264 0 N-CA-C 111.54 -0.624 . . . . 74.45 111.54 -176.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.561 HD12 HD11 ' C' ' 51' ' ' LEU . 30.7 mm -96.04 138.49 21.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.84 0 N-CA-C 109.389 -0.597 . . . . 74.25 109.389 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.553 ' CZ ' HD11 ' C' ' 106' ' ' LEU . 85.4 m-85 -136.36 123.08 21.11 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 123.36 0.664 . . . . 73.1 110.363 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . 0.446 ' HB2' HD23 ' E' ' 142' ' ' LEU . 28.2 p -79.36 102.78 8.86 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 107.971 -1.122 . . . . 71.11 107.971 167.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.407 HG21 ' HE1' ' C' ' 94' ' ' MET . 19.2 mt -117.21 114.94 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.949 0.899 . . . . 62.2 110.412 -176.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -122.01 170.88 9.39 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.885 0.874 . . . . 65.25 109.131 172.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . 0.673 ' HA2' ' HA ' ' C' ' 5' ' ' ASN . . . 98.73 -22.72 39.54 Favored Glycine 0 C--N 1.341 0.809 0 N-CA-C 114.308 0.483 . . . . 63.43 114.308 170.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' C' ' 94' ' ' MET . 44.8 pt -122.66 162.35 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 112.613 0.597 . . . . 74.14 112.613 -172.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -159.09 156.64 29.53 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 115.011 -0.995 . . . . 72.3 109.909 175.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.13 -122.36 6.15 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 123.802 0.689 . . . . 63.13 113.008 171.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 42.3 p -67.56 -29.89 69.37 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.504 0.722 . . . . 73.12 110.958 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.641 ' HG2' HE21 ' C' ' 144' ' ' GLN . 27.5 mt-30 -64.69 -59.94 3.68 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.753 0.821 . . . . 73.54 110.489 175.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.493 ' HE3' ' HA ' ' C' ' 94' ' ' MET . 5.2 tpt -46.64 -53.93 10.59 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.951 1.3 . . . . 72.04 112.2 173.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.09 -44.61 91.92 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.447 0.699 . . . . 73.33 111.41 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -64.12 -33.44 75.77 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.027 0.931 . . . . 75.21 111.73 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.478 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 19.4 t -68.85 -55.85 9.81 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.551 -0.907 . . . . 75.44 108.551 177.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 72.7 mt -65.43 -25.61 67.6 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.611 1.164 . . . . 73.22 112.964 -175.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . 0.436 ' HA2' HG21 ' C' ' 46' ' ' THR . . . -109.16 -8.77 26.92 Favored Glycine 0 C--N 1.347 1.174 0 N-CA-C 115.035 0.774 . . . . 41.13 115.035 -171.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.09 -52.88 0.38 Allowed 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 118.213 1.007 . . . . 74.11 111.766 -175.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.478 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 73.7 t80 -70.75 -58.49 3.58 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.272 0.629 . . . . 74.11 111.498 -173.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.569 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 83.0 m -53.52 -59.07 10.35 Favored Pre-proline 0 CA--C 1.559 1.321 0 CA-C-O 117.663 -1.161 . . . . 72.44 110.968 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.569 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 82.4 Cg_exo -50.51 -34.22 41.43 Favored 'Trans proline' 0 C--N 1.395 3.012 0 C-N-CA 122.822 2.348 . . . . 64.02 114.85 -177.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -65.03 -32.32 73.99 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.442 0.697 . . . . 70.52 111.24 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.438 HG23 ' NH1' ' A' ' 111' ' ' ARG . 35.3 mm -72.63 -31.77 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 123.922 0.889 . . . . 72.14 110.414 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.553 HD11 ' CZ ' ' C' ' 84' ' ' PHE . 5.5 mp -90.03 -17.12 28.4 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 123.474 0.71 . . . . 73.31 111.734 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -55.93 -49.6 92.05 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-O 117.829 -1.081 . . . . 61.13 113.778 -177.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -61.16 -34.68 88.67 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 121.935 1.757 . . . . 74.21 113.07 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.426 ' HE2' HG21 ' A' ' 115' ' ' THR . 59.9 m-85 -64.24 -46.8 82.18 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.555 0.742 . . . . 75.43 110.217 175.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.07 -36.29 83.87 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.122 -0.945 . . . . 62.55 110.723 177.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 -64.96 -49.45 70.28 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.058 1.343 . . . . 61.43 110.238 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -67.89 -32.52 73.06 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.484 0.714 . . . . 63.44 109.625 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 9.0 t -70.24 -39.7 74.9 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 122.985 0.514 . . . . 71.31 110.964 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.472 HG21 HG21 ' C' ' 64' ' ' VAL . 96.6 mt -67.68 -48.79 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.346 0.658 . . . . 73.1 109.828 177.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 15.7 m -66.03 -29.34 69.68 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.915 -0.584 . . . . 55.33 110.755 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 30.2 t -64.77 -50.29 67.38 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 109.363 -0.606 . . . . 73.03 109.363 174.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.465 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -55.8 -46.9 77.91 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.432 1.093 . . . . 65.24 111.59 177.536 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 69.2 t -65.69 -40.48 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.874 0.87 . . . . 73.42 110.87 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 33.8 t -72.18 -29.52 64.08 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.607 0.763 . . . . 73.55 111.481 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.584 HH22 ' HG2' ' D' ' 112' ' ' GLU . 64.6 mtt-85 -74.1 -29.62 61.94 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.447 -0.797 . . . . 71.51 109.782 176.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.23 12.43 58.35 Favored Glycine 0 C--N 1.353 1.479 0 O-C-N 124.015 0.822 . . . . 24.34 112.886 172.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.43 HG23 ' HB3' ' D' ' 17' ' ' TYR . 69.4 p 54.16 28.34 8.9 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 126.519 1.928 . . . . 70.33 114.214 176.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -84.24 151.93 60.58 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 109.365 -0.605 . . . . 74.44 109.365 172.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -47.39 136.23 19.93 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.35 2.7 . . . . 71.41 113.11 175.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.422 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 41.9 mm-40 -53.69 110.98 0.64 Allowed 'General case' 0 N--CA 1.478 0.965 0 O-C-N 124.317 1.01 . . . . 74.04 111.839 -175.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.461 HD21 HG11 ' C' ' 40' ' ' VAL . 3.9 tt -113.95 90.46 3.35 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.983 -1.117 . . . . 65.42 107.983 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -94.41 122.31 36.84 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.463 -0.94 . . . . 73.41 108.463 173.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 6.4 mp -66.73 145.18 55.81 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 124.174 0.921 . . . . 75.04 111.288 -171.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.8 151.9 77.06 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-N 115.602 -0.726 . . . . 64.32 110.791 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.546 ' HG3' HD12 ' A' ' 16' ' ' ILE . 21.6 Cg_exo -63.82 107.32 0.74 Allowed 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 123.062 2.508 . . . . 60.43 112.385 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.515 HG11 HD11 ' C' ' 44' ' ' LEU . 7.4 p -103.84 139.84 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 123.926 0.89 . . . . 73.33 109.096 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -94.43 104.35 16.32 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.709 0.804 . . . . 63.24 110.325 -171.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -63.4 -34.58 78.03 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.909 0.884 . . . . 74.23 112.425 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -64.99 -40.15 94.53 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.218 0.607 . . . . 61.21 110.414 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.43 -30.42 67.26 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.573 0.749 . . . . 65.51 111.177 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 91.6 mt -72.39 -40.23 67.4 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.011 0.524 . . . . 75.42 110.139 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -75.4 -18.04 60.03 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.198 -0.91 . . . . 73.4 110.226 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.725 ' HA ' ' HB2' ' C' ' 142' ' ' GLN . 47.8 ttm -65.86 -34.27 77.76 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.491 0.716 . . . . 74.3 110.363 176.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -65.8 -38.16 88.23 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.515 -0.766 . . . . 73.42 110.14 172.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -70.88 -90.15 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.054 0.942 . . . . 62.5 110.337 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mp -138.0 104.09 5.15 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.984 0.913 . . . . 75.32 109.345 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.725 ' HB2' ' HA ' ' C' ' 138' ' ' MET . 5.9 tp-100 -118.87 106.46 12.52 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.062 -0.718 . . . . 71.1 109.062 173.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -149.52 3.12 0.56 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.55 0.74 . . . . 62.11 109.715 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . 0.641 HE21 ' HG2' ' C' ' 93' ' ' GLN . 1.5 tm0? -100.87 126.76 47.49 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.592 -0.892 . . . . 63.12 108.592 -178.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -131.48 13.78 5.0 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.868 0.867 . . . . 62.34 110.295 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.98 115.09 4.21 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 111.324 -0.711 . . . . 54.23 111.324 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -91.94 106.06 18.17 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 107.798 -1.186 . . . . 63.31 107.798 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -90.13 74.96 1.78 Allowed Glycine 0 C--N 1.343 0.924 0 CA-C-N 115.818 -0.628 . . . . 54.45 112.198 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 9.1 t -73.21 119.73 17.85 Favored 'General case' 0 C--O 1.246 0.881 0 C-N-CA 123.454 0.702 . . . . 73.01 110.678 177.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -132.84 144.33 50.14 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.259 0.624 . . . . 63.15 110.168 172.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -154.4 138.06 16.07 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.925 -1.139 . . . . 40.22 107.925 166.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -155.07 93.4 1.53 Allowed 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 108.362 -0.977 . . . . 72.04 108.362 175.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -88.82 86.79 7.04 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.723 0.809 . . . . 63.53 110.165 -176.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -173.78 -178.14 1.52 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.902 1.281 . . . . 65.3 108.686 173.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.216 0 C-N-CA 124.637 1.175 . . . . 73.12 110.953 177.657 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 109.331 -0.618 . . . . 72.2 109.331 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 7.8 m -133.83 105.68 6.91 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.745 0.818 . . . . 72.34 109.109 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -148.86 100.45 3.08 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.651 0.781 . . . . 72.12 109.135 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.84 80.94 8.01 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 106.126 -1.805 . . . . 71.11 106.126 164.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -165.71 159.83 16.68 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 114.363 -1.289 . . . . 71.43 108.139 -169.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -72.46 80.09 1.05 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.11 -0.7 . . . . 61.03 109.11 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 14.0 t 176.37 -170.91 0.07 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 126.164 1.786 . . . . 65.32 108.243 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' D' ' 9' ' ' MET . 8.2 tp10 69.53 -169.28 0.17 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.064 0.946 . . . . 71.1 110.881 168.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.475 ' HG2' HG13 ' D' ' 89' ' ' ILE . 0.4 OUTLIER -28.96 125.44 0.11 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.836 1.654 . . . . 73.12 112.455 164.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 11.1 t -115.0 139.99 49.4 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.334 0.654 . . . . 74.05 109.899 -176.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -133.23 92.4 3.0 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 106.875 -1.528 . . . . 75.33 106.875 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . 0.502 HE22 ' HE2' ' E' ' 94' ' ' PHE . 41.7 mt-30 -114.19 117.35 30.92 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.629 0.772 . . . . 74.45 109.163 -175.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 9.0 mt -82.25 132.59 31.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.009 -1.108 . . . . 55.03 108.009 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -101.35 -28.59 12.52 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.624 0.77 . . . . 74.1 110.556 -174.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -173.44 133.12 0.48 Allowed 'General case' 0 C--N 1.361 1.09 0 O-C-N 123.618 0.574 . . . . 75.03 110.41 -176.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.413 HD12 ' N ' ' D' ' 16' ' ' ILE . 3.3 mp -114.04 130.47 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 107.212 -1.403 . . . . 63.15 107.212 173.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.458 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 37.4 p90 -163.65 175.79 10.25 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.987 0.899 . . . . 72.12 112.45 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.8 p -108.18 118.76 37.61 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 114.218 -1.356 . . . . 72.32 108.871 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.458 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 29.9 mtpt -90.52 -11.27 40.68 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.991 -0.744 . . . . 55.23 108.991 177.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.751 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 18.7 t70 -166.23 135.67 3.18 Favored 'General case' 0 C--N 1.359 1.002 0 C-N-CA 124.766 1.226 . . . . 75.24 109.376 -175.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.465 HD13 ' HE3' ' C' ' 117' ' ' MET . 52.8 mt -144.36 138.22 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.185 1.394 . . . . 63.43 107.937 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -145.45 138.64 26.32 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.838 0.855 . . . . 74.22 109.21 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.598 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.4 t80 -142.07 135.69 29.41 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 107.113 -1.44 . . . . 75.32 107.113 170.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -135.74 148.45 48.82 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 108.837 -0.801 . . . . 72.22 108.837 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -142.87 75.72 17.63 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 107.104 -1.443 . . . . 65.15 107.104 175.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -68.92 -27.81 30.17 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.777 2.318 . . . . 70.14 112.938 -169.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -108.2 1.01 21.82 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 115.415 -0.811 . . . . 64.3 110.696 -175.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.476 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -20.87 -73.09 0.03 OUTLIER Pre-proline 0 CA--C 1.567 1.61 0 N-CA-C 116.612 2.078 . . . . 73.54 116.612 -166.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.538 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 93.1 Cg_endo -75.15 -20.55 16.47 Favored 'Trans proline' 0 C--N 1.379 2.182 0 CA-C-N 123.962 2.451 . . . . 73.34 114.135 -173.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.464 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 5.1 t-160 -72.7 -40.63 66.06 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.877 0.871 . . . . 62.43 109.495 174.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.476 HG12 ' O ' ' D' ' 28' ' ' ALA . 5.5 p -83.52 -20.66 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 CA-C-N 115.612 -0.722 . . . . 72.45 111.566 -173.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.4 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 22.5 m-85 -66.99 -20.65 65.92 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 111.982 0.364 . . . . 73.35 111.982 178.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 62.0 mt-30 -64.03 -15.05 58.58 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.374 1.069 . . . . 73.34 110.926 176.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -92.7 96.62 10.28 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.117 1.367 . . . . 75.32 109.718 175.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -92.07 79.67 5.16 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.808 -1.087 . . . . 51.14 110.808 -172.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -158.89 171.33 20.26 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.447 -0.797 . . . . 73.54 109.727 168.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.481 HE21 ' HD2' ' D' ' 38' ' ' PRO . 31.1 tp60 -67.65 115.3 25.9 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 123.836 0.855 . . . . 75.23 109.274 177.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.481 ' HD2' HE21 ' D' ' 37' ' ' GLN . 81.3 Cg_exo -49.05 131.12 25.3 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 123.079 2.519 . . . . 52.21 112.475 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -65.04 110.37 2.46 Favored 'General case' 0 C--N 1.346 0.428 0 N-CA-C 107.008 -1.478 . . . . 73.21 107.008 171.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.709 HG13 HG13 ' D' ' 64' ' ' VAL . 96.9 t -113.05 127.19 70.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 108.517 -0.92 . . . . 73.14 108.517 -175.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.466 ' HE3' ' HB3' ' D' ' 41' ' ' LYS . 0.5 OUTLIER -120.76 129.42 53.6 Favored 'General case' 0 C--O 1.248 0.991 0 N-CA-C 106.493 -1.669 . . . . 63.23 106.493 172.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.631 HD11 HG13 ' D' ' 62' ' ' VAL . 33.1 tp -97.1 129.29 44.53 Favored 'General case' 0 C--O 1.238 0.477 0 O-C-N 123.931 0.77 . . . . 73.45 110.111 -172.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.601 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.2 m-20 -108.98 112.38 24.55 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.535 -1.654 . . . . 64.12 106.535 177.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.411 ' CD2' HG22 ' D' ' 62' ' ' VAL . 25.8 mt -107.23 131.95 53.62 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.374 0.606 . . . . 65.4 109.903 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.3 t70 -133.85 153.65 51.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.21 -1.359 . . . . 53.43 108.063 176.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 5.1 t -126.61 149.85 49.23 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.006 0.922 . . . . 64.13 109.047 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.478 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -148.78 141.11 24.14 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.216 -1.031 . . . . 63.03 108.216 178.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 91.3 p -155.73 -172.15 4.03 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 108.438 -0.949 . . . . 72.31 108.438 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 21.3 p -150.27 139.01 20.77 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 122.829 0.452 . . . . 60.42 109.847 -175.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -67.22 91.44 0.24 Allowed 'General case' 0 C--N 1.352 0.678 0 N-CA-C 108.215 -1.032 . . . . 74.55 108.215 169.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 42.7 tp -141.55 99.26 3.52 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 107.547 -1.279 . . . . 74.52 107.547 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.92 -142.13 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.614 0.766 . . . . 64.55 110.972 -175.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 70.99 12.24 7.02 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.852 1.261 . . . . 72.23 111.285 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.62 26.8 16.41 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.593 1.157 . . . . 75.02 111.024 -175.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 2.0 p -133.57 101.06 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.398 1.079 . . . . 64.25 108.217 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -118.24 144.27 45.9 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 114.634 -1.166 . . . . 75.24 108.84 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -105.43 136.26 45.31 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.428 0.632 . . . . 64.3 110.81 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 90.3 t -114.54 144.8 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-N 114.098 -1.41 . . . . 71.42 108.03 174.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 52.2 t -135.99 127.76 44.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.668 -1.234 . . . . 71.52 107.668 176.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.535 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -109.67 102.14 10.99 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 106.844 -1.539 . . . . 63.25 106.844 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.507 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.6 ttt180 -83.8 95.2 8.37 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.46 -0.941 . . . . 75.24 108.46 176.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.631 HG13 HD11 ' D' ' 42' ' ' LEU . 66.5 t -96.33 117.18 40.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.661 -1.154 . . . . 73.42 108.97 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.601 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 23.8 m -123.06 130.25 52.54 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-N 114.9 -1.045 . . . . 75.11 108.725 -174.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.709 HG13 HG13 ' D' ' 40' ' ' VAL . 47.2 t -111.25 121.37 63.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 C-N-CA 124.821 1.248 . . . . 73.4 108.967 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 18.4 m -100.26 110.92 23.18 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.463 -1.31 . . . . 52.53 107.463 164.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.07 138.62 54.1 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.986 -0.746 . . . . 63.41 108.986 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.482 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 80.9 p -142.07 140.67 32.62 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.347 0.594 . . . . 73.53 111.241 -175.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.427 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 35.3 mt -112.92 114.5 27.02 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 106.889 -1.522 . . . . 64.5 106.889 169.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.19 -129.2 9.23 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 123.166 0.291 . . . . 73.43 112.423 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.76 5.34 36.03 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.492 0.717 . . . . 72.04 110.901 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -121.97 165.15 16.43 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.469 0.708 . . . . 61.44 109.586 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 94.1 m -69.26 135.26 50.26 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.803 -0.635 . . . . 75.1 111.484 177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.482 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -82.32 -68.69 0.68 Allowed 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.595 -1.261 . . . . 75.04 107.595 170.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -149.3 161.88 41.17 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 114.974 -1.012 . . . . 71.41 110.363 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 78.7 mt -120.9 120.35 35.26 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.482 1.113 . . . . 73.14 108.22 176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.658 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 1.7 m -116.78 139.15 50.91 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.214 -1.032 . . . . 70.13 108.214 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -157.12 121.85 4.46 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.931 0.493 . . . . 70.11 109.676 173.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -136.13 119.12 22.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 123.705 0.802 . . . . 52.1 109.041 -175.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.751 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.2 mt-30 -89.04 88.59 7.63 Favored 'General case' 0 C--O 1.245 0.864 0 N-CA-C 108.647 -0.871 . . . . 73.43 108.647 170.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -80.27 99.19 7.73 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.371 -1.286 . . . . 70.32 108.739 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -102.35 142.33 15.56 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 116.316 -0.402 . . . . 71.42 112.141 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.68 140.88 11.64 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 111.117 -0.793 . . . . 61.52 111.117 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 61.3 mt -90.78 119.14 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.933 -1.136 . . . . 72.23 107.933 175.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -119.85 131.31 55.24 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.692 0.797 . . . . 71.11 110.192 -176.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 35.4 t -107.9 100.47 9.83 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.363 -0.977 . . . . 62.23 108.363 172.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 39.9 pt -110.54 147.67 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.674 1.19 . . . . 73.41 108.807 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.7 168.56 12.45 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.792 0.682 . . . . 64.12 111.033 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.6 21.92 49.09 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.596 0.56 . . . . 54.34 114.166 174.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.475 HG13 ' HG2' ' D' ' 9' ' ' MET . 0.7 OUTLIER -138.84 161.14 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.8 0.84 . . . . 72.34 111.475 -177.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -149.22 -171.89 3.99 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.215 -1.357 . . . . 74.33 109.192 176.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' B' ' 150' ' ' GLU . . . 77.31 -140.19 24.22 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-O 119.709 -0.495 . . . . 50.51 111.934 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 81.1 p -91.87 -35.82 13.84 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 117.529 0.664 . . . . 73.21 111.268 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.568 ' HA ' ' HB3' ' D' ' 96' ' ' HIS . 27.8 tp60 -65.63 -22.03 66.62 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.203 1.001 . . . . 71.24 112.023 -172.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.475 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 0.0 OUTLIER -60.85 -43.59 98.12 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.802 0.441 . . . . 71.12 111.433 177.257 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . 0.475 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -79.59 -31.01 41.72 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.775 0.83 . . . . 62.4 110.543 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.568 ' HB3' ' HA ' ' D' ' 93' ' ' GLN . 18.8 t-80 -75.06 -25.3 58.53 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 123.935 0.894 . . . . 75.12 112.153 -175.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 85.2 m -65.87 -38.27 88.35 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.56 0.695 . . . . 74.11 109.795 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.614 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 12.9 tp -77.97 -35.96 49.63 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.831 -1.077 . . . . 72.34 110.421 177.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.74 -28.45 42.63 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.434 -0.803 . . . . 62.23 115.03 -171.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.24 -47.2 2.27 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 118.295 1.047 . . . . 74.12 111.396 -175.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -74.7 -34.59 62.65 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 112.031 0.382 . . . . 72.42 112.031 -174.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.614 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 90.3 m -67.01 -47.55 52.35 Favored Pre-proline 0 CA--C 1.565 1.553 0 CA-C-O 118.46 -0.781 . . . . 75.32 112.174 177.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.535 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.5 Cg_exo -55.84 -34.27 90.92 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 122.158 1.905 . . . . 63.44 113.136 169.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -61.96 -37.34 84.38 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.482 0.713 . . . . 65.04 111.123 176.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 44.9 mm -68.25 -41.53 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.528 0.731 . . . . 74.15 110.601 174.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 96.6 mt -78.17 -15.13 59.11 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.742 -0.663 . . . . 70.14 112.331 -172.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -70.03 -44.09 20.63 Favored Pre-proline 0 N--CA 1.485 1.294 0 N-CA-C 113.858 1.059 . . . . 61.21 113.858 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . 0.538 ' HB2' ' HG2' ' B' ' 108' ' ' PRO . 18.8 Cg_endo -58.03 -29.24 86.2 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 121.624 1.55 . . . . 65.31 112.771 172.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -81.18 -31.23 34.1 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.782 0.833 . . . . 71.54 111.493 175.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.91 -50.28 71.48 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.792 0.837 . . . . 34.44 109.934 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -73.51 -29.47 62.5 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.198 -0.91 . . . . 74.12 110.593 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . 0.584 ' HG2' HH22 ' C' ' 120' ' ' ARG . 23.5 tt0 -53.19 -46.18 68.88 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.458 0.703 . . . . 65.34 110.479 173.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.1 t -70.38 -47.37 61.23 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.426 -0.806 . . . . 43.44 111.226 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.449 ' O ' HG23 ' D' ' 118' ' ' VAL . 76.8 mt -60.12 -61.27 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.887 0.875 . . . . 74.2 111.643 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 10.3 m -50.94 -38.94 53.54 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.448 1.099 . . . . 75.24 111.638 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -64.27 -48.29 76.32 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.347 -0.842 . . . . 64.03 110.012 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 73.7 mtm -67.24 -29.85 69.6 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.148 0.579 . . . . 74.42 111.767 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.449 HG23 ' O ' ' D' ' 114' ' ' ILE . 76.0 t -64.84 -46.69 91.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.62 0.768 . . . . 73.34 109.39 176.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.5 p -72.87 -31.42 64.72 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.875 -0.602 . . . . 62.21 110.588 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 77.6 mtt-85 -69.46 -28.87 66.47 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.775 0.83 . . . . 72.31 110.405 174.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.8 10.01 74.1 Favored Glycine 0 C--N 1.351 1.378 0 CA-C-O 119.317 -0.713 . . . . 71.24 112.647 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.539 HG23 ' HB3' ' C' ' 17' ' ' TYR . 74.5 p 52.68 37.45 23.6 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 126.12 1.768 . . . . 65.32 113.499 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -99.81 151.86 37.62 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 115.01 -0.995 . . . . 75.3 109.645 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.535 ' HB3' ' HA ' ' E' ' 129' ' ' THR . 80.3 Cg_exo -51.84 145.38 32.05 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 123.478 2.786 . . . . 73.11 113.194 171.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.511 ' HB3' ' HB3' ' E' ' 128' ' ' ALA . 65.1 tt0 -61.16 136.86 58.2 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.836 0.854 . . . . 73.54 112.631 -169.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.442 HD13 HG21 ' D' ' 40' ' ' VAL . 16.4 tp -124.81 99.42 6.14 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.434 1.094 . . . . 65.53 109.267 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -100.11 108.28 20.38 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 107.702 -1.222 . . . . 64.4 107.702 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 6.7 mp -70.81 116.28 10.94 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 109.333 -0.618 . . . . 73.34 109.333 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.495 ' HB2' ' HB3' ' E' ' 125' ' ' ALA . . . -61.11 141.38 93.84 Favored Pre-proline 0 CA--C 1.55 0.972 0 O-C-N 124.078 0.861 . . . . 62.44 111.772 -177.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.67 116.05 3.03 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.537 2.158 . . . . 60.12 110.868 175.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 13.1 p -108.62 146.53 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 123.811 0.845 . . . . 65.31 109.315 -172.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -73.6 104.45 4.55 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.834 -0.802 . . . . 72.41 108.834 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.697 ' HA ' HD23 ' D' ' 136' ' ' LEU . 75.3 m-85 -62.82 -36.89 84.66 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.571 0.748 . . . . 74.12 111.516 -178.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' E' ' 112' ' ' ASN . 24.8 m-20 -55.0 -38.23 67.62 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.242 0.617 . . . . 71.11 110.89 173.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.65 -18.62 59.6 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.073 0.949 . . . . 73.52 112.46 -176.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.697 HD23 ' HA ' ' D' ' 133' ' ' PHE . 3.6 mm? -59.81 -51.25 70.56 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 112.783 0.661 . . . . 71.5 112.783 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.45 ' HB2' ' HB3' ' E' ' 112' ' ' ASN . 13.5 m-85 -75.62 -30.45 59.54 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 119.708 -0.187 . . . . 74.02 111.025 176.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.419 ' HB3' ' N ' ' E' ' 117' ' ' LYS . 55.6 mtt -60.56 -34.82 74.71 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 120.879 0.371 . . . . 74.4 110.851 173.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.486 ' O ' ' HG3' ' D' ' 142' ' ' GLN . 7.1 t30 -76.59 -38.75 54.31 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.082 0.953 . . . . 74.12 109.396 176.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . 0.438 ' HB3' ' HA ' ' D' ' 137' ' ' PHE . 61.5 t80 -58.33 -38.08 76.42 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.204 1.001 . . . . 75.14 111.212 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.408 HD13 ' O ' ' D' ' 137' ' ' PHE . 8.3 mp -61.65 -43.07 99.55 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.13 0.572 . . . . 71.14 111.1 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' D' ' 139' ' ' ASN . 4.1 pp0? -86.9 7.99 24.95 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.106 0.562 . . . . 74.41 111.173 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . 0.514 ' HG3' ' HB3' ' D' ' 147' ' ' GLU . 33.7 tt0 -120.19 92.81 3.86 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.875 0.87 . . . . 63.54 109.371 -171.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -145.33 84.68 1.7 Allowed 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.221 -1.029 . . . . 70.43 108.221 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . 58.75 20.9 8.34 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.584 1.154 . . . . 75.42 112.55 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -140.51 23.44 2.67 Favored Glycine 0 C--N 1.348 1.221 0 C-N-CA 123.154 0.407 . . . . 72.14 112.409 -173.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . 0.514 ' HB3' ' HG3' ' D' ' 143' ' ' GLN . 0.1 OUTLIER -90.81 -27.9 18.56 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.437 0.695 . . . . 73.23 109.643 174.145 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.57 172.84 12.17 Favored Glycine 0 C--N 1.356 1.643 0 CA-C-O 121.253 0.363 . . . . 33.05 113.059 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 47.0 p -139.08 140.87 38.15 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.515 -0.92 . . . . 61.21 108.515 174.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -130.3 119.59 23.06 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.257 -0.645 . . . . 73.33 109.257 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -95.71 38.29 1.17 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.964 0.906 . . . . 64.35 110.749 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . 0.407 ' NE2' ' HB3' ' D' ' 154' ' ' ASP . 37.3 t60 -69.7 91.82 0.63 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.491 -0.559 . . . . 75.15 109.491 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -77.41 -9.95 59.17 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.731 0.812 . . . . 74.32 112.709 -174.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . 0.407 ' HB3' ' NE2' ' D' ' 152' ' ' HIS . 34.6 t70 -70.15 81.1 0.51 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.389 0.676 . . . . 75.31 109.516 176.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.277 0 CA-C-N 114.897 -1.047 . . . . 73.33 109.423 -177.624 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.878 0 N-CA-C 112.028 -0.429 . . . . 72.14 112.028 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . -90.29 -134.89 5.85 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 111.738 -0.545 . . . . 50.32 111.738 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 59.11 80.25 0.2 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.803 1.241 . . . . 75.45 111.759 173.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 94' ' ' PHE . . . . . 0.502 ' HE2' HE22 ' D' ' 12' ' ' GLN . 97.5 m-85 -104.81 -160.22 0.75 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.491 0.717 . . . . 73.43 109.671 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -133.32 135.96 45.13 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 108.323 -0.991 . . . . 72.21 108.323 169.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.99 -43.06 0.18 Allowed Glycine 0 C--N 1.339 0.721 0 N-CA-C 112.18 -0.368 . . . . 44.35 112.18 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 97' ' ' ILE . . . . . 0.452 HG12 ' CD2' ' E' ' 100' ' ' LEU . 4.7 tt -103.64 80.55 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 CA-C-O 123.252 1.501 . . . . 73.13 109.502 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -108.44 -40.93 4.98 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 114.897 -1.047 . . . . 72.12 110.586 -174.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -82.08 75.57 9.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.571 0.748 . . . . 52.43 111.588 -173.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 100' ' ' LEU . . . . . 0.478 HD12 HD23 ' E' ' 102' ' ' LEU . 2.3 pt? -164.5 136.21 3.53 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 123.927 0.891 . . . . 73.04 109.656 170.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.77 -14.34 11.32 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.527 2.151 . . . . 55.25 112.07 168.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 102' ' ' LEU . . . . . 0.478 HD23 HD12 ' E' ' 100' ' ' LEU . 1.0 OUTLIER 53.35 51.17 15.94 Favored 'General case' 0 C--N 1.367 1.332 0 C-N-CA 125.029 1.332 . . . . 73.21 108.903 -172.518 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 65.4 p 47.61 75.64 0.13 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.813 1.245 . . . . 55.12 111.072 -173.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.91 152.64 35.55 Favored Glycine 0 C--N 1.353 1.487 0 CA-C-N 115.755 -0.657 . . . . 54.35 113.32 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 66.98 68.42 0.41 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.923 1.289 . . . . 74.52 109.86 -170.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 54.3 t80 68.85 157.19 0.14 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.788 1.235 . . . . 70.21 111.336 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 4.2 m -67.08 108.27 2.58 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 122.985 0.514 . . . . 54.44 110.817 -177.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -80.26 -65.79 0.96 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.88 0.472 . . . . 73.42 109.854 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -139.18 138.09 36.62 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.306 -0.998 . . . . 72.14 108.306 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -164.84 -46.76 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.034 0.445 . . . . 54.44 111.384 -171.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . 0.505 ' HB3' ' O ' ' D' ' 133' ' ' PHE . 5.3 mp -87.15 65.15 8.73 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.954 0.902 . . . . 74.24 108.875 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 112' ' ' ASN . . . . . 0.45 ' HB3' ' HB2' ' D' ' 137' ' ' PHE . 22.5 p-10 -157.82 177.61 11.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.148 0.979 . . . . 52.4 109.837 -177.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -157.11 -62.17 0.09 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 122.222 0.209 . . . . 75.43 111.085 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.74 156.22 29.44 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.955 0.502 . . . . 74.13 111.483 -172.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 29.2 m 61.14 -91.83 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 125.142 1.377 . . . . 42.35 112.942 171.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 147.12 155.66 6.64 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 110.85 -0.9 . . . . 53.12 110.85 -168.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 117' ' ' LYS . . . . . 0.419 ' N ' ' HB3' ' D' ' 138' ' ' MET . 74.7 mmtt -118.97 154.24 53.06 Favored Pre-proline 0 N--CA 1.476 0.858 0 C-N-CA 123.703 0.801 . . . . 72.32 109.505 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -72.94 -156.73 0.05 OUTLIER 'Trans proline' 0 CA--C 1.555 1.534 0 C-N-CA 122.995 2.463 . . . . 51.21 111.566 166.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -61.39 85.71 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.374 1.07 . . . . 75.44 110.613 176.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -89.84 -66.67 0.9 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.168 -0.924 . . . . 73.24 111.136 -175.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 121' ' ' VAL . . . . . 0.502 HG21 HD13 ' D' ' 136' ' ' LEU . 39.5 t -76.76 83.57 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 109.627 -0.508 . . . . 72.43 109.627 -172.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 4.2 m -147.5 7.74 0.88 Allowed 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 123.89 0.876 . . . . 72.14 109.784 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -131.05 -179.5 5.37 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.551 0.741 . . . . 74.34 111.192 -173.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 23.1 t -163.23 176.23 10.17 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.294 1.037 . . . . 45.32 109.064 175.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . 0.658 ' HB1' ' HG3' ' B' ' 12' ' ' GLN . . . -146.08 99.15 3.21 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.328 0.651 . . . . 75.23 109.785 177.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -172.67 130.52 0.54 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.163 0.985 . . . . 74.41 108.98 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 35.3 p -149.26 100.36 3.02 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.721 0.408 . . . . 73.22 109.973 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 128' ' ' ALA . . . . . 0.511 ' HB3' ' HB3' ' D' ' 125' ' ' GLN . . . -161.11 82.53 0.64 Allowed 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.124 0.97 . . . . 73.44 108.686 174.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 129' ' ' THR . . . . . 0.535 ' HA ' ' HB3' ' D' ' 124' ' ' PRO . 7.5 t -116.09 114.03 23.97 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.912 -0.585 . . . . 75.13 110.319 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -178.69 111.17 0.06 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.797 1.639 . . . . 70.31 106.576 176.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 131' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -162.31 56.46 0.23 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.413 0.625 . . . . 72.43 110.126 -175.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 36.2 t -137.87 95.09 2.98 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.503 -0.925 . . . . 74.22 108.503 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 23.8 m -145.79 91.35 2.08 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 122.959 0.503 . . . . 72.24 110.388 -176.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.94 87.92 0.66 Allowed Glycine 0 C--N 1.343 0.921 0 N-CA-C 111.046 -0.821 . . . . 64.33 111.046 169.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 3.4 p -55.58 132.64 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 C-N-CA 124.63 1.172 . . . . 65.42 112.598 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -126.33 120.64 30.41 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 108.168 -1.049 . . . . 70.12 108.168 174.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 1.2 p -147.95 -59.07 0.25 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.389 0.676 . . . . 73.43 110.769 -176.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -104.98 -79.07 0.56 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.436 -0.347 . . . . 65.41 110.386 -169.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -75.02 166.1 24.21 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.856 0.862 . . . . 71.24 111.308 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.34 142.0 36.54 Favored Glycine 0 C--N 1.349 1.254 0 O-C-N 123.624 0.578 . . . . 43.55 112.216 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.83 94.38 3.31 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.988 0.423 . . . . 63.13 109.868 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 142' ' ' LEU . . . . . 0.446 HD23 ' HB2' ' C' ' 85' ' ' SER . 48.2 tp -67.63 -42.72 81.89 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.288 -0.869 . . . . 74.1 109.791 172.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -156.51 143.15 9.38 Favored Glycine 0 C--N 1.33 0.23 0 N-CA-C 109.244 -1.542 . . . . 71.14 109.244 171.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 11.4 m -145.9 151.56 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 124.151 0.98 . . . . 72.54 109.355 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 36.2 t70 . . . . . 0 C--O 1.246 0.908 0 CA-C-O 118.621 -0.704 . . . . 64.44 109.717 179.173 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.772 0 N-CA-C 111.356 -0.698 . . . . 64.21 111.356 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.0 -55.46 3.67 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-O 119.979 -0.345 . . . . 34.44 113.089 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -77.38 71.91 3.89 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.747 0.819 . . . . 64.51 109.706 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -104.42 136.36 44.14 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 107.696 -1.224 . . . . 74.24 107.696 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -68.07 110.51 3.98 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.637 0.732 . . . . 75.41 112.111 -176.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -143.59 -166.0 11.06 Favored Glycine 0 C--O 1.245 0.824 0 N-CA-C 108.964 -1.655 . . . . 64.41 108.964 167.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 97' ' ' ILE . . . . . 0.782 HG23 ' SD ' ' B' ' 94' ' ' MET . 9.3 mt 71.45 -28.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.573 1.844 0 N-CA-C 114.786 1.402 . . . . 72.45 114.786 168.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 35.4 t70 81.45 -86.96 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.809 2.044 . . . . 61.14 111.434 -166.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -112.54 -46.23 3.17 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.35 0.66 . . . . 61.41 111.794 -169.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 100' ' ' LEU . . . . . 0.455 ' HB2' HG21 ' F' ' 97' ' ' ILE . 8.2 tp 75.42 74.04 0.2 Allowed Pre-proline 0 N--CA 1.479 0.996 0 C-N-CA 126.152 1.781 . . . . 74.3 112.473 -176.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -97.68 114.28 0.11 Allowed 'Trans proline' 0 CA--C 1.558 1.683 0 C-N-CA 123.13 2.553 . . . . 72.3 111.552 162.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 102' ' ' LEU . . . . . . . . . . . . . 1.7 tt -86.91 67.04 9.69 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 107.873 -1.158 . . . . 74.11 107.873 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 51.9 p 51.33 25.29 2.47 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.013 1.325 . . . . 70.42 113.284 174.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 83.66 49.62 4.78 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 111.955 -0.458 . . . . 62.12 111.955 -173.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 67.96 -75.51 0.06 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 125.494 1.517 . . . . 75.21 112.617 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -69.69 134.91 49.21 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.542 0.737 . . . . 72.3 110.052 -176.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 26.6 m -70.93 128.8 37.22 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.636 0.774 . . . . 72.53 110.581 -177.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -76.23 -32.82 59.11 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.847 0.859 . . . . 74.12 110.377 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -65.61 119.01 10.35 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.032 -1.099 . . . . 74.52 108.032 170.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . 0.717 ' HB1' ' HB2' ' F' ' 113' ' ' LYS . . . -68.11 -5.89 20.11 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.342 0.867 . . . . 74.4 113.342 -170.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 22.7 tp 73.15 -74.07 0.09 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.986 1.314 . . . . 73.44 109.7 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -141.84 12.05 2.05 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.819 0.848 . . . . 70.24 110.358 177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 113' ' ' LYS . . . . . 0.717 ' HB2' ' HB1' ' F' ' 110' ' ' ALA . 52.6 mtpt -86.1 25.69 1.12 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.468 -0.77 . . . . 74.43 112.767 -174.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . 0.413 ' HA ' ' HG3' ' F' ' 118' ' ' PRO . 93.8 mttt 77.76 -52.34 0.52 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.28 1.432 . . . . 73.21 113.911 165.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 8.0 t -64.56 154.48 36.03 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 122.687 0.395 . . . . 63.43 110.172 171.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 84.95 -117.0 4.4 Favored Glycine 0 C--N 1.342 0.862 0 N-CA-C 110.32 -1.112 . . . . 70.41 110.32 -171.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 5.2 ttmp? -159.48 81.07 2.55 Favored Pre-proline 0 N--CA 1.482 1.129 0 C-N-CA 123.25 0.62 . . . . 74.53 109.931 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 118' ' ' PRO . . . . . 0.413 ' HG3' ' HA ' ' F' ' 114' ' ' LYS . 29.8 Cg_endo -88.43 23.14 0.79 Allowed 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 123.138 2.558 . . . . 63.12 112.627 -178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.82 84.91 0.66 Allowed 'General case' 0 C--N 1.35 0.613 0 C-N-CA 124.463 1.105 . . . . 74.45 110.804 -174.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 120' ' ' TYR . . . . . 0.435 ' HB3' HD13 ' B' ' 136' ' ' LEU . 81.9 t80 -174.27 -50.35 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.633 1.573 . . . . 74.31 106.912 -174.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 42.2 t -87.11 113.26 24.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 114.724 -1.125 . . . . 65.34 108.193 175.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 23.1 m -70.45 -14.0 62.36 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.134 0.573 . . . . 65.4 111.504 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 25.5 t70 72.03 5.91 5.45 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.548 1.139 . . . . 54.01 112.557 169.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 26.7 m -137.41 105.17 5.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.267 1.027 . . . . 43.53 109.114 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -166.51 170.33 12.92 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.686 0.794 . . . . 62.54 110.534 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . 73.74 109.37 0.07 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.601 1.56 . . . . 51.23 111.869 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 45.3 t -127.38 102.17 6.78 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.477 1.111 . . . . 71.01 108.172 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 128' ' ' ALA . . . . . 0.492 ' HB3' ' HD2' ' B' ' 38' ' ' PRO . . . -85.9 77.99 9.59 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.483 0.713 . . . . 75.44 111.895 -170.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 129' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' B' ' 37' ' ' GLN . 4.4 m -101.4 65.2 1.04 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 108.703 -0.851 . . . . 74.3 108.703 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -160.13 107.52 1.63 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.038 -0.528 . . . . 75.11 110.373 -174.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 131' ' ' TRP . . . . . 0.475 ' HZ2' HH22 ' A' ' 15' ' ' ARG . 1.3 t90 -138.59 158.29 44.53 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 108.866 -0.79 . . . . 65.21 108.866 -176.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 132' ' ' SER . . . . . 0.454 ' HB3' ' HA ' ' C' ' 126' ' ' LEU . 43.6 p -65.8 157.61 29.92 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.152 0.581 . . . . 62.44 111.901 177.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 14.8 t -76.64 -173.16 2.47 Favored 'General case' 0 CA--C 1.556 1.193 0 CA-C-N 115.186 -0.916 . . . . 62.32 109.664 171.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.84 77.04 0.68 Allowed Glycine 0 CA--C 1.536 1.346 0 CA-C-N 117.459 0.118 . . . . 70.54 113.166 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.79 126.83 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 108.591 -0.892 . . . . 53.41 108.591 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -140.81 -146.76 0.2 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.224 1.01 . . . . 75.41 108.675 -176.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 36.1 p -51.96 -75.12 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.648 0.779 . . . . 75.32 110.85 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -147.33 -83.92 0.11 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.574 -0.898 . . . . 74.13 108.574 177.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 54.2 t30 57.63 107.32 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.077 1.351 . . . . 75.54 112.4 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.21 78.27 0.97 Allowed Glycine 0 C--N 1.351 1.386 0 N-CA-C 112.265 -0.334 . . . . 63.5 112.265 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -143.33 152.62 41.85 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.774 0.83 . . . . 51.5 110.634 -175.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 142' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' C' ' 39' ' ' GLU . 3.3 mp -125.0 -60.61 1.35 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.407 1.083 . . . . 75.33 108.526 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . 128.22 119.3 2.19 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-N 114.738 -1.119 . . . . 45.31 110.508 -173.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.67 -37.42 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-O 121.895 0.855 . . . . 71.21 109.763 172.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 18.3 t70 . . . . . 0 C--O 1.246 0.879 0 N-CA-C 107.381 -1.34 . . . . 71.51 107.381 175.206 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.46 ' SD ' ' HB2' ' C' ' 141' ' ' LEU . 94.6 mmm . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 108.864 -0.791 . . . . 75.35 108.864 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 m -64.38 89.27 0.06 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.319 0.58 . . . . 72.31 110.69 -178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.486 ' HA ' ' NE2' ' C' ' 144' ' ' GLN . 32.7 tt0 -91.21 -46.06 8.29 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.545 1.138 . . . . 54.51 108.93 176.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -141.32 144.15 34.44 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 113.997 -1.456 . . . . 75.12 108.781 -176.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -73.52 102.56 3.87 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 109.846 -0.427 . . . . 73.23 109.846 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -71.51 154.69 41.3 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.954 0.902 . . . . 63.11 109.954 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.1 t -61.28 157.52 16.24 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.241 1.017 . . . . 74.44 113.193 -174.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -76.37 118.8 19.44 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.254 -0.885 . . . . 73.41 110.415 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.535 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -156.31 179.86 8.83 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.136 0.975 . . . . 75.43 110.058 -178.279 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.2 m -135.35 129.11 32.91 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.489 0.716 . . . . 62.33 109.177 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -131.42 112.48 12.73 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.823 -1.547 . . . . 64.25 106.823 167.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -137.72 114.15 10.27 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 107.809 -1.182 . . . . 72.14 107.809 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.618 HG21 ' HG2' ' C' ' 130' ' ' PRO . 51.0 mt -69.41 114.42 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 109.034 -0.728 . . . . 74.3 109.034 177.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -78.79 -34.74 45.21 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.285 -0.635 . . . . 73.23 109.285 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.43 ' HE ' ' HB ' ' B' ' 122' ' ' THR . 14.0 ttt85 -172.63 132.52 0.58 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.973 0.509 . . . . 72.05 110.227 -174.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.455 HD11 HD13 ' A' ' 13' ' ' ILE . 80.6 mt -117.44 127.35 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.021 -1.103 . . . . 75.14 108.021 166.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 25.0 p90 -163.78 154.02 15.28 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 123.787 0.679 . . . . 62.33 110.827 -171.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.7 p -80.03 116.78 20.35 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 109.712 -0.477 . . . . 73.41 109.712 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.45 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 42.9 mtpt -79.11 -25.52 43.0 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.601 -0.518 . . . . 72.1 109.601 172.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.495 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.1 t70 -155.06 146.8 23.31 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 114.882 -1.054 . . . . 55.22 110.526 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.485 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 81.2 mt -141.28 141.7 30.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 C-N-CA 126.114 1.766 . . . . 72.41 107.012 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.4 t -143.72 132.76 22.88 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.218 -1.03 . . . . 64.15 108.218 170.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.539 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 85.2 t80 -139.87 141.8 36.59 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.539 -1.282 . . . . 73.12 107.539 172.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -144.37 149.41 36.09 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.773 0.829 . . . . 72.25 108.889 177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.28 74.83 11.67 Favored Pre-proline 0 C--O 1.241 0.639 0 N-CA-C 106.173 -1.788 . . . . 43.23 106.173 170.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.72 -29.93 28.53 Favored 'Trans proline' 0 C--N 1.377 2.058 0 C-N-CA 122.233 1.955 . . . . 71.14 111.88 -171.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -96.82 9.43 41.81 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.798 0.839 . . . . 73.32 111.899 -175.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.464 ' HA ' HG12 ' A' ' 31' ' ' VAL . . . -47.36 -58.56 7.11 Favored Pre-proline 0 CA--C 1.563 1.471 0 N-CA-C 114.4 1.259 . . . . 41.32 114.4 -166.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 71.8 Cg_exo -49.84 -40.3 48.41 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.884 2.389 . . . . 71.44 114.455 -177.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -100.16 -13.97 18.73 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.214 0.82 . . . . 72.45 113.214 -175.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.597 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.7 p -77.27 -18.75 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-O 120.892 0.377 . . . . 74.34 110.912 -175.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -74.11 -19.96 60.41 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.393 0.677 . . . . 75.3 111.127 175.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -73.87 -28.92 61.82 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.631 0.773 . . . . 74.13 109.779 174.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -69.8 159.5 33.48 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.956 0.902 . . . . 65.32 112.119 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -68.94 123.35 20.76 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.538 -0.756 . . . . 45.41 109.234 171.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.494 ' CE3' HD21 ' A' ' 68' ' ' LEU . 71.9 t-105 -75.04 84.88 2.29 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.894 0.854 . . . . 74.43 109.841 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.433 ' H ' HD22 ' A' ' 68' ' ' LEU . 23.7 tt0 -120.48 79.63 29.44 Favored Pre-proline 0 CA--C 1.555 1.15 0 C-N-CA 125.48 1.512 . . . . 74.41 107.53 173.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.31 112.66 3.52 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.04 1.826 . . . . 64.04 112.446 -174.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.56 97.32 9.67 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 105.38 -2.082 . . . . 75.33 105.38 168.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.435 HG11 HD21 ' A' ' 126' ' ' LEU . 17.6 t -95.45 100.87 11.73 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 CA-C-N 115.406 -0.815 . . . . 74.35 110.826 -170.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.1 tttm -77.84 114.03 16.31 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.774 -1.103 . . . . 71.24 110.027 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.3 mt -103.36 111.16 23.45 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.591 0.756 . . . . 53.31 109.671 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.598 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.8 m-20 -102.23 147.28 26.84 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.592 -0.892 . . . . 74.3 108.592 172.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.612 HD11 HG21 ' A' ' 131' ' ' VAL . 77.0 mt -131.23 141.34 50.0 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.413 0.685 . . . . 75.13 110.293 177.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 25.6 t70 -144.51 122.11 11.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.412 -1.267 . . . . 74.13 108.056 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.4 m -113.37 129.09 56.62 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.926 -0.768 . . . . 73.24 108.926 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.74 117.46 15.03 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.583 0.753 . . . . 33.33 109.567 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.43 ' HB3' ' HB3' ' A' ' 98' ' ' LEU . 19.4 p -88.86 173.32 8.59 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 122.968 0.507 . . . . 75.12 110.552 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.6 t -163.82 145.57 9.17 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.377 1.071 . . . . 74.55 108.771 -170.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -114.9 122.7 47.12 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.272 0.629 . . . . 64.34 109.31 170.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 51.6 mt -97.65 -37.61 9.84 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.387 0.675 . . . . 73.13 109.824 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.474 ' HB3' ' CG2' ' A' ' 55' ' ' VAL . . . -153.1 177.45 10.79 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.874 0.87 . . . . 60.11 109.481 177.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -64.59 125.36 24.45 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.853 0.461 . . . . 64.11 109.986 170.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 68.22 8.75 6.77 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.139 1.376 . . . . 71.34 112.163 -174.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.474 ' CG2' ' HB3' ' A' ' 52' ' ' ALA . 51.5 t -115.62 92.74 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 108.31 -0.996 . . . . 65.44 108.31 176.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -110.59 122.3 47.42 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.077 0.465 . . . . 75.12 109.751 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -93.86 147.49 23.03 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.818 0.847 . . . . 65.5 109.101 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.8 t -131.79 143.32 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 107.986 -1.116 . . . . 75.12 107.986 173.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.526 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 60.6 t -121.42 137.96 53.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 108.487 -0.931 . . . . 71.22 108.487 176.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.89 98.76 6.51 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.243 -1.392 . . . . 72.24 107.243 175.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.486 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 43.3 ttp180 -84.98 101.23 12.21 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.48 -0.933 . . . . 74.44 108.48 173.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.6 t -95.69 132.71 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 108.003 -1.11 . . . . 70.33 108.003 175.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.598 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 12.0 m -112.93 142.15 45.93 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.927 -0.768 . . . . 64.22 108.927 171.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.604 HG21 HG21 ' A' ' 114' ' ' ILE . 77.1 t -135.84 114.85 16.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 107.502 -1.296 . . . . 71.4 107.502 -176.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.4 m -121.92 107.63 12.49 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.928 -0.767 . . . . 72.01 108.928 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.74 111.59 23.98 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 106.703 -1.592 . . . . 72.41 106.703 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 54.7 m -120.73 135.91 55.01 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.716 0.77 . . . . 70.41 111.289 -173.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.509 HD12 HG22 ' A' ' 31' ' ' VAL . 35.1 mt -88.86 81.66 6.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.482 1.513 . . . . 62.31 107.779 175.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.12 -99.06 1.03 Allowed Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.471 -0.786 . . . . 54.42 111.894 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -94.84 -29.58 14.65 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.274 0.63 . . . . 74.42 111.175 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -98.18 127.82 44.33 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.269 0.628 . . . . 65.14 109.892 -170.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.3 m -69.25 132.81 47.07 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 120.993 0.425 . . . . 45.35 110.406 173.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.597 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -76.93 -52.21 9.82 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.188 -0.914 . . . . 71.13 108.728 174.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -160.26 164.17 32.88 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.814 -1.085 . . . . 75.31 110.916 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.9 tp -124.31 132.07 53.55 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.414 1.086 . . . . 54.22 108.438 172.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.462 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 37.0 m -130.48 116.63 18.47 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.78 0.832 . . . . 64.42 109.147 175.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -131.04 116.25 17.54 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.494 -0.558 . . . . 74.02 109.494 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.0 t -124.25 114.3 40.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 124.14 0.976 . . . . 63.2 109.374 -173.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.495 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 35.4 mt-30 -85.36 83.59 7.91 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.5 -0.926 . . . . 73.32 108.5 172.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -75.77 94.55 3.3 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 114.773 -1.103 . . . . 73.55 108.564 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.24 169.49 47.88 Favored Glycine 0 C--O 1.241 0.557 0 N-CA-C 111.013 -0.835 . . . . 73.41 111.013 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.23 120.74 0.91 Allowed Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 110.87 -0.892 . . . . 74.44 110.87 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.425 HG13 ' HE1' ' A' ' 17' ' ' TYR . 51.6 mt -82.61 127.07 40.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 107.805 -1.183 . . . . 64.45 107.805 174.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.692 ' HB3' HD11 ' A' ' 86' ' ' ILE . 66.7 m-85 -128.06 123.51 34.77 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.528 -0.916 . . . . 60.45 108.528 -174.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.7 t -87.32 93.55 9.43 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.361 -0.977 . . . . 73.42 108.361 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.692 HD11 ' HB3' ' A' ' 84' ' ' PHE . 18.9 mm -117.23 147.95 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.451 0.7 . . . . 71.23 111.146 -169.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.61 173.73 11.62 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.666 0.786 . . . . 75.11 110.307 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 96.22 -33.2 5.77 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.973 -0.558 . . . . 71.21 113.022 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.56 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -124.42 140.12 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.602 0.761 . . . . 71.53 110.515 -173.286 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.452 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 11.6 mp0 -131.52 174.78 9.74 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.709 0.804 . . . . 72.33 110.02 178.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.88 -123.21 27.98 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 124.0 0.813 . . . . 71.31 114.205 173.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.9 t -71.93 -25.25 61.82 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.289 0.635 . . . . 65.12 111.354 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -75.37 -38.0 60.28 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.599 0.76 . . . . 54.42 109.527 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.452 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 6.1 tpt -66.5 -45.55 79.17 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.511 -0.768 . . . . 55.35 109.367 174.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.8 -37.01 77.93 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.358 -0.837 . . . . 53.22 110.883 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -68.54 -34.62 76.17 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.738 -0.664 . . . . 75.55 111.001 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.2 t -69.3 -45.61 69.16 Favored 'General case' 0 C--N 1.348 0.5 0 N-CA-C 109.445 -0.576 . . . . 72.43 109.445 178.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 94' ' ' MET . 49.2 mt -80.85 -22.3 40.01 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.47 -0.787 . . . . 33.41 112.273 -172.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.13 4.14 30.08 Favored Glycine 0 N--CA 1.475 1.239 0 CA-C-O 119.677 -0.513 . . . . 64.15 114.055 -174.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.484 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -142.71 -65.91 0.39 Allowed 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 117.406 0.603 . . . . 74.54 111.192 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -69.94 -43.34 71.81 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 111.988 0.366 . . . . 74.45 111.988 -173.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 65.6 m -66.65 -47.22 56.9 Favored Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 124.044 0.937 . . . . 71.0 112.806 -176.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.458 ' HA ' ' HB2' ' A' ' 106' ' ' LEU . 52.2 Cg_endo -67.41 -23.61 43.88 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 121.77 1.646 . . . . 64.42 113.168 170.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -66.39 -38.21 87.0 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 122.604 0.362 . . . . 64.21 110.033 173.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.9 mm -65.12 -45.71 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.742 0.817 . . . . 63.01 110.276 171.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 103' ' ' PRO . 61.4 mt -72.02 -21.77 61.5 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.763 0.825 . . . . 74.01 113.074 -172.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -66.85 -44.28 51.67 Favored Pre-proline 0 N--CA 1.484 1.264 0 N-CA-C 114.057 1.132 . . . . 73.45 114.057 -169.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -54.89 -31.54 73.78 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.812 1.675 . . . . 51.11 113.714 172.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.443 ' OH ' ' HB3' ' C' ' 130' ' ' PRO . 67.8 m-85 -84.49 -37.13 21.69 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.497 0.719 . . . . 71.11 111.305 -175.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.5 -46.87 78.03 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.286 -0.635 . . . . 54.34 109.286 172.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.545 ' NH1' HD12 ' C' ' 105' ' ' ILE . 32.9 ttm180 -49.57 -52.66 28.52 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 124.884 1.365 . . . . 74.4 110.463 174.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -63.27 -45.89 89.37 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.223 0.952 . . . . 73.13 112.05 -175.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.428 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 45.1 t -58.14 -46.25 85.98 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 124.045 0.84 . . . . 73.12 110.364 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.604 HG21 HG21 ' A' ' 64' ' ' VAL . 32.5 mt -60.93 -52.5 60.93 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 115.2 -0.909 . . . . 64.44 110.632 175.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.4 m -56.21 -40.16 73.6 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.127 0.892 . . . . 71.22 111.28 -174.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.516 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 41.9 t -67.62 -42.97 81.5 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 114.772 -1.104 . . . . 54.31 110.356 178.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.9 mtp -62.5 -37.38 85.79 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.552 0.741 . . . . 73.1 111.661 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 114' ' ' ILE . 86.1 t -62.2 -53.7 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.254 1.022 . . . . 41.42 109.917 177.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.5 p -69.92 -26.71 64.28 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.95 -1.023 . . . . 54.55 111.587 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.516 ' HB2' ' O ' ' A' ' 116' ' ' SER . 18.0 ttm-85 -75.49 -31.61 60.27 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.182 0.993 . . . . 71.44 109.083 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.437 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.88 19.82 18.96 Favored Glycine 0 C--N 1.354 1.576 0 CA-C-N 114.948 -1.024 . . . . 34.13 112.916 171.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.5 t 61.44 9.12 2.48 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 127.497 2.319 . . . . 75.11 114.03 175.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -78.93 140.05 57.8 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 108.409 -0.96 . . . . 74.34 108.409 175.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.08 136.06 44.94 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.857 2.372 . . . . 54.41 111.854 175.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -52.07 133.54 33.09 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.308 1.005 . . . . 73.42 113.269 -170.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.435 HD21 HG11 ' A' ' 40' ' ' VAL . 58.7 tp -112.42 137.3 50.8 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.406 -1.27 . . . . 65.03 108.986 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.563 HD21 ' HA ' ' C' ' 15' ' ' ARG . 83.7 m-20 -122.93 123.75 41.64 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 107.806 -1.183 . . . . 74.43 107.806 178.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.453 HD11 HD13 ' A' ' 114' ' ' ILE . 7.5 mt -74.78 125.6 29.13 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.122 -0.696 . . . . 60.12 109.122 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.31 135.99 96.49 Favored Pre-proline 0 CA--C 1.555 1.17 0 CA-C-O 119.186 -0.435 . . . . 75.02 111.028 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.85 131.59 46.96 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 123.284 2.656 . . . . 75.12 113.705 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.612 HG21 HD11 ' A' ' 44' ' ' LEU . 67.2 t -115.07 133.56 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.87 0.868 . . . . 74.32 110.513 -177.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -88.49 87.87 7.42 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 108.663 -0.866 . . . . 63.54 108.663 173.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -60.87 -26.9 67.74 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.001 0.92 . . . . 72.32 111.965 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.484 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 4.1 t70 -71.02 -40.77 71.59 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 123.592 0.557 . . . . 51.25 109.648 -178.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.26 -41.52 94.17 Favored 'General case' 0 C--N 1.351 0.635 0 O-C-N 123.897 0.748 . . . . 60.02 110.772 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.7 mt -58.71 -50.95 71.99 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.694 0.621 . . . . 63.54 110.59 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -63.71 -35.96 82.29 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.855 -0.611 . . . . 64.45 110.363 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.539 ' HA ' ' HB3' ' A' ' 141' ' ' LEU . 26.4 ttm -67.02 -30.69 70.86 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.253 0.621 . . . . 73.23 111.199 -176.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -59.26 -32.02 69.63 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.683 0.793 . . . . 73.11 110.927 174.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -83.65 -43.3 15.74 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.821 0.849 . . . . 52.31 111.075 171.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.539 ' HB3' ' HA ' ' A' ' 138' ' ' MET . 57.2 tp -59.97 -52.39 65.58 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.209 1.004 . . . . 73.13 112.202 -165.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -178.83 -15.16 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.463 0.705 . . . . 73.25 111.087 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 74.73 -34.68 0.27 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.875 1.67 . . . . 72.21 112.701 -177.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -54.33 107.75 0.31 Allowed 'General case' 0 C--N 1.354 0.762 0 C-N-CA 124.304 1.042 . . . . 71.31 108.961 172.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.443 ' HA ' ' SD ' ' A' ' 138' ' ' MET . . . -87.9 146.25 25.65 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 123.57 0.748 . . . . 60.21 111.158 -175.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -132.69 158.13 22.91 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 110.375 -1.09 . . . . 73.35 110.375 173.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.84 157.05 43.93 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.452 0.644 . . . . 72.12 111.486 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 175.01 168.34 35.48 Favored Glycine 0 C--O 1.24 0.517 0 CA-C-N 114.633 -1.167 . . . . 64.03 111.078 -176.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 1' ' ' MET . 4.7 t -144.42 154.87 43.41 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 122.735 0.414 . . . . 72.12 110.225 176.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -143.16 168.54 19.52 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.367 1.067 . . . . 74.22 109.467 -173.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 76.74 114.62 0.06 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.87 1.668 . . . . 62.1 111.286 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -172.73 114.51 0.28 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.529 1.131 . . . . 62.52 108.879 174.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.402 ' NE2' ' HB3' ' C' ' 139' ' ' ASN . 0.8 OUTLIER -160.15 28.86 0.17 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.152 0.581 . . . . 71.12 111.463 -173.445 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -57.19 152.48 13.63 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.891 1.276 . . . . 63.12 112.549 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 C-N-CA 123.6 0.76 . . . . 54.45 109.074 179.332 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.1 tpt . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 110.139 -0.319 . . . . 75.24 110.139 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 69.6 m -74.89 -179.42 4.23 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.782 0.833 . . . . 73.45 111.176 174.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -82.28 85.64 6.81 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.522 0.729 . . . . 72.23 109.376 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -59.49 123.4 16.71 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.271 -1.011 . . . . 74.22 108.271 171.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -58.44 113.69 2.1 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.011 0.819 . . . . 73.44 111.839 -166.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -54.3 92.43 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.324 1.85 . . . . 75.14 113.814 -170.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 33.5 p -80.7 79.57 7.32 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.51 -0.768 . . . . 71.42 110.032 173.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 64.85 53.37 1.47 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.514 1.125 . . . . 75.24 111.141 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 14.6 ptm 54.16 -172.42 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 126.714 2.005 . . . . 63.31 114.053 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 91.5 m -151.72 111.04 3.93 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.513 1.125 . . . . 71.43 108.424 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -109.56 144.48 37.81 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.853 0.461 . . . . 71.24 109.918 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -156.69 139.97 15.63 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.888 0.875 . . . . 44.51 109.505 175.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.8 mt -94.08 131.47 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.258 -1.386 . . . . 73.42 107.258 169.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -93.73 -46.69 7.12 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 120.968 0.414 . . . . 73.11 109.986 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -176.74 130.9 0.19 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 115.22 -0.9 . . . . 70.52 109.067 -172.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.513 HG21 ' CD1' ' B' ' 109' ' ' TYR . 81.6 mt -116.2 148.37 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 108.45 -0.945 . . . . 64.23 108.45 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -165.17 147.01 7.74 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 113.059 0.763 . . . . 73.35 113.059 -173.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.2 m -73.53 121.42 20.57 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 114.457 -1.247 . . . . 74.43 108.991 168.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.414 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.9 mtpt -99.4 -20.79 16.3 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.499 0.719 . . . . 75.45 111.929 -177.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -164.67 135.54 4.14 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 122.326 0.25 . . . . 63.44 110.742 -171.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 48.4 mm -132.57 139.11 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.871 1.268 . . . . 63.42 109.601 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 37.2 t -136.28 126.73 26.78 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.38 -1.341 . . . . 70.54 107.38 174.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.485 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.8 t80 -145.01 111.6 5.75 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 107.589 -1.263 . . . . 73.53 107.589 170.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -128.32 112.73 14.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.311 -0.996 . . . . 61.51 108.311 -173.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.62 85.06 8.73 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 107.792 -1.188 . . . . 63.11 107.792 174.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.5 -30.07 12.73 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.579 2.186 . . . . 72.22 112.256 -175.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.451 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 2.1 m-20 -98.46 10.06 41.72 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.193 0.997 . . . . 71.13 110.571 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.469 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -41.92 -61.89 1.35 Allowed Pre-proline 0 CA--C 1.56 1.357 0 N-CA-C 115.293 1.59 . . . . 53.42 115.293 -164.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.409 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 15.5 Cg_exo -62.76 -27.65 75.69 Favored 'Trans proline' 0 C--N 1.391 2.765 0 C-N-CA 122.347 2.031 . . . . 71.51 112.721 -169.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -94.24 -37.89 11.31 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.704 -1.134 . . . . 71.53 111.804 -172.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.589 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.1 p -69.6 -12.22 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 122.753 0.421 . . . . 74.32 112.109 -173.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -70.38 -9.72 57.07 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 112.868 0.692 . . . . 73.24 112.868 177.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -61.92 -26.2 68.03 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.623 0.769 . . . . 62.33 110.915 171.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.614 ' HB2' HD13 ' B' ' 68' ' ' LEU . 30.4 mmtp -89.24 84.73 6.51 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.482 1.113 . . . . 54.24 110.171 -174.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -88.3 82.53 7.04 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.125 0.488 . . . . 70.22 110.834 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 26.8 p90 -160.92 -172.05 3.32 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.513 1.125 . . . . 72.12 108.966 169.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -79.59 119.29 76.4 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 123.152 0.581 . . . . 74.54 110.722 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.473 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 20.6 Cg_endo -68.59 152.02 74.89 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 121.843 1.695 . . . . 74.02 111.343 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -71.35 102.68 2.67 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.596 -0.89 . . . . 72.35 108.596 173.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.425 HG11 HD11 ' B' ' 126' ' ' LEU . 50.6 t -94.84 142.77 13.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-N 114.667 -1.151 . . . . 74.31 110.24 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -140.0 109.74 6.35 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 106.933 -1.506 . . . . 75.35 106.933 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.484 HD13 HD22 ' B' ' 128' ' ' LEU . 35.6 tp -92.61 146.08 23.94 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.949 0.9 . . . . 74.54 109.845 -173.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.598 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 16.2 m-20 -131.34 143.16 50.29 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.758 1.223 . . . . 65.44 108.62 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.501 HD12 HG21 ' F' ' 121' ' ' VAL . 98.0 mt -129.99 128.63 42.44 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.922 -1.14 . . . . 73.34 107.922 174.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -140.84 143.96 35.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.091 0.956 . . . . 71.0 108.595 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 25.8 m -118.91 102.35 8.72 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 109.644 -0.502 . . . . 74.04 109.644 -175.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' B' ' 59' ' ' VAL . . . -125.3 115.62 20.64 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 106.672 -1.603 . . . . 42.53 106.672 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 24.2 m -142.42 -178.27 5.67 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.75 0.42 . . . . 63.3 111.401 -164.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 69.4 p -150.67 137.01 18.65 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 123.396 0.678 . . . . 44.34 109.91 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -95.17 128.47 42.03 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.7 0.4 . . . . 60.44 110.097 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 19.0 mt -92.6 -30.99 15.34 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.491 0.494 . . . . 64.22 110.234 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.495 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -171.41 175.15 4.23 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.842 0.857 . . . . 72.24 111.418 -176.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.72 137.33 57.74 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 107.019 -1.475 . . . . 74.44 107.019 159.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 70.81 -4.1 1.8 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.421 1.088 . . . . 74.33 113.234 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 41.2 t -135.15 96.71 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 108.334 -0.987 . . . . 74.22 108.334 -178.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -115.9 140.71 48.98 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.73 -0.841 . . . . 73.43 108.73 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -110.44 96.84 6.45 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.149 -1.426 . . . . 71.24 107.149 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -99.85 146.77 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 115.893 -0.594 . . . . 72.34 109.999 -174.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' B' ' 47' ' ' ALA . 26.9 t -127.86 143.54 40.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 123.942 0.897 . . . . 60.44 108.802 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.466 HD13 ' HE2' ' B' ' 133' ' ' PHE . 46.4 tp -119.46 114.34 22.15 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 108.547 -0.909 . . . . 74.44 108.547 170.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -84.39 111.92 19.88 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.377 -0.972 . . . . 75.43 108.377 171.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.414 ' CG1' HD11 ' B' ' 42' ' ' LEU . 20.8 t -105.78 103.37 15.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.458 -1.312 . . . . 75.03 107.458 173.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.598 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 16.8 m -103.29 131.09 50.63 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.699 -0.482 . . . . 73.42 109.699 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.592 HG11 HD21 ' B' ' 126' ' ' LEU . 88.0 t -116.84 128.12 74.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 123.377 0.671 . . . . 54.2 109.903 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 90.0 m -106.67 141.19 38.33 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.637 -1.246 . . . . 74.42 107.637 163.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -147.47 140.58 25.12 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.537 -0.912 . . . . 53.33 108.537 174.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.49 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 29.2 p -142.91 128.28 18.87 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.748 -0.66 . . . . 73.25 110.589 -171.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.614 HD13 ' HB2' ' B' ' 34' ' ' LYS . 39.0 mt -99.52 108.81 21.33 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.133 0.973 . . . . 65.4 109.668 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.66 -125.86 9.49 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 116.018 -0.537 . . . . 74.32 111.872 -175.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -96.72 2.95 52.58 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.425 0.69 . . . . 64.34 112.105 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.451 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 17.3 pt-20 -125.01 159.43 31.32 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.901 0.48 . . . . 60.35 111.3 -174.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 85.0 m -67.77 130.58 43.43 Favored 'General case' 0 C--N 1.351 0.642 0 C-N-CA 123.582 0.753 . . . . 64.34 110.329 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.589 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -84.86 -67.51 0.79 Allowed 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.598 -1.26 . . . . 64.41 107.598 170.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -147.71 156.87 43.21 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.157 -0.929 . . . . 64.43 110.988 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 89.0 mt -124.24 109.89 13.97 Favored 'General case' 0 C--O 1.222 -0.379 0 N-CA-C 107.008 -1.479 . . . . 70.05 107.008 172.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.5 t -117.87 156.72 27.93 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.653 -0.499 . . . . 32.11 109.653 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 38.1 tt0 -165.11 139.32 4.92 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.615 -0.883 . . . . 75.31 108.615 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.42 HG22 HD12 ' B' ' 21' ' ' ILE . 84.5 t -133.79 145.5 33.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.879 -1.156 . . . . 63.44 107.879 173.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -125.77 93.63 3.89 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.48 -0.933 . . . . 70.32 108.48 175.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.418 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.2 tp-100 -87.77 104.91 17.01 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.395 -0.821 . . . . 73.44 109.24 -177.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.414 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -97.06 173.37 29.02 Favored Glycine 0 C--N 1.336 0.553 0 O-C-N 123.664 0.603 . . . . 65.04 112.168 175.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.39 139.65 4.64 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 121.784 -0.246 . . . . 35.23 112.785 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 52.1 mt -85.69 113.45 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 108.37 -0.974 . . . . 71.33 108.37 173.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -117.4 135.45 53.87 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.643 0.777 . . . . 73.31 109.943 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 72.4 m -94.9 105.45 17.37 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.744 0.818 . . . . 65.23 109.633 172.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.637 ' HB ' HD11 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -114.3 105.15 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 124.236 1.015 . . . . 74.14 108.685 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.0 163.02 24.64 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.335 0.654 . . . . 71.42 111.523 -174.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.72 -30.76 3.43 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 114.402 0.521 . . . . 53.22 114.402 172.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.637 HD11 ' HB ' ' B' ' 86' ' ' ILE . 2.0 pt -67.83 161.29 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 124.495 1.118 . . . . 64.51 111.443 172.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -148.6 171.96 15.3 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 123.863 0.865 . . . . 75.21 111.062 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.52 -130.85 11.5 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 114.557 -1.201 . . . . 62.52 113.875 173.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 24.5 m -86.59 -35.7 19.3 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.853 0.861 . . . . 63.5 109.636 174.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -65.17 -23.33 67.08 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.103 -1.408 . . . . 71.24 111.666 -170.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.598 ' HA ' HD12 ' B' ' 89' ' ' ILE . 19.0 ptt? -66.23 -51.23 59.64 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.526 -0.761 . . . . 73.2 111.761 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.74 -13.46 59.43 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.483 0.713 . . . . 55.35 111.128 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -68.91 -32.57 72.29 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.308 0.643 . . . . 64.24 110.516 169.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -65.32 -52.09 56.27 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 120.899 0.381 . . . . 61.25 110.729 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.432 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.4 pp -71.13 -22.09 62.11 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 116.049 -0.523 . . . . 44.53 111.135 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.15 4.38 44.82 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 118.764 -1.02 . . . . 53.12 115.029 -172.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.27 -45.95 0.11 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 118.557 1.178 . . . . 72.03 111.294 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -74.82 -40.77 60.87 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.093 0.557 . . . . 73.45 110.686 -176.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.432 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 74.3 m -73.46 -46.19 7.55 Favored Pre-proline 0 CA--C 1.561 1.38 0 CA-C-O 118.492 -0.766 . . . . 65.2 112.94 -177.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.64 -16.48 54.95 Favored 'Trans proline' 0 C--N 1.396 3.064 0 C-N-CA 121.9 1.734 . . . . 73.52 113.246 171.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -73.33 -32.19 64.42 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.123 0.569 . . . . 74.04 110.644 172.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.475 HG23 ' NH2' ' D' ' 111' ' ' ARG . 91.3 mt -70.35 -39.73 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 124.04 0.936 . . . . 73.42 109.758 172.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 76.1 mt -75.57 -32.22 60.29 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.88 -1.054 . . . . 72.0 111.912 -174.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -57.24 -50.11 90.04 Favored Pre-proline 0 N--CA 1.488 1.471 0 CA-C-O 117.78 -1.105 . . . . 75.31 113.451 -173.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.35 -37.44 97.57 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 121.84 1.693 . . . . 63.41 112.593 177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.513 ' CD1' HG21 ' B' ' 16' ' ' ILE . 3.6 m-30 -66.37 -39.37 89.08 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.727 0.811 . . . . 72.42 110.078 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.12 -31.56 67.91 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.15 0.98 . . . . 65.13 111.331 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -69.12 -52.96 22.93 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.529 1.132 . . . . 71.24 111.068 -173.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.0 -27.33 66.47 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.52 -0.548 . . . . 74.1 109.52 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.485 ' O ' ' HG2' ' B' ' 117' ' ' MET . 31.0 t -65.29 -42.6 92.95 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 122.945 0.498 . . . . 54.21 111.256 178.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.562 HD13 HG23 ' B' ' 64' ' ' VAL . 65.0 mt -62.74 -54.16 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.209 0.604 . . . . 62.34 109.573 173.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 4.3 m -62.32 -23.22 66.64 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 124.053 0.846 . . . . 73.13 111.334 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.447 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.3 t -69.19 -50.93 43.01 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 109.072 -0.714 . . . . 44.4 109.072 174.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.0 mmt -67.86 -34.96 77.7 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.074 0.55 . . . . 61.0 111.241 -176.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 70.4 t -64.75 -43.93 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.775 1.23 . . . . 72.53 110.216 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 31.4 t -64.74 -34.72 78.99 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.007 -0.997 . . . . 62.12 111.291 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' B' ' 116' ' ' SER . 82.1 mtt-85 -67.84 -35.88 79.36 Favored 'General case' 0 C--O 1.214 -0.771 0 CA-C-N 115.718 -0.674 . . . . 62.25 109.802 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.31 -7.04 81.92 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.595 0.559 . . . . 64.15 113.324 172.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.43 ' HB ' ' HE ' ' A' ' 15' ' ' ARG . 8.5 m 64.94 33.4 9.89 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 125.144 1.377 . . . . 74.52 110.447 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -86.21 162.8 45.06 Favored Pre-proline 0 CA--C 1.555 1.173 0 CA-C-N 114.407 -1.269 . . . . 74.15 110.395 174.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.536 ' HA ' ' HB3' ' F' ' 131' ' ' TRP . 60.1 Cg_endo -68.21 169.97 15.61 Favored 'Trans proline' 0 C--N 1.388 2.64 0 C-N-CA 122.528 2.152 . . . . 71.01 113.415 -176.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.488 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 62.4 tp60 -64.44 115.93 5.6 Favored 'General case' 0 C--N 1.349 0.575 0 CA-C-N 115.224 -0.898 . . . . 75.31 111.759 -169.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.592 HD21 HG11 ' B' ' 64' ' ' VAL . 55.8 tp -109.82 98.04 7.44 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.334 -0.848 . . . . 70.12 109.357 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.409 ' ND2' HE21 ' B' ' 125' ' ' GLN . 19.2 m120 -103.5 103.05 12.97 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.611 -1.255 . . . . 73.11 107.611 173.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.484 HD22 HD13 ' B' ' 42' ' ' LEU . 91.0 mt -62.54 141.54 58.39 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.566 0.346 . . . . 74.1 111.14 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.3 140.28 88.07 Favored Pre-proline 0 CA--C 1.55 0.96 0 O-C-N 124.016 0.822 . . . . 53.41 111.128 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -65.92 97.35 0.34 Allowed 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.513 2.142 . . . . 74.33 111.072 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.455 ' HA ' ' HE2' ' F' ' 120' ' ' TYR . 27.4 m -90.86 112.37 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.728 0.775 . . . . 55.41 110.501 -177.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . 0.502 HD22 ' HB2' ' B' ' 135' ' ' ALA . 55.7 t30 -87.44 104.9 16.89 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.936 -1.135 . . . . 73.32 107.936 171.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.466 ' HE2' HD13 ' B' ' 60' ' ' LEU . 3.4 t80 -59.15 -34.52 72.19 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.798 1.239 . . . . 74.44 110.138 -177.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.39 -47.09 83.47 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.399 -1.273 . . . . 72.15 111.474 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.502 ' HB2' HD22 ' B' ' 132' ' ' ASN . . . -63.06 -32.02 73.29 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.442 0.697 . . . . 72.13 112.171 -176.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.415 HD12 HG23 ' F' ' 121' ' ' VAL . 6.4 tt -63.25 -45.83 89.72 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.97 0.908 . . . . 75.23 109.863 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.554 ' HA ' ' HD2' ' B' ' 140' ' ' TYR . 2.9 m-85 -77.43 -22.69 51.1 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.787 0.835 . . . . 74.45 111.96 177.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 13.1 tmm? -69.13 -35.96 76.94 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.024 0.93 . . . . 72.32 110.651 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -74.61 -29.55 61.34 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.497 -0.774 . . . . 62.4 110.965 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . 0.554 ' HD2' ' HA ' ' B' ' 137' ' ' PHE . 37.6 m-85 -63.34 -19.83 64.97 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 122.562 0.345 . . . . 75.55 111.345 171.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 6.8 tp -106.43 35.25 3.02 Favored 'General case' 0 CA--C 1.557 1.223 0 N-CA-C 108.821 -0.807 . . . . 73.42 108.821 174.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 64.23 -87.49 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.814 1.645 . . . . 64.54 111.823 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -154.61 121.69 5.6 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.499 -0.926 . . . . 71.24 108.499 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -110.04 9.95 24.16 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.852 0.861 . . . . 74.03 110.562 176.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.45 175.26 10.7 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.788 0.835 . . . . 35.01 109.797 170.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 124.05 4.91 7.66 Favored Glycine 0 N--CA 1.473 1.142 0 N-CA-C 111.779 -0.529 . . . . 73.15 111.779 -174.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.44 -37.56 70.41 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.796 1.238 . . . . 74.35 110.236 169.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -110.36 -166.04 19.35 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 115.701 -0.682 . . . . 43.13 111.51 171.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 57.6 m -137.81 -79.62 0.36 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.95 -1.13 . . . . 70.04 107.95 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . 0.544 ' HA ' ' HA2' ' D' ' 88' ' ' GLY . 39.0 tt0 165.88 102.14 0.0 OUTLIER 'General case' 0 C--O 1.24 0.588 0 C-N-CA 125.485 1.514 . . . . 73.33 107.048 -171.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -67.51 -66.61 0.54 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 109.892 -0.41 . . . . 73.55 109.892 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 54.43 60.76 3.35 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.104 0.962 . . . . 72.12 111.638 170.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -113.37 137.33 51.68 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 115.335 -0.848 . . . . 70.01 109.377 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -158.35 -177.12 6.31 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.393 0.677 . . . . 74.42 110.073 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.184 0 C-N-CA 123.644 0.778 . . . . 71.33 109.219 -179.101 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . 0.463 ' SD ' ' N ' ' C' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.484 1.226 0 N-CA-C 109.606 -0.516 . . . . 74.23 109.606 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 80.8 p 63.92 129.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 127.064 2.146 . . . . 45.31 114.211 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -57.58 -57.19 13.8 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 124.426 1.09 . . . . 74.54 110.935 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -171.62 173.26 4.72 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 123.915 0.76 . . . . 74.23 111.538 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -136.5 97.2 3.51 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.149 1.38 . . . . 75.42 107.412 171.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -144.61 155.98 43.89 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.251 0.62 . . . . 74.25 111.192 -166.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 6.5 t -76.9 75.5 3.5 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-O 122.342 1.067 . . . . 74.03 110.367 174.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -167.98 -46.85 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.588 -1.187 . . . . 74.31 108.92 -169.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 23.5 ttt 63.69 110.8 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.367 1.467 . . . . 75.0 110.965 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.634 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 7.4 m -88.36 77.73 8.09 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.695 0.798 . . . . 73.02 109.586 -176.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -106.14 137.22 44.45 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.605 0.762 . . . . 75.5 109.354 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.673 ' HB2' ' HA3' ' E' ' 140' ' ' GLY . 6.5 tp-100 -154.13 141.58 19.72 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.679 0.392 . . . . 75.42 110.11 171.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 17.1 mt -91.31 123.56 43.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 109.452 -0.573 . . . . 65.53 109.452 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -88.22 -42.89 11.99 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.127 0.571 . . . . 44.34 109.542 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.563 ' HA ' HD21 ' A' ' 127' ' ' ASN . 14.2 ptp180 -172.56 147.35 1.83 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.154 0.982 . . . . 70.24 110.307 -178.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 70.6 mt -125.03 130.79 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.104 1.362 . . . . 73.1 107.535 174.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.529 ' HB3' HG23 ' D' ' 122' ' ' THR . 31.1 p90 -162.96 173.26 13.87 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.682 0.753 . . . . 73.52 111.523 -167.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -98.36 117.28 32.42 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.982 -1.008 . . . . 60.31 109.586 179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.491 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 21.4 mmtp -67.61 -48.08 67.83 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 107.904 -1.147 . . . . 63.45 107.904 168.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -139.32 144.01 38.08 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 113.85 -1.523 . . . . 73.04 109.921 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.425 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.9 mt -133.88 142.99 39.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 125.393 1.477 . . . . 74.24 107.078 173.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.0 t -152.5 146.0 24.91 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.325 0.583 . . . . 72.21 110.342 174.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -150.18 128.26 11.93 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 107.066 -1.457 . . . . 74.23 107.066 172.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -133.92 112.16 11.04 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.195 -0.668 . . . . 64.41 109.195 -177.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.56 80.81 69.32 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 107.695 -1.224 . . . . 61.13 107.695 166.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.29 -21.69 30.66 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.453 2.102 . . . . 70.23 111.609 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -100.49 15.0 29.38 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.985 1.314 . . . . 75.41 110.946 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.436 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -42.21 -56.51 5.32 Favored Pre-proline 0 N--CA 1.487 1.423 0 N-CA-C 114.385 1.254 . . . . 43.54 114.385 -169.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.436 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 36.1 Cg_exo -60.68 -41.6 45.78 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.286 1.991 . . . . 52.11 112.666 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -68.36 -39.09 81.94 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.025 -0.989 . . . . 62.32 112.059 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.758 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.1 p -79.2 -17.13 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.507 0 N-CA-C 112.841 0.682 . . . . 63.44 112.841 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -69.41 -26.85 64.83 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 112.745 0.646 . . . . 71.44 112.745 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -87.14 13.63 9.11 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.174 0.59 . . . . 65.31 111.591 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.79 160.34 15.31 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.796 0.838 . . . . 74.33 110.756 -173.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -71.59 129.83 39.7 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.603 0.761 . . . . 71.44 109.877 173.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -82.9 90.19 6.93 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.574 0.75 . . . . 72.24 110.724 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . 0.443 ' H ' HD22 ' C' ' 68' ' ' LEU . 52.6 tt0 -146.55 79.46 10.4 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 124.095 0.958 . . . . 74.41 108.845 173.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -86.24 158.36 9.75 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.547 2.165 . . . . 70.42 112.852 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.47 79.3 9.02 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 106.703 -1.592 . . . . 70.44 106.703 167.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 25.7 t -71.73 96.75 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.112 -0.949 . . . . 73.15 108.845 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.93 104.0 12.55 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.767 -1.568 . . . . 73.25 106.767 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 pp -85.48 145.59 27.35 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.967 -0.753 . . . . 72.52 108.967 176.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.406 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 22.5 t70 -128.12 115.44 18.43 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.746 -0.835 . . . . 70.15 108.746 178.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.524 HD11 HG11 ' C' ' 131' ' ' VAL . 93.0 mt -97.35 110.97 23.42 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.598 -0.519 . . . . 73.13 109.598 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -113.52 145.96 40.39 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.374 -1.343 . . . . 71.41 107.374 169.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.0 t -137.42 146.76 44.78 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.232 -0.655 . . . . 71.11 109.232 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.84 171.82 13.55 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.116 0.967 . . . . 61.05 108.8 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 32.8 p -156.15 156.03 33.53 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.284 0.633 . . . . 42.11 109.621 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -145.41 127.62 15.73 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.49 -0.93 . . . . 74.41 108.49 -178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -78.9 113.46 17.02 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 107.452 -1.314 . . . . 73.32 107.452 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.63 HD11 HD12 ' C' ' 83' ' ' ILE . 67.0 mt -84.61 -27.35 27.26 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.008 0.523 . . . . 72.04 110.444 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.3 -175.06 2.78 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.737 -1.12 . . . . 71.22 110.182 -176.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -64.37 104.11 0.73 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.101 -0.954 . . . . 64.35 110.343 -177.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 65.56 21.33 11.73 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.453 1.101 . . . . 71.35 112.302 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.5 t -108.55 114.96 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 107.613 -1.254 . . . . 74.32 107.613 166.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -121.63 124.39 44.21 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.343 0.657 . . . . 54.11 109.542 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.433 ' HB2' HD11 ' C' ' 51' ' ' LEU . 26.3 tt0 -82.95 143.22 30.83 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 124.542 1.137 . . . . 74.41 108.563 165.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.445 HG11 ' HD3' ' C' ' 103' ' ' PRO . 96.0 t -132.95 133.55 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.787 -0.82 . . . . 73.44 108.787 171.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.45 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 58.7 t -113.4 139.71 37.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 123.661 0.785 . . . . 74.52 109.112 177.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.465 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -122.63 100.73 7.07 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.045 -1.465 . . . . 65.2 107.045 173.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -82.48 107.42 15.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.193 -0.912 . . . . 72.33 109.244 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 24.4 t -107.76 114.75 47.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.885 -1.154 . . . . 65.52 107.885 173.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.406 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 21.4 m -105.1 145.51 30.43 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.195 0.998 . . . . 74.02 108.783 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.54 HG21 HG21 ' C' ' 114' ' ' ILE . 87.4 t -126.49 119.49 53.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 109.103 -0.703 . . . . 71.41 109.103 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 38.6 m -99.14 134.72 41.59 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 107.559 -1.274 . . . . 72.53 107.559 166.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.27 103.83 4.5 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.115 -1.068 . . . . 71.33 108.115 -176.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 42.4 m -130.31 132.25 45.79 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-O 121.156 0.503 . . . . 73.25 109.862 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.443 HD22 ' H ' ' C' ' 37' ' ' GLN . 12.7 mt -85.54 38.21 0.73 Allowed 'General case' 0 CA--C 1.556 1.212 0 C-N-CA 124.793 1.237 . . . . 62.42 109.87 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.49 -111.8 2.64 Favored Glycine 0 C--N 1.354 1.533 0 N-CA-C 110.217 -1.153 . . . . 64.25 110.217 -168.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -90.47 -31.22 16.88 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.151 0.981 . . . . 72.5 109.879 174.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -67.16 101.03 0.84 Allowed 'General case' 0 C--N 1.346 0.423 0 C-N-CA 124.032 0.933 . . . . 75.11 109.793 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 46.4 m -72.43 116.31 12.73 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.978 -0.749 . . . . 45.23 108.978 173.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.758 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -64.44 -49.17 72.53 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 124.072 0.858 . . . . 73.5 109.506 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -167.54 164.73 14.79 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 114.133 -1.394 . . . . 65.34 110.459 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.49 138.2 53.3 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 106.38 -1.711 . . . . 35.55 106.38 164.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 51.3 t -144.89 145.71 31.7 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.777 -0.823 . . . . 73.43 108.777 -177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -159.94 136.89 9.31 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.796 -0.446 . . . . 64.54 109.796 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 69.1 t -131.24 124.39 55.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.174 0.99 . . . . 63.31 108.668 175.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -99.85 84.12 2.85 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.789 -1.189 . . . . 73.41 107.789 177.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -78.63 95.74 5.32 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.33 -0.85 . . . . 63.03 109.502 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -94.56 146.52 18.2 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 115.697 -0.683 . . . . 72.41 111.905 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.08 140.74 9.64 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.346 -0.702 . . . . 72.43 111.346 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.63 HD12 HD11 ' C' ' 51' ' ' LEU . 15.4 mm -97.12 133.1 40.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 109.52 -0.548 . . . . 71.15 109.52 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.435 ' HZ ' HD11 ' C' ' 106' ' ' LEU . 25.7 m-85 -135.84 147.09 48.12 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.854 0.721 . . . . 74.42 110.029 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . 0.48 ' HB2' ' HB3' ' E' ' 141' ' ' ALA . 12.9 p -101.2 101.16 11.8 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.806 -1.183 . . . . 65.34 107.806 168.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.629 HD13 ' SG ' ' C' ' 97' ' ' CYS . 22.5 mt -116.25 129.94 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.39 0.676 . . . . 72.5 110.303 -172.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.634 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -153.05 172.82 16.27 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.21 1.004 . . . . 74.23 109.516 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.32 -34.04 5.08 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-N 116.547 -0.297 . . . . 62.32 112.654 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.457 ' HB ' ' HB3' ' C' ' 93' ' ' GLN . 33.8 pt -96.69 162.28 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.54 0.736 . . . . 74.01 111.517 -176.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -158.52 152.47 23.69 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.674 0.79 . . . . 54.24 110.417 176.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.58 -127.94 8.38 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-O 119.717 -0.491 . . . . 31.44 112.879 174.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -59.46 -32.91 70.67 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 123.258 0.623 . . . . 71.05 110.817 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.457 ' HB3' ' HB ' ' C' ' 89' ' ' ILE . 21.6 mt-30 -62.74 -48.95 76.99 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.357 1.063 . . . . 64.31 111.695 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.547 ' HE3' ' HA ' ' C' ' 94' ' ' MET . 4.2 tpt -55.09 -52.67 62.49 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 123.784 0.677 . . . . 72.54 110.453 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.06 -32.49 73.87 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.146 0.578 . . . . 33.42 111.955 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -70.4 -32.64 70.35 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.87 0.868 . . . . 74.21 111.153 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.629 ' SG ' HD13 ' C' ' 86' ' ' ILE . 18.7 t -72.11 -43.96 63.93 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.295 0.569 . . . . 71.33 109.622 177.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 67.6 mt -81.02 -25.3 37.29 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 114.625 -1.17 . . . . 44.33 112.121 -174.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.4 3.29 20.23 Favored Glycine 0 N--CA 1.476 1.337 0 CA-C-O 119.201 -0.777 . . . . 41.14 114.719 -172.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.99 -53.15 0.15 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 118.151 0.976 . . . . 73.11 112.559 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -70.58 -58.6 3.51 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.884 0.474 . . . . 64.11 110.404 -171.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 58.9 m -64.64 -44.18 72.98 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-O 118.494 -0.765 . . . . 72.4 112.191 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.465 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 82.7 Cg_exo -53.7 -32.87 67.26 Favored 'Trans proline' 0 C--N 1.389 2.692 0 C-N-CA 122.366 2.044 . . . . 71.45 114.021 169.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -67.55 -40.72 84.95 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 122.974 0.51 . . . . 65.41 111.028 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.545 HD12 ' NH1' ' A' ' 111' ' ' ARG . 35.8 mm -70.66 -32.57 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 C-N-CA 122.812 0.445 . . . . 63.24 110.204 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.435 HD11 ' HZ ' ' C' ' 84' ' ' PHE . 2.5 mp -83.89 -20.83 32.38 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.455 1.102 . . . . 74.44 112.105 -176.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -58.44 -47.91 97.92 Favored Pre-proline 0 CA--C 1.554 1.108 0 CA-C-O 117.811 -1.09 . . . . 72.31 113.9 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -60.14 -37.37 84.24 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 121.91 1.74 . . . . 73.21 113.044 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -68.87 -43.74 74.75 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.602 0.761 . . . . 73.44 110.309 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.11 -40.17 94.96 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.035 -0.984 . . . . 51.1 110.35 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 42.8 ttt180 -63.98 -48.89 74.66 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.7 1.2 . . . . 73.54 110.496 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.74 -38.91 84.16 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.136 0.575 . . . . 70.4 109.805 -178.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.44 ' O ' ' SD ' ' C' ' 117' ' ' MET . 6.8 t -63.88 -42.78 97.42 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.685 0.394 . . . . 71.12 111.136 -178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.54 HG21 HG21 ' C' ' 64' ' ' VAL . 75.8 mt -63.27 -52.01 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 122.911 0.484 . . . . 71.42 110.244 175.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 22.0 m -63.32 -27.92 69.65 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.849 -0.614 . . . . 74.14 110.877 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 26.6 t -66.86 -52.18 46.58 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.491 0.717 . . . . 72.13 109.274 173.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.635 ' HE2' HD13 ' D' ' 21' ' ' ILE . 0.1 OUTLIER -48.76 -46.56 41.42 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.706 1.202 . . . . 75.54 112.354 175.044 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 93.4 t -67.35 -43.03 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.557 1.143 . . . . 75.1 111.004 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 15.0 t -65.72 -30.99 71.74 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.226 1.011 . . . . 75.14 111.619 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.42 HH12 ' CD ' ' D' ' 112' ' ' GLU . 70.9 mtt-85 -75.0 -39.5 61.19 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.805 0.842 . . . . 71.41 109.676 178.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.68 -2.54 64.64 Favored Glycine 0 C--N 1.356 1.645 0 CA-C-N 115.436 -0.802 . . . . 64.51 112.876 170.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.1 p 65.38 30.01 11.18 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.316 1.846 . . . . 75.15 113.533 169.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -83.81 144.28 44.89 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 108.348 -0.982 . . . . 75.11 108.348 169.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.488 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 77.8 Cg_exo -50.42 143.26 27.74 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 123.318 2.679 . . . . 72.4 113.728 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.441 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 55.5 mm-40 -51.76 119.71 4.5 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.639 1.212 . . . . 52.53 112.337 -174.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 36.6 tp -124.15 84.22 2.25 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 107.587 -1.264 . . . . 75.21 107.587 -177.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . 0.401 ' HB2' HG23 ' B' ' 122' ' ' THR . 20.0 m120 -92.68 97.68 10.94 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.377 -0.829 . . . . 73.32 108.864 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -60.36 143.82 52.17 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.47 0.708 . . . . 75.42 112.019 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.2 142.54 97.92 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-N 115.171 -0.922 . . . . 74.11 110.617 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.618 ' HG2' HG21 ' A' ' 13' ' ' ILE . 4.9 Cg_exo -67.13 152.73 79.36 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.027 1.818 . . . . 71.42 112.762 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.524 HG11 HD11 ' C' ' 44' ' ' LEU . 7.2 p -136.5 134.92 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.442 -0.799 . . . . 55.32 108.855 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -87.57 103.4 15.52 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.975 0.51 . . . . 74.42 110.254 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -61.87 -29.53 70.25 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.897 0.879 . . . . 73.23 111.82 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -56.58 -55.19 37.02 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.559 0.744 . . . . 73.42 110.061 173.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.23 -47.95 77.45 Favored 'General case' 0 C--N 1.349 0.55 0 O-C-N 124.227 0.954 . . . . 61.01 111.594 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 73.2 mt -59.02 -38.3 78.96 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.559 0.744 . . . . 54.44 111.559 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -77.56 -30.45 52.64 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.138 -0.937 . . . . 65.02 110.806 -177.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.403 ' SD ' ' N ' ' A' ' 1' ' ' MET . 25.2 mmt -70.0 -38.92 76.11 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.129 0.572 . . . . 72.14 109.882 175.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . 0.402 ' HB3' ' NE2' ' A' ' 153' ' ' GLN . 68.5 m-80 -60.56 -39.0 86.37 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 123.748 0.655 . . . . 64.03 110.219 173.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -72.7 -155.69 0.03 OUTLIER 'General case' 0 CA--C 1.579 2.062 0 C-N-CA 124.004 0.921 . . . . 70.42 110.217 171.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.46 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 94.4 mt 62.12 179.25 0.13 Allowed 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 124.719 1.208 . . . . 63.1 112.23 -175.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -140.72 -56.29 0.51 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.921 0.888 . . . . 71.14 109.465 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -69.32 122.09 18.2 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.107 0.963 . . . . 63.33 110.758 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . 0.486 ' NE2' ' HA ' ' A' ' 3' ' ' GLU . 34.0 tt0 -66.81 105.32 1.55 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.106 0.562 . . . . 74.25 110.163 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -152.69 112.3 3.91 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 123.297 0.639 . . . . 74.02 109.715 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -177.42 124.5 0.95 Allowed Glycine 0 C--N 1.339 0.724 0 N-CA-C 110.081 -1.208 . . . . 43.42 110.081 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.78 166.44 32.23 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 117.383 0.591 . . . . 71.32 111.005 -176.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -130.59 35.91 2.39 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-N 116.301 -0.408 . . . . 73.1 113.214 -172.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 63.5 m -70.59 119.48 14.81 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 122.942 0.497 . . . . 74.01 109.771 171.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -150.24 141.95 23.65 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.082 0.553 . . . . 74.31 110.727 -178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -145.95 124.54 12.49 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 107.507 -1.294 . . . . 65.53 107.507 163.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -79.07 77.07 5.56 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.881 0.848 . . . . 63.11 110.644 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -145.81 128.78 16.47 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.122 -0.944 . . . . 51.13 108.494 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -76.25 91.67 3.23 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.3 0.64 . . . . 74.51 110.173 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.138 0 C-N-CA 124.355 1.062 . . . . 71.42 108.55 178.633 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 109.621 -0.511 . . . . 74.45 109.621 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 25.5 m -73.55 85.53 1.56 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.611 0.764 . . . . 72.34 109.384 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -82.92 143.82 30.45 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.191 -0.913 . . . . 73.43 110.965 -170.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . 0.447 ' HB3' ' HG2' ' E' ' 95' ' ' LYS . 95.7 mt-30 -84.87 109.08 17.86 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.578 0.751 . . . . 73.04 109.772 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . 0.409 ' O ' ' HD3' ' E' ' 95' ' ' LYS . 6.4 p30 -94.98 131.7 40.64 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.755 0.822 . . . . 71.33 110.898 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.76 112.53 2.06 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.24 1.016 . . . . 71.15 111.066 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -141.03 149.83 42.21 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.514 1.126 . . . . 61.01 109.46 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -74.51 169.14 18.35 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.523 -0.547 . . . . 65.1 109.523 173.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.678 ' SD ' HG13 ' D' ' 89' ' ' ILE . 10.2 tpt -31.69 123.18 0.27 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.622 1.169 . . . . 73.54 114.119 177.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -119.23 131.97 55.88 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.167 0.987 . . . . 61.15 108.938 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.478 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 60.4 t80 -133.62 99.87 4.62 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.565 -1.272 . . . . 75.34 107.565 177.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -124.63 126.72 46.21 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.713 0.805 . . . . 73.53 108.868 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.421 HG21 HD11 ' D' ' 16' ' ' ILE . 11.0 mt -89.84 122.56 41.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.339 -0.985 . . . . 61.15 108.339 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -95.34 -18.94 20.36 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.37 0.668 . . . . 75.0 111.639 -171.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 179.05 124.28 0.05 Allowed 'General case' 0 C--N 1.359 0.989 0 C-N-CA 122.958 0.503 . . . . 72.34 109.818 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.421 HD11 HG21 ' D' ' 13' ' ' ILE . 3.7 mp -103.54 136.34 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 106.854 -1.536 . . . . 71.4 106.854 167.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -160.6 145.08 14.14 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 123.389 0.43 . . . . 74.34 111.363 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.2 p -84.48 112.3 20.26 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.681 -0.69 . . . . 64.44 109.677 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -79.81 -18.07 51.78 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.664 -0.698 . . . . 64.02 109.377 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.523 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 4.3 t70 -157.51 147.5 20.55 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 124.803 1.241 . . . . 65.44 110.005 175.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.635 HD13 ' HE2' ' C' ' 117' ' ' MET . 69.6 mt -141.99 147.28 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 125.661 1.584 . . . . 62.22 107.423 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . 0.646 ' HB3' ' HB2' ' D' ' 77' ' ' GLU . 32.8 t -155.35 144.48 20.88 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.327 1.051 . . . . 64.53 109.266 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.425 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 91.6 t80 -151.96 129.43 11.4 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.37 -1.715 . . . . 75.1 106.37 170.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -134.14 126.98 31.14 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.527 0.731 . . . . 62.32 109.248 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.43 86.41 48.38 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 107.621 -1.251 . . . . 74.24 107.621 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.48 -36.24 15.75 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.721 2.281 . . . . 70.03 112.815 -170.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -110.53 12.32 22.86 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.856 0.862 . . . . 74.45 110.359 -175.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.461 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -20.98 -70.23 0.04 OUTLIER Pre-proline 0 CA--C 1.57 1.714 0 N-CA-C 116.776 2.139 . . . . 65.31 116.776 -169.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.499 ' HB3' HD11 ' C' ' 83' ' ' ILE . 83.0 Cg_endo -76.26 -23.11 12.09 Favored 'Trans proline' 0 C--N 1.38 2.187 0 CA-C-N 123.741 2.372 . . . . 61.51 114.309 -174.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -71.24 -39.34 71.71 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.183 0.993 . . . . 74.35 109.3 178.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.576 HG21 ' HA ' ' D' ' 73' ' ' ALA . 9.8 p -84.0 -20.6 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.232 0 CA-C-N 114.798 -1.092 . . . . 61.13 111.825 -173.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.406 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 22.8 m-85 -67.22 -19.8 65.59 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 112.198 0.444 . . . . 72.43 112.198 177.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -63.09 -13.45 36.37 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.786 0.834 . . . . 62.44 110.958 176.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -99.18 91.14 4.84 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.24 1.416 . . . . 73.12 109.804 176.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -88.25 85.45 6.91 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.271 0.558 . . . . 72.23 110.691 -177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 38.9 p90 -156.91 172.22 19.04 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.001 -1.111 . . . . 75.44 108.001 165.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -68.13 116.75 42.31 Favored Pre-proline 0 CA--C 1.551 0.982 0 N-CA-C 109.351 -0.611 . . . . 63.52 109.351 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -57.38 131.14 42.92 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.648 2.232 . . . . 74.54 111.752 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 22.5 tt0 -60.02 109.98 1.09 Allowed 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.837 0.711 . . . . 72.21 109.366 175.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.845 HG13 HG13 ' D' ' 64' ' ' VAL . 45.8 t -105.43 115.25 46.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 114.622 -1.172 . . . . 62.55 109.377 -177.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.31 126.36 52.14 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 106.71 -1.589 . . . . 70.34 106.71 170.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.508 HD11 HG13 ' D' ' 62' ' ' VAL . 50.1 tp -97.57 141.92 30.02 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.605 0.762 . . . . 51.34 110.046 -168.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.764 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.5 m-20 -125.05 123.92 40.83 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 107.244 -1.391 . . . . 74.54 107.244 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 88.7 mt -124.37 138.48 54.37 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.173 0.511 . . . . 72.22 111.078 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 9.5 t70 -143.18 155.35 44.52 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.434 1.494 . . . . 64.22 107.685 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . 0.4 HG23 HG21 ' E' ' 107' ' ' THR . 9.7 t -139.71 153.48 47.24 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-O 121.386 0.612 . . . . 72.32 110.074 174.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.9 170.46 18.76 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 114.588 -1.187 . . . . 63.4 109.005 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.3 p -161.55 -169.47 2.28 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.406 0.682 . . . . 74.05 109.574 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 25.0 p -149.79 126.72 11.16 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.838 -0.801 . . . . 73.03 108.838 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . 0.53 ' HB3' ' HB2' ' E' ' 102' ' ' LEU . 11.5 pm0 -72.14 96.12 1.74 Allowed 'General case' 0 C--N 1.348 0.506 0 CA-C-O 121.599 0.714 . . . . 63.33 110.066 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.448 HD12 HG13 ' D' ' 55' ' ' VAL . 1.2 tm? -142.46 104.8 4.46 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 106.025 -1.843 . . . . 71.0 106.025 177.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.452 ' HA ' ' CZ ' ' D' ' 56' ' ' TYR . . . -80.67 -154.96 0.11 Allowed 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 119.075 -0.488 . . . . 72.11 110.775 -175.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 39.0 t70 67.78 28.3 7.2 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.523 1.154 . . . . 73.03 109.226 -171.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.603 ' HB2' ' HA ' ' E' ' 93' ' ' PHE . 12.8 m-20 64.59 17.25 10.79 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 113.466 -1.697 . . . . 73.25 112.914 172.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.448 HG13 HD12 ' D' ' 51' ' ' LEU . 4.1 p -118.0 95.54 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 122.265 1.031 . . . . 73.1 108.95 175.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.452 ' CZ ' ' HA ' ' D' ' 52' ' ' ALA . 96.7 m-85 -117.46 146.56 43.41 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.12 -0.945 . . . . 65.32 109.924 -174.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -102.82 145.41 29.8 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.876 -0.602 . . . . 65.1 110.462 173.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 70.3 t -131.45 141.82 44.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 114.06 -1.427 . . . . 70.53 107.523 172.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.441 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 46.3 t -131.23 132.07 63.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 108.294 -1.002 . . . . 75.33 108.294 176.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.484 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -107.96 117.45 34.16 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 106.632 -1.618 . . . . 71.31 106.632 172.308 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.662 ' HG2' ' HG2' ' D' ' 79' ' ' GLN . 0.0 OUTLIER -101.32 97.23 7.75 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.208 -1.405 . . . . 65.31 107.208 178.312 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.508 HG13 HD11 ' D' ' 42' ' ' LEU . 54.2 t -91.08 144.25 9.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.43 -0.952 . . . . 71.22 108.43 172.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.764 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 52.2 m -138.77 135.89 35.14 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.571 -1.27 . . . . 73.33 107.571 174.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.845 HG13 HG13 ' D' ' 40' ' ' VAL . 94.9 t -117.52 127.11 75.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 108.976 -0.75 . . . . 73.31 108.976 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 6.0 m -111.49 93.95 4.72 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.16 -1.052 . . . . 72.23 108.16 173.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.567 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -105.29 142.29 35.31 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.002 0.521 . . . . 52.31 111.295 -177.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.505 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 42.0 m -145.52 142.27 29.05 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.153 0.581 . . . . 61.22 110.81 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.512 HD12 HG22 ' D' ' 31' ' ' VAL . 19.4 mt -108.57 109.49 20.73 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.7 -1.222 . . . . 72.02 107.7 170.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.61 -124.39 7.51 Favored Glycine 0 C--N 1.345 1.056 0 O-C-N 123.212 0.32 . . . . 61.32 112.953 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.4 5.61 37.23 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.171 0.588 . . . . 73.52 111.842 -177.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -124.3 155.39 38.75 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.093 0.557 . . . . 74.41 109.986 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 75.7 m -66.32 136.53 55.94 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 122.767 0.427 . . . . 64.4 110.726 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.576 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.51 -64.66 1.11 Allowed 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.348 -1.352 . . . . 52.23 107.348 174.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -154.96 164.13 39.33 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 114.409 -1.269 . . . . 73.3 110.68 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 62.6 mt -130.12 144.49 51.38 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 105.821 -1.918 . . . . 75.55 105.821 174.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.59 ' SG ' HG23 ' D' ' 114' ' ' ILE . 9.1 t -152.72 106.81 3.11 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 118.812 0.733 . . . . 63.15 110.777 -173.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . 0.646 ' HB2' ' HB3' ' D' ' 22' ' ' SER . 10.9 mp0 -122.69 127.82 49.78 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.193 0.997 . . . . 71.53 109.793 -169.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 64.3 t -138.53 121.81 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 122.876 0.47 . . . . 61.02 109.741 -177.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.662 ' HG2' ' HG2' ' D' ' 61' ' ' ARG . 43.2 mt-30 -89.99 88.58 7.36 Favored 'General case' 0 C--N 1.35 0.607 0 N-CA-C 108.965 -0.754 . . . . 71.31 108.965 167.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . 0.414 ' O ' HD13 ' D' ' 106' ' ' LEU . 6.9 tp-100 -82.58 94.58 7.54 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.236 -0.893 . . . . 64.13 108.925 178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.78 173.06 37.88 Favored Glycine 0 C--O 1.242 0.623 0 CA-C-N 116.141 -0.481 . . . . 63.34 112.432 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.44 148.27 10.95 Favored Glycine 0 C--N 1.335 0.478 0 CA-C-N 115.519 -0.34 . . . . 42.14 112.459 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 70.4 mt -100.44 113.67 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 108.211 -1.033 . . . . 73.22 108.211 175.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -114.24 133.51 55.58 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.969 0.908 . . . . 72.23 109.891 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 35.6 p -96.68 105.44 17.55 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.977 -0.749 . . . . 43.3 108.977 172.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.504 HD11 ' SG ' ' D' ' 102' ' ' CYS . 61.7 mt -117.12 119.23 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.252 1.021 . . . . 54.24 109.25 -173.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.49 ' HA ' ' HB ' ' E' ' 97' ' ' ILE . . . -158.19 125.66 5.1 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.539 0.735 . . . . 53.42 110.569 -176.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' B' ' 150' ' ' GLU . . . 111.93 19.47 7.27 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-O 119.583 -0.565 . . . . 55.4 114.497 170.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.678 HG13 ' SD ' ' D' ' 9' ' ' MET . 0.8 OUTLIER -118.15 149.25 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 108.86 -0.793 . . . . 72.03 108.86 167.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -129.33 -179.96 5.44 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.183 0.993 . . . . 73.15 108.664 -171.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.07 -140.44 34.22 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 116.152 -0.477 . . . . 73.51 113.685 173.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 61.4 p -82.0 -33.79 29.93 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.313 0.645 . . . . 72.04 111.038 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -64.65 -26.25 68.31 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.516 0.726 . . . . 71.53 111.891 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.615 ' HA ' HD13 ' D' ' 89' ' ' ILE . 48.2 ttp -46.37 -60.46 2.32 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.913 1.285 . . . . 74.34 112.805 -176.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.68 -14.41 48.58 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.38 0.672 . . . . 62.13 112.248 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 45.2 m170 -72.05 -28.79 63.58 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.926 0.49 . . . . 73.45 110.579 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 70.9 m -62.02 -30.15 70.76 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.158 0.583 . . . . 73.44 111.078 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.2 tt -89.49 -44.98 9.75 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.827 0.851 . . . . 72.01 110.197 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.3 -13.3 74.1 Favored Glycine 0 N--CA 1.472 1.095 0 CA-C-N 115.983 -0.553 . . . . 53.05 114.331 -170.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.7 -53.16 0.81 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 117.314 0.557 . . . . 72.41 111.544 -173.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -68.37 -40.95 81.27 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 112.043 0.386 . . . . 74.33 112.043 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.504 ' SG ' HD11 ' D' ' 86' ' ' ILE . 78.2 m -66.33 -46.13 60.37 Favored Pre-proline 0 CA--C 1.562 1.415 0 CA-C-O 118.447 -0.787 . . . . 65.43 112.655 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.484 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 73.4 Cg_exo -55.08 -37.4 94.02 Favored 'Trans proline' 0 C--N 1.396 3.039 0 C-N-CA 122.152 1.901 . . . . 72.31 112.812 168.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -62.47 -36.86 83.82 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.256 0.622 . . . . 63.44 111.018 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 38.2 mm -69.98 -40.6 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.923 0.889 . . . . 73.33 110.865 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.414 HD13 ' O ' ' D' ' 80' ' ' GLN . 89.4 mt -73.26 -16.89 61.38 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.877 -0.602 . . . . 72.3 111.937 -176.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -68.53 -43.39 30.62 Favored Pre-proline 0 CA--C 1.555 1.168 0 CA-C-O 118.095 -0.955 . . . . 70.43 113.235 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -46.09 -43.42 20.49 Favored 'Trans proline' 0 C--N 1.382 2.322 0 C-N-CA 122.151 1.901 . . . . 55.01 113.897 167.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -77.78 -36.66 50.26 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.64 0.776 . . . . 71.13 111.769 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.84 -50.68 47.95 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.405 0.682 . . . . 64.32 110.127 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.619 HH12 ' HB3' ' D' ' 130' ' ' PRO . 36.5 ttp180 -54.92 -41.81 71.47 Favored 'General case' 0 C--O 1.211 -0.969 0 O-C-N 124.727 1.267 . . . . 75.04 111.02 172.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . 0.42 ' CD ' HH12 ' C' ' 120' ' ' ARG . 1.6 tm-20 -56.97 -53.84 53.52 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.161 0.913 . . . . 71.23 111.293 -175.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.0 t -55.02 -41.56 71.5 Favored 'General case' 0 C--N 1.348 0.523 0 O-C-N 124.469 1.106 . . . . 71.3 110.955 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.59 HG23 ' SG ' ' D' ' 76' ' ' CYS . 90.5 mt -64.22 -53.56 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.949 0.9 . . . . 74.03 110.834 177.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 93.2 m -55.45 -39.63 70.58 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.202 1.401 . . . . 71.42 110.375 -174.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.0 t -66.97 -47.52 71.32 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.824 -1.535 . . . . 74.34 110.596 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.422 ' HE2' ' HA ' ' D' ' 114' ' ' ILE . 78.8 mtm -68.4 -25.56 65.11 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 112.557 0.577 . . . . 74.34 112.557 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' D' ' 126' ' ' LEU . 76.0 t -68.65 -45.8 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.656 0.782 . . . . 74.51 109.294 175.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 72.5 p -73.95 -27.21 60.89 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 115.536 -0.757 . . . . 75.52 110.48 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 78.0 mtt-85 -74.4 -27.3 60.57 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.694 0.798 . . . . 75.21 110.123 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.7 10.22 73.03 Favored Glycine 0 C--N 1.351 1.372 0 O-C-N 123.653 0.595 . . . . 51.12 112.704 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.529 HG23 ' HB3' ' C' ' 17' ' ' TYR . 82.5 p 51.38 37.18 18.38 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.195 1.798 . . . . 71.32 114.203 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -95.99 154.04 39.04 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.148 -0.933 . . . . 72.22 109.345 168.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -49.62 132.53 30.78 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 123.173 2.582 . . . . 74.23 112.517 168.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -50.1 128.45 19.04 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.155 0.982 . . . . 65.13 112.508 -174.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.569 HD13 HG21 ' D' ' 40' ' ' VAL . 21.4 tp -107.68 128.74 54.82 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.938 0.895 . . . . 62.33 109.066 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -129.16 99.78 5.37 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.164 -1.05 . . . . 64.35 108.164 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.492 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 2.8 mm? -64.26 121.18 13.65 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.513 0.725 . . . . 73.34 110.032 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.35 123.0 74.28 Favored Pre-proline 0 CA--C 1.559 1.308 0 C-N-CA 123.123 0.569 . . . . 64.4 111.179 -176.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.619 ' HB3' HH12 ' D' ' 111' ' ' ARG . 72.2 Cg_endo -76.41 114.77 3.95 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.542 2.161 . . . . 63.5 112.431 -176.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.25 145.22 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.806 0.842 . . . . 63.42 109.355 176.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -70.38 115.06 9.12 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.341 -0.615 . . . . 73.24 109.341 173.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -64.08 -22.99 67.16 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.801 0.84 . . . . 62.11 111.367 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -54.86 -40.39 69.62 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.861 1.264 . . . . 75.03 111.496 172.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.55 -58.16 9.53 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 123.922 0.764 . . . . 62.41 110.405 177.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 56.6 tp -61.62 -32.87 73.03 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.558 0.743 . . . . 64.24 111.833 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -69.4 -46.23 67.36 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.016 0.927 . . . . 74.32 110.655 -174.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 22.8 ptp -74.69 -33.96 62.55 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.866 -0.606 . . . . 74.14 110.817 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -61.29 -35.94 78.71 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.896 0.479 . . . . 62.01 110.915 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -52.59 -46.62 67.0 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 124.473 1.108 . . . . 62.05 111.381 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.27 -28.22 69.56 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.011 0.524 . . . . 64.15 111.359 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -91.74 -1.18 57.5 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.889 0.876 . . . . 65.45 113.245 -174.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.23 45.63 2.61 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.925 0.869 . . . . 64.02 111.405 -174.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' D' ' 150' ' ' GLU . 9.9 pt20 -150.75 -177.96 6.29 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.306 -0.861 . . . . 72.3 109.91 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . 0.514 ' HA ' ' H ' ' D' ' 150' ' ' GLU . . . -72.14 -29.06 63.67 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.748 0.819 . . . . 74.03 111.395 176.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.8 -77.04 0.97 Allowed Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.544 -0.753 . . . . 72.1 112.275 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -130.58 -21.89 2.76 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.435 1.094 . . . . 64.42 110.573 -177.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -141.4 -80.12 0.06 OUTLIER Glycine 0 C--N 1.351 1.389 0 N-CA-C 112.271 -0.331 . . . . 64.34 112.271 -177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 10.2 t -161.21 120.63 2.57 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.007 0.923 . . . . 75.3 109.783 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . 0.514 ' H ' ' HA ' ' D' ' 145' ' ' ALA . 37.6 mt-10 -140.86 44.71 1.81 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.098 0.959 . . . . 72.11 109.219 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . 0.628 ' HG2' ' H ' ' D' ' 152' ' ' HIS . 20.5 tt0 -73.98 -171.53 1.13 Allowed 'General case' 0 CA--C 1.563 1.451 0 C-N-CA 123.369 0.668 . . . . 75.25 110.398 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . 0.628 ' H ' ' HG2' ' D' ' 151' ' ' GLU . 73.3 m-70 74.75 85.54 0.1 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.027 1.331 . . . . 72.14 110.258 -171.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -71.29 -57.04 4.85 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 107.409 -1.33 . . . . 72.33 107.409 166.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 61.09 -77.97 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.852 1.661 . . . . 73.13 112.335 173.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.288 0 C-N-CA 124.767 1.227 . . . . 54.34 110.344 -178.525 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 CA-C-O 119.76 -0.467 . . . . 72.33 111.994 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.81 -52.06 4.64 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-N 117.102 0.451 . . . . 31.44 112.495 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 93' ' ' PHE . . . . . 0.603 ' HA ' ' HB2' ' D' ' 54' ' ' ASP . 3.7 m-85 -70.16 94.32 0.89 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.241 0.616 . . . . 55.24 109.46 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 94' ' ' PHE . . . . . 0.403 ' CD1' ' HE2' ' E' ' 95' ' ' LYS . 0.6 OUTLIER -168.8 154.35 6.38 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.845 0.458 . . . . 75.33 112.047 176.116 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 95' ' ' LYS . . . . . 0.447 ' HG2' ' HB3' ' D' ' 4' ' ' GLN . 40.2 mtmt 79.82 -47.56 0.35 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 126.196 1.798 . . . . 71.42 112.745 171.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.14 101.47 2.18 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.243 -0.743 . . . . 75.33 111.243 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 97' ' ' ILE . . . . . 0.49 ' HB ' ' HA ' ' D' ' 87' ' ' ALA . 4.1 tt -56.35 -44.41 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.392 1.077 . . . . 72.05 111.063 175.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 24.7 t70 65.42 166.14 0.18 Allowed 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 124.488 1.115 . . . . 64.41 112.957 175.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . 65.77 8.91 5.58 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.436 1.494 . . . . 63.02 113.072 177.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 100' ' ' LEU . . . . . . . . . . . . . 37.2 tp -114.77 92.03 28.15 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 124.773 1.229 . . . . 73.34 109.574 -174.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -96.23 3.76 1.99 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.527 2.818 . . . . 71.41 113.36 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 102' ' ' LEU . . . . . 0.53 ' HB2' ' HB3' ' D' ' 50' ' ' GLN . 4.1 mm? 59.96 24.73 13.87 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.476 1.11 . . . . 61.02 111.453 -172.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 43.3 p 58.6 -68.29 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.506 1.922 . . . . 61.01 111.725 -170.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.21 153.35 8.35 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 112.188 -0.365 . . . . 74.1 112.188 173.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.09 47.54 3.29 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.576 1.15 . . . . 74.14 109.586 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 40.6 t80 73.01 165.85 0.3 Allowed 'General case' 0 CA--C 1.563 1.479 0 C-N-CA 124.975 1.31 . . . . 74.53 111.055 173.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . 0.4 HG21 HG23 ' D' ' 46' ' ' THR . 27.9 m -62.8 127.09 29.63 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.932 0.893 . . . . 71.21 111.566 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -116.54 13.84 15.41 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.041 0.936 . . . . 61.42 110.946 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -101.42 -156.69 0.57 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.171 0.988 . . . . 62.13 110.801 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.54 177.73 0.13 Allowed 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.011 0.924 . . . . 64.51 113.13 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . . . . . . . . . 7.6 mp 69.32 -78.79 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.976 1.31 . . . . 60.24 109.49 -169.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -82.11 97.83 8.37 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 109.417 -0.586 . . . . 64.43 109.417 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 113' ' ' LYS . . . . . 0.602 ' HA ' ' HE2' ' E' ' 113' ' ' LYS . 7.5 mmpt? -132.33 50.51 2.23 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.974 0.892 . . . . 71.34 109.686 175.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -64.48 -45.18 88.49 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 113.788 -1.551 . . . . 44.4 109.153 172.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 43.2 p -95.01 93.27 7.29 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.314 -0.995 . . . . 50.45 108.314 167.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 137.8 -179.65 17.99 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 114.84 -1.073 . . . . 75.0 110.793 -174.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -126.15 104.61 25.7 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 123.353 0.661 . . . . 75.05 109.478 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -88.5 172.57 4.82 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.545 2.163 . . . . 72.02 112.763 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -149.57 -176.0 5.23 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.409 1.084 . . . . 75.33 108.451 168.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 36.5 t80 68.22 126.9 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.889 1.276 . . . . 62.22 111.705 175.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 121' ' ' VAL . . . . . . . . . . . . . 79.8 t 62.78 83.08 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.299 1.04 . . . . 62.14 110.21 -173.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 67.7 p -67.66 -39.94 84.53 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.224 -0.898 . . . . 71.11 108.719 169.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 123' ' ' ASP . . . . . 0.412 ' HA ' ' HB3' ' D' ' 42' ' ' LEU . 3.8 p30 -157.67 164.1 37.53 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.126 -1.397 . . . . 71.12 109.882 174.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 74.3 m -138.35 106.63 5.78 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.904 0.882 . . . . 62.1 108.909 173.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -160.1 141.56 12.58 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.836 0.855 . . . . 64.55 109.48 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -158.7 103.66 1.74 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.648 0.779 . . . . 73.25 109.377 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 33.0 p -173.06 162.66 4.61 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.065 0.946 . . . . 63.41 110.437 -178.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -159.43 123.82 3.93 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.439 0.696 . . . . 74.12 110.182 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 50.3 m -151.33 144.0 24.35 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.808 0.843 . . . . 74.42 109.865 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -93.74 155.49 17.21 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.169 -0.678 . . . . 61.44 109.169 167.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 131' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -140.11 79.76 1.73 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.305 0.574 . . . . 73.25 111.04 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 35.9 t -156.22 147.21 22.15 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.615 1.166 . . . . 73.02 108.764 173.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 5.7 p -132.53 -44.13 0.91 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.401 0.68 . . . . 65.43 110.434 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.69 61.58 2.89 Favored Glycine 0 C--N 1.346 1.11 0 N-CA-C 110.902 -0.879 . . . . 55.41 110.902 -171.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 78.7 t -63.07 117.31 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.942 0.897 . . . . 74.4 110.456 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -166.94 79.04 0.21 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.713 0.805 . . . . 74.23 109.385 177.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 18.2 m -93.38 -38.66 11.35 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.7 -0.482 . . . . 74.33 109.7 174.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -132.01 107.62 8.79 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.494 0.717 . . . . 65.4 110.096 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 57.32 -165.09 0.16 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 124.885 1.274 . . . . 71.23 112.979 172.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 140' ' ' GLY . . . . . 0.673 ' HA3' ' HB2' ' C' ' 12' ' ' GLN . . . 100.9 150.38 24.19 Favored Glycine 0 C--N 1.349 1.26 0 CA-C-N 116.368 -0.378 . . . . 72.22 113.432 171.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 141' ' ' ALA . . . . . 0.48 ' HB3' ' HB2' ' C' ' 85' ' ' SER . . . -84.78 154.47 22.36 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.837 0.855 . . . . 71.42 110.576 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 1.5 tt -70.27 130.61 42.46 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 106.964 -1.495 . . . . 71.03 106.964 172.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -73.88 73.26 1.25 Allowed Glycine 0 C--N 1.35 1.358 0 O-C-N 123.298 0.374 . . . . 72.05 112.684 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 18.2 m -100.8 128.01 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.323 1.049 . . . . 74.41 109.821 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 119.222 -0.418 . . . . 75.21 110.849 175.756 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.68 0 N-CA-C 112.69 -0.164 . . . . 30.31 112.69 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.07 -83.4 1.18 Allowed Glycine 0 C--N 1.348 1.231 0 N-CA-C 111.758 -0.537 . . . . 65.52 111.758 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -74.02 124.0 25.42 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.564 -0.532 . . . . 63.43 109.564 173.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -107.46 140.1 40.95 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.549 0.74 . . . . 74.43 109.309 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.41 157.3 16.51 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.01 0.524 . . . . 71.42 111.099 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.63 -59.3 0.03 OUTLIER Glycine 0 C--O 1.245 0.814 0 N-CA-C 110.739 -0.944 . . . . 74.34 110.739 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 97' ' ' ILE . . . . . 0.491 HG12 ' O ' ' B' ' 89' ' ' ILE . 19.6 mt -62.7 103.19 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 108.893 -0.78 . . . . 72.41 108.893 172.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -57.57 -48.68 78.69 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.613 0.765 . . . . 34.42 111.57 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -132.67 95.54 3.62 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.504 -0.771 . . . . 74.41 109.73 -175.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 100' ' ' LEU . . . . . . . . . . . . . 46.1 tp -103.06 104.79 42.3 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 123.727 0.811 . . . . 72.45 110.571 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 101' ' ' PRO . . . . . 0.461 ' HB2' ' H ' ' F' ' 103' ' ' THR . 43.1 Cg_endo -100.88 -177.29 0.15 Allowed 'Trans proline' 0 C--N 1.366 1.466 0 C-N-CA 123.011 2.474 . . . . 74.04 112.291 161.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 102' ' ' LEU . . . . . . . . . . . . . 28.1 tp -102.66 7.44 39.85 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.785 0.834 . . . . 75.02 108.827 165.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 103' ' ' THR . . . . . 0.461 ' H ' ' HB2' ' F' ' 101' ' ' PRO . 62.5 p 55.64 36.23 26.79 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 126.335 1.854 . . . . 73.11 111.772 -175.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 124.71 168.58 12.85 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 114.808 -1.087 . . . . 61.04 111.836 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -81.96 129.28 34.73 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.274 0.63 . . . . 73.14 109.351 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 41.4 t80 71.46 157.85 0.18 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.294 1.437 . . . . 72.2 111.343 -175.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 7.3 t -71.05 142.0 50.89 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.473 0.709 . . . . 72.32 110.969 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -70.55 -49.48 47.64 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.696 -0.483 . . . . 71.03 109.696 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -77.3 90.11 3.75 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.449 -0.796 . . . . 75.34 109.009 172.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.68 134.0 50.32 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.256 0.623 . . . . 55.14 110.343 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 6.8 mp -80.16 -153.47 0.09 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.814 0.845 . . . . 75.0 110.709 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 112' ' ' ASN . . . . . 0.454 HD22 ' HA ' ' B' ' 43' ' ' ASP . 5.8 t30 -67.34 87.28 0.18 Allowed 'General case' 0 C--N 1.356 0.882 0 N-CA-C 109.355 -0.609 . . . . 63.21 109.355 174.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -158.96 87.01 0.84 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.127 0.971 . . . . 74.25 109.127 -176.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 63.8 mttm 57.45 -89.47 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.425 1.49 . . . . 74.42 112.772 172.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 23.5 m -93.92 134.91 35.81 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.131 0.972 . . . . 60.04 110.104 -173.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 136.99 -177.58 19.62 Favored Glycine 0 C--N 1.34 0.79 0 N-CA-C 111.289 -0.724 . . . . 73.0 111.289 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.06 82.81 9.05 Favored Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 109.163 -0.68 . . . . 64.43 109.163 171.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.78 88.21 0.79 Allowed 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.774 2.316 . . . . 74.22 110.144 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -62.0 -47.64 83.88 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.601 1.16 . . . . 64.42 112.57 -175.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 120' ' ' TYR . . . . . 0.455 ' HE2' ' HA ' ' B' ' 131' ' ' VAL . 76.8 t80 -87.39 -56.88 3.17 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.234 1.013 . . . . 74.45 110.842 -171.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 121' ' ' VAL . . . . . 0.501 HG21 HD12 ' B' ' 44' ' ' LEU . 40.6 t -94.43 91.17 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 109.013 -0.736 . . . . 73.31 109.013 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 15.3 t -154.67 -6.26 0.14 Allowed 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.854 0.862 . . . . 64.12 110.602 175.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -111.64 141.3 45.42 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.751 0.82 . . . . 70.15 110.682 -171.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 26.0 p -82.86 105.23 13.69 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.838 0.855 . . . . 72.02 109.908 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.18 157.57 44.71 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.791 0.836 . . . . 55.33 110.624 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . 62.37 84.27 0.14 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.625 1.17 . . . . 70.2 111.975 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 46.8 m -138.21 128.56 26.11 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.807 0.843 . . . . 73.04 109.186 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.43 167.24 12.11 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.216 0.606 . . . . 62.12 110.29 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 41.2 p -75.21 -172.67 1.78 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.725 0.81 . . . . 73.33 112.097 -176.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.07 162.03 12.27 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 123.943 0.897 . . . . 74.23 112.734 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 131' ' ' TRP . . . . . 0.536 ' HB3' ' HA ' ' B' ' 124' ' ' PRO . 8.2 p90 -94.28 8.87 40.28 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.654 -1.157 . . . . 75.32 111.018 -178.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 15.3 m -50.1 95.35 0.01 OUTLIER 'General case' 0 C--N 1.357 0.898 0 C-N-CA 124.99 1.316 . . . . 72.31 112.433 -169.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 43.2 m -76.59 119.81 20.93 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.557 -1.202 . . . . 73.23 110.493 -176.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.39 -21.99 70.86 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.913 -0.585 . . . . 53.35 113.472 178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 55.6 t -66.2 97.38 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 N-CA-C 109.225 -0.657 . . . . 73.1 109.225 173.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -63.94 -53.55 48.48 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.961 0.904 . . . . 74.43 109.755 175.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 137' ' ' THR . . . . . 0.422 HG21 ' HB3' ' F' ' 141' ' ' ALA . 8.9 t -157.69 -171.7 3.66 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 114.656 -1.156 . . . . 65.52 109.035 -177.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -76.19 -167.1 0.7 Allowed 'General case' 0 CA--C 1.565 1.54 0 C-N-CA 124.493 1.117 . . . . 75.33 110.258 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -61.13 110.02 1.26 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.67 0.788 . . . . 72.22 110.47 175.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . 119.33 157.77 10.45 Favored Glycine 0 N--CA 1.472 1.064 0 N-CA-C 111.152 -0.779 . . . . 75.22 111.152 -173.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 141' ' ' ALA . . . . . 0.422 ' HB3' HG21 ' F' ' 137' ' ' THR . . . 62.79 35.48 13.78 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.869 0.868 . . . . 63.31 111.754 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 64.7 tp -61.78 123.58 18.36 Favored 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.871 1.268 . . . . 75.52 111.289 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.7 153.92 22.35 Favored Glycine 0 N--CA 1.476 1.324 0 O-C-N 123.231 0.332 . . . . 61.44 113.015 -178.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 6.9 p -164.05 -34.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 124.393 1.077 . . . . 72.15 110.232 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 C--O 1.253 1.261 0 C-N-CA 124.025 0.93 . . . . 71.44 108.71 177.615 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.5 ptm . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 110.026 -0.361 . . . . 72.44 110.026 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.423 ' HB2' HE21 ' A' ' 4' ' ' GLN . 20.2 m -65.34 149.48 49.91 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.063 0.545 . . . . 71.32 110.293 176.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -70.47 -34.83 72.85 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.003 0.921 . . . . 63.05 110.841 -171.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.423 HE21 ' HB2' ' A' ' 2' ' ' SER . 79.2 mm-40 59.34 35.69 23.25 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 124.43 1.081 . . . . 73.41 110.186 -177.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -68.49 107.54 2.95 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 114.626 -1.17 . . . . 63.02 111.197 -170.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -71.89 127.9 34.04 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.646 -0.706 . . . . 71.25 109.988 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.8 m -101.41 127.01 48.25 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.426 0.69 . . . . 74.51 109.425 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -66.7 -75.22 0.1 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.367 0.667 . . . . 74.22 110.058 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.609 ' HG2' HD12 ' A' ' 89' ' ' ILE . 1.3 tmt? 62.77 142.57 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 125.229 1.412 . . . . 71.11 113.182 177.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.3 m -146.1 134.02 21.35 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.855 0.862 . . . . 72.11 109.261 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -129.01 120.75 26.57 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.006 -1.109 . . . . 74.25 108.006 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -147.65 108.92 4.28 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 109.472 -0.566 . . . . 74.51 109.472 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.485 ' CD1' HG21 ' A' ' 105' ' ' ILE . 12.6 mt -72.84 123.55 27.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 109.117 -0.698 . . . . 61.33 109.117 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -88.25 -37.55 15.96 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.167 0.587 . . . . 72.53 110.73 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -167.41 141.46 3.66 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 116.269 -0.423 . . . . 74.41 109.903 -173.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.0 mt -130.16 134.85 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 108.277 -1.008 . . . . 74.32 108.277 173.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -163.09 178.17 8.51 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 124.296 0.998 . . . . 74.34 111.434 -170.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -108.55 122.03 46.22 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.949 -0.76 . . . . 71.23 108.949 175.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.481 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 37.2 mtpt -81.38 -25.93 35.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.176 0.59 . . . . 61.31 110.338 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -160.13 152.63 20.96 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.331 -0.849 . . . . 74.12 109.186 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 73.9 mt -144.14 150.82 16.49 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 C-N-CA 125.346 1.458 . . . . 63.34 107.725 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.0 t -155.35 137.5 14.71 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.467 0.707 . . . . 75.12 109.842 173.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.494 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 86.5 t80 -143.67 122.07 12.38 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 107.402 -1.333 . . . . 74.24 107.402 174.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -124.76 114.72 19.64 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 109.227 -0.657 . . . . 73.44 109.227 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.05 80.75 0.44 Allowed Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 105.919 -1.882 . . . . 64.54 105.919 165.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.458 ' HG2' ' ND2' ' A' ' 27' ' ' ASN . 57.7 Cg_endo -68.99 -29.02 28.28 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.784 2.322 . . . . 53.31 112.59 -162.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.458 ' ND2' ' HG2' ' A' ' 26' ' ' PRO . 1.6 m-80 -115.86 30.13 7.54 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.864 0.865 . . . . 72.32 108.822 -175.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.457 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -44.8 -58.91 4.7 Favored Pre-proline 0 CA--C 1.569 1.673 0 N-CA-C 114.703 1.371 . . . . 73.4 114.703 -165.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 38.7 Cg_exo -60.34 -31.97 93.46 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 122.06 1.84 . . . . 63.12 113.087 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.518 ' HA ' ' NE2' ' A' ' 33' ' ' GLN . 6.8 t60 -81.74 -35.2 29.97 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.308 1.043 . . . . 74.55 112.385 -177.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.837 HG21 ' HA ' ' A' ' 73' ' ' ALA . 6.0 p -79.87 -15.1 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 121.395 0.617 . . . . 64.41 111.718 -171.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -74.9 -12.19 60.3 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 116.089 -0.505 . . . . 73.22 111.482 168.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.518 ' NE2' ' HA ' ' A' ' 30' ' ' HIS . 9.3 mt-30 -83.37 -18.0 40.36 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 124.009 0.923 . . . . 65.03 110.584 171.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.538 ' HE2' ' HB3' ' A' ' 71' ' ' GLU . 26.3 mmmt -79.33 146.19 33.05 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.361 1.065 . . . . 65.14 111.451 -177.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -61.67 128.14 34.84 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.134 0.974 . . . . 65.33 109.74 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.493 ' CE3' HD21 ' A' ' 68' ' ' LEU . 73.5 t-105 -82.21 88.83 6.48 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 121.121 0.486 . . . . 52.32 110.617 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 17.5 tm0? -129.33 84.96 60.62 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 106.205 -1.776 . . . . 74.14 106.205 167.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.07 125.23 10.72 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.475 2.117 . . . . 53.31 112.694 -173.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -97.0 92.95 6.32 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.757 -1.201 . . . . 62.31 107.757 169.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.666 HG11 HD11 ' A' ' 126' ' ' LEU . 88.2 t -94.82 107.63 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.345 0.658 . . . . 62.14 110.98 -175.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -88.13 129.52 35.29 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.361 -0.836 . . . . 73.45 109.415 175.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -95.88 119.33 34.18 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.897 -1.149 . . . . 64.31 107.897 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -130.18 141.6 50.64 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 108.795 -0.817 . . . . 52.34 108.795 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.664 HD11 HG21 ' A' ' 131' ' ' VAL . 56.6 mt -140.36 146.66 38.71 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.663 0.785 . . . . 74.42 110.0 -175.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -154.88 118.32 4.51 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.591 -0.892 . . . . 52.21 108.591 177.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.0 m -108.59 151.59 25.91 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.696 0.798 . . . . 74.34 110.453 -173.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.686 ' HB2' HH22 ' A' ' 61' ' ' ARG . . . -145.33 154.23 42.1 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.139 0.976 . . . . 72.13 109.886 172.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.419 ' HB3' HD13 ' A' ' 98' ' ' LEU . 4.1 m -112.87 154.68 25.95 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.991 -0.744 . . . . 71.23 108.991 172.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.0 t -149.61 117.57 6.31 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.125 -1.065 . . . . 74.03 108.125 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -79.96 105.14 11.02 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.154 -0.684 . . . . 75.23 109.154 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.608 HD11 ' HB2' ' A' ' 57' ' ' GLU . 45.9 mt -78.96 -35.68 42.73 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.094 0.558 . . . . 73.54 109.616 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.46 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -155.57 175.28 14.1 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.104 0.962 . . . . 60.3 109.848 176.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -65.25 124.98 23.62 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.583 -0.895 . . . . 75.23 108.583 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 66.67 11.32 8.1 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.251 1.42 . . . . 54.12 112.728 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 41.8 t -124.03 107.06 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.401 -0.962 . . . . 73.24 108.401 173.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -119.69 126.11 50.32 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.864 0.866 . . . . 73.35 109.018 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.608 ' HB2' HD11 ' A' ' 51' ' ' LEU . 32.2 tt0 -86.32 146.15 26.61 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.162 -0.681 . . . . 74.4 109.162 167.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.8 t -128.19 133.89 66.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.045 -1.095 . . . . 71.2 108.045 171.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.401 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 46.4 t -115.28 132.53 64.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.256 -0.646 . . . . 74.35 109.256 176.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.04 108.67 18.97 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.639 -0.874 . . . . 75.54 108.639 172.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.686 HH22 ' HB2' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -80.53 99.92 8.31 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 106.489 -1.671 . . . . 74.23 106.489 164.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.2 t -96.46 122.01 47.55 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.748 0 N-CA-C 107.583 -1.266 . . . . 74.22 107.583 172.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.4 m -118.47 137.87 52.88 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 123.91 0.756 . . . . 73.11 109.034 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 77.0 t -140.98 139.05 34.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 125.055 1.342 . . . . 73.32 107.435 -172.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 37.1 m -137.53 130.77 30.77 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 109.411 -0.588 . . . . 72.44 109.411 171.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.489 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -114.68 120.37 39.88 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.298 -1.371 . . . . 72.31 107.298 174.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -125.93 135.45 51.89 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.392 0.677 . . . . 64.21 110.607 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.535 HD12 HG22 ' A' ' 31' ' ' VAL . 27.4 mt -92.92 84.69 4.96 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.944 1.298 . . . . 64.24 108.8 177.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.41 -100.95 1.45 Allowed Glycine 0 C--N 1.342 0.877 0 CA-C-N 115.267 -0.878 . . . . 64.52 111.782 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.33 -19.62 13.41 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.871 0.868 . . . . 73.45 109.85 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.538 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 10.0 tp10 -94.02 124.69 38.19 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.637 1.175 . . . . 71.15 109.317 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -74.41 134.51 42.4 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.207 0.458 . . . . 73.14 110.963 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.837 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -78.3 -59.31 2.83 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.721 -0.844 . . . . 74.4 108.721 174.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -159.12 161.52 36.35 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.303 -0.862 . . . . 64.52 112.139 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.431 HD12 ' O ' ' A' ' 64' ' ' VAL . 38.7 tp -111.71 148.35 33.64 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.992 1.717 . . . . 54.44 107.645 168.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.55 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 94.6 m -140.97 136.8 32.54 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.273 1.029 . . . . 75.24 109.154 177.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -149.29 137.96 21.05 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.076 -0.713 . . . . 73.15 109.076 172.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.6 t -141.73 115.69 4.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 123.967 0.907 . . . . 71.51 108.91 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.525 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 79.1 mt-30 -83.63 84.43 7.54 Favored 'General case' 0 C--N 1.343 0.31 0 N-CA-C 108.705 -0.85 . . . . 63.02 108.705 170.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.42 ' HG3' HD22 ' A' ' 106' ' ' LEU . 8.5 tp-100 -77.88 92.0 4.22 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.514 -0.921 . . . . 75.44 108.514 177.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -95.03 144.94 17.49 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 110.746 -0.942 . . . . 71.35 110.746 178.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.17 134.35 5.33 Favored Glycine 0 CA--C 1.506 -0.47 0 N-CA-C 111.081 -0.808 . . . . 74.52 111.081 -174.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.9 mt -82.07 124.77 39.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 N-CA-C 108.416 -0.957 . . . . 75.33 108.416 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.801 ' HB3' HD11 ' A' ' 86' ' ' ILE . 92.4 m-85 -129.79 121.57 27.09 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.736 0.814 . . . . 65.35 109.029 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.4 t -86.36 103.44 14.93 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.436 -0.95 . . . . 61.11 108.436 174.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.801 HD11 ' HB3' ' A' ' 84' ' ' PHE . 3.5 mm -118.56 149.67 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 109.689 -0.486 . . . . 63.51 109.689 -177.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.53 168.14 25.67 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.061 0.544 . . . . 74.14 110.735 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 95.23 -32.35 6.27 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 116.044 -0.526 . . . . 72.15 113.061 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.609 HD12 ' HG2' ' A' ' 9' ' ' MET . 0.2 OUTLIER -122.21 141.12 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.622 0.769 . . . . 70.3 111.343 -173.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.628 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 21.7 mt-10 -142.37 173.54 11.44 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.54 1.136 . . . . 74.43 110.135 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.5 -125.33 28.68 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-O 119.771 -0.461 . . . . 64.24 112.614 -176.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 77.3 p -76.83 -27.93 55.33 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.342 0.571 . . . . 70.12 110.616 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.562 ' HA ' ' HB ' ' C' ' 149' ' ' THR . 0.8 OUTLIER -58.98 -41.98 88.86 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.588 0.755 . . . . 74.3 109.25 175.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.628 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 3.0 tpt -69.98 -42.27 73.33 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 114.662 -1.153 . . . . 75.33 110.986 175.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.42 -25.21 67.06 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.09 0.956 . . . . 74.52 111.901 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -70.67 -49.36 48.11 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.806 0.442 . . . . 63.41 110.364 172.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.44 -37.46 85.93 Favored 'General case' 0 C--O 1.217 -0.613 0 O-C-N 123.177 0.298 . . . . 65.4 110.755 -176.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.419 HD13 ' HB3' ' A' ' 48' ' ' SER . 52.7 mt -91.26 -30.89 16.36 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.032 0.533 . . . . 73.44 112.438 -175.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.95 4.08 33.91 Favored Glycine 0 N--CA 1.476 1.333 0 CA-C-O 119.94 -0.366 . . . . 71.14 113.752 -172.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.468 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -142.85 -61.92 0.43 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 117.006 0.403 . . . . 74.3 111.192 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.41 ' O ' HG12 ' A' ' 105' ' ' ILE . 45.6 t80 -73.63 -46.28 47.79 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 112.17 0.433 . . . . 72.51 112.17 -172.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 47.5 m -64.8 -47.91 73.88 Favored Pre-proline 0 N--CA 1.49 1.539 0 CA-C-O 118.303 -0.856 . . . . 75.21 112.465 -178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.17 -21.11 67.74 Favored 'Trans proline' 0 C--N 1.39 2.72 0 C-N-CA 121.805 1.67 . . . . 54.1 112.786 173.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -75.41 -33.0 60.93 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.866 0.466 . . . . 74.12 109.856 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.485 HG21 ' CD1' ' A' ' 13' ' ' ILE . 48.4 mm -69.93 -41.49 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.381 0.672 . . . . 61.43 109.753 171.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.42 HD22 ' HG3' ' A' ' 80' ' ' GLN . 66.1 mt -72.04 -30.51 65.24 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.654 0.781 . . . . 73.04 111.807 -175.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -61.01 -40.51 74.77 Favored Pre-proline 0 N--CA 1.488 1.431 0 N-CA-C 114.401 1.259 . . . . 74.52 114.401 -171.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -51.57 -42.99 53.26 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.071 1.847 . . . . 75.13 113.462 168.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -75.83 -35.7 59.89 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.269 0.628 . . . . 65.45 111.045 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.81 -48.38 71.9 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.734 0.813 . . . . 73.33 109.52 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.539 ' NH1' HD12 ' C' ' 105' ' ' ILE . 27.8 ttm105 -51.46 -52.15 48.86 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 125.05 1.469 . . . . 75.41 110.289 174.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -62.6 -45.98 90.41 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.61 1.194 . . . . 64.24 111.78 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.533 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.3 t -60.88 -36.98 80.61 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 123.872 0.733 . . . . 34.42 110.759 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.493 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.6 mt -67.94 -47.2 80.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.127 0.971 . . . . 72.52 110.439 174.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.434 HG21 ' HE2' ' C' ' 109' ' ' TYR . 35.7 m -59.37 -39.29 82.81 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.621 1.168 . . . . 75.45 111.27 -177.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -68.68 -44.12 74.7 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.364 -1.289 . . . . 64.2 110.224 -176.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.483 ' HG3' ' O ' ' A' ' 113' ' ' CYS . 25.6 mtm -60.48 -39.43 87.61 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 122.987 0.515 . . . . 45.2 110.831 177.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 114' ' ' ILE . 71.6 t -63.19 -47.85 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.296 1.038 . . . . 74.32 111.424 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.8 p -71.52 -33.36 69.13 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 116.147 -0.478 . . . . 73.0 111.178 -176.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.47 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 90.0 mtt-85 -67.96 -33.28 74.35 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.739 0.816 . . . . 65.52 109.742 173.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.446 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.14 15.12 40.67 Favored Glycine 0 C--N 1.352 1.417 0 CA-C-N 115.437 -0.801 . . . . 32.1 113.37 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.6 t 62.0 9.47 3.07 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 127.281 2.232 . . . . 71.15 114.016 173.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -81.33 138.79 48.32 Favored Pre-proline 0 C--O 1.244 0.793 0 N-CA-C 107.672 -1.232 . . . . 73.51 107.672 172.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.509 ' HB3' ' H ' ' E' ' 132' ' ' SER . 54.1 Cg_exo -53.98 142.53 64.57 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.75 2.3 . . . . 75.31 112.154 176.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -49.41 130.72 20.25 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.539 1.136 . . . . 71.34 113.779 -164.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.666 HD11 HG11 ' A' ' 40' ' ' VAL . 36.6 tp -109.27 108.62 19.28 Favored 'General case' 0 C--N 1.345 0.384 0 C-N-CA 123.169 0.588 . . . . 70.14 110.441 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.576 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 88.8 m-20 -103.26 125.76 50.08 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 107.699 -1.223 . . . . 74.03 107.699 175.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.47 ' H ' ' HG3' ' A' ' 111' ' ' ARG . 17.8 mt -72.85 144.59 47.4 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 117.735 0.243 . . . . 65.21 110.809 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.532 ' HB1' ' HB2' ' E' ' 138' ' ' TYR . . . -70.74 133.49 86.48 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.105 0.562 . . . . 64.14 110.089 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.53 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 32.3 Cg_exo -59.97 114.4 2.07 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.576 2.85 . . . . 62.31 113.604 -173.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.664 HG21 HD11 ' A' ' 44' ' ' LEU . 45.6 t -100.23 135.64 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.372 0.669 . . . . 71.03 110.017 -177.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -101.84 89.93 3.83 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.207 -1.034 . . . . 75.44 108.207 175.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.496 ' CE1' HD13 ' A' ' 44' ' ' LEU . 44.5 m-85 -63.82 -30.79 71.84 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.814 0.846 . . . . 64.22 111.568 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.523 ' O ' ' HB2' ' A' ' 138' ' ' MET . 6.4 m-20 -66.08 -33.35 75.58 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.347 -0.842 . . . . 43.31 110.476 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.76 -42.25 64.23 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.155 0.582 . . . . 70.11 110.491 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.12 -49.07 79.26 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 121.521 0.677 . . . . 63.04 110.59 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -64.93 -36.62 84.97 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.142 -1.39 . . . . 71.15 110.071 177.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.523 ' HB2' ' O ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -69.02 -34.81 75.84 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 119.011 -0.518 . . . . 71.1 110.39 -176.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -54.74 -40.17 69.02 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.095 0.474 . . . . 72.5 110.791 176.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -68.12 -48.77 64.53 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 114.955 -1.02 . . . . 64.42 110.496 172.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.464 ' HB3' ' HA ' ' A' ' 138' ' ' MET . 51.8 tp -61.94 -56.07 22.97 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.894 0.878 . . . . 73.52 112.675 -168.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 141' ' ' LEU . 87.0 mt-30 -168.78 -17.25 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.614 0 C-N-CA 124.875 1.27 . . . . 74.13 110.748 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.459 ' N ' ' SD ' ' A' ' 138' ' ' MET . 33.1 tt0 72.06 -5.86 1.64 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 126.761 2.024 . . . . 75.42 112.795 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -149.98 110.56 4.25 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.052 0.541 . . . . 71.34 110.699 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -179.64 150.82 0.42 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.75 1.62 . . . . 71.24 108.181 171.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.547 ' HA2' ' H ' ' C' ' 3' ' ' GLU . . . 162.58 52.24 0.02 OUTLIER Glycine 0 C--N 1.347 1.156 0 C-N-CA 120.783 -0.722 . . . . 74.51 114.119 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.12 133.22 29.55 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.002 0.521 . . . . 61.41 109.847 176.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 135.3 30.14 0.36 Allowed Glycine 0 C--N 1.345 1.039 0 CA-C-N 115.479 -0.782 . . . . 72.5 111.427 -173.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.61 ' HA ' ' HB3' ' C' ' 145' ' ' ALA . 59.4 p -80.95 105.88 12.52 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.248 0.619 . . . . 72.24 109.906 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -153.61 135.76 14.8 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.64 0.776 . . . . 61.14 109.709 176.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -103.4 152.85 21.13 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.888 -0.782 . . . . 74.51 108.888 167.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.83 7.99 1.1 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.478 1.111 . . . . 74.54 110.301 176.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.452 ' HG2' ' H ' ' A' ' 155' ' ' ALA . 28.3 tt0 -175.29 129.08 0.28 Allowed 'General case' 0 C--N 1.356 0.876 0 C-N-CA 124.397 1.079 . . . . 73.02 108.528 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -84.73 7.08 21.76 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.127 0.571 . . . . 51.1 111.9 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.452 ' H ' ' HG2' ' A' ' 153' ' ' GLN . . . . . . . . 0 C--O 1.251 1.154 0 C-N-CA 125.592 1.557 . . . . 74.32 110.662 -175.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 110.184 -0.302 . . . . 73.24 110.184 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 33.6 m -64.33 -25.35 68.0 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.027 0.931 . . . . 72.11 112.379 -174.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.48 ' HG2' ' HB2' ' B' ' 5' ' ' ASN . 38.9 tt0 -76.51 111.5 12.05 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.939 -0.763 . . . . 72.51 108.939 174.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -70.69 -56.08 7.25 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.448 0.699 . . . . 63.0 109.257 176.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . 0.48 ' HB2' ' HG2' ' B' ' 3' ' ' GLU . 37.4 t30 60.29 20.2 9.68 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 125.518 1.527 . . . . 53.13 112.537 176.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -72.71 104.49 3.96 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.652 0.781 . . . . 74.23 110.417 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 32.1 p -75.84 136.16 40.2 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.591 -0.731 . . . . 73.11 111.146 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -115.15 107.59 15.51 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 107.777 -1.194 . . . . 74.13 107.777 173.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.554 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 19.6 ptm 50.47 -167.45 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.949 1.699 . . . . 54.34 111.976 -172.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 5.5 t -153.09 138.99 18.06 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 109.147 -0.686 . . . . 71.44 109.147 166.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.539 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 68.9 t80 -134.28 137.74 44.5 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.13 0.972 . . . . 75.32 108.418 176.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -144.51 141.28 29.41 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 122.991 0.516 . . . . 55.32 109.938 175.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 66.9 mt -88.86 110.01 20.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 107.699 -1.223 . . . . 74.5 107.699 171.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -81.8 -39.1 24.57 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 123.282 0.364 . . . . 72.41 110.322 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -169.3 134.71 1.55 Allowed 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.304 0.377 . . . . 74.41 110.384 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.0 mt -114.97 142.58 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 107.247 -1.39 . . . . 70.41 107.247 171.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.434 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 40.1 p90 -169.81 162.67 9.59 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-O 122.045 0.926 . . . . 74.24 113.127 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 56.7 m -90.04 121.18 31.88 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 113.414 -1.721 . . . . 74.11 108.585 171.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.434 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 22.7 mtpp -87.29 -32.43 19.69 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.724 0.81 . . . . 73.42 110.52 178.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -158.52 143.49 16.25 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.022 -0.536 . . . . 74.44 110.89 -170.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 45.9 mm -136.3 142.88 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.466 1.506 . . . . 72.15 109.093 176.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 24.1 t -145.56 134.66 22.73 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.521 -1.218 . . . . 74.31 107.907 168.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.484 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 91.2 t80 -138.71 128.08 24.41 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.421 -1.696 . . . . 74.31 106.421 169.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -135.47 112.02 9.96 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.913 -1.143 . . . . 74.13 107.913 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.576 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -108.83 87.34 4.42 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 107.144 -1.428 . . . . 71.41 107.144 171.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -63.86 -42.01 21.48 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.654 2.236 . . . . 70.33 111.298 -174.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -97.39 5.77 49.28 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.726 -1.125 . . . . 71.2 111.65 -175.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.576 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -29.81 -67.78 0.13 Allowed Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 115.428 1.64 . . . . 72.04 115.428 -166.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.481 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 21.3 Cg_endo -60.43 -28.49 86.84 Favored 'Trans proline' 0 C--N 1.397 3.106 0 C-N-CA 122.605 2.203 . . . . 53.13 113.03 -171.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -95.86 -39.76 9.66 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.981 -1.009 . . . . 63.41 111.996 -171.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.445 HG22 HD12 ' B' ' 68' ' ' LEU . 10.5 p -69.47 -11.76 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 123.22 0.608 . . . . 70.12 111.419 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -63.39 -13.18 36.95 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.269 0.628 . . . . 75.43 112.65 172.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -68.84 -13.07 62.18 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 123.874 0.87 . . . . 73.42 112.077 175.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.581 ' HB2' HD13 ' B' ' 68' ' ' LEU . 32.8 mmtp -97.41 92.71 6.09 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.494 1.118 . . . . 74.13 109.813 -174.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -92.81 80.44 4.68 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.364 0.665 . . . . 74.53 110.914 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 37.3 p90 -165.07 177.53 7.68 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.056 0.942 . . . . 64.1 110.123 170.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.581 ' HG3' ' HB3' ' F' ' 128' ' ' ALA . 42.7 tt0 -69.12 116.65 44.17 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 123.677 0.791 . . . . 61.23 109.667 173.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.431 ' HD3' ' HG2' ' B' ' 124' ' ' PRO . 34.2 Cg_endo -68.28 148.77 74.91 Favored 'Trans proline' 0 C--N 1.372 1.78 0 C-N-CA 121.704 1.602 . . . . 72.31 110.727 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -71.19 104.07 2.98 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.776 -1.194 . . . . 74.35 107.776 172.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.524 HG11 HD11 ' B' ' 126' ' ' LEU . 32.9 t -98.09 141.51 16.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 114.705 -1.134 . . . . 71.22 109.568 -177.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -118.75 114.53 22.84 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.405 -1.702 . . . . 72.22 106.405 174.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.587 HD13 HD22 ' B' ' 128' ' ' LEU . 17.8 tp -89.15 132.21 34.93 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.238 -0.652 . . . . 73.32 109.238 174.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -129.41 148.2 51.3 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.871 1.268 . . . . 70.32 108.398 -177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.528 HD13 HD23 ' F' ' 111' ' ' LEU . 0.6 OUTLIER -142.77 151.53 41.32 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.643 0.777 . . . . 75.42 110.469 -178.43 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 19.8 t70 -148.11 139.37 23.45 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.654 1.182 . . . . 64.14 108.252 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.5 m -113.5 115.37 27.89 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.732 -0.84 . . . . 61.22 108.732 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.62 134.31 55.16 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.632 -0.877 . . . . 62.33 108.632 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.673 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 16.4 m -142.76 160.24 40.71 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.849 -0.426 . . . . 65.42 109.849 -175.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 29.5 p -166.63 136.9 3.21 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.678 0.791 . . . . 75.14 110.379 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -85.96 79.64 9.14 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 108.242 -1.021 . . . . 72.33 108.242 172.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.426 HD21 ' HB3' ' B' ' 57' ' ' GLU . 2.7 pp -93.1 6.57 47.49 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.506 -0.77 . . . . 73.31 111.02 -177.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.405 ' HB3' HG23 ' B' ' 55' ' ' VAL . . . -162.65 154.61 18.48 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.77 1.228 . . . . 74.3 108.773 173.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -75.75 129.19 36.68 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.646 0.378 . . . . 74.02 110.726 -177.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 70.62 -3.12 2.01 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.957 1.303 . . . . 73.34 113.55 173.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.405 HG23 ' HB3' ' B' ' 52' ' ' ALA . 30.7 m -134.65 122.9 40.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.013 -1.106 . . . . 61.22 108.013 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.673 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 0.1 OUTLIER -99.34 156.76 16.83 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.654 0.782 . . . . 63.33 109.424 -177.087 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.426 ' HB3' HD21 ' B' ' 51' ' ' LEU . 4.5 tm-20 -121.41 97.43 5.51 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 105.728 -1.953 . . . . 72.22 105.728 166.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 12.5 p -100.56 141.76 16.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.768 -0.827 . . . . 75.1 108.768 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.436 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 18.4 t -115.57 148.25 18.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 124.944 1.298 . . . . 73.15 108.645 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 60.1 tp -128.36 107.06 9.44 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.477 -0.935 . . . . 75.53 108.477 171.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.468 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 31.3 ttm180 -86.64 132.72 33.81 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.151 -1.055 . . . . 73.53 108.151 172.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 38.9 t -129.46 124.65 60.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 107.243 -1.391 . . . . 75.43 107.243 175.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 6.3 m -120.78 131.06 54.28 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.378 -0.601 . . . . 72.41 109.378 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.663 HG11 HD21 ' B' ' 126' ' ' LEU . 89.6 t -119.41 108.41 23.66 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 123.905 0.882 . . . . 65.32 109.335 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 93.9 m -90.21 138.4 31.56 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.346 -0.983 . . . . 71.53 108.346 167.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.25 142.47 26.13 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.234 -0.654 . . . . 74.1 109.234 175.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.429 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 17.0 p -144.28 134.69 24.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.367 -0.833 . . . . 55.33 109.973 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.581 HD13 ' HB2' ' B' ' 34' ' ' LYS . 62.9 mt -101.19 113.89 27.35 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.577 1.151 . . . . 73.15 110.072 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.18 -112.02 3.62 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-N 115.686 -0.688 . . . . 65.45 111.548 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.58 27.62 6.85 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.396 0.679 . . . . 63.3 109.795 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -141.23 153.27 45.17 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.192 -0.67 . . . . 73.52 109.192 176.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 56.8 m -68.17 135.2 51.71 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.225 0.536 . . . . 51.33 110.855 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.429 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -88.26 -66.01 0.96 Allowed 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.41 -1.33 . . . . 75.14 107.41 174.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -150.27 159.29 44.55 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 114.881 -1.054 . . . . 73.41 110.267 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 78.4 mt -134.07 108.53 8.39 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.396 -1.705 . . . . 74.01 106.396 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.1 t -119.82 151.53 38.7 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.104 -0.702 . . . . 71.04 109.104 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -159.23 134.39 8.29 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.511 -0.922 . . . . 71.24 108.511 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' B' ' 113' ' ' CYS . 85.4 t -128.99 143.92 39.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.997 -1.112 . . . . 74.13 107.997 175.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -122.94 96.18 4.91 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.382 -0.97 . . . . 62.02 108.382 175.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -91.12 102.38 15.13 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.284 -0.636 . . . . 75.23 109.284 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -94.9 165.84 25.81 Favored Glycine 0 C--N 1.339 0.749 0 O-C-N 123.58 0.55 . . . . 41.44 112.138 177.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.9 134.6 3.27 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-O 119.772 -0.46 . . . . 71.41 113.314 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.413 HD12 ' HE1' ' B' ' 17' ' ' TYR . 3.9 mp -86.12 117.82 31.47 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 107.226 -1.398 . . . . 70.21 107.226 170.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -121.84 135.94 54.92 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.592 0.757 . . . . 73.53 109.112 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 56.1 m -89.34 126.26 35.46 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.785 0.834 . . . . 72.22 109.254 173.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.569 ' HB ' HD11 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -133.65 130.3 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.079 0.951 . . . . 72.41 108.468 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.67 ' HA ' ' HB ' ' F' ' 97' ' ' ILE . . . -157.67 171.98 19.35 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.505 0.722 . . . . 50.22 110.645 177.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.554 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 87.18 -50.13 4.07 Favored Glycine 0 C--N 1.352 1.437 0 C-N-CA 123.608 0.623 . . . . 52.42 111.949 -178.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.569 HD11 ' HB ' ' B' ' 86' ' ' ILE . 11.3 pt -59.08 148.08 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 124.981 1.313 . . . . 45.31 111.81 171.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -153.19 163.31 40.11 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 123.837 0.855 . . . . 71.33 109.595 -176.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.35 -121.73 6.22 Favored Glycine 0 C--N 1.351 1.371 0 C-N-CA 123.358 0.504 . . . . 53.43 112.847 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 18.8 m -73.58 -39.71 64.44 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.883 0.849 . . . . 74.2 109.909 174.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -66.68 -27.11 67.39 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 113.623 -1.626 . . . . 71.41 111.96 -167.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.677 ' HB2' HD11 ' F' ' 97' ' ' ILE . 9.6 ptm -65.95 -57.71 7.22 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.675 -0.693 . . . . 74.04 111.661 -175.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.23 -14.51 57.42 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.352 0.661 . . . . 44.23 111.89 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -61.12 -40.28 93.18 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.735 0.814 . . . . 71.31 110.906 169.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.1 t -66.36 -54.27 26.47 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.705 0.402 . . . . 72.41 111.29 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.472 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.2 pp -68.34 -25.38 65.07 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.855 0.462 . . . . 72.44 112.167 -176.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.89 2.88 58.5 Favored Glycine 0 C--N 1.352 1.439 0 CA-C-O 119.649 -0.528 . . . . 65.34 114.2 -175.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.564 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -148.73 -55.06 0.19 Allowed 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 117.56 0.68 . . . . 65.45 112.136 -174.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -70.56 -43.34 69.7 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.426 0.69 . . . . 74.34 111.146 -176.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.539 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 56.5 m -72.86 -43.27 8.12 Favored Pre-proline 0 CA--C 1.566 1.586 0 CA-C-O 118.621 -0.704 . . . . 55.41 112.784 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.0 -30.52 93.62 Favored 'Trans proline' 0 C--N 1.396 3.058 0 C-N-CA 122.229 1.953 . . . . 73.02 113.906 170.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -59.15 -37.66 77.85 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.567 0.747 . . . . 72.23 111.503 178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 54.9 mt -65.11 -39.08 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.882 0.873 . . . . 73.12 110.782 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.19 -23.06 54.64 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.152 -0.931 . . . . 64.24 112.215 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -60.66 -47.17 96.73 Favored Pre-proline 0 CA--C 1.567 1.606 0 N-CA-C 114.281 1.215 . . . . 75.54 114.281 -174.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -53.86 -41.74 72.25 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 122.517 2.145 . . . . 65.35 114.106 175.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -68.98 -42.17 76.91 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.4 0.68 . . . . 74.12 110.754 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.05 98.92 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.321 -0.854 . . . . 31.43 110.774 177.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 28.9 ttt180 -61.35 -49.69 75.95 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.469 1.108 . . . . 70.32 110.763 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -67.3 -32.67 73.81 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.149 0.58 . . . . 72.12 110.19 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.509 ' O ' ' HG2' ' B' ' 117' ' ' MET . 9.1 t -71.11 -38.49 72.34 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 122.879 0.472 . . . . 73.43 111.082 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.415 HD13 HG23 ' B' ' 64' ' ' VAL . 81.8 mt -62.25 -56.77 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 123.684 0.794 . . . . 65.14 109.712 173.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 19.7 m -63.08 -24.74 68.04 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.763 0.825 . . . . 72.12 111.371 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.455 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.9 t -63.62 -52.45 60.79 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 109.265 -0.642 . . . . 74.33 109.265 171.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.9 mmt -66.67 -32.49 73.84 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.42 0.688 . . . . 61.15 111.357 -176.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.463 HG21 HD22 ' B' ' 126' ' ' LEU . 93.3 t -69.78 -40.28 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.073 0.949 . . . . 71.35 110.672 175.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 40.4 t -67.26 -32.07 72.84 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.304 -0.862 . . . . 72.14 110.367 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.533 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 77.8 mtt-85 -68.66 -34.6 75.99 Favored 'General case' 0 C--O 1.208 -1.126 0 CA-C-N 115.478 -0.783 . . . . 65.42 109.851 176.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.01 -17.95 80.23 Favored Glycine 0 C--N 1.351 1.39 0 O-C-N 123.544 0.528 . . . . 52.23 112.483 170.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 18.0 m 66.93 31.23 7.23 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 123.153 1.454 . . . . 74.11 110.193 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.432 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 41.5 m-85 -78.02 167.26 37.25 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-N 114.099 -1.41 . . . . 75.42 111.168 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.646 ' HB3' ' HA ' ' F' ' 130' ' ' ALA . 50.4 Cg_exo -45.23 145.12 3.74 Favored 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 123.366 2.711 . . . . 72.12 114.566 170.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.422 HE21 ' ND2' ' B' ' 127' ' ' ASN . 58.9 tp60 -60.09 118.38 6.24 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.083 0.953 . . . . 72.11 111.301 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.663 HD21 HG11 ' B' ' 64' ' ' VAL . 12.0 tp -110.03 119.46 39.38 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.358 1.063 . . . . 62.51 108.727 -175.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.422 ' ND2' HE21 ' B' ' 125' ' ' GLN . 53.7 m-80 -125.0 127.85 47.64 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.265 -1.013 . . . . 61.52 108.265 174.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.587 HD22 HD13 ' B' ' 42' ' ' LEU . 43.6 mt -86.55 143.29 27.76 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.022 0.529 . . . . 73.54 110.639 -178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.67 132.51 94.09 Favored Pre-proline 0 CA--C 1.548 0.889 0 O-C-N 124.085 0.866 . . . . 54.1 111.014 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.26 89.34 0.32 Allowed 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.085 2.524 . . . . 65.4 111.595 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.55 113.55 26.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 CA-C-O 121.535 0.683 . . . . 61.34 109.501 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -82.44 107.85 15.41 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.665 -1.235 . . . . 72.42 107.665 171.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -67.74 -24.89 65.41 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.508 0.723 . . . . 63.11 110.294 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.564 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 25.6 t70 -62.28 -41.95 98.93 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.999 -1.001 . . . . 74.12 110.737 171.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.43 -25.68 68.12 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 123.911 0.757 . . . . 65.05 111.803 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.417 ' HG ' HD12 ' F' ' 111' ' ' LEU . 1.0 OUTLIER -61.84 -55.43 29.95 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.761 -0.829 . . . . 75.3 108.761 176.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -74.82 -26.27 59.59 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.715 0.806 . . . . 63.5 111.493 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 15.7 tpt -75.55 -36.34 60.47 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.188 0.595 . . . . 74.42 110.247 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.496 ' HA ' ' HB2' ' B' ' 142' ' ' GLN . 14.6 m120 -80.77 -29.59 36.16 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.943 0.497 . . . . 73.0 110.234 175.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -73.15 -25.98 61.02 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.857 0.463 . . . . 72.11 110.914 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 18.2 tp -118.61 28.91 8.04 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-O 121.576 0.703 . . . . 60.33 109.771 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . 0.496 ' HB2' ' HA ' ' B' ' 139' ' ' ASN . 47.0 tt0 -72.18 -12.94 61.4 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.719 0.807 . . . . 33.35 111.789 -177.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -54.71 -29.2 52.55 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.919 0.887 . . . . 74.41 110.835 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -95.02 106.26 18.24 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.78 -0.822 . . . . 70.23 108.78 172.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -152.07 159.01 43.78 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.493 1.117 . . . . 64.24 108.756 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -162.33 6.44 0.08 OUTLIER Glycine 0 N--CA 1.471 1.029 0 CA-C-O 119.851 -0.416 . . . . 75.02 114.099 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -112.86 91.4 3.64 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.386 0.675 . . . . 73.01 109.66 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -90.47 179.77 43.48 Favored Glycine 0 C--N 1.341 0.838 0 CA-C-N 115.292 -0.867 . . . . 33.43 111.054 173.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 22.1 p -136.55 126.14 25.32 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.29 0.636 . . . . 73.43 110.505 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -92.64 156.4 17.11 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.316 1.046 . . . . 72.01 109.378 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . 0.673 ' HB2' ' HB2' ' D' ' 6' ' ' ASN . 40.8 tt0 -115.7 126.65 54.37 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.059 -0.719 . . . . 63.42 109.059 172.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -147.08 54.57 1.09 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 105.803 -1.925 . . . . 61.32 105.803 172.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -70.55 115.5 9.79 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-N 115.325 -0.852 . . . . 64.12 110.516 -172.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -67.21 -32.92 74.31 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 114.631 -1.168 . . . . 71.52 109.968 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.225 0 C-N-CA 124.692 1.197 . . . . 62.43 107.88 171.797 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 53.9 ttm . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 109.277 -0.638 . . . . 44.33 109.277 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 16.5 p -91.95 88.61 6.66 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 108.906 -0.776 . . . . 73.45 108.906 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . 0.547 ' H ' ' HA2' ' A' ' 146' ' ' GLY . 32.6 mm-40 -103.62 163.25 12.43 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.866 0.466 . . . . 75.21 111.162 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -108.18 126.72 53.12 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.563 -0.903 . . . . 64.52 108.563 167.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -144.59 143.32 30.74 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.563 0.745 . . . . 74.21 109.696 -172.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -98.8 132.92 43.79 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 109.007 -0.738 . . . . 74.11 109.007 174.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 20.3 p -77.45 -54.19 6.73 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.486 1.114 . . . . 73.21 110.78 -176.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' C' ' 9' ' ' MET . 0.0 OUTLIER -149.53 -74.69 0.17 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.533 0.733 . . . . 71.13 109.985 171.046 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.566 ' HE2' HG21 ' C' ' 89' ' ' ILE . 56.8 ttm 50.43 113.6 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.255 1.822 . . . . 74.12 112.917 -174.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 86.3 m -83.94 76.4 10.04 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.009 -1.108 . . . . 53.54 108.009 173.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.53 ' HD2' ' HG2' ' A' ' 130' ' ' PRO . 28.9 t80 -102.85 119.63 39.18 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.335 -1.357 . . . . 73.31 107.335 176.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 -137.97 133.35 33.58 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.206 -1.035 . . . . 54.24 108.206 172.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.485 HD13 HD11 ' C' ' 16' ' ' ILE . 17.3 mt -77.82 126.86 38.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 108.739 -0.838 . . . . 63.43 108.739 174.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.412 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 27.5 mm-40 -82.05 -53.36 6.17 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.259 -1.015 . . . . 73.34 108.259 173.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.576 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -172.96 146.84 1.57 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.648 0.779 . . . . 74.12 110.471 178.323 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.485 HD11 HD13 ' C' ' 13' ' ' ILE . 72.5 mt -116.68 132.84 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.202 1.401 . . . . 74.41 107.586 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.442 ' HB3' HG23 ' D' ' 122' ' ' THR . 39.5 p90 -161.62 156.52 23.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.372 0.606 . . . . 63.34 112.105 -164.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 42.4 p -88.18 107.65 18.89 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.511 -0.768 . . . . 54.34 109.572 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.41 ' HG2' ' CE1' ' C' ' 17' ' ' TYR . 20.6 mtmt -74.32 -29.26 61.53 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.495 -0.557 . . . . 74.42 109.495 172.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.603 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 30.7 t70 -150.21 140.91 22.65 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.309 -0.86 . . . . 55.51 110.16 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 93.7 mt -137.37 144.81 30.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 C-N-CA 125.562 1.545 . . . . 62.42 106.943 173.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -150.26 145.51 26.24 Favored 'General case' 0 C--O 1.243 0.74 0 O-C-N 123.595 0.559 . . . . 75.03 109.624 173.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -151.52 116.77 5.3 Favored 'General case' 0 C--O 1.225 -0.21 0 N-CA-C 107.987 -1.116 . . . . 75.54 107.987 171.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -121.64 121.47 37.45 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.077 0.951 . . . . 72.11 108.547 176.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.17 87.6 6.22 Favored Pre-proline 0 C--O 1.239 0.525 0 N-CA-C 106.275 -1.75 . . . . 75.04 106.275 169.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.06 -21.65 36.46 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.631 2.221 . . . . 72.23 111.828 -168.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -125.65 31.18 5.57 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.201 1.0 . . . . 74.2 109.742 -177.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.24 -61.0 2.02 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 114.644 1.35 . . . . 53.13 114.644 -169.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.11 -34.73 45.29 Favored 'Trans proline' 0 C--N 1.382 2.337 0 CA-C-N 121.848 1.696 . . . . 73.14 112.268 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -69.0 -36.7 78.12 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.773 -1.103 . . . . 75.11 111.837 -176.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.593 ' HA ' ' HZ2' ' C' ' 34' ' ' LYS . 14.5 p -80.71 -28.67 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 N-CA-C 112.863 0.69 . . . . 75.15 112.863 -176.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -63.71 -31.42 72.59 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.718 0.407 . . . . 71.14 111.984 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -88.12 12.48 13.52 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.419 1.088 . . . . 54.15 111.803 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.63 ' HZ3' ' HG2' ' C' ' 71' ' ' GLU . 10.2 ttpp -126.73 160.39 30.96 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.046 0.938 . . . . 75.01 111.434 -174.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -51.25 122.66 8.09 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.539 1.536 . . . . 74.2 112.435 178.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -86.13 82.56 8.02 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.622 0.725 . . . . 72.31 109.523 170.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -135.79 76.6 53.15 Favored Pre-proline 0 N--CA 1.472 0.662 0 N-CA-C 107.528 -1.286 . . . . 45.31 107.528 169.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -83.88 152.43 12.92 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.641 2.227 . . . . 61.25 111.703 -175.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -86.41 113.32 22.27 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.419 -1.326 . . . . 64.04 107.419 171.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.539 HG11 HG13 ' F' ' 135' ' ' VAL . 39.4 t -74.36 96.69 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 108.615 -0.883 . . . . 51.33 108.615 -177.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.476 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 14.2 mptt -101.04 101.47 12.24 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 106.33 -1.73 . . . . 74.52 106.33 168.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pp -105.64 162.88 13.13 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.823 0.449 . . . . 75.01 110.065 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.634 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 4.7 t70 -148.08 135.32 20.43 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.103 0.961 . . . . 63.34 108.878 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 45.5 mt -131.86 110.98 11.2 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.123 -1.066 . . . . 63.32 108.123 174.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -131.77 128.31 38.57 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.961 -1.125 . . . . 74.21 107.961 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -126.68 140.9 52.06 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 109.444 -0.576 . . . . 74.34 109.444 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.54 142.63 33.53 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.38 0.672 . . . . 70.14 109.81 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 20.4 m -124.34 148.5 47.44 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.331 0.653 . . . . 43.45 110.776 -175.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 21.4 p -147.38 127.11 13.41 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.134 0.974 . . . . 63.54 108.881 176.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -78.84 120.44 23.47 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.108 -0.701 . . . . 74.24 109.108 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' C' ' 57' ' ' GLU . 33.7 mt -84.07 -44.56 13.95 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.766 0.826 . . . . 73.2 109.89 -176.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.93 -174.52 4.82 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.255 -0.884 . . . . 41.22 109.789 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.44 111.52 1.42 Allowed 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.84 0.712 . . . . 71.44 110.417 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 64.91 17.09 10.89 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.763 1.225 . . . . 55.33 112.471 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.77 113.65 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.151 -1.055 . . . . 71.02 108.151 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -122.54 126.36 47.62 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.153 0.981 . . . . 64.0 109.706 -173.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.499 ' HB2' HD11 ' C' ' 51' ' ' LEU . 43.4 tt0 -89.36 132.82 34.78 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.792 -0.818 . . . . 64.05 108.792 167.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 90.5 t -122.68 137.28 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 107.582 -1.266 . . . . 62.4 107.582 168.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -128.14 133.07 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 109.17 -0.678 . . . . 72.12 109.17 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.15 98.98 8.12 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.403 -1.332 . . . . 75.24 107.403 178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -83.2 106.53 15.07 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.932 -0.766 . . . . 64.43 108.932 171.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 16.4 t -103.32 129.42 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 108.175 -1.046 . . . . 62.52 108.175 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.634 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 22.6 m -119.0 139.97 50.8 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.674 -0.862 . . . . 64.1 108.674 176.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.633 HG21 HG21 ' C' ' 114' ' ' ILE . 91.6 t -129.58 120.44 50.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 124.097 0.959 . . . . 65.52 108.792 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.494 HG23 HD23 ' C' ' 75' ' ' LEU . 2.0 m -115.4 109.21 17.54 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.182 -1.044 . . . . 71.02 108.182 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.44 105.52 15.67 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.945 -1.131 . . . . 30.32 107.945 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 43.0 m -131.16 128.82 40.84 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 109.797 -0.446 . . . . 51.12 109.797 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.413 HD12 ' HG2' ' C' ' 71' ' ' GLU . 16.0 mt -86.96 35.79 0.7 Allowed 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 124.617 1.167 . . . . 72.15 110.379 -177.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.27 -112.36 2.79 Favored Glycine 0 C--N 1.346 1.084 0 N-CA-C 110.523 -1.031 . . . . 55.35 110.523 -169.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -90.97 -26.26 19.33 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.44 0.696 . . . . 74.04 110.78 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . 0.63 ' HG2' ' HZ3' ' C' ' 34' ' ' LYS . 14.4 tp10 -68.87 118.49 11.88 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.334 -0.848 . . . . 74.24 109.095 170.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 94.9 m -87.49 120.5 28.86 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.82 -0.808 . . . . 74.33 108.82 165.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.97 -50.92 44.83 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.823 -1.08 . . . . 71.32 108.545 177.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -165.11 168.35 17.35 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 114.043 -1.435 . . . . 53.01 111.048 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.494 HD23 HG23 ' C' ' 65' ' ' THR . 2.6 tm? -127.46 140.9 51.85 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 106.269 -1.752 . . . . 74.41 106.269 166.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 51.2 t -142.83 148.39 37.0 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.656 -0.868 . . . . 74.32 108.656 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -157.81 140.13 14.45 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 109.708 -0.478 . . . . 71.14 109.708 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.408 HG11 ' HA ' ' C' ' 110' ' ' ALA . 68.9 t -136.13 115.04 15.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 124.462 1.105 . . . . 44.21 108.518 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.603 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.7 mt-30 -91.75 88.6 6.74 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.74 -0.837 . . . . 73.11 108.74 169.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -80.12 96.69 6.59 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.031 -0.986 . . . . 63.11 109.083 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.51 153.3 30.04 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 111.185 -0.766 . . . . 54.53 111.185 175.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.83 123.78 1.38 Allowed Glycine 0 CA--C 1.498 -1.011 0 N-CA-C 110.722 -0.951 . . . . 50.43 110.722 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.502 HD11 ' HB3' ' D' ' 29' ' ' PRO . 32.1 mm -89.96 130.48 39.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 108.758 -0.83 . . . . 63.25 108.758 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -132.03 119.35 20.91 Favored 'General case' 0 C--O 1.241 0.651 0 O-C-N 124.191 0.932 . . . . 75.54 108.49 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 21.1 p -79.36 100.48 7.62 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.656 -1.238 . . . . 71.02 107.656 171.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.431 HD13 ' SG ' ' C' ' 97' ' ' CYS . 25.2 mt -115.2 129.58 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.226 0.61 . . . . 73.21 109.612 -175.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.521 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -146.42 168.04 22.14 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.443 0.697 . . . . 72.53 110.315 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.76 -32.15 6.3 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 115.324 -0.853 . . . . 35.01 112.634 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.566 HG21 ' HE2' ' C' ' 9' ' ' MET . 37.9 pt -106.97 164.06 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 123.16 0.584 . . . . 70.22 111.791 -173.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -154.17 163.5 40.01 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.112 0.965 . . . . 64.23 109.189 177.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.97 -126.54 9.66 Favored Glycine 0 C--N 1.351 1.374 0 O-C-N 123.364 0.415 . . . . 63.3 113.923 168.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 67.2 p -69.58 -29.74 67.36 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.504 0.721 . . . . 74.04 111.223 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -63.82 -52.21 61.22 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.655 0.782 . . . . 73.4 110.157 175.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.509 ' HE3' ' HA ' ' C' ' 94' ' ' MET . 4.6 tpt -53.53 -50.88 64.5 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 124.318 1.011 . . . . 72.4 111.904 173.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.35 -40.02 92.73 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.162 0.585 . . . . 74.24 111.829 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -70.6 -34.09 71.76 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.197 0.999 . . . . 73.33 111.087 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.431 ' SG ' HD13 ' C' ' 86' ' ' ILE . 38.5 t -69.86 -37.12 76.01 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.764 -0.653 . . . . 60.14 109.896 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 90.8 mt -84.69 -32.32 23.63 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.299 1.04 . . . . 75.24 112.297 -176.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -111.52 11.38 28.19 Favored Glycine 0 N--CA 1.475 1.234 0 CA-C-O 119.785 -0.453 . . . . 73.04 114.102 -170.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.28 -51.58 0.11 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 117.372 0.586 . . . . 73.11 111.662 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -72.99 -49.88 26.43 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.32 0.248 . . . . 63.02 111.006 -175.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.432 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 86.0 m -64.68 -49.33 70.49 Favored Pre-proline 0 CA--C 1.561 1.39 0 CA-C-O 118.244 -0.884 . . . . 73.21 112.251 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.432 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 49.1 Cg_exo -58.75 -27.71 84.45 Favored 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 122.655 2.237 . . . . 65.02 113.547 174.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -64.51 -39.7 94.26 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.462 0.705 . . . . 55.03 110.415 174.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.539 HD12 ' NH1' ' A' ' 111' ' ' ARG . 29.2 mm -75.46 -35.73 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 O-C-N 123.267 0.355 . . . . 73.4 110.177 178.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 87.8 mt -74.41 -31.67 62.4 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.563 0.745 . . . . 71.23 112.223 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -55.83 -49.96 89.88 Favored Pre-proline 0 N--CA 1.484 1.26 0 CA-C-O 117.465 -1.255 . . . . 73.55 114.346 -173.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.63 -37.79 95.67 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.425 2.083 . . . . 72.1 113.445 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.434 ' HE2' HG21 ' A' ' 115' ' ' THR . 52.4 m-85 -67.6 -44.27 78.49 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.624 0.77 . . . . 74.54 110.247 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.408 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -64.9 -38.69 91.81 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.963 -1.017 . . . . 70.24 110.66 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -65.04 -46.06 82.83 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.385 1.474 . . . . 63.44 110.449 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.94 -38.45 79.47 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.586 -0.734 . . . . 52.13 109.402 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 32.1 t -65.35 -36.2 83.29 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.955 0.502 . . . . 60.44 111.663 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.633 HG21 HG21 ' C' ' 64' ' ' VAL . 96.3 mt -68.85 -57.95 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.218 0.607 . . . . 74.23 110.054 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 10.8 m -65.26 -27.69 68.83 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 122.792 0.437 . . . . 71.11 111.277 -174.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.419 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 40.8 t -64.12 -48.87 74.41 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.359 0.664 . . . . 44.42 109.242 170.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.548 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.03 -38.44 76.22 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.428 1.091 . . . . 73.22 112.351 177.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.462 HG23 ' O ' ' C' ' 114' ' ' ILE . 91.8 t -69.75 -38.44 76.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.019 0.928 . . . . 73.33 110.105 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 28.5 t -71.56 -27.66 63.32 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.37 1.068 . . . . 61.44 111.729 174.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' C' ' 116' ' ' SER . 76.4 mtt-85 -73.63 -40.96 63.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.582 0.753 . . . . 43.44 109.09 178.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.27 1.0 66.27 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 115.365 -0.834 . . . . 72.14 112.505 170.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.439 HG21 ' O ' ' D' ' 16' ' ' ILE . 30.8 p 62.25 29.25 17.36 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.505 1.922 . . . . 64.23 113.588 170.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -80.29 151.18 72.12 Favored Pre-proline 0 C--O 1.246 0.882 0 N-CA-C 107.704 -1.221 . . . . 74.11 107.704 168.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.485 ' HG3' ' HB ' ' F' ' 129' ' ' THR . 31.4 Cg_exo -57.04 150.76 54.22 Favored 'Trans proline' 0 C--N 1.366 1.457 0 C-N-CA 122.015 1.81 . . . . 53.15 111.393 172.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' B' ' 123' ' ' PHE . 57.6 mm-40 -45.8 129.8 9.29 Favored 'General case' 0 N--CA 1.478 0.967 0 O-C-N 124.551 1.157 . . . . 62.15 112.274 -175.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 38.3 tp -136.09 86.78 2.25 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.026 -1.472 . . . . 74.42 107.026 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -92.6 122.36 34.95 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.934 -1.03 . . . . 72.21 109.267 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.57 121.88 17.32 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 108.749 -0.834 . . . . 74.44 108.749 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.14 140.66 97.95 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 123.717 0.807 . . . . 73.33 110.917 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.8 108.64 0.43 Allowed 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.603 2.202 . . . . 73.41 112.759 177.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 26.3 t -99.9 122.0 51.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 N-CA-C 108.386 -0.968 . . . . 52.11 108.386 173.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.425 ' O ' ' HG ' ' C' ' 136' ' ' LEU . 56.7 t-20 -75.0 104.53 5.62 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.377 1.071 . . . . 74.33 110.297 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -66.65 -27.05 67.37 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.835 0.854 . . . . 72.21 112.687 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -66.87 -39.44 87.54 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.565 0.746 . . . . 72.25 110.201 174.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.04 92.66 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.7 -0.682 . . . . 73.44 110.708 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' C' ' 132' ' ' ASN . 71.5 mt -68.17 -32.79 73.29 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.368 0.667 . . . . 62.01 111.051 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -76.87 -22.49 53.39 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.03 -0.532 . . . . 73.33 109.917 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.401 ' SD ' ' HG3' ' C' ' 142' ' ' GLN . 13.7 tpt -76.35 -35.45 58.72 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 109.858 -0.423 . . . . 74.24 109.858 173.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -64.33 -35.52 81.13 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.249 0.62 . . . . 72.43 110.536 168.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -69.85 -86.86 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.273 0.629 . . . . 71.34 110.355 174.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 4.5 tt -166.65 99.55 0.58 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.888 0.475 . . . . 64.11 110.191 -175.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.401 ' HG3' ' SD ' ' C' ' 138' ' ' MET . 24.3 pt20 -165.46 -166.81 1.03 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.61 1.164 . . . . 75.32 108.864 166.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -139.15 95.28 2.92 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.725 -0.842 . . . . 63.35 108.725 170.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -112.84 125.94 54.9 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.811 0.845 . . . . 62.13 111.02 -175.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . 0.61 ' HB3' ' HA ' ' A' ' 149' ' ' THR . . . -175.61 105.36 0.08 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.31 1.444 . . . . 72.32 108.042 171.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -141.7 55.93 0.59 Allowed Glycine 0 C--N 1.348 1.217 0 N-CA-C 113.579 0.192 . . . . 42.14 113.579 -170.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -150.17 103.16 3.15 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.03 0.532 . . . . 65.51 110.121 172.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -150.16 41.38 0.81 Allowed Glycine 0 C--N 1.343 0.959 0 N-CA-C 109.97 -1.252 . . . . 73.52 109.97 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . 0.562 ' HB ' ' HA ' ' A' ' 93' ' ' GLN . 97.9 m -62.62 114.39 3.55 Favored 'General case' 0 C--O 1.216 -0.68 0 C-N-CA 125.62 1.568 . . . . 75.22 113.678 -169.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.29 157.59 36.0 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 120.946 0.403 . . . . 75.3 111.036 175.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.92 -18.67 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.92 1.288 . . . . 74.42 109.848 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 43.2 m80 73.35 67.85 0.11 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.083 1.753 . . . . 72.45 112.047 173.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -86.25 175.58 8.39 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 115.245 -0.889 . . . . 74.23 110.829 170.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -83.7 146.39 28.24 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 115.132 -0.94 . . . . 71.14 108.622 172.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.984 0 C-N-CA 123.644 0.777 . . . . 74.14 111.111 -175.353 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 51.6 mtp . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 107.603 -1.258 . . . . 70.32 107.603 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 17.5 m -59.41 -54.12 50.38 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.941 0.896 . . . . 71.21 111.464 -175.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.96 75.59 6.33 Favored 'General case' 0 CA--C 1.547 0.86 0 CA-C-N 115.335 -0.848 . . . . 73.41 110.359 -171.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.27 152.96 19.28 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 108.284 -1.006 . . . . 64.14 108.284 171.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -77.72 165.31 24.38 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.321 0.582 . . . . 73.22 111.827 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . 0.673 ' HB2' ' HB2' ' B' ' 151' ' ' GLU . 65.5 t30 -72.64 158.17 36.15 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.893 -1.049 . . . . 61.54 110.029 174.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 12.4 t -136.07 -179.84 5.91 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 123.441 0.696 . . . . 61.21 109.933 -175.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.29 112.83 4.75 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 107.953 -1.129 . . . . 63.12 107.953 175.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.561 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 0.0 OUTLIER -33.59 124.06 0.43 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.73 1.612 . . . . 61.31 113.416 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 8.2 t -132.24 158.09 42.68 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.994 0.918 . . . . 70.03 109.965 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.57 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 62.6 t80 -152.14 103.99 2.93 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.209 -1.404 . . . . 73.21 107.209 -177.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . 0.521 ' HB2' ' HB3' ' D' ' 85' ' ' SER . 38.2 mt-30 -112.77 114.0 26.35 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.345 -0.983 . . . . 74.41 108.345 -175.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.496 HG21 HD11 ' D' ' 16' ' ' ILE . 53.9 mt -77.91 125.13 37.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.489 -0.93 . . . . 64.43 108.489 175.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -88.77 -41.66 12.39 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 123.844 0.715 . . . . 74.35 109.861 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -177.43 136.91 0.2 Allowed 'General case' 0 N--CA 1.481 1.1 0 O-C-N 123.436 0.46 . . . . 74.11 110.864 -169.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.496 HD11 HG21 ' D' ' 13' ' ' ILE . 4.1 mp -110.98 142.72 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 107.193 -1.41 . . . . 74.53 107.193 169.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -166.35 163.42 17.51 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.868 0.842 . . . . 72.52 111.768 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 59.3 p -97.65 116.14 29.29 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.797 -1.092 . . . . 74.34 108.929 176.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.455 ' HD2' ' HA3' ' D' ' 81' ' ' GLY . 41.1 mtpt -85.39 -26.98 26.11 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.822 -0.807 . . . . 71.45 108.822 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.666 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 26.7 t70 -152.75 142.71 22.2 Favored 'General case' 0 C--N 1.35 0.597 0 C-N-CA 124.397 1.079 . . . . 71.52 109.749 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.548 HG21 ' HE2' ' C' ' 117' ' ' MET . 55.9 mt -141.96 145.65 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.865 1.266 . . . . 71.54 108.45 175.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -148.15 141.0 24.71 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.765 1.226 . . . . 44.51 109.384 174.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -144.81 129.45 18.1 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.319 -1.363 . . . . 63.03 107.319 167.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -137.44 111.56 8.42 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 123.98 0.912 . . . . 73.21 108.895 -171.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.19 86.08 1.91 Allowed Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 108.055 -1.091 . . . . 63.5 108.055 174.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -68.19 -35.67 18.67 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.808 2.338 . . . . 72.41 113.333 -165.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.486 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 50.1 m-20 -107.26 15.62 24.86 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.896 0.878 . . . . 54.2 110.813 -174.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.469 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -27.0 -71.19 0.05 OUTLIER Pre-proline 0 CA--C 1.561 1.397 0 N-CA-C 116.459 2.022 . . . . 54.34 116.459 -160.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.502 ' HB3' HD11 ' C' ' 83' ' ' ILE . 93.9 Cg_endo -74.12 -24.18 15.08 Favored 'Trans proline' 0 C--N 1.378 2.086 0 CA-C-N 123.491 2.283 . . . . 65.1 113.936 -172.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.468 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 4.8 t-160 -73.1 -40.96 64.56 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.649 0.78 . . . . 70.13 109.776 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.608 HG22 HD12 ' D' ' 68' ' ' LEU . 7.6 p -79.37 -26.58 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 CA-C-N 115.506 -0.77 . . . . 72.12 111.609 -170.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -61.45 -23.69 66.03 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 122.797 0.439 . . . . 65.41 112.16 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.468 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 64.6 mt-30 -67.21 -9.07 36.51 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.698 1.199 . . . . 71.03 112.009 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -97.73 98.47 9.89 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.996 1.319 . . . . 73.12 110.182 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -88.78 88.44 7.6 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.792 0.837 . . . . 70.41 110.826 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 22.0 p90 -167.08 -177.99 3.98 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.103 0.961 . . . . 74.52 109.715 170.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.483 HE21 ' HD2' ' D' ' 38' ' ' PRO . 29.6 tp60 -80.58 115.31 54.36 Favored Pre-proline 0 CA--C 1.556 1.196 0 C-N-CA 123.551 0.74 . . . . 70.51 109.471 177.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.483 ' HD2' HE21 ' D' ' 37' ' ' GLN . 52.6 Cg_exo -58.38 142.68 97.92 Favored 'Trans proline' 0 C--N 1.386 2.501 0 C-N-CA 123.028 2.486 . . . . 72.44 112.379 177.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 14.0 mm-40 -67.18 106.46 2.02 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 107.531 -1.285 . . . . 72.11 107.531 171.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.625 HG13 HG13 ' D' ' 64' ' ' VAL . 62.4 t -106.17 116.09 49.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 O-C-N 123.729 0.643 . . . . 72.34 109.797 -178.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -98.98 152.64 19.58 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.642 -0.708 . . . . 45.34 109.569 169.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.444 HD11 HG13 ' D' ' 62' ' ' VAL . 31.9 tp -126.63 134.52 50.74 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.967 -1.015 . . . . 73.14 109.759 -173.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.551 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 13.2 t70 -130.35 113.77 14.77 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.415 -1.328 . . . . 74.22 107.415 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.709 HD12 HG23 ' E' ' 121' ' ' VAL . 94.3 mt -118.56 129.14 55.17 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.22 0.608 . . . . 70.33 109.438 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.436 ' HA ' ' HB2' ' E' ' 111' ' ' LEU . 8.5 t70 -160.03 155.76 25.86 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.633 -0.877 . . . . 73.32 108.633 172.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . 0.499 HG22 ' HA ' ' D' ' 60' ' ' LEU . 30.4 p -123.61 168.64 12.37 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 122.167 0.984 . . . . 74.24 113.035 -170.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.13 143.97 26.33 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 113.465 -1.698 . . . . 60.22 107.208 173.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 37.2 p -144.65 152.88 41.11 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 120.58 0.229 . . . . 72.33 111.322 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 58.1 p -179.32 142.2 0.18 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.746 1.218 . . . . 74.03 109.603 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . 0.456 ' HB3' ' H ' ' D' ' 51' ' ' LEU . 0.7 OUTLIER -174.87 -98.02 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.27 1.028 . . . . 71.13 108.292 166.17 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.456 ' H ' ' HB3' ' D' ' 50' ' ' GLN . 84.6 mt -143.05 128.03 18.44 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.306 1.043 . . . . 73.1 109.291 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.33 78.03 0.74 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.764 0.825 . . . . 62.52 110.752 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . 0.515 ' HB3' ' H ' ' E' ' 92' ' ' GLY . 22.8 t70 -174.73 49.27 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.072 -1.455 . . . . 61.44 107.072 -176.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' D' ' 85' ' ' SER . 6.0 m-20 63.08 24.23 14.37 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.162 -1.381 . . . . 75.03 112.932 172.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.414 ' O ' ' HB3' ' D' ' 50' ' ' GLN . 58.8 t -134.87 102.16 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 107.635 -1.246 . . . . 74.45 107.635 177.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -135.33 135.06 40.47 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.039 0.535 . . . . 75.31 109.856 -174.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.514 ' HG2' HG12 ' D' ' 83' ' ' ILE . 42.3 mt-10 -87.14 115.02 24.25 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.882 -1.155 . . . . 64.04 107.882 167.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 70.6 t -97.58 136.22 29.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 106.797 -1.557 . . . . 70.12 106.797 171.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.426 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.1 t -128.41 123.76 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 108.239 -1.023 . . . . 73.33 108.239 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.499 ' HA ' HG22 ' D' ' 46' ' ' THR . 0.2 OUTLIER -103.31 121.21 42.27 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.824 -1.176 . . . . 60.51 107.824 176.189 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -100.53 105.99 17.47 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.237 -1.394 . . . . 61.5 107.237 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.444 HG13 HD11 ' D' ' 42' ' ' LEU . 59.1 t -99.99 120.43 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 N-CA-C 108.234 -1.025 . . . . 73.35 108.234 176.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 28.2 m -120.84 140.13 52.2 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.872 -0.788 . . . . 72.43 108.872 -177.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.625 HG13 HG13 ' D' ' 40' ' ' VAL . 77.3 t -131.37 130.36 62.86 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 115.398 -0.819 . . . . 74.15 109.914 -173.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 10.2 m -119.84 93.03 3.93 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.409 -0.96 . . . . 70.03 108.409 172.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.509 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -100.53 146.34 27.21 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.191 0.596 . . . . 63.13 110.037 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.521 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 23.5 p -153.89 127.93 8.97 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 112.815 0.672 . . . . 64.2 112.815 -169.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.608 HD12 HG22 ' D' ' 31' ' ' VAL . 80.0 mt -96.31 102.24 14.0 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.667 0.787 . . . . 70.24 109.121 174.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.84 -132.66 11.74 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 116.286 -0.415 . . . . 72.04 112.389 -178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.51 2.85 56.45 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.752 0.421 . . . . 71.33 111.038 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -114.94 158.31 22.19 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.362 -0.607 . . . . 71.2 109.362 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 91.6 m -75.33 139.14 42.25 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.083 0.553 . . . . 72.13 110.722 178.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.607 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.04 -62.32 1.51 Allowed 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.548 -1.279 . . . . 74.44 107.548 175.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -158.41 149.53 20.75 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 114.784 -1.098 . . . . 75.41 110.864 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 74.9 mt -116.75 120.8 39.7 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 125.689 1.596 . . . . 72.01 107.412 174.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.532 ' SG ' HG23 ' D' ' 114' ' ' ILE . 38.9 t -131.97 137.34 47.87 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.855 -0.424 . . . . 70.44 109.855 -174.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' D' ' 62' ' ' VAL . 38.5 tt0 -154.24 130.84 10.67 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.702 0.401 . . . . 72.42 110.984 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . 0.413 HG22 HG23 ' D' ' 21' ' ' ILE . 96.2 t -134.31 121.59 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.048 0.939 . . . . 71.52 109.487 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.666 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.7 mt-30 -90.2 86.35 6.5 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.677 -0.86 . . . . 71.44 108.677 169.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -80.36 101.29 8.89 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.217 -1.356 . . . . 65.13 109.073 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.455 ' HA3' ' HD2' ' D' ' 19' ' ' LYS . . . -96.85 161.07 21.78 Favored Glycine 0 N--CA 1.464 0.544 0 N-CA-C 112.479 -0.249 . . . . 70.53 112.479 178.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.03 140.72 6.63 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.729 -0.549 . . . . 74.14 111.729 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.514 HG12 ' HG2' ' D' ' 57' ' ' GLU . 50.1 mt -89.2 123.23 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.547 -1.279 . . . . 54.02 107.547 175.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -125.24 151.06 46.41 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.929 0.891 . . . . 71.45 109.768 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.521 ' HB3' ' HB2' ' D' ' 12' ' ' GLN . 33.7 t -113.19 103.76 11.66 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.324 -0.991 . . . . 71.31 108.324 173.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.63 HG22 HD11 ' D' ' 89' ' ' ILE . 3.1 mp -108.4 119.33 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 107.607 -1.257 . . . . 72.23 107.607 -176.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.33 168.69 24.59 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 123.645 0.591 . . . . 71.21 112.276 -172.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 77.83 22.59 68.82 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 115.307 -0.86 . . . . 53.21 112.957 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.63 HD11 HG22 ' D' ' 86' ' ' ILE . 0.5 OUTLIER -135.62 156.67 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.04 1.336 . . . . 55.01 108.401 176.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -152.08 163.85 38.47 Favored 'General case' 0 CA--C 1.561 1.379 0 N-CA-C 107.96 -1.126 . . . . 43.23 107.96 -176.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.19 -134.31 13.65 Favored Glycine 0 C--N 1.349 1.279 0 C-N-CA 123.545 0.593 . . . . 51.51 111.971 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 13.1 m -81.89 -25.13 35.26 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 117.964 0.882 . . . . 75.32 110.625 176.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -66.99 -19.04 65.65 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.634 1.174 . . . . 74.44 112.898 -174.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.512 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 0.0 OUTLIER -81.06 -43.41 19.55 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 112.618 0.599 . . . . 75.12 112.618 -176.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . 0.512 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -78.73 -15.31 58.61 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.046 0.539 . . . . 54.22 110.614 177.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -58.9 -46.89 86.81 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.63 1.172 . . . . 71.42 110.734 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . 0.406 ' HB2' HG21 ' D' ' 86' ' ' ILE . 51.3 m -72.23 -31.12 65.55 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.577 0.751 . . . . 73.5 111.538 -177.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.417 HD12 HG23 ' E' ' 103' ' ' THR . 2.3 tm? -64.51 -52.5 57.49 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.678 1.191 . . . . 70.32 109.457 177.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.78 -25.43 62.6 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 115.364 -0.835 . . . . 72.32 114.054 -173.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.9 -55.4 2.42 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 117.621 0.71 . . . . 65.13 112.25 -170.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -74.54 -39.76 62.14 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 111.799 0.296 . . . . 73.22 111.799 -171.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.57 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 73.8 m -63.47 -47.4 83.53 Favored Pre-proline 0 CA--C 1.569 1.708 0 CA-C-O 118.762 -0.637 . . . . 63.25 112.273 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.489 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 50.3 Cg_exo -59.72 -31.86 94.8 Favored 'Trans proline' 0 C--N 1.396 3.048 0 C-N-CA 122.656 2.237 . . . . 72.53 113.546 169.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -67.23 -28.84 68.4 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.279 0.631 . . . . 73.34 110.746 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.9 mm -74.12 -40.94 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.482 0.713 . . . . 73.32 110.227 172.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 88.3 mt -73.72 -24.92 59.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.367 0.667 . . . . 75.52 112.548 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -64.56 -44.69 75.33 Favored Pre-proline 0 N--CA 1.485 1.284 0 N-CA-C 113.766 1.024 . . . . 72.3 113.766 -171.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -55.1 -38.85 93.27 Favored 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 121.946 1.764 . . . . 74.15 113.17 173.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -73.77 -37.38 65.03 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.528 0.731 . . . . 51.12 111.074 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.62 -46.01 73.76 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.912 0.885 . . . . 73.13 110.759 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -73.8 -30.84 62.97 Favored 'General case' 0 C--O 1.217 -0.644 0 CA-C-N 115.08 -0.963 . . . . 61.31 110.781 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -64.45 -46.52 82.74 Favored 'General case' 0 N--CA 1.482 1.148 0 O-C-N 124.105 0.878 . . . . 71.14 109.809 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.1 t -55.68 -44.84 77.7 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 124.14 0.9 . . . . 64.01 110.405 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.532 HG23 ' SG ' ' D' ' 76' ' ' CYS . 72.1 mt -62.99 -50.22 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.859 0.864 . . . . 64.44 111.064 176.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 63.0 m -55.27 -47.08 76.0 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.08 0.952 . . . . 64.33 110.781 -175.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.4 t -62.57 -42.18 99.39 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 113.778 -1.555 . . . . 62.44 109.967 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.2 mtm -70.18 -31.89 69.57 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.194 0.597 . . . . 71.43 112.047 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.505 HG23 ' O ' ' D' ' 114' ' ' ILE . 76.4 t -67.74 -42.67 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.659 0.784 . . . . 73.04 110.058 176.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.5 p -73.15 -28.05 62.02 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-N 115.628 -0.715 . . . . 65.53 110.449 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' C' ' 17' ' ' TYR . 68.8 mtt-85 -70.65 -30.41 67.02 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.426 0.69 . . . . 61.34 109.601 172.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.93 11.61 66.41 Favored Glycine 0 C--N 1.353 1.477 0 CA-C-O 119.54 -0.589 . . . . 61.12 113.587 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.442 HG23 ' HB3' ' C' ' 17' ' ' TYR . 74.2 p 58.07 21.77 8.25 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 126.122 1.769 . . . . 74.02 114.365 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -90.55 155.92 45.67 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 109.409 -0.589 . . . . 72.22 109.409 171.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.3 137.86 71.86 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 122.902 2.402 . . . . 71.1 112.076 173.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -49.35 122.17 5.82 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.05 1.34 . . . . 74.15 112.215 -175.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.436 ' HB3' HG21 ' D' ' 118' ' ' VAL . 37.7 tp -107.64 99.54 9.02 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.423 0.689 . . . . 74.11 110.431 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -99.33 104.59 16.49 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 106.956 -1.498 . . . . 75.11 106.956 172.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.428 HD21 HG21 ' D' ' 114' ' ' ILE . 3.0 mm? -62.9 129.25 39.61 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.038 -0.727 . . . . 73.53 109.038 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.27 134.11 90.78 Favored Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 123.854 0.862 . . . . 60.41 111.533 -170.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -68.47 111.11 2.44 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.758 2.306 . . . . 60.15 111.85 -174.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.8 m -107.99 142.25 21.14 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 CA-C-O 121.218 0.532 . . . . 62.12 109.603 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -86.42 111.66 20.73 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 107.916 -1.142 . . . . 54.3 107.916 174.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.436 ' HA ' HD13 ' D' ' 136' ' ' LEU . 60.1 m-85 -68.14 -18.19 64.56 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.269 0.628 . . . . 70.11 112.532 -174.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -63.71 -39.75 95.08 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.705 0.402 . . . . 72.31 110.127 171.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.3 -21.51 66.73 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.004 0.921 . . . . 64.35 111.79 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.574 HD23 ' HB3' ' E' ' 111' ' ' LEU . 7.3 mp -74.85 -28.24 60.59 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.801 0.84 . . . . 71.34 110.883 176.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -90.97 -32.12 16.08 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.734 0.413 . . . . 75.41 110.689 176.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 73.1 mtm -70.51 -22.62 62.61 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.201 0.6 . . . . 63.22 109.933 170.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.492 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 2.8 t-20 -58.62 -41.64 86.4 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 123.789 0.836 . . . . 74.32 110.137 173.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -59.31 -39.44 83.05 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 124.146 0.904 . . . . 74.33 110.709 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.1 mp -73.81 -35.35 64.86 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.596 0.758 . . . . 53.14 111.531 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.492 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 21.1 pt20 -89.23 26.69 1.57 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.315 0.578 . . . . 72.2 111.231 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -117.1 51.7 1.0 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 107.469 -1.308 . . . . 43.44 107.469 172.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.72 113.81 7.68 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 104.946 -2.242 . . . . 74.33 104.946 176.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.44 90.56 0.38 Allowed 'General case' 0 CA--C 1.542 0.635 0 O-C-N 123.771 0.67 . . . . 73.44 110.719 -171.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.59 -124.85 5.48 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 115.432 -0.804 . . . . 73.33 111.381 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -151.77 156.69 40.76 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.402 0.681 . . . . 74.12 110.797 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -173.78 -179.0 44.14 Favored Glycine 0 C--O 1.24 0.523 0 CA-C-N 114.442 -1.253 . . . . 52.33 111.244 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 26.8 m -120.57 131.48 54.68 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.754 0.822 . . . . 60.45 108.91 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -67.73 134.71 51.51 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 123.19 0.596 . . . . 64.43 109.459 174.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -72.05 142.79 49.25 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 109.453 -0.573 . . . . 74.11 109.453 174.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -66.63 94.69 0.3 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.607 -0.516 . . . . 61.44 109.607 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -67.32 95.75 0.45 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.883 0.873 . . . . 65.14 111.204 -174.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -74.86 107.77 7.16 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 114.955 -1.021 . . . . 41.32 110.194 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.142 0 C-N-CA 123.773 0.829 . . . . 72.32 109.625 -179.319 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.691 0 N-CA-C 111.767 -0.533 . . . . 74.44 111.767 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 92' ' ' GLY . . . . . 0.515 ' H ' ' HB3' ' D' ' 53' ' ' ASP . . . -93.34 -107.39 1.84 Allowed Glycine 0 C--N 1.339 0.733 0 CA-C-O 119.553 -0.582 . . . . 53.44 111.757 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -159.79 16.64 0.15 Allowed 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.459 0.911 . . . . 75.22 113.459 -173.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -152.08 172.57 16.12 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 119.152 0.887 . . . . 74.12 111.711 -177.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -130.35 131.08 45.17 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 123.235 0.614 . . . . 64.02 111.159 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.99 -57.03 0.05 OUTLIER Glycine 0 C--N 1.343 0.947 0 N-CA-C 109.06 -1.616 . . . . 74.31 109.06 168.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 97' ' ' ILE . . . . . 0.431 HG21 HD23 ' E' ' 100' ' ' LEU . 2.0 mt -114.15 109.4 28.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 C-N-CA 124.526 1.13 . . . . 63.02 108.163 175.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -92.09 -35.83 13.68 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 120.937 0.398 . . . . 64.05 109.968 174.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -125.79 132.11 52.34 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.647 0.779 . . . . 73.22 109.989 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 100' ' ' LEU . . . . . 0.47 ' HB3' ' SD ' ' D' ' 94' ' ' MET . 0.3 OUTLIER -151.33 149.29 24.19 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.081 0.952 . . . . 61.23 111.221 173.03 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -67.19 -15.25 45.76 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.574 2.183 . . . . 65.13 111.567 163.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 102' ' ' LEU . . . . . . . . . . . . . 29.5 tp 79.0 -86.34 0.02 OUTLIER 'General case' 0 C--N 1.369 1.432 0 C-N-CA 125.742 1.617 . . . . 74.31 110.066 173.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 103' ' ' THR . . . . . 0.417 HG23 HD12 ' D' ' 98' ' ' LEU . 15.0 p -138.25 7.16 2.62 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.702 1.201 . . . . 72.11 109.297 171.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.64 -164.96 45.59 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 110.823 -0.911 . . . . 74.44 110.823 -166.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -70.36 107.35 3.74 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.347 -0.983 . . . . 71.41 108.347 171.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 58.5 t80 66.49 -80.51 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.621 1.168 . . . . 73.0 109.378 -175.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 3.2 p -151.02 125.97 9.79 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.249 1.42 . . . . 51.21 107.821 167.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -88.79 -25.74 22.08 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.083 0.553 . . . . 73.44 110.838 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -87.32 -33.49 19.18 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.449 0.7 . . . . 75.13 111.44 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . 67.22 131.39 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.018 1.327 . . . . 73.11 110.799 -166.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . 0.574 ' HB3' HD23 ' D' ' 136' ' ' LEU . 11.1 mp -77.56 -76.94 0.16 Allowed 'General case' 0 N--CA 1.477 0.904 0 O-C-N 122.052 -0.405 . . . . 73.25 111.783 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -68.32 -48.81 63.92 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 123.053 0.221 . . . . 74.13 111.259 -171.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 47.0 mttp 70.58 -42.26 0.52 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 126.166 1.787 . . . . 74.42 113.419 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . 0.448 ' HD2' HG22 ' E' ' 122' ' ' THR . 22.1 tptp 77.87 -8.44 1.67 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.118 1.767 . . . . 52.4 111.822 177.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 61.7 p -77.04 -21.94 53.74 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.077 0.951 . . . . 72.45 110.632 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.96 169.65 48.41 Favored Glycine 0 C--N 1.354 1.574 0 CA-C-N 116.087 -0.506 . . . . 55.33 112.349 173.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.35 164.29 62.13 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 124.544 1.138 . . . . 61.33 111.346 -177.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 118' ' ' PRO . . . . . 0.414 ' HA ' ' OG1' ' E' ' 122' ' ' THR . 25.9 Cg_exo -63.09 -167.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.393 2.872 0 C-N-CA 123.115 2.543 . . . . 71.04 113.368 175.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 23.2 t70 78.24 -51.2 0.49 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.669 1.587 . . . . 74.1 112.325 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -88.56 -113.55 0.06 Allowed 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 123.422 0.689 . . . . 75.21 111.386 -168.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 121' ' ' VAL . . . . . 0.709 HG23 HD12 ' D' ' 44' ' ' LEU . 13.4 p -94.45 43.87 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 123.57 1.653 . . . . 40.53 110.519 -172.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . 0.448 HG22 ' HD2' ' E' ' 114' ' ' LYS . 19.5 p -144.82 -28.43 0.47 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 113.929 -1.487 . . . . 60.14 109.213 -176.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 123' ' ' ASP . . . . . 0.408 ' H ' ' H ' ' E' ' 122' ' ' THR . 17.8 t70 -132.62 153.49 51.0 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.642 1.177 . . . . 73.5 109.961 -172.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 65.4 m -142.61 83.75 1.83 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.159 0.984 . . . . 52.12 108.399 168.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.6 -52.49 64.94 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 115.452 -0.795 . . . . 72.33 111.143 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . 56.18 -158.84 0.23 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 124.378 1.049 . . . . 53.1 110.854 -176.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 6.6 p -171.75 118.01 0.42 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.889 0.876 . . . . 61.41 109.681 172.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -158.08 156.37 30.9 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.682 0.793 . . . . 73.45 110.613 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 8.8 t -78.42 141.31 38.41 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 115.743 -0.662 . . . . 64.15 109.629 175.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.46 174.53 10.54 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 123.239 0.615 . . . . 72.23 110.66 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 131' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -61.4 111.35 1.74 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.085 0.554 . . . . 70.14 109.901 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 132' ' ' SER . . . . . 0.509 ' H ' ' HB3' ' A' ' 124' ' ' PRO . 15.5 p -140.63 28.02 2.01 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.785 0.834 . . . . 70.22 111.34 -175.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 133' ' ' THR . . . . . 0.406 ' OG1' ' HB2' ' A' ' 124' ' ' PRO . 32.7 m -124.1 97.41 5.33 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.804 -0.443 . . . . 61.35 109.804 173.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -101.02 116.67 5.64 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 109.659 -1.376 . . . . 73.05 109.659 169.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 12.6 p -71.59 158.59 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 117.092 0.446 . . . . 60.43 110.603 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 136' ' ' LYS . . . . . 0.71 ' H ' ' HD3' ' E' ' 136' ' ' LYS . 0.4 OUTLIER -88.56 170.59 10.73 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.43 1.092 . . . . 61.53 109.745 173.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 15.3 t -81.65 176.46 9.62 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 123.12 0.568 . . . . 63.34 110.965 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 138' ' ' TYR . . . . . 0.532 ' HB2' ' HB1' ' A' ' 129' ' ' ALA . 6.2 t80 -137.69 3.27 2.49 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.332 0.653 . . . . 72.14 110.569 -177.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -69.46 166.7 18.22 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 112.313 0.486 . . . . 74.44 112.313 -174.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -89.03 150.79 21.68 Favored Glycine 0 C--N 1.347 1.147 0 CA-C-N 115.907 -0.588 . . . . 71.22 112.785 -178.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -78.73 100.27 7.01 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.505 0.722 . . . . 54.42 110.5 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -73.1 -54.75 7.73 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.721 0.808 . . . . 70.42 109.367 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . 112.7 -164.7 12.03 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-N 115.199 -0.91 . . . . 61.2 110.89 -172.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 17.3 m -114.89 55.97 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 CA-C-O 122.391 1.091 . . . . 71.11 110.775 -176.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 C--O 1.251 1.14 0 CA-C-N 114.615 -1.175 . . . . 75.54 109.031 175.38 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.765 0 CA-C-O 120.344 -0.142 . . . . 61.24 112.887 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . -87.0 120.04 5.37 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 111.0 -0.84 . . . . 74.55 111.0 173.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -110.63 -80.95 0.58 Allowed 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 117.324 0.562 . . . . 75.34 110.484 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -171.4 -173.83 1.31 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.067 0.947 . . . . 75.01 109.657 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -141.03 140.51 34.29 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.526 0.73 . . . . 65.01 110.716 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . 179.3 8.86 0.02 OUTLIER Glycine 0 C--N 1.356 1.682 0 CA-C-O 119.396 -0.669 . . . . 44.43 114.674 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 97' ' ' ILE . . . . . 0.677 HD11 ' HB2' ' B' ' 94' ' ' MET . 17.3 tt -132.91 114.59 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-N 118.335 1.068 . . . . 72.53 108.952 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -74.76 87.44 2.22 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.188 0.595 . . . . 73.02 111.114 -169.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . 66.2 163.54 0.17 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.464 1.506 . . . . 71.42 111.712 -174.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 100' ' ' LEU . . . . . . . . . . . . . 3.6 mp -138.05 72.04 47.41 Favored Pre-proline 0 CA--C 1.553 1.06 0 N-CA-C 108.833 -0.803 . . . . 61.24 108.833 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -68.1 -3.13 10.1 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.776 2.984 . . . . 73.21 115.62 -170.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 102' ' ' LEU . . . . . . . . . . . . . 30.4 tp 58.9 44.71 16.24 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.908 0.883 . . . . 72.23 110.802 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 42.7 p 55.06 25.68 7.29 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 125.699 1.6 . . . . 75.21 112.844 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.03 -82.48 0.99 Allowed Glycine 0 C--N 1.351 1.386 0 CA-C-N 115.859 -0.61 . . . . 51.12 111.822 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -96.41 164.13 12.76 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.599 0.76 . . . . 75.43 110.852 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -55.5 97.38 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.183 1.393 . . . . 74.43 109.793 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 9.9 m 52.38 67.61 0.95 Allowed 'General case' 0 CA--C 1.558 1.281 0 O-C-N 124.568 1.167 . . . . 53.12 109.963 -174.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -65.81 -39.0 90.46 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 115.913 -0.585 . . . . 74.33 112.14 -172.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -61.95 -29.84 70.51 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.291 0.37 . . . . 71.31 110.73 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 69.86 120.88 0.03 OUTLIER 'General case' 0 C--N 1.357 0.929 0 C-N-CA 125.258 1.423 . . . . 74.13 111.571 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . 0.528 HD23 HD13 ' B' ' 44' ' ' LEU . 15.3 tp -74.04 -65.4 0.84 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.668 0.787 . . . . 71.53 110.768 -173.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -89.64 36.16 0.84 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.801 1.24 . . . . 63.2 111.51 -174.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -76.72 174.05 10.91 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.715 0.806 . . . . 75.12 112.882 -170.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -71.43 93.68 1.19 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.71 -1.132 . . . . 64.11 108.807 169.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 12.8 m -90.08 -17.65 27.33 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.452 0.701 . . . . 64.02 110.407 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 127.86 -52.26 0.83 Allowed Glycine 0 C--N 1.348 1.214 0 CA-C-O 121.212 0.34 . . . . 64.55 112.549 170.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -107.55 -175.47 0.36 Allowed Pre-proline 0 N--CA 1.478 0.961 0 N-CA-C 107.816 -1.179 . . . . 73.34 107.816 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -57.94 -37.33 96.51 Favored 'Trans proline' 0 C--N 1.375 1.945 0 CA-C-N 120.79 1.318 . . . . 71.52 110.745 158.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 61.95 -88.1 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.685 1.194 . . . . 72.04 111.178 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -157.37 149.47 22.58 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.117 0.967 . . . . 74.44 109.099 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 19.1 t 54.99 59.06 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 C-N-CA 125.195 1.398 . . . . 72.22 111.118 -177.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 16.4 p -145.31 -59.82 0.34 Allowed 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.676 -1.147 . . . . 62.35 108.594 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -138.56 140.38 39.03 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 124.932 1.293 . . . . 75.32 108.79 -176.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 20.4 m 66.25 105.16 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.068 1.347 . . . . 24.4 111.783 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -154.56 -61.27 0.12 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.387 0.675 . . . . 63.44 109.758 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -159.37 166.81 30.32 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.703 0.801 . . . . 61.14 110.267 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 27.0 p -119.26 152.29 36.94 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.681 0.792 . . . . 71.5 110.549 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 128' ' ' ALA . . . . . 0.581 ' HB3' ' HG3' ' B' ' 37' ' ' GLN . . . -88.81 149.23 23.5 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.487 0.715 . . . . 70.35 109.371 175.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 129' ' ' THR . . . . . 0.485 ' HB ' ' HG3' ' C' ' 124' ' ' PRO . 12.9 p -102.39 130.96 49.29 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 122.907 0.483 . . . . 72.25 109.76 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 130' ' ' ALA . . . . . 0.646 ' HA ' ' HB3' ' B' ' 124' ' ' PRO . . . -71.08 157.97 37.28 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 114.043 1.127 . . . . 62.35 114.043 -169.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 58.7 t-105 -92.32 102.45 14.95 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 107.476 -1.305 . . . . 64.4 107.476 168.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 68.9 m -145.59 73.72 1.36 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.43 0.692 . . . . 65.23 109.505 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 15.3 t -157.88 165.18 35.89 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.35 -0.841 . . . . 74.35 109.87 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -142.77 133.48 5.57 Favored Glycine 0 C--N 1.339 0.719 0 N-CA-C 110.349 -1.101 . . . . 74.22 110.349 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 135' ' ' VAL . . . . . 0.539 HG13 HG11 ' C' ' 40' ' ' VAL . 85.3 t -74.85 -78.69 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 109.58 -0.526 . . . . 53.03 109.58 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm 57.06 165.14 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.61 1.164 . . . . 75.32 111.687 -173.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 5.6 m 68.48 159.21 0.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 124.141 0.976 . . . . 71.42 111.361 174.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -134.38 90.8 2.71 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.516 -0.74 . . . . 72.15 109.351 172.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -170.36 153.67 4.47 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.347 -0.842 . . . . 72.31 110.221 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -114.99 -176.4 18.71 Favored Glycine 0 C--N 1.342 0.879 0 N-CA-C 111.541 -0.624 . . . . 63.31 111.541 172.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -163.57 -174.2 3.62 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.257 0.623 . . . . 71.33 110.936 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -65.76 153.63 41.26 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.198 0.999 . . . . 64.14 111.566 178.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -125.16 132.53 8.1 Favored Glycine 0 C--N 1.346 1.099 0 N-CA-C 110.726 -0.95 . . . . 70.21 110.726 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 18.7 t -95.66 76.02 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 109.08 -0.711 . . . . 73.34 109.08 -176.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--O 1.249 1.032 0 C-N-CA 123.472 0.709 . . . . 73.31 109.417 -178.179 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.496 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 109.861 -0.422 . . . . 65.2 109.861 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.2 m -124.88 122.43 37.36 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.166 0.586 . . . . 75.13 109.686 -174.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -139.77 169.86 16.94 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.025 0.93 . . . . 71.14 109.37 172.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -87.57 27.45 1.11 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.898 0.879 . . . . 63.45 112.291 -174.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -155.97 174.95 14.59 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.023 0.929 . . . . 75.54 109.733 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -65.97 97.11 0.34 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 121.185 0.516 . . . . 63.33 110.467 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.609 HG22 ' H ' ' A' ' 8' ' ' GLU . 2.2 m -110.46 -152.58 0.5 Allowed 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 107.666 -1.235 . . . . 71.44 107.666 176.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.609 ' H ' HG22 ' A' ' 7' ' ' THR . 10.8 pt-20 -55.66 162.36 1.72 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.998 0.919 . . . . 71.42 111.641 166.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.623 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 5.1 ppp? -84.69 177.46 8.03 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.677 -0.692 . . . . 73.02 110.989 178.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 99.4 m -145.06 114.49 7.14 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.175 0.99 . . . . 51.44 109.022 -174.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.536 ' CD1' HD12 ' A' ' 86' ' ' ILE . 15.0 t80 -125.31 133.44 52.62 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.534 -0.913 . . . . 53.54 108.534 177.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -147.91 135.51 20.81 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.472 0.709 . . . . 70.32 109.452 171.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.611 HG21 ' HG2' ' C' ' 130' ' ' PRO . 3.9 mt -82.47 115.74 25.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.433 -0.951 . . . . 64.13 108.433 169.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.76 -41.12 19.59 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 109.451 -0.574 . . . . 53.3 109.451 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.426 ' NH2' ' HB ' ' B' ' 122' ' ' THR . 23.1 ttt180 -169.51 126.74 0.91 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.629 0.372 . . . . 74.25 110.962 -175.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.407 HD12 ' HG3' ' C' ' 130' ' ' PRO . 86.6 mt -111.76 137.21 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.902 -0.777 . . . . 74.11 108.902 170.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' HB2' ' HA2' ' B' ' 121' ' ' GLY . 31.6 p90 -164.29 176.33 9.24 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 124.136 0.898 . . . . 53.2 111.178 -172.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.6 p -103.57 123.36 46.8 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.36 0.664 . . . . 64.53 109.289 174.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.482 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 39.5 mtpt -87.74 -27.23 22.49 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.506 -0.553 . . . . 73.43 109.506 174.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.449 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 22.3 t70 -152.25 142.05 21.98 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 114.931 -1.031 . . . . 71.45 109.418 -177.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 85.3 mt -139.63 142.24 33.14 Favored 'Isoleucine or valine' 0 C--O 1.245 0.846 0 C-N-CA 125.24 1.416 . . . . 70.05 107.409 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.8 t -149.64 123.22 9.15 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.934 0.494 . . . . 74.03 110.189 175.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.424 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 89.7 t80 -127.88 124.52 37.66 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 106.986 -1.487 . . . . 73.51 106.986 172.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 80.1 mt-10 -126.77 121.18 31.23 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.054 0.388 . . . . 75.13 110.105 -177.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.45 76.38 61.92 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 108.249 -1.019 . . . . 74.12 108.249 169.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -74.48 -23.59 14.84 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.676 2.25 . . . . 65.44 112.357 -177.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -97.43 15.57 22.73 Favored 'General case' 0 C--O 1.215 -0.716 0 CA-C-O 118.198 -0.906 . . . . 64.22 109.954 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.593 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -39.94 -59.24 1.84 Allowed Pre-proline 0 CA--C 1.572 1.79 0 C-N-CA 124.703 1.201 . . . . 63.44 113.705 -168.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 32.5 Cg_exo -60.11 -35.11 93.66 Favored 'Trans proline' 0 C--N 1.387 2.601 0 C-N-CA 122.075 1.85 . . . . 75.01 113.199 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.425 ' HA ' HE21 ' A' ' 33' ' ' GLN . 3.0 m-70 -76.38 -35.55 58.58 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.117 -0.947 . . . . 72.13 110.92 -174.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.752 HG21 ' HA ' ' A' ' 73' ' ' ALA . 5.5 p -80.61 -15.51 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 115.707 -0.679 . . . . 63.24 112.236 -168.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -77.11 -35.49 56.29 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.513 0.325 . . . . 71.44 110.51 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.425 HE21 ' HA ' ' A' ' 30' ' ' HIS . 29.3 pt20 -78.19 -16.19 58.11 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.161 0.584 . . . . 75.5 111.139 177.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -73.33 154.6 40.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.51 0.724 . . . . 63.43 111.368 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.52 119.25 7.69 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.753 1.221 . . . . 65.24 110.331 177.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -79.67 80.76 6.02 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.709 0.766 . . . . 74.45 109.842 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -123.62 81.15 54.61 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 106.094 -1.817 . . . . 73.5 106.094 169.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -86.91 122.0 1.84 Allowed 'Trans proline' 0 C--N 1.374 1.897 0 C-N-CA 122.695 2.264 . . . . 60.31 112.324 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -95.91 115.54 27.58 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 105.917 -1.883 . . . . 73.31 105.917 168.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.0 t -94.55 94.3 4.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 O-C-N 123.783 0.677 . . . . 65.0 109.711 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -80.19 113.55 18.45 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.922 -1.035 . . . . 64.14 109.282 175.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.594 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.6 pt? -109.81 111.64 23.21 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.549 0.69 . . . . 73.33 109.809 -177.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -101.6 137.72 39.54 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.576 1.15 . . . . 75.51 108.295 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.494 HD11 HG21 ' A' ' 131' ' ' VAL . 67.9 mt -126.56 120.45 29.63 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.412 0.625 . . . . 62.04 111.015 -173.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -125.17 122.12 36.16 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 114.028 -1.442 . . . . 74.4 108.047 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 83.8 m -122.9 135.81 54.64 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.312 0.645 . . . . 72.45 109.961 177.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.94 126.31 11.54 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.494 0.717 . . . . 61.31 109.734 176.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 64.7 p -96.94 172.78 7.64 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.457 0.703 . . . . 64.13 110.743 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.1 t -162.7 163.32 26.96 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.842 1.257 . . . . 53.24 108.871 -174.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -110.92 116.91 32.04 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.277 0.631 . . . . 75.44 109.446 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.9 mt -85.91 -33.59 21.16 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.092 0.557 . . . . 75.22 110.376 175.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.9 -176.49 4.95 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.767 0.827 . . . . 72.34 110.348 -178.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -62.37 118.99 8.23 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.131 0.572 . . . . 63.1 109.61 176.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 65.35 10.43 6.51 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.767 1.227 . . . . 74.33 112.438 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.38 106.65 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 108.772 -0.825 . . . . 73.32 108.772 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -113.99 126.42 55.11 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.991 0.916 . . . . 75.25 109.876 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -93.62 136.69 33.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.942 -0.762 . . . . 71.21 108.942 171.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.4 t -120.85 138.16 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 108.31 -0.996 . . . . 61.03 108.31 170.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.4 t -120.52 131.25 73.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 109.015 -0.735 . . . . 72.52 109.015 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.485 HD21 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -109.18 105.02 14.29 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.18 -1.415 . . . . 73.45 107.18 174.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -88.91 100.78 13.45 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.322 -1.362 . . . . 60.13 107.322 172.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.0 t -94.06 126.65 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.5 -1.296 . . . . 53.44 107.5 172.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.3 m -117.61 126.59 52.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.022 -0.733 . . . . 61.52 109.022 177.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.52 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 64.0 t -115.31 126.15 72.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 108.087 -1.079 . . . . 65.21 108.087 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.9 m -120.68 130.5 54.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.54 -0.911 . . . . 73.5 108.54 172.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.7 123.57 29.6 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.947 -1.501 . . . . 71.11 106.947 175.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.0 m -137.27 128.92 28.62 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.23 0.538 . . . . 72.02 110.691 -174.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.699 HD12 HG22 ' A' ' 31' ' ' VAL . 33.5 mt -92.29 81.36 4.95 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.145 1.378 . . . . 64.25 107.913 175.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.71 -119.51 6.08 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 110.852 -0.899 . . . . 73.24 110.852 -174.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.4 -19.36 25.28 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.926 0.49 . . . . 53.3 110.201 175.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -80.92 106.69 13.13 Favored 'General case' 0 C--N 1.347 0.469 0 C-N-CA 124.035 0.934 . . . . 72.05 109.038 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.8 m -68.76 131.07 44.56 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 118.16 0.436 . . . . 62.54 109.939 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.752 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -77.66 -61.26 2.05 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.286 -1.005 . . . . 71.53 108.286 175.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 46.6 p90 -158.9 157.78 32.1 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.525 -0.761 . . . . 75.54 111.801 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 64' ' ' VAL . 57.1 tp -123.44 109.29 13.67 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.46 -1.245 . . . . 73.34 107.734 171.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.52 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 86.0 m -108.17 96.27 6.25 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.111 0.565 . . . . 52.32 110.301 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -111.42 115.67 29.63 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.9 -0.778 . . . . 70.43 108.9 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.6 t -123.65 133.06 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.603 0.761 . . . . 53.05 109.887 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 61.9 mt-30 -105.12 88.22 2.82 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 107.956 -1.127 . . . . 74.15 107.956 175.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -76.8 96.43 4.27 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.166 -0.924 . . . . 70.14 109.208 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.54 145.09 20.1 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 111.349 -0.701 . . . . 73.33 111.349 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.5 122.95 1.79 Allowed Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.696 -0.962 . . . . 62.23 110.696 -176.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.441 HG13 ' HE1' ' A' ' 17' ' ' TYR . 53.7 mt -80.77 127.29 39.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 108.151 -1.055 . . . . 63.42 108.151 170.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.802 ' HB3' HD11 ' A' ' 86' ' ' ILE . 92.8 m-85 -131.74 123.91 28.65 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.371 0.668 . . . . 74.33 109.4 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 t -86.43 98.0 10.77 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 108.903 -0.777 . . . . 72.21 108.903 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.802 HD11 ' HB3' ' A' ' 84' ' ' PHE . 4.1 mm -112.5 149.24 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 122.857 0.463 . . . . 74.45 110.886 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.26 167.28 16.2 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.748 0.819 . . . . 52.05 110.827 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.623 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 97.44 -32.92 6.24 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 114.304 0.482 . . . . 74.21 114.304 172.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.671 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -113.01 150.33 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 123.411 0.684 . . . . 61.51 110.639 -174.513 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -138.8 174.58 10.37 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.379 1.072 . . . . 64.44 109.527 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.86 -133.28 40.56 Favored Glycine 0 C--N 1.345 1.07 0 O-C-N 123.792 0.683 . . . . 64.01 113.732 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 47.5 p -67.77 -25.51 65.65 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.876 0.87 . . . . 64.54 111.631 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -69.37 -42.74 74.79 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.387 0.675 . . . . 74.11 110.827 177.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 5.8 tpt -66.34 -46.72 75.85 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 116.004 -0.544 . . . . 60.51 109.897 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.36 -34.77 72.8 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.563 -0.744 . . . . 64.4 110.894 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -68.84 -34.29 75.24 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.651 -0.704 . . . . 72.44 111.431 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.9 t -65.76 -44.27 86.4 Favored 'General case' 0 C--N 1.348 0.516 0 N-CA-C 109.815 -0.439 . . . . 60.53 109.815 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 45.6 mt -84.22 -35.31 23.56 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.235 -0.893 . . . . 73.42 112.036 -170.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.86 3.93 49.25 Favored Glycine 0 N--CA 1.473 1.11 0 CA-C-O 119.713 -0.493 . . . . 73.53 114.2 -172.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.52 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -141.67 -66.57 0.41 Allowed 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 117.587 0.694 . . . . 73.43 111.537 -177.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -65.48 -44.59 86.61 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 115.968 -0.56 . . . . 71.31 111.581 -173.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.6 m -63.44 -51.08 70.22 Favored Pre-proline 0 CA--C 1.564 1.494 0 C-N-CA 124.03 0.932 . . . . 65.25 112.354 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -64.45 -27.13 62.48 Favored 'Trans proline' 0 C--N 1.395 2.985 0 C-N-CA 121.717 1.611 . . . . 73.34 113.491 173.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.511 HD21 ' HA ' ' A' ' 132' ' ' ASN . 3.0 m120 -60.88 -38.29 85.1 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 118.09 0.405 . . . . 71.35 110.613 172.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.506 HG21 ' CD1' ' A' ' 13' ' ' ILE . 47.3 mm -72.12 -44.21 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.467 0.707 . . . . 63.01 110.065 176.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 70.2 mt -71.75 -23.61 61.63 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.551 -0.749 . . . . 64.24 112.29 -173.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -63.98 -47.27 80.53 Favored Pre-proline 0 N--CA 1.483 1.207 0 CA-C-O 117.932 -1.033 . . . . 75.02 113.391 -172.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.412 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 83.0 Cg_exo -51.29 -36.15 56.01 Favored 'Trans proline' 0 C--N 1.385 2.448 0 C-N-CA 122.138 1.892 . . . . 65.23 113.943 172.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -80.55 -39.37 27.87 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.396 0.678 . . . . 65.03 111.716 -177.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.78 -47.49 74.96 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 109.457 -0.572 . . . . 40.32 109.457 176.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.614 HH12 HD12 ' C' ' 105' ' ' ILE . 27.9 ttm180 -51.6 -47.07 63.72 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.85 1.26 . . . . 72.12 110.568 172.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.43 -49.12 78.14 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 124.033 0.833 . . . . 55.25 111.433 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.4 t -57.17 -47.19 81.84 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.084 0.865 . . . . 50.42 110.193 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.527 HD13 HD11 ' A' ' 128' ' ' LEU . 23.5 mt -56.75 -51.76 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.743 1.217 . . . . 72.51 111.124 174.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.9 m -56.23 -45.09 80.09 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.535 1.134 . . . . 73.14 111.108 -176.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.2 t -67.66 -41.05 84.4 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.41 -1.268 . . . . 72.22 110.006 -178.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 11.6 mtp -59.66 -44.61 93.5 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.59 0.756 . . . . 71.53 111.054 176.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 114' ' ' ILE . 82.1 t -59.33 -48.41 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 124.225 1.01 . . . . 62.23 110.543 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.9 p -71.19 -30.6 66.6 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.603 -0.726 . . . . 63.22 111.617 -176.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.468 HH12 ' HG3' ' B' ' 112' ' ' GLU . 80.3 mtt-85 -72.66 -28.31 62.64 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.98 0.512 . . . . 73.24 109.974 176.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.436 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.34 17.17 35.16 Favored Glycine 0 C--N 1.354 1.559 0 CA-C-O 119.291 -0.727 . . . . 64.24 113.432 174.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.4 t 59.73 9.96 1.84 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 127.202 2.201 . . . . 74.42 113.404 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -79.26 140.04 56.5 Favored Pre-proline 0 C--O 1.242 0.671 0 N-CA-C 108.311 -0.996 . . . . 73.33 108.311 175.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.453 ' HB2' HG23 ' E' ' 133' ' ' THR . 89.6 Cg_exo -46.49 126.7 10.64 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 123.065 2.51 . . . . 60.4 112.268 172.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -50.67 131.6 25.66 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.599 1.187 . . . . 72.32 112.84 -168.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.4 tp -109.24 138.09 46.12 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.642 0.777 . . . . 70.05 109.858 -176.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -132.97 117.67 17.92 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.531 -0.914 . . . . 64.01 108.531 174.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.527 HD11 HD13 ' A' ' 114' ' ' ILE . 16.1 mt -72.72 135.29 45.33 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.152 -0.684 . . . . 63.24 109.152 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.453 ' HB2' HG23 ' E' ' 137' ' ' THR . . . -65.13 142.78 98.69 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 122.651 0.38 . . . . 73.25 111.254 -177.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.464 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 63.3 Cg_exo -54.17 118.39 4.95 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 123.421 2.748 . . . . 73.24 114.074 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.494 HG21 HD11 ' A' ' 44' ' ' LEU . 88.5 t -102.86 129.03 55.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 123.518 0.727 . . . . 64.43 110.272 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.511 ' HA ' HD21 ' A' ' 104' ' ' ASN . 56.6 t30 -96.37 92.89 6.54 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.678 0.791 . . . . 63.14 109.12 176.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -67.98 -22.84 64.99 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.55 -0.75 . . . . 71.14 111.368 177.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.52 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 13.5 t70 -54.91 -50.96 67.52 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.574 0.75 . . . . 75.13 110.105 172.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.91 -55.65 30.47 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 114.78 -1.1 . . . . 71.43 110.086 177.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 91.8 mt -56.82 -36.91 70.5 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 124.217 0.948 . . . . 71.33 112.479 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -68.14 -38.99 82.79 Favored 'General case' 0 C--O 1.219 -0.542 0 O-C-N 123.777 0.673 . . . . 63.34 110.257 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.443 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . 9.9 mmt -77.99 -48.94 15.07 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.364 0.505 . . . . 52.54 112.364 -175.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -60.69 -17.06 45.62 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 118.108 0.413 . . . . 73.33 111.445 173.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -84.51 -50.66 7.53 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.881 0.872 . . . . 75.0 111.22 168.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 48.9 tp -67.55 -55.22 14.31 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.46 0.704 . . . . 72.33 111.948 -167.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 170.54 -15.35 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 126.488 1.915 . . . . 70.32 109.68 -175.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.443 ' HA ' ' HB3' ' A' ' 138' ' ' MET . 0.0 OUTLIER 64.33 83.85 0.16 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.234 1.414 . . . . 61.52 108.917 -177.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -147.26 -178.75 6.39 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.688 0.795 . . . . 61.23 110.795 -169.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.78 96.47 2.56 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.526 0.73 . . . . 74.12 111.027 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -136.66 25.33 3.11 Favored Glycine 0 N--CA 1.473 1.138 0 N-CA-C 111.924 -0.47 . . . . 61.02 111.924 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -99.86 94.62 6.4 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.663 0.785 . . . . 74.44 109.461 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.449 ' O ' ' HG2' ' A' ' 9' ' ' MET . . . -163.71 41.98 0.32 Allowed Glycine 0 C--N 1.337 0.61 0 N-CA-C 110.519 -1.032 . . . . 43.42 110.519 177.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 32.6 p -135.55 95.34 3.24 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.412 1.085 . . . . 74.1 109.037 -177.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -139.16 153.4 47.93 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.576 0.751 . . . . 62.0 110.433 -175.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.422 ' HG2' ' CD2' ' A' ' 11' ' ' PHE . 37.1 mt-10 -74.43 113.21 11.4 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.949 0.9 . . . . 70.1 110.592 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -157.63 94.81 1.39 Allowed 'General case' 0 CA--C 1.554 1.098 0 CA-C-O 120.984 0.421 . . . . 73.12 111.327 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -178.11 -170.61 0.24 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.095 1.358 . . . . 74.22 108.939 170.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -115.64 133.25 56.21 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.545 0.738 . . . . 74.21 109.078 169.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.266 0 C-N-CA 124.108 0.963 . . . . 75.04 109.309 175.379 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 49.0 mtm . . . . . 0 N--CA 1.485 1.288 0 N-CA-C 109.763 -0.458 . . . . 74.21 109.763 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 59.1 m -145.81 34.26 1.03 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.706 0.803 . . . . 72.52 109.336 177.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -78.04 -170.57 1.99 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.462 1.105 . . . . 72.23 110.7 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 66.09 50.51 1.42 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.32 1.048 . . . . 65.3 110.403 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -56.55 134.25 54.13 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.687 1.195 . . . . 74.44 112.222 -176.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -77.21 146.53 36.93 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.35 0.66 . . . . 54.22 109.853 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 17.6 m -79.32 149.16 31.83 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.657 0.783 . . . . 73.13 110.281 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -70.24 80.0 0.52 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.731 -0.84 . . . . 65.12 108.731 173.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.57 ' HG3' HG13 ' B' ' 89' ' ' ILE . 27.0 ttt 64.78 166.8 0.17 Allowed 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 125.668 1.587 . . . . 74.01 111.59 -171.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.415 ' N ' ' HG2' ' B' ' 9' ' ' MET . 85.3 m -138.01 123.08 19.12 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.875 1.27 . . . . 61.33 108.13 169.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.636 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 62.1 t80 -137.29 133.79 35.39 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.248 0.619 . . . . 71.34 109.608 177.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -150.57 140.13 21.57 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.568 0.747 . . . . 74.04 109.223 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.505 HD11 HD13 ' B' ' 105' ' ' ILE . 53.4 mt -83.16 130.27 36.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 108.23 -1.026 . . . . 53.14 108.23 171.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -98.78 -41.57 7.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.975 0.51 . . . . 75.11 110.4 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.401 ' NH2' HG23 ' E' ' 129' ' ' THR . 55.3 ttt180 -173.03 129.29 0.48 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.617 -0.72 . . . . 74.22 109.177 -175.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.557 HG21 ' CD1' ' B' ' 109' ' ' TYR . 75.1 mt -116.32 148.89 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.448 -0.945 . . . . 61.45 108.448 173.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -167.09 161.95 15.06 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-O 121.671 0.748 . . . . 71.24 112.016 -175.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.4 m -88.26 123.03 32.46 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.191 -1.368 . . . . 64.02 108.408 168.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.543 ' HZ2' ' HA3' ' B' ' 81' ' ' GLY . 43.0 mttp -80.05 -51.76 8.64 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.233 0.613 . . . . 75.11 110.593 170.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -144.85 141.77 29.39 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.283 -0.417 . . . . 61.43 110.725 -164.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.507 HD11 ' SG ' ' B' ' 113' ' ' CYS . 46.3 mm -134.95 138.66 48.73 Favored 'Isoleucine or valine' 0 C--N 1.354 0.791 0 C-N-CA 124.572 1.149 . . . . 70.43 109.726 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.42 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 40.2 t -138.32 128.47 25.76 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.923 1.289 . . . . 62.14 107.65 176.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.416 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 77.5 t80 -144.29 114.32 7.36 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 107.974 -1.121 . . . . 53.52 107.974 171.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -122.43 116.98 24.91 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.076 0.95 . . . . 65.44 108.941 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.18 86.57 3.35 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 107.595 -1.261 . . . . 72.12 107.595 169.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.86 -30.64 40.08 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 122.956 2.437 . . . . 71.21 112.715 -170.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -107.87 12.27 27.35 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 118.407 -0.806 . . . . 74.23 110.899 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.421 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -31.24 -73.22 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.918 0 C-N-CA 126.026 1.73 . . . . 74.24 114.604 -164.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.482 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 27.6 Cg_endo -64.06 -26.19 65.88 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 122.084 1.856 . . . . 74.14 112.954 -170.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -87.11 -41.74 13.56 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.14 -0.936 . . . . 62.24 111.383 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.498 HG22 HD12 ' B' ' 68' ' ' LEU . 8.8 p -69.18 -17.75 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.218 0.607 . . . . 55.43 111.175 -175.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -65.54 -11.09 40.6 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.128 0.788 . . . . 74.1 113.128 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.501 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.2 pt20 -63.13 -13.72 40.02 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.455 0.702 . . . . 71.32 111.446 172.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.501 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 97.9 mttt -109.06 110.3 21.53 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.779 1.632 . . . . 74.12 110.629 -178.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -111.27 88.95 2.92 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.641 0.776 . . . . 64.22 109.822 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.607 ' HA ' ' HB2' ' F' ' 130' ' ' ALA . 33.7 p90 -167.66 172.49 9.28 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.879 0.872 . . . . 74.12 109.098 170.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -65.18 110.17 3.91 Favored Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 123.424 0.69 . . . . 54.33 110.704 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.414 ' O ' HG23 ' B' ' 40' ' ' VAL . 18.0 Cg_endo -64.83 166.3 18.63 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.051 1.834 . . . . 73.15 112.384 -177.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 33.8 tt0 -64.35 100.84 0.38 Allowed 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.509 -1.293 . . . . 54.31 107.509 168.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.689 HG11 HD11 ' B' ' 126' ' ' LEU . 54.6 t -104.32 149.31 8.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 115.213 -0.903 . . . . 70.01 109.125 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.504 ' HE3' ' HB2' ' B' ' 43' ' ' ASP . 12.6 ttpt -141.3 120.67 13.13 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.393 -1.336 . . . . 52.31 107.393 173.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.524 HD13 HD22 ' B' ' 128' ' ' LEU . 20.4 tp -88.53 134.62 33.81 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.614 -0.884 . . . . 73.24 108.614 174.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.504 ' HB2' ' HE3' ' B' ' 41' ' ' LYS . 2.5 t0 -142.41 146.66 35.11 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.879 -1.156 . . . . 62.42 107.879 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 mp -131.25 146.2 52.21 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.476 -0.565 . . . . 65.11 109.476 -175.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.519 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 35.0 m-20 -130.47 153.86 48.36 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.953 1.301 . . . . 73.52 108.087 170.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . 0.476 HG22 HD22 ' F' ' 111' ' ' LEU . 5.9 t -139.11 130.86 27.49 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 121.344 0.593 . . . . 64.03 110.251 176.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.05 136.46 18.97 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.918 1.287 . . . . 75.53 107.662 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 19.0 m -140.8 175.22 9.79 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.923 0.489 . . . . 71.41 110.948 -170.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 58.9 p -151.66 136.94 17.55 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.725 0.41 . . . . 75.24 111.146 -177.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -87.79 107.16 18.53 Favored 'General case' 0 C--N 1.349 0.545 0 N-CA-C 108.978 -0.749 . . . . 72.0 108.978 173.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.0 pp -125.34 15.43 8.32 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.273 -0.876 . . . . 62.13 109.717 177.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.76 151.1 14.25 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 124.439 1.096 . . . . 64.3 109.373 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -83.36 134.72 34.89 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.619 -0.882 . . . . 70.54 108.619 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' HB3' ' HB2' ' B' ' 87' ' ' ALA . 1.7 m-20 64.3 7.88 3.83 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.065 0.946 . . . . 74.52 112.275 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 86.8 t -142.03 112.17 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 107.556 -1.276 . . . . 71.53 107.556 -174.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.479 ' OH ' ' HB2' ' F' ' 102' ' ' LEU . 4.5 t80 -115.3 139.68 49.77 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 109.012 -0.736 . . . . 72.43 109.012 -171.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -101.33 104.37 15.36 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.79 -1.189 . . . . 72.52 107.79 -177.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.58 135.87 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.775 0.83 . . . . 72.42 110.072 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 15.4 t -122.81 111.28 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.6 0.76 . . . . 72.14 108.956 177.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 56.5 tp -98.27 115.0 27.47 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.261 -0.644 . . . . 72.03 109.261 175.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.519 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 37.9 ttm180 -85.39 130.74 34.52 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.893 -0.78 . . . . 75.45 108.893 170.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 64.6 t -123.45 104.72 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 108.228 -1.027 . . . . 74.35 108.228 173.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 11.9 m -100.66 136.7 40.12 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.737 0.815 . . . . 75.24 109.906 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.742 HG11 HD21 ' B' ' 126' ' ' LEU . 76.8 t -121.1 125.83 74.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 123.957 0.903 . . . . 74.01 109.227 173.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.4 m -100.49 138.67 37.25 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 107.806 -1.183 . . . . 74.43 107.806 169.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.03 144.49 27.96 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.887 0.375 . . . . 72.01 111.08 178.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.482 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 34.9 p -151.96 128.52 10.74 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.271 -0.877 . . . . 73.24 110.568 -178.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.498 HD12 HG22 ' B' ' 31' ' ' VAL . 66.9 mt -91.76 98.3 11.53 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.654 -1.239 . . . . 65.03 107.654 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.07 -119.49 5.93 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 114.397 -1.274 . . . . 65.13 112.287 -174.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -100.91 1.39 39.82 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.622 0.769 . . . . 62.33 111.552 -174.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -122.02 148.55 44.69 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.705 -0.48 . . . . 74.42 109.705 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.5 m -68.46 133.72 49.06 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.119 0.485 . . . . 71.44 111.019 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.482 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -87.95 -64.4 1.15 Allowed 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.914 -1.143 . . . . 73.43 107.914 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . 0.438 ' CZ ' HD22 ' B' ' 126' ' ' LEU . 43.0 p90 -154.06 155.09 34.82 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.262 -1.335 . . . . 63.31 109.364 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 72.4 mt -131.68 111.68 11.89 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.815 -1.55 . . . . 75.13 106.815 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 37.5 t -117.78 151.51 37.17 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.912 -0.773 . . . . 72.41 108.912 -176.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.42 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 34.9 tt0 -162.1 129.26 3.84 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.768 -0.826 . . . . 64.32 108.768 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 85.6 t -124.44 149.68 28.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 124.013 0.925 . . . . 73.22 108.535 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -126.51 95.83 4.48 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.181 -1.044 . . . . 71.03 108.181 171.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -90.75 107.39 19.15 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.671 -0.863 . . . . 75.04 108.671 -176.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.543 ' HA3' ' HZ2' ' B' ' 19' ' ' LYS . . . -97.94 154.82 20.3 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 112.075 -0.41 . . . . 74.54 112.075 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.5 132.83 3.13 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 117.089 0.444 . . . . 70.13 112.938 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 3.7 mp -86.02 113.66 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 N-CA-C 107.941 -1.133 . . . . 64.34 107.941 170.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -121.48 153.83 37.41 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.786 0.834 . . . . 74.4 109.266 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 49.1 m -100.71 107.41 19.01 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.245 0.618 . . . . 62.54 109.868 176.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.28 102.0 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 106.676 -1.601 . . . . 71.14 106.676 175.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.679 ' HB2' ' HB3' ' B' ' 54' ' ' ASP . . . -147.77 170.84 16.73 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.24 0.616 . . . . 53.53 111.368 -169.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.39 -54.62 4.86 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-O 121.253 0.363 . . . . 63.14 112.414 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.57 HG13 ' HG3' ' B' ' 9' ' ' MET . 1.1 pp -68.4 168.57 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 124.242 1.017 . . . . 65.23 111.826 171.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.59 -171.3 3.63 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.168 -0.924 . . . . 73.13 110.092 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.64 -132.57 22.53 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 115.081 -0.963 . . . . 64.31 114.166 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 15.8 m -83.55 -40.97 18.44 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.953 0.901 . . . . 63.25 109.86 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.518 ' HB2' ' HG3' ' B' ' 144' ' ' GLN . 38.9 tt0 -65.49 -25.99 67.72 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 113.609 -1.632 . . . . 74.52 112.131 -165.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.467 ' HB2' HD13 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -65.05 -40.82 95.31 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.054 0.942 . . . . 71.42 112.642 -177.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.23 -14.05 59.83 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.048 0.539 . . . . 75.14 112.276 -177.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -64.84 -32.44 74.15 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.833 0.453 . . . . 73.34 110.537 170.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.2 t -66.12 -56.29 12.2 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.592 0.357 . . . . 70.45 110.889 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.415 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.5 pp -67.2 -21.71 65.76 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.711 0.404 . . . . 75.02 111.378 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.84 0.37 57.73 Favored Glycine 0 C--N 1.354 1.558 0 CA-C-O 119.093 -0.837 . . . . 65.04 114.506 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.611 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -148.4 -56.07 0.21 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 118.39 1.095 . . . . 53.34 111.937 -177.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -68.4 -43.79 76.51 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.436 0.695 . . . . 70.44 111.393 -173.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.636 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 58.9 m -70.89 -47.42 15.41 Favored Pre-proline 0 CA--C 1.562 1.441 0 C-N-CA 123.477 0.711 . . . . 71.23 112.21 -176.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 31.9 Cg_exo -60.85 -28.32 86.22 Favored 'Trans proline' 0 C--N 1.394 2.931 0 C-N-CA 121.953 1.769 . . . . 72.35 113.346 173.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.25 -32.9 72.71 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.577 0.751 . . . . 70.22 111.849 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.505 HD13 HD11 ' B' ' 13' ' ' ILE . 70.0 mt -75.6 -34.94 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.639 0.776 . . . . 63.44 110.155 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 85.4 mt -75.44 -31.8 60.45 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.207 -0.906 . . . . 45.14 111.372 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -57.67 -48.63 96.87 Favored Pre-proline 0 N--CA 1.487 1.415 0 N-CA-C 113.885 1.068 . . . . 52.01 113.885 -173.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.8 -32.48 91.81 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 122.293 1.996 . . . . 74.2 113.211 177.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.557 ' CD1' HG21 ' B' ' 16' ' ' ILE . 5.0 m-30 -79.53 -37.69 35.96 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.315 0.646 . . . . 75.53 110.514 -176.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.46 -37.95 88.39 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.35 -0.841 . . . . 71.34 110.077 173.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.486 ' HA ' HD12 ' B' ' 128' ' ' LEU . 46.2 ttt-85 -61.02 -55.24 35.11 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.888 1.275 . . . . 74.25 110.181 177.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.468 ' HG3' HH12 ' A' ' 120' ' ' ARG . 13.3 tp10 -61.24 -35.23 76.67 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.903 0.881 . . . . 73.35 110.747 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.592 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.0 t -69.13 -32.59 72.06 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 110.267 -0.271 . . . . 73.0 110.267 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.548 HD13 HG23 ' B' ' 64' ' ' VAL . 69.0 mt -71.19 -56.42 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.443 0.697 . . . . 72.3 110.411 174.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 22.7 m -58.24 -28.56 64.99 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.39 1.076 . . . . 74.4 111.416 -174.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.5 t -63.05 -57.14 11.67 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-N 115.782 -0.645 . . . . 74.12 109.574 171.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.592 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.2 mmt -64.02 -36.75 85.0 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.562 0.745 . . . . 64.24 111.254 -173.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.479 HG21 HD23 ' B' ' 126' ' ' LEU . 82.3 t -57.97 -50.08 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 124.545 1.138 . . . . 61.32 110.075 175.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 47.2 t -73.48 -20.25 60.73 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.785 -1.098 . . . . 74.33 111.496 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.456 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 90.9 mtt-85 -68.77 -31.19 70.04 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 110.149 -0.315 . . . . 71.22 110.149 173.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.45 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -78.65 -4.72 87.99 Favored Glycine 0 C--N 1.355 1.607 0 O-C-N 123.62 0.575 . . . . 52.0 112.485 168.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.426 ' HB ' ' NH2' ' A' ' 15' ' ' ARG . 8.6 m 62.93 33.36 15.04 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 125.684 1.594 . . . . 63.22 110.19 -177.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -76.92 163.75 63.47 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-N 114.353 -1.294 . . . . 72.0 110.534 176.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.448 ' HG3' ' O ' ' B' ' 36' ' ' TRP . 36.3 Cg_endo -61.34 157.34 41.11 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 122.557 2.171 . . . . 75.34 111.63 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -63.01 130.11 43.29 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.374 0.606 . . . . 60.23 111.924 -171.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.742 HD21 HG11 ' B' ' 64' ' ' VAL . 59.9 tp -120.74 99.86 6.77 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.485 -1.234 . . . . 54.52 109.004 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -95.66 121.99 37.95 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.75 -1.204 . . . . 70.01 107.75 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.524 HD22 HD13 ' B' ' 42' ' ' LEU . 38.6 mt -79.79 132.88 36.25 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 117.831 0.287 . . . . 52.2 110.522 176.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.45 131.82 82.21 Favored Pre-proline 0 C--O 1.243 0.717 0 O-C-N 123.993 0.808 . . . . 62.25 110.91 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.582 ' HG3' HD11 ' D' ' 16' ' ' ILE . 54.0 Cg_endo -67.85 110.04 2.05 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.456 2.104 . . . . 75.33 110.698 172.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 7.7 p -88.18 141.95 13.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 N-CA-C 108.134 -1.062 . . . . 75.2 108.134 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -78.61 72.72 5.15 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 122.537 1.161 . . . . 62.54 108.645 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -65.24 -35.13 80.1 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 112.701 -2.045 . . . . 72.43 110.596 -170.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.611 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 20.6 t70 -58.44 -55.29 36.93 Favored 'General case' 0 C--N 1.349 0.554 0 CA-C-N 114.497 -1.229 . . . . 64.31 110.684 177.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' B' ' 138' ' ' MET . . . -63.49 -33.22 75.1 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 124.257 0.973 . . . . 53.2 112.057 -175.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.528 HD13 ' HB3' ' F' ' 120' ' ' TYR . 37.1 tp -55.15 -46.62 75.7 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.219 1.008 . . . . 72.43 110.918 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -92.19 -15.7 27.24 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.304 0.483 . . . . 74.11 112.304 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . 0.522 ' HB3' ' HA ' ' B' ' 135' ' ' ALA . 59.0 ttp -64.84 -37.24 86.97 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 122.766 0.426 . . . . 72.01 110.594 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -76.24 -24.21 54.56 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 123.208 0.317 . . . . 73.34 111.125 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -78.09 -38.43 44.14 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 109.9 -0.407 . . . . 55.42 109.9 177.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 6.1 mp -108.85 31.85 5.35 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.966 0.906 . . . . 63.13 110.308 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -67.4 -39.43 85.57 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.374 0.669 . . . . 73.03 110.111 178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -67.0 109.13 2.85 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.608 0.763 . . . . 71.12 111.187 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . 0.518 ' HG3' ' HB2' ' B' ' 93' ' ' GLN . 21.6 tm0? -164.15 -77.47 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 109.07 -0.715 . . . . 64.34 109.07 176.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -179.13 -173.79 0.3 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.802 1.241 . . . . 34.32 109.869 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -158.88 -156.18 7.93 Favored Glycine 0 C--N 1.345 1.035 0 N-CA-C 111.405 -0.678 . . . . 74.32 111.405 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -161.35 163.52 30.67 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.574 0.75 . . . . 74.42 110.803 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -103.28 -152.39 23.4 Favored Glycine 0 C--N 1.347 1.161 0 N-CA-C 111.401 -0.68 . . . . 41.24 111.401 174.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' D' ' 150' ' ' GLU . 17.9 p -124.74 -77.36 0.59 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.573 0.749 . . . . 75.22 109.769 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 178.99 117.38 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.158 0.983 . . . . 71.41 109.116 172.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -75.58 108.66 8.55 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.792 0.837 . . . . 73.21 110.761 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -165.27 178.97 6.54 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.133 0.973 . . . . 73.13 109.786 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -110.02 -67.3 1.0 Allowed 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.022 -0.732 . . . . 71.44 109.022 172.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -174.71 -48.42 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.376 1.071 . . . . 73.34 108.472 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.132 0 CA-C-N 115.335 -0.848 . . . . 62.24 109.213 178.061 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 84.8 mtp . . . . . 0 N--CA 1.484 1.275 0 CA-C-O 121.152 0.501 . . . . 74.11 110.119 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 52.4 p -136.58 36.21 2.68 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.998 0.919 . . . . 61.51 109.399 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.61 140.83 57.26 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 114.598 -1.183 . . . . 74.21 111.636 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -151.64 139.85 20.29 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.768 0.827 . . . . 71.02 109.653 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -86.0 -12.25 50.83 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.552 0.741 . . . . 74.4 111.068 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -62.86 130.76 46.25 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.32 0.648 . . . . 75.51 110.153 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 10.1 t -83.89 57.98 4.43 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 122.289 1.042 . . . . 71.45 109.975 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -61.68 -43.71 98.33 Favored 'General case' 0 C--N 1.352 0.697 0 CA-C-N 114.797 -1.092 . . . . 70.44 109.882 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.402 ' CE ' HD13 ' C' ' 89' ' ' ILE . 18.9 ttt 61.06 113.48 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.817 1.247 . . . . 63.13 110.962 -176.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.603 HG21 ' H ' ' E' ' 140' ' ' GLY . 19.5 m -128.42 108.41 10.54 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.039 0.447 . . . . 74.33 110.672 -174.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.479 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 75.6 t80 -97.58 145.64 26.06 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.229 1.012 . . . . 74.4 109.265 175.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 45.8 tp60 -151.81 142.87 23.16 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.268 0.627 . . . . 72.11 109.383 170.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 23.0 mt -88.18 131.9 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 108.107 -1.071 . . . . 74.43 108.107 173.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -90.26 -47.05 8.02 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.065 -0.717 . . . . 75.01 109.065 172.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -179.25 143.54 0.21 Allowed 'General case' 0 C--O 1.239 0.517 0 CA-C-N 113.914 -1.494 . . . . 75.31 108.424 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 pp -107.72 152.31 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 107.751 -1.203 . . . . 73.51 107.751 175.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.6 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 23.6 p90 -173.77 142.41 0.9 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.317 0.58 . . . . 74.43 111.368 -175.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -76.27 127.11 32.23 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.294 1.038 . . . . 63.42 110.669 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -86.31 -22.23 26.87 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.58 -0.896 . . . . 60.44 108.58 168.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.627 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.2 t70 -148.53 133.42 18.05 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.759 -0.655 . . . . 61.02 109.419 -175.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 63.6 mt -136.57 137.33 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 106.035 -1.839 . . . . 71.44 106.035 170.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.3 t -155.16 151.8 28.65 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.516 0.674 . . . . 61.25 112.174 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -153.31 143.73 22.48 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 113.747 -1.57 . . . . 73.23 107.843 174.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -145.57 113.52 6.48 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.174 0.589 . . . . 43.12 110.161 -177.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.23 77.21 48.83 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 108.059 -1.089 . . . . 44.21 108.059 164.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.46 -25.31 63.26 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.708 2.272 . . . . 73.3 111.938 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -94.39 18.65 10.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.111 1.364 . . . . 52.15 111.451 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.59 -57.24 5.9 Favored Pre-proline 0 CA--C 1.559 1.294 0 N-CA-C 113.837 1.051 . . . . 41.4 113.837 -170.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -61.72 -36.74 72.89 Favored 'Trans proline' 0 C--N 1.386 2.507 0 CA-C-N 121.575 1.598 . . . . 45.54 112.468 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -70.06 -40.25 75.18 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.967 0.907 . . . . 75.44 112.39 -178.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.777 HG21 ' HA ' ' C' ' 73' ' ' ALA . 11.3 p -76.78 -26.11 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 N-CA-C 112.649 0.611 . . . . 74.12 112.649 -176.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -61.73 -29.24 69.98 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 112.933 0.716 . . . . 71.12 112.933 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -91.72 13.09 19.16 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 122.921 0.488 . . . . 72.1 112.073 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.4 163.24 12.96 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.727 0.811 . . . . 74.11 109.662 177.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.62 127.96 34.91 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.425 0.69 . . . . 63.1 109.573 170.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -84.27 83.43 7.98 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.535 0.734 . . . . 74.12 110.808 -176.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -134.9 78.93 53.09 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.77 0.828 . . . . 74.14 108.799 171.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -86.76 154.39 8.77 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.755 2.303 . . . . 54.52 112.405 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -88.68 82.06 6.92 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.126 -1.435 . . . . 64.21 107.126 166.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 44.4 t -68.82 95.97 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.663 0 N-CA-C 107.856 -1.164 . . . . 64.0 107.856 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.414 ' NZ ' ' HB2' ' C' ' 43' ' ' ASP . 0.4 OUTLIER -104.18 104.87 14.86 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.124 -1.435 . . . . 60.44 107.124 -178.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.477 HD23 HD23 ' C' ' 128' ' ' LEU . 2.2 mp -86.74 144.97 26.84 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 107.689 -1.226 . . . . 73.51 107.689 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.534 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 32.6 t70 -138.26 140.97 39.87 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 109.176 -0.676 . . . . 64.55 109.176 177.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 92.8 mt -126.59 111.61 14.55 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.718 -0.845 . . . . 75.42 108.718 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -113.94 143.82 44.08 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.018 -1.475 . . . . 72.44 107.018 169.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.3 t -139.05 154.22 48.18 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-O 120.939 0.399 . . . . 63.44 110.034 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.82 156.26 42.98 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.172 -0.922 . . . . 74.23 108.99 175.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 30.5 p -152.66 150.45 29.48 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.27 0.628 . . . . 74.32 109.976 -175.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 49.9 p -160.56 144.85 14.05 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 123.201 0.6 . . . . 73.53 110.388 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -77.83 130.52 36.77 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.396 0.678 . . . . 53.43 110.176 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.703 HD11 ' HB2' ' C' ' 57' ' ' GLU . 54.0 mt -95.94 -39.75 9.63 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.521 0.729 . . . . 73.23 109.981 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.24 -171.41 2.6 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.847 0.859 . . . . 50.23 110.363 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -60.26 115.48 3.54 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.182 -0.917 . . . . 74.24 110.403 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 63.16 18.04 10.65 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.051 1.34 . . . . 65.54 111.733 177.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.8 t -121.76 117.56 52.89 Favored 'Isoleucine or valine' 0 C--N 1.354 0.763 0 C-N-CA 124.64 1.176 . . . . 43.33 108.578 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -131.14 130.35 42.96 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.313 1.045 . . . . 63.23 109.114 -176.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.703 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.0 tt0 -95.85 139.6 31.82 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.186 0.595 . . . . 73.51 109.841 173.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.01 135.01 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 108.648 -0.871 . . . . 45.45 108.648 170.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.535 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 84.3 t -113.75 144.08 22.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.111 0.964 . . . . 73.13 108.619 171.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.77 107.22 10.32 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.342 -0.984 . . . . 60.22 108.342 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 35.4 ttm-85 -82.08 107.63 14.93 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.517 0.727 . . . . 75.03 109.047 171.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 26.2 t -106.87 112.45 39.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.342 -0.984 . . . . 72.23 108.342 170.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 31.7 m -104.49 144.34 31.8 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.382 -0.827 . . . . 54.41 109.181 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.641 HG21 HG21 ' C' ' 114' ' ' ILE . 88.6 t -132.42 111.53 17.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 N-CA-C 107.301 -1.37 . . . . 74.41 107.301 175.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.0 m -99.11 137.27 37.87 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.908 -1.145 . . . . 71.41 107.908 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.38 104.88 5.29 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.441 -0.948 . . . . 52.44 108.441 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.9 m -129.56 132.2 46.76 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.99 0.424 . . . . 71.31 110.255 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 14.9 mt -85.36 36.94 0.66 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.623 1.169 . . . . 75.11 110.307 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.1 -108.05 2.64 Favored Glycine 0 C--N 1.352 1.447 0 N-CA-C 110.954 -0.858 . . . . 50.22 110.954 -172.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -90.21 -31.98 16.79 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.113 0.565 . . . . 75.3 110.42 176.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -70.58 119.99 15.54 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.521 -0.918 . . . . 71.11 108.521 171.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 31.3 m -82.72 125.12 30.89 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.333 -0.988 . . . . 72.01 108.333 170.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.777 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.17 -52.6 18.29 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 109.226 -0.657 . . . . 71.41 109.226 176.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . 0.564 ' HZ ' HD21 ' C' ' 126' ' ' LEU . 33.9 p90 -165.7 169.6 14.99 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.653 -1.158 . . . . 72.1 110.913 176.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.413 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -128.48 143.25 50.95 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.422 -1.695 . . . . 53.21 106.422 167.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.546 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.6 t -150.03 122.97 8.75 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.17 -0.678 . . . . 62.12 109.17 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -137.98 134.22 34.61 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.547 -0.538 . . . . 74.24 109.547 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.512 HG21 ' HB3' ' C' ' 113' ' ' CYS . 71.7 t -128.75 136.76 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.093 0.957 . . . . 75.33 108.895 175.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.627 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.1 mt-30 -116.37 87.73 2.75 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.048 -1.093 . . . . 72.12 108.048 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -78.8 102.53 8.2 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.517 -1.22 . . . . 65.32 110.139 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -84.32 -179.64 51.62 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 116.511 -0.313 . . . . 63.24 112.646 173.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -179.46 134.42 2.27 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-O 119.96 -0.356 . . . . 74.52 112.511 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.517 HG12 ' HE1' ' C' ' 17' ' ' TYR . 33.5 mm -88.66 127.53 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.336 -0.987 . . . . 75.41 108.336 173.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -129.35 140.01 51.52 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.371 0.668 . . . . 73.01 110.595 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 57.8 m -97.42 103.51 15.45 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.551 0.74 . . . . 54.02 109.492 170.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.66 HG21 ' HE1' ' C' ' 94' ' ' MET . 51.0 mt -116.71 135.15 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.639 0.776 . . . . 74.31 109.358 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.92 164.38 30.24 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.157 0.583 . . . . 72.05 110.783 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.46 -18.2 57.9 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.711 -0.677 . . . . 63.13 114.487 172.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' C' ' 94' ' ' MET . 40.3 pt -119.91 173.55 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-N 118.019 0.91 . . . . 73.51 112.948 -171.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.531 ' HA ' ' HB2' ' E' ' 145' ' ' ASP . 12.1 pt-20 -161.74 178.99 8.47 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 114.028 -1.442 . . . . 54.43 109.769 174.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.96 -124.27 31.96 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 115.072 0.789 . . . . 74.2 115.072 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 4.6 m -72.28 -27.6 62.58 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.004 0.922 . . . . 70.34 111.21 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -67.15 -47.77 70.04 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.493 0.717 . . . . 73.03 109.558 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.66 ' HE1' HG21 ' C' ' 86' ' ' ILE . 4.6 tpt -55.03 -49.26 72.01 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 114.936 -1.029 . . . . 72.24 111.43 169.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.71 -33.37 68.35 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.785 0.678 . . . . 72.11 111.439 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -77.35 -36.16 53.96 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.016 0.526 . . . . 73.13 111.795 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.4 ' SG ' HD13 ' C' ' 86' ' ' ILE . 30.2 t -67.06 -36.58 82.34 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.999 -0.741 . . . . 64.43 108.999 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 55.6 mt -86.96 -22.51 25.54 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.522 1.129 . . . . 73.32 111.439 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.91 -29.19 23.97 Favored Glycine 0 C--N 1.346 1.093 0 O-C-N 123.489 0.493 . . . . 71.32 113.962 -172.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.35 -56.0 0.85 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.854 0.462 . . . . 34.14 111.351 -171.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -63.87 -59.0 5.07 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 123.543 0.527 . . . . 70.03 111.74 -169.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.479 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 72.9 m -58.83 -49.93 90.72 Favored Pre-proline 0 CA--C 1.559 1.309 0 CA-C-O 118.241 -0.885 . . . . 54.1 111.9 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 52.7 Cg_exo -57.94 -33.56 97.28 Favored 'Trans proline' 0 C--N 1.393 2.903 0 C-N-CA 122.122 1.882 . . . . 32.13 113.54 174.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -70.74 -28.45 64.72 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.832 0.453 . . . . 71.04 110.833 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.614 HD12 HH12 ' A' ' 111' ' ' ARG . 33.0 mm -74.75 -37.39 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.004 0.522 . . . . 74.31 109.833 173.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 82.4 mt -73.01 -25.18 60.88 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.894 0.877 . . . . 54.13 112.038 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . 0.411 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 71.7 t80 -58.23 -52.6 73.38 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 117.717 -1.135 . . . . 74.2 113.813 -174.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 52.9 Cg_exo -55.3 -34.4 88.39 Favored 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 121.917 1.745 . . . . 74.14 113.258 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -74.82 -45.55 42.56 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.492 0.717 . . . . 63.11 111.264 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.77 -35.05 75.45 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.872 0.869 . . . . 71.13 110.325 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -64.23 -49.72 70.85 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.408 1.483 . . . . 75.14 110.481 178.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -68.48 -34.21 75.53 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.127 0.571 . . . . 75.0 110.571 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.634 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 18.1 m -60.18 -53.61 55.67 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.973 0.509 . . . . 72.23 111.124 174.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.641 HG21 HG21 ' C' ' 64' ' ' VAL . 98.6 mt -58.98 -50.43 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 123.494 0.496 . . . . 74.02 110.02 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.3 m -50.17 -44.91 52.94 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 124.36 1.037 . . . . 71.4 111.415 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.3 t -66.32 -43.15 87.01 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.232 -0.895 . . . . 53.32 109.786 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.8 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.1 OUTLIER -60.28 -46.19 90.71 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.226 1.01 . . . . 53.11 111.664 178.018 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.517 HG23 ' O ' ' C' ' 114' ' ' ILE . 61.4 t -60.88 -43.31 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.723 0.809 . . . . 61.3 109.482 177.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 13.5 t -63.26 -39.12 93.7 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.038 -1.437 . . . . 62.43 111.993 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -71.61 -37.15 70.98 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.342 0.657 . . . . 54.22 109.883 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.2 -4.08 67.25 Favored Glycine 0 C--N 1.352 1.422 0 O-C-N 123.982 0.801 . . . . 60.05 112.608 172.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.407 HG21 ' O ' ' D' ' 16' ' ' ILE . 24.9 p 65.61 26.19 11.6 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.527 1.931 . . . . 74.1 113.288 170.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -83.04 150.05 60.53 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 108.539 -0.912 . . . . 75.35 108.539 171.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -47.33 138.75 17.42 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 123.342 2.695 . . . . 54.33 113.02 174.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -57.26 145.78 30.73 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.196 0.935 . . . . 73.02 113.514 -171.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.564 HD21 ' HZ ' ' C' ' 74' ' ' PHE . 3.4 pp -147.47 119.12 7.99 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.182 -0.917 . . . . 62.31 109.133 173.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -113.72 115.11 27.31 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 107.352 -1.351 . . . . 73.24 107.352 176.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.477 HD23 HD23 ' C' ' 42' ' ' LEU . 6.0 mp -61.22 134.15 56.69 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 124.156 0.91 . . . . 70.44 111.321 -170.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.39 146.77 96.05 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 123.513 0.725 . . . . 73.33 110.59 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.611 ' HG2' HG21 ' A' ' 13' ' ' ILE . 46.0 Cg_exo -55.93 104.1 0.13 Allowed 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.584 2.189 . . . . 62.21 112.295 174.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 52.7 t -99.08 113.65 34.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.157 -1.053 . . . . 55.24 108.157 175.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -75.66 103.32 5.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.954 0.501 . . . . 53.13 110.124 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -62.8 -28.13 69.78 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.441 0.696 . . . . 71.51 111.185 177.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.38 -43.13 86.74 Favored 'General case' 0 C--N 1.349 0.572 0 O-C-N 123.726 0.641 . . . . 54.04 109.769 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.53 -40.31 71.67 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.186 0.994 . . . . 63.42 111.051 175.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 49.8 mt -76.46 -35.0 58.7 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.116 -0.947 . . . . 74.15 111.158 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -81.29 -21.48 39.3 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.922 0.489 . . . . 72.52 111.428 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 65.3 mtt -68.47 -33.52 74.32 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.709 0.403 . . . . 42.13 109.927 172.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -61.88 -36.63 81.82 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.848 0.859 . . . . 51.34 110.118 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -69.39 -87.97 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.486 -0.779 . . . . 72.13 110.021 172.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 43.3 tp 59.32 166.25 0.06 Allowed 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 124.367 1.067 . . . . 73.54 110.994 -169.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -148.7 -80.8 0.13 Allowed 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.094 -1.003 . . . . 63.32 109.38 174.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -109.29 108.09 18.54 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.607 -0.886 . . . . 51.44 108.607 -172.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -73.5 93.77 2.03 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.236 1.014 . . . . 74.15 111.648 -174.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 53.18 32.48 13.35 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.957 1.303 . . . . 74.34 114.411 163.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.44 70.38 3.11 Favored Glycine 0 C--N 1.347 1.19 0 N-CA-C 110.662 -0.975 . . . . 64.0 110.662 175.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -116.34 124.86 51.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.063 0.945 . . . . 64.24 108.611 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -155.55 24.72 0.58 Allowed Glycine 0 C--N 1.34 0.797 0 N-CA-C 111.362 -0.695 . . . . 42.5 111.362 175.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 46.2 m -73.89 106.74 5.74 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.042 0.937 . . . . 62.21 110.614 -174.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -113.89 104.61 12.35 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.258 -1.015 . . . . 53.3 108.258 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -106.23 127.01 52.92 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.206 0.602 . . . . 72.41 109.511 176.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -137.37 109.78 7.41 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.371 0.605 . . . . 63.22 111.229 -168.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -103.18 138.36 40.09 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 107.916 -1.142 . . . . 62.22 107.916 168.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -70.54 120.61 16.43 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.084 -0.71 . . . . 55.22 109.084 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 N-CA-C 108.395 -0.965 . . . . 54.11 108.395 178.923 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . 0.563 ' HA ' ' HA ' ' F' ' 123' ' ' ASP . 11.8 tpt . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.884 0.373 . . . . 74.44 110.074 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m -82.92 83.95 7.6 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.104 0.562 . . . . 61.43 110.66 -178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -175.3 143.07 0.64 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.679 0.792 . . . . 74.42 109.984 172.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -156.49 116.06 3.52 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.226 -1.398 . . . . 62.03 107.226 171.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -162.92 147.51 11.54 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.318 0.647 . . . . 71.03 109.451 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -75.28 124.17 26.61 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.334 -0.617 . . . . 54.54 109.334 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 45.3 p -110.65 -168.58 1.33 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.883 0.873 . . . . 60.52 109.559 176.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -72.03 -149.43 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.204 0.602 . . . . 52.45 110.508 170.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.516 ' HG2' HG13 ' D' ' 89' ' ' ILE . 0.3 OUTLIER -30.53 123.28 0.19 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 125.27 1.428 . . . . 73.55 112.761 177.467 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 27.2 p -105.38 126.96 52.7 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.303 0.641 . . . . 73.44 109.501 -177.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -142.78 104.44 4.35 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.434 -1.321 . . . . 71.5 107.434 174.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . 0.499 HE22 ' HB3' ' D' ' 85' ' ' SER . 0.4 OUTLIER -142.96 147.23 34.87 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.256 -0.646 . . . . 74.12 109.256 176.137 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mt -93.15 127.79 45.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.628 -1.249 . . . . 71.22 107.628 177.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.628 ' HB2' HG23 ' D' ' 83' ' ' ILE . 34.5 mt-30 -90.51 -31.02 16.93 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 123.588 0.555 . . . . 73.35 110.041 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -167.57 131.05 1.72 Allowed 'General case' 0 C--N 1.347 0.487 0 CA-C-N 115.984 -0.553 . . . . 73.34 110.259 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.582 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.8 mp -103.57 140.69 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 106.662 -1.607 . . . . 71.45 106.662 171.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -165.01 141.08 5.58 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.46 0.573 . . . . 74.13 111.981 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 66.7 p -84.08 114.33 21.67 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.651 -0.704 . . . . 73.31 109.772 175.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.0 mtpt -83.81 -10.25 58.19 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.309 -0.859 . . . . 74.11 110.309 175.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.638 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 14.2 t70 -166.01 144.86 5.94 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.609 1.164 . . . . 43.14 108.907 176.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.8 HD13 ' HE3' ' C' ' 117' ' ' MET . 82.6 mt -139.81 145.56 26.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 125.267 1.427 . . . . 71.11 107.428 174.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -153.41 144.36 22.84 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 123.634 0.584 . . . . 73.23 110.522 176.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.402 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 73.7 t80 -153.4 129.43 10.32 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 107.063 -1.458 . . . . 71.51 107.063 171.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -140.61 119.16 12.3 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.325 0.65 . . . . 71.43 110.407 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.02 90.04 3.37 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 108.132 -1.062 . . . . 63.41 108.132 170.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.97 -42.71 2.96 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 123.582 2.855 . . . . 53.21 113.072 -171.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.417 ' HB2' ' HB ' ' D' ' 31' ' ' VAL . 67.6 m-20 -96.81 20.9 10.26 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.491 0.716 . . . . 65.33 110.708 -176.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.6 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -40.13 -66.66 0.34 Allowed Pre-proline 0 CA--C 1.576 1.964 0 N-CA-C 116.109 1.892 . . . . 55.23 116.109 -155.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.516 ' HB3' HD11 ' C' ' 83' ' ' ILE . 66.9 Cg_endo -74.35 -22.49 16.3 Favored 'Trans proline' 0 C--N 1.393 2.881 0 CA-C-N 123.686 2.352 . . . . 55.33 113.712 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -70.97 -37.95 72.76 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.836 0.854 . . . . 73.53 110.079 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.524 HG23 ' HG3' ' D' ' 71' ' ' GLU . 5.1 p -83.85 -19.78 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 122.615 0.366 . . . . 60.54 111.392 -173.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.41 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 23.3 m-30 -64.12 -18.58 64.55 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 112.411 0.523 . . . . 73.22 112.411 173.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -57.6 -26.26 61.26 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.713 0.805 . . . . 64.2 110.696 172.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.456 ' CB ' ' HB3' ' D' ' 68' ' ' LEU . 28.8 mmtp -85.74 99.43 11.33 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.728 1.211 . . . . 74.33 109.233 174.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -94.58 85.11 4.42 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 122.726 0.411 . . . . 71.43 110.336 -178.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 39.6 p90 -167.68 179.73 4.69 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.216 1.006 . . . . 73.23 109.824 169.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -68.79 118.34 59.82 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 123.248 0.619 . . . . 74.32 110.045 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.61 124.94 16.91 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.863 2.375 . . . . 74.43 111.89 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -63.31 108.72 1.37 Allowed 'General case' 0 C--N 1.353 0.759 0 N-CA-C 109.285 -0.635 . . . . 75.03 109.285 175.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.703 HG13 HG13 ' D' ' 64' ' ' VAL . 73.4 t -100.07 131.56 47.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.258 -0.883 . . . . 61.12 108.878 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.07 149.13 31.23 Favored 'General case' 0 C--O 1.248 0.993 0 N-CA-C 107.815 -1.18 . . . . 43.13 107.815 169.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.453 HD11 HG13 ' D' ' 62' ' ' VAL . 37.1 tp -116.19 136.23 53.2 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 116.037 -0.529 . . . . 74.34 110.212 -177.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.56 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 0.6 OUTLIER -126.92 132.23 50.93 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 107.382 -1.34 . . . . 74.43 107.382 172.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.627 HD12 HG21 ' E' ' 121' ' ' VAL . 89.5 mt -125.18 130.81 52.89 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.093 0.473 . . . . 72.42 110.084 178.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -134.53 120.15 19.33 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.209 -1.404 . . . . 73.22 107.209 177.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . 0.406 HG21 ' HG3' ' D' ' 103' ' ' PRO . 56.7 m -105.56 148.51 27.2 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.365 0.602 . . . . 63.13 110.266 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.27 -179.11 6.93 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.668 1.187 . . . . 73.53 108.721 173.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 25.8 p -159.94 -164.13 1.25 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.112 -1.44 . . . . 71.14 107.112 174.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 79.1 p -150.91 145.13 25.43 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 109.694 -0.484 . . . . 74.44 109.694 174.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . 0.444 ' HG2' ' HB2' ' D' ' 52' ' ' ALA . 49.9 tt0 72.43 123.37 0.04 OUTLIER 'General case' 0 C--N 1.362 1.127 0 O-C-N 124.793 1.308 . . . . 74.34 111.0 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.613 HD11 ' HG3' ' E' ' 105' ' ' GLN . 3.7 mm? -58.58 -52.31 66.19 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.408 0.683 . . . . 65.25 109.48 177.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.444 ' HB2' ' HG2' ' D' ' 50' ' ' GLN . . . 67.89 -177.43 0.21 Allowed 'General case' 0 C--N 1.348 0.534 0 N-CA-C 114.775 1.398 . . . . 74.5 114.775 163.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -147.56 110.3 4.71 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 113.815 -1.539 . . . . 65.32 107.471 171.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 58.21 12.66 2.0 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.907 1.683 . . . . 72.34 114.372 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 72.8 t -135.13 98.12 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 108.306 -0.998 . . . . 62.12 108.306 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.466 ' OH ' HD21 ' E' ' 100' ' ' LEU . 4.4 m-85 -138.08 131.2 30.2 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.221 -0.659 . . . . 63.14 109.221 -174.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.48 118.51 36.91 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.026 -1.101 . . . . 65.33 108.026 170.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.405 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 85.7 t -101.9 141.29 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.771 0.828 . . . . 52.45 109.33 -177.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 15.3 t -121.63 131.45 73.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 124.2 1.0 . . . . 71.35 108.747 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.403 HD21 HD22 ' D' ' 44' ' ' LEU . 0.2 OUTLIER -106.19 122.94 47.22 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 107.244 -1.391 . . . . 74.52 107.244 176.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.499 ' HG2' ' HG2' ' D' ' 79' ' ' GLN . 0.0 OUTLIER -101.69 95.6 6.54 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 106.732 -1.581 . . . . 64.52 106.732 177.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.458 HG22 ' CD2' ' D' ' 44' ' ' LEU . 84.0 t -90.73 134.52 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 108.764 -0.828 . . . . 64.15 108.764 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.56 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 89.9 m -124.19 132.91 53.65 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 124.393 1.058 . . . . 73.42 109.246 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.703 HG13 HG13 ' D' ' 40' ' ' VAL . 73.5 t -127.31 130.3 70.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 124.671 1.188 . . . . 71.3 108.09 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 30.7 m -130.0 103.52 6.82 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.099 -1.074 . . . . 70.23 108.099 171.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.679 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -97.29 141.73 30.03 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.353 -0.84 . . . . 64.14 109.088 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.441 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 40.6 p -145.6 139.84 26.95 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.847 -0.615 . . . . 64.04 110.707 -172.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.456 ' HB3' ' CB ' ' D' ' 34' ' ' LYS . 31.7 mt -116.69 106.1 13.14 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.537 1.135 . . . . 61.21 108.832 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.4 -113.89 3.97 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 111.429 -0.668 . . . . 40.4 111.429 -173.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -121.06 23.2 10.73 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.531 0.732 . . . . 60.42 110.169 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . 0.524 ' HG3' HG23 ' D' ' 31' ' ' VAL . 12.9 pt-20 -134.74 158.1 45.01 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 121.698 -0.626 . . . . 61.32 110.416 175.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 40.5 m -75.41 124.29 26.88 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.236 -0.893 . . . . 75.02 111.89 -175.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.491 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -75.32 -69.96 0.45 Allowed 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.117 -1.068 . . . . 63.02 108.117 171.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -148.08 169.22 20.45 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.222 -0.899 . . . . 73.1 110.528 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 58.3 mt -130.38 151.18 51.15 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.103 -1.814 . . . . 52.41 106.103 178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.661 ' SG ' HG12 ' D' ' 114' ' ' ILE . 12.0 t -159.17 128.22 5.35 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.561 -0.533 . . . . 71.33 109.561 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -150.7 121.44 7.53 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.611 0.244 . . . . 70.31 110.545 -171.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 93.7 t -131.6 126.87 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.696 0.798 . . . . 74.31 109.918 -171.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.638 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 44.3 mt-30 -91.6 89.02 6.98 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.679 -0.86 . . . . 72.41 108.679 166.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -87.34 98.14 11.19 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.357 -0.838 . . . . 64.23 109.359 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.07 165.0 23.92 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.797 -0.638 . . . . 74.13 112.69 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.67 137.57 4.72 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 111.642 -0.583 . . . . 42.31 111.642 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.628 HG23 ' HB2' ' D' ' 14' ' ' GLN . 8.4 tp -90.66 118.32 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 CA-C-O 121.568 0.699 . . . . 74.33 109.969 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.405 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 64.7 m-85 -112.99 138.91 49.15 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.624 1.17 . . . . 64.31 109.893 -178.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.499 ' HB3' HE22 ' D' ' 12' ' ' GLN . 23.7 t -115.49 104.36 11.67 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 107.639 -1.245 . . . . 42.43 107.639 169.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 50.2 pt -119.2 138.62 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.406 0.283 . . . . 62.41 110.466 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.89 169.01 22.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.432 1.093 . . . . 72.43 110.243 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.63 -13.68 66.76 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 114.519 0.568 . . . . 65.04 114.519 171.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.516 HG13 ' HG2' ' D' ' 9' ' ' MET . 0.8 OUTLIER -107.74 153.79 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.424 0.69 . . . . 73.0 110.781 -179.347 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -134.52 170.34 15.91 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.682 1.193 . . . . 65.14 109.818 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.34 -141.49 28.93 Favored Glycine 0 N--CA 1.472 1.074 0 O-C-N 123.271 0.357 . . . . 63.52 113.901 174.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 36.4 p -80.77 -43.81 19.57 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.355 0.662 . . . . 71.03 110.779 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -56.93 -26.95 60.44 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.196 0.998 . . . . 65.4 112.3 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.736 ' SD ' HD23 ' E' ' 100' ' ' LEU . 10.6 tmm? -59.15 -60.93 3.08 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 124.79 1.236 . . . . 74.42 112.103 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.91 -15.7 55.57 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.911 0.484 . . . . 64.33 111.345 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -66.35 -41.58 89.33 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.78 0.832 . . . . 74.25 109.851 175.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 73.0 m -60.65 -29.58 69.36 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.165 0.586 . . . . 43.55 111.406 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.594 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 18.5 tp -82.7 -43.26 17.07 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.06 0.544 . . . . 72.12 110.948 178.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . 0.432 ' HA3' HG21 ' E' ' 103' ' ' THR . . . -76.88 -21.83 73.29 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-N 115.682 -0.69 . . . . 74.2 113.661 -174.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -122.44 -56.55 1.79 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.241 0.616 . . . . 62.43 111.531 -174.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . 0.42 ' O ' HG12 ' D' ' 105' ' ' ILE . 31.6 t80 -73.28 -31.9 64.33 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 112.001 0.371 . . . . 74.3 112.001 -172.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.594 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 84.4 m -65.82 -49.89 56.79 Favored Pre-proline 0 CA--C 1.566 1.588 0 CA-C-O 118.309 -0.853 . . . . 74.22 112.334 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.406 ' HG3' HG21 ' D' ' 46' ' ' THR . 33.4 Cg_endo -65.13 -23.83 59.98 Favored 'Trans proline' 0 C--N 1.389 2.683 0 C-N-CA 121.753 1.635 . . . . 65.55 113.259 171.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -64.34 -36.28 83.62 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 109.694 -0.484 . . . . 72.33 109.694 174.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.42 HG12 ' O ' ' D' ' 101' ' ' TYR . 28.8 mm -70.13 -40.47 78.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.743 1.217 . . . . 74.24 111.012 175.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 55.4 mt -70.17 -20.36 63.14 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 116.017 -0.538 . . . . 63.33 111.617 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -68.84 -43.95 29.04 Favored Pre-proline 0 CA--C 1.56 1.334 0 N-CA-C 113.997 1.11 . . . . 75.34 113.997 -173.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' D' ' 105' ' ' ILE . 71.4 Cg_exo -45.93 -43.0 20.21 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 122.53 2.153 . . . . 62.34 113.732 168.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -80.53 -29.85 37.17 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.683 0.793 . . . . 74.51 112.206 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.93 -49.87 64.14 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.586 0.708 . . . . 74.45 109.397 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.541 HH12 ' HB3' ' D' ' 130' ' ' PRO . 34.4 ttp180 -63.0 -34.73 78.19 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 113.843 -1.526 . . . . 74.4 110.756 174.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . 0.482 ' HA ' ' CE2' ' B' ' 109' ' ' TYR . 9.5 tt0 -55.14 -54.2 46.25 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.625 0.77 . . . . 55.3 111.351 177.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.0 t -59.28 -46.24 89.06 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.726 -1.125 . . . . 75.03 110.508 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.661 HG12 ' SG ' ' D' ' 76' ' ' CYS . 74.9 mt -60.95 -56.5 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.411 1.084 . . . . 75.54 111.785 -179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 95.5 m -55.02 -40.95 70.75 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.823 1.249 . . . . 54.4 111.693 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 42.7 t -69.53 -27.95 65.61 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.435 -0.802 . . . . 33.34 111.327 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.602 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 76.8 mtm -84.33 -30.12 25.77 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.174 0.59 . . . . 73.22 111.873 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.421 HG23 ' O ' ' D' ' 114' ' ' ILE . 61.0 t -66.33 -39.38 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.725 0.81 . . . . 72.44 110.656 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.7 p -66.62 -27.29 67.58 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 115.652 -0.704 . . . . 72.43 110.678 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.634 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 64.3 mtt-85 -80.61 -16.25 54.56 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.775 0.83 . . . . 74.54 111.582 177.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -93.3 4.71 74.15 Favored Glycine 0 C--N 1.352 1.468 0 CA-C-O 119.621 -0.544 . . . . 54.21 113.156 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.555 HG23 ' HB3' ' C' ' 17' ' ' TYR . 81.0 p 56.17 27.67 11.95 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.874 1.669 . . . . 71.14 113.003 -174.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -95.08 149.62 36.5 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 123.121 0.568 . . . . 64.35 109.533 172.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -50.4 146.96 17.69 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 123.174 2.583 . . . . 70.43 113.966 171.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 41.2 tp60 -47.64 124.18 6.8 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.28 1.832 . . . . 73.43 112.911 -175.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.561 HD13 HG21 ' D' ' 40' ' ' VAL . 13.0 tp -107.24 117.72 34.81 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.535 -0.913 . . . . 74.31 108.535 175.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -121.12 100.09 6.86 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.62 -1.252 . . . . 70.21 107.62 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.405 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 90.1 mt -65.21 120.09 12.08 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 109.411 -0.588 . . . . 72.43 109.411 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.87 122.96 69.49 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 122.839 0.455 . . . . 72.3 110.599 -177.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.541 ' HB3' HH12 ' D' ' 111' ' ' ARG . 60.1 Cg_endo -71.42 114.31 3.89 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.395 2.063 . . . . 70.44 111.44 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 12.3 p -108.43 150.08 11.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 123.461 0.704 . . . . 73.0 109.276 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -79.03 109.53 13.43 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.116 -0.698 . . . . 73.03 109.116 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.576 ' HA ' HD13 ' D' ' 136' ' ' LEU . 1.3 m-85 -67.13 -21.43 65.84 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.725 0.81 . . . . 75.41 110.904 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -62.92 -37.69 88.01 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.844 0.857 . . . . 64.22 110.08 171.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.79 -33.62 74.17 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.682 0.793 . . . . 45.23 110.945 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.576 HD13 ' HA ' ' D' ' 133' ' ' PHE . 10.3 mp -59.34 -33.95 71.77 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.185 0.594 . . . . 74.03 110.495 175.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -77.6 -33.41 53.83 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.218 0.607 . . . . 71.32 111.763 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 45.5 mtt -58.21 -34.71 70.68 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 122.642 0.377 . . . . 61.4 110.423 176.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.434 ' HA ' HE21 ' D' ' 142' ' ' GLN . 27.1 t-20 -51.07 -44.87 61.26 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.897 1.279 . . . . 54.33 111.796 175.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . 0.463 ' HB2' ' HB2' ' E' ' 110' ' ' ALA . 81.2 t80 -80.62 -38.74 28.71 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.634 -0.712 . . . . 74.05 110.837 -179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.3 mp -68.26 -27.69 66.55 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.012 0.925 . . . . 73.11 112.153 -174.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.434 HE21 ' HA ' ' D' ' 139' ' ' ASN . 26.8 pt20 -85.68 2.96 43.16 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.991 0.516 . . . . 74.22 111.301 177.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -118.17 44.5 2.2 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 122.968 1.366 . . . . 75.13 108.209 -173.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -173.24 -177.91 1.63 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 113.792 -1.549 . . . . 72.42 108.009 -175.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.81 82.95 1.18 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.021 -0.733 . . . . 71.41 109.021 172.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -139.88 36.55 1.81 Allowed Glycine 0 C--N 1.345 1.072 0 CA-C-N 114.569 -1.196 . . . . 33.02 110.772 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -59.11 133.71 56.34 Favored 'General case' 0 C--N 1.351 0.672 0 C-N-CA 124.251 1.02 . . . . 52.42 110.876 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 154.52 37.06 0.02 OUTLIER Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.612 -0.722 . . . . 11.4 111.406 -176.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 42.8 p -98.96 129.11 45.25 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.449 0.7 . . . . 54.53 109.805 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' B' ' 149' ' ' THR . 37.5 tt0 -122.62 117.12 25.08 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.913 0.885 . . . . 74.34 109.044 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -74.74 105.22 5.71 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.466 -0.939 . . . . 73.34 108.466 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -101.61 149.71 23.84 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.256 0.622 . . . . 64.35 111.026 -173.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -158.66 124.06 4.36 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.497 -1.297 . . . . 61.54 107.497 168.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -65.91 -39.66 90.77 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.795 0.438 . . . . 33.3 110.387 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.175 0 N-CA-C 108.48 -0.933 . . . . 73.54 108.48 170.837 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.495 0 N-CA-C 110.826 -0.91 . . . . 62.14 110.826 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.12 76.91 2.09 Favored Glycine 0 C--N 1.342 0.87 0 N-CA-C 111.408 -0.677 . . . . 75.24 111.408 173.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 66.01 -169.14 0.2 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.29 1.036 . . . . 74.34 111.509 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -103.69 175.5 5.46 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.628 0.771 . . . . 63.31 109.815 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -144.61 143.35 30.73 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.843 0.857 . . . . 62.3 109.999 166.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 176.34 -18.05 0.04 OUTLIER Glycine 0 C--N 1.347 1.156 0 CA-C-O 119.672 -0.516 . . . . 44.25 113.525 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 97' ' ' ILE . . . . . . . . . . . . . 41.5 mt -79.22 117.04 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 117.374 0.587 . . . . 74.44 110.264 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -81.61 78.87 8.31 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.103 0.961 . . . . 52.4 109.864 176.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . 64.89 149.57 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.132 1.373 . . . . 61.21 113.983 175.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 100' ' ' LEU . . . . . 0.736 HD23 ' SD ' ' D' ' 94' ' ' MET . 0.3 OUTLIER -161.32 147.69 11.31 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 123.684 0.793 . . . . 72.03 111.138 171.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -94.58 11.22 1.71 Allowed 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 123.137 2.558 . . . . 74.12 111.98 164.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 102' ' ' LEU . . . . . 0.452 HD23 HD22 ' E' ' 100' ' ' LEU . 28.0 mt 58.58 -164.38 0.2 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.37 1.068 . . . . 61.22 110.931 -171.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 103' ' ' THR . . . . . 0.432 HG21 ' HA3' ' D' ' 99' ' ' GLY . 23.5 p -80.76 73.88 7.72 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.022 0.529 . . . . 73.01 109.961 173.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 58.02 34.94 74.15 Favored Glycine 0 C--N 1.356 1.655 0 CA-C-N 115.888 -0.596 . . . . 43.43 114.334 176.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 105' ' ' GLN . . . . . 0.613 ' HG3' HD11 ' D' ' 51' ' ' LEU . 1.9 mp0 65.2 4.29 2.55 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 124.647 1.179 . . . . 61.31 113.079 -178.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -159.67 -85.4 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.162 0.585 . . . . 74.54 109.607 -177.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 2.7 p -137.75 -72.6 0.42 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.007 0.923 . . . . 75.54 108.696 170.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 11.4 m170 71.29 -54.77 0.67 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.43 1.492 . . . . 70.13 112.846 177.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -59.52 -75.24 0.06 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.122 0.969 . . . . 74.43 110.941 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . 0.463 ' HB2' ' HB2' ' D' ' 140' ' ' TYR . . . -160.55 -158.68 0.63 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.311 0.645 . . . . 63.51 109.605 -172.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . 0.493 ' HA ' HD23 ' D' ' 136' ' ' LEU . 3.2 tt 80.64 -59.58 0.28 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 125.696 1.598 . . . . 71.11 109.651 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -54.41 107.92 0.33 Allowed 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.99 0.916 . . . . 30.35 109.528 172.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -69.4 92.33 0.6 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.194 -0.912 . . . . 62.11 109.904 -175.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -84.61 78.83 9.77 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.906 -1.043 . . . . 71.32 109.1 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 24.6 m 62.78 -77.28 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 124.921 1.288 . . . . 70.03 111.794 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . -148.86 28.14 1.29 Allowed Glycine 0 C--N 1.35 1.309 0 CA-C-O 119.748 -0.473 . . . . 72.34 112.678 -178.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -67.06 -48.82 48.57 Favored Pre-proline 0 CA--C 1.558 1.269 0 CA-C-O 118.636 -0.697 . . . . 71.41 111.034 174.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -86.53 131.43 3.43 Favored 'Trans proline' 0 C--N 1.393 2.883 0 C-N-CA 121.403 1.402 . . . . 71.41 111.636 171.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -66.46 -26.7 67.32 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.452 0.701 . . . . 61.41 110.024 173.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -76.76 149.02 36.33 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.048 -0.978 . . . . 74.32 109.878 172.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 121' ' ' VAL . . . . . 0.627 HG21 HD12 ' D' ' 44' ' ' LEU . 45.3 t 60.27 79.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.177 0.991 . . . . 64.43 110.574 176.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 13.7 t -173.34 -27.0 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.131 0.972 . . . . 53.01 109.782 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -74.9 154.58 38.13 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.546 0.738 . . . . 72.5 110.078 176.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 11.9 m -70.46 133.15 46.56 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.69 0.796 . . . . 64.51 111.005 -174.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -67.09 98.27 0.57 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.273 0.629 . . . . 53.13 109.873 177.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.48 111.51 9.74 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.791 0.837 . . . . 71.34 111.744 -173.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 64.1 m -139.62 166.06 25.61 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.356 1.062 . . . . 62.43 109.031 174.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -153.48 108.34 3.15 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.731 0.412 . . . . 75.13 110.53 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 129' ' ' THR . . . . . 0.401 HG23 ' NH2' ' B' ' 15' ' ' ARG . 42.5 m -150.67 141.34 22.67 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.181 0.993 . . . . 71.24 109.388 177.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -97.2 141.12 30.71 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 108.886 -0.783 . . . . 62.22 108.886 174.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 131' ' ' TRP . . . . . 0.452 ' HA ' ' HG3' ' A' ' 124' ' ' PRO . 7.0 t-105 -145.37 95.09 2.61 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.603 -0.517 . . . . 71.44 109.603 -174.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 41.7 t -159.05 138.78 11.78 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.446 0.699 . . . . 70.14 110.303 175.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 133' ' ' THR . . . . . 0.453 HG23 ' HB2' ' A' ' 124' ' ' PRO . 6.5 p -139.83 -69.01 0.41 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.545 1.138 . . . . 73.24 108.898 173.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . 64.3 55.15 25.23 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 111.572 -0.611 . . . . 73.12 111.572 -176.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 4.2 p -59.31 110.56 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.316 0 C-N-CA 123.69 0.796 . . . . 64.41 111.979 -173.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -119.01 89.79 3.2 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.335 1.054 . . . . 74.32 108.344 174.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 137' ' ' THR . . . . . 0.453 HG23 ' HB2' ' A' ' 129' ' ' ALA . 10.1 t -138.46 147.33 43.14 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.752 -0.462 . . . . 51.31 109.752 177.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 138' ' ' TYR . . . . . 0.419 ' HD2' ' HB3' ' A' ' 129' ' ' ALA . 34.3 m-85 60.31 33.34 20.87 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.096 0.959 . . . . 74.13 110.668 -172.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -131.68 142.09 49.74 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.924 0.89 . . . . 55.12 110.287 -176.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 140' ' ' GLY . . . . . 0.603 ' H ' HG21 ' C' ' 10' ' ' THR . . . 161.86 90.88 0.08 OUTLIER Glycine 0 C--N 1.354 1.572 0 N-CA-C 112.3 -0.32 . . . . 65.32 112.3 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -160.93 -171.44 3.08 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.209 1.004 . . . . 74.33 110.2 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 16.0 tp -150.09 145.8 26.56 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.117 -0.697 . . . . 73.11 109.117 176.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . 143.2 77.0 0.04 OUTLIER Glycine 0 C--N 1.346 1.129 0 N-CA-C 111.405 -0.678 . . . . 61.33 111.405 176.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 11.5 p -83.54 138.69 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.344 0.658 . . . . 64.3 110.469 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 145' ' ' ASP . . . . . 0.531 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 30.9 t70 . . . . . 0 C--O 1.248 1.021 0 N-CA-C 108.29 -1.004 . . . . 74.12 108.29 167.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.783 0 N-CA-C 112.203 -0.359 . . . . 65.52 112.203 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . -159.4 -152.59 6.53 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 110.786 -0.926 . . . . 72.41 110.786 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 56.32 69.08 0.77 Allowed 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 124.029 0.932 . . . . 74.41 111.425 176.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -156.29 29.36 0.34 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 113.381 0.882 . . . . 53.23 113.381 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 36.65 77.27 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 126.368 1.867 . . . . 62.33 114.133 175.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -131.12 -36.9 0.32 Allowed Glycine 0 N--CA 1.473 1.128 0 CA-C-N 115.893 -0.594 . . . . 61.14 112.457 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 97' ' ' ILE . . . . . 0.411 HD11 ' HB2' ' B' ' 94' ' ' MET . 14.6 tt -78.74 167.5 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.225 0 C-N-CA 123.05 0.54 . . . . 73.3 109.846 176.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.87 -84.43 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.798 0.839 . . . . 73.21 112.12 -175.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -153.6 5.74 0.33 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.133 0.573 . . . . 61.22 111.526 -172.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 100' ' ' LEU . . . . . 0.41 ' N ' ' HD3' ' F' ' 101' ' ' PRO . 86.8 mt 50.0 47.25 4.53 Favored Pre-proline 0 CA--C 1.571 1.767 0 C-N-CA 124.252 1.021 . . . . 75.03 113.038 -175.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 101' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' F' ' 100' ' ' LEU . 90.5 Cg_endo -86.68 112.31 1.01 Allowed 'Trans proline' 0 C--N 1.387 2.598 0 C-N-CA 122.242 1.961 . . . . 74.02 111.745 -176.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 102' ' ' LEU . . . . . 0.479 ' HB2' ' OH ' ' B' ' 56' ' ' TYR . 22.2 tp -74.94 153.48 38.57 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 109.354 -0.61 . . . . 64.23 109.354 177.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 27.9 p -71.03 90.58 0.84 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 121.624 0.726 . . . . 70.52 110.327 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.31 -93.0 0.78 Allowed Glycine 0 C--N 1.348 1.244 0 CA-C-N 114.866 -1.061 . . . . 73.5 110.535 -171.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -172.82 -69.75 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.497 1.119 . . . . 62.23 108.403 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -85.35 104.12 14.89 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 106.877 -1.527 . . . . 74.44 106.877 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 59.5 m -62.85 101.7 0.29 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.039 0.536 . . . . 65.03 110.7 -176.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 108' ' ' HIS . . . . . 0.533 ' HA ' ' HB3' ' F' ' 112' ' ' ASN . 81.2 m-70 -92.21 19.85 6.56 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.981 0.912 . . . . 74.42 112.101 -178.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -130.82 158.91 38.87 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 109.375 -0.602 . . . . 72.11 109.375 170.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 73.08 -67.49 0.26 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.068 1.347 . . . . 73.31 112.086 174.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . 0.476 HD22 HG22 ' B' ' 46' ' ' THR . 9.3 mp -78.61 -36.88 43.55 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.83 0.852 . . . . 70.31 110.408 175.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 112' ' ' ASN . . . . . 0.533 ' HB3' ' HA ' ' F' ' 108' ' ' HIS . 23.9 t-20 -117.79 153.05 34.11 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.443 1.097 . . . . 71.44 108.299 -177.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm 57.71 31.57 20.61 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 123.627 0.771 . . . . 74.14 111.664 -174.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . 0.418 ' H ' ' HD3' ' F' ' 114' ' ' LYS . 0.1 OUTLIER -84.19 59.45 5.34 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 123.142 1.448 . . . . 62.3 109.807 179.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 19.4 p -126.46 170.05 12.38 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 114.059 -1.428 . . . . 72.24 110.807 -172.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.21 -99.34 1.69 Allowed Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.511 -0.768 . . . . 71.44 111.826 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -77.32 163.82 62.19 Favored Pre-proline 0 CA--C 1.56 1.341 0 C-N-CA 123.742 0.817 . . . . 75.21 110.902 -177.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -40.83 117.2 0.48 Allowed 'Trans proline' 0 C--N 1.388 2.646 0 C-N-CA 124.257 3.305 . . . . 65.4 114.64 173.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -91.85 -173.6 3.55 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.584 0.754 . . . . 62.14 109.399 173.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 120' ' ' TYR . . . . . 0.528 ' HB3' HD13 ' B' ' 136' ' ' LEU . 52.4 t80 -146.53 41.78 1.15 Allowed 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.894 0.855 . . . . 75.15 109.139 -172.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 8.6 p -147.29 146.76 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 115.685 -0.689 . . . . 63.54 110.104 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 5.9 m 71.01 14.02 6.87 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.634 1.174 . . . . 72.32 112.136 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 123' ' ' ASP . . . . . 0.563 ' HA ' ' HA ' ' D' ' 1' ' ' MET . 3.9 m-20 -54.54 101.67 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.152 0.981 . . . . 73.3 111.711 -177.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 38.9 t 79.41 -44.4 0.32 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.097 1.759 . . . . 71.35 112.842 177.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . 71.14 168.9 0.32 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.086 1.354 . . . . 72.13 111.472 -171.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.62 -62.76 1.35 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.911 0.484 . . . . 75.2 110.967 -173.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 42.0 m 53.76 -148.17 0.46 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.1 0.96 . . . . 55.32 110.755 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -159.57 -91.45 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.333 0.515 . . . . 73.1 110.798 168.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 15.1 t -178.85 -177.35 0.49 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.47 0.708 . . . . 72.31 110.105 -171.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 130' ' ' ALA . . . . . 0.607 ' HB2' ' HA ' ' B' ' 36' ' ' TRP . . . -70.16 -173.2 0.65 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.151 0.98 . . . . 64.24 111.474 174.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -142.76 129.98 20.94 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 122.729 0.411 . . . . 70.44 110.08 -174.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 30.9 p -107.76 77.37 1.12 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.523 0.729 . . . . 71.01 109.726 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 15.8 p -83.89 93.84 8.11 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.525 -0.762 . . . . 61.43 110.49 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.94 7.23 29.37 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 115.817 -0.629 . . . . 72.11 114.05 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 p -69.54 92.33 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.089 0 CA-C-O 122.161 0.981 . . . . 65.42 110.086 173.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -122.85 107.53 11.97 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.151 -1.055 . . . . 75.32 108.151 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 10.4 m 64.11 -80.39 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.528 1.131 . . . . 53.34 109.806 -167.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -149.02 -170.76 3.71 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.389 1.476 . . . . 72.34 108.556 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -78.21 145.6 35.44 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.876 -0.416 . . . . 73.32 109.876 173.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -153.62 -107.0 0.29 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 110.859 -0.897 . . . . 71.24 110.859 -177.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -138.29 84.14 2.01 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 108.973 -0.751 . . . . 61.14 108.973 175.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.0 176.25 7.76 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.759 0.824 . . . . 63.25 111.654 -176.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . 97.5 137.04 9.41 Favored Glycine 0 C--N 1.353 1.476 0 CA-C-N 115.567 -0.742 . . . . 72.13 111.838 -177.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 20.8 m -85.14 141.67 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.001 0.52 . . . . 75.01 111.129 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 C--O 1.254 1.305 0 C-N-CA 124.02 0.928 . . . . 73.34 109.297 176.762 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 109.487 -0.56 . . . . 63.44 109.487 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.444 ' HB2' ' HE1' ' A' ' 96' ' ' HIS . 10.9 t -129.61 98.38 4.81 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.604 0.362 . . . . 71.34 110.093 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -92.09 -173.9 3.6 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 108.611 -0.885 . . . . 72.12 108.611 170.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -93.19 53.13 1.89 Allowed 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.06 0.944 . . . . 74.11 110.586 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.562 HD22 ' HB2' ' A' ' 8' ' ' GLU . 6.5 t30 -74.7 88.81 2.24 Favored 'General case' 0 C--O 1.242 0.705 0 N-CA-C 108.668 -0.864 . . . . 44.24 108.668 177.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -63.39 -42.47 98.8 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 114.989 -1.005 . . . . 62.12 110.954 -176.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.9 p -77.82 73.13 4.39 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.674 0.79 . . . . 74.52 111.3 -178.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.562 ' HB2' HD22 ' A' ' 5' ' ' ASN . 3.6 mm-40 179.58 -32.32 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.691 1.597 . . . . 72.44 110.085 177.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.636 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 22.7 ptp -147.24 178.49 8.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.608 0.718 . . . . 73.04 111.962 -167.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 76.2 m -137.59 102.41 4.75 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.328 -1.306 . . . . 71.43 107.611 174.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -100.27 116.29 31.91 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.881 -1.155 . . . . 64.01 107.881 174.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.5 tp60 -133.99 132.91 40.68 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.541 -0.911 . . . . 74.22 108.541 174.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.2 mt -91.17 119.84 39.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.233 -1.025 . . . . 75.3 108.233 175.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.54 -41.73 21.2 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.044 -0.725 . . . . 74.22 109.044 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -170.38 131.43 0.95 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.885 0.474 . . . . 72.03 110.049 -169.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.4 mt -117.46 131.22 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 108.492 -0.929 . . . . 64.2 108.492 173.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.452 ' HE1' HG13 ' A' ' 83' ' ' ILE . 27.2 p90 -161.78 177.85 9.51 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 123.952 0.783 . . . . 72.15 111.52 -173.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.6 p -107.09 126.29 52.17 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 109.438 -0.579 . . . . 63.44 109.438 173.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.448 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 44.4 mtpt -86.14 -33.44 20.87 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.623 -0.51 . . . . 74.03 109.623 175.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -148.15 142.95 26.75 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.632 -1.167 . . . . 61.02 109.874 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.458 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 81.7 mt -142.02 142.3 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.821 1.249 . . . . 53.4 108.23 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -149.42 121.5 8.29 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.03 0.532 . . . . 64.25 109.797 173.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.594 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 86.0 t80 -116.37 141.94 47.5 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.315 -1.365 . . . . 72.01 107.315 168.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 26.9 mt-10 -136.39 143.14 43.84 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.998 0.519 . . . . 74.25 109.834 175.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.17 75.74 10.53 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 107.427 -1.323 . . . . 73.45 107.427 170.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -65.83 -33.01 44.86 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.767 2.311 . . . . 71.05 112.267 -174.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -100.86 15.5 28.26 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 114.682 -1.145 . . . . 71.32 110.171 -176.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.59 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -41.18 -56.19 4.45 Favored Pre-proline 0 N--CA 1.496 1.859 0 CA-C-O 117.698 -1.144 . . . . 53.03 113.477 -170.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -61.78 -32.43 85.99 Favored 'Trans proline' 0 C--N 1.391 2.783 0 CA-C-N 121.524 1.58 . . . . 74.03 112.788 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -75.96 -46.02 31.88 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.126 -0.943 . . . . 71.15 111.096 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.836 HG21 ' HA ' ' A' ' 73' ' ' ALA . 10.0 p -76.77 -14.8 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 124.111 0.964 . . . . 74.54 112.771 -160.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -69.02 -20.09 64.13 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.842 0.457 . . . . 55.4 111.439 171.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -82.81 -22.43 34.18 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.494 1.117 . . . . 75.52 111.016 174.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 71' ' ' GLU . 24.8 mmmt -67.1 154.61 40.81 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.235 1.014 . . . . 71.1 112.172 -178.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -74.92 125.55 29.1 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.286 -0.87 . . . . 72.04 109.259 173.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -77.71 88.33 3.97 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.605 0.717 . . . . 71.11 110.604 -174.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -117.14 83.51 15.51 Favored Pre-proline 0 N--CA 1.472 0.672 0 N-CA-C 106.313 -1.736 . . . . 64.12 106.313 170.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -73.8 93.85 0.87 Allowed 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 121.678 1.586 . . . . 71.52 111.151 -175.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -93.68 83.87 4.53 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 105.751 -1.944 . . . . 72.21 105.751 175.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 66' ' ' ALA . 42.7 t -91.68 117.84 35.82 Favored 'Isoleucine or valine' 0 C--N 1.342 0.279 0 CA-C-N 113.573 -1.649 . . . . 61.33 110.456 -168.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.601 ' HE2' ' HB2' ' A' ' 43' ' ' ASP . 85.6 tttt -79.28 121.59 25.28 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.932 -0.766 . . . . 43.21 108.932 169.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.0 mt -101.38 106.54 17.71 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.267 -1.012 . . . . 74.33 108.267 169.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.601 ' HB2' ' HE2' ' A' ' 41' ' ' LYS . 16.5 t70 -106.1 136.8 45.15 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.167 -1.42 . . . . 74.44 107.167 175.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.587 HD22 HD21 ' A' ' 60' ' ' LEU . 87.1 mt -130.56 134.3 46.91 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.22 0.533 . . . . 64.45 110.784 -174.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 21.3 t70 -134.48 146.78 50.08 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.63 1.172 . . . . 74.44 108.331 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.8 m -136.47 127.29 27.42 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.991 0.516 . . . . 53.11 109.633 177.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.62 110.53 9.95 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.555 0.742 . . . . 54.44 109.987 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 61.4 p -102.17 153.98 19.44 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.773 0.429 . . . . 74.43 110.747 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.3 t -150.78 125.13 9.47 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.65 0.78 . . . . 51.02 109.044 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -72.24 105.96 4.24 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.712 -0.477 . . . . 64.22 109.712 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.632 HD11 ' HB2' ' A' ' 57' ' ' GLU . 76.3 mt -78.83 -38.49 37.9 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.051 0.54 . . . . 65.33 109.902 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.65 176.21 11.99 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.455 1.102 . . . . 54.34 109.253 173.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -68.13 123.19 19.99 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 108.667 -0.864 . . . . 75.14 108.667 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 66.54 20.09 10.84 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.466 1.106 . . . . 71.44 111.793 -174.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 43.2 t -132.17 105.19 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 107.734 -1.21 . . . . 72.35 107.734 172.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -123.15 126.4 46.94 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.716 -0.846 . . . . 71.11 108.716 -177.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.632 ' HB2' HD11 ' A' ' 51' ' ' LEU . 33.9 tt0 -84.7 149.34 25.86 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.014 -0.736 . . . . 71.25 109.014 171.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.516 HG11 ' HD3' ' A' ' 103' ' ' PRO . 73.8 t -131.48 138.68 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 C-N-CA 124.364 1.066 . . . . 74.1 108.19 169.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.41 135.74 57.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.806 -0.812 . . . . 54.25 108.806 174.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.587 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -110.19 99.35 8.43 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 106.796 -1.557 . . . . 74.34 106.796 172.037 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.473 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 30.4 ttp180 -87.11 100.56 12.74 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.086 -1.079 . . . . 62.52 108.086 173.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 32.0 t -95.29 134.56 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 108.222 -1.029 . . . . 61.14 108.222 176.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.548 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 9.4 m -121.89 125.14 45.75 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.078 -0.712 . . . . 65.25 109.078 174.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.477 ' O ' HD12 ' A' ' 75' ' ' LEU . 70.4 t -121.81 120.02 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 124.456 1.103 . . . . 50.44 109.156 -174.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 21.6 m -128.54 116.6 19.91 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.406 0.548 . . . . 71.22 109.867 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.444 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -102.94 113.07 26.22 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 107.838 -1.171 . . . . 65.1 107.838 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 46.3 m -108.89 128.52 54.99 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.21 0.604 . . . . 72.32 110.012 177.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.432 HD11 ' HB2' ' A' ' 73' ' ' ALA . 19.6 mt -95.84 77.76 3.22 Favored 'General case' 0 C--O 1.247 0.961 0 C-N-CA 124.365 1.066 . . . . 22.5 108.566 -178.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.99 -85.69 0.89 Allowed Glycine 0 C--N 1.344 0.998 0 CA-C-N 115.376 -0.829 . . . . 62.21 111.764 -174.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -112.62 -30.92 6.93 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.844 0.857 . . . . 70.53 110.354 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.474 ' HB3' ' HE2' ' A' ' 34' ' ' LYS . 7.6 tp10 -101.98 119.07 38.19 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.858 0.463 . . . . 62.21 110.26 -170.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 88.2 m -70.99 135.59 47.93 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 122.809 0.443 . . . . 43.33 111.176 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.836 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -77.06 -64.42 1.14 Allowed 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.333 1.053 . . . . 50.31 110.135 175.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -151.08 170.39 19.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.751 0.786 . . . . 63.44 112.786 -177.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.477 HD12 ' O ' ' A' ' 64' ' ' VAL . 62.5 tp -123.92 144.94 49.48 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 113.809 -1.541 . . . . 71.13 107.911 169.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.44 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.1 m -146.44 102.5 3.59 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.722 0.809 . . . . 72.34 109.268 176.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 37.4 tt0 -119.5 116.31 25.83 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.311 0.644 . . . . 72.52 109.276 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 113' ' ' CYS . 39.4 t -127.31 113.68 33.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.221 1.008 . . . . 41.14 109.629 -174.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -85.27 87.24 7.36 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.539 -0.912 . . . . 74.22 108.539 171.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -76.44 92.8 3.43 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.453 -0.794 . . . . 74.35 109.173 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.74 146.13 19.79 Favored Glycine 0 C--N 1.341 0.834 0 CA-C-N 115.703 -0.681 . . . . 74.23 111.467 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.27 122.67 1.68 Allowed Glycine 0 CA--C 1.503 -0.708 0 N-CA-C 110.258 -1.137 . . . . 61.45 110.258 -175.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.492 HG23 HD12 ' A' ' 51' ' ' LEU . 49.0 mt -81.81 129.23 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.578 -1.267 . . . . 70.22 107.578 172.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.638 ' HB3' HD11 ' A' ' 86' ' ' ILE . 92.9 m-85 -130.46 134.5 47.14 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.326 -0.99 . . . . 71.1 108.326 -176.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.3 t -98.31 99.9 11.14 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.928 -1.138 . . . . 52.15 107.928 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.638 HD11 ' HB3' ' A' ' 84' ' ' PHE . 20.0 mm -120.35 129.86 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.235 0.614 . . . . 75.23 110.632 -169.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.41 173.26 12.44 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.964 0.905 . . . . 64.31 110.567 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.636 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 97.56 -32.1 7.12 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 116.309 -0.405 . . . . 63.12 112.925 175.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -122.39 159.98 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.942 0.897 . . . . 71.54 110.447 -176.056 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.464 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 19.7 tt0 -150.24 -179.29 7.07 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 108.886 -0.783 . . . . 63.21 108.886 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.464 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 59.3 -125.77 40.47 Favored Glycine 0 C--N 1.348 1.2 0 N-CA-C 114.547 0.579 . . . . 74.32 114.547 176.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.2 t -70.58 -27.14 63.89 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.116 0.566 . . . . 54.21 111.503 -176.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -73.05 -36.14 66.84 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.96 0.904 . . . . 75.35 110.002 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.4 tpt -65.43 -46.42 80.0 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-N 115.381 -0.827 . . . . 73.05 109.628 175.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.4 -34.71 75.81 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.447 -0.797 . . . . 75.34 111.357 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.444 ' HE1' ' HB2' ' A' ' 2' ' ' SER . 39.5 t-80 -71.92 -32.97 67.89 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.462 0.705 . . . . 61.12 111.426 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -71.64 -44.8 63.7 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.019 0.438 . . . . 73.25 109.854 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 76.2 mt -80.73 -32.37 35.73 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.496 -0.775 . . . . 73.3 112.193 -173.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.42 3.49 59.65 Favored Glycine 0 N--CA 1.469 0.856 0 CA-C-O 119.591 -0.56 . . . . 44.12 113.736 -174.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.676 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.16 -62.61 0.26 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.664 0.616 . . . . 64.22 112.664 -174.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -68.05 -44.59 76.04 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 120.827 0.346 . . . . 65.55 111.572 -172.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 99.3 m -69.13 -47.38 29.15 Favored Pre-proline 0 CA--C 1.563 1.457 0 C-N-CA 124.086 0.954 . . . . 55.15 112.936 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.516 ' HD3' HG11 ' A' ' 58' ' ' VAL . 44.8 Cg_endo -66.89 -19.24 52.66 Favored 'Trans proline' 0 C--N 1.395 3.025 0 CA-C-N 121.694 1.641 . . . . 34.13 112.755 173.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -70.86 -38.18 73.13 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.021 0.528 . . . . 73.41 109.951 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 38.7 mm -64.22 -42.91 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.896 0.879 . . . . 72.23 110.155 171.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.408 ' HB2' ' HA ' ' A' ' 103' ' ' PRO . 49.5 mt -73.92 -22.73 59.57 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.325 -0.852 . . . . 74.34 112.289 -174.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -61.57 -46.64 93.97 Favored Pre-proline 0 N--CA 1.486 1.33 0 N-CA-C 114.416 1.265 . . . . 74.13 114.416 -172.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -52.89 -35.84 72.18 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 121.784 1.656 . . . . 74.31 113.045 172.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -79.88 -36.94 35.84 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.946 0.898 . . . . 60.11 111.877 -177.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.76 -49.6 65.42 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 109.161 -0.681 . . . . 53.34 109.161 176.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.4 HH12 HD12 ' C' ' 105' ' ' ILE . 32.5 ttm180 -50.17 -45.92 53.75 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.905 1.378 . . . . 72.32 110.218 173.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -62.94 -52.21 63.91 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.836 0.71 . . . . 54.0 111.504 -177.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.498 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 52.6 t -59.43 -34.78 72.91 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.827 0.704 . . . . 73.32 111.588 -178.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.572 HD13 HD11 ' A' ' 128' ' ' LEU . 24.4 mt -66.7 -59.27 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.691 0.796 . . . . 72.22 109.952 173.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 94.6 m -53.51 -37.65 62.98 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.829 1.252 . . . . 74.13 111.696 -174.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.2 t -69.62 -42.63 74.09 Favored 'General case' 0 C--O 1.213 -0.843 0 CA-C-N 114.232 -1.349 . . . . 60.21 109.889 -178.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.594 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 35.3 mtm -65.69 -35.57 81.14 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.492 0.317 . . . . 63.05 110.998 176.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 114' ' ' ILE . 85.5 t -58.82 -49.42 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.892 0.877 . . . . 72.31 109.536 175.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.5 p -76.93 -27.97 55.07 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.644 -0.707 . . . . 71.23 111.725 -175.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -73.77 -28.96 61.93 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.48 0.712 . . . . 45.43 109.46 174.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.461 ' O ' HG22 ' A' ' 122' ' ' THR . . . -86.29 12.25 61.07 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.956 0.785 . . . . 73.41 112.557 171.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.3 t 63.2 11.5 5.37 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 127.127 2.171 . . . . 72.23 114.23 173.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -77.35 148.25 77.14 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 109.492 -0.559 . . . . 64.32 109.492 176.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.4 ' HG3' ' HB1' ' E' ' 130' ' ' ALA . 53.9 Cg_exo -52.9 128.1 27.42 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.788 2.326 . . . . 74.14 111.93 175.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -46.85 125.43 7.36 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.804 1.315 . . . . 63.33 112.404 -171.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 61.0 tp -106.77 137.33 45.0 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.625 -0.88 . . . . 70.45 108.625 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.41 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 90.9 m-20 -129.7 113.95 15.39 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.802 -1.185 . . . . 72.13 107.802 -178.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.572 HD11 HD13 ' A' ' 114' ' ' ILE . 7.4 mt -70.57 133.08 46.41 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.951 -0.759 . . . . 74.35 108.951 -176.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.55 136.66 94.59 Favored Pre-proline 0 CA--C 1.552 1.049 0 CA-C-O 118.997 -0.525 . . . . 43.31 111.047 -178.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -55.72 109.88 0.48 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.272 2.648 . . . . 72.31 113.558 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.488 HG21 HD11 ' A' ' 44' ' ' LEU . 58.9 t -98.43 133.05 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-O 121.07 0.462 . . . . 74.55 110.215 -175.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -92.15 80.04 5.09 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 114.597 -1.183 . . . . 75.34 109.049 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -57.35 -35.52 70.02 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.179 0.992 . . . . 74.25 111.615 175.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.676 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 24.1 t70 -54.29 -47.78 72.01 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 124.373 1.046 . . . . 74.54 111.095 175.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.41 -42.02 83.94 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.953 0.783 . . . . 72.03 111.083 176.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 92.5 mt -54.48 -41.28 69.34 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.067 0.547 . . . . 74.13 111.224 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.44 ' HE2' HD13 ' A' ' 141' ' ' LEU . 33.6 t80 -78.16 -39.99 39.21 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.591 -0.731 . . . . 74.41 110.253 176.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.62 ' SD ' HD23 ' A' ' 141' ' ' LEU . 12.6 tpt -60.81 -32.12 71.5 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.001 0.92 . . . . 73.4 111.364 -173.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -63.96 -43.35 96.08 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.209 1.003 . . . . 75.44 110.14 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.415 ' HA ' ' HB2' ' A' ' 143' ' ' GLN . 53.9 t80 -74.81 -32.76 62.07 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.885 0.874 . . . . 63.34 111.143 175.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.62 HD23 ' SD ' ' A' ' 138' ' ' MET . 41.7 tp -64.56 -23.35 67.24 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.462 1.105 . . . . 70.24 111.697 -171.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -141.3 28.99 1.82 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.144 0.977 . . . . 63.44 108.607 -173.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.415 ' HB2' ' HA ' ' A' ' 140' ' ' TYR . 16.8 tt0 -71.81 -26.83 62.56 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 114.853 -1.067 . . . . 74.44 111.151 -176.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -137.84 -76.63 0.39 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 108.611 -0.885 . . . . 63.34 108.611 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -103.55 140.11 37.97 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.701 0.8 . . . . 74.41 109.672 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 107.78 135.17 7.61 Favored Glycine 0 C--N 1.341 0.831 0 N-CA-C 111.47 -0.652 . . . . 54.23 111.47 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -168.8 -177.93 3.2 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.461 1.104 . . . . 74.43 109.045 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 158.52 -126.95 1.77 Allowed Glycine 0 C--N 1.341 0.845 0 N-CA-C 111.892 -0.483 . . . . 62.54 111.892 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.9 t -171.78 167.12 6.44 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 123.8 0.84 . . . . 74.2 109.28 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -76.87 87.47 3.45 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.46 -0.941 . . . . 64.21 108.46 171.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.64 109.8 8.41 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.523 -0.762 . . . . 70.53 110.82 -175.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 33.1 p-80 -84.82 169.64 13.97 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.248 -0.887 . . . . 72.5 110.054 173.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -151.0 125.21 9.35 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.591 -0.892 . . . . 72.13 108.591 176.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -62.95 129.0 38.46 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.976 0.51 . . . . 74.44 110.857 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.936 0 O-C-N 124.048 0.843 . . . . 63.13 110.113 -177.967 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 108.638 -0.875 . . . . 74.33 108.638 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 72.9 m -147.85 -47.18 0.16 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.6 0.76 . . . . 75.21 109.844 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 66.87 146.66 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.112 1.365 . . . . 74.23 113.447 174.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.458 ' HG3' ' HA3' ' B' ' 91' ' ' GLY . 27.9 tt0 -169.73 99.63 0.31 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.513 1.125 . . . . 53.33 108.11 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -164.93 178.82 6.85 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.728 -0.471 . . . . 75.44 109.728 -175.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -64.28 105.87 0.99 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.413 0.685 . . . . 50.5 109.767 174.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 31.7 p -91.53 136.14 33.34 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.451 1.1 . . . . 54.1 111.353 -175.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -76.27 -29.92 57.63 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.89 0.876 . . . . 72.14 110.174 177.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 18.7 ptm 58.12 -179.41 0.07 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 127.325 2.25 . . . . 75.13 114.776 174.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 5.2 t -135.08 130.09 35.01 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 106.627 -1.62 . . . . 63.1 106.627 167.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.47 ' HD1' HG22 ' B' ' 86' ' ' ILE . 87.9 t80 -135.02 145.44 48.05 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.141 0.576 . . . . 71.34 110.016 -171.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -151.13 140.04 20.95 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.021 0.929 . . . . 74.41 109.121 171.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 49.8 mt -87.78 127.21 41.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.077 -1.083 . . . . 65.43 108.077 170.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -84.03 -49.21 9.14 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 109.187 -0.672 . . . . 65.23 109.187 176.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.401 ' HE ' ' CG2' ' A' ' 122' ' ' THR . 48.4 ttt180 -170.31 134.54 1.19 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.314 -0.857 . . . . 72.13 110.231 -172.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.446 HD12 HD22 ' D' ' 127' ' ' ASN . 91.4 mt -114.82 137.62 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 N-CA-C 107.673 -1.232 . . . . 73.55 107.673 175.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -161.96 142.09 10.21 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.097 0.475 . . . . 65.2 111.537 -172.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.605 HG21 HD11 ' B' ' 21' ' ' ILE . 18.9 m -77.65 126.62 31.16 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 108.57 -0.9 . . . . 55.31 108.57 171.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.59 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 42.3 mtpt -99.57 -18.35 17.41 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.969 0.907 . . . . 73.33 111.798 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -161.31 138.73 8.98 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 122.9 0.48 . . . . 73.11 110.82 -178.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.605 HD11 HG21 ' B' ' 18' ' ' THR . 47.0 mm -126.97 143.23 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.399 1.08 . . . . 43.23 108.331 168.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 27.9 t -144.79 119.81 10.03 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.227 -1.027 . . . . 63.24 108.227 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.458 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 82.9 t80 -132.1 116.46 17.06 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.808 -1.182 . . . . 72.23 107.808 173.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -123.01 113.89 19.67 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.87 0.868 . . . . 73.32 109.124 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -107.55 87.21 3.27 Favored Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 106.82 -1.548 . . . . 64.43 106.82 166.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.73 -26.41 45.56 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 122.559 2.173 . . . . 64.33 111.778 -173.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.446 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 72.2 m-20 -110.13 10.57 23.91 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 118.048 -0.977 . . . . 72.34 110.901 -177.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.473 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -33.71 -64.28 0.28 Allowed Pre-proline 0 N--CA 1.502 2.13 0 C-N-CA 124.955 1.302 . . . . 74.3 114.07 -171.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 11.9 Cg_exo -64.5 -29.75 61.8 Favored 'Trans proline' 0 C--N 1.396 3.041 0 C-N-CA 122.27 1.98 . . . . 74.34 112.889 -171.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -95.14 -26.49 15.99 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.848 0.859 . . . . 73.03 111.993 -171.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.487 HG21 ' HA ' ' B' ' 73' ' ' ALA . 4.8 p -82.43 -14.57 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 C-N-CA 122.678 0.391 . . . . 71.13 110.756 -176.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -68.39 -9.88 51.28 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 113.378 0.881 . . . . 65.52 113.378 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -71.37 -13.0 61.72 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 122.907 0.483 . . . . 75.3 110.8 173.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.427 ' HB2' HD13 ' B' ' 68' ' ' LEU . 89.3 mttt -103.21 81.57 1.97 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.597 1.159 . . . . 74.42 109.582 -175.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -88.48 74.86 8.48 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.453 -0.794 . . . . 62.35 110.077 -176.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -153.17 179.1 9.03 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.819 -0.628 . . . . 73.34 109.66 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.06 110.15 6.69 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.057 0.943 . . . . 74.11 109.283 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -71.54 145.97 48.5 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 121.956 1.771 . . . . 75.32 111.274 176.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 9.8 tp10 -64.56 102.09 0.52 Allowed 'General case' 0 C--N 1.343 0.321 0 N-CA-C 108.068 -1.086 . . . . 60.33 108.068 173.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.678 HG11 HD11 ' B' ' 126' ' ' LEU . 23.4 t -98.6 154.49 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 108.771 -0.826 . . . . 73.14 108.771 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -145.11 130.07 18.33 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.447 -0.946 . . . . 71.11 108.447 170.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.534 HD11 ' CG1' ' B' ' 62' ' ' VAL . 14.8 tp -86.21 138.21 32.05 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.491 -0.929 . . . . 63.34 108.491 170.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -137.0 117.02 13.29 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.933 -1.136 . . . . 64.35 107.933 -177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.407 HD23 ' CE2' ' B' ' 133' ' ' PHE . 4.4 mp -99.91 128.06 46.03 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.464 -0.939 . . . . 75.12 108.464 -171.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -132.17 143.87 50.27 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 109.325 -0.62 . . . . 73.31 109.325 175.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 18.5 p -128.91 125.86 38.46 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.472 0.709 . . . . 71.13 109.979 -174.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.415 ' O ' ' HB ' ' B' ' 59' ' ' VAL . . . -147.41 125.99 12.5 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 107.72 -1.215 . . . . 73.34 107.72 175.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.55 ' HB2' HD11 ' F' ' 102' ' ' LEU . 35.8 m -130.18 -179.01 4.99 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.085 0.554 . . . . 75.53 110.498 -176.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.8 p -152.17 135.64 16.05 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.916 -0.772 . . . . 72.2 108.916 172.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.44 ' NE2' HD13 ' F' ' 100' ' ' LEU . 52.1 tt0 -91.83 119.14 31.36 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.286 -1.005 . . . . 71.5 108.286 170.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 pp -130.56 16.61 5.37 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.094 0.958 . . . . 53.44 110.077 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.19 157.8 36.51 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 123.583 0.753 . . . . 72.42 110.388 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -89.24 136.35 33.07 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 107.755 -1.202 . . . . 71.53 107.755 163.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.534 ' H ' HD11 ' F' ' 100' ' ' LEU . 5.0 m-20 71.97 4.35 4.99 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.793 1.237 . . . . 73.14 111.852 -176.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.625 HG22 ' HA ' ' B' ' 85' ' ' SER . 25.6 t -146.53 129.05 8.24 Favored 'Isoleucine or valine' 0 C--N 1.355 0.838 0 C-N-CA 124.08 0.952 . . . . 74.44 109.691 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.468 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 0.4 OUTLIER -113.53 163.53 14.8 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 108.713 -0.847 . . . . 74.41 108.713 166.38 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -119.92 107.23 12.87 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.287 -1.375 . . . . 61.3 107.287 177.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 65.8 t -100.42 125.21 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.714 0.805 . . . . 24.31 110.145 -173.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.494 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.2 t -107.52 112.16 38.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 108.723 -0.843 . . . . 71.24 108.723 174.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 62.0 tp -93.92 112.58 24.45 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.633 -0.506 . . . . 71.5 109.633 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -95.76 106.06 18.14 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.482 0.713 . . . . 74.24 109.275 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.534 ' CG1' HD11 ' B' ' 42' ' ' LEU . 45.0 t -105.81 111.16 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 108.399 -0.963 . . . . 60.34 108.399 179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 21.0 m -108.45 135.68 49.33 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.879 0.871 . . . . 71.51 109.965 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.739 HG11 HD21 ' B' ' 126' ' ' LEU . 44.4 t -129.36 115.69 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.945 1.298 . . . . 75.05 109.592 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 64.2 m -103.3 138.94 39.4 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.805 -0.813 . . . . 72.12 108.805 171.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -145.61 143.19 29.72 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.995 0.518 . . . . 64.32 109.776 176.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.549 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 67.4 p -141.5 131.81 25.07 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.546 -0.752 . . . . 71.33 110.913 -175.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.427 HD13 ' HB2' ' B' ' 34' ' ' LYS . 61.7 mt -100.49 111.55 23.82 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.556 1.142 . . . . 72.43 108.522 174.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.01 -128.63 11.06 Favored Glycine 0 C--N 1.342 0.887 0 O-C-N 123.436 0.46 . . . . 44.51 112.634 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -90.5 2.51 55.66 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.95 0.9 . . . . 73.25 112.207 -176.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.446 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 12.6 pt-20 -137.84 157.25 46.81 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.768 0.427 . . . . 74.2 111.565 -169.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.5 m -69.1 128.43 36.63 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.435 -0.802 . . . . 61.43 110.938 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.549 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -79.96 -64.02 1.28 Allowed 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.565 -1.272 . . . . 74.41 107.565 174.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -150.52 158.48 44.2 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 114.83 -1.077 . . . . 74.32 111.687 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 95.8 mt -125.27 113.34 17.48 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 106.333 -1.729 . . . . 61.41 106.333 172.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 27.0 t -118.28 146.35 44.37 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 107.915 -1.143 . . . . 40.23 107.915 175.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -161.62 126.76 3.53 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.254 -1.017 . . . . 62.45 108.254 -176.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.2 t -124.54 148.29 28.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.007 0.923 . . . . 54.43 108.729 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -121.95 96.82 5.21 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.226 -1.027 . . . . 74.23 108.226 169.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.429 ' HG3' HD22 ' B' ' 106' ' ' LEU . 7.9 tp-100 -89.19 101.34 14.0 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.992 -0.744 . . . . 74.25 108.992 177.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.29 170.75 37.68 Favored Glycine 0 C--N 1.339 0.698 0 O-C-N 123.523 0.514 . . . . 72.42 112.017 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.99 132.76 2.5 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.512 -0.375 . . . . 64.53 112.659 -176.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 79.4 mt -91.26 111.11 23.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 108.001 -1.111 . . . . 62.32 108.001 173.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -113.34 133.8 54.95 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.104 0.562 . . . . 72.51 109.933 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.625 ' HA ' HG22 ' B' ' 55' ' ' VAL . 66.9 m -95.56 122.06 37.92 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.015 0.926 . . . . 70.25 109.319 175.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.474 HG12 HD12 ' F' ' 97' ' ' ILE . 0.2 OUTLIER -138.36 134.32 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.991 0.917 . . . . 74.54 110.599 -173.377 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.93 171.08 20.69 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.534 1.134 . . . . 64.32 108.191 169.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.9 -43.14 3.06 Favored Glycine 0 N--CA 1.469 0.878 0 N-CA-C 111.991 -0.444 . . . . 42.1 111.991 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.628 ' HB ' ' HA ' ' B' ' 94' ' ' MET . 9.4 pt -58.34 143.46 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.42 0.688 . . . . 73.32 110.802 171.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -161.26 152.68 18.97 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 123.858 0.724 . . . . 73.14 110.813 -174.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.458 ' HA3' ' HG3' ' B' ' 4' ' ' GLN . . . 78.65 -133.88 13.3 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.625 -0.716 . . . . 75.5 111.854 -178.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 2.8 m -67.15 -44.03 80.82 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.666 0.787 . . . . 65.41 110.326 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -67.3 -18.93 65.38 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.048 -1.433 . . . . 74.15 111.757 -168.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.628 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 17.7 tmm? -68.14 -66.36 0.58 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.155 0.982 . . . . 72.41 111.56 -174.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.412 ' HB2' ' HD2' ' F' ' 101' ' ' PRO . . . -80.76 -9.36 59.81 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 120.857 0.36 . . . . 71.41 111.909 177.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -60.99 -31.74 71.34 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 122.866 0.467 . . . . 53.23 110.807 164.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.6 t -61.39 -40.45 94.39 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.831 0.852 . . . . 75.32 112.411 -174.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' B' ' 95' ' ' ALA . 4.1 pp -69.69 -22.92 63.38 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.895 0.478 . . . . 65.33 112.001 177.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.05 -12.75 51.62 Favored Glycine 0 C--N 1.348 1.209 0 O-C-N 123.309 0.381 . . . . 75.44 113.797 -177.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.86 -57.67 1.04 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 117.364 0.582 . . . . 44.23 112.047 -173.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -75.16 -46.58 33.32 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.144 0.578 . . . . 73.31 111.615 -169.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.468 ' SG ' ' HE1' ' B' ' 56' ' ' TYR . 78.4 m -65.99 -47.18 63.93 Favored Pre-proline 0 CA--C 1.561 1.394 0 CA-C-O 118.459 -0.781 . . . . 61.01 112.595 -177.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.96 -26.87 66.45 Favored 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 121.735 1.623 . . . . 71.3 112.746 172.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.42 -37.11 82.31 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.127 0.571 . . . . 73.33 110.868 175.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 66.7 mt -71.85 -44.49 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.758 0.823 . . . . 72.34 110.322 176.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.429 HD22 ' HG3' ' B' ' 80' ' ' GLN . 86.9 mt -78.47 -17.31 56.48 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.166 -0.924 . . . . 73.44 112.509 -171.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.422 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 55.4 t80 -63.33 -50.82 72.45 Favored Pre-proline 0 CA--C 1.55 0.957 0 CA-C-O 117.953 -1.022 . . . . 75.31 112.728 -176.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.597 ' HG2' ' HB2' ' D' ' 108' ' ' PRO . 93.6 Cg_exo -50.84 -42.58 50.87 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.261 1.974 . . . . 64.03 114.185 174.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -66.74 -44.44 81.5 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.361 0.665 . . . . 74.23 111.364 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.17 -37.2 83.34 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.676 -0.693 . . . . 73.23 110.995 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 60.7 ttt-85 -62.18 -51.54 67.43 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.341 1.456 . . . . 63.2 110.203 177.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -62.41 -36.8 83.48 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.238 0.961 . . . . 73.22 110.448 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.537 ' SG ' HD11 ' B' ' 21' ' ' ILE . 1.9 t -73.84 -30.2 62.55 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 122.018 0.127 . . . . 71.13 111.085 -177.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.569 HD13 HG23 ' B' ' 64' ' ' VAL . 41.8 mt -66.29 -55.82 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.679 0.791 . . . . 73.24 109.008 172.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.531 HG21 ' OG ' ' C' ' 119' ' ' SER . 31.9 m -62.08 -26.51 68.32 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 114.928 -1.033 . . . . 71.02 111.577 -177.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.3 t -61.65 -53.75 51.94 Favored 'General case' 0 C--N 1.347 0.458 0 N-CA-C 109.295 -0.631 . . . . 74.24 109.295 174.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.8 mmt -70.22 -30.81 67.98 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.599 0.76 . . . . 74.52 111.331 -174.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 68.8 t -66.41 -44.34 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.339 1.056 . . . . 52.2 110.271 172.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.1 t -67.28 -31.36 71.63 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.226 -0.897 . . . . 62.14 110.045 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.498 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 75.6 mtt-85 -68.44 -41.06 80.86 Favored 'General case' 0 C--O 1.211 -0.948 0 CA-C-N 115.818 -0.628 . . . . 73.23 109.561 176.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.97 -11.86 70.52 Favored Glycine 0 C--N 1.357 1.729 0 O-C-N 123.647 0.592 . . . . 71.43 112.628 171.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 11.3 m 67.11 30.74 7.2 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 125.51 1.524 . . . . 54.13 110.407 176.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -77.49 165.69 49.67 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-N 115.189 -0.914 . . . . 73.0 111.085 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.532 ' HG3' ' HB2' ' F' ' 131' ' ' TRP . 80.9 Cg_exo -48.23 151.07 4.65 Favored 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 123.257 2.638 . . . . 41.42 113.52 173.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.563 ' HB2' ' H ' ' C' ' 125' ' ' GLN . 29.2 tp60 -61.71 114.89 3.56 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.055 0.542 . . . . 71.41 111.572 -172.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.739 HD21 HG11 ' B' ' 64' ' ' VAL . 34.7 tp -108.79 110.35 21.71 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.888 -1.051 . . . . 73.14 108.656 -177.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -121.77 116.89 25.31 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.049 -1.093 . . . . 73.34 108.049 176.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 73.3 mt -75.37 144.75 42.13 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 120.909 0.385 . . . . 73.1 111.541 -175.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.5 ' H ' ' HB2' ' F' ' 126' ' ' ALA . . . -76.85 151.62 82.31 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 124.481 1.112 . . . . 72.25 110.708 -177.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.439 ' HG3' HD13 ' D' ' 16' ' ' ILE . 3.8 Cg_endo -80.23 84.53 2.0 Allowed 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.843 2.362 . . . . 74.13 110.666 -177.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 p -89.07 111.32 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 N-CA-C 108.714 -0.847 . . . . 74.52 108.714 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -80.8 107.56 13.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.521 -0.763 . . . . 61.02 109.539 -176.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.407 ' CE2' HD23 ' B' ' 44' ' ' LEU . 56.2 m-85 -54.83 -38.28 67.19 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.764 1.226 . . . . 60.01 111.137 -177.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -58.42 -49.76 76.15 Favored 'General case' 0 C--N 1.346 0.437 0 CA-C-N 114.466 -1.243 . . . . 72.43 110.479 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.26 -35.25 71.47 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 123.955 0.784 . . . . 64.12 112.364 -175.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.4 ' CD2' ' HB3' ' F' ' 111' ' ' LEU . 10.1 mp -69.28 -50.06 50.3 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.881 0.472 . . . . 65.51 110.993 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -68.66 -30.76 69.52 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.7 0.4 . . . . 71.15 111.423 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 10.6 tmm? -68.5 -40.33 80.91 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.517 0.727 . . . . 63.13 109.187 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.514 ' HA ' ' HB2' ' B' ' 142' ' ' GLN . 5.8 t-20 -82.51 -26.39 32.56 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.313 -0.858 . . . . 52.32 110.741 -173.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . 0.512 ' OH ' ' HG2' ' F' ' 114' ' ' LYS . 3.1 t80 -75.75 -34.5 60.29 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.44 -0.8 . . . . 60.21 110.594 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mp -104.75 18.74 21.73 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.516 0.726 . . . . 70.15 110.49 177.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . 0.514 ' HB2' ' HA ' ' B' ' 139' ' ' ASN . 15.5 tm0? -77.51 143.85 38.12 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.488 0.715 . . . . 74.13 110.314 -174.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -135.31 140.57 45.23 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.927 -1.138 . . . . 54.11 107.927 173.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 76.79 74.13 0.08 Allowed 'General case' 0 N--CA 1.481 1.093 0 O-C-N 124.837 1.335 . . . . 63.01 110.433 -177.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -164.22 100.1 0.84 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.909 0.883 . . . . 44.35 109.489 172.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.82 23.23 2.31 Favored Glycine 0 N--CA 1.466 0.635 0 N-CA-C 110.712 -0.955 . . . . 50.11 110.712 173.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -85.65 79.8 9.22 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.106 0.962 . . . . 63.12 108.936 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -105.69 72.1 0.23 Allowed Glycine 0 C--N 1.339 0.727 0 CA-C-N 114.987 -1.006 . . . . 75.22 110.835 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 27.4 p -68.88 145.34 53.77 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.242 0.617 . . . . 63.2 110.563 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -115.95 170.42 8.5 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.726 0.811 . . . . 74.01 110.581 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -158.97 159.63 35.07 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.562 0.745 . . . . 74.03 109.115 173.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -55.06 108.64 0.43 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 124.221 1.009 . . . . 73.04 112.475 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -75.61 125.9 29.94 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.456 -0.942 . . . . 63.52 108.456 167.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -101.55 158.18 16.27 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.289 0.636 . . . . 72.22 111.49 -172.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 C-N-CA 124.404 1.082 . . . . 72.41 109.855 -177.224 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . 0.477 ' SD ' ' N ' ' C' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 107.892 -1.151 . . . . 72.01 107.892 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 69.5 m -151.35 173.86 14.0 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.542 0.737 . . . . 72.33 110.72 -176.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -141.26 156.88 45.83 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.137 0.975 . . . . 74.43 110.026 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -69.26 101.59 1.53 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.498 -0.556 . . . . 73.53 109.498 176.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -77.99 144.62 36.57 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.994 0.918 . . . . 71.51 111.947 -174.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -101.97 158.54 16.07 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.576 0.75 . . . . 75.32 109.229 172.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 21.9 p -76.51 -32.86 58.55 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.819 0.847 . . . . 62.01 112.907 -171.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -85.39 73.99 10.44 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 107.966 -1.124 . . . . 71.32 107.966 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.475 ' HB3' HD21 ' E' ' 139' ' ' ASN . 17.7 ttt 41.67 113.76 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 127.127 2.171 . . . . 62.43 115.573 175.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.576 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 21.0 m -105.74 108.42 19.92 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 108.388 -0.968 . . . . 63.22 108.388 173.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -125.98 136.85 53.47 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.358 -0.608 . . . . 75.43 109.358 174.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -150.53 135.24 17.4 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.821 0.848 . . . . 53.23 108.884 169.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 53.4 mt -77.22 119.11 25.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 107.655 -1.239 . . . . 70.23 107.655 166.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -84.56 -43.08 14.84 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.7 -0.852 . . . . 75.33 108.7 177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.41 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER 178.97 158.31 0.55 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.195 1.398 . . . . 71.04 109.44 176.761 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.427 ' O ' HD12 ' C' ' 16' ' ' ILE . 2.0 pp -128.68 141.52 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.382 -1.34 . . . . 74.04 107.382 175.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.443 ' HB3' HG23 ' D' ' 122' ' ' THR . 17.7 p90 -170.52 157.57 5.96 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.284 0.564 . . . . 73.04 111.694 -168.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 66.5 p -80.33 113.31 18.42 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.982 -0.554 . . . . 75.0 109.639 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -34.6 71.58 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 108.04 -1.096 . . . . 75.04 108.04 171.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.5 t70 -151.24 145.55 25.45 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.372 -1.285 . . . . 53.22 110.385 -175.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.577 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.4 mt -139.82 147.42 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.9 1.68 . . . . 73.24 106.778 175.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -159.42 150.03 19.39 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.046 0.45 . . . . 73.02 110.217 171.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -151.12 135.89 17.24 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 107.454 -1.313 . . . . 61.3 107.454 174.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -136.0 124.73 23.86 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.888 0.475 . . . . 75.43 109.878 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.16 75.55 77.85 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 107.76 -1.2 . . . . 54.41 107.76 162.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -74.92 -10.01 21.14 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.291 1.994 . . . . 64.22 111.677 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -106.17 13.15 29.35 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.803 1.241 . . . . 71.12 109.798 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.98 -57.0 7.78 Favored Pre-proline 0 N--CA 1.492 1.643 0 N-CA-C 115.078 1.51 . . . . 73.0 115.078 -165.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -64.34 -41.14 22.01 Favored 'Trans proline' 0 C--N 1.378 2.116 0 CA-C-N 121.813 1.683 . . . . 60.43 112.177 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -68.67 -34.31 75.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.36 1.064 . . . . 52.3 111.702 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.93 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.1 p -79.67 -27.43 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 CA-C-N 116.147 -0.479 . . . . 60.32 111.877 -178.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -69.79 -31.51 69.47 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 111.598 0.221 . . . . 63.32 111.598 174.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -96.49 30.78 2.45 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.203 0.601 . . . . 72.11 110.552 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.75 167.44 10.48 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.315 1.046 . . . . 71.1 109.334 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -75.99 120.64 21.59 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.538 -0.541 . . . . 70.34 109.538 171.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -85.23 89.28 7.61 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.73 0.812 . . . . 74.35 110.857 -174.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -131.09 80.61 68.59 Favored Pre-proline 0 N--CA 1.481 1.109 0 C-N-CA 123.999 0.92 . . . . 71.45 108.839 167.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -71.8 111.41 3.14 Favored 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 122.292 1.994 . . . . 62.42 110.814 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -83.02 91.72 7.23 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 104.522 -2.399 . . . . 73.24 104.522 170.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.643 HG21 ' H ' ' F' ' 135' ' ' VAL . 62.0 t -75.28 140.59 17.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-N 113.623 -1.626 . . . . 74.43 110.729 -167.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -128.36 103.16 7.0 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.352 1.061 . . . . 71.3 108.766 171.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.549 HD11 HG13 ' F' ' 135' ' ' VAL . 87.0 mt -85.3 150.06 25.03 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.929 0.892 . . . . 74.43 108.74 174.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.426 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 31.6 t70 -143.64 141.93 30.8 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.296 0.638 . . . . 63.21 109.613 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 47.9 mt -132.42 133.18 43.58 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.192 0.997 . . . . 62.23 109.116 177.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -143.23 123.44 13.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.801 -1.555 . . . . 74.43 106.801 175.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . 0.429 ' OG1' ' HG3' ' C' ' 103' ' ' PRO . 15.0 t -118.42 130.47 55.99 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.471 0.653 . . . . 72.13 109.418 176.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.35 153.41 29.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.177 -0.92 . . . . 53.4 109.095 176.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 37.2 p -146.64 143.0 28.48 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.862 -0.792 . . . . 75.51 108.862 175.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 45.9 t -156.89 135.82 11.78 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.163 0.585 . . . . 70.1 109.487 -177.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -79.48 116.82 19.93 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.764 -0.828 . . . . 72.22 108.764 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.602 HD11 ' HB2' ' C' ' 57' ' ' GLU . 63.4 mt -84.75 -34.94 22.75 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.613 0.765 . . . . 73.22 110.616 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.67 -176.02 5.63 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.143 -0.935 . . . . 44.3 109.868 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -58.44 108.61 0.65 Allowed 'General case' 0 C--O 1.242 0.674 0 O-C-N 124.122 0.889 . . . . 73.22 109.695 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . 0.585 ' HB3' ' HB2' ' C' ' 87' ' ' ALA . 16.9 m-20 66.2 24.63 10.74 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 124.311 1.007 . . . . 74.45 111.853 175.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.7 t -122.24 118.97 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 108.835 -0.802 . . . . 43.1 108.835 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -120.6 125.44 47.76 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.082 0.953 . . . . 73.34 109.997 -176.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.602 ' HB2' HD11 ' C' ' 51' ' ' LEU . 36.2 tt0 -84.71 131.99 34.51 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.531 -0.915 . . . . 73.51 108.531 166.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.484 HG11 ' HD3' ' C' ' 103' ' ' PRO . 61.3 t -122.45 123.05 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.08 -1.081 . . . . 73.14 108.08 168.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.574 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 73.5 t -108.84 145.44 15.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 109.19 -0.67 . . . . 65.01 109.19 174.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.06 101.27 7.44 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.651 -1.241 . . . . 75.13 107.651 174.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 35.9 ttm-85 -79.98 106.29 11.89 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.068 -1.086 . . . . 72.41 108.068 169.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.446 ' HB ' HD11 ' C' ' 114' ' ' ILE . 16.0 t -107.17 123.9 62.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.731 -1.211 . . . . 54.45 107.731 172.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 12.5 m -122.83 116.19 23.27 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.721 -0.844 . . . . 55.45 108.721 -176.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.415 HG21 HG21 ' C' ' 114' ' ' ILE . 73.8 t -111.35 110.69 33.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 C-N-CA 124.463 1.105 . . . . 41.53 108.767 -174.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.4 m -99.67 139.28 35.56 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 115.356 -0.838 . . . . 71.21 108.88 175.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.45 105.23 6.81 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.093 -1.447 . . . . 74.42 107.093 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.0 m -123.33 135.28 54.12 Favored 'General case' 0 C--O 1.219 -0.509 0 N-CA-C 108.179 -1.045 . . . . 45.02 108.179 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 36.2 mt -84.13 25.98 0.79 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.474 1.11 . . . . 63.25 110.714 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.76 -91.75 0.8 Allowed Glycine 0 C--N 1.357 1.722 0 N-CA-C 111.041 -0.823 . . . . 72.43 111.041 -177.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -89.11 -31.33 18.05 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.587 0.755 . . . . 73.34 110.261 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -89.34 124.06 34.08 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.819 1.248 . . . . 74.5 109.466 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.0 m -80.93 126.45 31.39 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.603 -0.888 . . . . 73.41 108.603 166.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.93 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -78.47 -55.81 4.93 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.42 -0.585 . . . . 72.14 109.42 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -159.01 166.05 32.64 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.665 0.745 . . . . 62.41 112.16 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.413 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.1 tm? -130.05 143.14 50.63 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 106.683 -1.599 . . . . 75.24 106.683 167.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.413 ' N ' HD13 ' C' ' 75' ' ' LEU . 48.5 t -149.87 112.08 4.65 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.661 -0.496 . . . . 52.03 109.661 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -116.68 124.61 50.14 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.219 -0.66 . . . . 54.41 109.219 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 49.4 t -122.97 115.07 44.68 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.77 -0.826 . . . . 72.2 108.77 172.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.468 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.1 mt-30 -93.86 87.69 5.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.046 0.938 . . . . 74.41 109.209 175.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -80.2 101.56 8.91 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.855 -1.066 . . . . 63.31 109.976 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -100.66 150.2 18.73 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-O 121.143 0.302 . . . . 35.01 112.746 177.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.7 132.51 4.78 Favored Glycine 0 CA--C 1.501 -0.798 0 N-CA-C 110.756 -0.937 . . . . 45.55 110.756 -175.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 34.7 mm -90.87 128.14 42.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 108.531 -0.915 . . . . 73.13 108.531 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -136.15 119.39 16.68 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.609 -0.885 . . . . 71.03 108.609 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 33.3 p -78.49 102.26 7.76 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.472 -0.936 . . . . 75.13 108.472 173.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.549 HD13 ' SG ' ' C' ' 97' ' ' CYS . 5.7 mt -116.07 140.32 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 122.832 0.453 . . . . 63.1 110.073 -176.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' C' ' 54' ' ' ASP . . . -160.35 172.07 17.97 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.777 0.831 . . . . 60.04 110.732 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.99 -47.19 3.5 Favored Glycine 0 C--N 1.345 1.062 0 O-C-N 123.896 0.747 . . . . 73.54 111.61 175.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.429 HD13 ' CE ' ' C' ' 9' ' ' MET . 41.7 pt -83.1 146.77 6.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 123.64 0.776 . . . . 63.1 111.154 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -149.38 -179.13 6.83 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.907 0.883 . . . . 75.32 109.595 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.57 -126.94 30.89 Favored Glycine 0 C--N 1.343 0.953 0 CA-C-O 119.603 -0.554 . . . . 63.03 112.107 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.6 -26.0 62.41 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.269 0.627 . . . . 50.53 111.611 178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.419 ' HB3' ' HB ' ' C' ' 89' ' ' ILE . 26.5 mt-30 -65.42 -60.77 2.6 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.527 0.331 . . . . 74.21 110.266 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.423 ' HE3' HD11 ' C' ' 89' ' ' ILE . 1.8 tpt -54.93 -48.36 73.24 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 123.796 0.685 . . . . 65.1 112.152 173.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.2 -40.2 76.92 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.728 0.642 . . . . 75.24 111.608 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -83.46 -23.34 32.28 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.403 0.681 . . . . 71.1 111.638 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.549 ' SG ' HD13 ' C' ' 86' ' ' ILE . 34.3 t -69.56 -37.89 77.19 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 108.354 -0.98 . . . . 73.1 108.354 175.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.421 ' HG ' ' HE2' ' C' ' 94' ' ' MET . 76.9 mt -81.1 -31.81 34.13 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.972 -1.013 . . . . 74.13 110.801 174.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . 0.418 ' HA3' ' CE2' ' C' ' 137' ' ' PHE . . . -78.05 -28.88 55.52 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.163 -0.926 . . . . 74.34 114.755 -168.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.99 -47.57 0.09 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.469 0.544 . . . . 73.52 112.469 -167.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.47 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 70.3 t80 -56.05 -59.3 5.11 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.345 0.658 . . . . 73.32 111.772 -176.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 88.6 m -63.66 -46.01 82.7 Favored Pre-proline 0 CA--C 1.566 1.582 0 C-N-CA 124.173 0.989 . . . . 73.32 111.691 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.484 ' HD3' HG11 ' C' ' 58' ' ' VAL . 96.0 Cg_exo -49.67 -36.11 40.24 Favored 'Trans proline' 0 C--N 1.395 2.997 0 C-N-CA 123.088 2.525 . . . . 35.33 114.832 168.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -67.97 -31.98 72.08 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.477 0.711 . . . . 62.02 111.249 177.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.4 HD12 HH12 ' A' ' 111' ' ' ARG . 32.2 mm -69.66 -38.78 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 109.185 -0.672 . . . . 64.14 109.185 175.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 53.5 mt -78.82 -34.4 45.27 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.262 1.025 . . . . 71.21 112.516 -174.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -54.46 -47.11 98.64 Favored Pre-proline 0 N--CA 1.484 1.24 0 N-CA-C 114.238 1.199 . . . . 74.32 114.238 -170.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.48 -39.06 58.54 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.167 1.912 . . . . 72.53 113.345 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -68.5 -40.42 80.9 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.278 0.631 . . . . 64.41 110.793 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.28 -41.86 99.04 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.16 -0.927 . . . . 73.33 109.866 174.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . 0.407 ' HA ' HD21 ' C' ' 128' ' ' LEU . 56.2 ttt180 -60.71 -49.35 77.86 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.936 1.294 . . . . 73.34 110.61 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.27 -40.88 90.42 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.724 0.64 . . . . 74.22 109.943 -176.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 49.4 t -68.83 -34.88 76.22 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.504 0.503 . . . . 74.44 111.986 -176.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.446 HD11 ' HB ' ' C' ' 62' ' ' VAL . 97.0 mt -69.43 -52.33 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.443 0.697 . . . . 72.12 110.363 175.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.4 m -67.95 -27.23 66.43 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 122.974 0.509 . . . . 53.14 111.254 -175.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 40.4 t -62.97 -47.06 84.81 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.971 0.908 . . . . 63.44 109.367 170.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.601 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.86 -38.68 91.79 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.433 1.093 . . . . 74.23 112.125 178.227 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 98.9 t -58.39 -45.79 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.462 0.705 . . . . 60.43 109.685 173.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.531 ' OG ' HG21 ' B' ' 115' ' ' THR . 28.9 t -68.76 -31.65 70.84 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.836 -1.074 . . . . 71.44 112.268 -178.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.446 HH12 ' HG2' ' D' ' 112' ' ' GLU . 73.0 mtt-85 -69.47 -40.4 77.11 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.162 -0.681 . . . . 65.02 109.162 177.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.56 -1.07 86.01 Favored Glycine 0 C--N 1.356 1.683 0 O-C-N 123.983 0.802 . . . . 62.42 112.66 172.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 30.3 p 65.46 25.61 11.89 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 126.819 2.048 . . . . 50.24 114.075 169.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -83.67 143.83 44.53 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 109.313 -0.625 . . . . 75.12 109.313 174.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.448 ' HG3' HG21 ' F' ' 129' ' ' THR . 78.0 Cg_exo -45.61 135.9 12.63 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 123.459 2.773 . . . . 75.04 113.055 171.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.563 ' H ' ' HB2' ' B' ' 125' ' ' GLN . 36.8 mm-40 -44.07 112.82 0.44 Allowed 'General case' 0 N--CA 1.483 1.211 0 O-C-N 124.882 1.364 . . . . 72.4 111.934 -174.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.497 HD11 ' H ' ' F' ' 135' ' ' VAL . 20.2 tp -108.18 83.94 1.86 Allowed 'General case' 0 C--O 1.239 0.525 0 N-CA-C 106.565 -1.643 . . . . 63.4 106.565 170.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -97.54 94.52 7.05 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 114.357 -1.292 . . . . 73.32 108.378 -170.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.577 HD23 ' H ' ' C' ' 128' ' ' LEU . 1.5 pt? -56.3 139.09 49.41 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.089 0.956 . . . . 65.02 111.967 -175.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.51 150.83 64.19 Favored Pre-proline 0 CA--C 1.548 0.891 0 CA-C-N 114.759 -1.109 . . . . 64.14 110.945 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.41 113.7 1.8 Allowed 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.852 2.368 . . . . 75.42 112.674 175.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 49.0 t -99.31 118.39 45.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 107.676 -1.231 . . . . 64.24 107.676 171.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -71.84 103.44 3.15 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.265 0.626 . . . . 61.24 110.42 -175.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -62.64 -31.46 72.32 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.253 1.021 . . . . 73.31 111.944 177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -66.36 -37.66 85.81 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.278 0.631 . . . . 74.53 110.685 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.16 -39.92 86.56 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.516 0.726 . . . . 64.0 110.373 175.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.401 ' HA ' HD21 ' C' ' 139' ' ' ASN . 98.4 mt -64.94 -35.34 80.83 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.925 -1.034 . . . . 72.22 110.889 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . 0.418 ' CE2' ' HA3' ' C' ' 99' ' ' GLY . 3.4 t80 -81.48 -26.12 35.46 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.95 -0.568 . . . . 74.32 111.307 -179.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 37.9 ttp -67.56 -46.74 71.83 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 123.827 0.704 . . . . 65.23 109.867 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . 0.401 HD21 ' HA ' ' C' ' 136' ' ' LEU . 10.4 p30 -71.5 -34.88 70.51 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 115.739 -0.664 . . . . 74.02 110.564 177.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 93.5 t80 -55.42 -84.26 0.01 OUTLIER 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.112 0.965 . . . . 70.43 110.362 174.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 38.7 tp 61.67 160.59 0.06 Allowed 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 124.623 1.169 . . . . 64.21 111.569 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.29 -73.55 0.28 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 106.671 -1.603 . . . . 75.23 106.671 173.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -148.09 119.59 7.94 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.859 -0.793 . . . . 71.21 108.859 -178.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -77.44 118.21 19.66 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-O 121.327 0.584 . . . . 62.51 110.03 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -151.83 56.05 0.85 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.286 -1.005 . . . . 73.41 108.286 177.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.78 59.06 4.99 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 114.129 -1.396 . . . . 42.22 112.197 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -105.01 112.59 25.79 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.376 1.07 . . . . 74.25 110.045 -174.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -151.25 36.48 0.87 Allowed Glycine 0 C--N 1.341 0.837 0 O-C-N 123.617 0.573 . . . . 72.22 111.834 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 15.3 t -101.2 142.33 32.79 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.552 0.741 . . . . 72.42 110.732 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -176.86 -27.07 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.626 1.17 . . . . 74.5 109.623 176.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.58 111.15 0.74 Allowed 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 124.262 1.025 . . . . 74.24 112.03 177.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -122.06 164.25 18.02 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.725 1.21 . . . . 73.51 108.507 174.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -62.95 98.7 0.13 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 109.348 -0.612 . . . . 74.34 109.348 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -63.3 -52.62 61.22 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.609 0.764 . . . . 54.31 110.267 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.303 0 CA-C-N 114.852 -1.067 . . . . 71.14 109.597 177.762 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . 0.41 ' SD ' ' N ' ' D' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.479 0.977 0 CA-C-O 119.444 -0.312 . . . . 63.35 110.963 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 37.4 p -167.36 144.54 4.52 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.872 0.469 . . . . 74.44 111.262 -173.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -91.62 161.17 15.03 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.773 1.229 . . . . 73.45 109.743 174.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -68.94 140.68 55.09 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.443 0.697 . . . . 74.32 110.228 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.87 -73.13 0.15 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.298 1.039 . . . . 63.44 110.228 -171.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -170.75 150.78 3.32 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.749 1.219 . . . . 64.43 107.748 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 14.7 t -160.34 -154.56 0.39 Allowed 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 124.095 0.958 . . . . 63.3 108.787 -174.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.509 ' HG2' ' H ' ' D' ' 9' ' ' MET . 19.3 tt0 -73.24 -169.97 0.71 Allowed 'General case' 0 CA--C 1.572 1.798 0 C-N-CA 123.807 0.843 . . . . 74.4 109.95 173.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.509 ' H ' ' HG2' ' D' ' 8' ' ' GLU . 0.1 OUTLIER -29.54 125.07 0.14 Allowed 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 125.95 1.7 . . . . 65.11 113.113 178.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 8.2 t -112.59 134.55 54.06 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.797 0.839 . . . . 60.34 109.942 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.531 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 49.9 t80 -135.3 91.01 2.68 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 106.781 -1.563 . . . . 65.34 106.781 176.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -121.2 126.8 50.54 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.474 0.71 . . . . 63.42 109.252 -176.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mt -96.21 132.77 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 107.84 -1.17 . . . . 73.22 107.84 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -104.09 -19.58 14.12 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 119.116 -0.468 . . . . 70.2 111.417 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.416 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 41.1 ttt180 -172.29 131.92 0.62 Allowed 'General case' 0 C--N 1.36 1.042 0 N-CA-C 112.065 0.395 . . . . 73.33 112.065 -176.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.439 HD13 ' HG3' ' B' ' 130' ' ' PRO . 2.6 mp -110.41 134.95 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 N-CA-C 106.842 -1.54 . . . . 64.51 106.842 170.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.416 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 22.2 p90 -158.16 140.28 14.14 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 123.521 0.513 . . . . 64.31 111.685 -177.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -78.6 113.17 16.4 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.498 -0.774 . . . . 75.35 109.668 175.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -85.76 -11.24 54.06 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.602 -0.726 . . . . 75.11 109.9 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.651 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.4 t70 -165.54 145.25 6.59 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.594 1.158 . . . . 53.41 109.846 177.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.601 HD13 ' HE3' ' C' ' 117' ' ' MET . 66.4 mt -148.41 148.23 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 125.622 1.569 . . . . 74.43 107.695 175.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.1 t -154.98 146.24 22.89 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.356 1.062 . . . . 53.3 109.092 171.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.577 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 92.0 t80 -143.61 126.32 16.07 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 106.669 -1.604 . . . . 71.51 106.669 169.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 47.9 mt-10 -121.16 142.73 49.61 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.549 0.74 . . . . 73.53 109.227 175.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.433 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -138.69 75.51 37.1 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 107.018 -1.475 . . . . 60.01 107.018 169.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -71.99 -19.93 26.09 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.453 2.102 . . . . 72.54 112.772 -171.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -110.7 3.98 19.69 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.655 0.782 . . . . 74.24 111.153 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.452 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -27.33 -70.63 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 116.805 2.15 . . . . 64.24 116.805 -167.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.32 -19.46 15.17 Favored 'Trans proline' 0 C--N 1.388 2.618 0 CA-C-N 124.036 2.477 . . . . 52.44 114.011 -174.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -74.5 -39.6 62.32 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.045 0.938 . . . . 53.52 109.816 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' D' ' 73' ' ' ALA . 9.3 p -82.98 -16.25 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 CA-C-N 116.065 -0.516 . . . . 75.1 111.101 -171.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -68.42 -13.42 62.28 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.07 0.767 . . . . 75.55 113.07 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -60.34 -27.29 67.24 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.788 0.835 . . . . 72.4 110.713 173.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -91.78 88.13 6.55 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.494 1.518 . . . . 71.14 110.179 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -83.11 90.92 7.12 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.221 -0.9 . . . . 72.22 110.682 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 40.7 p90 -165.4 172.01 12.72 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.138 0.975 . . . . 75.43 109.29 166.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -70.58 111.27 9.02 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.644 0.778 . . . . 62.01 109.321 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.44 128.47 30.23 Favored 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 122.937 2.424 . . . . 63.51 112.058 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -67.74 113.1 5.23 Favored 'General case' 0 C--O 1.24 0.566 0 O-C-N 123.773 0.671 . . . . 74.25 109.462 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.925 HG13 HG13 ' D' ' 64' ' ' VAL . 78.7 t -98.53 107.13 19.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-N 115.343 -0.844 . . . . 72.54 110.102 -174.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -87.65 111.04 20.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 105.693 -1.965 . . . . 64.11 105.693 165.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.441 HD11 HG13 ' D' ' 62' ' ' VAL . 49.7 tp -95.52 143.44 26.84 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.498 -0.927 . . . . 64.51 108.498 -172.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.613 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 15.8 m-20 -120.02 117.01 26.88 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.688 -1.226 . . . . 74.42 107.688 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.717 ' HB3' HD23 ' E' ' 111' ' ' LEU . 23.4 mt -116.31 131.0 57.06 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.048 0.452 . . . . 65.12 110.014 177.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.617 ' HA ' ' HB3' ' E' ' 111' ' ' LEU . 38.4 t70 -143.99 145.2 32.06 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.246 -1.02 . . . . 71.34 108.246 171.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . 0.76 HG23 HD22 ' E' ' 111' ' ' LEU . 22.8 p -104.6 170.57 7.81 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.105 0.562 . . . . 64.43 110.493 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -166.35 163.08 17.49 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.463 1.105 . . . . 62.55 108.621 172.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 53.7 p -155.52 153.3 30.01 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 108.147 -1.057 . . . . 61.42 108.147 169.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 68.6 p -165.78 159.33 16.02 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.631 0.772 . . . . 65.31 109.481 -174.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . 0.452 ' HB2' ' HG3' ' D' ' 57' ' ' GLU . 25.1 tp60 152.09 -91.63 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 126.781 2.033 . . . . 71.32 107.855 164.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.461 ' HB2' HG13 ' D' ' 55' ' ' VAL . 80.7 mt -151.74 133.01 14.5 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.317 1.447 . . . . 63.23 107.482 -175.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.39 78.1 3.91 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 109.111 -0.7 . . . . 63.53 109.111 173.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -166.1 42.37 0.06 Allowed 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.095 -0.957 . . . . 74.51 108.762 -171.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 66.11 -1.79 1.09 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 124.622 1.169 . . . . 73.34 113.586 178.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.461 HG13 ' HB2' ' D' ' 51' ' ' LEU . 2.3 p -109.24 94.54 3.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 107.305 -1.368 . . . . 51.21 107.305 177.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -122.18 128.3 51.05 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.676 -0.861 . . . . 73.12 108.676 -171.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.452 ' HG3' ' HB2' ' D' ' 50' ' ' GLN . 31.4 mt-10 -85.89 152.99 22.53 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 107.318 -1.364 . . . . 73.14 107.318 162.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 53.3 t -130.16 138.57 53.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.302 -1.37 . . . . 64.1 107.302 165.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.471 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 32.3 t -126.11 130.12 72.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 108.249 -1.019 . . . . 71.23 108.249 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.595 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -109.02 119.96 41.1 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 106.824 -1.547 . . . . 72.44 106.824 178.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -99.36 97.99 8.97 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.384 -0.969 . . . . 72.01 108.384 178.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.441 HG13 HD11 ' D' ' 42' ' ' LEU . 31.9 t -101.82 117.14 46.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 115.291 -0.868 . . . . 74.14 108.713 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.613 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 22.6 m -126.7 119.14 26.24 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.382 0.673 . . . . 73.33 109.25 -173.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.925 HG13 HG13 ' D' ' 40' ' ' VAL . 55.1 t -100.89 124.16 54.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 123.715 0.806 . . . . 63.43 110.022 -177.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 28.4 m -114.69 96.19 5.61 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.239 -1.022 . . . . 71.23 108.239 170.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.604 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -106.69 142.56 36.13 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 115.482 -0.781 . . . . 71.51 110.076 -175.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.52 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 48.9 m -139.75 141.64 36.83 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.441 0.638 . . . . 73.44 112.258 -173.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.442 HD12 HG22 ' D' ' 31' ' ' VAL . 46.7 mt -111.57 114.71 27.96 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.32 -1.309 . . . . 73.41 107.642 170.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.52 -131.73 22.09 Favored Glycine 0 C--N 1.341 0.835 0 O-C-N 123.155 0.284 . . . . 60.42 112.768 -176.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.84 1.61 55.38 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.942 0.497 . . . . 75.41 111.41 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -119.15 164.66 15.24 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.751 0.42 . . . . 71.31 110.366 -175.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 98.8 m -67.82 131.59 45.82 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.06 -0.973 . . . . 73.13 110.998 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.581 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -84.9 -63.49 1.32 Allowed 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.698 -1.223 . . . . 51.41 107.698 170.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -152.05 148.82 28.14 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 114.587 -1.188 . . . . 62.13 110.607 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.446 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 82.6 mt -109.65 154.12 23.27 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.454 1.102 . . . . 74.3 108.27 170.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.542 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 43.0 t -157.9 148.62 20.86 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.316 -0.624 . . . . 52.41 109.316 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -155.6 131.45 9.91 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.313 0.645 . . . . 41.44 109.796 174.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -135.13 113.82 16.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 108.267 -1.012 . . . . 74.54 108.267 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.651 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.8 mt-30 -89.54 83.88 6.35 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.239 -1.023 . . . . 74.41 108.239 169.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -80.31 96.87 6.77 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 113.734 -1.575 . . . . 64.32 109.377 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.25 168.51 35.23 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.689 -0.687 . . . . 73.14 112.468 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.02 138.09 4.75 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 110.707 -0.957 . . . . 53.11 110.707 173.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.99 123.97 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 N-CA-C 108.549 -0.908 . . . . 60.41 108.549 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -115.13 125.73 53.81 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.681 1.192 . . . . 72.31 110.002 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 35.0 m -87.87 95.08 9.97 Favored 'General case' 0 C--O 1.245 0.859 0 N-CA-C 108.513 -0.921 . . . . 41.45 108.513 168.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 37.0 pt -109.78 142.7 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 N-CA-C 109.415 -0.587 . . . . 75.43 109.415 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.63 166.94 9.82 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.933 0.893 . . . . 64.24 110.378 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.23 22.75 56.46 Favored Glycine 0 C--N 1.352 1.448 0 O-C-N 123.517 0.51 . . . . 52.35 113.796 175.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.581 ' HB ' ' HB3' ' D' ' 94' ' ' MET . 0.2 OUTLIER -120.33 148.97 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 124.187 0.995 . . . . 75.43 109.668 -179.068 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -129.06 -178.3 4.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.79 0.836 . . . . 64.52 109.904 -175.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.58 -142.58 47.05 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-N 115.363 -0.835 . . . . 53.14 112.63 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.2 p -90.81 -14.72 31.38 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.649 0.779 . . . . 74.41 111.267 173.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -56.38 -34.1 66.37 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.356 1.062 . . . . 72.34 112.247 -175.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.581 ' HB3' ' HB ' ' D' ' 89' ' ' ILE . 0.0 OUTLIER -62.57 -43.5 98.65 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.306 0.642 . . . . 64.13 112.049 -179.426 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . 0.453 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.05 -22.92 28.8 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.384 0.674 . . . . 54.0 111.862 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -74.93 -38.4 61.78 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.734 -0.469 . . . . 73.43 109.734 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 73.7 m -73.05 -26.7 61.38 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.493 0.717 . . . . 70.41 110.888 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 53.2 tp -63.89 -43.63 95.44 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.711 0.804 . . . . 65.32 110.319 175.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . 0.409 ' O ' HG21 ' D' ' 46' ' ' THR . . . -94.56 -12.05 56.28 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 119.298 -0.723 . . . . 62.32 114.381 -175.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.04 -58.34 1.88 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 118.439 1.12 . . . . 70.23 112.341 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -74.57 -41.73 60.01 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.224 0.453 . . . . 75.41 112.224 -172.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.531 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 75.5 m -61.46 -47.52 93.17 Favored Pre-proline 0 CA--C 1.568 1.636 0 C-N-CA 123.383 0.673 . . . . 70.22 111.69 178.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.595 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 53.2 Cg_exo -61.63 -31.24 86.63 Favored 'Trans proline' 0 C--N 1.39 2.718 0 C-N-CA 122.344 2.029 . . . . 65.12 113.795 170.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -63.0 -33.33 75.19 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.022 0.529 . . . . 64.2 110.843 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.4 mm -67.22 -42.08 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.776 0.83 . . . . 73.31 110.49 173.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 54.0 mt -76.18 -11.35 59.91 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.357 -0.838 . . . . 73.23 111.638 -175.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -70.63 -44.81 17.42 Favored Pre-proline 0 CA--C 1.558 1.282 0 N-CA-C 114.086 1.143 . . . . 72.43 114.086 -172.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . 0.597 ' HB2' ' HG2' ' B' ' 108' ' ' PRO . 29.1 Cg_endo -61.97 -32.07 84.42 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 121.649 1.566 . . . . 75.35 112.469 172.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . 0.415 ' O ' ' HB3' ' D' ' 112' ' ' GLU . 62.5 m-85 -72.82 -31.69 64.99 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.752 0.821 . . . . 73.22 111.634 175.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.98 -48.08 72.43 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.437 0.637 . . . . 75.4 109.334 175.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 33.2 ttp180 -65.66 -31.92 73.21 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.174 -1.375 . . . . 54.21 110.858 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . 0.446 ' HG2' HH12 ' C' ' 120' ' ' ARG . 16.0 tt0 -53.17 -52.63 58.17 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.343 1.057 . . . . 72.4 110.317 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.9 t -69.51 -47.59 63.31 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.511 -1.222 . . . . 74.31 111.061 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.52 HG21 HG21 ' D' ' 64' ' ' VAL . 63.4 mt -62.37 -58.23 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.346 0.658 . . . . 75.22 111.062 -176.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 86.0 m -52.84 -39.57 62.64 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 124.107 0.879 . . . . 74.23 111.564 -176.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 43.4 t -65.19 -45.11 86.14 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.128 -0.942 . . . . 52.0 110.121 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.452 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 79.0 mtm -66.31 -32.87 74.54 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.198 0.599 . . . . 75.43 111.959 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.428 HG23 ' O ' ' D' ' 114' ' ' ILE . 92.5 t -62.79 -48.47 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 123.616 0.767 . . . . 75.15 109.794 175.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 96.4 p -71.24 -27.67 63.63 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.593 -0.731 . . . . 74.45 110.787 -178.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' D' ' 116' ' ' SER . 90.4 mtt-85 -69.64 -33.76 73.08 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.541 0.736 . . . . 72.24 109.936 174.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.46 9.16 71.71 Favored Glycine 0 C--N 1.355 1.624 0 O-C-N 123.578 0.548 . . . . 62.33 112.933 176.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.443 HG23 ' HB3' ' C' ' 17' ' ' TYR . 82.1 p 56.51 36.56 27.76 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 125.93 1.692 . . . . 74.11 113.631 177.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -98.62 149.63 35.93 Favored Pre-proline 0 C--O 1.243 0.754 0 N-CA-C 108.557 -0.905 . . . . 73.34 108.557 171.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.46 ' HB3' ' HA ' ' E' ' 129' ' ' THR . 66.7 Cg_exo -45.58 131.1 12.44 Favored 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 123.308 2.672 . . . . 63.22 112.616 172.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -52.95 130.88 34.92 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 124.344 1.027 . . . . 75.5 111.479 -172.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.516 HD13 HG21 ' D' ' 40' ' ' VAL . 10.1 tp -105.71 98.61 8.28 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.182 -0.917 . . . . 72.42 108.603 -173.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . 0.446 HD22 HD12 ' B' ' 16' ' ' ILE . 10.2 m120 -100.51 78.61 2.02 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.94 -1.133 . . . . 63.33 107.94 177.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 pp -66.06 132.33 48.29 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 109.791 -0.448 . . . . 52.3 109.791 -175.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.77 144.03 97.99 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 123.815 0.846 . . . . 75.41 111.425 -174.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.65 132.63 46.67 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.635 2.223 . . . . 65.45 111.945 176.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 73.6 t -107.48 128.63 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 N-CA-C 108.729 -0.841 . . . . 73.34 108.729 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -85.59 97.84 10.31 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.657 0.783 . . . . 70.21 108.997 175.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -62.49 -26.88 68.77 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.658 1.183 . . . . 51.35 112.229 -173.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -58.69 -41.71 86.89 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.915 0.886 . . . . 71.11 110.608 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.71 -30.95 71.09 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.81 -1.087 . . . . 64.32 111.937 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.4 mp -74.43 -40.74 61.78 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.282 0.633 . . . . 74.21 111.287 -175.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -67.38 -35.49 79.44 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.805 0.442 . . . . 75.15 111.485 175.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 75.8 mtm -72.59 -38.15 67.94 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.103 0.561 . . . . 72.34 110.919 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.446 ' O ' ' HG3' ' D' ' 143' ' ' GLN . 66.3 t30 -71.08 -35.05 71.72 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.332 0.653 . . . . 71.31 110.262 -175.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . 0.424 ' HD2' HD12 ' D' ' 141' ' ' LEU . 87.7 t80 -49.21 -41.0 35.73 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.874 1.27 . . . . 75.4 111.688 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.424 HD12 ' HD2' ' D' ' 140' ' ' TYR . 9.2 mp -73.92 -43.13 59.37 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.694 0.798 . . . . 73.3 111.768 -178.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -91.22 27.99 1.76 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 113.194 0.813 . . . . 75.45 113.194 -169.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' D' ' 139' ' ' ASN . 46.8 mt-30 -121.44 87.25 2.72 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.276 0.56 . . . . 75.14 109.82 177.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -162.31 94.83 0.91 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.28 1.032 . . . . 62.12 109.336 -177.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.67 148.64 29.52 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.542 0.737 . . . . 74.43 110.519 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.29 102.86 1.87 Allowed Glycine 0 C--N 1.344 1.014 0 CA-C-N 115.909 -0.587 . . . . 75.42 111.768 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -68.43 137.5 54.54 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.887 0.875 . . . . 71.02 111.861 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -160.16 150.24 20.24 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 115.674 -0.693 . . . . 44.3 112.166 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 41.4 m -113.37 132.75 55.48 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.744 0.817 . . . . 74.53 109.576 178.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -75.63 173.56 10.89 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.193 0.597 . . . . 52.53 111.163 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -153.14 147.46 25.82 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.158 0.583 . . . . 75.14 110.391 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -136.72 121.41 18.5 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.796 0.839 . . . . 71.52 108.985 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -94.26 155.45 17.02 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.094 0.558 . . . . 63.2 109.574 171.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -162.77 147.81 11.93 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.384 -0.599 . . . . 72.22 109.384 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.285 0 C-N-CA 123.6 0.76 . . . . 64.21 109.138 -177.715 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.519 0 N-CA-C 111.823 -0.511 . . . . 73.24 111.823 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.52 -155.95 42.23 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 113.887 0.315 . . . . 73.2 113.887 175.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -121.09 169.05 10.89 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.422 1.089 . . . . 75.33 111.019 -178.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -93.81 -169.57 2.13 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.952 0.901 . . . . 75.44 111.304 -174.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -158.16 101.02 1.73 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 107.686 -1.228 . . . . 61.45 107.686 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . -177.48 -52.85 0.07 OUTLIER Glycine 0 C--N 1.346 1.114 0 O-C-N 123.106 0.254 . . . . 54.44 112.809 -176.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 97' ' ' ILE . . . . . 0.481 HD12 HD13 ' D' ' 89' ' ' ILE . 4.0 tt -83.12 101.73 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.248 0 CA-C-O 122.177 0.989 . . . . 42.13 110.689 -177.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -155.66 89.17 1.16 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 114.763 -1.108 . . . . 74.41 108.063 171.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 99' ' ' ALA . . . . . 0.575 ' H ' HD23 ' E' ' 100' ' ' LEU . . . -166.41 25.73 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.308 1.043 . . . . 71.52 109.673 -177.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 100' ' ' LEU . . . . . 0.575 HD23 ' H ' ' E' ' 99' ' ' ALA . 2.1 pt? -151.93 152.32 29.72 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 123.645 0.778 . . . . 64.24 110.289 -173.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -84.9 152.5 11.27 Favored 'Trans proline' 0 C--N 1.365 1.425 0 C-N-CA 122.454 2.103 . . . . 54.22 110.496 161.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 102' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -72.72 83.59 1.17 Allowed 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 109.323 -0.621 . . . . 62.13 109.323 178.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 48.4 p 54.41 15.75 1.08 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 126.356 1.862 . . . . 62.45 113.452 -174.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.65 -168.43 29.19 Favored Glycine 0 C--N 1.344 1.025 0 N-CA-C 111.778 -0.529 . . . . 75.23 111.778 -173.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -66.5 -43.45 85.32 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.59 0.756 . . . . 53.12 111.433 -176.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -153.91 59.57 0.73 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 108.289 -1.004 . . . . 71.31 108.289 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 18.2 m 54.14 79.14 0.14 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.843 1.257 . . . . 54.35 111.4 176.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -61.4 -33.11 73.13 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 114.985 -1.007 . . . . 72.11 112.562 -169.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -70.12 -46.3 65.09 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.458 0.474 . . . . 74.15 110.255 174.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' E' ' 113' ' ' LYS . . . 62.03 115.82 0.02 OUTLIER 'General case' 0 C--N 1.357 0.896 0 O-C-N 124.614 1.197 . . . . 72.42 110.03 -165.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . 0.76 HD22 HG23 ' D' ' 46' ' ' THR . 52.5 tp -51.74 -57.32 9.6 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.041 0.936 . . . . 60.4 112.714 -168.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -107.9 72.16 0.84 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 107.588 -1.264 . . . . 74.52 107.588 171.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 113' ' ' LYS . . . . . 0.425 ' HB2' ' HB3' ' E' ' 110' ' ' ALA . 21.6 tptm -79.44 86.76 5.11 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.807 -0.442 . . . . 60.21 109.807 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . 0.59 ' HD3' ' HB2' ' E' ' 117' ' ' LYS . 36.4 ttmt -168.3 109.22 0.54 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.252 -0.886 . . . . 73.33 108.743 175.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 77.5 p -100.17 -16.0 17.94 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.422 0.689 . . . . 73.11 111.984 -175.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . -95.24 -30.21 8.39 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 116.338 -0.392 . . . . 72.1 113.301 -175.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 117' ' ' LYS . . . . . 0.59 ' HB2' ' HD3' ' E' ' 114' ' ' LYS . 63.1 mttp -131.96 164.48 42.72 Favored Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 123.469 0.707 . . . . 62.31 110.328 -178.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.98 179.28 6.23 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.475 2.116 . . . . 62.31 111.888 165.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -150.67 -162.82 1.63 Allowed 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 108.411 -0.959 . . . . 74.01 108.411 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -50.15 -32.56 16.44 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 125.159 1.384 . . . . 62.45 111.568 173.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 121' ' ' VAL . . . . . . . . . . . . . 48.0 t -77.15 83.35 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 C-N-CA 123.932 0.893 . . . . 74.14 110.464 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 1.8 p -157.37 147.66 20.92 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.559 1.544 . . . . 55.33 108.286 175.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -139.17 128.57 24.25 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.399 -0.593 . . . . 71.32 109.399 174.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 54.3 m -145.72 19.59 1.48 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.764 1.225 . . . . 55.31 108.921 170.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -108.2 -17.56 13.99 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.915 0.886 . . . . 75.14 111.087 -173.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.25 139.62 41.22 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.422 -0.584 . . . . 60.11 109.422 171.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 38.5 p -155.8 87.3 1.07 Allowed 'General case' 0 C--O 1.241 0.615 0 CA-C-O 121.348 0.594 . . . . 74.43 110.109 -175.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -128.73 66.14 1.42 Allowed 'General case' 0 C--O 1.241 0.611 0 CA-C-O 121.73 0.776 . . . . 65.15 108.99 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 129' ' ' THR . . . . . 0.46 ' HA ' ' HB3' ' D' ' 124' ' ' PRO . 8.1 t -88.26 119.35 28.58 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.98 -1.009 . . . . 63.15 110.449 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 130' ' ' ALA . . . . . 0.4 ' HB1' ' HG3' ' A' ' 124' ' ' PRO . . . -167.03 98.54 0.53 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.9 0.88 . . . . 73.11 109.731 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 131' ' ' TRP . . . . . . . . . . . . . 68.2 t90 -164.52 109.32 0.96 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.881 0.872 . . . . 75.11 109.274 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 19.3 p 179.13 87.07 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.546 1.138 . . . . 72.44 109.813 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 16.9 m -149.98 142.15 24.08 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.271 -0.64 . . . . 54.45 109.271 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -171.2 122.95 1.0 Allowed Glycine 0 C--N 1.343 0.963 0 N-CA-C 110.473 -1.051 . . . . 64.21 110.473 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 31.1 m -120.5 144.73 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.713 0.805 . . . . 62.34 110.699 -175.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -138.08 45.5 2.11 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.797 0.808 . . . . 75.25 108.883 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 24.4 p -72.58 -28.79 63.02 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.815 -0.63 . . . . 51.41 109.97 173.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -119.18 170.93 8.66 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.665 1.186 . . . . 64.23 109.61 173.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 139' ' ' ASN . . . . . 0.475 HD21 ' HB3' ' C' ' 9' ' ' MET . 51.8 t30 -120.04 -92.26 0.54 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.476 0.71 . . . . 74.51 110.006 -176.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . 172.13 179.35 42.98 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 112.295 -0.322 . . . . 74.3 112.295 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -163.19 -160.32 0.6 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.577 1.151 . . . . 53.41 109.585 -174.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 142' ' ' LEU . . . . . 0.454 HD12 ' HD1' ' C' ' 101' ' ' TYR . 92.3 mt 74.14 22.37 2.33 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 125.419 1.488 . . . . 70.41 111.84 174.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -86.77 108.05 3.28 Favored Glycine 0 C--N 1.344 0.996 0 N-CA-C 111.173 -0.771 . . . . 72.35 111.173 174.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 27.3 m -81.46 146.25 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 123.16 0.584 . . . . 62.41 110.919 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 29.1 t70 . . . . . 0 C--O 1.252 1.191 0 C-N-CA 124.218 1.007 . . . . 70.34 110.591 179.946 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.415 0 N-CA-C 112.301 -0.32 . . . . 64.51 112.301 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . -143.61 152.07 23.84 Favored Glycine 0 C--N 1.343 0.939 0 N-CA-C 110.319 -1.112 . . . . 71.34 110.319 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -107.22 -66.2 1.04 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.079 0.552 . . . . 73.45 110.64 -174.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -109.22 -102.93 0.38 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.468 0.307 . . . . 72.33 111.502 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -148.06 -63.56 0.26 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.149 0.58 . . . . 70.21 111.146 -162.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . 170.52 72.08 0.04 OUTLIER Glycine 0 C--N 1.34 0.799 0 CA-C-N 115.11 -0.95 . . . . 71.22 110.793 -170.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 97' ' ' ILE . . . . . 0.474 HD12 HG12 ' B' ' 86' ' ' ILE . 5.2 tt -48.65 -46.15 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 124.998 1.319 . . . . 44.33 111.445 177.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 t0 174.18 -72.02 0.01 OUTLIER 'General case' 0 C--N 1.355 0.812 0 C-N-CA 125.612 1.565 . . . . 64.34 107.843 175.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -175.69 -20.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.166 0.986 . . . . 71.14 111.089 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 100' ' ' LEU . . . . . 0.534 HD11 ' H ' ' B' ' 54' ' ' ASP . 2.7 mp 61.36 92.54 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.445 0 C-N-CA 125.743 1.617 . . . . 54.35 110.881 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 101' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' B' ' 95' ' ' ALA . 95.5 Cg_endo -93.64 89.54 0.15 Allowed 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.257 2.638 . . . . 62.14 110.289 175.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 102' ' ' LEU . . . . . 0.55 HD11 ' HB2' ' B' ' 48' ' ' SER . 32.6 tp -66.02 161.73 20.92 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 114.727 -1.124 . . . . 63.32 109.963 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 39.2 p -79.08 52.72 1.32 Allowed 'General case' 0 CA--C 1.564 1.484 0 C-N-CA 124.548 1.139 . . . . 74.51 111.673 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.71 -72.16 2.82 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 111.237 -0.745 . . . . 70.51 111.237 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -174.0 -67.07 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 106.689 -1.597 . . . . 74.54 106.689 177.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -81.26 120.28 24.71 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 106.561 -1.644 . . . . 74.34 106.561 168.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 35.6 m -61.64 110.15 1.41 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.576 0.35 . . . . 62.12 110.725 -173.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -86.65 48.2 1.6 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.354 1.062 . . . . 73.04 109.928 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -169.94 90.27 0.18 Allowed 'General case' 0 C--O 1.239 0.547 0 N-CA-C 106.474 -1.676 . . . . 61.31 106.474 -178.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.02 171.13 8.62 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.232 0.613 . . . . 70.03 111.789 -172.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . 0.4 ' HB3' ' CD2' ' B' ' 136' ' ' LEU . 4.0 mm? -61.79 90.67 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 114.556 -1.202 . . . . 63.01 110.223 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 112' ' ' ASN . . . . . 0.411 ' ND2' ' H ' ' F' ' 120' ' ' TYR . 5.0 t30 71.85 7.39 5.86 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 125.183 1.393 . . . . 70.44 111.549 -178.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -130.25 149.41 51.95 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.164 -0.96 . . . . 51.52 112.82 -168.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . 0.512 ' HG2' ' OH ' ' B' ' 140' ' ' TYR . 0.0 OUTLIER -141.36 39.16 1.73 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.642 1.577 . . . . 73.45 107.544 167.181 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 12.0 m 75.3 83.04 0.1 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.369 1.468 . . . . 65.1 109.274 -165.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . -115.26 -159.13 12.07 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 115.742 -0.663 . . . . 55.31 112.286 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 117' ' ' LYS . . . . . 0.447 ' HB2' ' HD3' ' F' ' 118' ' ' PRO . 10.1 mtpm? -142.46 -57.67 0.02 OUTLIER Pre-proline 0 CA--C 1.564 1.484 0 C-N-CA 124.048 0.939 . . . . 75.5 110.472 177.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 118' ' ' PRO . . . . . 0.447 ' HD3' ' HB2' ' F' ' 117' ' ' LYS . 18.8 Cg_endo -92.97 45.5 0.34 Allowed 'Trans proline' 0 C--N 1.393 2.879 0 C-N-CA 122.364 2.042 . . . . 64.32 112.458 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -69.59 171.12 9.43 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.639 0.776 . . . . 72.15 111.895 -174.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 120' ' ' TYR . . . . . 0.411 ' H ' ' ND2' ' F' ' 112' ' ' ASN . 24.2 t80 -50.44 -53.55 28.69 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.437 1.095 . . . . 74.54 110.971 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 48.2 t -82.99 83.99 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 108.589 -0.893 . . . . 61.52 108.589 175.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 10.1 t -90.26 -14.0 34.21 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 114.679 -1.146 . . . . 71.41 111.265 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -124.68 172.77 9.01 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.753 0.821 . . . . 73.11 109.953 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 22.6 m -63.98 -34.91 79.05 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 115.842 -0.617 . . . . 64.54 110.683 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . 72.19 -63.47 0.43 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.219 1.808 . . . . 25.21 111.412 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 126' ' ' ALA . . . . . 0.5 ' HB2' ' H ' ' B' ' 129' ' ' ALA . . . -77.18 95.32 4.26 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.944 0.898 . . . . 61.14 110.339 176.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 58.9 p -98.81 125.49 44.19 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.472 -0.936 . . . . 64.31 108.472 172.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.81 -164.73 0.31 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.706 0.802 . . . . 72.55 110.588 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 129' ' ' THR . . . . . 0.524 HG22 ' HB3' ' B' ' 125' ' ' GLN . 13.2 t -123.15 -179.13 4.18 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.791 -0.818 . . . . 72.24 108.791 170.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.66 164.87 25.49 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 123.033 0.533 . . . . 61.23 111.084 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 131' ' ' TRP . . . . . 0.532 ' HB2' ' HG3' ' B' ' 124' ' ' PRO . 27.3 t90 -79.92 83.22 5.87 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.31 -0.996 . . . . 71.15 108.31 174.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 14.8 p -109.03 48.6 0.86 Allowed 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.069 0.947 . . . . 71.34 109.422 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 24.4 m -78.62 122.05 25.45 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.761 -1.109 . . . . 74.34 110.296 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -78.85 -85.51 0.54 Allowed Glycine 0 C--N 1.348 1.226 0 O-C-N 123.654 0.596 . . . . 63.23 112.039 176.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 135' ' ' VAL . . . . . 0.643 ' H ' HG21 ' C' ' 40' ' ' VAL . 48.0 t 59.33 19.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 C-N-CA 124.897 1.279 . . . . 43.25 110.971 -177.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 48.0 pttt -85.71 73.22 10.45 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 122.095 0.95 . . . . 74.23 110.62 -176.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 2.0 m -132.61 29.74 4.17 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 114.137 -1.392 . . . . 75.24 107.308 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -152.49 148.54 27.53 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-N 114.516 -1.22 . . . . 71.23 108.456 -170.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -59.68 111.56 1.48 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.5 0.72 . . . . 72.31 110.268 177.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . 133.6 20.48 0.88 Allowed Glycine 0 CA--C 1.532 1.147 0 CA-C-N 115.36 -0.836 . . . . 54.1 111.772 -172.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.66 134.42 40.59 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.686 0.794 . . . . 75.21 110.521 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -146.89 158.31 43.88 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.306 0.642 . . . . 71.11 110.44 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -131.65 116.24 1.86 Allowed Glycine 0 C--N 1.345 1.065 0 N-CA-C 110.403 -1.079 . . . . 30.15 110.403 174.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 48.5 t -105.4 133.53 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 117.536 0.668 . . . . 72.11 109.746 -177.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 . . . . . 0 C--O 1.254 1.318 0 N-CA-C 108.587 -0.894 . . . . 75.31 108.587 174.075 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.404 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.492 -0.558 . . . . 70.21 109.492 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.6 m -72.39 93.29 1.51 Allowed 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.536 0.734 . . . . 70.32 109.801 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -144.91 156.89 44.24 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 122.905 0.482 . . . . 74.01 110.292 -176.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -67.94 160.61 28.22 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.543 1.137 . . . . 74.35 112.122 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -152.77 155.18 36.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.699 0.799 . . . . 75.51 109.173 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -57.33 134.72 56.24 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.13 0.972 . . . . 74.24 110.886 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -109.11 79.95 1.27 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 122.746 1.26 . . . . 74.53 109.405 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -128.07 28.78 5.49 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 114.466 -1.243 . . . . 71.44 109.971 -175.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.451 ' N ' ' SD ' ' A' ' 9' ' ' MET . 1.0 OUTLIER -71.02 160.31 33.16 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.973 0.909 . . . . 74.23 110.995 -179.411 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.7 m -140.25 111.89 7.39 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.352 -1.351 . . . . 72.34 107.352 172.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -129.49 113.91 15.46 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.068 -1.086 . . . . 64.42 108.068 -178.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -134.08 118.44 17.74 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.016 -0.735 . . . . 65.35 109.016 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.471 HG21 ' HG2' ' C' ' 130' ' ' PRO . 43.4 mt -80.69 119.82 31.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 109.362 -0.607 . . . . 64.11 109.362 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -85.83 -38.78 17.76 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 123.607 0.567 . . . . 60.32 110.163 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.2 ttt180 -173.52 129.26 0.43 Allowed 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.599 -0.273 . . . . 65.21 110.365 -170.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.497 HD12 ' HG3' ' C' ' 130' ' ' PRO . 87.0 mt -119.79 134.02 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 108.235 -1.024 . . . . 53.2 108.235 173.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.435 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 36.8 p90 -162.27 168.1 22.87 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 124.036 0.835 . . . . 73.43 110.87 -170.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -89.78 119.49 30.21 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.665 -0.865 . . . . 62.31 108.665 172.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 32.8 mtpt -78.97 -26.33 43.44 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.736 -0.468 . . . . 74.24 109.736 172.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -159.08 146.31 17.31 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.292 1.037 . . . . 62.12 109.614 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.8 mt -135.85 146.36 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.092 1.357 . . . . 72.04 107.836 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.0 t -148.01 131.95 17.15 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 109.059 -0.719 . . . . 64.33 109.059 171.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 89.3 t80 -137.09 127.75 27.02 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 106.988 -1.486 . . . . 72.32 106.988 171.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -134.5 129.18 34.76 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.009 0.523 . . . . 74.41 109.856 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.93 75.21 79.84 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.479 -1.304 . . . . 73.43 107.479 173.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.49 -28.0 32.67 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.713 2.275 . . . . 54.34 112.377 -172.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -104.8 15.38 27.96 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 115.203 -0.908 . . . . 75.41 110.154 -177.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.563 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -43.85 -56.41 7.48 Favored Pre-proline 0 N--CA 1.494 1.763 0 N-CA-C 113.996 1.11 . . . . 71.21 113.996 -169.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 70.8 Cg_exo -54.98 -35.22 89.38 Favored 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 122.515 2.143 . . . . 71.04 113.607 176.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.409 ' HA ' ' NE2' ' A' ' 33' ' ' GLN . 1.9 m-70 -78.36 -42.47 30.36 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.508 0.723 . . . . 73.22 110.042 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.1 p -67.05 -27.57 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 114.593 -1.185 . . . . 74.42 111.951 -159.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -72.99 -29.33 62.96 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.952 -0.567 . . . . 74.11 110.767 -176.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.409 ' NE2' ' HA ' ' A' ' 30' ' ' HIS . 38.9 mt-30 -75.1 -24.29 58.08 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.239 1.016 . . . . 71.14 110.888 178.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -77.24 152.28 34.76 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.853 0.861 . . . . 35.34 110.707 -175.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -61.83 118.29 7.0 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.752 0.657 . . . . 54.33 109.623 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -83.82 85.06 7.35 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.679 0.752 . . . . 72.35 110.991 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -121.01 84.05 38.69 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 107.001 -1.481 . . . . 74.52 107.001 170.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.45 116.89 4.63 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.361 2.041 . . . . 62.45 111.982 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -96.38 101.79 13.48 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.319 -0.993 . . . . 75.31 108.319 174.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 t -97.39 108.1 21.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-N 114.818 -1.083 . . . . 70.14 110.796 -169.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -83.65 119.94 25.37 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.747 0.819 . . . . 72.5 109.035 170.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.6 tp -97.25 106.53 18.88 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.371 -0.974 . . . . 54.41 108.371 175.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.472 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.4 m-20 -107.92 148.52 29.53 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.373 1.069 . . . . 72.22 108.77 176.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.728 HD11 HG21 ' A' ' 131' ' ' VAL . 92.6 mt -137.68 154.91 49.62 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.306 0.642 . . . . 42.03 111.246 -175.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.606 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 6.8 m-20 -137.72 141.29 41.02 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.166 -1.379 . . . . 61.53 108.113 175.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.3 m -141.0 123.16 15.64 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.249 -0.649 . . . . 64.1 109.249 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.75 138.16 23.06 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.505 0.722 . . . . 64.33 109.511 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.8 m -90.57 165.77 13.57 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.078 0.551 . . . . 75.25 109.56 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.2 t -154.69 119.48 4.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.398 -0.964 . . . . 54.21 108.398 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -85.15 103.33 14.04 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.953 -1.129 . . . . 72.11 107.953 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 57' ' ' GLU . 83.4 mt -77.9 -40.1 40.97 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.12 0.568 . . . . 62.43 109.474 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.35 -178.41 6.96 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.0 -1.0 . . . . 71.01 109.731 178.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -61.7 115.85 4.31 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.475 -0.784 . . . . 73.12 109.358 172.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 72.05 -4.19 2.04 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 125.178 1.391 . . . . 74.44 113.427 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.1 t -100.94 104.59 16.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.477 -0.935 . . . . 75.33 108.477 175.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -115.18 123.31 48.56 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.622 -0.881 . . . . 72.14 108.622 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.466 ' HB2' HD11 ' A' ' 51' ' ' LEU . 32.4 tt0 -89.58 151.59 21.85 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 123.396 0.679 . . . . 54.3 109.313 166.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.457 HG11 ' HD3' ' A' ' 103' ' ' PRO . 83.2 t -130.03 138.03 55.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.983 -1.117 . . . . 64.32 107.983 168.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.1 t -114.3 132.51 63.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 CA-C-O 121.232 0.539 . . . . 60.11 109.749 174.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.546 HD21 HD22 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -113.68 110.3 19.98 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 106.313 -1.736 . . . . 72.01 106.313 174.326 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.606 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 16.8 ttp180 -101.31 107.07 18.33 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 107.878 -1.156 . . . . 73.22 107.878 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 36.1 t -93.67 123.61 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 108.585 -0.894 . . . . 64.22 108.585 176.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.472 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 22.1 m -114.7 111.88 21.97 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.212 -0.662 . . . . 72.32 109.212 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.528 HG21 HG21 ' A' ' 114' ' ' ILE . 81.7 t -103.02 120.9 53.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 124.539 1.135 . . . . 53.44 109.004 177.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.5 m -115.39 129.48 56.59 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.859 -0.793 . . . . 72.24 108.859 166.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.6 129.2 56.65 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.266 -1.383 . . . . 73.11 107.266 171.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.1 m -125.04 171.14 10.49 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.504 0.668 . . . . 73.13 109.936 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.7 mt -130.09 62.4 1.56 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 105.781 -1.933 . . . . 65.21 105.781 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.96 -103.52 2.01 Favored Glycine 0 C--N 1.338 0.648 0 CA-C-N 115.559 -0.746 . . . . 63.43 111.257 -173.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -91.16 -27.18 18.69 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.846 0.459 . . . . 71.52 111.708 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -97.44 123.84 41.42 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.802 0.441 . . . . 75.24 109.937 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 57.6 m -70.61 134.55 47.7 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 120.975 0.417 . . . . 71.55 110.391 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.581 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -79.26 -59.12 2.89 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.252 -0.885 . . . . 71.34 109.66 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -156.47 166.11 34.36 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.93 -1.032 . . . . 74.15 110.93 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.7 tp -135.46 114.11 11.81 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.366 1.066 . . . . 74.33 108.848 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.508 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 57.4 m -107.02 139.91 40.67 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.09 0.956 . . . . 70.11 108.917 174.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -149.95 117.81 6.26 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.592 -0.521 . . . . 72.11 109.592 175.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.5 t -127.59 114.5 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.835 0.854 . . . . 73.42 109.859 -175.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.604 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 10.4 mt-30 -86.77 81.18 8.27 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.548 -0.908 . . . . 64.4 108.548 174.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -76.57 95.94 4.02 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.59 -0.732 . . . . 74.12 109.407 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.85 146.48 16.38 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 111.351 -0.7 . . . . 64.1 111.351 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.29 134.05 6.49 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.104 -0.798 . . . . 51.13 111.104 -176.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.9 mt -81.24 125.57 39.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 108.777 -0.823 . . . . 71.43 108.777 173.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.812 ' HB3' HD11 ' A' ' 86' ' ' ILE . 82.0 m-85 -127.68 128.03 44.75 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.981 0.912 . . . . 74.15 109.202 -174.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 44.1 t -94.89 101.04 12.81 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.194 -1.039 . . . . 54.54 108.194 175.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.812 HD11 ' HB3' ' A' ' 84' ' ' PHE . 5.8 mm -113.5 153.52 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 122.4 0.28 . . . . 74.53 111.11 -171.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.06 167.5 12.51 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.546 1.139 . . . . 61.41 110.248 175.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.87 2.16 64.97 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-O 119.372 -0.682 . . . . 74.21 114.724 169.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.07 161.49 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 123.965 0.906 . . . . 74.01 110.554 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.475 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 18.1 tt0 -153.61 175.56 13.08 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 109.574 -0.528 . . . . 63.3 109.574 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.475 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 53.74 -121.23 17.22 Favored Glycine 0 C--N 1.349 1.299 0 O-C-N 124.099 0.874 . . . . 63.32 114.34 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.9 t -69.25 -30.35 68.45 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.028 0.931 . . . . 71.14 111.941 -176.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -74.42 -36.64 63.44 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.146 0.579 . . . . 62.42 110.459 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.411 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 4.9 tpt -65.26 -44.56 87.69 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.442 0.464 . . . . 74.52 110.405 175.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.62 -41.66 86.45 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.318 -0.855 . . . . 60.52 111.208 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.517 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 54.8 t-80 -78.58 -25.55 45.33 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.419 -0.809 . . . . 73.11 111.508 -177.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 44.0 t -69.95 -42.91 72.59 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.265 0.555 . . . . 75.44 109.962 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 88.0 mt -81.85 -40.97 21.68 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.846 -1.07 . . . . 74.51 111.732 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.32 3.16 81.91 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 116.035 -0.529 . . . . 71.11 114.284 -170.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.669 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -146.93 -58.76 0.28 Allowed 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.54 0.67 . . . . 64.24 112.007 -171.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -67.65 -45.29 75.73 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-N 116.006 -0.543 . . . . 73.44 111.049 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.406 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 88.3 m -63.45 -52.34 60.83 Favored Pre-proline 0 CA--C 1.566 1.573 0 N-CA-C 113.435 0.902 . . . . 63.13 113.435 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.457 ' HD3' HG11 ' A' ' 58' ' ' VAL . 44.3 Cg_endo -65.7 -20.6 59.35 Favored 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 122.051 1.834 . . . . 55.5 113.052 177.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -63.83 -43.69 95.45 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 120.99 0.424 . . . . 72.21 110.043 172.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' A' ' 102' ' ' CYS . 31.2 mm -61.74 -38.15 79.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 C-N-CA 124.405 1.082 . . . . 75.41 110.673 174.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 103' ' ' PRO . 78.0 mt -77.64 -22.46 50.66 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.079 0.952 . . . . 74.03 112.96 -173.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -70.3 -41.94 14.84 Favored Pre-proline 0 CA--C 1.557 1.245 0 N-CA-C 114.434 1.272 . . . . 74.24 114.434 -170.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -54.12 -39.39 86.07 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 121.902 1.734 . . . . 75.12 112.742 173.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -74.55 -40.81 61.45 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.748 0.819 . . . . 72.22 111.484 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.66 -49.01 74.91 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.974 0.509 . . . . 70.35 110.241 177.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.654 HH12 HD12 ' C' ' 105' ' ' ILE . 29.7 ttm180 -52.04 -48.88 64.36 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.719 1.262 . . . . 74.05 110.491 176.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -61.95 -50.51 71.82 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 124.204 0.94 . . . . 75.4 111.63 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.451 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 44.9 t -54.3 -44.75 72.24 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.361 1.038 . . . . 53.55 110.691 -179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.528 HG21 HG21 ' A' ' 64' ' ' VAL . 96.9 mt -63.05 -55.06 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 114.968 -1.014 . . . . 75.22 111.14 176.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 91.4 m -52.83 -43.44 66.0 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 124.12 0.968 . . . . 63.02 111.53 -175.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -68.0 -44.21 77.09 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.382 -1.281 . . . . 74.52 109.782 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 11.1 mtp -57.45 -42.45 82.51 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.887 0.875 . . . . 73.1 111.596 175.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 114' ' ' ILE . 72.3 t -59.72 -49.27 84.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 C-N-CA 124.4 1.08 . . . . 73.53 110.274 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -72.42 -27.66 62.48 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.855 -0.612 . . . . 71.24 111.775 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 50.3 mtt-85 -70.77 -31.43 68.21 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.363 0.665 . . . . 72.34 109.932 175.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.422 ' O ' HG22 ' A' ' 122' ' ' THR . . . -84.48 18.2 25.57 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.572 -0.74 . . . . 63.21 113.073 175.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 121' ' ' GLY . 2.5 t 59.61 11.57 2.44 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 126.952 2.101 . . . . 71.21 113.225 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -79.07 139.31 56.78 Favored Pre-proline 0 C--O 1.245 0.858 0 N-CA-C 108.271 -1.011 . . . . 55.3 108.271 174.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.555 ' HB3' ' H ' ' E' ' 132' ' ' SER . 91.6 Cg_exo -48.58 135.79 27.0 Favored 'Trans proline' 0 C--N 1.365 1.438 0 C-N-CA 123.249 2.633 . . . . 74.3 112.519 173.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -58.8 127.5 32.5 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 124.292 0.995 . . . . 70.44 111.988 -166.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.0 tp -110.22 134.61 52.06 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 123.974 0.91 . . . . 72.14 108.859 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.46 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 85.6 m-20 -129.02 122.22 29.58 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 108.823 -0.806 . . . . 44.2 108.823 178.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.2 mt -74.15 148.04 42.1 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.481 -0.562 . . . . 71.31 109.481 -176.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.686 ' HB2' ' HA ' ' E' ' 137' ' ' THR . . . -79.38 142.73 58.79 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 119.34 -0.362 . . . . 44.23 111.042 -179.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.507 ' HB3' ' OH ' ' C' ' 101' ' ' TYR . 53.3 Cg_exo -56.22 121.66 10.39 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 123.446 2.764 . . . . 73.45 113.774 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.728 HG21 HD11 ' A' ' 44' ' ' LEU . 57.7 t -102.35 121.03 52.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-N 115.485 -0.779 . . . . 74.14 109.265 176.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' C' ' 152' ' ' HIS . 46.5 t30 -91.15 81.31 5.57 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.618 -0.882 . . . . 74.11 108.618 176.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -59.29 -31.58 69.26 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-N 114.893 -1.049 . . . . 73.42 111.578 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.669 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 13.9 t70 -55.22 -47.84 74.75 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.966 0.906 . . . . 74.43 109.937 178.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.445 ' HB1' ' HB3' ' C' ' 153' ' ' GLN . . . -72.75 -42.43 64.05 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.384 -0.825 . . . . 73.4 111.694 178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.465 ' HA ' HD21 ' A' ' 139' ' ' ASN . 76.1 mt -65.22 -42.15 93.75 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.034 0.534 . . . . 70.51 112.323 -174.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.579 ' HE2' HD13 ' A' ' 141' ' ' LEU . 25.3 t80 -71.05 -33.49 70.33 Favored 'General case' 0 C--O 1.212 -0.915 0 N-CA-C 109.349 -0.611 . . . . 62.33 109.349 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.632 ' HG3' ' HB3' ' A' ' 144' ' ' GLN . 7.2 tpt -72.85 -36.68 67.49 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.552 0.341 . . . . 52.2 110.894 -173.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 17.1 p30 -75.29 -25.81 58.24 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 110.224 -0.287 . . . . 63.23 110.224 174.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -76.92 -32.87 57.69 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.18 0.592 . . . . 71.32 111.112 172.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.579 HD13 ' HE2' ' A' ' 137' ' ' PHE . 50.2 tp -62.33 -48.79 78.29 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.712 1.205 . . . . 70.11 111.168 -171.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -165.92 18.04 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.126 -0.943 . . . . 72.53 109.95 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 0.6 OUTLIER 54.49 83.8 0.07 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.017 0.927 . . . . 61.11 109.012 -167.065 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.632 ' HB3' ' HG3' ' A' ' 138' ' ' MET . 30.3 tp60 -128.16 124.61 37.26 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.726 -0.67 . . . . 71.5 109.257 -178.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -151.54 -178.1 6.49 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.338 1.055 . . . . 62.34 109.191 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 78.16 69.52 1.39 Allowed Glycine 0 C--N 1.341 0.837 0 N-CA-C 111.749 -0.54 . . . . 44.34 111.749 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.22 147.05 48.64 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.029 0.531 . . . . 70.13 111.065 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.01 89.88 1.53 Allowed Glycine 0 C--N 1.336 0.583 0 N-CA-C 109.721 -1.352 . . . . 54.33 109.721 170.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.5 m -72.81 76.95 1.14 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 121.703 0.763 . . . . 74.43 110.415 -176.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -165.27 40.27 0.07 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 106.983 -1.488 . . . . 65.4 106.983 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -76.7 131.02 38.55 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 115.032 -0.985 . . . . 70.53 109.863 -176.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -126.27 37.05 4.4 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 123.969 0.793 . . . . 74.23 109.317 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -65.8 103.27 0.87 Allowed 'General case' 0 C--N 1.351 0.653 0 N-CA-C 109.06 -0.719 . . . . 65.12 109.06 170.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -73.26 114.52 11.54 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 114.766 -1.106 . . . . 74.31 109.508 -178.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.324 0 CA-C-O 118.126 -0.94 . . . . 63.41 108.673 178.33 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 58.0 ttp . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 109.855 -0.424 . . . . 74.42 109.855 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 43.0 t -157.21 -84.19 0.05 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.812 0.845 . . . . 73.55 109.582 176.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -159.31 106.39 1.74 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.365 0.666 . . . . 64.51 109.545 177.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -144.99 152.54 40.32 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.55 0.74 . . . . 71.41 109.954 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . 0.7 ' H ' ' HB3' ' D' ' 147' ' ' GLU . 39.9 t30 -154.2 141.12 19.22 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.658 1.183 . . . . 64.43 109.244 -174.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -151.44 100.3 2.71 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.875 -1.158 . . . . 72.3 107.875 169.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 40.6 p -83.56 70.0 10.19 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 123.523 0.729 . . . . 74.01 110.408 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -75.59 104.14 6.01 Favored 'General case' 0 C--N 1.348 0.525 0 N-CA-C 107.226 -1.398 . . . . 73.14 107.226 169.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.606 ' HB3' HG23 ' B' ' 89' ' ' ILE . 21.4 ptm 54.71 -176.29 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.766 1.626 . . . . 70.41 113.225 -174.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 90.7 m -148.29 124.76 10.99 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.536 -1.283 . . . . 74.25 107.536 169.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -113.54 145.03 41.87 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.997 -0.742 . . . . 75.31 108.997 173.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.537 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -155.66 139.76 16.46 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.314 -0.624 . . . . 74.21 109.314 172.513 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.443 HD13 HD11 ' B' ' 16' ' ' ILE . 50.4 mt -82.07 132.25 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 108.022 -1.103 . . . . 65.24 108.022 168.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -100.61 -43.73 6.07 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.528 -0.545 . . . . 64.32 109.528 178.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.401 ' HE ' HG21 ' A' ' 122' ' ' THR . 55.0 ttt180 -173.27 134.22 0.53 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.473 -0.785 . . . . 75.32 108.907 -174.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.521 HG21 ' CD1' ' B' ' 109' ' ' TYR . 88.8 mt -121.1 148.37 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 108.596 -0.89 . . . . 74.33 108.596 177.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -162.39 142.87 9.99 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 112.857 0.688 . . . . 74.41 112.857 -175.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.3 m -73.15 117.14 14.52 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.686 -1.143 . . . . 64.45 108.445 167.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.466 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 42.3 mtpt -91.43 -33.76 15.11 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.076 0.551 . . . . 71.52 110.294 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.594 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 19.3 t70 -149.79 136.21 19.09 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.093 -0.503 . . . . 61.52 110.811 -167.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 43.9 mm -134.92 139.55 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.793 1.237 . . . . 74.31 108.033 174.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 47.0 t -144.21 115.1 7.81 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.256 -1.016 . . . . 74.22 108.256 177.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' B' ' 75' ' ' LEU . 77.9 t80 -126.4 130.47 50.79 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 107.715 -1.217 . . . . 64.12 107.715 171.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -140.24 120.69 14.08 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.863 0.865 . . . . 52.21 108.744 175.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.496 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -111.98 85.58 6.66 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 107.257 -1.386 . . . . 54.33 107.257 170.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.7 -26.57 53.16 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.799 2.333 . . . . 61.05 112.313 -173.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -108.5 5.24 25.02 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.469 -0.787 . . . . 64.23 111.078 -177.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.52 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -30.23 -67.18 0.15 Allowed Pre-proline 0 N--CA 1.498 1.959 0 C-N-CA 125.447 1.499 . . . . 51.03 114.868 -167.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 21.1 Cg_exo -61.95 -28.37 80.76 Favored 'Trans proline' 0 C--N 1.392 2.838 0 C-N-CA 122.043 1.828 . . . . 62.42 113.0 -170.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -94.03 -34.72 12.91 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.092 -0.958 . . . . 72.41 111.871 -172.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.682 HG22 HD12 ' B' ' 68' ' ' LEU . 9.9 p -72.19 -15.23 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 C-N-CA 122.659 0.383 . . . . 72.34 111.202 -176.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -68.36 -9.81 50.67 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.557 0.743 . . . . 61.13 112.573 177.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.503 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.2 pt20 -67.0 -20.47 65.88 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.036 0.534 . . . . 32.01 110.808 174.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.503 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 99.5 mttt -103.03 110.78 22.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.991 1.316 . . . . 72.34 110.116 -175.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -112.92 97.31 6.46 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.692 0.397 . . . . 74.12 110.529 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 35.1 p90 -167.49 -171.31 1.64 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.439 1.096 . . . . 54.44 108.943 170.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 13.0 pm0 -71.36 111.39 10.01 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.482 0.713 . . . . 75.31 110.416 176.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.521 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 15.2 Cg_endo -65.61 152.14 82.62 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 121.204 1.27 . . . . 75.5 110.452 177.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 32.0 tt0 -69.72 99.85 1.4 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 107.787 -1.19 . . . . 71.23 107.787 173.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.472 HG23 ' O ' ' B' ' 38' ' ' PRO . 31.7 t -101.73 142.04 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 O-C-N 123.655 0.597 . . . . 73.34 110.134 -171.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -126.91 107.67 10.3 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.519 1.128 . . . . 62.41 108.51 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 17.9 tp -87.25 125.57 34.28 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.39 -0.966 . . . . 65.23 108.39 172.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -137.45 111.39 8.3 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.842 -1.17 . . . . 74.41 107.842 -170.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mp -100.99 140.65 34.98 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.039 0.536 . . . . 70.33 109.737 -175.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -142.96 145.33 32.89 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.107 0.963 . . . . 74.1 109.846 -177.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 4.0 t -126.37 104.62 8.27 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.701 0.8 . . . . 63.54 109.177 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.76 113.91 23.23 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.341 -1.355 . . . . 62.22 107.341 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 30.9 p -146.51 164.7 31.69 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.583 0.353 . . . . 73.01 111.819 -167.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 55.0 p -151.39 142.94 23.59 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.201 0.601 . . . . 52.41 110.83 -177.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' F' ' 100' ' ' LEU . 62.1 tt0 -82.6 111.83 18.93 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 109.315 -0.624 . . . . 73.4 109.315 172.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 pp -121.64 21.81 10.75 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.336 -0.847 . . . . 72.13 109.851 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -168.04 148.37 4.95 Favored 'General case' 0 C--N 1.361 1.079 0 C-N-CA 123.401 0.68 . . . . 64.43 111.743 176.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.62 141.26 46.56 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 107.609 -1.256 . . . . 64.2 107.609 158.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.633 ' HB2' ' HB3' ' F' ' 93' ' ' PHE . 24.2 m-20 70.05 -2.49 2.05 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.692 1.197 . . . . 75.4 112.472 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.443 HG11 HG23 ' B' ' 83' ' ' ILE . 24.8 t -141.08 127.47 20.29 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 CA-C-N 118.755 0.707 . . . . 70.54 109.821 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.475 ' HD2' HG22 ' B' ' 58' ' ' VAL . 14.9 t80 -115.67 138.48 51.05 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 106.976 -1.49 . . . . 73.12 106.976 171.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -100.88 99.89 10.44 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 106.958 -1.497 . . . . 71.33 106.958 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.475 HG22 ' HD2' ' B' ' 56' ' ' TYR . 32.3 t -96.11 127.35 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.152 -0.931 . . . . 62.43 109.589 -173.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.414 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 17.5 t -114.9 112.44 40.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 109.149 -0.686 . . . . 74.15 109.149 175.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 63.4 tp -94.2 107.25 19.2 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 116.018 -0.537 . . . . 73.41 109.586 175.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -85.68 108.58 18.09 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.954 -0.758 . . . . 62.53 108.954 171.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 39.8 t -104.38 103.17 14.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 106.842 -1.54 . . . . 73.01 106.842 175.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 25.6 m -99.46 141.57 32.07 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.176 -0.92 . . . . 74.34 109.506 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.642 HG11 HD21 ' B' ' 126' ' ' LEU . 41.5 t -133.77 118.29 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.128 0.971 . . . . 75.11 109.425 175.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 40.5 m -105.3 139.65 39.62 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.162 -1.421 . . . . 72.41 107.162 172.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -146.06 141.02 27.19 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.537 0.608 . . . . 54.23 110.536 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.559 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 19.8 m -143.12 128.37 18.75 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 123.452 0.47 . . . . 73.24 112.018 -172.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.682 HD12 HG22 ' B' ' 31' ' ' VAL . 90.4 mt -95.1 117.74 30.72 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.673 0.789 . . . . 73.23 109.007 176.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.51 -110.59 3.09 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.948 -0.861 . . . . 44.14 110.948 -172.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -124.22 6.38 8.47 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.771 0.829 . . . . 74.55 109.698 177.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -113.75 148.34 36.66 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.039 0.536 . . . . 75.51 109.627 -175.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 27.7 m -66.1 120.75 13.73 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.787 0.435 . . . . 73.41 110.966 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.631 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -73.53 -63.8 1.12 Allowed 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.612 -1.255 . . . . 70.34 107.612 172.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . 0.402 ' HZ ' HD22 ' B' ' 126' ' ' LEU . 39.4 p90 -152.59 161.82 42.06 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 114.405 -1.271 . . . . 62.23 111.087 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 58.1 mt -123.26 112.34 17.52 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 105.328 -2.101 . . . . 50.42 105.328 171.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.525 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 47.5 t -120.43 139.94 52.11 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.612 -0.884 . . . . 71.43 108.612 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -157.09 135.47 11.31 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.273 -0.64 . . . . 55.25 109.273 -174.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 62.6 t -132.88 147.54 31.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.097 -0.956 . . . . 74.21 108.798 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.594 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 17.9 mt-30 -123.68 106.95 10.95 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.073 -1.084 . . . . 65.33 108.073 168.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.446 ' O ' HD13 ' B' ' 106' ' ' LEU . 8.2 tp-100 -97.03 104.39 16.4 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.356 -0.979 . . . . 73.13 108.356 176.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.466 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -94.77 167.57 27.05 Favored Glycine 0 C--N 1.338 0.649 0 O-C-N 123.543 0.527 . . . . 65.43 111.969 175.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.15 138.52 5.26 Favored Glycine 0 C--N 1.341 0.826 0 C-N-CA 121.156 -0.545 . . . . 70.42 114.053 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.443 HG23 HG11 ' B' ' 55' ' ' VAL . 70.3 mt -86.37 114.36 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 C-N-CA 124.862 1.265 . . . . 62.42 108.184 169.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -126.31 133.4 51.4 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.278 0.631 . . . . 74.54 110.514 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 58.3 m -89.39 106.06 18.2 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.573 0.749 . . . . 71.14 110.767 175.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.59 HG22 HD11 ' B' ' 89' ' ' ILE . 54.9 mt -116.95 104.74 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 125.274 1.43 . . . . 72.31 108.395 178.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.12 166.7 23.47 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.938 0.895 . . . . 54.4 110.648 -174.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.6 -53.17 2.7 Favored Glycine 0 N--CA 1.476 1.36 0 O-C-N 123.111 0.257 . . . . 53.13 112.635 177.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.606 HG23 ' HB3' ' B' ' 9' ' ' MET . 0.5 OUTLIER -62.5 166.38 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 124.283 1.033 . . . . 74.5 112.271 171.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -159.79 151.9 20.68 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.108 -0.951 . . . . 73.15 110.41 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.67 -127.7 9.02 Favored Glycine 0 C--N 1.354 1.562 0 CA-C-N 116.365 -0.379 . . . . 30.22 113.179 174.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.6 m -79.8 -39.31 31.12 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.995 0.903 . . . . 71.14 110.292 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -60.77 -34.38 74.39 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 113.217 -1.81 . . . . 74.53 111.731 -168.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.533 ' SD ' ' N ' ' B' ' 95' ' ' ALA . 2.1 ppp? -65.72 -46.09 80.22 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.091 -0.959 . . . . 72.2 111.822 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.533 ' N ' ' SD ' ' B' ' 94' ' ' MET . . . -79.44 -12.45 59.89 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.472 0.709 . . . . 63.11 112.724 -175.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -62.4 -34.74 77.33 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 110.18 -0.304 . . . . 64.24 110.18 167.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -68.67 -51.18 44.67 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.944 0.498 . . . . 34.03 111.049 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.511 ' HG ' ' HA ' ' B' ' 95' ' ' ALA . 4.2 pp -70.82 -27.81 64.15 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.636 0.375 . . . . 75.44 111.687 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.1 3.82 67.15 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-O 119.142 -0.81 . . . . 72.42 114.185 -174.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.95 -51.88 0.1 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 117.948 0.874 . . . . 74.51 112.257 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -71.52 -40.36 70.18 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.051 0.54 . . . . 72.13 111.263 -175.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.475 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 72.3 m -68.87 -48.51 29.42 Favored Pre-proline 0 CA--C 1.56 1.337 0 CA-C-O 118.544 -0.741 . . . . 74.22 111.493 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 89.1 Cg_exo -53.5 -32.72 64.47 Favored 'Trans proline' 0 C--N 1.399 3.189 0 C-N-CA 122.636 2.224 . . . . 74.11 113.627 169.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -61.94 -34.84 76.82 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.366 0.666 . . . . 74.35 111.47 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.439 HD13 HD11 ' B' ' 13' ' ' ILE . 72.4 mt -75.99 -41.45 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.765 0.826 . . . . 73.14 110.195 176.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.446 HD13 ' O ' ' B' ' 80' ' ' GLN . 78.2 mt -71.29 -25.0 62.25 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 114.718 -1.128 . . . . 75.2 111.207 -176.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -62.63 -52.14 67.2 Favored Pre-proline 0 CA--C 1.552 1.024 0 CA-C-O 117.363 -1.304 . . . . 73.2 113.2 -172.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -54.06 -40.26 82.18 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.266 1.977 . . . . 72.33 113.023 177.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.521 ' CD1' HG21 ' B' ' 16' ' ' ILE . 5.2 m-30 -65.92 -44.13 86.05 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.981 -1.009 . . . . 73.02 110.495 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.81 -37.16 73.22 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.889 0.876 . . . . 73.34 111.456 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.659 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 52.4 ttt-85 -65.73 -54.88 21.28 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.243 1.417 . . . . 71.24 110.815 -176.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -73.23 -18.06 61.28 Favored 'General case' 0 CA--C 1.551 0.982 0 O-C-N 123.898 0.749 . . . . 61.32 110.06 -177.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.47 ' O ' ' HG2' ' B' ' 117' ' ' MET . 15.6 t -72.8 -42.1 64.24 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 122.739 0.416 . . . . 73.44 109.93 172.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.525 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 75.3 mt -57.52 -54.32 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 123.637 0.775 . . . . 73.31 109.704 171.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.41 HG21 ' OG ' ' C' ' 119' ' ' SER . 21.3 m -59.43 -29.91 68.11 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 124.34 1.025 . . . . 72.23 111.517 -177.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.6 t -68.39 -47.83 66.32 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 123.004 0.522 . . . . 71.21 110.357 174.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.6 mmt -69.66 -30.14 67.76 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 122.83 0.452 . . . . 71.45 111.115 -176.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.406 HG23 ' O ' ' B' ' 114' ' ' ILE . 91.0 t -67.68 -41.87 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.194 0.998 . . . . 74.44 109.861 172.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.8 t -66.86 -29.72 69.7 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.206 -0.906 . . . . 73.42 111.058 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' B' ' 116' ' ' SER . 84.5 mtt-85 -72.11 -35.2 69.11 Favored 'General case' 0 C--O 1.217 -0.651 0 C-N-CA 123.116 0.566 . . . . 64.34 109.66 176.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.3 -9.85 81.41 Favored Glycine 0 C--N 1.354 1.562 0 O-C-N 123.531 0.519 . . . . 73.43 112.42 170.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.2 m 69.95 25.52 4.87 Favored 'General case' 0 CA--C 1.559 1.317 0 C-N-CA 125.444 1.497 . . . . 71.55 110.643 174.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -78.38 165.26 51.33 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 124.043 0.937 . . . . 75.13 111.764 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.04 163.77 4.04 Favored 'Trans proline' 0 C--N 1.392 2.851 0 C-N-CA 123.313 2.675 . . . . 75.14 113.673 174.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -64.83 113.59 3.91 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.128 -0.942 . . . . 71.04 112.175 -171.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.642 HD21 HG11 ' B' ' 64' ' ' VAL . 48.6 tp -112.57 88.63 2.87 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 115.829 -0.623 . . . . 74.44 109.774 177.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -93.92 110.13 21.82 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.763 -1.199 . . . . 70.35 107.763 169.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.659 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 74.1 mt -65.46 146.32 55.02 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.331 0.253 . . . . 71.33 111.047 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.74 144.94 98.9 Favored Pre-proline 0 CA--C 1.55 0.964 0 O-C-N 124.406 1.066 . . . . 65.05 112.387 -173.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -68.11 84.47 0.44 Allowed 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.919 2.413 . . . . 62.31 111.61 173.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 19.8 m -101.28 126.92 55.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-O 121.2 0.524 . . . . 73.54 109.976 -178.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . 0.408 HD22 ' HB2' ' B' ' 135' ' ' ALA . 54.4 t30 -87.0 104.99 16.84 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 108.04 -1.096 . . . . 73.53 108.04 172.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -53.61 -38.61 64.18 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.455 1.102 . . . . 74.51 110.225 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -61.83 -44.43 96.86 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.33 -1.305 . . . . 73.52 111.046 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.408 ' HB2' HD22 ' B' ' 132' ' ' ASN . . . -60.53 -39.57 88.33 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.645 0.778 . . . . 75.33 112.561 -173.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.63 -45.81 81.62 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.906 0.483 . . . . 74.13 110.392 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -79.6 -17.09 54.65 Favored 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 115.423 -0.808 . . . . 75.44 111.377 -176.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 57.7 ttm -63.91 -27.19 68.98 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.387 1.075 . . . . 73.23 111.7 -175.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -73.16 -22.52 60.49 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.24 0.616 . . . . 74.04 111.052 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . 0.458 ' HB2' ' CE2' ' F' ' 109' ' ' TYR . 46.6 t80 -67.21 -40.32 86.4 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.852 0.861 . . . . 72.51 109.827 175.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.423 HD12 ' HB3' ' B' ' 140' ' ' TYR . 4.6 mp -91.15 -5.67 54.68 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.113 -0.949 . . . . 63.33 110.855 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 70.66 169.3 0.31 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.189 1.395 . . . . 55.03 111.364 -177.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -70.2 115.86 9.89 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.832 -0.622 . . . . 74.45 109.51 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.28 -57.3 6.92 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.263 -0.643 . . . . 72.13 109.263 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . 63.08 -175.1 0.15 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.476 1.111 . . . . 64.02 112.04 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 155.69 -177.38 32.85 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 116.647 -0.251 . . . . 43.21 113.028 175.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -138.12 132.46 32.03 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.446 0.698 . . . . 71.22 110.338 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -138.81 49.54 0.83 Allowed Glycine 0 C--N 1.343 0.926 0 N-CA-C 110.646 -0.982 . . . . 63.24 110.646 176.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 22.0 p -76.23 170.26 16.65 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.764 0.826 . . . . 74.21 112.463 -175.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 63.31 -93.24 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.0 1.32 . . . . 61.4 111.324 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 40.21 83.47 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.797 1.239 . . . . 34.21 112.626 -167.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -76.66 127.34 32.59 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.026 -0.534 . . . . 73.25 110.606 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -165.83 126.63 1.83 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.78 1.232 . . . . 73.31 107.786 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -67.33 138.56 56.89 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.669 -0.493 . . . . 73.34 109.669 176.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 C-N-CA 123.833 0.853 . . . . 54.12 108.803 -176.404 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mpp? . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 108.758 -0.83 . . . . 74.51 108.758 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 37.1 p -170.26 35.8 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.986 0.914 . . . . 74.03 109.557 178.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -68.11 101.99 1.25 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.02 -0.991 . . . . 73.03 109.828 -174.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -75.93 114.79 14.96 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.101 -0.954 . . . . 60.14 109.607 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -148.41 1.64 0.62 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.419 0.526 . . . . 62.2 112.419 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . 0.639 ' HB2' HE21 ' C' ' 153' ' ' GLN . 94.5 m-20 -135.34 96.38 3.46 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.952 0.501 . . . . 74.54 110.221 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 39.7 p -120.39 101.13 7.58 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.979 -0.748 . . . . 35.42 108.979 170.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -126.92 156.16 41.92 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.992 -0.744 . . . . 73.31 108.992 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.544 ' HE2' HD13 ' C' ' 89' ' ' ILE . 53.2 ttm 64.43 112.23 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.522 1.529 . . . . 75.04 110.781 -172.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.564 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 28.4 m -89.88 76.09 7.16 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 107.441 -1.318 . . . . 73.12 107.441 166.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -88.52 117.55 27.54 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.1 -1.444 . . . . 73.43 107.1 174.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -140.49 114.8 9.26 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.891 -1.151 . . . . 73.31 107.891 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 37.6 mt -72.31 131.75 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.639 -0.875 . . . . 74.44 108.639 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -86.59 -49.47 7.52 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.352 -0.61 . . . . 71.15 109.352 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.577 HH21 ' HD2' ' D' ' 32' ' ' PHE . 0.0 OUTLIER -178.36 151.83 0.64 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.48 1.112 . . . . 71.34 109.104 173.213 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 pp -109.43 151.7 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 107.653 -1.24 . . . . 64.21 107.653 174.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.561 ' HE1' HG12 ' C' ' 83' ' ' ILE . 49.2 p90 -172.28 153.35 2.98 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.145 0.43 . . . . 64.53 111.245 -176.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.2 p -85.31 111.59 20.02 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.704 -0.68 . . . . 72.33 111.533 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.463 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 31.2 mmtp -65.52 -33.07 75.06 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.382 0.673 . . . . 74.55 110.733 170.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -151.79 146.28 25.6 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.7 -1.136 . . . . 71.21 109.756 -177.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.467 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 80.8 mt -142.84 139.81 27.79 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 106.37 -1.715 . . . . 73.14 106.37 171.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.4 t -154.27 147.53 24.85 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.452 0.644 . . . . 73.14 109.901 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -146.94 136.33 22.76 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 106.811 -1.551 . . . . 71.12 106.811 172.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -137.94 133.44 33.75 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.502 -0.925 . . . . 62.41 108.502 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.11 77.65 6.11 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 108.197 -1.038 . . . . 62.24 108.197 172.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.34 -27.8 28.05 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.761 2.308 . . . . 63.32 111.144 177.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -99.08 14.33 29.66 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.773 -1.103 . . . . 73.54 111.052 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.463 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -45.59 -55.39 12.41 Favored Pre-proline 0 N--CA 1.49 1.525 0 C-N-CA 124.429 1.092 . . . . 75.35 113.11 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 32.4 Cg_exo -59.55 -46.47 20.62 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.062 1.842 . . . . 73.43 112.316 -177.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -69.71 -32.51 71.13 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.567 -1.197 . . . . 73.24 112.534 -174.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.642 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.1 p -79.5 -29.27 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.029 0 N-CA-C 111.991 0.367 . . . . 75.24 111.991 -176.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -63.75 -32.28 73.73 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.704 0.401 . . . . 74.3 111.838 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -88.62 17.3 5.58 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.211 0.604 . . . . 72.44 111.621 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.408 ' HG2' HD13 ' C' ' 68' ' ' LEU . 2.4 ttpm? -120.33 152.06 38.37 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.076 0.951 . . . . 74.34 110.552 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -59.27 129.46 42.16 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.368 1.067 . . . . 65.31 111.361 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.4 ' HD1' ' HB2' ' F' ' 132' ' ' SER . 76.4 t-105 -85.49 85.7 7.41 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.973 0.909 . . . . 72.33 110.749 -177.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -131.53 78.36 71.47 Favored Pre-proline 0 N--CA 1.479 1.008 0 N-CA-C 107.118 -1.438 . . . . 63.5 107.118 171.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -93.44 143.4 2.0 Allowed 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.538 2.158 . . . . 75.4 113.312 -175.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -85.5 98.21 10.48 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 106.686 -1.598 . . . . 74.45 106.686 159.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 94.7 t -76.48 99.52 2.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.14 -1.059 . . . . 75.32 108.14 174.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -90.8 100.72 13.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.148 -1.797 . . . . 71.32 106.148 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.585 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.5 pt? -97.44 162.0 13.52 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 115.626 -0.716 . . . . 74.52 109.587 -174.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.82 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 25.6 m-20 -142.32 146.26 34.83 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.744 0.818 . . . . 74.5 110.055 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.527 HD11 HG11 ' C' ' 131' ' ' VAL . 95.1 mt -134.53 111.12 9.83 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.771 0.828 . . . . 74.04 108.949 174.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.401 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 5.7 t70 -116.43 142.87 46.29 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.27 1.428 . . . . 73.24 107.277 173.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.6 t -152.69 152.67 31.99 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.752 -0.462 . . . . 74.13 109.752 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.82 157.63 38.19 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.466 0.706 . . . . 63.52 109.988 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 6.2 m -130.01 144.59 51.41 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.134 0.574 . . . . 61.14 109.629 176.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 37.8 p -145.29 127.48 15.71 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.672 0.789 . . . . 53.53 109.438 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -75.99 120.65 21.61 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.475 0.71 . . . . 74.03 110.51 -177.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.577 HD11 ' HB2' ' C' ' 57' ' ' GLU . 40.6 mt -91.42 -31.06 16.16 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.427 0.691 . . . . 44.33 110.661 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.55 -177.41 5.92 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.778 0.831 . . . . 72.22 110.375 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -65.24 119.71 11.41 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.769 -0.65 . . . . 73.23 110.116 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 65.94 11.56 7.79 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.902 1.281 . . . . 73.13 112.126 -175.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.3 t -116.23 111.59 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.051 -0.722 . . . . 61.14 109.051 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -123.0 124.2 42.6 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.965 -1.124 . . . . 74.42 107.965 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.577 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.1 tt0 -85.78 137.96 32.42 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.773 -0.825 . . . . 74.31 108.773 170.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.66 138.43 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 108.27 -1.011 . . . . 54.21 108.27 170.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 44.9 t -127.07 133.74 67.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 109.283 -0.636 . . . . 74.43 109.283 174.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.486 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -117.56 105.24 11.86 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.669 -1.234 . . . . 70.43 107.669 -177.886 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.401 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 16.9 ttm-85 -81.62 108.36 15.12 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 123.599 0.76 . . . . 75.11 109.505 171.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 44.0 t -104.78 119.06 53.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 108.015 -1.106 . . . . 74.13 108.015 171.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.82 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 79.2 m -114.66 145.41 42.05 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.056 0.942 . . . . 71.41 108.95 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 35.7 t -135.45 112.43 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 124.69 1.196 . . . . 73.14 108.314 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.7 m -101.77 122.66 44.37 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.309 -0.997 . . . . 72.15 108.309 168.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.6 119.24 38.93 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.148 -1.427 . . . . 74.01 107.148 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 32.2 m -141.25 129.01 21.64 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.109 0.255 . . . . 74.13 110.343 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.408 HD13 ' HG2' ' C' ' 34' ' ' LYS . 23.0 mt -86.56 44.08 1.12 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.506 1.122 . . . . 73.42 109.914 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.95 -104.96 2.54 Favored Glycine 0 C--N 1.344 1.019 0 N-CA-C 110.275 -1.13 . . . . 74.12 110.275 -172.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -90.85 -31.52 16.42 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.57 0.748 . . . . 72.22 109.438 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -65.91 121.56 15.35 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.71 1.204 . . . . 54.43 110.478 174.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 52.2 m -83.87 120.27 25.87 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.973 -0.751 . . . . 45.44 108.973 167.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.642 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -71.94 -55.07 8.12 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 123.945 0.778 . . . . 54.04 108.944 174.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -162.03 162.5 28.86 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 115.446 -0.797 . . . . 74.13 110.316 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.434 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.9 tm? -114.33 142.65 46.04 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 106.491 -1.67 . . . . 65.04 106.491 163.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.434 ' N ' HD13 ' C' ' 75' ' ' LEU . 46.1 t -145.06 143.49 30.46 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.29 -1.004 . . . . 34.53 108.29 175.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -156.98 130.01 7.8 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.465 -0.569 . . . . 74.13 109.465 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 86.0 t -130.96 122.19 51.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.504 -0.924 . . . . 61.55 108.504 175.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -99.05 88.46 3.97 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.839 -1.171 . . . . 75.25 107.839 177.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -79.36 100.17 7.48 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.972 -1.013 . . . . 74.15 109.633 -175.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -82.09 174.55 53.7 Favored Glycine 0 C--O 1.237 0.316 0 CA-C-N 115.923 -0.58 . . . . 52.22 112.301 174.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.79 126.67 1.17 Allowed Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 111.786 -0.526 . . . . 72.24 111.786 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.561 HG12 ' HE1' ' C' ' 17' ' ' TYR . 31.7 mm -87.13 126.45 40.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.241 -1.022 . . . . 75.24 108.241 174.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -127.93 118.56 23.83 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.534 0.734 . . . . 63.24 109.431 -177.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 28.5 p -84.67 102.11 12.69 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.588 -0.893 . . . . 74.21 108.588 169.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 29.6 mt -115.43 118.59 59.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.692 1.197 . . . . 54.14 109.702 -175.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.564 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -124.96 170.1 11.44 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.712 0.805 . . . . 74.35 109.898 174.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.98 -39.64 2.68 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-N 116.432 -0.349 . . . . 65.53 113.616 171.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.544 HD13 ' HE2' ' C' ' 9' ' ' MET . 39.8 pt -103.93 165.33 3.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 123.283 0.633 . . . . 70.2 111.574 -171.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -159.92 154.35 23.84 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.254 -0.884 . . . . 74.22 109.195 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.2 -120.41 17.94 Favored Glycine 0 C--N 1.346 1.084 0 O-C-N 123.534 0.521 . . . . 63.25 113.579 174.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 35.1 p -61.6 -40.63 95.49 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.574 0.75 . . . . 72.2 111.831 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -63.49 -49.58 73.04 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.837 0.455 . . . . 75.41 110.908 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 6.2 tpt -52.36 -54.06 36.66 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 124.239 0.962 . . . . 65.43 111.909 174.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.63 -42.33 96.68 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.292 0.567 . . . . 73.13 111.639 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -65.4 -31.77 73.05 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.729 1.211 . . . . 61.44 111.037 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 48.7 t -76.63 -27.67 55.78 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 115.286 -0.87 . . . . 61.31 110.864 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 94.3 mt -94.53 -32.14 13.6 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.672 0.789 . . . . 72.13 112.975 -172.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.03 -8.0 37.19 Favored Glycine 0 N--CA 1.473 1.123 0 CA-C-O 119.963 -0.354 . . . . 41.32 113.7 -173.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.23 -54.42 1.11 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.853 0.461 . . . . 70.34 110.874 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.507 ' OH ' ' HB3' ' A' ' 130' ' ' PRO . 52.2 t80 -73.4 -49.84 24.98 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.898 -0.592 . . . . 64.22 112.0 -170.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.401 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 68.0 m -63.23 -47.74 84.44 Favored Pre-proline 0 CA--C 1.557 1.228 0 CA-C-O 118.64 -0.695 . . . . 74.43 111.55 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.486 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 78.1 Cg_exo -56.43 -31.8 86.89 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.453 2.102 . . . . 72.05 113.594 170.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -68.02 -32.48 72.89 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.971 0.508 . . . . 74.21 110.726 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.654 HD12 HH12 ' A' ' 111' ' ' ARG . 10.0 mm -72.62 -41.68 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 109.509 -0.552 . . . . 65.44 109.509 174.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 85.0 mt -74.48 -23.62 58.9 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.899 0.88 . . . . 73.23 112.238 -175.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . 0.401 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 53.7 t80 -59.77 -53.43 65.62 Favored Pre-proline 0 N--CA 1.48 1.027 0 CA-C-O 117.431 -1.271 . . . . 62.14 113.445 -174.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . 0.401 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 51.1 Cg_exo -56.29 -36.59 97.13 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 121.84 1.693 . . . . 74.2 113.155 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -67.4 -47.53 70.03 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.27 0.628 . . . . 74.34 111.271 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.2 -38.93 88.33 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.176 0.99 . . . . 71.41 110.601 177.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -64.72 -47.26 78.93 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.165 1.386 . . . . 73.04 110.178 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -67.48 -34.03 76.32 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 123.861 0.726 . . . . 54.51 110.062 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.6 t -72.11 -34.58 68.72 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.933 0.493 . . . . 71.31 111.052 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.413 HG23 ' SG ' ' C' ' 76' ' ' CYS . 65.2 mt -73.91 -50.36 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 122.856 0.462 . . . . 62.25 110.34 176.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.1 m -65.71 -28.43 69.06 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.101 0.56 . . . . 64.54 110.872 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 29.3 t -62.85 -49.18 75.89 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 108.951 -0.759 . . . . 72.3 108.951 169.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.528 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.64 -36.47 78.72 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.322 1.049 . . . . 74.14 112.629 179.04 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.4 HG23 ' O ' ' C' ' 114' ' ' ILE . 92.3 t -62.65 -49.25 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.544 0.737 . . . . 63.11 109.603 175.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.41 ' OG ' HG21 ' B' ' 115' ' ' THR . 29.2 t -65.44 -32.91 74.78 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.978 -1.01 . . . . 72.13 111.552 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.492 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 76.5 mtt-85 -67.18 -37.6 83.97 Favored 'General case' 0 C--O 1.214 -0.8 0 C-N-CA 123.448 0.699 . . . . 71.33 109.465 176.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.84 8.15 70.98 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.31 -0.717 . . . . 72.32 113.249 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.409 HG23 ' HB3' ' D' ' 17' ' ' TYR . 81.0 p 55.6 33.66 21.62 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.05 1.74 . . . . 73.51 113.124 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -93.28 145.7 30.52 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 108.431 -0.951 . . . . 74.5 108.431 171.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -51.32 148.58 18.77 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 123.72 2.946 . . . . 62.24 114.249 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 57.3 mm-40 -55.43 112.47 1.12 Allowed 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.274 0.984 . . . . 60.11 112.261 -176.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.535 HD12 HG23 ' F' ' 133' ' ' THR . 53.8 tp -110.49 86.87 2.39 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.481 -1.236 . . . . 73.02 107.805 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -91.6 101.62 14.25 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.555 -0.906 . . . . 74.33 108.555 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.9 127.84 33.35 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 123.898 0.879 . . . . 75.21 110.393 -174.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.72 151.48 94.71 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 123.916 0.886 . . . . 34.33 111.811 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.497 ' HG3' HD12 ' A' ' 16' ' ' ILE . 51.6 Cg_exo -52.95 107.93 0.23 Allowed 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 123.017 2.478 . . . . 63.24 112.995 175.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.527 HG11 HD11 ' C' ' 44' ' ' LEU . 6.3 p -101.56 124.25 55.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 109.254 -0.647 . . . . 65.43 109.254 175.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -85.54 104.65 15.5 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.176 0.59 . . . . 63.35 109.686 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -66.05 -22.41 66.43 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.948 -0.569 . . . . 71.14 111.493 176.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -71.18 -36.57 72.02 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.566 0.541 . . . . 71.42 109.802 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.71 -43.35 99.02 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.441 -0.8 . . . . 71.33 110.22 172.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.439 ' HA ' ' HB3' ' C' ' 139' ' ' ASN . 73.5 mt -71.3 -25.74 62.56 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.855 0.862 . . . . 63.32 111.537 178.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -75.09 -41.88 57.82 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.313 0.645 . . . . 73.43 110.01 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 73.5 mtm -69.1 -32.7 72.3 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.599 -0.728 . . . . 72.43 109.888 172.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' C' ' 136' ' ' LEU . 8.0 t30 -64.02 -34.47 78.09 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.035 1.334 . . . . 70.2 113.511 -175.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . 0.53 ' HD1' ' N ' ' C' ' 141' ' ' LEU . 0.8 OUTLIER -67.15 -151.22 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 118.661 0.664 . . . . 73.54 111.463 -176.082 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.53 ' N ' ' HD1' ' C' ' 140' ' ' TYR . 3.8 pp -67.04 13.8 0.06 Allowed 'General case' 0 CA--C 1.573 1.847 0 O-C-N 120.186 -1.571 . . . . 75.4 113.829 175.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -78.47 125.8 29.87 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.318 1.047 . . . . 71.33 109.693 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -114.89 71.42 0.76 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.797 0.839 . . . . 71.24 111.244 -175.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . 0.429 ' HB3' ' H ' ' C' ' 145' ' ' ALA . 0.9 OUTLIER -172.3 -101.56 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 107.972 -1.121 . . . . 70.42 107.972 170.031 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . 0.429 ' H ' ' HB3' ' C' ' 144' ' ' GLN . . . 173.57 -178.76 0.09 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.739 1.615 . . . . 62.42 108.608 -176.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -164.24 -82.86 0.05 OUTLIER Glycine 0 C--N 1.338 0.652 0 N-CA-C 109.916 -1.274 . . . . 63.34 109.916 177.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 61.29 -81.5 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 125.286 1.434 . . . . 73.12 111.824 174.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -115.49 109.11 2.0 Allowed Glycine 0 C--N 1.351 1.408 0 N-CA-C 111.667 -0.573 . . . . 74.15 111.667 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 3.3 t -159.38 100.4 1.5 Allowed 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.778 0.831 . . . . 71.43 109.412 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -176.27 135.84 0.27 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.304 1.041 . . . . 74.45 109.52 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -133.93 22.57 3.86 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.66 0.784 . . . . 73.24 112.184 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . 0.419 ' O ' ' HB3' ' A' ' 132' ' ' ASN . 20.9 t60 -66.1 98.85 0.47 Allowed 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 122.935 0.494 . . . . 73.14 110.015 175.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . 0.639 HE21 ' HB2' ' C' ' 6' ' ' ASN . 19.5 pt20 -132.3 73.69 1.54 Allowed 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.596 0.713 . . . . 74.33 112.643 -174.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.39 120.33 42.09 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.46 0.704 . . . . 55.05 109.247 169.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.327 0 C-N-CA 124.568 1.147 . . . . 61.01 109.588 -177.466 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.949 0.404 . . . . 62.44 110.136 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 29.7 t -146.13 -160.64 1.18 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 107.685 -1.228 . . . . 63.11 107.685 177.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . 0.662 ' HG2' ' HA3' ' D' ' 91' ' ' GLY . 34.4 mt-10 66.14 25.62 10.71 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.941 0.896 . . . . 73.34 111.712 170.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -139.81 151.23 45.57 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.764 1.226 . . . . 53.45 108.81 -174.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 59.72 93.15 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.465 1.106 . . . . 70.54 111.375 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . 0.532 HD22 ' HA ' ' D' ' 89' ' ' ILE . 23.6 m120 -115.69 108.25 16.14 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.008 -0.738 . . . . 75.11 109.008 178.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 29.8 m -58.47 159.18 6.61 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.455 1.102 . . . . 71.32 110.238 172.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -49.85 92.67 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.651 0.781 . . . . 72.35 110.454 175.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.447 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 0.0 OUTLIER -34.18 121.11 0.46 Allowed 'General case' 0 C--N 1.359 0.982 0 C-N-CA 125.852 1.661 . . . . 71.43 112.101 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 5.6 t -108.14 145.01 34.76 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 123.342 0.657 . . . . 71.32 109.5 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.415 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 54.8 t80 -152.88 103.25 2.74 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.734 -1.21 . . . . 73.02 107.734 -175.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -112.68 128.67 56.46 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.252 -1.018 . . . . 75.53 108.252 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 12.8 mt -94.24 134.97 29.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.173 -1.047 . . . . 64.11 108.173 175.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -106.34 -33.45 7.76 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 122.779 0.431 . . . . 75.31 111.629 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -169.32 127.0 0.95 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 120.592 0.234 . . . . 61.02 111.594 -166.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.22 134.46 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 107.67 -1.233 . . . . 72.11 107.67 168.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' C' ' 120' ' ' ARG . 39.4 p90 -163.73 150.39 11.88 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-O 121.821 0.82 . . . . 72.53 111.873 175.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . 0.4 HG21 HD11 ' D' ' 21' ' ' ILE . 81.4 p -85.89 126.3 33.96 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.684 -1.144 . . . . 63.41 109.199 176.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -99.37 -14.22 19.27 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.349 -0.611 . . . . 73.5 109.349 175.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.675 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.2 t70 -160.02 136.87 9.2 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.309 1.044 . . . . 63.34 109.032 176.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.528 HG21 ' HE2' ' C' ' 117' ' ' MET . 65.7 mt -137.67 144.66 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.626 1.17 . . . . 73.33 108.121 174.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.1 t -146.62 139.28 25.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.185 0.994 . . . . 72.44 108.955 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.467 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 77.5 t80 -150.31 123.24 8.73 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.753 -1.573 . . . . 60.25 106.753 167.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -127.38 129.67 48.0 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.15 -0.685 . . . . 75.11 109.15 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.441 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -118.1 79.49 14.32 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 107.57 -1.27 . . . . 44.23 107.57 169.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.75 -35.06 13.38 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.375 2.05 . . . . 74.44 112.151 -171.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -104.99 6.51 33.52 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.101 0.96 . . . . 64.02 110.515 -174.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.496 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -23.65 -77.75 0.02 OUTLIER Pre-proline 0 CA--C 1.567 1.613 0 N-CA-C 117.428 2.381 . . . . 51.45 117.428 -169.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.463 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 87.1 Cg_endo -75.29 -17.48 18.9 Favored 'Trans proline' 0 C--N 1.388 2.652 0 CA-C-N 124.643 2.694 . . . . 73.41 113.224 -170.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.474 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 6.4 t-160 -70.88 -43.71 67.84 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.949 -0.76 . . . . 63.23 108.949 172.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.496 HG12 ' O ' ' D' ' 28' ' ' ALA . 4.8 p -83.88 -19.62 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.13 0 CA-C-N 115.748 -0.66 . . . . 73.44 111.517 -170.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.577 ' HD2' HH21 ' C' ' 15' ' ' ARG . 22.7 m-85 -67.4 -20.72 65.57 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 120.914 0.388 . . . . 62.41 111.416 177.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.474 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 58.8 mt-30 -64.31 -18.33 64.51 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.103 0.961 . . . . 64.23 111.083 174.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -92.19 81.54 5.01 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.747 1.219 . . . . 72.25 108.784 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -83.43 79.7 9.33 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 122.074 0.94 . . . . 75.1 111.062 -174.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -152.93 -174.91 5.1 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.092 -0.958 . . . . 65.14 109.041 169.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -77.21 114.59 41.52 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 123.516 0.726 . . . . 63.34 110.43 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -53.94 119.98 7.17 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 122.53 2.154 . . . . 61.31 110.764 172.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -67.2 108.83 2.84 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.76 -1.2 . . . . 74.0 107.76 176.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.749 HG13 HG13 ' D' ' 64' ' ' VAL . 93.9 t -100.88 132.51 46.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 CA-C-N 115.419 -0.809 . . . . 73.5 109.823 -171.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -115.24 118.94 34.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.569 -1.271 . . . . 73.21 107.569 173.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.621 HD11 HG13 ' D' ' 62' ' ' VAL . 37.9 tp -97.39 137.58 36.16 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.27 0.557 . . . . 64.34 110.131 -178.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.42 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 6.5 m-20 -133.66 122.19 23.08 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.028 1.331 . . . . 60.03 108.083 -175.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.416 ' CD2' HG22 ' D' ' 62' ' ' VAL . 89.1 mt -119.8 144.58 47.24 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.814 0.445 . . . . 74.42 110.759 -176.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.48 ' HB2' ' HB3' ' D' ' 61' ' ' ARG . 11.7 m-20 -142.13 134.61 28.05 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.218 1.007 . . . . 72.21 109.061 176.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . 0.451 HG21 ' HA2' ' D' ' 99' ' ' GLY . 59.1 m -104.15 139.05 39.76 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.154 -1.054 . . . . 64.1 108.154 168.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.42 141.05 21.72 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.585 -1.265 . . . . 50.21 107.585 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 30.8 p -158.98 151.48 21.6 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 109.806 -0.442 . . . . 75.53 109.806 -175.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.403 ' O ' ' HG2' ' D' ' 50' ' ' GLN . 65.4 p -160.51 116.47 2.32 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 123.63 0.581 . . . . 55.45 110.791 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . 0.412 ' HB2' ' HA ' ' D' ' 56' ' ' TYR . 50.9 mm-40 -166.6 129.29 1.86 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 126.289 1.836 . . . . 72.34 106.809 175.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 40.9 tp -79.3 97.17 6.18 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 117.92 0.327 . . . . 71.1 110.583 -178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . 54.58 -151.36 0.37 Allowed 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 124.735 1.214 . . . . 72.41 112.609 171.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 19.9 t70 73.62 -0.64 3.3 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 124.919 1.288 . . . . 63.52 112.345 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' D' ' 85' ' ' SER . 80.9 m-20 64.66 26.32 13.15 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.681 1.192 . . . . 71.54 113.396 176.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 9.0 m -129.64 110.2 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.402 -0.962 . . . . 74.23 108.402 169.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.412 ' HA ' ' HB2' ' D' ' 50' ' ' GLN . 46.5 m-85 -126.88 132.58 50.89 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 109.31 -0.626 . . . . 73.2 109.31 -175.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -87.28 112.43 22.04 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.594 -0.891 . . . . 61.15 108.594 175.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.581 HG11 ' HD3' ' D' ' 103' ' ' PRO . 84.8 t -101.13 116.9 45.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.322 -0.992 . . . . 70.0 108.322 176.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.479 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 26.3 t -102.71 129.36 54.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 108.777 -0.823 . . . . 61.35 108.777 176.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' D' ' 79' ' ' GLN . 0.1 OUTLIER -110.31 122.78 48.48 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.41 -0.959 . . . . 74.43 108.41 -178.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.48 ' HB3' ' HB2' ' D' ' 45' ' ' ASP . 49.3 ttp180 -98.53 101.47 12.91 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.996 -0.742 . . . . 75.35 108.996 173.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.621 HG13 HD11 ' D' ' 42' ' ' LEU . 61.9 t -98.24 113.64 33.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 CA-C-N 114.898 -1.046 . . . . 62.23 108.678 173.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.42 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 11.0 m -122.44 124.22 43.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.356 -0.838 . . . . 73.21 109.706 -172.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.749 HG13 HG13 ' D' ' 40' ' ' VAL . 39.9 t -109.15 123.24 64.88 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 C-N-CA 125.409 1.484 . . . . 62.03 108.774 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 20.4 m -113.52 101.27 9.19 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.902 -1.147 . . . . 62.31 107.902 169.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.47 142.95 41.53 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.636 -0.711 . . . . 75.22 109.105 -173.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.473 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 17.1 p -149.72 134.0 17.32 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.746 0.647 . . . . 73.1 112.746 -171.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.449 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 34.3 mt -109.06 112.01 23.96 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.797 1.239 . . . . 50.45 107.733 173.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.5 -140.41 22.7 Favored Glycine 0 C--N 1.344 1.004 0 O-C-N 123.286 0.367 . . . . 43.33 112.545 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.29 6.64 42.11 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.348 0.659 . . . . 63.01 111.799 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -132.35 173.99 10.71 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.885 0.474 . . . . 72.5 110.611 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 31.2 m -73.6 140.03 45.94 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.452 -0.794 . . . . 71.41 111.775 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.473 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.25 -67.19 0.84 Allowed 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.404 -1.332 . . . . 75.51 107.404 169.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -148.41 148.75 30.68 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.52 -1.218 . . . . 72.53 110.26 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 78.6 mt -103.41 150.38 23.89 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.73 1.212 . . . . 70.31 108.197 169.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.539 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.9 t -158.12 140.58 14.45 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.359 -0.608 . . . . 73.33 109.359 176.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -155.54 127.62 7.61 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.106 0.562 . . . . 61.42 109.698 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.93 114.97 34.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 123.126 0.57 . . . . 62.04 109.553 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.675 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.0 mt-30 -90.71 85.67 6.13 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.872 0.844 . . . . 72.34 109.394 171.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -81.18 101.44 9.67 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 113.818 -1.537 . . . . 74.4 109.726 -177.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.42 143.89 17.56 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 112.273 -0.331 . . . . 72.31 112.273 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.65 134.0 6.57 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 111.855 -0.498 . . . . 74.04 111.855 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 61.6 mt -89.23 103.17 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 107.925 -1.139 . . . . 72.24 107.925 175.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -108.78 144.11 37.05 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.807 0.843 . . . . 73.22 110.641 -177.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' D' ' 54' ' ' ASP . 16.4 p -116.46 137.34 52.24 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.679 0.792 . . . . 55.44 110.097 171.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.449 HG12 HD11 ' D' ' 89' ' ' ILE . 6.3 tt -145.24 138.68 21.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.394 0.678 . . . . 60.15 110.81 -163.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.441 ' HA ' ' CG2' ' E' ' 97' ' ' ILE . . . -168.26 170.76 9.83 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.425 0.69 . . . . 61.43 111.645 175.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 93.61 7.58 61.56 Favored Glycine 0 C--N 1.348 1.22 0 CA-C-N 115.748 -0.66 . . . . 45.51 112.793 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.532 ' HA ' HD22 ' D' ' 6' ' ' ASN . 1.4 pp -140.1 149.96 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.542 1.137 . . . . 45.43 110.225 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.9 173.26 17.26 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.746 0.819 . . . . 72.32 110.456 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . 0.662 ' HA3' ' HG2' ' D' ' 3' ' ' GLU . . . 79.86 -118.26 4.68 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 114.781 0.673 . . . . 64.41 114.781 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 54.2 p -90.08 -44.67 9.66 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.384 0.674 . . . . 63.13 111.388 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.462 ' NE2' HG22 ' D' ' 89' ' ' ILE . 12.8 pt20 -66.86 -23.61 66.04 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 113.177 0.806 . . . . 71.44 113.177 -172.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.409 ' HE3' HG13 ' E' ' 97' ' ' ILE . 21.7 ptm -56.72 -51.31 69.33 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 113.851 1.056 . . . . 73.41 113.851 -174.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.9 -12.85 59.71 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.577 0.751 . . . . 65.34 112.411 -168.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -61.8 -37.62 85.05 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.942 0.497 . . . . 74.25 110.53 171.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 61.8 m -66.72 -25.48 66.54 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.876 -0.602 . . . . 72.03 111.943 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.444 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 89.6 mt -92.84 -39.34 11.25 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.815 0.846 . . . . 73.05 111.281 176.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . 0.451 ' HA2' HG21 ' D' ' 46' ' ' THR . . . -90.53 -1.85 73.9 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.622 -0.717 . . . . 44.3 113.54 -171.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.23 -49.64 0.13 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.157 0.429 . . . . 72.34 112.157 -173.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -73.63 -42.99 60.73 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 118.168 0.44 . . . . 72.55 111.958 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 89.8 m -60.27 -48.83 93.07 Favored Pre-proline 0 CA--C 1.562 1.425 0 CA-C-O 118.964 -0.541 . . . . 75.44 112.091 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.581 ' HD3' HG11 ' D' ' 58' ' ' VAL . 37.6 Cg_endo -65.54 -24.88 55.7 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 121.924 1.749 . . . . 63.33 112.835 173.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -67.98 -31.13 70.63 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.561 0.344 . . . . 65.21 110.262 174.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 37.5 mm -73.02 -38.92 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.025 0.93 . . . . 73.03 110.829 173.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' D' ' 103' ' ' PRO . 71.6 mt -69.76 -26.92 64.53 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.333 0.653 . . . . 70.05 111.899 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -62.82 -41.61 72.85 Favored Pre-proline 0 CA--C 1.554 1.132 0 N-CA-C 113.93 1.085 . . . . 74.41 113.93 -170.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -47.12 -45.43 21.54 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.205 1.937 . . . . 73.3 114.087 167.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -79.9 -32.69 40.22 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.678 0.791 . . . . 72.42 111.961 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.39 -36.14 66.0 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.236 0.614 . . . . 75.21 110.153 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.505 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.8 ttp180 -66.18 -45.1 82.02 Favored 'General case' 0 C--O 1.208 -1.116 0 CA-C-N 114.839 -1.073 . . . . 73.25 109.305 171.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -55.05 -48.56 73.29 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.958 0.903 . . . . 72.3 111.302 -177.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.417 ' O ' ' HG3' ' D' ' 117' ' ' MET . 46.0 t -58.35 -45.8 87.49 Favored 'General case' 0 C--N 1.347 0.487 0 O-C-N 124.22 0.95 . . . . 74.23 111.032 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.539 HG12 ' SG ' ' D' ' 76' ' ' CYS . 45.1 mt -64.06 -55.04 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.111 0.565 . . . . 72.23 110.915 177.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.2 m -50.71 -40.66 54.8 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.354 1.462 . . . . 71.5 111.455 -176.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 34.4 t -66.66 -47.85 71.22 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.912 -1.04 . . . . 55.33 110.434 177.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.417 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 64.2 mtm -69.57 -29.5 67.06 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.495 0.554 . . . . 74.14 112.495 -175.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.419 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.4 t -67.82 -44.44 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.503 0.721 . . . . 62.31 109.471 176.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 65.9 p -71.66 -28.44 63.75 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 115.626 -0.716 . . . . 74.42 110.048 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' D' ' 116' ' ' SER . 92.7 mtt-85 -71.79 -30.05 65.12 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.82 0.848 . . . . 73.14 110.191 173.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.85 8.64 77.18 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 123.642 0.588 . . . . 71.32 112.748 176.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.411 HG23 ' HB3' ' C' ' 17' ' ' TYR . 82.0 p 54.91 31.12 15.2 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 126.165 1.786 . . . . 44.44 113.99 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -95.27 153.19 39.72 Favored Pre-proline 0 C--O 1.245 0.819 0 N-CA-C 107.702 -1.222 . . . . 61.2 107.702 168.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.49 150.33 60.75 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.657 2.238 . . . . 54.25 112.314 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -59.15 122.02 12.76 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.768 0.827 . . . . 72.44 111.829 -169.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.444 HD13 HG21 ' D' ' 40' ' ' VAL . 19.8 tp -107.42 100.68 10.09 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.066 0.947 . . . . 44.52 109.087 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -100.04 104.97 16.59 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.214 -1.032 . . . . 71.32 108.214 172.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.505 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 2.9 mm? -66.57 115.73 6.76 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 109.183 -0.673 . . . . 64.4 109.183 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.475 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -57.24 129.48 79.61 Favored Pre-proline 0 CA--C 1.557 1.238 0 C-N-CA 123.294 0.638 . . . . 34.5 112.087 -172.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 1.2 Cg_endo -79.05 117.09 3.8 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.068 2.512 . . . . 74.24 111.243 -175.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 14.8 p -127.03 149.21 31.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 123.697 0.799 . . . . 73.11 109.126 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -69.75 113.73 7.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.908 -0.775 . . . . 70.21 108.908 172.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -60.59 -34.03 73.61 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.898 0.879 . . . . 73.1 111.213 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -63.63 -33.64 76.07 Favored 'General case' 0 C--O 1.213 -0.844 0 O-C-N 124.051 0.845 . . . . 71.44 110.861 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.98 -28.7 69.99 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.616 0.766 . . . . 73.23 112.134 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.473 HD23 ' HB2' ' E' ' 112' ' ' ASN . 9.4 mp -71.21 -40.53 71.09 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.311 0.644 . . . . 72.21 110.712 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -76.6 -37.49 56.36 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.079 0.952 . . . . 71.54 109.107 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.49 ' HG2' ' HG2' ' D' ' 142' ' ' GLN . 24.3 ttm -68.78 -32.64 72.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.878 1.271 . . . . 54.42 110.034 -176.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -66.93 -8.29 28.38 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.186 0.994 . . . . 73.52 111.507 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -85.51 -38.96 17.97 Favored 'General case' 0 CA--C 1.552 1.029 0 O-C-N 121.34 -0.85 . . . . 74.24 109.997 170.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.5 mp -83.22 -67.43 0.79 Allowed 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 123.756 0.822 . . . . 71.11 112.456 -175.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.49 ' HG2' ' HG2' ' D' ' 138' ' ' MET . 7.4 pt20 -79.98 38.61 0.41 Allowed 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 123.708 0.803 . . . . 70.21 112.922 -172.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -130.13 93.04 3.4 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.586 -0.696 . . . . 71.32 109.837 -165.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -147.62 171.41 15.65 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.484 1.114 . . . . 61.55 108.122 177.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.99 92.67 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.283 0.633 . . . . 74.52 111.241 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -168.04 44.78 0.24 Allowed Glycine 0 C--N 1.34 0.791 0 N-CA-C 110.771 -0.932 . . . . 71.14 110.771 -177.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . 0.7 ' HB3' ' H ' ' B' ' 5' ' ' ASN . 0.0 OUTLIER -113.72 -25.69 8.56 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.841 1.256 . . . . 74.22 111.218 -177.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 73.97 -114.39 4.54 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 111.173 -0.771 . . . . 71.52 111.173 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 12.8 t -171.05 18.03 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.039 0.935 . . . . 63.52 109.86 177.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -121.91 149.0 44.04 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.178 0.513 . . . . 75.14 111.783 -169.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -100.07 143.05 30.72 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.16 -1.422 . . . . 71.14 107.16 159.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -67.15 125.09 24.94 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.401 0.62 . . . . 73.14 112.465 -170.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -133.89 166.23 23.17 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.436 1.494 . . . . 60.02 108.241 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -61.09 90.61 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 CA-C-O 121.899 0.857 . . . . 73.43 111.725 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.211 0 C-N-CA 124.066 0.946 . . . . 50.04 108.859 -176.262 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.055 0 N-CA-C 110.779 -0.928 . . . . 64.14 110.779 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . -143.95 36.67 1.49 Allowed Glycine 0 C--N 1.343 0.94 0 CA-C-N 117.108 0.454 . . . . 74.53 113.49 -175.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -78.38 74.96 4.91 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 106.948 -1.501 . . . . 72.33 106.948 167.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -81.78 -101.96 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.62 -0.718 . . . . 72.22 110.193 -171.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -146.7 -60.16 0.29 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.498 0.666 . . . . 61.25 110.492 -166.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 152.4 122.29 0.95 Allowed Glycine 0 CA--C 1.519 0.301 0 N-CA-C 109.198 -1.561 . . . . 74.31 109.198 -171.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 97' ' ' ILE . . . . . 0.441 ' CG2' ' HA ' ' D' ' 87' ' ' ALA . 3.9 pt -81.11 48.71 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 124.111 0.964 . . . . 64.35 112.505 -177.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 20.1 t70 56.78 92.45 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.109 1.364 . . . . 73.32 110.836 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . 61.89 -168.56 0.18 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.874 0.87 . . . . 71.22 110.448 -172.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.83 72.21 3.64 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 109.033 -0.728 . . . . 75.51 109.033 175.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -80.04 71.06 7.25 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 122.877 2.385 . . . . 71.13 112.14 178.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 102' ' ' LEU . . . . . . . . . . . . . 1.8 tt -88.58 67.76 8.55 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 108.837 -0.801 . . . . 72.21 108.837 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 47.3 p 51.18 30.35 5.63 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.278 1.431 . . . . 62.45 113.07 176.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 98.38 -138.06 13.65 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 110.675 -0.97 . . . . 40.13 110.675 -171.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -94.9 -4.61 46.59 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.385 0.674 . . . . 64.35 111.032 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -164.09 148.9 10.23 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.753 1.221 . . . . 64.4 108.72 -174.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 8.3 m -77.41 88.75 3.79 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.436 -0.579 . . . . 73.15 109.436 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -66.19 -27.67 68.17 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.227 -0.897 . . . . 62.33 110.91 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -68.54 99.28 0.96 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 107.385 -1.339 . . . . 74.23 107.385 166.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.46 145.6 45.61 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 122.758 0.423 . . . . 62.13 110.991 -177.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . . . . . . . . . 5.4 mp -78.38 87.39 4.41 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.75 0.82 . . . . 74.42 109.9 -171.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 112' ' ' ASN . . . . . 0.473 ' HB2' HD23 ' D' ' 136' ' ' LEU . 66.8 t30 63.77 84.95 0.14 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.087 1.355 . . . . 53.5 111.672 176.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -124.61 -51.06 1.73 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.211 1.005 . . . . 73.2 108.483 175.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -71.89 114.17 9.7 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.638 -0.875 . . . . 44.42 108.638 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 39.4 m -79.1 129.68 34.7 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.923 0.889 . . . . 71.42 110.263 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 140.98 39.76 0.08 OUTLIER Glycine 0 N--CA 1.469 0.891 0 N-CA-C 110.912 -0.875 . . . . 64.22 110.912 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -137.3 141.11 32.86 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.047 0.939 . . . . 73.5 109.558 -172.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -37.56 134.74 0.52 Allowed 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 124.022 3.148 . . . . 63.32 113.697 167.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -59.86 114.79 2.98 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.486 1.114 . . . . 75.44 113.0 -165.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -120.76 -75.47 0.59 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.965 0.906 . . . . 62.13 108.907 172.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 121' ' ' VAL . . . . . 0.538 HG11 HD23 ' D' ' 42' ' ' LEU . 37.2 t -130.3 70.93 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 108.562 -0.903 . . . . 70.25 108.562 -179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 6.8 p -128.92 153.44 47.51 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.26 -0.882 . . . . 72.2 109.937 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 29.0 t70 62.78 -86.12 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 124.808 1.243 . . . . 74.41 111.879 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 79.5 p -157.65 176.69 12.29 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.056 0.942 . . . . 23.21 108.891 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -132.62 -78.7 0.5 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.692 0.397 . . . . 64.43 110.009 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -117.66 173.18 6.88 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.331 0.653 . . . . 55.35 110.896 -175.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 127' ' ' SER . . . . . 0.62 ' HB2' HG22 ' E' ' 129' ' ' THR . 24.6 p -103.75 -76.48 0.59 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.648 0.779 . . . . 73.25 110.183 176.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . 58.9 27.26 15.96 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.967 0.907 . . . . 72.01 111.358 -173.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 129' ' ' THR . . . . . 0.62 HG22 ' HB2' ' E' ' 127' ' ' SER . 5.4 t -89.36 117.48 28.32 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.773 0.829 . . . . 74.33 111.393 -175.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -167.82 94.63 0.41 Allowed 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.091 0.956 . . . . 71.15 108.985 174.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 131' ' ' TRP . . . . . . . . . . . . . 19.5 t90 -143.99 112.34 6.42 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.679 -0.86 . . . . 74.42 108.679 176.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 132' ' ' SER . . . . . 0.555 ' H ' ' HB3' ' A' ' 124' ' ' PRO . 44.9 p -167.77 114.75 0.73 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.877 1.271 . . . . 72.55 108.844 178.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 133' ' ' THR . . . . . 0.473 HG23 ' HB2' ' A' ' 124' ' ' PRO . 0.2 OUTLIER -149.99 161.62 41.97 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.847 0.459 . . . . 53.32 111.027 -179.465 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -148.45 111.57 0.54 Allowed Glycine 0 C--N 1.345 1.063 0 N-CA-C 110.586 -1.006 . . . . 54.15 110.586 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.9 115.17 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.394 0.678 . . . . 75.32 109.467 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -95.33 25.46 4.37 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.687 0.795 . . . . 64.54 111.185 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 137' ' ' THR . . . . . 0.686 ' HA ' ' HB2' ' A' ' 129' ' ' ALA . 45.8 p 48.3 -97.88 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 125.118 1.367 . . . . 44.13 112.05 -168.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -172.15 -38.4 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.482 1.113 . . . . 71.01 109.385 176.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -136.83 -170.27 2.66 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.647 1.179 . . . . 65.53 108.866 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -70.08 81.27 0.35 Allowed Glycine 0 C--N 1.348 1.213 0 O-C-N 123.621 0.575 . . . . 23.21 111.986 174.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.54 76.13 3.25 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.641 0.776 . . . . 72.13 109.913 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 92.7 mt -80.1 156.32 27.1 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.824 -0.626 . . . . 71.45 111.74 -173.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -139.98 49.95 0.78 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 109.392 -1.483 . . . . 61.11 109.392 174.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 14.5 p -112.31 147.56 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.411 0.684 . . . . 75.42 109.608 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 CA--C 1.55 0.952 0 C-N-CA 123.458 0.703 . . . . 72.31 110.447 175.422 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.639 0 CA-C-O 119.567 -0.574 . . . . 43.3 112.061 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.44 62.38 3.28 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-N 116.843 0.321 . . . . 52.42 112.744 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 93' ' ' PHE . . . . . 0.633 ' HB3' ' HB2' ' B' ' 54' ' ' ASP . 17.9 t80 -83.03 -37.03 24.47 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.149 0.58 . . . . 73.23 109.617 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.25 -57.5 1.39 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.949 0.5 . . . . 74.01 110.251 -173.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -164.74 -68.44 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 122.347 0.259 . . . . 73.13 110.994 177.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.53 138.18 4.46 Favored Glycine 0 C--N 1.348 1.234 0 C-N-CA 121.818 -0.229 . . . . 41.12 113.179 -172.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 97' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' B' ' 94' ' ' MET . 9.8 tt -166.4 138.97 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.457 1.503 . . . . 60.01 107.308 176.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -56.81 -51.89 67.19 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 112.922 0.712 . . . . 72.51 112.922 -167.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -177.04 148.17 0.61 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.652 1.181 . . . . 73.33 107.841 -177.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 100' ' ' LEU . . . . . 0.476 ' HA ' ' HE1' ' B' ' 94' ' ' MET . 5.1 mp -112.37 96.38 35.43 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-N 117.931 0.332 . . . . 70.31 110.751 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -93.14 -172.53 0.35 Allowed 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 123.101 2.534 . . . . 73.03 110.221 163.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 102' ' ' LEU . . . . . . . . . . . . . 44.9 tp -95.63 -59.63 1.83 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 107.922 -1.14 . . . . 74.52 107.922 168.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.94 -55.7 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.113 1.365 . . . . 72.12 108.619 170.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . -147.82 -162.38 10.05 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.77 -0.65 . . . . 63.23 112.255 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -71.6 84.33 0.86 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.508 0.723 . . . . 72.44 110.186 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 53.3 t80 48.27 82.19 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.764 1.626 . . . . 73.14 112.528 177.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 7.8 t -116.36 144.13 44.66 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.576 0.75 . . . . 72.41 109.992 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -98.92 -59.0 1.81 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.17 -0.678 . . . . 72.45 109.17 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 109' ' ' TYR . . . . . 0.458 ' CE2' ' HB2' ' B' ' 140' ' ' TYR . 70.5 t80 63.95 102.75 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.524 1.129 . . . . 72.31 109.828 -172.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 62.72 -137.91 0.42 Allowed 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 124.101 0.96 . . . . 73.5 109.448 -168.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 85.8 mt 72.75 -69.98 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 125.118 1.367 . . . . 74.12 112.734 174.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -87.41 34.45 0.7 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.424 1.09 . . . . 73.31 112.723 -171.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? 67.34 -71.5 0.1 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.064 1.346 . . . . 60.54 111.624 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt 50.54 -66.16 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 127.798 2.439 . . . . 74.25 115.7 175.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 21.5 m -61.97 -32.09 72.51 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.039 0.936 . . . . 71.41 111.979 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 131.78 -56.25 0.74 Allowed Glycine 0 C--N 1.345 1.042 0 N-CA-C 112.064 -0.414 . . . . 63.34 112.064 175.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -122.68 96.93 44.94 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 123.284 0.634 . . . . 73.21 109.996 -176.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.45 104.59 1.93 Allowed 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.17 1.914 . . . . 72.14 111.097 173.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -75.62 69.71 2.37 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.954 0.883 . . . . 73.45 110.153 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 28.7 t80 173.25 -179.24 0.08 Allowed 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 126.99 2.116 . . . . 74.23 107.071 -174.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 98.3 t 75.05 -79.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 124.619 1.168 . . . . 74.25 111.515 172.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 31.4 p -88.43 96.59 10.66 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.317 0.647 . . . . 62.44 110.606 -174.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -159.84 102.69 1.49 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.342 -0.614 . . . . 63.04 109.342 177.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 23.1 t 63.15 7.8 2.97 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.496 1.118 . . . . 61.44 112.206 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -89.33 104.9 17.42 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.075 0.95 . . . . 55.11 110.421 -167.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . 62.27 18.59 10.31 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.644 1.178 . . . . 72.13 112.48 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 16.1 m -76.95 89.35 3.51 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.644 0.778 . . . . 74.21 110.547 -176.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -159.53 -63.91 0.07 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.715 0.806 . . . . 74.41 109.277 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 92.0 m 65.07 124.44 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.187 1.395 . . . . 71.23 113.432 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -161.61 154.41 20.49 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 114.717 -1.129 . . . . 62.14 109.037 169.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 51.8 t90 -143.48 22.1 1.84 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.284 1.033 . . . . 72.53 108.325 177.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 132' ' ' SER . . . . . 0.4 ' HB2' ' HD1' ' C' ' 36' ' ' TRP . 14.1 m -67.15 88.08 0.17 Allowed 'General case' 0 C--N 1.352 0.701 0 CA-C-O 121.438 0.637 . . . . 74.15 110.003 -178.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 133' ' ' THR . . . . . 0.535 HG23 HD12 ' C' ' 126' ' ' LEU . 21.4 m -73.87 92.39 2.06 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.658 -1.155 . . . . 53.32 108.453 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -82.7 36.58 2.65 Favored Glycine 0 C--N 1.355 1.612 0 CA-C-N 116.089 -0.505 . . . . 71.4 113.089 -175.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 15.0 p -75.22 136.45 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.519 0.727 . . . . 53.32 109.649 -177.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -118.39 179.85 3.99 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.607 -0.516 . . . . 73.1 109.607 175.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 10.2 t -66.69 168.14 9.94 Favored 'General case' 0 C--O 1.25 1.079 0 CA-C-N 115.675 -0.693 . . . . 74.33 109.517 169.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -64.36 118.51 8.8 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.175 -1.046 . . . . 72.32 108.175 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -63.75 119.25 9.58 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.998 0.919 . . . . 74.15 112.016 -167.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -110.88 11.21 29.7 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 115.796 -0.638 . . . . 74.41 112.778 178.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -76.35 -41.69 47.39 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.477 -0.564 . . . . 50.34 109.477 174.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 2.1 tm? 68.12 -71.75 0.11 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.556 1.542 . . . . 62.5 109.608 -176.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.84 -168.1 11.74 Favored Glycine 0 C--N 1.342 0.881 0 N-CA-C 111.228 -0.749 . . . . 50.5 111.228 173.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 99.1 t -120.47 -55.64 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.681 0.793 . . . . 54.4 109.031 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 . . . . . 0 N--CA 1.48 1.051 0 C-N-CA 123.675 0.79 . . . . 75.04 110.237 179.028 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtp . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 109.066 -0.716 . . . . 73.21 109.066 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.1 p -164.68 16.78 0.05 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.863 1.265 . . . . 74.41 109.377 -176.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -124.63 -165.75 1.42 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.787 0.835 . . . . 72.3 110.311 -166.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -151.3 73.16 1.08 Allowed 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 122.1 0.952 . . . . 70.42 109.94 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -83.01 97.93 9.0 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.244 -0.889 . . . . 74.13 109.7 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.61 ' HA ' ' HA2' ' A' ' 88' ' ' GLY . 7.1 p30 -87.98 108.92 19.44 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.279 0.562 . . . . 61.42 109.86 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.5 m -143.62 -135.77 0.09 Allowed 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 107.908 -1.145 . . . . 73.15 107.908 -176.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -88.79 55.58 3.42 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.394 0.997 . . . . 74.21 109.426 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.2 mpt? 63.17 170.07 0.15 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.758 1.223 . . . . 73.33 112.038 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 58.5 m -140.56 114.7 9.15 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.08 -1.452 . . . . 62.52 107.08 167.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -131.66 118.82 20.55 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.047 -0.724 . . . . 74.43 109.047 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.486 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 0.0 OUTLIER -136.98 131.7 33.3 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 106.603 -1.628 . . . . 75.24 106.603 175.171 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.462 ' CD1' HG21 ' A' ' 105' ' ' ILE . 6.4 mt -94.38 107.54 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.496 -0.928 . . . . 73.04 108.496 173.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.96 -40.31 68.75 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.519 -0.919 . . . . 74.43 108.519 -176.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 -173.89 122.85 0.33 Allowed 'General case' 0 C--N 1.351 0.655 0 CA-C-N 115.949 -0.569 . . . . 54.51 110.527 -169.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.572 HD12 ' HG3' ' C' ' 130' ' ' PRO . 65.0 mt -106.49 134.72 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 107.979 -1.119 . . . . 72.33 107.979 169.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.5 ' HE1' HG13 ' A' ' 83' ' ' ILE . 30.9 p90 -164.5 178.79 7.14 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 124.165 0.916 . . . . 74.24 110.807 -172.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.1 p -109.47 124.15 50.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.624 -0.716 . . . . 60.22 109.316 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.414 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 42.7 mtpt -86.46 -30.73 21.81 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.66 -0.496 . . . . 75.54 109.66 175.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.46 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 31.9 t70 -149.6 145.59 26.86 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.065 -0.97 . . . . 52.44 109.739 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.3 mt -141.02 146.02 24.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 C-N-CA 125.086 1.354 . . . . 74.41 107.835 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.2 t -152.15 137.7 17.76 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.55 0.74 . . . . 41.15 109.791 175.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.502 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 92.2 t80 -144.42 132.49 21.6 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.993 -1.484 . . . . 71.4 106.993 173.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -133.05 111.75 11.23 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.869 -0.789 . . . . 74.24 108.869 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -104.36 81.92 0.57 Allowed Pre-proline 0 C--O 1.245 0.817 0 N-CA-C 106.415 -1.698 . . . . 65.3 106.415 161.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.56 -29.05 25.46 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.282 1.988 . . . . 72.24 111.281 -172.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -111.45 19.1 18.53 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-N 114.451 -1.25 . . . . 52.23 109.297 -175.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.49 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -44.83 -49.35 28.17 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 113.633 0.975 . . . . 55.34 113.633 -171.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -59.82 -39.62 70.71 Favored 'Trans proline' 0 C--N 1.392 2.858 0 C-N-CA 121.686 1.591 . . . . 75.12 112.744 176.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.432 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 3.7 m-70 -76.72 -38.04 55.0 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.223 -1.353 . . . . 62.32 110.588 -173.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.473 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.6 p -72.6 -25.68 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 124.563 1.145 . . . . 63.21 111.281 -163.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -76.21 -18.82 58.88 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.557 0.743 . . . . 74.41 110.98 176.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -85.11 -28.21 25.74 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.171 0.989 . . . . 71.41 110.258 173.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 1.3 mmmp? -79.35 159.69 27.04 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.291 1.036 . . . . 55.45 111.735 -173.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.85 119.74 9.96 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.853 0.861 . . . . 65.31 110.353 176.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -82.47 85.18 6.98 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.543 0.687 . . . . 64.5 110.16 -178.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.504 ' H ' HD22 ' A' ' 68' ' ' LEU . 8.3 tp-100 -121.07 76.05 30.32 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.673 1.189 . . . . 75.34 108.263 172.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.53 113.11 2.81 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.599 2.199 . . . . 71.21 112.622 -171.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -94.69 92.17 6.88 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.585 -1.265 . . . . 73.3 107.585 174.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.496 HG22 ' HB2' ' A' ' 66' ' ' ALA . 61.5 t -89.44 106.38 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.718 -1.128 . . . . 63.2 111.037 -173.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -86.45 140.43 29.98 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.372 0.669 . . . . 62.41 110.561 171.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.9 mt -106.67 106.21 16.61 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.038 -1.097 . . . . 74.12 108.038 171.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -107.4 108.59 20.02 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.691 1.196 . . . . 70.2 108.157 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.55 HD11 HG21 ' A' ' 131' ' ' VAL . 83.7 mt -104.25 155.07 19.04 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.692 0.758 . . . . 64.23 112.249 -170.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 17.3 t70 -158.2 139.45 13.36 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 113.705 -1.589 . . . . 64.52 108.357 -178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.8 m -138.87 122.25 17.16 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.163 -0.681 . . . . 75.53 109.163 175.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.86 111.8 11.91 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.56 0.744 . . . . 62.42 109.213 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.8 p -91.66 153.1 19.91 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.384 0.674 . . . . 71.32 110.342 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.2 t -149.64 121.21 8.0 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.711 0.804 . . . . 63.24 109.454 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -71.35 112.48 7.52 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.56 -0.533 . . . . 74.11 109.56 177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' A' ' 57' ' ' GLU . 46.8 mt -81.28 -43.76 18.69 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.128 0.571 . . . . 63.51 109.76 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.77 178.76 8.58 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.282 -0.872 . . . . 74.53 110.074 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.32 129.43 39.89 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 109.311 -0.626 . . . . 74.12 109.311 175.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 63.18 18.75 11.21 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.368 1.067 . . . . 72.03 111.262 -175.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.2 t -130.85 102.53 6.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.821 0 C-N-CA 124.374 1.069 . . . . 74.14 108.576 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -113.74 123.19 49.28 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.524 -1.287 . . . . 74.34 107.524 175.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.554 ' HB2' HD11 ' A' ' 51' ' ' LEU . 32.8 tt0 -85.46 151.38 24.02 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.686 -0.857 . . . . 73.12 108.686 173.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.423 HG11 ' HD3' ' A' ' 103' ' ' PRO . 70.2 t -130.3 135.57 60.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.137 -1.06 . . . . 73.11 108.137 169.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.2 t -117.49 128.35 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.748 -0.834 . . . . 75.21 108.748 173.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.95 100.03 9.55 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 106.769 -1.567 . . . . 53.15 106.769 176.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.495 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 21.0 ttp180 -86.83 101.61 13.51 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.617 -0.883 . . . . 72.41 108.617 173.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 37.3 t -97.85 126.95 50.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 107.442 -1.318 . . . . 71.0 107.442 173.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.6 m -124.05 123.48 40.45 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.499 -0.926 . . . . 51.31 108.499 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.591 HG11 HD21 ' A' ' 126' ' ' LEU . 69.3 t -117.09 135.42 57.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 124.843 1.257 . . . . 63.52 108.472 -174.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 30.6 m -136.47 127.93 28.54 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 109.657 -0.498 . . . . 64.13 109.657 169.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.496 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -106.05 128.3 53.76 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 107.025 -1.472 . . . . 75.23 107.025 172.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.1 m -132.21 129.82 40.2 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.05 0.54 . . . . 61.04 110.884 -175.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.504 HD22 ' H ' ' A' ' 37' ' ' GLN . 17.2 mt -89.92 51.48 2.08 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.355 1.462 . . . . 64.24 109.917 178.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.3 -86.37 1.12 Allowed Glycine 0 C--N 1.349 1.271 0 CA-C-N 116.228 -0.442 . . . . 55.15 113.097 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.42 -28.94 20.58 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.504 0.722 . . . . 73.33 111.044 -177.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -111.69 135.79 51.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.067 0.947 . . . . 64.11 109.181 -174.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.6 m -76.64 134.03 39.42 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.392 -0.596 . . . . 64.41 109.392 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.473 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -77.55 -60.2 2.46 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.436 0.694 . . . . 43.11 109.69 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -153.38 163.22 40.3 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.092 -0.958 . . . . 61.41 111.027 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.401 HD12 ' H ' ' A' ' 76' ' ' CYS . 28.1 tp -126.1 142.63 51.44 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.057 1.343 . . . . 74.03 108.277 173.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.571 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.2 m -137.77 139.49 40.1 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 124.784 1.234 . . . . 73.25 108.318 176.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -148.7 124.34 10.44 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.955 -0.757 . . . . 72.3 108.955 169.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 69.5 t -128.66 119.87 51.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 109.041 -0.725 . . . . 71.13 109.041 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.495 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 51.9 mt-30 -92.97 85.5 5.15 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.286 -1.005 . . . . 75.21 108.286 172.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -76.2 94.78 3.58 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 114.363 -1.29 . . . . 61.2 109.183 -177.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.0 145.47 19.27 Favored Glycine 0 C--N 1.341 0.828 0 N-CA-C 111.399 -0.681 . . . . 72.4 111.399 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.12 122.93 1.9 Allowed Glycine 0 CA--C 1.507 -0.415 0 N-CA-C 110.455 -1.058 . . . . 51.11 110.455 -176.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.5 HG13 ' HE1' ' A' ' 17' ' ' TYR . 53.0 mt -80.36 115.83 23.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 107.93 -1.137 . . . . 74.13 107.93 173.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.807 ' HB3' HD11 ' A' ' 86' ' ' ILE . 98.3 m-85 -120.3 123.78 43.98 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.92 -0.77 . . . . 74.35 108.92 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.486 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 17.8 m -86.33 94.28 9.31 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.631 -0.878 . . . . 33.43 108.631 176.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.807 HD11 ' HB3' ' A' ' 84' ' ' PHE . 6.3 mm -109.48 147.98 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 122.151 0.181 . . . . 63.42 110.598 -175.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.432 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -172.33 177.84 2.98 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.386 1.075 . . . . 71.11 109.566 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 6' ' ' ASN . . . 93.88 -24.09 27.97 Favored Glycine 0 N--CA 1.467 0.75 0 CA-C-O 120.246 -0.197 . . . . 51.1 113.192 176.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.485 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -129.54 170.16 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.816 0.846 . . . . 71.12 110.87 -176.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -155.55 179.15 9.45 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.337 -0.847 . . . . 72.05 109.478 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.53 -122.0 28.61 Favored Glycine 0 C--N 1.347 1.165 0 C-N-CA 123.531 0.586 . . . . 52.31 114.033 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.8 p -73.04 -30.81 64.0 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.032 0.933 . . . . 65.54 111.887 -176.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -71.19 -37.21 72.13 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.136 0.574 . . . . 74.05 110.189 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.403 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 4.9 tpt -66.47 -46.44 76.37 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.726 -0.67 . . . . 72.34 109.997 175.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.1 -35.6 75.58 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.654 -0.703 . . . . 53.1 110.798 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -71.12 -35.11 71.64 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.232 0.613 . . . . 73.03 111.327 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -65.12 -44.01 90.11 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 109.437 -0.579 . . . . 62.25 109.437 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.403 ' HG ' ' HE2' ' A' ' 94' ' ' MET . 33.0 mt -82.75 -27.53 31.02 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.213 -0.903 . . . . 73.35 112.534 -175.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.07 4.29 38.52 Favored Glycine 0 N--CA 1.473 1.16 0 CA-C-O 119.689 -0.506 . . . . 73.15 114.124 -171.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.93 -67.67 0.29 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 117.388 0.594 . . . . 54.01 111.503 -176.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -66.97 -47.76 70.58 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 112.506 0.558 . . . . 64.3 112.506 -172.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 86.6 m -64.55 -48.44 74.35 Favored Pre-proline 0 CA--C 1.561 1.397 0 CA-C-O 118.364 -0.827 . . . . 72.51 112.635 -177.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.423 ' HD3' HG11 ' A' ' 58' ' ' VAL . 32.5 Cg_endo -64.42 -24.08 64.45 Favored 'Trans proline' 0 C--N 1.395 2.999 0 C-N-CA 121.671 1.58 . . . . 71.51 112.797 172.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -67.7 -36.67 81.07 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.179 0.592 . . . . 71.04 110.38 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.462 HG21 ' CD1' ' A' ' 13' ' ' ILE . 44.2 mm -69.37 -42.5 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.635 0.774 . . . . 71.4 110.133 173.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.2 mt -72.41 -23.88 61.16 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.153 -0.931 . . . . 72.42 112.068 -174.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -66.41 -41.33 40.64 Favored Pre-proline 0 N--CA 1.484 1.262 0 N-CA-C 114.306 1.225 . . . . 74.21 114.306 -171.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -50.0 -44.39 37.57 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 121.92 1.746 . . . . 65.33 113.214 168.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -74.67 -36.37 62.8 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.627 0.771 . . . . 74.21 111.709 -177.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.19 -46.65 64.17 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.345 0.658 . . . . 44.41 109.846 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.535 ' NH1' HD12 ' C' ' 105' ' ' ILE . 33.2 ttm105 -49.72 -54.8 16.69 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.812 1.32 . . . . 71.23 109.994 173.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -63.06 -44.26 96.31 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.156 0.91 . . . . 71.54 111.798 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.453 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.6 t -61.79 -31.89 72.14 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.919 0.487 . . . . 73.54 111.432 -179.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.498 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 71.1 mt -71.49 -54.95 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 123.602 0.761 . . . . 75.15 109.657 172.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 46.2 m -56.32 -35.12 67.21 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.039 1.336 . . . . 72.11 111.605 -173.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.5 t -69.81 -44.24 70.41 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 114.956 -1.02 . . . . 74.25 109.734 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.502 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 51.7 mtm -63.42 -38.83 92.67 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.886 0.474 . . . . 74.14 110.715 177.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 114' ' ' ILE . 84.9 t -61.51 -47.85 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 124.399 1.08 . . . . 62.21 110.475 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.8 p -74.24 -34.38 63.62 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.124 0.569 . . . . 54.13 111.393 -175.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.524 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.1 mtt-85 -70.7 -27.22 63.83 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.744 0.818 . . . . 75.44 109.696 174.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.52 7.24 62.06 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 115.361 -0.836 . . . . 75.24 112.714 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.461 HG21 ' HE ' ' B' ' 15' ' ' ARG . 36.0 m 72.88 9.21 5.49 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 124.625 1.17 . . . . 70.13 112.083 173.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -83.91 139.91 40.21 Favored Pre-proline 0 C--O 1.244 0.794 0 O-C-N 121.225 -0.922 . . . . 71.35 108.785 173.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.682 ' HB3' ' HA ' ' E' ' 131' ' ' TRP . 9.2 Cg_endo -56.31 141.5 88.79 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.282 1.988 . . . . 75.13 110.85 174.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.7 ' HB3' ' HE1' ' E' ' 131' ' ' TRP . 26.2 tt0 -56.57 140.43 46.57 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 124.324 1.015 . . . . 72.55 113.08 -165.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.591 HD21 HG11 ' A' ' 64' ' ' VAL . 31.6 tp -119.56 105.29 11.08 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 113.665 -1.607 . . . . 71.32 109.424 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -99.28 118.85 36.87 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 107.941 -1.133 . . . . 75.54 107.941 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 11.9 mt -70.75 147.14 49.31 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.616 0.573 . . . . 72.04 110.012 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -64.55 132.52 95.42 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 123.043 0.537 . . . . 41.13 110.329 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 25.8 Cg_exo -62.87 116.85 3.81 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.794 2.329 . . . . 45.23 112.221 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.55 HG21 HD11 ' A' ' 44' ' ' LEU . 87.3 t -99.04 130.46 47.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 C-N-CA 123.131 0.572 . . . . 73.42 110.549 -172.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -90.76 89.06 7.33 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 108.324 -0.991 . . . . 54.04 108.324 174.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -65.03 -23.17 67.12 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.512 0.725 . . . . 74.33 112.373 178.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.31 -39.37 82.03 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.484 0.714 . . . . 64.34 110.29 174.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.46 -41.88 83.94 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.237 0.615 . . . . 60.51 110.309 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 60.3 mt -65.54 -41.32 93.19 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.033 0.533 . . . . 65.34 111.052 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -63.34 -45.17 92.49 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.432 -0.803 . . . . 71.04 109.808 178.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 17.3 mmt -61.71 -43.88 98.0 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 123.819 0.699 . . . . 61.02 111.025 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -53.98 -43.36 69.92 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.37 0.668 . . . . 74.3 111.141 177.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -69.06 -43.36 74.78 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.675 0.79 . . . . 75.13 111.237 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 60.6 tp -65.96 -50.94 62.58 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.248 1.019 . . . . 65.12 112.238 -168.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -175.9 -19.03 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.55 0.74 . . . . 73.25 111.034 -174.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 60.46 90.59 0.06 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.703 1.601 . . . . 71.14 109.493 -176.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -149.17 143.11 25.74 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.111 0.564 . . . . 71.11 109.544 -176.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.92 103.5 2.67 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.89 0.744 . . . . 74.52 109.833 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -169.18 -156.36 10.61 Favored Glycine 0 C--N 1.338 0.667 0 O-C-N 123.598 0.561 . . . . 75.44 112.582 -177.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.613 ' HG3' HG23 ' A' ' 149' ' ' THR . 10.3 tp10 70.87 -70.91 0.14 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.542 1.537 . . . . 71.24 110.388 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.405 ' HA3' ' H ' ' C' ' 148' ' ' GLY . . . 59.75 40.84 97.15 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 114.375 0.51 . . . . 72.32 114.375 169.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.613 HG23 ' HG3' ' A' ' 147' ' ' GLU . 22.6 p -61.69 -19.03 61.91 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.892 0.877 . . . . 65.51 113.25 -177.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.94 118.54 12.29 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.566 -0.901 . . . . 72.51 108.566 172.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -167.22 146.83 5.26 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.668 1.187 . . . . 73.35 108.325 175.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -116.01 38.82 3.23 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.573 1.149 . . . . 73.43 109.794 -176.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -49.56 -82.76 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.673 1.189 . . . . 70.43 112.617 -172.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 13.6 t70 177.7 70.04 0.01 OUTLIER 'General case' 0 C--O 1.245 0.829 0 N-CA-C 107.586 -1.265 . . . . 73.34 107.586 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.192 0 CA-C-N 115.051 -0.977 . . . . 75.24 108.714 178.676 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 49.0 ttp . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 108.732 -0.84 . . . . 70.23 108.732 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 20.4 t 70.35 155.51 0.14 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 125.111 1.364 . . . . 72.15 111.092 -177.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.605 ' HG3' ' H ' ' B' ' 5' ' ' ASN . 12.1 tp10 67.8 139.92 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 124.744 1.218 . . . . 73.05 111.662 -177.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.83 12.81 4.39 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.093 0.957 . . . . 71.02 112.662 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . 0.605 ' H ' ' HG3' ' B' ' 3' ' ' GLU . 1.6 m-20 61.63 63.69 1.13 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.393 1.077 . . . . 75.05 110.647 174.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -66.5 135.34 54.08 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 115.717 -0.674 . . . . 65.11 111.935 -172.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.475 ' HB ' ' HE1' ' E' ' 120' ' ' TYR . 9.1 t -172.01 158.55 4.74 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 124.702 1.201 . . . . 73.21 108.91 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -65.14 144.35 57.28 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 108.827 -0.805 . . . . 54.21 108.827 167.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.533 ' HG3' HG13 ' B' ' 89' ' ' ILE . 26.3 ttt 66.3 166.83 0.21 Allowed 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 124.785 1.234 . . . . 60.1 112.109 -176.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 41.7 m -142.39 101.98 4.0 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 107.262 -1.384 . . . . 60.3 107.262 172.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -123.54 132.96 54.04 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.547 -0.909 . . . . 74.54 108.547 175.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -157.8 140.34 14.64 Favored 'General case' 0 C--O 1.244 0.768 0 O-C-N 123.768 0.667 . . . . 73.22 109.621 171.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.591 HD13 HD11 ' B' ' 16' ' ' ILE . 41.2 mt -67.81 131.52 33.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 114.774 -1.103 . . . . 64.1 109.624 177.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . 0.438 ' OE1' ' HA3' ' F' ' 92' ' ' GLY . 30.6 mm-40 -94.9 -45.41 7.3 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.984 -0.747 . . . . 41.41 108.984 173.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.461 ' HE ' HG21 ' A' ' 122' ' ' THR . 16.4 ttt180 -169.96 131.68 1.06 Allowed 'General case' 0 C--N 1.353 0.725 0 CA-C-N 115.494 -0.775 . . . . 72.15 110.301 -174.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.591 HD11 HD13 ' B' ' 13' ' ' ILE . 93.9 mt -115.11 146.0 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 108.057 -1.09 . . . . 64.0 108.057 174.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -168.31 149.65 5.03 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 112.813 0.672 . . . . 71.33 112.813 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 46.4 m -76.84 123.82 26.8 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 114.834 -1.075 . . . . 74.11 109.61 170.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.589 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.4 mtpt -96.6 -17.65 20.27 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.602 0.761 . . . . 62.01 111.326 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -164.31 141.84 6.78 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 123.649 0.593 . . . . 35.25 110.406 -174.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.456 HD12 ' SG ' ' B' ' 113' ' ' CYS . 30.5 mm -130.9 144.35 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.062 0.945 . . . . 74.21 108.957 170.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 34.7 t -149.59 140.96 23.24 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.961 -1.018 . . . . 75.03 109.032 174.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.416 ' HB2' ' HB3' ' B' ' 117' ' ' MET . 91.5 t80 -148.2 124.83 11.09 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.07 -1.456 . . . . 71.51 107.07 169.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -132.18 112.92 12.7 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.527 0.731 . . . . 70.34 109.233 -177.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.568 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -107.8 87.69 3.84 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.469 -1.308 . . . . 71.15 107.469 171.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.3 -27.28 34.63 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.532 2.155 . . . . 72.22 112.081 -172.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.506 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 78.6 m-20 -110.4 9.71 23.42 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.069 0.948 . . . . 70.2 110.911 -177.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.568 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -30.64 -66.35 0.17 Allowed Pre-proline 0 N--CA 1.493 1.68 0 C-N-CA 125.668 1.587 . . . . 42.55 115.23 -167.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.507 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 28.8 Cg_exo -58.51 -36.27 97.61 Favored 'Trans proline' 0 C--N 1.398 3.173 0 C-N-CA 122.13 1.887 . . . . 72.2 113.266 -174.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -86.63 -37.66 17.83 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.168 -0.924 . . . . 71.14 111.79 -171.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.493 HG21 ' HA ' ' B' ' 73' ' ' ALA . 8.7 p -71.06 -9.21 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 123.371 0.668 . . . . 71.12 111.64 -174.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -72.87 -9.52 58.78 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.112 0.565 . . . . 71.41 112.301 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -67.97 -28.89 67.84 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.232 0.613 . . . . 61.11 110.221 171.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.44 ' HB2' HD13 ' B' ' 68' ' ' LEU . 30.5 mmtp -81.55 102.19 10.45 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.573 1.149 . . . . 52.34 108.941 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -107.38 87.95 2.62 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 120.956 0.408 . . . . 70.21 110.857 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -169.61 172.08 7.13 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 124.772 1.229 . . . . 71.01 108.64 169.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.7 117.74 53.71 Favored Pre-proline 0 N--CA 1.479 1.0 0 N-CA-C 109.021 -0.733 . . . . 73.04 109.021 175.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.432 ' O ' HG23 ' B' ' 40' ' ' VAL . 16.8 Cg_endo -60.52 150.21 82.65 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.245 1.963 . . . . 73.53 112.546 -176.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -70.64 112.31 6.78 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.087 -1.079 . . . . 72.23 108.087 172.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 38' ' ' PRO . 59.9 t -105.53 146.79 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 115.361 -0.836 . . . . 72.02 110.818 -172.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -129.78 106.44 8.7 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 106.933 -1.506 . . . . 74.44 106.933 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.44 HD13 HG22 ' B' ' 64' ' ' VAL . 23.6 tp -90.38 125.48 35.56 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 109.621 -0.511 . . . . 73.53 109.621 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -130.92 155.71 46.31 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.521 1.128 . . . . 71.42 108.112 -178.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.2 162.91 34.28 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.439 0.695 . . . . 62.53 111.547 -173.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.661 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 8.7 m-20 -138.5 126.11 22.08 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.753 1.221 . . . . 74.15 109.394 175.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . 0.418 HG21 ' HZ ' ' B' ' 137' ' ' PHE . 7.8 t -114.98 111.14 20.68 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.544 0.687 . . . . 64.13 109.902 174.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.41 141.85 21.64 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.812 0.845 . . . . 75.34 109.013 177.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.497 ' OG ' HD11 ' F' ' 102' ' ' LEU . 79.0 p -142.07 172.22 12.99 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.571 0.348 . . . . 72.03 111.183 -176.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 54.4 p -151.27 141.37 22.17 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.387 0.675 . . . . 75.35 110.407 -174.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.466 ' HB2' ' CE1' ' B' ' 56' ' ' TYR . 43.5 tt0 -85.98 103.71 14.94 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 109.218 -0.66 . . . . 72.53 109.218 173.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 pp -126.07 24.94 6.84 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.352 -0.84 . . . . 72.23 109.027 174.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.85 157.67 24.36 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.535 -1.211 . . . . 53.55 109.7 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -83.18 104.47 13.39 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.524 0.73 . . . . 75.35 111.575 -167.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 58.16 23.97 10.81 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 124.696 1.198 . . . . 71.43 111.534 -172.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 85.9 t -131.13 115.85 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 113.788 -1.551 . . . . 60.41 107.288 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.466 ' CE1' ' HB2' ' B' ' 50' ' ' GLN . 0.2 OUTLIER -104.78 140.92 37.38 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.107 0.563 . . . . 61.51 109.769 -174.167 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -100.18 97.64 8.42 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.481 -1.303 . . . . 64.15 107.481 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.434 ' HA ' ' HB3' ' B' ' 48' ' ' SER . 55.3 t -93.06 126.97 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 C-N-CA 123.642 0.777 . . . . 70.44 110.078 -177.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.429 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 20.3 t -107.22 142.77 19.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 123.453 0.701 . . . . 74.33 109.426 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.471 HD13 ' HB3' ' B' ' 103' ' ' PRO . 52.7 tp -129.73 108.8 10.46 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.253 -1.017 . . . . 74.54 108.253 171.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.661 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 37.9 ttm180 -87.06 115.34 24.38 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.063 -1.088 . . . . 72.05 108.063 171.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 25.1 t -103.89 119.4 52.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.548 -1.279 . . . . 71.11 107.548 173.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 24.4 m -119.83 128.81 54.04 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.207 -0.664 . . . . 73.34 109.207 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.587 HG11 HD21 ' B' ' 126' ' ' LEU . 84.9 t -117.96 109.55 27.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 123.975 0.91 . . . . 62.44 109.102 -175.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 99.5 m -89.13 138.04 31.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.676 -1.231 . . . . 71.45 107.676 168.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.41 141.09 25.61 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.191 -0.67 . . . . 71.05 109.191 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.46 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 31.9 p -145.28 138.07 26.15 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.522 0.514 . . . . 71.31 111.221 -173.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' B' ' 34' ' ' LYS . 77.7 mt -110.97 102.21 10.71 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.487 1.115 . . . . 71.32 109.159 176.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.77 -137.45 19.47 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 111.129 -0.788 . . . . 52.03 111.129 -172.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -92.54 3.14 56.11 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 117.405 0.602 . . . . 70.4 110.613 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.506 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 16.7 pt-20 -113.68 151.87 31.23 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.013 0.525 . . . . 74.44 109.654 -178.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 60.7 m -72.88 133.23 44.32 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.119 -0.491 . . . . 54.51 110.216 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.493 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -84.23 -64.57 1.14 Allowed 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.883 -1.155 . . . . 54.34 107.883 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -155.36 158.88 39.4 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.45 -1.25 . . . . 71.52 110.581 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 53.4 mt -132.35 108.89 9.49 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 106.432 -1.692 . . . . 74.12 106.432 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 48.5 t -119.5 116.34 25.89 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.076 -0.713 . . . . 74.34 109.076 -177.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.411 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 43.9 tt0 -124.67 121.76 35.61 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.761 -0.829 . . . . 74.03 108.761 -175.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 79.4 t -126.41 135.37 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.89 0.876 . . . . 74.23 109.014 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -107.7 119.77 40.36 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.073 -1.084 . . . . 74.31 108.073 173.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.432 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 8.0 tp-100 -110.03 106.01 15.35 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.659 -0.867 . . . . 73.32 108.659 174.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.589 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -98.94 160.81 20.13 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.189 -0.764 . . . . 45.43 111.189 174.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.32 126.2 1.7 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 112.18 -0.368 . . . . 53.02 112.18 -174.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -85.39 114.17 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 N-CA-C 107.718 -1.215 . . . . 74.1 107.718 173.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -129.75 143.66 50.92 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.043 0.937 . . . . 73.03 109.774 -175.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.3 m -88.98 123.3 33.18 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.47 -0.567 . . . . 55.22 109.47 172.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.567 HG22 HD11 ' B' ' 89' ' ' ILE . 4.2 mp -122.98 115.64 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 N-CA-C 108.159 -1.052 . . . . 75.11 108.159 177.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.599 ' HA ' ' HB ' ' F' ' 97' ' ' ILE . . . -154.91 172.64 17.71 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.786 0.835 . . . . 73.0 110.389 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.402 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 88.73 -37.93 3.25 Favored Glycine 0 N--CA 1.481 1.669 0 C-N-CA 123.042 0.353 . . . . 62.11 113.942 172.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.567 HD11 HG22 ' B' ' 86' ' ' ILE . 0.8 OUTLIER -81.15 169.14 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 124.433 1.093 . . . . 73.41 111.87 176.304 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.407 ' HB3' ' HG2' ' D' ' 153' ' ' GLN . 11.5 pt-20 -154.06 175.18 13.73 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.282 -0.872 . . . . 65.53 110.349 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.1 -136.87 27.41 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.802 -0.635 . . . . 4.04 113.221 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.4 m -93.82 -29.16 15.48 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.01 0.524 . . . . 64.12 110.907 -177.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -56.19 -29.55 61.05 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 123.916 0.887 . . . . 72.13 111.224 175.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.555 ' HG2' HD11 ' F' ' 97' ' ' ILE . 0.7 OUTLIER -66.8 -57.2 7.53 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.612 1.565 . . . . 75.31 112.592 -179.237 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.413 ' N ' ' SD ' ' B' ' 94' ' ' MET . . . -78.41 -15.12 59.01 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 111.958 0.355 . . . . 51.05 111.958 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -59.51 -30.03 68.28 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.834 0.854 . . . . 64.35 110.499 169.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -63.48 -55.38 24.59 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.072 0.549 . . . . 65.42 111.774 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.487 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.6 pp -69.45 -31.96 70.6 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.631 0.372 . . . . 73.53 111.961 -174.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.02 -23.77 51.0 Favored Glycine 0 C--N 1.348 1.207 0 O-C-N 123.379 0.424 . . . . 35.14 113.567 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.595 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -125.43 -59.28 1.39 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.054 0.542 . . . . 71.1 112.002 -169.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -64.48 -43.74 93.19 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.266 0.626 . . . . 74.15 111.798 -174.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 79.8 m -65.59 -48.13 65.88 Favored Pre-proline 0 CA--C 1.566 1.58 0 CA-C-O 118.309 -0.853 . . . . 63.22 112.201 -176.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.471 ' HB3' HD13 ' B' ' 60' ' ' LEU . 85.8 Cg_exo -53.47 -34.55 72.4 Favored 'Trans proline' 0 C--N 1.397 3.122 0 C-N-CA 122.557 2.171 . . . . 70.23 113.829 170.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.533 HD21 ' HB2' ' B' ' 134' ' ' ASP . 90.9 m-20 -65.4 -29.47 70.18 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.14 0.576 . . . . 70.55 111.941 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.418 HG23 ' NH2' ' D' ' 111' ' ' ARG . 62.6 mt -71.56 -41.54 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.085 0.554 . . . . 65.43 109.858 174.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.4 mt -78.3 -29.87 48.06 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 114.79 -1.096 . . . . 53.24 112.453 -169.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.526 ' HB2' ' HE1' ' B' ' 133' ' ' PHE . 47.9 t80 -55.67 -49.6 91.82 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-O 117.739 -1.124 . . . . 73.2 113.304 -174.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -48.12 -47.51 19.23 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 122.907 2.405 . . . . 53.23 114.695 176.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -65.01 -46.27 82.1 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.137 0.575 . . . . 75.43 110.931 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.432 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -62.41 -39.54 93.61 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.204 -0.907 . . . . 63.42 110.698 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.467 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 52.3 ttt-85 -62.92 -47.06 84.9 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.552 1.541 . . . . 74.41 111.213 -176.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.23 -34.95 73.49 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.598 0.561 . . . . 72.53 110.09 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.524 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 8.8 t -68.58 -36.61 78.96 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.612 -0.267 . . . . 71.14 111.082 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.522 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 85.0 mt -59.49 -53.65 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.745 0.818 . . . . 73.44 109.897 169.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 54.5 m -57.13 -32.54 66.46 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.654 0.781 . . . . 70.31 111.546 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.475 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 42.8 t -63.79 -49.8 71.5 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.666 0.786 . . . . 64.42 109.891 174.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.524 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.5 mmt -70.67 -30.76 67.45 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.096 0.558 . . . . 73.24 111.54 -175.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.483 HG23 ' O ' ' B' ' 114' ' ' ILE . 95.3 t -66.35 -41.74 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.667 0.787 . . . . 72.52 109.704 173.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.2 t -65.83 -32.22 73.62 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 114.879 -1.055 . . . . 53.11 110.804 176.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' B' ' 116' ' ' SER . 88.1 mtt-85 -70.02 -34.71 73.64 Favored 'General case' 0 C--O 1.206 -1.23 0 CA-C-N 115.782 -0.644 . . . . 74.15 110.179 176.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.05 -13.89 82.77 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.428 0.455 . . . . 71.52 112.364 170.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 12.6 m 69.55 24.1 5.73 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 125.125 1.37 . . . . 21.33 110.519 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.487 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 71.5 m-85 -77.57 159.05 77.87 Favored Pre-proline 0 N--CA 1.477 0.91 0 CA-C-N 114.875 -1.057 . . . . 73.13 110.366 175.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -52.14 158.56 4.99 Favored 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 123.204 2.603 . . . . 53.32 113.794 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.466 HE21 ' ND2' ' B' ' 127' ' ' ASN . 42.6 tp60 -62.14 126.35 27.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.71 0.804 . . . . 73.34 112.459 -170.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.587 HD21 HG11 ' B' ' 64' ' ' VAL . 39.6 tp -109.81 101.13 10.02 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-N 115.225 -0.898 . . . . 61.23 109.131 178.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.466 ' ND2' HE21 ' B' ' 125' ' ' GLN . 21.6 m-80 -99.25 105.69 17.74 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 107.187 -1.412 . . . . 61.53 107.187 167.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.467 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 46.8 mt -63.64 127.88 33.34 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.332 -0.618 . . . . 71.54 109.332 175.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.01 148.47 92.47 Favored Pre-proline 0 CA--C 1.553 1.078 0 O-C-N 123.775 0.672 . . . . 60.34 111.225 -175.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -69.57 90.3 0.5 Allowed 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.872 2.381 . . . . 65.04 111.863 -174.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 81.9 t -95.45 109.75 23.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.611 -0.885 . . . . 73.22 108.611 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -83.75 109.05 17.19 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.549 -1.278 . . . . 62.25 107.549 171.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.526 ' HE1' ' HB2' ' B' ' 107' ' ' PHE . 47.9 m-85 -67.61 -24.34 65.47 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.442 0.697 . . . . 53.14 110.521 -176.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.595 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 7.9 t70 -62.81 -37.79 88.13 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.34 -1.3 . . . . 73.42 110.989 177.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.11 -30.06 71.15 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.057 0.943 . . . . 73.42 112.52 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.62 -49.24 41.94 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 109.848 -0.427 . . . . 72.4 109.848 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.458 ' HA ' ' HD2' ' B' ' 140' ' ' TYR . 60.6 m-85 -67.41 -26.68 66.55 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 115.631 -0.713 . . . . 75.12 111.489 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 54.3 ttm -61.35 -27.29 68.4 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.508 1.123 . . . . 55.12 112.008 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -74.05 -40.96 62.47 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.49 0.316 . . . . 72.42 110.359 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . 0.458 ' HD2' ' HA ' ' B' ' 137' ' ' PHE . 53.2 m-85 -72.11 -32.91 67.41 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.711 -0.677 . . . . 73.23 110.649 -176.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 76.4 mt -103.93 36.36 2.36 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.109 -0.951 . . . . 73.43 111.267 -172.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -65.72 155.72 35.2 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 122.644 0.378 . . . . 71.25 110.699 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 17.7 mm-40 65.72 65.53 0.54 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.362 1.065 . . . . 74.21 108.708 -172.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -153.36 106.22 2.93 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.141 -1.39 . . . . 51.44 107.552 -175.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -139.92 164.49 29.86 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.133 0.573 . . . . 40.45 111.447 -172.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -177.78 159.78 25.83 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 114.939 -1.028 . . . . 72.51 110.658 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -153.63 152.69 31.14 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.519 0.728 . . . . 73.5 109.703 -173.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.61 173.54 46.86 Favored Glycine 0 C--N 1.351 1.377 0 O-C-N 123.749 0.656 . . . . 73.43 113.211 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 9.5 t -145.61 -35.84 0.29 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.203 0.601 . . . . 53.24 110.807 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -68.15 100.74 1.05 Allowed 'General case' 0 C--O 1.244 0.791 0 CA-C-O 121.765 0.793 . . . . 73.31 110.977 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -60.09 153.17 22.4 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.965 -1.016 . . . . 64.11 110.256 171.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . 0.433 ' HB3' ' HA3' ' E' ' 116' ' ' GLY . 59.3 m80 -138.13 87.02 2.21 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.104 -0.702 . . . . 73.45 109.104 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -114.98 134.13 55.45 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.359 0.664 . . . . 75.25 110.382 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . 0.416 ' HB3' ' HB ' ' E' ' 115' ' ' THR . 38.2 t70 -131.7 97.16 4.13 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.415 -0.958 . . . . 54.42 108.415 170.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 C-N-CA 123.946 0.898 . . . . 71.43 108.897 -176.324 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 121.285 0.564 . . . . 71.55 110.112 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 18.0 t -84.85 102.65 13.25 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 108.597 -0.89 . . . . 24.21 108.597 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -69.0 -59.39 3.08 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.057 0.943 . . . . 65.21 113.517 -165.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 55.58 45.98 23.79 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.983 0.913 . . . . 73.42 110.907 -172.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -76.61 69.09 2.98 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 122.732 1.253 . . . . 55.11 110.828 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . 0.43 ' HA ' ' HA2' ' C' ' 88' ' ' GLY . 5.2 p-10 -75.64 -44.5 42.31 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.448 -1.251 . . . . 65.43 110.366 -174.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 7.5 p -88.66 75.01 8.31 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 121.781 0.8 . . . . 74.53 109.542 172.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -170.46 -45.38 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.132 -1.394 . . . . 73.24 108.553 175.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.43 ' HA ' ' HA3' ' C' ' 88' ' ' GLY . 21.4 ttt 62.6 115.39 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.353 1.461 . . . . 72.53 111.159 -171.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 49.6 m -111.83 114.17 26.96 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 108.411 -0.959 . . . . 65.23 108.411 173.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -123.42 117.82 26.04 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 107.317 -1.364 . . . . 72.35 107.317 167.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.597 HE22 HG23 ' E' ' 135' ' ' VAL . 5.9 tp60 -141.27 136.03 31.23 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 120.919 0.39 . . . . 71.03 110.177 175.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.44 HG12 ' HE2' ' C' ' 84' ' ' PHE . 16.2 mt -75.92 120.11 25.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 115.083 -0.962 . . . . 72.44 108.407 174.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.523 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.0 mm-40 -87.88 -39.08 15.1 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 123.639 0.587 . . . . 75.44 109.486 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.3 ptt-85 177.96 153.86 0.31 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.513 1.125 . . . . 63.0 110.392 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 70.7 mt -135.05 125.69 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.179 1.391 . . . . 74.3 107.262 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.408 ' HB3' HG23 ' D' ' 122' ' ' THR . 29.8 p90 -164.42 158.68 18.73 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.229 0.538 . . . . 62.01 111.408 -166.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.7 p -87.8 109.63 19.88 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.455 -0.793 . . . . 54.51 110.164 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.534 ' HD2' ' HB3' ' D' ' 28' ' ' ALA . 13.8 mtmt -82.39 -16.68 48.2 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 110.069 -0.345 . . . . 74.42 110.069 172.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.684 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.4 t70 -153.7 139.01 17.53 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.862 -0.608 . . . . 71.44 109.911 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.6 mt -141.57 145.75 24.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 106.57 -1.641 . . . . 73.24 106.57 173.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.4 t -157.23 144.99 18.98 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.262 0.553 . . . . 74.12 110.2 173.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -142.93 129.68 20.4 Favored 'General case' 0 C--O 1.225 -0.208 0 N-CA-C 107.054 -1.462 . . . . 74.11 107.054 170.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -135.73 112.56 10.2 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.24 -0.652 . . . . 73.25 109.24 -175.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.25 85.73 5.77 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 106.981 -1.488 . . . . 24.55 106.981 168.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.26 -19.96 37.81 Favored 'Trans proline' 0 C--N 1.383 2.38 0 C-N-CA 122.69 2.26 . . . . 63.55 111.874 -174.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -120.02 31.01 6.71 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.332 1.053 . . . . 74.43 109.022 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.56 -60.63 2.77 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 114.24 1.2 . . . . 53.3 114.24 -170.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.21 -32.71 41.84 Favored 'Trans proline' 0 C--N 1.379 2.152 0 CA-C-N 121.34 1.514 . . . . 75.15 111.926 -177.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.538 ' HA ' HE21 ' C' ' 33' ' ' GLN . 81.4 t60 -69.32 -38.34 78.18 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.662 -1.153 . . . . 60.11 111.986 -177.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' C' ' 73' ' ' ALA . 13.9 p -79.08 -29.55 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 112.075 0.398 . . . . 73.13 112.075 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -62.61 -30.01 71.03 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.013 0.525 . . . . 62.13 112.383 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.538 HE21 ' HA ' ' C' ' 30' ' ' HIS . 29.3 pt20 -88.59 7.13 34.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.201 0.6 . . . . 71.01 111.949 178.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.403 ' HG2' HD13 ' C' ' 68' ' ' LEU . 2.8 ttpm? -114.71 143.2 45.43 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.659 0.783 . . . . 61.03 110.076 175.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -63.66 131.79 49.06 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.559 1.144 . . . . 72.11 111.985 -175.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.42 ' HZ2' HD21 ' C' ' 126' ' ' LEU . 75.3 t-105 -74.41 87.58 2.05 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.653 1.181 . . . . 64.51 111.683 -177.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . 0.424 ' H ' HD22 ' C' ' 68' ' ' LEU . 47.2 mt-30 -132.91 73.05 76.27 Favored Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 124.253 1.021 . . . . 75.32 108.732 169.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -91.39 148.92 3.57 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.816 2.344 . . . . 61.32 112.598 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -88.25 81.12 7.38 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 107.268 -1.382 . . . . 72.11 107.268 164.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 59.3 t -67.54 113.3 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 CA-C-N 114.911 -1.041 . . . . 73.34 109.964 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -94.02 101.31 13.35 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.561 -0.903 . . . . 72.11 108.561 175.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' F' ' 138' ' ' TYR . 4.7 tt -87.81 129.82 35.07 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 106.97 -1.493 . . . . 74.55 106.97 176.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 14.2 t70 -128.93 140.56 51.61 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.08 0.952 . . . . 64.41 109.477 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.447 HD23 HG22 ' C' ' 62' ' ' VAL . 45.5 mt -125.95 111.12 14.4 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.616 -0.883 . . . . 70.51 108.616 172.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -122.46 121.32 36.33 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 107.74 -1.207 . . . . 54.34 107.74 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.3 t -121.32 144.18 48.78 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.324 -0.621 . . . . 61.14 109.324 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.99 151.56 42.62 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.907 0.883 . . . . 74.45 108.729 177.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 56.7 p -138.06 143.4 40.47 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 122.863 0.465 . . . . 71.25 110.304 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 78.9 p -145.41 153.52 41.29 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.545 0.738 . . . . 74.23 110.006 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -81.94 118.02 22.63 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 109.035 -0.728 . . . . 75.14 109.035 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.651 HD11 ' HB2' ' C' ' 57' ' ' GLU . 87.5 mt -82.89 -53.14 6.08 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.32 0.648 . . . . 42.21 109.288 174.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.15 -172.59 3.52 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 114.206 -1.361 . . . . 24.44 109.14 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -64.44 107.73 1.44 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.702 0.801 . . . . 74.03 110.068 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 70.69 12.62 7.27 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.367 1.467 . . . . 63.52 112.683 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 90.4 t -110.55 118.92 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.064 -0.717 . . . . 72.42 109.064 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -121.5 129.98 53.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.621 1.169 . . . . 72.54 109.343 -174.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.651 ' HB2' HD11 ' C' ' 51' ' ' LEU . 44.8 tt0 -96.77 115.09 26.84 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.208 -0.664 . . . . 74.31 109.208 170.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 89.1 t -96.76 116.01 37.76 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.274 0 N-CA-C 107.894 -1.151 . . . . 62.2 107.894 169.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.46 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 61.0 t -103.76 131.53 52.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.882 -0.785 . . . . 74.42 108.882 173.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -104.47 98.51 8.27 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 107.709 -1.219 . . . . 64.04 107.709 172.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -82.44 106.78 14.59 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.525 -0.917 . . . . 75.41 108.525 172.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.448 ' HB ' HD11 ' C' ' 114' ' ' ILE . 12.8 t -104.61 125.19 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.906 -0.775 . . . . 64.1 108.906 177.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 89.9 m -110.23 130.7 55.5 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.94 -0.763 . . . . 54.32 108.94 178.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.668 HG21 HG21 ' C' ' 114' ' ' ILE . 97.4 t -124.37 109.05 21.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.506 -0.924 . . . . 52.34 108.506 174.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.8 m -101.56 141.89 33.75 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.824 -0.806 . . . . 72.41 108.824 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.21 117.96 18.92 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.266 -1.012 . . . . 73.51 108.266 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 37.3 m -140.03 125.99 19.64 Favored 'General case' 0 N--CA 1.471 0.594 0 O-C-N 123.201 0.313 . . . . 62.31 111.297 -177.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.424 HD22 ' H ' ' C' ' 37' ' ' GLN . 21.2 mt -87.9 46.63 1.4 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.728 1.211 . . . . 70.34 110.138 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.94 -114.45 4.65 Favored Glycine 0 C--N 1.344 1.011 0 N-CA-C 110.519 -1.033 . . . . 64.55 110.519 -170.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.18 -12.53 37.88 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.25 0.62 . . . . 73.4 110.395 174.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -75.27 121.33 22.02 Favored 'General case' 0 C--O 1.219 -0.544 0 C-N-CA 124.359 1.064 . . . . 71.22 109.678 174.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.1 m -82.58 115.9 21.75 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 108.685 -0.858 . . . . 62.01 108.685 165.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.618 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -69.96 -48.57 57.83 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.148 -1.056 . . . . 64.33 108.148 175.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -168.22 172.11 8.85 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 114.316 -1.311 . . . . 73.14 111.27 175.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.438 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.9 tm? -127.56 144.51 51.06 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 106.667 -1.605 . . . . 72.31 106.667 166.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.438 ' N ' HD13 ' C' ' 75' ' ' LEU . 54.1 t -145.86 145.86 30.9 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.71 -0.848 . . . . 71.45 108.71 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -158.81 140.28 13.31 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.762 -0.459 . . . . 63.02 109.762 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 27.0 t -135.81 114.39 15.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 124.65 1.18 . . . . 73.32 107.875 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.684 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.4 mt-30 -94.27 89.07 5.79 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.951 -0.759 . . . . 75.22 108.951 171.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -79.96 96.47 6.42 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 114.576 -1.193 . . . . 74.45 109.108 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -82.78 145.09 23.42 Favored Glycine 0 C--N 1.343 0.945 0 N-CA-C 111.425 -0.67 . . . . 70.53 111.425 177.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.05 117.68 1.09 Allowed Glycine 0 CA--C 1.507 -0.42 0 N-CA-C 111.028 -0.829 . . . . 73.44 111.028 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.523 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 15.5 mm -86.01 131.44 34.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.859 -0.793 . . . . 74.14 108.859 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.44 ' HE2' HG12 ' C' ' 13' ' ' ILE . 94.6 m-85 -137.8 120.54 16.31 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.667 0.787 . . . . 75.42 109.913 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 17.1 p -79.9 100.51 8.09 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 108.282 -1.007 . . . . 64.42 108.282 170.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.545 HD13 ' SG ' ' C' ' 97' ' ' CYS . 15.6 mt -114.3 140.28 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 123.168 0.587 . . . . 71.5 109.698 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.96 158.27 36.28 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.512 1.125 . . . . 74.32 109.315 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' C' ' 6' ' ' ASN . . . 96.01 -18.54 57.25 Favored Glycine 0 C--O 1.246 0.903 0 N-CA-C 115.761 1.064 . . . . 62.02 115.761 166.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 13.5 pt -106.98 170.53 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 117.315 0.558 . . . . 63.34 111.225 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.454 ' H ' HE21 ' C' ' 93' ' ' GLN . 12.4 tp10 -157.68 151.19 23.74 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.328 0.651 . . . . 74.02 110.65 -175.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.73 -121.99 10.02 Favored Glycine 0 C--N 1.348 1.213 0 O-C-N 123.929 0.768 . . . . 25.12 113.647 171.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.1 p -62.16 -30.56 71.14 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.836 0.855 . . . . 71.14 111.617 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.454 HE21 ' H ' ' C' ' 90' ' ' GLU . 17.4 mt-30 -69.98 -49.94 46.65 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.315 1.046 . . . . 72.3 111.137 -179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.04 -46.28 90.04 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 124.105 0.878 . . . . 73.14 110.429 176.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.39 90.92 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.477 0.711 . . . . 64.34 111.226 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -69.44 -35.88 76.11 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.221 0.609 . . . . 75.02 110.697 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.545 ' SG ' HD13 ' C' ' 86' ' ' ILE . 33.8 t -66.83 -51.28 57.51 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.871 0.732 . . . . 74.04 109.291 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 68.7 mt -74.85 -35.52 62.37 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.354 1.062 . . . . 64.33 113.063 -177.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.37 -14.05 33.97 Favored Glycine 0 N--CA 1.473 1.135 0 N-CA-C 115.032 0.773 . . . . 63.41 115.032 -165.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.507 ' HB2' ' HB2' ' C' ' 137' ' ' PHE . . . -138.01 -49.05 0.56 Allowed 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 117.854 0.827 . . . . 60.41 111.944 -173.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -73.12 -49.95 25.51 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.951 0.901 . . . . 73.3 111.633 -172.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.402 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 84.5 m -67.25 -47.49 49.71 Favored Pre-proline 0 CA--C 1.564 1.516 0 C-N-CA 123.478 0.711 . . . . 72.03 112.233 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 52.9 Cg_exo -58.19 -27.8 81.74 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 122.464 2.109 . . . . 74.4 113.552 175.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -65.68 -38.27 88.79 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.188 0.595 . . . . 61.2 110.543 176.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.535 HD12 ' NH1' ' A' ' 111' ' ' ARG . 30.1 mm -71.01 -36.94 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 116.029 -0.532 . . . . 75.02 109.732 177.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 6.1 mp -79.19 -25.5 42.75 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.431 1.092 . . . . 75.41 112.768 -176.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . 0.403 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 56.6 t80 -57.23 -50.71 86.62 Favored Pre-proline 0 N--CA 1.479 0.997 0 CA-C-O 117.849 -1.072 . . . . 72.25 113.394 -172.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 38.7 Cg_exo -60.71 -34.21 92.19 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.016 1.81 . . . . 72.52 113.158 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -64.7 -47.87 76.75 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.226 0.61 . . . . 43.31 110.633 177.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.73 -35.51 80.29 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.775 -0.648 . . . . 54.54 110.788 177.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -61.31 -53.13 60.64 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.246 1.418 . . . . 74.42 110.593 -178.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . 0.405 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.7 tm-20 -66.07 -34.31 77.78 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.403 -0.817 . . . . 70.23 110.28 -178.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.0 t -67.06 -39.17 86.82 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.06 0.544 . . . . 65.32 111.099 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.668 HG21 HG21 ' C' ' 64' ' ' VAL . 87.1 mt -69.17 -50.78 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.371 0.669 . . . . 74.15 110.579 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.2 m -64.14 -28.69 69.94 Favored 'General case' 0 CA--C 1.555 1.135 0 O-C-N 123.486 0.491 . . . . 70.44 110.476 -176.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.4 t -64.44 -51.82 61.21 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 123.57 0.748 . . . . 62.51 109.704 171.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.43 ' CE ' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -50.33 -47.92 55.63 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 124.361 1.064 . . . . 73.03 112.013 177.101 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 91.8 t -67.95 -38.83 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 124.228 1.011 . . . . 53.43 111.12 -177.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 77.6 p -72.7 -30.44 64.21 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.188 0.595 . . . . 73.53 111.44 -178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' C' ' 116' ' ' SER . 86.8 mtt-85 -67.82 -39.83 83.86 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.239 1.016 . . . . 72.12 110.252 175.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.84 7.23 59.66 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-N 115.295 -0.866 . . . . 44.15 112.659 174.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 29.9 p 62.59 26.87 15.93 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.567 1.947 . . . . 75.11 113.46 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -87.3 152.29 52.41 Favored Pre-proline 0 CA--C 1.55 0.947 0 N-CA-C 107.821 -1.177 . . . . 71.14 107.821 166.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.17 169.11 6.61 Favored 'Trans proline' 0 C--N 1.369 1.653 0 C-N-CA 122.783 2.322 . . . . 65.13 113.383 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' B' ' 123' ' ' PHE . 57.4 mm-40 -59.86 113.46 2.29 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.405 -1.27 . . . . 70.31 112.485 -177.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.42 HD21 ' HZ2' ' C' ' 36' ' ' TRP . 63.6 mt -107.33 87.92 2.61 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.965 -1.124 . . . . 65.25 107.965 168.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -89.94 112.65 24.1 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.925 -1.139 . . . . 75.44 107.925 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 40.2 mt -64.73 129.64 40.56 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 123.434 0.459 . . . . 70.25 110.686 -175.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.53 150.65 93.75 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.571 0.748 . . . . 64.42 110.468 178.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.572 ' HG3' HD12 ' A' ' 16' ' ' ILE . 26.8 Cg_exo -59.81 105.39 0.27 Allowed 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.34 2.027 . . . . 72.3 112.268 174.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 35.7 t -99.52 117.36 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 108.12 -1.067 . . . . 52.24 108.12 176.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -77.08 103.37 6.97 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.826 0.85 . . . . 71.33 110.515 -172.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -65.78 -24.98 67.05 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.63 -0.714 . . . . 72.43 111.654 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -67.1 -40.07 86.83 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.327 0.651 . . . . 74.43 109.973 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.8 -45.79 91.01 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.362 0.665 . . . . 64.34 110.509 174.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 81.2 mt -69.34 -23.46 63.77 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.043 -0.98 . . . . 74.11 111.388 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . 0.507 ' HB2' ' HB2' ' C' ' 100' ' ' ALA . 79.1 t80 -75.64 -58.03 3.53 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 116.313 -0.403 . . . . 72.21 110.104 176.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 52.5 mtm -61.29 -27.07 68.21 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.554 0.742 . . . . 65.23 111.256 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -49.94 -35.51 24.31 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.674 1.59 . . . . 71.11 113.074 174.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . 0.436 ' HE1' ' HG2' ' C' ' 142' ' ' GLN . 0.0 OUTLIER -70.38 -153.67 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.684 0 C-N-CA 122.587 0.355 . . . . 71.1 111.321 -177.286 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 59.8 tp -78.45 83.69 4.65 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.497 -0.752 . . . . 63.52 108.985 171.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.436 ' HG2' ' HE1' ' C' ' 140' ' ' TYR . 0.5 OUTLIER -109.32 103.45 12.4 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 107.152 -1.425 . . . . 73.32 107.152 176.11 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . 0.571 ' HA ' HE21 ' C' ' 143' ' ' GLN . 0.0 OUTLIER -85.93 -46.96 10.07 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.453 -0.339 . . . . 73.22 110.781 -175.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -105.82 105.29 15.26 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.188 0.518 . . . . 43.24 112.049 -170.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -107.85 -157.23 0.61 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.324 1.05 . . . . 75.51 108.364 167.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 118.17 118.72 2.87 Favored Glycine 0 C--N 1.347 1.169 0 CA-C-O 119.597 -0.557 . . . . 63.13 111.988 174.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.24 178.33 6.54 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.942 0.897 . . . . 73.22 112.404 -177.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . 0.405 ' H ' ' HA3' ' A' ' 148' ' ' GLY . . . 89.08 120.52 1.83 Allowed Glycine 0 C--N 1.352 1.466 0 N-CA-C 111.287 -0.725 . . . . 72.04 111.287 -175.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 14.6 t -152.56 162.31 41.39 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 117.501 0.65 . . . . 72.33 111.317 -174.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -70.98 139.07 50.45 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.745 0.818 . . . . 61.43 110.445 174.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.34 156.02 25.69 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 108.4 -0.963 . . . . 74.32 108.4 175.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -69.85 134.34 48.38 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 109.658 -0.497 . . . . 74.24 109.658 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -81.52 -57.21 3.57 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.483 0.313 . . . . 71.32 111.018 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -156.69 163.19 39.57 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.479 0.712 . . . . 63.24 109.159 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.403 0 C-N-CA 123.487 0.715 . . . . 64.24 109.29 176.246 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 80.4 mtp . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 109.707 -0.479 . . . . 74.23 109.707 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' E' ' 98' ' ' ASP . 19.5 m -127.01 117.45 22.5 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.504 0.722 . . . . 73.14 109.284 178.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.19 103.88 5.53 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.82 -0.807 . . . . 75.25 108.82 174.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -69.83 113.5 7.13 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.103 0.561 . . . . 74.12 109.74 -173.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . 0.444 ' HB3' ' HG2' ' E' ' 95' ' ' LYS . 34.4 t30 -134.69 132.49 38.94 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.448 0.699 . . . . 74.11 109.417 176.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.96 130.94 34.55 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.592 0.757 . . . . 72.33 109.555 178.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 9.3 t -150.58 179.64 8.0 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 124.071 0.948 . . . . 74.1 108.535 176.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -54.66 103.57 0.09 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.356 0.662 . . . . 75.14 110.812 175.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -32.52 122.51 0.34 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 125.289 1.436 . . . . 75.51 111.751 175.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 24.3 m -114.57 129.1 56.63 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.168 -0.679 . . . . 74.22 109.168 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.496 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 50.6 t80 -133.98 98.61 4.2 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.457 -1.312 . . . . 64.0 107.457 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -132.51 127.97 36.33 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.257 -0.646 . . . . 71.2 109.257 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 6.1 mt -83.88 127.22 39.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 108.572 -0.899 . . . . 64.34 108.572 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.505 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 75.1 mm-40 -81.96 -35.21 29.25 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.478 0.711 . . . . 73.32 110.302 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.0 ttt180 -171.25 133.8 0.87 Allowed 'General case' 0 C--N 1.357 0.914 0 O-C-N 123.737 0.648 . . . . 74.2 110.7 -175.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.434 HD12 ' N ' ' D' ' 16' ' ' ILE . 3.4 mp -105.57 141.85 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 107.144 -1.428 . . . . 72.34 107.144 171.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -166.72 152.92 8.45 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.438 0.637 . . . . 74.11 111.7 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 71.3 p -89.14 117.29 28.03 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-N 114.882 -1.054 . . . . 72.11 109.702 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -86.56 -29.74 22.42 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.652 -0.704 . . . . 60.41 109.371 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.6 t70 -150.87 142.15 23.28 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.815 -1.084 . . . . 65.31 109.589 176.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.43 HG21 ' CE ' ' C' ' 117' ' ' MET . 76.7 mt -140.73 141.07 32.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 C-N-CA 125.367 1.467 . . . . 72.02 107.402 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.7 t -147.21 144.29 28.81 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.681 0.793 . . . . 53.41 109.54 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.494 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.6 t80 -147.51 134.42 20.2 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 107.301 -1.37 . . . . 72.43 107.301 168.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.636 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 43.6 mt-10 -133.33 148.69 51.89 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.13 0.972 . . . . 74.1 108.954 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.418 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -150.73 80.07 6.92 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 107.44 -1.319 . . . . 55.23 107.44 171.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -67.46 -52.38 0.59 Allowed 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.545 2.163 . . . . 72.52 112.385 -174.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -87.61 19.63 3.31 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.457 0.703 . . . . 72.43 111.05 -176.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.534 ' HB3' ' HD2' ' C' ' 19' ' ' LYS . . . -48.26 -61.09 3.45 Favored Pre-proline 0 CA--C 1.556 1.201 0 N-CA-C 114.826 1.417 . . . . 25.21 114.826 -164.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.464 ' HB3' HD11 ' C' ' 83' ' ' ILE . 60.2 Cg_endo -68.13 -20.5 43.7 Favored 'Trans proline' 0 C--N 1.388 2.617 0 CA-C-N 121.704 1.644 . . . . 73.41 113.288 -173.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.422 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 6.1 t-160 -81.83 -40.72 22.09 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.987 -1.006 . . . . 61.53 110.795 177.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.434 HG22 HD12 ' D' ' 68' ' ' LEU . 9.8 p -83.12 -16.06 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 O-C-N 122.246 -0.284 . . . . 73.43 111.424 -169.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -62.58 -16.85 58.45 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 112.529 0.566 . . . . 75.45 112.529 170.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.422 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 56.8 mt-30 -69.12 -7.68 38.36 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.717 0.807 . . . . 73.14 111.424 174.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -106.27 100.57 10.1 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.797 1.239 . . . . 72.02 109.638 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -97.86 92.77 5.99 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.775 0.83 . . . . 72.03 110.327 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -167.09 -178.34 4.12 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.033 0.933 . . . . 74.31 109.918 171.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -69.64 113.14 14.99 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.132 0.973 . . . . 74.03 109.841 178.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -58.84 125.89 19.56 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.46 2.106 . . . . 53.42 111.239 176.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -76.75 114.09 15.12 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.085 -1.08 . . . . 62.41 108.085 173.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.549 ' CG1' HG13 ' D' ' 64' ' ' VAL . 9.0 t -112.69 129.79 67.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 CA-C-N 115.886 -0.597 . . . . 74.33 110.341 -171.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.591 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 72.0 mmtt -88.6 108.51 19.48 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.979 -1.119 . . . . 74.3 107.979 168.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.484 HD11 HG13 ' D' ' 62' ' ' VAL . 42.5 tp -98.52 121.08 40.02 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.785 -0.82 . . . . 64.21 108.785 173.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.503 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 8.8 t0 -120.38 143.99 48.14 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.009 -1.478 . . . . 70.21 107.009 177.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.418 ' H ' ' HB2' ' E' ' 112' ' ' ASN . 58.1 mt -133.84 129.67 36.8 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.495 0.718 . . . . 74.52 109.577 -175.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.424 ' HB2' ' HB3' ' D' ' 61' ' ' ARG . 54.0 m-20 -134.56 145.67 48.93 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.708 -1.219 . . . . 72.22 107.708 173.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 7.1 t -105.03 161.15 14.46 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.788 -0.819 . . . . 72.21 108.788 169.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.64 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.83 152.68 35.53 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.945 0.898 . . . . 74.32 108.649 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' E' ' 105' ' ' GLN . 5.2 p -161.31 177.82 9.8 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.35 0.66 . . . . 65.44 110.037 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 49.3 p -164.06 160.21 21.4 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 111.963 0.357 . . . . 61.21 111.963 -176.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . 0.679 ' HG2' HD23 ' D' ' 51' ' ' LEU . 40.8 tt0 69.84 152.07 0.1 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 126.181 1.792 . . . . 74.34 111.483 -176.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.679 HD23 ' HG2' ' D' ' 50' ' ' GLN . 2.6 pt? -59.45 -34.44 72.53 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.749 -0.463 . . . . 74.43 109.749 174.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . 68.36 93.79 0.07 Allowed 'General case' 0 C--N 1.361 1.103 0 C-N-CA 125.38 1.472 . . . . 73.12 113.302 164.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.38 78.24 9.78 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 124.274 1.03 . . . . 73.33 108.712 174.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.417 ' HA ' ' HE1' ' D' ' 56' ' ' TYR . 61.8 m-20 66.67 7.2 4.99 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 125.035 1.334 . . . . 64.25 113.36 -177.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 15.7 t -124.26 98.65 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 107.89 -1.152 . . . . 74.25 107.89 176.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.417 ' HE1' ' HA ' ' D' ' 54' ' ' ASP . 30.2 m-85 -115.63 135.01 54.48 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.075 0.55 . . . . 74.4 109.742 -174.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.45 ' HG2' HD13 ' D' ' 83' ' ' ILE . 39.4 mt-10 -90.62 114.06 26.24 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.068 -1.086 . . . . 73.24 108.068 162.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 88.7 t -103.19 140.08 22.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 107.849 -1.167 . . . . 73.41 107.849 168.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.64 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 41.7 t -133.56 146.97 31.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 107.625 -1.25 . . . . 62.35 107.625 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.63 115.91 20.19 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.63 -1.248 . . . . 55.21 107.63 178.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.424 ' HB3' ' HB2' ' D' ' 45' ' ' ASP . 24.8 ttm-85 -93.07 98.56 11.41 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.046 -1.094 . . . . 71.34 108.046 175.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.484 HG13 HD11 ' D' ' 42' ' ' LEU . 49.4 t -99.12 112.72 32.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.785 -0.82 . . . . 70.03 108.785 176.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 63.9 m -105.72 134.21 49.2 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.75 -1.114 . . . . 74.54 109.206 -175.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.549 HG13 ' CG1' ' D' ' 40' ' ' VAL . 71.5 t -131.63 119.75 43.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 124.287 1.035 . . . . 73.24 108.556 -177.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.591 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 24.1 m -126.49 90.76 3.23 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.757 -1.201 . . . . 75.0 107.757 177.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -97.37 146.43 25.18 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.831 -0.622 . . . . 73.41 110.136 -174.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.519 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 31.4 p -147.31 139.93 24.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 123.871 0.732 . . . . 75.14 110.97 -173.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.434 HD12 HG22 ' D' ' 31' ' ' VAL . 24.0 mt -112.08 112.89 24.84 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 107.755 -1.202 . . . . 75.22 107.755 171.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.73 -114.29 3.8 Favored Glycine 0 C--N 1.347 1.14 0 N-CA-C 113.692 0.237 . . . . 62.43 113.692 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.06 12.53 11.95 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.345 0.658 . . . . 63.15 110.487 -178.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -130.52 162.37 29.41 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.024 0.53 . . . . 73.14 109.63 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -71.89 130.41 40.95 Favored 'General case' 0 C--O 1.243 0.721 0 O-C-N 123.809 0.693 . . . . 45.32 110.71 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.519 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -81.68 -65.24 1.04 Allowed 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.648 -1.241 . . . . 65.25 107.648 172.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -151.61 150.22 30.04 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.132 -0.94 . . . . 73.53 111.125 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.636 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 63.4 mt -108.55 153.94 22.65 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.516 1.126 . . . . 75.12 108.765 171.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.504 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.2 t -160.33 142.53 12.94 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.086 0.555 . . . . 63.22 109.796 174.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -154.9 126.15 7.27 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.943 -0.392 . . . . 72.43 109.943 171.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.0 t -125.76 117.03 48.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 123.771 0.828 . . . . 53.11 109.187 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.597 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.6 mt-30 -90.23 86.94 6.65 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 108.816 -0.809 . . . . 75.52 108.816 172.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.14 110.5 15.61 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.181 -1.372 . . . . 71.35 109.342 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -108.39 173.03 17.5 Favored Glycine 0 C--N 1.338 0.659 0 O-C-N 123.067 0.23 . . . . 45.24 113.468 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.74 152.83 14.6 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 115.735 -0.233 . . . . 73.44 112.937 177.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 19.3 mm -90.19 115.72 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 107.997 -1.112 . . . . 74.22 107.997 173.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -112.65 135.08 53.8 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.759 0.823 . . . . 61.24 110.326 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 39.3 t -102.11 106.96 17.91 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.817 -0.808 . . . . 74.54 108.817 172.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 42.9 pt -121.34 132.84 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.104 -0.702 . . . . 64.34 109.104 173.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.87 165.61 22.66 Favored 'General case' 0 C--O 1.243 0.744 0 O-C-N 123.448 0.468 . . . . 53.31 111.796 -173.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.27 -4.63 83.19 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.15 -0.932 . . . . 64.02 114.015 177.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.459 HD12 ' H ' ' D' ' 89' ' ' ILE . 0.5 OUTLIER -104.57 163.34 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 121.365 0.602 . . . . 64.31 110.665 -177.56 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' D' ' 91' ' ' GLY . 29.6 tt0 -148.05 174.34 12.02 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 114.453 -1.249 . . . . 74.33 108.639 -173.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . 0.449 ' H ' ' HG2' ' D' ' 90' ' ' GLU . . . 77.6 -140.9 24.91 Favored Glycine 0 C--N 1.342 0.867 0 C-N-CA 123.218 0.437 . . . . 74.03 112.628 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 60.8 p -90.48 -29.64 17.8 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.212 0.605 . . . . 74.01 110.838 178.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.51 ' HA ' ' HB3' ' D' ' 96' ' ' HIS . 20.7 pt20 -64.63 -23.66 67.33 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.744 0.818 . . . . 74.24 112.401 -173.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.597 ' SD ' HD23 ' E' ' 100' ' ' LEU . 0.0 OUTLIER -64.78 -43.37 93.47 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.101 0.56 . . . . 32.43 111.327 178.054 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . 0.482 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -85.15 -17.33 37.55 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.477 0.711 . . . . 74.25 111.406 177.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.51 ' HB3' ' HA ' ' D' ' 93' ' ' GLN . 78.1 t60 -73.89 -37.58 64.64 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.67 0.788 . . . . 74.53 110.608 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 71.1 m -60.71 -34.91 75.09 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.947 0.499 . . . . 62.4 110.74 174.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.432 ' HA ' HD22 ' D' ' 98' ' ' LEU . 1.1 tm? -75.42 -43.45 49.82 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.264 1.026 . . . . 71.31 110.508 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.4 -26.68 60.93 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 115.565 -0.743 . . . . 74.3 114.06 -173.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.521 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -122.37 -59.02 1.67 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.026 0.53 . . . . 71.42 112.028 -169.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -71.04 -37.81 72.55 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 112.13 0.418 . . . . 70.31 112.13 -170.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.496 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 73.9 m -66.58 -47.76 56.28 Favored Pre-proline 0 CA--C 1.568 1.657 0 CA-C-O 118.723 -0.656 . . . . 71.13 111.943 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 51.8 Cg_exo -58.9 -33.3 98.57 Favored 'Trans proline' 0 C--N 1.394 2.948 0 C-N-CA 122.052 1.834 . . . . 75.23 113.372 170.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -64.22 -35.13 79.79 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.802 0.441 . . . . 75.42 110.849 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 24.1 mm -63.91 -39.52 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.08 0.952 . . . . 72.14 110.71 173.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 85.7 mt -78.13 -14.59 59.41 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.474 -0.784 . . . . 74.34 112.222 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -72.16 -40.68 7.76 Favored Pre-proline 0 N--CA 1.486 1.334 0 N-CA-C 113.497 0.925 . . . . 71.55 113.497 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -47.68 -49.06 14.22 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 122.351 2.034 . . . . 65.45 113.298 166.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -71.6 -35.15 70.41 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.43 0.692 . . . . 74.05 111.535 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.81 -57.46 8.83 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.713 0.805 . . . . 73.44 110.185 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.418 ' NH2' HG23 ' B' ' 105' ' ' ILE . 39.5 ttp180 -56.72 -42.2 78.77 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 114.332 -1.304 . . . . 71.44 110.761 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -56.78 -54.62 44.26 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.891 0.744 . . . . 74.25 110.727 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.4 t -54.87 -45.32 74.58 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.291 0.995 . . . . 62.14 110.867 -177.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.504 HG12 ' SG ' ' D' ' 76' ' ' CYS . 85.1 mt -61.16 -58.54 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 123.67 0.788 . . . . 54.51 110.923 176.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.7 m -51.87 -43.87 63.46 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.932 1.293 . . . . 75.03 111.598 -174.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.411 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 33.3 t -63.79 -44.72 92.53 Favored 'General case' 0 C--O 1.216 -0.698 0 CA-C-N 114.505 -1.225 . . . . 73.35 109.826 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 68.1 mtm -69.82 -30.88 68.5 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.034 0.534 . . . . 62.05 111.613 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.478 HG23 ' O ' ' D' ' 114' ' ' ILE . 80.3 t -64.4 -45.96 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.582 0.753 . . . . 75.44 109.573 175.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 95.2 p -74.4 -28.32 61.04 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.451 -0.795 . . . . 75.13 110.722 -178.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' D' ' 116' ' ' SER . 69.4 mtt-85 -70.26 -27.12 64.19 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.53 0.732 . . . . 71.31 109.932 173.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.75 10.5 67.44 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 123.804 0.69 . . . . 72.33 112.887 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.408 HG23 ' HB3' ' C' ' 17' ' ' TYR . 68.8 p 53.79 29.41 9.63 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 126.113 1.765 . . . . 64.51 113.561 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -92.47 158.49 38.53 Favored Pre-proline 0 C--O 1.242 0.688 0 CA-C-N 115.449 -0.796 . . . . 71.14 109.737 171.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -48.16 119.96 4.48 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.768 2.312 . . . . 74.41 112.113 169.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -46.54 124.51 5.99 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 124.72 1.262 . . . . 74.32 111.757 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.413 HD21 HG11 ' D' ' 40' ' ' VAL . 33.7 tp -107.5 98.69 8.27 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.962 0.41 . . . . 52.4 111.042 -173.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . 0.466 ' ND2' ' H ' ' B' ' 16' ' ' ILE . 83.4 m-20 -97.98 96.85 8.44 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 107.11 -1.441 . . . . 72.44 107.11 173.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.05 132.56 54.33 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.519 -0.764 . . . . 44.14 109.481 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.16 136.72 96.82 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 122.714 0.405 . . . . 61.15 110.45 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.542 ' HD3' HG13 ' B' ' 13' ' ' ILE . 93.8 Cg_endo -79.55 145.79 18.72 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 122.577 2.184 . . . . 75.14 111.864 -174.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 9.0 p -141.24 141.1 31.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 109.003 -0.74 . . . . 73.43 109.003 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -78.95 108.61 12.55 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.676 -0.861 . . . . 62.51 108.676 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.407 ' HA ' HD23 ' D' ' 136' ' ' LEU . 1.7 m-85 -62.69 -28.3 69.84 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.391 0.676 . . . . 65.32 110.346 178.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.521 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 5.6 t70 -60.53 -38.01 83.04 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.715 -1.129 . . . . 73.42 110.403 175.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.92 -32.46 74.19 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.807 0.843 . . . . 73.44 111.911 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' D' ' 133' ' ' PHE . 2.7 mm? -74.62 -46.97 34.91 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.75 0.42 . . . . 73.01 111.347 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.525 ' HE1' ' HB2' ' E' ' 108' ' ' HIS . 69.1 m-85 -70.0 -27.94 65.1 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 116.721 -0.218 . . . . 73.22 111.555 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 69.6 mtm -72.04 -37.2 69.75 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.456 0.303 . . . . 75.32 110.58 167.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.48 ' O ' ' HG3' ' D' ' 143' ' ' GLN . 0.1 OUTLIER -54.81 -40.52 69.6 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 124.075 0.95 . . . . 73.22 110.337 -178.447 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -57.3 -34.42 68.69 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.096 0.872 . . . . 75.21 111.849 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.2 mp -80.96 -29.48 35.35 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.892 0.877 . . . . 73.15 110.685 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -83.7 33.14 0.47 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.234 1.014 . . . . 72.24 111.778 -177.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' D' ' 139' ' ' ASN . 23.7 mt-30 -119.16 55.78 0.93 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 122.061 0.934 . . . . 73.52 109.141 -173.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -168.64 -60.02 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 114.028 -1.442 . . . . 74.3 108.573 -177.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.58 158.6 35.89 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.938 -1.028 . . . . 63.13 109.817 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -172.88 -27.92 0.02 OUTLIER Glycine 0 C--N 1.345 1.063 0 O-C-N 123.34 0.4 . . . . 73.35 112.572 178.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.35 89.79 0.08 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.535 1.534 . . . . 75.2 110.91 176.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -81.46 83.11 1.52 Allowed Glycine 0 C--N 1.346 1.097 0 CA-C-N 116.337 -0.392 . . . . 54.12 113.901 -174.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 7.6 t -119.04 120.95 38.73 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.896 -0.779 . . . . 75.44 108.896 172.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -117.59 147.42 42.86 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.838 0.455 . . . . 72.21 111.051 -176.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -132.8 79.04 1.83 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 106.999 -1.482 . . . . 74.21 106.999 170.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -152.07 -172.43 4.22 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.67 0.788 . . . . 71.42 109.746 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . 0.407 ' HG2' ' HB3' ' B' ' 90' ' ' GLU . 29.0 mm-40 -66.72 91.45 0.19 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.885 -0.413 . . . . 64.12 109.885 174.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -65.48 129.12 38.6 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.994 0.918 . . . . 71.12 110.327 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.217 0 C-N-CA 123.255 0.622 . . . . 72.11 109.98 -179.635 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.927 0 CA-C-O 119.922 -0.376 . . . . 75.52 112.597 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.67 44.44 89.6 Favored Glycine 0 C--N 1.357 1.698 0 CA-C-N 116.627 0.214 . . . . 74.41 112.888 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 56.66 -159.15 0.24 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.382 1.073 . . . . 73.04 110.442 -172.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -110.03 -161.55 0.76 Allowed 'General case' 0 N--CA 1.484 1.235 0 O-C-N 121.18 -0.95 . . . . 64.34 110.399 -172.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 95' ' ' LYS . . . . . 0.444 ' HG2' ' HB3' ' D' ' 5' ' ' ASN . 0.9 OUTLIER -71.25 109.55 5.35 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.828 -0.804 . . . . 75.4 108.828 171.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . -51.51 139.03 27.55 Favored Glycine 0 C--N 1.356 1.692 0 O-C-N 125.361 1.663 . . . . 72.14 113.499 -177.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 97' ' ' ILE . . . . . 0.448 HD13 ' HB2' ' D' ' 94' ' ' MET . 29.9 mt -51.2 -40.98 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.469 0.708 . . . . 73.13 111.57 -177.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 98' ' ' ASP . . . . . 0.4 ' HB2' ' HB2' ' D' ' 2' ' ' SER . 35.9 t70 76.0 -50.45 0.61 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.559 1.543 . . . . 54.53 113.268 169.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.34 -52.34 63.83 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.895 1.278 . . . . 74.35 112.512 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 100' ' ' LEU . . . . . 0.597 HD23 ' SD ' ' D' ' 94' ' ' MET . 3.6 pp -74.27 139.85 75.85 Favored Pre-proline 0 CA--C 1.549 0.916 0 O-C-N 123.099 0.25 . . . . 74.12 110.562 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 101' ' ' PRO . . . . . 0.504 ' HD2' HG23 ' E' ' 103' ' ' THR . 40.6 Cg_endo -94.9 24.27 0.37 Allowed 'Trans proline' 0 C--N 1.366 1.448 0 C-N-CA 123.127 2.551 . . . . 53.23 110.343 155.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 102' ' ' LEU . . . . . . . . . . . . . 1.4 tt 58.26 84.07 0.11 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.049 1.74 . . . . 74.43 109.689 -166.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 103' ' ' THR . . . . . 0.504 HG23 ' HD2' ' E' ' 101' ' ' PRO . 23.4 p -74.18 125.73 29.02 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.396 1.078 . . . . 65.42 111.663 -176.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.27 78.83 0.13 Allowed Glycine 0 C--N 1.355 1.594 0 O-C-N 123.974 0.796 . . . . 60.21 112.758 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 105' ' ' GLN . . . . . 0.418 ' HB3' ' O ' ' D' ' 48' ' ' SER . 22.6 mp0 -67.1 -60.84 2.28 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.933 0.493 . . . . 65.44 110.792 -172.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 106' ' ' TYR . . . . . 0.446 ' HA ' ' HA ' ' D' ' 47' ' ' ALA . 58.1 t80 -83.07 94.43 7.8 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.613 -0.884 . . . . 73.55 108.613 174.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 46.5 m 63.78 105.5 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.699 1.2 . . . . 63.33 110.963 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 108' ' ' HIS . . . . . 0.525 ' HB2' ' HE1' ' D' ' 137' ' ' PHE . 18.3 m-70 -66.09 -39.27 89.87 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 115.324 -0.853 . . . . 73.43 111.031 -170.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -138.97 -76.28 0.36 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.813 0.845 . . . . 63.14 109.001 173.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . 0.571 ' HB3' ' HE2' ' E' ' 114' ' ' LYS . . . -163.38 151.39 13.39 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.451 1.1 . . . . 73.24 108.578 176.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . 0.514 HD13 ' HE2' ' D' ' 137' ' ' PHE . 55.5 tp -131.0 -75.53 0.53 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.964 0.505 . . . . 54.31 110.363 -172.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 112' ' ' ASN . . . . . 0.418 ' HB2' ' H ' ' D' ' 44' ' ' LEU . 28.0 t-20 -57.36 -50.57 72.52 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.378 0.671 . . . . 72.32 112.127 -168.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -113.61 84.23 1.98 Allowed 'General case' 0 C--O 1.239 0.505 0 N-CA-C 109.255 -0.646 . . . . 73.23 109.255 176.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . 0.571 ' HE2' ' HB3' ' E' ' 110' ' ' ALA . 0.0 OUTLIER -84.81 122.76 29.6 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.662 -0.699 . . . . 64.5 109.19 168.554 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 115' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' B' ' 154' ' ' ASP . 23.3 p -73.88 80.49 1.64 Allowed 'General case' 0 CA--C 1.543 0.706 0 O-C-N 124.114 0.884 . . . . 74.42 109.877 174.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 116' ' ' GLY . . . . . 0.433 ' HA3' ' HB3' ' B' ' 152' ' ' HIS . . . -122.6 83.77 0.36 Allowed Glycine 0 C--N 1.341 0.848 0 CA-C-N 114.553 -1.203 . . . . 52.04 110.225 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 117' ' ' LYS . . . . . 0.586 ' HB3' ' HD2' ' E' ' 118' ' ' PRO . 46.6 mtmt 67.97 177.82 0.05 OUTLIER Pre-proline 0 CA--C 1.563 1.454 0 C-N-CA 124.766 1.227 . . . . 71.04 108.958 -159.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 118' ' ' PRO . . . . . 0.586 ' HD2' ' HB3' ' E' ' 117' ' ' LYS . 16.2 Cg_exo -27.4 -52.64 0.11 Allowed 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 123.891 3.061 . . . . 53.22 116.113 172.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -160.37 169.91 22.13 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 120.86 0.362 . . . . 75.24 110.937 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 120' ' ' TYR . . . . . 0.475 ' HE1' ' HB ' ' B' ' 7' ' ' THR . 55.8 t80 -150.36 -29.26 0.22 Allowed 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.355 1.062 . . . . 74.34 110.174 174.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 121' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.36 82.79 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 123.114 0.566 . . . . 63.11 110.278 -178.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . 0.477 ' H ' HD21 ' B' ' 5' ' ' ASN . 44.8 m -159.52 126.19 4.52 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.682 1.193 . . . . 62.13 108.732 166.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -172.2 165.79 6.02 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.123 0.889 . . . . 74.42 109.315 170.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 23.2 m -68.69 132.97 47.75 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.53 0.732 . . . . 70.42 110.649 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -84.11 157.68 21.65 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.587 0.755 . . . . 75.34 110.991 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 126' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' D' ' 127' ' ' ASN . . . -81.33 120.34 24.81 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.642 -0.708 . . . . 73.34 112.493 -170.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 39.5 m -138.29 -69.07 0.44 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.89 -0.781 . . . . 73.41 108.89 167.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . 56.26 21.81 5.65 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.193 0.997 . . . . 34.35 112.749 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 12.9 t -127.92 165.55 19.99 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.109 0.564 . . . . 73.45 111.153 -172.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -136.83 169.82 17.12 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.034 0.934 . . . . 65.42 110.406 -176.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 131' ' ' TRP . . . . . 0.7 ' HE1' ' HB3' ' A' ' 125' ' ' GLN . 29.6 t90 -114.32 103.2 10.83 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 108.723 -0.843 . . . . 70.4 108.723 173.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 55.0 m -151.77 66.84 0.87 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.621 0.768 . . . . 72.01 110.384 177.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 91.4 m -139.92 133.15 29.78 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.061 0.545 . . . . 51.14 109.712 173.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -162.99 148.93 16.11 Favored Glycine 0 C--N 1.342 0.882 0 N-CA-C 111.276 -0.73 . . . . 65.33 111.276 175.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 135' ' ' VAL . . . . . 0.597 HG23 HE22 ' C' ' 12' ' ' GLN . 29.2 m -87.8 -174.71 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.547 0.739 . . . . 74.13 110.546 176.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -97.92 156.61 16.53 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.201 0.6 . . . . 73.5 110.215 171.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 7.2 t -70.14 131.21 43.92 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-O 121.24 0.543 . . . . 63.21 111.872 -177.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -110.12 112.38 24.32 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 107.529 -1.286 . . . . 72.42 107.529 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -151.34 -55.34 0.14 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.206 0.602 . . . . 71.52 109.915 175.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . 63.03 28.6 72.35 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 120.88 0.156 . . . . 74.12 112.902 -177.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -91.36 152.86 20.26 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.682 0.793 . . . . 60.35 110.359 -176.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 47.9 tp -91.93 -5.2 53.59 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.732 0.813 . . . . 74.33 110.027 174.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.08 164.26 35.62 Favored Glycine 0 C--N 1.351 1.386 0 N-CA-C 111.818 -0.513 . . . . 53.22 111.818 -173.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 42.1 t -117.94 -65.11 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 N-CA-C 109.741 -0.466 . . . . 65.15 109.741 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 31.3 t70 . . . . . 0 C--O 1.249 1.054 0 C-N-CA 123.753 0.821 . . . . 64.11 109.01 -176.413 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.869 0 N-CA-C 112.192 -0.363 . . . . 71.24 112.192 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' F' F ' 92' ' ' GLY . . . . . 0.438 ' HA3' ' OE1' ' B' ' 14' ' ' GLN . . . 160.1 172.27 27.1 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-O 119.588 -0.562 . . . . 51.25 112.444 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 57.22 83.83 0.1 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.367 1.067 . . . . 74.44 110.869 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -120.82 -172.52 2.4 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.609 -0.723 . . . . 70.32 110.357 -173.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -141.96 89.78 2.21 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.82 -1.178 . . . . 75.34 107.82 172.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -157.53 11.1 0.25 Allowed Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.488 -0.778 . . . . 24.43 114.231 -174.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 97' ' ' ILE . . . . . 0.599 ' HB ' ' HA ' ' B' ' 87' ' ' ALA . 15.5 tt -124.46 157.2 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 109.282 -0.636 . . . . 64.4 109.282 174.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -75.96 -91.15 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 123.825 0.85 . . . . 63.41 111.356 -175.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -153.28 124.98 7.74 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 107.923 -1.14 . . . . 73.33 107.923 -176.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 100' ' ' LEU . . . . . 0.437 ' HB2' ' CE1' ' B' ' 56' ' ' TYR . 2.9 mp -98.86 106.09 35.33 Favored Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 123.43 0.692 . . . . 65.13 111.421 -164.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -89.88 152.27 4.96 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.74 2.293 . . . . 54.21 113.455 178.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 102' ' ' LEU . . . . . 0.497 HD11 ' OG ' ' B' ' 48' ' ' SER . 4.3 mm? -101.93 22.66 12.65 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.048 0.939 . . . . 72.24 109.777 167.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 72.9 p 51.16 29.87 5.16 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.788 1.635 . . . . 73.2 112.61 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 141.21 -87.46 0.19 Allowed Glycine 0 C--N 1.345 1.041 0 N-CA-C 110.139 -1.184 . . . . 74.42 110.139 -175.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -152.24 -62.72 0.17 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 108.103 -1.073 . . . . 71.54 108.103 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -126.22 78.35 1.76 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.134 -1.062 . . . . 74.31 108.134 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 29.2 m 58.72 113.48 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 124.722 1.209 . . . . 72.24 113.525 169.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -66.91 -26.52 66.9 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.939 0.496 . . . . 70.02 110.87 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -95.38 -109.78 0.14 Allowed 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 123.534 0.734 . . . . 62.15 109.82 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -178.48 154.93 0.83 Allowed 'General case' 0 C--N 1.362 1.113 0 C-N-CA 125.117 1.367 . . . . 54.3 108.925 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 53.8 tp -124.21 -46.75 1.92 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.131 0.572 . . . . 74.15 109.544 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -74.28 98.6 3.25 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.142 0.577 . . . . 75.35 110.58 174.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -133.21 165.32 25.06 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.892 0.877 . . . . 54.44 109.559 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . 0.562 ' HG3' ' H ' ' F' ' 116' ' ' GLY . 18.9 ptpt -144.07 -28.84 0.5 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.979 0.511 . . . . 52.25 111.943 -174.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 2.0 m 63.56 18.73 11.28 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.251 1.02 . . . . 63.31 111.342 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 116' ' ' GLY . . . . . 0.562 ' H ' ' HG3' ' F' ' 114' ' ' LYS . . . 72.3 -76.64 0.76 Allowed Glycine 0 C--N 1.353 1.481 0 N-CA-C 110.624 -0.991 . . . . 34.5 110.624 -168.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -86.7 110.74 34.7 Favored Pre-proline 0 CA--C 1.546 0.817 0 N-CA-C 107.592 -1.262 . . . . 61.1 107.592 169.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 118' ' ' PRO . . . . . 0.432 ' HB2' ' HA ' ' F' ' 122' ' ' THR . 30.7 Cg_exo -62.24 107.37 0.56 Allowed 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 123.056 2.504 . . . . 72.34 112.943 -176.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -71.69 -66.96 0.57 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.256 -0.884 . . . . 61.22 108.68 170.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -97.13 161.95 13.59 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.141 -1.059 . . . . 72.44 108.141 165.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 13.3 t 61.08 34.86 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 122.701 1.239 . . . . 64.03 108.874 -171.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . 0.432 ' HA ' ' HB2' ' F' ' 118' ' ' PRO . 11.1 t -83.37 173.84 11.2 Favored 'General case' 0 C--O 1.245 0.858 0 CA-C-N 114.79 -1.095 . . . . 63.14 110.825 -178.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.64 129.36 40.19 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.421 0.688 . . . . 61.24 110.221 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 18.8 p -155.27 124.04 6.1 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 124.114 0.966 . . . . 74.53 109.272 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . 64.46 -104.05 0.11 Allowed 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 124.364 1.066 . . . . 52.24 110.593 -177.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . 53.99 20.2 2.34 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.744 1.218 . . . . 73.42 114.213 176.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 21.0 m -110.77 114.42 27.76 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.245 0.618 . . . . 74.04 110.139 -176.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -164.79 140.63 5.7 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.243 0.617 . . . . 62.34 110.632 177.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 13.4 t -91.7 -164.94 1.25 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 123.889 0.876 . . . . 75.11 109.199 175.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -126.21 136.12 52.44 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.337 0.655 . . . . 71.24 110.327 176.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 21.3 m95 57.91 -102.73 0.16 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.09 1.356 . . . . 75.24 112.582 175.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 15.4 m 57.44 31.7 20.64 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.043 0.937 . . . . 54.45 110.517 -167.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 133' ' ' THR . . . . . 0.441 HG22 ' HB ' ' F' ' 135' ' ' VAL . 29.7 m -82.55 120.11 25.1 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 114.739 -1.119 . . . . 74.5 110.406 -174.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.29 -49.6 72.88 Favored Glycine 0 C--N 1.355 1.606 0 O-C-N 123.747 0.655 . . . . 54.14 112.487 177.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 135' ' ' VAL . . . . . 0.441 ' HB ' HG22 ' F' ' 133' ' ' THR . 6.3 p 45.01 32.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 C-N-CA 126.424 1.89 . . . . 65.03 113.162 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -75.56 -68.21 0.59 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.363 -0.835 . . . . 60.45 111.544 -171.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 16.8 p -104.46 134.77 47.09 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 123.464 0.705 . . . . 73.31 110.7 -174.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 138' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' C' ' 42' ' ' LEU . 59.7 m-85 -108.55 86.81 2.36 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.954 0.902 . . . . 73.34 109.029 -176.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -165.16 129.28 2.39 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.729 0.812 . . . . 62.11 109.295 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -120.61 50.37 0.83 Allowed Glycine 0 C--N 1.342 0.877 0 N-CA-C 111.065 -0.814 . . . . 60.23 111.065 176.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.06 151.31 44.68 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.987 0.515 . . . . 54.24 111.754 -177.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 2.3 pp -149.44 171.94 15.76 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.528 0.731 . . . . 50.12 110.768 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -171.06 66.42 0.15 Allowed Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.408 -0.814 . . . . 54.31 111.163 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 90.8 t -58.44 126.16 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 123.988 0.915 . . . . 53.44 110.185 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 19.2 t70 . . . . . 0 C--O 1.252 1.198 0 N-CA-C 108.541 -0.911 . . . . 62.41 108.541 -177.458 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 109.482 -0.562 . . . . 71.44 109.482 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.1 m -109.95 124.68 51.83 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.77 0.828 . . . . 73.33 109.711 177.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -142.93 147.21 34.87 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 106.894 -1.521 . . . . 72.2 106.894 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -70.86 90.18 0.79 Allowed 'General case' 0 C--O 1.241 0.629 0 C-N-CA 123.214 0.606 . . . . 72.54 109.822 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -75.33 84.83 2.48 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.461 -0.94 . . . . 74.13 108.461 174.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.452 ' ND2' ' HG2' ' A' ' 8' ' ' GLU . 4.3 p-10 -65.4 157.89 28.11 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.522 1.129 . . . . 74.4 111.205 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.6 t -71.05 81.99 0.68 Allowed 'General case' 0 CA--C 1.557 1.224 0 CA-C-O 122.191 0.996 . . . . 74.4 112.305 -171.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.452 ' HG2' ' ND2' ' A' ' 6' ' ' ASN . 72.4 mm-40 -105.7 -20.62 13.4 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.523 1.129 . . . . 73.04 109.648 170.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -62.59 150.01 41.75 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.255 1.022 . . . . 74.41 111.545 -170.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 63.0 m -140.7 126.85 19.64 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 106.496 -1.668 . . . . 53.03 106.496 172.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -137.45 125.21 22.45 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.845 -0.798 . . . . 75.55 108.845 -173.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -145.73 129.69 17.37 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.259 -0.645 . . . . 71.41 109.259 173.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.4 HD13 HD11 ' A' ' 16' ' ' ILE . 7.0 mt -84.77 126.18 40.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.505 -0.924 . . . . 73.11 108.505 175.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -93.04 -41.23 10.09 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.172 0.589 . . . . 64.33 110.347 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -172.73 121.49 0.41 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.62 -0.718 . . . . 74.43 109.969 -173.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.4 HD11 HD13 ' A' ' 13' ' ' ILE . 80.1 mt -105.4 132.43 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 107.373 -1.343 . . . . 61.52 107.373 172.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.478 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 28.2 p90 -162.98 164.02 25.86 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 123.687 0.617 . . . . 74.25 111.445 -172.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.7 p -90.37 122.19 33.02 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.779 -0.452 . . . . 61.03 109.779 174.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.478 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.1 mtpt -83.24 -33.55 26.05 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.055 0.542 . . . . 71.12 109.922 175.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -148.49 142.06 25.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.112 -0.949 . . . . 65.02 109.06 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.7 mt -135.47 145.9 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.778 1.231 . . . . 74.42 107.845 175.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -151.19 131.16 13.35 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.215 0.606 . . . . 71.15 109.999 172.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.449 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 90.6 t80 -131.37 133.1 44.95 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 106.781 -1.563 . . . . 75.22 106.781 171.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -135.67 125.97 26.5 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.627 -0.509 . . . . 74.23 109.627 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.82 79.21 4.41 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 106.16 -1.793 . . . . 75.03 106.16 163.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -65.7 -35.53 36.61 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.455 2.103 . . . . 74.01 112.027 -167.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -107.81 27.07 9.57 Favored 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 124.461 1.104 . . . . 73.52 109.261 -172.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.47 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -46.09 -54.94 14.85 Favored Pre-proline 0 CA--C 1.568 1.652 0 N-CA-C 114.723 1.379 . . . . 55.0 114.723 -165.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.453 ' HG3' ' HG3' ' B' ' 57' ' ' GLU . 28.0 Cg_exo -62.5 -25.85 76.0 Favored 'Trans proline' 0 C--N 1.39 2.736 0 CA-C-N 121.904 1.716 . . . . 74.02 113.26 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.505 ' O ' ' HG2' ' A' ' 33' ' ' GLN . 2.5 m-70 -86.83 -34.32 19.54 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.614 0.765 . . . . 54.31 110.479 -178.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.532 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.7 p -74.75 -12.04 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 C-N-CA 123.204 0.602 . . . . 71.2 111.894 -164.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -91.78 -18.44 23.87 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.44 0.696 . . . . 65.24 111.291 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 29.9 pt20 -96.98 -11.55 24.43 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.251 0.62 . . . . 72.33 110.251 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 14.3 mmmm -76.93 156.36 32.08 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.407 0.683 . . . . 65.53 111.106 177.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -65.06 119.3 10.54 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.467 0.707 . . . . 53.14 110.005 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.9 t-105 -76.89 84.74 3.45 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-O 121.596 0.713 . . . . 64.34 109.798 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -116.17 79.2 8.41 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 106.246 -1.761 . . . . 71.43 106.246 172.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -81.12 106.62 1.78 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.436 2.091 . . . . 63.51 112.188 -172.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -95.87 88.64 4.99 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 122.6 1.19 . . . . 71.33 107.859 174.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.556 HG22 ' HB2' ' A' ' 66' ' ' ALA . 61.6 t -86.85 101.55 11.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 114.474 -1.239 . . . . 73.43 110.237 -174.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -82.32 118.66 23.32 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.994 -1.003 . . . . 62.02 109.121 171.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.3 mp -95.56 108.16 20.39 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.633 -1.247 . . . . 71.51 107.633 173.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -105.93 150.67 25.44 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.267 -1.012 . . . . 64.42 108.267 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.511 HD22 HD21 ' A' ' 60' ' ' LEU . 67.1 mt -133.29 158.77 42.11 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.406 0.682 . . . . 75.11 110.766 -177.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 25.5 t70 -160.14 121.7 3.17 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 114.579 -1.191 . . . . 72.33 108.037 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.437 HG21 ' HA2' ' A' ' 99' ' ' GLY . 41.6 m -112.27 126.51 55.32 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 122.838 0.455 . . . . 73.05 110.196 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.46 112.91 11.32 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.776 0.83 . . . . 74.1 109.493 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.1 p -89.41 177.19 6.64 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.94 0.496 . . . . 52.52 109.867 176.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.441 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 26.0 t -165.38 153.31 11.21 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.284 1.034 . . . . 73.23 109.112 -168.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -113.73 131.1 56.31 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 109.034 -0.728 . . . . 73.24 109.034 172.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.419 HD12 HG23 ' A' ' 83' ' ' ILE . 80.5 mt -110.48 -34.45 6.31 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.5 0.72 . . . . 74.24 111.4 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.539 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -157.82 -171.23 3.46 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 123.536 0.734 . . . . 70.41 110.537 -177.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -70.59 119.09 14.23 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.533 -0.914 . . . . 75.41 108.533 172.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 65.54 10.72 6.88 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.361 1.065 . . . . 54.24 112.107 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 57.2 t -116.21 112.6 40.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 107.835 -1.172 . . . . 62.32 107.835 175.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -126.7 126.33 43.32 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.892 0.877 . . . . 72.4 109.036 -176.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 37.8 tt0 -86.65 149.11 25.14 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.512 -0.551 . . . . 63.51 109.512 175.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.409 HG21 ' CB ' ' A' ' 102' ' ' CYS . 91.1 t -130.77 142.13 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 108.062 -1.088 . . . . 73.45 108.062 173.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.53 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 52.5 t -123.48 133.02 70.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.434 -0.95 . . . . 65.14 108.434 175.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.511 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -113.57 106.81 14.98 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.506 -1.294 . . . . 75.2 107.506 173.129 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.455 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 24.8 ttp180 -93.63 100.59 12.81 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.856 -1.164 . . . . 71.13 107.856 175.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.6 t -94.57 122.92 46.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 107.562 -1.273 . . . . 74.3 107.562 174.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.4 m -116.77 107.61 14.86 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.567 0.698 . . . . 63.35 109.426 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.536 HG11 HD21 ' A' ' 126' ' ' LEU . 58.0 t -104.38 133.91 47.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 C-N-CA 124.788 1.235 . . . . 54.33 107.871 -178.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.0 m -135.44 136.4 41.32 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.697 -0.853 . . . . 75.03 108.697 170.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.556 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -116.19 130.89 57.01 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.487 -1.301 . . . . 73.01 107.487 171.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.7 m -124.79 169.76 11.7 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.102 -0.703 . . . . 54.34 109.102 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.7 mt -124.09 42.95 3.12 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.754 1.222 . . . . 73.4 108.265 -176.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.22 -89.66 1.58 Allowed Glycine 0 C--N 1.34 0.756 0 CA-C-N 114.725 -1.125 . . . . 42.5 111.34 -172.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.43 -19.53 19.81 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.74 0.816 . . . . 72.3 112.539 -173.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -121.49 132.78 54.91 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 109.693 -0.484 . . . . 75.23 109.693 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.0 m -72.18 137.13 46.7 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 122.449 0.3 . . . . 63.05 110.469 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.532 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -79.17 -62.24 1.76 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.721 -0.672 . . . . 70.12 109.609 176.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -157.07 168.4 27.58 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.164 -0.925 . . . . 70.13 111.614 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 64' ' ' VAL . 61.4 tp -125.41 141.97 51.76 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.939 1.296 . . . . 73.23 108.434 171.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.459 ' SG ' HG22 ' A' ' 118' ' ' VAL . 77.7 m -143.15 99.15 3.39 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.487 1.115 . . . . 72.41 109.289 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -124.25 117.55 24.81 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.711 -0.848 . . . . 70.12 108.711 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.7 t -130.65 128.86 63.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 123.84 0.856 . . . . 74.52 109.613 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.455 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 77.3 mt-30 -96.95 90.9 5.37 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.557 0.743 . . . . 74.41 109.151 169.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -77.59 94.16 4.32 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.79 -0.819 . . . . 72.32 108.79 174.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.84 172.35 49.86 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.986 -0.846 . . . . 72.45 110.986 175.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.08 126.36 1.2 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.16 -0.776 . . . . 74.0 111.16 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.419 HG23 HD12 ' A' ' 51' ' ' LEU . 50.0 mt -81.59 126.48 39.85 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 108.66 -0.867 . . . . 72.42 108.66 174.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.721 ' HB3' HD11 ' A' ' 86' ' ' ILE . 91.8 m-85 -132.23 121.0 22.96 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.15 0.58 . . . . 73.4 109.961 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.3 m -84.97 97.44 9.8 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.903 -0.777 . . . . 75.3 108.903 174.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.721 HD11 ' HB3' ' A' ' 84' ' ' PHE . 3.5 mm -108.28 153.89 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 122.949 0.5 . . . . 62.31 109.994 -178.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -165.27 166.03 19.1 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.943 0.497 . . . . 74.23 111.261 178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.45 -21.85 42.39 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-N 116.113 -0.494 . . . . 41.35 114.003 174.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.467 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -133.95 147.61 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.176 0.59 . . . . 64.45 111.535 -172.187 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -134.28 175.54 9.41 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.91 1.284 . . . . 71.32 109.439 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.62 -124.64 36.28 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.854 0.721 . . . . 54.11 113.828 175.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.0 t -71.19 -29.56 65.33 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.328 0.651 . . . . 62.41 111.741 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -69.33 -43.89 72.77 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.94 0.496 . . . . 52.1 110.324 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.5 tpt -66.79 -40.3 88.08 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.819 -0.628 . . . . 75.42 110.457 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.13 -32.59 74.36 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.236 0.614 . . . . 43.24 110.846 176.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -73.14 -30.94 63.96 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.343 0.657 . . . . 45.32 110.934 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.8 t -73.1 -51.6 17.4 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 109.27 -0.641 . . . . 64.24 109.27 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 77.2 mt -76.9 -26.9 54.68 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.427 0.691 . . . . 73.11 112.258 -174.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.437 ' HA2' HG21 ' A' ' 46' ' ' THR . . . -107.81 3.56 34.04 Favored Glycine 0 N--CA 1.468 0.815 0 CA-C-O 119.492 -0.616 . . . . 22.2 114.033 -171.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.477 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.72 -60.34 0.23 Allowed 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 117.671 0.736 . . . . 64.1 112.323 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.428 ' O ' HG12 ' A' ' 105' ' ' ILE . 73.5 t80 -66.44 -45.54 79.51 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.858 0.463 . . . . 75.54 111.509 -175.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.409 ' CB ' HG21 ' A' ' 58' ' ' VAL . 85.9 m -67.51 -46.79 47.85 Favored Pre-proline 0 CA--C 1.564 1.484 0 C-N-CA 124.381 1.072 . . . . 72.34 111.818 -179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -55.76 -34.17 90.13 Favored 'Trans proline' 0 C--N 1.397 3.126 0 C-N-CA 122.615 2.21 . . . . 61.1 113.523 168.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.403 ' HB3' ' O ' ' A' ' 101' ' ' TYR . 26.7 t-20 -63.42 -39.77 95.39 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.777 0.831 . . . . 61.01 110.499 176.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 101' ' ' TYR . 49.8 mm -66.41 -40.08 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.562 0.745 . . . . 74.44 110.212 174.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 68.9 mt -77.69 -22.38 50.58 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.244 -0.889 . . . . 62.21 112.5 -172.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -65.3 -42.33 58.13 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 114.291 1.219 . . . . 71.14 114.291 -172.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -53.2 -38.05 80.92 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 121.974 1.782 . . . . 72.1 113.12 171.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -82.03 -30.2 31.58 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.514 0.725 . . . . 70.32 111.651 -178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.85 -48.21 72.38 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.941 -0.763 . . . . 72.12 108.941 173.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.605 HH12 HD12 ' C' ' 105' ' ' ILE . 31.5 ttm180 -60.81 -39.86 90.54 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 113.741 -1.572 . . . . 71.52 110.088 176.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.4 ' HB2' ' HB3' ' C' ' 108' ' ' PRO . 14.5 tt0 -52.46 -56.37 15.54 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 124.376 1.07 . . . . 54.22 110.727 176.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 45.1 t -60.17 -47.82 84.31 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 113.945 -1.48 . . . . 45.05 111.206 -175.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.1 mt -63.22 -59.85 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.714 0.806 . . . . 73.34 110.926 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 92.4 m -49.1 -42.5 39.23 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 124.338 1.024 . . . . 74.23 112.226 -177.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.3 t -68.9 -46.75 67.54 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.745 -1.116 . . . . 53.45 110.582 -178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.449 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 9.9 mtp -53.67 -44.34 69.61 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.917 0.887 . . . . 72.44 111.226 175.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 114' ' ' ILE . 97.0 t -59.63 -49.71 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-N 114.726 -1.125 . . . . 60.23 110.772 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.4 p -70.9 -28.55 64.62 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.98 -0.554 . . . . 71.42 111.62 -177.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.489 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.4 mtt-85 -71.03 -29.9 65.94 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.674 0.79 . . . . 75.52 110.123 176.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.409 ' O ' HG22 ' A' ' 122' ' ' THR . . . -86.07 23.05 10.0 Favored Glycine 0 C--N 1.352 1.46 0 CA-C-O 118.957 -0.913 . . . . 55.41 113.407 176.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.409 HG22 ' O ' ' A' ' 121' ' ' GLY . 4.1 t 57.36 10.71 0.97 Allowed 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 127.047 2.139 . . . . 54.32 113.853 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -81.17 144.02 53.61 Favored Pre-proline 0 C--O 1.242 0.709 0 N-CA-C 108.392 -0.966 . . . . 73.22 108.392 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.501 ' HB3' ' N ' ' E' ' 132' ' ' SER . 83.0 Cg_exo -49.15 146.57 12.59 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 123.138 2.559 . . . . 72.13 111.94 173.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -59.74 133.24 55.92 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.105 0.478 . . . . 64.21 111.595 -174.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.536 HD21 HG11 ' A' ' 64' ' ' VAL . 28.1 tp -118.03 110.1 17.26 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.658 1.183 . . . . 75.13 108.753 176.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.438 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 72.3 m-20 -100.44 126.39 46.83 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.525 -1.287 . . . . 75.21 107.525 172.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 13.5 mt -73.27 141.37 47.22 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 123.125 0.266 . . . . 74.33 110.303 -178.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -65.59 135.65 95.78 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 123.299 0.64 . . . . 63.44 110.822 177.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 36.3 Cg_exo -61.74 120.69 8.44 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 123.307 2.671 . . . . 65.32 112.833 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.499 HG21 HD11 ' A' ' 44' ' ' LEU . 84.4 t -103.4 136.77 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.538 0.735 . . . . 62.03 110.809 -178.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.479 ' ND2' ' HB2' ' A' ' 135' ' ' ALA . 37.2 t30 -94.61 90.38 6.12 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 108.327 -0.99 . . . . 75.13 108.327 172.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.438 ' CE1' HD13 ' A' ' 44' ' ' LEU . 93.5 m-85 -63.44 -28.67 70.13 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.091 0.957 . . . . 74.2 112.561 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.477 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 7.9 m-20 -63.41 -35.79 81.57 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.122 0.569 . . . . 72.53 110.626 176.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.479 ' HB2' ' ND2' ' A' ' 132' ' ' ASN . . . -65.19 -48.93 71.71 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 123.549 0.531 . . . . 74.34 110.053 171.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 62.3 mt -56.67 -39.29 73.49 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.808 0.843 . . . . 61.42 111.329 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.456 ' HB2' ' HB2' ' A' ' 100' ' ' ALA . 84.8 t80 -65.66 -48.35 72.42 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 115.301 -0.863 . . . . 73.22 110.252 176.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 90.7 mmm -63.17 -27.72 69.56 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.571 0.544 . . . . 71.24 111.434 -177.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -67.89 -54.56 17.85 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.161 -0.681 . . . . 74.42 109.161 171.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -56.53 -30.42 63.03 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-O 121.088 0.47 . . . . 75.33 111.968 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 28.8 tp -64.34 -48.35 75.88 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.597 1.159 . . . . 72.04 111.72 -176.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -154.97 29.88 0.41 Allowed 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 114.554 1.316 . . . . 71.05 114.554 -171.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -73.56 -67.34 0.6 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.987 -0.746 . . . . 63.03 108.987 172.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -133.03 153.23 51.69 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.029 0.932 . . . . 53.01 109.126 173.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -78.06 79.55 4.52 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.441 0.696 . . . . 72.23 109.6 176.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 132.41 -61.69 0.65 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 111.041 -0.824 . . . . 75.31 111.041 -177.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -90.16 65.52 6.43 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.67 0.788 . . . . 74.33 110.235 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -88.77 66.47 3.13 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 110.35 -1.1 . . . . 71.44 110.35 175.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.6 m -73.24 140.92 47.21 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.252 0.621 . . . . 74.2 110.442 -175.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -78.62 73.6 5.17 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.349 1.06 . . . . 74.41 110.792 -177.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -162.97 153.6 16.63 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.762 1.225 . . . . 63.3 109.481 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 178.58 -174.02 0.16 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.042 0.937 . . . . 52.2 110.273 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -59.46 128.9 39.34 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.194 0.998 . . . . 72.52 108.637 168.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.488 ' HB3' HD22 ' E' ' 139' ' ' ASN . 1.3 p-10 -50.12 99.87 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.175 1.39 . . . . 75.21 112.755 -175.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.558 1.257 0 CA-C-N 114.517 -1.22 . . . . 65.34 108.974 178.358 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mpp? . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 109.366 -0.605 . . . . 73.24 109.366 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 61.9 p -75.51 137.1 40.67 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.657 0.783 . . . . 62.13 109.343 176.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -98.16 138.01 36.09 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 109.452 -0.573 . . . . 73.02 109.452 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -93.82 44.94 1.13 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.797 0.839 . . . . 74.3 109.013 177.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -91.36 78.89 5.67 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.939 0.896 . . . . 42.35 108.956 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -84.25 139.84 32.07 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.201 -0.909 . . . . 54.1 111.068 -170.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.7 t -139.73 138.18 35.73 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.858 0.863 . . . . 72.15 108.68 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 63.74 35.23 11.46 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 124.459 1.104 . . . . 63.45 109.49 -174.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 25.6 ttt 65.65 165.98 0.18 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 125.343 1.457 . . . . 75.33 112.766 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 89.5 m -151.05 128.12 11.12 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.965 1.306 . . . . 74.01 107.694 171.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.46 ' CE1' ' HE2' ' B' ' 101' ' ' TYR . 0.1 OUTLIER -146.86 135.54 22.11 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.304 0.573 . . . . 71.4 110.252 179.115 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.529 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -131.09 130.05 42.67 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 124.819 1.248 . . . . 75.11 109.212 -179.575 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 69.4 mt -73.24 127.49 35.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 108.357 -0.979 . . . . 71.51 108.357 170.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -92.42 -43.67 9.09 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 123.744 0.652 . . . . 75.34 109.595 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -174.27 135.84 0.46 Allowed 'General case' 0 C--N 1.352 0.71 0 CA-C-N 115.703 -0.68 . . . . 70.41 109.932 -173.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.486 HG21 ' CE1' ' B' ' 109' ' ' TYR . 80.7 mt -122.84 138.8 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 108.065 -1.087 . . . . 51.14 108.065 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -164.15 157.33 17.95 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.127 0.788 . . . . 72.44 113.127 -171.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 53.5 m -83.66 119.48 24.81 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.366 -1.288 . . . . 72.14 108.864 171.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.47 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 39.6 mtpt -91.81 -24.98 19.21 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.658 0.783 . . . . 71.23 111.522 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -159.57 142.76 14.25 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 123.387 0.429 . . . . 71.13 111.02 -175.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.422 HD11 ' SG ' ' B' ' 113' ' ' CYS . 48.6 mm -134.37 144.19 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.939 1.295 . . . . 63.43 108.321 171.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 29.5 t -147.68 134.45 20.04 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.221 1.009 . . . . 63.44 108.35 171.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -134.87 131.89 37.91 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 106.979 -1.489 . . . . 74.1 106.979 167.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -132.69 125.39 30.18 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.177 -1.046 . . . . 54.13 108.177 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.572 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -114.75 87.37 14.55 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 106.899 -1.519 . . . . 61.43 106.899 164.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.39 -35.04 74.89 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.554 2.17 . . . . 72.14 111.228 -173.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -110.29 14.93 22.59 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.47 -1.241 . . . . 53.13 110.742 -175.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.593 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -31.63 -66.3 0.19 Allowed Pre-proline 0 N--CA 1.493 1.715 0 C-N-CA 125.951 1.701 . . . . 62.41 115.278 -172.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 24.8 Cg_exo -60.83 -36.51 83.62 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 122.457 2.105 . . . . 71.31 113.269 -167.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -93.31 -32.22 14.39 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.403 0.52 . . . . 74.11 112.403 -174.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.673 HG22 HD12 ' B' ' 68' ' ' LEU . 7.2 p -67.6 -11.69 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-N 118.209 0.458 . . . . 74.24 111.534 -173.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -74.1 -15.09 61.06 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.868 0.867 . . . . 75.41 112.976 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -61.54 -28.91 69.66 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.476 0.655 . . . . 42.34 109.543 172.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -88.91 105.17 17.58 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.894 1.278 . . . . 70.45 109.451 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -113.43 99.18 7.57 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.625 -0.88 . . . . 65.13 108.625 172.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 11.2 p90 -160.71 -172.78 3.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.368 -0.975 . . . . 75.24 108.368 170.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -73.84 107.3 3.32 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.353 0.661 . . . . 74.34 111.014 175.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' F' ' 129' ' ' THR . 37.9 Cg_endo -68.11 143.65 60.36 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 121.533 1.488 . . . . 74.12 110.5 178.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -68.23 101.46 1.19 Allowed 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.543 -0.91 . . . . 74.44 108.543 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.423 HG11 HD11 ' B' ' 126' ' ' LEU . 33.9 t -91.78 144.71 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 114.245 -1.343 . . . . 74.43 109.695 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.15 119.65 10.35 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.067 -1.827 . . . . 43.15 106.067 -175.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 20.9 tp -95.06 147.23 23.64 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.625 0.77 . . . . 74.52 109.362 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.564 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 13.0 t70 -140.62 134.29 30.25 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.692 -1.225 . . . . 62.24 107.692 -175.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 64.3 mt -128.0 126.27 41.02 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.632 -0.877 . . . . 53.23 108.632 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 19.5 t70 -126.1 119.79 28.48 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.369 1.067 . . . . 74.32 108.612 -173.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.8 p -110.29 102.95 11.57 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.33 0.652 . . . . 74.14 111.516 -169.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.73 136.83 51.11 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.135 0.974 . . . . 44.54 108.554 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.1 p -139.86 175.86 9.23 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.418 0.687 . . . . 60.14 109.721 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 75.3 p -157.12 140.15 15.34 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.093 0.557 . . . . 75.15 110.337 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.547 ' HB2' HD23 ' F' ' 102' ' ' LEU . 63.2 tt0 -94.87 128.46 41.65 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.617 -0.883 . . . . 74.13 108.617 172.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -139.91 16.41 2.48 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.72 0.808 . . . . 55.42 110.923 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.74 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -173.67 165.12 4.49 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.819 1.248 . . . . 73.13 109.73 173.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.45 119.24 13.41 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.884 -0.784 . . . . 54.52 108.884 176.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 69.16 -5.63 1.05 Allowed 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 124.687 1.195 . . . . 63.13 113.145 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.74 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 44.4 t -119.57 97.49 5.26 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.226 -1.028 . . . . 75.13 108.226 -172.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.64 ' HE1' HD12 ' B' ' 86' ' ' ILE . 54.4 p90 -99.23 -176.86 3.43 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 114.556 -1.202 . . . . 73.45 109.207 177.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.453 ' HG3' ' HG3' ' A' ' 29' ' ' PRO . 5.5 tm-20 -138.69 107.2 5.85 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 106.383 -1.71 . . . . 70.45 106.383 173.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 14.8 p -101.0 135.03 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 109.863 -0.421 . . . . 74.24 109.863 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 29.9 t -109.38 115.23 49.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 123.754 0.821 . . . . 53.44 108.955 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 54.5 tp -93.89 101.13 13.2 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.378 -0.971 . . . . 52.51 108.378 170.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.586 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 14.1 ttm-85 -87.33 116.82 25.69 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.681 -0.859 . . . . 74.35 108.681 172.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.37 125.9 66.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.029 -1.1 . . . . 72.23 108.029 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.564 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 8.7 m -121.84 131.67 54.17 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.242 -0.651 . . . . 73.13 109.242 178.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.707 HG11 HD21 ' B' ' 126' ' ' LEU . 56.7 t -115.88 125.2 72.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 124.569 1.148 . . . . 75.11 109.131 176.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 88.9 m -105.06 138.72 40.82 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.463 -0.94 . . . . 71.25 108.463 164.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.19 144.27 33.32 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 107.96 -1.126 . . . . 71.12 107.96 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.51 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 49.6 p -144.7 134.26 23.34 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.388 0.43 . . . . 64.41 111.978 -171.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.673 HD12 HG22 ' B' ' 31' ' ' VAL . 70.6 mt -102.61 99.57 9.58 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.487 -0.931 . . . . 73.23 108.487 175.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.05 -134.3 14.18 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.991 -0.549 . . . . 73.22 112.364 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -82.32 3.55 27.29 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.26 0.624 . . . . 75.13 112.515 -177.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -128.76 150.68 50.19 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.789 0.435 . . . . 72.05 111.767 -174.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 68.3 m -68.7 128.43 36.62 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.418 -0.81 . . . . 71.24 110.36 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.51 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -80.14 -59.28 2.77 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.366 -0.976 . . . . 62.5 108.366 176.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -152.51 157.85 41.71 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 114.701 -1.136 . . . . 74.11 111.437 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 98.2 mt -125.15 113.58 17.88 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.682 1.593 . . . . 75.35 107.262 171.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.9 t -118.39 140.14 50.31 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.177 -1.045 . . . . 75.44 108.177 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -151.22 127.64 10.68 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.813 -0.81 . . . . 72.34 108.813 -174.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 90.4 t -124.44 147.71 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 123.942 0.897 . . . . 42.05 108.83 177.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -120.74 106.38 11.64 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.477 -1.305 . . . . 74.14 107.477 168.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -98.41 101.3 12.7 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.504 -1.295 . . . . 45.22 107.504 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.4 159.57 22.56 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 111.062 -0.815 . . . . 71.25 111.062 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.9 132.61 3.12 Favored Glycine 0 C--O 1.239 0.446 0 C-N-CA 121.718 -0.277 . . . . 72.42 112.411 -175.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 54.6 mt -91.66 108.13 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 108.497 -0.927 . . . . 72.22 108.497 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -119.47 143.89 47.28 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.159 -1.052 . . . . 75.35 108.159 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 15.8 m -115.17 114.23 25.0 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.476 -0.935 . . . . 75.13 108.476 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.64 HD12 ' HE1' ' B' ' 56' ' ' TYR . 0.2 OUTLIER -115.56 142.22 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.359 -0.978 . . . . 61.4 108.359 178.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.38 168.6 26.83 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.981 0.512 . . . . 65.1 110.622 -177.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.86 -44.92 2.69 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.966 -0.561 . . . . 72.03 111.895 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.455 HD13 ' HB2' ' B' ' 94' ' ' MET . 1.0 OUTLIER -81.74 157.25 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.5 1.12 . . . . 63.03 111.261 178.131 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.47 ' HA ' ' SD ' ' B' ' 94' ' ' MET . 9.7 mp0 -145.9 177.95 8.55 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.483 1.113 . . . . 73.01 109.605 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.62 -125.42 23.07 Favored Glycine 0 C--N 1.346 1.093 0 CA-C-N 115.127 -0.942 . . . . 73.42 113.81 173.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 27.2 m -79.27 -45.39 19.83 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.703 0.801 . . . . 51.22 110.724 -178.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -67.47 -28.91 68.25 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 113.953 -1.476 . . . . 52.34 111.886 -166.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.47 ' SD ' ' HA ' ' B' ' 90' ' ' GLU . 26.9 ptt? -64.34 -47.49 79.15 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.227 0.611 . . . . 72.53 111.373 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.477 ' HA ' ' HG ' ' B' ' 98' ' ' LEU . . . -81.0 -13.34 58.96 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.996 0.919 . . . . 41.24 112.186 -175.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -64.74 -32.13 73.67 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.655 0.382 . . . . 72.0 110.277 170.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . 0.408 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 48.0 t -67.51 -30.92 70.72 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.584 0.754 . . . . 64.31 111.53 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.763 HD21 HD11 ' F' ' 100' ' ' LEU . 4.0 pp -101.38 -24.48 14.19 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 112.942 0.719 . . . . 73.5 112.942 -175.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.76 -26.24 61.09 Favored Glycine 0 C--N 1.338 0.671 0 O-C-N 123.584 0.553 . . . . 40.4 112.736 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.08 -49.75 0.33 Allowed 'General case' 0 C--O 1.242 0.671 0 N-CA-C 112.568 0.581 . . . . 53.33 112.568 -165.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.46 ' HE2' ' CE1' ' B' ' 11' ' ' PHE . 16.0 t80 -68.02 -48.75 64.83 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.69 0.796 . . . . 64.02 112.155 -174.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 98.1 m -73.69 -37.94 3.74 Favored Pre-proline 0 CA--C 1.557 1.238 0 N-CA-C 112.627 0.603 . . . . 41.43 112.627 -177.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -51.43 -31.49 38.87 Favored 'Trans proline' 0 C--N 1.387 2.553 0 C-N-CA 122.399 2.066 . . . . 72.45 114.181 162.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -68.89 -25.41 64.59 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 122.767 0.427 . . . . 74.44 111.504 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.497 HG23 ' NH2' ' D' ' 111' ' ' ARG . 71.5 mt -69.05 -39.8 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 CA-C-O 121.336 0.589 . . . . 71.54 109.413 170.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.457 ' CD2' HG23 ' B' ' 16' ' ' ILE . 70.3 mt -77.09 -24.6 51.8 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.689 1.196 . . . . 72.43 111.893 -177.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -59.18 -53.71 63.58 Favored Pre-proline 0 N--CA 1.484 1.248 0 N-CA-C 113.822 1.045 . . . . 65.14 113.822 -171.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.16 -30.56 55.26 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 121.62 1.547 . . . . 75.21 111.98 -177.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.486 ' CE1' HG21 ' B' ' 16' ' ' ILE . 2.4 m-30 -64.54 -47.8 77.46 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.02 0.928 . . . . 72.53 110.058 176.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.18 -40.57 97.9 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.026 0.93 . . . . 71.55 110.747 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.4 ttt-85 -64.69 -46.34 82.79 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.225 1.41 . . . . 74.42 110.861 -175.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.38 -35.06 77.15 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 123.776 0.673 . . . . 64.22 109.454 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.496 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.4 t -68.99 -35.51 76.8 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.891 0.476 . . . . 44.31 111.157 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.446 HD13 HG23 ' B' ' 64' ' ' VAL . 49.2 mt -62.89 -56.88 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 123.649 0.78 . . . . 72.43 109.339 173.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 18.1 m -59.63 -28.21 67.02 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.941 0.896 . . . . 55.03 111.459 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.7 t -66.25 -51.45 57.42 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.981 0.912 . . . . 54.04 110.3 176.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.496 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.5 mmt -70.14 -29.98 67.03 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.183 0.593 . . . . 73.12 111.245 -176.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 77.6 t -67.95 -41.86 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.513 1.125 . . . . 72.21 110.389 172.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.7 t -67.69 -32.03 72.41 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.604 -0.726 . . . . 75.31 110.341 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' B' ' 116' ' ' SER . 70.3 mtt-85 -69.74 -42.59 73.74 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 115.688 -0.687 . . . . 73.41 109.162 175.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.12 -10.82 62.81 Favored Glycine 0 C--N 1.358 1.801 0 O-C-N 123.736 0.648 . . . . 75.53 112.639 172.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 8.9 m 68.75 23.1 7.11 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 125.762 1.625 . . . . 63.33 110.973 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -78.96 164.26 55.96 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 124.019 0.927 . . . . 73.24 111.341 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -45.28 147.56 2.35 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 123.839 3.026 . . . . 72.01 114.85 172.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.421 ' O ' ' HA ' ' F' ' 129' ' ' THR . 54.4 tp60 -59.95 113.29 2.23 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.272 1.029 . . . . 72.01 112.512 -172.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.707 HD21 HG11 ' B' ' 64' ' ' VAL . 28.5 tp -107.71 104.72 14.3 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.151 0.58 . . . . 73.4 109.457 -172.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.409 ' ND2' HE21 ' B' ' 125' ' ' GLN . 54.2 m-80 -111.49 120.9 43.7 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.442 -0.947 . . . . 74.22 108.442 175.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.437 HD21 ' CG2' ' B' ' 64' ' ' VAL . 57.9 mt -78.14 149.29 33.82 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 110.296 -0.261 . . . . 74.43 110.296 175.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.61 143.39 84.9 Favored Pre-proline 0 CA--C 1.55 0.961 0 O-C-N 123.503 0.502 . . . . 43.14 111.238 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.61 81.76 0.76 Allowed 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 123.345 2.697 . . . . 70.42 112.191 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 6.2 p -94.17 110.68 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 121.402 0.62 . . . . 61.32 109.423 177.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -86.17 111.61 20.54 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.692 -1.225 . . . . 65.14 107.692 171.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -64.26 -29.92 70.99 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.564 -0.744 . . . . 75.33 110.931 -171.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -61.71 -33.42 73.99 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.936 0.895 . . . . 74.42 111.546 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.82 -47.59 82.78 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 124.008 0.818 . . . . 72.1 111.018 175.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.615 HD22 HD23 ' F' ' 111' ' ' LEU . 7.1 mp -63.76 -39.73 94.97 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.029 0.532 . . . . 74.31 110.826 -177.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.468 ' HE1' HD11 ' F' ' 111' ' ' LEU . 5.7 m-85 -64.68 -44.2 91.12 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.268 0.627 . . . . 71.43 110.48 174.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . 0.521 ' O ' ' HB3' ' B' ' 142' ' ' GLN . 48.3 tpp -74.72 -13.06 60.56 Favored 'General case' 0 C--O 1.208 -1.083 0 CA-C-N 115.555 -0.748 . . . . 44.31 110.977 -176.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.74 -34.01 62.45 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 118.399 0.545 . . . . 75.21 110.242 174.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -90.88 -26.43 19.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.397 0.679 . . . . 75.34 110.858 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 96.0 mt -108.37 22.85 15.37 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.012 0.925 . . . . 70.12 111.237 -175.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . 0.521 ' HB3' ' O ' ' B' ' 138' ' ' MET . 13.6 pt20 -79.63 177.9 8.54 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.54 0.686 . . . . 71.34 111.791 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -152.17 -171.0 3.8 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.663 -1.153 . . . . 73.42 109.019 175.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -66.05 -16.01 63.55 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.424 0.69 . . . . 42.02 111.654 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.71 103.38 0.11 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.247 1.019 . . . . 45.2 111.373 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.07 34.95 0.03 OUTLIER Glycine 0 C--N 1.342 0.864 0 CA-C-N 115.336 -0.847 . . . . 75.43 111.083 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -147.26 142.37 27.13 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.358 1.063 . . . . 71.12 109.735 -174.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 116.02 76.97 0.65 Allowed Glycine 0 C--N 1.352 1.467 0 O-C-N 123.428 0.455 . . . . 75.02 112.731 177.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 8.8 t -148.07 127.7 13.31 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.662 -0.866 . . . . 72.12 108.662 172.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -161.33 122.61 2.85 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.492 -0.559 . . . . 61.44 109.492 -173.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -160.49 96.84 1.18 Allowed 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.443 0.697 . . . . 72.52 109.175 167.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -80.16 72.74 6.98 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.508 0.723 . . . . 74.42 111.706 -176.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -154.79 113.73 3.62 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.284 0.634 . . . . 72.13 109.482 176.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -81.29 -32.12 33.31 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.673 0.789 . . . . 74.21 111.07 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.406 0 C-N-CA 123.615 0.766 . . . . 63.2 109.157 179.062 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.954 0 CA-C-O 121.674 0.75 . . . . 71.44 110.755 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 30.8 t -161.28 109.8 1.54 Allowed 'General case' 0 C--O 1.241 0.626 0 N-CA-C 108.336 -0.987 . . . . 64.21 108.336 175.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -78.99 -174.67 4.15 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.426 0.69 . . . . 74.11 111.647 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -136.18 124.37 23.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.986 0.915 . . . . 70.24 109.691 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -149.8 153.39 36.72 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.869 0.868 . . . . 71.32 108.878 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -62.55 -40.86 98.19 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.659 0.784 . . . . 73.24 109.892 174.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 4.9 t -108.81 77.43 1.07 Allowed 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 122.573 1.177 . . . . 63.13 108.766 171.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -97.89 -60.7 1.51 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.751 -1.113 . . . . 64.31 109.911 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.607 ' HE3' HG21 ' C' ' 89' ' ' ILE . 54.5 ttm 63.26 114.97 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.547 1.539 . . . . 75.24 111.354 -171.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 20.2 m -103.78 95.44 6.03 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.585 -0.894 . . . . 61.11 108.585 171.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -110.74 139.96 45.56 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.799 0.839 . . . . 63.12 109.074 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.461 HE21 HE22 ' C' ' 14' ' ' GLN . 29.9 tt0 -151.59 124.62 8.66 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.989 -0.745 . . . . 64.35 108.989 174.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.417 ' HA ' ' HD2' ' C' ' 84' ' ' PHE . 53.0 mt -70.11 135.0 29.1 Favored 'Isoleucine or valine' 0 C--N 1.349 0.586 0 N-CA-C 108.45 -0.945 . . . . 72.03 108.45 174.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.461 HE22 HE21 ' C' ' 12' ' ' GLN . 23.3 mm-40 -97.5 -47.71 5.56 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.273 -0.64 . . . . 73.31 109.273 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.438 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 11.8 ptm180 -179.01 143.02 0.2 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.288 1.035 . . . . 74.34 109.255 -176.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.406 ' O ' HD12 ' C' ' 16' ' ' ILE . 2.4 pp -120.31 146.8 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 107.363 -1.347 . . . . 73.02 107.363 171.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.457 ' HB3' HG23 ' D' ' 122' ' ' THR . 28.6 p90 -170.78 154.58 4.4 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.201 0.524 . . . . 64.51 111.943 -168.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.0 p -81.01 109.24 15.4 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.216 -0.902 . . . . 71.44 108.848 173.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -77.3 -29.78 53.84 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.186 -0.672 . . . . 74.5 109.186 173.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.665 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 22.5 t70 -146.07 143.77 29.6 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.905 -1.043 . . . . 73.45 109.663 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 99.3 mt -137.92 145.34 29.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 125.237 1.415 . . . . 73.25 107.389 173.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.3 t -152.91 146.05 24.67 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.129 0.571 . . . . 73.55 109.723 175.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -147.48 118.58 7.74 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 107.861 -1.162 . . . . 62.31 107.861 170.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -120.79 113.48 20.23 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.073 0.949 . . . . 75.12 108.981 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.63 87.81 7.02 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 106.446 -1.687 . . . . 73.14 106.446 169.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.89 -42.67 23.35 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.845 2.363 . . . . 72.12 112.042 -170.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -113.06 35.53 3.89 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 114.759 -1.109 . . . . 71.12 109.239 -177.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.463 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -43.92 -53.27 13.34 Favored Pre-proline 0 C--N 1.373 1.604 0 C-N-CA 124.915 1.286 . . . . 61.22 114.113 -176.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -58.96 -50.88 7.91 Favored 'Trans proline' 0 C--N 1.39 2.749 0 C-N-CA 121.521 1.481 . . . . 74.32 111.906 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -70.04 -28.07 65.17 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.309 -1.314 . . . . 74.1 113.016 -173.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.723 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.0 p -77.79 -23.88 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 112.235 0.458 . . . . 64.22 112.235 -175.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -71.9 -21.27 61.66 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 112.118 0.414 . . . . 71.32 112.118 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -93.54 16.35 13.89 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.027 0.531 . . . . 75.4 111.016 175.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.794 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -104.17 154.01 20.27 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.748 0.819 . . . . 55.22 109.974 176.111 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -72.4 130.78 41.5 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.31 0.644 . . . . 64.03 109.711 171.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 46.7 t-105 -85.39 90.24 7.89 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.819 0.848 . . . . 74.1 112.2 -171.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -145.7 77.52 12.32 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 124.675 1.19 . . . . 74.54 108.907 170.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -91.53 165.77 3.47 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.758 2.305 . . . . 71.14 113.562 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' C' ' 67' ' ' SER . 7.4 pt-20 -87.97 100.56 13.0 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.969 -1.122 . . . . 72.52 107.969 166.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 42.0 t -79.89 98.59 3.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.549 -0.908 . . . . 61.52 108.549 177.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -93.06 102.52 14.85 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.068 -1.456 . . . . 71.12 107.068 175.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 tt -87.78 138.21 31.66 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 106.817 -1.549 . . . . 70.35 106.817 176.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.467 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 36.0 t70 -131.56 134.71 46.36 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.053 0.941 . . . . 65.13 108.85 -175.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 96.2 mt -128.54 114.48 16.79 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.602 0.761 . . . . 62.44 110.018 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -117.12 120.75 39.29 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.671 -1.233 . . . . 71.14 107.671 172.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 10.1 t -118.24 149.24 41.45 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 109.778 -0.453 . . . . 53.52 109.778 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.17 149.12 26.72 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.572 0.749 . . . . 75.03 109.359 174.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 14.3 m -123.77 152.53 42.09 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 109.122 -0.696 . . . . 53.44 109.122 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 72.9 p -154.61 127.37 8.11 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.506 -0.924 . . . . 70.51 108.506 177.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -79.62 117.7 20.78 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.994 -0.743 . . . . 63.44 108.994 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.675 HD11 ' HB2' ' C' ' 57' ' ' GLU . 41.5 mt -83.55 -44.76 14.3 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.492 0.717 . . . . 75.0 110.273 -176.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.99 -176.55 4.72 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.449 -0.796 . . . . 44.21 109.691 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.08 107.77 0.59 Allowed 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.786 -1.097 . . . . 72.12 110.505 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . 0.418 ' HB2' HG13 ' E' ' 144' ' ' VAL . 1.3 m-20 64.38 25.31 13.38 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.452 1.101 . . . . 75.21 112.113 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 87.9 t -119.05 114.77 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 108.328 -0.989 . . . . 73.14 108.328 174.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -117.81 125.55 50.78 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.354 1.062 . . . . 74.53 109.291 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.675 ' HB2' HD11 ' C' ' 51' ' ' LEU . 37.4 tt0 -91.17 117.71 29.84 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.246 -0.65 . . . . 64.22 109.246 168.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.8 t -99.61 142.02 15.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.083 -1.08 . . . . 65.35 108.083 169.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 90.5 t -127.4 144.08 38.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 108.786 -0.82 . . . . 72.21 108.786 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.42 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -130.37 99.02 4.87 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 107.848 -1.168 . . . . 73.02 107.848 177.61 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -82.52 110.78 17.93 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.369 0.668 . . . . 72.22 109.41 171.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 39.6 t -108.52 122.77 63.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.698 -0.853 . . . . 73.33 108.698 178.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 16.8 m -126.1 127.48 45.86 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.449 0.7 . . . . 65.11 109.521 -176.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 60.2 t -114.36 112.11 38.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 124.165 0.986 . . . . 72.01 108.893 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 11.2 m -98.12 135.86 39.18 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.457 -1.312 . . . . 75.33 107.457 171.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.71 118.22 17.86 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.225 -1.398 . . . . 62.02 107.225 -175.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . 0.41 ' O ' ' HG2' ' C' ' 39' ' ' GLU . 50.5 m -133.9 130.89 38.43 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.194 0.521 . . . . 73.11 110.545 178.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.794 HD13 ' HG2' ' C' ' 34' ' ' LYS . 14.2 mt -88.48 39.48 0.91 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.624 1.169 . . . . 72.31 109.626 174.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.91 -106.22 2.66 Favored Glycine 0 C--N 1.353 1.474 0 CA-C-N 115.823 -0.626 . . . . 63.44 111.701 -173.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -90.24 -30.05 17.79 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.792 -0.818 . . . . 71.13 108.792 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -65.76 121.05 14.14 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 114.713 -1.131 . . . . 73.1 109.435 169.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 89.8 m -83.97 120.65 26.36 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.124 -1.065 . . . . 71.24 108.124 164.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.723 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -67.41 -58.57 4.52 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 123.945 0.778 . . . . 51.12 109.139 175.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -165.13 176.57 8.39 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 121.984 0.897 . . . . 72.41 111.078 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.452 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.1 tm? -134.84 145.35 48.23 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 105.766 -1.939 . . . . 74.42 105.766 170.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.473 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.2 t -147.82 141.88 25.99 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.878 -1.156 . . . . 73.15 107.878 174.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -150.88 131.54 13.97 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.473 -0.566 . . . . 42.13 109.473 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 75.8 t -131.76 114.05 24.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.345 -0.983 . . . . 75.24 108.345 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.665 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.7 mt-30 -90.49 86.14 6.34 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.417 -0.957 . . . . 71.14 108.417 173.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -79.01 102.15 8.19 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 114.225 -1.352 . . . . 75.24 108.88 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.9 159.44 32.9 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 111.475 -0.65 . . . . 62.51 111.475 172.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.69 116.73 0.73 Allowed Glycine 0 CA--C 1.507 -0.428 0 N-CA-C 111.317 -0.713 . . . . 75.21 111.317 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.503 HD12 HD11 ' C' ' 51' ' ' LEU . 17.2 mm -84.4 132.42 31.61 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 N-CA-C 108.778 -0.823 . . . . 63.32 108.778 178.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.417 ' HD2' ' HA ' ' C' ' 13' ' ' ILE . 66.0 m-85 -135.66 139.07 43.44 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.483 0.713 . . . . 75.44 109.837 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 21.7 p -99.01 104.0 16.0 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.809 -1.182 . . . . 72.34 107.809 169.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.418 HG21 HD11 ' C' ' 89' ' ' ILE . 46.1 mt -115.72 132.62 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.898 0.879 . . . . 73.31 109.128 -176.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.83 164.46 33.58 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 122.902 0.481 . . . . 61.0 111.187 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.83 -41.75 2.71 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 115.353 -0.84 . . . . 75.32 113.392 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.607 HG21 ' HE3' ' C' ' 9' ' ' MET . 39.7 pt -85.98 168.84 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.274 0.629 . . . . 75.44 111.787 -174.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -164.5 168.23 18.58 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.981 1.312 . . . . 71.42 108.339 176.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.22 -119.46 11.7 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.805 -0.441 . . . . 62.51 112.982 171.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 69.9 p -69.0 -41.78 77.36 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.134 0.574 . . . . 73.34 110.644 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -61.93 -46.51 89.01 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.519 0.728 . . . . 72.11 110.9 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.434 ' HE3' ' HA ' ' C' ' 94' ' ' MET . 5.4 tpt -59.74 -51.45 69.69 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 123.734 0.646 . . . . 63.12 111.579 177.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.26 -40.88 97.67 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.68 0.612 . . . . 55.53 111.319 -176.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -72.36 -34.54 68.06 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.901 -1.045 . . . . 71.04 111.119 -177.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -65.11 -42.5 93.89 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.317 0.58 . . . . 65.12 109.885 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.44 -37.24 37.49 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.798 -1.092 . . . . 64.45 112.78 -175.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.78 11.66 45.81 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-O 119.429 -0.65 . . . . 42.31 114.597 -167.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.548 ' HB2' ' HB2' ' C' ' 137' ' ' PHE . . . -155.95 -56.67 0.09 Allowed 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 117.827 0.814 . . . . 65.3 111.385 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -63.7 -56.17 17.72 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.617 0.767 . . . . 70.4 111.815 -175.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.467 ' O ' HD13 ' C' ' 106' ' ' LEU . 85.5 m -65.25 -47.3 71.38 Favored Pre-proline 0 CA--C 1.561 1.397 0 C-N-CA 123.925 0.89 . . . . 62.12 112.371 -177.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.42 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 53.7 Cg_exo -55.66 -30.53 75.71 Favored 'Trans proline' 0 C--N 1.397 3.092 0 C-N-CA 122.44 2.093 . . . . 52.24 113.628 173.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -70.18 -28.71 65.54 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.289 0.636 . . . . 64.22 111.116 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.605 HD12 HH12 ' A' ' 111' ' ' ARG . 33.8 mm -77.91 -32.27 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 123.163 0.585 . . . . 71.35 109.971 175.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.467 HD13 ' O ' ' C' ' 102' ' ' CYS . 7.3 mp -78.4 -27.55 46.75 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.05 0.94 . . . . 55.41 111.578 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -56.82 -49.81 91.7 Favored Pre-proline 0 N--CA 1.48 1.069 0 CA-C-O 117.556 -1.212 . . . . 74.02 113.672 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . 0.4 ' HB3' ' HB2' ' A' ' 112' ' ' GLU . 97.3 Cg_exo -50.91 -40.68 57.83 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.72 2.28 . . . . 64.44 114.674 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.494 ' OH ' ' HG2' ' A' ' 111' ' ' ARG . 89.2 m-85 -79.15 -37.44 38.47 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.263 0.625 . . . . 71.21 111.455 -175.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.64 96.26 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.436 -0.802 . . . . 75.45 109.956 173.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 34.6 ttt-85 -62.97 -50.9 68.98 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.579 1.551 . . . . 75.41 110.394 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -60.67 -40.8 93.44 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 124.094 0.871 . . . . 72.13 110.126 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 31.8 t -72.33 -32.18 66.29 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.709 -0.678 . . . . 62.44 111.212 -176.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.473 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 44.2 mt -69.1 -53.35 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 109.905 -0.406 . . . . 73.31 109.905 174.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 22.5 m -62.62 -28.98 70.27 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.442 0.697 . . . . 73.44 111.196 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 37.6 t -67.51 -49.21 64.48 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.254 0.622 . . . . 62.12 109.348 173.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.525 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.39 -39.79 84.48 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 124.432 1.093 . . . . 64.34 112.402 179.838 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.417 HG23 ' O ' ' C' ' 114' ' ' ILE . 93.7 t -65.23 -43.99 95.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.73 0.812 . . . . 62.15 110.223 176.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 22.0 t -66.07 -29.87 70.28 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.067 -0.97 . . . . 43.31 111.577 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.41 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 88.1 mtt-85 -73.02 -39.82 65.68 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.603 0.761 . . . . 72.14 109.506 177.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.61 -0.79 68.99 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 123.895 0.747 . . . . 63.41 112.522 171.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.0 p 63.4 32.17 14.66 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.823 2.049 . . . . 75.0 113.384 170.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -83.98 149.83 57.16 Favored Pre-proline 0 CA--C 1.553 1.058 0 N-CA-C 108.027 -1.101 . . . . 64.23 108.027 166.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.06 161.06 5.37 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 123.3 2.667 . . . . 62.51 113.96 176.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 36.9 mm-40 -58.55 113.57 2.06 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.751 0.82 . . . . 72.21 112.222 -172.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 50.8 tp -109.35 87.83 2.59 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.924 -1.034 . . . . 61.4 108.254 173.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -90.2 106.7 18.66 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.175 -1.046 . . . . 73.21 108.175 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 86.5 mt -64.45 129.25 39.16 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.41 0.684 . . . . 61.44 110.618 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.07 151.2 96.11 Favored Pre-proline 0 CA--C 1.553 1.076 0 O-C-N 124.34 1.025 . . . . 73.55 111.089 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.87 116.71 3.4 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.15 2.566 . . . . 55.42 112.853 177.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 28.9 t -99.35 133.22 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.042 -0.725 . . . . 72.24 109.042 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -87.64 96.47 10.44 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.745 0.818 . . . . 63.45 109.169 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -68.92 -24.58 64.31 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.396 0.679 . . . . 75.44 112.085 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -66.13 -41.15 90.88 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 109.076 -0.713 . . . . 61.01 109.076 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.79 -39.98 95.91 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.303 -0.862 . . . . 72.11 110.819 175.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 77.2 mt -67.6 -26.23 66.16 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.551 -0.75 . . . . 64.13 111.012 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . 0.548 ' HB2' ' HB2' ' C' ' 100' ' ' ALA . 34.5 t80 -78.8 -27.01 44.39 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 120.613 0.244 . . . . 70.22 110.878 176.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 62.7 mtt -65.59 -36.88 85.05 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.352 -0.61 . . . . 71.32 109.352 170.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -71.79 -33.39 68.53 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.858 0.863 . . . . 75.34 111.743 173.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -51.23 -83.49 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.512 1.125 . . . . 73.0 110.701 176.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 33.9 tp -133.36 92.64 3.03 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.253 -0.647 . . . . 63.15 109.253 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -77.88 82.32 4.26 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.458 -0.941 . . . . 71.51 108.458 172.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -141.4 -14.03 0.88 Allowed 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.066 -1.424 . . . . 62.03 108.88 178.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -147.32 168.53 21.53 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 123.852 0.861 . . . . 64.14 110.957 -171.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.74 -179.06 6.94 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.714 1.205 . . . . 63.42 109.075 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 165.22 101.01 0.15 Allowed Glycine 0 C--N 1.342 0.867 0 N-CA-C 111.499 -0.64 . . . . 51.03 111.499 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.44 127.61 12.05 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.324 -0.991 . . . . 73.25 108.324 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -169.95 58.17 0.19 Allowed Glycine 0 C--N 1.344 0.974 0 N-CA-C 111.789 -0.524 . . . . 74.31 111.789 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 13.2 p -67.46 95.9 0.48 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.359 0.664 . . . . 51.42 110.66 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -90.87 -171.77 3.13 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.461 1.104 . . . . 70.23 110.006 176.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -141.71 141.39 33.3 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.141 -1.059 . . . . 71.54 108.141 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -156.09 77.01 0.94 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.967 0.907 . . . . 72.01 110.092 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -78.67 171.44 15.14 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 115.2 -0.909 . . . . 72.42 111.113 174.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -165.96 98.17 0.64 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.155 -0.684 . . . . 45.53 109.155 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.318 -0.849 . . . . 72.14 109.212 -175.771 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 109.868 -0.419 . . . . 74.23 109.868 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 38.0 m -149.87 106.89 3.57 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.081 0.952 . . . . 64.41 108.86 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.42 79.33 1.2 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 109.475 -0.565 . . . . 73.42 109.475 -176.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -136.75 46.84 2.19 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 107.428 -1.323 . . . . 71.12 107.428 167.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -127.37 127.41 44.16 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.306 -0.861 . . . . 65.13 109.455 -176.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -93.57 -31.8 14.38 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.022 0.929 . . . . 74.43 109.749 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 6.3 m -71.96 161.25 31.2 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 123.92 0.888 . . . . 73.22 110.13 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 73.15 122.71 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.185 1.394 . . . . 75.3 111.014 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -33.76 123.14 0.45 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.613 1.165 . . . . 72.23 111.736 172.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.421 HG22 ' HB3' ' D' ' 87' ' ' ALA . 10.2 t -119.18 140.74 49.69 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.941 0.4 . . . . 33.54 110.286 -176.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -133.37 111.2 10.58 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.642 -1.244 . . . . 74.11 107.642 173.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -136.4 139.64 42.61 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.086 0.954 . . . . 63.2 108.655 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.506 HG21 HD11 ' D' ' 16' ' ' ILE . 7.4 mt -100.2 142.02 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 108.717 -0.846 . . . . 61.1 108.717 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -103.45 -34.6 8.65 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.324 0.65 . . . . 75.53 111.483 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -169.42 137.13 1.8 Allowed 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.015 0.376 . . . . 72.14 112.015 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.506 HD11 HG21 ' D' ' 13' ' ' ILE . 3.5 mp -115.66 140.09 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 107.216 -1.402 . . . . 65.55 107.216 170.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.43 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 38.3 p90 -168.72 171.08 8.92 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.977 0.911 . . . . 73.31 110.15 176.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -98.41 117.83 33.71 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.888 -1.051 . . . . 71.25 109.089 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.43 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 22.4 mtpt -85.79 -25.8 26.15 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.721 -0.844 . . . . 65.01 108.721 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.629 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 26.6 t70 -155.68 136.87 13.83 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.648 -1.16 . . . . 74.0 109.576 -178.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.525 HG21 ' HE2' ' C' ' 117' ' ' MET . 67.9 mt -136.59 146.84 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.326 1.05 . . . . 71.15 109.019 174.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -145.5 141.25 28.13 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.608 1.163 . . . . 72.21 109.515 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.492 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.1 t80 -145.67 134.52 22.44 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 106.415 -1.698 . . . . 72.03 106.415 165.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.45 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 50.0 mt-10 -135.03 144.99 47.6 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.94 0.896 . . . . 74.34 109.366 -178.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.96 79.77 8.32 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 107.037 -1.468 . . . . 75.54 107.037 170.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.16 -15.49 28.73 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.821 2.347 . . . . 71.51 112.232 -175.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.415 ' ND2' ' HB ' ' D' ' 72' ' ' THR . 40.5 m-20 -114.78 16.38 17.38 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 124.383 1.073 . . . . 73.23 110.588 -174.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.55 -65.11 0.98 Allowed Pre-proline 0 CA--C 1.562 1.412 0 N-CA-C 115.067 1.506 . . . . 61.13 115.067 -159.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.501 ' HB3' HD11 ' C' ' 83' ' ' ILE . 57.4 Cg_endo -69.96 -22.98 30.42 Favored 'Trans proline' 0 C--N 1.392 2.833 0 CA-C-N 122.51 1.932 . . . . 62.12 113.484 -177.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -69.47 -44.63 70.79 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.275 1.03 . . . . 70.42 110.498 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.463 HG21 ' HA ' ' D' ' 73' ' ' ALA . 5.7 p -85.0 -18.52 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 123.192 0.597 . . . . 72.34 111.613 -170.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -60.9 -23.55 65.31 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 112.447 0.536 . . . . 54.54 112.447 172.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -63.8 -22.73 67.05 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.434 0.694 . . . . 55.42 110.919 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.594 ' HZ1' ' HB3' ' D' ' 71' ' ' GLU . 90.9 mttt -85.59 104.78 15.65 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.489 1.115 . . . . 72.12 109.599 176.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -102.09 90.56 3.99 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 109.379 -0.6 . . . . 63.34 109.379 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 35.4 p90 -165.42 -168.44 1.36 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.882 0.873 . . . . 75.11 109.624 171.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.444 HE21 ' HD2' ' D' ' 38' ' ' PRO . 27.3 tp60 -72.7 117.17 57.05 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.8 0.84 . . . . 65.24 110.497 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.444 ' HD2' HE21 ' D' ' 37' ' ' GLN . 53.0 Cg_exo -56.88 110.63 0.62 Allowed 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 121.788 1.659 . . . . 64.23 109.862 168.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -67.79 109.61 3.44 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.048 -1.093 . . . . 74.22 108.048 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.683 HG21 HD13 ' D' ' 126' ' ' LEU . 92.3 t -106.62 122.68 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.4 -0.364 . . . . 71.44 110.397 -170.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.95 119.29 38.97 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.726 -1.583 . . . . 71.31 106.726 172.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.499 HD11 HG13 ' D' ' 62' ' ' VAL . 45.3 tp -95.11 141.91 28.19 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.334 -0.987 . . . . 75.24 108.334 178.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -136.53 125.3 23.97 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.229 -1.397 . . . . 73.21 107.229 -177.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.426 ' CD2' HG22 ' D' ' 62' ' ' VAL . 83.6 mt -120.08 142.13 49.15 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.143 0.577 . . . . 74.11 110.491 -175.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -146.38 143.22 28.92 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.344 1.458 . . . . 74.02 107.612 174.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . 0.5 ' HB ' HD21 ' E' ' 111' ' ' LEU . 15.2 t -103.95 165.37 11.09 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.983 -0.747 . . . . 63.22 108.983 176.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.596 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.37 147.44 26.92 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.258 -1.386 . . . . 65.51 107.258 175.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 6.4 p -167.69 -170.61 1.43 Allowed 'General case' 0 C--O 1.246 0.899 0 C-N-CA 123.753 0.821 . . . . 62.23 108.879 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 27.8 p -148.5 119.27 7.55 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.167 0.587 . . . . 63.2 109.432 -173.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . 0.525 ' HB3' ' HB2' ' E' ' 102' ' ' LEU . 29.2 pt20 -79.12 -28.04 42.91 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.279 0.632 . . . . 74.15 111.282 -177.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 57.0 tp -69.51 85.0 0.43 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.906 0.882 . . . . 74.3 109.528 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -177.84 161.73 1.63 Allowed 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.301 1.041 . . . . 64.21 110.578 -175.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -116.59 92.87 4.0 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.424 -0.954 . . . . 44.12 108.424 171.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' D' ' 85' ' ' SER . 3.5 m-20 68.82 5.46 4.99 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 114.05 1.13 . . . . 55.52 114.05 169.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 89.8 t -134.18 100.54 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.001 -1.111 . . . . 62.31 108.001 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -117.84 138.47 52.07 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.034 0.934 . . . . 51.5 109.891 -170.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.672 ' HG2' HG13 ' D' ' 83' ' ' ILE . 33.8 mt-10 -87.95 108.34 19.15 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 108.521 -0.918 . . . . 72.2 108.521 170.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 97.4 t -101.08 123.79 54.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.77 -0.826 . . . . 55.31 108.77 175.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 21.3 t -114.24 130.86 67.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.994 -1.113 . . . . 74.34 107.994 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.583 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -105.35 119.81 40.01 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.792 -1.188 . . . . 71.52 107.792 -178.563 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -98.6 99.79 10.96 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.237 -1.024 . . . . 64.53 108.237 177.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.499 HG13 HD11 ' D' ' 42' ' ' LEU . 58.3 t -105.86 118.46 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 108.66 -0.867 . . . . 74.35 108.66 178.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 16.0 m -125.45 130.59 52.13 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.593 -0.73 . . . . 63.44 109.751 -170.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.661 HG13 HG13 ' D' ' 40' ' ' VAL . 70.3 t -113.22 130.6 66.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 124.845 1.258 . . . . 73.22 109.445 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 37.3 m -119.55 93.49 4.09 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.218 -1.401 . . . . 62.41 107.218 167.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.71 138.13 36.32 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.787 -0.82 . . . . 54.51 108.787 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.546 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 66.9 m -143.43 132.29 22.73 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.193 0.521 . . . . 75.54 111.232 -175.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.436 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 35.6 mt -95.55 99.26 11.16 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.482 -1.303 . . . . 51.41 107.482 173.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.57 -137.36 17.37 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.578 -0.737 . . . . 74.12 112.619 -177.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.44 5.26 31.84 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.611 0.764 . . . . 73.43 111.95 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . 0.594 ' HB3' ' HZ1' ' D' ' 34' ' ' LYS . 5.4 tp10 -136.6 145.67 45.17 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.194 0.998 . . . . 72.22 109.599 -169.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . 0.415 ' HB ' ' ND2' ' D' ' 27' ' ' ASN . 91.8 m -59.83 135.95 57.85 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.741 1.217 . . . . 53.22 112.522 -175.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.546 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.6 -65.62 1.0 Allowed 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.301 -1.37 . . . . 74.12 107.301 170.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -152.57 158.26 42.23 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 114.542 -1.208 . . . . 53.24 110.045 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 76.0 mt -116.84 155.02 29.73 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.867 1.267 . . . . 73.52 108.269 171.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.574 ' SG ' HG12 ' D' ' 114' ' ' ILE . 49.1 t -154.42 147.71 24.9 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.059 -0.719 . . . . 63.42 109.059 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -157.43 123.78 4.88 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.818 0.447 . . . . 64.11 110.129 174.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 50.2 t -124.3 116.93 49.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 123.523 0.729 . . . . 62.2 109.118 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.629 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.9 mt-30 -93.25 85.1 4.92 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-O 121.938 0.875 . . . . 62.3 109.08 171.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -80.4 102.64 9.74 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 113.713 -1.585 . . . . 71.33 109.465 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.84 150.83 21.31 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 116.742 -0.208 . . . . 73.5 113.219 -178.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -154.58 137.24 5.58 Favored Glycine 0 C--N 1.34 0.791 0 N-CA-C 112.092 -0.403 . . . . 52.24 112.092 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.672 HG13 ' HG2' ' D' ' 57' ' ' GLU . 2.6 mp -91.15 112.84 25.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 N-CA-C 107.775 -1.194 . . . . 65.13 107.775 174.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -115.33 145.29 42.64 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.69 0.796 . . . . 62.32 109.669 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' D' ' 54' ' ' ASP . 39.8 m -116.29 107.78 15.27 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.836 0.854 . . . . 63.41 109.766 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.488 HD11 HD23 ' D' ' 98' ' ' LEU . 46.9 pt -116.8 129.35 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.387 0.675 . . . . 73.42 109.391 176.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.421 ' HB3' HG22 ' D' ' 10' ' ' THR . . . -143.49 158.18 43.85 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.675 0.79 . . . . 71.44 110.149 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.07 23.64 44.18 Favored Glycine 0 C--N 1.347 1.16 0 O-C-N 123.709 0.631 . . . . 73.4 114.247 173.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.432 HD13 ' HG3' ' D' ' 94' ' ' MET . 0.7 OUTLIER -134.85 160.94 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.476 0.71 . . . . 62.45 110.726 178.254 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.13 160.2 40.48 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.137 0.898 . . . . 75.14 111.019 -171.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.67 -141.35 36.52 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.194 -0.912 . . . . 71.54 113.945 175.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.5 p -78.41 -32.31 48.62 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.138 0.575 . . . . 74.23 110.739 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 26.7 tp60 -56.46 -33.58 66.06 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.881 0.873 . . . . 74.23 111.266 177.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.514 ' SD ' HG23 ' E' ' 97' ' ' ILE . 40.0 ttp -62.44 -62.19 1.93 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.146 1.378 . . . . 71.22 112.165 177.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.28 -15.09 51.54 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.066 0.546 . . . . 51.11 112.176 -171.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -70.83 -26.59 63.35 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.109 0.564 . . . . 74.22 110.088 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.7 t -66.41 -45.65 79.21 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.273 0.629 . . . . 75.42 110.947 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.599 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 4.3 pp -74.35 -23.08 58.97 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 116.608 -0.269 . . . . 74.42 111.207 178.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.82 -28.59 34.44 Favored Glycine 0 C--N 1.348 1.23 0 O-C-N 123.458 0.474 . . . . 55.01 112.958 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.24 -57.37 2.01 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 117.332 0.566 . . . . 50.22 112.233 -170.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -72.48 -37.64 68.39 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.524 0.329 . . . . 74.24 111.833 -174.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.599 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 88.6 m -65.35 -46.62 70.81 Favored Pre-proline 0 CA--C 1.566 1.592 0 CA-C-O 118.775 -0.631 . . . . 73.41 112.198 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.583 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 76.2 Cg_exo -57.61 -31.3 91.4 Favored 'Trans proline' 0 C--N 1.394 2.923 0 C-N-CA 122.622 2.215 . . . . 73.44 113.902 168.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -65.57 -28.55 69.23 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.092 0.557 . . . . 61.43 111.186 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.4 mm -73.32 -35.29 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.316 0.646 . . . . 75.05 110.332 174.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 68.3 mt -77.1 -18.24 58.1 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.352 -0.84 . . . . 74.14 111.891 -177.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . 0.421 ' HE2' ' HA ' ' D' ' 130' ' ' PRO . 8.4 t80 -70.46 -39.91 10.5 Favored Pre-proline 0 CA--C 1.557 1.218 0 N-CA-C 114.353 1.242 . . . . 71.52 114.353 -171.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.79 -44.9 45.15 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.962 1.775 . . . . 60.33 112.68 169.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -71.83 -32.58 67.69 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.845 0.858 . . . . 71.12 111.554 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.99 -50.52 64.01 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.467 0.707 . . . . 32.33 110.237 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.497 ' NH2' HG23 ' B' ' 105' ' ' ILE . 31.3 ttp180 -60.22 -43.06 96.31 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 124.353 1.033 . . . . 63.24 110.031 176.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -57.0 -52.77 63.94 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.102 0.876 . . . . 55.22 111.455 -176.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.437 ' O ' ' HG3' ' D' ' 117' ' ' MET . 43.2 t -57.06 -44.17 82.76 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 124.177 0.923 . . . . 73.3 110.598 -177.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.574 HG12 ' SG ' ' D' ' 76' ' ' CYS . 83.7 mt -60.62 -54.95 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.743 0.817 . . . . 64.04 110.696 175.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 77.2 m -53.43 -43.74 68.23 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.382 1.473 . . . . 62.01 111.055 -175.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -65.36 -45.9 82.31 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.403 -1.272 . . . . 72.04 109.805 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.437 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 71.2 mtm -70.87 -26.97 63.48 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.0 0.52 . . . . 73.43 112.391 -177.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.467 HG21 ' HB3' ' D' ' 126' ' ' LEU . 71.0 t -68.64 -46.16 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.216 0.606 . . . . 70.51 109.419 175.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 81.5 p -70.75 -29.69 66.0 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.588 -0.733 . . . . 72.45 110.463 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -70.83 -34.15 71.41 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.815 0.846 . . . . 64.35 110.0 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.7 6.17 71.06 Favored Glycine 0 C--N 1.355 1.625 0 O-C-N 123.681 0.613 . . . . 51.13 113.203 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.457 HG23 ' HB3' ' C' ' 17' ' ' TYR . 65.3 p 56.18 28.94 13.87 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 126.39 1.876 . . . . 72.53 113.349 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -92.79 148.93 36.94 Favored Pre-proline 0 C--O 1.241 0.655 0 N-CA-C 108.598 -0.89 . . . . 75.54 108.598 167.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.35 125.96 13.04 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 123.318 2.679 . . . . 71.04 112.466 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -47.91 124.9 8.05 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 124.607 1.192 . . . . 74.54 112.149 -173.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.683 HD13 HG21 ' D' ' 40' ' ' VAL . 16.6 tp -106.49 106.1 16.46 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.165 0.986 . . . . 75.03 109.682 -176.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -109.47 83.01 1.68 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.322 1.049 . . . . 73.44 108.532 175.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.479 ' HA ' ' HB1' ' E' ' 125' ' ' ALA . 3.6 pp -62.98 141.91 58.57 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.958 0.503 . . . . 64.34 110.393 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.24 139.86 90.14 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 122.74 0.416 . . . . 75.42 111.609 -173.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.421 ' HA ' ' HE2' ' D' ' 107' ' ' PHE . 74.3 Cg_endo -73.51 144.73 36.54 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.682 2.255 . . . . 72.32 111.365 176.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.99 145.59 23.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.815 0 C-N-CA 122.977 0.511 . . . . 70.33 110.129 -177.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -78.71 112.28 15.67 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.508 0.723 . . . . 71.42 109.24 176.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.425 ' HD2' HD23 ' E' ' 111' ' ' LEU . 32.2 m-85 -65.57 -26.0 67.66 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.968 0.907 . . . . 74.23 112.146 -176.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -51.8 -47.02 64.43 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 124.384 1.052 . . . . 74.21 109.624 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.85 -43.5 98.25 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-N 113.846 -1.524 . . . . 73.31 111.705 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 7.0 mp -58.65 -35.83 73.16 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 124.51 1.124 . . . . 73.41 113.002 -171.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -69.76 -41.83 74.67 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.961 0.504 . . . . 74.1 110.896 178.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 70.9 mtm -74.65 -20.18 59.98 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.476 -0.783 . . . . 73.44 110.858 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' D' ' 143' ' ' GLN . 76.3 m-20 -78.23 -30.42 48.74 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.107 0.963 . . . . 73.44 111.385 178.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -55.62 -33.95 64.46 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.02 0.928 . . . . 73.44 112.596 -177.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.1 mp -71.41 -29.42 64.9 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.46 0.704 . . . . 72.33 110.696 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -82.53 -4.44 57.58 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.369 0.668 . . . . 65.43 112.09 -173.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' D' ' 139' ' ' ASN . 0.8 OUTLIER -123.35 83.24 2.1 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.857 0.863 . . . . 74.11 109.062 -173.639 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -164.94 173.73 11.3 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.677 1.191 . . . . 72.23 108.579 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.75 -65.82 0.62 Allowed 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 109.284 -0.636 . . . . 73.12 109.284 175.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 51.9 -95.38 0.01 OUTLIER Glycine 0 C--N 1.363 2.081 0 O-C-N 124.404 1.065 . . . . 53.24 112.384 -177.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -136.73 104.67 5.59 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 107.476 -1.305 . . . . 55.02 107.476 163.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 154.4 85.53 0.05 OUTLIER Glycine 0 C--N 1.339 0.748 0 O-C-N 123.721 0.638 . . . . 72.43 111.732 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 31.7 m -81.68 85.34 6.59 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.182 -0.674 . . . . 72.03 109.182 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -91.36 71.9 6.1 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.901 -0.778 . . . . 70.13 108.901 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.38 91.55 0.56 Allowed 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 115.225 -0.898 . . . . 74.21 109.385 176.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -73.07 90.99 1.56 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.717 -0.846 . . . . 75.1 108.717 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -70.24 132.76 46.22 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.086 -0.961 . . . . 74.24 110.163 179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -91.67 152.92 20.01 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.516 -0.92 . . . . 64.43 108.516 174.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.262 0 CA-C-O 118.505 -0.759 . . . . 73.51 110.982 -178.052 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.838 0 N-CA-C 112.729 -0.149 . . . . 53.13 112.729 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . -63.02 104.94 0.89 Allowed Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.383 -0.676 . . . . 62.25 112.163 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 49.1 t80 67.6 55.55 0.62 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.416 1.086 . . . . 61.15 109.921 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 73.07 132.56 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 125.926 1.69 . . . . 64.23 113.164 174.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 95' ' ' LYS . . . . . 0.437 ' HE2' ' HB2' ' E' ' 95' ' ' LYS . 0.0 OUTLIER -156.17 156.22 33.83 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-O 121.153 0.502 . . . . 63.23 110.383 167.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.48 -36.76 0.16 Allowed Glycine 0 C--N 1.34 0.805 0 N-CA-C 110.105 -1.198 . . . . 73.34 110.105 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 97' ' ' ILE . . . . . 0.514 HG23 ' SD ' ' D' ' 94' ' ' MET . 86.4 mt -86.18 114.89 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 125.282 1.433 . . . . 41.31 107.819 173.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -100.29 0.89 41.04 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.687 0.795 . . . . 72.11 111.414 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -162.02 116.18 1.87 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.227 1.011 . . . . 72.41 109.439 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 100' ' ' LEU . . . . . 0.492 HD23 HG21 ' E' ' 97' ' ' ILE . 0.7 OUTLIER -112.52 99.4 47.17 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 123.255 0.622 . . . . 72.53 109.337 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -94.89 100.82 0.11 Allowed 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 123.532 2.821 . . . . 75.11 110.413 165.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 102' ' ' LEU . . . . . 0.525 ' HB2' ' HB3' ' D' ' 50' ' ' GLN . 4.0 tt -79.79 73.12 6.54 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.543 0.737 . . . . 74.21 110.679 -169.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 62.6 p 51.29 12.02 0.13 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 125.994 1.718 . . . . 74.45 114.091 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 140.11 -65.09 0.52 Allowed Glycine 0 C--N 1.342 0.878 0 N-CA-C 109.738 -1.345 . . . . 54.13 109.738 -168.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -173.31 -38.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.836 1.255 . . . . 61.1 110.059 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -148.27 -160.57 1.19 Allowed 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 106.983 -1.488 . . . . 64.21 106.983 -172.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 16.0 m -52.14 88.19 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.727 1.211 . . . . 73.23 111.634 169.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 -79.21 -33.87 43.4 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.113 -0.949 . . . . 54.12 109.259 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -116.73 117.98 31.29 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.897 -1.149 . . . . 74.23 107.897 -178.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.98 142.53 58.4 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.03 0.832 . . . . 53.11 111.224 -177.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . 0.5 HD21 ' HB ' ' D' ' 46' ' ' THR . 5.5 mp -93.64 17.16 12.22 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.115 -0.948 . . . . 61.53 110.115 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -130.7 -164.77 1.47 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.588 1.155 . . . . 75.42 108.854 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -105.95 116.01 31.22 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.161 -0.681 . . . . 72.55 109.161 169.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -75.77 -23.65 55.94 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.723 0.809 . . . . 62.14 111.045 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 8.4 t -144.02 -45.45 0.26 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.992 0.517 . . . . 73.22 110.517 173.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 122.47 131.52 3.89 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-O 119.464 -0.631 . . . . 43.21 111.954 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -176.2 -58.89 0.0 OUTLIER Pre-proline 0 CA--C 1.564 1.494 0 C-N-CA 125.533 1.533 . . . . 75.15 108.938 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -81.94 -38.81 0.19 Allowed 'Trans proline' 0 C--N 1.397 3.112 0 C-N-CA 121.765 1.643 . . . . 75.11 112.475 175.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 54.3 38.52 29.54 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.87 1.268 . . . . 75.41 113.397 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -61.26 -38.08 85.44 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.08 0.552 . . . . 73.44 110.211 170.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 121' ' ' VAL . . . . . 0.498 HG21 ' O ' ' E' ' 111' ' ' LEU . 41.9 t -93.51 85.06 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 107.621 -1.251 . . . . 65.23 107.621 171.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 26.3 m -75.89 150.64 37.54 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.399 -1.273 . . . . 73.04 110.332 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -87.48 45.86 1.32 Allowed 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.989 0.899 . . . . 62.52 110.437 174.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 35.0 t -159.84 139.05 11.0 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.719 1.207 . . . . 72.2 108.201 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . 0.479 ' HB1' ' HA ' ' D' ' 128' ' ' LEU . . . -146.06 159.86 42.69 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.351 0.66 . . . . 73.43 110.511 -175.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.36 125.34 26.72 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.242 0.617 . . . . 62.4 109.787 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 42.0 t -161.53 166.88 26.4 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.56 0.744 . . . . 55.32 109.787 -178.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.72 170.16 15.39 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.624 0.77 . . . . 44.3 110.924 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 2.1 p -125.56 10.66 7.88 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.039 0.935 . . . . 43.32 111.006 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -144.22 146.18 32.52 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.257 0.623 . . . . 53.44 110.728 -175.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 131' ' ' TRP . . . . . . . . . . . . . 39.5 t-105 -162.4 169.69 20.06 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 124.045 0.938 . . . . 73.03 109.68 177.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 132' ' ' SER . . . . . 0.501 ' N ' ' HB3' ' A' ' 124' ' ' PRO . 24.1 m 74.16 105.47 0.07 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.758 1.623 . . . . 74.54 111.171 178.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 87.9 m -65.65 -31.84 73.08 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.325 1.05 . . . . 71.55 111.822 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.9 78.93 1.26 Allowed Glycine 0 C--N 1.342 0.883 0 N-CA-C 110.507 -1.037 . . . . 73.32 110.507 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 135' ' ' VAL . . . . . 0.406 HG11 ' HB ' ' C' ' 13' ' ' ILE . 58.2 t -73.49 126.63 34.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 123.579 0.751 . . . . 63.55 110.672 -175.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -114.06 177.42 4.65 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.352 1.061 . . . . 52.24 109.77 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 3.7 m -93.26 18.62 9.25 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.352 0.661 . . . . 75.31 110.391 176.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 71.5 t80 65.48 -76.7 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.152 1.381 . . . . 74.3 111.457 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 139' ' ' ASN . . . . . 0.488 HD22 ' HB3' ' A' ' 154' ' ' ASP . 6.2 t30 -90.13 -50.09 6.2 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.473 0.709 . . . . 70.43 109.231 177.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -74.03 164.96 54.81 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.793 -0.639 . . . . 71.45 113.015 -175.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -110.07 172.6 6.77 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.858 0.863 . . . . 73.34 109.985 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 46.2 tp -86.1 139.44 31.11 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 122.606 0.363 . . . . 73.44 110.196 175.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -97.1 -107.32 2.47 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-O 119.418 -0.657 . . . . 60.1 111.509 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 144' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' C' ' 54' ' ' ASP . 40.4 t 58.97 84.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.562 1.145 . . . . 75.31 109.565 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 32.8 t70 . . . . . 0 C--O 1.252 1.194 0 C-N-CA 123.388 0.675 . . . . 70.1 110.895 -174.16 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.43 0 N-CA-C 111.593 -0.603 . . . . 64.33 111.593 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . -88.35 39.35 3.12 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 114.344 0.498 . . . . 43.02 114.344 -174.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -89.91 89.46 7.74 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.535 -0.913 . . . . 75.34 108.535 172.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -113.53 173.66 6.3 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.367 1.067 . . . . 61.01 111.173 -174.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -130.31 153.8 48.29 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.076 0.95 . . . . 71.33 110.744 -175.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -166.94 -59.18 0.03 OUTLIER Glycine 0 C--N 1.352 1.454 0 O-C-N 123.545 0.528 . . . . 52.15 112.017 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 97' ' ' ILE . . . . . 0.513 HG21 ' HB2' ' F' ' 100' ' ' LEU . 37.0 mt -67.61 131.97 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 124.298 1.039 . . . . 75.51 109.291 173.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -85.62 7.0 24.93 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.239 0.829 . . . . 61.31 113.239 -176.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 99' ' ' ALA . . . . . 0.457 ' H ' HG22 ' F' ' 97' ' ' ILE . . . -158.16 -84.87 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 118.408 0.549 . . . . 33.14 111.47 -175.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 100' ' ' LEU . . . . . 0.763 HD11 HD21 ' B' ' 98' ' ' LEU . 38.5 tp 56.77 84.27 0.21 Allowed Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 124.812 1.245 . . . . 64.12 111.497 -175.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -90.47 6.77 3.92 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.853 2.369 . . . . 73.44 113.127 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 102' ' ' LEU . . . . . 0.547 HD23 ' HB2' ' B' ' 50' ' ' GLN . 3.6 mm? 60.71 14.13 4.83 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.913 0.885 . . . . 75.14 111.089 -176.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 9.2 p 45.5 36.39 2.46 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.951 1.7 . . . . 74.12 113.307 -171.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.71 172.93 16.08 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 116.251 -0.431 . . . . 75.5 112.376 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -67.69 -51.92 43.9 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.234 1.014 . . . . 62.14 110.824 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -110.6 141.94 43.12 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 108.196 -1.039 . . . . 73.41 108.196 175.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 32.4 m -72.47 118.01 14.84 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.33 0.652 . . . . 64.43 110.552 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -81.86 50.29 1.51 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.199 0.999 . . . . 75.44 110.397 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -169.19 45.79 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 106.395 -1.706 . . . . 73.12 106.395 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.49 147.49 47.73 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.877 -1.056 . . . . 23.42 109.636 176.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . 0.615 HD23 HD22 ' B' ' 136' ' ' LEU . 5.7 mp -79.61 3.74 18.09 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.374 0.67 . . . . 74.33 112.32 -171.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -152.92 -65.91 0.16 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.392 0.677 . . . . 32.55 109.428 177.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt 58.18 -96.06 0.06 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.283 1.033 . . . . 73.43 109.433 -172.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -169.19 -33.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 126.261 1.825 . . . . 71.25 108.637 171.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 8.9 m -88.7 16.61 6.46 Favored 'General case' 0 CA--C 1.562 1.442 0 C-N-CA 124.086 0.954 . . . . 63.03 110.115 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . -63.39 119.9 18.66 Favored Glycine 0 C--N 1.356 1.692 0 CA-C-N 116.338 -0.392 . . . . 63.42 112.604 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.34 159.39 83.6 Favored Pre-proline 0 N--CA 1.476 0.838 0 CA-C-O 117.503 -1.237 . . . . 71.03 109.148 175.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -24.2 103.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.398 3.143 1 C-N-CA 125.574 4.183 . . . . 72.3 114.438 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -89.69 -177.95 5.4 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.592 1.157 . . . . 73.12 112.214 -168.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -121.38 -8.08 9.18 Favored 'General case' 0 CA--C 1.555 1.154 0 CA-C-N 115.045 -0.979 . . . . 73.35 110.903 -178.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 13.6 p -77.94 -29.62 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 122.749 0.42 . . . . 61.43 110.953 -176.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 43.8 p 56.26 -170.37 0.08 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 125.964 1.706 . . . . 73.53 112.569 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -53.52 -67.72 0.23 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.593 0.757 . . . . 53.24 111.079 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 23.3 t -173.28 -22.3 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.208 0.603 . . . . 75.41 110.303 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . 56.55 29.63 15.84 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.526 1.131 . . . . 65.11 110.909 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -90.74 74.17 6.63 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.962 -1.017 . . . . 75.15 110.6 -170.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 21.8 m -86.09 59.52 5.68 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.223 -0.899 . . . . 73.31 110.157 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -155.73 4.36 0.19 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.196 0.999 . . . . 61.44 110.826 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 129' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' B' ' 38' ' ' PRO . 16.5 p -75.56 91.8 2.86 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.805 0.842 . . . . 62.31 111.26 -177.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -150.75 147.4 27.27 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.508 1.123 . . . . 71.52 109.313 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 35.3 t90 -124.33 -69.71 0.79 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.024 0.53 . . . . 75.33 111.15 -178.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 53.7 m -64.01 112.8 3.12 Favored 'General case' 0 C--N 1.363 1.192 0 CA-C-O 121.094 0.473 . . . . 74.21 111.512 -173.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 9.0 t -124.26 -174.27 2.96 Favored 'General case' 0 C--O 1.244 0.763 0 C-N-CA 124.476 1.11 . . . . 64.22 108.992 175.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.13 69.79 2.44 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 120.377 -0.124 . . . . 71.31 113.139 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 6.1 m -85.36 87.82 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-O 122.178 0.99 . . . . 54.12 109.549 173.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.52 -172.95 3.84 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.133 -0.939 . . . . 74.13 109.771 174.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 32.5 m -59.59 127.28 31.22 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.441 -0.948 . . . . 75.23 108.441 172.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -61.86 86.63 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 O-C-N 124.321 1.013 . . . . 73.41 112.184 -170.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -173.63 142.82 0.97 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.186 -1.37 . . . . 72.41 108.454 -173.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -82.77 143.96 22.71 Favored Glycine 0 C--N 1.342 0.878 0 N-CA-C 112.053 -0.419 . . . . 71.43 112.053 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -150.82 -92.63 0.06 Allowed 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.258 -1.015 . . . . 74.11 108.258 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 19.1 mt -155.26 88.66 1.17 Allowed 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 107.276 -1.379 . . . . 73.44 107.276 165.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.92 73.07 1.98 Allowed Glycine 0 C--N 1.348 1.236 0 N-CA-C 111.654 -0.579 . . . . 70.3 111.654 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 29.9 m -114.19 138.54 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 124.53 1.132 . . . . 45.1 110.998 -171.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 C--O 1.248 0.99 0 C-N-CA 124.048 0.939 . . . . 62.44 109.256 168.207 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.7 ttm . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 107.73 -1.211 . . . . 72.41 107.73 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.0 m -58.88 95.79 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.623 0.769 . . . . 62.11 112.45 -167.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -77.49 151.18 34.74 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.829 0.852 . . . . 70.0 110.833 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.1 134.34 43.17 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 124.012 0.925 . . . . 71.34 109.604 177.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -80.14 147.35 31.4 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.152 0.581 . . . . 64.13 109.964 177.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -88.44 147.73 24.55 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.993 0.517 . . . . 63.03 110.03 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -113.69 -8.1 13.27 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.72 0.808 . . . . 55.12 110.675 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -106.11 79.54 1.41 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.594 0.758 . . . . 72.31 110.434 -174.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -123.28 174.24 7.42 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.901 0.88 . . . . 53.14 109.987 175.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.3 m -141.21 116.07 9.76 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.404 1.082 . . . . 74.5 108.218 169.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -120.96 119.77 33.54 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.978 0.911 . . . . 65.43 109.211 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -135.25 132.47 37.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.006 0.923 . . . . 73.44 108.586 174.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.466 ' CD1' HG21 ' A' ' 105' ' ' ILE . 4.8 mt -96.17 114.47 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 108.617 -0.883 . . . . 62.32 108.617 173.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -78.32 -32.95 49.52 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.014 0.525 . . . . 70.2 110.249 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -171.85 148.69 2.37 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 123.378 0.424 . . . . 64.34 110.144 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.2 mt -133.12 135.26 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 124.632 1.173 . . . . 65.34 108.502 173.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -163.2 171.74 15.81 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 123.982 0.801 . . . . 75.32 112.104 -171.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -101.78 124.39 47.34 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.366 -0.976 . . . . 72.21 108.366 169.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.532 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 44.2 mtpt -85.91 -35.69 20.36 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.039 0.447 . . . . 74.25 109.889 175.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.528 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 19.7 t70 -146.66 138.96 24.9 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.15 -0.932 . . . . 74.11 109.401 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 81.0 mt -129.11 140.32 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.009 -1.108 . . . . 71.14 108.009 174.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.7 t -138.87 123.67 18.71 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.365 0.666 . . . . 72.11 109.279 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 86.9 t80 -133.59 129.38 36.89 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.265 -1.754 . . . . 74.33 106.265 170.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -139.17 124.45 19.11 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.955 -1.128 . . . . 74.13 107.955 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.7 89.26 7.42 Favored Pre-proline 0 C--O 1.241 0.658 0 N-CA-C 107.886 -1.153 . . . . 71.44 107.886 175.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -52.31 -53.39 7.0 Favored 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 123.684 2.923 . . . . 72.24 113.504 -169.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.26 41.27 2.83 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.779 -0.823 . . . . 74.53 108.779 -173.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -44.66 -59.13 4.34 Favored Pre-proline 0 N--CA 1.495 1.789 0 CA-C-O 117.584 -1.198 . . . . 71.21 113.968 -171.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 20.9 Cg_exo -62.37 -22.54 74.22 Favored 'Trans proline' 0 C--N 1.389 2.669 0 CA-C-N 121.952 1.733 . . . . 74.5 112.618 -177.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.43 ' HA ' HE21 ' A' ' 33' ' ' GLN . 9.4 m-70 -94.47 -28.36 15.5 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.613 1.165 . . . . 72.21 111.244 -173.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 28' ' ' ALA . 5.9 p -80.05 -17.09 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 122.698 0.399 . . . . 34.3 111.877 -170.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -78.23 -24.12 47.11 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.393 0.677 . . . . 75.24 111.206 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.43 HE21 ' HA ' ' A' ' 30' ' ' HIS . 29.5 pt20 -92.56 -16.08 26.15 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.782 0.833 . . . . 75.35 110.687 176.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.1 mmmm -67.57 157.81 33.5 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.29 0.636 . . . . 63.02 111.156 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -67.54 116.63 8.48 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.401 -0.963 . . . . 72.42 108.401 171.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.421 ' CE3' HD21 ' A' ' 68' ' ' LEU . 73.7 t-105 -83.8 82.13 8.46 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.092 0.557 . . . . 72.25 110.372 -175.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -115.16 81.78 8.33 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 107.572 -1.27 . . . . 73.42 107.572 168.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -86.53 121.34 1.88 Allowed 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.424 2.083 . . . . 73.4 112.499 -173.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -94.95 95.45 8.64 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.069 -1.456 . . . . 64.43 107.069 168.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.559 HG11 HD11 ' A' ' 126' ' ' LEU . 48.0 t -85.71 104.38 13.41 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-N 115.727 -0.67 . . . . 74.23 109.554 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -79.18 121.44 25.03 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.025 -1.102 . . . . 40.03 108.025 173.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tt -96.19 105.12 17.13 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 105.841 -1.911 . . . . 63.03 105.841 175.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -112.39 145.25 40.44 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 107.907 -1.146 . . . . 73.41 107.907 -178.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.552 HD11 HG21 ' A' ' 131' ' ' VAL . 90.1 mt -136.82 146.98 46.3 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.913 0.485 . . . . 72.22 112.094 -171.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -155.09 117.52 4.25 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.906 -1.043 . . . . 73.12 108.765 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.3 m -117.5 126.9 53.4 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.068 0.547 . . . . 64.2 109.997 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.52 127.15 23.42 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.179 0.591 . . . . 54.53 109.94 176.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 61.7 p -101.82 170.72 7.97 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.943 0.897 . . . . 64.33 111.391 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 94.5 p -150.17 124.4 9.48 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.94 0.896 . . . . 53.1 109.382 -173.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -78.88 103.7 9.0 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.187 -0.671 . . . . 63.1 109.187 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 57' ' ' GLU . 69.9 mt -79.39 -26.8 41.87 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.512 0.725 . . . . 71.01 110.848 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.14 -175.08 2.51 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.918 0.887 . . . . 72.04 110.049 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.92 112.33 2.27 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 109.152 -0.684 . . . . 70.22 109.152 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 68.21 6.33 5.21 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.745 1.218 . . . . 75.22 112.884 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.6 t -105.16 116.23 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.014 -1.106 . . . . 61.23 108.014 173.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -132.25 127.33 35.49 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.302 -0.999 . . . . 73.1 108.302 -177.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.445 ' HB2' HD11 ' A' ' 51' ' ' LEU . 23.9 tt0 -88.55 143.37 27.0 Favored 'General case' 0 C--O 1.218 -0.562 0 N-CA-C 108.036 -1.098 . . . . 74.22 108.036 167.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.6 t -118.51 134.67 61.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.049 -1.093 . . . . 74.14 108.049 170.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.411 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 42.8 t -117.72 124.46 73.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 108.607 -0.886 . . . . 73.55 108.607 174.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.23 119.68 39.49 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.535 -1.283 . . . . 63.21 107.535 175.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 46.3 ttp85 -109.48 100.98 9.98 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.559 -1.274 . . . . 63.41 107.559 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.7 t -96.23 103.0 14.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 114.204 -1.362 . . . . 71.21 107.909 -178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.8 m -96.27 107.45 19.8 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 122.066 0.936 . . . . 71.1 108.918 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.556 HG11 HD21 ' A' ' 126' ' ' LEU . 43.4 t -104.72 135.91 40.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 114.599 -1.182 . . . . 73.21 108.592 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 35.7 m -138.1 126.43 23.17 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.497 -0.557 . . . . 75.32 109.497 173.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.547 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -105.31 130.34 53.45 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.326 -1.361 . . . . 70.34 107.326 173.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 54.9 m -136.52 134.15 37.23 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 123.7 0.625 . . . . 74.41 110.507 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.421 HD21 ' CE3' ' A' ' 36' ' ' TRP . 23.7 mt -87.25 69.12 10.01 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 107.532 -1.284 . . . . 75.01 107.532 174.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.26 -100.83 1.3 Allowed Glycine 0 C--N 1.346 1.117 0 CA-C-N 114.307 -1.315 . . . . 74.22 111.939 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -91.14 -27.54 18.47 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.931 0.892 . . . . 75.42 111.604 -177.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -91.33 123.02 34.45 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.485 -0.561 . . . . 74.35 109.485 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.9 m -71.49 129.96 40.07 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.029 0.443 . . . . 44.51 110.431 172.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.33 -52.2 8.41 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.389 1.075 . . . . 75.12 109.162 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -160.47 160.49 32.11 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.225 -0.898 . . . . 73.22 111.615 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.503 HD12 ' O ' ' A' ' 64' ' ' VAL . 63.9 tp -112.68 143.53 43.74 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.806 1.242 . . . . 62.5 108.132 166.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.425 ' HB3' HG23 ' A' ' 114' ' ' ILE . 88.5 m -143.75 98.81 3.3 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.86 0.864 . . . . 74.21 109.651 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -122.37 116.12 23.48 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.915 -0.772 . . . . 61.04 108.915 -176.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.6 t -124.38 122.28 63.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-O 121.441 0.638 . . . . 64.41 109.885 -177.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -99.75 82.07 2.55 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.298 -1.319 . . . . 71.12 108.019 -178.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -76.02 94.47 3.43 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.038 -0.983 . . . . 74.14 109.11 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.05 150.99 21.8 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.664 -0.698 . . . . 72.12 111.383 177.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.76 132.68 3.35 Favored Glycine 0 CA--C 1.507 -0.446 0 N-CA-C 111.017 -0.833 . . . . 31.02 111.017 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.7 mt -81.41 127.07 39.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.384 -0.969 . . . . 63.43 108.384 175.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.602 ' HB3' HD11 ' A' ' 86' ' ' ILE . 95.8 m-85 -124.81 120.02 30.52 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.311 1.044 . . . . 62.54 108.618 -177.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.9 m -92.67 99.2 11.94 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.346 -1.353 . . . . 64.14 107.346 175.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.602 HD11 ' HB3' ' A' ' 84' ' ' PHE . 10.9 mm -117.15 145.99 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 122.787 0.435 . . . . 55.12 110.118 -174.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.91 169.95 17.41 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.688 0.617 . . . . 60.41 110.859 -178.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.45 -15.12 63.36 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.702 -0.681 . . . . 53.35 112.824 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.45 164.54 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 124.188 0.995 . . . . 64.23 110.412 -177.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.591 ' HA ' ' HB2' ' A' ' 94' ' ' MET . 13.8 tt0 -154.8 -177.74 6.72 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 109.402 -0.592 . . . . 74.12 109.402 173.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.528 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 67.53 -122.14 16.84 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 123.208 0.433 . . . . 65.44 113.513 176.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.5 t -74.36 -28.94 61.36 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.711 0.804 . . . . 73.22 111.522 -176.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -73.64 -37.29 65.38 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.518 0.727 . . . . 73.45 109.582 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.591 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 3.2 tpt -66.24 -42.79 88.09 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.237 -0.892 . . . . 72.21 110.053 175.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.18 88.82 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.362 -0.835 . . . . 50.41 111.109 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.534 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 55.8 t-80 -74.9 -20.53 59.68 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.014 0.526 . . . . 73.43 111.163 179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.5 t -78.21 -49.01 14.57 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.785 -0.572 . . . . 75.15 109.539 174.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 76.1 mt -78.81 -31.44 45.9 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.245 0.618 . . . . 74.03 112.575 -172.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.35 4.41 51.36 Favored Glycine 0 N--CA 1.47 0.953 0 CA-C-O 119.649 -0.528 . . . . 75.15 113.583 -174.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -144.47 -63.64 0.36 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 117.448 0.624 . . . . 63.22 112.009 -175.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -69.61 -47.1 64.63 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 112.083 0.401 . . . . 73.14 112.083 -172.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 88.8 m -65.78 -47.13 66.26 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.401 1.08 . . . . 60.33 112.966 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.0 -24.81 59.75 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 122.023 1.815 . . . . 44.24 112.955 173.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -68.83 -33.69 74.25 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.13 0.572 . . . . 73.31 110.505 174.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.466 HG21 ' CD1' ' A' ' 13' ' ' ILE . 43.8 mm -68.3 -42.44 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.77 0.828 . . . . 72.0 110.4 172.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.8 mt -74.25 -25.01 59.38 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.054 -0.976 . . . . 70.31 112.089 -174.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -64.69 -40.87 52.73 Favored Pre-proline 0 CA--C 1.558 1.282 0 N-CA-C 114.49 1.293 . . . . 72.33 114.49 -171.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -52.55 -42.05 64.33 Favored 'Trans proline' 0 C--N 1.385 2.452 0 CA-C-N 121.966 1.738 . . . . 62.22 113.23 170.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -73.43 -40.28 64.36 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.533 0.733 . . . . 75.2 111.318 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.52 -46.59 82.25 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.483 0.713 . . . . 65.32 110.106 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.535 ' NH1' HD12 ' C' ' 105' ' ' ILE . 29.8 ttm180 -52.06 -50.43 61.51 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.959 1.304 . . . . 74.54 110.869 174.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -62.6 -47.79 82.26 Favored 'General case' 0 C--N 1.346 0.429 0 O-C-N 124.431 1.082 . . . . 70.15 111.436 -175.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.416 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 49.7 t -57.51 -42.76 83.42 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 124.173 0.921 . . . . 64.13 110.455 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.461 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.6 mt -60.97 -50.13 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.488 1.115 . . . . 52.13 110.607 175.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.0 m -61.33 -39.31 90.08 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.015 0.926 . . . . 74.13 111.379 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -69.89 -43.11 72.45 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.98 -1.009 . . . . 71.21 109.813 -177.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 6.9 mtp -56.97 -43.95 82.14 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.774 0.83 . . . . 75.01 111.129 174.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 114' ' ' ILE . 68.8 t -62.07 -47.11 94.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 124.556 1.142 . . . . 70.01 111.101 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.7 p -73.95 -29.38 61.98 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 122.906 0.483 . . . . 31.03 111.654 -176.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.448 ' NH1' ' HA ' ' B' ' 113' ' ' CYS . 68.4 mtt-85 -71.62 -30.93 66.33 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.214 0.606 . . . . 53.32 109.627 174.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.92 14.24 44.34 Favored Glycine 0 C--N 1.35 1.33 0 CA-C-N 115.413 -0.812 . . . . 72.43 112.976 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.532 HG21 ' HE ' ' B' ' 15' ' ' ARG . 3.2 t 57.31 13.8 1.88 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 127.156 2.183 . . . . 60.11 113.605 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -77.47 142.14 66.52 Favored Pre-proline 0 C--O 1.244 0.774 0 N-CA-C 108.903 -0.777 . . . . 73.32 108.903 175.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.546 ' HB3' ' HA ' ' E' ' 131' ' ' TRP . 41.5 Cg_exo -43.84 128.25 6.88 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 123.612 2.875 . . . . 74.51 112.622 170.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -55.35 131.88 46.76 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.22 0.95 . . . . 65.41 112.375 -167.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.559 HD11 HG11 ' A' ' 40' ' ' VAL . 42.6 tp -112.62 117.16 31.51 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.751 1.22 . . . . 71.31 109.932 -174.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -121.14 104.61 9.9 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 109.028 -0.73 . . . . 72.23 109.028 -174.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 111' ' ' ARG . 79.2 mt -61.81 144.69 54.42 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.367 0.667 . . . . 53.35 112.336 -173.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.435 ' H ' HG21 ' E' ' 135' ' ' VAL . . . -70.98 144.84 90.82 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.299 0.64 . . . . 72.32 110.304 177.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.406 ' HA ' HH22 ' A' ' 111' ' ' ARG . 24.8 Cg_exo -64.05 117.51 4.52 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.834 2.356 . . . . 64.12 112.599 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.552 HG21 HD11 ' A' ' 44' ' ' LEU . 87.9 t -100.22 132.6 45.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 CA-C-N 116.126 -0.488 . . . . 61.23 110.299 -179.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.437 ' OD1' ' HB3' ' A' ' 134' ' ' ASP . 63.7 t30 -97.59 92.94 6.15 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.725 -1.213 . . . . 70.25 107.725 172.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.41 ' CE1' HD13 ' A' ' 44' ' ' LEU . 86.0 m-85 -65.3 -25.18 67.52 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.577 0.751 . . . . 62.24 111.355 177.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.459 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 1.1 t70 -54.74 -48.27 72.79 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.958 0.903 . . . . 72.32 110.291 168.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.504 ' HB1' ' HB2' ' C' ' 2' ' ' SER . . . -62.81 -45.41 92.77 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.571 0.748 . . . . 44.12 111.711 177.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.74 -35.98 79.66 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.365 0.666 . . . . 74.24 111.396 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -75.04 -35.68 61.89 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.504 -0.771 . . . . 64.32 109.858 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.608 ' SD ' HD23 ' A' ' 141' ' ' LEU . 17.8 mmt -57.99 -40.62 81.16 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 123.575 0.547 . . . . 73.13 111.464 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -49.77 -38.54 34.46 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 123.793 0.837 . . . . 74.41 111.966 177.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -88.83 -37.56 15.28 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.193 0.997 . . . . 73.23 111.514 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.608 HD23 ' SD ' ' A' ' 138' ' ' MET . 41.2 tp -62.65 -54.19 43.19 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.734 0.814 . . . . 75.42 111.954 -169.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.443 ' H ' ' H ' ' A' ' 143' ' ' GLN . 37.5 mt-30 -169.82 -14.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 124.709 1.203 . . . . 73.53 110.746 -177.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.443 ' H ' ' H ' ' A' ' 142' ' ' GLN . 14.3 tm0? 65.73 62.8 0.62 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.037 1.335 . . . . 72.14 108.674 -175.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -148.65 169.48 20.28 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.422 -0.808 . . . . 70.02 111.887 -173.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.36 167.36 18.6 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 114.542 -1.208 . . . . 71.44 110.888 170.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 139.53 93.75 0.26 Allowed Glycine 0 C--N 1.347 1.171 0 N-CA-C 110.946 -0.861 . . . . 70.01 110.946 -178.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -137.41 -85.29 0.31 Allowed 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 108.347 -0.983 . . . . 65.13 108.347 -176.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 64.65 63.97 3.89 Favored Glycine 0 C--N 1.355 1.618 0 N-CA-C 114.703 0.641 . . . . 63.2 114.703 171.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.7 t -84.85 161.81 19.76 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.626 0.37 . . . . 61.34 111.141 175.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -151.48 126.93 10.03 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.558 0.743 . . . . 73.04 109.05 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.51 102.7 3.91 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.875 0.87 . . . . 74.5 111.112 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.541 ' HA ' ' SD ' ' C' ' 138' ' ' MET . 10.8 m170 -148.99 128.66 13.22 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.429 0.692 . . . . 55.21 111.131 175.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -113.47 21.36 15.22 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.656 1.183 . . . . 62.24 110.189 173.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -108.22 140.57 41.26 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.64 0.776 . . . . 70.11 109.225 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.291 0 C-N-CA 124.0 0.92 . . . . 71.41 109.291 179.621 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.439 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 109.538 -0.542 . . . . 70.25 109.538 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 25.9 p -168.19 99.66 0.44 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.879 0.872 . . . . 75.43 109.287 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.482 ' H ' ' HB2' ' F' ' 99' ' ' ALA . 7.8 tp10 -123.75 173.52 8.08 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.365 0.666 . . . . 63.5 109.588 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.405 ' H ' ' HG3' ' B' ' 3' ' ' GLU . 17.2 mm-40 -76.26 -90.09 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.693 0.797 . . . . 73.21 112.044 -164.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -169.0 153.54 5.66 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.145 0.978 . . . . 65.34 109.176 -175.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.454 ' O ' ' HA ' ' B' ' 89' ' ' ILE . 57.5 t30 -162.95 129.95 3.53 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.044 -1.095 . . . . 71.41 108.044 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 19.0 p -105.77 177.72 4.77 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.368 0.667 . . . . 74.13 112.121 -173.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 80.08 -43.73 0.26 Allowed 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 126.621 1.968 . . . . 73.01 112.463 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.548 ' HB3' HG23 ' B' ' 89' ' ' ILE . 11.8 ptm 65.12 171.41 0.21 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 126.605 1.962 . . . . 71.03 115.442 172.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 5.0 t -135.79 126.93 28.04 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.46 -1.245 . . . . 72.33 107.701 168.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -130.82 144.18 51.27 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.909 0.484 . . . . 71.25 110.132 -176.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.422 ' HB3' ' HE2' ' F' ' 94' ' ' PHE . 59.0 tt0 -150.28 141.92 23.58 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 108.693 -0.855 . . . . 64.2 108.693 169.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 63.1 mt -81.44 125.2 39.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.527 -1.286 . . . . 73.1 107.527 171.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . 0.562 ' HB2' HG23 ' B' ' 83' ' ' ILE . 9.3 mm100 -90.16 -39.06 13.07 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.785 -0.45 . . . . 65.43 109.785 -176.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.532 ' HE ' HG21 ' A' ' 122' ' ' THR . 43.2 ttt180 -176.97 134.48 0.2 Allowed 'General case' 0 N--CA 1.477 0.917 0 O-C-N 123.919 0.762 . . . . 73.51 109.81 176.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.543 ' HB ' ' ND2' ' D' ' 127' ' ' ASN . 96.7 mt -115.63 141.37 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 N-CA-C 107.851 -1.166 . . . . 54.13 107.851 173.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -168.44 151.35 5.41 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-O 121.386 0.613 . . . . 73.45 111.568 -174.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 89.5 m -79.06 126.9 31.3 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.953 -1.021 . . . . 60.2 109.24 172.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -89.61 -42.74 11.22 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.73 0.412 . . . . 70.01 110.071 169.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.1 t70 -140.65 136.82 33.07 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.573 -0.285 . . . . 75.43 110.541 -169.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.45 HD11 ' SG ' ' B' ' 113' ' ' CYS . 46.6 mm -126.18 137.09 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.015 0.926 . . . . 70.11 108.772 169.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.488 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 47.7 t -140.52 131.62 26.34 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.686 1.194 . . . . 75.23 107.866 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 80.2 t80 -143.68 121.81 12.18 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.319 -1.734 . . . . 73.0 106.319 170.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -126.71 113.59 16.87 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.117 -1.068 . . . . 62.51 108.117 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -106.7 87.21 2.66 Favored Pre-proline 0 C--O 1.238 0.468 0 N-CA-C 106.633 -1.617 . . . . 65.1 106.633 167.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.66 -27.85 52.69 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.327 2.018 . . . . 74.21 110.962 -172.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.417 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 67.5 m-20 -109.82 11.49 24.31 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.507 1.123 . . . . 63.25 110.939 -177.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' B' ' 25' ' ' ALA . . . -30.48 -64.34 0.21 Allowed Pre-proline 0 N--CA 1.5 2.049 0 C-N-CA 125.517 1.527 . . . . 64.51 114.699 -172.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 14.3 Cg_exo -60.48 -34.8 92.52 Favored 'Trans proline' 0 C--N 1.395 3.015 0 C-N-CA 122.729 2.286 . . . . 70.31 112.199 -170.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.41 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 80.5 m80 -92.52 -39.76 11.19 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 114.442 -1.253 . . . . 71.24 112.39 -170.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.549 HG22 HD12 ' B' ' 68' ' ' LEU . 8.7 p -69.76 -12.66 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 123.032 0.533 . . . . 74.33 111.808 -171.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -69.76 -6.7 33.82 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.651 0.78 . . . . 71.44 112.92 173.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.452 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 29.4 pt20 -67.9 -22.11 65.1 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.816 0.447 . . . . 73.54 110.168 169.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.452 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 92.6 mttt -101.43 92.79 5.08 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.672 1.189 . . . . 74.31 109.869 -176.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -99.17 82.5 2.72 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.623 0.769 . . . . 63.53 110.057 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -157.01 -177.97 7.02 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.733 0.813 . . . . 52.4 109.61 172.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.711 ' HG3' ' HB ' ' F' ' 129' ' ' THR . 26.9 tt0 -66.86 114.77 19.41 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 123.63 0.772 . . . . 50.11 110.588 175.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.419 ' O ' HG23 ' B' ' 40' ' ' VAL . 41.8 Cg_endo -66.3 144.36 74.02 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 121.597 1.531 . . . . 73.55 110.678 172.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -71.4 113.3 8.29 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.525 -0.917 . . . . 70.22 108.525 172.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.494 HG11 HD11 ' B' ' 126' ' ' LEU . 57.4 t -106.5 150.41 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.063 0.945 . . . . 71.5 111.378 -170.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -138.0 119.29 14.66 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.925 1.29 . . . . 72.3 107.854 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.479 HD13 HD22 ' B' ' 128' ' ' LEU . 23.3 tp -85.43 138.62 32.13 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.359 -0.978 . . . . 34.31 108.359 173.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -140.05 112.38 7.77 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.858 -1.164 . . . . 45.24 107.858 -171.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 88.4 mt -103.1 139.57 38.45 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.275 0.63 . . . . 74.12 110.778 -171.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -148.28 146.02 28.43 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.126 1.37 . . . . 65.25 107.638 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.4 t -151.24 110.91 4.02 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 121.432 0.634 . . . . 65.32 111.737 -177.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.63 148.53 40.88 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.346 1.058 . . . . 74.2 108.367 175.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 20.8 p -142.8 177.18 8.51 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.429 0.691 . . . . 72.14 111.109 -172.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 58.7 p -156.2 134.6 11.52 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.314 1.045 . . . . 72.3 108.675 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -92.17 111.05 22.46 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.158 -1.053 . . . . 73.45 108.158 172.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 pp -120.53 17.31 12.09 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.945 0.898 . . . . 64.24 110.955 -175.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -162.3 150.86 14.88 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.321 1.048 . . . . 70.13 109.3 175.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -67.15 116.58 8.11 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.578 0.351 . . . . 53.24 110.341 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 72.35 -3.61 2.25 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.422 1.489 . . . . 61.12 112.357 177.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.577 HG21 ' HB3' ' F' ' 93' ' ' PHE . 44.0 t -119.32 102.15 12.48 Favored 'Isoleucine or valine' 0 C--N 1.347 0.483 0 N-CA-C 107.45 -1.315 . . . . 44.21 107.45 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.503 ' CE2' ' HB ' ' B' ' 58' ' ' VAL . 0.1 OUTLIER -94.31 -177.96 4.44 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.736 -0.838 . . . . 75.34 108.736 -178.055 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.519 ' HG2' ' HB ' ' B' ' 83' ' ' ILE . 4.2 tm-20 -142.34 118.54 10.76 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 107.218 -1.401 . . . . 75.13 107.218 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.503 ' HB ' ' CE2' ' B' ' 56' ' ' TYR . 12.0 p -111.09 148.19 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-O 121.094 0.473 . . . . 72.23 110.938 -178.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.474 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 28.7 t -119.02 134.36 62.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.052 -1.092 . . . . 73.14 108.052 171.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 59.1 tp -114.21 103.39 11.06 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 108.291 -1.003 . . . . 51.12 108.291 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -84.81 109.48 18.12 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.593 0.711 . . . . 74.14 109.241 175.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.433 HG13 HD11 ' B' ' 42' ' ' LEU . 56.1 t -107.06 103.44 15.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 107.769 -1.197 . . . . 51.53 107.769 174.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.9 m -102.21 132.69 47.98 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.738 -0.664 . . . . 72.22 109.567 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.894 HG11 HD21 ' B' ' 126' ' ' LEU . 82.6 t -116.76 117.31 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.138 0.975 . . . . 73.13 109.362 174.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 10.6 m -87.23 140.42 29.56 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.126 -1.064 . . . . 71.23 108.126 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.9 140.39 23.38 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 118.045 0.384 . . . . 65.54 110.413 175.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.462 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 52.6 p -146.44 133.13 19.93 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.058 0.456 . . . . 43.45 111.598 -175.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.549 HD12 HG22 ' B' ' 31' ' ' VAL . 72.9 mt -100.11 100.96 11.89 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.341 1.056 . . . . 75.35 108.661 176.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.58 -134.73 24.46 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.992 -0.549 . . . . 72.13 112.248 -176.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -83.01 4.28 26.66 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.755 0.822 . . . . 64.53 113.033 -179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.417 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 12.0 pt-20 -127.1 150.91 49.26 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.851 0.296 . . . . 74.01 110.49 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 85.8 m -69.4 135.84 50.85 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 123.533 0.521 . . . . 72.12 110.464 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.494 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -85.88 -63.64 1.29 Allowed 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.414 -1.328 . . . . 72.0 107.414 175.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -151.92 162.87 40.37 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.326 -1.306 . . . . 70.14 110.58 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 52.0 mt -132.32 110.42 10.57 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 105.443 -2.058 . . . . 73.31 105.443 175.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 34.4 t -116.96 145.32 43.71 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.323 -0.991 . . . . 75.34 108.323 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.488 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.9 tt0 -155.1 132.03 10.79 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.306 -0.998 . . . . 73.43 108.306 -177.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.47 HG21 ' HB3' ' B' ' 113' ' ' CYS . 94.7 t -127.26 143.53 40.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.973 -1.121 . . . . 43.1 107.973 174.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.486 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 26.2 mt-30 -119.6 86.99 2.65 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.092 -1.077 . . . . 60.03 108.092 174.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.462 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.5 tp-100 -82.95 102.84 11.97 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 114.738 -1.119 . . . . 74.42 109.281 -177.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -87.74 162.71 33.1 Favored Glycine 0 C--N 1.336 0.574 0 CA-C-N 115.893 -0.594 . . . . 62.21 111.634 177.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.9 125.76 1.34 Allowed Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.544 -1.022 . . . . 62.34 110.544 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.562 HG23 ' HB2' ' B' ' 14' ' ' GLN . 18.8 tt -95.68 131.01 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 108.57 -0.9 . . . . 74.22 108.57 175.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -137.0 141.25 42.54 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.604 0.762 . . . . 74.53 109.437 -175.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.2 m -88.77 106.93 18.68 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.658 -0.867 . . . . 72.51 108.658 172.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.504 HG22 HD12 ' F' ' 97' ' ' ILE . 23.8 mm -97.37 109.66 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 107.873 -1.158 . . . . 73.22 107.873 -173.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.31 172.14 18.69 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.025 0.441 . . . . 75.43 111.58 -172.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 83.28 -47.11 3.76 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.506 -0.77 . . . . 73.3 112.631 -178.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.548 HG23 ' HB3' ' B' ' 9' ' ' MET . 1.0 OUTLIER -78.52 159.43 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 109.743 -0.465 . . . . 74.21 109.743 168.647 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -165.75 145.16 6.33 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 123.556 0.535 . . . . 74.32 110.86 -171.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.97 -100.54 2.7 Favored Glycine 0 C--N 1.353 1.507 0 CA-C-O 120.174 -0.237 . . . . 73.02 113.347 175.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.1 m -95.96 -54.9 3.16 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 122.08 0.943 . . . . 71.34 110.12 -175.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -67.58 -18.23 64.92 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 113.52 -1.673 . . . . 61.44 111.383 -171.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.672 ' HB2' HD11 ' F' ' 97' ' ' ILE . 22.6 ptt? -61.42 -44.25 97.45 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.836 0.854 . . . . 74.52 113.057 -176.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.02 -11.72 60.01 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.049 0.54 . . . . 71.21 112.142 -175.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -63.79 -38.56 91.57 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.129 0.572 . . . . 64.32 110.359 168.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.5 t -58.75 -52.67 64.7 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.258 0.551 . . . . 74.02 111.164 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.8 pp -83.44 -27.19 29.7 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.525 -0.761 . . . . 73.4 112.146 -174.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.21 -16.62 62.37 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-O 120.016 -0.324 . . . . 72.22 113.338 -176.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.415 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -136.82 -58.13 0.72 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.784 0.434 . . . . 70.14 112.093 -170.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -66.37 -43.53 85.69 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.125 0.57 . . . . 74.13 112.196 -173.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.4 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 59.7 m -71.38 -44.81 13.39 Favored Pre-proline 0 CA--C 1.562 1.437 0 CA-C-O 118.567 -0.73 . . . . 74.2 112.33 -175.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.4 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 50.1 Cg_exo -59.17 -31.83 96.06 Favored 'Trans proline' 0 C--N 1.394 2.934 0 C-N-CA 121.887 1.725 . . . . 65.3 113.247 168.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -62.11 -36.81 82.87 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.192 0.597 . . . . 72.4 110.303 178.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 59.1 mt -65.39 -40.86 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.489 0.716 . . . . 73.35 110.433 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 94.7 mt -76.26 -24.88 54.51 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.698 -0.683 . . . . 71.22 112.668 -173.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -62.32 -45.04 89.93 Favored Pre-proline 0 CA--C 1.566 1.587 0 CA-C-O 117.78 -1.105 . . . . 72.41 113.691 -173.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -52.3 -43.33 54.55 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.516 2.144 . . . . 73.22 113.371 173.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.462 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 95.3 m-85 -64.17 -45.24 89.29 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.285 0.634 . . . . 74.44 110.149 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.87 82.37 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.457 -0.792 . . . . 33.31 111.049 177.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.491 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 65.0 ttt-85 -64.56 -61.34 2.27 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.454 1.102 . . . . 72.1 110.989 -175.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -67.44 -25.85 66.11 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 123.505 0.503 . . . . 45.44 111.032 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.552 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.9 t -66.19 -40.75 90.63 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 109.681 -0.488 . . . . 63.5 109.681 176.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.549 HD13 HG23 ' B' ' 64' ' ' VAL . 70.3 mt -62.9 -54.47 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.784 0.834 . . . . 60.32 110.418 172.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 6.3 m -60.89 -30.68 70.3 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.886 0.875 . . . . 52.43 111.68 -173.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.454 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 44.4 t -65.41 -48.63 72.17 Favored 'General case' 0 C--N 1.347 0.5 0 C-N-CA 123.6 0.76 . . . . 73.35 110.191 174.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.552 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.4 mmt -68.35 -29.74 68.54 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.032 0.533 . . . . 60.32 111.194 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.428 HG23 ' O ' ' B' ' 114' ' ' ILE . 69.5 t -65.37 -44.36 94.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.442 1.097 . . . . 74.25 110.02 173.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 40.5 t -68.72 -29.92 68.44 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.241 -0.89 . . . . 64.44 111.174 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' B' ' 116' ' ' SER . 88.7 mtt-85 -65.14 -39.7 93.37 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 108.934 -0.765 . . . . 54.44 108.934 174.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.0 -5.28 75.09 Favored Glycine 0 C--N 1.356 1.675 0 O-C-N 123.651 0.595 . . . . 51.05 113.558 172.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 8.0 m 67.58 31.11 6.31 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.136 1.374 . . . . 73.1 111.006 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -91.68 160.45 36.38 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-N 114.821 -1.081 . . . . 73.41 111.143 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.445 ' HG3' ' HB2' ' F' ' 131' ' ' TRP . 82.3 Cg_exo -51.31 157.72 4.33 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 123.838 3.025 . . . . 75.34 115.598 177.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.588 ' O ' ' HA ' ' F' ' 129' ' ' THR . 55.1 tp60 -58.26 113.91 2.16 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.257 1.423 . . . . 74.51 111.529 -177.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.894 HD21 HG11 ' B' ' 64' ' ' VAL . 32.5 tp -106.96 102.37 11.73 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.075 0.464 . . . . 74.33 109.771 -172.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.489 HD21 ' HG3' ' B' ' 125' ' ' GLN . 29.2 m-80 -101.07 117.88 35.89 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.271 0.629 . . . . 71.34 109.431 -177.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.491 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 69.4 mt -85.89 135.9 33.5 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 109.886 -0.413 . . . . 73.21 109.886 172.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.34 138.43 74.94 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 123.494 0.718 . . . . 41.05 110.807 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.492 ' HG3' HD11 ' D' ' 16' ' ' ILE . 21.3 Cg_endo -60.19 101.99 0.17 Allowed 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 123.207 2.605 . . . . 61.21 111.946 178.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 18.1 m -90.15 109.95 21.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 122.013 0.911 . . . . 65.12 109.38 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -88.2 85.95 7.01 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.068 -0.969 . . . . 75.24 109.402 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -53.53 -33.62 55.2 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 114.569 -1.196 . . . . 75.05 111.641 -178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.415 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 6.0 m-20 -52.76 -52.68 55.52 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.362 1.065 . . . . 65.41 111.87 177.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.487 ' HA ' ' HB3' ' B' ' 138' ' ' MET . . . -69.86 -32.33 70.64 Favored 'General case' 0 C--O 1.218 -0.559 0 O-C-N 124.025 0.828 . . . . 75.12 110.96 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 tt -57.41 -42.43 82.27 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.927 0.891 . . . . 74.21 110.248 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -81.67 -36.68 28.49 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.116 0.566 . . . . 75.52 111.525 174.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . 0.487 ' HB3' ' HA ' ' B' ' 135' ' ' ALA . 26.7 ttt -68.18 -19.86 64.82 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.677 0.791 . . . . 53.14 111.771 -174.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -74.76 -22.3 58.86 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.93 0.492 . . . . 71.41 110.754 178.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -90.09 -34.36 15.94 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.147 0.579 . . . . 75.44 110.186 174.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 7.6 mp -100.16 32.69 2.88 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.971 0.908 . . . . 73.1 110.724 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.8 110.15 9.99 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.146 0.579 . . . . 65.03 110.332 -173.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -156.56 179.74 8.97 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.661 1.184 . . . . 73.35 110.09 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 68.12 107.24 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.698 1.599 . . . . 72.14 111.007 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.95 0.72 1.99 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.036 0.934 . . . . 63.42 111.203 174.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.22 78.79 1.08 Allowed Glycine 0 C--N 1.354 1.574 0 O-C-N 123.488 0.492 . . . . 45.2 112.209 -177.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -111.29 162.54 14.9 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.348 1.059 . . . . 74.23 110.553 -175.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -78.37 141.37 24.77 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 115.301 -0.863 . . . . 60.52 112.096 176.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 41.5 m -143.54 143.36 31.5 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.937 0.895 . . . . 64.14 109.058 -178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 75.27 133.27 0.05 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.271 1.428 . . . . 73.51 112.575 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -158.38 130.0 6.65 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 124.469 1.107 . . . . 74.03 108.631 171.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -114.97 154.48 28.69 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.713 0.805 . . . . 62.34 110.368 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -153.88 93.55 1.66 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.342 1.057 . . . . 72.3 109.017 178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -169.76 152.57 4.59 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.687 0.795 . . . . 74.43 109.719 177.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 C-N-CA 123.967 0.907 . . . . 71.24 108.571 176.665 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 40.3 mtp . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 121.728 0.775 . . . . 71.24 109.663 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . 0.504 ' HB2' ' HB1' ' A' ' 135' ' ' ALA . 19.9 m -144.43 -131.61 0.08 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.604 -1.18 . . . . 60.04 108.376 -167.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . 0.442 ' HA ' ' HB2' ' C' ' 154' ' ' ASP . 10.2 pt-20 -119.09 140.93 49.27 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 106.749 -1.574 . . . . 65.15 106.749 153.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . 0.64 ' HG2' ' HA ' ' C' ' 154' ' ' ASP . 13.8 mm-40 -75.25 98.38 3.76 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.33 -0.619 . . . . 71.1 109.33 174.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 12.7 t30 -59.67 -60.12 4.35 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 124.226 0.954 . . . . 73.35 109.624 172.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -76.95 178.54 6.85 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.244 0.618 . . . . 72.1 109.599 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 5.1 t -51.02 142.72 11.57 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.396 1.078 . . . . 74.22 112.111 176.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -63.5 -76.4 0.07 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.911 0.884 . . . . 54.53 110.998 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.468 ' HE2' HD13 ' C' ' 89' ' ' ILE . 47.2 ttm 56.7 113.22 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.679 1.192 . . . . 74.34 111.31 -173.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 11.9 m -86.38 74.69 9.92 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 108.781 -0.822 . . . . 63.54 108.781 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.869 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 69.1 t80 -90.89 121.44 32.74 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.828 -1.078 . . . . 74.23 108.094 178.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -136.81 122.69 20.06 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.641 -0.874 . . . . 70.24 108.641 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.432 HD11 HG21 ' C' ' 105' ' ' ILE . 46.5 mt -83.05 126.78 40.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 109.279 -0.637 . . . . 45.11 109.279 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.409 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 27.7 mm-40 -87.06 -44.27 11.69 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.852 -0.796 . . . . 72.31 108.852 174.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 179.96 151.06 0.4 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.032 1.333 . . . . 74.12 109.462 179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 83.7 mt -123.44 128.44 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 107.877 -1.157 . . . . 70.21 107.877 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.608 ' HB3' HG23 ' D' ' 122' ' ' THR . 35.5 p90 -161.27 149.92 16.01 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.318 0.58 . . . . 75.01 111.56 -167.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.7 p -80.61 119.72 23.62 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.35 -0.841 . . . . 74.3 110.575 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp -71.88 -36.62 70.14 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.619 -0.882 . . . . 73.42 108.619 169.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -148.85 148.43 29.89 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-N 115.092 -0.958 . . . . 72.21 110.006 -177.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.1 mt -140.64 140.47 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 106.347 -1.724 . . . . 54.11 106.347 175.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 28.3 t -154.12 146.64 24.07 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.204 0.526 . . . . 74.12 110.526 -177.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -155.17 129.37 8.9 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 107.013 -1.477 . . . . 74.04 107.013 172.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -137.69 123.96 20.55 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.247 0.619 . . . . 73.35 109.544 173.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -121.38 84.13 41.04 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 107.145 -1.428 . . . . 71.11 107.145 166.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.47 -24.07 43.01 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 122.422 2.081 . . . . 74.1 111.578 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -104.0 17.27 24.45 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.36 1.064 . . . . 74.21 110.516 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.42 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -47.53 -57.1 10.54 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 113.526 0.936 . . . . 75.4 113.526 -171.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.42 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 21.7 Cg_exo -63.04 -39.16 41.51 Favored 'Trans proline' 0 C--N 1.393 2.884 0 C-N-CA 122.112 1.874 . . . . 64.02 111.962 -176.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -69.26 -37.06 77.75 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.367 -1.288 . . . . 73.24 111.996 -176.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.766 HG21 ' HA ' ' C' ' 73' ' ' ALA . 9.8 p -82.55 -21.03 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 N-CA-C 112.907 0.706 . . . . 62.41 112.907 -176.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -66.28 -29.22 69.4 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 120.856 0.36 . . . . 71.44 111.652 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -94.96 14.18 22.55 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.848 0.859 . . . . 71.54 111.371 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -104.55 158.26 16.61 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.708 0.803 . . . . 62.25 109.668 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -70.25 115.38 9.37 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.672 0.789 . . . . 75.24 110.158 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -80.6 91.57 5.84 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.243 1.017 . . . . 72.22 111.333 -171.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . 0.478 HE22 ' HB3' ' C' ' 68' ' ' LEU . 0.2 OUTLIER -139.58 73.72 34.89 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.368 1.067 . . . . 74.03 109.206 169.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -79.85 149.13 20.3 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.282 1.988 . . . . 71.01 112.192 -174.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -86.91 93.19 9.25 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.637 -1.616 . . . . 64.13 106.637 165.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.447 HG11 HG12 ' F' ' 135' ' ' VAL . 56.2 t -68.3 102.84 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 108.429 -0.952 . . . . 71.3 108.429 177.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -109.81 102.5 11.28 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.149 -1.056 . . . . 64.42 108.149 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.496 HD23 ' HB ' ' F' ' 135' ' ' VAL . 4.2 pp -87.96 139.57 30.38 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.011 -1.107 . . . . 62.4 108.011 172.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -139.86 118.64 12.42 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.148 -0.686 . . . . 75.42 109.148 -175.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 92.7 mt -111.95 138.95 47.88 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.77 0.828 . . . . 53.51 111.369 -171.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -147.62 127.08 13.17 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.788 1.235 . . . . 74.04 107.96 174.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 8.7 t -120.64 145.02 47.84 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 109.447 -0.575 . . . . 61.22 109.447 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.39 150.55 40.81 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.473 0.709 . . . . 75.01 109.781 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 32.8 m -141.64 155.0 45.73 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.053 0.541 . . . . 74.35 110.74 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 61.7 p -151.85 129.86 11.81 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.082 0.953 . . . . 63.54 109.06 178.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -73.71 117.44 15.48 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.04 -0.726 . . . . 72.04 109.04 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' C' ' 57' ' ' GLU . 71.1 mt -86.89 -43.56 12.34 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.41 0.684 . . . . 73.23 109.976 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.26 -173.93 4.52 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.341 -0.845 . . . . 61.55 110.249 -177.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.3 107.74 0.81 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.011 0.924 . . . . 72.05 110.217 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 66.37 22.05 10.84 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.221 1.008 . . . . 75.13 111.026 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 96.0 t -119.39 119.31 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.025 0.93 . . . . 65.31 108.732 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -127.15 126.82 43.56 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.289 1.036 . . . . 72.42 108.988 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.629 ' HB2' HD11 ' C' ' 51' ' ' LEU . 35.9 tt0 -83.9 126.19 32.74 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.402 -0.962 . . . . 73.23 108.402 168.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 88.6 t -118.05 137.09 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 109.25 -0.648 . . . . 62.13 109.25 173.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.459 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 44.8 t -128.67 145.26 35.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.096 0.958 . . . . 73.02 108.869 177.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.455 HD11 ' CZ ' ' C' ' 133' ' ' PHE . 0.0 OUTLIER -126.72 104.35 8.03 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.476 -1.305 . . . . 75.41 107.476 177.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -81.98 106.17 13.68 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.285 -1.006 . . . . 75.44 108.285 171.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 23.2 t -104.65 133.57 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 107.907 -1.145 . . . . 72.13 107.907 172.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 84.9 m -126.97 136.74 52.68 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.385 -0.969 . . . . 62.35 108.385 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.496 HG23 HD13 ' C' ' 114' ' ' ILE . 85.2 t -122.56 114.12 41.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 109.422 -0.584 . . . . 62.42 109.422 173.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 18.7 m -98.54 137.34 37.34 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.716 -0.846 . . . . 74.1 108.716 172.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.79 113.81 17.12 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.14 -1.43 . . . . 70.31 107.14 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 44.0 m -136.76 128.61 29.15 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.464 0.477 . . . . 75.25 110.17 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.478 ' HB3' HE22 ' C' ' 37' ' ' GLN . 49.8 mt -84.41 29.05 0.61 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.151 1.38 . . . . 61.52 111.265 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.64 -91.04 0.75 Allowed Glycine 0 C--N 1.35 1.345 0 N-CA-C 111.169 -0.772 . . . . 71.13 111.169 -175.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -90.67 -33.7 15.71 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.55 0.74 . . . . 71.15 109.27 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -88.87 122.18 31.99 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.597 1.159 . . . . 74.22 110.463 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 89.1 m -81.73 129.09 34.6 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.482 -0.562 . . . . 63.43 109.482 169.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.766 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -80.72 -58.45 3.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.791 0.836 . . . . 74.14 110.059 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -157.12 167.98 28.8 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.85 0.833 . . . . 75.32 111.224 177.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -131.51 137.35 48.5 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 106.655 -1.609 . . . . 53.21 106.655 166.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.604 ' SG ' HG23 ' C' ' 114' ' ' ILE . 41.8 t -137.07 149.32 47.32 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.582 -0.896 . . . . 54.45 108.582 176.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -157.78 133.65 9.27 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.44 -0.578 . . . . 71.3 109.44 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 73.7 t -132.75 132.46 59.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 124.143 0.977 . . . . 75.04 108.889 174.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -104.39 87.13 2.65 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.295 -1.002 . . . . 74.0 108.295 173.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -79.39 97.92 6.54 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.349 -0.841 . . . . 70.33 109.145 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -83.72 177.86 52.39 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 115.781 -0.645 . . . . 41.43 112.293 175.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 178.18 134.27 2.04 Favored Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 111.356 -0.698 . . . . 74.41 111.356 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.409 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 35.4 mm -88.7 125.81 41.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.361 -0.977 . . . . 71.23 108.361 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -130.3 117.86 20.44 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.47 0.708 . . . . 74.1 109.37 -178.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 11.4 p -85.01 102.19 12.99 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 108.466 -0.939 . . . . 72.23 108.466 172.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.435 HG21 ' HE1' ' C' ' 94' ' ' MET . 24.4 mt -114.29 129.54 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.814 0.845 . . . . 62.41 109.949 -175.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.86 171.15 14.86 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.654 0.782 . . . . 54.12 110.385 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.81 -35.06 4.62 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 116.26 -0.427 . . . . 50.44 113.075 176.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.468 HD13 ' HE2' ' C' ' 9' ' ' MET . 27.7 pt -108.12 171.71 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.251 0.62 . . . . 65.41 111.709 -171.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -167.19 156.93 10.79 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.801 0.84 . . . . 71.34 109.923 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.07 -115.62 6.24 Favored Glycine 0 C--N 1.349 1.304 0 O-C-N 123.324 0.39 . . . . 61.1 113.535 171.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 58.3 p -64.22 -40.07 95.28 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 123.688 0.795 . . . . 72.22 110.953 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -68.37 -47.66 66.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.899 0.88 . . . . 74.32 111.097 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.529 ' HE3' ' HA ' ' C' ' 94' ' ' MET . 5.2 tpt -53.86 -49.86 67.55 Favored 'General case' 0 C--N 1.352 0.694 0 O-C-N 123.875 0.734 . . . . 54.14 111.705 173.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.69 -38.76 89.01 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 123.637 0.585 . . . . 72.11 111.032 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.543 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 44.5 t-80 -71.59 -19.68 62.1 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.553 1.141 . . . . 75.13 111.483 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 9.3 t -82.2 -51.96 7.44 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.517 -0.92 . . . . 73.31 108.517 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.11 -30.11 69.19 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.841 -1.072 . . . . 64.1 112.978 -172.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.94 11.28 29.54 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-O 119.45 -0.639 . . . . 63.3 113.64 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -151.34 -61.14 0.18 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 117.535 0.667 . . . . 35.54 112.222 -176.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -74.04 -53.31 10.28 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.422 0.689 . . . . 74.41 112.14 -169.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.869 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 34.5 m -58.56 -49.18 94.88 Favored Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.15 0.98 . . . . 71.24 111.924 176.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.521 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 77.1 Cg_exo -53.83 -35.76 80.44 Favored 'Trans proline' 0 C--N 1.402 3.384 0 C-N-CA 122.686 2.257 . . . . 61.24 113.24 173.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -68.76 -33.15 73.4 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.418 0.687 . . . . 60.24 111.708 -176.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.535 HD12 ' NH1' ' A' ' 111' ' ' ARG . 31.4 mm -70.11 -43.03 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 122.332 0.253 . . . . 53.01 110.691 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.403 ' HA ' ' CD1' ' C' ' 109' ' ' TYR . 1.7 pp -95.93 -3.56 45.01 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.372 0.878 . . . . 74.43 113.372 -176.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . 0.504 ' HZ ' HD22 ' C' ' 128' ' ' LEU . 56.0 t80 -55.06 -48.15 96.76 Favored Pre-proline 0 N--CA 1.485 1.317 0 CA-C-O 117.742 -1.123 . . . . 74.22 113.578 172.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -60.94 -30.67 90.4 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 121.738 1.626 . . . . 73.25 112.979 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.403 ' CD1' ' HA ' ' C' ' 106' ' ' LEU . 19.3 m-85 -68.66 -43.05 77.01 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.371 0.669 . . . . 73.01 109.479 176.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.54 -39.34 94.16 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.041 -0.981 . . . . 74.31 110.625 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -61.87 -52.77 62.75 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.382 1.073 . . . . 70.45 110.191 176.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -67.22 -28.37 68.01 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.596 0.759 . . . . 72.11 110.383 -174.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.49 ' O ' ' SD ' ' C' ' 117' ' ' MET . 8.2 t -71.05 -49.2 47.32 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 122.997 0.519 . . . . 70.12 110.334 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.604 HG23 ' SG ' ' C' ' 76' ' ' CYS . 86.8 mt -59.77 -47.28 91.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 123.29 0.636 . . . . 74.15 110.167 174.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 99.4 m -63.53 -31.05 72.1 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.812 0.845 . . . . 61.42 111.109 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 25.2 t -65.51 -48.42 72.59 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 108.808 -0.812 . . . . 73.13 108.808 171.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.901 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.2 OUTLIER -56.29 -43.19 78.6 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.953 0.901 . . . . 75.24 112.485 178.441 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.426 HG23 ' O ' ' C' ' 114' ' ' ILE . 87.9 t -69.33 -41.89 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.869 0.868 . . . . 74.05 110.26 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 30.6 t -64.1 -37.8 88.75 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.111 -0.949 . . . . 73.43 111.454 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.535 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 60.3 mtt-85 -69.64 -40.14 76.69 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.149 -0.932 . . . . 61.44 110.222 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.64 2.26 64.03 Favored Glycine 0 C--N 1.355 1.631 0 O-C-N 123.796 0.685 . . . . 74.21 112.847 174.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 44.2 p 60.94 28.19 18.0 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.952 1.701 . . . . 70.04 113.098 168.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -83.23 144.08 46.27 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.12 -1.067 . . . . 62.21 108.12 169.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -44.75 141.93 5.4 Favored 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.791 2.994 . . . . 72.14 114.071 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.494 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 13.3 mm-40 -59.22 124.75 21.02 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.908 0.755 . . . . 75.21 112.802 -170.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.405 HD21 HG13 ' C' ' 40' ' ' VAL . 40.1 tp -121.38 103.26 8.82 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.268 -1.012 . . . . 72.41 108.268 -176.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -96.19 116.0 28.31 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.387 -0.824 . . . . 74.42 109.658 -176.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.504 HD22 ' HZ ' ' C' ' 107' ' ' PHE . 0.9 OUTLIER -71.59 117.4 13.1 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.588 0.755 . . . . 75.22 109.027 -178.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.74 159.15 70.98 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 123.95 0.9 . . . . 73.11 111.654 -178.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -55.49 100.74 0.08 OUTLIER 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.726 2.284 . . . . 63.31 113.199 174.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.9 t -99.56 111.09 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 108.218 -1.03 . . . . 63.12 108.218 172.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -86.06 104.38 15.61 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.407 0.683 . . . . 73.43 110.722 -175.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.455 ' CZ ' HD11 ' C' ' 60' ' ' LEU . 82.9 m-85 -64.51 -23.76 67.38 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.164 0.986 . . . . 72.43 112.041 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.457 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 2.4 t70 -65.25 -36.67 84.84 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.766 0.826 . . . . 62.3 109.753 178.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.4 -19.32 33.73 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.382 -1.281 . . . . 55.34 111.614 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 36.0 mt -82.88 -22.35 34.0 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 120.895 0.378 . . . . 62.21 110.697 174.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -75.1 -15.58 60.6 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.473 0.709 . . . . 65.13 110.469 177.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.541 ' SD ' ' HA ' ' A' ' 152' ' ' HIS . 48.2 ttp -43.92 -60.71 1.71 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.796 1.639 . . . . 74.13 112.325 173.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -72.87 -33.21 65.93 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.909 -1.041 . . . . 71.13 111.191 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -71.05 -155.98 0.03 OUTLIER 'General case' 0 CA--C 1.574 1.881 0 C-N-CA 123.635 0.774 . . . . 74.35 111.206 -175.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.597 HD23 ' HG2' ' C' ' 143' ' ' GLN . 32.2 tp 58.87 -85.23 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.013 1.325 . . . . 70.4 111.352 -176.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 175.96 -44.91 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.215 1.406 . . . . 71.22 108.425 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . 0.597 ' HG2' HD23 ' C' ' 141' ' ' LEU . 11.0 pt20 -83.61 168.83 15.99 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.305 -0.861 . . . . 63.11 110.907 179.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . 0.488 ' NE2' ' H ' ' C' ' 145' ' ' ALA . 0.0 OUTLIER -147.6 141.57 25.91 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 106.281 -1.748 . . . . 71.45 106.281 172.647 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . 0.488 ' H ' ' NE2' ' C' ' 144' ' ' GLN . . . 70.65 59.99 0.21 Allowed 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.527 1.131 . . . . 72.25 109.333 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.82 -140.85 1.17 Allowed Glycine 0 C--N 1.349 1.261 0 CA-C-N 114.155 -1.384 . . . . 62.23 112.033 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.22 -172.15 3.8 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.035 0.534 . . . . 72.33 110.992 -176.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -160.28 64.9 0.28 Allowed Glycine 0 C--N 1.342 0.895 0 N-CA-C 110.203 -1.159 . . . . 72.44 110.203 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 10.5 t -64.73 139.92 58.81 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-O 121.254 0.55 . . . . 73.34 111.525 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.95 131.01 54.08 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.917 0.887 . . . . 75.33 109.032 -178.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . 0.551 ' HG2' ' H ' ' C' ' 152' ' ' HIS . 30.7 tt0 -172.98 -173.34 0.94 Allowed 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 107.859 -1.163 . . . . 75.25 107.859 -174.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . 0.551 ' H ' ' HG2' ' C' ' 151' ' ' GLU . 86.5 m-70 80.27 -177.31 0.07 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.167 1.387 . . . . 71.21 111.526 170.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.12 159.87 37.66 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.2 -1.407 . . . . 73.43 107.2 -176.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . 0.64 ' HA ' ' HG2' ' C' ' 4' ' ' GLN . 12.2 t70 -52.85 102.44 0.05 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.513 1.125 . . . . 63.2 111.549 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.274 0 N-CA-C 107.843 -1.169 . . . . 61.25 107.843 177.636 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptt? . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 109.457 -0.571 . . . . 63.2 109.457 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 47.2 t 61.57 100.51 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.891 1.276 . . . . 63.42 110.652 -175.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -78.65 77.47 5.13 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-O 121.723 0.773 . . . . 74.22 110.562 -176.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . 0.55 ' HB2' ' HD2' ' E' ' 95' ' ' LYS . 74.2 mm-40 -138.53 128.77 25.77 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 106.68 -1.6 . . . . 74.05 106.68 175.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -169.68 -44.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.88 0.472 . . . . 73.22 110.372 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -75.96 98.71 4.33 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.592 0.757 . . . . 62.33 109.882 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.425 HG21 ' HE1' ' E' ' 94' ' ' PHE . 6.6 t -166.36 165.0 17.48 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.128 0.971 . . . . 71.23 109.409 179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -71.25 113.11 7.95 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.686 0.795 . . . . 75.13 109.897 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -31.74 123.76 0.27 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 125.717 1.607 . . . . 75.25 113.253 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 15.1 t -113.46 130.92 56.21 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 122.959 0.504 . . . . 73.32 109.644 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.572 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 51.0 t80 -138.64 93.88 2.77 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.397 -1.335 . . . . 73.44 107.397 174.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -124.3 126.11 45.49 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.754 -0.832 . . . . 72.04 108.754 -177.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 6.7 mt -82.41 121.35 35.44 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 N-CA-C 108.773 -0.825 . . . . 73.31 108.773 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -85.26 -29.66 24.44 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 124.282 1.033 . . . . 74.31 110.303 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -170.14 142.11 2.22 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 123.625 0.578 . . . . 72.15 110.426 -177.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.492 HD11 ' HG3' ' B' ' 130' ' ' PRO . 3.9 mp -118.24 130.4 73.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 105.503 -2.036 . . . . 71.23 105.503 170.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.4 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 25.2 p90 -159.99 141.92 12.98 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 118.701 0.682 . . . . 74.24 111.359 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 71.3 p -78.36 110.8 13.73 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.882 -1.054 . . . . 61.12 109.176 174.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.4 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 31.7 mtpt -78.41 -24.76 46.06 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.562 -0.744 . . . . 75.01 109.253 176.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.707 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 2.8 t70 -149.97 147.96 28.5 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.665 1.186 . . . . 71.34 110.02 174.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.901 HG21 ' HE2' ' C' ' 117' ' ' MET . 83.1 mt -139.51 146.51 25.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 126.07 1.748 . . . . 73.11 107.598 174.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 39.9 t -155.86 145.38 21.0 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.167 0.587 . . . . 75.12 110.428 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.513 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 79.7 t80 -151.98 139.88 20.01 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.703 -1.591 . . . . 74.42 106.703 171.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.441 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 40.6 mt-10 -142.99 146.3 33.77 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.404 0.681 . . . . 72.13 109.604 -175.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.75 85.57 6.55 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.039 0.935 . . . . 53.52 108.573 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.87 -36.9 21.72 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.348 2.699 . . . . 61.23 112.935 -177.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.434 ' ND2' ' HB2' ' D' ' 71' ' ' GLU . 67.9 m-20 -103.66 16.17 27.06 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.14 -0.936 . . . . 74.11 110.749 -173.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -34.06 -66.2 0.23 Allowed Pre-proline 0 CA--C 1.571 1.761 0 N-CA-C 116.292 1.96 . . . . 73.54 116.292 -162.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.406 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 95.7 Cg_endo -75.82 -21.96 13.88 Favored 'Trans proline' 0 C--N 1.386 2.529 0 CA-C-N 123.977 2.456 . . . . 75.11 114.165 -178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -70.51 -41.81 72.12 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.712 1.205 . . . . 73.31 110.306 178.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.63 HG21 ' HA ' ' D' ' 73' ' ' ALA . 13.4 p -82.53 -20.53 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-N 115.233 -0.894 . . . . 63.31 111.56 -173.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.406 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 19.5 m-30 -62.41 -29.04 70.21 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 112.299 0.481 . . . . 65.22 112.299 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -63.87 -14.66 55.14 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.42 1.088 . . . . 73.32 111.567 -176.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -93.6 109.36 20.98 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.829 1.252 . . . . 74.11 110.1 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -102.94 92.89 4.76 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.175 0.59 . . . . 53.44 111.059 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 42.4 p90 -168.46 -177.28 3.12 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.838 1.255 . . . . 65.35 108.421 168.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.448 ' HB2' ' HB2' ' E' ' 128' ' ' ALA . 61.0 tp60 -74.02 118.32 68.54 Favored Pre-proline 0 N--CA 1.479 0.985 0 CA-C-O 119.09 -0.481 . . . . 65.52 109.834 177.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -58.95 137.39 79.54 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.332 2.021 . . . . 70.31 111.195 174.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 25.5 mt-10 -62.81 106.9 0.87 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.447 -0.946 . . . . 73.12 108.447 174.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.668 HG13 HG13 ' D' ' 64' ' ' VAL . 57.2 t -99.96 108.48 22.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.374 -0.602 . . . . 55.1 109.374 -175.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -86.76 109.69 19.41 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.387 -1.338 . . . . 73.44 107.387 169.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.592 HD11 HG13 ' D' ' 62' ' ' VAL . 40.4 tp -96.08 123.31 39.64 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.5 -0.926 . . . . 74.32 108.5 178.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -118.86 143.91 46.69 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 106.282 -1.747 . . . . 63.02 106.282 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.626 ' H ' ' HB3' ' E' ' 112' ' ' ASN . 94.9 mt -136.73 148.23 47.18 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.419 0.688 . . . . 65.15 109.159 -174.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.755 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.8 t70 -145.38 136.32 24.64 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 108.426 -0.953 . . . . 72.12 108.426 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.3 t -102.43 158.42 16.22 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.967 -1.123 . . . . 74.41 107.967 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -161.9 165.92 26.95 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.995 0.518 . . . . 72.53 109.731 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.4 p -170.7 -159.79 0.18 Allowed 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.681 1.192 . . . . 75.52 108.201 -175.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 50.4 m -143.46 150.16 38.61 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.119 0.485 . . . . 64.33 110.295 -175.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -78.73 168.88 19.09 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.706 -1.134 . . . . 74.24 110.192 -177.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 3.7 tt 63.76 105.04 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.231 -1.026 . . . . 72.12 108.231 -174.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.39 -77.68 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.179 0.592 . . . . 74.03 112.064 -171.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 12.2 t70 60.87 7.93 1.66 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.783 1.233 . . . . 71.42 113.277 175.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 61.38 17.09 8.03 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.803 1.241 . . . . 75.24 112.445 -173.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 47.6 t -118.05 100.18 9.56 Favored 'Isoleucine or valine' 0 C--N 1.35 0.588 0 N-CA-C 107.452 -1.314 . . . . 65.54 107.452 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -119.82 129.93 54.67 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 107.908 -1.145 . . . . 75.25 107.908 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -111.02 118.33 35.76 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.059 -1.46 . . . . 75.52 107.059 165.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 72.1 t -100.29 134.98 38.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.382 -0.97 . . . . 75.14 108.382 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.58 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 24.8 t -114.97 137.97 46.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.341 -0.985 . . . . 65.42 108.341 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.524 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -115.08 118.61 33.86 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.382 -1.34 . . . . 62.25 107.382 174.339 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.755 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 45.3 ttm-85 -95.54 99.31 11.21 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.831 -1.174 . . . . 73.04 107.831 171.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.592 HG13 HD11 ' D' ' 42' ' ' LEU . 94.8 t -89.25 128.98 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 106.746 -1.576 . . . . 64.15 106.746 169.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 5.3 m -129.56 126.07 37.69 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.64 -0.874 . . . . 74.34 108.64 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.668 HG13 HG13 ' D' ' 40' ' ' VAL . 55.6 t -108.41 132.0 57.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 108.049 -1.093 . . . . 73.54 108.049 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 49.5 m -126.69 90.86 3.24 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.322 -1.362 . . . . 65.33 107.322 171.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -104.35 139.07 39.84 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.28 -0.873 . . . . 73.13 109.838 -176.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.551 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 77.4 p -144.17 128.95 18.31 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-O 121.07 0.462 . . . . 75.4 112.233 -172.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.602 HD12 HG22 ' D' ' 31' ' ' VAL . 43.9 mt -92.4 104.08 16.45 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.956 -1.498 . . . . 74.35 106.956 170.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.15 -145.85 38.52 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 123.674 0.608 . . . . 34.01 111.998 -172.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.69 2.93 31.23 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 112.503 0.556 . . . . 75.23 112.503 -177.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . 0.434 ' HB2' ' ND2' ' D' ' 27' ' ' ASN . 13.1 pt-20 -117.21 146.55 43.17 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 117.924 0.329 . . . . 74.1 110.163 -176.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 98.8 m -63.99 121.07 13.24 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 124.002 0.814 . . . . 74.52 111.108 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.63 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -76.86 -71.89 0.37 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.157 -1.423 . . . . 33.51 107.157 170.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -147.43 141.11 25.6 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.672 -0.695 . . . . 75.51 111.201 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.441 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 56.1 mt -103.96 149.53 25.05 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.218 -1.401 . . . . 73.21 107.218 166.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.578 ' SG ' HG12 ' D' ' 114' ' ' ILE . 6.3 t -157.94 106.23 2.02 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.081 0.401 . . . . 74.14 110.087 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -120.37 122.22 40.3 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.011 0.524 . . . . 74.41 110.204 -176.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 98.2 t -123.84 117.68 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.607 0.763 . . . . 54.44 109.42 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.707 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.1 mt-30 -88.68 83.37 6.74 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.482 -0.933 . . . . 72.54 108.482 168.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . 0.415 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.2 tp-100 -80.53 96.54 6.83 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.172 -1.376 . . . . 64.13 109.316 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.61 161.87 28.78 Favored Glycine 0 C--N 1.339 0.702 0 N-CA-C 111.765 -0.534 . . . . 74.43 111.765 177.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.21 134.55 3.36 Favored Glycine 0 C--N 1.332 0.315 0 N-CA-C 111.624 -0.59 . . . . 75.42 111.624 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 48.4 mt -90.03 117.45 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 108.687 -0.857 . . . . 73.42 108.687 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -115.64 125.94 53.53 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.473 1.109 . . . . 61.04 109.804 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 53.6 p -84.2 104.13 13.98 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.736 -0.839 . . . . 72.11 108.736 171.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 45.3 mt -115.61 122.6 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.403 0.681 . . . . 74.21 109.492 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.08 168.43 25.55 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.659 1.183 . . . . 73.12 109.595 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.28 22.66 43.55 Favored Glycine 0 N--CA 1.476 1.325 0 N-CA-C 114.364 0.505 . . . . 65.21 114.364 172.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' D' ' 94' ' ' MET . 1.0 OUTLIER -136.63 172.42 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 124.349 1.06 . . . . 64.41 109.569 -179.318 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -153.17 -170.76 3.71 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 122.854 0.462 . . . . 73.14 110.583 177.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.49 -141.66 30.11 Favored Glycine 0 C--N 1.349 1.281 0 CA-C-N 116.011 -0.54 . . . . 54.13 112.383 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 11.2 t -89.91 -20.91 22.81 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.364 0.666 . . . . 75.04 109.878 170.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -58.63 -30.93 67.66 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.692 1.197 . . . . 71.32 112.03 -176.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.693 ' HA ' HD12 ' D' ' 89' ' ' ILE . 12.5 ptp -53.48 -54.12 41.69 Favored 'General case' 0 CA--C 1.55 0.968 0 O-C-N 123.817 0.698 . . . . 65.41 111.905 177.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . 0.438 ' H ' ' HG3' ' D' ' 94' ' ' MET . . . -87.38 -15.48 37.71 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.051 0.94 . . . . 44.04 112.071 -176.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -66.1 -39.11 89.72 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.628 0.771 . . . . 73.5 110.319 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 75.0 m -63.97 -38.9 92.75 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.423 -0.808 . . . . 44.33 110.987 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.532 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 6.2 tt -71.96 -39.51 69.31 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 115.389 -0.823 . . . . 74.44 110.666 -176.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.21 -27.51 52.19 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-O 119.793 -0.449 . . . . 61.54 114.212 -173.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.7 -51.89 2.25 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 122.985 0.514 . . . . 61.54 112.019 -172.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . 0.4 ' O ' HG12 ' D' ' 105' ' ' ILE . 70.1 t80 -73.64 -39.97 64.1 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.057 0.543 . . . . 72.31 111.526 -171.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.572 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 85.7 m -63.04 -47.98 85.2 Favored Pre-proline 0 CA--C 1.563 1.466 0 CA-C-O 118.4 -0.809 . . . . 54.5 112.345 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.524 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 53.1 Cg_exo -58.19 -36.76 97.53 Favored 'Trans proline' 0 C--N 1.396 3.058 0 C-N-CA 122.231 1.954 . . . . 70.12 112.963 168.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -62.33 -33.82 75.44 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.424 0.69 . . . . 64.24 111.535 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.4 HG12 ' O ' ' D' ' 101' ' ' TYR . 46.0 mm -69.68 -39.27 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.665 0.786 . . . . 64.33 110.888 175.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.415 HD13 ' O ' ' D' ' 80' ' ' GLN . 77.3 mt -73.86 -21.48 60.09 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.645 -0.707 . . . . 64.25 112.091 -175.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -66.78 -41.18 36.24 Favored Pre-proline 0 CA--C 1.56 1.364 0 CA-C-O 117.718 -1.134 . . . . 73.33 113.909 -172.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -45.63 -48.19 12.43 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 122.516 2.144 . . . . 74.12 113.75 168.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -72.2 -40.78 67.61 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.864 0.865 . . . . 75.44 111.771 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.01 -44.04 90.5 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.622 0.769 . . . . 63.14 110.933 -177.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -61.99 -46.96 86.94 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.685 -1.143 . . . . 75.41 110.364 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -61.49 -44.9 96.25 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.976 0.91 . . . . 63.33 111.327 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.535 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 51.9 t -56.01 -46.59 78.71 Favored 'General case' 0 C--N 1.349 0.565 0 O-C-N 124.086 0.866 . . . . 73.44 110.472 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.578 HG12 ' SG ' ' D' ' 76' ' ' CYS . 69.8 mt -63.29 -48.84 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 114.956 -1.02 . . . . 71.42 111.472 176.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 86.1 m -56.05 -44.11 78.54 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 124.029 0.932 . . . . 72.54 111.123 -172.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 40.6 t -65.16 -41.47 94.65 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 114.386 -1.279 . . . . 71.23 110.467 179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.447 ' HE2' ' HA ' ' D' ' 114' ' ' ILE . 75.5 mtm -71.29 -29.64 65.3 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.961 0.504 . . . . 73.44 111.754 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.517 HG23 ' O ' ' D' ' 114' ' ' ILE . 75.1 t -65.47 -43.35 94.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.008 0.923 . . . . 73.0 109.606 175.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 96.3 p -74.74 -24.45 58.72 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.613 -0.721 . . . . 62.01 110.902 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' D' ' 116' ' ' SER . 92.5 mtt-85 -70.08 -31.37 68.92 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.876 0.47 . . . . 70.33 110.107 172.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.92 10.24 68.96 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 123.581 0.55 . . . . 63.45 112.901 174.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.608 HG23 ' HB3' ' C' ' 17' ' ' TYR . 50.3 p 60.51 12.16 3.4 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 126.844 2.057 . . . . 64.14 114.411 -178.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -79.46 155.31 76.48 Favored Pre-proline 0 N--CA 1.48 1.031 0 CA-C-O 118.966 -0.54 . . . . 74.32 110.629 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -47.53 122.89 7.35 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.307 2.672 . . . . 51.12 111.474 173.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -50.27 132.33 24.22 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 124.759 1.287 . . . . 73.33 111.592 -171.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.482 HD13 HG21 ' D' ' 40' ' ' VAL . 48.7 tp -106.39 98.53 8.2 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 121.635 0.731 . . . . 75.23 109.968 -173.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . 0.543 ' ND2' ' HB ' ' B' ' 16' ' ' ILE . 6.9 m120 -99.08 89.32 4.22 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 106.269 -1.752 . . . . 74.11 106.269 174.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 87.7 mt -55.79 113.47 1.49 Allowed 'General case' 0 C--N 1.357 0.903 0 O-C-N 123.739 0.649 . . . . 73.3 109.518 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.91 123.03 82.55 Favored Pre-proline 0 CA--C 1.547 0.862 0 O-C-N 123.829 0.705 . . . . 72.34 109.393 -175.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.21 136.04 33.39 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.641 2.228 . . . . 74.14 112.4 -168.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.43 143.37 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.201 1.0 . . . . 73.35 109.079 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -73.99 115.2 13.18 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.226 0.61 . . . . 74.13 109.395 177.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -60.36 -38.59 84.34 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.384 1.074 . . . . 75.41 111.845 -175.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.44 -26.51 63.69 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.651 -0.704 . . . . 61.14 111.055 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.83 -30.38 70.99 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.869 0.468 . . . . 72.02 111.287 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 45.9 tp -75.87 -37.75 58.6 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.741 0.816 . . . . 64.04 110.511 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -64.72 -51.3 63.11 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.907 0.483 . . . . 72.12 110.967 174.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 75.3 mtm -62.55 -39.32 93.24 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.32 0.648 . . . . 75.23 110.642 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.479 ' O ' ' HG3' ' D' ' 143' ' ' GLN . 3.2 t-20 -52.46 -49.76 64.0 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 124.087 0.867 . . . . 74.42 110.257 173.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . 0.454 ' HE1' ' HG2' ' E' ' 114' ' ' LYS . 59.5 t80 -60.12 -42.9 95.74 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.451 1.094 . . . . 52.12 112.621 -177.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.4 -29.93 70.23 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 122.898 0.479 . . . . 43.11 111.191 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -92.24 25.33 2.96 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.329 1.052 . . . . 64.03 111.833 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' D' ' 139' ' ' ASN . 97.1 mt-30 -120.06 94.35 4.36 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.82 0.848 . . . . 71.21 109.67 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -143.82 41.84 1.44 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.892 0.877 . . . . 63.34 109.132 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . 70.15 -0.08 2.93 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 125.235 1.414 . . . . 71.41 113.254 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.26 -34.06 42.31 Favored Glycine 0 C--N 1.351 1.385 0 N-CA-C 111.712 -0.555 . . . . 61.43 111.712 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.71 -66.42 0.9 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.757 0.823 . . . . 71.02 110.683 178.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 58.34 29.15 62.82 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 123.341 0.401 . . . . 72.34 113.547 -175.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 20.8 m -85.73 99.78 11.56 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.7 0.8 . . . . 71.23 110.792 -172.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -90.07 98.73 11.94 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.45 0.7 . . . . 71.45 109.443 176.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -135.49 132.62 37.56 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.505 0.722 . . . . 71.32 110.868 -177.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 26.5 p-80 -159.62 148.13 17.59 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.742 1.217 . . . . 75.31 108.399 170.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -90.81 148.31 22.62 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.854 -0.795 . . . . 51.31 108.854 172.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.86 115.75 5.14 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.506 0.722 . . . . 75.15 109.167 173.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.221 0 C-N-CA 123.749 0.819 . . . . 61.33 109.628 -173.019 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.569 0 N-CA-C 111.838 -0.505 . . . . 72.33 111.838 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.85 -37.63 60.85 Favored Glycine 0 C--N 1.355 1.623 0 C-N-CA 122.987 0.327 . . . . 72.43 112.803 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -81.76 98.4 8.42 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 109.482 -0.562 . . . . 62.24 109.482 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 94' ' ' PHE . . . . . 0.425 ' HE1' HG21 ' D' ' 7' ' ' THR . 54.8 p90 -97.81 167.11 11.14 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.622 -0.881 . . . . 73.5 108.622 166.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 95' ' ' LYS . . . . . 0.686 ' HE2' ' HB3' ' E' ' 98' ' ' ASP . 12.2 tmtt? -81.69 134.61 35.48 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.304 0.642 . . . . 65.1 110.202 -177.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . -148.0 -70.35 0.01 OUTLIER Glycine 0 C--N 1.343 0.947 0 N-CA-C 110.542 -1.023 . . . . 72.03 110.542 172.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 97' ' ' ILE . . . . . 0.563 HD12 HD21 ' E' ' 100' ' ' LEU . 36.9 pt -102.32 120.86 52.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 CA-C-O 121.71 0.767 . . . . 62.53 110.523 178.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 98' ' ' ASP . . . . . 0.686 ' HB3' ' HE2' ' E' ' 95' ' ' LYS . 7.0 p-10 -116.67 -11.01 11.05 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.1 0.96 . . . . 73.55 112.153 -173.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.82 102.94 4.4 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.228 -0.656 . . . . 74.14 109.228 -174.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 100' ' ' LEU . . . . . 0.563 HD21 HD12 ' E' ' 97' ' ' ILE . 5.7 mp -117.69 143.31 32.14 Favored Pre-proline 0 N--CA 1.48 1.026 0 N-CA-C 108.909 -0.774 . . . . 63.43 108.909 176.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.38 -47.94 23.24 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 123.034 2.489 . . . . 74.15 113.464 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 102' ' ' LEU . . . . . 0.458 HD11 HD13 ' D' ' 98' ' ' LEU . 3.8 pp -75.37 -21.5 58.27 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.811 0.671 . . . . 73.12 112.811 -174.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 60.9 p -76.25 1.09 16.96 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.558 0.343 . . . . 53.32 111.531 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . -69.58 -40.08 78.13 Favored Glycine 0 C--N 1.35 1.336 0 N-CA-C 111.458 -0.657 . . . . 72.11 111.458 165.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -164.05 -82.07 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.466 0.706 . . . . 73.23 109.921 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -173.17 151.53 2.1 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.339 1.056 . . . . 70.41 108.637 -174.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 8.4 t -69.93 132.94 46.74 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.287 0.635 . . . . 75.44 110.757 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -60.66 -50.09 74.91 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.574 0.75 . . . . 75.14 110.964 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -81.95 108.4 15.42 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.727 -0.842 . . . . 73.43 108.727 169.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.29 168.91 14.89 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.811 0.445 . . . . 52.1 110.362 173.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . . . . . . . . . 26.3 tp -49.22 -65.08 0.63 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.027 1.331 . . . . 74.24 112.366 -174.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 112' ' ' ASN . . . . . 0.626 ' HB3' ' H ' ' D' ' 44' ' ' LEU . 6.5 t30 -115.65 95.54 5.19 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 107.734 -1.209 . . . . 72.31 107.734 170.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 16.5 tptm -152.82 177.53 10.63 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 107.508 -1.293 . . . . 71.53 107.508 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . 0.454 ' HG2' ' HE1' ' D' ' 140' ' ' TYR . 58.6 tptt 63.3 -179.93 0.15 Allowed 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.389 0.676 . . . . 75.42 109.905 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 21.2 m 73.39 157.05 0.18 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.034 0.934 . . . . 74.11 110.456 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.41 -60.52 8.79 Favored Glycine 0 C--N 1.353 1.476 0 N-CA-C 111.71 -0.556 . . . . 61.12 111.71 172.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -142.04 113.07 6.3 Favored Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 124.423 1.089 . . . . 75.24 108.263 171.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -82.05 74.28 5.3 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 123.04 2.493 . . . . 73.43 111.587 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -89.2 26.03 1.73 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.909 0.884 . . . . 73.01 111.362 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -65.06 -36.23 83.67 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.359 1.063 . . . . 74.41 110.242 173.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 121' ' ' VAL . . . . . . . . . . . . . 33.3 m -82.4 -26.52 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 115.176 -0.92 . . . . 71.23 111.151 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 14.9 m -85.54 73.4 10.48 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-O 121.75 0.786 . . . . 65.53 109.812 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -83.69 -60.97 1.95 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.972 -1.013 . . . . 74.5 109.6 176.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 19.2 t -159.04 -179.11 7.74 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.1 -0.955 . . . . 71.42 109.52 -177.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -144.48 -177.73 5.63 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.007 0.923 . . . . 70.54 109.592 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -153.19 172.0 17.62 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.766 0.426 . . . . 64.23 111.958 -171.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 19.6 m 61.94 30.22 18.02 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.368 1.467 . . . . 72.23 113.103 175.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 128' ' ' ALA . . . . . 0.448 ' HB2' ' HB2' ' D' ' 37' ' ' GLN . . . -68.68 102.12 1.44 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.596 -0.729 . . . . 65.25 109.173 171.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 51.3 m -148.17 145.78 28.45 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.427 0.691 . . . . 74.2 109.928 -176.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.36 154.05 42.32 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.865 0.866 . . . . 64.32 111.179 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 131' ' ' TRP . . . . . 0.546 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 13.8 p90 -130.18 109.76 11.06 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 121.472 0.653 . . . . 75.2 110.394 178.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 132' ' ' SER . . . . . 0.507 ' H ' ' HB3' ' A' ' 124' ' ' PRO . 32.4 t -165.3 114.47 1.04 Allowed 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.991 -1.115 . . . . 71.43 107.991 175.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 133' ' ' THR . . . . . 0.409 ' OG1' ' HB2' ' A' ' 124' ' ' PRO . 63.5 m -142.23 -51.0 0.39 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.509 0.724 . . . . 74.41 109.235 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 134' ' ' GLY . . . . . 0.478 ' O ' HD12 ' A' ' 126' ' ' LEU . . . 70.75 -98.83 0.71 Allowed Glycine 0 C--N 1.349 1.276 0 CA-C-N 115.269 -0.878 . . . . 54.11 112.28 178.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 135' ' ' VAL . . . . . 0.435 HG21 ' H ' ' A' ' 129' ' ' ALA . 2.7 p -174.76 -49.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.712 1.205 . . . . 63.44 109.243 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp 67.7 -69.71 0.13 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.898 1.679 . . . . 74.24 112.413 -178.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 18.5 m -68.99 92.03 0.5 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.572 0.749 . . . . 64.0 110.956 -174.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -104.19 -61.6 1.42 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.731 1.212 . . . . 71.22 109.582 176.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -65.81 -69.46 0.3 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.178 0.991 . . . . 73.04 110.995 -171.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . 77.28 -78.65 1.42 Allowed Glycine 0 CA--C 1.531 1.074 0 CA-C-N 116.583 -0.28 . . . . 52.24 112.751 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -124.48 179.1 5.08 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.768 0.827 . . . . 53.34 110.533 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 36.3 tp -130.14 141.81 50.65 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.516 0.726 . . . . 74.05 109.466 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.8 41.89 1.34 Allowed Glycine 0 C--N 1.351 1.382 0 O-C-N 123.26 0.35 . . . . 74.14 113.036 -176.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 12.3 p -105.94 113.64 43.25 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 CA-C-O 121.271 0.558 . . . . 75.21 110.056 174.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 37.5 t70 . . . . . 0 CA--C 1.554 1.107 0 C-N-CA 125.55 1.54 . . . . 74.33 111.362 174.54 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.306 0 N-CA-C 112.301 -0.32 . . . . 54.34 112.301 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.28 -58.01 4.51 Favored Glycine 0 C--N 1.351 1.372 0 N-CA-C 111.529 -0.629 . . . . 73.24 111.529 -176.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 93' ' ' PHE . . . . . 0.577 ' HB3' HG21 ' B' ' 55' ' ' VAL . 49.6 m-85 -71.12 109.34 5.13 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.211 1.004 . . . . 65.05 110.536 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 94' ' ' PHE . . . . . 0.422 ' HE2' ' HB3' ' B' ' 12' ' ' GLN . 52.0 p90 -108.74 159.39 16.79 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.303 0.641 . . . . 71.43 110.373 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -130.15 154.41 47.55 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.616 0.366 . . . . 71.34 110.853 -173.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . 160.65 48.27 0.02 OUTLIER Glycine 0 C--N 1.351 1.396 0 CA-C-O 120.948 0.193 . . . . 72.3 113.447 177.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 97' ' ' ILE . . . . . 0.672 HD11 ' HB2' ' B' ' 94' ' ' MET . 18.8 tt -133.15 -30.99 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.806 0.842 . . . . 64.11 108.79 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 30.0 t70 70.38 -71.39 0.13 Allowed 'General case' 0 C--N 1.359 1.004 0 C-N-CA 126.357 1.863 . . . . 64.03 113.444 171.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 99' ' ' ALA . . . . . 0.482 ' HB2' ' H ' ' B' ' 3' ' ' GLU . . . -82.32 26.04 0.57 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.356 1.062 . . . . 44.02 113.607 -167.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 100' ' ' LEU . . . . . 0.536 HD12 ' H ' ' F' ' 102' ' ' LEU . 36.6 tp -100.89 100.74 13.52 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 123.677 0.791 . . . . 63.35 110.647 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 101' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' F' ' 99' ' ' ALA . 42.9 Cg_endo -97.42 13.7 0.84 Allowed 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.589 2.859 . . . . 73.42 112.224 166.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 102' ' ' LEU . . . . . 0.536 ' H ' HD12 ' F' ' 100' ' ' LEU . 29.7 tp 71.0 142.72 0.05 Allowed 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.775 1.63 . . . . 62.13 111.601 -177.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 103' ' ' THR . . . . . 0.438 ' H ' HD12 ' F' ' 102' ' ' LEU . 17.5 m -73.4 73.63 1.37 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.539 1.136 . . . . 75.03 110.977 -177.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 57.69 20.85 41.04 Favored Glycine 0 C--N 1.352 1.448 0 N-CA-C 115.555 0.982 . . . . 52.41 115.555 176.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 61.41 19.42 10.24 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.757 0.823 . . . . 75.2 112.222 -176.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -168.65 118.87 0.74 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.488 -1.301 . . . . 73.4 107.488 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 16.5 m -75.51 84.92 2.59 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 121.189 0.519 . . . . 60.33 110.631 -177.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 46.8 p-80 -100.75 105.02 16.31 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.796 0.839 . . . . 75.21 109.905 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -167.06 -59.71 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 107.476 -1.305 . . . . 72.33 107.476 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -125.85 -166.12 1.52 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 114.388 -1.278 . . . . 65.23 109.199 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 8.2 mp 71.01 -67.46 0.25 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 125.237 1.415 . . . . 61.13 109.195 -171.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -61.86 126.95 29.14 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.612 -0.884 . . . . 74.55 108.612 165.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -66.42 98.35 0.48 Allowed 'General case' 0 CA--C 1.549 0.935 0 CA-C-O 122.231 1.015 . . . . 72.54 110.784 -174.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -82.38 -78.75 0.2 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.241 -1.345 . . . . 72.01 110.151 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 31.9 m -156.75 -44.72 0.07 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.85 0.86 . . . . 71.42 109.047 -172.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . -61.37 158.06 31.89 Favored Glycine 0 C--N 1.355 1.628 0 CA-C-N 115.371 -0.831 . . . . 64.15 113.394 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -74.83 126.41 88.41 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 123.127 0.571 . . . . 72.02 110.999 -173.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 118' ' ' PRO . . . . . 0.447 ' HB2' ' HB ' ' F' ' 121' ' ' VAL . 95.8 Cg_endo -81.39 92.68 1.02 Allowed 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 123.112 2.541 . . . . 61.43 111.623 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -52.68 -76.46 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.525 1.13 . . . . 54.23 113.086 -174.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -88.89 -14.72 36.12 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.298 0.239 . . . . 73.14 110.542 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 121' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' F' ' 118' ' ' PRO . 25.7 t -76.45 84.86 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 109.017 -0.735 . . . . 73.13 109.017 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 5.6 t -99.06 -49.1 4.62 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.21 -0.905 . . . . 71.52 110.361 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -178.82 -54.85 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.349 1.06 . . . . 61.41 109.877 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 32.1 t 179.25 -48.52 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.022 1.329 . . . . 60.3 107.981 -174.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . 64.92 -79.59 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.481 1.512 . . . . 52.12 111.659 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -81.34 97.22 7.6 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.882 0.473 . . . . 50.14 110.314 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 35.4 p -87.05 -49.57 7.24 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.498 0.719 . . . . 72.55 110.251 176.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . 55.74 32.56 19.69 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.733 1.213 . . . . 63.15 111.303 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 129' ' ' THR . . . . . 0.711 ' HB ' ' HG3' ' B' ' 37' ' ' GLN . 20.4 m -91.04 100.68 13.5 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.481 -0.781 . . . . 54.51 111.429 -170.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -142.93 147.45 35.27 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.013 0.925 . . . . 44.53 109.752 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 131' ' ' TRP . . . . . 0.445 ' HB2' ' HG3' ' B' ' 124' ' ' PRO . 8.5 t90 -106.89 140.32 39.89 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 109.13 -0.693 . . . . 74.24 109.13 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 33.7 t -83.79 157.66 21.99 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 109.887 -0.412 . . . . 72.21 109.887 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 14.2 t -65.76 163.93 15.66 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.146 0.578 . . . . 74.32 110.961 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.2 160.67 26.79 Favored Glycine 0 C--N 1.35 1.352 0 O-C-N 123.649 0.593 . . . . 54.23 112.929 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 135' ' ' VAL . . . . . 0.496 ' HB ' HD23 ' C' ' 42' ' ' LEU . 21.7 m -77.73 75.27 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-O 122.628 1.204 . . . . 62.32 110.892 -175.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 136' ' ' LYS . . . . . 0.437 ' NZ ' ' HB3' ' F' ' 136' ' ' LYS . 0.0 OUTLIER -77.68 88.69 3.95 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.521 -1.218 . . . . 63.44 108.823 -175.094 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 10.8 m -139.91 -38.85 0.46 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.53 1.132 . . . . 71.24 109.028 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -81.55 -171.24 3.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.86 0.864 . . . . 74.2 111.354 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -66.19 88.64 0.12 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.717 0.807 . . . . 60.52 109.843 176.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.91 54.93 0.08 OUTLIER Glycine 0 C--O 1.239 0.438 0 N-CA-C 109.535 -1.426 . . . . 64.53 109.535 -176.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -136.03 144.59 45.35 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.957 0.903 . . . . 72.42 110.62 -169.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 pp -141.29 167.05 23.11 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 123.971 0.908 . . . . 75.32 109.836 172.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.02 105.81 2.19 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.014 -0.834 . . . . 74.02 111.014 173.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.63 -50.73 79.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.725 0.81 . . . . 65.54 110.076 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 C--O 1.248 1.004 0 N-CA-C 108.296 -1.001 . . . . 61.2 108.296 176.926 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 mmt . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.363 -0.606 . . . . 65.03 109.363 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -131.21 123.25 28.06 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.779 0.832 . . . . 74.23 109.423 -174.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -147.1 92.98 2.19 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.532 0.682 . . . . 53.23 110.866 -171.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -171.92 127.9 0.6 Allowed 'General case' 0 C--O 1.239 0.516 0 N-CA-C 106.861 -1.533 . . . . 64.21 106.861 176.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -70.09 91.12 0.68 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.131 0.491 . . . . 74.54 109.915 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -58.62 -56.04 27.3 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.831 1.252 . . . . 71.33 110.506 -177.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.497 HG23 HG22 ' A' ' 89' ' ' ILE . 6.0 t -153.58 152.03 30.44 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 115.328 -0.851 . . . . 42.1 110.345 -174.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -84.58 179.34 7.41 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.648 -0.706 . . . . 73.54 109.424 175.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.546 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 2.8 ppp? -145.28 175.18 10.48 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.122 0.569 . . . . 71.21 111.515 -172.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.4 m -140.88 129.7 23.02 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.388 1.075 . . . . 62.5 108.19 173.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -119.99 117.5 28.19 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.95 1.3 . . . . 72.13 108.337 -177.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.454 ' HG3' HE21 ' A' ' 14' ' ' GLN . 19.4 tp60 -133.89 109.8 9.29 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.619 -0.882 . . . . 71.4 108.619 -178.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.8 mt -74.17 122.17 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.749 -0.834 . . . . 73.11 108.749 174.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.454 HE21 ' HG3' ' A' ' 12' ' ' GLN . 25.7 mm-40 -92.91 -42.17 9.64 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.088 0.555 . . . . 72.42 110.818 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -170.68 121.8 0.59 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 110.05 -0.352 . . . . 71.03 110.05 -175.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.401 HD12 ' HG3' ' C' ' 130' ' ' PRO . 98.1 mt -105.71 126.14 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 107.57 -1.27 . . . . 74.3 107.57 172.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.502 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 28.3 p90 -162.11 157.11 22.85 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 123.736 0.647 . . . . 75.11 110.896 -171.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.1 p -85.01 117.09 23.77 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 109.408 -0.59 . . . . 44.15 109.408 174.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.0 mtpt -78.19 -31.31 49.47 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.407 -0.59 . . . . 71.33 109.407 174.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 30.4 t70 -150.25 145.82 26.43 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.759 -1.109 . . . . 61.24 110.68 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 75.0 mt -138.92 145.41 27.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 C-N-CA 125.395 1.478 . . . . 61.42 107.951 176.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.3 t -149.26 133.05 16.95 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.833 0.853 . . . . 73.54 109.538 173.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -130.54 139.39 50.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.087 -1.449 . . . . 74.14 107.087 169.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -135.12 134.11 39.9 Favored 'General case' 0 C--O 1.218 -0.604 0 C-N-CA 123.068 0.547 . . . . 55.2 109.621 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.8 71.57 11.45 Favored Pre-proline 0 C--O 1.243 0.738 0 N-CA-C 105.829 -1.915 . . . . 73.43 105.829 169.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.78 -30.99 10.9 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.142 1.895 . . . . 74.44 111.389 -177.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -94.03 12.97 24.41 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 118.35 -0.833 . . . . 70.52 109.91 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.559 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -42.91 -59.08 3.28 Favored Pre-proline 0 CA--C 1.573 1.844 0 CA-C-O 118.146 -0.931 . . . . 72.11 112.919 -173.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 20.5 Cg_exo -63.46 -15.02 45.91 Favored 'Trans proline' 0 C--N 1.395 2.995 0 C-N-CA 122.541 2.16 . . . . 52.51 113.956 -178.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -92.29 -42.65 9.71 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.868 0.867 . . . . 71.14 110.154 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.72 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.3 p -79.32 -13.48 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-N 114.02 -1.446 . . . . 54.43 112.617 -161.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -72.42 -15.38 61.83 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.186 0.594 . . . . 52.15 110.968 173.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -87.46 -12.56 45.71 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.352 1.061 . . . . 74.25 111.15 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -82.46 155.71 24.47 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.646 0.778 . . . . 63.12 111.394 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.98 128.53 36.31 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.49 0.716 . . . . 72.33 109.457 170.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.444 ' CE3' HD21 ' A' ' 68' ' ' LEU . 49.9 t-105 -81.04 76.34 7.99 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.848 0.832 . . . . 74.42 110.266 -177.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.3 tm0? -126.8 81.88 68.39 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 105.025 -2.213 . . . . 64.14 105.025 168.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -83.68 144.98 11.42 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.347 2.031 . . . . 73.43 112.141 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -96.46 84.11 3.64 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.457 -1.312 . . . . 64.33 107.457 173.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.423 HG13 HG13 ' A' ' 64' ' ' VAL . 43.3 t -88.13 94.44 4.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 CA-C-N 115.537 -0.756 . . . . 71.34 109.819 -175.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -92.93 134.12 35.43 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.056 -0.974 . . . . 62.04 109.978 178.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 41.1 mt -103.66 108.95 20.46 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.477 -0.935 . . . . 71.03 108.477 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.605 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 10.2 m-20 -101.63 107.92 19.31 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.367 -1.346 . . . . 60.41 107.367 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.594 HD11 HG21 ' A' ' 131' ' ' VAL . 86.8 mt -103.52 135.53 44.94 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.448 0.642 . . . . 70.5 111.279 -174.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 24.8 t70 -132.55 143.45 49.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.334 -1.303 . . . . 61.31 108.254 178.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.6 m -127.25 133.4 50.21 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.663 0.785 . . . . 55.43 108.963 175.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.77 147.71 52.32 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 124.547 1.139 . . . . 71.12 108.502 175.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.1 m -131.68 156.51 45.76 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 122.747 0.419 . . . . 73.21 109.883 174.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.9 t -154.31 118.89 4.87 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.257 -1.016 . . . . 73.21 108.257 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -72.87 107.48 5.3 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 108.544 -0.91 . . . . 74.33 108.544 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.5 mt -79.95 -36.62 35.96 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.987 -0.552 . . . . 64.24 110.454 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.55 -174.02 4.81 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.272 0.629 . . . . 44.04 110.869 -177.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -65.29 119.84 11.67 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.203 0.601 . . . . 54.11 109.634 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 65.73 5.61 3.45 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.988 1.315 . . . . 55.33 112.532 -175.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.5 t -107.12 111.12 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 109.108 -0.701 . . . . 73.23 109.108 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -121.23 124.58 45.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.108 -1.071 . . . . 72.05 108.108 176.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -87.78 143.63 27.05 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.677 -0.86 . . . . 72.02 108.677 170.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.458 HG11 ' HD3' ' A' ' 103' ' ' PRO . 96.9 t -126.4 137.58 57.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 107.873 -1.158 . . . . 71.15 107.873 170.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.458 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 44.7 t -119.27 130.75 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.473 -0.936 . . . . 74.25 108.473 174.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.548 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -104.74 105.91 16.19 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 105.957 -1.868 . . . . 65.45 105.957 173.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.568 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 28.6 ttp180 -92.88 99.98 12.53 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.345 -1.354 . . . . 72.41 107.345 176.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.5 t -94.93 129.24 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 N-CA-C 107.705 -1.22 . . . . 70.1 107.705 176.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.605 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.3 m -121.71 114.58 21.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.887 -0.783 . . . . 72.12 108.887 176.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 90.6 t -102.06 106.89 20.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.32 -0.993 . . . . 73.13 108.32 177.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 26.9 m -103.3 132.68 49.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.43 -0.952 . . . . 64.14 108.43 172.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.98 118.26 13.65 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.527 -0.545 . . . . 74.31 109.527 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.0 m -123.24 138.2 54.69 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.368 0.667 . . . . 63.35 110.521 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.698 HD12 HG22 ' A' ' 31' ' ' VAL . 22.0 mt -92.32 86.31 5.67 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.973 1.309 . . . . 70.42 108.396 172.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.5 -95.75 0.89 Allowed Glycine 0 C--N 1.339 0.705 0 O-C-N 123.393 0.433 . . . . 74.01 112.34 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.85 -26.17 13.23 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.634 0.773 . . . . 70.15 110.752 -177.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -104.07 126.19 50.99 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.398 0.679 . . . . 55.02 110.4 -174.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.1 m -63.62 125.94 25.92 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 123.561 0.538 . . . . 51.54 110.75 173.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.72 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -72.63 -60.26 2.32 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.818 -0.808 . . . . 71.55 108.818 174.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -160.31 168.17 25.88 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.652 0.739 . . . . 55.44 111.757 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 64' ' ' VAL . 65.1 tp -127.2 143.11 51.32 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.003 1.321 . . . . 63.22 107.739 169.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.563 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 70.9 m -144.76 98.28 3.16 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.386 0.674 . . . . 63.02 109.777 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -118.64 116.93 27.61 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.673 -0.491 . . . . 74.34 109.673 -176.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.0 t -125.33 110.87 25.6 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 123.836 0.855 . . . . 75.13 109.022 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 51.9 mt-30 -84.9 82.51 8.41 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.231 -1.026 . . . . 55.03 108.231 172.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -76.07 94.43 3.45 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 114.474 -1.239 . . . . 71.35 108.574 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.46 163.34 40.73 Favored Glycine 0 C--O 1.24 0.474 0 N-CA-C 111.011 -0.836 . . . . 61.44 111.011 177.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.83 121.71 1.05 Allowed Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 110.371 -1.092 . . . . 32.31 110.371 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.8 mt -81.49 122.65 36.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.499 -1.297 . . . . 70.25 107.499 173.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.703 ' HB3' HD11 ' A' ' 86' ' ' ILE . 93.3 m-85 -128.19 121.17 28.8 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.359 0.664 . . . . 73.13 109.513 -178.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.1 t -85.25 98.1 10.31 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.418 -0.956 . . . . 74.35 108.418 173.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.703 HD11 ' HB3' ' A' ' 84' ' ' PHE . 4.2 mm -107.87 147.95 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.418 -0.586 . . . . 75.33 109.418 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.53 170.1 23.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.647 -0.706 . . . . 74.43 110.121 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 100.15 -34.17 5.73 Favored Glycine 0 C--N 1.341 0.818 0 O-C-N 123.613 0.571 . . . . 73.34 113.574 176.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.57 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -127.5 146.34 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 122.928 0.491 . . . . 71.01 111.739 -169.259 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.24 175.17 9.49 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.658 1.183 . . . . 65.43 109.335 175.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.26 -131.29 27.32 Favored Glycine 0 C--N 1.352 1.443 0 O-C-N 123.46 0.475 . . . . 51.41 113.611 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.9 t -72.8 -21.53 60.97 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.23 0.612 . . . . 54.2 111.212 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -73.64 -42.39 61.47 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.606 0.762 . . . . 70.23 109.387 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 2.3 tpt -66.55 -42.52 87.02 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 115.596 -0.729 . . . . 72.4 110.262 173.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.54 -29.2 70.4 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.385 -0.825 . . . . 72.43 111.13 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.488 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 60.4 t-80 -71.53 -35.27 70.61 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.98 -0.555 . . . . 74.44 110.926 176.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.9 t -71.89 -44.16 64.2 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 110.005 -0.368 . . . . 52.3 110.005 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 55.6 mt -82.38 -32.07 29.38 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.66 0.615 . . . . 73.04 112.66 -173.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.89 4.36 42.07 Favored Glycine 0 N--CA 1.472 1.034 0 CA-C-O 119.89 -0.395 . . . . 71.42 113.639 -172.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.538 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -140.49 -68.6 0.41 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 117.014 0.407 . . . . 55.23 110.759 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -67.97 -45.33 74.46 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 116.01 -0.541 . . . . 73.31 112.266 -168.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 82.4 m -67.19 -48.42 48.16 Favored Pre-proline 0 CA--C 1.559 1.296 0 CA-C-O 118.065 -0.969 . . . . 62.42 112.783 -176.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.458 ' HD3' HG11 ' A' ' 58' ' ' VAL . 41.0 Cg_endo -66.51 -18.72 54.72 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 121.576 1.517 . . . . 74.22 112.682 173.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -76.12 -34.62 59.47 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.923 0.489 . . . . 74.11 110.529 173.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.2 mm -64.35 -43.84 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.448 0.699 . . . . 71.51 109.447 170.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.2 mt -73.36 -23.48 60.21 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.045 -0.98 . . . . 73.24 112.522 -174.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -63.61 -45.64 82.88 Favored Pre-proline 0 N--CA 1.485 1.279 0 N-CA-C 114.331 1.234 . . . . 75.25 114.331 -172.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -52.95 -36.53 75.58 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 121.985 1.79 . . . . 73.14 113.47 172.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -79.08 -39.36 33.98 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.559 0.744 . . . . 71.12 111.352 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.45 -49.53 73.33 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.252 0.621 . . . . 63.22 109.369 175.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.47 ' NH1' HD12 ' C' ' 105' ' ' ILE . 27.4 ttm180 -49.96 -50.5 46.56 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 125.137 1.523 . . . . 71.32 111.084 175.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -65.24 -47.85 75.37 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 124.374 1.046 . . . . 75.24 111.747 -176.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.525 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 53.7 t -56.0 -42.01 75.75 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.135 0.897 . . . . 54.11 110.468 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.556 HG21 HG21 ' A' ' 64' ' ' VAL . 68.8 mt -62.66 -53.69 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 114.736 -1.12 . . . . 72.1 110.616 174.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.404 HG21 ' HE2' ' C' ' 109' ' ' TYR . 33.1 m -55.87 -36.86 68.04 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.679 0.791 . . . . 72.33 111.027 -175.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.7 t -68.68 -46.9 67.86 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.582 -1.19 . . . . 72.21 110.186 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.6 mtp -59.94 -42.29 93.7 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.605 0.762 . . . . 73.34 111.897 177.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 114' ' ' ILE . 84.5 t -63.76 -44.16 98.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 124.254 1.022 . . . . 64.45 110.252 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 99.4 p -73.23 -32.3 64.67 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 115.803 -0.635 . . . . 65.13 111.108 -176.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -67.78 -33.38 74.72 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.469 0.708 . . . . 70.33 109.738 173.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.54 15.05 37.67 Favored Glycine 0 C--N 1.354 1.562 0 CA-C-N 115.585 -0.734 . . . . 41.41 113.578 175.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.4 t 59.9 11.54 2.63 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 127.26 2.224 . . . . 62.34 114.488 174.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -79.76 140.01 54.56 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 107.96 -1.126 . . . . 72.3 107.96 175.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -43.15 133.56 6.21 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 123.529 2.819 . . . . 72.33 112.647 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -52.36 131.0 32.71 Favored 'General case' 0 C--N 1.363 1.164 0 O-C-N 123.93 0.769 . . . . 71.35 112.474 -169.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.419 HD21 HG11 ' A' ' 64' ' ' VAL . 22.3 tp -120.22 115.73 24.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.688 1.195 . . . . 63.51 109.303 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.551 ' HB2' HG22 ' E' ' 135' ' ' VAL . 35.9 m-80 -109.17 128.04 54.7 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 105.715 -1.957 . . . . 63.44 105.715 173.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.454 ' H ' ' HG3' ' A' ' 111' ' ' ARG . 15.4 mt -71.7 147.44 47.41 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 118.29 0.496 . . . . 64.12 110.926 -175.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.33 137.6 86.53 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 122.98 0.512 . . . . 50.23 110.677 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.2 124.21 15.65 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 123.132 2.555 . . . . 62.5 113.329 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.594 HG21 HD11 ' A' ' 44' ' ' LEU . 68.6 t -109.43 128.6 65.3 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 C-N-CA 123.78 0.832 . . . . 53.22 110.388 178.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -92.18 84.3 5.22 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.466 -0.939 . . . . 73.24 108.466 177.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -60.83 -29.67 69.64 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.884 0.874 . . . . 74.43 111.587 177.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.538 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 5.5 t70 -64.24 -42.24 96.62 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 124.007 0.817 . . . . 70.41 109.559 178.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.92 -40.18 87.56 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.125 0.891 . . . . 50.53 111.275 176.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.64 -42.86 99.48 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 123.779 0.674 . . . . 75.33 111.016 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -71.32 -36.56 71.63 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 116.014 -0.539 . . . . 61.15 109.834 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.527 ' HG2' ' HA ' ' A' ' 143' ' ' GLN . 33.4 ttm -64.7 -27.97 69.28 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.51 0.506 . . . . 75.03 111.374 -174.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -58.33 -42.94 87.9 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.432 0.693 . . . . 74.15 110.668 172.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -78.05 -30.28 49.72 Favored 'General case' 0 CA--C 1.558 1.263 0 C-N-CA 125.012 1.325 . . . . 65.04 111.403 176.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.483 ' HB3' ' HA ' ' A' ' 138' ' ' MET . 51.9 tp -68.28 -51.2 47.58 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.215 1.006 . . . . 63.14 111.508 -175.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 169.99 -18.81 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 C-N-CA 125.002 1.321 . . . . 75.14 111.238 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.527 ' HA ' ' HG2' ' A' ' 138' ' ' MET . 0.0 OUTLIER 49.39 72.82 0.28 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.695 1.598 . . . . 73.4 111.273 -173.191 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -160.63 -54.06 0.05 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.632 -0.713 . . . . 64.34 109.261 177.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.59 155.39 48.38 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-N 115.463 -0.789 . . . . 55.24 110.614 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 174.59 124.36 0.79 Allowed Glycine 0 C--N 1.346 1.095 0 O-C-N 123.73 0.644 . . . . 44.55 112.713 176.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -145.3 -171.07 3.58 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.786 1.234 . . . . 62.12 108.33 170.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 120.95 65.57 0.25 Allowed Glycine 0 C--N 1.349 1.302 0 N-CA-C 112.47 -0.252 . . . . 63.42 112.47 177.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.8 t -153.26 152.81 31.58 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.319 0.647 . . . . 53.51 110.722 175.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -175.79 150.24 1.01 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.545 1.138 . . . . 74.02 109.156 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.64 124.65 52.31 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 108.81 -0.811 . . . . 64.54 108.81 172.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -158.32 117.73 3.18 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.162 1.385 . . . . 74.1 107.726 177.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -146.16 161.54 39.99 Favored 'General case' 0 C--O 1.24 0.572 0 O-C-N 123.79 0.681 . . . . 73.05 110.763 -175.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -116.67 -62.31 1.6 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.32 1.048 . . . . 42.12 108.553 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.918 0 C-N-CA 124.244 1.018 . . . . 44.43 108.686 179.39 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.708 ' SD ' ' HD2' ' F' ' 95' ' ' LYS . 57.2 mtm . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 109.12 -0.696 . . . . 72.0 109.12 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.2 t -103.47 93.48 4.97 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 109.053 -0.721 . . . . 72.3 109.053 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 68.8 80.26 0.2 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.754 1.222 . . . . 75.23 111.531 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -136.73 78.5 1.7 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.522 1.129 . . . . 44.43 108.553 170.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -152.78 123.49 7.34 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.423 -0.954 . . . . 75.12 108.423 -178.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -126.36 121.27 32.06 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.466 0.707 . . . . 72.13 109.239 -176.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 13.3 t -75.9 160.86 29.48 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.218 0.607 . . . . 74.33 110.705 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 61.94 27.83 16.92 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.376 1.071 . . . . 71.32 110.576 -173.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.529 ' HB3' HG23 ' B' ' 89' ' ' ILE . 20.7 ptm 49.43 -174.44 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 127.037 2.135 . . . . 65.22 112.71 -170.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -147.68 140.03 24.47 Favored 'General case' 0 C--O 1.248 0.982 0 N-CA-C 108.425 -0.954 . . . . 71.02 108.425 169.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -138.35 140.46 39.47 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.741 -0.837 . . . . 74.45 108.741 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -151.5 140.02 20.59 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 109.087 -0.708 . . . . 72.32 109.087 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.459 HD13 HD11 ' B' ' 16' ' ' ILE . 33.8 mt -75.1 133.0 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 107.535 -1.283 . . . . 51.33 107.535 167.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 -98.43 -43.76 6.78 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.054 -0.721 . . . . 74.43 109.054 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -172.88 131.72 0.52 Allowed 'General case' 0 C--N 1.348 0.536 0 CA-C-N 115.723 -0.671 . . . . 62.41 109.69 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.507 HG21 ' CD1' ' B' ' 109' ' ' TYR . 58.6 mt -115.63 144.13 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.108 -1.071 . . . . 72.14 108.108 173.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -164.69 145.58 7.82 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.489 0.661 . . . . 75.22 111.931 -175.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.1 m -72.91 118.17 15.53 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.405 -1.27 . . . . 71.33 108.086 169.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -94.59 -23.29 17.7 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.509 0.724 . . . . 65.11 111.02 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -161.48 143.47 11.76 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.986 0.179 . . . . 60.21 110.9 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.448 HD11 ' SG ' ' B' ' 113' ' ' CYS . 47.1 mm -136.1 143.92 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.536 1.135 . . . . 61.43 109.536 176.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 68.9 m -141.27 132.58 26.63 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.962 1.705 . . . . 63.11 107.208 169.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 88.0 t80 -142.87 109.26 5.33 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.483 -1.673 . . . . 72.2 106.483 166.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 38.8 mt-10 -119.53 111.54 18.22 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.501 -0.925 . . . . 75.42 108.501 -176.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.56 86.47 1.78 Allowed Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 106.566 -1.642 . . . . 71.2 106.566 173.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.28 -35.7 8.13 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.464 2.11 . . . . 73.15 112.199 -165.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -106.93 21.02 18.2 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.1 -0.954 . . . . 64.32 109.663 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.436 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -42.66 -62.33 1.31 Allowed Pre-proline 0 N--CA 1.487 1.424 0 C-N-CA 125.221 1.408 . . . . 64.43 114.722 -165.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.436 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 16.6 Cg_exo -61.81 -30.18 84.05 Favored 'Trans proline' 0 C--N 1.394 2.959 0 C-N-CA 122.08 1.854 . . . . 74.33 112.375 -171.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -96.04 -27.99 14.84 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.564 -1.198 . . . . 74.31 111.983 -169.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' B' ' 73' ' ' ALA . 6.4 p -81.81 -10.02 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-O 120.775 0.322 . . . . 72.12 111.043 -176.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -70.57 -19.96 62.83 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.383 0.673 . . . . 65.22 112.678 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -65.92 -12.78 57.3 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.144 0.497 . . . . 72.24 111.229 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -97.36 92.26 5.89 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.053 1.341 . . . . 65.21 109.744 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -97.38 78.92 2.73 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.755 -0.657 . . . . 73.15 109.622 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 15.1 p90 -153.8 -173.24 4.5 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.092 0.557 . . . . 62.14 110.017 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -73.03 109.47 6.33 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 124.143 0.977 . . . . 72.14 110.088 -179.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.476 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 55.6 Cg_endo -72.91 132.24 18.1 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 121.199 1.266 . . . . 70.02 111.317 175.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -65.6 104.86 1.09 Allowed 'General case' 0 C--O 1.243 0.725 0 C-N-CA 123.184 0.594 . . . . 64.01 109.809 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.525 ' HB ' ' O ' ' F' ' 126' ' ' ALA . 74.8 t -99.5 143.38 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 114.355 -1.293 . . . . 71.32 111.221 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -124.09 132.05 53.61 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 106.949 -1.5 . . . . 73.43 106.949 173.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.453 HD13 HD22 ' B' ' 128' ' ' LEU . 17.1 tp -102.06 124.98 48.6 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.073 -1.084 . . . . 52.11 108.073 172.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -124.85 139.59 53.7 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 107.615 -1.254 . . . . 72.24 107.615 -175.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mp -122.3 138.25 54.57 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.837 0.855 . . . . 65.42 109.453 -171.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.553 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 9.8 t70 -135.22 146.85 49.05 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.715 1.206 . . . . 74.4 108.442 173.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.1 m -126.74 103.42 7.53 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.919 -0.771 . . . . 74.14 108.919 -176.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.75 117.89 31.52 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 108.625 -0.879 . . . . 61.25 108.625 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 51.7 p -144.6 161.04 40.14 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 122.429 0.291 . . . . 75.42 110.752 -176.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.7 p -159.45 138.88 11.35 Favored 'General case' 0 C--O 1.244 0.799 0 O-C-N 123.444 0.465 . . . . 74.0 111.211 -174.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.453 ' HG3' HD12 ' F' ' 100' ' ' LEU . 61.0 tt0 -78.37 104.57 9.04 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 108.845 -0.798 . . . . 70.35 108.845 171.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 3.0 pp -122.53 11.31 9.88 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.647 -0.706 . . . . 44.41 109.928 175.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.07 158.49 43.09 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 115.702 -0.681 . . . . 61.23 110.49 -174.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.93 107.74 17.86 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.418 1.087 . . . . 72.23 110.883 -172.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 62.53 18.63 10.6 Favored 'General case' 0 N--CA 1.501 2.122 0 C-N-CA 124.275 1.03 . . . . 71.12 111.589 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 90.3 t -135.6 121.63 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.372 1.469 . . . . 61.3 107.248 -174.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -113.43 139.25 49.07 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.69 -0.856 . . . . 75.32 108.69 -172.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -104.51 101.29 10.96 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 106.578 -1.638 . . . . 42.43 106.578 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 7.7 p -104.04 133.66 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.201 0.601 . . . . 73.43 109.491 -177.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.505 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 25.8 t -118.4 122.11 68.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 C-N-CA 124.183 0.993 . . . . 73.15 108.437 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.45 109.94 21.78 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 107.796 -1.187 . . . . 72.11 107.796 174.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.553 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 39.2 ttm180 -85.85 112.23 20.94 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.889 -0.782 . . . . 53.13 108.889 175.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.447 HG13 HD11 ' B' ' 42' ' ' LEU . 61.7 t -105.37 103.59 15.6 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 108.42 -0.956 . . . . 73.4 108.42 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 7.5 m -99.44 131.39 45.48 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.427 -0.806 . . . . 73.53 109.648 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.664 HG11 HD21 ' B' ' 126' ' ' LEU . 72.4 t -120.05 133.14 67.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 123.758 0.823 . . . . 65.34 110.042 176.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 72.6 m -110.76 147.35 34.63 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 108.355 -0.98 . . . . 65.31 108.355 167.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.442 ' HB2' HG22 ' B' ' 40' ' ' VAL . . . -144.5 133.19 22.28 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.446 0.698 . . . . 62.23 109.359 173.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.463 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 16.6 m -133.98 126.38 30.15 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 123.418 0.449 . . . . 55.32 110.675 -174.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.476 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 60.4 mt -99.08 101.29 12.61 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.841 -1.17 . . . . 73.25 107.841 174.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.82 -144.82 24.33 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 115.747 -0.661 . . . . 74.43 111.54 -173.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -82.41 2.36 32.91 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.017 0.927 . . . . 71.43 112.652 -178.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -123.34 158.83 30.18 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.638 0.775 . . . . 70.34 110.354 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 92.4 m -81.35 126.16 31.26 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.683 0.793 . . . . 63.43 110.689 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.468 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -77.67 -57.85 3.59 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 124.321 1.049 . . . . 71.43 108.96 174.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -143.99 162.41 36.26 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 122.249 1.023 . . . . 73.34 111.937 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.4 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 84.4 mt -126.76 147.5 49.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 112.886 -1.961 . . . . 65.03 106.554 171.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 32.5 t -149.45 150.85 33.01 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.006 -1.109 . . . . 53.5 108.006 174.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 35.7 tt0 -161.84 125.15 3.1 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.207 -1.034 . . . . 74.41 108.207 178.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 84.6 t -122.94 146.6 27.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.542 -0.911 . . . . 63.01 108.542 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -117.72 107.53 14.29 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 108.012 -1.107 . . . . 73.33 108.012 169.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -99.43 100.62 11.69 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.224 -1.028 . . . . 72.12 108.224 175.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -96.22 162.2 22.67 Favored Glycine 0 C--N 1.336 0.55 0 O-C-N 123.785 0.678 . . . . 53.34 111.599 177.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.9 131.98 2.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.695 -0.288 . . . . 64.32 112.642 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 47.0 mt -85.54 115.03 26.41 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 N-CA-C 107.612 -1.255 . . . . 65.24 107.612 171.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -127.32 140.95 51.85 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.832 0.853 . . . . 60.2 109.621 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 56.1 m -95.19 123.26 38.59 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.381 0.672 . . . . 75.34 110.191 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.727 HG22 HD11 ' B' ' 89' ' ' ILE . 2.4 mp -127.63 113.07 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 108.018 -1.104 . . . . 44.44 108.018 -178.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.82 155.46 35.84 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.176 0.59 . . . . 52.44 110.812 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.425 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 102.02 -34.15 5.93 Favored Glycine 0 N--CA 1.48 1.571 0 C-N-CA 123.786 0.707 . . . . 73.0 112.496 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.727 HD11 HG22 ' B' ' 86' ' ' ILE . 0.9 OUTLIER -80.74 167.63 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 124.509 1.124 . . . . 63.13 112.345 178.804 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.468 ' HA ' ' HB2' ' F' ' 98' ' ' ASP . 44.3 tt0 -156.59 148.98 23.37 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.819 0.848 . . . . 71.13 110.655 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.15 -134.16 12.34 Favored Glycine 0 C--N 1.356 1.673 0 C-N-CA 123.013 0.34 . . . . 70.5 113.655 172.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 23.5 m -64.64 -48.47 74.71 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.42 1.088 . . . . 44.11 110.255 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -66.28 -24.7 66.61 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 113.437 -1.711 . . . . 74.21 111.466 -170.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.8 -65.7 0.65 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.637 1.175 . . . . 73.44 112.215 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -78.52 -13.24 59.93 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.686 0.395 . . . . 42.41 111.983 -178.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -59.82 -36.07 76.03 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.286 0.634 . . . . 75.32 110.402 168.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.4 t -65.16 -55.43 18.68 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 123.215 0.606 . . . . 74.12 111.524 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.619 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.6 pp -76.49 -18.25 58.86 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 112.646 0.61 . . . . 75.3 112.646 -177.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.93 -19.6 30.8 Favored Glycine 0 C--N 1.348 1.239 0 CA-C-O 119.766 -0.463 . . . . 52.03 113.861 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.72 -51.94 1.06 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 117.324 0.562 . . . . 52.22 111.49 -173.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -70.17 -40.15 74.87 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.414 0.686 . . . . 71.51 111.244 -175.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.619 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 81.8 m -70.99 -48.83 13.64 Favored Pre-proline 0 CA--C 1.56 1.36 0 CA-C-O 118.443 -0.789 . . . . 72.23 112.086 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 84.2 Cg_exo -54.14 -29.12 54.53 Favored 'Trans proline' 0 C--N 1.393 2.906 0 C-N-CA 122.49 2.127 . . . . 62.54 114.029 169.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -64.75 -33.31 75.68 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.4 0.68 . . . . 71.21 111.488 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.425 HG23 ' NH2' ' D' ' 111' ' ' ARG . 65.0 mt -72.89 -39.12 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.772 0.829 . . . . 75.04 110.122 175.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 71.2 mt -75.33 -34.18 61.19 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 114.737 -1.119 . . . . 64.33 111.722 -174.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -57.73 -47.34 99.11 Favored Pre-proline 0 N--CA 1.487 1.377 0 CA-C-O 117.559 -1.21 . . . . 62.11 113.776 -171.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -54.94 -35.93 90.78 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.21 1.94 . . . . 43.54 113.299 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.507 ' CD1' HG21 ' B' ' 16' ' ' ILE . 5.0 m-30 -76.03 -40.43 53.47 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.827 -0.624 . . . . 75.04 110.364 -176.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.04 -42.76 99.83 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.486 -0.779 . . . . 54.2 110.257 174.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 28.4 ttt-85 -60.47 -49.61 76.89 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.075 1.35 . . . . 74.1 110.819 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -69.32 -31.5 70.0 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.885 0.741 . . . . 74.52 109.998 -176.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.533 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.9 t -68.51 -40.54 80.78 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 122.915 0.486 . . . . 54.41 110.316 177.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.501 HD13 HG23 ' B' ' 64' ' ' VAL . 81.8 mt -62.37 -54.82 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.63 0.772 . . . . 74.31 110.128 174.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.9 m -61.18 -27.95 68.78 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 123.916 0.76 . . . . 73.02 111.068 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.3 t -64.92 -53.27 49.12 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 123.208 0.603 . . . . 50.1 109.555 173.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.533 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.1 mmt -65.92 -33.8 76.66 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.27 0.628 . . . . 73.14 111.573 -175.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 78.2 t -68.3 -41.72 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.732 1.213 . . . . 61.12 110.604 176.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 39.0 t -67.11 -31.15 71.43 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.227 -0.897 . . . . 72.51 110.785 175.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.525 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 82.0 mtt-85 -69.55 -37.78 77.17 Favored 'General case' 0 C--O 1.218 -0.556 0 C-N-CA 123.237 0.615 . . . . 75.41 110.001 176.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.31 -11.42 71.38 Favored Glycine 0 C--N 1.353 1.515 0 O-C-N 123.429 0.456 . . . . 64.13 112.749 170.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 10.1 m 67.93 26.93 7.36 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 125.804 1.641 . . . . 55.4 110.204 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -78.07 164.99 53.76 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-N 114.964 -1.016 . . . . 75.3 111.448 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -47.54 154.48 1.7 Allowed 'Trans proline' 0 C--N 1.393 2.911 0 C-N-CA 123.429 2.753 . . . . 72.42 114.351 171.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.652 ' HB3' ' HB3' ' F' ' 130' ' ' ALA . 0.0 OUTLIER -62.37 115.95 4.64 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.003 0.921 . . . . 53.31 111.595 -175.508 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.664 HD21 HG11 ' B' ' 64' ' ' VAL . 37.8 tp -109.57 108.13 18.46 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.546 -0.752 . . . . 72.14 109.392 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -114.35 120.51 40.63 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 107.73 -1.211 . . . . 61.13 107.73 169.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.456 HD21 HG21 ' B' ' 64' ' ' VAL . 87.9 mt -74.98 130.13 38.83 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 122.873 0.469 . . . . 64.24 110.32 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.11 136.24 90.94 Favored Pre-proline 0 CA--C 1.55 0.971 0 O-C-N 124.393 1.058 . . . . 64.45 110.77 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.03 94.23 0.08 OUTLIER 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.711 2.274 . . . . 61.33 111.907 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 19.5 m -90.61 110.44 22.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.847 0.832 . . . . 75.14 109.201 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . 0.443 ' ND2' ' HB2' ' B' ' 135' ' ' ALA . 13.2 p-10 -85.77 106.02 16.71 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.542 -0.91 . . . . 74.11 108.542 174.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.459 ' HD1' HD21 ' F' ' 111' ' ' LEU . 15.0 m-85 -58.51 -33.28 69.66 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.116 -1.402 . . . . 72.2 109.843 176.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -56.36 -36.39 68.76 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 113.419 -1.719 . . . . 64.5 111.791 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.443 ' HB2' ' ND2' ' B' ' 132' ' ' ASN . . . -57.88 -35.31 70.81 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.951 0.9 . . . . 45.42 112.183 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.401 HD11 ' HB2' ' F' ' 120' ' ' TYR . 3.5 mm? -64.26 -49.16 72.99 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 123.761 0.663 . . . . 61.12 109.612 175.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -71.1 -23.39 62.1 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.368 0.667 . . . . 73.21 112.611 -177.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . 0.481 ' HG2' ' NE2' ' B' ' 143' ' ' GLN . 60.7 mtt -65.34 -37.39 86.92 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.638 0.775 . . . . 73.04 111.298 177.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -106.53 -31.93 8.3 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.504 -0.771 . . . . 52.54 111.314 -167.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -76.46 -48.6 19.07 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.287 0.635 . . . . 52.41 109.794 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 6.4 mp -89.91 -7.68 53.6 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.783 0.433 . . . . 61.22 111.051 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 60.11 123.74 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 125.202 1.401 . . . . 52.44 112.876 -177.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . 0.481 ' NE2' ' HG2' ' B' ' 138' ' ' MET . 25.0 mt-30 -113.53 -65.4 1.19 Allowed 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.661 -0.866 . . . . 71.32 108.661 170.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 55.7 86.27 0.06 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.65 1.18 . . . . 72.44 109.602 -178.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.0 -23.47 64.11 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.567 0.747 . . . . 73.45 112.953 -171.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.23 24.49 54.43 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-O 119.735 -0.481 . . . . 62.23 112.746 -174.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 64.48 -78.46 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.972 1.309 . . . . 63.35 110.642 -175.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.17 7.53 2.24 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-O 119.437 -0.646 . . . . 73.34 112.906 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 7.7 m 59.79 81.94 0.16 Allowed 'General case' 0 C--N 1.357 0.922 0 C-N-CA 124.536 1.135 . . . . 61.04 110.757 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -79.47 156.82 27.67 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.329 0.652 . . . . 75.43 110.824 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -145.57 -176.79 5.26 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.059 0.944 . . . . 74.11 109.37 178.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . 0.73 ' HB3' ' HB3' ' D' ' 90' ' ' GLU . 5.0 p80 -155.85 86.15 1.04 Allowed 'General case' 0 C--N 1.355 0.806 0 CA-C-O 121.536 0.684 . . . . 72.14 111.546 174.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -75.29 -45.46 39.72 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.955 -0.757 . . . . 74.22 108.955 165.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -105.99 172.71 6.66 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.641 1.176 . . . . 73.51 110.885 -173.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' E' ' 99' ' ' ALA . . . . . . . . 0 C--O 1.248 1.014 0 C-N-CA 124.171 0.988 . . . . 75.15 109.45 -177.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.82 0.343 . . . . 74.3 110.144 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . 0.473 ' HB3' ' HG3' ' E' ' 136' ' ' LYS . 73.5 m -147.12 170.87 16.27 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.445 1.098 . . . . 71.53 109.24 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -66.19 88.42 0.12 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 108.739 -0.837 . . . . 75.11 108.739 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -136.08 88.88 2.43 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.825 -1.079 . . . . 65.15 108.894 -170.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -166.66 137.5 3.32 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.658 0.783 . . . . 74.11 109.094 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -141.64 169.51 17.46 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.223 1.009 . . . . 70.43 108.519 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 46.1 m -46.26 -44.04 16.07 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.541 1.137 . . . . 74.44 111.435 174.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -161.85 158.48 25.57 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.415 -1.266 . . . . 73.44 108.245 173.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 20.7 ttt 64.94 111.87 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.01 1.324 . . . . 61.34 110.894 -173.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 23.3 m -101.26 79.05 1.95 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.262 1.025 . . . . 54.42 108.461 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -99.07 130.45 45.4 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.325 -0.991 . . . . 61.53 108.325 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.482 HE21 ' HB ' ' E' ' 135' ' ' VAL . 60.7 tp60 -150.3 126.05 10.37 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 109.045 -0.724 . . . . 75.2 109.045 174.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.628 ' HB ' HG21 ' E' ' 135' ' ' VAL . 59.5 mt -64.79 134.69 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 107.88 -1.156 . . . . 75.23 107.88 168.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.423 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 31.5 mm-40 -102.73 -39.22 7.12 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.847 0.459 . . . . 74.33 109.822 176.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -178.6 142.31 0.23 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.506 1.123 . . . . 74.32 109.448 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 35.1 mm -119.84 117.8 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 108.128 -1.064 . . . . 72.33 108.128 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.559 ' HB3' HG23 ' D' ' 122' ' ' THR . 41.2 p90 -145.4 162.03 38.26 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.489 0.661 . . . . 74.02 112.031 -167.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.4 p -93.72 115.36 27.79 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.112 -0.949 . . . . 61.32 109.086 175.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.416 ' HG2' ' HE2' ' C' ' 17' ' ' TYR . 77.6 mttt -77.59 -45.31 25.62 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.477 -0.935 . . . . 75.25 108.477 170.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.675 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 26.4 t70 -131.08 135.65 47.72 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 113.662 -1.608 . . . . 64.32 109.435 -171.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 77.5 mt -138.09 142.02 36.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 106.423 -1.695 . . . . 73.14 106.423 174.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.0 t -154.32 145.62 22.96 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.401 0.619 . . . . 71.13 110.326 177.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -149.68 126.03 10.81 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 106.745 -1.576 . . . . 64.13 106.745 170.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -131.63 116.54 17.5 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 123.478 0.711 . . . . 73.33 109.521 -175.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.54 78.34 62.59 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 124.021 0.928 . . . . 62.14 108.502 172.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.73 -25.99 39.4 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 122.431 2.087 . . . . 62.24 111.037 174.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -97.67 14.04 28.17 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.127 0.971 . . . . 72.42 110.937 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.413 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -49.65 -55.15 24.74 Favored Pre-proline 0 N--CA 1.491 1.602 0 CA-C-O 117.96 -1.019 . . . . 43.43 113.502 -172.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.413 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 37.5 Cg_exo -59.13 -43.79 39.35 Favored 'Trans proline' 0 C--N 1.391 2.815 0 C-N-CA 121.836 1.691 . . . . 62.14 112.077 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -68.78 -32.94 73.05 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.271 -1.331 . . . . 73.03 112.649 -174.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.607 HG21 ' HA ' ' C' ' 73' ' ' ALA . 12.9 p -80.81 -27.19 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 N-CA-C 112.146 0.425 . . . . 41.22 112.146 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -64.86 -27.73 69.07 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 122.893 0.477 . . . . 64.52 111.834 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -88.86 8.37 29.54 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.619 0.767 . . . . 74.14 111.504 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.464 ' HG2' HD13 ' C' ' 68' ' ' LEU . 1.0 OUTLIER -114.69 152.16 32.44 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.014 0.926 . . . . 75.3 110.258 -179.467 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -62.77 128.65 36.91 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.238 0.615 . . . . 64.53 111.12 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 65.8 t-105 -85.05 95.86 9.23 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.298 -0.865 . . . . 74.35 111.121 -174.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . 0.456 ' H ' HD22 ' C' ' 68' ' ' LEU . 34.5 tt0 -144.43 75.44 15.05 Favored Pre-proline 0 CA--C 1.549 0.918 0 N-CA-C 108.132 -1.062 . . . . 53.43 108.132 172.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -87.52 162.35 8.06 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.602 2.201 . . . . 74.43 112.686 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -90.08 108.1 19.53 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 114.407 -1.27 . . . . 72.22 107.692 171.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.45 96.99 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 109.078 -0.712 . . . . 63.23 109.078 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.684 ' HE3' ' HA3' ' F' ' 140' ' ' GLY . 0.8 OUTLIER -101.48 101.98 12.66 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.021 -1.103 . . . . 53.12 108.021 176.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.554 HD21 HG13 ' C' ' 62' ' ' VAL . 1.9 tt -103.65 127.44 51.1 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 107.3 -1.37 . . . . 74.23 107.3 177.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -119.56 117.85 29.46 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.575 0.75 . . . . 53.45 109.008 174.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -99.97 109.27 21.62 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.725 -0.843 . . . . 72.21 108.725 173.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -121.65 121.04 36.46 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 107.869 -1.16 . . . . 75.45 107.869 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.1 t -124.91 148.01 48.54 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.146 0.498 . . . . 73.43 110.309 -176.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.65 151.07 35.56 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.144 0.977 . . . . 72.14 108.733 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 14.4 m -123.1 150.41 43.22 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 123.715 0.806 . . . . 64.0 109.386 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 25.8 t -147.64 126.4 12.64 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.481 0.712 . . . . 70.34 109.319 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -76.86 117.56 18.59 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 109.206 -0.664 . . . . 74.34 109.206 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.532 HD11 ' HB2' ' C' ' 57' ' ' GLU . 50.3 mt -84.1 -43.64 14.84 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.618 0.767 . . . . 71.04 110.413 -175.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.47 -176.14 4.92 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.985 -1.007 . . . . 74.24 109.815 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.71 109.86 2.17 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.967 0.907 . . . . 71.41 110.4 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 65.27 19.98 11.79 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 124.923 1.289 . . . . 73.54 112.385 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 57.7 t -113.25 110.01 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 N-CA-C 108.362 -0.977 . . . . 71.14 108.362 172.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -112.4 124.89 53.5 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.438 1.095 . . . . 70.14 109.794 -177.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.532 ' HB2' HD11 ' C' ' 51' ' ' LEU . 43.1 tt0 -91.24 142.66 27.48 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.759 -0.83 . . . . 75.24 108.759 170.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 82.8 t -124.81 139.4 51.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.995 -1.113 . . . . 53.22 107.995 167.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.06 130.07 72.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.975 -0.75 . . . . 74.34 108.975 173.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.541 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -110.48 111.73 23.17 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 107.218 -1.401 . . . . 72.12 107.218 178.545 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -90.67 107.24 19.04 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.303 -0.999 . . . . 52.33 108.303 173.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.554 HG13 HD21 ' C' ' 42' ' ' LEU . 38.9 t -101.32 118.89 48.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 107.949 -1.13 . . . . 74.34 107.949 173.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 26.0 m -118.7 137.48 53.29 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.984 -0.747 . . . . 61.14 108.984 -175.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.458 HG23 HD13 ' C' ' 114' ' ' ILE . 84.8 t -132.02 120.39 43.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 124.02 0.928 . . . . 75.14 109.046 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 10.0 m -113.17 130.31 56.25 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.349 -0.982 . . . . 60.02 108.349 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.88 115.71 24.36 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.16 -1.052 . . . . 73.21 108.16 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 54.5 m -134.02 130.21 37.22 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.431 0.457 . . . . 54.42 110.342 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.464 HD13 ' HG2' ' C' ' 34' ' ' LYS . 39.2 mt -85.84 39.34 0.8 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.699 1.2 . . . . 75.55 109.687 179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.43 -102.48 2.2 Favored Glycine 0 C--N 1.348 1.24 0 N-CA-C 110.19 -1.164 . . . . 64.21 110.19 -170.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -89.79 -30.72 17.78 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.753 0.821 . . . . 72.43 110.397 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . 0.441 ' HG2' HD12 ' C' ' 68' ' ' LEU . 4.3 tp10 -69.7 121.36 17.03 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 123.95 0.9 . . . . 74.33 109.788 176.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.8 m -81.19 117.28 21.59 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.262 -1.014 . . . . 61.54 108.262 165.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.607 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.91 -50.8 21.48 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 108.654 -0.869 . . . . 73.51 108.654 176.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . 0.488 ' HZ ' HD21 ' C' ' 126' ' ' LEU . 31.3 p90 -164.86 164.49 20.91 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.284 -1.326 . . . . 62.52 110.723 177.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.42 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.0 tm? -121.62 144.57 48.67 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 105.965 -1.865 . . . . 61.15 105.965 164.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.527 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.9 t -149.13 137.73 21.07 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.085 -1.08 . . . . 63.34 108.085 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -155.69 132.74 10.7 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.892 -0.41 . . . . 62.34 109.892 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 92.8 t -126.02 135.93 62.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.122 0.969 . . . . 64.51 109.037 174.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.675 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.7 mt-30 -109.99 96.2 6.08 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.069 0.948 . . . . 73.34 108.925 171.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -80.66 102.31 9.78 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.501 -1.227 . . . . 51.35 109.189 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.41 148.85 25.51 Favored Glycine 0 C--N 1.342 0.898 0 N-CA-C 111.181 -0.767 . . . . 43.24 111.181 174.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.74 119.23 1.04 Allowed Glycine 0 N--CA 1.465 0.591 0 CA-C-N 117.419 0.609 . . . . 42.14 111.98 -176.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.446 HG12 ' HE1' ' C' ' 17' ' ' TYR . 22.8 mm -86.75 129.12 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.024 -0.732 . . . . 72.43 109.024 179.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -133.41 126.64 31.69 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.912 0.885 . . . . 74.04 109.227 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 10.2 p -87.49 101.67 13.82 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.881 -1.155 . . . . 52.21 107.881 168.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 7.7 mt -117.27 124.87 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.648 0.779 . . . . 75.5 110.317 -174.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.442 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -142.5 171.31 14.23 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.098 0.959 . . . . 64.23 109.2 177.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.21 -25.36 12.63 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-O 119.701 -0.499 . . . . 62.14 114.091 174.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.569 HD11 ' HE3' ' C' ' 94' ' ' MET . 37.7 pt -106.63 164.09 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 123.366 0.667 . . . . 72.33 111.393 -178.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -156.04 154.84 31.65 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.639 0.776 . . . . 73.24 110.127 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.41 -117.85 8.72 Favored Glycine 0 C--N 1.351 1.383 0 O-C-N 123.724 0.64 . . . . 61.11 113.411 169.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 17.7 m -62.19 -38.36 88.83 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.006 0.922 . . . . 73.42 111.134 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -67.43 -51.25 53.95 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.947 0.899 . . . . 74.33 111.239 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.569 ' HE3' HD11 ' C' ' 89' ' ' ILE . 5.3 tpt -55.55 -50.72 69.29 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 124.176 0.923 . . . . 62.12 111.431 174.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.32 -43.36 92.69 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.377 0.671 . . . . 74.51 111.801 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -70.93 -36.49 72.65 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.684 0.794 . . . . 75.31 111.288 -175.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -64.23 -36.79 85.23 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.601 -0.727 . . . . 61.33 110.394 177.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.505 ' HG ' ' HE2' ' C' ' 94' ' ' MET . 91.7 mt -83.65 -37.56 22.66 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.295 1.038 . . . . 63.35 112.752 -176.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.87 -13.62 36.66 Favored Glycine 0 N--CA 1.475 1.279 0 N-CA-C 113.996 0.359 . . . . 72.41 113.996 -168.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.17 -54.32 1.19 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 117.014 0.407 . . . . 50.14 111.488 -175.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -70.72 -52.05 23.42 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 116.251 -0.431 . . . . 75.42 111.781 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.436 ' O ' HD13 ' C' ' 106' ' ' LEU . 96.9 m -64.18 -48.67 76.33 Favored Pre-proline 0 CA--C 1.559 1.309 0 CA-C-O 118.101 -0.952 . . . . 42.4 112.487 -177.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.541 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 50.4 Cg_exo -57.46 -27.3 75.59 Favored 'Trans proline' 0 C--N 1.393 2.891 0 C-N-CA 122.228 1.952 . . . . 61.14 113.373 175.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.43 -38.02 80.81 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.413 0.685 . . . . 73.12 109.878 177.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.47 HD12 ' NH1' ' A' ' 111' ' ' ARG . 47.3 mm -72.47 -34.28 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.684 0.794 . . . . 74.14 110.338 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.436 HD13 ' O ' ' C' ' 102' ' ' CYS . 7.3 mp -80.52 -24.19 39.53 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.906 0.883 . . . . 53.32 112.259 -177.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -58.86 -50.73 86.4 Favored Pre-proline 0 N--CA 1.481 1.081 0 CA-C-O 117.335 -1.317 . . . . 75.0 113.968 -172.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -59.53 -37.34 89.49 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 121.968 1.779 . . . . 74.11 113.206 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.404 ' HE2' HG21 ' A' ' 115' ' ' THR . 58.6 m-85 -65.2 -47.27 77.49 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.643 0.777 . . . . 64.35 110.392 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.96 -34.25 77.97 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 114.48 -1.236 . . . . 60.14 111.329 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -67.3 -50.19 61.24 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.205 1.402 . . . . 73.41 110.701 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -65.76 -35.26 80.21 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 123.805 0.69 . . . . 74.31 109.696 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 18.9 t -67.83 -29.49 68.65 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.305 0.642 . . . . 41.41 111.964 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.527 HG23 ' SG ' ' C' ' 76' ' ' CYS . 65.4 mt -79.07 -53.51 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 123.15 0.58 . . . . 74.13 110.678 174.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 17.8 m -61.91 -28.36 69.47 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 123.283 0.633 . . . . 71.31 111.162 -175.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.6 t -65.52 -50.07 66.59 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.676 0.791 . . . . 74.1 109.568 171.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.495 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.69 -40.35 87.57 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.464 1.105 . . . . 65.43 112.519 -179.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.42 -42.61 95.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.752 0.821 . . . . 71.1 109.995 175.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 39.7 t -71.45 -27.6 63.38 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.082 -0.963 . . . . 71.13 111.776 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' C' ' 116' ' ' SER . 79.9 mtt-85 -72.88 -41.83 64.26 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.002 -0.74 . . . . 73.13 109.002 176.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.88 -3.33 63.68 Favored Glycine 0 C--N 1.357 1.733 0 CA-C-N 115.419 -0.81 . . . . 65.32 112.901 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 26.1 p 62.32 30.49 17.47 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.632 1.973 . . . . 63.43 112.823 172.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -83.75 145.84 48.19 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 108.504 -0.924 . . . . 53.42 108.504 169.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -46.01 140.51 10.26 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 124.013 3.142 . . . . 64.34 114.898 176.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.474 ' HB2' ' HD1' ' F' ' 131' ' ' TRP . 24.0 mm-40 -60.24 134.6 57.21 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.659 1.184 . . . . 72.0 113.116 -174.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.488 HD21 ' HZ ' ' C' ' 74' ' ' PHE . 0.8 OUTLIER -141.53 98.7 3.4 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 114.791 -1.095 . . . . 74.53 108.567 174.429 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -91.5 102.82 15.48 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.412 -0.959 . . . . 74.25 108.412 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.467 ' H ' HD22 ' C' ' 128' ' ' LEU . 2.7 mm? -57.58 129.93 44.08 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.62 1.168 . . . . 75.12 112.498 -167.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.68 144.53 98.92 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.096 0.958 . . . . 74.14 111.6 -178.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.401 ' HG3' HD12 ' A' ' 16' ' ' ILE . 24.1 Cg_exo -62.19 123.62 12.85 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.948 2.432 . . . . 62.22 112.918 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 24.2 t -115.5 121.4 67.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 108.49 -0.929 . . . . 75.31 108.49 175.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.481 HD21 ' HB3' ' C' ' 134' ' ' ASP . 57.3 t30 -75.13 107.47 7.24 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.587 0.755 . . . . 64.1 111.276 -175.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -65.37 -18.35 65.25 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.77 0.828 . . . . 52.11 112.994 178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.481 ' HB3' HD21 ' C' ' 132' ' ' ASN . 9.9 t70 -65.52 -43.09 91.13 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.143 0.577 . . . . 71.52 109.846 172.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.09 -42.43 96.93 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.52 -0.764 . . . . 65.24 110.656 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 76.3 mt -70.64 -24.54 62.73 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 115.164 -0.925 . . . . 73.01 111.844 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -66.13 -35.8 81.45 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.26 0.624 . . . . 74.21 110.868 -178.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 59.8 mtt -57.21 -28.25 62.7 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 124.211 1.004 . . . . 65.34 112.211 -177.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -68.46 -28.31 66.92 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.893 1.277 . . . . 75.24 114.245 -176.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -158.01 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.486 0 N-CA-C 115.529 1.678 . . . . 64.05 115.529 -168.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 5.1 mp -126.97 133.7 50.54 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.386 -0.968 . . . . 71.15 108.386 175.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.657 ' HG3' ' H ' ' C' ' 144' ' ' GLN . 55.5 tp60 -170.61 136.53 1.26 Allowed 'General case' 0 N--CA 1.47 0.569 0 O-C-N 124.094 0.871 . . . . 73.41 109.25 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -79.81 -7.39 58.65 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.732 0.813 . . . . 75.21 111.135 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . 0.657 ' H ' ' HG3' ' C' ' 142' ' ' GLN . 9.2 tp-100 -106.08 122.79 46.88 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.295 1.038 . . . . 65.23 108.56 170.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.52 -35.82 81.19 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.333 0.587 . . . . 71.24 109.958 174.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 128.06 -152.66 19.12 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 114.857 -1.065 . . . . 74.42 110.72 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -161.38 -55.99 0.05 OUTLIER 'General case' 0 C--O 1.24 0.575 0 N-CA-C 109.103 -0.702 . . . . 71.54 109.103 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 76.61 160.79 10.94 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 114.952 -1.022 . . . . 54.5 111.812 -171.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 7.8 t -162.08 142.77 10.41 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.308 0.643 . . . . 74.54 109.702 177.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -90.83 67.17 6.15 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 107.472 -1.307 . . . . 73.13 107.472 169.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -92.81 115.61 28.27 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.394 -0.821 . . . . 74.02 109.073 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . 0.468 ' CE1' ' SD ' ' A' ' 138' ' ' MET . 11.1 p80 -171.9 139.65 1.17 Allowed 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.44 -0.948 . . . . 74.43 108.44 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . 0.436 ' HB3' ' O ' ' E' ' 144' ' ' VAL . 3.7 tp-100 -161.95 143.53 11.06 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.693 -0.484 . . . . 64.52 109.693 177.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -108.02 163.92 12.73 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.101 0.56 . . . . 73.43 110.383 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.844 0 N-CA-C 108.0 -1.111 . . . . 72.35 108.0 171.48 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 55.6 ttm . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 110.209 -0.293 . . . . 63.24 110.209 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 34.3 t -159.04 -37.56 0.06 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.405 0.682 . . . . 34.43 110.575 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 65.44 160.08 0.12 Allowed 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 124.819 1.248 . . . . 61.41 112.855 178.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -169.54 166.3 10.12 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.405 0.682 . . . . 72.11 111.22 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -96.06 12.11 31.77 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.662 0.785 . . . . 73.33 111.57 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -64.26 122.1 15.84 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.119 0.568 . . . . 70.14 111.475 -176.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 13.3 t -76.74 -21.69 54.91 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.082 0.953 . . . . 72.15 111.361 -177.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -68.73 144.36 54.41 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 107.636 -1.246 . . . . 74.23 107.636 172.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.641 ' HG2' HG13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -27.3 122.6 0.09 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 126.147 1.779 . . . . 73.24 114.28 -167.842 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 13.0 t -120.81 138.58 53.97 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.15 0.58 . . . . 74.41 109.836 -176.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.431 ' HD2' HG22 ' D' ' 86' ' ' ILE . 84.9 t80 -134.84 101.93 5.08 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 107.861 -1.163 . . . . 52.41 107.861 176.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -127.5 120.07 27.46 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.421 -0.955 . . . . 55.43 108.421 -177.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 10.5 mt -80.25 133.01 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 109.341 -0.614 . . . . 63.5 109.341 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -89.82 -40.58 12.36 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.829 0.852 . . . . 54.45 110.805 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -167.69 137.77 2.76 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.351 -0.386 . . . . 73.24 110.385 -175.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.9 mp -110.17 137.26 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 107.048 -1.464 . . . . 61.14 107.048 169.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -164.31 142.49 7.04 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.372 0.533 . . . . 71.41 111.457 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 67.9 p -77.95 121.0 23.6 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.866 -0.606 . . . . 73.5 109.749 176.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.518 ' HD2' ' HA3' ' D' ' 81' ' ' GLY . 34.9 mtpt -96.08 -13.89 23.31 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.297 0.639 . . . . 71.21 109.909 -178.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.4 t70 -163.79 139.7 6.51 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.352 1.061 . . . . 71.41 108.915 177.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.495 HG21 ' HE2' ' C' ' 117' ' ' MET . 76.8 mt -141.9 147.41 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.614 1.166 . . . . 55.14 108.488 177.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 74.3 m -148.85 142.01 24.99 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.0 1.72 . . . . 72.41 108.155 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 83.0 t80 -145.86 113.53 6.38 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 105.012 -2.218 . . . . 73.03 105.012 166.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -131.07 110.04 10.92 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.79 0.436 . . . . 63.41 110.254 -168.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.35 82.06 11.5 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 107.92 -1.141 . . . . 63.24 107.92 176.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.74 -17.6 17.85 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.57 2.18 . . . . 71.23 112.361 -175.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.422 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 76.8 m-20 -107.48 9.08 29.69 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.84 0.856 . . . . 72.53 110.735 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.412 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -33.31 -67.82 0.18 Allowed Pre-proline 0 CA--C 1.572 1.808 0 N-CA-C 115.976 1.843 . . . . 51.43 115.976 -165.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.79 -15.19 15.26 Favored 'Trans proline' 0 C--N 1.385 2.495 0 CA-C-N 124.077 2.492 . . . . 65.24 114.014 -176.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.422 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 7.2 t-160 -72.99 -40.99 64.79 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.652 1.181 . . . . 71.23 109.399 173.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.568 HG22 HD12 ' D' ' 68' ' ' LEU . 8.7 p -86.08 -19.69 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 CA-C-N 115.018 -0.992 . . . . 63.43 111.473 -175.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -67.66 -19.66 65.22 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 117.837 0.29 . . . . 75.21 111.658 176.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -67.28 -14.14 62.64 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.711 0.804 . . . . 70.3 110.832 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -103.22 69.1 1.0 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.958 1.303 . . . . 72.22 109.255 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -84.07 74.6 10.25 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-O 122.314 1.054 . . . . 72.25 110.489 -176.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 4.7 p90 -142.8 -165.05 1.97 Allowed 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.587 -0.733 . . . . 73.41 109.311 175.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -64.5 108.51 1.99 Allowed Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 124.163 0.985 . . . . 72.44 111.027 177.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -72.24 126.89 12.12 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.168 1.912 . . . . 51.53 110.747 176.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.91 111.83 11.69 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.915 -1.142 . . . . 74.22 107.915 176.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.676 HG13 HG13 ' D' ' 64' ' ' VAL . 65.9 t -108.61 137.01 42.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 C-N-CA 123.846 0.858 . . . . 65.44 108.911 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 29.7 mmtm -126.85 134.47 50.51 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.456 0.702 . . . . 74.4 109.796 170.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.733 HD11 HG13 ' D' ' 62' ' ' VAL . 20.7 tp -96.68 147.68 23.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.255 -0.884 . . . . 63.04 109.971 -175.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.549 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 19.9 t70 -139.98 112.48 7.86 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.83 -1.174 . . . . 73.24 107.83 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.597 ' HB2' ' HB2' ' E' ' 111' ' ' LEU . 96.0 mt -115.08 132.73 56.51 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.391 0.677 . . . . 73.12 109.817 -172.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.577 ' HB2' ' HB3' ' D' ' 61' ' ' ARG . 3.5 m-20 -132.49 151.28 51.96 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.816 1.246 . . . . 75.43 108.658 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . 0.414 HG21 ' O ' ' D' ' 99' ' ' GLY . 20.5 p -107.88 146.48 32.26 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.368 0.667 . . . . 71.43 110.47 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.639 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.37 163.39 37.88 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.126 0.97 . . . . 61.21 109.217 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 61.6 p -167.41 -171.8 1.79 Allowed 'General case' 0 CA--C 1.542 0.642 0 O-C-N 123.798 0.686 . . . . 73.44 110.917 -173.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' D' ' 57' ' ' GLU . 49.0 m -147.14 144.06 28.72 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.814 1.245 . . . . 52.44 108.331 174.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . 0.483 ' HA ' HD23 ' E' ' 102' ' ' LEU . 23.8 pt20 -79.19 -164.97 0.69 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.446 1.098 . . . . 71.11 111.722 -174.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 tm? 83.72 112.02 0.06 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 125.798 1.639 . . . . 72.41 109.308 -176.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' E' ' 100' ' ' LEU . . . -95.41 110.22 22.28 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.734 0.813 . . . . 53.31 112.415 -171.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -161.63 23.75 0.12 Allowed 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 120.731 0.3 . . . . 61.14 110.889 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 65.68 7.68 4.66 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 124.376 1.07 . . . . 73.25 112.015 -171.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.495 HG21 ' HA3' ' E' ' 92' ' ' GLY . 11.7 t -113.13 99.2 8.17 Favored 'Isoleucine or valine' 0 C--N 1.349 0.571 0 N-CA-C 107.422 -1.325 . . . . 63.31 107.422 177.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -127.84 131.79 49.46 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 120.596 0.236 . . . . 73.53 110.443 -173.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.461 ' HB3' ' HB2' ' D' ' 49' ' ' SER . 35.6 tp10 -87.6 138.49 31.42 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.651 -0.87 . . . . 74.11 108.651 174.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 78.7 t -136.25 138.33 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 C-N-CA 124.846 1.258 . . . . 63.1 107.909 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.639 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 21.5 t -132.94 120.24 40.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.424 -0.954 . . . . 53.12 108.424 -178.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.539 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -93.2 124.84 37.46 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.112 -1.07 . . . . 73.02 108.112 174.149 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.591 ' HG2' ' HG2' ' D' ' 79' ' ' GLN . 1.5 tmm_? -100.27 104.65 16.14 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.095 -1.076 . . . . 62.02 108.095 174.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.733 HG13 HD11 ' D' ' 42' ' ' LEU . 82.8 t -103.1 121.5 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 123.923 0.889 . . . . 71.14 108.734 175.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.549 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 60.3 m -120.82 133.69 55.31 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.617 0.722 . . . . 73.31 109.47 175.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.676 HG13 HG13 ' D' ' 40' ' ' VAL . 34.5 t -110.26 119.69 59.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 114.457 -1.247 . . . . 74.42 108.662 174.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 15.6 m -109.04 91.86 3.81 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.21 -1.404 . . . . 63.24 107.21 171.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.63 147.19 25.07 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.513 -0.767 . . . . 71.41 109.372 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.423 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 53.8 p -156.28 132.86 10.2 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 123.513 0.508 . . . . 63.41 111.092 -173.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.568 HD12 HG22 ' D' ' 31' ' ' VAL . 21.5 mt -104.62 112.22 25.22 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.077 -1.083 . . . . 52.32 108.077 170.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.34 -115.94 4.41 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.926 -0.579 . . . . 72.42 111.737 -172.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -115.91 4.53 13.86 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 117.381 0.591 . . . . 65.34 111.388 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -114.25 154.86 27.2 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.49 0.316 . . . . 70.34 110.656 -175.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 95.3 m -63.12 120.06 10.74 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 123.975 0.797 . . . . 73.24 111.144 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.548 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -76.18 -67.37 0.69 Allowed 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.02 -1.474 . . . . 52.12 107.02 167.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . 0.402 ' HD1' ' HB2' ' D' ' 76' ' ' CYS . 53.2 p90 -154.23 142.95 20.9 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.997 -0.547 . . . . 71.41 110.997 176.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 57.8 mt -106.12 107.95 19.21 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 107.249 -1.389 . . . . 71.1 107.249 170.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.612 ' SG ' HG23 ' D' ' 114' ' ' ILE . 17.5 t -118.45 107.78 14.22 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.023 -0.732 . . . . 41.04 109.023 -172.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -128.9 131.37 47.58 Favored 'General case' 0 C--O 1.22 -0.487 0 C-N-CA 123.265 0.626 . . . . 74.52 110.088 -171.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . 0.446 HG21 ' HB3' ' D' ' 113' ' ' CYS . 86.3 t -134.43 116.18 21.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 123.734 0.814 . . . . 74.13 108.928 178.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.604 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 78.6 mt-30 -88.88 84.43 6.65 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.177 -1.045 . . . . 71.45 108.177 171.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -82.32 108.05 15.46 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 113.998 -1.456 . . . . 64.0 109.52 -176.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.518 ' HA3' ' HD2' ' D' ' 19' ' ' LYS . . . -99.61 172.95 25.45 Favored Glycine 0 C--O 1.241 0.558 0 O-C-N 123.374 0.421 . . . . 34.22 112.893 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.63 144.26 6.53 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.513 -0.344 . . . . 51.43 112.865 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 54.7 mt -90.11 128.08 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.019 -1.104 . . . . 74.42 108.019 172.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -124.57 140.27 53.1 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.914 0.886 . . . . 75.55 110.771 -175.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 7.1 m -98.83 98.73 9.79 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.387 1.075 . . . . 62.55 108.92 172.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.664 HG12 HD21 ' D' ' 98' ' ' LEU . 2.6 pp -115.96 132.87 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 109.26 -0.645 . . . . 75.2 109.26 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.92 168.19 19.71 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.234 1.014 . . . . 51.11 109.404 -177.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 90.74 -21.55 32.62 Favored Glycine 0 N--CA 1.477 1.381 0 C-N-CA 123.221 0.439 . . . . 42.32 113.91 175.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.641 HG13 ' HG2' ' D' ' 9' ' ' MET . 1.0 OUTLIER -101.03 155.85 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.864 0.865 . . . . 65.41 109.374 172.517 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.73 ' HB3' ' HB3' ' B' ' 152' ' ' HIS . 30.7 mt-10 -144.4 175.11 10.35 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.286 1.034 . . . . 63.42 110.457 -176.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.26 -140.56 23.05 Favored Glycine 0 C--N 1.357 1.732 0 N-CA-C 114.68 0.632 . . . . 72.11 114.68 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 86.2 m -79.79 -38.35 33.27 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.974 0.91 . . . . 73.33 111.046 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -60.72 -36.37 78.68 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.365 1.066 . . . . 53.54 111.198 -174.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.627 ' HB2' HD11 ' E' ' 97' ' ' ILE . 0.0 OUTLIER -68.07 -37.53 81.37 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.973 0.731 . . . . 73.2 112.973 -172.219 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.58 -25.35 33.36 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.383 0.673 . . . . 71.23 109.927 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -66.89 -27.39 67.47 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.099 0.96 . . . . 73.33 110.302 174.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 94.8 m -62.21 -42.83 99.65 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.383 0.673 . . . . 73.42 111.387 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.664 HD21 HG12 ' D' ' 86' ' ' ILE . 86.9 mt -70.71 -22.24 62.47 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.586 0.355 . . . . 73.0 111.361 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . 0.414 ' O ' HG21 ' D' ' 46' ' ' THR . . . -102.63 14.02 56.44 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-O 119.499 -0.612 . . . . 64.41 113.28 176.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.489 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -155.98 -66.11 0.11 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 118.277 1.039 . . . . 62.03 112.355 -177.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -65.43 -51.63 58.87 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.12 0.568 . . . . 75.02 111.632 -172.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.429 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 78.8 m -60.89 -47.01 96.87 Favored Pre-proline 0 CA--C 1.565 1.554 0 C-N-CA 123.772 0.829 . . . . 71.11 112.359 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.539 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.7 Cg_exo -54.32 -40.01 84.54 Favored 'Trans proline' 0 C--N 1.394 2.955 0 C-N-CA 122.388 2.059 . . . . 60.12 113.678 168.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . 0.418 ' HB2' ' HB2' ' D' ' 133' ' ' PHE . 2.6 t-20 -61.98 -33.5 74.43 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 123.458 0.703 . . . . 64.12 111.325 -178.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.404 HG13 ' CZ ' ' D' ' 11' ' ' PHE . 43.6 mm -72.85 -36.12 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.361 1.064 . . . . 72.13 110.76 175.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 91.1 mt -71.93 -19.06 61.97 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.907 -0.588 . . . . 74.42 111.629 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -65.96 -44.42 61.37 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-O 117.782 -1.104 . . . . 72.12 113.335 -173.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.89 -42.12 31.57 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 122.343 2.028 . . . . 75.04 113.964 168.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -79.52 -32.35 42.32 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.687 0.795 . . . . 64.33 111.921 -177.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.94 -44.69 65.58 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.415 0.626 . . . . 73.53 109.996 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.577 HH12 ' HB3' ' D' ' 130' ' ' PRO . 37.4 ttp180 -65.67 -35.65 81.39 Favored 'General case' 0 C--O 1.206 -1.216 0 CA-C-N 114.012 -1.449 . . . . 74.03 110.365 174.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . 0.473 ' HA ' ' CE2' ' B' ' 109' ' ' TYR . 6.1 tt0 -52.86 -51.21 61.91 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.845 0.858 . . . . 73.44 111.151 176.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.456 ' O ' ' HG3' ' D' ' 117' ' ' MET . 43.8 t -63.7 -45.04 91.82 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.527 -1.215 . . . . 75.32 110.717 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.612 HG23 ' SG ' ' D' ' 76' ' ' CYS . 31.5 mt -60.55 -64.42 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.392 0.677 . . . . 65.51 111.269 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.4 m -40.54 -46.89 2.59 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.027 1.731 . . . . 71.14 112.63 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -62.95 -48.14 80.19 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 114.867 -1.061 . . . . 72.44 110.657 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.456 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 71.6 mtm -67.24 -31.46 71.83 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.42 0.688 . . . . 64.31 112.296 -178.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.485 HG21 ' HB3' ' D' ' 126' ' ' LEU . 87.2 t -65.53 -45.06 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.765 0.826 . . . . 52.33 109.946 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 56.0 p -70.38 -33.05 70.96 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 115.289 -0.869 . . . . 44.21 110.363 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 51.8 mtt-85 -67.36 -35.07 78.63 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.872 0.869 . . . . 75.14 110.576 175.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.21 11.19 61.31 Favored Glycine 0 C--N 1.355 1.6 0 CA-C-O 119.581 -0.566 . . . . 51.22 114.082 -178.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.559 HG23 ' HB3' ' C' ' 17' ' ' TYR . 66.9 p 57.2 30.25 18.06 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 126.2 1.8 . . . . 65.13 114.073 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -97.87 149.36 35.64 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.147 0.579 . . . . 75.21 109.781 170.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -45.17 120.99 3.36 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 123.75 2.967 . . . . 74.24 112.832 169.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' E' ' 127' ' ' SER . 46.3 tt0 -48.54 122.75 5.81 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 124.539 1.149 . . . . 74.1 111.876 -174.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.485 ' HB3' HG21 ' D' ' 118' ' ' VAL . 22.5 tp -105.44 106.59 17.16 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.45 0.7 . . . . 70.11 109.598 -174.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -106.53 89.87 3.16 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.288 1.035 . . . . 73.45 108.936 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.42 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 37.6 mt -57.39 117.88 4.57 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 124.048 0.939 . . . . 75.54 110.498 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.43 123.81 78.07 Favored Pre-proline 0 CA--C 1.56 1.338 0 C-N-CA 122.679 0.391 . . . . 55.11 111.176 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.577 ' HB3' HH12 ' D' ' 111' ' ' ARG . 76.6 Cg_endo -75.54 141.31 24.97 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 122.603 2.202 . . . . 71.1 111.876 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.87 152.22 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 123.574 0.75 . . . . 63.52 109.748 -175.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -68.58 103.9 1.82 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.382 0.673 . . . . 70.31 110.391 176.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.418 ' HB2' ' HB2' ' D' ' 104' ' ' ASN . 3.7 m-30 -62.36 -24.48 67.38 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.097 0.959 . . . . 70.45 112.639 -177.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.489 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 4.5 t70 -62.28 -40.11 95.18 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.797 0.685 . . . . 73.31 109.858 -178.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.52 -34.56 70.18 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.179 -0.919 . . . . 60.23 111.539 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.405 HD22 HD23 ' E' ' 111' ' ' LEU . 10.2 mp -65.76 -47.56 74.82 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 122.925 0.49 . . . . 65.24 110.621 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -68.69 -31.19 70.12 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 124.064 0.946 . . . . 61.44 109.893 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 32.8 ttm -66.3 -41.64 89.45 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.306 1.042 . . . . 74.11 110.668 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.46 ' HB3' HE21 ' D' ' 143' ' ' GLN . 32.8 m-80 -80.08 -16.58 54.71 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.547 -0.752 . . . . 72.42 111.988 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -54.93 -39.9 69.35 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.648 0.779 . . . . 74.45 110.559 173.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.8 mp -68.12 -33.58 74.76 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 114.763 -1.108 . . . . 74.04 110.96 176.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.441 HE21 ' HA ' ' D' ' 139' ' ' ASN . 45.4 mt-30 -87.28 4.59 42.15 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.239 1.016 . . . . 34.04 112.159 -174.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . 0.46 HE21 ' HB3' ' D' ' 139' ' ' ASN . 78.0 mt-30 -120.06 95.25 4.68 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.965 0.906 . . . . 73.11 109.262 -176.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -142.69 -168.18 2.7 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.661 0.784 . . . . 74.52 110.484 -175.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.03 -18.31 63.19 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.523 1.129 . . . . 72.41 113.144 -176.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.64 9.47 43.22 Favored Glycine 0 C--N 1.352 1.465 0 O-C-N 123.396 0.435 . . . . 61.05 113.306 175.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.25 139.42 39.2 Favored 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 106.952 -1.499 . . . . 74.01 106.952 174.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . 0.414 ' HA2' ' HE2' ' E' ' 117' ' ' LYS . . . -156.67 42.01 0.55 Allowed Glycine 0 C--N 1.351 1.392 0 N-CA-C 114.339 0.496 . . . . 73.1 114.339 -174.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 13.1 t -93.71 173.37 7.72 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 117.582 0.691 . . . . 35.34 110.161 173.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -156.25 150.05 25.0 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.833 0.853 . . . . 64.13 109.575 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -169.04 175.42 5.78 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.406 0.622 . . . . 65.31 111.481 171.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -126.12 137.43 53.6 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.496 1.118 . . . . 73.51 108.039 167.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -148.82 146.27 27.91 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.645 0.378 . . . . 75.22 111.17 -170.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 65.45 150.46 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.114 1.366 . . . . 74.23 113.502 171.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.057 0 C-N-CA 124.434 1.094 . . . . 61.12 108.85 176.482 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.16 0 CA-C-O 120.037 -0.313 . . . . 73.41 113.461 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' E' E ' 92' ' ' GLY . . . . . 0.495 ' HA3' HG21 ' D' ' 55' ' ' VAL . . . -158.42 -73.98 0.02 OUTLIER Glycine 0 C--N 1.342 0.9 0 N-CA-C 111.435 -0.666 . . . . 74.21 111.435 -177.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -166.01 172.32 11.57 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 112.854 0.687 . . . . 61.14 112.854 -172.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 5.1 t80 61.08 -94.39 0.05 OUTLIER 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 126.216 1.806 . . . . 73.14 111.421 177.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 95' ' ' LYS . . . . . 0.43 ' HE3' ' HB2' ' E' ' 95' ' ' LYS . 39.0 mtmt -149.53 -80.92 0.12 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.409 0.623 . . . . 74.32 110.862 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 141.3 75.67 0.04 OUTLIER Glycine 0 C--N 1.345 1.042 0 N-CA-C 109.586 -1.406 . . . . 65.14 109.586 -166.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 97' ' ' ILE . . . . . 0.627 HD11 ' HB2' ' D' ' 94' ' ' MET . 1.5 tt -37.01 105.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 126.659 1.983 . . . . 71.44 113.908 -176.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 25.4 t70 52.41 -92.09 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.909 1.684 . . . . 63.03 112.284 172.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 99' ' ' ALA . . . . . 0.485 ' HB3' ' HB1' ' B' ' 155' ' ' ALA . . . -161.38 40.22 0.14 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.678 0.791 . . . . 63.53 109.885 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 100' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' D' ' 52' ' ' ALA . 12.8 tp -69.57 101.72 0.35 Allowed Pre-proline 0 N--CA 1.484 1.27 0 C-N-CA 124.913 1.285 . . . . 64.44 111.684 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -100.23 -2.78 0.63 Allowed 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 123.236 2.624 . . . . 70.31 113.595 -175.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 102' ' ' LEU . . . . . 0.483 HD23 ' HA ' ' D' ' 50' ' ' GLN . 4.0 mm? 62.22 167.14 0.11 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 125.227 1.411 . . . . 72.21 112.313 -168.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 74.0 p -83.23 -43.62 15.89 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.545 -0.752 . . . . 73.14 109.508 175.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 168.71 -177.67 42.49 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-N 115.094 -0.957 . . . . 63.41 112.019 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -76.06 105.29 7.02 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.593 -0.892 . . . . 64.04 108.593 175.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 106' ' ' TYR . . . . . 0.441 ' HA ' ' HA ' ' D' ' 47' ' ' ALA . 59.3 t80 72.01 132.59 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.903 1.281 . . . . 71.13 110.972 -176.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 8.3 t -124.62 157.26 35.92 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.453 0.701 . . . . 74.53 110.089 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -97.73 18.27 16.05 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.007 0.923 . . . . 72.32 110.634 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -80.58 71.27 7.44 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 108.785 -0.82 . . . . 72.41 108.785 166.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -78.09 138.62 38.85 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.408 -1.269 . . . . 75.23 110.207 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . 0.597 ' HB2' ' HB2' ' D' ' 44' ' ' LEU . 5.8 mp -65.09 -33.21 75.47 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.211 0.605 . . . . 61.42 110.096 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -98.38 95.48 7.38 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.552 -0.907 . . . . 70.43 108.552 171.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -103.59 77.89 1.53 Allowed 'General case' 0 C--O 1.242 0.69 0 N-CA-C 106.596 -1.631 . . . . 72.01 106.596 175.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -63.95 116.75 6.14 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 114.795 -1.093 . . . . 70.52 111.399 -175.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 5.5 m -140.51 5.67 2.04 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.909 0.884 . . . . 71.12 109.642 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 100.04 -29.24 12.56 Favored Glycine 0 C--N 1.35 1.341 0 N-CA-C 111.958 -0.457 . . . . 54.14 111.958 -175.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 117' ' ' LYS . . . . . 0.414 ' HE2' ' HA2' ' D' ' 148' ' ' GLY . 0.7 OUTLIER -68.93 131.2 91.07 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 108.573 -0.899 . . . . 75.33 108.573 174.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.18 112.4 0.92 Allowed 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.838 2.359 . . . . 74.12 111.474 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -60.89 154.71 21.5 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.734 0.814 . . . . 72.04 111.089 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -82.76 -2.23 53.79 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.925 -0.58 . . . . 75.01 111.055 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 121' ' ' VAL . . . . . 0.4 HG22 HD23 ' D' ' 136' ' ' LEU . 35.0 t -68.3 132.72 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 123.638 0.775 . . . . 63.24 109.553 172.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 29.6 m -62.56 138.23 58.44 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 122.811 0.444 . . . . 71.14 109.824 173.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -58.2 147.74 29.33 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.311 0.577 . . . . 63.44 111.126 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 4.6 m -88.57 42.83 1.09 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.017 -0.992 . . . . 65.25 111.117 -171.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -73.85 -159.62 0.08 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.728 1.211 . . . . 70.43 110.568 173.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . 65.56 54.28 1.13 Allowed 'General case' 0 C--N 1.356 0.891 0 CA-C-O 121.863 0.839 . . . . 45.03 110.31 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 127' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' D' ' 125' ' ' GLN . 4.7 p -122.72 113.82 19.72 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.93 -1.032 . . . . 72.33 109.779 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.81 99.68 1.07 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.426 1.09 . . . . 74.11 111.267 -174.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 32.7 p -87.94 74.53 8.95 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.923 0.889 . . . . 64.03 112.854 -171.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -166.68 109.31 0.71 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 107.667 -1.235 . . . . 54.01 107.667 170.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 131' ' ' TRP . . . . . . . . . . . . . 8.0 t-105 -148.64 158.33 44.06 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.419 0.525 . . . . 63.23 112.419 -175.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 14.4 t 70.36 104.09 0.06 Allowed 'General case' 0 C--N 1.357 0.922 0 C-N-CA 126.384 1.873 . . . . 64.04 110.998 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 29.1 m -79.52 -20.39 47.31 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.623 0.769 . . . . 50.41 109.959 169.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.2 -135.33 13.77 Favored Glycine 0 C--N 1.342 0.904 0 N-CA-C 109.46 -1.456 . . . . 75.44 109.46 -164.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 135' ' ' VAL . . . . . 0.628 HG21 ' HB ' ' C' ' 13' ' ' ILE . 77.0 t -141.07 -63.13 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 123.231 0.612 . . . . 64.14 110.232 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 136' ' ' LYS . . . . . 0.473 ' HG3' ' HB3' ' C' ' 2' ' ' SER . 4.2 mtmt 62.95 -160.21 0.31 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 124.068 0.855 . . . . 74.45 110.514 -171.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 7.6 t -134.63 150.64 50.69 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.851 -0.531 . . . . 74.53 110.542 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -64.15 -36.28 83.51 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.204 1.002 . . . . 64.34 110.677 172.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -160.57 126.65 4.04 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.014 0.926 . . . . 73.1 108.583 173.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -115.07 123.19 5.87 Favored Glycine 0 C--N 1.345 1.077 0 N-CA-C 111.979 -0.448 . . . . 52.32 111.979 -177.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -159.5 145.94 16.4 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 123.412 0.685 . . . . 55.33 109.921 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 6.2 mp -86.02 123.45 31.35 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.688 -0.856 . . . . 43.32 108.688 175.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -81.69 -107.47 0.37 Allowed Glycine 0 CA--C 1.532 1.135 0 N-CA-C 112.158 -0.377 . . . . 74.54 112.158 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 144' ' ' VAL . . . . . 0.436 ' O ' ' HB3' ' C' ' 153' ' ' GLN . 10.5 p -171.63 172.7 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 124.799 1.24 . . . . 62.21 108.049 178.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 N--CA 1.49 1.563 0 CA-C-N 118.656 0.662 . . . . 64.4 110.441 174.808 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.914 0 CA-C-O 119.874 -0.403 . . . . 65.2 112.847 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . -132.92 59.72 0.68 Allowed Glycine 0 C--N 1.352 1.463 0 N-CA-C 111.366 -0.693 . . . . 60.12 111.366 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -93.81 90.31 6.49 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.734 0.814 . . . . 64.14 109.373 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -159.79 148.65 17.62 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.35 0.66 . . . . 74.24 110.346 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 95' ' ' LYS . . . . . 0.708 ' HD2' ' SD ' ' B' ' 1' ' ' MET . 0.7 OUTLIER -63.73 97.7 0.16 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.403 1.081 . . . . 74.23 111.772 -173.156 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . -149.81 -6.02 0.2 Allowed Glycine 0 CA--C 1.535 1.317 0 CA-C-N 115.327 -0.851 . . . . 65.41 113.424 174.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 97' ' ' ILE . . . . . 0.516 HG21 ' HB2' ' F' ' 100' ' ' LEU . 8.8 tp -81.63 165.89 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 123.489 0.716 . . . . 51.45 110.863 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 98' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 22.2 t70 -93.53 -79.0 0.42 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.707 0.803 . . . . 71.25 110.17 173.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.31 78.7 1.86 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 108.85 -0.796 . . . . 64.25 108.85 -178.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 100' ' ' LEU . . . . . 0.516 ' HB2' HG21 ' F' ' 97' ' ' ILE . 1.7 tm? -55.63 -43.2 99.04 Favored Pre-proline 0 N--CA 1.491 1.616 0 C-N-CA 124.768 1.227 . . . . 72.01 113.444 -171.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.65 133.52 20.55 Favored 'Trans proline' 0 C--N 1.381 2.249 0 CA-C-N 121.071 1.418 . . . . 73.35 110.032 167.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 102' ' ' LEU . . . . . . . . . . . . . 61.1 mt -58.19 102.0 0.09 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.886 0.474 . . . . 70.0 110.648 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 6.3 t -54.56 137.52 43.04 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 125.261 1.424 . . . . 72.02 112.529 -174.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.92 -78.68 0.61 Allowed Glycine 0 C--N 1.341 0.86 0 N-CA-C 111.377 -0.689 . . . . 71.22 111.377 -176.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 105' ' ' GLN . . . . . 0.408 ' H ' ' HB2' ' F' ' 108' ' ' HIS . 50.9 tp60 -159.67 167.85 27.4 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.885 0.474 . . . . 62.25 110.023 -171.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -38.06 94.31 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.569 1.948 . . . . 64.31 111.641 168.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 19.3 m 50.05 73.27 0.27 Allowed 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 124.688 1.195 . . . . 62.54 110.669 -173.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 108' ' ' HIS . . . . . 0.408 ' HB2' ' H ' ' F' ' 105' ' ' GLN . 21.2 t-160 -65.3 -33.82 76.88 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 114.754 -1.112 . . . . 73.01 112.138 -173.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -71.0 -24.45 62.39 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.029 0.532 . . . . 74.21 111.137 176.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 62.94 94.38 0.05 OUTLIER 'General case' 0 C--N 1.356 0.86 0 C-N-CA 125.052 1.341 . . . . 73.24 112.196 174.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . 0.459 HD21 ' HD1' ' B' ' 133' ' ' PHE . 21.5 tp -65.3 -58.77 5.1 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.62 0.724 . . . . 61.21 109.182 173.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -153.88 75.89 1.04 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 106.167 -1.79 . . . . 75.33 106.167 170.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -86.26 -17.93 33.4 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.898 -1.046 . . . . 74.11 110.652 -176.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -125.87 156.85 38.99 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.07 0.948 . . . . 74.42 110.223 177.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 41.0 p -69.32 -20.79 63.87 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.642 0.777 . . . . 75.53 111.257 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.54 76.71 1.57 Allowed Glycine 0 C--N 1.346 1.104 0 N-CA-C 111.117 -0.793 . . . . 61.13 111.117 172.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 117' ' ' LYS . . . . . 0.481 ' HG3' ' HB ' ' F' ' 121' ' ' VAL . 0.0 OUTLIER -58.84 124.11 71.67 Favored Pre-proline 0 CA--C 1.562 1.434 0 C-N-CA 123.376 0.67 . . . . 72.32 111.243 174.204 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -64.23 -26.09 64.61 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.64 2.894 . . . . 63.51 115.684 -169.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -158.42 -54.87 0.07 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 120.916 0.389 . . . . 75.4 111.377 -169.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 120' ' ' TYR . . . . . 0.401 ' HB2' HD11 ' B' ' 136' ' ' LEU . 8.2 t80 -70.11 171.93 8.83 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.009 0.923 . . . . 65.32 110.913 -176.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 121' ' ' VAL . . . . . 0.481 ' HB ' ' HG3' ' F' ' 117' ' ' LYS . 62.1 t 62.31 87.36 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.393 1.077 . . . . 74.34 109.55 -178.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . 0.467 HG23 ' H ' ' F' ' 124' ' ' SER . 13.0 t -113.52 -166.84 1.13 Allowed 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.954 -1.021 . . . . 71.11 109.88 -172.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -58.14 -30.42 66.33 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.268 1.027 . . . . 64.44 111.576 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 124' ' ' SER . . . . . 0.467 ' H ' HG23 ' F' ' 122' ' ' THR . 55.3 m -65.66 93.1 0.16 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.739 0.815 . . . . 42.41 110.41 175.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -144.17 -177.67 5.57 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.659 1.184 . . . . 25.13 109.279 -178.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 126' ' ' ALA . . . . . 0.525 ' O ' ' HB ' ' B' ' 40' ' ' VAL . . . -75.0 106.3 6.43 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.004 0.522 . . . . 72.43 110.338 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 66.5 m -139.43 93.38 2.67 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.426 -0.953 . . . . 71.32 108.426 174.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -158.74 149.24 19.9 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.477 0.711 . . . . 62.24 109.915 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 15.6 p -77.66 -78.18 0.14 Allowed 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.864 -0.791 . . . . 62.44 108.864 170.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 130' ' ' ALA . . . . . 0.652 ' HB3' ' HB3' ' B' ' 125' ' ' GLN . . . 45.09 61.0 2.71 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.145 0.978 . . . . 74.32 110.968 -171.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 131' ' ' TRP . . . . . 0.474 ' HD1' ' HB2' ' C' ' 125' ' ' GLN . 9.7 t90 -154.61 18.06 0.46 Allowed 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 114.621 -1.172 . . . . 73.24 109.166 -176.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 57.2 p -64.34 -21.06 66.49 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.356 0.663 . . . . 65.1 111.843 -176.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 34.0 m -73.91 83.43 1.7 Allowed 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 121.256 0.55 . . . . 74.13 109.691 170.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.89 94.89 0.89 Allowed Glycine 0 C--N 1.351 1.39 0 N-CA-C 109.872 -1.291 . . . . 73.3 109.872 173.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 59.2 t -59.3 113.94 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 123.813 0.845 . . . . 74.33 111.228 -172.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 136' ' ' LYS . . . . . 0.479 ' HD3' ' H ' ' F' ' 136' ' ' LYS . 0.2 OUTLIER -128.45 -164.63 1.4 Allowed 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.558 1.143 . . . . 61.22 108.967 -175.645 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 5.4 t -57.96 132.58 53.85 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.219 0.607 . . . . 60.52 110.196 170.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -70.6 125.67 27.46 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.577 0.751 . . . . 72.22 111.627 -170.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -163.79 152.7 13.9 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.185 -1.042 . . . . 74.41 108.185 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 140' ' ' GLY . . . . . 0.684 ' HA3' ' HE3' ' C' ' 41' ' ' LYS . . . -132.08 -112.87 1.44 Allowed Glycine 0 C--N 1.337 0.634 0 CA-C-O 119.025 -0.875 . . . . 64.0 111.343 173.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . 70.12 -65.58 0.31 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.181 1.392 . . . . 72.34 110.561 -174.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 38.7 tp 64.47 -82.28 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.484 1.513 . . . . 63.41 111.399 174.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.99 59.52 6.91 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 111.377 -0.689 . . . . 63.13 111.377 -174.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 3.4 p -60.44 106.17 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 C-N-CA 123.777 0.831 . . . . 71.34 111.032 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 35.6 t70 . . . . . 0 C--O 1.244 0.797 0 C-N-CA 124.224 1.009 . . . . 74.33 108.521 -178.612 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 ttp . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 109.387 -0.597 . . . . 74.32 109.387 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.8 m -55.02 120.07 6.37 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.181 0.992 . . . . 74.44 111.004 174.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -151.4 119.41 6.24 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.421 0.688 . . . . 65.33 110.584 -177.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -122.59 -34.72 3.2 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.788 0.835 . . . . 73.21 109.596 166.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 61.3 t30 55.57 61.04 3.01 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 124.31 1.044 . . . . 74.55 110.13 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -159.39 154.61 25.29 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.817 -0.628 . . . . 73.41 110.518 -172.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.4 t -70.14 -9.24 54.99 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.408 1.083 . . . . 72.04 112.509 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.13 158.6 10.99 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.567 0.747 . . . . 74.3 111.704 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 41.1 mtt -46.72 144.33 2.38 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.538 1.935 . . . . 72.43 112.55 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.0 m -141.27 126.67 18.72 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.889 0.875 . . . . 61.01 109.586 -178.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -125.32 113.09 17.13 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.554 -0.906 . . . . 63.42 108.554 170.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -135.72 136.66 41.01 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.508 -0.923 . . . . 54.45 108.508 170.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.471 ' CD1' HG21 ' A' ' 105' ' ' ILE . 5.2 mt -93.35 117.15 36.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 108.762 -0.829 . . . . 74.21 108.762 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.03 -42.36 32.7 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.948 0.78 . . . . 72.35 109.32 -177.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -173.69 121.41 0.32 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 110.276 -0.268 . . . . 73.25 110.276 -171.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 65.8 mt -106.26 133.92 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.767 -0.827 . . . . 74.13 108.767 173.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.513 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 31.4 p90 -164.12 158.09 18.87 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 124.011 0.819 . . . . 74.32 111.33 -174.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.6 p -86.78 117.0 25.24 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.291 -0.633 . . . . 61.3 109.291 172.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.445 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 38.5 mtpt -75.82 -34.13 60.13 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.415 -0.587 . . . . 73.43 109.415 175.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 23.4 t70 -149.59 142.85 25.13 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.607 -1.179 . . . . 72.33 110.064 -178.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 76.1 mt -137.34 144.88 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.762 1.225 . . . . 60.14 108.119 175.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.5 t -148.92 138.3 21.71 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.667 0.787 . . . . 72.55 109.034 171.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.505 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 91.5 t80 -135.22 134.61 40.22 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.572 -1.64 . . . . 75.13 106.572 169.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -133.3 137.54 46.03 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.347 0.659 . . . . 71.13 109.542 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.94 76.64 11.38 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 106.582 -1.636 . . . . 63.32 106.582 171.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.75 -28.59 36.74 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.316 2.011 . . . . 63.25 111.199 -178.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -97.99 11.23 38.19 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.067 -0.969 . . . . 64.22 111.189 -175.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.439 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -44.87 -59.61 3.96 Favored Pre-proline 0 CA--C 1.564 1.51 0 N-CA-C 114.2 1.185 . . . . 70.31 114.2 -165.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.78 -36.85 96.41 Favored 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 122.015 1.81 . . . . 63.22 113.675 -171.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -99.39 -12.47 20.24 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.491 0.716 . . . . 60.25 112.863 -175.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.775 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.6 p -77.07 -23.49 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-N 118.073 0.397 . . . . 74.43 110.396 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -71.46 -18.47 62.31 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.514 0.726 . . . . 62.45 111.328 173.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -80.03 -27.58 39.45 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.496 0.719 . . . . 74.11 110.543 175.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.494 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 12.7 mmmm -72.87 152.64 41.39 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.942 0.897 . . . . 73.23 111.371 -175.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -63.25 123.45 18.69 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.547 0.739 . . . . 74.33 109.322 174.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -76.97 81.35 3.51 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.75 0.786 . . . . 74.42 110.116 -175.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.442 ' H ' HD22 ' A' ' 68' ' ' LEU . 19.5 tm0? -115.64 78.77 6.99 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 106.478 -1.675 . . . . 54.12 106.478 172.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -84.63 112.5 1.57 Allowed 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.224 1.95 . . . . 44.41 111.62 -172.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -92.88 88.09 6.06 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.445 -1.687 . . . . 61.45 106.445 171.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.7 t -88.15 102.92 13.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 114.332 -1.304 . . . . 63.14 110.392 -173.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -78.12 115.66 18.01 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.682 -1.145 . . . . 63.5 109.181 172.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 128' ' ' LEU . 3.6 tt -96.89 107.49 20.0 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 106.504 -1.665 . . . . 73.02 106.504 176.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -104.94 147.19 28.05 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.407 1.083 . . . . 72.13 108.739 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.761 HD11 HG21 ' A' ' 131' ' ' VAL . 87.5 mt -133.58 138.9 46.25 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.198 0.599 . . . . 51.23 110.891 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.561 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 24.2 t70 -136.62 144.82 44.27 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.105 1.362 . . . . 53.41 107.847 177.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.9 m -139.11 126.83 21.97 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.808 0.443 . . . . 72.13 110.354 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.2 127.01 32.85 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.867 0.867 . . . . 73.4 109.931 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.7 m -112.73 161.42 16.89 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.486 0.66 . . . . 62.32 111.185 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 90.0 p -149.12 162.12 40.6 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.344 1.458 . . . . 73.23 107.654 175.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -113.46 107.45 15.85 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.806 -0.812 . . . . 71.11 108.806 169.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.3 mt -79.4 -29.3 41.94 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.7 -0.682 . . . . 65.25 111.523 -175.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.67 -172.47 3.12 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.128 0.571 . . . . 74.04 111.352 -177.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -61.47 112.5 2.22 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.992 0.917 . . . . 45.23 109.751 174.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 69.89 2.0 3.69 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 125.955 1.702 . . . . 75.31 112.703 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.68 108.11 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 O-C-N 121.661 -0.65 . . . . 72.34 109.645 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -114.49 126.24 54.72 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.609 1.164 . . . . 75.22 108.31 177.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -91.71 139.9 30.23 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 108.46 -0.941 . . . . 72.45 108.46 171.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.446 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 98.1 t -123.5 139.64 49.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.196 -1.039 . . . . 71.45 108.196 170.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.449 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 50.3 t -120.04 132.64 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.424 -0.954 . . . . 43.23 108.424 174.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.667 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -111.94 104.5 12.78 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.751 -1.574 . . . . 72.01 106.751 170.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.561 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 13.3 ttp180 -94.28 100.49 12.53 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.443 -1.317 . . . . 63.23 107.443 176.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 36.0 t -93.72 123.99 46.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.663 -1.236 . . . . 63.41 107.663 177.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.2 m -118.68 115.72 25.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.829 0.823 . . . . 71.31 109.448 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.604 HG11 HD21 ' A' ' 126' ' ' LEU . 91.8 t -104.2 128.92 57.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 C-N-CA 124.866 1.266 . . . . 73.15 108.98 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.1 m -125.4 128.56 48.3 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 108.586 -0.894 . . . . 73.11 108.586 171.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.12 129.28 55.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.818 -1.178 . . . . 70.25 107.818 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.7 m -135.57 139.08 43.61 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.595 0.712 . . . . 74.22 110.655 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.442 HD22 ' H ' ' A' ' 37' ' ' GLN . 59.4 mt -95.86 62.63 2.28 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.373 1.869 . . . . 64.21 108.701 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.11 -84.63 0.92 Allowed Glycine 0 CA--C 1.529 0.955 0 CA-C-N 115.806 -0.634 . . . . 21.52 112.275 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.35 -26.79 11.84 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.542 0.737 . . . . 60.12 111.737 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.494 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 2.9 tp10 -95.66 112.86 24.49 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.702 0.801 . . . . 72.41 109.641 -174.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.9 m -67.96 129.97 41.53 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.933 0.788 . . . . 72.35 110.124 176.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.775 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -76.78 -60.64 2.27 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.34 -0.846 . . . . 72.43 109.173 177.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.415 ' HZ ' HD22 ' A' ' 126' ' ' LEU . 51.9 p90 -159.09 170.45 21.99 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.48 -0.782 . . . . 72.31 111.489 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.4 tp -140.75 113.32 8.1 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.885 1.274 . . . . 74.05 108.457 176.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.541 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 58.9 m -105.63 141.66 36.7 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.181 0.993 . . . . 70.31 108.85 176.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -148.3 116.75 6.56 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.449 -0.575 . . . . 70.33 109.449 173.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.5 t -127.05 112.82 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.713 0.805 . . . . 43.53 109.38 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -84.82 83.36 8.07 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.181 -1.044 . . . . 73.43 108.181 170.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -76.17 92.17 3.22 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.191 -1.04 . . . . 74.44 108.191 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.93 164.91 41.27 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.777 -0.929 . . . . 70.31 110.777 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.25 122.01 1.06 Allowed Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 110.132 -1.187 . . . . 54.31 110.132 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.443 HG13 ' HE1' ' A' ' 17' ' ' TYR . 57.0 mt -81.13 125.92 39.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 107.654 -1.239 . . . . 54.31 107.654 171.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.573 ' HB3' HD11 ' A' ' 86' ' ' ILE . 87.7 m-85 -127.25 136.92 52.65 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.518 0.727 . . . . 72.34 109.285 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.5 p -100.38 90.98 4.5 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.695 0.798 . . . . 61.51 109.023 174.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.573 HD11 ' HB3' ' A' ' 84' ' ' PHE . 14.7 mm -111.12 147.45 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 114.859 -1.064 . . . . 75.21 110.638 -173.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.85 167.38 18.82 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.581 0.352 . . . . 61.21 111.754 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.96 1.67 88.72 Favored Glycine 0 C--N 1.35 1.335 0 N-CA-C 115.145 0.818 . . . . 75.21 115.145 172.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.2 172.13 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.642 0.777 . . . . 73.54 110.179 177.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.483 ' HG3' ' HB2' ' A' ' 153' ' ' GLN . 0.6 OUTLIER -160.64 177.78 10.15 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.25 -0.886 . . . . 74.53 109.607 176.231 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.9 -116.36 8.61 Favored Glycine 0 C--N 1.351 1.391 0 O-C-N 123.793 0.683 . . . . 75.11 113.786 172.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.4 p -64.2 -41.15 97.19 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.762 1.225 . . . . 72.24 111.528 -177.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -74.38 -36.87 63.56 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.045 0.538 . . . . 65.53 111.323 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.478 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 4.8 tpt -68.16 -45.92 72.2 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.55 -0.537 . . . . 71.52 109.55 177.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.88 -32.18 73.38 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.181 -0.918 . . . . 74.34 110.781 176.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -73.69 -38.04 65.02 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.105 0.562 . . . . 63.31 110.342 176.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.412 ' SG ' HG21 ' A' ' 86' ' ' ILE . 50.8 t -67.92 -39.31 83.56 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.619 -0.511 . . . . 63.34 109.619 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 78.8 mt -85.68 -28.1 24.92 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.679 0.792 . . . . 73.0 111.975 -177.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -114.7 4.48 22.88 Favored Glycine 0 N--CA 1.474 1.232 0 N-CA-C 114.508 0.563 . . . . 72.31 114.508 -170.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 133' ' ' PHE . . . -143.31 -62.19 0.41 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 117.72 0.76 . . . . 65.11 110.958 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -62.84 -57.78 9.68 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 123.961 0.904 . . . . 71.44 111.593 -173.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 82.6 m -64.43 -46.78 78.12 Favored Pre-proline 0 CA--C 1.558 1.269 0 CA-C-O 117.895 -1.05 . . . . 73.35 113.102 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.7 -20.25 59.43 Favored 'Trans proline' 0 C--N 1.396 3.059 0 CA-C-N 121.446 1.552 . . . . 61.35 112.896 174.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -76.58 -32.32 58.05 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.952 0.501 . . . . 53.25 109.883 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.471 HG21 ' CD1' ' A' ' 13' ' ' ILE . 46.2 mm -67.0 -45.19 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.445 0.698 . . . . 74.34 109.7 169.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 59.1 mt -73.14 -22.97 60.41 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.788 -1.096 . . . . 60.52 111.946 -174.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -65.3 -44.49 68.55 Favored Pre-proline 0 N--CA 1.481 1.076 0 CA-C-O 117.296 -1.335 . . . . 75.3 113.78 -172.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 77.8 Cg_exo -54.33 -36.69 87.75 Favored 'Trans proline' 0 C--N 1.387 2.553 0 CA-C-N 121.96 1.736 . . . . 71.1 113.383 171.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -76.49 -39.2 53.83 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.187 0.595 . . . . 73.41 111.5 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.97 -47.07 75.79 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.519 0.728 . . . . 73.4 109.346 177.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -51.44 -52.66 44.4 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 125.546 1.538 . . . . 74.55 110.016 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -61.93 -47.74 83.57 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 124.554 1.159 . . . . 72.42 111.853 -175.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.516 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 49.9 t -55.91 -45.16 78.77 Favored 'General case' 0 C--N 1.351 0.631 0 O-C-N 124.498 1.124 . . . . 54.32 110.242 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.508 HG21 HG21 ' A' ' 64' ' ' VAL . 84.2 mt -62.35 -53.14 51.39 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 CA-C-N 114.844 -1.071 . . . . 74.31 110.804 175.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 38.5 m -57.73 -37.35 73.43 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.263 1.025 . . . . 62.42 110.964 -173.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.6 t -69.26 -46.24 67.76 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.766 -1.106 . . . . 72.31 109.818 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.505 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 9.0 mtp -58.84 -37.31 76.17 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.796 0.839 . . . . 64.44 111.837 176.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 114' ' ' ILE . 74.2 t -67.27 -45.61 85.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 124.183 0.993 . . . . 62.31 110.284 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 94.2 p -73.63 -28.04 61.58 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 116.248 -0.433 . . . . 72.14 110.772 -177.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -70.38 -33.97 72.03 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.698 0.799 . . . . 74.14 109.376 172.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 122' ' ' THR . . . -81.99 8.13 61.17 Favored Glycine 0 C--N 1.353 1.502 0 CA-C-N 115.095 -0.957 . . . . 71.04 112.767 172.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.4 t 65.14 11.47 7.2 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 127.42 2.288 . . . . 54.41 113.888 171.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -79.38 143.81 60.68 Favored Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 108.962 -0.755 . . . . 65.5 108.962 177.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -48.05 143.54 13.8 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 123.372 2.715 . . . . 55.24 113.285 176.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -53.13 116.09 2.21 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.835 1.254 . . . . 73.32 113.283 -165.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.604 HD21 HG11 ' A' ' 64' ' ' VAL . 55.6 tp -110.71 96.06 5.94 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.159 0.584 . . . . 75.02 109.625 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.646 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 1.0 OUTLIER -100.31 113.51 26.28 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 106.287 -1.745 . . . . 73.32 106.287 175.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.442 ' HB3' HD11 ' A' ' 42' ' ' LEU . 16.2 mt -65.65 130.57 43.74 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 123.553 0.533 . . . . 61.3 109.751 -174.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.73 139.11 97.56 Favored Pre-proline 0 CA--C 1.554 1.128 0 CA-C-O 118.767 -0.635 . . . . 60.1 110.755 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.593 ' HD2' HE21 ' C' ' 12' ' ' GLN . 75.6 Cg_exo -50.31 140.51 34.06 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 123.617 2.878 . . . . 63.45 113.686 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.761 HG21 HD11 ' A' ' 44' ' ' LEU . 70.9 t -115.6 132.34 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 122.95 0.5 . . . . 75.11 110.082 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -93.06 79.77 4.56 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.201 -1.037 . . . . 70.22 108.201 177.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.454 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 84.8 m-85 -58.42 -25.0 61.66 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.977 0.911 . . . . 75.14 111.791 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -67.97 -49.67 60.3 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.223 1.009 . . . . 65.31 110.594 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.57 92.66 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.076 0.86 . . . . 71.44 110.194 177.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.466 ' HA ' HD21 ' A' ' 139' ' ' ASN . 88.7 mt -62.46 -36.62 83.02 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 114.727 -1.124 . . . . 64.0 111.312 178.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -67.32 -42.72 83.16 Favored 'General case' 0 C--O 1.216 -0.67 0 O-C-N 123.789 0.681 . . . . 71.12 110.109 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 22.5 mmt -59.99 -51.78 68.21 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 123.656 0.597 . . . . 52.34 111.208 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.466 HD21 ' HA ' ' A' ' 136' ' ' LEU . 12.1 p30 -70.55 -30.24 66.91 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.245 0.218 . . . . 62.03 111.436 -177.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -74.73 -32.36 62.1 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.354 0.662 . . . . 73.34 111.126 176.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 59.8 tp -65.14 -50.39 66.22 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.998 0.919 . . . . 74.22 109.608 -175.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 174.86 -13.36 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.224 0 O-C-N 124.698 1.249 . . . . 72.4 110.909 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 68.73 154.33 0.11 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.048 1.339 . . . . 75.21 110.46 -172.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 67.37 -79.79 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.701 1.2 . . . . 74.43 110.869 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.84 143.76 47.71 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.619 0.767 . . . . 73.15 110.694 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -176.18 44.86 0.11 Allowed Glycine 0 C--N 1.336 0.534 0 N-CA-C 110.857 -0.897 . . . . 45.34 110.857 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -69.16 144.25 53.86 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.245 1.018 . . . . 71.32 111.018 -174.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -79.48 96.42 1.51 Allowed Glycine 0 C--N 1.345 1.035 0 CA-C-N 116.058 -0.519 . . . . 50.35 113.128 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.1 t -70.04 131.66 44.68 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-O 121.233 0.539 . . . . 62.45 111.139 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -136.54 171.9 13.81 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.916 1.287 . . . . 51.4 108.988 -178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 69.32 0.52 2.91 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 124.501 1.121 . . . . 71.1 111.928 175.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -103.75 97.45 7.46 Favored 'General case' 0 C--O 1.216 -0.681 0 N-CA-C 107.309 -1.367 . . . . 75.33 107.309 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.483 ' HB2' ' HG3' ' A' ' 90' ' ' GLU . 22.9 mt-30 64.08 168.39 0.16 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.399 1.08 . . . . 73.43 112.988 175.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.4 t70 179.81 96.25 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 107.46 -1.311 . . . . 63.24 107.46 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.479 0 C-N-CA 124.109 0.964 . . . . 74.4 108.999 -175.899 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.416 ' HB3' ' O ' ' B' ' 143' ' ' GLN . 1.2 tmt? . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 109.403 -0.591 . . . . 71.45 109.403 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 36.0 t -162.08 122.11 2.49 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.3 1.04 . . . . 72.52 108.275 174.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 59.86 73.31 0.49 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.775 1.23 . . . . 75.14 111.102 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -80.58 -55.87 4.55 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.285 -0.87 . . . . 73.11 108.962 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -85.74 116.67 24.14 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.265 1.026 . . . . 53.43 108.775 167.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -162.02 -58.74 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 108.399 -0.963 . . . . 70.34 108.399 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 40.3 p -88.96 144.15 26.37 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.433 -0.803 . . . . 75.54 109.721 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -68.96 -32.85 72.74 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.985 0.514 . . . . 72.41 110.901 176.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.531 ' HG3' HG13 ' B' ' 89' ' ' ILE . 26.9 ttt 63.44 165.16 0.12 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.88 1.672 . . . . 60.42 112.148 -177.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.8 m -140.84 125.69 18.14 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.936 -1.135 . . . . 62.14 107.936 167.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -136.18 142.07 44.1 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.705 0.802 . . . . 70.31 108.975 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -156.11 141.44 17.56 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 109.124 -0.695 . . . . 73.24 109.124 170.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.571 ' HB ' ' HB1' ' E' ' 126' ' ' ALA . 61.6 mt -80.77 134.23 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 108.033 -1.099 . . . . 55.12 108.033 175.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -99.98 -50.61 3.94 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.591 0.357 . . . . 70.32 110.224 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.434 ' HE ' HG21 ' A' ' 122' ' ' THR . 46.2 ttt180 -167.47 129.72 1.62 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.255 -0.646 . . . . 72.25 109.255 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.488 HG21 ' CD1' ' B' ' 109' ' ' TYR . 86.8 mt -115.32 149.6 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 108.539 -0.912 . . . . 74.3 108.539 175.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -167.41 162.85 14.88 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.63 0.728 . . . . 71.1 111.492 -173.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.443 ' H ' ' HA2' ' A' ' 121' ' ' GLY . 55.4 m -90.19 124.29 34.72 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 114.342 -1.299 . . . . 75.35 108.307 170.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -85.96 -45.56 11.37 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.944 0.898 . . . . 72.5 110.343 172.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.437 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 24.4 t70 -144.64 142.76 30.36 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.519 -0.309 . . . . 61.04 110.91 -167.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 46.4 mm -136.25 142.76 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.628 1.171 . . . . 72.1 109.116 177.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 29.4 m -138.17 135.37 35.6 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.102 1.361 . . . . 75.22 108.029 168.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 80.9 t80 -142.12 108.42 5.27 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 105.659 -1.978 . . . . 63.35 105.659 164.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -118.95 112.18 19.28 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.315 -0.994 . . . . 73.5 108.315 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.446 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -109.01 87.08 4.34 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 107.029 -1.471 . . . . 72.24 107.029 171.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.91 -26.63 21.93 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 122.24 1.96 . . . . 72.25 111.911 -172.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.556 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 75.2 m-20 -107.99 14.62 25.09 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.537 1.135 . . . . 64.52 110.453 -176.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.513 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -43.98 -55.27 9.58 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 125.339 1.456 . . . . 61.25 114.832 -167.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -55.46 -44.68 46.21 Favored 'Trans proline' 0 C--N 1.4 3.239 0 C-N-CA 122.054 1.836 . . . . 61.44 113.348 -175.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -98.03 -16.79 19.48 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.899 1.074 . . . . 75.12 113.899 -171.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.404 HG21 ' HA ' ' B' ' 73' ' ' ALA . 9.5 p -76.1 -8.72 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-N 118.811 0.732 . . . . 75.4 112.05 -172.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -80.45 -1.62 42.37 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 122.897 0.479 . . . . 74.13 112.187 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -64.01 -25.19 68.01 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.086 0.554 . . . . 55.32 110.304 166.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.605 ' HB2' HD13 ' B' ' 68' ' ' LEU . 31.1 mmtp -90.96 107.94 19.53 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.988 1.315 . . . . 52.4 108.979 -178.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -115.89 86.09 2.41 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.384 0.611 . . . . 72.23 110.806 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 37.4 p90 -163.97 160.51 21.99 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.325 1.45 . . . . 72.2 107.78 171.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -62.75 116.18 22.1 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 108.376 -0.972 . . . . 73.42 108.376 172.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.01 157.54 58.91 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.042 1.828 . . . . 72.3 111.665 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -69.13 115.32 8.28 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 108.233 -1.025 . . . . 62.32 108.233 172.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.57 HG13 HG13 ' B' ' 64' ' ' VAL . 60.8 t -106.21 129.45 59.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 O-C-N 124.146 0.904 . . . . 62.12 110.602 -173.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.487 ' HE3' ' HB2' ' B' ' 43' ' ' ASP . 18.7 ttpt -106.48 120.5 42.08 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.509 -0.923 . . . . 70.54 108.509 168.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 16.1 tp -88.03 134.16 33.8 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.585 -0.894 . . . . 71.42 108.585 173.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 9.4 t0 -134.66 112.11 10.54 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.094 -1.076 . . . . 72.04 108.094 -172.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.433 HD11 HG11 ' B' ' 131' ' ' VAL . 78.4 mt -107.35 150.88 26.23 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.094 0.558 . . . . 71.2 110.306 -173.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.2 t70 -151.66 139.27 19.67 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.607 0.763 . . . . 63.14 109.686 -173.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 4.7 t -114.55 103.66 11.24 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-O 121.694 0.759 . . . . 73.13 109.68 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -121.28 118.67 30.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.555 -0.906 . . . . 73.43 108.555 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 54.0 p -145.77 172.35 13.43 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 122.086 -0.383 . . . . 61.13 111.563 -175.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 24.4 p -159.62 137.39 10.03 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.684 0.793 . . . . 74.23 110.702 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.48 ' HB2' ' CE2' ' B' ' 56' ' ' TYR . 58.8 tt0 -84.98 105.71 15.95 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 108.566 -0.901 . . . . 61.42 108.566 170.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 pp -123.72 14.12 9.35 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.1 -0.954 . . . . 74.04 110.161 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.67 142.98 12.73 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.6 -1.182 . . . . 71.32 108.571 -176.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -75.99 117.25 17.51 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.642 0.777 . . . . 73.44 109.982 -172.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 66.12 5.21 3.45 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 125.566 1.547 . . . . 75.12 112.758 -176.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.9 t -125.07 96.64 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.422 -1.325 . . . . 65.13 107.422 -175.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.48 ' CE2' ' HB2' ' B' ' 50' ' ' GLN . 1.8 t80 -94.27 140.24 30.03 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.97 -0.752 . . . . 75.54 108.97 -172.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -106.47 105.09 14.96 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.524 -1.287 . . . . 70.41 107.524 -177.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -103.11 129.08 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.331 1.052 . . . . 73.1 109.718 -174.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.405 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 16.3 t -115.84 112.44 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.762 -0.829 . . . . 75.33 108.762 176.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -94.18 110.31 22.04 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.751 -1.203 . . . . 74.04 107.751 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.535 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 7.1 tmm_? -91.19 124.67 35.58 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.758 -0.83 . . . . 72.54 108.758 176.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 19.3 t -111.63 135.35 51.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.66 -1.237 . . . . 72.53 107.66 173.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 22.9 m -128.64 128.52 44.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.81 0.814 . . . . 72.13 109.274 171.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.57 HG13 HG13 ' B' ' 40' ' ' VAL . 79.6 t -107.09 114.84 47.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 114.09 -1.414 . . . . 44.33 108.584 172.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 88.6 m -96.03 135.93 37.16 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.017 -1.105 . . . . 73.41 108.017 165.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.35 141.82 25.35 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.207 -0.664 . . . . 63.14 109.207 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.572 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 18.5 p -143.61 134.87 25.85 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.646 -0.707 . . . . 65.04 111.207 -172.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.605 HD13 ' HB2' ' B' ' 34' ' ' LYS . 85.2 mt -106.88 104.01 13.59 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.925 1.29 . . . . 72.11 110.733 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.44 -125.08 7.15 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-O 120.118 -0.268 . . . . 73.4 112.781 178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -91.01 3.54 54.44 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.456 0.703 . . . . 64.43 111.77 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.556 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 13.1 pt-20 -135.2 146.68 48.92 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.066 0.546 . . . . 74.33 110.945 -170.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 49.1 m -71.91 130.54 41.27 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.843 -0.617 . . . . 73.33 110.842 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.572 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -79.33 -65.48 0.99 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.881 -1.054 . . . . 70.01 108.306 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -151.18 152.02 32.73 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.221 -0.899 . . . . 75.52 111.459 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 78.4 mt -118.99 109.39 15.89 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 105.928 -1.878 . . . . 52.23 105.928 168.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.6 t -117.29 135.43 53.83 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.877 -1.156 . . . . 62.23 107.877 -178.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.416 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 38.1 tt0 -149.5 135.96 19.23 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 108.725 -0.843 . . . . 73.22 108.725 -172.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.416 HG21 ' HB3' ' B' ' 113' ' ' CYS . 58.0 t -131.16 143.2 41.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 108.845 -0.798 . . . . 63.22 108.845 175.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -116.56 96.69 5.62 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.811 -1.181 . . . . 74.31 107.811 171.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 7.6 tp-100 -90.89 100.02 12.95 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.95 -0.759 . . . . 60.13 108.95 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.74 142.26 16.15 Favored Glycine 0 C--N 1.344 1.027 0 O-C-N 123.624 0.578 . . . . 74.23 111.705 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.45 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -142.67 125.93 2.75 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.643 -0.583 . . . . 71.44 111.643 -176.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 40.8 mt -84.93 115.73 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 107.517 -1.29 . . . . 63.13 107.517 171.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -128.93 146.26 51.0 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.583 0.753 . . . . 65.43 109.913 -177.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 44.4 m -94.0 110.09 21.8 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.374 0.67 . . . . 64.22 109.36 172.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 4.7 mp -112.91 111.42 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 108.154 -1.054 . . . . 75.52 108.154 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.679 ' HA ' ' HB ' ' F' ' 97' ' ' ILE . . . -155.51 169.24 24.73 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.11 0.564 . . . . 72.31 111.325 178.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.12 -67.63 0.85 Allowed Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.525 -0.63 . . . . 65.04 111.525 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.531 HG13 ' HG3' ' B' ' 9' ' ' MET . 0.9 OUTLIER -52.69 159.05 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 124.338 1.055 . . . . 65.35 111.759 168.333 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -151.46 145.77 25.45 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 112.624 0.602 . . . . 75.35 112.624 -171.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.442 ' O ' ' HG2' ' B' ' 94' ' ' MET . . . 70.09 -111.88 4.06 Favored Glycine 0 C--N 1.358 1.781 0 CA-C-N 115.453 -0.794 . . . . 70.31 113.985 173.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 8.9 m -73.44 -38.03 65.64 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 122.081 0.943 . . . . 70.44 109.625 177.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -69.63 -27.73 65.31 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 113.404 -1.725 . . . . 74.23 110.903 -170.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.525 ' HB2' HD11 ' F' ' 97' ' ' ILE . 25.1 ptt? -81.45 -43.91 18.2 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.345 0.658 . . . . 63.34 112.687 -173.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -79.3 -11.29 59.94 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.598 0.759 . . . . 62.21 112.19 -173.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -61.25 -35.31 76.91 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 122.505 0.322 . . . . 74.43 110.259 165.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.3 t -61.34 -61.09 2.79 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.812 0.445 . . . . 62.55 111.282 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.567 HD13 HD12 ' F' ' 102' ' ' LEU . 0.4 OUTLIER -71.56 -15.82 62.29 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 113.004 0.742 . . . . 74.21 113.004 -178.529 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.31 -2.45 59.02 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.689 -0.506 . . . . 71.14 113.532 -178.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.83 -59.87 0.18 Allowed 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.405 0.603 . . . . 54.4 111.881 -174.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -67.61 -48.25 67.34 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.077 0.951 . . . . 63.34 111.784 -173.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.523 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 63.6 m -65.0 -48.69 70.78 Favored Pre-proline 0 CA--C 1.563 1.47 0 C-N-CA 123.802 0.841 . . . . 73.32 111.509 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.523 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 74.6 Cg_exo -57.33 -29.49 84.32 Favored 'Trans proline' 0 C--N 1.4 3.26 0 C-N-CA 122.731 2.287 . . . . 75.24 113.991 170.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -67.7 -30.35 69.84 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 124.032 0.933 . . . . 65.1 110.682 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.475 HD13 HD11 ' B' ' 13' ' ' ILE . 62.2 mt -76.04 -41.29 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.466 0.706 . . . . 72.42 110.135 175.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.45 HD21 ' HA3' ' B' ' 82' ' ' GLY . 80.9 mt -71.86 -34.22 69.04 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.801 -1.091 . . . . 75.14 111.912 -175.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -59.49 -47.62 97.47 Favored Pre-proline 0 CA--C 1.56 1.327 0 CA-C-O 117.513 -1.232 . . . . 73.25 113.167 -170.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -56.2 -36.72 96.99 Favored 'Trans proline' 0 C--N 1.392 2.849 0 C-N-CA 122.363 2.042 . . . . 75.3 113.229 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.488 ' CD1' HG21 ' B' ' 16' ' ' ILE . 4.0 m-30 -70.68 -42.62 70.48 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.526 0.731 . . . . 61.54 109.978 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -66.76 -36.53 82.64 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.009 -0.996 . . . . 71.14 110.91 176.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.473 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 50.4 ttt-85 -64.36 -48.91 73.69 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.231 1.413 . . . . 75.31 110.749 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -70.07 -31.62 69.32 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.549 0.739 . . . . 44.11 109.768 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.511 ' O ' ' HG2' ' B' ' 117' ' ' MET . 11.5 t -67.29 -38.64 85.34 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 123.017 0.527 . . . . 75.02 110.515 177.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.454 HD13 HG23 ' B' ' 64' ' ' VAL . 63.5 mt -63.36 -55.71 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.971 0.908 . . . . 70.04 110.141 174.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.425 HG21 ' OG ' ' C' ' 119' ' ' SER . 24.2 m -60.97 -30.41 70.23 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 124.136 0.898 . . . . 64.02 111.268 -175.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 29.8 t -60.49 -52.29 65.83 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.469 0.708 . . . . 74.15 109.235 173.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.511 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 10.6 mmt -65.85 -35.82 81.72 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.28 0.632 . . . . 73.42 111.414 -175.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.6 t -63.75 -44.59 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 124.144 0.978 . . . . 52.24 110.655 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.3 t -67.55 -32.59 73.46 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.713 -1.13 . . . . 75.15 111.294 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.516 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 77.3 mtt-85 -66.55 -43.46 85.01 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.572 -0.74 . . . . 71.43 109.507 175.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.68 -7.79 66.05 Favored Glycine 0 C--N 1.352 1.444 0 O-C-N 123.801 0.688 . . . . 74.44 113.259 175.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.637 HG23 HD22 ' C' ' 127' ' ' ASN . 7.4 m 63.94 29.98 14.33 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.897 1.279 . . . . 71.51 110.662 177.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.408 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 37.0 m-85 -83.14 159.47 62.33 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.138 0.975 . . . . 74.15 111.062 176.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.422 ' HA ' ' HB2' ' F' ' 131' ' ' TRP . 87.2 Cg_exo -48.76 149.12 7.87 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.489 2.793 . . . . 34.04 114.65 177.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.478 HE21 ' ND2' ' B' ' 127' ' ' ASN . 65.9 tp60 -59.49 114.34 2.65 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 124.382 1.051 . . . . 73.33 111.613 -171.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.465 HD21 HG11 ' B' ' 64' ' ' VAL . 21.2 tp -111.66 102.07 10.41 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.891 0.876 . . . . 75.01 109.88 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.478 ' ND2' HE21 ' B' ' 125' ' ' GLN . 58.2 m-80 -107.58 119.01 38.24 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 107.793 -1.188 . . . . 72.41 107.793 167.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.473 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 42.1 mt -69.01 148.54 49.95 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 123.159 0.287 . . . . 75.31 110.711 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.36 147.5 97.08 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 123.429 0.692 . . . . 64.12 110.589 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.12 92.49 0.1 Allowed 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.505 2.137 . . . . 74.42 112.111 173.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.433 HG11 HD11 ' B' ' 44' ' ' LEU . 69.7 t -90.17 110.83 22.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 N-CA-C 109.321 -0.622 . . . . 72.14 109.321 177.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -96.75 105.19 17.27 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.34 -0.985 . . . . 65.01 108.34 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -65.46 -27.94 68.86 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.145 0.978 . . . . 63.15 111.302 -176.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -54.17 -43.59 70.77 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.504 1.122 . . . . 73.35 110.909 176.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.84 -42.28 98.84 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.812 0.845 . . . . 52.53 111.846 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 9.2 mp -61.22 -47.07 87.79 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.315 0.646 . . . . 74.0 110.926 -176.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -78.64 -47.04 17.84 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.957 -0.565 . . . . 71.24 111.915 -177.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 88.5 mtp -67.78 -36.32 80.25 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 122.856 0.462 . . . . 73.21 112.022 -173.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -76.81 -21.2 55.44 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.521 0.329 . . . . 75.2 111.029 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -76.62 -39.23 53.11 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.855 -0.424 . . . . 71.12 109.855 171.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 11.1 mp -81.01 11.09 4.3 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.085 0.954 . . . . 73.43 111.727 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 72.55 150.75 0.1 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.56 1.544 . . . . 73.11 111.766 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . 0.416 ' O ' ' HB3' ' B' ' 1' ' ' MET . 49.6 mt-30 -84.01 -53.86 5.26 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.502 0.721 . . . . 70.21 109.886 177.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 54.47 86.42 0.05 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.832 1.253 . . . . 72.45 109.64 -178.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -141.76 135.77 30.07 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.161 0.584 . . . . 41.33 109.636 -175.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.18 -161.55 27.4 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 123.482 0.489 . . . . 53.03 111.972 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 70.38 100.62 0.06 Allowed 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.503 1.121 . . . . 75.42 111.476 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . 0.452 ' HA2' ' OD1' ' D' ' 5' ' ' ASN . . . -109.73 74.85 0.21 Allowed Glycine 0 C--N 1.347 1.182 0 CA-C-N 115.445 -0.798 . . . . 73.23 111.933 177.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 36.9 p -67.11 154.68 40.64 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 121.243 0.544 . . . . 64.01 112.011 -176.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -119.63 177.56 4.9 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.828 1.251 . . . . 61.03 109.384 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.28 -121.38 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 107.529 -1.285 . . . . 72.24 107.529 -177.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -144.82 133.88 22.69 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.524 1.129 . . . . 72.3 108.001 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -76.63 80.86 3.28 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.996 0.518 . . . . 73.01 109.622 174.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -56.24 120.26 7.28 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.05 0.94 . . . . 72.4 111.305 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 C-N-CA 123.618 0.767 . . . . 64.14 110.289 -176.212 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 109.171 -0.677 . . . . 75.31 109.171 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -50.58 -56.61 10.94 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.324 1.449 . . . . 63.31 111.049 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -175.35 -83.78 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 104.199 -2.519 . . . . 70.11 104.199 172.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -147.01 124.64 11.78 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 107.283 -1.377 . . . . 73.24 107.283 168.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . 0.411 ' ND2' ' HB1' ' C' ' 87' ' ' ALA . 48.9 t30 -75.63 122.14 23.5 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.748 0.419 . . . . 53.51 110.657 -174.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -80.88 97.82 7.58 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.842 0.857 . . . . 62.43 110.632 -174.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 8.5 t -171.34 149.85 2.82 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.069 0.947 . . . . 73.1 110.016 174.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -101.45 72.0 1.38 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.676 0.79 . . . . 63.31 108.954 -177.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.4 ' CE ' HD13 ' C' ' 89' ' ' ILE . 9.3 ttt 65.69 122.57 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.662 1.585 . . . . 72.33 113.113 -176.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 32.0 m -133.38 119.03 19.15 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 124.103 0.961 . . . . 72.42 108.828 170.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.412 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 55.7 t80 -109.18 136.24 48.98 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.713 -0.847 . . . . 75.14 108.713 169.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.813 ' HG2' ' HA ' ' E' ' 136' ' ' LYS . 1.3 tp60 -157.91 144.23 17.55 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.3 0.375 . . . . 75.24 110.54 168.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 57.2 mt -82.65 135.07 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 115.467 -0.788 . . . . 64.2 109.384 175.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.512 HE22 ' HB2' ' E' ' 136' ' ' LYS . 29.8 mm-40 -98.92 -46.47 5.61 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.475 0.71 . . . . 65.13 109.706 172.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.646 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -170.69 146.16 2.61 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.603 0.761 . . . . 74.31 110.746 174.037 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 36.3 mm -115.64 139.23 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 106.467 -1.679 . . . . 70.41 106.467 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.532 ' HB3' HG23 ' D' ' 122' ' ' THR . 19.3 p90 -169.45 157.78 7.53 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.896 0.855 . . . . 72.2 111.987 -171.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.6 p -82.9 102.87 11.96 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 114.222 -1.354 . . . . 74.43 109.422 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.642 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 11.2 mmmm -65.14 -34.36 78.21 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.381 0.61 . . . . 74.01 109.392 171.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.593 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.5 t70 -153.4 145.7 23.93 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.63 -1.168 . . . . 74.42 109.24 -175.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.525 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.5 mt -140.85 145.77 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 125.615 1.566 . . . . 52.54 107.098 176.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.6 t -156.27 150.57 25.5 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.179 0.514 . . . . 61.13 110.266 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -149.37 131.74 15.62 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.168 -1.419 . . . . 74.1 107.168 174.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -133.92 111.8 10.74 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 109.108 -0.701 . . . . 72.33 109.108 -177.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.66 82.14 67.45 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 107.657 -1.238 . . . . 70.32 107.657 170.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -61.84 -44.97 18.37 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.552 2.168 . . . . 71.54 111.276 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -92.89 21.06 5.96 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.472 -1.24 . . . . 75.4 111.082 -176.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.423 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -46.62 -58.3 7.07 Favored Pre-proline 0 N--CA 1.492 1.655 0 C-N-CA 124.226 1.01 . . . . 62.31 113.471 -172.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -60.94 -38.95 65.11 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 121.679 1.586 . . . . 63.31 112.44 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -69.24 -39.38 78.55 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.348 -0.842 . . . . 73.54 111.419 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.71 HG21 ' HA ' ' C' ' 73' ' ' ALA . 8.5 p -78.46 -17.29 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.187 0 C-N-CA 123.009 0.524 . . . . 62.21 112.308 -171.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -70.81 -15.54 62.66 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 112.194 0.442 . . . . 74.53 112.194 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -109.17 19.68 19.19 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.13 0.572 . . . . 72.55 111.09 174.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.85 158.7 15.72 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.385 0.674 . . . . 71.14 109.757 173.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.56 125.33 23.91 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.34 0.656 . . . . 52.3 109.377 167.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 62.3 t-105 -85.37 80.25 9.2 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.164 0.586 . . . . 73.53 110.364 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -121.79 76.92 38.56 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 124.368 1.067 . . . . 73.33 108.316 170.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.612 ' HG2' HG23 ' F' ' 133' ' ' THR . 1.9 Cg_endo -85.35 119.45 2.03 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 123.553 2.835 . . . . 55.23 112.608 -170.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -87.35 94.62 9.73 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.468 -1.242 . . . . 70.34 108.487 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.02 110.12 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 113.869 -1.514 . . . . 61.11 110.526 -172.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.516 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 18.2 tptm -92.2 105.47 17.68 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.45 -0.945 . . . . 55.51 108.45 169.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 pp -86.9 128.89 35.06 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 106.64 -1.615 . . . . 74.3 106.64 169.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.532 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 16.3 t70 -125.78 105.31 8.87 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 108.897 -0.779 . . . . 75.43 108.897 -172.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 96.1 mt -96.27 130.85 43.26 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.356 0.662 . . . . 64.11 110.521 -174.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -144.58 125.71 14.6 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.731 1.212 . . . . 73.12 107.938 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.1 t -121.86 151.74 40.34 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 109.621 -0.511 . . . . 73.4 109.621 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.93 148.24 31.58 Favored 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 124.355 1.062 . . . . 74.23 108.354 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 13.6 m -143.43 143.77 31.75 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.332 -0.618 . . . . 74.52 109.332 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 65.0 p -145.22 136.36 24.88 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.931 0.892 . . . . 73.54 109.34 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -79.07 117.69 20.34 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 109.016 -0.735 . . . . 75.23 109.016 176.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.631 HD11 ' HB2' ' C' ' 57' ' ' GLU . 68.4 mt -84.25 -38.91 19.92 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.483 0.713 . . . . 61.2 110.19 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.22 -169.48 3.06 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.349 -0.841 . . . . 74.03 110.273 -178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.02 104.27 0.1 Allowed 'General case' 0 N--CA 1.481 1.088 0 O-C-N 124.185 0.928 . . . . 51.5 110.985 176.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 60.25 35.74 20.85 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 124.603 1.19 . . . . 73.15 111.338 174.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 84.4 t -127.7 119.24 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.867 -1.16 . . . . 72.11 107.867 174.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -123.63 124.13 42.1 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.961 0.905 . . . . 73.43 109.602 -177.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.631 ' HB2' HD11 ' C' ' 51' ' ' LEU . 39.0 tt0 -85.51 132.11 34.25 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.471 -0.937 . . . . 74.35 108.471 167.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 51.5 t -118.82 143.71 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 109.32 -0.622 . . . . 52.02 109.32 171.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 90.3 t -124.33 140.54 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 C-N-CA 125.226 1.41 . . . . 53.41 108.433 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.403 HD11 ' CZ ' ' C' ' 133' ' ' PHE . 0.0 OUTLIER -121.14 96.96 5.3 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.184 -1.413 . . . . 75.1 107.184 173.833 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -82.2 105.91 13.67 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.465 -0.939 . . . . 74.25 108.465 173.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.415 ' HB ' HD11 ' C' ' 114' ' ' ILE . 28.6 t -105.38 129.01 58.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.769 -1.197 . . . . 75.42 107.769 173.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 69.5 m -116.42 125.06 51.49 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.499 -0.926 . . . . 62.01 108.499 175.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.45 HG21 HG21 ' C' ' 114' ' ' ILE . 68.0 t -103.83 110.25 29.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 109.2 -0.667 . . . . 70.22 109.2 170.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.516 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 7.4 m -96.48 131.97 42.52 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 106.83 -1.544 . . . . 73.31 106.83 170.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.75 113.39 14.66 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 106.682 -1.599 . . . . 72.23 106.682 -176.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 36.8 m -134.04 126.97 31.28 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-O 121.0 0.429 . . . . 75.24 110.144 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 16.2 mt -85.09 36.9 0.64 Allowed 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 125.829 1.652 . . . . 43.22 110.482 177.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.5 -92.62 1.04 Allowed Glycine 0 C--N 1.358 1.8 0 N-CA-C 111.085 -0.806 . . . . 74.2 111.085 176.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -90.33 -19.61 23.84 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.424 1.09 . . . . 73.14 110.697 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -103.54 124.13 48.21 Favored 'General case' 0 C--O 1.218 -0.602 0 C-N-CA 125.335 1.454 . . . . 73.51 109.293 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 83.5 m -78.78 123.94 27.7 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.042 0.837 . . . . 72.4 109.222 167.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.71 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -70.55 -59.03 3.08 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.957 0.786 . . . . 74.51 109.335 174.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -162.54 173.77 13.54 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-O 121.468 0.651 . . . . 64.2 110.953 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.434 HD23 HG23 ' C' ' 65' ' ' THR . 2.7 tm? -138.0 104.16 5.17 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 106.435 -1.691 . . . . 64.34 106.435 175.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 49.3 t -108.21 145.42 34.28 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.26 -1.015 . . . . 71.31 108.26 176.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -154.25 128.79 9.23 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.304 -0.628 . . . . 75.25 109.304 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 69.1 t -126.91 136.2 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.011 0.924 . . . . 74.32 109.025 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.593 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.1 mt-30 -105.03 90.2 3.37 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.165 -1.05 . . . . 62.44 108.165 170.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -80.33 98.85 7.62 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.475 -0.784 . . . . 71.11 109.862 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.47 170.28 48.39 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 116.255 -0.429 . . . . 44.45 112.274 176.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.94 119.75 0.78 Allowed Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.82 -0.912 . . . . 54.51 110.82 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.448 HD12 HD11 ' C' ' 51' ' ' LEU . 36.0 mm -82.02 124.96 39.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.741 -0.837 . . . . 64.01 108.741 176.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -126.7 119.06 26.03 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 124.059 0.849 . . . . 64.24 108.779 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 12.4 p -80.65 99.21 8.04 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.895 -1.15 . . . . 74.55 107.895 172.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.562 HG21 ' HE3' ' C' ' 94' ' ' MET . 20.9 mt -118.14 123.87 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 109.403 -0.591 . . . . 74.55 109.403 -177.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.411 ' HB1' ' ND2' ' C' ' 5' ' ' ASN . . . -127.59 155.22 44.2 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.903 0.705 . . . . 54.32 112.903 -171.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.88 -28.13 6.79 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.13 -0.941 . . . . 50.52 115.14 168.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.643 HD11 ' HE3' ' C' ' 94' ' ' MET . 37.5 pt -96.16 159.04 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-O 121.726 0.774 . . . . 75.14 112.232 -175.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -149.41 -173.08 4.29 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 113.781 -1.554 . . . . 74.45 108.069 171.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.74 -128.22 46.15 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.494 0.496 . . . . 55.43 113.973 171.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 10.2 t -74.08 -32.13 63.12 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.142 0.977 . . . . 61.24 112.571 -174.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -65.88 -52.72 47.77 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.186 0.595 . . . . 75.44 109.987 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.643 ' HE3' HD11 ' C' ' 89' ' ' ILE . 4.6 tpt -54.72 -48.75 72.13 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 124.149 0.905 . . . . 75.31 111.632 173.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.43 -38.14 76.82 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.988 0.805 . . . . 71.12 111.388 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -80.42 -29.58 37.65 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.31 0.644 . . . . 74.41 111.805 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.413 ' SG ' HD13 ' C' ' 86' ' ' ILE . 35.0 t -70.35 -34.79 73.05 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.999 -0.741 . . . . 73.44 108.999 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 69.3 mt -87.36 -28.8 21.99 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.035 1.334 . . . . 62.41 111.123 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.42 -28.07 41.24 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 115.804 -0.635 . . . . 52.22 114.397 -170.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -139.21 -52.33 0.55 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 111.934 0.346 . . . . 63.1 111.934 -169.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -64.73 -53.65 43.81 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 123.293 0.371 . . . . 73.42 110.988 -173.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.412 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 94.9 m -59.23 -49.93 90.24 Favored Pre-proline 0 CA--C 1.564 1.5 0 CA-C-O 118.173 -0.918 . . . . 72.55 111.976 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -53.79 -33.25 69.93 Favored 'Trans proline' 0 C--N 1.397 3.125 0 C-N-CA 122.666 2.244 . . . . 72.35 114.628 171.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -67.1 -32.3 73.37 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 122.86 0.464 . . . . 71.12 110.958 176.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 44.0 mm -72.87 -40.71 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.041 0.536 . . . . 72.23 109.637 176.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 76.0 mt -78.9 -27.01 43.85 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.144 0.978 . . . . 71.11 112.272 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -56.43 -49.41 93.63 Favored Pre-proline 0 CA--C 1.56 1.328 0 N-CA-C 114.547 1.314 . . . . 71.23 114.547 -173.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -60.84 -38.65 68.54 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 122.022 1.815 . . . . 63.45 112.67 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -67.93 -41.06 83.13 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.451 -0.795 . . . . 72.14 110.119 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.9 -42.69 99.87 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.784 0.834 . . . . 75.11 109.929 175.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 49.0 ttt180 -57.76 -55.65 32.16 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.329 1.052 . . . . 72.34 110.377 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -66.07 -30.59 71.13 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.16 0.584 . . . . 75.31 110.426 -174.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.401 ' SG ' HG12 ' C' ' 21' ' ' ILE . 21.4 t -72.54 -33.89 67.15 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 122.94 0.496 . . . . 74.01 111.453 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.45 HG21 HG21 ' C' ' 64' ' ' VAL . 96.3 mt -75.15 -49.58 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 123.554 0.742 . . . . 74.34 110.144 175.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 13.5 m -67.14 -28.95 68.56 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.249 1.02 . . . . 71.14 110.819 -175.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 27.2 t -63.07 -50.07 72.05 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 108.612 -0.884 . . . . 71.53 108.612 170.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.534 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.52 -35.44 77.72 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.585 1.154 . . . . 73.33 112.602 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 93.3 t -63.36 -47.01 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.61 0.764 . . . . 63.3 109.706 173.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.425 ' OG ' HG21 ' B' ' 115' ' ' THR . 46.5 t -68.53 -28.94 67.43 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.813 -1.085 . . . . 63.42 111.506 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' C' ' 116' ' ' SER . 86.5 mtt-85 -72.06 -42.45 66.22 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.031 -0.729 . . . . 72.33 109.031 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.65 -0.82 60.04 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 115.588 -0.733 . . . . 70.03 112.686 170.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.8 p 61.59 32.68 18.57 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 126.493 1.917 . . . . 73.52 113.375 171.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -83.34 155.19 66.53 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 108.638 -0.875 . . . . 73.14 108.638 170.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -50.63 159.42 2.23 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.994 2.462 . . . . 71.34 113.947 171.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' B' ' 123' ' ' PHE . 2.9 mm-40 -51.01 138.79 18.82 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.815 1.246 . . . . 74.41 112.292 -176.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.454 HD13 HG21 ' F' ' 133' ' ' THR . 50.7 tp -149.1 86.2 1.49 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.123 -0.695 . . . . 42.34 109.123 178.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . 0.637 HD22 HG23 ' B' ' 122' ' ' THR . 83.6 m-20 -91.64 123.29 34.93 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.219 -0.9 . . . . 74.11 108.707 175.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.08 119.81 15.74 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.403 -0.962 . . . . 75.43 108.403 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.29 143.57 95.45 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 123.768 0.827 . . . . 75.14 110.923 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -51.71 98.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 123.128 2.552 . . . . 62.42 113.014 174.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 60.2 t -98.29 111.7 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.489 -1.301 . . . . 74.12 107.489 173.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -74.03 102.82 4.3 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.048 0.539 . . . . 52.24 110.566 -174.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.403 ' CZ ' HD11 ' C' ' 60' ' ' LEU . 81.0 m-85 -62.18 -25.26 67.68 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.841 0.856 . . . . 74.12 111.454 176.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' C' ' 138' ' ' MET . 23.9 t70 -62.17 -49.96 73.71 Favored 'General case' 0 C--N 1.347 0.485 0 O-C-N 123.881 0.738 . . . . 62.15 109.713 177.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.16 -43.05 92.09 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 124.176 0.922 . . . . 43.54 111.654 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 79.7 mt -64.28 -39.89 94.85 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 114.953 -1.021 . . . . 73.54 111.428 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -82.45 -23.6 34.7 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.256 -0.429 . . . . 74.54 111.468 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.491 ' HG2' ' O ' ' C' ' 134' ' ' ASP . 22.2 mmt -63.81 -30.19 71.31 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 110.024 -0.362 . . . . 72.02 110.024 174.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -61.47 -41.88 97.92 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.035 0.934 . . . . 74.32 110.699 173.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -69.75 -83.35 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 115.315 -0.857 . . . . 64.12 109.745 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 15.0 tp -140.03 132.7 28.89 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.292 -1.003 . . . . 54.32 108.292 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -121.57 13.77 10.94 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.611 0.967 . . . . 74.14 113.611 -163.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 -88.37 139.79 30.13 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 109.69 -0.485 . . . . 74.3 109.69 177.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -170.84 174.46 4.84 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.631 0.772 . . . . 74.45 111.642 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -136.68 93.26 2.84 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 106.929 -1.508 . . . . 70.41 106.929 162.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -82.94 47.34 3.8 Favored Glycine 0 N--CA 1.476 1.357 0 C-N-CA 123.298 0.475 . . . . 31.2 113.953 -173.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -164.24 112.8 1.15 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.172 1.389 . . . . 74.41 107.885 177.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -110.82 178.84 19.91 Favored Glycine 0 C--N 1.339 0.705 0 CA-C-N 116.253 -0.43 . . . . 53.33 113.649 -175.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 1.4 p -156.14 111.04 2.88 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.131 1.373 . . . . 74.54 109.617 -176.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.58 158.94 16.71 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 107.906 -1.146 . . . . 60.12 107.906 171.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -120.62 -68.45 0.91 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.72 -0.845 . . . . 72.52 108.72 172.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -156.52 138.93 14.84 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.388 1.075 . . . . 75.41 110.008 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -144.37 161.66 38.43 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.582 1.153 . . . . 54.42 109.584 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -76.13 170.67 15.85 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.308 0.643 . . . . 64.41 111.472 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.188 0 C-N-CA 124.024 0.93 . . . . 75.32 109.814 178.4 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.483 1.197 0 CA-C-O 120.856 0.36 . . . . 72.54 110.198 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 39.5 t -148.49 118.14 7.04 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.622 -0.881 . . . . 71.43 108.622 178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -70.82 176.74 4.03 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.438 0.695 . . . . 73.11 111.354 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . 0.45 ' NE2' ' HA ' ' E' ' 97' ' ' ILE . 20.8 mm-40 -99.27 105.59 17.62 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.305 0.642 . . . . 74.23 109.829 -175.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . 0.452 ' OD1' ' HA2' ' B' ' 148' ' ' GLY . 16.1 t30 -111.23 133.99 53.16 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.1 0.96 . . . . 72.51 109.884 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -60.25 -41.66 93.67 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.388 1.075 . . . . 74.01 111.713 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.81 -16.16 60.13 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.496 0.554 . . . . 72.25 112.496 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' D' ' 5' ' ' ASN . 30.8 tt0 -72.87 -30.32 63.88 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 118.679 -0.677 . . . . 75.12 110.889 174.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.413 ' HG2' HG13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -29.15 123.68 0.13 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 125.483 1.74 . . . . 74.22 113.746 -169.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 7.4 p -118.83 142.36 47.8 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.361 1.064 . . . . 64.42 109.806 -173.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.404 ' HD2' HG22 ' D' ' 86' ' ' ILE . 82.0 t80 -142.67 102.34 4.03 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.078 -1.082 . . . . 73.41 108.078 176.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -119.55 126.29 50.87 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.46 0.704 . . . . 74.14 109.465 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mt -91.79 137.89 21.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 123.657 0.783 . . . . 54.11 109.203 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.406 ' NE2' HG22 ' D' ' 83' ' ' ILE . 51.2 mt-30 -110.92 -44.41 3.62 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.191 0.596 . . . . 55.51 111.678 -176.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -169.03 122.98 0.82 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.822 -0.172 . . . . 64.11 110.566 -168.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.1 mp -103.82 137.17 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 107.287 -1.375 . . . . 73.14 107.287 166.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -158.33 146.62 18.62 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.228 0.611 . . . . 73.44 110.804 174.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -76.88 114.53 15.75 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.398 -0.819 . . . . 61.02 109.034 173.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -81.12 -21.13 40.09 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.586 -0.733 . . . . 53.12 109.896 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 7.3 t70 -162.12 142.67 10.29 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.941 1.297 . . . . 71.31 109.225 -176.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.534 HG21 ' HE2' ' C' ' 117' ' ' MET . 79.5 mt -142.94 148.73 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 124.889 1.276 . . . . 73.12 108.549 176.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.3 t -150.28 145.3 26.1 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.052 1.341 . . . . 51.13 108.352 172.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.525 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.5 t80 -151.69 136.18 16.92 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.497 -1.668 . . . . 75.33 106.497 171.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.508 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 48.0 mt-10 -138.97 148.55 43.64 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.335 0.654 . . . . 74.33 109.819 -176.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.68 78.43 9.1 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 107.718 -1.216 . . . . 74.22 107.718 175.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.6 -31.31 8.86 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.514 2.142 . . . . 74.52 112.827 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -94.46 -1.48 53.48 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.368 0.667 . . . . 71.31 111.096 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.642 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -24.55 -66.96 0.07 OUTLIER Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 126.841 2.057 . . . . 71.24 116.356 -164.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.71 -20.7 11.83 Favored 'Trans proline' 0 C--N 1.385 2.472 0 CA-C-N 123.046 2.124 . . . . 55.32 113.92 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.505 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 3.9 t-160 -73.25 -39.24 65.61 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.055 0.942 . . . . 75.43 109.365 174.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.517 HG22 HD12 ' D' ' 68' ' ' LEU . 5.6 p -83.57 -24.12 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 CA-C-N 115.627 -0.715 . . . . 60.41 111.14 -172.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -63.83 -29.31 70.52 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.085 0.469 . . . . 75.14 111.207 176.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.505 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 69.5 mt-30 -56.87 -29.3 62.81 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.547 -1.206 . . . . 71.22 110.493 176.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -84.42 71.48 10.7 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 124.731 1.212 . . . . 74.31 109.498 169.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -76.85 92.92 3.66 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.185 -0.916 . . . . 71.22 109.676 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 7.7 p90 -164.91 -165.82 0.96 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.128 0.971 . . . . 73.31 109.964 173.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -77.68 115.02 46.43 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.471 1.108 . . . . 73.12 110.965 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.73 130.45 26.3 Favored 'Trans proline' 0 C--N 1.388 2.645 0 C-N-CA 122.649 2.233 . . . . 71.31 111.203 173.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.436 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 30.0 mm-40 -67.52 109.6 3.3 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 108.122 -1.066 . . . . 63.44 108.122 171.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.66 HG13 HG13 ' D' ' 64' ' ' VAL . 45.7 t -99.16 128.07 51.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 108.774 -0.824 . . . . 75.33 108.774 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.02 127.87 48.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.605 -1.628 . . . . 63.32 106.605 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.613 HD11 HG13 ' D' ' 62' ' ' VAL . 55.4 tp -95.82 145.64 25.19 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.533 0.733 . . . . 72.41 110.522 -173.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.512 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 10.1 t70 -142.47 111.9 6.65 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 106.486 -1.672 . . . . 71.25 106.486 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.44 ' HB3' HD23 ' E' ' 111' ' ' LEU . 79.1 mt -109.71 145.27 36.86 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.256 0.55 . . . . 55.45 110.87 -174.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.701 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.0 t70 -137.33 149.88 47.35 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.71 1.204 . . . . 71.32 108.378 177.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . 0.47 ' HB ' HG21 ' E' ' 107' ' ' THR . 30.2 m -120.92 144.16 48.59 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.82 -0.807 . . . . 60.43 108.82 173.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.546 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -147.23 170.31 17.51 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.931 1.292 . . . . 24.33 107.653 -177.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 10.0 p -168.38 165.32 12.79 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.692 0.397 . . . . 60.14 110.7 -172.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 12.0 p -169.68 165.95 9.94 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.646 0.778 . . . . 74.4 110.152 -173.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . 0.438 ' HB2' ' HA ' ' D' ' 56' ' ' TYR . 69.1 mm-40 79.93 157.55 0.16 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.193 1.797 . . . . 74.13 111.255 -176.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.697 ' H ' HD23 ' D' ' 51' ' ' LEU . 1.1 pt? -63.5 133.15 53.37 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.391 -1.277 . . . . 63.01 111.444 -177.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -86.66 82.4 7.89 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.387 1.075 . . . . 73.04 111.951 -167.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -150.72 74.37 1.17 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.864 0.84 . . . . 63.31 109.202 175.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' D' ' 85' ' ' SER . 68.0 m-20 62.84 -9.15 0.11 Allowed 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 125.856 1.663 . . . . 62.24 114.74 -176.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 40.4 t -135.62 96.04 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 119.316 0.962 . . . . 62.52 108.557 -173.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.438 ' HA ' ' HB2' ' D' ' 50' ' ' GLN . 1.3 p90 -152.51 161.27 42.81 Favored 'General case' 0 C--O 1.247 0.921 0 CA-C-N 114.299 -1.319 . . . . 61.52 108.649 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.545 ' HG2' HG12 ' D' ' 83' ' ' ILE . 36.1 mt-10 -89.77 143.74 26.55 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 114.934 -1.03 . . . . 74.2 110.323 177.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.431 HG11 ' HD3' ' D' ' 103' ' ' PRO . 91.6 t -116.75 139.67 42.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 113.251 -1.795 . . . . 52.33 106.902 167.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 41.5 t -129.22 129.87 67.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.426 -0.953 . . . . 74.15 108.426 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.537 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -110.95 120.64 43.07 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.251 -1.389 . . . . 73.22 107.251 173.849 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.701 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 7.3 ttm180 -102.03 100.88 11.19 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.091 -1.077 . . . . 75.52 108.091 175.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.613 HG13 HD11 ' D' ' 42' ' ' LEU . 49.0 t -92.12 122.84 43.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 108.299 -1.0 . . . . 64.54 108.299 173.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 17.5 m -122.05 129.13 52.14 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.745 -0.835 . . . . 73.41 108.745 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.66 HG13 HG13 ' D' ' 40' ' ' VAL . 67.5 t -118.8 121.02 65.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 124.281 1.032 . . . . 73.11 109.186 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 49.8 m -106.84 114.61 28.8 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 107.155 -1.424 . . . . 75.44 107.155 164.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.55 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -119.86 142.84 48.29 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.553 0.741 . . . . 64.25 109.25 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.561 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 68.6 p -147.32 130.92 16.83 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.141 0.422 . . . . 71.12 112.141 -170.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.517 HD12 HG22 ' D' ' 31' ' ' VAL . 18.7 mt -93.84 105.95 17.95 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.15 0.98 . . . . 61.51 108.38 175.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.08 -116.28 4.29 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 110.94 -0.864 . . . . 70.43 110.94 -174.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.51 4.95 16.44 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.312 0.645 . . . . 54.42 111.955 177.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -115.9 155.43 27.97 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.604 0.361 . . . . 70.55 110.842 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 61.7 m -64.91 119.85 11.46 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.924 0.889 . . . . 75.41 112.209 -177.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.561 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -79.24 -69.8 0.55 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.623 -1.251 . . . . 72.44 107.623 171.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -145.6 149.52 34.7 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 114.988 -1.005 . . . . 73.34 110.704 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 65.6 mt -112.54 152.97 28.21 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.906 1.282 . . . . 74.41 107.957 172.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.745 ' SG ' HG12 ' D' ' 114' ' ' ILE . 53.3 t -158.35 144.91 17.43 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.784 0.434 . . . . 53.01 110.058 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -155.65 125.89 6.68 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.042 0.537 . . . . 73.43 109.757 173.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 87.7 t -131.26 115.42 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 123.759 0.824 . . . . 73.41 109.231 -177.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.518 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.7 mt-30 -88.63 85.16 6.75 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.636 -0.876 . . . . 70.2 108.636 170.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -81.05 98.86 8.17 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 113.998 -1.456 . . . . 64.54 109.377 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.51 162.16 24.37 Favored Glycine 0 N--CA 1.465 0.596 0 N-CA-C 112.295 -0.322 . . . . 63.12 112.295 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.87 136.94 4.49 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.676 -0.569 . . . . 74.24 111.676 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.545 HG12 ' HG2' ' D' ' 57' ' ' GLU . 44.2 mt -90.76 105.59 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 108.779 -0.823 . . . . 73.22 108.779 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -107.93 141.75 39.09 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.727 0.811 . . . . 73.13 109.821 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' D' ' 54' ' ' ASP . 3.9 t -115.73 110.36 19.01 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 109.078 -0.712 . . . . 52.31 109.078 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.404 HG22 ' HD2' ' D' ' 11' ' ' PHE . 44.2 pt -126.67 134.33 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 123.531 0.732 . . . . 74.54 110.942 -174.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.95 170.36 17.87 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.888 0.875 . . . . 65.13 110.813 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.3 23.81 53.3 Favored Glycine 0 C--N 1.355 1.602 0 O-C-N 123.424 0.452 . . . . 71.34 113.171 173.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.611 HG22 HE21 ' D' ' 93' ' ' GLN . 0.7 OUTLIER -140.82 144.86 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.449 0.7 . . . . 75.0 110.327 179.016 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -131.65 175.92 8.76 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.406 1.082 . . . . 73.44 110.492 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.82 -128.22 10.94 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 115.628 -0.715 . . . . 73.13 113.518 173.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 9.7 t -87.0 -38.39 16.63 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.233 0.613 . . . . 70.22 110.903 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.611 HE21 HG22 ' D' ' 89' ' ' ILE . 13.8 pt20 -69.05 -22.07 64.05 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.261 0.625 . . . . 75.34 112.666 -171.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -64.49 -49.63 70.6 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.078 0.466 . . . . 74.12 111.081 177.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.09 -13.82 49.13 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.868 0.867 . . . . 70.23 110.965 -177.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -75.49 -22.83 56.85 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.061 0.545 . . . . 74.43 109.677 175.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 75.3 m -71.33 -50.98 26.9 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.077 0.551 . . . . 72.35 110.749 176.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 pp -67.03 -28.1 67.95 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.854 0.461 . . . . 64.25 111.772 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.15 -20.64 48.65 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.609 -0.551 . . . . 53.43 113.584 -178.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.52 -57.31 1.21 Allowed 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 117.794 0.797 . . . . 64.05 112.689 -170.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -68.94 -39.04 79.8 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 122.907 0.483 . . . . 74.51 111.281 -173.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 91.9 m -68.29 -47.09 38.82 Favored Pre-proline 0 CA--C 1.57 1.723 0 CA-C-O 118.401 -0.809 . . . . 73.42 111.767 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.537 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 86.4 Cg_exo -54.98 -33.31 82.46 Favored 'Trans proline' 0 C--N 1.402 3.355 0 C-N-CA 122.605 2.204 . . . . 72.04 113.685 166.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -65.86 -29.06 69.45 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.967 0.507 . . . . 54.44 111.139 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.1 mm -79.33 -33.66 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.901 0.88 . . . . 52.43 110.689 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 89.7 mt -75.1 -24.13 58.05 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.057 0.543 . . . . 72.32 112.147 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -67.37 -39.29 19.45 Favored Pre-proline 0 CA--C 1.562 1.437 0 CA-C-O 117.742 -1.123 . . . . 70.41 113.751 -172.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -50.48 -44.19 40.9 Favored 'Trans proline' 0 C--N 1.389 2.661 0 C-N-CA 122.182 1.921 . . . . 73.53 113.419 168.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -77.37 -35.49 54.47 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.778 0.831 . . . . 75.12 111.566 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.26 -47.51 67.53 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.546 0.738 . . . . 74.33 109.757 -177.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.489 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 34.8 ttp180 -59.27 -43.67 92.49 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-N 114.643 -1.162 . . . . 71.25 110.254 172.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -55.13 -50.35 69.48 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 124.022 0.826 . . . . 52.35 111.365 -176.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.461 ' O ' ' HG3' ' D' ' 117' ' ' MET . 42.5 t -56.77 -44.58 81.97 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 124.453 1.096 . . . . 71.15 110.549 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.745 HG12 ' SG ' ' D' ' 76' ' ' CYS . 76.7 mt -62.71 -52.6 57.6 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 C-N-CA 124.159 0.984 . . . . 72.05 110.941 176.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 91.9 m -53.39 -45.58 69.33 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.502 1.521 . . . . 74.51 110.337 -175.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.9 t -64.94 -45.82 84.16 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.514 -1.676 . . . . 75.12 110.072 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.461 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 71.8 mtm -68.99 -30.13 68.48 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.824 0.449 . . . . 73.53 111.964 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.437 HG23 ' O ' ' D' ' 114' ' ' ILE . 78.6 t -67.07 -46.03 85.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.793 0.837 . . . . 74.41 109.218 176.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 83.4 p -72.61 -28.42 62.76 Favored 'General case' 0 CA--C 1.554 1.125 0 CA-C-N 115.737 -0.665 . . . . 75.34 110.682 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 55.0 mtt-85 -74.61 -31.04 61.89 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.68 0.792 . . . . 75.3 110.165 175.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.94 4.41 85.37 Favored Glycine 0 C--N 1.354 1.574 0 O-C-N 123.466 0.479 . . . . 41.44 112.629 177.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.532 HG23 ' HB3' ' C' ' 17' ' ' TYR . 43.5 p 58.9 32.1 21.93 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 126.152 1.781 . . . . 64.52 112.67 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -96.83 150.11 36.52 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 115.392 -0.822 . . . . 73.33 109.786 170.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.499 ' HB3' ' HA ' ' E' ' 129' ' ' THR . 22.5 Cg_exo -43.29 122.82 3.15 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 124.042 3.161 . . . . 65.21 114.121 172.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -52.44 123.18 10.31 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.858 1.263 . . . . 72.54 112.049 -173.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.515 HD13 HG21 ' D' ' 40' ' ' VAL . 28.1 tp -107.63 112.46 25.19 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.299 1.04 . . . . 75.15 109.655 -176.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -116.07 79.63 1.33 Allowed 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.505 -0.924 . . . . 62.23 108.505 176.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.516 HD11 HD22 ' D' ' 42' ' ' LEU . 0.3 OUTLIER -58.42 119.7 7.44 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 123.153 0.581 . . . . 53.54 109.918 -174.159 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -54.32 130.04 60.93 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 124.233 1.013 . . . . 54.31 112.317 -175.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.467 ' HG3' HH12 ' D' ' 111' ' ' ARG . 1.6 Cg_endo -76.59 118.19 4.79 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.481 2.121 . . . . 74.53 111.134 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 12.8 p -108.47 152.07 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.531 0.733 . . . . 74.05 109.51 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -72.99 102.21 3.42 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.414 -0.587 . . . . 73.3 109.414 177.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -60.81 -32.55 71.9 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.766 0.826 . . . . 64.44 111.205 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -56.83 -39.48 74.28 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.535 1.134 . . . . 73.43 110.263 176.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.401 ' HA ' ' HG2' ' D' ' 138' ' ' MET . . . -66.35 -42.65 87.79 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 114.872 -1.058 . . . . 74.43 111.145 176.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 10.6 mp -53.71 -41.54 67.08 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 123.165 0.586 . . . . 63.22 111.979 -177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -69.75 -49.99 47.73 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.929 0.491 . . . . 73.12 111.522 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.401 ' HG2' ' HA ' ' D' ' 135' ' ' ALA . 16.8 ptp -66.4 -32.1 73.27 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 119.695 -0.193 . . . . 72.44 111.128 -175.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -66.71 -33.58 75.96 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.237 1.015 . . . . 74.22 111.023 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -68.52 -46.16 70.32 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.124 0.57 . . . . 62.41 110.35 175.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.6 mp -73.41 -30.34 63.18 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.173 0.589 . . . . 73.42 112.25 -175.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -89.74 4.5 49.46 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 122.991 0.516 . . . . 63.52 111.849 -175.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -118.61 95.89 5.05 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.772 0.796 . . . . 73.34 110.85 -176.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -138.36 20.18 2.75 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 114.014 -1.448 . . . . 72.13 107.169 172.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.03 -44.47 18.01 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-N 114.623 -1.172 . . . . 43.23 110.619 -176.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 67.72 31.3 75.7 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.938 -0.574 . . . . 74.34 112.389 -177.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -84.91 88.52 7.43 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.791 0.836 . . . . 52.43 109.279 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -160.28 109.78 0.41 Allowed Glycine 0 C--N 1.345 1.042 0 CA-C-N 115.974 -0.557 . . . . 65.21 111.921 -177.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 14.9 t -154.07 135.76 14.41 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.41 0.684 . . . . 75.55 109.642 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -147.04 132.21 18.35 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.993 0.917 . . . . 74.31 109.735 174.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -135.76 143.51 45.3 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.267 1.027 . . . . 71.41 109.015 173.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -162.35 53.46 0.22 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.165 -1.42 . . . . 73.53 107.165 175.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -65.29 128.18 34.77 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 114.913 -1.039 . . . . 71.31 111.772 -173.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -143.8 116.34 8.63 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.567 1.147 . . . . 51.24 108.295 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.013 0 N-CA-C 109.373 -0.603 . . . . 55.4 109.373 177.405 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.673 0 N-CA-C 111.973 -0.451 . . . . 63.05 111.973 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.93 60.24 6.69 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.672 0.278 . . . . 74.23 112.441 -177.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -81.26 74.94 8.24 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.575 0.75 . . . . 70.14 109.74 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 67.06 173.47 0.26 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.937 1.295 . . . . 75.01 112.305 173.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -108.1 -52.41 2.77 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 112.812 0.671 . . . . 75.45 112.812 -166.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 118.14 94.14 1.66 Allowed Glycine 0 C--N 1.342 0.891 0 N-CA-C 111.099 -0.8 . . . . 63.22 111.099 -171.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 97' ' ' ILE . . . . . 0.517 HG13 HD11 ' E' ' 100' ' ' LEU . 26.2 pt -72.88 131.62 34.59 Favored 'Isoleucine or valine' 0 C--N 1.357 0.932 0 N-CA-C 107.8 -1.185 . . . . 62.31 107.8 172.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -105.06 167.92 9.39 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.18 -0.464 . . . . 61.14 110.585 -167.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . 71.07 23.99 4.04 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.3 1.44 . . . . 50.25 111.188 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 100' ' ' LEU . . . . . 0.517 HD11 HG13 ' E' ' 97' ' ' ILE . 69.5 mt -76.11 118.33 70.47 Favored Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 123.291 0.636 . . . . 71.31 110.916 176.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -92.33 0.07 4.05 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.557 2.171 . . . . 73.41 111.36 163.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.23 71.66 0.56 Allowed 'General case' 0 C--N 1.363 1.156 0 C-N-CA 125.381 1.472 . . . . 71.34 108.513 -168.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 103' ' ' THR . . . . . 0.619 ' HB ' ' HA ' ' E' ' 107' ' ' THR . 28.5 m 61.65 -73.18 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.522 1.529 . . . . 55.31 111.211 -170.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 104' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' E' ' 108' ' ' HIS . . . -157.89 51.19 0.41 Allowed Glycine 0 C--N 1.35 1.308 0 N-CA-C 111.984 -0.446 . . . . 74.21 111.984 175.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 69.75 97.13 0.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 125.126 1.37 . . . . 44.14 110.037 -175.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 53.2 t80 61.81 37.94 15.14 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.212 1.005 . . . . 74.31 110.206 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . 0.619 ' HA ' ' HB ' ' E' ' 103' ' ' THR . 28.3 m 77.73 -55.8 0.51 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.922 1.689 . . . . 70.13 111.773 -177.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 108' ' ' HIS . . . . . 0.409 ' HB2' ' O ' ' E' ' 104' ' ' GLY . 54.4 t-80 78.68 -59.56 0.41 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 125.814 1.646 . . . . 71.41 112.191 176.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 18.6 m-30 -68.29 127.07 31.62 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.726 0.411 . . . . 72.34 110.269 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.35 137.91 58.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.422 0.689 . . . . 61.04 109.773 173.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . 0.44 HD23 ' HB3' ' D' ' 44' ' ' LEU . 47.1 tp -79.57 67.93 5.46 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 121.967 0.889 . . . . 72.34 109.783 -178.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 112' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 172.79 -59.68 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 106.018 -1.845 . . . . 75.32 106.018 -174.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 18.1 tptp 65.44 128.72 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 126.294 1.837 . . . . 74.1 111.488 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -72.33 82.63 1.04 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.06 0.544 . . . . 63.43 110.225 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 13.3 t -122.79 -16.87 7.01 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.61 0.764 . . . . 62.52 110.799 -175.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 161.3 -88.32 0.11 Allowed Glycine 0 C--N 1.351 1.373 0 N-CA-C 112.491 -0.244 . . . . 73.13 112.491 175.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 32.9 pttt -156.21 141.81 12.67 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 123.788 0.835 . . . . 71.23 109.634 -175.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -96.75 68.09 0.13 Allowed 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.49 2.793 . . . . 70.25 113.656 -174.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -61.47 -45.45 94.22 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 123.826 0.85 . . . . 71.55 111.229 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -67.33 -26.92 66.74 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 114.89 -1.05 . . . . 74.33 112.017 -176.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 121' ' ' VAL . . . . . . . . . . . . . 47.2 t -77.89 -12.24 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 C-N-CA 123.653 0.781 . . . . 61.22 110.452 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 28.2 p 74.05 -49.0 0.67 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 127.395 2.278 . . . . 50.32 112.691 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 15.9 t70 71.57 -80.41 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.732 1.213 . . . . 74.04 111.064 171.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 15.8 m -92.74 81.48 4.72 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.59 0.756 . . . . 70.42 109.253 177.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -155.0 155.94 35.08 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.896 -0.593 . . . . 74.55 110.516 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 126' ' ' ALA . . . . . 0.571 ' HB1' ' HB ' ' B' ' 13' ' ' ILE . . . 64.38 86.07 0.13 Allowed 'General case' 0 CA--C 1.551 1.014 0 O-C-N 124.809 1.318 . . . . 62.3 112.607 173.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 30.8 t -156.92 162.67 39.64 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.692 0.797 . . . . 43.03 109.881 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -141.58 110.74 6.29 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.898 0.879 . . . . 70.34 109.684 -173.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 129' ' ' THR . . . . . 0.499 ' HA ' ' HB3' ' D' ' 124' ' ' PRO . 3.6 t -96.73 124.89 40.85 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.526 0.731 . . . . 74.1 111.634 -176.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -166.34 117.35 0.99 Allowed 'General case' 0 C--N 1.357 0.928 0 C-N-CA 124.423 1.089 . . . . 74.32 109.454 178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 131' ' ' TRP . . . . . . . . . . . . . 8.8 t90 -152.01 -174.39 4.85 Favored 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 124.075 0.95 . . . . 74.52 109.173 -178.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 23.7 t 83.35 95.0 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.464 1.906 . . . . 61.4 109.743 176.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.48 37.69 0.2 Allowed 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 125.007 1.323 . . . . 64.33 109.636 -176.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.12 90.02 0.5 Allowed Glycine 0 C--N 1.352 1.466 0 CA-C-N 115.56 -0.746 . . . . 72.32 112.195 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 29.9 m -71.1 122.15 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.174 0 C-N-CA 123.555 0.742 . . . . 71.21 111.127 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 136' ' ' LYS . . . . . 0.813 ' HA ' ' HG2' ' C' ' 12' ' ' GLN . 35.3 ttpt -145.39 16.8 1.5 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.405 0.621 . . . . 74.04 110.588 177.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 137' ' ' THR . . . . . 0.639 ' HA ' HG11 ' E' ' 144' ' ' VAL . 1.1 p -151.92 107.59 3.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.255 1.022 . . . . 75.24 109.059 174.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -138.24 5.99 2.55 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.918 0.887 . . . . 62.5 110.131 176.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -134.36 126.1 28.94 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.332 -0.988 . . . . 65.33 108.332 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -103.31 28.35 16.05 Favored Glycine 0 C--N 1.345 1.07 0 O-C-N 123.705 0.628 . . . . 73.44 112.904 -176.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.49 -55.74 9.38 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.404 0.682 . . . . 73.04 110.245 176.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 67.7 tp -174.97 -48.86 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.565 1.546 . . . . 74.13 106.91 177.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -131.92 -171.18 12.76 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-N 114.441 -1.254 . . . . 44.13 111.329 173.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 144' ' ' VAL . . . . . 0.639 HG11 ' HA ' ' E' ' 137' ' ' THR . 22.3 m -132.2 162.91 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.656 1.183 . . . . 75.05 110.995 -175.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 28.1 t70 . . . . . 0 C--O 1.254 1.34 0 C-N-CA 125.14 1.376 . . . . 75.04 107.527 174.486 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.671 0 N-CA-C 111.899 -0.481 . . . . 52.12 111.899 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . -121.23 114.66 2.64 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 111.851 -0.5 . . . . 65.22 111.851 -173.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -150.21 18.26 0.85 Allowed 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 112.886 0.699 . . . . 74.15 112.886 -174.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -166.45 146.39 5.97 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 122.517 0.327 . . . . 54.0 110.944 173.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -122.44 145.14 48.57 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.805 0.842 . . . . 74.41 109.094 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . 163.45 -24.33 0.19 Allowed Glycine 0 C--N 1.347 1.193 0 CA-C-O 119.442 -0.643 . . . . 63.24 114.472 173.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 97' ' ' ILE . . . . . 0.706 HD13 HD22 ' F' ' 100' ' ' LEU . 13.2 tt -109.75 140.96 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-N 117.883 0.841 . . . . 64.23 109.75 -177.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -87.92 118.38 27.42 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.918 -0.401 . . . . 53.42 109.918 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . 58.94 -75.86 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.601 1.56 . . . . 64.5 113.617 172.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 100' ' ' LEU . . . . . 0.706 HD22 HD13 ' F' ' 97' ' ' ILE . 29.6 tp 68.17 83.07 0.18 Allowed Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.49 1.516 . . . . 75.23 110.797 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -88.32 40.2 0.55 Allowed 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 123.619 2.879 . . . . 72.0 112.369 177.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 102' ' ' LEU . . . . . 0.567 HD12 HD13 ' B' ' 98' ' ' LEU . 68.4 tp 65.92 -80.61 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.516 1.127 . . . . 60.23 108.494 -165.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 4.7 p -163.59 -50.56 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.424 2.29 . . . . 73.53 105.0 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 177.24 -157.19 21.82 Favored Glycine 0 C--N 1.347 1.141 0 CA-C-N 113.629 -1.623 . . . . 22.22 110.134 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -70.96 103.82 2.78 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.2 0.6 . . . . 74.04 110.426 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 42.8 t80 63.28 14.76 8.08 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 125.49 1.516 . . . . 74.2 112.137 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 29.8 m 68.35 119.26 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.42 1.088 . . . . 75.24 110.168 -169.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -70.71 83.76 0.63 Allowed 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.715 0.769 . . . . 74.44 109.1 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 78.9 t80 180.0 -50.32 0.01 OUTLIER 'General case' 0 C--O 1.241 0.61 0 N-CA-C 106.032 -1.84 . . . . 73.13 106.032 -170.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 67.36 120.84 0.03 OUTLIER 'General case' 0 C--N 1.36 1.045 0 O-C-N 125.463 1.727 . . . . 71.12 111.268 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 16.4 tp -85.87 20.72 2.12 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-O 121.664 0.745 . . . . 55.22 110.942 -175.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -92.38 19.85 6.74 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.883 1.273 . . . . 73.01 111.002 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -67.73 102.24 1.18 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.65 0.78 . . . . 53.11 109.42 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . 0.652 ' HA ' HG21 ' F' ' 122' ' ' THR . 37.0 mtmt -141.95 166.85 23.57 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.882 0.873 . . . . 63.32 110.905 -177.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 20.2 m 58.39 72.67 0.51 Allowed 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 125.376 1.47 . . . . 72.14 112.684 170.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.93 -25.1 2.24 Favored Glycine 0 C--N 1.354 1.532 0 N-CA-C 115.1 0.8 . . . . 63.55 115.1 170.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -68.07 -46.72 41.47 Favored Pre-proline 0 CA--C 1.562 1.409 0 C-N-CA 123.691 0.796 . . . . 74.01 111.442 -176.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -89.62 -156.27 0.06 OUTLIER 'Trans proline' 0 C--N 1.39 2.724 0 C-N-CA 122.2 1.934 . . . . 74.22 111.372 170.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -151.61 167.63 27.51 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.385 0.674 . . . . 74.02 109.614 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 120' ' ' TYR . . . . . . . . . . . . . 74.5 t80 74.23 -67.93 0.24 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.5 1.52 . . . . 72.55 112.088 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.8 -40.5 87.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.727 0.811 . . . . 62.42 111.402 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . 0.652 HG21 ' HA ' ' F' ' 114' ' ' LYS . 73.2 p -105.75 11.92 31.51 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.558 0.743 . . . . 73.12 111.378 -178.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -116.2 -65.5 1.18 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.426 0.69 . . . . 75.53 109.978 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 30.0 p -92.05 137.96 31.93 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.556 0.743 . . . . 64.32 109.535 178.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -121.48 -85.31 0.66 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.547 0.739 . . . . 63.15 109.935 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -177.23 -172.04 0.37 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.344 1.058 . . . . 73.45 110.006 -174.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 48.8 p -75.14 144.96 42.55 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 109.086 -0.709 . . . . 72.14 109.086 169.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.41 -33.04 73.03 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.851 0.86 . . . . 55.24 112.858 -173.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 129' ' ' THR . . . . . 0.523 HG22 ' H ' ' F' ' 130' ' ' ALA . 1.7 m 59.1 -154.94 0.36 Allowed 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 108.881 -0.785 . . . . 61.13 108.881 -176.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 130' ' ' ALA . . . . . 0.523 ' H ' HG22 ' F' ' 129' ' ' THR . . . -166.35 176.14 7.69 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 119.437 1.017 . . . . 62.13 111.486 176.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 131' ' ' TRP . . . . . 0.422 ' HB2' ' HA ' ' B' ' 124' ' ' PRO . 0.6 OUTLIER -142.26 95.51 2.81 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.155 0.982 . . . . 72.44 109.638 170.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 65.0 m -145.65 -66.25 0.31 Allowed 'General case' 0 C--O 1.239 0.527 0 N-CA-C 106.541 -1.651 . . . . 74.41 106.541 165.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 133' ' ' THR . . . . . 0.612 HG23 ' HG2' ' C' ' 38' ' ' PRO . 62.8 m 62.97 -79.55 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.941 0 O-C-N 124.634 1.209 . . . . 74.13 110.778 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.42 158.09 33.78 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 112.641 -0.184 . . . . 72.05 112.641 177.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 7.5 p -147.24 130.2 8.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 C-N-CA 123.723 0.809 . . . . 50.53 108.999 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -72.66 -55.85 6.21 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.323 0.649 . . . . 75.11 109.766 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 10.4 t -171.47 -147.87 0.05 OUTLIER 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 106.7 -1.593 . . . . 72.53 106.7 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -56.96 -42.09 79.52 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 118.979 0.809 . . . . 75.15 110.45 173.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -107.81 148.82 29.01 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.907 0.883 . . . . 75.3 109.9 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -87.7 128.54 9.07 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 111.227 -0.749 . . . . 74.35 111.227 171.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -91.6 102.81 15.46 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 109.439 -0.578 . . . . 63.12 109.439 -179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 71.6 mt -65.82 81.28 0.07 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.967 0.907 . . . . 41.04 110.999 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -132.21 47.05 1.03 Allowed Glycine 0 C--N 1.341 0.828 0 N-CA-C 110.976 -0.85 . . . . 74.24 110.976 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 53.6 t -67.3 93.66 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 124.269 1.028 . . . . 71.14 109.96 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 34.0 t70 . . . . . 0 C--O 1.249 1.057 0 CA-C-N 114.607 -1.179 . . . . 73.14 110.205 -177.233 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptm . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 110.257 -0.275 . . . . 52.35 110.257 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.3 t -170.07 110.33 0.41 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.875 0.87 . . . . 62.13 108.963 177.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -82.26 88.66 6.51 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.597 0.713 . . . . 63.33 110.187 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -75.19 118.46 18.14 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 114.201 -1.363 . . . . 75.11 109.313 177.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.422 HD22 ' N ' ' A' ' 5' ' ' ASN . 0.8 OUTLIER -76.59 74.38 3.29 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.86 0.864 . . . . 74.31 110.241 -176.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -175.58 -160.53 0.08 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.85 1.66 . . . . 71.0 107.95 -174.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.8 p -91.5 2.21 56.59 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 112.707 0.632 . . . . 65.53 112.707 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -76.05 112.61 12.67 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.211 -1.033 . . . . 75.15 108.211 174.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.67 ' HB3' HG23 ' A' ' 89' ' ' ILE . 4.8 ppp? -139.88 179.2 6.74 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.09 -0.959 . . . . 73.14 110.418 -170.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.2 m -136.26 115.26 12.3 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.475 0.71 . . . . 65.33 109.375 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.455 ' HE1' ' SG ' ' A' ' 102' ' ' CYS . 62.0 t80 -110.24 121.39 45.16 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.737 -1.209 . . . . 74.01 107.737 173.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -133.92 134.62 42.84 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.148 -0.686 . . . . 71.41 109.148 176.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.426 HG21 ' HG2' ' C' ' 130' ' ' PRO . 47.8 mt -92.55 114.09 28.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 108.252 -1.018 . . . . 63.32 108.252 175.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -83.95 -35.46 23.98 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 123.399 0.437 . . . . 74.22 110.533 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -175.93 121.73 0.18 Allowed 'General case' 0 C--N 1.351 0.652 0 N-CA-C 109.553 -0.536 . . . . 73.5 109.553 -168.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.555 HD12 ' HG3' ' C' ' 130' ' ' PRO . 78.7 mt -109.42 135.75 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 107.832 -1.173 . . . . 63.14 107.832 171.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.434 ' CE2' ' HB1' ' B' ' 28' ' ' ALA . 31.3 p90 -161.83 177.1 10.17 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 124.021 0.826 . . . . 73.2 111.66 -174.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.5 p -102.49 118.64 37.29 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.942 -0.762 . . . . 61.34 108.942 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.1 mtpt -75.95 -35.87 59.52 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.229 -0.441 . . . . 72.25 110.002 172.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 18.2 t70 -145.51 144.46 30.56 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.654 -0.703 . . . . 55.01 109.787 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 57.4 mt -140.5 141.66 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 107.563 -1.273 . . . . 74.2 107.563 175.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.5 t -154.54 139.85 17.64 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.714 -0.476 . . . . 64.54 109.714 170.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.516 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 80.6 t80 -142.33 116.15 9.26 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.221 -1.4 . . . . 71.13 107.221 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -118.32 134.28 55.18 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.809 0.443 . . . . 71.44 109.991 -176.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.8 74.34 58.3 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 107.651 -1.24 . . . . 55.15 107.651 172.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -71.07 -27.23 20.59 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.528 2.152 . . . . 43.21 111.964 -175.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -99.2 9.82 42.67 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.067 -0.97 . . . . 73.33 110.587 -177.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.483 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -45.82 -60.32 3.59 Favored Pre-proline 0 C--N 1.371 1.529 0 C-N-CA 124.295 1.038 . . . . 35.24 113.724 -166.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 23.4 Cg_exo -60.07 -31.31 93.21 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 121.755 1.636 . . . . 72.14 113.027 -171.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.52 -15.73 18.55 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.515 -0.766 . . . . 75.2 112.25 -175.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.78 HG21 ' HA ' ' A' ' 73' ' ' ALA . 4.8 p -77.04 -24.71 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-N 117.945 0.339 . . . . 73.21 110.391 -176.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -69.02 -22.34 64.06 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.92 -0.582 . . . . 75.24 110.583 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -74.68 -21.57 59.33 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.042 0.937 . . . . 74.43 111.437 176.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -81.93 161.42 23.09 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.208 0.603 . . . . 73.11 110.521 -177.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -63.11 117.52 6.62 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.244 0.618 . . . . 73.14 109.389 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.423 ' CE3' HD21 ' A' ' 68' ' ' LEU . 71.7 t-105 -81.32 89.05 6.06 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.629 0.728 . . . . 75.45 110.684 -178.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.465 ' H ' HD22 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -145.85 74.54 13.39 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 125.061 1.344 . . . . 74.3 108.569 172.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.0 149.79 17.76 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.924 2.416 . . . . 72.22 113.618 -171.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -97.92 97.79 9.24 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 107.108 -1.441 . . . . 55.44 107.108 167.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' A' ' 66' ' ' ALA . 59.4 t -83.03 94.71 3.25 Favored 'Isoleucine or valine' 0 C--N 1.345 0.382 0 CA-C-O 121.699 0.762 . . . . 74.11 109.303 176.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -78.02 117.12 19.03 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.299 -1.773 . . . . 73.41 109.456 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.5 tp -97.79 106.68 19.03 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.842 -0.617 . . . . 63.43 109.542 -175.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.673 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 2.0 m-20 -104.86 145.26 30.64 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.498 1.119 . . . . 72.44 108.51 172.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.463 HD11 HG21 ' A' ' 131' ' ' VAL . 95.7 mt -137.84 148.1 45.12 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.677 0.791 . . . . 73.54 109.626 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -148.55 142.22 25.54 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.507 1.123 . . . . 42.22 108.269 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.7 m -140.81 136.42 32.42 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.198 0.599 . . . . 75.42 110.129 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.99 130.22 9.62 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.687 0.795 . . . . 42.05 109.508 174.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 68.4 p -90.45 -179.52 5.61 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.71 0.804 . . . . 41.03 110.6 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.513 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 39.1 t -159.63 141.04 12.84 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.855 0.862 . . . . 54.01 109.149 -177.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -93.44 107.84 19.62 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.434 -0.95 . . . . 72.45 108.434 171.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 57' ' ' GLU . 53.6 mt -84.79 -43.57 14.1 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.004 0.522 . . . . 65.12 109.731 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.07 -173.34 4.53 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.26 -0.882 . . . . 52.41 110.041 -177.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -70.05 118.33 12.75 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.641 0.776 . . . . 72.01 109.295 176.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 64.18 14.26 8.48 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.152 1.381 . . . . 72.23 112.237 -174.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.0 t -117.41 110.26 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 108.664 -0.865 . . . . 71.24 108.664 176.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -121.99 124.66 44.52 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.198 0.999 . . . . 72.42 109.066 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 30.6 tt0 -86.12 152.85 22.52 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.763 -0.828 . . . . 55.15 108.763 169.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 77.2 t -132.03 138.79 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 N-CA-C 108.232 -1.025 . . . . 65.13 108.232 167.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.43 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 51.1 t -113.93 134.81 55.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 109.262 -0.644 . . . . 73.4 109.262 174.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.62 105.32 12.93 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.408 -1.331 . . . . 73.53 107.408 168.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 42.0 ttp180 -93.67 101.99 14.15 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.95 -1.13 . . . . 65.02 107.95 177.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 32.5 t -93.72 132.27 38.34 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 108.174 -1.047 . . . . 64.44 108.174 176.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.673 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 24.2 m -120.27 139.39 52.78 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.563 -0.902 . . . . 75.22 108.563 172.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.67 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.2 t -142.51 109.11 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 124.878 1.271 . . . . 72.42 107.692 -169.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.3 m -115.17 124.18 50.8 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 109.351 -0.611 . . . . 74.55 109.351 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.514 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -103.38 120.65 41.21 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.478 -1.675 . . . . 64.22 106.478 172.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 59.5 m -129.16 134.74 48.16 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.024 0.44 . . . . 72.24 110.496 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.465 HD22 ' H ' ' A' ' 37' ' ' GLN . 32.9 mt -88.46 64.39 7.47 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 107.338 -1.356 . . . . 75.34 107.338 174.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.26 -109.11 2.72 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 114.74 -1.118 . . . . 62.12 111.954 -174.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -86.93 -21.45 26.25 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.793 0.837 . . . . 73.42 109.133 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 68' ' ' LEU . 9.5 tp10 -77.9 133.0 38.18 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.001 0.92 . . . . 70.34 108.857 172.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.4 m -89.03 129.07 35.73 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.799 0.727 . . . . 71.31 109.469 167.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.78 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -78.4 -59.58 2.72 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.019 -0.734 . . . . 72.31 109.019 173.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -159.47 169.63 23.48 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.443 -0.799 . . . . 65.22 110.892 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.426 HD12 ' H ' ' A' ' 76' ' ' CYS . 20.0 tp -132.44 142.17 49.14 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.484 -1.234 . . . . 72.24 107.939 174.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.67 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 64.6 m -137.32 132.96 34.38 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.773 1.229 . . . . 65.22 108.155 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -145.94 119.51 9.12 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.258 -0.645 . . . . 44.54 109.258 173.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.3 t -127.91 110.51 22.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 124.51 1.124 . . . . 62.05 108.7 -176.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 18.3 mt-30 -85.33 82.58 8.28 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.105 -1.072 . . . . 71.35 108.105 172.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -75.23 92.94 2.77 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.308 -0.86 . . . . 74.51 108.924 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -97.47 146.16 18.14 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 115.407 -0.815 . . . . 42.32 111.19 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.88 133.31 5.64 Favored Glycine 0 CA--C 1.505 -0.584 0 N-CA-C 110.64 -0.984 . . . . 40.34 110.64 -176.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.424 HG23 HD12 ' A' ' 51' ' ' LEU . 43.6 mt -81.59 126.41 39.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 108.43 -0.952 . . . . 64.03 108.43 173.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.743 ' HB3' HD11 ' A' ' 86' ' ' ILE . 84.7 m-85 -130.1 120.87 25.31 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.207 1.003 . . . . 61.01 109.036 -176.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.9 t -89.39 101.54 14.22 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.987 -0.746 . . . . 74.33 108.987 176.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.743 HD11 ' HB3' ' A' ' 84' ' ' PHE . 2.2 mm -113.45 137.81 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 122.789 0.436 . . . . 73.53 110.068 -175.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.9 167.24 25.32 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.755 0.822 . . . . 71.43 110.243 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.29 -31.8 8.14 Favored Glycine 0 C--N 1.352 1.426 0 N-CA-C 114.176 0.43 . . . . 74.01 114.176 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.67 HG23 ' HB3' ' A' ' 9' ' ' MET . 0.2 OUTLIER -131.51 163.08 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 123.331 0.652 . . . . 73.41 112.486 -166.477 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.76 175.11 13.67 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 114.454 -1.248 . . . . 61.23 109.105 175.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.02 -132.45 19.29 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 116.168 -0.469 . . . . 65.43 112.781 176.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.0 p -68.59 -30.63 69.42 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.503 0.721 . . . . 43.11 112.526 -177.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -66.38 -42.41 87.99 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 120.861 0.362 . . . . 73.14 110.12 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.431 ' HE2' ' HG ' ' A' ' 98' ' ' LEU . 6.1 tpt -68.87 -47.8 65.0 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.428 -0.806 . . . . 45.25 110.078 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.47 -41.34 72.82 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.623 0.769 . . . . 70.13 111.048 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -65.93 -37.38 85.89 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.473 -0.785 . . . . 72.42 111.422 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.7 t -66.52 -44.66 81.89 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.744 -0.465 . . . . 43.2 109.744 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 48' ' ' SER . 70.8 mt -78.04 -29.71 49.51 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.342 -0.844 . . . . 75.53 112.37 -171.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.34 0.22 43.63 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-O 119.592 -0.56 . . . . 62.23 114.488 -172.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.455 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -139.83 -63.41 0.5 Allowed 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 117.726 0.763 . . . . 32.03 111.406 -175.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -68.67 -43.92 75.17 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 116.067 -0.515 . . . . 74.42 111.851 -174.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.455 ' SG ' ' HE1' ' A' ' 11' ' ' PHE . 77.6 m -66.19 -49.6 54.46 Favored Pre-proline 0 CA--C 1.564 1.495 0 C-N-CA 124.218 1.007 . . . . 71.53 112.452 -176.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.39 -22.91 59.16 Favored 'Trans proline' 0 C--N 1.394 2.929 0 C-N-CA 121.751 1.634 . . . . 72.51 112.684 174.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -68.43 -37.17 80.03 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.248 0.619 . . . . 71.12 110.245 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.3 mm -65.46 -40.07 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 123.649 0.78 . . . . 72.45 110.233 172.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 49.7 mt -78.3 -19.12 54.25 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.032 0.933 . . . . 64.21 112.526 -174.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -70.63 -41.91 13.31 Favored Pre-proline 0 CA--C 1.559 1.29 0 N-CA-C 114.351 1.241 . . . . 74.24 114.351 -171.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.0 -37.23 78.45 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 121.901 1.734 . . . . 73.04 112.657 172.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -80.44 -36.01 34.18 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.857 0.863 . . . . 70.41 111.611 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.45 -51.2 64.29 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.073 0.549 . . . . 54.12 109.701 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.423 ' NH1' HD12 ' C' ' 105' ' ' ILE . 30.3 ttm180 -47.57 -53.28 14.99 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 124.862 1.351 . . . . 72.2 110.277 173.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -62.01 -45.98 91.23 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 124.433 1.083 . . . . 71.51 111.859 -174.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.614 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.3 t -57.2 -45.91 83.36 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 123.84 0.713 . . . . 73.12 110.352 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 118' ' ' VAL . 56.0 mt -61.8 -52.71 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 115.113 -0.948 . . . . 75.3 110.739 176.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 47.9 m -54.17 -42.33 69.51 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.219 1.008 . . . . 74.35 111.401 -174.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.3 t -69.05 -44.79 71.93 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.736 -1.12 . . . . 63.34 110.355 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.516 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 8.9 mtp -56.04 -43.58 77.97 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.762 0.825 . . . . 64.33 111.082 176.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 114' ' ' ILE . 73.4 t -59.71 -48.96 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.711 1.204 . . . . 71.45 110.465 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 86.0 p -72.47 -27.41 62.27 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.137 0.575 . . . . 71.33 111.632 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.475 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.3 mtt-85 -72.37 -29.05 63.42 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.46 0.704 . . . . 72.54 109.942 175.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.436 ' O ' HG22 ' A' ' 122' ' ' THR . . . -86.56 18.05 36.12 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-O 119.165 -0.797 . . . . 74.32 113.32 172.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 121' ' ' GLY . 1.5 t 60.41 9.82 2.18 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 127.227 2.211 . . . . 73.21 113.76 177.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -80.79 142.66 52.92 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 108.161 -1.051 . . . . 71.54 108.161 172.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.616 ' HB3' ' HA ' ' E' ' 131' ' ' TRP . 11.7 Cg_endo -55.49 147.16 59.54 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.74 2.293 . . . . 70.33 112.768 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -54.28 129.0 33.69 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 124.65 1.219 . . . . 65.41 112.63 -172.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 31.3 tp -117.42 105.94 12.67 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.032 0.933 . . . . 61.41 109.901 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -99.93 113.02 25.29 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.306 -0.998 . . . . 63.01 108.306 176.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.434 HD11 HD13 ' A' ' 114' ' ' ILE . 18.4 mt -67.64 154.48 41.38 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 120.714 0.292 . . . . 74.43 110.984 -175.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.22 136.37 93.77 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 123.535 0.734 . . . . 74.54 111.377 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -62.45 112.1 1.49 Allowed 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.547 2.165 . . . . 75.14 111.528 173.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.463 HG21 HD11 ' A' ' 44' ' ' LEU . 90.7 t -101.88 139.98 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 121.126 0.489 . . . . 70.14 111.17 -173.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.411 ' OD1' ' HB3' ' A' ' 134' ' ' ASP . 46.4 t-20 -90.63 86.68 6.45 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.285 -1.325 . . . . 72.53 109.024 176.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -62.87 -23.99 67.59 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 112.804 0.668 . . . . 75.24 112.804 172.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.455 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 21.8 t70 -65.61 -37.89 87.9 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.028 0.531 . . . . 74.21 109.639 175.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.15 -50.04 51.4 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.822 0.849 . . . . 53.3 110.294 174.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 80.9 mt -56.04 -41.98 75.87 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.416 0.687 . . . . 65.14 111.435 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -71.07 -41.68 70.37 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.767 -0.651 . . . . 74.33 110.094 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.7 -36.25 80.36 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 123.712 0.632 . . . . 73.21 109.856 -175.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 143' ' ' GLN . 81.8 m-20 -56.27 -31.36 63.53 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.397 1.079 . . . . 65.25 111.925 176.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -87.92 -44.5 11.0 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.589 0.755 . . . . 73.43 110.463 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 45.0 tp -48.83 -40.85 30.92 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.12 1.768 . . . . 52.52 113.271 -168.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -147.49 30.27 0.92 Allowed 'General case' 0 CA--C 1.549 0.907 0 CA-C-O 120.973 0.416 . . . . 43.43 111.219 -169.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 139' ' ' ASN . 20.5 tt0 -61.9 -62.04 2.07 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.357 0.598 . . . . 70.15 110.398 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -134.77 15.02 3.64 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.304 1.042 . . . . 72.02 109.504 176.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.59 -167.8 2.43 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.282 1.033 . . . . 61.45 109.5 -171.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 136.82 84.38 0.15 Allowed Glycine 0 C--N 1.343 0.919 0 N-CA-C 110.294 -1.122 . . . . 72.21 110.294 177.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -74.11 74.99 1.76 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.986 0.915 . . . . 62.34 110.859 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -81.26 57.65 4.87 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.825 -0.625 . . . . 74.11 112.07 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.6 t -120.55 137.92 54.13 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 124.519 1.127 . . . . 72.22 109.669 -174.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -131.61 159.09 39.28 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.586 -0.894 . . . . 64.24 108.586 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -138.55 134.19 33.54 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.259 0.624 . . . . 73.11 109.794 174.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -98.34 -28.1 13.81 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.754 0.821 . . . . 74.15 110.116 177.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -63.92 93.85 0.09 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.34 0.656 . . . . 73.41 110.538 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -76.16 87.92 3.04 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.14 0.976 . . . . 64.42 109.544 178.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 CA-C-N 114.933 -1.031 . . . . 72.11 109.387 -175.735 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 40.0 mtm . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 108.673 -0.862 . . . . 50.43 108.673 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 46.1 p -99.87 -45.8 5.59 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.528 0.731 . . . . 63.43 111.119 -176.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 54.32 48.85 19.81 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.252 1.021 . . . . 74.53 109.982 -176.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.557 ' HG2' ' H ' ' B' ' 5' ' ' ASN . 42.3 tt0 -159.72 -171.12 3.15 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 114.203 -1.362 . . . . 63.33 108.298 -167.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . 0.557 ' H ' ' HG2' ' B' ' 4' ' ' GLN . 1.3 m-20 -61.82 96.52 0.07 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.046 0.938 . . . . 75.12 109.236 174.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -136.87 178.78 6.81 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 108.489 -0.93 . . . . 70.1 108.489 -174.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.434 ' OG1' ' HA ' ' B' ' 89' ' ' ILE . 7.5 t -71.68 92.65 1.19 Allowed 'General case' 0 CA--C 1.553 1.094 0 CA-C-O 122.701 1.239 . . . . 73.01 111.201 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -90.2 -11.1 42.03 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 114.34 -1.3 . . . . 65.22 110.061 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.454 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 18.2 ptm 59.35 171.64 0.07 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 127.315 2.246 . . . . 64.23 114.197 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 54.9 m -135.41 122.71 21.74 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.71 -1.218 . . . . 72.32 107.71 172.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -111.69 142.27 44.23 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.811 -0.811 . . . . 74.22 108.811 -177.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -150.08 120.52 7.4 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.72 0.408 . . . . 72.14 110.092 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 58.1 mt -77.96 126.83 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.368 -0.975 . . . . 72.53 108.368 171.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -98.27 -40.07 8.52 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.066 0.546 . . . . 73.13 109.838 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -173.09 134.96 0.57 Allowed 'General case' 0 C--N 1.353 0.745 0 O-C-N 123.554 0.534 . . . . 70.12 109.686 -173.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.2 mt -122.06 143.79 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 107.119 -1.437 . . . . 73.3 107.119 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -169.25 153.48 5.41 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.599 0.592 . . . . 75.54 112.599 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.665 HG21 HD11 ' B' ' 21' ' ' ILE . 30.6 m -82.05 118.58 23.13 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.03 -0.986 . . . . 54.41 109.778 176.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.437 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 44.4 mtpt -95.81 -18.01 20.72 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.437 0.695 . . . . 72.05 111.521 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 28.8 t70 -155.09 140.04 17.31 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.47 0.481 . . . . 72.2 110.916 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.665 HD11 HG21 ' B' ' 18' ' ' THR . 32.3 mm -129.25 144.38 38.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 N-CA-C 107.763 -1.199 . . . . 75.4 107.763 172.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.47 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 46.6 t -147.82 132.76 18.12 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.381 -1.282 . . . . 74.52 108.296 169.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.42 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.3 t80 -145.29 118.02 8.67 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 107.189 -1.411 . . . . 73.54 107.189 168.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -119.84 133.68 55.5 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.664 -0.865 . . . . 63.11 108.664 173.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.672 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -117.32 82.15 14.42 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 106.51 -1.663 . . . . 70.45 106.51 166.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.2 -24.96 27.06 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.885 2.39 . . . . 75.34 111.96 -171.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -114.41 9.67 16.87 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.908 0.883 . . . . 63.43 110.751 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.672 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -30.8 -64.99 0.2 Allowed Pre-proline 0 N--CA 1.494 1.736 0 C-N-CA 125.992 1.717 . . . . 70.24 114.812 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 14.6 Cg_exo -64.09 -36.72 46.46 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 122.398 2.065 . . . . 64.22 112.338 -166.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.454 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 77.5 m80 -95.98 -18.63 20.11 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.006 -0.997 . . . . 65.54 112.321 -173.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 3.6 p -83.17 -10.33 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 117.991 0.36 . . . . 50.34 110.654 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -76.06 -3.49 36.19 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 112.843 0.683 . . . . 75.33 112.843 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.8 pt20 -78.98 -5.01 52.79 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.8 0.44 . . . . 75.32 110.223 169.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -107.22 87.57 2.54 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.832 1.253 . . . . 64.23 110.395 -177.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -93.37 87.57 5.66 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.135 -0.939 . . . . 71.23 110.318 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 18.6 p90 -162.97 -171.24 2.6 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.416 0.686 . . . . 72.54 110.04 172.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.543 ' H ' ' NE2' ' B' ' 37' ' ' GLN . 0.0 OUTLIER -79.1 111.82 23.09 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 124.367 1.067 . . . . 71.23 110.295 178.47 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.84 141.03 36.36 Favored 'Trans proline' 0 C--N 1.371 1.731 0 C-N-CA 121.879 1.719 . . . . 75.21 111.522 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.64 108.07 2.76 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 109.626 -0.509 . . . . 64.43 109.626 176.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 88.0 t -99.21 149.29 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 115.045 -0.979 . . . . 72.02 110.554 -175.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -135.46 129.67 33.54 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.354 1.462 . . . . 71.45 107.541 172.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.44 HD13 HD22 ' B' ' 128' ' ' LEU . 20.5 tp -97.04 140.82 30.99 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.449 -0.945 . . . . 74.04 108.449 170.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.639 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 7.2 t70 -137.93 141.0 40.6 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.222 -1.399 . . . . 73.12 107.222 -179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 49.3 mt -137.61 126.71 24.39 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 109.42 -0.585 . . . . 73.43 109.42 -170.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -124.57 139.95 53.4 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.023 1.329 . . . . 72.11 108.753 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.12 105.61 11.17 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 109.084 -0.71 . . . . 63.13 109.084 -172.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.76 152.01 50.7 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.034 0.933 . . . . 40.11 109.208 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 29.5 p -149.72 -169.54 3.4 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.932 -0.48 . . . . 73.42 110.94 -175.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 50.9 p -155.23 136.16 13.7 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.884 0.874 . . . . 63.21 109.183 170.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -91.26 112.24 24.07 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.566 -1.272 . . . . 72.52 107.566 168.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 pp -131.17 17.23 5.02 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.119 0.567 . . . . 62.01 110.474 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.26 152.15 21.93 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.691 -0.686 . . . . 71.54 110.568 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -72.38 117.35 13.93 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.242 -0.89 . . . . 73.32 109.168 172.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 65.65 13.79 9.13 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.075 0.95 . . . . 64.53 112.979 172.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.5 t -137.3 123.52 27.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.794 -1.558 . . . . 73.43 106.794 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.583 ' HB2' HD11 ' B' ' 86' ' ' ILE . 16.2 t80 -124.4 140.34 53.04 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.473 -0.566 . . . . 74.52 109.473 -167.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -108.96 106.13 15.96 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 107.843 -1.169 . . . . 63.32 107.843 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 94.5 t -100.78 138.28 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.652 0.781 . . . . 73.23 109.703 -176.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 24.1 t -122.79 110.77 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.029 0.932 . . . . 73.32 109.255 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -95.19 112.29 24.02 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.997 -1.112 . . . . 74.13 107.997 174.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -85.18 118.79 24.95 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 108.487 -0.931 . . . . 74.53 108.487 174.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 23.0 t -105.63 131.87 53.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 107.848 -1.167 . . . . 65.51 107.848 171.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.639 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 19.9 m -121.18 139.13 53.78 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.924 -1.139 . . . . 74.21 107.924 173.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.821 HG11 HD21 ' B' ' 126' ' ' LEU . 80.8 t -130.12 130.91 66.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 121.242 0.544 . . . . 63.21 109.707 175.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.4 m -106.57 144.57 33.05 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.727 -1.124 . . . . 70.11 108.871 168.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.97 136.47 20.31 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.895 -1.15 . . . . 72.35 107.895 171.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 15.6 m -137.65 128.07 26.46 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.585 0.553 . . . . 71.23 111.436 -173.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.465 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 44.8 mt -94.56 105.2 17.15 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.569 -0.9 . . . . 62.51 108.569 176.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.62 -120.42 5.13 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.881 -0.599 . . . . 50.54 111.873 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.42 10.75 25.32 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.506 0.722 . . . . 74.0 110.972 -178.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -129.25 156.01 44.66 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.382 0.673 . . . . 73.44 109.734 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 32.3 m -65.18 136.25 56.44 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 123.544 0.528 . . . . 63.24 110.433 176.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.465 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -89.27 -60.72 1.87 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 107.397 -1.335 . . . . 71.32 107.397 172.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -155.39 163.51 39.98 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 114.169 -1.378 . . . . 73.1 110.891 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 93.1 mt -136.42 113.54 10.57 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.156 1.383 . . . . 71.3 107.696 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.541 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 39.2 t -121.73 117.26 26.18 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.758 -0.46 . . . . 73.31 109.758 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.47 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 37.9 tt0 -124.54 123.21 39.6 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.6 1.16 . . . . 52.13 108.993 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 96.8 t -128.84 130.42 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.583 0.753 . . . . 64.12 110.272 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.518 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 26.3 mt-30 -100.01 119.84 38.89 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.135 -1.061 . . . . 64.11 108.135 171.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.561 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 7.9 tp-100 -108.9 109.05 20.05 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.224 -1.028 . . . . 73.23 108.224 176.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.437 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -104.84 170.24 17.77 Favored Glycine 0 C--N 1.335 0.5 0 O-C-N 123.883 0.739 . . . . 53.44 112.115 177.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.22 144.63 7.64 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.201 -0.523 . . . . 63.21 113.321 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 3.2 mp -85.64 117.41 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 107.607 -1.257 . . . . 73.13 107.607 172.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -121.93 134.59 54.84 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.836 0.854 . . . . 73.12 109.152 176.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 49.1 m -88.87 113.51 24.49 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.473 -0.936 . . . . 74.23 108.473 174.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.583 HD11 ' HB2' ' B' ' 56' ' ' TYR . 1.0 OUTLIER -121.99 105.1 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.096 0.958 . . . . 65.5 108.536 -174.676 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.541 ' HA ' ' HB ' ' F' ' 97' ' ' ILE . . . -151.22 170.42 19.52 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.041 0.448 . . . . 63.44 110.338 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 97.83 -57.5 1.1 Allowed Glycine 0 C--N 1.339 0.725 0 N-CA-C 110.069 -1.212 . . . . 75.22 110.069 -170.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.527 HD13 ' HB2' ' B' ' 94' ' ' MET . 1.0 OUTLIER -67.18 156.53 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 124.019 0.928 . . . . 73.41 111.845 175.425 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -155.5 147.14 23.05 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.765 0.826 . . . . 74.14 109.368 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.95 -123.91 7.94 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 123.328 0.392 . . . . 72.24 113.323 174.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.0 m -84.08 -44.71 13.79 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.801 0.81 . . . . 63.11 110.217 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -64.96 -19.92 66.21 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 113.877 -1.511 . . . . 74.45 111.8 -169.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.527 ' HB2' HD13 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -74.73 -41.9 59.28 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.557 0.743 . . . . 74.54 111.422 -178.559 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.81 -15.19 59.26 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.448 0.699 . . . . 64.21 111.4 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -66.02 -37.81 86.82 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.725 0.81 . . . . 63.01 110.149 170.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 37.2 t -64.75 -62.87 1.31 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.435 0.636 . . . . 65.43 110.81 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.595 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.4 pp -70.09 -20.74 63.19 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 116.065 -0.516 . . . . 73.23 112.298 -176.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.15 -2.08 64.45 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-O 119.435 -0.647 . . . . 51.01 114.43 -177.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.526 ' HB1' ' HB2' ' B' ' 134' ' ' ASP . . . -148.88 -49.57 0.15 Allowed 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 117.714 0.757 . . . . 75.54 111.611 -175.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -71.81 -44.97 63.03 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.666 0.786 . . . . 63.43 111.087 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 80.7 m -66.01 -47.81 62.16 Favored Pre-proline 0 CA--C 1.562 1.404 0 CA-C-O 118.734 -0.65 . . . . 75.21 111.818 178.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 76.2 Cg_exo -51.01 -37.63 57.32 Favored 'Trans proline' 0 C--N 1.388 2.652 0 C-N-CA 122.796 2.33 . . . . 65.35 113.866 169.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.55 -32.28 73.69 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.58 0.752 . . . . 65.12 111.406 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.0 mt -74.53 -37.69 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.631 0.772 . . . . 64.23 110.403 176.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 80.4 mt -75.45 -29.65 59.73 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.808 0.843 . . . . 71.01 111.961 -176.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -57.64 -47.99 98.0 Favored Pre-proline 0 CA--C 1.561 1.385 0 CA-C-O 117.777 -1.106 . . . . 74.35 113.201 -174.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.429 ' HB3' ' HB2' ' D' ' 112' ' ' GLU . 68.4 Cg_exo -47.13 -45.87 20.56 Favored 'Trans proline' 0 C--N 1.387 2.599 0 C-N-CA 122.976 2.451 . . . . 74.21 114.664 174.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -72.36 -41.91 65.88 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.079 0.552 . . . . 73.42 111.032 -175.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.561 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -64.61 -40.68 95.93 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 122.599 0.36 . . . . 73.13 110.503 176.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 53.2 ttt-85 -60.16 -50.54 73.26 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.351 1.461 . . . . 72.33 110.734 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -68.38 -32.53 72.68 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.629 0.772 . . . . 73.41 109.98 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.572 ' SG ' HD11 ' B' ' 21' ' ' ILE . 5.6 t -69.96 -41.15 74.89 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.961 0.504 . . . . 53.12 110.577 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.541 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 73.6 mt -57.77 -53.77 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.391 1.077 . . . . 53.13 110.132 172.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.441 HG21 ' OG ' ' C' ' 119' ' ' SER . 17.7 m -60.78 -30.42 70.03 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.166 0.586 . . . . 63.3 111.138 -177.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.0 t -63.37 -50.48 69.74 Favored 'General case' 0 C--N 1.348 0.537 0 C-N-CA 123.041 0.536 . . . . 74.14 109.559 173.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.508 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.7 mmt -65.51 -32.66 74.38 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.439 0.696 . . . . 73.41 111.459 -176.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.411 HG23 ' O ' ' B' ' 114' ' ' ILE . 97.5 t -68.8 -42.69 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.733 0.813 . . . . 72.24 110.345 174.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.3 t -62.91 -35.1 78.95 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 115.326 -0.852 . . . . 44.24 110.838 177.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.614 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 77.0 mtt-85 -70.18 -38.53 75.4 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 114.679 -1.146 . . . . 74.2 110.096 177.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.39 -7.73 68.98 Favored Glycine 0 C--N 1.352 1.429 0 O-C-N 123.845 0.715 . . . . 71.24 112.839 173.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 16.8 m 66.94 24.92 9.51 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 125.118 1.367 . . . . 63.13 110.329 176.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -85.07 163.23 46.62 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 123.861 0.864 . . . . 71.42 111.145 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.21 166.76 1.5 Allowed 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 123.339 2.693 . . . . 73.32 114.524 175.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -65.05 114.64 4.74 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.329 1.051 . . . . 64.24 111.353 -172.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.821 HD21 HG11 ' B' ' 64' ' ' VAL . 26.4 tp -112.4 107.1 15.78 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.032 -0.729 . . . . 54.51 109.032 174.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -121.55 127.11 50.62 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 108.133 -1.062 . . . . 63.53 108.133 171.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.49 HD21 HG21 ' B' ' 64' ' ' VAL . 84.0 mt -77.56 138.58 39.25 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 123.427 0.454 . . . . 70.35 110.267 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.05 147.26 98.91 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 123.714 0.805 . . . . 50.12 111.066 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.27 81.01 0.29 Allowed 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.261 2.64 . . . . 61.03 111.678 176.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 4.1 p -96.51 112.24 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 115.259 -0.882 . . . . 54.15 109.545 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -78.85 114.65 17.96 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.302 -0.999 . . . . 73.3 108.302 172.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -56.88 -38.27 72.53 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.121 0.968 . . . . 63.33 110.775 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.526 ' HB2' ' HB1' ' B' ' 100' ' ' ALA . 27.7 t70 -65.92 -36.2 82.71 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 114.481 -1.236 . . . . 71.45 111.187 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.23 -37.76 86.64 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.986 0.514 . . . . 75.44 111.038 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.6 mp -69.58 -35.31 75.24 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.615 0.766 . . . . 61.52 110.047 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -69.03 -34.08 74.65 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.962 -0.563 . . . . 75.11 110.643 173.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' B' ' 134' ' ' ASP . 91.5 mtp -72.92 -20.32 61.09 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.265 1.026 . . . . 72.13 111.472 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.4 ' HB3' HG21 ' B' ' 149' ' ' THR . 1.0 OUTLIER -72.47 -39.82 67.42 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.592 -0.522 . . . . 72.31 109.592 176.229 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -77.8 -35.49 51.35 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 120.949 0.404 . . . . 74.32 110.07 175.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 28.9 tp -76.75 -7.31 55.15 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.547 0.739 . . . . 55.22 110.88 -175.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 69.22 -71.19 0.12 Allowed 'General case' 0 C--N 1.363 1.167 0 C-N-CA 125.743 1.617 . . . . 71.14 110.039 -176.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 70.54 -66.19 0.3 Allowed 'General case' 0 C--N 1.361 1.067 0 C-N-CA 125.907 1.683 . . . . 65.11 111.178 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -68.69 150.71 47.61 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.489 0.715 . . . . 74.23 110.238 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.62 98.6 0.05 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.05 0.94 . . . . 72.12 109.606 177.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 140.43 -134.93 6.74 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 110.286 -1.126 . . . . 31.53 110.286 -173.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -171.3 -63.41 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.681 0.792 . . . . 63.02 109.3 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 82.49 -62.44 4.59 Favored Glycine 0 C--N 1.35 1.33 0 CA-C-N 115.698 -0.683 . . . . 42.11 112.964 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . 0.4 HG21 ' HB3' ' B' ' 139' ' ' ASN . 65.8 p -74.05 134.94 43.01 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.893 0.877 . . . . 55.33 110.871 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.2 146.27 28.62 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.053 -1.091 . . . . 71.33 108.053 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 60.79 20.67 10.78 Favored 'General case' 0 CA--C 1.575 1.905 0 C-N-CA 124.203 1.001 . . . . 73.54 111.85 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -148.34 53.95 1.02 Allowed 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.246 1.418 . . . . 73.52 107.356 174.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -73.3 -76.51 0.12 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.184 -1.371 . . . . 74.23 110.352 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . 0.472 ' HA ' ' HB2' ' F' ' 110' ' ' ALA . 4.4 p30 -148.29 170.48 17.81 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.424 0.69 . . . . 75.01 110.303 -173.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.3 0 C-N-CA 124.038 0.935 . . . . 65.24 109.522 -179.445 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 87.7 mmm . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 110.07 -0.345 . . . . 61.32 110.07 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 73.0 p -76.87 90.48 3.5 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.556 0.693 . . . . 63.45 109.677 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -89.96 113.0 24.58 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.868 -1.06 . . . . 51.12 111.775 -172.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -136.09 155.61 49.94 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.715 1.206 . . . . 74.51 108.267 174.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . 0.569 ' HB3' ' HG2' ' C' ' 8' ' ' GLU . 33.8 t-20 -89.19 -81.23 0.28 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.594 -0.891 . . . . 72.04 108.594 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 154.32 -52.03 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 127.328 2.251 . . . . 65.14 106.864 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 80.9 p -124.54 56.34 1.29 Allowed 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.292 -0.867 . . . . 71.32 110.767 -175.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.634 ' HG3' ' H ' ' C' ' 155' ' ' ALA . 7.7 mm-40 -64.48 -33.67 76.43 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.109 0.481 . . . . 72.1 110.978 173.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.435 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 16.6 ttt 65.34 113.7 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.165 1.786 . . . . 71.12 111.601 -174.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 99.3 m -123.43 106.75 10.9 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 124.158 0.983 . . . . 74.32 108.594 176.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -105.48 128.59 53.64 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.396 -0.964 . . . . 70.23 108.396 174.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -141.71 122.51 14.39 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.015 0.526 . . . . 73.41 109.675 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.411 ' HA ' ' HD2' ' C' ' 84' ' ' PHE . 55.5 mt -71.88 120.49 20.28 Favored 'Isoleucine or valine' 0 C--N 1.35 0.624 0 N-CA-C 108.586 -0.894 . . . . 64.44 108.586 171.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -84.72 -45.28 12.58 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.545 -0.909 . . . . 73.22 108.545 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 178.15 165.71 0.74 Allowed 'General case' 0 C--N 1.353 0.724 0 CA-C-N 114.34 -1.3 . . . . 75.35 109.848 -176.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.496 ' HA ' ' HA2' ' C' ' 82' ' ' GLY . 2.8 pp -130.53 150.13 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 106.476 -1.676 . . . . 74.23 106.476 168.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.452 ' HB3' HG23 ' D' ' 122' ' ' THR . 19.2 p90 -178.35 141.38 0.23 Allowed 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 118.852 0.751 . . . . 72.24 110.777 -176.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . 0.406 HG21 ' SG ' ' C' ' 113' ' ' CYS . 69.6 p -72.44 119.83 17.2 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.976 0.91 . . . . 64.12 110.116 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -73.16 -44.07 60.56 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.211 -1.033 . . . . 73.44 108.211 169.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 26.9 t70 -134.49 141.89 46.88 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 113.577 -1.647 . . . . 62.55 109.772 -169.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.567 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.6 mt -144.77 143.8 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 106.92 -1.511 . . . . 73.25 106.92 176.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.3 t -156.38 150.92 25.69 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.161 0.505 . . . . 64.11 110.306 176.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -152.83 123.43 7.28 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 107.065 -1.458 . . . . 72.31 107.065 172.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -131.0 113.46 14.0 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.245 0.618 . . . . 72.14 109.765 -174.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.11 82.7 67.95 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 107.666 -1.235 . . . . 40.21 107.666 167.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.2 -24.82 31.81 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.783 2.322 . . . . 54.52 112.04 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -106.9 26.03 10.58 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.132 1.373 . . . . 54.54 110.315 178.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.66 -52.25 18.71 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 113.915 1.08 . . . . 60.14 113.915 -174.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.97 -42.64 29.25 Favored 'Trans proline' 0 C--N 1.384 2.405 0 C-N-CA 121.75 1.633 . . . . 74.05 112.251 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -68.32 -33.89 75.13 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 114.611 -1.177 . . . . 75.23 111.897 -175.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.716 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.1 p -80.23 -25.27 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.263 0 N-CA-C 112.757 0.651 . . . . 73.11 112.757 177.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -69.48 -28.98 66.54 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.55 -0.719 . . . . 70.22 112.184 175.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -89.4 35.04 0.81 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.378 0.671 . . . . 65.4 110.346 176.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -125.69 165.34 18.76 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.77 0.828 . . . . 70.12 110.856 -174.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -78.39 124.19 27.84 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 115.459 -0.791 . . . . 74.1 109.709 169.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.6 t-105 -85.38 96.06 9.44 Favored 'General case' 0 C--O 1.242 0.674 0 O-C-N 123.514 0.509 . . . . 72.2 110.18 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -150.38 76.77 8.34 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 107.106 -1.442 . . . . 74.22 107.106 169.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -90.95 164.95 3.89 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.733 2.289 . . . . 65.11 113.025 -175.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -88.6 82.51 6.88 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.147 -1.427 . . . . 72.54 107.147 170.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 56.5 t -73.93 114.96 14.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 114.809 -1.087 . . . . 53.54 109.344 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -135.53 125.24 25.37 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.274 -0.875 . . . . 75.43 109.427 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.424 HD23 HD22 ' C' ' 128' ' ' LEU . 3.8 pp -89.3 159.59 17.31 Favored 'General case' 0 C--O 1.246 0.913 0 N-CA-C 108.71 -0.848 . . . . 73.45 108.71 165.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.525 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 17.5 t70 -134.33 134.21 41.55 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.636 -1.246 . . . . 75.22 107.636 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.439 HD11 HG21 ' C' ' 131' ' ' VAL . 78.6 mt -123.54 110.98 15.72 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.602 0.715 . . . . 74.33 110.341 -176.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -120.76 129.73 53.73 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 106.543 -1.651 . . . . 71.32 106.543 173.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.8 t -129.95 150.67 51.13 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.624 -0.509 . . . . 72.21 109.624 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.24 149.78 29.81 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.342 0.657 . . . . 54.14 110.274 -177.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 32.9 p -125.59 150.3 47.63 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.697 0.799 . . . . 72.33 109.744 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 36.1 t -145.44 126.6 14.72 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.84 -1.17 . . . . 72.34 107.84 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -81.89 117.32 22.05 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.94 -0.763 . . . . 65.34 108.94 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.497 HD11 ' HB2' ' C' ' 57' ' ' GLU . 51.0 mt -86.23 -43.15 13.2 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.862 0.865 . . . . 73.01 110.081 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.47 -177.31 5.7 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 114.501 -1.227 . . . . 74.54 108.777 176.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -66.76 116.94 8.2 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.242 -0.651 . . . . 62.23 109.242 -177.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 68.62 21.84 7.8 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.824 1.25 . . . . 74.2 112.887 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 97.3 t -126.81 110.76 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 108.873 -0.788 . . . . 75.23 108.873 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -117.99 125.37 50.26 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.853 0.861 . . . . 73.01 110.583 -174.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.497 ' HB2' HD11 ' C' ' 51' ' ' LEU . 28.4 tt0 -83.11 109.99 17.63 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.238 1.015 . . . . 74.04 108.543 168.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 77.5 t -99.18 139.04 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.341 -0.985 . . . . 61.54 108.341 169.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.0 t -134.1 132.83 56.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 108.779 -0.822 . . . . 74.32 108.779 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -112.63 105.06 13.15 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.628 -1.249 . . . . 73.42 107.628 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 30.4 ttm-85 -81.13 111.23 17.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.766 0.826 . . . . 62.12 109.216 171.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 24.6 t -111.28 113.54 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 108.12 -1.067 . . . . 72.11 108.12 173.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 22.0 m -116.21 123.25 47.3 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.925 0.89 . . . . 73.53 109.603 -174.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.529 HG23 HD13 ' C' ' 114' ' ' ILE . 71.6 t -100.99 120.12 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 122.965 0.506 . . . . 61.53 109.786 177.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 3.8 m -107.29 110.03 21.95 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.174 -1.047 . . . . 72.41 108.174 172.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.37 115.86 28.76 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.337 -0.986 . . . . 70.12 108.337 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.6 m -138.38 127.51 24.22 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.008 0.523 . . . . 72.42 110.097 178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 16.9 mt -83.07 32.52 0.44 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.586 1.554 . . . . 64.01 111.276 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.68 -109.22 2.79 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 110.454 -1.058 . . . . 61.1 110.454 -171.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -89.94 -19.74 24.16 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.611 0.764 . . . . 73.2 110.366 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -87.43 121.12 29.45 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.51 1.124 . . . . 53.4 108.765 174.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 88.7 m -75.48 131.3 40.03 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.856 -0.794 . . . . 74.23 108.856 168.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.716 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -75.43 -61.1 2.02 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.05 -0.722 . . . . 74.41 109.05 171.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -162.57 155.14 19.27 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.365 -0.834 . . . . 74.54 109.918 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -114.38 135.81 53.68 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.979 -1.489 . . . . 62.04 106.979 167.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 49.8 t -142.13 148.03 37.65 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.321 -0.992 . . . . 62.41 108.321 -175.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -154.99 131.11 10.24 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.166 0.586 . . . . 74.2 109.703 177.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 68.8 t -125.23 132.03 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 108.273 -1.01 . . . . 73.53 108.273 167.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -107.83 90.81 3.41 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.96 -1.126 . . . . 53.23 107.96 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -78.4 108.6 11.87 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 114.876 -1.056 . . . . 74.44 109.072 -178.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.71 171.87 54.14 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 111.778 -0.529 . . . . 70.01 111.778 173.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' C' ' 16' ' ' ILE . . . 179.18 116.28 0.5 Allowed Glycine 0 CA--C 1.508 -0.403 0 N-CA-C 110.055 -1.218 . . . . 72.23 110.055 -178.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.423 HG12 ' HA ' ' C' ' 57' ' ' GLU . 66.9 mt -105.93 136.29 40.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 123.607 0.763 . . . . 62.24 109.234 -173.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.411 ' HD2' ' HA ' ' C' ' 13' ' ' ILE . 64.3 m-85 -137.34 126.58 24.66 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.426 1.09 . . . . 63.22 109.274 -171.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 70.8 m -78.52 101.25 7.27 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.362 -0.977 . . . . 72.21 108.362 168.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.474 HD13 ' SG ' ' C' ' 97' ' ' CYS . 21.2 mt -116.21 126.84 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.183 -0.673 . . . . 73.4 109.183 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -135.92 168.33 19.54 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 122.937 0.495 . . . . 75.01 110.649 -177.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.84 -49.96 3.67 Favored Glycine 0 C--N 1.345 1.08 0 O-C-N 123.868 0.73 . . . . 71.33 112.479 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.44 HD11 HG21 ' C' ' 86' ' ' ILE . 26.5 pt -82.19 161.19 3.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 123.296 0.639 . . . . 54.24 111.671 -175.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -156.63 156.13 32.98 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.477 -0.783 . . . . 74.12 110.113 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.5 -113.6 5.99 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 124.069 0.856 . . . . 50.11 113.744 171.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 9.6 t -64.85 -36.18 83.51 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.828 0.851 . . . . 65.01 111.65 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -68.3 -44.06 76.28 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.585 0.754 . . . . 72.31 109.722 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.465 ' HE1' HG21 ' C' ' 86' ' ' ILE . 5.9 tpt -64.42 -47.26 79.82 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.777 -1.101 . . . . 62.2 110.372 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.84 -39.51 81.48 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.029 0.932 . . . . 71.32 111.034 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -65.35 -32.39 74.01 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.244 -0.889 . . . . 63.35 111.602 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.474 ' SG ' HD13 ' C' ' 86' ' ' ILE . 22.1 t -75.49 -45.32 39.08 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 109.644 -0.502 . . . . 52.02 109.644 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 61.4 mt -74.21 -32.7 63.14 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.21 1.004 . . . . 63.24 112.786 -172.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.71 11.77 30.06 Favored Glycine 0 N--CA 1.473 1.104 0 CA-C-O 119.646 -0.53 . . . . 62.54 114.361 -170.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.26 -56.91 0.12 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 117.677 0.739 . . . . 73.41 111.967 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -70.61 -48.33 55.64 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 123.037 0.535 . . . . 72.3 111.426 -175.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.415 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 70.7 m -69.77 -47.4 24.15 Favored Pre-proline 0 CA--C 1.563 1.472 0 C-N-CA 123.958 0.903 . . . . 63.51 111.92 -176.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.464 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 77.8 Cg_exo -56.67 -26.29 64.54 Favored 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.407 2.072 . . . . 74.25 113.924 172.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -66.99 -37.96 85.15 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.981 0.513 . . . . 74.44 110.606 175.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.423 HD12 ' NH1' ' A' ' 111' ' ' ARG . 44.5 mm -73.85 -35.81 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.189 0.596 . . . . 71.15 109.928 177.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.23 -28.6 47.93 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.132 0.973 . . . . 74.45 112.744 -176.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -57.29 -51.39 82.07 Favored Pre-proline 0 N--CA 1.486 1.331 0 N-CA-C 113.951 1.093 . . . . 73.33 113.951 -172.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -58.51 -36.75 97.01 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 121.722 1.614 . . . . 74.33 113.239 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -67.97 -46.58 70.98 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.265 0.626 . . . . 73.33 110.918 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.66 -36.86 79.75 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.233 1.013 . . . . 61.45 110.78 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . 0.502 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 38.9 ttt-85 -62.61 -55.52 26.34 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.294 1.438 . . . . 62.54 110.408 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -64.69 -35.77 82.12 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 123.853 0.72 . . . . 71.42 110.203 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.406 ' SG ' HG21 ' C' ' 18' ' ' THR . 14.0 t -66.22 -33.79 76.54 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.055 0.542 . . . . 73.5 111.313 -177.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.529 HD13 HG23 ' C' ' 64' ' ' VAL . 96.0 mt -72.07 -52.21 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 122.833 0.453 . . . . 63.43 109.806 172.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -61.65 -28.97 69.76 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.141 0.576 . . . . 72.15 111.634 -173.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 25.9 t -66.13 -47.08 75.28 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.782 0.833 . . . . 54.13 108.967 173.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.623 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.3 -40.99 92.51 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.473 1.109 . . . . 74.43 111.757 176.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.436 HG23 ' O ' ' C' ' 114' ' ' ILE . 64.1 t -61.18 -44.6 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.655 0.782 . . . . 64.33 109.33 176.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.441 ' OG ' HG21 ' B' ' 115' ' ' THR . 30.1 t -66.69 -34.59 78.19 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 114.989 -1.005 . . . . 73.54 112.037 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.423 ' NH1' ' HA ' ' D' ' 113' ' ' CYS . 68.3 mtt-85 -69.81 -39.4 76.54 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.329 0.652 . . . . 70.05 109.585 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.28 6.48 71.89 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 123.853 0.721 . . . . 75.22 112.696 173.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.9 p 58.42 31.79 21.35 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.394 1.878 . . . . 63.03 113.204 171.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -87.2 150.64 49.93 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 108.678 -0.86 . . . . 73.51 108.678 168.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -44.41 147.05 1.73 Allowed 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 124.575 3.517 . . . . 73.24 115.73 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -51.83 117.18 2.54 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.356 1.062 . . . . 74.1 112.008 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 52.6 tp -107.71 90.57 3.34 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.607 0.718 . . . . 74.21 109.401 -177.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -96.91 95.35 7.78 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.403 -0.817 . . . . 62.53 109.254 -175.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.502 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 90.6 mt -62.32 146.91 49.83 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.524 0.73 . . . . 64.4 112.096 -174.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.56 147.93 64.65 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 123.819 0.848 . . . . 63.35 110.791 -177.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.555 ' HG3' HD12 ' A' ' 16' ' ' ILE . 43.9 Cg_exo -57.63 116.1 2.99 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 123.218 2.612 . . . . 63.34 112.279 175.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.439 HG21 HD11 ' C' ' 44' ' ' LEU . 60.5 t -100.02 132.93 44.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 110.243 -0.28 . . . . 73.42 110.243 176.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -94.99 92.32 6.81 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.888 0.875 . . . . 62.43 108.953 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -66.65 -26.99 67.32 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.503 0.721 . . . . 74.01 111.851 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -66.03 -41.21 91.21 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.552 0.741 . . . . 74.34 110.18 178.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.37 -42.3 96.27 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.774 0.829 . . . . 71.32 110.746 176.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 79.5 mt -66.1 -36.02 82.07 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.443 -0.799 . . . . 53.54 111.08 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -70.98 -33.7 70.68 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.754 0.822 . . . . 73.52 110.135 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 35.5 ttm -66.5 -39.56 88.75 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.445 1.098 . . . . 63.12 110.077 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -71.56 -36.98 71.11 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.358 -0.837 . . . . 72.21 110.827 171.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -72.17 -153.02 0.02 OUTLIER 'General case' 0 CA--C 1.57 1.716 0 C-N-CA 123.637 0.775 . . . . 71.43 109.767 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.428 HD22 ' H ' ' C' ' 142' ' ' GLN . 0.5 OUTLIER 57.25 -144.22 0.65 Allowed 'General case' 0 CA--C 1.566 1.593 0 C-N-CA 124.221 1.008 . . . . 61.23 109.137 -175.748 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.428 ' H ' HD22 ' C' ' 141' ' ' LEU . 63.6 tt0 -168.15 -64.37 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 107.196 -1.409 . . . . 64.41 107.196 178.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -88.31 111.04 21.25 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 115.845 -0.616 . . . . 72.2 109.739 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -71.81 97.27 1.77 Allowed 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.418 -0.81 . . . . 74.04 108.962 172.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -132.79 128.06 35.95 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.747 -1.205 . . . . 73.41 107.747 176.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -150.29 120.14 1.1 Allowed Glycine 0 C--N 1.334 0.433 0 N-CA-C 110.918 -0.873 . . . . 73.44 110.918 -175.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -157.48 -171.01 3.42 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.98 0.912 . . . . 61.44 109.07 -175.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 91.6 155.54 31.85 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 112.063 -0.415 . . . . 63.15 112.063 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 9.9 t -113.21 163.6 14.58 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.97 0.508 . . . . 64.22 111.242 -175.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -153.87 79.87 1.14 Allowed 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.375 -1.343 . . . . 74.23 107.375 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -134.87 -9.31 2.37 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.639 -0.71 . . . . 74.42 112.226 -172.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -161.72 156.77 23.39 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.168 -0.678 . . . . 53.34 109.168 -172.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . 0.492 ' HB3' HD21 ' E' ' 142' ' ' LEU . 26.6 mt-30 -112.81 110.45 20.57 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.67 0.788 . . . . 62.54 110.15 -178.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -155.6 -84.36 0.06 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.964 0.505 . . . . 73.31 109.874 174.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . 0.634 ' H ' ' HG3' ' C' ' 8' ' ' GLU . . . . . . . . 0 C--O 1.252 1.232 0 C-N-CA 124.447 1.099 . . . . 55.0 108.546 -177.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 109.993 -0.373 . . . . 72.51 109.993 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 40.8 t 70.82 154.22 0.13 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.842 1.257 . . . . 63.54 109.976 -168.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 67.5 128.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.728 1.211 . . . . 73.34 112.402 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -90.6 151.25 21.39 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.391 1.077 . . . . 63.23 108.316 175.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -63.64 -28.65 70.06 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 122.84 0.456 . . . . 71.52 110.88 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 55.2 28.57 11.3 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 124.357 1.063 . . . . 74.41 112.179 174.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.0 t -63.96 164.97 9.51 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.852 0.861 . . . . 72.34 110.931 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.44 154.14 39.33 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 109.472 -0.566 . . . . 71.05 109.472 169.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.623 ' HG2' HG13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -32.87 124.5 0.36 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.973 1.309 . . . . 60.31 112.38 179.457 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 10.2 t -148.25 158.23 43.96 Favored 'General case' 0 C--O 1.247 0.951 0 C-N-CA 123.681 0.792 . . . . 64.43 109.223 -178.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -156.35 120.11 4.36 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.097 -1.075 . . . . 62.42 108.097 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -132.81 116.59 16.72 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.486 0.714 . . . . 72.4 109.376 -177.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 63.8 mt -78.92 129.06 38.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 115.288 -0.869 . . . . 74.42 108.932 176.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -99.2 -44.57 6.21 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.716 0.406 . . . . 73.32 110.98 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -167.84 147.41 4.89 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.265 0.226 . . . . 64.44 111.181 -174.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.0 mp -125.56 140.48 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 106.031 -1.84 . . . . 74.11 106.031 172.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -164.28 146.97 9.09 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 124.038 0.836 . . . . 75.42 110.614 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.1 p -85.01 112.87 20.99 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.396 -0.82 . . . . 63.11 109.622 176.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -83.76 -18.92 36.16 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.394 0.678 . . . . 73.33 109.661 177.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.674 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 30.6 t70 -159.8 131.73 6.27 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.976 0.91 . . . . 73.12 109.694 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.623 HG21 ' HE2' ' C' ' 117' ' ' MET . 77.3 mt -134.94 142.43 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 107.375 -1.342 . . . . 70.42 107.375 171.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . 0.427 ' HB3' ' HB2' ' D' ' 77' ' ' GLU . 33.8 t -142.67 143.88 32.51 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.794 1.237 . . . . 62.03 107.961 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.567 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.9 t80 -152.69 117.91 5.22 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.279 -1.378 . . . . 71.04 107.279 172.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -130.28 113.1 13.98 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.717 0.807 . . . . 74.31 109.112 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.611 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -105.3 90.55 3.96 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 107.912 -1.144 . . . . 45.51 107.912 172.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.8 -30.47 9.36 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.977 2.452 . . . . 70.12 112.733 -172.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -109.57 7.64 24.7 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.593 0.757 . . . . 44.23 111.439 -171.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.611 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -44.45 -60.58 2.78 Favored Pre-proline 0 CA--C 1.558 1.25 0 N-CA-C 115.298 1.592 . . . . 64.22 115.298 -158.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.82 -34.54 23.88 Favored 'Trans proline' 0 C--N 1.377 2.035 0 CA-C-N 122.474 1.919 . . . . 64.01 113.873 -172.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -86.19 -21.34 27.55 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 116.637 -0.256 . . . . 74.51 110.497 -175.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.443 HG12 ' O ' ' D' ' 28' ' ' ALA . 1.8 p -83.1 -21.1 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.068 0.547 . . . . 53.11 110.307 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -57.88 -23.6 53.85 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.601 0.76 . . . . 72.1 112.864 174.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -59.31 -27.38 65.82 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.839 0.856 . . . . 70.54 111.167 176.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -83.92 90.79 7.45 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.697 1.199 . . . . 62.14 109.749 177.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -83.45 92.7 7.63 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.935 -1.03 . . . . 64.34 111.46 -175.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 44.6 p90 -167.8 172.68 8.93 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.247 1.019 . . . . 72.41 109.234 166.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -64.19 114.83 15.37 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 108.518 -0.919 . . . . 71.12 108.518 173.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.415 ' O ' HG23 ' D' ' 40' ' ' VAL . 53.3 Cg_exo -54.25 119.35 6.2 Favored 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 122.762 2.308 . . . . 74.52 110.457 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.47 111.05 3.38 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.991 -0.744 . . . . 64.25 108.991 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.655 HG13 HG13 ' D' ' 64' ' ' VAL . 88.3 t -99.07 140.86 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 113.983 -1.462 . . . . 73.31 108.6 -175.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -124.6 122.95 38.99 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.012 -1.477 . . . . 73.22 107.012 171.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 64.3 tp -97.17 138.54 34.52 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.757 0.823 . . . . 75.53 109.863 -170.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.762 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 9.0 m-20 -125.64 114.01 18.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.728 -1.124 . . . . 53.41 108.033 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 90.5 mt -109.23 135.27 50.6 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.091 -0.707 . . . . 54.42 109.091 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -146.04 154.03 41.41 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 124.388 1.075 . . . . 73.02 108.477 -177.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 8.8 t -117.96 150.84 38.57 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.294 0.569 . . . . 74.15 110.274 -177.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.07 170.35 19.61 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.415 1.486 . . . . 74.13 107.777 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 72.1 p -171.13 -171.33 0.95 Allowed 'General case' 0 C--O 1.243 0.724 0 CA-C-O 121.174 0.512 . . . . 65.3 110.925 -177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 36.4 m -147.42 119.62 8.32 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 106.239 -1.763 . . . . 50.53 106.239 172.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -83.62 130.47 34.98 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.108 0.563 . . . . 72.12 111.479 -169.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -159.1 99.25 1.5 Allowed 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.257 -1.757 . . . . 64.35 106.257 170.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.458 ' HB1' ' HB2' ' E' ' 98' ' ' ASP . . . -73.61 83.05 1.54 Allowed 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 121.751 0.786 . . . . 61.4 112.128 -171.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -145.49 19.32 1.52 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.936 1.294 . . . . 73.44 108.2 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' D' ' 85' ' ' SER . 1.0 OUTLIER 71.17 5.63 5.53 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 125.24 1.416 . . . . 71.34 113.112 -176.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 16.4 m -122.44 112.22 33.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 107.933 -1.136 . . . . 72.35 107.933 175.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.578 ' HB2' HD11 ' D' ' 98' ' ' LEU . 9.8 m-85 -134.88 133.12 39.33 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 106.746 -1.575 . . . . 71.1 106.746 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.471 ' HB3' HG13 ' D' ' 83' ' ' ILE . 7.4 pt-20 -86.92 122.67 31.1 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.708 -0.849 . . . . 71.43 108.708 173.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 78.3 t -101.06 141.44 17.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.421 -1.263 . . . . 54.54 108.272 177.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.574 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 36.3 t -128.18 123.97 61.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 108.181 -1.044 . . . . 54.21 108.181 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.514 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -95.09 109.11 21.21 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 106.828 -1.545 . . . . 75.34 106.828 177.763 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.49 95.3 10.21 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.388 -1.708 . . . . 73.13 106.388 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.48 HG21 ' CB ' ' D' ' 110' ' ' ALA . 44.9 t -97.69 145.13 9.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 CA-C-N 115.406 -0.816 . . . . 74.01 109.057 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.762 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 52.7 m -141.21 143.12 34.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.939 -1.028 . . . . 74.12 108.683 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.655 HG13 HG13 ' D' ' 40' ' ' VAL . 12.3 t -133.6 115.69 22.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 123.796 0.838 . . . . 70.45 108.784 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 17.2 m -106.68 94.77 5.3 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.796 -0.816 . . . . 63.34 108.796 171.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.625 ' HB2' HG22 ' D' ' 40' ' ' VAL . . . -99.07 145.85 26.69 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 109.595 -0.52 . . . . 54.3 109.595 176.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 22.7 p -153.4 137.63 16.54 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.737 -0.665 . . . . 63.52 111.257 -171.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.428 ' HB2' HG22 ' D' ' 31' ' ' VAL . 22.1 mt -107.54 116.4 31.87 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.898 1.279 . . . . 71.45 108.225 173.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.26 -133.54 18.33 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-N 116.161 -0.472 . . . . 42.01 112.081 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -94.57 3.57 54.94 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.148 0.579 . . . . 64.22 111.551 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -124.39 167.43 14.39 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.729 0.412 . . . . 64.43 110.249 -176.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 12.0 m -68.1 144.91 54.85 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 124.137 0.898 . . . . 74.45 111.731 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.54 -59.91 1.63 Allowed 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.308 -1.367 . . . . 60.22 107.308 168.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . 0.426 ' CE1' HG22 ' D' ' 118' ' ' VAL . 54.1 p90 -157.97 158.95 35.91 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.476 -1.238 . . . . 74.23 110.306 178.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 51.2 mt -124.73 145.39 49.72 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 107.137 -1.431 . . . . 74.53 107.137 176.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.447 ' SG ' HG12 ' D' ' 114' ' ' ILE . 45.6 t -156.49 109.45 2.61 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 117.884 0.311 . . . . 55.21 110.738 -171.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' D' ' 22' ' ' SER . 12.1 mp0 -124.5 127.69 47.84 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.079 0.952 . . . . 74.35 109.384 -173.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 87.1 t -135.47 115.17 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.125 0.57 . . . . 73.45 109.887 -178.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.674 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.9 mt-30 -88.68 84.75 6.72 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.428 -0.953 . . . . 70.33 108.428 170.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . 0.403 ' O ' HD13 ' D' ' 106' ' ' LEU . 6.7 tp-100 -83.1 96.92 8.53 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 113.736 -1.574 . . . . 71.41 109.604 -176.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -100.02 170.53 22.8 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.538 -0.301 . . . . 74.52 113.678 -175.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -178.78 148.5 8.36 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-O 119.243 -0.754 . . . . 71.14 112.675 177.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.471 HG13 ' HB3' ' D' ' 57' ' ' GLU . 3.4 mp -89.32 126.3 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.099 -1.075 . . . . 71.03 108.099 176.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -123.37 149.77 44.54 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.97 0.908 . . . . 73.11 110.239 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' D' ' 54' ' ' ASP . 31.2 t -115.44 111.71 21.19 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.884 0.874 . . . . 64.43 109.073 176.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.407 HD13 ' HB2' ' D' ' 98' ' ' LEU . 46.0 pt -114.88 140.07 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.966 0.906 . . . . 72.25 108.985 177.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.588 ' HA ' HG12 ' E' ' 97' ' ' ILE . . . -162.16 161.92 28.21 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.062 0.458 . . . . 51.4 111.917 177.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.93 8.89 81.78 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 115.065 -0.971 . . . . 73.44 115.099 167.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.623 HG13 ' HG2' ' D' ' 9' ' ' MET . 0.5 OUTLIER -98.77 171.69 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.168 0 N-CA-C 107.986 -1.116 . . . . 73.33 107.986 174.773 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.428 ' H ' HG22 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -138.96 175.3 9.67 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.87 -0.519 . . . . 64.42 110.85 -177.57 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.8 -133.12 29.41 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 114.876 -1.057 . . . . 34.0 112.805 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -92.08 -29.99 16.25 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.639 0.776 . . . . 44.21 111.057 175.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -68.8 -15.5 63.52 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.234 0.613 . . . . 73.33 112.359 -173.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.506 ' HA ' ' HB ' ' D' ' 89' ' ' ILE . 0.0 OUTLIER -59.21 -37.74 78.2 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 112.708 0.633 . . . . 70.42 112.708 173.538 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . 0.516 ' HB1' HD23 ' E' ' 102' ' ' LEU . . . -83.73 -16.97 42.88 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.399 0.68 . . . . 62.23 111.481 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -66.62 -38.2 86.44 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.935 0.894 . . . . 74.33 111.154 -178.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 63.8 m -59.91 -30.47 69.06 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.623 0.769 . . . . 74.12 111.96 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.615 HD23 HD21 ' E' ' 102' ' ' LEU . 14.5 tp -79.53 -42.58 24.82 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.047 -0.979 . . . . 61.15 110.45 -177.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.08 -18.52 69.36 Favored Glycine 0 C--N 1.345 1.08 0 CA-C-N 115.739 -0.664 . . . . 72.52 113.794 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.16 -63.08 1.37 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.06 0.544 . . . . 63.54 112.289 -170.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -70.59 -31.88 69.04 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 112.236 0.458 . . . . 75.33 112.236 -174.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.454 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 87.4 m -68.32 -49.5 32.4 Favored Pre-proline 0 CA--C 1.568 1.669 0 CA-C-O 118.531 -0.747 . . . . 53.0 112.114 177.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.514 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 51.7 Cg_exo -60.46 -27.36 84.71 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 122.273 1.982 . . . . 63.35 113.373 169.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -64.76 -36.07 83.13 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.325 0.65 . . . . 41.33 110.532 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 31.1 mm -66.5 -43.14 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 123.724 0.81 . . . . 61.21 110.371 172.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.403 HD13 ' O ' ' D' ' 80' ' ' GLN . 75.0 mt -75.52 -12.37 60.21 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.8 0.84 . . . . 75.34 112.979 -173.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -75.47 -45.9 4.36 Favored Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 113.559 0.948 . . . . 75.15 113.559 -174.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.53 -33.57 78.83 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 121.871 1.714 . . . . 71.34 112.578 169.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -76.65 -32.06 57.74 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.468 0.707 . . . . 75.53 111.793 176.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . 0.48 ' CB ' HG21 ' D' ' 62' ' ' VAL . . . -64.2 -45.96 85.98 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 109.836 -0.431 . . . . 70.2 109.836 177.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' D' ' 111' ' ' ARG . 9.6 ptt-85 -76.61 -29.11 56.39 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 123.313 0.383 . . . . 73.32 110.697 178.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . 0.429 ' HB2' ' HB3' ' B' ' 108' ' ' PRO . 23.0 tt0 -51.13 -43.34 61.16 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.851 0.834 . . . . 74.33 109.878 172.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.423 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 18.8 t -72.8 -60.93 1.99 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.071 -1.422 . . . . 63.11 109.927 177.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.688 ' HA ' ' HE1' ' D' ' 117' ' ' MET . 80.4 mt -53.5 -56.7 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 124.77 1.228 . . . . 74.44 112.873 -174.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 28.7 m -48.72 -38.35 21.26 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.873 0.869 . . . . 74.43 111.545 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 12.7 t -69.02 -47.59 65.06 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.741 -1.118 . . . . 70.44 110.25 -178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.688 ' HE1' ' HA ' ' D' ' 114' ' ' ILE . 4.0 mpp? -63.14 -32.59 74.01 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 117.973 0.351 . . . . 63.53 111.65 178.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.484 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.2 t -62.24 -49.47 83.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 123.397 0.679 . . . . 73.45 109.927 176.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.7 p -71.92 -29.07 63.92 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.776 -0.647 . . . . 73.12 110.768 -177.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.4 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 86.4 mtt-85 -71.36 -30.41 66.13 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.746 0.818 . . . . 73.42 110.367 175.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.61 8.41 75.31 Favored Glycine 0 C--N 1.355 1.591 0 CA-C-O 119.367 -0.685 . . . . 52.23 112.82 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.452 HG23 ' HB3' ' C' ' 17' ' ' TYR . 74.7 p 51.75 56.8 7.3 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.497 1.519 . . . . 71.52 112.274 -175.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -120.74 148.28 47.9 Favored Pre-proline 0 C--O 1.241 0.632 0 N-CA-C 108.518 -0.919 . . . . 71.02 108.518 169.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -50.28 141.13 32.53 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 123.167 2.578 . . . . 63.45 112.668 174.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -55.4 140.54 39.58 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.383 1.073 . . . . 74.52 113.2 -167.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.465 HD22 HG21 ' D' ' 40' ' ' VAL . 13.4 tp -126.8 98.55 5.41 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.008 0.923 . . . . 73.3 109.328 -178.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -102.1 103.0 13.54 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.163 -1.051 . . . . 54.03 108.163 175.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.08 121.92 14.25 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 123.59 0.556 . . . . 62.24 110.412 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.89 128.95 91.31 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.811 0.844 . . . . 72.11 110.977 -175.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -79.99 105.61 1.82 Allowed 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.905 2.403 . . . . 44.24 111.938 -170.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -107.79 124.62 64.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 108.015 -1.105 . . . . 75.21 108.015 172.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -68.2 117.06 9.53 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.932 -0.766 . . . . 75.54 108.932 175.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.593 ' HA ' HD23 ' D' ' 136' ' ' LEU . 1.5 m-85 -61.94 -21.4 64.75 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.025 1.33 . . . . 62.45 112.048 -171.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -53.07 -35.21 59.3 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.195 1.398 . . . . 65.44 111.481 173.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.31 -31.0 69.18 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.265 1.026 . . . . 74.51 112.404 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.593 HD23 ' HA ' ' D' ' 133' ' ' PHE . 3.5 mm? -72.83 -35.8 67.35 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.09 0.556 . . . . 72.24 110.586 177.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -78.39 -31.18 48.2 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.738 -0.665 . . . . 70.44 110.782 177.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 70.8 mtm -73.94 -26.15 60.35 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 122.883 0.473 . . . . 62.14 110.798 172.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.52 ' O ' ' HG2' ' D' ' 143' ' ' GLN . 6.7 t30 -51.35 -43.61 61.84 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.348 0.659 . . . . 73.23 109.759 173.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -52.81 -41.67 64.39 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.906 1.282 . . . . 64.12 112.222 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.4 mp -72.87 -38.86 66.87 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.19 0.596 . . . . 73.24 111.509 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -89.43 40.61 1.0 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.409 0.683 . . . . 62.14 112.191 -174.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . 0.52 ' HG2' ' O ' ' D' ' 139' ' ' ASN . 24.1 mm-40 -117.92 76.62 1.08 Allowed 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.557 -0.905 . . . . 64.54 108.557 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . 0.562 ' HG2' ' H ' ' D' ' 145' ' ' ALA . 44.2 tt0 -169.83 -150.67 0.08 Allowed 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 106.72 -1.585 . . . . 74.54 106.72 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . 0.562 ' H ' ' HG2' ' D' ' 144' ' ' GLN . . . -78.05 10.54 2.82 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 119.112 0.869 . . . . 61.22 112.13 175.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.5 60.65 4.0 Favored Glycine 0 C--N 1.355 1.607 0 C-N-CA 123.507 0.575 . . . . 73.22 112.269 172.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -79.08 173.85 12.16 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.343 1.057 . . . . 72.3 109.533 173.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -161.87 104.33 0.24 Allowed Glycine 0 C--N 1.335 0.499 0 N-CA-C 111.757 -0.537 . . . . 64.02 111.757 -175.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 3.8 t -77.37 71.18 3.84 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.997 0.919 . . . . 73.44 110.226 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -74.38 100.31 3.75 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.842 -0.799 . . . . 71.22 108.842 -178.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -104.77 103.49 13.12 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.67 0.788 . . . . 55.34 109.699 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -151.44 82.13 1.3 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.276 -1.009 . . . . 73.44 108.276 171.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -140.44 121.98 15.16 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.949 -1.023 . . . . 73.34 109.212 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -94.83 122.35 37.36 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.938 -1.134 . . . . 75.11 107.938 170.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.942 0 C-N-CA 123.392 0.677 . . . . 38.07 110.286 -177.084 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.677 0 CA-C-O 120.124 -0.265 . . . . 74.05 112.488 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . -136.36 151.45 20.82 Favored Glycine 0 C--N 1.341 0.853 0 N-CA-C 111.124 -0.791 . . . . 61.44 111.124 177.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -96.51 98.6 10.35 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.34 -1.356 . . . . 75.21 107.34 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -104.38 -22.31 13.35 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.898 0.879 . . . . 74.01 113.083 -165.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm 72.28 158.84 0.2 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.93 1.292 . . . . 73.52 112.854 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 96' ' ' GLY . . . . . . . . . . . . . . . 177.54 -48.94 0.1 Allowed Glycine 0 C--N 1.343 0.944 0 N-CA-C 111.464 -0.654 . . . . 13.53 111.464 -177.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 97' ' ' ILE . . . . . 0.588 HG12 ' HA ' ' D' ' 87' ' ' ALA . 29.4 pt -132.81 96.27 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-O 122.884 1.326 . . . . 61.4 110.141 177.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 98' ' ' ASP . . . . . 0.458 ' HB2' ' HB1' ' D' ' 52' ' ' ALA . 4.9 p-10 -107.14 -170.91 1.78 Allowed 'General case' 0 C--O 1.244 0.81 0 CA-C-N 114.95 -1.023 . . . . 75.02 108.67 170.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . 63.65 15.14 8.7 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.943 0.897 . . . . 71.03 112.254 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 100' ' ' LEU . . . . . . . . . . . . . 4.0 pp -85.16 114.97 59.14 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 108.596 -0.89 . . . . 74.22 108.596 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -87.85 0.89 6.96 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.784 2.323 . . . . 62.23 112.454 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 102' ' ' LEU . . . . . 0.615 HD21 HD23 ' D' ' 98' ' ' LEU . 97.0 mt 59.04 29.78 19.43 Favored 'General case' 0 C--N 1.368 1.389 0 C-N-CA 124.248 1.019 . . . . 52.33 110.918 -173.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 70.2 p 53.27 22.27 2.64 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.931 1.692 . . . . 74.44 112.539 -175.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 150.31 145.42 4.12 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 109.181 -1.567 . . . . 64.44 109.181 -172.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 105' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -77.38 33.11 0.16 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.391 1.076 . . . . 74.41 112.859 -169.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -165.06 -64.99 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 106.41 -1.7 . . . . 73.34 106.41 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -177.11 142.07 0.35 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.732 2.013 . . . . 70.23 107.512 169.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -74.14 -38.0 63.89 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.662 -0.496 . . . . 72.42 109.662 172.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -134.76 126.61 29.3 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.595 1.158 . . . . 72.43 108.36 177.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.23 -174.54 3.11 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 123.568 0.747 . . . . 72.35 111.526 -172.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . . . . . . . . . 4.7 mp -83.89 177.86 8.14 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.741 1.216 . . . . 75.11 110.352 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 112' ' ' ASN . . . . . 0.6 ' HA ' HG21 ' E' ' 121' ' ' VAL . 5.6 m-20 58.88 95.78 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.209 1.004 . . . . 73.14 111.462 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -70.07 127.69 33.72 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 108.217 -1.031 . . . . 74.1 108.217 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . 0.445 ' HD2' ' N ' ' E' ' 114' ' ' LYS . 10.6 mptt -80.03 -39.59 29.56 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 108.837 -0.801 . . . . 74.45 108.837 179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 115' ' ' THR . . . . . . . . . . . . . 12.4 t -158.94 153.28 24.02 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 114.494 -1.23 . . . . 74.12 109.006 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 144.06 -98.4 0.21 Allowed Glycine 0 C--N 1.338 0.653 0 N-CA-C 111.893 -0.483 . . . . 72.24 111.893 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 117' ' ' LYS . . . . . 0.554 ' HD2' ' HD2' ' E' ' 118' ' ' PRO . 24.1 tptm -104.88 119.65 52.67 Favored Pre-proline 0 CA--C 1.548 0.873 0 N-CA-C 108.966 -0.753 . . . . 75.44 108.966 -179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 118' ' ' PRO . . . . . 0.554 ' HD2' ' HD2' ' E' ' 117' ' ' LYS . 52.8 Cg_endo -65.62 -177.9 0.82 Allowed 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.181 2.587 . . . . 65.24 113.551 -177.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 78.2 -36.15 0.2 Allowed 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 126.027 1.731 . . . . 71.11 112.701 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -64.23 124.02 20.62 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.794 0.838 . . . . 72.34 111.931 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 121' ' ' VAL . . . . . 0.6 HG21 ' HA ' ' E' ' 112' ' ' ASN . 61.7 t 68.81 100.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.55 1.54 . . . . 42.11 111.233 -177.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 35.4 p -105.54 171.13 7.49 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 124.428 1.091 . . . . 74.15 109.223 170.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.92 -87.69 0.09 Allowed 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 112.243 0.46 . . . . 51.2 112.243 -174.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 22.0 t -85.57 84.38 7.62 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.504 0.722 . . . . 64.23 109.766 -174.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -153.12 26.18 0.54 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.946 0.898 . . . . 73.43 110.401 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . -135.67 130.16 33.87 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.115 0.566 . . . . 24.01 109.9 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 47.9 t 69.24 156.92 0.14 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 125.259 1.424 . . . . 74.32 112.298 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . -157.12 15.03 0.27 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.806 0.842 . . . . 72.23 110.376 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 44.6 m -111.24 134.58 52.73 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.408 0.683 . . . . 71.43 110.45 -173.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.08 -169.63 2.12 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.339 1.055 . . . . 50.54 111.856 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 131' ' ' TRP . . . . . 0.616 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 0.9 OUTLIER -135.29 97.28 3.67 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 124.13 0.972 . . . . 72.34 108.554 -178.702 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' E' E ' 132' ' ' SER . . . . . . . . . . . . . 20.7 m -128.15 100.72 5.97 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.788 -0.57 . . . . 64.3 110.639 -173.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 22.8 m -142.28 106.11 4.71 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 107.664 -1.235 . . . . 53.11 107.664 171.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.61 -36.07 58.79 Favored Glycine 0 C--N 1.35 1.355 0 O-C-N 123.514 0.509 . . . . 71.42 112.931 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 63.8 t 65.21 -70.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 125.589 1.555 . . . . 75.41 111.694 -176.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 59.06 41.27 20.98 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.93 1.292 . . . . 75.12 110.706 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 137' ' ' THR . . . . . . . . . . . . . 40.2 p 52.44 28.61 6.05 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.563 1.545 . . . . 73.22 112.986 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 30.0 t80 57.89 29.26 17.3 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-O 122.363 1.078 . . . . 72.2 110.673 174.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 139' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -152.17 166.29 32.17 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 115.302 -0.863 . . . . 74.01 109.34 -173.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -69.07 81.17 0.25 Allowed Glycine 0 C--N 1.343 0.921 0 CA-C-N 116.503 -0.317 . . . . 54.32 112.323 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -79.28 168.0 20.15 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 124.046 0.938 . . . . 73.41 111.003 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 142' ' ' LEU . . . . . 0.492 HD21 ' HB3' ' C' ' 153' ' ' GLN . 3.8 mm? -72.01 160.56 32.3 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.76 -0.654 . . . . 74.12 110.421 177.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.34 73.19 1.83 Allowed Glycine 0 C--N 1.346 1.131 0 O-C-N 123.534 0.522 . . . . 43.14 112.009 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 6.7 m -109.79 100.81 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 124.031 0.932 . . . . 74.2 109.438 -177.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 33.1 t70 . . . . . 0 C--O 1.25 1.124 0 N-CA-C 108.754 -0.832 . . . . 45.51 108.754 -176.575 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.463 0 N-CA-C 111.841 -0.504 . . . . 74.33 111.841 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . -90.41 54.78 3.52 Favored Glycine 0 C--N 1.351 1.363 0 C-N-CA 122.867 0.27 . . . . 52.12 113.246 -175.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 93' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -137.74 112.71 9.06 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.996 0.919 . . . . 74.43 109.368 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 94' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -89.58 154.53 19.91 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.344 1.058 . . . . 75.43 109.657 175.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.06 168.24 14.86 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.941 0.496 . . . . 64.44 110.117 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . 140.77 31.57 0.16 Allowed Glycine 0 C--N 1.344 1.02 0 CA-C-N 116.302 -0.408 . . . . 74.33 113.298 177.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 97' ' ' ILE . . . . . 0.541 ' HB ' ' HA ' ' B' ' 87' ' ' ALA . 15.0 tt -104.24 -40.77 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 109.022 -0.732 . . . . 54.44 109.022 170.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 98' ' ' ASP . . . . . . . . . . . . . 30.5 t70 58.19 109.03 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.615 1.566 . . . . 73.11 112.848 174.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . 68.79 110.69 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.44 1.096 . . . . 73.02 111.828 174.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 100' ' ' LEU . . . . . . . . . . . . . 5.4 mp -114.18 86.98 12.5 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 123.016 0.526 . . . . 72.52 109.665 174.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -86.49 -3.84 8.43 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.917 2.412 . . . . 74.02 112.031 168.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 102' ' ' LEU . . . . . 0.455 HD12 HD11 ' B' ' 98' ' ' LEU . 2.2 mm? 57.17 -95.78 0.06 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.526 1.53 . . . . 73.21 110.623 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 3.3 t -167.82 94.37 0.41 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.391 1.077 . . . . 61.43 108.67 174.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.47 -74.17 1.95 Allowed Glycine 0 C--N 1.344 1.014 0 CA-C-N 115.255 -0.884 . . . . 54.51 111.663 -174.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.21 -56.7 1.9 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.605 1.162 . . . . 74.1 107.985 176.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -166.66 165.11 16.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.758 1.223 . . . . 45.53 108.793 -177.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 28.8 m -45.47 102.26 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.104 1.362 . . . . 72.12 111.936 177.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -136.15 131.39 34.64 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 124.107 0.963 . . . . 71.23 108.494 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -142.97 -77.64 0.24 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 107.685 -1.228 . . . . 73.41 107.685 173.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . 0.472 ' HB2' ' HA ' ' B' ' 154' ' ' ASP . . . -153.64 -52.24 0.1 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.159 -1.052 . . . . 65.41 108.159 176.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 43.2 tp 58.74 -88.57 0.02 OUTLIER 'General case' 0 C--N 1.359 0.982 0 C-N-CA 125.33 1.452 . . . . 74.34 110.884 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 112' ' ' ASN . . . . . 0.505 HD22 ' HA ' ' B' ' 43' ' ' ASP . 2.9 t30 -169.35 15.14 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.981 0.912 . . . . 71.31 108.976 -172.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 113' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -79.94 127.3 32.1 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 123.277 0.631 . . . . 71.43 110.666 -171.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 50.9 tptt 58.92 40.72 22.24 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.477 1.111 . . . . 73.42 109.043 -175.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 115' ' ' THR . . . . . . . . . . . . . 3.2 m 63.53 33.0 13.81 Favored 'General case' 0 CA--C 1.557 1.231 0 CA-C-N 114.361 -1.29 . . . . 70.33 109.821 -176.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.66 74.14 1.58 Allowed Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.178 -0.919 . . . . 40.42 112.352 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -76.28 134.25 70.72 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 123.602 0.761 . . . . 63.24 111.091 -174.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 118' ' ' PRO . . . . . 0.483 ' HG2' ' HB3' ' F' ' 120' ' ' TYR . 66.9 Cg_endo -84.94 31.51 0.49 Allowed 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 123.368 2.712 . . . . 75.3 111.167 166.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 9.4 t70 56.57 40.84 29.24 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 125.895 1.678 . . . . 75.32 110.598 -171.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 120' ' ' TYR . . . . . 0.483 ' HB3' ' HG2' ' F' ' 118' ' ' PRO . 38.5 t80 -148.97 147.48 28.65 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 114.887 -1.051 . . . . 73.01 109.401 -173.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 99.1 t 65.27 104.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 125.184 1.394 . . . . 51.31 111.431 -175.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 32.2 m -95.92 136.72 35.98 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.145 -0.687 . . . . 63.42 109.145 173.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -83.45 -11.65 57.27 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.968 0.907 . . . . 63.41 112.544 -170.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 124' ' ' SER . . . . . . . . . . . . . 15.1 m -68.96 -9.98 55.01 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.851 0.86 . . . . 72.31 112.445 -177.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.87 -24.62 67.81 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.761 0.825 . . . . 74.55 111.85 174.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 126' ' ' ALA . . . . . . . . . . . . . . . -83.06 -21.5 33.75 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.799 0.84 . . . . 44.13 111.937 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 41.3 m -81.64 98.02 8.17 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.388 0.675 . . . . 71.34 110.609 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -142.97 143.52 31.98 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.785 0.834 . . . . 64.15 109.949 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 129' ' ' THR . . . . . . . . . . . . . 26.0 m -73.76 98.73 2.99 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.832 0.853 . . . . 74.31 108.902 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -151.06 90.32 1.6 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.946 -0.57 . . . . 72.34 110.487 -174.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 64.2 t90 -151.29 153.31 34.58 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.337 0.655 . . . . 75.53 109.577 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 70.7 m -153.21 151.28 29.91 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.756 1.223 . . . . 52.24 109.799 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 14.4 t -87.82 -174.95 4.96 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.867 0.867 . . . . 73.33 109.925 174.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.28 -94.24 0.15 Allowed Glycine 0 C--N 1.348 1.199 0 CA-C-O 120.064 -0.298 . . . . 53.12 112.471 175.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 135' ' ' VAL . . . . . . . . . . . . . 12.3 p -163.55 151.26 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.096 0.558 . . . . 72.22 109.644 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -123.09 130.49 52.85 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 107.758 -1.201 . . . . 73.51 107.758 168.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 88.0 m 68.26 120.26 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.557 1.143 . . . . 45.15 109.832 -167.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -60.4 -30.91 69.9 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.354 0.662 . . . . 72.04 111.323 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 66.08 96.08 0.05 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.274 1.43 . . . . 73.42 111.373 174.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . -123.17 10.17 8.81 Favored Glycine 0 N--CA 1.472 1.063 0 N-CA-C 111.936 -0.466 . . . . 50.45 111.936 174.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -89.24 -63.98 1.21 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.718 0.807 . . . . 72.2 110.104 -177.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 45.2 tp 49.85 80.27 0.07 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.314 1.446 . . . . 61.31 111.939 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -104.09 121.89 7.18 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 111.233 -0.747 . . . . 42.23 111.233 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.84 -26.43 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.006 0.523 . . . . 65.32 111.211 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 27.5 t70 . . . . . 0 C--O 1.251 1.132 0 C-N-CA 124.402 1.081 . . . . 73.42 108.928 177.713 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptt? . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 120.738 0.304 . . . . 74.43 110.548 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.5 t -159.77 173.62 15.73 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.221 1.008 . . . . 62.12 109.121 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -88.84 122.55 32.35 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 108.434 -0.95 . . . . 63.03 108.434 169.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -99.34 112.06 24.31 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.638 -0.875 . . . . 75.34 108.638 175.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -72.32 139.74 48.13 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.117 0.967 . . . . 74.32 110.522 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -81.36 138.46 35.63 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.091 0.556 . . . . 74.35 111.329 -176.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.9 p -121.86 -34.44 3.37 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.421 1.088 . . . . 53.25 109.517 176.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -105.5 -78.61 0.57 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.838 0.855 . . . . 70.12 109.802 175.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 68.9 mtm -148.13 159.56 43.81 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.177 1.391 . . . . 72.23 108.105 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 79.2 m -153.93 118.79 5.0 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.994 0.518 . . . . 74.35 110.845 176.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.402 ' HZ ' HG13 ' A' ' 105' ' ' ILE . 93.9 t80 -99.36 114.58 27.54 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 106.359 -1.719 . . . . 74.22 106.359 161.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -133.32 112.5 11.69 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.189 -0.671 . . . . 73.43 109.189 -177.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.658 HG21 ' HG2' ' C' ' 130' ' ' PRO . 41.3 mt -83.65 113.96 23.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 107.745 -1.206 . . . . 74.41 107.745 169.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -94.77 -28.72 15.13 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 109.705 -0.48 . . . . 65.45 109.705 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.416 ' NH2' ' HB ' ' B' ' 122' ' ' THR . 20.2 ttt180 -166.37 139.96 4.09 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 122.741 0.416 . . . . 43.11 111.101 -177.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.571 HD12 ' HG3' ' C' ' 130' ' ' PRO . 95.5 mt -128.45 138.45 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.687 1.195 . . . . 64.13 107.828 169.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.468 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 32.5 p90 -163.74 174.88 11.09 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.735 0.647 . . . . 71.43 111.395 -175.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.0 p -101.17 121.89 42.65 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.196 -0.668 . . . . 63.22 109.196 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.468 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 35.5 mtpt -81.5 -38.2 26.68 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.129 0.49 . . . . 63.33 109.908 175.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.494 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 21.0 t70 -142.59 144.24 32.77 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.825 -1.079 . . . . 74.31 110.17 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.574 HD13 ' SD ' ' B' ' 117' ' ' MET . 97.4 mt -144.03 144.75 22.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 125.581 1.552 . . . . 63.32 107.43 176.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.4 t -159.13 142.85 14.99 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 122.917 0.487 . . . . 64.14 110.22 168.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -136.84 143.74 43.26 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 107.427 -1.323 . . . . 72.41 107.427 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -137.84 127.0 24.42 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.841 0.456 . . . . 74.32 110.387 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.21 66.31 9.28 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 125.382 1.473 . . . . 72.44 108.236 167.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.89 -34.25 30.69 Favored 'Trans proline' 0 C--N 1.383 2.356 0 C-N-CA 122.25 1.967 . . . . 73.33 110.804 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.418 ' HB2' ' HB2' ' A' ' 30' ' ' HIS . 20.0 p-10 -89.96 24.68 2.35 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-N 114.175 -1.375 . . . . 55.55 111.292 174.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.87 -49.8 71.89 Favored Pre-proline 0 CA--C 1.571 1.773 0 CA-C-O 118.44 -0.79 . . . . 55.32 112.659 178.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.48 -26.79 70.21 Favored 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 121.718 1.612 . . . . 53.41 113.765 175.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.418 ' HB2' ' HB2' ' A' ' 27' ' ' ASN . 16.9 m-70 -77.33 -49.04 15.83 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.664 0.745 . . . . 71.53 110.564 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.804 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.9 p -72.4 -25.61 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 CA-C-N 114.302 -1.317 . . . . 62.52 112.741 -167.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -64.72 -19.75 65.95 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 122.875 0.47 . . . . 70.03 111.882 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -86.47 -31.39 21.37 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.426 1.091 . . . . 64.22 110.129 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.52 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 4.0 tmtp? -68.97 142.9 54.54 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.138 0.975 . . . . 71.2 109.642 -174.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.52 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 10.2 m-20 -53.23 124.03 13.45 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.566 1.146 . . . . 73.33 110.922 176.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.6 t-105 -85.13 85.07 7.5 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 121.629 0.728 . . . . 74.2 110.722 -175.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -130.96 76.97 76.14 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 107.137 -1.431 . . . . 71.5 107.137 167.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -85.55 133.43 4.49 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.281 1.988 . . . . 75.2 112.432 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -97.06 90.7 5.26 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.061 -1.459 . . . . 72.11 107.061 166.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.678 HG22 ' HB2' ' A' ' 66' ' ' ALA . 62.1 t -77.69 93.12 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 108.581 -0.896 . . . . 63.22 108.581 175.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.489 ' HD2' ' HB ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -90.35 127.12 36.09 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.903 -1.044 . . . . 74.35 109.168 177.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.679 HD21 HG13 ' A' ' 62' ' ' VAL . 3.7 tt -108.48 123.05 48.29 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.205 -1.035 . . . . 74.34 108.205 -171.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.51 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 10.8 m-20 -113.24 114.69 27.08 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.471 1.108 . . . . 74.22 109.514 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.459 HD22 HD21 ' A' ' 60' ' ' LEU . 45.7 mt -99.38 146.96 25.74 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.068 0.547 . . . . 53.13 112.033 -178.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -148.02 146.9 29.09 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.079 1.351 . . . . 64.43 108.46 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 84.4 m -134.61 140.82 46.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.276 0.63 . . . . 63.32 110.169 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.07 154.04 49.29 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.662 1.185 . . . . 73.12 109.339 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.5 p -130.43 155.46 46.39 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.21 0.604 . . . . 62.43 109.63 173.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.7 t -149.09 120.21 7.75 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.217 1.007 . . . . 74.34 108.371 -176.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -73.27 111.11 8.09 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.382 -0.599 . . . . 61.55 109.382 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.612 HD11 ' HB2' ' A' ' 57' ' ' GLU . 52.6 mt -84.81 -30.45 24.56 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.215 0.606 . . . . 73.33 110.072 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.42 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -161.74 177.02 10.3 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.667 1.187 . . . . 74.04 109.596 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -63.67 125.06 23.07 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.581 -0.896 . . . . 72.33 108.581 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 60.0 18.92 8.04 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.129 0.972 . . . . 71.14 112.72 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 49.5 t -126.05 110.43 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 107.824 -1.176 . . . . 75.21 107.824 173.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -123.52 127.86 48.94 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.849 0.86 . . . . 74.11 109.008 -175.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.612 ' HB2' HD11 ' A' ' 51' ' ' LEU . 31.5 tt0 -84.55 139.32 32.21 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.487 -0.931 . . . . 74.53 108.487 165.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.48 HG11 ' HD3' ' A' ' 103' ' ' PRO . 72.0 t -120.71 136.41 57.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.936 -1.135 . . . . 62.11 107.936 169.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.11 131.97 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 108.687 -0.857 . . . . 72.21 108.687 174.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.459 HD21 HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -107.59 107.22 17.95 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.8 -1.556 . . . . 63.12 106.8 173.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.0 ttp180 -92.97 99.84 12.4 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.192 -1.04 . . . . 55.21 108.192 176.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.679 HG13 HD21 ' A' ' 42' ' ' LEU . 40.4 t -95.91 124.75 48.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 114.256 -1.338 . . . . 62.2 107.648 176.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 5.0 m -115.61 136.88 52.63 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.91 -1.144 . . . . 74.42 107.91 179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 71.8 t -137.91 126.2 31.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 107.487 -1.301 . . . . 63.23 107.487 -172.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.489 ' HB ' ' HD2' ' A' ' 41' ' ' LYS . 27.5 m -137.72 131.69 31.71 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.984 -0.747 . . . . 73.34 108.984 169.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.678 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -105.56 120.76 42.45 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 107.618 -1.253 . . . . 72.02 107.618 174.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.3 m -118.02 126.47 52.36 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.744 0.418 . . . . 71.21 110.006 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 36.2 mt -90.54 66.51 6.3 Favored 'General case' 0 C--O 1.248 1.011 0 C-N-CA 125.046 1.339 . . . . 74.12 108.68 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.05 -86.74 0.78 Allowed Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.796 -0.638 . . . . 70.2 111.842 -176.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -108.95 -29.19 8.72 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.004 0.922 . . . . 64.33 110.902 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -89.3 113.57 24.85 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.663 -0.865 . . . . 72.31 108.663 -177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 90.2 m -69.0 130.37 42.58 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.81 0.732 . . . . 44.41 109.203 174.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.804 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -75.99 -58.65 3.16 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.387 -0.824 . . . . 53.34 109.884 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -159.33 163.68 35.44 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.723 -1.126 . . . . 72.11 110.691 177.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.2 tp -124.27 135.57 53.49 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.483 1.113 . . . . 72.44 108.705 172.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.551 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 68.6 m -133.5 133.11 41.81 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.54 1.136 . . . . 63.14 109.133 175.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -145.36 123.05 11.83 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.872 -0.788 . . . . 72.05 108.872 172.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.7 t -131.09 125.12 57.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 123.947 0.899 . . . . 75.14 108.948 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.494 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 53.8 mt-30 -99.67 91.63 4.96 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.919 0.887 . . . . 71.53 108.879 173.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -78.66 97.98 6.03 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.969 -1.014 . . . . 73.53 109.625 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.54 150.65 23.57 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 111.54 -0.624 . . . . 74.04 111.54 177.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.48 125.82 2.08 Favored Glycine 0 CA--C 1.508 -0.384 0 N-CA-C 110.665 -0.974 . . . . 74.02 110.665 -177.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.2 mt -84.59 112.87 22.36 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 N-CA-C 109.052 -0.721 . . . . 63.35 109.052 176.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.659 ' HB3' HD11 ' A' ' 86' ' ' ILE . 81.7 m-85 -121.77 118.69 29.65 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.093 0.957 . . . . 70.25 108.752 -177.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.5 t -92.75 95.87 9.82 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.771 -1.196 . . . . 61.24 107.771 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.659 HD11 ' HB3' ' A' ' 84' ' ' PHE . 11.9 mm -112.72 142.73 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.902 -0.59 . . . . 72.43 110.109 -172.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.9 164.87 30.9 Favored 'General case' 0 C--O 1.241 0.615 0 O-C-N 123.584 0.553 . . . . 64.23 112.25 -172.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.77 6.65 85.15 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 114.852 -1.067 . . . . 63.0 114.191 177.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.436 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -134.11 165.23 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.159 0.984 . . . . 74.41 108.89 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -159.27 175.95 12.77 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 109.451 -0.574 . . . . 65.23 109.451 175.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.01 -117.19 8.42 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.007 0.813 . . . . 62.02 114.323 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 t -70.12 -31.08 68.44 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.279 1.032 . . . . 72.1 111.755 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -74.61 -39.72 61.99 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 123.181 0.592 . . . . 71.3 110.713 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.9 tpt -68.13 -40.8 82.4 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.311 0.382 . . . . 72.32 110.111 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.88 98.13 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.329 -0.85 . . . . 55.45 110.745 175.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.435 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 54.5 t-80 -68.4 -31.93 71.62 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.076 -0.511 . . . . 73.52 111.632 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.496 ' SG ' HG21 ' A' ' 86' ' ' ILE . 48.5 t -69.46 -44.97 70.14 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 110.062 -0.347 . . . . 34.23 110.062 -178.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 65.0 mt -83.12 -26.68 30.77 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.38 0.672 . . . . 55.44 111.961 -174.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.23 3.35 37.71 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-O 119.525 -0.597 . . . . 61.5 114.15 -173.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.493 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -142.38 -68.44 0.37 Allowed 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 117.684 0.742 . . . . 73.32 111.646 -178.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -69.38 -41.93 75.83 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 112.465 0.543 . . . . 63.41 112.465 -170.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 70.1 m -66.46 -50.08 49.29 Favored Pre-proline 0 CA--C 1.568 1.659 0 CA-C-O 118.53 -0.747 . . . . 64.01 111.93 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.48 ' HD3' HG11 ' A' ' 58' ' ' VAL . 37.8 Cg_endo -65.86 -21.02 58.12 Favored 'Trans proline' 0 C--N 1.395 3.019 0 C-N-CA 121.781 1.654 . . . . 54.54 113.288 172.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -66.25 -42.91 87.89 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.161 0.584 . . . . 72.5 109.812 172.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.419 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 39.7 mm -62.01 -43.39 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.899 0.879 . . . . 64.03 110.318 174.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.7 mt -72.04 -24.13 61.49 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.398 -0.819 . . . . 61.13 112.627 -173.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -62.93 -44.89 86.6 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 114.339 1.237 . . . . 73.4 114.339 -172.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.419 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 92.5 Cg_exo -50.06 -40.98 50.13 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 122.203 1.935 . . . . 70.14 114.083 171.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -76.92 -39.56 50.39 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.619 0.768 . . . . 75.5 111.049 -177.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.37 -47.24 82.89 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.648 0.779 . . . . 74.22 110.016 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.463 ' NH1' HD12 ' C' ' 105' ' ' ILE . 29.7 ttm180 -49.4 -55.93 11.36 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 125.023 1.452 . . . . 64.43 110.142 172.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -60.89 -45.48 94.4 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.496 1.122 . . . . 74.14 111.664 -174.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.402 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 45.1 t -56.91 -45.32 82.72 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.026 0.829 . . . . 73.14 110.434 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 118' ' ' VAL . 66.2 mt -63.27 -51.62 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 115.077 -0.965 . . . . 73.21 110.535 175.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 50.6 m -55.54 -41.48 73.26 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.113 0.965 . . . . 71.12 111.246 -174.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -69.78 -42.85 73.26 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.498 -1.228 . . . . 63.21 109.913 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.498 ' SD ' HG23 ' A' ' 21' ' ' ILE . 10.2 mtp -58.79 -41.73 87.39 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.642 0.777 . . . . 75.54 111.19 175.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 114' ' ' ILE . 83.1 t -65.08 -48.13 85.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 124.384 1.074 . . . . 74.3 110.329 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.3 p -71.62 -30.94 66.34 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.911 -0.586 . . . . 53.22 111.298 -176.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.478 HH12 ' HG3' ' B' ' 112' ' ' GLU . 64.8 mtt-85 -72.4 -30.25 64.48 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.554 0.742 . . . . 63.42 109.197 173.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.43 -2.6 74.91 Favored Glycine 0 C--N 1.356 1.643 0 O-C-N 123.88 0.737 . . . . 73.15 112.921 174.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.514 HG21 ' HE ' ' B' ' 15' ' ' ARG . 92.2 m 71.68 26.59 3.07 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 122.912 1.339 . . . . 75.11 111.288 174.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -98.26 145.08 29.23 Favored Pre-proline 0 C--O 1.244 0.801 0 N-CA-C 108.51 -0.922 . . . . 72.3 108.51 170.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.651 ' HB3' ' H ' ' E' ' 132' ' ' SER . 61.2 Cg_exo -43.98 132.68 8.44 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.389 2.726 . . . . 75.21 112.891 174.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -52.93 123.2 10.9 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 124.162 0.914 . . . . 74.35 112.399 -170.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 45.5 tp -109.24 100.68 9.78 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.908 0.883 . . . . 62.51 110.207 -174.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.434 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 88.9 m-20 -97.78 113.06 24.76 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.63 -1.248 . . . . 74.15 107.63 174.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 19.1 mt -65.21 147.68 53.02 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 123.58 0.55 . . . . 74.12 110.46 -175.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.76 134.74 88.05 Favored Pre-proline 0 CA--C 1.549 0.933 0 CA-C-O 118.914 -0.565 . . . . 52.51 111.158 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.49 120.93 9.17 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 123.256 2.637 . . . . 74.21 113.337 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.434 HG21 HD11 ' A' ' 44' ' ' LEU . 64.7 t -107.31 130.44 59.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 123.644 0.778 . . . . 74.34 110.37 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -92.51 92.22 7.97 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.051 -1.092 . . . . 75.24 108.051 173.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -62.64 -29.4 70.6 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.88 0.872 . . . . 73.31 112.22 176.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.493 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 6.7 m-20 -70.86 -25.48 62.84 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.291 0.636 . . . . 73.15 111.131 177.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.01 -40.96 37.32 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.239 0.616 . . . . 43.34 110.233 172.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 94.1 mt -61.61 -44.69 96.53 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.207 0.603 . . . . 74.41 110.938 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -73.83 -29.29 62.06 Favored 'General case' 0 C--O 1.216 -0.708 0 CA-C-N 115.073 -0.967 . . . . 73.12 109.74 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.857 ' HE3' HD23 ' A' ' 141' ' ' LEU . 3.2 tpt -55.94 -41.44 74.65 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.623 0.769 . . . . 64.31 111.02 178.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -58.04 -34.43 70.06 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 124.167 0.917 . . . . 62.41 111.289 178.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -90.19 -30.28 17.69 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.804 1.242 . . . . 72.12 111.507 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.857 HD23 ' HE3' ' A' ' 138' ' ' MET . 51.4 tp -68.26 -50.53 53.2 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.91 0.884 . . . . 72.24 111.18 -168.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 174.1 -15.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 124.381 1.05 . . . . 65.42 110.653 177.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 70.02 -50.12 0.64 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.565 1.146 . . . . 72.51 111.225 -166.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -71.15 95.09 1.2 Allowed 'General case' 0 C--N 1.358 0.937 0 C-N-CA 123.068 0.547 . . . . 53.04 110.366 170.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -177.56 171.88 1.86 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.698 1.599 . . . . 65.41 108.344 170.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -127.26 -115.02 1.9 Allowed Glycine 0 C--N 1.339 0.719 0 N-CA-C 112.29 -0.324 . . . . 74.32 112.29 -177.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -146.3 160.75 41.6 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.079 0.952 . . . . 73.42 110.263 -173.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -165.44 135.47 3.73 Favored Glycine 0 C--N 1.339 0.695 0 CA-C-N 115.802 -0.635 . . . . 65.14 111.559 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.8 t -133.63 156.09 48.5 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 123.686 0.794 . . . . 55.41 109.572 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -88.69 151.58 22.35 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.121 0.568 . . . . 71.44 110.956 178.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -108.99 90.34 3.26 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 107.733 -1.21 . . . . 63.44 107.733 163.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -72.39 98.37 2.23 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.999 -1.111 . . . . 70.21 107.999 173.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 19.1 tm0? -59.86 104.37 0.29 Allowed 'General case' 0 C--N 1.352 0.698 0 N-CA-C 108.192 -1.04 . . . . 61.34 108.192 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -76.5 143.82 40.2 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 123.774 0.671 . . . . 72.11 109.549 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 C-N-CA 123.3 0.64 . . . . 60.51 110.166 -178.596 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptp . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 109.911 -0.403 . . . . 63.11 109.911 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.9 t 70.0 173.33 0.3 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.751 1.22 . . . . 70.32 110.705 -172.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -82.59 72.98 9.66 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.645 0.736 . . . . 75.42 110.441 -176.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -97.96 -3.97 37.27 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.808 -1.087 . . . . 71.04 111.267 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 65.44 63.79 0.62 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.535 1.134 . . . . 75.23 110.009 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -112.79 142.81 44.99 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.57 -1.195 . . . . 72.01 108.215 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 13.4 t -65.04 -16.86 63.92 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.419 0.687 . . . . 64.04 111.264 175.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 68.02 -105.85 0.08 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.279 1.432 . . . . 74.52 109.45 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.659 ' HG2' HG23 ' B' ' 89' ' ' ILE . 0.1 OUTLIER 55.17 170.0 0.02 OUTLIER 'General case' 0 CA--C 1.57 1.713 0 C-N-CA 124.753 1.221 . . . . 53.13 111.701 -174.623 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 85.2 m -154.41 102.26 2.41 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.11 -1.07 . . . . 74.34 108.11 168.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.428 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 50.9 t80 -119.9 134.35 55.27 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.068 -1.086 . . . . 72.11 108.068 173.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -164.01 142.12 7.3 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 123.702 0.626 . . . . 60.52 110.791 169.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.52 HD13 HD11 ' B' ' 16' ' ' ILE . 37.8 mt -80.07 132.4 31.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 115.021 -0.991 . . . . 74.45 109.43 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -99.12 -38.72 8.82 Favored 'General case' 0 C--O 1.242 0.662 0 O-C-N 123.816 0.697 . . . . 70.43 110.299 178.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.514 ' HE ' HG21 ' A' ' 122' ' ' THR . 40.3 ttt180 -173.46 137.18 0.63 Allowed 'General case' 0 C--N 1.349 0.583 0 O-C-N 123.747 0.654 . . . . 72.24 109.8 -175.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.52 HD11 HD13 ' B' ' 13' ' ' ILE . 96.6 mt -120.31 143.43 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 107.577 -1.268 . . . . 64.22 107.577 174.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -162.9 139.48 7.44 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.696 0.628 . . . . 75.43 112.696 -173.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.9 m -73.96 118.01 16.43 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 124.042 0.937 . . . . 53.43 109.499 172.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.474 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.6 mtpt -98.15 -9.98 24.89 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.932 0.893 . . . . 71.13 112.045 -176.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 16.1 t70 -174.27 144.6 0.95 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.168 0.587 . . . . 52.43 110.745 -176.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.507 HD11 ' SG ' ' B' ' 113' ' ' CYS . 43.8 mm -138.28 148.67 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 125.047 1.339 . . . . 64.4 108.792 175.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.51 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 38.9 t -148.68 139.99 23.3 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 125.159 1.384 . . . . 52.33 108.214 172.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.498 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 81.2 t80 -152.85 113.7 4.13 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.375 -1.343 . . . . 75.44 107.375 171.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -121.18 119.09 31.32 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.953 0.901 . . . . 72.52 108.712 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.637 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -107.45 87.12 3.11 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 107.194 -1.41 . . . . 72.14 107.194 167.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.68 -34.44 31.97 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.987 2.458 . . . . 71.13 111.662 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -101.84 3.39 39.25 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.44 1.096 . . . . 70.15 110.375 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.637 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -30.0 -65.06 0.19 Allowed Pre-proline 0 N--CA 1.499 1.997 0 C-N-CA 126.331 1.853 . . . . 44.11 114.886 -172.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 28.8 Cg_exo -57.69 -48.07 18.53 Favored 'Trans proline' 0 C--N 1.391 2.802 0 C-N-CA 122.934 2.423 . . . . 50.42 113.462 -166.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -96.36 -15.37 21.89 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.297 -0.865 . . . . 73.21 112.648 -172.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.421 HG22 HD12 ' B' ' 68' ' ' LEU . 3.4 p -73.76 -17.7 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-N 118.657 0.662 . . . . 64.13 110.647 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -68.62 -6.32 25.08 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 113.764 1.024 . . . . 70.12 113.764 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -71.24 -13.53 61.94 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 120.991 0.424 . . . . 71.03 110.747 172.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.59 ' HB2' HD13 ' B' ' 68' ' ' LEU . 91.1 mttt -98.62 88.0 3.96 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.729 1.212 . . . . 54.42 110.049 -177.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.45 77.92 9.92 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.989 -1.005 . . . . 70.22 110.99 -178.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.405 ' O ' ' HG2' ' B' ' 124' ' ' PRO . 38.5 p90 -158.37 164.58 36.18 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.881 0.873 . . . . 65.54 108.721 169.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.54 117.4 60.34 Favored Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 108.181 -1.044 . . . . 73.13 108.181 177.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.442 ' O ' HG23 ' B' ' 40' ' ' VAL . 31.8 Cg_endo -65.98 147.56 84.8 Favored 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 122.207 1.938 . . . . 75.31 112.231 -177.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -69.93 114.17 7.86 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 109.004 -0.739 . . . . 75.2 109.004 178.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' F' ' 126' ' ' ALA . 77.7 t -111.04 138.06 40.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 114.998 -1.001 . . . . 74.22 111.939 -172.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.578 ' HE2' ' HD3' ' F' ' 114' ' ' LYS . 44.4 tttp -107.27 126.97 53.12 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 126.017 1.727 . . . . 71.53 107.503 174.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.747 HD13 HD22 ' B' ' 128' ' ' LEU . 15.6 tp -103.01 127.3 50.3 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.729 -0.841 . . . . 74.02 108.729 174.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -143.8 136.13 26.85 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 106.999 -1.482 . . . . 44.11 106.999 -177.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.7 mp -127.05 149.24 50.0 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.952 -0.758 . . . . 74.34 108.952 -171.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.577 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 7.6 t70 -125.77 146.29 49.84 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.772 1.229 . . . . 54.34 109.255 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 26.9 m -124.84 105.64 9.41 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.495 0.718 . . . . 72.21 109.643 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.7 120.45 39.39 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.366 -1.346 . . . . 71.51 107.366 176.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.721 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 25.1 m -135.41 161.57 35.06 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.495 0.318 . . . . 75.53 111.506 -168.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 42.0 p -165.15 139.29 4.88 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.322 0.649 . . . . 74.45 111.06 -177.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -87.57 96.65 10.48 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 108.782 -0.822 . . . . 74.41 108.782 171.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 pp -107.53 14.78 25.46 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.801 0.44 . . . . 65.14 110.688 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.98 143.75 22.83 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 123.775 0.83 . . . . 63.54 109.56 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -74.06 132.13 42.02 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.646 -0.872 . . . . 74.41 108.646 170.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 67.76 1.9 2.83 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.946 1.298 . . . . 51.23 113.442 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.489 HG21 ' HD2' ' F' ' 93' ' ' PHE . 58.2 t -140.08 128.28 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 107.851 -1.166 . . . . 72.24 107.851 -172.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.721 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 6.7 t80 -115.38 154.26 29.52 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.797 -0.565 . . . . 71.21 109.566 -176.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -124.24 117.67 25.08 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 107.739 -1.208 . . . . 61.0 107.739 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 p -118.71 127.8 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.881 0.873 . . . . 70.42 109.363 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.41 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.9 t -103.77 112.33 36.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 108.072 -1.085 . . . . 62.25 108.072 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -103.18 108.68 19.98 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.473 -0.936 . . . . 71.41 108.473 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.577 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 6.2 ttm180 -85.12 135.4 33.99 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.131 -0.941 . . . . 73.32 109.238 174.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.466 ' CG1' HD11 ' B' ' 42' ' ' LEU . 17.5 t -122.57 117.13 51.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.14 -1.059 . . . . 52.13 108.14 169.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 17.3 m -109.78 133.36 53.23 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.874 0.87 . . . . 63.23 109.786 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.557 HG21 HG21 ' B' ' 114' ' ' ILE . 55.4 t -115.78 114.5 46.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 125.308 1.443 . . . . 65.14 109.139 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 41.4 m -91.79 138.09 31.84 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 107.698 -1.223 . . . . 72.12 107.698 166.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.538 ' HB2' HG22 ' B' ' 40' ' ' VAL . . . -148.78 143.01 26.08 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 117.943 0.338 . . . . 64.2 110.467 178.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 73.7 p -147.96 133.42 18.64 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 123.768 0.667 . . . . 74.24 111.032 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.59 HD13 ' HB2' ' B' ' 34' ' ' LYS . 54.0 mt -93.89 108.73 20.49 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.171 0.988 . . . . 74.43 108.508 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.87 -116.64 4.39 Favored Glycine 0 C--N 1.342 0.861 0 N-CA-C 111.469 -0.652 . . . . 42.41 111.469 -175.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -111.62 -0.08 16.21 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.054 0.942 . . . . 72.44 110.645 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.426 ' HG2' ' NZ ' ' B' ' 34' ' ' LYS . 9.8 pt-20 -116.77 154.37 30.79 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.328 -0.619 . . . . 72.01 109.328 -178.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 39.4 m -62.81 141.4 58.64 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.972 0.509 . . . . 63.51 111.285 -178.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.435 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -97.78 -64.06 1.07 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.658 -1.238 . . . . 74.32 107.658 172.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -151.88 154.4 36.07 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.639 -1.164 . . . . 73.23 109.949 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 88.5 mt -130.44 112.87 13.64 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 106.916 -1.513 . . . . 55.25 106.916 175.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.1 t -117.63 156.19 28.59 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.134 -0.691 . . . . 62.2 109.134 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.51 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.0 tt0 -161.93 129.63 4.03 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.649 0.78 . . . . 75.23 108.997 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 94.2 t -126.41 150.13 31.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.125 -1.065 . . . . 75.15 108.125 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.444 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.6 mt-30 -124.86 97.95 5.49 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.181 -1.044 . . . . 74.24 108.181 170.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -93.26 103.14 15.42 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.676 -0.693 . . . . 73.11 109.255 -179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.474 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -94.19 172.32 31.91 Favored Glycine 0 C--O 1.243 0.675 0 CA-C-N 115.824 -0.626 . . . . 62.0 111.862 176.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -172.91 142.71 6.88 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.808 -0.517 . . . . 71.1 111.808 -178.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 16.3 tt -107.54 116.86 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.254 0 C-N-CA 123.997 0.919 . . . . 74.21 108.661 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -123.3 134.7 54.04 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.089 0.955 . . . . 62.41 109.578 -172.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.0 m -89.12 130.83 35.49 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.024 0.53 . . . . 64.21 109.592 174.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.551 ' HB ' HD11 ' B' ' 89' ' ' ILE . 0.1 OUTLIER -135.75 139.55 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.14 0.976 . . . . 72.44 109.114 -178.472 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.534 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -157.9 169.39 24.69 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.98 0.912 . . . . 73.35 110.426 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.31 -41.47 3.0 Favored Glycine 0 C--N 1.352 1.449 0 C-N-CA 123.718 0.675 . . . . 65.24 113.35 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.659 HG23 ' HG2' ' B' ' 9' ' ' MET . 9.5 pt -65.5 153.29 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.388 1.475 . . . . 72.12 113.052 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -151.36 172.37 16.03 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.515 1.126 . . . . 64.35 110.049 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.73 -133.72 32.28 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-N 116.231 -0.44 . . . . 30.11 114.0 177.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.0 m -80.73 -47.27 14.2 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.972 0.909 . . . . 74.44 110.888 -175.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -65.51 -20.73 66.46 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 114.818 -1.083 . . . . 74.13 111.259 -172.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.576 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 11.0 ttt -52.47 -70.22 0.09 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.29 1.436 . . . . 70.52 112.428 174.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.414 ' HB1' HD23 ' F' ' 102' ' ' LEU . . . -78.9 -12.74 60.04 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.427 -0.351 . . . . 51.45 111.489 -175.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -61.87 -41.58 98.03 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.215 0.606 . . . . 60.12 110.713 167.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 t -64.06 -28.08 69.55 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.291 0.636 . . . . 43.41 112.346 -176.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.714 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.5 pp -103.23 -17.72 15.21 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.352 0.661 . . . . 73.32 111.501 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.11 -4.09 41.58 Favored Glycine 0 N--CA 1.478 1.48 0 N-CA-C 114.201 0.44 . . . . 51.22 114.201 -173.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.87 -49.71 0.52 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.459 0.704 . . . . 63.43 110.362 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -71.15 -39.02 72.19 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 122.7 0.4 . . . . 71.43 111.648 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.714 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 84.5 m -67.72 -47.45 44.48 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-O 118.493 -0.765 . . . . 71.21 111.717 177.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.44 -34.4 41.49 Favored 'Trans proline' 0 C--N 1.394 2.928 0 C-N-CA 122.66 2.24 . . . . 75.32 114.244 167.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -67.41 -35.6 79.59 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.043 0.937 . . . . 73.43 110.563 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.467 HD13 HD11 ' B' ' 13' ' ' ILE . 79.6 mt -68.58 -40.45 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.759 0.824 . . . . 63.5 110.164 173.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 95.5 mt -75.72 -20.97 57.97 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.971 -1.013 . . . . 73.12 112.191 -174.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -61.68 -50.29 82.7 Favored Pre-proline 0 CA--C 1.561 1.376 0 CA-C-O 118.012 -0.994 . . . . 51.33 112.8 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -50.9 -40.38 57.92 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 122.633 2.222 . . . . 63.01 114.145 173.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -67.97 -44.57 76.39 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.518 0.727 . . . . 72.21 110.879 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.67 -34.86 79.29 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.248 0.619 . . . . 63.42 110.829 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.495 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 31.5 ttt180 -66.35 -52.63 45.04 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.219 1.407 . . . . 71.34 110.094 -175.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.478 ' HG3' HH12 ' A' ' 120' ' ' ARG . 12.3 tp10 -65.0 -33.43 76.03 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.033 0.933 . . . . 74.31 110.647 176.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.507 ' SG ' HD11 ' B' ' 21' ' ' ILE . 1.9 t -70.57 -32.57 70.01 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 122.439 -0.163 . . . . 63.44 110.967 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.557 HG21 HG21 ' B' ' 64' ' ' VAL . 66.3 mt -70.56 -57.9 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.277 0.631 . . . . 63.51 109.445 173.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 13.3 m -61.54 -22.96 65.61 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 124.205 0.94 . . . . 64.31 111.346 -173.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.3 t -62.04 -52.7 62.9 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 123.444 0.698 . . . . 73.14 109.851 170.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.574 ' SD ' HD13 ' A' ' 21' ' ' ILE . 12.7 mmt -68.44 -33.39 74.12 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.862 0.865 . . . . 63.33 111.113 -175.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.413 HG21 HD23 ' B' ' 126' ' ' LEU . 86.4 t -65.45 -43.96 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.806 1.242 . . . . 71.04 110.135 173.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.5 t -63.83 -34.87 78.9 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.73 -1.123 . . . . 73.53 110.564 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.476 ' HG3' ' O ' ' B' ' 116' ' ' SER . 77.4 mtt-85 -69.24 -33.31 73.09 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.05 -0.977 . . . . 72.43 110.373 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.37 -15.75 81.25 Favored Glycine 0 C--N 1.356 1.686 0 O-C-N 123.57 0.544 . . . . 73.43 112.389 170.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.416 ' HB ' ' NH2' ' A' ' 15' ' ' ARG . 15.7 m 65.33 37.91 6.08 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.715 1.606 . . . . 71.42 110.261 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -81.5 156.92 70.66 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 114.61 -1.177 . . . . 71.15 109.53 172.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.405 ' HG2' ' O ' ' B' ' 36' ' ' TRP . 88.1 Cg_exo -50.91 163.83 0.71 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.38 2.72 . . . . 74.33 114.48 175.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -59.4 118.25 5.78 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 115.481 -0.782 . . . . 60.45 111.342 -171.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.547 HD13 HG21 ' B' ' 40' ' ' VAL . 54.8 tp -107.62 95.21 5.54 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.614 -0.884 . . . . 70.02 108.614 178.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -96.55 106.4 18.66 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.998 -1.112 . . . . 73.23 107.998 172.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.747 HD22 HD13 ' B' ' 42' ' ' LEU . 30.4 mt -67.05 134.84 52.68 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 110.135 -0.32 . . . . 61.3 110.135 175.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.71 131.46 94.9 Favored Pre-proline 0 CA--C 1.549 0.914 0 O-C-N 124.106 0.879 . . . . 74.32 110.713 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -61.75 90.79 0.11 Allowed 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.087 2.525 . . . . 64.14 111.618 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 p -90.35 111.69 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.591 -0.731 . . . . 73.14 109.493 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -79.47 113.69 17.81 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.671 -1.233 . . . . 55.24 107.671 171.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -65.4 -40.0 92.89 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.706 0.802 . . . . 74.44 110.182 -177.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -57.23 -28.18 62.67 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 114.03 -1.441 . . . . 73.34 111.129 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.453 ' O ' ' HG2' ' B' ' 138' ' ' MET . . . -71.1 -39.26 72.22 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 124.023 0.929 . . . . 43.34 111.715 177.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.402 ' HG ' ' HB3' ' F' ' 120' ' ' TYR . 7.8 mp -64.19 -38.35 90.75 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 122.179 -0.326 . . . . 73.51 110.391 178.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -74.71 -35.98 62.7 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.289 0.636 . . . . 75.12 111.766 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' B' ' 135' ' ' ALA . 18.3 ptm -68.89 -36.09 77.64 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 110.02 -0.363 . . . . 52.42 110.02 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -80.78 -23.77 39.07 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.652 0.781 . . . . 64.14 111.12 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -71.85 -42.31 67.06 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.927 0.491 . . . . 73.24 109.911 175.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 10.3 mp -85.33 1.32 48.94 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.48 0.712 . . . . 63.21 111.185 175.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 64.37 85.49 0.14 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.446 1.498 . . . . 74.22 111.593 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -155.85 91.99 1.33 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 105.5 -2.037 . . . . 75.13 105.5 172.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -127.25 86.11 2.45 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.779 0.832 . . . . 54.45 109.859 -169.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . 61.56 -152.69 0.37 Allowed 'General case' 0 CA--C 1.559 1.325 0 C-N-CA 124.254 1.022 . . . . 71.33 112.104 172.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 101.54 165.82 27.38 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-O 119.598 -0.557 . . . . 64.12 112.154 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 68.6 104.47 0.05 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.78 1.232 . . . . 72.14 111.759 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 156.93 49.99 0.01 OUTLIER Glycine 0 C--N 1.343 0.941 0 N-CA-C 111.247 -0.741 . . . . 41.05 111.247 177.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 70.8 p -87.43 179.28 6.6 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.706 0.802 . . . . 71.23 111.194 -172.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 74.49 126.98 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.907 1.683 . . . . 75.14 109.852 -171.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -165.19 132.89 3.08 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.466 1.107 . . . . 51.13 108.108 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 29.5 t60 -113.1 -72.39 0.71 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 107.747 -1.205 . . . . 73.24 107.747 172.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -176.21 -79.53 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.442 1.097 . . . . 71.1 109.414 172.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -142.32 101.95 4.0 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.75 1.22 . . . . 73.24 107.827 -178.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.561 1.378 0 O-C-N 124.508 1.13 . . . . 70.31 110.732 -175.133 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 43.8 ttm . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 109.742 -0.466 . . . . 74.14 109.742 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 72.0 m -159.03 92.9 1.12 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.691 0.796 . . . . 71.44 110.036 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.73 152.52 42.7 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.586 -0.733 . . . . 61.34 109.23 170.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -147.09 152.53 38.66 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.216 0.532 . . . . 73.11 110.844 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -121.64 30.88 6.5 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 106.958 -1.497 . . . . 75.34 106.958 168.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -70.78 149.8 46.5 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-N 114.818 -1.083 . . . . 72.1 110.299 -172.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 39.6 p -126.46 109.36 12.1 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.01 0.924 . . . . 74.2 110.019 -172.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -173.84 -44.47 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.635 0.774 . . . . 63.15 111.138 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.543 ' H ' ' HA3' ' C' ' 88' ' ' GLY . 12.2 ttt 57.05 110.41 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.046 1.738 . . . . 73.45 111.871 -164.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 88.5 m -126.95 114.47 17.88 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.368 1.067 . . . . 61.41 108.252 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.525 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 78.8 t80 -107.98 129.42 55.12 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.959 -0.756 . . . . 73.34 108.959 177.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -140.42 128.45 22.13 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.136 -0.69 . . . . 72.04 109.136 174.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 50.2 mt -76.77 128.85 37.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 N-CA-C 108.809 -0.811 . . . . 70.53 108.809 172.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -90.15 -49.59 6.48 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.934 -0.765 . . . . 55.32 108.934 172.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.434 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -176.46 153.52 1.18 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.431 1.092 . . . . 62.21 110.049 179.213 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 84.3 mt -127.7 134.92 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.087 1.355 . . . . 71.41 107.71 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.516 ' HE2' ' HD3' ' C' ' 19' ' ' LYS . 42.4 p90 -163.72 174.2 11.94 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 123.439 0.695 . . . . 64.52 110.288 -164.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.7 p -105.92 116.16 31.46 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 122.988 0.515 . . . . 71.15 109.838 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.516 ' HD3' ' HE2' ' C' ' 17' ' ' TYR . 30.8 mmtp -65.78 -37.97 87.74 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.947 -0.76 . . . . 75.53 108.947 167.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.434 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 13.1 t70 -149.56 147.19 27.87 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 114.482 -1.235 . . . . 73.33 110.4 -174.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.507 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 91.5 mt -139.36 146.11 26.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 106.505 -1.665 . . . . 75.23 106.505 173.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 18.2 t -157.35 148.13 21.37 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 121.064 0.459 . . . . 54.24 110.32 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -156.2 108.56 2.58 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.635 -1.246 . . . . 74.45 107.635 174.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -117.29 112.02 20.18 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 122.92 0.488 . . . . 73.41 110.065 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -121.47 83.05 40.33 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.63 1.172 . . . . 75.21 107.951 169.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.66 -17.82 25.87 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.684 2.256 . . . . 64.53 111.385 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -102.8 12.26 36.45 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.543 1.137 . . . . 74.04 110.543 -178.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.99 -57.9 5.47 Favored Pre-proline 0 C--N 1.374 1.646 0 C-N-CA 124.761 1.224 . . . . 53.41 113.687 -169.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -60.25 -46.62 17.61 Favored 'Trans proline' 0 C--N 1.385 2.484 0 CA-C-N 121.427 1.545 . . . . 73.14 113.143 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -69.41 -29.41 67.14 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.155 -0.929 . . . . 70.02 111.899 -174.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.851 HG21 ' HA ' ' C' ' 73' ' ' ALA . 6.7 p -83.14 -21.14 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 N-CA-C 113.286 0.847 . . . . 63.41 113.286 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -67.9 -18.02 64.66 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 112.517 0.562 . . . . 75.04 112.517 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -100.12 16.25 24.72 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.875 0.87 . . . . 75.14 111.253 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.59 155.54 17.81 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.474 0.71 . . . . 73.32 110.339 -174.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.32 125.07 25.56 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.089 0.556 . . . . 75.33 110.303 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 72.1 t-105 -83.03 87.97 6.88 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.731 0.812 . . . . 72.42 110.627 -173.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -139.54 75.95 31.31 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 123.932 0.893 . . . . 64.1 108.891 168.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -82.83 145.03 12.54 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.224 1.949 . . . . 73.32 112.056 -175.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -86.15 89.1 7.73 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 104.849 -2.278 . . . . 74.01 104.849 168.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 58.1 t -78.64 98.33 2.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 114.996 -1.002 . . . . 61.13 109.175 -175.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -97.5 102.31 14.05 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.548 -0.908 . . . . 73.4 108.548 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.411 HD12 ' O ' ' C' ' 42' ' ' LEU . 3.1 pp -87.31 123.5 32.36 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.446 -1.316 . . . . 70.33 107.446 171.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -130.46 143.42 50.75 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.393 -0.966 . . . . 74.4 108.393 -172.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.459 HD13 ' CE1' ' C' ' 133' ' ' PHE . 91.9 mt -131.6 112.64 12.78 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.959 0.504 . . . . 61.14 110.959 -171.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -115.03 126.72 55.05 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 107.46 -1.311 . . . . 74.41 107.46 169.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -116.2 153.93 30.97 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 109.091 -0.707 . . . . 65.43 109.091 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.72 133.4 23.7 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.763 -0.828 . . . . 63.33 108.763 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 32.9 p -144.87 144.79 31.3 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.834 0.453 . . . . 73.54 110.154 -174.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 62.9 p -149.07 152.65 36.56 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.658 0.783 . . . . 72.11 109.872 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -85.43 117.99 24.68 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.043 -1.095 . . . . 71.34 108.043 173.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.698 HD11 ' HB2' ' C' ' 57' ' ' GLU . 31.9 mt -84.64 -40.2 17.73 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.595 0.758 . . . . 73.31 109.689 -176.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.31 -173.73 4.56 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.707 -1.133 . . . . 60.12 109.119 175.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -62.43 126.65 28.07 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.445 -0.798 . . . . 75.44 109.565 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 66.13 -0.72 1.33 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.847 1.259 . . . . 55.14 112.965 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 45.7 t -118.29 111.39 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 109.367 -0.605 . . . . 74.53 109.367 -176.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -113.32 166.62 11.3 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.973 0.909 . . . . 74.31 109.751 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.698 ' HB2' HD11 ' C' ' 51' ' ' LEU . 41.4 tt0 -127.86 144.55 51.09 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.174 0.99 . . . . 72.11 108.734 171.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 82.6 t -131.23 133.73 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 108.182 -1.044 . . . . 70.33 108.182 167.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.488 ' HA ' ' HA2' ' C' ' 81' ' ' GLY . 60.2 t -120.25 130.1 74.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 107.66 -1.237 . . . . 71.45 107.66 176.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.454 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.0 OUTLIER -113.18 97.36 6.45 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 107.742 -1.207 . . . . 51.41 107.742 -176.678 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 7.9 ttm-85 -81.84 110.45 17.15 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.961 -0.755 . . . . 75.32 108.961 173.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.509 ' HB ' HD11 ' C' ' 114' ' ' ILE . 19.4 t -106.68 123.86 61.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.074 -1.084 . . . . 63.41 108.074 173.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 59.6 m -115.03 132.11 56.71 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.026 -1.102 . . . . 72.4 108.026 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.491 HG21 HG21 ' C' ' 114' ' ' ILE . 89.0 t -121.28 116.95 51.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 109.141 -0.689 . . . . 75.24 109.141 176.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 12.5 m -101.76 139.04 37.95 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.635 -0.876 . . . . 73.11 108.635 173.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.57 105.72 4.58 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.607 -0.886 . . . . 62.12 108.607 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 36.9 m -127.04 133.54 50.47 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.356 0.662 . . . . 71.35 109.705 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 11.3 mt -91.04 15.0 12.43 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.988 1.315 . . . . 64.41 111.474 -176.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 145.25 -110.46 0.55 Allowed Glycine 0 C--N 1.351 1.377 0 N-CA-C 110.026 -1.229 . . . . 44.23 110.026 -177.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -88.74 -27.25 21.3 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.523 0.729 . . . . 72.34 109.088 169.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -74.55 119.47 18.79 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 124.438 1.095 . . . . 74.21 109.492 175.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 53.4 m -84.29 124.41 31.22 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.994 -0.743 . . . . 75.31 108.994 169.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.851 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -70.07 -54.86 11.24 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.462 0.705 . . . . 52.03 109.457 176.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -163.85 163.24 23.86 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.101 -0.954 . . . . 73.04 110.906 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.41 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.5 tm? -126.94 141.25 51.85 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 106.635 -1.617 . . . . 64.11 106.635 167.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.45 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.9 t -141.17 150.72 43.12 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.976 -0.749 . . . . 52.03 108.976 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -158.18 136.45 10.89 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.321 0.648 . . . . 65.33 109.853 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -135.82 114.21 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 124.496 1.118 . . . . 64.1 108.201 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.415 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 68.7 mt-30 -94.19 88.25 5.54 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.562 -0.903 . . . . 74.5 108.562 173.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -81.01 95.51 6.83 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.243 -0.89 . . . . 75.22 109.743 -176.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -83.58 149.1 25.53 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 116.016 -0.538 . . . . 31.25 112.23 178.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.08 125.49 1.79 Allowed Glycine 0 CA--C 1.505 -0.586 0 N-CA-C 111.143 -0.783 . . . . 71.44 111.143 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.581 HD11 ' HB3' ' D' ' 29' ' ' PRO . 26.4 mm -85.29 130.8 35.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.893 0 N-CA-C 108.475 -0.935 . . . . 64.15 108.475 175.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -135.75 118.76 16.38 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.474 0.71 . . . . 74.23 109.977 -178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 64.7 m -76.87 102.44 6.34 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.898 -0.778 . . . . 64.53 108.898 171.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.632 HG21 ' HE1' ' C' ' 94' ' ' MET . 22.3 mt -116.95 137.87 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 108.69 -0.855 . . . . 74.12 108.69 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -145.44 169.82 17.59 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.355 0.662 . . . . 64.52 109.309 176.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . 0.543 ' HA3' ' H ' ' C' ' 9' ' ' MET . . . 91.62 -15.5 61.37 Favored Glycine 0 C--N 1.343 0.936 0 N-CA-C 114.881 0.713 . . . . 75.11 114.881 169.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.449 HD11 ' HE1' ' C' ' 94' ' ' MET . 27.6 pt -117.14 169.66 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-N 117.762 0.781 . . . . 74.02 111.561 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -159.97 152.03 20.51 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.289 -0.869 . . . . 73.11 109.995 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.67 -126.86 9.28 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 123.524 0.515 . . . . 70.44 113.345 172.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 35.5 p -67.37 -26.01 66.25 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.129 0.971 . . . . 61.54 111.828 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -65.57 -52.92 48.7 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.692 0.797 . . . . 70.31 109.711 174.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.632 ' HE1' HG21 ' C' ' 86' ' ' ILE . 5.5 tpt -54.14 -48.7 70.55 Favored 'General case' 0 C--N 1.353 0.72 0 CA-C-N 114.916 -1.038 . . . . 73.2 112.096 172.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.8 -38.84 83.07 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.313 0.645 . . . . 61.22 111.181 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -68.05 -34.23 76.06 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.257 -0.883 . . . . 74.32 111.342 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.448 ' SG ' HD13 ' C' ' 86' ' ' ILE . 33.7 t -72.86 -42.08 64.08 Favored 'General case' 0 C--N 1.347 0.488 0 N-CA-C 109.392 -0.595 . . . . 74.22 109.392 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 92.3 mt -77.46 -28.79 52.47 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.959 0.904 . . . . 63.25 112.518 -175.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -114.44 11.1 21.73 Favored Glycine 0 N--CA 1.477 1.423 0 CA-C-O 119.597 -0.557 . . . . 55.25 114.27 -170.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.22 -55.05 0.12 Allowed 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 117.52 0.66 . . . . 55.44 111.846 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -70.4 -55.25 9.53 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.061 0.544 . . . . 73.32 111.705 -173.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.525 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 50.3 m -68.31 -43.92 34.63 Favored Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 123.764 0.826 . . . . 70.25 112.454 -176.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.454 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 72.6 Cg_exo -55.62 -27.58 61.15 Favored 'Trans proline' 0 C--N 1.399 3.188 0 C-N-CA 122.402 2.068 . . . . 71.13 114.182 172.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -67.67 -35.42 78.82 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.328 0.651 . . . . 72.1 110.75 176.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.463 HD12 ' NH1' ' A' ' 111' ' ' ARG . 49.7 mm -75.71 -32.42 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.358 0.663 . . . . 74.43 110.212 177.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 79.8 mt -76.75 -28.79 55.86 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.867 0.867 . . . . 54.24 111.79 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -56.78 -48.78 96.69 Favored Pre-proline 0 N--CA 1.482 1.175 0 N-CA-C 114.458 1.281 . . . . 71.13 114.458 -173.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -57.63 -38.69 92.64 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 121.895 1.73 . . . . 73.0 113.119 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -67.54 -43.56 80.41 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.832 0.853 . . . . 74.14 110.671 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.402 ' O ' HG13 ' C' ' 114' ' ' ILE . . . -65.22 -39.6 92.98 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.548 -0.751 . . . . 75.24 110.338 176.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -59.65 -49.89 75.97 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.205 1.402 . . . . 73.43 110.527 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.74 -37.8 88.83 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 123.944 0.778 . . . . 75.42 109.727 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.7 t -69.54 -33.13 72.35 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.176 0.59 . . . . 72.43 111.593 -176.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.509 HD11 ' HB ' ' C' ' 62' ' ' VAL . 88.2 mt -71.98 -51.91 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 123.236 0.614 . . . . 53.03 109.54 176.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.2 m -67.24 -29.23 68.81 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 123.695 0.622 . . . . 75.42 111.193 -175.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 48.3 t -63.47 -46.53 85.8 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.523 0.729 . . . . 74.34 109.077 172.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.532 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.53 -35.46 81.03 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.018 0.927 . . . . 62.53 112.32 178.105 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' C' ' 123' ' ' PHE . 95.4 t -68.85 -36.63 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.346 0.658 . . . . 53.21 109.71 174.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.0 t -71.13 -32.31 68.83 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.18 0.992 . . . . 64.43 111.447 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' C' ' 116' ' ' SER . 81.2 mtt-85 -73.3 -39.19 65.52 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.17 -0.678 . . . . 53.04 109.17 177.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.49 -3.72 78.59 Favored Glycine 0 C--N 1.353 1.488 0 O-C-N 123.928 0.767 . . . . 51.33 112.663 172.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 25.7 p 63.11 28.66 16.11 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 126.797 2.039 . . . . 64.55 113.627 170.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.427 ' HB2' HG13 ' C' ' 118' ' ' VAL . 94.8 m-85 -82.62 161.22 59.58 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.663 0.785 . . . . 72.33 109.077 169.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.402 ' HG3' HG21 ' F' ' 129' ' ' THR . 78.4 Cg_exo -51.91 140.94 47.51 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.815 2.343 . . . . 74.51 112.817 172.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -55.35 109.17 0.5 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.312 1.045 . . . . 71.11 112.323 -175.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 56.4 tp -112.02 88.43 2.81 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.318 -0.623 . . . . 71.0 109.318 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -90.54 123.04 33.89 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.783 -0.821 . . . . 73.24 108.783 177.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.67 140.55 51.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.659 0.784 . . . . 73.51 110.781 -176.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.528 ' HB2' HG12 ' F' ' 135' ' ' VAL . . . -76.95 155.17 82.91 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 115.33 -0.85 . . . . 71.24 111.058 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.658 ' HG2' HG21 ' A' ' 13' ' ' ILE . 39.6 Cg_exo -55.55 106.99 0.21 Allowed 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.995 2.463 . . . . 61.43 112.132 173.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 18.3 t -99.6 120.59 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 108.361 -0.977 . . . . 74.33 108.361 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.406 ' O ' ' HG ' ' C' ' 136' ' ' LEU . 56.5 t-20 -79.53 100.9 7.96 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.82 0.848 . . . . 75.55 109.751 -176.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.459 ' CE1' HD13 ' C' ' 44' ' ' LEU . 93.6 m-85 -66.47 -29.13 69.19 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.826 0.85 . . . . 63.24 112.48 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -64.28 -42.79 96.25 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.341 0.657 . . . . 65.22 109.605 176.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.42 -36.38 81.15 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.229 -0.896 . . . . 75.4 110.858 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.487 ' HA ' HD21 ' C' ' 139' ' ' ASN . 54.0 mt -66.63 -38.9 87.88 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.902 0.481 . . . . 73.45 110.779 177.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -73.69 -26.99 60.99 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.367 -0.833 . . . . 65.14 110.41 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 47.2 ttm -66.07 -48.78 69.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.039 0.936 . . . . 61.22 110.651 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . 0.487 HD21 ' HA ' ' C' ' 136' ' ' LEU . 10.9 p30 -71.36 -34.37 70.41 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 116.287 -0.415 . . . . 64.21 110.907 176.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -71.7 -155.72 0.03 OUTLIER 'General case' 0 CA--C 1.579 2.083 0 C-N-CA 123.316 0.646 . . . . 74.23 109.679 169.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.521 ' HG ' ' H ' ' C' ' 143' ' ' GLN . 22.0 tp 65.26 161.3 0.13 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 124.791 1.237 . . . . 71.24 111.034 179.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -131.48 16.18 4.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.049 -1.032 . . . . 41.45 111.078 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . 0.521 ' H ' ' HG ' ' C' ' 141' ' ' LEU . 4.6 tp60 -155.21 -157.74 0.77 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 108.908 -0.775 . . . . 72.5 108.908 -172.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -149.12 171.37 16.53 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.457 0.703 . . . . 53.02 110.023 175.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -127.23 145.18 50.86 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.291 1.036 . . . . 61.42 109.368 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -167.24 74.17 0.14 Allowed Glycine 0 C--N 1.342 0.887 0 N-CA-C 111.118 -0.793 . . . . 55.43 111.118 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -152.73 91.69 1.58 Allowed 'General case' 0 C--O 1.24 0.59 0 N-CA-C 109.11 -0.7 . . . . 63.5 109.11 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -91.66 130.89 10.51 Favored Glycine 0 C--N 1.344 1.024 0 N-CA-C 111.077 -0.809 . . . . 61.32 111.077 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 2.3 t -151.48 128.84 11.29 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.568 0.747 . . . . 75.32 110.03 -174.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -138.46 70.45 1.38 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.337 0.655 . . . . 74.02 110.678 -171.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -159.73 148.29 17.5 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.583 0.353 . . . . 74.04 111.438 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -170.86 31.02 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.03 1.332 . . . . 74.24 109.982 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -67.19 97.98 0.57 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.553 0.741 . . . . 72.45 110.829 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -94.11 124.73 38.31 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.473 -0.936 . . . . 70.01 108.473 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.185 0 C-N-CA 123.562 0.745 . . . . 54.3 109.458 -175.124 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mmt . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 110.152 -0.314 . . . . 74.45 110.152 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 68.4 p -78.54 73.57 5.09 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.483 0.713 . . . . 73.3 109.397 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -74.55 147.69 41.54 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.989 0.915 . . . . 63.45 111.703 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -158.2 129.9 6.74 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.721 0.808 . . . . 70.24 109.921 -176.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -143.49 144.39 31.96 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.272 1.029 . . . . 73.22 109.465 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -76.37 111.89 12.3 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.376 0.67 . . . . 53.42 110.303 -177.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 13.3 p -137.29 156.07 48.7 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.406 1.082 . . . . 62.11 109.326 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -74.31 176.64 6.51 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 109.454 -0.573 . . . . 74.2 109.454 175.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 18.3 121.13 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 127.179 2.192 . . . . 70.32 115.853 -165.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -139.09 150.76 46.08 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.731 -0.668 . . . . 63.34 110.855 -175.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.438 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 69.8 t80 -138.91 106.3 5.54 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 106.418 -1.697 . . . . 74.45 106.418 175.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . 0.483 ' HB2' ' OG ' ' D' ' 85' ' ' SER . 41.9 mt-30 -119.6 116.89 26.94 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.409 -0.589 . . . . 65.33 109.409 -175.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.556 HG21 HD11 ' D' ' 16' ' ' ILE . 63.1 mt -78.94 118.77 26.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.29 -1.004 . . . . 53.43 108.29 174.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.486 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 8.5 mm-40 -95.84 -39.71 9.69 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.433 0.293 . . . . 62.11 110.474 -174.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 26.6 ttt180 -173.36 137.87 0.68 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.699 0.4 . . . . 74.33 110.166 -176.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.556 HD11 HG21 ' D' ' 13' ' ' ILE . 3.5 mp -115.09 142.4 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 107.195 -1.409 . . . . 65.11 107.195 172.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -163.12 147.27 11.08 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.305 0.642 . . . . 61.23 110.866 175.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.6 p -82.59 114.39 20.95 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.059 -0.973 . . . . 74.33 109.39 175.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -87.24 -15.76 37.23 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.919 0.888 . . . . 64.34 109.634 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.675 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.9 t70 -163.34 130.85 3.54 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.81 1.244 . . . . 63.23 109.081 -177.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.532 HG21 ' HE2' ' C' ' 117' ' ' MET . 76.2 mt -134.56 142.86 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.225 -1.028 . . . . 72.51 108.225 173.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.9 t -143.17 137.25 28.91 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.502 1.121 . . . . 54.33 108.556 172.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.507 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.1 t80 -135.44 121.44 19.96 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.134 -1.802 . . . . 75.23 106.134 166.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 40.5 mt-10 -127.08 110.49 12.98 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.662 0.785 . . . . 73.35 109.054 -177.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.99 89.14 3.45 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 107.761 -1.199 . . . . 40.42 107.761 171.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -71.46 -37.74 5.28 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.596 2.197 . . . . 71.0 112.314 -174.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -99.44 4.55 46.19 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.085 0.954 . . . . 74.42 110.367 -174.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.404 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -25.14 -70.22 0.05 OUTLIER Pre-proline 0 CA--C 1.564 1.514 0 C-N-CA 127.471 2.309 . . . . 74.24 116.62 -166.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.581 ' HB3' HD11 ' C' ' 83' ' ' ILE . 76.7 Cg_endo -76.99 -19.76 13.58 Favored 'Trans proline' 0 C--N 1.382 2.291 0 CA-C-N 123.293 2.212 . . . . 72.43 113.95 -171.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -78.56 -38.55 40.05 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.274 1.03 . . . . 72.24 109.922 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.746 HG21 ' HA ' ' D' ' 73' ' ' ALA . 11.1 p -82.8 -19.53 10.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 CA-C-N 115.61 -0.723 . . . . 65.24 111.574 -171.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -62.9 -23.39 67.33 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 112.558 0.577 . . . . 74.44 112.558 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -57.1 -31.1 64.92 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.346 1.058 . . . . 74.54 110.668 177.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -84.92 78.93 9.8 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.905 1.282 . . . . 71.21 110.047 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -79.87 83.79 5.75 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 121.684 0.754 . . . . 70.44 110.698 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -157.77 -179.08 7.81 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.508 -0.923 . . . . 73.41 108.508 167.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -64.02 114.48 13.89 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 123.771 0.828 . . . . 71.34 110.693 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.434 ' O ' HG23 ' D' ' 40' ' ' VAL . 60.5 Cg_exo -56.46 122.69 12.24 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 121.897 1.732 . . . . 72.34 110.677 171.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -66.43 110.58 3.17 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 107.391 -1.337 . . . . 74.34 107.391 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.728 HG21 HD13 ' D' ' 126' ' ' LEU . 85.2 t -100.82 136.71 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.987 0.915 . . . . 74.54 110.845 -170.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -111.0 119.34 38.73 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.507 -0.923 . . . . 60.31 108.507 167.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 63.2 tp -96.94 143.23 28.01 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.194 -0.669 . . . . 73.2 109.194 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.669 ' HA ' HD22 ' E' ' 112' ' ' ASN . 31.5 t70 -142.15 144.14 33.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.041 -0.981 . . . . 61.12 108.575 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.71 ' HB2' ' HB3' ' E' ' 111' ' ' LEU . 72.8 mt -134.65 133.89 40.58 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.393 -0.965 . . . . 65.43 108.393 -177.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 16.4 t70 -134.04 151.18 51.32 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.847 1.259 . . . . 70.13 107.764 177.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.22 163.58 14.19 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.506 0.67 . . . . 72.43 111.396 -175.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -167.25 147.7 5.48 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 113.84 -1.527 . . . . 75.43 107.382 169.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 29.0 p -161.36 147.47 14.26 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.835 -0.431 . . . . 54.45 109.835 171.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.567 ' HA ' HD21 ' E' ' 102' ' ' LEU . 35.4 p -177.88 128.99 0.14 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.441 0.696 . . . . 74.4 110.233 -176.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . 0.524 ' HB2' ' H ' ' D' ' 57' ' ' GLU . 10.7 tm0? -160.76 -85.46 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 106.736 -1.579 . . . . 62.34 106.736 171.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.411 ' H ' ' HB3' ' D' ' 50' ' ' GLN . 80.0 mt -138.15 -160.36 1.05 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.962 1.305 . . . . 71.15 107.545 170.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.536 ' HA ' ' HE2' ' D' ' 56' ' ' TYR . . . -133.38 78.45 1.78 Allowed 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.566 -0.902 . . . . 55.12 108.566 170.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -163.97 50.58 0.14 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.646 -0.706 . . . . 73.33 109.496 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' D' ' 85' ' ' SER . 0.0 OUTLIER 72.88 -6.05 1.76 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 126.2 1.8 . . . . 61.2 113.419 177.126 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 60.7 t -110.96 105.52 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 108.869 -0.789 . . . . 64.43 108.869 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.536 ' HE2' ' HA ' ' D' ' 52' ' ' ALA . 47.0 m-85 -132.19 131.62 42.37 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.228 0.611 . . . . 74.44 110.478 -174.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.699 ' HG2' HG13 ' D' ' 83' ' ' ILE . 53.4 mt-10 -90.11 111.68 22.89 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.897 -0.779 . . . . 73.34 108.897 168.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 84.1 t -100.85 135.91 34.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 O-C-N 124.112 0.882 . . . . 73.3 109.379 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.527 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 47.2 t -122.78 133.96 67.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.033 1.333 . . . . 54.24 108.199 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.475 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -113.82 117.44 31.45 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.506 -1.294 . . . . 70.41 107.506 174.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.416 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 50.0 ttm-85 -93.87 95.02 8.83 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.419 -1.326 . . . . 70.11 107.419 174.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 49.0 t -91.11 144.13 9.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.44 -0.948 . . . . 72.33 108.44 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 36.0 m -139.87 141.25 36.61 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.036 -0.727 . . . . 62.13 109.036 -176.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.644 HG13 HG13 ' D' ' 40' ' ' VAL . 50.5 t -132.97 128.66 56.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 124.465 1.106 . . . . 75.14 108.49 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 56.6 m -125.01 93.37 3.87 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.371 -1.344 . . . . 65.4 107.371 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -95.71 154.59 17.14 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.941 -0.763 . . . . 74.42 108.941 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 28.7 p -153.37 132.56 12.67 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 123.331 0.394 . . . . 75.1 110.878 -173.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.496 HD12 HG22 ' D' ' 31' ' ' VAL . 52.1 mt -105.42 112.42 25.52 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.167 -1.049 . . . . 73.21 108.167 174.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.88 -133.42 15.3 Favored Glycine 0 C--N 1.345 1.057 0 O-C-N 123.38 0.425 . . . . 74.34 112.563 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.77 2.5 56.72 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.969 0.507 . . . . 75.4 111.758 -178.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -123.3 160.89 25.73 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.207 0.603 . . . . 74.54 110.528 -176.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 94.6 m -64.59 140.51 58.87 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.108 0.963 . . . . 72.34 110.992 175.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.746 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -92.33 -62.49 1.39 Allowed 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.855 -1.165 . . . . 74.14 107.855 172.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.84 165.78 35.55 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 114.347 -1.297 . . . . 64.14 109.937 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 87.5 mt -132.32 153.02 51.14 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.616 1.566 . . . . 54.35 107.257 -179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.652 ' SG ' HG12 ' D' ' 114' ' ' ILE . 53.0 t -158.61 145.1 17.2 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.747 0.419 . . . . 52.13 110.168 -177.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -154.54 126.8 7.84 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 123.103 0.561 . . . . 73.11 110.168 172.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 95.3 t -128.76 116.69 42.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 124.033 0.933 . . . . 75.1 109.059 -178.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.675 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.5 mt-30 -87.98 86.32 7.11 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.899 0.857 . . . . 64.53 108.863 168.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -82.46 97.9 8.63 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 113.831 -1.531 . . . . 73.11 109.394 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -96.2 166.62 24.58 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-N 116.48 -0.327 . . . . 60.11 112.706 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -177.7 153.26 12.97 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-O 119.837 -0.424 . . . . 63.22 112.783 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.699 HG13 ' HG2' ' D' ' 57' ' ' GLU . 3.0 mp -94.24 128.6 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 108.083 -1.08 . . . . 71.13 108.083 176.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -131.35 124.59 30.7 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.165 -1.05 . . . . 73.42 108.165 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' D' ' 54' ' ' ASP . 51.4 p -95.92 126.43 41.17 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 109.06 -0.719 . . . . 75.12 109.06 174.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.415 HG13 HD11 ' E' ' 97' ' ' ILE . 31.2 pt -133.61 129.39 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.452 -0.944 . . . . 74.43 108.452 -170.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.07 167.93 28.98 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.263 0.225 . . . . 63.1 111.18 -171.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.03 23.43 71.77 Favored Glycine 0 C--N 1.353 1.485 0 O-C-N 124.122 0.888 . . . . 74.02 114.484 171.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.673 HD13 ' HA ' ' D' ' 94' ' ' MET . 0.7 OUTLIER -133.54 155.45 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 123.158 0.583 . . . . 70.54 110.593 177.637 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.33 177.19 8.1 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.824 -1.08 . . . . 73.22 109.506 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.79 -140.78 25.49 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 123.29 0.368 . . . . 42.12 113.108 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 81.8 p -77.32 -43.09 34.3 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.772 0.829 . . . . 50.34 111.107 -175.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -57.96 -33.36 68.76 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.34 1.056 . . . . 74.21 111.771 -177.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.673 ' HA ' HD13 ' D' ' 89' ' ' ILE . 1.6 tmt? -47.56 -60.66 2.38 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.522 1.529 . . . . 74.44 112.729 -176.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.15 -15.7 46.19 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.204 0.601 . . . . 60.11 112.034 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -76.95 -17.52 58.85 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 122.859 0.464 . . . . 71.24 111.895 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 71.5 m -60.7 -44.26 96.77 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.586 0.354 . . . . 75.44 111.135 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.504 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 4.3 pp -79.27 -30.35 43.0 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.1 0.56 . . . . 75.25 111.816 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.55 -29.09 25.24 Favored Glycine 0 C--N 1.35 1.335 0 O-C-N 123.247 0.342 . . . . 55.44 113.669 -172.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.42 -57.12 2.02 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.447 0.699 . . . . 61.11 111.336 -171.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -72.87 -38.96 66.83 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 112.225 0.454 . . . . 61.4 112.225 -171.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.504 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 72.1 m -66.97 -46.1 53.58 Favored Pre-proline 0 CA--C 1.567 1.609 0 CA-C-O 118.679 -0.677 . . . . 71.44 111.937 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.475 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.4 Cg_exo -59.54 -32.0 95.46 Favored 'Trans proline' 0 C--N 1.393 2.913 0 C-N-CA 122.016 1.81 . . . . 73.51 112.911 169.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -64.63 -29.02 70.02 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.076 0.55 . . . . 71.22 111.125 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.407 ' O ' ' HD2' ' D' ' 108' ' ' PRO . 46.2 mm -78.23 -33.86 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 123.812 0.845 . . . . 73.1 110.786 174.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 65.3 mt -74.63 -18.79 60.49 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.24 0.616 . . . . 74.13 111.752 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -66.28 -45.81 60.63 Favored Pre-proline 0 CA--C 1.559 1.315 0 CA-C-O 118.195 -0.907 . . . . 75.31 113.306 -176.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' D' ' 105' ' ' ILE . 81.7 Cg_exo -52.37 -42.57 59.95 Favored 'Trans proline' 0 C--N 1.387 2.555 0 C-N-CA 122.371 2.047 . . . . 72.32 114.323 171.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -71.99 -40.44 68.55 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.554 0.742 . . . . 70.35 111.49 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.03 -44.72 91.71 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.623 -0.717 . . . . 73.55 109.912 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.522 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 27.3 ttp180 -57.72 -49.1 77.66 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.74 1.275 . . . . 70.41 110.311 178.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -58.71 -49.02 79.12 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 124.373 1.045 . . . . 74.34 110.45 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 43.1 t -57.26 -45.64 83.8 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 124.031 0.832 . . . . 54.01 111.186 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.652 HG12 ' SG ' ' D' ' 76' ' ' CYS . 89.0 mt -61.17 -55.94 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.772 0.829 . . . . 74.32 110.673 175.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 90.7 m -52.86 -42.3 65.1 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 124.764 1.226 . . . . 72.25 111.088 -174.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 29.9 t -66.69 -43.14 85.18 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.492 -1.231 . . . . 44.44 109.863 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.6 mtm -70.69 -26.93 63.65 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.056 0.543 . . . . 32.03 111.941 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.472 HG21 ' HB3' ' D' ' 126' ' ' LEU . 79.8 t -64.73 -47.75 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.384 0.674 . . . . 71.42 109.38 173.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.9 p -72.82 -28.94 62.86 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.569 -0.741 . . . . 75.01 110.559 -178.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' D' ' 116' ' ' SER . 76.4 mtt-85 -71.16 -27.17 63.34 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.757 0.823 . . . . 73.14 110.097 173.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.46 8.87 79.11 Favored Glycine 0 C--N 1.351 1.398 0 CA-C-O 119.354 -0.692 . . . . 34.24 112.615 174.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.404 HG23 ' HB3' ' C' ' 17' ' ' TYR . 69.7 p 55.88 40.81 30.54 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 125.781 1.632 . . . . 64.54 113.761 177.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -105.93 152.95 40.4 Favored Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 109.001 -0.74 . . . . 75.33 109.001 170.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -48.91 133.46 28.08 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 123.024 2.483 . . . . 73.4 112.141 171.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -55.78 128.6 35.7 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 124.308 1.005 . . . . 75.04 112.389 -170.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.728 HD13 HG21 ' D' ' 40' ' ' VAL . 14.2 tp -111.23 102.57 10.98 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.139 0.976 . . . . 70.41 108.973 -176.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -100.9 104.39 15.59 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.647 -1.242 . . . . 53.1 107.647 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.522 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.2 mm? -64.32 114.75 4.47 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.189 0.595 . . . . 75.4 109.806 -177.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.14 132.76 93.94 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 123.105 0.562 . . . . 75.34 111.023 -174.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -61.43 116.66 3.55 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.06 2.507 . . . . 73.32 112.357 -175.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . 0.426 HG11 HG23 ' E' ' 121' ' ' VAL . 7.2 p -110.54 136.1 47.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.69 0 N-CA-C 108.901 -0.777 . . . . 73.41 108.901 176.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -80.65 113.13 18.63 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.798 -0.816 . . . . 55.21 108.798 176.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -62.17 -40.02 94.63 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.027 0.931 . . . . 71.22 110.952 -177.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -51.59 -33.2 31.69 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.856 1.262 . . . . 73.21 112.481 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.26 -35.63 81.45 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.461 0.704 . . . . 32.43 111.572 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.534 ' HB3' ' HB1' ' E' ' 110' ' ' ALA . 2.5 mm? -75.33 -28.89 59.81 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.224 0.61 . . . . 74.25 111.389 178.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -75.54 -37.4 60.04 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.831 0.453 . . . . 73.31 110.649 175.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 73.7 mtm -71.43 -25.8 62.47 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.033 0.533 . . . . 73.35 110.297 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.518 ' O ' ' HG2' ' D' ' 143' ' ' GLN . 5.4 t30 -67.29 -43.93 80.5 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.267 0.627 . . . . 43.35 109.6 169.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . 0.458 ' HD1' ' HG2' ' E' ' 114' ' ' LYS . 90.2 t80 -57.94 -43.32 86.29 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.841 0.857 . . . . 74.31 111.938 -176.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.59 -35.46 81.07 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.927 -0.578 . . . . 61.22 111.355 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -91.36 30.72 1.24 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 122.978 0.511 . . . . 62.42 111.273 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . 0.518 ' HG2' ' O ' ' D' ' 139' ' ' ASN . 16.2 mm100 -118.22 52.29 1.03 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.266 1.026 . . . . 55.12 108.338 174.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -167.77 154.08 7.71 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-N 114.292 -1.322 . . . . 54.3 108.693 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.1 86.6 0.06 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.435 0.694 . . . . 61.44 110.218 174.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -164.63 40.86 0.3 Allowed Glycine 0 C--N 1.338 0.688 0 CA-C-N 114.987 -1.006 . . . . 73.33 111.075 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -89.18 161.37 16.49 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.907 0.883 . . . . 61.41 109.991 -178.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.49 75.72 0.66 Allowed Glycine 0 C--N 1.343 0.932 0 N-CA-C 110.76 -0.936 . . . . 54.3 110.76 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 3.3 t -141.33 100.58 3.82 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.999 0.92 . . . . 61.31 109.628 -176.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -170.33 149.42 3.39 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.332 1.053 . . . . 63.43 110.033 -176.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -143.89 89.46 2.05 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.084 0.953 . . . . 65.11 108.72 172.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -84.61 86.62 7.29 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.771 0.796 . . . . 73.35 109.133 170.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -136.99 111.96 8.94 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.557 0.743 . . . . 64.45 109.829 -176.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -132.57 158.81 41.23 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.316 1.046 . . . . 55.22 109.449 176.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.14 0 N-CA-C 108.671 -0.863 . . . . 74.1 108.671 177.486 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.948 0 N-CA-C 112.273 -0.331 . . . . 22.33 112.273 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.3 -87.84 0.5 Allowed Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.131 -0.788 . . . . 44.01 111.131 -172.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 93' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -172.76 173.89 3.77 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.959 1.304 . . . . 64.23 109.835 179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 94' ' ' PHE . . . . . . . . . . . . . 51.3 t80 67.92 -72.04 0.1 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.903 1.681 . . . . 73.44 112.897 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 95' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm 77.21 106.28 0.08 Allowed 'General case' 0 C--N 1.363 1.181 0 C-N-CA 125.774 1.629 . . . . 70.54 109.452 -173.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 96' ' ' GLY . . . . . 0.489 ' H ' ' HB3' ' D' ' 54' ' ' ASP . . . -131.87 -69.28 0.09 OUTLIER Glycine 0 C--N 1.337 0.602 0 N-CA-C 111.566 -0.614 . . . . 60.13 111.566 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 97' ' ' ILE . . . . . 0.476 ' HB ' ' HE2' ' D' ' 94' ' ' MET . 34.9 pt -123.66 131.65 72.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.516 0.727 . . . . 75.45 109.333 177.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 98' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -122.32 -47.1 2.14 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.228 0.611 . . . . 75.35 111.391 -172.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 99' ' ' ALA . . . . . . . . . . . . . . . -80.14 79.77 6.65 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.331 0.586 . . . . 70.2 111.247 -173.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 100' ' ' LEU . . . . . . . . . . . . . 2.0 pp -140.83 150.31 59.31 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 124.343 1.057 . . . . 74.44 109.123 172.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 101' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.03 -3.33 13.11 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 122.487 2.125 . . . . 71.43 113.059 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 102' ' ' LEU . . . . . 0.567 HD21 ' HA ' ' D' ' 49' ' ' SER . 25.0 tp 61.48 27.24 16.83 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.342 1.057 . . . . 74.53 109.872 -178.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 103' ' ' THR . . . . . . . . . . . . . 17.3 p 49.17 36.9 9.84 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.385 1.474 . . . . 72.34 112.452 -175.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.7 24.33 67.65 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.626 -0.716 . . . . 74.14 113.494 176.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 105' ' ' GLN . . . . . 0.541 ' HG3' HD23 ' E' ' 102' ' ' LEU . 1.4 mp0 59.99 10.69 2.3 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 125.112 1.365 . . . . 64.01 113.378 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 106' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -150.29 -40.19 0.13 Allowed 'General case' 0 N--CA 1.472 0.652 0 O-C-N 122.104 -0.373 . . . . 72.12 110.294 -170.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 7.3 m 66.94 -78.42 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.272 1.029 . . . . 62.33 109.648 -176.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 108' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 76.1 -52.76 0.61 Allowed 'General case' 0 C--N 1.36 1.052 0 C-N-CA 126.016 1.726 . . . . 73.23 112.946 173.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 109' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -59.23 149.98 26.96 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.664 0.786 . . . . 73.05 112.602 -171.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . 0.534 ' HB1' ' HB3' ' D' ' 136' ' ' LEU . . . 70.07 -151.67 0.11 Allowed 'General case' 0 CA--C 1.554 1.108 0 O-C-N 124.429 1.08 . . . . 75.31 111.321 174.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . 0.71 ' HB3' ' HB2' ' D' ' 44' ' ' LEU . 7.1 mp 73.78 -1.51 3.04 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.652 1.581 . . . . 61.45 113.424 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 112' ' ' ASN . . . . . 0.669 HD22 ' HA ' ' D' ' 43' ' ' ASP . 20.6 t-20 -176.88 -58.0 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.644 1.178 . . . . 73.02 107.909 -177.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -103.97 -159.0 0.69 Allowed 'General case' 0 C--O 1.243 0.723 0 CA-C-N 114.062 -1.427 . . . . 71.5 109.599 -176.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . 0.458 ' HG2' ' HD1' ' D' ' 140' ' ' TYR . 49.1 tptt 65.45 38.61 5.56 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 122.435 1.112 . . . . 71.41 109.213 -175.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 115' ' ' THR . . . . . 0.469 ' HB ' HD21 ' D' ' 139' ' ' ASN . 9.0 t -164.42 -43.44 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.412 -1.267 . . . . 72.15 109.671 -177.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 116' ' ' GLY . . . . . . . . . . . . . . . 149.01 -96.06 0.17 Allowed Glycine 0 C--N 1.343 0.969 0 N-CA-C 110.518 -1.033 . . . . 51.43 110.518 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 117' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -92.83 157.22 39.87 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 123.774 0.829 . . . . 74.11 110.632 -172.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 118' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -83.6 17.27 1.71 Allowed 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.66 2.906 . . . . 73.53 113.045 172.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 119' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -60.31 -30.19 69.34 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.983 0.913 . . . . 75.14 112.573 -174.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 120' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -75.83 -54.83 6.3 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.013 0.525 . . . . 61.4 110.956 -177.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 121' ' ' VAL . . . . . 0.426 HG23 HG11 ' D' ' 131' ' ' VAL . 8.5 p -71.19 -39.79 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.356 0.662 . . . . 72.05 110.803 -177.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 33.7 m -99.63 78.98 2.2 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.377 1.071 . . . . 72.33 108.15 176.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 123' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -96.19 107.88 20.27 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 107.666 -1.235 . . . . 55.2 107.666 171.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 124' ' ' SER . . . . . . . . . . . . . 21.6 p -77.85 116.92 18.73 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.961 -0.563 . . . . 73.12 110.628 -174.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 125' ' ' ALA . . . . . . . . . . . . . . . -151.91 -161.09 1.25 Allowed 'General case' 0 C--O 1.246 0.918 0 C-N-CA 125.028 1.331 . . . . 71.41 107.891 172.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 126' ' ' ALA . . . . . . . . . . . . . . . 66.1 -178.24 0.19 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.845 0.858 . . . . 70.12 110.999 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 127' ' ' SER . . . . . . . . . . . . . 33.0 p -157.49 -74.75 0.09 Allowed 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 110.023 -0.362 . . . . 72.32 110.023 175.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 128' ' ' ALA . . . . . . . . . . . . . . . 56.03 27.37 11.22 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.969 0.907 . . . . 75.23 111.756 -175.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 129' ' ' THR . . . . . . . . . . . . . 24.1 p -79.84 89.93 5.27 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 124.294 1.038 . . . . 52.42 110.932 -173.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 130' ' ' ALA . . . . . . . . . . . . . . . -149.8 96.75 2.51 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.832 0.853 . . . . 62.22 108.918 176.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 131' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -149.36 98.3 2.77 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.902 0.881 . . . . 72.51 108.879 177.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 132' ' ' SER . . . . . 0.651 ' H ' ' HB3' ' A' ' 124' ' ' PRO . 32.5 t -174.88 103.08 0.09 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.108 1.363 . . . . 65.02 108.026 176.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 133' ' ' THR . . . . . . . . . . . . . 30.6 m -119.8 105.5 11.18 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.653 0.381 . . . . 50.4 110.739 -178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.23 87.21 1.0 Allowed Glycine 0 C--N 1.34 0.8 0 N-CA-C 109.653 -1.379 . . . . 71.01 109.653 167.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 135' ' ' VAL . . . . . . . . . . . . . 82.6 t -59.68 -56.99 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.553 0.741 . . . . 64.25 109.978 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 136' ' ' LYS . . . . . . . . . . . . . 93.4 mttt 65.9 -7.28 0.38 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.088 1.355 . . . . 64.5 113.96 172.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 137' ' ' THR . . . . . 0.665 HG22 ' H ' ' E' ' 139' ' ' ASN . 30.0 m 69.86 148.61 0.07 Allowed 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 124.956 1.303 . . . . 63.11 111.039 -168.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 138' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -55.08 -34.99 64.09 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.55 0.69 . . . . 71.12 110.181 171.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 139' ' ' ASN . . . . . 0.665 ' H ' HG22 ' E' ' 137' ' ' THR . 24.7 t-20 -91.31 85.29 5.78 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 107.808 -1.182 . . . . 63.31 107.808 167.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 140' ' ' GLY . . . . . . . . . . . . . . . -66.57 138.36 35.77 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 115.323 -0.853 . . . . 41.21 112.934 -174.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.89 141.32 58.81 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.237 0.615 . . . . 63.12 111.094 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 142' ' ' LEU . . . . . . . . . . . . . 89.9 mt -59.89 137.43 58.07 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.365 0.666 . . . . 64.41 110.778 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 143' ' ' GLY . . . . . . . . . . . . . . . -72.65 74.2 0.93 Allowed Glycine 0 C--N 1.348 1.235 0 O-C-N 123.946 0.779 . . . . 53.21 112.001 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 144' ' ' VAL . . . . . . . . . . . . . 13.0 m -88.83 84.69 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.191 0.996 . . . . 70.23 110.003 -174.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 145' ' ' ASP . . . . . . . . . . . . . 16.1 t70 . . . . . 0 C--O 1.252 1.199 0 N-CA-C 108.25 -1.019 . . . . 64.22 108.25 -175.263 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.796 0 N-CA-C 112.079 -0.408 . . . . 62.3 112.079 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.26 -53.92 40.62 Favored Glycine 0 C--N 1.355 1.603 0 N-CA-C 114.146 0.418 . . . . 53.34 114.146 -172.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 93' ' ' PHE . . . . . 0.489 ' HD2' HG21 ' B' ' 55' ' ' VAL . 86.6 m-85 -70.73 97.52 1.38 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.799 0.84 . . . . 64.41 110.671 -178.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 94' ' ' PHE . . . . . 0.42 ' CD2' HG21 ' B' ' 10' ' ' THR . 70.4 t80 -95.18 160.42 14.56 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.453 0.701 . . . . 71.01 109.381 175.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 95' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -136.3 149.84 48.62 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.179 0.592 . . . . 54.32 112.451 -173.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.72 51.35 0.01 OUTLIER Glycine 0 C--N 1.351 1.413 0 CA-C-N 115.443 -0.799 . . . . 73.15 112.309 174.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 97' ' ' ILE . . . . . 0.505 ' HB ' ' HA ' ' B' ' 87' ' ' ALA . 7.2 tt -152.48 -20.37 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 124.502 1.121 . . . . 64.54 109.828 -177.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 98' ' ' ASP . . . . . 0.428 ' H ' ' H ' ' F' ' 97' ' ' ILE . 33.6 t70 65.93 -96.33 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.891 1.676 . . . . 53.03 112.009 177.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 99' ' ' ALA . . . . . . . . . . . . . . . -98.78 144.13 28.35 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.635 0.774 . . . . 72.4 109.951 -172.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 100' ' ' LEU . . . . . . . . . . . . . 3.0 mp -128.19 86.17 58.65 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 123.198 0.599 . . . . 73.25 109.726 -177.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 101' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.92 -61.36 0.25 Allowed 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.632 2.221 . . . . 72.21 112.141 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 102' ' ' LEU . . . . . 0.414 HD23 ' HB1' ' B' ' 95' ' ' ALA . 2.2 tm? 56.55 94.53 0.02 OUTLIER 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.908 1.283 . . . . 72.34 109.824 -173.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 103' ' ' THR . . . . . . . . . . . . . 32.0 p 66.14 -63.69 0.23 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.384 1.874 . . . . 60.45 111.752 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 104' ' ' GLY . . . . . . . . . . . . . . . 178.17 -38.46 0.08 OUTLIER Glycine 0 C--N 1.339 0.731 0 N-CA-C 110.959 -0.856 . . . . 63.12 110.959 173.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 105' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -170.97 -51.68 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.222 1.009 . . . . 72.54 109.493 -175.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 106' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -131.21 118.57 20.61 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.694 0.797 . . . . 74.11 109.384 -174.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 27.9 m -64.81 121.28 14.22 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.734 0.814 . . . . 74.33 110.656 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 108' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -128.31 7.46 5.92 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.533 0.733 . . . . 72.3 110.795 -177.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 109' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -82.15 73.11 9.2 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.723 0.809 . . . . 75.33 109.53 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 60.31 -167.92 0.17 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.179 0.992 . . . . 75.31 110.031 -170.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 86.2 mt 53.6 74.2 0.33 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.666 0.787 . . . . 72.41 111.204 176.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 112' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -160.07 -64.0 0.07 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.477 -0.783 . . . . 64.15 109.961 -171.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 113' ' ' LYS . . . . . 0.564 ' HE3' ' HB ' ' F' ' 115' ' ' THR . 54.3 pttt -175.3 -165.76 0.19 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.065 0.946 . . . . 73.34 110.187 -172.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . 0.578 ' HD3' ' HE2' ' B' ' 41' ' ' LYS . 53.7 mtmt -93.12 31.23 1.48 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.795 0.838 . . . . 64.02 111.322 178.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 115' ' ' THR . . . . . 0.564 ' HB ' ' HE3' ' F' ' 113' ' ' LYS . 57.4 m -130.43 148.62 52.26 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.464 1.106 . . . . 62.21 108.881 175.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.46 -136.07 13.12 Favored Glycine 0 C--N 1.341 0.859 0 N-CA-C 110.61 -0.996 . . . . 24.21 110.61 -175.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 117' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -128.24 84.14 64.1 Favored Pre-proline 0 CA--C 1.551 1.004 0 CA-C-N 117.392 0.596 . . . . 73.01 110.123 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 118' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -90.75 112.54 0.4 Allowed 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 123.914 3.076 . . . . 72.4 110.378 172.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 119' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -125.19 171.57 10.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.408 0.683 . . . . 62.33 110.658 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 120' ' ' TYR . . . . . 0.402 ' HB3' ' HG ' ' B' ' 136' ' ' LEU . 28.6 t80 74.58 -70.59 0.15 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.541 1.536 . . . . 74.22 110.966 175.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 121' ' ' VAL . . . . . . . . . . . . . 99.7 t -129.45 114.21 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 123.466 0.706 . . . . 73.42 109.325 175.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 14.8 t -169.61 20.53 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.564 0.746 . . . . 72.54 110.361 176.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 123' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -123.16 -173.0 2.62 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.382 0.673 . . . . 62.03 111.353 -165.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 124' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' B' ' 41' ' ' LYS . 28.1 t -83.37 140.72 32.24 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 115.172 -0.922 . . . . 71.23 109.531 170.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 125' ' ' ALA . . . . . . . . . . . . . . . -163.74 -34.52 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.604 0.762 . . . . 64.03 110.212 -176.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 126' ' ' ALA . . . . . 0.589 ' HB3' ' HB ' ' B' ' 40' ' ' VAL . . . -62.9 108.97 1.31 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.519 0.728 . . . . 52.04 111.626 -175.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 127' ' ' SER . . . . . . . . . . . . . 15.5 p -147.63 62.98 1.14 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.703 1.201 . . . . 61.14 108.381 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.84 -84.06 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.86 -1.064 . . . . 64.14 110.823 -173.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 129' ' ' THR . . . . . 0.402 HG21 ' HG3' ' C' ' 124' ' ' PRO . 14.8 m -154.71 140.36 17.98 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.803 0.441 . . . . 71.24 110.166 -178.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 130' ' ' ALA . . . . . . . . . . . . . . . -70.99 167.29 19.5 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.384 1.074 . . . . 62.34 112.144 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 131' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -137.11 132.72 34.46 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.826 0.85 . . . . 64.13 108.85 176.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 132' ' ' SER . . . . . . . . . . . . . 21.3 t -162.16 76.8 0.48 Allowed 'General case' 0 C--O 1.238 0.49 0 O-C-N 123.957 0.786 . . . . 75.15 109.122 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 133' ' ' THR . . . . . . . . . . . . . 53.8 m -146.98 120.05 8.81 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.883 -0.784 . . . . 75.42 108.883 177.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.49 83.7 1.11 Allowed Glycine 0 C--N 1.348 1.227 0 N-CA-C 111.694 -0.563 . . . . 52.51 111.694 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 135' ' ' VAL . . . . . 0.528 HG12 ' HB2' ' C' ' 129' ' ' ALA . 21.7 t -73.85 86.44 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 N-CA-C 108.31 -0.996 . . . . 74.32 108.31 176.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 136' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -107.88 106.08 16.19 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.593 1.157 . . . . 62.04 109.728 -173.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 137' ' ' THR . . . . . . . . . . . . . 82.2 p 51.82 -80.61 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 126.602 1.961 . . . . 72.25 112.937 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 138' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -156.66 133.86 10.54 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.346 1.058 . . . . 54.22 109.326 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 139' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -178.36 -62.43 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 124.083 0.953 . . . . 72.44 109.309 174.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 140' ' ' GLY . . . . . . . . . . . . . . . 74.7 -91.4 0.77 Allowed Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.136 -0.938 . . . . 44.21 112.197 -175.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 141' ' ' ALA . . . . . . . . . . . . . . . -171.82 167.1 6.41 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.64 1.176 . . . . 42.34 109.363 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 142' ' ' LEU . . . . . . . . . . . . . 4.7 pp -79.22 138.2 37.73 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 107.908 -1.145 . . . . 63.22 107.908 169.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 143' ' ' GLY . . . . . . . . . . . . . . . -78.93 170.19 54.57 Favored Glycine 0 C--N 1.342 0.885 0 O-C-N 123.229 0.33 . . . . 63.25 112.92 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 144' ' ' VAL . . . . . . . . . . . . . 40.9 t -69.11 -52.73 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 108.33 -0.989 . . . . 65.35 108.33 175.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 145' ' ' ASP . . . . . . . . . . . . . 31.2 t70 . . . . . 0 C--O 1.247 0.937 0 CA-C-N 114.401 -1.272 . . . . 71.43 108.841 173.047 . . . . . . . . 0 0 . 1 stop_ save_